id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
33388836|NCT00225212|101313532|FG000|Overall Study|Disease progression|2|||
33388837|NCT00225212|101313532|FG000|Overall Study|Death|1|||
33388838|NCT00225212|101313532|FG000|Overall Study|Adverse Event|2|||
33492535|NCT03597295|101697990|FG000|Overall Study|Death|70|||
33182970|NCT04327999|100582772|FG000|Overall Study|Protocol Violation|1|||
33492536|NCT03597295|101697990|FG000|Overall Study|Lost to Follow-up|7|||
33492537|NCT00652340|101697992|FG000|Overall Study|Had not progressed.|4|||
33492538|NCT00652340|101697993|FG001|Overall Study|Had not progressed.|3|||
33492539|NCT00124748|101697994|FG000|Overall Study|Adverse Event|8|||
33492540|NCT00124748|101697995|FG001|Overall Study|Adverse Event|39|||
33492541|NCT00124748|101697994|FG000|Overall Study|Abnormal laboratory Value|2|||
33492542|NCT00124748|101697995|FG001|Overall Study|Abnormal laboratory Value|2|||
33492543|NCT00124748|101697994|FG000|Overall Study|Abnormal Procedure|0|||
33492544|NCT00124748|101697995|FG001|Overall Study|Abnormal Procedure|1|||
33492545|NCT00124748|101697994|FG000|Overall Study|Lack of Efficacy|20|||
33182971|NCT00006478|100582773|FG000|Overall Study|Vaccine could not be produced|1|||
33182972|NCT00006478|100582773|FG000|Overall Study|Physician Decision|6|||
33182973|NCT00312494|100582774|FG000|Overall Study|Randomized; not treated with study drug|9|||
33182974|NCT00312494|100582775|FG001|Overall Study|Randomized; not treated with study drug|10|||
33182975|NCT00312494|100582776|FG002|Overall Study|Randomized; not treated with study drug|5|||
33182976|NCT00312494|100582774|FG000|Overall Study|Adverse Event|33|||
33182977|NCT00312494|100582775|FG001|Overall Study|Adverse Event|15|||
33182978|NCT00312494|100582776|FG002|Overall Study|Adverse Event|11|||
33182979|NCT00312494|100582774|FG000|Overall Study|Lack of Efficacy|4|||
33182980|NCT00312494|100582775|FG001|Overall Study|Lack of Efficacy|6|||
33182981|NCT00312494|100582776|FG002|Overall Study|Lack of Efficacy|8|||
33182982|NCT00312494|100582774|FG000|Overall Study|Laboratory abnormality|1|||
33492546|NCT00124748|101697995|FG001|Overall Study|Lack of Efficacy|41|||
33492547|NCT00124748|101697994|FG000|Overall Study|No longer requires study drug|1|||
33492548|NCT00124748|101697995|FG001|Overall Study|No longer requires study drug|1|||
33492549|NCT00124748|101697994|FG000|Overall Study|Protocol Violation|3|||
33492550|NCT00124748|101697995|FG001|Overall Study|Protocol Violation|1|||
33492551|NCT00124748|101697994|FG000|Overall Study|Withdrawal by Subject|5|||
33492552|NCT00124748|101697995|FG001|Overall Study|Withdrawal by Subject|15|||
33492553|NCT00124748|101697994|FG000|Overall Study|Lost to Follow-up|2|||
33492554|NCT00124748|101697995|FG001|Overall Study|Lost to Follow-up|7|||
33492555|NCT00124748|101697994|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
33492556|NCT00124748|101697995|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
33492557|NCT00124748|101697994|FG000|Overall Study|Death|1|||
33492558|NCT00124748|101697995|FG001|Overall Study|Death|3|||
33492559|NCT04342819|101697996|FG000|Overall Study|Declined|4|||
33492560|NCT04342819|101697996|FG000|Overall Study|Not meeeting selection criteria|1|||
33492561|NCT02071225|101697997|FG000|Overall Study|Withdrawal of Consent|2|||
33492562|NCT02071225|101697997|FG000|Overall Study|Protocol Deviation|1|||
33492563|NCT02071225|101697997|FG000|Overall Study|Lost to Follow-up|2|||
33492564|NCT02071225|101697997|FG000|Overall Study|Death|25|||
33182983|NCT00312494|100582775|FG001|Overall Study|Laboratory abnormality|0|||
33492565|NCT02094300|101697999|FG000|Overall Study|Death|7|||
33492566|NCT02094300|101697999|FG000|Overall Study|Lost to Follow-up|10|||
33492567|NCT02094300|101697999|FG000|Overall Study|Still be eligible for follow-up|3|||
33492568|NCT00638508|101698000|FG000|Overall Study|Physician Decision|5|||
33492569|NCT00638508|101698001|FG001|Overall Study|Physician Decision|2|||
33492570|NCT04720053|101698002|FG000|Overall Study|Lost to Follow-up|12|||
33492571|NCT02548832|101698009|FG000|Overall Study|Lost to Follow-up|2|||
33286525|NCT01313624|100947622|FG000|Double-Blind Phase|Adverse Event|27|||
33492572|NCT02548832|101698010|FG001|Overall Study|Lost to Follow-up|2|||
33182984|NCT00312494|100582776|FG002|Overall Study|Laboratory abnormality|0|||
33182985|NCT00312494|100582774|FG000|Overall Study|Lost to Follow-up|8|||
33182986|NCT00312494|100582775|FG001|Overall Study|Lost to Follow-up|8|||
33182987|NCT00312494|100582776|FG002|Overall Study|Lost to Follow-up|8|||
33182988|NCT00312494|100582774|FG000|Overall Study|Withdrawal by Subject|6|||
33286526|NCT01313624|100947623|FG001|Double-Blind Phase|Adverse Event|4|||
33286527|NCT01313624|100947622|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
33286528|NCT01313624|100947623|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
33286529|NCT01313624|100947622|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33492573|NCT02548832|101698011|FG002|Overall Study|Lost to Follow-up|2|||
33492574|NCT03500198|101698012|FG000|Overall Study|Lost to Follow-up|0|||
33492575|NCT03500198|101698013|FG001|Overall Study|Lost to Follow-up|1|||
33182989|NCT00312494|100582775|FG001|Overall Study|Withdrawal by Subject|9|||
33182990|NCT00312494|100582776|FG002|Overall Study|Withdrawal by Subject|10|||
33492576|NCT02001987|101698014|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
33492577|NCT02001987|101698014|FG000|Core Study Period (24 Weeks)|Death|1|||
33492578|NCT02001987|101698014|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
33492579|NCT02001987|101698014|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
33492580|NCT02001987|101698014|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
33492581|NCT02001987|101698014|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
33182991|NCT00312494|100582774|FG000|Overall Study|Other|10|||
33182992|NCT00312494|100582775|FG001|Overall Study|Other|10|||
33182993|NCT00312494|100582776|FG002|Overall Study|Other|1|||
33182994|NCT01712256|100582779|FG000|Overall Study|Lost to Follow-up|1|||
33182995|NCT02120794|100582781|FG000|Overall Study|Withdrawal by Subject|43|||
33182996|NCT02120794|100582781|FG000|Overall Study|Adverse Event|10|||
33182997|NCT02120794|100582781|FG000|Overall Study|Physician Decision|4|||
33182998|NCT02120794|100582781|FG000|Overall Study|Due to insurance coverage|1|||
33182999|NCT01736696|100582785|FG000|Overall Study|Withdrawal by Subject|0|||
33183000|NCT01736696|100582786|FG001|Overall Study|Withdrawal by Subject|0|||
33183001|NCT01736696|100582787|FG002|Overall Study|Withdrawal by Subject|1|||
33183002|NCT01736696|100582788|FG003|Overall Study|Withdrawal by Subject|0|||
33183003|NCT01736696|100582789|FG004|Overall Study|Withdrawal by Subject|0|||
33183004|NCT01736696|100582790|FG005|Overall Study|Withdrawal by Subject|0|||
33183005|NCT01736696|100582791|FG006|Overall Study|Withdrawal by Subject|0|||
33183006|NCT01559012|100582792|FG000|Overall Study|Withdrawal by Subject|0|||
33183007|NCT01559012|100582793|FG001|Overall Study|Withdrawal by Subject|1|||
33183008|NCT01452412|100582794|FG000|Overall Study|Withdrawal by Subject|15|||
33183009|NCT01452412|100582795|FG001|Overall Study|Withdrawal by Subject|11|||
33183010|NCT01452412|100582794|FG000|Overall Study|Adverse Event|4|||
33183011|NCT01452412|100582795|FG001|Overall Study|Adverse Event|3|||
33183012|NCT01452412|100582794|FG000|Overall Study|Lost to Follow-up|5|||
33183013|NCT01452412|100582795|FG001|Overall Study|Lost to Follow-up|3|||
33183014|NCT01452412|100582794|FG000|Overall Study|Death|1|||
33183015|NCT01452412|100582795|FG001|Overall Study|Death|0|||
33183016|NCT01452412|100582794|FG000|Overall Study|Initiated dialysis|1|||
33183017|NCT01452412|100582795|FG001|Overall Study|Initiated dialysis|0|||
33183018|NCT01452412|100582794|FG000|Overall Study|Other|2|||
33183019|NCT01452412|100582795|FG001|Overall Study|Other|0|||
33183020|NCT00112502|100582796|FG000|Overall Study|Withdrawal by Subject|0|||
33183021|NCT00112502|100582797|FG001|Overall Study|Withdrawal by Subject|1|||
33388839|NCT00225212|101313532|FG000|Overall Study|Intercurrent illness|1|||
33492582|NCT02001987|101698014|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
33492583|NCT02001987|101698014|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
33492584|NCT02001987|101698014|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
33492585|NCT02001987|101698014|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
33492586|NCT02001987|101698014|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
33492587|NCT02001987|101698014|FG000|LTE Period (52 Weeks)|Other|3|||
33492588|NCT01050530|101698015|FG000|Overall Study|Adverse Event|6|||
33492589|NCT01050530|101698016|FG001|Overall Study|Adverse Event|3|||
33492590|NCT01050530|101698015|FG000|Overall Study|Lack of Efficacy|1|||
33492591|NCT01050530|101698016|FG001|Overall Study|Lack of Efficacy|4|||
33492592|NCT01050530|101698015|FG000|Overall Study|Withdrawal by Subject|0|||
33492593|NCT01050530|101698016|FG001|Overall Study|Withdrawal by Subject|3|||
33492594|NCT01050530|101698015|FG000|Overall Study|Protocol Violation|1|||
33492595|NCT01050530|101698016|FG001|Overall Study|Protocol Violation|0|||
33492596|NCT03565900|101698017|FG000|Overall Study|Disposition Unknown|4|||
33492597|NCT03565900|101698018|FG001|Overall Study|Disposition Unknown|1|||
33492598|NCT03565900|101698017|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
33492599|NCT03565900|101698018|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
33492600|NCT03565900|101698017|FG000|Overall Study|Withdrawal by Subject|4|||
33492601|NCT03565900|101698018|FG001|Overall Study|Withdrawal by Subject|5|||
33492602|NCT03565900|101698017|FG000|Overall Study|Randomized By Mistake|0|||
33492603|NCT03565900|101698018|FG001|Overall Study|Randomized By Mistake|2|||
33492604|NCT03565900|101698017|FG000|Overall Study|Physician Decision|7|||
33492605|NCT03565900|101698018|FG001|Overall Study|Physician Decision|11|||
33492606|NCT03565900|101698017|FG000|Overall Study|Death|9|||
33492607|NCT03565900|101698018|FG001|Overall Study|Death|7|||
33492608|NCT01762800|101698019|FG000|Overall Study|Adverse Event|8|||
33492609|NCT01762800|101698020|FG001|Overall Study|Adverse Event|13|||
33492610|NCT01762800|101698019|FG000|Overall Study|Lack of Efficacy|3|||
33492611|NCT01762800|101698020|FG001|Overall Study|Lack of Efficacy|2|||
33492612|NCT01762800|101698019|FG000|Overall Study|Study Closed/Terminated|0|||
33492613|NCT01762800|101698020|FG001|Overall Study|Study Closed/Terminated|1|||
33492614|NCT01762800|101698019|FG000|Overall Study|Physician Decision|1|||
33492615|NCT01762800|101698020|FG001|Overall Study|Physician Decision|1|||
33492616|NCT01762800|101698019|FG000|Overall Study|Withdrawal by Subject|7|||
33183022|NCT00112502|100582798|FG002|Overall Study|Withdrawal by Subject|1|||
33183023|NCT00112502|100582799|FG003|Overall Study|Withdrawal by Subject|4|||
33183024|NCT00112502|100582800|FG004|Overall Study|Withdrawal by Subject|2|||
33183025|NCT00112502|100582801|FG005|Overall Study|Withdrawal by Subject|5|||
33183026|NCT00112502|100582802|FG006|Overall Study|Withdrawal by Subject|3|||
33183027|NCT00112502|100582803|FG007|Overall Study|Withdrawal by Subject|7|||
33183028|NCT02073279|100582804|FG000|Double-blind Period|Adverse Event|1|||
33183029|NCT02073279|100582805|FG001|Double-blind Period|Adverse Event|1|||
33183030|NCT02073279|100582804|FG000|Double-blind Period|Switched to another treatment|1|||
33492617|NCT01762800|101698020|FG001|Overall Study|Withdrawal by Subject|4|||
33492618|NCT02969044|101698021|FG000|Overall Study|Withdrawal by Subject|2|||
33492619|NCT02969044|101698022|FG001|Overall Study|Withdrawal by Subject|6|||
33492620|NCT02969044|101698021|FG000|Overall Study|Adverse Event|3|||
33492621|NCT02969044|101698022|FG001|Overall Study|Adverse Event|0|||
33492622|NCT02301169|101698023|FG000|Overall Study|Adverse Event|1|||
33492623|NCT02301169|101698024|FG001|Overall Study|Adverse Event|0|||
33492624|NCT01870778|101698025|FG000|Overall Study|Withdrawal by Subject|8|||
33492625|NCT01870778|101698026|FG001|Overall Study|Withdrawal by Subject|7|||
33492626|NCT01870778|101698025|FG000|Overall Study|Lost to Follow-up|0|||
33492627|NCT01870778|101698026|FG001|Overall Study|Lost to Follow-up|2|||
33492628|NCT00262028|101698029|FG000|Overall Study|Withdrawal by Subject|6|||
33492629|NCT00262028|101698030|FG001|Overall Study|Withdrawal by Subject|3|||
33492630|NCT00262028|101698031|FG002|Overall Study|Withdrawal by Subject|6|||
33492631|NCT00262028|101698032|FG003|Overall Study|Withdrawal by Subject|5|||
33492632|NCT00262028|101698033|FG004|Overall Study|Withdrawal by Subject|2|||
33492633|NCT00262028|101698034|FG005|Overall Study|Withdrawal by Subject|3|||
33492634|NCT00262028|101698035|FG006|Overall Study|Withdrawal by Subject|5|||
33492635|NCT00262028|101698036|FG007|Overall Study|Withdrawal by Subject|7|||
33492636|NCT00262028|101698037|FG008|Overall Study|Withdrawal by Subject|2|||
33492637|NCT00262028|101698029|FG000|Overall Study|Lost to Follow-up|7|||
33492638|NCT00262028|101698030|FG001|Overall Study|Lost to Follow-up|7|||
33492639|NCT00262028|101698031|FG002|Overall Study|Lost to Follow-up|5|||
33492640|NCT00262028|101698032|FG003|Overall Study|Lost to Follow-up|5|||
33492641|NCT00262028|101698033|FG004|Overall Study|Lost to Follow-up|4|||
33492642|NCT00262028|101698034|FG005|Overall Study|Lost to Follow-up|3|||
33492643|NCT00262028|101698035|FG006|Overall Study|Lost to Follow-up|3|||
33492644|NCT00262028|101698036|FG007|Overall Study|Lost to Follow-up|5|||
33492645|NCT00262028|101698037|FG008|Overall Study|Lost to Follow-up|6|||
33286530|NCT01313624|100947623|FG001|Double-Blind Phase|Lost to Follow-up|2|||
33286531|NCT01313624|100947622|FG000|Double-Blind Phase|Physician Decision|1|||
33286532|NCT01313624|100947623|FG001|Double-Blind Phase|Physician Decision|0|||
33286533|NCT01313624|100947622|FG000|Double-Blind Phase|Lack of Efficacy|1|||
33286534|NCT01313624|100947623|FG001|Double-Blind Phase|Lack of Efficacy|0|||
33286535|NCT01313624|100947622|FG000|Open-Label Phase|Adverse Event|1|||
33286536|NCT01313624|100947623|FG001|Open-Label Phase|Adverse Event|10|||
33286537|NCT01313624|100947622|FG000|Open-Label Phase|Withdrawal by Subject|2|||
33286538|NCT01313624|100947623|FG001|Open-Label Phase|Withdrawal by Subject|2|||
33286539|NCT01313624|100947622|FG000|Open-Label Phase|Lost to Follow-up|1|||
33286540|NCT01313624|100947623|FG001|Open-Label Phase|Lost to Follow-up|1|||
33286541|NCT02447432|100947624|FG000|Epoch 001|Adverse Event|1|||
33286542|NCT02447432|100947625|FG001|Epoch 001|Adverse Event|1|||
33286543|NCT02447432|100947624|FG000|Epoch 001|Withdrawal by Subject|0|||
33286544|NCT02447432|100947625|FG001|Epoch 001|Withdrawal by Subject|4|||
33286545|NCT02447432|100947624|FG000|Epoch 001|Migrated/moved from study area|3|||
33286546|NCT02447432|100947625|FG001|Epoch 001|Migrated/moved from study area|5|||
33492646|NCT00262028|101698029|FG000|Overall Study|Administrative Reason|11|||
33492647|NCT00262028|101698030|FG001|Overall Study|Administrative Reason|14|||
33492648|NCT00262028|101698031|FG002|Overall Study|Administrative Reason|9|||
33492649|NCT00262028|101698032|FG003|Overall Study|Administrative Reason|12|||
33492650|NCT00262028|101698033|FG004|Overall Study|Administrative Reason|6|||
33492651|NCT00262028|101698034|FG005|Overall Study|Administrative Reason|7|||
33492652|NCT00262028|101698035|FG006|Overall Study|Administrative Reason|4|||
33492653|NCT00262028|101698036|FG007|Overall Study|Administrative Reason|6|||
33492654|NCT00262028|101698037|FG008|Overall Study|Administrative Reason|10|||
33492655|NCT00262028|101698029|FG000|Overall Study|Protocol Violation|0|||
33492656|NCT00262028|101698030|FG001|Overall Study|Protocol Violation|0|||
33492657|NCT00262028|101698031|FG002|Overall Study|Protocol Violation|0|||
33492658|NCT00262028|101698032|FG003|Overall Study|Protocol Violation|1|||
33492659|NCT00262028|101698033|FG004|Overall Study|Protocol Violation|0|||
33492660|NCT00262028|101698034|FG005|Overall Study|Protocol Violation|0|||
33492661|NCT00262028|101698035|FG006|Overall Study|Protocol Violation|0|||
33492662|NCT00262028|101698036|FG007|Overall Study|Protocol Violation|0|||
33492663|NCT00262028|101698037|FG008|Overall Study|Protocol Violation|0|||
33492664|NCT00262028|101698029|FG000|Overall Study|Unable to classify|0|||
33286547|NCT02447432|100947624|FG000|Epoch 001|Lost to Follow-up|1|||
33286548|NCT02447432|100947625|FG001|Epoch 001|Lost to Follow-up|3|||
33286549|NCT01004185|100947628|FG000|Overall Study|Adverse Event|1|||
33286550|NCT01004185|100947629|FG001|Overall Study|Adverse Event|1|||
33286551|NCT01004185|100947628|FG000|Overall Study|Lost to Follow-up|0|||
33286552|NCT01004185|100947629|FG001|Overall Study|Lost to Follow-up|1|||
33388840|NCT01390038|101313533|FG000|Overall Study|Death|1|||
33492665|NCT00262028|101698030|FG001|Overall Study|Unable to classify|3|||
33492666|NCT00262028|101698031|FG002|Overall Study|Unable to classify|0|||
33492667|NCT00262028|101698032|FG003|Overall Study|Unable to classify|0|||
33492668|NCT00262028|101698033|FG004|Overall Study|Unable to classify|0|||
33492669|NCT00262028|101698034|FG005|Overall Study|Unable to classify|0|||
33492670|NCT00262028|101698035|FG006|Overall Study|Unable to classify|0|||
33492671|NCT00262028|101698036|FG007|Overall Study|Unable to classify|0|||
33492672|NCT00262028|101698037|FG008|Overall Study|Unable to classify|1|||
33286553|NCT01004185|100947628|FG000|Overall Study|Lack of Efficacy|2|||
33388841|NCT01390038|101313533|FG000|Overall Study|Lost to Follow-up|1|||
33492673|NCT00711243|101698050|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
33492674|NCT00711243|101698051|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
33492675|NCT00711243|101698052|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
33492676|NCT00711243|101698053|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
33492677|NCT00711243|101698054|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
33492678|NCT00711243|101698055|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
33492679|NCT00711243|101698050|FG000|Reached First Response/4 Cycles|Death|0|||
33492680|NCT00711243|101698051|FG001|Reached First Response/4 Cycles|Death|0|||
33492681|NCT00711243|101698052|FG002|Reached First Response/4 Cycles|Death|0|||
33492682|NCT00711243|101698053|FG003|Reached First Response/4 Cycles|Death|0|||
33492683|NCT00711243|101698054|FG004|Reached First Response/4 Cycles|Death|0|||
33492684|NCT00711243|101698055|FG005|Reached First Response/4 Cycles|Death|2|||
33492685|NCT00711243|101698050|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
33492686|NCT00711243|101698051|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
33492687|NCT00711243|101698052|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
33492688|NCT00711243|101698053|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
33492689|NCT00711243|101698054|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
33183031|NCT02073279|100582805|FG001|Double-blind Period|Switched to another treatment|2|||
33492690|NCT00711243|101698055|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
33492691|NCT00711243|101698050|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
33183032|NCT02073279|100582804|FG000|Double-blind Period|Protocol Violation|0|||
33183033|NCT02073279|100582805|FG001|Double-blind Period|Protocol Violation|1|||
33183034|NCT02073279|100582804|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
33183035|NCT02073279|100582805|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
33183036|NCT02073279|100582804|FG000|Double-blind Period|Withdrawal by Subject|2|||
33183037|NCT02073279|100582805|FG001|Double-blind Period|Withdrawal by Subject|2|||
33183038|NCT02073279|100582804|FG000|Open-label Extension Period|Adverse Event|1|||
33183039|NCT02073279|100582805|FG001|Open-label Extension Period|Adverse Event|0|||
33183040|NCT02073279|100582804|FG000|Open-label Extension Period|Lack of Efficacy|1|||
33183041|NCT02073279|100582805|FG001|Open-label Extension Period|Lack of Efficacy|0|||
33183042|NCT02073279|100582804|FG000|Open-label Extension Period|Lost to Follow-up|0|||
33183043|NCT02073279|100582805|FG001|Open-label Extension Period|Lost to Follow-up|4|||
33183044|NCT02073279|100582804|FG000|Open-label Extension Period|Switched to another treatment|1|||
33183045|NCT02073279|100582805|FG001|Open-label Extension Period|Switched to another treatment|4|||
33183046|NCT02073279|100582804|FG000|Open-label Extension Period|Protocol Violation|0|||
33183047|NCT02073279|100582805|FG001|Open-label Extension Period|Protocol Violation|1|||
33183048|NCT02073279|100582804|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
33183049|NCT02073279|100582805|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
33183050|NCT02073279|100582804|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
33183051|NCT02073279|100582805|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
33183052|NCT02775344|100582806|FG000|Overall Study|No ovarian cyst identified|3|||
33183053|NCT02775344|100582807|FG001|Overall Study|No ovarian cyst identified|2|||
33183054|NCT00778700|100582808|FG000|Overall Study|Adverse Event|6|||
33183055|NCT00778700|100582809|FG001|Overall Study|Adverse Event|1|||
33183056|NCT00778700|100582810|FG002|Overall Study|Adverse Event|3|||
33183057|NCT00778700|100582811|FG003|Overall Study|Adverse Event|5|||
33286554|NCT01004185|100947629|FG001|Overall Study|Lack of Efficacy|1|||
33286555|NCT01004185|100947628|FG000|Overall Study|Sponsor Terminated Study|4|||
33286556|NCT01004185|100947629|FG001|Overall Study|Sponsor Terminated Study|5|||
33286557|NCT01004185|100947628|FG000|Overall Study|Withdrawal by Subject|2|||
33286558|NCT01004185|100947629|FG001|Overall Study|Withdrawal by Subject|1|||
33286559|NCT01919398|100947635|FG000|Overall Study|Progressive Disease|0|||
33286560|NCT01919398|100947636|FG001|Overall Study|Progressive Disease|0|||
33492692|NCT00711243|101698051|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
33492693|NCT00711243|101698052|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
33492694|NCT00711243|101698053|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
33492695|NCT00711243|101698054|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
33492696|NCT00711243|101698055|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
33492697|NCT00711243|101698050|FG000|Treated Cycle 5 After First Response|Death|0|||
33492698|NCT00711243|101698051|FG001|Treated Cycle 5 After First Response|Death|0|||
33492699|NCT00711243|101698052|FG002|Treated Cycle 5 After First Response|Death|0|||
33492700|NCT00711243|101698053|FG003|Treated Cycle 5 After First Response|Death|0|||
33492701|NCT00711243|101698054|FG004|Treated Cycle 5 After First Response|Death|0|||
33492702|NCT00711243|101698055|FG005|Treated Cycle 5 After First Response|Death|2|||
33183058|NCT00778700|100582808|FG000|Overall Study|Protocol Violation|1|||
33183059|NCT00778700|100582809|FG001|Overall Study|Protocol Violation|1|||
33183060|NCT00778700|100582810|FG002|Overall Study|Protocol Violation|0|||
33183061|NCT00778700|100582811|FG003|Overall Study|Protocol Violation|0|||
33286561|NCT01919398|100947637|FG002|Overall Study|Progressive Disease|4|||
33183062|NCT00778700|100582808|FG000|Overall Study|Subject Withdrew Consent|6|||
33286562|NCT00338949|100947642|FG000|Subject Screening|Screen failures|11|||
33286563|NCT00338949|100947643|FG001|Subject Screening|Screen failures|11|||
33492703|NCT00711243|101698050|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
33492704|NCT00711243|101698051|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
33492705|NCT00711243|101698052|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
33492706|NCT00711243|101698053|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
33492707|NCT00711243|101698054|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
33492708|NCT00711243|101698055|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
33286564|NCT00338949|100947642|FG000|Randomization|Withdrawal by Subject|1|||
33286565|NCT00338949|100947643|FG001|Randomization|Withdrawal by Subject|0|||
33286566|NCT00338949|100947642|FG000|Randomization|Adverse Event|0|||
33286567|NCT00338949|100947643|FG001|Randomization|Adverse Event|5|||
33286568|NCT03924947|100947646|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
33286569|NCT03924947|100947647|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
33286570|NCT03924947|100947648|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
33286571|NCT03924947|100947649|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
33286572|NCT03924947|100947650|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
33286573|NCT03924947|100947651|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
33286574|NCT00634920|100947654|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
33286575|NCT00634920|100947655|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
33286576|NCT00634920|100947656|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
33286577|NCT00634920|100947654|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
33286578|NCT00634920|100947655|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
33286579|NCT00634920|100947656|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
33286580|NCT00634920|100947654|FG000|Period 1 - Pre-Randomization|Rejections|0|||
33286581|NCT00634920|100947655|FG001|Period 1 - Pre-Randomization|Rejections|0|||
33492709|NCT00711243|101698050|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
33492710|NCT00711243|101698051|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
33492711|NCT00711243|101698052|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
33492712|NCT00711243|101698053|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
33492713|NCT00711243|101698054|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
33492714|NCT00711243|101698055|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
33492715|NCT00982657|101698061|FG000|Overall Study|Death|1|||
33492716|NCT00982657|101698062|FG001|Overall Study|Death|0|||
33492717|NCT00982657|101698063|FG002|Overall Study|Death|1|||
33492718|NCT00982657|101698064|FG003|Overall Study|Death|1|||
33492719|NCT00982657|101698061|FG000|Overall Study|Withdrawal by Subject|0|||
33492720|NCT00982657|101698062|FG001|Overall Study|Withdrawal by Subject|0|||
33492721|NCT00982657|101698063|FG002|Overall Study|Withdrawal by Subject|1|||
33492722|NCT00982657|101698064|FG003|Overall Study|Withdrawal by Subject|3|||
33492723|NCT00982657|101698061|FG000|Overall Study|Other|0|||
33183063|NCT00778700|100582809|FG001|Overall Study|Subject Withdrew Consent|4|||
33183064|NCT00778700|100582810|FG002|Overall Study|Subject Withdrew Consent|1|||
33183065|NCT00778700|100582811|FG003|Overall Study|Subject Withdrew Consent|4|||
33183066|NCT00778700|100582808|FG000|Overall Study|Lost to Follow-up|3|||
33183067|NCT00778700|100582809|FG001|Overall Study|Lost to Follow-up|1|||
33183068|NCT00778700|100582810|FG002|Overall Study|Lost to Follow-up|0|||
33183069|NCT00778700|100582811|FG003|Overall Study|Lost to Follow-up|1|||
33183070|NCT00778700|100582808|FG000|Overall Study|Reason not Specified|2|||
33183071|NCT00778700|100582809|FG001|Overall Study|Reason not Specified|0|||
33183072|NCT00778700|100582810|FG002|Overall Study|Reason not Specified|1|||
33183073|NCT00778700|100582811|FG003|Overall Study|Reason not Specified|3|||
33183074|NCT00778700|100582808|FG000|Overall Study|Other|0|||
33492724|NCT00982657|101698062|FG001|Overall Study|Other|0|||
33492725|NCT00982657|101698063|FG002|Overall Study|Other|0|||
33492726|NCT00982657|101698064|FG003|Overall Study|Other|4|||
33492727|NCT00982657|101698061|FG000|Overall Study|On going at date of cut-off|0|||
33183075|NCT00778700|100582809|FG001|Overall Study|Other|0|||
33183076|NCT00778700|100582810|FG002|Overall Study|Other|1|||
33183077|NCT00778700|100582811|FG003|Overall Study|Other|0|||
33183078|NCT00746941|100582812|FG000|Overall Study|Death|2|||
33183079|NCT00746941|100582813|FG001|Overall Study|Death|0|||
33183080|NCT00746941|100582814|FG002|Overall Study|Death|0|||
33183081|NCT00746941|100582815|FG003|Overall Study|Death|6|||
33183082|NCT00746941|100582812|FG000|Overall Study|Physician Decision|0|||
33286582|NCT00634920|100947656|FG002|Period 1 - Pre-Randomization|Rejections|55|||
33286583|NCT00634920|100947654|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
33286584|NCT00634920|100947655|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
33286585|NCT00634920|100947656|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
33286586|NCT00634920|100947654|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
33286587|NCT00634920|100947655|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
33183083|NCT00746941|100582813|FG001|Overall Study|Physician Decision|0|||
33183084|NCT00746941|100582814|FG002|Overall Study|Physician Decision|2|||
33183085|NCT00746941|100582815|FG003|Overall Study|Physician Decision|0|||
33183086|NCT00746941|100582812|FG000|Overall Study|Withdrawal by Subject|3|||
33183087|NCT00746941|100582813|FG001|Overall Study|Withdrawal by Subject|0|||
33183088|NCT00746941|100582814|FG002|Overall Study|Withdrawal by Subject|0|||
33183089|NCT00746941|100582815|FG003|Overall Study|Withdrawal by Subject|2|||
33183090|NCT00746941|100582812|FG000|Overall Study|Other, reason not provided|2|||
33183091|NCT00746941|100582813|FG001|Overall Study|Other, reason not provided|4|||
33183092|NCT00746941|100582814|FG002|Overall Study|Other, reason not provided|0|||
33183093|NCT00746941|100582815|FG003|Overall Study|Other, reason not provided|4|||
33183094|NCT00746941|100582812|FG000|Overall Study|Adverse Event|0|||
33492728|NCT00982657|101698062|FG001|Overall Study|On going at date of cut-off|0|||
33286588|NCT00634920|100947656|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
33286589|NCT00634920|100947654|FG000|Period 1 - Pre-Randomization|Other issues|0|||
33286590|NCT00634920|100947655|FG001|Period 1 - Pre-Randomization|Other issues|0|||
33286591|NCT00634920|100947656|FG002|Period 1 - Pre-Randomization|Other issues|6|||
33286592|NCT00634920|100947654|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
33286593|NCT00634920|100947655|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
33286594|NCT00634920|100947656|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
33286595|NCT00634920|100947654|FG000|Period 2 - Post-Randomization|Rejection|11|||
33286596|NCT00634920|100947655|FG001|Period 2 - Post-Randomization|Rejection|5|||
33286597|NCT00634920|100947656|FG002|Period 2 - Post-Randomization|Rejection|0|||
33286598|NCT00634920|100947654|FG000|Period 2 - Post-Randomization|Death|2|||
33286599|NCT00634920|100947655|FG001|Period 2 - Post-Randomization|Death|5|||
33286600|NCT00634920|100947656|FG002|Period 2 - Post-Randomization|Death|0|||
33286601|NCT00634920|100947654|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
33286602|NCT00634920|100947655|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
33286603|NCT00634920|100947656|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
33286604|NCT00634920|100947654|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
33286605|NCT00634920|100947655|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
33286606|NCT00634920|100947656|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
33286607|NCT00591409|100947657|FG000|Overall Study|Not Treated|0|||
33286608|NCT00591409|100947658|FG001|Overall Study|Not Treated|0|||
33286609|NCT00591409|100947659|FG002|Overall Study|Not Treated|0|||
33286610|NCT00591409|100947660|FG003|Overall Study|Not Treated|0|||
33388842|NCT01390038|101313533|FG000|Overall Study|Withdrawal by Subject|4|||
33388843|NCT01390038|101313533|FG000|Overall Study|Simpliciti System Removal|2|||
33388844|NCT00441480|101313538|FG000|Overall Study|Protocol Violation|1|||
33388845|NCT00441480|101313539|FG001|Overall Study|Protocol Violation|1|||
33388846|NCT00441480|101313538|FG000|Overall Study|Withdrawal by Subject|2|||
33388847|NCT00441480|101313539|FG001|Overall Study|Withdrawal by Subject|3|||
33388848|NCT01024920|101313540|FG000|Overall Study|Progressive disease|47|||
33388849|NCT01024920|101313541|FG001|Overall Study|Progressive disease|25|||
33388850|NCT01024920|101313540|FG000|Overall Study|Adverse Event|8|||
33388851|NCT01024920|101313541|FG001|Overall Study|Adverse Event|4|||
33388852|NCT01024920|101313540|FG000|Overall Study|Lost to Follow-up|0|||
33388853|NCT01024920|101313541|FG001|Overall Study|Lost to Follow-up|1|||
33388854|NCT01024920|101313540|FG000|Overall Study|Patient refusal to continue|4|||
33388855|NCT01024920|101313541|FG001|Overall Study|Patient refusal to continue|0|||
33388856|NCT01024920|101313540|FG000|Overall Study|Other than listed|5|||
33388857|NCT01024920|101313541|FG001|Overall Study|Other than listed|1|||
33388858|NCT01024920|101313540|FG000|Overall Study|Not treated|3|||
33388859|NCT01024920|101313541|FG001|Overall Study|Not treated|0|||
33492729|NCT00982657|101698063|FG002|Overall Study|On going at date of cut-off|0|||
33388860|NCT01024920|101313540|FG000|Overall Study|Protocol Violation|0|||
33388861|NCT01024920|101313541|FG001|Overall Study|Protocol Violation|1|||
33492730|NCT00982657|101698064|FG003|Overall Study|On going at date of cut-off|1|||
33492731|NCT01154231|101698065|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
33492732|NCT01154231|101698065|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
33492733|NCT02058069|101698074|FG000|Overall Study|Exclusion due to implant size|5|||
33183095|NCT00746941|100582813|FG001|Overall Study|Adverse Event|0|||
33183096|NCT00746941|100582814|FG002|Overall Study|Adverse Event|0|||
33183097|NCT00746941|100582815|FG003|Overall Study|Adverse Event|1|||
33183098|NCT01838642|100582816|FG000|Overall Study|Died on study|1|||
33183099|NCT04220411|100582817|FG000|Overall Study|Adverse Event|0|||
33183100|NCT04220411|100582818|FG001|Overall Study|Adverse Event|0|||
33183101|NCT04220411|100582819|FG002|Overall Study|Adverse Event|0|||
33183102|NCT04220411|100582820|FG003|Overall Study|Adverse Event|1|||
33183103|NCT03220217|100582825|FG000|Overall Study|Withdrawal by Subject|0|||
33286611|NCT00591409|100947661|FG004|Overall Study|Not Treated|1|||
33286612|NCT00591409|100947662|FG005|Overall Study|Not Treated|0|||
33286613|NCT00591409|100947663|FG006|Overall Study|Not Treated|0|||
33286614|NCT00591409|100947664|FG007|Overall Study|Not Treated|0|||
33286615|NCT00591409|100947665|FG008|Overall Study|Not Treated|0|||
33286616|NCT00591409|100947666|FG009|Overall Study|Not Treated|1|||
33286617|NCT01101334|100947668|FG000|Overall Study|Adverse Event|9|||
33388862|NCT00814307|101313542|FG000|Overall Study|Randomized but not treated|1|||
33183104|NCT03220217|100582826|FG001|Overall Study|Withdrawal by Subject|1|||
33183105|NCT03220217|100582827|FG002|Overall Study|Withdrawal by Subject|0|||
33183106|NCT03220217|100582825|FG000|Overall Study|Subject Missed Procedure|0|||
33183107|NCT03220217|100582826|FG001|Overall Study|Subject Missed Procedure|0|||
33183108|NCT03220217|100582827|FG002|Overall Study|Subject Missed Procedure|1|||
33183109|NCT01068509|100582828|FG000|Overall Study|Death|0|||
33183110|NCT01068509|100582829|FG001|Overall Study|Death|0|||
33183111|NCT01068509|100582830|FG002|Overall Study|Death|1|||
33286618|NCT01101334|100947669|FG001|Overall Study|Adverse Event|4|||
33286619|NCT01101334|100947668|FG000|Overall Study|Death|7|||
33286620|NCT01101334|100947669|FG001|Overall Study|Death|1|||
33286621|NCT01101334|100947668|FG000|Overall Study|Withdrawal by Subject|4|||
33286622|NCT01101334|100947669|FG001|Overall Study|Withdrawal by Subject|3|||
33286623|NCT01101334|100947668|FG000|Overall Study|Withdrawal by Sponsor|1|||
33492734|NCT02058069|101698074|FG000|Overall Study|Withdrawal by Subject|6|||
33492735|NCT00460603|101698077|FG000|Phase 1|Death|1|||
33492736|NCT00460603|101698078|FG001|Phase 1|Death|0|||
33492737|NCT00460603|101698079|FG002|Phase 1|Death|0|||
33286624|NCT01101334|100947669|FG001|Overall Study|Withdrawal by Sponsor|1|||
33286625|NCT01101334|100947668|FG000|Overall Study|Progressive Disease|22|||
33286626|NCT01101334|100947669|FG001|Overall Study|Progressive Disease|35|||
33286627|NCT01101334|100947668|FG000|Overall Study|Other|2|||
33286628|NCT01101334|100947669|FG001|Overall Study|Other|1|||
33286629|NCT00115336|100947672|FG000|Overall Study|Hospital discharge before study drug|0|||
33286630|NCT00115336|100947673|FG001|Overall Study|Hospital discharge before study drug|1|||
33286631|NCT03023423|100947674|FG000|Overall Study|Death|5|||
33286632|NCT03023423|100947675|FG001|Overall Study|Death|12|||
33286633|NCT03023423|100947676|FG002|Overall Study|Death|20|||
33286634|NCT03023423|100947674|FG000|Overall Study|Other|0|||
33286635|NCT03023423|100947675|FG001|Overall Study|Other|2|||
33492738|NCT00460603|101698080|FG003|Phase 1|Death|2|||
33492739|NCT00460603|101698081|FG004|Phase 1|Death|0|||
33492740|NCT00460603|101698082|FG005|Phase 1|Death|0|||
33492741|NCT00460603|101698083|FG006|Phase 1|Death|0|||
33492742|NCT00460603|101698084|FG007|Phase 1|Death|0|||
33492743|NCT00460603|101698085|FG008|Phase 1|Death|1|||
33492744|NCT00460603|101698086|FG009|Phase 1|Death|0|||
33183112|NCT01068509|100582828|FG000|Overall Study|Disease Progression|5|||
33183113|NCT01068509|100582829|FG001|Overall Study|Disease Progression|20|||
33183114|NCT01068509|100582830|FG002|Overall Study|Disease Progression|18|||
33183115|NCT01068509|100582828|FG000|Overall Study|Lost to Follow-up|1|||
33183116|NCT01068509|100582829|FG001|Overall Study|Lost to Follow-up|0|||
33286636|NCT03023423|100947676|FG002|Overall Study|Other|2|||
33286637|NCT03023423|100947674|FG000|Overall Study|Ongoing|2|||
33286638|NCT03023423|100947675|FG001|Overall Study|Ongoing|32|||
33286639|NCT03023423|100947676|FG002|Overall Study|Ongoing|24|||
33286640|NCT01171183|100947677|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
33286641|NCT01171183|100947678|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
33286642|NCT01171183|100947677|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
33286643|NCT01171183|100947678|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
33286644|NCT01171183|100947677|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
33286645|NCT01171183|100947678|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
33286646|NCT01171183|100947677|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
33492745|NCT00460603|101698087|FG010|Phase 1|Death|0|||
33492746|NCT00460603|101698088|FG011|Phase 1|Death|0|||
33492747|NCT00460603|101698077|FG000|Phase 1|Adverse Event|3|||
33492748|NCT00460603|101698078|FG001|Phase 1|Adverse Event|1|||
33492749|NCT00460603|101698079|FG002|Phase 1|Adverse Event|1|||
33492750|NCT00460603|101698080|FG003|Phase 1|Adverse Event|2|||
33492751|NCT00460603|101698081|FG004|Phase 1|Adverse Event|0|||
33492752|NCT00460603|101698082|FG005|Phase 1|Adverse Event|0|||
33492753|NCT00460603|101698083|FG006|Phase 1|Adverse Event|3|||
33492754|NCT00460603|101698084|FG007|Phase 1|Adverse Event|0|||
33492755|NCT00460603|101698085|FG008|Phase 1|Adverse Event|4|||
33492756|NCT00460603|101698086|FG009|Phase 1|Adverse Event|0|||
33492757|NCT00460603|101698087|FG010|Phase 1|Adverse Event|0|||
33388863|NCT00814307|101313543|FG001|Overall Study|Randomized but not treated|0|||
33388864|NCT00814307|101313544|FG002|Overall Study|Randomized but not treated|0|||
33492758|NCT00460603|101698088|FG011|Phase 1|Adverse Event|0|||
33492759|NCT00460603|101698077|FG000|Phase 1|Lack of Efficacy|1|||
33492760|NCT00460603|101698078|FG001|Phase 1|Lack of Efficacy|0|||
33286647|NCT01171183|100947678|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
33388865|NCT00814307|101313545|FG003|Overall Study|Randomized but not treated|0|||
33388866|NCT00814307|101313542|FG000|Overall Study|Adverse Event|3|||
33388867|NCT00814307|101313543|FG001|Overall Study|Adverse Event|9|||
33492761|NCT00460603|101698079|FG002|Phase 1|Lack of Efficacy|1|||
33364867|NCT00726323|101223670|FG000|Overall Study|Progressive disease|23|||
33492762|NCT00460603|101698080|FG003|Phase 1|Lack of Efficacy|2|||
33492763|NCT00460603|101698081|FG004|Phase 1|Lack of Efficacy|2|||
33183117|NCT01068509|100582830|FG002|Overall Study|Lost to Follow-up|0|||
33183118|NCT01068509|100582828|FG000|Overall Study|Withdrew Consent|0|||
33492764|NCT00460603|101698082|FG005|Phase 1|Lack of Efficacy|2|||
33492765|NCT00460603|101698083|FG006|Phase 1|Lack of Efficacy|2|||
33492766|NCT00460603|101698084|FG007|Phase 1|Lack of Efficacy|2|||
33492767|NCT00460603|101698085|FG008|Phase 1|Lack of Efficacy|11|||
33492768|NCT00460603|101698086|FG009|Phase 1|Lack of Efficacy|0|||
33492769|NCT00460603|101698087|FG010|Phase 1|Lack of Efficacy|0|||
33492770|NCT00460603|101698088|FG011|Phase 1|Lack of Efficacy|0|||
33388868|NCT00814307|101313544|FG002|Overall Study|Adverse Event|3|||
33388869|NCT00814307|101313545|FG003|Overall Study|Adverse Event|2|||
33388870|NCT00814307|101313542|FG000|Overall Study|Lack of Efficacy|1|||
33388871|NCT00814307|101313543|FG001|Overall Study|Lack of Efficacy|1|||
33388872|NCT00814307|101313544|FG002|Overall Study|Lack of Efficacy|3|||
33388873|NCT00814307|101313545|FG003|Overall Study|Lack of Efficacy|4|||
33388874|NCT00814307|101313542|FG000|Overall Study|Other|1|||
33388875|NCT00814307|101313543|FG001|Overall Study|Other|2|||
33388876|NCT00814307|101313544|FG002|Overall Study|Other|0|||
33388877|NCT00814307|101313545|FG003|Overall Study|Other|1|||
33388878|NCT00814307|101313542|FG000|Overall Study|Protocol Violation|2|||
33388879|NCT00814307|101313543|FG001|Overall Study|Protocol Violation|8|||
33388880|NCT00814307|101313544|FG002|Overall Study|Protocol Violation|1|||
33388881|NCT00814307|101313545|FG003|Overall Study|Protocol Violation|1|||
33388882|NCT00814307|101313542|FG000|Overall Study|Withdrawal by Subject|4|||
33388883|NCT00814307|101313543|FG001|Overall Study|Withdrawal by Subject|6|||
33388884|NCT00814307|101313544|FG002|Overall Study|Withdrawal by Subject|0|||
33388885|NCT00814307|101313545|FG003|Overall Study|Withdrawal by Subject|2|||
33388886|NCT00814307|101313542|FG000|Overall Study|Death|0|||
33388887|NCT00814307|101313543|FG001|Overall Study|Death|1|||
33388888|NCT00814307|101313544|FG002|Overall Study|Death|0|||
33388889|NCT00814307|101313545|FG003|Overall Study|Death|0|||
33388890|NCT00845845|101313550|FG000|Overall Study|Lost to Follow-up|0|||
33388891|NCT00845845|101313551|FG001|Overall Study|Lost to Follow-up|4|||
33492771|NCT00460603|101698077|FG000|Phase 1|Withdrawal by Subject|1|||
33492772|NCT00460603|101698078|FG001|Phase 1|Withdrawal by Subject|2|||
33492773|NCT00460603|101698079|FG002|Phase 1|Withdrawal by Subject|1|||
33286648|NCT01171183|100947677|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
33286649|NCT01171183|100947678|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
33286650|NCT01171183|100947677|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
33492774|NCT00460603|101698080|FG003|Phase 1|Withdrawal by Subject|1|||
33492775|NCT00460603|101698081|FG004|Phase 1|Withdrawal by Subject|3|||
33492776|NCT00460603|101698082|FG005|Phase 1|Withdrawal by Subject|0|||
33492777|NCT00460603|101698083|FG006|Phase 1|Withdrawal by Subject|1|||
33492778|NCT00460603|101698084|FG007|Phase 1|Withdrawal by Subject|0|||
33492779|NCT00460603|101698085|FG008|Phase 1|Withdrawal by Subject|2|||
33492780|NCT00460603|101698086|FG009|Phase 1|Withdrawal by Subject|0|||
33492781|NCT00460603|101698087|FG010|Phase 1|Withdrawal by Subject|0|||
33492782|NCT00460603|101698088|FG011|Phase 1|Withdrawal by Subject|0|||
33492783|NCT00460603|101698077|FG000|Phase 1|Other|0|||
33492784|NCT00460603|101698078|FG001|Phase 1|Other|3|||
33492785|NCT00460603|101698079|FG002|Phase 1|Other|1|||
33492786|NCT00460603|101698080|FG003|Phase 1|Other|1|||
33492787|NCT00460603|101698081|FG004|Phase 1|Other|1|||
33492788|NCT00460603|101698082|FG005|Phase 1|Other|2|||
33492789|NCT00460603|101698083|FG006|Phase 1|Other|0|||
33492790|NCT00460603|101698084|FG007|Phase 1|Other|1|||
33492791|NCT00460603|101698085|FG008|Phase 1|Other|0|||
33492792|NCT00460603|101698086|FG009|Phase 1|Other|0|||
33492793|NCT00460603|101698087|FG010|Phase 1|Other|0|||
33492794|NCT00460603|101698088|FG011|Phase 1|Other|0|||
33492795|NCT00460603|101698077|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33492796|NCT00460603|101698078|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33286651|NCT01171183|100947678|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
33286652|NCT01560871|100947681|FG000|Overall Study|transportation issues|2|||
33286653|NCT01560871|100947682|FG001|Overall Study|transportation issues|1|||
33286654|NCT01560871|100947681|FG000|Overall Study|relocation|1|||
33286655|NCT01560871|100947682|FG001|Overall Study|relocation|0|||
33286656|NCT01560871|100947681|FG000|Overall Study|readmission to a hospital|2|||
33286657|NCT01560871|100947682|FG001|Overall Study|readmission to a hospital|1|||
33286658|NCT01560871|100947681|FG000|Overall Study|Lost to Follow-up|1|||
33286659|NCT01560871|100947682|FG001|Overall Study|Lost to Follow-up|0|||
33286660|NCT02972242|100947683|FG000|Overall Study|Withdrawal by Subject|1|||
33286661|NCT02972242|100947684|FG001|Overall Study|Withdrawal by Subject|0|||
33286662|NCT02101983|100947687|FG000|Overall Study|Physician Decision|1|||
33286663|NCT02101983|100947688|FG001|Overall Study|Physician Decision|0|||
33388892|NCT02911519|101313552|FG000|Overall Study|Lost to Follow-up|2|||
33388893|NCT02911519|101313553|FG001|Overall Study|Lost to Follow-up|2|||
33492797|NCT00460603|101698079|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33492798|NCT00460603|101698080|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33492799|NCT00460603|101698081|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33492800|NCT00460603|101698082|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33492801|NCT00460603|101698083|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33492802|NCT00460603|101698084|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33492803|NCT00460603|101698085|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33492804|NCT00460603|101698086|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
33594245|NCT02780856|102064877|FG000|Overall Study|Lost to Follow-up|1|||
33286664|NCT03845023|100947697|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
33286665|NCT03845023|100947698|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
33286666|NCT03845023|100947699|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
33286667|NCT03845023|100947700|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
33286668|NCT03845023|100947697|FG000|Follow-Up (14 Days)|Adverse Event|0|||
33286669|NCT03845023|100947698|FG001|Follow-Up (14 Days)|Adverse Event|0|||
33286670|NCT03845023|100947699|FG002|Follow-Up (14 Days)|Adverse Event|1|||
33286671|NCT03845023|100947700|FG003|Follow-Up (14 Days)|Adverse Event|1|||
33286672|NCT01316887|100947701|FG000|Overall Study|Adverse Event|13|||
33286673|NCT01316887|100947702|FG001|Overall Study|Adverse Event|21|||
33286674|NCT01316887|100947703|FG002|Overall Study|Adverse Event|17|||
33286675|NCT01316887|100947701|FG000|Overall Study|Lack of Efficacy|9|||
33286676|NCT01316887|100947702|FG001|Overall Study|Lack of Efficacy|3|||
33286677|NCT01316887|100947703|FG002|Overall Study|Lack of Efficacy|1|||
33286678|NCT01316887|100947701|FG000|Overall Study|Protocol Violation|2|||
33286679|NCT01316887|100947702|FG001|Overall Study|Protocol Violation|6|||
33492805|NCT00460603|101698087|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33286680|NCT01316887|100947703|FG002|Overall Study|Protocol Violation|6|||
33286681|NCT01316887|100947701|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
33286682|NCT01316887|100947702|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
33286683|NCT01316887|100947703|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
33286684|NCT01316887|100947701|FG000|Overall Study|Study Closed/Terminated|2|||
33286685|NCT01316887|100947702|FG001|Overall Study|Study Closed/Terminated|4|||
33286686|NCT01316887|100947703|FG002|Overall Study|Study Closed/Terminated|3|||
33286687|NCT01316887|100947701|FG000|Overall Study|Lost to Follow-up|1|||
33286688|NCT01316887|100947702|FG001|Overall Study|Lost to Follow-up|7|||
33286689|NCT01316887|100947703|FG002|Overall Study|Lost to Follow-up|5|||
33286690|NCT01316887|100947701|FG000|Overall Study|Withdrawal by Subject|8|||
33286691|NCT01316887|100947702|FG001|Overall Study|Withdrawal by Subject|16|||
33286692|NCT01316887|100947703|FG002|Overall Study|Withdrawal by Subject|15|||
33286693|NCT00713206|100947704|FG000|Overall Study|Lost to Follow-up|4|||
33286694|NCT00713206|100947705|FG001|Overall Study|Lost to Follow-up|4|||
33286695|NCT00713206|100947704|FG000|Overall Study|Death|1|||
33286696|NCT00713206|100947705|FG001|Overall Study|Death|0|||
33286697|NCT00510198|100947706|FG000|Overall Study|Withdrawal by Subject|5|||
33286698|NCT00510198|100947707|FG001|Overall Study|Withdrawal by Subject|4|||
33286699|NCT01200485|100947709|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
33286700|NCT01200485|100947710|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
33286701|NCT01200485|100947711|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
33286702|NCT01200485|100947709|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
33286703|NCT01200485|100947710|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
33286704|NCT01200485|100947711|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
33286705|NCT03305809|100947712|FG000|Overall Study|Adverse Event|2|||
33286706|NCT03305809|100947713|FG001|Overall Study|Adverse Event|2|||
33286707|NCT03305809|100947714|FG002|Overall Study|Adverse Event|6|||
33286708|NCT03305809|100947715|FG003|Overall Study|Adverse Event|6|||
33286709|NCT03305809|100947712|FG000|Overall Study|Death|0|||
33286710|NCT03305809|100947713|FG001|Overall Study|Death|0|||
33286711|NCT03305809|100947714|FG002|Overall Study|Death|1|||
33286712|NCT03305809|100947715|FG003|Overall Study|Death|1|||
33492806|NCT00460603|101698088|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
33492807|NCT00460603|101698077|FG000|Phase 2|Adverse Event|0|||
33492808|NCT00460603|101698078|FG001|Phase 2|Adverse Event|0|||
33492809|NCT00460603|101698079|FG002|Phase 2|Adverse Event|0|||
33492810|NCT00460603|101698080|FG003|Phase 2|Adverse Event|0|||
33492811|NCT00460603|101698081|FG004|Phase 2|Adverse Event|0|||
33492812|NCT00460603|101698082|FG005|Phase 2|Adverse Event|0|||
33492813|NCT00460603|101698083|FG006|Phase 2|Adverse Event|0|||
33492814|NCT00460603|101698084|FG007|Phase 2|Adverse Event|0|||
33492815|NCT00460603|101698085|FG008|Phase 2|Adverse Event|0|||
33492816|NCT00460603|101698086|FG009|Phase 2|Adverse Event|12|||
33492817|NCT00460603|101698087|FG010|Phase 2|Adverse Event|9|||
33492818|NCT00460603|101698088|FG011|Phase 2|Adverse Event|10|||
33286713|NCT03305809|100947712|FG000|Overall Study|Lost to Follow-up|1|||
33492819|NCT00460603|101698077|FG000|Phase 2|Death|0|||
33286714|NCT03305809|100947713|FG001|Overall Study|Lost to Follow-up|2|||
33286715|NCT03305809|100947714|FG002|Overall Study|Lost to Follow-up|0|||
33286716|NCT03305809|100947715|FG003|Overall Study|Lost to Follow-up|0|||
33286717|NCT03305809|100947712|FG000|Overall Study|Sponsor Decision|1|||
33286718|NCT03305809|100947713|FG001|Overall Study|Sponsor Decision|0|||
33286719|NCT03305809|100947714|FG002|Overall Study|Sponsor Decision|1|||
33286720|NCT03305809|100947715|FG003|Overall Study|Sponsor Decision|8|||
33286721|NCT03305809|100947712|FG000|Overall Study|Physician Decision|0|||
33492820|NCT00460603|101698078|FG001|Phase 2|Death|0|||
33492821|NCT00460603|101698079|FG002|Phase 2|Death|0|||
33492822|NCT00460603|101698080|FG003|Phase 2|Death|0|||
33492823|NCT00460603|101698081|FG004|Phase 2|Death|0|||
33492824|NCT00460603|101698082|FG005|Phase 2|Death|0|||
33492825|NCT00460603|101698083|FG006|Phase 2|Death|0|||
33492826|NCT00460603|101698084|FG007|Phase 2|Death|0|||
33492827|NCT00460603|101698085|FG008|Phase 2|Death|0|||
33492828|NCT00460603|101698086|FG009|Phase 2|Death|4|||
33492829|NCT00460603|101698087|FG010|Phase 2|Death|2|||
33492830|NCT00460603|101698088|FG011|Phase 2|Death|2|||
33492831|NCT00460603|101698077|FG000|Phase 2|Protocol Violation|0|||
33492832|NCT00460603|101698078|FG001|Phase 2|Protocol Violation|0|||
33492833|NCT00460603|101698079|FG002|Phase 2|Protocol Violation|0|||
33492834|NCT00460603|101698080|FG003|Phase 2|Protocol Violation|0|||
33492835|NCT00460603|101698081|FG004|Phase 2|Protocol Violation|0|||
33492836|NCT00460603|101698082|FG005|Phase 2|Protocol Violation|0|||
33492837|NCT00460603|101698083|FG006|Phase 2|Protocol Violation|0|||
33492838|NCT00460603|101698084|FG007|Phase 2|Protocol Violation|0|||
33492839|NCT00460603|101698085|FG008|Phase 2|Protocol Violation|0|||
33492840|NCT00460603|101698086|FG009|Phase 2|Protocol Violation|1|||
33492841|NCT00460603|101698087|FG010|Phase 2|Protocol Violation|1|||
33492842|NCT00460603|101698088|FG011|Phase 2|Protocol Violation|0|||
33492843|NCT00460603|101698077|FG000|Phase 2|Lost to Follow-up|0|||
33492844|NCT00460603|101698078|FG001|Phase 2|Lost to Follow-up|0|||
33492845|NCT00460603|101698079|FG002|Phase 2|Lost to Follow-up|0|||
33492846|NCT00460603|101698080|FG003|Phase 2|Lost to Follow-up|0|||
33492847|NCT00460603|101698081|FG004|Phase 2|Lost to Follow-up|0|||
33492848|NCT00460603|101698082|FG005|Phase 2|Lost to Follow-up|0|||
33492849|NCT00460603|101698083|FG006|Phase 2|Lost to Follow-up|0|||
33492850|NCT00460603|101698084|FG007|Phase 2|Lost to Follow-up|0|||
33492851|NCT00460603|101698085|FG008|Phase 2|Lost to Follow-up|0|||
33492852|NCT00460603|101698086|FG009|Phase 2|Lost to Follow-up|1|||
33492853|NCT00460603|101698087|FG010|Phase 2|Lost to Follow-up|0|||
33492854|NCT00460603|101698088|FG011|Phase 2|Lost to Follow-up|0|||
33492855|NCT00460603|101698077|FG000|Phase 2|Other|0|||
33492856|NCT00460603|101698078|FG001|Phase 2|Other|0|||
33492857|NCT00460603|101698079|FG002|Phase 2|Other|0|||
33492858|NCT00460603|101698080|FG003|Phase 2|Other|0|||
33492859|NCT00460603|101698081|FG004|Phase 2|Other|0|||
33492860|NCT00460603|101698082|FG005|Phase 2|Other|0|||
33492861|NCT00460603|101698083|FG006|Phase 2|Other|0|||
33492862|NCT00460603|101698084|FG007|Phase 2|Other|0|||
33492863|NCT00460603|101698085|FG008|Phase 2|Other|0|||
33492864|NCT00460603|101698086|FG009|Phase 2|Other|6|||
33492865|NCT00460603|101698087|FG010|Phase 2|Other|16|||
33492866|NCT00460603|101698088|FG011|Phase 2|Other|7|||
33492867|NCT00460603|101698077|FG000|Phase 2|Objective Progression or Relapse|0|||
33492868|NCT00460603|101698078|FG001|Phase 2|Objective Progression or Relapse|0|||
33492869|NCT00460603|101698079|FG002|Phase 2|Objective Progression or Relapse|0|||
33492870|NCT00460603|101698080|FG003|Phase 2|Objective Progression or Relapse|0|||
33492871|NCT00460603|101698081|FG004|Phase 2|Objective Progression or Relapse|0|||
33492872|NCT00460603|101698082|FG005|Phase 2|Objective Progression or Relapse|0|||
33492873|NCT00460603|101698083|FG006|Phase 2|Objective Progression or Relapse|0|||
33492874|NCT00460603|101698084|FG007|Phase 2|Objective Progression or Relapse|0|||
33492875|NCT00460603|101698085|FG008|Phase 2|Objective Progression or Relapse|0|||
33492876|NCT00460603|101698086|FG009|Phase 2|Objective Progression or Relapse|9|||
33492877|NCT00460603|101698087|FG010|Phase 2|Objective Progression or Relapse|10|||
33492878|NCT00460603|101698088|FG011|Phase 2|Objective Progression or Relapse|17|||
33492879|NCT00460603|101698077|FG000|Phase 2|Global Deterioration of Health Status|0|||
33492880|NCT00460603|101698078|FG001|Phase 2|Global Deterioration of Health Status|0|||
33492881|NCT00460603|101698079|FG002|Phase 2|Global Deterioration of Health Status|0|||
33492882|NCT00460603|101698080|FG003|Phase 2|Global Deterioration of Health Status|0|||
33492883|NCT00460603|101698081|FG004|Phase 2|Global Deterioration of Health Status|0|||
33492884|NCT00460603|101698082|FG005|Phase 2|Global Deterioration of Health Status|0|||
33492885|NCT00460603|101698083|FG006|Phase 2|Global Deterioration of Health Status|0|||
33492886|NCT00460603|101698084|FG007|Phase 2|Global Deterioration of Health Status|0|||
33492887|NCT00460603|101698085|FG008|Phase 2|Global Deterioration of Health Status|0|||
33492888|NCT00460603|101698086|FG009|Phase 2|Global Deterioration of Health Status|0|||
33492889|NCT00460603|101698087|FG010|Phase 2|Global Deterioration of Health Status|1|||
33492890|NCT00460603|101698088|FG011|Phase 2|Global Deterioration of Health Status|0|||
33388894|NCT02911519|101313552|FG000|Overall Study|Death|0|||
33388895|NCT02911519|101313553|FG001|Overall Study|Death|2|||
33388896|NCT00318370|101313564|FG000|Period 1|Lack of Efficacy|5|||
33388897|NCT00318370|101313565|FG001|Period 1|Lack of Efficacy|0|||
33492891|NCT00460603|101698077|FG000|Phase 2|Withdrawal by Subject|0|||
33492892|NCT00460603|101698078|FG001|Phase 2|Withdrawal by Subject|0|||
33492893|NCT00460603|101698079|FG002|Phase 2|Withdrawal by Subject|0|||
33492894|NCT00460603|101698080|FG003|Phase 2|Withdrawal by Subject|0|||
33492895|NCT00460603|101698081|FG004|Phase 2|Withdrawal by Subject|0|||
33492896|NCT00460603|101698082|FG005|Phase 2|Withdrawal by Subject|0|||
33492897|NCT00460603|101698083|FG006|Phase 2|Withdrawal by Subject|0|||
33492898|NCT00460603|101698084|FG007|Phase 2|Withdrawal by Subject|0|||
33388898|NCT00318370|101313566|FG002|Period 1|Lack of Efficacy|0|||
33492899|NCT00460603|101698085|FG008|Phase 2|Withdrawal by Subject|0|||
33492900|NCT00460603|101698086|FG009|Phase 2|Withdrawal by Subject|5|||
33492901|NCT00460603|101698087|FG010|Phase 2|Withdrawal by Subject|4|||
33492902|NCT00460603|101698088|FG011|Phase 2|Withdrawal by Subject|5|||
33492903|NCT00460603|101698077|FG000|Phase 2|Randomized, but not treated|0|||
33492904|NCT00460603|101698078|FG001|Phase 2|Randomized, but not treated|0|||
33388899|NCT00318370|101313564|FG000|Period 1|Physician Decision|1|||
33388900|NCT00318370|101313565|FG001|Period 1|Physician Decision|0|||
33388901|NCT00318370|101313566|FG002|Period 1|Physician Decision|0|||
33388902|NCT00318370|101313564|FG000|Period 1|Withdrawal by Subject|1|||
33388903|NCT00318370|101313565|FG001|Period 1|Withdrawal by Subject|0|||
33388904|NCT00318370|101313566|FG002|Period 1|Withdrawal by Subject|0|||
33388905|NCT00318370|101313564|FG000|Period 2|Adverse Event|0|||
33388906|NCT00318370|101313565|FG001|Period 2|Adverse Event|3|||
33388907|NCT00318370|101313566|FG002|Period 2|Adverse Event|0|||
33388908|NCT00318370|101313564|FG000|Period 2|Lack of Efficacy|0|||
33388909|NCT00318370|101313565|FG001|Period 2|Lack of Efficacy|5|||
33388910|NCT00318370|101313566|FG002|Period 2|Lack of Efficacy|0|||
33388911|NCT00318370|101313564|FG000|Period 2|Physician Decision|0|||
33388912|NCT00318370|101313565|FG001|Period 2|Physician Decision|1|||
33388913|NCT00318370|101313566|FG002|Period 2|Physician Decision|0|||
33388914|NCT00318370|101313564|FG000|Period 2|Withdrawal by Subject|0|||
33388915|NCT00318370|101313565|FG001|Period 2|Withdrawal by Subject|1|||
33388916|NCT00318370|101313566|FG002|Period 2|Withdrawal by Subject|0|||
33388917|NCT00318370|101313564|FG000|Period 2|Other|0|||
33388918|NCT00318370|101313565|FG001|Period 2|Other|1|||
33388919|NCT00318370|101313566|FG002|Period 2|Other|0|||
33388920|NCT00318370|101313564|FG000|Period 3|Adverse Event|0|||
33388921|NCT00318370|101313565|FG001|Period 3|Adverse Event|0|||
33286722|NCT03305809|100947713|FG001|Overall Study|Physician Decision|0|||
33286723|NCT03305809|100947714|FG002|Overall Study|Physician Decision|2|||
33286724|NCT03305809|100947715|FG003|Overall Study|Physician Decision|4|||
33286725|NCT03305809|100947712|FG000|Overall Study|Progressive Disease|0|||
33286726|NCT03305809|100947713|FG001|Overall Study|Progressive Disease|0|||
33286727|NCT03305809|100947714|FG002|Overall Study|Progressive Disease|1|||
33286728|NCT03305809|100947715|FG003|Overall Study|Progressive Disease|0|||
33286729|NCT03305809|100947712|FG000|Overall Study|Protocol Violation|1|||
33286730|NCT03305809|100947713|FG001|Overall Study|Protocol Violation|0|||
33286731|NCT03305809|100947714|FG002|Overall Study|Protocol Violation|2|||
33286732|NCT03305809|100947715|FG003|Overall Study|Protocol Violation|3|||
33286733|NCT03305809|100947712|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
33286734|NCT03305809|100947713|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
33286735|NCT03305809|100947714|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
33286736|NCT03305809|100947715|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
33286737|NCT03305809|100947712|FG000|Overall Study|Withdrawal by Subject|2|||
33286738|NCT03305809|100947713|FG001|Overall Study|Withdrawal by Subject|4|||
33286739|NCT03305809|100947714|FG002|Overall Study|Withdrawal by Subject|5|||
33286740|NCT03305809|100947715|FG003|Overall Study|Withdrawal by Subject|2|||
33492905|NCT00460603|101698079|FG002|Phase 2|Randomized, but not treated|0|||
33492906|NCT00460603|101698080|FG003|Phase 2|Randomized, but not treated|0|||
33492907|NCT00460603|101698081|FG004|Phase 2|Randomized, but not treated|0|||
33492908|NCT00460603|101698082|FG005|Phase 2|Randomized, but not treated|0|||
33492909|NCT00460603|101698083|FG006|Phase 2|Randomized, but not treated|0|||
33492910|NCT00460603|101698084|FG007|Phase 2|Randomized, but not treated|0|||
33492911|NCT00460603|101698085|FG008|Phase 2|Randomized, but not treated|0|||
33492912|NCT00460603|101698086|FG009|Phase 2|Randomized, but not treated|3|||
33492913|NCT00460603|101698087|FG010|Phase 2|Randomized, but not treated|0|||
33492914|NCT00460603|101698088|FG011|Phase 2|Randomized, but not treated|0|||
33492915|NCT02762929|101698090|FG000|Overall Study|Adverse Event|0|||
33492916|NCT02762929|101698091|FG001|Overall Study|Adverse Event|0|||
33183119|NCT01068509|100582829|FG001|Overall Study|Withdrew Consent|1|||
33286741|NCT03305809|100947712|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
33286742|NCT03305809|100947713|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
33286743|NCT03305809|100947714|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
33183120|NCT01068509|100582830|FG002|Overall Study|Withdrew Consent|2|||
33286744|NCT03305809|100947715|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
33286745|NCT00846768|100947716|FG000|Overall Study|Adverse Event|0|||
33388922|NCT00318370|101313566|FG002|Period 3|Adverse Event|1|||
33286746|NCT00846768|100947717|FG001|Overall Study|Adverse Event|1|||
33286747|NCT00846768|100947718|FG002|Overall Study|Adverse Event|0|||
33286748|NCT00846768|100947719|FG003|Overall Study|Adverse Event|0|||
33286749|NCT00025662|100947720|FG000|Overall Study|Withdrawal by Subject|2|||
33388923|NCT00318370|101313564|FG000|Period 3|Lack of Efficacy|0|||
33388924|NCT00318370|101313565|FG001|Period 3|Lack of Efficacy|0|||
33388925|NCT00318370|101313566|FG002|Period 3|Lack of Efficacy|24|||
33388926|NCT00318370|101313564|FG000|Period 3|Death|0|||
33388927|NCT00318370|101313565|FG001|Period 3|Death|0|||
33388928|NCT00318370|101313566|FG002|Period 3|Death|1|||
33388929|NCT00318370|101313564|FG000|Period 3|Physician Decision|0|||
33388930|NCT00318370|101313565|FG001|Period 3|Physician Decision|0|||
33594246|NCT02743949|102064878|FG000|Overall Study|Adverse Event|0|||
33388931|NCT00318370|101313566|FG002|Period 3|Physician Decision|1|||
33388932|NCT00318370|101313564|FG000|Period 3|Withdrawal by Subject|0|||
33492917|NCT02762929|101698092|FG002|Overall Study|Adverse Event|0|||
33492918|NCT02762929|101698093|FG003|Overall Study|Adverse Event|1|||
33492919|NCT02762929|101698094|FG004|Overall Study|Adverse Event|0|||
33286750|NCT00025662|100947720|FG000|Overall Study|Technical failure of manipulation|1|||
33286751|NCT00727415|100947721|FG000|Phase I|Dose Limiting Toxicity|2|||
33286752|NCT01263925|100947722|FG000|Overall Study|Protocol Violation|1|||
33286753|NCT01263925|100947723|FG001|Overall Study|Protocol Violation|0|||
33286754|NCT01263925|100947722|FG000|Overall Study|Lack of Efficacy|0|||
33286755|NCT01263925|100947723|FG001|Overall Study|Lack of Efficacy|1|||
33286756|NCT01263925|100947722|FG000|Overall Study|Adverse Event|23|||
33286757|NCT01263925|100947723|FG001|Overall Study|Adverse Event|22|||
33286758|NCT01263925|100947722|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
33286759|NCT01263925|100947723|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
33286760|NCT01263925|100947722|FG000|Overall Study|Withdrawal by Subject|6|||
33286761|NCT01263925|100947723|FG001|Overall Study|Withdrawal by Subject|8|||
33286762|NCT01263925|100947722|FG000|Overall Study|Other|4|||
33286763|NCT01263925|100947723|FG001|Overall Study|Other|4|||
33286764|NCT01263925|100947722|FG000|Overall Study|Lost to Follow-up|3|||
33286765|NCT01263925|100947723|FG001|Overall Study|Lost to Follow-up|1|||
33286766|NCT01263925|100947722|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
33286767|NCT01263925|100947723|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
33286768|NCT01263925|100947722|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
33286769|NCT01263925|100947723|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
33286770|NCT01263925|100947722|FG000|Overall Study|AE/ Withdrawal|1|||
33286771|NCT01263925|100947723|FG001|Overall Study|AE/ Withdrawal|4|||
33286772|NCT01263925|100947722|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
33492920|NCT02762929|101698095|FG005|Overall Study|Adverse Event|0|||
33492921|NCT02762929|101698090|FG000|Overall Study|Lost to Follow-up|1|||
33286773|NCT01263925|100947723|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
33286774|NCT01263925|100947722|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
33286775|NCT01263925|100947723|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
33286776|NCT01263925|100947722|FG000|Overall Study|Withdrawal/ Not specified|0|||
33286777|NCT01263925|100947723|FG001|Overall Study|Withdrawal/ Not specified|1|||
33286778|NCT01185171|100947724|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
33286779|NCT01185171|100947724|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
33286780|NCT01185171|100947724|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
33286781|NCT01185171|100947724|FG000|Maintenance|Elevated liver transaminases|3|||
33286782|NCT01185171|100947724|FG000|Maintenance|Rush|2|||
33286783|NCT01185171|100947724|FG000|Maintenance|Diarrhea|1|||
33286784|NCT01185171|100947724|FG000|Maintenance|Xerostomia|1|||
33286785|NCT01185171|100947724|FG000|Maintenance|Nausea|1|||
33286786|NCT01185171|100947724|FG000|Maintenance|Comorbid Illness|2|||
33286787|NCT01185171|100947724|FG000|Maintenance|Withdrawal by Subject|1|||
33286788|NCT01185171|100947724|FG000|Maintenance|Disease Recurrence|1|||
33492922|NCT02762929|101698091|FG001|Overall Study|Lost to Follow-up|2|||
33286789|NCT00129649|100947725|FG000|Overall Study|Withdrawal by Subject|76|||
33286790|NCT00129649|100947726|FG001|Overall Study|Withdrawal by Subject|65|||
33286791|NCT04035577|100947727|FG000|Overall Study|Lost to Follow-up|1|||
33286792|NCT04035577|100947727|FG000|Overall Study|Withdrawal by Subject|1|||
33492923|NCT02762929|101698092|FG002|Overall Study|Lost to Follow-up|0|||
33492924|NCT02762929|101698093|FG003|Overall Study|Lost to Follow-up|1|||
33492925|NCT02762929|101698094|FG004|Overall Study|Lost to Follow-up|0|||
33492926|NCT02762929|101698095|FG005|Overall Study|Lost to Follow-up|0|||
33492927|NCT02762929|101698090|FG000|Overall Study|Withdrawal by Subject|0|||
33492928|NCT02762929|101698091|FG001|Overall Study|Withdrawal by Subject|1|||
33492929|NCT02762929|101698092|FG002|Overall Study|Withdrawal by Subject|0|||
33183121|NCT01068509|100582828|FG000|Overall Study|Reason Not Specified|0|||
33286793|NCT00611715|100947728|FG000|Overall Study|Disease Progression|24|||
33286794|NCT00611715|100947729|FG001|Overall Study|Disease Progression|4|||
33286795|NCT00611715|100947728|FG000|Overall Study|Withdrawal by Subject|5|||
33286796|NCT00611715|100947729|FG001|Overall Study|Withdrawal by Subject|1|||
33286797|NCT00611715|100947728|FG000|Overall Study|Adverse Event|9|||
33286798|NCT00611715|100947729|FG001|Overall Study|Adverse Event|1|||
33286799|NCT00611715|100947728|FG000|Overall Study|Death|1|||
33286800|NCT00611715|100947729|FG001|Overall Study|Death|0|||
33286801|NCT00611715|100947728|FG000|Overall Study|two patients are still on treatment|2|||
33286802|NCT00611715|100947729|FG001|Overall Study|two patients are still on treatment|0|||
33286803|NCT00630552|100947730|FG000|Overall Study|Adverse Event|0|||
33286804|NCT00630552|100947731|FG001|Overall Study|Adverse Event|1|||
33286805|NCT00630552|100947732|FG002|Overall Study|Adverse Event|5|||
33286806|NCT00630552|100947733|FG003|Overall Study|Adverse Event|4|||
33286807|NCT00630552|100947734|FG004|Overall Study|Adverse Event|2|||
33286808|NCT00630552|100947730|FG000|Overall Study|Disease progression|5|||
33286809|NCT00630552|100947731|FG001|Overall Study|Disease progression|6|||
33286810|NCT00630552|100947732|FG002|Overall Study|Disease progression|27|||
33286811|NCT00630552|100947733|FG003|Overall Study|Disease progression|22|||
33286812|NCT00630552|100947734|FG004|Overall Study|Disease progression|31|||
33492930|NCT02762929|101698093|FG003|Overall Study|Withdrawal by Subject|0|||
33492931|NCT02762929|101698094|FG004|Overall Study|Withdrawal by Subject|0|||
33492932|NCT02762929|101698095|FG005|Overall Study|Withdrawal by Subject|0|||
33492933|NCT02762929|101698090|FG000|Overall Study|exclusionary medication disclosed late|0|||
33492934|NCT02762929|101698091|FG001|Overall Study|exclusionary medication disclosed late|0|||
33492935|NCT02762929|101698092|FG002|Overall Study|exclusionary medication disclosed late|0|||
33492936|NCT02762929|101698093|FG003|Overall Study|exclusionary medication disclosed late|1|||
33492937|NCT02762929|101698094|FG004|Overall Study|exclusionary medication disclosed late|0|||
33492938|NCT02762929|101698095|FG005|Overall Study|exclusionary medication disclosed late|0|||
33492939|NCT00235755|101698096|FG000|4-Week Titration Phase|Adverse Event|6|||
33492940|NCT00235755|101698097|FG001|4-Week Titration Phase|Adverse Event|14|||
33492941|NCT00235755|101698098|FG002|4-Week Titration Phase|Adverse Event|20|||
33492942|NCT00235755|101698096|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
33492943|NCT00235755|101698097|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
33492944|NCT00235755|101698098|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
33183122|NCT01068509|100582829|FG001|Overall Study|Reason Not Specified|1|||
33183123|NCT01068509|100582830|FG002|Overall Study|Reason Not Specified|0|||
33183124|NCT01413360|100582831|FG000|Overall Study|Lost to Follow-up|2|||
33183125|NCT01413360|100582831|FG000|Overall Study|Adverse Event|1|||
33183126|NCT00978068|100582832|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
33286813|NCT00630552|100947730|FG000|Overall Study|Never received IP|0|||
33286814|NCT00630552|100947731|FG001|Overall Study|Never received IP|0|||
33286815|NCT00630552|100947732|FG002|Overall Study|Never received IP|0|||
33286816|NCT00630552|100947733|FG003|Overall Study|Never received IP|2|||
33286817|NCT00630552|100947734|FG004|Overall Study|Never received IP|2|||
33286818|NCT00630552|100947730|FG000|Overall Study|Ineligibility determined|0|||
33286819|NCT00630552|100947731|FG001|Overall Study|Ineligibility determined|0|||
33286820|NCT00630552|100947732|FG002|Overall Study|Ineligibility determined|0|||
33286821|NCT00630552|100947733|FG003|Overall Study|Ineligibility determined|0|||
33286822|NCT00630552|100947734|FG004|Overall Study|Ineligibility determined|1|||
33286823|NCT00630552|100947730|FG000|Overall Study|Protocol Violation|0|||
33286824|NCT00630552|100947731|FG001|Overall Study|Protocol Violation|0|||
33286825|NCT00630552|100947732|FG002|Overall Study|Protocol Violation|0|||
33286826|NCT00630552|100947733|FG003|Overall Study|Protocol Violation|1|||
33286827|NCT00630552|100947734|FG004|Overall Study|Protocol Violation|0|||
33286828|NCT00630552|100947730|FG000|Overall Study|Physician Decision|0|||
33286829|NCT00630552|100947731|FG001|Overall Study|Physician Decision|0|||
33286830|NCT00630552|100947732|FG002|Overall Study|Physician Decision|0|||
33286831|NCT00630552|100947733|FG003|Overall Study|Physician Decision|0|||
33286832|NCT00630552|100947734|FG004|Overall Study|Physician Decision|1|||
33286833|NCT00630552|100947730|FG000|Overall Study|Death|0|||
33286834|NCT00630552|100947731|FG001|Overall Study|Death|0|||
33286835|NCT00630552|100947732|FG002|Overall Study|Death|1|||
33286836|NCT00630552|100947733|FG003|Overall Study|Death|2|||
33286837|NCT00630552|100947734|FG004|Overall Study|Death|2|||
33286838|NCT00630552|100947730|FG000|Overall Study|Withdrawal by Subject|0|||
33286839|NCT00630552|100947731|FG001|Overall Study|Withdrawal by Subject|0|||
33286840|NCT00630552|100947732|FG002|Overall Study|Withdrawal by Subject|0|||
33183127|NCT00978068|100582833|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
33183128|NCT00978068|100582832|FG000|Overall Study|Death|1|||
33183129|NCT00978068|100582833|FG001|Overall Study|Death|2|||
33183130|NCT00978068|100582832|FG000|Overall Study|Lost to Follow-up|1|||
33183131|NCT00978068|100582833|FG001|Overall Study|Lost to Follow-up|2|||
33183132|NCT00978068|100582832|FG000|Overall Study|Physician Decision|0|||
33183133|NCT00978068|100582833|FG001|Overall Study|Physician Decision|1|||
33183134|NCT00978068|100582832|FG000|Overall Study|Unable to Comply with Study|0|||
33183135|NCT00978068|100582833|FG001|Overall Study|Unable to Comply with Study|2|||
33183136|NCT01498952|100582837|FG000|Overall Study|Death|2|||
33183137|NCT01498952|100582838|FG001|Overall Study|Death|2|||
33183138|NCT01498952|100582839|FG002|Overall Study|Death|0|||
33183139|NCT01498952|100582840|FG003|Overall Study|Death|0|||
33286841|NCT00630552|100947733|FG003|Overall Study|Withdrawal by Subject|1|||
33286842|NCT00630552|100947734|FG004|Overall Study|Withdrawal by Subject|0|||
33286843|NCT00630552|100947730|FG000|Overall Study|Other|0|||
33286844|NCT00630552|100947731|FG001|Overall Study|Other|0|||
33286845|NCT00630552|100947732|FG002|Overall Study|Other|4|||
33286846|NCT00630552|100947733|FG003|Overall Study|Other|2|||
33286847|NCT00630552|100947734|FG004|Overall Study|Other|0|||
33286848|NCT02637856|100947740|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
33286849|NCT02637856|100947741|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
33286850|NCT02637856|100947740|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
33286851|NCT02637856|100947741|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
33286852|NCT02637856|100947740|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
33286853|NCT02637856|100947741|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
33388933|NCT00318370|101313565|FG001|Period 3|Withdrawal by Subject|0|||
33492945|NCT00235755|101698096|FG000|4-Week Titration Phase|Protocol Violation|2|||
33492946|NCT00235755|101698097|FG001|4-Week Titration Phase|Protocol Violation|2|||
33183140|NCT01498952|100582841|FG004|Overall Study|Death|0|||
33183141|NCT00702403|100582842|FG000|From Consent to Engraftment|Progressive leukemia|6|||
33286854|NCT02637856|100947740|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
33183142|NCT00702403|100582842|FG000|From Consent to Engraftment|Critically ill|2|||
33183143|NCT00702403|100582842|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
33183144|NCT00702403|100582842|FG000|From Consent to Engraftment|Myocardial infarction|1|||
33183145|NCT00702403|100582842|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
33183146|NCT00702403|100582842|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
33183147|NCT00702403|100582842|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
33183148|NCT00702403|100582842|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
33183149|NCT00702403|100582842|FG000|From Engraftment to Study Completion|Non-compliance|2|||
33183150|NCT00702403|100582842|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
33183151|NCT00702403|100582842|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
33183152|NCT00702403|100582842|FG000|From Engraftment to Study Completion|Suicide|1|||
33183153|NCT00702403|100582842|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
33183154|NCT00702403|100582842|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
33183155|NCT00702403|100582842|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
33183156|NCT03526458|100582848|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
33183157|NCT03526458|100582849|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
33183158|NCT03526458|100582848|FG000|Overall Study|Stone passed, surgery cancelled|2|||
33183159|NCT03526458|100582849|FG001|Overall Study|Stone passed, surgery cancelled|1|||
33183160|NCT03526458|100582848|FG000|Overall Study|Withdrawal by Subject|1|||
33183161|NCT03526458|100582849|FG001|Overall Study|Withdrawal by Subject|0|||
33183162|NCT03526458|100582848|FG000|Overall Study|Physician Decision|2|||
33183163|NCT03526458|100582849|FG001|Overall Study|Physician Decision|1|||
33183164|NCT03526458|100582848|FG000|Overall Study|Lack of equipment|1|||
33183165|NCT03526458|100582849|FG001|Overall Study|Lack of equipment|1|||
33183166|NCT00798369|100582850|FG000|Overall Study|Subject withdrew consent|0|||
33183167|NCT00798369|100582851|FG001|Overall Study|Subject withdrew consent|0|||
33183168|NCT00798369|100582852|FG002|Overall Study|Subject withdrew consent|1|||
33183169|NCT00798369|100582853|FG003|Overall Study|Subject withdrew consent|1|||
33183170|NCT00798369|100582854|FG004|Overall Study|Subject withdrew consent|0|||
33183171|NCT00798369|100582855|FG005|Overall Study|Subject withdrew consent|2|||
33183172|NCT00798369|100582850|FG000|Overall Study|Lost to Follow-up|1|||
33183173|NCT00798369|100582851|FG001|Overall Study|Lost to Follow-up|1|||
33183174|NCT00798369|100582852|FG002|Overall Study|Lost to Follow-up|1|||
33183175|NCT00798369|100582853|FG003|Overall Study|Lost to Follow-up|0|||
33183176|NCT00798369|100582854|FG004|Overall Study|Lost to Follow-up|1|||
33183177|NCT00798369|100582855|FG005|Overall Study|Lost to Follow-up|0|||
33183178|NCT00798369|100582850|FG000|Overall Study|Adminstrative problems|0|||
33183179|NCT00798369|100582851|FG001|Overall Study|Adminstrative problems|0|||
33183180|NCT00798369|100582852|FG002|Overall Study|Adminstrative problems|0|||
33183181|NCT00798369|100582853|FG003|Overall Study|Adminstrative problems|0|||
33183182|NCT00798369|100582854|FG004|Overall Study|Adminstrative problems|0|||
33183183|NCT00798369|100582855|FG005|Overall Study|Adminstrative problems|1|||
33183184|NCT04568590|100582856|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
33183185|NCT03792672|100582857|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
33183186|NCT03792672|100582858|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
33183187|NCT03792672|100582859|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
33183188|NCT03792672|100582860|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
33183189|NCT03792672|100582861|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
33183190|NCT03792672|100582862|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
33183191|NCT03792672|100582857|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
33183192|NCT03792672|100582858|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
33183193|NCT03792672|100582859|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
33183194|NCT03792672|100582860|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
33183195|NCT03792672|100582861|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
33183196|NCT03792672|100582862|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
33183197|NCT03792672|100582857|FG000|Treatment Period 4 (2 Days)|Other|1|||
33183198|NCT03792672|100582858|FG001|Treatment Period 4 (2 Days)|Other|0|||
33183199|NCT03792672|100582859|FG002|Treatment Period 4 (2 Days)|Other|0|||
33183200|NCT03792672|100582860|FG003|Treatment Period 4 (2 Days)|Other|0|||
33183201|NCT03792672|100582861|FG004|Treatment Period 4 (2 Days)|Other|0|||
33183202|NCT03792672|100582862|FG005|Treatment Period 4 (2 Days)|Other|0|||
33183203|NCT03465878|100582863|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
33183204|NCT03465878|100582864|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
33286855|NCT02637856|100947741|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
33388934|NCT00318370|101313566|FG002|Period 3|Withdrawal by Subject|3|||
33183205|NCT03465878|100582865|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
33183206|NCT03465878|100582866|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
33183207|NCT03465878|100582863|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
33286856|NCT02637856|100947740|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
33286857|NCT02637856|100947741|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
33388935|NCT00318370|101313564|FG000|Period 3|Other|0|||
33183208|NCT03465878|100582864|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
33183209|NCT03465878|100582865|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
33183210|NCT03465878|100582866|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
33286858|NCT02637856|100947740|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
33286859|NCT02637856|100947741|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
33286860|NCT02637856|100947740|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
33286861|NCT02637856|100947741|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
33286862|NCT02637856|100947740|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
33286863|NCT02637856|100947741|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
33286864|NCT02637856|100947740|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
33286865|NCT02637856|100947741|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
33286866|NCT02637856|100947740|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
33286867|NCT02637856|100947741|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
33286868|NCT02637856|100947740|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
33286869|NCT02637856|100947741|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
33286870|NCT02637856|100947740|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
33286871|NCT02637856|100947741|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
33286872|NCT02637856|100947740|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
33286873|NCT02637856|100947741|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
33286874|NCT00827775|100947748|FG000|Overall Study|Withdrawal by Subject|0|||
33286875|NCT00827775|100947749|FG001|Overall Study|Withdrawal by Subject|5|||
33286876|NCT01093599|100947752|FG000|Overall Study|Lost to Follow-up|32|||
33286877|NCT01093599|100947753|FG001|Overall Study|Lost to Follow-up|46|||
33183211|NCT03465878|100582863|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
33183212|NCT03465878|100582864|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
33286878|NCT00443898|100947756|FG000|Overall Study|Adverse Event|0|||
33286879|NCT00443898|100947757|FG001|Overall Study|Adverse Event|0|||
33286880|NCT00443898|100947758|FG002|Overall Study|Adverse Event|1|||
33286881|NCT00443898|100947759|FG003|Overall Study|Adverse Event|1|||
33286882|NCT00443898|100947756|FG000|Overall Study|Lack of Efficacy|2|||
33286883|NCT00443898|100947757|FG001|Overall Study|Lack of Efficacy|3|||
33286884|NCT00443898|100947758|FG002|Overall Study|Lack of Efficacy|3|||
33183213|NCT03465878|100582865|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
33183214|NCT03465878|100582866|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
33183215|NCT01177540|100582867|FG000|Overall Study|Adverse Event|1|||
33183216|NCT01177540|100582868|FG001|Overall Study|Adverse Event|0|||
33183217|NCT02519712|100582871|FG000|Overall Study|Disease Relapse|1|||
33183218|NCT02519712|100582871|FG000|Overall Study|Disease Progression|1|||
33183219|NCT02519712|100582871|FG000|Overall Study|Accruals are donors|2|||
33183220|NCT00718328|100582873|FG000|Overall Study|Lost to Follow-up|1|||
33183221|NCT00718328|100582874|FG001|Overall Study|Lost to Follow-up|0|||
33183222|NCT00116831|100582875|FG000|Overall Study|Adverse Event|14|||
33183223|NCT00116831|100582876|FG001|Overall Study|Adverse Event|16|||
33183224|NCT00116831|100582875|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
33183225|NCT00116831|100582876|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
33183226|NCT00116831|100582875|FG000|Overall Study|Lost to Follow-up|8|||
33183227|NCT00116831|100582876|FG001|Overall Study|Lost to Follow-up|6|||
33183228|NCT00116831|100582875|FG000|Overall Study|Protocol Violation|3|||
33183229|NCT00116831|100582876|FG001|Overall Study|Protocol Violation|6|||
33183230|NCT00116831|100582875|FG000|Overall Study|Hypoglycaemic events|1|||
33286885|NCT00443898|100947759|FG003|Overall Study|Lack of Efficacy|1|||
33183231|NCT00116831|100582876|FG001|Overall Study|Hypoglycaemic events|0|||
33183232|NCT00116831|100582875|FG000|Overall Study|Low haemoglobin on screening|1|||
33183233|NCT00116831|100582876|FG001|Overall Study|Low haemoglobin on screening|0|||
33183234|NCT00116831|100582875|FG000|Overall Study|Withdrawn investigational product|1|||
33183235|NCT00116831|100582876|FG001|Overall Study|Withdrawn investigational product|0|||
33183236|NCT00116831|100582875|FG000|Overall Study|Withdrawal by Subject|32|||
33183237|NCT00116831|100582876|FG001|Overall Study|Withdrawal by Subject|32|||
33183238|NCT00116831|100582875|FG000|Overall Study|Insufficient therapeutic effect|0|||
33183239|NCT00116831|100582876|FG001|Overall Study|Insufficient therapeutic effect|1|||
33286886|NCT00443898|100947756|FG000|Overall Study|Protocol Violation|1|||
33183240|NCT00116831|100582875|FG000|Overall Study|Missing data for participant|1|||
33183241|NCT00116831|100582876|FG001|Overall Study|Missing data for participant|0|||
33286887|NCT00443898|100947757|FG001|Overall Study|Protocol Violation|1|||
33286888|NCT00443898|100947758|FG002|Overall Study|Protocol Violation|1|||
33286889|NCT00443898|100947759|FG003|Overall Study|Protocol Violation|0|||
33286890|NCT00443898|100947756|FG000|Overall Study|Withdrawal by Subject|11|||
33286891|NCT00443898|100947757|FG001|Overall Study|Withdrawal by Subject|10|||
33286892|NCT00443898|100947758|FG002|Overall Study|Withdrawal by Subject|10|||
33183242|NCT02466555|100582877|FG000|Overall Study|Lost to Follow-up|2|||
33183243|NCT04248933|100582878|FG000|Overall Study|Lost to Follow-up|9|||
33183244|NCT04248933|100582878|FG000|Overall Study|Withdrawal by Subject|2|||
33183245|NCT00748215|100582879|FG000|Overall Study|Withdrawal by Subject|7|||
33183246|NCT00748215|100582880|FG001|Overall Study|Withdrawal by Subject|7|||
33183247|NCT00748215|100582879|FG000|Overall Study|Treatment change|2|||
33183248|NCT00748215|100582880|FG001|Overall Study|Treatment change|1|||
33183249|NCT00748215|100582879|FG000|Overall Study|Change in patient condition|0|||
33183250|NCT00748215|100582880|FG001|Overall Study|Change in patient condition|3|||
33183251|NCT00748215|100582879|FG000|Overall Study|Non-compliant|0|||
33183252|NCT00748215|100582880|FG001|Overall Study|Non-compliant|2|||
33183253|NCT00748215|100582879|FG000|Overall Study|Adverse Event|0|||
33183254|NCT00748215|100582880|FG001|Overall Study|Adverse Event|5|||
33183255|NCT00696137|100582881|FG000|Overall Study|Withdrawal by Subject|2|||
33183256|NCT01417481|100582882|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
33183257|NCT01417481|100582883|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
33183258|NCT04059146|100582889|FG000|Overall Study|Withdrawal by Subject|0|||
33183259|NCT04059146|100582890|FG001|Overall Study|Withdrawal by Subject|1|||
33183260|NCT03257631|100582891|FG000|Overall Study|Death|1|||
33183261|NCT03257631|100582892|FG001|Overall Study|Death|0|||
33183262|NCT03257631|100582893|FG002|Overall Study|Death|1|||
33183263|NCT03257631|100582894|FG003|Overall Study|Death|1|||
33183264|NCT03257631|100582891|FG000|Overall Study|Progressive Disease|10|||
33183265|NCT03257631|100582892|FG001|Overall Study|Progressive Disease|9|||
33183266|NCT03257631|100582893|FG002|Overall Study|Progressive Disease|17|||
33183267|NCT03257631|100582894|FG003|Overall Study|Progressive Disease|8|||
33183268|NCT03257631|100582891|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33183269|NCT03257631|100582892|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33183270|NCT03257631|100582893|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
33183271|NCT03257631|100582894|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
33286893|NCT00443898|100947759|FG003|Overall Study|Withdrawal by Subject|6|||
33286894|NCT00443898|100947756|FG000|Overall Study|Lost to Follow-up|10|||
33286895|NCT00443898|100947757|FG001|Overall Study|Lost to Follow-up|10|||
33286896|NCT00443898|100947758|FG002|Overall Study|Lost to Follow-up|14|||
33286897|NCT00443898|100947759|FG003|Overall Study|Lost to Follow-up|10|||
33286898|NCT00443898|100947756|FG000|Overall Study|Death|0|||
33286899|NCT00443898|100947757|FG001|Overall Study|Death|1|||
33286900|NCT00443898|100947758|FG002|Overall Study|Death|0|||
33286901|NCT00443898|100947759|FG003|Overall Study|Death|0|||
33286902|NCT01664923|100947760|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
33286903|NCT01664923|100947761|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
33286904|NCT01664923|100947760|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
33286905|NCT01664923|100947761|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
33286906|NCT01664923|100947760|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
33286907|NCT01664923|100947761|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
33286908|NCT01664923|100947760|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
33286909|NCT01664923|100947761|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
33286910|NCT01664923|100947760|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
33286911|NCT01664923|100947761|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
33286912|NCT01664923|100947760|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
33286913|NCT01664923|100947761|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
33286914|NCT01664923|100947760|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
33286915|NCT01664923|100947761|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
33286916|NCT01664923|100947760|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
33286917|NCT01664923|100947761|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
33286918|NCT01664923|100947760|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
33286919|NCT01664923|100947761|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
33286920|NCT01664923|100947760|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
33286921|NCT01664923|100947761|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
33286922|NCT01664923|100947760|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
33286923|NCT01664923|100947761|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
33286924|NCT01664923|100947760|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
33286925|NCT01664923|100947761|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
33286926|NCT01664923|100947760|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
33286927|NCT01664923|100947761|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
33183272|NCT03257631|100582891|FG000|Overall Study|Adverse Event|0|||
33286928|NCT01664923|100947760|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
33183273|NCT03257631|100582892|FG001|Overall Study|Adverse Event|0|||
33183274|NCT03257631|100582893|FG002|Overall Study|Adverse Event|2|||
33286929|NCT01664923|100947761|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
33286930|NCT01776008|100947762|FG000|Overall Study|ineligible|2|||
33388936|NCT00318370|101313565|FG001|Period 3|Other|0|||
33183275|NCT03257631|100582894|FG003|Overall Study|Adverse Event|0|||
33183276|NCT04608500|100582908|FG000|Overall Study|Adverse Event|2|||
33183277|NCT04608500|100582909|FG001|Overall Study|Adverse Event|0|||
33183278|NCT04608500|100582908|FG000|Overall Study|Lost to Follow-up|15|||
33183279|NCT04608500|100582909|FG001|Overall Study|Lost to Follow-up|9|||
33183280|NCT04608500|100582908|FG000|Overall Study|Participant request|11|||
33183281|NCT04608500|100582909|FG001|Overall Study|Participant request|7|||
33183282|NCT04608500|100582908|FG000|Overall Study|Protocol Violation|1|||
33183283|NCT04608500|100582909|FG001|Overall Study|Protocol Violation|0|||
33183284|NCT04608500|100582908|FG000|Overall Study|Other|6|||
33183285|NCT04608500|100582909|FG001|Overall Study|Other|2|||
33183286|NCT03336216|100582910|FG000|Randomization|Not reported|2|||
33183287|NCT03336216|100582911|FG001|Randomization|Not reported|0|||
33183288|NCT03336216|100582912|FG002|Randomization|Not reported|1|||
33183289|NCT03336216|100582913|FG003|Randomization|Not reported|0|||
33286931|NCT03599622|100947763|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
33286932|NCT03599622|100947764|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
33286933|NCT03599622|100947765|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
33286934|NCT03599622|100947766|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
33183290|NCT03336216|100582910|FG000|Randomization|Other reasons|1|||
33183291|NCT03336216|100582911|FG001|Randomization|Other reasons|1|||
33183292|NCT03336216|100582912|FG002|Randomization|Other reasons|1|||
33183293|NCT03336216|100582913|FG003|Randomization|Other reasons|0|||
33183294|NCT03336216|100582910|FG000|Randomization|Participant no longer meets study criteria|0|||
33286935|NCT03599622|100947763|FG000|Pre-Treatment Period|Other reasons|1|||
33286936|NCT03599622|100947764|FG001|Pre-Treatment Period|Other reasons|1|||
33286937|NCT03599622|100947765|FG002|Pre-Treatment Period|Other reasons|1|||
33286938|NCT03599622|100947766|FG003|Pre-Treatment Period|Other reasons|0|||
33286939|NCT03599622|100947763|FG000|Treatment Period|Adverse Event|11|||
33388937|NCT00318370|101313566|FG002|Period 3|Other|3|||
33388938|NCT03619837|101313567|FG000|Screening|received organs from HCV-negative donors|47|||
33388939|NCT03619837|101313567|FG000|Screening|died on the wait-list|2|||
33388940|NCT03619837|101313567|FG000|Screening|remained on the wait list|40|||
33388941|NCT03619837|101313567|FG000|Screening|didn't meet eligibility criteria|3|||
33388942|NCT03619837|101313567|FG000|Screening|withdrew consent|2|||
33388943|NCT03619837|101313567|FG000|Screening|never listed for HCV-viremic donor|1|||
33388944|NCT03619837|101313567|FG000|Screening|developed exclusion criteria|2|||
33388945|NCT03619837|101313567|FG000|Screening|excluded by the investigator due to non-compliance|1|||
33388946|NCT02384993|101313571|FG000|Overall Study|Adverse Event|0|||
33388947|NCT02384993|101313572|FG001|Overall Study|Adverse Event|1|||
33388948|NCT00368472|101313576|FG000|Overall Study|Adverse Event|22|||
33388949|NCT00368472|101313576|FG000|Overall Study|Medication non-compliance|4|||
33388950|NCT00368472|101313576|FG000|Overall Study|Protocol Violation|2|||
33388951|NCT00368472|101313576|FG000|Overall Study|Request of Investigator or Sponsor|3|||
33388952|NCT00368472|101313576|FG000|Overall Study|Withdrawal by Subject|40|||
33388953|NCT00368472|101313576|FG000|Overall Study|Diary non-compliance|1|||
33388954|NCT00368472|101313576|FG000|Overall Study|Other|32|||
33388955|NCT00368472|101313576|FG000|Overall Study|Missing Final Disposition Date|1|||
33388956|NCT02786836|101313579|FG000|Overall Study|Death|1|||
33388957|NCT02786836|101313579|FG000|Overall Study|Lack of Efficacy|2|||
33388958|NCT02786836|101313579|FG000|Overall Study|Protocol Violation|3|||
33388959|NCT02786836|101313579|FG000|Overall Study|Withdrawal by Subject|3|||
33388960|NCT02786836|101313579|FG000|Overall Study|Liver Transplantation|2|||
33388961|NCT02786836|101313579|FG000|Overall Study|Device or Pharmacy Issues|3|||
33388962|NCT03907969|101313583|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
33388963|NCT03907969|101313584|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
33388964|NCT03907969|101313585|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
33388965|NCT03907969|101313586|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
33388966|NCT03907969|101313587|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
33388967|NCT03907969|101313588|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
33388968|NCT03907969|101313589|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
33388969|NCT03907969|101313590|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
33183295|NCT03336216|100582911|FG001|Randomization|Participant no longer meets study criteria|2|||
33183296|NCT03336216|100582912|FG002|Randomization|Participant no longer meets study criteria|4|||
33183297|NCT03336216|100582913|FG003|Randomization|Participant no longer meets study criteria|1|||
33183298|NCT03336216|100582910|FG000|Randomization|Lost to Follow-up|1|||
33183299|NCT03336216|100582911|FG001|Randomization|Lost to Follow-up|0|||
33183300|NCT03336216|100582912|FG002|Randomization|Lost to Follow-up|0|||
33286940|NCT03599622|100947764|FG001|Treatment Period|Adverse Event|20|||
33388970|NCT03907969|101313591|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
33388971|NCT03907969|101313592|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
33388972|NCT03907969|101313593|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
33388973|NCT03907969|101313583|FG000|Monotherapy Part A|Progressive Disease|0|||
33388974|NCT03907969|101313584|FG001|Monotherapy Part A|Progressive Disease|1|||
33388975|NCT03907969|101313585|FG002|Monotherapy Part A|Progressive Disease|0|||
33183301|NCT03336216|100582913|FG003|Randomization|Lost to Follow-up|0|||
33183302|NCT03336216|100582910|FG000|Randomization|Participant withdrew consent|9|||
33183303|NCT03336216|100582911|FG001|Randomization|Participant withdrew consent|1|||
33183304|NCT03336216|100582912|FG002|Randomization|Participant withdrew consent|0|||
33183305|NCT03336216|100582913|FG003|Randomization|Participant withdrew consent|0|||
33286941|NCT03599622|100947765|FG002|Treatment Period|Adverse Event|18|||
33388976|NCT03907969|101313586|FG003|Monotherapy Part A|Progressive Disease|0|||
33388977|NCT03907969|101313587|FG004|Monotherapy Part A|Progressive Disease|0|||
33388978|NCT03907969|101313588|FG005|Monotherapy Part A|Progressive Disease|1|||
33388979|NCT03907969|101313589|FG006|Monotherapy Part A|Progressive Disease|2|||
33388980|NCT03907969|101313590|FG007|Monotherapy Part A|Progressive Disease|0|||
33388981|NCT03907969|101313591|FG008|Monotherapy Part A|Progressive Disease|0|||
33388982|NCT03907969|101313592|FG009|Monotherapy Part A|Progressive Disease|0|||
33388983|NCT03907969|101313593|FG010|Monotherapy Part A|Progressive Disease|0|||
33388984|NCT03907969|101313583|FG000|Monotherapy Part A|Death|0|||
33388985|NCT03907969|101313584|FG001|Monotherapy Part A|Death|0|||
33388986|NCT03907969|101313585|FG002|Monotherapy Part A|Death|1|||
33388987|NCT03907969|101313586|FG003|Monotherapy Part A|Death|1|||
33388988|NCT03907969|101313587|FG004|Monotherapy Part A|Death|0|||
33388989|NCT03907969|101313588|FG005|Monotherapy Part A|Death|1|||
33388990|NCT03907969|101313589|FG006|Monotherapy Part A|Death|0|||
33388991|NCT03907969|101313590|FG007|Monotherapy Part A|Death|0|||
33388992|NCT03907969|101313591|FG008|Monotherapy Part A|Death|0|||
33388993|NCT03907969|101313592|FG009|Monotherapy Part A|Death|0|||
33388994|NCT03907969|101313593|FG010|Monotherapy Part A|Death|0|||
33388995|NCT03907969|101313583|FG000|Combination Therapy Part A|Adverse Event|0|||
33388996|NCT03907969|101313584|FG001|Combination Therapy Part A|Adverse Event|0|||
33388997|NCT03907969|101313585|FG002|Combination Therapy Part A|Adverse Event|0|||
33388998|NCT03907969|101313586|FG003|Combination Therapy Part A|Adverse Event|0|||
33388999|NCT03907969|101313587|FG004|Combination Therapy Part A|Adverse Event|0|||
33389000|NCT03907969|101313588|FG005|Combination Therapy Part A|Adverse Event|0|||
33183306|NCT03336216|100582910|FG000|Randomization|Adverse Event|1|||
33286942|NCT03599622|100947766|FG003|Treatment Period|Adverse Event|2|||
33286943|NCT03599622|100947763|FG000|Treatment Period|Lack of Efficacy|18|||
33286944|NCT03599622|100947764|FG001|Treatment Period|Lack of Efficacy|12|||
33286945|NCT03599622|100947765|FG002|Treatment Period|Lack of Efficacy|13|||
33286946|NCT03599622|100947766|FG003|Treatment Period|Lack of Efficacy|2|||
33286947|NCT03599622|100947763|FG000|Treatment Period|Withdrawal by Subject|5|||
33286948|NCT03599622|100947764|FG001|Treatment Period|Withdrawal by Subject|11|||
33286949|NCT03599622|100947765|FG002|Treatment Period|Withdrawal by Subject|16|||
33286950|NCT03599622|100947766|FG003|Treatment Period|Withdrawal by Subject|1|||
33286951|NCT03599622|100947763|FG000|Treatment Period|Other reasons|4|||
33286952|NCT03599622|100947764|FG001|Treatment Period|Other reasons|6|||
33286953|NCT03599622|100947765|FG002|Treatment Period|Other reasons|7|||
33286954|NCT03599622|100947766|FG003|Treatment Period|Other reasons|0|||
33286955|NCT03599622|100947763|FG000|Treatment Period|Lost to Follow-up|1|||
33286956|NCT03599622|100947764|FG001|Treatment Period|Lost to Follow-up|0|||
33286957|NCT03599622|100947765|FG002|Treatment Period|Lost to Follow-up|0|||
33286958|NCT03599622|100947766|FG003|Treatment Period|Lost to Follow-up|0|||
33286959|NCT03599622|100947763|FG000|Treatment Period|Study terminated by sponsor|7|||
33286960|NCT03599622|100947764|FG001|Treatment Period|Study terminated by sponsor|20|||
33286961|NCT03599622|100947765|FG002|Treatment Period|Study terminated by sponsor|15|||
33286962|NCT03599622|100947766|FG003|Treatment Period|Study terminated by sponsor|0|||
33286963|NCT03599622|100947763|FG000|Treatment Period|Site terminated by sponsor|0|||
33286964|NCT03599622|100947764|FG001|Treatment Period|Site terminated by sponsor|1|||
33286965|NCT03599622|100947765|FG002|Treatment Period|Site terminated by sponsor|0|||
33286966|NCT03599622|100947766|FG003|Treatment Period|Site terminated by sponsor|0|||
33286967|NCT02509312|100947768|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
33286968|NCT02509312|100947769|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
33286969|NCT02509312|100947768|FG000|Overall Study|Obstetrician refusal|0|||
33286970|NCT02509312|100947769|FG001|Overall Study|Obstetrician refusal|1|||
33286971|NCT02509312|100947768|FG000|Overall Study|Patient elected for TOLAC|1|||
33286972|NCT02509312|100947769|FG001|Overall Study|Patient elected for TOLAC|0|||
33286973|NCT02509312|100947768|FG000|Overall Study|Cesarean deemed stat|1|||
33286974|NCT02509312|100947769|FG001|Overall Study|Cesarean deemed stat|0|||
33286975|NCT02509312|100947768|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
33286976|NCT02509312|100947769|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
33286977|NCT00505414|100947770|FG000|Titration Phase|Adverse Event|0|||
33286978|NCT00505414|100947771|FG001|Titration Phase|Adverse Event|0|||
33286979|NCT00505414|100947772|FG002|Titration Phase|Adverse Event|0|||
33286980|NCT00505414|100947773|FG003|Titration Phase|Adverse Event|8|||
33286981|NCT00505414|100947774|FG004|Titration Phase|Adverse Event|3|||
33286982|NCT00505414|100947770|FG000|Titration Phase|Death|0|||
33286983|NCT00505414|100947771|FG001|Titration Phase|Death|0|||
33286984|NCT00505414|100947772|FG002|Titration Phase|Death|0|||
33286985|NCT00505414|100947773|FG003|Titration Phase|Death|2|||
33389001|NCT03907969|101313589|FG006|Combination Therapy Part A|Adverse Event|0|||
33389002|NCT03907969|101313590|FG007|Combination Therapy Part A|Adverse Event|0|||
33183307|NCT03336216|100582911|FG001|Randomization|Adverse Event|1|||
33286986|NCT00505414|100947774|FG004|Titration Phase|Death|0|||
33286987|NCT00505414|100947770|FG000|Titration Phase|Lack of Efficacy|0|||
33389003|NCT03907969|101313591|FG008|Combination Therapy Part A|Adverse Event|0|||
33389004|NCT03907969|101313592|FG009|Combination Therapy Part A|Adverse Event|1|||
33286988|NCT00505414|100947771|FG001|Titration Phase|Lack of Efficacy|0|||
33286989|NCT00505414|100947772|FG002|Titration Phase|Lack of Efficacy|0|||
33286990|NCT00505414|100947773|FG003|Titration Phase|Lack of Efficacy|10|||
33286991|NCT00505414|100947774|FG004|Titration Phase|Lack of Efficacy|1|||
33286992|NCT00505414|100947770|FG000|Titration Phase|Protocol Violation|0|||
33286993|NCT00505414|100947771|FG001|Titration Phase|Protocol Violation|0|||
33286994|NCT00505414|100947772|FG002|Titration Phase|Protocol Violation|0|||
33286995|NCT00505414|100947773|FG003|Titration Phase|Protocol Violation|0|||
33286996|NCT00505414|100947774|FG004|Titration Phase|Protocol Violation|1|||
33286997|NCT00505414|100947770|FG000|Titration Phase|Withdrawal by Subject|0|||
33286998|NCT00505414|100947771|FG001|Titration Phase|Withdrawal by Subject|0|||
33286999|NCT00505414|100947772|FG002|Titration Phase|Withdrawal by Subject|0|||
33183308|NCT03336216|100582912|FG002|Randomization|Adverse Event|0|||
33183309|NCT03336216|100582913|FG003|Randomization|Adverse Event|0|||
33183310|NCT03336216|100582910|FG000|Treatment|Adverse Event|2|||
33183311|NCT03336216|100582911|FG001|Treatment|Adverse Event|3|||
33287000|NCT00505414|100947773|FG003|Titration Phase|Withdrawal by Subject|3|||
33183312|NCT03336216|100582912|FG002|Treatment|Adverse Event|4|||
33183313|NCT03336216|100582913|FG003|Treatment|Adverse Event|4|||
33183314|NCT03336216|100582910|FG000|Treatment|Participant request to discontinue treatment|2|||
33183315|NCT03336216|100582911|FG001|Treatment|Participant request to discontinue treatment|1|||
33183316|NCT03336216|100582912|FG002|Treatment|Participant request to discontinue treatment|2|||
33183317|NCT03336216|100582913|FG003|Treatment|Participant request to discontinue treatment|2|||
33287001|NCT00505414|100947774|FG004|Titration Phase|Withdrawal by Subject|4|||
33287002|NCT00505414|100947770|FG000|Titration Phase|Underlying disease and therapy required|0|||
33287003|NCT00505414|100947771|FG001|Titration Phase|Underlying disease and therapy required|0|||
33287004|NCT00505414|100947772|FG002|Titration Phase|Underlying disease and therapy required|0|||
33287005|NCT00505414|100947773|FG003|Titration Phase|Underlying disease and therapy required|7|||
33287006|NCT00505414|100947774|FG004|Titration Phase|Underlying disease and therapy required|3|||
33287007|NCT00505414|100947770|FG000|Maintenance Phase|Adverse Event|2|||
33287008|NCT00505414|100947771|FG001|Maintenance Phase|Adverse Event|2|||
33287009|NCT00505414|100947772|FG002|Maintenance Phase|Adverse Event|3|||
33287010|NCT00505414|100947773|FG003|Maintenance Phase|Adverse Event|0|||
33287011|NCT00505414|100947774|FG004|Maintenance Phase|Adverse Event|0|||
33287012|NCT00505414|100947770|FG000|Maintenance Phase|Death|2|||
33287013|NCT00505414|100947771|FG001|Maintenance Phase|Death|0|||
33183318|NCT03336216|100582910|FG000|Treatment|Participant withdrew consent|7|||
33287014|NCT00505414|100947772|FG002|Maintenance Phase|Death|1|||
33287015|NCT00505414|100947773|FG003|Maintenance Phase|Death|0|||
33287016|NCT00505414|100947774|FG004|Maintenance Phase|Death|0|||
33287017|NCT00505414|100947770|FG000|Maintenance Phase|Lack of Efficacy|2|||
33287018|NCT00505414|100947771|FG001|Maintenance Phase|Lack of Efficacy|1|||
33287019|NCT00505414|100947772|FG002|Maintenance Phase|Lack of Efficacy|1|||
33389005|NCT03907969|101313593|FG010|Combination Therapy Part A|Adverse Event|1|||
33389006|NCT03907969|101313583|FG000|Combination Therapy Part A|Progressive disease|0|||
33389007|NCT03907969|101313584|FG001|Combination Therapy Part A|Progressive disease|0|||
33389008|NCT03907969|101313585|FG002|Combination Therapy Part A|Progressive disease|0|||
33389009|NCT03907969|101313586|FG003|Combination Therapy Part A|Progressive disease|0|||
33389010|NCT03907969|101313587|FG004|Combination Therapy Part A|Progressive disease|0|||
33183319|NCT03336216|100582911|FG001|Treatment|Participant withdrew consent|2|||
33389011|NCT03907969|101313588|FG005|Combination Therapy Part A|Progressive disease|0|||
33389012|NCT03907969|101313589|FG006|Combination Therapy Part A|Progressive disease|0|||
33389013|NCT03907969|101313590|FG007|Combination Therapy Part A|Progressive disease|1|||
33389014|NCT03907969|101313591|FG008|Combination Therapy Part A|Progressive disease|0|||
33389015|NCT03907969|101313592|FG009|Combination Therapy Part A|Progressive disease|2|||
33389016|NCT03907969|101313593|FG010|Combination Therapy Part A|Progressive disease|3|||
33389017|NCT03907969|101313583|FG000|Combination Therapy Part A|Death|0|||
33389018|NCT03907969|101313584|FG001|Combination Therapy Part A|Death|0|||
33389019|NCT03907969|101313585|FG002|Combination Therapy Part A|Death|0|||
33389020|NCT03907969|101313586|FG003|Combination Therapy Part A|Death|0|||
33389021|NCT03907969|101313587|FG004|Combination Therapy Part A|Death|0|||
33287020|NCT00505414|100947773|FG003|Maintenance Phase|Lack of Efficacy|0|||
33287021|NCT00505414|100947774|FG004|Maintenance Phase|Lack of Efficacy|0|||
33389022|NCT03907969|101313588|FG005|Combination Therapy Part A|Death|0|||
33389023|NCT03907969|101313589|FG006|Combination Therapy Part A|Death|0|||
33389024|NCT03907969|101313590|FG007|Combination Therapy Part A|Death|0|||
33389025|NCT03907969|101313591|FG008|Combination Therapy Part A|Death|1|||
33389026|NCT03907969|101313592|FG009|Combination Therapy Part A|Death|0|||
33389027|NCT03907969|101313593|FG010|Combination Therapy Part A|Death|1|||
33183320|NCT03336216|100582912|FG002|Treatment|Participant withdrew consent|3|||
33183321|NCT03336216|100582913|FG003|Treatment|Participant withdrew consent|2|||
33183322|NCT03336216|100582910|FG000|Treatment|Death|2|||
33364868|NCT00726323|101223671|FG001|Overall Study|Progressive disease|16|||
33389028|NCT03907969|101313583|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
33389029|NCT03907969|101313584|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
33183323|NCT03336216|100582911|FG001|Treatment|Death|3|||
33389030|NCT03907969|101313585|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
33492947|NCT00235755|101698098|FG002|4-Week Titration Phase|Protocol Violation|1|||
33183324|NCT03336216|100582912|FG002|Treatment|Death|3|||
33183325|NCT03336216|100582913|FG003|Treatment|Death|4|||
33183326|NCT03336216|100582910|FG000|Treatment|Participant no longer meets study criteria|0|||
33183327|NCT03336216|100582911|FG001|Treatment|Participant no longer meets study criteria|1|||
33183328|NCT03336216|100582912|FG002|Treatment|Participant no longer meets study criteria|0|||
33183329|NCT03336216|100582913|FG003|Treatment|Participant no longer meets study criteria|0|||
33183330|NCT03336216|100582910|FG000|Treatment|Other reasons|2|||
33183331|NCT03336216|100582911|FG001|Treatment|Other reasons|0|||
33183332|NCT03336216|100582912|FG002|Treatment|Other reasons|0|||
33183333|NCT03336216|100582913|FG003|Treatment|Other reasons|3|||
33183334|NCT03336216|100582910|FG000|Treatment|Disease progression|23|||
33183335|NCT03336216|100582911|FG001|Treatment|Disease progression|34|||
33183336|NCT03336216|100582912|FG002|Treatment|Disease progression|33|||
33183337|NCT03336216|100582913|FG003|Treatment|Disease progression|26|||
33183338|NCT03336216|100582910|FG000|Treatment|Study drug toxicity|0|||
33183339|NCT03336216|100582911|FG001|Treatment|Study drug toxicity|3|||
33183340|NCT03336216|100582912|FG002|Treatment|Study drug toxicity|2|||
33183341|NCT03336216|100582913|FG003|Treatment|Study drug toxicity|0|||
33183342|NCT03336216|100582910|FG000|Treatment|Adverse Event unrelated to study drug|1|||
33183343|NCT03336216|100582911|FG001|Treatment|Adverse Event unrelated to study drug|1|||
33183344|NCT03336216|100582912|FG002|Treatment|Adverse Event unrelated to study drug|1|||
33183345|NCT03336216|100582913|FG003|Treatment|Adverse Event unrelated to study drug|0|||
33183346|NCT03336216|100582910|FG000|Treatment|Disease Recurrence|1|||
33183347|NCT03336216|100582911|FG001|Treatment|Disease Recurrence|0|||
33183348|NCT03336216|100582912|FG002|Treatment|Disease Recurrence|0|||
33183349|NCT03336216|100582913|FG003|Treatment|Disease Recurrence|0|||
33183350|NCT04475588|100582914|FG000|Overall Study|Adverse Event|2|||
33183351|NCT04475588|100582915|FG001|Overall Study|Adverse Event|0|||
33183352|NCT02046148|100582916|FG000|Overall Study|Lost to Follow-up|1|||
33183353|NCT02046148|100582917|FG001|Overall Study|Lost to Follow-up|1|||
33183354|NCT02046148|100582916|FG000|Overall Study|Withdrawal by Subject|0|||
33183355|NCT02046148|100582917|FG001|Overall Study|Withdrawal by Subject|2|||
33183356|NCT02113956|100582918|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
33183357|NCT02113956|100582919|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
33183358|NCT02113956|100582918|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
33183359|NCT02113956|100582919|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
33183360|NCT02113956|100582918|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
33183361|NCT02113956|100582919|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
33183362|NCT02276872|100582937|FG000|Overall Study|Adverse Event|1|||
33183363|NCT02276872|100582938|FG001|Overall Study|Adverse Event|0|||
33183364|NCT02276872|100582939|FG002|Overall Study|Adverse Event|0|||
33183365|NCT02932904|100582944|FG000|Overall Study|Reason not Specified|1|||
33183366|NCT02932904|100582945|FG001|Overall Study|Reason not Specified|0|||
33183367|NCT02932904|100582946|FG002|Overall Study|Reason not Specified|2|||
33183368|NCT02932904|100582947|FG003|Overall Study|Reason not Specified|2|||
33183369|NCT02932904|100582944|FG000|Overall Study|Noncompliance with Study Drug|2|||
33183370|NCT02932904|100582945|FG001|Overall Study|Noncompliance with Study Drug|3|||
33183371|NCT02932904|100582946|FG002|Overall Study|Noncompliance with Study Drug|3|||
33183372|NCT02932904|100582947|FG003|Overall Study|Noncompliance with Study Drug|4|||
33183373|NCT02932904|100582944|FG000|Overall Study|Pregnancy|0|||
33183374|NCT02932904|100582945|FG001|Overall Study|Pregnancy|1|||
33183375|NCT02932904|100582946|FG002|Overall Study|Pregnancy|1|||
33183376|NCT02932904|100582947|FG003|Overall Study|Pregnancy|0|||
33183377|NCT02932904|100582944|FG000|Overall Study|Study Termination|0|||
33183378|NCT02932904|100582945|FG001|Overall Study|Study Termination|1|||
33183379|NCT02932904|100582946|FG002|Overall Study|Study Termination|0|||
33183380|NCT02932904|100582947|FG003|Overall Study|Study Termination|0|||
33183381|NCT02932904|100582944|FG000|Overall Study|Voluntary Withdrawal|2|||
33183382|NCT02932904|100582945|FG001|Overall Study|Voluntary Withdrawal|1|||
33183383|NCT02932904|100582946|FG002|Overall Study|Voluntary Withdrawal|4|||
33183384|NCT02932904|100582947|FG003|Overall Study|Voluntary Withdrawal|2|||
33389031|NCT03907969|101313586|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
33183385|NCT02932904|100582944|FG000|Overall Study|Lost to Follow-up|5|||
33183386|NCT02932904|100582945|FG001|Overall Study|Lost to Follow-up|3|||
33183387|NCT02932904|100582946|FG002|Overall Study|Lost to Follow-up|6|||
33183388|NCT02932904|100582947|FG003|Overall Study|Lost to Follow-up|0|||
33183389|NCT02932904|100582944|FG000|Overall Study|Significant Protocol Deviation|2|||
33183390|NCT02932904|100582945|FG001|Overall Study|Significant Protocol Deviation|3|||
33183391|NCT02932904|100582946|FG002|Overall Study|Significant Protocol Deviation|6|||
33183392|NCT02932904|100582947|FG003|Overall Study|Significant Protocol Deviation|1|||
33183393|NCT02932904|100582944|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
33183394|NCT02932904|100582945|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
33183395|NCT02932904|100582946|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
33183396|NCT02932904|100582947|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
33183397|NCT02932904|100582944|FG000|Overall Study|Randomized But Not Treated|1|||
33183398|NCT02932904|100582945|FG001|Overall Study|Randomized But Not Treated|1|||
33183399|NCT02932904|100582946|FG002|Overall Study|Randomized But Not Treated|0|||
33183400|NCT02932904|100582947|FG003|Overall Study|Randomized But Not Treated|2|||
33183401|NCT01652664|100582952|FG000|Overall Study|Treatment Failure|5|||
33183402|NCT01652664|100582953|FG001|Overall Study|Treatment Failure|1|||
33183403|NCT01652664|100582952|FG000|Overall Study|Inadequate IOP control|1|||
33183404|NCT01652664|100582953|FG001|Overall Study|Inadequate IOP control|0|||
33183405|NCT00642668|100582956|FG000|Overall Study|Lost to Follow-up|1|||
33183406|NCT00642668|100582956|FG000|Overall Study|Adverse Event|2|||
33183407|NCT00642668|100582956|FG000|Overall Study|Death|2|||
33183408|NCT00642668|100582956|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33183409|NCT00642668|100582956|FG000|Overall Study|Failure to Return|1|||
33183410|NCT00642668|100582956|FG000|Overall Study|Dialysis Initiation|5|||
33183411|NCT00642668|100582956|FG000|Overall Study|Blood Transfusion|2|||
33183412|NCT00903617|100582957|FG000|Overall Study|Adverse Event|0|||
33183413|NCT00903617|100582958|FG001|Overall Study|Adverse Event|1|||
33183414|NCT00903617|100582959|FG002|Overall Study|Adverse Event|1|||
33183415|NCT00903617|100582960|FG003|Overall Study|Adverse Event|0|||
33183416|NCT00903617|100582957|FG000|Overall Study|Protocol-defined stopping criteria|0|||
33183417|NCT00903617|100582958|FG001|Overall Study|Protocol-defined stopping criteria|2|||
33183418|NCT00903617|100582959|FG002|Overall Study|Protocol-defined stopping criteria|0|||
33183419|NCT00903617|100582960|FG003|Overall Study|Protocol-defined stopping criteria|0|||
33183420|NCT00903617|100582957|FG000|Overall Study|Lost to Follow-up|2|||
33183421|NCT00903617|100582958|FG001|Overall Study|Lost to Follow-up|0|||
33183422|NCT00903617|100582959|FG002|Overall Study|Lost to Follow-up|1|||
33183423|NCT00903617|100582960|FG003|Overall Study|Lost to Follow-up|1|||
33183424|NCT00903617|100582957|FG000|Overall Study|Withdrawal by Subject|1|||
33183425|NCT00903617|100582958|FG001|Overall Study|Withdrawal by Subject|2|||
33183426|NCT00903617|100582959|FG002|Overall Study|Withdrawal by Subject|3|||
33183427|NCT00903617|100582960|FG003|Overall Study|Withdrawal by Subject|0|||
33183428|NCT00297037|100582966|FG000|Overall Study|Withdrawal by Subject|2|||
33183429|NCT00297037|100582967|FG001|Overall Study|Withdrawal by Subject|0|||
33183430|NCT01894152|100582968|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
33183431|NCT02141997|100582973|FG000|Overall Study|Adverse Event|0|||
33183432|NCT02141997|100582974|FG001|Overall Study|Adverse Event|2|||
33183433|NCT02141997|100582975|FG002|Overall Study|Adverse Event|0|||
33183434|NCT02141997|100582976|FG003|Overall Study|Adverse Event|1|||
33183435|NCT02141997|100582973|FG000|Overall Study|Participant noncompliance|1|||
33183436|NCT02141997|100582974|FG001|Overall Study|Participant noncompliance|0|||
33183437|NCT02141997|100582975|FG002|Overall Study|Participant noncompliance|0|||
33183438|NCT02141997|100582976|FG003|Overall Study|Participant noncompliance|0|||
33183439|NCT02141997|100582973|FG000|Overall Study|Withdrew consent|1|||
33183440|NCT02141997|100582974|FG001|Overall Study|Withdrew consent|0|||
33183441|NCT02141997|100582975|FG002|Overall Study|Withdrew consent|3|||
33183442|NCT02141997|100582976|FG003|Overall Study|Withdrew consent|0|||
33183443|NCT02141997|100582973|FG000|Overall Study|Other|1|||
33183444|NCT02141997|100582974|FG001|Overall Study|Other|4|||
33183445|NCT02141997|100582975|FG002|Overall Study|Other|0|||
33389032|NCT03907969|101313587|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
33389033|NCT03907969|101313588|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
33389034|NCT03907969|101313589|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
33389035|NCT03907969|101313590|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
33389036|NCT03907969|101313591|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
33389037|NCT03907969|101313592|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
33389038|NCT03907969|101313593|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
33389039|NCT03907969|101313583|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
33389040|NCT03907969|101313584|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
33389041|NCT03907969|101313585|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
33389042|NCT03907969|101313586|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
33389043|NCT03907969|101313587|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
33183446|NCT02141997|100582976|FG003|Overall Study|Other|0|||
33183447|NCT01104636|100582977|FG000|Overall Study|Lack of Efficacy|43|||
33183448|NCT01104636|100582977|FG000|Overall Study|Lost to Follow-up|24|||
33183449|NCT01104636|100582977|FG000|Overall Study|Withdrawal by Subject|4|||
33389044|NCT03907969|101313588|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
33389045|NCT03907969|101313589|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
33389046|NCT03907969|101313590|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
33417151|NCT00720304|101420215|FG000|Overall Study|Disease progression|6|||
33183450|NCT01104636|100582977|FG000|Overall Study|Other|43|||
33183451|NCT01104636|100582977|FG000|Overall Study|Study terminated by sponsor|1|||
33183452|NCT01104636|100582977|FG000|Overall Study|Pregnancy|2|||
33183453|NCT01104636|100582977|FG000|Overall Study|Adverse Event|40|||
33183454|NCT01104636|100582977|FG000|Overall Study|Ongoing|21|||
33183455|NCT02488681|100582982|FG000|Overall Study|Implant unsuccessful|7|||
33183456|NCT00615056|100582983|FG000|Overall Study|Death|31|||
33183457|NCT00615056|100582984|FG001|Overall Study|Death|31|||
33183458|NCT00615056|100582985|FG002|Overall Study|Death|21|||
33183459|NCT00615056|100582986|FG003|Overall Study|Death|23|||
33183460|NCT00615056|100582983|FG000|Overall Study|Lost to Follow-up|1|||
33183461|NCT00615056|100582984|FG001|Overall Study|Lost to Follow-up|2|||
33183462|NCT00615056|100582985|FG002|Overall Study|Lost to Follow-up|4|||
33183463|NCT00615056|100582986|FG003|Overall Study|Lost to Follow-up|5|||
33183464|NCT00615056|100582983|FG000|Overall Study|Other|13|||
33389047|NCT03907969|101313591|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
33389048|NCT03907969|101313592|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
33389049|NCT03907969|101313593|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
33594247|NCT02743949|102064879|FG001|Overall Study|Adverse Event|0|||
33389050|NCT03907969|101313583|FG000|Combination Therapy Part A|Physician Decision|0|||
33389051|NCT03907969|101313584|FG001|Combination Therapy Part A|Physician Decision|0|||
33389052|NCT03907969|101313585|FG002|Combination Therapy Part A|Physician Decision|0|||
33389053|NCT03907969|101313586|FG003|Combination Therapy Part A|Physician Decision|0|||
33389054|NCT03907969|101313587|FG004|Combination Therapy Part A|Physician Decision|0|||
33389055|NCT03907969|101313588|FG005|Combination Therapy Part A|Physician Decision|0|||
33389056|NCT03907969|101313589|FG006|Combination Therapy Part A|Physician Decision|0|||
33389057|NCT03907969|101313590|FG007|Combination Therapy Part A|Physician Decision|1|||
33389058|NCT03907969|101313591|FG008|Combination Therapy Part A|Physician Decision|0|||
33389059|NCT03907969|101313592|FG009|Combination Therapy Part A|Physician Decision|0|||
33389060|NCT03907969|101313593|FG010|Combination Therapy Part A|Physician Decision|1|||
33389061|NCT00383708|101313594|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
33389062|NCT00383708|101313594|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
33389063|NCT00383708|101313594|FG000|Run-in Period|Protocol Violation|4|||
33389064|NCT00383708|101313594|FG000|Run-in Period|Adverse Event|2|||
33389065|NCT00383708|101313594|FG000|Run-in Period|Claustrophobia|1|||
33389066|NCT00383708|101313594|FG000|Co-administration Period|Adverse Event|5|||
33389067|NCT00422669|101313596|FG000|Overall Study|The study was terminated early.|98|||
33389068|NCT00422669|101313597|FG001|Overall Study|The study was terminated early.|100|||
33389069|NCT00422669|101313598|FG002|Overall Study|The study was terminated early.|7|||
33389070|NCT00928512|101313599|FG000|Overall Study|Adverse Event|4|||
33594248|NCT02743949|102064880|FG002|Overall Study|Adverse Event|2|||
33594249|NCT02743949|102064878|FG000|Overall Study|Significant Protocol Deviation|2|||
33594250|NCT02743949|102064879|FG001|Overall Study|Significant Protocol Deviation|0|||
33594251|NCT02743949|102064880|FG002|Overall Study|Significant Protocol Deviation|1|||
33594252|NCT02743949|102064878|FG000|Overall Study|Voluntary Withdrawal|2|||
33594253|NCT02743949|102064879|FG001|Overall Study|Voluntary Withdrawal|1|||
33594254|NCT02743949|102064880|FG002|Overall Study|Voluntary Withdrawal|0|||
33594255|NCT01865812|102064881|FG000|Primary Treatment Phase|Adverse Event|2|||
33594256|NCT01865812|102064882|FG001|Primary Treatment Phase|Adverse Event|0|||
33594257|NCT01865812|102064881|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
33594258|NCT01865812|102064882|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
33594259|NCT01865812|102064881|FG000|Long-term Safety Extension Phase|Pruritus|0|||
33594260|NCT01865812|102064882|FG001|Long-term Safety Extension Phase|Pruritus|3|||
33594261|NCT01865812|102064881|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
33594262|NCT01865812|102064882|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
33594263|NCT01865812|102064881|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
33594264|NCT01865812|102064882|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
33594265|NCT02186652|102064884|FG000|Overall Study|Lost to Follow-up|2|||
33594266|NCT02186652|102064885|FG001|Overall Study|Lost to Follow-up|0|||
33594267|NCT02685748|102064888|FG000|Overall Study|Withdrawal by Subject|3|||
33594268|NCT02685748|102064889|FG001|Overall Study|Withdrawal by Subject|2|||
33594269|NCT00931723|102064893|FG000|Overall Study|Withdrawal by Subject|11|||
33594270|NCT00931723|102064894|FG001|Overall Study|Withdrawal by Subject|13|||
33594271|NCT00931723|102064893|FG000|Overall Study|Adverse Event|6|||
33594272|NCT00931723|102064894|FG001|Overall Study|Adverse Event|13|||
33594273|NCT00931723|102064893|FG000|Overall Study|Lithium found in blood|0|||
33389071|NCT00928512|101313600|FG001|Overall Study|Adverse Event|3|||
33389072|NCT00928512|101313601|FG002|Overall Study|Adverse Event|2|||
33492948|NCT00235755|101698096|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
33492949|NCT00235755|101698097|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
33492950|NCT00235755|101698098|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
33389073|NCT00928512|101313602|FG003|Overall Study|Adverse Event|8|||
33389074|NCT00928512|101313603|FG004|Overall Study|Adverse Event|6|||
33389075|NCT00928512|101313599|FG000|Overall Study|Lack of Efficacy|2|||
33594274|NCT00931723|102064894|FG001|Overall Study|Lithium found in blood|1|||
33594275|NCT00931723|102064893|FG000|Overall Study|Condition under investigation worsened|1|||
33183465|NCT00615056|100582984|FG001|Overall Study|Other|15|||
33183466|NCT00615056|100582985|FG002|Overall Study|Other|10|||
33183467|NCT00615056|100582986|FG003|Overall Study|Other|7|||
33183468|NCT00615056|100582983|FG000|Overall Study|Objective progression or relapse|0|||
33631258|NCT01231906|102202898|FG001|Overall Study|Lack of Efficacy|68|||
33594276|NCT00931723|102064894|FG001|Overall Study|Condition under investigation worsened|2|||
33492951|NCT00235755|101698096|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
33492952|NCT00235755|101698097|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
33492953|NCT00235755|101698098|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
33492954|NCT00235755|101698096|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
33492955|NCT00235755|101698097|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
33492956|NCT00235755|101698098|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
33492957|NCT00235755|101698096|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
33492958|NCT00235755|101698097|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
33492959|NCT00235755|101698098|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
33492960|NCT00235755|101698096|FG000|12-Week Maintenance Phase|Adverse Event|8|||
33492961|NCT00235755|101698097|FG001|12-Week Maintenance Phase|Adverse Event|12|||
33492962|NCT00235755|101698098|FG002|12-Week Maintenance Phase|Adverse Event|26|||
33492963|NCT00235755|101698096|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
33492964|NCT00235755|101698097|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
33492965|NCT00235755|101698098|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
33492966|NCT00235755|101698096|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
33492967|NCT00235755|101698097|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
33492968|NCT00235755|101698098|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
33492969|NCT00235755|101698096|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
33492970|NCT00235755|101698097|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
33492971|NCT00235755|101698098|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
33492972|NCT00235755|101698096|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
33492973|NCT00235755|101698097|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
33492974|NCT00235755|101698098|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
33492975|NCT00235755|101698096|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
33492976|NCT00235755|101698097|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
33492977|NCT00235755|101698098|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
33492978|NCT03484702|101698107|FG000|Treatment Period|Death|3|||
33492979|NCT03484702|101698108|FG001|Treatment Period|Death|1|||
33492980|NCT03484702|101698109|FG002|Treatment Period|Death|0|||
33492981|NCT03484702|101698110|FG003|Treatment Period|Death|0|||
33492982|NCT03484702|101698111|FG004|Treatment Period|Death|0|||
33492983|NCT03484702|101698112|FG005|Treatment Period|Death|0|||
33492984|NCT03484702|101698107|FG000|Treatment Period|Adverse Event|1|||
33492985|NCT03484702|101698108|FG001|Treatment Period|Adverse Event|0|||
33492986|NCT03484702|101698109|FG002|Treatment Period|Adverse Event|0|||
33492987|NCT03484702|101698110|FG003|Treatment Period|Adverse Event|0|||
33492988|NCT03484702|101698111|FG004|Treatment Period|Adverse Event|0|||
33492989|NCT03484702|101698112|FG005|Treatment Period|Adverse Event|0|||
33492990|NCT03484702|101698107|FG000|Treatment Period|Participant Withdrew from Study|0|||
33492991|NCT03484702|101698108|FG001|Treatment Period|Participant Withdrew from Study|1|||
33492992|NCT03484702|101698109|FG002|Treatment Period|Participant Withdrew from Study|0|||
33492993|NCT03484702|101698110|FG003|Treatment Period|Participant Withdrew from Study|0|||
33492994|NCT03484702|101698111|FG004|Treatment Period|Participant Withdrew from Study|0|||
33492995|NCT03484702|101698112|FG005|Treatment Period|Participant Withdrew from Study|0|||
33492996|NCT03484702|101698107|FG000|Treatment Period|Physician Decision|0|||
33492997|NCT03484702|101698108|FG001|Treatment Period|Physician Decision|1|||
33492998|NCT03484702|101698109|FG002|Treatment Period|Physician Decision|0|||
33492999|NCT03484702|101698110|FG003|Treatment Period|Physician Decision|0|||
33493000|NCT03484702|101698111|FG004|Treatment Period|Physician Decision|0|||
33493001|NCT03484702|101698112|FG005|Treatment Period|Physician Decision|1|||
33493002|NCT00071110|101698113|FG000|Overall Study|Protocol Violation|0|||
33493003|NCT00071110|101698114|FG001|Overall Study|Protocol Violation|4|||
33493004|NCT00276484|101698115|FG000|Overall Study|Adverse Event|4|||
33493005|NCT00276484|101698116|FG001|Overall Study|Adverse Event|7|||
33493006|NCT00276484|101698115|FG000|Overall Study|Lost to Follow-up|1|||
33493007|NCT00276484|101698116|FG001|Overall Study|Lost to Follow-up|1|||
33594277|NCT00931723|102064893|FG000|Overall Study|Lost to Follow-up|1|||
33594278|NCT00931723|102064894|FG001|Overall Study|Lost to Follow-up|2|||
33594279|NCT00931723|102064893|FG000|Overall Study|Study-specific discontinuation criteria|1|||
33594280|NCT00931723|102064894|FG001|Overall Study|Study-specific discontinuation criteria|1|||
33594281|NCT00931723|102064893|FG000|Overall Study|Severe non-compliance to protocol|2|||
33594282|NCT00931723|102064894|FG001|Overall Study|Severe non-compliance to protocol|0|||
33493008|NCT00276484|101698115|FG000|Overall Study|Protocol Violation|0|||
33493009|NCT00276484|101698116|FG001|Overall Study|Protocol Violation|1|||
33493010|NCT00276484|101698115|FG000|Overall Study|Withdrawal by Subject|4|||
33594283|NCT00931723|102064893|FG000|Overall Study|Safety reasons|0|||
33493011|NCT00276484|101698116|FG001|Overall Study|Withdrawal by Subject|3|||
33493012|NCT00276484|101698115|FG000|Overall Study|Could not take time off work|0|||
33389076|NCT00928512|101313600|FG001|Overall Study|Lack of Efficacy|0|||
33493013|NCT00276484|101698116|FG001|Overall Study|Could not take time off work|1|||
33493014|NCT03499067|101698117|FG000|First Intervention|Physician Decision|2|||
33493015|NCT03499067|101698118|FG001|First Intervention|Physician Decision|1|||
33493016|NCT03499067|101698117|FG000|First Intervention|Withdrawal by Subject|3|||
33493017|NCT03499067|101698118|FG001|First Intervention|Withdrawal by Subject|6|||
33493018|NCT00758524|101698121|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
33493019|NCT00758524|101698122|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
33493020|NCT00758524|101698123|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
33493021|NCT00758524|101698124|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33493022|NCT00758524|101698125|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
33594284|NCT00931723|102064894|FG001|Overall Study|Safety reasons|1|||
33493023|NCT00758524|101698126|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
33493024|NCT00758524|101698127|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33493025|NCT00758524|101698128|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33493026|NCT00758524|101698129|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33493027|NCT00758524|101698130|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33493028|NCT00758524|101698131|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33493029|NCT00758524|101698132|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33493030|NCT00758524|101698133|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33493031|NCT00758524|101698134|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33493032|NCT00758524|101698135|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33493033|NCT00758524|101698136|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33493034|NCT00758524|101698137|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
33594285|NCT00931723|102064893|FG000|Overall Study|Took prohibited concomitant medication|0|||
33594286|NCT00931723|102064894|FG001|Overall Study|Took prohibited concomitant medication|1|||
33594287|NCT00931723|102064893|FG000|Overall Study|Lack or insufficient theraputic response|2|||
33594288|NCT00931723|102064894|FG001|Overall Study|Lack or insufficient theraputic response|5|||
33493035|NCT00758524|101698121|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
33389077|NCT00928512|101313601|FG002|Overall Study|Lack of Efficacy|4|||
33389078|NCT00928512|101313602|FG003|Overall Study|Lack of Efficacy|7|||
33594289|NCT00931723|102064893|FG000|Overall Study|Sponsor decision|1|||
33594290|NCT00931723|102064894|FG001|Overall Study|Sponsor decision|0|||
33594291|NCT00931723|102064893|FG000|Overall Study|Late hospital discharge|1|||
33594292|NCT00931723|102064894|FG001|Overall Study|Late hospital discharge|0|||
33594293|NCT00191724|102064895|FG000|Overall Study|Adverse Event|0|||
33594294|NCT00191724|102064896|FG001|Overall Study|Adverse Event|0|||
33594295|NCT00191724|102064897|FG002|Overall Study|Adverse Event|1|||
33594296|NCT00191724|102064898|FG003|Overall Study|Adverse Event|0|||
33594297|NCT00191724|102064899|FG004|Overall Study|Adverse Event|0|||
33594298|NCT00191724|102064895|FG000|Overall Study|Lost to Follow-up|1|||
33594299|NCT00191724|102064896|FG001|Overall Study|Lost to Follow-up|1|||
33594300|NCT00191724|102064897|FG002|Overall Study|Lost to Follow-up|0|||
33594301|NCT00191724|102064898|FG003|Overall Study|Lost to Follow-up|2|||
33183469|NCT00615056|100582984|FG001|Overall Study|Objective progression or relapse|2|||
33183470|NCT00615056|100582985|FG002|Overall Study|Objective progression or relapse|0|||
33183471|NCT00615056|100582986|FG003|Overall Study|Objective progression or relapse|0|||
33183472|NCT00615056|100582983|FG000|Overall Study|Withdrawal by Subject|0|||
33183473|NCT00615056|100582984|FG001|Overall Study|Withdrawal by Subject|1|||
33183474|NCT00615056|100582985|FG002|Overall Study|Withdrawal by Subject|1|||
33183475|NCT00615056|100582986|FG003|Overall Study|Withdrawal by Subject|0|||
33183476|NCT00615056|100582983|FG000|Overall Study|Discontinued by Sponsor|1|||
33389079|NCT00928512|101313603|FG004|Overall Study|Lack of Efficacy|3|||
33594302|NCT00191724|102064899|FG004|Overall Study|Lost to Follow-up|3|||
33594303|NCT00191724|102064895|FG000|Overall Study|Withdrawal by Subject|0|||
33594304|NCT00191724|102064896|FG001|Overall Study|Withdrawal by Subject|0|||
33594305|NCT00191724|102064897|FG002|Overall Study|Withdrawal by Subject|0|||
33594306|NCT00191724|102064898|FG003|Overall Study|Withdrawal by Subject|1|||
33594307|NCT00191724|102064899|FG004|Overall Study|Withdrawal by Subject|0|||
33594308|NCT02109432|102064908|FG000|Overall Study|Withdrawal by Subject|1|||
33183477|NCT00615056|100582984|FG001|Overall Study|Discontinued by Sponsor|0|||
33594309|NCT00489424|102064909|FG000|Overall Study|Adverse Event|3|||
33594310|NCT00489424|102064910|FG001|Overall Study|Adverse Event|3|||
33594311|NCT00489424|102064911|FG002|Overall Study|Adverse Event|4|||
33183478|NCT00615056|100582985|FG002|Overall Study|Discontinued by Sponsor|0|||
33183479|NCT00615056|100582986|FG003|Overall Study|Discontinued by Sponsor|0|||
33183480|NCT00615056|100582983|FG000|Overall Study|Randomized but not treated|3|||
33183481|NCT00615056|100582984|FG001|Overall Study|Randomized but not treated|0|||
33183482|NCT00615056|100582985|FG002|Overall Study|Randomized but not treated|0|||
33183483|NCT00615056|100582986|FG003|Overall Study|Randomized but not treated|0|||
33183484|NCT00858442|100582987|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
33389080|NCT00928512|101313599|FG000|Overall Study|Protocol Violation|0|||
33389081|NCT00928512|101313600|FG001|Overall Study|Protocol Violation|1|||
33493036|NCT00758524|101698122|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33493037|NCT00758524|101698123|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
33594312|NCT00489424|102064909|FG000|Overall Study|Lack of Efficacy|1|||
33594313|NCT00489424|102064910|FG001|Overall Study|Lack of Efficacy|0|||
33493038|NCT00758524|101698124|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
33493039|NCT00758524|101698125|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
33493040|NCT00758524|101698126|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
33493041|NCT00758524|101698127|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33493042|NCT00758524|101698128|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33493043|NCT00758524|101698129|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33493044|NCT00758524|101698130|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33493045|NCT00758524|101698131|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33493046|NCT00758524|101698132|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33493047|NCT00758524|101698133|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33493048|NCT00758524|101698134|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33493049|NCT00758524|101698135|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33493050|NCT00758524|101698136|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33183485|NCT00858442|100582988|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
33493051|NCT00758524|101698137|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
33493052|NCT00758524|101698121|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
33493053|NCT00758524|101698122|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
33493054|NCT00758524|101698123|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
33183486|NCT02063737|100582989|FG000|Overall Study|Lost to Follow-up|11|||
33183487|NCT02063737|100582990|FG001|Overall Study|Lost to Follow-up|4|||
33183488|NCT04536727|100582991|FG000|Overall Study|Lost to Follow-up|1|||
33183489|NCT04536727|100582992|FG001|Overall Study|Lost to Follow-up|1|||
33183490|NCT04536727|100582991|FG000|Overall Study|Death|0|||
33183491|NCT04536727|100582992|FG001|Overall Study|Death|1|||
33183492|NCT02910167|100582997|FG000|Overall Study|Adverse Event|1|||
33183493|NCT02910167|100582997|FG000|Overall Study|Lost to Follow-up|18|||
33183494|NCT04356963|100583006|FG000|First Session|Withdrawal by Subject|1|||
33183495|NCT04356963|100583006|FG000|Second Session|Withdrawal by Subject|3|||
33183496|NCT04356963|100583006|FG000|Second Session|Lost to Follow-up|1|||
33183497|NCT04356963|100583006|FG000|Third Session|Lost to Follow-up|6|||
33183498|NCT04356963|100583006|FG000|Third Session|Withdrawal by Subject|1|||
33183499|NCT02689258|100583009|FG000|Overall Study|Subject Non-Compliance|0|||
33183500|NCT02689258|100583010|FG001|Overall Study|Subject Non-Compliance|1|||
33183501|NCT02689258|100583011|FG002|Overall Study|Subject Non-Compliance|0|||
33183502|NCT02689258|100583012|FG003|Overall Study|Subject Non-Compliance|0|||
33183503|NCT02689258|100583013|FG004|Overall Study|Subject Non-Compliance|0|||
33183504|NCT02689258|100583014|FG005|Overall Study|Subject Non-Compliance|0|||
33183505|NCT02689258|100583015|FG006|Overall Study|Subject Non-Compliance|0|||
33389082|NCT00928512|101313601|FG002|Overall Study|Protocol Violation|0|||
33389083|NCT00928512|101313602|FG003|Overall Study|Protocol Violation|1|||
33389084|NCT00928512|101313603|FG004|Overall Study|Protocol Violation|3|||
33389085|NCT00928512|101313599|FG000|Overall Study|Withdrawal by Subject|3|||
33389086|NCT00928512|101313600|FG001|Overall Study|Withdrawal by Subject|0|||
33389087|NCT00928512|101313601|FG002|Overall Study|Withdrawal by Subject|3|||
33389088|NCT00928512|101313602|FG003|Overall Study|Withdrawal by Subject|4|||
33389089|NCT00928512|101313603|FG004|Overall Study|Withdrawal by Subject|0|||
33389090|NCT00928512|101313599|FG000|Overall Study|Lost to Follow-up|1|||
33389091|NCT00928512|101313600|FG001|Overall Study|Lost to Follow-up|1|||
33389092|NCT00928512|101313601|FG002|Overall Study|Lost to Follow-up|2|||
33389093|NCT00928512|101313602|FG003|Overall Study|Lost to Follow-up|1|||
33389094|NCT00928512|101313603|FG004|Overall Study|Lost to Follow-up|3|||
33389095|NCT00928512|101313599|FG000|Overall Study|Administrative Problems|0|||
33389096|NCT00928512|101313600|FG001|Overall Study|Administrative Problems|1|||
33389097|NCT00928512|101313601|FG002|Overall Study|Administrative Problems|0|||
33389098|NCT00928512|101313602|FG003|Overall Study|Administrative Problems|0|||
33389099|NCT00928512|101313603|FG004|Overall Study|Administrative Problems|0|||
33389100|NCT02820038|101313615|FG000|Overall Study|Lost to Follow-up|7|||
33389101|NCT02820038|101313616|FG001|Overall Study|Lost to Follow-up|11|||
33389102|NCT02820038|101313617|FG002|Overall Study|Lost to Follow-up|2|||
33389103|NCT02820038|101313618|FG003|Overall Study|Lost to Follow-up|9|||
33389104|NCT02820038|101313615|FG000|Overall Study|Withdrawal by Subject|3|||
33389105|NCT02820038|101313616|FG001|Overall Study|Withdrawal by Subject|14|||
33594314|NCT00489424|102064911|FG002|Overall Study|Lack of Efficacy|0|||
33183506|NCT02689258|100583016|FG007|Overall Study|Subject Non-Compliance|0|||
33183507|NCT02689258|100583017|FG008|Overall Study|Subject Non-Compliance|0|||
33594315|NCT00489424|102064909|FG000|Overall Study|Administrative problems|0|||
33183508|NCT02689258|100583018|FG009|Overall Study|Subject Non-Compliance|0|||
33183509|NCT02689258|100583019|FG010|Overall Study|Subject Non-Compliance|0|||
33183510|NCT02689258|100583020|FG011|Overall Study|Subject Non-Compliance|0|||
33183511|NCT02689258|100583009|FG000|Overall Study|Subject Refusal to Continue|0|||
33389106|NCT02820038|101313617|FG002|Overall Study|Withdrawal by Subject|3|||
33183512|NCT02689258|100583010|FG001|Overall Study|Subject Refusal to Continue|1|||
33389107|NCT02820038|101313618|FG003|Overall Study|Withdrawal by Subject|13|||
33389108|NCT01095666|101313621|FG000|Overall Study|Lack of Efficacy|0|||
33493055|NCT00758524|101698124|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
33183513|NCT02689258|100583011|FG002|Overall Study|Subject Refusal to Continue|0|||
33183514|NCT02689258|100583012|FG003|Overall Study|Subject Refusal to Continue|0|||
33183515|NCT02689258|100583013|FG004|Overall Study|Subject Refusal to Continue|0|||
33183516|NCT02689258|100583014|FG005|Overall Study|Subject Refusal to Continue|0|||
33183517|NCT02689258|100583015|FG006|Overall Study|Subject Refusal to Continue|0|||
33183518|NCT02689258|100583016|FG007|Overall Study|Subject Refusal to Continue|0|||
33594316|NCT00489424|102064910|FG001|Overall Study|Administrative problems|2|||
33389109|NCT01095666|101313622|FG001|Overall Study|Lack of Efficacy|0|||
33389110|NCT01095666|101313623|FG002|Overall Study|Lack of Efficacy|1|||
33389111|NCT01095666|101313621|FG000|Overall Study|Adverse Event|2|||
33389112|NCT01095666|101313622|FG001|Overall Study|Adverse Event|1|||
33389113|NCT01095666|101313623|FG002|Overall Study|Adverse Event|3|||
33389114|NCT01095666|101313621|FG000|Overall Study|Lost to Follow-up|2|||
33389115|NCT01095666|101313622|FG001|Overall Study|Lost to Follow-up|2|||
33389116|NCT01095666|101313623|FG002|Overall Study|Lost to Follow-up|0|||
33389117|NCT01095666|101313621|FG000|Overall Study|Withdrawal by Subject|6|||
33389118|NCT01095666|101313622|FG001|Overall Study|Withdrawal by Subject|6|||
33389119|NCT01095666|101313623|FG002|Overall Study|Withdrawal by Subject|1|||
33389120|NCT01095666|101313621|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
33493056|NCT00758524|101698125|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
33594317|NCT00489424|102064911|FG002|Overall Study|Administrative problems|1|||
33183519|NCT02689258|100583017|FG008|Overall Study|Subject Refusal to Continue|1|||
33183520|NCT02689258|100583018|FG009|Overall Study|Subject Refusal to Continue|0|||
33183521|NCT02689258|100583019|FG010|Overall Study|Subject Refusal to Continue|0|||
33183522|NCT02689258|100583020|FG011|Overall Study|Subject Refusal to Continue|1|||
33183523|NCT02689258|100583009|FG000|Overall Study|Other|0|||
33183524|NCT02689258|100583010|FG001|Overall Study|Other|2|||
33183525|NCT02689258|100583011|FG002|Overall Study|Other|0|||
33183526|NCT02689258|100583012|FG003|Overall Study|Other|0|||
33183527|NCT02689258|100583013|FG004|Overall Study|Other|1|||
33183528|NCT02689258|100583014|FG005|Overall Study|Other|0|||
33183529|NCT02689258|100583015|FG006|Overall Study|Other|0|||
33183530|NCT02689258|100583016|FG007|Overall Study|Other|0|||
33183531|NCT02689258|100583017|FG008|Overall Study|Other|1|||
33183532|NCT02689258|100583018|FG009|Overall Study|Other|0|||
33183533|NCT02689258|100583019|FG010|Overall Study|Other|0|||
33389121|NCT01095666|101313622|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
33389122|NCT01095666|101313623|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
33389123|NCT01136746|101313628|FG000|Overall Study|Lost to Follow-up|0|||
33594318|NCT03457142|102064917|FG000|Overall Study|Death|1|||
33594319|NCT01774097|102064920|FG000|Overall Study|Withdrawal by Subject|1|||
33594320|NCT01774097|102064921|FG001|Overall Study|Withdrawal by Subject|1|||
33594321|NCT01774097|102064920|FG000|Overall Study|Adverse Event|1|||
33594322|NCT01774097|102064921|FG001|Overall Study|Adverse Event|1|||
33594323|NCT00570037|102064922|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
33594324|NCT00570037|102064923|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
33594325|NCT02596958|102064924|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
33594326|NCT02596958|102064924|FG000|Overall Study|Cancer Progression|441|||
33594327|NCT02596958|102064924|FG000|Overall Study|Death From Cancer|112|||
33594328|NCT02596958|102064924|FG000|Overall Study|Death From Other Cause|33|||
33594329|NCT02596958|102064924|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
33594330|NCT02596958|102064924|FG000|Overall Study|Administrative Reasons/Other|231|||
33594331|NCT02596958|102064924|FG000|Overall Study|Lost to Follow-up|33|||
33594332|NCT02596958|102064924|FG000|Overall Study|Missing|32|||
33594333|NCT02596958|102064924|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
33594334|NCT03260894|102064925|FG000|Overall Study|Death|6|||
33389124|NCT01136746|101313629|FG001|Overall Study|Lost to Follow-up|2|||
33389125|NCT01136746|101313628|FG000|Overall Study|Protocol Violation|2|||
33389126|NCT01136746|101313629|FG001|Overall Study|Protocol Violation|1|||
33389127|NCT01136746|101313628|FG000|Overall Study|Death|1|||
33594335|NCT03260894|102064926|FG001|Overall Study|Death|8|||
33594336|NCT03260894|102064925|FG000|Overall Study|Withdrawal by Subject|4|||
33594337|NCT03260894|102064926|FG001|Overall Study|Withdrawal by Subject|11|||
33594338|NCT03260894|102064925|FG000|Overall Study|On-going at clinical cut off date|36|||
33594339|NCT03260894|102064926|FG001|Overall Study|On-going at clinical cut off date|31|||
33594340|NCT00835640|102064927|FG000|Second Intervention|Protocol Violation|1|||
33594341|NCT00835640|102064928|FG001|Second Intervention|Protocol Violation|0|||
33594342|NCT00884039|102064932|FG000|Overall Study|Withdrawal by Subject|0|||
33594343|NCT00884039|102064933|FG001|Overall Study|Withdrawal by Subject|1|||
33594344|NCT00884039|102064932|FG000|Overall Study|Lack of Efficacy|2|||
33183534|NCT02689258|100583020|FG011|Overall Study|Other|0|||
33183535|NCT00531232|100583021|FG000|Overall Study|Investigator decision|0|||
33183536|NCT00531232|100583022|FG001|Overall Study|Investigator decision|0|||
33183537|NCT00531232|100583023|FG002|Overall Study|Investigator decision|4|||
33389128|NCT01136746|101313629|FG001|Overall Study|Death|0|||
33389129|NCT02017704|101313639|FG000|Overall Study|Withdrawal by Subject|2|||
33389130|NCT02017704|101313640|FG001|Overall Study|Withdrawal by Subject|0|||
33389131|NCT01634113|101313641|FG000|Overall Study|Not treated|0|||
33594345|NCT00884039|102064933|FG001|Overall Study|Lack of Efficacy|0|||
33594346|NCT00516893|102064934|FG000|Overall Study|Lost to Follow-up|4|||
33594347|NCT00516893|102064934|FG000|Overall Study|Adverse Event|3|||
33594348|NCT00516893|102064934|FG000|Overall Study|Withdrawal by Subject|2|||
33183538|NCT00531232|100583021|FG000|Overall Study|Participants refused further treatment|0|||
33183539|NCT00531232|100583022|FG001|Overall Study|Participants refused further treatment|1|||
33183540|NCT00531232|100583023|FG002|Overall Study|Participants refused further treatment|2|||
33183541|NCT00531232|100583021|FG000|Overall Study|Adverse events (AEs)|1|||
33183542|NCT00531232|100583022|FG001|Overall Study|Adverse events (AEs)|2|||
33183543|NCT00531232|100583023|FG002|Overall Study|Adverse events (AEs)|2|||
33183544|NCT00531232|100583021|FG000|Overall Study|Treatment failure|1|||
33183545|NCT00531232|100583022|FG001|Overall Study|Treatment failure|3|||
33183546|NCT00531232|100583023|FG002|Overall Study|Treatment failure|7|||
33183547|NCT00531232|100583021|FG000|Overall Study|Disease recurrence|0|||
33493057|NCT00758524|101698126|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
33493058|NCT00758524|101698127|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33493059|NCT00758524|101698128|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33493060|NCT00758524|101698129|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33493061|NCT00758524|101698130|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33493062|NCT00758524|101698131|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33493063|NCT00758524|101698132|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33493064|NCT00758524|101698133|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33493065|NCT00758524|101698134|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33493066|NCT00758524|101698135|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33493067|NCT00758524|101698136|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33183548|NCT00531232|100583022|FG001|Overall Study|Disease recurrence|0|||
33493068|NCT00758524|101698137|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
33183549|NCT00531232|100583023|FG002|Overall Study|Disease recurrence|1|||
33183550|NCT00531232|100583021|FG000|Overall Study|Deceased|2|||
33183551|NCT00531232|100583022|FG001|Overall Study|Deceased|2|||
33183552|NCT00531232|100583023|FG002|Overall Study|Deceased|2|||
33183553|NCT00531232|100583021|FG000|Overall Study|Withdrawal by Subject|0|||
33183554|NCT00531232|100583022|FG001|Overall Study|Withdrawal by Subject|1|||
33183555|NCT00531232|100583023|FG002|Overall Study|Withdrawal by Subject|2|||
33183556|NCT00531232|100583021|FG000|Overall Study|Other|0|||
33183557|NCT00531232|100583022|FG001|Overall Study|Other|0|||
33183558|NCT00531232|100583023|FG002|Overall Study|Other|5|||
33183559|NCT01113879|100583030|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
33183560|NCT01113879|100583031|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
33183561|NCT02442778|100583033|FG000|Overall Study|Adverse Event|2|||
33183562|NCT02442778|100583034|FG001|Overall Study|Adverse Event|6|||
33183563|NCT02442778|100583035|FG002|Overall Study|Adverse Event|6|||
33493069|NCT00758524|101698121|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33493070|NCT00758524|101698122|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
33493071|NCT00758524|101698123|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
33493072|NCT00758524|101698124|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33183564|NCT02442778|100583033|FG000|Overall Study|Death|0|||
33389132|NCT01634113|101313642|FG001|Overall Study|Not treated|0|||
33389133|NCT01634113|101313643|FG002|Overall Study|Not treated|1|||
33183565|NCT02442778|100583034|FG001|Overall Study|Death|2|||
33183566|NCT02442778|100583035|FG002|Overall Study|Death|0|||
33183567|NCT02442778|100583033|FG000|Overall Study|Lack of Efficacy|1|||
33183568|NCT02442778|100583034|FG001|Overall Study|Lack of Efficacy|0|||
33389134|NCT01810380|101313644|FG000|Overall Study|Randomised not treated|2|||
33389135|NCT01810380|101313645|FG001|Overall Study|Randomised not treated|1|||
33389136|NCT01810380|101313646|FG002|Overall Study|Randomised not treated|1|||
33389137|NCT01810380|101313644|FG000|Overall Study|Adverse Event|11|||
33389138|NCT01810380|101313645|FG001|Overall Study|Adverse Event|14|||
33389139|NCT01810380|101313646|FG002|Overall Study|Adverse Event|4|||
33389140|NCT01810380|101313644|FG000|Overall Study|Lack of Efficacy|24|||
33389141|NCT01810380|101313645|FG001|Overall Study|Lack of Efficacy|10|||
33389142|NCT01810380|101313646|FG002|Overall Study|Lack of Efficacy|11|||
33183569|NCT02442778|100583035|FG002|Overall Study|Lack of Efficacy|0|||
33389143|NCT01810380|101313644|FG000|Overall Study|Protocol Violation|1|||
33389144|NCT01810380|101313645|FG001|Overall Study|Protocol Violation|0|||
33183570|NCT02442778|100583033|FG000|Overall Study|Lost to Follow-up|1|||
33183571|NCT02442778|100583034|FG001|Overall Study|Lost to Follow-up|1|||
33183572|NCT02442778|100583035|FG002|Overall Study|Lost to Follow-up|1|||
33183573|NCT02442778|100583033|FG000|Overall Study|Non-compliance with study drug|2|||
33183574|NCT02442778|100583034|FG001|Overall Study|Non-compliance with study drug|0|||
33183575|NCT02442778|100583035|FG002|Overall Study|Non-compliance with study drug|1|||
33183576|NCT02442778|100583033|FG000|Overall Study|Physician Decision|1|||
33183577|NCT02442778|100583034|FG001|Overall Study|Physician Decision|1|||
33389145|NCT01810380|101313646|FG002|Overall Study|Protocol Violation|1|||
33493073|NCT00758524|101698125|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
33493074|NCT00758524|101698126|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
33389146|NCT01810380|101313644|FG000|Overall Study|Withdrawal by Subject|6|||
33183578|NCT02442778|100583035|FG002|Overall Study|Physician Decision|1|||
33183579|NCT02442778|100583033|FG000|Overall Study|Protocol Deviation|3|||
33183580|NCT02442778|100583034|FG001|Overall Study|Protocol Deviation|0|||
33594349|NCT00516893|102064934|FG000|Overall Study|Noncompliance|2|||
33594350|NCT00516893|102064934|FG000|Overall Study|Death|1|||
33594351|NCT00516893|102064934|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
33389147|NCT01810380|101313645|FG001|Overall Study|Withdrawal by Subject|0|||
33389148|NCT01810380|101313646|FG002|Overall Study|Withdrawal by Subject|6|||
33389149|NCT01810380|101313644|FG000|Overall Study|Administrative or other reasons|11|||
33389150|NCT01810380|101313645|FG001|Overall Study|Administrative or other reasons|13|||
33389151|NCT01810380|101313646|FG002|Overall Study|Administrative or other reasons|9|||
33493075|NCT00758524|101698127|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33493076|NCT00758524|101698128|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33594352|NCT00516893|102064934|FG000|Overall Study|Relocated|1|||
33389152|NCT03037307|101313647|FG000|Period 1|Did Not Meet Study Criteria|0|||
33389153|NCT03037307|101313648|FG001|Period 1|Did Not Meet Study Criteria|0|||
33389154|NCT03037307|101313649|FG002|Period 1|Did Not Meet Study Criteria|0|||
33389155|NCT03037307|101313650|FG003|Period 1|Did Not Meet Study Criteria|1|||
33389156|NCT03037307|101313651|FG004|Period 1|Did Not Meet Study Criteria|0|||
33594353|NCT00516893|102064934|FG000|Overall Study|Pregnancy|1|||
33594354|NCT00516893|102064934|FG000|Overall Study|Received Medication From Another Study|1|||
33594355|NCT02359045|102064937|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
33594356|NCT02359045|102064938|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33594357|NCT02359045|102064937|FG000|Overall Study|Lost to Follow-up|1|||
33594358|NCT02359045|102064938|FG001|Overall Study|Lost to Follow-up|1|||
33594359|NCT02359045|102064937|FG000|Overall Study|Adverse Event|0|||
33594360|NCT02359045|102064938|FG001|Overall Study|Adverse Event|1|||
33594361|NCT00713349|102064939|FG000|Overall Study|Protocol Violation|1|||
33389157|NCT03037307|101313652|FG005|Period 1|Did Not Meet Study Criteria|0|||
33389158|NCT00880607|101313653|FG000|Overall Study|Physician Decision|2|||
33389159|NCT00880607|101313654|FG001|Overall Study|Physician Decision|2|||
33389160|NCT00880607|101313653|FG000|Overall Study|Protocol Violation|2|||
33389161|NCT00880607|101313654|FG001|Overall Study|Protocol Violation|1|||
33389162|NCT00880607|101313653|FG000|Overall Study|surgery did not extend past L1 level|3|||
33389163|NCT00880607|101313654|FG001|Overall Study|surgery did not extend past L1 level|0|||
33389164|NCT00212758|101313655|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
33389165|NCT00212758|101313656|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
33389166|NCT00212758|101313655|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
33389167|NCT00212758|101313656|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
33389168|NCT01831804|101313657|FG000|Overall Study|Adverse Event|0|||
33389169|NCT01831804|101313658|FG001|Overall Study|Adverse Event|0|||
33389170|NCT01831804|101313659|FG002|Overall Study|Adverse Event|0|||
33389171|NCT01831804|101313660|FG003|Overall Study|Adverse Event|0|||
33389172|NCT01831804|101313661|FG004|Overall Study|Adverse Event|0|||
33389173|NCT01831804|101313662|FG005|Overall Study|Adverse Event|0|||
33389174|NCT01831804|101313663|FG006|Overall Study|Adverse Event|1|||
33389175|NCT01831804|101313664|FG007|Overall Study|Adverse Event|0|||
33389176|NCT01831804|101313665|FG008|Overall Study|Adverse Event|1|||
33389177|NCT01831804|101313657|FG000|Overall Study|Protocol Violation|0|||
33389178|NCT01831804|101313658|FG001|Overall Study|Protocol Violation|0|||
33389179|NCT01831804|101313659|FG002|Overall Study|Protocol Violation|2|||
33389180|NCT01831804|101313660|FG003|Overall Study|Protocol Violation|0|||
33594362|NCT04686084|102064940|FG000|Overall Study|Lost to Follow-up|1|||
33594363|NCT01824823|102064941|FG000|Overall Study|Lack of Efficacy|1|||
33594364|NCT01824823|102064942|FG001|Overall Study|Lack of Efficacy|1|||
33389181|NCT01831804|101313661|FG004|Overall Study|Protocol Violation|0|||
33389182|NCT01831804|101313662|FG005|Overall Study|Protocol Violation|0|||
33389183|NCT01831804|101313663|FG006|Overall Study|Protocol Violation|0|||
33389184|NCT01831804|101313664|FG007|Overall Study|Protocol Violation|0|||
33389185|NCT01831804|101313665|FG008|Overall Study|Protocol Violation|0|||
33389186|NCT01831804|101313657|FG000|Overall Study|Protocol defined stopping criteria|1|||
33389187|NCT01831804|101313658|FG001|Overall Study|Protocol defined stopping criteria|1|||
33594365|NCT01824823|102064941|FG000|Overall Study|Off-treatment reason not submitted|1|||
33594366|NCT01824823|102064942|FG001|Overall Study|Off-treatment reason not submitted|0|||
33183581|NCT02442778|100583035|FG002|Overall Study|Protocol Deviation|1|||
33183582|NCT02442778|100583033|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
33389188|NCT01831804|101313659|FG002|Overall Study|Protocol defined stopping criteria|3|||
33389189|NCT01831804|101313660|FG003|Overall Study|Protocol defined stopping criteria|0|||
33389190|NCT01831804|101313661|FG004|Overall Study|Protocol defined stopping criteria|1|||
33389191|NCT01831804|101313662|FG005|Overall Study|Protocol defined stopping criteria|0|||
33389192|NCT01831804|101313663|FG006|Overall Study|Protocol defined stopping criteria|0|||
33389193|NCT01831804|101313664|FG007|Overall Study|Protocol defined stopping criteria|0|||
33389194|NCT01831804|101313665|FG008|Overall Study|Protocol defined stopping criteria|0|||
33183583|NCT02442778|100583034|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
33183584|NCT02442778|100583035|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
33389195|NCT01831804|101313657|FG000|Overall Study|Lost to Follow-up|0|||
33389196|NCT01831804|101313658|FG001|Overall Study|Lost to Follow-up|0|||
33389197|NCT01831804|101313659|FG002|Overall Study|Lost to Follow-up|1|||
33389198|NCT01831804|101313660|FG003|Overall Study|Lost to Follow-up|0|||
33389199|NCT01831804|101313661|FG004|Overall Study|Lost to Follow-up|0|||
33389200|NCT01831804|101313662|FG005|Overall Study|Lost to Follow-up|0|||
33389201|NCT01831804|101313663|FG006|Overall Study|Lost to Follow-up|0|||
33389202|NCT01831804|101313664|FG007|Overall Study|Lost to Follow-up|0|||
33389203|NCT01831804|101313665|FG008|Overall Study|Lost to Follow-up|1|||
33389204|NCT01831804|101313657|FG000|Overall Study|Investigator discretion|0|||
33389205|NCT01831804|101313658|FG001|Overall Study|Investigator discretion|0|||
33389206|NCT01831804|101313659|FG002|Overall Study|Investigator discretion|0|||
33389207|NCT01831804|101313660|FG003|Overall Study|Investigator discretion|0|||
33389208|NCT01831804|101313661|FG004|Overall Study|Investigator discretion|1|||
33389209|NCT01831804|101313662|FG005|Overall Study|Investigator discretion|0|||
33389210|NCT01831804|101313663|FG006|Overall Study|Investigator discretion|0|||
33389211|NCT01831804|101313664|FG007|Overall Study|Investigator discretion|1|||
33389212|NCT01831804|101313665|FG008|Overall Study|Investigator discretion|0|||
33389213|NCT01831804|101313657|FG000|Overall Study|Withdrew Consent|0|||
33389214|NCT01831804|101313658|FG001|Overall Study|Withdrew Consent|1|||
33389215|NCT01831804|101313659|FG002|Overall Study|Withdrew Consent|0|||
33389216|NCT01831804|101313660|FG003|Overall Study|Withdrew Consent|0|||
33389217|NCT01831804|101313661|FG004|Overall Study|Withdrew Consent|0|||
33389218|NCT01831804|101313662|FG005|Overall Study|Withdrew Consent|0|||
33389219|NCT01831804|101313663|FG006|Overall Study|Withdrew Consent|0|||
33389220|NCT01831804|101313664|FG007|Overall Study|Withdrew Consent|2|||
33389221|NCT01831804|101313665|FG008|Overall Study|Withdrew Consent|0|||
33389222|NCT02843178|101313669|FG000|Overall Study|Lost to Follow-up|8|||
33389223|NCT02843178|101313670|FG001|Overall Study|Lost to Follow-up|8|||
33389224|NCT02843178|101313671|FG002|Overall Study|Lost to Follow-up|6|||
33389225|NCT02843178|101313672|FG003|Overall Study|Lost to Follow-up|3|||
33389226|NCT02843178|101313669|FG000|Overall Study|Withdrawal by Subject|0|||
33389227|NCT02843178|101313670|FG001|Overall Study|Withdrawal by Subject|0|||
33389228|NCT02843178|101313671|FG002|Overall Study|Withdrawal by Subject|1|||
33389229|NCT02843178|101313672|FG003|Overall Study|Withdrawal by Subject|1|||
33389230|NCT01001572|101313673|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
33389231|NCT01001572|101313674|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
33389232|NCT01001572|101313675|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
33389233|NCT01001572|101313673|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
33389234|NCT01001572|101313674|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
33389235|NCT01001572|101313675|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
33389236|NCT01001572|101313673|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
33389237|NCT01001572|101313674|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
33389238|NCT01001572|101313675|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
33389239|NCT01001572|101313673|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
33389240|NCT01001572|101313674|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
33389241|NCT01001572|101313675|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
33389242|NCT01001572|101313673|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
33389243|NCT01001572|101313674|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
33389244|NCT01001572|101313675|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
33389245|NCT01001572|101313673|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
33389246|NCT01001572|101313674|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
33389247|NCT01001572|101313675|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
33389248|NCT01001572|101313673|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
33389249|NCT01001572|101313674|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
33389250|NCT01001572|101313675|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
33389251|NCT01001572|101313673|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
33389252|NCT01001572|101313674|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
33594367|NCT01345591|102064943|FG000|Overall Study|Lost to Follow-up|1|||
33389253|NCT01001572|101313675|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
33389254|NCT01001572|101313673|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
33389255|NCT01001572|101313674|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
33389256|NCT01001572|101313675|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
33389257|NCT01001572|101313673|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
33389258|NCT01001572|101313674|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
33389259|NCT01001572|101313675|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
33389260|NCT01001572|101313673|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
33183585|NCT02442778|100583033|FG000|Overall Study|Withdrawal by Subject|4|||
33183586|NCT02442778|100583034|FG001|Overall Study|Withdrawal by Subject|4|||
33183587|NCT02442778|100583035|FG002|Overall Study|Withdrawal by Subject|3|||
33389261|NCT01001572|101313674|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
33417152|NCT00720304|101420216|FG001|Overall Study|Disease progression|1|||
33389262|NCT01001572|101313675|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
33389263|NCT01001572|101313673|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
33183588|NCT02442778|100583033|FG000|Overall Study|Reason not specified|1|||
33183589|NCT02442778|100583034|FG001|Overall Study|Reason not specified|4|||
33183590|NCT02442778|100583035|FG002|Overall Study|Reason not specified|0|||
33183591|NCT03913091|100583036|FG000|Overall Study|Lost to Follow-up|18|||
33183592|NCT03913091|100583037|FG001|Overall Study|Lost to Follow-up|11|||
33183593|NCT03913091|100583036|FG000|Overall Study|Required additional meds/surgery|1|||
33183594|NCT03913091|100583037|FG001|Overall Study|Required additional meds/surgery|2|||
33594368|NCT00241631|102064944|FG000|Run in (2 Weeks)|Physician Decision|3|||
33594369|NCT00241631|102064945|FG001|Run in (2 Weeks)|Physician Decision|3|||
33594370|NCT00241631|102064944|FG000|Phase 1 (4 Weeks)|sore throat|1|||
33594371|NCT00241631|102064945|FG001|Phase 1 (4 Weeks)|sore throat|0|||
33594372|NCT00241631|102064944|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
33594373|NCT00241631|102064945|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
33594374|NCT00241631|102064944|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
33594375|NCT00241631|102064945|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
33183595|NCT03913091|100583036|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
33183596|NCT03913091|100583037|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
33183597|NCT00291668|100583047|FG000|Overall Study|Lack of Efficacy|1|||
33183598|NCT00291668|100583048|FG001|Overall Study|Lack of Efficacy|0|||
33183599|NCT00291668|100583049|FG002|Overall Study|Lack of Efficacy|0|||
33389264|NCT01001572|101313674|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
33389265|NCT01001572|101313675|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
33389266|NCT01001572|101313673|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
33389267|NCT01001572|101313674|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
33389268|NCT01001572|101313675|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
33389269|NCT01001572|101313673|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33389270|NCT01001572|101313674|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33389271|NCT01001572|101313675|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
33389272|NCT01197794|101313676|FG000|Overall Study|Adverse Event|3|||
33389273|NCT01197794|101313677|FG001|Overall Study|Adverse Event|2|||
33389274|NCT01197794|101313678|FG002|Overall Study|Adverse Event|4|||
33389275|NCT01197794|101313679|FG003|Overall Study|Adverse Event|4|||
33389276|NCT01197794|101313680|FG004|Overall Study|Adverse Event|4|||
33389277|NCT01197794|101313681|FG005|Overall Study|Adverse Event|2|||
33389278|NCT01197794|101313682|FG006|Overall Study|Adverse Event|3|||
33183600|NCT00291668|100583047|FG000|Overall Study|SAE, non-fatal|1|||
33183601|NCT00291668|100583048|FG001|Overall Study|SAE, non-fatal|1|||
33183602|NCT00291668|100583049|FG002|Overall Study|SAE, non-fatal|1|||
33389279|NCT01197794|101313676|FG000|Overall Study|Protocol Violation|0|||
33389280|NCT01197794|101313677|FG001|Overall Study|Protocol Violation|0|||
33389281|NCT01197794|101313678|FG002|Overall Study|Protocol Violation|0|||
33389282|NCT01197794|101313679|FG003|Overall Study|Protocol Violation|0|||
33389283|NCT01197794|101313680|FG004|Overall Study|Protocol Violation|2|||
33389284|NCT01197794|101313681|FG005|Overall Study|Protocol Violation|0|||
33389285|NCT01197794|101313682|FG006|Overall Study|Protocol Violation|1|||
33389286|NCT01197794|101313676|FG000|Overall Study|Development of study withdrawal criteria|3|||
33389287|NCT01197794|101313677|FG001|Overall Study|Development of study withdrawal criteria|0|||
33389288|NCT01197794|101313678|FG002|Overall Study|Development of study withdrawal criteria|0|||
33389289|NCT01197794|101313679|FG003|Overall Study|Development of study withdrawal criteria|1|||
33389290|NCT01197794|101313680|FG004|Overall Study|Development of study withdrawal criteria|0|||
33389291|NCT01197794|101313681|FG005|Overall Study|Development of study withdrawal criteria|0|||
33389292|NCT01197794|101313682|FG006|Overall Study|Development of study withdrawal criteria|1|||
33594376|NCT00241631|102064944|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
33594377|NCT00241631|102064945|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
33594378|NCT04043234|102064946|FG000|Overall Study|Lost to Follow-up|1|||
33594379|NCT04043234|102064946|FG000|Overall Study|Withdrawal by Subject|1|||
33594380|NCT02534935|102064948|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
33594381|NCT02534935|102064949|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
33594382|NCT02534935|102064950|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
33594383|NCT02534935|102064948|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
33594384|NCT02534935|102064949|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
33594385|NCT02534935|102064950|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
33594386|NCT02534935|102064948|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
33594387|NCT02534935|102064949|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
33389293|NCT01197794|101313676|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
33594388|NCT02534935|102064950|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
33594389|NCT02534935|102064948|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
33594390|NCT02534935|102064949|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
33594391|NCT02534935|102064950|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
33594392|NCT02534935|102064948|FG000|Stage 1: 24 Months|Adverse Event|0|||
33183603|NCT00291668|100583047|FG000|Overall Study|AE, non-serious non-fatal|1|||
33183604|NCT00291668|100583048|FG001|Overall Study|AE, non-serious non-fatal|0|||
33183605|NCT00291668|100583049|FG002|Overall Study|AE, non-serious non-fatal|0|||
33183606|NCT00291668|100583047|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33183607|NCT00291668|100583048|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
33183608|NCT00291668|100583049|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
33183609|NCT02818777|100583050|FG000|Overall Study|Adverse Event|3|||
33183610|NCT01644175|100583051|FG000|Overall Study|Randomized But Not Treated|0|||
33183611|NCT01644175|100583052|FG001|Overall Study|Randomized But Not Treated|2|||
33183612|NCT01644175|100583051|FG000|Overall Study|Adverse Event|8|||
33183613|NCT01644175|100583052|FG001|Overall Study|Adverse Event|13|||
33183614|NCT01644175|100583051|FG000|Overall Study|Death|1|||
33183615|NCT01644175|100583052|FG001|Overall Study|Death|2|||
33183616|NCT01644175|100583051|FG000|Overall Study|Poor compliance to protocol|9|||
33183617|NCT01644175|100583052|FG001|Overall Study|Poor compliance to protocol|10|||
33183618|NCT01644175|100583051|FG000|Overall Study|Physician Decision|1|||
33183619|NCT01644175|100583052|FG001|Overall Study|Physician Decision|2|||
33183620|NCT01644175|100583051|FG000|Overall Study|Participant Moved|1|||
33183621|NCT01644175|100583052|FG001|Overall Study|Participant Moved|2|||
33183622|NCT01644175|100583051|FG000|Overall Study|Consent withdrawn by participant|3|||
33183623|NCT01644175|100583052|FG001|Overall Study|Consent withdrawn by participant|4|||
33183624|NCT01644175|100583051|FG000|Overall Study|Related to Autoinjector Administration|2|||
33183625|NCT01644175|100583052|FG001|Overall Study|Related to Autoinjector Administration|1|||
33183626|NCT01644175|100583051|FG000|Overall Study|Last visit outside protocol visit window|4|||
33183627|NCT01644175|100583052|FG001|Overall Study|Last visit outside protocol visit window|11|||
33183628|NCT01644175|100583051|FG000|Overall Study|Selection criteria finally not met|0|||
33183629|NCT01644175|100583052|FG001|Overall Study|Selection criteria finally not met|1|||
33183630|NCT01644175|100583051|FG000|Overall Study|Site closure|2|||
33183631|NCT01644175|100583052|FG001|Overall Study|Site closure|2|||
33183632|NCT01644175|100583051|FG000|Overall Study|Lost to Follow-up|1|||
33183633|NCT01644175|100583052|FG001|Overall Study|Lost to Follow-up|0|||
33183634|NCT01644175|100583051|FG000|Overall Study|Other than specified above|0|||
33389294|NCT01197794|101313677|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
33389295|NCT01197794|101313678|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
33389296|NCT01197794|101313679|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
33389297|NCT01197794|101313680|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
33389298|NCT01197794|101313681|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
33389299|NCT01197794|101313682|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
33389300|NCT01197794|101313676|FG000|Overall Study|Withdrawal by Subject|3|||
33389301|NCT01197794|101313677|FG001|Overall Study|Withdrawal by Subject|3|||
33389302|NCT01197794|101313678|FG002|Overall Study|Withdrawal by Subject|4|||
33389303|NCT01197794|101313679|FG003|Overall Study|Withdrawal by Subject|1|||
33389304|NCT01197794|101313680|FG004|Overall Study|Withdrawal by Subject|1|||
33389305|NCT01197794|101313681|FG005|Overall Study|Withdrawal by Subject|5|||
33389306|NCT01197794|101313682|FG006|Overall Study|Withdrawal by Subject|6|||
33389307|NCT01197794|101313676|FG000|Overall Study|Lost to Follow-up|1|||
33389308|NCT01197794|101313677|FG001|Overall Study|Lost to Follow-up|1|||
33389309|NCT01197794|101313678|FG002|Overall Study|Lost to Follow-up|0|||
33389310|NCT01197794|101313679|FG003|Overall Study|Lost to Follow-up|1|||
33389311|NCT01197794|101313680|FG004|Overall Study|Lost to Follow-up|0|||
33389312|NCT01197794|101313681|FG005|Overall Study|Lost to Follow-up|1|||
33389313|NCT01197794|101313682|FG006|Overall Study|Lost to Follow-up|0|||
33389314|NCT01197794|101313676|FG000|Overall Study|Other|1|||
33389315|NCT01197794|101313677|FG001|Overall Study|Other|1|||
33183635|NCT01644175|100583052|FG001|Overall Study|Other than specified above|3|||
33183636|NCT01859507|100583053|FG000|Overall Study|left the country|4|||
33183637|NCT02159521|100583054|FG000|Overall Study|Enrolled but not treated|3|||
33183638|NCT02159521|100583054|FG000|Overall Study|Withdrawal by Subject|7|||
33183639|NCT02159521|100583054|FG000|Overall Study|Lost to Follow-up|6|||
33183640|NCT02159521|100583054|FG000|Overall Study|Death|1|||
33183641|NCT02159521|100583054|FG000|Overall Study|Other than specified|1|||
33183642|NCT02780804|100583055|FG000|Overall Study|Death|1|||
33183643|NCT02780804|100583056|FG001|Overall Study|Death|0|||
33183644|NCT02780804|100583057|FG002|Overall Study|Death|0|||
33183645|NCT02780804|100583055|FG000|Overall Study|Lack of Efficacy|5|||
33183646|NCT02780804|100583056|FG001|Overall Study|Lack of Efficacy|8|||
33183647|NCT02780804|100583057|FG002|Overall Study|Lack of Efficacy|4|||
33183648|NCT02780804|100583055|FG000|Overall Study|Physician Decision|0|||
33183649|NCT02780804|100583056|FG001|Overall Study|Physician Decision|0|||
33183650|NCT02780804|100583057|FG002|Overall Study|Physician Decision|2|||
33183651|NCT02780804|100583055|FG000|Overall Study|Withdrawal by Subject|0|||
33183652|NCT02780804|100583056|FG001|Overall Study|Withdrawal by Subject|1|||
33287022|NCT00505414|100947770|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33389316|NCT01197794|101313678|FG002|Overall Study|Other|3|||
33389317|NCT01197794|101313679|FG003|Overall Study|Other|0|||
33389318|NCT01197794|101313680|FG004|Overall Study|Other|2|||
33389319|NCT01197794|101313681|FG005|Overall Study|Other|2|||
33389320|NCT01197794|101313682|FG006|Overall Study|Other|4|||
33183653|NCT02780804|100583057|FG002|Overall Study|Withdrawal by Subject|0|||
33183654|NCT01549964|100583058|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
33183655|NCT01549964|100583059|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
33183656|NCT01549964|100583060|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
33183657|NCT01549964|100583061|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
33183658|NCT01549964|100583058|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
33183659|NCT01549964|100583059|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
33183660|NCT01549964|100583060|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
33183661|NCT01549964|100583061|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
33183662|NCT01549964|100583058|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
33183663|NCT01549964|100583059|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
33594393|NCT02534935|102064949|FG001|Stage 1: 24 Months|Adverse Event|2|||
33594394|NCT02534935|102064950|FG002|Stage 1: 24 Months|Adverse Event|0|||
33594395|NCT02534935|102064948|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
33594396|NCT02534935|102064949|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
33594397|NCT02534935|102064950|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
33594398|NCT02534935|102064948|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
33594399|NCT02534935|102064949|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
33594400|NCT02534935|102064950|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
33594401|NCT00510718|102064951|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
33594402|NCT00510718|102064952|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
33594403|NCT00510718|102064951|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
33594404|NCT00510718|102064952|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
33594405|NCT00510718|102064951|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
33594406|NCT00510718|102064952|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
33594407|NCT00510718|102064951|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
33594408|NCT00510718|102064952|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
33594409|NCT00510718|102064951|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
33594410|NCT00510718|102064952|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
33594411|NCT00510718|102064951|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
33594412|NCT00510718|102064952|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
33594413|NCT02300558|102064957|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
33183664|NCT01549964|100583060|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
33183665|NCT01549964|100583061|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
33183666|NCT01549964|100583058|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
33183667|NCT01549964|100583059|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
33183668|NCT01549964|100583060|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
33183669|NCT01549964|100583061|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
33183670|NCT01549964|100583058|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
33183671|NCT01549964|100583059|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
33183672|NCT01549964|100583060|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
33594414|NCT02300558|102064957|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
33594415|NCT02300558|102064957|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
33594416|NCT02300558|102064957|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
33594417|NCT04752566|102064958|FG000|Overall Study|Protocol Violation|0|||
33594418|NCT04752566|102064959|FG001|Overall Study|Protocol Violation|1|||
33594419|NCT04752566|102064958|FG000|Overall Study|Death|1|||
33594420|NCT04752566|102064959|FG001|Overall Study|Death|0|||
33594421|NCT04752566|102064958|FG000|Overall Study|Adverse Event|1|||
33594422|NCT04752566|102064959|FG001|Overall Study|Adverse Event|0|||
33594423|NCT04752566|102064958|FG000|Overall Study|Withdrawal by Subject|2|||
33594424|NCT04752566|102064959|FG001|Overall Study|Withdrawal by Subject|0|||
33594425|NCT04752566|102064958|FG000|Overall Study|Physician Decision|1|||
33594426|NCT04752566|102064959|FG001|Overall Study|Physician Decision|1|||
33594427|NCT01574157|102064964|FG000|Overall Study|Withdrawal by Subject|4|||
33594428|NCT01574157|102064965|FG001|Overall Study|Withdrawal by Subject|5|||
33594429|NCT01574157|102064964|FG000|Overall Study|Lost to Follow-up|0|||
33594430|NCT01574157|102064965|FG001|Overall Study|Lost to Follow-up|3|||
33183673|NCT01549964|100583061|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
33183674|NCT01549964|100583058|FG000|24-Week Treatment Period|Other|1|||
33183675|NCT01549964|100583059|FG001|24-Week Treatment Period|Other|0|||
33183676|NCT01549964|100583060|FG002|24-Week Treatment Period|Other|1|||
33183677|NCT01549964|100583061|FG003|24-Week Treatment Period|Other|0|||
33183678|NCT01549964|100583058|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
33183679|NCT01549964|100583059|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
33183680|NCT01549964|100583060|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
33183681|NCT01549964|100583061|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
33183682|NCT01549964|100583058|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
33183683|NCT01549964|100583059|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
33183684|NCT01549964|100583060|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
33183685|NCT01549964|100583061|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
33183686|NCT01549964|100583058|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
33183687|NCT01549964|100583059|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
33183688|NCT01549964|100583060|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
33183689|NCT01549964|100583061|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
33183690|NCT01549964|100583058|FG000|80-Week Extension Period|Pregnancy|0|||
33183691|NCT01549964|100583059|FG001|80-Week Extension Period|Pregnancy|0|||
33183692|NCT01549964|100583060|FG002|80-Week Extension Period|Pregnancy|1|||
33389321|NCT01415908|101313683|FG000|Overall Study|Withdrawal by Subject|1|||
33493077|NCT00758524|101698129|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33493078|NCT00758524|101698130|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33183693|NCT01549964|100583061|FG003|80-Week Extension Period|Pregnancy|0|||
33183694|NCT01549964|100583058|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
33183695|NCT01549964|100583059|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
33183696|NCT01549964|100583060|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
33183697|NCT01549964|100583061|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
33493079|NCT00758524|101698131|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33493080|NCT00758524|101698132|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33493081|NCT00758524|101698133|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33493082|NCT00758524|101698134|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33493083|NCT00758524|101698135|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33493084|NCT00758524|101698136|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33493085|NCT00758524|101698137|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
33493086|NCT00758524|101698121|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33183698|NCT01549964|100583058|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
33183699|NCT01549964|100583059|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
33183700|NCT01549964|100583060|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
33183701|NCT01549964|100583061|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
33183702|NCT01549964|100583058|FG000|80-Week Extension Period|Lost to Follow-up|1|||
33183703|NCT01549964|100583059|FG001|80-Week Extension Period|Lost to Follow-up|0|||
33183704|NCT01549964|100583060|FG002|80-Week Extension Period|Lost to Follow-up|2|||
33183705|NCT01549964|100583061|FG003|80-Week Extension Period|Lost to Follow-up|1|||
33183706|NCT01549964|100583058|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
33493087|NCT00758524|101698122|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33183707|NCT01549964|100583059|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
33183708|NCT01549964|100583060|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
33183709|NCT01549964|100583061|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
33183710|NCT01124604|100583071|FG000|Overall Study|Adverse Event|10|||
33183711|NCT01124604|100583072|FG001|Overall Study|Adverse Event|1|||
33183712|NCT01124604|100583071|FG000|Overall Study|Lack of Efficacy|1|||
33183713|NCT01124604|100583072|FG001|Overall Study|Lack of Efficacy|0|||
33183714|NCT01124604|100583071|FG000|Overall Study|Withdrawal by Subject|4|||
33183715|NCT01124604|100583072|FG001|Overall Study|Withdrawal by Subject|0|||
33183716|NCT01124604|100583071|FG000|Overall Study|Disease Progression|0|||
33183717|NCT01124604|100583072|FG001|Overall Study|Disease Progression|1|||
33183718|NCT02018458|100583078|FG000|Overall Study|Death|4|||
33183719|NCT01531387|100583081|FG000|Overall Study|Early termination of study|11|||
33183720|NCT01531387|100583082|FG001|Overall Study|Early termination of study|11|||
33183721|NCT03434041|100583083|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
33183722|NCT03434041|100583084|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
33183723|NCT03434041|100583083|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
33183724|NCT03434041|100583084|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
33183725|NCT03434041|100583083|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
33183726|NCT03434041|100583084|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
33183727|NCT03434041|100583083|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
33183728|NCT03434041|100583084|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
33183729|NCT03434041|100583083|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
33183730|NCT03434041|100583084|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
33183731|NCT03434041|100583083|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
33183732|NCT03434041|100583084|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
33183733|NCT03434041|100583083|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
33183734|NCT03434041|100583084|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
33183735|NCT03434041|100583083|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
33183736|NCT03434041|100583084|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
33183737|NCT03434041|100583083|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
33183738|NCT03434041|100583084|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
33389322|NCT01415908|101313684|FG001|Overall Study|Withdrawal by Subject|0|||
33389323|NCT01750840|101313689|FG000|Overall Study|Lost to Follow-up|4|||
33493088|NCT00758524|101698123|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
33183739|NCT03434041|100583083|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
33183740|NCT03434041|100583084|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
33183741|NCT03434041|100583083|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
33183742|NCT03434041|100583084|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
33183743|NCT00453999|100583085|FG000|Overall Study|Adverse Event|1|||
33183744|NCT00453999|100583086|FG001|Overall Study|Adverse Event|2|||
33183745|NCT00453999|100583087|FG002|Overall Study|Adverse Event|1|||
33183746|NCT00453999|100583085|FG000|Overall Study|Lost to Follow-up|0|||
33183747|NCT00453999|100583086|FG001|Overall Study|Lost to Follow-up|1|||
33183748|NCT00453999|100583087|FG002|Overall Study|Lost to Follow-up|1|||
33183749|NCT00453999|100583085|FG000|Overall Study|Withdrawal by Subject|2|||
33183750|NCT00453999|100583086|FG001|Overall Study|Withdrawal by Subject|1|||
33183751|NCT00453999|100583087|FG002|Overall Study|Withdrawal by Subject|1|||
33183752|NCT00453999|100583085|FG000|Overall Study|Subject Request|2|||
33183753|NCT00453999|100583086|FG001|Overall Study|Subject Request|1|||
33183754|NCT00453999|100583087|FG002|Overall Study|Subject Request|0|||
33183755|NCT03412084|100583090|FG000|Overall Study|Withdrawal by Subject|2|||
33493089|NCT00758524|101698124|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
33493090|NCT00758524|101698125|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33493091|NCT00758524|101698126|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33493092|NCT00758524|101698127|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33493093|NCT00758524|101698128|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33493094|NCT00758524|101698129|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33493095|NCT00758524|101698130|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33389324|NCT01544478|101313692|FG000|Overall Study|Adverse Event|1|||
33389325|NCT01544478|101313692|FG000|Overall Study|Death|1|||
33183756|NCT03412084|100583091|FG001|Overall Study|Withdrawal by Subject|0|||
33183757|NCT03412084|100583090|FG000|Overall Study|Participant moved|1|||
33183758|NCT03412084|100583091|FG001|Overall Study|Participant moved|0|||
33183759|NCT03412084|100583090|FG000|Overall Study|Lost to Follow-up|1|||
33183760|NCT03412084|100583091|FG001|Overall Study|Lost to Follow-up|1|||
33183761|NCT00313612|100583092|FG000|Overall Study|Patient never received treatment|0|||
33183762|NCT00313612|100583093|FG001|Overall Study|Patient never received treatment|1|||
33183763|NCT00573755|100583095|FG000|Overall Study|Still receiving treatment|1|||
33183764|NCT00573755|100583096|FG001|Overall Study|Still receiving treatment|0|||
33183765|NCT03025828|100583099|FG000|Overall Study|Lost to Follow-up|1|||
33183766|NCT00603746|100583100|FG000|Overall Study|Adverse Event|2|||
33183767|NCT00603746|100583101|FG001|Overall Study|Adverse Event|3|||
33183768|NCT00603746|100583102|FG002|Overall Study|Adverse Event|0|||
33183769|NCT00603746|100583103|FG003|Overall Study|Adverse Event|1|||
33183770|NCT00603746|100583104|FG004|Overall Study|Adverse Event|0|||
33183771|NCT00603746|100583105|FG005|Overall Study|Adverse Event|4|||
33183772|NCT00603746|100583100|FG000|Overall Study|Lack of Efficacy|34|||
33183773|NCT00603746|100583101|FG001|Overall Study|Lack of Efficacy|11|||
33183774|NCT00603746|100583102|FG002|Overall Study|Lack of Efficacy|6|||
33183775|NCT00603746|100583103|FG003|Overall Study|Lack of Efficacy|11|||
33183776|NCT00603746|100583104|FG004|Overall Study|Lack of Efficacy|12|||
33183777|NCT00603746|100583105|FG005|Overall Study|Lack of Efficacy|8|||
33183778|NCT00603746|100583100|FG000|Overall Study|Protocol Violation|0|||
33183779|NCT00603746|100583101|FG001|Overall Study|Protocol Violation|3|||
33183780|NCT00603746|100583102|FG002|Overall Study|Protocol Violation|1|||
33183781|NCT00603746|100583103|FG003|Overall Study|Protocol Violation|0|||
33183782|NCT00603746|100583104|FG004|Overall Study|Protocol Violation|1|||
33183783|NCT00603746|100583105|FG005|Overall Study|Protocol Violation|0|||
33183784|NCT00603746|100583100|FG000|Overall Study|Lost to Follow-up|0|||
33183785|NCT00603746|100583101|FG001|Overall Study|Lost to Follow-up|1|||
33183786|NCT00603746|100583102|FG002|Overall Study|Lost to Follow-up|1|||
33183787|NCT00603746|100583103|FG003|Overall Study|Lost to Follow-up|0|||
33183788|NCT00603746|100583104|FG004|Overall Study|Lost to Follow-up|0|||
33493096|NCT00758524|101698131|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33183789|NCT00603746|100583105|FG005|Overall Study|Lost to Follow-up|0|||
33183790|NCT00603746|100583100|FG000|Overall Study|Physician Decision|1|||
33183791|NCT00603746|100583101|FG001|Overall Study|Physician Decision|0|||
33183792|NCT00603746|100583102|FG002|Overall Study|Physician Decision|0|||
33183793|NCT00603746|100583103|FG003|Overall Study|Physician Decision|0|||
33183794|NCT00603746|100583104|FG004|Overall Study|Physician Decision|1|||
33183795|NCT00603746|100583105|FG005|Overall Study|Physician Decision|0|||
33183796|NCT00603746|100583100|FG000|Overall Study|Withdrawal by Subject|1|||
33183797|NCT00603746|100583101|FG001|Overall Study|Withdrawal by Subject|0|||
33183798|NCT00603746|100583102|FG002|Overall Study|Withdrawal by Subject|0|||
33183799|NCT00603746|100583103|FG003|Overall Study|Withdrawal by Subject|1|||
33183800|NCT00603746|100583104|FG004|Overall Study|Withdrawal by Subject|3|||
33183801|NCT00603746|100583105|FG005|Overall Study|Withdrawal by Subject|1|||
33594431|NCT00027378|102064966|FG000|Overall Study|Physician Decision|0|||
33183802|NCT00811577|100583106|FG000|Overall Study|Lost to Follow-up|7|||
33183803|NCT00811577|100583107|FG001|Overall Study|Lost to Follow-up|1|||
33183804|NCT00811577|100583106|FG000|Overall Study|Withdrawal by Subject|3|||
33183805|NCT00811577|100583107|FG001|Overall Study|Withdrawal by Subject|0|||
33183806|NCT02529137|100583112|FG000|Overall Study|Discontinuation for different reasons|8|||
33183807|NCT00962104|100583114|FG000|Overall Study|Adverse Event|10|||
33183808|NCT00962104|100583115|FG001|Overall Study|Adverse Event|3|||
33183809|NCT00962104|100583114|FG000|Overall Study|Entry Criteria Not Met|1|||
33183810|NCT00962104|100583115|FG001|Overall Study|Entry Criteria Not Met|2|||
33183811|NCT00962104|100583114|FG000|Overall Study|Lack of Efficacy|0|||
33183812|NCT00962104|100583115|FG001|Overall Study|Lack of Efficacy|1|||
33183813|NCT00962104|100583114|FG000|Overall Study|Lost to Follow-up|10|||
33183814|NCT00962104|100583115|FG001|Overall Study|Lost to Follow-up|4|||
33183815|NCT00962104|100583114|FG000|Overall Study|Physician Decision|1|||
33183816|NCT00962104|100583115|FG001|Overall Study|Physician Decision|0|||
33183817|NCT00962104|100583114|FG000|Overall Study|Protocol Violation|6|||
33183818|NCT00962104|100583115|FG001|Overall Study|Protocol Violation|8|||
33183819|NCT00962104|100583114|FG000|Overall Study|Sponsor Decision|0|||
33183820|NCT00962104|100583115|FG001|Overall Study|Sponsor Decision|1|||
33183821|NCT00962104|100583114|FG000|Overall Study|Withdrawal by Subject|10|||
33183822|NCT00962104|100583115|FG001|Overall Study|Withdrawal by Subject|6|||
33183823|NCT00962104|100583114|FG000|Overall Study|Other|2|||
33183824|NCT00962104|100583115|FG001|Overall Study|Other|0|||
33183825|NCT01251380|100583116|FG000|Overall Study|Other (Not otherwise specified)|12|||
33183826|NCT01251380|100583116|FG000|Overall Study|Withdrawal by Subject|6|||
33183827|NCT01251380|100583116|FG000|Overall Study|Lack of Efficacy|1|||
33183828|NCT01251380|100583116|FG000|Overall Study|Adverse Event|1|||
33183829|NCT01251380|100583116|FG000|Overall Study|Lost to Follow-up|2|||
33183830|NCT02641379|100583117|FG000|Overall Study|Exclusion criterion during screening|1|||
33389326|NCT01544478|101313692|FG000|Overall Study|Lost to Follow-up|48|||
33183831|NCT02641379|100583118|FG001|Overall Study|Exclusion criterion during screening|0|||
33183832|NCT02641379|100583119|FG002|Overall Study|Exclusion criterion during screening|0|||
33183833|NCT02641379|100583120|FG003|Overall Study|Exclusion criterion during screening|1|||
33183834|NCT02641379|100583121|FG004|Overall Study|Exclusion criterion during screening|2|||
33183835|NCT02641379|100583122|FG005|Overall Study|Exclusion criterion during screening|0|||
33183836|NCT02641379|100583123|FG006|Overall Study|Exclusion criterion during screening|0|||
33183837|NCT02641379|100583124|FG007|Overall Study|Exclusion criterion during screening|0|||
33183838|NCT02641379|100583125|FG008|Overall Study|Exclusion criterion during screening|0|||
33183839|NCT02641379|100583126|FG009|Overall Study|Exclusion criterion during screening|0|||
33183840|NCT02641379|100583127|FG010|Overall Study|Exclusion criterion during screening|0|||
33183841|NCT02641379|100583117|FG000|Overall Study|Withdrawal of informed consent|0|||
33183842|NCT02641379|100583118|FG001|Overall Study|Withdrawal of informed consent|1|||
33183843|NCT02641379|100583119|FG002|Overall Study|Withdrawal of informed consent|0|||
33183844|NCT02641379|100583120|FG003|Overall Study|Withdrawal of informed consent|0|||
33183845|NCT02641379|100583121|FG004|Overall Study|Withdrawal of informed consent|0|||
33183846|NCT02641379|100583122|FG005|Overall Study|Withdrawal of informed consent|0|||
33183847|NCT02641379|100583123|FG006|Overall Study|Withdrawal of informed consent|0|||
33389327|NCT01544478|101313692|FG000|Overall Study|Physician Decision|15|||
33389328|NCT01544478|101313692|FG000|Overall Study|Pregnancy|1|||
33389329|NCT01544478|101313692|FG000|Overall Study|Withdrawal by Subject|52|||
33493097|NCT00758524|101698132|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33493098|NCT00758524|101698133|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33493099|NCT00758524|101698134|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33493100|NCT00758524|101698135|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33493101|NCT00758524|101698136|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33493102|NCT00758524|101698137|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
33493103|NCT00758524|101698121|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33493104|NCT00758524|101698122|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33493105|NCT00758524|101698123|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33493106|NCT00758524|101698124|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33493107|NCT00758524|101698125|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
33183848|NCT02641379|100583124|FG007|Overall Study|Withdrawal of informed consent|1|||
33493108|NCT00758524|101698126|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33594432|NCT00027378|102064967|FG001|Overall Study|Physician Decision|3|||
33183849|NCT02641379|100583125|FG008|Overall Study|Withdrawal of informed consent|0|||
33183850|NCT02641379|100583126|FG009|Overall Study|Withdrawal of informed consent|0|||
33183851|NCT02641379|100583127|FG010|Overall Study|Withdrawal of informed consent|0|||
33183852|NCT02641379|100583117|FG000|Overall Study|Adverse Event|7|||
33183853|NCT02641379|100583118|FG001|Overall Study|Adverse Event|8|||
33183854|NCT02641379|100583119|FG002|Overall Study|Adverse Event|2|||
33183855|NCT02641379|100583120|FG003|Overall Study|Adverse Event|2|||
33183856|NCT02641379|100583121|FG004|Overall Study|Adverse Event|5|||
33183857|NCT02641379|100583122|FG005|Overall Study|Adverse Event|1|||
33389330|NCT01202760|101313693|FG000|Overall Study|Entry Criteria Not Met|0|||
33389331|NCT01202760|101313694|FG001|Overall Study|Entry Criteria Not Met|3|||
33493109|NCT00758524|101698127|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33493110|NCT00758524|101698128|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33493111|NCT00758524|101698129|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33594433|NCT01177553|102064968|FG000|Overall Study|babies not yet 6 months of age|1|||
33389332|NCT01202760|101313695|FG002|Overall Study|Entry Criteria Not Met|1|||
33389333|NCT01202760|101313693|FG000|Overall Study|Adverse Event|11|||
33389334|NCT01202760|101313694|FG001|Overall Study|Adverse Event|9|||
33389335|NCT01202760|101313695|FG002|Overall Study|Adverse Event|10|||
33389336|NCT01202760|101313693|FG000|Overall Study|Death|2|||
33389337|NCT01202760|101313694|FG001|Overall Study|Death|1|||
33389338|NCT01202760|101313695|FG002|Overall Study|Death|0|||
33389339|NCT01202760|101313693|FG000|Overall Study|Lack of Efficacy|6|||
33389340|NCT01202760|101313694|FG001|Overall Study|Lack of Efficacy|8|||
33389341|NCT01202760|101313695|FG002|Overall Study|Lack of Efficacy|7|||
33389342|NCT01202760|101313693|FG000|Overall Study|Lost to Follow-up|0|||
33389343|NCT01202760|101313694|FG001|Overall Study|Lost to Follow-up|2|||
33389344|NCT01202760|101313695|FG002|Overall Study|Lost to Follow-up|1|||
33389345|NCT01202760|101313693|FG000|Overall Study|Parent / Caregiver Decision|0|||
33389346|NCT01202760|101313694|FG001|Overall Study|Parent / Caregiver Decision|1|||
33389347|NCT01202760|101313695|FG002|Overall Study|Parent / Caregiver Decision|0|||
33389348|NCT01202760|101313693|FG000|Overall Study|Withdrawal by Subject|17|||
33389349|NCT01202760|101313694|FG001|Overall Study|Withdrawal by Subject|18|||
33389350|NCT01202760|101313695|FG002|Overall Study|Withdrawal by Subject|14|||
33389351|NCT01202760|101313693|FG000|Overall Study|Physician Decision|0|||
33389352|NCT01202760|101313694|FG001|Overall Study|Physician Decision|1|||
33389353|NCT01202760|101313695|FG002|Overall Study|Physician Decision|0|||
33389354|NCT01202760|101313693|FG000|Overall Study|Protocol Violation|7|||
33389355|NCT01202760|101313694|FG001|Overall Study|Protocol Violation|5|||
33389356|NCT01202760|101313695|FG002|Overall Study|Protocol Violation|2|||
33389357|NCT01202760|101313693|FG000|Overall Study|Sponsor Decision|4|||
33389358|NCT01202760|101313694|FG001|Overall Study|Sponsor Decision|4|||
33389359|NCT01202760|101313695|FG002|Overall Study|Sponsor Decision|0|||
33389360|NCT00770224|101313698|FG000|Step 1: Induction|Adverse Event|3|||
33389361|NCT00770224|101313699|FG001|Step 1: Induction|Adverse Event|0|||
33389362|NCT00770224|101313698|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
33389363|NCT00770224|101313699|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
33389364|NCT00770224|101313698|FG000|Step 1: Induction|Other reason not protocol specified|2|||
33389365|NCT00770224|101313699|FG001|Step 1: Induction|Other reason not protocol specified|0|||
33389366|NCT00770224|101313698|FG000|Step 1: Induction|Ineligible|2|||
33389367|NCT00770224|101313699|FG001|Step 1: Induction|Ineligible|0|||
33389368|NCT00770224|101313698|FG000|Step 1: Induction|No protocol treatment given|1|||
33389369|NCT00770224|101313699|FG001|Step 1: Induction|No protocol treatment given|0|||
33389370|NCT00770224|101313698|FG000|Step 2: Maintenance|Adverse Event|0|||
33389371|NCT00770224|101313699|FG001|Step 2: Maintenance|Adverse Event|10|||
33389372|NCT00770224|101313698|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
33389373|NCT00770224|101313699|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
33389374|NCT00770224|101313698|FG000|Step 2: Maintenance|Progression/relapse|0|||
33389375|NCT00770224|101313699|FG001|Step 2: Maintenance|Progression/relapse|1|||
33389376|NCT00770224|101313698|FG000|Step 2: Maintenance|Death|0|||
33389377|NCT00770224|101313699|FG001|Step 2: Maintenance|Death|2|||
33389378|NCT00770224|101313698|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
33389379|NCT00770224|101313699|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
33389380|NCT00770224|101313698|FG000|Step 2: Maintenance|Ineligible|0|||
33389381|NCT00770224|101313699|FG001|Step 2: Maintenance|Ineligible|2|||
33389382|NCT00520299|101313700|FG000|Overall Study|Withdrawal by Subject|0|||
33389383|NCT00520299|101313701|FG001|Overall Study|Withdrawal by Subject|0|||
33183858|NCT02641379|100583123|FG006|Overall Study|Adverse Event|5|||
33183859|NCT02641379|100583124|FG007|Overall Study|Adverse Event|0|||
33183860|NCT02641379|100583125|FG008|Overall Study|Adverse Event|1|||
33183861|NCT02641379|100583126|FG009|Overall Study|Adverse Event|1|||
33183862|NCT02641379|100583127|FG010|Overall Study|Adverse Event|5|||
33183863|NCT02641379|100583117|FG000|Overall Study|Lack of Efficacy|0|||
33183864|NCT02641379|100583118|FG001|Overall Study|Lack of Efficacy|0|||
33183865|NCT02641379|100583119|FG002|Overall Study|Lack of Efficacy|2|||
33183866|NCT02641379|100583120|FG003|Overall Study|Lack of Efficacy|0|||
33183867|NCT02641379|100583121|FG004|Overall Study|Lack of Efficacy|0|||
33183868|NCT02641379|100583122|FG005|Overall Study|Lack of Efficacy|2|||
33389384|NCT00520299|101313702|FG002|Overall Study|Withdrawal by Subject|2|||
33389385|NCT00520299|101313700|FG000|Overall Study|Progressive disease|0|||
33389386|NCT00520299|101313701|FG001|Overall Study|Progressive disease|3|||
33389387|NCT00520299|101313702|FG002|Overall Study|Progressive disease|4|||
33183869|NCT02641379|100583123|FG006|Overall Study|Lack of Efficacy|0|||
33389388|NCT00432562|101313703|FG000|Overall Study|Death|3|||
33389389|NCT00432562|101313704|FG001|Overall Study|Death|0|||
33389390|NCT02177812|101313705|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
33389391|NCT02177812|101313706|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
33183870|NCT02641379|100583124|FG007|Overall Study|Lack of Efficacy|5|||
33183871|NCT02641379|100583125|FG008|Overall Study|Lack of Efficacy|0|||
33183872|NCT02641379|100583126|FG009|Overall Study|Lack of Efficacy|0|||
33183873|NCT02641379|100583127|FG010|Overall Study|Lack of Efficacy|0|||
33183874|NCT02641379|100583117|FG000|Overall Study|Participant unable to attend study visit|4|||
33389392|NCT02177812|101313707|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
33389393|NCT02177812|101313708|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
33389394|NCT02177812|101313709|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
33389395|NCT02177812|101313710|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
33389396|NCT02177812|101313711|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
33389397|NCT02177812|101313712|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
33389398|NCT02177812|101313713|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
33389399|NCT02177812|101313705|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
33389400|NCT02177812|101313706|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
33389401|NCT02177812|101313707|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
33389402|NCT02177812|101313708|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
33389403|NCT02177812|101313709|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
33389404|NCT02177812|101313710|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
33389405|NCT02177812|101313711|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
33389406|NCT02177812|101313712|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
33389407|NCT02177812|101313713|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
33389408|NCT02177812|101313705|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
33389409|NCT02177812|101313706|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
33389410|NCT02177812|101313707|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
33389411|NCT02177812|101313708|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
33389412|NCT02177812|101313709|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
33389413|NCT02177812|101313710|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
33389414|NCT02177812|101313711|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
33389415|NCT02177812|101313712|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
33493112|NCT00758524|101698130|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33493113|NCT00758524|101698131|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33493114|NCT00758524|101698132|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33493115|NCT00758524|101698133|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33493116|NCT00758524|101698134|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33493117|NCT00758524|101698135|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33493118|NCT00758524|101698136|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33631259|NCT01231906|102202897|FG000|Overall Study|Lost to Follow-up|1|||
33183875|NCT02641379|100583118|FG001|Overall Study|Participant unable to attend study visit|10|||
33389416|NCT02177812|101313713|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
33389417|NCT02699125|101313718|FG000|Placebo|Lost to Follow-up|2|||
33389418|NCT02699125|101313719|FG001|Placebo|Lost to Follow-up|0|||
33389419|NCT02699125|101313718|FG000|Placebo|Protocol Violation|1|||
33389420|NCT02699125|101313719|FG001|Placebo|Protocol Violation|0|||
33389421|NCT02699125|101313718|FG000|Placebo|Withdrawal by Subject|0|||
33389422|NCT02699125|101313719|FG001|Placebo|Withdrawal by Subject|4|||
33389423|NCT02699125|101313718|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
33389424|NCT02699125|101313719|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
33183876|NCT02641379|100583119|FG002|Overall Study|Participant unable to attend study visit|1|||
33183877|NCT02641379|100583120|FG003|Overall Study|Participant unable to attend study visit|2|||
33183878|NCT02641379|100583121|FG004|Overall Study|Participant unable to attend study visit|5|||
33183879|NCT02641379|100583122|FG005|Overall Study|Participant unable to attend study visit|1|||
33183880|NCT02641379|100583123|FG006|Overall Study|Participant unable to attend study visit|1|||
33183881|NCT02641379|100583124|FG007|Overall Study|Participant unable to attend study visit|1|||
33183882|NCT02641379|100583125|FG008|Overall Study|Participant unable to attend study visit|0|||
33183883|NCT02641379|100583126|FG009|Overall Study|Participant unable to attend study visit|2|||
33183884|NCT02641379|100583127|FG010|Overall Study|Participant unable to attend study visit|0|||
33183885|NCT02641379|100583117|FG000|Overall Study|Participant's compliance|0|||
33183886|NCT02641379|100583118|FG001|Overall Study|Participant's compliance|1|||
33183887|NCT02641379|100583119|FG002|Overall Study|Participant's compliance|0|||
33183888|NCT02641379|100583120|FG003|Overall Study|Participant's compliance|1|||
33183889|NCT02641379|100583121|FG004|Overall Study|Participant's compliance|0|||
33183890|NCT02641379|100583122|FG005|Overall Study|Participant's compliance|2|||
33183891|NCT02641379|100583123|FG006|Overall Study|Participant's compliance|0|||
33389425|NCT02079519|101313720|FG000|Overall Study|Disease Progression|9|||
33389426|NCT02079519|101313720|FG000|Overall Study|Adverse Event|1|||
33389427|NCT00910728|101313721|FG000|Overall Study|Lack of Efficacy|2|||
33389428|NCT00910728|101313722|FG001|Overall Study|Lack of Efficacy|3|||
33389429|NCT00910728|101313723|FG002|Overall Study|Lack of Efficacy|1|||
33389430|NCT00910728|101313724|FG003|Overall Study|Lack of Efficacy|2|||
33389431|NCT00910728|101313725|FG004|Overall Study|Lack of Efficacy|1|||
33389432|NCT00910728|101313726|FG005|Overall Study|Lack of Efficacy|0|||
33389433|NCT00910728|101313727|FG006|Overall Study|Lack of Efficacy|2|||
33389434|NCT00910728|101313728|FG007|Overall Study|Lack of Efficacy|2|||
33389435|NCT00910728|101313729|FG008|Overall Study|Lack of Efficacy|2|||
33493119|NCT00758524|101698137|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
33493120|NCT00758524|101698121|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33493121|NCT00758524|101698122|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
33493122|NCT00758524|101698123|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33493123|NCT00758524|101698124|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33493124|NCT00758524|101698125|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33493125|NCT00758524|101698126|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33493126|NCT00758524|101698127|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33493127|NCT00758524|101698128|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33493128|NCT00758524|101698129|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33493129|NCT00758524|101698130|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33493130|NCT00758524|101698131|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33493131|NCT00758524|101698132|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33389436|NCT00910728|101313721|FG000|Overall Study|Withdrawal by Subject|0|||
33389437|NCT00910728|101313722|FG001|Overall Study|Withdrawal by Subject|0|||
33389438|NCT00910728|101313723|FG002|Overall Study|Withdrawal by Subject|0|||
33389439|NCT00910728|101313724|FG003|Overall Study|Withdrawal by Subject|0|||
33389440|NCT00910728|101313725|FG004|Overall Study|Withdrawal by Subject|3|||
33389441|NCT00910728|101313726|FG005|Overall Study|Withdrawal by Subject|1|||
33493132|NCT00758524|101698133|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33493133|NCT00758524|101698134|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33493134|NCT00758524|101698135|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33493135|NCT00758524|101698136|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33389442|NCT00910728|101313727|FG006|Overall Study|Withdrawal by Subject|2|||
33493136|NCT00758524|101698137|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
33493137|NCT00758524|101698121|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33389443|NCT00910728|101313728|FG007|Overall Study|Withdrawal by Subject|0|||
33389444|NCT00910728|101313729|FG008|Overall Study|Withdrawal by Subject|0|||
33389445|NCT00910728|101313721|FG000|Overall Study|(not specified)|2|||
33389446|NCT00910728|101313722|FG001|Overall Study|(not specified)|0|||
33389447|NCT00910728|101313723|FG002|Overall Study|(not specified)|1|||
33389448|NCT00910728|101313724|FG003|Overall Study|(not specified)|0|||
33389449|NCT00910728|101313725|FG004|Overall Study|(not specified)|1|||
33389450|NCT00910728|101313726|FG005|Overall Study|(not specified)|0|||
33389451|NCT00910728|101313727|FG006|Overall Study|(not specified)|0|||
33389452|NCT00910728|101313728|FG007|Overall Study|(not specified)|0|||
33389453|NCT00910728|101313729|FG008|Overall Study|(not specified)|0|||
33389454|NCT00910728|101313721|FG000|Overall Study|Adverse Event|2|||
33389455|NCT00910728|101313722|FG001|Overall Study|Adverse Event|0|||
33389456|NCT00910728|101313723|FG002|Overall Study|Adverse Event|1|||
33389457|NCT00910728|101313724|FG003|Overall Study|Adverse Event|1|||
33389458|NCT00910728|101313725|FG004|Overall Study|Adverse Event|0|||
33389459|NCT00910728|101313726|FG005|Overall Study|Adverse Event|0|||
33389460|NCT00910728|101313727|FG006|Overall Study|Adverse Event|2|||
33389461|NCT00910728|101313728|FG007|Overall Study|Adverse Event|1|||
33389462|NCT00910728|101313729|FG008|Overall Study|Adverse Event|1|||
33389463|NCT02658968|101313730|FG000|Received Rituximab|Adverse Event|0|||
33389464|NCT02658968|101313731|FG001|Received Rituximab|Adverse Event|0|||
33389465|NCT02658968|101313732|FG002|Received Rituximab|Adverse Event|0|||
33389466|NCT02658968|101313733|FG003|Received Rituximab|Adverse Event|0|||
33389467|NCT02658968|101313734|FG004|Received Rituximab|Adverse Event|1|||
33389468|NCT02658968|101313730|FG000|Received Rituximab|Progressive disease|0|||
33389469|NCT02658968|101313731|FG001|Received Rituximab|Progressive disease|0|||
33389470|NCT02658968|101313732|FG002|Received Rituximab|Progressive disease|0|||
33389471|NCT02658968|101313733|FG003|Received Rituximab|Progressive disease|0|||
33389472|NCT02658968|101313734|FG004|Received Rituximab|Progressive disease|1|||
33389473|NCT02658968|101313730|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
33389474|NCT02658968|101313731|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
33389475|NCT02658968|101313732|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
33493138|NCT00758524|101698122|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
33493139|NCT00758524|101698123|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33493140|NCT00758524|101698124|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33389476|NCT02658968|101313733|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
33389477|NCT02658968|101313734|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
33389478|NCT02658968|101313730|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
33493141|NCT00758524|101698125|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33389479|NCT02658968|101313731|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
33389480|NCT02658968|101313732|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
33389481|NCT02658968|101313733|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
33493142|NCT00758524|101698126|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33493143|NCT00758524|101698127|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33493144|NCT00758524|101698128|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33493145|NCT00758524|101698129|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33493146|NCT00758524|101698130|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33493147|NCT00758524|101698131|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33493148|NCT00758524|101698132|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33493149|NCT00758524|101698133|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33493150|NCT00758524|101698134|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33493151|NCT00758524|101698135|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33493152|NCT00758524|101698136|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33493153|NCT00758524|101698137|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
33493154|NCT00758524|101698121|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493155|NCT00758524|101698122|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493156|NCT00758524|101698123|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493157|NCT00758524|101698124|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493158|NCT00758524|101698125|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493159|NCT00758524|101698126|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493160|NCT00758524|101698127|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493161|NCT00758524|101698128|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493162|NCT00758524|101698129|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
33493163|NCT00758524|101698130|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493164|NCT00758524|101698131|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493165|NCT00758524|101698132|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493166|NCT00758524|101698133|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493167|NCT00758524|101698134|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493168|NCT00758524|101698135|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493169|NCT00758524|101698136|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493170|NCT00758524|101698137|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
33493171|NCT00758524|101698121|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493172|NCT00758524|101698122|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493173|NCT00758524|101698123|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493174|NCT00758524|101698124|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493175|NCT00758524|101698125|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493176|NCT00758524|101698126|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493177|NCT00758524|101698127|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
33493178|NCT00758524|101698128|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493179|NCT00758524|101698129|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493180|NCT00758524|101698130|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493181|NCT00758524|101698131|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493182|NCT00758524|101698132|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493183|NCT00758524|101698133|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493184|NCT00758524|101698134|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493185|NCT00758524|101698135|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493186|NCT00758524|101698136|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493187|NCT00758524|101698137|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
33493188|NCT02892331|101698138|FG000|Overall Study|Withdrawal by Subject|0|||
33493189|NCT02892331|101698139|FG001|Overall Study|Withdrawal by Subject|1|||
33493190|NCT02892331|101698140|FG002|Overall Study|Withdrawal by Subject|1|||
33493191|NCT02892331|101698138|FG000|Overall Study|Sick family member|0|||
33493192|NCT02892331|101698139|FG001|Overall Study|Sick family member|0|||
33389482|NCT02658968|101313734|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
33389483|NCT02658968|101313730|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
33389484|NCT02658968|101313731|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
33389485|NCT02658968|101313732|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
33389486|NCT02658968|101313733|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
33389487|NCT02658968|101313734|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
33389488|NCT02658968|101313730|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
33493193|NCT02892331|101698140|FG002|Overall Study|Sick family member|1|||
33493194|NCT02892331|101698138|FG000|Overall Study|Corona virus pandemic|1|||
33493195|NCT02892331|101698139|FG001|Overall Study|Corona virus pandemic|0|||
33493196|NCT02892331|101698140|FG002|Overall Study|Corona virus pandemic|1|||
33493197|NCT02892331|101698138|FG000|Overall Study|Lost to Follow-up|1|||
33493198|NCT02892331|101698139|FG001|Overall Study|Lost to Follow-up|0|||
33493199|NCT02892331|101698140|FG002|Overall Study|Lost to Follow-up|1|||
33493200|NCT02892331|101698138|FG000|Overall Study|Blood pressure was too elevated|0|||
33493201|NCT02892331|101698139|FG001|Overall Study|Blood pressure was too elevated|1|||
33389489|NCT02658968|101313731|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
33389490|NCT02658968|101313732|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
33389491|NCT02658968|101313733|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
33389492|NCT02658968|101313734|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
33389493|NCT02658968|101313730|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
33389494|NCT02658968|101313731|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
33389495|NCT02658968|101313732|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
33389496|NCT02658968|101313733|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
33389497|NCT02658968|101313734|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
33389498|NCT02762708|101313743|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
33389499|NCT02762708|101313744|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
33389500|NCT02762708|101313745|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
33389501|NCT02762708|101313746|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
33389502|NCT01628393|101313750|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
33389503|NCT01628393|101313751|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
33389504|NCT01628393|101313752|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
33389505|NCT01628393|101313753|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
33389506|NCT01628393|101313754|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
33389507|NCT01628393|101313750|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
33389508|NCT01628393|101313751|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
33389509|NCT01628393|101313752|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
33389510|NCT01628393|101313753|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
33389511|NCT01628393|101313754|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
33389512|NCT01628393|101313750|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
33389513|NCT01628393|101313751|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
33389514|NCT01628393|101313752|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
33389515|NCT01628393|101313753|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
33389516|NCT01628393|101313754|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
33389517|NCT01628393|101313750|FG000|Blinded Active Extension Period|Adverse Event|0|||
33389518|NCT01628393|101313751|FG001|Blinded Active Extension Period|Adverse Event|1|||
33389519|NCT01628393|101313752|FG002|Blinded Active Extension Period|Adverse Event|0|||
33389520|NCT01628393|101313753|FG003|Blinded Active Extension Period|Adverse Event|2|||
33389521|NCT01628393|101313754|FG004|Blinded Active Extension Period|Adverse Event|2|||
33389522|NCT01628393|101313750|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
33389523|NCT01628393|101313751|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
33389524|NCT01628393|101313752|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
33389525|NCT01628393|101313753|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
33389526|NCT01628393|101313754|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
33389527|NCT01628393|101313750|FG000|Blinded Active Extension Period|Physician Decision|0|||
33389528|NCT01628393|101313751|FG001|Blinded Active Extension Period|Physician Decision|3|||
33389529|NCT01628393|101313752|FG002|Blinded Active Extension Period|Physician Decision|0|||
33389530|NCT01628393|101313753|FG003|Blinded Active Extension Period|Physician Decision|1|||
33389531|NCT01628393|101313754|FG004|Blinded Active Extension Period|Physician Decision|0|||
33493202|NCT02892331|101698140|FG002|Overall Study|Blood pressure was too elevated|0|||
33389532|NCT01628393|101313750|FG000|Blinded Active Extension Period|Protocol Violation|0|||
33389533|NCT01628393|101313751|FG001|Blinded Active Extension Period|Protocol Violation|0|||
33389534|NCT01628393|101313752|FG002|Blinded Active Extension Period|Protocol Violation|2|||
33389535|NCT01628393|101313753|FG003|Blinded Active Extension Period|Protocol Violation|1|||
33389536|NCT01628393|101313754|FG004|Blinded Active Extension Period|Protocol Violation|0|||
33389537|NCT01628393|101313750|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
33389538|NCT01628393|101313751|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
33389539|NCT01628393|101313752|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
33389540|NCT01628393|101313753|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
33389541|NCT01628393|101313754|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
33389542|NCT01607073|101313755|FG000|Overall Study|Adverse Event|1|||
33389543|NCT00437203|101313756|FG000|Overall Study|Death|0|||
33493203|NCT02892331|101698138|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
33631260|NCT01231906|102202898|FG001|Overall Study|Lost to Follow-up|0|||
33389544|NCT00437203|101313757|FG001|Overall Study|Death|0|||
33389545|NCT00437203|101313758|FG002|Overall Study|Death|1|||
33389546|NCT00437203|101313759|FG003|Overall Study|Death|0|||
33389547|NCT00437203|101313760|FG004|Overall Study|Death|0|||
33389548|NCT00437203|101313761|FG005|Overall Study|Death|0|||
33389549|NCT00437203|101313762|FG006|Overall Study|Death|0|||
33389550|NCT00437203|101313763|FG007|Overall Study|Death|1|||
33389551|NCT00437203|101313764|FG008|Overall Study|Death|0|||
33389552|NCT00437203|101313765|FG009|Overall Study|Death|1|||
33389553|NCT00437203|101313756|FG000|Overall Study|Adverse Event|1|||
33389554|NCT00437203|101313757|FG001|Overall Study|Adverse Event|1|||
33389555|NCT00437203|101313758|FG002|Overall Study|Adverse Event|0|||
33389556|NCT00437203|101313759|FG003|Overall Study|Adverse Event|0|||
33389557|NCT00437203|101313760|FG004|Overall Study|Adverse Event|0|||
33389558|NCT00437203|101313761|FG005|Overall Study|Adverse Event|0|||
33389559|NCT00437203|101313762|FG006|Overall Study|Adverse Event|0|||
33389560|NCT00437203|101313763|FG007|Overall Study|Adverse Event|1|||
33389561|NCT00437203|101313764|FG008|Overall Study|Adverse Event|0|||
33389562|NCT00437203|101313765|FG009|Overall Study|Adverse Event|1|||
33389563|NCT00437203|101313756|FG000|Overall Study|Study terminated by sponsor|0|||
33389564|NCT00437203|101313757|FG001|Overall Study|Study terminated by sponsor|0|||
33389565|NCT00437203|101313758|FG002|Overall Study|Study terminated by sponsor|0|||
33389566|NCT00437203|101313759|FG003|Overall Study|Study terminated by sponsor|0|||
33389567|NCT00437203|101313760|FG004|Overall Study|Study terminated by sponsor|0|||
33389568|NCT00437203|101313761|FG005|Overall Study|Study terminated by sponsor|0|||
33389569|NCT00437203|101313762|FG006|Overall Study|Study terminated by sponsor|0|||
33389570|NCT00437203|101313763|FG007|Overall Study|Study terminated by sponsor|0|||
33389571|NCT00437203|101313764|FG008|Overall Study|Study terminated by sponsor|1|||
33389572|NCT00437203|101313765|FG009|Overall Study|Study terminated by sponsor|0|||
33389573|NCT00437203|101313756|FG000|Overall Study|Objective progression or relapse|5|||
33389574|NCT00437203|101313757|FG001|Overall Study|Objective progression or relapse|6|||
33389575|NCT00437203|101313758|FG002|Overall Study|Objective progression or relapse|2|||
33389576|NCT00437203|101313759|FG003|Overall Study|Objective progression or relapse|3|||
33389577|NCT00437203|101313760|FG004|Overall Study|Objective progression or relapse|3|||
33389578|NCT00437203|101313761|FG005|Overall Study|Objective progression or relapse|3|||
33389579|NCT00437203|101313762|FG006|Overall Study|Objective progression or relapse|6|||
33389580|NCT00437203|101313763|FG007|Overall Study|Objective progression or relapse|1|||
33389581|NCT00437203|101313764|FG008|Overall Study|Objective progression or relapse|2|||
33389582|NCT00437203|101313765|FG009|Overall Study|Objective progression or relapse|2|||
33389583|NCT00437203|101313756|FG000|Overall Study|Other|0|||
33389584|NCT00437203|101313757|FG001|Overall Study|Other|1|||
33389585|NCT00437203|101313758|FG002|Overall Study|Other|0|||
33389586|NCT00437203|101313759|FG003|Overall Study|Other|0|||
33389587|NCT00437203|101313760|FG004|Overall Study|Other|0|||
33389588|NCT00437203|101313761|FG005|Overall Study|Other|0|||
33389589|NCT00437203|101313762|FG006|Overall Study|Other|1|||
33389590|NCT00437203|101313763|FG007|Overall Study|Other|0|||
33389591|NCT00437203|101313764|FG008|Overall Study|Other|0|||
33389592|NCT00437203|101313765|FG009|Overall Study|Other|0|||
33389593|NCT00527072|101313766|FG000|Overall Study|Adverse Event|13|||
33389594|NCT00527072|101313766|FG000|Overall Study|Lack of Efficacy|11|||
33389595|NCT00527072|101313766|FG000|Overall Study|Lost to Follow-up|3|||
33389596|NCT00527072|101313766|FG000|Overall Study|Protocol Violation|2|||
33389597|NCT00527072|101313766|FG000|Overall Study|Withdrawal by Subject|7|||
33389598|NCT00614991|101313767|FG000|Overall Study|Adverse Event|3|||
33389599|NCT00614991|101313768|FG001|Overall Study|Adverse Event|3|||
33389600|NCT00614991|101313769|FG002|Overall Study|Adverse Event|0|||
33389601|NCT00614991|101313770|FG003|Overall Study|Adverse Event|0|||
33389602|NCT00614991|101313771|FG004|Overall Study|Adverse Event|1|||
33389603|NCT00614991|101313772|FG005|Overall Study|Adverse Event|0|||
33389604|NCT01963780|101313775|FG000|Overall Study|Death|7|||
33389605|NCT02738580|101313776|FG000|Overall Study|Adverse Event|1|||
33389606|NCT02738580|101313777|FG001|Overall Study|Adverse Event|0|||
33389607|NCT02738580|101313776|FG000|Overall Study|Lack of Efficacy|3|||
33389608|NCT02738580|101313777|FG001|Overall Study|Lack of Efficacy|2|||
33389609|NCT02738580|101313776|FG000|Overall Study|Withdrawal by Subject|0|||
33389610|NCT02738580|101313777|FG001|Overall Study|Withdrawal by Subject|1|||
33389611|NCT02738580|101313776|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
33389612|NCT02738580|101313777|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
33389613|NCT01057862|101313778|FG000|Overall Study|Withdrawal by Subject|1|||
33389614|NCT01057862|101313779|FG001|Overall Study|Withdrawal by Subject|2|||
33389615|NCT00294684|101313780|FG000|Overall Study|Lost to Follow-up|5|||
33389616|NCT00294684|101313781|FG001|Overall Study|Lost to Follow-up|8|||
33389617|NCT04134728|101313782|FG000|Overall Study|Adverse Event|3|||
33389618|NCT04134728|101313783|FG001|Overall Study|Adverse Event|2|||
33631261|NCT01231906|102202897|FG000|Overall Study|Physician Decision|34|||
33389619|NCT04134728|101313784|FG002|Overall Study|Adverse Event|9|||
33389620|NCT04134728|101313785|FG003|Overall Study|Adverse Event|0|||
33389621|NCT04134728|101313786|FG004|Overall Study|Adverse Event|0|||
33389622|NCT04134728|101313787|FG005|Overall Study|Adverse Event|0|||
33389623|NCT04134728|101313782|FG000|Overall Study|Lack of Efficacy|3|||
33389624|NCT04134728|101313783|FG001|Overall Study|Lack of Efficacy|3|||
33389625|NCT04134728|101313784|FG002|Overall Study|Lack of Efficacy|1|||
33389626|NCT04134728|101313785|FG003|Overall Study|Lack of Efficacy|2|||
33389627|NCT04134728|101313786|FG004|Overall Study|Lack of Efficacy|0|||
33389628|NCT04134728|101313787|FG005|Overall Study|Lack of Efficacy|0|||
33389629|NCT04134728|101313782|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
33389630|NCT04134728|101313783|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33389631|NCT04134728|101313784|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
33389632|NCT04134728|101313785|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33389633|NCT04134728|101313786|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33389634|NCT04134728|101313787|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33389635|NCT04134728|101313782|FG000|Overall Study|Protocol Deviation|0|||
33389636|NCT04134728|101313783|FG001|Overall Study|Protocol Deviation|0|||
33389637|NCT04134728|101313784|FG002|Overall Study|Protocol Deviation|1|||
33389638|NCT04134728|101313785|FG003|Overall Study|Protocol Deviation|0|||
33389639|NCT04134728|101313786|FG004|Overall Study|Protocol Deviation|0|||
33389640|NCT04134728|101313787|FG005|Overall Study|Protocol Deviation|0|||
33389641|NCT04134728|101313782|FG000|Overall Study|Informed Consent Withdrawn|3|||
33389642|NCT04134728|101313783|FG001|Overall Study|Informed Consent Withdrawn|6|||
33389643|NCT04134728|101313784|FG002|Overall Study|Informed Consent Withdrawn|8|||
33389644|NCT04134728|101313785|FG003|Overall Study|Informed Consent Withdrawn|1|||
33389645|NCT04134728|101313786|FG004|Overall Study|Informed Consent Withdrawn|1|||
33389646|NCT04134728|101313787|FG005|Overall Study|Informed Consent Withdrawn|0|||
33389647|NCT04134728|101313782|FG000|Overall Study|Physician Decision|2|||
33389648|NCT04134728|101313783|FG001|Overall Study|Physician Decision|0|||
33389649|NCT04134728|101313784|FG002|Overall Study|Physician Decision|0|||
33389650|NCT04134728|101313785|FG003|Overall Study|Physician Decision|0|||
33389651|NCT04134728|101313786|FG004|Overall Study|Physician Decision|0|||
33493204|NCT02892331|101698139|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
33493205|NCT02892331|101698140|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
33493206|NCT02232984|101698141|FG000|Overall Study|Withdrawal by Subject|5|||
33493207|NCT02232984|101698141|FG000|Overall Study|Death|1|||
33493208|NCT02232984|101698141|FG000|Overall Study|Investigator withdrawal|10|||
33493209|NCT02232984|101698141|FG000|Overall Study|Device implant unsuccessful|53|||
33493210|NCT02232984|101698141|FG000|Overall Study|not disclosed by site|7|||
33493211|NCT02232984|101698141|FG000|Overall Study|Protocol Violation|1|||
33493212|NCT02287922|101698142|FG000|Overall Study|Adverse Event|1|||
33493213|NCT02287922|101698143|FG001|Overall Study|Adverse Event|1|||
33493214|NCT02287922|101698144|FG002|Overall Study|Adverse Event|3|||
33493215|NCT02287922|101698145|FG003|Overall Study|Adverse Event|4|||
33493216|NCT02287922|101698142|FG000|Overall Study|Withdrawal by Subject|1|||
33493217|NCT02287922|101698143|FG001|Overall Study|Withdrawal by Subject|1|||
33493218|NCT02287922|101698144|FG002|Overall Study|Withdrawal by Subject|1|||
33493219|NCT02287922|101698145|FG003|Overall Study|Withdrawal by Subject|2|||
33493220|NCT02287922|101698142|FG000|Overall Study|Lost to Follow-up|0|||
33493221|NCT02287922|101698143|FG001|Overall Study|Lost to Follow-up|0|||
33389652|NCT04134728|101313787|FG005|Overall Study|Physician Decision|0|||
33389653|NCT04134728|101313782|FG000|Overall Study|Lost to Follow-up|1|||
33389654|NCT04134728|101313783|FG001|Overall Study|Lost to Follow-up|2|||
33389655|NCT04134728|101313784|FG002|Overall Study|Lost to Follow-up|1|||
33389656|NCT04134728|101313785|FG003|Overall Study|Lost to Follow-up|0|||
33389657|NCT04134728|101313786|FG004|Overall Study|Lost to Follow-up|0|||
33389658|NCT04134728|101313787|FG005|Overall Study|Lost to Follow-up|1|||
33389659|NCT04134728|101313782|FG000|Overall Study|Investigator Site Closed|0|||
33389660|NCT04134728|101313783|FG001|Overall Study|Investigator Site Closed|1|||
33389661|NCT04134728|101313784|FG002|Overall Study|Investigator Site Closed|1|||
33389662|NCT04134728|101313785|FG003|Overall Study|Investigator Site Closed|0|||
33389663|NCT04134728|101313786|FG004|Overall Study|Investigator Site Closed|0|||
33389664|NCT04134728|101313787|FG005|Overall Study|Investigator Site Closed|0|||
33389665|NCT03706040|101313788|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
33389666|NCT03706040|101313789|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
33389667|NCT03706040|101313790|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
33389668|NCT03706040|101313791|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
33493222|NCT02287922|101698144|FG002|Overall Study|Lost to Follow-up|1|||
33389669|NCT03706040|101313792|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
33389670|NCT03706040|101313793|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
33389671|NCT03706040|101313794|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
33389672|NCT03706040|101313788|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
33389673|NCT03706040|101313789|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
33389674|NCT03706040|101313790|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
33493223|NCT02287922|101698145|FG003|Overall Study|Lost to Follow-up|0|||
33389675|NCT03706040|101313791|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
33389676|NCT03706040|101313792|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
33389677|NCT03706040|101313793|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
33389678|NCT03706040|101313794|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
33389679|NCT03706040|101313788|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
33389680|NCT03706040|101313789|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
33389681|NCT03706040|101313790|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
33493224|NCT02287922|101698142|FG000|Overall Study|Sponsor's decision|0|||
33493225|NCT02287922|101698143|FG001|Overall Study|Sponsor's decision|0|||
33389682|NCT03706040|101313791|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
33389683|NCT03706040|101313792|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
33389684|NCT03706040|101313793|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
33389685|NCT03706040|101313794|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
33389686|NCT03706040|101313788|FG000|Period A (Week 0 to Week 16)|Other|2|||
33389687|NCT03706040|101313789|FG001|Period A (Week 0 to Week 16)|Other|0|||
33389688|NCT03706040|101313790|FG002|Period A (Week 0 to Week 16)|Other|2|||
33389689|NCT03706040|101313791|FG003|Period A (Week 0 to Week 16)|Other|0|||
33389690|NCT03706040|101313792|FG004|Period A (Week 0 to Week 16)|Other|0|||
33389691|NCT03706040|101313793|FG005|Period A (Week 0 to Week 16)|Other|0|||
33389692|NCT03706040|101313794|FG006|Period A (Week 0 to Week 16)|Other|0|||
33389693|NCT03706040|101313788|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
33389694|NCT03706040|101313789|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
33389695|NCT03706040|101313790|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
33389696|NCT03706040|101313791|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
33389697|NCT03706040|101313792|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
33389698|NCT03706040|101313793|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
33389699|NCT03706040|101313794|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
33389700|NCT03706040|101313788|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
33389701|NCT03706040|101313789|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
33389702|NCT03706040|101313790|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
33389703|NCT03706040|101313791|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
33389704|NCT03706040|101313792|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
33389705|NCT03706040|101313793|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
33389706|NCT03706040|101313794|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
33389707|NCT03706040|101313788|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
33389708|NCT03706040|101313789|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
33389709|NCT03706040|101313790|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
33389710|NCT03706040|101313791|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
33389711|NCT03706040|101313792|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
33389712|NCT03706040|101313793|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
33389713|NCT03706040|101313794|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
33389714|NCT03706040|101313788|FG000|Period B (Week 16 to Week 52)|Other|0|||
33389715|NCT03706040|101313789|FG001|Period B (Week 16 to Week 52)|Other|0|||
33389716|NCT03706040|101313790|FG002|Period B (Week 16 to Week 52)|Other|0|||
33389717|NCT03706040|101313791|FG003|Period B (Week 16 to Week 52)|Other|4|||
33389718|NCT03706040|101313792|FG004|Period B (Week 16 to Week 52)|Other|5|||
33389719|NCT03706040|101313793|FG005|Period B (Week 16 to Week 52)|Other|23|||
33389720|NCT03706040|101313794|FG006|Period B (Week 16 to Week 52)|Other|17|||
33389721|NCT01614795|101313796|FG000|Overall Study|Adverse Event|0|||
33389722|NCT01614795|101313797|FG001|Overall Study|Adverse Event|0|||
33389723|NCT01614795|101313798|FG002|Overall Study|Adverse Event|1|||
33389724|NCT01614795|101313799|FG003|Overall Study|Adverse Event|1|||
33389725|NCT01614795|101313796|FG000|Overall Study|Lack of Efficacy|10|||
33389726|NCT01614795|101313797|FG001|Overall Study|Lack of Efficacy|10|||
33389727|NCT01614795|101313798|FG002|Overall Study|Lack of Efficacy|9|||
33389728|NCT01614795|101313799|FG003|Overall Study|Lack of Efficacy|8|||
33389729|NCT01614795|101313796|FG000|Overall Study|Physician Decision|1|||
33389730|NCT01614795|101313797|FG001|Overall Study|Physician Decision|0|||
33389731|NCT01614795|101313798|FG002|Overall Study|Physician Decision|1|||
33389732|NCT01614795|101313799|FG003|Overall Study|Physician Decision|1|||
33389733|NCT01614795|101313796|FG000|Overall Study|Withdrawal by Subject|0|||
33389734|NCT01614795|101313797|FG001|Overall Study|Withdrawal by Subject|1|||
33389735|NCT01614795|101313798|FG002|Overall Study|Withdrawal by Subject|0|||
33389736|NCT01614795|101313799|FG003|Overall Study|Withdrawal by Subject|2|||
33389737|NCT01614795|101313796|FG000|Overall Study|Ineligible|0|||
33389738|NCT01614795|101313797|FG001|Overall Study|Ineligible|1|||
33389739|NCT01614795|101313798|FG002|Overall Study|Ineligible|0|||
33389740|NCT01614795|101313799|FG003|Overall Study|Ineligible|0|||
33389741|NCT02475629|101313800|FG000|Overall Study|Adverse Event|1|||
33389742|NCT02475629|101313800|FG000|Overall Study|Death|4|||
33389743|NCT02475629|101313800|FG000|Overall Study|Physician Decision|1|||
33389744|NCT02475629|101313800|FG000|Overall Study|Withdrawal by Subject|1|||
33389745|NCT02475629|101313800|FG000|Overall Study|Lost to Follow-up|1|||
33389746|NCT02475629|101313800|FG000|Overall Study|Subject non-compliance|1|||
33389747|NCT00701441|101313801|FG000|Overall Study|failure in cpap compliance|0|||
33389748|NCT00701441|101313802|FG001|Overall Study|failure in cpap compliance|4|||
33389749|NCT02255760|101313805|FG000|Overall Study|Lost to Follow-up|0|||
33389750|NCT02255760|101313806|FG001|Overall Study|Lost to Follow-up|1|||
33389751|NCT02255760|101313807|FG002|Overall Study|Lost to Follow-up|0|||
33389752|NCT02255760|101313808|FG003|Overall Study|Lost to Follow-up|0|||
33389753|NCT02255760|101313809|FG004|Overall Study|Lost to Follow-up|0|||
33389754|NCT00841672|101313812|FG000|Overall Study|Adverse Event|7|||
33389755|NCT00841672|101313813|FG001|Overall Study|Adverse Event|16|||
33389756|NCT00841672|101313812|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33389757|NCT00841672|101313813|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33389758|NCT00841672|101313812|FG000|Overall Study|Subject withdrew consent|2|||
33389759|NCT00841672|101313813|FG001|Overall Study|Subject withdrew consent|4|||
33389760|NCT00841672|101313812|FG000|Overall Study|Lost to Follow-up|1|||
33389761|NCT00841672|101313813|FG001|Overall Study|Lost to Follow-up|1|||
33389762|NCT00841672|101313812|FG000|Overall Study|Administrative problems|9|||
33389763|NCT00841672|101313813|FG001|Overall Study|Administrative problems|9|||
33389764|NCT00841672|101313812|FG000|Overall Study|Misrandomized|1|||
33389765|NCT00841672|101313813|FG001|Overall Study|Misrandomized|0|||
33389766|NCT00841672|101313812|FG000|Overall Study|Protocol Deviation|0|||
33389767|NCT00841672|101313813|FG001|Overall Study|Protocol Deviation|1|||
33389768|NCT03457636|101313814|FG000|Overall Study|Lost to Follow-up|2|||
33389769|NCT00618813|101313821|FG000|Overall Study|Lack of Efficacy|1|||
33389770|NCT00618813|101313821|FG000|Overall Study|Physician Decision|2|||
33389771|NCT00618813|101313821|FG000|Overall Study|Withdrawal by Subject|1|||
33389772|NCT00064077|101313822|FG000|Overall Study|Improper prior treatment|1|||
33389773|NCT00064077|101313823|FG001|Overall Study|Improper prior treatment|0|||
33389774|NCT00064077|101313824|FG002|Overall Study|Improper prior treatment|0|||
33389775|NCT00064077|101313825|FG003|Overall Study|Improper prior treatment|0|||
33389776|NCT00064077|101313822|FG000|Overall Study|Poor risk|2|||
33389777|NCT00064077|101313823|FG001|Overall Study|Poor risk|0|||
33389778|NCT00064077|101313824|FG002|Overall Study|Poor risk|1|||
33389779|NCT00064077|101313825|FG003|Overall Study|Poor risk|1|||
33389780|NCT00064077|101313822|FG000|Overall Study|Pathology|10|||
33389781|NCT00064077|101313823|FG001|Overall Study|Pathology|7|||
33389782|NCT00064077|101313824|FG002|Overall Study|Pathology|3|||
33389783|NCT00064077|101313825|FG003|Overall Study|Pathology|4|||
33389784|NCT00064077|101313822|FG000|Overall Study|No surgery|0|||
33389785|NCT00064077|101313823|FG001|Overall Study|No surgery|0|||
33389786|NCT00064077|101313824|FG002|Overall Study|No surgery|1|||
33389787|NCT00064077|101313825|FG003|Overall Study|No surgery|0|||
33389788|NCT00064077|101313822|FG000|Overall Study|No tumor|0|||
33389789|NCT00064077|101313823|FG001|Overall Study|No tumor|0|||
33389790|NCT00064077|101313824|FG002|Overall Study|No tumor|1|||
33389791|NCT00064077|101313825|FG003|Overall Study|No tumor|0|||
33389792|NCT00064077|101313822|FG000|Overall Study|Other reasons|2|||
33389793|NCT00064077|101313823|FG001|Overall Study|Other reasons|2|||
33389794|NCT00064077|101313824|FG002|Overall Study|Other reasons|1|||
33389795|NCT00064077|101313825|FG003|Overall Study|Other reasons|2|||
33389796|NCT04153929|101313836|FG000|Overall Study|Other than listed|2|||
33389797|NCT04153929|101313837|FG001|Overall Study|Other than listed|2|||
33389798|NCT04153929|101313838|FG002|Overall Study|Other than listed|0|||
33389799|NCT04153929|101313839|FG003|Overall Study|Other than listed|1|||
33389800|NCT04153929|101313840|FG004|Overall Study|Other than listed|0|||
33389801|NCT04153929|101313841|FG005|Overall Study|Other than listed|2|||
33389802|NCT04153929|101313842|FG006|Overall Study|Other than listed|2|||
33389803|NCT04153929|101313843|FG007|Overall Study|Other than listed|1|||
33389804|NCT04153929|101313836|FG000|Overall Study|Lost to Follow-up|2|||
33389805|NCT04153929|101313837|FG001|Overall Study|Lost to Follow-up|1|||
33389806|NCT04153929|101313838|FG002|Overall Study|Lost to Follow-up|0|||
33389807|NCT04153929|101313839|FG003|Overall Study|Lost to Follow-up|1|||
33389808|NCT04153929|101313840|FG004|Overall Study|Lost to Follow-up|1|||
33389809|NCT04153929|101313841|FG005|Overall Study|Lost to Follow-up|0|||
33389810|NCT04153929|101313842|FG006|Overall Study|Lost to Follow-up|0|||
33389811|NCT04153929|101313843|FG007|Overall Study|Lost to Follow-up|0|||
33389812|NCT04153929|101313836|FG000|Overall Study|Withdrawal by Subject|3|||
33389813|NCT04153929|101313837|FG001|Overall Study|Withdrawal by Subject|1|||
33389814|NCT04153929|101313838|FG002|Overall Study|Withdrawal by Subject|0|||
33389815|NCT04153929|101313839|FG003|Overall Study|Withdrawal by Subject|3|||
33389816|NCT04153929|101313840|FG004|Overall Study|Withdrawal by Subject|1|||
33389817|NCT04153929|101313841|FG005|Overall Study|Withdrawal by Subject|0|||
33389818|NCT04153929|101313842|FG006|Overall Study|Withdrawal by Subject|1|||
33389819|NCT04153929|101313843|FG007|Overall Study|Withdrawal by Subject|0|||
33389820|NCT04153929|101313836|FG000|Overall Study|Protocol Violation|0|||
33389821|NCT04153929|101313837|FG001|Overall Study|Protocol Violation|0|||
33389822|NCT04153929|101313838|FG002|Overall Study|Protocol Violation|0|||
33389823|NCT04153929|101313839|FG003|Overall Study|Protocol Violation|0|||
33389824|NCT04153929|101313840|FG004|Overall Study|Protocol Violation|0|||
33389825|NCT04153929|101313841|FG005|Overall Study|Protocol Violation|0|||
33389826|NCT04153929|101313842|FG006|Overall Study|Protocol Violation|1|||
33389827|NCT04153929|101313843|FG007|Overall Study|Protocol Violation|2|||
33389828|NCT04153929|101313836|FG000|Overall Study|Adverse Event|3|||
33389829|NCT04153929|101313837|FG001|Overall Study|Adverse Event|5|||
33389830|NCT04153929|101313838|FG002|Overall Study|Adverse Event|5|||
33389831|NCT04153929|101313839|FG003|Overall Study|Adverse Event|11|||
33389832|NCT04153929|101313840|FG004|Overall Study|Adverse Event|15|||
33389833|NCT04153929|101313841|FG005|Overall Study|Adverse Event|4|||
33594434|NCT01177553|102064969|FG001|Overall Study|babies not yet 6 months of age|0|||
33389834|NCT04153929|101313842|FG006|Overall Study|Adverse Event|8|||
33389835|NCT04153929|101313843|FG007|Overall Study|Adverse Event|2|||
33389836|NCT04153929|101313836|FG000|Overall Study|Not treated|1|||
33389837|NCT04153929|101313837|FG001|Overall Study|Not treated|0|||
33389838|NCT04153929|101313838|FG002|Overall Study|Not treated|0|||
33493226|NCT02287922|101698144|FG002|Overall Study|Sponsor's decision|0|||
33493227|NCT02287922|101698145|FG003|Overall Study|Sponsor's decision|1|||
33493228|NCT02287922|101698142|FG000|Overall Study|Other|1|||
33493229|NCT02287922|101698143|FG001|Overall Study|Other|0|||
33493230|NCT02287922|101698144|FG002|Overall Study|Other|2|||
33493231|NCT02287922|101698145|FG003|Overall Study|Other|0|||
33493232|NCT03022084|101698146|FG000|Overall Study|Lost to Follow-up|2|||
33493233|NCT03022084|101698147|FG001|Overall Study|Lost to Follow-up|3|||
33493234|NCT02392481|101698148|FG000|Overall Study|Adverse Event|0|||
33493235|NCT02392481|101698149|FG001|Overall Study|Adverse Event|0|||
33493236|NCT02392481|101698150|FG002|Overall Study|Adverse Event|1|||
33493237|NCT02392481|101698151|FG003|Overall Study|Adverse Event|2|||
33493238|NCT02392481|101698148|FG000|Overall Study|Withdrawal by Subject|0|||
33493239|NCT02392481|101698149|FG001|Overall Study|Withdrawal by Subject|0|||
33493240|NCT02392481|101698150|FG002|Overall Study|Withdrawal by Subject|1|||
33493241|NCT02392481|101698151|FG003|Overall Study|Withdrawal by Subject|0|||
33493242|NCT03408639|101698152|FG000|Overall Study|Death|5|||
33493243|NCT03408639|101698153|FG001|Overall Study|Death|5|||
33493244|NCT03408639|101698152|FG000|Overall Study|Lost to Follow-up|1|||
33493245|NCT03408639|101698153|FG001|Overall Study|Lost to Follow-up|4|||
33493246|NCT03408639|101698152|FG000|Overall Study|Withdrawal by Subject|2|||
33493247|NCT03408639|101698153|FG001|Overall Study|Withdrawal by Subject|7|||
33493248|NCT03408639|101698152|FG000|Overall Study|Physician Decision|3|||
33389839|NCT04153929|101313839|FG003|Overall Study|Not treated|0|||
33389840|NCT04153929|101313840|FG004|Overall Study|Not treated|0|||
33389841|NCT04153929|101313841|FG005|Overall Study|Not treated|0|||
33389842|NCT04153929|101313842|FG006|Overall Study|Not treated|1|||
33389843|NCT04153929|101313843|FG007|Overall Study|Not treated|0|||
33389844|NCT02266004|101313844|FG000|Overall Study|unrelated adverse event|1|||
33389845|NCT02266004|101313844|FG000|Overall Study|Physician Decision|1|||
33389846|NCT00588523|101313847|FG000|Overall Study|Not treated|3|||
33389847|NCT02499575|101313848|FG000|Overall Study|Protocol Violation|0|||
33389848|NCT02499575|101313849|FG001|Overall Study|Protocol Violation|1|||
33389849|NCT00126672|101313852|FG000|Overall Study|Adverse Event|4|||
33493249|NCT03408639|101698153|FG001|Overall Study|Physician Decision|6|||
33493250|NCT02002221|101698156|FG000|Overall Study|Adverse Event|2|||
33493251|NCT02002221|101698157|FG001|Overall Study|Adverse Event|1|||
33493252|NCT02002221|101698156|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33493253|NCT02002221|101698157|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33493254|NCT02002221|101698156|FG000|Overall Study|Patient withdrew consent|0|||
33493255|NCT02002221|101698157|FG001|Overall Study|Patient withdrew consent|1|||
33493256|NCT00495391|101698158|FG000|Overall Study|Lack of Efficacy|34|||
33493257|NCT00495391|101698159|FG001|Overall Study|Lack of Efficacy|18|||
33493258|NCT00495391|101698158|FG000|Overall Study|Withdrawal by Subject|2|||
33493259|NCT00495391|101698159|FG001|Overall Study|Withdrawal by Subject|3|||
33493260|NCT04173507|101698162|FG000|Overall Study|On Treatment|3|||
33493261|NCT04173507|101698162|FG000|Overall Study|Adverse Event|3|||
33493262|NCT04173507|101698162|FG000|Overall Study|Progression/Relapse|34|||
33493263|NCT04173507|101698162|FG000|Overall Study|Death|2|||
33493264|NCT00443729|101698163|FG000|Overall Study|Never Treated|0|||
33493265|NCT00443729|101698164|FG001|Overall Study|Never Treated|1|||
33493266|NCT00443729|101698163|FG000|Overall Study|Lack of Efficacy|4|||
33493267|NCT00443729|101698164|FG001|Overall Study|Lack of Efficacy|2|||
33493268|NCT00443729|101698163|FG000|Overall Study|Lost to Follow-up|0|||
33493269|NCT00443729|101698164|FG001|Overall Study|Lost to Follow-up|1|||
33493270|NCT00443729|101698163|FG000|Overall Study|Physician Decision|2|||
33493271|NCT00443729|101698164|FG001|Overall Study|Physician Decision|1|||
33493272|NCT00443729|101698163|FG000|Overall Study|Protocol Violation|1|||
33493273|NCT00443729|101698164|FG001|Overall Study|Protocol Violation|1|||
33493274|NCT00443729|101698163|FG000|Overall Study|Withdrawal by Subject|3|||
33493275|NCT00443729|101698164|FG001|Overall Study|Withdrawal by Subject|1|||
33493276|NCT04650204|101698165|FG000|Overall Study|Study was Terminated|2|||
33493277|NCT04650204|101698166|FG001|Overall Study|Study was Terminated|1|||
33493278|NCT01127256|101698171|FG000|Overall Study|Adverse Event|13|||
33493279|NCT01127256|101698172|FG001|Overall Study|Adverse Event|13|||
33493280|NCT01127256|101698171|FG000|Overall Study|Lack of Efficacy|4|||
33493281|NCT01127256|101698172|FG001|Overall Study|Lack of Efficacy|0|||
33183892|NCT02641379|100583124|FG007|Overall Study|Participant's compliance|0|||
33183893|NCT02641379|100583125|FG008|Overall Study|Participant's compliance|1|||
33389850|NCT00126672|101313852|FG000|Overall Study|Lost to Follow-up|4|||
33493282|NCT01127256|101698171|FG000|Overall Study|Lost to Follow-up|16|||
33493283|NCT01127256|101698172|FG001|Overall Study|Lost to Follow-up|17|||
33493284|NCT01127256|101698171|FG000|Overall Study|Withdrawal by Subject|5|||
33493285|NCT01127256|101698172|FG001|Overall Study|Withdrawal by Subject|9|||
33493286|NCT01127256|101698171|FG000|Overall Study|Protocol Violation|1|||
33389851|NCT01143714|101313853|FG000|Overall Study|Adverse Event|4|||
33389852|NCT01143714|101313854|FG001|Overall Study|Adverse Event|2|||
33389853|NCT01143714|101313853|FG000|Overall Study|Withdrawal by Subject|1|||
33493287|NCT01127256|101698172|FG001|Overall Study|Protocol Violation|0|||
33493288|NCT01342081|101698174|FG000|Overall Study|Did not receive allocated intervention|0|||
33493289|NCT01342081|101698175|FG001|Overall Study|Did not receive allocated intervention|0|||
33493290|NCT01342081|101698176|FG002|Overall Study|Did not receive allocated intervention|1|||
33493291|NCT01342081|101698174|FG000|Overall Study|Adverse Event|1|||
33493292|NCT01342081|101698175|FG001|Overall Study|Adverse Event|0|||
33493293|NCT01342081|101698176|FG002|Overall Study|Adverse Event|0|||
33389854|NCT01143714|101313854|FG001|Overall Study|Withdrawal by Subject|0|||
33389855|NCT01143714|101313853|FG000|Overall Study|Subject non-compliance|0|||
33389856|NCT01143714|101313854|FG001|Overall Study|Subject non-compliance|1|||
33493294|NCT01342081|101698174|FG000|Overall Study|Physician Decision|0|||
33493295|NCT01342081|101698175|FG001|Overall Study|Physician Decision|1|||
33493296|NCT01342081|101698176|FG002|Overall Study|Physician Decision|0|||
33493297|NCT01342081|101698174|FG000|Overall Study|Withdrawal by Subject|1|||
33493298|NCT01342081|101698175|FG001|Overall Study|Withdrawal by Subject|1|||
33493299|NCT01342081|101698176|FG002|Overall Study|Withdrawal by Subject|0|||
33493300|NCT00615199|101698177|FG000|Overall Study|Adverse Event|3|||
33493301|NCT00615199|101698178|FG001|Overall Study|Adverse Event|1|||
33493302|NCT00615199|101698179|FG002|Overall Study|Adverse Event|1|||
33493303|NCT00615199|101698180|FG003|Overall Study|Adverse Event|0|||
33493304|NCT00615199|101698177|FG000|Overall Study|Lack of Efficacy|2|||
33493305|NCT00615199|101698178|FG001|Overall Study|Lack of Efficacy|0|||
33493306|NCT00615199|101698179|FG002|Overall Study|Lack of Efficacy|0|||
33493307|NCT00615199|101698180|FG003|Overall Study|Lack of Efficacy|1|||
33493308|NCT00615199|101698177|FG000|Overall Study|Lost to Follow-up|1|||
33493309|NCT00615199|101698178|FG001|Overall Study|Lost to Follow-up|0|||
33493310|NCT00615199|101698179|FG002|Overall Study|Lost to Follow-up|0|||
33493311|NCT00615199|101698180|FG003|Overall Study|Lost to Follow-up|0|||
33493312|NCT00615199|101698177|FG000|Overall Study|Other|0|||
33493313|NCT00615199|101698178|FG001|Overall Study|Other|0|||
33493314|NCT00615199|101698179|FG002|Overall Study|Other|0|||
33493315|NCT00615199|101698180|FG003|Overall Study|Other|1|||
33493316|NCT00615199|101698177|FG000|Overall Study|Withdrawal by Subject|2|||
33493317|NCT00615199|101698178|FG001|Overall Study|Withdrawal by Subject|1|||
33389857|NCT01143714|101313853|FG000|Overall Study|wound closed = deemed healed|1|||
33389858|NCT01143714|101313854|FG001|Overall Study|wound closed = deemed healed|0|||
33389859|NCT01143714|101313853|FG000|Overall Study|wound size increased|1|||
33389860|NCT01143714|101313854|FG001|Overall Study|wound size increased|0|||
33389861|NCT00899678|101313855|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
33389862|NCT00899678|101313856|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
33389863|NCT00899678|101313857|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
33389864|NCT00899678|101313855|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
33389865|NCT00899678|101313856|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
33389866|NCT00899678|101313857|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
33389867|NCT00899678|101313855|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
33389868|NCT00899678|101313856|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
33389869|NCT00899678|101313857|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
33389870|NCT00899678|101313855|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
33389871|NCT00899678|101313856|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
33389872|NCT00899678|101313857|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
33389873|NCT00899678|101313855|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
33389874|NCT00899678|101313856|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
33389875|NCT00899678|101313857|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
33389876|NCT00899678|101313855|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
33389877|NCT00899678|101313856|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
33389878|NCT00899678|101313857|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
33389879|NCT00899678|101313855|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
33389880|NCT00899678|101313856|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
33389881|NCT00899678|101313857|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
33389882|NCT00899678|101313855|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
33389883|NCT00899678|101313856|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
33389884|NCT00899678|101313857|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
33389885|NCT00899678|101313855|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
33389886|NCT00899678|101313856|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
33389887|NCT00899678|101313857|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
33389888|NCT02999191|101313861|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
33389889|NCT02999191|101313862|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
33389890|NCT02999191|101313863|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
33389891|NCT00251589|101313866|FG000|Overall Study|Adverse Event|5|||
33389892|NCT00251589|101313867|FG001|Overall Study|Adverse Event|1|||
33389893|NCT00251589|101313868|FG002|Overall Study|Adverse Event|2|||
33389894|NCT00251589|101313869|FG003|Overall Study|Adverse Event|1|||
33493318|NCT00615199|101698179|FG002|Overall Study|Withdrawal by Subject|0|||
33493319|NCT00615199|101698180|FG003|Overall Study|Withdrawal by Subject|0|||
33493320|NCT02860546|101698183|FG000|Overall Study|Clinical Progression|6|||
33389895|NCT00251589|101313866|FG000|Overall Study|Withdrawal by Subject|1|||
33389896|NCT00251589|101313867|FG001|Overall Study|Withdrawal by Subject|1|||
33389897|NCT00251589|101313868|FG002|Overall Study|Withdrawal by Subject|0|||
33389898|NCT00251589|101313869|FG003|Overall Study|Withdrawal by Subject|0|||
33389899|NCT00251589|101313866|FG000|Overall Study|Discontinued due to progressive disease|9|||
33389900|NCT00251589|101313867|FG001|Overall Study|Discontinued due to progressive disease|1|||
33389901|NCT00251589|101313868|FG002|Overall Study|Discontinued due to progressive disease|0|||
33389902|NCT00251589|101313869|FG003|Overall Study|Discontinued due to progressive disease|1|||
33389903|NCT03370913|101313870|FG000|Overall Study|Death|1|||
33389904|NCT03370913|101313870|FG000|Overall Study|Lost to Follow-up|1|||
33389905|NCT01112982|101313874|FG000|Overall Study|Withdrawal by Subject|1|||
33389906|NCT01112982|101313874|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
33389907|NCT04857892|101313875|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
33389908|NCT04857892|101313876|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
33389909|NCT04857892|101313877|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
33389910|NCT04857892|101313878|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
33389911|NCT04857892|101313879|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
33493321|NCT02860546|101698183|FG000|Overall Study|Radiological Progression|12|||
33493322|NCT00485264|101698184|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
33493323|NCT00485264|101698185|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
33493324|NCT00485264|101698186|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
33493325|NCT00485264|101698187|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
33493326|NCT00485264|101698188|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
33493327|NCT00485264|101698189|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
33493328|NCT00485264|101698184|FG000|Overall Study|Death|1|||
33493329|NCT00485264|101698185|FG001|Overall Study|Death|0|||
33493330|NCT00485264|101698186|FG002|Overall Study|Death|0|||
33493331|NCT00485264|101698187|FG003|Overall Study|Death|0|||
33493332|NCT00485264|101698188|FG004|Overall Study|Death|1|||
33493333|NCT00485264|101698189|FG005|Overall Study|Death|0|||
33493334|NCT00485264|101698184|FG000|Overall Study|Adverse Event|1|||
33493335|NCT00485264|101698185|FG001|Overall Study|Adverse Event|0|||
33493336|NCT00485264|101698186|FG002|Overall Study|Adverse Event|2|||
33493337|NCT00485264|101698187|FG003|Overall Study|Adverse Event|3|||
33493338|NCT00485264|101698188|FG004|Overall Study|Adverse Event|1|||
33493339|NCT00485264|101698189|FG005|Overall Study|Adverse Event|3|||
33493340|NCT00485264|101698184|FG000|Overall Study|Pregnancy|4|||
33493341|NCT00485264|101698185|FG001|Overall Study|Pregnancy|0|||
33493342|NCT00485264|101698186|FG002|Overall Study|Pregnancy|0|||
33493343|NCT00485264|101698187|FG003|Overall Study|Pregnancy|0|||
33493344|NCT00485264|101698188|FG004|Overall Study|Pregnancy|0|||
33493345|NCT00485264|101698189|FG005|Overall Study|Pregnancy|0|||
33493346|NCT00485264|101698184|FG000|Overall Study|Disallowed Medication|0|||
33493347|NCT00485264|101698185|FG001|Overall Study|Disallowed Medication|0|||
33493348|NCT00485264|101698186|FG002|Overall Study|Disallowed Medication|0|||
33493349|NCT00485264|101698187|FG003|Overall Study|Disallowed Medication|0|||
33493350|NCT00485264|101698188|FG004|Overall Study|Disallowed Medication|0|||
33493351|NCT00485264|101698189|FG005|Overall Study|Disallowed Medication|1|||
33493352|NCT00485264|101698184|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
33493353|NCT00485264|101698185|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
33493354|NCT00485264|101698186|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
33493355|NCT00485264|101698187|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
33493356|NCT00485264|101698188|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
33493357|NCT00485264|101698189|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
33493358|NCT00485264|101698184|FG000|Overall Study|Lack of Efficacy|0|||
33493359|NCT00485264|101698185|FG001|Overall Study|Lack of Efficacy|1|||
33493360|NCT00485264|101698186|FG002|Overall Study|Lack of Efficacy|0|||
33493361|NCT00485264|101698187|FG003|Overall Study|Lack of Efficacy|0|||
33493362|NCT00485264|101698188|FG004|Overall Study|Lack of Efficacy|0|||
33493363|NCT00485264|101698189|FG005|Overall Study|Lack of Efficacy|0|||
33493364|NCT00485264|101698184|FG000|Overall Study|Guardian Consent Withdrawn|1|||
33493365|NCT00485264|101698185|FG001|Overall Study|Guardian Consent Withdrawn|0|||
33389912|NCT04857892|101313875|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
33493366|NCT00485264|101698186|FG002|Overall Study|Guardian Consent Withdrawn|0|||
33493367|NCT00485264|101698187|FG003|Overall Study|Guardian Consent Withdrawn|0|||
33493368|NCT00485264|101698188|FG004|Overall Study|Guardian Consent Withdrawn|1|||
33493369|NCT00485264|101698189|FG005|Overall Study|Guardian Consent Withdrawn|0|||
33493370|NCT00485264|101698184|FG000|Overall Study|Physician Decision|0|||
33493371|NCT00485264|101698185|FG001|Overall Study|Physician Decision|2|||
33493372|NCT00485264|101698186|FG002|Overall Study|Physician Decision|0|||
33493373|NCT00485264|101698187|FG003|Overall Study|Physician Decision|0|||
33493374|NCT00485264|101698188|FG004|Overall Study|Physician Decision|0|||
33493375|NCT00485264|101698189|FG005|Overall Study|Physician Decision|0|||
33493376|NCT00485264|101698184|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
33493377|NCT00485264|101698185|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
33493378|NCT00485264|101698186|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
33493379|NCT00485264|101698187|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
33493380|NCT00485264|101698188|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
33493381|NCT00485264|101698189|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
33493382|NCT00485264|101698184|FG000|Overall Study|Not Able to Attend Clinic|5|||
33493383|NCT00485264|101698185|FG001|Overall Study|Not Able to Attend Clinic|0|||
33493384|NCT00485264|101698186|FG002|Overall Study|Not Able to Attend Clinic|0|||
33493385|NCT00485264|101698187|FG003|Overall Study|Not Able to Attend Clinic|1|||
33493386|NCT00485264|101698188|FG004|Overall Study|Not Able to Attend Clinic|1|||
33493387|NCT00485264|101698189|FG005|Overall Study|Not Able to Attend Clinic|2|||
33493388|NCT00485264|101698184|FG000|Overall Study|Non-Compliant|17|||
33493389|NCT00485264|101698185|FG001|Overall Study|Non-Compliant|2|||
33493390|NCT00485264|101698186|FG002|Overall Study|Non-Compliant|1|||
33493391|NCT00485264|101698187|FG003|Overall Study|Non-Compliant|0|||
33493392|NCT00485264|101698188|FG004|Overall Study|Non-Compliant|1|||
33493393|NCT00485264|101698189|FG005|Overall Study|Non-Compliant|0|||
33493394|NCT00485264|101698184|FG000|Overall Study|Lost to Follow-up|2|||
33493395|NCT00485264|101698185|FG001|Overall Study|Lost to Follow-up|1|||
33493396|NCT00485264|101698186|FG002|Overall Study|Lost to Follow-up|1|||
33493397|NCT00485264|101698187|FG003|Overall Study|Lost to Follow-up|0|||
33493398|NCT00485264|101698188|FG004|Overall Study|Lost to Follow-up|0|||
33493399|NCT00485264|101698189|FG005|Overall Study|Lost to Follow-up|1|||
33493400|NCT00485264|101698184|FG000|Overall Study|Other Reason|3|||
33493401|NCT00485264|101698185|FG001|Overall Study|Other Reason|0|||
33493402|NCT00485264|101698186|FG002|Overall Study|Other Reason|0|||
33493403|NCT00485264|101698187|FG003|Overall Study|Other Reason|0|||
33493404|NCT00485264|101698188|FG004|Overall Study|Other Reason|0|||
33493405|NCT00485264|101698189|FG005|Overall Study|Other Reason|0|||
33493406|NCT01130532|101698190|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
33493407|NCT01130532|101698191|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
33493408|NCT01130532|101698192|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
33493409|NCT01130532|101698193|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
33493410|NCT01130532|101698190|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
33493411|NCT01130532|101698191|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
33493412|NCT01130532|101698192|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
33493413|NCT01130532|101698193|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
33493414|NCT01130532|101698190|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
33493415|NCT01130532|101698191|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
33493416|NCT01130532|101698192|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
33493417|NCT01130532|101698193|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
33493418|NCT01130532|101698190|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
33493419|NCT01130532|101698191|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
33493420|NCT01130532|101698192|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
33493421|NCT01130532|101698193|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
33493422|NCT01130532|101698190|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
33493423|NCT01130532|101698191|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
33493424|NCT01130532|101698192|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
33493425|NCT01130532|101698193|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
33493426|NCT01130532|101698190|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
33493427|NCT01130532|101698191|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
33493428|NCT01130532|101698192|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
33493429|NCT01130532|101698193|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
33493430|NCT01130532|101698190|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
33493431|NCT01130532|101698191|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
33493432|NCT01130532|101698192|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
33493433|NCT01130532|101698193|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
33493434|NCT01130532|101698190|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
33493435|NCT01130532|101698191|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
33493436|NCT01130532|101698192|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
33493437|NCT01130532|101698193|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
33493438|NCT01130532|101698190|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
33493439|NCT01130532|101698191|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
33493440|NCT01130532|101698192|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
33493441|NCT01130532|101698193|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
33183894|NCT02641379|100583126|FG009|Overall Study|Participant's compliance|1|||
33183895|NCT02641379|100583127|FG010|Overall Study|Participant's compliance|1|||
33493442|NCT01130532|101698190|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
33493443|NCT01130532|101698191|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
33493444|NCT01130532|101698192|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
33493445|NCT01130532|101698193|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
33493446|NCT01130532|101698190|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
33493447|NCT01130532|101698191|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
33493448|NCT01130532|101698192|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
33493449|NCT01130532|101698193|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
33493450|NCT00967330|101698194|FG000|Overall Study|Protocol Violation|3|||
33493451|NCT00967330|101698195|FG001|Overall Study|Protocol Violation|4|||
33493452|NCT00967330|101698194|FG000|Overall Study|Regular|10|||
33493453|NCT00967330|101698195|FG001|Overall Study|Regular|3|||
33493454|NCT00967330|101698194|FG000|Overall Study|Withdrawal by Subject|6|||
33493455|NCT00967330|101698195|FG001|Overall Study|Withdrawal by Subject|0|||
33493456|NCT00967330|101698194|FG000|Overall Study|Lost to Follow-up|1|||
33493457|NCT00967330|101698195|FG001|Overall Study|Lost to Follow-up|1|||
33493458|NCT00967330|101698194|FG000|Overall Study|Death|102|||
33493459|NCT00967330|101698195|FG001|Overall Study|Death|51|||
33493460|NCT00967330|101698194|FG000|Overall Study|Severe protocol deviation|0|||
33493461|NCT00967330|101698195|FG001|Overall Study|Severe protocol deviation|1|||
33493462|NCT02387840|101698196|FG000|Overall Study|Death|0|||
33493463|NCT02387840|101698197|FG001|Overall Study|Death|0|||
33493464|NCT02387840|101698198|FG002|Overall Study|Death|0|||
33493465|NCT02387840|101698199|FG003|Overall Study|Death|0|||
33493466|NCT02387840|101698200|FG004|Overall Study|Death|0|||
33493467|NCT02387840|101698201|FG005|Overall Study|Death|1|||
33493468|NCT04747470|101698202|FG000|Overall Study|Death|0|||
33493469|NCT04747470|101698203|FG001|Overall Study|Death|3|||
33493470|NCT04747470|101698204|FG002|Overall Study|Death|2|||
33493471|NCT04747470|101698205|FG003|Overall Study|Death|2|||
33493472|NCT04747470|101698206|FG004|Overall Study|Death|2|||
33493473|NCT04747470|101698207|FG005|Overall Study|Death|0|||
33493474|NCT04747470|101698208|FG006|Overall Study|Death|0|||
33493475|NCT04747470|101698209|FG007|Overall Study|Death|0|||
33493476|NCT04747470|101698210|FG008|Overall Study|Death|0|||
33493477|NCT04747470|101698211|FG009|Overall Study|Death|0|||
33493478|NCT04747470|101698212|FG010|Overall Study|Death|0|||
33493479|NCT04747470|101698202|FG000|Overall Study|Withdrew Consent|0|||
33493480|NCT04747470|101698203|FG001|Overall Study|Withdrew Consent|0|||
33493481|NCT04747470|101698204|FG002|Overall Study|Withdrew Consent|0|||
33493482|NCT04747470|101698205|FG003|Overall Study|Withdrew Consent|1|||
33493483|NCT04747470|101698206|FG004|Overall Study|Withdrew Consent|0|||
33493484|NCT04747470|101698207|FG005|Overall Study|Withdrew Consent|0|||
33493485|NCT04747470|101698208|FG006|Overall Study|Withdrew Consent|0|||
33493486|NCT04747470|101698209|FG007|Overall Study|Withdrew Consent|0|||
33493487|NCT04747470|101698210|FG008|Overall Study|Withdrew Consent|0|||
33594435|NCT00006164|102064972|FG000|Overall Study|Withdrew or lost to follow-up|70|||
33594436|NCT00006164|102064973|FG001|Overall Study|Withdrew or lost to follow-up|81|||
33594437|NCT00394901|102064975|FG000|Baseline Phase|Protocol Violation|0|||
33183896|NCT02641379|100583117|FG000|Overall Study|Participant cannot be reached|4|||
33183897|NCT02641379|100583118|FG001|Overall Study|Participant cannot be reached|4|||
33183898|NCT02641379|100583119|FG002|Overall Study|Participant cannot be reached|0|||
33183899|NCT02641379|100583120|FG003|Overall Study|Participant cannot be reached|8|||
33183900|NCT02641379|100583121|FG004|Overall Study|Participant cannot be reached|2|||
33183901|NCT02641379|100583122|FG005|Overall Study|Participant cannot be reached|1|||
33183902|NCT02641379|100583123|FG006|Overall Study|Participant cannot be reached|0|||
33183903|NCT02641379|100583124|FG007|Overall Study|Participant cannot be reached|1|||
33183904|NCT02641379|100583125|FG008|Overall Study|Participant cannot be reached|0|||
33183905|NCT02641379|100583126|FG009|Overall Study|Participant cannot be reached|2|||
33183906|NCT02641379|100583127|FG010|Overall Study|Participant cannot be reached|1|||
33183907|NCT02641379|100583117|FG000|Overall Study|PCR positive at Week 24|15|||
33183908|NCT02641379|100583118|FG001|Overall Study|PCR positive at Week 24|21|||
33183909|NCT02641379|100583119|FG002|Overall Study|PCR positive at Week 24|62|||
33183910|NCT02641379|100583120|FG003|Overall Study|PCR positive at Week 24|0|||
33183911|NCT02641379|100583121|FG004|Overall Study|PCR positive at Week 24|0|||
33183912|NCT02641379|100583122|FG005|Overall Study|PCR positive at Week 24|6|||
33183913|NCT02641379|100583123|FG006|Overall Study|PCR positive at Week 24|3|||
33183914|NCT02641379|100583124|FG007|Overall Study|PCR positive at Week 24|8|||
33183915|NCT02641379|100583125|FG008|Overall Study|PCR positive at Week 24|0|||
33389913|NCT04857892|101313876|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
33389914|NCT04857892|101313877|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
33389915|NCT04857892|101313878|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
33389916|NCT04857892|101313879|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
33389917|NCT04857892|101313875|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
33389918|NCT04857892|101313876|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
33389919|NCT04857892|101313877|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
33493488|NCT04747470|101698211|FG009|Overall Study|Withdrew Consent|0|||
33493489|NCT04747470|101698212|FG010|Overall Study|Withdrew Consent|0|||
33493490|NCT04747470|101698202|FG000|Overall Study|Study Terminated by Sponsor|0|||
33493491|NCT04747470|101698203|FG001|Overall Study|Study Terminated by Sponsor|0|||
33493492|NCT04747470|101698204|FG002|Overall Study|Study Terminated by Sponsor|1|||
33493493|NCT04747470|101698205|FG003|Overall Study|Study Terminated by Sponsor|0|||
33493494|NCT04747470|101698206|FG004|Overall Study|Study Terminated by Sponsor|2|||
33493495|NCT04747470|101698207|FG005|Overall Study|Study Terminated by Sponsor|0|||
33493496|NCT04747470|101698208|FG006|Overall Study|Study Terminated by Sponsor|0|||
33183916|NCT02641379|100583126|FG009|Overall Study|PCR positive at Week 24|1|||
33493497|NCT04747470|101698209|FG007|Overall Study|Study Terminated by Sponsor|0|||
33493498|NCT04747470|101698210|FG008|Overall Study|Study Terminated by Sponsor|0|||
33493499|NCT04747470|101698211|FG009|Overall Study|Study Terminated by Sponsor|0|||
33493500|NCT04747470|101698212|FG010|Overall Study|Study Terminated by Sponsor|0|||
33493501|NCT01891864|101698213|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
33493502|NCT01891864|101698214|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
33493503|NCT01891864|101698215|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
33493504|NCT01891864|101698216|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
33493505|NCT01891864|101698217|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
33493506|NCT01891864|101698218|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
33493507|NCT01891864|101698213|FG000|Treatment Period 1|Physician Decision|0|||
33493508|NCT01891864|101698214|FG001|Treatment Period 1|Physician Decision|1|||
33493509|NCT01891864|101698215|FG002|Treatment Period 1|Physician Decision|0|||
33493510|NCT01891864|101698216|FG003|Treatment Period 1|Physician Decision|0|||
33493511|NCT01891864|101698217|FG004|Treatment Period 1|Physician Decision|0|||
33493512|NCT01891864|101698218|FG005|Treatment Period 1|Physician Decision|0|||
33493513|NCT01891864|101698213|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
33493514|NCT01891864|101698214|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
33493515|NCT01891864|101698215|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
33493516|NCT01891864|101698216|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
33493517|NCT01891864|101698217|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
33493518|NCT01891864|101698218|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
33493519|NCT01891864|101698213|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
33493520|NCT01891864|101698214|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
33493521|NCT01891864|101698215|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
33493522|NCT01891864|101698216|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
33493523|NCT01891864|101698217|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
33493524|NCT01891864|101698218|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
33493525|NCT01891864|101698213|FG000|Treatment Period 1|Withdrawal by Subject|2|||
33493526|NCT01891864|101698214|FG001|Treatment Period 1|Withdrawal by Subject|5|||
33493527|NCT01891864|101698215|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33493528|NCT01891864|101698216|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33493529|NCT01891864|101698217|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33493530|NCT01891864|101698218|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33493531|NCT01891864|101698213|FG000|Treatment Period 1|Lost to Follow-up|1|||
33493532|NCT01891864|101698214|FG001|Treatment Period 1|Lost to Follow-up|0|||
33493533|NCT01891864|101698215|FG002|Treatment Period 1|Lost to Follow-up|0|||
33493534|NCT01891864|101698216|FG003|Treatment Period 1|Lost to Follow-up|0|||
33493535|NCT01891864|101698217|FG004|Treatment Period 1|Lost to Follow-up|0|||
33493536|NCT01891864|101698218|FG005|Treatment Period 1|Lost to Follow-up|0|||
33493537|NCT01891864|101698213|FG000|Treatment Period 2|Protocol Violation|0|||
33493538|NCT01891864|101698214|FG001|Treatment Period 2|Protocol Violation|0|||
33493539|NCT01891864|101698215|FG002|Treatment Period 2|Protocol Violation|0|||
33493540|NCT01891864|101698216|FG003|Treatment Period 2|Protocol Violation|1|||
33493541|NCT01891864|101698217|FG004|Treatment Period 2|Protocol Violation|0|||
33493542|NCT01891864|101698218|FG005|Treatment Period 2|Protocol Violation|0|||
33493543|NCT01891864|101698213|FG000|Treatment Period 2|Physician Decision|0|||
33493544|NCT01891864|101698214|FG001|Treatment Period 2|Physician Decision|0|||
33493545|NCT01891864|101698215|FG002|Treatment Period 2|Physician Decision|1|||
33493546|NCT01891864|101698216|FG003|Treatment Period 2|Physician Decision|0|||
33493547|NCT01891864|101698217|FG004|Treatment Period 2|Physician Decision|0|||
33493548|NCT01891864|101698218|FG005|Treatment Period 2|Physician Decision|0|||
33493549|NCT01891864|101698213|FG000|Treatment Period 2|Site Termination|0|||
33493550|NCT01891864|101698214|FG001|Treatment Period 2|Site Termination|0|||
33493551|NCT01891864|101698215|FG002|Treatment Period 2|Site Termination|1|||
33493552|NCT01891864|101698216|FG003|Treatment Period 2|Site Termination|2|||
33493553|NCT01891864|101698217|FG004|Treatment Period 2|Site Termination|0|||
33493554|NCT01891864|101698218|FG005|Treatment Period 2|Site Termination|0|||
33493555|NCT01891864|101698213|FG000|Treatment Period 2|Lack of Efficacy|0|||
33493556|NCT01891864|101698214|FG001|Treatment Period 2|Lack of Efficacy|0|||
33493557|NCT01891864|101698215|FG002|Treatment Period 2|Lack of Efficacy|1|||
33493558|NCT01891864|101698216|FG003|Treatment Period 2|Lack of Efficacy|0|||
33493559|NCT01891864|101698217|FG004|Treatment Period 2|Lack of Efficacy|1|||
33493560|NCT01891864|101698218|FG005|Treatment Period 2|Lack of Efficacy|0|||
33493561|NCT01891864|101698213|FG000|Treatment Period 2|Adverse Event|0|||
33493562|NCT01891864|101698214|FG001|Treatment Period 2|Adverse Event|0|||
33493563|NCT01891864|101698215|FG002|Treatment Period 2|Adverse Event|1|||
33493564|NCT01891864|101698216|FG003|Treatment Period 2|Adverse Event|2|||
33493565|NCT01891864|101698217|FG004|Treatment Period 2|Adverse Event|0|||
33493566|NCT01891864|101698218|FG005|Treatment Period 2|Adverse Event|4|||
33493567|NCT01891864|101698213|FG000|Treatment Period 2|Termination of Site|0|||
33493568|NCT01891864|101698214|FG001|Treatment Period 2|Termination of Site|0|||
33493569|NCT01891864|101698215|FG002|Treatment Period 2|Termination of Site|0|||
33594438|NCT00394901|102064976|FG001|Baseline Phase|Protocol Violation|0|||
33493570|NCT01891864|101698216|FG003|Treatment Period 2|Termination of Site|0|||
33493571|NCT01891864|101698217|FG004|Treatment Period 2|Termination of Site|2|||
33493572|NCT01891864|101698218|FG005|Treatment Period 2|Termination of Site|0|||
33493573|NCT01891864|101698213|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33493574|NCT01891864|101698214|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33493575|NCT01891864|101698215|FG002|Treatment Period 2|Withdrawal by Subject|3|||
33493576|NCT01891864|101698216|FG003|Treatment Period 2|Withdrawal by Subject|4|||
33493577|NCT01891864|101698217|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33493578|NCT01891864|101698218|FG005|Treatment Period 2|Withdrawal by Subject|1|||
33493579|NCT01891864|101698213|FG000|Extension Period|Lack of Efficacy|0|||
33493580|NCT01891864|101698214|FG001|Extension Period|Lack of Efficacy|0|||
33493581|NCT01891864|101698215|FG002|Extension Period|Lack of Efficacy|0|||
33493582|NCT01891864|101698216|FG003|Extension Period|Lack of Efficacy|1|||
33493583|NCT01891864|101698217|FG004|Extension Period|Lack of Efficacy|1|||
33493584|NCT01891864|101698218|FG005|Extension Period|Lack of Efficacy|0|||
33493585|NCT01891864|101698213|FG000|Extension Period|Pregnancy|0|||
33493586|NCT01891864|101698214|FG001|Extension Period|Pregnancy|0|||
33493587|NCT01891864|101698215|FG002|Extension Period|Pregnancy|1|||
33493588|NCT01891864|101698216|FG003|Extension Period|Pregnancy|0|||
33493589|NCT01891864|101698217|FG004|Extension Period|Pregnancy|0|||
33493590|NCT01891864|101698218|FG005|Extension Period|Pregnancy|0|||
33493591|NCT01891864|101698213|FG000|Extension Period|Adverse Event|0|||
33493592|NCT01891864|101698214|FG001|Extension Period|Adverse Event|0|||
33493593|NCT01891864|101698215|FG002|Extension Period|Adverse Event|4|||
33493594|NCT01891864|101698216|FG003|Extension Period|Adverse Event|2|||
33493595|NCT01891864|101698217|FG004|Extension Period|Adverse Event|2|||
33493596|NCT01891864|101698218|FG005|Extension Period|Adverse Event|0|||
33493597|NCT01891864|101698213|FG000|Extension Period|Withdrawal by Subject|0|||
33493598|NCT01891864|101698214|FG001|Extension Period|Withdrawal by Subject|0|||
33493599|NCT01891864|101698215|FG002|Extension Period|Withdrawal by Subject|1|||
33493600|NCT01891864|101698216|FG003|Extension Period|Withdrawal by Subject|2|||
33493601|NCT01891864|101698217|FG004|Extension Period|Withdrawal by Subject|4|||
33493602|NCT01891864|101698218|FG005|Extension Period|Withdrawal by Subject|0|||
33493603|NCT01891864|101698213|FG000|Extension Period|Lost to Follow-up|0|||
33493604|NCT01891864|101698214|FG001|Extension Period|Lost to Follow-up|0|||
33493605|NCT01891864|101698215|FG002|Extension Period|Lost to Follow-up|2|||
33493606|NCT01891864|101698216|FG003|Extension Period|Lost to Follow-up|0|||
33493607|NCT01891864|101698217|FG004|Extension Period|Lost to Follow-up|0|||
33493608|NCT01891864|101698218|FG005|Extension Period|Lost to Follow-up|0|||
33493609|NCT02548156|101698219|FG000|Washout Period 1|Lost to Follow-up|0|||
33493610|NCT02548156|101698220|FG001|Washout Period 1|Lost to Follow-up|0|||
33493611|NCT02548156|101698221|FG002|Washout Period 1|Lost to Follow-up|0|||
33493612|NCT02548156|101698222|FG003|Washout Period 1|Lost to Follow-up|0|||
33493613|NCT02548156|101698223|FG004|Washout Period 1|Lost to Follow-up|1|||
33493614|NCT02548156|101698224|FG005|Washout Period 1|Lost to Follow-up|0|||
33493615|NCT01071915|101698225|FG000|Overall Study|Adverse Event|3|||
33493616|NCT01071915|101698225|FG000|Overall Study|Physician Decision|2|||
33493617|NCT01071915|101698225|FG000|Overall Study|Withdrawal by Subject|2|||
33493618|NCT01071915|101698225|FG000|Overall Study|Miscellaneous Reasons|2|||
33493619|NCT02968576|101698228|FG000|Overall Study|Pregnancy|0|||
33493620|NCT02968576|101698229|FG001|Overall Study|Pregnancy|1|||
33493621|NCT02955212|101698230|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
33493622|NCT02955212|101698231|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
33493623|NCT02955212|101698230|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
33493624|NCT02955212|101698231|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
33493625|NCT02955212|101698230|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
33493626|NCT02955212|101698231|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
33493627|NCT02955212|101698230|FG000|Period 1: Double-blind Treatment Period|Other|3|||
33493628|NCT02955212|101698231|FG001|Period 1: Double-blind Treatment Period|Other|2|||
33493629|NCT02955212|101698230|FG000|Period 2: Open-label Extension|Adverse Event|11|||
33493630|NCT02955212|101698231|FG001|Period 2: Open-label Extension|Adverse Event|7|||
33493631|NCT02955212|101698230|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
33493632|NCT02955212|101698231|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
33493633|NCT02955212|101698230|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
33493634|NCT02955212|101698231|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
33493635|NCT02955212|101698230|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
33493636|NCT02955212|101698231|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
33183917|NCT02641379|100583127|FG010|Overall Study|PCR positive at Week 24|0|||
33493637|NCT02955212|101698230|FG000|Period 2: Open-label Extension|Other|2|||
33493638|NCT02955212|101698231|FG001|Period 2: Open-label Extension|Other|4|||
33493639|NCT00927589|101698232|FG000|Overall Study|Death|1|||
33493640|NCT00927589|101698232|FG000|Overall Study|Physician Decision|1|||
33493641|NCT00927589|101698232|FG000|Overall Study|Withdrawal by Subject|3|||
33493642|NCT00927589|101698232|FG000|Overall Study|Adverse Event|2|||
33493643|NCT00927589|101698232|FG000|Overall Study|Disease Progression|8|||
33493644|NCT00927589|101698232|FG000|Overall Study|Non-compliance|1|||
33493645|NCT00610129|101698236|FG000|Overall Study|Not treated since patients ineligible|3|||
33493646|NCT02932462|101698241|FG000|Overall Study|Adverse Event|1|||
33493647|NCT02932462|101698242|FG001|Overall Study|Adverse Event|2|||
33493648|NCT02932462|101698241|FG000|Overall Study|Lost to Follow-up|4|||
33493649|NCT02932462|101698242|FG001|Overall Study|Lost to Follow-up|1|||
33493650|NCT02932462|101698241|FG000|Overall Study|Protocol Violation|0|||
33493651|NCT02932462|101698242|FG001|Overall Study|Protocol Violation|5|||
33493652|NCT02932462|101698241|FG000|Overall Study|Withdrawal by Subject|1|||
33493653|NCT02932462|101698242|FG001|Overall Study|Withdrawal by Subject|4|||
33493654|NCT02932462|101698241|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33493655|NCT02932462|101698242|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33493656|NCT02932462|101698241|FG000|Overall Study|Progressive Disease|1|||
33493657|NCT02932462|101698242|FG001|Overall Study|Progressive Disease|0|||
33493658|NCT01530464|101698244|FG000|Washout (24h)|Withdrawal by Subject|1|||
33493659|NCT01530464|101698245|FG001|Washout (24h)|Withdrawal by Subject|0|||
33493660|NCT01530464|101698244|FG000|Washout (24h)|Withdrawal by Subject|0|||
33493661|NCT01530464|101698245|FG001|Washout (24h)|Withdrawal by Subject|1|||
33493662|NCT01403051|101698246|FG000|Overall Study|Protocol Violation|2|||
33493663|NCT01403051|101698247|FG001|Overall Study|Protocol Violation|0|||
33493664|NCT01403051|101698246|FG000|Overall Study|Death|1|||
33493665|NCT01403051|101698247|FG001|Overall Study|Death|0|||
33493666|NCT01403051|101698246|FG000|Overall Study|Withdrawal by Subject|2|||
33493667|NCT01403051|101698247|FG001|Overall Study|Withdrawal by Subject|1|||
33493668|NCT01403051|101698246|FG000|Overall Study|Lost to Follow-up|5|||
33493669|NCT01403051|101698247|FG001|Overall Study|Lost to Follow-up|5|||
33493670|NCT03367819|101698248|FG000|Overall Study|Adverse Event|4|||
33493671|NCT03367819|101698249|FG001|Overall Study|Adverse Event|4|||
33493672|NCT03367819|101698248|FG000|Overall Study|Progressive Disease|15|||
33493673|NCT03367819|101698249|FG001|Overall Study|Progressive Disease|13|||
33493674|NCT03367819|101698248|FG000|Overall Study|Withdrawal by Subject|1|||
33493675|NCT03367819|101698249|FG001|Overall Study|Withdrawal by Subject|0|||
33493676|NCT03367819|101698248|FG000|Overall Study|Other|4|||
33493677|NCT03367819|101698249|FG001|Overall Study|Other|2|||
33493678|NCT01215136|101698251|FG000|Overall Study|Adverse Event|2|||
33493679|NCT01215136|101698252|FG001|Overall Study|Adverse Event|9|||
33493680|NCT01215136|101698251|FG000|Overall Study|Disease Progression|3|||
33493681|NCT01215136|101698252|FG001|Overall Study|Disease Progression|14|||
33493682|NCT01215136|101698251|FG000|Overall Study|Symptomatic Deterioration|1|||
33493683|NCT01215136|101698252|FG001|Overall Study|Symptomatic Deterioration|1|||
33493684|NCT01215136|101698251|FG000|Overall Study|Death|0|||
33493685|NCT01215136|101698252|FG001|Overall Study|Death|2|||
33493686|NCT01215136|101698251|FG000|Overall Study|Withdrawal by Subject|0|||
33493687|NCT01215136|101698252|FG001|Overall Study|Withdrawal by Subject|1|||
33493688|NCT00879086|101698255|FG000|Overall Study|Adverse Event|3|||
33493689|NCT00879086|101698256|FG001|Overall Study|Adverse Event|15|||
33493690|NCT00879086|101698255|FG000|Overall Study|Participant choice|2|||
33493691|NCT00879086|101698256|FG001|Overall Study|Participant choice|2|||
33493692|NCT00879086|101698255|FG000|Overall Study|Progression of disease|40|||
33493693|NCT00879086|101698256|FG001|Overall Study|Progression of disease|26|||
33493694|NCT00879086|101698255|FG000|Overall Study|Withdrawal of consent|2|||
33493695|NCT00879086|101698256|FG001|Overall Study|Withdrawal of consent|1|||
33493696|NCT00879086|101698255|FG000|Overall Study|Other|4|||
33493697|NCT00879086|101698256|FG001|Overall Study|Other|6|||
33493698|NCT00879086|101698255|FG000|Overall Study|Death|1|||
33493699|NCT00879086|101698256|FG001|Overall Study|Death|2|||
33493700|NCT02500589|101698261|FG000|Overall Study|Withdrawal by Subject|11|||
33493701|NCT02500589|101698262|FG001|Overall Study|Withdrawal by Subject|14|||
33493702|NCT02500589|101698261|FG000|Overall Study|Lost to Follow-up|10|||
33493703|NCT02500589|101698262|FG001|Overall Study|Lost to Follow-up|12|||
33493704|NCT02500589|101698261|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
33493705|NCT02500589|101698262|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
33493706|NCT02500589|101698261|FG000|Overall Study|Death|7|||
33493707|NCT02500589|101698262|FG001|Overall Study|Death|5|||
33493708|NCT01214655|101698263|FG000|Part A|Progressive Disease|7|||
33493709|NCT01214655|101698264|FG001|Part A|Progressive Disease|0|||
33389920|NCT04857892|101313878|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
33493710|NCT01214655|101698265|FG002|Part A|Progressive Disease|0|||
33493711|NCT01214655|101698263|FG000|Part A|Physician Decision|1|||
33493712|NCT01214655|101698264|FG001|Part A|Physician Decision|0|||
33493713|NCT01214655|101698265|FG002|Part A|Physician Decision|0|||
33493714|NCT01214655|101698263|FG000|Part B|Progressive disease|0|||
33493715|NCT01214655|101698264|FG001|Part B|Progressive disease|10|||
33493716|NCT01214655|101698265|FG002|Part B|Progressive disease|0|||
33493717|NCT01214655|101698263|FG000|Part B|Death|0|||
33493718|NCT01214655|101698264|FG001|Part B|Death|1|||
33493719|NCT01214655|101698265|FG002|Part B|Death|0|||
33493720|NCT01214655|101698263|FG000|Part B|Withdrawal by Subject|0|||
33493721|NCT01214655|101698264|FG001|Part B|Withdrawal by Subject|2|||
33493722|NCT01214655|101698265|FG002|Part B|Withdrawal by Subject|0|||
33493723|NCT01214655|101698263|FG000|Part C|Progressive Disease|0|||
33493724|NCT01214655|101698264|FG001|Part C|Progressive Disease|0|||
33493725|NCT01214655|101698265|FG002|Part C|Progressive Disease|5|||
33493726|NCT01214655|101698263|FG000|Part C|Death|0|||
33493727|NCT01214655|101698264|FG001|Part C|Death|0|||
33493728|NCT01214655|101698265|FG002|Part C|Death|1|||
33493729|NCT01214655|101698263|FG000|Part C|Physician Decision|0|||
33493730|NCT01214655|101698264|FG001|Part C|Physician Decision|0|||
33493731|NCT01214655|101698265|FG002|Part C|Physician Decision|1|||
33493732|NCT03871543|101698267|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
33493733|NCT03871543|101698267|FG000|Period 1|Investigator Error|1|||
33493734|NCT03871543|101698267|FG000|Period 1|Protocol Violation|2|||
33493735|NCT03871543|101698267|FG000|Period 1|COVID-19 Related|1|||
33493736|NCT03871543|101698267|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
33493737|NCT03871543|101698267|FG000|Period 1|Withdrawal by Subject|10|||
33493738|NCT03871543|101698267|FG000|Period 2|Adverse Event|1|||
33493739|NCT03871543|101698267|FG000|Period 2|Withdrawal by Subject|1|||
33493740|NCT01213966|101698268|FG000|Overall Study|Protocol Violation|1|||
33493741|NCT01213966|101698269|FG001|Overall Study|Protocol Violation|0|||
33493742|NCT01213966|101698270|FG002|Overall Study|Protocol Violation|3|||
33493743|NCT01213966|101698271|FG003|Overall Study|Protocol Violation|1|||
33493744|NCT03832686|101698272|FG000|Overall Study|Lost to Follow-up|6|||
33493745|NCT03832686|101698273|FG001|Overall Study|Lost to Follow-up|9|||
33493746|NCT03832686|101698272|FG000|Overall Study|Discontinued Intervention|5|||
33493747|NCT03832686|101698273|FG001|Overall Study|Discontinued Intervention|4|||
33493748|NCT01197534|101698274|FG000|Overall Study|Not reported|16|||
33493749|NCT01197534|101698275|FG001|Overall Study|Not reported|10|||
33493750|NCT01197534|101698276|FG002|Overall Study|Not reported|16|||
33493751|NCT01197534|101698274|FG000|Overall Study|Enrolment in long term extension|57|||
33493752|NCT01197534|101698275|FG001|Overall Study|Enrolment in long term extension|66|||
33493753|NCT01197534|101698276|FG002|Overall Study|Enrolment in long term extension|119|||
33493754|NCT01197534|101698274|FG000|Overall Study|Severe non-compliance to protocol|3|||
33493755|NCT01197534|101698275|FG001|Overall Study|Severe non-compliance to protocol|4|||
33493756|NCT01197534|101698276|FG002|Overall Study|Severe non-compliance to protocol|1|||
33493757|NCT01197534|101698274|FG000|Overall Study|Lack of therapeutic response|9|||
33493758|NCT01197534|101698275|FG001|Overall Study|Lack of therapeutic response|4|||
33493759|NCT01197534|101698276|FG002|Overall Study|Lack of therapeutic response|9|||
33493760|NCT01197534|101698274|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
33493761|NCT01197534|101698275|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
33493762|NCT01197534|101698276|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
33493763|NCT01197534|101698274|FG000|Overall Study|Lost to Follow-up|1|||
33493764|NCT01197534|101698275|FG001|Overall Study|Lost to Follow-up|4|||
33493765|NCT01197534|101698276|FG002|Overall Study|Lost to Follow-up|2|||
33493766|NCT01197534|101698274|FG000|Overall Study|Adverse Event|35|||
33493767|NCT01197534|101698275|FG001|Overall Study|Adverse Event|36|||
33493768|NCT01197534|101698276|FG002|Overall Study|Adverse Event|24|||
33493769|NCT01692626|101698280|FG000|Overall Study|Death|0|||
33493770|NCT01692626|101698281|FG001|Overall Study|Death|1|||
33493771|NCT01692626|101698280|FG000|Overall Study|Adverse Event|2|||
33493772|NCT01692626|101698281|FG001|Overall Study|Adverse Event|3|||
33493773|NCT01692626|101698280|FG000|Overall Study|Protocol Violation|1|||
33493774|NCT01692626|101698281|FG001|Overall Study|Protocol Violation|2|||
33493775|NCT01692626|101698280|FG000|Overall Study|Withdrawal by Subject|1|||
33493776|NCT01692626|101698281|FG001|Overall Study|Withdrawal by Subject|0|||
33493777|NCT00118157|101698287|FG000|Overall Study|Adverse Event|2|||
33493778|NCT00118157|101698287|FG000|Overall Study|Death|8|||
33493779|NCT00118157|101698287|FG000|Overall Study|Withdrawal by Subject|2|||
33493780|NCT02969382|101698288|FG000|Overall Study|Adverse Event|8|||
33493781|NCT02969382|101698289|FG001|Overall Study|Adverse Event|10|||
33493782|NCT02969382|101698288|FG000|Overall Study|Lack of Efficacy|4|||
33493783|NCT02969382|101698289|FG001|Overall Study|Lack of Efficacy|5|||
33493784|NCT02969382|101698288|FG000|Overall Study|Death|0|||
33493785|NCT02969382|101698289|FG001|Overall Study|Death|1|||
33493786|NCT02969382|101698288|FG000|Overall Study|PROTOCOL DEVIATION|0|||
33493787|NCT02969382|101698289|FG001|Overall Study|PROTOCOL DEVIATION|1|||
33493788|NCT02969382|101698288|FG000|Overall Study|Withdrawal by Subject|14|||
33493789|NCT02969382|101698289|FG001|Overall Study|Withdrawal by Subject|9|||
33493790|NCT01499095|101698290|FG000|Overall Study|Randomized But Not Treated|1|||
33493791|NCT01499095|101698291|FG001|Overall Study|Randomized But Not Treated|1|||
33493792|NCT01499095|101698290|FG000|Overall Study|Adverse Event|12|||
33493793|NCT01499095|101698291|FG001|Overall Study|Adverse Event|7|||
33493794|NCT01499095|101698290|FG000|Overall Study|Lack of Efficacy|2|||
33493795|NCT01499095|101698291|FG001|Overall Study|Lack of Efficacy|1|||
33493796|NCT01499095|101698290|FG000|Overall Study|Protocol Violation|6|||
33493797|NCT01499095|101698291|FG001|Overall Study|Protocol Violation|7|||
33493798|NCT01499095|101698290|FG000|Overall Study|Received Rescue Therapy|32|||
33493799|NCT01499095|101698291|FG001|Overall Study|Received Rescue Therapy|40|||
33493800|NCT01499095|101698290|FG000|Overall Study|Diverse Reasons|22|||
33493801|NCT01499095|101698291|FG001|Overall Study|Diverse Reasons|25|||
33493802|NCT01499095|101698290|FG000|Overall Study|Lost to Follow-up|6|||
33493803|NCT01499095|101698291|FG001|Overall Study|Lost to Follow-up|4|||
33493804|NCT01499095|101698290|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
33389921|NCT04857892|101313879|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
33389922|NCT00643448|101313880|FG000|Overall Study|Lack of Efficacy|2|||
33389923|NCT00643448|101313881|FG001|Overall Study|Lack of Efficacy|0|||
33389924|NCT00643448|101313882|FG002|Overall Study|Lack of Efficacy|4|||
33389925|NCT00643448|101313880|FG000|Overall Study|Adverse Event|2|||
33183918|NCT02641379|100583117|FG000|Overall Study|PCR positive at follow up 2|1|||
33183919|NCT02641379|100583118|FG001|Overall Study|PCR positive at follow up 2|0|||
33183920|NCT02641379|100583119|FG002|Overall Study|PCR positive at follow up 2|0|||
33183921|NCT02641379|100583120|FG003|Overall Study|PCR positive at follow up 2|0|||
33183922|NCT02641379|100583121|FG004|Overall Study|PCR positive at follow up 2|0|||
33183923|NCT02641379|100583122|FG005|Overall Study|PCR positive at follow up 2|0|||
33183924|NCT02641379|100583123|FG006|Overall Study|PCR positive at follow up 2|0|||
33183925|NCT02641379|100583124|FG007|Overall Study|PCR positive at follow up 2|0|||
33183926|NCT02641379|100583125|FG008|Overall Study|PCR positive at follow up 2|0|||
33183927|NCT02641379|100583126|FG009|Overall Study|PCR positive at follow up 2|0|||
33183928|NCT02641379|100583127|FG010|Overall Study|PCR positive at follow up 2|0|||
33493805|NCT01499095|101698291|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
33493806|NCT01499095|101698290|FG000|Overall Study|Hypoglycemia|3|||
33493807|NCT01499095|101698291|FG001|Overall Study|Hypoglycemia|1|||
33493808|NCT01499095|101698290|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
33493809|NCT01499095|101698291|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
33493810|NCT01499095|101698290|FG000|Overall Study|Change in Injection Schedule|2|||
33493811|NCT01499095|101698291|FG001|Overall Study|Change in Injection Schedule|0|||
33493812|NCT01499095|101698290|FG000|Overall Study|Perceived Lack of Efficacy|1|||
33493813|NCT01499095|101698291|FG001|Overall Study|Perceived Lack of Efficacy|1|||
33493814|NCT02105987|101698292|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
33493815|NCT02105987|101698293|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
33493816|NCT02105987|101698294|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
33493817|NCT02105987|101698295|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
33493818|NCT02105987|101698296|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
33493819|NCT02105987|101698297|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
33493820|NCT02105987|101698292|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
33183929|NCT02641379|100583117|FG000|Overall Study|Participant showed relapse|1|||
33594439|NCT00394901|102064977|FG002|Baseline Phase|Protocol Violation|1|||
33594440|NCT00394901|102064978|FG003|Baseline Phase|Protocol Violation|0|||
33594441|NCT00394901|102064975|FG000|Double-blind Phase|Adverse Event|5|||
33594442|NCT00394901|102064976|FG001|Double-blind Phase|Adverse Event|7|||
33594443|NCT00394901|102064977|FG002|Double-blind Phase|Adverse Event|16|||
33594444|NCT00394901|102064978|FG003|Double-blind Phase|Adverse Event|20|||
33594445|NCT00394901|102064975|FG000|Double-blind Phase|Lack of Efficacy|6|||
33594446|NCT00394901|102064976|FG001|Double-blind Phase|Lack of Efficacy|4|||
33594447|NCT00394901|102064977|FG002|Double-blind Phase|Lack of Efficacy|1|||
33594448|NCT00394901|102064978|FG003|Double-blind Phase|Lack of Efficacy|3|||
33594449|NCT00394901|102064975|FG000|Double-blind Phase|Withdrawal by Subject|2|||
33594450|NCT00394901|102064976|FG001|Double-blind Phase|Withdrawal by Subject|0|||
33594451|NCT00394901|102064977|FG002|Double-blind Phase|Withdrawal by Subject|0|||
33594452|NCT00394901|102064978|FG003|Double-blind Phase|Withdrawal by Subject|0|||
33594453|NCT00394901|102064975|FG000|Double-blind Phase|Lost to Follow-up|0|||
33594454|NCT00394901|102064976|FG001|Double-blind Phase|Lost to Follow-up|0|||
33594455|NCT00394901|102064977|FG002|Double-blind Phase|Lost to Follow-up|0|||
33594456|NCT00394901|102064978|FG003|Double-blind Phase|Lost to Follow-up|1|||
33594457|NCT00394901|102064975|FG000|Double-blind Phase|Protocol Violation|0|||
33594458|NCT00394901|102064976|FG001|Double-blind Phase|Protocol Violation|0|||
33183930|NCT02641379|100583118|FG001|Overall Study|Participant showed relapse|0|||
33183931|NCT02641379|100583119|FG002|Overall Study|Participant showed relapse|0|||
33183932|NCT02641379|100583120|FG003|Overall Study|Participant showed relapse|0|||
33183933|NCT02641379|100583121|FG004|Overall Study|Participant showed relapse|0|||
33183934|NCT02641379|100583122|FG005|Overall Study|Participant showed relapse|0|||
33183935|NCT02641379|100583123|FG006|Overall Study|Participant showed relapse|1|||
33183936|NCT02641379|100583124|FG007|Overall Study|Participant showed relapse|0|||
33183937|NCT02641379|100583125|FG008|Overall Study|Participant showed relapse|0|||
33183938|NCT02641379|100583126|FG009|Overall Study|Participant showed relapse|0|||
33183939|NCT02641379|100583127|FG010|Overall Study|Participant showed relapse|0|||
33183940|NCT02641379|100583117|FG000|Overall Study|Participant stopped study/treatment|1|||
33183941|NCT02641379|100583118|FG001|Overall Study|Participant stopped study/treatment|3|||
33183942|NCT02641379|100583119|FG002|Overall Study|Participant stopped study/treatment|1|||
33183943|NCT02641379|100583120|FG003|Overall Study|Participant stopped study/treatment|0|||
33594459|NCT00394901|102064977|FG002|Double-blind Phase|Protocol Violation|0|||
33183944|NCT02641379|100583121|FG004|Overall Study|Participant stopped study/treatment|0|||
33183945|NCT02641379|100583122|FG005|Overall Study|Participant stopped study/treatment|1|||
33389926|NCT00643448|101313881|FG001|Overall Study|Adverse Event|2|||
33493821|NCT02105987|101698293|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
33493822|NCT02105987|101698294|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
33493823|NCT02105987|101698295|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
33493824|NCT02105987|101698296|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
33493825|NCT02105987|101698297|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
33493826|NCT02105987|101698292|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
33493827|NCT02105987|101698293|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
33493828|NCT02105987|101698294|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33493829|NCT02105987|101698295|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33493830|NCT02105987|101698296|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33493831|NCT02105987|101698297|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33493832|NCT02105987|101698292|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
33493833|NCT02105987|101698293|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
33493834|NCT02105987|101698294|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33493835|NCT02105987|101698295|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33493836|NCT02105987|101698296|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33493837|NCT02105987|101698297|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33493838|NCT02105987|101698292|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
33493839|NCT02105987|101698293|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
33493840|NCT02105987|101698294|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
33493841|NCT02105987|101698295|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
33493842|NCT02105987|101698296|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
33493843|NCT02105987|101698297|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
33493844|NCT02105987|101698292|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
33493845|NCT02105987|101698293|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
33493846|NCT02105987|101698294|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
33493847|NCT02105987|101698295|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
33493848|NCT02105987|101698296|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
33493849|NCT02105987|101698297|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
33493850|NCT02105987|101698292|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
33493851|NCT02105987|101698293|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
33493852|NCT02105987|101698294|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
33493853|NCT02105987|101698295|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
33493854|NCT02105987|101698296|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
33493855|NCT02105987|101698297|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
33493856|NCT02105987|101698292|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
33493857|NCT02105987|101698293|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
33493858|NCT02105987|101698294|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
33493859|NCT02105987|101698295|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
33493860|NCT02105987|101698296|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
33493861|NCT02105987|101698297|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
33493862|NCT02105987|101698292|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33493863|NCT02105987|101698293|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33493864|NCT02105987|101698294|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
33493865|NCT02105987|101698295|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
33493866|NCT02105987|101698296|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33493867|NCT02105987|101698297|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
33493868|NCT02105987|101698292|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33493869|NCT02105987|101698293|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33493870|NCT02105987|101698294|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
33493871|NCT02105987|101698295|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
33493872|NCT02105987|101698296|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33493873|NCT02105987|101698297|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
33493874|NCT02105987|101698292|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
33493875|NCT02105987|101698293|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
33493876|NCT02105987|101698294|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
33493877|NCT02105987|101698295|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
33493878|NCT02105987|101698296|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
33493879|NCT02105987|101698297|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
33493880|NCT02105987|101698292|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
33493881|NCT02105987|101698293|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
33493882|NCT02105987|101698294|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
33493883|NCT02105987|101698295|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
33493884|NCT02105987|101698296|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
33493885|NCT02105987|101698297|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
33493886|NCT02105987|101698292|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
33493887|NCT02105987|101698293|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
33631262|NCT01231906|102202898|FG001|Overall Study|Physician Decision|24|||
33493888|NCT02105987|101698294|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
33493889|NCT02105987|101698295|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
33493890|NCT02105987|101698296|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
33493891|NCT02105987|101698297|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
33493892|NCT02105987|101698292|FG000|Continuation Phase|Protocol Violation|0|||
33493893|NCT02105987|101698293|FG001|Continuation Phase|Protocol Violation|0|||
33493894|NCT02105987|101698294|FG002|Continuation Phase|Protocol Violation|0|||
33493895|NCT02105987|101698295|FG003|Continuation Phase|Protocol Violation|0|||
33493896|NCT02105987|101698296|FG004|Continuation Phase|Protocol Violation|1|||
33493897|NCT02105987|101698297|FG005|Continuation Phase|Protocol Violation|0|||
33493898|NCT01866826|101698300|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
33493899|NCT01866826|101698301|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
33493900|NCT01866826|101698300|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
33493901|NCT01866826|101698301|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
33493902|NCT01866826|101698300|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
33493903|NCT01866826|101698301|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
33493904|NCT02152137|101698302|FG000|Overall Study|Withdrawal by Subject|1|||
33493905|NCT02152137|101698302|FG000|Overall Study|Originally assigned to Arm B|3|||
33493906|NCT03759392|101698305|FG000|Overall Study|Adverse Event|12|||
33493907|NCT03759392|101698306|FG001|Overall Study|Adverse Event|4|||
33493908|NCT03759392|101698305|FG000|Overall Study|Death|2|||
33493909|NCT03759392|101698306|FG001|Overall Study|Death|1|||
33493910|NCT03759392|101698305|FG000|Overall Study|Withdrawal by Subject|2|||
33493911|NCT03759392|101698306|FG001|Overall Study|Withdrawal by Subject|0|||
33493912|NCT03759392|101698305|FG000|Overall Study|Protocol Violation|2|||
33183946|NCT02641379|100583123|FG006|Overall Study|Participant stopped study/treatment|2|||
33183947|NCT02641379|100583124|FG007|Overall Study|Participant stopped study/treatment|0|||
33183948|NCT02641379|100583125|FG008|Overall Study|Participant stopped study/treatment|1|||
33183949|NCT02641379|100583126|FG009|Overall Study|Participant stopped study/treatment|0|||
33183950|NCT02641379|100583127|FG010|Overall Study|Participant stopped study/treatment|0|||
33183951|NCT02641379|100583117|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
33183952|NCT02641379|100583118|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
33183953|NCT02641379|100583119|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
33183954|NCT02641379|100583120|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
33183955|NCT02641379|100583121|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
33183956|NCT02641379|100583122|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
33183957|NCT02641379|100583123|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
33183958|NCT02641379|100583124|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
33183959|NCT02641379|100583125|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
33183960|NCT02641379|100583126|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
33183961|NCT02641379|100583127|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
33183962|NCT02641379|100583117|FG000|Overall Study|Financial problems|0|||
33183963|NCT02641379|100583118|FG001|Overall Study|Financial problems|1|||
33493913|NCT03759392|101698306|FG001|Overall Study|Protocol Violation|0|||
33493914|NCT03759392|101698305|FG000|Overall Study|Physician Decision|0|||
33493915|NCT03759392|101698306|FG001|Overall Study|Physician Decision|1|||
33493916|NCT03759392|101698305|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
33493917|NCT03759392|101698306|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
33493918|NCT03759392|101698305|FG000|Overall Study|No longer able to take medicines|1|||
33493919|NCT03759392|101698306|FG001|Overall Study|No longer able to take medicines|0|||
33493920|NCT03759392|101698305|FG000|Overall Study|Stopped taking study drug|1|||
33493921|NCT03759392|101698306|FG001|Overall Study|Stopped taking study drug|0|||
33493922|NCT02440464|101698308|FG000|Overall Study|Withdrawal by Subject|3|||
33493923|NCT02440464|101698309|FG001|Overall Study|Withdrawal by Subject|2|||
33493924|NCT01330303|101698310|FG000|Period 1|Adverse Event|1|||
33493925|NCT01330303|101698311|FG001|Period 1|Adverse Event|0|||
33493926|NCT01330303|101698310|FG000|Period 1|Protocol Violation|0|||
33493927|NCT01330303|101698311|FG001|Period 1|Protocol Violation|1|||
33493928|NCT01330303|101698310|FG000|Period 1|Withdrawal by Subject|0|||
33493929|NCT01330303|101698311|FG001|Period 1|Withdrawal by Subject|1|||
33493930|NCT05317312|101698312|FG000|Overall Study|Withdrawal by Subject|0|||
33493931|NCT05317312|101698313|FG001|Overall Study|Withdrawal by Subject|1|||
33493932|NCT05317312|101698314|FG002|Overall Study|Withdrawal by Subject|0|||
33493933|NCT05317312|101698315|FG003|Overall Study|Withdrawal by Subject|0|||
33493934|NCT05317312|101698312|FG000|Overall Study|Lost to Follow-up|0|||
33493935|NCT05317312|101698313|FG001|Overall Study|Lost to Follow-up|0|||
33493936|NCT05317312|101698314|FG002|Overall Study|Lost to Follow-up|0|||
33493937|NCT05317312|101698315|FG003|Overall Study|Lost to Follow-up|1|||
33493938|NCT05317312|101698312|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
33493939|NCT05317312|101698313|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
33493940|NCT05317312|101698314|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
33183964|NCT02641379|100583119|FG002|Overall Study|Financial problems|0|||
33183965|NCT02641379|100583120|FG003|Overall Study|Financial problems|0|||
33183966|NCT02641379|100583121|FG004|Overall Study|Financial problems|0|||
33183967|NCT02641379|100583122|FG005|Overall Study|Financial problems|0|||
33183968|NCT02641379|100583123|FG006|Overall Study|Financial problems|0|||
33183969|NCT02641379|100583124|FG007|Overall Study|Financial problems|0|||
33183970|NCT02641379|100583125|FG008|Overall Study|Financial problems|0|||
33183971|NCT02641379|100583126|FG009|Overall Study|Financial problems|0|||
33183972|NCT02641379|100583127|FG010|Overall Study|Financial problems|0|||
33183973|NCT02641379|100583117|FG000|Overall Study|PCR positive at Week 68|0|||
33183974|NCT02641379|100583118|FG001|Overall Study|PCR positive at Week 68|1|||
33183975|NCT02641379|100583119|FG002|Overall Study|PCR positive at Week 68|0|||
33183976|NCT02641379|100583120|FG003|Overall Study|PCR positive at Week 68|0|||
33183977|NCT02641379|100583121|FG004|Overall Study|PCR positive at Week 68|0|||
33183978|NCT02641379|100583122|FG005|Overall Study|PCR positive at Week 68|0|||
33183979|NCT02641379|100583123|FG006|Overall Study|PCR positive at Week 68|0|||
33183980|NCT02641379|100583124|FG007|Overall Study|PCR positive at Week 68|0|||
33183981|NCT02641379|100583125|FG008|Overall Study|PCR positive at Week 68|0|||
33183982|NCT02641379|100583126|FG009|Overall Study|PCR positive at Week 68|0|||
33183983|NCT02641379|100583127|FG010|Overall Study|PCR positive at Week 68|0|||
33183984|NCT02641379|100583117|FG000|Overall Study|PCR positive at Week 48|0|||
33183985|NCT02641379|100583118|FG001|Overall Study|PCR positive at Week 48|1|||
33183986|NCT02641379|100583119|FG002|Overall Study|PCR positive at Week 48|0|||
33594460|NCT00394901|102064978|FG003|Double-blind Phase|Protocol Violation|1|||
33594461|NCT00394901|102064975|FG000|Double-blind Phase|Death|1|||
33594462|NCT00394901|102064976|FG001|Double-blind Phase|Death|0|||
33594463|NCT00394901|102064977|FG002|Double-blind Phase|Death|0|||
33594464|NCT00394901|102064978|FG003|Double-blind Phase|Death|0|||
33594465|NCT00394901|102064975|FG000|Double-blind Phase|Subject's Personal Reason|1|||
33594466|NCT00394901|102064976|FG001|Double-blind Phase|Subject's Personal Reason|0|||
33594467|NCT00394901|102064977|FG002|Double-blind Phase|Subject's Personal Reason|0|||
33594468|NCT00394901|102064978|FG003|Double-blind Phase|Subject's Personal Reason|1|||
33594469|NCT00394901|102064975|FG000|Double-blind Phase|Lack of Compliance|0|||
33594470|NCT00394901|102064976|FG001|Double-blind Phase|Lack of Compliance|3|||
33594471|NCT00394901|102064977|FG002|Double-blind Phase|Lack of Compliance|0|||
33594472|NCT00394901|102064978|FG003|Double-blind Phase|Lack of Compliance|0|||
33594473|NCT00394901|102064975|FG000|Double-blind Phase|Entry into another study was found|0|||
33594474|NCT00394901|102064976|FG001|Double-blind Phase|Entry into another study was found|0|||
33594475|NCT00394901|102064977|FG002|Double-blind Phase|Entry into another study was found|1|||
33594476|NCT00394901|102064978|FG003|Double-blind Phase|Entry into another study was found|0|||
33594477|NCT00394901|102064975|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
33594478|NCT00394901|102064976|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
33594479|NCT00394901|102064977|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
33594480|NCT00394901|102064978|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
33594481|NCT01510145|102064979|FG000|Overall Study|Adverse Event|6|||
33594482|NCT01510145|102064979|FG000|Overall Study|Lost to Follow-up|5|||
33594483|NCT01510145|102064979|FG000|Overall Study|Withdrawal by Subject|6|||
33594484|NCT01510145|102064979|FG000|Overall Study|Relative reported subject withdrew|1|||
33594485|NCT03842969|102064980|FG000|Overall Study|Participant declined follow-up visit|0|||
33594486|NCT03842969|102064981|FG001|Overall Study|Participant declined follow-up visit|1|||
33594487|NCT03842969|102064982|FG002|Overall Study|Participant declined follow-up visit|0|||
33594488|NCT03842969|102064980|FG000|Overall Study|Sponsor's decision|12|||
33594489|NCT03842969|102064981|FG001|Overall Study|Sponsor's decision|99|||
33594490|NCT03842969|102064982|FG002|Overall Study|Sponsor's decision|61|||
33493941|NCT05317312|101698315|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
33493942|NCT03154125|101698316|FG000|Overall Study|Lost to Follow-up|11|||
33493943|NCT03154125|101698317|FG001|Overall Study|Lost to Follow-up|11|||
33493944|NCT03154125|101698318|FG002|Overall Study|Lost to Follow-up|0|||
33594491|NCT03842969|102064980|FG000|Overall Study|Pregnancy|0|||
33594492|NCT03842969|102064981|FG001|Overall Study|Pregnancy|0|||
33594493|NCT03842969|102064982|FG002|Overall Study|Pregnancy|1|||
33594494|NCT03842969|102064980|FG000|Overall Study|Death|1|||
33594495|NCT03842969|102064981|FG001|Overall Study|Death|0|||
33594496|NCT03842969|102064982|FG002|Overall Study|Death|1|||
33594497|NCT03842969|102064980|FG000|Overall Study|Withdrawal by Subject|3|||
33594498|NCT03842969|102064981|FG001|Overall Study|Withdrawal by Subject|30|||
33594499|NCT03842969|102064982|FG002|Overall Study|Withdrawal by Subject|18|||
33493945|NCT03154125|101698316|FG000|Overall Study|Withdrawal by Subject|49|||
33594500|NCT03842969|102064980|FG000|Overall Study|Protocol Violation|1|||
33594501|NCT03842969|102064981|FG001|Overall Study|Protocol Violation|1|||
33594502|NCT03842969|102064982|FG002|Overall Study|Protocol Violation|0|||
33594503|NCT03842969|102064980|FG000|Overall Study|Physician Decision|0|||
33594504|NCT03842969|102064981|FG001|Overall Study|Physician Decision|3|||
33594505|NCT03842969|102064982|FG002|Overall Study|Physician Decision|0|||
33594506|NCT03842969|102064980|FG000|Overall Study|Lost to Follow-up|0|||
33594507|NCT03842969|102064981|FG001|Overall Study|Lost to Follow-up|2|||
33594508|NCT03842969|102064982|FG002|Overall Study|Lost to Follow-up|0|||
33594509|NCT03842969|102064980|FG000|Overall Study|Adverse Event|0|||
33594510|NCT03842969|102064981|FG001|Overall Study|Adverse Event|2|||
33594511|NCT03842969|102064982|FG002|Overall Study|Adverse Event|0|||
33594512|NCT03549871|102064983|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
33594513|NCT03549871|102064984|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
33594514|NCT03549871|102064983|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
33594515|NCT03549871|102064984|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
33594516|NCT03549871|102064983|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
33594517|NCT03549871|102064984|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
33594518|NCT03549871|102064983|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
33594519|NCT03549871|102064984|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
33594520|NCT03549871|102064983|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
33594521|NCT03549871|102064984|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
33594522|NCT03549871|102064983|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
33594523|NCT03549871|102064984|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
33594524|NCT03549871|102064983|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
33594525|NCT03549871|102064984|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
33594526|NCT03549871|102064983|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
33594527|NCT03549871|102064984|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
33594528|NCT03549871|102064983|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
33594529|NCT03549871|102064984|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
33594530|NCT03549871|102064983|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
33594531|NCT03549871|102064984|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
33594532|NCT03549871|102064983|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
33594533|NCT03549871|102064984|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
33594534|NCT01174004|102064988|FG000|Overall Study|Adverse Event|2|||
33594535|NCT01174004|102064989|FG001|Overall Study|Adverse Event|10|||
33594536|NCT01174004|102064988|FG000|Overall Study|Withdrawal by Subject|2|||
33594537|NCT01174004|102064989|FG001|Overall Study|Withdrawal by Subject|3|||
33594538|NCT01174004|102064988|FG000|Overall Study|At Discretion of Sponsor|2|||
33594539|NCT01174004|102064989|FG001|Overall Study|At Discretion of Sponsor|2|||
33594540|NCT01174004|102064988|FG000|Overall Study|Protocol Violation|0|||
33594541|NCT01174004|102064989|FG001|Overall Study|Protocol Violation|1|||
33594542|NCT01174004|102064988|FG000|Overall Study|Physician Decision|1|||
33594543|NCT01174004|102064989|FG001|Overall Study|Physician Decision|0|||
33594544|NCT02334683|102064991|FG000|First 12 Week Period|Lost to Follow-up|1|||
33594545|NCT02334683|102064992|FG001|First 12 Week Period|Lost to Follow-up|0|||
33594546|NCT02334683|102064991|FG000|Second 12 Week Period|Adverse Event|0|||
33594547|NCT02334683|102064992|FG001|Second 12 Week Period|Adverse Event|1|||
33594548|NCT03372460|102064998|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
33594549|NCT03372460|102064999|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
33594550|NCT03483038|102065010|FG000|Overall Study|Subjects still in follow-up|18|||
33594551|NCT01133405|102065011|FG000|Period 1|Withdrawal by Subject|0|||
33594552|NCT01133405|102065012|FG001|Period 1|Withdrawal by Subject|1|||
33594553|NCT01133405|102065013|FG002|Period 1|Withdrawal by Subject|0|||
33594554|NCT01133405|102065014|FG003|Period 1|Withdrawal by Subject|1|||
33183987|NCT02641379|100583120|FG003|Overall Study|PCR positive at Week 48|0|||
33183988|NCT02641379|100583121|FG004|Overall Study|PCR positive at Week 48|0|||
33183989|NCT02641379|100583122|FG005|Overall Study|PCR positive at Week 48|0|||
33183990|NCT02641379|100583123|FG006|Overall Study|PCR positive at Week 48|0|||
33183991|NCT02641379|100583124|FG007|Overall Study|PCR positive at Week 48|0|||
33183992|NCT02641379|100583125|FG008|Overall Study|PCR positive at Week 48|0|||
33183993|NCT02641379|100583126|FG009|Overall Study|PCR positive at Week 48|0|||
33183994|NCT02641379|100583127|FG010|Overall Study|PCR positive at Week 48|0|||
33183995|NCT02641379|100583117|FG000|Overall Study|PCR not performed at Week 12|0|||
33183996|NCT02641379|100583118|FG001|Overall Study|PCR not performed at Week 12|0|||
33183997|NCT02641379|100583119|FG002|Overall Study|PCR not performed at Week 12|1|||
33183998|NCT02641379|100583120|FG003|Overall Study|PCR not performed at Week 12|0|||
33183999|NCT02641379|100583121|FG004|Overall Study|PCR not performed at Week 12|0|||
33184000|NCT02641379|100583122|FG005|Overall Study|PCR not performed at Week 12|0|||
33184001|NCT02641379|100583123|FG006|Overall Study|PCR not performed at Week 12|0|||
33184002|NCT02641379|100583124|FG007|Overall Study|PCR not performed at Week 12|0|||
33184003|NCT02641379|100583125|FG008|Overall Study|PCR not performed at Week 12|0|||
33184004|NCT02641379|100583126|FG009|Overall Study|PCR not performed at Week 12|0|||
33184005|NCT02641379|100583127|FG010|Overall Study|PCR not performed at Week 12|0|||
33184006|NCT02641379|100583117|FG000|Overall Study|No PCR at baseline|0|||
33184007|NCT02641379|100583118|FG001|Overall Study|No PCR at baseline|0|||
33184008|NCT02641379|100583119|FG002|Overall Study|No PCR at baseline|1|||
33184009|NCT02641379|100583120|FG003|Overall Study|No PCR at baseline|0|||
33184010|NCT02641379|100583121|FG004|Overall Study|No PCR at baseline|0|||
33184011|NCT02641379|100583122|FG005|Overall Study|No PCR at baseline|0|||
33184012|NCT02641379|100583123|FG006|Overall Study|No PCR at baseline|0|||
33184013|NCT02641379|100583124|FG007|Overall Study|No PCR at baseline|0|||
33184014|NCT02641379|100583125|FG008|Overall Study|No PCR at baseline|0|||
33184015|NCT02641379|100583126|FG009|Overall Study|No PCR at baseline|0|||
33184016|NCT02641379|100583127|FG010|Overall Study|No PCR at baseline|0|||
33184017|NCT02641379|100583117|FG000|Overall Study|PCR positive at Week 28|0|||
33184018|NCT02641379|100583118|FG001|Overall Study|PCR positive at Week 28|0|||
33184019|NCT02641379|100583119|FG002|Overall Study|PCR positive at Week 28|1|||
33184020|NCT02641379|100583120|FG003|Overall Study|PCR positive at Week 28|0|||
33184021|NCT02641379|100583121|FG004|Overall Study|PCR positive at Week 28|0|||
33184022|NCT02641379|100583122|FG005|Overall Study|PCR positive at Week 28|0|||
33184023|NCT02641379|100583123|FG006|Overall Study|PCR positive at Week 28|0|||
33184024|NCT02641379|100583124|FG007|Overall Study|PCR positive at Week 28|0|||
33184025|NCT02641379|100583125|FG008|Overall Study|PCR positive at Week 28|0|||
33184026|NCT02641379|100583126|FG009|Overall Study|PCR positive at Week 28|0|||
33184027|NCT02641379|100583127|FG010|Overall Study|PCR positive at Week 28|0|||
33184028|NCT02641379|100583117|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
33184029|NCT02641379|100583118|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
33184030|NCT02641379|100583119|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
33184031|NCT02641379|100583120|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
33184032|NCT02641379|100583121|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
33184033|NCT02641379|100583122|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
33184034|NCT02641379|100583123|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
33184035|NCT02641379|100583124|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
33184036|NCT02641379|100583125|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
33184037|NCT02641379|100583126|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
33184038|NCT02641379|100583127|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
33184039|NCT02641379|100583117|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
33184040|NCT02641379|100583118|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
33184041|NCT02641379|100583119|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
33184042|NCT02641379|100583120|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
33184043|NCT02641379|100583121|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
33184044|NCT02641379|100583122|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
33184045|NCT02641379|100583123|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
33184046|NCT02641379|100583124|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
33184047|NCT02641379|100583125|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
33184048|NCT02641379|100583126|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
33184049|NCT02641379|100583127|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
33184050|NCT02641379|100583117|FG000|Overall Study|Baseline viral load unavailable|0|||
33184051|NCT02641379|100583118|FG001|Overall Study|Baseline viral load unavailable|0|||
33184052|NCT02641379|100583119|FG002|Overall Study|Baseline viral load unavailable|0|||
33184053|NCT02641379|100583120|FG003|Overall Study|Baseline viral load unavailable|1|||
33184054|NCT02641379|100583121|FG004|Overall Study|Baseline viral load unavailable|0|||
33184055|NCT02641379|100583122|FG005|Overall Study|Baseline viral load unavailable|0|||
33184056|NCT02641379|100583123|FG006|Overall Study|Baseline viral load unavailable|0|||
33184057|NCT02641379|100583124|FG007|Overall Study|Baseline viral load unavailable|0|||
33184058|NCT02641379|100583125|FG008|Overall Study|Baseline viral load unavailable|0|||
33184059|NCT02641379|100583126|FG009|Overall Study|Baseline viral load unavailable|0|||
33184060|NCT02641379|100583127|FG010|Overall Study|Baseline viral load unavailable|0|||
33184061|NCT02641379|100583117|FG000|Overall Study|Blood could not be drawn|0|||
33184062|NCT02641379|100583118|FG001|Overall Study|Blood could not be drawn|0|||
33184063|NCT02641379|100583119|FG002|Overall Study|Blood could not be drawn|0|||
33184064|NCT02641379|100583120|FG003|Overall Study|Blood could not be drawn|0|||
33184065|NCT02641379|100583121|FG004|Overall Study|Blood could not be drawn|1|||
33184066|NCT02641379|100583122|FG005|Overall Study|Blood could not be drawn|0|||
33184067|NCT02641379|100583123|FG006|Overall Study|Blood could not be drawn|0|||
33184068|NCT02641379|100583124|FG007|Overall Study|Blood could not be drawn|0|||
33184069|NCT02641379|100583125|FG008|Overall Study|Blood could not be drawn|0|||
33184070|NCT02641379|100583126|FG009|Overall Study|Blood could not be drawn|0|||
33184071|NCT02641379|100583127|FG010|Overall Study|Blood could not be drawn|0|||
33184072|NCT02641379|100583117|FG000|Overall Study|Protocol Violation|0|||
33184073|NCT02641379|100583118|FG001|Overall Study|Protocol Violation|0|||
33184074|NCT02641379|100583119|FG002|Overall Study|Protocol Violation|0|||
33184075|NCT02641379|100583120|FG003|Overall Study|Protocol Violation|0|||
33184076|NCT02641379|100583121|FG004|Overall Study|Protocol Violation|2|||
33184077|NCT02641379|100583122|FG005|Overall Study|Protocol Violation|0|||
33184078|NCT02641379|100583123|FG006|Overall Study|Protocol Violation|0|||
33184079|NCT02641379|100583124|FG007|Overall Study|Protocol Violation|0|||
33184080|NCT02641379|100583125|FG008|Overall Study|Protocol Violation|1|||
33184081|NCT02641379|100583126|FG009|Overall Study|Protocol Violation|0|||
33184082|NCT02641379|100583127|FG010|Overall Study|Protocol Violation|0|||
33184083|NCT02641379|100583117|FG000|Overall Study|Participation in sili rescue study|0|||
33184084|NCT02641379|100583118|FG001|Overall Study|Participation in sili rescue study|0|||
33184085|NCT02641379|100583119|FG002|Overall Study|Participation in sili rescue study|0|||
33184086|NCT02641379|100583120|FG003|Overall Study|Participation in sili rescue study|0|||
33184087|NCT02641379|100583121|FG004|Overall Study|Participation in sili rescue study|0|||
33184088|NCT02641379|100583122|FG005|Overall Study|Participation in sili rescue study|1|||
33184089|NCT02641379|100583123|FG006|Overall Study|Participation in sili rescue study|0|||
33184090|NCT02641379|100583124|FG007|Overall Study|Participation in sili rescue study|0|||
33184091|NCT02641379|100583125|FG008|Overall Study|Participation in sili rescue study|0|||
33184092|NCT02641379|100583126|FG009|Overall Study|Participation in sili rescue study|0|||
33184093|NCT02641379|100583127|FG010|Overall Study|Participation in sili rescue study|0|||
33184094|NCT02641379|100583117|FG000|Overall Study|Lost to Follow-up|0|||
33184095|NCT02641379|100583118|FG001|Overall Study|Lost to Follow-up|0|||
33184096|NCT02641379|100583119|FG002|Overall Study|Lost to Follow-up|0|||
33184097|NCT02641379|100583120|FG003|Overall Study|Lost to Follow-up|0|||
33184098|NCT02641379|100583121|FG004|Overall Study|Lost to Follow-up|0|||
33184099|NCT02641379|100583122|FG005|Overall Study|Lost to Follow-up|0|||
33184100|NCT02641379|100583123|FG006|Overall Study|Lost to Follow-up|0|||
33184101|NCT02641379|100583124|FG007|Overall Study|Lost to Follow-up|0|||
33184102|NCT02641379|100583125|FG008|Overall Study|Lost to Follow-up|1|||
33184103|NCT02641379|100583126|FG009|Overall Study|Lost to Follow-up|0|||
33184104|NCT02641379|100583127|FG010|Overall Study|Lost to Follow-up|0|||
33184105|NCT02641379|100583117|FG000|Overall Study|Source data not found|0|||
33184106|NCT02641379|100583118|FG001|Overall Study|Source data not found|0|||
33184107|NCT02641379|100583119|FG002|Overall Study|Source data not found|0|||
33184108|NCT02641379|100583120|FG003|Overall Study|Source data not found|0|||
33184109|NCT02641379|100583121|FG004|Overall Study|Source data not found|0|||
33184110|NCT02641379|100583122|FG005|Overall Study|Source data not found|1|||
33184111|NCT02641379|100583123|FG006|Overall Study|Source data not found|0|||
33184112|NCT02641379|100583124|FG007|Overall Study|Source data not found|0|||
33184113|NCT02641379|100583125|FG008|Overall Study|Source data not found|0|||
33184114|NCT02641379|100583126|FG009|Overall Study|Source data not found|0|||
33184115|NCT02641379|100583127|FG010|Overall Study|Source data not found|0|||
33184116|NCT02641379|100583117|FG000|Overall Study|Participant showed weight reduction|0|||
33184117|NCT02641379|100583118|FG001|Overall Study|Participant showed weight reduction|0|||
33184118|NCT02641379|100583119|FG002|Overall Study|Participant showed weight reduction|0|||
33184119|NCT02641379|100583120|FG003|Overall Study|Participant showed weight reduction|0|||
33184120|NCT02641379|100583121|FG004|Overall Study|Participant showed weight reduction|0|||
33184121|NCT02641379|100583122|FG005|Overall Study|Participant showed weight reduction|0|||
33184122|NCT02641379|100583123|FG006|Overall Study|Participant showed weight reduction|0|||
33184123|NCT02641379|100583124|FG007|Overall Study|Participant showed weight reduction|1|||
33184124|NCT02641379|100583125|FG008|Overall Study|Participant showed weight reduction|0|||
33184125|NCT02641379|100583126|FG009|Overall Study|Participant showed weight reduction|0|||
33184126|NCT02641379|100583127|FG010|Overall Study|Participant showed weight reduction|0|||
33184127|NCT02641379|100583117|FG000|Overall Study|Non-response Week 12|0|||
33184128|NCT02641379|100583118|FG001|Overall Study|Non-response Week 12|0|||
33184129|NCT02641379|100583119|FG002|Overall Study|Non-response Week 12|0|||
33184130|NCT02641379|100583120|FG003|Overall Study|Non-response Week 12|0|||
33184131|NCT02641379|100583121|FG004|Overall Study|Non-response Week 12|0|||
33184132|NCT02641379|100583122|FG005|Overall Study|Non-response Week 12|0|||
33184133|NCT02641379|100583123|FG006|Overall Study|Non-response Week 12|0|||
33184134|NCT02641379|100583124|FG007|Overall Study|Non-response Week 12|1|||
33184135|NCT02641379|100583125|FG008|Overall Study|Non-response Week 12|0|||
33184136|NCT02641379|100583126|FG009|Overall Study|Non-response Week 12|0|||
33184137|NCT02641379|100583127|FG010|Overall Study|Non-response Week 12|0|||
33184138|NCT02641379|100583117|FG000|Overall Study|No 2 Log drop at Week 12|0|||
33184139|NCT02641379|100583118|FG001|Overall Study|No 2 Log drop at Week 12|0|||
33184140|NCT02641379|100583119|FG002|Overall Study|No 2 Log drop at Week 12|0|||
33184141|NCT02641379|100583120|FG003|Overall Study|No 2 Log drop at Week 12|0|||
33184142|NCT02641379|100583121|FG004|Overall Study|No 2 Log drop at Week 12|0|||
33184143|NCT02641379|100583122|FG005|Overall Study|No 2 Log drop at Week 12|0|||
33184144|NCT02641379|100583123|FG006|Overall Study|No 2 Log drop at Week 12|0|||
33184145|NCT02641379|100583124|FG007|Overall Study|No 2 Log drop at Week 12|0|||
33184146|NCT02641379|100583125|FG008|Overall Study|No 2 Log drop at Week 12|0|||
33184147|NCT02641379|100583126|FG009|Overall Study|No 2 Log drop at Week 12|0|||
33184148|NCT02641379|100583127|FG010|Overall Study|No 2 Log drop at Week 12|1|||
33184149|NCT02641379|100583117|FG000|Overall Study|Negative PCR result|0|||
33184150|NCT02641379|100583118|FG001|Overall Study|Negative PCR result|0|||
33184151|NCT02641379|100583119|FG002|Overall Study|Negative PCR result|0|||
33184152|NCT02641379|100583120|FG003|Overall Study|Negative PCR result|0|||
33184153|NCT02641379|100583121|FG004|Overall Study|Negative PCR result|0|||
33184154|NCT02641379|100583122|FG005|Overall Study|Negative PCR result|0|||
33184155|NCT02641379|100583123|FG006|Overall Study|Negative PCR result|0|||
33184156|NCT02641379|100583124|FG007|Overall Study|Negative PCR result|0|||
33184157|NCT02641379|100583125|FG008|Overall Study|Negative PCR result|0|||
33184158|NCT02641379|100583126|FG009|Overall Study|Negative PCR result|1|||
33184159|NCT02641379|100583127|FG010|Overall Study|Negative PCR result|0|||
33184160|NCT02641379|100583117|FG000|Overall Study|Participant's PCR high|0|||
33184161|NCT02641379|100583118|FG001|Overall Study|Participant's PCR high|0|||
33184162|NCT02641379|100583119|FG002|Overall Study|Participant's PCR high|0|||
33184163|NCT02641379|100583120|FG003|Overall Study|Participant's PCR high|0|||
33184164|NCT02641379|100583121|FG004|Overall Study|Participant's PCR high|0|||
33184165|NCT02641379|100583122|FG005|Overall Study|Participant's PCR high|0|||
33184166|NCT02641379|100583123|FG006|Overall Study|Participant's PCR high|0|||
33184167|NCT02641379|100583124|FG007|Overall Study|Participant's PCR high|1|||
33184168|NCT02641379|100583125|FG008|Overall Study|Participant's PCR high|0|||
33184169|NCT02641379|100583126|FG009|Overall Study|Participant's PCR high|0|||
33184170|NCT02641379|100583127|FG010|Overall Study|Participant's PCR high|0|||
33184171|NCT02641379|100583117|FG000|Overall Study|Participant treated after Week 24|0|||
33184172|NCT02641379|100583118|FG001|Overall Study|Participant treated after Week 24|0|||
33184173|NCT02641379|100583119|FG002|Overall Study|Participant treated after Week 24|0|||
33184174|NCT02641379|100583120|FG003|Overall Study|Participant treated after Week 24|0|||
33184175|NCT02641379|100583121|FG004|Overall Study|Participant treated after Week 24|0|||
33184176|NCT02641379|100583122|FG005|Overall Study|Participant treated after Week 24|0|||
33184177|NCT02641379|100583123|FG006|Overall Study|Participant treated after Week 24|0|||
33184178|NCT02641379|100583124|FG007|Overall Study|Participant treated after Week 24|0|||
33184179|NCT02641379|100583125|FG008|Overall Study|Participant treated after Week 24|1|||
33184180|NCT02641379|100583126|FG009|Overall Study|Participant treated after Week 24|0|||
33184181|NCT02641379|100583127|FG010|Overall Study|Participant treated after Week 24|0|||
33184182|NCT02641379|100583117|FG000|Overall Study|Missing PCR result at Week 8|0|||
33184183|NCT02641379|100583118|FG001|Overall Study|Missing PCR result at Week 8|0|||
33184184|NCT02641379|100583119|FG002|Overall Study|Missing PCR result at Week 8|0|||
33184185|NCT02641379|100583120|FG003|Overall Study|Missing PCR result at Week 8|0|||
33184186|NCT02641379|100583121|FG004|Overall Study|Missing PCR result at Week 8|0|||
33184187|NCT02641379|100583122|FG005|Overall Study|Missing PCR result at Week 8|0|||
33184188|NCT02641379|100583123|FG006|Overall Study|Missing PCR result at Week 8|0|||
33184189|NCT02641379|100583124|FG007|Overall Study|Missing PCR result at Week 8|0|||
33184190|NCT02641379|100583125|FG008|Overall Study|Missing PCR result at Week 8|0|||
33184191|NCT02641379|100583126|FG009|Overall Study|Missing PCR result at Week 8|1|||
33184192|NCT02641379|100583127|FG010|Overall Study|Missing PCR result at Week 8|0|||
33184193|NCT02641379|100583117|FG000|Overall Study|PCR positive|0|||
33184194|NCT02641379|100583118|FG001|Overall Study|PCR positive|0|||
33184195|NCT02641379|100583119|FG002|Overall Study|PCR positive|0|||
33184196|NCT02641379|100583120|FG003|Overall Study|PCR positive|0|||
33184197|NCT02641379|100583121|FG004|Overall Study|PCR positive|0|||
33184198|NCT02641379|100583122|FG005|Overall Study|PCR positive|0|||
33184199|NCT02641379|100583123|FG006|Overall Study|PCR positive|1|||
33184200|NCT02641379|100583124|FG007|Overall Study|PCR positive|0|||
33184201|NCT02641379|100583125|FG008|Overall Study|PCR positive|0|||
33184202|NCT02641379|100583126|FG009|Overall Study|PCR positive|0|||
33184203|NCT02641379|100583127|FG010|Overall Study|PCR positive|0|||
33184204|NCT02476968|100583139|FG000|Overall Study|Other|0|||
33184205|NCT02476968|100583140|FG001|Overall Study|Other|2|||
33184206|NCT02476968|100583141|FG002|Overall Study|Other|0|||
33184207|NCT02476968|100583139|FG000|Overall Study|Lost to Follow-up|10|||
33184208|NCT02476968|100583140|FG001|Overall Study|Lost to Follow-up|0|||
33184209|NCT02476968|100583141|FG002|Overall Study|Lost to Follow-up|1|||
33184210|NCT02476968|100583139|FG000|Overall Study|Death|48|||
33184211|NCT02476968|100583140|FG001|Overall Study|Death|8|||
33184212|NCT02476968|100583141|FG002|Overall Study|Death|1|||
33184213|NCT02476968|100583139|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33184214|NCT02476968|100583140|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33184215|NCT02476968|100583141|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
33184216|NCT02476968|100583139|FG000|Overall Study|Patient decision|37|||
33184217|NCT02476968|100583140|FG001|Overall Study|Patient decision|8|||
33184218|NCT02476968|100583141|FG002|Overall Study|Patient decision|0|||
33184219|NCT01124643|100583142|FG000|Overall Study|Death|1|||
33184220|NCT00449644|100583145|FG000|Overall Study|Adverse Event|0|||
33184221|NCT00449644|100583146|FG001|Overall Study|Adverse Event|0|||
33184222|NCT00449644|100583147|FG002|Overall Study|Adverse Event|3|||
33184223|NCT00449644|100583148|FG003|Overall Study|Adverse Event|5|||
33184224|NCT00449644|100583145|FG000|Overall Study|Death|1|||
33184225|NCT00449644|100583146|FG001|Overall Study|Death|0|||
33184226|NCT00449644|100583147|FG002|Overall Study|Death|6|||
33184227|NCT00449644|100583148|FG003|Overall Study|Death|1|||
33184228|NCT00449644|100583145|FG000|Overall Study|Lost to Follow-up|1|||
33184229|NCT00449644|100583146|FG001|Overall Study|Lost to Follow-up|1|||
33184230|NCT00449644|100583147|FG002|Overall Study|Lost to Follow-up|5|||
33184231|NCT00449644|100583148|FG003|Overall Study|Lost to Follow-up|3|||
33184232|NCT00449644|100583145|FG000|Overall Study|Pregnancy|0|||
33184233|NCT00449644|100583146|FG001|Overall Study|Pregnancy|0|||
33184234|NCT00449644|100583147|FG002|Overall Study|Pregnancy|3|||
33184235|NCT00449644|100583148|FG003|Overall Study|Pregnancy|2|||
33184236|NCT00449644|100583145|FG000|Overall Study|Protocol Violation|4|||
33184237|NCT00449644|100583146|FG001|Overall Study|Protocol Violation|4|||
33184238|NCT00449644|100583147|FG002|Overall Study|Protocol Violation|3|||
33184239|NCT00449644|100583148|FG003|Overall Study|Protocol Violation|7|||
33184240|NCT00449644|100583145|FG000|Overall Study|Withdrawal by Subject|3|||
33184241|NCT00449644|100583146|FG001|Overall Study|Withdrawal by Subject|4|||
33184242|NCT00449644|100583147|FG002|Overall Study|Withdrawal by Subject|6|||
33184243|NCT00449644|100583148|FG003|Overall Study|Withdrawal by Subject|7|||
33184244|NCT00449644|100583145|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
33184245|NCT00449644|100583146|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
33184246|NCT00449644|100583147|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
33184247|NCT00449644|100583148|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
33184248|NCT00449644|100583145|FG000|Overall Study|Other|1|||
33184249|NCT00449644|100583146|FG001|Overall Study|Other|4|||
33184250|NCT00449644|100583147|FG002|Overall Study|Other|1|||
33184251|NCT00449644|100583148|FG003|Overall Study|Other|0|||
33184252|NCT00449644|100583145|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
33184253|NCT00449644|100583146|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
33184254|NCT00449644|100583147|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
33184255|NCT00449644|100583148|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
33184256|NCT01904604|100583149|FG000|Overall Study|Withdrew before receiving dosing|0|||
33184257|NCT01904604|100583150|FG001|Overall Study|Withdrew before receiving dosing|1|||
33184258|NCT01904604|100583151|FG002|Overall Study|Withdrew before receiving dosing|0|||
33184259|NCT01904604|100583149|FG000|Overall Study|Non-compliance|1|||
33184260|NCT01904604|100583150|FG001|Overall Study|Non-compliance|0|||
33184261|NCT01904604|100583151|FG002|Overall Study|Non-compliance|0|||
33184262|NCT01904604|100583149|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
33184263|NCT01904604|100583150|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
33184264|NCT01904604|100583151|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
33184265|NCT01904604|100583149|FG000|Overall Study|Patch site reactions|1|||
33184266|NCT01904604|100583150|FG001|Overall Study|Patch site reactions|1|||
33184267|NCT01904604|100583151|FG002|Overall Study|Patch site reactions|0|||
33184268|NCT01904604|100583149|FG000|Overall Study|Increased syncope|0|||
33184269|NCT01904604|100583150|FG001|Overall Study|Increased syncope|1|||
33184270|NCT01904604|100583151|FG002|Overall Study|Increased syncope|0|||
33184271|NCT01904604|100583149|FG000|Overall Study|Unrelated illness|0|||
33184272|NCT01904604|100583150|FG001|Overall Study|Unrelated illness|1|||
33184273|NCT01904604|100583151|FG002|Overall Study|Unrelated illness|0|||
33184274|NCT01904604|100583149|FG000|Overall Study|Passed Week 52 OFC|1|||
33184275|NCT01904604|100583150|FG001|Overall Study|Passed Week 52 OFC|0|||
33184276|NCT01904604|100583151|FG002|Overall Study|Passed Week 52 OFC|0|||
33184277|NCT01904604|100583149|FG000|Overall Study|Withdrawal by Subject|1|||
33184278|NCT01904604|100583150|FG001|Overall Study|Withdrawal by Subject|2|||
33184279|NCT01904604|100583151|FG002|Overall Study|Withdrawal by Subject|0|||
33184280|NCT01904604|100583149|FG000|Overall Study|Participant Relocated|1|||
33184281|NCT01904604|100583150|FG001|Overall Study|Participant Relocated|1|||
33184282|NCT01904604|100583151|FG002|Overall Study|Participant Relocated|1|||
33184283|NCT01904604|100583149|FG000|Overall Study|Lost to Follow-up|0|||
33184284|NCT01904604|100583150|FG001|Overall Study|Lost to Follow-up|0|||
33184285|NCT01904604|100583151|FG002|Overall Study|Lost to Follow-up|1|||
33184286|NCT02276612|100586833|FG000|Overall Study|Death|1|||
33184287|NCT02276612|100586834|FG001|Overall Study|Death|0|||
33184288|NCT02276612|100586833|FG000|Overall Study|Pregnancy|1|||
33184289|NCT02276612|100586834|FG001|Overall Study|Pregnancy|0|||
33184290|NCT02276612|100586833|FG000|Overall Study|Withdrew Consent|1|||
33184291|NCT02276612|100586834|FG001|Overall Study|Withdrew Consent|0|||
33184292|NCT02276612|100586833|FG000|Overall Study|Lost to Follow-up|1|||
33184293|NCT02276612|100586834|FG001|Overall Study|Lost to Follow-up|0|||
33184294|NCT02680639|100586835|FG000|Screening Period|Screen Failure|7|||
33184295|NCT02680639|100586836|FG001|Screening Period|Screen Failure|0|||
33184296|NCT02680639|100586837|FG002|Screening Period|Screen Failure|0|||
33184297|NCT02290821|100586838|FG000|Overall Study|Withdrawal by Subject|1|||
33184298|NCT02290821|100586839|FG001|Overall Study|Withdrawal by Subject|1|||
33184299|NCT02290821|100586838|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
33184300|NCT02290821|100586839|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
33184301|NCT02290821|100586838|FG000|Overall Study|Lost to Follow-up|3|||
33184302|NCT02290821|100586839|FG001|Overall Study|Lost to Follow-up|2|||
33184303|NCT02357940|100586841|FG000|Overall Study|Adverse Event|0|||
33184304|NCT02357940|100586842|FG001|Overall Study|Adverse Event|1|||
33184305|NCT02357940|100586841|FG000|Overall Study|Investigator's judgement|0|||
33184306|NCT02357940|100586842|FG001|Overall Study|Investigator's judgement|1|||
33184307|NCT00344773|100586844|FG000|Overall Study|Adverse Event|2|||
33184308|NCT00344773|100586844|FG000|Overall Study|Objective Disease Progression|16|||
33184309|NCT00344773|100586844|FG000|Overall Study|Withdrawal by Subject|1|||
33184310|NCT00344773|100586844|FG000|Overall Study|Not Eligible for the study|2|||
33184311|NCT01649375|100586845|FG000|Up to Week 16|Adverse Event|2|||
33184312|NCT01649375|100586846|FG001|Up to Week 16|Adverse Event|5|||
33184313|NCT01649375|100586847|FG002|Up to Week 16|Adverse Event|4|||
33184314|NCT01649375|100586848|FG003|Up to Week 16|Adverse Event|0|||
33184315|NCT01649375|100586849|FG004|Up to Week 16|Adverse Event|0|||
33184316|NCT01649375|100586845|FG000|Up to Week 16|Lack of Efficacy|0|||
33184317|NCT01649375|100586846|FG001|Up to Week 16|Lack of Efficacy|0|||
33184318|NCT01649375|100586847|FG002|Up to Week 16|Lack of Efficacy|1|||
33184319|NCT01649375|100586848|FG003|Up to Week 16|Lack of Efficacy|0|||
33184320|NCT01649375|100586849|FG004|Up to Week 16|Lack of Efficacy|0|||
33184321|NCT01649375|100586845|FG000|Up to Week 16|Physician Decision|0|||
33184322|NCT01649375|100586846|FG001|Up to Week 16|Physician Decision|0|||
33184323|NCT01649375|100586847|FG002|Up to Week 16|Physician Decision|1|||
33184324|NCT01649375|100586848|FG003|Up to Week 16|Physician Decision|0|||
33184325|NCT01649375|100586849|FG004|Up to Week 16|Physician Decision|0|||
33184326|NCT01649375|100586845|FG000|Up to Week 16|Withdrawal by Subject|2|||
33184327|NCT01649375|100586846|FG001|Up to Week 16|Withdrawal by Subject|1|||
33184328|NCT01649375|100586847|FG002|Up to Week 16|Withdrawal by Subject|2|||
33184329|NCT01649375|100586848|FG003|Up to Week 16|Withdrawal by Subject|0|||
33184330|NCT01649375|100586849|FG004|Up to Week 16|Withdrawal by Subject|0|||
33184331|NCT01649375|100586845|FG000|Up to Week 16|Death|1|||
33184332|NCT01649375|100586846|FG001|Up to Week 16|Death|0|||
33184333|NCT01649375|100586847|FG002|Up to Week 16|Death|0|||
33184334|NCT01649375|100586848|FG003|Up to Week 16|Death|0|||
33184335|NCT01649375|100586849|FG004|Up to Week 16|Death|0|||
33184336|NCT01649375|100586845|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
33184337|NCT01649375|100586846|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
33184338|NCT01649375|100586847|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
33184339|NCT01649375|100586848|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
33184340|NCT01649375|100586849|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
33184341|NCT01649375|100586845|FG000|Week 16 up to Week 260|Non-compliance|0|||
33184342|NCT01649375|100586846|FG001|Week 16 up to Week 260|Non-compliance|1|||
33184343|NCT01649375|100586847|FG002|Week 16 up to Week 260|Non-compliance|0|||
33184344|NCT01649375|100586848|FG003|Week 16 up to Week 260|Non-compliance|1|||
33184345|NCT01649375|100586849|FG004|Week 16 up to Week 260|Non-compliance|0|||
33184346|NCT01649375|100586845|FG000|Week 16 up to Week 260|Physician Decision|0|||
33184347|NCT01649375|100586846|FG001|Week 16 up to Week 260|Physician Decision|2|||
33184348|NCT01649375|100586847|FG002|Week 16 up to Week 260|Physician Decision|0|||
33184349|NCT01649375|100586848|FG003|Week 16 up to Week 260|Physician Decision|0|||
33184350|NCT01649375|100586849|FG004|Week 16 up to Week 260|Physician Decision|0|||
33184351|NCT01649375|100586845|FG000|Week 16 up to Week 260|Technical issues|0|||
33184352|NCT01649375|100586846|FG001|Week 16 up to Week 260|Technical issues|1|||
33184353|NCT01649375|100586847|FG002|Week 16 up to Week 260|Technical issues|0|||
33184354|NCT01649375|100586848|FG003|Week 16 up to Week 260|Technical issues|1|||
33184355|NCT01649375|100586849|FG004|Week 16 up to Week 260|Technical issues|0|||
33184356|NCT01649375|100586845|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
33184357|NCT01649375|100586846|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
33184358|NCT01649375|100586847|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
33184359|NCT01649375|100586848|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
33184360|NCT01649375|100586849|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
33184361|NCT01649375|100586845|FG000|Week 16 up to Week 260|Death|1|||
33184362|NCT01649375|100586846|FG001|Week 16 up to Week 260|Death|1|||
33184363|NCT01649375|100586847|FG002|Week 16 up to Week 260|Death|0|||
33184364|NCT01649375|100586848|FG003|Week 16 up to Week 260|Death|0|||
33184365|NCT01649375|100586849|FG004|Week 16 up to Week 260|Death|0|||
33184366|NCT01649375|100586845|FG000|Week 16 up to Week 260|Adverse Event|5|||
33184367|NCT01649375|100586846|FG001|Week 16 up to Week 260|Adverse Event|2|||
33184368|NCT01649375|100586847|FG002|Week 16 up to Week 260|Adverse Event|0|||
33184369|NCT01649375|100586848|FG003|Week 16 up to Week 260|Adverse Event|3|||
33184370|NCT01649375|100586849|FG004|Week 16 up to Week 260|Adverse Event|2|||
33184371|NCT01462357|100586850|FG000|Overall Study|Death|0|||
33184372|NCT01462357|100586851|FG001|Overall Study|Death|0|||
33184373|NCT01462357|100586852|FG002|Overall Study|Death|1|||
33184374|NCT01462357|100586850|FG000|Overall Study|Withdrawal by Subject|3|||
33184375|NCT01462357|100586851|FG001|Overall Study|Withdrawal by Subject|11|||
33184376|NCT01462357|100586852|FG002|Overall Study|Withdrawal by Subject|3|||
33184377|NCT01462357|100586850|FG000|Overall Study|Migrated/moved from study area|2|||
33184378|NCT01462357|100586851|FG001|Overall Study|Migrated/moved from study area|3|||
33184379|NCT01462357|100586852|FG002|Overall Study|Migrated/moved from study area|1|||
33184380|NCT01462357|100586850|FG000|Overall Study|Lost to Follow-up|3|||
33184381|NCT01462357|100586851|FG001|Overall Study|Lost to Follow-up|5|||
33184382|NCT01462357|100586852|FG002|Overall Study|Lost to Follow-up|7|||
33184383|NCT00048542|100586853|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
33184384|NCT00048542|100586854|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
33184385|NCT00048542|100586855|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
33184386|NCT00048542|100586856|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
33184387|NCT00048542|100586857|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
33184388|NCT00048542|100586858|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
33184389|NCT00048542|100586859|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
33184390|NCT00048542|100586860|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
33184391|NCT00048542|100586853|FG000|Double-Blind Phase|Protocol Violation|0|||
33184392|NCT00048542|100586854|FG001|Double-Blind Phase|Protocol Violation|0|||
33184393|NCT00048542|100586855|FG002|Double-Blind Phase|Protocol Violation|1|||
33184394|NCT00048542|100586856|FG003|Double-Blind Phase|Protocol Violation|0|||
33184395|NCT00048542|100586857|FG004|Double-Blind Phase|Protocol Violation|0|||
33184396|NCT00048542|100586858|FG005|Double-Blind Phase|Protocol Violation|0|||
33184397|NCT00048542|100586859|FG006|Double-Blind Phase|Protocol Violation|0|||
33184398|NCT00048542|100586860|FG007|Double-Blind Phase|Protocol Violation|0|||
33184399|NCT00048542|100586853|FG000|Double-Blind Phase|Sponsor request or decision|2|||
33184400|NCT00048542|100586854|FG001|Double-Blind Phase|Sponsor request or decision|0|||
33184401|NCT00048542|100586855|FG002|Double-Blind Phase|Sponsor request or decision|0|||
33184402|NCT00048542|100586856|FG003|Double-Blind Phase|Sponsor request or decision|0|||
33184403|NCT00048542|100586857|FG004|Double-Blind Phase|Sponsor request or decision|0|||
33184404|NCT00048542|100586858|FG005|Double-Blind Phase|Sponsor request or decision|0|||
33184405|NCT00048542|100586859|FG006|Double-Blind Phase|Sponsor request or decision|0|||
33184406|NCT00048542|100586860|FG007|Double-Blind Phase|Sponsor request or decision|0|||
33184407|NCT00048542|100586853|FG000|Double-Blind Phase|Randomized in error|1|||
33184408|NCT00048542|100586854|FG001|Double-Blind Phase|Randomized in error|0|||
33184409|NCT00048542|100586855|FG002|Double-Blind Phase|Randomized in error|0|||
33184410|NCT00048542|100586856|FG003|Double-Blind Phase|Randomized in error|0|||
33184411|NCT00048542|100586857|FG004|Double-Blind Phase|Randomized in error|0|||
33184412|NCT00048542|100586858|FG005|Double-Blind Phase|Randomized in error|0|||
33184413|NCT00048542|100586859|FG006|Double-Blind Phase|Randomized in error|0|||
33184414|NCT00048542|100586860|FG007|Double-Blind Phase|Randomized in error|0|||
33184415|NCT00048542|100586853|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
33184416|NCT00048542|100586854|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
33184417|NCT00048542|100586855|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
33184418|NCT00048542|100586856|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
33184419|NCT00048542|100586857|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
33184420|NCT00048542|100586858|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
33184421|NCT00048542|100586859|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
33184422|NCT00048542|100586860|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
33184423|NCT00048542|100586853|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
33184424|NCT00048542|100586854|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
33184425|NCT00048542|100586855|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
33184426|NCT00048542|100586856|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
33184427|NCT00048542|100586857|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
33184428|NCT00048542|100586858|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
33184429|NCT00048542|100586859|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
33184430|NCT00048542|100586860|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
33184431|NCT00048542|100586853|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
33184432|NCT00048542|100586854|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
33184433|NCT00048542|100586855|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
33184434|NCT00048542|100586856|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
33184435|NCT00048542|100586857|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
33184436|NCT00048542|100586858|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
33184437|NCT00048542|100586859|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
33184438|NCT00048542|100586860|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
33184439|NCT00048542|100586853|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
33184440|NCT00048542|100586854|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
33184441|NCT00048542|100586855|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
33184442|NCT00048542|100586856|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
33184443|NCT00048542|100586857|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
33184444|NCT00048542|100586858|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
33184445|NCT00048542|100586859|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
33184446|NCT00048542|100586860|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
33184447|NCT00048542|100586853|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
33184448|NCT00048542|100586854|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
33184449|NCT00048542|100586855|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
33184450|NCT00048542|100586856|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
33184451|NCT00048542|100586857|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
33184452|NCT00048542|100586858|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
33184453|NCT00048542|100586859|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
33184454|NCT00048542|100586860|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
33184455|NCT00048542|100586853|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
33184456|NCT00048542|100586854|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
33184457|NCT00048542|100586855|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
33184458|NCT00048542|100586856|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
33184459|NCT00048542|100586857|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
33184460|NCT00048542|100586858|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
33184461|NCT00048542|100586859|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
33184462|NCT00048542|100586860|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
33184463|NCT00048542|100586853|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
33184464|NCT00048542|100586854|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
33184465|NCT00048542|100586855|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
33184466|NCT00048542|100586856|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
33184467|NCT00048542|100586857|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
33184468|NCT00048542|100586858|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
33184469|NCT00048542|100586859|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
33184470|NCT00048542|100586860|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
33184471|NCT00048542|100586853|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
33184472|NCT00048542|100586854|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
33184473|NCT00048542|100586855|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
33184474|NCT00048542|100586856|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
33184475|NCT00048542|100586857|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
33184476|NCT00048542|100586858|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
33184477|NCT00048542|100586859|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
33184478|NCT00048542|100586860|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
33184479|NCT00048542|100586853|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
33184480|NCT00048542|100586854|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
33184481|NCT00048542|100586855|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
33184482|NCT00048542|100586856|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
33184483|NCT00048542|100586857|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
33184484|NCT00048542|100586858|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
33184485|NCT00048542|100586859|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
33184486|NCT00048542|100586860|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
33184487|NCT00048542|100586853|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
33184488|NCT00048542|100586854|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
33184489|NCT00048542|100586855|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
33184490|NCT00048542|100586856|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
33184491|NCT00048542|100586857|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
33184492|NCT00048542|100586858|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
33184493|NCT00048542|100586859|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
33184494|NCT00048542|100586860|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
33184495|NCT00048542|100586853|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
33184496|NCT00048542|100586854|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
33184497|NCT00048542|100586855|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
33184498|NCT00048542|100586856|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
33184499|NCT00048542|100586857|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
33184500|NCT00048542|100586858|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
33184501|NCT00048542|100586859|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
33184502|NCT00048542|100586860|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
33184503|NCT01527292|100586861|FG000|Overall Study|Physician Decision|0|||
33184504|NCT01527292|100586862|FG001|Overall Study|Physician Decision|3|||
33184505|NCT03873987|100586863|FG000|Overall Study|Adverse Event|1|||
33184506|NCT03873987|100586864|FG001|Overall Study|Adverse Event|0|||
33184507|NCT03873987|100586863|FG000|Overall Study|staff was unable to start a new IV line|1|||
33184508|NCT03873987|100586864|FG001|Overall Study|staff was unable to start a new IV line|0|||
33184509|NCT03873987|100586863|FG000|Overall Study|Lost to Follow-up|0|||
33184510|NCT03873987|100586864|FG001|Overall Study|Lost to Follow-up|1|||
33184511|NCT01398956|100586865|FG000|Overall Study|Withdrawal by Subject|4|||
33184512|NCT01398956|100586865|FG000|Overall Study|AE, non-serious non-fatal|4|||
33184513|NCT01398956|100586865|FG000|Overall Study|Withdrawal Criteria No.3|1|||
33184514|NCT01398956|100586865|FG000|Overall Study|Subject moved a long distance|1|||
33184515|NCT03662542|100586867|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
33184516|NCT03662542|100586868|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
33184517|NCT03662542|100586869|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
33184518|NCT03662542|100586870|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
33184519|NCT03662542|100586871|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
33184520|NCT03662542|100586872|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
33184521|NCT03662542|100586873|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
33184522|NCT03662542|100586874|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
33184523|NCT03662542|100586875|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
33184524|NCT03662542|100586867|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
33184525|NCT03662542|100586868|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
33184526|NCT03662542|100586869|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
33184527|NCT03662542|100586870|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
33184528|NCT03662542|100586871|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
33184529|NCT03662542|100586872|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
33184530|NCT03662542|100586873|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
33184531|NCT03662542|100586874|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
33184532|NCT03662542|100586875|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
33184533|NCT03662542|100586867|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
33184534|NCT03662542|100586868|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
33184535|NCT03662542|100586869|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
33184536|NCT03662542|100586870|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
33184537|NCT03662542|100586871|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
33184538|NCT03662542|100586872|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
33184539|NCT03662542|100586873|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
33184540|NCT03662542|100586874|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
33184541|NCT03662542|100586875|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
33184542|NCT03662542|100586867|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
33184543|NCT03662542|100586868|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
33184544|NCT03662542|100586869|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
33184545|NCT03662542|100586870|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
33184546|NCT03662542|100586871|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
33184547|NCT03662542|100586872|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
33184548|NCT03662542|100586873|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
33184549|NCT03662542|100586874|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
33184550|NCT03662542|100586875|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
33184551|NCT03662542|100586867|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
33184552|NCT03662542|100586868|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
33184553|NCT03662542|100586869|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
33184554|NCT03662542|100586870|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
33184555|NCT03662542|100586871|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
33184556|NCT03662542|100586872|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
33184557|NCT03662542|100586873|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
33184558|NCT03662542|100586874|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
33184559|NCT03662542|100586875|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
33184560|NCT03662542|100586867|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
33184561|NCT03662542|100586868|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
33184562|NCT03662542|100586869|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
33184563|NCT03662542|100586870|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
33184564|NCT03662542|100586871|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
33184565|NCT03662542|100586872|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
33184566|NCT03662542|100586873|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
33184567|NCT03662542|100586874|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
33184568|NCT03662542|100586875|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
33184569|NCT03662542|100586867|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
33184570|NCT03662542|100586868|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
33184571|NCT03662542|100586869|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
33184572|NCT03662542|100586870|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
33184573|NCT03662542|100586871|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
33184574|NCT03662542|100586872|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
33184575|NCT03662542|100586873|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
33184576|NCT03662542|100586874|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
33184577|NCT03662542|100586875|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
33184578|NCT03662542|100586867|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
33184579|NCT03662542|100586868|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
33184580|NCT03662542|100586869|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
33184581|NCT03662542|100586870|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
33184582|NCT03662542|100586871|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
33184583|NCT03662542|100586872|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
33184584|NCT03662542|100586873|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
33184585|NCT03662542|100586874|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
33184586|NCT03662542|100586875|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
33184587|NCT03662542|100586867|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
33184588|NCT03662542|100586868|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
33184589|NCT03662542|100586869|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
33184590|NCT03662542|100586870|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
33184591|NCT03662542|100586871|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
33184592|NCT03662542|100586872|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
33184593|NCT03662542|100586873|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
33594555|NCT01133405|102065015|FG004|Period 1|Withdrawal by Subject|0|||
33184594|NCT03662542|100586874|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
33184595|NCT03662542|100586875|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
33184596|NCT03662542|100586867|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
33184597|NCT03662542|100586868|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
33184598|NCT03662542|100586869|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
33184599|NCT03662542|100586870|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
33184600|NCT03662542|100586871|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
33184601|NCT03662542|100586872|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
33184602|NCT03662542|100586873|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
33184603|NCT03662542|100586874|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
33184604|NCT03662542|100586875|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
33184605|NCT03662542|100586867|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
33184606|NCT03662542|100586868|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
33184607|NCT03662542|100586869|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
33184608|NCT03662542|100586870|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
33184609|NCT03662542|100586871|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
33184610|NCT03662542|100586872|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
33184611|NCT03662542|100586873|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
33184612|NCT03662542|100586874|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
33184613|NCT03662542|100586875|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
33184614|NCT03662542|100586867|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
33184615|NCT03662542|100586868|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
33184616|NCT03662542|100586869|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
33184617|NCT03662542|100586870|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
33184618|NCT03662542|100586871|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
33184619|NCT03662542|100586872|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
33184620|NCT03662542|100586873|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
33184621|NCT03662542|100586874|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
33184622|NCT03662542|100586875|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
33184623|NCT03662542|100586867|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
33184624|NCT03662542|100586868|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
33184625|NCT03662542|100586869|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
33184626|NCT03662542|100586870|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
33184627|NCT03662542|100586871|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
33184628|NCT03662542|100586872|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
33184629|NCT03662542|100586873|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
33184630|NCT03662542|100586874|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
33184631|NCT03662542|100586875|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
33184632|NCT00235872|100586876|FG000|Overall Study|Adverse Event|34|||
33184633|NCT00235872|100586876|FG000|Overall Study|Death|1|||
33184634|NCT00235872|100586876|FG000|Overall Study|Lost to Follow-up|1|||
33184635|NCT00235872|100586876|FG000|Overall Study|Withdrawal by Subject|50|||
33184636|NCT00235872|100586876|FG000|Overall Study|Administrative reason|61|||
33184637|NCT03238911|100586878|FG000|Overall Study|Withdrawal by Subject|1|||
33184638|NCT03238911|100586879|FG001|Overall Study|Withdrawal by Subject|2|||
33184639|NCT03238911|100586878|FG000|Overall Study|Lost to Follow-up|2|||
33184640|NCT03238911|100586879|FG001|Overall Study|Lost to Follow-up|1|||
33184641|NCT00244712|100586891|FG000|Overall Study|Adverse Event|20|||
33184642|NCT00244712|100586892|FG001|Overall Study|Adverse Event|21|||
33184643|NCT00244712|100586891|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
33184644|NCT00244712|100586892|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
33184645|NCT00244712|100586891|FG000|Overall Study|Lack of Compliance|10|||
33184646|NCT00244712|100586892|FG001|Overall Study|Lack of Compliance|11|||
33184647|NCT00244712|100586891|FG000|Overall Study|Lost to Follow-up|45|||
33184648|NCT00244712|100586892|FG001|Overall Study|Lost to Follow-up|52|||
33184649|NCT00244712|100586891|FG000|Overall Study|Withdrawal by Subject|13|||
33184650|NCT00244712|100586892|FG001|Overall Study|Withdrawal by Subject|23|||
33184651|NCT00244712|100586891|FG000|Overall Study|Protocol Violation, disease progression|13|||
33184652|NCT00244712|100586892|FG001|Overall Study|Protocol Violation, disease progression|11|||
33184653|NCT01856790|100586893|FG000|Closed Loop Control|Withdrawal by Subject|2|||
33184654|NCT01856790|100586893|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
33184655|NCT00449956|100586894|FG000|Overall Study|Adverse Event|7|||
33184656|NCT00449956|100586895|FG001|Overall Study|Adverse Event|1|||
33184657|NCT00449956|100586896|FG002|Overall Study|Adverse Event|6|||
33184658|NCT00449956|100586894|FG000|Overall Study|Lack of Efficacy|0|||
33184659|NCT00449956|100586895|FG001|Overall Study|Lack of Efficacy|0|||
33184660|NCT00449956|100586896|FG002|Overall Study|Lack of Efficacy|1|||
33184661|NCT00449956|100586894|FG000|Overall Study|Protocol Violation|1|||
33184662|NCT00449956|100586895|FG001|Overall Study|Protocol Violation|1|||
33184663|NCT00449956|100586896|FG002|Overall Study|Protocol Violation|1|||
33184664|NCT00449956|100586894|FG000|Overall Study|Withdrawal by Subject|0|||
33184665|NCT00449956|100586895|FG001|Overall Study|Withdrawal by Subject|1|||
33184666|NCT00449956|100586896|FG002|Overall Study|Withdrawal by Subject|0|||
33184667|NCT00449956|100586894|FG000|Overall Study|Physician Decision|2|||
33184668|NCT00449956|100586895|FG001|Overall Study|Physician Decision|1|||
33184669|NCT00449956|100586896|FG002|Overall Study|Physician Decision|1|||
33184670|NCT04649164|100586897|FG000|Overall Study|Withdrawal by Subject|1|||
33184671|NCT04649164|100586898|FG001|Overall Study|Withdrawal by Subject|1|||
33184672|NCT04649164|100586899|FG002|Overall Study|Withdrawal by Subject|2|||
33184673|NCT04649164|100586897|FG000|Overall Study|Participant's care recipient expired|0|||
33184674|NCT04649164|100586898|FG001|Overall Study|Participant's care recipient expired|0|||
33184675|NCT04649164|100586899|FG002|Overall Study|Participant's care recipient expired|2|||
33184676|NCT02622828|100586900|FG000|Overall Study|participant withdrew|3|||
33184677|NCT05620576|100586901|FG000|Overall Study|Adverse Event|1|||
33184678|NCT05620576|100586902|FG001|Overall Study|Adverse Event|1|||
33184679|NCT05620576|100586901|FG000|Overall Study|Lost to Follow-up|3|||
33184680|NCT05620576|100586902|FG001|Overall Study|Lost to Follow-up|1|||
33184681|NCT05620576|100586901|FG000|Overall Study|Physician Decision|0|||
33184682|NCT05620576|100586902|FG001|Overall Study|Physician Decision|1|||
33184683|NCT05620576|100586901|FG000|Overall Study|Protocol Deviation|1|||
33184684|NCT05620576|100586902|FG001|Overall Study|Protocol Deviation|1|||
33184685|NCT05620576|100586901|FG000|Overall Study|Withdrawal by Subject|2|||
33184686|NCT05620576|100586902|FG001|Overall Study|Withdrawal by Subject|3|||
33184687|NCT00914810|100586903|FG000|Overall Study|Withdrawal by Subject|1|||
33184688|NCT00914810|100586904|FG001|Overall Study|Withdrawal by Subject|0|||
33184689|NCT00914810|100586903|FG000|Overall Study|Relocated out of state|1|||
33184690|NCT00914810|100586904|FG001|Overall Study|Relocated out of state|0|||
33184691|NCT00914810|100586903|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
33184692|NCT00914810|100586904|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
33184693|NCT03034954|100586907|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
33184694|NCT03034954|100586908|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
33184695|NCT03373383|100586909|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
33184696|NCT03373383|100586910|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
33184697|NCT03373383|100586911|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
33184698|NCT03373383|100586912|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
33184699|NCT03373383|100586913|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
33184700|NCT03373383|100586909|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
33184701|NCT03373383|100586910|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
33184702|NCT03373383|100586911|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
33184703|NCT03373383|100586912|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
33184704|NCT03373383|100586913|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
33184705|NCT03373383|100586909|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
33184706|NCT03373383|100586910|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
33184707|NCT03373383|100586911|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
33184708|NCT03373383|100586912|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
33184709|NCT03373383|100586913|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
33184710|NCT03373383|100586909|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
33184711|NCT03373383|100586910|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
33184712|NCT03373383|100586911|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
33184713|NCT03373383|100586912|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
33184714|NCT03373383|100586913|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
33184715|NCT03373383|100586909|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
33184716|NCT03373383|100586910|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
33184717|NCT03373383|100586911|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
33184718|NCT03373383|100586912|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
33184719|NCT03373383|100586913|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
33184720|NCT03373383|100586909|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
33184721|NCT03373383|100586910|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
33184722|NCT03373383|100586911|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
33184723|NCT03373383|100586912|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
33184724|NCT03373383|100586913|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
33184725|NCT03373383|100586909|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
33184726|NCT03373383|100586910|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
33184727|NCT03373383|100586911|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
33184728|NCT03373383|100586912|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
33184729|NCT03373383|100586913|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
33184730|NCT03373383|100586909|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
33184731|NCT03373383|100586910|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
33184732|NCT03373383|100586911|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
33184733|NCT03373383|100586912|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
33184734|NCT03373383|100586913|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
33184735|NCT03373383|100586909|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
33184736|NCT03373383|100586910|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
33184737|NCT03373383|100586911|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
33287023|NCT00505414|100947771|FG001|Maintenance Phase|Withdrawal by Subject|0|||
33184738|NCT03373383|100586912|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
33184739|NCT03373383|100586913|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
33184740|NCT02357147|100586917|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
33184741|NCT02357147|100586918|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
33184742|NCT02357147|100586917|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
33184743|NCT02357147|100586918|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
33184744|NCT02357147|100586917|FG000|Combination Treatment Phase|Investigator Discretion|1|||
33184745|NCT02357147|100586918|FG001|Combination Treatment Phase|Investigator Discretion|1|||
33184746|NCT02357147|100586917|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
33184747|NCT02357147|100586918|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
33184748|NCT02357147|100586917|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
33184749|NCT02357147|100586918|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
33184750|NCT02357147|100586917|FG000|Combination Treatment Phase|Adverse Event|12|||
33184751|NCT02357147|100586918|FG001|Combination Treatment Phase|Adverse Event|4|||
33184752|NCT02357147|100586917|FG000|Combination Treatment Phase|Death|1|||
33184753|NCT02357147|100586918|FG001|Combination Treatment Phase|Death|1|||
33184754|NCT02357147|100586917|FG000|Combination Treatment Phase|Sponsor Decision|0|||
33184755|NCT02357147|100586918|FG001|Combination Treatment Phase|Sponsor Decision|12|||
33184756|NCT02357147|100586917|FG000|Combination Treatment Phase|Other|1|||
33184757|NCT02357147|100586918|FG001|Combination Treatment Phase|Other|0|||
33184758|NCT02357147|100586917|FG000|Combination Treatment Phase|Not treated|0|||
33184759|NCT02357147|100586918|FG001|Combination Treatment Phase|Not treated|2|||
33184760|NCT02357147|100586917|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
33184761|NCT02357147|100586918|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
33184762|NCT02357147|100586917|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33184763|NCT02357147|100586918|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
33184764|NCT02357147|100586917|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
33184765|NCT02357147|100586918|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
33184766|NCT02357147|100586917|FG000|Maintenance Treatment Phase|Adverse Event|0|||
33184767|NCT02357147|100586918|FG001|Maintenance Treatment Phase|Adverse Event|3|||
33184768|NCT02357147|100586917|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
33184769|NCT02357147|100586918|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
33184770|NCT02357147|100586917|FG000|Maintenance Treatment Phase|Not Treated|1|||
33184771|NCT02357147|100586918|FG001|Maintenance Treatment Phase|Not Treated|0|||
33184772|NCT02558790|100586919|FG000|Overall Study|Lost to Follow-up|2|||
33184773|NCT02558790|100586919|FG000|Overall Study|Physician Decision|1|||
33184774|NCT02558790|100586919|FG000|Overall Study|Withdrawal by Subject|1|||
33184775|NCT02558790|100586919|FG000|Overall Study|Screen Fail|3|||
33184776|NCT02552316|100586920|FG000|Overall Study|Withdrawal by Subject|1|||
33184777|NCT02552316|100586920|FG000|Overall Study|Withdrawal due to non-compliance|1|||
33184778|NCT04372602|100586921|FG000|Overall Study|Withdrawal by Subject|1|||
33184779|NCT04372602|100586922|FG001|Overall Study|Withdrawal by Subject|1|||
33184780|NCT04372602|100586921|FG000|Overall Study|Adverse Event|0|||
33184781|NCT04372602|100586922|FG001|Overall Study|Adverse Event|1|||
33184782|NCT04372602|100586921|FG000|Overall Study|Transitioned to comfort care|0|||
33184783|NCT04372602|100586922|FG001|Overall Study|Transitioned to comfort care|1|||
33184784|NCT02286193|100586929|FG000|Overall Study|Referred: CRS unable to make contact|62|||
33184785|NCT02286193|100586929|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
33184786|NCT02286193|100586929|FG000|Overall Study|Referred: Declined service|38|||
33184787|NCT02596854|100586931|FG000|Overall Study|Withdrawn|8|||
33184788|NCT00066066|100586934|FG000|Overall Study|Lost to Follow-up|6|||
33184789|NCT00066066|100586935|FG001|Overall Study|Lost to Follow-up|4|||
33184790|NCT00066066|100586936|FG002|Overall Study|Lost to Follow-up|7|||
33184791|NCT00066066|100586937|FG003|Overall Study|Lost to Follow-up|4|||
33184792|NCT00066066|100586938|FG004|Overall Study|Lost to Follow-up|3|||
33184793|NCT00066066|100586939|FG005|Overall Study|Lost to Follow-up|5|||
33184794|NCT04656132|100586940|FG000|Overall Study|Lost to Follow-up|4|||
33184795|NCT04656132|100586940|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
33184796|NCT01446965|100586941|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
33184797|NCT01446965|100586942|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
33184798|NCT01446965|100586941|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
33184799|NCT01446965|100586942|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
33184800|NCT03161483|100586943|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
33184801|NCT03161483|100586944|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
33184802|NCT03161483|100586945|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
33184803|NCT03161483|100586946|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
33184804|NCT03161483|100586943|FG000|Treatment Period|Death|1|||
33184805|NCT03161483|100586944|FG001|Treatment Period|Death|0|||
33184806|NCT03161483|100586945|FG002|Treatment Period|Death|0|||
33184807|NCT03161483|100586946|FG003|Treatment Period|Death|0|||
33184808|NCT03161483|100586943|FG000|Treatment Period|Adverse Event|5|||
33184809|NCT03161483|100586944|FG001|Treatment Period|Adverse Event|2|||
33184810|NCT03161483|100586945|FG002|Treatment Period|Adverse Event|1|||
33184811|NCT03161483|100586946|FG003|Treatment Period|Adverse Event|11|||
33184812|NCT03161483|100586943|FG000|Treatment Period|Pregnancy|1|||
33184813|NCT03161483|100586944|FG001|Treatment Period|Pregnancy|0|||
33184814|NCT03161483|100586945|FG002|Treatment Period|Pregnancy|0|||
33184815|NCT03161483|100586946|FG003|Treatment Period|Pregnancy|0|||
33184816|NCT03161483|100586943|FG000|Treatment Period|Lack of Efficacy|0|||
33184817|NCT03161483|100586944|FG001|Treatment Period|Lack of Efficacy|0|||
33184818|NCT03161483|100586945|FG002|Treatment Period|Lack of Efficacy|0|||
33184819|NCT03161483|100586946|FG003|Treatment Period|Lack of Efficacy|1|||
33184820|NCT03161483|100586943|FG000|Treatment Period|Withdrawal by Subject|2|||
33184821|NCT03161483|100586944|FG001|Treatment Period|Withdrawal by Subject|5|||
33184822|NCT03161483|100586945|FG002|Treatment Period|Withdrawal by Subject|2|||
33184823|NCT03161483|100586946|FG003|Treatment Period|Withdrawal by Subject|6|||
33184824|NCT03161483|100586943|FG000|Treatment Period|Lost to Follow-up|0|||
33184825|NCT03161483|100586944|FG001|Treatment Period|Lost to Follow-up|0|||
33184826|NCT03161483|100586945|FG002|Treatment Period|Lost to Follow-up|0|||
33184827|NCT03161483|100586946|FG003|Treatment Period|Lost to Follow-up|1|||
33184828|NCT03161483|100586943|FG000|Treatment Period|Protocol Violation|0|||
33184829|NCT03161483|100586944|FG001|Treatment Period|Protocol Violation|0|||
33184830|NCT03161483|100586945|FG002|Treatment Period|Protocol Violation|0|||
33184831|NCT03161483|100586946|FG003|Treatment Period|Protocol Violation|1|||
33184832|NCT03161483|100586943|FG000|Treatment Period|Other reasons|1|||
33184833|NCT03161483|100586944|FG001|Treatment Period|Other reasons|1|||
33184834|NCT03161483|100586945|FG002|Treatment Period|Other reasons|0|||
33184835|NCT03161483|100586946|FG003|Treatment Period|Other reasons|0|||
33184836|NCT01982253|100586947|FG000|Overall Study|Withdrawal by Subject|1|||
33184837|NCT01982253|100586948|FG001|Overall Study|Withdrawal by Subject|0|||
33184838|NCT01982253|100586949|FG002|Overall Study|Withdrawal by Subject|0|||
33184839|NCT01982253|100586947|FG000|Overall Study|Study terminated by sponsor|1|||
33184840|NCT01982253|100586948|FG001|Overall Study|Study terminated by sponsor|4|||
33184841|NCT01982253|100586949|FG002|Overall Study|Study terminated by sponsor|4|||
33184842|NCT02678676|100586950|FG000|Overall Study|Death|619|||
33184843|NCT02678676|100586951|FG001|Overall Study|Death|649|||
33184844|NCT02678676|100586950|FG000|Overall Study|Withdrawal by Subject|13|||
33184845|NCT02678676|100586951|FG001|Overall Study|Withdrawal by Subject|5|||
33184846|NCT02678676|100586950|FG000|Overall Study|Lost to Follow-up|171|||
33184847|NCT02678676|100586951|FG001|Overall Study|Lost to Follow-up|151|||
33184848|NCT02678676|100586950|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
33184849|NCT02678676|100586951|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
33184850|NCT02865915|100586952|FG000|Overall Study|Pregnancy|1|||
33184851|NCT02865915|100586953|FG001|Overall Study|Pregnancy|0|||
33184852|NCT02865915|100586952|FG000|Overall Study|Withdrawal by Subject|1|||
33184853|NCT02865915|100586953|FG001|Overall Study|Withdrawal by Subject|1|||
33184854|NCT02865915|100586952|FG000|Overall Study|Adverse Event|0|||
33184855|NCT02865915|100586953|FG001|Overall Study|Adverse Event|4|||
33184856|NCT02865915|100586952|FG000|Overall Study|Lost to Follow-up|0|||
33184857|NCT02865915|100586953|FG001|Overall Study|Lost to Follow-up|1|||
33184858|NCT02865915|100586952|FG000|Overall Study|Protocol Violation|0|||
33184859|NCT02865915|100586953|FG001|Overall Study|Protocol Violation|1|||
33184860|NCT02865915|100586952|FG000|Overall Study|Study terminated by sponsor|23|||
33184861|NCT02865915|100586953|FG001|Overall Study|Study terminated by sponsor|18|||
33184862|NCT02865915|100586952|FG000|Overall Study|Dosing group discontinued|0|||
33184863|NCT02865915|100586953|FG001|Overall Study|Dosing group discontinued|5|||
33184864|NCT00902564|100586954|FG000|Overall Study|Withdrawal by Subject|2|||
33184865|NCT01928862|100586958|FG000|Overall Study|Lost to Follow-up|1|||
33184866|NCT01928862|100586959|FG001|Overall Study|Lost to Follow-up|0|||
33184867|NCT01928862|100586960|FG002|Overall Study|Lost to Follow-up|0|||
33184868|NCT01928862|100586961|FG003|Overall Study|Lost to Follow-up|0|||
33184869|NCT01928862|100586962|FG004|Overall Study|Lost to Follow-up|1|||
33184870|NCT02734810|100586963|FG000|Overall Study|Adverse Event|1|||
33184871|NCT02734810|100586964|FG001|Overall Study|Adverse Event|0|||
33184872|NCT02734810|100586963|FG000|Overall Study|Lack of Efficacy|1|||
33184873|NCT02734810|100586964|FG001|Overall Study|Lack of Efficacy|0|||
33184874|NCT00004888|100586967|FG000|Overall Study|Adverse Event|5|||
33184875|NCT00004888|100586968|FG001|Overall Study|Adverse Event|10|||
33184876|NCT00004888|100586967|FG000|Overall Study|Withdrawal by Subject|0|||
33184877|NCT00004888|100586968|FG001|Overall Study|Withdrawal by Subject|3|||
33184878|NCT00004888|100586967|FG000|Overall Study|Physician Decision|1|||
33184879|NCT00004888|100586968|FG001|Overall Study|Physician Decision|1|||
33184880|NCT00004888|100586967|FG000|Overall Study|Progressive Disease|4|||
33184881|NCT00004888|100586968|FG001|Overall Study|Progressive Disease|9|||
33184882|NCT00004888|100586967|FG000|Overall Study|Death without progressive disease|0|||
33184883|NCT00004888|100586968|FG001|Overall Study|Death without progressive disease|1|||
33184884|NCT00004888|100586967|FG000|Overall Study|Toxic death|1|||
33184885|NCT00004888|100586968|FG001|Overall Study|Toxic death|0|||
33184886|NCT02871739|100586969|FG000|Overall Study|Lost to Follow-up|3|||
33184887|NCT02871739|100586970|FG001|Overall Study|Lost to Follow-up|2|||
33184888|NCT02871739|100586971|FG002|Overall Study|Lost to Follow-up|0|||
33184889|NCT02871739|100586972|FG003|Overall Study|Lost to Follow-up|2|||
33184890|NCT01498640|100586977|FG000|Overall Study|Lost to Follow-up|1|||
33184891|NCT01498640|100586977|FG000|Overall Study|Death|1|||
33184892|NCT01498640|100586977|FG000|Overall Study|Other|3|||
33184893|NCT02515942|100586978|FG000|Overall Study|Adverse Event|5|||
33184894|NCT02515942|100586979|FG001|Overall Study|Adverse Event|0|||
33184895|NCT02515942|100586980|FG002|Overall Study|Adverse Event|0|||
33184896|NCT02515942|100586978|FG000|Overall Study|Death|0|||
33184897|NCT02515942|100586979|FG001|Overall Study|Death|0|||
33184898|NCT02515942|100586980|FG002|Overall Study|Death|1|||
33184899|NCT02515942|100586978|FG000|Overall Study|Lack of Efficacy|0|||
33184900|NCT02515942|100586979|FG001|Overall Study|Lack of Efficacy|0|||
33184901|NCT02515942|100586980|FG002|Overall Study|Lack of Efficacy|1|||
33184902|NCT02515942|100586978|FG000|Overall Study|Lost to Follow-up|2|||
33184903|NCT02515942|100586979|FG001|Overall Study|Lost to Follow-up|0|||
33184904|NCT02515942|100586980|FG002|Overall Study|Lost to Follow-up|0|||
33184905|NCT02515942|100586978|FG000|Overall Study|Withdrawal by Subject|0|||
33184906|NCT02515942|100586979|FG001|Overall Study|Withdrawal by Subject|3|||
33184907|NCT02515942|100586980|FG002|Overall Study|Withdrawal by Subject|2|||
33184908|NCT01334866|100586993|FG000|Overall Study|Withdrawal by Subject|10|||
33184909|NCT01334866|100586993|FG000|Overall Study|Lost to Follow-up|3|||
33184910|NCT01334866|100586993|FG000|Overall Study|Physician Decision|3|||
33184911|NCT01334866|100586993|FG000|Overall Study|medically necessary prior to procedure|2|||
33184912|NCT01334866|100586993|FG000|Overall Study|medically necessary post-procedure|1|||
33184913|NCT03239470|100586994|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
33184914|NCT03239470|100586995|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
33184915|NCT00581776|100586997|FG000|Overall Study|Disease progression or no response|3|||
33184916|NCT01851720|100586998|FG000|Overall Study|Lost to Follow-up|0|||
33184917|NCT01851720|100586999|FG001|Overall Study|Lost to Follow-up|1|||
33184918|NCT03690388|100587001|FG000|Overall Study|Adverse Event|8|||
33184919|NCT03690388|100587002|FG001|Overall Study|Adverse Event|1|||
33184920|NCT03690388|100587001|FG000|Overall Study|Radiographic Progression|14|||
33184921|NCT03690388|100587002|FG001|Overall Study|Radiographic Progression|29|||
33184922|NCT03690388|100587001|FG000|Overall Study|Clinical deterioration|10|||
33184923|NCT03690388|100587002|FG001|Overall Study|Clinical deterioration|6|||
33184924|NCT03690388|100587001|FG000|Overall Study|Withdrawal by Subject|2|||
33184925|NCT03690388|100587002|FG001|Overall Study|Withdrawal by Subject|0|||
33184926|NCT03690388|100587001|FG000|Overall Study|Lack of Efficacy|1|||
33184927|NCT03690388|100587002|FG001|Overall Study|Lack of Efficacy|0|||
33184928|NCT03690388|100587001|FG000|Overall Study|Lost to Follow-up|1|||
33184929|NCT03690388|100587002|FG001|Overall Study|Lost to Follow-up|0|||
33184930|NCT01364428|100587003|FG000|Overall Study|Adverse Event|1|||
33184931|NCT01364428|100587004|FG001|Overall Study|Adverse Event|2|||
33184932|NCT01364428|100587003|FG000|Overall Study|Protocol Violation|2|||
33184933|NCT01364428|100587004|FG001|Overall Study|Protocol Violation|0|||
33184934|NCT01364428|100587003|FG000|Overall Study|Withdrawal Criteria|14|||
33184935|NCT01364428|100587004|FG001|Overall Study|Withdrawal Criteria|10|||
33184936|NCT01364428|100587003|FG000|Overall Study|Other|3|||
33184937|NCT01364428|100587004|FG001|Overall Study|Other|3|||
33184938|NCT00451035|100587005|FG000|Overall Study|Disease progression|11|||
33184939|NCT00451035|100587005|FG000|Overall Study|Death|3|||
33184940|NCT00451035|100587005|FG000|Overall Study|New anti-neoplastic therapy|3|||
33184941|NCT01224639|100587009|FG000|Overall Study|Withdrawal by Subject|0|||
33184942|NCT01224639|100587010|FG001|Overall Study|Withdrawal by Subject|0|||
33184943|NCT01224639|100587011|FG002|Overall Study|Withdrawal by Subject|0|||
33184944|NCT01224639|100587012|FG003|Overall Study|Withdrawal by Subject|0|||
33184945|NCT01224639|100587013|FG004|Overall Study|Withdrawal by Subject|2|||
33184946|NCT01224639|100587014|FG005|Overall Study|Withdrawal by Subject|0|||
33184947|NCT01224639|100587015|FG006|Overall Study|Withdrawal by Subject|1|||
33184948|NCT01224639|100587016|FG007|Overall Study|Withdrawal by Subject|1|||
33184949|NCT01224639|100587009|FG000|Overall Study|Adverse Event|0|||
33184950|NCT01224639|100587010|FG001|Overall Study|Adverse Event|0|||
33184951|NCT01224639|100587011|FG002|Overall Study|Adverse Event|0|||
33184952|NCT01224639|100587012|FG003|Overall Study|Adverse Event|0|||
33184953|NCT01224639|100587013|FG004|Overall Study|Adverse Event|0|||
33184954|NCT01224639|100587014|FG005|Overall Study|Adverse Event|0|||
33184955|NCT01224639|100587015|FG006|Overall Study|Adverse Event|0|||
33184956|NCT01224639|100587016|FG007|Overall Study|Adverse Event|1|||
33184957|NCT00922766|100587017|FG000|Overall Study|Death|3|||
33184958|NCT00922766|100587017|FG000|Overall Study|Withdrawal by Subject|2|||
33184959|NCT00922766|100587017|FG000|Overall Study|Other|1|||
33184960|NCT00922766|100587017|FG000|Overall Study|Adverse Event|1|||
33184961|NCT00405548|100587018|FG000|Overall Study|Cognitive Memory problems on study day|1|||
33184962|NCT00405548|100587019|FG001|Overall Study|Cognitive Memory problems on study day|0|||
33184963|NCT00405548|100587018|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
33184964|NCT00405548|100587019|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
33184965|NCT00405548|100587018|FG000|Overall Study|Unable to self-administer shots|1|||
33184966|NCT00405548|100587019|FG001|Overall Study|Unable to self-administer shots|0|||
33184967|NCT00405548|100587018|FG000|Overall Study|Venous access failed during study day|1|||
33184968|NCT00405548|100587019|FG001|Overall Study|Venous access failed during study day|0|||
33184969|NCT00405548|100587018|FG000|Overall Study|Withdrawal by Subject|1|||
33184970|NCT00405548|100587019|FG001|Overall Study|Withdrawal by Subject|0|||
33184971|NCT02174848|100587021|FG000|Overall Study|Adverse Event|2|||
33184972|NCT02174848|100587022|FG001|Overall Study|Adverse Event|1|||
33184973|NCT02174848|100587021|FG000|Overall Study|Withdrawal by Subject|3|||
33184974|NCT02174848|100587022|FG001|Overall Study|Withdrawal by Subject|3|||
33184975|NCT02174848|100587021|FG000|Overall Study|Lost to Follow-up|0|||
33184976|NCT02174848|100587022|FG001|Overall Study|Lost to Follow-up|1|||
33184977|NCT02174848|100587021|FG000|Overall Study|Worsening of disease|1|||
33184978|NCT02174848|100587022|FG001|Overall Study|Worsening of disease|1|||
33184979|NCT02174848|100587021|FG000|Overall Study|Unable to comply with study requirements|1|||
33184980|NCT02174848|100587022|FG001|Overall Study|Unable to comply with study requirements|0|||
33184981|NCT01203072|100587027|FG000|Overall Study|Adverse Event|5|||
33184982|NCT01203072|100587028|FG001|Overall Study|Adverse Event|3|||
33184983|NCT01203072|100587029|FG002|Overall Study|Adverse Event|2|||
33184984|NCT01203072|100587030|FG003|Overall Study|Adverse Event|4|||
33184985|NCT01203072|100587031|FG004|Overall Study|Adverse Event|2|||
33184986|NCT01203072|100587027|FG000|Overall Study|Lack of Efficacy|1|||
33184987|NCT01203072|100587028|FG001|Overall Study|Lack of Efficacy|0|||
33184988|NCT01203072|100587029|FG002|Overall Study|Lack of Efficacy|0|||
33184989|NCT01203072|100587030|FG003|Overall Study|Lack of Efficacy|0|||
33184990|NCT01203072|100587031|FG004|Overall Study|Lack of Efficacy|0|||
33184991|NCT01203072|100587027|FG000|Overall Study|Lost to Follow-up|0|||
33184992|NCT01203072|100587028|FG001|Overall Study|Lost to Follow-up|1|||
33184993|NCT01203072|100587029|FG002|Overall Study|Lost to Follow-up|0|||
33184994|NCT01203072|100587030|FG003|Overall Study|Lost to Follow-up|0|||
33184995|NCT01203072|100587031|FG004|Overall Study|Lost to Follow-up|0|||
33184996|NCT01203072|100587027|FG000|Overall Study|Protocol Violation|2|||
33184997|NCT01203072|100587028|FG001|Overall Study|Protocol Violation|0|||
33184998|NCT01203072|100587029|FG002|Overall Study|Protocol Violation|0|||
33184999|NCT01203072|100587030|FG003|Overall Study|Protocol Violation|0|||
33185000|NCT01203072|100587031|FG004|Overall Study|Protocol Violation|1|||
33185001|NCT01203072|100587027|FG000|Overall Study|Withdrawal by Subject|2|||
33185002|NCT01203072|100587028|FG001|Overall Study|Withdrawal by Subject|2|||
33185003|NCT01203072|100587029|FG002|Overall Study|Withdrawal by Subject|1|||
33185004|NCT01203072|100587030|FG003|Overall Study|Withdrawal by Subject|2|||
33185005|NCT01203072|100587031|FG004|Overall Study|Withdrawal by Subject|3|||
33185006|NCT01215227|100587032|FG000|Overall Study|Adverse Event|11|||
33185007|NCT01215227|100587033|FG001|Overall Study|Adverse Event|11|||
33185008|NCT01215227|100587034|FG002|Overall Study|Adverse Event|4|||
33185009|NCT01215227|100587035|FG003|Overall Study|Adverse Event|8|||
33185010|NCT01215227|100587036|FG004|Overall Study|Adverse Event|7|||
33185011|NCT01215227|100587037|FG005|Overall Study|Adverse Event|6|||
33185012|NCT01215227|100587032|FG000|Overall Study|Treatment Failure|8|||
33185013|NCT01215227|100587033|FG001|Overall Study|Treatment Failure|4|||
33185014|NCT01215227|100587034|FG002|Overall Study|Treatment Failure|1|||
33185015|NCT01215227|100587035|FG003|Overall Study|Treatment Failure|5|||
33185016|NCT01215227|100587036|FG004|Overall Study|Treatment Failure|1|||
33185017|NCT01215227|100587037|FG005|Overall Study|Treatment Failure|1|||
33185018|NCT01215227|100587032|FG000|Overall Study|Lost to Follow-up|1|||
33185019|NCT01215227|100587033|FG001|Overall Study|Lost to Follow-up|4|||
33185020|NCT01215227|100587034|FG002|Overall Study|Lost to Follow-up|1|||
33185021|NCT01215227|100587035|FG003|Overall Study|Lost to Follow-up|1|||
33185022|NCT01215227|100587036|FG004|Overall Study|Lost to Follow-up|1|||
33185023|NCT01215227|100587037|FG005|Overall Study|Lost to Follow-up|2|||
33185024|NCT01215227|100587032|FG000|Overall Study|Subject Withdrew Consent|16|||
33185025|NCT01215227|100587033|FG001|Overall Study|Subject Withdrew Consent|20|||
33185026|NCT01215227|100587034|FG002|Overall Study|Subject Withdrew Consent|7|||
33185027|NCT01215227|100587035|FG003|Overall Study|Subject Withdrew Consent|10|||
33185028|NCT01215227|100587036|FG004|Overall Study|Subject Withdrew Consent|11|||
33185029|NCT01215227|100587037|FG005|Overall Study|Subject Withdrew Consent|8|||
33185030|NCT01215227|100587032|FG000|Overall Study|Non-Compliance With Protocol|2|||
33185031|NCT01215227|100587033|FG001|Overall Study|Non-Compliance With Protocol|6|||
33185032|NCT01215227|100587034|FG002|Overall Study|Non-Compliance With Protocol|1|||
33185033|NCT01215227|100587035|FG003|Overall Study|Non-Compliance With Protocol|0|||
33185034|NCT01215227|100587036|FG004|Overall Study|Non-Compliance With Protocol|0|||
33185035|NCT01215227|100587037|FG005|Overall Study|Non-Compliance With Protocol|0|||
33185036|NCT01215227|100587032|FG000|Overall Study|Administrative|83|||
33185037|NCT01215227|100587033|FG001|Overall Study|Administrative|73|||
33185038|NCT01215227|100587034|FG002|Overall Study|Administrative|42|||
33185039|NCT01215227|100587035|FG003|Overall Study|Administrative|24|||
33185040|NCT01215227|100587036|FG004|Overall Study|Administrative|28|||
33185041|NCT01215227|100587037|FG005|Overall Study|Administrative|40|||
33185042|NCT01215227|100587032|FG000|Overall Study|Missing Status|0|||
33185043|NCT01215227|100587033|FG001|Overall Study|Missing Status|1|||
33185044|NCT01215227|100587034|FG002|Overall Study|Missing Status|0|||
33185045|NCT01215227|100587035|FG003|Overall Study|Missing Status|0|||
33185046|NCT01215227|100587036|FG004|Overall Study|Missing Status|0|||
33185047|NCT01215227|100587037|FG005|Overall Study|Missing Status|0|||
33185048|NCT01215227|100587032|FG000|Overall Study|Randomized but not treated|0|||
33185049|NCT01215227|100587033|FG001|Overall Study|Randomized but not treated|0|||
33185050|NCT01215227|100587034|FG002|Overall Study|Randomized but not treated|1|||
33185051|NCT01215227|100587035|FG003|Overall Study|Randomized but not treated|1|||
33185052|NCT01215227|100587036|FG004|Overall Study|Randomized but not treated|0|||
33185053|NCT01215227|100587037|FG005|Overall Study|Randomized but not treated|1|||
33185054|NCT02404350|100587038|FG000|Overall Study|Adverse Event|2|||
33185055|NCT02404350|100587039|FG001|Overall Study|Adverse Event|2|||
33185056|NCT02404350|100587040|FG002|Overall Study|Adverse Event|3|||
33185057|NCT02404350|100587041|FG003|Overall Study|Adverse Event|9|||
33185058|NCT02404350|100587038|FG000|Overall Study|Lack of Efficacy|3|||
33185059|NCT02404350|100587039|FG001|Overall Study|Lack of Efficacy|1|||
33185060|NCT02404350|100587040|FG002|Overall Study|Lack of Efficacy|0|||
33185061|NCT02404350|100587041|FG003|Overall Study|Lack of Efficacy|3|||
33185062|NCT02404350|100587038|FG000|Overall Study|Lost to Follow-up|2|||
33185063|NCT02404350|100587039|FG001|Overall Study|Lost to Follow-up|0|||
33185064|NCT02404350|100587040|FG002|Overall Study|Lost to Follow-up|0|||
33185065|NCT02404350|100587041|FG003|Overall Study|Lost to Follow-up|1|||
33185066|NCT02404350|100587038|FG000|Overall Study|Physician Decision|1|||
33185067|NCT02404350|100587039|FG001|Overall Study|Physician Decision|0|||
33185068|NCT02404350|100587040|FG002|Overall Study|Physician Decision|0|||
33185069|NCT02404350|100587041|FG003|Overall Study|Physician Decision|2|||
33185070|NCT02404350|100587038|FG000|Overall Study|Pregnancy|0|||
33185071|NCT02404350|100587039|FG001|Overall Study|Pregnancy|0|||
33185072|NCT02404350|100587040|FG002|Overall Study|Pregnancy|0|||
33185073|NCT02404350|100587041|FG003|Overall Study|Pregnancy|1|||
33185074|NCT02404350|100587038|FG000|Overall Study|Withdrawal by Subject|7|||
33185075|NCT02404350|100587039|FG001|Overall Study|Withdrawal by Subject|3|||
33185076|NCT02404350|100587040|FG002|Overall Study|Withdrawal by Subject|3|||
33185077|NCT02404350|100587041|FG003|Overall Study|Withdrawal by Subject|19|||
33185078|NCT02404350|100587038|FG000|Overall Study|Due to Non-compliance with treatment|0|||
33185079|NCT02404350|100587039|FG001|Overall Study|Due to Non-compliance with treatment|0|||
33185080|NCT02404350|100587040|FG002|Overall Study|Due to Non-compliance with treatment|0|||
33185081|NCT02404350|100587041|FG003|Overall Study|Due to Non-compliance with treatment|1|||
33185082|NCT02404350|100587038|FG000|Overall Study|Due to Technical problems|0|||
33185083|NCT02404350|100587039|FG001|Overall Study|Due to Technical problems|0|||
33185084|NCT02404350|100587040|FG002|Overall Study|Due to Technical problems|0|||
33185085|NCT02404350|100587041|FG003|Overall Study|Due to Technical problems|1|||
33185086|NCT02439320|100587042|FG000|Overall Study|Adverse Event|0|||
33185087|NCT02439320|100587043|FG001|Overall Study|Adverse Event|2|||
33185088|NCT02439320|100587044|FG002|Overall Study|Adverse Event|0|||
33185089|NCT02439320|100587042|FG000|Overall Study|Lost to Follow-up|37|||
33185090|NCT02439320|100587043|FG001|Overall Study|Lost to Follow-up|34|||
33185091|NCT02439320|100587044|FG002|Overall Study|Lost to Follow-up|42|||
33185092|NCT02439320|100587042|FG000|Overall Study|Death|0|||
33185093|NCT02439320|100587043|FG001|Overall Study|Death|1|||
33185094|NCT02439320|100587044|FG002|Overall Study|Death|0|||
33185095|NCT02439320|100587042|FG000|Overall Study|Noncompliance with Protocol|10|||
33185096|NCT02439320|100587043|FG001|Overall Study|Noncompliance with Protocol|11|||
33185097|NCT02439320|100587044|FG002|Overall Study|Noncompliance with Protocol|7|||
33185098|NCT02439320|100587042|FG000|Overall Study|Pregnancy|0|||
33185099|NCT02439320|100587043|FG001|Overall Study|Pregnancy|1|||
33185100|NCT02439320|100587044|FG002|Overall Study|Pregnancy|1|||
33185101|NCT02439320|100587042|FG000|Overall Study|Withdrawal by Subject|12|||
33185102|NCT02439320|100587043|FG001|Overall Study|Withdrawal by Subject|16|||
33185103|NCT02439320|100587044|FG002|Overall Study|Withdrawal by Subject|14|||
33185104|NCT02439320|100587042|FG000|Overall Study|Physician Decision|2|||
33185105|NCT02439320|100587043|FG001|Overall Study|Physician Decision|1|||
33185106|NCT02439320|100587044|FG002|Overall Study|Physician Decision|0|||
33185107|NCT02439320|100587042|FG000|Overall Study|Sponsor Request|0|||
33185108|NCT02439320|100587043|FG001|Overall Study|Sponsor Request|2|||
33185109|NCT02439320|100587044|FG002|Overall Study|Sponsor Request|1|||
33185110|NCT02439320|100587042|FG000|Overall Study|Randomization Failure|35|||
33185111|NCT02439320|100587043|FG001|Overall Study|Randomization Failure|46|||
33185112|NCT02439320|100587044|FG002|Overall Study|Randomization Failure|34|||
33185113|NCT01063764|100587045|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
33185114|NCT01063764|100587045|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
33185115|NCT01063764|100587045|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
33185116|NCT01063764|100587045|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
33185117|NCT01063764|100587045|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
33185118|NCT01063764|100587045|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
33185119|NCT01063764|100587045|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
33185120|NCT00129129|100587046|FG000|Primary Phase|Adverse Event|2|||
33185121|NCT00129129|100587047|FG001|Primary Phase|Adverse Event|1|||
33185122|NCT00129129|100587048|FG002|Primary Phase|Adverse Event|0|||
33185123|NCT00129129|100587049|FG003|Primary Phase|Adverse Event|0|||
33185124|NCT00129129|100587050|FG004|Primary Phase|Adverse Event|0|||
33185125|NCT00129129|100587046|FG000|Primary Phase|Withdrawal by Subject|12|||
33185126|NCT00129129|100587047|FG001|Primary Phase|Withdrawal by Subject|10|||
33185127|NCT00129129|100587048|FG002|Primary Phase|Withdrawal by Subject|0|||
33185128|NCT00129129|100587049|FG003|Primary Phase|Withdrawal by Subject|0|||
33185129|NCT00129129|100587050|FG004|Primary Phase|Withdrawal by Subject|0|||
33185130|NCT00129129|100587046|FG000|Primary Phase|Migration from study area|1|||
33185131|NCT00129129|100587047|FG001|Primary Phase|Migration from study area|3|||
33185132|NCT00129129|100587048|FG002|Primary Phase|Migration from study area|0|||
33185133|NCT00129129|100587049|FG003|Primary Phase|Migration from study area|0|||
33185134|NCT00129129|100587050|FG004|Primary Phase|Migration from study area|0|||
33185135|NCT00129129|100587046|FG000|Primary Phase|Lost to Follow-up|8|||
33185136|NCT00129129|100587047|FG001|Primary Phase|Lost to Follow-up|6|||
33185137|NCT00129129|100587048|FG002|Primary Phase|Lost to Follow-up|0|||
33185138|NCT00129129|100587049|FG003|Primary Phase|Lost to Follow-up|0|||
33185139|NCT00129129|100587050|FG004|Primary Phase|Lost to Follow-up|0|||
33185140|NCT00129129|100587046|FG000|Primary Phase|Other|2|||
33185141|NCT00129129|100587047|FG001|Primary Phase|Other|5|||
33185142|NCT00129129|100587048|FG002|Primary Phase|Other|0|||
33185143|NCT00129129|100587049|FG003|Primary Phase|Other|0|||
33185144|NCT00129129|100587050|FG004|Primary Phase|Other|0|||
33185145|NCT00129129|100587046|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
33185146|NCT00129129|100587047|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
33185147|NCT00129129|100587048|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
33185148|NCT00129129|100587049|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
33185149|NCT00129129|100587050|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
33185150|NCT00129129|100587046|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
33185151|NCT00129129|100587047|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
33185152|NCT00129129|100587048|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
33185153|NCT00129129|100587049|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
33185154|NCT00129129|100587050|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
33185155|NCT00129129|100587046|FG000|Fourth Dose Phase|Migration from study area|0|||
33185156|NCT00129129|100587047|FG001|Fourth Dose Phase|Migration from study area|0|||
33185157|NCT00129129|100587048|FG002|Fourth Dose Phase|Migration from study area|0|||
33185158|NCT00129129|100587049|FG003|Fourth Dose Phase|Migration from study area|0|||
33185159|NCT00129129|100587050|FG004|Fourth Dose Phase|Migration from study area|2|||
33185160|NCT00129129|100587046|FG000|Fourth Dose Phase|Other|0|||
33185161|NCT00129129|100587047|FG001|Fourth Dose Phase|Other|0|||
33185162|NCT00129129|100587048|FG002|Fourth Dose Phase|Other|0|||
33185163|NCT00129129|100587049|FG003|Fourth Dose Phase|Other|1|||
33185164|NCT00129129|100587050|FG004|Fourth Dose Phase|Other|1|||
33185165|NCT00129129|100587046|FG000|Fourth Dose Phase|Protocol Violation|0|||
33185166|NCT00129129|100587047|FG001|Fourth Dose Phase|Protocol Violation|0|||
33185167|NCT00129129|100587048|FG002|Fourth Dose Phase|Protocol Violation|0|||
33185168|NCT00129129|100587049|FG003|Fourth Dose Phase|Protocol Violation|1|||
33185169|NCT00129129|100587050|FG004|Fourth Dose Phase|Protocol Violation|0|||
33185170|NCT03168464|100587051|FG000|Overall Study|Death|9|||
33185171|NCT03168464|100587051|FG000|Overall Study|Progression of disease|6|||
33185172|NCT01675882|100587063|FG000|Overall Study|Adverse Event|0|||
33185173|NCT01675882|100587064|FG001|Overall Study|Adverse Event|2|||
33185174|NCT01675882|100587065|FG002|Overall Study|Adverse Event|1|||
33185175|NCT01675882|100587066|FG003|Overall Study|Adverse Event|0|||
33185176|NCT01675882|100587063|FG000|Overall Study|Participant unwilling to continue|2|||
33185177|NCT01675882|100587064|FG001|Overall Study|Participant unwilling to continue|4|||
33185178|NCT01675882|100587065|FG002|Overall Study|Participant unwilling to continue|2|||
33185179|NCT01675882|100587066|FG003|Overall Study|Participant unwilling to continue|1|||
33185180|NCT01675882|100587063|FG000|Overall Study|Lost to Follow-up|0|||
33185181|NCT01675882|100587064|FG001|Overall Study|Lost to Follow-up|1|||
33185182|NCT01675882|100587065|FG002|Overall Study|Lost to Follow-up|0|||
33185183|NCT01675882|100587066|FG003|Overall Study|Lost to Follow-up|0|||
33185184|NCT01675882|100587063|FG000|Overall Study|Non-compliance|0|||
33185185|NCT01675882|100587064|FG001|Overall Study|Non-compliance|0|||
33185186|NCT01675882|100587065|FG002|Overall Study|Non-compliance|0|||
33185187|NCT01675882|100587066|FG003|Overall Study|Non-compliance|1|||
33185188|NCT00578175|100587076|FG000|Overall Study|Adverse Event|0|||
33185189|NCT00578175|100587077|FG001|Overall Study|Adverse Event|1|||
33185190|NCT00578175|100587078|FG002|Overall Study|Adverse Event|1|||
33185191|NCT00578175|100587076|FG000|Overall Study|Other reasons|70|||
33185192|NCT00578175|100587077|FG001|Overall Study|Other reasons|42|||
33185193|NCT00578175|100587078|FG002|Overall Study|Other reasons|23|||
33389927|NCT00643448|101313882|FG002|Overall Study|Adverse Event|2|||
33185194|NCT02659020|100587079|FG000|Overall Study|Adverse Event|0|||
33185195|NCT02659020|100587080|FG001|Overall Study|Adverse Event|0|||
33185196|NCT02659020|100587081|FG002|Overall Study|Adverse Event|0|||
33185197|NCT02659020|100587082|FG003|Overall Study|Adverse Event|2|||
33185198|NCT02659020|100587083|FG004|Overall Study|Adverse Event|0|||
33185199|NCT02659020|100587084|FG005|Overall Study|Adverse Event|0|||
33185200|NCT02659020|100587085|FG006|Overall Study|Adverse Event|2|||
33185201|NCT02659020|100587079|FG000|Overall Study|Lost to Follow-up|1|||
33185202|NCT02659020|100587080|FG001|Overall Study|Lost to Follow-up|2|||
33185203|NCT02659020|100587081|FG002|Overall Study|Lost to Follow-up|1|||
33185204|NCT02659020|100587082|FG003|Overall Study|Lost to Follow-up|6|||
33185205|NCT02659020|100587083|FG004|Overall Study|Lost to Follow-up|1|||
33185206|NCT02659020|100587084|FG005|Overall Study|Lost to Follow-up|5|||
33185207|NCT02659020|100587085|FG006|Overall Study|Lost to Follow-up|0|||
33185208|NCT02659020|100587079|FG000|Overall Study|Physician Decision|0|||
33185209|NCT02659020|100587080|FG001|Overall Study|Physician Decision|0|||
33185210|NCT02659020|100587081|FG002|Overall Study|Physician Decision|0|||
33185211|NCT02659020|100587082|FG003|Overall Study|Physician Decision|1|||
33185212|NCT02659020|100587083|FG004|Overall Study|Physician Decision|1|||
33185213|NCT02659020|100587084|FG005|Overall Study|Physician Decision|0|||
33185214|NCT02659020|100587085|FG006|Overall Study|Physician Decision|1|||
33185215|NCT02659020|100587079|FG000|Overall Study|Withdrawal by Subject|2|||
33185216|NCT02659020|100587080|FG001|Overall Study|Withdrawal by Subject|1|||
33185217|NCT02659020|100587081|FG002|Overall Study|Withdrawal by Subject|0|||
33185218|NCT02659020|100587082|FG003|Overall Study|Withdrawal by Subject|3|||
33185219|NCT02659020|100587083|FG004|Overall Study|Withdrawal by Subject|3|||
33185220|NCT02659020|100587084|FG005|Overall Study|Withdrawal by Subject|6|||
33185221|NCT02659020|100587085|FG006|Overall Study|Withdrawal by Subject|3|||
33185222|NCT02659020|100587079|FG000|Overall Study|Progressive Disease|0|||
33185223|NCT02659020|100587080|FG001|Overall Study|Progressive Disease|0|||
33185224|NCT02659020|100587081|FG002|Overall Study|Progressive Disease|0|||
33185225|NCT02659020|100587082|FG003|Overall Study|Progressive Disease|4|||
33185226|NCT02659020|100587083|FG004|Overall Study|Progressive Disease|1|||
33185227|NCT02659020|100587084|FG005|Overall Study|Progressive Disease|0|||
33185228|NCT02659020|100587085|FG006|Overall Study|Progressive Disease|2|||
33185229|NCT02028988|100587086|FG000|Overall Study|Withdrawal by Subject|2|||
33185230|NCT00666757|100587087|FG000|Overall Study|Lost to Follow-up|39|||
33185231|NCT00666757|100587088|FG001|Overall Study|Lost to Follow-up|35|||
33185232|NCT00666757|100587087|FG000|Overall Study|Protocol Violation|23|||
33185233|NCT00666757|100587088|FG001|Overall Study|Protocol Violation|24|||
33185234|NCT00666757|100587087|FG000|Overall Study|Adverse Event|22|||
33185235|NCT00666757|100587088|FG001|Overall Study|Adverse Event|12|||
33185236|NCT00666757|100587087|FG000|Overall Study|Withdrawal by Subject|13|||
33185237|NCT00666757|100587088|FG001|Overall Study|Withdrawal by Subject|17|||
33185238|NCT00666757|100587087|FG000|Overall Study|Lack of Efficacy|3|||
33185239|NCT00666757|100587088|FG001|Overall Study|Lack of Efficacy|6|||
33185240|NCT00666757|100587087|FG000|Overall Study|Physician Decision|0|||
33185241|NCT00666757|100587088|FG001|Overall Study|Physician Decision|2|||
33185242|NCT00666757|100587087|FG000|Overall Study|Sponsor decision|0|||
33185243|NCT00666757|100587088|FG001|Overall Study|Sponsor decision|1|||
33185244|NCT01449526|100587093|FG000|Overall Study|Lost to Follow-up|1|||
33185245|NCT01449526|100587094|FG001|Overall Study|Lost to Follow-up|2|||
33185246|NCT01449526|100587093|FG000|Overall Study|Withdrawal by Subject|1|||
33185247|NCT01449526|100587094|FG001|Overall Study|Withdrawal by Subject|1|||
33185248|NCT01449526|100587093|FG000|Overall Study|Symptoms/complaints|0|||
33185249|NCT01449526|100587094|FG001|Overall Study|Symptoms/complaints|1|||
33185250|NCT01449526|100587093|FG000|Overall Study|Lack of Motivation|0|||
33185251|NCT01449526|100587094|FG001|Overall Study|Lack of Motivation|1|||
33185252|NCT01449526|100587093|FG000|Overall Study|Cannot maintain visits|0|||
33185253|NCT01449526|100587094|FG001|Overall Study|Cannot maintain visits|1|||
33185254|NCT00907374|100587095|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
33185255|NCT00907374|100587096|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
33185256|NCT03240133|100587100|FG000|Overall Study|Withdrawal by Subject|0|||
33185257|NCT03240133|100587101|FG001|Overall Study|Withdrawal by Subject|1|||
33185258|NCT03240133|100587102|FG002|Overall Study|Withdrawal by Subject|0|||
33185259|NCT03240133|100587100|FG000|Overall Study|Adverse Event|1|||
33185260|NCT03240133|100587101|FG001|Overall Study|Adverse Event|1|||
33185261|NCT03240133|100587102|FG002|Overall Study|Adverse Event|0|||
33185262|NCT03240133|100587100|FG000|Overall Study|Rash|1|||
33185263|NCT03240133|100587101|FG001|Overall Study|Rash|0|||
33185264|NCT03240133|100587102|FG002|Overall Study|Rash|0|||
33185265|NCT03240133|100587100|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
33185266|NCT03240133|100587101|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
33185267|NCT03240133|100587102|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
33185268|NCT03240133|100587100|FG000|Overall Study|Intercurrent illness.|0|||
33185269|NCT03240133|100587101|FG001|Overall Study|Intercurrent illness.|1|||
33493946|NCT03154125|101698317|FG001|Overall Study|Withdrawal by Subject|55|||
33185270|NCT03240133|100587102|FG002|Overall Study|Intercurrent illness.|0|||
33185271|NCT03240133|100587100|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
33185272|NCT03240133|100587101|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
33185273|NCT03240133|100587102|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
33185274|NCT01023581|100587105|FG000|Overall Study|Adverse Event|4|||
33185275|NCT01023581|100587106|FG001|Overall Study|Adverse Event|4|||
33185276|NCT01023581|100587107|FG002|Overall Study|Adverse Event|7|||
33185277|NCT01023581|100587108|FG003|Overall Study|Adverse Event|3|||
33185278|NCT01023581|100587109|FG004|Overall Study|Adverse Event|2|||
33185279|NCT01023581|100587110|FG005|Overall Study|Adverse Event|5|||
33185280|NCT01023581|100587111|FG006|Overall Study|Adverse Event|11|||
33185281|NCT01023581|100587105|FG000|Overall Study|Major protocol deviation|2|||
33185282|NCT01023581|100587106|FG001|Overall Study|Major protocol deviation|0|||
33185283|NCT01023581|100587107|FG002|Overall Study|Major protocol deviation|3|||
33185284|NCT01023581|100587108|FG003|Overall Study|Major protocol deviation|0|||
33185285|NCT01023581|100587109|FG004|Overall Study|Major protocol deviation|0|||
33185286|NCT01023581|100587110|FG005|Overall Study|Major protocol deviation|0|||
33185287|NCT01023581|100587111|FG006|Overall Study|Major protocol deviation|0|||
33185288|NCT01023581|100587105|FG000|Overall Study|Lost to Follow-up|4|||
33185289|NCT01023581|100587106|FG001|Overall Study|Lost to Follow-up|8|||
33185290|NCT01023581|100587107|FG002|Overall Study|Lost to Follow-up|7|||
33185291|NCT01023581|100587108|FG003|Overall Study|Lost to Follow-up|2|||
33185292|NCT01023581|100587109|FG004|Overall Study|Lost to Follow-up|5|||
33185293|NCT01023581|100587110|FG005|Overall Study|Lost to Follow-up|2|||
33185294|NCT01023581|100587111|FG006|Overall Study|Lost to Follow-up|2|||
33185295|NCT01023581|100587105|FG000|Overall Study|Withdrawal by Subject|13|||
33185296|NCT01023581|100587106|FG001|Overall Study|Withdrawal by Subject|8|||
33185297|NCT01023581|100587107|FG002|Overall Study|Withdrawal by Subject|16|||
33185298|NCT01023581|100587108|FG003|Overall Study|Withdrawal by Subject|10|||
33185299|NCT01023581|100587109|FG004|Overall Study|Withdrawal by Subject|6|||
33185300|NCT01023581|100587110|FG005|Overall Study|Withdrawal by Subject|8|||
33185301|NCT01023581|100587111|FG006|Overall Study|Withdrawal by Subject|5|||
33185302|NCT01023581|100587105|FG000|Overall Study|Pregnancy|0|||
33185303|NCT01023581|100587106|FG001|Overall Study|Pregnancy|0|||
33185304|NCT01023581|100587107|FG002|Overall Study|Pregnancy|0|||
33185305|NCT01023581|100587108|FG003|Overall Study|Pregnancy|2|||
33185306|NCT01023581|100587109|FG004|Overall Study|Pregnancy|0|||
33185307|NCT01023581|100587110|FG005|Overall Study|Pregnancy|1|||
33185308|NCT01023581|100587111|FG006|Overall Study|Pregnancy|0|||
33185309|NCT01023581|100587105|FG000|Overall Study|Lack of Efficacy|9|||
33185310|NCT01023581|100587106|FG001|Overall Study|Lack of Efficacy|3|||
33185311|NCT01023581|100587107|FG002|Overall Study|Lack of Efficacy|6|||
33185312|NCT01023581|100587108|FG003|Overall Study|Lack of Efficacy|2|||
33185313|NCT01023581|100587109|FG004|Overall Study|Lack of Efficacy|1|||
33185314|NCT01023581|100587110|FG005|Overall Study|Lack of Efficacy|2|||
33185315|NCT01023581|100587111|FG006|Overall Study|Lack of Efficacy|1|||
33185316|NCT01023581|100587105|FG000|Overall Study|Physician Decision|2|||
33185317|NCT01023581|100587106|FG001|Overall Study|Physician Decision|0|||
33185318|NCT01023581|100587107|FG002|Overall Study|Physician Decision|2|||
33185319|NCT01023581|100587108|FG003|Overall Study|Physician Decision|1|||
33185320|NCT01023581|100587109|FG004|Overall Study|Physician Decision|1|||
33185321|NCT01023581|100587110|FG005|Overall Study|Physician Decision|1|||
33185322|NCT01023581|100587111|FG006|Overall Study|Physician Decision|1|||
33185323|NCT01023581|100587105|FG000|Overall Study|Other|1|||
33185324|NCT01023581|100587106|FG001|Overall Study|Other|0|||
33185325|NCT01023581|100587107|FG002|Overall Study|Other|1|||
33185326|NCT01023581|100587108|FG003|Overall Study|Other|0|||
33185327|NCT01023581|100587109|FG004|Overall Study|Other|1|||
33185328|NCT01023581|100587110|FG005|Overall Study|Other|0|||
33185329|NCT01023581|100587111|FG006|Overall Study|Other|0|||
33185330|NCT00913744|100587112|FG000|Overall Study|Adverse Event|2|||
33185331|NCT00913744|100587113|FG001|Overall Study|Adverse Event|0|||
33185332|NCT00913744|100587112|FG000|Overall Study|Withdrawal by Subject|2|||
33185333|NCT00913744|100587113|FG001|Overall Study|Withdrawal by Subject|1|||
33185334|NCT00913744|100587112|FG000|Overall Study|Death|1|||
33185335|NCT00913744|100587113|FG001|Overall Study|Death|0|||
33185336|NCT02253810|100587114|FG000|Overall Study|Withdrawal by Subject|2|||
33185337|NCT02253810|100587115|FG001|Overall Study|Withdrawal by Subject|1|||
33185338|NCT02253810|100587114|FG000|Overall Study|Unknown concomitant procedure|3|||
33185339|NCT02253810|100587115|FG001|Overall Study|Unknown concomitant procedure|2|||
33185340|NCT01120756|100587116|FG000|Overall Study|Withdrawal by Subject|1|||
33185341|NCT01120756|100587117|FG001|Overall Study|Withdrawal by Subject|1|||
33185342|NCT00394212|100587119|FG000|Overall Study|Lost to Follow-up|3|||
33185343|NCT00394212|100587120|FG001|Overall Study|Lost to Follow-up|0|||
33185344|NCT00394212|100587119|FG000|Overall Study|Withdrawal by Subject|4|||
33185345|NCT00394212|100587120|FG001|Overall Study|Withdrawal by Subject|1|||
33185346|NCT00694369|100587121|FG000|Overall Study|Adverse Event|0|||
33185347|NCT00694369|100587122|FG001|Overall Study|Adverse Event|1|||
33185348|NCT00694369|100587123|FG002|Overall Study|Adverse Event|0|||
33287024|NCT00505414|100947772|FG002|Maintenance Phase|Withdrawal by Subject|1|||
33185349|NCT00694369|100587124|FG003|Overall Study|Adverse Event|1|||
33185350|NCT00694369|100587125|FG004|Overall Study|Adverse Event|3|||
33185351|NCT00694369|100587121|FG000|Overall Study|Lost to Follow-up|0|||
33185352|NCT00694369|100587122|FG001|Overall Study|Lost to Follow-up|0|||
33185353|NCT00694369|100587123|FG002|Overall Study|Lost to Follow-up|1|||
33185354|NCT00694369|100587124|FG003|Overall Study|Lost to Follow-up|1|||
33185355|NCT00694369|100587125|FG004|Overall Study|Lost to Follow-up|0|||
33185356|NCT00694369|100587121|FG000|Overall Study|Physician Decision|0|||
33185357|NCT00694369|100587122|FG001|Overall Study|Physician Decision|0|||
33185358|NCT00694369|100587123|FG002|Overall Study|Physician Decision|0|||
33185359|NCT00694369|100587124|FG003|Overall Study|Physician Decision|0|||
33185360|NCT00694369|100587125|FG004|Overall Study|Physician Decision|1|||
33185361|NCT00694369|100587121|FG000|Overall Study|Protocol Violation|0|||
33185362|NCT00694369|100587122|FG001|Overall Study|Protocol Violation|1|||
33185363|NCT00694369|100587123|FG002|Overall Study|Protocol Violation|0|||
33185364|NCT00694369|100587124|FG003|Overall Study|Protocol Violation|0|||
33185365|NCT00694369|100587125|FG004|Overall Study|Protocol Violation|0|||
33185366|NCT00694369|100587121|FG000|Overall Study|Withdrawal by Subject|1|||
33185367|NCT00694369|100587122|FG001|Overall Study|Withdrawal by Subject|1|||
33185368|NCT00694369|100587123|FG002|Overall Study|Withdrawal by Subject|1|||
33185369|NCT00694369|100587124|FG003|Overall Study|Withdrawal by Subject|1|||
33185370|NCT00694369|100587125|FG004|Overall Study|Withdrawal by Subject|2|||
33185371|NCT03090100|100587126|FG000|Overall Study|Adverse Event|9|||
33185372|NCT03090100|100587127|FG001|Overall Study|Adverse Event|11|||
33185373|NCT03090100|100587126|FG000|Overall Study|Pregnancy|1|||
33185374|NCT03090100|100587127|FG001|Overall Study|Pregnancy|1|||
33185375|NCT03090100|100587126|FG000|Overall Study|Lack of Efficacy|2|||
33185376|NCT03090100|100587127|FG001|Overall Study|Lack of Efficacy|7|||
33185377|NCT03090100|100587126|FG000|Overall Study|Lost to Follow-up|2|||
33185378|NCT03090100|100587127|FG001|Overall Study|Lost to Follow-up|2|||
33185379|NCT03090100|100587126|FG000|Overall Study|Withdrawal by Subject|7|||
33185380|NCT03090100|100587127|FG001|Overall Study|Withdrawal by Subject|19|||
33185381|NCT03090100|100587126|FG000|Overall Study|Protocol Violation|2|||
33185382|NCT03090100|100587127|FG001|Overall Study|Protocol Violation|6|||
33185383|NCT03090100|100587126|FG000|Overall Study|Non-compliance|2|||
33185384|NCT03090100|100587127|FG001|Overall Study|Non-compliance|0|||
33185385|NCT03090100|100587126|FG000|Overall Study|Other|2|||
33185386|NCT03090100|100587127|FG001|Overall Study|Other|2|||
33185387|NCT03979638|100587128|FG000|Period 1|Physician Decision|1|||
33185388|NCT03979638|100587129|FG001|Period 1|Physician Decision|1|||
33185389|NCT03979638|100587128|FG000|Period 1|Withdrawal by Subject|4|||
33185390|NCT03979638|100587129|FG001|Period 1|Withdrawal by Subject|3|||
33185391|NCT03979638|100587128|FG000|Period 1|Study terminated by Sponsor|1|||
33185392|NCT03979638|100587129|FG001|Period 1|Study terminated by Sponsor|3|||
33185393|NCT03979638|100587128|FG000|Period 1|Protocol Violation|1|||
33185394|NCT03979638|100587129|FG001|Period 1|Protocol Violation|0|||
33185395|NCT03979638|100587128|FG000|Period 2|Study terminated by Sponsor|1|||
33185396|NCT03979638|100587129|FG001|Period 2|Study terminated by Sponsor|1|||
33185397|NCT00500292|100587130|FG000|Overall Study|Adverse Event|3|||
33185398|NCT00500292|100587131|FG001|Overall Study|Adverse Event|6|||
33185399|NCT00500292|100587132|FG002|Overall Study|Adverse Event|4|||
33185400|NCT00500292|100587130|FG000|Overall Study|Condition under investigation worsened|21|||
33185401|NCT00500292|100587131|FG001|Overall Study|Condition under investigation worsened|23|||
33185402|NCT00500292|100587132|FG002|Overall Study|Condition under investigation worsened|19|||
33185403|NCT00500292|100587130|FG000|Overall Study|Withdrawal by Subject|0|||
33185404|NCT00500292|100587131|FG001|Overall Study|Withdrawal by Subject|1|||
33185405|NCT00500292|100587132|FG002|Overall Study|Withdrawal by Subject|0|||
33185406|NCT00500292|100587130|FG000|Overall Study|Other|1|||
33185407|NCT00500292|100587131|FG001|Overall Study|Other|1|||
33185408|NCT00500292|100587132|FG002|Overall Study|Other|4|||
33185409|NCT00314574|100587133|FG000|Overall Study|Death|3|||
33185410|NCT00314574|100587134|FG001|Overall Study|Death|0|||
33185411|NCT00314574|100587133|FG000|Overall Study|Adverse Event|11|||
33493947|NCT03154125|101698318|FG002|Overall Study|Withdrawal by Subject|8|||
33185412|NCT00314574|100587134|FG001|Overall Study|Adverse Event|16|||
33185413|NCT00314574|100587133|FG000|Overall Study|Lost to Follow-up|19|||
33185414|NCT00314574|100587134|FG001|Overall Study|Lost to Follow-up|25|||
33185415|NCT00314574|100587133|FG000|Overall Study|Withdrawal by Subject|33|||
33185416|NCT00314574|100587134|FG001|Overall Study|Withdrawal by Subject|22|||
33185417|NCT00314574|100587133|FG000|Overall Study|Physician Decision|22|||
33185418|NCT00314574|100587134|FG001|Overall Study|Physician Decision|15|||
33185419|NCT00314574|100587133|FG000|Overall Study|Pregnancy|6|||
33185420|NCT00314574|100587134|FG001|Overall Study|Pregnancy|4|||
33185421|NCT00314574|100587133|FG000|Overall Study|Data unknown at database lock|0|||
33185422|NCT00314574|100587134|FG001|Overall Study|Data unknown at database lock|1|||
33185423|NCT02321462|100587137|FG000|Overall Study|Withdrawal by Subject|5|||
33185424|NCT02321462|100587138|FG001|Overall Study|Withdrawal by Subject|2|||
33389928|NCT00643448|101313880|FG000|Overall Study|QTcF>550 ms|0|||
33185425|NCT02321462|100587137|FG000|Overall Study|Subject withdrawn before any treatment|1|||
33185426|NCT02321462|100587138|FG001|Overall Study|Subject withdrawn before any treatment|1|||
33185427|NCT03999892|100587139|FG000|Overall Study|Lost to Follow-up|1|||
33185428|NCT00558103|100587165|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
33185429|NCT00558103|100587166|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
33185430|NCT00558103|100587167|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
33185431|NCT00558103|100587168|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
33185432|NCT00558103|100587169|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
33185433|NCT00558103|100587170|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
33185434|NCT00558103|100587165|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
33185435|NCT00558103|100587166|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
33185436|NCT00558103|100587167|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
33185437|NCT00558103|100587168|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
33185438|NCT00558103|100587169|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
33185439|NCT00558103|100587170|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
33185440|NCT00558103|100587165|FG000|Randomized Treatment Phase|Disease Progression|1|||
33185441|NCT00558103|100587166|FG001|Randomized Treatment Phase|Disease Progression|0|||
33185442|NCT00558103|100587167|FG002|Randomized Treatment Phase|Disease Progression|1|||
33185443|NCT00558103|100587168|FG003|Randomized Treatment Phase|Disease Progression|0|||
33185444|NCT00558103|100587169|FG004|Randomized Treatment Phase|Disease Progression|0|||
33185445|NCT00558103|100587170|FG005|Randomized Treatment Phase|Disease Progression|0|||
33185446|NCT00558103|100587165|FG000|Randomized Treatment Phase|Adverse Event|0|||
33185447|NCT00558103|100587166|FG001|Randomized Treatment Phase|Adverse Event|0|||
33185448|NCT00558103|100587167|FG002|Randomized Treatment Phase|Adverse Event|0|||
33185449|NCT00558103|100587168|FG003|Randomized Treatment Phase|Adverse Event|1|||
33185450|NCT00558103|100587169|FG004|Randomized Treatment Phase|Adverse Event|1|||
33185451|NCT00558103|100587170|FG005|Randomized Treatment Phase|Adverse Event|0|||
33185452|NCT00558103|100587165|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
33185453|NCT00558103|100587166|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
33185454|NCT00558103|100587167|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
33185455|NCT00558103|100587168|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
33185456|NCT00558103|100587169|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
33185457|NCT00558103|100587170|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
33185458|NCT00558103|100587165|FG000|Monotherapy Extension Phase|Disease Progression|0|||
33185459|NCT00558103|100587166|FG001|Monotherapy Extension Phase|Disease Progression|0|||
33185460|NCT00558103|100587167|FG002|Monotherapy Extension Phase|Disease Progression|0|||
33185461|NCT00558103|100587168|FG003|Monotherapy Extension Phase|Disease Progression|0|||
33185462|NCT00558103|100587169|FG004|Monotherapy Extension Phase|Disease Progression|0|||
33185463|NCT00558103|100587170|FG005|Monotherapy Extension Phase|Disease Progression|8|||
33185464|NCT00116558|100587171|FG000|Overall Study|Death|11|||
33185465|NCT00116558|100587172|FG001|Overall Study|Death|5|||
33185466|NCT00116558|100587173|FG002|Overall Study|Death|3|||
33185467|NCT00116558|100587171|FG000|Overall Study|Withdrawal by Subject|17|||
33185468|NCT00116558|100587172|FG001|Overall Study|Withdrawal by Subject|3|||
33185469|NCT00116558|100587173|FG002|Overall Study|Withdrawal by Subject|12|||
33185470|NCT00116558|100587171|FG000|Overall Study|disease progression|3|||
33185471|NCT00116558|100587172|FG001|Overall Study|disease progression|7|||
33185472|NCT00116558|100587173|FG002|Overall Study|disease progression|18|||
33185473|NCT01554618|100587174|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
33185474|NCT01554618|100587175|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
33185475|NCT01554618|100587174|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
33185476|NCT01554618|100587175|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
33185477|NCT01554618|100587174|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
33185478|NCT01554618|100587175|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
33185479|NCT01554618|100587174|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
33185480|NCT01554618|100587175|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
33185481|NCT01554618|100587174|FG000|Open-Label Extension Period|Physician Decision|0|||
33185482|NCT01554618|100587175|FG001|Open-Label Extension Period|Physician Decision|1|||
33185483|NCT01554618|100587174|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
33185484|NCT01554618|100587175|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
33185485|NCT05179421|100587176|FG000|First Infusion Day|Adverse Event|1|||
33185486|NCT05179421|100587177|FG001|First Infusion Day|Adverse Event|0|||
33185487|NCT01727141|100587178|FG000|Overall Study|Physician Decision|0|||
33185488|NCT01727141|100587179|FG001|Overall Study|Physician Decision|1|||
33185489|NCT01727141|100587180|FG002|Overall Study|Physician Decision|0|||
33185490|NCT01727141|100587181|FG003|Overall Study|Physician Decision|2|||
33185491|NCT01727141|100587178|FG000|Overall Study|Lost to Follow-up|0|||
33185492|NCT01727141|100587179|FG001|Overall Study|Lost to Follow-up|2|||
33185493|NCT01727141|100587180|FG002|Overall Study|Lost to Follow-up|0|||
33185494|NCT01727141|100587181|FG003|Overall Study|Lost to Follow-up|0|||
33185495|NCT01727141|100587178|FG000|Overall Study|Death|0|||
33185496|NCT01727141|100587179|FG001|Overall Study|Death|1|||
33185497|NCT01727141|100587180|FG002|Overall Study|Death|1|||
33185498|NCT01727141|100587181|FG003|Overall Study|Death|1|||
33185499|NCT01727141|100587178|FG000|Overall Study|Protocol deviation|1|||
33185500|NCT01727141|100587179|FG001|Overall Study|Protocol deviation|1|||
33185501|NCT01727141|100587180|FG002|Overall Study|Protocol deviation|0|||
33185502|NCT01727141|100587181|FG003|Overall Study|Protocol deviation|1|||
33185503|NCT01727141|100587178|FG000|Overall Study|Withdrawal by Subject|4|||
33185504|NCT01727141|100587179|FG001|Overall Study|Withdrawal by Subject|4|||
33185505|NCT01727141|100587180|FG002|Overall Study|Withdrawal by Subject|2|||
33185506|NCT01727141|100587181|FG003|Overall Study|Withdrawal by Subject|11|||
33185507|NCT00747435|100587182|FG000|Overall Study|Lost to Follow-up|2|||
33185508|NCT00747435|100587182|FG000|Overall Study|Withdrawal by Subject|3|||
33185509|NCT00747435|100587182|FG000|Overall Study|Still undergoing follow up|1|||
33185510|NCT00663052|100587183|FG000|Overall Study|Adverse Event|6|||
33185511|NCT00663052|100587184|FG001|Overall Study|Adverse Event|3|||
33185512|NCT00663052|100587183|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
33185513|NCT00663052|100587184|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
33185514|NCT00663052|100587183|FG000|Overall Study|Protocol Violation|1|||
33185515|NCT00663052|100587184|FG001|Overall Study|Protocol Violation|0|||
33185516|NCT00663052|100587183|FG000|Overall Study|Withdrawal by Subject|2|||
33185517|NCT00663052|100587184|FG001|Overall Study|Withdrawal by Subject|5|||
33185518|NCT00663052|100587183|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
33185519|NCT00663052|100587184|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
33185520|NCT00663052|100587183|FG000|Overall Study|Other|0|||
33185521|NCT00663052|100587184|FG001|Overall Study|Other|1|||
33185522|NCT01350128|100587185|FG000|Overall Study|Withdrawal by Subject|3|||
33185523|NCT01350128|100587185|FG000|Overall Study|Protocol discontinuation criteria|8|||
33185524|NCT01350128|100587185|FG000|Overall Study|Physician Decision|1|||
33185525|NCT01350128|100587185|FG000|Overall Study|Lost to Follow-up|2|||
33185526|NCT00805935|100590393|FG000|Overall Study|Stimulation Failure|1|||
33185527|NCT00805935|100590394|FG001|Overall Study|Stimulation Failure|5|||
33185528|NCT00805935|100590395|FG002|Overall Study|Stimulation Failure|2|||
33185529|NCT00805935|100590396|FG003|Overall Study|Stimulation Failure|2|||
33185530|NCT00805935|100590393|FG000|Overall Study|Cycle cancelled|0|||
33185531|NCT00805935|100590394|FG001|Overall Study|Cycle cancelled|0|||
33185532|NCT00805935|100590395|FG002|Overall Study|Cycle cancelled|2|||
33185533|NCT00805935|100590396|FG003|Overall Study|Cycle cancelled|0|||
33185534|NCT00805935|100590393|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
33185535|NCT00805935|100590394|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
33185536|NCT00805935|100590395|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
33185537|NCT00805935|100590396|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
33185538|NCT00805935|100590393|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
33185539|NCT00805935|100590394|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
33185540|NCT00805935|100590395|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
33185541|NCT00805935|100590396|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
33185542|NCT00805935|100590393|FG000|Overall Study|Lost to Follow-up|1|||
33185543|NCT00805935|100590394|FG001|Overall Study|Lost to Follow-up|0|||
33185544|NCT00805935|100590395|FG002|Overall Study|Lost to Follow-up|0|||
33185545|NCT00805935|100590396|FG003|Overall Study|Lost to Follow-up|0|||
33185546|NCT00805935|100590393|FG000|Overall Study|No positive serum pregnancy|8|||
33185547|NCT00805935|100590394|FG001|Overall Study|No positive serum pregnancy|7|||
33185548|NCT00805935|100590395|FG002|Overall Study|No positive serum pregnancy|6|||
33185549|NCT00805935|100590396|FG003|Overall Study|No positive serum pregnancy|5|||
33185550|NCT00805935|100590393|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
33185551|NCT00805935|100590394|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
33185552|NCT00805935|100590395|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
33185553|NCT00805935|100590396|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
33185554|NCT00805935|100590393|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
33185555|NCT00805935|100590394|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
33185556|NCT00805935|100590395|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
33185557|NCT00805935|100590396|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
33185558|NCT00805935|100590393|FG000|Overall Study|Biochemical pregnancy|0|||
33185559|NCT00805935|100590394|FG001|Overall Study|Biochemical pregnancy|1|||
33185560|NCT00805935|100590395|FG002|Overall Study|Biochemical pregnancy|0|||
33185561|NCT00805935|100590396|FG003|Overall Study|Biochemical pregnancy|0|||
33185562|NCT00805935|100590393|FG000|Overall Study|Chemical pregnancy|0|||
33185563|NCT00805935|100590394|FG001|Overall Study|Chemical pregnancy|5|||
33185564|NCT00805935|100590395|FG002|Overall Study|Chemical pregnancy|3|||
33185565|NCT00805935|100590396|FG003|Overall Study|Chemical pregnancy|2|||
33185566|NCT00805935|100590393|FG000|Overall Study|Ectopic pregnancy|0|||
33185567|NCT00805935|100590394|FG001|Overall Study|Ectopic pregnancy|0|||
33185568|NCT00805935|100590395|FG002|Overall Study|Ectopic pregnancy|1|||
33185569|NCT00805935|100590396|FG003|Overall Study|Ectopic pregnancy|0|||
33185570|NCT00805935|100590393|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
33185571|NCT00805935|100590394|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
33185572|NCT00805935|100590395|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
33185573|NCT00805935|100590396|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
33185574|NCT00606892|100590397|FG000|First Intervention|Protocol Violation|1|||
33185575|NCT00606892|100590398|FG001|First Intervention|Protocol Violation|4|||
33185576|NCT03026257|100590399|FG000|Overall Study|Adverse Event|3|||
33287025|NCT00505414|100947773|FG003|Maintenance Phase|Withdrawal by Subject|0|||
33185577|NCT03026257|100590400|FG001|Overall Study|Adverse Event|0|||
33185578|NCT03026257|100590401|FG002|Overall Study|Adverse Event|0|||
33185579|NCT03026257|100590402|FG003|Overall Study|Adverse Event|0|||
33185580|NCT03026257|100590403|FG004|Overall Study|Adverse Event|0|||
33185581|NCT03026257|100590404|FG005|Overall Study|Adverse Event|0|||
33185582|NCT03026257|100590399|FG000|Overall Study|Lost to Follow-up|1|||
33185583|NCT03026257|100590400|FG001|Overall Study|Lost to Follow-up|0|||
33185584|NCT03026257|100590401|FG002|Overall Study|Lost to Follow-up|0|||
33185585|NCT03026257|100590402|FG003|Overall Study|Lost to Follow-up|0|||
33185586|NCT03026257|100590403|FG004|Overall Study|Lost to Follow-up|0|||
33185587|NCT03026257|100590404|FG005|Overall Study|Lost to Follow-up|0|||
33185588|NCT03026257|100590399|FG000|Overall Study|Protocol Violation|1|||
33185589|NCT03026257|100590400|FG001|Overall Study|Protocol Violation|0|||
33185590|NCT03026257|100590401|FG002|Overall Study|Protocol Violation|0|||
33185591|NCT03026257|100590402|FG003|Overall Study|Protocol Violation|1|||
33185592|NCT03026257|100590403|FG004|Overall Study|Protocol Violation|1|||
33185593|NCT03026257|100590404|FG005|Overall Study|Protocol Violation|0|||
33185594|NCT03026257|100590399|FG000|Overall Study|Withdrawal by Subject|1|||
33185595|NCT03026257|100590400|FG001|Overall Study|Withdrawal by Subject|1|||
33185596|NCT03026257|100590401|FG002|Overall Study|Withdrawal by Subject|0|||
33185597|NCT03026257|100590402|FG003|Overall Study|Withdrawal by Subject|0|||
33185598|NCT03026257|100590403|FG004|Overall Study|Withdrawal by Subject|0|||
33185599|NCT03026257|100590404|FG005|Overall Study|Withdrawal by Subject|0|||
33185600|NCT00542919|100590407|FG000|Overall Study|Adverse Event|1|||
33185601|NCT00542919|100590408|FG001|Overall Study|Adverse Event|5|||
33185602|NCT00542919|100590409|FG002|Overall Study|Adverse Event|1|||
33185603|NCT00542919|100590407|FG000|Overall Study|Withdrawal by Subject|1|||
33185604|NCT00542919|100590408|FG001|Overall Study|Withdrawal by Subject|0|||
33185605|NCT00542919|100590409|FG002|Overall Study|Withdrawal by Subject|3|||
33185606|NCT00542919|100590407|FG000|Overall Study|Physician Decision|2|||
33185607|NCT00542919|100590408|FG001|Overall Study|Physician Decision|2|||
33185608|NCT00542919|100590409|FG002|Overall Study|Physician Decision|1|||
33185609|NCT00542919|100590407|FG000|Overall Study|Sponsor Decision|1|||
33185610|NCT00542919|100590408|FG001|Overall Study|Sponsor Decision|0|||
33185611|NCT00542919|100590409|FG002|Overall Study|Sponsor Decision|0|||
33185612|NCT00542919|100590407|FG000|Overall Study|Lost to Follow-up|2|||
33185613|NCT00542919|100590408|FG001|Overall Study|Lost to Follow-up|0|||
33185614|NCT00542919|100590409|FG002|Overall Study|Lost to Follow-up|1|||
33185615|NCT02535741|100590410|FG000|Overall Study|Adverse Event|3|||
33185616|NCT02535741|100590410|FG000|Overall Study|Withdrawal by Subject|9|||
33185617|NCT02535741|100590410|FG000|Overall Study|Lost to Follow-up|10|||
33185618|NCT02535741|100590410|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
33185619|NCT02535741|100590410|FG000|Overall Study|Missing data|6|||
33185620|NCT01217060|100590416|FG000|Overall Study|Withdrawal by Subject|1|||
33185621|NCT04327986|100590419|FG000|Overall Study|Physician Decision|2|||
33185622|NCT04327986|100590420|FG001|Overall Study|Physician Decision|0|||
33185623|NCT04327986|100590421|FG002|Overall Study|Physician Decision|0|||
33185624|NCT04327986|100590419|FG000|Overall Study|Death|1|||
33185625|NCT04327986|100590420|FG001|Overall Study|Death|0|||
33185626|NCT04327986|100590421|FG002|Overall Study|Death|0|||
33185627|NCT00006489|100590422|FG000|Overall Study|Adverse Event|3|||
33185628|NCT00006489|100590423|FG001|Overall Study|Adverse Event|2|||
33185629|NCT00006489|100590424|FG002|Overall Study|Adverse Event|4|||
33185630|NCT00006489|100590425|FG003|Overall Study|Adverse Event|3|||
33185631|NCT00006489|100590422|FG000|Overall Study|Withdrawal by Subject|10|||
33185632|NCT00006489|100590423|FG001|Overall Study|Withdrawal by Subject|9|||
33185633|NCT00006489|100590424|FG002|Overall Study|Withdrawal by Subject|9|||
33185634|NCT00006489|100590425|FG003|Overall Study|Withdrawal by Subject|6|||
33185635|NCT00006489|100590422|FG000|Overall Study|Scheduling Conflict|0|||
33185636|NCT00006489|100590423|FG001|Overall Study|Scheduling Conflict|3|||
33185637|NCT00006489|100590424|FG002|Overall Study|Scheduling Conflict|2|||
33185638|NCT00006489|100590425|FG003|Overall Study|Scheduling Conflict|1|||
33185639|NCT00006489|100590422|FG000|Overall Study|Death|0|||
33185640|NCT00006489|100590423|FG001|Overall Study|Death|0|||
33185641|NCT00006489|100590424|FG002|Overall Study|Death|0|||
33185642|NCT00006489|100590425|FG003|Overall Study|Death|1|||
33185643|NCT03323658|100590426|FG000|Overall Study|Adverse Event|0|||
33185644|NCT03323658|100590427|FG001|Overall Study|Adverse Event|1|||
33185645|NCT03323658|100590428|FG002|Overall Study|Adverse Event|0|||
33185646|NCT03829046|100590429|FG000|Overall Study|Withdrawal by Subject|1|||
33185647|NCT03829046|100590430|FG001|Overall Study|Withdrawal by Subject|0|||
33185648|NCT02579265|100590431|FG000|Overall Study|Weaned off earlier than 28 days|44|||
33185649|NCT02579265|100590432|FG001|Overall Study|Weaned off earlier than 28 days|43|||
33185650|NCT02579265|100590431|FG000|Overall Study|Adverse Event|2|||
33185651|NCT02579265|100590432|FG001|Overall Study|Adverse Event|0|||
33185652|NCT02579265|100590431|FG000|Overall Study|Any other reason not specified|0|||
33185653|NCT02579265|100590432|FG001|Overall Study|Any other reason not specified|2|||
33185654|NCT02579265|100590431|FG000|Overall Study|Withdrawal by Subject|2|||
33185655|NCT02579265|100590432|FG001|Overall Study|Withdrawal by Subject|0|||
33185656|NCT02579265|100590431|FG000|Overall Study|Physician Decision|1|||
33185657|NCT02579265|100590432|FG001|Overall Study|Physician Decision|0|||
33185658|NCT02579265|100590431|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
33185659|NCT02579265|100590432|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
33185660|NCT01293240|100590433|FG000|Overall Study|Noncompliance|2|||
33185661|NCT02114879|100590436|FG000|Overall Study|Withdrawal by Subject|9|||
33185662|NCT02114879|100590437|FG001|Overall Study|Withdrawal by Subject|5|||
33185663|NCT02114879|100590436|FG000|Overall Study|Death|6|||
33185664|NCT02114879|100590437|FG001|Overall Study|Death|11|||
33185665|NCT02114879|100590436|FG000|Overall Study|Lost to Follow-up|4|||
33185666|NCT02114879|100590437|FG001|Overall Study|Lost to Follow-up|6|||
33185667|NCT02114879|100590436|FG000|Overall Study|Physician Decision|0|||
33185668|NCT02114879|100590437|FG001|Overall Study|Physician Decision|2|||
33185669|NCT04033159|100590453|FG000|Washout Period|Physician Decision|0|||
33185670|NCT04033159|100590454|FG001|Washout Period|Physician Decision|1|||
33185671|NCT04033159|100590455|FG002|Washout Period|Physician Decision|0|||
33185672|NCT04033159|100590453|FG000|Washout Period|Study terminated by Sponsor|0|||
33185673|NCT04033159|100590454|FG001|Washout Period|Study terminated by Sponsor|7|||
33185674|NCT04033159|100590455|FG002|Washout Period|Study terminated by Sponsor|0|||
33185675|NCT04033159|100590453|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
33185676|NCT04033159|100590454|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
33185677|NCT04033159|100590455|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
33185678|NCT01660412|100590456|FG000|Overall Study|Protocol Violation|0|||
33185679|NCT01660412|100590457|FG001|Overall Study|Protocol Violation|3|||
33185680|NCT02586493|100590458|FG000|Overall Study|Adverse Event|4|||
33185681|NCT02586493|100590458|FG000|Overall Study|Protocol Violation|6|||
33185682|NCT02586493|100590458|FG000|Overall Study|Lost to Follow-up|1|||
33185683|NCT02586493|100590458|FG000|Overall Study|Withdrawal by Subject|1|||
33185684|NCT02196324|100590463|FG000|Overall Study|Withdrawal by Subject|8|||
33185685|NCT02196324|100590464|FG001|Overall Study|Withdrawal by Subject|4|||
33185686|NCT02196324|100590463|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
33185687|NCT02196324|100590464|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
33185688|NCT02196324|100590463|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
33185689|NCT02196324|100590464|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
33185690|NCT02196324|100590463|FG000|Overall Study|Other|1|||
33185691|NCT02196324|100590464|FG001|Overall Study|Other|0|||
33185692|NCT04145895|100590467|FG000|Overall Study|Physician Decision|2|||
33185693|NCT04145895|100590468|FG001|Overall Study|Physician Decision|0|||
33185694|NCT04145895|100590467|FG000|Overall Study|Withdrawal by Subject|0|||
33185695|NCT04145895|100590468|FG001|Overall Study|Withdrawal by Subject|2|||
33185696|NCT02739269|100590472|FG000|Overall Study|Protocol Violation|5|||
33185697|NCT02739269|100590473|FG001|Overall Study|Protocol Violation|0|||
33185698|NCT02739269|100590472|FG000|Overall Study|Cycle cancellation|2|||
33185699|NCT02739269|100590473|FG001|Overall Study|Cycle cancellation|2|||
33185700|NCT02739269|100590472|FG000|Overall Study|Withdrawal by Subject|0|||
33185701|NCT02739269|100590473|FG001|Overall Study|Withdrawal by Subject|2|||
33185702|NCT01200797|100590476|FG000|Overall Study|symptomatic deterioration|2|||
33185703|NCT01200797|100590476|FG000|Overall Study|Adverse Event|4|||
33185704|NCT01200797|100590476|FG000|Overall Study|Disease Progression|13|||
33185705|NCT00600756|100590477|FG000|Analysis After 6 Months|Adverse Event|43|||
33185706|NCT00600756|100590478|FG001|Analysis After 6 Months|Adverse Event|33|||
33185707|NCT00600756|100590477|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
33185708|NCT00600756|100590478|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
33185709|NCT00600756|100590477|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
33185710|NCT00600756|100590478|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
33185711|NCT00600756|100590477|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
33185712|NCT00600756|100590478|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
33185713|NCT00600756|100590477|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
33185714|NCT00600756|100590478|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
33185715|NCT00600756|100590477|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
33185716|NCT00600756|100590478|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
33185717|NCT00600756|100590477|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
33185718|NCT00600756|100590478|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
33185719|NCT00600756|100590477|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
33185720|NCT00600756|100590478|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
33185721|NCT00600756|100590477|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
33185722|NCT00600756|100590478|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
33185723|NCT00600756|100590477|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
33185724|NCT00600756|100590478|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
33185725|NCT00600756|100590477|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
33185726|NCT00600756|100590478|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
33185727|NCT00600756|100590477|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
33224219|NCT03489057|100721756|FG001|Overall Study|Withdrawal by Subject|12|||
33185728|NCT00600756|100590478|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
33185729|NCT00600756|100590477|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
33185730|NCT00600756|100590478|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
33185731|NCT00600756|100590477|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
33185732|NCT00600756|100590478|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
33185733|NCT00788827|100590479|FG000|Overall Study|Lack of Efficacy|2|||
33185734|NCT02972632|100590482|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
33185735|NCT02972632|100590482|FG000|Overall Study|Lost to Follow-up|4|||
33185736|NCT02972632|100590482|FG000|Overall Study|Voluntary Withdrawal|10|||
33185737|NCT01907828|100590483|FG000|Overall Study|Exclusion criteria not met|0|||
33185738|NCT01907828|100590484|FG001|Overall Study|Exclusion criteria not met|1|||
33185739|NCT01907828|100590483|FG000|Overall Study|Withdrawal by Subject|3|||
33185740|NCT01907828|100590484|FG001|Overall Study|Withdrawal by Subject|4|||
33185741|NCT01907828|100590483|FG000|Overall Study|Lost to Follow-up|3|||
33185742|NCT01907828|100590484|FG001|Overall Study|Lost to Follow-up|0|||
33185743|NCT01907828|100590483|FG000|Overall Study|Participant refused 24-month follow-up|1|||
33185744|NCT01907828|100590484|FG001|Overall Study|Participant refused 24-month follow-up|0|||
33185745|NCT01907828|100590483|FG000|Overall Study|Participant met exclusion criteria|0|||
33185746|NCT01907828|100590484|FG001|Overall Study|Participant met exclusion criteria|1|||
33185747|NCT02849548|100590485|FG000|Overall Study|Lost to Follow-up|1|||
33185748|NCT02849548|100590486|FG001|Overall Study|Lost to Follow-up|2|||
33185749|NCT02849548|100590485|FG000|Overall Study|Protocol Violation|1|||
33185750|NCT02849548|100590486|FG001|Overall Study|Protocol Violation|0|||
33185751|NCT02506816|100590487|FG000|Overall Study|Adverse Event|3|||
33185752|NCT00613509|100590488|FG000|Cycle 1|Adverse Event|2|||
33185753|NCT00613509|100590489|FG001|Cycle 1|Adverse Event|1|||
33185754|NCT00613509|100590488|FG000|Cycle 1|Disease Progression|2|||
33185755|NCT00613509|100590489|FG001|Cycle 1|Disease Progression|6|||
33185756|NCT00613509|100590488|FG000|Cycle 1|Unacceptable Toxicity|1|||
33185757|NCT00613509|100590489|FG001|Cycle 1|Unacceptable Toxicity|0|||
33185758|NCT00613509|100590488|FG000|Cycle 1|Other administrative reason|0|||
33185759|NCT00613509|100590489|FG001|Cycle 1|Other administrative reason|1|||
33185760|NCT01640366|100590491|FG000|Overall Study|Withdrawal by Subject|1|||
33185761|NCT01640366|100590491|FG000|Overall Study|Protocol Violation|16|||
33185762|NCT01640366|100590491|FG000|Overall Study|Lost to Follow-up|5|||
33185763|NCT01921179|100590499|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
33185764|NCT01921179|100590500|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
33185765|NCT01921179|100590499|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
33185766|NCT01921179|100590500|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
33185767|NCT02356783|100590501|FG000|Overall Study|Lost to Follow-up|1|||
33185768|NCT02356783|100590502|FG001|Overall Study|Lost to Follow-up|3|||
33185769|NCT00594464|100590505|FG000|Overall Study|Withdrawal by Subject|1|||
33185770|NCT00594464|100590505|FG000|Overall Study|Delay in operation|2|||
33185771|NCT03551210|100590506|FG000|Overall Study|Adverse Event|5|||
33185772|NCT03551210|100590507|FG001|Overall Study|Adverse Event|6|||
33185773|NCT03551210|100590506|FG000|Overall Study|Withdrawal by Subject|1|||
33185774|NCT03551210|100590507|FG001|Overall Study|Withdrawal by Subject|7|||
33185775|NCT03551210|100590506|FG000|Overall Study|Needed in other antibiotic treatment|2|||
33185776|NCT03551210|100590507|FG001|Overall Study|Needed in other antibiotic treatment|5|||
33185777|NCT03551210|100590506|FG000|Overall Study|Lost to Follow-up|1|||
33185778|NCT03551210|100590507|FG001|Overall Study|Lost to Follow-up|1|||
33185779|NCT03551210|100590506|FG000|Overall Study|Absence of visit 4 and 5|1|||
33185780|NCT03551210|100590507|FG001|Overall Study|Absence of visit 4 and 5|0|||
33185781|NCT03551210|100590506|FG000|Overall Study|No drug for dispensing|0|||
33185782|NCT03551210|100590507|FG001|Overall Study|No drug for dispensing|1|||
33185783|NCT00348556|100590508|FG000|Overall Study|Adverse Event|1|||
33185784|NCT04098458|100590512|FG000|Overall Study|Death|1|||
33185785|NCT04098458|100590512|FG000|Overall Study|did not meet study inclusion criteria|3|||
33185786|NCT03569371|100590513|FG000|Overall Study|Lack of Efficacy|1|||
33185787|NCT03569371|100590513|FG000|Overall Study|Lost to Follow-up|1|||
33185788|NCT03569371|100590513|FG000|Overall Study|Adverse Event|1|||
33185789|NCT02244580|100590514|FG000|Overall Study|No cancer tissues available|241|||
33185790|NCT00677807|100590515|FG000|Overall Study|Adverse Event|4|||
33185791|NCT00677807|100590516|FG001|Overall Study|Adverse Event|1|||
33185792|NCT00677807|100590517|FG002|Overall Study|Adverse Event|6|||
33185793|NCT00677807|100590515|FG000|Overall Study|Lack of Efficacy|0|||
33185794|NCT00677807|100590516|FG001|Overall Study|Lack of Efficacy|0|||
33185795|NCT00677807|100590517|FG002|Overall Study|Lack of Efficacy|2|||
33185796|NCT00677807|100590515|FG000|Overall Study|Participant no longer needs study drug|0|||
33185797|NCT00677807|100590516|FG001|Overall Study|Participant no longer needs study drug|0|||
33185798|NCT00677807|100590517|FG002|Overall Study|Participant no longer needs study drug|1|||
33185799|NCT00677807|100590515|FG000|Overall Study|Withdrawal by Subject|10|||
33493948|NCT03154125|101698316|FG000|Overall Study|Physician Decision|13|||
33185800|NCT00677807|100590516|FG001|Overall Study|Withdrawal by Subject|3|||
33185801|NCT00677807|100590517|FG002|Overall Study|Withdrawal by Subject|6|||
33185802|NCT00677807|100590515|FG000|Overall Study|Lost to Follow-up|2|||
33185803|NCT00677807|100590516|FG001|Overall Study|Lost to Follow-up|2|||
33185804|NCT00677807|100590517|FG002|Overall Study|Lost to Follow-up|2|||
33185805|NCT00677807|100590515|FG000|Overall Study|Administrative problems|1|||
33185806|NCT00677807|100590516|FG001|Overall Study|Administrative problems|1|||
33185807|NCT00677807|100590517|FG002|Overall Study|Administrative problems|2|||
33185808|NCT00677807|100590515|FG000|Overall Study|Death|0|||
33185809|NCT00677807|100590516|FG001|Overall Study|Death|1|||
33185810|NCT00677807|100590517|FG002|Overall Study|Death|1|||
33185811|NCT00677807|100590515|FG000|Overall Study|Protocol Deviation|1|||
33185812|NCT00677807|100590516|FG001|Overall Study|Protocol Deviation|3|||
33185813|NCT00677807|100590517|FG002|Overall Study|Protocol Deviation|0|||
33185814|NCT03595878|100590528|FG000|Overall Study|Death|2|||
33185815|NCT03595878|100590529|FG001|Overall Study|Death|1|||
33185816|NCT03595878|100590530|FG002|Overall Study|Death|0|||
33185817|NCT03595878|100590528|FG000|Overall Study|Disease progression|2|||
33185818|NCT03595878|100590529|FG001|Overall Study|Disease progression|1|||
33185819|NCT03595878|100590530|FG002|Overall Study|Disease progression|2|||
33185820|NCT04056195|100590531|FG000|Overall Study|Adverse Event|1|||
33185821|NCT04056195|100590532|FG001|Overall Study|Adverse Event|0|||
33185822|NCT04056195|100590533|FG002|Overall Study|Adverse Event|0|||
33185823|NCT04056195|100590531|FG000|Overall Study|Withdrawal by Subject|0|||
33185824|NCT04056195|100590532|FG001|Overall Study|Withdrawal by Subject|1|||
33185825|NCT04056195|100590533|FG002|Overall Study|Withdrawal by Subject|1|||
33185826|NCT04056195|100590531|FG000|Overall Study|Physician Decision|1|||
33185827|NCT04056195|100590532|FG001|Overall Study|Physician Decision|1|||
33185828|NCT04056195|100590533|FG002|Overall Study|Physician Decision|1|||
33185829|NCT01933048|100590534|FG000|Overall Study|Lost to Follow-up|15|||
33185830|NCT01933048|100590535|FG001|Overall Study|Lost to Follow-up|18|||
33185831|NCT01933048|100590534|FG000|Overall Study|personal reasons|1|||
33185832|NCT01933048|100590535|FG001|Overall Study|personal reasons|1|||
33185833|NCT01933048|100590534|FG000|Overall Study|Protocol Violation|7|||
33185834|NCT01933048|100590535|FG001|Overall Study|Protocol Violation|8|||
33185835|NCT01933048|100590534|FG000|Overall Study|Physician Decision|1|||
33185836|NCT01933048|100590535|FG001|Overall Study|Physician Decision|0|||
33185837|NCT01933048|100590534|FG000|Overall Study|unknown reasons|1|||
33185838|NCT01933048|100590535|FG001|Overall Study|unknown reasons|1|||
33185839|NCT03509675|100590538|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
33185840|NCT03509675|100590539|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
33185841|NCT03509675|100590538|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
33287026|NCT00505414|100947774|FG004|Maintenance Phase|Withdrawal by Subject|0|||
33287027|NCT00505414|100947770|FG000|Maintenance Phase|underlying disease and therapy required|0|||
33287028|NCT00505414|100947771|FG001|Maintenance Phase|underlying disease and therapy required|2|||
33287029|NCT00505414|100947772|FG002|Maintenance Phase|underlying disease and therapy required|2|||
33287030|NCT00505414|100947773|FG003|Maintenance Phase|underlying disease and therapy required|0|||
33287031|NCT00505414|100947774|FG004|Maintenance Phase|underlying disease and therapy required|0|||
33287032|NCT00043186|100947775|FG000|Overall Study|Physician Decision|0|||
33287033|NCT00043186|100947776|FG001|Overall Study|Physician Decision|0|||
33287034|NCT00043186|100947777|FG002|Overall Study|Physician Decision|3|||
33287035|NCT00043186|100947778|FG003|Overall Study|Physician Decision|0|||
33287036|NCT00043186|100947779|FG004|Overall Study|Physician Decision|1|||
33287037|NCT00043186|100947780|FG005|Overall Study|Physician Decision|0|||
33287038|NCT00043186|100947781|FG006|Overall Study|Physician Decision|0|||
33287039|NCT00043186|100947782|FG007|Overall Study|Physician Decision|1|||
33287040|NCT00043186|100947783|FG008|Overall Study|Physician Decision|1|||
33287041|NCT00043186|100947775|FG000|Overall Study|Adverse Event|2|||
33287042|NCT00043186|100947776|FG001|Overall Study|Adverse Event|2|||
33287043|NCT00043186|100947777|FG002|Overall Study|Adverse Event|2|||
33287044|NCT00043186|100947778|FG003|Overall Study|Adverse Event|3|||
33287045|NCT00043186|100947779|FG004|Overall Study|Adverse Event|2|||
33287046|NCT00043186|100947780|FG005|Overall Study|Adverse Event|1|||
33287047|NCT00043186|100947781|FG006|Overall Study|Adverse Event|2|||
33287048|NCT00043186|100947782|FG007|Overall Study|Adverse Event|1|||
33287049|NCT00043186|100947783|FG008|Overall Study|Adverse Event|3|||
33287050|NCT00043186|100947775|FG000|Overall Study|Withdrawal by Subject|11|||
33287051|NCT00043186|100947776|FG001|Overall Study|Withdrawal by Subject|8|||
33287052|NCT00043186|100947777|FG002|Overall Study|Withdrawal by Subject|11|||
33287053|NCT00043186|100947778|FG003|Overall Study|Withdrawal by Subject|13|||
33287054|NCT00043186|100947779|FG004|Overall Study|Withdrawal by Subject|14|||
33287055|NCT00043186|100947780|FG005|Overall Study|Withdrawal by Subject|6|||
33287056|NCT00043186|100947781|FG006|Overall Study|Withdrawal by Subject|12|||
33287057|NCT00043186|100947782|FG007|Overall Study|Withdrawal by Subject|9|||
33287058|NCT00043186|100947783|FG008|Overall Study|Withdrawal by Subject|10|||
33287059|NCT00043186|100947775|FG000|Overall Study|Death|0|||
33287060|NCT00043186|100947776|FG001|Overall Study|Death|0|||
33185842|NCT03509675|100590539|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
33185843|NCT03509675|100590538|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
33287061|NCT00043186|100947777|FG002|Overall Study|Death|1|||
33287062|NCT00043186|100947778|FG003|Overall Study|Death|0|||
33287063|NCT00043186|100947779|FG004|Overall Study|Death|0|||
33287064|NCT00043186|100947780|FG005|Overall Study|Death|0|||
33287065|NCT00043186|100947781|FG006|Overall Study|Death|2|||
33287066|NCT00043186|100947782|FG007|Overall Study|Death|0|||
33287067|NCT00043186|100947783|FG008|Overall Study|Death|0|||
33287068|NCT00043186|100947775|FG000|Overall Study|Disease progression|1|||
33287069|NCT00043186|100947776|FG001|Overall Study|Disease progression|0|||
33287070|NCT00043186|100947777|FG002|Overall Study|Disease progression|0|||
33287071|NCT00043186|100947778|FG003|Overall Study|Disease progression|3|||
33287072|NCT00043186|100947779|FG004|Overall Study|Disease progression|0|||
33287073|NCT00043186|100947780|FG005|Overall Study|Disease progression|0|||
33287074|NCT00043186|100947781|FG006|Overall Study|Disease progression|0|||
33287075|NCT00043186|100947782|FG007|Overall Study|Disease progression|4|||
33287076|NCT00043186|100947783|FG008|Overall Study|Disease progression|0|||
33287077|NCT00043186|100947775|FG000|Overall Study|Ineligibility determined|0|||
33287078|NCT00043186|100947776|FG001|Overall Study|Ineligibility determined|0|||
33287079|NCT00043186|100947777|FG002|Overall Study|Ineligibility determined|0|||
33287080|NCT00043186|100947778|FG003|Overall Study|Ineligibility determined|0|||
33287081|NCT00043186|100947779|FG004|Overall Study|Ineligibility determined|0|||
33287082|NCT00043186|100947780|FG005|Overall Study|Ineligibility determined|0|||
33287083|NCT00043186|100947781|FG006|Overall Study|Ineligibility determined|0|||
33287084|NCT00043186|100947782|FG007|Overall Study|Ineligibility determined|0|||
33287085|NCT00043186|100947783|FG008|Overall Study|Ineligibility determined|1|||
33287086|NCT00043186|100947775|FG000|Overall Study|Lost to Follow-up|3|||
33287087|NCT00043186|100947776|FG001|Overall Study|Lost to Follow-up|5|||
33287088|NCT00043186|100947777|FG002|Overall Study|Lost to Follow-up|1|||
33287089|NCT00043186|100947778|FG003|Overall Study|Lost to Follow-up|1|||
33287090|NCT00043186|100947779|FG004|Overall Study|Lost to Follow-up|1|||
33287091|NCT00043186|100947780|FG005|Overall Study|Lost to Follow-up|1|||
33287092|NCT00043186|100947781|FG006|Overall Study|Lost to Follow-up|1|||
33287093|NCT00043186|100947782|FG007|Overall Study|Lost to Follow-up|1|||
33287094|NCT00043186|100947783|FG008|Overall Study|Lost to Follow-up|2|||
33287095|NCT00043186|100947775|FG000|Overall Study|Noncompliance|0|||
33287096|NCT00043186|100947776|FG001|Overall Study|Noncompliance|0|||
33287097|NCT00043186|100947777|FG002|Overall Study|Noncompliance|1|||
33287098|NCT00043186|100947778|FG003|Overall Study|Noncompliance|1|||
33287099|NCT00043186|100947779|FG004|Overall Study|Noncompliance|0|||
33287100|NCT00043186|100947780|FG005|Overall Study|Noncompliance|0|||
33287101|NCT00043186|100947781|FG006|Overall Study|Noncompliance|0|||
33287102|NCT00043186|100947782|FG007|Overall Study|Noncompliance|0|||
33287103|NCT00043186|100947783|FG008|Overall Study|Noncompliance|0|||
33287104|NCT00043186|100947775|FG000|Overall Study|Other|0|||
33287105|NCT00043186|100947776|FG001|Overall Study|Other|0|||
33287106|NCT00043186|100947777|FG002|Overall Study|Other|1|||
33287107|NCT00043186|100947778|FG003|Overall Study|Other|1|||
33287108|NCT00043186|100947779|FG004|Overall Study|Other|0|||
33287109|NCT00043186|100947780|FG005|Overall Study|Other|0|||
33287110|NCT00043186|100947781|FG006|Overall Study|Other|0|||
33287111|NCT00043186|100947782|FG007|Overall Study|Other|0|||
33287112|NCT00043186|100947783|FG008|Overall Study|Other|0|||
33287113|NCT00604188|100947784|FG000|Overall Study|Adverse Event|1|||
33287114|NCT00604188|100947785|FG001|Overall Study|Adverse Event|4|||
33287115|NCT00604188|100947784|FG000|Overall Study|Lost to Follow-up|17|||
33287116|NCT00604188|100947785|FG001|Overall Study|Lost to Follow-up|15|||
33287117|NCT00604188|100947784|FG000|Overall Study|Withdrawal by Subject|5|||
33287118|NCT00604188|100947785|FG001|Overall Study|Withdrawal by Subject|1|||
33287119|NCT00604188|100947784|FG000|Overall Study|Non-compliance with protocol|4|||
33287120|NCT00604188|100947785|FG001|Overall Study|Non-compliance with protocol|4|||
33287121|NCT00604188|100947784|FG000|Overall Study|Did not receive study drug|0|||
33287122|NCT00604188|100947785|FG001|Overall Study|Did not receive study drug|1|||
33287123|NCT03864341|100947793|FG000|Overall Study|Withdrawal by Subject|1|||
33287124|NCT01836198|100947795|FG000|Part A, Period 2|Protocol Violation|0|||
33185844|NCT03509675|100590539|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
33185845|NCT03509675|100590538|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
33185846|NCT03509675|100590539|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
33185847|NCT02603432|100590542|FG000|Overall Study|Adverse Event|1|||
33185848|NCT02603432|100590543|FG001|Overall Study|Adverse Event|0|||
33185849|NCT02603432|100590542|FG000|Overall Study|Death|221|||
33185850|NCT02603432|100590543|FG001|Overall Study|Death|242|||
33185851|NCT02603432|100590542|FG000|Overall Study|Lost to Follow-up|3|||
33287125|NCT01836198|100947796|FG001|Part A, Period 2|Protocol Violation|1|||
33287126|NCT01836198|100947797|FG002|Part A, Period 2|Protocol Violation|0|||
33185852|NCT02603432|100590543|FG001|Overall Study|Lost to Follow-up|9|||
33185853|NCT02603432|100590542|FG000|Overall Study|Progressive Disease|7|||
33185854|NCT02603432|100590543|FG001|Overall Study|Progressive Disease|5|||
33287127|NCT01086384|100947798|FG000|2-week Run-in Period|Adverse Event|1|||
33287128|NCT01086384|100947799|FG001|2-week Run-in Period|Adverse Event|0|||
33287129|NCT01086384|100947800|FG002|2-week Run-in Period|Adverse Event|0|||
33185855|NCT02603432|100590542|FG000|Overall Study|Withdrawal by Subject|12|||
33185856|NCT02603432|100590543|FG001|Overall Study|Withdrawal by Subject|18|||
33185857|NCT02603432|100590542|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
33185858|NCT02603432|100590543|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33185859|NCT02603432|100590542|FG000|Overall Study|Study terminated by sponsor|74|||
33185860|NCT02603432|100590543|FG001|Overall Study|Study terminated by sponsor|75|||
33185861|NCT02603432|100590542|FG000|Overall Study|Other|13|||
33185862|NCT02603432|100590543|FG001|Overall Study|Other|0|||
33185863|NCT01822132|100590544|FG000|Overall Study|Lost to Follow-up|4|||
33185864|NCT01822132|100590545|FG001|Overall Study|Lost to Follow-up|2|||
33185865|NCT01945489|100590549|FG000|Cycle 1|Adverse Event|2|||
33185866|NCT01945489|100590550|FG001|Cycle 1|Adverse Event|0|||
33185867|NCT01945489|100590549|FG000|Cycle 1|Lost to Follow-up|4|||
33185868|NCT01945489|100590550|FG001|Cycle 1|Lost to Follow-up|0|||
33185869|NCT01945489|100590549|FG000|Cycle 1|Personal Reasons|4|||
33185870|NCT01945489|100590550|FG001|Cycle 1|Personal Reasons|2|||
33185871|NCT01945489|100590549|FG000|Cycle 1|Protocol Violation|0|||
33185872|NCT01945489|100590550|FG001|Cycle 1|Protocol Violation|1|||
33185873|NCT01945489|100590549|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
33185874|NCT01945489|100590550|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
33185875|NCT01945489|100590549|FG000|Cycle 2|Adverse Event|1|||
33185876|NCT01945489|100590550|FG001|Cycle 2|Adverse Event|0|||
33185877|NCT01945489|100590549|FG000|Cycle 2|Lost to Follow-up|0|||
33185878|NCT01945489|100590550|FG001|Cycle 2|Lost to Follow-up|1|||
33185879|NCT04248816|100590551|FG000|Overall Study|Ineligible post-randomization|7|||
33185880|NCT04248816|100590552|FG001|Overall Study|Ineligible post-randomization|21|||
33185881|NCT04248816|100590553|FG002|Overall Study|Ineligible post-randomization|25|||
33185882|NCT02731729|100590554|FG000|Overall Study|Death|2|||
33185883|NCT02731729|100590555|FG001|Overall Study|Death|2|||
33185884|NCT02731729|100590554|FG000|Overall Study|Study terminated by Sponsor|6|||
33185885|NCT02731729|100590555|FG001|Overall Study|Study terminated by Sponsor|6|||
33185886|NCT02731729|100590554|FG000|Overall Study|Withdrawal by Subject|1|||
33185887|NCT02731729|100590555|FG001|Overall Study|Withdrawal by Subject|0|||
33185888|NCT00692770|100590559|FG000|Overall Study|Protocol Violation|2|||
33185889|NCT00692770|100590560|FG001|Overall Study|Protocol Violation|7|||
33185890|NCT00692770|100590559|FG000|Overall Study|Withdrawal by Subject|97|||
33185891|NCT00692770|100590560|FG001|Overall Study|Withdrawal by Subject|36|||
33185892|NCT00692770|100590559|FG000|Overall Study|Adverse Event|136|||
33185893|NCT00692770|100590560|FG001|Overall Study|Adverse Event|41|||
33185894|NCT00692770|100590559|FG000|Overall Study|Death|10|||
33185895|NCT00692770|100590560|FG001|Overall Study|Death|5|||
33287130|NCT01086384|100947798|FG000|2-week Run-in Period|Protocol Violation|1|||
33287131|NCT01086384|100947799|FG001|2-week Run-in Period|Protocol Violation|0|||
33287132|NCT01086384|100947800|FG002|2-week Run-in Period|Protocol Violation|0|||
33287133|NCT01086384|100947798|FG000|2-week Run-in Period|Lost to Follow-up|1|||
33287134|NCT01086384|100947799|FG001|2-week Run-in Period|Lost to Follow-up|0|||
33287135|NCT01086384|100947800|FG002|2-week Run-in Period|Lost to Follow-up|0|||
33287136|NCT01086384|100947798|FG000|2-week Run-in Period|Physician Decision|6|||
33287137|NCT01086384|100947799|FG001|2-week Run-in Period|Physician Decision|0|||
33287138|NCT01086384|100947800|FG002|2-week Run-in Period|Physician Decision|0|||
33287139|NCT01086384|100947798|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
33287140|NCT01086384|100947799|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
33287141|NCT01086384|100947800|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
33287142|NCT01086384|100947798|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
33287143|NCT01086384|100947799|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
33287144|NCT01086384|100947800|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
33287145|NCT01086384|100947798|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
33287146|NCT01086384|100947799|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
33287147|NCT01086384|100947800|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
33287148|NCT01086384|100947798|FG000|2-week Run-in Period|Randomized in Error|1|||
33287149|NCT01086384|100947799|FG001|2-week Run-in Period|Randomized in Error|0|||
33287150|NCT01086384|100947800|FG002|2-week Run-in Period|Randomized in Error|0|||
33287151|NCT01086384|100947798|FG000|Treatment Period|Withdrawal by Subject|0|||
33287152|NCT01086384|100947799|FG001|Treatment Period|Withdrawal by Subject|53|||
33287153|NCT01086384|100947800|FG002|Treatment Period|Withdrawal by Subject|55|||
33287154|NCT01086384|100947798|FG000|Treatment Period|Protocol Violation|0|||
33287155|NCT01086384|100947799|FG001|Treatment Period|Protocol Violation|26|||
33287156|NCT01086384|100947800|FG002|Treatment Period|Protocol Violation|17|||
33287157|NCT01086384|100947798|FG000|Treatment Period|Lack of Efficacy|0|||
33287158|NCT01086384|100947799|FG001|Treatment Period|Lack of Efficacy|22|||
33287159|NCT01086384|100947800|FG002|Treatment Period|Lack of Efficacy|13|||
33287160|NCT01086384|100947798|FG000|Treatment Period|Adverse Event|0|||
33287161|NCT01086384|100947799|FG001|Treatment Period|Adverse Event|19|||
33185896|NCT00692770|100590559|FG000|Overall Study|Lost to Follow-up|7|||
33287162|NCT01086384|100947800|FG002|Treatment Period|Adverse Event|15|||
33185897|NCT00692770|100590560|FG001|Overall Study|Lost to Follow-up|3|||
33185898|NCT00692770|100590559|FG000|Overall Study|Non-compliant with study medication|11|||
33287163|NCT01086384|100947798|FG000|Treatment Period|Lost to Follow-up|0|||
33287164|NCT01086384|100947799|FG001|Treatment Period|Lost to Follow-up|11|||
33287165|NCT01086384|100947800|FG002|Treatment Period|Lost to Follow-up|9|||
33287166|NCT01086384|100947798|FG000|Treatment Period|Physician Decision|0|||
33287167|NCT01086384|100947799|FG001|Treatment Period|Physician Decision|9|||
33287168|NCT01086384|100947800|FG002|Treatment Period|Physician Decision|6|||
33287169|NCT01086384|100947798|FG000|Treatment Period|Study Closed/Terminated|0|||
33287170|NCT01086384|100947799|FG001|Treatment Period|Study Closed/Terminated|7|||
33287171|NCT01086384|100947800|FG002|Treatment Period|Study Closed/Terminated|8|||
33287172|NCT01086384|100947798|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
33287173|NCT01086384|100947799|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
33287174|NCT01086384|100947800|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
33185899|NCT00692770|100590560|FG001|Overall Study|Non-compliant with study medication|5|||
33185900|NCT00692770|100590559|FG000|Overall Study|Progression by clinical judgment|2|||
33287175|NCT01086384|100947798|FG000|Treatment Period|Received Treatment in Error|0|||
33287176|NCT01086384|100947799|FG001|Treatment Period|Received Treatment in Error|1|||
33287177|NCT01086384|100947800|FG002|Treatment Period|Received Treatment in Error|0|||
33287178|NCT01321723|100947804|FG000|Overall Study|Adverse Event|3|||
33287179|NCT01321723|100947805|FG001|Overall Study|Adverse Event|5|||
33287180|NCT01321723|100947806|FG002|Overall Study|Adverse Event|2|||
33287181|NCT01321723|100947804|FG000|Overall Study|Withdrawal by Subject|2|||
33287182|NCT01321723|100947805|FG001|Overall Study|Withdrawal by Subject|0|||
33287183|NCT01321723|100947806|FG002|Overall Study|Withdrawal by Subject|2|||
33287184|NCT00719212|100947807|FG000|Overall Study|Death|41|||
33287185|NCT00719212|100947807|FG000|Overall Study|Lost to Follow-up|2|||
33287186|NCT00719212|100947807|FG000|Overall Study|Withdrawal by Subject|1|||
33287187|NCT05239598|100947808|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
33287188|NCT05239598|100947809|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
33287189|NCT05239598|100947808|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
33287190|NCT05239598|100947809|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
33287191|NCT00236184|100947811|FG000|Overall Study|Adverse Event|5|||
33287192|NCT00236184|100947812|FG001|Overall Study|Adverse Event|2|||
33287193|NCT00236184|100947811|FG000|Overall Study|Lack of Efficacy|0|||
33287194|NCT00236184|100947812|FG001|Overall Study|Lack of Efficacy|1|||
33287195|NCT00236184|100947811|FG000|Overall Study|Lost to Follow-up|3|||
33287196|NCT00236184|100947812|FG001|Overall Study|Lost to Follow-up|4|||
33287197|NCT00236184|100947811|FG000|Overall Study|Physician Decision|1|||
33287198|NCT00236184|100947812|FG001|Overall Study|Physician Decision|1|||
33287199|NCT00236184|100947811|FG000|Overall Study|Withdrawal by Subject|3|||
33287200|NCT00236184|100947812|FG001|Overall Study|Withdrawal by Subject|0|||
33287201|NCT00236184|100947811|FG000|Overall Study|Protocol Violation|3|||
33287202|NCT00236184|100947812|FG001|Overall Study|Protocol Violation|0|||
33287203|NCT00236184|100947811|FG000|Overall Study|non-compliance with study drug|2|||
33287204|NCT00236184|100947812|FG001|Overall Study|non-compliance with study drug|1|||
33287205|NCT00236184|100947811|FG000|Overall Study|other|1|||
33287206|NCT00236184|100947812|FG001|Overall Study|other|2|||
33287207|NCT02720185|100947813|FG000|Overall Study|Lost to Follow-up|1|||
33287208|NCT00381888|100947823|FG000|Overall Study|Death|1|||
33287209|NCT00381888|100947823|FG000|Overall Study|Withdrawal by Subject|1|||
33287210|NCT00381888|100947823|FG000|Overall Study|Physician Decision|1|||
33287211|NCT00381888|100947823|FG000|Overall Study|Protocol Violation|9|||
33287212|NCT00381888|100947823|FG000|Overall Study|Had laparoscopic surgery|2|||
33287213|NCT00381888|100947823|FG000|Overall Study|Surgery was cancelled|2|||
33287214|NCT00381888|100947823|FG000|Overall Study|Adverse Event|1|||
33287215|NCT00843115|100947827|FG000|Overall Study|Death|4|||
33287216|NCT00843115|100947827|FG000|Overall Study|Adverse Event|30|||
33287217|NCT00843115|100947827|FG000|Overall Study|Lost to Follow-up|4|||
33287218|NCT00843115|100947827|FG000|Overall Study|Withdrawal by Subject|17|||
33287219|NCT00843115|100947827|FG000|Overall Study|Family wanted meds stopped|1|||
33287220|NCT00843115|100947827|FG000|Overall Study|Family does not want continuation|1|||
33287221|NCT00843115|100947827|FG000|Overall Study|Patient forgot to take meds|1|||
33287222|NCT00843115|100947827|FG000|Overall Study|Does not meet entrance criteria|1|||
33287223|NCT00843115|100947827|FG000|Overall Study|Physician Decision|1|||
33287224|NCT00843115|100947827|FG000|Overall Study|Family discontinued meds|1|||
33287225|NCT00843115|100947827|FG000|Overall Study|patient took for 2 days then stopped|1|||
33287226|NCT00843115|100947827|FG000|Overall Study|patient never took the medication|1|||
33287227|NCT00843115|100947827|FG000|Overall Study|hospitalized due to deterioration|1|||
33287228|NCT00843115|100947827|FG000|Overall Study|week 12 not done|1|||
33287229|NCT00843115|100947827|FG000|Overall Study|Syndrome De Glissement|1|||
33287230|NCT04191148|100947834|FG000|Overall Study|Withdrawal by Subject|1|||
33287231|NCT04191148|100947835|FG001|Overall Study|Withdrawal by Subject|0|||
33287232|NCT04191148|100947834|FG000|Overall Study|Adverse Event|1|||
33287233|NCT04191148|100947835|FG001|Overall Study|Adverse Event|0|||
33287234|NCT00551135|100947836|FG000|Overall Study|Adverse Event|1|||
33287235|NCT00551135|100947837|FG001|Overall Study|Adverse Event|0|||
33287236|NCT00551135|100947838|FG002|Overall Study|Adverse Event|1|||
33287237|NCT00551135|100947839|FG003|Overall Study|Adverse Event|1|||
33287238|NCT00551135|100947836|FG000|Overall Study|Lost to Follow-up|0|||
33287239|NCT00551135|100947837|FG001|Overall Study|Lost to Follow-up|0|||
33287240|NCT00551135|100947838|FG002|Overall Study|Lost to Follow-up|0|||
33287241|NCT00551135|100947839|FG003|Overall Study|Lost to Follow-up|1|||
33287242|NCT00551135|100947836|FG000|Overall Study|Other|3|||
33287243|NCT00551135|100947837|FG001|Overall Study|Other|2|||
33287244|NCT00551135|100947838|FG002|Overall Study|Other|1|||
33287245|NCT00551135|100947839|FG003|Overall Study|Other|2|||
33287246|NCT00551135|100947836|FG000|Overall Study|Withdrawal by Subject|1|||
33287247|NCT00551135|100947837|FG001|Overall Study|Withdrawal by Subject|0|||
33287248|NCT00551135|100947838|FG002|Overall Study|Withdrawal by Subject|3|||
33287249|NCT00551135|100947839|FG003|Overall Study|Withdrawal by Subject|1|||
33287250|NCT04629443|100947848|FG000|Overall Study|Adverse Event|2|||
33287251|NCT04629443|100947849|FG001|Overall Study|Adverse Event|1|||
33287252|NCT04629443|100947850|FG002|Overall Study|Adverse Event|2|||
33287253|NCT04629443|100947848|FG000|Overall Study|Progressive Disease|2|||
33287254|NCT04629443|100947849|FG001|Overall Study|Progressive Disease|3|||
33287255|NCT04629443|100947850|FG002|Overall Study|Progressive Disease|3|||
33287256|NCT04629443|100947848|FG000|Overall Study|Physician Decision|1|||
33287257|NCT04629443|100947849|FG001|Overall Study|Physician Decision|3|||
33287258|NCT04629443|100947850|FG002|Overall Study|Physician Decision|0|||
33287259|NCT02554383|100947851|FG000|Overall Study|Ineligible|3|||
33287260|NCT02554383|100947852|FG001|Overall Study|Ineligible|2|||
33287261|NCT02554383|100947851|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
33287262|NCT02554383|100947852|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
33287263|NCT02554383|100947851|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
33287264|NCT02554383|100947852|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
33287265|NCT02554383|100947851|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
33287266|NCT02554383|100947852|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
33287267|NCT02215954|100947853|FG000|Overall Study|Adverse Event|0|||
33287268|NCT02215954|100947854|FG001|Overall Study|Adverse Event|0|||
33287269|NCT02215954|100947855|FG002|Overall Study|Adverse Event|1|||
33287270|NCT02215954|100947853|FG000|Overall Study|Withdrawal by Subject|0|||
33287271|NCT02215954|100947854|FG001|Overall Study|Withdrawal by Subject|0|||
33287272|NCT02215954|100947855|FG002|Overall Study|Withdrawal by Subject|2|||
33287273|NCT02215954|100947853|FG000|Overall Study|Not exposed|1|||
33287274|NCT02215954|100947854|FG001|Overall Study|Not exposed|1|||
33287275|NCT02215954|100947855|FG002|Overall Study|Not exposed|3|||
33287276|NCT03000348|100947858|FG000|Overall Study|Adverse Event|1|||
33287277|NCT03000348|100947859|FG001|Overall Study|Adverse Event|1|||
33287278|NCT03000348|100947860|FG002|Overall Study|Adverse Event|1|||
33287279|NCT03000348|100947861|FG003|Overall Study|Adverse Event|1|||
33287280|NCT03000348|100947862|FG004|Overall Study|Adverse Event|1|||
33287281|NCT03000348|100947863|FG005|Overall Study|Adverse Event|1|||
33287282|NCT03000348|100947858|FG000|Overall Study|Lost to Follow-up|0|||
33287283|NCT03000348|100947859|FG001|Overall Study|Lost to Follow-up|0|||
33287284|NCT03000348|100947860|FG002|Overall Study|Lost to Follow-up|1|||
33287285|NCT03000348|100947861|FG003|Overall Study|Lost to Follow-up|0|||
33287286|NCT03000348|100947862|FG004|Overall Study|Lost to Follow-up|0|||
33287287|NCT03000348|100947863|FG005|Overall Study|Lost to Follow-up|0|||
33287288|NCT03000348|100947858|FG000|Overall Study|Withdrawal by Subject|0|||
33287289|NCT03000348|100947859|FG001|Overall Study|Withdrawal by Subject|1|||
33287290|NCT03000348|100947860|FG002|Overall Study|Withdrawal by Subject|0|||
33287291|NCT03000348|100947861|FG003|Overall Study|Withdrawal by Subject|0|||
33287292|NCT03000348|100947862|FG004|Overall Study|Withdrawal by Subject|0|||
33287293|NCT03000348|100947863|FG005|Overall Study|Withdrawal by Subject|0|||
33287294|NCT03000348|100947858|FG000|Overall Study|Consent|0|||
33287295|NCT03000348|100947859|FG001|Overall Study|Consent|0|||
33287296|NCT03000348|100947860|FG002|Overall Study|Consent|0|||
33287297|NCT03000348|100947861|FG003|Overall Study|Consent|0|||
33287298|NCT03000348|100947862|FG004|Overall Study|Consent|1|||
33287299|NCT03000348|100947863|FG005|Overall Study|Consent|0|||
33287300|NCT03000348|100947858|FG000|Overall Study|Failure to expectorate sputum|1|||
33287301|NCT03000348|100947859|FG001|Overall Study|Failure to expectorate sputum|0|||
33287302|NCT03000348|100947860|FG002|Overall Study|Failure to expectorate sputum|1|||
33287303|NCT03000348|100947861|FG003|Overall Study|Failure to expectorate sputum|0|||
33287304|NCT03000348|100947862|FG004|Overall Study|Failure to expectorate sputum|1|||
33287305|NCT03000348|100947863|FG005|Overall Study|Failure to expectorate sputum|0|||
33287306|NCT03000348|100947858|FG000|Overall Study|No gram negative|1|||
33287307|NCT03000348|100947859|FG001|Overall Study|No gram negative|2|||
33287308|NCT03000348|100947860|FG002|Overall Study|No gram negative|1|||
33287309|NCT03000348|100947861|FG003|Overall Study|No gram negative|1|||
33287310|NCT03000348|100947862|FG004|Overall Study|No gram negative|1|||
33287311|NCT03000348|100947863|FG005|Overall Study|No gram negative|1|||
33287312|NCT03000348|100947858|FG000|Overall Study|Patient had no transport|0|||
33287313|NCT03000348|100947859|FG001|Overall Study|Patient had no transport|0|||
33287314|NCT03000348|100947860|FG002|Overall Study|Patient had no transport|0|||
33287315|NCT03000348|100947861|FG003|Overall Study|Patient had no transport|1|||
33287316|NCT03000348|100947862|FG004|Overall Study|Patient had no transport|0|||
33287317|NCT03000348|100947863|FG005|Overall Study|Patient had no transport|0|||
33287318|NCT03000348|100947858|FG000|Overall Study|Dosing|0|||
33287319|NCT03000348|100947859|FG001|Overall Study|Dosing|0|||
33287320|NCT03000348|100947860|FG002|Overall Study|Dosing|0|||
33287321|NCT03000348|100947861|FG003|Overall Study|Dosing|0|||
33287322|NCT03000348|100947862|FG004|Overall Study|Dosing|1|||
33287323|NCT03000348|100947863|FG005|Overall Study|Dosing|0|||
33287324|NCT03318783|100947864|FG000|Overall Study|Withdrawal by Subject|0|||
33287325|NCT03318783|100947865|FG001|Overall Study|Withdrawal by Subject|1|||
33287326|NCT03318783|100947864|FG000|Overall Study|Death|0|||
33287327|NCT03318783|100947865|FG001|Overall Study|Death|1|||
33287328|NCT00409409|100947869|FG000|Overall Study|Adverse Event|7|||
33287329|NCT00409409|100947870|FG001|Overall Study|Adverse Event|2|||
33287330|NCT00409409|100947869|FG000|Overall Study|Withdrawal by Subject|1|||
33287331|NCT00409409|100947870|FG001|Overall Study|Withdrawal by Subject|1|||
33287332|NCT00409409|100947869|FG000|Overall Study|Any other reason not above-mentioned|0|||
33287333|NCT00409409|100947870|FG001|Overall Study|Any other reason not above-mentioned|1|||
33287334|NCT00371462|100947876|FG000|Overall Study|Withdrawal by Subject|1|||
33287335|NCT00371462|100947877|FG001|Overall Study|Withdrawal by Subject|0|||
33287336|NCT00371462|100947876|FG000|Overall Study|Other|7|||
33287337|NCT00371462|100947877|FG001|Overall Study|Other|8|||
33287338|NCT04081389|100947878|FG000|Overall Study|Withdrawal by Subject|0|||
33287339|NCT04081389|100947879|FG001|Overall Study|Withdrawal by Subject|0|||
33287340|NCT04081389|100947880|FG002|Overall Study|Withdrawal by Subject|1|||
33287341|NCT04081389|100947881|FG003|Overall Study|Withdrawal by Subject|0|||
33287342|NCT00607997|100947887|FG000|Overall Study|Lack of Efficacy|6|||
33287343|NCT00607997|100947888|FG001|Overall Study|Lack of Efficacy|20|||
33287344|NCT00607997|100947889|FG002|Overall Study|Lack of Efficacy|14|||
33287345|NCT00607997|100947890|FG003|Overall Study|Lack of Efficacy|10|||
33287346|NCT00607997|100947887|FG000|Overall Study|Death|8|||
33287347|NCT00607997|100947888|FG001|Overall Study|Death|5|||
33287348|NCT00607997|100947889|FG002|Overall Study|Death|2|||
33287349|NCT00607997|100947890|FG003|Overall Study|Death|5|||
33287350|NCT00607997|100947887|FG000|Overall Study|Adverse Event|3|||
33287351|NCT00607997|100947888|FG001|Overall Study|Adverse Event|1|||
33287352|NCT00607997|100947889|FG002|Overall Study|Adverse Event|2|||
33287353|NCT00607997|100947890|FG003|Overall Study|Adverse Event|0|||
33287354|NCT00607997|100947887|FG000|Overall Study|Physician Decision|4|||
33287355|NCT00607997|100947888|FG001|Overall Study|Physician Decision|1|||
33287356|NCT00607997|100947889|FG002|Overall Study|Physician Decision|0|||
33287357|NCT00607997|100947890|FG003|Overall Study|Physician Decision|0|||
33287358|NCT00607997|100947887|FG000|Overall Study|Relapse, recurrent illness|4|||
33287359|NCT00607997|100947888|FG001|Overall Study|Relapse, recurrent illness|0|||
33287360|NCT00607997|100947889|FG002|Overall Study|Relapse, recurrent illness|2|||
33287361|NCT00607997|100947890|FG003|Overall Study|Relapse, recurrent illness|0|||
33287362|NCT00607997|100947887|FG000|Overall Study|Other without explanation|2|||
33287363|NCT00607997|100947888|FG001|Overall Study|Other without explanation|0|||
33287364|NCT00607997|100947889|FG002|Overall Study|Other without explanation|4|||
33287365|NCT00607997|100947890|FG003|Overall Study|Other without explanation|1|||
33287366|NCT03022578|100947891|FG000|Overall Study|Adverse Event|1|||
33287367|NCT03022578|100947891|FG000|Overall Study|Lack of Efficacy|2|||
33287368|NCT03022578|100947891|FG000|Overall Study|Withdrawal by Subject|1|||
33287369|NCT01227928|100947892|FG000|Overall Study|Lost to Follow-up|4|||
33287370|NCT01227928|100947893|FG001|Overall Study|Lost to Follow-up|2|||
33287371|NCT01227928|100947892|FG000|Overall Study|Withdrawal by Subject|4|||
33287372|NCT01227928|100947893|FG001|Overall Study|Withdrawal by Subject|3|||
33287373|NCT01227928|100947892|FG000|Overall Study|Death|14|||
33287374|NCT01227928|100947893|FG001|Overall Study|Death|12|||
33287375|NCT01402063|100947894|FG000|Overall Study|Withdrawal by Subject|3|||
33287376|NCT01402063|100947895|FG001|Overall Study|Withdrawal by Subject|3|||
33287377|NCT01161446|100947896|FG000|Overall Study|Lost to Follow-up|18|||
33287378|NCT01161446|100947897|FG001|Overall Study|Lost to Follow-up|14|||
33287379|NCT01161446|100947896|FG000|Overall Study|Withdrawal by Subject|0|||
33287380|NCT01161446|100947897|FG001|Overall Study|Withdrawal by Subject|1|||
33287381|NCT04333147|100947906|FG000|Overall Study|Adverse Event|43|||
33287382|NCT04333147|100947907|FG001|Overall Study|Adverse Event|40|||
33287383|NCT04333147|100947906|FG000|Overall Study|Lack of Efficacy|49|||
33287384|NCT04333147|100947907|FG001|Overall Study|Lack of Efficacy|48|||
33287385|NCT04333147|100947906|FG000|Overall Study|Lost to Follow-up|19|||
33287386|NCT04333147|100947907|FG001|Overall Study|Lost to Follow-up|16|||
33287387|NCT04333147|100947906|FG000|Overall Study|Physician Decision|17|||
33287388|NCT04333147|100947907|FG001|Overall Study|Physician Decision|20|||
33287389|NCT04333147|100947906|FG000|Overall Study|Withdrawal by Subject|65|||
33287390|NCT04333147|100947907|FG001|Overall Study|Withdrawal by Subject|68|||
33287391|NCT04333147|100947906|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
33287392|NCT04333147|100947907|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
33287393|NCT04333147|100947906|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
33287394|NCT04333147|100947907|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
33287395|NCT04333147|100947906|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
33287396|NCT04333147|100947907|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
33287397|NCT00585975|100947911|FG000|Overall Study|Withdrawal by Subject|3|||
33287398|NCT00585975|100947912|FG001|Overall Study|Withdrawal by Subject|3|||
33185901|NCT00692770|100590560|FG001|Overall Study|Progression by clinical judgment|3|||
33185902|NCT00692770|100590559|FG000|Overall Study|Physician decision not protocol driven|10|||
33185903|NCT00692770|100590560|FG001|Overall Study|Physician decision not protocol driven|14|||
33185904|NCT00692770|100590559|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
33185905|NCT00692770|100590560|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
33185906|NCT00692770|100590559|FG000|Overall Study|Protocol driven decision point|3|||
33185907|NCT00692770|100590560|FG001|Overall Study|Protocol driven decision point|7|||
33185908|NCT00692770|100590559|FG000|Overall Study|Completed all planned assessments|79|||
33185909|NCT00692770|100590560|FG001|Overall Study|Completed all planned assessments|101|||
33185910|NCT00692770|100590559|FG000|Overall Study|Radiological and clinical progression|8|||
33185911|NCT00692770|100590560|FG001|Overall Study|Radiological and clinical progression|8|||
33287399|NCT00585975|100947911|FG000|Overall Study|Lost to Follow-up|2|||
33287400|NCT00585975|100947912|FG001|Overall Study|Lost to Follow-up|1|||
33287401|NCT00585975|100947911|FG000|Overall Study|Enrollment met/over-enrolled|10|||
33287402|NCT00585975|100947912|FG001|Overall Study|Enrollment met/over-enrolled|9|||
33287403|NCT01340014|100947913|FG000|Period 1, First 7 Days|Adverse Event|1|||
33287404|NCT01340014|100947914|FG001|Period 1, First 7 Days|Adverse Event|0|||
33287405|NCT01340014|100947913|FG000|Period 1, First 7 Days|Personal Reasons|1|||
33287406|NCT01340014|100947914|FG001|Period 1, First 7 Days|Personal Reasons|0|||
33287407|NCT01340014|100947913|FG000|Period 2, Second 7 Days|Adverse Event|0|||
33287408|NCT01340014|100947914|FG001|Period 2, Second 7 Days|Adverse Event|1|||
33287409|NCT01253447|100947919|FG000|Overall Study|Adverse Event|2|||
33287410|NCT01816685|100947920|FG000|Overall Study|Lost to Follow-up|7|||
33287411|NCT01816685|100947921|FG001|Overall Study|Lost to Follow-up|9|||
33287412|NCT01816685|100947920|FG000|Overall Study|Surgery Cancelled|3|||
33287413|NCT01816685|100947921|FG001|Overall Study|Surgery Cancelled|2|||
33287414|NCT01114139|100947923|FG000|Overall Study|Adverse Event|3|||
33287415|NCT01114139|100947924|FG001|Overall Study|Adverse Event|2|||
33287416|NCT01114139|100947923|FG000|Overall Study|Lost to Follow-up|15|||
33287417|NCT01114139|100947924|FG001|Overall Study|Lost to Follow-up|3|||
33287418|NCT01114139|100947923|FG000|Overall Study|Withdrawal by Subject|17|||
33287419|NCT01114139|100947924|FG001|Overall Study|Withdrawal by Subject|6|||
33287420|NCT01114139|100947923|FG000|Overall Study|Other-Missed 1 visit|1|||
33287421|NCT01114139|100947924|FG001|Overall Study|Other-Missed 1 visit|0|||
33287422|NCT01114139|100947923|FG000|Overall Study|Other-Protocol Violation|1|||
33287423|NCT01114139|100947924|FG001|Overall Study|Other-Protocol Violation|0|||
33287424|NCT01114139|100947923|FG000|Overall Study|Other-Out of window for study drug dose|1|||
33287425|NCT01114139|100947924|FG001|Overall Study|Other-Out of window for study drug dose|0|||
33287426|NCT01114139|100947923|FG000|Overall Study|Other-Participant falsified records|0|||
33287427|NCT01114139|100947924|FG001|Overall Study|Other-Participant falsified records|1|||
33287428|NCT01114139|100947923|FG000|Overall Study|Other-Participant went on hospice|0|||
33287429|NCT01114139|100947924|FG001|Overall Study|Other-Participant went on hospice|1|||
33287430|NCT01114139|100947923|FG000|Overall Study|Other-Physician changed treatment|1|||
33287431|NCT01114139|100947924|FG001|Overall Study|Other-Physician changed treatment|0|||
33287432|NCT01114139|100947923|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
33287433|NCT01114139|100947924|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
33287434|NCT01726049|100947926|FG000|Overall Study|Death|1|||
33287435|NCT01726049|100947927|FG001|Overall Study|Death|1|||
33287436|NCT01726049|100947926|FG000|Overall Study|Adverse Event|4|||
33287437|NCT01726049|100947927|FG001|Overall Study|Adverse Event|1|||
33287438|NCT01726049|100947926|FG000|Overall Study|refused second HC|0|||
33287439|NCT01726049|100947927|FG001|Overall Study|refused second HC|2|||
33287440|NCT00937521|100947928|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
33287441|NCT00937521|100947929|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
33287442|NCT00937521|100947930|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
33287443|NCT00937521|100947931|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
33287444|NCT00937521|100947932|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
33287445|NCT00937521|100947933|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
33287446|NCT00937521|100947934|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
33287447|NCT00937521|100947935|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
33287448|NCT00937521|100947928|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
33287449|NCT00937521|100947929|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
33287450|NCT00937521|100947930|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
33287451|NCT00937521|100947931|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
33287452|NCT00937521|100947932|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
33389929|NCT00643448|101313881|FG001|Overall Study|QTcF>550 ms|3|||
33185912|NCT00692770|100590559|FG000|Overall Study|Clinical endpoint reached|16|||
33185913|NCT00692770|100590560|FG001|Overall Study|Clinical endpoint reached|43|||
33185914|NCT00692770|100590559|FG000|Overall Study|Study terminated by sponsor|2|||
33185915|NCT00692770|100590560|FG001|Overall Study|Study terminated by sponsor|2|||
33185916|NCT00692770|100590559|FG000|Overall Study|Randomized but not treated|3|||
33185917|NCT00692770|100590560|FG001|Overall Study|Randomized but not treated|4|||
33185918|NCT02155738|100590561|FG000|Overall Study|Missing critical information|1|||
33287453|NCT00937521|100947933|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
33287454|NCT00937521|100947934|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
33287455|NCT00937521|100947935|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
33287456|NCT00937521|100947928|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
33185919|NCT02155738|100590562|FG001|Overall Study|Missing critical information|0|||
33287457|NCT00937521|100947929|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
33287458|NCT00937521|100947930|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
33287459|NCT00937521|100947931|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
33185920|NCT02155738|100590563|FG002|Overall Study|Missing critical information|0|||
33185921|NCT02155738|100590564|FG003|Overall Study|Missing critical information|1|||
33185922|NCT00006916|100590572|FG000|Overall Study|Device not inserted|4|||
33185923|NCT00006916|100590572|FG000|Overall Study|Complication of device insertion|1|||
33185924|NCT01709695|100590576|FG000|Overall Study|Withdrawal by Subject|1|||
33287460|NCT00937521|100947932|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
33287461|NCT00937521|100947933|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
33287462|NCT00937521|100947934|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
33287463|NCT00937521|100947935|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
33287464|NCT00937521|100947928|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
33287465|NCT00937521|100947929|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
33287466|NCT00937521|100947930|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
33287467|NCT00937521|100947931|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
33287468|NCT00937521|100947932|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
33287469|NCT00937521|100947933|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
33287470|NCT00937521|100947934|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
33287471|NCT00937521|100947935|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
33287472|NCT00937521|100947928|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
33287473|NCT00937521|100947929|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
33287474|NCT00937521|100947930|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
33287475|NCT00937521|100947931|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
33287476|NCT00937521|100947932|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
33287477|NCT00937521|100947933|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
33287478|NCT00937521|100947934|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
33287479|NCT00937521|100947935|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
33287480|NCT00937521|100947928|FG000|Booster Phase|Adverse Event|0|||
33287481|NCT00937521|100947929|FG001|Booster Phase|Adverse Event|0|||
33287482|NCT00937521|100947930|FG002|Booster Phase|Adverse Event|0|||
33287483|NCT00937521|100947931|FG003|Booster Phase|Adverse Event|0|||
33287484|NCT00937521|100947932|FG004|Booster Phase|Adverse Event|0|||
33287485|NCT00937521|100947933|FG005|Booster Phase|Adverse Event|0|||
33287486|NCT00937521|100947934|FG006|Booster Phase|Adverse Event|1|||
33287487|NCT00937521|100947935|FG007|Booster Phase|Adverse Event|0|||
33287488|NCT00937521|100947928|FG000|Booster Phase|Withdrawal by Subject|1|||
33287489|NCT00937521|100947929|FG001|Booster Phase|Withdrawal by Subject|0|||
33287490|NCT00937521|100947930|FG002|Booster Phase|Withdrawal by Subject|0|||
33287491|NCT00937521|100947931|FG003|Booster Phase|Withdrawal by Subject|1|||
33287492|NCT00937521|100947932|FG004|Booster Phase|Withdrawal by Subject|0|||
33287493|NCT00937521|100947933|FG005|Booster Phase|Withdrawal by Subject|0|||
33287494|NCT00937521|100947934|FG006|Booster Phase|Withdrawal by Subject|0|||
33287495|NCT00937521|100947935|FG007|Booster Phase|Withdrawal by Subject|2|||
33287496|NCT00937521|100947928|FG000|Booster Phase|Lost to Follow-up|2|||
33287497|NCT00937521|100947929|FG001|Booster Phase|Lost to Follow-up|2|||
33287498|NCT00937521|100947930|FG002|Booster Phase|Lost to Follow-up|4|||
33287499|NCT00937521|100947931|FG003|Booster Phase|Lost to Follow-up|2|||
33287500|NCT00937521|100947932|FG004|Booster Phase|Lost to Follow-up|4|||
33287501|NCT00937521|100947933|FG005|Booster Phase|Lost to Follow-up|4|||
33287502|NCT00937521|100947934|FG006|Booster Phase|Lost to Follow-up|3|||
33287503|NCT00937521|100947935|FG007|Booster Phase|Lost to Follow-up|0|||
33389930|NCT00643448|101313882|FG002|Overall Study|QTcF>550 ms|0|||
33389931|NCT02671760|101313883|FG000|Overall Study|Lost to Follow-up|0|||
33185925|NCT01709695|100590577|FG001|Overall Study|Withdrawal by Subject|1|||
33185926|NCT01869192|100590578|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
33287504|NCT00937521|100947928|FG000|Booster Phase|Administrative Reason|0|||
33287505|NCT00937521|100947929|FG001|Booster Phase|Administrative Reason|0|||
33185927|NCT01869192|100590579|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
33287506|NCT00937521|100947930|FG002|Booster Phase|Administrative Reason|1|||
33287507|NCT00937521|100947931|FG003|Booster Phase|Administrative Reason|0|||
33287508|NCT00937521|100947932|FG004|Booster Phase|Administrative Reason|1|||
33287509|NCT00937521|100947933|FG005|Booster Phase|Administrative Reason|1|||
33287510|NCT00937521|100947934|FG006|Booster Phase|Administrative Reason|0|||
33287511|NCT00937521|100947935|FG007|Booster Phase|Administrative Reason|0|||
33287512|NCT00937521|100947928|FG000|Booster Phase|Protocol Deviation|0|||
33287513|NCT00937521|100947929|FG001|Booster Phase|Protocol Deviation|0|||
33287514|NCT00937521|100947930|FG002|Booster Phase|Protocol Deviation|0|||
33287515|NCT00937521|100947931|FG003|Booster Phase|Protocol Deviation|0|||
33287516|NCT00937521|100947932|FG004|Booster Phase|Protocol Deviation|0|||
33287517|NCT00937521|100947933|FG005|Booster Phase|Protocol Deviation|0|||
33287518|NCT00937521|100947934|FG006|Booster Phase|Protocol Deviation|1|||
33287519|NCT00937521|100947935|FG007|Booster Phase|Protocol Deviation|0|||
33287520|NCT00552513|100947939|FG000|Overall Study|Lost to Follow-up|5|||
33287521|NCT00552513|100947940|FG001|Overall Study|Lost to Follow-up|1|||
33287522|NCT00623363|100947941|FG000|Overall Study|Adverse Event|2|||
33287523|NCT00623363|100947942|FG001|Overall Study|Adverse Event|2|||
33287524|NCT02561078|100947943|FG000|Overall Study|Adverse Event|5|||
33287525|NCT02561078|100947944|FG001|Overall Study|Adverse Event|2|||
33287526|NCT02561078|100947943|FG000|Overall Study|Death|2|||
33287527|NCT02561078|100947944|FG001|Overall Study|Death|1|||
33287528|NCT02561078|100947943|FG000|Overall Study|Lost to Follow-up|2|||
33287529|NCT02561078|100947944|FG001|Overall Study|Lost to Follow-up|6|||
33287530|NCT02561078|100947943|FG000|Overall Study|Non-Compliance with Study Drug|6|||
33287531|NCT02561078|100947944|FG001|Overall Study|Non-Compliance with Study Drug|3|||
33287532|NCT02561078|100947943|FG000|Overall Study|Physician Decision|2|||
33287533|NCT02561078|100947944|FG001|Overall Study|Physician Decision|3|||
33287534|NCT02561078|100947943|FG000|Overall Study|Withdrawal by Subject|13|||
33287535|NCT02561078|100947944|FG001|Overall Study|Withdrawal by Subject|10|||
33287536|NCT01278615|100947945|FG000|Overall Study|Withdrawal by Subject|2|||
33287537|NCT01340300|100947946|FG000|Overall Study|Lost to Follow-up|3|||
33287538|NCT01340300|100947947|FG001|Overall Study|Lost to Follow-up|0|||
33287539|NCT01340300|100947948|FG002|Overall Study|Lost to Follow-up|5|||
33287540|NCT01340300|100947949|FG003|Overall Study|Lost to Follow-up|10|||
33287541|NCT01340300|100947946|FG000|Overall Study|Withdrawal by Subject|5|||
33287542|NCT01340300|100947947|FG001|Overall Study|Withdrawal by Subject|6|||
33287543|NCT01340300|100947948|FG002|Overall Study|Withdrawal by Subject|6|||
33287544|NCT01340300|100947949|FG003|Overall Study|Withdrawal by Subject|3|||
33287545|NCT01340300|100947946|FG000|Overall Study|Adverse Event|1|||
33287546|NCT01340300|100947947|FG001|Overall Study|Adverse Event|0|||
33287547|NCT01340300|100947948|FG002|Overall Study|Adverse Event|4|||
33287548|NCT01340300|100947949|FG003|Overall Study|Adverse Event|0|||
33287549|NCT01340300|100947946|FG000|Overall Study|Physician Decision|0|||
33287550|NCT01340300|100947947|FG001|Overall Study|Physician Decision|1|||
33287551|NCT01340300|100947948|FG002|Overall Study|Physician Decision|0|||
33287552|NCT01340300|100947949|FG003|Overall Study|Physician Decision|0|||
33287553|NCT01340300|100947946|FG000|Overall Study|Unrelated sickness|0|||
33287554|NCT01340300|100947947|FG001|Overall Study|Unrelated sickness|2|||
33287555|NCT01340300|100947948|FG002|Overall Study|Unrelated sickness|0|||
33287556|NCT01340300|100947949|FG003|Overall Study|Unrelated sickness|1|||
33287557|NCT00740870|100947950|FG000|Overall Study|Not Catheterized|4|||
33287558|NCT00740870|100947950|FG000|Overall Study|Further testing contraindicated implant|17|||
33287559|NCT00951171|100947951|FG000|Overall Study|Adverse Event|2|||
33287560|NCT00951171|100947952|FG001|Overall Study|Adverse Event|0|||
33287561|NCT01264887|100947953|FG000|Overall Study|Adverse Event|5|||
33287562|NCT01264887|100947953|FG000|Overall Study|Death|7|||
33287563|NCT01264887|100947953|FG000|Overall Study|Lack of Efficacy|5|||
33287564|NCT01264887|100947953|FG000|Overall Study|Physician Decision|4|||
33287565|NCT01264887|100947953|FG000|Overall Study|Withdrawal by Subject|6|||
33287566|NCT01264887|100947953|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
33287567|NCT01264887|100947953|FG000|Overall Study|Other|2|||
33287568|NCT04486313|100947954|FG000|Overall Study|Lost to Follow-up|7|||
33287569|NCT04486313|100947955|FG001|Overall Study|Lost to Follow-up|9|||
33287570|NCT04486313|100947954|FG000|Overall Study|Withdrawal by Subject|8|||
33287571|NCT04486313|100947955|FG001|Overall Study|Withdrawal by Subject|6|||
33287572|NCT04486313|100947954|FG000|Overall Study|Physician Decision|1|||
33287573|NCT04486313|100947955|FG001|Overall Study|Physician Decision|1|||
33287574|NCT04486313|100947954|FG000|Overall Study|Death|2|||
33287575|NCT04486313|100947955|FG001|Overall Study|Death|0|||
33389932|NCT02671760|101313884|FG001|Overall Study|Lost to Follow-up|1|||
33287576|NCT04486313|100947954|FG000|Overall Study|Protocol Violation|1|||
33287577|NCT04486313|100947955|FG001|Overall Study|Protocol Violation|1|||
33287578|NCT03638258|100947956|FG000|Overall Study|Adverse Event|1|||
33287579|NCT03638258|100947957|FG001|Overall Study|Adverse Event|0|||
33287580|NCT03638258|100947958|FG002|Overall Study|Adverse Event|2|||
33287581|NCT03638258|100947956|FG000|Overall Study|Lost to Follow-up|2|||
33287582|NCT03638258|100947957|FG001|Overall Study|Lost to Follow-up|4|||
33287583|NCT03638258|100947958|FG002|Overall Study|Lost to Follow-up|5|||
33287584|NCT03638258|100947956|FG000|Overall Study|Pregnancy|0|||
33287585|NCT03638258|100947957|FG001|Overall Study|Pregnancy|0|||
33287586|NCT03638258|100947958|FG002|Overall Study|Pregnancy|1|||
33287587|NCT03638258|100947956|FG000|Overall Study|Protocol Violation|0|||
33287588|NCT03638258|100947957|FG001|Overall Study|Protocol Violation|0|||
33287589|NCT03638258|100947958|FG002|Overall Study|Protocol Violation|1|||
33287590|NCT03638258|100947956|FG000|Overall Study|Withdrawal by Subject|4|||
33287591|NCT03638258|100947957|FG001|Overall Study|Withdrawal by Subject|5|||
33287592|NCT03638258|100947958|FG002|Overall Study|Withdrawal by Subject|12|||
33287593|NCT03638258|100947956|FG000|Overall Study|Lack of Efficacy|0|||
33287594|NCT03638258|100947957|FG001|Overall Study|Lack of Efficacy|0|||
33287595|NCT03638258|100947958|FG002|Overall Study|Lack of Efficacy|2|||
33287596|NCT04706793|100947961|FG000|Treatment|Disease worsening|10|||
33287597|NCT04706793|100947962|FG001|Treatment|Disease worsening|10|||
33287598|NCT04706793|100947961|FG000|Follow-up|Lack of Efficacy|1|||
33287599|NCT04706793|100947962|FG001|Follow-up|Lack of Efficacy|0|||
33287600|NCT04706793|100947961|FG000|Follow-up|Disease worsening|8|||
33287601|NCT04706793|100947962|FG001|Follow-up|Disease worsening|10|||
33287602|NCT04706793|100947961|FG000|Follow-up|Adverse Event|1|||
33287603|NCT04706793|100947962|FG001|Follow-up|Adverse Event|0|||
33287604|NCT00983892|100947963|FG000|Overall Study|Withdrawal by Subject|10|||
33287605|NCT00983892|100947964|FG001|Overall Study|Withdrawal by Subject|12|||
33287606|NCT03991988|100947965|FG000|Overall Study|Withdrawal by Subject|2|||
33287607|NCT03991988|100947966|FG001|Overall Study|Withdrawal by Subject|2|||
33287608|NCT02669407|100947971|FG000|Overall Study|Physician Decision|3|||
33287609|NCT03589300|100947972|FG000|Overall Study|Adverse Event|2|||
33185928|NCT01869192|100590578|FG000|Postoperative Chemotherapy|Physician Decision|0|||
33185929|NCT01869192|100590579|FG001|Postoperative Chemotherapy|Physician Decision|2|||
33287610|NCT03589300|100947972|FG000|Overall Study|Death|4|||
33287611|NCT03589300|100947972|FG000|Overall Study|Lost to Follow-up|12|||
33287612|NCT03589300|100947972|FG000|Overall Study|Withdrawal by Subject|5|||
33287613|NCT05043883|100947973|FG000|Overall Study|Minimum required measurements could not be taken|4|||
33287614|NCT00917462|100947974|FG000|Overall Study|Clinical Deterioration|1|||
33287615|NCT01461005|100947975|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
33287616|NCT02916706|100947976|FG000|Overall Study|Adverse Event|0|||
33287617|NCT02916706|100947977|FG001|Overall Study|Adverse Event|1|||
33287618|NCT02916706|100947976|FG000|Overall Study|Lost to Follow-up|0|||
33287619|NCT02916706|100947977|FG001|Overall Study|Lost to Follow-up|1|||
33287620|NCT02916706|100947976|FG000|Overall Study|Physician Decision|1|||
33287621|NCT02916706|100947977|FG001|Overall Study|Physician Decision|0|||
33287622|NCT02916706|100947976|FG000|Overall Study|Protocol Violation|3|||
33287623|NCT02916706|100947977|FG001|Overall Study|Protocol Violation|1|||
33287624|NCT02916706|100947976|FG000|Overall Study|Withdrawal by Subject|6|||
33287625|NCT02916706|100947977|FG001|Overall Study|Withdrawal by Subject|9|||
33287626|NCT02916706|100947976|FG000|Overall Study|Other|5|||
33287627|NCT02916706|100947977|FG001|Overall Study|Other|19|||
33287628|NCT02194829|100947978|FG000|Overall Study|Adverse Event|2|||
33287629|NCT02194829|100947979|FG001|Overall Study|Adverse Event|2|||
33287630|NCT02194829|100947978|FG000|Overall Study|Death|0|||
33287631|NCT02194829|100947979|FG001|Overall Study|Death|1|||
33287632|NCT02194829|100947978|FG000|Overall Study|Disease progression|0|||
33287633|NCT02194829|100947979|FG001|Overall Study|Disease progression|1|||
33287634|NCT02194829|100947978|FG000|Overall Study|Withdrawal by Subject|0|||
33287635|NCT02194829|100947979|FG001|Overall Study|Withdrawal by Subject|1|||
33287636|NCT02194829|100947978|FG000|Overall Study|Never started protocol therapy|0|||
33287637|NCT02194829|100947979|FG001|Overall Study|Never started protocol therapy|1|||
33287638|NCT03245619|100947980|FG000|Part A (Up to Day 22)|Physician Decision|4|||
33287639|NCT03245619|100947981|FG001|Part A (Up to Day 22)|Physician Decision|6|||
33287640|NCT03245619|100947982|FG002|Part A (Up to Day 22)|Physician Decision|6|||
33287641|NCT03245619|100947983|FG003|Part A (Up to Day 22)|Physician Decision|0|||
33287642|NCT03245619|100947984|FG004|Part A (Up to Day 22)|Physician Decision|0|||
33287643|NCT03245619|100947985|FG005|Part A (Up to Day 22)|Physician Decision|0|||
33287644|NCT03245619|100947986|FG006|Part A (Up to Day 22)|Physician Decision|0|||
33287645|NCT03245619|100947987|FG007|Part A (Up to Day 22)|Physician Decision|0|||
33287646|NCT03245619|100947988|FG008|Part A (Up to Day 22)|Physician Decision|0|||
33287647|NCT03245619|100947989|FG009|Part A (Up to Day 22)|Physician Decision|0|||
33287648|NCT03245619|100947990|FG010|Part A (Up to Day 22)|Physician Decision|0|||
33287649|NCT03245619|100947991|FG011|Part A (Up to Day 22)|Physician Decision|0|||
33287650|NCT03245619|100947992|FG012|Part A (Up to Day 22)|Physician Decision|0|||
33287651|NCT03245619|100947993|FG013|Part A (Up to Day 22)|Physician Decision|0|||
33287652|NCT03245619|100947994|FG014|Part A (Up to Day 22)|Physician Decision|0|||
33287653|NCT03245619|100947995|FG015|Part A (Up to Day 22)|Physician Decision|0|||
33287654|NCT03245619|100947996|FG016|Part A (Up to Day 22)|Physician Decision|0|||
33287655|NCT00847132|100951778|FG000|Overall Study|Death|1|||
33287656|NCT00847132|100951779|FG001|Overall Study|Death|1|||
33287657|NCT04969276|100951780|FG000|Overall Study|Protocol Deviation|0|||
33287658|NCT04969276|100951781|FG001|Overall Study|Protocol Deviation|1|||
33287659|NCT04969276|100951782|FG002|Overall Study|Protocol Deviation|0|||
33287660|NCT04969276|100951780|FG000|Overall Study|Withdrawal by Subject|1|||
33287661|NCT04969276|100951781|FG001|Overall Study|Withdrawal by Subject|10|||
33287662|NCT04969276|100951782|FG002|Overall Study|Withdrawal by Subject|0|||
33287663|NCT04969276|100951780|FG000|Overall Study|Lost to Follow-up|0|||
33287664|NCT04969276|100951781|FG001|Overall Study|Lost to Follow-up|1|||
33287665|NCT04969276|100951782|FG002|Overall Study|Lost to Follow-up|0|||
33287666|NCT01056263|100951796|FG000|Overall Study|Adverse Event|12|||
33287667|NCT01056263|100951796|FG000|Overall Study|Death|1|||
33287668|NCT01056263|100951796|FG000|Overall Study|Withdrawal by Subject|1|||
33287669|NCT01056263|100951796|FG000|Overall Study|Lack of Efficacy|29|||
33287670|NCT01056263|100951796|FG000|Overall Study|Progressive disease|2|||
33287671|NCT01056263|100951796|FG000|Overall Study|Neoplasm progression|1|||
33287672|NCT01056263|100951796|FG000|Overall Study|Objective progression or relapse|1|||
33287673|NCT01056263|100951796|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
33287674|NCT01644188|100951799|FG000|Overall Study|Adverse Event|44|||
33287675|NCT01644188|100951800|FG001|Overall Study|Adverse Event|20|||
33287676|NCT01644188|100951799|FG000|Overall Study|Poor compliance to protocol|26|||
33287677|NCT01644188|100951800|FG001|Overall Study|Poor compliance to protocol|14|||
33287678|NCT01644188|100951799|FG000|Overall Study|Physician Decision|1|||
33287679|NCT01644188|100951800|FG001|Overall Study|Physician Decision|3|||
33287680|NCT01644188|100951799|FG000|Overall Study|Participant moved|7|||
33287681|NCT01644188|100951800|FG001|Overall Study|Participant moved|2|||
33287682|NCT01644188|100951799|FG000|Overall Study|Related to auto-injector administration|2|||
33287683|NCT01644188|100951800|FG001|Overall Study|Related to auto-injector administration|2|||
33287684|NCT01644188|100951799|FG000|Overall Study|Consent withdrawn by participant|14|||
33287685|NCT01644188|100951800|FG001|Overall Study|Consent withdrawn by participant|7|||
33287686|NCT01644188|100951799|FG000|Overall Study|Selection criteria finally not met|2|||
33287687|NCT01644188|100951800|FG001|Overall Study|Selection criteria finally not met|0|||
33287688|NCT01644188|100951799|FG000|Overall Study|Lost to Follow-up|1|||
33287689|NCT01644188|100951800|FG001|Overall Study|Lost to Follow-up|0|||
33287690|NCT01644188|100951799|FG000|Overall Study|Death|4|||
33287691|NCT01644188|100951800|FG001|Overall Study|Death|3|||
33287692|NCT01644188|100951799|FG000|Overall Study|Last visit outside protocol visit window|14|||
33287693|NCT01644188|100951800|FG001|Overall Study|Last visit outside protocol visit window|16|||
33287694|NCT01644188|100951799|FG000|Overall Study|Site closure|1|||
33287695|NCT01644188|100951800|FG001|Overall Study|Site closure|1|||
33287696|NCT01644188|100951799|FG000|Overall Study|Other than specified above|6|||
33287697|NCT01644188|100951800|FG001|Overall Study|Other than specified above|7|||
33287698|NCT00545571|100951801|FG000|Overall Study|Administrative Reasons|1|||
33287699|NCT00545571|100951801|FG000|Overall Study|Adverse Event|2|||
33287700|NCT00545571|100951801|FG000|Overall Study|Death|5|||
33287701|NCT00545571|100951801|FG000|Overall Study|Lack of Efficacy|1|||
33287702|NCT00545571|100951801|FG000|Overall Study|Protocol Violation|2|||
33287703|NCT00545571|100951801|FG000|Overall Study|Refused Treatment|1|||
33287704|NCT00545571|100951801|FG000|Overall Study|Screen Failure|16|||
33287705|NCT00545571|100951801|FG000|Overall Study|Transfusion|12|||
33287706|NCT00545571|100951801|FG000|Overall Study|Early Termination of Study|24|||
33287707|NCT00545571|100951801|FG000|Overall Study|Kidney Transplantation|3|||
33287708|NCT00526097|100951810|FG000|Overall Study|Adverse Event|6|||
33287709|NCT00526097|100951811|FG001|Overall Study|Adverse Event|44|||
33287710|NCT00526097|100951810|FG000|Overall Study|Protocol Violation|4|||
33287711|NCT00526097|100951811|FG001|Overall Study|Protocol Violation|10|||
33287712|NCT00526097|100951810|FG000|Overall Study|Withdrawal by Subject|3|||
33287713|NCT00526097|100951811|FG001|Overall Study|Withdrawal by Subject|1|||
33287714|NCT00526097|100951810|FG000|Overall Study|Other|2|||
33287715|NCT00526097|100951811|FG001|Overall Study|Other|1|||
33185930|NCT03848845|100590581|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
33287716|NCT02438371|100951812|FG000|Overall Study|Lost to Follow-up|3|||
33287717|NCT02438371|100951813|FG001|Overall Study|Lost to Follow-up|2|||
33287718|NCT02438371|100951812|FG000|Overall Study|Withdrawal by Subject|1|||
33287719|NCT02438371|100951813|FG001|Overall Study|Withdrawal by Subject|1|||
33287720|NCT01947517|100951814|FG000|Overall Study|Withdrawal by Subject|1|||
33287721|NCT01947517|100951815|FG001|Overall Study|Withdrawal by Subject|1|||
33287722|NCT02716298|100951817|FG000|First Intervention (1 Month)|Lens discomfort|1|||
33287723|NCT02716298|100951818|FG001|First Intervention (1 Month)|Lens discomfort|1|||
33287724|NCT02575950|100951819|FG000|Overall Study|Withdrawal by Subject|0|||
33287725|NCT02575950|100951820|FG001|Overall Study|Withdrawal by Subject|0|||
33287726|NCT02575950|100951821|FG002|Overall Study|Withdrawal by Subject|0|||
33287727|NCT02575950|100951822|FG003|Overall Study|Withdrawal by Subject|2|||
33287728|NCT02575950|100951819|FG000|Overall Study|Lost to Follow-up|0|||
33287729|NCT02575950|100951820|FG001|Overall Study|Lost to Follow-up|1|||
33287730|NCT02575950|100951821|FG002|Overall Study|Lost to Follow-up|0|||
33287731|NCT02575950|100951822|FG003|Overall Study|Lost to Follow-up|3|||
33287732|NCT00350298|100951826|FG000|Overall Study|Death|7|||
33287733|NCT00350298|100951827|FG001|Overall Study|Death|8|||
33287734|NCT00350298|100951826|FG000|Overall Study|Lost to Follow-up|1|||
33287735|NCT00350298|100951827|FG001|Overall Study|Lost to Follow-up|2|||
33287736|NCT00350298|100951826|FG000|Overall Study|Withdrawal by Subject|1|||
33287737|NCT00350298|100951827|FG001|Overall Study|Withdrawal by Subject|3|||
33287738|NCT01588366|100951828|FG000|Overall Study|Adverse Event|0|||
33287739|NCT01588366|100951829|FG001|Overall Study|Adverse Event|1|||
33287740|NCT01588366|100951830|FG002|Overall Study|Adverse Event|0|||
33287741|NCT01588366|100951831|FG003|Overall Study|Adverse Event|1|||
33287742|NCT01588366|100951832|FG004|Overall Study|Adverse Event|0|||
33287743|NCT01588366|100951833|FG005|Overall Study|Adverse Event|2|||
33287744|NCT02647788|100951836|FG000|Overall Study|Lost to Follow-up|13|||
33287745|NCT02647788|100951837|FG001|Overall Study|Lost to Follow-up|11|||
33287746|NCT02647788|100951836|FG000|Overall Study|Did not want opiate|0|||
33287747|NCT02647788|100951837|FG001|Overall Study|Did not want opiate|1|||
33287748|NCT02647788|100951836|FG000|Overall Study|Withdrawal by Subject|1|||
33287749|NCT02647788|100951837|FG001|Overall Study|Withdrawal by Subject|0|||
33287750|NCT02647788|100951836|FG000|Overall Study|Felt itchy with assigned medication|1|||
33185931|NCT03848845|100590582|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
33287751|NCT02647788|100951837|FG001|Overall Study|Felt itchy with assigned medication|0|||
33287752|NCT02647788|100951836|FG000|Overall Study|Felt nauseous with assigned medication|1|||
33287753|NCT02647788|100951837|FG001|Overall Study|Felt nauseous with assigned medication|1|||
33287754|NCT02804399|100951845|FG000|Period 2|Adverse Event|0|||
33287755|NCT02804399|100951846|FG001|Period 2|Adverse Event|1|||
33287756|NCT00661713|100951847|FG000|Overall Study|Death|1|||
33287757|NCT00661713|100951848|FG001|Overall Study|Death|0|||
33287758|NCT00661713|100951849|FG002|Overall Study|Death|0|||
33287759|NCT00661713|100951850|FG003|Overall Study|Death|0|||
33287760|NCT00661713|100951851|FG004|Overall Study|Death|1|||
33287761|NCT00661713|100951852|FG005|Overall Study|Death|0|||
33287762|NCT00661713|100951853|FG006|Overall Study|Death|0|||
33185932|NCT03848845|100590583|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
33185933|NCT03848845|100590584|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
33185934|NCT03848845|100590581|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
33185935|NCT03848845|100590582|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
33185936|NCT03848845|100590583|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
33185937|NCT03848845|100590584|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
33185938|NCT03848845|100590581|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
33185939|NCT03848845|100590582|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
33185940|NCT03848845|100590583|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
33185941|NCT03848845|100590584|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
33185942|NCT03848845|100590581|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
33185943|NCT03848845|100590582|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
33185944|NCT03848845|100590583|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
33185945|NCT03848845|100590584|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
33185946|NCT05402995|100590586|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
33185947|NCT05402995|100590587|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
33185948|NCT05402995|100590588|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
33185949|NCT05402995|100590589|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
33185950|NCT00578942|100590599|FG000|Overall Study|Lost to Follow-up|1|||
33185951|NCT02658890|100590601|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185952|NCT02658890|100590602|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185953|NCT02658890|100590603|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185954|NCT02658890|100590604|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185955|NCT02658890|100590605|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185956|NCT02658890|100590606|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185957|NCT02658890|100590607|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185958|NCT02658890|100590608|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185959|NCT02658890|100590609|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
33185960|NCT02658890|100590610|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185961|NCT02658890|100590611|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185962|NCT02658890|100590612|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185963|NCT02658890|100590613|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185964|NCT02658890|100590614|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185965|NCT02658890|100590615|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185966|NCT02658890|100590616|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185967|NCT02658890|100590617|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33287763|NCT00661713|100951854|FG007|Overall Study|Death|0|||
33287764|NCT00661713|100951847|FG000|Overall Study|Unable to Classify|1|||
33287765|NCT00661713|100951848|FG001|Overall Study|Unable to Classify|0|||
33287766|NCT00661713|100951849|FG002|Overall Study|Unable to Classify|0|||
33287767|NCT00661713|100951850|FG003|Overall Study|Unable to Classify|0|||
33287768|NCT00661713|100951851|FG004|Overall Study|Unable to Classify|0|||
33287769|NCT00661713|100951852|FG005|Overall Study|Unable to Classify|0|||
33389933|NCT02671760|101313885|FG002|Overall Study|Lost to Follow-up|0|||
33287770|NCT00661713|100951853|FG006|Overall Study|Unable to Classify|0|||
33287771|NCT00661713|100951854|FG007|Overall Study|Unable to Classify|0|||
33287772|NCT00661713|100951847|FG000|Overall Study|Protocol Violation|1|||
33287773|NCT00661713|100951848|FG001|Overall Study|Protocol Violation|6|||
33287774|NCT00661713|100951849|FG002|Overall Study|Protocol Violation|3|||
33287775|NCT00661713|100951850|FG003|Overall Study|Protocol Violation|3|||
33287776|NCT00661713|100951851|FG004|Overall Study|Protocol Violation|0|||
33287777|NCT00661713|100951852|FG005|Overall Study|Protocol Violation|2|||
33287778|NCT00661713|100951853|FG006|Overall Study|Protocol Violation|2|||
33287779|NCT00661713|100951854|FG007|Overall Study|Protocol Violation|1|||
33287780|NCT00661713|100951847|FG000|Overall Study|Withdrawal by Subject|11|||
33287781|NCT00661713|100951848|FG001|Overall Study|Withdrawal by Subject|25|||
33287782|NCT00661713|100951849|FG002|Overall Study|Withdrawal by Subject|12|||
33287783|NCT00661713|100951850|FG003|Overall Study|Withdrawal by Subject|21|||
33287784|NCT00661713|100951851|FG004|Overall Study|Withdrawal by Subject|12|||
33287785|NCT00661713|100951852|FG005|Overall Study|Withdrawal by Subject|26|||
33287786|NCT00661713|100951853|FG006|Overall Study|Withdrawal by Subject|45|||
33287787|NCT00661713|100951854|FG007|Overall Study|Withdrawal by Subject|9|||
33287788|NCT00661713|100951847|FG000|Overall Study|Lost to Follow-up|2|||
33287789|NCT00661713|100951848|FG001|Overall Study|Lost to Follow-up|7|||
33287790|NCT00661713|100951849|FG002|Overall Study|Lost to Follow-up|2|||
33287791|NCT00661713|100951850|FG003|Overall Study|Lost to Follow-up|2|||
33287792|NCT00661713|100951851|FG004|Overall Study|Lost to Follow-up|5|||
33287793|NCT00661713|100951852|FG005|Overall Study|Lost to Follow-up|7|||
33287794|NCT00661713|100951853|FG006|Overall Study|Lost to Follow-up|14|||
33287795|NCT00661713|100951854|FG007|Overall Study|Lost to Follow-up|1|||
33287796|NCT00661713|100951847|FG000|Overall Study|Administrative Reason|0|||
33287797|NCT00661713|100951848|FG001|Overall Study|Administrative Reason|1|||
33287798|NCT00661713|100951849|FG002|Overall Study|Administrative Reason|0|||
33287799|NCT00661713|100951850|FG003|Overall Study|Administrative Reason|2|||
33287800|NCT00661713|100951851|FG004|Overall Study|Administrative Reason|2|||
33287801|NCT00661713|100951852|FG005|Overall Study|Administrative Reason|2|||
33287802|NCT00661713|100951853|FG006|Overall Study|Administrative Reason|1|||
33287803|NCT00661713|100951854|FG007|Overall Study|Administrative Reason|0|||
33287804|NCT00661713|100951847|FG000|Overall Study|Adverse Event|0|||
33287805|NCT00661713|100951848|FG001|Overall Study|Adverse Event|0|||
33287806|NCT00661713|100951849|FG002|Overall Study|Adverse Event|0|||
33287807|NCT00661713|100951850|FG003|Overall Study|Adverse Event|0|||
33287808|NCT00661713|100951851|FG004|Overall Study|Adverse Event|0|||
33287809|NCT00661713|100951852|FG005|Overall Study|Adverse Event|0|||
33287810|NCT00661713|100951853|FG006|Overall Study|Adverse Event|1|||
33287811|NCT00661713|100951854|FG007|Overall Study|Adverse Event|0|||
33287812|NCT00661713|100951847|FG000|Overall Study|Inappropriate Enrollment|0|||
33287813|NCT00661713|100951848|FG001|Overall Study|Inappropriate Enrollment|0|||
33287814|NCT00661713|100951849|FG002|Overall Study|Inappropriate Enrollment|0|||
33287815|NCT00661713|100951850|FG003|Overall Study|Inappropriate Enrollment|0|||
33287816|NCT00661713|100951851|FG004|Overall Study|Inappropriate Enrollment|0|||
33287817|NCT00661713|100951852|FG005|Overall Study|Inappropriate Enrollment|0|||
33287818|NCT00661713|100951853|FG006|Overall Study|Inappropriate Enrollment|1|||
33287819|NCT00661713|100951854|FG007|Overall Study|Inappropriate Enrollment|0|||
33287820|NCT02973802|100951861|FG000|Overall Study|Lost to Follow-up|1|||
33287821|NCT02973802|100951861|FG000|Overall Study|Withdrawal by Subject|1|||
33287822|NCT04014790|100951864|FG000|Overall Study|Death|4|||
33287823|NCT04014790|100951864|FG000|Overall Study|Adverse Event|1|||
33287824|NCT04014790|100951864|FG000|Overall Study|Withdrawal by Subject|1|||
33287825|NCT04947436|100951865|FG000|Overall Study|Lost to Follow-up|3|||
33287826|NCT04947436|100951866|FG001|Overall Study|Lost to Follow-up|7|||
33287827|NCT04947436|100951867|FG002|Overall Study|Lost to Follow-up|5|||
33287828|NCT04947436|100951865|FG000|Overall Study|Death|1|||
33287829|NCT04947436|100951866|FG001|Overall Study|Death|1|||
33287830|NCT04947436|100951867|FG002|Overall Study|Death|1|||
33287831|NCT02344173|100951871|FG000|Procedure|Ablation Procedure Not Performed|7|||
33287832|NCT02344173|100951871|FG000|12-month Visit|Death|8|||
33287833|NCT02344173|100951871|FG000|12-month Visit|Withdrawal by Subject|30|||
33287834|NCT02344173|100951871|FG000|12-month Visit|Lost to Follow-up|58|||
33287835|NCT00746785|100951872|FG000|Overall Study|Lost to Follow-up|29|||
33287836|NCT00746785|100951873|FG001|Overall Study|Lost to Follow-up|25|||
33287837|NCT00746785|100951874|FG002|Overall Study|Lost to Follow-up|27|||
33287838|NCT00436956|100951875|FG000|Overall Study|Not evaluable|1|||
33287839|NCT00436956|100951876|FG001|Overall Study|Not evaluable|0|||
33287840|NCT02210208|100951880|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
33287841|NCT02210208|100951880|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
33287842|NCT02210208|100951880|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
33287843|NCT01157351|100951881|FG000|Overall Study|Adverse Event|5|||
33287844|NCT01157351|100951882|FG001|Overall Study|Adverse Event|4|||
33287845|NCT01157351|100951881|FG000|Overall Study|Death|1|||
33287846|NCT01157351|100951882|FG001|Overall Study|Death|0|||
33287847|NCT01157351|100951881|FG000|Overall Study|Lost to Follow-up|53|||
33287848|NCT01157351|100951882|FG001|Overall Study|Lost to Follow-up|55|||
33287849|NCT01157351|100951881|FG000|Overall Study|Withdrawal by Subject|37|||
33287850|NCT01157351|100951882|FG001|Overall Study|Withdrawal by Subject|27|||
33287851|NCT01157351|100951881|FG000|Overall Study|Physician Decision|5|||
33287852|NCT01157351|100951882|FG001|Overall Study|Physician Decision|4|||
33287853|NCT01157351|100951881|FG000|Overall Study|Protocol Violation|0|||
33287854|NCT01157351|100951882|FG001|Overall Study|Protocol Violation|1|||
33287855|NCT01157351|100951881|FG000|Overall Study|Other|32|||
33287856|NCT01157351|100951882|FG001|Overall Study|Other|36|||
33287857|NCT01157351|100951881|FG000|Overall Study|Noncompliance with Study Drug|0|||
33287858|NCT01157351|100951882|FG001|Overall Study|Noncompliance with Study Drug|3|||
33287859|NCT01157351|100951881|FG000|Overall Study|Randomized but not Treated|4|||
33287860|NCT01157351|100951882|FG001|Overall Study|Randomized but not Treated|2|||
33287861|NCT03927690|100951891|FG000|Overall Study|Withdrawal by Subject|3|||
33287862|NCT03927690|100951892|FG001|Overall Study|Withdrawal by Subject|1|||
33287863|NCT03927690|100951893|FG002|Overall Study|Withdrawal by Subject|1|||
33287864|NCT03927690|100951891|FG000|Overall Study|Adverse Event|1|||
33287865|NCT03927690|100951892|FG001|Overall Study|Adverse Event|0|||
33287866|NCT03927690|100951893|FG002|Overall Study|Adverse Event|0|||
33287867|NCT03927690|100951891|FG000|Overall Study|Death|1|||
33287868|NCT03927690|100951892|FG001|Overall Study|Death|0|||
33287869|NCT03927690|100951893|FG002|Overall Study|Death|0|||
33287870|NCT03927690|100951891|FG000|Overall Study|Lost to Follow-up|2|||
33287871|NCT03927690|100951892|FG001|Overall Study|Lost to Follow-up|2|||
33287872|NCT03927690|100951893|FG002|Overall Study|Lost to Follow-up|1|||
33287873|NCT03296566|100951897|FG000|Overall Study|Lost to Follow-up|19|||
33287874|NCT03296566|100951898|FG001|Overall Study|Lost to Follow-up|46|||
33287875|NCT03296566|100951897|FG000|Overall Study|Withdrawal by Subject|0|||
33287876|NCT03296566|100951898|FG001|Overall Study|Withdrawal by Subject|3|||
33287877|NCT04582669|100951899|FG000|Overall Study|Subject missed appointment(s).|1|||
33287878|NCT04582669|100951900|FG001|Overall Study|Subject missed appointment(s).|0|||
33287879|NCT04582669|100951901|FG002|Overall Study|Subject missed appointment(s).|1|||
33287880|NCT04582669|100951902|FG003|Overall Study|Subject missed appointment(s).|2|||
33287881|NCT04582669|100951899|FG000|Overall Study|Protocol Violation|0|||
33287882|NCT04582669|100951900|FG001|Overall Study|Protocol Violation|1|||
33287883|NCT04582669|100951901|FG002|Overall Study|Protocol Violation|1|||
33287884|NCT04582669|100951902|FG003|Overall Study|Protocol Violation|0|||
33287885|NCT01243411|100951903|FG000|Overall Study|Withdrawal by Subject|18|||
33287886|NCT01243411|100951903|FG000|Overall Study|Lost to Follow-up|10|||
33287887|NCT01243411|100951903|FG000|Overall Study|Adverse Event|5|||
33287888|NCT01243411|100951903|FG000|Overall Study|Other|8|||
33287889|NCT00863798|100951904|FG000|Overall Study|Adverse Event|5|||
33287890|NCT00863798|100951905|FG001|Overall Study|Adverse Event|2|||
33287891|NCT00863798|100951906|FG002|Overall Study|Adverse Event|4|||
33287892|NCT00863798|100951904|FG000|Overall Study|Participant failed to return|2|||
33287893|NCT00863798|100951905|FG001|Overall Study|Participant failed to return|1|||
33287894|NCT00863798|100951906|FG002|Overall Study|Participant failed to return|0|||
33287895|NCT00863798|100951904|FG000|Overall Study|Investigator request|1|||
33287896|NCT00863798|100951905|FG001|Overall Study|Investigator request|2|||
33287897|NCT00863798|100951906|FG002|Overall Study|Investigator request|1|||
33287898|NCT00863798|100951904|FG000|Overall Study|Lack of Efficacy|4|||
33287899|NCT00863798|100951905|FG001|Overall Study|Lack of Efficacy|3|||
33287900|NCT00863798|100951906|FG002|Overall Study|Lack of Efficacy|6|||
33287901|NCT00863798|100951904|FG000|Overall Study|Lost to Follow-up|6|||
33287902|NCT00863798|100951905|FG001|Overall Study|Lost to Follow-up|9|||
33287903|NCT00863798|100951906|FG002|Overall Study|Lost to Follow-up|5|||
33287904|NCT00863798|100951904|FG000|Overall Study|Other|2|||
33287905|NCT00863798|100951905|FG001|Overall Study|Other|3|||
33287906|NCT00863798|100951906|FG002|Overall Study|Other|1|||
33287907|NCT00863798|100951904|FG000|Overall Study|Protocol Violation|0|||
33287908|NCT00863798|100951905|FG001|Overall Study|Protocol Violation|1|||
33287909|NCT00863798|100951906|FG002|Overall Study|Protocol Violation|1|||
33287910|NCT00863798|100951904|FG000|Overall Study|Withdrawal by Subject|8|||
33287911|NCT00863798|100951905|FG001|Overall Study|Withdrawal by Subject|7|||
33287912|NCT00863798|100951906|FG002|Overall Study|Withdrawal by Subject|4|||
33287913|NCT00863798|100951904|FG000|Overall Study|Randomized not treated|4|||
33185968|NCT02658890|100590618|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33287914|NCT00863798|100951905|FG001|Overall Study|Randomized not treated|2|||
33287915|NCT00863798|100951906|FG002|Overall Study|Randomized not treated|3|||
33287916|NCT00458393|100951913|FG000|Overall Study|Withdrawal by Subject|67|||
33287917|NCT00458393|100951914|FG001|Overall Study|Withdrawal by Subject|80|||
33287918|NCT00458393|100951913|FG000|Overall Study|Physician Decision|31|||
33287919|NCT00458393|100951914|FG001|Overall Study|Physician Decision|22|||
33287920|NCT00458393|100951913|FG000|Overall Study|Relocated|77|||
33287921|NCT00458393|100951914|FG001|Overall Study|Relocated|81|||
33287922|NCT00458393|100951913|FG000|Overall Study|Lost to Follow-up|115|||
33287923|NCT00458393|100951914|FG001|Overall Study|Lost to Follow-up|92|||
33287924|NCT00458393|100951913|FG000|Overall Study|Sites marked other on the form.|19|||
33287925|NCT00458393|100951914|FG001|Overall Study|Sites marked other on the form.|20|||
33287926|NCT01657877|100951915|FG000|Overall Study|Withdrawal by Subject|4|||
33287927|NCT01657877|100951915|FG000|Overall Study|Protocol Violation|6|||
33287928|NCT01657877|100951915|FG000|Overall Study|Adverse Event|2|||
33287929|NCT01657877|100951915|FG000|Overall Study|Other Reason|2|||
33287930|NCT03119688|100951916|FG000|Overall Study|Adverse Event|4|||
33287931|NCT03765164|100951919|FG000|Pre-intervention|Withdrawal by Subject|5|||
33287932|NCT03765164|100951920|FG001|Pre-intervention|Withdrawal by Subject|6|||
33287933|NCT02560389|100951921|FG000|Overall Study|Lost to Follow-up|1|||
33287934|NCT02560389|100951922|FG001|Overall Study|Lost to Follow-up|2|||
33287935|NCT02560389|100951923|FG002|Overall Study|Lost to Follow-up|2|||
33287936|NCT02560389|100951921|FG000|Overall Study|Tested positive for illicit substance|0|||
33287937|NCT02560389|100951922|FG001|Overall Study|Tested positive for illicit substance|1|||
33287938|NCT02560389|100951923|FG002|Overall Study|Tested positive for illicit substance|0|||
33287939|NCT02484547|100951924|FG000|Placebo-Controlled Period|Adverse Event|10|||
33287940|NCT02484547|100951925|FG001|Placebo-Controlled Period|Adverse Event|13|||
33287941|NCT02484547|100951926|FG002|Placebo-Controlled Period|Adverse Event|20|||
33287942|NCT02484547|100951927|FG003|Placebo-Controlled Period|Adverse Event|0|||
33287943|NCT02484547|100951928|FG004|Placebo-Controlled Period|Adverse Event|0|||
33287944|NCT02484547|100951929|FG005|Placebo-Controlled Period|Adverse Event|0|||
33287945|NCT02484547|100951930|FG006|Placebo-Controlled Period|Adverse Event|0|||
33287946|NCT02484547|100951924|FG000|Placebo-Controlled Period|Change of Treatment|0|||
33287947|NCT02484547|100951925|FG001|Placebo-Controlled Period|Change of Treatment|0|||
33287948|NCT02484547|100951926|FG002|Placebo-Controlled Period|Change of Treatment|1|||
33287949|NCT02484547|100951927|FG003|Placebo-Controlled Period|Change of Treatment|0|||
33287950|NCT02484547|100951928|FG004|Placebo-Controlled Period|Change of Treatment|0|||
33287951|NCT02484547|100951929|FG005|Placebo-Controlled Period|Change of Treatment|0|||
33287952|NCT02484547|100951930|FG006|Placebo-Controlled Period|Change of Treatment|0|||
33287953|NCT02484547|100951924|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
33287954|NCT02484547|100951925|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
33287955|NCT02484547|100951926|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
33287956|NCT02484547|100951927|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
33287957|NCT02484547|100951928|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
33287958|NCT02484547|100951929|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
33287959|NCT02484547|100951930|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
33287960|NCT02484547|100951924|FG000|Placebo-Controlled Period|Death|5|||
33287961|NCT02484547|100951925|FG001|Placebo-Controlled Period|Death|0|||
33287962|NCT02484547|100951926|FG002|Placebo-Controlled Period|Death|6|||
33287963|NCT02484547|100951927|FG003|Placebo-Controlled Period|Death|0|||
33287964|NCT02484547|100951928|FG004|Placebo-Controlled Period|Death|0|||
33287965|NCT02484547|100951929|FG005|Placebo-Controlled Period|Death|0|||
33287966|NCT02484547|100951930|FG006|Placebo-Controlled Period|Death|0|||
33287967|NCT02484547|100951924|FG000|Placebo-Controlled Period|Disease Progression|2|||
33287968|NCT02484547|100951925|FG001|Placebo-Controlled Period|Disease Progression|0|||
33287969|NCT02484547|100951926|FG002|Placebo-Controlled Period|Disease Progression|1|||
33287970|NCT02484547|100951927|FG003|Placebo-Controlled Period|Disease Progression|0|||
33287971|NCT02484547|100951928|FG004|Placebo-Controlled Period|Disease Progression|0|||
33287972|NCT02484547|100951929|FG005|Placebo-Controlled Period|Disease Progression|0|||
33287973|NCT02484547|100951930|FG006|Placebo-Controlled Period|Disease Progression|0|||
33287974|NCT02484547|100951924|FG000|Placebo-Controlled Period|Investigator Decision|2|||
33287975|NCT02484547|100951925|FG001|Placebo-Controlled Period|Investigator Decision|2|||
33287976|NCT02484547|100951926|FG002|Placebo-Controlled Period|Investigator Decision|5|||
33287977|NCT02484547|100951927|FG003|Placebo-Controlled Period|Investigator Decision|0|||
33287978|NCT02484547|100951928|FG004|Placebo-Controlled Period|Investigator Decision|0|||
33287979|NCT02484547|100951929|FG005|Placebo-Controlled Period|Investigator Decision|0|||
33287980|NCT02484547|100951930|FG006|Placebo-Controlled Period|Investigator Decision|0|||
33287981|NCT02484547|100951924|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
33287982|NCT02484547|100951925|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
33287983|NCT02484547|100951926|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
33287984|NCT02484547|100951927|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
33287985|NCT02484547|100951928|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
33287986|NCT02484547|100951929|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
33287987|NCT02484547|100951930|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
33287988|NCT02484547|100951924|FG000|Placebo-Controlled Period|Relocation|1|||
33287989|NCT02484547|100951925|FG001|Placebo-Controlled Period|Relocation|1|||
33287990|NCT02484547|100951926|FG002|Placebo-Controlled Period|Relocation|1|||
33287991|NCT02484547|100951927|FG003|Placebo-Controlled Period|Relocation|0|||
33287992|NCT02484547|100951928|FG004|Placebo-Controlled Period|Relocation|0|||
33287993|NCT02484547|100951929|FG005|Placebo-Controlled Period|Relocation|0|||
33287994|NCT02484547|100951930|FG006|Placebo-Controlled Period|Relocation|0|||
33287995|NCT02484547|100951924|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
33287996|NCT02484547|100951925|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
33287997|NCT02484547|100951926|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
33287998|NCT02484547|100951927|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
33287999|NCT02484547|100951928|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
33288000|NCT02484547|100951929|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
33288001|NCT02484547|100951930|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
33288002|NCT02484547|100951924|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
33288003|NCT02484547|100951925|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
33288004|NCT02484547|100951926|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
33288005|NCT02484547|100951927|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33288006|NCT02484547|100951928|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33288007|NCT02484547|100951929|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33288008|NCT02484547|100951930|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33288009|NCT02484547|100951924|FG000|Placebo-Controlled Period|Reason not Specified|216|||
33288010|NCT02484547|100951925|FG001|Placebo-Controlled Period|Reason not Specified|194|||
33288011|NCT02484547|100951926|FG002|Placebo-Controlled Period|Reason not Specified|183|||
33288012|NCT02484547|100951927|FG003|Placebo-Controlled Period|Reason not Specified|0|||
33288013|NCT02484547|100951928|FG004|Placebo-Controlled Period|Reason not Specified|0|||
33288014|NCT02484547|100951929|FG005|Placebo-Controlled Period|Reason not Specified|0|||
33288015|NCT02484547|100951930|FG006|Placebo-Controlled Period|Reason not Specified|0|||
33288016|NCT02484547|100951924|FG000|Long-Term Extension Period|Adverse Event|0|||
33288017|NCT02484547|100951925|FG001|Long-Term Extension Period|Adverse Event|0|||
33288018|NCT02484547|100951926|FG002|Long-Term Extension Period|Adverse Event|0|||
33288019|NCT02484547|100951927|FG003|Long-Term Extension Period|Adverse Event|0|||
33288020|NCT02484547|100951928|FG004|Long-Term Extension Period|Adverse Event|1|||
33288021|NCT02484547|100951929|FG005|Long-Term Extension Period|Adverse Event|3|||
33288022|NCT02484547|100951930|FG006|Long-Term Extension Period|Adverse Event|2|||
33288023|NCT02484547|100951924|FG000|Long-Term Extension Period|Death|0|||
33288024|NCT02484547|100951925|FG001|Long-Term Extension Period|Death|0|||
33288025|NCT02484547|100951926|FG002|Long-Term Extension Period|Death|0|||
33288026|NCT02484547|100951927|FG003|Long-Term Extension Period|Death|0|||
33288027|NCT02484547|100951928|FG004|Long-Term Extension Period|Death|0|||
33288028|NCT02484547|100951929|FG005|Long-Term Extension Period|Death|3|||
33288029|NCT02484547|100951930|FG006|Long-Term Extension Period|Death|0|||
33288030|NCT02484547|100951924|FG000|Long-Term Extension Period|Disease Progression|0|||
33288031|NCT02484547|100951925|FG001|Long-Term Extension Period|Disease Progression|0|||
33288032|NCT02484547|100951926|FG002|Long-Term Extension Period|Disease Progression|0|||
33288033|NCT02484547|100951927|FG003|Long-Term Extension Period|Disease Progression|0|||
33288034|NCT02484547|100951928|FG004|Long-Term Extension Period|Disease Progression|2|||
33288035|NCT02484547|100951929|FG005|Long-Term Extension Period|Disease Progression|4|||
33288036|NCT02484547|100951930|FG006|Long-Term Extension Period|Disease Progression|0|||
33288037|NCT02484547|100951924|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
33288038|NCT02484547|100951925|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
33288039|NCT02484547|100951926|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
33288040|NCT02484547|100951927|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
33288041|NCT02484547|100951928|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
33288042|NCT02484547|100951929|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
33288043|NCT02484547|100951930|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
33288044|NCT02484547|100951924|FG000|Long-Term Extension Period|Loss of Capacity|0|||
33288045|NCT02484547|100951925|FG001|Long-Term Extension Period|Loss of Capacity|0|||
33288046|NCT02484547|100951926|FG002|Long-Term Extension Period|Loss of Capacity|0|||
33288047|NCT02484547|100951927|FG003|Long-Term Extension Period|Loss of Capacity|0|||
33288048|NCT02484547|100951928|FG004|Long-Term Extension Period|Loss of Capacity|1|||
33288049|NCT02484547|100951929|FG005|Long-Term Extension Period|Loss of Capacity|0|||
33288050|NCT02484547|100951930|FG006|Long-Term Extension Period|Loss of Capacity|0|||
33288051|NCT02484547|100951924|FG000|Long-Term Extension Period|Change of Treatment|0|||
33288052|NCT02484547|100951925|FG001|Long-Term Extension Period|Change of Treatment|0|||
33288053|NCT02484547|100951926|FG002|Long-Term Extension Period|Change of Treatment|0|||
33288054|NCT02484547|100951927|FG003|Long-Term Extension Period|Change of Treatment|0|||
33288055|NCT02484547|100951928|FG004|Long-Term Extension Period|Change of Treatment|0|||
33288056|NCT02484547|100951929|FG005|Long-Term Extension Period|Change of Treatment|0|||
33288057|NCT02484547|100951930|FG006|Long-Term Extension Period|Change of Treatment|1|||
33288058|NCT02484547|100951924|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
33288059|NCT02484547|100951925|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
33288060|NCT02484547|100951926|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
33288061|NCT02484547|100951927|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
33288062|NCT02484547|100951928|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
33288063|NCT02484547|100951929|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
33288064|NCT02484547|100951930|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
33288065|NCT02484547|100951924|FG000|Long-Term Extension Period|Investigator Decision|0|||
33288066|NCT02484547|100951925|FG001|Long-Term Extension Period|Investigator Decision|0|||
33288067|NCT02484547|100951926|FG002|Long-Term Extension Period|Investigator Decision|0|||
33288068|NCT02484547|100951927|FG003|Long-Term Extension Period|Investigator Decision|2|||
33288069|NCT02484547|100951928|FG004|Long-Term Extension Period|Investigator Decision|1|||
33288070|NCT02484547|100951929|FG005|Long-Term Extension Period|Investigator Decision|0|||
33288071|NCT02484547|100951930|FG006|Long-Term Extension Period|Investigator Decision|1|||
33288072|NCT02484547|100951924|FG000|Long-Term Extension Period|Relocation|0|||
33288073|NCT02484547|100951925|FG001|Long-Term Extension Period|Relocation|0|||
33288074|NCT02484547|100951926|FG002|Long-Term Extension Period|Relocation|0|||
33288075|NCT02484547|100951927|FG003|Long-Term Extension Period|Relocation|1|||
33288076|NCT02484547|100951928|FG004|Long-Term Extension Period|Relocation|1|||
33288077|NCT02484547|100951929|FG005|Long-Term Extension Period|Relocation|0|||
33288078|NCT02484547|100951930|FG006|Long-Term Extension Period|Relocation|0|||
33288079|NCT02484547|100951924|FG000|Long-Term Extension Period|Study Visit Burden|0|||
33288080|NCT02484547|100951925|FG001|Long-Term Extension Period|Study Visit Burden|0|||
33288081|NCT02484547|100951926|FG002|Long-Term Extension Period|Study Visit Burden|0|||
33288082|NCT02484547|100951927|FG003|Long-Term Extension Period|Study Visit Burden|2|||
33288083|NCT02484547|100951928|FG004|Long-Term Extension Period|Study Visit Burden|0|||
33288084|NCT02484547|100951929|FG005|Long-Term Extension Period|Study Visit Burden|0|||
33288085|NCT02484547|100951930|FG006|Long-Term Extension Period|Study Visit Burden|3|||
33288086|NCT02484547|100951924|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
33288087|NCT02484547|100951925|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
33288088|NCT02484547|100951926|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
33288089|NCT02484547|100951927|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
33288090|NCT02484547|100951928|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
33288091|NCT02484547|100951929|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
33288092|NCT02484547|100951930|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
33288093|NCT02484547|100951924|FG000|Long-Term Extension Period|Reason not Specified|0|||
33288094|NCT02484547|100951925|FG001|Long-Term Extension Period|Reason not Specified|0|||
33288095|NCT02484547|100951926|FG002|Long-Term Extension Period|Reason not Specified|0|||
33288096|NCT02484547|100951927|FG003|Long-Term Extension Period|Reason not Specified|119|||
33288097|NCT02484547|100951928|FG004|Long-Term Extension Period|Reason not Specified|117|||
33288098|NCT02484547|100951929|FG005|Long-Term Extension Period|Reason not Specified|223|||
33288099|NCT02484547|100951930|FG006|Long-Term Extension Period|Reason not Specified|231|||
33288100|NCT03414047|100951931|FG000|Overall Study|Adverse Event|0|||
33288101|NCT03414047|100951932|FG001|Overall Study|Adverse Event|0|||
33288102|NCT03414047|100951933|FG002|Overall Study|Adverse Event|1|||
33288103|NCT03414047|100951934|FG003|Overall Study|Adverse Event|1|||
33288104|NCT03414047|100951931|FG000|Overall Study|Physician Decision|1|||
33288105|NCT03414047|100951932|FG001|Overall Study|Physician Decision|0|||
33288106|NCT03414047|100951933|FG002|Overall Study|Physician Decision|0|||
33288107|NCT03414047|100951934|FG003|Overall Study|Physician Decision|1|||
33288108|NCT03414047|100951931|FG000|Overall Study|Withdrawal by Subject|1|||
33288109|NCT03414047|100951932|FG001|Overall Study|Withdrawal by Subject|0|||
33288110|NCT03414047|100951933|FG002|Overall Study|Withdrawal by Subject|2|||
33288111|NCT03414047|100951934|FG003|Overall Study|Withdrawal by Subject|0|||
33288112|NCT00809341|100951939|FG000|Overall Study|Physician Decision|0|||
33288113|NCT00809341|100951940|FG001|Overall Study|Physician Decision|1|||
33288114|NCT00508274|100951941|FG000|Overall Study|Adverse Event|5|||
33288115|NCT00508274|100951941|FG000|Overall Study|Death|7|||
33288116|NCT00508274|100951941|FG000|Overall Study|Disease progression|32|||
33288117|NCT00508274|100951941|FG000|Overall Study|Withdrawal by Subject|1|||
33288118|NCT00508274|100951941|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
33288119|NCT00508274|100951941|FG000|Overall Study|Missing|3|||
33288120|NCT03246347|100951943|FG000|Overall Study|On Study|23|||
33288121|NCT03371823|100951944|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
33288122|NCT03371823|100951945|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
33288123|NCT00004445|100951946|FG000|Overall Study|Physician Decision|2|||
33288124|NCT00004445|100951946|FG000|Overall Study|Withdrawal by Subject|1|||
33288125|NCT02057575|100951949|FG000|Overall Study|Adverse Event|0|||
33288126|NCT02057575|100951950|FG001|Overall Study|Adverse Event|2|||
33288127|NCT02057575|100951951|FG002|Overall Study|Adverse Event|0|||
33288128|NCT02057575|100951952|FG003|Overall Study|Adverse Event|1|||
33288129|NCT02057575|100951949|FG000|Overall Study|Withdrawal by Subject|1|||
33288130|NCT02057575|100951950|FG001|Overall Study|Withdrawal by Subject|0|||
33288131|NCT02057575|100951951|FG002|Overall Study|Withdrawal by Subject|0|||
33288132|NCT02057575|100951952|FG003|Overall Study|Withdrawal by Subject|0|||
33288133|NCT02057575|100951949|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
33288134|NCT02057575|100951950|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
33288135|NCT02057575|100951951|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
33288136|NCT02057575|100951952|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
33288137|NCT02057575|100951949|FG000|Overall Study|Protocol Violation|0|||
33288138|NCT02057575|100951950|FG001|Overall Study|Protocol Violation|1|||
33288139|NCT02057575|100951951|FG002|Overall Study|Protocol Violation|0|||
33288140|NCT02057575|100951952|FG003|Overall Study|Protocol Violation|0|||
33288141|NCT01850823|100951953|FG000|Overall Study|Early Visit Window|0|||
33288142|NCT01850823|100951954|FG001|Overall Study|Early Visit Window|1|||
33389934|NCT00255034|101317566|FG000|Overall Study|Withdrawal by Subject|15|||
33288143|NCT01850823|100951955|FG002|Overall Study|Early Visit Window|4|||
33288144|NCT01850823|100951953|FG000|Overall Study|Enrolled in Error|0|||
33288145|NCT01850823|100951954|FG001|Overall Study|Enrolled in Error|1|||
33288146|NCT01850823|100951955|FG002|Overall Study|Enrolled in Error|2|||
33288147|NCT01850823|100951953|FG000|Overall Study|Lack of Efficacy|1|||
33288148|NCT01850823|100951954|FG001|Overall Study|Lack of Efficacy|0|||
33288149|NCT01850823|100951955|FG002|Overall Study|Lack of Efficacy|0|||
33288150|NCT01850823|100951953|FG000|Overall Study|Lost to Follow-up|0|||
33288151|NCT01850823|100951954|FG001|Overall Study|Lost to Follow-up|0|||
33288152|NCT01850823|100951955|FG002|Overall Study|Lost to Follow-up|1|||
33288153|NCT01850823|100951953|FG000|Overall Study|Restricted Medication|0|||
33185969|NCT02658890|100590619|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185970|NCT02658890|100590620|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185971|NCT02658890|100590621|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185972|NCT02658890|100590622|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185973|NCT02658890|100590623|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185974|NCT02658890|100590624|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185975|NCT02658890|100590625|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185976|NCT02658890|100590626|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185977|NCT02658890|100590627|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33185978|NCT02658890|100590601|FG000|Treatment Phase|Adverse Event|0|||
33185979|NCT02658890|100590602|FG001|Treatment Phase|Adverse Event|1|||
33185980|NCT02658890|100590603|FG002|Treatment Phase|Adverse Event|2|||
33185981|NCT02658890|100590604|FG003|Treatment Phase|Adverse Event|2|||
33185982|NCT02658890|100590605|FG004|Treatment Phase|Adverse Event|1|||
33185983|NCT02658890|100590606|FG005|Treatment Phase|Adverse Event|0|||
33185984|NCT02658890|100590607|FG006|Treatment Phase|Adverse Event|0|||
33185985|NCT02658890|100590608|FG007|Treatment Phase|Adverse Event|2|||
33288154|NCT01850823|100951954|FG001|Overall Study|Restricted Medication|0|||
33288155|NCT01850823|100951955|FG002|Overall Study|Restricted Medication|2|||
33288156|NCT01850823|100951953|FG000|Overall Study|Significant worstening of SAR|0|||
33288157|NCT01850823|100951954|FG001|Overall Study|Significant worstening of SAR|1|||
33288158|NCT01850823|100951955|FG002|Overall Study|Significant worstening of SAR|0|||
33288159|NCT01850823|100951953|FG000|Overall Study|Withdrawal by Subject|2|||
33288160|NCT01850823|100951954|FG001|Overall Study|Withdrawal by Subject|0|||
33288161|NCT01850823|100951955|FG002|Overall Study|Withdrawal by Subject|1|||
33288162|NCT02062645|100951959|FG000|Overall Study|Adverse Event|2|||
33288163|NCT02062645|100951959|FG000|Overall Study|Protocol Violation|8|||
33288164|NCT02062645|100951959|FG000|Overall Study|Lost to Follow-up|5|||
33288165|NCT00365547|100951961|FG000|Overall Study|Insurance did not cover Avastin|1|||
33288166|NCT00365547|100951961|FG000|Overall Study|Screen failure|1|||
33288167|NCT00365547|100951961|FG000|Overall Study|Withdrawal by Subject|1|||
33288168|NCT03418493|100951964|FG000|Overall Study|Adverse Event|1|||
33288169|NCT03418493|100951965|FG001|Overall Study|Adverse Event|0|||
33288170|NCT03418493|100951966|FG002|Overall Study|Adverse Event|0|||
33288171|NCT03418493|100951967|FG003|Overall Study|Adverse Event|0|||
33288172|NCT03418493|100951968|FG004|Overall Study|Adverse Event|0|||
33288173|NCT03418493|100951969|FG005|Overall Study|Adverse Event|0|||
33288174|NCT03418493|100951970|FG006|Overall Study|Adverse Event|0|||
33288175|NCT03418493|100951971|FG007|Overall Study|Adverse Event|0|||
33288176|NCT03418493|100951972|FG008|Overall Study|Adverse Event|0|||
33288177|NCT03418493|100951973|FG009|Overall Study|Adverse Event|0|||
33288178|NCT03418493|100951974|FG010|Overall Study|Adverse Event|0|||
33288179|NCT03418493|100951964|FG000|Overall Study|Protocol Violation|0|||
33288180|NCT03418493|100951965|FG001|Overall Study|Protocol Violation|0|||
33288181|NCT03418493|100951966|FG002|Overall Study|Protocol Violation|0|||
33288182|NCT03418493|100951967|FG003|Overall Study|Protocol Violation|0|||
33288183|NCT03418493|100951968|FG004|Overall Study|Protocol Violation|0|||
33288184|NCT03418493|100951969|FG005|Overall Study|Protocol Violation|0|||
33288185|NCT03418493|100951970|FG006|Overall Study|Protocol Violation|0|||
33288186|NCT03418493|100951971|FG007|Overall Study|Protocol Violation|0|||
33288187|NCT03418493|100951972|FG008|Overall Study|Protocol Violation|0|||
33288188|NCT03418493|100951973|FG009|Overall Study|Protocol Violation|1|||
33288189|NCT03418493|100951974|FG010|Overall Study|Protocol Violation|0|||
33288190|NCT03464383|100951975|FG000|Overall Study|Lost to Follow-up|1|||
33288191|NCT03464383|100951976|FG001|Overall Study|Lost to Follow-up|0|||
33288192|NCT03464383|100951977|FG002|Overall Study|Lost to Follow-up|0|||
33288193|NCT03464383|100951975|FG000|Overall Study|Withdrawal by Subject|0|||
33288194|NCT03464383|100951976|FG001|Overall Study|Withdrawal by Subject|1|||
33288195|NCT03464383|100951977|FG002|Overall Study|Withdrawal by Subject|0|||
33288196|NCT00469859|100951981|FG000|Overall Study|Inevaluable|0|||
33288197|NCT00469859|100951982|FG001|Overall Study|Inevaluable|2|||
33288198|NCT00320398|100951985|FG000|Overall Study|Adverse Event|1|||
33288199|NCT00320398|100951986|FG001|Overall Study|Adverse Event|4|||
33288200|NCT00320398|100951985|FG000|Overall Study|Other|1|||
33288201|NCT00320398|100951986|FG001|Overall Study|Other|0|||
33288202|NCT00805285|100951988|FG000|Overall Study|Lack of Efficacy|1|||
33288203|NCT00715117|100951989|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
33288204|NCT00715117|100951990|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
33288205|NCT02980705|100951992|FG000|Overall Study|Adverse Event|0|||
33288206|NCT02980705|100951993|FG001|Overall Study|Adverse Event|1|||
33288207|NCT02980705|100951992|FG000|Overall Study|Withdrawal by Subject|6|||
33288208|NCT02980705|100951993|FG001|Overall Study|Withdrawal by Subject|9|||
33288209|NCT02980705|100951992|FG000|Overall Study|withdrew participation|0|||
33288210|NCT02980705|100951993|FG001|Overall Study|withdrew participation|1|||
33288211|NCT02980705|100951992|FG000|Overall Study|Lost to Follow-up|2|||
33288212|NCT02980705|100951993|FG001|Overall Study|Lost to Follow-up|0|||
33288213|NCT00878553|100951994|FG000|Sleep Study|Withdrawal by Subject|2|||
33288214|NCT00878553|100951995|FG001|Sleep Study|Withdrawal by Subject|0|||
33288215|NCT00878553|100951996|FG002|Sleep Study|Withdrawal by Subject|0|||
33288216|NCT00878553|100951997|FG003|Sleep Study|Withdrawal by Subject|0|||
33288217|NCT00878553|100951998|FG004|Sleep Study|Withdrawal by Subject|0|||
33288218|NCT00878553|100951994|FG000|Sleep Study|Lost to Follow-up|1|||
33288219|NCT00878553|100951995|FG001|Sleep Study|Lost to Follow-up|0|||
33288220|NCT00878553|100951996|FG002|Sleep Study|Lost to Follow-up|0|||
33288221|NCT00878553|100951997|FG003|Sleep Study|Lost to Follow-up|0|||
33288222|NCT00878553|100951998|FG004|Sleep Study|Lost to Follow-up|0|||
33288223|NCT00878553|100951994|FG000|Sleep Study|car accident|1|||
33288224|NCT00878553|100951995|FG001|Sleep Study|car accident|0|||
33288225|NCT00878553|100951996|FG002|Sleep Study|car accident|0|||
33288226|NCT00878553|100951997|FG003|Sleep Study|car accident|0|||
33288227|NCT00878553|100951998|FG004|Sleep Study|car accident|0|||
33288228|NCT00878553|100951994|FG000|Sleep Study|family emergency|1|||
33288229|NCT00878553|100951995|FG001|Sleep Study|family emergency|0|||
33288230|NCT00878553|100951996|FG002|Sleep Study|family emergency|0|||
33288231|NCT00878553|100951997|FG003|Sleep Study|family emergency|0|||
33288232|NCT00878553|100951998|FG004|Sleep Study|family emergency|0|||
33288233|NCT00878553|100951994|FG000|PK Study|Withdrawal by Subject|0|||
33288234|NCT00878553|100951995|FG001|PK Study|Withdrawal by Subject|0|||
33288235|NCT00878553|100951996|FG002|PK Study|Withdrawal by Subject|0|||
33288236|NCT00878553|100951997|FG003|PK Study|Withdrawal by Subject|1|||
33288237|NCT00878553|100951998|FG004|PK Study|Withdrawal by Subject|0|||
33288238|NCT02806505|100952002|FG000|Overall Study|Adverse event/intercurrent illness|1|||
33288239|NCT02806505|100952003|FG001|Overall Study|Adverse event/intercurrent illness|3|||
33288240|NCT02806505|100952002|FG000|Overall Study|Death|4|||
33288241|NCT02806505|100952003|FG001|Overall Study|Death|0|||
33288242|NCT02806505|100952002|FG000|Overall Study|Did not cooperate/refused treatment|3|||
33288243|NCT02806505|100952003|FG001|Overall Study|Did not cooperate/refused treatment|3|||
33288244|NCT02806505|100952002|FG000|Overall Study|Failure to return|0|||
33288245|NCT02806505|100952003|FG001|Overall Study|Failure to return|1|||
33288246|NCT02806505|100952002|FG000|Overall Study|Insufficient therapeutic response|2|||
33288247|NCT02806505|100952003|FG001|Overall Study|Insufficient therapeutic response|4|||
33288248|NCT01006889|100952007|FG000|Overall Study|Withdrawal by Subject|3|||
33288249|NCT00665223|100952008|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
33288250|NCT00665223|100952009|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
33288251|NCT00665223|100952010|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
33288252|NCT00665223|100952008|FG000|Randomized Phase (26 Weeks)|Death|0|||
33288253|NCT00665223|100952009|FG001|Randomized Phase (26 Weeks)|Death|0|||
33288254|NCT00665223|100952010|FG002|Randomized Phase (26 Weeks)|Death|1|||
33288255|NCT00665223|100952008|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
33288256|NCT00665223|100952009|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
33288257|NCT00665223|100952010|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
33288258|NCT00665223|100952008|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
33288259|NCT00665223|100952009|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
33288260|NCT00665223|100952010|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
33288261|NCT00665223|100952008|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
33288262|NCT00665223|100952009|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
33288263|NCT00665223|100952010|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
33288264|NCT00665223|100952008|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
33288265|NCT00665223|100952009|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
33288266|NCT00665223|100952010|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
33288267|NCT00665223|100952008|FG000|Open-Label Period (26 Weeks)|Death|0|||
33288268|NCT00665223|100952009|FG001|Open-Label Period (26 Weeks)|Death|1|||
33185986|NCT02658890|100590609|FG008|Treatment Phase|Adverse Event|1|||
33288269|NCT00665223|100952010|FG002|Open-Label Period (26 Weeks)|Death|0|||
33288270|NCT00665223|100952008|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
33288271|NCT00665223|100952009|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
33288272|NCT00665223|100952010|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
33288273|NCT00665223|100952008|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
33288274|NCT00665223|100952009|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
33288275|NCT00665223|100952010|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
33288276|NCT00665223|100952008|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
33288277|NCT00665223|100952009|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
33288278|NCT00665223|100952010|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
33288279|NCT00665223|100952008|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
33288280|NCT00665223|100952009|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
33288281|NCT00665223|100952010|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
33288282|NCT02635386|100952015|FG000|Overall Study|Pregnancy|2|||
33288283|NCT02635386|100952016|FG001|Overall Study|Pregnancy|0|||
33288284|NCT02635386|100952017|FG002|Overall Study|Pregnancy|0|||
33288285|NCT02635386|100952018|FG003|Overall Study|Pregnancy|0|||
33288286|NCT02635386|100952019|FG004|Overall Study|Pregnancy|2|||
33288287|NCT02635386|100952015|FG000|Overall Study|Withdrawal by Subject|1|||
33288288|NCT02635386|100952016|FG001|Overall Study|Withdrawal by Subject|1|||
33288289|NCT02635386|100952017|FG002|Overall Study|Withdrawal by Subject|0|||
33288290|NCT02635386|100952018|FG003|Overall Study|Withdrawal by Subject|1|||
33288291|NCT02635386|100952019|FG004|Overall Study|Withdrawal by Subject|0|||
33288292|NCT02635386|100952015|FG000|Overall Study|Physician Decision|0|||
33288293|NCT02635386|100952016|FG001|Overall Study|Physician Decision|1|||
33288294|NCT02635386|100952017|FG002|Overall Study|Physician Decision|0|||
33288295|NCT02635386|100952018|FG003|Overall Study|Physician Decision|0|||
33288296|NCT02635386|100952019|FG004|Overall Study|Physician Decision|0|||
33288297|NCT02635386|100952015|FG000|Overall Study|Moved Out of State|0|||
33288298|NCT02635386|100952016|FG001|Overall Study|Moved Out of State|1|||
33288299|NCT02635386|100952017|FG002|Overall Study|Moved Out of State|0|||
33288300|NCT02635386|100952018|FG003|Overall Study|Moved Out of State|0|||
33288301|NCT02635386|100952019|FG004|Overall Study|Moved Out of State|0|||
33288302|NCT02635386|100952015|FG000|Overall Study|Noncompliant|0|||
33288303|NCT02635386|100952016|FG001|Overall Study|Noncompliant|2|||
33288304|NCT02635386|100952017|FG002|Overall Study|Noncompliant|1|||
33288305|NCT02635386|100952018|FG003|Overall Study|Noncompliant|1|||
33288306|NCT02635386|100952019|FG004|Overall Study|Noncompliant|1|||
33389935|NCT00255034|101317567|FG001|Overall Study|Withdrawal by Subject|38|||
33389936|NCT01709708|101317578|FG000|Overall Study|Protocol Violation|1|||
33389937|NCT01709708|101317579|FG001|Overall Study|Protocol Violation|2|||
33389938|NCT01927068|101317584|FG000|Overall Study|Death|37|||
33389939|NCT01927068|101317585|FG001|Overall Study|Death|3|||
33389940|NCT01927068|101317584|FG000|Overall Study|Withdrawal by Subject|50|||
33389941|NCT01927068|101317585|FG001|Overall Study|Withdrawal by Subject|3|||
33389942|NCT01927068|101317584|FG000|Overall Study|Lost to Follow-up|10|||
33185987|NCT02658890|100590610|FG009|Treatment Phase|Adverse Event|2|||
33389943|NCT01927068|101317585|FG001|Overall Study|Lost to Follow-up|2|||
33389944|NCT01927068|101317584|FG000|Overall Study|Physician Decision|9|||
33389945|NCT01927068|101317585|FG001|Overall Study|Physician Decision|0|||
33389946|NCT01927068|101317584|FG000|Overall Study|Missed last follow-up visit|2|||
33389947|NCT01927068|101317585|FG001|Overall Study|Missed last follow-up visit|0|||
33389948|NCT01190020|101317590|FG000|Overall Study|Adverse Event|2|||
33389949|NCT01190020|101317591|FG001|Overall Study|Adverse Event|0|||
33389950|NCT01190020|101317590|FG000|Overall Study|Lost to Follow-up|2|||
33389951|NCT01190020|101317591|FG001|Overall Study|Lost to Follow-up|0|||
33389952|NCT01190020|101317590|FG000|Overall Study|Withdrawal by Subject|3|||
33389953|NCT01190020|101317591|FG001|Overall Study|Withdrawal by Subject|0|||
33389954|NCT00093470|101317593|FG000|Overall Study|Disease progression|39|||
33389955|NCT00093470|101317594|FG001|Overall Study|Disease progression|0|||
33288307|NCT02635386|100952015|FG000|Overall Study|side effects|0|||
33288308|NCT02635386|100952016|FG001|Overall Study|side effects|0|||
33288309|NCT02635386|100952017|FG002|Overall Study|side effects|1|||
33288310|NCT02635386|100952018|FG003|Overall Study|side effects|4|||
33185988|NCT02658890|100590611|FG010|Treatment Phase|Adverse Event|3|||
33288311|NCT02635386|100952019|FG004|Overall Study|side effects|6|||
33288312|NCT02635386|100952015|FG000|Overall Study|needed other major surgery|0|||
33288313|NCT02635386|100952016|FG001|Overall Study|needed other major surgery|1|||
33288314|NCT02635386|100952017|FG002|Overall Study|needed other major surgery|0|||
33389956|NCT00093470|101317593|FG000|Overall Study|Adverse Event|15|||
33389957|NCT00093470|101317594|FG001|Overall Study|Adverse Event|0|||
33389958|NCT00093470|101317593|FG000|Overall Study|Death|2|||
33389959|NCT00093470|101317594|FG001|Overall Study|Death|0|||
33389960|NCT00093470|101317593|FG000|Overall Study|Withdrawal by Subject|8|||
33389961|NCT00093470|101317594|FG001|Overall Study|Withdrawal by Subject|0|||
33389962|NCT00093470|101317593|FG000|Overall Study|Alternative therapy|2|||
33389963|NCT00093470|101317594|FG001|Overall Study|Alternative therapy|0|||
33185989|NCT02658890|100590612|FG011|Treatment Phase|Adverse Event|0|||
33389964|NCT00093470|101317593|FG000|Overall Study|Other complicating disease|3|||
33389965|NCT00093470|101317594|FG001|Overall Study|Other complicating disease|0|||
33389966|NCT00093470|101317593|FG000|Overall Study|Physician Decision|2|||
33389967|NCT00093470|101317594|FG001|Overall Study|Physician Decision|0|||
33185990|NCT02658890|100590613|FG012|Treatment Phase|Adverse Event|1|||
33389968|NCT00093470|101317593|FG000|Overall Study|Never started treatment|1|||
33389969|NCT00093470|101317594|FG001|Overall Study|Never started treatment|0|||
33389970|NCT00093470|101317593|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
33389971|NCT00093470|101317594|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
33389972|NCT01105936|101317595|FG000|Period 1|Adverse Event|0|||
33389973|NCT01105936|101317596|FG001|Period 1|Adverse Event|0|||
33389974|NCT01105936|101317597|FG002|Period 1|Adverse Event|0|||
33389975|NCT01105936|101317598|FG003|Period 1|Adverse Event|1|||
33389976|NCT01105936|101317595|FG000|Period 2|Adverse Event|1|||
33389977|NCT01105936|101317596|FG001|Period 2|Adverse Event|0|||
33389978|NCT01105936|101317597|FG002|Period 2|Adverse Event|0|||
33493949|NCT03154125|101698317|FG001|Overall Study|Physician Decision|6|||
33493950|NCT03154125|101698318|FG002|Overall Study|Physician Decision|0|||
33493951|NCT03154125|101698316|FG000|Overall Study|Protocol Violation|3|||
33493952|NCT03154125|101698317|FG001|Overall Study|Protocol Violation|5|||
33493953|NCT03154125|101698318|FG002|Overall Study|Protocol Violation|0|||
33493954|NCT03644342|101698321|FG000|Overall Study|Adverse Event|2|||
33493955|NCT03644342|101698322|FG001|Overall Study|Adverse Event|0|||
33493956|NCT03644342|101698321|FG000|Overall Study|Protocol Violation|0|||
33493957|NCT03644342|101698322|FG001|Overall Study|Protocol Violation|1|||
33493958|NCT00752128|101698323|FG000|Overall Study|Withdrawal by Subject|4|||
33493959|NCT02847260|101698326|FG000|Overall Study|Adverse Event|3|||
33493960|NCT02847260|101698326|FG000|Overall Study|Withdrawal by Subject|2|||
33493961|NCT02847260|101698326|FG000|Overall Study|Clinical Deterioration|1|||
33493962|NCT02847260|101698326|FG000|Overall Study|Physician Decision|1|||
33493963|NCT03571828|101698330|FG000|Overall Study|Withdrawal by Subject|1|||
33493964|NCT03571828|101698331|FG001|Overall Study|Withdrawal by Subject|0|||
33493965|NCT03571828|101698330|FG000|Overall Study|Decision by sponsor|5|||
33493966|NCT03571828|101698331|FG001|Overall Study|Decision by sponsor|1|||
33493967|NCT03571828|101698330|FG000|Overall Study|Death|2|||
33493968|NCT03571828|101698331|FG001|Overall Study|Death|0|||
33493969|NCT01000155|101698334|FG000|Overall Study|Withdrawal by Subject|1|||
33493970|NCT01000155|101698334|FG000|Overall Study|Adverse Event|1|||
33493971|NCT03411863|101698335|FG000|Overall Study|Withdrawal by Subject|3|||
33493972|NCT03411863|101698336|FG001|Overall Study|Withdrawal by Subject|1|||
33493973|NCT03411863|101698335|FG000|Overall Study|Physician Decision|0|||
33288315|NCT02635386|100952018|FG003|Overall Study|needed other major surgery|0|||
33389979|NCT01105936|101317598|FG003|Period 2|Adverse Event|0|||
33389980|NCT01105936|101317595|FG000|Period 3|Protocol Violation|0|||
33389981|NCT01105936|101317596|FG001|Period 3|Protocol Violation|2|||
33389982|NCT01105936|101317597|FG002|Period 3|Protocol Violation|0|||
33389983|NCT01105936|101317598|FG003|Period 3|Protocol Violation|0|||
33389984|NCT03997760|101317599|FG000|Overall Study|Protocol Deviation|0|||
33389985|NCT03997760|101317600|FG001|Overall Study|Protocol Deviation|1|||
33389986|NCT03997760|101317601|FG002|Overall Study|Protocol Deviation|0|||
33389987|NCT03997760|101317602|FG003|Overall Study|Protocol Deviation|0|||
33389988|NCT04914819|101317603|FG000|Overall Study|Pregnancy|3|||
33389989|NCT04914819|101317604|FG001|Overall Study|Pregnancy|1|||
33389990|NCT04914819|101317603|FG000|Overall Study|Discontinued study|4|||
33389991|NCT04914819|101317604|FG001|Overall Study|Discontinued study|1|||
33389992|NCT04914819|101317603|FG000|Overall Study|Lost to Follow-up|7|||
33389993|NCT04914819|101317604|FG001|Overall Study|Lost to Follow-up|0|||
33389994|NCT01316380|101317607|FG000|Overall Study|Adverse Event|0|||
33389995|NCT01316380|101317608|FG001|Overall Study|Adverse Event|2|||
33389996|NCT01316380|101317609|FG002|Overall Study|Adverse Event|1|||
33389997|NCT01316380|101317607|FG000|Overall Study|Protocol Violation|0|||
33389998|NCT01316380|101317608|FG001|Overall Study|Protocol Violation|0|||
33389999|NCT01316380|101317609|FG002|Overall Study|Protocol Violation|1|||
33390000|NCT01316380|101317607|FG000|Overall Study|Withdrawal by Subject|1|||
33390001|NCT01316380|101317608|FG001|Overall Study|Withdrawal by Subject|2|||
33390002|NCT01316380|101317609|FG002|Overall Study|Withdrawal by Subject|0|||
33390003|NCT01316380|101317607|FG000|Overall Study|Other|0|||
33288316|NCT02635386|100952019|FG004|Overall Study|needed other major surgery|0|||
33288317|NCT02635386|100952015|FG000|Overall Study|Other medical problems not drug related|0|||
33288318|NCT02635386|100952016|FG001|Overall Study|Other medical problems not drug related|0|||
33288319|NCT02635386|100952017|FG002|Overall Study|Other medical problems not drug related|0|||
33288320|NCT02635386|100952018|FG003|Overall Study|Other medical problems not drug related|1|||
33288321|NCT02635386|100952019|FG004|Overall Study|Other medical problems not drug related|0|||
33288322|NCT03796208|100952028|FG000|Overall Study|Withdrawal by Subject|3|||
33288323|NCT03796208|100952029|FG001|Overall Study|Withdrawal by Subject|0|||
33288324|NCT03796208|100952028|FG000|Overall Study|Loss of pregnancy|1|||
33288325|NCT03796208|100952029|FG001|Overall Study|Loss of pregnancy|1|||
33288326|NCT03796208|100952028|FG000|Overall Study|Changed prenatal clinics|0|||
33390004|NCT01316380|101317608|FG001|Overall Study|Other|1|||
33493974|NCT03411863|101698336|FG001|Overall Study|Physician Decision|1|||
33493975|NCT00065156|101698337|FG000|Overall Study|Adverse Event|37|||
33493976|NCT00065156|101698337|FG000|Overall Study|Lack of Efficacy|52|||
33493977|NCT00065156|101698337|FG000|Overall Study|Withdrawal by Subject|8|||
33493978|NCT00065156|101698337|FG000|Overall Study|Lost to Follow-up|1|||
33390005|NCT01316380|101317609|FG002|Overall Study|Other|1|||
33390006|NCT01316380|101317607|FG000|Overall Study|Not treated|1|||
33390007|NCT01316380|101317608|FG001|Overall Study|Not treated|0|||
33390008|NCT01316380|101317609|FG002|Overall Study|Not treated|0|||
33390009|NCT03250624|101317613|FG000|Overall Study|Lack of Efficacy|1|||
33390010|NCT03250624|101317614|FG001|Overall Study|Lack of Efficacy|4|||
33288327|NCT03796208|100952029|FG001|Overall Study|Changed prenatal clinics|5|||
33288328|NCT03796208|100952028|FG000|Overall Study|Lost to Follow-up|20|||
33288329|NCT03796208|100952029|FG001|Overall Study|Lost to Follow-up|16|||
33288330|NCT00263575|100952030|FG000|Titration Period|Adverse Event|14|||
33288331|NCT00263575|100952030|FG000|Titration Period|Withdrawal by Subject|10|||
33288332|NCT00263575|100952030|FG000|Titration Period|Protocol Violation|9|||
33288333|NCT00263575|100952030|FG000|Titration Period|Sponsor Decision|2|||
33288334|NCT00263575|100952030|FG000|Titration Period|Other|2|||
33288335|NCT00263575|100952030|FG000|Titration Period|Lack of Efficacy|6|||
33288336|NCT00263575|100952030|FG000|Maintence Period|Adverse Event|23|||
33288337|NCT00263575|100952030|FG000|Maintence Period|Withdrawal by Subject|8|||
33288338|NCT00263575|100952030|FG000|Maintence Period|Protocol Violation|4|||
33288339|NCT00263575|100952030|FG000|Maintence Period|Lack of Efficacy|4|||
33288340|NCT00263575|100952030|FG000|Maintence Period|Physician Decision|6|||
33288341|NCT00263575|100952030|FG000|Maintence Period|Lost to Follow-up|1|||
33288342|NCT00263575|100952030|FG000|Maintence Period|Sponsor Decision|24|||
33288343|NCT00263575|100952030|FG000|Maintence Period|Other|7|||
33288344|NCT00776659|100952031|FG000|Overall Study|Lost to Follow-up|15|||
33288345|NCT00776659|100952031|FG000|Overall Study|Withdrawal by Subject|10|||
33288346|NCT00776659|100952031|FG000|Overall Study|Study Terminated by Sponsor|1|||
33288347|NCT02835092|100952032|FG000|Overall Study|Withdrawal by Subject|3|||
33288348|NCT02835092|100952033|FG001|Overall Study|Withdrawal by Subject|6|||
33288349|NCT02835092|100952034|FG002|Overall Study|Withdrawal by Subject|3|||
33288350|NCT02835092|100952032|FG000|Overall Study|Lost to Follow-up|0|||
33288351|NCT02835092|100952033|FG001|Overall Study|Lost to Follow-up|2|||
33288352|NCT02835092|100952034|FG002|Overall Study|Lost to Follow-up|0|||
33288353|NCT03458728|100952038|FG000|Overall Study|Adverse Event|1|||
33288354|NCT03458728|100952039|FG001|Overall Study|Adverse Event|0|||
33288355|NCT03458728|100952038|FG000|Overall Study|Physician Decision|1|||
33288356|NCT03458728|100952039|FG001|Overall Study|Physician Decision|0|||
33288357|NCT03458728|100952038|FG000|Overall Study|Progressive disease - clinical assessment|1|||
33288358|NCT03458728|100952039|FG001|Overall Study|Progressive disease - clinical assessment|0|||
33288359|NCT03458728|100952038|FG000|Overall Study|Progressive disease - radiological progression|21|||
33288360|NCT03458728|100952039|FG001|Overall Study|Progressive disease - radiological progression|6|||
33288361|NCT03458728|100952038|FG000|Overall Study|Withdrawal by Subject|0|||
33288362|NCT03458728|100952039|FG001|Overall Study|Withdrawal by Subject|1|||
33288363|NCT01728623|100952040|FG000|Overall Study|Disease progression|26|||
33288364|NCT01728623|100952040|FG000|Overall Study|Adverse Event|1|||
33288365|NCT01728623|100952040|FG000|Overall Study|Withdrawal by Subject|1|||
33288366|NCT00477464|100952041|FG000|Overall Study|Lost to Follow-up|1|||
33288367|NCT00477464|100952041|FG000|Overall Study|Death|36|||
33288368|NCT00477464|100952041|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
33288369|NCT02196077|100952042|FG000|Overall Study|Adverse Event|4|||
33288370|NCT02196077|100952042|FG000|Overall Study|Lack of Efficacy|1|||
33288371|NCT02196077|100952042|FG000|Overall Study|Withdrawal by Subject|14|||
33288372|NCT02196077|100952042|FG000|Overall Study|Physician Decision|1|||
33288373|NCT02196077|100952042|FG000|Overall Study|Lost to Follow-up|3|||
33288374|NCT02196077|100952042|FG000|Overall Study|Protocol Violation|24|||
33288375|NCT00905359|100952043|FG000|Overall Study|Lost to Follow-up|17|||
33288376|NCT00905359|100952044|FG001|Overall Study|Lost to Follow-up|10|||
33288377|NCT00905359|100952043|FG000|Overall Study|Death|2|||
33288378|NCT00905359|100952044|FG001|Overall Study|Death|0|||
33288379|NCT00905359|100952043|FG000|Overall Study|Withdrawal consent|5|||
33288380|NCT00905359|100952044|FG001|Overall Study|Withdrawal consent|6|||
33288381|NCT03712449|100952045|FG000|Overall Study|Withdraw Consent|0|||
33288382|NCT03712449|100952046|FG001|Overall Study|Withdraw Consent|1|||
33288383|NCT01438840|100952049|FG000|Core Study|Adverse Event|0|||
33288384|NCT01438840|100952050|FG001|Core Study|Adverse Event|3|||
33288385|NCT01438840|100952051|FG002|Core Study|Adverse Event|0|||
33185991|NCT02658890|100590614|FG013|Treatment Phase|Adverse Event|4|||
33288386|NCT01438840|100952049|FG000|Core Study|Lack of Efficacy|15|||
33288387|NCT01438840|100952050|FG001|Core Study|Lack of Efficacy|7|||
33288388|NCT01438840|100952051|FG002|Core Study|Lack of Efficacy|0|||
33288389|NCT01438840|100952049|FG000|Core Study|Withdrawal of consent|1|||
33288390|NCT01438840|100952050|FG001|Core Study|Withdrawal of consent|0|||
33288391|NCT01438840|100952051|FG002|Core Study|Withdrawal of consent|0|||
33288392|NCT01438840|100952049|FG000|Extension Phase|Adverse Event|0|||
33288393|NCT01438840|100952050|FG001|Extension Phase|Adverse Event|0|||
33288394|NCT01438840|100952051|FG002|Extension Phase|Adverse Event|3|||
33288395|NCT01438840|100952049|FG000|Extension Phase|Lost to Follow-up|0|||
33185992|NCT02658890|100590615|FG014|Treatment Phase|Adverse Event|0|||
33288396|NCT01438840|100952050|FG001|Extension Phase|Lost to Follow-up|0|||
33288397|NCT01438840|100952051|FG002|Extension Phase|Lost to Follow-up|1|||
33288398|NCT01438840|100952049|FG000|Extension Phase|Withdrawal by Subject|0|||
33288399|NCT01438840|100952050|FG001|Extension Phase|Withdrawal by Subject|0|||
33288400|NCT01438840|100952051|FG002|Extension Phase|Withdrawal by Subject|3|||
33288401|NCT01438840|100952049|FG000|Extension Phase|Lack of Efficacy|0|||
33185993|NCT02658890|100590616|FG015|Treatment Phase|Adverse Event|0|||
33288402|NCT01438840|100952050|FG001|Extension Phase|Lack of Efficacy|0|||
33288403|NCT01438840|100952051|FG002|Extension Phase|Lack of Efficacy|2|||
33288404|NCT01438840|100952049|FG000|Extension Phase|Other|0|||
33288405|NCT01438840|100952050|FG001|Extension Phase|Other|0|||
33288406|NCT01438840|100952051|FG002|Extension Phase|Other|1|||
33288407|NCT02826798|100952053|FG000|Overall Study|Withdrawal by Subject|0|||
33288408|NCT02826798|100952054|FG001|Overall Study|Withdrawal by Subject|1|||
33288409|NCT02826798|100952055|FG002|Overall Study|Withdrawal by Subject|0|||
33288410|NCT02826798|100952056|FG003|Overall Study|Withdrawal by Subject|1|||
33288411|NCT02826798|100952057|FG004|Overall Study|Withdrawal by Subject|0|||
33288412|NCT01930214|100952060|FG000|Overall Study|Death|4|||
33288413|NCT01930214|100952061|FG001|Overall Study|Death|4|||
33288414|NCT01930214|100952062|FG002|Overall Study|Death|11|||
33288415|NCT01930214|100952060|FG000|Overall Study|Lost to Follow-up|12|||
33288416|NCT01930214|100952061|FG001|Overall Study|Lost to Follow-up|13|||
33288417|NCT01930214|100952062|FG002|Overall Study|Lost to Follow-up|12|||
33288418|NCT01930214|100952060|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
33288419|NCT01930214|100952061|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
33288420|NCT01930214|100952062|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
33288421|NCT01930214|100952060|FG000|Overall Study|Physician Decision|2|||
33288422|NCT01930214|100952061|FG001|Overall Study|Physician Decision|0|||
33288423|NCT01930214|100952062|FG002|Overall Study|Physician Decision|0|||
33288424|NCT01124838|100952063|FG000|Overall Study|Miscellaneous|4|||
33288425|NCT01124838|100952064|FG001|Overall Study|Miscellaneous|2|||
33288426|NCT01124838|100952063|FG000|Overall Study|Adverse Event|7|||
33288427|NCT01124838|100952064|FG001|Overall Study|Adverse Event|11|||
33288428|NCT01124838|100952063|FG000|Overall Study|Lack of Efficacy|2|||
33288429|NCT01124838|100952064|FG001|Overall Study|Lack of Efficacy|0|||
33288430|NCT01124838|100952063|FG000|Overall Study|Withdrawal by Subject|3|||
33288431|NCT01124838|100952064|FG001|Overall Study|Withdrawal by Subject|2|||
33288432|NCT01124838|100952063|FG000|Overall Study|Lost to Follow-up|2|||
33288433|NCT01124838|100952064|FG001|Overall Study|Lost to Follow-up|0|||
33288434|NCT01036165|100952065|FG000|Overall Study|Adverse Event|6|||
33288435|NCT01036165|100952065|FG000|Overall Study|Lost to Follow-up|2|||
33288436|NCT01036165|100952065|FG000|Overall Study|Withdrawal by Subject|3|||
33288437|NCT01036165|100952065|FG000|Overall Study|Device Related Issues|3|||
33288438|NCT01036165|100952065|FG000|Overall Study|Problems finding proper area to inject|1|||
33288439|NCT02353871|100952066|FG000|Overall Study|Protocol deviation|0|||
33288440|NCT02353871|100952067|FG001|Overall Study|Protocol deviation|1|||
33288441|NCT02353871|100952066|FG000|Overall Study|Consent withdrawn|1|||
33288442|NCT02353871|100952067|FG001|Overall Study|Consent withdrawn|8|||
33288443|NCT02353871|100952066|FG000|Overall Study|Lost to Follow-up|2|||
33288444|NCT02353871|100952067|FG001|Overall Study|Lost to Follow-up|0|||
33288445|NCT03774875|100952070|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
33288446|NCT03774875|100952071|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
33288447|NCT03774875|100952070|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
33288448|NCT03774875|100952071|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
33288449|NCT03774875|100952070|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
33288450|NCT03774875|100952071|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
33288451|NCT03774875|100952070|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
33288452|NCT03774875|100952071|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
33288453|NCT03774875|100952070|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
33288454|NCT03774875|100952071|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
33288455|NCT03774875|100952070|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
33288456|NCT03774875|100952071|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
33288457|NCT03774875|100952070|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
33288458|NCT03774875|100952071|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
33288459|NCT03774875|100952070|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
33288460|NCT03774875|100952071|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
33288461|NCT03774875|100952070|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
33288462|NCT03774875|100952071|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
33288463|NCT03774875|100952070|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
33288464|NCT03774875|100952071|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
33288465|NCT03774875|100952070|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
33288466|NCT03774875|100952071|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
33288467|NCT03774875|100952070|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
33288468|NCT03774875|100952071|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
33288469|NCT03774875|100952070|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
33288470|NCT03774875|100952071|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
33288471|NCT01427738|100952072|FG000|Overall Study|Death|12|||
33288472|NCT01427738|100952073|FG001|Overall Study|Death|9|||
33288473|NCT01427738|100952072|FG000|Overall Study|Severe debilitation, unable to continue|0|||
33288474|NCT01427738|100952073|FG001|Overall Study|Severe debilitation, unable to continue|1|||
33390011|NCT03250624|101317613|FG000|Overall Study|Adverse Event|0|||
33288475|NCT01427738|100952072|FG000|Overall Study|Subject unable to get to clinic|5|||
33288476|NCT01427738|100952073|FG001|Overall Study|Subject unable to get to clinic|2|||
33288477|NCT01427738|100952072|FG000|Overall Study|Withdrawal by Subject|0|||
33288478|NCT01427738|100952073|FG001|Overall Study|Withdrawal by Subject|2|||
33288479|NCT01427738|100952072|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
33288480|NCT01427738|100952073|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
33288481|NCT01427738|100952072|FG000|Overall Study|Lost to Follow-up|1|||
33288482|NCT01427738|100952073|FG001|Overall Study|Lost to Follow-up|5|||
33288483|NCT01114672|100952082|FG000|Overall Study|Death|0|||
33288484|NCT01114672|100952083|FG001|Overall Study|Death|1|||
33288485|NCT01114672|100952082|FG000|Overall Study|Withdrawal by Subject|2|||
33288486|NCT01114672|100952083|FG001|Overall Study|Withdrawal by Subject|1|||
33288487|NCT01114672|100952082|FG000|Overall Study|Lost to Follow-up|1|||
33288488|NCT01114672|100952083|FG001|Overall Study|Lost to Follow-up|0|||
33288489|NCT01114672|100952082|FG000|Overall Study|transplanted|1|||
33288490|NCT01114672|100952083|FG001|Overall Study|transplanted|0|||
33288491|NCT00468130|100952084|FG000|Overall Study|Adverse Event|2|||
33288492|NCT00468130|100952085|FG001|Overall Study|Adverse Event|1|||
33288493|NCT00468130|100952084|FG000|Overall Study|Withdrawal by Subject|0|||
33288494|NCT00468130|100952085|FG001|Overall Study|Withdrawal by Subject|1|||
33185994|NCT02658890|100590617|FG016|Treatment Phase|Adverse Event|0|||
33185995|NCT02658890|100590618|FG017|Treatment Phase|Adverse Event|0|||
33185996|NCT02658890|100590619|FG018|Treatment Phase|Adverse Event|5|||
33185997|NCT02658890|100590620|FG019|Treatment Phase|Adverse Event|1|||
33288495|NCT01801982|100952089|FG000|Overall Study|Lost to Follow-up|1|||
33288496|NCT02202109|100952090|FG000|Overall Study|Lost to Follow-up|88|||
33288497|NCT02202109|100952091|FG001|Overall Study|Lost to Follow-up|87|||
33288498|NCT02202109|100952090|FG000|Overall Study|Withdrawal by Subject|2|||
33288499|NCT02202109|100952091|FG001|Overall Study|Withdrawal by Subject|0|||
33288500|NCT00107978|100952096|FG000|Overall Study|Adverse Event|1|||
33288501|NCT00107978|100952097|FG001|Overall Study|Adverse Event|5|||
33288502|NCT00107978|100952096|FG000|Overall Study|Death|3|||
33288503|NCT00107978|100952097|FG001|Overall Study|Death|3|||
33288504|NCT00107978|100952096|FG000|Overall Study|Lost to Follow-up|20|||
33288505|NCT00107978|100952097|FG001|Overall Study|Lost to Follow-up|28|||
33288506|NCT00107978|100952096|FG000|Overall Study|Withdrawal by Subject|4|||
33288507|NCT00107978|100952097|FG001|Overall Study|Withdrawal by Subject|9|||
33288508|NCT00107978|100952096|FG000|Overall Study|Protocol Violation|0|||
33288509|NCT00107978|100952097|FG001|Overall Study|Protocol Violation|1|||
33288510|NCT00107978|100952096|FG000|Overall Study|Other|5|||
33288511|NCT00107978|100952097|FG001|Overall Study|Other|4|||
33288512|NCT00280683|100952098|FG000|Overall Study|Withdrawal by Subject|1|||
33288513|NCT00280683|100952099|FG001|Overall Study|Withdrawal by Subject|2|||
33288514|NCT00280683|100952098|FG000|Overall Study|Adverse Event|1|||
33288515|NCT00280683|100952099|FG001|Overall Study|Adverse Event|1|||
33288516|NCT00494026|100952100|FG000|Overall Study|Sponsor Decision|4|||
33288517|NCT00934700|100952101|FG000|Overall Study|missing scan|5|||
33288518|NCT00934700|100952102|FG001|Overall Study|missing scan|9|||
33288519|NCT00934700|100952101|FG000|Overall Study|Death|8|||
33288520|NCT00934700|100952102|FG001|Overall Study|Death|3|||
33288521|NCT00197106|100952103|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
33288522|NCT00197106|100952104|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
33288523|NCT00197106|100952105|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
33288524|NCT00197106|100952103|FG000|Overall Treatment Period|Lack of Efficacy|0|||
33185998|NCT02658890|100590621|FG020|Treatment Phase|Adverse Event|3|||
33185999|NCT02658890|100590622|FG021|Treatment Phase|Adverse Event|0|||
33186000|NCT02658890|100590623|FG022|Treatment Phase|Adverse Event|5|||
33186001|NCT02658890|100590624|FG023|Treatment Phase|Adverse Event|0|||
33186002|NCT02658890|100590625|FG024|Treatment Phase|Adverse Event|0|||
33186003|NCT02658890|100590626|FG025|Treatment Phase|Adverse Event|2|||
33186004|NCT02658890|100590627|FG026|Treatment Phase|Adverse Event|1|||
33186005|NCT02658890|100590601|FG000|Treatment Phase|Death|0|||
33186006|NCT02658890|100590602|FG001|Treatment Phase|Death|0|||
33186007|NCT02658890|100590603|FG002|Treatment Phase|Death|0|||
33288525|NCT00197106|100952104|FG001|Overall Treatment Period|Lack of Efficacy|1|||
33186008|NCT02658890|100590604|FG003|Treatment Phase|Death|0|||
33186009|NCT02658890|100590605|FG004|Treatment Phase|Death|0|||
33186010|NCT02658890|100590606|FG005|Treatment Phase|Death|0|||
33186011|NCT02658890|100590607|FG006|Treatment Phase|Death|0|||
33186012|NCT02658890|100590608|FG007|Treatment Phase|Death|0|||
33288526|NCT00197106|100952105|FG002|Overall Treatment Period|Lack of Efficacy|0|||
33186013|NCT02658890|100590609|FG008|Treatment Phase|Death|0|||
33186014|NCT02658890|100590610|FG009|Treatment Phase|Death|0|||
33186015|NCT02658890|100590611|FG010|Treatment Phase|Death|0|||
33288527|NCT00197106|100952103|FG000|Overall Treatment Period|Lost to Follow-up|0|||
33288528|NCT00197106|100952104|FG001|Overall Treatment Period|Lost to Follow-up|0|||
33288529|NCT00197106|100952105|FG002|Overall Treatment Period|Lost to Follow-up|2|||
33288530|NCT00197106|100952103|FG000|Overall Treatment Period|Protocol Violation|0|||
33288531|NCT00197106|100952104|FG001|Overall Treatment Period|Protocol Violation|0|||
33288532|NCT00197106|100952105|FG002|Overall Treatment Period|Protocol Violation|2|||
33288533|NCT00197106|100952103|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
33288534|NCT00197106|100952104|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
33288535|NCT00197106|100952105|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
33288536|NCT00704171|100954938|FG000|Overall Study|Withdrawal by Subject|1|||
33288537|NCT00704171|100954939|FG001|Overall Study|Withdrawal by Subject|0|||
33288538|NCT01482429|100954940|FG000|Care Usual|Protocol Violation|0|||
33288539|NCT01482429|100954941|FG001|Care Usual|Protocol Violation|172|||
33288540|NCT01482429|100954940|FG000|Care Usual|Lost to Follow-up|0|||
33288541|NCT01482429|100954941|FG001|Care Usual|Lost to Follow-up|1|||
33288542|NCT01482429|100954940|FG000|Protocol|Protocol Violation|275|||
33288543|NCT01482429|100954941|FG001|Protocol|Protocol Violation|0|||
33288544|NCT03201900|100954942|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
33288545|NCT03201900|100954942|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
33288546|NCT03201900|100954942|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
33288547|NCT03201900|100954942|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
33288548|NCT03201900|100954942|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
33288549|NCT03201900|100954942|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
33288550|NCT03201900|100954942|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
33288551|NCT03201900|100954942|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
33288552|NCT03201900|100954942|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
33288553|NCT03201900|100954942|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
33288554|NCT03201900|100954942|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
33288555|NCT03201900|100954942|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
33288556|NCT03201900|100954942|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
33288557|NCT02803593|100954943|FG000|Overall Study|Lost to Follow-up|17|||
33288558|NCT02803593|100954944|FG001|Overall Study|Lost to Follow-up|35|||
33288559|NCT00639769|100954945|FG000|Overall Study|Death|2|||
33288560|NCT00639769|100954945|FG000|Overall Study|Adverse Event|7|||
33288561|NCT00639769|100954945|FG000|Overall Study|Lack of Efficacy|1|||
33288562|NCT00639769|100954945|FG000|Overall Study|Disease progression|26|||
33288563|NCT00639769|100954945|FG000|Overall Study|Withdrawal by Subject|4|||
33288564|NCT03512197|100954946|FG000|Overall Study|Guardian decision|1|||
33288565|NCT03512197|100954947|FG001|Overall Study|Guardian decision|1|||
33288566|NCT03512197|100954946|FG000|Overall Study|Lack of Efficacy|19|||
33288567|NCT03512197|100954947|FG001|Overall Study|Lack of Efficacy|11|||
33288568|NCT03512197|100954946|FG000|Overall Study|New Therapy for Study Indication|16|||
33288569|NCT03512197|100954947|FG001|Overall Study|New Therapy for Study Indication|16|||
33288570|NCT03512197|100954946|FG000|Overall Study|Physician Decision|60|||
33288571|NCT03512197|100954947|FG001|Overall Study|Physician Decision|60|||
33288572|NCT03512197|100954946|FG000|Overall Study|Protocol Violation|0|||
33288573|NCT03512197|100954947|FG001|Overall Study|Protocol Violation|2|||
33288574|NCT03512197|100954946|FG000|Overall Study|Terminated by Sponsored|46|||
33288575|NCT03512197|100954947|FG001|Overall Study|Terminated by Sponsored|50|||
33288576|NCT03512197|100954946|FG000|Overall Study|Subject Decision|15|||
33288577|NCT03512197|100954947|FG001|Overall Study|Subject Decision|12|||
33288578|NCT03512197|100954946|FG000|Overall Study|Withdrawal of informed consent|20|||
33288579|NCT03512197|100954947|FG001|Overall Study|Withdrawal of informed consent|14|||
33288580|NCT03512197|100954946|FG000|Overall Study|Adverse Event|30|||
33288581|NCT03512197|100954947|FG001|Overall Study|Adverse Event|34|||
33288582|NCT03512197|100954946|FG000|Overall Study|Death|14|||
33288583|NCT03512197|100954947|FG001|Overall Study|Death|9|||
33288584|NCT03512197|100954946|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
33288585|NCT03512197|100954947|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
33288586|NCT03512197|100954946|FG000|Overall Study|Missing|3|||
33288587|NCT03512197|100954947|FG001|Overall Study|Missing|13|||
33288588|NCT03297398|100954951|FG000|Overall Study|Sponsor's decision|6|||
33288589|NCT03297398|100954952|FG001|Overall Study|Sponsor's decision|9|||
33288590|NCT03297398|100954953|FG002|Overall Study|Sponsor's decision|7|||
33288591|NCT03297398|100954951|FG000|Overall Study|Adverse Event|1|||
33390012|NCT03250624|101317614|FG001|Overall Study|Adverse Event|1|||
33390013|NCT03250624|101317613|FG000|Overall Study|Other|1|||
33390014|NCT03250624|101317614|FG001|Overall Study|Other|2|||
33390015|NCT02848313|101317621|FG000|Overall Study|Adverse Event|1|||
33390016|NCT02848313|101317622|FG001|Overall Study|Adverse Event|2|||
33186016|NCT02658890|100590612|FG011|Treatment Phase|Death|0|||
33186017|NCT02658890|100590613|FG012|Treatment Phase|Death|0|||
33186018|NCT02658890|100590614|FG013|Treatment Phase|Death|0|||
33288592|NCT03297398|100954952|FG001|Overall Study|Adverse Event|4|||
33288593|NCT03297398|100954953|FG002|Overall Study|Adverse Event|4|||
33288594|NCT03297398|100954951|FG000|Overall Study|Withdrawal by Subject|1|||
33288595|NCT03297398|100954952|FG001|Overall Study|Withdrawal by Subject|2|||
33288596|NCT03297398|100954953|FG002|Overall Study|Withdrawal by Subject|2|||
33288597|NCT03297398|100954951|FG000|Overall Study|Protocol Violation|0|||
33288598|NCT03297398|100954952|FG001|Overall Study|Protocol Violation|2|||
33390017|NCT02848313|101317621|FG000|Overall Study|Lack of Efficacy|0|||
33390018|NCT02848313|101317622|FG001|Overall Study|Lack of Efficacy|1|||
33390019|NCT02848313|101317621|FG000|Overall Study|Withdrawal by Subject|1|||
33288599|NCT03297398|100954953|FG002|Overall Study|Protocol Violation|0|||
33288600|NCT03297398|100954951|FG000|Overall Study|Physician Decision|0|||
33288601|NCT03297398|100954952|FG001|Overall Study|Physician Decision|0|||
33288602|NCT03297398|100954953|FG002|Overall Study|Physician Decision|1|||
33288603|NCT03297398|100954951|FG000|Overall Study|Lost to Follow-up|0|||
33288604|NCT03297398|100954952|FG001|Overall Study|Lost to Follow-up|0|||
33288605|NCT03297398|100954953|FG002|Overall Study|Lost to Follow-up|1|||
33288606|NCT04016272|100954957|FG000|Overall Study|Withdrawal by Subject|1|||
33390020|NCT02848313|101317622|FG001|Overall Study|Withdrawal by Subject|1|||
33390021|NCT02848313|101317621|FG000|Overall Study|Lost to follow up|1|||
33390022|NCT02848313|101317622|FG001|Overall Study|Lost to follow up|0|||
33390023|NCT02578992|101317623|FG000|Overall Study|equipment not available or malfunction|3|||
33390024|NCT02578992|101317624|FG001|Overall Study|equipment not available or malfunction|3|||
33390025|NCT00611767|101317625|FG000|Overall Study|Withdrawal by Subject|4|||
33390026|NCT00611767|101317626|FG001|Overall Study|Withdrawal by Subject|1|||
33390027|NCT00611767|101317625|FG000|Overall Study|Thiopental not available|3|||
33390028|NCT00611767|101317626|FG001|Overall Study|Thiopental not available|0|||
33288607|NCT04016272|100954958|FG001|Overall Study|Withdrawal by Subject|2|||
33288608|NCT01013740|100954961|FG000|Overall Study|Lost to Follow-up|3|||
33288609|NCT01013740|100954962|FG001|Overall Study|Lost to Follow-up|5|||
33288610|NCT01013740|100954961|FG000|Overall Study|Physician Decision|2|||
33288611|NCT01013740|100954962|FG001|Overall Study|Physician Decision|0|||
33288612|NCT01013740|100954961|FG000|Overall Study|Withdrawal by Subject|2|||
33288613|NCT01013740|100954962|FG001|Overall Study|Withdrawal by Subject|10|||
33288614|NCT01013740|100954961|FG000|Overall Study|study close / terminated : done in error|2|||
33288615|NCT01013740|100954962|FG001|Overall Study|study close / terminated : done in error|1|||
33288616|NCT01013740|100954961|FG000|Overall Study|Missing|2|||
33288617|NCT01013740|100954962|FG001|Overall Study|Missing|1|||
33390029|NCT00611767|101317625|FG000|Overall Study|didn't like the medication|1|||
33390030|NCT00611767|101317626|FG001|Overall Study|didn't like the medication|1|||
33390031|NCT00611767|101317625|FG000|Overall Study|Physician Decision|1|||
33390032|NCT00611767|101317626|FG001|Overall Study|Physician Decision|0|||
33390033|NCT00262314|101317627|FG000|Overall Study|Changing physicians|38|||
33390034|NCT00262314|101317627|FG000|Overall Study|Death|12|||
33390035|NCT00262314|101317627|FG000|Overall Study|Patient's decision|92|||
33390036|NCT00262314|101317627|FG000|Overall Study|Other|95|||
33390037|NCT00262314|101317627|FG000|Overall Study|Lost to Follow-up|70|||
33390038|NCT00262314|101317627|FG000|Overall Study|Administrative withdrawal|30|||
33390039|NCT00224003|101317628|FG000|Overall Study|Adverse Event|1|||
33390040|NCT00224003|101317628|FG000|Overall Study|Protocol Violation|2|||
33288618|NCT01013740|100954961|FG000|Overall Study|Ongoing: Study records not completed|0|||
33288619|NCT01013740|100954962|FG001|Overall Study|Ongoing: Study records not completed|2|||
33288620|NCT00003477|100954964|FG000|Overall Study|Not evalauable|4|||
33288621|NCT02859064|100954965|FG000|Overall Study|Progressive Disease|3|||
33288622|NCT02859064|100954965|FG000|Overall Study|Physician Decision|1|||
33288623|NCT02859064|100954965|FG000|Overall Study|Withdrawal by Subject|1|||
33493979|NCT00065156|101698337|FG000|Overall Study|Death|11|||
33493980|NCT00065156|101698337|FG000|Overall Study|Study Closed by Sponsor|2|||
33493981|NCT00065156|101698337|FG000|Overall Study|Disease Progression|7|||
33493982|NCT00065156|101698337|FG000|Overall Study|Investigator Decision|2|||
33493983|NCT00065156|101698337|FG000|Overall Study|Non-Compliance|2|||
33493984|NCT00065156|101698337|FG000|Overall Study|Loss of Response|1|||
33493985|NCT00065156|101698337|FG000|Overall Study|Secondary Malign Disease|1|||
33493986|NCT04067050|101698340|FG000|One Month|Lost to Follow-up|4|||
33493987|NCT04067050|101698341|FG001|One Month|Lost to Follow-up|0|||
33493988|NCT04067050|101698340|FG000|Two Month|Lost to Follow-up|1|||
33493989|NCT04067050|101698341|FG001|Two Month|Lost to Follow-up|0|||
33493990|NCT04067050|101698340|FG000|Two Month|Adverse Event|1|||
33493991|NCT04067050|101698341|FG001|Two Month|Adverse Event|0|||
33493992|NCT03668808|101698342|FG000|First Intervention|Withdrawal by Subject|2|||
33288624|NCT02859064|100954965|FG000|Overall Study|Death|1|||
33288625|NCT01018732|100954967|FG000|Overall Study|Lost to Follow-up|0|||
33288626|NCT01018732|100954968|FG001|Overall Study|Lost to Follow-up|0|||
33288627|NCT01018732|100954969|FG002|Overall Study|Lost to Follow-up|3|||
33288628|NCT01018732|100954967|FG000|Overall Study|Protocol Violation|1|||
33288629|NCT01018732|100954968|FG001|Overall Study|Protocol Violation|1|||
33288630|NCT01018732|100954969|FG002|Overall Study|Protocol Violation|0|||
33288631|NCT01018732|100954967|FG000|Overall Study|Inappropriate Enrollment|0|||
33390041|NCT00224003|101317628|FG000|Overall Study|Withdrawal by Subject|1|||
33390042|NCT00224003|101317628|FG000|Overall Study|unk|3|||
33390043|NCT01119963|101317629|FG000|Overall Study|Lost to Follow-up|1|||
33594556|NCT01133405|102065016|FG005|Period 1|Withdrawal by Subject|1|||
33390044|NCT01119963|101317630|FG001|Overall Study|Lost to Follow-up|1|||
33390045|NCT03682055|101317631|FG000|Overall Study|Lack of Efficacy|1|||
33390046|NCT03682055|101317632|FG001|Overall Study|Lack of Efficacy|2|||
33390047|NCT03682055|101317633|FG002|Overall Study|Lack of Efficacy|1|||
33493993|NCT03668808|101698343|FG001|First Intervention|Withdrawal by Subject|2|||
33493994|NCT03022370|101698346|FG000|Overall Study|Death|6|||
33493995|NCT03022370|101698347|FG001|Overall Study|Death|12|||
33493996|NCT03022370|101698346|FG000|Overall Study|Lost to Follow-up|174|||
33493997|NCT03022370|101698347|FG001|Overall Study|Lost to Follow-up|109|||
33493998|NCT01202175|101698350|FG000|Overall Study|Lost to Follow-up|2|||
33493999|NCT01202175|101698350|FG000|Overall Study|Withdrawal by Subject|1|||
33494000|NCT01202175|101698350|FG000|Overall Study|Adverse Event|2|||
33494001|NCT03103087|101698351|FG000|Overall Study|Did not receive any study drug|1|||
33494002|NCT03103087|101698352|FG001|Overall Study|Did not receive any study drug|0|||
33494003|NCT03103087|101698353|FG002|Overall Study|Did not receive any study drug|0|||
33494004|NCT03103087|101698351|FG000|Overall Study|Protocol Violation|1|||
33494005|NCT03103087|101698352|FG001|Overall Study|Protocol Violation|2|||
33494006|NCT03103087|101698353|FG002|Overall Study|Protocol Violation|1|||
33494007|NCT03103087|101698351|FG000|Overall Study|Lack of Efficacy|2|||
33494008|NCT03103087|101698352|FG001|Overall Study|Lack of Efficacy|1|||
33494009|NCT03103087|101698353|FG002|Overall Study|Lack of Efficacy|1|||
33494010|NCT03103087|101698351|FG000|Overall Study|Pregnancy|0|||
33494011|NCT03103087|101698352|FG001|Overall Study|Pregnancy|0|||
33494012|NCT03103087|101698353|FG002|Overall Study|Pregnancy|1|||
33494013|NCT03103087|101698351|FG000|Overall Study|Adverse Event|2|||
33494014|NCT03103087|101698352|FG001|Overall Study|Adverse Event|15|||
33494015|NCT03103087|101698353|FG002|Overall Study|Adverse Event|6|||
33494016|NCT03103087|101698351|FG000|Overall Study|Withdrawal by Subject|13|||
33494017|NCT03103087|101698352|FG001|Overall Study|Withdrawal by Subject|6|||
33494018|NCT03103087|101698353|FG002|Overall Study|Withdrawal by Subject|6|||
33494019|NCT03103087|101698351|FG000|Overall Study|Lost to Follow-up|4|||
33494020|NCT03103087|101698352|FG001|Overall Study|Lost to Follow-up|2|||
33494021|NCT03103087|101698353|FG002|Overall Study|Lost to Follow-up|7|||
33494022|NCT03103087|101698351|FG000|Overall Study|Other reason not reported|1|||
33494023|NCT03103087|101698352|FG001|Overall Study|Other reason not reported|3|||
33494024|NCT03103087|101698353|FG002|Overall Study|Other reason not reported|5|||
33494025|NCT02414958|101698354|FG000|Overall Study|Adverse Event|6|||
33494026|NCT02414958|101698355|FG001|Overall Study|Adverse Event|6|||
33494027|NCT02414958|101698356|FG002|Overall Study|Adverse Event|3|||
33494028|NCT02414958|101698354|FG000|Overall Study|Protocol Violation|10|||
33494029|NCT02414958|101698355|FG001|Overall Study|Protocol Violation|3|||
33494030|NCT02414958|101698356|FG002|Overall Study|Protocol Violation|1|||
33494031|NCT02414958|101698354|FG000|Overall Study|Lost to Follow-up|7|||
33494032|NCT02414958|101698355|FG001|Overall Study|Lost to Follow-up|4|||
33494033|NCT02414958|101698356|FG002|Overall Study|Lost to Follow-up|0|||
33494034|NCT02414958|101698354|FG000|Overall Study|Withdrawal by Subject|5|||
33494035|NCT02414958|101698355|FG001|Overall Study|Withdrawal by Subject|3|||
33494036|NCT02414958|101698356|FG002|Overall Study|Withdrawal by Subject|5|||
33494037|NCT02414958|101698354|FG000|Overall Study|Other than specified|4|||
33494038|NCT02414958|101698355|FG001|Overall Study|Other than specified|4|||
33494039|NCT02414958|101698356|FG002|Overall Study|Other than specified|5|||
33494040|NCT01125917|101698357|FG000|Overall Study|Adverse Event|43|||
33494041|NCT01125917|101698357|FG000|Overall Study|Lost to Follow-up|23|||
33494042|NCT01125917|101698357|FG000|Overall Study|Withdrawal by Subject|31|||
33494043|NCT01125917|101698357|FG000|Overall Study|Administrative|223|||
33494044|NCT01125917|101698357|FG000|Overall Study|Lack of Efficacy|19|||
33494045|NCT02115269|101698358|FG000|Overall Study|Lost to Follow-up|43|||
33494046|NCT02115269|101698358|FG000|Overall Study|Did not complete patient diary|3|||
33494047|NCT02115269|101698358|FG000|Overall Study|Moved to another city|7|||
33494048|NCT02115269|101698358|FG000|Overall Study|Withdrawal by Subject|2|||
33494049|NCT02115269|101698358|FG000|Overall Study|Didn't take study drug|2|||
33494050|NCT00513240|101698359|FG000|Overall Study|Did not have intended surgery|3|||
33494051|NCT00513240|101698360|FG001|Overall Study|Did not have intended surgery|0|||
33494052|NCT00513240|101698359|FG000|Overall Study|Death|3|||
33494053|NCT00513240|101698360|FG001|Overall Study|Death|3|||
33494054|NCT00513240|101698359|FG000|Overall Study|Withdrawal by Subject|7|||
33494055|NCT00513240|101698360|FG001|Overall Study|Withdrawal by Subject|4|||
33494056|NCT00470470|101698363|FG000|Overall Study|Adverse Event|2|||
33494057|NCT00470470|101698363|FG000|Overall Study|Death|2|||
33494058|NCT00470470|101698363|FG000|Overall Study|Not treated|1|||
33494059|NCT00075816|101698364|FG000|Overall Study|Did not undergo transplantation|14|||
33494060|NCT00075816|101698365|FG001|Overall Study|Did not undergo transplantation|11|||
33186019|NCT02658890|100590615|FG014|Treatment Phase|Death|0|||
33186020|NCT02658890|100590616|FG015|Treatment Phase|Death|0|||
33494061|NCT01977417|101698366|FG000|Overall Study|Adverse Event|1|||
33494062|NCT01977417|101698367|FG001|Overall Study|Adverse Event|0|||
33494063|NCT01977417|101698366|FG000|Overall Study|Withdrawal by Subject|2|||
33494064|NCT01977417|101698367|FG001|Overall Study|Withdrawal by Subject|4|||
33494065|NCT01977417|101698366|FG000|Overall Study|Female enrollment goal met|0|||
33494066|NCT01977417|101698367|FG001|Overall Study|Female enrollment goal met|2|||
33494067|NCT01009814|101698368|FG000|Overall Study|No longer met study criteria|1|||
33494068|NCT01009814|101698369|FG001|Overall Study|No longer met study criteria|1|||
33494069|NCT01009814|101698370|FG002|Overall Study|No longer met study criteria|0|||
33494070|NCT01009814|101698371|FG003|Overall Study|No longer met study criteria|0|||
33494071|NCT01009814|101698372|FG004|Overall Study|No longer met study criteria|0|||
33494072|NCT04688671|101702206|FG000|Overall Study|Adverse Event|3|||
33494073|NCT04688671|101702207|FG001|Overall Study|Adverse Event|1|||
33494074|NCT04688671|101702206|FG000|Overall Study|Withdrawal by Subject|3|||
33494075|NCT04688671|101702207|FG001|Overall Study|Withdrawal by Subject|1|||
33494076|NCT04688671|101702206|FG000|Overall Study|Lack of Efficacy|1|||
33494077|NCT04688671|101702207|FG001|Overall Study|Lack of Efficacy|1|||
33494078|NCT04688671|101702206|FG000|Overall Study|Protocol Violation|1|||
33494079|NCT04688671|101702207|FG001|Overall Study|Protocol Violation|0|||
33494080|NCT04688671|101702206|FG000|Overall Study|Lost to Follow-up|0|||
33494081|NCT04688671|101702207|FG001|Overall Study|Lost to Follow-up|1|||
33494082|NCT02640482|101702208|FG000|Overall Study|Lost to Follow-up|3|||
33494083|NCT02640482|101702209|FG001|Overall Study|Lost to Follow-up|0|||
33494084|NCT00280735|101702210|FG000|Overall Study|Adverse Event|5|||
33390048|NCT03682055|101317634|FG003|Overall Study|Lack of Efficacy|2|||
33494085|NCT00280735|101702210|FG000|Overall Study|Lack of Efficacy|3|||
33494086|NCT00280735|101702210|FG000|Overall Study|Withdrawal by Subject|8|||
33494087|NCT00280735|101702210|FG000|Overall Study|Intercurrent Illness|2|||
33494088|NCT03170544|101702213|FG000|Part 1|Lost to Follow-up|1|||
33494089|NCT03170544|101702214|FG001|Part 1|Lost to Follow-up|0|||
33494090|NCT03170544|101702215|FG002|Part 1|Lost to Follow-up|0|||
33494091|NCT03170544|101702216|FG003|Part 1|Lost to Follow-up|0|||
33494092|NCT03170544|101702217|FG004|Part 1|Lost to Follow-up|0|||
33494093|NCT03170544|101702218|FG005|Part 1|Lost to Follow-up|0|||
33494094|NCT03170544|101702219|FG006|Part 1|Lost to Follow-up|0|||
33494095|NCT03170544|101702220|FG007|Part 1|Lost to Follow-up|0|||
33494096|NCT03170544|101702221|FG008|Part 1|Lost to Follow-up|0|||
33494097|NCT03170544|101702222|FG009|Part 1|Lost to Follow-up|0|||
33494098|NCT03170544|101702223|FG010|Part 1|Lost to Follow-up|0|||
33494099|NCT03170544|101702224|FG011|Part 1|Lost to Follow-up|0|||
33494100|NCT03170544|101702213|FG000|Part 1|Not treated|0|||
33494101|NCT03170544|101702214|FG001|Part 1|Not treated|0|||
33494102|NCT03170544|101702215|FG002|Part 1|Not treated|0|||
33494103|NCT03170544|101702216|FG003|Part 1|Not treated|1|||
33494104|NCT03170544|101702217|FG004|Part 1|Not treated|0|||
33494105|NCT03170544|101702218|FG005|Part 1|Not treated|0|||
33494106|NCT03170544|101702219|FG006|Part 1|Not treated|0|||
33494107|NCT03170544|101702220|FG007|Part 1|Not treated|0|||
33494108|NCT03170544|101702221|FG008|Part 1|Not treated|0|||
33494109|NCT03170544|101702222|FG009|Part 1|Not treated|0|||
33494110|NCT03170544|101702223|FG010|Part 1|Not treated|0|||
33494111|NCT03170544|101702224|FG011|Part 1|Not treated|0|||
33494112|NCT02687451|101702229|FG000|Overall Study|Withdrawal by Subject|1|||
33494113|NCT02687451|101702230|FG001|Overall Study|Withdrawal by Subject|0|||
33494114|NCT02687451|101702231|FG002|Overall Study|Withdrawal by Subject|0|||
33494115|NCT02687451|101702232|FG003|Overall Study|Withdrawal by Subject|0|||
33494116|NCT02687451|101702233|FG004|Overall Study|Withdrawal by Subject|0|||
33494117|NCT02687451|101702234|FG005|Overall Study|Withdrawal by Subject|1|||
33494118|NCT00595621|101702238|FG000|Open Label Run in|Adverse Event|1|||
33494119|NCT00595621|101702239|FG001|Open Label Run in|Adverse Event|0|||
33494120|NCT00595621|101702238|FG000|Open Label Run in|Physician Decision|1|||
33494121|NCT00595621|101702239|FG001|Open Label Run in|Physician Decision|0|||
33494122|NCT00595621|101702238|FG000|Open Label Run in|Withdrawal by Subject|1|||
33494123|NCT00595621|101702239|FG001|Open Label Run in|Withdrawal by Subject|0|||
33494124|NCT00595621|101702238|FG000|Randomization and Study|Adverse Event|2|||
33494125|NCT00595621|101702239|FG001|Randomization and Study|Adverse Event|0|||
33494126|NCT00595621|101702238|FG000|Randomization and Study|Withdrawal by Subject|0|||
33494127|NCT00595621|101702239|FG001|Randomization and Study|Withdrawal by Subject|1|||
33494128|NCT02676882|101702244|FG000|Overall Study|Adverse Event|1|||
33494129|NCT02676882|101702245|FG001|Overall Study|Adverse Event|0|||
33494130|NCT02676882|101702244|FG000|Overall Study|Lost to Follow-up|1|||
33494131|NCT02676882|101702245|FG001|Overall Study|Lost to Follow-up|0|||
33494132|NCT02676882|101702244|FG000|Overall Study|Withdrawal by Subject|1|||
33494133|NCT02676882|101702245|FG001|Overall Study|Withdrawal by Subject|2|||
33494134|NCT02038010|101702249|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
33494135|NCT02038010|101702250|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
33494136|NCT02038010|101702251|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
33494137|NCT02038010|101702252|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
33494138|NCT02038010|101702249|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
33494139|NCT02038010|101702250|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
33494140|NCT02038010|101702251|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
33494141|NCT02038010|101702252|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
33494142|NCT02038010|101702249|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
33494143|NCT02038010|101702250|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
33494144|NCT02038010|101702251|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
33494145|NCT02038010|101702252|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
33494146|NCT02038010|101702249|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
33494147|NCT02038010|101702250|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
33494148|NCT02038010|101702251|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
33494149|NCT02038010|101702252|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
33494150|NCT02038010|101702249|FG000|Follow Up|Death|4|||
33494151|NCT02038010|101702250|FG001|Follow Up|Death|3|||
33494152|NCT02038010|101702251|FG002|Follow Up|Death|0|||
33494153|NCT02038010|101702252|FG003|Follow Up|Death|0|||
33494154|NCT02038010|101702249|FG000|Follow Up|Other|3|||
33494155|NCT02038010|101702250|FG001|Follow Up|Other|0|||
33494156|NCT02038010|101702251|FG002|Follow Up|Other|0|||
33494157|NCT02038010|101702252|FG003|Follow Up|Other|0|||
33494158|NCT03631706|101702253|FG000|Overall Study|Randomized, not treated|1|||
33494159|NCT03631706|101702254|FG001|Overall Study|Randomized, not treated|0|||
33494160|NCT03631706|101702253|FG000|Overall Study|Treatment ongoing|26|||
33494161|NCT03631706|101702254|FG001|Overall Study|Treatment ongoing|57|||
33494162|NCT03631706|101702253|FG000|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|65|||
33494163|NCT03631706|101702254|FG001|Overall Study|Off treatment (Treatment completed and discontinued) and in follow up)|41|||
33494164|NCT01254643|101702255|FG000|Overall Study|Withdrawal by Subject|1|||
33494165|NCT01321879|101702256|FG000|Overall Study|Lack of Efficacy|5|||
33494166|NCT01321879|101702256|FG000|Overall Study|Adverse Event|5|||
33494167|NCT01321879|101702256|FG000|Overall Study|Death|3|||
33494168|NCT01321879|101702256|FG000|Overall Study|Withdrawal by Subject|1|||
33494169|NCT01786993|101702259|FG000|Overall Study|Death|6|||
33494170|NCT01786993|101702260|FG001|Overall Study|Death|7|||
33494171|NCT01786993|101702259|FG000|Overall Study|Withdrawal by Subject|3|||
33494172|NCT01786993|101702260|FG001|Overall Study|Withdrawal by Subject|2|||
33494173|NCT01786993|101702259|FG000|Overall Study|Lost to Follow-up|0|||
33494174|NCT01786993|101702260|FG001|Overall Study|Lost to Follow-up|1|||
33494175|NCT01786993|101702259|FG000|Overall Study|Subject Non-Compliance|1|||
33494176|NCT01786993|101702260|FG001|Overall Study|Subject Non-Compliance|0|||
33494177|NCT01786993|101702259|FG000|Overall Study|System Explant|1|||
33494178|NCT01786993|101702260|FG001|Overall Study|System Explant|0|||
33494179|NCT01786993|101702259|FG000|Overall Study|Hospice Admission|1|||
33494180|NCT01786993|101702260|FG001|Overall Study|Hospice Admission|0|||
33494181|NCT03830333|101702261|FG000|Overall Study|Death|0|||
33494182|NCT03830333|101702262|FG001|Overall Study|Death|1|||
33494183|NCT03830333|101702261|FG000|Overall Study|Withdrawal by Subject|5|||
33494184|NCT03830333|101702262|FG001|Overall Study|Withdrawal by Subject|1|||
33494185|NCT03830333|101702261|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
33494186|NCT03830333|101702262|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
33494187|NCT00570063|101702271|FG000|Overall Study|Adverse Event|4|||
33494188|NCT00570063|101702272|FG001|Overall Study|Adverse Event|1|||
33494189|NCT00570063|101702271|FG000|Overall Study|Lack of Efficacy|0|||
33494190|NCT00570063|101702272|FG001|Overall Study|Lack of Efficacy|1|||
33494191|NCT00570063|101702271|FG000|Overall Study|Withdrawal by Subject|4|||
33494192|NCT00570063|101702272|FG001|Overall Study|Withdrawal by Subject|3|||
33494193|NCT00570063|101702271|FG000|Overall Study|Sponsor's Decision|7|||
33494194|NCT00570063|101702272|FG001|Overall Study|Sponsor's Decision|3|||
33494195|NCT01753570|101702274|FG000|Overall Study|Adverse Event|1|||
33494196|NCT01753570|101702275|FG001|Overall Study|Adverse Event|0|||
33494197|NCT01753570|101702276|FG002|Overall Study|Adverse Event|1|||
33494198|NCT01753570|101702274|FG000|Overall Study|Physician Decision|0|||
33494199|NCT01753570|101702275|FG001|Overall Study|Physician Decision|1|||
33494200|NCT01753570|101702276|FG002|Overall Study|Physician Decision|0|||
33494201|NCT01753570|101702274|FG000|Overall Study|Withdrawal by Subject|1|||
33494202|NCT01753570|101702275|FG001|Overall Study|Withdrawal by Subject|4|||
33494203|NCT01753570|101702276|FG002|Overall Study|Withdrawal by Subject|0|||
33494204|NCT00931411|101702277|FG000|First Intervention - 42 Days|Adverse Event|2|||
33494205|NCT00931411|101702278|FG001|First Intervention - 42 Days|Adverse Event|3|||
33494206|NCT00931411|101702277|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
33494207|NCT00931411|101702278|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
33494208|NCT00931411|101702277|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
33494209|NCT00931411|101702278|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
33494210|NCT01383174|101702292|FG000|3 Month Assessment|Death|0|||
33494211|NCT01383174|101702293|FG001|3 Month Assessment|Death|1|||
33186021|NCT02658890|100590617|FG016|Treatment Phase|Death|0|||
33494212|NCT01383174|101702292|FG000|3 Month Assessment|Lost to Follow-up|2|||
33494213|NCT01383174|101702293|FG001|3 Month Assessment|Lost to Follow-up|0|||
33494214|NCT01383174|101702292|FG000|3 Month Assessment|Refused to complete|4|||
33494215|NCT01383174|101702293|FG001|3 Month Assessment|Refused to complete|0|||
33494216|NCT01383174|101702292|FG000|6 Month Assessment|Lost to Follow-up|1|||
33494217|NCT01383174|101702293|FG001|6 Month Assessment|Lost to Follow-up|1|||
33494218|NCT01383174|101702292|FG000|6 Month Assessment|Refused to complete|4|||
33494219|NCT01383174|101702293|FG001|6 Month Assessment|Refused to complete|0|||
33494220|NCT02342678|101702294|FG000|Overall Study|Lost to Follow-up|0|||
33494221|NCT02342678|101702295|FG001|Overall Study|Lost to Follow-up|1|||
33494222|NCT02342678|101702294|FG000|Overall Study|Too busy to complete study|0|||
33494223|NCT02342678|101702295|FG001|Overall Study|Too busy to complete study|2|||
33494224|NCT02342678|101702294|FG000|Overall Study|Family illness/emergency|0|||
33494225|NCT02342678|101702295|FG001|Overall Study|Family illness/emergency|1|||
33494226|NCT02342678|101702294|FG000|Overall Study|Illness/medical reason|1|||
33494227|NCT02342678|101702295|FG001|Overall Study|Illness/medical reason|1|||
33494228|NCT00450437|101702296|FG000|Overall Study|Withdrawal by Subject|10|||
33494229|NCT00450437|101702297|FG001|Overall Study|Withdrawal by Subject|2|||
33494230|NCT00450437|101702298|FG002|Overall Study|Withdrawal by Subject|0|||
33494231|NCT00450437|101702299|FG003|Overall Study|Withdrawal by Subject|1|||
33494232|NCT00450437|101702296|FG000|Overall Study|Lost to Follow-up|31|||
33494233|NCT00450437|101702297|FG001|Overall Study|Lost to Follow-up|12|||
33494234|NCT00450437|101702298|FG002|Overall Study|Lost to Follow-up|19|||
33494235|NCT00450437|101702299|FG003|Overall Study|Lost to Follow-up|9|||
33494236|NCT00450437|101702296|FG000|Overall Study|Protocol Violation|0|||
33494237|NCT00450437|101702297|FG001|Overall Study|Protocol Violation|1|||
33494238|NCT00450437|101702298|FG002|Overall Study|Protocol Violation|0|||
33494239|NCT00450437|101702299|FG003|Overall Study|Protocol Violation|1|||
33494240|NCT00450437|101702296|FG000|Overall Study|Inappropriate enrollment|4|||
33494241|NCT00450437|101702297|FG001|Overall Study|Inappropriate enrollment|1|||
33494242|NCT00450437|101702298|FG002|Overall Study|Inappropriate enrollment|3|||
33494243|NCT00450437|101702299|FG003|Overall Study|Inappropriate enrollment|0|||
33494244|NCT00450437|101702296|FG000|Overall Study|Administrative reason|0|||
33494245|NCT00450437|101702297|FG001|Overall Study|Administrative reason|0|||
33494246|NCT00450437|101702298|FG002|Overall Study|Administrative reason|1|||
33494247|NCT00450437|101702299|FG003|Overall Study|Administrative reason|0|||
33494248|NCT00450437|101702296|FG000|Overall Study|Unable to Classify|1|||
33494249|NCT00450437|101702297|FG001|Overall Study|Unable to Classify|0|||
33494250|NCT00450437|101702298|FG002|Overall Study|Unable to Classify|1|||
33494251|NCT00450437|101702299|FG003|Overall Study|Unable to Classify|0|||
33494252|NCT03347110|101702300|FG000|Overall Study|Other (Participant is incarcerated)|1|||
33494253|NCT03347110|101702300|FG000|Overall Study|Withdrawal by Subject|9|||
33494254|NCT03347110|101702300|FG000|Overall Study|Lost to Follow-up|1|||
33494255|NCT03347110|101702300|FG000|Overall Study|Lack of Efficacy|2|||
33494256|NCT03347110|101702300|FG000|Overall Study|Adverse Event, non-fatal|9|||
33494257|NCT01199939|101702303|FG000|Overall Study|Adverse Event|4|||
33494258|NCT01199939|101702303|FG000|Overall Study|Protocol Violation|3|||
33494259|NCT01199939|101702303|FG000|Overall Study|Lost to Follow-up|2|||
33494260|NCT01199939|101702303|FG000|Overall Study|Reached a virologic endpoint|4|||
33494261|NCT01777282|101702309|FG000|Overall Study|Persistent Hyperglycemia|0|||
33494262|NCT01777282|101702310|FG001|Overall Study|Persistent Hyperglycemia|0|||
33494263|NCT01777282|101702311|FG002|Overall Study|Persistent Hyperglycemia|1|||
33494264|NCT01777282|101702312|FG003|Overall Study|Persistent Hyperglycemia|0|||
33494265|NCT01777282|101702313|FG004|Overall Study|Persistent Hyperglycemia|0|||
33494266|NCT01777282|101702309|FG000|Overall Study|New Antidiabetic Medication|0|||
33494267|NCT01777282|101702310|FG001|Overall Study|New Antidiabetic Medication|0|||
33494268|NCT01777282|101702311|FG002|Overall Study|New Antidiabetic Medication|1|||
33494269|NCT01777282|101702312|FG003|Overall Study|New Antidiabetic Medication|0|||
33494270|NCT01777282|101702313|FG004|Overall Study|New Antidiabetic Medication|0|||
33494271|NCT01777282|101702309|FG000|Overall Study|Adverse Event|4|||
33494272|NCT01777282|101702310|FG001|Overall Study|Adverse Event|4|||
33494273|NCT01777282|101702311|FG002|Overall Study|Adverse Event|2|||
33494274|NCT01777282|101702312|FG003|Overall Study|Adverse Event|1|||
33494275|NCT01777282|101702313|FG004|Overall Study|Adverse Event|3|||
33494276|NCT01777282|101702309|FG000|Overall Study|Withdrawal by Subject|4|||
33494277|NCT01777282|101702310|FG001|Overall Study|Withdrawal by Subject|0|||
33494278|NCT01777282|101702311|FG002|Overall Study|Withdrawal by Subject|0|||
33494279|NCT01777282|101702312|FG003|Overall Study|Withdrawal by Subject|1|||
33494280|NCT01777282|101702313|FG004|Overall Study|Withdrawal by Subject|2|||
33494281|NCT01777282|101702309|FG000|Overall Study|Protocol Violation|2|||
33494282|NCT01777282|101702310|FG001|Overall Study|Protocol Violation|0|||
33494283|NCT01777282|101702311|FG002|Overall Study|Protocol Violation|1|||
33494284|NCT01777282|101702312|FG003|Overall Study|Protocol Violation|0|||
33594557|NCT01133405|102065017|FG006|Period 1|Withdrawal by Subject|0|||
33186022|NCT02658890|100590618|FG017|Treatment Phase|Death|0|||
33186023|NCT02658890|100590619|FG018|Treatment Phase|Death|1|||
33494285|NCT01777282|101702313|FG004|Overall Study|Protocol Violation|2|||
33494286|NCT01777282|101702309|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
33494287|NCT01777282|101702310|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
33494288|NCT01777282|101702311|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
33494289|NCT01777282|101702312|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
33494290|NCT01777282|101702313|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
33494291|NCT00991887|101702314|FG000|Overall Study|Lost to Follow-up|2|||
33494292|NCT00991887|101702315|FG001|Overall Study|Lost to Follow-up|1|||
33494293|NCT02291237|101702318|FG000|Overall Study|Study Terminated by Sponsor|72|||
33494294|NCT02291237|101702319|FG001|Overall Study|Study Terminated by Sponsor|67|||
33494295|NCT02291237|101702318|FG000|Overall Study|Adverse Event|1|||
33494296|NCT02291237|101702319|FG001|Overall Study|Adverse Event|3|||
33494297|NCT02291237|101702318|FG000|Overall Study|Investigator's Discretion|0|||
33494298|NCT02291237|101702319|FG001|Overall Study|Investigator's Discretion|3|||
33494299|NCT02291237|101702318|FG000|Overall Study|Withdrew Consent|11|||
33494300|NCT02291237|101702319|FG001|Overall Study|Withdrew Consent|11|||
33494301|NCT02291237|101702318|FG000|Overall Study|Lost to Follow-up|0|||
33494302|NCT02291237|101702319|FG001|Overall Study|Lost to Follow-up|2|||
33494303|NCT02291237|101702318|FG000|Overall Study|Subject Required Prohibited Medication|2|||
33494304|NCT02291237|101702319|FG001|Overall Study|Subject Required Prohibited Medication|0|||
33494305|NCT02623725|101702320|FG000|Overall Study|Non compliance with protocol|9|||
33494306|NCT02623725|101702321|FG001|Overall Study|Non compliance with protocol|3|||
33494307|NCT02623725|101702320|FG000|Overall Study|Serious adverse event|0|||
33494308|NCT02623725|101702321|FG001|Overall Study|Serious adverse event|2|||
33494309|NCT02623725|101702320|FG000|Overall Study|Withdrawal by Subject|7|||
33494310|NCT02623725|101702321|FG001|Overall Study|Withdrawal by Subject|1|||
33494311|NCT01433471|101702322|FG000|Overall Study|Withdrawal by Subject|0|||
33494312|NCT01433471|101702323|FG001|Overall Study|Withdrawal by Subject|1|||
33494313|NCT03657797|101702331|FG000|Overall Study|Lost to Follow-up|0|||
33494314|NCT03657797|101702332|FG001|Overall Study|Lost to Follow-up|1|||
33494315|NCT03657797|101702333|FG002|Overall Study|Lost to Follow-up|1|||
33494316|NCT03657797|101702334|FG003|Overall Study|Lost to Follow-up|0|||
33494317|NCT03657797|101702331|FG000|Overall Study|Physician Decision|0|||
33494318|NCT03657797|101702332|FG001|Overall Study|Physician Decision|1|||
33494319|NCT03657797|101702333|FG002|Overall Study|Physician Decision|0|||
33494320|NCT03657797|101702334|FG003|Overall Study|Physician Decision|0|||
33494321|NCT03657797|101702331|FG000|Overall Study|Withdrawal by Subject|0|||
33494322|NCT03657797|101702332|FG001|Overall Study|Withdrawal by Subject|1|||
33494323|NCT03657797|101702333|FG002|Overall Study|Withdrawal by Subject|2|||
33494324|NCT03657797|101702334|FG003|Overall Study|Withdrawal by Subject|0|||
33494325|NCT03657797|101702331|FG000|Overall Study|Adverse Event|0|||
33494326|NCT03657797|101702332|FG001|Overall Study|Adverse Event|0|||
33288632|NCT01018732|100954968|FG001|Overall Study|Inappropriate Enrollment|1|||
33288633|NCT01018732|100954969|FG002|Overall Study|Inappropriate Enrollment|0|||
33288634|NCT01018732|100954967|FG000|Overall Study|Unable to Classify|0|||
33288635|NCT01018732|100954968|FG001|Overall Study|Unable to Classify|0|||
33288636|NCT01018732|100954969|FG002|Overall Study|Unable to Classify|1|||
33288637|NCT00469456|100954970|FG000|Overall Study|Adverse Event|4|||
33288638|NCT00469456|100954971|FG001|Overall Study|Adverse Event|3|||
33288639|NCT00469456|100954970|FG000|Overall Study|Protocol Violation|1|||
33288640|NCT00469456|100954971|FG001|Overall Study|Protocol Violation|0|||
33288641|NCT00469456|100954970|FG000|Overall Study|Withdrawal by Subject|4|||
33288642|NCT00469456|100954971|FG001|Overall Study|Withdrawal by Subject|1|||
33288643|NCT02872311|100954972|FG000|Overall Study|Death|2|||
33288644|NCT02872311|100954973|FG001|Overall Study|Death|0|||
33288645|NCT02872311|100954974|FG002|Overall Study|Death|0|||
33288646|NCT02872311|100954975|FG003|Overall Study|Death|0|||
33288647|NCT02872311|100954976|FG004|Overall Study|Death|0|||
33288648|NCT02872311|100954972|FG000|Overall Study|Lost to Follow-up|2|||
33288649|NCT02872311|100954973|FG001|Overall Study|Lost to Follow-up|0|||
33288650|NCT02872311|100954974|FG002|Overall Study|Lost to Follow-up|0|||
33288651|NCT02872311|100954975|FG003|Overall Study|Lost to Follow-up|0|||
33288652|NCT02872311|100954976|FG004|Overall Study|Lost to Follow-up|0|||
33288653|NCT02872311|100954972|FG000|Overall Study|Protocol Violation|0|||
33288654|NCT02872311|100954973|FG001|Overall Study|Protocol Violation|2|||
33288655|NCT02872311|100954974|FG002|Overall Study|Protocol Violation|1|||
33390049|NCT03682055|101317635|FG004|Overall Study|Lack of Efficacy|1|||
33390050|NCT03682055|101317636|FG005|Overall Study|Lack of Efficacy|3|||
33390051|NCT03682055|101317631|FG000|Overall Study|Withdrawal by Subject|0|||
33390052|NCT03682055|101317632|FG001|Overall Study|Withdrawal by Subject|0|||
33390053|NCT03682055|101317633|FG002|Overall Study|Withdrawal by Subject|0|||
33390054|NCT03682055|101317634|FG003|Overall Study|Withdrawal by Subject|0|||
33390055|NCT03682055|101317635|FG004|Overall Study|Withdrawal by Subject|0|||
33390056|NCT03682055|101317636|FG005|Overall Study|Withdrawal by Subject|1|||
33390057|NCT03682055|101317631|FG000|Overall Study|Termination of Study by Sponsor|0|||
33494327|NCT03657797|101702333|FG002|Overall Study|Adverse Event|2|||
33288656|NCT02872311|100954975|FG003|Overall Study|Protocol Violation|0|||
33594558|NCT01133405|102065018|FG007|Period 1|Withdrawal by Subject|0|||
33186024|NCT02658890|100590620|FG019|Treatment Phase|Death|0|||
33288657|NCT02872311|100954976|FG004|Overall Study|Protocol Violation|0|||
33288658|NCT00478647|100954977|FG000|Overall Study|Adverse Event|1|||
33288659|NCT00478647|100954977|FG000|Overall Study|Withdrawal by Subject|1|||
33494328|NCT03657797|101702334|FG003|Overall Study|Adverse Event|0|||
33494329|NCT04753216|101702341|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
33494330|NCT04753216|101702341|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
33494331|NCT04753216|101702341|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
33494332|NCT00699816|101702342|FG000|Overall Study|Protocol Violation|1|||
33494333|NCT00699816|101702343|FG001|Overall Study|Protocol Violation|3|||
33494334|NCT01062425|101702344|FG000|Overall Study|Protocol Violation|3|||
33494335|NCT01062425|101702345|FG001|Overall Study|Protocol Violation|6|||
33494336|NCT00942084|101702346|FG000|Overall Study|Death|2|||
33494337|NCT00503698|101702347|FG000|Overall Study|Protocol Violation|5|||
33494338|NCT00503698|101702348|FG001|Overall Study|Protocol Violation|6|||
33494339|NCT00503698|101702347|FG000|Overall Study|Adverse Event|52|||
33494340|NCT00503698|101702348|FG001|Overall Study|Adverse Event|41|||
33494341|NCT00503698|101702347|FG000|Overall Study|Death|1|||
33494342|NCT00503698|101702348|FG001|Overall Study|Death|0|||
33494343|NCT00503698|101702347|FG000|Overall Study|Lack of Efficacy|3|||
33494344|NCT00503698|101702348|FG001|Overall Study|Lack of Efficacy|4|||
33494345|NCT00503698|101702347|FG000|Overall Study|Trial terminated|216|||
33494346|NCT00503698|101702348|FG001|Overall Study|Trial terminated|253|||
33494347|NCT00503698|101702347|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
33494348|NCT00503698|101702348|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
33494349|NCT00503698|101702347|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
33494350|NCT00503698|101702348|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
33494351|NCT00503698|101702347|FG000|Overall Study|Any condition in exclusion criteria|4|||
33494352|NCT00503698|101702348|FG001|Overall Study|Any condition in exclusion criteria|6|||
33494353|NCT00503698|101702347|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
33494354|NCT00503698|101702348|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
33494355|NCT00503698|101702347|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
33494356|NCT00503698|101702348|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
33494357|NCT00503698|101702347|FG000|Overall Study|Critically ill|2|||
33494358|NCT00503698|101702348|FG001|Overall Study|Critically ill|0|||
33494359|NCT00503698|101702347|FG000|Overall Study|Unclassified|48|||
33494360|NCT00503698|101702348|FG001|Overall Study|Unclassified|32|||
33494361|NCT00503698|101702347|FG000|Overall Study|Not exposed to trial drug|11|||
33494362|NCT00503698|101702348|FG001|Overall Study|Not exposed to trial drug|6|||
33494363|NCT01103180|101702349|FG000|Overall Study|Withdrawal by Subject|8|||
33494364|NCT01103180|101702350|FG001|Overall Study|Withdrawal by Subject|13|||
33494365|NCT01103180|101702349|FG000|Overall Study|Lost to Follow-up|13|||
33494366|NCT01103180|101702350|FG001|Overall Study|Lost to Follow-up|7|||
33494367|NCT01103180|101702349|FG000|Overall Study|Physician Decision|1|||
33494368|NCT01103180|101702350|FG001|Overall Study|Physician Decision|0|||
33494369|NCT01103180|101702349|FG000|Overall Study|Protocol Violation|0|||
33494370|NCT01103180|101702350|FG001|Overall Study|Protocol Violation|1|||
33494371|NCT03307252|101702351|FG000|Part 2, Period 1|Treatment not received|0|||
33494372|NCT03307252|101702352|FG001|Part 2, Period 1|Treatment not received|0|||
33494373|NCT03307252|101702353|FG002|Part 2, Period 1|Treatment not received|0|||
33494374|NCT03307252|101702354|FG003|Part 2, Period 1|Treatment not received|0|||
33494375|NCT03307252|101702355|FG004|Part 2, Period 1|Treatment not received|0|||
33494376|NCT03307252|101702356|FG005|Part 2, Period 1|Treatment not received|1|||
33494377|NCT03307252|101702357|FG006|Part 2, Period 1|Treatment not received|0|||
33494378|NCT03307252|101702358|FG007|Part 2, Period 1|Treatment not received|0|||
33494379|NCT03307252|101702359|FG008|Part 2, Period 1|Treatment not received|0|||
33494380|NCT03307252|101702360|FG009|Part 2, Period 1|Treatment not received|0|||
33494381|NCT03307252|101702361|FG010|Part 2, Period 1|Treatment not received|0|||
33494382|NCT03307252|101702351|FG000|Part 2, Period 3|Other than listed|0|||
33494383|NCT03307252|101702352|FG001|Part 2, Period 3|Other than listed|0|||
33494384|NCT03307252|101702353|FG002|Part 2, Period 3|Other than listed|0|||
33494385|NCT03307252|101702354|FG003|Part 2, Period 3|Other than listed|0|||
33494386|NCT03307252|101702355|FG004|Part 2, Period 3|Other than listed|1|||
33494387|NCT03307252|101702356|FG005|Part 2, Period 3|Other than listed|0|||
33494388|NCT03307252|101702357|FG006|Part 2, Period 3|Other than listed|0|||
33494389|NCT03307252|101702358|FG007|Part 2, Period 3|Other than listed|0|||
33494390|NCT03307252|101702359|FG008|Part 2, Period 3|Other than listed|0|||
33494391|NCT03307252|101702360|FG009|Part 2, Period 3|Other than listed|0|||
33494392|NCT03307252|101702361|FG010|Part 2, Period 3|Other than listed|0|||
33494393|NCT03307252|101702351|FG000|Part 2, Period 4|Other than listed|0|||
33494394|NCT03307252|101702352|FG001|Part 2, Period 4|Other than listed|0|||
33494395|NCT03307252|101702353|FG002|Part 2, Period 4|Other than listed|0|||
33494396|NCT03307252|101702354|FG003|Part 2, Period 4|Other than listed|0|||
33494397|NCT03307252|101702355|FG004|Part 2, Period 4|Other than listed|0|||
33494398|NCT03307252|101702356|FG005|Part 2, Period 4|Other than listed|0|||
33494399|NCT03307252|101702357|FG006|Part 2, Period 4|Other than listed|1|||
33494400|NCT03307252|101702358|FG007|Part 2, Period 4|Other than listed|0|||
33494401|NCT03307252|101702359|FG008|Part 2, Period 4|Other than listed|0|||
33494402|NCT03307252|101702360|FG009|Part 2, Period 4|Other than listed|0|||
33494403|NCT03307252|101702361|FG010|Part 2, Period 4|Other than listed|0|||
33494404|NCT03307252|101702351|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33494405|NCT03307252|101702352|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33494406|NCT03307252|101702353|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33494407|NCT03307252|101702354|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33494408|NCT03307252|101702355|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33494409|NCT03307252|101702356|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33494410|NCT03307252|101702357|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33494411|NCT03307252|101702358|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33494412|NCT03307252|101702359|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33494413|NCT03307252|101702360|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
33494414|NCT03307252|101702361|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
33494415|NCT03093259|101702362|FG000|Overall Study|Adverse Event|1|||
33494416|NCT03093259|101702363|FG001|Overall Study|Adverse Event|0|||
33494417|NCT03093259|101702362|FG000|Overall Study|Withdrawal by Subject|1|||
33494418|NCT03093259|101702363|FG001|Overall Study|Withdrawal by Subject|0|||
33494419|NCT00122382|101702376|FG000|Double-Blind Study|Adverse Event|9|||
33494420|NCT00122382|101702377|FG001|Double-Blind Study|Adverse Event|11|||
33494421|NCT00122382|101702378|FG002|Double-Blind Study|Adverse Event|0|||
33494422|NCT00122382|101702376|FG000|Double-Blind Study|Death|2|||
33494423|NCT00122382|101702377|FG001|Double-Blind Study|Death|2|||
33494424|NCT00122382|101702378|FG002|Double-Blind Study|Death|0|||
33494425|NCT00122382|101702376|FG000|Double-Blind Study|Lack of Efficacy|0|||
33494426|NCT00122382|101702377|FG001|Double-Blind Study|Lack of Efficacy|8|||
33494427|NCT00122382|101702378|FG002|Double-Blind Study|Lack of Efficacy|0|||
33494428|NCT00122382|101702376|FG000|Double-Blind Study|Lost to Follow-up|2|||
33186025|NCT02658890|100590621|FG020|Treatment Phase|Death|0|||
33186026|NCT02658890|100590622|FG021|Treatment Phase|Death|0|||
33186027|NCT02658890|100590623|FG022|Treatment Phase|Death|0|||
33186028|NCT02658890|100590624|FG023|Treatment Phase|Death|0|||
33186029|NCT02658890|100590625|FG024|Treatment Phase|Death|0|||
33186030|NCT02658890|100590626|FG025|Treatment Phase|Death|0|||
33186031|NCT02658890|100590627|FG026|Treatment Phase|Death|0|||
33186032|NCT02658890|100590601|FG000|Treatment Phase|Lost to Follow-up|0|||
33186033|NCT02658890|100590602|FG001|Treatment Phase|Lost to Follow-up|0|||
33186034|NCT02658890|100590603|FG002|Treatment Phase|Lost to Follow-up|0|||
33186035|NCT02658890|100590604|FG003|Treatment Phase|Lost to Follow-up|0|||
33288660|NCT00510146|100954978|FG000|Double-Blind Treatment|Adverse Event|30|||
33494429|NCT00122382|101702377|FG001|Double-Blind Study|Lost to Follow-up|1|||
33494430|NCT00122382|101702378|FG002|Double-Blind Study|Lost to Follow-up|0|||
33494431|NCT00122382|101702376|FG000|Double-Blind Study|Pregnancy|2|||
33494432|NCT00122382|101702377|FG001|Double-Blind Study|Pregnancy|0|||
33494433|NCT00122382|101702378|FG002|Double-Blind Study|Pregnancy|0|||
33494434|NCT00122382|101702376|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
33288661|NCT00510146|100954979|FG001|Double-Blind Treatment|Adverse Event|13|||
33288662|NCT00510146|100954978|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
33288663|NCT00510146|100954979|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
33288664|NCT00510146|100954978|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
33288665|NCT00510146|100954979|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
33288666|NCT00510146|100954978|FG000|Double-Blind Treatment|Physician Decision|6|||
33288667|NCT00510146|100954979|FG001|Double-Blind Treatment|Physician Decision|0|||
33288668|NCT00510146|100954978|FG000|Double-Blind Treatment|Protocol Violation|1|||
33288669|NCT00510146|100954979|FG001|Double-Blind Treatment|Protocol Violation|2|||
33288670|NCT00510146|100954978|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
33288671|NCT00510146|100954979|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
33288672|NCT00510146|100954978|FG000|Double-Blind Treatment|Clinical Relapse|0|||
33288673|NCT00510146|100954979|FG001|Double-Blind Treatment|Clinical Relapse|1|||
33288674|NCT00510146|100954978|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
33288675|NCT00510146|100954979|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
33288676|NCT00510146|100954978|FG000|Open-Label Treatment|Adverse Event|22|||
33288677|NCT00510146|100954979|FG001|Open-Label Treatment|Adverse Event|8|||
33390058|NCT03682055|101317632|FG001|Overall Study|Termination of Study by Sponsor|0|||
33494435|NCT00122382|101702377|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
33494436|NCT00122382|101702378|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
33494437|NCT00122382|101702376|FG000|Double-Blind Study|Withdrawal of Consent|7|||
33494438|NCT00122382|101702377|FG001|Double-Blind Study|Withdrawal of Consent|3|||
33494439|NCT00122382|101702378|FG002|Double-Blind Study|Withdrawal of Consent|0|||
33494440|NCT00122382|101702376|FG000|Double-Blind Study|Protocol Violation|1|||
33494441|NCT00122382|101702377|FG001|Double-Blind Study|Protocol Violation|0|||
33494442|NCT00122382|101702378|FG002|Double-Blind Study|Protocol Violation|0|||
33494443|NCT00122382|101702376|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
33494444|NCT00122382|101702377|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
33494445|NCT00122382|101702378|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
33494446|NCT00122382|101702376|FG000|Double-Blind Study|Randomized but not treated|0|||
33494447|NCT00122382|101702377|FG001|Double-Blind Study|Randomized but not treated|2|||
33494448|NCT00122382|101702378|FG002|Double-Blind Study|Randomized but not treated|0|||
33494449|NCT00122382|101702376|FG000|Open-Label Study|Adverse Event|0|||
33594559|NCT01133405|102065019|FG008|Period 1|Withdrawal by Subject|0|||
33186036|NCT02658890|100590605|FG004|Treatment Phase|Lost to Follow-up|0|||
33288678|NCT00510146|100954978|FG000|Open-Label Treatment|Death|1|||
33288679|NCT00510146|100954979|FG001|Open-Label Treatment|Death|1|||
33494450|NCT00122382|101702377|FG001|Open-Label Study|Adverse Event|0|||
33494451|NCT00122382|101702378|FG002|Open-Label Study|Adverse Event|11|||
33494452|NCT00122382|101702376|FG000|Open-Label Study|Death|0|||
33494453|NCT00122382|101702377|FG001|Open-Label Study|Death|0|||
33494454|NCT00122382|101702378|FG002|Open-Label Study|Death|2|||
33494455|NCT00122382|101702376|FG000|Open-Label Study|Lack of Efficacy|0|||
33494456|NCT00122382|101702377|FG001|Open-Label Study|Lack of Efficacy|0|||
33494457|NCT00122382|101702378|FG002|Open-Label Study|Lack of Efficacy|3|||
33494458|NCT00122382|101702376|FG000|Open-Label Study|Lost to Follow-up|0|||
33494459|NCT00122382|101702377|FG001|Open-Label Study|Lost to Follow-up|0|||
33494460|NCT00122382|101702378|FG002|Open-Label Study|Lost to Follow-up|3|||
33494461|NCT00122382|101702376|FG000|Open-Label Study|Pregnancy|0|||
33288680|NCT00510146|100954978|FG000|Open-Label Treatment|Lack of Efficacy|4|||
33288681|NCT00510146|100954979|FG001|Open-Label Treatment|Lack of Efficacy|0|||
33288682|NCT00510146|100954978|FG000|Open-Label Treatment|Lost to Follow-up|10|||
33288683|NCT00510146|100954979|FG001|Open-Label Treatment|Lost to Follow-up|1|||
33288684|NCT00510146|100954978|FG000|Open-Label Treatment|Physician Decision|3|||
33288685|NCT00510146|100954979|FG001|Open-Label Treatment|Physician Decision|1|||
33288686|NCT00510146|100954978|FG000|Open-Label Treatment|Protocol Violation|4|||
33288687|NCT00510146|100954979|FG001|Open-Label Treatment|Protocol Violation|2|||
33288688|NCT00510146|100954978|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
33288689|NCT00510146|100954979|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
33288690|NCT00510146|100954978|FG000|Open-Label Treatment|Clinical Relapse|1|||
33288691|NCT00510146|100954979|FG001|Open-Label Treatment|Clinical Relapse|1|||
33288692|NCT00510146|100954978|FG000|Open-Label Treatment|Sponsor Decision|2|||
33288693|NCT00510146|100954979|FG001|Open-Label Treatment|Sponsor Decision|0|||
33288694|NCT00344032|100954981|FG000|Overall Study|Adverse Event|0|||
33288695|NCT00344032|100954982|FG001|Overall Study|Adverse Event|1|||
33288696|NCT00344032|100954981|FG000|Overall Study|Withdrawal by Subject|6|||
33288697|NCT00344032|100954982|FG001|Overall Study|Withdrawal by Subject|2|||
33288698|NCT00344032|100954981|FG000|Overall Study|Lost to Follow-up|4|||
33288699|NCT00344032|100954982|FG001|Overall Study|Lost to Follow-up|6|||
33288700|NCT00344032|100954981|FG000|Overall Study|Physician Decision|4|||
33288701|NCT00344032|100954982|FG001|Overall Study|Physician Decision|1|||
33288702|NCT02760485|100954983|FG000|Phase 1|Death|3|||
33288703|NCT02760485|100954984|FG001|Phase 1|Death|6|||
33288704|NCT02760485|100954985|FG002|Phase 1|Death|0|||
33288705|NCT02760485|100954983|FG000|Phase 1|Withdrawal by Subject|2|||
33288706|NCT02760485|100954984|FG001|Phase 1|Withdrawal by Subject|0|||
33288707|NCT02760485|100954985|FG002|Phase 1|Withdrawal by Subject|0|||
33288708|NCT02760485|100954983|FG000|Phase 1|Progressive Disease|1|||
33288709|NCT02760485|100954984|FG001|Phase 1|Progressive Disease|0|||
33288710|NCT02760485|100954985|FG002|Phase 1|Progressive Disease|0|||
33288711|NCT02760485|100954983|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
33288712|NCT02760485|100954984|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
33288713|NCT02760485|100954985|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
33288714|NCT02760485|100954983|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
33288715|NCT02760485|100954984|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
33288716|NCT02760485|100954985|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
33288717|NCT02760485|100954983|FG000|Phase 2|Death|0|||
33288718|NCT02760485|100954984|FG001|Phase 2|Death|0|||
33288719|NCT02760485|100954985|FG002|Phase 2|Death|12|||
33288720|NCT02760485|100954983|FG000|Phase 2|Withdrawal by Subject|0|||
33288721|NCT02760485|100954984|FG001|Phase 2|Withdrawal by Subject|0|||
33288722|NCT02760485|100954985|FG002|Phase 2|Withdrawal by Subject|3|||
33288723|NCT02760485|100954983|FG000|Phase 2|Progressive Disease|0|||
33288724|NCT02760485|100954984|FG001|Phase 2|Progressive Disease|0|||
33288725|NCT02760485|100954985|FG002|Phase 2|Progressive Disease|1|||
33288726|NCT02760485|100954983|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
33288727|NCT02760485|100954984|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
33288728|NCT02760485|100954985|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
33288729|NCT02394665|100954986|FG000|Overall Study|Physician Decision|1|||
33288730|NCT02394665|100954987|FG001|Overall Study|Physician Decision|0|||
33288731|NCT02394665|100954988|FG002|Overall Study|Physician Decision|0|||
33288732|NCT02165826|100954991|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
33288733|NCT02165826|100954992|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
33288734|NCT02165826|100954993|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
33288735|NCT02165826|100954991|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
33288736|NCT02165826|100954992|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
33288737|NCT02165826|100954993|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
33494462|NCT00122382|101702377|FG001|Open-Label Study|Pregnancy|0|||
33494463|NCT00122382|101702378|FG002|Open-Label Study|Pregnancy|2|||
33288738|NCT02165826|100954991|FG000|Main Treatment Period|Lost to Follow-up|4|||
33288739|NCT02165826|100954992|FG001|Main Treatment Period|Lost to Follow-up|2|||
33288740|NCT02165826|100954993|FG002|Main Treatment Period|Lost to Follow-up|1|||
33494464|NCT00122382|101702376|FG000|Open-Label Study|Poor/Non-Compliance|0|||
33494465|NCT00122382|101702377|FG001|Open-Label Study|Poor/Non-Compliance|0|||
33288741|NCT02165826|100954991|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
33288742|NCT02165826|100954992|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
33288743|NCT02165826|100954993|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
33288744|NCT02165826|100954991|FG000|Main Treatment Period|Lack of Efficacy|2|||
33288745|NCT02165826|100954992|FG001|Main Treatment Period|Lack of Efficacy|0|||
33288746|NCT02165826|100954993|FG002|Main Treatment Period|Lack of Efficacy|0|||
33288747|NCT02165826|100954991|FG000|Main Treatment Period|Reason Not Specified|8|||
33288748|NCT02165826|100954992|FG001|Main Treatment Period|Reason Not Specified|5|||
33390059|NCT03682055|101317633|FG002|Overall Study|Termination of Study by Sponsor|0|||
33390060|NCT03682055|101317634|FG003|Overall Study|Termination of Study by Sponsor|0|||
33494466|NCT00122382|101702378|FG002|Open-Label Study|Poor/Non-Compliance|1|||
33494467|NCT00122382|101702376|FG000|Open-Label Study|Withdrawal of Consent|0|||
33494468|NCT00122382|101702377|FG001|Open-Label Study|Withdrawal of Consent|0|||
33494469|NCT00122382|101702378|FG002|Open-Label Study|Withdrawal of Consent|4|||
33494470|NCT00322712|101702387|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
33494471|NCT01349192|101702388|FG000|Overall Study|Protocol Violation|0|||
33494472|NCT01349192|101702389|FG001|Overall Study|Protocol Violation|1|||
33494473|NCT01349192|101702388|FG000|Overall Study|Withdrawal by Subject|0|||
33494474|NCT01349192|101702389|FG001|Overall Study|Withdrawal by Subject|2|||
33494475|NCT01349192|101702388|FG000|Overall Study|Lost to Follow-up|1|||
33494476|NCT01349192|101702389|FG001|Overall Study|Lost to Follow-up|3|||
33494477|NCT01349192|101702388|FG000|Overall Study|Failure to adhere to Protocol|2|||
33494478|NCT01349192|101702389|FG001|Overall Study|Failure to adhere to Protocol|0|||
33494479|NCT02286713|101702392|FG000|One Week Follow-Up|Death|1|||
33390061|NCT03682055|101317635|FG004|Overall Study|Termination of Study by Sponsor|0|||
33494480|NCT02286713|101702393|FG001|One Week Follow-Up|Death|0|||
33494481|NCT02286713|101702392|FG000|One Week Follow-Up|Lost to Follow-up|17|||
33494482|NCT02286713|101702393|FG001|One Week Follow-Up|Lost to Follow-up|21|||
33494483|NCT02286713|101702392|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
33494484|NCT02286713|101702393|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
33494485|NCT02286713|101702392|FG000|Three Month Follow-Up|Death|1|||
33494486|NCT02286713|101702393|FG001|Three Month Follow-Up|Death|1|||
33494487|NCT02286713|101702392|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
33494488|NCT02286713|101702393|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
33494489|NCT02286713|101702392|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
33494490|NCT02286713|101702393|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
33494491|NCT02286713|101702392|FG000|Six Month Follow-Up|Death|2|||
33494492|NCT02286713|101702393|FG001|Six Month Follow-Up|Death|0|||
33494493|NCT02286713|101702392|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
33494494|NCT02286713|101702393|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
33494495|NCT01169350|101702394|FG000|Overall Study|Physician Decision|3|||
33494496|NCT01169350|101702394|FG000|Overall Study|Lost to Follow-up|2|||
33494497|NCT04720105|101702395|FG000|Overall Study|Lack of Efficacy|1|||
33494498|NCT04720105|101702395|FG000|Overall Study|Lost to Follow-up|1|||
33494499|NCT04720105|101702395|FG000|Overall Study|Withdrawal by Subject|3|||
33494500|NCT00273182|101702396|FG000|Overall Study|Death|450|||
33494501|NCT00273182|101702396|FG000|Overall Study|Lost to Follow-up|88|||
33494502|NCT00273182|101702396|FG000|Overall Study|Withdrawal by Subject|257|||
33494503|NCT00273182|101702396|FG000|Overall Study|Device/System Explant|154|||
33494504|NCT00273182|101702396|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
33494505|NCT00955617|101702404|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
33494506|NCT00955617|101702405|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
33494507|NCT00955617|101702404|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
33494508|NCT00955617|101702405|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
33494509|NCT00955617|101702404|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
33494510|NCT00955617|101702405|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
33494511|NCT00955617|101702404|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
33494512|NCT00955617|101702405|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
33494513|NCT04358081|101702409|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
33494514|NCT04358081|101702410|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
33494515|NCT04358081|101702411|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
33494516|NCT04358081|101702409|FG000|Treatment Phase of Study|Adverse Event|1|||
33494517|NCT04358081|101702410|FG001|Treatment Phase of Study|Adverse Event|0|||
33494518|NCT04358081|101702411|FG002|Treatment Phase of Study|Adverse Event|1|||
33494519|NCT04358081|101702409|FG000|Treatment Phase of Study|Physician Decision|2|||
33494520|NCT04358081|101702410|FG001|Treatment Phase of Study|Physician Decision|0|||
33494521|NCT04358081|101702411|FG002|Treatment Phase of Study|Physician Decision|1|||
33494522|NCT04358081|101702409|FG000|Treatment Phase of Study|Protocol Violation|1|||
33494523|NCT04358081|101702410|FG001|Treatment Phase of Study|Protocol Violation|0|||
33494524|NCT04358081|101702411|FG002|Treatment Phase of Study|Protocol Violation|0|||
33186037|NCT02658890|100590606|FG005|Treatment Phase|Lost to Follow-up|0|||
33288749|NCT02165826|100954993|FG002|Main Treatment Period|Reason Not Specified|16|||
33288750|NCT02165826|100954991|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
33494525|NCT04358081|101702409|FG000|Study Completion Phase|Death|0|||
33494526|NCT04358081|101702410|FG001|Study Completion Phase|Death|0|||
33288751|NCT02165826|100954992|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
33288752|NCT02165826|100954993|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
33288753|NCT02165826|100954991|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
33288754|NCT02165826|100954992|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
33288755|NCT02165826|100954993|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
33288756|NCT02165826|100954991|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
33288757|NCT02165826|100954992|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
33288758|NCT02165826|100954993|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
33288759|NCT02165826|100954991|FG000|Down-Titration Period|Reason Not Specified|1|||
33288760|NCT02165826|100954992|FG001|Down-Titration Period|Reason Not Specified|0|||
33288761|NCT02165826|100954993|FG002|Down-Titration Period|Reason Not Specified|2|||
33288762|NCT02019641|100954997|FG000|10-Week Follow up|Withdrawal by investigator|2|||
33288763|NCT02019641|100954998|FG001|10-Week Follow up|Withdrawal by investigator|0|||
33288764|NCT02019641|100954999|FG002|10-Week Follow up|Withdrawal by investigator|0|||
33288765|NCT02019641|100954997|FG000|10-Week Follow up|Withdrawal by Subject|1|||
33288766|NCT02019641|100954998|FG001|10-Week Follow up|Withdrawal by Subject|1|||
33288767|NCT02019641|100954999|FG002|10-Week Follow up|Withdrawal by Subject|0|||
33288768|NCT02019641|100954997|FG000|20-Week Follow up|Withdrawal by investigator|0|||
33288769|NCT02019641|100954998|FG001|20-Week Follow up|Withdrawal by investigator|0|||
33288770|NCT02019641|100954999|FG002|20-Week Follow up|Withdrawal by investigator|1|||
33288771|NCT03277352|100955000|FG000|Overall Study|Study Terminated By Sponsor|2|||
33288772|NCT03277352|100955000|FG000|Overall Study|Withdrawal by Subject|4|||
33288773|NCT03277352|100955000|FG000|Overall Study|Death|4|||
33288774|NCT00839332|100955001|FG000|Phase 1|Disease Progression|38|||
33288775|NCT00839332|100955002|FG001|Phase 1|Disease Progression|0|||
33288776|NCT00839332|100955003|FG002|Phase 1|Disease Progression|0|||
33288777|NCT00839332|100955001|FG000|Phase 1|Adverse Event|6|||
33288778|NCT00839332|100955002|FG001|Phase 1|Adverse Event|0|||
33288779|NCT00839332|100955003|FG002|Phase 1|Adverse Event|0|||
33288780|NCT00839332|100955001|FG000|Phase 1|Withdrawal by Subject|4|||
33390062|NCT03682055|101317636|FG005|Overall Study|Termination of Study by Sponsor|3|||
33390063|NCT04058158|101317641|FG000|Period 1|Death|1|||
33390064|NCT04058158|101317642|FG001|Period 1|Death|0|||
33390065|NCT04058158|101317641|FG000|Period 1|Adverse Event|1|||
33390066|NCT04058158|101317642|FG001|Period 1|Adverse Event|1|||
33390067|NCT04058158|101317641|FG000|Period 1|Pregnancy|0|||
33390068|NCT04058158|101317642|FG001|Period 1|Pregnancy|1|||
33390069|NCT02829775|101317643|FG000|Overall Study|Death|1|||
33390070|NCT02829775|101317643|FG000|Overall Study|Withdrawal by Subject|3|||
33390071|NCT02829775|101317643|FG000|Overall Study|Disease remission|1|||
33390072|NCT01316939|101317650|FG000|Overall Study|Study closed/terminated|26|||
33390073|NCT01316939|101317651|FG001|Overall Study|Study closed/terminated|25|||
33390074|NCT01316939|101317652|FG002|Overall Study|Study closed/terminated|23|||
33390075|NCT01316939|101317650|FG000|Overall Study|Lack of Efficacy|24|||
33390076|NCT01316939|101317651|FG001|Overall Study|Lack of Efficacy|25|||
33390077|NCT01316939|101317652|FG002|Overall Study|Lack of Efficacy|25|||
33288781|NCT00839332|100955002|FG001|Phase 1|Withdrawal by Subject|0|||
33288782|NCT00839332|100955003|FG002|Phase 1|Withdrawal by Subject|0|||
33288783|NCT00839332|100955001|FG000|Phase 1|Physician Decision|2|||
33288784|NCT00839332|100955002|FG001|Phase 1|Physician Decision|0|||
33390078|NCT01316939|101317650|FG000|Overall Study|Adverse Event|9|||
33390079|NCT01316939|101317651|FG001|Overall Study|Adverse Event|12|||
33390080|NCT01316939|101317652|FG002|Overall Study|Adverse Event|11|||
33390081|NCT01316939|101317650|FG000|Overall Study|Withdrawal by Subject|1|||
33390082|NCT01316939|101317651|FG001|Overall Study|Withdrawal by Subject|3|||
33390083|NCT01316939|101317652|FG002|Overall Study|Withdrawal by Subject|6|||
33390084|NCT01316939|101317650|FG000|Overall Study|Physician Decision|2|||
33390085|NCT01316939|101317651|FG001|Overall Study|Physician Decision|2|||
33390086|NCT01316939|101317652|FG002|Overall Study|Physician Decision|1|||
33390087|NCT01316939|101317650|FG000|Overall Study|Lost to Follow-up|0|||
33390088|NCT01316939|101317651|FG001|Overall Study|Lost to Follow-up|0|||
33390089|NCT01316939|101317652|FG002|Overall Study|Lost to Follow-up|2|||
33390090|NCT01316939|101317650|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
33390091|NCT01316939|101317651|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
33390092|NCT01316939|101317652|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
33390093|NCT01316939|101317650|FG000|Overall Study|Protocol Violation|0|||
33390094|NCT01316939|101317651|FG001|Overall Study|Protocol Violation|1|||
33390095|NCT01316939|101317652|FG002|Overall Study|Protocol Violation|0|||
33390096|NCT03146403|101317653|FG000|Overall Study|Withdrawal by Subject|0|||
33390097|NCT03146403|101317654|FG001|Overall Study|Withdrawal by Subject|3|||
33390098|NCT03146403|101317653|FG000|Overall Study|Lost to Follow-up|2|||
33390099|NCT03146403|101317654|FG001|Overall Study|Lost to Follow-up|0|||
33390100|NCT03148795|101317655|FG000|Overall Study|Progressive Disease|1|||
33288785|NCT00839332|100955003|FG002|Phase 1|Physician Decision|0|||
33390101|NCT04445688|101317656|FG000|Washout (One Week)|Adverse Event|2|||
33390102|NCT04445688|101317656|FG000|Washout (One Week)|Withdrawal by Subject|1|||
33390103|NCT04731922|101317660|FG000|Overall Study|Adverse Event|0|||
33390104|NCT04731922|101317661|FG001|Overall Study|Adverse Event|0|||
33390105|NCT04731922|101317662|FG002|Overall Study|Adverse Event|0|||
33390106|NCT04731922|101317663|FG003|Overall Study|Adverse Event|0|||
33390107|NCT04731922|101317664|FG004|Overall Study|Adverse Event|0|||
33494527|NCT04358081|101702411|FG002|Study Completion Phase|Death|1|||
33494528|NCT04358081|101702409|FG000|Study Completion Phase|Lost to Follow-up|1|||
33494529|NCT04358081|101702410|FG001|Study Completion Phase|Lost to Follow-up|0|||
33494530|NCT04358081|101702411|FG002|Study Completion Phase|Lost to Follow-up|1|||
33494531|NCT00882518|101702412|FG000|Overall Study|Adverse Event|9|||
33494532|NCT00882518|101702413|FG001|Overall Study|Adverse Event|18|||
33494533|NCT00882518|101702412|FG000|Overall Study|Withdrawal by Subject|9|||
33494534|NCT00882518|101702413|FG001|Overall Study|Withdrawal by Subject|13|||
33494535|NCT00882518|101702412|FG000|Overall Study|Lack of Efficacy|12|||
33494536|NCT00882518|101702413|FG001|Overall Study|Lack of Efficacy|9|||
33494537|NCT00882518|101702412|FG000|Overall Study|Severe non-compliance to protocol|3|||
33494538|NCT00882518|101702413|FG001|Overall Study|Severe non-compliance to protocol|1|||
33494539|NCT00882518|101702412|FG000|Overall Study|Incorrect enrolment|4|||
33494540|NCT00882518|101702413|FG001|Overall Study|Incorrect enrolment|2|||
33494541|NCT00882518|101702412|FG000|Overall Study|Central lab closure for National day|1|||
33494542|NCT00882518|101702413|FG001|Overall Study|Central lab closure for National day|0|||
33494543|NCT00882518|101702412|FG000|Overall Study|Allocating random number by mistake|0|||
33494544|NCT00882518|101702413|FG001|Overall Study|Allocating random number by mistake|1|||
33494545|NCT04135937|101702414|FG000|Overall Study|Lost to Follow-up|2|||
33494546|NCT04135937|101702414|FG000|Overall Study|Withdrawal by Subject|1|||
33494547|NCT02273388|101702415|FG000|Overall Study|Adverse Event|0|||
33494548|NCT02273388|101702416|FG001|Overall Study|Adverse Event|0|||
33494549|NCT02273388|101702417|FG002|Overall Study|Adverse Event|0|||
33494550|NCT02273388|101702418|FG003|Overall Study|Adverse Event|0|||
33494551|NCT02273388|101702419|FG004|Overall Study|Adverse Event|0|||
33494552|NCT02273388|101702420|FG005|Overall Study|Adverse Event|0|||
33494553|NCT02273388|101702421|FG006|Overall Study|Adverse Event|1|||
33390108|NCT04731922|101317665|FG005|Overall Study|Adverse Event|0|||
33390109|NCT04731922|101317666|FG006|Overall Study|Adverse Event|0|||
33494554|NCT02273388|101702422|FG007|Overall Study|Adverse Event|2|||
33494555|NCT02273388|101702423|FG008|Overall Study|Adverse Event|0|||
33494556|NCT02273388|101702424|FG009|Overall Study|Adverse Event|0|||
33494557|NCT02273388|101702425|FG010|Overall Study|Adverse Event|0|||
33494558|NCT02273388|101702426|FG011|Overall Study|Adverse Event|0|||
33494559|NCT02273388|101702415|FG000|Overall Study|Adverse Event study disease worse|4|||
33494560|NCT02273388|101702416|FG001|Overall Study|Adverse Event study disease worse|3|||
33494561|NCT02273388|101702417|FG002|Overall Study|Adverse Event study disease worse|3|||
33494562|NCT02273388|101702418|FG003|Overall Study|Adverse Event study disease worse|2|||
33390110|NCT04731922|101317667|FG007|Overall Study|Adverse Event|0|||
33390111|NCT04731922|101317668|FG008|Overall Study|Adverse Event|0|||
33390112|NCT04731922|101317669|FG009|Overall Study|Adverse Event|0|||
33390113|NCT04731922|101317670|FG010|Overall Study|Adverse Event|1|||
33390114|NCT04731922|101317671|FG011|Overall Study|Adverse Event|0|||
33390115|NCT04731922|101317672|FG012|Overall Study|Adverse Event|0|||
33390116|NCT04731922|101317673|FG013|Overall Study|Adverse Event|0|||
33390117|NCT04731922|101317674|FG014|Overall Study|Adverse Event|0|||
33390118|NCT04731922|101317675|FG015|Overall Study|Adverse Event|0|||
33390119|NCT04731922|101317676|FG016|Overall Study|Adverse Event|0|||
33390120|NCT04731922|101317660|FG000|Overall Study|Lost to Follow-up|0|||
33390121|NCT04731922|101317661|FG001|Overall Study|Lost to Follow-up|0|||
33390122|NCT04731922|101317662|FG002|Overall Study|Lost to Follow-up|0|||
33390123|NCT04731922|101317663|FG003|Overall Study|Lost to Follow-up|1|||
33390124|NCT04731922|101317664|FG004|Overall Study|Lost to Follow-up|0|||
33390125|NCT04731922|101317665|FG005|Overall Study|Lost to Follow-up|1|||
33390126|NCT04731922|101317666|FG006|Overall Study|Lost to Follow-up|0|||
33390127|NCT04731922|101317667|FG007|Overall Study|Lost to Follow-up|0|||
33390128|NCT04731922|101317668|FG008|Overall Study|Lost to Follow-up|0|||
33390129|NCT04731922|101317669|FG009|Overall Study|Lost to Follow-up|0|||
33390130|NCT04731922|101317670|FG010|Overall Study|Lost to Follow-up|0|||
33390131|NCT04731922|101317671|FG011|Overall Study|Lost to Follow-up|0|||
33390132|NCT04731922|101317672|FG012|Overall Study|Lost to Follow-up|0|||
33494563|NCT02273388|101702419|FG004|Overall Study|Adverse Event study disease worse|4|||
33494564|NCT02273388|101702420|FG005|Overall Study|Adverse Event study disease worse|3|||
33494565|NCT02273388|101702421|FG006|Overall Study|Adverse Event study disease worse|14|||
33186038|NCT02658890|100590607|FG006|Treatment Phase|Lost to Follow-up|1|||
33390133|NCT04731922|101317673|FG013|Overall Study|Lost to Follow-up|0|||
33390134|NCT04731922|101317674|FG014|Overall Study|Lost to Follow-up|0|||
33494566|NCT02273388|101702422|FG007|Overall Study|Adverse Event study disease worse|6|||
33186039|NCT02658890|100590608|FG007|Treatment Phase|Lost to Follow-up|0|||
33390135|NCT04731922|101317675|FG015|Overall Study|Lost to Follow-up|0|||
33390136|NCT04731922|101317676|FG016|Overall Study|Lost to Follow-up|0|||
33390137|NCT04731922|101317660|FG000|Overall Study|Withdrawal by Subject|1|||
33390138|NCT04731922|101317661|FG001|Overall Study|Withdrawal by Subject|0|||
33390139|NCT04731922|101317662|FG002|Overall Study|Withdrawal by Subject|0|||
33390140|NCT04731922|101317663|FG003|Overall Study|Withdrawal by Subject|0|||
33390141|NCT04731922|101317664|FG004|Overall Study|Withdrawal by Subject|1|||
33390142|NCT04731922|101317665|FG005|Overall Study|Withdrawal by Subject|0|||
33390143|NCT04731922|101317666|FG006|Overall Study|Withdrawal by Subject|1|||
33390144|NCT04731922|101317667|FG007|Overall Study|Withdrawal by Subject|0|||
33390145|NCT04731922|101317668|FG008|Overall Study|Withdrawal by Subject|0|||
33390146|NCT04731922|101317669|FG009|Overall Study|Withdrawal by Subject|0|||
33390147|NCT04731922|101317670|FG010|Overall Study|Withdrawal by Subject|0|||
33390148|NCT04731922|101317671|FG011|Overall Study|Withdrawal by Subject|0|||
33390149|NCT04731922|101317672|FG012|Overall Study|Withdrawal by Subject|0|||
33390150|NCT04731922|101317673|FG013|Overall Study|Withdrawal by Subject|1|||
33390151|NCT04731922|101317674|FG014|Overall Study|Withdrawal by Subject|0|||
33390152|NCT04731922|101317675|FG015|Overall Study|Withdrawal by Subject|0|||
33390153|NCT04731922|101317676|FG016|Overall Study|Withdrawal by Subject|0|||
33494567|NCT02273388|101702423|FG008|Overall Study|Adverse Event study disease worse|6|||
33494568|NCT02273388|101702424|FG009|Overall Study|Adverse Event study disease worse|5|||
33494569|NCT02273388|101702425|FG010|Overall Study|Adverse Event study disease worse|10|||
33494570|NCT02273388|101702426|FG011|Overall Study|Adverse Event study disease worse|1|||
33494571|NCT02273388|101702415|FG000|Overall Study|Sponsor decision|0|||
33494572|NCT02273388|101702416|FG001|Overall Study|Sponsor decision|0|||
33494573|NCT02273388|101702417|FG002|Overall Study|Sponsor decision|0|||
33494574|NCT02273388|101702418|FG003|Overall Study|Sponsor decision|0|||
33494575|NCT02273388|101702419|FG004|Overall Study|Sponsor decision|0|||
33494576|NCT02273388|101702420|FG005|Overall Study|Sponsor decision|0|||
33494577|NCT02273388|101702421|FG006|Overall Study|Sponsor decision|0|||
33494578|NCT02273388|101702422|FG007|Overall Study|Sponsor decision|0|||
33494579|NCT02273388|101702423|FG008|Overall Study|Sponsor decision|0|||
33494580|NCT02273388|101702424|FG009|Overall Study|Sponsor decision|0|||
33494581|NCT02273388|101702425|FG010|Overall Study|Sponsor decision|0|||
33494582|NCT02273388|101702426|FG011|Overall Study|Sponsor decision|1|||
33494583|NCT01153815|101702428|FG000|Overall Study|Adverse Event|3|||
33494584|NCT01153815|101702429|FG001|Overall Study|Adverse Event|1|||
33494585|NCT01153815|101702428|FG000|Overall Study|Withdrawal by Subject|6|||
33494586|NCT01153815|101702429|FG001|Overall Study|Withdrawal by Subject|4|||
33494587|NCT02763046|101702432|FG000|Overall Study|Adverse Event|5|||
33494588|NCT02763046|101702433|FG001|Overall Study|Adverse Event|4|||
33494589|NCT02763046|101702434|FG002|Overall Study|Adverse Event|0|||
33494590|NCT02763046|101702432|FG000|Overall Study|Lack of Efficacy|1|||
33494591|NCT02763046|101702433|FG001|Overall Study|Lack of Efficacy|1|||
33494592|NCT02763046|101702434|FG002|Overall Study|Lack of Efficacy|3|||
33494593|NCT02763046|101702432|FG000|Overall Study|Physician Decision|1|||
33494594|NCT02763046|101702433|FG001|Overall Study|Physician Decision|0|||
33494595|NCT02763046|101702434|FG002|Overall Study|Physician Decision|1|||
33494596|NCT02763046|101702432|FG000|Overall Study|Subject/guardian decision|2|||
33494597|NCT02763046|101702433|FG001|Overall Study|Subject/guardian decision|0|||
33494598|NCT02763046|101702434|FG002|Overall Study|Subject/guardian decision|4|||
33494599|NCT03359850|101702435|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
33494600|NCT03359850|101702436|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
33494601|NCT03359850|101702435|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
33494602|NCT03359850|101702436|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
33494603|NCT03359850|101702435|FG000|Extension Phase (Up to 28 Months)|Death|2|||
33494604|NCT03359850|101702436|FG001|Extension Phase (Up to 28 Months)|Death|4|||
33494605|NCT03359850|101702435|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
33494606|NCT03359850|101702436|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
33494607|NCT03359850|101702435|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
33494608|NCT03359850|101702436|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
33494609|NCT00289848|101702437|FG000|Overall Study|Adverse Event|6|||
33494610|NCT00289848|101702438|FG001|Overall Study|Adverse Event|4|||
33494611|NCT00289848|101702437|FG000|Overall Study|Death|1|||
33494612|NCT00289848|101702438|FG001|Overall Study|Death|0|||
33494613|NCT00289848|101702437|FG000|Overall Study|Lack of Efficacy|20|||
33494614|NCT00289848|101702438|FG001|Overall Study|Lack of Efficacy|24|||
33494615|NCT00289848|101702437|FG000|Overall Study|Lost to Follow-up|3|||
33494616|NCT00289848|101702438|FG001|Overall Study|Lost to Follow-up|1|||
33494617|NCT00289848|101702437|FG000|Overall Study|Protocol Violation|5|||
33494618|NCT00289848|101702438|FG001|Overall Study|Protocol Violation|2|||
33390154|NCT04731922|101317660|FG000|Overall Study|Other|0|||
33494619|NCT00289848|101702437|FG000|Overall Study|Withdrawal by Subject|5|||
33494620|NCT00289848|101702438|FG001|Overall Study|Withdrawal by Subject|11|||
33494621|NCT00289848|101702437|FG000|Overall Study|Patient Moved|6|||
33494622|NCT00289848|101702438|FG001|Overall Study|Patient Moved|2|||
33494623|NCT00289848|101702437|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
33494624|NCT00289848|101702438|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
33494625|NCT03875508|101702439|FG000|Overall Study|Adverse Event|1|||
33494626|NCT03875508|101702439|FG000|Overall Study|Lost to Follow-up|8|||
33494627|NCT03875508|101702439|FG000|Overall Study|Lack of Efficacy|1|||
33494628|NCT03875508|101702439|FG000|Overall Study|Other, not specified|2|||
33494629|NCT01269918|101702450|FG000|Overall Study|Did not receive study drug|0|||
33494630|NCT01269918|101702451|FG001|Overall Study|Did not receive study drug|3|||
33494631|NCT00764881|101702452|FG000|Overall Study|Adverse Event|5|||
33494632|NCT00764881|101702453|FG001|Overall Study|Adverse Event|1|||
33494633|NCT00764881|101702452|FG000|Overall Study|Withdrawal by Subject|1|||
33494634|NCT00764881|101702453|FG001|Overall Study|Withdrawal by Subject|3|||
33494635|NCT00764881|101702452|FG000|Overall Study|Protocol Violation|2|||
33494636|NCT00764881|101702453|FG001|Overall Study|Protocol Violation|2|||
33494637|NCT00764881|101702452|FG000|Overall Study|Lost to Follow-up|2|||
33494638|NCT00764881|101702453|FG001|Overall Study|Lost to Follow-up|0|||
33494639|NCT00764881|101702452|FG000|Overall Study|Noncompliant|1|||
33494640|NCT00764881|101702453|FG001|Overall Study|Noncompliant|0|||
33494641|NCT00764881|101702452|FG000|Overall Study|Accidentally discontinued study drug|1|||
33494642|NCT00764881|101702453|FG001|Overall Study|Accidentally discontinued study drug|0|||
33494643|NCT00764881|101702452|FG000|Overall Study|Wished to become pregnant|1|||
33494644|NCT00764881|101702453|FG001|Overall Study|Wished to become pregnant|0|||
33494645|NCT00764881|101702452|FG000|Overall Study|Carcinoma detected|1|||
33494646|NCT00764881|101702453|FG001|Overall Study|Carcinoma detected|0|||
33494647|NCT00764881|101702452|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
33494648|NCT00764881|101702453|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
33494649|NCT00764881|101702452|FG000|Overall Study|no treatment or no observation|2|||
33494650|NCT00764881|101702453|FG001|Overall Study|no treatment or no observation|2|||
33494651|NCT00459355|101702459|FG000|Overall Study|Subject no longer met inc criteria|20|||
33494652|NCT00459355|101702460|FG001|Overall Study|Subject no longer met inc criteria|18|||
33494653|NCT03866577|101702464|FG000|Overall Study|Protocol Violation|0|||
33494654|NCT03866577|101702465|FG001|Overall Study|Protocol Violation|0|||
33494655|NCT03866577|101702466|FG002|Overall Study|Protocol Violation|0|||
33494656|NCT03866577|101702467|FG003|Overall Study|Protocol Violation|0|||
33494657|NCT03866577|101702468|FG004|Overall Study|Protocol Violation|0|||
33494658|NCT03866577|101702469|FG005|Overall Study|Protocol Violation|0|||
33494659|NCT03866577|101702470|FG006|Overall Study|Protocol Violation|0|||
33494660|NCT03866577|101702471|FG007|Overall Study|Protocol Violation|0|||
33494661|NCT03866577|101702472|FG008|Overall Study|Protocol Violation|0|||
33494662|NCT03866577|101702473|FG009|Overall Study|Protocol Violation|0|||
33494663|NCT03866577|101702474|FG010|Overall Study|Protocol Violation|0|||
33494664|NCT03866577|101702475|FG011|Overall Study|Protocol Violation|1|||
33494665|NCT03866577|101702476|FG012|Overall Study|Protocol Violation|0|||
33494666|NCT03866577|101702464|FG000|Overall Study|Withdrawal by Subject|0|||
33494667|NCT03866577|101702465|FG001|Overall Study|Withdrawal by Subject|0|||
33494668|NCT03866577|101702466|FG002|Overall Study|Withdrawal by Subject|0|||
33494669|NCT03866577|101702467|FG003|Overall Study|Withdrawal by Subject|0|||
33494670|NCT03866577|101702468|FG004|Overall Study|Withdrawal by Subject|0|||
33494671|NCT03866577|101702469|FG005|Overall Study|Withdrawal by Subject|0|||
33494672|NCT03866577|101702470|FG006|Overall Study|Withdrawal by Subject|0|||
33494673|NCT03866577|101702471|FG007|Overall Study|Withdrawal by Subject|0|||
33494674|NCT03866577|101702472|FG008|Overall Study|Withdrawal by Subject|1|||
33494675|NCT03866577|101702473|FG009|Overall Study|Withdrawal by Subject|1|||
33494676|NCT03866577|101702474|FG010|Overall Study|Withdrawal by Subject|0|||
33494677|NCT03866577|101702475|FG011|Overall Study|Withdrawal by Subject|0|||
33494678|NCT03866577|101702476|FG012|Overall Study|Withdrawal by Subject|0|||
33494679|NCT03866577|101702464|FG000|Overall Study|Not qualified for IVIg infusion|0|||
33494680|NCT03866577|101702465|FG001|Overall Study|Not qualified for IVIg infusion|0|||
33494681|NCT03866577|101702466|FG002|Overall Study|Not qualified for IVIg infusion|0|||
33494682|NCT03866577|101702467|FG003|Overall Study|Not qualified for IVIg infusion|0|||
33494683|NCT03866577|101702468|FG004|Overall Study|Not qualified for IVIg infusion|0|||
33186040|NCT02658890|100590609|FG008|Treatment Phase|Lost to Follow-up|0|||
33390155|NCT04731922|101317661|FG001|Overall Study|Other|0|||
33390156|NCT04731922|101317662|FG002|Overall Study|Other|0|||
33494684|NCT03866577|101702469|FG005|Overall Study|Not qualified for IVIg infusion|0|||
33494685|NCT03866577|101702470|FG006|Overall Study|Not qualified for IVIg infusion|0|||
33494686|NCT03866577|101702471|FG007|Overall Study|Not qualified for IVIg infusion|0|||
33494687|NCT03866577|101702472|FG008|Overall Study|Not qualified for IVIg infusion|0|||
33494688|NCT03866577|101702473|FG009|Overall Study|Not qualified for IVIg infusion|1|||
33494689|NCT03866577|101702474|FG010|Overall Study|Not qualified for IVIg infusion|0|||
33494690|NCT03866577|101702475|FG011|Overall Study|Not qualified for IVIg infusion|0|||
33494691|NCT03866577|101702476|FG012|Overall Study|Not qualified for IVIg infusion|0|||
33494692|NCT00987337|101702477|FG000|Overall Study|Adverse Event|10|||
33494693|NCT00987337|101702478|FG001|Overall Study|Adverse Event|9|||
33494694|NCT00987337|101702479|FG002|Overall Study|Adverse Event|8|||
33494695|NCT00987337|101702477|FG000|Overall Study|Insufficient Virologic Response|10|||
33494696|NCT00987337|101702478|FG001|Overall Study|Insufficient Virologic Response|7|||
33494697|NCT00987337|101702479|FG002|Overall Study|Insufficient Virologic Response|12|||
33494698|NCT00987337|101702477|FG000|Overall Study|Virologic Breakthrough|2|||
33494699|NCT00987337|101702478|FG001|Overall Study|Virologic Breakthrough|2|||
33494700|NCT00987337|101702479|FG002|Overall Study|Virologic Breakthrough|8|||
33494701|NCT00987337|101702477|FG000|Overall Study|Lost to Follow-up|10|||
33494702|NCT00987337|101702478|FG001|Overall Study|Lost to Follow-up|6|||
33494703|NCT00987337|101702479|FG002|Overall Study|Lost to Follow-up|2|||
33494704|NCT00987337|101702477|FG000|Overall Study|Withdrawal by Subject|6|||
33494705|NCT00987337|101702478|FG001|Overall Study|Withdrawal by Subject|9|||
33494706|NCT00987337|101702479|FG002|Overall Study|Withdrawal by Subject|9|||
33494707|NCT00987337|101702477|FG000|Overall Study|Other|0|||
33494708|NCT00987337|101702478|FG001|Overall Study|Other|2|||
33494709|NCT00987337|101702479|FG002|Overall Study|Other|5|||
33494710|NCT00987337|101702477|FG000|Overall Study|Protocol Violation|1|||
33494711|NCT00987337|101702478|FG001|Overall Study|Protocol Violation|0|||
33494712|NCT00987337|101702479|FG002|Overall Study|Protocol Violation|2|||
33494713|NCT00987337|101702477|FG000|Overall Study|Participant Relapsed|18|||
33494714|NCT00987337|101702478|FG001|Overall Study|Participant Relapsed|20|||
33494715|NCT00987337|101702479|FG002|Overall Study|Participant Relapsed|5|||
33494716|NCT00129389|101702480|FG000|Overall Study|Adverse Event|19|||
33494717|NCT00129389|101702481|FG001|Overall Study|Adverse Event|87|||
33494718|NCT00129389|101702480|FG000|Overall Study|Death|0|||
33494719|NCT00129389|101702481|FG001|Overall Study|Death|1|||
33494720|NCT00129389|101702480|FG000|Overall Study|Lost to Follow-up|2|||
33494721|NCT00129389|101702481|FG001|Overall Study|Lost to Follow-up|1|||
33494722|NCT00129389|101702480|FG000|Overall Study|Physician Decision|0|||
33494723|NCT00129389|101702481|FG001|Overall Study|Physician Decision|4|||
33494724|NCT00129389|101702480|FG000|Overall Study|Protocol Violation|0|||
33494725|NCT00129389|101702481|FG001|Overall Study|Protocol Violation|6|||
33494726|NCT00129389|101702480|FG000|Overall Study|Withdrawal by Subject|9|||
33494727|NCT00129389|101702481|FG001|Overall Study|Withdrawal by Subject|23|||
33494728|NCT00129389|101702480|FG000|Overall Study|Relapse|1|||
33494729|NCT00129389|101702481|FG001|Overall Study|Relapse|0|||
33494730|NCT00129389|101702480|FG000|Overall Study|Not eligible|1|||
33494731|NCT00129389|101702481|FG001|Overall Study|Not eligible|2|||
33494732|NCT00129389|101702480|FG000|Overall Study|Crossed to the other arm|1|||
33494733|NCT00129389|101702481|FG001|Overall Study|Crossed to the other arm|16|||
33494734|NCT01431079|101702485|FG000|Overall Study|Lost to Follow-up|35|||
33494735|NCT01431079|101702486|FG001|Overall Study|Lost to Follow-up|39|||
33494736|NCT02090725|101702490|FG000|Overall Study|Withdrawal by Subject|1|||
33494737|NCT02090725|101702490|FG000|Overall Study|participants moved from area|3|||
33494738|NCT03055624|101702492|FG000|Overall Study|Study closed|9|||
33494739|NCT03627546|101702494|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
33494740|NCT03627546|101702495|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
33494741|NCT03627546|101702496|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
33494742|NCT03627546|101702494|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
33494743|NCT03627546|101702495|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
33494744|NCT03627546|101702496|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
33494745|NCT03640312|101702497|FG000|Overall Study|Lost to Follow-up|3|||
33494746|NCT03640312|101702498|FG001|Overall Study|Lost to Follow-up|6|||
33494747|NCT01487525|101702499|FG000|Overall Study|Withdrawal by Subject|0|||
33494748|NCT01487525|101702500|FG001|Overall Study|Withdrawal by Subject|1|||
33494749|NCT00897715|101702502|FG000|Overall Study|Lost to Follow-up|0|||
33494750|NCT00897715|101702503|FG001|Overall Study|Lost to Follow-up|1|||
33494751|NCT00897715|101702502|FG000|Overall Study|Physician Decision|1|||
33494752|NCT00897715|101702503|FG001|Overall Study|Physician Decision|0|||
33494753|NCT00897715|101702502|FG000|Overall Study|increased risk of infection|1|||
33494754|NCT00897715|101702503|FG001|Overall Study|increased risk of infection|0|||
33494755|NCT01622673|101702504|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33494756|NCT01622673|101702505|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33494757|NCT01622673|101702506|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33494758|NCT01622673|101702507|FG003|Treatment Period 1|Withdrawal by Subject|1|||
33494759|NCT01622673|101702508|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33494760|NCT01622673|101702509|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33494761|NCT01622673|101702504|FG000|Treatment Period 1|Protocol Violation|0|||
33494762|NCT01622673|101702505|FG001|Treatment Period 1|Protocol Violation|1|||
33186041|NCT02658890|100590610|FG009|Treatment Phase|Lost to Follow-up|0|||
33186042|NCT02658890|100590611|FG010|Treatment Phase|Lost to Follow-up|0|||
33186043|NCT02658890|100590612|FG011|Treatment Phase|Lost to Follow-up|0|||
33494763|NCT01622673|101702506|FG002|Treatment Period 1|Protocol Violation|0|||
33494764|NCT01622673|101702507|FG003|Treatment Period 1|Protocol Violation|0|||
33494765|NCT01622673|101702508|FG004|Treatment Period 1|Protocol Violation|0|||
33494766|NCT01622673|101702509|FG005|Treatment Period 1|Protocol Violation|0|||
33494767|NCT01622673|101702504|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33494768|NCT01622673|101702505|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33494769|NCT01622673|101702506|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33494770|NCT01622673|101702507|FG003|Treatment Period 2|Withdrawal by Subject|1|||
33494771|NCT01622673|101702508|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33494772|NCT01622673|101702509|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33494773|NCT01622673|101702504|FG000|Treatment Period 3|Protocol Violation|0|||
33494774|NCT01622673|101702505|FG001|Treatment Period 3|Protocol Violation|1|||
33494775|NCT01622673|101702506|FG002|Treatment Period 3|Protocol Violation|0|||
33494776|NCT01622673|101702507|FG003|Treatment Period 3|Protocol Violation|0|||
33494777|NCT01622673|101702508|FG004|Treatment Period 3|Protocol Violation|0|||
33494778|NCT01622673|101702509|FG005|Treatment Period 3|Protocol Violation|0|||
33494779|NCT01207687|101702519|FG000|Overall Study|Adverse Event|1|||
33494780|NCT01207687|101702519|FG000|Overall Study|Withdrawal by Subject|1|||
33494781|NCT02656303|101702520|FG000|Overall Study|Adverse Event|3|||
33494782|NCT02656303|101702521|FG001|Overall Study|Adverse Event|2|||
33494783|NCT02656303|101702522|FG002|Overall Study|Adverse Event|0|||
33494784|NCT02656303|101702520|FG000|Overall Study|Death|12|||
33494785|NCT02656303|101702521|FG001|Overall Study|Death|4|||
33494786|NCT02656303|101702522|FG002|Overall Study|Death|1|||
33494787|NCT02656303|101702520|FG000|Overall Study|Lack of Efficacy|1|||
33494788|NCT02656303|101702521|FG001|Overall Study|Lack of Efficacy|0|||
33494789|NCT02656303|101702522|FG002|Overall Study|Lack of Efficacy|0|||
33494790|NCT02656303|101702520|FG000|Overall Study|Non-Compliance with Study|1|||
33494791|NCT02656303|101702521|FG001|Overall Study|Non-Compliance with Study|1|||
33494792|NCT02656303|101702522|FG002|Overall Study|Non-Compliance with Study|0|||
33494793|NCT02656303|101702520|FG000|Overall Study|Investigator Decision|2|||
33494794|NCT02656303|101702521|FG001|Overall Study|Investigator Decision|1|||
33494795|NCT02656303|101702522|FG002|Overall Study|Investigator Decision|0|||
33494796|NCT02656303|101702520|FG000|Overall Study|Progressive Disease|25|||
33494797|NCT02656303|101702521|FG001|Overall Study|Progressive Disease|14|||
33494798|NCT02656303|101702522|FG002|Overall Study|Progressive Disease|10|||
33494799|NCT02656303|101702520|FG000|Overall Study|Study Terminated by Sponsor|20|||
33494800|NCT02656303|101702521|FG001|Overall Study|Study Terminated by Sponsor|7|||
33494801|NCT02656303|101702522|FG002|Overall Study|Study Terminated by Sponsor|5|||
33494802|NCT02656303|101702520|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
33494803|NCT02656303|101702521|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
33494804|NCT02656303|101702522|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
33494805|NCT02656303|101702520|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
33494806|NCT02656303|101702521|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
33494807|NCT02656303|101702522|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
33494808|NCT02656303|101702520|FG000|Overall Study|Reason not Specified|1|||
33494809|NCT02656303|101702521|FG001|Overall Study|Reason not Specified|1|||
33494810|NCT02656303|101702522|FG002|Overall Study|Reason not Specified|2|||
33494811|NCT01149863|101702523|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
33494812|NCT03859427|101702524|FG000|Overall Study|Withdrawal by Subject|4|||
33494813|NCT03859427|101702525|FG001|Overall Study|Withdrawal by Subject|7|||
33494814|NCT03859427|101702524|FG000|Overall Study|Decision by sponsor|0|||
33494815|NCT03859427|101702525|FG001|Overall Study|Decision by sponsor|3|||
33494816|NCT03859427|101702524|FG000|Overall Study|Lost to Follow-up|3|||
33494817|NCT03859427|101702525|FG001|Overall Study|Lost to Follow-up|2|||
33494818|NCT03859427|101702524|FG000|Overall Study|Death|22|||
33494819|NCT03859427|101702525|FG001|Overall Study|Death|25|||
33494820|NCT01709500|101702526|FG000|Overall Study|Randomized but not treated|0|||
33494821|NCT01709500|101702527|FG001|Overall Study|Randomized but not treated|1|||
33494822|NCT01709500|101702526|FG000|Overall Study|Adverse Event|5|||
33494823|NCT01709500|101702527|FG001|Overall Study|Adverse Event|1|||
33494824|NCT01709500|101702526|FG000|Overall Study|Poor compliance to protocol|2|||
33494825|NCT01709500|101702527|FG001|Overall Study|Poor compliance to protocol|1|||
33494826|NCT01709500|101702526|FG000|Overall Study|Other|3|||
33494827|NCT01709500|101702527|FG001|Overall Study|Other|1|||
33494828|NCT01709500|101702526|FG000|Overall Study|Related to IMP administration|1|||
33494829|NCT01709500|101702527|FG001|Overall Study|Related to IMP administration|0|||
33494830|NCT01709500|101702526|FG000|Overall Study|Treatment ongoing|156|||
33494831|NCT01709500|101702527|FG001|Overall Study|Treatment ongoing|78|||
33494832|NCT04176250|101702528|FG000|Overall Study|Adverse Event|0|||
33494833|NCT04176250|101702529|FG001|Overall Study|Adverse Event|1|||
33494834|NCT04176250|101702530|FG002|Overall Study|Adverse Event|0|||
33494835|NCT04176250|101702531|FG003|Overall Study|Adverse Event|1|||
33494836|NCT04176250|101702532|FG004|Overall Study|Adverse Event|0|||
33494837|NCT04176250|101702533|FG005|Overall Study|Adverse Event|1|||
33494838|NCT04176250|101702528|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
33494839|NCT04176250|101702529|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
33494840|NCT04176250|101702530|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
33494841|NCT04176250|101702531|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
33494842|NCT04176250|101702532|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
33494843|NCT04176250|101702533|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
33494844|NCT04176250|101702528|FG000|Overall Study|Withdrawal by Subject|0|||
33494845|NCT04176250|101702529|FG001|Overall Study|Withdrawal by Subject|0|||
33494846|NCT04176250|101702530|FG002|Overall Study|Withdrawal by Subject|0|||
33494847|NCT04176250|101702531|FG003|Overall Study|Withdrawal by Subject|0|||
33494848|NCT04176250|101702532|FG004|Overall Study|Withdrawal by Subject|0|||
33494849|NCT04176250|101702533|FG005|Overall Study|Withdrawal by Subject|1|||
33494850|NCT04176250|101702528|FG000|Overall Study|Randomized in error|0|||
33494851|NCT04176250|101702529|FG001|Overall Study|Randomized in error|0|||
33494852|NCT04176250|101702530|FG002|Overall Study|Randomized in error|0|||
33494853|NCT04176250|101702531|FG003|Overall Study|Randomized in error|0|||
33494854|NCT04176250|101702532|FG004|Overall Study|Randomized in error|1|||
33494855|NCT04176250|101702533|FG005|Overall Study|Randomized in error|0|||
33494856|NCT04495829|101702534|FG000|Overall Study|Lost to Follow-up|2|||
33494857|NCT04495829|101702534|FG000|Overall Study|Inclusion criterion not met|3|||
33494858|NCT01894919|101702535|FG000|Overall Study|Withdrawal by Subject|1|||
33494859|NCT01894919|101702536|FG001|Overall Study|Withdrawal by Subject|0|||
33494860|NCT01894919|101702537|FG002|Overall Study|Withdrawal by Subject|0|||
33494861|NCT01894919|101702538|FG003|Overall Study|Withdrawal by Subject|0|||
33494862|NCT01894919|101702539|FG004|Overall Study|Withdrawal by Subject|1|||
33494863|NCT01894919|101702540|FG005|Overall Study|Withdrawal by Subject|0|||
33494864|NCT01894919|101702541|FG006|Overall Study|Withdrawal by Subject|0|||
33494865|NCT01894919|101702542|FG007|Overall Study|Withdrawal by Subject|0|||
33494866|NCT01894919|101702543|FG008|Overall Study|Withdrawal by Subject|0|||
33494867|NCT01894919|101702544|FG009|Overall Study|Withdrawal by Subject|1|||
33494868|NCT01894919|101702545|FG010|Overall Study|Withdrawal by Subject|1|||
33494869|NCT01894919|101702546|FG011|Overall Study|Withdrawal by Subject|0|||
33494870|NCT01894919|101702547|FG012|Overall Study|Withdrawal by Subject|0|||
33494871|NCT01894919|101702535|FG000|Overall Study|Adverse Event|0|||
33494872|NCT01894919|101702536|FG001|Overall Study|Adverse Event|0|||
33494873|NCT01894919|101702537|FG002|Overall Study|Adverse Event|0|||
33494874|NCT01894919|101702538|FG003|Overall Study|Adverse Event|0|||
33494875|NCT01894919|101702539|FG004|Overall Study|Adverse Event|0|||
33494876|NCT01894919|101702540|FG005|Overall Study|Adverse Event|0|||
33494877|NCT01894919|101702541|FG006|Overall Study|Adverse Event|0|||
33494878|NCT01894919|101702542|FG007|Overall Study|Adverse Event|0|||
33494879|NCT01894919|101702543|FG008|Overall Study|Adverse Event|0|||
33494880|NCT01894919|101702544|FG009|Overall Study|Adverse Event|0|||
33494881|NCT01894919|101702545|FG010|Overall Study|Adverse Event|1|||
33494882|NCT01894919|101702546|FG011|Overall Study|Adverse Event|0|||
33494883|NCT01894919|101702547|FG012|Overall Study|Adverse Event|0|||
33494884|NCT01894919|101702535|FG000|Overall Study|Other-Unspecified|1|||
33494885|NCT01894919|101702536|FG001|Overall Study|Other-Unspecified|0|||
33494886|NCT01894919|101702537|FG002|Overall Study|Other-Unspecified|0|||
33494887|NCT01894919|101702538|FG003|Overall Study|Other-Unspecified|0|||
33494888|NCT01894919|101702539|FG004|Overall Study|Other-Unspecified|0|||
33494889|NCT01894919|101702540|FG005|Overall Study|Other-Unspecified|0|||
33494890|NCT01894919|101702541|FG006|Overall Study|Other-Unspecified|0|||
33494891|NCT01894919|101702542|FG007|Overall Study|Other-Unspecified|0|||
33494892|NCT01894919|101702543|FG008|Overall Study|Other-Unspecified|0|||
33494893|NCT01894919|101702544|FG009|Overall Study|Other-Unspecified|0|||
33494894|NCT01894919|101702545|FG010|Overall Study|Other-Unspecified|0|||
33494895|NCT01894919|101702546|FG011|Overall Study|Other-Unspecified|0|||
33494896|NCT01894919|101702547|FG012|Overall Study|Other-Unspecified|0|||
33494897|NCT01894919|101702535|FG000|Overall Study|Lost to Follow-up|0|||
33494898|NCT01894919|101702536|FG001|Overall Study|Lost to Follow-up|0|||
33494899|NCT01894919|101702537|FG002|Overall Study|Lost to Follow-up|0|||
33494900|NCT01894919|101702538|FG003|Overall Study|Lost to Follow-up|0|||
33494901|NCT01894919|101702539|FG004|Overall Study|Lost to Follow-up|2|||
33494902|NCT01894919|101702540|FG005|Overall Study|Lost to Follow-up|0|||
33594560|NCT01133405|102065020|FG009|Period 1|Withdrawal by Subject|0|||
33390157|NCT04731922|101317663|FG003|Overall Study|Other|0|||
33390158|NCT04731922|101317664|FG004|Overall Study|Other|0|||
33594561|NCT01133405|102065011|FG000|Period 1|Physician Decision|0|||
33594562|NCT01133405|102065012|FG001|Period 1|Physician Decision|0|||
33594563|NCT01133405|102065013|FG002|Period 1|Physician Decision|0|||
33594564|NCT01133405|102065014|FG003|Period 1|Physician Decision|1|||
33594565|NCT01133405|102065015|FG004|Period 1|Physician Decision|0|||
33494903|NCT01894919|101702541|FG006|Overall Study|Lost to Follow-up|0|||
33494904|NCT01894919|101702542|FG007|Overall Study|Lost to Follow-up|0|||
33494905|NCT01894919|101702543|FG008|Overall Study|Lost to Follow-up|0|||
33494906|NCT01894919|101702544|FG009|Overall Study|Lost to Follow-up|0|||
33494907|NCT01894919|101702545|FG010|Overall Study|Lost to Follow-up|0|||
33494908|NCT01894919|101702546|FG011|Overall Study|Lost to Follow-up|0|||
33494909|NCT01894919|101702547|FG012|Overall Study|Lost to Follow-up|0|||
33494910|NCT00720213|101702550|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
33494911|NCT00720213|101702551|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
33494912|NCT00720213|101702552|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
33494913|NCT02070965|101702554|FG000|Overall Study|Lost to Follow-up|0|||
33494914|NCT02070965|101702555|FG001|Overall Study|Lost to Follow-up|1|||
33494915|NCT02070965|101702556|FG002|Overall Study|Lost to Follow-up|0|||
33494916|NCT02070965|101702554|FG000|Overall Study|Withdrawal by Subject|1|||
33186044|NCT02658890|100590613|FG012|Treatment Phase|Lost to Follow-up|0|||
33186045|NCT02658890|100590614|FG013|Treatment Phase|Lost to Follow-up|0|||
33494917|NCT02070965|101702555|FG001|Overall Study|Withdrawal by Subject|1|||
33494918|NCT02070965|101702556|FG002|Overall Study|Withdrawal by Subject|1|||
33494919|NCT02070965|101702554|FG000|Overall Study|Subject moved|1|||
33494920|NCT02070965|101702555|FG001|Overall Study|Subject moved|0|||
33494921|NCT02070965|101702556|FG002|Overall Study|Subject moved|0|||
33494922|NCT01863667|101702557|FG000|Overall Study|Adverse Event|1|||
33494923|NCT01863667|101702558|FG001|Overall Study|Adverse Event|0|||
33494924|NCT01863667|101702557|FG000|Overall Study|Study terminated by Sponsor|30|||
33494925|NCT01863667|101702558|FG001|Overall Study|Study terminated by Sponsor|30|||
33494926|NCT01863667|101702557|FG000|Overall Study|Withdrawal by Subject|2|||
33494927|NCT01863667|101702558|FG001|Overall Study|Withdrawal by Subject|2|||
33494928|NCT03591874|101705843|FG000|Overall Study|Adverse Event|4|||
33494929|NCT03591874|101705844|FG001|Overall Study|Adverse Event|0|||
33494930|NCT03591874|101705843|FG000|Overall Study|Withdrawal by Subject|2|||
33494931|NCT03591874|101705844|FG001|Overall Study|Withdrawal by Subject|1|||
33494932|NCT03591874|101705843|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
33494933|NCT03591874|101705844|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
33494934|NCT03591874|101705843|FG000|Overall Study|On Study at Time of Study Termination|12|||
33494935|NCT03591874|101705844|FG001|Overall Study|On Study at Time of Study Termination|6|||
33494936|NCT02515331|101705845|FG000|Overall Study|Withdrawal by Subject|0|||
33494937|NCT02515331|101705846|FG001|Overall Study|Withdrawal by Subject|0|||
33494938|NCT02515331|101705847|FG002|Overall Study|Withdrawal by Subject|1|||
33494939|NCT02515331|101705845|FG000|Overall Study|Protocol deviation|0|||
33494940|NCT02515331|101705846|FG001|Overall Study|Protocol deviation|0|||
33494941|NCT02515331|101705847|FG002|Overall Study|Protocol deviation|3|||
33494942|NCT02515331|101705845|FG000|Overall Study|Adverse Event|2|||
33594566|NCT01133405|102065016|FG005|Period 1|Physician Decision|0|||
33594567|NCT01133405|102065017|FG006|Period 1|Physician Decision|0|||
33594568|NCT01133405|102065018|FG007|Period 1|Physician Decision|0|||
33594569|NCT01133405|102065019|FG008|Period 1|Physician Decision|0|||
33594570|NCT01133405|102065020|FG009|Period 1|Physician Decision|0|||
33594571|NCT01133405|102065011|FG000|Period 1|Discontinued after randomization|1|||
33594572|NCT01133405|102065012|FG001|Period 1|Discontinued after randomization|0|||
33494943|NCT02515331|101705846|FG001|Overall Study|Adverse Event|0|||
33594573|NCT01133405|102065013|FG002|Period 1|Discontinued after randomization|0|||
33594574|NCT01133405|102065014|FG003|Period 1|Discontinued after randomization|0|||
33594575|NCT01133405|102065015|FG004|Period 1|Discontinued after randomization|0|||
33594576|NCT01133405|102065016|FG005|Period 1|Discontinued after randomization|0|||
33594577|NCT01133405|102065017|FG006|Period 1|Discontinued after randomization|1|||
33594578|NCT01133405|102065018|FG007|Period 1|Discontinued after randomization|0|||
33594579|NCT01133405|102065019|FG008|Period 1|Discontinued after randomization|0|||
33594580|NCT01133405|102065020|FG009|Period 1|Discontinued after randomization|0|||
33594581|NCT01133405|102065011|FG000|Period 1|Received drug only in period 2|0|||
33594582|NCT01133405|102065012|FG001|Period 1|Received drug only in period 2|1|||
33594583|NCT01133405|102065013|FG002|Period 1|Received drug only in period 2|0|||
33594584|NCT01133405|102065014|FG003|Period 1|Received drug only in period 2|2|||
33594585|NCT01133405|102065015|FG004|Period 1|Received drug only in period 2|0|||
33594586|NCT01133405|102065016|FG005|Period 1|Received drug only in period 2|1|||
33594587|NCT01133405|102065017|FG006|Period 1|Received drug only in period 2|0|||
33594588|NCT01133405|102065018|FG007|Period 1|Received drug only in period 2|0|||
33594589|NCT01133405|102065019|FG008|Period 1|Received drug only in period 2|0|||
33594590|NCT01133405|102065020|FG009|Period 1|Received drug only in period 2|0|||
33594591|NCT01133405|102065011|FG000|Period 1|Received drug only in period 3|0|||
33594592|NCT01133405|102065012|FG001|Period 1|Received drug only in period 3|1|||
33594593|NCT01133405|102065013|FG002|Period 1|Received drug only in period 3|1|||
33594594|NCT01133405|102065014|FG003|Period 1|Received drug only in period 3|0|||
33594595|NCT01133405|102065015|FG004|Period 1|Received drug only in period 3|0|||
33594596|NCT01133405|102065016|FG005|Period 1|Received drug only in period 3|0|||
33594597|NCT01133405|102065017|FG006|Period 1|Received drug only in period 3|0|||
33594598|NCT01133405|102065018|FG007|Period 1|Received drug only in period 3|0|||
33594599|NCT01133405|102065019|FG008|Period 1|Received drug only in period 3|0|||
33594600|NCT01133405|102065020|FG009|Period 1|Received drug only in period 3|0|||
33594601|NCT01133405|102065011|FG000|Period 2|Adverse Event|0|||
33594602|NCT01133405|102065012|FG001|Period 2|Adverse Event|0|||
33594603|NCT01133405|102065013|FG002|Period 2|Adverse Event|1|||
33594604|NCT01133405|102065014|FG003|Period 2|Adverse Event|0|||
33594605|NCT01133405|102065015|FG004|Period 2|Adverse Event|0|||
33594606|NCT01133405|102065016|FG005|Period 2|Adverse Event|0|||
33594607|NCT01133405|102065017|FG006|Period 2|Adverse Event|0|||
33594608|NCT01133405|102065018|FG007|Period 2|Adverse Event|0|||
33594609|NCT01133405|102065019|FG008|Period 2|Adverse Event|0|||
33594610|NCT01133405|102065020|FG009|Period 2|Adverse Event|0|||
33594611|NCT01133405|102065011|FG000|Period 2|Withdrawal by Subject|0|||
33594612|NCT01133405|102065012|FG001|Period 2|Withdrawal by Subject|0|||
33594613|NCT01133405|102065013|FG002|Period 2|Withdrawal by Subject|0|||
33594614|NCT01133405|102065014|FG003|Period 2|Withdrawal by Subject|1|||
33594615|NCT01133405|102065015|FG004|Period 2|Withdrawal by Subject|0|||
33594616|NCT01133405|102065016|FG005|Period 2|Withdrawal by Subject|1|||
33594617|NCT01133405|102065017|FG006|Period 2|Withdrawal by Subject|0|||
33594618|NCT01133405|102065018|FG007|Period 2|Withdrawal by Subject|0|||
33594619|NCT01133405|102065019|FG008|Period 2|Withdrawal by Subject|0|||
33594620|NCT01133405|102065020|FG009|Period 2|Withdrawal by Subject|0|||
33594621|NCT01133405|102065011|FG000|Period 2|Entry Criteria Not Met|0|||
33594622|NCT01133405|102065012|FG001|Period 2|Entry Criteria Not Met|1|||
33594623|NCT01133405|102065013|FG002|Period 2|Entry Criteria Not Met|0|||
33594624|NCT01133405|102065014|FG003|Period 2|Entry Criteria Not Met|0|||
33594625|NCT01133405|102065015|FG004|Period 2|Entry Criteria Not Met|0|||
33186046|NCT02658890|100590615|FG014|Treatment Phase|Lost to Follow-up|0|||
33186047|NCT02658890|100590616|FG015|Treatment Phase|Lost to Follow-up|0|||
33186048|NCT02658890|100590617|FG016|Treatment Phase|Lost to Follow-up|0|||
33186049|NCT02658890|100590618|FG017|Treatment Phase|Lost to Follow-up|0|||
33186050|NCT02658890|100590619|FG018|Treatment Phase|Lost to Follow-up|0|||
33186051|NCT02658890|100590620|FG019|Treatment Phase|Lost to Follow-up|0|||
33186052|NCT02658890|100590621|FG020|Treatment Phase|Lost to Follow-up|0|||
33186053|NCT02658890|100590622|FG021|Treatment Phase|Lost to Follow-up|0|||
33186054|NCT02658890|100590623|FG022|Treatment Phase|Lost to Follow-up|0|||
33186055|NCT02658890|100590624|FG023|Treatment Phase|Lost to Follow-up|0|||
33186056|NCT02658890|100590625|FG024|Treatment Phase|Lost to Follow-up|0|||
33186057|NCT02658890|100590626|FG025|Treatment Phase|Lost to Follow-up|0|||
33186058|NCT02658890|100590627|FG026|Treatment Phase|Lost to Follow-up|0|||
33186059|NCT02658890|100590601|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
33186060|NCT02658890|100590602|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
33186061|NCT02658890|100590603|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
33594626|NCT01133405|102065016|FG005|Period 2|Entry Criteria Not Met|0|||
33594627|NCT01133405|102065017|FG006|Period 2|Entry Criteria Not Met|0|||
33594628|NCT01133405|102065018|FG007|Period 2|Entry Criteria Not Met|0|||
33594629|NCT01133405|102065019|FG008|Period 2|Entry Criteria Not Met|0|||
33594630|NCT01133405|102065020|FG009|Period 2|Entry Criteria Not Met|0|||
33594631|NCT01133405|102065011|FG000|Period 2|Physician Decision|0|||
33594632|NCT01133405|102065012|FG001|Period 2|Physician Decision|0|||
33594633|NCT01133405|102065013|FG002|Period 2|Physician Decision|0|||
33594634|NCT01133405|102065014|FG003|Period 2|Physician Decision|0|||
33594635|NCT01133405|102065015|FG004|Period 2|Physician Decision|0|||
33594636|NCT01133405|102065016|FG005|Period 2|Physician Decision|1|||
33594637|NCT01133405|102065017|FG006|Period 2|Physician Decision|0|||
33594638|NCT01133405|102065018|FG007|Period 2|Physician Decision|0|||
33594639|NCT01133405|102065019|FG008|Period 2|Physician Decision|0|||
33594640|NCT01133405|102065020|FG009|Period 2|Physician Decision|0|||
33594641|NCT01973387|102065021|FG000|Overall Study|Adverse Event|14|||
33594642|NCT01973387|102065022|FG001|Overall Study|Adverse Event|4|||
33594643|NCT01973387|102065021|FG000|Overall Study|Withdrawal by Subject|7|||
33594644|NCT01973387|102065022|FG001|Overall Study|Withdrawal by Subject|4|||
33594645|NCT01973387|102065021|FG000|Overall Study|Study terminated by sponsor|63|||
33594646|NCT01973387|102065022|FG001|Overall Study|Study terminated by sponsor|0|||
33594647|NCT01973387|102065021|FG000|Overall Study|Progressive disease or relapse|16|||
33594648|NCT01973387|102065022|FG001|Overall Study|Progressive disease or relapse|5|||
33594649|NCT01973387|102065021|FG000|Overall Study|Death|4|||
33594650|NCT01973387|102065022|FG001|Overall Study|Death|3|||
33594651|NCT01973387|102065021|FG000|Overall Study|Randomized, not treated|2|||
33594652|NCT01973387|102065022|FG001|Overall Study|Randomized, not treated|2|||
33594653|NCT04417218|102065023|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
33594654|NCT04417218|102065024|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
33594655|NCT01566695|102065026|FG000|Overall Study|Lack of Efficacy|18|||
33594656|NCT01566695|102065027|FG001|Overall Study|Lack of Efficacy|45|||
33594657|NCT01566695|102065026|FG000|Overall Study|Adverse Event|28|||
33594658|NCT01566695|102065027|FG001|Overall Study|Adverse Event|27|||
33594659|NCT01566695|102065026|FG000|Overall Study|Death|20|||
33186062|NCT02658890|100590604|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
33186063|NCT02658890|100590605|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
33186064|NCT02658890|100590606|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
33186065|NCT02658890|100590607|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
33594660|NCT01566695|102065027|FG001|Overall Study|Death|8|||
33594661|NCT01566695|102065026|FG000|Overall Study|Withdrawal by Subject|14|||
33594662|NCT01566695|102065027|FG001|Overall Study|Withdrawal by Subject|7|||
33594663|NCT01566695|102065026|FG000|Overall Study|Progressive Disease|11|||
33594664|NCT01566695|102065027|FG001|Overall Study|Progressive Disease|6|||
33594665|NCT01566695|102065026|FG000|Overall Study|Miscellaneous|4|||
33594666|NCT01566695|102065027|FG001|Overall Study|Miscellaneous|6|||
33594667|NCT03392883|102065028|FG000|Overall Study|Lost to Follow-up|122|||
33594668|NCT03392883|102065029|FG001|Overall Study|Lost to Follow-up|13|||
33594669|NCT03392883|102065030|FG002|Overall Study|Lost to Follow-up|9|||
33594670|NCT03392883|102065028|FG000|Overall Study|Death|4|||
33594671|NCT03392883|102065029|FG001|Overall Study|Death|0|||
33594672|NCT03392883|102065030|FG002|Overall Study|Death|0|||
33594673|NCT03392883|102065028|FG000|Overall Study|Lack of Efficacy|29|||
33186066|NCT02658890|100590608|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
33594674|NCT03392883|102065029|FG001|Overall Study|Lack of Efficacy|0|||
33594675|NCT03392883|102065030|FG002|Overall Study|Lack of Efficacy|0|||
33594676|NCT03392883|102065028|FG000|Overall Study|Withdrawal by Subject|180|||
33594677|NCT03392883|102065029|FG001|Overall Study|Withdrawal by Subject|0|||
33594678|NCT03392883|102065030|FG002|Overall Study|Withdrawal by Subject|0|||
33594679|NCT03392883|102065028|FG000|Overall Study|Adverse Event|1|||
33594680|NCT03392883|102065029|FG001|Overall Study|Adverse Event|0|||
33594681|NCT03392883|102065030|FG002|Overall Study|Adverse Event|0|||
33594682|NCT01032291|102065031|FG000|Safety Lead-in|Adverse Event|1|||
33594683|NCT01032291|102065032|FG001|Safety Lead-in|Adverse Event|0|||
33594684|NCT01032291|102065033|FG002|Safety Lead-in|Adverse Event|0|||
33594685|NCT01032291|102065031|FG000|Safety Lead-in|Death|1|||
33594686|NCT01032291|102065032|FG001|Safety Lead-in|Death|0|||
33594687|NCT01032291|102065033|FG002|Safety Lead-in|Death|0|||
33594688|NCT01032291|102065031|FG000|Proof of Concept|Adverse Event|0|||
33594689|NCT01032291|102065032|FG001|Proof of Concept|Adverse Event|5|||
33594690|NCT01032291|102065033|FG002|Proof of Concept|Adverse Event|1|||
33594691|NCT01032291|102065031|FG000|Proof of Concept|Death|0|||
33594692|NCT01032291|102065032|FG001|Proof of Concept|Death|1|||
33594693|NCT01032291|102065033|FG002|Proof of Concept|Death|2|||
33594694|NCT01032291|102065031|FG000|Proof of Concept|Lack of Efficacy|0|||
33594695|NCT01032291|102065032|FG001|Proof of Concept|Lack of Efficacy|1|||
33594696|NCT01032291|102065033|FG002|Proof of Concept|Lack of Efficacy|0|||
33594697|NCT01032291|102065031|FG000|Proof of Concept|Never Received Study Drug|0|||
33594698|NCT01032291|102065032|FG001|Proof of Concept|Never Received Study Drug|1|||
33594699|NCT01032291|102065033|FG002|Proof of Concept|Never Received Study Drug|0|||
33594700|NCT03158012|102065036|FG000|Overall Study|Withdrawal by Subject|0|||
33594701|NCT03158012|102065037|FG001|Overall Study|Withdrawal by Subject|1|||
33594702|NCT01360398|102065038|FG000|Overall Study|Withdrawal by Subject|14|||
33594703|NCT01360398|102065038|FG000|Overall Study|Other|7|||
33594704|NCT01360398|102065038|FG000|Overall Study|Migrated/moved from study area|1|||
33594705|NCT03263923|102065042|FG000|Overall Study|Withdrawal by Subject|10|||
33594706|NCT03263923|102065043|FG001|Overall Study|Withdrawal by Subject|8|||
33594707|NCT03263923|102065042|FG000|Overall Study|Lost to Follow-up|15|||
33594708|NCT03263923|102065043|FG001|Overall Study|Lost to Follow-up|13|||
33594709|NCT02439450|102065044|FG000|Overall Study|Adverse Event|4|||
33594710|NCT02439450|102065045|FG001|Overall Study|Adverse Event|1|||
33594711|NCT02439450|102065046|FG002|Overall Study|Adverse Event|0|||
33594712|NCT02439450|102065047|FG003|Overall Study|Adverse Event|0|||
33594713|NCT02439450|102065044|FG000|Overall Study|Withdrawal by Subject|1|||
33594714|NCT02439450|102065045|FG001|Overall Study|Withdrawal by Subject|2|||
33594715|NCT02439450|102065046|FG002|Overall Study|Withdrawal by Subject|0|||
33594716|NCT02439450|102065047|FG003|Overall Study|Withdrawal by Subject|0|||
33594717|NCT02439450|102065044|FG000|Overall Study|Death|3|||
33594718|NCT02439450|102065045|FG001|Overall Study|Death|0|||
33594719|NCT02439450|102065046|FG002|Overall Study|Death|0|||
33594720|NCT02439450|102065047|FG003|Overall Study|Death|1|||
33594721|NCT02439450|102065044|FG000|Overall Study|Progressive Disease|18|||
33594722|NCT02439450|102065045|FG001|Overall Study|Progressive Disease|41|||
33594723|NCT02439450|102065046|FG002|Overall Study|Progressive Disease|2|||
33594724|NCT02439450|102065047|FG003|Overall Study|Progressive Disease|3|||
33594725|NCT02701777|102065049|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
33594726|NCT02701777|102065050|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
33594727|NCT02701777|102065051|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
33594728|NCT02701777|102065052|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
33594729|NCT02701777|102065049|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
33594730|NCT02701777|102065050|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
33594731|NCT02701777|102065051|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
33594732|NCT02701777|102065052|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
33594733|NCT03440918|102065053|FG000|Overall Study|Protocol Violation|0|||
33594734|NCT03440918|102065054|FG001|Overall Study|Protocol Violation|16|||
33186067|NCT02658890|100590609|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
33186068|NCT02658890|100590610|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
33186069|NCT02658890|100590611|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
33594735|NCT01559259|102065055|FG000|Overall Study|Withdrawal by Subject|0|||
33594736|NCT01559259|102065056|FG001|Overall Study|Withdrawal by Subject|0|||
33594737|NCT01559259|102065057|FG002|Overall Study|Withdrawal by Subject|0|||
33594738|NCT01559259|102065058|FG003|Overall Study|Withdrawal by Subject|1|||
33594739|NCT01559259|102065059|FG004|Overall Study|Withdrawal by Subject|0|||
33594740|NCT01559259|102065055|FG000|Overall Study|Adverse Event|0|||
33594741|NCT01559259|102065056|FG001|Overall Study|Adverse Event|1|||
33594742|NCT01559259|102065057|FG002|Overall Study|Adverse Event|1|||
33594743|NCT01559259|102065058|FG003|Overall Study|Adverse Event|0|||
33594744|NCT01559259|102065059|FG004|Overall Study|Adverse Event|0|||
33594745|NCT02099344|102065061|FG000|Overall Study|Physician Decision|1|||
33594746|NCT02099344|102065062|FG001|Overall Study|Physician Decision|0|||
33594747|NCT00923975|102065063|FG000|Overall Study|Did not meet inclusion criteria|1|||
33594748|NCT01166958|102065066|FG000|Overall Study|Withdrawal by Subject|1|||
33594749|NCT01166958|102065067|FG001|Overall Study|Withdrawal by Subject|0|||
33594750|NCT03640052|102065068|FG000|Overall Study|Lost to Follow-up|0|||
33594751|NCT03640052|102065069|FG001|Overall Study|Lost to Follow-up|1|||
33594752|NCT03640052|102065070|FG002|Overall Study|Lost to Follow-up|0|||
33594753|NCT03640052|102065071|FG003|Overall Study|Lost to Follow-up|0|||
33594754|NCT03640052|102065072|FG004|Overall Study|Lost to Follow-up|0|||
33594755|NCT02210221|102065073|FG000|Overall Study|Lack of Efficacy|7|||
33594756|NCT02210221|102065073|FG000|Overall Study|Withdrawal by Subject|43|||
33594757|NCT02242435|102065075|FG000|Overall Study|Lost to Follow-up|3|||
33594758|NCT02242435|102065076|FG001|Overall Study|Lost to Follow-up|4|||
33594759|NCT02242435|102065075|FG000|Overall Study|Adverse Event|3|||
33594760|NCT02242435|102065076|FG001|Overall Study|Adverse Event|2|||
33594761|NCT02242435|102065075|FG000|Overall Study|Withdrawal by Subject|13|||
33594762|NCT02242435|102065076|FG001|Overall Study|Withdrawal by Subject|8|||
33594763|NCT02242435|102065075|FG000|Overall Study|Death|0|||
33594764|NCT02242435|102065076|FG001|Overall Study|Death|1|||
33186070|NCT02658890|100590612|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
33186071|NCT02658890|100590613|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
33594765|NCT02242435|102065075|FG000|Overall Study|Protocol Violation|1|||
33594766|NCT02242435|102065076|FG001|Overall Study|Protocol Violation|0|||
33594767|NCT02242435|102065075|FG000|Overall Study|Physician Decision|0|||
33594768|NCT02242435|102065076|FG001|Overall Study|Physician Decision|1|||
33594769|NCT00457821|102065077|FG000|Part 2|Withdrawal by Subject|0|||
33594770|NCT00457821|102065078|FG001|Part 2|Withdrawal by Subject|0|||
33594771|NCT00457821|102065079|FG002|Part 2|Withdrawal by Subject|0|||
33594772|NCT00457821|102065080|FG003|Part 2|Withdrawal by Subject|0|||
33594773|NCT00457821|102065081|FG004|Part 2|Withdrawal by Subject|0|||
33594774|NCT00457821|102065082|FG005|Part 2|Withdrawal by Subject|0|||
33594775|NCT00457821|102065083|FG006|Part 2|Withdrawal by Subject|0|||
33594776|NCT00457821|102065084|FG007|Part 2|Withdrawal by Subject|1|||
33594777|NCT02763254|102065087|FG000|Overall Study|Adverse Event|1|||
33594778|NCT00549900|102065088|FG000|Overall Study|Adverse Event|1|||
33594779|NCT02264665|102065090|FG000|Overall Study|Other|0|||
33594780|NCT02264665|102065091|FG001|Overall Study|Other|0|||
33594781|NCT02264665|102065092|FG002|Overall Study|Other|3|||
33594782|NCT02264665|102065093|FG003|Overall Study|Other|0|||
33594783|NCT02264665|102065094|FG004|Overall Study|Other|0|||
33594784|NCT02264665|102065095|FG005|Overall Study|Other|0|||
33594785|NCT02264665|102065096|FG006|Overall Study|Other|0|||
33594786|NCT02264665|102065090|FG000|Overall Study|Death|9|||
33594787|NCT02264665|102065091|FG001|Overall Study|Death|8|||
33594788|NCT02264665|102065092|FG002|Overall Study|Death|13|||
33594789|NCT02264665|102065093|FG003|Overall Study|Death|5|||
33594790|NCT02264665|102065094|FG004|Overall Study|Death|0|||
33594791|NCT02264665|102065095|FG005|Overall Study|Death|0|||
33594792|NCT02264665|102065096|FG006|Overall Study|Death|1|||
33594793|NCT02264665|102065090|FG000|Overall Study|Lost to Follow-up|1|||
33594794|NCT02264665|102065091|FG001|Overall Study|Lost to Follow-up|0|||
33594795|NCT02264665|102065092|FG002|Overall Study|Lost to Follow-up|2|||
33594796|NCT02264665|102065093|FG003|Overall Study|Lost to Follow-up|1|||
33594797|NCT02264665|102065094|FG004|Overall Study|Lost to Follow-up|0|||
33594798|NCT02264665|102065095|FG005|Overall Study|Lost to Follow-up|0|||
33594799|NCT02264665|102065096|FG006|Overall Study|Lost to Follow-up|0|||
33594800|NCT02264665|102065090|FG000|Overall Study|Participant decision|0|||
33594801|NCT02264665|102065091|FG001|Overall Study|Participant decision|0|||
33594802|NCT02264665|102065092|FG002|Overall Study|Participant decision|0|||
33594803|NCT02264665|102065093|FG003|Overall Study|Participant decision|1|||
33186072|NCT02658890|100590614|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
33186073|NCT02658890|100590615|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
33186074|NCT02658890|100590616|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
33186075|NCT02658890|100590617|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
33594804|NCT02264665|102065094|FG004|Overall Study|Participant decision|0|||
33594805|NCT02264665|102065095|FG005|Overall Study|Participant decision|0|||
33594806|NCT02264665|102065096|FG006|Overall Study|Participant decision|0|||
33594807|NCT02264665|102065090|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
33594808|NCT02264665|102065091|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
33594809|NCT02264665|102065092|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
33594810|NCT02264665|102065093|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
33594811|NCT02264665|102065094|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
33594812|NCT02264665|102065095|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
33594813|NCT02264665|102065096|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
33594814|NCT02264665|102065090|FG000|Overall Study|Data Missing|0|||
33594815|NCT02264665|102065091|FG001|Overall Study|Data Missing|0|||
33594816|NCT02264665|102065092|FG002|Overall Study|Data Missing|1|||
33594817|NCT02264665|102065093|FG003|Overall Study|Data Missing|0|||
33594818|NCT02264665|102065094|FG004|Overall Study|Data Missing|0|||
33594819|NCT02264665|102065095|FG005|Overall Study|Data Missing|0|||
33594820|NCT02264665|102065096|FG006|Overall Study|Data Missing|0|||
33186076|NCT02658890|100590618|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
33186077|NCT02658890|100590619|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
33186078|NCT02658890|100590620|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
33186079|NCT02658890|100590621|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
33594821|NCT01740089|102065103|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
33594822|NCT01740089|102065104|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
33594823|NCT01740089|102065105|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
33594824|NCT01740089|102065103|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
33594825|NCT01740089|102065104|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
33594826|NCT01740089|102065105|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
33594827|NCT01740089|102065103|FG000|After 12 Weeks|Lack of Efficacy|3|||
33594828|NCT01740089|102065104|FG001|After 12 Weeks|Lack of Efficacy|1|||
33594829|NCT01740089|102065105|FG002|After 12 Weeks|Lack of Efficacy|4|||
33594830|NCT01740089|102065103|FG000|After 12 Weeks|Adverse Event|2|||
33594831|NCT01740089|102065104|FG001|After 12 Weeks|Adverse Event|0|||
33594832|NCT01740089|102065105|FG002|After 12 Weeks|Adverse Event|5|||
33594833|NCT01740089|102065103|FG000|After 12 Weeks|Protocol Violation|1|||
33594834|NCT01740089|102065104|FG001|After 12 Weeks|Protocol Violation|1|||
33594835|NCT01740089|102065105|FG002|After 12 Weeks|Protocol Violation|1|||
33594836|NCT01740089|102065103|FG000|After 12 Weeks|Withdrawal by Subject|1|||
33594837|NCT01740089|102065104|FG001|After 12 Weeks|Withdrawal by Subject|1|||
33594838|NCT01740089|102065105|FG002|After 12 Weeks|Withdrawal by Subject|1|||
33594839|NCT03447314|102065106|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
33594840|NCT03447314|102065107|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
33594841|NCT03447314|102065108|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
33594842|NCT03447314|102065109|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
33594843|NCT03447314|102065110|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
33594844|NCT03447314|102065111|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
33594845|NCT03447314|102065112|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
33594846|NCT03447314|102065113|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33594847|NCT03447314|102065114|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33594848|NCT03447314|102065115|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33594849|NCT03447314|102065116|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
33594850|NCT03447314|102065117|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
33594851|NCT03447314|102065118|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33594852|NCT03447314|102065119|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33594853|NCT03447314|102065120|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33594854|NCT03447314|102065121|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33594855|NCT03447314|102065122|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33594856|NCT03447314|102065123|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
33594857|NCT03447314|102065106|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
33594858|NCT03447314|102065107|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33594859|NCT03447314|102065108|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
33594860|NCT03447314|102065109|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33594861|NCT03447314|102065110|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33594862|NCT03447314|102065111|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
33594863|NCT03447314|102065112|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
33594864|NCT03447314|102065113|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33594865|NCT03447314|102065114|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33594866|NCT03447314|102065115|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33594867|NCT03447314|102065116|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33594868|NCT03447314|102065117|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33594869|NCT03447314|102065118|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33594870|NCT03447314|102065119|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33594871|NCT03447314|102065120|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33594872|NCT03447314|102065121|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33594873|NCT03447314|102065122|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33594874|NCT03447314|102065123|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
33186080|NCT02658890|100590622|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
33186081|NCT02658890|100590623|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
33186082|NCT02658890|100590624|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
33594875|NCT03447314|102065106|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594876|NCT03447314|102065107|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594877|NCT03447314|102065108|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
33186083|NCT02658890|100590625|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
33594878|NCT03447314|102065109|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594879|NCT03447314|102065110|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33186084|NCT02658890|100590626|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
33186085|NCT02658890|100590627|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
33288786|NCT00839332|100955001|FG000|Phase 2|Protocol Violation|0|||
33594880|NCT03447314|102065111|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594881|NCT03447314|102065112|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594882|NCT03447314|102065113|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594883|NCT03447314|102065114|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594884|NCT03447314|102065115|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594885|NCT03447314|102065116|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594886|NCT03447314|102065117|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594887|NCT03447314|102065118|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594888|NCT03447314|102065119|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594889|NCT03447314|102065120|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594890|NCT03447314|102065121|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594891|NCT03447314|102065122|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594892|NCT03447314|102065123|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
33594893|NCT03447314|102065106|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594894|NCT03447314|102065107|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594895|NCT03447314|102065108|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
33594896|NCT03447314|102065109|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594897|NCT03447314|102065110|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594898|NCT03447314|102065111|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594899|NCT03447314|102065112|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594900|NCT03447314|102065113|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594901|NCT03447314|102065114|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594902|NCT03447314|102065115|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594903|NCT03447314|102065116|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594904|NCT03447314|102065117|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594905|NCT03447314|102065118|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594906|NCT03447314|102065119|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594907|NCT03447314|102065120|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594908|NCT03447314|102065121|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594909|NCT03447314|102065122|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594910|NCT03447314|102065123|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
33594911|NCT03447314|102065106|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594912|NCT03447314|102065107|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594913|NCT03447314|102065108|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594914|NCT03447314|102065109|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594915|NCT03447314|102065110|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594916|NCT03447314|102065111|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594917|NCT03447314|102065112|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594918|NCT03447314|102065113|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594919|NCT03447314|102065114|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594920|NCT03447314|102065115|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594921|NCT03447314|102065116|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
33594922|NCT03447314|102065117|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594923|NCT03447314|102065118|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594924|NCT03447314|102065119|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594925|NCT03447314|102065120|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594926|NCT03447314|102065121|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594927|NCT03447314|102065122|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594928|NCT03447314|102065123|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
33594929|NCT03447314|102065106|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594930|NCT03447314|102065107|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594931|NCT03447314|102065108|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594932|NCT03447314|102065109|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
33594933|NCT03447314|102065110|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594934|NCT03447314|102065111|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
33594935|NCT03447314|102065112|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594936|NCT03447314|102065113|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594937|NCT03447314|102065114|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594938|NCT03447314|102065115|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594939|NCT03447314|102065116|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594940|NCT03447314|102065117|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594941|NCT03447314|102065118|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594942|NCT03447314|102065119|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594943|NCT03447314|102065120|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594944|NCT03447314|102065121|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594945|NCT03447314|102065122|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594946|NCT03447314|102065123|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
33594947|NCT03754582|102065124|FG000|Treatment Phase|Adverse Event|0|||
33594948|NCT03754582|102065125|FG001|Treatment Phase|Adverse Event|1|||
33594949|NCT03754582|102065126|FG002|Treatment Phase|Adverse Event|0|||
33594950|NCT03754582|102065124|FG000|Follow-up Phase|Other|0|||
33594951|NCT03754582|102065125|FG001|Follow-up Phase|Other|0|||
33594952|NCT03754582|102065126|FG002|Follow-up Phase|Other|1|||
33594953|NCT03895086|102065127|FG000|Overall Study|Early termination study|1|||
33594954|NCT03895086|102065128|FG001|Overall Study|Early termination study|0|||
33594955|NCT02578680|102065133|FG000|Overall Study|Death|329|||
33594956|NCT02578680|102065134|FG001|Overall Study|Death|181|||
33594957|NCT02578680|102065133|FG000|Overall Study|Lost to Follow-up|3|||
33594958|NCT02578680|102065134|FG001|Overall Study|Lost to Follow-up|1|||
33594959|NCT02578680|102065133|FG000|Overall Study|Physician Decision|0|||
33594960|NCT02578680|102065134|FG001|Overall Study|Physician Decision|1|||
33594961|NCT02578680|102065133|FG000|Overall Study|Protocol Violation|1|||
33594962|NCT02578680|102065134|FG001|Overall Study|Protocol Violation|1|||
33594963|NCT02578680|102065133|FG000|Overall Study|Sponsor Decision|64|||
33594964|NCT02578680|102065134|FG001|Overall Study|Sponsor Decision|13|||
33594965|NCT02578680|102065133|FG000|Overall Study|Withdrawal by Subject|13|||
33594966|NCT02578680|102065134|FG001|Overall Study|Withdrawal by Subject|9|||
33594967|NCT03703817|102065135|FG000|Overall Study|Not meeting eligibility criteria|7|||
33594968|NCT03703817|102065136|FG001|Overall Study|Not meeting eligibility criteria|4|||
33594969|NCT02150057|102065137|FG000|Overall Study|Lost to Follow-up|6|||
33594970|NCT02150057|102065138|FG001|Overall Study|Lost to Follow-up|4|||
33594971|NCT00664560|102065139|FG000|Overall Study|Adverse Event|19|||
33594972|NCT00664560|102065140|FG001|Overall Study|Adverse Event|16|||
33594973|NCT00664560|102065141|FG002|Overall Study|Adverse Event|7|||
33594974|NCT00664560|102065139|FG000|Overall Study|Withdrawal by Subject|9|||
33594975|NCT00664560|102065140|FG001|Overall Study|Withdrawal by Subject|13|||
33594976|NCT00664560|102065141|FG002|Overall Study|Withdrawal by Subject|7|||
33594977|NCT00664560|102065139|FG000|Overall Study|Lost to Follow-up|0|||
33594978|NCT00664560|102065140|FG001|Overall Study|Lost to Follow-up|2|||
33594979|NCT00664560|102065141|FG002|Overall Study|Lost to Follow-up|0|||
33594980|NCT00664560|102065139|FG000|Overall Study|Other|11|||
33594981|NCT00664560|102065140|FG001|Overall Study|Other|4|||
33594982|NCT00664560|102065141|FG002|Overall Study|Other|5|||
33594983|NCT00856206|102065142|FG000|Overall Study|Protocol Violation|6|||
33594984|NCT00856206|102065143|FG001|Overall Study|Protocol Violation|18|||
33594985|NCT00856206|102065142|FG000|Overall Study|Adverse Event|10|||
33594986|NCT00856206|102065143|FG001|Overall Study|Adverse Event|46|||
33594987|NCT00856206|102065142|FG000|Overall Study|Lack of Efficacy|1|||
33594988|NCT00856206|102065143|FG001|Overall Study|Lack of Efficacy|2|||
33594989|NCT00856206|102065142|FG000|Overall Study|Withdrawal by Subject|15|||
33594990|NCT00856206|102065143|FG001|Overall Study|Withdrawal by Subject|36|||
33594991|NCT00856206|102065142|FG000|Overall Study|Lost to Follow-up|13|||
33594992|NCT00856206|102065143|FG001|Overall Study|Lost to Follow-up|39|||
33594993|NCT00856206|102065142|FG000|Overall Study|Death|2|||
33594994|NCT00856206|102065143|FG001|Overall Study|Death|2|||
33594995|NCT00856206|102065142|FG000|Overall Study|Decision by the Sponsor|4|||
33594996|NCT00856206|102065143|FG001|Overall Study|Decision by the Sponsor|8|||
33186086|NCT02658890|100590601|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
33186087|NCT02658890|100590602|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
33594997|NCT00856206|102065142|FG000|Overall Study|Other than specified above|3|||
33594998|NCT00856206|102065143|FG001|Overall Study|Other than specified above|10|||
33594999|NCT01474772|102065151|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
33186088|NCT02658890|100590603|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
33186089|NCT02658890|100590604|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
33595000|NCT01474772|102065152|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
33595001|NCT01474772|102065151|FG000|Period 1|AE not Related to Study Drug|1|||
33595002|NCT01474772|102065152|FG001|Period 1|AE not Related to Study Drug|0|||
33595003|NCT01474772|102065151|FG000|Period 1|Withdrawal by Subject|3|||
33595004|NCT01474772|102065152|FG001|Period 1|Withdrawal by Subject|1|||
33595005|NCT01474772|102065151|FG000|Period 1|Lost to Follow-up|1|||
33595006|NCT01474772|102065152|FG001|Period 1|Lost to Follow-up|0|||
33595007|NCT01474772|102065151|FG000|Period 1|Reason not Specified|1|||
33595008|NCT01474772|102065152|FG001|Period 1|Reason not Specified|1|||
33595009|NCT01474772|102065151|FG000|Washout|AE not Related to Study Drug|2|||
33595010|NCT01474772|102065152|FG001|Washout|AE not Related to Study Drug|0|||
33595011|NCT01474772|102065151|FG000|Washout|Withdrawal by Subject|1|||
33595012|NCT01474772|102065152|FG001|Washout|Withdrawal by Subject|0|||
33595013|NCT01474772|102065151|FG000|Washout|Lost to Follow-up|0|||
33595014|NCT01474772|102065152|FG001|Washout|Lost to Follow-up|1|||
33595015|NCT01474772|102065151|FG000|Washout|Reason not Specified|0|||
33595016|NCT01474772|102065152|FG001|Washout|Reason not Specified|1|||
33595017|NCT01474772|102065151|FG000|Period 2|Death|0|||
33595018|NCT01474772|102065152|FG001|Period 2|Death|1|||
33595019|NCT01474772|102065151|FG000|Period 2|AE Related to Study Drug|0|||
33595020|NCT01474772|102065152|FG001|Period 2|AE Related to Study Drug|1|||
33595021|NCT01474772|102065151|FG000|Period 2|AE not Related to Study Drug|4|||
33595022|NCT01474772|102065152|FG001|Period 2|AE not Related to Study Drug|1|||
33595023|NCT01474772|102065151|FG000|Period 2|Lack of Efficacy|1|||
33595024|NCT01474772|102065152|FG001|Period 2|Lack of Efficacy|0|||
33595025|NCT01474772|102065151|FG000|Period 2|Withdrawal by Subject|3|||
33595026|NCT01474772|102065152|FG001|Period 2|Withdrawal by Subject|4|||
33595027|NCT01474772|102065151|FG000|Period 2|Lost to Follow-up|1|||
33595028|NCT01474772|102065152|FG001|Period 2|Lost to Follow-up|1|||
33595029|NCT01474772|102065151|FG000|Period 2|Reason not Specified|0|||
33595030|NCT01474772|102065152|FG001|Period 2|Reason not Specified|2|||
33595031|NCT01474772|102065151|FG000|Follow-up|AE not Related to Study Drug|0|||
33595032|NCT01474772|102065152|FG001|Follow-up|AE not Related to Study Drug|1|||
33595033|NCT02135029|102065153|FG000|Overall Study|Adverse Event|2|||
33595034|NCT02135029|102065154|FG001|Overall Study|Adverse Event|2|||
33595035|NCT02135029|102065155|FG002|Overall Study|Adverse Event|2|||
33595036|NCT02135029|102065153|FG000|Overall Study|Lost to Follow-up|0|||
33595037|NCT02135029|102065154|FG001|Overall Study|Lost to Follow-up|1|||
33595038|NCT02135029|102065155|FG002|Overall Study|Lost to Follow-up|0|||
33595039|NCT02135029|102065153|FG000|Overall Study|Withdrawal by Subject|2|||
33595040|NCT02135029|102065154|FG001|Overall Study|Withdrawal by Subject|0|||
33595041|NCT02135029|102065155|FG002|Overall Study|Withdrawal by Subject|1|||
33595042|NCT02135029|102065153|FG000|Overall Study|Other|0|||
33595043|NCT02135029|102065154|FG001|Overall Study|Other|1|||
33595044|NCT02135029|102065155|FG002|Overall Study|Other|0|||
33595045|NCT02135029|102065153|FG000|Overall Study|Death|0|||
33595046|NCT02135029|102065154|FG001|Overall Study|Death|1|||
33595047|NCT02135029|102065155|FG002|Overall Study|Death|0|||
33595048|NCT03555981|102065157|FG000|Overall Study|Lost to Follow-up|0|||
33595049|NCT03555981|102065158|FG001|Overall Study|Lost to Follow-up|2|||
33595050|NCT00075946|102065161|FG000|Overall Study|Path ineligible: undetermined histology|0|||
33595051|NCT00075946|102065162|FG001|Overall Study|Path ineligible: undetermined histology|0|||
33595052|NCT00075946|102065163|FG002|Overall Study|Path ineligible: undetermined histology|0|||
33595053|NCT00075946|102065164|FG003|Overall Study|Path ineligible: undetermined histology|0|||
33595054|NCT00075946|102065165|FG004|Overall Study|Path ineligible: undetermined histology|6|||
33595055|NCT00075946|102065161|FG000|Overall Study|Did not achieve response after induction|0|||
33595056|NCT00075946|102065162|FG001|Overall Study|Did not achieve response after induction|0|||
33595057|NCT00075946|102065163|FG002|Overall Study|Did not achieve response after induction|0|||
33595058|NCT00075946|102065164|FG003|Overall Study|Did not achieve response after induction|0|||
33595059|NCT00075946|102065165|FG004|Overall Study|Did not achieve response after induction|182|||
33595060|NCT00075946|102065161|FG000|Overall Study|Incorrectly randomized (no response)|5|||
33595061|NCT00075946|102065162|FG001|Overall Study|Incorrectly randomized (no response)|5|||
33595062|NCT00075946|102065163|FG002|Overall Study|Incorrectly randomized (no response)|5|||
33186090|NCT02658890|100590605|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
33186091|NCT02658890|100590606|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
33186092|NCT02658890|100590607|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
33186093|NCT02658890|100590608|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
33186094|NCT02658890|100590609|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
33186095|NCT02658890|100590610|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
33186096|NCT02658890|100590611|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
33186097|NCT02658890|100590612|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
33186098|NCT02658890|100590613|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
33186099|NCT02658890|100590614|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
33186100|NCT02658890|100590615|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
33186101|NCT02658890|100590616|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
33186102|NCT02658890|100590617|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
33186103|NCT02658890|100590618|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
33595063|NCT00075946|102065164|FG003|Overall Study|Incorrectly randomized (no response)|1|||
33595064|NCT00075946|102065165|FG004|Overall Study|Incorrectly randomized (no response)|0|||
33595065|NCT00075946|102065161|FG000|Overall Study|Adverse Event|2|||
33595066|NCT00075946|102065162|FG001|Overall Study|Adverse Event|10|||
33595067|NCT00075946|102065163|FG002|Overall Study|Adverse Event|0|||
33595068|NCT00075946|102065164|FG003|Overall Study|Adverse Event|2|||
33595069|NCT00075946|102065165|FG004|Overall Study|Adverse Event|0|||
33595070|NCT00075946|102065161|FG000|Overall Study|Death|0|||
33595071|NCT00075946|102065162|FG001|Overall Study|Death|1|||
33186104|NCT02658890|100590619|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
33186105|NCT02658890|100590620|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
33186106|NCT02658890|100590621|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
33186107|NCT02658890|100590622|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
33186108|NCT02658890|100590623|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
33186109|NCT02658890|100590624|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
33186110|NCT02658890|100590625|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
33186111|NCT02658890|100590626|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
33186112|NCT02658890|100590627|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
33186113|NCT02658890|100590601|FG000|Treatment Phase|Other Reasons|0|||
33186114|NCT02658890|100590602|FG001|Treatment Phase|Other Reasons|0|||
33186115|NCT02658890|100590603|FG002|Treatment Phase|Other Reasons|0|||
33186116|NCT02658890|100590604|FG003|Treatment Phase|Other Reasons|0|||
33186117|NCT02658890|100590605|FG004|Treatment Phase|Other Reasons|0|||
33186118|NCT02658890|100590606|FG005|Treatment Phase|Other Reasons|0|||
33186119|NCT02658890|100590607|FG006|Treatment Phase|Other Reasons|1|||
33186120|NCT02658890|100590608|FG007|Treatment Phase|Other Reasons|0|||
33186121|NCT02658890|100590609|FG008|Treatment Phase|Other Reasons|1|||
33186122|NCT02658890|100590610|FG009|Treatment Phase|Other Reasons|0|||
33186123|NCT02658890|100590611|FG010|Treatment Phase|Other Reasons|0|||
33186124|NCT02658890|100590612|FG011|Treatment Phase|Other Reasons|0|||
33186125|NCT02658890|100590613|FG012|Treatment Phase|Other Reasons|0|||
33186126|NCT02658890|100590614|FG013|Treatment Phase|Other Reasons|2|||
33186127|NCT02658890|100590615|FG014|Treatment Phase|Other Reasons|0|||
33186128|NCT02658890|100590616|FG015|Treatment Phase|Other Reasons|0|||
33186129|NCT02658890|100590617|FG016|Treatment Phase|Other Reasons|0|||
33186130|NCT02658890|100590618|FG017|Treatment Phase|Other Reasons|0|||
33186131|NCT02658890|100590619|FG018|Treatment Phase|Other Reasons|1|||
33186132|NCT02658890|100590620|FG019|Treatment Phase|Other Reasons|0|||
33186133|NCT02658890|100590621|FG020|Treatment Phase|Other Reasons|0|||
33186134|NCT02658890|100590622|FG021|Treatment Phase|Other Reasons|0|||
33186135|NCT02658890|100590623|FG022|Treatment Phase|Other Reasons|0|||
33186136|NCT02658890|100590624|FG023|Treatment Phase|Other Reasons|0|||
33186137|NCT02658890|100590625|FG024|Treatment Phase|Other Reasons|1|||
33186138|NCT02658890|100590626|FG025|Treatment Phase|Other Reasons|0|||
33186139|NCT02658890|100590627|FG026|Treatment Phase|Other Reasons|1|||
33186140|NCT02658890|100590601|FG000|Treatment Phase|Progressive Disease|6|||
33186141|NCT02658890|100590602|FG001|Treatment Phase|Progressive Disease|7|||
33186142|NCT02658890|100590603|FG002|Treatment Phase|Progressive Disease|6|||
33186143|NCT02658890|100590604|FG003|Treatment Phase|Progressive Disease|12|||
33186144|NCT02658890|100590605|FG004|Treatment Phase|Progressive Disease|6|||
33186145|NCT02658890|100590606|FG005|Treatment Phase|Progressive Disease|18|||
33186146|NCT02658890|100590607|FG006|Treatment Phase|Progressive Disease|12|||
33186147|NCT02658890|100590608|FG007|Treatment Phase|Progressive Disease|19|||
33186148|NCT02658890|100590609|FG008|Treatment Phase|Progressive Disease|26|||
33186149|NCT02658890|100590610|FG009|Treatment Phase|Progressive Disease|8|||
33186150|NCT02658890|100590611|FG010|Treatment Phase|Progressive Disease|7|||
33186151|NCT02658890|100590612|FG011|Treatment Phase|Progressive Disease|9|||
33186152|NCT02658890|100590613|FG012|Treatment Phase|Progressive Disease|8|||
33186153|NCT02658890|100590614|FG013|Treatment Phase|Progressive Disease|29|||
33186154|NCT02658890|100590615|FG014|Treatment Phase|Progressive Disease|6|||
33186155|NCT02658890|100590616|FG015|Treatment Phase|Progressive Disease|2|||
33186156|NCT02658890|100590617|FG016|Treatment Phase|Progressive Disease|32|||
33186157|NCT02658890|100590618|FG017|Treatment Phase|Progressive Disease|14|||
33186158|NCT02658890|100590619|FG018|Treatment Phase|Progressive Disease|40|||
33186159|NCT02658890|100590620|FG019|Treatment Phase|Progressive Disease|32|||
33186160|NCT02658890|100590621|FG020|Treatment Phase|Progressive Disease|19|||
33186161|NCT02658890|100590622|FG021|Treatment Phase|Progressive Disease|30|||
33186162|NCT02658890|100590623|FG022|Treatment Phase|Progressive Disease|15|||
33186163|NCT02658890|100590624|FG023|Treatment Phase|Progressive Disease|0|||
33186164|NCT02658890|100590625|FG024|Treatment Phase|Progressive Disease|0|||
33186165|NCT02658890|100590626|FG025|Treatment Phase|Progressive Disease|14|||
33186166|NCT02658890|100590627|FG026|Treatment Phase|Progressive Disease|11|||
33186167|NCT02658890|100590601|FG000|Treatment Phase|Study Drug Toxicity|0|||
33186168|NCT02658890|100590602|FG001|Treatment Phase|Study Drug Toxicity|0|||
33186169|NCT02658890|100590603|FG002|Treatment Phase|Study Drug Toxicity|2|||
33186170|NCT02658890|100590604|FG003|Treatment Phase|Study Drug Toxicity|0|||
33186171|NCT02658890|100590605|FG004|Treatment Phase|Study Drug Toxicity|0|||
33186172|NCT02658890|100590606|FG005|Treatment Phase|Study Drug Toxicity|0|||
33186173|NCT02658890|100590607|FG006|Treatment Phase|Study Drug Toxicity|0|||
33186174|NCT02658890|100590608|FG007|Treatment Phase|Study Drug Toxicity|0|||
33186175|NCT02658890|100590609|FG008|Treatment Phase|Study Drug Toxicity|3|||
33186176|NCT02658890|100590610|FG009|Treatment Phase|Study Drug Toxicity|0|||
33186177|NCT02658890|100590611|FG010|Treatment Phase|Study Drug Toxicity|1|||
33186178|NCT02658890|100590612|FG011|Treatment Phase|Study Drug Toxicity|1|||
33186179|NCT02658890|100590613|FG012|Treatment Phase|Study Drug Toxicity|2|||
33288787|NCT00839332|100955002|FG001|Phase 2|Protocol Violation|1|||
33186180|NCT02658890|100590614|FG013|Treatment Phase|Study Drug Toxicity|9|||
33186181|NCT02658890|100590615|FG014|Treatment Phase|Study Drug Toxicity|0|||
33186182|NCT02658890|100590616|FG015|Treatment Phase|Study Drug Toxicity|1|||
33186183|NCT02658890|100590617|FG016|Treatment Phase|Study Drug Toxicity|1|||
33186184|NCT02658890|100590618|FG017|Treatment Phase|Study Drug Toxicity|0|||
33186185|NCT02658890|100590619|FG018|Treatment Phase|Study Drug Toxicity|8|||
33186186|NCT02658890|100590620|FG019|Treatment Phase|Study Drug Toxicity|3|||
33186187|NCT02658890|100590621|FG020|Treatment Phase|Study Drug Toxicity|2|||
33186188|NCT02658890|100590622|FG021|Treatment Phase|Study Drug Toxicity|0|||
33186189|NCT02658890|100590623|FG022|Treatment Phase|Study Drug Toxicity|8|||
33186190|NCT02658890|100590624|FG023|Treatment Phase|Study Drug Toxicity|0|||
33186191|NCT02658890|100590625|FG024|Treatment Phase|Study Drug Toxicity|0|||
33186192|NCT02658890|100590626|FG025|Treatment Phase|Study Drug Toxicity|2|||
33186193|NCT02658890|100590627|FG026|Treatment Phase|Study Drug Toxicity|0|||
33186194|NCT02658890|100590601|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186195|NCT02658890|100590602|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186196|NCT02658890|100590603|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186197|NCT02658890|100590604|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
33186198|NCT02658890|100590605|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186199|NCT02658890|100590606|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186200|NCT02658890|100590607|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186201|NCT02658890|100590608|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186202|NCT02658890|100590609|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186203|NCT02658890|100590610|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
33186204|NCT02658890|100590611|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186205|NCT02658890|100590612|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186206|NCT02658890|100590613|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186207|NCT02658890|100590614|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186208|NCT02658890|100590615|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186209|NCT02658890|100590616|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186210|NCT02658890|100590617|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186211|NCT02658890|100590618|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186212|NCT02658890|100590619|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
33186213|NCT02658890|100590620|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186214|NCT02658890|100590621|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186215|NCT02658890|100590622|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186216|NCT02658890|100590623|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
33186217|NCT02658890|100590624|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186218|NCT02658890|100590625|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186219|NCT02658890|100590626|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186220|NCT02658890|100590627|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
33186221|NCT02658890|100590601|FG000|Treatment Phase|Withdrawal by Subject|0|||
33186222|NCT02658890|100590602|FG001|Treatment Phase|Withdrawal by Subject|1|||
33186223|NCT02658890|100590603|FG002|Treatment Phase|Withdrawal by Subject|0|||
33186224|NCT02658890|100590604|FG003|Treatment Phase|Withdrawal by Subject|0|||
33186225|NCT02658890|100590605|FG004|Treatment Phase|Withdrawal by Subject|0|||
33186226|NCT02658890|100590606|FG005|Treatment Phase|Withdrawal by Subject|0|||
33186227|NCT02658890|100590607|FG006|Treatment Phase|Withdrawal by Subject|1|||
33186228|NCT02658890|100590608|FG007|Treatment Phase|Withdrawal by Subject|0|||
33186229|NCT02658890|100590609|FG008|Treatment Phase|Withdrawal by Subject|0|||
33186230|NCT02658890|100590610|FG009|Treatment Phase|Withdrawal by Subject|1|||
33595072|NCT00075946|102065163|FG002|Overall Study|Death|0|||
33595073|NCT00075946|102065164|FG003|Overall Study|Death|0|||
33595074|NCT00075946|102065165|FG004|Overall Study|Death|0|||
33595075|NCT00075946|102065161|FG000|Overall Study|Withdrawal by Subject|23|||
33595076|NCT00075946|102065162|FG001|Overall Study|Withdrawal by Subject|58|||
33595077|NCT00075946|102065163|FG002|Overall Study|Withdrawal by Subject|4|||
33595078|NCT00075946|102065164|FG003|Overall Study|Withdrawal by Subject|9|||
33595079|NCT00075946|102065165|FG004|Overall Study|Withdrawal by Subject|0|||
33595080|NCT00075946|102065161|FG000|Overall Study|Alternative therapy|16|||
33595081|NCT00075946|102065162|FG001|Overall Study|Alternative therapy|2|||
33595082|NCT00075946|102065163|FG002|Overall Study|Alternative therapy|5|||
33595083|NCT00075946|102065164|FG003|Overall Study|Alternative therapy|0|||
33595084|NCT00075946|102065165|FG004|Overall Study|Alternative therapy|0|||
33595085|NCT00075946|102065161|FG000|Overall Study|Other complicating disease|7|||
33595086|NCT00075946|102065162|FG001|Overall Study|Other complicating disease|13|||
33595087|NCT00075946|102065163|FG002|Overall Study|Other complicating disease|1|||
33595088|NCT00075946|102065164|FG003|Overall Study|Other complicating disease|4|||
33595089|NCT00075946|102065165|FG004|Overall Study|Other complicating disease|0|||
33595090|NCT00075946|102065161|FG000|Overall Study|No response to retreatment|23|||
33595091|NCT00075946|102065162|FG001|Overall Study|No response to retreatment|0|||
33595092|NCT00075946|102065163|FG002|Overall Study|No response to retreatment|2|||
33595093|NCT00075946|102065164|FG003|Overall Study|No response to retreatment|0|||
33595094|NCT00075946|102065165|FG004|Overall Study|No response to retreatment|0|||
33595095|NCT00075946|102065161|FG000|Overall Study|Time to progression less than 6 months|15|||
33595096|NCT00075946|102065162|FG001|Overall Study|Time to progression less than 6 months|30|||
33595097|NCT00075946|102065163|FG002|Overall Study|Time to progression less than 6 months|8|||
33595098|NCT00075946|102065164|FG003|Overall Study|Time to progression less than 6 months|3|||
33595099|NCT00075946|102065165|FG004|Overall Study|Time to progression less than 6 months|0|||
33595100|NCT00075946|102065161|FG000|Overall Study|Other|57|||
33595101|NCT00075946|102065162|FG001|Overall Study|Other|32|||
33595102|NCT00075946|102065163|FG002|Overall Study|Other|3|||
33595103|NCT00075946|102065164|FG003|Overall Study|Other|11|||
33595104|NCT00075946|102065165|FG004|Overall Study|Other|0|||
33595105|NCT00758264|102065166|FG000|Active Phase|Withdrawal by Subject|0|||
33595106|NCT00758264|102065167|FG001|Active Phase|Withdrawal by Subject|0|||
33595107|NCT00758264|102065168|FG002|Active Phase|Withdrawal by Subject|1|||
33595108|NCT00758264|102065166|FG000|Active Phase|Lost to Follow-up|1|||
33595109|NCT00758264|102065167|FG001|Active Phase|Lost to Follow-up|0|||
33595110|NCT00758264|102065168|FG002|Active Phase|Lost to Follow-up|0|||
33595111|NCT00758264|102065166|FG000|Active Phase|Other|0|||
33595112|NCT00758264|102065167|FG001|Active Phase|Other|0|||
33186231|NCT02658890|100590611|FG010|Treatment Phase|Withdrawal by Subject|0|||
33186232|NCT02658890|100590612|FG011|Treatment Phase|Withdrawal by Subject|0|||
33186233|NCT02658890|100590613|FG012|Treatment Phase|Withdrawal by Subject|1|||
33186234|NCT02658890|100590614|FG013|Treatment Phase|Withdrawal by Subject|3|||
33186235|NCT02658890|100590615|FG014|Treatment Phase|Withdrawal by Subject|0|||
33186236|NCT02658890|100590616|FG015|Treatment Phase|Withdrawal by Subject|0|||
33186237|NCT02658890|100590617|FG016|Treatment Phase|Withdrawal by Subject|1|||
33186238|NCT02658890|100590618|FG017|Treatment Phase|Withdrawal by Subject|0|||
33186239|NCT02658890|100590619|FG018|Treatment Phase|Withdrawal by Subject|4|||
33186240|NCT02658890|100590620|FG019|Treatment Phase|Withdrawal by Subject|3|||
33186241|NCT02658890|100590621|FG020|Treatment Phase|Withdrawal by Subject|0|||
33186242|NCT02658890|100590622|FG021|Treatment Phase|Withdrawal by Subject|4|||
33186243|NCT02658890|100590623|FG022|Treatment Phase|Withdrawal by Subject|1|||
33186244|NCT02658890|100590624|FG023|Treatment Phase|Withdrawal by Subject|1|||
33186245|NCT02658890|100590625|FG024|Treatment Phase|Withdrawal by Subject|0|||
33186246|NCT02658890|100590626|FG025|Treatment Phase|Withdrawal by Subject|0|||
33186247|NCT02658890|100590627|FG026|Treatment Phase|Withdrawal by Subject|0|||
33186248|NCT04907032|100590632|FG000|Overall Study|Withdrawal by Subject|7|||
33186249|NCT04907032|100590633|FG001|Overall Study|Withdrawal by Subject|1|||
33186250|NCT02027844|100590634|FG000|Overall Study|Withdrawal by Subject|3|||
33186251|NCT02027844|100590635|FG001|Overall Study|Withdrawal by Subject|2|||
33186252|NCT02027844|100590636|FG002|Overall Study|Withdrawal by Subject|1|||
33186253|NCT02027844|100590634|FG000|Overall Study|Lost to Follow-up|0|||
33186254|NCT02027844|100590635|FG001|Overall Study|Lost to Follow-up|2|||
33186255|NCT02027844|100590636|FG002|Overall Study|Lost to Follow-up|1|||
33186256|NCT02027844|100590634|FG000|Overall Study|Protocol Violation|0|||
33186257|NCT02027844|100590635|FG001|Overall Study|Protocol Violation|2|||
33186258|NCT02027844|100590636|FG002|Overall Study|Protocol Violation|0|||
33186259|NCT02027844|100590634|FG000|Overall Study|Incomlete data|2|||
33186260|NCT02027844|100590635|FG001|Overall Study|Incomlete data|0|||
33186261|NCT02027844|100590636|FG002|Overall Study|Incomlete data|0|||
33186262|NCT01723163|100590637|FG000|Treatment Phase|Withdrawal by Subject|14|||
33186263|NCT01723163|100590638|FG001|Treatment Phase|Withdrawal by Subject|6|||
33186264|NCT01723163|100590637|FG000|Treatment Phase|Withdrawal by PI|5|||
33186265|NCT01723163|100590638|FG001|Treatment Phase|Withdrawal by PI|1|||
33186266|NCT01723163|100590637|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
33186267|NCT01723163|100590638|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
33186268|NCT01723163|100590637|FG000|3-Month Follow-up|Unable to Contact|12|||
33186269|NCT01723163|100590638|FG001|3-Month Follow-up|Unable to Contact|19|||
33186270|NCT01723163|100590637|FG000|6-Month Follow-up|Death|1|||
33186271|NCT01723163|100590638|FG001|6-Month Follow-up|Death|0|||
33390159|NCT04731922|101317665|FG005|Overall Study|Other|0|||
33390160|NCT04731922|101317666|FG006|Overall Study|Other|1|||
33390161|NCT04731922|101317667|FG007|Overall Study|Other|0|||
33390162|NCT04731922|101317668|FG008|Overall Study|Other|0|||
33390163|NCT04731922|101317669|FG009|Overall Study|Other|0|||
33595113|NCT00758264|102065168|FG002|Active Phase|Other|4|||
33595114|NCT02437305|102065170|FG000|Overall Study|Lost to Follow-up|18|||
33595115|NCT02437305|102065171|FG001|Overall Study|Lost to Follow-up|12|||
33595116|NCT04600076|102065176|FG000|Overall Study|Lost to Follow-up|3|||
33186272|NCT01723163|100590637|FG000|6-Month Follow-up|Unable to Contact|17|||
33186273|NCT01723163|100590638|FG001|6-Month Follow-up|Unable to Contact|15|||
33390164|NCT04731922|101317670|FG010|Overall Study|Other|0|||
33186274|NCT01723163|100590637|FG000|12-Month Follow-up|Death|1|||
33186275|NCT01723163|100590638|FG001|12-Month Follow-up|Death|0|||
33390165|NCT04731922|101317671|FG011|Overall Study|Other|0|||
33186276|NCT01723163|100590637|FG000|12-Month Follow-up|Unable to Contact|23|||
33186277|NCT01723163|100590638|FG001|12-Month Follow-up|Unable to Contact|28|||
33186278|NCT01116232|100590639|FG000|Overall Study|Progressive diease|4|||
33186279|NCT01520363|100590640|FG000|Overall Study|Withdrawal by Subject|2|||
33186280|NCT01520363|100590641|FG001|Overall Study|Withdrawal by Subject|0|||
33186281|NCT02281552|100590644|FG000|Overall Study|Medication error|1|||
33186282|NCT02281552|100590645|FG001|Overall Study|Medication error|0|||
33186283|NCT02281552|100590644|FG000|Overall Study|Insufficient clinical response|0|||
33186284|NCT02281552|100590645|FG001|Overall Study|Insufficient clinical response|1|||
33186285|NCT02281552|100590644|FG000|Overall Study|Adverse Event|3|||
33186286|NCT02281552|100590645|FG001|Overall Study|Adverse Event|9|||
33186287|NCT00136084|100590646|FG000|Overall Study|Death|12|||
33186288|NCT00136084|100590647|FG001|Overall Study|Death|5|||
33186289|NCT00136084|100590646|FG000|Overall Study|Unacceptable toxicity|8|||
33186290|NCT00136084|100590647|FG001|Overall Study|Unacceptable toxicity|11|||
33186291|NCT00136084|100590646|FG000|Overall Study|Relapse|20|||
33186292|NCT00136084|100590647|FG001|Overall Study|Relapse|23|||
33186293|NCT00136084|100590646|FG000|Overall Study|Lost to Follow-up|2|||
33186294|NCT00136084|100590647|FG001|Overall Study|Lost to Follow-up|0|||
33186295|NCT00136084|100590646|FG000|Overall Study|No Response|1|||
33595117|NCT01874275|102065177|FG000|Overall Study|Lost to Follow-up|1|||
33595118|NCT01874275|102065178|FG001|Overall Study|Lost to Follow-up|0|||
33595119|NCT03280303|102065181|FG000|Overall Study|Death|505|||
33595120|NCT03280303|102065181|FG000|Overall Study|Study terminated by sponsor|383|||
33595121|NCT03280303|102065181|FG000|Overall Study|Other|148|||
33595122|NCT03280303|102065181|FG000|Overall Study|No longer willing to participate in study|101|||
33595123|NCT03280303|102065181|FG000|Overall Study|Lost to follow up|39|||
33595124|NCT03280303|102065181|FG000|Overall Study|Adverse Event|20|||
33595125|NCT00683917|102065182|FG000|Overall Study|Study prematurely terminated|10|||
33595126|NCT03764631|102065185|FG000|Overall Study|Personal Reasons|3|||
33595127|NCT03764631|102065186|FG001|Overall Study|Personal Reasons|2|||
33595128|NCT03764631|102065185|FG000|Overall Study|Switching Therapy|3|||
33595129|NCT03764631|102065186|FG001|Overall Study|Switching Therapy|3|||
33595130|NCT03764631|102065185|FG000|Overall Study|Adverse Event|0|||
33595131|NCT03764631|102065186|FG001|Overall Study|Adverse Event|1|||
33595132|NCT03764631|102065185|FG000|Overall Study|Lost to Follow-up|33|||
33595133|NCT03764631|102065186|FG001|Overall Study|Lost to Follow-up|41|||
33595134|NCT03764631|102065185|FG000|Overall Study|No data as study site was closed|2|||
33595135|NCT03764631|102065186|FG001|Overall Study|No data as study site was closed|6|||
33595136|NCT01498575|102065187|FG000|Overall Sample|Withdrawal by Subject|60|||
33595137|NCT01498575|102065188|FG001|Overall Sample|Withdrawal by Subject|14|||
33595138|NCT01498575|102065187|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
33595139|NCT01498575|102065188|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
33595140|NCT01498575|102065187|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
33595141|NCT01498575|102065188|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
33595142|NCT01159171|102065191|FG000|Overall Study|Adverse Event|11|||
33595143|NCT01159171|102065191|FG000|Overall Study|Progression of Disease|28|||
33595144|NCT01159171|102065191|FG000|Overall Study|Protocol Violation|1|||
33595145|NCT01159171|102065191|FG000|Overall Study|Need for Surgery|5|||
33595146|NCT01159171|102065191|FG000|Overall Study|Medical Decision|4|||
33595147|NCT01159171|102065191|FG000|Overall Study|Death|1|||
33595148|NCT00624819|102065192|FG000|Follow-up Period: Year 4|Parents decision|0|||
33595149|NCT00624819|102065193|FG001|Follow-up Period: Year 4|Parents decision|0|||
33595150|NCT00624819|102065194|FG002|Follow-up Period: Year 4|Parents decision|1|||
33595151|NCT00624819|102065195|FG003|Follow-up Period: Year 4|Parents decision|0|||
33595152|NCT00624819|102065192|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
33595153|NCT00624819|102065193|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
33595154|NCT00624819|102065194|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
33595155|NCT00624819|102065195|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
33595156|NCT02526524|102065196|FG000|Overall Study|Withdrawal by Subject|3|||
33595157|NCT02526524|102065197|FG001|Overall Study|Withdrawal by Subject|3|||
33595158|NCT02526524|102065198|FG002|Overall Study|Withdrawal by Subject|6|||
33595159|NCT02526524|102065199|FG003|Overall Study|Withdrawal by Subject|1|||
33595160|NCT02526524|102065200|FG004|Overall Study|Withdrawal by Subject|9|||
33595161|NCT02526524|102065201|FG005|Overall Study|Withdrawal by Subject|5|||
33186296|NCT00136084|100590647|FG001|Overall Study|No Response|2|||
33186297|NCT00136084|100590646|FG000|Overall Study|Withdrawal by Subject|5|||
33186298|NCT00136084|100590647|FG001|Overall Study|Withdrawal by Subject|1|||
33595162|NCT02526524|102065196|FG000|Overall Study|Adverse Event|3|||
33595163|NCT02526524|102065197|FG001|Overall Study|Adverse Event|2|||
33595164|NCT02526524|102065198|FG002|Overall Study|Adverse Event|4|||
33595165|NCT02526524|102065199|FG003|Overall Study|Adverse Event|2|||
33595166|NCT02526524|102065200|FG004|Overall Study|Adverse Event|6|||
33595167|NCT02526524|102065201|FG005|Overall Study|Adverse Event|8|||
33595168|NCT02526524|102065196|FG000|Overall Study|Lost to Follow-up|2|||
33595169|NCT02526524|102065197|FG001|Overall Study|Lost to Follow-up|3|||
33186299|NCT00854581|100590650|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
33595170|NCT02526524|102065198|FG002|Overall Study|Lost to Follow-up|8|||
33595171|NCT02526524|102065199|FG003|Overall Study|Lost to Follow-up|1|||
33595172|NCT02526524|102065200|FG004|Overall Study|Lost to Follow-up|2|||
33595173|NCT02526524|102065201|FG005|Overall Study|Lost to Follow-up|5|||
33595174|NCT02526524|102065196|FG000|Overall Study|Protocol Violation|3|||
33595175|NCT02526524|102065197|FG001|Overall Study|Protocol Violation|1|||
33595176|NCT02526524|102065198|FG002|Overall Study|Protocol Violation|5|||
33595177|NCT02526524|102065199|FG003|Overall Study|Protocol Violation|3|||
33595178|NCT02526524|102065200|FG004|Overall Study|Protocol Violation|4|||
33595179|NCT02526524|102065201|FG005|Overall Study|Protocol Violation|3|||
33595180|NCT02526524|102065196|FG000|Overall Study|Loss of Glucose Control|0|||
33595181|NCT02526524|102065197|FG001|Overall Study|Loss of Glucose Control|0|||
33595182|NCT02526524|102065198|FG002|Overall Study|Loss of Glucose Control|3|||
33595183|NCT02526524|102065199|FG003|Overall Study|Loss of Glucose Control|0|||
33595184|NCT02526524|102065200|FG004|Overall Study|Loss of Glucose Control|2|||
33595185|NCT02526524|102065201|FG005|Overall Study|Loss of Glucose Control|0|||
33595186|NCT02526524|102065196|FG000|Overall Study|Physician Decision|0|||
33595187|NCT02526524|102065197|FG001|Overall Study|Physician Decision|0|||
33595188|NCT02526524|102065198|FG002|Overall Study|Physician Decision|0|||
33595189|NCT02526524|102065199|FG003|Overall Study|Physician Decision|0|||
33595190|NCT02526524|102065200|FG004|Overall Study|Physician Decision|1|||
33595191|NCT02526524|102065201|FG005|Overall Study|Physician Decision|0|||
33595192|NCT02526524|102065196|FG000|Overall Study|Sponsor Decision|1|||
33595193|NCT02526524|102065197|FG001|Overall Study|Sponsor Decision|0|||
33595194|NCT02526524|102065198|FG002|Overall Study|Sponsor Decision|0|||
33595195|NCT02526524|102065199|FG003|Overall Study|Sponsor Decision|0|||
33595196|NCT02526524|102065200|FG004|Overall Study|Sponsor Decision|0|||
33595197|NCT02526524|102065201|FG005|Overall Study|Sponsor Decision|0|||
33595198|NCT04239222|102069623|FG000|Baseline|Withdrawal by Subject|0|||
33595199|NCT04239222|102069624|FG001|Baseline|Withdrawal by Subject|0|||
33595200|NCT04239222|102069625|FG002|Baseline|Withdrawal by Subject|1|||
33595201|NCT04239222|102069626|FG003|Baseline|Withdrawal by Subject|1|||
33595202|NCT04239222|102069623|FG000|First Foot Assignment|Withdrawal by Subject|0|||
33595203|NCT04239222|102069624|FG001|First Foot Assignment|Withdrawal by Subject|0|||
33595204|NCT04239222|102069625|FG002|First Foot Assignment|Withdrawal by Subject|1|||
33595205|NCT04239222|102069626|FG003|First Foot Assignment|Withdrawal by Subject|0|||
33186300|NCT00854581|100590650|FG000|Induction (Up to Day 21)|Death|1|||
33186301|NCT00854581|100590650|FG000|Induction (Up to Day 21)|Physician Decision|1|||
33186302|NCT00854581|100590650|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
33186303|NCT00486265|100590651|FG000|Overall Study|Adverse Event|1|||
33186304|NCT00486265|100590651|FG000|Overall Study|Lack of Efficacy|8|||
33186305|NCT01752855|100590652|FG000|Overall Study|Adverse Event|1|||
33186306|NCT01752855|100590653|FG001|Overall Study|Adverse Event|0|||
33186307|NCT01752855|100590652|FG000|Overall Study|Withdrew Consent|0|||
33186308|NCT01752855|100590653|FG001|Overall Study|Withdrew Consent|2|||
33186309|NCT01752855|100590652|FG000|Overall Study|Lack of Efficacy|0|||
33186310|NCT01752855|100590653|FG001|Overall Study|Lack of Efficacy|2|||
33186311|NCT02382016|100590656|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
33186312|NCT02382016|100590657|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
33186313|NCT02382016|100590656|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
33186314|NCT02382016|100590657|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
33186315|NCT02382016|100590656|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
33186316|NCT02382016|100590657|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
33186317|NCT02382016|100590656|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
33186318|NCT02382016|100590657|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
33186319|NCT02382016|100590656|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
33186320|NCT02382016|100590657|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
33186321|NCT02382016|100590656|FG000|Open-label (OL) Treatment Period|Death|4|||
33186322|NCT02382016|100590657|FG001|Open-label (OL) Treatment Period|Death|0|||
33186323|NCT02382016|100590656|FG000|OL Extension Period|Physician Decision|3|||
33186324|NCT02382016|100590657|FG001|OL Extension Period|Physician Decision|0|||
33186325|NCT02382016|100590656|FG000|OL Extension Period|Death|2|||
33186326|NCT02382016|100590657|FG001|OL Extension Period|Death|0|||
33390166|NCT04731922|101317672|FG012|Overall Study|Other|0|||
33595206|NCT04239222|102069623|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
33595207|NCT04239222|102069624|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
33186327|NCT02382016|100590656|FG000|OL Extension Period|Withdrawal by Subject|1|||
33186328|NCT02382016|100590657|FG001|OL Extension Period|Withdrawal by Subject|0|||
33186329|NCT00058825|100590658|FG000|Overall Study|Relapse|9|||
33186330|NCT00058825|100590658|FG000|Overall Study|Progressive Disease|5|||
33186331|NCT00058825|100590658|FG000|Overall Study|Graft Failure|5|||
33186332|NCT00058825|100590658|FG000|Overall Study|Death|3|||
33186333|NCT00588445|100590659|FG000|Overall Study|Protocol Violation|1|||
33186334|NCT00588445|100590659|FG000|Overall Study|Withdrawal by Subject|3|||
33595208|NCT04239222|102069625|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
33595209|NCT04239222|102069626|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
33186335|NCT00588445|100590659|FG000|Overall Study|Disease Progression|1|||
33186336|NCT00588445|100590659|FG000|Overall Study|Not Treated|10|||
33186337|NCT00308711|100590665|FG000|Overall Study|Withdrawal by Subject|1|||
33186338|NCT00308711|100590666|FG001|Overall Study|Withdrawal by Subject|0|||
33186339|NCT00308711|100590667|FG002|Overall Study|Withdrawal by Subject|1|||
33186340|NCT00308711|100590665|FG000|Overall Study|Protocol Violation|0|||
33186341|NCT00308711|100590666|FG001|Overall Study|Protocol Violation|1|||
33186342|NCT00308711|100590667|FG002|Overall Study|Protocol Violation|1|||
33186343|NCT00308711|100590665|FG000|Overall Study|Lost to Follow-up|0|||
33186344|NCT00308711|100590666|FG001|Overall Study|Lost to Follow-up|1|||
33186345|NCT00308711|100590667|FG002|Overall Study|Lost to Follow-up|0|||
33186346|NCT00308711|100590665|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
33186347|NCT00308711|100590666|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
33186348|NCT00308711|100590667|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
33186349|NCT00308711|100590665|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
33186350|NCT00308711|100590666|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
33186351|NCT00308711|100590667|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
33186352|NCT00660348|100590669|FG000|Overall Study|Withdrawal by Subject|1|||
33186353|NCT00660348|100590670|FG001|Overall Study|Withdrawal by Subject|0|||
33595210|NCT01813721|102069627|FG000|Overall Study|Ineligibility determined|63|||
33595211|NCT01813721|102069627|FG000|Overall Study|Withdrawal by Subject|1|||
33595212|NCT01626118|102069628|FG000|Overall Study|Lack of Efficacy|1|||
33595213|NCT01626118|102069629|FG001|Overall Study|Lack of Efficacy|0|||
33595214|NCT01626118|102069630|FG002|Overall Study|Lack of Efficacy|1|||
33595215|NCT01626118|102069631|FG003|Overall Study|Lack of Efficacy|3|||
33595216|NCT01626118|102069628|FG000|Overall Study|Lost to Follow-up|1|||
33595217|NCT01626118|102069629|FG001|Overall Study|Lost to Follow-up|0|||
33595218|NCT01626118|102069630|FG002|Overall Study|Lost to Follow-up|0|||
33595219|NCT01626118|102069631|FG003|Overall Study|Lost to Follow-up|0|||
33595220|NCT01626118|102069628|FG000|Overall Study|Adverse Event|0|||
33595221|NCT01626118|102069629|FG001|Overall Study|Adverse Event|1|||
33186354|NCT01063595|100590671|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
33186355|NCT01063595|100590672|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
33186356|NCT01063595|100590671|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
33186357|NCT01063595|100590672|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
33186358|NCT01063595|100590671|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
33186359|NCT01063595|100590672|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
33186360|NCT01063595|100590671|FG000|First Intervention|Adverse Event|1|||
33186361|NCT01063595|100590672|FG001|First Intervention|Adverse Event|4|||
33186362|NCT01063595|100590671|FG000|First Intervention|Withdrawal by Subject|1|||
33186363|NCT01063595|100590672|FG001|First Intervention|Withdrawal by Subject|0|||
33186364|NCT01063595|100590671|FG000|First Intervention|Reason not Specified|0|||
33595222|NCT01626118|102069630|FG002|Overall Study|Adverse Event|1|||
33595223|NCT01626118|102069631|FG003|Overall Study|Adverse Event|0|||
33595224|NCT01626118|102069628|FG000|Overall Study|Investigator Decision|0|||
33595225|NCT01626118|102069629|FG001|Overall Study|Investigator Decision|1|||
33595226|NCT01626118|102069630|FG002|Overall Study|Investigator Decision|0|||
33595227|NCT01626118|102069631|FG003|Overall Study|Investigator Decision|0|||
33595228|NCT01691885|102069632|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
33595229|NCT01691885|102069633|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
33595230|NCT01691885|102069632|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
33595231|NCT01691885|102069633|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
33595232|NCT02118766|102069636|FG000|Overall Study|Adverse Event|7|||
33595233|NCT02118766|102069637|FG001|Overall Study|Adverse Event|2|||
33595234|NCT02118766|102069636|FG000|Overall Study|Withdrawal by Subject|3|||
33595235|NCT02118766|102069637|FG001|Overall Study|Withdrawal by Subject|6|||
33595236|NCT02118766|102069636|FG000|Overall Study|Lost to Follow-up|5|||
33595237|NCT02118766|102069637|FG001|Overall Study|Lost to Follow-up|4|||
33186365|NCT01063595|100590672|FG001|First Intervention|Reason not Specified|1|||
33186366|NCT01132495|100590673|FG000|Overall Study|Various reasons|40|||
33186367|NCT01132495|100590674|FG001|Overall Study|Various reasons|38|||
33186368|NCT01132495|100590675|FG002|Overall Study|Various reasons|20|||
33186369|NCT01132495|100590676|FG003|Overall Study|Various reasons|12|||
33186370|NCT00743652|100590681|FG000|Overall Study|Parent/Legal Guardian Request|3|||
33186371|NCT00743652|100590682|FG001|Overall Study|Parent/Legal Guardian Request|2|||
33186372|NCT00743652|100590683|FG002|Overall Study|Parent/Legal Guardian Request|2|||
33186373|NCT00743652|100590684|FG003|Overall Study|Parent/Legal Guardian Request|2|||
33186374|NCT00743652|100590685|FG004|Overall Study|Parent/Legal Guardian Request|0|||
33186375|NCT00743652|100590681|FG000|Overall Study|Adverse Event|3|||
33186376|NCT00743652|100590682|FG001|Overall Study|Adverse Event|0|||
33186377|NCT00743652|100590683|FG002|Overall Study|Adverse Event|0|||
33186378|NCT00743652|100590684|FG003|Overall Study|Adverse Event|0|||
33186379|NCT00743652|100590685|FG004|Overall Study|Adverse Event|0|||
33186380|NCT00743652|100590681|FG000|Overall Study|Death|2|||
33595238|NCT02118766|102069636|FG000|Overall Study|Withdrawal by parent/guardian|12|||
33595239|NCT02118766|102069637|FG001|Overall Study|Withdrawal by parent/guardian|18|||
33186381|NCT00743652|100590682|FG001|Overall Study|Death|0|||
33186382|NCT00743652|100590683|FG002|Overall Study|Death|0|||
33186383|NCT00743652|100590684|FG003|Overall Study|Death|0|||
33186384|NCT00743652|100590685|FG004|Overall Study|Death|0|||
33186385|NCT00743652|100590681|FG000|Overall Study|Investigator Request|0|||
33186386|NCT00743652|100590682|FG001|Overall Study|Investigator Request|0|||
33186387|NCT00743652|100590683|FG002|Overall Study|Investigator Request|0|||
33186388|NCT00743652|100590684|FG003|Overall Study|Investigator Request|2|||
33186389|NCT00743652|100590685|FG004|Overall Study|Investigator Request|0|||
33186390|NCT00743652|100590681|FG000|Overall Study|Other|1|||
33186391|NCT00743652|100590682|FG001|Overall Study|Other|1|||
33186392|NCT00743652|100590683|FG002|Overall Study|Other|0|||
33186393|NCT00743652|100590684|FG003|Overall Study|Other|0|||
33186394|NCT00743652|100590685|FG004|Overall Study|Other|0|||
33186395|NCT00743652|100590681|FG000|Overall Study|Lost to Follow-up|1|||
33186396|NCT00743652|100590682|FG001|Overall Study|Lost to Follow-up|0|||
33186397|NCT00743652|100590683|FG002|Overall Study|Lost to Follow-up|0|||
33186398|NCT00743652|100590684|FG003|Overall Study|Lost to Follow-up|0|||
33186399|NCT00743652|100590685|FG004|Overall Study|Lost to Follow-up|0|||
33186400|NCT02347527|100590686|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
33186401|NCT02347527|100590687|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
33186402|NCT02347527|100590688|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
33186403|NCT02347527|100590689|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
33186404|NCT02347527|100590686|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
33186405|NCT02347527|100590687|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
33186406|NCT02347527|100590688|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
33186407|NCT02347527|100590689|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
33186408|NCT02347527|100590686|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
33186409|NCT02347527|100590687|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
33186410|NCT02347527|100590688|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
33186411|NCT02347527|100590689|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
33186412|NCT02347527|100590686|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
33186413|NCT02347527|100590687|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
33186414|NCT02347527|100590688|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
33186415|NCT02347527|100590689|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
33186416|NCT02347527|100590686|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
33186417|NCT02347527|100590687|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
33186418|NCT02347527|100590688|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
33186419|NCT02347527|100590689|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
33186420|NCT02086110|100590690|FG000|Overall Study|Withdrawal by Subject|1|||
33186421|NCT02086110|100590691|FG001|Overall Study|Withdrawal by Subject|1|||
33186422|NCT00856908|100590693|FG000|Overall Study|Lost to Follow-up|1|||
33186423|NCT00856908|100590694|FG001|Overall Study|Lost to Follow-up|0|||
33186424|NCT02268409|100590702|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
33186425|NCT02268409|100590702|FG000|Overall Study|Death|1|||
33186426|NCT02268409|100590702|FG000|Overall Study|Lost to Follow-up|1|||
33186427|NCT02268409|100590702|FG000|Overall Study|Protocol Violation|3|||
33186428|NCT02268409|100590702|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
33186429|NCT02268409|100590702|FG000|Overall Study|Withdrawal by Subject|5|||
33186430|NCT02016625|100590703|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
33186431|NCT02016625|100590704|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
33186432|NCT02016625|100590703|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
33186433|NCT02016625|100590704|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
33186434|NCT02016625|100590703|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
33186435|NCT02016625|100590704|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
33186436|NCT00805766|100590706|FG000|Screening Period|Adverse Event|1|||
33186437|NCT00805766|100590706|FG000|Screening Period|Lack of Efficacy|2|||
33186438|NCT00805766|100590706|FG000|Screening Period|Pregnancy|1|||
33186439|NCT00805766|100590706|FG000|Screening Period|Responder|2|||
33186440|NCT00805766|100590706|FG000|Increased Dose Period|Adverse Event|4|||
33186441|NCT00805766|100590706|FG000|Increased Dose Period|Lack of Efficacy|7|||
33186442|NCT00805766|100590706|FG000|Increased Dose Period|Pregnancy|1|||
33186443|NCT00805766|100590706|FG000|Increased Dose Period|Withdrawal by Subject|1|||
33186444|NCT01236755|100590714|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
33186445|NCT01236755|100590714|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
33186446|NCT01236755|100590714|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
33186447|NCT01236755|100590714|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
33186448|NCT00500370|100590720|FG000|Overall Study|Adverse Event|9|||
33186449|NCT00500370|100590721|FG001|Overall Study|Adverse Event|3|||
33186450|NCT00500370|100590720|FG000|Overall Study|Lost to Follow-up|10|||
33186451|NCT00500370|100590721|FG001|Overall Study|Lost to Follow-up|10|||
33186452|NCT00500370|100590720|FG000|Overall Study|Protocol Violation|2|||
33186453|NCT00500370|100590721|FG001|Overall Study|Protocol Violation|4|||
33186454|NCT00500370|100590720|FG000|Overall Study|Sponsor Decision|2|||
33186455|NCT00500370|100590721|FG001|Overall Study|Sponsor Decision|0|||
33186456|NCT00500370|100590720|FG000|Overall Study|Subject Decision|10|||
33186457|NCT00500370|100590721|FG001|Overall Study|Subject Decision|17|||
33186458|NCT00277212|100590724|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
33186459|NCT00277212|100590725|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
33186460|NCT00277212|100590726|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
33186461|NCT00277212|100590724|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
33186462|NCT00277212|100590725|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
33186463|NCT00277212|100590726|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
33186464|NCT00277212|100590724|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
33186465|NCT00277212|100590725|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
33186466|NCT00277212|100590726|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
33186467|NCT00277212|100590724|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
33186468|NCT00277212|100590725|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
33186469|NCT00277212|100590726|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
33186470|NCT00277212|100590724|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
33186471|NCT00277212|100590725|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
33186472|NCT00277212|100590726|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
33186473|NCT00277212|100590724|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
33186474|NCT00277212|100590725|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
33186475|NCT00277212|100590726|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
33186476|NCT00277212|100590724|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
33186477|NCT00277212|100590725|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
33186478|NCT00277212|100590726|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
33186479|NCT00277212|100590724|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
33186480|NCT00277212|100590725|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
33186481|NCT00277212|100590726|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
33186482|NCT00277212|100590724|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
33186483|NCT00277212|100590725|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
33186484|NCT00277212|100590726|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
33186485|NCT00277212|100590724|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
33186486|NCT00277212|100590725|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
33186487|NCT00277212|100590726|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
33186488|NCT00277212|100590724|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
33186489|NCT00277212|100590725|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
33186490|NCT00277212|100590726|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
33186491|NCT00277212|100590724|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
33186492|NCT00277212|100590725|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
33186493|NCT00277212|100590726|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
33186494|NCT00277212|100590724|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
33186495|NCT00277212|100590725|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
33186496|NCT00277212|100590726|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
33186497|NCT00277212|100590724|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
33186498|NCT00277212|100590725|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
33186499|NCT00277212|100590726|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
33186500|NCT00277212|100590724|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
33186501|NCT00277212|100590725|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
33186502|NCT00277212|100590726|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
33186503|NCT00277212|100590724|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
33186504|NCT00277212|100590725|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
33186505|NCT00277212|100590726|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
33186506|NCT00277212|100590724|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
33186507|NCT00277212|100590725|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
33186508|NCT00277212|100590726|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
33186509|NCT00277212|100590724|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
33186510|NCT00277212|100590725|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
33186511|NCT00277212|100590726|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
33186512|NCT04244786|100590728|FG000|Overall Study|Adverse Event|0|||
33186513|NCT04244786|100590729|FG001|Overall Study|Adverse Event|0|||
33186514|NCT04244786|100590730|FG002|Overall Study|Adverse Event|2|||
33186515|NCT04244786|100590728|FG000|Overall Study|Withdrawal by Subject|0|||
33186516|NCT04244786|100590729|FG001|Overall Study|Withdrawal by Subject|0|||
33186517|NCT04244786|100590730|FG002|Overall Study|Withdrawal by Subject|5|||
33186518|NCT01418937|100594238|FG000|Overall Study|Lost to Follow-up|5|||
33186519|NCT01418937|100594238|FG000|Overall Study|Protocol Violation|1|||
33186520|NCT01418937|100594238|FG000|Overall Study|Pregnancy|1|||
33186521|NCT01418937|100594238|FG000|Overall Study|Withdrawal by Subject|1|||
33186522|NCT00586469|100594239|FG000|Overall Study|Adverse Event|0|||
33186523|NCT00586469|100594240|FG001|Overall Study|Adverse Event|1|||
33186524|NCT00082433|100594250|FG000|Overall Study|Adverse Event|12|||
33186525|NCT00082433|100594251|FG001|Overall Study|Adverse Event|17|||
33186526|NCT00082433|100594250|FG000|Overall Study|Death|8|||
33186527|NCT00082433|100594251|FG001|Overall Study|Death|18|||
33186528|NCT00082433|100594250|FG000|Overall Study|Disease Progression/Relapse|270|||
33186529|NCT00082433|100594251|FG001|Overall Study|Disease Progression/Relapse|388|||
33186530|NCT00082433|100594250|FG000|Overall Study|Physician Decision|50|||
33186531|NCT00082433|100594251|FG001|Overall Study|Physician Decision|61|||
33186532|NCT00082433|100594250|FG000|Overall Study|Lost to Follow-up|1|||
33186533|NCT00082433|100594251|FG001|Overall Study|Lost to Follow-up|2|||
33186534|NCT00082433|100594250|FG000|Overall Study|Study Drug Toxicity|179|||
33186535|NCT00082433|100594251|FG001|Overall Study|Study Drug Toxicity|66|||
33186536|NCT00082433|100594250|FG000|Overall Study|Withdrawal by Subject|55|||
33186537|NCT00082433|100594251|FG001|Overall Study|Withdrawal by Subject|30|||
33186538|NCT00082433|100594250|FG000|Overall Study|Still On Treatment|2|||
33186539|NCT00082433|100594251|FG001|Overall Study|Still On Treatment|1|||
33186540|NCT00082433|100594250|FG000|Overall Study|Not Treated|12|||
33186541|NCT00082433|100594251|FG001|Overall Study|Not Treated|11|||
33186542|NCT00082433|100594250|FG000|Overall Study|Ineligible|2|||
33186543|NCT00082433|100594251|FG001|Overall Study|Ineligible|1|||
33186544|NCT00082433|100594250|FG000|Overall Study|Noncompliance|2|||
33186545|NCT00082433|100594251|FG001|Overall Study|Noncompliance|1|||
33186546|NCT00082433|100594250|FG000|Overall Study|New primary cancer|1|||
33186547|NCT00082433|100594251|FG001|Overall Study|New primary cancer|0|||
33186548|NCT00082433|100594250|FG000|Overall Study|Impending surgery|0|||
33186549|NCT00082433|100594251|FG001|Overall Study|Impending surgery|1|||
33186550|NCT01365273|100594252|FG000|Overall Study|Lost to Follow-up|1|||
33186551|NCT01365273|100594253|FG001|Overall Study|Lost to Follow-up|0|||
33186552|NCT01365273|100594252|FG000|Overall Study|Protocol Violation|0|||
33186553|NCT01365273|100594253|FG001|Overall Study|Protocol Violation|1|||
33186554|NCT01365273|100594252|FG000|Overall Study|Physician Decision|1|||
33186555|NCT01365273|100594253|FG001|Overall Study|Physician Decision|0|||
33186556|NCT00590954|100594254|FG000|Overall Study|Inevaluable|2|||
33186557|NCT04292730|100594255|FG000|Overall Study|Lost to Follow-up|8|||
33186558|NCT04292730|100594256|FG001|Overall Study|Lost to Follow-up|12|||
33186559|NCT04292730|100594257|FG002|Overall Study|Lost to Follow-up|12|||
33186560|NCT04292730|100594258|FG003|Overall Study|Lost to Follow-up|48|||
33186561|NCT04292730|100594255|FG000|Overall Study|Death|2|||
33186562|NCT04292730|100594256|FG001|Overall Study|Death|2|||
33186563|NCT04292730|100594257|FG002|Overall Study|Death|4|||
33186564|NCT04292730|100594258|FG003|Overall Study|Death|12|||
33186565|NCT04292730|100594255|FG000|Overall Study|Withdrew Consent|2|||
33186566|NCT04292730|100594256|FG001|Overall Study|Withdrew Consent|2|||
33186567|NCT04292730|100594257|FG002|Overall Study|Withdrew Consent|5|||
33186568|NCT04292730|100594258|FG003|Overall Study|Withdrew Consent|6|||
33186569|NCT04292730|100594255|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33186570|NCT04292730|100594256|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33186571|NCT04292730|100594257|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33186572|NCT04292730|100594258|FG003|Overall Study|Non-Compliance with Study Drug|0|||
33186573|NCT04292730|100594255|FG000|Overall Study|Protocol Violation|0|||
33186574|NCT04292730|100594256|FG001|Overall Study|Protocol Violation|0|||
33186575|NCT04292730|100594257|FG002|Overall Study|Protocol Violation|1|||
33186576|NCT04292730|100594258|FG003|Overall Study|Protocol Violation|0|||
33186577|NCT04292730|100594255|FG000|Overall Study|Randomized but not Treated|8|||
33186578|NCT04292730|100594256|FG001|Overall Study|Randomized but not Treated|4|||
33186579|NCT04292730|100594257|FG002|Overall Study|Randomized but not Treated|0|||
33186580|NCT04292730|100594258|FG003|Overall Study|Randomized but not Treated|14|||
33186581|NCT00806546|100594259|FG000|Overall Study|Enrolled, not treated|35|||
33186582|NCT00806546|100594259|FG000|Overall Study|Lost to Follow-up|32|||
33186583|NCT00806546|100594259|FG000|Overall Study|Adverse Event|74|||
33186584|NCT00806546|100594259|FG000|Overall Study|Withdrawal by Subject|75|||
33186585|NCT00806546|100594259|FG000|Overall Study|Protocol Violation|49|||
33186586|NCT00806546|100594259|FG000|Overall Study|Various|42|||
33186587|NCT00097721|100594260|FG000|Overall Study|Adverse Event|8|||
33186588|NCT00097721|100594261|FG001|Overall Study|Adverse Event|1|||
33186589|NCT00097721|100594260|FG000|Overall Study|Withdrawal by Subject|6|||
33186590|NCT00097721|100594261|FG001|Overall Study|Withdrawal by Subject|1|||
33186591|NCT00097721|100594260|FG000|Overall Study|Progressive Disease|55|||
33186592|NCT00097721|100594261|FG001|Overall Study|Progressive Disease|27|||
33186593|NCT00097721|100594260|FG000|Overall Study|Physician Decision|1|||
33186594|NCT00097721|100594261|FG001|Overall Study|Physician Decision|3|||
33186595|NCT00097721|100594260|FG000|Overall Study|Reason not given|1|||
33186596|NCT00097721|100594261|FG001|Overall Study|Reason not given|1|||
33186597|NCT02308735|100594269|FG000|Overall Study|Physician Decision|2|||
33186598|NCT02308735|100594270|FG001|Overall Study|Physician Decision|0|||
33186599|NCT02308735|100594271|FG002|Overall Study|Physician Decision|0|||
33186600|NCT02308735|100594272|FG003|Overall Study|Physician Decision|2|||
33186601|NCT04200248|100594279|FG000|Overall Study|Personal reasons|0|||
33186602|NCT04200248|100594280|FG001|Overall Study|Personal reasons|0|||
33186603|NCT04200248|100594281|FG002|Overall Study|Personal reasons|1|||
33186604|NCT04200248|100594279|FG000|Overall Study|Discontinued prior to treatment|3|||
33186605|NCT04200248|100594280|FG001|Overall Study|Discontinued prior to treatment|3|||
33186606|NCT04200248|100594281|FG002|Overall Study|Discontinued prior to treatment|2|||
33186607|NCT00579826|100594282|FG000|Overall Study|Withdrawal by Subject|5|||
33186608|NCT00579826|100594283|FG001|Overall Study|Withdrawal by Subject|3|||
33186609|NCT01256593|100594284|FG000|Overall Study|Protocol Violation|26|||
33186610|NCT01256593|100594284|FG000|Overall Study|No Drug Administration Information|2|||
33186611|NCT01256593|100594284|FG000|Overall Study|No Visit After Treatment|186|||
33186612|NCT01755416|100594286|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
33186613|NCT01755416|100594287|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
33186614|NCT03013543|100594296|FG000|Overall Study|Withdrawal by Subject|0|||
33186615|NCT03013543|100594297|FG001|Overall Study|Withdrawal by Subject|2|||
33186616|NCT03013543|100594298|FG002|Overall Study|Withdrawal by Subject|0|||
33186617|NCT03013543|100594299|FG003|Overall Study|Withdrawal by Subject|5|||
33186618|NCT03013543|100594300|FG004|Overall Study|Withdrawal by Subject|6|||
33186619|NCT03013543|100594301|FG005|Overall Study|Withdrawal by Subject|2|||
33186620|NCT03013543|100594302|FG006|Overall Study|Withdrawal by Subject|3|||
33186621|NCT03013543|100594303|FG007|Overall Study|Withdrawal by Subject|1|||
33186622|NCT03013543|100594304|FG008|Overall Study|Withdrawal by Subject|0|||
33186623|NCT03013543|100594305|FG009|Overall Study|Withdrawal by Subject|4|||
33186624|NCT03013543|100594296|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
33186625|NCT03013543|100594297|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
33186626|NCT03013543|100594298|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
33186627|NCT03013543|100594299|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
33186628|NCT03013543|100594300|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
33186629|NCT03013543|100594301|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
33186630|NCT03013543|100594302|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
33186631|NCT03013543|100594303|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
33186632|NCT03013543|100594304|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
33186633|NCT03013543|100594305|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
33186634|NCT03013543|100594296|FG000|Overall Study|Other|0|||
33186635|NCT03013543|100594297|FG001|Overall Study|Other|0|||
33186636|NCT03013543|100594298|FG002|Overall Study|Other|2|||
33595240|NCT02118766|102069636|FG000|Overall Study|Other|3|||
33595241|NCT02118766|102069637|FG001|Overall Study|Other|1|||
33595242|NCT04484649|102069640|FG000|Overall Study|Lost to Follow-up|2|||
33595243|NCT04484649|102069641|FG001|Overall Study|Lost to Follow-up|1|||
33595244|NCT04484649|102069640|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
33595245|NCT04484649|102069641|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
33595246|NCT03389555|102069642|FG000|Overall Study|Protocol Violation|1|||
33595247|NCT03389555|102069643|FG001|Overall Study|Protocol Violation|3|||
33595248|NCT03389555|102069642|FG000|Overall Study|Death|1|||
33595249|NCT03389555|102069643|FG001|Overall Study|Death|0|||
33595250|NCT05438602|102069644|FG000|Treatment (15 Days)|Adverse Event|2|||
33595251|NCT05438602|102069645|FG001|Treatment (15 Days)|Adverse Event|1|||
33595252|NCT05438602|102069646|FG002|Treatment (15 Days)|Adverse Event|3|||
33595253|NCT05438602|102069644|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
33595254|NCT05438602|102069645|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
33595255|NCT05438602|102069646|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
33595256|NCT05438602|102069644|FG000|Treatment (15 Days)|Other|0|||
33595257|NCT05438602|102069645|FG001|Treatment (15 Days)|Other|0|||
33595258|NCT05438602|102069646|FG002|Treatment (15 Days)|Other|1|||
33595259|NCT05438602|102069644|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
33186637|NCT03013543|100594299|FG003|Overall Study|Other|0|||
33186638|NCT03013543|100594300|FG004|Overall Study|Other|2|||
33186639|NCT03013543|100594301|FG005|Overall Study|Other|0|||
33186640|NCT03013543|100594302|FG006|Overall Study|Other|0|||
33186641|NCT03013543|100594303|FG007|Overall Study|Other|0|||
33186642|NCT03013543|100594304|FG008|Overall Study|Other|1|||
33186643|NCT03013543|100594305|FG009|Overall Study|Other|0|||
33186644|NCT03013543|100594296|FG000|Overall Study|Adverse Event|0|||
33186645|NCT03013543|100594297|FG001|Overall Study|Adverse Event|0|||
33186646|NCT03013543|100594298|FG002|Overall Study|Adverse Event|0|||
33186647|NCT03013543|100594299|FG003|Overall Study|Adverse Event|3|||
33186648|NCT03013543|100594300|FG004|Overall Study|Adverse Event|2|||
33186649|NCT03013543|100594301|FG005|Overall Study|Adverse Event|1|||
33186650|NCT03013543|100594302|FG006|Overall Study|Adverse Event|3|||
33186651|NCT03013543|100594303|FG007|Overall Study|Adverse Event|8|||
33186652|NCT03013543|100594304|FG008|Overall Study|Adverse Event|0|||
33186653|NCT03013543|100594305|FG009|Overall Study|Adverse Event|2|||
33186654|NCT03013543|100594296|FG000|Overall Study|Death|0|||
33186655|NCT03013543|100594297|FG001|Overall Study|Death|0|||
33186656|NCT03013543|100594298|FG002|Overall Study|Death|0|||
33186657|NCT03013543|100594299|FG003|Overall Study|Death|1|||
33186658|NCT03013543|100594300|FG004|Overall Study|Death|0|||
33186659|NCT03013543|100594301|FG005|Overall Study|Death|0|||
33186660|NCT03013543|100594302|FG006|Overall Study|Death|0|||
33186661|NCT03013543|100594303|FG007|Overall Study|Death|0|||
33186662|NCT03013543|100594304|FG008|Overall Study|Death|0|||
33186663|NCT03013543|100594305|FG009|Overall Study|Death|0|||
33186664|NCT03013543|100594296|FG000|Overall Study|Lack of Efficacy|0|||
33186665|NCT03013543|100594297|FG001|Overall Study|Lack of Efficacy|0|||
33186666|NCT03013543|100594298|FG002|Overall Study|Lack of Efficacy|0|||
33186667|NCT03013543|100594299|FG003|Overall Study|Lack of Efficacy|1|||
33186668|NCT03013543|100594300|FG004|Overall Study|Lack of Efficacy|0|||
33186669|NCT03013543|100594301|FG005|Overall Study|Lack of Efficacy|0|||
33186670|NCT03013543|100594302|FG006|Overall Study|Lack of Efficacy|0|||
33186671|NCT03013543|100594303|FG007|Overall Study|Lack of Efficacy|0|||
33186672|NCT03013543|100594304|FG008|Overall Study|Lack of Efficacy|0|||
33186673|NCT03013543|100594305|FG009|Overall Study|Lack of Efficacy|0|||
33186674|NCT03013543|100594296|FG000|Overall Study|Lost to Follow-up|0|||
33186675|NCT03013543|100594297|FG001|Overall Study|Lost to Follow-up|0|||
33186676|NCT03013543|100594298|FG002|Overall Study|Lost to Follow-up|0|||
33186677|NCT03013543|100594299|FG003|Overall Study|Lost to Follow-up|1|||
33186678|NCT03013543|100594300|FG004|Overall Study|Lost to Follow-up|0|||
33186679|NCT03013543|100594301|FG005|Overall Study|Lost to Follow-up|0|||
33186680|NCT03013543|100594302|FG006|Overall Study|Lost to Follow-up|1|||
33186681|NCT03013543|100594303|FG007|Overall Study|Lost to Follow-up|0|||
33186682|NCT03013543|100594304|FG008|Overall Study|Lost to Follow-up|0|||
33186683|NCT03013543|100594305|FG009|Overall Study|Lost to Follow-up|2|||
33186684|NCT03013543|100594296|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33186685|NCT03013543|100594297|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33186686|NCT03013543|100594298|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33595260|NCT05438602|102069645|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
33595261|NCT05438602|102069646|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
33595262|NCT05438602|102069644|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
33595263|NCT05438602|102069645|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
33595264|NCT05438602|102069646|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
33595265|NCT05438602|102069644|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
33595266|NCT05438602|102069645|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
33595267|NCT05438602|102069646|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
33595268|NCT05438602|102069644|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
33595269|NCT05438602|102069645|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
33595270|NCT05438602|102069646|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
33595271|NCT05438602|102069644|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
33595272|NCT05438602|102069645|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
33595273|NCT05438602|102069646|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
33595274|NCT05438602|102069644|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
33595275|NCT05438602|102069645|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
33595276|NCT05438602|102069646|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
33595277|NCT05438602|102069644|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
33595278|NCT05438602|102069645|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
33595279|NCT05438602|102069646|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
33595280|NCT05275010|102069655|FG000|Overall Study|Reason Not Specified|4|||
33186687|NCT03013543|100594299|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33186688|NCT03013543|100594300|FG004|Overall Study|Non-Compliance With Study Drug|0|||
33186689|NCT03013543|100594301|FG005|Overall Study|Non-Compliance With Study Drug|0|||
33186690|NCT03013543|100594302|FG006|Overall Study|Non-Compliance With Study Drug|0|||
33186691|NCT03013543|100594303|FG007|Overall Study|Non-Compliance With Study Drug|0|||
33186692|NCT03013543|100594304|FG008|Overall Study|Non-Compliance With Study Drug|1|||
33186693|NCT03013543|100594305|FG009|Overall Study|Non-Compliance With Study Drug|0|||
33186694|NCT03013543|100594296|FG000|Overall Study|Physician Decision|0|||
33186695|NCT03013543|100594297|FG001|Overall Study|Physician Decision|0|||
33595281|NCT05275010|102069656|FG001|Overall Study|Reason Not Specified|1|||
33595282|NCT05275010|102069655|FG000|Overall Study|Withdrawal by Subject|1|||
33595283|NCT05275010|102069656|FG001|Overall Study|Withdrawal by Subject|0|||
33595284|NCT05275010|102069655|FG000|Overall Study|Lost to Follow-up|0|||
33595285|NCT05275010|102069656|FG001|Overall Study|Lost to Follow-up|1|||
33595286|NCT01886690|102069657|FG000|Overall Study|Protocol Violation|0|||
33595287|NCT01886690|102069658|FG001|Overall Study|Protocol Violation|1|||
33595288|NCT01886690|102069657|FG000|Overall Study|Personal Reasons|0|||
33595289|NCT01886690|102069658|FG001|Overall Study|Personal Reasons|1|||
33595290|NCT03515551|102069661|FG000|Overall Study|Death|4|||
33595291|NCT03515551|102069662|FG001|Overall Study|Death|1|||
33595292|NCT03515551|102069663|FG002|Overall Study|Death|2|||
33595293|NCT03515551|102069664|FG003|Overall Study|Death|2|||
33186696|NCT03013543|100594298|FG002|Overall Study|Physician Decision|0|||
33186697|NCT03013543|100594299|FG003|Overall Study|Physician Decision|0|||
33186698|NCT03013543|100594300|FG004|Overall Study|Physician Decision|1|||
33186699|NCT03013543|100594301|FG005|Overall Study|Physician Decision|0|||
33186700|NCT03013543|100594302|FG006|Overall Study|Physician Decision|0|||
33186701|NCT03013543|100594303|FG007|Overall Study|Physician Decision|0|||
33186702|NCT03013543|100594304|FG008|Overall Study|Physician Decision|0|||
33186703|NCT03013543|100594305|FG009|Overall Study|Physician Decision|0|||
33186704|NCT03013543|100594296|FG000|Overall Study|Protocol Violation|0|||
33186705|NCT03013543|100594297|FG001|Overall Study|Protocol Violation|0|||
33186706|NCT03013543|100594298|FG002|Overall Study|Protocol Violation|0|||
33186707|NCT03013543|100594299|FG003|Overall Study|Protocol Violation|0|||
33186708|NCT03013543|100594300|FG004|Overall Study|Protocol Violation|0|||
33186709|NCT03013543|100594301|FG005|Overall Study|Protocol Violation|0|||
33186710|NCT03013543|100594302|FG006|Overall Study|Protocol Violation|0|||
33186711|NCT03013543|100594303|FG007|Overall Study|Protocol Violation|0|||
33186712|NCT03013543|100594304|FG008|Overall Study|Protocol Violation|0|||
33186713|NCT03013543|100594305|FG009|Overall Study|Protocol Violation|1|||
33186714|NCT02584504|100594310|FG000|Double-blind Treatment|Participant withdrew consent|0|||
33186715|NCT02584504|100594311|FG001|Double-blind Treatment|Participant withdrew consent|0|||
33186716|NCT02584504|100594312|FG002|Double-blind Treatment|Participant withdrew consent|1|||
33186717|NCT02584504|100594310|FG000|Double-blind Treatment|Adverse Event|0|||
33186718|NCT02584504|100594311|FG001|Double-blind Treatment|Adverse Event|1|||
33186719|NCT02584504|100594312|FG002|Double-blind Treatment|Adverse Event|0|||
33186720|NCT02584504|100594310|FG000|Double-blind Treatment|Family Matter|0|||
33186721|NCT02584504|100594311|FG001|Double-blind Treatment|Family Matter|1|||
33186722|NCT02584504|100594312|FG002|Double-blind Treatment|Family Matter|0|||
33186723|NCT02584504|100594310|FG000|Open-label Treatment|Participant withdrew consent|0|||
33186724|NCT02584504|100594311|FG001|Open-label Treatment|Participant withdrew consent|0|||
33186725|NCT02584504|100594312|FG002|Open-label Treatment|Participant withdrew consent|4|||
33186726|NCT02584504|100594310|FG000|Open-label Treatment|Adverse Event|2|||
33186727|NCT02584504|100594311|FG001|Open-label Treatment|Adverse Event|2|||
33186728|NCT02584504|100594312|FG002|Open-label Treatment|Adverse Event|3|||
33186729|NCT02584504|100594310|FG000|Open-label Treatment|Physician Decision|0|||
33186730|NCT02584504|100594311|FG001|Open-label Treatment|Physician Decision|1|||
33186731|NCT02584504|100594312|FG002|Open-label Treatment|Physician Decision|0|||
33186732|NCT02584504|100594310|FG000|Open-label Treatment|Entered but not treated|0|||
33186733|NCT02584504|100594311|FG001|Open-label Treatment|Entered but not treated|1|||
33186734|NCT02584504|100594312|FG002|Open-label Treatment|Entered but not treated|1|||
33186735|NCT03388138|100594313|FG000|Overall Study|Protocol Violation|1|||
33186736|NCT03388138|100594314|FG001|Overall Study|Protocol Violation|0|||
33186737|NCT00445328|100594317|FG000|Overall Study|Death|0|||
33186738|NCT00445328|100594318|FG001|Overall Study|Death|1|||
33186739|NCT00445328|100594317|FG000|Overall Study|Adverse Event|0|||
33186740|NCT00445328|100594318|FG001|Overall Study|Adverse Event|3|||
33186741|NCT00445328|100594317|FG000|Overall Study|Other|0|||
33186742|NCT00445328|100594318|FG001|Overall Study|Other|2|||
33186743|NCT00445328|100594317|FG000|Overall Study|Withdrawal by Subject|2|||
33186744|NCT00445328|100594318|FG001|Overall Study|Withdrawal by Subject|0|||
33186745|NCT00445328|100594317|FG000|Overall Study|Protocol Violation|1|||
33186746|NCT00445328|100594318|FG001|Overall Study|Protocol Violation|0|||
33186747|NCT02188485|100594321|FG000|Overall Study|Withdrawal by Subject|2|||
33186748|NCT02188485|100594322|FG001|Overall Study|Withdrawal by Subject|1|||
33186749|NCT02188485|100594321|FG000|Overall Study|PI withdrew, lack of capacity|0|||
33186750|NCT02188485|100594322|FG001|Overall Study|PI withdrew, lack of capacity|2|||
33186751|NCT02342704|100594323|FG000|Overall Study|Physician Decision|0|||
33186752|NCT02342704|100594324|FG001|Overall Study|Physician Decision|3|||
33186753|NCT02342704|100594323|FG000|Overall Study|Sponsor Termination|49|||
33186754|NCT02342704|100594324|FG001|Overall Study|Sponsor Termination|43|||
33595294|NCT03515551|102069665|FG004|Overall Study|Death|2|||
33595295|NCT03515551|102069666|FG005|Overall Study|Death|4|||
33186755|NCT02342704|100594323|FG000|Overall Study|Other|0|||
33186756|NCT02342704|100594324|FG001|Overall Study|Other|1|||
33186757|NCT02342704|100594323|FG000|Overall Study|Withdrawal by Subject|1|||
33186758|NCT02342704|100594324|FG001|Overall Study|Withdrawal by Subject|0|||
33595296|NCT03515551|102069667|FG006|Overall Study|Death|1|||
33186759|NCT02342704|100594323|FG000|Overall Study|Lost to Follow-up|2|||
33186760|NCT02342704|100594324|FG001|Overall Study|Lost to Follow-up|1|||
33186761|NCT02342704|100594323|FG000|Overall Study|Adverse Event|1|||
33186762|NCT02342704|100594324|FG001|Overall Study|Adverse Event|3|||
33186763|NCT00714259|100594325|FG000|Overall Study|Death|2|||
33186764|NCT02759120|100594326|FG000|Overall Study|Death|34|||
33186765|NCT02759120|100594327|FG001|Overall Study|Death|36|||
33186766|NCT02759120|100594326|FG000|Overall Study|Lost to Follow-up|4|||
33186767|NCT02759120|100594327|FG001|Overall Study|Lost to Follow-up|7|||
33186768|NCT02759120|100594326|FG000|Overall Study|Physician Decision|3|||
33186769|NCT02759120|100594327|FG001|Overall Study|Physician Decision|0|||
33186770|NCT02759120|100594326|FG000|Overall Study|Withdrawal by Subject|28|||
33186771|NCT02759120|100594327|FG001|Overall Study|Withdrawal by Subject|15|||
33186772|NCT02759120|100594326|FG000|Overall Study|Moved out of area|3|||
33186773|NCT02759120|100594327|FG001|Overall Study|Moved out of area|4|||
33186774|NCT02759120|100594326|FG000|Overall Study|Lung transplant|3|||
33186775|NCT02759120|100594327|FG001|Overall Study|Lung transplant|5|||
33186776|NCT02759120|100594326|FG000|Overall Study|Other reason not completed|10|||
33186777|NCT02759120|100594327|FG001|Overall Study|Other reason not completed|12|||
33186778|NCT00423891|100594330|FG000|Enrolled|Withdrawal by Subject|0|||
33186779|NCT00423891|100594331|FG001|Enrolled|Withdrawal by Subject|0|||
33186780|NCT00423891|100594332|FG002|Enrolled|Withdrawal by Subject|1|||
33186781|NCT00423891|100594330|FG000|Enrolled|Lost to Follow-up|0|||
33186782|NCT00423891|100594331|FG001|Enrolled|Lost to Follow-up|0|||
33186783|NCT00423891|100594332|FG002|Enrolled|Lost to Follow-up|1|||
33186784|NCT00423891|100594330|FG000|Enrolled|No longer met criteria|11|||
33186785|NCT00423891|100594331|FG001|Enrolled|No longer met criteria|2|||
33186786|NCT00423891|100594332|FG002|Enrolled|No longer met criteria|1|||
33186787|NCT00423891|100594330|FG000|Treatment|Withdrawal by Subject|1|||
33186788|NCT00423891|100594331|FG001|Treatment|Withdrawal by Subject|0|||
33186789|NCT00423891|100594332|FG002|Treatment|Withdrawal by Subject|0|||
33186790|NCT00423891|100594330|FG000|Treatment|Lost to Follow-up|1|||
33186791|NCT00423891|100594331|FG001|Treatment|Lost to Follow-up|0|||
33186792|NCT00423891|100594332|FG002|Treatment|Lost to Follow-up|0|||
33186793|NCT00423891|100594330|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
33186794|NCT00423891|100594331|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
33186795|NCT00423891|100594332|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
33186796|NCT00423891|100594330|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
33186797|NCT00423891|100594331|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
33186798|NCT00423891|100594332|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
33186799|NCT01466192|100594333|FG000|Overall Study|Physician Decision|1|||
33186800|NCT01466192|100594333|FG000|Overall Study|Withdrawal by Subject|3|||
33186801|NCT01354496|100594336|FG000|Period 1|Adverse Event|0|||
33186802|NCT01354496|100594337|FG001|Period 1|Adverse Event|0|||
33186803|NCT01354496|100594338|FG002|Period 1|Adverse Event|1|||
33186804|NCT01354496|100594339|FG003|Period 1|Adverse Event|0|||
33186805|NCT01354496|100594340|FG004|Period 1|Adverse Event|0|||
33186806|NCT01354496|100594341|FG005|Period 1|Adverse Event|0|||
33186807|NCT01354496|100594336|FG000|Period 1|Physician Decision|0|||
33186808|NCT01354496|100594337|FG001|Period 1|Physician Decision|0|||
33186809|NCT01354496|100594338|FG002|Period 1|Physician Decision|1|||
33186810|NCT01354496|100594339|FG003|Period 1|Physician Decision|0|||
33186811|NCT01354496|100594340|FG004|Period 1|Physician Decision|0|||
33186812|NCT01354496|100594341|FG005|Period 1|Physician Decision|0|||
33186813|NCT01354496|100594336|FG000|Period 2|Adverse Event|0|||
33186814|NCT01354496|100594337|FG001|Period 2|Adverse Event|0|||
33186815|NCT01354496|100594338|FG002|Period 2|Adverse Event|0|||
33186816|NCT01354496|100594339|FG003|Period 2|Adverse Event|1|||
33186817|NCT01354496|100594340|FG004|Period 2|Adverse Event|0|||
33186818|NCT01354496|100594341|FG005|Period 2|Adverse Event|0|||
33186819|NCT01354496|100594336|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
33186820|NCT01354496|100594337|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
33186821|NCT01354496|100594338|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
33186822|NCT01354496|100594339|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
33186823|NCT01354496|100594340|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
33186824|NCT01354496|100594341|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
33186825|NCT01344447|100594342|FG000|Overall Study|Adverse Event|1|||
33186826|NCT01344447|100594342|FG000|Overall Study|Protocol Violation|1|||
33186827|NCT01344447|100594342|FG000|Overall Study|Withdrawal by Subject|1|||
33186828|NCT01344447|100594342|FG000|Overall Study|The contrast was not seen|1|||
33186829|NCT01344447|100594342|FG000|Overall Study|Physician Decision|1|||
33186830|NCT01344447|100594342|FG000|Overall Study|MRA unsuccessful|1|||
33186831|NCT01344447|100594342|FG000|Overall Study|Bolus tracking failed|1|||
33186832|NCT01344447|100594342|FG000|Overall Study|Error of power injector|1|||
33186833|NCT03591575|100594345|FG000|Overall Study|Adverse Event|2|||
33186834|NCT03591575|100594346|FG001|Overall Study|Adverse Event|0|||
33186835|NCT03591575|100594345|FG000|Overall Study|Withdrawal by Subject|4|||
33186836|NCT03591575|100594346|FG001|Overall Study|Withdrawal by Subject|1|||
33186837|NCT01147653|100594349|FG000|Year 2|Withdrawal by Subject|2|||
33186838|NCT01147653|100594350|FG001|Year 2|Withdrawal by Subject|3|||
33186839|NCT01071512|100594351|FG000|Overall Study|Adverse Event|1|||
33186840|NCT01071512|100594351|FG000|Overall Study|Development of antibodies to drug|2|||
33186841|NCT01071512|100594351|FG000|Overall Study|positive anti-JC virus antibody test|2|||
33186842|NCT00380393|100594352|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
33186843|NCT00380393|100594353|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
33186844|NCT00380393|100594352|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
33186845|NCT00380393|100594353|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
33186846|NCT00380393|100594352|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
33186847|NCT00380393|100594353|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
33186848|NCT00380393|100594352|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
33186849|NCT00380393|100594353|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
33186850|NCT00380393|100594352|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
33186851|NCT00380393|100594353|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
33186852|NCT00380393|100594352|FG000|Month 14|Withdrawal by Subject|9|||
33186853|NCT00380393|100594353|FG001|Month 14|Withdrawal by Subject|7|||
33186854|NCT00380393|100594352|FG000|Month 14|Death|1|||
33186855|NCT00380393|100594353|FG001|Month 14|Death|0|||
33186856|NCT00380393|100594352|FG000|Month 14|Lost to Follow-up|0|||
33186857|NCT00380393|100594353|FG001|Month 14|Lost to Follow-up|1|||
33186858|NCT00380393|100594352|FG000|Month 14|Migrated/moved from study area|39|||
33186859|NCT00380393|100594353|FG001|Month 14|Migrated/moved from study area|42|||
33186860|NCT00380393|100594352|FG000|Month 14|Protocol Violation|2|||
33186861|NCT00380393|100594353|FG001|Month 14|Protocol Violation|0|||
33186862|NCT00380393|100594352|FG000|Month 14|Others|6|||
33186863|NCT00380393|100594353|FG001|Month 14|Others|6|||
33186864|NCT00983580|100594354|FG000|Overall Study|Cancel Prior to treatment|1|||
33186865|NCT00983580|100594355|FG001|Overall Study|Cancel Prior to treatment|3|||
33186866|NCT00983580|100594354|FG000|Overall Study|Protocol Violation|1|||
33186867|NCT00983580|100594355|FG001|Overall Study|Protocol Violation|1|||
33186868|NCT00983580|100594354|FG000|Overall Study|Ineligible|3|||
33186869|NCT00983580|100594355|FG001|Overall Study|Ineligible|0|||
33186870|NCT01192152|100594361|FG000|Period 1|left prematurely (while on treatment B)|0|||
33186871|NCT01192152|100594362|FG001|Period 1|left prematurely (while on treatment B)|1|||
33186872|NCT01192152|100594361|FG000|Period 3|family emergency|1|||
33186873|NCT01192152|100594362|FG001|Period 3|family emergency|0|||
33186874|NCT04753164|100594368|FG000|Overall Study|Adverse Event|0|||
33186875|NCT04753164|100594369|FG001|Overall Study|Adverse Event|2|||
33186876|NCT04753164|100594368|FG000|Overall Study|Withdrawal by Subject|9|||
33186877|NCT04753164|100594369|FG001|Overall Study|Withdrawal by Subject|7|||
33186878|NCT04753164|100594368|FG000|Overall Study|Lost to Follow-up|6|||
33186879|NCT04753164|100594369|FG001|Overall Study|Lost to Follow-up|6|||
33186880|NCT04753164|100594368|FG000|Overall Study|Other|12|||
33186881|NCT04753164|100594369|FG001|Overall Study|Other|5|||
33186882|NCT04371380|100594370|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
33186883|NCT04371380|100594371|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
33186884|NCT04371380|100594372|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
33186885|NCT01275066|100594380|FG000|Overall Study|Withdrawal by Subject|0|||
33186886|NCT01275066|100594381|FG001|Overall Study|Withdrawal by Subject|0|||
33186887|NCT01275066|100594382|FG002|Overall Study|Withdrawal by Subject|1|||
33186888|NCT01275066|100594380|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
33186889|NCT01275066|100594381|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
33186890|NCT01275066|100594382|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
33186891|NCT01572038|100594383|FG000|Overall Study|Death|648|||
33186892|NCT01572038|100594383|FG000|Overall Study|Withdrawal by Subject|204|||
33186893|NCT01572038|100594383|FG000|Overall Study|Lost to Follow-up|81|||
33186894|NCT01572038|100594383|FG000|Overall Study|Physician Decision|20|||
33186895|NCT01572038|100594383|FG000|Overall Study|Patient Decision|14|||
33186896|NCT01572038|100594383|FG000|Overall Study|Progressive Disease|8|||
33186897|NCT01572038|100594383|FG000|Overall Study|Site Closed Before Completing Form|6|||
33186898|NCT01572038|100594383|FG000|Overall Study|Enrolled into Another Trial|3|||
33186899|NCT01572038|100594383|FG000|Overall Study|Participated in Another Trial|3|||
33186900|NCT01572038|100594383|FG000|Overall Study|Termination by Sponsor|2|||
33186901|NCT01572038|100594383|FG000|Overall Study|Patient Deterioration|1|||
33186902|NCT01572038|100594383|FG000|Overall Study|Sponsor Decision|1|||
33186903|NCT00262067|100594384|FG000|Overall Study|Death|190|||
33186904|NCT00262067|100594385|FG001|Overall Study|Death|89|||
33186905|NCT00262067|100594386|FG002|Overall Study|Death|186|||
33186906|NCT00262067|100594387|FG003|Overall Study|Death|99|||
33186907|NCT00262067|100594384|FG000|Overall Study|Lost to Follow-up|5|||
33186908|NCT00262067|100594385|FG001|Overall Study|Lost to Follow-up|4|||
33186909|NCT00262067|100594386|FG002|Overall Study|Lost to Follow-up|7|||
33186910|NCT00262067|100594387|FG003|Overall Study|Lost to Follow-up|5|||
33186911|NCT00262067|100594384|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
33186912|NCT00262067|100594385|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
33186913|NCT00262067|100594386|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
33595297|NCT03515551|102069661|FG000|Overall Study|Lost to Follow-up|0|||
33186914|NCT00262067|100594387|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
33186915|NCT00262067|100594384|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
33186916|NCT00262067|100594385|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
33186917|NCT00262067|100594386|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
33186918|NCT00262067|100594387|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
33186919|NCT03925727|100594390|FG000|Overall Study|Adverse Event|4|||
33186920|NCT03925727|100594391|FG001|Overall Study|Adverse Event|0|||
33186921|NCT03925727|100594392|FG002|Overall Study|Adverse Event|3|||
33186922|NCT03925727|100594390|FG000|Overall Study|Protocol Violation|1|||
33186923|NCT03925727|100594391|FG001|Overall Study|Protocol Violation|2|||
33186924|NCT03925727|100594392|FG002|Overall Study|Protocol Violation|2|||
33186925|NCT03925727|100594390|FG000|Overall Study|Withdrawal by Subject|3|||
33186926|NCT03925727|100594391|FG001|Overall Study|Withdrawal by Subject|2|||
33186927|NCT03925727|100594392|FG002|Overall Study|Withdrawal by Subject|4|||
33186928|NCT03925727|100594390|FG000|Overall Study|Administrative Reasons|3|||
33186929|NCT03925727|100594391|FG001|Overall Study|Administrative Reasons|1|||
33186930|NCT03925727|100594392|FG002|Overall Study|Administrative Reasons|2|||
33186931|NCT03925727|100594390|FG000|Overall Study|Randomized in error or Disqualified|8|||
33186932|NCT03925727|100594391|FG001|Overall Study|Randomized in error or Disqualified|1|||
33186933|NCT03925727|100594392|FG002|Overall Study|Randomized in error or Disqualified|7|||
33186934|NCT00834912|100594393|FG000|Treatment Period 1|Adverse Event|0|||
33186935|NCT00834912|100594394|FG001|Treatment Period 1|Adverse Event|1|||
33186936|NCT00834912|100594395|FG002|Treatment Period 1|Adverse Event|0|||
33186937|NCT00834912|100594396|FG003|Treatment Period 1|Adverse Event|1|||
33186938|NCT00834912|100594397|FG004|Treatment Period 1|Adverse Event|0|||
33186939|NCT00834912|100594398|FG005|Treatment Period 1|Adverse Event|0|||
33186940|NCT00834912|100594393|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33186941|NCT00834912|100594394|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33186942|NCT00834912|100594395|FG002|Treatment Period 2|Withdrawal by Subject|1|||
33186943|NCT00834912|100594396|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33186944|NCT00834912|100594397|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33186945|NCT00834912|100594398|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33186946|NCT03616912|100594399|FG000|Overall Study|Adverse Event|17|||
33186947|NCT03616912|100594400|FG001|Overall Study|Adverse Event|21|||
33186948|NCT03616912|100594401|FG002|Overall Study|Adverse Event|9|||
33186949|NCT03616912|100594402|FG003|Overall Study|Adverse Event|0|||
33186950|NCT03616912|100594403|FG004|Overall Study|Adverse Event|0|||
33186951|NCT03616912|100594404|FG005|Overall Study|Adverse Event|0|||
33186952|NCT03616912|100594399|FG000|Overall Study|Death|1|||
33186953|NCT03616912|100594400|FG001|Overall Study|Death|1|||
33186954|NCT03616912|100594401|FG002|Overall Study|Death|0|||
33186955|NCT03616912|100594402|FG003|Overall Study|Death|0|||
33186956|NCT03616912|100594403|FG004|Overall Study|Death|0|||
33186957|NCT03616912|100594404|FG005|Overall Study|Death|0|||
33186958|NCT03616912|100594399|FG000|Overall Study|Lack of Efficacy|13|||
33186959|NCT03616912|100594400|FG001|Overall Study|Lack of Efficacy|6|||
33186960|NCT03616912|100594401|FG002|Overall Study|Lack of Efficacy|8|||
33186961|NCT03616912|100594402|FG003|Overall Study|Lack of Efficacy|4|||
33186962|NCT03616912|100594403|FG004|Overall Study|Lack of Efficacy|5|||
33186963|NCT03616912|100594404|FG005|Overall Study|Lack of Efficacy|1|||
33390167|NCT04731922|101317673|FG013|Overall Study|Other|0|||
33186964|NCT03616912|100594399|FG000|Overall Study|Lost to Follow-up|1|||
33186965|NCT03616912|100594400|FG001|Overall Study|Lost to Follow-up|2|||
33186966|NCT03616912|100594401|FG002|Overall Study|Lost to Follow-up|3|||
33186967|NCT03616912|100594402|FG003|Overall Study|Lost to Follow-up|0|||
33186968|NCT03616912|100594403|FG004|Overall Study|Lost to Follow-up|0|||
33186969|NCT03616912|100594404|FG005|Overall Study|Lost to Follow-up|0|||
33186970|NCT03616912|100594399|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
33186971|NCT03616912|100594400|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
33186972|NCT03616912|100594401|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
33186973|NCT03616912|100594402|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
33186974|NCT03616912|100594403|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
33186975|NCT03616912|100594404|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
33186976|NCT03616912|100594399|FG000|Overall Study|Withdrawal by Subject|12|||
33186977|NCT03616912|100594400|FG001|Overall Study|Withdrawal by Subject|12|||
33186978|NCT03616912|100594401|FG002|Overall Study|Withdrawal by Subject|15|||
33186979|NCT03616912|100594402|FG003|Overall Study|Withdrawal by Subject|2|||
33186980|NCT03616912|100594403|FG004|Overall Study|Withdrawal by Subject|0|||
33186981|NCT03616912|100594404|FG005|Overall Study|Withdrawal by Subject|2|||
33186982|NCT03616912|100594399|FG000|Overall Study|Study Terminated by Sponsor|0|||
33186983|NCT03616912|100594400|FG001|Overall Study|Study Terminated by Sponsor|0|||
33186984|NCT03616912|100594401|FG002|Overall Study|Study Terminated by Sponsor|0|||
33186985|NCT03616912|100594402|FG003|Overall Study|Study Terminated by Sponsor|10|||
33186986|NCT03616912|100594403|FG004|Overall Study|Study Terminated by Sponsor|9|||
33186987|NCT03616912|100594404|FG005|Overall Study|Study Terminated by Sponsor|11|||
33186988|NCT03616912|100594399|FG000|Overall Study|Protocol Deviation|1|||
33186989|NCT03616912|100594400|FG001|Overall Study|Protocol Deviation|1|||
33186990|NCT03616912|100594401|FG002|Overall Study|Protocol Deviation|0|||
33186991|NCT03616912|100594402|FG003|Overall Study|Protocol Deviation|0|||
33186992|NCT03616912|100594403|FG004|Overall Study|Protocol Deviation|0|||
33186993|NCT03616912|100594404|FG005|Overall Study|Protocol Deviation|0|||
33186994|NCT03616912|100594399|FG000|Overall Study|Pregnancy|1|||
33186995|NCT03616912|100594400|FG001|Overall Study|Pregnancy|0|||
33186996|NCT03616912|100594401|FG002|Overall Study|Pregnancy|4|||
33186997|NCT03616912|100594402|FG003|Overall Study|Pregnancy|0|||
33186998|NCT03616912|100594403|FG004|Overall Study|Pregnancy|0|||
33186999|NCT03616912|100594404|FG005|Overall Study|Pregnancy|0|||
33187000|NCT03616912|100594399|FG000|Overall Study|Protocol Violation|1|||
33187001|NCT03616912|100594400|FG001|Overall Study|Protocol Violation|0|||
33187002|NCT03616912|100594401|FG002|Overall Study|Protocol Violation|2|||
33187003|NCT03616912|100594402|FG003|Overall Study|Protocol Violation|0|||
33187004|NCT03616912|100594403|FG004|Overall Study|Protocol Violation|0|||
33187005|NCT03616912|100594404|FG005|Overall Study|Protocol Violation|0|||
33187006|NCT03616912|100594399|FG000|Overall Study|Physician Decision|2|||
33187007|NCT03616912|100594400|FG001|Overall Study|Physician Decision|0|||
33187008|NCT03616912|100594401|FG002|Overall Study|Physician Decision|0|||
33187009|NCT03616912|100594402|FG003|Overall Study|Physician Decision|0|||
33187010|NCT03616912|100594403|FG004|Overall Study|Physician Decision|1|||
33187011|NCT03616912|100594404|FG005|Overall Study|Physician Decision|0|||
33187012|NCT03616912|100594399|FG000|Overall Study|Randomized But Never Treated|0|||
33187013|NCT03616912|100594400|FG001|Overall Study|Randomized But Never Treated|2|||
33187014|NCT03616912|100594401|FG002|Overall Study|Randomized But Never Treated|0|||
33187015|NCT03616912|100594402|FG003|Overall Study|Randomized But Never Treated|0|||
33187016|NCT03616912|100594403|FG004|Overall Study|Randomized But Never Treated|0|||
33187017|NCT03616912|100594404|FG005|Overall Study|Randomized But Never Treated|0|||
33187018|NCT01802775|100594405|FG000|Overall Study|Death|0|||
33187019|NCT01802775|100594406|FG001|Overall Study|Death|3|||
33187020|NCT01802775|100594405|FG000|Overall Study|Reason not provided|0|||
33187021|NCT01802775|100594406|FG001|Overall Study|Reason not provided|1|||
33187022|NCT01802775|100594405|FG000|Overall Study|Physician Decision|1|||
33187023|NCT01802775|100594406|FG001|Overall Study|Physician Decision|0|||
33187024|NCT01802775|100594405|FG000|Overall Study|Adverse Event|1|||
33187025|NCT01802775|100594406|FG001|Overall Study|Adverse Event|1|||
33187026|NCT01802775|100594405|FG000|Overall Study|Withdrawal by Subject|3|||
33187027|NCT01802775|100594406|FG001|Overall Study|Withdrawal by Subject|5|||
33187028|NCT01802775|100594405|FG000|Overall Study|Lost to Follow-up|1|||
33187029|NCT01802775|100594406|FG001|Overall Study|Lost to Follow-up|2|||
33187030|NCT00994448|100594410|FG000|Overall Study|Adverse Event|1|||
33187031|NCT00994448|100594411|FG001|Overall Study|Adverse Event|0|||
33187032|NCT00994448|100594410|FG000|Overall Study|Lost to Follow-up|5|||
33187033|NCT00994448|100594411|FG001|Overall Study|Lost to Follow-up|1|||
33187034|NCT00994448|100594410|FG000|Overall Study|Withdrawal by Subject|1|||
33187035|NCT00994448|100594411|FG001|Overall Study|Withdrawal by Subject|1|||
33187036|NCT00994448|100594410|FG000|Overall Study|Physician Decision|1|||
33187037|NCT00994448|100594411|FG001|Overall Study|Physician Decision|0|||
33187038|NCT02129803|100594419|FG000|Overall Study|Protocol Violation|4|||
33187039|NCT02129803|100594420|FG001|Overall Study|Protocol Violation|0|||
33187040|NCT02129803|100594419|FG000|Overall Study|Physician Decision|0|||
33187041|NCT02129803|100594420|FG001|Overall Study|Physician Decision|1|||
33187042|NCT02129803|100594419|FG000|Overall Study|Difficulty sleeping|1|||
33187043|NCT02129803|100594420|FG001|Overall Study|Difficulty sleeping|0|||
33187044|NCT02129803|100594419|FG000|Overall Study|Morning headache|0|||
33187045|NCT02129803|100594420|FG001|Overall Study|Morning headache|1|||
33187046|NCT02129803|100594419|FG000|Overall Study|Withdrawal by Subject|1|||
33187047|NCT02129803|100594420|FG001|Overall Study|Withdrawal by Subject|1|||
33187048|NCT00813358|100594421|FG000|Overall Study|Death|32|||
33187049|NCT00813358|100594421|FG000|Overall Study|Lost to Follow-up|12|||
33187050|NCT00813358|100594421|FG000|Overall Study|other endpoints|5|||
33187051|NCT00813358|100594421|FG000|Overall Study|Withdrawal by Subject|20|||
33187052|NCT02703636|100594423|FG000|Overall Study|Adverse Event|14|||
33187053|NCT02703636|100594423|FG000|Overall Study|Study stopped by sponsor|1|||
33390168|NCT04731922|101317674|FG014|Overall Study|Other|0|||
33187054|NCT02703636|100594423|FG000|Overall Study|Withdrawal by Subject|1|||
33187055|NCT02296112|100594429|FG000|Overall Study|Disease progression|7|||
33187056|NCT02296112|100594429|FG000|Overall Study|Toxicity|1|||
33187057|NCT02296112|100594429|FG000|Overall Study|Began an alternate therapy|1|||
33187058|NCT01488097|100594436|FG000|Overall Study|Lost to Follow-up|1|||
33187059|NCT03670810|100594437|FG000|Main Study|Adverse Event|37|||
33187060|NCT03670810|100594438|FG001|Main Study|Adverse Event|38|||
33187061|NCT03670810|100594439|FG002|Main Study|Adverse Event|3|||
33187062|NCT03670810|100594440|FG003|Main Study|Adverse Event|4|||
33390169|NCT04731922|101317675|FG015|Overall Study|Other|0|||
33187063|NCT03670810|100594441|FG004|Main Study|Adverse Event|4|||
33187064|NCT03670810|100594442|FG005|Main Study|Adverse Event|5|||
33187065|NCT03670810|100594443|FG006|Main Study|Adverse Event|0|||
33187066|NCT03670810|100594444|FG007|Main Study|Adverse Event|0|||
33187067|NCT03670810|100594445|FG008|Main Study|Adverse Event|0|||
33187068|NCT03670810|100594437|FG000|Main Study|Lack of Efficacy|8|||
33187069|NCT03670810|100594438|FG001|Main Study|Lack of Efficacy|9|||
33187070|NCT03670810|100594439|FG002|Main Study|Lack of Efficacy|3|||
33187071|NCT03670810|100594440|FG003|Main Study|Lack of Efficacy|4|||
33187072|NCT03670810|100594441|FG004|Main Study|Lack of Efficacy|0|||
33187073|NCT03670810|100594442|FG005|Main Study|Lack of Efficacy|0|||
33187074|NCT03670810|100594443|FG006|Main Study|Lack of Efficacy|0|||
33187075|NCT03670810|100594444|FG007|Main Study|Lack of Efficacy|0|||
33288788|NCT00839332|100955003|FG002|Phase 2|Protocol Violation|0|||
33288789|NCT00839332|100955001|FG000|Phase 2|Disease Progression|0|||
33288790|NCT00839332|100955002|FG001|Phase 2|Disease Progression|46|||
33288791|NCT00839332|100955003|FG002|Phase 2|Disease Progression|21|||
33288792|NCT00839332|100955001|FG000|Phase 2|Adverse Event|0|||
33288793|NCT00839332|100955002|FG001|Phase 2|Adverse Event|8|||
33288794|NCT00839332|100955003|FG002|Phase 2|Adverse Event|6|||
33187076|NCT03670810|100594445|FG008|Main Study|Lack of Efficacy|0|||
33187077|NCT03670810|100594437|FG000|Main Study|Lost to Follow-up|9|||
33187078|NCT03670810|100594438|FG001|Main Study|Lost to Follow-up|7|||
33187079|NCT03670810|100594439|FG002|Main Study|Lost to Follow-up|4|||
33187080|NCT03670810|100594440|FG003|Main Study|Lost to Follow-up|6|||
33187081|NCT03670810|100594441|FG004|Main Study|Lost to Follow-up|1|||
33187082|NCT03670810|100594442|FG005|Main Study|Lost to Follow-up|0|||
33187083|NCT03670810|100594443|FG006|Main Study|Lost to Follow-up|0|||
33187084|NCT03670810|100594444|FG007|Main Study|Lost to Follow-up|0|||
33187085|NCT03670810|100594445|FG008|Main Study|Lost to Follow-up|0|||
33187086|NCT03670810|100594437|FG000|Main Study|Non-compliance with Study Drug|0|||
33187087|NCT03670810|100594438|FG001|Main Study|Non-compliance with Study Drug|2|||
33187088|NCT03670810|100594439|FG002|Main Study|Non-compliance with Study Drug|3|||
33187089|NCT03670810|100594440|FG003|Main Study|Non-compliance with Study Drug|0|||
33187090|NCT03670810|100594441|FG004|Main Study|Non-compliance with Study Drug|0|||
33187091|NCT03670810|100594442|FG005|Main Study|Non-compliance with Study Drug|0|||
33187092|NCT03670810|100594443|FG006|Main Study|Non-compliance with Study Drug|0|||
33187093|NCT03670810|100594444|FG007|Main Study|Non-compliance with Study Drug|1|||
33187094|NCT03670810|100594445|FG008|Main Study|Non-compliance with Study Drug|0|||
33187095|NCT03670810|100594437|FG000|Main Study|Physician Decision|3|||
33187096|NCT03670810|100594438|FG001|Main Study|Physician Decision|0|||
33187097|NCT03670810|100594439|FG002|Main Study|Physician Decision|1|||
33187098|NCT03670810|100594440|FG003|Main Study|Physician Decision|0|||
33187099|NCT03670810|100594441|FG004|Main Study|Physician Decision|0|||
33187100|NCT03670810|100594442|FG005|Main Study|Physician Decision|0|||
33187101|NCT03670810|100594443|FG006|Main Study|Physician Decision|1|||
33187102|NCT03670810|100594444|FG007|Main Study|Physician Decision|1|||
33187103|NCT03670810|100594445|FG008|Main Study|Physician Decision|0|||
33187104|NCT03670810|100594437|FG000|Main Study|Pregnancy|1|||
33187105|NCT03670810|100594438|FG001|Main Study|Pregnancy|2|||
33187106|NCT03670810|100594439|FG002|Main Study|Pregnancy|0|||
33187107|NCT03670810|100594440|FG003|Main Study|Pregnancy|0|||
33187108|NCT03670810|100594441|FG004|Main Study|Pregnancy|0|||
33187109|NCT03670810|100594442|FG005|Main Study|Pregnancy|0|||
33187110|NCT03670810|100594443|FG006|Main Study|Pregnancy|0|||
33187111|NCT03670810|100594444|FG007|Main Study|Pregnancy|0|||
33187112|NCT03670810|100594445|FG008|Main Study|Pregnancy|0|||
33187113|NCT03670810|100594437|FG000|Main Study|Protocol Deviation|2|||
33187114|NCT03670810|100594438|FG001|Main Study|Protocol Deviation|12|||
33187115|NCT03670810|100594439|FG002|Main Study|Protocol Deviation|8|||
33187116|NCT03670810|100594440|FG003|Main Study|Protocol Deviation|4|||
33187117|NCT03670810|100594441|FG004|Main Study|Protocol Deviation|0|||
33187118|NCT03670810|100594442|FG005|Main Study|Protocol Deviation|0|||
33187119|NCT03670810|100594443|FG006|Main Study|Protocol Deviation|0|||
33187120|NCT03670810|100594444|FG007|Main Study|Protocol Deviation|0|||
33187121|NCT03670810|100594445|FG008|Main Study|Protocol Deviation|0|||
33187122|NCT03670810|100594437|FG000|Main Study|Withdrawal by Subject|21|||
33187123|NCT03670810|100594438|FG001|Main Study|Withdrawal by Subject|21|||
33187124|NCT03670810|100594439|FG002|Main Study|Withdrawal by Subject|8|||
33187125|NCT03670810|100594440|FG003|Main Study|Withdrawal by Subject|9|||
33187126|NCT03670810|100594441|FG004|Main Study|Withdrawal by Subject|5|||
33187127|NCT03670810|100594442|FG005|Main Study|Withdrawal by Subject|2|||
33187128|NCT03670810|100594443|FG006|Main Study|Withdrawal by Subject|1|||
33187129|NCT03670810|100594444|FG007|Main Study|Withdrawal by Subject|1|||
33288795|NCT00839332|100955001|FG000|Phase 2|Death|0|||
33288796|NCT00839332|100955002|FG001|Phase 2|Death|4|||
33187130|NCT03670810|100594445|FG008|Main Study|Withdrawal by Subject|0|||
33187131|NCT03670810|100594437|FG000|Main Study|Participant did not want to take the three other treatments|1|||
33187132|NCT03670810|100594438|FG001|Main Study|Participant did not want to take the three other treatments|0|||
33187133|NCT03670810|100594439|FG002|Main Study|Participant did not want to take the three other treatments|0|||
33187134|NCT03670810|100594440|FG003|Main Study|Participant did not want to take the three other treatments|0|||
33187135|NCT03670810|100594441|FG004|Main Study|Participant did not want to take the three other treatments|0|||
33187136|NCT03670810|100594442|FG005|Main Study|Participant did not want to take the three other treatments|0|||
33187137|NCT03670810|100594443|FG006|Main Study|Participant did not want to take the three other treatments|0|||
33187138|NCT03670810|100594444|FG007|Main Study|Participant did not want to take the three other treatments|0|||
33288797|NCT00839332|100955003|FG002|Phase 2|Death|2|||
33288798|NCT00839332|100955001|FG000|Phase 2|Withdrawal by Subject|0|||
33187139|NCT03670810|100594445|FG008|Main Study|Participant did not want to take the three other treatments|0|||
33187140|NCT03670810|100594437|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33187141|NCT03670810|100594438|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
33187142|NCT03670810|100594439|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33187143|NCT03670810|100594440|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33187144|NCT03670810|100594441|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33187145|NCT03670810|100594442|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33187146|NCT03670810|100594443|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33187147|NCT03670810|100594444|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33187148|NCT03670810|100594445|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
33187149|NCT03670810|100594437|FG000|Main Study|Travel and Coronavirus issues|0|||
33187150|NCT03670810|100594438|FG001|Main Study|Travel and Coronavirus issues|0|||
33187151|NCT03670810|100594439|FG002|Main Study|Travel and Coronavirus issues|0|||
33187152|NCT03670810|100594440|FG003|Main Study|Travel and Coronavirus issues|1|||
33187153|NCT03670810|100594441|FG004|Main Study|Travel and Coronavirus issues|0|||
33187154|NCT03670810|100594442|FG005|Main Study|Travel and Coronavirus issues|0|||
33187155|NCT03670810|100594443|FG006|Main Study|Travel and Coronavirus issues|0|||
33187156|NCT03670810|100594444|FG007|Main Study|Travel and Coronavirus issues|0|||
33187157|NCT03670810|100594445|FG008|Main Study|Travel and Coronavirus issues|0|||
33187158|NCT03670810|100594437|FG000|Open Label Extension|Protocol Deviation|0|||
33187159|NCT03670810|100594438|FG001|Open Label Extension|Protocol Deviation|0|||
33187160|NCT03670810|100594439|FG002|Open Label Extension|Protocol Deviation|0|||
33187161|NCT03670810|100594440|FG003|Open Label Extension|Protocol Deviation|0|||
33187162|NCT03670810|100594441|FG004|Open Label Extension|Protocol Deviation|0|||
33187163|NCT03670810|100594442|FG005|Open Label Extension|Protocol Deviation|0|||
33187164|NCT03670810|100594443|FG006|Open Label Extension|Protocol Deviation|0|||
33187165|NCT03670810|100594444|FG007|Open Label Extension|Protocol Deviation|0|||
33187166|NCT03670810|100594445|FG008|Open Label Extension|Protocol Deviation|5|||
33187167|NCT03670810|100594437|FG000|Open Label Extension|Death|0|||
33187168|NCT03670810|100594438|FG001|Open Label Extension|Death|0|||
33187169|NCT03670810|100594439|FG002|Open Label Extension|Death|0|||
33187170|NCT03670810|100594440|FG003|Open Label Extension|Death|0|||
33187171|NCT03670810|100594441|FG004|Open Label Extension|Death|0|||
33187172|NCT03670810|100594442|FG005|Open Label Extension|Death|0|||
33187173|NCT03670810|100594443|FG006|Open Label Extension|Death|0|||
33187174|NCT03670810|100594444|FG007|Open Label Extension|Death|0|||
33187175|NCT03670810|100594445|FG008|Open Label Extension|Death|1|||
33187176|NCT03670810|100594437|FG000|Open Label Extension|COVID-19|0|||
33187177|NCT03670810|100594438|FG001|Open Label Extension|COVID-19|0|||
33187178|NCT03670810|100594439|FG002|Open Label Extension|COVID-19|0|||
33187179|NCT03670810|100594440|FG003|Open Label Extension|COVID-19|0|||
33187180|NCT03670810|100594441|FG004|Open Label Extension|COVID-19|0|||
33187181|NCT03670810|100594442|FG005|Open Label Extension|COVID-19|0|||
33187182|NCT03670810|100594443|FG006|Open Label Extension|COVID-19|0|||
33187183|NCT03670810|100594444|FG007|Open Label Extension|COVID-19|0|||
33187184|NCT03670810|100594445|FG008|Open Label Extension|COVID-19|1|||
33187185|NCT03670810|100594437|FG000|Open Label Extension|Lack of Efficacy|0|||
33187186|NCT03670810|100594438|FG001|Open Label Extension|Lack of Efficacy|0|||
33187187|NCT03670810|100594439|FG002|Open Label Extension|Lack of Efficacy|0|||
33187188|NCT03670810|100594440|FG003|Open Label Extension|Lack of Efficacy|0|||
33187189|NCT03670810|100594441|FG004|Open Label Extension|Lack of Efficacy|0|||
33187190|NCT03670810|100594442|FG005|Open Label Extension|Lack of Efficacy|0|||
33187191|NCT03670810|100594443|FG006|Open Label Extension|Lack of Efficacy|0|||
33187192|NCT03670810|100594444|FG007|Open Label Extension|Lack of Efficacy|0|||
33187193|NCT03670810|100594445|FG008|Open Label Extension|Lack of Efficacy|39|||
33187194|NCT03670810|100594437|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
33187195|NCT03670810|100594438|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
33187196|NCT03670810|100594439|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
33187197|NCT03670810|100594440|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
33187198|NCT03670810|100594441|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
33187199|NCT03670810|100594442|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
33187200|NCT03670810|100594443|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
33187201|NCT03670810|100594444|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
33187202|NCT03670810|100594445|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
33187203|NCT03670810|100594437|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33187204|NCT03670810|100594438|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33187205|NCT03670810|100594439|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33187206|NCT03670810|100594440|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33187207|NCT03670810|100594441|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33187208|NCT03670810|100594442|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33187209|NCT03670810|100594443|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33187210|NCT03670810|100594444|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
33187211|NCT03670810|100594445|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
33187212|NCT03670810|100594437|FG000|Open Label Extension|Withdrawal by Subject|0|||
33187213|NCT03670810|100594438|FG001|Open Label Extension|Withdrawal by Subject|0|||
33187214|NCT03670810|100594439|FG002|Open Label Extension|Withdrawal by Subject|0|||
33187215|NCT03670810|100594440|FG003|Open Label Extension|Withdrawal by Subject|0|||
33187216|NCT03670810|100594441|FG004|Open Label Extension|Withdrawal by Subject|0|||
33187217|NCT03670810|100594442|FG005|Open Label Extension|Withdrawal by Subject|0|||
33187218|NCT03670810|100594443|FG006|Open Label Extension|Withdrawal by Subject|0|||
33187219|NCT03670810|100594444|FG007|Open Label Extension|Withdrawal by Subject|0|||
33187220|NCT03670810|100594445|FG008|Open Label Extension|Withdrawal by Subject|46|||
33187221|NCT03670810|100594437|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33187222|NCT03670810|100594438|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33187223|NCT03670810|100594439|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33187224|NCT03670810|100594440|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33187225|NCT03670810|100594441|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33187226|NCT03670810|100594442|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33187227|NCT03670810|100594443|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33187228|NCT03670810|100594444|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
33187229|NCT03670810|100594445|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
33187230|NCT03670810|100594437|FG000|Open Label Extension|Physician Decision|0|||
33187231|NCT03670810|100594438|FG001|Open Label Extension|Physician Decision|0|||
33187232|NCT03670810|100594439|FG002|Open Label Extension|Physician Decision|0|||
33187233|NCT03670810|100594440|FG003|Open Label Extension|Physician Decision|0|||
33187234|NCT03670810|100594441|FG004|Open Label Extension|Physician Decision|0|||
33187235|NCT03670810|100594442|FG005|Open Label Extension|Physician Decision|0|||
33187236|NCT03670810|100594443|FG006|Open Label Extension|Physician Decision|0|||
33187237|NCT03670810|100594444|FG007|Open Label Extension|Physician Decision|0|||
33187238|NCT03670810|100594445|FG008|Open Label Extension|Physician Decision|2|||
33187239|NCT03670810|100594437|FG000|Open Label Extension|Non-compliance with study drug|0|||
33187240|NCT03670810|100594438|FG001|Open Label Extension|Non-compliance with study drug|0|||
33187241|NCT03670810|100594439|FG002|Open Label Extension|Non-compliance with study drug|0|||
33187242|NCT03670810|100594440|FG003|Open Label Extension|Non-compliance with study drug|0|||
33187243|NCT03670810|100594441|FG004|Open Label Extension|Non-compliance with study drug|0|||
33187244|NCT03670810|100594442|FG005|Open Label Extension|Non-compliance with study drug|0|||
33187245|NCT03670810|100594443|FG006|Open Label Extension|Non-compliance with study drug|0|||
33187246|NCT03670810|100594444|FG007|Open Label Extension|Non-compliance with study drug|0|||
33187247|NCT03670810|100594445|FG008|Open Label Extension|Non-compliance with study drug|5|||
33187248|NCT03670810|100594437|FG000|Open Label Extension|Pregnancy|0|||
33187249|NCT03670810|100594438|FG001|Open Label Extension|Pregnancy|0|||
33187250|NCT03670810|100594439|FG002|Open Label Extension|Pregnancy|0|||
33187251|NCT03670810|100594440|FG003|Open Label Extension|Pregnancy|0|||
33187252|NCT03670810|100594441|FG004|Open Label Extension|Pregnancy|0|||
33187253|NCT03670810|100594442|FG005|Open Label Extension|Pregnancy|0|||
33187254|NCT03670810|100594443|FG006|Open Label Extension|Pregnancy|0|||
33187255|NCT03670810|100594444|FG007|Open Label Extension|Pregnancy|0|||
33187256|NCT03670810|100594445|FG008|Open Label Extension|Pregnancy|3|||
33187257|NCT03670810|100594437|FG000|Open Label Extension|Adverse Event|0|||
33187258|NCT03670810|100594438|FG001|Open Label Extension|Adverse Event|0|||
33187259|NCT03670810|100594439|FG002|Open Label Extension|Adverse Event|0|||
33187260|NCT03670810|100594440|FG003|Open Label Extension|Adverse Event|0|||
33187261|NCT03670810|100594441|FG004|Open Label Extension|Adverse Event|0|||
33187262|NCT03670810|100594442|FG005|Open Label Extension|Adverse Event|0|||
33187263|NCT03670810|100594443|FG006|Open Label Extension|Adverse Event|0|||
33187264|NCT03670810|100594444|FG007|Open Label Extension|Adverse Event|0|||
33187265|NCT03670810|100594445|FG008|Open Label Extension|Adverse Event|24|||
33187266|NCT03670810|100594437|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
33187267|NCT03670810|100594438|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
33187268|NCT03670810|100594439|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
33187269|NCT03670810|100594440|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
33187270|NCT03670810|100594441|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
33187271|NCT03670810|100594442|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
33187272|NCT03670810|100594443|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
33187273|NCT03670810|100594444|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
33187274|NCT03670810|100594445|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
33390170|NCT04731922|101317676|FG016|Overall Study|Other|0|||
33187275|NCT03670810|100594437|FG000|Open Label Extension|Lost to Follow-up|0|||
33187276|NCT03670810|100594438|FG001|Open Label Extension|Lost to Follow-up|0|||
33187277|NCT03670810|100594439|FG002|Open Label Extension|Lost to Follow-up|0|||
33187278|NCT03670810|100594440|FG003|Open Label Extension|Lost to Follow-up|0|||
33187279|NCT03670810|100594441|FG004|Open Label Extension|Lost to Follow-up|0|||
33187280|NCT03670810|100594442|FG005|Open Label Extension|Lost to Follow-up|0|||
33187281|NCT03670810|100594443|FG006|Open Label Extension|Lost to Follow-up|0|||
33187282|NCT03670810|100594444|FG007|Open Label Extension|Lost to Follow-up|0|||
33187283|NCT03670810|100594445|FG008|Open Label Extension|Lost to Follow-up|23|||
33187284|NCT00302003|100594446|FG000|Overall Study|Lack of Efficacy|62|||
33187285|NCT00302003|100594446|FG000|Overall Study|Lost to Follow-up|1|||
33187286|NCT00302003|100594446|FG000|Overall Study|Physician Decision|2|||
33187287|NCT00302003|100594446|FG000|Overall Study|Withdrawal by Subject|5|||
33187288|NCT00302003|100594446|FG000|Overall Study|Ineligible|9|||
33187289|NCT00302003|100594446|FG000|Overall Study|Protocol Violation|1|||
33187290|NCT03299192|100594455|FG000|Overall Study|Fell before classes started|1|||
33187291|NCT03299192|100594456|FG001|Overall Study|Fell before classes started|0|||
33187292|NCT03299192|100594457|FG002|Overall Study|Fell before classes started|0|||
33187293|NCT03299192|100594455|FG000|Overall Study|Other|0|||
33187294|NCT03299192|100594456|FG001|Overall Study|Other|2|||
33187295|NCT03299192|100594457|FG002|Overall Study|Other|1|||
33187296|NCT04765358|100594458|FG000|Overall Study|Withdrawal by Subject|1|||
33187297|NCT02501096|100594471|FG000|Overall Study|Lost to Follow-up|0|||
33187298|NCT02501096|100594472|FG001|Overall Study|Lost to Follow-up|0|||
33187299|NCT02501096|100594473|FG002|Overall Study|Lost to Follow-up|0|||
33187300|NCT02501096|100594474|FG003|Overall Study|Lost to Follow-up|0|||
33187301|NCT02501096|100594475|FG004|Overall Study|Lost to Follow-up|1|||
33187302|NCT02501096|100594476|FG005|Overall Study|Lost to Follow-up|1|||
33187303|NCT02501096|100594477|FG006|Overall Study|Lost to Follow-up|3|||
33187304|NCT02501096|100594478|FG007|Overall Study|Lost to Follow-up|0|||
33187305|NCT02501096|100594479|FG008|Overall Study|Lost to Follow-up|0|||
33187306|NCT02501096|100594471|FG000|Overall Study|Withdrawal by Subject|1|||
33187307|NCT02501096|100594472|FG001|Overall Study|Withdrawal by Subject|0|||
33187308|NCT02501096|100594473|FG002|Overall Study|Withdrawal by Subject|7|||
33187309|NCT02501096|100594474|FG003|Overall Study|Withdrawal by Subject|13|||
33187310|NCT02501096|100594475|FG004|Overall Study|Withdrawal by Subject|2|||
33187311|NCT02501096|100594476|FG005|Overall Study|Withdrawal by Subject|2|||
33187312|NCT02501096|100594477|FG006|Overall Study|Withdrawal by Subject|2|||
33187313|NCT02501096|100594478|FG007|Overall Study|Withdrawal by Subject|3|||
33187314|NCT02501096|100594479|FG008|Overall Study|Withdrawal by Subject|0|||
33187315|NCT02501096|100594471|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
33187316|NCT02501096|100594472|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
33187317|NCT02501096|100594473|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
33187318|NCT02501096|100594474|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
33187319|NCT02501096|100594475|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
33187320|NCT02501096|100594476|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
33187321|NCT02501096|100594477|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
33187322|NCT02501096|100594478|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
33187323|NCT02501096|100594479|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
33187324|NCT02501096|100594471|FG000|Overall Study|Death|1|||
33187325|NCT02501096|100594472|FG001|Overall Study|Death|1|||
33187326|NCT02501096|100594473|FG002|Overall Study|Death|88|||
33187327|NCT02501096|100594474|FG003|Overall Study|Death|74|||
33187328|NCT02501096|100594475|FG004|Overall Study|Death|15|||
33187329|NCT02501096|100594476|FG005|Overall Study|Death|16|||
33187330|NCT02501096|100594477|FG006|Overall Study|Death|15|||
33187331|NCT02501096|100594478|FG007|Overall Study|Death|16|||
33187332|NCT02501096|100594479|FG008|Overall Study|Death|1|||
33187333|NCT00539838|100594480|FG000|Overall Study|Fail to return|2|||
33187334|NCT00539838|100594481|FG001|Overall Study|Fail to return|0|||
33187335|NCT00539838|100594482|FG002|Overall Study|Fail to return|0|||
33187336|NCT00539838|100594480|FG000|Overall Study|Withdrawal by Subject|0|||
33187337|NCT00539838|100594481|FG001|Overall Study|Withdrawal by Subject|4|||
33187338|NCT00539838|100594482|FG002|Overall Study|Withdrawal by Subject|0|||
33187339|NCT00539838|100594480|FG000|Overall Study|Death|0|||
33187340|NCT00539838|100594481|FG001|Overall Study|Death|2|||
33187341|NCT00539838|100594482|FG002|Overall Study|Death|0|||
33187342|NCT00539838|100594480|FG000|Overall Study|Did not cooperate|1|||
33187343|NCT00539838|100594481|FG001|Overall Study|Did not cooperate|0|||
33187344|NCT00539838|100594482|FG002|Overall Study|Did not cooperate|1|||
33187345|NCT00539838|100594480|FG000|Overall Study|Administrative|4|||
33187346|NCT00539838|100594481|FG001|Overall Study|Administrative|0|||
33187347|NCT00539838|100594482|FG002|Overall Study|Administrative|8|||
33187348|NCT00404352|100594485|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
33187349|NCT00404352|100594486|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
33187350|NCT00404352|100594487|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
33187351|NCT00404352|100594488|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
33288799|NCT00839332|100955002|FG001|Phase 2|Withdrawal by Subject|5|||
33187352|NCT00404352|100594489|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
33187353|NCT00404352|100594490|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
33187354|NCT00404352|100594491|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
33187355|NCT00404352|100594492|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
33187356|NCT00404352|100594493|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
33187357|NCT00404352|100594485|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
33187358|NCT00404352|100594486|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
33187359|NCT00404352|100594487|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
33187360|NCT00404352|100594488|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
33187361|NCT00404352|100594489|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
33187362|NCT00404352|100594490|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
33187363|NCT00404352|100594491|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
33187364|NCT00404352|100594492|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
33187365|NCT00404352|100594493|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
33187366|NCT00404352|100594485|FG000|Double Blind (up to 24 Month)|Death|0|||
33187367|NCT00404352|100594486|FG001|Double Blind (up to 24 Month)|Death|0|||
33187368|NCT00404352|100594487|FG002|Double Blind (up to 24 Month)|Death|1|||
33187369|NCT00404352|100594488|FG003|Double Blind (up to 24 Month)|Death|0|||
33187370|NCT00404352|100594489|FG004|Double Blind (up to 24 Month)|Death|0|||
33187371|NCT00404352|100594490|FG005|Double Blind (up to 24 Month)|Death|0|||
33187372|NCT00404352|100594491|FG006|Double Blind (up to 24 Month)|Death|0|||
33187373|NCT00404352|100594492|FG007|Double Blind (up to 24 Month)|Death|0|||
33187374|NCT00404352|100594493|FG008|Double Blind (up to 24 Month)|Death|0|||
33187375|NCT00404352|100594485|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
33187376|NCT00404352|100594486|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
33187377|NCT00404352|100594487|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
33187378|NCT00404352|100594488|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
33288800|NCT00839332|100955003|FG002|Phase 2|Withdrawal by Subject|8|||
33288801|NCT00839332|100955001|FG000|Phase 2|Physician Decision|0|||
33288802|NCT00839332|100955002|FG001|Phase 2|Physician Decision|4|||
33288803|NCT00839332|100955003|FG002|Phase 2|Physician Decision|1|||
33288804|NCT00839332|100955001|FG000|Phase 2|Lost to Follow-up|0|||
33288805|NCT00839332|100955002|FG001|Phase 2|Lost to Follow-up|0|||
33288806|NCT00839332|100955003|FG002|Phase 2|Lost to Follow-up|1|||
33288807|NCT01470599|100955008|FG000|Overall Study|Did not meet entrance criteria|1|||
33288808|NCT01470599|100955009|FG001|Overall Study|Did not meet entrance criteria|0|||
33288809|NCT01470599|100955008|FG000|Overall Study|Lost to Follow-up|2|||
33187379|NCT00404352|100594489|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
33187380|NCT00404352|100594490|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
33187381|NCT00404352|100594491|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
33187382|NCT00404352|100594492|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
33187383|NCT00404352|100594493|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
33187384|NCT00404352|100594485|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
33187385|NCT00404352|100594486|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
33187386|NCT00404352|100594487|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
33187387|NCT00404352|100594488|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
33187388|NCT00404352|100594489|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
33187389|NCT00404352|100594490|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
33187390|NCT00404352|100594491|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
33187391|NCT00404352|100594492|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
33187392|NCT00404352|100594493|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
33187393|NCT00404352|100594485|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
33187394|NCT00404352|100594486|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
33187395|NCT00404352|100594487|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
33187396|NCT00404352|100594488|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
33187397|NCT00404352|100594489|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
33187398|NCT00404352|100594490|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
33187399|NCT00404352|100594491|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
33187400|NCT00404352|100594492|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
33187401|NCT00404352|100594493|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
33187402|NCT00404352|100594485|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
33187403|NCT00404352|100594486|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
33187404|NCT00404352|100594487|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
33187405|NCT00404352|100594488|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
33187406|NCT00404352|100594489|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
33187407|NCT00404352|100594490|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
33187408|NCT00404352|100594491|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
33187409|NCT00404352|100594492|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
33187410|NCT00404352|100594493|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
33187411|NCT00404352|100594485|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
33288810|NCT01470599|100955009|FG001|Overall Study|Lost to Follow-up|1|||
33288811|NCT01470599|100955008|FG000|Overall Study|Withdrawal by Subject|3|||
33187412|NCT00404352|100594486|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
33187413|NCT00404352|100594487|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
33187414|NCT00404352|100594488|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
33187415|NCT00404352|100594489|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
33187416|NCT00404352|100594490|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
33187417|NCT00404352|100594491|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
33288812|NCT01470599|100955009|FG001|Overall Study|Withdrawal by Subject|4|||
33288813|NCT01470599|100955008|FG000|Overall Study|Other|1|||
33288814|NCT01470599|100955009|FG001|Overall Study|Other|0|||
33288815|NCT01470599|100955008|FG000|Overall Study|Protocol Violation|3|||
33288816|NCT01470599|100955009|FG001|Overall Study|Protocol Violation|1|||
33288817|NCT01470599|100955008|FG000|Overall Study|Adverse event related to study drug|2|||
33288818|NCT01470599|100955009|FG001|Overall Study|Adverse event related to study drug|5|||
33288819|NCT01470599|100955008|FG000|Overall Study|Insufficient clinical response|6|||
33288820|NCT01470599|100955009|FG001|Overall Study|Insufficient clinical response|27|||
33288821|NCT01470599|100955008|FG000|Overall Study|Adverse event not related to study drug|1|||
33288822|NCT01470599|100955009|FG001|Overall Study|Adverse event not related to study drug|5|||
33288823|NCT01169636|100955011|FG000|Overall Study|Adverse Event|0|||
33288824|NCT01169636|100955012|FG001|Overall Study|Adverse Event|0|||
33288825|NCT01169636|100955013|FG002|Overall Study|Adverse Event|1|||
33288826|NCT01169636|100955014|FG003|Overall Study|Adverse Event|1|||
33288827|NCT01169636|100955015|FG004|Overall Study|Adverse Event|0|||
33288828|NCT01169636|100955011|FG000|Overall Study|Screen failure|0|||
33288829|NCT01169636|100955012|FG001|Overall Study|Screen failure|0|||
33288830|NCT01169636|100955013|FG002|Overall Study|Screen failure|2|||
33288831|NCT01169636|100955014|FG003|Overall Study|Screen failure|0|||
33288832|NCT01169636|100955015|FG004|Overall Study|Screen failure|0|||
33288833|NCT01169636|100955011|FG000|Overall Study|Withdrawal by Subject|0|||
33288834|NCT01169636|100955012|FG001|Overall Study|Withdrawal by Subject|0|||
33288835|NCT01169636|100955013|FG002|Overall Study|Withdrawal by Subject|0|||
33288836|NCT01169636|100955014|FG003|Overall Study|Withdrawal by Subject|0|||
33288837|NCT01169636|100955015|FG004|Overall Study|Withdrawal by Subject|3|||
33288838|NCT03842436|100955016|FG000|Overall Study|Lost to Follow-up|1|||
33288839|NCT01078922|100955017|FG000|Overall Study|Adverse Event|1|||
33288840|NCT01710800|100955022|FG000|Overall Study|Withdrawal by Subject|21|||
33288841|NCT01710800|100955022|FG000|Overall Study|Protocol Violation|1|||
33288842|NCT00746356|100955023|FG000|Overall Study|Withdrawal by Subject|2|||
33288843|NCT00746356|100955024|FG001|Overall Study|Withdrawal by Subject|3|||
33288844|NCT00746356|100955023|FG000|Overall Study|Death|7|||
33288845|NCT00746356|100955024|FG001|Overall Study|Death|3|||
33288846|NCT00746356|100955023|FG000|Overall Study|Lost to Follow-up|1|||
33288847|NCT00746356|100955024|FG001|Overall Study|Lost to Follow-up|0|||
33288848|NCT00746356|100955023|FG000|Overall Study|Removal of Device|0|||
33288849|NCT00746356|100955024|FG001|Overall Study|Removal of Device|1|||
33288850|NCT00746356|100955023|FG000|Overall Study|Patient relocated|1|||
33288851|NCT00746356|100955024|FG001|Overall Study|Patient relocated|0|||
33288852|NCT04952701|100955031|FG000|Control Lens|Physician Decision|4|||
33288853|NCT04952701|100955031|FG000|Test Lens|Physician Decision|1|||
33288854|NCT03470545|100955036|FG000|Overall Study|Death|0|||
33288855|NCT03470545|100955037|FG001|Overall Study|Death|1|||
33288856|NCT03470545|100955036|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
33288857|NCT03470545|100955037|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
33288858|NCT03470545|100955036|FG000|Overall Study|Adverse Event|2|||
33288859|NCT03470545|100955037|FG001|Overall Study|Adverse Event|0|||
33187418|NCT00404352|100594492|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
33187419|NCT00404352|100594493|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
33187420|NCT00404352|100594485|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33187421|NCT00404352|100594486|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
33187422|NCT00404352|100594487|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33187423|NCT00404352|100594488|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33187424|NCT00404352|100594489|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33187425|NCT00404352|100594490|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33187426|NCT00404352|100594491|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33187427|NCT00404352|100594492|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33187428|NCT00404352|100594493|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
33187429|NCT00404352|100594485|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
33187430|NCT00404352|100594486|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
33187431|NCT00404352|100594487|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
33187432|NCT00404352|100594488|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
33187433|NCT00404352|100594489|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
33187434|NCT00404352|100594490|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
33187435|NCT00404352|100594491|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
33288860|NCT03470545|100955036|FG000|Overall Study|Withdrawal by Subject|1|||
33288861|NCT03470545|100955037|FG001|Overall Study|Withdrawal by Subject|1|||
33288862|NCT03470545|100955036|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
33288863|NCT03470545|100955037|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
33288864|NCT00732992|100955038|FG000|Overall Study|Adverse Event|1|||
33288865|NCT00732992|100955039|FG001|Overall Study|Adverse Event|1|||
33288866|NCT00732992|100955038|FG000|Overall Study|Objective Progression or Relapse|3|||
33288867|NCT00732992|100955039|FG001|Overall Study|Objective Progression or Relapse|5|||
33288868|NCT00732992|100955038|FG000|Overall Study|Global Deterioration of Health Status|1|||
33288869|NCT00732992|100955039|FG001|Overall Study|Global Deterioration of Health Status|0|||
33288870|NCT00732992|100955038|FG000|Overall Study|Withdrawal by Subject|1|||
33288871|NCT00732992|100955039|FG001|Overall Study|Withdrawal by Subject|0|||
33288872|NCT03021551|100955046|FG000|Overall Study|Equipment Issues|2|||
33288873|NCT03021551|100955046|FG000|Overall Study|Protocol Violation|1|||
33288874|NCT01128114|100955051|FG000|Overall Study|Treatment Withdrawn|6|||
33288875|NCT01128114|100955051|FG000|Overall Study|Screening Failed|2|||
33288876|NCT02725567|100955054|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
33288877|NCT02725567|100955055|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
33288878|NCT02725567|100955054|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
33288879|NCT02725567|100955055|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
33288880|NCT02725567|100955054|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
33288881|NCT02725567|100955055|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
33288882|NCT03020069|100955056|FG000|Overall Study|Lost to Follow-up|0|||
33288883|NCT03020069|100955057|FG001|Overall Study|Lost to Follow-up|1|||
33288884|NCT01017263|100955058|FG000|Overall Study|not eligible|12|||
33288885|NCT03029819|100955060|FG000|Overall Study|Lost to Follow-up|3|||
33288886|NCT03029819|100955061|FG001|Overall Study|Lost to Follow-up|5|||
33288887|NCT03029819|100955060|FG000|Overall Study|Removed due to disruptive behavior|0|||
33288888|NCT03029819|100955061|FG001|Overall Study|Removed due to disruptive behavior|1|||
33288889|NCT01918371|100955062|FG000|Overall Study|Missing Data|1|||
33288890|NCT01918371|100955063|FG001|Overall Study|Missing Data|1|||
33288891|NCT01426113|100955064|FG000|Overall Study|Study Discontinued|1|||
33288892|NCT01426113|100955065|FG001|Overall Study|Study Discontinued|1|||
33288893|NCT01426113|100955064|FG000|Overall Study|Adverse Event|0|||
33288894|NCT01426113|100955065|FG001|Overall Study|Adverse Event|1|||
33288895|NCT00321685|100955066|FG000|Overall Study|Adverse Event|18|||
33288896|NCT00321685|100955066|FG000|Overall Study|Death|2|||
33288897|NCT00321685|100955066|FG000|Overall Study|Withdrawal by Subject|8|||
33288898|NCT00321685|100955066|FG000|Overall Study|Alternative therapy|1|||
33288899|NCT00321685|100955066|FG000|Overall Study|Complicating disese|1|||
33288900|NCT00321685|100955066|FG000|Overall Study|Other|5|||
33288901|NCT00321685|100955066|FG000|Overall Study|Not start protocol therapy|2|||
33288902|NCT00321685|100955066|FG000|Overall Study|Ineligible|2|||
33288903|NCT01547598|100955067|FG000|Overall Study|Withdrew consent|1|||
33288904|NCT01547598|100955068|FG001|Overall Study|Withdrew consent|1|||
33288905|NCT01547598|100955067|FG000|Overall Study|Lost to Follow-up|1|||
33288906|NCT01547598|100955068|FG001|Overall Study|Lost to Follow-up|1|||
33288907|NCT01547598|100955067|FG000|Overall Study|Adverse Event|1|||
33288908|NCT01547598|100955068|FG001|Overall Study|Adverse Event|1|||
33288909|NCT01547598|100955067|FG000|Overall Study|Protocol Violation|1|||
33288910|NCT01547598|100955068|FG001|Overall Study|Protocol Violation|1|||
33288911|NCT01547598|100955067|FG000|Overall Study|Other Miscellaneous Reasons|2|||
33288912|NCT01547598|100955068|FG001|Overall Study|Other Miscellaneous Reasons|1|||
33288913|NCT01503164|100955073|FG000|Overall Study|Withdrawal by Subject|2|||
33288914|NCT01503164|100955074|FG001|Overall Study|Withdrawal by Subject|1|||
33288915|NCT02171130|100955075|FG000|Overall Study|Death|1|||
33288916|NCT02171130|100955075|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
33288917|NCT02171130|100955075|FG000|Overall Study|Discontinued; Site Termination|5|||
33288918|NCT02171130|100955075|FG000|Overall Study|Withdrawal by Subject|3|||
33288919|NCT02171130|100955075|FG000|Overall Study|Physician Decision|1|||
33288920|NCT02171130|100955075|FG000|Overall Study|Lost to Follow-up|1|||
33288921|NCT02171130|100955075|FG000|Overall Study|Met Exclusion Criteria|1|||
33288922|NCT02561806|100955079|FG000|Induction Period|Adverse Event|0|||
33288923|NCT02561806|100955080|FG001|Induction Period|Adverse Event|2|||
33288924|NCT02561806|100955079|FG000|Induction Period|Lack of Efficacy|1|||
33288925|NCT02561806|100955080|FG001|Induction Period|Lack of Efficacy|0|||
33288926|NCT02561806|100955079|FG000|Induction Period|Withdrawal by Subject|0|||
33288927|NCT02561806|100955080|FG001|Induction Period|Withdrawal by Subject|2|||
33288928|NCT02561806|100955079|FG000|Induction Period|Site staff became unblinded|1|||
33288929|NCT02561806|100955080|FG001|Induction Period|Site staff became unblinded|0|||
33390171|NCT00607919|101317677|FG000|Acute Phase|Adverse Event|9|||
33390172|NCT00607919|101317678|FG001|Acute Phase|Adverse Event|2|||
33288930|NCT02561806|100955079|FG000|Induction Period|Randomized but not treated|0|||
33288931|NCT02561806|100955080|FG001|Induction Period|Randomized but not treated|1|||
33288932|NCT02561806|100955079|FG000|Maintenance Period|Adverse Event|2|||
33288933|NCT02561806|100955080|FG001|Maintenance Period|Adverse Event|1|||
33390173|NCT00607919|101317677|FG000|Acute Phase|Entry Criteria Not Met|1|||
33288934|NCT02561806|100955079|FG000|Maintenance Period|Lack of Efficacy|3|||
33288935|NCT02561806|100955080|FG001|Maintenance Period|Lack of Efficacy|1|||
33288936|NCT02561806|100955079|FG000|Maintenance Period|Lost to Follow-up|2|||
33288937|NCT02561806|100955080|FG001|Maintenance Period|Lost to Follow-up|2|||
33288938|NCT02561806|100955079|FG000|Maintenance Period|Protocol Violation|1|||
33288939|NCT02561806|100955080|FG001|Maintenance Period|Protocol Violation|0|||
33288940|NCT02561806|100955079|FG000|Maintenance Period|Withdrawal by Subject|5|||
33288941|NCT02561806|100955080|FG001|Maintenance Period|Withdrawal by Subject|3|||
33288942|NCT02561806|100955079|FG000|Maintenance Period|Site staff became unblinded|0|||
33288943|NCT02561806|100955080|FG001|Maintenance Period|Site staff became unblinded|1|||
33288944|NCT02561806|100955079|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
33288945|NCT02561806|100955080|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
33288946|NCT02561806|100955079|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
33288947|NCT02561806|100955080|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
33288948|NCT01192776|100955084|FG000|Overall Study|Death|8|||
33288949|NCT01192776|100955085|FG001|Overall Study|Death|15|||
33288950|NCT01192776|100955086|FG002|Overall Study|Death|18|||
33288951|NCT01192776|100955087|FG003|Overall Study|Death|15|||
33288952|NCT01192776|100955084|FG000|Overall Study|Lost to Follow-up|3|||
33288953|NCT01192776|100955085|FG001|Overall Study|Lost to Follow-up|6|||
33288954|NCT01192776|100955086|FG002|Overall Study|Lost to Follow-up|3|||
33288955|NCT01192776|100955087|FG003|Overall Study|Lost to Follow-up|5|||
33288956|NCT00085566|100955088|FG000|Overall Study|Adverse Event|0|||
33288957|NCT00085566|100955089|FG001|Overall Study|Adverse Event|0|||
33288958|NCT00085566|100955090|FG002|Overall Study|Adverse Event|10|||
33288959|NCT00085566|100955088|FG000|Overall Study|Patient Not treated|0|||
33288960|NCT00085566|100955089|FG001|Overall Study|Patient Not treated|0|||
33288961|NCT00085566|100955090|FG002|Overall Study|Patient Not treated|3|||
33288962|NCT00085566|100955088|FG000|Overall Study|Clinical progression|0|||
33288963|NCT00085566|100955089|FG001|Overall Study|Clinical progression|0|||
33288964|NCT00085566|100955090|FG002|Overall Study|Clinical progression|1|||
33288965|NCT01587118|100955091|FG000|Overall Study|Adverse Event|3|||
33288966|NCT01587118|100955091|FG000|Overall Study|Lost to Follow-up|2|||
33288967|NCT01587118|100955091|FG000|Overall Study|Relocation|1|||
33288968|NCT01587118|100955091|FG000|Overall Study|nonresponse|1|||
33288969|NCT00778921|100955092|FG000|Overall Study|Adverse Event|9|||
33288970|NCT00778921|100955093|FG001|Overall Study|Adverse Event|10|||
33288971|NCT00778921|100955094|FG002|Overall Study|Adverse Event|14|||
33288972|NCT00778921|100955092|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
33288973|NCT00778921|100955093|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
33288974|NCT00778921|100955094|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
33288975|NCT00778921|100955092|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
33288976|NCT00778921|100955093|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
33288977|NCT00778921|100955094|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
33288978|NCT00778921|100955092|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
33288979|NCT00778921|100955093|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
33288980|NCT00778921|100955094|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
33288981|NCT00778921|100955092|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
33288982|NCT00778921|100955093|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
33288983|NCT00778921|100955094|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
33288984|NCT00778921|100955092|FG000|Overall Study|Patient withdrew request|3|||
33288985|NCT00778921|100955093|FG001|Overall Study|Patient withdrew request|1|||
33288986|NCT00778921|100955094|FG002|Overall Study|Patient withdrew request|6|||
33288987|NCT00778921|100955092|FG000|Overall Study|Lost to Follow-up|0|||
33288988|NCT00778921|100955093|FG001|Overall Study|Lost to Follow-up|2|||
33288989|NCT00778921|100955094|FG002|Overall Study|Lost to Follow-up|1|||
33288990|NCT00778921|100955092|FG000|Overall Study|Administrative Problems|1|||
33288991|NCT00778921|100955093|FG001|Overall Study|Administrative Problems|2|||
33288992|NCT00778921|100955094|FG002|Overall Study|Administrative Problems|0|||
33288993|NCT00778921|100955092|FG000|Overall Study|Protocol Violation|3|||
33288994|NCT00778921|100955093|FG001|Overall Study|Protocol Violation|0|||
33288995|NCT00778921|100955094|FG002|Overall Study|Protocol Violation|2|||
33288996|NCT00778921|100955092|FG000|Overall Study|Not treated|0|||
33288997|NCT00778921|100955093|FG001|Overall Study|Not treated|2|||
33288998|NCT00778921|100955094|FG002|Overall Study|Not treated|2|||
33288999|NCT03845075|100955095|FG000|Part 1 - DB|Withdrawal by Subject|1|||
33289000|NCT03845075|100955096|FG001|Part 1 - DB|Withdrawal by Subject|1|||
33289001|NCT03845075|100955097|FG002|Part 1 - DB|Withdrawal by Subject|0|||
33289002|NCT03845075|100955098|FG003|Part 1 - DB|Withdrawal by Subject|0|||
33289003|NCT03845075|100955095|FG000|Part 1 - DB|Adverse Event|0|||
33289004|NCT03845075|100955096|FG001|Part 1 - DB|Adverse Event|1|||
33289005|NCT03845075|100955097|FG002|Part 1 - DB|Adverse Event|0|||
33289006|NCT03845075|100955098|FG003|Part 1 - DB|Adverse Event|0|||
33289007|NCT03845075|100955095|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
33289008|NCT03845075|100955096|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
33289009|NCT03845075|100955097|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
33494944|NCT02515331|101705847|FG002|Overall Study|Adverse Event|0|||
33289010|NCT03845075|100955098|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
33289011|NCT00723125|100955099|FG000|Overall Study|Met Dx|1|||
33289012|NCT00723125|100955100|FG001|Overall Study|Met Dx|0|||
33289013|NCT00723125|100955099|FG000|Overall Study|Withdrawal by Subject|15|||
33289014|NCT00723125|100955100|FG001|Overall Study|Withdrawal by Subject|6|||
33289015|NCT00723125|100955099|FG000|Overall Study|Adverse Event|2|||
33289016|NCT00723125|100955100|FG001|Overall Study|Adverse Event|0|||
33289017|NCT00381797|100955101|FG000|Overall Study|Withdrawal by Subject|1|||
33289018|NCT00381797|100955102|FG001|Overall Study|Withdrawal by Subject|1|||
33289019|NCT00381797|100955103|FG002|Overall Study|Withdrawal by Subject|0|||
33289020|NCT00381797|100955104|FG003|Overall Study|Withdrawal by Subject|0|||
33289021|NCT00381797|100955105|FG004|Overall Study|Withdrawal by Subject|2|||
33289022|NCT00381797|100955101|FG000|Overall Study|Ineligible|0|||
33289023|NCT00381797|100955102|FG001|Overall Study|Ineligible|0|||
33289024|NCT00381797|100955103|FG002|Overall Study|Ineligible|0|||
33289025|NCT00381797|100955104|FG003|Overall Study|Ineligible|1|||
33289026|NCT00381797|100955105|FG004|Overall Study|Ineligible|0|||
33289027|NCT00832000|100955106|FG000|Overall Study|Adverse Event|2|||
33289028|NCT00832000|100955107|FG001|Overall Study|Adverse Event|0|||
33289029|NCT00832000|100955106|FG000|Overall Study|Withdrawal by Subject|1|||
33289030|NCT00832000|100955107|FG001|Overall Study|Withdrawal by Subject|0|||
33289031|NCT00832000|100955106|FG000|Overall Study|No calls to IVR in either period|1|||
33289032|NCT00832000|100955107|FG001|Overall Study|No calls to IVR in either period|1|||
33289033|NCT00832000|100955106|FG000|Overall Study|No calls to IVR in period 2|2|||
33289034|NCT00832000|100955107|FG001|Overall Study|No calls to IVR in period 2|0|||
33289035|NCT00983905|100955108|FG000|Theophylline Alone|Adverse Event|1|||
33289036|NCT00983905|100955108|FG000|Colchicine Alone|Adverse Event|2|||
33289037|NCT01006616|100955109|FG000|Period 1 (6 Months)|Adverse Event|10|||
33289038|NCT01006616|100955110|FG001|Period 1 (6 Months)|Adverse Event|31|||
33289039|NCT01006616|100955111|FG002|Period 1 (6 Months)|Adverse Event|37|||
33289040|NCT01006616|100955112|FG003|Period 1 (6 Months)|Adverse Event|9|||
33289041|NCT01006616|100955109|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
33289042|NCT01006616|100955110|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
33289043|NCT01006616|100955111|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
33289044|NCT01006616|100955112|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
33289045|NCT01006616|100955109|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
33289046|NCT01006616|100955110|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
33289047|NCT01006616|100955111|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
33289048|NCT01006616|100955112|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
33289049|NCT01006616|100955109|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
33289050|NCT01006616|100955110|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
33289051|NCT01006616|100955111|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
33289052|NCT01006616|100955112|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
33289053|NCT01006616|100955109|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
33289054|NCT01006616|100955110|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
33289055|NCT01006616|100955111|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
33289056|NCT01006616|100955112|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
33289057|NCT01006616|100955109|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
33289058|NCT01006616|100955110|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
33289059|NCT01006616|100955111|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
33289060|NCT01006616|100955112|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
33289061|NCT01006616|100955109|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
33289062|NCT01006616|100955110|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
33289063|NCT01006616|100955111|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
33289064|NCT01006616|100955112|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
33289065|NCT01006616|100955109|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
33289066|NCT01006616|100955110|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
33289067|NCT01006616|100955111|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
33289068|NCT01006616|100955112|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
33289069|NCT01006616|100955109|FG000|Period 1 (6 Months)|Not Treated|0|||
33289070|NCT01006616|100955110|FG001|Period 1 (6 Months)|Not Treated|0|||
33289071|NCT01006616|100955111|FG002|Period 1 (6 Months)|Not Treated|1|||
33289072|NCT01006616|100955112|FG003|Period 1 (6 Months)|Not Treated|1|||
33289073|NCT01006616|100955109|FG000|Period 2 (18 Months)|Adverse Event|6|||
33289074|NCT01006616|100955110|FG001|Period 2 (18 Months)|Adverse Event|6|||
33289075|NCT01006616|100955111|FG002|Period 2 (18 Months)|Adverse Event|6|||
33289076|NCT01006616|100955112|FG003|Period 2 (18 Months)|Adverse Event|4|||
33289077|NCT01006616|100955109|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
33289078|NCT01006616|100955110|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
33289079|NCT01006616|100955111|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
33289080|NCT01006616|100955112|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
33289081|NCT01006616|100955109|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
33390174|NCT00607919|101317678|FG001|Acute Phase|Entry Criteria Not Met|1|||
33289082|NCT01006616|100955110|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
33289083|NCT01006616|100955111|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
33289084|NCT01006616|100955112|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
33289085|NCT01006616|100955109|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
33289086|NCT01006616|100955110|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
33289087|NCT01006616|100955111|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
33289088|NCT01006616|100955112|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
33289089|NCT01006616|100955109|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
33289090|NCT01006616|100955110|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
33289091|NCT01006616|100955111|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
33289092|NCT01006616|100955112|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
33289093|NCT01006616|100955109|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
33289094|NCT01006616|100955110|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
33289095|NCT01006616|100955111|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
33289096|NCT01006616|100955112|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
33289097|NCT01006616|100955109|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
33289098|NCT01006616|100955110|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
33289099|NCT01006616|100955111|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
33289100|NCT01006616|100955112|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
33289101|NCT01006616|100955109|FG000|Period 2 (18 Months)|Study Terminated|63|||
33289102|NCT01006616|100955110|FG001|Period 2 (18 Months)|Study Terminated|46|||
33289103|NCT01006616|100955111|FG002|Period 2 (18 Months)|Study Terminated|44|||
33289104|NCT01006616|100955112|FG003|Period 2 (18 Months)|Study Terminated|70|||
33289105|NCT03636373|100955113|FG000|Overall Study|Study closure due to Covid-19|1|||
33289106|NCT03636373|100955114|FG001|Overall Study|Study closure due to Covid-19|0|||
33289107|NCT00490945|100955115|FG000|Overall Study|Adverse Event|0|||
33289108|NCT00490945|100955116|FG001|Overall Study|Adverse Event|1|||
33289109|NCT00490945|100955117|FG002|Overall Study|Adverse Event|0|||
33289110|NCT00490945|100955118|FG003|Overall Study|Adverse Event|0|||
33289111|NCT00490945|100955119|FG004|Overall Study|Adverse Event|0|||
33289112|NCT02670122|100955123|FG000|Overall Study|Lost to Follow-up|4|||
33289113|NCT01547117|100955124|FG000|Overall Study|Physician Decision|0|||
33289114|NCT01547117|100955125|FG001|Overall Study|Physician Decision|1|||
33289115|NCT01547117|100955126|FG002|Overall Study|Physician Decision|1|||
33289116|NCT01547117|100955127|FG003|Overall Study|Physician Decision|3|||
33289117|NCT01547117|100955124|FG000|Overall Study|Withdrawal by Subject|1|||
33289118|NCT01547117|100955125|FG001|Overall Study|Withdrawal by Subject|2|||
33289119|NCT01547117|100955126|FG002|Overall Study|Withdrawal by Subject|1|||
33289120|NCT01547117|100955127|FG003|Overall Study|Withdrawal by Subject|2|||
33289121|NCT00559377|100955128|FG000|Overall Study|Withdrawal by Subject|9|||
33289122|NCT02650466|100955130|FG000|Overall Study|Physician Decision|1|||
33289123|NCT02650466|100955130|FG000|Overall Study|Withdrawal by Subject|5|||
33289124|NCT02650466|100955130|FG000|Overall Study|Lost to Follow-up|1|||
33289125|NCT01057251|100955134|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
33289126|NCT01057251|100955135|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
33289127|NCT01057251|100955134|FG000|Overall Study|Adverse Event|4|||
33289128|NCT01057251|100955135|FG001|Overall Study|Adverse Event|2|||
33289129|NCT01057251|100955134|FG000|Overall Study|Lack of Efficacy|2|||
33289130|NCT01057251|100955135|FG001|Overall Study|Lack of Efficacy|11|||
33289131|NCT01057251|100955134|FG000|Overall Study|Protocol Violation|6|||
33289132|NCT01057251|100955135|FG001|Overall Study|Protocol Violation|2|||
33289133|NCT01057251|100955134|FG000|Overall Study|Withdrawal by Subject|4|||
33289134|NCT01057251|100955135|FG001|Overall Study|Withdrawal by Subject|5|||
33289135|NCT01057251|100955134|FG000|Overall Study|Lost to Follow-up|7|||
33289136|NCT01057251|100955135|FG001|Overall Study|Lost to Follow-up|6|||
33289137|NCT01057251|100955134|FG000|Overall Study|Other Reason|1|||
33289138|NCT01057251|100955135|FG001|Overall Study|Other Reason|1|||
33289139|NCT03569475|100955140|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
33289140|NCT03569475|100955141|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
33289141|NCT03569475|100955142|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
33289142|NCT03569475|100955140|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
33289143|NCT03569475|100955141|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
33289144|NCT03569475|100955142|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
33289145|NCT03569475|100955140|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
33289146|NCT03569475|100955141|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
33289147|NCT03569475|100955142|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
33289148|NCT03569475|100955140|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
33289149|NCT03569475|100955141|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
33289150|NCT03569475|100955142|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
33289151|NCT03569475|100955140|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
33289152|NCT03569475|100955141|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
33289153|NCT03569475|100955142|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
33289154|NCT03569475|100955140|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
33289155|NCT03569475|100955141|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
33289156|NCT03569475|100955142|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
33289157|NCT03569475|100955140|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
33289158|NCT03569475|100955141|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
33289159|NCT03569475|100955142|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
33289160|NCT03569475|100955140|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
33289161|NCT03569475|100955141|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
33289162|NCT03569475|100955142|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
33289163|NCT03569475|100955140|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
33289164|NCT03569475|100955141|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
33289165|NCT03569475|100955142|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
33289166|NCT00719043|100955143|FG000|Overall Study|Adverse Event|5|||
33289167|NCT00719043|100955144|FG001|Overall Study|Adverse Event|1|||
33289168|NCT00719043|100955145|FG002|Overall Study|Adverse Event|2|||
33289169|NCT00719043|100955146|FG003|Overall Study|Adverse Event|2|||
33289170|NCT00719043|100955147|FG004|Overall Study|Adverse Event|1|||
33289171|NCT00719043|100955148|FG005|Overall Study|Adverse Event|4|||
33289172|NCT00719043|100955149|FG006|Overall Study|Adverse Event|4|||
33289173|NCT00719043|100955143|FG000|Overall Study|Lost to Follow-up|14|||
33289174|NCT00719043|100955144|FG001|Overall Study|Lost to Follow-up|10|||
33289175|NCT00719043|100955145|FG002|Overall Study|Lost to Follow-up|8|||
33289176|NCT00719043|100955146|FG003|Overall Study|Lost to Follow-up|9|||
33289177|NCT00719043|100955147|FG004|Overall Study|Lost to Follow-up|10|||
33289178|NCT00719043|100955148|FG005|Overall Study|Lost to Follow-up|9|||
33289179|NCT00719043|100955149|FG006|Overall Study|Lost to Follow-up|9|||
33289180|NCT00719043|100955143|FG000|Overall Study|Protocol Violation|0|||
33289181|NCT00719043|100955144|FG001|Overall Study|Protocol Violation|0|||
33289182|NCT00719043|100955145|FG002|Overall Study|Protocol Violation|0|||
33289183|NCT00719043|100955146|FG003|Overall Study|Protocol Violation|0|||
33289184|NCT00719043|100955147|FG004|Overall Study|Protocol Violation|0|||
33289185|NCT00719043|100955148|FG005|Overall Study|Protocol Violation|1|||
33289186|NCT00719043|100955149|FG006|Overall Study|Protocol Violation|0|||
33289187|NCT00719043|100955143|FG000|Overall Study|Other|1|||
33289188|NCT00719043|100955144|FG001|Overall Study|Other|0|||
33289189|NCT00719043|100955145|FG002|Overall Study|Other|1|||
33289190|NCT00719043|100955146|FG003|Overall Study|Other|2|||
33289191|NCT00719043|100955147|FG004|Overall Study|Other|0|||
33289192|NCT00719043|100955148|FG005|Overall Study|Other|2|||
33289193|NCT00719043|100955149|FG006|Overall Study|Other|1|||
33289194|NCT00719043|100955143|FG000|Overall Study|Withdrawal by Subject|12|||
33289195|NCT00719043|100955144|FG001|Overall Study|Withdrawal by Subject|14|||
33289196|NCT00719043|100955145|FG002|Overall Study|Withdrawal by Subject|9|||
33289197|NCT00719043|100955146|FG003|Overall Study|Withdrawal by Subject|10|||
33289198|NCT00719043|100955147|FG004|Overall Study|Withdrawal by Subject|16|||
33289199|NCT00719043|100955148|FG005|Overall Study|Withdrawal by Subject|18|||
33289200|NCT00719043|100955149|FG006|Overall Study|Withdrawal by Subject|14|||
33289201|NCT00573651|100955150|FG000|Overall Study|Lost to Follow-up|3|||
33289202|NCT00573651|100955150|FG000|Overall Study|Withdrawal by Subject|1|||
33289203|NCT01441583|100955152|FG000|Overall Study|Withdrawal by Subject|1|||
33289204|NCT01441583|100955153|FG001|Overall Study|Withdrawal by Subject|1|||
33289205|NCT01441583|100955154|FG002|Overall Study|Withdrawal by Subject|1|||
33289206|NCT01441583|100955152|FG000|Overall Study|Death|1|||
33289207|NCT01441583|100955153|FG001|Overall Study|Death|0|||
33289208|NCT01441583|100955154|FG002|Overall Study|Death|4|||
33289209|NCT01441583|100955152|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
33289210|NCT01441583|100955153|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
33289211|NCT01441583|100955154|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
33289212|NCT01407276|100955161|FG000|Overall Study|Withdrawal by Subject|0|||
33289213|NCT01407276|100955162|FG001|Overall Study|Withdrawal by Subject|0|||
33289214|NCT01407276|100955163|FG002|Overall Study|Withdrawal by Subject|0|||
33289215|NCT01407276|100955164|FG003|Overall Study|Withdrawal by Subject|0|||
33289216|NCT01407276|100955165|FG004|Overall Study|Withdrawal by Subject|0|||
33289217|NCT01407276|100955166|FG005|Overall Study|Withdrawal by Subject|0|||
33289218|NCT01407276|100955167|FG006|Overall Study|Withdrawal by Subject|0|||
33289219|NCT01407276|100955168|FG007|Overall Study|Withdrawal by Subject|1|||
33289220|NCT00912223|100955169|FG000|Overall Study|Withdrawal by Subject|1|||
33289221|NCT00912223|100955169|FG000|Overall Study|Not transplanted|1|||
33289222|NCT00912223|100955169|FG000|Overall Study|Transformed disease|1|||
33289223|NCT04354168|100955170|FG000|Overall Study|Lost to Follow-up|22|||
33289224|NCT04962698|100955171|FG000|Motor Imagery|Technical difficulty|1|||
33289225|NCT04962698|100955172|FG001|Motor Imagery|Technical difficulty|0|||
33289226|NCT04962698|100955171|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
33289227|NCT04962698|100955172|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
33289228|NCT04962698|100955171|FG000|Kinesthetic MI|Technical difficulty|1|||
33289229|NCT04962698|100955172|FG001|Kinesthetic MI|Technical difficulty|0|||
33289230|NCT04962698|100955171|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
33289231|NCT04962698|100955172|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
33289232|NCT04962698|100955171|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
33289233|NCT04962698|100955172|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
33289234|NCT04962698|100955171|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
33289235|NCT04962698|100955172|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
33289236|NCT04962698|100955171|FG000|Virtual-hand Interaction|Technical difficulty|1|||
33289237|NCT04962698|100955172|FG001|Virtual-hand Interaction|Technical difficulty|0|||
33289238|NCT04962698|100955171|FG000|Robotic Action Observation|Technical difficulty|1|||
33289239|NCT04962698|100955172|FG001|Robotic Action Observation|Technical difficulty|0|||
33289240|NCT04962698|100955171|FG000|Rest|Technical difficulty|1|||
33289241|NCT04962698|100955172|FG001|Rest|Technical difficulty|0|||
33289242|NCT04962698|100955171|FG000|Rest|Exclusion criteria met after enrollment|0|||
33289243|NCT04962698|100955172|FG001|Rest|Exclusion criteria met after enrollment|2|||
33289244|NCT03856047|100955173|FG000|Overall Study|Withdrawal by Subject|0|||
33289245|NCT03856047|100955174|FG001|Overall Study|Withdrawal by Subject|1|||
33289246|NCT03856047|100955175|FG002|Overall Study|Withdrawal by Subject|1|||
33289247|NCT03856047|100955176|FG003|Overall Study|Withdrawal by Subject|0|||
33289248|NCT03856047|100955177|FG004|Overall Study|Withdrawal by Subject|3|||
33289249|NCT03856047|100955178|FG005|Overall Study|Withdrawal by Subject|0|||
33289250|NCT03856047|100955179|FG006|Overall Study|Withdrawal by Subject|2|||
33289251|NCT03856047|100955173|FG000|Overall Study|Lost to Follow-up|4|||
33289252|NCT03856047|100955174|FG001|Overall Study|Lost to Follow-up|2|||
33289253|NCT03856047|100955175|FG002|Overall Study|Lost to Follow-up|3|||
33289254|NCT03856047|100955176|FG003|Overall Study|Lost to Follow-up|1|||
33289255|NCT03856047|100955177|FG004|Overall Study|Lost to Follow-up|4|||
33289256|NCT03856047|100955178|FG005|Overall Study|Lost to Follow-up|4|||
33289257|NCT03856047|100955179|FG006|Overall Study|Lost to Follow-up|4|||
33289258|NCT04698915|100955180|FG000|Overall Study|Adverse Event|2|||
33289259|NCT04698915|100955181|FG001|Overall Study|Adverse Event|0|||
33289260|NCT04698915|100955180|FG000|Overall Study|Death|23|||
33289261|NCT04698915|100955181|FG001|Overall Study|Death|20|||
33289262|NCT04698915|100955180|FG000|Overall Study|Physician Decision|1|||
33289263|NCT04698915|100955181|FG001|Overall Study|Physician Decision|1|||
33289264|NCT04698915|100955180|FG000|Overall Study|Lost to Follow-up|1|||
33289265|NCT04698915|100955181|FG001|Overall Study|Lost to Follow-up|0|||
33289266|NCT04698915|100955180|FG000|Overall Study|Study Terminated by Sponsor|55|||
33289267|NCT04698915|100955181|FG001|Overall Study|Study Terminated by Sponsor|60|||
33289268|NCT04698915|100955180|FG000|Overall Study|Withdrawal by Subject|2|||
33289269|NCT04698915|100955181|FG001|Overall Study|Withdrawal by Subject|3|||
33289270|NCT00826228|100955182|FG000|Overall Study|Withdrawal by Subject|1|||
33289271|NCT02658175|100955185|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
33289272|NCT02658175|100955186|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
33289273|NCT02658175|100955187|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
33289274|NCT02658175|100955185|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
33289275|NCT02658175|100955186|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
33289276|NCT02658175|100955187|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
33289277|NCT02658175|100955185|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
33289278|NCT02658175|100955186|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
33289279|NCT02658175|100955187|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
33289280|NCT02658175|100955185|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
33289281|NCT02658175|100955186|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
33289282|NCT02658175|100955187|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
33289283|NCT02658175|100955185|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
33289284|NCT02658175|100955186|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
33289285|NCT02658175|100955187|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
33289286|NCT02658175|100955185|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
33289287|NCT02658175|100955186|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
33289288|NCT02658175|100955187|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
33289289|NCT02658175|100955185|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
33289290|NCT02658175|100955186|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
33289291|NCT02658175|100955187|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
33289292|NCT02658175|100955185|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
33289293|NCT02658175|100955186|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
33289294|NCT02658175|100955187|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
33289295|NCT02658175|100955185|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
33289296|NCT02658175|100955186|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
33289297|NCT02658175|100955187|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
33289298|NCT02658175|100955185|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
33289299|NCT02658175|100955186|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
33289300|NCT02658175|100955187|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
33289301|NCT00966979|100958789|FG000|Overall Study|Death|1|||
33289302|NCT00966979|100958789|FG000|Overall Study|Lost to Follow-up|6|||
33289303|NCT00966979|100958789|FG000|Overall Study|Withdrawal by Subject|14|||
33289304|NCT00966979|100958789|FG000|Overall Study|Adverse Event|5|||
33289305|NCT00966979|100958789|FG000|Overall Study|Sponsor terminated early|49|||
33289306|NCT00966979|100958789|FG000|Overall Study|Censored because surgery not done|2|||
33289307|NCT00966979|100958789|FG000|Overall Study|Censored because study device was not implanted|14|||
33289308|NCT00966979|100958789|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
33289309|NCT00224029|100958790|FG000|Overall Study|Lost to Follow-up|1|||
33289310|NCT00224029|100958790|FG000|Overall Study|Withdrawal by Subject|4|||
33289311|NCT00224029|100958790|FG000|Overall Study|Other|1|||
33289312|NCT04334278|100958820|FG000|Overall Study|Lost to Follow-up|0|||
33289313|NCT04334278|100958821|FG001|Overall Study|Lost to Follow-up|3|||
33289314|NCT04334278|100958820|FG000|Overall Study|Withdrawal by Subject|4|||
33289315|NCT04334278|100958821|FG001|Overall Study|Withdrawal by Subject|2|||
33289316|NCT04156399|100958825|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
33289317|NCT04156399|100958825|FG000|Overall Study|study suspension due to COVID pandemic|3|||
33289318|NCT00872001|100958826|FG000|Overall Study|Adverse Event|34|||
33289319|NCT00872001|100958827|FG001|Overall Study|Adverse Event|23|||
33289320|NCT00872001|100958826|FG000|Overall Study|Protocol Defined Clinical Event|5|||
33289321|NCT00872001|100958827|FG001|Overall Study|Protocol Defined Clinical Event|7|||
33289322|NCT00872001|100958826|FG000|Overall Study|Lost to Follow-up|13|||
33289323|NCT00872001|100958827|FG001|Overall Study|Lost to Follow-up|12|||
33289324|NCT00872001|100958826|FG000|Overall Study|Withdrawal by Subject|18|||
33289325|NCT00872001|100958827|FG001|Overall Study|Withdrawal by Subject|30|||
33289326|NCT00872001|100958826|FG000|Overall Study|Protocol Violation|5|||
33289327|NCT00872001|100958827|FG001|Overall Study|Protocol Violation|8|||
33289328|NCT00872001|100958826|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
33289329|NCT00872001|100958827|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
33289330|NCT00872001|100958826|FG000|Overall Study|Administrative|23|||
33289331|NCT00872001|100958827|FG001|Overall Study|Administrative|15|||
33289332|NCT01181609|100958830|FG000|Overall Study|Adverse Event|1|||
33289333|NCT01181609|100958830|FG000|Overall Study|Withdrawal by Subject|1|||
33289334|NCT01181609|100958830|FG000|Overall Study|Lost to Follow-up|1|||
33289335|NCT01181609|100958830|FG000|Overall Study|Death|50|||
33289336|NCT01740154|100958832|FG000|Overall Study|Adverse Event|1|||
33289337|NCT02201901|100958833|FG000|Overall Study|Randomized but never treated|0|||
33289338|NCT02201901|100958834|FG001|Overall Study|Randomized but never treated|1|||
33289339|NCT02201901|100958835|FG002|Overall Study|Randomized but never treated|0|||
33289340|NCT02201901|100958833|FG000|Overall Study|Lack of Efficacy|7|||
33289341|NCT02201901|100958834|FG001|Overall Study|Lack of Efficacy|1|||
33289342|NCT02201901|100958835|FG002|Overall Study|Lack of Efficacy|6|||
33289343|NCT02201901|100958833|FG000|Overall Study|Death|3|||
33289344|NCT02201901|100958834|FG001|Overall Study|Death|3|||
33289345|NCT02201901|100958835|FG002|Overall Study|Death|3|||
33289346|NCT02201901|100958833|FG000|Overall Study|Lost to Follow-up|2|||
33289347|NCT02201901|100958834|FG001|Overall Study|Lost to Follow-up|3|||
33289348|NCT02201901|100958835|FG002|Overall Study|Lost to Follow-up|2|||
33289349|NCT02201901|100958833|FG000|Overall Study|Withdrew Consent|2|||
33289350|NCT02201901|100958834|FG001|Overall Study|Withdrew Consent|0|||
33289351|NCT02201901|100958835|FG002|Overall Study|Withdrew Consent|2|||
33289352|NCT02201901|100958833|FG000|Overall Study|Adverse Event|1|||
33289353|NCT02201901|100958834|FG001|Overall Study|Adverse Event|1|||
33289354|NCT02201901|100958835|FG002|Overall Study|Adverse Event|0|||
33289355|NCT00550446|100958836|FG000|Up To Week 12|Adverse Event|2|||
33289356|NCT00550446|100958837|FG001|Up To Week 12|Adverse Event|2|||
33289357|NCT00550446|100958838|FG002|Up To Week 12|Adverse Event|0|||
33289358|NCT00550446|100958839|FG003|Up To Week 12|Adverse Event|0|||
33289359|NCT00550446|100958840|FG004|Up To Week 12|Adverse Event|2|||
33289360|NCT00550446|100958841|FG005|Up To Week 12|Adverse Event|2|||
33289361|NCT00550446|100958842|FG006|Up To Week 12|Adverse Event|1|||
33289362|NCT00550446|100958843|FG007|Up To Week 12|Adverse Event|0|||
33289363|NCT00550446|100958844|FG008|Up To Week 12|Adverse Event|0|||
33289364|NCT00550446|100958845|FG009|Up To Week 12|Adverse Event|0|||
33289365|NCT00550446|100958846|FG010|Up To Week 12|Adverse Event|0|||
33289366|NCT00550446|100958836|FG000|Up To Week 12|Lack of Efficacy|3|||
33289367|NCT00550446|100958837|FG001|Up To Week 12|Lack of Efficacy|1|||
33289368|NCT00550446|100958838|FG002|Up To Week 12|Lack of Efficacy|0|||
33289369|NCT00550446|100958839|FG003|Up To Week 12|Lack of Efficacy|1|||
33289370|NCT00550446|100958840|FG004|Up To Week 12|Lack of Efficacy|0|||
33289371|NCT00550446|100958841|FG005|Up To Week 12|Lack of Efficacy|3|||
33289372|NCT00550446|100958842|FG006|Up To Week 12|Lack of Efficacy|3|||
33289373|NCT00550446|100958843|FG007|Up To Week 12|Lack of Efficacy|0|||
33289374|NCT00550446|100958844|FG008|Up To Week 12|Lack of Efficacy|0|||
33289375|NCT00550446|100958845|FG009|Up To Week 12|Lack of Efficacy|0|||
33289376|NCT00550446|100958846|FG010|Up To Week 12|Lack of Efficacy|0|||
33289377|NCT00550446|100958836|FG000|Up To Week 12|Lost to Follow-up|0|||
33289378|NCT00550446|100958837|FG001|Up To Week 12|Lost to Follow-up|1|||
33289379|NCT00550446|100958838|FG002|Up To Week 12|Lost to Follow-up|0|||
33289380|NCT00550446|100958839|FG003|Up To Week 12|Lost to Follow-up|0|||
33289381|NCT00550446|100958840|FG004|Up To Week 12|Lost to Follow-up|1|||
33289382|NCT00550446|100958841|FG005|Up To Week 12|Lost to Follow-up|1|||
33289383|NCT00550446|100958842|FG006|Up To Week 12|Lost to Follow-up|2|||
33289384|NCT00550446|100958843|FG007|Up To Week 12|Lost to Follow-up|0|||
33289385|NCT00550446|100958844|FG008|Up To Week 12|Lost to Follow-up|0|||
33289386|NCT00550446|100958845|FG009|Up To Week 12|Lost to Follow-up|0|||
33289387|NCT00550446|100958846|FG010|Up To Week 12|Lost to Follow-up|0|||
33289388|NCT00550446|100958836|FG000|Up To Week 12|Withdrawal by Subject|2|||
33289389|NCT00550446|100958837|FG001|Up To Week 12|Withdrawal by Subject|0|||
33289390|NCT00550446|100958838|FG002|Up To Week 12|Withdrawal by Subject|3|||
33289391|NCT00550446|100958839|FG003|Up To Week 12|Withdrawal by Subject|2|||
33289392|NCT00550446|100958840|FG004|Up To Week 12|Withdrawal by Subject|0|||
33289393|NCT00550446|100958841|FG005|Up To Week 12|Withdrawal by Subject|1|||
33289394|NCT00550446|100958842|FG006|Up To Week 12|Withdrawal by Subject|3|||
33289395|NCT00550446|100958843|FG007|Up To Week 12|Withdrawal by Subject|0|||
33289396|NCT00550446|100958844|FG008|Up To Week 12|Withdrawal by Subject|0|||
33289397|NCT00550446|100958845|FG009|Up To Week 12|Withdrawal by Subject|0|||
33289398|NCT00550446|100958846|FG010|Up To Week 12|Withdrawal by Subject|0|||
33289399|NCT00550446|100958836|FG000|Up To Week 12|Other|3|||
33289400|NCT00550446|100958837|FG001|Up To Week 12|Other|0|||
33289401|NCT00550446|100958838|FG002|Up To Week 12|Other|0|||
33289402|NCT00550446|100958839|FG003|Up To Week 12|Other|0|||
33289403|NCT00550446|100958840|FG004|Up To Week 12|Other|0|||
33289404|NCT00550446|100958841|FG005|Up To Week 12|Other|1|||
33289405|NCT00550446|100958842|FG006|Up To Week 12|Other|4|||
33289406|NCT00550446|100958843|FG007|Up To Week 12|Other|0|||
33289407|NCT00550446|100958844|FG008|Up To Week 12|Other|0|||
33289408|NCT00550446|100958845|FG009|Up To Week 12|Other|0|||
33289409|NCT00550446|100958846|FG010|Up To Week 12|Other|0|||
33390175|NCT00607919|101317677|FG000|Acute Phase|Lack of Efficacy|1|||
33390176|NCT00607919|101317678|FG001|Acute Phase|Lack of Efficacy|2|||
33390177|NCT00607919|101317677|FG000|Acute Phase|Lost to Follow-up|9|||
33390178|NCT00607919|101317678|FG001|Acute Phase|Lost to Follow-up|3|||
33390179|NCT00607919|101317677|FG000|Acute Phase|Parent/Caregiver Decision|6|||
33390180|NCT00607919|101317678|FG001|Acute Phase|Parent/Caregiver Decision|4|||
33390181|NCT00607919|101317677|FG000|Acute Phase|Protocol Violation|5|||
33390182|NCT00607919|101317678|FG001|Acute Phase|Protocol Violation|1|||
33289410|NCT00550446|100958836|FG000|Up To Week 12|Randomized not treated|0|||
33289411|NCT00550446|100958837|FG001|Up To Week 12|Randomized not treated|1|||
33289412|NCT00550446|100958838|FG002|Up To Week 12|Randomized not treated|1|||
33289413|NCT00550446|100958839|FG003|Up To Week 12|Randomized not treated|0|||
33289414|NCT00550446|100958840|FG004|Up To Week 12|Randomized not treated|0|||
33289415|NCT00550446|100958841|FG005|Up To Week 12|Randomized not treated|0|||
33289416|NCT00550446|100958842|FG006|Up To Week 12|Randomized not treated|0|||
33289417|NCT00550446|100958843|FG007|Up To Week 12|Randomized not treated|0|||
33289418|NCT00550446|100958844|FG008|Up To Week 12|Randomized not treated|0|||
33289419|NCT00550446|100958845|FG009|Up To Week 12|Randomized not treated|0|||
33289420|NCT00550446|100958846|FG010|Up To Week 12|Randomized not treated|0|||
33289421|NCT00550446|100958836|FG000|Post Week 12|Adverse Event|2|||
33289422|NCT00550446|100958837|FG001|Post Week 12|Adverse Event|1|||
33289423|NCT00550446|100958838|FG002|Post Week 12|Adverse Event|1|||
33289424|NCT00550446|100958839|FG003|Post Week 12|Adverse Event|1|||
33289425|NCT00550446|100958840|FG004|Post Week 12|Adverse Event|1|||
33289426|NCT00550446|100958841|FG005|Post Week 12|Adverse Event|1|||
33289427|NCT00550446|100958842|FG006|Post Week 12|Adverse Event|0|||
33289428|NCT00550446|100958843|FG007|Post Week 12|Adverse Event|0|||
33289429|NCT00550446|100958844|FG008|Post Week 12|Adverse Event|0|||
33289430|NCT00550446|100958845|FG009|Post Week 12|Adverse Event|4|||
33289431|NCT00550446|100958846|FG010|Post Week 12|Adverse Event|0|||
33289432|NCT00550446|100958836|FG000|Post Week 12|Lack of Efficacy|0|||
33289433|NCT00550446|100958837|FG001|Post Week 12|Lack of Efficacy|0|||
33289434|NCT00550446|100958838|FG002|Post Week 12|Lack of Efficacy|1|||
33289435|NCT00550446|100958839|FG003|Post Week 12|Lack of Efficacy|0|||
33390183|NCT00607919|101317677|FG000|Acute Phase|Withdrawal by Subject|3|||
33390184|NCT00607919|101317678|FG001|Acute Phase|Withdrawal by Subject|3|||
33289436|NCT00550446|100958840|FG004|Post Week 12|Lack of Efficacy|0|||
33289437|NCT00550446|100958841|FG005|Post Week 12|Lack of Efficacy|0|||
33289438|NCT00550446|100958842|FG006|Post Week 12|Lack of Efficacy|0|||
33289439|NCT00550446|100958843|FG007|Post Week 12|Lack of Efficacy|1|||
33289440|NCT00550446|100958844|FG008|Post Week 12|Lack of Efficacy|1|||
33289441|NCT00550446|100958845|FG009|Post Week 12|Lack of Efficacy|2|||
33289442|NCT00550446|100958846|FG010|Post Week 12|Lack of Efficacy|1|||
33390185|NCT00607919|101317677|FG000|Open-Label Phase|Adverse Event|1|||
33289443|NCT00550446|100958836|FG000|Post Week 12|Lost to Follow-up|0|||
33289444|NCT00550446|100958837|FG001|Post Week 12|Lost to Follow-up|0|||
33289445|NCT00550446|100958838|FG002|Post Week 12|Lost to Follow-up|1|||
33289446|NCT00550446|100958839|FG003|Post Week 12|Lost to Follow-up|1|||
33289447|NCT00550446|100958840|FG004|Post Week 12|Lost to Follow-up|0|||
33289448|NCT00550446|100958841|FG005|Post Week 12|Lost to Follow-up|0|||
33289449|NCT00550446|100958842|FG006|Post Week 12|Lost to Follow-up|1|||
33289450|NCT00550446|100958843|FG007|Post Week 12|Lost to Follow-up|0|||
33289451|NCT00550446|100958844|FG008|Post Week 12|Lost to Follow-up|0|||
33289452|NCT00550446|100958845|FG009|Post Week 12|Lost to Follow-up|0|||
33289453|NCT00550446|100958846|FG010|Post Week 12|Lost to Follow-up|0|||
33289454|NCT00550446|100958836|FG000|Post Week 12|Withdrawal by Subject|0|||
33289455|NCT00550446|100958837|FG001|Post Week 12|Withdrawal by Subject|0|||
33289456|NCT00550446|100958838|FG002|Post Week 12|Withdrawal by Subject|0|||
33289457|NCT00550446|100958839|FG003|Post Week 12|Withdrawal by Subject|0|||
33289458|NCT00550446|100958840|FG004|Post Week 12|Withdrawal by Subject|1|||
33289459|NCT00550446|100958841|FG005|Post Week 12|Withdrawal by Subject|0|||
33289460|NCT00550446|100958842|FG006|Post Week 12|Withdrawal by Subject|0|||
33289461|NCT00550446|100958843|FG007|Post Week 12|Withdrawal by Subject|0|||
33289462|NCT00550446|100958844|FG008|Post Week 12|Withdrawal by Subject|0|||
33289463|NCT00550446|100958845|FG009|Post Week 12|Withdrawal by Subject|0|||
33289464|NCT00550446|100958846|FG010|Post Week 12|Withdrawal by Subject|0|||
33289465|NCT00550446|100958836|FG000|Post Week 12|Other|1|||
33289466|NCT00550446|100958837|FG001|Post Week 12|Other|1|||
33289467|NCT00550446|100958838|FG002|Post Week 12|Other|0|||
33289468|NCT00550446|100958839|FG003|Post Week 12|Other|1|||
33289469|NCT00550446|100958840|FG004|Post Week 12|Other|0|||
33289470|NCT00550446|100958841|FG005|Post Week 12|Other|0|||
33289471|NCT00550446|100958842|FG006|Post Week 12|Other|1|||
33289472|NCT00550446|100958843|FG007|Post Week 12|Other|0|||
33289473|NCT00550446|100958844|FG008|Post Week 12|Other|1|||
33289474|NCT00550446|100958845|FG009|Post Week 12|Other|1|||
33289475|NCT00550446|100958846|FG010|Post Week 12|Other|0|||
33289476|NCT02031536|100958847|FG000|Overall Study|ineligible|1|||
33289477|NCT02031536|100958848|FG001|Overall Study|ineligible|0|||
33289478|NCT00908349|100958849|FG000|Overall Study|Adverse Event|10|||
33289479|NCT00908349|100958849|FG000|Overall Study|Withdrawal by Subject|9|||
33289480|NCT00908349|100958849|FG000|Overall Study|Physician Decision|5|||
33289481|NCT00908349|100958849|FG000|Overall Study|Lost to Follow-up|5|||
33289482|NCT00908349|100958849|FG000|Overall Study|Various|6|||
33289483|NCT01657799|100958850|FG000|Overall Study|Adverse Event Related to progression|6|||
33289484|NCT01657799|100958851|FG001|Overall Study|Adverse Event Related to progression|8|||
33289485|NCT01657799|100958852|FG002|Overall Study|Adverse Event Related to progression|12|||
33289486|NCT01657799|100958850|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
33289487|NCT01657799|100958851|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
33289488|NCT01657799|100958852|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
33289489|NCT01657799|100958850|FG000|Overall Study|Withdrawal by Subject|13|||
33289490|NCT01657799|100958851|FG001|Overall Study|Withdrawal by Subject|10|||
33289491|NCT01657799|100958852|FG002|Overall Study|Withdrawal by Subject|10|||
33289492|NCT01657799|100958850|FG000|Overall Study|Lost to Follow-up|1|||
33289493|NCT01657799|100958851|FG001|Overall Study|Lost to Follow-up|0|||
33289494|NCT01657799|100958852|FG002|Overall Study|Lost to Follow-up|1|||
33289495|NCT01657799|100958850|FG000|Overall Study|Disease Progression|2|||
33289496|NCT01657799|100958851|FG001|Overall Study|Disease Progression|4|||
33289497|NCT01657799|100958852|FG002|Overall Study|Disease Progression|4|||
33289498|NCT01657799|100958850|FG000|Overall Study|Progressive Disease Clinical|7|||
33289499|NCT01657799|100958851|FG001|Overall Study|Progressive Disease Clinical|4|||
33289500|NCT01657799|100958852|FG002|Overall Study|Progressive Disease Clinical|7|||
33289501|NCT01657799|100958850|FG000|Overall Study|Radiographic & Clinical Progression|16|||
33289502|NCT01657799|100958851|FG001|Overall Study|Radiographic & Clinical Progression|11|||
33289503|NCT01657799|100958852|FG002|Overall Study|Radiographic & Clinical Progression|15|||
33289504|NCT01657799|100958850|FG000|Overall Study|Other|52|||
33289505|NCT01657799|100958851|FG001|Overall Study|Other|62|||
33289506|NCT01657799|100958852|FG002|Overall Study|Other|49|||
33289507|NCT00598871|100958853|FG000|Overall Study|Adverse Event|0|||
33289508|NCT00598871|100958854|FG001|Overall Study|Adverse Event|1|||
33289509|NCT00943722|100958861|FG000|Base Study|Adverse Event|0|||
33289510|NCT00943722|100958862|FG001|Base Study|Adverse Event|0|||
33289511|NCT00943722|100958863|FG002|Base Study|Adverse Event|0|||
33289512|NCT00943722|100958864|FG003|Base Study|Adverse Event|1|||
33289513|NCT00943722|100958865|FG004|Base Study|Adverse Event|0|||
33289514|NCT00943722|100958866|FG005|Base Study|Adverse Event|0|||
33289515|NCT00943722|100958867|FG006|Base Study|Adverse Event|0|||
33289516|NCT00943722|100958861|FG000|Base Study|Lost to Follow-up|12|||
33289517|NCT00943722|100958862|FG001|Base Study|Lost to Follow-up|8|||
33289518|NCT00943722|100958863|FG002|Base Study|Lost to Follow-up|10|||
33289519|NCT00943722|100958864|FG003|Base Study|Lost to Follow-up|8|||
33289520|NCT00943722|100958865|FG004|Base Study|Lost to Follow-up|11|||
33289521|NCT00943722|100958866|FG005|Base Study|Lost to Follow-up|0|||
33289522|NCT00943722|100958867|FG006|Base Study|Lost to Follow-up|0|||
33390186|NCT00607919|101317678|FG001|Open-Label Phase|Adverse Event|5|||
33390187|NCT00607919|101317677|FG000|Open-Label Phase|Lost to Follow-up|4|||
33390188|NCT00607919|101317678|FG001|Open-Label Phase|Lost to Follow-up|1|||
33390189|NCT00607919|101317677|FG000|Open-Label Phase|Protocol Violation|2|||
33390190|NCT00607919|101317678|FG001|Open-Label Phase|Protocol Violation|2|||
33390191|NCT00607919|101317677|FG000|Open-Label Phase|Withdrawal by Subject|2|||
33390192|NCT00607919|101317678|FG001|Open-Label Phase|Withdrawal by Subject|2|||
33390193|NCT00607919|101317677|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
33390194|NCT00607919|101317678|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
33390195|NCT04498468|101317679|FG000|Overall Study|Lost to Follow-up|3|||
33390196|NCT02725268|101317683|FG000|Overall Study|Death|58|||
33390197|NCT02725268|101317684|FG001|Overall Study|Death|59|||
33390198|NCT02725268|101317685|FG002|Overall Study|Death|30|||
33390199|NCT02725268|101317686|FG003|Overall Study|Death|16|||
33289523|NCT00943722|100958861|FG000|Base Study|Physician Decision|1|||
33289524|NCT00943722|100958862|FG001|Base Study|Physician Decision|0|||
33289525|NCT00943722|100958863|FG002|Base Study|Physician Decision|0|||
33289526|NCT00943722|100958864|FG003|Base Study|Physician Decision|0|||
33289527|NCT00943722|100958865|FG004|Base Study|Physician Decision|1|||
33289528|NCT00943722|100958866|FG005|Base Study|Physician Decision|0|||
33289529|NCT00943722|100958867|FG006|Base Study|Physician Decision|0|||
33289530|NCT00943722|100958861|FG000|Base Study|Pregnancy|0|||
33289531|NCT00943722|100958862|FG001|Base Study|Pregnancy|0|||
33289532|NCT00943722|100958863|FG002|Base Study|Pregnancy|1|||
33289533|NCT00943722|100958864|FG003|Base Study|Pregnancy|0|||
33289534|NCT00943722|100958865|FG004|Base Study|Pregnancy|2|||
33289535|NCT00943722|100958866|FG005|Base Study|Pregnancy|0|||
33289536|NCT00943722|100958867|FG006|Base Study|Pregnancy|0|||
33289537|NCT00943722|100958861|FG000|Base Study|Protocol Violation|0|||
33289538|NCT00943722|100958862|FG001|Base Study|Protocol Violation|1|||
33289539|NCT00943722|100958863|FG002|Base Study|Protocol Violation|0|||
33289540|NCT00943722|100958864|FG003|Base Study|Protocol Violation|0|||
33289541|NCT00943722|100958865|FG004|Base Study|Protocol Violation|2|||
33289542|NCT00943722|100958866|FG005|Base Study|Protocol Violation|0|||
33289543|NCT00943722|100958867|FG006|Base Study|Protocol Violation|0|||
33289544|NCT00943722|100958861|FG000|Base Study|Withdrawal by Subject|12|||
33289545|NCT00943722|100958862|FG001|Base Study|Withdrawal by Subject|13|||
33289546|NCT00943722|100958863|FG002|Base Study|Withdrawal by Subject|2|||
33289547|NCT00943722|100958864|FG003|Base Study|Withdrawal by Subject|13|||
33289548|NCT00943722|100958865|FG004|Base Study|Withdrawal by Subject|8|||
33289549|NCT00943722|100958866|FG005|Base Study|Withdrawal by Subject|0|||
33289550|NCT00943722|100958867|FG006|Base Study|Withdrawal by Subject|0|||
33289551|NCT00943722|100958861|FG000|Base Study|Month 12 visit not completed|0|||
33289552|NCT00943722|100958862|FG001|Base Study|Month 12 visit not completed|0|||
33289553|NCT00943722|100958863|FG002|Base Study|Month 12 visit not completed|0|||
33289554|NCT00943722|100958864|FG003|Base Study|Month 12 visit not completed|0|||
33289555|NCT00943722|100958865|FG004|Base Study|Month 12 visit not completed|2|||
33289556|NCT00943722|100958866|FG005|Base Study|Month 12 visit not completed|0|||
33289557|NCT00943722|100958867|FG006|Base Study|Month 12 visit not completed|0|||
33289558|NCT00943722|100958861|FG000|First Extension Study: EXT 1|Adverse Event|0|||
33289559|NCT00943722|100958862|FG001|First Extension Study: EXT 1|Adverse Event|0|||
33289560|NCT00943722|100958863|FG002|First Extension Study: EXT 1|Adverse Event|0|||
33289561|NCT00943722|100958864|FG003|First Extension Study: EXT 1|Adverse Event|0|||
33289562|NCT00943722|100958865|FG004|First Extension Study: EXT 1|Adverse Event|0|||
33289563|NCT00943722|100958866|FG005|First Extension Study: EXT 1|Adverse Event|1|||
33289564|NCT00943722|100958867|FG006|First Extension Study: EXT 1|Adverse Event|0|||
33289565|NCT00943722|100958861|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
33289566|NCT00943722|100958862|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
33289567|NCT00943722|100958863|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
33289568|NCT00943722|100958864|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
33289569|NCT00943722|100958865|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
33289570|NCT00943722|100958866|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
33289571|NCT00943722|100958867|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
33289572|NCT00943722|100958861|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
33289573|NCT00943722|100958862|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
33289574|NCT00943722|100958863|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
33289575|NCT00943722|100958864|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
33289576|NCT00943722|100958865|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
33289577|NCT00943722|100958866|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
33289578|NCT00943722|100958867|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
33289579|NCT00943722|100958861|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
33289580|NCT00943722|100958862|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
33390200|NCT02725268|101317683|FG000|Overall Study|Lost to Follow-up|4|||
33289581|NCT00943722|100958863|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
33289582|NCT00943722|100958864|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
33390201|NCT02725268|101317684|FG001|Overall Study|Lost to Follow-up|3|||
33289583|NCT00943722|100958865|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
33289584|NCT00943722|100958866|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
33289585|NCT00943722|100958867|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
33289586|NCT00943722|100958861|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
33289587|NCT00943722|100958862|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
33289588|NCT00943722|100958863|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
33289589|NCT00943722|100958864|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
33289590|NCT00943722|100958865|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
33289591|NCT00943722|100958866|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
33289592|NCT00943722|100958867|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
33390202|NCT02725268|101317685|FG002|Overall Study|Lost to Follow-up|0|||
33390203|NCT02725268|101317686|FG003|Overall Study|Lost to Follow-up|1|||
33390204|NCT02725268|101317683|FG000|Overall Study|Site Terminated by Sponsor|0|||
33390205|NCT02725268|101317684|FG001|Overall Study|Site Terminated by Sponsor|1|||
33390206|NCT02725268|101317685|FG002|Overall Study|Site Terminated by Sponsor|0|||
33390207|NCT02725268|101317686|FG003|Overall Study|Site Terminated by Sponsor|0|||
33390208|NCT02725268|101317683|FG000|Overall Study|Withdrawal by Subject|8|||
33390209|NCT02725268|101317684|FG001|Overall Study|Withdrawal by Subject|6|||
33390210|NCT02725268|101317685|FG002|Overall Study|Withdrawal by Subject|8|||
33390211|NCT02725268|101317686|FG003|Overall Study|Withdrawal by Subject|1|||
33390212|NCT02725268|101317683|FG000|Overall Study|Reason not Specified|2|||
33390213|NCT02725268|101317684|FG001|Overall Study|Reason not Specified|1|||
33390214|NCT02725268|101317685|FG002|Overall Study|Reason not Specified|0|||
33390215|NCT02725268|101317686|FG003|Overall Study|Reason not Specified|0|||
33390216|NCT00136357|101317687|FG000|Overall Study|Withdrawal by Subject|3|||
33390217|NCT00136357|101317688|FG001|Overall Study|Withdrawal by Subject|2|||
33390218|NCT03654560|101317689|FG000|Overall Study|Death|3|||
33390219|NCT03654560|101317690|FG001|Overall Study|Death|1|||
33390220|NCT03654560|101317689|FG000|Overall Study|Lost to Follow-up|1|||
33390221|NCT03654560|101317690|FG001|Overall Study|Lost to Follow-up|0|||
33390222|NCT00425945|101317691|FG000|Overall Study|Concern about Supplement|2|||
33390223|NCT00425945|101317692|FG001|Overall Study|Concern about Supplement|0|||
33390224|NCT00425945|101317691|FG000|Overall Study|Inconvenience|0|||
33390225|NCT00425945|101317692|FG001|Overall Study|Inconvenience|2|||
33390226|NCT00425945|101317691|FG000|Overall Study|Lost to Follow-up|0|||
33390227|NCT00425945|101317692|FG001|Overall Study|Lost to Follow-up|2|||
33390228|NCT00425945|101317691|FG000|Overall Study|Began hypertension medication|1|||
33390229|NCT00425945|101317692|FG001|Overall Study|Began hypertension medication|0|||
33390230|NCT00425945|101317691|FG000|Overall Study|Began cancer treatments|1|||
33390231|NCT00425945|101317692|FG001|Overall Study|Began cancer treatments|0|||
33390232|NCT00425945|101317691|FG000|Overall Study|Moved from area|0|||
33390233|NCT00425945|101317692|FG001|Overall Study|Moved from area|1|||
33390234|NCT04757376|101317693|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
33390235|NCT04757376|101317694|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
33390236|NCT04757376|101317695|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
33390237|NCT04757376|101317696|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
33390238|NCT04757376|101317697|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
33390239|NCT04757376|101317693|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
33390240|NCT04757376|101317694|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
33390241|NCT04757376|101317695|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
33390242|NCT04757376|101317696|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
33390243|NCT04757376|101317697|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
33390244|NCT04757376|101317693|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
33390245|NCT04757376|101317694|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
33390246|NCT04757376|101317695|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
33390247|NCT04757376|101317696|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
33390248|NCT04757376|101317697|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
33390249|NCT04757376|101317693|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
33390250|NCT04757376|101317694|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
33390251|NCT04757376|101317695|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
33390252|NCT04757376|101317696|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
33390253|NCT04757376|101317697|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
33390254|NCT04757376|101317693|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
33390255|NCT04757376|101317694|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
33390256|NCT04757376|101317695|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
33390257|NCT04757376|101317696|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
33390258|NCT04757376|101317697|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
33390259|NCT04757376|101317693|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
33390260|NCT04757376|101317694|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
33390261|NCT04757376|101317695|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
33390262|NCT04757376|101317696|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
33390263|NCT04757376|101317697|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
33390264|NCT04757376|101317693|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
33390265|NCT04757376|101317694|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
33390266|NCT04757376|101317695|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
33390267|NCT04757376|101317696|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
33390268|NCT04757376|101317697|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
33390269|NCT04757376|101317693|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
33390270|NCT04757376|101317694|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
33390271|NCT04757376|101317695|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
33390272|NCT04757376|101317696|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
33390273|NCT04757376|101317697|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
33390274|NCT04038385|101317699|FG000|Overall Study|Completed baseline assessment only|7|||
33390275|NCT04038385|101317700|FG001|Overall Study|Completed baseline assessment only|4|||
33390276|NCT04038385|101317699|FG000|Overall Study|Moved out of area|4|||
33390277|NCT04038385|101317700|FG001|Overall Study|Moved out of area|2|||
33390278|NCT04038385|101317699|FG000|Overall Study|Discontinued study involvement|6|||
33390279|NCT04038385|101317700|FG001|Overall Study|Discontinued study involvement|1|||
33390280|NCT01376388|101317705|FG000|Overall Study|Adverse Event|13|||
33390281|NCT01376388|101317705|FG000|Overall Study|Lack of Efficacy|2|||
33390282|NCT01376388|101317705|FG000|Overall Study|Withdrawal by Subject|3|||
33390283|NCT01448707|101317706|FG000|Overall Study|Adverse Event|3|||
33390284|NCT01448707|101317707|FG001|Overall Study|Adverse Event|1|||
33390285|NCT01448707|101317706|FG000|Overall Study|Lost to Follow-up|2|||
33390286|NCT01448707|101317707|FG001|Overall Study|Lost to Follow-up|6|||
33390287|NCT01448707|101317706|FG000|Overall Study|Withdrawal by Subject|6|||
33390288|NCT01448707|101317707|FG001|Overall Study|Withdrawal by Subject|7|||
33390289|NCT01448707|101317706|FG000|Overall Study|Other|7|||
33390290|NCT01448707|101317707|FG001|Overall Study|Other|4|||
33390291|NCT01770145|101317721|FG000|Baseline|Adverse Event|20|||
33390292|NCT01770145|101317721|FG000|Baseline|Withdrawal by Subject|1|||
33390293|NCT01770145|101317721|FG000|Baseline|Lost to Follow-up|1|||
33390294|NCT01770145|101317721|FG000|Baseline|Unable to define optimal dose|4|||
33390295|NCT01770145|101317721|FG000|Treatment|Adverse Event|3|||
33390296|NCT01770145|101317721|FG000|Treatment|Withdrawal by Subject|1|||
33390297|NCT01993667|101317722|FG000|Overall Study|Insufficient data to analyze|16|||
33390298|NCT01993667|101317723|FG001|Overall Study|Insufficient data to analyze|16|||
33390299|NCT01993667|101317722|FG000|Overall Study|Insufficient altitude reached|3|||
33390300|NCT01993667|101317723|FG001|Overall Study|Insufficient altitude reached|1|||
33390301|NCT01993667|101317722|FG000|Overall Study|Lost to Follow-up|2|||
33390302|NCT01993667|101317723|FG001|Overall Study|Lost to Follow-up|2|||
33289593|NCT00943722|100958861|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
33289594|NCT00943722|100958862|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
33289595|NCT00943722|100958863|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
33289596|NCT00943722|100958864|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
33289597|NCT00943722|100958865|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
33289598|NCT00943722|100958866|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
33289599|NCT00943722|100958867|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
33289600|NCT00943722|100958861|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
33289601|NCT00943722|100958862|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
33289602|NCT00943722|100958863|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
33289603|NCT00943722|100958864|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
33289604|NCT00943722|100958865|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
33289605|NCT00943722|100958866|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
33289606|NCT00943722|100958867|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
33289607|NCT00943722|100958861|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
33289608|NCT00943722|100958862|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
33289609|NCT00943722|100958863|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
33289610|NCT00943722|100958864|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
33289611|NCT00943722|100958865|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
33289612|NCT00943722|100958866|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
33289613|NCT00943722|100958867|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
33289614|NCT00943722|100958861|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
33289615|NCT00943722|100958862|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
33289616|NCT00943722|100958863|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
33289617|NCT00943722|100958864|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
33390303|NCT01868594|101317732|FG000|Overall Study|Do not meet inclusion criteria|4|||
33289618|NCT00943722|100958865|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
33289619|NCT00943722|100958866|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
33289620|NCT00943722|100958867|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
33289621|NCT02058836|100958868|FG000|Overall Study|Withdrawal by Subject|1|||
33289622|NCT02058836|100958869|FG001|Overall Study|Withdrawal by Subject|1|||
33289623|NCT01447576|100958870|FG000|Overall Study|Lost to Follow-up|52|||
33289624|NCT01447576|100958870|FG000|Overall Study|Adverse Event|127|||
33289625|NCT01447576|100958870|FG000|Overall Study|Participant met withdrawal criteria|40|||
33289626|NCT01447576|100958870|FG000|Overall Study|Withdrawal by Subject|100|||
33289627|NCT01447576|100958870|FG000|Overall Study|Protocol deviation|83|||
33289628|NCT01447576|100958870|FG000|Overall Study|Lack of Efficacy|68|||
33289629|NCT01447576|100958870|FG000|Overall Study|Physician Decision|6|||
33289630|NCT01772823|100958876|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
33289631|NCT01772823|100958877|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
33289632|NCT01772823|100958876|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
33289633|NCT01772823|100958877|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
33289634|NCT01772823|100958876|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
33390304|NCT01868594|101317733|FG001|Overall Study|Do not meet inclusion criteria|3|||
33390305|NCT02580591|101317734|FG000|Overall Study|Adverse Event|0|||
33390306|NCT02580591|101317735|FG001|Overall Study|Adverse Event|1|||
33390307|NCT02580591|101317736|FG002|Overall Study|Adverse Event|2|||
33390308|NCT02580591|101317737|FG003|Overall Study|Adverse Event|5|||
33390309|NCT02580591|101317734|FG000|Overall Study|Protocol Violation|3|||
33390310|NCT02580591|101317735|FG001|Overall Study|Protocol Violation|2|||
33390311|NCT02580591|101317736|FG002|Overall Study|Protocol Violation|1|||
33390312|NCT02580591|101317737|FG003|Overall Study|Protocol Violation|1|||
33390313|NCT02580591|101317734|FG000|Overall Study|Lost to Follow-up|5|||
33390314|NCT02580591|101317735|FG001|Overall Study|Lost to Follow-up|3|||
33390315|NCT02580591|101317736|FG002|Overall Study|Lost to Follow-up|3|||
33390316|NCT02580591|101317737|FG003|Overall Study|Lost to Follow-up|1|||
33390317|NCT02580591|101317734|FG000|Overall Study|Withdrawal by Subject|6|||
33390318|NCT02580591|101317735|FG001|Overall Study|Withdrawal by Subject|1|||
33390319|NCT02580591|101317736|FG002|Overall Study|Withdrawal by Subject|2|||
33390320|NCT02580591|101317737|FG003|Overall Study|Withdrawal by Subject|3|||
33390321|NCT02580591|101317734|FG000|Overall Study|Not treated|1|||
33595298|NCT03515551|102069662|FG001|Overall Study|Lost to Follow-up|0|||
33595299|NCT03515551|102069663|FG002|Overall Study|Lost to Follow-up|1|||
33595300|NCT03515551|102069664|FG003|Overall Study|Lost to Follow-up|0|||
33390322|NCT02580591|101317735|FG001|Overall Study|Not treated|1|||
33390323|NCT02580591|101317736|FG002|Overall Study|Not treated|0|||
33390324|NCT02580591|101317737|FG003|Overall Study|Not treated|0|||
33390325|NCT02580591|101317734|FG000|Overall Study|Other than specified|3|||
33390326|NCT02580591|101317735|FG001|Overall Study|Other than specified|2|||
33390327|NCT02580591|101317736|FG002|Overall Study|Other than specified|5|||
33390328|NCT02580591|101317737|FG003|Overall Study|Other than specified|2|||
33390329|NCT00693693|101317738|FG000|Overall Study|Lost to Follow-up|1|||
33390330|NCT00693693|101317739|FG001|Overall Study|Lost to Follow-up|1|||
33390331|NCT00693693|101317740|FG002|Overall Study|Lost to Follow-up|2|||
33390332|NCT02443155|101317741|FG000|Overall Study|Adverse Event|3|||
33390333|NCT02443155|101317742|FG001|Overall Study|Adverse Event|4|||
33390334|NCT02443155|101317743|FG002|Overall Study|Adverse Event|1|||
33390335|NCT02443155|101317744|FG003|Overall Study|Adverse Event|2|||
33390336|NCT02443155|101317741|FG000|Overall Study|Unclassified|0|||
33390337|NCT02443155|101317742|FG001|Overall Study|Unclassified|0|||
33390338|NCT02443155|101317743|FG002|Overall Study|Unclassified|2|||
33390339|NCT02443155|101317744|FG003|Overall Study|Unclassified|1|||
33390340|NCT02443155|101317741|FG000|Overall Study|Withdrawal by Subject|4|||
33390341|NCT02443155|101317742|FG001|Overall Study|Withdrawal by Subject|7|||
33390342|NCT02443155|101317743|FG002|Overall Study|Withdrawal by Subject|3|||
33390343|NCT02443155|101317744|FG003|Overall Study|Withdrawal by Subject|9|||
33390344|NCT02443155|101317741|FG000|Overall Study|Pregnancy|3|||
33390345|NCT02443155|101317742|FG001|Overall Study|Pregnancy|1|||
33390346|NCT02443155|101317743|FG002|Overall Study|Pregnancy|1|||
33390347|NCT02443155|101317744|FG003|Overall Study|Pregnancy|2|||
33390348|NCT02443155|101317741|FG000|Overall Study|Lost to Follow-up|1|||
33390349|NCT02443155|101317742|FG001|Overall Study|Lost to Follow-up|2|||
33390350|NCT02443155|101317743|FG002|Overall Study|Lost to Follow-up|0|||
33390351|NCT02443155|101317744|FG003|Overall Study|Lost to Follow-up|1|||
33390352|NCT02443155|101317741|FG000|Overall Study|Protocol Violation|1|||
33595301|NCT03515551|102069665|FG004|Overall Study|Lost to Follow-up|0|||
33289635|NCT01772823|100958877|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
33289636|NCT01772823|100958876|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
33390353|NCT02443155|101317742|FG001|Overall Study|Protocol Violation|0|||
33390354|NCT02443155|101317743|FG002|Overall Study|Protocol Violation|1|||
33390355|NCT02443155|101317744|FG003|Overall Study|Protocol Violation|1|||
33390356|NCT02443155|101317741|FG000|Overall Study|Death|0|||
33390357|NCT02443155|101317742|FG001|Overall Study|Death|0|||
33595302|NCT03515551|102069666|FG005|Overall Study|Lost to Follow-up|0|||
33390358|NCT02443155|101317743|FG002|Overall Study|Death|1|||
33390359|NCT02443155|101317744|FG003|Overall Study|Death|0|||
33390360|NCT05041062|101317745|FG000|Overall Study|Adverse Event|2|||
33390361|NCT01192100|101317748|FG000|Overall Study|Withdrawal by Subject|0|||
33390362|NCT01192100|101317749|FG001|Overall Study|Withdrawal by Subject|0|||
33390363|NCT01192100|101317750|FG002|Overall Study|Withdrawal by Subject|0|||
33289637|NCT01772823|100958877|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
33289638|NCT01772823|100958876|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
33289639|NCT01772823|100958877|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
33187436|NCT00404352|100594492|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
33289640|NCT01772823|100958876|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
33289641|NCT01772823|100958877|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
33289642|NCT01772823|100958876|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
33289643|NCT01772823|100958877|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
33289644|NCT01772823|100958876|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
33289645|NCT01772823|100958877|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
33289646|NCT01772823|100958876|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
33289647|NCT01772823|100958877|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
33289648|NCT01772823|100958876|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
33289649|NCT01772823|100958877|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
33289650|NCT01772823|100958876|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
33289651|NCT01772823|100958877|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
33289652|NCT01772823|100958876|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
33289653|NCT01772823|100958877|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
33289654|NCT01772823|100958876|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
33289655|NCT01772823|100958877|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
33289656|NCT01772823|100958876|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
33289657|NCT01772823|100958877|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
33289658|NCT01772823|100958876|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
33289659|NCT01772823|100958877|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
33289660|NCT01772823|100958876|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
33289661|NCT01772823|100958877|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
33289662|NCT01434680|100958878|FG000|Overall Study|Withdrawal by Subject|1|||
33289663|NCT01434680|100958879|FG001|Overall Study|Withdrawal by Subject|0|||
33289664|NCT01434680|100958880|FG002|Overall Study|Withdrawal by Subject|2|||
33289665|NCT01434680|100958881|FG003|Overall Study|Withdrawal by Subject|0|||
33289666|NCT01434680|100958878|FG000|Overall Study|Lost to Follow-up|1|||
33289667|NCT01434680|100958879|FG001|Overall Study|Lost to Follow-up|1|||
33289668|NCT01434680|100958880|FG002|Overall Study|Lost to Follow-up|0|||
33289669|NCT01434680|100958881|FG003|Overall Study|Lost to Follow-up|0|||
33289670|NCT01434680|100958878|FG000|Overall Study|Protocol Violation|1|||
33289671|NCT01434680|100958879|FG001|Overall Study|Protocol Violation|1|||
33289672|NCT01434680|100958880|FG002|Overall Study|Protocol Violation|0|||
33289673|NCT01434680|100958881|FG003|Overall Study|Protocol Violation|0|||
33289674|NCT03448536|100958884|FG000|Overall Study|Protocol Violation|2|||
33289675|NCT03448536|100958885|FG001|Overall Study|Protocol Violation|0|||
33289676|NCT03448536|100958884|FG000|Overall Study|Pregnancy|1|||
33289677|NCT03448536|100958885|FG001|Overall Study|Pregnancy|0|||
33289678|NCT03448536|100958884|FG000|Overall Study|Withdrawal by Subject|1|||
33289679|NCT03448536|100958885|FG001|Overall Study|Withdrawal by Subject|2|||
33289680|NCT03448536|100958884|FG000|Overall Study|Lost to Follow-up|3|||
33289681|NCT03448536|100958885|FG001|Overall Study|Lost to Follow-up|2|||
33289682|NCT03448536|100958884|FG000|Overall Study|Inadequate pain reporter|1|||
33289683|NCT03448536|100958885|FG001|Overall Study|Inadequate pain reporter|0|||
33289684|NCT03448536|100958884|FG000|Overall Study|Other|3|||
33289685|NCT03448536|100958885|FG001|Overall Study|Other|0|||
33289686|NCT03448536|100958884|FG000|Overall Study|Physician Decision|1|||
33289687|NCT03448536|100958885|FG001|Overall Study|Physician Decision|0|||
33289688|NCT00666198|100958892|FG000|Overall Study|Protocol Violation|10|||
33289689|NCT00666198|100958892|FG000|Overall Study|No Visit After First Day of Treatment|13|||
33289690|NCT00666198|100958892|FG000|Overall Study|Safety Not Assessable|6|||
33289691|NCT00666198|100958892|FG000|Overall Study|No Drug Administration|4|||
33289692|NCT01099579|100958896|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
33289693|NCT01099579|100958897|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
33289694|NCT01099579|100958898|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
33289695|NCT01099579|100958896|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
33289696|NCT01099579|100958897|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
33289697|NCT01099579|100958898|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
33390364|NCT01192100|101317751|FG003|Overall Study|Withdrawal by Subject|0|||
33390365|NCT01192100|101317752|FG004|Overall Study|Withdrawal by Subject|1|||
33390366|NCT01192100|101317753|FG005|Overall Study|Withdrawal by Subject|0|||
33390367|NCT01192100|101317748|FG000|Overall Study|Protocol Violation|0|||
33390368|NCT01192100|101317749|FG001|Overall Study|Protocol Violation|0|||
33390369|NCT01192100|101317750|FG002|Overall Study|Protocol Violation|0|||
33390370|NCT01192100|101317751|FG003|Overall Study|Protocol Violation|1|||
33390371|NCT01192100|101317752|FG004|Overall Study|Protocol Violation|0|||
33390372|NCT01192100|101317753|FG005|Overall Study|Protocol Violation|0|||
33390373|NCT02116361|101317754|FG000|Overall Study|Pregnancy|0|||
33390374|NCT02116361|101317755|FG001|Overall Study|Pregnancy|0|||
33390375|NCT02116361|101317756|FG002|Overall Study|Pregnancy|0|||
33390376|NCT02116361|101317757|FG003|Overall Study|Pregnancy|1|||
33390377|NCT02116361|101317754|FG000|Overall Study|Protocol Violation|1|||
33390378|NCT02116361|101317755|FG001|Overall Study|Protocol Violation|0|||
33390379|NCT02116361|101317756|FG002|Overall Study|Protocol Violation|0|||
33390380|NCT02116361|101317757|FG003|Overall Study|Protocol Violation|2|||
33390381|NCT02116361|101317754|FG000|Overall Study|Physician Decision|2|||
33390382|NCT02116361|101317755|FG001|Overall Study|Physician Decision|3|||
33289698|NCT01099579|100958896|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
33289699|NCT01099579|100958897|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
33289700|NCT01099579|100958898|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
33289701|NCT01099579|100958896|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
33289702|NCT01099579|100958897|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
33289703|NCT01099579|100958898|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
33289704|NCT01099579|100958896|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
33289705|NCT01099579|100958897|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
33289706|NCT01099579|100958898|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
33289707|NCT01099579|100958896|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
33289708|NCT01099579|100958897|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
33289709|NCT01099579|100958898|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
33289710|NCT01099579|100958896|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
33289711|NCT01099579|100958897|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
33289712|NCT01099579|100958898|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
33289713|NCT01099579|100958896|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
33289714|NCT01099579|100958897|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
33289715|NCT01099579|100958898|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
33289716|NCT01099579|100958896|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
33289717|NCT01099579|100958897|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
33289718|NCT01099579|100958898|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
33289719|NCT01099579|100958896|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
33289720|NCT01099579|100958897|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
33289721|NCT01099579|100958898|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
33289722|NCT01983462|100958899|FG000|Overall Study|Adverse Event|1|||
33289723|NCT01983462|100958900|FG001|Overall Study|Adverse Event|0|||
33289724|NCT01983462|100958901|FG002|Overall Study|Adverse Event|0|||
33289725|NCT01101061|100958902|FG000|Overall Study|Adverse Event|0|||
33289726|NCT01101061|100958903|FG001|Overall Study|Adverse Event|0|||
33289727|NCT01101061|100958904|FG002|Overall Study|Adverse Event|1|||
33289728|NCT01101061|100958905|FG003|Overall Study|Adverse Event|0|||
33289729|NCT01101061|100958906|FG004|Overall Study|Adverse Event|0|||
33289730|NCT01101061|100958907|FG005|Overall Study|Adverse Event|0|||
33289731|NCT01263054|100958908|FG000|Overall Study|Death|1|||
33289732|NCT01263054|100958909|FG001|Overall Study|Death|0|||
33289733|NCT01263054|100958908|FG000|Overall Study|Lost to Follow-up|2|||
33289734|NCT01263054|100958909|FG001|Overall Study|Lost to Follow-up|2|||
33289735|NCT01263054|100958908|FG000|Overall Study|Withdrawal by Subject|1|||
33289736|NCT01263054|100958909|FG001|Overall Study|Withdrawal by Subject|3|||
33289737|NCT01263054|100958908|FG000|Overall Study|Qualification Violation|1|||
33289738|NCT01263054|100958909|FG001|Overall Study|Qualification Violation|0|||
33289739|NCT01263054|100958908|FG000|Overall Study|Other|0|||
33289740|NCT01263054|100958909|FG001|Overall Study|Other|1|||
33289741|NCT03635086|100958910|FG000|Overall Study|Withdrawal of consent|0|||
33289742|NCT03635086|100958911|FG001|Overall Study|Withdrawal of consent|0|||
33289743|NCT03635086|100958912|FG002|Overall Study|Withdrawal of consent|1|||
33289744|NCT03635086|100958913|FG003|Overall Study|Withdrawal of consent|0|||
33390383|NCT02116361|101317756|FG002|Overall Study|Physician Decision|0|||
33390384|NCT02116361|101317757|FG003|Overall Study|Physician Decision|0|||
33289745|NCT03635086|100958914|FG004|Overall Study|Withdrawal of consent|0|||
33289746|NCT03635086|100958910|FG000|Overall Study|Adverse Event|0|||
33289747|NCT03635086|100958911|FG001|Overall Study|Adverse Event|1|||
33289748|NCT03635086|100958912|FG002|Overall Study|Adverse Event|0|||
33289749|NCT03635086|100958913|FG003|Overall Study|Adverse Event|0|||
33289750|NCT03635086|100958914|FG004|Overall Study|Adverse Event|0|||
33289751|NCT03635086|100958910|FG000|Overall Study|Lost to Follow-up|1|||
33289752|NCT03635086|100958911|FG001|Overall Study|Lost to Follow-up|0|||
33390385|NCT02116361|101317754|FG000|Overall Study|Adverse Event|1|||
33289753|NCT03635086|100958912|FG002|Overall Study|Lost to Follow-up|0|||
33390386|NCT02116361|101317755|FG001|Overall Study|Adverse Event|0|||
33390387|NCT02116361|101317756|FG002|Overall Study|Adverse Event|0|||
33390388|NCT02116361|101317757|FG003|Overall Study|Adverse Event|3|||
33390389|NCT02116361|101317754|FG000|Overall Study|Other Reasons|3|||
33390390|NCT02116361|101317755|FG001|Overall Study|Other Reasons|3|||
33390391|NCT02116361|101317756|FG002|Overall Study|Other Reasons|3|||
33390392|NCT02116361|101317757|FG003|Overall Study|Other Reasons|3|||
33390393|NCT02116361|101317754|FG000|Overall Study|Lack of Efficacy|5|||
33390394|NCT02116361|101317755|FG001|Overall Study|Lack of Efficacy|7|||
33390395|NCT02116361|101317756|FG002|Overall Study|Lack of Efficacy|4|||
33390396|NCT02116361|101317757|FG003|Overall Study|Lack of Efficacy|3|||
33390397|NCT02116361|101317754|FG000|Overall Study|Lost to Follow-up|4|||
33390398|NCT02116361|101317755|FG001|Overall Study|Lost to Follow-up|5|||
33390399|NCT02116361|101317756|FG002|Overall Study|Lost to Follow-up|7|||
33390400|NCT02116361|101317757|FG003|Overall Study|Lost to Follow-up|5|||
33390401|NCT02116361|101317754|FG000|Overall Study|Personal Reasons|6|||
33390402|NCT02116361|101317755|FG001|Overall Study|Personal Reasons|6|||
33390403|NCT02116361|101317756|FG002|Overall Study|Personal Reasons|4|||
33390404|NCT02116361|101317757|FG003|Overall Study|Personal Reasons|9|||
33390405|NCT02116361|101317754|FG000|Overall Study|Investigator Decision - Relapse|9|||
33390406|NCT02116361|101317755|FG001|Overall Study|Investigator Decision - Relapse|7|||
33390407|NCT02116361|101317756|FG002|Overall Study|Investigator Decision - Relapse|8|||
33390408|NCT02116361|101317757|FG003|Overall Study|Investigator Decision - Relapse|5|||
33390409|NCT00329784|101317758|FG000|Overall Study|Lost to Follow-up|0|||
33390410|NCT00329784|101317759|FG001|Overall Study|Lost to Follow-up|1|||
33390411|NCT00329784|101317760|FG002|Overall Study|Lost to Follow-up|0|||
33390412|NCT00329784|101317761|FG003|Overall Study|Lost to Follow-up|0|||
33390413|NCT00329784|101317758|FG000|Overall Study|Withdrawal by Subject|4|||
33390414|NCT00329784|101317759|FG001|Overall Study|Withdrawal by Subject|2|||
33390415|NCT00329784|101317760|FG002|Overall Study|Withdrawal by Subject|0|||
33390416|NCT00329784|101317761|FG003|Overall Study|Withdrawal by Subject|0|||
33390417|NCT00329784|101317758|FG000|Overall Study|Other|1|||
33390418|NCT00329784|101317759|FG001|Overall Study|Other|2|||
33390419|NCT00329784|101317760|FG002|Overall Study|Other|0|||
33390420|NCT00329784|101317761|FG003|Overall Study|Other|0|||
33390421|NCT00398138|101317762|FG000|Overall Study|Adverse Event|2|||
33390422|NCT00937326|101317763|FG000|Overall Study|Adverse Event|0|||
33390423|NCT00937326|101317764|FG001|Overall Study|Adverse Event|3|||
33390424|NCT00937326|101317765|FG002|Overall Study|Adverse Event|1|||
33390425|NCT00937326|101317766|FG003|Overall Study|Adverse Event|1|||
33390426|NCT00937326|101317767|FG004|Overall Study|Adverse Event|2|||
33390427|NCT00937326|101317763|FG000|Overall Study|Death|0|||
33390428|NCT00937326|101317764|FG001|Overall Study|Death|0|||
33390429|NCT00937326|101317765|FG002|Overall Study|Death|1|||
33390430|NCT00937326|101317766|FG003|Overall Study|Death|0|||
33390431|NCT00937326|101317767|FG004|Overall Study|Death|0|||
33390432|NCT00937326|101317763|FG000|Overall Study|Withdrawal by Subject|3|||
33390433|NCT00937326|101317764|FG001|Overall Study|Withdrawal by Subject|4|||
33390434|NCT00937326|101317765|FG002|Overall Study|Withdrawal by Subject|1|||
33390435|NCT00937326|101317766|FG003|Overall Study|Withdrawal by Subject|4|||
33390436|NCT00937326|101317767|FG004|Overall Study|Withdrawal by Subject|3|||
33390437|NCT00937326|101317763|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
33390438|NCT00937326|101317764|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
33390439|NCT00937326|101317765|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
33390440|NCT00937326|101317766|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
33390441|NCT00937326|101317767|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
33390442|NCT00420342|101317774|FG000|Overall Study|Lost to Follow-up|1|||
33390443|NCT00420342|101317775|FG001|Overall Study|Lost to Follow-up|0|||
33390444|NCT00420342|101317776|FG002|Overall Study|Lost to Follow-up|1|||
33390445|NCT00420342|101317774|FG000|Overall Study|Withdrawal by Subject|0|||
33390446|NCT00420342|101317775|FG001|Overall Study|Withdrawal by Subject|2|||
33390447|NCT00420342|101317776|FG002|Overall Study|Withdrawal by Subject|0|||
33390448|NCT02001688|101317777|FG000|Overall Study|Withdrawal by Subject|0|||
33390449|NCT02001688|101317778|FG001|Overall Study|Withdrawal by Subject|0|||
33390450|NCT02001688|101317779|FG002|Overall Study|Withdrawal by Subject|1|||
33390451|NCT02001688|101317777|FG000|Overall Study|Adverse Event|0|||
33390452|NCT02001688|101317778|FG001|Overall Study|Adverse Event|1|||
33390453|NCT02001688|101317779|FG002|Overall Study|Adverse Event|0|||
33390454|NCT00810043|101317780|FG000|Overall Study|Withdrawal by Subject|1|||
33390455|NCT00810043|101317781|FG001|Overall Study|Withdrawal by Subject|0|||
33390456|NCT00810043|101317782|FG002|Overall Study|Withdrawal by Subject|2|||
33390457|NCT00810043|101317780|FG000|Overall Study|Lost to Follow-up|1|||
33390458|NCT00810043|101317781|FG001|Overall Study|Lost to Follow-up|0|||
33390459|NCT00810043|101317782|FG002|Overall Study|Lost to Follow-up|0|||
33390460|NCT00810043|101317780|FG000|Overall Study|Physician Decision|0|||
33390461|NCT00810043|101317781|FG001|Overall Study|Physician Decision|0|||
33390462|NCT00810043|101317782|FG002|Overall Study|Physician Decision|2|||
33390463|NCT00810043|101317780|FG000|Overall Study|Death|2|||
33390464|NCT00810043|101317781|FG001|Overall Study|Death|0|||
33390465|NCT00810043|101317782|FG002|Overall Study|Death|0|||
33390466|NCT00810043|101317780|FG000|Overall Study|Unrelated medical problem|0|||
33390467|NCT00810043|101317781|FG001|Overall Study|Unrelated medical problem|1|||
33390468|NCT00810043|101317782|FG002|Overall Study|Unrelated medical problem|0|||
33390469|NCT00810043|101317780|FG000|Overall Study|Non-medical problem|0|||
33390470|NCT00810043|101317781|FG001|Overall Study|Non-medical problem|0|||
33390471|NCT00810043|101317782|FG002|Overall Study|Non-medical problem|1|||
33390472|NCT00810043|101317780|FG000|Overall Study|No longer met enrollment criteria|0|||
33390473|NCT00810043|101317781|FG001|Overall Study|No longer met enrollment criteria|0|||
33390474|NCT00810043|101317782|FG002|Overall Study|No longer met enrollment criteria|3|||
33390475|NCT03796195|101317783|FG000|Overall Study|Study closed early|1|||
33390476|NCT01673490|101317784|FG000|Overall Study|Lost to Follow-up|1|||
33390477|NCT01673490|101317784|FG000|Overall Study|Adverse Event|3|||
33390478|NCT01673490|101317784|FG000|Overall Study|Withdrawal by Subject|3|||
33390479|NCT00429572|101317792|FG000|Overall Study|Disease progression|1|||
33390480|NCT02348840|101317794|FG000|Overall Study|Withdrawal by Subject|2|||
33390481|NCT02348840|101317795|FG001|Overall Study|Withdrawal by Subject|1|||
33390482|NCT02348840|101317796|FG002|Overall Study|Withdrawal by Subject|0|||
33390483|NCT02348840|101317797|FG003|Overall Study|Withdrawal by Subject|0|||
33390484|NCT03639987|101317798|FG000|Overall Study|Study terminated by sponsor|26|||
33390485|NCT03639987|101317799|FG001|Overall Study|Study terminated by sponsor|25|||
33390486|NCT03639987|101317798|FG000|Overall Study|Lost to Follow-up|0|||
33390487|NCT03639987|101317799|FG001|Overall Study|Lost to Follow-up|1|||
33390488|NCT00641706|101317800|FG000|Overall Study|Adverse Event|2|||
33390489|NCT00641706|101317801|FG001|Overall Study|Adverse Event|1|||
33390490|NCT00641706|101317800|FG000|Overall Study|Withdrawal by Subject|6|||
33390491|NCT00641706|101317801|FG001|Overall Study|Withdrawal by Subject|1|||
33390492|NCT00641706|101317800|FG000|Overall Study|Clinical Decline|1|||
33390493|NCT00641706|101317801|FG001|Overall Study|Clinical Decline|0|||
33390494|NCT00641706|101317800|FG000|Overall Study|Lead Investigator Decision|0|||
33390495|NCT00641706|101317801|FG001|Overall Study|Lead Investigator Decision|1|||
33390496|NCT05406440|101317802|FG000|Overall Study|Lost to Follow-up|0|||
33390497|NCT05406440|101317803|FG001|Overall Study|Lost to Follow-up|0|||
33390498|NCT05406440|101317804|FG002|Overall Study|Lost to Follow-up|0|||
33390499|NCT05406440|101317805|FG003|Overall Study|Lost to Follow-up|0|||
33390500|NCT05406440|101317806|FG004|Overall Study|Lost to Follow-up|2|||
33390501|NCT05406440|101317807|FG005|Overall Study|Lost to Follow-up|0|||
33390502|NCT05406440|101317808|FG006|Overall Study|Lost to Follow-up|0|||
33390503|NCT05406440|101317802|FG000|Overall Study|Physician Decision|0|||
33390504|NCT05406440|101317803|FG001|Overall Study|Physician Decision|0|||
33390505|NCT05406440|101317804|FG002|Overall Study|Physician Decision|0|||
33390506|NCT05406440|101317805|FG003|Overall Study|Physician Decision|0|||
33390507|NCT05406440|101317806|FG004|Overall Study|Physician Decision|1|||
33390508|NCT05406440|101317807|FG005|Overall Study|Physician Decision|0|||
33390509|NCT05406440|101317808|FG006|Overall Study|Physician Decision|0|||
33390510|NCT05406440|101317802|FG000|Overall Study|Withdrawal by Subject|0|||
33390511|NCT05406440|101317803|FG001|Overall Study|Withdrawal by Subject|0|||
33390512|NCT05406440|101317804|FG002|Overall Study|Withdrawal by Subject|0|||
33390513|NCT05406440|101317805|FG003|Overall Study|Withdrawal by Subject|0|||
33390514|NCT05406440|101317806|FG004|Overall Study|Withdrawal by Subject|0|||
33390515|NCT05406440|101317807|FG005|Overall Study|Withdrawal by Subject|2|||
33390516|NCT05406440|101317808|FG006|Overall Study|Withdrawal by Subject|0|||
33390517|NCT03472040|101317809|FG000|Overall Study|Physician Decision|0|||
33390518|NCT03472040|101317810|FG001|Overall Study|Physician Decision|3|||
33390519|NCT03472040|101317809|FG000|Overall Study|Withdrawal by Subject|10|||
33390520|NCT03472040|101317810|FG001|Overall Study|Withdrawal by Subject|23|||
33390521|NCT03472040|101317809|FG000|Overall Study|Perceived Lack of Efficacy|29|||
33390522|NCT03472040|101317810|FG001|Overall Study|Perceived Lack of Efficacy|30|||
33390523|NCT03472040|101317809|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
33390524|NCT03472040|101317810|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
33390525|NCT03472040|101317809|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
33390526|NCT03472040|101317810|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
33390527|NCT03472040|101317809|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
33390528|NCT03472040|101317810|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
33390529|NCT03472040|101317809|FG000|Overall Study|Subject Non-compliance|2|||
33390530|NCT03472040|101317810|FG001|Overall Study|Subject Non-compliance|5|||
33390531|NCT03472040|101317809|FG000|Overall Study|Discontinuation due to Rash|0|||
33390532|NCT03472040|101317810|FG001|Overall Study|Discontinuation due to Rash|1|||
33390533|NCT03472040|101317809|FG000|Overall Study|Subsequent Ineligibility|0|||
33390534|NCT03472040|101317810|FG001|Overall Study|Subsequent Ineligibility|2|||
33390535|NCT03472040|101317809|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
33390536|NCT03472040|101317810|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
33390537|NCT02204410|101317815|FG000|Overall Study|Lost to Follow-up|5|||
33390538|NCT02204410|101317815|FG000|Overall Study|Physician Decision|2|||
33390539|NCT02204410|101317815|FG000|Overall Study|Protocol Violation|1|||
33390540|NCT02204410|101317815|FG000|Overall Study|Withdrawal by Subject|3|||
33390541|NCT01685203|101317816|FG000|Overall Study|Lost to Follow-up|3|||
33390542|NCT01685203|101317817|FG001|Overall Study|Lost to Follow-up|3|||
33390543|NCT01685203|101317818|FG002|Overall Study|Lost to Follow-up|0|||
33390544|NCT01685203|101317819|FG003|Overall Study|Lost to Follow-up|1|||
33390545|NCT01685203|101317820|FG004|Overall Study|Lost to Follow-up|0|||
33390546|NCT01685203|101317821|FG005|Overall Study|Lost to Follow-up|0|||
33390547|NCT01685203|101317822|FG006|Overall Study|Lost to Follow-up|0|||
33390548|NCT01685203|101317816|FG000|Overall Study|Adverse Event|0|||
33390549|NCT01685203|101317817|FG001|Overall Study|Adverse Event|0|||
33390550|NCT01685203|101317818|FG002|Overall Study|Adverse Event|0|||
33390551|NCT01685203|101317819|FG003|Overall Study|Adverse Event|0|||
33390552|NCT01685203|101317820|FG004|Overall Study|Adverse Event|0|||
33390553|NCT01685203|101317821|FG005|Overall Study|Adverse Event|2|||
33390554|NCT01685203|101317822|FG006|Overall Study|Adverse Event|0|||
33390555|NCT01685203|101317816|FG000|Overall Study|Adverse event and withdrew consent|1|||
33390556|NCT01685203|101317817|FG001|Overall Study|Adverse event and withdrew consent|0|||
33390557|NCT01685203|101317818|FG002|Overall Study|Adverse event and withdrew consent|0|||
33390558|NCT01685203|101317819|FG003|Overall Study|Adverse event and withdrew consent|0|||
33390559|NCT01685203|101317820|FG004|Overall Study|Adverse event and withdrew consent|0|||
33390560|NCT01685203|101317821|FG005|Overall Study|Adverse event and withdrew consent|0|||
33390561|NCT01685203|101317822|FG006|Overall Study|Adverse event and withdrew consent|0|||
33390562|NCT01685203|101317816|FG000|Overall Study|Patient's decision|0|||
33390563|NCT01685203|101317817|FG001|Overall Study|Patient's decision|0|||
33390564|NCT01685203|101317818|FG002|Overall Study|Patient's decision|0|||
33390565|NCT01685203|101317819|FG003|Overall Study|Patient's decision|0|||
33390566|NCT01685203|101317820|FG004|Overall Study|Patient's decision|0|||
33390567|NCT01685203|101317821|FG005|Overall Study|Patient's decision|1|||
33390568|NCT01685203|101317822|FG006|Overall Study|Patient's decision|0|||
33390569|NCT01094808|101317823|FG000|Overall Study|Withdrawal by Subject|1|||
33390570|NCT01094808|101317824|FG001|Overall Study|Withdrawal by Subject|1|||
33390571|NCT01094808|101317825|FG002|Overall Study|Withdrawal by Subject|0|||
33390572|NCT03630016|101317826|FG000|Overall Study|Poor Sensor Placement|1|||
33390573|NCT00561340|101317828|FG000|Overall Study|refused to drink pediasure|6|||
33390574|NCT00561340|101317829|FG001|Overall Study|refused to drink pediasure|0|||
33390575|NCT01412151|101317830|FG000|Week 0 - 306 - Treatment Period|Death|1|||
33390576|NCT01412151|101317830|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
33390577|NCT01412151|101317830|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
33390578|NCT01412151|101317830|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
33390579|NCT02215616|101317831|FG000|Overall Study|Sponsor requested to stop study drug|0|||
33390580|NCT02215616|101317832|FG001|Overall Study|Sponsor requested to stop study drug|0|||
33390581|NCT02215616|101317833|FG002|Overall Study|Sponsor requested to stop study drug|1|||
33390582|NCT02215616|101317834|FG003|Overall Study|Sponsor requested to stop study drug|4|||
33390583|NCT02215616|101317831|FG000|Overall Study|Death|1|||
33390584|NCT02215616|101317832|FG001|Overall Study|Death|0|||
33390585|NCT02215616|101317833|FG002|Overall Study|Death|0|||
33390586|NCT02215616|101317834|FG003|Overall Study|Death|0|||
33390587|NCT02215616|101317831|FG000|Overall Study|Adverse Event|7|||
33390588|NCT02215616|101317832|FG001|Overall Study|Adverse Event|4|||
33390589|NCT02215616|101317833|FG002|Overall Study|Adverse Event|9|||
33390590|NCT02215616|101317834|FG003|Overall Study|Adverse Event|2|||
33390591|NCT02215616|101317831|FG000|Overall Study|Withdrawal by Subject|1|||
33390592|NCT02215616|101317832|FG001|Overall Study|Withdrawal by Subject|8|||
33390593|NCT02215616|101317833|FG002|Overall Study|Withdrawal by Subject|2|||
33390594|NCT02215616|101317834|FG003|Overall Study|Withdrawal by Subject|5|||
33390595|NCT02215616|101317831|FG000|Overall Study|Non-compliance|0|||
33390596|NCT02215616|101317832|FG001|Overall Study|Non-compliance|2|||
33390597|NCT02215616|101317833|FG002|Overall Study|Non-compliance|1|||
33390598|NCT02215616|101317834|FG003|Overall Study|Non-compliance|0|||
33390599|NCT02215616|101317831|FG000|Overall Study|Protocol Violation|0|||
33390600|NCT02215616|101317832|FG001|Overall Study|Protocol Violation|2|||
33390601|NCT02215616|101317833|FG002|Overall Study|Protocol Violation|0|||
33390602|NCT02215616|101317834|FG003|Overall Study|Protocol Violation|0|||
33289754|NCT03635086|100958913|FG003|Overall Study|Lost to Follow-up|0|||
33390603|NCT02215616|101317831|FG000|Overall Study|Lost to Follow-up|1|||
33390604|NCT02215616|101317832|FG001|Overall Study|Lost to Follow-up|1|||
33390605|NCT02215616|101317833|FG002|Overall Study|Lost to Follow-up|0|||
33390606|NCT02215616|101317834|FG003|Overall Study|Lost to Follow-up|1|||
33390607|NCT02215616|101317831|FG000|Overall Study|Other than specified|1|||
33390608|NCT02215616|101317832|FG001|Overall Study|Other than specified|0|||
33390609|NCT02215616|101317833|FG002|Overall Study|Other than specified|1|||
33390610|NCT02215616|101317834|FG003|Overall Study|Other than specified|1|||
33390611|NCT03039790|101317835|FG000|Overall Study|Lost to Follow-up|2|||
33390612|NCT03039790|101317836|FG001|Overall Study|Lost to Follow-up|0|||
33390613|NCT03039790|101317837|FG002|Overall Study|Lost to Follow-up|1|||
33390614|NCT03039790|101317838|FG003|Overall Study|Lost to Follow-up|1|||
33390615|NCT03039790|101317839|FG004|Overall Study|Lost to Follow-up|0|||
33390616|NCT03039790|101317840|FG005|Overall Study|Lost to Follow-up|1|||
33390617|NCT03039790|101317841|FG006|Overall Study|Lost to Follow-up|1|||
33390618|NCT03039790|101317842|FG007|Overall Study|Lost to Follow-up|1|||
33390619|NCT03039790|101317843|FG008|Overall Study|Lost to Follow-up|0|||
33390620|NCT03039790|101317844|FG009|Overall Study|Lost to Follow-up|1|||
33390621|NCT03039790|101317845|FG010|Overall Study|Lost to Follow-up|1|||
33390622|NCT03039790|101317846|FG011|Overall Study|Lost to Follow-up|0|||
33390623|NCT03039790|101317847|FG012|Overall Study|Lost to Follow-up|1|||
33390624|NCT03039790|101317848|FG013|Overall Study|Lost to Follow-up|0|||
33390625|NCT03039790|101317849|FG014|Overall Study|Lost to Follow-up|3|||
33390626|NCT03039790|101317850|FG015|Overall Study|Lost to Follow-up|1|||
33390627|NCT03039790|101317851|FG016|Overall Study|Lost to Follow-up|2|||
33390628|NCT03039790|101317852|FG017|Overall Study|Lost to Follow-up|2|||
33390629|NCT03039790|101317853|FG018|Overall Study|Lost to Follow-up|1|||
33390630|NCT03039790|101317854|FG019|Overall Study|Lost to Follow-up|3|||
33390631|NCT03039790|101317835|FG000|Overall Study|Withdrawal of Consent|1|||
33390632|NCT03039790|101317836|FG001|Overall Study|Withdrawal of Consent|0|||
33390633|NCT03039790|101317837|FG002|Overall Study|Withdrawal of Consent|0|||
33390634|NCT03039790|101317838|FG003|Overall Study|Withdrawal of Consent|1|||
33390635|NCT03039790|101317839|FG004|Overall Study|Withdrawal of Consent|0|||
33390636|NCT03039790|101317840|FG005|Overall Study|Withdrawal of Consent|0|||
33390637|NCT03039790|101317841|FG006|Overall Study|Withdrawal of Consent|0|||
33390638|NCT03039790|101317842|FG007|Overall Study|Withdrawal of Consent|0|||
33390639|NCT03039790|101317843|FG008|Overall Study|Withdrawal of Consent|0|||
33390640|NCT03039790|101317844|FG009|Overall Study|Withdrawal of Consent|1|||
33390641|NCT03039790|101317845|FG010|Overall Study|Withdrawal of Consent|0|||
33390642|NCT03039790|101317846|FG011|Overall Study|Withdrawal of Consent|0|||
33390643|NCT03039790|101317847|FG012|Overall Study|Withdrawal of Consent|2|||
33390644|NCT03039790|101317848|FG013|Overall Study|Withdrawal of Consent|0|||
33390645|NCT03039790|101317849|FG014|Overall Study|Withdrawal of Consent|1|||
33390646|NCT03039790|101317850|FG015|Overall Study|Withdrawal of Consent|5|||
33390647|NCT03039790|101317851|FG016|Overall Study|Withdrawal of Consent|3|||
33390648|NCT03039790|101317852|FG017|Overall Study|Withdrawal of Consent|0|||
33390649|NCT03039790|101317853|FG018|Overall Study|Withdrawal of Consent|2|||
33390650|NCT03039790|101317854|FG019|Overall Study|Withdrawal of Consent|5|||
33390651|NCT03039790|101317835|FG000|Overall Study|Death|0|||
33390652|NCT03039790|101317836|FG001|Overall Study|Death|0|||
33390653|NCT03039790|101317837|FG002|Overall Study|Death|0|||
33390654|NCT03039790|101317838|FG003|Overall Study|Death|0|||
33390655|NCT03039790|101317839|FG004|Overall Study|Death|0|||
33390656|NCT03039790|101317840|FG005|Overall Study|Death|0|||
33390657|NCT03039790|101317841|FG006|Overall Study|Death|0|||
33390658|NCT03039790|101317842|FG007|Overall Study|Death|0|||
33390659|NCT03039790|101317843|FG008|Overall Study|Death|0|||
33390660|NCT03039790|101317844|FG009|Overall Study|Death|0|||
33390661|NCT03039790|101317845|FG010|Overall Study|Death|0|||
33390662|NCT03039790|101317846|FG011|Overall Study|Death|0|||
33390663|NCT03039790|101317847|FG012|Overall Study|Death|0|||
33390664|NCT03039790|101317848|FG013|Overall Study|Death|0|||
33390665|NCT03039790|101317849|FG014|Overall Study|Death|0|||
33390666|NCT03039790|101317850|FG015|Overall Study|Death|1|||
33390667|NCT03039790|101317851|FG016|Overall Study|Death|3|||
33390668|NCT03039790|101317852|FG017|Overall Study|Death|0|||
33390669|NCT03039790|101317853|FG018|Overall Study|Death|2|||
33390670|NCT03039790|101317854|FG019|Overall Study|Death|0|||
33390671|NCT03039790|101317835|FG000|Overall Study|Reason, not Specified|1|||
33390672|NCT03039790|101317836|FG001|Overall Study|Reason, not Specified|0|||
33390673|NCT03039790|101317837|FG002|Overall Study|Reason, not Specified|0|||
33390674|NCT03039790|101317838|FG003|Overall Study|Reason, not Specified|0|||
33390675|NCT03039790|101317839|FG004|Overall Study|Reason, not Specified|0|||
33390676|NCT03039790|101317840|FG005|Overall Study|Reason, not Specified|0|||
33390677|NCT03039790|101317841|FG006|Overall Study|Reason, not Specified|0|||
33390678|NCT03039790|101317842|FG007|Overall Study|Reason, not Specified|0|||
33390679|NCT03039790|101317843|FG008|Overall Study|Reason, not Specified|0|||
33390680|NCT03039790|101317844|FG009|Overall Study|Reason, not Specified|0|||
33390681|NCT03039790|101317845|FG010|Overall Study|Reason, not Specified|0|||
33390682|NCT03039790|101317846|FG011|Overall Study|Reason, not Specified|0|||
33390683|NCT03039790|101317847|FG012|Overall Study|Reason, not Specified|0|||
33390684|NCT03039790|101317848|FG013|Overall Study|Reason, not Specified|0|||
33390685|NCT03039790|101317849|FG014|Overall Study|Reason, not Specified|0|||
33390686|NCT03039790|101317850|FG015|Overall Study|Reason, not Specified|0|||
33390687|NCT03039790|101317851|FG016|Overall Study|Reason, not Specified|2|||
33390688|NCT03039790|101317852|FG017|Overall Study|Reason, not Specified|0|||
33390689|NCT03039790|101317853|FG018|Overall Study|Reason, not Specified|1|||
33390690|NCT03039790|101317854|FG019|Overall Study|Reason, not Specified|0|||
33390691|NCT01749800|101317857|FG000|Overall Study|not meeting inclusion criteria|3|||
33390692|NCT01749800|101317858|FG001|Overall Study|not meeting inclusion criteria|0|||
33390693|NCT01749800|101317859|FG002|Overall Study|not meeting inclusion criteria|0|||
33390694|NCT01749800|101317857|FG000|Overall Study|Withdrawal by Subject|0|||
33390695|NCT01749800|101317858|FG001|Overall Study|Withdrawal by Subject|1|||
33390696|NCT01749800|101317859|FG002|Overall Study|Withdrawal by Subject|0|||
33390697|NCT00324740|101317860|FG000|Overall Study|Withdrawal by Subject|1|||
33390698|NCT00324740|101317861|FG001|Overall Study|Withdrawal by Subject|0|||
33390699|NCT00324740|101317862|FG002|Overall Study|Withdrawal by Subject|1|||
33390700|NCT03518034|101317864|FG000|Overall Study|Not Treated|5|||
33390701|NCT03518034|101317865|FG001|Overall Study|Not Treated|1|||
33390702|NCT03518034|101317864|FG000|Overall Study|Withdrawal by Subject|309|||
33390703|NCT03518034|101317865|FG001|Overall Study|Withdrawal by Subject|351|||
33390704|NCT03518034|101317864|FG000|Overall Study|Lost to Follow-up|446|||
33390705|NCT03518034|101317865|FG001|Overall Study|Lost to Follow-up|458|||
33390706|NCT03518034|101317864|FG000|Overall Study|Adverse Event|138|||
33390707|NCT03518034|101317865|FG001|Overall Study|Adverse Event|130|||
33390708|NCT03518034|101317864|FG000|Overall Study|Lack of Efficacy|11|||
33390709|NCT03518034|101317865|FG001|Overall Study|Lack of Efficacy|23|||
33390710|NCT03518034|101317864|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
33390711|NCT03518034|101317865|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
33390712|NCT03518034|101317864|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
33390713|NCT03518034|101317865|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
33390714|NCT03518034|101317864|FG000|Overall Study|Other, Not Specified|84|||
33390715|NCT03518034|101317865|FG001|Overall Study|Other, Not Specified|53|||
33390716|NCT03518034|101317864|FG000|Overall Study|Reason Missing|2|||
33390717|NCT03518034|101317865|FG001|Overall Study|Reason Missing|3|||
33390718|NCT03039569|101317866|FG000|Overall Study|Lost to Follow-up|5|||
33390719|NCT03039569|101317867|FG001|Overall Study|Lost to Follow-up|4|||
33390720|NCT00322387|101317868|FG000|Treatment Period|Adverse Event|0|||
33390721|NCT00322387|101317869|FG001|Treatment Period|Adverse Event|1|||
33390722|NCT00322387|101317868|FG000|Follow-up Period|Final assessment not done|1|||
33390723|NCT00322387|101317869|FG001|Follow-up Period|Final assessment not done|3|||
33390724|NCT00322387|101317868|FG000|Follow-up Period|Death|1|||
33390725|NCT00322387|101317869|FG001|Follow-up Period|Death|0|||
33390726|NCT03510910|101317870|FG000|Overall Study|Incomplete Survey|2|||
33390727|NCT03510910|101317871|FG001|Overall Study|Incomplete Survey|3|||
33390728|NCT02975349|101317872|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33390729|NCT02975349|101317873|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33390730|NCT02975349|101317874|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
33390731|NCT02975349|101317875|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
33390732|NCT02975349|101317876|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33390733|NCT02975349|101317877|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33390734|NCT02975349|101317872|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
33390735|NCT02975349|101317873|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33390736|NCT02975349|101317874|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33390737|NCT02975349|101317875|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33390738|NCT02975349|101317876|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33390739|NCT02975349|101317877|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33390740|NCT02975349|101317872|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
33390741|NCT02975349|101317873|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
33390742|NCT02975349|101317874|FG002|Active Treatment Period (24 Weeks)|Adverse Event|1|||
33390743|NCT02975349|101317875|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
33390744|NCT02975349|101317876|FG004|Active Treatment Period (24 Weeks)|Adverse Event|6|||
33390745|NCT02975349|101317877|FG005|Active Treatment Period (24 Weeks)|Adverse Event|2|||
33390746|NCT02975349|101317872|FG000|Active Treatment Period (24 Weeks)|Un-specified|0|||
33390747|NCT02975349|101317873|FG001|Active Treatment Period (24 Weeks)|Un-specified|0|||
33390748|NCT02975349|101317874|FG002|Active Treatment Period (24 Weeks)|Un-specified|1|||
33390749|NCT02975349|101317875|FG003|Active Treatment Period (24 Weeks)|Un-specified|0|||
33390750|NCT02975349|101317876|FG004|Active Treatment Period (24 Weeks)|Un-specified|0|||
33390751|NCT02975349|101317877|FG005|Active Treatment Period (24 Weeks)|Un-specified|0|||
33390752|NCT02975349|101317872|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
33390753|NCT02975349|101317873|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
33390754|NCT02975349|101317874|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
33390755|NCT02975349|101317875|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|2|||
33390756|NCT02975349|101317876|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
33390757|NCT02975349|101317877|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
33390758|NCT02975349|101317872|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
33390759|NCT02975349|101317873|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
33390760|NCT02975349|101317874|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
33390761|NCT02975349|101317875|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
33390762|NCT02975349|101317876|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
33390763|NCT02975349|101317877|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
33390764|NCT02975349|101317872|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
33390765|NCT02975349|101317873|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
33390766|NCT02975349|101317874|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
33390767|NCT02975349|101317875|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
33390768|NCT02975349|101317876|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
33390769|NCT02975349|101317877|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
33390770|NCT02975349|101317872|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
33390771|NCT02975349|101317873|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
33390772|NCT02975349|101317874|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
33390773|NCT02975349|101317875|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
33390774|NCT02975349|101317876|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
33390775|NCT02975349|101317877|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
33390776|NCT02975349|101317872|FG000|Blinded Extension Period (24 Weeks)|Un-specified|0|||
33390777|NCT02975349|101317873|FG001|Blinded Extension Period (24 Weeks)|Un-specified|0|||
33390778|NCT02975349|101317874|FG002|Blinded Extension Period (24 Weeks)|Un-specified|0|||
33390779|NCT02975349|101317875|FG003|Blinded Extension Period (24 Weeks)|Un-specified|1|||
33390780|NCT02975349|101317876|FG004|Blinded Extension Period (24 Weeks)|Un-specified|0|||
33390781|NCT02975349|101317877|FG005|Blinded Extension Period (24 Weeks)|Un-specified|0|||
33390782|NCT00445341|101317878|FG000|Overall Study|refused further treatment|1|||
33390783|NCT00445341|101317878|FG000|Overall Study|taken off treatment too early|1|||
33390784|NCT00572728|101317885|FG000|Overall Study|Withdrawal by Subject|10|||
33390785|NCT00572728|101317885|FG000|Overall Study|Ineligible|3|||
33390786|NCT00572728|101317885|FG000|Overall Study|Enrolled under Amendment 4|5|||
33390787|NCT00572728|101317885|FG000|Overall Study|Offstudy due to complicating disease|1|||
33390788|NCT00572728|101317885|FG000|Overall Study|FLT1 not completed|4|||
33390789|NCT00572728|101317885|FG000|Overall Study|First Chemotherapy not initiated|2|||
33390790|NCT00572728|101317885|FG000|Overall Study|FLT2 not completed|5|||
33390791|NCT00572728|101317885|FG000|Overall Study|Second chemotherapy not initiated|1|||
33390792|NCT00572728|101317885|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
33390793|NCT00572728|101317885|FG000|Overall Study|Pathology missing|1|||
33390794|NCT00571519|101317886|FG000|Overall Study|Subject withdrew consent|0|||
33390795|NCT00571519|101317887|FG001|Overall Study|Subject withdrew consent|1|||
33390796|NCT00571519|101317888|FG002|Overall Study|Subject withdrew consent|0|||
33390797|NCT00571519|101317889|FG003|Overall Study|Subject withdrew consent|2|||
33390798|NCT00571519|101317890|FG004|Overall Study|Subject withdrew consent|1|||
33390799|NCT00571519|101317891|FG005|Overall Study|Subject withdrew consent|1|||
33390800|NCT00571519|101317892|FG006|Overall Study|Subject withdrew consent|2|||
33390801|NCT00571519|101317886|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
33390802|NCT00571519|101317887|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
33390803|NCT00571519|101317888|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
33390804|NCT00571519|101317889|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
33390805|NCT00571519|101317890|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
33390806|NCT00571519|101317891|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
33390807|NCT00571519|101317892|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
33390808|NCT00571519|101317886|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
33390809|NCT00571519|101317887|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
33390810|NCT00571519|101317888|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
33390811|NCT00571519|101317889|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
33390812|NCT00571519|101317890|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
33390813|NCT00571519|101317891|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
33390814|NCT00571519|101317892|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
33390815|NCT00571519|101317886|FG000|Overall Study|Termination of study by Sponsor|2|||
33390816|NCT00571519|101317887|FG001|Overall Study|Termination of study by Sponsor|7|||
33390817|NCT00571519|101317888|FG002|Overall Study|Termination of study by Sponsor|10|||
33390818|NCT00571519|101317889|FG003|Overall Study|Termination of study by Sponsor|24|||
33390819|NCT00571519|101317890|FG004|Overall Study|Termination of study by Sponsor|8|||
33390820|NCT00571519|101317891|FG005|Overall Study|Termination of study by Sponsor|9|||
33390821|NCT00571519|101317892|FG006|Overall Study|Termination of study by Sponsor|22|||
33390822|NCT00571519|101317886|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
33390823|NCT00571519|101317887|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
33390824|NCT00571519|101317888|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
33390825|NCT00571519|101317889|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
33390826|NCT00571519|101317890|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
33390827|NCT00571519|101317891|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
33390828|NCT00571519|101317892|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
33390829|NCT00247273|101317893|FG000|Overall Study|Adverse Event|85|||
33390830|NCT00247273|101317894|FG001|Overall Study|Adverse Event|80|||
33390831|NCT00247273|101317893|FG000|Overall Study|Physician Decision|6|||
33390832|NCT00247273|101317894|FG001|Overall Study|Physician Decision|3|||
33390833|NCT00247273|101317893|FG000|Overall Study|Lost to Follow-up|7|||
33390834|NCT00247273|101317894|FG001|Overall Study|Lost to Follow-up|7|||
33390835|NCT00247273|101317893|FG000|Overall Study|Withdrawal by Subject|46|||
33390836|NCT00247273|101317894|FG001|Overall Study|Withdrawal by Subject|47|||
33390837|NCT00247273|101317893|FG000|Overall Study|Did not take any study drug|2|||
33390838|NCT00247273|101317894|FG001|Overall Study|Did not take any study drug|0|||
33390839|NCT01975675|101317900|FG000|Overall Study|Death|0|||
33390840|NCT01975675|101317901|FG001|Overall Study|Death|1|||
33390841|NCT01975675|101317902|FG002|Overall Study|Death|0|||
33390842|NCT01975675|101317903|FG003|Overall Study|Death|0|||
33390843|NCT02959970|101321618|FG000|Overall Study|Adverse Event|1|||
33390844|NCT02959970|101321619|FG001|Overall Study|Adverse Event|0|||
33390845|NCT02959970|101321618|FG000|Overall Study|Withdrawal by Subject|0|||
33390846|NCT02959970|101321619|FG001|Overall Study|Withdrawal by Subject|2|||
33390847|NCT02959970|101321618|FG000|Overall Study|Lost to Follow-up|1|||
33390848|NCT02959970|101321619|FG001|Overall Study|Lost to Follow-up|5|||
33390849|NCT04445051|101321625|FG000|Overall Study|Adverse Event|0|||
33390850|NCT04445051|101321626|FG001|Overall Study|Adverse Event|0|||
33390851|NCT04445051|101321627|FG002|Overall Study|Adverse Event|1|||
33390852|NCT04445051|101321628|FG003|Overall Study|Adverse Event|0|||
33390853|NCT04445051|101321629|FG004|Overall Study|Adverse Event|0|||
33390854|NCT04445051|101321630|FG005|Overall Study|Adverse Event|0|||
33390855|NCT01352845|101321631|FG000|Overall Study|Lost to Follow-up|313|||
33390856|NCT01352845|101321632|FG001|Overall Study|Lost to Follow-up|92|||
33390857|NCT01352845|101321631|FG000|Overall Study|No Longer Willing to Participate|205|||
33390858|NCT01352845|101321632|FG001|Overall Study|No Longer Willing to Participate|58|||
33390859|NCT01352845|101321631|FG000|Overall Study|Withdrawal by Subject|48|||
33390860|NCT01352845|101321632|FG001|Overall Study|Withdrawal by Subject|16|||
33390861|NCT01352845|101321631|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
33390862|NCT01352845|101321632|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
33390863|NCT01352845|101321631|FG000|Overall Study|Pregnancy|27|||
33390864|NCT01352845|101321632|FG001|Overall Study|Pregnancy|7|||
33390865|NCT01352845|101321631|FG000|Overall Study|Adverse Event|22|||
33390866|NCT01352845|101321632|FG001|Overall Study|Adverse Event|6|||
33390867|NCT01352845|101321631|FG000|Overall Study|Other|17|||
33390868|NCT01352845|101321632|FG001|Overall Study|Other|7|||
33390869|NCT01352845|101321631|FG000|Overall Study|Protocol Violation|12|||
33390870|NCT01352845|101321632|FG001|Overall Study|Protocol Violation|6|||
33390871|NCT01352845|101321631|FG000|Overall Study|Death|3|||
33390872|NCT01352845|101321632|FG001|Overall Study|Death|0|||
33390873|NCT02025530|101321633|FG000|Overall Study|No longer met elligibility criteria|5|||
33390874|NCT02025530|101321634|FG001|Overall Study|No longer met elligibility criteria|1|||
33390875|NCT01712490|101321635|FG000|Overall Study|Ongoing|601|||
33390876|NCT01712490|101321636|FG001|Overall Study|Ongoing|586|||
33390877|NCT01712490|101321635|FG000|Overall Study|Other|11|||
33390878|NCT01712490|101321636|FG001|Overall Study|Other|11|||
33390879|NCT01712490|101321635|FG000|Overall Study|Withdrawal by Subject|36|||
33390880|NCT01712490|101321636|FG001|Overall Study|Withdrawal by Subject|44|||
33390881|NCT01712490|101321635|FG000|Overall Study|Lost to Follow-up|16|||
33390882|NCT01712490|101321636|FG001|Overall Study|Lost to Follow-up|29|||
33390883|NCT00653068|101321637|FG000|Overall Study|Death|9|||
33390884|NCT00653068|101321637|FG000|Overall Study|Lack of Efficacy|34|||
33390885|NCT00653068|101321637|FG000|Overall Study|Physician Decision|4|||
33390886|NCT00653068|101321637|FG000|Overall Study|Withdrawal by Subject|1|||
33390887|NCT00653068|101321637|FG000|Overall Study|Ineligible|2|||
33390888|NCT03799627|101321647|FG000|Overall Study|Adverse Event|1|||
33390889|NCT03799627|101321648|FG001|Overall Study|Adverse Event|2|||
33390890|NCT03799627|101321649|FG002|Overall Study|Adverse Event|0|||
33390891|NCT03799627|101321650|FG003|Overall Study|Adverse Event|0|||
33390892|NCT03799627|101321651|FG004|Overall Study|Adverse Event|2|||
33390893|NCT03799627|101321652|FG005|Overall Study|Adverse Event|5|||
33390894|NCT03799627|101321653|FG006|Overall Study|Adverse Event|0|||
33390895|NCT03799627|101321654|FG007|Overall Study|Adverse Event|2|||
33390896|NCT03799627|101321655|FG008|Overall Study|Adverse Event|0|||
33390897|NCT03799627|101321647|FG000|Overall Study|Physician Decision|2|||
33390898|NCT03799627|101321648|FG001|Overall Study|Physician Decision|2|||
33390899|NCT03799627|101321649|FG002|Overall Study|Physician Decision|0|||
33390900|NCT03799627|101321650|FG003|Overall Study|Physician Decision|0|||
33390901|NCT03799627|101321651|FG004|Overall Study|Physician Decision|2|||
33390902|NCT03799627|101321652|FG005|Overall Study|Physician Decision|2|||
33390903|NCT03799627|101321653|FG006|Overall Study|Physician Decision|0|||
33390904|NCT03799627|101321654|FG007|Overall Study|Physician Decision|0|||
33390905|NCT03799627|101321655|FG008|Overall Study|Physician Decision|0|||
33390906|NCT03799627|101321647|FG000|Overall Study|Withdrawal by Subject|1|||
33390907|NCT03799627|101321648|FG001|Overall Study|Withdrawal by Subject|1|||
33390908|NCT03799627|101321649|FG002|Overall Study|Withdrawal by Subject|0|||
33390909|NCT03799627|101321650|FG003|Overall Study|Withdrawal by Subject|2|||
33390910|NCT03799627|101321651|FG004|Overall Study|Withdrawal by Subject|0|||
33390911|NCT03799627|101321652|FG005|Overall Study|Withdrawal by Subject|3|||
33390912|NCT03799627|101321653|FG006|Overall Study|Withdrawal by Subject|0|||
33390913|NCT03799627|101321654|FG007|Overall Study|Withdrawal by Subject|0|||
33390914|NCT03799627|101321655|FG008|Overall Study|Withdrawal by Subject|0|||
33390915|NCT03799627|101321647|FG000|Overall Study|Lack of Efficacy|0|||
33390916|NCT03799627|101321648|FG001|Overall Study|Lack of Efficacy|0|||
33390917|NCT03799627|101321649|FG002|Overall Study|Lack of Efficacy|0|||
33390918|NCT03799627|101321650|FG003|Overall Study|Lack of Efficacy|1|||
33390919|NCT03799627|101321651|FG004|Overall Study|Lack of Efficacy|0|||
33390920|NCT03799627|101321652|FG005|Overall Study|Lack of Efficacy|0|||
33390921|NCT03799627|101321653|FG006|Overall Study|Lack of Efficacy|0|||
33390922|NCT03799627|101321654|FG007|Overall Study|Lack of Efficacy|0|||
33390923|NCT03799627|101321655|FG008|Overall Study|Lack of Efficacy|0|||
33390924|NCT03799627|101321647|FG000|Overall Study|Lost to Follow-up|0|||
33390925|NCT03799627|101321648|FG001|Overall Study|Lost to Follow-up|0|||
33390926|NCT03799627|101321649|FG002|Overall Study|Lost to Follow-up|0|||
33390927|NCT03799627|101321650|FG003|Overall Study|Lost to Follow-up|0|||
33390928|NCT03799627|101321651|FG004|Overall Study|Lost to Follow-up|0|||
33390929|NCT03799627|101321652|FG005|Overall Study|Lost to Follow-up|0|||
33390930|NCT03799627|101321653|FG006|Overall Study|Lost to Follow-up|1|||
33390931|NCT03799627|101321654|FG007|Overall Study|Lost to Follow-up|0|||
33390932|NCT03799627|101321655|FG008|Overall Study|Lost to Follow-up|1|||
33390933|NCT03799627|101321647|FG000|Overall Study|Death|0|||
33390934|NCT03799627|101321648|FG001|Overall Study|Death|0|||
33390935|NCT03799627|101321649|FG002|Overall Study|Death|0|||
33390936|NCT03799627|101321650|FG003|Overall Study|Death|1|||
33390937|NCT03799627|101321651|FG004|Overall Study|Death|0|||
33390938|NCT03799627|101321652|FG005|Overall Study|Death|0|||
33390939|NCT03799627|101321653|FG006|Overall Study|Death|0|||
33390940|NCT03799627|101321654|FG007|Overall Study|Death|0|||
33390941|NCT03799627|101321655|FG008|Overall Study|Death|0|||
33390942|NCT03799627|101321647|FG000|Overall Study|Study Drug Put on Hold|1|||
33390943|NCT03799627|101321648|FG001|Overall Study|Study Drug Put on Hold|0|||
33390944|NCT03799627|101321649|FG002|Overall Study|Study Drug Put on Hold|0|||
33390945|NCT03799627|101321650|FG003|Overall Study|Study Drug Put on Hold|0|||
33390946|NCT03799627|101321651|FG004|Overall Study|Study Drug Put on Hold|0|||
33390947|NCT03799627|101321652|FG005|Overall Study|Study Drug Put on Hold|0|||
33390948|NCT03799627|101321653|FG006|Overall Study|Study Drug Put on Hold|0|||
33390949|NCT03799627|101321654|FG007|Overall Study|Study Drug Put on Hold|0|||
33390950|NCT03799627|101321655|FG008|Overall Study|Study Drug Put on Hold|0|||
33390951|NCT03799627|101321647|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
33390952|NCT03799627|101321648|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
33390953|NCT03799627|101321649|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
33390954|NCT03799627|101321650|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
33390955|NCT03799627|101321651|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
33390956|NCT03799627|101321652|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
33390957|NCT03799627|101321653|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
33390958|NCT03799627|101321654|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
33390959|NCT03799627|101321655|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
33390960|NCT03799627|101321647|FG000|Overall Study|Kidney Transplantation|1|||
33390961|NCT03799627|101321648|FG001|Overall Study|Kidney Transplantation|0|||
33390962|NCT03799627|101321649|FG002|Overall Study|Kidney Transplantation|0|||
33390963|NCT03799627|101321650|FG003|Overall Study|Kidney Transplantation|1|||
33390964|NCT03799627|101321651|FG004|Overall Study|Kidney Transplantation|1|||
33390965|NCT03799627|101321652|FG005|Overall Study|Kidney Transplantation|0|||
33390966|NCT03799627|101321653|FG006|Overall Study|Kidney Transplantation|0|||
33390967|NCT03799627|101321654|FG007|Overall Study|Kidney Transplantation|0|||
33390968|NCT03799627|101321655|FG008|Overall Study|Kidney Transplantation|0|||
33390969|NCT03799627|101321647|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
33390970|NCT03799627|101321648|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
33390971|NCT03799627|101321649|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
33390972|NCT03799627|101321650|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
33390973|NCT03799627|101321651|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
33390974|NCT03799627|101321652|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
33390975|NCT03799627|101321653|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
33390976|NCT03799627|101321654|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
33390977|NCT03799627|101321655|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
33390978|NCT03799627|101321647|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33390979|NCT03799627|101321648|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
33390980|NCT03799627|101321649|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33390981|NCT03799627|101321650|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33390982|NCT03799627|101321651|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33390983|NCT03799627|101321652|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33390984|NCT03799627|101321653|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33390985|NCT03799627|101321654|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33390986|NCT03799627|101321655|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
33390987|NCT03799627|101321647|FG000|Overall Study|Met Exclusion Criteria|0|||
33595303|NCT03515551|102069667|FG006|Overall Study|Lost to Follow-up|0|||
33390988|NCT03799627|101321648|FG001|Overall Study|Met Exclusion Criteria|0|||
33390989|NCT03799627|101321649|FG002|Overall Study|Met Exclusion Criteria|0|||
33390990|NCT03799627|101321650|FG003|Overall Study|Met Exclusion Criteria|1|||
33390991|NCT03799627|101321651|FG004|Overall Study|Met Exclusion Criteria|0|||
33390992|NCT03799627|101321652|FG005|Overall Study|Met Exclusion Criteria|0|||
33390993|NCT03799627|101321653|FG006|Overall Study|Met Exclusion Criteria|0|||
33390994|NCT03799627|101321654|FG007|Overall Study|Met Exclusion Criteria|0|||
33390995|NCT03799627|101321655|FG008|Overall Study|Met Exclusion Criteria|0|||
33390996|NCT03799627|101321647|FG000|Overall Study|Investigational Product Noncompliance|0|||
33390997|NCT03799627|101321648|FG001|Overall Study|Investigational Product Noncompliance|0|||
33390998|NCT03799627|101321649|FG002|Overall Study|Investigational Product Noncompliance|0|||
33390999|NCT03799627|101321650|FG003|Overall Study|Investigational Product Noncompliance|1|||
33391000|NCT03799627|101321651|FG004|Overall Study|Investigational Product Noncompliance|0|||
33391001|NCT03799627|101321652|FG005|Overall Study|Investigational Product Noncompliance|0|||
33391002|NCT03799627|101321653|FG006|Overall Study|Investigational Product Noncompliance|0|||
33391003|NCT03799627|101321654|FG007|Overall Study|Investigational Product Noncompliance|0|||
33391004|NCT03799627|101321655|FG008|Overall Study|Investigational Product Noncompliance|0|||
33391005|NCT03799627|101321647|FG000|Overall Study|Participant Relocation|0|||
33391006|NCT03799627|101321648|FG001|Overall Study|Participant Relocation|0|||
33391007|NCT03799627|101321649|FG002|Overall Study|Participant Relocation|0|||
33391008|NCT03799627|101321650|FG003|Overall Study|Participant Relocation|1|||
33391009|NCT03799627|101321651|FG004|Overall Study|Participant Relocation|0|||
33391010|NCT03799627|101321652|FG005|Overall Study|Participant Relocation|1|||
33391011|NCT03799627|101321653|FG006|Overall Study|Participant Relocation|0|||
33391012|NCT03799627|101321654|FG007|Overall Study|Participant Relocation|0|||
33391013|NCT03799627|101321655|FG008|Overall Study|Participant Relocation|0|||
33391014|NCT03799627|101321647|FG000|Overall Study|Eurofin Issue|0|||
33391015|NCT03799627|101321648|FG001|Overall Study|Eurofin Issue|0|||
33391016|NCT03799627|101321649|FG002|Overall Study|Eurofin Issue|0|||
33391017|NCT03799627|101321650|FG003|Overall Study|Eurofin Issue|0|||
33391018|NCT03799627|101321651|FG004|Overall Study|Eurofin Issue|1|||
33391019|NCT03799627|101321652|FG005|Overall Study|Eurofin Issue|0|||
33391020|NCT03799627|101321653|FG006|Overall Study|Eurofin Issue|0|||
33391021|NCT03799627|101321654|FG007|Overall Study|Eurofin Issue|0|||
33391022|NCT03799627|101321655|FG008|Overall Study|Eurofin Issue|0|||
33391023|NCT03799627|101321647|FG000|Overall Study|Noncompliance with Site Instructions|0|||
33391024|NCT03799627|101321648|FG001|Overall Study|Noncompliance with Site Instructions|0|||
33391025|NCT03799627|101321649|FG002|Overall Study|Noncompliance with Site Instructions|0|||
33391026|NCT03799627|101321650|FG003|Overall Study|Noncompliance with Site Instructions|0|||
33391027|NCT03799627|101321651|FG004|Overall Study|Noncompliance with Site Instructions|1|||
33391028|NCT03799627|101321652|FG005|Overall Study|Noncompliance with Site Instructions|0|||
33391029|NCT03799627|101321653|FG006|Overall Study|Noncompliance with Site Instructions|0|||
33391030|NCT03799627|101321654|FG007|Overall Study|Noncompliance with Site Instructions|0|||
33391031|NCT03799627|101321655|FG008|Overall Study|Noncompliance with Site Instructions|0|||
33391032|NCT03799627|101321647|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33391033|NCT03799627|101321648|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33391034|NCT03799627|101321649|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33391035|NCT03799627|101321650|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33391036|NCT03799627|101321651|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
33391037|NCT03799627|101321652|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33391038|NCT03799627|101321653|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33391039|NCT03799627|101321654|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33391040|NCT03799627|101321655|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
33391041|NCT03799627|101321647|FG000|Overall Study|Changes In Hemoglobin Values|1|||
33391042|NCT03799627|101321648|FG001|Overall Study|Changes In Hemoglobin Values|2|||
33391043|NCT03799627|101321649|FG002|Overall Study|Changes In Hemoglobin Values|1|||
33391044|NCT03799627|101321650|FG003|Overall Study|Changes In Hemoglobin Values|0|||
33391045|NCT03799627|101321651|FG004|Overall Study|Changes In Hemoglobin Values|0|||
33391046|NCT03799627|101321652|FG005|Overall Study|Changes In Hemoglobin Values|2|||
33391047|NCT03799627|101321653|FG006|Overall Study|Changes In Hemoglobin Values|1|||
33391048|NCT03799627|101321654|FG007|Overall Study|Changes In Hemoglobin Values|0|||
33391049|NCT03799627|101321655|FG008|Overall Study|Changes In Hemoglobin Values|1|||
33391050|NCT01039428|101321656|FG000|Overall Study|Protocol Violation|1|||
33391051|NCT01039428|101321657|FG001|Overall Study|Protocol Violation|0|||
33391052|NCT01039428|101321656|FG000|Overall Study|Withdrawal by Subject|1|||
33391053|NCT01039428|101321657|FG001|Overall Study|Withdrawal by Subject|0|||
33391054|NCT00106249|101321658|FG000|Overall Study|Lost to Follow-up|3|||
33391055|NCT00106249|101321659|FG001|Overall Study|Lost to Follow-up|2|||
33391056|NCT00918346|101321660|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
33391057|NCT00918346|101321661|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
33391058|NCT01855945|101321662|FG000|Overall Study|Adverse Event|0|||
33391059|NCT01855945|101321663|FG001|Overall Study|Adverse Event|0|||
33391060|NCT01855945|101321664|FG002|Overall Study|Adverse Event|0|||
33391061|NCT01855945|101321665|FG003|Overall Study|Adverse Event|0|||
33391062|NCT01855945|101321666|FG004|Overall Study|Adverse Event|0|||
33391063|NCT01855945|101321667|FG005|Overall Study|Adverse Event|0|||
33391064|NCT01855945|101321668|FG006|Overall Study|Adverse Event|1|||
33391065|NCT01855945|101321669|FG007|Overall Study|Adverse Event|0|||
33391066|NCT01855945|101321670|FG008|Overall Study|Adverse Event|0|||
33391067|NCT01855945|101321671|FG009|Overall Study|Adverse Event|0|||
33391068|NCT01855945|101321672|FG010|Overall Study|Adverse Event|0|||
33391069|NCT01855945|101321673|FG011|Overall Study|Adverse Event|0|||
33391070|NCT01855945|101321662|FG000|Overall Study|Death|0|||
33391071|NCT01855945|101321663|FG001|Overall Study|Death|0|||
33391072|NCT01855945|101321664|FG002|Overall Study|Death|0|||
33391073|NCT01855945|101321665|FG003|Overall Study|Death|0|||
33391074|NCT01855945|101321666|FG004|Overall Study|Death|0|||
33391075|NCT01855945|101321667|FG005|Overall Study|Death|0|||
33391076|NCT01855945|101321668|FG006|Overall Study|Death|2|||
33391077|NCT01855945|101321669|FG007|Overall Study|Death|0|||
33391078|NCT01855945|101321670|FG008|Overall Study|Death|0|||
33391079|NCT01855945|101321671|FG009|Overall Study|Death|0|||
33391080|NCT01855945|101321672|FG010|Overall Study|Death|0|||
33391081|NCT01855945|101321673|FG011|Overall Study|Death|0|||
33391082|NCT01855945|101321662|FG000|Overall Study|Lost to Follow-up|11|||
33391083|NCT01855945|101321663|FG001|Overall Study|Lost to Follow-up|10|||
33391084|NCT01855945|101321664|FG002|Overall Study|Lost to Follow-up|7|||
33391085|NCT01855945|101321665|FG003|Overall Study|Lost to Follow-up|3|||
33391086|NCT01855945|101321666|FG004|Overall Study|Lost to Follow-up|0|||
33391087|NCT01855945|101321667|FG005|Overall Study|Lost to Follow-up|3|||
33391088|NCT01855945|101321668|FG006|Overall Study|Lost to Follow-up|4|||
33391089|NCT01855945|101321669|FG007|Overall Study|Lost to Follow-up|7|||
33391090|NCT01855945|101321670|FG008|Overall Study|Lost to Follow-up|2|||
33391091|NCT01855945|101321671|FG009|Overall Study|Lost to Follow-up|0|||
33391092|NCT01855945|101321672|FG010|Overall Study|Lost to Follow-up|0|||
33391093|NCT01855945|101321673|FG011|Overall Study|Lost to Follow-up|2|||
33391094|NCT01855945|101321662|FG000|Overall Study|Other - Unclassified|1|||
33391095|NCT01855945|101321663|FG001|Overall Study|Other - Unclassified|1|||
33391096|NCT01855945|101321664|FG002|Overall Study|Other - Unclassified|1|||
33391097|NCT01855945|101321665|FG003|Overall Study|Other - Unclassified|0|||
33391098|NCT01855945|101321666|FG004|Overall Study|Other - Unclassified|0|||
33391099|NCT01855945|101321667|FG005|Overall Study|Other - Unclassified|0|||
33391100|NCT01855945|101321668|FG006|Overall Study|Other - Unclassified|2|||
33391101|NCT01855945|101321669|FG007|Overall Study|Other - Unclassified|1|||
33391102|NCT01855945|101321670|FG008|Overall Study|Other - Unclassified|0|||
33391103|NCT01855945|101321671|FG009|Overall Study|Other - Unclassified|0|||
33391104|NCT01855945|101321672|FG010|Overall Study|Other - Unclassified|1|||
33391105|NCT01855945|101321673|FG011|Overall Study|Other - Unclassified|0|||
33391106|NCT01855945|101321662|FG000|Overall Study|Withdrawal by Subject|4|||
33391107|NCT01855945|101321663|FG001|Overall Study|Withdrawal by Subject|0|||
33391108|NCT01855945|101321664|FG002|Overall Study|Withdrawal by Subject|4|||
33391109|NCT01855945|101321665|FG003|Overall Study|Withdrawal by Subject|1|||
33391110|NCT01855945|101321666|FG004|Overall Study|Withdrawal by Subject|1|||
33391111|NCT01855945|101321667|FG005|Overall Study|Withdrawal by Subject|0|||
33391112|NCT01855945|101321668|FG006|Overall Study|Withdrawal by Subject|1|||
33391113|NCT01855945|101321669|FG007|Overall Study|Withdrawal by Subject|0|||
33391114|NCT01855945|101321670|FG008|Overall Study|Withdrawal by Subject|0|||
33391115|NCT01855945|101321671|FG009|Overall Study|Withdrawal by Subject|2|||
33391116|NCT01855945|101321672|FG010|Overall Study|Withdrawal by Subject|4|||
33391117|NCT01855945|101321673|FG011|Overall Study|Withdrawal by Subject|1|||
33391118|NCT05083949|101321674|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
33391119|NCT05083949|101321675|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
33391120|NCT05083949|101321674|FG000|Period 1|Adverse Event|1|||
33391121|NCT05083949|101321675|FG001|Period 1|Adverse Event|1|||
33391122|NCT05083949|101321674|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
33391123|NCT05083949|101321675|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
33391124|NCT05083949|101321674|FG000|Period 2|Adverse Event|0|||
33391125|NCT05083949|101321675|FG001|Period 2|Adverse Event|2|||
33391126|NCT00010803|101321676|FG000|Overall Study|Withdrawal by Subject|97|||
33391127|NCT00010803|101321677|FG001|Overall Study|Withdrawal by Subject|98|||
33391128|NCT02687711|101321678|FG000|Overall Study|Adverse Event|89|||
33391129|NCT02687711|101321678|FG000|Overall Study|Lack of Efficacy|70|||
33391130|NCT02687711|101321678|FG000|Overall Study|Lost to Follow-up|20|||
33391131|NCT02687711|101321678|FG000|Overall Study|Consent withdrawn|15|||
33391132|NCT02687711|101321678|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
33391133|NCT02687711|101321678|FG000|Overall Study|Too expensive|4|||
33391134|NCT02687711|101321678|FG000|Overall Study|Participant moved abroad|1|||
33391135|NCT02687711|101321678|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
33391136|NCT02687711|101321678|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
33391137|NCT02687711|101321678|FG000|Overall Study|Disliked taste|1|||
33391138|NCT02687711|101321678|FG000|Overall Study|Low mood|1|||
33391139|NCT02687711|101321678|FG000|Overall Study|Side effects|1|||
33391140|NCT02687711|101321678|FG000|Overall Study|Change of Hospital|1|||
33391141|NCT02687711|101321678|FG000|Overall Study|Liver Encephalopathy|1|||
33391142|NCT02687711|101321678|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
33391143|NCT02687711|101321678|FG000|Overall Study|Withdrawn due to intake interruption|1|||
33391144|NCT02687711|101321678|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
33391145|NCT02687711|101321678|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
33391146|NCT02687711|101321678|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
33391147|NCT00481988|101321680|FG000|Overall Study|Withdrawal by Subject|1|||
33391148|NCT00481988|101321681|FG001|Overall Study|Withdrawal by Subject|1|||
33391149|NCT03077243|101321682|FG000|Overall Study|Death|1|||
33391150|NCT03077243|101321683|FG001|Overall Study|Death|2|||
33391151|NCT03077243|101321684|FG002|Overall Study|Death|0|||
33391152|NCT03077243|101321685|FG003|Overall Study|Death|0|||
33391153|NCT03077243|101321682|FG000|Overall Study|Withdrawal by Subject|1|||
33391154|NCT03077243|101321683|FG001|Overall Study|Withdrawal by Subject|3|||
33391155|NCT03077243|101321684|FG002|Overall Study|Withdrawal by Subject|0|||
33391156|NCT03077243|101321685|FG003|Overall Study|Withdrawal by Subject|0|||
33391157|NCT03077243|101321682|FG000|Overall Study|Physician Decision|1|||
33391158|NCT03077243|101321683|FG001|Overall Study|Physician Decision|0|||
33391159|NCT03077243|101321684|FG002|Overall Study|Physician Decision|0|||
33391160|NCT03077243|101321685|FG003|Overall Study|Physician Decision|0|||
33391161|NCT03077243|101321682|FG000|Overall Study|Research at two study sites terminated early|0|||
33391162|NCT03077243|101321683|FG001|Overall Study|Research at two study sites terminated early|0|||
33391163|NCT03077243|101321684|FG002|Overall Study|Research at two study sites terminated early|0|||
33391164|NCT03077243|101321685|FG003|Overall Study|Research at two study sites terminated early|69|||
33391165|NCT01802515|101321686|FG000|Overall Study|Withdrawal by Subject|3|||
33391166|NCT01802515|101321687|FG001|Overall Study|Withdrawal by Subject|0|||
33391167|NCT01802515|101321688|FG002|Overall Study|Withdrawal by Subject|0|||
33391168|NCT01678313|101321691|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
33391169|NCT01678313|101321692|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
33391170|NCT01678313|101321691|FG000|Completed the 3-month Therapy|Physician Decision|3|||
33391171|NCT01678313|101321692|FG001|Completed the 3-month Therapy|Physician Decision|4|||
33391172|NCT01678313|101321691|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
33391173|NCT01678313|101321692|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
33391174|NCT01678313|101321691|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
33391175|NCT01678313|101321692|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
33391176|NCT00608881|101321693|FG000|Overall Study|Death|22|||
33391177|NCT00608881|101321694|FG001|Overall Study|Death|13|||
33391178|NCT00608881|101321693|FG000|Overall Study|Adverse Event|5|||
33391179|NCT00608881|101321694|FG001|Overall Study|Adverse Event|3|||
33391180|NCT00608881|101321693|FG000|Overall Study|Lost to Follow-up|28|||
33391181|NCT00608881|101321694|FG001|Overall Study|Lost to Follow-up|14|||
33391182|NCT00608881|101321693|FG000|Overall Study|Withdrawal by Subject|18|||
33391183|NCT00608881|101321694|FG001|Overall Study|Withdrawal by Subject|29|||
33391184|NCT00608881|101321693|FG000|Overall Study|Physician Decision|5|||
33391185|NCT00608881|101321694|FG001|Overall Study|Physician Decision|5|||
33391186|NCT00608881|101321693|FG000|Overall Study|Institutionalized|1|||
33391187|NCT00608881|101321694|FG001|Overall Study|Institutionalized|2|||
33391188|NCT00688623|101321695|FG000|Overall Study|Adverse Event|22|||
33391189|NCT00688623|101321695|FG000|Overall Study|abnormal lab value|1|||
33391190|NCT00688623|101321695|FG000|Overall Study|Withdrawal by Subject|4|||
33391191|NCT00688623|101321695|FG000|Overall Study|Death|3|||
33391192|NCT00688623|101321695|FG000|Overall Study|disease progression|23|||
33391193|NCT00688623|101321695|FG000|Overall Study|Protocol Violation|2|||
33391194|NCT05166603|101321696|FG000|Overall Study|Withdrawal by Subject|68|||
33391195|NCT05166603|101321697|FG001|Overall Study|Withdrawal by Subject|0|||
33391196|NCT03383614|101321700|FG000|Overall Study|Withdrawal by Subject|0|||
33391197|NCT03383614|101321701|FG001|Overall Study|Withdrawal by Subject|1|||
33391198|NCT03383614|101321702|FG002|Overall Study|Withdrawal by Subject|0|||
33391199|NCT03383614|101321703|FG003|Overall Study|Withdrawal by Subject|0|||
33391200|NCT03238352|101321705|FG000|Overall Study|Lost to Follow-up|0|||
33391201|NCT03238352|101321706|FG001|Overall Study|Lost to Follow-up|2|||
33391202|NCT03238352|101321707|FG002|Overall Study|Lost to Follow-up|1|||
33391203|NCT03238352|101321705|FG000|Overall Study|Withdrawal by Subject|0|||
33391204|NCT03238352|101321706|FG001|Overall Study|Withdrawal by Subject|1|||
33391205|NCT03238352|101321707|FG002|Overall Study|Withdrawal by Subject|0|||
33391206|NCT00291187|101321708|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
33391207|NCT00291187|101321709|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
33391208|NCT00291187|101321710|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
33391209|NCT00291187|101321711|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
33391210|NCT01055457|101321712|FG000|Overall Study|Lost to Follow-up|0|||
33391211|NCT01055457|101321713|FG001|Overall Study|Lost to Follow-up|1|||
33391212|NCT01055457|101321714|FG002|Overall Study|Lost to Follow-up|0|||
33391213|NCT01055457|101321715|FG003|Overall Study|Lost to Follow-up|0|||
33391214|NCT01055457|101321716|FG004|Overall Study|Lost to Follow-up|0|||
33391215|NCT01055457|101321717|FG005|Overall Study|Lost to Follow-up|1|||
33391216|NCT01055457|101321718|FG006|Overall Study|Lost to Follow-up|0|||
33391217|NCT01055457|101321719|FG007|Overall Study|Lost to Follow-up|0|||
33391218|NCT01055457|101321720|FG008|Overall Study|Lost to Follow-up|0|||
33391219|NCT01055457|101321721|FG009|Overall Study|Lost to Follow-up|0|||
33391220|NCT01055457|101321712|FG000|Overall Study|Protocol Violation|0|||
33391221|NCT01055457|101321713|FG001|Overall Study|Protocol Violation|0|||
33391222|NCT01055457|101321714|FG002|Overall Study|Protocol Violation|1|||
33391223|NCT01055457|101321715|FG003|Overall Study|Protocol Violation|1|||
33391224|NCT01055457|101321716|FG004|Overall Study|Protocol Violation|1|||
33391225|NCT01055457|101321717|FG005|Overall Study|Protocol Violation|2|||
33391226|NCT01055457|101321718|FG006|Overall Study|Protocol Violation|1|||
33391227|NCT01055457|101321719|FG007|Overall Study|Protocol Violation|0|||
33391228|NCT01055457|101321720|FG008|Overall Study|Protocol Violation|0|||
33391229|NCT01055457|101321721|FG009|Overall Study|Protocol Violation|1|||
33391230|NCT01055457|101321712|FG000|Overall Study|Subject Disinterest|0|||
33391231|NCT01055457|101321713|FG001|Overall Study|Subject Disinterest|0|||
33391232|NCT01055457|101321714|FG002|Overall Study|Subject Disinterest|0|||
33391233|NCT01055457|101321715|FG003|Overall Study|Subject Disinterest|0|||
33391234|NCT01055457|101321716|FG004|Overall Study|Subject Disinterest|0|||
33391235|NCT01055457|101321717|FG005|Overall Study|Subject Disinterest|0|||
33391236|NCT01055457|101321718|FG006|Overall Study|Subject Disinterest|0|||
33391237|NCT01055457|101321719|FG007|Overall Study|Subject Disinterest|1|||
33391238|NCT01055457|101321720|FG008|Overall Study|Subject Disinterest|0|||
33391239|NCT01055457|101321721|FG009|Overall Study|Subject Disinterest|0|||
33391240|NCT01055457|101321712|FG000|Overall Study|Subject Ineligible|1|||
33391241|NCT01055457|101321713|FG001|Overall Study|Subject Ineligible|0|||
33391242|NCT01055457|101321714|FG002|Overall Study|Subject Ineligible|1|||
33391243|NCT01055457|101321715|FG003|Overall Study|Subject Ineligible|0|||
33391244|NCT01055457|101321716|FG004|Overall Study|Subject Ineligible|1|||
33391245|NCT01055457|101321717|FG005|Overall Study|Subject Ineligible|0|||
33391246|NCT01055457|101321718|FG006|Overall Study|Subject Ineligible|0|||
33391247|NCT01055457|101321719|FG007|Overall Study|Subject Ineligible|0|||
33391248|NCT01055457|101321720|FG008|Overall Study|Subject Ineligible|0|||
33391249|NCT01055457|101321721|FG009|Overall Study|Subject Ineligible|0|||
33391250|NCT01055457|101321712|FG000|Overall Study|Discomfort|0|||
33391251|NCT01055457|101321713|FG001|Overall Study|Discomfort|0|||
33391252|NCT01055457|101321714|FG002|Overall Study|Discomfort|0|||
33391253|NCT01055457|101321715|FG003|Overall Study|Discomfort|0|||
33391254|NCT01055457|101321716|FG004|Overall Study|Discomfort|1|||
33391255|NCT01055457|101321717|FG005|Overall Study|Discomfort|0|||
33391256|NCT01055457|101321718|FG006|Overall Study|Discomfort|0|||
33391257|NCT01055457|101321719|FG007|Overall Study|Discomfort|0|||
33391258|NCT01055457|101321720|FG008|Overall Study|Discomfort|0|||
33391259|NCT01055457|101321721|FG009|Overall Study|Discomfort|0|||
33391260|NCT01055457|101321712|FG000|Overall Study|Pregnancy|0|||
33391261|NCT01055457|101321713|FG001|Overall Study|Pregnancy|0|||
33391262|NCT01055457|101321714|FG002|Overall Study|Pregnancy|0|||
33391263|NCT01055457|101321715|FG003|Overall Study|Pregnancy|1|||
33391264|NCT01055457|101321716|FG004|Overall Study|Pregnancy|0|||
33391265|NCT01055457|101321717|FG005|Overall Study|Pregnancy|0|||
33391266|NCT01055457|101321718|FG006|Overall Study|Pregnancy|0|||
33391267|NCT01055457|101321719|FG007|Overall Study|Pregnancy|0|||
33391268|NCT01055457|101321720|FG008|Overall Study|Pregnancy|0|||
33391269|NCT01055457|101321721|FG009|Overall Study|Pregnancy|0|||
33391270|NCT01055457|101321712|FG000|Overall Study|Adverse Event|0|||
33391271|NCT01055457|101321713|FG001|Overall Study|Adverse Event|0|||
33391272|NCT01055457|101321714|FG002|Overall Study|Adverse Event|0|||
33391273|NCT01055457|101321715|FG003|Overall Study|Adverse Event|1|||
33391274|NCT01055457|101321716|FG004|Overall Study|Adverse Event|0|||
33391275|NCT01055457|101321717|FG005|Overall Study|Adverse Event|0|||
33391276|NCT01055457|101321718|FG006|Overall Study|Adverse Event|0|||
33391277|NCT01055457|101321719|FG007|Overall Study|Adverse Event|0|||
33391278|NCT01055457|101321720|FG008|Overall Study|Adverse Event|0|||
33391279|NCT01055457|101321721|FG009|Overall Study|Adverse Event|0|||
33391280|NCT03127852|101321724|FG000|Overall Study|Withdrawal by Subject|4|||
33391281|NCT03127852|101321725|FG001|Overall Study|Withdrawal by Subject|1|||
33391282|NCT03127852|101321724|FG000|Overall Study|Death|1|||
33391283|NCT03127852|101321725|FG001|Overall Study|Death|1|||
33391284|NCT00367341|101321735|FG000|Overall Study|Physician Decision|1|||
33391285|NCT00367341|101321736|FG001|Overall Study|Physician Decision|0|||
33391286|NCT00367341|101321735|FG000|Overall Study|Protocol Violation|1|||
33391287|NCT00367341|101321736|FG001|Overall Study|Protocol Violation|0|||
33391288|NCT01690988|101321750|FG000|Overall Study|Withdrawal by Subject|2|||
33391289|NCT01690988|101321751|FG001|Overall Study|Withdrawal by Subject|2|||
33391290|NCT01690988|101321752|FG002|Overall Study|Withdrawal by Subject|3|||
33391291|NCT01690988|101321750|FG000|Overall Study|Physician Decision|0|||
33391292|NCT01690988|101321751|FG001|Overall Study|Physician Decision|0|||
33391293|NCT01690988|101321752|FG002|Overall Study|Physician Decision|1|||
33391294|NCT01690988|101321750|FG000|Overall Study|Operation Cancelled|1|||
33391295|NCT01690988|101321751|FG001|Overall Study|Operation Cancelled|1|||
33391296|NCT01690988|101321752|FG002|Overall Study|Operation Cancelled|0|||
33391297|NCT01690988|101321750|FG000|Overall Study|Determined ineligible|1|||
33391298|NCT01690988|101321751|FG001|Overall Study|Determined ineligible|0|||
33391299|NCT01690988|101321752|FG002|Overall Study|Determined ineligible|0|||
33391300|NCT01690988|101321750|FG000|Overall Study|Death|1|||
33391301|NCT01690988|101321751|FG001|Overall Study|Death|1|||
33391302|NCT01690988|101321752|FG002|Overall Study|Death|1|||
33391303|NCT01690988|101321750|FG000|Overall Study|Sedated|1|||
33391304|NCT01690988|101321751|FG001|Overall Study|Sedated|1|||
33391305|NCT01690988|101321752|FG002|Overall Study|Sedated|2|||
33391306|NCT03417505|101321754|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
33391307|NCT03417505|101321755|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
33391308|NCT04363944|101321759|FG000|Overall Study|Withdrawal by Subject|2|||
33391309|NCT04363944|101321760|FG001|Overall Study|Withdrawal by Subject|0|||
33391310|NCT02007252|101321761|FG000|Overall Study|Administrative problems|3|||
33391311|NCT02007252|101321762|FG001|Overall Study|Administrative problems|7|||
33391312|NCT02007252|101321761|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33391313|NCT02007252|101321762|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33391314|NCT02007252|101321761|FG000|Overall Study|Adverse Event|7|||
33391315|NCT02007252|101321762|FG001|Overall Study|Adverse Event|4|||
33391316|NCT02768103|101321765|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
33391317|NCT03689972|101321766|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
33391318|NCT03689972|101321767|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
33391319|NCT03689972|101321768|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
33391320|NCT03689972|101321769|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
33391321|NCT03689972|101321770|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
33391322|NCT03689972|101321766|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
33391323|NCT03689972|101321767|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
33391324|NCT03689972|101321768|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
33391325|NCT03689972|101321769|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
33391326|NCT03689972|101321770|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
33391327|NCT03689972|101321766|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
33391328|NCT03689972|101321767|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
33391329|NCT03689972|101321768|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
33391330|NCT03689972|101321769|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
33391331|NCT03689972|101321770|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
33391332|NCT03689972|101321766|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
33391333|NCT03689972|101321767|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
33391334|NCT03689972|101321768|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
33391335|NCT03689972|101321769|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
33391336|NCT03689972|101321770|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
33391337|NCT03689972|101321766|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
33391338|NCT03689972|101321767|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
33391339|NCT03689972|101321768|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
33391340|NCT03689972|101321769|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
33391341|NCT03689972|101321770|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
33391342|NCT03689972|101321766|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
33391343|NCT03689972|101321767|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
33391344|NCT03689972|101321768|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
33391345|NCT03689972|101321769|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
33391346|NCT03689972|101321770|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
33391347|NCT03689972|101321766|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
33391348|NCT03689972|101321767|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
33391349|NCT03689972|101321768|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
33391350|NCT03689972|101321769|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
33391351|NCT03689972|101321770|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
33391352|NCT03689972|101321766|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
33391353|NCT03689972|101321767|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
33391354|NCT03689972|101321768|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
33391355|NCT03689972|101321769|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
33391356|NCT03689972|101321770|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
33391357|NCT03689972|101321766|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
33391358|NCT03689972|101321767|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
33391359|NCT03689972|101321768|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
33391360|NCT03689972|101321769|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
33391361|NCT03689972|101321770|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
33391362|NCT03689972|101321766|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
33391363|NCT03689972|101321767|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
33391364|NCT03689972|101321768|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
33391365|NCT03689972|101321769|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
33391366|NCT03689972|101321770|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
33391367|NCT03689972|101321766|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
33391368|NCT03689972|101321767|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
33391369|NCT03689972|101321768|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
33391370|NCT03689972|101321769|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
33391371|NCT03689972|101321770|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
33391372|NCT03689972|101321766|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
33391373|NCT03689972|101321767|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
33391374|NCT03689972|101321768|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
33391375|NCT03689972|101321769|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
33391376|NCT03689972|101321770|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
33391377|NCT03689972|101321766|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
33391378|NCT03689972|101321767|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
33391379|NCT03689972|101321768|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
33391380|NCT03689972|101321769|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
33391381|NCT03689972|101321770|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
33391382|NCT03689972|101321766|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
33391383|NCT03689972|101321767|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
33391384|NCT03689972|101321768|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
33391385|NCT03689972|101321769|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
33391386|NCT03689972|101321770|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
33391387|NCT03689972|101321766|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
33391388|NCT03689972|101321767|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
33391389|NCT03689972|101321768|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
33391390|NCT03689972|101321769|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
33391391|NCT03689972|101321770|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
33391392|NCT03689972|101321766|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
33391393|NCT03689972|101321767|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
33391394|NCT03689972|101321768|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
33391395|NCT03689972|101321769|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
33391396|NCT03689972|101321770|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
33391397|NCT03689972|101321766|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
33391398|NCT03689972|101321767|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
33391399|NCT03689972|101321768|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
33391400|NCT03689972|101321769|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
33391401|NCT03689972|101321770|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
33391402|NCT03689972|101321766|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
33391403|NCT03689972|101321767|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
33391404|NCT03689972|101321768|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
33391405|NCT03689972|101321769|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
33391406|NCT03689972|101321770|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
33391407|NCT03689972|101321766|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
33391408|NCT03689972|101321767|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
33391409|NCT03689972|101321768|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
33391410|NCT03689972|101321769|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
33391411|NCT03689972|101321770|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
33391412|NCT00107172|101321771|FG000|Overall Study|Withdrawal by Subject|1|||
33391413|NCT00107172|101321772|FG001|Overall Study|Withdrawal by Subject|0|||
33391414|NCT00107172|101321771|FG000|Overall Study|Death|0|||
33391415|NCT00107172|101321772|FG001|Overall Study|Death|2|||
33391416|NCT00107172|101321771|FG000|Overall Study|Other Reason|4|||
33391417|NCT00107172|101321772|FG001|Overall Study|Other Reason|3|||
33391418|NCT04083794|101321773|FG000|Overall Study|Lost to Follow-up|9|||
33391419|NCT00557323|101321775|FG000|Overall Study|Death|3|||
33391420|NCT00557323|101321775|FG000|Overall Study|Withdrawal by Subject|2|||
33391421|NCT00557323|101321775|FG000|Overall Study|Administrative change|2|||
33391422|NCT04964557|101321780|FG000|Overall Study|Withdrawal by Subject|3|||
33391423|NCT04964557|101321781|FG001|Overall Study|Withdrawal by Subject|2|||
33391424|NCT04964557|101321780|FG000|Overall Study|Lost to Follow-up|1|||
33391425|NCT04964557|101321781|FG001|Overall Study|Lost to Follow-up|2|||
33391426|NCT04964557|101321780|FG000|Overall Study|Physician Decision|2|||
33391427|NCT04964557|101321781|FG001|Overall Study|Physician Decision|0|||
33391428|NCT04964557|101321780|FG000|Overall Study|Death|3|||
33391429|NCT04964557|101321781|FG001|Overall Study|Death|0|||
33391430|NCT04964557|101321780|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
33391431|NCT04964557|101321781|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
33391432|NCT03382262|101321782|FG000|Overall Study|Physician Decision|0|||
33391433|NCT03382262|101321783|FG001|Overall Study|Physician Decision|0|||
33391434|NCT03382262|101321784|FG002|Overall Study|Physician Decision|1|||
33391435|NCT03382262|101321785|FG003|Overall Study|Physician Decision|0|||
33391436|NCT03382262|101321782|FG000|Overall Study|Withdrawal by Subject|0|||
33391437|NCT03382262|101321783|FG001|Overall Study|Withdrawal by Subject|0|||
33391438|NCT03382262|101321784|FG002|Overall Study|Withdrawal by Subject|0|||
33391439|NCT03382262|101321785|FG003|Overall Study|Withdrawal by Subject|1|||
33391440|NCT00439725|101321786|FG000|Treatment Period|Withdrawal by Subject|22|||
33391441|NCT00439725|101321787|FG001|Treatment Period|Withdrawal by Subject|19|||
33391442|NCT00439725|101321786|FG000|Treatment Period|Study terminated by sponsor|156|||
33391443|NCT00439725|101321787|FG001|Treatment Period|Study terminated by sponsor|148|||
33391444|NCT00439725|101321786|FG000|Treatment Period|Site closed by investigator|1|||
33391445|NCT00439725|101321787|FG001|Treatment Period|Site closed by investigator|2|||
33391446|NCT00439725|101321786|FG000|Treatment Period|Adverse Event|39|||
33391447|NCT00439725|101321787|FG001|Treatment Period|Adverse Event|18|||
33391448|NCT00439725|101321786|FG000|Treatment Period|Physician Decision|1|||
33391449|NCT00439725|101321787|FG001|Treatment Period|Physician Decision|1|||
33391450|NCT00439725|101321786|FG000|Treatment Period|Protocol Violation|2|||
33391451|NCT00439725|101321787|FG001|Treatment Period|Protocol Violation|1|||
33391452|NCT00439725|101321786|FG000|Treatment Period|Clinical endpoint reached|6|||
33391453|NCT00439725|101321787|FG001|Treatment Period|Clinical endpoint reached|50|||
33391454|NCT00439725|101321786|FG000|Treatment Period|Technical problems|1|||
33391455|NCT00439725|101321787|FG001|Treatment Period|Technical problems|0|||
33391456|NCT00439725|101321786|FG000|Treatment Period|Lost to Follow-up|1|||
33391457|NCT00439725|101321787|FG001|Treatment Period|Lost to Follow-up|1|||
33391458|NCT00439725|101321786|FG000|Treatment Period|Participant convenience|1|||
33391459|NCT00439725|101321787|FG001|Treatment Period|Participant convenience|0|||
33391460|NCT00439725|101321786|FG000|Treatment Period|Protocol driven decision point|1|||
33391461|NCT00439725|101321787|FG001|Treatment Period|Protocol driven decision point|1|||
33391462|NCT00439725|101321786|FG000|Treatment Period|Death|1|||
33391463|NCT00439725|101321787|FG001|Treatment Period|Death|1|||
33391464|NCT00439725|101321786|FG000|Treatment Period|Participant did not receive treatment|4|||
33391465|NCT00439725|101321787|FG001|Treatment Period|Participant did not receive treatment|4|||
33391466|NCT00439725|101321786|FG000|Observational Period|Withdrawal by Subject|2|||
33391467|NCT00439725|101321787|FG001|Observational Period|Withdrawal by Subject|2|||
33391468|NCT00439725|101321786|FG000|Observational Period|Lost to Follow-up|0|||
33391469|NCT00439725|101321787|FG001|Observational Period|Lost to Follow-up|1|||
33391470|NCT00439725|101321786|FG000|Observational Period|Death|0|||
33391471|NCT00439725|101321787|FG001|Observational Period|Death|2|||
33391472|NCT00439725|101321786|FG000|Observational Period|Study termination by sponsor|1|||
33391473|NCT00439725|101321787|FG001|Observational Period|Study termination by sponsor|1|||
33391474|NCT00439725|101321786|FG000|Observational Period|Clinical endpoint reached|3|||
33391475|NCT00439725|101321787|FG001|Observational Period|Clinical endpoint reached|1|||
33391476|NCT00439725|101321786|FG000|Observational Period|Technical problems|1|||
33391477|NCT00439725|101321787|FG001|Observational Period|Technical problems|0|||
33391478|NCT00439725|101321786|FG000|Observational Period|Participant convenience|1|||
33391479|NCT00439725|101321787|FG001|Observational Period|Participant convenience|0|||
33391480|NCT01313039|101321788|FG000|Overall Study|Physician Decision|1|||
33391481|NCT01313039|101321788|FG000|Overall Study|Adverse Event|1|||
33391482|NCT02392468|101321792|FG000|Overall Study|Adverse Event|0|||
33391483|NCT02392468|101321793|FG001|Overall Study|Adverse Event|1|||
33391484|NCT02392468|101321794|FG002|Overall Study|Adverse Event|0|||
33391485|NCT02392468|101321795|FG003|Overall Study|Adverse Event|0|||
33391486|NCT02392468|101321796|FG004|Overall Study|Adverse Event|0|||
33391487|NCT02392468|101321797|FG005|Overall Study|Adverse Event|1|||
33391488|NCT00610207|101321798|FG000|Overall Study|Lost to Follow-up|3|||
33391489|NCT00003838|101321799|FG000|Overall Study|Death|0|||
33391490|NCT00003838|101321800|FG001|Overall Study|Death|12|||
33391491|NCT00003838|101321801|FG002|Overall Study|Death|7|||
33391492|NCT00003838|101321799|FG000|Overall Study|Lost to Follow-up|0|||
33391493|NCT00003838|101321800|FG001|Overall Study|Lost to Follow-up|1|||
33391494|NCT00003838|101321801|FG002|Overall Study|Lost to Follow-up|1|||
33391495|NCT00003838|101321799|FG000|Overall Study|Disease Progression|0|||
33391496|NCT00003838|101321800|FG001|Overall Study|Disease Progression|12|||
33391497|NCT00003838|101321801|FG002|Overall Study|Disease Progression|0|||
33391498|NCT01235338|101321804|FG000|Overall Study|Adverse Event|3|||
33391499|NCT01235338|101321805|FG001|Overall Study|Adverse Event|2|||
33391500|NCT01235338|101321804|FG000|Overall Study|Protocol Violation|1|||
33391501|NCT01235338|101321805|FG001|Overall Study|Protocol Violation|1|||
33391502|NCT01235338|101321804|FG000|Overall Study|Withdrawal by Subject|5|||
33391503|NCT01235338|101321805|FG001|Overall Study|Withdrawal by Subject|0|||
33391504|NCT01235338|101321804|FG000|Overall Study|Exclusion criteria violations|1|||
33391505|NCT01235338|101321805|FG001|Overall Study|Exclusion criteria violations|1|||
33391506|NCT01235338|101321804|FG000|Overall Study|Positive drug screen|0|||
33391507|NCT01235338|101321805|FG001|Overall Study|Positive drug screen|1|||
33391508|NCT01235338|101321804|FG000|Overall Study|Prohibited meds|1|||
33391509|NCT01235338|101321805|FG001|Overall Study|Prohibited meds|0|||
33391510|NCT00044213|101321808|FG000|Overall Study|Withdrawal by Subject|50|||
33391511|NCT00044213|101321809|FG001|Overall Study|Withdrawal by Subject|65|||
33391512|NCT00044213|101321810|FG002|Overall Study|Withdrawal by Subject|91|||
33391513|NCT00044213|101321811|FG003|Overall Study|Withdrawal by Subject|83|||
33391514|NCT00044213|101321808|FG000|Overall Study|Death|42|||
33391515|NCT00044213|101321809|FG001|Overall Study|Death|42|||
33391516|NCT00044213|101321810|FG002|Overall Study|Death|42|||
33391517|NCT00044213|101321811|FG003|Overall Study|Death|49|||
33391518|NCT00044213|101321808|FG000|Overall Study|Lost to Follow-up|8|||
33391519|NCT00044213|101321809|FG001|Overall Study|Lost to Follow-up|5|||
33391520|NCT00044213|101321810|FG002|Overall Study|Lost to Follow-up|5|||
33391521|NCT00044213|101321811|FG003|Overall Study|Lost to Follow-up|4|||
33391522|NCT03565991|101321812|FG000|Overall Study|Other|11|||
33391523|NCT03565991|101321813|FG001|Overall Study|Other|0|||
33391524|NCT03565991|101321812|FG000|Overall Study|Global deterioration of health status|14|||
33391525|NCT03565991|101321813|FG001|Overall Study|Global deterioration of health status|4|||
33391526|NCT03565991|101321812|FG000|Overall Study|Withdrawal by Subject|2|||
33391527|NCT03565991|101321813|FG001|Overall Study|Withdrawal by Subject|6|||
33391528|NCT03565991|101321812|FG000|Overall Study|Progressive disease|121|||
33391529|NCT03565991|101321813|FG001|Overall Study|Progressive disease|29|||
33391530|NCT03565991|101321812|FG000|Overall Study|Death|3|||
33391531|NCT03565991|101321813|FG001|Overall Study|Death|0|||
33391532|NCT03565991|101321812|FG000|Overall Study|Adverse Event|7|||
33391533|NCT03565991|101321813|FG001|Overall Study|Adverse Event|2|||
33391534|NCT04599972|101321815|FG000|Overall Study|Withdrawal by Subject|6|||
33391535|NCT04599972|101321816|FG001|Overall Study|Withdrawal by Subject|1|||
33391536|NCT04599972|101321815|FG000|Overall Study|Adverse Event|1|||
33391537|NCT04599972|101321816|FG001|Overall Study|Adverse Event|1|||
33391538|NCT04599972|101321815|FG000|Overall Study|Lost to Follow-up|1|||
33391539|NCT04599972|101321816|FG001|Overall Study|Lost to Follow-up|6|||
33391540|NCT04599972|101321815|FG000|Overall Study|Protocol Violation|1|||
33391541|NCT04599972|101321816|FG001|Overall Study|Protocol Violation|0|||
33391542|NCT04599972|101321815|FG000|Overall Study|Other reason|1|||
33391543|NCT04599972|101321816|FG001|Overall Study|Other reason|0|||
33391544|NCT03512275|101321817|FG000|Overall Study|Withdrawal by Subject|1|||
33391545|NCT03512275|101321818|FG001|Overall Study|Withdrawal by Subject|3|||
33391546|NCT03512275|101321817|FG000|Overall Study|Physician Decision|0|||
33391547|NCT03512275|101321818|FG001|Overall Study|Physician Decision|1|||
33391548|NCT03512275|101321817|FG000|Overall Study|Lost to Follow-up|0|||
33494945|NCT05271175|101705848|FG000|One Week Follow up|Lost to Follow-up|10|||
33494946|NCT05271175|101705849|FG001|One Week Follow up|Lost to Follow-up|7|||
33494947|NCT05271175|101705850|FG002|One Week Follow up|Lost to Follow-up|5|||
33494948|NCT05271175|101705848|FG000|One Month Follow up|Lost to Follow-up|12|||
33494949|NCT05271175|101705849|FG001|One Month Follow up|Lost to Follow-up|7|||
33494950|NCT05271175|101705850|FG002|One Month Follow up|Lost to Follow-up|9|||
33494951|NCT05271175|101705848|FG000|Six Months Follow up|Lost to Follow-up|8|||
33494952|NCT05271175|101705849|FG001|Six Months Follow up|Lost to Follow-up|2|||
33494953|NCT05271175|101705850|FG002|Six Months Follow up|Lost to Follow-up|2|||
33494954|NCT03468218|101705855|FG000|Overall Study|Adverse Event|5|||
33494955|NCT03468218|101705855|FG000|Overall Study|Progressive Disease|16|||
33494956|NCT03468218|101705855|FG000|Overall Study|Death|1|||
33494957|NCT03468218|101705855|FG000|Overall Study|Alternate therapy|1|||
33494958|NCT03468218|101705855|FG000|Overall Study|Withdrawal by Subject|2|||
33494959|NCT00942357|101705856|FG000|Overall Study|Ineligible|37|||
33494960|NCT00942357|101705857|FG001|Overall Study|Ineligible|40|||
33494961|NCT01252095|101705858|FG000|Overall Study|Disease progression|1|||
33494962|NCT01252095|101705859|FG001|Overall Study|Disease progression|0|||
33391549|NCT03512275|101321818|FG001|Overall Study|Lost to Follow-up|3|||
33391550|NCT03512275|101321817|FG000|Overall Study|Other|1|||
33391551|NCT03512275|101321818|FG001|Overall Study|Other|0|||
33391552|NCT01436357|101321819|FG000|Overall Study|Death|5|||
33391553|NCT01436357|101321820|FG001|Overall Study|Death|1|||
33391554|NCT01436357|101321819|FG000|Overall Study|Enrolled but not vaccinated|1|||
33391555|NCT01436357|101321820|FG001|Overall Study|Enrolled but not vaccinated|1|||
33391556|NCT01436357|101321819|FG000|Overall Study|Incarceration|18|||
33391557|NCT01436357|101321820|FG001|Overall Study|Incarceration|20|||
33391558|NCT01436357|101321819|FG000|Overall Study|Lost to Follow-up|67|||
33391559|NCT01436357|101321820|FG001|Overall Study|Lost to Follow-up|61|||
33391560|NCT01436357|101321819|FG000|Overall Study|Protocol Violation|1|||
33391561|NCT01436357|101321820|FG001|Overall Study|Protocol Violation|0|||
33391562|NCT01436357|101321819|FG000|Overall Study|Withdrawal by Subject|26|||
33391563|NCT01436357|101321820|FG001|Overall Study|Withdrawal by Subject|38|||
33494963|NCT03805412|101705860|FG000|Overall Study|Lost to Follow-up|0|||
33391564|NCT01436357|101321819|FG000|Overall Study|Physician Decision|3|||
33391565|NCT01436357|101321820|FG001|Overall Study|Physician Decision|4|||
33391566|NCT01436357|101321819|FG000|Overall Study|Moved out of area|1|||
33391567|NCT01436357|101321820|FG001|Overall Study|Moved out of area|2|||
33391568|NCT01436357|101321819|FG000|Overall Study|Subject in rehab|0|||
33391569|NCT01436357|101321820|FG001|Overall Study|Subject in rehab|1|||
33391570|NCT00654420|101321821|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
33391571|NCT00654420|101321822|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
33391572|NCT00654420|101321823|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
33391573|NCT00654420|101321824|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
33391574|NCT00654420|101321821|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
33391575|NCT00654420|101321822|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
33391576|NCT00654420|101321823|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
33391577|NCT00654420|101321824|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
33391578|NCT00654420|101321821|FG000|Phase II|Adverse Event|0|||
33391579|NCT00654420|101321822|FG001|Phase II|Adverse Event|0|||
33391580|NCT00654420|101321823|FG002|Phase II|Adverse Event|3|||
33391581|NCT00654420|101321824|FG003|Phase II|Adverse Event|3|||
33391582|NCT00654420|101321821|FG000|Phase II|Lost to Follow-up|0|||
33391583|NCT00654420|101321822|FG001|Phase II|Lost to Follow-up|0|||
33391584|NCT00654420|101321823|FG002|Phase II|Lost to Follow-up|0|||
33391585|NCT00654420|101321824|FG003|Phase II|Lost to Follow-up|1|||
33391586|NCT00654420|101321821|FG000|Phase II|Physician Decision|0|||
33391587|NCT00654420|101321822|FG001|Phase II|Physician Decision|0|||
33391588|NCT00654420|101321823|FG002|Phase II|Physician Decision|0|||
33391589|NCT00654420|101321824|FG003|Phase II|Physician Decision|4|||
33391590|NCT00654420|101321821|FG000|Phase II|Progressive Disease|0|||
33391591|NCT00654420|101321822|FG001|Phase II|Progressive Disease|0|||
33391592|NCT00654420|101321823|FG002|Phase II|Progressive Disease|29|||
33391593|NCT00654420|101321824|FG003|Phase II|Progressive Disease|29|||
33391594|NCT00654420|101321821|FG000|Phase II|Withdrawal by Subject|0|||
33391595|NCT00654420|101321822|FG001|Phase II|Withdrawal by Subject|0|||
33391596|NCT00654420|101321823|FG002|Phase II|Withdrawal by Subject|4|||
33391597|NCT00654420|101321824|FG003|Phase II|Withdrawal by Subject|1|||
33391598|NCT00654420|101321821|FG000|Phase II|Missing Disposition Record|0|||
33391599|NCT00654420|101321822|FG001|Phase II|Missing Disposition Record|0|||
33391600|NCT00654420|101321823|FG002|Phase II|Missing Disposition Record|1|||
33391601|NCT00654420|101321824|FG003|Phase II|Missing Disposition Record|0|||
33391602|NCT03964493|101321825|FG000|Overall Study|Withdrawal by Subject|4|||
33391603|NCT03964493|101321826|FG001|Overall Study|Withdrawal by Subject|1|||
33391604|NCT03964493|101321825|FG000|Overall Study|Lost to Follow-up|13|||
33391605|NCT03964493|101321826|FG001|Overall Study|Lost to Follow-up|4|||
33391606|NCT02187224|101321829|FG000|Overall Study|Did not show up for test day|1|||
33391607|NCT02187224|101321830|FG001|Overall Study|Did not show up for test day|0|||
33391608|NCT00422240|101321833|FG000|Overall Study|Lack of Efficacy|1|||
33391609|NCT00422240|101321834|FG001|Overall Study|Lack of Efficacy|2|||
33391610|NCT00422240|101321835|FG002|Overall Study|Lack of Efficacy|0|||
33391611|NCT00422240|101321836|FG003|Overall Study|Lack of Efficacy|1|||
33391612|NCT00422240|101321833|FG000|Overall Study|Adverse Event|11|||
33391613|NCT00422240|101321834|FG001|Overall Study|Adverse Event|4|||
33391614|NCT00422240|101321835|FG002|Overall Study|Adverse Event|5|||
33391615|NCT00422240|101321836|FG003|Overall Study|Adverse Event|2|||
33391616|NCT00422240|101321833|FG000|Overall Study|Subject request|21|||
33391617|NCT00422240|101321834|FG001|Overall Study|Subject request|17|||
33391618|NCT00422240|101321835|FG002|Overall Study|Subject request|18|||
33391619|NCT00422240|101321836|FG003|Overall Study|Subject request|30|||
33391620|NCT00422240|101321833|FG000|Overall Study|Protocol Violation|0|||
33391621|NCT00422240|101321834|FG001|Overall Study|Protocol Violation|1|||
33391622|NCT00422240|101321835|FG002|Overall Study|Protocol Violation|0|||
33391623|NCT00422240|101321836|FG003|Overall Study|Protocol Violation|1|||
33391624|NCT00422240|101321833|FG000|Overall Study|Lost to Follow-up|31|||
33391625|NCT00422240|101321834|FG001|Overall Study|Lost to Follow-up|32|||
33391626|NCT00422240|101321835|FG002|Overall Study|Lost to Follow-up|19|||
33391627|NCT00422240|101321836|FG003|Overall Study|Lost to Follow-up|34|||
33391628|NCT00422240|101321833|FG000|Overall Study|Other|1|||
33391629|NCT00422240|101321834|FG001|Overall Study|Other|0|||
33391630|NCT00422240|101321835|FG002|Overall Study|Other|0|||
33391631|NCT00422240|101321836|FG003|Overall Study|Other|1|||
33391632|NCT00422240|101321833|FG000|Overall Study|Pregnancy|3|||
33391633|NCT00422240|101321834|FG001|Overall Study|Pregnancy|1|||
33391634|NCT00422240|101321835|FG002|Overall Study|Pregnancy|1|||
33391635|NCT00422240|101321836|FG003|Overall Study|Pregnancy|2|||
33391636|NCT02963766|101321840|FG000|Double-Blind Period|Adverse Event|1|||
33391637|NCT02963766|101321841|FG001|Double-Blind Period|Adverse Event|0|||
33391638|NCT02963766|101321842|FG002|Double-Blind Period|Adverse Event|1|||
33391639|NCT02963766|101321840|FG000|Double-Blind Period|Physician Decision|1|||
33391640|NCT02963766|101321841|FG001|Double-Blind Period|Physician Decision|0|||
33391641|NCT02963766|101321842|FG002|Double-Blind Period|Physician Decision|0|||
33391642|NCT02963766|101321840|FG000|Double-Blind Period|Withdrawal by Subject|1|||
33391643|NCT02963766|101321841|FG001|Double-Blind Period|Withdrawal by Subject|1|||
33391644|NCT02963766|101321842|FG002|Double-Blind Period|Withdrawal by Subject|0|||
33391645|NCT02963766|101321840|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
33391646|NCT02963766|101321841|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
33391647|NCT02963766|101321842|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
33391648|NCT02963766|101321840|FG000|Double-Blind Period|Protocol Violation|1|||
33391649|NCT02963766|101321841|FG001|Double-Blind Period|Protocol Violation|0|||
33391650|NCT02963766|101321842|FG002|Double-Blind Period|Protocol Violation|0|||
33391651|NCT02963766|101321840|FG000|Double-Blind Period|Lost to Follow-up|0|||
33391652|NCT02963766|101321841|FG001|Double-Blind Period|Lost to Follow-up|1|||
33391653|NCT02963766|101321842|FG002|Double-Blind Period|Lost to Follow-up|0|||
33391654|NCT02963766|101321840|FG000|Open Label Extension (OLE)|Physician Decision|1|||
33391655|NCT02963766|101321841|FG001|Open Label Extension (OLE)|Physician Decision|2|||
33391656|NCT02963766|101321842|FG002|Open Label Extension (OLE)|Physician Decision|2|||
33391657|NCT02963766|101321840|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
33391658|NCT02963766|101321841|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
33391659|NCT02963766|101321842|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
33391660|NCT00255008|101321843|FG000|Overall Study|Adverse Event|1|||
33391661|NCT00255008|101321844|FG001|Overall Study|Adverse Event|1|||
33391662|NCT00255008|101321845|FG002|Overall Study|Adverse Event|2|||
33391663|NCT00255008|101321846|FG003|Overall Study|Adverse Event|0|||
33391664|NCT00255008|101321843|FG000|Overall Study|Lost to Follow-up|1|||
33391665|NCT00255008|101321844|FG001|Overall Study|Lost to Follow-up|0|||
33391666|NCT00255008|101321845|FG002|Overall Study|Lost to Follow-up|1|||
33391667|NCT00255008|101321846|FG003|Overall Study|Lost to Follow-up|2|||
33391668|NCT00255008|101321843|FG000|Overall Study|Did not meet viral reduction criteria|4|||
33391669|NCT00255008|101321844|FG001|Overall Study|Did not meet viral reduction criteria|5|||
33391670|NCT00255008|101321845|FG002|Overall Study|Did not meet viral reduction criteria|0|||
33391671|NCT00255008|101321846|FG003|Overall Study|Did not meet viral reduction criteria|1|||
33391672|NCT00255008|101321843|FG000|Overall Study|Withdrew consent|0|||
33391673|NCT00255008|101321844|FG001|Overall Study|Withdrew consent|0|||
33391674|NCT00255008|101321845|FG002|Overall Study|Withdrew consent|2|||
33391675|NCT00255008|101321846|FG003|Overall Study|Withdrew consent|0|||
33391676|NCT00255008|101321843|FG000|Overall Study|Sponsor request|18|||
33391677|NCT00255008|101321844|FG001|Overall Study|Sponsor request|3|||
33391678|NCT00255008|101321845|FG002|Overall Study|Sponsor request|8|||
33391679|NCT00255008|101321846|FG003|Overall Study|Sponsor request|17|||
33391680|NCT00255008|101321843|FG000|Overall Study|Adverse lab experience|1|||
33391681|NCT00255008|101321844|FG001|Overall Study|Adverse lab experience|0|||
33391682|NCT00255008|101321845|FG002|Overall Study|Adverse lab experience|0|||
33391683|NCT00255008|101321846|FG003|Overall Study|Adverse lab experience|0|||
33391684|NCT00255008|101321843|FG000|Overall Study|Other|7|||
33391685|NCT00255008|101321844|FG001|Overall Study|Other|0|||
33391686|NCT00255008|101321845|FG002|Overall Study|Other|3|||
33391687|NCT00255008|101321846|FG003|Overall Study|Other|2|||
33391688|NCT04055844|101321847|FG000|Overall Study|Adverse Event|12|||
33391689|NCT04055844|101321847|FG000|Overall Study|Poor Performance|1|||
33391690|NCT04055844|101321847|FG000|Overall Study|Death|1|||
33391691|NCT02043509|101321848|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
33391692|NCT02043509|101321849|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
33391693|NCT02043509|101321848|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
33391694|NCT02043509|101321849|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
33391695|NCT02043509|101321848|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
33391696|NCT02043509|101321849|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
33391697|NCT02043509|101321848|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
33391698|NCT02043509|101321849|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
33391699|NCT00638690|101321850|FG000|Overall Study|Death|655|||
33391700|NCT00638690|101321851|FG001|Overall Study|Death|335|||
33391701|NCT00638690|101321850|FG000|Overall Study|Withdrawal by Subject|22|||
33391702|NCT00638690|101321851|FG001|Overall Study|Withdrawal by Subject|5|||
33391703|NCT00638690|101321850|FG000|Overall Study|Lost to Follow-up|4|||
33391704|NCT00638690|101321851|FG001|Overall Study|Lost to Follow-up|2|||
33391705|NCT02959190|101321852|FG000|Open Label|Adverse Event|5|||
33391706|NCT02959190|101321853|FG001|Open Label|Adverse Event|7|||
33391707|NCT02959190|101321854|FG002|Open Label|Adverse Event|3|||
33391708|NCT02959190|101321855|FG003|Open Label|Adverse Event|4|||
33391709|NCT02959190|101321852|FG000|Open Label|Pregnancy|0|||
33391710|NCT02959190|101321853|FG001|Open Label|Pregnancy|1|||
33391711|NCT02959190|101321854|FG002|Open Label|Pregnancy|0|||
33494964|NCT03805412|101705861|FG001|Overall Study|Lost to Follow-up|1|||
33494965|NCT00634036|101705865|FG000|Overall Study|Lost to Follow-up|1|||
33494966|NCT00634036|101705866|FG001|Overall Study|Lost to Follow-up|1|||
33494967|NCT00634036|101705865|FG000|Overall Study|Withdrawal by Subject|1|||
33494968|NCT00634036|101705866|FG001|Overall Study|Withdrawal by Subject|1|||
33494969|NCT01368497|101705867|FG000|Overall Study|Lost to Follow-up|2|||
33494970|NCT01662492|101705872|FG000|Overall Study|Other miscellaneous reasons.|1|||
33391712|NCT02959190|101321855|FG003|Open Label|Pregnancy|0|||
33391713|NCT02959190|101321852|FG000|Open Label|Withdrawal by Subject|2|||
33494971|NCT01662492|101705873|FG001|Overall Study|Other miscellaneous reasons.|0|||
33494972|NCT01662492|101705874|FG002|Overall Study|Other miscellaneous reasons.|1|||
33494973|NCT01662492|101705872|FG000|Overall Study|Withdrawal by Subject|0|||
33494974|NCT01662492|101705873|FG001|Overall Study|Withdrawal by Subject|0|||
33494975|NCT01662492|101705874|FG002|Overall Study|Withdrawal by Subject|1|||
33494976|NCT01662492|101705872|FG000|Overall Study|Protocol Violation|1|||
33494977|NCT01662492|101705873|FG001|Overall Study|Protocol Violation|0|||
33494978|NCT01662492|101705874|FG002|Overall Study|Protocol Violation|0|||
33494979|NCT01662492|101705872|FG000|Overall Study|Lost to Follow-up|0|||
33494980|NCT01662492|101705873|FG001|Overall Study|Lost to Follow-up|0|||
33494981|NCT01662492|101705874|FG002|Overall Study|Lost to Follow-up|2|||
33494982|NCT01662492|101705872|FG000|Overall Study|Lack of Efficacy|1|||
33494983|NCT01662492|101705873|FG001|Overall Study|Lack of Efficacy|1|||
33494984|NCT01662492|101705874|FG002|Overall Study|Lack of Efficacy|2|||
33494985|NCT01129557|101705875|FG000|Overall Study|Adverse Event|1|||
33494986|NCT01129557|101705876|FG001|Overall Study|Adverse Event|2|||
33494987|NCT01129557|101705877|FG002|Overall Study|Adverse Event|2|||
33494988|NCT01129557|101705875|FG000|Overall Study|Novartis terminated study early|3|||
33494989|NCT01129557|101705876|FG001|Overall Study|Novartis terminated study early|3|||
33494990|NCT01129557|101705877|FG002|Overall Study|Novartis terminated study early|2|||
33494991|NCT03817125|101705878|FG000|Overall Study|Adverse Event|1|||
33494992|NCT03817125|101705879|FG001|Overall Study|Adverse Event|0|||
33494993|NCT03817125|101705878|FG000|Overall Study|Physician Decision|0|||
33494994|NCT03817125|101705879|FG001|Overall Study|Physician Decision|1|||
33494995|NCT03817125|101705878|FG000|Overall Study|Lack of Efficacy|1|||
33494996|NCT03817125|101705879|FG001|Overall Study|Lack of Efficacy|5|||
33494997|NCT01372618|101705880|FG000|Overall Study|PI Died. Study Terminated|9|||
33494998|NCT00162981|101705881|FG000|Overall Study|Adverse Event|2|||
33494999|NCT00162981|101705882|FG001|Overall Study|Adverse Event|5|||
33495000|NCT00162981|101705881|FG000|Overall Study|Withdrawal by Subject|1|||
33495001|NCT00162981|101705882|FG001|Overall Study|Withdrawal by Subject|1|||
33495002|NCT00162981|101705881|FG000|Overall Study|Physician Decision|1|||
33495003|NCT00162981|101705882|FG001|Overall Study|Physician Decision|0|||
33495004|NCT00413699|101705883|FG000|Initial Period|Death|25|||
33495005|NCT00413699|101705884|FG001|Initial Period|Death|30|||
33495006|NCT00413699|101705885|FG002|Initial Period|Death|0|||
33495007|NCT00413699|101705883|FG000|Initial Period|Lack of Efficacy|59|||
33495008|NCT00413699|101705884|FG001|Initial Period|Lack of Efficacy|115|||
33495009|NCT00413699|101705885|FG002|Initial Period|Lack of Efficacy|0|||
33495010|NCT00413699|101705883|FG000|Initial Period|Lost to Follow-up|31|||
33495011|NCT00413699|101705884|FG001|Initial Period|Lost to Follow-up|101|||
33495012|NCT00413699|101705885|FG002|Initial Period|Lost to Follow-up|0|||
33495013|NCT00413699|101705883|FG000|Initial Period|Protocol Violation|38|||
33495014|NCT00413699|101705884|FG001|Initial Period|Protocol Violation|89|||
33495015|NCT00413699|101705885|FG002|Initial Period|Protocol Violation|0|||
33495016|NCT00413699|101705883|FG000|Initial Period|Pregnancy|10|||
33495017|NCT00413699|101705884|FG001|Initial Period|Pregnancy|8|||
33495018|NCT00413699|101705885|FG002|Initial Period|Pregnancy|0|||
33495019|NCT00413699|101705883|FG000|Initial Period|Did not meet entrance criteria|2|||
33495020|NCT00413699|101705884|FG001|Initial Period|Did not meet entrance criteria|2|||
33495021|NCT00413699|101705885|FG002|Initial Period|Did not meet entrance criteria|0|||
33495022|NCT00413699|101705883|FG000|Initial Period|Medication error without adverse event|0|||
33495023|NCT00413699|101705884|FG001|Initial Period|Medication error without adverse event|1|||
33495024|NCT00413699|101705885|FG002|Initial Period|Medication error without adverse event|0|||
33495025|NCT00413699|101705883|FG000|Initial Period|Study terminated by Sponsor|0|||
33495026|NCT00413699|101705884|FG001|Initial Period|Study terminated by Sponsor|1|||
33495027|NCT00413699|101705885|FG002|Initial Period|Study terminated by Sponsor|0|||
33495028|NCT00413699|101705883|FG000|Initial Period|Other|67|||
33495029|NCT00413699|101705884|FG001|Initial Period|Other|211|||
33495030|NCT00413699|101705885|FG002|Initial Period|Other|0|||
33495031|NCT00413699|101705883|FG000|Initial Period|Adverse event related to study drug|178|||
33495032|NCT00413699|101705884|FG001|Initial Period|Adverse event related to study drug|527|||
33495033|NCT00413699|101705885|FG002|Initial Period|Adverse event related to study drug|0|||
33495034|NCT00413699|101705883|FG000|Initial Period|Adverse event not related to study drug|113|||
33495035|NCT00413699|101705884|FG001|Initial Period|Adverse event not related to study drug|248|||
33495036|NCT00413699|101705885|FG002|Initial Period|Adverse event not related to study drug|0|||
33495037|NCT00413699|101705883|FG000|Initial Period|Missing end of study page|0|||
33495038|NCT00413699|101705884|FG001|Initial Period|Missing end of study page|4|||
33495039|NCT00413699|101705885|FG002|Initial Period|Missing end of study page|0|||
33495040|NCT00413699|101705883|FG000|Initial Period|No longer willing to participate|116|||
33495041|NCT00413699|101705884|FG001|Initial Period|No longer willing to participate|368|||
33495042|NCT00413699|101705885|FG002|Initial Period|No longer willing to participate|0|||
33495043|NCT00413699|101705883|FG000|Extension Period|No Longer Willing to Participate|0|||
33495044|NCT00413699|101705884|FG001|Extension Period|No Longer Willing to Participate|0|||
33495045|NCT00413699|101705885|FG002|Extension Period|No Longer Willing to Participate|2|||
33495046|NCT00413699|101705883|FG000|Extension Period|Protocol Violation|0|||
33495047|NCT00413699|101705884|FG001|Extension Period|Protocol Violation|0|||
33495048|NCT00413699|101705885|FG002|Extension Period|Protocol Violation|1|||
33495049|NCT00413699|101705883|FG000|Extension Period|Adverse Event|0|||
33495050|NCT00413699|101705884|FG001|Extension Period|Adverse Event|0|||
33495051|NCT00413699|101705885|FG002|Extension Period|Adverse Event|2|||
33495052|NCT03660930|101705886|FG000|Overall Study|Adverse Event|0|||
33495053|NCT03660930|101705887|FG001|Overall Study|Adverse Event|0|||
33495054|NCT03660930|101705888|FG002|Overall Study|Adverse Event|0|||
33495055|NCT03660930|101705889|FG003|Overall Study|Adverse Event|2|||
33495056|NCT03660930|101705890|FG004|Overall Study|Adverse Event|0|||
33495057|NCT03660930|101705891|FG005|Overall Study|Adverse Event|1|||
33495058|NCT03660930|101705892|FG006|Overall Study|Adverse Event|0|||
33495059|NCT03660930|101705893|FG007|Overall Study|Adverse Event|0|||
33495060|NCT03660930|101705886|FG000|Overall Study|Withdrawal by Subject|0|||
33495061|NCT03660930|101705887|FG001|Overall Study|Withdrawal by Subject|0|||
33495062|NCT03660930|101705888|FG002|Overall Study|Withdrawal by Subject|0|||
33495063|NCT03660930|101705889|FG003|Overall Study|Withdrawal by Subject|0|||
33495064|NCT03660930|101705890|FG004|Overall Study|Withdrawal by Subject|0|||
33495065|NCT03660930|101705891|FG005|Overall Study|Withdrawal by Subject|1|||
33495066|NCT03660930|101705892|FG006|Overall Study|Withdrawal by Subject|0|||
33495067|NCT03660930|101705893|FG007|Overall Study|Withdrawal by Subject|0|||
33495068|NCT03660930|101705886|FG000|Overall Study|On Treatment|0|||
33495069|NCT03660930|101705887|FG001|Overall Study|On Treatment|0|||
33495070|NCT03660930|101705888|FG002|Overall Study|On Treatment|0|||
33495071|NCT03660930|101705889|FG003|Overall Study|On Treatment|0|||
33495072|NCT03660930|101705890|FG004|Overall Study|On Treatment|0|||
33495073|NCT03660930|101705891|FG005|Overall Study|On Treatment|0|||
33495074|NCT03660930|101705892|FG006|Overall Study|On Treatment|0|||
33495075|NCT03660930|101705893|FG007|Overall Study|On Treatment|1|||
33495076|NCT03660930|101705886|FG000|Overall Study|In Follow-up|0|||
33495077|NCT03660930|101705887|FG001|Overall Study|In Follow-up|0|||
33495078|NCT03660930|101705888|FG002|Overall Study|In Follow-up|0|||
33495079|NCT03660930|101705889|FG003|Overall Study|In Follow-up|0|||
33495080|NCT03660930|101705890|FG004|Overall Study|In Follow-up|0|||
33495081|NCT03660930|101705891|FG005|Overall Study|In Follow-up|0|||
33495082|NCT03660930|101705892|FG006|Overall Study|In Follow-up|1|||
33495083|NCT03660930|101705893|FG007|Overall Study|In Follow-up|2|||
33495084|NCT01234350|101705894|FG000|Overall Study|Adverse Event|277|||
33495085|NCT01234350|101705895|FG001|Overall Study|Adverse Event|92|||
33495086|NCT01234350|101705894|FG000|Overall Study|Withdrawal by Subject|61|||
33495087|NCT01234350|101705895|FG001|Overall Study|Withdrawal by Subject|36|||
33495088|NCT01234350|101705894|FG000|Overall Study|Lost to Follow-up|115|||
33495089|NCT01234350|101705895|FG001|Overall Study|Lost to Follow-up|47|||
33495090|NCT01234350|101705894|FG000|Overall Study|Covers a diverse set of reasons|234|||
33495091|NCT01234350|101705895|FG001|Overall Study|Covers a diverse set of reasons|92|||
33495092|NCT01965860|101705901|FG000|Overall Study|Pregnancy|1|||
33495093|NCT01965860|101705902|FG001|Overall Study|Pregnancy|0|||
33495094|NCT01965860|101705903|FG002|Overall Study|Pregnancy|1|||
33495095|NCT01965860|101705901|FG000|Overall Study|Logistics|1|||
33495096|NCT01965860|101705902|FG001|Overall Study|Logistics|0|||
33495097|NCT01965860|101705903|FG002|Overall Study|Logistics|0|||
33495098|NCT02548143|101705904|FG000|Overall Study|Adverse Event|1|||
33495099|NCT02548143|101705905|FG001|Overall Study|Adverse Event|0|||
33495100|NCT02548143|101705904|FG000|Overall Study|Withdrawal by Subject|0|||
33495101|NCT02548143|101705905|FG001|Overall Study|Withdrawal by Subject|1|||
33495102|NCT00517881|101705906|FG000|Overall Study|Protocol Violation|2|||
33495103|NCT00517881|101705906|FG000|Overall Study|Adverse Event|1|||
33495104|NCT00517881|101705906|FG000|Overall Study|Renal transplantation|2|||
33495105|NCT03361306|101705907|FG000|Overall Study|Death|5|||
33495106|NCT03361306|101705907|FG000|Overall Study|Still On Study (on study treatment)|3|||
33495107|NCT03361306|101705907|FG000|Overall Study|Still On Study (in follow up)|7|||
33495108|NCT04030299|101705908|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
33495109|NCT04030299|101705908|FG000|Overall Study|Withdrawal by Subject|3|||
33495110|NCT03214224|101705909|FG000|Overall Study|Protocol Violation|1|||
33495111|NCT03214224|101705909|FG000|Overall Study|Withdrawal by Subject|2|||
33495112|NCT03214224|101705909|FG000|Overall Study|Practice controls or therapists|6|||
33495113|NCT03896022|101705910|FG000|Overall Study|Withdrawal by Subject|1|||
33495114|NCT03896022|101705911|FG001|Overall Study|Withdrawal by Subject|0|||
33495115|NCT03896022|101705912|FG002|Overall Study|Withdrawal by Subject|0|||
33495116|NCT03896022|101705910|FG000|Overall Study|Did not have procedure|3|||
33495117|NCT03896022|101705911|FG001|Overall Study|Did not have procedure|0|||
33495118|NCT03896022|101705912|FG002|Overall Study|Did not have procedure|0|||
33495119|NCT02554682|101705913|FG000|Overall Study|Lost to Follow-up|11|||
33495120|NCT02554682|101705914|FG001|Overall Study|Lost to Follow-up|9|||
33495121|NCT02554682|101705915|FG002|Overall Study|Lost to Follow-up|4|||
33495122|NCT02554682|101705916|FG003|Overall Study|Lost to Follow-up|3|||
33495123|NCT02554682|101705917|FG004|Overall Study|Lost to Follow-up|2|||
33495124|NCT02554682|101705918|FG005|Overall Study|Lost to Follow-up|1|||
33495125|NCT02554682|101705919|FG006|Overall Study|Lost to Follow-up|6|||
33495126|NCT02554682|101705920|FG007|Overall Study|Lost to Follow-up|6|||
33495127|NCT02554682|101705921|FG008|Overall Study|Lost to Follow-up|2|||
33495128|NCT02554682|101705922|FG009|Overall Study|Lost to Follow-up|2|||
33495129|NCT02554682|101705913|FG000|Overall Study|Withdrawal by Subject|2|||
33495130|NCT02554682|101705914|FG001|Overall Study|Withdrawal by Subject|1|||
33495131|NCT02554682|101705915|FG002|Overall Study|Withdrawal by Subject|0|||
33495132|NCT02554682|101705916|FG003|Overall Study|Withdrawal by Subject|0|||
33495133|NCT02554682|101705917|FG004|Overall Study|Withdrawal by Subject|0|||
33495134|NCT02554682|101705918|FG005|Overall Study|Withdrawal by Subject|0|||
33495135|NCT02554682|101705919|FG006|Overall Study|Withdrawal by Subject|0|||
33495136|NCT02554682|101705920|FG007|Overall Study|Withdrawal by Subject|0|||
33495137|NCT02554682|101705921|FG008|Overall Study|Withdrawal by Subject|0|||
33495138|NCT02554682|101705922|FG009|Overall Study|Withdrawal by Subject|0|||
33495139|NCT02554682|101705913|FG000|Overall Study|Physician Decision|2|||
33495140|NCT02554682|101705914|FG001|Overall Study|Physician Decision|2|||
33495141|NCT02554682|101705915|FG002|Overall Study|Physician Decision|0|||
33495142|NCT02554682|101705916|FG003|Overall Study|Physician Decision|0|||
33495143|NCT02554682|101705917|FG004|Overall Study|Physician Decision|0|||
33495144|NCT02554682|101705918|FG005|Overall Study|Physician Decision|0|||
33495145|NCT02554682|101705919|FG006|Overall Study|Physician Decision|0|||
33495146|NCT02554682|101705920|FG007|Overall Study|Physician Decision|0|||
33495147|NCT02554682|101705921|FG008|Overall Study|Physician Decision|0|||
33495148|NCT02554682|101705922|FG009|Overall Study|Physician Decision|0|||
33495149|NCT01139775|101705923|FG000|Overall Study|Adverse Event|0|||
33495150|NCT01139775|101705924|FG001|Overall Study|Adverse Event|6|||
33495151|NCT01139775|101705925|FG002|Overall Study|Adverse Event|2|||
33495152|NCT01139775|101705923|FG000|Overall Study|Protocol Violation|0|||
33495153|NCT01139775|101705924|FG001|Overall Study|Protocol Violation|5|||
33495154|NCT01139775|101705925|FG002|Overall Study|Protocol Violation|0|||
33495155|NCT01139775|101705923|FG000|Overall Study|Withdrawal by Subject|1|||
33495156|NCT01139775|101705924|FG001|Overall Study|Withdrawal by Subject|0|||
33495157|NCT01139775|101705925|FG002|Overall Study|Withdrawal by Subject|2|||
33495158|NCT01139775|101705923|FG000|Overall Study|Physician Decision|0|||
33495159|NCT01139775|101705924|FG001|Overall Study|Physician Decision|2|||
33495160|NCT01139775|101705925|FG002|Overall Study|Physician Decision|2|||
33495161|NCT02747108|101705926|FG000|Overall Study|Death|2|||
33495162|NCT02747108|101705927|FG001|Overall Study|Death|2|||
33495163|NCT02747108|101705926|FG000|Overall Study|Withdrawal by Subject|1|||
33495164|NCT02747108|101705927|FG001|Overall Study|Withdrawal by Subject|0|||
33495165|NCT02747108|101705926|FG000|Overall Study|Protocol Violation|2|||
33495166|NCT02747108|101705927|FG001|Overall Study|Protocol Violation|0|||
33495167|NCT01119859|101705928|FG000|Overall Study|Adverse Event|9|||
33495168|NCT01119859|101705929|FG001|Overall Study|Adverse Event|10|||
33495169|NCT01119859|101705928|FG000|Overall Study|Death|2|||
33495170|NCT01119859|101705929|FG001|Overall Study|Death|0|||
33495171|NCT01119859|101705928|FG000|Overall Study|Insufficient therapeutic response|7|||
33495172|NCT01119859|101705929|FG001|Overall Study|Insufficient therapeutic response|14|||
33495173|NCT01119859|101705928|FG000|Overall Study|Refused treatment|3|||
33495174|NCT01119859|101705929|FG001|Overall Study|Refused treatment|6|||
33495175|NCT01119859|101705928|FG000|Overall Study|Failure to return|3|||
33495176|NCT01119859|101705929|FG001|Overall Study|Failure to return|0|||
33495177|NCT03534687|101705930|FG000|Overall Study|Lost to Follow-up|7|||
33495178|NCT03534687|101705931|FG001|Overall Study|Lost to Follow-up|2|||
33495179|NCT01827111|101705936|FG000|Overall Study|Disease Progression|1|||
33495180|NCT00711087|101705937|FG000|Overall Study|Lost to Follow-up|1|||
33495181|NCT00711087|101705938|FG001|Overall Study|Lost to Follow-up|0|||
33495182|NCT01578239|101705939|FG000|Treatment Period|Progressive Disease|19|||
33495183|NCT01578239|101705940|FG001|Treatment Period|Progressive Disease|64|||
33495184|NCT01578239|101705939|FG000|Treatment Period|Physician Decision|17|||
33495185|NCT01578239|101705940|FG001|Treatment Period|Physician Decision|17|||
33495186|NCT01578239|101705939|FG000|Treatment Period|Adverse Event|13|||
33495187|NCT01578239|101705940|FG001|Treatment Period|Adverse Event|10|||
33495188|NCT01578239|101705939|FG000|Treatment Period|Non-compliance|2|||
33495189|NCT01578239|101705940|FG001|Treatment Period|Non-compliance|0|||
33495190|NCT01578239|101705939|FG000|Treatment Period|Withdrawal by Subject|10|||
33495191|NCT01578239|101705940|FG001|Treatment Period|Withdrawal by Subject|9|||
33495192|NCT01578239|101705939|FG000|Treatment Period|Other|6|||
33495193|NCT01578239|101705940|FG001|Treatment Period|Other|1|||
33495194|NCT01578239|101705939|FG000|Long-term Follow-Up Period|Death|69|||
33495195|NCT01578239|101705940|FG001|Long-term Follow-Up Period|Death|64|||
33495196|NCT01578239|101705939|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
33495197|NCT01578239|101705940|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
33495198|NCT01578239|101705939|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
33495199|NCT01578239|101705940|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
33495200|NCT01578239|101705939|FG000|Long-term Follow-Up Period|Other|2|||
33495201|NCT01578239|101705940|FG001|Long-term Follow-Up Period|Other|2|||
33495202|NCT04509076|101705946|FG000|Overall Study|Withdrawal by Subject|1|||
33495203|NCT04509076|101705947|FG001|Overall Study|Withdrawal by Subject|2|||
33495204|NCT04509076|101705946|FG000|Overall Study|Lost to Follow-up|1|||
33495205|NCT04509076|101705947|FG001|Overall Study|Lost to Follow-up|2|||
33495206|NCT01753999|101705951|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
33495207|NCT01753999|101705952|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
33495208|NCT01753999|101705951|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
33495209|NCT01753999|101705952|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
33495210|NCT01753999|101705951|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
33495211|NCT01753999|101705952|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
33495212|NCT01753999|101705951|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
33495213|NCT01753999|101705952|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
33495214|NCT01753999|101705951|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
33495215|NCT01753999|101705952|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
33495216|NCT01753999|101705951|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
33495217|NCT01753999|101705952|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
33495218|NCT02347813|101705955|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
33495219|NCT02347813|101705956|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
33495220|NCT02347813|101705955|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
33495221|NCT02347813|101705956|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
33495222|NCT01831635|101705960|FG000|Overall Study|Withdrawal by Subject|0|||
33495223|NCT01831635|101705961|FG001|Overall Study|Withdrawal by Subject|2|||
33495224|NCT01831635|101705962|FG002|Overall Study|Withdrawal by Subject|0|||
33495225|NCT04054765|101705967|FG000|Baseline|Withdrawal by Subject|5|||
33495226|NCT04054765|101705968|FG001|Baseline|Withdrawal by Subject|3|||
33495227|NCT04054765|101705967|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
33495228|NCT04054765|101705968|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
33495229|NCT04054765|101705967|FG000|3-month Follow up|Withdrawal by Subject|0|||
33495230|NCT04054765|101705968|FG001|3-month Follow up|Withdrawal by Subject|3|||
33495231|NCT04054765|101705967|FG000|6-month Follow up|Lost to Follow-up|32|||
33495232|NCT04054765|101705968|FG001|6-month Follow up|Lost to Follow-up|32|||
33495233|NCT00740636|101705969|FG000|Overall Study|Adverse Event|0|||
33495234|NCT00740636|101705970|FG001|Overall Study|Adverse Event|2|||
33495235|NCT00740636|101705969|FG000|Overall Study|Patient Ineligible|0|||
33495236|NCT00740636|101705970|FG001|Overall Study|Patient Ineligible|1|||
33495237|NCT00740636|101705969|FG000|Overall Study|Patient Not Treated|0|||
33495238|NCT00740636|101705970|FG001|Overall Study|Patient Not Treated|1|||
33495239|NCT00740636|101705969|FG000|Overall Study|Progressive Disease|1|||
33495240|NCT00740636|101705970|FG001|Overall Study|Progressive Disease|0|||
33495241|NCT00740636|101705969|FG000|Overall Study|Death|1|||
33495242|NCT00740636|101705970|FG001|Overall Study|Death|0|||
33495243|NCT03380429|101705971|FG000|Overall Study|Physician Decision|0|||
33495244|NCT03380429|101705972|FG001|Overall Study|Physician Decision|1|||
33495245|NCT03380429|101705973|FG002|Overall Study|Physician Decision|0|||
33495246|NCT03380429|101705974|FG003|Overall Study|Physician Decision|1|||
33495247|NCT03380429|101705975|FG004|Overall Study|Physician Decision|1|||
33495248|NCT03380429|101705971|FG000|Overall Study|Withdrawal by Subject|3|||
33495249|NCT03380429|101705972|FG001|Overall Study|Withdrawal by Subject|3|||
33495250|NCT03380429|101705973|FG002|Overall Study|Withdrawal by Subject|5|||
33495251|NCT03380429|101705974|FG003|Overall Study|Withdrawal by Subject|2|||
33495252|NCT03380429|101705975|FG004|Overall Study|Withdrawal by Subject|1|||
33495253|NCT03380429|101705971|FG000|Overall Study|Lost to Follow-up|0|||
33495254|NCT03380429|101705972|FG001|Overall Study|Lost to Follow-up|2|||
33495255|NCT03380429|101705973|FG002|Overall Study|Lost to Follow-up|4|||
33495256|NCT03380429|101705974|FG003|Overall Study|Lost to Follow-up|3|||
33495257|NCT03380429|101705975|FG004|Overall Study|Lost to Follow-up|1|||
33495258|NCT03380429|101705971|FG000|Overall Study|Protocol Violation|1|||
33495259|NCT03380429|101705972|FG001|Overall Study|Protocol Violation|0|||
33495260|NCT03380429|101705973|FG002|Overall Study|Protocol Violation|1|||
33495261|NCT03380429|101705974|FG003|Overall Study|Protocol Violation|0|||
33495262|NCT03380429|101705975|FG004|Overall Study|Protocol Violation|1|||
33495263|NCT03380429|101705971|FG000|Overall Study|Lack of Efficacy|0|||
33495264|NCT03380429|101705972|FG001|Overall Study|Lack of Efficacy|0|||
33495265|NCT03380429|101705973|FG002|Overall Study|Lack of Efficacy|0|||
33495266|NCT03380429|101705974|FG003|Overall Study|Lack of Efficacy|2|||
33495267|NCT03380429|101705975|FG004|Overall Study|Lack of Efficacy|1|||
33495268|NCT03380429|101705971|FG000|Overall Study|Adverse Event|1|||
33495269|NCT03380429|101705972|FG001|Overall Study|Adverse Event|1|||
33495270|NCT03380429|101705973|FG002|Overall Study|Adverse Event|1|||
33495271|NCT03380429|101705974|FG003|Overall Study|Adverse Event|2|||
33495272|NCT03380429|101705975|FG004|Overall Study|Adverse Event|0|||
33495273|NCT05377749|101705976|FG000|3 Weeks|Lost to Follow-up|2|||
33495274|NCT05377749|101705977|FG001|3 Weeks|Lost to Follow-up|4|||
33495275|NCT05377749|101705976|FG000|3 Weeks|Withdrawal by Subject|1|||
33495276|NCT05377749|101705977|FG001|3 Weeks|Withdrawal by Subject|1|||
33495277|NCT00708461|101705978|FG000|Overall Study|Lost to Follow-up|18|||
33495278|NCT00708461|101705979|FG001|Overall Study|Lost to Follow-up|11|||
33495279|NCT00708461|101705978|FG000|Overall Study|Withdrawal by Subject|8|||
33495280|NCT00708461|101705979|FG001|Overall Study|Withdrawal by Subject|9|||
33495281|NCT00708461|101705978|FG000|Overall Study|left workforce|115|||
33495282|NCT00708461|101705979|FG001|Overall Study|left workforce|180|||
33495283|NCT02653625|101705980|FG000|Overall Study|Adverse Event|1|||
33495284|NCT02653625|101705980|FG000|Overall Study|Non-compliance with Study Drug|1|||
33495285|NCT02653625|101705980|FG000|Overall Study|Protocol Violation|1|||
33495286|NCT02653625|101705980|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
33495287|NCT01641640|101705983|FG000|Overall Study|Enrolled but not treated|1|||
33495288|NCT01641640|101705983|FG000|Overall Study|Efficacy failure|29|||
33495289|NCT01641640|101705983|FG000|Overall Study|Lost to Follow-up|3|||
33495290|NCT01641640|101705983|FG000|Overall Study|Withdrawal by Subject|2|||
33495291|NCT01641640|101705983|FG000|Overall Study|Adverse Event|1|||
33495292|NCT01982682|101705988|FG000|Overall Study|Physician Decision|1|||
33495293|NCT02942017|101705989|FG000|Overall Study|Adverse Event|0|||
33495294|NCT02942017|101705990|FG001|Overall Study|Adverse Event|1|||
33495295|NCT02942017|101705989|FG000|Overall Study|Withdrawal by Subject|0|||
33495296|NCT02942017|101705990|FG001|Overall Study|Withdrawal by Subject|1|||
33495297|NCT02942017|101705989|FG000|Overall Study|Lost to Follow-up|1|||
33495298|NCT02942017|101705990|FG001|Overall Study|Lost to Follow-up|1|||
33495299|NCT02942017|101705989|FG000|Overall Study|Randomized but not dosed|1|||
33495300|NCT02942017|101705990|FG001|Overall Study|Randomized but not dosed|3|||
33495301|NCT01518322|101705991|FG000|Overall Study|FeNO measurement was missing|13|||
33495302|NCT00733005|101705993|FG000|Overall Study|Adverse Event|0|||
33495303|NCT00733005|101705994|FG001|Overall Study|Adverse Event|1|||
33495304|NCT00733005|101705993|FG000|Overall Study|Treatment Failure|0|||
33495305|NCT00733005|101705994|FG001|Overall Study|Treatment Failure|1|||
33495306|NCT00733005|101705993|FG000|Overall Study|Withdrawal by Subject|0|||
33495307|NCT00733005|101705994|FG001|Overall Study|Withdrawal by Subject|1|||
33495308|NCT00733005|101705993|FG000|Overall Study|Protocol Violation|2|||
33495309|NCT00733005|101705994|FG001|Overall Study|Protocol Violation|0|||
33495310|NCT00856492|101705995|FG000|Overall Study|Ineligible or withdrew consent|1|||
33495311|NCT00856492|101705996|FG001|Overall Study|Ineligible or withdrew consent|1|||
33495312|NCT00856492|101705997|FG002|Overall Study|Ineligible or withdrew consent|2|||
33495313|NCT00314327|101706000|FG000|Overall Study|Withdrawal by Subject|1|||
33495314|NCT04314037|101706007|FG000|Treatment Period 2|Adverse Event|1|||
33495315|NCT04314037|101706008|FG001|Treatment Period 2|Adverse Event|0|||
33495316|NCT04314037|101706007|FG000|Treatment Period 3|Protocol Violation|1|||
33495317|NCT04314037|101706008|FG001|Treatment Period 3|Protocol Violation|0|||
33495318|NCT04314037|101706007|FG000|Treatment Period 3|Adverse Event|0|||
33495319|NCT04314037|101706008|FG001|Treatment Period 3|Adverse Event|1|||
33495320|NCT02568072|101706009|FG000|Overall Study|Unavailable for appointment|23|||
33495321|NCT02568072|101706009|FG000|Overall Study|Unable to contact|3|||
33495322|NCT02568072|101706009|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
33495323|NCT02568072|101706009|FG000|Overall Study|Withdrawal by Subject|1|||
33495324|NCT02568072|101706009|FG000|Overall Study|Sustained injury, marathon not run|24|||
33495325|NCT00380874|101706010|FG000|Overall Study|Adverse Event|7|||
33495326|NCT00380874|101706011|FG001|Overall Study|Adverse Event|7|||
33495327|NCT00380874|101706010|FG000|Overall Study|Death|1|||
33495328|NCT00380874|101706011|FG001|Overall Study|Death|0|||
33495329|NCT00380874|101706010|FG000|Overall Study|Withdrawal by Subject|2|||
33495330|NCT00380874|101706011|FG001|Overall Study|Withdrawal by Subject|1|||
33495331|NCT00380874|101706010|FG000|Overall Study|Not related to study drug|3|||
33495332|NCT00380874|101706011|FG001|Overall Study|Not related to study drug|2|||
33495333|NCT00682786|101706012|FG000|Overall Study|Withdrawal by Subject|2|||
33495334|NCT00682786|101706013|FG001|Overall Study|Withdrawal by Subject|2|||
33495335|NCT00682786|101706012|FG000|Overall Study|Did not receive irinotecan|0|||
33495336|NCT00682786|101706013|FG001|Overall Study|Did not receive irinotecan|1|||
33495337|NCT00116779|101706014|FG000|Overall Study|Adverse Event|4|||
33495338|NCT00116779|101706015|FG001|Overall Study|Adverse Event|2|||
33495339|NCT00116779|101706014|FG000|Overall Study|Protocol Violation|1|||
33495340|NCT00116779|101706015|FG001|Overall Study|Protocol Violation|4|||
33495341|NCT00116779|101706014|FG000|Overall Study|Withdrawal by Subject|4|||
33495342|NCT00116779|101706015|FG001|Overall Study|Withdrawal by Subject|1|||
33595304|NCT03515551|102069661|FG000|Overall Study|Withdrawal by Subject|0|||
33595305|NCT03515551|102069662|FG001|Overall Study|Withdrawal by Subject|1|||
33595306|NCT03515551|102069663|FG002|Overall Study|Withdrawal by Subject|0|||
33595307|NCT03515551|102069664|FG003|Overall Study|Withdrawal by Subject|0|||
33495343|NCT00116779|101706014|FG000|Overall Study|Inadequate testosterone suppression|7|||
33495344|NCT00116779|101706015|FG001|Overall Study|Inadequate testosterone suppression|9|||
33495345|NCT00116779|101706014|FG000|Overall Study|Physician Decision|3|||
33495346|NCT00116779|101706015|FG001|Overall Study|Physician Decision|1|||
33495347|NCT00116779|101706014|FG000|Overall Study|Elevated PSA levels|2|||
33495348|NCT00116779|101706015|FG001|Overall Study|Elevated PSA levels|2|||
33495349|NCT05266053|101706016|FG000|Overall Study|Withdrawal by Subject|8|||
33495350|NCT05266053|101706017|FG001|Overall Study|Withdrawal by Subject|4|||
33495351|NCT03539302|101706018|FG000|Overall Study|Spontaneous cardio version|0|||
33495352|NCT03539302|101706019|FG001|Overall Study|Spontaneous cardio version|0|||
33595308|NCT03515551|102069665|FG004|Overall Study|Withdrawal by Subject|0|||
33495353|NCT03539302|101706020|FG002|Overall Study|Spontaneous cardio version|0|||
33495354|NCT03539302|101706021|FG003|Overall Study|Spontaneous cardio version|0|||
33495355|NCT03539302|101706022|FG004|Overall Study|Spontaneous cardio version|0|||
33495356|NCT03539302|101706023|FG005|Overall Study|Spontaneous cardio version|1|||
33495357|NCT03539302|101706024|FG006|Overall Study|Spontaneous cardio version|1|||
33495358|NCT03839628|101706025|FG000|Overall Study|Withdrawal by Subject|1|||
33495359|NCT00287586|101706029|FG000|Overall Study|Withdrew Consent|19|||
33495360|NCT00287586|101706030|FG001|Overall Study|Withdrew Consent|30|||
33495361|NCT00287586|101706029|FG000|Overall Study|Lost to Follow-up|5|||
33495362|NCT00287586|101706030|FG001|Overall Study|Lost to Follow-up|4|||
33495363|NCT00287586|101706029|FG000|Overall Study|Death|2|||
33495364|NCT00287586|101706030|FG001|Overall Study|Death|3|||
33495365|NCT00287586|101706029|FG000|Overall Study|Elevated Hematocrit|3|||
33495366|NCT00287586|101706030|FG001|Overall Study|Elevated Hematocrit|0|||
33495367|NCT00287586|101706029|FG000|Overall Study|Rash|3|||
33495368|NCT00287586|101706030|FG001|Overall Study|Rash|0|||
33495369|NCT00287586|101706029|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
33495370|NCT00287586|101706030|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
33495371|NCT00287586|101706029|FG000|Overall Study|Stroke|2|||
33495372|NCT00287586|101706030|FG001|Overall Study|Stroke|0|||
33495373|NCT00287586|101706029|FG000|Overall Study|Myocardial Infarction|1|||
33495374|NCT00287586|101706030|FG001|Overall Study|Myocardial Infarction|0|||
33495375|NCT00287586|101706029|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
33495376|NCT00287586|101706030|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
33495377|NCT00287586|101706029|FG000|Overall Study|Cognitive Impairment|1|||
33495378|NCT00287586|101706030|FG001|Overall Study|Cognitive Impairment|0|||
33495379|NCT00287586|101706029|FG000|Overall Study|Pancreatic Cancer|1|||
33495380|NCT00287586|101706030|FG001|Overall Study|Pancreatic Cancer|3|||
33495381|NCT00287586|101706029|FG000|Overall Study|Sleep Apnea|1|||
33495382|NCT00287586|101706030|FG001|Overall Study|Sleep Apnea|0|||
33495383|NCT00287586|101706029|FG000|Overall Study|Shoulder Pain|1|||
33495384|NCT00287586|101706030|FG001|Overall Study|Shoulder Pain|0|||
33495385|NCT00287586|101706029|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
33495386|NCT00287586|101706030|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
33495387|NCT00287586|101706029|FG000|Overall Study|Nonadherence|1|||
33495388|NCT00287586|101706030|FG001|Overall Study|Nonadherence|1|||
33495389|NCT00287586|101706029|FG000|Overall Study|Enrolled in Another Study|1|||
33495390|NCT00287586|101706030|FG001|Overall Study|Enrolled in Another Study|0|||
33495391|NCT00287586|101706029|FG000|Overall Study|Major Depression|0|||
33495392|NCT00287586|101706030|FG001|Overall Study|Major Depression|2|||
33495393|NCT00287586|101706029|FG000|Overall Study|Lung Cancer|0|||
33495394|NCT00287586|101706030|FG001|Overall Study|Lung Cancer|2|||
33495395|NCT00287586|101706029|FG000|Overall Study|Elevated IPSS Score|0|||
33495396|NCT00287586|101706030|FG001|Overall Study|Elevated IPSS Score|1|||
33495397|NCT00287586|101706029|FG000|Overall Study|Retroperitoneal Cancer|0|||
33495398|NCT00287586|101706030|FG001|Overall Study|Retroperitoneal Cancer|1|||
33495399|NCT00287586|101706029|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
33495400|NCT00287586|101706030|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
33495401|NCT00287586|101706029|FG000|Overall Study|Mood Swings and Irritability|0|||
33495402|NCT00287586|101706030|FG001|Overall Study|Mood Swings and Irritability|1|||
33495403|NCT00287586|101706029|FG000|Overall Study|Bradycardia|0|||
33495404|NCT00287586|101706030|FG001|Overall Study|Bradycardia|1|||
33495405|NCT00287586|101706029|FG000|Overall Study|Itchy Swollen Eyes|0|||
33495406|NCT00287586|101706030|FG001|Overall Study|Itchy Swollen Eyes|1|||
33495407|NCT00287586|101706029|FG000|Overall Study|Recurrent Melanoma|0|||
33495408|NCT00287586|101706030|FG001|Overall Study|Recurrent Melanoma|1|||
33495409|NCT04263311|101706031|FG000|Overall Study|Lost to Follow-up|1|||
33495410|NCT04263311|101706032|FG001|Overall Study|Lost to Follow-up|2|||
33495411|NCT04263311|101706033|FG002|Overall Study|Lost to Follow-up|0|||
33495412|NCT04263311|101706031|FG000|Overall Study|Health Issues|1|||
33495413|NCT04263311|101706032|FG001|Overall Study|Health Issues|0|||
33495414|NCT04263311|101706033|FG002|Overall Study|Health Issues|0|||
33495415|NCT04263311|101706031|FG000|Overall Study|Left the country|1|||
33495416|NCT04263311|101706032|FG001|Overall Study|Left the country|0|||
33495417|NCT04263311|101706033|FG002|Overall Study|Left the country|0|||
33495418|NCT04263311|101706031|FG000|Overall Study|Unable to maintain time commitment|1|||
33495419|NCT04263311|101706032|FG001|Overall Study|Unable to maintain time commitment|0|||
33495420|NCT04263311|101706033|FG002|Overall Study|Unable to maintain time commitment|0|||
33495421|NCT04263311|101706031|FG000|Overall Study|No longer interested|1|||
33495422|NCT04263311|101706032|FG001|Overall Study|No longer interested|0|||
33495423|NCT04263311|101706033|FG002|Overall Study|No longer interested|0|||
33495424|NCT04263311|101706031|FG000|Overall Study|Ineligible post consent|0|||
33495425|NCT04263311|101706032|FG001|Overall Study|Ineligible post consent|0|||
33495426|NCT04263311|101706033|FG002|Overall Study|Ineligible post consent|5|||
33495427|NCT01422213|101706037|FG000|Overall Study|Adverse Event|8|||
33495428|NCT01422213|101706038|FG001|Overall Study|Adverse Event|7|||
33495429|NCT01422213|101706039|FG002|Overall Study|Adverse Event|11|||
33495430|NCT01422213|101706037|FG000|Overall Study|Lack of Efficacy|10|||
33495431|NCT01422213|101706038|FG001|Overall Study|Lack of Efficacy|2|||
33495432|NCT01422213|101706039|FG002|Overall Study|Lack of Efficacy|2|||
33495433|NCT01422213|101706037|FG000|Overall Study|Non-compliance with study drug|0|||
33495434|NCT01422213|101706038|FG001|Overall Study|Non-compliance with study drug|1|||
33495435|NCT01422213|101706039|FG002|Overall Study|Non-compliance with study drug|0|||
33495436|NCT01422213|101706037|FG000|Overall Study|Protocol Violation|0|||
33495437|NCT01422213|101706038|FG001|Overall Study|Protocol Violation|2|||
33495438|NCT01422213|101706039|FG002|Overall Study|Protocol Violation|4|||
33495439|NCT01422213|101706037|FG000|Overall Study|Withdrawal of Consent|7|||
33495440|NCT01422213|101706038|FG001|Overall Study|Withdrawal of Consent|3|||
33495441|NCT01422213|101706039|FG002|Overall Study|Withdrawal of Consent|5|||
33495442|NCT01422213|101706037|FG000|Overall Study|Lost to Follow-up|3|||
33495443|NCT01422213|101706038|FG001|Overall Study|Lost to Follow-up|3|||
33495444|NCT01422213|101706039|FG002|Overall Study|Lost to Follow-up|5|||
33495445|NCT01422213|101706037|FG000|Overall Study|Administrative or Other Reason(s)|5|||
33495446|NCT01422213|101706038|FG001|Overall Study|Administrative or Other Reason(s)|4|||
33495447|NCT01422213|101706039|FG002|Overall Study|Administrative or Other Reason(s)|2|||
33495448|NCT00745901|101706040|FG000|Overall Study|Adverse Event|3|||
33495449|NCT00745901|101706041|FG001|Overall Study|Adverse Event|4|||
33495450|NCT00745901|101706040|FG000|Overall Study|Protocol Violation|0|||
33495451|NCT00745901|101706041|FG001|Overall Study|Protocol Violation|1|||
33495452|NCT00745901|101706040|FG000|Overall Study|Withdrawal by Subject|1|||
33495453|NCT00745901|101706041|FG001|Overall Study|Withdrawal by Subject|0|||
33495454|NCT00745901|101706040|FG000|Overall Study|Lost to Follow-up|7|||
33495455|NCT00745901|101706041|FG001|Overall Study|Lost to Follow-up|4|||
33495456|NCT00745901|101706040|FG000|Overall Study|Pregnancy|2|||
33495457|NCT00745901|101706041|FG001|Overall Study|Pregnancy|4|||
33495458|NCT00745901|101706040|FG000|Overall Study|Lack of compliance|2|||
33495459|NCT00745901|101706041|FG001|Overall Study|Lack of compliance|2|||
33495460|NCT00745901|101706040|FG000|Overall Study|Patient's next menses did not start with|1|||
33495461|NCT00745901|101706041|FG001|Overall Study|Patient's next menses did not start with|0|||
33495462|NCT00745901|101706040|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
33495463|NCT00745901|101706041|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
33495464|NCT00745901|101706040|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
33495465|NCT00745901|101706041|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
33495466|NCT00745901|101706040|FG000|Overall Study|Patient didn't take any study medication|7|||
33495467|NCT00745901|101706041|FG001|Overall Study|Patient didn't take any study medication|3|||
33495468|NCT03472014|101706042|FG000|Overall Study|Lost to Follow-up|4|||
33495469|NCT01779440|101706046|FG000|Overall Study|Withdrawal by Subject|3|||
33495470|NCT01779440|101706047|FG001|Overall Study|Withdrawal by Subject|5|||
33495471|NCT00837148|101706050|FG000|Overall Study|Adverse Event|1|||
33495472|NCT00837148|101706050|FG000|Overall Study|Death|1|||
33495473|NCT01942993|101706053|FG000|Overall Study|Lost to Follow-up|1|||
33495474|NCT01942993|101706053|FG000|Overall Study|Physician Decision|1|||
33495475|NCT03203473|101706054|FG000|Induction Phase|Never started primary treatment|2|||
33495476|NCT03203473|101706055|FG001|Induction Phase|Never started primary treatment|0|||
33495477|NCT03203473|101706056|FG002|Induction Phase|Never started primary treatment|0|||
33495478|NCT03203473|101706054|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
33495479|NCT03203473|101706055|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
33495480|NCT03203473|101706056|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
33495481|NCT03203473|101706054|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
33495482|NCT03203473|101706055|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
33495483|NCT03203473|101706056|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
33495484|NCT03203473|101706054|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
33495485|NCT03203473|101706055|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
33495486|NCT03203473|101706056|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
33495487|NCT03203473|101706054|FG000|Arm Allocation Phase|started salvage therapy|0|||
33495488|NCT03203473|101706055|FG001|Arm Allocation Phase|started salvage therapy|5|||
33495489|NCT03203473|101706056|FG002|Arm Allocation Phase|started salvage therapy|0|||
33495490|NCT03203473|101706054|FG000|Arm Allocation Phase|Disease progression|0|||
33495491|NCT03203473|101706055|FG001|Arm Allocation Phase|Disease progression|0|||
33495492|NCT03203473|101706056|FG002|Arm Allocation Phase|Disease progression|37|||
33495493|NCT03203473|101706054|FG000|Arm Allocation Phase|Adverse Event|0|||
33495494|NCT03203473|101706055|FG001|Arm Allocation Phase|Adverse Event|0|||
33495495|NCT03203473|101706056|FG002|Arm Allocation Phase|Adverse Event|11|||
33495496|NCT03203473|101706054|FG000|Arm Allocation Phase|Physician Decision|0|||
33495497|NCT03203473|101706055|FG001|Arm Allocation Phase|Physician Decision|0|||
33495498|NCT03203473|101706056|FG002|Arm Allocation Phase|Physician Decision|3|||
33495499|NCT03203473|101706054|FG000|Arm Allocation Phase|Death|0|||
33495500|NCT03203473|101706055|FG001|Arm Allocation Phase|Death|0|||
33495501|NCT03203473|101706056|FG002|Arm Allocation Phase|Death|1|||
33495502|NCT03203473|101706054|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
33495503|NCT03203473|101706055|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
33495504|NCT03203473|101706056|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
33495505|NCT03203473|101706054|FG000|Arm Allocation Phase|Intercurrent illness|0|||
33495506|NCT03203473|101706055|FG001|Arm Allocation Phase|Intercurrent illness|0|||
33495507|NCT03203473|101706056|FG002|Arm Allocation Phase|Intercurrent illness|1|||
33495508|NCT03203473|101706054|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
33495509|NCT03203473|101706055|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
33495510|NCT03203473|101706056|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
33495511|NCT00979654|101706061|FG000|Overall Study|Lost to Follow-up|1|||
33495512|NCT00979654|101706061|FG000|Overall Study|Withdrawal by Subject|22|||
33495513|NCT00979654|101706061|FG000|Overall Study|Death|1|||
33495514|NCT00979654|101706061|FG000|Overall Study|Lack of Efficacy|6|||
33495515|NCT00979654|101706061|FG000|Overall Study|Adverse Event|1|||
33495516|NCT00979654|101706061|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
33495517|NCT00979654|101706061|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
33495518|NCT00979654|101706061|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
33495519|NCT00979654|101706061|FG000|Overall Study|Serious Adverse Event|1|||
33495520|NCT00979654|101706061|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
33495521|NCT02727478|101706066|FG000|Overall Study|Withdrawal by Subject|8|||
33495522|NCT02727478|101706067|FG001|Overall Study|Withdrawal by Subject|10|||
33495523|NCT05966584|101706068|FG000|Overall Study|Lost to Follow-up|1|||
33495524|NCT00529373|101706069|FG000|Base Study|Adverse Event|525|||
33495525|NCT00529373|101706070|FG001|Base Study|Adverse Event|470|||
33495526|NCT00529373|101706069|FG000|Base Study|Lack of Efficacy|16|||
33495527|NCT00529373|101706070|FG001|Base Study|Lack of Efficacy|75|||
33495528|NCT00529373|101706069|FG000|Base Study|Lost to Follow-up|221|||
33495529|NCT00529373|101706070|FG001|Base Study|Lost to Follow-up|208|||
33495530|NCT00529373|101706069|FG000|Base Study|Other Protocol Specified Criteria|19|||
33495531|NCT00529373|101706070|FG001|Base Study|Other Protocol Specified Criteria|20|||
33495532|NCT00529373|101706069|FG000|Base Study|Physician Decision|60|||
33495533|NCT00529373|101706070|FG001|Base Study|Physician Decision|52|||
33495534|NCT00529373|101706069|FG000|Base Study|Protocol Violation|48|||
33495535|NCT00529373|101706070|FG001|Base Study|Protocol Violation|38|||
33495536|NCT00529373|101706069|FG000|Base Study|Withdrawal by Subject|1062|||
33495537|NCT00529373|101706070|FG001|Base Study|Withdrawal by Subject|967|||
33495538|NCT00529373|101706069|FG000|Base Study|Did not continue into Extension|1795|||
33495539|NCT00529373|101706070|FG001|Base Study|Did not continue into Extension|2238|||
33495540|NCT00529373|101706069|FG000|First Extension Study|Adverse Event|162|||
33495541|NCT00529373|101706070|FG001|First Extension Study|Adverse Event|142|||
33495542|NCT00529373|101706069|FG000|First Extension Study|Lack of Efficacy|65|||
33495543|NCT00529373|101706070|FG001|First Extension Study|Lack of Efficacy|427|||
33495544|NCT00529373|101706069|FG000|First Extension Study|Lost to Follow-up|41|||
33495545|NCT00529373|101706070|FG001|First Extension Study|Lost to Follow-up|37|||
33495546|NCT00529373|101706069|FG000|First Extension Study|Other|27|||
33495547|NCT00529373|101706070|FG001|First Extension Study|Other|47|||
33495548|NCT00529373|101706069|FG000|First Extension Study|Physician Decision|50|||
33495549|NCT00529373|101706070|FG001|First Extension Study|Physician Decision|45|||
33495550|NCT00529373|101706069|FG000|First Extension Study|Protocol Violation|16|||
33495551|NCT00529373|101706070|FG001|First Extension Study|Protocol Violation|13|||
33495552|NCT00529373|101706069|FG000|First Extension Study|Withdrawal by Subject|296|||
33495553|NCT00529373|101706070|FG001|First Extension Study|Withdrawal by Subject|287|||
33495554|NCT00529373|101706069|FG000|First Extension Study|Disposition record non-existing|0|||
33495555|NCT00529373|101706070|FG001|First Extension Study|Disposition record non-existing|1|||
33495556|NCT00529373|101706069|FG000|First Extension Study|Discontinued after 5 years completion|208|||
33495557|NCT00529373|101706070|FG001|First Extension Study|Discontinued after 5 years completion|346|||
33495558|NCT00529373|101706069|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
33495559|NCT00529373|101706070|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
33495560|NCT00529373|101706069|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
33495561|NCT00529373|101706070|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
33495562|NCT00529373|101706069|FG000|Second Extension Study|Adverse Event|101|||
33495563|NCT00529373|101706070|FG001|Second Extension Study|Adverse Event|51|||
33495564|NCT00529373|101706069|FG000|Second Extension Study|Lack of Efficacy|7|||
33495565|NCT00529373|101706070|FG001|Second Extension Study|Lack of Efficacy|15|||
33495566|NCT00529373|101706069|FG000|Second Extension Study|Lost to Follow-up|18|||
33495567|NCT00529373|101706070|FG001|Second Extension Study|Lost to Follow-up|12|||
33495568|NCT00529373|101706069|FG000|Second Extension Study|Other|7|||
33495569|NCT00529373|101706070|FG001|Second Extension Study|Other|12|||
33495570|NCT00529373|101706069|FG000|Second Extension Study|Physician Decision|63|||
33495571|NCT00529373|101706070|FG001|Second Extension Study|Physician Decision|26|||
33495572|NCT00529373|101706069|FG000|Second Extension Study|Protocol Violation|2|||
33595309|NCT03515551|102069666|FG005|Overall Study|Withdrawal by Subject|0|||
33495573|NCT00529373|101706070|FG001|Second Extension Study|Protocol Violation|1|||
33495574|NCT00529373|101706069|FG000|Second Extension Study|Withdrawal by Subject|97|||
33495575|NCT00529373|101706070|FG001|Second Extension Study|Withdrawal by Subject|75|||
33495576|NCT00529373|101706069|FG000|Second Extension Study|Status Missing|5|||
33495577|NCT00529373|101706070|FG001|Second Extension Study|Status Missing|5|||
33495578|NCT01924689|101706074|FG000|Overall Study|Death|0|||
33495579|NCT01924689|101706075|FG001|Overall Study|Death|1|||
33495580|NCT01924689|101706076|FG002|Overall Study|Death|0|||
33495581|NCT01924689|101706077|FG003|Overall Study|Death|1|||
33495582|NCT01924689|101706078|FG004|Overall Study|Death|0|||
33495583|NCT01924689|101706079|FG005|Overall Study|Death|0|||
33495584|NCT01924689|101706074|FG000|Overall Study|Disease progression|0|||
33495585|NCT01924689|101706075|FG001|Overall Study|Disease progression|0|||
33495586|NCT01924689|101706076|FG002|Overall Study|Disease progression|2|||
33495587|NCT01924689|101706077|FG003|Overall Study|Disease progression|0|||
33495588|NCT01924689|101706078|FG004|Overall Study|Disease progression|3|||
33495589|NCT01924689|101706079|FG005|Overall Study|Disease progression|2|||
33495590|NCT01924689|101706074|FG000|Overall Study|New therapy or study|3|||
33495591|NCT01924689|101706075|FG001|Overall Study|New therapy or study|2|||
33495592|NCT01924689|101706076|FG002|Overall Study|New therapy or study|1|||
33495593|NCT01924689|101706077|FG003|Overall Study|New therapy or study|4|||
33495594|NCT01924689|101706078|FG004|Overall Study|New therapy or study|2|||
33495595|NCT01924689|101706079|FG005|Overall Study|New therapy or study|0|||
33495596|NCT01924689|101706074|FG000|Overall Study|Withdrawal of consent|0|||
33495597|NCT01924689|101706075|FG001|Overall Study|Withdrawal of consent|0|||
33495598|NCT01924689|101706076|FG002|Overall Study|Withdrawal of consent|1|||
33495599|NCT01924689|101706077|FG003|Overall Study|Withdrawal of consent|1|||
33495600|NCT01924689|101706078|FG004|Overall Study|Withdrawal of consent|0|||
33495601|NCT01924689|101706079|FG005|Overall Study|Withdrawal of consent|0|||
33495602|NCT01924689|101706074|FG000|Overall Study|Other|0|||
33495603|NCT01924689|101706075|FG001|Overall Study|Other|0|||
33495604|NCT01924689|101706076|FG002|Overall Study|Other|0|||
33495605|NCT01924689|101706077|FG003|Overall Study|Other|0|||
33495606|NCT01924689|101706078|FG004|Overall Study|Other|1|||
33495607|NCT01924689|101706079|FG005|Overall Study|Other|0|||
33495608|NCT02810457|101706080|FG000|Overall Study|Randomised but no treatment received|2|||
33495609|NCT02810457|101706081|FG001|Overall Study|Randomised but no treatment received|1|||
33495610|NCT02810457|101706080|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
33495611|NCT02810457|101706081|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
33495612|NCT02810457|101706080|FG000|Overall Study|Adverse Event|37|||
33495613|NCT02810457|101706081|FG001|Overall Study|Adverse Event|43|||
33495614|NCT02810457|101706080|FG000|Overall Study|Patient decision|31|||
33495615|NCT02810457|101706081|FG001|Overall Study|Patient decision|35|||
33495616|NCT02810457|101706080|FG000|Overall Study|Patient lost to follow-up|2|||
33495617|NCT02810457|101706081|FG001|Overall Study|Patient lost to follow-up|2|||
33495618|NCT02810457|101706080|FG000|Overall Study|Death|39|||
33495619|NCT02810457|101706081|FG001|Overall Study|Death|28|||
33495620|NCT02810457|101706080|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
33495621|NCT02810457|101706081|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
33495622|NCT02810457|101706080|FG000|Overall Study|Clinical progression|15|||
33495623|NCT02810457|101706081|FG001|Overall Study|Clinical progression|16|||
33495624|NCT02810457|101706080|FG000|Overall Study|Investigator decision|3|||
33495625|NCT02810457|101706081|FG001|Overall Study|Investigator decision|2|||
33495626|NCT02810457|101706080|FG000|Overall Study|Patient ineligibility|3|||
33495627|NCT02810457|101706081|FG001|Overall Study|Patient ineligibility|0|||
33495628|NCT02810457|101706080|FG000|Overall Study|Miscalculated PD|1|||
33495629|NCT02810457|101706081|FG001|Overall Study|Miscalculated PD|0|||
33495630|NCT02810457|101706080|FG000|Overall Study|Physician Decision|0|||
33495631|NCT02810457|101706081|FG001|Overall Study|Physician Decision|1|||
33495632|NCT02222922|101706084|FG000|Overall Study|Death|0|||
33495633|NCT02222922|101706085|FG001|Overall Study|Death|0|||
33495634|NCT02222922|101706086|FG002|Overall Study|Death|0|||
33495635|NCT02222922|101706087|FG003|Overall Study|Death|0|||
33495636|NCT02222922|101706088|FG004|Overall Study|Death|13|||
33495637|NCT02222922|101706089|FG005|Overall Study|Death|0|||
33495638|NCT02222922|101706090|FG006|Overall Study|Death|0|||
33495639|NCT02222922|101706091|FG007|Overall Study|Death|0|||
33495640|NCT02222922|101706092|FG008|Overall Study|Death|2|||
33495641|NCT02222922|101706084|FG000|Overall Study|Lost to Follow-up|0|||
33495642|NCT02222922|101706085|FG001|Overall Study|Lost to Follow-up|0|||
33495643|NCT02222922|101706086|FG002|Overall Study|Lost to Follow-up|1|||
33495644|NCT02222922|101706087|FG003|Overall Study|Lost to Follow-up|0|||
33495645|NCT02222922|101706088|FG004|Overall Study|Lost to Follow-up|9|||
33495646|NCT02222922|101706089|FG005|Overall Study|Lost to Follow-up|1|||
33495647|NCT02222922|101706090|FG006|Overall Study|Lost to Follow-up|0|||
33495648|NCT02222922|101706091|FG007|Overall Study|Lost to Follow-up|0|||
33595310|NCT03515551|102069667|FG006|Overall Study|Withdrawal by Subject|1|||
33595311|NCT03515551|102069661|FG000|Overall Study|Study ended by sponsor|0|||
33595312|NCT03515551|102069662|FG001|Overall Study|Study ended by sponsor|0|||
33595313|NCT03515551|102069663|FG002|Overall Study|Study ended by sponsor|2|||
33595314|NCT03515551|102069664|FG003|Overall Study|Study ended by sponsor|1|||
33595315|NCT03515551|102069665|FG004|Overall Study|Study ended by sponsor|3|||
33495649|NCT02222922|101706092|FG008|Overall Study|Lost to Follow-up|0|||
33495650|NCT02222922|101706084|FG000|Overall Study|Other|0|||
33495651|NCT02222922|101706085|FG001|Overall Study|Other|0|||
33495652|NCT02222922|101706086|FG002|Overall Study|Other|0|||
33595316|NCT03515551|102069666|FG005|Overall Study|Study ended by sponsor|0|||
33595317|NCT03515551|102069667|FG006|Overall Study|Study ended by sponsor|3|||
33595318|NCT03515551|102069661|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
33595319|NCT03515551|102069662|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
33595320|NCT03515551|102069663|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
33595321|NCT03515551|102069664|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
33595322|NCT03515551|102069665|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
33595323|NCT03515551|102069666|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
33595324|NCT03515551|102069667|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
33595325|NCT03334851|102069670|FG000|Overall Study|Other|0|||
33595326|NCT03334851|102069671|FG001|Overall Study|Other|0|||
33595327|NCT03334851|102069672|FG002|Overall Study|Other|0|||
33595328|NCT03334851|102069673|FG003|Overall Study|Other|0|||
33595329|NCT03334851|102069674|FG004|Overall Study|Other|0|||
33495653|NCT02222922|101706087|FG003|Overall Study|Other|2|||
33495654|NCT02222922|101706088|FG004|Overall Study|Other|10|||
33495655|NCT02222922|101706089|FG005|Overall Study|Other|2|||
33495656|NCT02222922|101706090|FG006|Overall Study|Other|2|||
33495657|NCT02222922|101706091|FG007|Overall Study|Other|4|||
33495658|NCT02222922|101706092|FG008|Overall Study|Other|1|||
33495659|NCT02222922|101706084|FG000|Overall Study|Participant refused further follow-up|1|||
33495660|NCT02222922|101706085|FG001|Overall Study|Participant refused further follow-up|0|||
33495661|NCT02222922|101706086|FG002|Overall Study|Participant refused further follow-up|0|||
33495662|NCT02222922|101706087|FG003|Overall Study|Participant refused further follow-up|1|||
33495663|NCT02222922|101706088|FG004|Overall Study|Participant refused further follow-up|6|||
33495664|NCT02222922|101706089|FG005|Overall Study|Participant refused further follow-up|0|||
33495665|NCT02222922|101706090|FG006|Overall Study|Participant refused further follow-up|0|||
33495666|NCT02222922|101706091|FG007|Overall Study|Participant refused further follow-up|0|||
33495667|NCT02222922|101706092|FG008|Overall Study|Participant refused further follow-up|3|||
33495668|NCT02462603|101706108|FG000|Overall Study|Investigator Decision|1|||
33495669|NCT02462603|101706108|FG000|Overall Study|Non-Compliance|1|||
33495670|NCT02462603|101706108|FG000|Overall Study|Withdrawal by Subject|2|||
33495671|NCT00586703|101706109|FG000|Overall Study|Death|12|||
33495672|NCT02550561|101706112|FG000|Overall Study|Lost to Follow-up|5|||
33495673|NCT02550561|101706112|FG000|Overall Study|Withdrawal by Subject|1|||
33495674|NCT03564119|101706113|FG000|Overall Study|Adverse Event|4|||
33495675|NCT03564119|101706114|FG001|Overall Study|Adverse Event|0|||
33495676|NCT03564119|101706113|FG000|Overall Study|Lost to Follow-up|1|||
33495677|NCT03564119|101706114|FG001|Overall Study|Lost to Follow-up|4|||
33495678|NCT03564119|101706113|FG000|Overall Study|Protocol Violation|1|||
33495679|NCT03564119|101706114|FG001|Overall Study|Protocol Violation|0|||
33495680|NCT03564119|101706113|FG000|Overall Study|Withdrawal by Subject|9|||
33495681|NCT03564119|101706114|FG001|Overall Study|Withdrawal by Subject|4|||
33495682|NCT03564119|101706113|FG000|Overall Study|Other Than Specified|0|||
33495683|NCT03564119|101706114|FG001|Overall Study|Other Than Specified|1|||
33495684|NCT00468819|101706121|FG000|Overall Study|Withdrawal by Subject|4|||
33495685|NCT00468819|101706122|FG001|Overall Study|Withdrawal by Subject|0|||
33495686|NCT00468819|101706123|FG002|Overall Study|Withdrawal by Subject|1|||
33495687|NCT00468819|101706121|FG000|Overall Study|Lost to Follow-up|0|||
33495688|NCT00468819|101706122|FG001|Overall Study|Lost to Follow-up|0|||
33495689|NCT00468819|101706123|FG002|Overall Study|Lost to Follow-up|1|||
33495690|NCT00468819|101706121|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
33495691|NCT00468819|101706122|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
33495692|NCT00468819|101706123|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
33495693|NCT02105467|101706124|FG000|Period 1|Lost to Follow-up|1|||
33495694|NCT02105467|101706125|FG001|Period 1|Lost to Follow-up|0|||
33495695|NCT02105467|101706124|FG000|Period 1|Death|1|||
33495696|NCT02105467|101706125|FG001|Period 1|Death|0|||
33495697|NCT02105467|101706124|FG000|Period 2|Lost to Follow-up|1|||
33495698|NCT02105467|101706125|FG001|Period 2|Lost to Follow-up|0|||
33495699|NCT02105467|101706124|FG000|Period 2|Death|1|||
33495700|NCT02105467|101706125|FG001|Period 2|Death|0|||
33495701|NCT02105467|101706124|FG000|Period 2|Withdrawal by Subject|0|||
33495702|NCT02105467|101706125|FG001|Period 2|Withdrawal by Subject|2|||
33495703|NCT02105467|101706124|FG000|Period 3|Lost to Follow-up|0|||
33495704|NCT02105467|101706125|FG001|Period 3|Lost to Follow-up|1|||
33495705|NCT00697463|101706128|FG000|Overall Study|Withdrawal by Subject|1|||
33495706|NCT02633293|101706129|FG000|Overall Study|Death|56|||
33495707|NCT02633293|101706129|FG000|Overall Study|Progressive Disease|12|||
33495708|NCT02633293|101706129|FG000|Overall Study|Adverse Event|29|||
33495709|NCT02633293|101706129|FG000|Overall Study|Withdrawal by Subject|41|||
33495710|NCT02633293|101706129|FG000|Overall Study|Protocol Violation|1|||
33495711|NCT02633293|101706129|FG000|Overall Study|Lost to Follow-up|1|||
33495712|NCT02633293|101706129|FG000|Overall Study|Study Terminated by Sponsor|24|||
33495713|NCT02633293|101706129|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
33495714|NCT02633293|101706129|FG000|Overall Study|Lung Transplant|5|||
33495715|NCT02633293|101706129|FG000|Overall Study|Lack of Efficacy|2|||
33495716|NCT02633293|101706129|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
33495717|NCT00349973|101706132|FG000|Overall Study|Adverse Event|3|||
33495718|NCT00349973|101706133|FG001|Overall Study|Adverse Event|3|||
33495719|NCT00349973|101706132|FG000|Overall Study|Withdrawal by Subject|1|||
33495720|NCT00349973|101706133|FG001|Overall Study|Withdrawal by Subject|0|||
33495721|NCT03918629|101706137|FG000|Overall Study|Adverse Event|19|||
33495722|NCT03918629|101706138|FG001|Overall Study|Adverse Event|20|||
33495723|NCT03918629|101706137|FG000|Overall Study|Death|14|||
33495724|NCT03918629|101706138|FG001|Overall Study|Death|7|||
33495725|NCT03918629|101706137|FG000|Overall Study|Lost to Follow-up|36|||
33495726|NCT03918629|101706138|FG001|Overall Study|Lost to Follow-up|28|||
33495727|NCT03918629|101706137|FG000|Overall Study|Physician Decision|1|||
33495728|NCT03918629|101706138|FG001|Overall Study|Physician Decision|0|||
33595330|NCT03334851|102069675|FG005|Overall Study|Other|0|||
33595331|NCT03334851|102069676|FG006|Overall Study|Other|0|||
33495729|NCT03918629|101706137|FG000|Overall Study|Protocol Violation|7|||
33495730|NCT03918629|101706138|FG001|Overall Study|Protocol Violation|4|||
33495731|NCT03918629|101706137|FG000|Overall Study|Withdrawal by Subject|47|||
33495732|NCT03918629|101706138|FG001|Overall Study|Withdrawal by Subject|47|||
33595332|NCT03334851|102069677|FG007|Overall Study|Other|1|||
33595333|NCT03334851|102069678|FG008|Overall Study|Other|0|||
33495733|NCT03918629|101706137|FG000|Overall Study|Other|7|||
33495734|NCT03918629|101706138|FG001|Overall Study|Other|11|||
33495735|NCT03918629|101706137|FG000|Overall Study|Randomized but not vaccinated|2|||
33495736|NCT03918629|101706138|FG001|Overall Study|Randomized but not vaccinated|1|||
33495737|NCT02077140|101706139|FG000|Overall Study|Lost to Follow-up|4|||
33495738|NCT02077140|101706140|FG001|Overall Study|Lost to Follow-up|1|||
33495739|NCT02077140|101706141|FG002|Overall Study|Lost to Follow-up|2|||
33495740|NCT02077140|101706142|FG003|Overall Study|Lost to Follow-up|2|||
33495741|NCT02077140|101706143|FG004|Overall Study|Lost to Follow-up|3|||
33495742|NCT02077140|101706139|FG000|Overall Study|Withdrawal by Subject|0|||
33495743|NCT02077140|101706140|FG001|Overall Study|Withdrawal by Subject|1|||
33495744|NCT02077140|101706141|FG002|Overall Study|Withdrawal by Subject|0|||
33495745|NCT02077140|101706142|FG003|Overall Study|Withdrawal by Subject|2|||
33495746|NCT02077140|101706143|FG004|Overall Study|Withdrawal by Subject|2|||
33495747|NCT00666328|101706145|FG000|Overall Study|Death|2|||
33495748|NCT00666328|101706145|FG000|Overall Study|Lost to Follow-up|2|||
33495749|NCT00666328|101706145|FG000|Overall Study|No longer met eligibility criteria|1|||
33495750|NCT03642262|101709882|FG000|Period 1|Withdrawal by Subject|1|||
33495751|NCT03642262|101709883|FG001|Period 1|Withdrawal by Subject|1|||
33495752|NCT03642262|101709882|FG000|Period 1|Adverse Event|0|||
33495753|NCT03642262|101709883|FG001|Period 1|Adverse Event|1|||
33495754|NCT03194542|101709892|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
33495755|NCT03194542|101709893|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
33495756|NCT03194542|101709894|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
33495757|NCT03194542|101709895|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
33495758|NCT03194542|101709892|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
33495759|NCT03194542|101709893|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
33495760|NCT03194542|101709894|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
33495761|NCT03194542|101709895|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
33495762|NCT03194542|101709892|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
33495763|NCT03194542|101709893|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
33495764|NCT03194542|101709894|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
33495765|NCT03194542|101709895|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
33495766|NCT03194542|101709892|FG000|Overall Study|Loss of Response|4|||
33495767|NCT03194542|101709893|FG001|Overall Study|Loss of Response|2|||
33495768|NCT03194542|101709894|FG002|Overall Study|Loss of Response|3|||
33495769|NCT03194542|101709895|FG003|Overall Study|Loss of Response|4|||
33495770|NCT03194542|101709892|FG000|Overall Study|Physician Decision|0|||
33495771|NCT03194542|101709893|FG001|Overall Study|Physician Decision|1|||
33495772|NCT03194542|101709894|FG002|Overall Study|Physician Decision|0|||
33495773|NCT03194542|101709895|FG003|Overall Study|Physician Decision|0|||
33495774|NCT03194542|101709892|FG000|Overall Study|Lack of Efficacy|2|||
33495775|NCT03194542|101709893|FG001|Overall Study|Lack of Efficacy|2|||
33495776|NCT03194542|101709894|FG002|Overall Study|Lack of Efficacy|2|||
33495777|NCT03194542|101709895|FG003|Overall Study|Lack of Efficacy|6|||
33495778|NCT03194542|101709892|FG000|Overall Study|Withdrawal by Subject|2|||
33495779|NCT03194542|101709893|FG001|Overall Study|Withdrawal by Subject|1|||
33495780|NCT03194542|101709894|FG002|Overall Study|Withdrawal by Subject|5|||
33495781|NCT03194542|101709895|FG003|Overall Study|Withdrawal by Subject|4|||
33495782|NCT03194542|101709892|FG000|Overall Study|Progressive Disease|1|||
33495783|NCT03194542|101709893|FG001|Overall Study|Progressive Disease|0|||
33495784|NCT03194542|101709894|FG002|Overall Study|Progressive Disease|1|||
33495785|NCT03194542|101709895|FG003|Overall Study|Progressive Disease|1|||
33495786|NCT03194542|101709892|FG000|Overall Study|Adverse Event|1|||
33495787|NCT03194542|101709893|FG001|Overall Study|Adverse Event|2|||
33495788|NCT03194542|101709894|FG002|Overall Study|Adverse Event|0|||
33495789|NCT03194542|101709895|FG003|Overall Study|Adverse Event|5|||
33495790|NCT03194542|101709892|FG000|Overall Study|Death|1|||
33495791|NCT03194542|101709893|FG001|Overall Study|Death|2|||
33495792|NCT03194542|101709894|FG002|Overall Study|Death|0|||
33495793|NCT03194542|101709895|FG003|Overall Study|Death|5|||
33495794|NCT03194542|101709892|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
33495795|NCT03194542|101709893|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
33495796|NCT03194542|101709894|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
33495797|NCT03194542|101709895|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
33495798|NCT01125189|101709896|FG000|Treatment Period|Lack of Efficacy|15|||
33495799|NCT01125189|101709897|FG001|Treatment Period|Lack of Efficacy|18|||
33495800|NCT01125189|101709898|FG002|Treatment Period|Lack of Efficacy|25|||
33495801|NCT01125189|101709896|FG000|Treatment Period|Adverse Event|7|||
33495802|NCT01125189|101709897|FG001|Treatment Period|Adverse Event|8|||
33495803|NCT01125189|101709898|FG002|Treatment Period|Adverse Event|8|||
33495804|NCT01125189|101709896|FG000|Treatment Period|Withdrawal by Subject|3|||
33495805|NCT01125189|101709897|FG001|Treatment Period|Withdrawal by Subject|1|||
33495806|NCT01125189|101709898|FG002|Treatment Period|Withdrawal by Subject|1|||
33495807|NCT01125189|101709896|FG000|Treatment Period|Death|1|||
33495808|NCT01125189|101709897|FG001|Treatment Period|Death|0|||
33495809|NCT01125189|101709898|FG002|Treatment Period|Death|0|||
33495810|NCT01125189|101709896|FG000|Treatment Period|Lost to Follow-up|1|||
33495811|NCT01125189|101709897|FG001|Treatment Period|Lost to Follow-up|2|||
33495812|NCT01125189|101709898|FG002|Treatment Period|Lost to Follow-up|1|||
33495813|NCT01125189|101709896|FG000|Treatment Period|Poor compliance/noncompliance|0|||
33495814|NCT01125189|101709897|FG001|Treatment Period|Poor compliance/noncompliance|1|||
33495815|NCT01125189|101709898|FG002|Treatment Period|Poor compliance/noncompliance|0|||
33495816|NCT01125189|101709896|FG000|Treatment Period|Participants requested to discontinue|1|||
33495817|NCT01125189|101709897|FG001|Treatment Period|Participants requested to discontinue|3|||
33495818|NCT01125189|101709898|FG002|Treatment Period|Participants requested to discontinue|4|||
33495819|NCT01125189|101709896|FG000|Treatment Period|Other reasons|1|||
33495820|NCT01125189|101709897|FG001|Treatment Period|Other reasons|1|||
33495821|NCT01125189|101709898|FG002|Treatment Period|Other reasons|0|||
33495822|NCT01125189|101709896|FG000|Treatment Period|Completed 24 week treatment period only|2|||
33495823|NCT01125189|101709897|FG001|Treatment Period|Completed 24 week treatment period only|1|||
33595334|NCT03334851|102069679|FG009|Overall Study|Other|0|||
33495824|NCT01125189|101709898|FG002|Treatment Period|Completed 24 week treatment period only|2|||
33495825|NCT01125189|101709896|FG000|Follow up Period|Withdrawal by Subject|3|||
33495826|NCT01125189|101709897|FG001|Follow up Period|Withdrawal by Subject|2|||
33495827|NCT01125189|101709898|FG002|Follow up Period|Withdrawal by Subject|5|||
33495828|NCT01125189|101709896|FG000|Follow up Period|Death|1|||
33495829|NCT01125189|101709897|FG001|Follow up Period|Death|0|||
33495830|NCT01125189|101709898|FG002|Follow up Period|Death|0|||
33495831|NCT01125189|101709896|FG000|Follow up Period|Lost to Follow-up|12|||
33495832|NCT01125189|101709897|FG001|Follow up Period|Lost to Follow-up|9|||
33495833|NCT01125189|101709898|FG002|Follow up Period|Lost to Follow-up|6|||
33495834|NCT01125189|101709896|FG000|Follow up Period|Other reasons|4|||
33495835|NCT01125189|101709897|FG001|Follow up Period|Other reasons|4|||
33495836|NCT01125189|101709898|FG002|Follow up Period|Other reasons|5|||
33495837|NCT02949973|101709905|FG000|Overall Study|Physician Decision|1|||
33495838|NCT03743415|101709906|FG000|Overall Study|Death|5|||
33595335|NCT03334851|102069680|FG010|Overall Study|Other|0|||
33595336|NCT03334851|102069681|FG011|Overall Study|Other|0|||
33595337|NCT03334851|102069682|FG012|Overall Study|Other|0|||
33595338|NCT03334851|102069670|FG000|Overall Study|Adverse Event|0|||
33595339|NCT03334851|102069671|FG001|Overall Study|Adverse Event|0|||
33595340|NCT03334851|102069672|FG002|Overall Study|Adverse Event|0|||
33595341|NCT03334851|102069673|FG003|Overall Study|Adverse Event|0|||
33595342|NCT03334851|102069674|FG004|Overall Study|Adverse Event|0|||
33495839|NCT03743415|101709907|FG001|Overall Study|Death|3|||
33495840|NCT03743415|101709908|FG002|Overall Study|Death|1|||
33495841|NCT03743415|101709909|FG003|Overall Study|Death|4|||
33495842|NCT03743415|101709910|FG004|Overall Study|Death|0|||
33495843|NCT03743415|101709911|FG005|Overall Study|Death|0|||
33495844|NCT03743415|101709912|FG006|Overall Study|Death|0|||
33495845|NCT03743415|101709913|FG007|Overall Study|Death|0|||
33495846|NCT03743415|101709914|FG008|Overall Study|Death|1|||
33495847|NCT03743415|101709915|FG009|Overall Study|Death|0|||
33495848|NCT03743415|101709906|FG000|Overall Study|Withdrawal by Subject|1|||
33495849|NCT03743415|101709907|FG001|Overall Study|Withdrawal by Subject|0|||
33495850|NCT03743415|101709908|FG002|Overall Study|Withdrawal by Subject|4|||
33495851|NCT03743415|101709909|FG003|Overall Study|Withdrawal by Subject|5|||
33495852|NCT03743415|101709910|FG004|Overall Study|Withdrawal by Subject|5|||
33495853|NCT03743415|101709911|FG005|Overall Study|Withdrawal by Subject|2|||
33495854|NCT03743415|101709912|FG006|Overall Study|Withdrawal by Subject|2|||
33495855|NCT03743415|101709913|FG007|Overall Study|Withdrawal by Subject|5|||
33495856|NCT03743415|101709914|FG008|Overall Study|Withdrawal by Subject|9|||
33495857|NCT03743415|101709915|FG009|Overall Study|Withdrawal by Subject|10|||
33595343|NCT03334851|102069675|FG005|Overall Study|Adverse Event|0|||
33595344|NCT03334851|102069676|FG006|Overall Study|Adverse Event|0|||
33595345|NCT03334851|102069677|FG007|Overall Study|Adverse Event|1|||
33595346|NCT03334851|102069678|FG008|Overall Study|Adverse Event|0|||
33495858|NCT03743415|101709906|FG000|Overall Study|Lost to Follow-up|2|||
33495859|NCT03743415|101709907|FG001|Overall Study|Lost to Follow-up|0|||
33495860|NCT03743415|101709908|FG002|Overall Study|Lost to Follow-up|2|||
33495861|NCT03743415|101709909|FG003|Overall Study|Lost to Follow-up|1|||
33495862|NCT03743415|101709910|FG004|Overall Study|Lost to Follow-up|1|||
33495863|NCT03743415|101709911|FG005|Overall Study|Lost to Follow-up|0|||
33495864|NCT03743415|101709912|FG006|Overall Study|Lost to Follow-up|1|||
33495865|NCT03743415|101709913|FG007|Overall Study|Lost to Follow-up|4|||
33495866|NCT03743415|101709914|FG008|Overall Study|Lost to Follow-up|13|||
33495867|NCT03743415|101709915|FG009|Overall Study|Lost to Follow-up|13|||
33495868|NCT03802825|101709916|FG000|Overall Study|Lost to follow-up for intervention|12|||
33495869|NCT03802825|101709917|FG001|Overall Study|Lost to follow-up for intervention|3|||
33495870|NCT03802825|101709916|FG000|Overall Study|Received only 1 component of intervention|0|||
33495871|NCT03802825|101709917|FG001|Overall Study|Received only 1 component of intervention|13|||
33495872|NCT00886015|101709922|FG000|Overall Study|Death|0|||
33495873|NCT00886015|101709923|FG001|Overall Study|Death|2|||
33495874|NCT02750618|101709928|FG000|Overall Study|Withdrawal by Subject|1|||
33495875|NCT00811733|101709931|FG000|Overall Study|Investigator Discretion|10|||
33495876|NCT00811733|101709932|FG001|Overall Study|Investigator Discretion|8|||
33495877|NCT00811733|101709931|FG000|Overall Study|Withdrawal by Subject|1|||
33495878|NCT00811733|101709932|FG001|Overall Study|Withdrawal by Subject|2|||
33495879|NCT00985504|101709933|FG000|Acute Treatment Period|Adverse Event|3|||
33495880|NCT00985504|101709934|FG001|Acute Treatment Period|Adverse Event|4|||
33495881|NCT00985504|101709933|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
33495882|NCT00985504|101709934|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
33495883|NCT00985504|101709933|FG000|Acute Treatment Period|Protocol Violation|2|||
33495884|NCT00985504|101709934|FG001|Acute Treatment Period|Protocol Violation|0|||
33495885|NCT00985504|101709933|FG000|Acute Treatment Period|Sponsor Decision|0|||
33495886|NCT00985504|101709934|FG001|Acute Treatment Period|Sponsor Decision|1|||
33495887|NCT00985504|101709933|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
33495888|NCT00985504|101709934|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
33495889|NCT00985504|101709933|FG000|Optimization Period|Adverse Event|7|||
33495890|NCT00985504|101709934|FG001|Optimization Period|Adverse Event|9|||
33495891|NCT00985504|101709933|FG000|Optimization Period|Death|0|||
33495892|NCT00985504|101709934|FG001|Optimization Period|Death|1|||
33495893|NCT00985504|101709933|FG000|Optimization Period|Lack of Efficacy|5|||
33495894|NCT00985504|101709934|FG001|Optimization Period|Lack of Efficacy|3|||
33495895|NCT00985504|101709933|FG000|Optimization Period|Lost to Follow-up|0|||
33495896|NCT00985504|101709934|FG001|Optimization Period|Lost to Follow-up|1|||
33495897|NCT00985504|101709933|FG000|Optimization Period|Physician Decision|1|||
33495898|NCT00985504|101709934|FG001|Optimization Period|Physician Decision|0|||
33495899|NCT00985504|101709933|FG000|Optimization Period|Protocol Violation|3|||
33495900|NCT00985504|101709934|FG001|Optimization Period|Protocol Violation|1|||
33495901|NCT00985504|101709933|FG000|Optimization Period|Withdrawal by Subject|10|||
33495902|NCT00985504|101709934|FG001|Optimization Period|Withdrawal by Subject|8|||
33495903|NCT04341363|101709938|FG000|Overall Study|Adverse Event|1|||
33495904|NCT04341363|101709938|FG000|Overall Study|Withdrawal by Subject|1|||
33495905|NCT01808066|101709939|FG000|Overall Study|Withdrawal by Subject|15|||
33495906|NCT03517540|101709940|FG000|Overall Study|Protocol Violation|2|||
33495907|NCT03517540|101709941|FG001|Overall Study|Protocol Violation|0|||
33495908|NCT03517540|101709942|FG002|Overall Study|Protocol Violation|0|||
33495909|NCT03517540|101709943|FG003|Overall Study|Protocol Violation|1|||
33495910|NCT03517540|101709940|FG000|Overall Study|Adverse Event|9|||
33495911|NCT03517540|101709941|FG001|Overall Study|Adverse Event|3|||
33495912|NCT03517540|101709942|FG002|Overall Study|Adverse Event|8|||
33495913|NCT03517540|101709943|FG003|Overall Study|Adverse Event|1|||
33495914|NCT03517540|101709940|FG000|Overall Study|Withdrawal by Subject|3|||
33495915|NCT03517540|101709941|FG001|Overall Study|Withdrawal by Subject|4|||
33495916|NCT03517540|101709942|FG002|Overall Study|Withdrawal by Subject|1|||
33495917|NCT03517540|101709943|FG003|Overall Study|Withdrawal by Subject|3|||
33495918|NCT01052480|101709944|FG000|Overall Study|Lost to Follow-up|3|||
33495919|NCT01052480|101709945|FG001|Overall Study|Lost to Follow-up|3|||
33495920|NCT01052480|101709944|FG000|Overall Study|Protocol Violation|1|||
33495921|NCT01052480|101709945|FG001|Overall Study|Protocol Violation|0|||
33495922|NCT01052480|101709944|FG000|Overall Study|Withdrawal by Subject|3|||
33495923|NCT01052480|101709945|FG001|Overall Study|Withdrawal by Subject|7|||
33495924|NCT01052480|101709944|FG000|Overall Study|Physician Decision|0|||
33495925|NCT01052480|101709945|FG001|Overall Study|Physician Decision|2|||
33495926|NCT01052480|101709944|FG000|Overall Study|Death|1|||
33495927|NCT01052480|101709945|FG001|Overall Study|Death|5|||
33495928|NCT04982575|101709947|FG000|Overall Study|Withdrawal by Subject|2|||
33495929|NCT04982575|101709948|FG001|Overall Study|Withdrawal by Subject|0|||
33495930|NCT04982575|101709949|FG002|Overall Study|Withdrawal by Subject|2|||
33495931|NCT04390113|101709952|FG000|Overall Study|Not Treated|0|||
33495932|NCT04390113|101709953|FG001|Overall Study|Not Treated|1|||
33495933|NCT04390113|101709952|FG000|Overall Study|Adverse Event|1|||
33495934|NCT04390113|101709953|FG001|Overall Study|Adverse Event|0|||
33495935|NCT04390113|101709952|FG000|Overall Study|Death|2|||
33495936|NCT04390113|101709953|FG001|Overall Study|Death|1|||
33495937|NCT04390113|101709952|FG000|Overall Study|Physician Decision|1|||
33495938|NCT04390113|101709953|FG001|Overall Study|Physician Decision|3|||
33495939|NCT04390113|101709952|FG000|Overall Study|Study Terminated by Sponsor|5|||
33495940|NCT04390113|101709953|FG001|Overall Study|Study Terminated by Sponsor|3|||
33495941|NCT04390113|101709952|FG000|Overall Study|Withdrawal by Subject|10|||
33495942|NCT04390113|101709953|FG001|Overall Study|Withdrawal by Subject|5|||
33495943|NCT04390113|101709952|FG000|Overall Study|Other|1|||
33495944|NCT04390113|101709953|FG001|Overall Study|Other|0|||
33495945|NCT04390113|101709952|FG000|Overall Study|Missing|0|||
33495946|NCT04390113|101709953|FG001|Overall Study|Missing|1|||
33495947|NCT00765102|101709954|FG000|Overall Study|Progressive disease|18|||
33495948|NCT00765102|101709954|FG000|Overall Study|Adverse Event|6|||
33495949|NCT00765102|101709954|FG000|Overall Study|Physician Decision|4|||
33495950|NCT00765102|101709954|FG000|Overall Study|Withdrawal by Subject|2|||
33495951|NCT00765102|101709954|FG000|Overall Study|Protocol Violation|1|||
33495952|NCT03989102|101709955|FG000|Year 1|Withdrawal by Subject|6|||
33495953|NCT03989102|101709956|FG001|Year 1|Withdrawal by Subject|2|||
33495954|NCT03989102|101709957|FG002|Year 1|Withdrawal by Subject|7|||
33495955|NCT03989102|101709955|FG000|Year 1|Lost to Follow-up|5|||
33495956|NCT03989102|101709956|FG001|Year 1|Lost to Follow-up|2|||
33495957|NCT03989102|101709957|FG002|Year 1|Lost to Follow-up|5|||
33495958|NCT03989102|101709955|FG000|Year 1|Subject met withdrawal criteria|1|||
33495959|NCT03989102|101709956|FG001|Year 1|Subject met withdrawal criteria|0|||
33495960|NCT03989102|101709957|FG002|Year 1|Subject met withdrawal criteria|1|||
33495961|NCT03989102|101709955|FG000|Year 2|Lost to Follow-up|7|||
33495962|NCT03989102|101709956|FG001|Year 2|Lost to Follow-up|3|||
33495963|NCT03989102|101709957|FG002|Year 2|Lost to Follow-up|4|||
33495964|NCT03989102|101709955|FG000|Year 2|Withdrawal by Subject|3|||
33495965|NCT03989102|101709956|FG001|Year 2|Withdrawal by Subject|1|||
33495966|NCT03989102|101709957|FG002|Year 2|Withdrawal by Subject|2|||
33495967|NCT03989102|101709955|FG000|Year 2|Subject non-compliant|3|||
33495968|NCT03989102|101709956|FG001|Year 2|Subject non-compliant|2|||
33495969|NCT03989102|101709957|FG002|Year 2|Subject non-compliant|0|||
33495970|NCT03989102|101709955|FG000|Year 2|Travel|1|||
33495971|NCT03989102|101709956|FG001|Year 2|Travel|0|||
33495972|NCT03989102|101709957|FG002|Year 2|Travel|1|||
33495973|NCT03989102|101709955|FG000|Year 2|P16 missing|4|||
33495974|NCT03989102|101709956|FG001|Year 2|P16 missing|2|||
33495975|NCT03989102|101709957|FG002|Year 2|P16 missing|1|||
33495976|NCT03989102|101709955|FG000|Year 2|P11 missing|1|||
33495977|NCT03989102|101709956|FG001|Year 2|P11 missing|3|||
33495978|NCT03989102|101709957|FG002|Year 2|P11 missing|7|||
33495979|NCT03989102|101709955|FG000|Year 2|Definitive displacement outside the study site|0|||
33495980|NCT03989102|101709956|FG001|Year 2|Definitive displacement outside the study site|1|||
33495981|NCT03989102|101709957|FG002|Year 2|Definitive displacement outside the study site|0|||
33495982|NCT03989102|101709955|FG000|Year 2|Subject missed last study visit|0|||
33495983|NCT03989102|101709956|FG001|Year 2|Subject missed last study visit|1|||
33495984|NCT03989102|101709957|FG002|Year 2|Subject missed last study visit|0|||
33495985|NCT03989102|101709955|FG000|Year 2|Death|0|||
33495986|NCT03989102|101709956|FG001|Year 2|Death|1|||
33495987|NCT03989102|101709957|FG002|Year 2|Death|0|||
33495988|NCT03989102|101709955|FG000|Year 2|Subject not reachable|0|||
33495989|NCT03989102|101709956|FG001|Year 2|Subject not reachable|0|||
33495990|NCT03989102|101709957|FG002|Year 2|Subject not reachable|1|||
33495991|NCT03989102|101709955|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
33495992|NCT03989102|101709956|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
33495993|NCT03989102|101709957|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
33495994|NCT03989102|101709955|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
33495995|NCT03989102|101709956|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
33495996|NCT03989102|101709957|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
33495997|NCT03989102|101709955|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
33495998|NCT03989102|101709956|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
33495999|NCT03989102|101709957|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
33496000|NCT03989102|101709955|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
33496001|NCT03989102|101709956|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
33496002|NCT03989102|101709957|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
33496003|NCT03989102|101709955|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
33496004|NCT03989102|101709956|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
33496005|NCT03989102|101709957|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
33496006|NCT03989102|101709955|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
33496007|NCT03989102|101709956|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
33496008|NCT03989102|101709957|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
33496009|NCT00884117|101709960|FG000|Overall Study|Adverse Event|2|||
33496010|NCT00884117|101709960|FG000|Overall Study|Withdrawal by Subject|89|||
33496011|NCT00884117|101709960|FG000|Overall Study|Death|3|||
33496012|NCT00884117|101709960|FG000|Overall Study|Lost to Follow-up|143|||
33496013|NCT00884117|101709960|FG000|Overall Study|Other|12|||
33496014|NCT02741076|101709969|FG000|Overall Study|Adverse Event|0|||
33496015|NCT02741076|101709970|FG001|Overall Study|Adverse Event|1|||
33496016|NCT02741076|101709971|FG002|Overall Study|Adverse Event|1|||
33496017|NCT02741076|101709972|FG003|Overall Study|Adverse Event|0|||
33496018|NCT02741076|101709969|FG000|Overall Study|Lack of Efficacy|1|||
33496019|NCT02741076|101709970|FG001|Overall Study|Lack of Efficacy|0|||
33496020|NCT02741076|101709971|FG002|Overall Study|Lack of Efficacy|0|||
33496021|NCT02741076|101709972|FG003|Overall Study|Lack of Efficacy|0|||
33496022|NCT02741076|101709969|FG000|Overall Study|Withdrawal by Subject|0|||
33496023|NCT02741076|101709970|FG001|Overall Study|Withdrawal by Subject|1|||
33496024|NCT02741076|101709971|FG002|Overall Study|Withdrawal by Subject|0|||
33496025|NCT02741076|101709972|FG003|Overall Study|Withdrawal by Subject|0|||
33496026|NCT02741076|101709969|FG000|Overall Study|Sponsor Request|2|||
33496027|NCT02741076|101709970|FG001|Overall Study|Sponsor Request|3|||
33496028|NCT02741076|101709971|FG002|Overall Study|Sponsor Request|0|||
33496029|NCT02741076|101709972|FG003|Overall Study|Sponsor Request|1|||
33496030|NCT02741076|101709969|FG000|Overall Study|No additional information available|0|||
33496031|NCT02741076|101709970|FG001|Overall Study|No additional information available|0|||
33496032|NCT02741076|101709971|FG002|Overall Study|No additional information available|1|||
33496033|NCT02741076|101709972|FG003|Overall Study|No additional information available|1|||
33496034|NCT01037218|101709975|FG000|Overall Study|Adverse Event|4|||
33496035|NCT01037218|101709976|FG001|Overall Study|Adverse Event|2|||
33496036|NCT01037218|101709977|FG002|Overall Study|Adverse Event|2|||
33496037|NCT01037218|101709978|FG003|Overall Study|Adverse Event|1|||
33496038|NCT01037218|101709975|FG000|Overall Study|Lack of Efficacy|0|||
33496039|NCT01037218|101709976|FG001|Overall Study|Lack of Efficacy|2|||
33496040|NCT01037218|101709977|FG002|Overall Study|Lack of Efficacy|1|||
33496041|NCT01037218|101709978|FG003|Overall Study|Lack of Efficacy|5|||
33496042|NCT01037218|101709975|FG000|Overall Study|Lost to Follow-up|3|||
33496043|NCT01037218|101709976|FG001|Overall Study|Lost to Follow-up|5|||
33496044|NCT01037218|101709977|FG002|Overall Study|Lost to Follow-up|4|||
33496045|NCT01037218|101709978|FG003|Overall Study|Lost to Follow-up|2|||
33496046|NCT01037218|101709975|FG000|Overall Study|Withdrawal by Subject|6|||
33496047|NCT01037218|101709976|FG001|Overall Study|Withdrawal by Subject|7|||
33496048|NCT01037218|101709977|FG002|Overall Study|Withdrawal by Subject|7|||
33496049|NCT01037218|101709978|FG003|Overall Study|Withdrawal by Subject|4|||
33496050|NCT01037218|101709975|FG000|Overall Study|Partner Withdrew Consent|0|||
33496051|NCT01037218|101709976|FG001|Overall Study|Partner Withdrew Consent|3|||
33496052|NCT01037218|101709977|FG002|Overall Study|Partner Withdrew Consent|2|||
33496053|NCT01037218|101709978|FG003|Overall Study|Partner Withdrew Consent|1|||
33496054|NCT01037218|101709975|FG000|Overall Study|Protocol Violation|0|||
33496055|NCT01037218|101709976|FG001|Overall Study|Protocol Violation|0|||
33496056|NCT01037218|101709977|FG002|Overall Study|Protocol Violation|2|||
33496057|NCT01037218|101709978|FG003|Overall Study|Protocol Violation|2|||
33496058|NCT01037218|101709975|FG000|Overall Study|Various|3|||
33496059|NCT01037218|101709976|FG001|Overall Study|Various|2|||
33496060|NCT01037218|101709977|FG002|Overall Study|Various|3|||
33496061|NCT01037218|101709978|FG003|Overall Study|Various|1|||
33496062|NCT01836471|101709986|FG000|Overall Study|Pregnancy|1|||
33496063|NCT01836471|101709987|FG001|Overall Study|Pregnancy|0|||
33496064|NCT01836471|101709988|FG002|Overall Study|Pregnancy|0|||
33496065|NCT01836471|101709989|FG003|Overall Study|Pregnancy|0|||
33496066|NCT01836471|101709990|FG004|Overall Study|Pregnancy|0|||
33496067|NCT01836471|101709986|FG000|Overall Study|Withdrawal by Subject|3|||
33496068|NCT01836471|101709987|FG001|Overall Study|Withdrawal by Subject|4|||
33496069|NCT01836471|101709988|FG002|Overall Study|Withdrawal by Subject|1|||
33496070|NCT01836471|101709989|FG003|Overall Study|Withdrawal by Subject|0|||
33496071|NCT01836471|101709990|FG004|Overall Study|Withdrawal by Subject|2|||
33496072|NCT01836471|101709986|FG000|Overall Study|Physician Decision|0|||
33496073|NCT01836471|101709987|FG001|Overall Study|Physician Decision|1|||
33496074|NCT01836471|101709988|FG002|Overall Study|Physician Decision|0|||
33496075|NCT01836471|101709989|FG003|Overall Study|Physician Decision|0|||
33496076|NCT01836471|101709990|FG004|Overall Study|Physician Decision|0|||
33496077|NCT01836471|101709986|FG000|Overall Study|Lost to Follow-up|0|||
33496078|NCT01836471|101709987|FG001|Overall Study|Lost to Follow-up|0|||
33496079|NCT01836471|101709988|FG002|Overall Study|Lost to Follow-up|0|||
33496080|NCT01836471|101709989|FG003|Overall Study|Lost to Follow-up|1|||
33595347|NCT03334851|102069679|FG009|Overall Study|Adverse Event|0|||
33595348|NCT03334851|102069680|FG010|Overall Study|Adverse Event|0|||
33595349|NCT03334851|102069681|FG011|Overall Study|Adverse Event|0|||
33595350|NCT03334851|102069682|FG012|Overall Study|Adverse Event|0|||
33496081|NCT01836471|101709990|FG004|Overall Study|Lost to Follow-up|1|||
33496082|NCT01836471|101709986|FG000|Overall Study|Adverse Event|6|||
33496083|NCT01836471|101709987|FG001|Overall Study|Adverse Event|3|||
33496084|NCT01836471|101709988|FG002|Overall Study|Adverse Event|1|||
33496085|NCT01836471|101709989|FG003|Overall Study|Adverse Event|1|||
33496086|NCT01836471|101709990|FG004|Overall Study|Adverse Event|2|||
33496087|NCT01836471|101709986|FG000|Overall Study|Non compliance with tx|1|||
33496088|NCT01836471|101709987|FG001|Overall Study|Non compliance with tx|1|||
33496089|NCT01836471|101709988|FG002|Overall Study|Non compliance with tx|0|||
33496090|NCT01836471|101709989|FG003|Overall Study|Non compliance with tx|0|||
33496091|NCT01836471|101709990|FG004|Overall Study|Non compliance with tx|0|||
33496092|NCT02288325|101709991|FG000|Run-in Period|Adverse Event|48|||
33496093|NCT02288325|101709992|FG001|Run-in Period|Adverse Event|0|||
33496094|NCT02288325|101709993|FG002|Run-in Period|Adverse Event|0|||
33496095|NCT02288325|101709991|FG000|Run-in Period|Lack of Efficacy|16|||
33496096|NCT02288325|101709992|FG001|Run-in Period|Lack of Efficacy|0|||
33496097|NCT02288325|101709993|FG002|Run-in Period|Lack of Efficacy|0|||
33496098|NCT02288325|101709991|FG000|Run-in Period|Withdrawal of Consent|28|||
33496099|NCT02288325|101709992|FG001|Run-in Period|Withdrawal of Consent|0|||
33496100|NCT02288325|101709993|FG002|Run-in Period|Withdrawal of Consent|0|||
33496101|NCT02288325|101709991|FG000|Run-in Period|Lost to Follow-up|25|||
33496102|NCT02288325|101709992|FG001|Run-in Period|Lost to Follow-up|0|||
33496103|NCT02288325|101709993|FG002|Run-in Period|Lost to Follow-up|0|||
33496104|NCT02288325|101709991|FG000|Run-in Period|Protocol Violation|17|||
33496105|NCT02288325|101709992|FG001|Run-in Period|Protocol Violation|0|||
33496106|NCT02288325|101709993|FG002|Run-in Period|Protocol Violation|0|||
33496107|NCT02288325|101709991|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
33496108|NCT02288325|101709992|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
33496109|NCT02288325|101709993|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
33496110|NCT02288325|101709991|FG000|Run-in Period|Reason not Specified|8|||
33496111|NCT02288325|101709992|FG001|Run-in Period|Reason not Specified|0|||
33496112|NCT02288325|101709993|FG002|Run-in Period|Reason not Specified|0|||
33496113|NCT02288325|101709991|FG000|Stabilization Period|Adverse Event|13|||
33496114|NCT02288325|101709992|FG001|Stabilization Period|Adverse Event|0|||
33496115|NCT02288325|101709993|FG002|Stabilization Period|Adverse Event|0|||
33496116|NCT02288325|101709991|FG000|Stabilization Period|Lack of Efficacy|22|||
33496117|NCT02288325|101709992|FG001|Stabilization Period|Lack of Efficacy|0|||
33496118|NCT02288325|101709993|FG002|Stabilization Period|Lack of Efficacy|0|||
33496119|NCT02288325|101709991|FG000|Stabilization Period|Withdrawal of Consent|23|||
33496120|NCT02288325|101709992|FG001|Stabilization Period|Withdrawal of Consent|0|||
33496121|NCT02288325|101709993|FG002|Stabilization Period|Withdrawal of Consent|0|||
33496122|NCT02288325|101709991|FG000|Stabilization Period|Lost to Follow-up|12|||
33496123|NCT02288325|101709992|FG001|Stabilization Period|Lost to Follow-up|0|||
33496124|NCT02288325|101709993|FG002|Stabilization Period|Lost to Follow-up|0|||
33496125|NCT02288325|101709991|FG000|Stabilization Period|Protocol Violation|8|||
33496126|NCT02288325|101709992|FG001|Stabilization Period|Protocol Violation|0|||
33496127|NCT02288325|101709993|FG002|Stabilization Period|Protocol Violation|0|||
33496128|NCT02288325|101709991|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
33496129|NCT02288325|101709992|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
33496130|NCT02288325|101709993|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
33496131|NCT02288325|101709991|FG000|Stabilization Period|Reason not Specified|15|||
33496132|NCT02288325|101709992|FG001|Stabilization Period|Reason not Specified|0|||
33496133|NCT02288325|101709993|FG002|Stabilization Period|Reason not Specified|0|||
33496134|NCT02288325|101709991|FG000|Double-blind Treatment Period|Adverse Event|0|||
33496135|NCT02288325|101709992|FG001|Double-blind Treatment Period|Adverse Event|2|||
33496136|NCT02288325|101709993|FG002|Double-blind Treatment Period|Adverse Event|5|||
33496137|NCT02288325|101709991|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
33496138|NCT02288325|101709992|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
33496139|NCT02288325|101709993|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
33496140|NCT02288325|101709991|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
33496141|NCT02288325|101709992|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
33496142|NCT02288325|101709993|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
33496143|NCT02288325|101709991|FG000|Double-blind Treatment Period|Protocol Violation|0|||
33496144|NCT02288325|101709992|FG001|Double-blind Treatment Period|Protocol Violation|1|||
33496145|NCT02288325|101709993|FG002|Double-blind Treatment Period|Protocol Violation|2|||
33496146|NCT02288325|101709991|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
33496147|NCT02288325|101709992|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
33496148|NCT02288325|101709993|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
33496149|NCT02288325|101709991|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
33496150|NCT02288325|101709992|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
33496151|NCT02288325|101709993|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
33496152|NCT01960257|101709994|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
33496153|NCT01960257|101709995|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
33496154|NCT01960257|101709996|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
33496155|NCT01960257|101709994|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
33496156|NCT01960257|101709995|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
33496157|NCT01960257|101709996|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
33496158|NCT01960257|101709994|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
33496159|NCT01960257|101709995|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
33496160|NCT01960257|101709996|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
33496161|NCT03164551|101709997|FG000|Overall Study|Imaging discontinued prior completion|8|||
33496162|NCT03164551|101709998|FG001|Overall Study|Imaging discontinued prior completion|0|||
33496163|NCT03164551|101709997|FG000|Overall Study|Participant was non-compliant|1|||
33496164|NCT03164551|101709998|FG001|Overall Study|Participant was non-compliant|0|||
33496165|NCT03164551|101709997|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
33496166|NCT03164551|101709998|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
33496167|NCT03164551|101709997|FG000|Overall Study|Other|8|||
33496168|NCT03164551|101709998|FG001|Overall Study|Other|2|||
33496169|NCT02069015|101709999|FG000|Overall Study|Lost to Follow-up|39|||
33496170|NCT02069015|101710000|FG001|Overall Study|Lost to Follow-up|32|||
33496171|NCT02069015|101709999|FG000|Overall Study|Withdrawal by Subject|1|||
33496172|NCT02069015|101710000|FG001|Overall Study|Withdrawal by Subject|1|||
33496173|NCT02832687|101710001|FG000|Overall Study|Adverse Event|0|||
33496174|NCT02832687|101710002|FG001|Overall Study|Adverse Event|2|||
33496175|NCT03473925|101710003|FG000|Overall Study|Death|48|||
33496176|NCT03473925|101710004|FG001|Overall Study|Death|44|||
33496177|NCT03473925|101710003|FG000|Overall Study|Sponsor Decision|2|||
33496178|NCT03473925|101710004|FG001|Overall Study|Sponsor Decision|7|||
33496179|NCT03473925|101710003|FG000|Overall Study|Withdrawal by Subject|1|||
33496180|NCT03473925|101710004|FG001|Overall Study|Withdrawal by Subject|3|||
33496181|NCT03473925|101710003|FG000|Overall Study|Not Treated|1|||
33496182|NCT03473925|101710004|FG001|Overall Study|Not Treated|1|||
33496183|NCT01991743|101710005|FG000|Overall Study|external cephalic version not performed|0|||
33496184|NCT01991743|101710006|FG001|Overall Study|external cephalic version not performed|0|||
33496185|NCT01991743|101710007|FG002|Overall Study|external cephalic version not performed|1|||
33496186|NCT01991743|101710008|FG003|Overall Study|external cephalic version not performed|0|||
33496187|NCT02291510|101710009|FG000|Overall Study|Adverse Event|0|||
33496188|NCT02291510|101710010|FG001|Overall Study|Adverse Event|0|||
33496189|NCT02291510|101710011|FG002|Overall Study|Adverse Event|0|||
33496190|NCT02291510|101710012|FG003|Overall Study|Adverse Event|1|||
33496191|NCT01998919|101710015|FG000|Overall Study|Death|2|||
33496192|NCT01998919|101710016|FG001|Overall Study|Death|2|||
33496193|NCT01998919|101710015|FG000|Overall Study|Adverse Event|0|||
33496194|NCT01998919|101710016|FG001|Overall Study|Adverse Event|5|||
33496195|NCT01998919|101710015|FG000|Overall Study|Disease progression|31|||
33496196|NCT01998919|101710016|FG001|Overall Study|Disease progression|22|||
33496197|NCT01998919|101710015|FG000|Overall Study|Withdrawal by Subject|2|||
33496198|NCT01998919|101710016|FG001|Overall Study|Withdrawal by Subject|4|||
33496199|NCT01998919|101710015|FG000|Overall Study|Lost to Follow-up|2|||
33496200|NCT01998919|101710016|FG001|Overall Study|Lost to Follow-up|0|||
33496201|NCT01998919|101710015|FG000|Overall Study|Other|5|||
33496202|NCT01998919|101710016|FG001|Overall Study|Other|2|||
33496203|NCT01486446|101710019|FG000|Overall Study|Adverse Event|1|||
33496204|NCT01486446|101710020|FG001|Overall Study|Adverse Event|0|||
33496205|NCT04231825|101710033|FG000|Overall Study|Protocol Violation|3|||
33496206|NCT04231825|101710034|FG001|Overall Study|Protocol Violation|3|||
33496207|NCT04231825|101710033|FG000|Overall Study|Lost to Follow-up|0|||
33496208|NCT04231825|101710034|FG001|Overall Study|Lost to Follow-up|1|||
33496209|NCT00725283|101710038|FG000|Overall Study|Missing Code|3|||
33496210|NCT00725283|101710038|FG000|Overall Study|Death|5|||
33496211|NCT00725283|101710038|FG000|Overall Study|Other|6|||
33496212|NCT00725283|101710038|FG000|Overall Study|Withdrawal by Subject|10|||
33496213|NCT00707239|101710039|FG000|Overall Study|Adverse Event|5|||
33496214|NCT00707239|101710040|FG001|Overall Study|Adverse Event|3|||
33496215|NCT00707239|101710041|FG002|Overall Study|Adverse Event|2|||
33496216|NCT00707239|101710039|FG000|Overall Study|Death|3|||
33496217|NCT00707239|101710040|FG001|Overall Study|Death|1|||
33496218|NCT00707239|101710041|FG002|Overall Study|Death|3|||
33496219|NCT00707239|101710039|FG000|Overall Study|Physician Decision|1|||
33496220|NCT00707239|101710040|FG001|Overall Study|Physician Decision|1|||
33496221|NCT00707239|101710041|FG002|Overall Study|Physician Decision|2|||
33595351|NCT03334851|102069670|FG000|Overall Study|Withdrawal by Subject|0|||
33595352|NCT03334851|102069671|FG001|Overall Study|Withdrawal by Subject|0|||
33496222|NCT00707239|101710039|FG000|Overall Study|Protocol Violation|0|||
33496223|NCT00707239|101710040|FG001|Overall Study|Protocol Violation|0|||
33496224|NCT00707239|101710041|FG002|Overall Study|Protocol Violation|1|||
33496225|NCT00707239|101710039|FG000|Overall Study|Lack of Efficacy|1|||
33496226|NCT00707239|101710040|FG001|Overall Study|Lack of Efficacy|2|||
33496227|NCT00707239|101710041|FG002|Overall Study|Lack of Efficacy|0|||
33496228|NCT00707239|101710039|FG000|Overall Study|Randomized, but not treated|1|||
33496229|NCT00707239|101710040|FG001|Overall Study|Randomized, but not treated|1|||
33496230|NCT00707239|101710041|FG002|Overall Study|Randomized, but not treated|1|||
33496231|NCT00707239|101710039|FG000|Overall Study|Other|8|||
33496232|NCT00707239|101710040|FG001|Overall Study|Other|3|||
33496233|NCT00707239|101710041|FG002|Overall Study|Other|5|||
33496234|NCT02013817|101710042|FG000|Overall Study|Adverse Event|12|||
33595353|NCT03334851|102069672|FG002|Overall Study|Withdrawal by Subject|0|||
33595354|NCT03334851|102069673|FG003|Overall Study|Withdrawal by Subject|0|||
33595355|NCT03334851|102069674|FG004|Overall Study|Withdrawal by Subject|0|||
33595356|NCT03334851|102069675|FG005|Overall Study|Withdrawal by Subject|0|||
33595357|NCT03334851|102069676|FG006|Overall Study|Withdrawal by Subject|0|||
33595358|NCT03334851|102069677|FG007|Overall Study|Withdrawal by Subject|0|||
33595359|NCT03334851|102069678|FG008|Overall Study|Withdrawal by Subject|0|||
33595360|NCT03334851|102069679|FG009|Overall Study|Withdrawal by Subject|0|||
33595361|NCT03334851|102069680|FG010|Overall Study|Withdrawal by Subject|1|||
33595362|NCT03334851|102069681|FG011|Overall Study|Withdrawal by Subject|0|||
33595363|NCT03334851|102069682|FG012|Overall Study|Withdrawal by Subject|1|||
33595364|NCT03334851|102069670|FG000|Overall Study|Lost to Follow-up|0|||
33595365|NCT03334851|102069671|FG001|Overall Study|Lost to Follow-up|0|||
33595366|NCT03334851|102069672|FG002|Overall Study|Lost to Follow-up|0|||
33595367|NCT03334851|102069673|FG003|Overall Study|Lost to Follow-up|0|||
33595368|NCT03334851|102069674|FG004|Overall Study|Lost to Follow-up|0|||
33595369|NCT03334851|102069675|FG005|Overall Study|Lost to Follow-up|0|||
33595370|NCT03334851|102069676|FG006|Overall Study|Lost to Follow-up|0|||
33595371|NCT03334851|102069677|FG007|Overall Study|Lost to Follow-up|0|||
33595372|NCT03334851|102069678|FG008|Overall Study|Lost to Follow-up|0|||
33595373|NCT03334851|102069679|FG009|Overall Study|Lost to Follow-up|0|||
33595374|NCT03334851|102069680|FG010|Overall Study|Lost to Follow-up|2|||
33595375|NCT03334851|102069681|FG011|Overall Study|Lost to Follow-up|1|||
33595376|NCT03334851|102069682|FG012|Overall Study|Lost to Follow-up|0|||
33595377|NCT01456195|102069683|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
33595378|NCT01456195|102069684|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
33595379|NCT01456195|102069685|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
33595380|NCT01456195|102069683|FG000|Overall Study|Lost to Follow-up|3|||
33595381|NCT01456195|102069684|FG001|Overall Study|Lost to Follow-up|1|||
33595382|NCT01456195|102069685|FG002|Overall Study|Lost to Follow-up|3|||
33595383|NCT01456195|102069683|FG000|Overall Study|Voluntary Withdrawal|5|||
33595384|NCT01456195|102069684|FG001|Overall Study|Voluntary Withdrawal|3|||
33595385|NCT01456195|102069685|FG002|Overall Study|Voluntary Withdrawal|7|||
33595386|NCT01456195|102069683|FG000|Overall Study|Lack of Efficacy|0|||
33595387|NCT01456195|102069684|FG001|Overall Study|Lack of Efficacy|1|||
33595388|NCT01456195|102069685|FG002|Overall Study|Lack of Efficacy|0|||
33595389|NCT01456195|102069683|FG000|Overall Study|Other Reasons|2|||
33595390|NCT01456195|102069684|FG001|Overall Study|Other Reasons|1|||
33595391|NCT01456195|102069685|FG002|Overall Study|Other Reasons|3|||
33595392|NCT01062841|102069688|FG000|Overall Study|Indwelling Device Removed|41|||
33595393|NCT01062841|102069689|FG001|Overall Study|Indwelling Device Removed|48|||
33595394|NCT01062841|102069688|FG000|Overall Study|Death|3|||
33595395|NCT01062841|102069689|FG001|Overall Study|Death|5|||
33595396|NCT01062841|102069688|FG000|Overall Study|Withdrawal by Subject|2|||
33595397|NCT01062841|102069689|FG001|Overall Study|Withdrawal by Subject|0|||
33595398|NCT01062841|102069688|FG000|Overall Study|Withdrawal by Study|3|||
33595399|NCT01062841|102069689|FG001|Overall Study|Withdrawal by Study|0|||
33595400|NCT04753658|102069692|FG000|Overall Study|Progressive disease|7|||
33595401|NCT04753658|102069692|FG000|Overall Study|Other|7|||
33595402|NCT04753658|102069692|FG000|Overall Study|Adverse Event|1|||
33595403|NCT02136680|102069694|FG000|Overall Study|No Longer Interested|1|||
33595404|NCT02136680|102069695|FG001|Overall Study|No Longer Interested|1|||
33595405|NCT02136680|102069694|FG000|Overall Study|No longer receiving care at clinic|3|||
33595406|NCT02136680|102069695|FG001|Overall Study|No longer receiving care at clinic|5|||
33595407|NCT02136680|102069694|FG000|Overall Study|Moved away|5|||
33595408|NCT02136680|102069695|FG001|Overall Study|Moved away|4|||
33595409|NCT02136680|102069694|FG000|Overall Study|Unable to schedule|17|||
33595410|NCT02136680|102069695|FG001|Overall Study|Unable to schedule|16|||
33595411|NCT02136680|102069694|FG000|Overall Study|Study ended before interview due|6|||
33595412|NCT02136680|102069695|FG001|Overall Study|Study ended before interview due|3|||
33595413|NCT03305419|102069718|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
33595414|NCT03305419|102069719|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
33595415|NCT03305419|102069720|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
33595416|NCT03305419|102069721|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
33595417|NCT03305419|102069722|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
33595418|NCT03305419|102069723|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
33595419|NCT03305419|102069724|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
33595420|NCT03305419|102069725|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
33595421|NCT03305419|102069718|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
33595422|NCT03305419|102069719|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
33595423|NCT03305419|102069720|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
33595424|NCT03305419|102069721|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
33595425|NCT03305419|102069722|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
33595426|NCT03305419|102069723|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
33595427|NCT03305419|102069724|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
33595428|NCT03305419|102069725|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
33595429|NCT03305419|102069718|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
33595430|NCT03305419|102069719|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
33595431|NCT03305419|102069720|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
33595432|NCT03305419|102069721|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
33595433|NCT03305419|102069722|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
33595434|NCT03305419|102069723|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
33595435|NCT03305419|102069724|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
33595436|NCT03305419|102069725|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
33595437|NCT03305419|102069718|FG000|Part B (14 Days)|Adverse Event|0|||
33595438|NCT03305419|102069719|FG001|Part B (14 Days)|Adverse Event|0|||
33595439|NCT03305419|102069720|FG002|Part B (14 Days)|Adverse Event|0|||
33595440|NCT03305419|102069721|FG003|Part B (14 Days)|Adverse Event|0|||
33595441|NCT03305419|102069722|FG004|Part B (14 Days)|Adverse Event|1|||
33595442|NCT03305419|102069723|FG005|Part B (14 Days)|Adverse Event|2|||
33595443|NCT03305419|102069724|FG006|Part B (14 Days)|Adverse Event|4|||
33595444|NCT03305419|102069725|FG007|Part B (14 Days)|Adverse Event|0|||
33595445|NCT03305419|102069718|FG000|Part B (14 Days)|Physician Decision|0|||
33595446|NCT03305419|102069719|FG001|Part B (14 Days)|Physician Decision|0|||
33595447|NCT03305419|102069720|FG002|Part B (14 Days)|Physician Decision|0|||
33595448|NCT03305419|102069721|FG003|Part B (14 Days)|Physician Decision|0|||
33595449|NCT03305419|102069722|FG004|Part B (14 Days)|Physician Decision|2|||
33595450|NCT03305419|102069723|FG005|Part B (14 Days)|Physician Decision|8|||
33595451|NCT03305419|102069724|FG006|Part B (14 Days)|Physician Decision|1|||
33595452|NCT03305419|102069725|FG007|Part B (14 Days)|Physician Decision|0|||
33595453|NCT02358031|102069726|FG000|Overall Study|Death|253|||
33595454|NCT02358031|102069727|FG001|Overall Study|Death|237|||
33595455|NCT02358031|102069728|FG002|Overall Study|Death|266|||
33595456|NCT02358031|102069726|FG000|Overall Study|Lost to Follow-up|1|||
33595457|NCT02358031|102069727|FG001|Overall Study|Lost to Follow-up|1|||
33595458|NCT02358031|102069728|FG002|Overall Study|Lost to Follow-up|0|||
33595459|NCT02358031|102069726|FG000|Overall Study|Withdrawal by Subject|19|||
33595460|NCT02358031|102069727|FG001|Overall Study|Withdrawal by Subject|14|||
33595461|NCT02358031|102069728|FG002|Overall Study|Withdrawal by Subject|18|||
33595462|NCT02358031|102069726|FG000|Overall Study|Sponsor Decision|26|||
33595463|NCT02358031|102069727|FG001|Overall Study|Sponsor Decision|28|||
33595464|NCT02358031|102069728|FG002|Overall Study|Sponsor Decision|16|||
33595465|NCT03349645|102069734|FG000|Overall Study|Sponsor Terminated Study|75|||
33595466|NCT03349645|102069734|FG000|Overall Study|Withdrawal by Subject|4|||
33595467|NCT03349645|102069734|FG000|Overall Study|Protocol Violation|1|||
33595468|NCT03349645|102069734|FG000|Overall Study|Other|2|||
33595469|NCT04979897|102069735|FG000|Overall Study|Death|1|||
33595470|NCT04979897|102069736|FG001|Overall Study|Death|8|||
33595471|NCT04979897|102069735|FG000|Overall Study|Lost to Follow-up|111|||
33595472|NCT04979897|102069736|FG001|Overall Study|Lost to Follow-up|56|||
33595473|NCT04979897|102069735|FG000|Overall Study|Withdrawal by Subject|7|||
33595474|NCT04979897|102069736|FG001|Overall Study|Withdrawal by Subject|2|||
33595475|NCT03272828|102069743|FG000|Overall Study|Lost to Follow-up|7|||
33595476|NCT03272828|102069744|FG001|Overall Study|Lost to Follow-up|7|||
33595477|NCT03272828|102069743|FG000|Overall Study|Withdrawal by Subject|2|||
33595478|NCT03272828|102069744|FG001|Overall Study|Withdrawal by Subject|0|||
33595479|NCT03272828|102069743|FG000|Overall Study|Deceased|1|||
33595480|NCT03272828|102069744|FG001|Overall Study|Deceased|1|||
33595481|NCT03272828|102069743|FG000|Overall Study|Failed implant|1|||
33595482|NCT03272828|102069744|FG001|Overall Study|Failed implant|2|||
33595483|NCT02927925|102069745|FG000|Overall Study|Death|16|||
33595484|NCT02927925|102069745|FG000|Overall Study|Physician Decision|1|||
33595485|NCT02927925|102069745|FG000|Overall Study|Withdrawal by Subject|11|||
33595486|NCT02927925|102069745|FG000|Overall Study|Other|3|||
33595487|NCT02927925|102069745|FG000|Overall Study|Disease progression at clinical cutoff|1|||
33595488|NCT01071200|102069746|FG000|Overall Study|Lack of ovarian response|1|||
33595489|NCT01071200|102069747|FG001|Overall Study|Lack of ovarian response|1|||
33595490|NCT01071200|102069746|FG000|Overall Study|No fertilization|4|||
33595491|NCT01071200|102069747|FG001|Overall Study|No fertilization|0|||
33595492|NCT01071200|102069746|FG000|Overall Study|No oocytes retrieved|1|||
33595493|NCT01071200|102069747|FG001|Overall Study|No oocytes retrieved|1|||
33595494|NCT01071200|102069746|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
33595495|NCT01071200|102069747|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
33595496|NCT01071200|102069746|FG000|Overall Study|No viable embryos|0|||
33595497|NCT01071200|102069747|FG001|Overall Study|No viable embryos|1|||
33595498|NCT02279719|102069753|FG000|Overall Study|Patients randomized but never treated|0|||
33595499|NCT02279719|102069754|FG001|Overall Study|Patients randomized but never treated|0|||
33595500|NCT02279719|102069755|FG002|Overall Study|Patients randomized but never treated|0|||
33595501|NCT02279719|102069756|FG003|Overall Study|Patients randomized but never treated|0|||
33595502|NCT02279719|102069757|FG004|Overall Study|Patients randomized but never treated|3|||
33595503|NCT02279719|102069758|FG005|Overall Study|Patients randomized but never treated|0|||
33595504|NCT02279719|102069759|FG006|Overall Study|Patients randomized but never treated|3|||
33595505|NCT01089023|102069766|FG000|Overall Study|Lost to Follow-up|3|||
33595506|NCT01089023|102069766|FG000|Overall Study|Adverse Event|1|||
33595507|NCT01089023|102069766|FG000|Overall Study|Withdrawal by Subject|1|||
33595508|NCT01089023|102069766|FG000|Overall Study|Protocol Violation|1|||
33595509|NCT01089023|102069766|FG000|Overall Study|Lack of Efficacy|1|||
33595510|NCT04070326|102069769|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
33595511|NCT04070326|102069770|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
33595512|NCT02754141|102069771|FG000|Overall Study|Disease progression|11|||
33595513|NCT02754141|102069772|FG001|Overall Study|Disease progression|7|||
33595514|NCT02754141|102069773|FG002|Overall Study|Disease progression|8|||
33595515|NCT02754141|102069774|FG003|Overall Study|Disease progression|5|||
33595516|NCT02754141|102069775|FG004|Overall Study|Disease progression|7|||
33595517|NCT02754141|102069776|FG005|Overall Study|Disease progression|7|||
33595518|NCT02754141|102069777|FG006|Overall Study|Disease progression|7|||
33595519|NCT02754141|102069778|FG007|Overall Study|Disease progression|6|||
33595520|NCT02754141|102069779|FG008|Overall Study|Disease progression|11|||
33595521|NCT02754141|102069780|FG009|Overall Study|Disease progression|16|||
33595522|NCT02754141|102069781|FG010|Overall Study|Disease progression|18|||
33595523|NCT02754141|102069782|FG011|Overall Study|Disease progression|13|||
33595524|NCT02754141|102069783|FG012|Overall Study|Disease progression|10|||
33595525|NCT02754141|102069784|FG013|Overall Study|Disease progression|12|||
33595526|NCT02754141|102069785|FG014|Overall Study|Disease progression|12|||
33595527|NCT02754141|102069786|FG015|Overall Study|Disease progression|14|||
33595528|NCT02754141|102069787|FG016|Overall Study|Disease progression|0|||
33595529|NCT02754141|102069788|FG017|Overall Study|Disease progression|1|||
33595530|NCT02754141|102069771|FG000|Overall Study|Study drug toxicity|1|||
33595531|NCT02754141|102069772|FG001|Overall Study|Study drug toxicity|1|||
33595532|NCT02754141|102069773|FG002|Overall Study|Study drug toxicity|0|||
33595533|NCT02754141|102069774|FG003|Overall Study|Study drug toxicity|0|||
33595534|NCT02754141|102069775|FG004|Overall Study|Study drug toxicity|0|||
33595535|NCT02754141|102069776|FG005|Overall Study|Study drug toxicity|0|||
33595536|NCT02754141|102069777|FG006|Overall Study|Study drug toxicity|0|||
33595537|NCT02754141|102069778|FG007|Overall Study|Study drug toxicity|0|||
33595538|NCT02754141|102069779|FG008|Overall Study|Study drug toxicity|0|||
33595539|NCT02754141|102069780|FG009|Overall Study|Study drug toxicity|0|||
33595540|NCT02754141|102069781|FG010|Overall Study|Study drug toxicity|2|||
33595541|NCT02754141|102069782|FG011|Overall Study|Study drug toxicity|1|||
33595542|NCT02754141|102069783|FG012|Overall Study|Study drug toxicity|1|||
33595543|NCT02754141|102069784|FG013|Overall Study|Study drug toxicity|0|||
33595544|NCT02754141|102069785|FG014|Overall Study|Study drug toxicity|0|||
33595545|NCT02754141|102069786|FG015|Overall Study|Study drug toxicity|0|||
33595546|NCT02754141|102069787|FG016|Overall Study|Study drug toxicity|0|||
33595547|NCT02754141|102069788|FG017|Overall Study|Study drug toxicity|0|||
33595548|NCT02754141|102069771|FG000|Overall Study|AE unrelated to study drug|1|||
33595549|NCT02754141|102069772|FG001|Overall Study|AE unrelated to study drug|1|||
33595550|NCT02754141|102069773|FG002|Overall Study|AE unrelated to study drug|0|||
33595551|NCT02754141|102069774|FG003|Overall Study|AE unrelated to study drug|1|||
33595552|NCT02754141|102069775|FG004|Overall Study|AE unrelated to study drug|3|||
33595553|NCT02754141|102069776|FG005|Overall Study|AE unrelated to study drug|2|||
33595554|NCT02754141|102069777|FG006|Overall Study|AE unrelated to study drug|1|||
33595555|NCT02754141|102069778|FG007|Overall Study|AE unrelated to study drug|0|||
33595556|NCT02754141|102069779|FG008|Overall Study|AE unrelated to study drug|0|||
33595557|NCT02754141|102069780|FG009|Overall Study|AE unrelated to study drug|0|||
33595558|NCT02754141|102069781|FG010|Overall Study|AE unrelated to study drug|0|||
33595559|NCT02754141|102069782|FG011|Overall Study|AE unrelated to study drug|0|||
33595560|NCT02754141|102069783|FG012|Overall Study|AE unrelated to study drug|0|||
33595561|NCT02754141|102069784|FG013|Overall Study|AE unrelated to study drug|0|||
33595562|NCT02754141|102069785|FG014|Overall Study|AE unrelated to study drug|0|||
33595563|NCT02754141|102069786|FG015|Overall Study|AE unrelated to study drug|0|||
33595564|NCT02754141|102069787|FG016|Overall Study|AE unrelated to study drug|0|||
33595565|NCT02754141|102069788|FG017|Overall Study|AE unrelated to study drug|0|||
33595566|NCT02754141|102069771|FG000|Overall Study|Request to discontinue|0|||
33595567|NCT02754141|102069772|FG001|Overall Study|Request to discontinue|0|||
33595568|NCT02754141|102069773|FG002|Overall Study|Request to discontinue|0|||
33595569|NCT02754141|102069774|FG003|Overall Study|Request to discontinue|0|||
33595570|NCT02754141|102069775|FG004|Overall Study|Request to discontinue|0|||
33595571|NCT02754141|102069776|FG005|Overall Study|Request to discontinue|0|||
33595572|NCT02754141|102069777|FG006|Overall Study|Request to discontinue|0|||
33595573|NCT02754141|102069778|FG007|Overall Study|Request to discontinue|0|||
33595574|NCT02754141|102069779|FG008|Overall Study|Request to discontinue|1|||
33595575|NCT02754141|102069780|FG009|Overall Study|Request to discontinue|0|||
33595576|NCT02754141|102069781|FG010|Overall Study|Request to discontinue|0|||
33595577|NCT02754141|102069782|FG011|Overall Study|Request to discontinue|0|||
33595578|NCT02754141|102069783|FG012|Overall Study|Request to discontinue|0|||
33595579|NCT02754141|102069784|FG013|Overall Study|Request to discontinue|1|||
33595580|NCT02754141|102069785|FG014|Overall Study|Request to discontinue|1|||
33595581|NCT02754141|102069786|FG015|Overall Study|Request to discontinue|0|||
33595582|NCT02754141|102069787|FG016|Overall Study|Request to discontinue|0|||
33595583|NCT02754141|102069788|FG017|Overall Study|Request to discontinue|0|||
33595584|NCT02754141|102069771|FG000|Overall Study|Withdrew consent|0|||
33595585|NCT02754141|102069772|FG001|Overall Study|Withdrew consent|0|||
33595586|NCT02754141|102069773|FG002|Overall Study|Withdrew consent|0|||
33595587|NCT02754141|102069774|FG003|Overall Study|Withdrew consent|0|||
33595588|NCT02754141|102069775|FG004|Overall Study|Withdrew consent|0|||
33595589|NCT02754141|102069776|FG005|Overall Study|Withdrew consent|0|||
33595590|NCT02754141|102069777|FG006|Overall Study|Withdrew consent|0|||
33595591|NCT02754141|102069778|FG007|Overall Study|Withdrew consent|0|||
33595592|NCT02754141|102069779|FG008|Overall Study|Withdrew consent|0|||
33595593|NCT02754141|102069780|FG009|Overall Study|Withdrew consent|1|||
33595594|NCT02754141|102069781|FG010|Overall Study|Withdrew consent|0|||
33595595|NCT02754141|102069782|FG011|Overall Study|Withdrew consent|0|||
33595596|NCT02754141|102069783|FG012|Overall Study|Withdrew consent|0|||
33595597|NCT02754141|102069784|FG013|Overall Study|Withdrew consent|0|||
33595598|NCT02754141|102069785|FG014|Overall Study|Withdrew consent|0|||
33595599|NCT02754141|102069786|FG015|Overall Study|Withdrew consent|0|||
33595600|NCT02754141|102069787|FG016|Overall Study|Withdrew consent|0|||
33595601|NCT02754141|102069788|FG017|Overall Study|Withdrew consent|0|||
33595602|NCT02754141|102069771|FG000|Overall Study|Maximum clinical benefit|0|||
33595603|NCT02754141|102069772|FG001|Overall Study|Maximum clinical benefit|0|||
33595604|NCT02754141|102069773|FG002|Overall Study|Maximum clinical benefit|0|||
33595605|NCT02754141|102069774|FG003|Overall Study|Maximum clinical benefit|1|||
33595606|NCT02754141|102069775|FG004|Overall Study|Maximum clinical benefit|0|||
33595607|NCT02754141|102069776|FG005|Overall Study|Maximum clinical benefit|0|||
33595608|NCT02754141|102069777|FG006|Overall Study|Maximum clinical benefit|0|||
33595609|NCT02754141|102069778|FG007|Overall Study|Maximum clinical benefit|0|||
33595610|NCT02754141|102069779|FG008|Overall Study|Maximum clinical benefit|0|||
33595611|NCT02754141|102069780|FG009|Overall Study|Maximum clinical benefit|0|||
33595612|NCT02754141|102069781|FG010|Overall Study|Maximum clinical benefit|0|||
33595613|NCT02754141|102069782|FG011|Overall Study|Maximum clinical benefit|0|||
33595614|NCT02754141|102069783|FG012|Overall Study|Maximum clinical benefit|0|||
33595615|NCT02754141|102069784|FG013|Overall Study|Maximum clinical benefit|0|||
33595616|NCT02754141|102069785|FG014|Overall Study|Maximum clinical benefit|0|||
33595617|NCT02754141|102069786|FG015|Overall Study|Maximum clinical benefit|0|||
33595618|NCT02754141|102069787|FG016|Overall Study|Maximum clinical benefit|0|||
33595619|NCT02754141|102069788|FG017|Overall Study|Maximum clinical benefit|0|||
33595620|NCT02754141|102069771|FG000|Overall Study|No longer meets study criteria|0|||
33595621|NCT02754141|102069772|FG001|Overall Study|No longer meets study criteria|0|||
33595622|NCT02754141|102069773|FG002|Overall Study|No longer meets study criteria|0|||
33595623|NCT02754141|102069774|FG003|Overall Study|No longer meets study criteria|1|||
33595624|NCT02754141|102069775|FG004|Overall Study|No longer meets study criteria|0|||
33595625|NCT02754141|102069776|FG005|Overall Study|No longer meets study criteria|0|||
33595626|NCT02754141|102069777|FG006|Overall Study|No longer meets study criteria|0|||
33595627|NCT02754141|102069778|FG007|Overall Study|No longer meets study criteria|0|||
33595628|NCT02754141|102069779|FG008|Overall Study|No longer meets study criteria|0|||
33595629|NCT02754141|102069780|FG009|Overall Study|No longer meets study criteria|0|||
33595630|NCT02754141|102069781|FG010|Overall Study|No longer meets study criteria|0|||
33595631|NCT02754141|102069782|FG011|Overall Study|No longer meets study criteria|0|||
33595632|NCT02754141|102069783|FG012|Overall Study|No longer meets study criteria|0|||
33595633|NCT02754141|102069784|FG013|Overall Study|No longer meets study criteria|0|||
33595634|NCT02754141|102069785|FG014|Overall Study|No longer meets study criteria|0|||
33595635|NCT02754141|102069786|FG015|Overall Study|No longer meets study criteria|0|||
33595636|NCT02754141|102069787|FG016|Overall Study|No longer meets study criteria|0|||
33595637|NCT02754141|102069788|FG017|Overall Study|No longer meets study criteria|0|||
33595638|NCT02754141|102069771|FG000|Overall Study|Other reasons|0|||
33595639|NCT02754141|102069772|FG001|Overall Study|Other reasons|0|||
33595640|NCT02754141|102069773|FG002|Overall Study|Other reasons|0|||
33595641|NCT02754141|102069774|FG003|Overall Study|Other reasons|0|||
33595642|NCT02754141|102069775|FG004|Overall Study|Other reasons|0|||
33595643|NCT02754141|102069776|FG005|Overall Study|Other reasons|0|||
33595644|NCT02754141|102069777|FG006|Overall Study|Other reasons|0|||
33595645|NCT02754141|102069778|FG007|Overall Study|Other reasons|1|||
33595646|NCT02754141|102069779|FG008|Overall Study|Other reasons|0|||
33595647|NCT02754141|102069780|FG009|Overall Study|Other reasons|0|||
33595648|NCT02754141|102069781|FG010|Overall Study|Other reasons|0|||
33595649|NCT02754141|102069782|FG011|Overall Study|Other reasons|0|||
33595650|NCT02754141|102069783|FG012|Overall Study|Other reasons|2|||
33595651|NCT02754141|102069784|FG013|Overall Study|Other reasons|0|||
33595652|NCT02754141|102069785|FG014|Overall Study|Other reasons|0|||
33595653|NCT02754141|102069786|FG015|Overall Study|Other reasons|0|||
33595654|NCT02754141|102069787|FG016|Overall Study|Other reasons|0|||
33595655|NCT02754141|102069788|FG017|Overall Study|Other reasons|0|||
33595656|NCT02754141|102069771|FG000|Overall Study|Completed treatment as per protocol|0|||
33595657|NCT02754141|102069772|FG001|Overall Study|Completed treatment as per protocol|1|||
33595658|NCT02754141|102069773|FG002|Overall Study|Completed treatment as per protocol|0|||
33595659|NCT02754141|102069774|FG003|Overall Study|Completed treatment as per protocol|0|||
33595660|NCT02754141|102069775|FG004|Overall Study|Completed treatment as per protocol|0|||
33595661|NCT02754141|102069776|FG005|Overall Study|Completed treatment as per protocol|0|||
33595662|NCT02754141|102069777|FG006|Overall Study|Completed treatment as per protocol|0|||
33595663|NCT02754141|102069778|FG007|Overall Study|Completed treatment as per protocol|0|||
33595664|NCT02754141|102069779|FG008|Overall Study|Completed treatment as per protocol|0|||
33595665|NCT02754141|102069780|FG009|Overall Study|Completed treatment as per protocol|0|||
33595666|NCT02754141|102069781|FG010|Overall Study|Completed treatment as per protocol|0|||
33595667|NCT02754141|102069782|FG011|Overall Study|Completed treatment as per protocol|0|||
33595668|NCT02754141|102069783|FG012|Overall Study|Completed treatment as per protocol|1|||
33595669|NCT02754141|102069784|FG013|Overall Study|Completed treatment as per protocol|0|||
33595670|NCT02754141|102069785|FG014|Overall Study|Completed treatment as per protocol|0|||
33595671|NCT02754141|102069786|FG015|Overall Study|Completed treatment as per protocol|0|||
33595672|NCT02754141|102069787|FG016|Overall Study|Completed treatment as per protocol|0|||
33595673|NCT02754141|102069788|FG017|Overall Study|Completed treatment as per protocol|0|||
33595674|NCT02754141|102069771|FG000|Overall Study|Not completing monotherapy|0|||
33595675|NCT02754141|102069772|FG001|Overall Study|Not completing monotherapy|0|||
33595676|NCT02754141|102069773|FG002|Overall Study|Not completing monotherapy|0|||
33595677|NCT02754141|102069774|FG003|Overall Study|Not completing monotherapy|0|||
33595678|NCT02754141|102069775|FG004|Overall Study|Not completing monotherapy|0|||
33595679|NCT02754141|102069776|FG005|Overall Study|Not completing monotherapy|0|||
33595680|NCT02754141|102069777|FG006|Overall Study|Not completing monotherapy|0|||
33595681|NCT02754141|102069778|FG007|Overall Study|Not completing monotherapy|0|||
33595682|NCT02754141|102069779|FG008|Overall Study|Not completing monotherapy|0|||
33595683|NCT02754141|102069780|FG009|Overall Study|Not completing monotherapy|0|||
33595684|NCT02754141|102069781|FG010|Overall Study|Not completing monotherapy|0|||
33595685|NCT02754141|102069782|FG011|Overall Study|Not completing monotherapy|0|||
33595686|NCT02754141|102069783|FG012|Overall Study|Not completing monotherapy|0|||
33595687|NCT02754141|102069784|FG013|Overall Study|Not completing monotherapy|1|||
33595688|NCT02754141|102069785|FG014|Overall Study|Not completing monotherapy|0|||
33595689|NCT02754141|102069786|FG015|Overall Study|Not completing monotherapy|0|||
33595690|NCT02754141|102069787|FG016|Overall Study|Not completing monotherapy|0|||
33595691|NCT02754141|102069788|FG017|Overall Study|Not completing monotherapy|0|||
33595692|NCT00610441|102069789|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
33595693|NCT00610441|102069790|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
33595694|NCT00610441|102069791|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
33595695|NCT00610441|102069792|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
33595696|NCT00610441|102069789|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
33595697|NCT00610441|102069790|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
33595698|NCT00610441|102069791|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
33595699|NCT00610441|102069792|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
33595700|NCT00610441|102069789|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
33595701|NCT00610441|102069790|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
33595702|NCT00610441|102069791|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
33595703|NCT00610441|102069792|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
33595704|NCT00610441|102069789|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
33595705|NCT00610441|102069790|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
33595706|NCT00610441|102069791|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
33595707|NCT00610441|102069792|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
33595708|NCT00610441|102069789|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
33595709|NCT00610441|102069790|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
33595710|NCT00610441|102069791|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
33595711|NCT00610441|102069792|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
33595712|NCT00610441|102069789|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
33595713|NCT00610441|102069790|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
33595714|NCT00610441|102069791|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
33595715|NCT00610441|102069792|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
33595716|NCT00610441|102069789|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
33595717|NCT00610441|102069790|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
33595718|NCT00610441|102069791|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
33595719|NCT00610441|102069792|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
33595720|NCT00610441|102069789|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
33595721|NCT00610441|102069790|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
33595722|NCT00610441|102069791|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
33595723|NCT00610441|102069792|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
33595724|NCT00610441|102069789|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
33595725|NCT00610441|102069790|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
33595726|NCT00610441|102069791|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
33595727|NCT00610441|102069792|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
33595728|NCT03089944|102069793|FG000|Overall Study|Lost to Follow-up|8|||
33595729|NCT03089944|102069793|FG000|Overall Study|Withdrew Consent|2|||
33595730|NCT03089944|102069793|FG000|Overall Study|Adverse Event|1|||
33595731|NCT03089944|102069793|FG000|Overall Study|Other|1|||
33595732|NCT02640625|102069794|FG000|Overall Study|Adverse Event|1|||
33595733|NCT02210689|102069795|FG000|Overall Study|Withdrawal by Subject|7|||
33595734|NCT02210689|102069796|FG001|Overall Study|Withdrawal by Subject|4|||
33595735|NCT02210689|102069797|FG002|Overall Study|Withdrawal by Subject|2|||
33595736|NCT02210689|102069795|FG000|Overall Study|Adverse Event|0|||
33595737|NCT02210689|102069796|FG001|Overall Study|Adverse Event|1|||
33595738|NCT02210689|102069797|FG002|Overall Study|Adverse Event|0|||
33595739|NCT02210689|102069795|FG000|Overall Study|Protocol Violation|1|||
33595740|NCT02210689|102069796|FG001|Overall Study|Protocol Violation|0|||
33595741|NCT02210689|102069797|FG002|Overall Study|Protocol Violation|0|||
33595742|NCT02210689|102069795|FG000|Overall Study|Lost to Follow-up|11|||
33595743|NCT02210689|102069796|FG001|Overall Study|Lost to Follow-up|9|||
33595744|NCT02210689|102069797|FG002|Overall Study|Lost to Follow-up|5|||
33595745|NCT02210689|102069795|FG000|Overall Study|Pregnancy|0|||
33595746|NCT02210689|102069796|FG001|Overall Study|Pregnancy|1|||
33595747|NCT02210689|102069797|FG002|Overall Study|Pregnancy|0|||
33595748|NCT02210689|102069795|FG000|Overall Study|Lack of Efficacy|0|||
33595749|NCT02210689|102069796|FG001|Overall Study|Lack of Efficacy|1|||
33595750|NCT02210689|102069797|FG002|Overall Study|Lack of Efficacy|5|||
33595751|NCT02210689|102069795|FG000|Overall Study|Prohibited medication|2|||
33595752|NCT02210689|102069796|FG001|Overall Study|Prohibited medication|8|||
33595753|NCT02210689|102069797|FG002|Overall Study|Prohibited medication|1|||
33595754|NCT02210689|102069795|FG000|Overall Study|Negative Nugent score at baseline|6|||
33595755|NCT02210689|102069796|FG001|Overall Study|Negative Nugent score at baseline|2|||
33595756|NCT02210689|102069797|FG002|Overall Study|Negative Nugent score at baseline|2|||
33595757|NCT02210689|102069795|FG000|Overall Study|Other|25|||
33595758|NCT02210689|102069796|FG001|Overall Study|Other|21|||
33595759|NCT02210689|102069797|FG002|Overall Study|Other|8|||
33595760|NCT02226562|102069798|FG000|Overall Study|Lost to Follow-up|0|||
33595761|NCT02226562|102069799|FG001|Overall Study|Lost to Follow-up|1|||
33595762|NCT03352453|102069806|FG000|Overall Study|Miscellaneous Reasons|1|||
33595763|NCT03352453|102069807|FG001|Overall Study|Miscellaneous Reasons|2|||
33595764|NCT03352453|102069806|FG000|Overall Study|Lack of Efficacy|1|||
33595765|NCT03352453|102069807|FG001|Overall Study|Lack of Efficacy|0|||
33595766|NCT03352453|102069806|FG000|Overall Study|Withdrawal by Subject|8|||
33595767|NCT03352453|102069807|FG001|Overall Study|Withdrawal by Subject|14|||
33595768|NCT03352453|102069806|FG000|Overall Study|Study Terminated by Sponsor|2|||
33595769|NCT03352453|102069807|FG001|Overall Study|Study Terminated by Sponsor|1|||
33595770|NCT03352453|102069806|FG000|Overall Study|Protocol Deviation|1|||
33595771|NCT03352453|102069807|FG001|Overall Study|Protocol Deviation|0|||
33595772|NCT03352453|102069806|FG000|Overall Study|Lost to Follow-up|7|||
33595773|NCT03352453|102069807|FG001|Overall Study|Lost to Follow-up|6|||
33595774|NCT03352453|102069806|FG000|Overall Study|Adverse Event|2|||
33595775|NCT03352453|102069807|FG001|Overall Study|Adverse Event|9|||
33595776|NCT01804582|102069808|FG000|Overall Study|Lost to Follow-up|47|||
33595777|NCT01804582|102069809|FG001|Overall Study|Lost to Follow-up|56|||
33595778|NCT01804582|102069808|FG000|Overall Study|Physician Decision|2|||
33595779|NCT01804582|102069809|FG001|Overall Study|Physician Decision|0|||
33595780|NCT01866423|102069810|FG000|Overall Study|Lack of Efficacy|3|||
33595781|NCT01866423|102069810|FG000|Overall Study|Sponsor Decision|1|||
33595782|NCT03618628|102069811|FG000|Overall Study|Death|1|||
33595783|NCT03618628|102069811|FG000|Overall Study|Lost to Follow-up|1|||
33595784|NCT03664674|102069815|FG000|Overall Study|Adverse Event|1|||
33595785|NCT03664674|102069816|FG001|Overall Study|Adverse Event|1|||
33595786|NCT03664674|102069815|FG000|Overall Study|Physician Decision|0|||
33595787|NCT03664674|102069816|FG001|Overall Study|Physician Decision|1|||
33595788|NCT03664674|102069815|FG000|Overall Study|Withdrawal by Subject|2|||
33595789|NCT03664674|102069816|FG001|Overall Study|Withdrawal by Subject|0|||
33595790|NCT00525824|102069820|FG000|Overall Study|Adverse Event|7|||
33595791|NCT00525824|102069821|FG001|Overall Study|Adverse Event|11|||
33595792|NCT00525824|102069822|FG002|Overall Study|Adverse Event|6|||
33595793|NCT00525824|102069823|FG003|Overall Study|Adverse Event|7|||
33595794|NCT00525824|102069820|FG000|Overall Study|Withdrawal by Subject|5|||
33595795|NCT00525824|102069821|FG001|Overall Study|Withdrawal by Subject|9|||
33595796|NCT00525824|102069822|FG002|Overall Study|Withdrawal by Subject|3|||
33595797|NCT00525824|102069823|FG003|Overall Study|Withdrawal by Subject|4|||
33595798|NCT00525824|102069820|FG000|Overall Study|Lost to Follow-up|4|||
33595799|NCT00525824|102069821|FG001|Overall Study|Lost to Follow-up|2|||
33595800|NCT00525824|102069822|FG002|Overall Study|Lost to Follow-up|4|||
33595801|NCT00525824|102069823|FG003|Overall Study|Lost to Follow-up|0|||
33595802|NCT00525824|102069820|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
33595803|NCT00525824|102069821|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
33595804|NCT00525824|102069822|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
33595805|NCT00525824|102069823|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
33595806|NCT00525824|102069820|FG000|Overall Study|Severe non-compliance|0|||
33595807|NCT00525824|102069821|FG001|Overall Study|Severe non-compliance|1|||
33595808|NCT00525824|102069822|FG002|Overall Study|Severe non-compliance|1|||
33595809|NCT00525824|102069823|FG003|Overall Study|Severe non-compliance|1|||
33595810|NCT00525824|102069820|FG000|Overall Study|Safety reasons|1|||
33595811|NCT00525824|102069821|FG001|Overall Study|Safety reasons|0|||
33595812|NCT00525824|102069822|FG002|Overall Study|Safety reasons|1|||
33595813|NCT00525824|102069823|FG003|Overall Study|Safety reasons|0|||
33595814|NCT00525824|102069820|FG000|Overall Study|Other|1|||
33595815|NCT00525824|102069821|FG001|Overall Study|Other|3|||
33595816|NCT00525824|102069822|FG002|Overall Study|Other|3|||
33595817|NCT00525824|102069823|FG003|Overall Study|Other|1|||
33595818|NCT00772369|102069824|FG000|Overall Study|Did not return record release form|1|||
33595819|NCT02576535|102069827|FG000|Overall Study|Withdrawal by Subject|2|||
33595820|NCT00350272|102069828|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
33595821|NCT00350272|102069829|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
33595822|NCT00350272|102069828|FG000|Blinded 12-Week Treatment|Death|1|||
33595823|NCT00350272|102069829|FG001|Blinded 12-Week Treatment|Death|0|||
33595824|NCT00350272|102069828|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
33595825|NCT00350272|102069829|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
33595826|NCT00350272|102069828|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
33595827|NCT00350272|102069829|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
33595828|NCT00350272|102069828|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
33595829|NCT00350272|102069829|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
33595830|NCT00350272|102069828|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
33595831|NCT00350272|102069829|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
33595832|NCT00350272|102069828|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
33595833|NCT00350272|102069829|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
33595834|NCT00350272|102069828|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
33595835|NCT00350272|102069829|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
33595836|NCT00350272|102069828|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
33595837|NCT00350272|102069829|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
33595838|NCT00350272|102069828|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
33595839|NCT00350272|102069829|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
33595840|NCT00350272|102069828|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
33595841|NCT00350272|102069829|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
33595842|NCT02981407|102069830|FG000|Overall Study|Withdrawal by Subject|2|||
33595843|NCT02981407|102069831|FG001|Overall Study|Withdrawal by Subject|0|||
33595844|NCT00223977|102069832|FG000|Overall Study|Adverse Event|7|||
33595845|NCT00223977|102069833|FG001|Overall Study|Adverse Event|10|||
33595846|NCT00223977|102069834|FG002|Overall Study|Adverse Event|0|||
33595847|NCT00223977|102069832|FG000|Overall Study|Protocol Violation|0|||
33595848|NCT00223977|102069833|FG001|Overall Study|Protocol Violation|0|||
33595849|NCT00223977|102069834|FG002|Overall Study|Protocol Violation|1|||
33595850|NCT00223977|102069832|FG000|Overall Study|Withdrawal by Subject|1|||
33595851|NCT00223977|102069833|FG001|Overall Study|Withdrawal by Subject|1|||
33595852|NCT00223977|102069834|FG002|Overall Study|Withdrawal by Subject|2|||
33595853|NCT00223977|102069832|FG000|Overall Study|Other|1|||
33595854|NCT00223977|102069833|FG001|Overall Study|Other|0|||
33595855|NCT00223977|102069834|FG002|Overall Study|Other|0|||
33595856|NCT00744978|102069836|FG000|Period 1|Lost to Follow-up|1|||
33595857|NCT00744978|102069837|FG001|Period 1|Lost to Follow-up|0|||
33595858|NCT00744978|102069836|FG000|Period 1|Withdrawal by Subject|0|||
33595859|NCT00744978|102069837|FG001|Period 1|Withdrawal by Subject|2|||
33595860|NCT00744978|102069836|FG000|Period 1|Other|0|||
33595861|NCT00744978|102069837|FG001|Period 1|Other|2|||
33595862|NCT00744978|102069836|FG000|Period 1|Adverse Event|4|||
33595863|NCT00744978|102069837|FG001|Period 1|Adverse Event|0|||
33595864|NCT00744978|102069836|FG000|Period 1|Randomized but not Treated|1|||
33595865|NCT00744978|102069837|FG001|Period 1|Randomized but not Treated|1|||
33595866|NCT00744978|102069836|FG000|Period 2|Adverse Event|0|||
33595867|NCT00744978|102069837|FG001|Period 2|Adverse Event|1|||
33595868|NCT01846663|102069838|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
33595869|NCT01846663|102069839|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
33595870|NCT01846663|102069838|FG000|Overall Study|Withdrawal by Subject|1|||
33595871|NCT01846663|102069839|FG001|Overall Study|Withdrawal by Subject|0|||
33595872|NCT01846663|102069838|FG000|Overall Study|Adverse Event|1|||
33595873|NCT01846663|102069839|FG001|Overall Study|Adverse Event|2|||
33595874|NCT03920293|102069846|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
33595875|NCT03920293|102069847|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
33595876|NCT03920293|102069846|FG000|Randomized-Controlled Period|Physician Decision|1|||
33595877|NCT03920293|102069847|FG001|Randomized-Controlled Period|Physician Decision|2|||
33595878|NCT03920293|102069846|FG000|Randomized-Controlled Period|Adverse Event|0|||
33595879|NCT03920293|102069847|FG001|Randomized-Controlled Period|Adverse Event|2|||
33595880|NCT03920293|102069846|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
33595881|NCT03920293|102069847|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
33595882|NCT03920293|102069846|FG000|Randomized-Controlled Period|Death|2|||
33595883|NCT03920293|102069847|FG001|Randomized-Controlled Period|Death|0|||
33595884|NCT03920293|102069846|FG000|Randomized-Controlled Period|Protocol Violation|1|||
33595885|NCT03920293|102069847|FG001|Randomized-Controlled Period|Protocol Violation|0|||
33595886|NCT03920293|102069846|FG000|Randomized-Controlled Period|Noncompliance|1|||
33595887|NCT03920293|102069847|FG001|Randomized-Controlled Period|Noncompliance|0|||
33595888|NCT03920293|102069846|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
33595889|NCT03920293|102069847|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
33595890|NCT03920293|102069846|FG000|Open- Label Extension Period|Death|3|||
33595891|NCT03920293|102069847|FG001|Open- Label Extension Period|Death|3|||
33595892|NCT03920293|102069846|FG000|Open- Label Extension Period|Physician Decision|5|||
33595893|NCT03920293|102069847|FG001|Open- Label Extension Period|Physician Decision|3|||
33595894|NCT03920293|102069846|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
33595895|NCT03920293|102069847|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
33595896|NCT03960580|102069850|FG000|Overall Study|Adverse Event|2|||
33595897|NCT03960580|102069851|FG001|Overall Study|Adverse Event|1|||
33595898|NCT03960580|102069852|FG002|Overall Study|Adverse Event|1|||
33595899|NCT03960580|102069850|FG000|Overall Study|Lost to Follow-up|1|||
33595900|NCT03960580|102069851|FG001|Overall Study|Lost to Follow-up|0|||
33595901|NCT03960580|102069852|FG002|Overall Study|Lost to Follow-up|0|||
33595902|NCT03960580|102069850|FG000|Overall Study|Lack of Efficacy|2|||
33595903|NCT03960580|102069851|FG001|Overall Study|Lack of Efficacy|1|||
33595904|NCT03960580|102069852|FG002|Overall Study|Lack of Efficacy|0|||
33595905|NCT03960580|102069850|FG000|Overall Study|Protocol Violation|0|||
33595906|NCT03960580|102069851|FG001|Overall Study|Protocol Violation|0|||
33595907|NCT03960580|102069852|FG002|Overall Study|Protocol Violation|1|||
33595908|NCT03960580|102069850|FG000|Overall Study|Withdrawal by Subject|1|||
33595909|NCT03960580|102069851|FG001|Overall Study|Withdrawal by Subject|1|||
33595910|NCT03960580|102069852|FG002|Overall Study|Withdrawal by Subject|1|||
33595911|NCT03960580|102069850|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
33595912|NCT03960580|102069851|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
33595913|NCT03960580|102069852|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
33595914|NCT02456636|102069853|FG000|Overall Study|Death|0|||
33595915|NCT02456636|102069854|FG001|Overall Study|Death|3|||
33595916|NCT02456636|102069855|FG002|Overall Study|Death|0|||
33595917|NCT02456636|102069853|FG000|Overall Study|Pregnancy|1|||
33595918|NCT02456636|102069854|FG001|Overall Study|Pregnancy|3|||
33595919|NCT02456636|102069855|FG002|Overall Study|Pregnancy|5|||
33595920|NCT02456636|102069853|FG000|Overall Study|Physician Decision|4|||
33595921|NCT02456636|102069854|FG001|Overall Study|Physician Decision|5|||
33595922|NCT02456636|102069855|FG002|Overall Study|Physician Decision|4|||
33595923|NCT02456636|102069853|FG000|Overall Study|Withdrawal by Subject|13|||
33595924|NCT02456636|102069854|FG001|Overall Study|Withdrawal by Subject|14|||
33595925|NCT02456636|102069855|FG002|Overall Study|Withdrawal by Subject|16|||
33595926|NCT02456636|102069853|FG000|Overall Study|Lost to Follow-up|50|||
33595927|NCT02456636|102069854|FG001|Overall Study|Lost to Follow-up|44|||
33595928|NCT02456636|102069855|FG002|Overall Study|Lost to Follow-up|50|||
33595929|NCT02791191|102069858|FG000|Overall Study|Adverse Event|2|||
33595930|NCT02791191|102069859|FG001|Overall Study|Adverse Event|4|||
33595931|NCT02791191|102069860|FG002|Overall Study|Adverse Event|5|||
33595932|NCT02791191|102069858|FG000|Overall Study|Lack of Efficacy|0|||
33595933|NCT02791191|102069859|FG001|Overall Study|Lack of Efficacy|1|||
33595934|NCT02791191|102069860|FG002|Overall Study|Lack of Efficacy|0|||
33595935|NCT02791191|102069858|FG000|Overall Study|Study Drug Non-Compliance|0|||
33595936|NCT02791191|102069859|FG001|Overall Study|Study Drug Non-Compliance|2|||
33595937|NCT02791191|102069860|FG002|Overall Study|Study Drug Non-Compliance|0|||
33595938|NCT02791191|102069858|FG000|Overall Study|Site Closed by Sponsor|1|||
33595939|NCT02791191|102069859|FG001|Overall Study|Site Closed by Sponsor|1|||
33595940|NCT02791191|102069860|FG002|Overall Study|Site Closed by Sponsor|3|||
33595941|NCT02791191|102069858|FG000|Overall Study|Progressive Disease|1|||
33595942|NCT02791191|102069859|FG001|Overall Study|Progressive Disease|0|||
33595943|NCT02791191|102069860|FG002|Overall Study|Progressive Disease|0|||
33595944|NCT02791191|102069858|FG000|Overall Study|Study Terminated by Sponsor|29|||
33595945|NCT02791191|102069859|FG001|Overall Study|Study Terminated by Sponsor|101|||
33595946|NCT02791191|102069860|FG002|Overall Study|Study Terminated by Sponsor|109|||
33595947|NCT02791191|102069858|FG000|Overall Study|Withdrawal by Subject|3|||
33595948|NCT02791191|102069859|FG001|Overall Study|Withdrawal by Subject|1|||
33595949|NCT02791191|102069860|FG002|Overall Study|Withdrawal by Subject|3|||
33595950|NCT02791191|102069858|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
33595951|NCT02791191|102069859|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
33595952|NCT02791191|102069860|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
33595953|NCT02813668|102069865|FG000|Overall Study|Death|4|||
33595954|NCT02813668|102069865|FG000|Overall Study|Lost to Follow-up|509|||
33595955|NCT02813668|102069865|FG000|Overall Study|Withdrawal by Subject|148|||
33595956|NCT02813668|102069865|FG000|Overall Study|No longer at worksite|85|||
33595957|NCT02813668|102069865|FG000|Overall Study|Medical reasons not related to the study|4|||
33595958|NCT00468676|102069868|FG000|Overall Study|Lost to Follow-up|14|||
33595959|NCT00468676|102069869|FG001|Overall Study|Lost to Follow-up|11|||
33595960|NCT00468676|102069868|FG000|Overall Study|Death|2|||
33595961|NCT00468676|102069869|FG001|Overall Study|Death|1|||
33595962|NCT02298179|102069870|FG000|Overall Study|Lost to Follow-up|0|||
33595963|NCT02298179|102069871|FG001|Overall Study|Lost to Follow-up|0|||
33595964|NCT02298179|102069872|FG002|Overall Study|Lost to Follow-up|1|||
33595965|NCT02298179|102069873|FG003|Overall Study|Lost to Follow-up|0|||
33595966|NCT02298179|102069874|FG004|Overall Study|Lost to Follow-up|0|||
33595967|NCT02298179|102069875|FG005|Overall Study|Lost to Follow-up|0|||
33595968|NCT02298179|102069876|FG006|Overall Study|Lost to Follow-up|0|||
33595969|NCT02298179|102069877|FG007|Overall Study|Lost to Follow-up|1|||
33595970|NCT02298179|102069878|FG008|Overall Study|Lost to Follow-up|0|||
33595971|NCT02298179|102069879|FG009|Overall Study|Lost to Follow-up|0|||
33595972|NCT02298179|102069880|FG010|Overall Study|Lost to Follow-up|0|||
33595973|NCT02298179|102069881|FG011|Overall Study|Lost to Follow-up|0|||
33595974|NCT04195438|102069885|FG000|Overall Study|Withdrawal by Subject|1|||
33595975|NCT01688921|102069886|FG000|Overall Study|Lost to Follow-up|7|||
33595976|NCT01688921|102069887|FG001|Overall Study|Lost to Follow-up|13|||
33595977|NCT01688921|102069886|FG000|Overall Study|Physician Decision|6|||
33595978|NCT01688921|102069887|FG001|Overall Study|Physician Decision|1|||
33595979|NCT01688921|102069886|FG000|Overall Study|Protocol Violation|0|||
33595980|NCT01688921|102069887|FG001|Overall Study|Protocol Violation|1|||
33595981|NCT01688921|102069886|FG000|Overall Study|informed consent|3|||
33595982|NCT01688921|102069887|FG001|Overall Study|informed consent|0|||
33595983|NCT03593681|102069888|FG000|Overall Study|Inadequate sample collected|12|||
33595984|NCT03593681|102069888|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
33595985|NCT03593681|102069888|FG000|Overall Study|Protocol Violation|3|||
33595986|NCT03593681|102069888|FG000|Overall Study|Withdrawal by Subject|3|||
33595987|NCT03593681|102069888|FG000|Overall Study|Procedure not attempted|3|||
33595988|NCT03593681|102069888|FG000|Overall Study|Adverse Event|2|||
33595989|NCT03593681|102069888|FG000|Overall Study|Physician Decision|1|||
33595990|NCT01904149|102069891|FG000|Overall Study|Adverse Event|3|||
33595991|NCT01904149|102069892|FG001|Overall Study|Adverse Event|4|||
33595992|NCT01904149|102069893|FG002|Overall Study|Adverse Event|0|||
33595993|NCT01904149|102069894|FG003|Overall Study|Adverse Event|1|||
33595994|NCT01904149|102069895|FG004|Overall Study|Adverse Event|1|||
33595995|NCT01904149|102069896|FG005|Overall Study|Adverse Event|2|||
33595996|NCT01904149|102069891|FG000|Overall Study|Lack of Efficacy|0|||
33595997|NCT01904149|102069892|FG001|Overall Study|Lack of Efficacy|3|||
33595998|NCT01904149|102069893|FG002|Overall Study|Lack of Efficacy|1|||
33595999|NCT01904149|102069894|FG003|Overall Study|Lack of Efficacy|3|||
33596000|NCT01904149|102069895|FG004|Overall Study|Lack of Efficacy|3|||
33596001|NCT01904149|102069896|FG005|Overall Study|Lack of Efficacy|1|||
33596002|NCT01904149|102069891|FG000|Overall Study|Withdrawal by Subject|1|||
33596003|NCT01904149|102069892|FG001|Overall Study|Withdrawal by Subject|3|||
33596004|NCT01904149|102069893|FG002|Overall Study|Withdrawal by Subject|1|||
33596005|NCT01904149|102069894|FG003|Overall Study|Withdrawal by Subject|0|||
33596006|NCT01904149|102069895|FG004|Overall Study|Withdrawal by Subject|1|||
33596007|NCT01904149|102069896|FG005|Overall Study|Withdrawal by Subject|0|||
33596008|NCT01904149|102069891|FG000|Overall Study|Protocol Violation|0|||
33596009|NCT01904149|102069892|FG001|Overall Study|Protocol Violation|1|||
33596010|NCT01904149|102069893|FG002|Overall Study|Protocol Violation|0|||
33596011|NCT01904149|102069894|FG003|Overall Study|Protocol Violation|0|||
33596012|NCT01904149|102069895|FG004|Overall Study|Protocol Violation|0|||
33596013|NCT01904149|102069896|FG005|Overall Study|Protocol Violation|0|||
33596014|NCT01904149|102069891|FG000|Overall Study|non compliance with study drug|1|||
33596015|NCT01904149|102069892|FG001|Overall Study|non compliance with study drug|0|||
33596016|NCT01904149|102069893|FG002|Overall Study|non compliance with study drug|0|||
33596017|NCT01904149|102069894|FG003|Overall Study|non compliance with study drug|0|||
33596018|NCT01904149|102069895|FG004|Overall Study|non compliance with study drug|0|||
33596019|NCT01904149|102069896|FG005|Overall Study|non compliance with study drug|0|||
33596020|NCT00969761|102069898|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
33596021|NCT00969761|102069899|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33596022|NCT00969761|102069900|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33596023|NCT00969761|102069901|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
33596024|NCT00969761|102069902|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33596025|NCT00969761|102069903|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33596026|NCT00969761|102069904|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33596027|NCT00969761|102069905|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33596028|NCT00969761|102069906|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
33596029|NCT00969761|102069907|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
33596030|NCT00969761|102069908|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33596031|NCT00969761|102069909|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
33596032|NCT00969761|102069898|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33596033|NCT00969761|102069899|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33596034|NCT00969761|102069900|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
33596035|NCT00969761|102069901|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33596036|NCT00969761|102069902|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33596037|NCT00969761|102069903|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33596038|NCT00969761|102069904|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33596039|NCT00969761|102069905|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33596040|NCT00969761|102069906|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33596041|NCT00969761|102069907|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33596042|NCT00969761|102069908|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33596043|NCT00969761|102069909|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
33596044|NCT00969761|102069898|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33596045|NCT00969761|102069899|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33596046|NCT00969761|102069900|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
33596047|NCT00969761|102069901|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33596048|NCT00969761|102069902|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33596049|NCT00969761|102069903|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33596050|NCT00969761|102069904|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33596051|NCT00969761|102069905|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33596052|NCT00969761|102069906|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33596053|NCT00969761|102069907|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33596054|NCT00969761|102069908|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33596055|NCT00969761|102069909|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
33596056|NCT00969761|102069898|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33596057|NCT00969761|102069899|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33596058|NCT00969761|102069900|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33596059|NCT00969761|102069901|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33596060|NCT00969761|102069902|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33596061|NCT00969761|102069903|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33596062|NCT00969761|102069904|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33596063|NCT00969761|102069905|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33596064|NCT00969761|102069906|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
33596065|NCT00969761|102069907|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33596066|NCT00969761|102069908|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33596067|NCT00969761|102069909|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
33596068|NCT00969761|102069898|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
33596069|NCT00969761|102069899|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
33596070|NCT00969761|102069900|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
33596071|NCT00969761|102069901|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
33596072|NCT00969761|102069902|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
33596073|NCT00969761|102069903|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
33596074|NCT00969761|102069904|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
33596075|NCT00969761|102069905|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
33596076|NCT00969761|102069906|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
33596077|NCT00969761|102069907|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
33596078|NCT00969761|102069908|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
33596079|NCT00969761|102069909|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
33596080|NCT00969761|102069898|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33596081|NCT00969761|102069899|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33596082|NCT00969761|102069900|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33596083|NCT00969761|102069901|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
33596084|NCT00969761|102069902|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
33596085|NCT00969761|102069903|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33596086|NCT00969761|102069904|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33596087|NCT00969761|102069905|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33596088|NCT00969761|102069906|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
33596089|NCT00969761|102069907|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33596090|NCT00969761|102069908|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33596091|NCT00969761|102069909|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
33596092|NCT01323270|102069910|FG000|Overall Study|Withdrawal by Subject|19|||
33596093|NCT01323270|102069911|FG001|Overall Study|Withdrawal by Subject|10|||
33596094|NCT01323270|102069910|FG000|Overall Study|Protocol Violation|9|||
33596095|NCT01323270|102069911|FG001|Overall Study|Protocol Violation|7|||
33596096|NCT01323270|102069910|FG000|Overall Study|Lost to Follow-up|4|||
33596097|NCT01323270|102069911|FG001|Overall Study|Lost to Follow-up|6|||
33596098|NCT01323270|102069910|FG000|Overall Study|Adverse Event|8|||
33596099|NCT01323270|102069911|FG001|Overall Study|Adverse Event|0|||
33596100|NCT01323270|102069910|FG000|Overall Study|Other|0|||
33596101|NCT01323270|102069911|FG001|Overall Study|Other|3|||
33596102|NCT01323270|102069910|FG000|Overall Study|Physician Decision|0|||
33596103|NCT01323270|102069911|FG001|Overall Study|Physician Decision|2|||
33596104|NCT01323270|102069910|FG000|Overall Study|Not eligible|1|||
33596105|NCT01323270|102069911|FG001|Overall Study|Not eligible|1|||
33596106|NCT01323270|102069910|FG000|Overall Study|Death|1|||
33596107|NCT01323270|102069911|FG001|Overall Study|Death|0|||
33596108|NCT01323270|102069910|FG000|Overall Study|Randomized, but not vaccinated|1|||
33596109|NCT01323270|102069911|FG001|Overall Study|Randomized, but not vaccinated|0|||
33596110|NCT01819129|102069912|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
33596111|NCT01819129|102069913|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
33596112|NCT01819129|102069912|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
33596113|NCT01819129|102069913|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
33596114|NCT01819129|102069912|FG000|Overall Study|Other, Subject moved out of the country|0|||
33596115|NCT01819129|102069913|FG001|Overall Study|Other, Subject moved out of the country|1|||
33596116|NCT01819129|102069912|FG000|Overall Study|Withdrawal by Subject|15|||
33596117|NCT01819129|102069913|FG001|Overall Study|Withdrawal by Subject|15|||
33596118|NCT01819129|102069912|FG000|Overall Study|Lost to Follow-up|5|||
33596119|NCT01819129|102069913|FG001|Overall Study|Lost to Follow-up|2|||
33596120|NCT01819129|102069912|FG000|Overall Study|Lack of Efficacy|0|||
33596121|NCT01819129|102069913|FG001|Overall Study|Lack of Efficacy|1|||
33596122|NCT01819129|102069912|FG000|Overall Study|Adverse Event|1|||
33596123|NCT01819129|102069913|FG001|Overall Study|Adverse Event|4|||
33596124|NCT01819129|102069912|FG000|Overall Study|Death|1|||
33596125|NCT01819129|102069913|FG001|Overall Study|Death|1|||
33596126|NCT01819129|102069912|FG000|Overall Study|Withdrawal Criteria|20|||
33596127|NCT01819129|102069913|FG001|Overall Study|Withdrawal Criteria|15|||
33596128|NCT00645528|102069916|FG000|Overall Study|Did not show up for Visit 2|7|||
33596129|NCT02323204|102069917|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
33596130|NCT02323204|102069918|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
33596131|NCT02323204|102069919|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
33596132|NCT02323204|102069920|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
33596133|NCT02323204|102069917|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
33596134|NCT02323204|102069918|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
33596135|NCT02323204|102069919|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
33596136|NCT02323204|102069920|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
33596137|NCT02323204|102069917|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
33596138|NCT02323204|102069918|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
33596139|NCT02323204|102069919|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
33596140|NCT02323204|102069920|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
33596141|NCT02323204|102069917|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
33596142|NCT02323204|102069918|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
33596143|NCT02323204|102069919|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
33596144|NCT02323204|102069920|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
33596145|NCT02323204|102069917|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
33596146|NCT02323204|102069918|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
33596147|NCT02323204|102069919|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
33596148|NCT02323204|102069920|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
33596149|NCT02323204|102069917|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
33596150|NCT02323204|102069918|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
33596151|NCT02323204|102069919|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
33596152|NCT02323204|102069920|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
33596153|NCT02323204|102069917|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
33596154|NCT02323204|102069918|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
33596155|NCT02323204|102069919|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
33596156|NCT02323204|102069920|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
33596157|NCT02323204|102069917|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
33596158|NCT02323204|102069918|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
33596159|NCT02323204|102069919|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
33596160|NCT02323204|102069920|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
33596161|NCT02323204|102069917|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
33596162|NCT02323204|102069918|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
33596163|NCT02323204|102069919|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
33596164|NCT02323204|102069920|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
33596165|NCT00717522|102069921|FG000|Overall Study|Disease Progression|5|||
33596166|NCT00717522|102069921|FG000|Overall Study|Adverse Event|1|||
33596167|NCT00717522|102069921|FG000|Overall Study|Death|1|||
33596168|NCT03344549|102069922|FG000|Overall Study|Withdrawal by Subject|3|||
33596169|NCT03344549|102069923|FG001|Overall Study|Withdrawal by Subject|2|||
33596170|NCT03344549|102069922|FG000|Overall Study|Dialysis|2|||
33596171|NCT03344549|102069923|FG001|Overall Study|Dialysis|0|||
33596172|NCT03344549|102069922|FG000|Overall Study|Cancer|1|||
33596173|NCT03344549|102069923|FG001|Overall Study|Cancer|0|||
33596174|NCT03344549|102069922|FG000|Overall Study|Lack of electronic device|1|||
33596175|NCT03344549|102069923|FG001|Overall Study|Lack of electronic device|0|||
33596176|NCT03344549|102069922|FG000|Overall Study|Transportation difficulty|0|||
33596177|NCT03344549|102069923|FG001|Overall Study|Transportation difficulty|13|||
33596178|NCT00916058|102069924|FG000|Phase 1|Screen Failure|0|||
33596179|NCT00916058|102069925|FG001|Phase 1|Screen Failure|0|||
33596180|NCT00916058|102069926|FG002|Phase 1|Screen Failure|0|||
33596181|NCT00916058|102069927|FG003|Phase 1|Screen Failure|0|||
33596182|NCT00916058|102069928|FG004|Phase 1|Screen Failure|0|||
33596183|NCT00916058|102069929|FG005|Phase 1|Screen Failure|1|||
33596184|NCT00916058|102069930|FG006|Phase 1|Screen Failure|0|||
33596185|NCT00916058|102069924|FG000|Phase 2|Screen Failure|0|||
33596186|NCT00916058|102069925|FG001|Phase 2|Screen Failure|0|||
33596187|NCT00916058|102069926|FG002|Phase 2|Screen Failure|0|||
33596188|NCT00916058|102069927|FG003|Phase 2|Screen Failure|0|||
33596189|NCT00916058|102069928|FG004|Phase 2|Screen Failure|0|||
33596190|NCT00916058|102069929|FG005|Phase 2|Screen Failure|0|||
33596191|NCT00916058|102069930|FG006|Phase 2|Screen Failure|3|||
33596192|NCT01140568|102069931|FG000|Overall Study|disease progression|31|||
33596193|NCT01140568|102069931|FG000|Overall Study|Withdrawal by Subject|1|||
33596194|NCT01140568|102069931|FG000|Overall Study|Screen Fail|4|||
33596195|NCT00435162|102069935|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
33596196|NCT00435162|102069936|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
33596197|NCT00435162|102069937|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
33596198|NCT00435162|102069938|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
33596199|NCT00435162|102069939|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
33596200|NCT00435162|102069940|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
33596201|NCT00596154|102069943|FG000|Overall Study|Not Evaluable|2|||
33596202|NCT01643850|102069948|FG000|Overall Study|Withdrawal by Subject|0|||
33596203|NCT01643850|102069949|FG001|Overall Study|Withdrawal by Subject|0|||
33596204|NCT01643850|102069950|FG002|Overall Study|Withdrawal by Subject|0|||
33596205|NCT01643850|102069951|FG003|Overall Study|Withdrawal by Subject|0|||
33596206|NCT01643850|102069952|FG004|Overall Study|Withdrawal by Subject|1|||
33596207|NCT01643850|102069953|FG005|Overall Study|Withdrawal by Subject|0|||
33596208|NCT01643850|102069954|FG006|Overall Study|Withdrawal by Subject|0|||
33596209|NCT01643850|102069955|FG007|Overall Study|Withdrawal by Subject|0|||
33596210|NCT01643850|102069956|FG008|Overall Study|Withdrawal by Subject|0|||
33596211|NCT01643850|102069948|FG000|Overall Study|Lost to Follow-up|0|||
33596212|NCT01643850|102069949|FG001|Overall Study|Lost to Follow-up|0|||
33596213|NCT01643850|102069950|FG002|Overall Study|Lost to Follow-up|0|||
33596214|NCT01643850|102069951|FG003|Overall Study|Lost to Follow-up|0|||
33596215|NCT01643850|102069952|FG004|Overall Study|Lost to Follow-up|0|||
33596216|NCT01643850|102069953|FG005|Overall Study|Lost to Follow-up|0|||
33596217|NCT01643850|102069954|FG006|Overall Study|Lost to Follow-up|1|||
33596218|NCT01643850|102069955|FG007|Overall Study|Lost to Follow-up|0|||
33596219|NCT01643850|102069956|FG008|Overall Study|Lost to Follow-up|1|||
33596220|NCT01643850|102069948|FG000|Overall Study|Adverse Event|0|||
33596221|NCT01643850|102069949|FG001|Overall Study|Adverse Event|0|||
33596222|NCT01643850|102069950|FG002|Overall Study|Adverse Event|0|||
33596223|NCT01643850|102069951|FG003|Overall Study|Adverse Event|0|||
33596224|NCT01643850|102069952|FG004|Overall Study|Adverse Event|1|||
33596225|NCT01643850|102069953|FG005|Overall Study|Adverse Event|0|||
33596226|NCT01643850|102069954|FG006|Overall Study|Adverse Event|0|||
33596227|NCT01643850|102069955|FG007|Overall Study|Adverse Event|0|||
33596228|NCT01643850|102069956|FG008|Overall Study|Adverse Event|0|||
33596229|NCT01643850|102069948|FG000|Overall Study|Administrative Problems|0|||
33596230|NCT01643850|102069949|FG001|Overall Study|Administrative Problems|0|||
33596231|NCT01643850|102069950|FG002|Overall Study|Administrative Problems|1|||
33596232|NCT01643850|102069951|FG003|Overall Study|Administrative Problems|0|||
33596233|NCT01643850|102069952|FG004|Overall Study|Administrative Problems|1|||
33596234|NCT01643850|102069953|FG005|Overall Study|Administrative Problems|0|||
33596235|NCT01643850|102069954|FG006|Overall Study|Administrative Problems|0|||
33596236|NCT01643850|102069955|FG007|Overall Study|Administrative Problems|0|||
33596237|NCT01643850|102069956|FG008|Overall Study|Administrative Problems|0|||
33596238|NCT04795167|102069960|FG000|Overall Study|Death|1|||
33596239|NCT04795167|102069961|FG001|Overall Study|Death|18|||
33596240|NCT04795167|102069962|FG002|Overall Study|Death|1|||
33596241|NCT04795167|102069960|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
33596242|NCT04795167|102069961|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
33596243|NCT04795167|102069962|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
33596244|NCT00536874|102069965|FG000|Overall Study|Adverse Event|1|||
33596245|NCT00536874|102069965|FG000|Overall Study|Death|2|||
33596246|NCT00536874|102069965|FG000|Overall Study|Withdrawal by Subject|1|||
33596247|NCT00867087|102069966|FG000|Overall Study|Other|1|||
33596248|NCT00867087|102069966|FG000|Overall Study|Withdrawal by Subject|4|||
33596249|NCT00867087|102069966|FG000|Overall Study|Death|37|||
33596250|NCT00107315|102069967|FG000|Overall Study|Disease Progression|9|||
33596251|NCT00107315|102069967|FG000|Overall Study|Adverse Event|4|||
33596252|NCT00107315|102069967|FG000|Overall Study|Withdrawal by Subject|2|||
33596253|NCT02723006|102069969|FG000|Overall Study|Withdrawal by Subject|0|||
33596254|NCT02723006|102069970|FG001|Overall Study|Withdrawal by Subject|1|||
33596255|NCT02723006|102069971|FG002|Overall Study|Withdrawal by Subject|1|||
33596256|NCT02723006|102069969|FG000|Overall Study|Study Terminated by Sponsor|1|||
33596257|NCT02723006|102069970|FG001|Overall Study|Study Terminated by Sponsor|6|||
33596258|NCT02723006|102069971|FG002|Overall Study|Study Terminated by Sponsor|6|||
33596259|NCT02928029|102073141|FG000|Overall Study|Withdrawal by Subject|0|||
33596260|NCT02928029|102073142|FG001|Overall Study|Withdrawal by Subject|1|||
33596261|NCT02928029|102073141|FG000|Overall Study|Radiological progression|1|||
33596262|NCT02928029|102073142|FG001|Overall Study|Radiological progression|0|||
33596263|NCT02928029|102073141|FG000|Overall Study|Clinical progression|1|||
33596264|NCT02928029|102073142|FG001|Overall Study|Clinical progression|2|||
33596265|NCT02928029|102073141|FG000|Overall Study|AE not related to clinical progression|1|||
33596266|NCT02928029|102073142|FG001|Overall Study|AE not related to clinical progression|1|||
33596267|NCT04677660|102073147|FG000|Overall Study|Lost to Follow-up|0|||
33596268|NCT04677660|102073148|FG001|Overall Study|Lost to Follow-up|2|||
33596269|NCT04677660|102073147|FG000|Overall Study|Withdrawal by Subject|0|||
33596270|NCT04677660|102073148|FG001|Overall Study|Withdrawal by Subject|1|||
33596271|NCT04677660|102073147|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
33596272|NCT04677660|102073148|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
33596273|NCT00693017|102073164|FG000|Overall Study|Sponsor Decision|2|||
33596274|NCT00693017|102073165|FG001|Overall Study|Sponsor Decision|1|||
33596275|NCT00693017|102073164|FG000|Overall Study|Death|0|||
33596276|NCT00693017|102073165|FG001|Overall Study|Death|1|||
33596277|NCT00765882|102073166|FG000|Overall Study|Adverse Event|10|||
33596278|NCT00765882|102073167|FG001|Overall Study|Adverse Event|21|||
33596279|NCT00765882|102073168|FG002|Overall Study|Adverse Event|20|||
33596280|NCT00765882|102073166|FG000|Overall Study|Lack of Efficacy|4|||
33596281|NCT00765882|102073167|FG001|Overall Study|Lack of Efficacy|0|||
33596282|NCT00765882|102073168|FG002|Overall Study|Lack of Efficacy|1|||
33596283|NCT00765882|102073166|FG000|Overall Study|Protocol Violation|4|||
33596284|NCT00765882|102073167|FG001|Overall Study|Protocol Violation|3|||
33596285|NCT00765882|102073168|FG002|Overall Study|Protocol Violation|1|||
33596286|NCT00765882|102073166|FG000|Overall Study|Withdrawal by Subject|2|||
33596287|NCT00765882|102073167|FG001|Overall Study|Withdrawal by Subject|6|||
33596288|NCT00765882|102073168|FG002|Overall Study|Withdrawal by Subject|6|||
33596289|NCT00765882|102073166|FG000|Overall Study|Lost to Follow-up|1|||
33596290|NCT00765882|102073167|FG001|Overall Study|Lost to Follow-up|9|||
33596291|NCT00765882|102073168|FG002|Overall Study|Lost to Follow-up|6|||
33596292|NCT00765882|102073166|FG000|Overall Study|Other Reason|3|||
33596293|NCT00765882|102073167|FG001|Overall Study|Other Reason|1|||
33596294|NCT00765882|102073168|FG002|Overall Study|Other Reason|2|||
33596295|NCT02759107|102073169|FG000|Overall Study|Adverse Event|0|||
33596296|NCT02759107|102073170|FG001|Overall Study|Adverse Event|0|||
33596297|NCT02759107|102073171|FG002|Overall Study|Adverse Event|0|||
33596298|NCT02759107|102073172|FG003|Overall Study|Adverse Event|0|||
33596299|NCT02759107|102073173|FG004|Overall Study|Adverse Event|0|||
33596300|NCT02759107|102073174|FG005|Overall Study|Adverse Event|0|||
33596301|NCT02759107|102073175|FG006|Overall Study|Adverse Event|0|||
33596302|NCT02759107|102073176|FG007|Overall Study|Adverse Event|0|||
33596303|NCT02759107|102073177|FG008|Overall Study|Adverse Event|0|||
33596304|NCT02759107|102073178|FG009|Overall Study|Adverse Event|0|||
33596305|NCT02759107|102073179|FG010|Overall Study|Adverse Event|0|||
33596306|NCT02759107|102073180|FG011|Overall Study|Adverse Event|0|||
33596307|NCT02759107|102073181|FG012|Overall Study|Adverse Event|2|||
33596308|NCT02759107|102073182|FG013|Overall Study|Adverse Event|0|||
33596309|NCT02759107|102073183|FG014|Overall Study|Adverse Event|0|||
33596310|NCT02759107|102073184|FG015|Overall Study|Adverse Event|1|||
33596311|NCT02759107|102073185|FG016|Overall Study|Adverse Event|0|||
33596312|NCT02759107|102073186|FG017|Overall Study|Adverse Event|2|||
33596313|NCT02759107|102073169|FG000|Overall Study|Scheduling Conflict|0|||
33596314|NCT02759107|102073170|FG001|Overall Study|Scheduling Conflict|0|||
33596315|NCT02759107|102073171|FG002|Overall Study|Scheduling Conflict|0|||
33596316|NCT02759107|102073172|FG003|Overall Study|Scheduling Conflict|0|||
33596317|NCT02759107|102073173|FG004|Overall Study|Scheduling Conflict|0|||
33596318|NCT02759107|102073174|FG005|Overall Study|Scheduling Conflict|0|||
33596319|NCT02759107|102073175|FG006|Overall Study|Scheduling Conflict|0|||
33596320|NCT02759107|102073176|FG007|Overall Study|Scheduling Conflict|0|||
33596321|NCT02759107|102073177|FG008|Overall Study|Scheduling Conflict|0|||
33596322|NCT02759107|102073178|FG009|Overall Study|Scheduling Conflict|1|||
33596323|NCT02759107|102073179|FG010|Overall Study|Scheduling Conflict|0|||
33596324|NCT02759107|102073180|FG011|Overall Study|Scheduling Conflict|0|||
33596325|NCT02759107|102073181|FG012|Overall Study|Scheduling Conflict|0|||
33596326|NCT02759107|102073182|FG013|Overall Study|Scheduling Conflict|0|||
33596327|NCT02759107|102073183|FG014|Overall Study|Scheduling Conflict|0|||
33596328|NCT02759107|102073184|FG015|Overall Study|Scheduling Conflict|0|||
33596329|NCT02759107|102073185|FG016|Overall Study|Scheduling Conflict|0|||
33596330|NCT02759107|102073186|FG017|Overall Study|Scheduling Conflict|0|||
33596331|NCT03553498|102073187|FG000|Overall Study|Missing primary outcome|1|||
33596332|NCT03553498|102073188|FG001|Overall Study|Missing primary outcome|2|||
33596333|NCT05599451|102073191|FG000|Overall Study|Not randomized|11|||
33596334|NCT05599451|102073192|FG001|Overall Study|Not randomized|0|||
33596335|NCT05599451|102073193|FG002|Overall Study|Not randomized|0|||
33596336|NCT05599451|102073194|FG003|Overall Study|Not randomized|0|||
33596337|NCT05599451|102073195|FG004|Overall Study|Not randomized|0|||
33596338|NCT05599451|102073191|FG000|Overall Study|Physician Decision|0|||
33596339|NCT05599451|102073192|FG001|Overall Study|Physician Decision|0|||
33596340|NCT05599451|102073193|FG002|Overall Study|Physician Decision|0|||
33596341|NCT05599451|102073194|FG003|Overall Study|Physician Decision|1|||
33596342|NCT05599451|102073195|FG004|Overall Study|Physician Decision|0|||
33596343|NCT00521599|102073205|FG000|Overall Study|Adverse Event|5|||
33596344|NCT00521599|102073206|FG001|Overall Study|Adverse Event|7|||
33596345|NCT00521599|102073207|FG002|Overall Study|Adverse Event|6|||
33596346|NCT00521599|102073205|FG000|Overall Study|Treatment Failure|8|||
33596347|NCT00521599|102073206|FG001|Overall Study|Treatment Failure|9|||
33596348|NCT00521599|102073207|FG002|Overall Study|Treatment Failure|22|||
33596349|NCT00521599|102073205|FG000|Overall Study|Lost to Follow-up|2|||
33596350|NCT00521599|102073206|FG001|Overall Study|Lost to Follow-up|1|||
33596351|NCT00521599|102073207|FG002|Overall Study|Lost to Follow-up|2|||
33596352|NCT00521599|102073205|FG000|Overall Study|Withdrawal by Subject|3|||
33596353|NCT00521599|102073206|FG001|Overall Study|Withdrawal by Subject|5|||
33596354|NCT00521599|102073207|FG002|Overall Study|Withdrawal by Subject|1|||
33596355|NCT00521599|102073205|FG000|Overall Study|Withdrawal by subject treatment related|3|||
33596356|NCT00521599|102073206|FG001|Overall Study|Withdrawal by subject treatment related|1|||
33596357|NCT00521599|102073207|FG002|Overall Study|Withdrawal by subject treatment related|2|||
33596358|NCT00521599|102073205|FG000|Overall Study|Protocol Violation|2|||
33596359|NCT00521599|102073206|FG001|Overall Study|Protocol Violation|4|||
33596360|NCT00521599|102073207|FG002|Overall Study|Protocol Violation|2|||
33596361|NCT00521599|102073205|FG000|Overall Study|Did not meet protocol eligibility|2|||
33596362|NCT00521599|102073206|FG001|Overall Study|Did not meet protocol eligibility|2|||
33596363|NCT00521599|102073207|FG002|Overall Study|Did not meet protocol eligibility|1|||
33596364|NCT00230282|102073212|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
33596365|NCT00230282|102073212|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
33596366|NCT00230282|102073212|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
33596367|NCT00230282|102073212|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
33596368|NCT01921218|102073224|FG000|Overall Study|Death|2|||
33596369|NCT01921218|102073225|FG001|Overall Study|Death|1|||
33596370|NCT01921218|102073224|FG000|Overall Study|Withdrawal by Subject|0|||
33596371|NCT01921218|102073225|FG001|Overall Study|Withdrawal by Subject|2|||
33596372|NCT01921218|102073224|FG000|Overall Study|Kidney transplant|1|||
33596373|NCT01921218|102073225|FG001|Overall Study|Kidney transplant|1|||
33596374|NCT01352741|102073226|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
33596375|NCT01352741|102073227|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
33596376|NCT01352741|102073226|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
33596377|NCT01352741|102073227|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
33596378|NCT01352741|102073226|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
33596379|NCT01352741|102073227|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
33596380|NCT01352741|102073226|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
33596381|NCT01352741|102073227|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
33596382|NCT01352741|102073226|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
33596383|NCT01352741|102073227|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
33596384|NCT01352741|102073226|FG000|Open-label Tapentadol Titration Period|Other|4|||
33596385|NCT01352741|102073227|FG001|Open-label Tapentadol Titration Period|Other|0|||
33596386|NCT01352741|102073226|FG000|Double-blind Comparative Period|Protocol Violation|2|||
33596387|NCT01352741|102073227|FG001|Double-blind Comparative Period|Protocol Violation|0|||
33596388|NCT01352741|102073226|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
33596389|NCT01352741|102073227|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
33596390|NCT01352741|102073226|FG000|Double-blind Comparative Period|Adverse Event|16|||
33596391|NCT01352741|102073227|FG001|Double-blind Comparative Period|Adverse Event|17|||
33596392|NCT01352741|102073226|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
33596393|NCT01352741|102073227|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
33596394|NCT01352741|102073226|FG000|Double-blind Comparative Period|Death|0|||
33596395|NCT01352741|102073227|FG001|Double-blind Comparative Period|Death|1|||
33596396|NCT01352741|102073226|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
33596397|NCT01352741|102073227|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
33596398|NCT01352741|102073226|FG000|Double-blind Comparative Period|Other|1|||
33596399|NCT01352741|102073227|FG001|Double-blind Comparative Period|Other|2|||
33596400|NCT01352741|102073226|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
33596401|NCT01352741|102073227|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
33596402|NCT01352741|102073226|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
33596403|NCT01352741|102073227|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
33596404|NCT01352741|102073226|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
33596405|NCT01352741|102073227|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
33596406|NCT01352741|102073226|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
33596407|NCT01352741|102073227|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
33596408|NCT00866047|102073228|FG000|Treatment Period|Progressive disease|13|||
33596409|NCT00866047|102073228|FG000|Treatment Period|Adverse Event|16|||
33596410|NCT00866047|102073228|FG000|Treatment Period|Physician Decision|14|||
33596411|NCT00866047|102073228|FG000|Treatment Period|Withdrawal by Subject|5|||
33596412|NCT00866047|102073228|FG000|Follow-up Period|Lost to Follow-up|5|||
33596413|NCT01571284|102073229|FG000|Overall Study|Participant's decision|84|||
33596414|NCT01571284|102073229|FG000|Overall Study|Lost to Follow-up|3|||
33596415|NCT01571284|102073229|FG000|Overall Study|Enrolled but not treated|2|||
33596416|NCT01571284|102073229|FG000|Overall Study|Other than specified above|80|||
33596417|NCT00896363|102073230|FG000|Overall Study|Adverse Event|3|||
33596418|NCT00896363|102073231|FG001|Overall Study|Adverse Event|4|||
33596419|NCT00896363|102073232|FG002|Overall Study|Adverse Event|2|||
33596420|NCT00896363|102073230|FG000|Overall Study|Lack of Efficacy|0|||
33596421|NCT00896363|102073231|FG001|Overall Study|Lack of Efficacy|2|||
33596422|NCT00896363|102073232|FG002|Overall Study|Lack of Efficacy|1|||
33596423|NCT00896363|102073230|FG000|Overall Study|Withdrawal by Subject|3|||
33596424|NCT00896363|102073231|FG001|Overall Study|Withdrawal by Subject|5|||
33596425|NCT00896363|102073232|FG002|Overall Study|Withdrawal by Subject|5|||
33596426|NCT01779869|102073233|FG000|Overall Study|Physician Decision|2|||
33596427|NCT01327053|102073234|FG000|Overall Study|Adverse Event|23|||
33596428|NCT01327053|102073235|FG001|Overall Study|Adverse Event|57|||
33596429|NCT01327053|102073234|FG000|Overall Study|Patient/guardian decision|11|||
33596430|NCT01327053|102073235|FG001|Overall Study|Patient/guardian decision|35|||
33596431|NCT01327053|102073234|FG000|Overall Study|Physician Decision|10|||
33596432|NCT01327053|102073235|FG001|Overall Study|Physician Decision|14|||
33596433|NCT01327053|102073234|FG000|Overall Study|Death|1|||
33596434|NCT01327053|102073235|FG001|Overall Study|Death|5|||
33596435|NCT01327053|102073234|FG000|Overall Study|Lost to Follow-up|2|||
33596436|NCT01327053|102073235|FG001|Overall Study|Lost to Follow-up|4|||
33596437|NCT01327053|102073234|FG000|Overall Study|Non-compliance with study treatment|0|||
33596438|NCT01327053|102073235|FG001|Overall Study|Non-compliance with study treatment|5|||
33596439|NCT01327053|102073234|FG000|Overall Study|Study terminated by Sponsor|1|||
33596440|NCT01327053|102073235|FG001|Overall Study|Study terminated by Sponsor|3|||
33596441|NCT01327053|102073234|FG000|Overall Study|Progressive disease|31|||
33596442|NCT01327053|102073235|FG001|Overall Study|Progressive disease|26|||
33596443|NCT01327053|102073234|FG000|Overall Study|Protocol Violation|0|||
33596444|NCT01327053|102073235|FG001|Overall Study|Protocol Violation|1|||
33596445|NCT01327053|102073234|FG000|Overall Study|Untreated|0|||
33596446|NCT01327053|102073235|FG001|Overall Study|Untreated|1|||
33596447|NCT01080768|102073236|FG000|Overall Study|Protocol Deviation|2|||
33596448|NCT01080768|102073237|FG001|Overall Study|Protocol Deviation|1|||
33596449|NCT02229214|102073238|FG000|Overall Study|Adverse Event|2|||
33596450|NCT02229214|102073239|FG001|Overall Study|Adverse Event|0|||
33596451|NCT02229214|102073238|FG000|Overall Study|Withdrawal by Subject|4|||
33596452|NCT02229214|102073239|FG001|Overall Study|Withdrawal by Subject|0|||
33596453|NCT02509039|102073240|FG000|Overall Study|Adverse Event|0|||
33596454|NCT02509039|102073241|FG001|Overall Study|Adverse Event|1|||
33596455|NCT02509039|102073242|FG002|Overall Study|Adverse Event|1|||
33596456|NCT02509039|102073243|FG003|Overall Study|Adverse Event|1|||
33596457|NCT02509039|102073240|FG000|Overall Study|Withdrawal by Subject|0|||
33596458|NCT02509039|102073241|FG001|Overall Study|Withdrawal by Subject|0|||
33596459|NCT02509039|102073242|FG002|Overall Study|Withdrawal by Subject|1|||
33596460|NCT02509039|102073243|FG003|Overall Study|Withdrawal by Subject|0|||
33596461|NCT02509039|102073240|FG000|Overall Study|Progressive disease|2|||
33596462|NCT02509039|102073241|FG001|Overall Study|Progressive disease|2|||
33596463|NCT02509039|102073242|FG002|Overall Study|Progressive disease|1|||
33596464|NCT02509039|102073243|FG003|Overall Study|Progressive disease|5|||
33596465|NCT02509039|102073240|FG000|Overall Study|Study terminated by Sponsor|1|||
33596466|NCT02509039|102073241|FG001|Overall Study|Study terminated by Sponsor|0|||
33596467|NCT02509039|102073242|FG002|Overall Study|Study terminated by Sponsor|0|||
33596468|NCT02509039|102073243|FG003|Overall Study|Study terminated by Sponsor|0|||
33596469|NCT04508751|102073244|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
33596470|NCT04508751|102073245|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
33596471|NCT04508751|102073246|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
33596472|NCT02240368|102073247|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
33596473|NCT02240368|102073248|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
33596474|NCT02240368|102073249|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
33596475|NCT02240368|102073247|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
33596476|NCT02240368|102073248|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
33596477|NCT02240368|102073249|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
33596478|NCT01799239|102073250|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
33596479|NCT01799239|102073251|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
33596480|NCT01799239|102073250|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
33596481|NCT01799239|102073251|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
33596482|NCT01799239|102073250|FG000|Period 1 (7 Days)|Protocol Violation|0|||
33596483|NCT01799239|102073251|FG001|Period 1 (7 Days)|Protocol Violation|1|||
33596484|NCT01799239|102073250|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
33596485|NCT01799239|102073251|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
33596486|NCT01799239|102073250|FG000|Period 2 (7 Days)|Protocol Violation|1|||
33596487|NCT01799239|102073251|FG001|Period 2 (7 Days)|Protocol Violation|0|||
33596488|NCT03054350|102073252|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
33596489|NCT03054350|102073253|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
33596490|NCT03054350|102073254|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
33596491|NCT03054350|102073255|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
33596492|NCT03054350|102073256|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
33596493|NCT03054350|102073257|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
33596494|NCT03054350|102073252|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
33596495|NCT03054350|102073253|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
33596496|NCT03054350|102073254|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
33596497|NCT03054350|102073255|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
33596498|NCT03054350|102073256|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
33596499|NCT03054350|102073257|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
33596500|NCT03054350|102073252|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
33596501|NCT03054350|102073253|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
33596502|NCT03054350|102073254|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
33596503|NCT03054350|102073255|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
33596504|NCT03054350|102073256|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
33596505|NCT03054350|102073257|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
33596506|NCT03054350|102073252|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
33596507|NCT03054350|102073253|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
33596508|NCT03054350|102073254|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
33596509|NCT03054350|102073255|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
33596510|NCT03054350|102073256|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
33596511|NCT03054350|102073257|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
33596512|NCT00613925|102073260|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
33596513|NCT00613925|102073261|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
33596514|NCT03362931|102073267|FG000|Overall Study|Adverse Event|1|||
33596515|NCT03362931|102073267|FG000|Overall Study|Death|2|||
33596516|NCT01396265|102073270|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
33596517|NCT03831880|102073271|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
33596518|NCT03831880|102073272|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
33596519|NCT03831880|102073271|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
33596520|NCT03831880|102073272|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
33596521|NCT02256267|102073275|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
33596522|NCT02256267|102073275|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
33596523|NCT00585546|102073276|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
33596524|NCT00585546|102073276|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
33596525|NCT02460783|102073279|FG000|Overall Study|Withdrawal by Subject|1|||
33596526|NCT02460783|102073280|FG001|Overall Study|Withdrawal by Subject|3|||
33596527|NCT02460783|102073279|FG000|Overall Study|Lost to Follow-up|1|||
33596528|NCT02460783|102073280|FG001|Overall Study|Lost to Follow-up|1|||
33596529|NCT05427539|102073281|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
33596530|NCT05427539|102073282|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
33596531|NCT05427539|102073281|FG000|Period 1|Withdrawal by Subject|1|||
33596532|NCT05427539|102073282|FG001|Period 1|Withdrawal by Subject|0|||
33596533|NCT01218100|102073283|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
33596534|NCT01218100|102073284|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
33596535|NCT01218100|102073285|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
33596536|NCT01218100|102073286|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
33596537|NCT01218100|102073283|FG000|Overall Study|Adverse Event|4|||
33596538|NCT01218100|102073284|FG001|Overall Study|Adverse Event|6|||
33596539|NCT01218100|102073285|FG002|Overall Study|Adverse Event|6|||
33596540|NCT01218100|102073286|FG003|Overall Study|Adverse Event|7|||
33596541|NCT01218100|102073283|FG000|Overall Study|Lack of Efficacy|9|||
33596542|NCT01218100|102073284|FG001|Overall Study|Lack of Efficacy|6|||
33596543|NCT01218100|102073285|FG002|Overall Study|Lack of Efficacy|5|||
33596544|NCT01218100|102073286|FG003|Overall Study|Lack of Efficacy|12|||
33596545|NCT01218100|102073283|FG000|Overall Study|Protocol Violation|0|||
33596546|NCT01218100|102073284|FG001|Overall Study|Protocol Violation|0|||
33596547|NCT01218100|102073285|FG002|Overall Study|Protocol Violation|1|||
33596548|NCT01218100|102073286|FG003|Overall Study|Protocol Violation|1|||
33596549|NCT01218100|102073283|FG000|Overall Study|Withdrawal by Subject|5|||
33596550|NCT01218100|102073284|FG001|Overall Study|Withdrawal by Subject|2|||
33596551|NCT01218100|102073285|FG002|Overall Study|Withdrawal by Subject|6|||
33596552|NCT01218100|102073286|FG003|Overall Study|Withdrawal by Subject|7|||
33596553|NCT01218100|102073283|FG000|Overall Study|Lost to Follow-up|3|||
33596554|NCT01218100|102073284|FG001|Overall Study|Lost to Follow-up|8|||
33596555|NCT01218100|102073285|FG002|Overall Study|Lost to Follow-up|2|||
33596556|NCT01218100|102073286|FG003|Overall Study|Lost to Follow-up|1|||
33596557|NCT01218100|102073283|FG000|Overall Study|Other Reason|2|||
33596558|NCT01218100|102073284|FG001|Overall Study|Other Reason|2|||
33596559|NCT01218100|102073285|FG002|Overall Study|Other Reason|6|||
33596560|NCT01218100|102073286|FG003|Overall Study|Other Reason|4|||
33596561|NCT02141490|102073287|FG000|Overall Study|Screening failures|4|||
33596562|NCT02141490|102073288|FG001|Overall Study|Screening failures|0|||
33596563|NCT02141490|102073289|FG002|Overall Study|Screening failures|0|||
33596564|NCT00937404|102073298|FG000|Overall Study|Protocol Violation|1|||
33596565|NCT00937404|102073298|FG000|Overall Study|Withdrawal by Subject|1|||
33596566|NCT02098369|102073299|FG000|Overall Study|Withdrawal by Subject|1|||
33596567|NCT02098369|102073300|FG001|Overall Study|Withdrawal by Subject|5|||
33596568|NCT02098369|102073301|FG002|Overall Study|Withdrawal by Subject|0|||
33596569|NCT02098369|102073299|FG000|Overall Study|Lost to Follow-up|5|||
33596570|NCT02098369|102073300|FG001|Overall Study|Lost to Follow-up|1|||
33596571|NCT02098369|102073301|FG002|Overall Study|Lost to Follow-up|3|||
33596572|NCT02098369|102073299|FG000|Overall Study|Death|1|||
33596573|NCT02098369|102073300|FG001|Overall Study|Death|1|||
33596574|NCT02098369|102073301|FG002|Overall Study|Death|1|||
33596575|NCT02098369|102073299|FG000|Overall Study|Other|0|||
33596576|NCT02098369|102073300|FG001|Overall Study|Other|2|||
33596577|NCT02098369|102073301|FG002|Overall Study|Other|1|||
33596578|NCT01665430|102073302|FG000|Overall Study|Adverse Event|1|||
33596579|NCT01665430|102073302|FG000|Overall Study|Withdrawal by Subject|6|||
33596580|NCT01665430|102073302|FG000|Overall Study|Other Unspecified|2|||
33596581|NCT03100539|102073303|FG000|Overall Study|Lost to Follow-up|60|||
33596582|NCT03100539|102073304|FG001|Overall Study|Lost to Follow-up|54|||
33596583|NCT03100539|102073305|FG002|Overall Study|Lost to Follow-up|17|||
33596584|NCT03100539|102073303|FG000|Overall Study|Uncollected|8|||
33596585|NCT03100539|102073304|FG001|Overall Study|Uncollected|8|||
33596586|NCT03100539|102073305|FG002|Overall Study|Uncollected|0|||
33596587|NCT03100539|102073303|FG000|Overall Study|Ally Health|0|||
33596588|NCT03100539|102073304|FG001|Overall Study|Ally Health|0|||
33596589|NCT03100539|102073305|FG002|Overall Study|Ally Health|3|||
33596590|NCT03100539|102073303|FG000|Overall Study|Disinterest|0|||
33596591|NCT03100539|102073304|FG001|Overall Study|Disinterest|0|||
33596592|NCT03100539|102073305|FG002|Overall Study|Disinterest|22|||
33596593|NCT03100539|102073303|FG000|Overall Study|Veteran Health|0|||
33596594|NCT03100539|102073304|FG001|Overall Study|Veteran Health|0|||
33596595|NCT03100539|102073305|FG002|Overall Study|Veteran Health|8|||
33596596|NCT03100539|102073303|FG000|Overall Study|Moved|0|||
33596597|NCT03100539|102073304|FG001|Overall Study|Moved|0|||
33596598|NCT03100539|102073305|FG002|Overall Study|Moved|1|||
33596599|NCT03100539|102073303|FG000|Overall Study|Scheduling Conflicts|0|||
33596600|NCT03100539|102073304|FG001|Overall Study|Scheduling Conflicts|0|||
33596601|NCT03100539|102073305|FG002|Overall Study|Scheduling Conflicts|12|||
33596602|NCT00787930|102073306|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
33596603|NCT04569136|102073307|FG000|Overall Study|Lost to Follow-up|2|||
33596604|NCT04569136|102073308|FG001|Overall Study|Lost to Follow-up|0|||
33596605|NCT04569136|102073309|FG002|Overall Study|Lost to Follow-up|1|||
33596606|NCT02370641|102073310|FG000|Overall Study|dropped study|4|||
33596607|NCT02370641|102073311|FG001|Overall Study|dropped study|2|||
33596608|NCT00888329|102073312|FG000|Overall Study|Physician Decision|6|||
33596609|NCT00888329|102073313|FG001|Overall Study|Physician Decision|9|||
33596610|NCT01466660|102073314|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
33596611|NCT01466660|102073315|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
33596612|NCT01466660|102073314|FG000|Overall Study|Worsening of underlying cancer disease|5|||
33596613|NCT01466660|102073315|FG001|Overall Study|Worsening of underlying cancer disease|2|||
33596614|NCT01466660|102073314|FG000|Overall Study|Other adverse event|19|||
33596615|NCT01466660|102073315|FG001|Overall Study|Other adverse event|18|||
33596616|NCT01466660|102073314|FG000|Overall Study|Protocol Violation|2|||
33596617|NCT01466660|102073315|FG001|Overall Study|Protocol Violation|1|||
33596618|NCT01466660|102073314|FG000|Overall Study|Refused continuation of trial medication|4|||
33596619|NCT01466660|102073315|FG001|Overall Study|Refused continuation of trial medication|3|||
33596620|NCT01466660|102073314|FG000|Overall Study|Other reason not defined above|10|||
33596621|NCT01466660|102073315|FG001|Overall Study|Other reason not defined above|8|||
33596622|NCT03500172|102073316|FG000|Period 1: Baseline Randomization|Death|0|||
33596623|NCT03500172|102073317|FG001|Period 1: Baseline Randomization|Death|0|||
33596624|NCT03500172|102073318|FG002|Period 1: Baseline Randomization|Death|0|||
33596625|NCT03500172|102073319|FG003|Period 1: Baseline Randomization|Death|0|||
33596626|NCT03500172|102073320|FG004|Period 1: Baseline Randomization|Death|0|||
33596627|NCT03500172|102073321|FG005|Period 1: Baseline Randomization|Death|0|||
33596628|NCT03500172|102073322|FG006|Period 1: Baseline Randomization|Death|0|||
33596629|NCT03500172|102073323|FG007|Period 1: Baseline Randomization|Death|0|||
33596630|NCT03500172|102073324|FG008|Period 1: Baseline Randomization|Death|0|||
33596631|NCT03500172|102073325|FG009|Period 1: Baseline Randomization|Death|2|||
33596632|NCT03500172|102073326|FG010|Period 1: Baseline Randomization|Death|0|||
33596633|NCT03500172|102073316|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
33596634|NCT03500172|102073317|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
33596635|NCT03500172|102073318|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
33596636|NCT03500172|102073319|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
33596637|NCT03500172|102073320|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
33596638|NCT03500172|102073321|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
33596639|NCT03500172|102073322|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
33596640|NCT03500172|102073323|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
33596641|NCT03500172|102073324|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
33596642|NCT03500172|102073325|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
33596643|NCT03500172|102073326|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
33596644|NCT03500172|102073316|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
33596645|NCT03500172|102073317|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
33596646|NCT03500172|102073318|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
33596647|NCT03500172|102073319|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
33596648|NCT03500172|102073320|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
33596649|NCT03500172|102073321|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
33596650|NCT03500172|102073322|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
33596651|NCT03500172|102073323|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
33596652|NCT03500172|102073324|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
33596653|NCT03500172|102073325|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
33596654|NCT03500172|102073326|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
33596655|NCT03500172|102073316|FG000|Period 2: Re-Randomization|Death|0|||
33596656|NCT03500172|102073317|FG001|Period 2: Re-Randomization|Death|0|||
33596657|NCT03500172|102073318|FG002|Period 2: Re-Randomization|Death|0|||
33596658|NCT03500172|102073319|FG003|Period 2: Re-Randomization|Death|4|||
33596659|NCT03500172|102073320|FG004|Period 2: Re-Randomization|Death|2|||
33596660|NCT03500172|102073321|FG005|Period 2: Re-Randomization|Death|0|||
33596661|NCT03500172|102073322|FG006|Period 2: Re-Randomization|Death|5|||
33596662|NCT03500172|102073323|FG007|Period 2: Re-Randomization|Death|2|||
33596663|NCT03500172|102073324|FG008|Period 2: Re-Randomization|Death|0|||
33596664|NCT03500172|102073325|FG009|Period 2: Re-Randomization|Death|0|||
33596665|NCT03500172|102073326|FG010|Period 2: Re-Randomization|Death|0|||
33596666|NCT01453946|102073330|FG000|Overall Study|Did not receive drug for the taper phase|1|||
33596667|NCT01453946|102073330|FG000|Overall Study|Protocol Violation|2|||
33596668|NCT01453946|102073330|FG000|Overall Study|Lack of Efficacy|3|||
33596669|NCT01453946|102073330|FG000|Overall Study|Adverse Event|3|||
33596670|NCT01028716|102073331|FG000|Overall Study|Physician Decision|1|||
33596671|NCT02233738|102073334|FG000|Overall Study|Lost to Follow-up|5|||
33596672|NCT02233738|102073335|FG001|Overall Study|Lost to Follow-up|12|||
33596673|NCT02233738|102073334|FG000|Overall Study|Death|0|||
33596674|NCT02233738|102073335|FG001|Overall Study|Death|1|||
33596675|NCT02233738|102073334|FG000|Overall Study|Withdrawal by Subject|0|||
33596676|NCT02233738|102073335|FG001|Overall Study|Withdrawal by Subject|1|||
33596677|NCT02233738|102073334|FG000|Overall Study|Did not return after Baseline|3|||
33596678|NCT02233738|102073335|FG001|Overall Study|Did not return after Baseline|2|||
33596679|NCT03770728|102073336|FG000|Overall Study|Adverse Event|1|||
33596680|NCT03770728|102073337|FG001|Overall Study|Adverse Event|0|||
33596681|NCT03770728|102073338|FG002|Overall Study|Adverse Event|1|||
33596682|NCT03770728|102073339|FG003|Overall Study|Adverse Event|0|||
33596683|NCT03770728|102073336|FG000|Overall Study|Poor compliance to protocol|0|||
33596684|NCT03770728|102073337|FG001|Overall Study|Poor compliance to protocol|0|||
33596685|NCT03770728|102073338|FG002|Overall Study|Poor compliance to protocol|1|||
33596686|NCT03770728|102073339|FG003|Overall Study|Poor compliance to protocol|0|||
33596687|NCT03770728|102073336|FG000|Overall Study|Withdrawal by Subject|13|||
33596688|NCT03770728|102073337|FG001|Overall Study|Withdrawal by Subject|8|||
33596689|NCT03770728|102073338|FG002|Overall Study|Withdrawal by Subject|9|||
33596690|NCT03770728|102073339|FG003|Overall Study|Withdrawal by Subject|13|||
33596691|NCT03770728|102073336|FG000|Overall Study|Other than specified|24|||
33596692|NCT03770728|102073337|FG001|Overall Study|Other than specified|23|||
33596693|NCT03770728|102073338|FG002|Overall Study|Other than specified|21|||
33596694|NCT03770728|102073339|FG003|Overall Study|Other than specified|22|||
33596695|NCT03724981|102073340|FG000|First Device|Protocol Violation|1|||
33596696|NCT03724981|102073341|FG001|First Device|Protocol Violation|1|||
33596697|NCT01135914|102073342|FG000|Overall Study|Withdrawal by Subject|1|||
33596698|NCT01135914|102073343|FG001|Overall Study|Withdrawal by Subject|3|||
33596699|NCT01135914|102073344|FG002|Overall Study|Withdrawal by Subject|6|||
33596700|NCT01135914|102073342|FG000|Overall Study|Lost to Follow-up|1|||
33596701|NCT01135914|102073343|FG001|Overall Study|Lost to Follow-up|0|||
33596702|NCT01135914|102073344|FG002|Overall Study|Lost to Follow-up|1|||
33596703|NCT01135914|102073342|FG000|Overall Study|Protocol Violation|0|||
33596704|NCT01135914|102073343|FG001|Overall Study|Protocol Violation|0|||
33596705|NCT01135914|102073344|FG002|Overall Study|Protocol Violation|3|||
33596706|NCT01135914|102073342|FG000|Overall Study|Lack of Efficacy|2|||
33596707|NCT01135914|102073343|FG001|Overall Study|Lack of Efficacy|1|||
33596708|NCT01135914|102073344|FG002|Overall Study|Lack of Efficacy|10|||
33596709|NCT01135914|102073342|FG000|Overall Study|Adverse Event|0|||
33596710|NCT01135914|102073343|FG001|Overall Study|Adverse Event|1|||
33596711|NCT01135914|102073344|FG002|Overall Study|Adverse Event|2|||
33596712|NCT03610581|102073348|FG000|Overall Study|Study terminated by sponsor|2|||
33596713|NCT03610581|102073349|FG001|Overall Study|Study terminated by sponsor|0|||
33596714|NCT03610581|102073348|FG000|Overall Study|Other|0|||
33596715|NCT03610581|102073349|FG001|Overall Study|Other|1|||
33596716|NCT03610581|102073348|FG000|Overall Study|Withdrawal by Subject|1|||
33596717|NCT03610581|102073349|FG001|Overall Study|Withdrawal by Subject|0|||
33596718|NCT00006046|102073353|FG000|Overall Study|Adverse Event|3|||
33596719|NCT00006046|102073354|FG001|Overall Study|Adverse Event|0|||
33596720|NCT00006046|102073355|FG002|Overall Study|Adverse Event|0|||
33596721|NCT00006046|102073356|FG003|Overall Study|Adverse Event|0|||
33596722|NCT00006046|102073357|FG004|Overall Study|Adverse Event|0|||
33596723|NCT00006046|102073353|FG000|Overall Study|Disease Progression|2|||
33596724|NCT00006046|102073354|FG001|Overall Study|Disease Progression|0|||
33596725|NCT00006046|102073355|FG002|Overall Study|Disease Progression|0|||
33596726|NCT00006046|102073356|FG003|Overall Study|Disease Progression|0|||
33596727|NCT00006046|102073357|FG004|Overall Study|Disease Progression|0|||
33596728|NCT00493636|102073358|FG000|Overall Study|Withdrawal by Subject|1|||
33596729|NCT00493636|102073359|FG001|Overall Study|Withdrawal by Subject|0|||
33596730|NCT00493636|102073358|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
33596731|NCT00493636|102073359|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
33596732|NCT00493636|102073358|FG000|Overall Study|Mis-randomization|1|||
33596733|NCT00493636|102073359|FG001|Overall Study|Mis-randomization|1|||
33596734|NCT03158272|102073360|FG000|Overall Study|Disease progression|3|||
33596735|NCT03158272|102073361|FG001|Overall Study|Disease progression|3|||
33596736|NCT03158272|102073362|FG002|Overall Study|Disease progression|4|||
33596737|NCT03158272|102073363|FG003|Overall Study|Disease progression|6|||
33596738|NCT03158272|102073360|FG000|Overall Study|Death|0|||
33596739|NCT03158272|102073361|FG001|Overall Study|Death|0|||
33596740|NCT03158272|102073362|FG002|Overall Study|Death|1|||
33596741|NCT03158272|102073363|FG003|Overall Study|Death|0|||
33596742|NCT03158272|102073360|FG000|Overall Study|Other reasons|0|||
33596743|NCT03158272|102073361|FG001|Overall Study|Other reasons|0|||
33596744|NCT03158272|102073362|FG002|Overall Study|Other reasons|1|||
33596745|NCT03158272|102073363|FG003|Overall Study|Other reasons|0|||
33596746|NCT03158272|102073360|FG000|Overall Study|Adverse event unrelated to the drug|0|||
33596747|NCT03158272|102073361|FG001|Overall Study|Adverse event unrelated to the drug|1|||
33596748|NCT03158272|102073362|FG002|Overall Study|Adverse event unrelated to the drug|0|||
33596749|NCT03158272|102073363|FG003|Overall Study|Adverse event unrelated to the drug|0|||
33596750|NCT03510468|102073366|FG000|Overall Study|Lost to Follow-up|1|||
33596751|NCT03510468|102073366|FG000|Overall Study|Adverse Event|5|||
33596752|NCT03510468|102073366|FG000|Overall Study|Physician Decision|1|||
33596753|NCT03510468|102073366|FG000|Overall Study|non-compliant with treatment|2|||
33596754|NCT03510468|102073366|FG000|Overall Study|Missed visit|1|||
33596755|NCT03176472|102073367|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
33596756|NCT03176472|102073368|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
33596757|NCT03176472|102073367|FG000|Double Blind Treatment Period|Adverse Event|0|||
33596758|NCT03176472|102073368|FG001|Double Blind Treatment Period|Adverse Event|5|||
33596759|NCT03176472|102073367|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
33596760|NCT03176472|102073368|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
33596761|NCT03176472|102073367|FG000|Double Blind Treatment Period|Physician Decision|0|||
33596762|NCT03176472|102073368|FG001|Double Blind Treatment Period|Physician Decision|1|||
33596763|NCT03176472|102073367|FG000|Double Blind Treatment Period|Protocol Violation|1|||
33596764|NCT03176472|102073368|FG001|Double Blind Treatment Period|Protocol Violation|0|||
33596765|NCT03176472|102073367|FG000|Double Blind Treatment Period|Not Provided|1|||
33596766|NCT03176472|102073368|FG001|Double Blind Treatment Period|Not Provided|0|||
33596767|NCT03176472|102073367|FG000|Open Label Extension|Withdrawal by Subject|3|||
33596768|NCT03176472|102073368|FG001|Open Label Extension|Withdrawal by Subject|4|||
33596769|NCT03176472|102073367|FG000|Open Label Extension|Adverse Event|2|||
33596770|NCT03176472|102073368|FG001|Open Label Extension|Adverse Event|4|||
33596771|NCT03176472|102073367|FG000|Open Label Extension|Lost to Follow-up|1|||
33596772|NCT03176472|102073368|FG001|Open Label Extension|Lost to Follow-up|2|||
33596773|NCT03176472|102073367|FG000|Open Label Extension|Protocol Violation|0|||
33596774|NCT03176472|102073368|FG001|Open Label Extension|Protocol Violation|1|||
33596775|NCT03176472|102073367|FG000|Open Label Extension|Not Provided|2|||
33596776|NCT03176472|102073368|FG001|Open Label Extension|Not Provided|1|||
33596777|NCT01598753|102073375|FG000|Overall Study|Adverse Event|1|||
33596778|NCT01598753|102073376|FG001|Overall Study|Adverse Event|9|||
33596779|NCT01598753|102073377|FG002|Overall Study|Adverse Event|1|||
33596780|NCT01598753|102073378|FG003|Overall Study|Adverse Event|7|||
33596781|NCT01598753|102073375|FG000|Overall Study|Lost to Follow-up|4|||
33596782|NCT01598753|102073376|FG001|Overall Study|Lost to Follow-up|3|||
33596783|NCT01598753|102073377|FG002|Overall Study|Lost to Follow-up|7|||
33596784|NCT01598753|102073378|FG003|Overall Study|Lost to Follow-up|5|||
33596785|NCT01598753|102073375|FG000|Overall Study|Physician Decision|0|||
33596786|NCT01598753|102073376|FG001|Overall Study|Physician Decision|1|||
33596787|NCT01598753|102073377|FG002|Overall Study|Physician Decision|0|||
33596788|NCT01598753|102073378|FG003|Overall Study|Physician Decision|2|||
33596789|NCT01598753|102073375|FG000|Overall Study|Withdrawal by Subject|7|||
33596790|NCT01598753|102073376|FG001|Overall Study|Withdrawal by Subject|2|||
33596791|NCT01598753|102073377|FG002|Overall Study|Withdrawal by Subject|0|||
33596792|NCT01598753|102073378|FG003|Overall Study|Withdrawal by Subject|1|||
33596793|NCT00246025|102073381|FG000|Overall Study|Adverse Event|7|||
33596794|NCT00246025|102073382|FG001|Overall Study|Adverse Event|9|||
33596795|NCT00246025|102073383|FG002|Overall Study|Adverse Event|9|||
33596796|NCT00246025|102073384|FG003|Overall Study|Adverse Event|10|||
33596797|NCT00246025|102073381|FG000|Overall Study|Withdrawal by Subject|3|||
33596798|NCT00246025|102073382|FG001|Overall Study|Withdrawal by Subject|0|||
33596799|NCT00246025|102073383|FG002|Overall Study|Withdrawal by Subject|1|||
33596800|NCT00246025|102073384|FG003|Overall Study|Withdrawal by Subject|2|||
33596801|NCT00246025|102073381|FG000|Overall Study|unsuitable medical history was found|0|||
33596802|NCT00246025|102073382|FG001|Overall Study|unsuitable medical history was found|0|||
33596803|NCT00246025|102073383|FG002|Overall Study|unsuitable medical history was found|0|||
33596804|NCT00246025|102073384|FG003|Overall Study|unsuitable medical history was found|1|||
33596805|NCT00076336|102073390|FG000|Overall Study|Death|13|||
33596806|NCT00076336|102073391|FG001|Overall Study|Death|17|||
33596807|NCT00076336|102073390|FG000|Overall Study|Adverse Event|4|||
33596808|NCT00076336|102073391|FG001|Overall Study|Adverse Event|4|||
33596809|NCT00076336|102073390|FG000|Overall Study|Lost to Follow-up|4|||
33596810|NCT00076336|102073391|FG001|Overall Study|Lost to Follow-up|4|||
33596811|NCT00076336|102073390|FG000|Overall Study|Non-Compliance|2|||
33596812|NCT00076336|102073391|FG001|Overall Study|Non-Compliance|0|||
33596813|NCT00076336|102073390|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
33596814|NCT00076336|102073391|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
33596815|NCT00076336|102073390|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
33596816|NCT00076336|102073391|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
33596817|NCT00076336|102073390|FG000|Overall Study|Liver Transplantation|3|||
33596818|NCT00076336|102073391|FG001|Overall Study|Liver Transplantation|3|||
33596819|NCT00076336|102073390|FG000|Overall Study|Virologic Breakthrough|14|||
33596820|NCT00076336|102073391|FG001|Overall Study|Virologic Breakthrough|16|||
33596821|NCT00076336|102073390|FG000|Overall Study|Treatment failure|4|||
33596822|NCT00076336|102073391|FG001|Overall Study|Treatment failure|5|||
33596823|NCT01238835|102073392|FG000|Overall Study|Death|124|||
33596824|NCT01238835|102073392|FG000|Overall Study|Withdrawal by Subject|9|||
33596825|NCT01238835|102073392|FG000|Overall Study|Lost to Follow-up|1|||
33596826|NCT01238835|102073392|FG000|Overall Study|Site early discontinuation|2|||
33596827|NCT04346108|102073393|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
33596828|NCT04346108|102073394|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
33596829|NCT04346108|102073395|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
33596830|NCT04346108|102073393|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
33596831|NCT04346108|102073394|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
33596832|NCT04346108|102073395|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
33596833|NCT00445848|102073403|FG000|Overall Study|Adverse Event|14|||
33596834|NCT00445848|102073403|FG000|Overall Study|Withdrawal by Subject|4|||
33596835|NCT00445848|102073403|FG000|Overall Study|Progression|62|||
33596836|NCT00445848|102073403|FG000|Overall Study|Other-Not protocol specified|5|||
33596837|NCT02088073|102073404|FG000|Acute Phase|Withdrawal by Subject|5|||
33596838|NCT02088073|102073405|FG001|Acute Phase|Withdrawal by Subject|0|||
33596839|NCT02088073|102073406|FG002|Acute Phase|Withdrawal by Subject|0|||
33596840|NCT02088073|102073407|FG003|Acute Phase|Withdrawal by Subject|0|||
33596841|NCT02088073|102073408|FG004|Acute Phase|Withdrawal by Subject|0|||
33596842|NCT02088073|102073404|FG000|Acute Phase|Hyperkalemia|2|||
33596843|NCT02088073|102073405|FG001|Acute Phase|Hyperkalemia|0|||
33596844|NCT02088073|102073406|FG002|Acute Phase|Hyperkalemia|0|||
33596845|NCT02088073|102073407|FG003|Acute Phase|Hyperkalemia|0|||
33596846|NCT02088073|102073408|FG004|Acute Phase|Hyperkalemia|0|||
33596847|NCT02088073|102073404|FG000|Maintanance Phase|Withdrawal by Subject|0|||
33596848|NCT02088073|102073405|FG001|Maintanance Phase|Withdrawal by Subject|2|||
33596849|NCT02088073|102073406|FG002|Maintanance Phase|Withdrawal by Subject|0|||
33596850|NCT02088073|102073407|FG003|Maintanance Phase|Withdrawal by Subject|0|||
33596851|NCT02088073|102073408|FG004|Maintanance Phase|Withdrawal by Subject|0|||
33596852|NCT02088073|102073404|FG000|Maintanance Phase|Adverse Event|0|||
33596853|NCT02088073|102073405|FG001|Maintanance Phase|Adverse Event|0|||
33596854|NCT02088073|102073406|FG002|Maintanance Phase|Adverse Event|3|||
33596855|NCT02088073|102073407|FG003|Maintanance Phase|Adverse Event|0|||
33596856|NCT02088073|102073408|FG004|Maintanance Phase|Adverse Event|1|||
33596857|NCT02088073|102073404|FG000|Maintanance Phase|Physician Decision|0|||
33596858|NCT02088073|102073405|FG001|Maintanance Phase|Physician Decision|0|||
33596859|NCT02088073|102073406|FG002|Maintanance Phase|Physician Decision|0|||
33596860|NCT02088073|102073407|FG003|Maintanance Phase|Physician Decision|0|||
33596861|NCT02088073|102073408|FG004|Maintanance Phase|Physician Decision|1|||
33596862|NCT02088073|102073404|FG000|Maintanance Phase|Sponsor's decision|0|||
33596863|NCT02088073|102073405|FG001|Maintanance Phase|Sponsor's decision|2|||
33596864|NCT02088073|102073406|FG002|Maintanance Phase|Sponsor's decision|0|||
33596865|NCT02088073|102073407|FG003|Maintanance Phase|Sponsor's decision|2|||
33596866|NCT02088073|102073408|FG004|Maintanance Phase|Sponsor's decision|1|||
33596867|NCT02088073|102073404|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
33596868|NCT02088073|102073405|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
33596869|NCT02088073|102073406|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
33596870|NCT02088073|102073407|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
33596871|NCT02088073|102073408|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
33596872|NCT02088073|102073404|FG000|Maintanance Phase|Miscellaneous|0|||
33596873|NCT02088073|102073405|FG001|Maintanance Phase|Miscellaneous|2|||
33596874|NCT02088073|102073406|FG002|Maintanance Phase|Miscellaneous|1|||
33596875|NCT02088073|102073407|FG003|Maintanance Phase|Miscellaneous|2|||
33596876|NCT02088073|102073408|FG004|Maintanance Phase|Miscellaneous|1|||
33596877|NCT02088073|102073404|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
33596878|NCT02088073|102073405|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
33596879|NCT02088073|102073406|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
33596880|NCT02088073|102073407|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
33596881|NCT02088073|102073408|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
33596882|NCT02088073|102073404|FG000|Maintanance Phase|Subject compliance|0|||
33596883|NCT02088073|102073405|FG001|Maintanance Phase|Subject compliance|1|||
33596884|NCT02088073|102073406|FG002|Maintanance Phase|Subject compliance|0|||
33596885|NCT02088073|102073407|FG003|Maintanance Phase|Subject compliance|0|||
33596886|NCT02088073|102073408|FG004|Maintanance Phase|Subject compliance|0|||
33596887|NCT00996281|102073409|FG000|Overall Study|Adverse Event|75|||
33596888|NCT00996281|102073410|FG001|Overall Study|Adverse Event|37|||
33596889|NCT00996281|102073409|FG000|Overall Study|Major Protocol Deviation|6|||
33596890|NCT00996281|102073410|FG001|Overall Study|Major Protocol Deviation|7|||
33596891|NCT00996281|102073409|FG000|Overall Study|Lost to Follow-up|14|||
33596892|NCT00996281|102073410|FG001|Overall Study|Lost to Follow-up|16|||
33596893|NCT00996281|102073409|FG000|Overall Study|Withdrawal by Subject|31|||
33596894|NCT00996281|102073410|FG001|Overall Study|Withdrawal by Subject|20|||
33596895|NCT00996281|102073409|FG000|Overall Study|Lack of Efficacy|0|||
33596896|NCT00996281|102073410|FG001|Overall Study|Lack of Efficacy|2|||
33596897|NCT00996281|102073409|FG000|Overall Study|Other|5|||
33596898|NCT00996281|102073410|FG001|Overall Study|Other|7|||
33596899|NCT00068250|102073411|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
33596900|NCT00068250|102073412|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
33596901|NCT00068250|102073413|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
33596902|NCT00068250|102073414|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
33596903|NCT01185964|102073415|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
33596904|NCT01185964|102073416|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
33596905|NCT01185964|102073417|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
33596906|NCT01185964|102073418|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
33596907|NCT01185964|102073415|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
33596908|NCT01185964|102073416|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
33596909|NCT01185964|102073417|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
33596910|NCT01185964|102073418|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
33596911|NCT01185964|102073415|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
33596912|NCT01185964|102073416|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
33596913|NCT01185964|102073417|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
33596914|NCT01185964|102073418|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
33596915|NCT01185964|102073415|FG000|Phase 1b and Phase 2|Adverse Event|1|||
33596916|NCT01185964|102073416|FG001|Phase 1b and Phase 2|Adverse Event|0|||
33596917|NCT01185964|102073417|FG002|Phase 1b and Phase 2|Adverse Event|2|||
33596918|NCT01185964|102073418|FG003|Phase 1b and Phase 2|Adverse Event|0|||
33596919|NCT01185964|102073415|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
33596920|NCT01185964|102073416|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
33596921|NCT01185964|102073417|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
33596922|NCT01185964|102073418|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
33596923|NCT01185964|102073415|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
33596924|NCT01185964|102073416|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
33596925|NCT01185964|102073417|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
33596926|NCT01185964|102073418|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
33596927|NCT01185964|102073415|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
33596928|NCT01185964|102073416|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
33596929|NCT01185964|102073417|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
33596930|NCT01185964|102073418|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
33596931|NCT01185964|102073415|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
33596932|NCT01185964|102073416|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
33596933|NCT01185964|102073417|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
33596934|NCT01185964|102073418|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
33596935|NCT01967823|102073423|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
33596936|NCT01778049|102073426|FG000|Open Label Treatment Period|Adverse Event|5|||
33596937|NCT01778049|102073427|FG001|Open Label Treatment Period|Adverse Event|15|||
33596938|NCT01778049|102073428|FG002|Open Label Treatment Period|Adverse Event|0|||
33596939|NCT01778049|102073429|FG003|Open Label Treatment Period|Adverse Event|0|||
33596940|NCT01778049|102073430|FG004|Open Label Treatment Period|Adverse Event|0|||
33596941|NCT01778049|102073431|FG005|Open Label Treatment Period|Adverse Event|0|||
33596942|NCT01778049|102073426|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
33596943|NCT01778049|102073427|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
33596944|NCT01778049|102073428|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
33596945|NCT01778049|102073429|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
33596946|NCT01778049|102073430|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
33596947|NCT01778049|102073431|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
33596948|NCT01778049|102073426|FG000|Open Label Treatment Period|Protocol Violation|5|||
33596949|NCT01778049|102073427|FG001|Open Label Treatment Period|Protocol Violation|5|||
33596950|NCT01778049|102073428|FG002|Open Label Treatment Period|Protocol Violation|0|||
33596951|NCT01778049|102073429|FG003|Open Label Treatment Period|Protocol Violation|0|||
33596952|NCT01778049|102073430|FG004|Open Label Treatment Period|Protocol Violation|0|||
33596953|NCT01778049|102073431|FG005|Open Label Treatment Period|Protocol Violation|0|||
33596954|NCT01778049|102073426|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
33596955|NCT01778049|102073427|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
33596956|NCT01778049|102073428|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
33596957|NCT01778049|102073429|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
33596958|NCT01778049|102073430|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
33596959|NCT01778049|102073431|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
33596960|NCT01778049|102073426|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
33596961|NCT01778049|102073427|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
33596962|NCT01778049|102073428|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
33596963|NCT01778049|102073429|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
33596964|NCT01778049|102073430|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
33596965|NCT01778049|102073431|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
33596966|NCT01778049|102073426|FG000|Open Label Treatment Period|Not treated|2|||
33596967|NCT01778049|102073427|FG001|Open Label Treatment Period|Not treated|1|||
33596968|NCT01778049|102073428|FG002|Open Label Treatment Period|Not treated|0|||
33596969|NCT01778049|102073429|FG003|Open Label Treatment Period|Not treated|0|||
33596970|NCT01778049|102073430|FG004|Open Label Treatment Period|Not treated|0|||
33596971|NCT01778049|102073431|FG005|Open Label Treatment Period|Not treated|0|||
33596972|NCT01778049|102073426|FG000|Open Label Treatment Period|Other reason not defined above|77|||
33596973|NCT01778049|102073427|FG001|Open Label Treatment Period|Other reason not defined above|94|||
33596974|NCT01778049|102073428|FG002|Open Label Treatment Period|Other reason not defined above|0|||
33596975|NCT01778049|102073429|FG003|Open Label Treatment Period|Other reason not defined above|0|||
33596976|NCT01778049|102073430|FG004|Open Label Treatment Period|Other reason not defined above|0|||
33596977|NCT01778049|102073431|FG005|Open Label Treatment Period|Other reason not defined above|0|||
33596978|NCT01778049|102073426|FG000|Double Blind Treatment Period|Adverse Event|0|||
33596979|NCT01778049|102073427|FG001|Double Blind Treatment Period|Adverse Event|0|||
33596980|NCT01778049|102073428|FG002|Double Blind Treatment Period|Adverse Event|4|||
33596981|NCT01778049|102073429|FG003|Double Blind Treatment Period|Adverse Event|5|||
33596982|NCT01778049|102073430|FG004|Double Blind Treatment Period|Adverse Event|3|||
33596983|NCT01778049|102073431|FG005|Double Blind Treatment Period|Adverse Event|2|||
33596984|NCT01778049|102073426|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
33596985|NCT01778049|102073427|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
33596986|NCT01778049|102073428|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
33596987|NCT01778049|102073429|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
33596988|NCT01778049|102073430|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
33596989|NCT01778049|102073431|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
33596990|NCT01778049|102073426|FG000|Double Blind Treatment Period|Protocol Violation|0|||
33596991|NCT01778049|102073427|FG001|Double Blind Treatment Period|Protocol Violation|0|||
33596992|NCT01778049|102073428|FG002|Double Blind Treatment Period|Protocol Violation|2|||
33596993|NCT01778049|102073429|FG003|Double Blind Treatment Period|Protocol Violation|0|||
33596994|NCT01778049|102073430|FG004|Double Blind Treatment Period|Protocol Violation|0|||
33596995|NCT01778049|102073431|FG005|Double Blind Treatment Period|Protocol Violation|0|||
33596996|NCT01778049|102073426|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
33596997|NCT01778049|102073427|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
33596998|NCT01778049|102073428|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
33596999|NCT01778049|102073429|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
33597000|NCT01778049|102073430|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
33597001|NCT01778049|102073431|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
33597002|NCT01778049|102073426|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
33597003|NCT01778049|102073427|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
33597004|NCT01778049|102073428|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
33597005|NCT01778049|102073429|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
33597006|NCT01778049|102073430|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
33597007|NCT01778049|102073431|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
33597008|NCT01778049|102073426|FG000|Double Blind Treatment Period|Not treated|0|||
33597009|NCT01778049|102073427|FG001|Double Blind Treatment Period|Not treated|0|||
33597010|NCT01778049|102073428|FG002|Double Blind Treatment Period|Not treated|0|||
33597011|NCT01778049|102073429|FG003|Double Blind Treatment Period|Not treated|2|||
33597012|NCT01778049|102073430|FG004|Double Blind Treatment Period|Not treated|2|||
33597013|NCT01778049|102073431|FG005|Double Blind Treatment Period|Not treated|0|||
33597014|NCT01778049|102073426|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
33597015|NCT01778049|102073427|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
33597016|NCT01778049|102073428|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
33597017|NCT01778049|102073429|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
33597018|NCT01778049|102073430|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
33597019|NCT01778049|102073431|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
33597020|NCT00983515|102073434|FG000|Ritonavir Alone|liver panel out of range|6|||
33597021|NCT00983515|102073434|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
33597022|NCT01069861|102073435|FG000|Overall Study|Death|1|||
33597023|NCT01069861|102073435|FG000|Overall Study|Adverse Event|1|||
33597024|NCT01069861|102073435|FG000|Overall Study|Did not meet entrance criteria|1|||
33597025|NCT05028517|102073438|FG000|Overall Study|Lost to Follow-up|13|||
33597026|NCT05028517|102073439|FG001|Overall Study|Lost to Follow-up|20|||
33597027|NCT05028517|102073440|FG002|Overall Study|Lost to Follow-up|12|||
33597028|NCT05028517|102073438|FG000|Overall Study|Withdrawal by Subject|0|||
33597029|NCT05028517|102073439|FG001|Overall Study|Withdrawal by Subject|0|||
33597030|NCT05028517|102073440|FG002|Overall Study|Withdrawal by Subject|1|||
33597031|NCT03385265|102073443|FG000|Overall Study|Withdrawal by Subject|5|||
33597032|NCT03385265|102073444|FG001|Overall Study|Withdrawal by Subject|2|||
33597033|NCT03385265|102073445|FG002|Overall Study|Withdrawal by Subject|5|||
33597034|NCT03385265|102073446|FG003|Overall Study|Withdrawal by Subject|2|||
33597035|NCT00871117|102073454|FG000|Overall Study|Lost to Follow-up|5|||
33597036|NCT00871117|102073455|FG001|Overall Study|Lost to Follow-up|6|||
33597037|NCT00871117|102073454|FG000|Overall Study|Other|0|||
33597038|NCT00871117|102073455|FG001|Overall Study|Other|4|||
33597039|NCT03249935|102077705|FG000|Overall Study|Discharged from facility early|36|||
33597040|NCT03249935|102077705|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
33597041|NCT03249935|102077705|FG000|Overall Study|Protocol Violation|5|||
33597042|NCT02242981|102077706|FG000|Overall Study|Withdrawal by Subject|1|||
33597043|NCT00539513|102077709|FG000|Overall Study|Withdrawal by Subject|2|||
33597044|NCT00539513|102077710|FG001|Overall Study|Withdrawal by Subject|1|||
33597045|NCT00539513|102077709|FG000|Overall Study|Lost to Follow-up|0|||
33597046|NCT00539513|102077710|FG001|Overall Study|Lost to Follow-up|1|||
33597047|NCT01129882|102077711|FG000|Overall Study|Adverse Event|39|||
33597048|NCT01129882|102077711|FG000|Overall Study|Death|6|||
33597049|NCT01129882|102077711|FG000|Overall Study|Lack of Efficacy|5|||
33597050|NCT01129882|102077711|FG000|Overall Study|Lost to Follow-up|13|||
33597051|NCT01129882|102077711|FG000|Overall Study|Physician Decision|27|||
33597052|NCT01129882|102077711|FG000|Overall Study|Protocol Deviation|3|||
33597053|NCT01129882|102077711|FG000|Overall Study|Withdrawal Criteria Met|19|||
33597054|NCT01129882|102077711|FG000|Overall Study|Trial Termination by Sponsor|6|||
33597055|NCT01129882|102077711|FG000|Overall Study|Withdrawal by Subject|160|||
33597056|NCT01338610|102077713|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
33597057|NCT01338610|102077714|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
33597058|NCT01338610|102077715|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
33597059|NCT01338610|102077713|FG000|Overall Study|Protocol Violation|1|||
33597060|NCT01338610|102077714|FG001|Overall Study|Protocol Violation|0|||
33597061|NCT01338610|102077715|FG002|Overall Study|Protocol Violation|1|||
33597062|NCT01338610|102077713|FG000|Overall Study|Adverse Event|3|||
33597063|NCT01338610|102077714|FG001|Overall Study|Adverse Event|0|||
33597064|NCT01338610|102077715|FG002|Overall Study|Adverse Event|0|||
33597065|NCT02838901|102077717|FG000|Overall Study|Withdrawal by Subject|1|||
33597066|NCT02838901|102077718|FG001|Overall Study|Withdrawal by Subject|1|||
33597067|NCT02838901|102077717|FG000|Overall Study|Lost to Follow-up|1|||
33597068|NCT02838901|102077718|FG001|Overall Study|Lost to Follow-up|1|||
33597069|NCT01133275|102077719|FG000|Overall Study|Withdrawal by Subject|1|||
33597070|NCT01133275|102077719|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
33597071|NCT00953680|102077721|FG000|Period 1|Withdrawal by Subject|0|||
33597072|NCT00953680|102077722|FG001|Period 1|Withdrawal by Subject|1|||
33597073|NCT01605227|102077723|FG000|Overall Study|Did not receive study treatment|2|||
33597074|NCT01605227|102077724|FG001|Overall Study|Did not receive study treatment|3|||
33597075|NCT01605227|102077723|FG000|Overall Study|Adverse Event|228|||
33597076|NCT01605227|102077724|FG001|Overall Study|Adverse Event|42|||
33597077|NCT01605227|102077723|FG000|Overall Study|Progressive Disease|132|||
33597078|NCT01605227|102077724|FG001|Overall Study|Progressive Disease|128|||
33597079|NCT01605227|102077723|FG000|Overall Study|Clinical Deterioration|227|||
33597080|NCT01605227|102077724|FG001|Overall Study|Clinical Deterioration|133|||
33597081|NCT01605227|102077723|FG000|Overall Study|Lost to Follow-up|1|||
33597082|NCT01605227|102077724|FG001|Overall Study|Lost to Follow-up|0|||
33597083|NCT01605227|102077723|FG000|Overall Study|Protocol Violation|1|||
33597084|NCT01605227|102077724|FG001|Overall Study|Protocol Violation|0|||
33597085|NCT01605227|102077723|FG000|Overall Study|Physician Decision|9|||
33597086|NCT01605227|102077724|FG001|Overall Study|Physician Decision|7|||
33597087|NCT01605227|102077723|FG000|Overall Study|Withdrawal by Subject|18|||
33597088|NCT01605227|102077724|FG001|Overall Study|Withdrawal by Subject|14|||
33597089|NCT01605227|102077723|FG000|Overall Study|Sponsor Decision|2|||
33597090|NCT01605227|102077724|FG001|Overall Study|Sponsor Decision|0|||
33597091|NCT01605227|102077723|FG000|Overall Study|Started New Therapy|1|||
33597092|NCT01605227|102077724|FG001|Overall Study|Started New Therapy|0|||
33597093|NCT01605227|102077723|FG000|Overall Study|Subject Decision|0|||
33597094|NCT01605227|102077724|FG001|Overall Study|Subject Decision|1|||
33597095|NCT01605227|102077723|FG000|Overall Study|Dose Held >6 weeks|0|||
33597096|NCT01605227|102077724|FG001|Overall Study|Dose Held >6 weeks|1|||
33597097|NCT01287221|102077727|FG000|Overall Study|Lack of Perceived Benefit|1|||
33597098|NCT01287221|102077728|FG001|Overall Study|Lack of Perceived Benefit|1|||
33597099|NCT01287221|102077727|FG000|Overall Study|Adverse Event|3|||
33597100|NCT01287221|102077728|FG001|Overall Study|Adverse Event|3|||
33597101|NCT01287221|102077727|FG000|Overall Study|Withdrawal by Subject|0|||
33597102|NCT01287221|102077728|FG001|Overall Study|Withdrawal by Subject|1|||
33597103|NCT00642174|102077729|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
33597104|NCT00642174|102077730|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
33597105|NCT02825420|102077731|FG000|Overall Study|Death|30|||
33597106|NCT02825420|102077732|FG001|Overall Study|Death|12|||
33597107|NCT02825420|102077731|FG000|Overall Study|Progressive disease|6|||
33597108|NCT02825420|102077732|FG001|Overall Study|Progressive disease|1|||
33597109|NCT02825420|102077731|FG000|Overall Study|Lost to Follow-up|2|||
33597110|NCT02825420|102077732|FG001|Overall Study|Lost to Follow-up|2|||
33597111|NCT02825420|102077731|FG000|Overall Study|Withdrawal by Subject|1|||
33597112|NCT02825420|102077732|FG001|Overall Study|Withdrawal by Subject|1|||
33597113|NCT02825420|102077731|FG000|Overall Study|Protocol amendment not signed|1|||
33597114|NCT02825420|102077732|FG001|Overall Study|Protocol amendment not signed|1|||
33597115|NCT02825420|102077731|FG000|Overall Study|Physician Decision|1|||
33597116|NCT02825420|102077732|FG001|Overall Study|Physician Decision|0|||
33597117|NCT02825420|102077731|FG000|Overall Study|Did not receive PLD|2|||
33597118|NCT02825420|102077732|FG001|Overall Study|Did not receive PLD|0|||
33597119|NCT01286987|102077733|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
33597120|NCT01286987|102077734|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
33597121|NCT01286987|102077735|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
33597122|NCT01286987|102077736|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
33597123|NCT01286987|102077737|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
33597124|NCT01286987|102077738|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
33597125|NCT01286987|102077739|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
33597126|NCT01286987|102077740|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
33597127|NCT01286987|102077741|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
33597128|NCT01286987|102077742|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
33597129|NCT01286987|102077743|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
33597130|NCT01286987|102077744|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
33597131|NCT01286987|102077745|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
33597132|NCT01286987|102077746|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
33597133|NCT01286987|102077747|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
33597134|NCT01286987|102077733|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
33597135|NCT01286987|102077734|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
33597136|NCT01286987|102077735|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
33597137|NCT01286987|102077736|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
33597138|NCT01286987|102077737|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
33597139|NCT01286987|102077738|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
33597140|NCT01286987|102077739|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
33597141|NCT01286987|102077740|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
33597142|NCT01286987|102077741|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
33597143|NCT01286987|102077742|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
33597144|NCT01286987|102077743|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
33597145|NCT01286987|102077744|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
33597146|NCT01286987|102077745|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
33597147|NCT01286987|102077746|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
33597148|NCT01286987|102077747|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
33597149|NCT01286987|102077733|FG000|Part 1: Dose Escalation|Physician Decision|0|||
33597150|NCT01286987|102077734|FG001|Part 1: Dose Escalation|Physician Decision|0|||
33597151|NCT01286987|102077735|FG002|Part 1: Dose Escalation|Physician Decision|0|||
33597152|NCT01286987|102077736|FG003|Part 1: Dose Escalation|Physician Decision|0|||
33597153|NCT01286987|102077737|FG004|Part 1: Dose Escalation|Physician Decision|1|||
33597154|NCT01286987|102077738|FG005|Part 1: Dose Escalation|Physician Decision|0|||
33597155|NCT01286987|102077739|FG006|Part 1: Dose Escalation|Physician Decision|0|||
33597156|NCT01286987|102077740|FG007|Part 1: Dose Escalation|Physician Decision|0|||
33597157|NCT01286987|102077741|FG008|Part 1: Dose Escalation|Physician Decision|0|||
33597158|NCT01286987|102077742|FG009|Part 1: Dose Escalation|Physician Decision|0|||
33597159|NCT01286987|102077743|FG010|Part 1: Dose Escalation|Physician Decision|0|||
33597160|NCT01286987|102077744|FG011|Part 1: Dose Escalation|Physician Decision|0|||
33597161|NCT01286987|102077745|FG012|Part 1: Dose Escalation|Physician Decision|0|||
33597162|NCT01286987|102077746|FG013|Part 1: Dose Escalation|Physician Decision|0|||
33597163|NCT01286987|102077747|FG014|Part 1: Dose Escalation|Physician Decision|0|||
33597164|NCT01286987|102077733|FG000|Part 2: Dose Expansion|Death|0|||
33597165|NCT01286987|102077734|FG001|Part 2: Dose Expansion|Death|0|||
33597166|NCT01286987|102077735|FG002|Part 2: Dose Expansion|Death|0|||
33597167|NCT01286987|102077736|FG003|Part 2: Dose Expansion|Death|0|||
33597168|NCT01286987|102077737|FG004|Part 2: Dose Expansion|Death|0|||
33597169|NCT01286987|102077738|FG005|Part 2: Dose Expansion|Death|0|||
33597170|NCT01286987|102077739|FG006|Part 2: Dose Expansion|Death|0|||
33597171|NCT01286987|102077740|FG007|Part 2: Dose Expansion|Death|0|||
33597172|NCT01286987|102077741|FG008|Part 2: Dose Expansion|Death|0|||
33597173|NCT01286987|102077742|FG009|Part 2: Dose Expansion|Death|0|||
33597174|NCT01286987|102077743|FG010|Part 2: Dose Expansion|Death|0|||
33597175|NCT01286987|102077744|FG011|Part 2: Dose Expansion|Death|0|||
33597176|NCT01286987|102077745|FG012|Part 2: Dose Expansion|Death|1|||
33597177|NCT01286987|102077746|FG013|Part 2: Dose Expansion|Death|1|||
33597178|NCT01286987|102077747|FG014|Part 2: Dose Expansion|Death|0|||
33597179|NCT01286987|102077733|FG000|Part 2: Dose Expansion|Physician Decision|0|||
33597180|NCT01286987|102077734|FG001|Part 2: Dose Expansion|Physician Decision|0|||
33597181|NCT01286987|102077735|FG002|Part 2: Dose Expansion|Physician Decision|0|||
33597182|NCT01286987|102077736|FG003|Part 2: Dose Expansion|Physician Decision|0|||
33597183|NCT01286987|102077737|FG004|Part 2: Dose Expansion|Physician Decision|0|||
33597184|NCT01286987|102077738|FG005|Part 2: Dose Expansion|Physician Decision|0|||
33597185|NCT01286987|102077739|FG006|Part 2: Dose Expansion|Physician Decision|0|||
33597186|NCT01286987|102077740|FG007|Part 2: Dose Expansion|Physician Decision|0|||
33597187|NCT01286987|102077741|FG008|Part 2: Dose Expansion|Physician Decision|0|||
33597188|NCT01286987|102077742|FG009|Part 2: Dose Expansion|Physician Decision|0|||
33597189|NCT01286987|102077743|FG010|Part 2: Dose Expansion|Physician Decision|1|||
33597190|NCT01286987|102077744|FG011|Part 2: Dose Expansion|Physician Decision|1|||
33597191|NCT01286987|102077745|FG012|Part 2: Dose Expansion|Physician Decision|0|||
33597192|NCT01286987|102077746|FG013|Part 2: Dose Expansion|Physician Decision|1|||
33597193|NCT01286987|102077747|FG014|Part 2: Dose Expansion|Physician Decision|0|||
33597194|NCT01286987|102077733|FG000|Part 2: Dose Expansion|Other|0|||
33597195|NCT01286987|102077734|FG001|Part 2: Dose Expansion|Other|0|||
33597196|NCT01286987|102077735|FG002|Part 2: Dose Expansion|Other|0|||
33597197|NCT01286987|102077736|FG003|Part 2: Dose Expansion|Other|0|||
33597198|NCT01286987|102077737|FG004|Part 2: Dose Expansion|Other|0|||
33597199|NCT01286987|102077738|FG005|Part 2: Dose Expansion|Other|0|||
33597200|NCT01286987|102077739|FG006|Part 2: Dose Expansion|Other|0|||
33597201|NCT01286987|102077740|FG007|Part 2: Dose Expansion|Other|0|||
33597202|NCT01286987|102077741|FG008|Part 2: Dose Expansion|Other|0|||
33597203|NCT01286987|102077742|FG009|Part 2: Dose Expansion|Other|0|||
33597204|NCT01286987|102077743|FG010|Part 2: Dose Expansion|Other|0|||
33597205|NCT01286987|102077744|FG011|Part 2: Dose Expansion|Other|0|||
33597206|NCT01286987|102077745|FG012|Part 2: Dose Expansion|Other|0|||
33597207|NCT01286987|102077746|FG013|Part 2: Dose Expansion|Other|1|||
33597208|NCT01286987|102077747|FG014|Part 2: Dose Expansion|Other|0|||
33597209|NCT01286987|102077733|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
33597210|NCT01286987|102077734|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
33597211|NCT01286987|102077735|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
33597212|NCT01286987|102077736|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
33597213|NCT01286987|102077737|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
33597214|NCT01286987|102077738|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
33597215|NCT01286987|102077739|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
33597216|NCT01286987|102077740|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
33597217|NCT01286987|102077741|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
33597218|NCT01286987|102077742|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
33597219|NCT01286987|102077743|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
33597220|NCT01286987|102077744|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
33597221|NCT01286987|102077745|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
33597222|NCT01286987|102077746|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
33597223|NCT01286987|102077747|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
33597224|NCT01286987|102077733|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
33597225|NCT01286987|102077734|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
33597226|NCT01286987|102077735|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
33597227|NCT01286987|102077736|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
33597228|NCT01286987|102077737|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
33597229|NCT01286987|102077738|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
33597230|NCT01286987|102077739|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
33597231|NCT01286987|102077740|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
33597232|NCT01286987|102077741|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
33597233|NCT01286987|102077742|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
33597234|NCT01286987|102077743|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
33597235|NCT01286987|102077744|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
33597236|NCT01286987|102077745|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
33597237|NCT01286987|102077746|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
33597238|NCT01286987|102077747|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
33597239|NCT01286987|102077733|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33597240|NCT01286987|102077734|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33597241|NCT01286987|102077735|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33597242|NCT01286987|102077736|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33597243|NCT01286987|102077737|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33597244|NCT01286987|102077738|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33597245|NCT01286987|102077739|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33597246|NCT01286987|102077740|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33597247|NCT01286987|102077741|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33597248|NCT01286987|102077742|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33597249|NCT01286987|102077743|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
33597250|NCT01286987|102077744|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33597251|NCT01286987|102077745|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33597252|NCT01286987|102077746|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33597253|NCT01286987|102077747|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
33597254|NCT01367704|102077753|FG000|Overall Study|Lost to Follow-up|47|||
33597255|NCT01367704|102077754|FG001|Overall Study|Lost to Follow-up|161|||
33597256|NCT03095027|102077757|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
33597257|NCT03095027|102077758|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
33597258|NCT00694096|102077765|FG000|Overall Study|Withdrawal by Subject|5|||
33597259|NCT00355342|102077767|FG000|Overall Study|Adverse Event|13|||
33597260|NCT00355342|102077768|FG001|Overall Study|Adverse Event|15|||
33597261|NCT00355342|102077767|FG000|Overall Study|Lost to Follow-up|4|||
33597262|NCT00355342|102077768|FG001|Overall Study|Lost to Follow-up|2|||
33597263|NCT00355342|102077767|FG000|Overall Study|Withdrawal by Subject|14|||
33597264|NCT00355342|102077768|FG001|Overall Study|Withdrawal by Subject|11|||
33597265|NCT00355342|102077767|FG000|Overall Study|Sponsor terminated study|2|||
33597266|NCT00355342|102077768|FG001|Overall Study|Sponsor terminated study|2|||
33597267|NCT00355342|102077767|FG000|Overall Study|Overcompliant-PI discretion|1|||
33597268|NCT00355342|102077768|FG001|Overall Study|Overcompliant-PI discretion|0|||
33597269|NCT00355342|102077767|FG000|Overall Study|Use of prohibited medication|1|||
33597270|NCT00355342|102077768|FG001|Overall Study|Use of prohibited medication|0|||
33597271|NCT00355342|102077767|FG000|Overall Study|COPD exacerbation|1|||
33597272|NCT00355342|102077768|FG001|Overall Study|COPD exacerbation|1|||
33597273|NCT00355342|102077767|FG000|Overall Study|Dispensed wrong study drug kit|1|||
33597274|NCT00355342|102077768|FG001|Overall Study|Dispensed wrong study drug kit|0|||
33597275|NCT00355342|102077767|FG000|Overall Study|Non-compliance with Dexa scans|1|||
33597276|NCT00355342|102077768|FG001|Overall Study|Non-compliance with Dexa scans|0|||
33597277|NCT00355342|102077767|FG000|Overall Study|Withdrawal by participant and physician|1|||
33597278|NCT00355342|102077768|FG001|Overall Study|Withdrawal by participant and physician|0|||
33597279|NCT00355342|102077767|FG000|Overall Study|Participant relocated|0|||
33597280|NCT00355342|102077768|FG001|Overall Study|Participant relocated|1|||
33597281|NCT00355342|102077767|FG000|Overall Study|Participant discontinued study drug|0|||
33597282|NCT00355342|102077768|FG001|Overall Study|Participant discontinued study drug|1|||
33597283|NCT00355342|102077767|FG000|Overall Study|Study management|0|||
33597284|NCT00355342|102077768|FG001|Overall Study|Study management|1|||
33597285|NCT00355342|102077767|FG000|Overall Study|Protocol Violation|0|||
33597286|NCT00355342|102077768|FG001|Overall Study|Protocol Violation|1|||
33597287|NCT00355342|102077767|FG000|Overall Study|Use of protocol excluded medication|0|||
33597288|NCT00355342|102077768|FG001|Overall Study|Use of protocol excluded medication|1|||
33597289|NCT02969590|102077769|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
33597290|NCT02969590|102077770|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
33597291|NCT02969590|102077771|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
33597292|NCT00789581|102077774|FG000|AC Therapy|Adverse Event|2|||
33597293|NCT00789581|102077775|FG001|AC Therapy|Adverse Event|3|||
33597294|NCT00789581|102077774|FG000|AC Therapy|Withdrawal by Subject|4|||
33597295|NCT00789581|102077775|FG001|AC Therapy|Withdrawal by Subject|7|||
33597296|NCT00789581|102077774|FG000|AC Therapy|Disease recurrence|3|||
33597297|NCT00789581|102077775|FG001|AC Therapy|Disease recurrence|1|||
33597298|NCT00789581|102077774|FG000|AC Therapy|Intercurrent Illness|1|||
33597299|NCT00789581|102077775|FG001|AC Therapy|Intercurrent Illness|0|||
33597300|NCT00789581|102077774|FG000|AC Therapy|Never Treated|1|||
33597301|NCT00789581|102077775|FG001|AC Therapy|Never Treated|4|||
33597302|NCT00789581|102077774|FG000|AC Therapy|Other|0|||
33597303|NCT00789581|102077775|FG001|AC Therapy|Other|2|||
33597304|NCT00789581|102077774|FG000|Adjuvant Therapy|Never treated|2|||
33597305|NCT00789581|102077775|FG001|Adjuvant Therapy|Never treated|2|||
33597306|NCT00789581|102077774|FG000|Adjuvant Therapy|Adverse Event|20|||
33597307|NCT00789581|102077775|FG001|Adjuvant Therapy|Adverse Event|44|||
33597308|NCT00789581|102077774|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
33597309|NCT00789581|102077775|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
33597310|NCT00789581|102077774|FG000|Adjuvant Therapy|Disease recurrence|2|||
33597311|NCT00789581|102077775|FG001|Adjuvant Therapy|Disease recurrence|1|||
33597312|NCT00789581|102077774|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
33597313|NCT00789581|102077775|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
33597314|NCT00789581|102077774|FG000|Adjuvant Therapy|Protocol Violation|1|||
33597315|NCT00789581|102077775|FG001|Adjuvant Therapy|Protocol Violation|1|||
33597316|NCT00789581|102077774|FG000|Adjuvant Therapy|Other|0|||
33597317|NCT00789581|102077775|FG001|Adjuvant Therapy|Other|1|||
33597318|NCT03245736|102077776|FG000|Overall Study|Adverse Event|1|||
33597319|NCT03245736|102077776|FG000|Overall Study|Progressive Disease|4|||
33597320|NCT02403635|102077779|FG000|Overall Study|Not eligible|9|||
33597321|NCT04209114|102077780|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
33597322|NCT04209114|102077781|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
33597323|NCT04209114|102077782|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
33597324|NCT04209114|102077780|FG000|Pre-Treatment Phase|Other reasons|0|||
33597325|NCT04209114|102077781|FG001|Pre-Treatment Phase|Other reasons|0|||
33597326|NCT04209114|102077782|FG002|Pre-Treatment Phase|Other reasons|1|||
33597327|NCT04209114|102077780|FG000|Pre-Treatment Phase|Death|0|||
33597328|NCT04209114|102077781|FG001|Pre-Treatment Phase|Death|0|||
33597329|NCT04209114|102077782|FG002|Pre-Treatment Phase|Death|1|||
33597330|NCT04209114|102077780|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
33597331|NCT04209114|102077781|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
33597332|NCT04209114|102077782|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
33597333|NCT04209114|102077780|FG000|Treatment Phase|Other reasons|5|||
33597334|NCT04209114|102077781|FG001|Treatment Phase|Other reasons|3|||
33597335|NCT04209114|102077782|FG002|Treatment Phase|Other reasons|0|||
33597336|NCT04209114|102077780|FG000|Treatment Phase|Lost to Follow-up|1|||
33597337|NCT04209114|102077781|FG001|Treatment Phase|Lost to Follow-up|0|||
33597338|NCT04209114|102077782|FG002|Treatment Phase|Lost to Follow-up|0|||
33597339|NCT04209114|102077780|FG000|Treatment Phase|Participant withdrew consent|1|||
33597340|NCT04209114|102077781|FG001|Treatment Phase|Participant withdrew consent|0|||
33597341|NCT04209114|102077782|FG002|Treatment Phase|Participant withdrew consent|0|||
33597342|NCT04209114|102077780|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
33597343|NCT04209114|102077781|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
33597344|NCT04209114|102077782|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
33597345|NCT04209114|102077780|FG000|Treatment Phase|Death|4|||
33597346|NCT04209114|102077781|FG001|Treatment Phase|Death|1|||
33597347|NCT04209114|102077782|FG002|Treatment Phase|Death|0|||
33597348|NCT04209114|102077780|FG000|Treatment Phase|Study drug toxicity|4|||
33597349|NCT04209114|102077781|FG001|Treatment Phase|Study drug toxicity|6|||
33597350|NCT04209114|102077782|FG002|Treatment Phase|Study drug toxicity|0|||
33597351|NCT04209114|102077780|FG000|Treatment Phase|Disease progression|6|||
33597352|NCT04209114|102077781|FG001|Treatment Phase|Disease progression|9|||
33597353|NCT04209114|102077782|FG002|Treatment Phase|Disease progression|0|||
33597354|NCT03894969|102077785|FG000|Overall Study|Adverse Event|0|||
33597355|NCT03894969|102077786|FG001|Overall Study|Adverse Event|2|||
33597356|NCT03894969|102077787|FG002|Overall Study|Adverse Event|0|||
33597357|NCT03894969|102077788|FG003|Overall Study|Adverse Event|1|||
33597358|NCT03894969|102077789|FG004|Overall Study|Adverse Event|2|||
33597359|NCT03894969|102077785|FG000|Overall Study|Lost to Follow-up|3|||
33597360|NCT03894969|102077786|FG001|Overall Study|Lost to Follow-up|1|||
33597361|NCT03894969|102077787|FG002|Overall Study|Lost to Follow-up|1|||
33597362|NCT03894969|102077788|FG003|Overall Study|Lost to Follow-up|0|||
33597363|NCT03894969|102077789|FG004|Overall Study|Lost to Follow-up|0|||
33597364|NCT03894969|102077785|FG000|Overall Study|Withdrawal by Subject|2|||
33597365|NCT03894969|102077786|FG001|Overall Study|Withdrawal by Subject|1|||
33597366|NCT03894969|102077787|FG002|Overall Study|Withdrawal by Subject|3|||
33597367|NCT03894969|102077788|FG003|Overall Study|Withdrawal by Subject|4|||
33597368|NCT03894969|102077789|FG004|Overall Study|Withdrawal by Subject|8|||
33597369|NCT03894969|102077785|FG000|Overall Study|Other|0|||
33597370|NCT03894969|102077786|FG001|Overall Study|Other|0|||
33597371|NCT03894969|102077787|FG002|Overall Study|Other|0|||
33597372|NCT03894969|102077788|FG003|Overall Study|Other|0|||
33597373|NCT03894969|102077789|FG004|Overall Study|Other|3|||
33597374|NCT03894969|102077785|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
33597375|NCT03894969|102077786|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
33597376|NCT03894969|102077787|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
33597377|NCT03894969|102077788|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
33597378|NCT03894969|102077789|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
33597379|NCT03894969|102077785|FG000|Overall Study|Solicited Adverse Event|0|||
33597380|NCT03894969|102077786|FG001|Overall Study|Solicited Adverse Event|1|||
33597381|NCT03894969|102077787|FG002|Overall Study|Solicited Adverse Event|0|||
33597382|NCT03894969|102077788|FG003|Overall Study|Solicited Adverse Event|0|||
33597383|NCT03894969|102077789|FG004|Overall Study|Solicited Adverse Event|0|||
33597384|NCT01154283|102077790|FG000|0-6 Weeks|Withdrawal by Subject|7|||
33597385|NCT01154283|102077791|FG001|0-6 Weeks|Withdrawal by Subject|2|||
33597386|NCT01154283|102077790|FG000|0-6 Weeks|Death|0|||
33597387|NCT01154283|102077791|FG001|0-6 Weeks|Death|1|||
33597388|NCT01154283|102077790|FG000|7-12 Weeks|Death|1|||
33597389|NCT01154283|102077791|FG001|7-12 Weeks|Death|0|||
33597390|NCT01154283|102077790|FG000|7-12 Weeks|Withdrawal by Subject|0|||
33597391|NCT01154283|102077791|FG001|7-12 Weeks|Withdrawal by Subject|1|||
33597392|NCT01952665|102077792|FG000|Overall Study|Physician Decision|3|||
33597393|NCT01952665|102077793|FG001|Overall Study|Physician Decision|2|||
33597394|NCT01952665|102077792|FG000|Overall Study|Lost to Follow-up|1|||
33597395|NCT01952665|102077793|FG001|Overall Study|Lost to Follow-up|2|||
33597396|NCT01952665|102077792|FG000|Overall Study|Adverse Event|2|||
33597397|NCT01952665|102077793|FG001|Overall Study|Adverse Event|1|||
33597398|NCT01952665|102077792|FG000|Overall Study|Protocol Violation|0|||
33597399|NCT01952665|102077793|FG001|Overall Study|Protocol Violation|1|||
33597400|NCT03777917|102077794|FG000|Overall Study|Withdrawal by Subject|1|||
33597401|NCT03777917|102077795|FG001|Overall Study|Withdrawal by Subject|0|||
33597402|NCT03777917|102077794|FG000|Overall Study|Physician Decision|1|||
33597403|NCT03777917|102077795|FG001|Overall Study|Physician Decision|0|||
33597404|NCT03777917|102077794|FG000|Overall Study|Lost to Follow-up|6|||
33597405|NCT03777917|102077795|FG001|Overall Study|Lost to Follow-up|2|||
33597406|NCT03777917|102077794|FG000|Overall Study|Other|1|||
33597407|NCT03777917|102077795|FG001|Overall Study|Other|0|||
33597408|NCT03220581|102077814|FG000|Overall Study|Withdrawal by Subject|0|||
33597409|NCT03220581|102077815|FG001|Overall Study|Withdrawal by Subject|1|||
33597410|NCT03220581|102077814|FG000|Overall Study|Lost to Follow-up|3|||
33597411|NCT03220581|102077815|FG001|Overall Study|Lost to Follow-up|6|||
33597412|NCT02255565|102077816|FG000|Overall Study|Withdrawal by Subject|0|||
33597413|NCT02255565|102077817|FG001|Overall Study|Withdrawal by Subject|1|||
33597414|NCT02255565|102077818|FG002|Overall Study|Withdrawal by Subject|0|||
33597415|NCT00853125|102077820|FG000|Overall Study|Study participant's donor was CMV +|1|||
33597416|NCT03080883|102077821|FG000|Overall Study|Withdrawal by Subject|11|||
33597417|NCT03080883|102077822|FG001|Overall Study|Withdrawal by Subject|15|||
33597418|NCT03080883|102077821|FG000|Overall Study|Adverse Event|22|||
33597419|NCT03080883|102077822|FG001|Overall Study|Adverse Event|22|||
33597420|NCT03080883|102077821|FG000|Overall Study|Alternative Therapy|0|||
33597421|NCT03080883|102077822|FG001|Overall Study|Alternative Therapy|3|||
33597422|NCT03080883|102077821|FG000|Overall Study|Other Complicating Disease|9|||
33597423|NCT03080883|102077822|FG001|Overall Study|Other Complicating Disease|5|||
33597424|NCT03080883|102077821|FG000|Overall Study|Death|21|||
33597425|NCT03080883|102077822|FG001|Overall Study|Death|16|||
33597426|NCT03080883|102077821|FG000|Overall Study|Physician Decision|2|||
33597427|NCT03080883|102077822|FG001|Overall Study|Physician Decision|2|||
33597428|NCT03080883|102077821|FG000|Overall Study|Disease Progression|2|||
33597429|NCT03080883|102077822|FG001|Overall Study|Disease Progression|8|||
33597430|NCT03080883|102077821|FG000|Overall Study|Lost to Follow-up|1|||
33597431|NCT03080883|102077822|FG001|Overall Study|Lost to Follow-up|1|||
33597432|NCT00477269|102077823|FG000|Core Study|Adverse Event|6|||
33597433|NCT00477269|102077824|FG001|Core Study|Adverse Event|4|||
33597434|NCT00477269|102077825|FG002|Core Study|Adverse Event|0|||
33597435|NCT00477269|102077823|FG000|Core Study|Death|3|||
33597436|NCT00477269|102077824|FG001|Core Study|Death|3|||
33597437|NCT00477269|102077825|FG002|Core Study|Death|0|||
33597438|NCT00477269|102077823|FG000|Core Study|Withdrawn Consent|0|||
33597439|NCT00477269|102077824|FG001|Core Study|Withdrawn Consent|1|||
33597440|NCT00477269|102077825|FG002|Core Study|Withdrawn Consent|0|||
33597441|NCT00477269|102077823|FG000|Open Label Extension|Adverse Event|0|||
33597442|NCT00477269|102077824|FG001|Open Label Extension|Adverse Event|0|||
33597443|NCT00477269|102077825|FG002|Open Label Extension|Adverse Event|4|||
33597444|NCT00477269|102077823|FG000|Open Label Extension|Abnormal laboratory values|0|||
33597445|NCT00477269|102077824|FG001|Open Label Extension|Abnormal laboratory values|0|||
33597446|NCT00477269|102077825|FG002|Open Label Extension|Abnormal laboratory values|1|||
33597447|NCT00477269|102077823|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
33597448|NCT00477269|102077824|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
33597449|NCT00477269|102077825|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
33597450|NCT00477269|102077823|FG000|Open Label Extension|Adminiatrative problems|0|||
33597451|NCT00477269|102077824|FG001|Open Label Extension|Adminiatrative problems|0|||
33597452|NCT00477269|102077825|FG002|Open Label Extension|Adminiatrative problems|2|||
33597453|NCT00477269|102077823|FG000|Open Label Extension|Death|0|||
33597454|NCT00477269|102077824|FG001|Open Label Extension|Death|0|||
33597455|NCT00477269|102077825|FG002|Open Label Extension|Death|4|||
33597456|NCT00159913|102077828|FG000|Overall Study|Adverse Event|1|||
33597457|NCT00159913|102077829|FG001|Overall Study|Adverse Event|0|||
33597458|NCT00159913|102077830|FG002|Overall Study|Adverse Event|1|||
33597459|NCT00159913|102077831|FG003|Overall Study|Adverse Event|0|||
33597460|NCT00159913|102077828|FG000|Overall Study|Withdrawal by Subject|0|||
33597461|NCT00159913|102077829|FG001|Overall Study|Withdrawal by Subject|0|||
33597462|NCT00159913|102077830|FG002|Overall Study|Withdrawal by Subject|0|||
33597463|NCT00159913|102077831|FG003|Overall Study|Withdrawal by Subject|1|||
33597464|NCT00159913|102077828|FG000|Overall Study|Lost to Follow-up|0|||
33597465|NCT00159913|102077829|FG001|Overall Study|Lost to Follow-up|0|||
33597466|NCT00159913|102077830|FG002|Overall Study|Lost to Follow-up|0|||
33597467|NCT00159913|102077831|FG003|Overall Study|Lost to Follow-up|1|||
33597468|NCT00159913|102077828|FG000|Overall Study|Protocol Violation|1|||
33597469|NCT00159913|102077829|FG001|Overall Study|Protocol Violation|0|||
33597470|NCT00159913|102077830|FG002|Overall Study|Protocol Violation|1|||
33597471|NCT00159913|102077831|FG003|Overall Study|Protocol Violation|0|||
33597472|NCT02014480|102077832|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
33597473|NCT02014480|102077833|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
33597474|NCT02014480|102077834|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
33597475|NCT02014480|102077835|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
33597476|NCT02014480|102077836|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
33597477|NCT02014480|102077837|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
33597478|NCT02014480|102077832|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33597479|NCT02014480|102077833|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33597480|NCT02014480|102077834|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33597481|NCT02014480|102077835|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
33597482|NCT02014480|102077836|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33597483|NCT02014480|102077837|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33597484|NCT02014480|102077832|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33597485|NCT02014480|102077833|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33597486|NCT02014480|102077834|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
33597487|NCT02014480|102077835|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33597488|NCT02014480|102077836|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33597489|NCT02014480|102077837|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33597490|NCT02014480|102077832|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
33597491|NCT02014480|102077833|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
33597492|NCT02014480|102077834|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
33597493|NCT02014480|102077835|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
33597494|NCT02014480|102077836|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33597495|NCT02014480|102077837|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33597496|NCT02014480|102077832|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33597497|NCT02014480|102077833|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
33597498|NCT02014480|102077834|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33597499|NCT02014480|102077835|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33597500|NCT02014480|102077836|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33597501|NCT02014480|102077837|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33597502|NCT02014480|102077832|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
33597503|NCT02014480|102077833|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
33597504|NCT02014480|102077834|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
33597505|NCT02014480|102077835|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
33597506|NCT02014480|102077836|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
33597507|NCT02014480|102077837|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
33597508|NCT02014480|102077832|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33597509|NCT02014480|102077833|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33597510|NCT02014480|102077834|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33597511|NCT02014480|102077835|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33597512|NCT02014480|102077836|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33597513|NCT02014480|102077837|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
33597514|NCT02370537|102077838|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
33597515|NCT02370537|102077839|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
33597516|NCT02370537|102077840|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
33597517|NCT02370537|102077838|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
33597518|NCT02370537|102077839|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
33597519|NCT02370537|102077840|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
33597520|NCT02370537|102077838|FG000|Part B|Not randomised to receive treatment|1|||
33597521|NCT02370537|102077839|FG001|Part B|Not randomised to receive treatment|2|||
33597522|NCT02370537|102077840|FG002|Part B|Not randomised to receive treatment|259|||
33597523|NCT02370537|102077838|FG000|Part B|Withdrawal by Subject|0|||
33597524|NCT02370537|102077839|FG001|Part B|Withdrawal by Subject|1|||
33597525|NCT02370537|102077840|FG002|Part B|Withdrawal by Subject|0|||
33597526|NCT02743780|102077843|FG000|Part 3 (7 Days)|Adverse Event|0|||
33597527|NCT02743780|102077844|FG001|Part 3 (7 Days)|Adverse Event|0|||
33597528|NCT02743780|102077845|FG002|Part 3 (7 Days)|Adverse Event|1|||
33597529|NCT02743780|102077846|FG003|Part 3 (7 Days)|Adverse Event|0|||
33597530|NCT02743780|102077847|FG004|Part 3 (7 Days)|Adverse Event|0|||
33597531|NCT02785458|102077850|FG000|1 Month|Withdrawal by Subject|2|||
33597532|NCT02785458|102077851|FG001|1 Month|Withdrawal by Subject|1|||
33597533|NCT02785458|102077850|FG000|1 Month|Lost to Follow-up|38|||
33597534|NCT02785458|102077851|FG001|1 Month|Lost to Follow-up|31|||
33597535|NCT02785458|102077850|FG000|1 Month|Deemed Ineligible|1|||
33597536|NCT02785458|102077851|FG001|1 Month|Deemed Ineligible|0|||
33597537|NCT02785458|102077850|FG000|1 Month|Completed Evaluation by Baseline|42|||
33597538|NCT02785458|102077851|FG001|1 Month|Completed Evaluation by Baseline|39|||
33597539|NCT02785458|102077850|FG000|1 Month|Partial Interview|0|||
33597540|NCT02785458|102077851|FG001|1 Month|Partial Interview|4|||
33597541|NCT02785458|102077850|FG000|3 Months|Withdrawal by Subject|3|||
33597542|NCT02785458|102077851|FG001|3 Months|Withdrawal by Subject|1|||
33597543|NCT02785458|102077850|FG000|3 Months|Lost to Follow-up|25|||
33597544|NCT02785458|102077851|FG001|3 Months|Lost to Follow-up|21|||
33597545|NCT02785458|102077850|FG000|3 Months|Completed Evaluation at 1 Month|100|||
33597546|NCT02785458|102077851|FG001|3 Months|Completed Evaluation at 1 Month|89|||
33597547|NCT04706273|102077852|FG000|Overall Study|Withdrawal by Subject|27|||
33597548|NCT04706273|102077852|FG000|Overall Study|Physician Decision|1|||
33597549|NCT04706273|102077852|FG000|Overall Study|Lost to Follow-up|42|||
33597550|NCT04706273|102077852|FG000|Overall Study|Death|85|||
33597551|NCT04706273|102077852|FG000|Overall Study|Amputation that removes study device|2|||
33597552|NCT04706273|102077852|FG000|Overall Study|Surgical bypass|3|||
33597553|NCT04706273|102077852|FG000|Overall Study|Changing hospital|23|||
33597554|NCT04706273|102077852|FG000|Overall Study|Unable to attend hospital|2|||
33597555|NCT03023826|102077853|FG000|Period 1|Withdrawal by Subject|0|||
33597556|NCT03023826|102077854|FG001|Period 1|Withdrawal by Subject|0|||
33597557|NCT03023826|102077855|FG002|Period 1|Withdrawal by Subject|0|||
33597558|NCT03023826|102077856|FG003|Period 1|Withdrawal by Subject|0|||
33597559|NCT03023826|102077857|FG004|Period 1|Withdrawal by Subject|1|||
33597560|NCT03023826|102077858|FG005|Period 1|Withdrawal by Subject|0|||
33597561|NCT00824005|102077859|FG000|Overall Study|Death|0|||
33597562|NCT00824005|102077860|FG001|Overall Study|Death|1|||
33597563|NCT00824005|102077859|FG000|Overall Study|Lost to Follow-up|0|||
33597564|NCT00824005|102077860|FG001|Overall Study|Lost to Follow-up|1|||
33597565|NCT03733028|102077863|FG000|Overall Study|Study was stopped by PI|1|||
33597566|NCT03733028|102077864|FG001|Overall Study|Study was stopped by PI|2|||
33597567|NCT03028480|102077865|FG000|Overall Study|No revisit after the first prescription date|2|||
33597568|NCT03028480|102077865|FG000|Overall Study|Did not use the drug|1|||
33597569|NCT03028480|102077865|FG000|Overall Study|Violation of the enrollment deadline|10|||
33597570|NCT03028480|102077865|FG000|Overall Study|Case report forms were not collected|21|||
33597571|NCT03294135|102077868|FG000|Overall Study|Serious Adverse Event|1|||
33597572|NCT03294135|102077869|FG001|Overall Study|Serious Adverse Event|0|||
33597573|NCT03294135|102077870|FG002|Overall Study|Serious Adverse Event|0|||
33597574|NCT03294135|102077868|FG000|Overall Study|Lost to Follow-up|1|||
33597575|NCT03294135|102077869|FG001|Overall Study|Lost to Follow-up|0|||
33597576|NCT03294135|102077870|FG002|Overall Study|Lost to Follow-up|1|||
33597577|NCT03294135|102077868|FG000|Overall Study|Withdrawal by Subject|0|||
33597578|NCT03294135|102077869|FG001|Overall Study|Withdrawal by Subject|0|||
33597579|NCT03294135|102077870|FG002|Overall Study|Withdrawal by Subject|1|||
33597580|NCT03294135|102077868|FG000|Overall Study|Other|2|||
33597581|NCT03294135|102077869|FG001|Overall Study|Other|0|||
33597582|NCT03294135|102077870|FG002|Overall Study|Other|0|||
33597583|NCT02446418|102077875|FG000|Overall Study|Adverse Event|4|||
33597584|NCT02446418|102077876|FG001|Overall Study|Adverse Event|8|||
33597585|NCT02446418|102077875|FG000|Overall Study|Physician Decision|5|||
33597586|NCT02446418|102077876|FG001|Overall Study|Physician Decision|1|||
33597587|NCT02446418|102077875|FG000|Overall Study|Withdrawal by Subject|3|||
33597588|NCT02446418|102077876|FG001|Overall Study|Withdrawal by Subject|3|||
33597589|NCT02446418|102077875|FG000|Overall Study|Lost to Follow-up|2|||
33597590|NCT02446418|102077876|FG001|Overall Study|Lost to Follow-up|2|||
33597591|NCT02446418|102077875|FG000|Overall Study|Protocol Violation|1|||
33597592|NCT02446418|102077876|FG001|Overall Study|Protocol Violation|2|||
33597593|NCT02446418|102077875|FG000|Overall Study|Lack of Efficacy|2|||
33597594|NCT02446418|102077876|FG001|Overall Study|Lack of Efficacy|0|||
33597595|NCT02446418|102077875|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
33597596|NCT02446418|102077876|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
33597597|NCT03773133|102077881|FG000|Overall Study|Screen Failure|8|||
33597598|NCT01390779|102077882|FG000|Overall Study|Physician Decision|1|||
33597599|NCT02435680|102077883|FG000|Overall Study|Physician Decision|3|||
33597600|NCT02435680|102077884|FG001|Overall Study|Physician Decision|0|||
33597601|NCT02435680|102077885|FG002|Overall Study|Physician Decision|0|||
33597602|NCT02435680|102077883|FG000|Overall Study|subject / guardian decision|0|||
33597603|NCT02435680|102077884|FG001|Overall Study|subject / guardian decision|3|||
33597604|NCT02435680|102077885|FG002|Overall Study|subject / guardian decision|2|||
33597605|NCT02435680|102077883|FG000|Overall Study|Adverse Event|8|||
33597606|NCT02435680|102077884|FG001|Overall Study|Adverse Event|3|||
33597607|NCT02435680|102077885|FG002|Overall Study|Adverse Event|2|||
33597608|NCT02435680|102077883|FG000|Overall Study|progressive disease|10|||
33597609|NCT02435680|102077884|FG001|Overall Study|progressive disease|7|||
33597610|NCT02435680|102077885|FG002|Overall Study|progressive disease|11|||
33597611|NCT02435680|102077883|FG000|Overall Study|not treated|0|||
33597612|NCT02435680|102077884|FG001|Overall Study|not treated|0|||
33597613|NCT02435680|102077885|FG002|Overall Study|not treated|1|||
33597614|NCT00591149|102077886|FG000|Overall Study|Adverse Event|4|||
33597615|NCT00591149|102077886|FG000|Overall Study|Withdrawal by Subject|1|||
33597616|NCT04662073|102077888|FG000|Overall Study|Withdrawal by Subject|1|||
33597617|NCT04662073|102077889|FG001|Overall Study|Withdrawal by Subject|0|||
33597618|NCT00495521|102077890|FG000|Overall Study|Physician Decision|0|||
33597619|NCT00495521|102077891|FG001|Overall Study|Physician Decision|1|||
33597620|NCT01741532|102077897|FG000|Overall Study|Adverse Event|4|||
33597621|NCT01741532|102077898|FG001|Overall Study|Adverse Event|0|||
33597622|NCT01741532|102077897|FG000|Overall Study|Withdrawal by Subject|1|||
33597623|NCT01741532|102077898|FG001|Overall Study|Withdrawal by Subject|1|||
33597624|NCT01741532|102077897|FG000|Overall Study|Protocol Violation|0|||
33597625|NCT01741532|102077898|FG001|Overall Study|Protocol Violation|1|||
33597626|NCT01741532|102077897|FG000|Overall Study|Worsening of the disease|3|||
33597627|NCT01741532|102077898|FG001|Overall Study|Worsening of the disease|1|||
33597628|NCT01741532|102077897|FG000|Overall Study|Sponsor decision|1|||
33597629|NCT01741532|102077898|FG001|Overall Study|Sponsor decision|0|||
33597630|NCT01741532|102077897|FG000|Overall Study|Medical event|1|||
33597631|NCT01741532|102077898|FG001|Overall Study|Medical event|0|||
33597632|NCT03834506|102077899|FG000|Overall Study|Death|336|||
33597633|NCT03834506|102077900|FG001|Overall Study|Death|326|||
33597634|NCT03834506|102077899|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
33597635|NCT03834506|102077900|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33597636|NCT03834506|102077899|FG000|Overall Study|Withdrawal by Subject|10|||
33597637|NCT03834506|102077900|FG001|Overall Study|Withdrawal by Subject|8|||
33597638|NCT03834506|102077899|FG000|Overall Study|Sponsor decision|165|||
33597639|NCT03834506|102077900|FG001|Overall Study|Sponsor decision|178|||
33597640|NCT03834506|102077899|FG000|Overall Study|Physician Decision|3|||
33597641|NCT03834506|102077900|FG001|Overall Study|Physician Decision|1|||
33597642|NCT03834506|102077899|FG000|Overall Study|Lost to Follow-up|0|||
33597643|NCT03834506|102077900|FG001|Overall Study|Lost to Follow-up|1|||
33597644|NCT01510184|102077901|FG000|Overall Study|Sponsor discretion|28|||
33597645|NCT01510184|102077902|FG001|Overall Study|Sponsor discretion|28|||
33597646|NCT01510184|102077901|FG000|Overall Study|Death|1|||
33597647|NCT01510184|102077902|FG001|Overall Study|Death|2|||
33597648|NCT01510184|102077901|FG000|Overall Study|Withdrawal by Subject|1|||
33597649|NCT01510184|102077902|FG001|Overall Study|Withdrawal by Subject|4|||
33597650|NCT01510184|102077901|FG000|Overall Study|Other|0|||
33597651|NCT01510184|102077902|FG001|Overall Study|Other|1|||
33597652|NCT04422561|102077903|FG000|Overall Study|Lost to Follow-up|25|||
33597653|NCT04422561|102077904|FG001|Overall Study|Lost to Follow-up|11|||
33597654|NCT02498067|102077905|FG000|Overall Study|Lost to Follow-up|22|||
33597655|NCT02498067|102077905|FG000|Overall Study|Did not meet inclusion criteria|11|||
33597656|NCT03532932|102077908|FG000|Overall Study|Protocol Deviation|33|||
33597657|NCT03532932|102077909|FG001|Overall Study|Protocol Deviation|31|||
33597658|NCT03532932|102077908|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
33597659|NCT03532932|102077909|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
33597660|NCT03532932|102077908|FG000|Overall Study|Withdrawal by Subject|2|||
33597661|NCT03532932|102077909|FG001|Overall Study|Withdrawal by Subject|0|||
33597662|NCT03532932|102077908|FG000|Overall Study|Lost to Follow-up|15|||
33597663|NCT03532932|102077909|FG001|Overall Study|Lost to Follow-up|9|||
33597664|NCT03532932|102077908|FG000|Overall Study|Adverse Event|4|||
33597665|NCT03532932|102077909|FG001|Overall Study|Adverse Event|3|||
33597666|NCT03532932|102077908|FG000|Overall Study|Death|0|||
33597667|NCT03532932|102077909|FG001|Overall Study|Death|2|||
33597668|NCT03532932|102077908|FG000|Overall Study|Other|11|||
33597669|NCT03532932|102077909|FG001|Overall Study|Other|16|||
33597670|NCT00445939|102077913|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
33597671|NCT00445939|102077914|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
33597672|NCT00445939|102077915|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
33597673|NCT00445939|102077916|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
33597674|NCT00445939|102077913|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
33597675|NCT00445939|102077914|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
33597676|NCT00445939|102077915|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
33597677|NCT00445939|102077916|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
33597678|NCT02818036|102077922|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
33597679|NCT02818036|102077923|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
33597680|NCT02818036|102077922|FG000|Overall Study|Withdrawal by Subject|1|||
33597681|NCT02818036|102077923|FG001|Overall Study|Withdrawal by Subject|0|||
33597682|NCT00642369|102077927|FG000|Overall Study|Adverse Event|2|||
33597683|NCT00642369|102077928|FG001|Overall Study|Adverse Event|3|||
33597684|NCT00642369|102077927|FG000|Overall Study|Withdrawal by Subject|1|||
33597685|NCT00642369|102077928|FG001|Overall Study|Withdrawal by Subject|0|||
33597686|NCT00642369|102077927|FG000|Overall Study|misdiagnosis|0|||
33597687|NCT00642369|102077928|FG001|Overall Study|misdiagnosis|1|||
33597688|NCT00642369|102077927|FG000|Overall Study|Lack of Efficacy|2|||
33597689|NCT00642369|102077928|FG001|Overall Study|Lack of Efficacy|2|||
33597690|NCT00293709|102077929|FG000|Overall Study|Other|47|||
33597691|NCT03622112|102077932|FG000|Overall Study|Withdrawal by Subject|6|||
33597692|NCT03622112|102077933|FG001|Overall Study|Withdrawal by Subject|2|||
33597693|NCT03622112|102077934|FG002|Overall Study|Withdrawal by Subject|4|||
33597694|NCT03622112|102077935|FG003|Overall Study|Withdrawal by Subject|2|||
33597695|NCT03622112|102077936|FG004|Overall Study|Withdrawal by Subject|1|||
33597696|NCT03622112|102077937|FG005|Overall Study|Withdrawal by Subject|2|||
33597697|NCT03622112|102077938|FG006|Overall Study|Withdrawal by Subject|2|||
33597698|NCT03622112|102077932|FG000|Overall Study|Death|0|||
33597699|NCT03622112|102077933|FG001|Overall Study|Death|0|||
33597700|NCT03622112|102077934|FG002|Overall Study|Death|0|||
33597701|NCT03622112|102077935|FG003|Overall Study|Death|1|||
33597702|NCT03622112|102077936|FG004|Overall Study|Death|0|||
33597703|NCT03622112|102077937|FG005|Overall Study|Death|0|||
33597704|NCT03622112|102077938|FG006|Overall Study|Death|0|||
33597705|NCT03622112|102077932|FG000|Overall Study|Lost to Follow-up|1|||
33597706|NCT03622112|102077933|FG001|Overall Study|Lost to Follow-up|1|||
33597707|NCT03622112|102077934|FG002|Overall Study|Lost to Follow-up|0|||
33597708|NCT03622112|102077935|FG003|Overall Study|Lost to Follow-up|0|||
33597709|NCT03622112|102077936|FG004|Overall Study|Lost to Follow-up|0|||
33597710|NCT03622112|102077937|FG005|Overall Study|Lost to Follow-up|0|||
33597711|NCT03622112|102077938|FG006|Overall Study|Lost to Follow-up|0|||
33597712|NCT03622112|102077932|FG000|Overall Study|Study-specific withdrawal criteria|10|||
33597713|NCT03622112|102077933|FG001|Overall Study|Study-specific withdrawal criteria|8|||
33597714|NCT03622112|102077934|FG002|Overall Study|Study-specific withdrawal criteria|7|||
33597715|NCT03622112|102077935|FG003|Overall Study|Study-specific withdrawal criteria|6|||
33597716|NCT03622112|102077936|FG004|Overall Study|Study-specific withdrawal criteria|4|||
33597717|NCT03622112|102077937|FG005|Overall Study|Study-specific withdrawal criteria|18|||
33597718|NCT03622112|102077938|FG006|Overall Study|Study-specific withdrawal criteria|4|||
33597719|NCT03622112|102077932|FG000|Overall Study|Protocol Violation|2|||
33597720|NCT03622112|102077933|FG001|Overall Study|Protocol Violation|0|||
33597721|NCT03622112|102077934|FG002|Overall Study|Protocol Violation|1|||
33597722|NCT03622112|102077935|FG003|Overall Study|Protocol Violation|1|||
33597723|NCT03622112|102077936|FG004|Overall Study|Protocol Violation|0|||
33597724|NCT03622112|102077937|FG005|Overall Study|Protocol Violation|0|||
33597725|NCT03622112|102077938|FG006|Overall Study|Protocol Violation|0|||
33597726|NCT03622112|102077932|FG000|Overall Study|Adverse Event|6|||
33597727|NCT03622112|102077933|FG001|Overall Study|Adverse Event|8|||
33597728|NCT03622112|102077934|FG002|Overall Study|Adverse Event|4|||
33597729|NCT03622112|102077935|FG003|Overall Study|Adverse Event|11|||
33597730|NCT03622112|102077936|FG004|Overall Study|Adverse Event|4|||
33597731|NCT03622112|102077937|FG005|Overall Study|Adverse Event|20|||
33597732|NCT03622112|102077938|FG006|Overall Study|Adverse Event|2|||
33597733|NCT03622112|102077932|FG000|Overall Study|Reason not specified|0|||
33597734|NCT03622112|102077933|FG001|Overall Study|Reason not specified|1|||
33597735|NCT03622112|102077934|FG002|Overall Study|Reason not specified|0|||
33597736|NCT03622112|102077935|FG003|Overall Study|Reason not specified|1|||
33597737|NCT03622112|102077936|FG004|Overall Study|Reason not specified|1|||
33597738|NCT03622112|102077937|FG005|Overall Study|Reason not specified|2|||
33597739|NCT03622112|102077938|FG006|Overall Study|Reason not specified|1|||
33597740|NCT01448824|102077939|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
33597741|NCT01448824|102077940|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
33597742|NCT01448824|102077941|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
33597743|NCT01448824|102077942|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
33597744|NCT01448824|102077943|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
33597745|NCT01448824|102077944|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
33597746|NCT01448824|102077945|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
33597747|NCT01448824|102077946|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
33597748|NCT01448824|102077939|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
33597749|NCT01448824|102077940|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
33597750|NCT01448824|102077941|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
33597751|NCT01448824|102077942|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
33597752|NCT01448824|102077943|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
33597753|NCT01448824|102077944|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
33597754|NCT01448824|102077945|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
33597755|NCT01448824|102077946|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
33597756|NCT01448824|102077939|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
33597757|NCT01448824|102077940|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
33597758|NCT01448824|102077941|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
33597759|NCT01448824|102077942|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
33597760|NCT01448824|102077943|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
33597761|NCT01448824|102077944|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
33597762|NCT01448824|102077945|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
33597763|NCT01448824|102077946|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
33597764|NCT01448824|102077939|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
33597765|NCT01448824|102077940|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
33597766|NCT01448824|102077941|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
33597767|NCT01448824|102077942|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
33597768|NCT01448824|102077943|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
33597769|NCT01448824|102077944|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
33597770|NCT01448824|102077945|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
33597771|NCT01448824|102077946|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
33597772|NCT01448824|102077939|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
33597773|NCT01448824|102077940|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
33597774|NCT01448824|102077941|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
33597775|NCT01448824|102077942|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
33597776|NCT01448824|102077943|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
33597777|NCT01448824|102077944|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
33597778|NCT01448824|102077945|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
33597779|NCT01448824|102077946|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
33597780|NCT01448824|102077939|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
33597781|NCT01448824|102077940|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
33597782|NCT01448824|102077941|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
33597783|NCT01448824|102077942|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
33597784|NCT01448824|102077943|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
33597785|NCT01448824|102077944|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
33597786|NCT01448824|102077945|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
33597787|NCT01448824|102077946|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
33597788|NCT01448824|102077939|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
33597789|NCT01448824|102077940|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
33597790|NCT01448824|102077941|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
33597791|NCT01448824|102077942|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
33597792|NCT01448824|102077943|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
33597793|NCT01448824|102077944|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
33597794|NCT01448824|102077945|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
33597795|NCT01448824|102077946|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
33597796|NCT01448824|102077939|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
33597797|NCT01448824|102077940|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
33597798|NCT01448824|102077941|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
33597799|NCT01448824|102077942|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
33597800|NCT01448824|102077943|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
33597801|NCT01448824|102077944|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
33597802|NCT01448824|102077945|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
33597803|NCT01448824|102077946|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
33597804|NCT03060512|102077947|FG000|Overall Study|Adverse Event|4|||
33597805|NCT03060512|102077948|FG001|Overall Study|Adverse Event|6|||
33597806|NCT03060512|102077947|FG000|Overall Study|Lost to Follow-up|1|||
33597807|NCT03060512|102077948|FG001|Overall Study|Lost to Follow-up|1|||
33597808|NCT03060512|102077947|FG000|Overall Study|Withdrawal by Subject|1|||
33597809|NCT03060512|102077948|FG001|Overall Study|Withdrawal by Subject|0|||
33597810|NCT03060512|102077947|FG000|Overall Study|Non-compliance with study medication|1|||
33597811|NCT03060512|102077948|FG001|Overall Study|Non-compliance with study medication|2|||
33597812|NCT02908685|102077949|FG000|Part 1 OLE|Withdrawal by Subject|0|||
33597813|NCT02908685|102077950|FG001|Part 1 OLE|Withdrawal by Subject|0|||
33597814|NCT02908685|102077951|FG002|Part 1 OLE|Withdrawal by Subject|0|||
33597815|NCT02908685|102077952|FG003|Part 1 OLE|Withdrawal by Subject|0|||
33597816|NCT02908685|102077953|FG004|Part 1 OLE|Withdrawal by Subject|0|||
33597817|NCT02908685|102077954|FG005|Part 1 OLE|Withdrawal by Subject|0|||
33597818|NCT02908685|102077955|FG006|Part 1 OLE|Withdrawal by Subject|0|||
33597819|NCT02908685|102077956|FG007|Part 1 OLE|Withdrawal by Subject|0|||
33597820|NCT02908685|102077957|FG008|Part 1 OLE|Withdrawal by Subject|0|||
33597821|NCT02908685|102077958|FG009|Part 1 OLE|Withdrawal by Subject|0|||
33597822|NCT02908685|102077959|FG010|Part 1 OLE|Withdrawal by Subject|2|||
33597823|NCT02908685|102077960|FG011|Part 1 OLE|Withdrawal by Subject|1|||
33597824|NCT02908685|102077961|FG012|Part 1 OLE|Withdrawal by Subject|0|||
33597825|NCT02908685|102077962|FG013|Part 1 OLE|Withdrawal by Subject|0|||
33597826|NCT02908685|102077949|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
33597827|NCT02908685|102077950|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
33597828|NCT02908685|102077951|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
33597829|NCT02908685|102077952|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
33597830|NCT02908685|102077953|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
33597831|NCT02908685|102077954|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
33597832|NCT02908685|102077955|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
33597833|NCT02908685|102077956|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
33597834|NCT02908685|102077957|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
33597835|NCT02908685|102077958|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
33597836|NCT02908685|102077959|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
33597837|NCT02908685|102077960|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
33597838|NCT02908685|102077961|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
33597839|NCT02908685|102077962|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
33597840|NCT02908685|102077949|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
33597841|NCT02908685|102077950|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
33597842|NCT02908685|102077951|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
33597843|NCT02908685|102077952|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
33597844|NCT02908685|102077953|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
33597845|NCT02908685|102077954|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
33597846|NCT02908685|102077955|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
33597847|NCT02908685|102077956|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
33597848|NCT02908685|102077957|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
33597849|NCT02908685|102077958|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
33597850|NCT02908685|102077959|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
33597851|NCT02908685|102077960|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
33597852|NCT02908685|102077961|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
33597853|NCT02908685|102077962|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
33597854|NCT02908685|102077949|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
33597855|NCT02908685|102077950|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
33597856|NCT02908685|102077951|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
33597857|NCT02908685|102077952|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
33597858|NCT02908685|102077953|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
33597859|NCT02908685|102077954|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
33597860|NCT02908685|102077955|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
33597861|NCT02908685|102077956|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
33597862|NCT02908685|102077957|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
33597863|NCT02908685|102077958|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
33597864|NCT02908685|102077959|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
33597865|NCT02908685|102077960|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
33597866|NCT02908685|102077961|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
33597867|NCT02908685|102077962|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
33597868|NCT02908685|102077949|FG000|Part 2 OLE: > Month 24|Death|0|||
33597869|NCT02908685|102077950|FG001|Part 2 OLE: > Month 24|Death|0|||
33597870|NCT02908685|102077951|FG002|Part 2 OLE: > Month 24|Death|0|||
33597871|NCT02908685|102077952|FG003|Part 2 OLE: > Month 24|Death|0|||
33597872|NCT02908685|102077953|FG004|Part 2 OLE: > Month 24|Death|0|||
33597873|NCT02908685|102077954|FG005|Part 2 OLE: > Month 24|Death|0|||
33597874|NCT02908685|102077955|FG006|Part 2 OLE: > Month 24|Death|0|||
33597875|NCT02908685|102077956|FG007|Part 2 OLE: > Month 24|Death|0|||
33597876|NCT02908685|102077957|FG008|Part 2 OLE: > Month 24|Death|0|||
33597877|NCT02908685|102077958|FG009|Part 2 OLE: > Month 24|Death|0|||
33597878|NCT02908685|102077959|FG010|Part 2 OLE: > Month 24|Death|0|||
33597879|NCT02908685|102077960|FG011|Part 2 OLE: > Month 24|Death|0|||
33597880|NCT02908685|102077961|FG012|Part 2 OLE: > Month 24|Death|1|||
33597881|NCT02908685|102077962|FG013|Part 2 OLE: > Month 24|Death|0|||
33597882|NCT02908685|102077949|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
33597883|NCT02908685|102077950|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
33597884|NCT02908685|102077951|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
33597885|NCT02908685|102077952|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
33597886|NCT02908685|102077953|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
33597887|NCT02908685|102077954|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
33597888|NCT02908685|102077955|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
33597889|NCT02908685|102077956|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
33597890|NCT02908685|102077957|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
33597891|NCT02908685|102077958|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
33597892|NCT02908685|102077959|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
33597893|NCT02908685|102077960|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
33597894|NCT02908685|102077961|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
33597895|NCT02908685|102077962|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
33597896|NCT02908685|102077949|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
33597897|NCT02908685|102077950|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
33597898|NCT02908685|102077951|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
33597899|NCT02908685|102077952|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
33597900|NCT02908685|102077953|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
33597901|NCT02908685|102077954|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
33597902|NCT02908685|102077955|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
33597903|NCT02908685|102077956|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
33597904|NCT02908685|102077957|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
33597905|NCT02908685|102077958|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
33597906|NCT02908685|102077959|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
33597907|NCT02908685|102077960|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
33597908|NCT02908685|102077961|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
33597909|NCT02908685|102077962|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
33597910|NCT00523705|102077966|FG000|Overall Study|No time for study.|0|||
33597911|NCT00523705|102077967|FG001|Overall Study|No time for study.|1|||
33597912|NCT01007123|102077968|FG000|Overall Study|Adverse Event|3|||
33597913|NCT01007123|102077969|FG001|Overall Study|Adverse Event|4|||
33597914|NCT01007123|102077970|FG002|Overall Study|Adverse Event|7|||
33597915|NCT01007123|102077971|FG003|Overall Study|Adverse Event|1|||
33597916|NCT01007123|102077968|FG000|Overall Study|Lack of Efficacy|1|||
33597917|NCT01007123|102077969|FG001|Overall Study|Lack of Efficacy|0|||
33597918|NCT01007123|102077970|FG002|Overall Study|Lack of Efficacy|1|||
33597919|NCT01007123|102077971|FG003|Overall Study|Lack of Efficacy|4|||
33597920|NCT01007123|102077968|FG000|Overall Study|Protocol Violation|1|||
33597921|NCT01007123|102077969|FG001|Overall Study|Protocol Violation|1|||
33597922|NCT01007123|102077970|FG002|Overall Study|Protocol Violation|2|||
33597923|NCT01007123|102077971|FG003|Overall Study|Protocol Violation|1|||
33597924|NCT01007123|102077968|FG000|Overall Study|Withdrawal by Subject|1|||
33597925|NCT01007123|102077969|FG001|Overall Study|Withdrawal by Subject|0|||
33597926|NCT01007123|102077970|FG002|Overall Study|Withdrawal by Subject|1|||
33597927|NCT01007123|102077971|FG003|Overall Study|Withdrawal by Subject|0|||
33597928|NCT01007123|102077968|FG000|Overall Study|Lost to Follow-up|0|||
33597929|NCT01007123|102077969|FG001|Overall Study|Lost to Follow-up|1|||
33597930|NCT01007123|102077970|FG002|Overall Study|Lost to Follow-up|0|||
33597931|NCT01007123|102077971|FG003|Overall Study|Lost to Follow-up|0|||
33597932|NCT01340937|102077972|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
33597933|NCT01340937|102077973|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
33597934|NCT01340937|102077974|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
33597935|NCT01340937|102077975|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
33597936|NCT01340937|102077972|FG000|Period 1: Infant Series|Adverse Event|0|||
33597937|NCT01340937|102077973|FG001|Period 1: Infant Series|Adverse Event|1|||
33597938|NCT01340937|102077974|FG002|Period 1: Infant Series|Adverse Event|4|||
33597939|NCT01340937|102077975|FG003|Period 1: Infant Series|Adverse Event|0|||
33597940|NCT01340937|102077972|FG000|Period 1: Infant Series|Death|2|||
33597941|NCT01340937|102077973|FG001|Period 1: Infant Series|Death|0|||
33597942|NCT01340937|102077974|FG002|Period 1: Infant Series|Death|2|||
33597943|NCT01340937|102077975|FG003|Period 1: Infant Series|Death|0|||
33597944|NCT01340937|102077972|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
33597945|NCT01340937|102077973|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
33597946|NCT01340937|102077974|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
33597947|NCT01340937|102077975|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
33597948|NCT01340937|102077972|FG000|Period 1: Infant Series|Physician Decision|2|||
33597949|NCT01340937|102077973|FG001|Period 1: Infant Series|Physician Decision|3|||
33597950|NCT01340937|102077974|FG002|Period 1: Infant Series|Physician Decision|1|||
33597951|NCT01340937|102077975|FG003|Period 1: Infant Series|Physician Decision|0|||
33597952|NCT01340937|102077972|FG000|Period 1: Infant Series|Protocol Violation|1|||
33597953|NCT01340937|102077973|FG001|Period 1: Infant Series|Protocol Violation|4|||
33597954|NCT01340937|102077974|FG002|Period 1: Infant Series|Protocol Violation|4|||
33597955|NCT01340937|102077975|FG003|Period 1: Infant Series|Protocol Violation|3|||
33597956|NCT01340937|102077972|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
33597957|NCT01340937|102077973|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
33597958|NCT01340937|102077974|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
33597959|NCT01340937|102077975|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
33597960|NCT01340937|102077972|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
33597961|NCT01340937|102077973|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
33597962|NCT01340937|102077974|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
33597963|NCT01340937|102077975|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
33597964|NCT01340937|102077972|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
33597965|NCT01340937|102077973|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
33597966|NCT01340937|102077974|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
33597967|NCT01340937|102077975|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
33597968|NCT01340937|102077972|FG000|Period 2: Interim Period|Adverse Event|1|||
33597969|NCT01340937|102077973|FG001|Period 2: Interim Period|Adverse Event|0|||
33597970|NCT01340937|102077974|FG002|Period 2: Interim Period|Adverse Event|1|||
33597971|NCT01340937|102077975|FG003|Period 2: Interim Period|Adverse Event|0|||
33597972|NCT01340937|102077972|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
33597973|NCT01340937|102077973|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
33597974|NCT01340937|102077974|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
33597975|NCT01340937|102077975|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
33597976|NCT01340937|102077972|FG000|Period 2: Interim Period|Physician Decision|0|||
33597977|NCT01340937|102077973|FG001|Period 2: Interim Period|Physician Decision|1|||
33597978|NCT01340937|102077974|FG002|Period 2: Interim Period|Physician Decision|1|||
33597979|NCT01340937|102077975|FG003|Period 2: Interim Period|Physician Decision|0|||
33597980|NCT01340937|102077972|FG000|Period 2: Interim Period|Protocol Violation|5|||
33597981|NCT01340937|102077973|FG001|Period 2: Interim Period|Protocol Violation|3|||
33597982|NCT01340937|102077974|FG002|Period 2: Interim Period|Protocol Violation|6|||
33597983|NCT01340937|102077975|FG003|Period 2: Interim Period|Protocol Violation|3|||
33597984|NCT01340937|102077972|FG000|Period 2: Interim Period|Technical problems|4|||
33597985|NCT01340937|102077973|FG001|Period 2: Interim Period|Technical problems|4|||
33597986|NCT01340937|102077974|FG002|Period 2: Interim Period|Technical problems|6|||
33597987|NCT01340937|102077975|FG003|Period 2: Interim Period|Technical problems|3|||
33597988|NCT01340937|102077972|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
33597989|NCT01340937|102077973|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
33597990|NCT01340937|102077974|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
33597991|NCT01340937|102077975|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
33597992|NCT01340937|102077972|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
33597993|NCT01340937|102077973|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
33597994|NCT01340937|102077974|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
33597995|NCT01340937|102077975|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
33597996|NCT01340937|102077972|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
33597997|NCT01340937|102077973|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
33597998|NCT01340937|102077974|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
33597999|NCT01340937|102077975|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
33598000|NCT01340937|102077972|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
33598001|NCT01340937|102077973|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
33598002|NCT01340937|102077974|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
33598003|NCT01340937|102077975|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
33598004|NCT02961790|102077983|FG000|Overall Study|Canceled|4|||
33598005|NCT02961790|102077984|FG001|Overall Study|Canceled|5|||
33598006|NCT02961790|102077985|FG002|Overall Study|Canceled|1|||
33598007|NCT02961790|102077986|FG003|Overall Study|Canceled|4|||
33598008|NCT02961790|102077983|FG000|Overall Study|without baseline data|4|||
33598009|NCT02961790|102077984|FG001|Overall Study|without baseline data|0|||
33598010|NCT02961790|102077985|FG002|Overall Study|without baseline data|1|||
33598011|NCT02961790|102077986|FG003|Overall Study|without baseline data|0|||
33598012|NCT02961790|102077983|FG000|Overall Study|without post baseline data|7|||
33598013|NCT02961790|102077984|FG001|Overall Study|without post baseline data|6|||
33598014|NCT02961790|102077985|FG002|Overall Study|without post baseline data|4|||
33598015|NCT02961790|102077986|FG003|Overall Study|without post baseline data|1|||
33598016|NCT01730339|102077991|FG000|Overall Study|Withdrawal by Subject|3|||
33598017|NCT01730339|102077992|FG001|Overall Study|Withdrawal by Subject|2|||
33598018|NCT01730339|102077991|FG000|Overall Study|Lost to Follow-up|1|||
33598019|NCT01730339|102077992|FG001|Overall Study|Lost to Follow-up|1|||
33598020|NCT01730339|102077991|FG000|Overall Study|Un-specified|1|||
33598021|NCT01730339|102077992|FG001|Overall Study|Un-specified|0|||
33598022|NCT00846040|102077993|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
33598023|NCT00846040|102077994|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
33598024|NCT00846040|102077995|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
33598025|NCT00846040|102077993|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
33598026|NCT00846040|102077994|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
33598027|NCT00846040|102077995|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
33598028|NCT02699450|102077999|FG000|Overall Study|Death|2|||
33598029|NCT02699450|102078000|FG001|Overall Study|Death|1|||
33598030|NCT02699450|102078001|FG002|Overall Study|Death|2|||
33598031|NCT02699450|102077999|FG000|Overall Study|Met Criteria for Study Exit|0|||
33598032|NCT02699450|102078000|FG001|Overall Study|Met Criteria for Study Exit|0|||
33598033|NCT02699450|102078001|FG002|Overall Study|Met Criteria for Study Exit|1|||
33598034|NCT02699450|102077999|FG000|Overall Study|Protocol Violation|4|||
33598035|NCT02699450|102078000|FG001|Overall Study|Protocol Violation|3|||
33598036|NCT02699450|102078001|FG002|Overall Study|Protocol Violation|5|||
33598037|NCT02699450|102077999|FG000|Overall Study|Lost to Follow-up|3|||
33598038|NCT02699450|102078000|FG001|Overall Study|Lost to Follow-up|0|||
33598039|NCT02699450|102078001|FG002|Overall Study|Lost to Follow-up|5|||
33598040|NCT02699450|102077999|FG000|Overall Study|Physician Decision|2|||
33598041|NCT02699450|102078000|FG001|Overall Study|Physician Decision|0|||
33598042|NCT02699450|102078001|FG002|Overall Study|Physician Decision|0|||
33598043|NCT02699450|102077999|FG000|Overall Study|Withdrawal by Subject|3|||
33598044|NCT02699450|102078000|FG001|Overall Study|Withdrawal by Subject|1|||
33598045|NCT02699450|102078001|FG002|Overall Study|Withdrawal by Subject|2|||
33598046|NCT02699450|102077999|FG000|Overall Study|Adverse Event|1|||
33598047|NCT02699450|102078000|FG001|Overall Study|Adverse Event|0|||
33598048|NCT02699450|102078001|FG002|Overall Study|Adverse Event|0|||
33598049|NCT01514240|102078002|FG000|Overall Study|Adverse Event|4|||
33598050|NCT01514240|102078003|FG001|Overall Study|Adverse Event|4|||
33598051|NCT01514240|102078002|FG000|Overall Study|Subject Decision|2|||
33598052|NCT01514240|102078003|FG001|Overall Study|Subject Decision|7|||
33598053|NCT00168103|102078006|FG000|Overall Study|Withdrawal by Subject|1|||
33598054|NCT00168103|102078007|FG001|Overall Study|Withdrawal by Subject|2|||
33598055|NCT00168103|102078008|FG002|Overall Study|Withdrawal by Subject|1|||
33598056|NCT00168103|102078009|FG003|Overall Study|Withdrawal by Subject|0|||
33598057|NCT00168103|102078006|FG000|Overall Study|Lost to Follow-up|1|||
33598058|NCT00168103|102078007|FG001|Overall Study|Lost to Follow-up|3|||
33598059|NCT00168103|102078008|FG002|Overall Study|Lost to Follow-up|0|||
33598060|NCT00168103|102078009|FG003|Overall Study|Lost to Follow-up|0|||
33598061|NCT01187446|102078024|FG000|Overall Study|Patient started non-protocol therapy|0|||
33598062|NCT01187446|102078025|FG001|Overall Study|Patient started non-protocol therapy|1|||
33598063|NCT01767493|102078026|FG000|Overall Study|screen failures|3|||
33598064|NCT02590562|102078029|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
33598065|NCT02275117|102078037|FG000|Overall Study|Adverse Event|0|||
33598066|NCT02275117|102078038|FG001|Overall Study|Adverse Event|0|||
33598067|NCT02275117|102078039|FG002|Overall Study|Adverse Event|0|||
33598068|NCT02275117|102078040|FG003|Overall Study|Adverse Event|0|||
33598069|NCT02275117|102078041|FG004|Overall Study|Adverse Event|1|||
33598070|NCT02275117|102078037|FG000|Overall Study|Lack of Efficacy|6|||
33598071|NCT02275117|102078038|FG001|Overall Study|Lack of Efficacy|7|||
33598072|NCT02275117|102078039|FG002|Overall Study|Lack of Efficacy|5|||
33598073|NCT02275117|102078040|FG003|Overall Study|Lack of Efficacy|2|||
33598074|NCT02275117|102078041|FG004|Overall Study|Lack of Efficacy|10|||
33598075|NCT02275117|102078037|FG000|Overall Study|Lost to Follow-up|11|||
33598076|NCT02275117|102078038|FG001|Overall Study|Lost to Follow-up|16|||
33598077|NCT02275117|102078039|FG002|Overall Study|Lost to Follow-up|15|||
33598078|NCT02275117|102078040|FG003|Overall Study|Lost to Follow-up|16|||
33598079|NCT02275117|102078041|FG004|Overall Study|Lost to Follow-up|8|||
33598080|NCT02275117|102078037|FG000|Overall Study|Physician Decision|0|||
33598081|NCT02275117|102078038|FG001|Overall Study|Physician Decision|1|||
33598082|NCT02275117|102078039|FG002|Overall Study|Physician Decision|1|||
33598083|NCT02275117|102078040|FG003|Overall Study|Physician Decision|0|||
33598084|NCT02275117|102078041|FG004|Overall Study|Physician Decision|1|||
33598085|NCT02275117|102078037|FG000|Overall Study|Protocol Violation|1|||
33598086|NCT02275117|102078038|FG001|Overall Study|Protocol Violation|0|||
33598087|NCT02275117|102078039|FG002|Overall Study|Protocol Violation|1|||
33598088|NCT02275117|102078040|FG003|Overall Study|Protocol Violation|1|||
33598089|NCT02275117|102078041|FG004|Overall Study|Protocol Violation|0|||
33598090|NCT02275117|102078037|FG000|Overall Study|Withdrawal by Subject|6|||
33598091|NCT02275117|102078038|FG001|Overall Study|Withdrawal by Subject|4|||
33598092|NCT02275117|102078039|FG002|Overall Study|Withdrawal by Subject|7|||
33598093|NCT02275117|102078040|FG003|Overall Study|Withdrawal by Subject|3|||
33598094|NCT02275117|102078041|FG004|Overall Study|Withdrawal by Subject|3|||
33598095|NCT02275117|102078037|FG000|Overall Study|Terminated by Sponsor|4|||
33598096|NCT02275117|102078038|FG001|Overall Study|Terminated by Sponsor|4|||
33598097|NCT02275117|102078039|FG002|Overall Study|Terminated by Sponsor|4|||
33598098|NCT02275117|102078040|FG003|Overall Study|Terminated by Sponsor|6|||
33598099|NCT02275117|102078041|FG004|Overall Study|Terminated by Sponsor|4|||
33598100|NCT02275117|102078037|FG000|Overall Study|Worsening of Study Indication|0|||
33598101|NCT02275117|102078038|FG001|Overall Study|Worsening of Study Indication|1|||
33598102|NCT02275117|102078039|FG002|Overall Study|Worsening of Study Indication|2|||
33598103|NCT02275117|102078040|FG003|Overall Study|Worsening of Study Indication|0|||
33598104|NCT02275117|102078041|FG004|Overall Study|Worsening of Study Indication|0|||
33598105|NCT02275117|102078037|FG000|Overall Study|Study Burden|5|||
33598106|NCT02275117|102078038|FG001|Overall Study|Study Burden|4|||
33598107|NCT02275117|102078039|FG002|Overall Study|Study Burden|7|||
33598108|NCT02275117|102078040|FG003|Overall Study|Study Burden|5|||
33598109|NCT02275117|102078041|FG004|Overall Study|Study Burden|7|||
33598110|NCT02275117|102078037|FG000|Overall Study|Other|1|||
33598111|NCT02275117|102078038|FG001|Overall Study|Other|0|||
33598112|NCT02275117|102078039|FG002|Overall Study|Other|0|||
33598113|NCT02275117|102078040|FG003|Overall Study|Other|0|||
33598114|NCT02275117|102078041|FG004|Overall Study|Other|2|||
33598115|NCT01728077|102078042|FG000|Overall Study|Lack of Efficacy|3|||
33598116|NCT01728077|102078043|FG001|Overall Study|Lack of Efficacy|1|||
33598117|NCT01728077|102078042|FG000|Overall Study|Lost to Follow-up|1|||
33598118|NCT01728077|102078043|FG001|Overall Study|Lost to Follow-up|0|||
33598119|NCT01728077|102078042|FG000|Overall Study|Subject choice|2|||
33598120|NCT01728077|102078043|FG001|Overall Study|Subject choice|3|||
33598121|NCT01728077|102078042|FG000|Overall Study|Death|0|||
33598122|NCT01728077|102078043|FG001|Overall Study|Death|1|||
33598123|NCT01728077|102078042|FG000|Overall Study|Patient moving|1|||
33598124|NCT01728077|102078043|FG001|Overall Study|Patient moving|0|||
33598125|NCT01728077|102078042|FG000|Overall Study|Non compliance|1|||
33598126|NCT01728077|102078043|FG001|Overall Study|Non compliance|0|||
33598127|NCT02046174|102078045|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
33598128|NCT02046174|102078046|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
33598129|NCT03946124|102078049|FG000|Overall Study|Withdrawal by Subject|19|||
33598130|NCT01143051|102078050|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
33598131|NCT01143051|102078051|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
33598132|NCT01143051|102078052|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
33598133|NCT01143051|102078053|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
33598134|NCT01143051|102078054|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
33598135|NCT01143051|102078055|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
33598136|NCT01143051|102078050|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
33598137|NCT01143051|102078051|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
33598138|NCT01143051|102078052|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
33598139|NCT01143051|102078053|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
33598140|NCT01143051|102078054|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
33598141|NCT01143051|102078055|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
33598142|NCT02573246|102078059|FG000|Overall Study|Lost to Follow-up|2|||
33598143|NCT02573246|102078060|FG001|Overall Study|Lost to Follow-up|0|||
33598144|NCT02573246|102078061|FG002|Overall Study|Lost to Follow-up|0|||
33598145|NCT02573246|102078062|FG003|Overall Study|Lost to Follow-up|0|||
33598146|NCT02573246|102078063|FG004|Overall Study|Lost to Follow-up|1|||
33598147|NCT02573246|102078059|FG000|Overall Study|Withdrawal by Subject|0|||
33598148|NCT02573246|102078060|FG001|Overall Study|Withdrawal by Subject|0|||
33598149|NCT02573246|102078061|FG002|Overall Study|Withdrawal by Subject|0|||
33598150|NCT02573246|102078062|FG003|Overall Study|Withdrawal by Subject|0|||
33598151|NCT02573246|102078063|FG004|Overall Study|Withdrawal by Subject|1|||
33598152|NCT02573246|102078059|FG000|Overall Study|Physician Decision|1|||
33598153|NCT02573246|102078060|FG001|Overall Study|Physician Decision|1|||
33598154|NCT02573246|102078061|FG002|Overall Study|Physician Decision|3|||
33598155|NCT02573246|102078062|FG003|Overall Study|Physician Decision|2|||
33598156|NCT02573246|102078063|FG004|Overall Study|Physician Decision|2|||
33598157|NCT01457950|102078066|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
33598158|NCT01457950|102078067|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
33598159|NCT01457950|102078068|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
33598160|NCT01457950|102078069|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
33598161|NCT01457950|102078066|FG000|Double-Blind Phase|Protocol Violation|2|||
33598162|NCT01457950|102078067|FG001|Double-Blind Phase|Protocol Violation|1|||
33598163|NCT01457950|102078068|FG002|Double-Blind Phase|Protocol Violation|0|||
33598164|NCT01457950|102078069|FG003|Double-Blind Phase|Protocol Violation|0|||
33598165|NCT01457950|102078066|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
33598166|NCT01457950|102078067|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
33598167|NCT01457950|102078068|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
33598168|NCT01457950|102078069|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
33598169|NCT01457950|102078066|FG000|Open-Label Phase|Adverse Event|0|||
33598170|NCT01457950|102078067|FG001|Open-Label Phase|Adverse Event|0|||
33598171|NCT01457950|102078068|FG002|Open-Label Phase|Adverse Event|0|||
33598172|NCT01457950|102078069|FG003|Open-Label Phase|Adverse Event|1|||
33598173|NCT01457950|102078066|FG000|Open-Label Phase|Protocol Violation|0|||
33598174|NCT01457950|102078067|FG001|Open-Label Phase|Protocol Violation|0|||
33598175|NCT01457950|102078068|FG002|Open-Label Phase|Protocol Violation|0|||
33598176|NCT01457950|102078069|FG003|Open-Label Phase|Protocol Violation|1|||
33598177|NCT01457950|102078066|FG000|Open-Label Phase|Withdrawal by Subject|0|||
33598178|NCT01457950|102078067|FG001|Open-Label Phase|Withdrawal by Subject|0|||
33598179|NCT01457950|102078068|FG002|Open-Label Phase|Withdrawal by Subject|2|||
33598180|NCT01457950|102078069|FG003|Open-Label Phase|Withdrawal by Subject|0|||
33598181|NCT00875056|102078072|FG000|Overall Study|Adverse Event|6|||
33598182|NCT00875056|102078073|FG001|Overall Study|Adverse Event|1|||
33598183|NCT00875056|102078074|FG002|Overall Study|Adverse Event|2|||
33598184|NCT00875056|102078072|FG000|Overall Study|Progressive Disease|14|||
33598185|NCT00875056|102078073|FG001|Overall Study|Progressive Disease|8|||
33598186|NCT00875056|102078074|FG002|Overall Study|Progressive Disease|3|||
33598187|NCT00875056|102078072|FG000|Overall Study|Withdrawal by Subject|3|||
33598188|NCT00875056|102078073|FG001|Overall Study|Withdrawal by Subject|0|||
33598189|NCT00875056|102078074|FG002|Overall Study|Withdrawal by Subject|1|||
33598190|NCT02956850|102078075|FG000|Overall Study|Withdrawal by Subject|0|||
33598191|NCT02956850|102078076|FG001|Overall Study|Withdrawal by Subject|0|||
33598192|NCT02956850|102078077|FG002|Overall Study|Withdrawal by Subject|0|||
33598193|NCT02956850|102078078|FG003|Overall Study|Withdrawal by Subject|0|||
33598194|NCT02956850|102078079|FG004|Overall Study|Withdrawal by Subject|0|||
33598195|NCT02956850|102078080|FG005|Overall Study|Withdrawal by Subject|0|||
33598196|NCT02956850|102078081|FG006|Overall Study|Withdrawal by Subject|0|||
33598197|NCT02956850|102078082|FG007|Overall Study|Withdrawal by Subject|0|||
33598198|NCT02956850|102078083|FG008|Overall Study|Withdrawal by Subject|0|||
33598199|NCT02956850|102078084|FG009|Overall Study|Withdrawal by Subject|0|||
33598200|NCT02956850|102078085|FG010|Overall Study|Withdrawal by Subject|0|||
33598201|NCT02956850|102078086|FG011|Overall Study|Withdrawal by Subject|0|||
33598202|NCT02956850|102078087|FG012|Overall Study|Withdrawal by Subject|0|||
33598203|NCT02956850|102078088|FG013|Overall Study|Withdrawal by Subject|0|||
33598204|NCT02956850|102078089|FG014|Overall Study|Withdrawal by Subject|0|||
33598205|NCT02956850|102078090|FG015|Overall Study|Withdrawal by Subject|0|||
33598206|NCT02956850|102078091|FG016|Overall Study|Withdrawal by Subject|0|||
33598207|NCT02956850|102078092|FG017|Overall Study|Withdrawal by Subject|1|||
33598208|NCT01537081|102081491|FG000|Overall Study|Adverse Event|5|||
33598209|NCT01537081|102081492|FG001|Overall Study|Adverse Event|2|||
33598210|NCT01537081|102081493|FG002|Overall Study|Adverse Event|2|||
33598211|NCT01537081|102081491|FG000|Overall Study|Lack of Efficacy|2|||
33598212|NCT01537081|102081492|FG001|Overall Study|Lack of Efficacy|1|||
33598213|NCT01537081|102081493|FG002|Overall Study|Lack of Efficacy|0|||
33598214|NCT01537081|102081491|FG000|Overall Study|Lost to Follow-up|17|||
33598215|NCT01537081|102081492|FG001|Overall Study|Lost to Follow-up|15|||
33598216|NCT01537081|102081493|FG002|Overall Study|Lost to Follow-up|9|||
33598217|NCT01537081|102081491|FG000|Overall Study|Protocol Violation|3|||
33598218|NCT01537081|102081492|FG001|Overall Study|Protocol Violation|2|||
33598219|NCT01537081|102081493|FG002|Overall Study|Protocol Violation|2|||
33598220|NCT01537081|102081491|FG000|Overall Study|Withdrawal by Subject|6|||
33598221|NCT01537081|102081492|FG001|Overall Study|Withdrawal by Subject|11|||
33598222|NCT01537081|102081493|FG002|Overall Study|Withdrawal by Subject|3|||
33598223|NCT01537081|102081491|FG000|Overall Study|Physician Decision|5|||
33598224|NCT01537081|102081492|FG001|Overall Study|Physician Decision|6|||
33598225|NCT01537081|102081493|FG002|Overall Study|Physician Decision|0|||
33598226|NCT01537081|102081491|FG000|Overall Study|Sponsor decision|0|||
33598227|NCT01537081|102081492|FG001|Overall Study|Sponsor decision|1|||
33598228|NCT01537081|102081493|FG002|Overall Study|Sponsor decision|0|||
33598229|NCT01537081|102081491|FG000|Overall Study|Assigned but never dosed|1|||
33598230|NCT01537081|102081492|FG001|Overall Study|Assigned but never dosed|0|||
33598231|NCT01537081|102081493|FG002|Overall Study|Assigned but never dosed|0|||
33598232|NCT00066469|102081496|FG000|Overall Study|Death|3|||
33598233|NCT00066469|102081496|FG000|Overall Study|Lack of Efficacy|9|||
33598234|NCT00066469|102081496|FG000|Overall Study|Lost to Follow-up|1|||
33598235|NCT00066469|102081496|FG000|Overall Study|Physician Decision|1|||
33598236|NCT00066469|102081496|FG000|Overall Study|Withdrawal by Subject|1|||
33598237|NCT00066469|102081496|FG000|Overall Study|ineligible|1|||
33598238|NCT01703117|102081500|FG000|Overall Study|Adverse Event|4|||
33598239|NCT01703117|102081501|FG001|Overall Study|Adverse Event|3|||
33598240|NCT01703117|102081500|FG000|Overall Study|Withdrawal by Subject|0|||
33598241|NCT01703117|102081501|FG001|Overall Study|Withdrawal by Subject|1|||
33598242|NCT02434354|102081502|FG000|Overall Study|screen fail|3|||
33598243|NCT02761694|102081503|FG000|Overall Study|Lack of Efficacy|0|||
33598244|NCT02761694|102081504|FG001|Overall Study|Lack of Efficacy|0|||
33598245|NCT02761694|102081505|FG002|Overall Study|Lack of Efficacy|0|||
33598246|NCT02761694|102081506|FG003|Overall Study|Lack of Efficacy|0|||
33598247|NCT02761694|102081507|FG004|Overall Study|Lack of Efficacy|0|||
33598248|NCT02761694|102081508|FG005|Overall Study|Lack of Efficacy|0|||
33598249|NCT02761694|102081509|FG006|Overall Study|Lack of Efficacy|6|||
33598250|NCT02761694|102081510|FG007|Overall Study|Lack of Efficacy|0|||
33598251|NCT02761694|102081511|FG008|Overall Study|Lack of Efficacy|0|||
33598252|NCT02761694|102081512|FG009|Overall Study|Lack of Efficacy|1|||
33598253|NCT02761694|102081513|FG010|Overall Study|Lack of Efficacy|1|||
33598254|NCT02761694|102081514|FG011|Overall Study|Lack of Efficacy|4|||
33598255|NCT02761694|102081503|FG000|Overall Study|Death|0|||
33598256|NCT02761694|102081504|FG001|Overall Study|Death|0|||
33598257|NCT02761694|102081505|FG002|Overall Study|Death|0|||
33598258|NCT02761694|102081506|FG003|Overall Study|Death|0|||
33598259|NCT02761694|102081507|FG004|Overall Study|Death|0|||
33598260|NCT02761694|102081508|FG005|Overall Study|Death|0|||
33598261|NCT02761694|102081509|FG006|Overall Study|Death|2|||
33598262|NCT02761694|102081510|FG007|Overall Study|Death|0|||
33598263|NCT02761694|102081511|FG008|Overall Study|Death|2|||
33598264|NCT02761694|102081512|FG009|Overall Study|Death|2|||
33598265|NCT02761694|102081513|FG010|Overall Study|Death|1|||
33598266|NCT02761694|102081514|FG011|Overall Study|Death|0|||
33598267|NCT02761694|102081503|FG000|Overall Study|Physician Decision|0|||
33598268|NCT02761694|102081504|FG001|Overall Study|Physician Decision|0|||
33598269|NCT02761694|102081505|FG002|Overall Study|Physician Decision|0|||
33598270|NCT02761694|102081506|FG003|Overall Study|Physician Decision|0|||
33598271|NCT02761694|102081507|FG004|Overall Study|Physician Decision|0|||
33598272|NCT02761694|102081508|FG005|Overall Study|Physician Decision|0|||
33598273|NCT02761694|102081509|FG006|Overall Study|Physician Decision|1|||
33598274|NCT02761694|102081510|FG007|Overall Study|Physician Decision|0|||
33598275|NCT02761694|102081511|FG008|Overall Study|Physician Decision|0|||
33598276|NCT02761694|102081512|FG009|Overall Study|Physician Decision|0|||
33598277|NCT02761694|102081513|FG010|Overall Study|Physician Decision|0|||
33598278|NCT02761694|102081514|FG011|Overall Study|Physician Decision|0|||
33598279|NCT02761694|102081503|FG000|Overall Study|Withdrawal by Subject|0|||
33598280|NCT02761694|102081504|FG001|Overall Study|Withdrawal by Subject|0|||
33598281|NCT02761694|102081505|FG002|Overall Study|Withdrawal by Subject|0|||
33598282|NCT02761694|102081506|FG003|Overall Study|Withdrawal by Subject|1|||
33598283|NCT02761694|102081507|FG004|Overall Study|Withdrawal by Subject|0|||
33598284|NCT02761694|102081508|FG005|Overall Study|Withdrawal by Subject|0|||
33598285|NCT02761694|102081509|FG006|Overall Study|Withdrawal by Subject|4|||
33598286|NCT02761694|102081510|FG007|Overall Study|Withdrawal by Subject|0|||
33598287|NCT02761694|102081511|FG008|Overall Study|Withdrawal by Subject|2|||
33598288|NCT02761694|102081512|FG009|Overall Study|Withdrawal by Subject|1|||
33598289|NCT02761694|102081513|FG010|Overall Study|Withdrawal by Subject|0|||
33598290|NCT02761694|102081514|FG011|Overall Study|Withdrawal by Subject|0|||
33598291|NCT02761694|102081503|FG000|Overall Study|Lost to Follow-up|0|||
33598292|NCT02761694|102081504|FG001|Overall Study|Lost to Follow-up|0|||
33598293|NCT02761694|102081505|FG002|Overall Study|Lost to Follow-up|0|||
33598294|NCT02761694|102081506|FG003|Overall Study|Lost to Follow-up|0|||
33598295|NCT02761694|102081507|FG004|Overall Study|Lost to Follow-up|0|||
33598296|NCT02761694|102081508|FG005|Overall Study|Lost to Follow-up|0|||
33598297|NCT02761694|102081509|FG006|Overall Study|Lost to Follow-up|1|||
33598298|NCT02761694|102081510|FG007|Overall Study|Lost to Follow-up|0|||
33598299|NCT02761694|102081511|FG008|Overall Study|Lost to Follow-up|0|||
33598300|NCT02761694|102081512|FG009|Overall Study|Lost to Follow-up|0|||
33598301|NCT02761694|102081513|FG010|Overall Study|Lost to Follow-up|0|||
33598302|NCT02761694|102081514|FG011|Overall Study|Lost to Follow-up|1|||
33598303|NCT02761694|102081503|FG000|Overall Study|Adverse Event|0|||
33598304|NCT02761694|102081504|FG001|Overall Study|Adverse Event|0|||
33598305|NCT02761694|102081505|FG002|Overall Study|Adverse Event|0|||
33598306|NCT02761694|102081506|FG003|Overall Study|Adverse Event|0|||
33598307|NCT02761694|102081507|FG004|Overall Study|Adverse Event|0|||
33598308|NCT02761694|102081508|FG005|Overall Study|Adverse Event|0|||
33598309|NCT02761694|102081509|FG006|Overall Study|Adverse Event|1|||
33598310|NCT02761694|102081510|FG007|Overall Study|Adverse Event|0|||
33598311|NCT02761694|102081511|FG008|Overall Study|Adverse Event|1|||
33598312|NCT02761694|102081512|FG009|Overall Study|Adverse Event|0|||
33598313|NCT02761694|102081513|FG010|Overall Study|Adverse Event|0|||
33598314|NCT02761694|102081514|FG011|Overall Study|Adverse Event|1|||
33598315|NCT02761694|102081503|FG000|Overall Study|Other|4|||
33598316|NCT02761694|102081504|FG001|Overall Study|Other|4|||
33598317|NCT02761694|102081505|FG002|Overall Study|Other|1|||
33598318|NCT02761694|102081506|FG003|Overall Study|Other|2|||
33598319|NCT02761694|102081507|FG004|Overall Study|Other|3|||
33598320|NCT02761694|102081508|FG005|Overall Study|Other|3|||
33598321|NCT02761694|102081509|FG006|Overall Study|Other|18|||
33598322|NCT02761694|102081510|FG007|Overall Study|Other|8|||
33598323|NCT02761694|102081511|FG008|Overall Study|Other|0|||
33598324|NCT02761694|102081512|FG009|Overall Study|Other|1|||
33598325|NCT02761694|102081513|FG010|Overall Study|Other|1|||
33598326|NCT02761694|102081514|FG011|Overall Study|Other|0|||
33598327|NCT02891681|102081515|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
33598328|NCT02891681|102081516|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
33598329|NCT02891681|102081517|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
33598330|NCT02891681|102081515|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
33598331|NCT02891681|102081516|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
33598332|NCT02891681|102081517|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
33598333|NCT02891681|102081515|FG000|Overall Study|Taken off study after first imaging appointment|1|||
33598334|NCT02891681|102081516|FG001|Overall Study|Taken off study after first imaging appointment|0|||
33598335|NCT02891681|102081517|FG002|Overall Study|Taken off study after first imaging appointment|0|||
33598336|NCT01515475|102081518|FG000|Overall Study|Lost to Follow-up|20|||
33598337|NCT01515475|102081519|FG001|Overall Study|Lost to Follow-up|15|||
33598338|NCT01515475|102081520|FG002|Overall Study|Lost to Follow-up|12|||
33598339|NCT01515475|102081521|FG003|Overall Study|Lost to Follow-up|12|||
33598340|NCT02436408|102081526|FG000|Overall Study|Death|1|||
33598341|NCT02635347|102081529|FG000|Overall Study|Failed screening|20|||
33598342|NCT02635347|102081530|FG001|Overall Study|Failed screening|7|||
33598343|NCT02653495|102081540|FG000|Overall Study|Lost to Follow-up|2|||
33598344|NCT02653495|102081541|FG001|Overall Study|Lost to Follow-up|0|||
33598345|NCT02653495|102081540|FG000|Overall Study|Screening Failure|10|||
33598346|NCT02653495|102081541|FG001|Overall Study|Screening Failure|0|||
33598347|NCT02851407|102081544|FG000|Overall Study|Withdrawal by parent/guardian|2|||
33598348|NCT02851407|102081545|FG001|Overall Study|Withdrawal by parent/guardian|7|||
33598349|NCT02851407|102081544|FG000|Overall Study|Protocol deviation|0|||
33598350|NCT02851407|102081545|FG001|Overall Study|Protocol deviation|1|||
33598351|NCT02851407|102081544|FG000|Overall Study|Transferred to another hospital to continue|1|||
33598352|NCT02851407|102081545|FG001|Overall Study|Transferred to another hospital to continue|0|||
33598353|NCT02851407|102081544|FG000|Overall Study|Other Death|30|||
33598354|NCT02851407|102081545|FG001|Overall Study|Other Death|20|||
33598355|NCT02851407|102081544|FG000|Overall Study|Adverse event, serious fatal|6|||
33598356|NCT02851407|102081545|FG001|Overall Study|Adverse event, serious fatal|8|||
33598357|NCT02851407|102081544|FG000|Overall Study|Consent withdrawn by participant|5|||
33598358|NCT02851407|102081545|FG001|Overall Study|Consent withdrawn by participant|3|||
33598359|NCT02851407|102081544|FG000|Overall Study|Screen failure|2|||
33598360|NCT02851407|102081545|FG001|Overall Study|Screen failure|1|||
33598361|NCT02851407|102081544|FG000|Overall Study|Disease relapse|9|||
33598362|NCT02851407|102081545|FG001|Overall Study|Disease relapse|6|||
33598363|NCT02851407|102081544|FG000|Overall Study|Physician Decision|7|||
33598364|NCT02851407|102081545|FG001|Overall Study|Physician Decision|6|||
33598365|NCT02851407|102081544|FG000|Overall Study|Transferred to hospital closer to home|0|||
33598366|NCT02851407|102081545|FG001|Overall Study|Transferred to hospital closer to home|1|||
33598367|NCT02851407|102081544|FG000|Overall Study|Enrolled in an investigational study|0|||
33598368|NCT02851407|102081545|FG001|Overall Study|Enrolled in an investigational study|1|||
33598369|NCT02851407|102081544|FG000|Overall Study|Early recovery|1|||
33598370|NCT02851407|102081545|FG001|Overall Study|Early recovery|0|||
33598371|NCT02851407|102081544|FG000|Overall Study|Adverse event, non-fatal|7|||
33598372|NCT02851407|102081545|FG001|Overall Study|Adverse event, non-fatal|5|||
33598373|NCT02851407|102081544|FG000|Overall Study|Lost to Follow-up|0|||
33598374|NCT02851407|102081545|FG001|Overall Study|Lost to Follow-up|2|||
33598375|NCT00171925|102081547|FG000|Overall Study|Adverse Event|10|||
33598376|NCT00171925|102081548|FG001|Overall Study|Adverse Event|6|||
33598377|NCT00171925|102081547|FG000|Overall Study|Protocol Violation|1|||
33598378|NCT00171925|102081548|FG001|Overall Study|Protocol Violation|1|||
33598379|NCT00171925|102081547|FG000|Overall Study|Withdrawal by Subject|6|||
33598380|NCT00171925|102081548|FG001|Overall Study|Withdrawal by Subject|9|||
33598381|NCT00171925|102081547|FG000|Overall Study|Lost to Follow-up|2|||
33598382|NCT00171925|102081548|FG001|Overall Study|Lost to Follow-up|2|||
33598383|NCT00171925|102081547|FG000|Overall Study|Administrative problems|10|||
33598384|NCT00171925|102081548|FG001|Overall Study|Administrative problems|11|||
33598385|NCT00171925|102081547|FG000|Overall Study|Death|1|||
33598386|NCT00171925|102081548|FG001|Overall Study|Death|2|||
33598387|NCT00977938|102081549|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
33598388|NCT00977938|102081550|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
33598389|NCT00977938|102081551|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
33598390|NCT00977938|102081552|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
33598391|NCT00977938|102081549|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
33598392|NCT00977938|102081550|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
33598393|NCT00977938|102081551|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
33598394|NCT00977938|102081552|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
33598395|NCT00977938|102081549|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
33598396|NCT00977938|102081550|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
33598397|NCT00977938|102081551|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
33598398|NCT00977938|102081552|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
33598399|NCT00977938|102081549|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
33598400|NCT00977938|102081550|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
33598401|NCT00977938|102081551|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
33598402|NCT00977938|102081552|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
33598403|NCT00977938|102081549|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
33598404|NCT00977938|102081550|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
33598405|NCT00977938|102081551|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
33598406|NCT00977938|102081552|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
33598407|NCT00977938|102081549|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
33598408|NCT00977938|102081550|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
33598409|NCT00977938|102081551|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
33598410|NCT00977938|102081552|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
33598411|NCT00276094|102081553|FG000|Overall Study|Adverse Event|15|||
33598412|NCT00276094|102081554|FG001|Overall Study|Adverse Event|13|||
33598413|NCT00276094|102081555|FG002|Overall Study|Adverse Event|11|||
33598414|NCT00276094|102081553|FG000|Overall Study|Withdrawal by Subject|14|||
33598415|NCT00276094|102081554|FG001|Overall Study|Withdrawal by Subject|14|||
33598416|NCT00276094|102081555|FG002|Overall Study|Withdrawal by Subject|12|||
33598417|NCT00276094|102081553|FG000|Overall Study|Protocol Violation|16|||
33598418|NCT00276094|102081554|FG001|Overall Study|Protocol Violation|7|||
33598419|NCT00276094|102081555|FG002|Overall Study|Protocol Violation|10|||
33598420|NCT00276094|102081553|FG000|Overall Study|Lost to Follow-up|8|||
33598421|NCT00276094|102081554|FG001|Overall Study|Lost to Follow-up|6|||
33598422|NCT00276094|102081555|FG002|Overall Study|Lost to Follow-up|4|||
33598423|NCT00276094|102081553|FG000|Overall Study|Other-Subject moved out of country|1|||
33598424|NCT00276094|102081554|FG001|Overall Study|Other-Subject moved out of country|0|||
33598425|NCT00276094|102081555|FG002|Overall Study|Other-Subject moved out of country|0|||
33598426|NCT00276094|102081553|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
33598427|NCT00276094|102081554|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
33598428|NCT00276094|102081555|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
33598429|NCT00276094|102081553|FG000|Overall Study|Other-Lack of efficacy|1|||
33598430|NCT00276094|102081554|FG001|Overall Study|Other-Lack of efficacy|0|||
33598431|NCT00276094|102081555|FG002|Overall Study|Other-Lack of efficacy|0|||
33598432|NCT00276094|102081553|FG000|Overall Study|Other-Refused follow-up visit|1|||
33598433|NCT00276094|102081554|FG001|Overall Study|Other-Refused follow-up visit|0|||
33598434|NCT00276094|102081555|FG002|Overall Study|Other-Refused follow-up visit|0|||
33598435|NCT00276094|102081553|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
33598436|NCT00276094|102081554|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
33598437|NCT00276094|102081555|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
33598438|NCT00276094|102081553|FG000|Overall Study|Other-Relocation|0|||
33598439|NCT00276094|102081554|FG001|Overall Study|Other-Relocation|1|||
33598440|NCT00276094|102081555|FG002|Overall Study|Other-Relocation|0|||
33598441|NCT00276094|102081553|FG000|Overall Study|Other-Study medication lost|0|||
33598442|NCT00276094|102081554|FG001|Overall Study|Other-Study medication lost|0|||
33598443|NCT00276094|102081555|FG002|Overall Study|Other-Study medication lost|1|||
33598444|NCT03283098|102081556|FG000|Overall Study|Withdrawal by Subject|0|||
33598445|NCT03283098|102081557|FG001|Overall Study|Withdrawal by Subject|1|||
33598446|NCT01095653|102081561|FG000|Overall Study|Lack of Efficacy|3|||
33598447|NCT01095653|102081562|FG001|Overall Study|Lack of Efficacy|0|||
33598448|NCT01095653|102081563|FG002|Overall Study|Lack of Efficacy|0|||
33598449|NCT01095653|102081561|FG000|Overall Study|Adverse Event|1|||
33598450|NCT01095653|102081562|FG001|Overall Study|Adverse Event|4|||
33598451|NCT01095653|102081563|FG002|Overall Study|Adverse Event|4|||
33598452|NCT01095653|102081561|FG000|Overall Study|Lost to Follow-up|1|||
33598453|NCT01095653|102081562|FG001|Overall Study|Lost to Follow-up|0|||
33598454|NCT01095653|102081563|FG002|Overall Study|Lost to Follow-up|4|||
33598455|NCT01095653|102081561|FG000|Overall Study|Withdrawal by Subject|4|||
33598456|NCT01095653|102081562|FG001|Overall Study|Withdrawal by Subject|5|||
33598457|NCT01095653|102081563|FG002|Overall Study|Withdrawal by Subject|3|||
33598458|NCT01095653|102081561|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
33598459|NCT01095653|102081562|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
33598460|NCT01095653|102081563|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
33598461|NCT02549352|102081564|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
33598462|NCT02549352|102081565|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
33598463|NCT02549352|102081564|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
33598464|NCT02549352|102081565|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
33598465|NCT02549352|102081564|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
33598466|NCT02549352|102081565|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
33598467|NCT02549352|102081564|FG000|12-month Follow-up|Withdrawal by Subject|4|||
33598468|NCT02549352|102081565|FG001|12-month Follow-up|Withdrawal by Subject|5|||
33598469|NCT02549352|102081564|FG000|12-month Follow-up|Lost to Follow-up|3|||
33598470|NCT02549352|102081565|FG001|12-month Follow-up|Lost to Follow-up|2|||
33598471|NCT02549352|102081564|FG000|12-month Follow-up|Death|0|||
33598472|NCT02549352|102081565|FG001|12-month Follow-up|Death|1|||
33598473|NCT02549352|102081564|FG000|12-month Follow-up|Protocol Violation|0|||
33598474|NCT02549352|102081565|FG001|12-month Follow-up|Protocol Violation|1|||
33598475|NCT02549352|102081564|FG000|12-month Follow-up|Other|1|||
33598476|NCT02549352|102081565|FG001|12-month Follow-up|Other|3|||
33598477|NCT01342965|102081566|FG000|Overall Study|Death|58|||
33598478|NCT01342965|102081567|FG001|Overall Study|Death|57|||
33598479|NCT01342965|102081566|FG000|Overall Study|Lost to Follow-up|5|||
33598480|NCT01342965|102081567|FG001|Overall Study|Lost to Follow-up|3|||
33598481|NCT01342965|102081566|FG000|Overall Study|Other Reasons- Unspecified|44|||
33598482|NCT01342965|102081567|FG001|Overall Study|Other Reasons- Unspecified|38|||
33598483|NCT01342965|102081566|FG000|Overall Study|Withdrawal by Subject|2|||
33598484|NCT01342965|102081567|FG001|Overall Study|Withdrawal by Subject|9|||
33598485|NCT04316741|102081568|FG000|Baseline Enrollment|Lost to Follow-up|1|||
33598486|NCT04316741|102081569|FG001|Baseline Enrollment|Lost to Follow-up|1|||
33598487|NCT04316741|102081568|FG000|Immediate Post-Test|Lost to Follow-up|5|||
33598488|NCT04316741|102081569|FG001|Immediate Post-Test|Lost to Follow-up|1|||
33598489|NCT04316741|102081568|FG000|1-month Post-test|Lost to Follow-up|7|||
33598490|NCT04316741|102081569|FG001|1-month Post-test|Lost to Follow-up|2|||
33598491|NCT04316741|102081568|FG000|3-month Follow-up|Lost to Follow-up|10|||
33598492|NCT04316741|102081569|FG001|3-month Follow-up|Lost to Follow-up|2|||
33598493|NCT01294462|102081570|FG000|Overall Study|Lost to Follow-up|1|||
33598494|NCT01294462|102081571|FG001|Overall Study|Lost to Follow-up|0|||
33598495|NCT01294462|102081570|FG000|Overall Study|Withdrawal by Subject|65|||
33598496|NCT01294462|102081571|FG001|Overall Study|Withdrawal by Subject|63|||
33598497|NCT01697462|102081572|FG000|Overall Study|Disease Progression|1|||
33598498|NCT01697462|102081572|FG000|Overall Study|Adverse Event|6|||
33598499|NCT01697462|102081572|FG000|Overall Study|Lost to Follow-up|21|||
33598500|NCT01697462|102081572|FG000|Overall Study|Withdrawal by Subject|12|||
33598501|NCT01697462|102081572|FG000|Overall Study|Investigator Decision|21|||
33598502|NCT01697462|102081572|FG000|Overall Study|Death|1|||
33598503|NCT01697462|102081572|FG000|Overall Study|Other|10|||
33598504|NCT01697462|102081572|FG000|Overall Study|Missing|5|||
33598505|NCT02744612|102081573|FG000|Overall Study|Withdrawal by Subject|0|||
33598506|NCT02744612|102081574|FG001|Overall Study|Withdrawal by Subject|2|||
33598507|NCT02174523|102081575|FG000|Overall Study|Withdrawal by Subject|1|||
33598508|NCT02174523|102081576|FG001|Overall Study|Withdrawal by Subject|0|||
33598509|NCT00160199|102081581|FG000|Overall Study|Adverse Event|5|||
33598510|NCT00160199|102081582|FG001|Overall Study|Adverse Event|14|||
33598511|NCT00160199|102081581|FG000|Overall Study|Lack of Efficacy|0|||
33598512|NCT00160199|102081582|FG001|Overall Study|Lack of Efficacy|1|||
33598513|NCT00160199|102081581|FG000|Overall Study|Lost to Follow-up|7|||
33598514|NCT00160199|102081582|FG001|Overall Study|Lost to Follow-up|7|||
33598515|NCT00160199|102081581|FG000|Overall Study|Withdrawal by Subject|4|||
33598516|NCT00160199|102081582|FG001|Overall Study|Withdrawal by Subject|6|||
33598517|NCT00160199|102081581|FG000|Overall Study|Administrative|0|||
33598518|NCT00160199|102081582|FG001|Overall Study|Administrative|1|||
33598519|NCT00160199|102081581|FG000|Overall Study|Protocol Violation|8|||
33598520|NCT00160199|102081582|FG001|Overall Study|Protocol Violation|8|||
33598521|NCT02193087|102081585|FG000|Overall Study|Adverse Event|2|||
33598522|NCT02193087|102081586|FG001|Overall Study|Adverse Event|0|||
33598523|NCT02193087|102081587|FG002|Overall Study|Adverse Event|0|||
33598524|NCT02193087|102081588|FG003|Overall Study|Adverse Event|11|||
33598525|NCT02193087|102081585|FG000|Overall Study|Lost to Follow-up|14|||
33598526|NCT02193087|102081586|FG001|Overall Study|Lost to Follow-up|6|||
33598527|NCT02193087|102081587|FG002|Overall Study|Lost to Follow-up|4|||
33598528|NCT02193087|102081588|FG003|Overall Study|Lost to Follow-up|37|||
33598529|NCT02193087|102081585|FG000|Overall Study|Protocol Violation|2|||
33598530|NCT02193087|102081586|FG001|Overall Study|Protocol Violation|0|||
33598531|NCT02193087|102081587|FG002|Overall Study|Protocol Violation|1|||
33598532|NCT02193087|102081588|FG003|Overall Study|Protocol Violation|2|||
33598533|NCT02193087|102081585|FG000|Overall Study|Withdrawal by Subject|10|||
33598534|NCT02193087|102081586|FG001|Overall Study|Withdrawal by Subject|3|||
33598535|NCT02193087|102081587|FG002|Overall Study|Withdrawal by Subject|1|||
33598536|NCT02193087|102081588|FG003|Overall Study|Withdrawal by Subject|19|||
33598537|NCT02193087|102081585|FG000|Overall Study|Other Reason Not Specified|7|||
33598538|NCT02193087|102081586|FG001|Overall Study|Other Reason Not Specified|2|||
33598539|NCT02193087|102081587|FG002|Overall Study|Other Reason Not Specified|1|||
33598540|NCT02193087|102081588|FG003|Overall Study|Other Reason Not Specified|9|||
33598541|NCT02193087|102081585|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
33598542|NCT02193087|102081586|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
33598543|NCT02193087|102081587|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
33598544|NCT02193087|102081588|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
33598545|NCT01920893|102081591|FG000|Overall Study|Adverse Event|5|||
33598546|NCT01920893|102081592|FG001|Overall Study|Adverse Event|2|||
33598547|NCT01920893|102081591|FG000|Overall Study|Lack of Efficacy|2|||
33598548|NCT01920893|102081592|FG001|Overall Study|Lack of Efficacy|0|||
33598549|NCT02133664|102081593|FG000|Overall Study|Lost to Follow-up|2|||
33598550|NCT02133664|102081594|FG001|Overall Study|Lost to Follow-up|1|||
33598551|NCT02133664|102081593|FG000|Overall Study|Adverse Event|3|||
33598552|NCT02133664|102081594|FG001|Overall Study|Adverse Event|6|||
33598553|NCT02726880|102081596|FG000|Overall Study|Withdrawal by Subject|2|||
33598554|NCT02726880|102081597|FG001|Overall Study|Withdrawal by Subject|0|||
33598555|NCT02726880|102081596|FG000|Overall Study|Lost to Follow-up|1|||
33598556|NCT02726880|102081597|FG001|Overall Study|Lost to Follow-up|3|||
33598557|NCT03455829|102081600|FG000|Overall Study|Death|2|||
33598558|NCT03455829|102081601|FG001|Overall Study|Death|3|||
33598559|NCT03455829|102081602|FG002|Overall Study|Death|2|||
33598560|NCT03455829|102081603|FG003|Overall Study|Death|4|||
33598561|NCT03455829|102081604|FG004|Overall Study|Death|2|||
33598562|NCT03455829|102081600|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
33598563|NCT03455829|102081601|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
33598564|NCT03455829|102081602|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
33598565|NCT03455829|102081603|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
33598566|NCT03455829|102081604|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
33598567|NCT03455829|102081600|FG000|Overall Study|Disease progression|0|||
33598568|NCT03455829|102081601|FG001|Overall Study|Disease progression|0|||
33598569|NCT03455829|102081602|FG002|Overall Study|Disease progression|0|||
33598570|NCT03455829|102081603|FG003|Overall Study|Disease progression|1|||
33598571|NCT03455829|102081604|FG004|Overall Study|Disease progression|1|||
33598572|NCT02739321|102081605|FG000|Overall Study|Lack of Efficacy|1|||
33598573|NCT02739321|102081606|FG001|Overall Study|Lack of Efficacy|1|||
33598574|NCT02739321|102081605|FG000|Overall Study|Lost to Follow-up|1|||
33598575|NCT02739321|102081606|FG001|Overall Study|Lost to Follow-up|1|||
33598576|NCT02739321|102081605|FG000|Overall Study|Withdrawal by Subject|1|||
33598577|NCT02739321|102081606|FG001|Overall Study|Withdrawal by Subject|2|||
33598578|NCT01902888|102081607|FG000|Overall Study|Study Terminated|3|||
33598579|NCT00847665|102081608|FG000|Overall Study|Withdrawal by Subject|1|||
33598580|NCT00847665|102081609|FG001|Overall Study|Withdrawal by Subject|0|||
33598581|NCT00496197|102081614|FG000|Overall Study|Discontinued study due to death|43|||
33598582|NCT00496197|102081614|FG000|Overall Study|Adverse Event|13|||
33598583|NCT00496197|102081614|FG000|Overall Study|Does not meet entrance criteria|5|||
33598584|NCT00496197|102081614|FG000|Overall Study|Insufficient clinical response|3|||
33598585|NCT00496197|102081614|FG000|Overall Study|Insufficient bacteriological response|10|||
33598586|NCT00496197|102081614|FG000|Overall Study|Lost to Follow-up|11|||
33598587|NCT00496197|102081614|FG000|Overall Study|Withdrawal by Subject|11|||
33598588|NCT00496197|102081614|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
33598589|NCT00496197|102081614|FG000|Overall Study|Other|14|||
33598590|NCT00496197|102081614|FG000|Overall Study|Protocol Violation|8|||
33598591|NCT03351114|102081615|FG000|Overall Study|Withdrawal by Subject|1|||
33598592|NCT00106691|102081616|FG000|Overall Study|Adverse Event|60|||
33598593|NCT00106691|102081617|FG001|Overall Study|Adverse Event|64|||
33598594|NCT00106691|102081616|FG000|Overall Study|Lost to Follow-up|23|||
33598595|NCT00106691|102081617|FG001|Overall Study|Lost to Follow-up|18|||
33598596|NCT00106691|102081616|FG000|Overall Study|Physician Decision|18|||
33598597|NCT00106691|102081617|FG001|Overall Study|Physician Decision|21|||
33598598|NCT00106691|102081616|FG000|Overall Study|Protocol Violation|13|||
33598599|NCT00106691|102081617|FG001|Overall Study|Protocol Violation|18|||
33598600|NCT00106691|102081616|FG000|Overall Study|Withdrawal by Subject|75|||
33598601|NCT00106691|102081617|FG001|Overall Study|Withdrawal by Subject|70|||
33598602|NCT00106691|102081616|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
33598603|NCT00106691|102081617|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
33598604|NCT00106691|102081616|FG000|Overall Study|QTc>480|3|||
33598605|NCT00106691|102081617|FG001|Overall Study|QTc>480|1|||
33598606|NCT00106691|102081616|FG000|Overall Study|mililtary deployment|2|||
33598607|NCT00106691|102081617|FG001|Overall Study|mililtary deployment|0|||
33598608|NCT00106691|102081616|FG000|Overall Study|Study Site Closing/PI Moved|1|||
33598609|NCT00106691|102081617|FG001|Overall Study|Study Site Closing/PI Moved|2|||
33598610|NCT00106691|102081616|FG000|Overall Study|Cardiologist recommendation|1|||
33598611|NCT00106691|102081617|FG001|Overall Study|Cardiologist recommendation|0|||
33598612|NCT00106691|102081616|FG000|Overall Study|Pt. moved to another state|1|||
33598613|NCT00106691|102081617|FG001|Overall Study|Pt. moved to another state|0|||
33598614|NCT00106691|102081616|FG000|Overall Study|Taking exclusionary avodart|1|||
33598615|NCT00106691|102081617|FG001|Overall Study|Taking exclusionary avodart|0|||
33598616|NCT00106691|102081616|FG000|Overall Study|Not able to discontinue plavix|0|||
33598617|NCT00106691|102081617|FG001|Overall Study|Not able to discontinue plavix|1|||
33598618|NCT02419131|102081620|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
33598619|NCT02419131|102081621|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
33598620|NCT02419131|102081622|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
33598621|NCT02419131|102081620|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
33598622|NCT02419131|102081621|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
33598623|NCT02419131|102081622|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
33598624|NCT03943550|102081623|FG000|Overall Study|Adverse Event|0|||
33598625|NCT03943550|102081624|FG001|Overall Study|Adverse Event|0|||
33598626|NCT03943550|102081625|FG002|Overall Study|Adverse Event|1|||
33598627|NCT03943550|102081623|FG000|Overall Study|Lost to Follow-up|0|||
33598628|NCT03943550|102081624|FG001|Overall Study|Lost to Follow-up|0|||
33289755|NCT03635086|100958914|FG004|Overall Study|Lost to Follow-up|0|||
33598629|NCT03943550|102081625|FG002|Overall Study|Lost to Follow-up|1|||
33598630|NCT03943550|102081623|FG000|Overall Study|Progressive Disease|0|||
33598631|NCT03943550|102081624|FG001|Overall Study|Progressive Disease|0|||
33598632|NCT03943550|102081625|FG002|Overall Study|Progressive Disease|2|||
33598633|NCT03943550|102081623|FG000|Overall Study|Participant Moved Out of the Country|0|||
33598634|NCT03943550|102081624|FG001|Overall Study|Participant Moved Out of the Country|1|||
33598635|NCT03943550|102081625|FG002|Overall Study|Participant Moved Out of the Country|0|||
33598636|NCT00197145|102081630|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
33598637|NCT00197145|102081631|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
33598638|NCT00197145|102081630|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
33598639|NCT00197145|102081631|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
33598640|NCT00197145|102081630|FG000|Period 1: Randomized Treatment Phase|Other|2|||
33598641|NCT00197145|102081631|FG001|Period 1: Randomized Treatment Phase|Other|2|||
33598642|NCT00197145|102081630|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
33598643|NCT00197145|102081631|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
33598644|NCT00197145|102081630|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
33598645|NCT00197145|102081631|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
33598646|NCT00197145|102081630|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
33598647|NCT00197145|102081631|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
33598648|NCT00197145|102081630|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
33598649|NCT00197145|102081631|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
33598650|NCT00197145|102081630|FG000|Period 2 : Open Label Phase|Other|1|||
33598651|NCT00197145|102081631|FG001|Period 2 : Open Label Phase|Other|0|||
33598652|NCT00953524|102081637|FG000|Overall Study|Adverse Event|2|||
33598653|NCT00953524|102081638|FG001|Overall Study|Adverse Event|0|||
33598654|NCT00953524|102081639|FG002|Overall Study|Adverse Event|1|||
33598655|NCT00953524|102081640|FG003|Overall Study|Adverse Event|2|||
33598656|NCT00953524|102081637|FG000|Overall Study|Protocol Violation|18|||
33598657|NCT00953524|102081638|FG001|Overall Study|Protocol Violation|10|||
33598658|NCT00953524|102081639|FG002|Overall Study|Protocol Violation|11|||
33598659|NCT00953524|102081640|FG003|Overall Study|Protocol Violation|6|||
33598660|NCT00953524|102081637|FG000|Overall Study|Lost to Follow-up|0|||
33598661|NCT00953524|102081638|FG001|Overall Study|Lost to Follow-up|1|||
33598662|NCT00953524|102081639|FG002|Overall Study|Lost to Follow-up|1|||
33598663|NCT00953524|102081640|FG003|Overall Study|Lost to Follow-up|0|||
33598664|NCT00953524|102081637|FG000|Overall Study|Withdrawal by Subject|2|||
33598665|NCT00953524|102081638|FG001|Overall Study|Withdrawal by Subject|4|||
33598666|NCT00953524|102081639|FG002|Overall Study|Withdrawal by Subject|1|||
33598667|NCT00953524|102081640|FG003|Overall Study|Withdrawal by Subject|0|||
33598668|NCT01479595|102081645|FG000|Overall Study|Protocol deviation|0|||
33598669|NCT01479595|102081646|FG001|Overall Study|Protocol deviation|1|||
33598670|NCT01479595|102081645|FG000|Overall Study|Adverse Event|2|||
33598671|NCT01479595|102081646|FG001|Overall Study|Adverse Event|1|||
33598672|NCT01463111|102081647|FG000|Overall Study|Withdrawal by Subject|2|||
33598673|NCT01463111|102081647|FG000|Overall Study|Lost to Follow-up|5|||
33598674|NCT01463111|102081647|FG000|Overall Study|Physician Decision|2|||
33598675|NCT03344640|102081648|FG000|Overall Study|Adverse Event|1|||
33598676|NCT03344640|102081649|FG001|Overall Study|Adverse Event|0|||
33598677|NCT03344640|102081648|FG000|Overall Study|Physician Decision|1|||
33598678|NCT03344640|102081649|FG001|Overall Study|Physician Decision|1|||
33598679|NCT03344640|102081648|FG000|Overall Study|Withdrawal by Subject|1|||
33598680|NCT03344640|102081649|FG001|Overall Study|Withdrawal by Subject|2|||
33598681|NCT03344640|102081648|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
33598682|NCT03344640|102081649|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
33598683|NCT00598078|102081650|FG000|Period 2 (Day 2)|Adverse Event|1|||
33598684|NCT00598078|102081651|FG001|Period 2 (Day 2)|Adverse Event|0|||
33598685|NCT00545532|102081652|FG000|Overall Study|Withdrawal by Subject|1|||
33598686|NCT00545532|102081653|FG001|Overall Study|Withdrawal by Subject|3|||
33598687|NCT00545532|102081652|FG000|Overall Study|Lost to Follow-up|5|||
33598688|NCT00545532|102081653|FG001|Overall Study|Lost to Follow-up|6|||
33598689|NCT00545532|102081652|FG000|Overall Study|Death|0|||
33598690|NCT00545532|102081653|FG001|Overall Study|Death|1|||
33598691|NCT00900146|102081654|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
33598692|NCT00900146|102081655|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
33598693|NCT00900146|102081656|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
33289756|NCT02250534|100958917|FG000|Overall Study|Lost to Follow-up|18|||
33598694|NCT00900146|102081657|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
33598695|NCT00900146|102081658|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
33598696|NCT00900146|102081654|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
33598697|NCT00900146|102081655|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
33598698|NCT00900146|102081656|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
33598699|NCT00900146|102081657|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
33598700|NCT00900146|102081658|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
33598701|NCT00900146|102081654|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
33598702|NCT00900146|102081655|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
33598703|NCT00900146|102081656|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
33598704|NCT00900146|102081657|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
33598705|NCT00900146|102081658|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
33598706|NCT00900146|102081654|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
33598707|NCT00900146|102081655|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
33598708|NCT00900146|102081656|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
33598709|NCT00900146|102081657|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
33598710|NCT00900146|102081658|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
33598711|NCT00900146|102081654|FG000|Intermediate: Period III|Lost to Follow-up|2|||
33598712|NCT00900146|102081655|FG001|Intermediate: Period III|Lost to Follow-up|0|||
33598713|NCT00900146|102081656|FG002|Intermediate: Period III|Lost to Follow-up|0|||
33598714|NCT00900146|102081657|FG003|Intermediate: Period III|Lost to Follow-up|0|||
33598715|NCT00900146|102081658|FG004|Intermediate: Period III|Lost to Follow-up|1|||
33598716|NCT00900146|102081654|FG000|Intermediate: Period III|Administrative problems|85|||
33598717|NCT00900146|102081655|FG001|Intermediate: Period III|Administrative problems|92|||
33598718|NCT00900146|102081656|FG002|Intermediate: Period III|Administrative problems|84|||
33598719|NCT00900146|102081657|FG003|Intermediate: Period III|Administrative problems|90|||
33598720|NCT00900146|102081658|FG004|Intermediate: Period III|Administrative problems|163|||
33598721|NCT01344538|102081661|FG000|Overall Study|Adverse Event|1|||
33598722|NCT01344538|102081662|FG001|Overall Study|Adverse Event|1|||
33598723|NCT01344538|102081661|FG000|Overall Study|Lost to Follow-up|1|||
33598724|NCT01344538|102081662|FG001|Overall Study|Lost to Follow-up|0|||
33598725|NCT01561755|102081663|FG000|Overall Study|Lost to Follow-up|0|||
33598726|NCT01561755|102081664|FG001|Overall Study|Lost to Follow-up|1|||
33598727|NCT02312219|102081666|FG000|Overall Study|Withdrawal by Subject|1|||
33598728|NCT02312219|102081667|FG001|Overall Study|Withdrawal by Subject|2|||
33598729|NCT02312219|102081666|FG000|Overall Study|could not schedule imaging in time|0|||
33598730|NCT02312219|102081667|FG001|Overall Study|could not schedule imaging in time|2|||
33598731|NCT02312219|102081666|FG000|Overall Study|Other|0|||
33598732|NCT02312219|102081667|FG001|Overall Study|Other|1|||
33598733|NCT02312219|102081666|FG000|Overall Study|Not randomized. Ineligible|0|||
33598734|NCT02312219|102081667|FG001|Overall Study|Not randomized. Ineligible|1|||
33598735|NCT00320255|102081668|FG000|Overall Study|Lack of Efficacy|1|||
33598736|NCT00320255|102081669|FG001|Overall Study|Lack of Efficacy|0|||
33598737|NCT00320255|102081670|FG002|Overall Study|Lack of Efficacy|0|||
33598738|NCT00320255|102081671|FG003|Overall Study|Lack of Efficacy|0|||
33598739|NCT00320255|102081672|FG004|Overall Study|Lack of Efficacy|0|||
33598740|NCT00320255|102081673|FG005|Overall Study|Lack of Efficacy|0|||
33598741|NCT00320255|102081668|FG000|Overall Study|Adverse Event|5|||
33598742|NCT00320255|102081669|FG001|Overall Study|Adverse Event|2|||
33598743|NCT00320255|102081670|FG002|Overall Study|Adverse Event|3|||
33598744|NCT00320255|102081671|FG003|Overall Study|Adverse Event|2|||
33598745|NCT00320255|102081672|FG004|Overall Study|Adverse Event|0|||
33598746|NCT00320255|102081673|FG005|Overall Study|Adverse Event|0|||
33598747|NCT00320255|102081668|FG000|Overall Study|Withdrawal by Subject|1|||
33598748|NCT00320255|102081669|FG001|Overall Study|Withdrawal by Subject|2|||
33598749|NCT00320255|102081670|FG002|Overall Study|Withdrawal by Subject|2|||
33598750|NCT00320255|102081671|FG003|Overall Study|Withdrawal by Subject|4|||
33598751|NCT00320255|102081672|FG004|Overall Study|Withdrawal by Subject|0|||
33598752|NCT00320255|102081673|FG005|Overall Study|Withdrawal by Subject|0|||
33598753|NCT00320255|102081668|FG000|Overall Study|Poor compliance/noncompliance|1|||
33598754|NCT00320255|102081669|FG001|Overall Study|Poor compliance/noncompliance|1|||
33598755|NCT00320255|102081670|FG002|Overall Study|Poor compliance/noncompliance|0|||
33598756|NCT00320255|102081671|FG003|Overall Study|Poor compliance/noncompliance|1|||
33598757|NCT00320255|102081672|FG004|Overall Study|Poor compliance/noncompliance|0|||
33598758|NCT00320255|102081673|FG005|Overall Study|Poor compliance/noncompliance|0|||
33598759|NCT00320255|102081668|FG000|Overall Study|No longer meets study criteria|0|||
33598760|NCT00320255|102081669|FG001|Overall Study|No longer meets study criteria|0|||
33598761|NCT00320255|102081670|FG002|Overall Study|No longer meets study criteria|0|||
33598762|NCT00320255|102081671|FG003|Overall Study|No longer meets study criteria|1|||
33598763|NCT00320255|102081672|FG004|Overall Study|No longer meets study criteria|0|||
33598764|NCT00320255|102081673|FG005|Overall Study|No longer meets study criteria|0|||
33598765|NCT00320255|102081668|FG000|Overall Study|Other|3|||
33598766|NCT00320255|102081669|FG001|Overall Study|Other|2|||
33598767|NCT00320255|102081670|FG002|Overall Study|Other|1|||
33598768|NCT00320255|102081671|FG003|Overall Study|Other|0|||
33598769|NCT00320255|102081672|FG004|Overall Study|Other|0|||
33598770|NCT00320255|102081673|FG005|Overall Study|Other|0|||
33598771|NCT00590824|102081674|FG000|Overall Study|Disease could not be resected|0|||
33598772|NCT00590824|102081675|FG001|Overall Study|Disease could not be resected|2|||
33598773|NCT00590824|102081676|FG002|Overall Study|Disease could not be resected|1|||
33598774|NCT00590824|102081677|FG003|Overall Study|Disease could not be resected|0|||
33598775|NCT00590824|102081674|FG000|Overall Study|Adverse Event|0|||
33598776|NCT00590824|102081675|FG001|Overall Study|Adverse Event|0|||
33598777|NCT00590824|102081676|FG002|Overall Study|Adverse Event|0|||
33598778|NCT00590824|102081677|FG003|Overall Study|Adverse Event|1|||
33598779|NCT00934947|102081681|FG000|Overall Study|Adverse Event|0|||
33598780|NCT00934947|102081682|FG001|Overall Study|Adverse Event|2|||
33598781|NCT03002818|102081683|FG000|Overall Study|Decision of the investigator|1|||
33598782|NCT02142283|102081684|FG000|Overall Study|Death|20|||
33598783|NCT02142283|102081685|FG001|Overall Study|Death|18|||
33598784|NCT02142283|102081684|FG000|Overall Study|Withdrawal by Subject|1|||
33598785|NCT02142283|102081685|FG001|Overall Study|Withdrawal by Subject|3|||
33598786|NCT01996592|102081686|FG000|Overall Study|no response to text/no diary entry|32|||
33598787|NCT01996592|102081686|FG000|Overall Study|change in surgical date|4|||
33598788|NCT01996592|102081686|FG000|Overall Study|Withdrawal by Subject|5|||
33598789|NCT01996592|102081686|FG000|Overall Study|change in mode of delivery|4|||
33598790|NCT01133626|102081689|FG000|Overall Study|Adverse Event|0|||
33598791|NCT01133626|102081690|FG001|Overall Study|Adverse Event|1|||
33598792|NCT01133626|102081691|FG002|Overall Study|Adverse Event|0|||
33598793|NCT01133626|102081689|FG000|Overall Study|Withdrawal by Subject|1|||
33598794|NCT01133626|102081690|FG001|Overall Study|Withdrawal by Subject|2|||
33598795|NCT01133626|102081691|FG002|Overall Study|Withdrawal by Subject|2|||
33598796|NCT01133626|102081689|FG000|Overall Study|Other|0|||
33598797|NCT01133626|102081690|FG001|Overall Study|Other|2|||
33598798|NCT01133626|102081691|FG002|Overall Study|Other|0|||
33598799|NCT03831945|102081700|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
33598800|NCT03831945|102081701|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
33598801|NCT03831945|102081700|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
33598802|NCT03831945|102081701|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
33598803|NCT03831945|102081700|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
33598804|NCT03831945|102081701|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
33598805|NCT01269385|102081702|FG000|Overall Study|Adverse Event|1|||
33598806|NCT01269385|102081703|FG001|Overall Study|Adverse Event|1|||
33598807|NCT01269385|102081704|FG002|Overall Study|Adverse Event|0|||
33598808|NCT01269385|102081705|FG003|Overall Study|Adverse Event|0|||
33598809|NCT00681564|102081712|FG000|Overall Study|Lost to Follow-up|6|||
33598810|NCT00681564|102081713|FG001|Overall Study|Lost to Follow-up|6|||
33598811|NCT00681564|102081712|FG000|Overall Study|Withdrawal by Subject|0|||
33598812|NCT00681564|102081713|FG001|Overall Study|Withdrawal by Subject|1|||
33598813|NCT00681564|102081712|FG000|Overall Study|Death|0|||
33598814|NCT00681564|102081713|FG001|Overall Study|Death|1|||
33598815|NCT01962987|102081716|FG000|Overall Study|Adverse Event|4|||
33598816|NCT01962987|102081717|FG001|Overall Study|Adverse Event|4|||
33598817|NCT01962987|102081718|FG002|Overall Study|Adverse Event|0|||
33598818|NCT01962987|102081716|FG000|Overall Study|Lost to Follow-up|0|||
33598819|NCT01962987|102081717|FG001|Overall Study|Lost to Follow-up|0|||
33598820|NCT01962987|102081718|FG002|Overall Study|Lost to Follow-up|1|||
33598821|NCT01962987|102081716|FG000|Overall Study|Non compliance with dosing requirements|4|||
33598822|NCT01962987|102081717|FG001|Overall Study|Non compliance with dosing requirements|2|||
33598823|NCT01962987|102081718|FG002|Overall Study|Non compliance with dosing requirements|0|||
33598824|NCT01962987|102081716|FG000|Overall Study|Miscellaneous|1|||
33598825|NCT01962987|102081717|FG001|Overall Study|Miscellaneous|9|||
33598826|NCT01962987|102081718|FG002|Overall Study|Miscellaneous|2|||
33598827|NCT01962987|102081716|FG000|Overall Study|Restricted medication|5|||
33598828|NCT01962987|102081717|FG001|Overall Study|Restricted medication|1|||
33598829|NCT01962987|102081718|FG002|Overall Study|Restricted medication|1|||
33391714|NCT02959190|101321853|FG001|Open Label|Withdrawal by Subject|8|||
33391715|NCT02959190|101321854|FG002|Open Label|Withdrawal by Subject|0|||
33598830|NCT01962987|102081716|FG000|Overall Study|Serious Adverse Event|1|||
33598831|NCT01962987|102081717|FG001|Overall Study|Serious Adverse Event|0|||
33598832|NCT01962987|102081718|FG002|Overall Study|Serious Adverse Event|0|||
33598833|NCT01962987|102081716|FG000|Overall Study|Withdrawal by Subject|11|||
33598834|NCT01962987|102081717|FG001|Overall Study|Withdrawal by Subject|10|||
33598835|NCT01962987|102081718|FG002|Overall Study|Withdrawal by Subject|6|||
33598836|NCT01962987|102081716|FG000|Overall Study|Randomized in Error|4|||
33598837|NCT01962987|102081717|FG001|Overall Study|Randomized in Error|2|||
33598838|NCT01962987|102081718|FG002|Overall Study|Randomized in Error|2|||
33598839|NCT01666119|102081722|FG000|Overall Study|Adverse Event|6|||
33598840|NCT01666119|102081722|FG000|Overall Study|Withdrawal by Subject|16|||
33598841|NCT01666119|102081722|FG000|Overall Study|Lost to Follow-up|7|||
33598842|NCT01666119|102081722|FG000|Overall Study|non compliance with study medication, pa|18|||
33598843|NCT01666119|102081722|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
33598844|NCT00868530|102081723|FG000|Overall Study|Adverse Event|3|||
33598845|NCT00868530|102081723|FG000|Overall Study|Lost to Follow-up|1|||
33598846|NCT03366103|102081724|FG000|Overall Study|Disease Progression|3|||
33598847|NCT03366103|102081725|FG001|Overall Study|Disease Progression|1|||
33598848|NCT03366103|102081726|FG002|Overall Study|Disease Progression|0|||
33598849|NCT03366103|102081724|FG000|Overall Study|Adverse Event|0|||
33598850|NCT03366103|102081725|FG001|Overall Study|Adverse Event|1|||
33598851|NCT03366103|102081726|FG002|Overall Study|Adverse Event|0|||
33598852|NCT00511433|102081727|FG000|Overall Study|Adverse Event|5|||
33598853|NCT00511433|102081728|FG001|Overall Study|Adverse Event|0|||
33598854|NCT00511433|102081727|FG000|Overall Study|Other Reason|1|||
33598855|NCT00511433|102081728|FG001|Overall Study|Other Reason|1|||
33598856|NCT00815191|102081729|FG000|Overall Study|Protocol Violation|1|||
33598857|NCT00815191|102081730|FG001|Overall Study|Protocol Violation|1|||
33598858|NCT00042432|102081742|FG000|Overall Study|Adverse Event|4|||
33598859|NCT00042432|102081743|FG001|Overall Study|Adverse Event|1|||
33598860|NCT00042432|102081742|FG000|Overall Study|Withdrawal by Subject|1|||
33598861|NCT00042432|102081743|FG001|Overall Study|Withdrawal by Subject|3|||
33598862|NCT00042432|102081742|FG000|Overall Study|Death|0|||
33598863|NCT00042432|102081743|FG001|Overall Study|Death|2|||
33598864|NCT00042432|102081742|FG000|Overall Study|Ineligibility determined|1|||
33598865|NCT00042432|102081743|FG001|Overall Study|Ineligibility determined|0|||
33598866|NCT00042432|102081742|FG000|Overall Study|Initiation of maintenance dialysis|1|||
33598867|NCT00042432|102081743|FG001|Overall Study|Initiation of maintenance dialysis|1|||
33598868|NCT00042432|102081742|FG000|Overall Study|Other|2|||
33598869|NCT00042432|102081743|FG001|Overall Study|Other|0|||
33598870|NCT01777542|102081745|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
33598871|NCT01777542|102081746|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
33598872|NCT02594098|102081747|FG000|Overall Study|Lack of Efficacy|17|||
33598873|NCT02594098|102081748|FG001|Overall Study|Lack of Efficacy|6|||
33598874|NCT02594098|102081747|FG000|Overall Study|Withdrawal by Subject|1|||
33598875|NCT02594098|102081748|FG001|Overall Study|Withdrawal by Subject|3|||
33598876|NCT02594098|102081747|FG000|Overall Study|Terminated participation|6|||
33598877|NCT02594098|102081748|FG001|Overall Study|Terminated participation|2|||
33598878|NCT02594098|102081747|FG000|Overall Study|Seek alternative treatment|2|||
33598879|NCT02594098|102081748|FG001|Overall Study|Seek alternative treatment|1|||
33598880|NCT02594098|102081747|FG000|Overall Study|Other|0|||
33598881|NCT02594098|102081748|FG001|Overall Study|Other|1|||
33598882|NCT01156389|102081749|FG000|Overall Study|Elevated liver enzymes|4|||
33598883|NCT01156389|102081750|FG001|Overall Study|Elevated liver enzymes|0|||
33598884|NCT01156389|102081749|FG000|Overall Study|Vomiting|0|||
33598885|NCT01156389|102081750|FG001|Overall Study|Vomiting|1|||
33598886|NCT03784846|102081751|FG000|Pre-COVID Study|Lost to Follow-up|3|||
33598887|NCT03784846|102081752|FG001|Pre-COVID Study|Lost to Follow-up|3|||
33598888|NCT03784846|102081753|FG002|Pre-COVID Study|Lost to Follow-up|2|||
33598889|NCT03784846|102081751|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
33598890|NCT03784846|102081752|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
33598891|NCT03784846|102081753|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
33598892|NCT03784846|102081751|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
33598893|NCT03784846|102081752|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
33598894|NCT03784846|102081753|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
33598895|NCT03784846|102081751|FG000|Post-COVID Study|Lost to Follow-up|3|||
33598896|NCT03784846|102081752|FG001|Post-COVID Study|Lost to Follow-up|5|||
33598897|NCT03784846|102081753|FG002|Post-COVID Study|Lost to Follow-up|1|||
33598898|NCT03784846|102081751|FG000|Post-COVID Study|Withdrawal by Subject|1|||
33598899|NCT03784846|102081752|FG001|Post-COVID Study|Withdrawal by Subject|2|||
33598900|NCT03784846|102081753|FG002|Post-COVID Study|Withdrawal by Subject|0|||
33598901|NCT02650128|102081754|FG000|Overall Study|Death|2|||
33598902|NCT01710527|102081755|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
33598903|NCT01710527|102081756|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
33598904|NCT01873729|102081757|FG000|Overall Study|Withdrawal by Subject|1|||
33598905|NCT00869050|102081758|FG000|Overall Study|Screen Failure|3|||
33598906|NCT01371643|102081764|FG000|Overall Study|Withdrawal by Subject|3|||
33598907|NCT01371643|102081765|FG001|Overall Study|Withdrawal by Subject|0|||
33598908|NCT02153346|102081766|FG000|Overall Study|Lost to Follow-up|11|||
33598909|NCT00367744|102081767|FG000|Overall Study|Lost to Follow-up|4|||
33598910|NCT00367744|102081768|FG001|Overall Study|Lost to Follow-up|5|||
33598911|NCT00546260|102081769|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
33598912|NCT00546260|102081770|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
33598913|NCT02966795|102081771|FG000|Overall Study|Patient Left the Country|0|||
33598914|NCT02966795|102081772|FG001|Overall Study|Patient Left the Country|1|||
33598915|NCT03630302|102081773|FG000|Surgery|hardware issue prevented LFP recordings|1|||
33598916|NCT03630302|102081773|FG000|3 Month Visit|Adverse Event|2|||
33598917|NCT03630302|102081773|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
33598918|NCT01146652|102081774|FG000|Overall Study|Adverse Event|506|||
33598919|NCT01146652|102081775|FG001|Overall Study|Adverse Event|15|||
33598920|NCT01146652|102081774|FG000|Overall Study|Lack of Efficacy|91|||
33598921|NCT01146652|102081775|FG001|Overall Study|Lack of Efficacy|7|||
33598922|NCT01146652|102081774|FG000|Overall Study|Poor compliance to protocol|38|||
33598923|NCT01146652|102081775|FG001|Overall Study|Poor compliance to protocol|1|||
33598924|NCT01146652|102081774|FG000|Overall Study|Other unspecified reasons|314|||
33598925|NCT01146652|102081775|FG001|Overall Study|Other unspecified reasons|22|||
33598926|NCT01146652|102081774|FG000|Overall Study|Enrolled but not treated|2|||
33598927|NCT01146652|102081775|FG001|Overall Study|Enrolled but not treated|0|||
33598928|NCT03353922|102081776|FG000|Overall Study|Withdrawal by Subject|1|||
33598929|NCT03353922|102081777|FG001|Overall Study|Withdrawal by Subject|0|||
33598930|NCT03353922|102081778|FG002|Overall Study|Withdrawal by Subject|1|||
33598931|NCT03353922|102081779|FG003|Overall Study|Withdrawal by Subject|1|||
33598932|NCT03353922|102081780|FG004|Overall Study|Withdrawal by Subject|0|||
33598933|NCT03353922|102081781|FG005|Overall Study|Withdrawal by Subject|0|||
33598934|NCT03353922|102081776|FG000|Overall Study|Adverse Event|0|||
33598935|NCT03353922|102081777|FG001|Overall Study|Adverse Event|1|||
33598936|NCT03353922|102081778|FG002|Overall Study|Adverse Event|0|||
33598937|NCT03353922|102081779|FG003|Overall Study|Adverse Event|0|||
33598938|NCT03353922|102081780|FG004|Overall Study|Adverse Event|0|||
33598939|NCT03353922|102081781|FG005|Overall Study|Adverse Event|0|||
33598940|NCT03093974|102081784|FG000|Overall Study|Withdrawal by Subject|32|||
33598941|NCT03093974|102081785|FG001|Overall Study|Withdrawal by Subject|27|||
33598942|NCT03093974|102081784|FG000|Overall Study|Adverse Event|17|||
33598943|NCT03093974|102081785|FG001|Overall Study|Adverse Event|24|||
33598944|NCT03093974|102081784|FG000|Overall Study|Death|0|||
33598945|NCT03093974|102081785|FG001|Overall Study|Death|1|||
33598946|NCT03093974|102081784|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33598947|NCT03093974|102081785|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33598948|NCT03093974|102081784|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
33598949|NCT03093974|102081785|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
33598950|NCT03093974|102081784|FG000|Overall Study|Lost to Follow-up|0|||
33391716|NCT02959190|101321855|FG003|Open Label|Withdrawal by Subject|0|||
33391717|NCT02959190|101321852|FG000|Open Label|Physician Decision|0|||
33598951|NCT03093974|102081785|FG001|Overall Study|Lost to Follow-up|1|||
33598952|NCT03093974|102081784|FG000|Overall Study|Other|1|||
33598953|NCT03093974|102081785|FG001|Overall Study|Other|2|||
33598954|NCT00413920|102081786|FG000|Overall Study|Adverse Event|9|||
33598955|NCT00413920|102081787|FG001|Overall Study|Adverse Event|11|||
33598956|NCT00413920|102081786|FG000|Overall Study|Lack of Efficacy|11|||
33598957|NCT00413920|102081787|FG001|Overall Study|Lack of Efficacy|9|||
33391718|NCT02959190|101321853|FG001|Open Label|Physician Decision|0|||
33187437|NCT00404352|100594493|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
33598958|NCT00413920|102081786|FG000|Overall Study|Death|3|||
33598959|NCT00413920|102081787|FG001|Overall Study|Death|5|||
33598960|NCT00413920|102081786|FG000|Overall Study|Graft Loss|5|||
33598961|NCT00413920|102081787|FG001|Overall Study|Graft Loss|3|||
33598962|NCT04143217|102081788|FG000|Overall Study|Withdrawal by Subject|42|||
33598963|NCT04143217|102081788|FG000|Overall Study|Adverse Event|29|||
33598964|NCT04143217|102081788|FG000|Overall Study|Lost to Follow-up|29|||
33598965|NCT04143217|102081788|FG000|Overall Study|Lack of Efficacy|15|||
33598966|NCT04143217|102081788|FG000|Overall Study|Physician Decision|1|||
33598967|NCT04143217|102081788|FG000|Overall Study|Non-Compliance With Study Drug|6|||
33598968|NCT04143217|102081788|FG000|Overall Study|Other, Multiple Categories|11|||
33598969|NCT01691014|102081789|FG000|Overall Study|Premature Termination|1|||
33598970|NCT01691014|102081790|FG001|Overall Study|Premature Termination|6|||
33598971|NCT01691014|102081791|FG002|Overall Study|Premature Termination|0|||
33598972|NCT01691014|102081792|FG003|Overall Study|Premature Termination|3|||
33598973|NCT01691014|102081789|FG000|Overall Study|Other|0|||
33598974|NCT01691014|102081790|FG001|Overall Study|Other|0|||
33598975|NCT01691014|102081791|FG002|Overall Study|Other|2|||
33598976|NCT01691014|102081792|FG003|Overall Study|Other|0|||
33598977|NCT01691014|102081789|FG000|Overall Study|Withdrawal by Subject|0|||
33598978|NCT01691014|102081790|FG001|Overall Study|Withdrawal by Subject|1|||
33598979|NCT01691014|102081791|FG002|Overall Study|Withdrawal by Subject|1|||
33598980|NCT01691014|102081792|FG003|Overall Study|Withdrawal by Subject|1|||
33598981|NCT01691014|102081789|FG000|Overall Study|Adverse Event|0|||
33598982|NCT01691014|102081790|FG001|Overall Study|Adverse Event|5|||
33598983|NCT01691014|102081791|FG002|Overall Study|Adverse Event|1|||
33598984|NCT01691014|102081792|FG003|Overall Study|Adverse Event|1|||
33598985|NCT01691014|102081789|FG000|Overall Study|Lack of Efficacy|2|||
33598986|NCT01691014|102081790|FG001|Overall Study|Lack of Efficacy|3|||
33598987|NCT01691014|102081791|FG002|Overall Study|Lack of Efficacy|7|||
33598988|NCT01691014|102081792|FG003|Overall Study|Lack of Efficacy|0|||
33598989|NCT01155466|102081793|FG000|Overall Study|Adverse Event|13|||
33598990|NCT01155466|102081794|FG001|Overall Study|Adverse Event|15|||
33598991|NCT01155466|102081795|FG002|Overall Study|Adverse Event|6|||
33598992|NCT01155466|102081796|FG003|Overall Study|Adverse Event|17|||
33598993|NCT01155466|102081797|FG004|Overall Study|Adverse Event|18|||
33598994|NCT01155466|102081793|FG000|Overall Study|Lost to Follow-up|0|||
33391719|NCT02959190|101321854|FG002|Open Label|Physician Decision|1|||
33187438|NCT00404352|100594485|FG000|Double Blind (up to 24 Month)|Other|0|||
33187439|NCT00404352|100594486|FG001|Double Blind (up to 24 Month)|Other|1|||
33187440|NCT00404352|100594487|FG002|Double Blind (up to 24 Month)|Other|0|||
33187441|NCT00404352|100594488|FG003|Double Blind (up to 24 Month)|Other|0|||
33187442|NCT00404352|100594489|FG004|Double Blind (up to 24 Month)|Other|0|||
33187443|NCT00404352|100594490|FG005|Double Blind (up to 24 Month)|Other|0|||
33187444|NCT00404352|100594491|FG006|Double Blind (up to 24 Month)|Other|0|||
33187445|NCT00404352|100594492|FG007|Double Blind (up to 24 Month)|Other|0|||
33187446|NCT00404352|100594493|FG008|Double Blind (up to 24 Month)|Other|0|||
33187447|NCT00404352|100594485|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
33187448|NCT00404352|100594486|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
33187449|NCT00404352|100594487|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
33187450|NCT00404352|100594488|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
33187451|NCT00404352|100594489|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
33187452|NCT00404352|100594490|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
33187453|NCT00404352|100594491|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
33187454|NCT00404352|100594492|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
33187455|NCT00404352|100594493|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
33187456|NCT00404352|100594485|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
33187457|NCT00404352|100594486|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
33187458|NCT00404352|100594487|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
33187459|NCT00404352|100594488|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
33187460|NCT00404352|100594489|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
33187461|NCT00404352|100594490|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
33187462|NCT00404352|100594491|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
33187463|NCT00404352|100594492|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
33187464|NCT00404352|100594493|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
33187465|NCT00404352|100594485|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33187466|NCT00404352|100594486|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33187467|NCT00404352|100594487|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33187468|NCT00404352|100594488|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33187469|NCT00404352|100594489|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
33187470|NCT00404352|100594490|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33187471|NCT00404352|100594491|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33187472|NCT00404352|100594492|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33187473|NCT00404352|100594493|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
33187474|NCT00404352|100594485|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33187475|NCT00404352|100594486|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33187476|NCT00404352|100594487|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33187477|NCT00404352|100594488|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33187478|NCT00404352|100594489|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33187479|NCT00404352|100594490|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
33187480|NCT00404352|100594491|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33187481|NCT00404352|100594492|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33187482|NCT00404352|100594493|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
33187483|NCT00404352|100594485|FG000|Open Label (up to 24 Month)|Disease progression|0|||
33187484|NCT00404352|100594486|FG001|Open Label (up to 24 Month)|Disease progression|0|||
33187485|NCT00404352|100594487|FG002|Open Label (up to 24 Month)|Disease progression|0|||
33187486|NCT00404352|100594488|FG003|Open Label (up to 24 Month)|Disease progression|1|||
33187487|NCT00404352|100594489|FG004|Open Label (up to 24 Month)|Disease progression|0|||
33187488|NCT00404352|100594490|FG005|Open Label (up to 24 Month)|Disease progression|0|||
33187489|NCT00404352|100594491|FG006|Open Label (up to 24 Month)|Disease progression|0|||
33187490|NCT00404352|100594492|FG007|Open Label (up to 24 Month)|Disease progression|0|||
33187491|NCT00404352|100594493|FG008|Open Label (up to 24 Month)|Disease progression|0|||
33187492|NCT00404352|100594485|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
33187493|NCT00404352|100594486|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
33187494|NCT00404352|100594487|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
33187495|NCT00404352|100594488|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
33187496|NCT00404352|100594489|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
33187497|NCT00404352|100594490|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
33187498|NCT00404352|100594491|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
33187499|NCT00404352|100594492|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
33187500|NCT00404352|100594493|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
33187501|NCT00404352|100594485|FG000|Open Label Extension (up to 36 Months)|Other|0|||
33187502|NCT00404352|100594486|FG001|Open Label Extension (up to 36 Months)|Other|0|||
33187503|NCT00404352|100594487|FG002|Open Label Extension (up to 36 Months)|Other|0|||
33187504|NCT00404352|100594488|FG003|Open Label Extension (up to 36 Months)|Other|0|||
33187505|NCT00404352|100594489|FG004|Open Label Extension (up to 36 Months)|Other|0|||
33187506|NCT00404352|100594490|FG005|Open Label Extension (up to 36 Months)|Other|0|||
33187507|NCT00404352|100594491|FG006|Open Label Extension (up to 36 Months)|Other|0|||
33187508|NCT00404352|100594492|FG007|Open Label Extension (up to 36 Months)|Other|0|||
33187509|NCT00404352|100594493|FG008|Open Label Extension (up to 36 Months)|Other|2|||
33187510|NCT04889625|100594494|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
33187511|NCT04889625|100594495|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
33187512|NCT04889625|100594494|FG000|Period 1|Subject out of window|0|||
33187513|NCT04889625|100594495|FG001|Period 1|Subject out of window|1|||
33187514|NCT04889625|100594494|FG000|Period 1|Wrong add power dispensed|0|||
33187515|NCT04889625|100594495|FG001|Period 1|Wrong add power dispensed|1|||
33187516|NCT04889625|100594494|FG000|Period 1|Discontinued due to fitting guide error|1|||
33187517|NCT04889625|100594495|FG001|Period 1|Discontinued due to fitting guide error|1|||
33187518|NCT04889625|100594494|FG000|Period 2|Test article no longer available|1|||
33187519|NCT04889625|100594495|FG001|Period 2|Test article no longer available|0|||
33187520|NCT04889625|100594494|FG000|Period 2|Incorrect lens dispensed|1|||
33187521|NCT04889625|100594495|FG001|Period 2|Incorrect lens dispensed|0|||
33187522|NCT04889625|100594494|FG000|Period 2|Wrong add power dispensed|0|||
33187523|NCT04889625|100594495|FG001|Period 2|Wrong add power dispensed|1|||
33187524|NCT00547703|100594498|FG000|Overall Study|Lost to Follow-up|1|||
33187525|NCT00547703|100594499|FG001|Overall Study|Lost to Follow-up|0|||
33187526|NCT03149237|100594500|FG000|Overall Study|Withdrawal by Subject|4|||
33187527|NCT03149237|100594501|FG001|Overall Study|Withdrawal by Subject|5|||
33187528|NCT04568122|100594503|FG000|Overall Study|Lost to Follow-up|48|||
33187529|NCT04568122|100594504|FG001|Overall Study|Lost to Follow-up|44|||
33187530|NCT04568122|100594505|FG002|Overall Study|Lost to Follow-up|4|||
33187531|NCT04568122|100594506|FG003|Overall Study|Lost to Follow-up|0|||
33187532|NCT04568122|100594507|FG004|Overall Study|Lost to Follow-up|0|||
33187533|NCT04382911|100594508|FG000|Overall Study|unable to be imaged prior to surgery|2|||
33187534|NCT00735371|100594509|FG000|Overall Study|Adverse Event|3|||
33187535|NCT00735371|100594510|FG001|Overall Study|Adverse Event|3|||
33187536|NCT00735371|100594511|FG002|Overall Study|Adverse Event|4|||
33187537|NCT00735371|100594512|FG003|Overall Study|Adverse Event|1|||
33187538|NCT00735371|100594509|FG000|Overall Study|Protocol Violation|2|||
33187539|NCT00735371|100594510|FG001|Overall Study|Protocol Violation|2|||
33187540|NCT00735371|100594511|FG002|Overall Study|Protocol Violation|0|||
33187541|NCT00735371|100594512|FG003|Overall Study|Protocol Violation|3|||
33187542|NCT00735371|100594509|FG000|Overall Study|Withdrawal by Subject|0|||
33187543|NCT00735371|100594510|FG001|Overall Study|Withdrawal by Subject|2|||
33187544|NCT00735371|100594511|FG002|Overall Study|Withdrawal by Subject|2|||
33187545|NCT00735371|100594512|FG003|Overall Study|Withdrawal by Subject|0|||
33187546|NCT00735371|100594509|FG000|Overall Study|Lost to Follow-up|1|||
33187547|NCT00735371|100594510|FG001|Overall Study|Lost to Follow-up|1|||
33187548|NCT00735371|100594511|FG002|Overall Study|Lost to Follow-up|3|||
33598995|NCT01155466|102081794|FG001|Overall Study|Lost to Follow-up|0|||
33187549|NCT00735371|100594512|FG003|Overall Study|Lost to Follow-up|1|||
33187550|NCT00735371|100594509|FG000|Overall Study|Lack of Efficacy|4|||
33187551|NCT00735371|100594510|FG001|Overall Study|Lack of Efficacy|2|||
33187552|NCT00735371|100594511|FG002|Overall Study|Lack of Efficacy|0|||
33187553|NCT00735371|100594512|FG003|Overall Study|Lack of Efficacy|4|||
33187554|NCT00735371|100594509|FG000|Overall Study|Sponsor Decision|3|||
33187555|NCT00735371|100594510|FG001|Overall Study|Sponsor Decision|1|||
33187556|NCT00735371|100594511|FG002|Overall Study|Sponsor Decision|0|||
33187557|NCT00735371|100594512|FG003|Overall Study|Sponsor Decision|1|||
33187558|NCT00735371|100594509|FG000|Overall Study|Protocol Violation|0|||
33187559|NCT00735371|100594510|FG001|Overall Study|Protocol Violation|1|||
33187560|NCT00735371|100594511|FG002|Overall Study|Protocol Violation|2|||
33187561|NCT00735371|100594512|FG003|Overall Study|Protocol Violation|0|||
33187562|NCT00735371|100594509|FG000|Overall Study|Prior Vyvanse Exposure|1|||
33187563|NCT00735371|100594510|FG001|Overall Study|Prior Vyvanse Exposure|1|||
33187564|NCT00735371|100594511|FG002|Overall Study|Prior Vyvanse Exposure|0|||
33187565|NCT00735371|100594512|FG003|Overall Study|Prior Vyvanse Exposure|0|||
33187566|NCT00735371|100594509|FG000|Overall Study|Exclusion criteria|1|||
33187567|NCT00735371|100594510|FG001|Overall Study|Exclusion criteria|0|||
33187568|NCT00735371|100594511|FG002|Overall Study|Exclusion criteria|0|||
33187569|NCT00735371|100594512|FG003|Overall Study|Exclusion criteria|0|||
33187570|NCT02385799|100594513|FG000|Overall Study|Lost to Follow-up|1|||
33187571|NCT02385799|100594514|FG001|Overall Study|Lost to Follow-up|2|||
33187572|NCT02385799|100594513|FG000|Overall Study|Adverse Event|4|||
33187573|NCT02385799|100594514|FG001|Overall Study|Adverse Event|2|||
33187574|NCT02385799|100594513|FG000|Overall Study|Withdrawal by Subject|0|||
33187575|NCT02385799|100594514|FG001|Overall Study|Withdrawal by Subject|4|||
33187576|NCT01574703|100594515|FG000|Overall Study|Adverse Event|0|||
33187577|NCT01574703|100594516|FG001|Overall Study|Adverse Event|2|||
33187578|NCT01574703|100594517|FG002|Overall Study|Adverse Event|1|||
33187579|NCT01574703|100594518|FG003|Overall Study|Adverse Event|1|||
33187580|NCT01574703|100594515|FG000|Overall Study|Protocol Violation|0|||
33187581|NCT01574703|100594516|FG001|Overall Study|Protocol Violation|0|||
33187582|NCT01574703|100594517|FG002|Overall Study|Protocol Violation|0|||
33187583|NCT01574703|100594518|FG003|Overall Study|Protocol Violation|1|||
33187584|NCT01574703|100594515|FG000|Overall Study|Unspecified Reason|27|||
33187585|NCT01574703|100594516|FG001|Overall Study|Unspecified Reason|15|||
33187586|NCT01574703|100594517|FG002|Overall Study|Unspecified Reason|20|||
33187587|NCT01574703|100594518|FG003|Overall Study|Unspecified Reason|16|||
33187588|NCT01574703|100594515|FG000|Overall Study|Withdrawal by Subject|53|||
33187589|NCT01574703|100594516|FG001|Overall Study|Withdrawal by Subject|52|||
33187590|NCT01574703|100594517|FG002|Overall Study|Withdrawal by Subject|36|||
33187591|NCT01574703|100594518|FG003|Overall Study|Withdrawal by Subject|61|||
33187592|NCT01574703|100594515|FG000|Overall Study|Met Withdrawal Criteria|0|||
33187593|NCT01574703|100594516|FG001|Overall Study|Met Withdrawal Criteria|1|||
33187594|NCT01574703|100594517|FG002|Overall Study|Met Withdrawal Criteria|1|||
33187595|NCT01574703|100594518|FG003|Overall Study|Met Withdrawal Criteria|0|||
33187596|NCT01574703|100594515|FG000|Overall Study|Lost to Follow-up|43|||
33187597|NCT01574703|100594516|FG001|Overall Study|Lost to Follow-up|41|||
33187598|NCT01574703|100594517|FG002|Overall Study|Lost to Follow-up|46|||
33187599|NCT01574703|100594518|FG003|Overall Study|Lost to Follow-up|35|||
33187600|NCT01574703|100594515|FG000|Overall Study|Death|2|||
33187601|NCT01574703|100594516|FG001|Overall Study|Death|1|||
33187602|NCT01574703|100594517|FG002|Overall Study|Death|1|||
33187603|NCT01574703|100594518|FG003|Overall Study|Death|0|||
33187604|NCT01914666|100594522|FG000|Treatment Period|Lack of Efficacy|0|||
33187605|NCT01914666|100594523|FG001|Treatment Period|Lack of Efficacy|0|||
33187606|NCT01914666|100594524|FG002|Treatment Period|Lack of Efficacy|2|||
33187607|NCT01914666|100594522|FG000|Treatment Period|Adverse Event|10|||
33187608|NCT01914666|100594523|FG001|Treatment Period|Adverse Event|4|||
33187609|NCT01914666|100594524|FG002|Treatment Period|Adverse Event|2|||
33187610|NCT01914666|100594522|FG000|Treatment Period|Withdrawal by Subject|3|||
33187611|NCT01914666|100594523|FG001|Treatment Period|Withdrawal by Subject|2|||
33187612|NCT01914666|100594524|FG002|Treatment Period|Withdrawal by Subject|2|||
33187613|NCT01914666|100594522|FG000|Treatment Period|Physician Decision|0|||
33598996|NCT01155466|102081795|FG002|Overall Study|Lost to Follow-up|0|||
33187614|NCT01914666|100594523|FG001|Treatment Period|Physician Decision|0|||
33187615|NCT01914666|100594524|FG002|Treatment Period|Physician Decision|2|||
33187616|NCT00323414|100594531|FG000|Overall Study|Withdrawal by Subject|0|||
33187617|NCT00323414|100594532|FG001|Overall Study|Withdrawal by Subject|1|||
33187618|NCT01574352|100594534|FG000|Overall Study|Withdrawal by Subject|6|||
33187619|NCT01574352|100594535|FG001|Overall Study|Withdrawal by Subject|13|||
33187620|NCT01574352|100594534|FG000|Overall Study|Injury in non-camp related sport|1|||
33187621|NCT01574352|100594535|FG001|Overall Study|Injury in non-camp related sport|0|||
33187622|NCT00508742|100594537|FG000|Period 1: Infant Series|Adverse Event|5|||
33187623|NCT00508742|100594538|FG001|Period 1: Infant Series|Adverse Event|4|||
33187624|NCT00508742|100594537|FG000|Period 1: Infant Series|Protocol Violation|1|||
33187625|NCT00508742|100594538|FG001|Period 1: Infant Series|Protocol Violation|0|||
33187626|NCT00508742|100594537|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
33187627|NCT00508742|100594538|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
33187628|NCT00508742|100594537|FG000|Period 1: Infant Series|Physician Decision|1|||
33187629|NCT00508742|100594538|FG001|Period 1: Infant Series|Physician Decision|0|||
33187630|NCT00508742|100594537|FG000|Period 1: Infant Series|Other|4|||
33187631|NCT00508742|100594538|FG001|Period 1: Infant Series|Other|1|||
33187632|NCT00508742|100594537|FG000|Period 2: After Infant Series|Adverse Event|2|||
33187633|NCT00508742|100594538|FG001|Period 2: After Infant Series|Adverse Event|6|||
33187634|NCT00508742|100594537|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
33187635|NCT00508742|100594538|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
33187636|NCT00508742|100594537|FG000|Period 2: After Infant Series|Protocol Violation|1|||
33187637|NCT00508742|100594538|FG001|Period 2: After Infant Series|Protocol Violation|0|||
33187638|NCT00508742|100594537|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
33187639|NCT00508742|100594538|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
33187640|NCT00508742|100594537|FG000|Period 2: After Infant Series|Failed to Return|1|||
33187641|NCT00508742|100594538|FG001|Period 2: After Infant Series|Failed to Return|0|||
33187642|NCT00508742|100594537|FG000|Period 2: After Infant Series|Other|2|||
33187643|NCT00508742|100594538|FG001|Period 2: After Infant Series|Other|1|||
33187644|NCT00508742|100594537|FG000|Period 3: Toddler Dose|Adverse Event|1|||
33187645|NCT00508742|100594538|FG001|Period 3: Toddler Dose|Adverse Event|0|||
33187646|NCT00508742|100594537|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
33187647|NCT00508742|100594538|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
33187648|NCT00508742|100594537|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
33187649|NCT00508742|100594538|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
33187650|NCT00508742|100594537|FG000|Period 3: Toddler Dose|Other|5|||
33187651|NCT00508742|100594538|FG001|Period 3: Toddler Dose|Other|4|||
33187652|NCT00829296|100594539|FG000|Overall Study|Adverse Event|5|||
33187653|NCT00829296|100594540|FG001|Overall Study|Adverse Event|4|||
33187654|NCT02181556|100594548|FG000|Overall Study|Withdrawal by Subject|1|||
33187655|NCT00337103|100594549|FG000|Overall Study|Progressive Disease|414|||
33187656|NCT00337103|100594550|FG001|Overall Study|Progressive Disease|410|||
33187657|NCT00337103|100594549|FG000|Overall Study|Adverse Event|45|||
33187658|NCT00337103|100594550|FG001|Overall Study|Adverse Event|59|||
33187659|NCT00337103|100594549|FG000|Overall Study|Subject Choice|34|||
33187660|NCT00337103|100594550|FG001|Overall Study|Subject Choice|27|||
33187661|NCT00337103|100594549|FG000|Overall Study|Clinical Progression|27|||
33187662|NCT00337103|100594550|FG001|Overall Study|Clinical Progression|24|||
33187663|NCT00337103|100594549|FG000|Overall Study|Physician Decision|15|||
33187664|NCT00337103|100594550|FG001|Overall Study|Physician Decision|14|||
33187665|NCT00337103|100594549|FG000|Overall Study|Withdrawal by Subject|8|||
33187666|NCT00337103|100594550|FG001|Overall Study|Withdrawal by Subject|5|||
33187667|NCT00337103|100594549|FG000|Overall Study|Other|5|||
33187668|NCT00337103|100594550|FG001|Overall Study|Other|6|||
33187669|NCT00337103|100594549|FG000|Overall Study|Entry Criteria Not Met|4|||
33187670|NCT00337103|100594550|FG001|Overall Study|Entry Criteria Not Met|1|||
33187671|NCT00337103|100594549|FG000|Overall Study|Lost to Follow-up|1|||
33187672|NCT00337103|100594550|FG001|Overall Study|Lost to Follow-up|2|||
33187673|NCT00337103|100594549|FG000|Overall Study|Death|1|||
33187674|NCT00337103|100594550|FG001|Overall Study|Death|0|||
33187675|NCT03350503|100594551|FG000|Overall Study|Adverse Event|5|||
33187676|NCT03350503|100594551|FG000|Overall Study|Withdrawal by Subject|5|||
33187677|NCT03350503|100594551|FG000|Overall Study|Continuation impossible due to move|4|||
33187678|NCT03350503|100594551|FG000|Overall Study|Physician Decision|3|||
33187679|NCT00283439|100594552|FG000|Overall Study|Adverse Event|0|||
33187680|NCT00283439|100594553|FG001|Overall Study|Adverse Event|0|||
33187681|NCT00283439|100594554|FG002|Overall Study|Adverse Event|0|||
33187682|NCT00283439|100594555|FG003|Overall Study|Adverse Event|1|||
33187683|NCT00283439|100594552|FG000|Overall Study|Death|0|||
33187684|NCT00283439|100594553|FG001|Overall Study|Death|0|||
33187685|NCT00283439|100594554|FG002|Overall Study|Death|1|||
33187686|NCT00283439|100594555|FG003|Overall Study|Death|0|||
33187687|NCT00283439|100594552|FG000|Overall Study|Disease progression|0|||
33187688|NCT00283439|100594553|FG001|Overall Study|Disease progression|1|||
33187689|NCT00283439|100594554|FG002|Overall Study|Disease progression|0|||
33187690|NCT00283439|100594555|FG003|Overall Study|Disease progression|0|||
33187691|NCT00283439|100594552|FG000|Overall Study|Requirement for alternative therapy|1|||
33187692|NCT00283439|100594553|FG001|Overall Study|Requirement for alternative therapy|2|||
33187693|NCT00283439|100594554|FG002|Overall Study|Requirement for alternative therapy|5|||
33187694|NCT00283439|100594555|FG003|Overall Study|Requirement for alternative therapy|2|||
33187695|NCT00283439|100594552|FG000|Overall Study|Stem cell transplant|6|||
33187696|NCT00283439|100594553|FG001|Overall Study|Stem cell transplant|6|||
33187697|NCT00283439|100594554|FG002|Overall Study|Stem cell transplant|4|||
33187698|NCT00283439|100594555|FG003|Overall Study|Stem cell transplant|3|||
33187699|NCT00283439|100594552|FG000|Overall Study|Treatment discontinued|0|||
33187700|NCT00283439|100594553|FG001|Overall Study|Treatment discontinued|2|||
33187701|NCT00283439|100594554|FG002|Overall Study|Treatment discontinued|1|||
33187702|NCT00283439|100594555|FG003|Overall Study|Treatment discontinued|3|||
33187703|NCT00283439|100594552|FG000|Overall Study|Other|1|||
33187704|NCT00283439|100594553|FG001|Overall Study|Other|0|||
33187705|NCT00283439|100594554|FG002|Overall Study|Other|0|||
33187706|NCT00283439|100594555|FG003|Overall Study|Other|0|||
33187707|NCT00706641|100594556|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
33187708|NCT00706641|100594556|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
33187709|NCT00706641|100594556|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
33187710|NCT00908960|100594557|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
33187711|NCT00908960|100594558|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
33187712|NCT00908960|100594559|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
33187713|NCT02042924|100594560|FG000|Overall Study|Early Death|1|||
33187714|NCT00836875|100594563|FG000|Overall Study|Death|3|||
33187715|NCT00836875|100594564|FG001|Overall Study|Death|2|||
33187716|NCT00836875|100594563|FG000|Overall Study|Withdrawal by Subject|0|||
33187717|NCT00836875|100594564|FG001|Overall Study|Withdrawal by Subject|1|||
33187718|NCT00489853|100594565|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
33391720|NCT02959190|101321855|FG003|Open Label|Physician Decision|0|||
33187719|NCT00489853|100594566|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
33187720|NCT00489853|100594567|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
33187721|NCT00489853|100594565|FG000|Wash-out Period 1|Adverse Event|0|||
33187722|NCT00489853|100594566|FG001|Wash-out Period 1|Adverse Event|1|||
33187723|NCT00489853|100594567|FG002|Wash-out Period 1|Adverse Event|1|||
33187724|NCT00489853|100594565|FG000|Wash-out Period 1|Protocol Violation|0|||
33187725|NCT00489853|100594566|FG001|Wash-out Period 1|Protocol Violation|1|||
33187726|NCT00489853|100594567|FG002|Wash-out Period 1|Protocol Violation|1|||
33187727|NCT00489853|100594565|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
33187728|NCT00489853|100594566|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
33187729|NCT00489853|100594567|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
33187730|NCT00489853|100594565|FG000|Wash-out Period 2|Adverse Event|1|||
33187731|NCT00489853|100594566|FG001|Wash-out Period 2|Adverse Event|1|||
33187732|NCT00489853|100594567|FG002|Wash-out Period 2|Adverse Event|0|||
33187733|NCT00489853|100594565|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
33187734|NCT00489853|100594566|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
33187735|NCT00489853|100594567|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
33187736|NCT00489853|100594565|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
33187737|NCT00489853|100594566|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
33187738|NCT00489853|100594567|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
33187739|NCT01070316|100594568|FG000|Extension Phase|Lack of Efficacy|3|||
33187740|NCT01070316|100594568|FG000|Extension Phase|Withdrawal by Subject|1|||
33187741|NCT01418209|100594569|FG000|Overall Study|Withdrawal by Subject|1|||
33187742|NCT01418209|100594570|FG001|Overall Study|Withdrawal by Subject|0|||
33187743|NCT01418209|100594571|FG002|Overall Study|Withdrawal by Subject|1|||
33187744|NCT01418209|100594569|FG000|Overall Study|Did not provide hot flash diary data|1|||
33187745|NCT01418209|100594570|FG001|Overall Study|Did not provide hot flash diary data|3|||
33187746|NCT01418209|100594571|FG002|Overall Study|Did not provide hot flash diary data|3|||
33187747|NCT04211337|100594574|FG000|Overall Study|On Treatment|175|||
33187748|NCT04211337|100594575|FG001|Overall Study|On Treatment|40|||
33187749|NCT04211337|100594574|FG000|Overall Study|Withdrawal by Subject|0|||
33187750|NCT04211337|100594575|FG001|Overall Study|Withdrawal by Subject|2|||
33187751|NCT02821962|100594576|FG000|Overall Study|Lost to Follow-up|2|||
33187752|NCT02821962|100594577|FG001|Overall Study|Lost to Follow-up|0|||
33187753|NCT02082210|100594578|FG000|Overall Study|Death|0|||
33187754|NCT02082210|100594579|FG001|Overall Study|Death|0|||
33187755|NCT02082210|100594580|FG002|Overall Study|Death|1|||
33187756|NCT02082210|100594581|FG003|Overall Study|Death|1|||
33187757|NCT02082210|100594582|FG004|Overall Study|Death|1|||
33187758|NCT02082210|100594583|FG005|Overall Study|Death|0|||
33187759|NCT02082210|100594578|FG000|Overall Study|Withdrawal by Subject|0|||
33187760|NCT02082210|100594579|FG001|Overall Study|Withdrawal by Subject|0|||
33187761|NCT02082210|100594580|FG002|Overall Study|Withdrawal by Subject|0|||
33187762|NCT02082210|100594581|FG003|Overall Study|Withdrawal by Subject|1|||
33187763|NCT02082210|100594582|FG004|Overall Study|Withdrawal by Subject|2|||
33187764|NCT02082210|100594583|FG005|Overall Study|Withdrawal by Subject|2|||
33187765|NCT02082210|100594578|FG000|Overall Study|Clinical Progression|0|||
33187766|NCT02082210|100594579|FG001|Overall Study|Clinical Progression|0|||
33187767|NCT02082210|100594580|FG002|Overall Study|Clinical Progression|0|||
33187768|NCT02082210|100594581|FG003|Overall Study|Clinical Progression|1|||
33187769|NCT02082210|100594582|FG004|Overall Study|Clinical Progression|0|||
33187770|NCT02082210|100594583|FG005|Overall Study|Clinical Progression|0|||
33187771|NCT02082210|100594578|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
33187772|NCT02082210|100594579|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
33187773|NCT02082210|100594580|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
33187774|NCT02082210|100594581|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
33187775|NCT02082210|100594582|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
33187776|NCT02082210|100594583|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
33187777|NCT02082210|100594578|FG000|Overall Study|Physician Decision|0|||
33187778|NCT02082210|100594579|FG001|Overall Study|Physician Decision|0|||
33187779|NCT02082210|100594580|FG002|Overall Study|Physician Decision|1|||
33187780|NCT02082210|100594581|FG003|Overall Study|Physician Decision|1|||
33187781|NCT02082210|100594582|FG004|Overall Study|Physician Decision|0|||
33187782|NCT02082210|100594583|FG005|Overall Study|Physician Decision|0|||
33187783|NCT02702401|100594584|FG000|Overall Study|Death|242|||
33187784|NCT02702401|100594585|FG001|Overall Study|Death|125|||
33187785|NCT02702401|100594584|FG000|Overall Study|Withdrawal by Subject|15|||
33187786|NCT02702401|100594585|FG001|Overall Study|Withdrawal by Subject|5|||
33187787|NCT02702401|100594584|FG000|Overall Study|Sponsor Decision|19|||
33187788|NCT02702401|100594585|FG001|Overall Study|Sponsor Decision|3|||
33187789|NCT02702401|100594584|FG000|Overall Study|Physician Decision|1|||
33187790|NCT02702401|100594585|FG001|Overall Study|Physician Decision|2|||
33187791|NCT02702401|100594584|FG000|Overall Study|Lost to Follow-up|1|||
33187792|NCT02702401|100594585|FG001|Overall Study|Lost to Follow-up|0|||
33187793|NCT00314366|100594588|FG000|Overall Study|not treated due to patient medical condi|1|||
33187794|NCT00314366|100594589|FG001|Overall Study|not treated due to patient medical condi|0|||
33187795|NCT00717769|100594590|FG000|Overall Study|Adverse Event|9|||
33187796|NCT00717769|100594591|FG001|Overall Study|Adverse Event|6|||
33187797|NCT00717769|100594592|FG002|Overall Study|Adverse Event|1|||
33187798|NCT00717769|100594590|FG000|Overall Study|Lack of compliance|0|||
33187799|NCT00717769|100594591|FG001|Overall Study|Lack of compliance|2|||
33391721|NCT02959190|101321852|FG000|Open Label|Protocol Violation|0|||
33391722|NCT02959190|101321853|FG001|Open Label|Protocol Violation|0|||
33391723|NCT02959190|101321854|FG002|Open Label|Protocol Violation|0|||
33187800|NCT00717769|100594592|FG002|Overall Study|Lack of compliance|0|||
33187801|NCT00717769|100594590|FG000|Overall Study|Lost to Follow-up|3|||
33187802|NCT00717769|100594591|FG001|Overall Study|Lost to Follow-up|4|||
33187803|NCT00717769|100594592|FG002|Overall Study|Lost to Follow-up|0|||
33187804|NCT00717769|100594590|FG000|Overall Study|Lack of Efficacy|1|||
33187805|NCT00717769|100594591|FG001|Overall Study|Lack of Efficacy|2|||
33187806|NCT00717769|100594592|FG002|Overall Study|Lack of Efficacy|0|||
33187807|NCT00717769|100594590|FG000|Overall Study|Protocol Violation|0|||
33187808|NCT00717769|100594591|FG001|Overall Study|Protocol Violation|2|||
33187809|NCT00717769|100594592|FG002|Overall Study|Protocol Violation|0|||
33187810|NCT00717769|100594590|FG000|Overall Study|Sponsor decision|1|||
33187811|NCT00717769|100594591|FG001|Overall Study|Sponsor decision|0|||
33187812|NCT00717769|100594592|FG002|Overall Study|Sponsor decision|10|||
33187813|NCT00717769|100594590|FG000|Overall Study|Withdrew consent|2|||
33187814|NCT00717769|100594591|FG001|Overall Study|Withdrew consent|2|||
33187815|NCT00717769|100594592|FG002|Overall Study|Withdrew consent|0|||
33187816|NCT01232296|100594593|FG000|Overall Study|Adverse Event|24|||
33187817|NCT01232296|100594594|FG001|Overall Study|Adverse Event|12|||
33187818|NCT01232296|100594593|FG000|Overall Study|Physician Decision|1|||
33187819|NCT01232296|100594594|FG001|Overall Study|Physician Decision|1|||
33187820|NCT01232296|100594593|FG000|Overall Study|Progressive disease|43|||
33187821|NCT01232296|100594594|FG001|Overall Study|Progressive disease|61|||
33187822|NCT01232296|100594593|FG000|Overall Study|Study terminated by sponsor|0|||
33187823|NCT01232296|100594594|FG001|Overall Study|Study terminated by sponsor|1|||
33187824|NCT01232296|100594593|FG000|Overall Study|Technical problems|3|||
33187825|NCT01232296|100594594|FG001|Overall Study|Technical problems|0|||
33187826|NCT01232296|100594593|FG000|Overall Study|Subject/guardian decision|10|||
33187827|NCT01232296|100594594|FG001|Overall Study|Subject/guardian decision|2|||
33187828|NCT01232296|100594593|FG000|Overall Study|Death|1|||
33187829|NCT01232296|100594594|FG001|Overall Study|Death|6|||
33187830|NCT00480779|100594597|FG000|Overall Study|Other|2|||
33187831|NCT00480779|100594598|FG001|Overall Study|Other|0|||
33187832|NCT00480779|100594597|FG000|Overall Study|Job and Health-related|0|||
33187833|NCT00480779|100594598|FG001|Overall Study|Job and Health-related|3|||
33187834|NCT02418468|100594602|FG000|Overall Study|Adverse Event|1|||
33187835|NCT02418468|100594603|FG001|Overall Study|Adverse Event|0|||
33187836|NCT02418468|100594602|FG000|Overall Study|Withdrawal of informed consent|1|||
33187837|NCT02418468|100594603|FG001|Overall Study|Withdrawal of informed consent|1|||
33187838|NCT00582933|100594609|FG000|Overall Study|Physician Decision|3|||
33187839|NCT02167256|100594610|FG000|Overall Study|Adverse Event|13|||
33187840|NCT02167256|100594611|FG001|Overall Study|Adverse Event|6|||
33187841|NCT02167256|100594610|FG000|Overall Study|Withdrawal by Subject|4|||
33187842|NCT02167256|100594611|FG001|Overall Study|Withdrawal by Subject|4|||
33187843|NCT02167256|100594610|FG000|Overall Study|non-compliance|3|||
33187844|NCT02167256|100594611|FG001|Overall Study|non-compliance|0|||
33187845|NCT02167256|100594610|FG000|Overall Study|Study partner unable to participate|1|||
33187846|NCT02167256|100594611|FG001|Overall Study|Study partner unable to participate|0|||
33187847|NCT02239536|100597804|FG000|Overall Study|Non-neoplastic polyp|23|||
33187848|NCT02239536|100597805|FG001|Overall Study|Non-neoplastic polyp|17|||
33187849|NCT01466270|100597808|FG000|Overall Study|Withdrawal by Subject|4|||
33187850|NCT01466270|100597809|FG001|Overall Study|Withdrawal by Subject|1|||
33187851|NCT01466270|100597808|FG000|Overall Study|Physician Decision|1|||
33187852|NCT01466270|100597809|FG001|Overall Study|Physician Decision|0|||
33187853|NCT01466270|100597808|FG000|Overall Study|Lost to Follow-up|1|||
33187854|NCT01466270|100597809|FG001|Overall Study|Lost to Follow-up|3|||
33187855|NCT01466270|100597808|FG000|Overall Study|Progression|1|||
33187856|NCT01466270|100597809|FG001|Overall Study|Progression|0|||
33187857|NCT01466270|100597808|FG000|Overall Study|Toxicity|4|||
33187858|NCT01466270|100597809|FG001|Overall Study|Toxicity|1|||
33187859|NCT01466270|100597808|FG000|Overall Study|Multiple|1|||
33187860|NCT01466270|100597809|FG001|Overall Study|Multiple|1|||
33187861|NCT03818516|100597815|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
33187862|NCT03299842|100597827|FG000|Overall Study|Caregiver withdrew consent|2|||
33187863|NCT03299842|100597827|FG000|Overall Study|Child would not keep the watch on|3|||
33187864|NCT00697346|100597828|FG000|Overall Study|Adverse Event|4|||
33187865|NCT00697346|100597829|FG001|Overall Study|Adverse Event|5|||
33187866|NCT00697346|100597830|FG002|Overall Study|Adverse Event|0|||
33187867|NCT00697346|100597828|FG000|Overall Study|Progressive Disease|19|||
33187868|NCT00697346|100597829|FG001|Overall Study|Progressive Disease|18|||
33187869|NCT00697346|100597830|FG002|Overall Study|Progressive Disease|0|||
33187870|NCT00697346|100597828|FG000|Overall Study|Symptomatic Deterioration|0|||
33187871|NCT00697346|100597829|FG001|Overall Study|Symptomatic Deterioration|1|||
33187872|NCT00697346|100597830|FG002|Overall Study|Symptomatic Deterioration|0|||
33187873|NCT00697346|100597828|FG000|Overall Study|Withdrawal by Subject|2|||
33187874|NCT00697346|100597829|FG001|Overall Study|Withdrawal by Subject|2|||
33187875|NCT00697346|100597830|FG002|Overall Study|Withdrawal by Subject|0|||
33598997|NCT01155466|102081796|FG003|Overall Study|Lost to Follow-up|0|||
33187876|NCT00697346|100597828|FG000|Overall Study|Reason not Specified|3|||
33187877|NCT00697346|100597829|FG001|Overall Study|Reason not Specified|0|||
33187878|NCT00697346|100597830|FG002|Overall Study|Reason not Specified|1|||
33187879|NCT04847674|100597833|FG000|Overall Study|Withdrawal by Subject|0|||
33187880|NCT04847674|100597834|FG001|Overall Study|Withdrawal by Subject|1|||
33187881|NCT04847674|100597835|FG002|Overall Study|Withdrawal by Subject|0|||
33187882|NCT04847674|100597833|FG000|Overall Study|Lost to Follow-up|0|||
33187883|NCT04847674|100597834|FG001|Overall Study|Lost to Follow-up|0|||
33187884|NCT04847674|100597835|FG002|Overall Study|Lost to Follow-up|2|||
33187885|NCT04847674|100597833|FG000|Overall Study|Other than specified|21|||
33187886|NCT04847674|100597834|FG001|Overall Study|Other than specified|20|||
33187887|NCT04847674|100597835|FG002|Overall Study|Other than specified|20|||
33187888|NCT01434290|100597836|FG000|Overall Study|Protocol Violation|6|||
33187889|NCT01434290|100597837|FG001|Overall Study|Protocol Violation|3|||
33187890|NCT01434290|100597836|FG000|Overall Study|No protocol treatment|2|||
33187891|NCT01434290|100597837|FG001|Overall Study|No protocol treatment|4|||
33187892|NCT01339390|100597838|FG000|Overall Study|Death|32|||
33187893|NCT01339390|100597839|FG001|Overall Study|Death|29|||
33187894|NCT01339390|100597838|FG000|Overall Study|Lost to Follow-up|125|||
33187895|NCT01339390|100597839|FG001|Overall Study|Lost to Follow-up|127|||
33187896|NCT04187196|100597843|FG000|Overall Study|Screen Failure|2|||
33187897|NCT04187196|100597844|FG001|Overall Study|Screen Failure|0|||
33187898|NCT02540954|100597845|FG000|Overall Study|Physician Decision|3|||
33187899|NCT02540954|100597846|FG001|Overall Study|Physician Decision|1|||
33187900|NCT02540954|100597845|FG000|Overall Study|Withdrawal by Subject|6|||
33187901|NCT02540954|100597846|FG001|Overall Study|Withdrawal by Subject|5|||
33187902|NCT02540954|100597845|FG000|Overall Study|Lost to Follow-up|1|||
33187903|NCT02540954|100597846|FG001|Overall Study|Lost to Follow-up|1|||
33187904|NCT02540954|100597845|FG000|Overall Study|Adverse Event|4|||
33187905|NCT02540954|100597846|FG001|Overall Study|Adverse Event|2|||
33187906|NCT02540954|100597845|FG000|Overall Study|Death|0|||
33187907|NCT02540954|100597846|FG001|Overall Study|Death|3|||
33187908|NCT02540954|100597845|FG000|Overall Study|Treatment failure|1|||
33187909|NCT02540954|100597846|FG001|Overall Study|Treatment failure|0|||
33187910|NCT02540954|100597845|FG000|Overall Study|Other reason|4|||
33187911|NCT02540954|100597846|FG001|Overall Study|Other reason|2|||
33187912|NCT00794196|100597851|FG000|Overall Study|Lost to Follow-up|5|||
33187913|NCT00794196|100597852|FG001|Overall Study|Lost to Follow-up|23|||
33187914|NCT02920983|100597855|FG000|Dispense 1|Unacceptable Lens Fit|0|||
33187915|NCT02920983|100597856|FG001|Dispense 1|Unacceptable Lens Fit|0|||
33187916|NCT02920983|100597857|FG002|Dispense 1|Unacceptable Lens Fit|0|||
33187917|NCT02920983|100597858|FG003|Dispense 1|Unacceptable Lens Fit|0|||
33187918|NCT02920983|100597859|FG004|Dispense 1|Unacceptable Lens Fit|1|||
33187919|NCT02920983|100597860|FG005|Dispense 1|Unacceptable Lens Fit|0|||
33187920|NCT02920983|100597855|FG000|Dispense 2|Unscceptable lens fit|1|||
33187921|NCT02920983|100597856|FG001|Dispense 2|Unscceptable lens fit|0|||
33187922|NCT02920983|100597857|FG002|Dispense 2|Unscceptable lens fit|0|||
33187923|NCT02920983|100597858|FG003|Dispense 2|Unscceptable lens fit|0|||
33187924|NCT02920983|100597859|FG004|Dispense 2|Unscceptable lens fit|1|||
33187925|NCT02920983|100597860|FG005|Dispense 2|Unscceptable lens fit|0|||
33187926|NCT02920983|100597855|FG000|Dispense 3|Unacceptable Lens Fit|1|||
33187927|NCT02920983|100597856|FG001|Dispense 3|Unacceptable Lens Fit|1|||
33187928|NCT02920983|100597857|FG002|Dispense 3|Unacceptable Lens Fit|0|||
33187929|NCT02920983|100597858|FG003|Dispense 3|Unacceptable Lens Fit|0|||
33187930|NCT02920983|100597859|FG004|Dispense 3|Unacceptable Lens Fit|1|||
33187931|NCT02920983|100597860|FG005|Dispense 3|Unacceptable Lens Fit|0|||
33187932|NCT00855309|100597863|FG000|Overall Study|patient never recieved drug|1|||
33187933|NCT00855309|100597864|FG001|Overall Study|patient never recieved drug|0|||
33187934|NCT01482767|100597866|FG000|Overall Study|Death|1|||
33187935|NCT01482767|100597867|FG001|Overall Study|Death|1|||
33187936|NCT01482767|100597866|FG000|Overall Study|Withdrawal by Subject|7|||
33187937|NCT01482767|100597867|FG001|Overall Study|Withdrawal by Subject|5|||
33187938|NCT01482767|100597866|FG000|Overall Study|Lost to Follow-up|12|||
33187939|NCT01482767|100597867|FG001|Overall Study|Lost to Follow-up|6|||
33187940|NCT01482767|100597866|FG000|Overall Study|Adverse Event|0|||
33187941|NCT01482767|100597867|FG001|Overall Study|Adverse Event|3|||
33187942|NCT01482767|100597866|FG000|Overall Study|Site closure|22|||
33187943|NCT01482767|100597867|FG001|Overall Study|Site closure|14|||
33187944|NCT01482767|100597866|FG000|Overall Study|Non-adherence to study requirements|4|||
33187945|NCT01482767|100597867|FG001|Overall Study|Non-adherence to study requirements|7|||
33187946|NCT01482767|100597866|FG000|Overall Study|Alternate HCV treatment|7|||
33187947|NCT01482767|100597867|FG001|Overall Study|Alternate HCV treatment|8|||
33187948|NCT01482767|100597866|FG000|Overall Study|Ineligible|0|||
33187949|NCT01482767|100597867|FG001|Overall Study|Ineligible|5|||
33187950|NCT01482767|100597866|FG000|Overall Study|Nurse error|1|||
33187951|NCT01482767|100597867|FG001|Overall Study|Nurse error|0|||
33187952|NCT00397982|100597872|FG000|Overall Study|Withdrawal by Subject|1|||
33187953|NCT00397982|100597872|FG000|Overall Study|Adverse Event|1|||
33187954|NCT00397982|100597872|FG000|Overall Study|noncompliance|1|||
33187955|NCT00397982|100597872|FG000|Overall Study|Unrelated health issues|1|||
33187956|NCT01552772|100597873|FG000|Overall Study|Lost to Follow-up|2|||
33187957|NCT01552772|100597873|FG000|Overall Study|Adverse Event|1|||
33187958|NCT01552772|100597873|FG000|Overall Study|Protocol Deviation|1|||
33187959|NCT02789176|100597874|FG000|Overall Study|Death|0|||
33187960|NCT02789176|100597875|FG001|Overall Study|Death|0|||
33187961|NCT02789176|100597876|FG002|Overall Study|Death|3|||
33187962|NCT02789176|100597877|FG003|Overall Study|Death|0|||
33187963|NCT02789176|100597874|FG000|Overall Study|Withdrawal by Subject|0|||
33187964|NCT02789176|100597875|FG001|Overall Study|Withdrawal by Subject|0|||
33187965|NCT02789176|100597876|FG002|Overall Study|Withdrawal by Subject|1|||
33391724|NCT02959190|101321855|FG003|Open Label|Protocol Violation|2|||
33187966|NCT02789176|100597877|FG003|Overall Study|Withdrawal by Subject|0|||
33187967|NCT02789176|100597874|FG000|Overall Study|Lost to Follow-up|8|||
33187968|NCT02789176|100597875|FG001|Overall Study|Lost to Follow-up|2|||
33187969|NCT02789176|100597876|FG002|Overall Study|Lost to Follow-up|6|||
33187970|NCT02789176|100597877|FG003|Overall Study|Lost to Follow-up|1|||
33187971|NCT01524770|100597884|FG000|First Intervention|Withdrawal by Subject|1|||
33187972|NCT01524770|100597885|FG001|First Intervention|Withdrawal by Subject|0|||
33187973|NCT01524770|100597884|FG000|First Intervention|Adverse Event|1|||
33187974|NCT01524770|100597885|FG001|First Intervention|Adverse Event|1|||
33187975|NCT01524770|100597884|FG000|First Intervention|Protocol Violation|1|||
33187976|NCT01524770|100597885|FG001|First Intervention|Protocol Violation|0|||
33187977|NCT00439556|100597886|FG000|Overall Study|Patient was taken off study for non-comp|0|||
33187978|NCT00439556|100597887|FG001|Overall Study|Patient was taken off study for non-comp|1|||
33187979|NCT00439556|100597888|FG002|Overall Study|Patient was taken off study for non-comp|0|||
33187980|NCT03851016|100597893|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33187981|NCT03851016|100597894|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
33187982|NCT01541930|100597895|FG000|Overall Study|Withdrawal by Subject|1|||
33187983|NCT02448875|100597899|FG000|Overall Study|Adverse Event|2|||
33187984|NCT02448875|100597900|FG001|Overall Study|Adverse Event|1|||
33187985|NCT02448875|100597901|FG002|Overall Study|Adverse Event|0|||
33187986|NCT02448875|100597899|FG000|Overall Study|Lost to Follow-up|1|||
33187987|NCT02448875|100597900|FG001|Overall Study|Lost to Follow-up|0|||
33187988|NCT02448875|100597901|FG002|Overall Study|Lost to Follow-up|0|||
33187989|NCT02448875|100597899|FG000|Overall Study|Investigator Decision|3|||
33187990|NCT02448875|100597900|FG001|Overall Study|Investigator Decision|0|||
33187991|NCT02448875|100597901|FG002|Overall Study|Investigator Decision|1|||
33187992|NCT02448875|100597899|FG000|Overall Study|Withdrawal by Subject|1|||
33187993|NCT02448875|100597900|FG001|Overall Study|Withdrawal by Subject|0|||
33187994|NCT02448875|100597901|FG002|Overall Study|Withdrawal by Subject|0|||
33187995|NCT01143090|100597905|FG000|Overall Study|Lack of Efficacy|2|||
33187996|NCT01143090|100597905|FG000|Overall Study|Adverse Event|17|||
33187997|NCT01143090|100597905|FG000|Overall Study|Lost to Follow-up|9|||
33187998|NCT01143090|100597905|FG000|Overall Study|Protocol Violation|2|||
33187999|NCT01143090|100597905|FG000|Overall Study|Withdrawal by Subject|18|||
33188000|NCT01143090|100597905|FG000|Overall Study|Non-compliance with study drug|1|||
33188001|NCT01143090|100597905|FG000|Overall Study|Failure to meet eligibility criteria|1|||
33188002|NCT01143090|100597905|FG000|Overall Study|Administrative|1|||
33188003|NCT04334460|100597906|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
33188004|NCT04334460|100597907|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
33188005|NCT04334460|100597906|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
33188006|NCT04334460|100597907|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
33188007|NCT01073865|100597908|FG000|Overall Study|Reasons other than below|19|||
33188008|NCT01073865|100597909|FG001|Overall Study|Reasons other than below|31|||
33188009|NCT01073865|100597908|FG000|Overall Study|Lost to Follow-up|1|||
33188010|NCT01073865|100597909|FG001|Overall Study|Lost to Follow-up|1|||
33188011|NCT01073865|100597908|FG000|Overall Study|Death|3|||
33188012|NCT01073865|100597909|FG001|Overall Study|Death|2|||
33188013|NCT01073865|100597908|FG000|Overall Study|Withdrawal by Subject|5|||
33188014|NCT01073865|100597909|FG001|Overall Study|Withdrawal by Subject|5|||
33188015|NCT02318693|100597915|FG000|Overall Study|Protocol Violation|0|||
33188016|NCT02318693|100597916|FG001|Overall Study|Protocol Violation|1|||
33188017|NCT03711162|100597919|FG000|Overall Study|Adverse Event|5|||
33188018|NCT03711162|100597920|FG001|Overall Study|Adverse Event|2|||
33188019|NCT03711162|100597921|FG002|Overall Study|Adverse Event|4|||
33188020|NCT03711162|100597919|FG000|Overall Study|Death|11|||
33188021|NCT03711162|100597920|FG001|Overall Study|Death|7|||
33188022|NCT03711162|100597921|FG002|Overall Study|Death|8|||
33188023|NCT03711162|100597919|FG000|Overall Study|Lost to Follow-up|1|||
33188024|NCT03711162|100597920|FG001|Overall Study|Lost to Follow-up|0|||
33188025|NCT03711162|100597921|FG002|Overall Study|Lost to Follow-up|1|||
33188026|NCT03711162|100597919|FG000|Overall Study|Study Terminated by Sponsor|139|||
33188027|NCT03711162|100597920|FG001|Overall Study|Study Terminated by Sponsor|152|||
33188028|NCT03711162|100597921|FG002|Overall Study|Study Terminated by Sponsor|146|||
33188029|NCT03711162|100597919|FG000|Overall Study|Withdrawal by Subject|17|||
33188030|NCT03711162|100597920|FG001|Overall Study|Withdrawal by Subject|10|||
33188031|NCT03711162|100597921|FG002|Overall Study|Withdrawal by Subject|10|||
33188032|NCT03711162|100597919|FG000|Overall Study|Miscellaneous|1|||
33188033|NCT03711162|100597920|FG001|Overall Study|Miscellaneous|2|||
33188034|NCT03711162|100597921|FG002|Overall Study|Miscellaneous|2|||
33188035|NCT03711162|100597919|FG000|Overall Study|Not Treated|1|||
33188036|NCT03711162|100597920|FG001|Overall Study|Not Treated|0|||
33188037|NCT03711162|100597921|FG002|Overall Study|Not Treated|1|||
33188038|NCT03711162|100597919|FG000|Overall Study|Physician Decision|0|||
33188039|NCT03711162|100597920|FG001|Overall Study|Physician Decision|2|||
33188040|NCT03711162|100597921|FG002|Overall Study|Physician Decision|0|||
33188041|NCT03711162|100597919|FG000|Overall Study|Lack of Efficacy|0|||
33188042|NCT03711162|100597920|FG001|Overall Study|Lack of Efficacy|0|||
33188043|NCT03711162|100597921|FG002|Overall Study|Lack of Efficacy|2|||
33188044|NCT03711162|100597919|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
33188045|NCT03711162|100597920|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
33188046|NCT03711162|100597921|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
33188047|NCT01857063|100597926|FG000|Period 1 (7 Days)|Adverse Event|0|||
33188048|NCT01857063|100597927|FG001|Period 1 (7 Days)|Adverse Event|1|||
33188049|NCT01857063|100597926|FG000|Period 1 (7 Days)|Physician Decision|1|||
33188050|NCT01857063|100597927|FG001|Period 1 (7 Days)|Physician Decision|0|||
33188051|NCT01857063|100597926|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
33188052|NCT01857063|100597927|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
33188053|NCT01857063|100597926|FG000|Period 2 (7 Days)|Adverse Event|2|||
33188054|NCT01857063|100597927|FG001|Period 2 (7 Days)|Adverse Event|1|||
33188055|NCT01857063|100597926|FG000|Period 2 (7 Days)|Physician Decision|1|||
33188056|NCT01857063|100597927|FG001|Period 2 (7 Days)|Physician Decision|1|||
33188057|NCT01857063|100597926|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
33188058|NCT01857063|100597927|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
33188059|NCT03742141|100597928|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
33188060|NCT04116710|100597929|FG000|Overall Study|Death|4|||
33188061|NCT04116710|100597930|FG001|Overall Study|Death|6|||
33188062|NCT04116710|100597931|FG002|Overall Study|Death|3|||
33188063|NCT04116710|100597932|FG003|Overall Study|Death|1|||
33188064|NCT04116710|100597929|FG000|Overall Study|Withdrawal by Subject|0|||
33188065|NCT04116710|100597930|FG001|Overall Study|Withdrawal by Subject|0|||
33188066|NCT04116710|100597931|FG002|Overall Study|Withdrawal by Subject|0|||
33188067|NCT04116710|100597932|FG003|Overall Study|Withdrawal by Subject|1|||
33188068|NCT02449239|100597933|FG000|Induction Phase|Lack of Efficacy|64|||
33188069|NCT02449239|100597933|FG000|Induction Phase|Adverse Event|1|||
33188070|NCT02449239|100597933|FG000|Induction Phase|Lost to Follow-up|1|||
33188071|NCT02449239|100597933|FG000|Induction Phase|Protocol Violation|1|||
33188072|NCT02449239|100597933|FG000|Induction Phase|Physician Decision|1|||
33188073|NCT02449239|100597933|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
33188074|NCT02449239|100597933|FG000|Induction Phase|Withdrawal by Subject|1|||
33188075|NCT02449239|100597933|FG000|Maintenance Month 3|Lack of Efficacy|14|||
33188076|NCT02449239|100597933|FG000|Maintenance Month 6|Lack of Efficacy|10|||
33188077|NCT02449239|100597933|FG000|Maintenance Month 6|Adverse Event|2|||
33188078|NCT02449239|100597933|FG000|Maintenance Month 6|Physician Decision|1|||
33188079|NCT02449239|100597933|FG000|Maintenance Month 9|Lack of Efficacy|2|||
33188080|NCT02449239|100597933|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
33188081|NCT02449239|100597933|FG000|Maintenance Month 12|Lack of Efficacy|5|||
33188082|NCT02449239|100597933|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
33188083|NCT02449239|100597933|FG000|Maintenance Month 12|Subject moved from area|1|||
33188084|NCT02449239|100597933|FG000|Maintenance Month 15|Lack of Efficacy|1|||
33188085|NCT02449239|100597933|FG000|Maintenance Month 21|Lack of Efficacy|1|||
33188086|NCT02449239|100597933|FG000|Maintenance Month 21|Sponsor decision|1|||
33188087|NCT02777125|100597934|FG000|Overall Study|Consent form violation|14|||
33188088|NCT02777125|100597935|FG001|Overall Study|Consent form violation|12|||
33188089|NCT02777125|100597934|FG000|Overall Study|Assent form violation|21|||
33188090|NCT02777125|100597935|FG001|Overall Study|Assent form violation|23|||
33188091|NCT02777125|100597934|FG000|Overall Study|Protocol Violation|8|||
33188092|NCT02777125|100597935|FG001|Overall Study|Protocol Violation|12|||
33188093|NCT03907683|100597936|FG000|Overall Study|Pregnancy|1|||
33188094|NCT03907683|100597936|FG000|Overall Study|Withdrawal by Subject|1|||
33188095|NCT00842348|100597937|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
33188096|NCT00842348|100597938|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
33188097|NCT00842348|100597937|FG000|Study 729|Disease progression/death|19|||
33188098|NCT00842348|100597938|FG001|Study 729|Disease progression/death|30|||
33188099|NCT00842348|100597937|FG000|Study 729|Adverse Event|1|||
33188100|NCT00842348|100597938|FG001|Study 729|Adverse Event|1|||
33188101|NCT00842348|100597937|FG000|Study 729|Protocol Violation|1|||
33188102|NCT00842348|100597938|FG001|Study 729|Protocol Violation|1|||
33188103|NCT00842348|100597937|FG000|Study 729|Withdrawal by Subject|2|||
33188104|NCT00842348|100597938|FG001|Study 729|Withdrawal by Subject|4|||
33188105|NCT00842348|100597937|FG000|Study 729|Due to Sponsor stopping the study|1|||
33188106|NCT00842348|100597938|FG001|Study 729|Due to Sponsor stopping the study|1|||
33188107|NCT00842348|100597937|FG000|Study 729|Due to non-availability of IP|0|||
33598998|NCT01155466|102081797|FG004|Overall Study|Lost to Follow-up|2|||
33598999|NCT01155466|102081793|FG000|Overall Study|Withdrawal by Subject|7|||
33599000|NCT01155466|102081794|FG001|Overall Study|Withdrawal by Subject|5|||
33599001|NCT01155466|102081795|FG002|Overall Study|Withdrawal by Subject|9|||
33599002|NCT01155466|102081796|FG003|Overall Study|Withdrawal by Subject|4|||
33599003|NCT01155466|102081797|FG004|Overall Study|Withdrawal by Subject|4|||
33599004|NCT01155466|102081793|FG000|Overall Study|Protocol Violation|0|||
33599005|NCT01155466|102081794|FG001|Overall Study|Protocol Violation|0|||
33599006|NCT01155466|102081795|FG002|Overall Study|Protocol Violation|2|||
33599007|NCT01155466|102081796|FG003|Overall Study|Protocol Violation|0|||
33599008|NCT01155466|102081797|FG004|Overall Study|Protocol Violation|1|||
33599009|NCT01155466|102081793|FG000|Overall Study|Administrative|0|||
33599010|NCT01155466|102081794|FG001|Overall Study|Administrative|3|||
33599011|NCT01155466|102081795|FG002|Overall Study|Administrative|0|||
33599012|NCT01155466|102081796|FG003|Overall Study|Administrative|0|||
33599013|NCT01155466|102081797|FG004|Overall Study|Administrative|0|||
33599014|NCT01155466|102081793|FG000|Overall Study|Randomized not treated|2|||
33599015|NCT01155466|102081794|FG001|Overall Study|Randomized not treated|2|||
33599016|NCT01155466|102081795|FG002|Overall Study|Randomized not treated|3|||
33599017|NCT01155466|102081796|FG003|Overall Study|Randomized not treated|0|||
33599018|NCT01155466|102081797|FG004|Overall Study|Randomized not treated|2|||
33599019|NCT01669421|102081798|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
33599020|NCT01669421|102081798|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
33599021|NCT01628367|102081808|FG000|Overall Study|Adverse Event|1|||
33599022|NCT01628367|102081809|FG001|Overall Study|Adverse Event|0|||
33599023|NCT01011933|102081810|FG000|Overall Study|Wrong cell type|1|||
33188108|NCT00842348|100597938|FG001|Study 729|Due to non-availability of IP|1|||
33188109|NCT00842348|100597937|FG000|Study 729|Sponsor's decision|1|||
33188110|NCT00842348|100597938|FG001|Study 729|Sponsor's decision|0|||
33599024|NCT01011933|102081810|FG000|Overall Study|Improper pre-protocol Rx|1|||
33599025|NCT01011933|102081810|FG000|Overall Study|Inadequate pathology|1|||
33599026|NCT01011933|102081810|FG000|Overall Study|Never treated|1|||
33599027|NCT00989235|102081811|FG000|Overall Study|Death|0|||
33599028|NCT00989235|102081812|FG001|Overall Study|Death|1|||
33599029|NCT00989235|102081811|FG000|Overall Study|Adverse Event|0|||
33599030|NCT00989235|102081812|FG001|Overall Study|Adverse Event|1|||
33599031|NCT00989235|102081811|FG000|Overall Study|Lack of Efficacy|1|||
33599032|NCT00989235|102081812|FG001|Overall Study|Lack of Efficacy|0|||
33599033|NCT00989235|102081811|FG000|Overall Study|Withdrawal of Consent|1|||
33599034|NCT00989235|102081812|FG001|Overall Study|Withdrawal of Consent|1|||
33599035|NCT00989235|102081811|FG000|Overall Study|Desire to Become Pregnant|1|||
33188111|NCT00842348|100597937|FG000|Study 729|Surgical resection|1|||
33188112|NCT00842348|100597938|FG001|Study 729|Surgical resection|0|||
33188113|NCT03080961|100597946|FG000|Overall Study|Withdrawal by Subject|3|||
33188114|NCT04206293|100597953|FG000|Overall Study|Consent withdrawal|1|||
33188115|NCT00838565|100597959|FG000|Overall Study|Withdrawal by Subject|0|||
33188116|NCT00838565|100597960|FG001|Overall Study|Withdrawal by Subject|0|||
33188117|NCT00838565|100597961|FG002|Overall Study|Withdrawal by Subject|1|||
33188118|NCT00838565|100597962|FG003|Overall Study|Withdrawal by Subject|0|||
33188119|NCT00838565|100597963|FG004|Overall Study|Withdrawal by Subject|0|||
33188120|NCT00838565|100597964|FG005|Overall Study|Withdrawal by Subject|2|||
33188121|NCT00838565|100597959|FG000|Overall Study|Other|0|||
33188122|NCT00838565|100597960|FG001|Overall Study|Other|2|||
33188123|NCT00838565|100597961|FG002|Overall Study|Other|0|||
33188124|NCT00838565|100597962|FG003|Overall Study|Other|0|||
33188125|NCT00838565|100597963|FG004|Overall Study|Other|0|||
33188126|NCT00838565|100597964|FG005|Overall Study|Other|0|||
33188127|NCT00838565|100597959|FG000|Overall Study|Randomized but not Treated|0|||
33188128|NCT00838565|100597960|FG001|Overall Study|Randomized but not Treated|1|||
33188129|NCT00838565|100597961|FG002|Overall Study|Randomized but not Treated|0|||
33188130|NCT00838565|100597962|FG003|Overall Study|Randomized but not Treated|0|||
33188131|NCT00838565|100597963|FG004|Overall Study|Randomized but not Treated|0|||
33188132|NCT00838565|100597964|FG005|Overall Study|Randomized but not Treated|0|||
33188133|NCT02346136|100597969|FG000|Overall Study|Withdrawal by Subject|7|||
33188134|NCT02346136|100597970|FG001|Overall Study|Withdrawal by Subject|5|||
33188135|NCT02346136|100597969|FG000|Overall Study|Death|1|||
33188136|NCT02346136|100597970|FG001|Overall Study|Death|0|||
33188137|NCT02346136|100597969|FG000|Overall Study|Study termination|14|||
33188138|NCT02346136|100597970|FG001|Overall Study|Study termination|18|||
33188139|NCT00414388|100597971|FG000|Overall Study|Adverse Event|1|||
33188140|NCT01465464|100597982|FG000|Overall Study|Adverse Event|96|||
33188141|NCT01465464|100597983|FG001|Overall Study|Adverse Event|49|||
33188142|NCT01465464|100597982|FG000|Overall Study|Lack of Efficacy|139|||
33188143|NCT01465464|100597983|FG001|Overall Study|Lack of Efficacy|190|||
33188144|NCT01465464|100597982|FG000|Overall Study|Physician Decision|13|||
33188145|NCT01465464|100597983|FG001|Overall Study|Physician Decision|5|||
33188146|NCT01465464|100597982|FG000|Overall Study|Protocol Violation|1|||
33188147|NCT01465464|100597983|FG001|Overall Study|Protocol Violation|1|||
33188148|NCT01465464|100597982|FG000|Overall Study|Withdrawal by Subject|46|||
33289757|NCT02250534|100958918|FG001|Overall Study|Lost to Follow-up|28|||
33289758|NCT02250534|100958919|FG002|Overall Study|Lost to Follow-up|33|||
33289759|NCT02250534|100958917|FG000|Overall Study|Personal reasons|7|||
33289760|NCT02250534|100958918|FG001|Overall Study|Personal reasons|8|||
33289761|NCT02250534|100958919|FG002|Overall Study|Personal reasons|14|||
33289762|NCT02250534|100958917|FG000|Overall Study|Adverse Event|6|||
33289763|NCT02250534|100958918|FG001|Overall Study|Adverse Event|3|||
33289764|NCT02250534|100958919|FG002|Overall Study|Adverse Event|8|||
33289765|NCT02250534|100958917|FG000|Overall Study|incarcerated|2|||
33289766|NCT02250534|100958918|FG001|Overall Study|incarcerated|1|||
33289767|NCT02250534|100958919|FG002|Overall Study|incarcerated|2|||
33289768|NCT02250534|100958917|FG000|Overall Study|Withdrawal by Subject|0|||
33289769|NCT02250534|100958918|FG001|Overall Study|Withdrawal by Subject|1|||
33289770|NCT02250534|100958919|FG002|Overall Study|Withdrawal by Subject|2|||
33289771|NCT02250534|100958917|FG000|Overall Study|Death|0|||
33289772|NCT02250534|100958918|FG001|Overall Study|Death|1|||
33289773|NCT02250534|100958919|FG002|Overall Study|Death|1|||
33289774|NCT02250534|100958917|FG000|Overall Study|Physician Decision|1|||
33289775|NCT02250534|100958918|FG001|Overall Study|Physician Decision|3|||
33289776|NCT02250534|100958919|FG002|Overall Study|Physician Decision|1|||
33289777|NCT02250534|100958917|FG000|Overall Study|Protocol Violation|1|||
33289778|NCT02250534|100958918|FG001|Overall Study|Protocol Violation|0|||
33289779|NCT02250534|100958919|FG002|Overall Study|Protocol Violation|1|||
33289780|NCT02250534|100958917|FG000|Overall Study|Reason unknown|1|||
33289781|NCT02250534|100958918|FG001|Overall Study|Reason unknown|0|||
33289782|NCT02250534|100958919|FG002|Overall Study|Reason unknown|0|||
33289783|NCT01606319|100958920|FG000|Overall Study|Lost to Follow-up|17|||
33289784|NCT01606319|100958921|FG001|Overall Study|Lost to Follow-up|14|||
33289785|NCT01606319|100958920|FG000|Overall Study|Withdrawal by Subject|9|||
33289786|NCT01606319|100958921|FG001|Overall Study|Withdrawal by Subject|12|||
33289787|NCT01606319|100958920|FG000|Overall Study|Physician Decision|1|||
33289788|NCT01606319|100958921|FG001|Overall Study|Physician Decision|2|||
33289789|NCT01606319|100958920|FG000|Overall Study|Lack of Efficacy|6|||
33289790|NCT01606319|100958921|FG001|Overall Study|Lack of Efficacy|8|||
33289791|NCT01606319|100958920|FG000|Overall Study|Adverse Event|1|||
33289792|NCT01606319|100958921|FG001|Overall Study|Adverse Event|4|||
33289793|NCT04245345|100958922|FG000|Overall Study|Death|1|||
33289794|NCT04245345|100958922|FG000|Overall Study|Exited prior to implant|5|||
33289795|NCT04245345|100958922|FG000|Overall Study|Exited prior to 1-month|9|||
33188149|NCT01465464|100597983|FG001|Overall Study|Withdrawal by Subject|30|||
33289796|NCT04245345|100958922|FG000|Overall Study|Missed 1-month visit|3|||
33289797|NCT04245345|100958922|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
33289798|NCT04245345|100958922|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
33289799|NCT02447718|100958925|FG000|Overall Study|Lost to Follow-up|8|||
33289800|NCT02447718|100958926|FG001|Overall Study|Lost to Follow-up|0|||
33289801|NCT02447718|100958925|FG000|Overall Study|Withdrawal by Subject|3|||
33289802|NCT02447718|100958926|FG001|Overall Study|Withdrawal by Subject|0|||
33289803|NCT02447718|100958925|FG000|Overall Study|Screen Failure|1|||
33289804|NCT02447718|100958926|FG001|Overall Study|Screen Failure|0|||
33289805|NCT02460562|100958927|FG000|Overall Study|Lost to Follow-up|15|||
33289806|NCT02460562|100958928|FG001|Overall Study|Lost to Follow-up|16|||
33289807|NCT00810342|100958929|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
33289808|NCT00810342|100958930|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
33289809|NCT00810342|100958929|FG000|Month 1 Follow-up|Pregnancy|1|||
33289810|NCT00810342|100958930|FG001|Month 1 Follow-up|Pregnancy|0|||
33289811|NCT00810342|100958929|FG000|6-month Follow-up|Lost to Follow-up|18|||
33289812|NCT00810342|100958930|FG001|6-month Follow-up|Lost to Follow-up|6|||
33289813|NCT00810342|100958929|FG000|6-month Follow-up|Pregnancy|6|||
33289814|NCT00810342|100958930|FG001|6-month Follow-up|Pregnancy|2|||
33289815|NCT00810342|100958929|FG000|12-month Followup|Pregnancy|9|||
33289816|NCT00810342|100958930|FG001|12-month Followup|Pregnancy|10|||
33289817|NCT00810342|100958929|FG000|12-month Followup|Lost to Follow-up|3|||
33289818|NCT00810342|100958930|FG001|12-month Followup|Lost to Follow-up|1|||
33599036|NCT00989235|102081812|FG001|Overall Study|Desire to Become Pregnant|0|||
33599037|NCT00989235|102081811|FG000|Overall Study|Randomized by Mistake|0|||
33599038|NCT00989235|102081812|FG001|Overall Study|Randomized by Mistake|2|||
33599039|NCT00989235|102081811|FG000|Overall Study|Lost to Follow-up|0|||
33599040|NCT00989235|102081812|FG001|Overall Study|Lost to Follow-up|1|||
33289819|NCT00813098|100958936|FG000|Overall Study|Adverse Event|2|||
33289820|NCT00813098|100958937|FG001|Overall Study|Adverse Event|4|||
33289821|NCT00813098|100958938|FG002|Overall Study|Adverse Event|1|||
33289822|NCT00813098|100958936|FG000|Overall Study|Withdrawal by Subject|0|||
33289823|NCT00813098|100958937|FG001|Overall Study|Withdrawal by Subject|1|||
33289824|NCT00813098|100958938|FG002|Overall Study|Withdrawal by Subject|0|||
33289825|NCT00813098|100958936|FG000|Overall Study|Inability to complete study procedures|1|||
33289826|NCT00813098|100958937|FG001|Overall Study|Inability to complete study procedures|0|||
33289827|NCT00813098|100958938|FG002|Overall Study|Inability to complete study procedures|0|||
33289828|NCT00813098|100958936|FG000|Overall Study|Lost to Follow-up|0|||
33289829|NCT00813098|100958937|FG001|Overall Study|Lost to Follow-up|1|||
33289830|NCT00813098|100958938|FG002|Overall Study|Lost to Follow-up|0|||
33289831|NCT00813098|100958936|FG000|Overall Study|Protocol Violation|0|||
33289832|NCT00813098|100958937|FG001|Overall Study|Protocol Violation|0|||
33289833|NCT00813098|100958938|FG002|Overall Study|Protocol Violation|1|||
33289834|NCT00813098|100958936|FG000|Overall Study|Principal Investigator decision|0|||
33289835|NCT00813098|100958937|FG001|Overall Study|Principal Investigator decision|1|||
33289836|NCT00813098|100958938|FG002|Overall Study|Principal Investigator decision|0|||
33289837|NCT00813098|100958936|FG000|Overall Study|Withdrew Consent|0|||
33289838|NCT00813098|100958937|FG001|Overall Study|Withdrew Consent|1|||
33289839|NCT00813098|100958938|FG002|Overall Study|Withdrew Consent|0|||
33289840|NCT01519778|100958939|FG000|Overall Study|Withdrawal by Subject|3|||
33289841|NCT01519778|100958939|FG000|Overall Study|Lost to Follow-up|10|||
33289842|NCT01519778|100958939|FG000|Overall Study|Physician Decision|1|||
33289843|NCT02166476|100958942|FG000|Overall Study|Withdrawal by Subject|5|||
33289844|NCT02166476|100958943|FG001|Overall Study|Withdrawal by Subject|7|||
33289845|NCT02166476|100958942|FG000|Overall Study|Adverse Event|3|||
33289846|NCT02166476|100958943|FG001|Overall Study|Adverse Event|3|||
33289847|NCT02166476|100958942|FG000|Overall Study|Lost to Follow-up|5|||
33289848|NCT02166476|100958943|FG001|Overall Study|Lost to Follow-up|10|||
33289849|NCT02166476|100958942|FG000|Overall Study|Physician Decision|1|||
33289850|NCT02166476|100958943|FG001|Overall Study|Physician Decision|0|||
33289851|NCT02166476|100958942|FG000|Overall Study|Unable to Come for Visit|0|||
33289852|NCT02166476|100958943|FG001|Overall Study|Unable to Come for Visit|3|||
33289853|NCT03834623|100958944|FG000|Overall Study|Progression|0|||
33289854|NCT03834623|100958945|FG001|Overall Study|Progression|1|||
33289855|NCT00420784|100958947|FG000|Overall Study|Adverse Event|11|||
33289856|NCT00420784|100958948|FG001|Overall Study|Adverse Event|29|||
33289857|NCT00420784|100958949|FG002|Overall Study|Adverse Event|10|||
33289858|NCT00420784|100958950|FG003|Overall Study|Adverse Event|5|||
33289859|NCT00420784|100958947|FG000|Overall Study|Withdrawal by Subject|0|||
33599041|NCT01822535|102081816|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
33599042|NCT01822535|102081817|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
33289860|NCT00420784|100958948|FG001|Overall Study|Withdrawal by Subject|1|||
33289861|NCT00420784|100958949|FG002|Overall Study|Withdrawal by Subject|0|||
33289862|NCT00420784|100958950|FG003|Overall Study|Withdrawal by Subject|0|||
33289863|NCT00420784|100958947|FG000|Overall Study|Lost to Follow-up|0|||
33289864|NCT00420784|100958948|FG001|Overall Study|Lost to Follow-up|0|||
33289865|NCT00420784|100958949|FG002|Overall Study|Lost to Follow-up|2|||
33289866|NCT00420784|100958950|FG003|Overall Study|Lost to Follow-up|1|||
33289867|NCT00420784|100958947|FG000|Overall Study|Virologic Stopping Rule|17|||
33289868|NCT00420784|100958948|FG001|Overall Study|Virologic Stopping Rule|26|||
33289869|NCT00420784|100958949|FG002|Overall Study|Virologic Stopping Rule|41|||
33289870|NCT00420784|100958950|FG003|Overall Study|Virologic Stopping Rule|67|||
33289871|NCT00420784|100958947|FG000|Overall Study|Other|1|||
33289872|NCT00420784|100958948|FG001|Overall Study|Other|2|||
33289873|NCT00420784|100958949|FG002|Overall Study|Other|0|||
33289874|NCT00420784|100958950|FG003|Overall Study|Other|5|||
33289875|NCT01755546|100958951|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
33289876|NCT01755546|100958951|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
33289877|NCT01755546|100958951|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
33289878|NCT01755546|100958951|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
33289879|NCT01755546|100958951|FG000|Titration Phase|Adverse Event|11|||
33289880|NCT01755546|100958951|FG000|Titration Phase|Lack of Efficacy|18|||
33289881|NCT01755546|100958951|FG000|Titration Phase|Protocol Violation|9|||
33289882|NCT01755546|100958951|FG000|Titration Phase|Lost to Follow-up|2|||
33289883|NCT01755546|100958951|FG000|Titration Phase|Other and Continuing|22|||
33289884|NCT01755546|100958951|FG000|Titration Phase|Withdrawal by Subject|8|||
33289885|NCT01755546|100958951|FG000|Long Term Treatment|Adverse Event|12|||
33289886|NCT01755546|100958951|FG000|Long Term Treatment|Lack of Efficacy|6|||
33289887|NCT01755546|100958951|FG000|Long Term Treatment|Protocol Violation|10|||
33289888|NCT01755546|100958951|FG000|Long Term Treatment|Withdrawal by Subject|35|||
33289889|NCT01755546|100958951|FG000|Long Term Treatment|Lost to Follow-up|17|||
33289890|NCT01755546|100958951|FG000|Long Term Treatment|other and ongoing|41|||
33289891|NCT01310699|100958954|FG000|Overall Study|Patients did not complete tandem.|4|||
33289892|NCT01310699|100958955|FG001|Overall Study|Patients did not complete tandem.|6|||
33289893|NCT01266161|100958956|FG000|Overall Study|Ineligible|1|||
33289894|NCT01266161|100958957|FG001|Overall Study|Ineligible|0|||
33289895|NCT01266161|100958956|FG000|Overall Study|Lack of Efficacy|0|||
33289896|NCT01266161|100958957|FG001|Overall Study|Lack of Efficacy|1|||
33289897|NCT01266161|100958956|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
33289898|NCT01266161|100958957|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
33289899|NCT00952848|100958958|FG000|Overall Study|Withdrawal by Subject|4|||
33289900|NCT04398368|100958959|FG000|Overall Study|Withdrawal by Subject|2|||
33289901|NCT02881047|100958960|FG000|Overall Study|Adverse Event|1|||
33289902|NCT02881047|100958960|FG000|Overall Study|Withdrawal by Subject|1|||
33289903|NCT00025506|100958963|FG000|Overall Study|Ineligible: clerical error|1|||
33289904|NCT00025506|100958963|FG000|Overall Study|Ineligible: wrong cell type|5|||
33289905|NCT00025506|100958963|FG000|Overall Study|Ineligible: inadequate pathology|2|||
33289906|NCT00025506|100958963|FG000|Overall Study|Never Treated|2|||
33289907|NCT00884650|100958964|FG000|Overall Study|Did not return complete pain diaries|7|||
33289908|NCT00884650|100958965|FG001|Overall Study|Did not return complete pain diaries|7|||
33289909|NCT00884650|100958964|FG000|Overall Study|Admitted Post-Op|1|||
33289910|NCT00884650|100958965|FG001|Overall Study|Admitted Post-Op|0|||
33289911|NCT00884650|100958964|FG000|Overall Study|Femoral Stress Fracture|1|||
33289912|NCT00884650|100958965|FG001|Overall Study|Femoral Stress Fracture|0|||
33289913|NCT00884650|100958964|FG000|Overall Study|Pain Pump Complication|0|||
33289914|NCT00884650|100958965|FG001|Overall Study|Pain Pump Complication|1|||
33289915|NCT00585078|100958966|FG000|Overall Study|Withdrawal by Subject|4|||
33289916|NCT00585078|100958966|FG000|Overall Study|Poor performance status|1|||
33289917|NCT00585078|100958966|FG000|Overall Study|Disease Progression|24|||
33289918|NCT00585078|100958966|FG000|Overall Study|Adverse Event|10|||
33289919|NCT00585078|100958966|FG000|Overall Study|Death|1|||
33289920|NCT01806389|100958969|FG000|Overall Study|Withdrawal by Subject|4|||
33289921|NCT00394589|100958970|FG000|Overall Study|Adverse Event|2|||
33289922|NCT00394589|100958971|FG001|Overall Study|Adverse Event|1|||
33289923|NCT00394589|100958972|FG002|Overall Study|Adverse Event|2|||
33289924|NCT00394589|100958970|FG000|Overall Study|Lack of Efficacy|2|||
33289925|NCT00394589|100958971|FG001|Overall Study|Lack of Efficacy|2|||
33289926|NCT00394589|100958972|FG002|Overall Study|Lack of Efficacy|3|||
33289927|NCT00394589|100958970|FG000|Overall Study|Protocol Violation|4|||
33289928|NCT00394589|100958971|FG001|Overall Study|Protocol Violation|0|||
33289929|NCT00394589|100958972|FG002|Overall Study|Protocol Violation|2|||
33289930|NCT00745498|100958975|FG000|Overall Study|Lost to Follow-up|1|||
33289931|NCT00745498|100958976|FG001|Overall Study|Lost to Follow-up|1|||
33289932|NCT00745498|100958977|FG002|Overall Study|Lost to Follow-up|3|||
33289933|NCT00745498|100958975|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
33289934|NCT00745498|100958976|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
33289935|NCT00745498|100958977|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
33289936|NCT00745498|100958975|FG000|Overall Study|Non-PDR related VH|0|||
33289937|NCT00745498|100958976|FG001|Overall Study|Non-PDR related VH|1|||
33289938|NCT00745498|100958977|FG002|Overall Study|Non-PDR related VH|1|||
33289939|NCT00745498|100958975|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
33289940|NCT00745498|100958976|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
33289941|NCT00745498|100958977|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
33289942|NCT03065933|100958978|FG000|Overall Study|study terminated|5|||
33289943|NCT02762903|100958979|FG000|Overall Study|Lost to Follow-up|0|||
33289944|NCT02762903|100958980|FG001|Overall Study|Lost to Follow-up|1|||
33289945|NCT00975676|100958985|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
33289946|NCT00975676|100958986|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
33289947|NCT03016598|100958987|FG000|Overall Study|Lost to Follow-up|0|||
33289948|NCT03016598|100958988|FG001|Overall Study|Lost to Follow-up|2|||
33289949|NCT01233999|100958989|FG000|Overall Study|Withdrawal by Subject|1|||
33289950|NCT01233999|100958989|FG000|Overall Study|Lost to Follow-up|1|||
33289951|NCT02296892|100958992|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
33289952|NCT02296892|100958993|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
33289953|NCT02296892|100958994|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
33289954|NCT02296892|100958992|FG000|Overall Study|Lost to Follow-up|5|||
33289955|NCT02296892|100958993|FG001|Overall Study|Lost to Follow-up|0|||
33289956|NCT02296892|100958994|FG002|Overall Study|Lost to Follow-up|1|||
33289957|NCT01813305|100959003|FG000|Overall Study|Withdrawal by Subject|12|||
33289958|NCT01813305|100959004|FG001|Overall Study|Withdrawal by Subject|5|||
33289959|NCT01813305|100959003|FG000|Overall Study|Safety Concern|4|||
33289960|NCT01813305|100959004|FG001|Overall Study|Safety Concern|0|||
33289961|NCT01813305|100959003|FG000|Overall Study|Ulcer became worse|4|||
33289962|NCT01813305|100959004|FG001|Overall Study|Ulcer became worse|0|||
33188150|NCT01465464|100597982|FG000|Overall Study|Other|9|||
33188151|NCT01465464|100597983|FG001|Overall Study|Other|3|||
33188152|NCT01465464|100597982|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
33188153|NCT01465464|100597983|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
33188154|NCT02643251|100597984|FG000|Overall Study|Adverse Event|3|||
33188155|NCT02643251|100597985|FG001|Overall Study|Adverse Event|1|||
33188156|NCT02643251|100597984|FG000|Overall Study|Withdrawal by Subject|2|||
33188157|NCT02643251|100597985|FG001|Overall Study|Withdrawal by Subject|0|||
33188158|NCT02643251|100597984|FG000|Overall Study|Lost to Follow-up|4|||
33188159|NCT02643251|100597985|FG001|Overall Study|Lost to Follow-up|1|||
33188160|NCT02643251|100597984|FG000|Overall Study|Protocol Violation|1|||
33188161|NCT02643251|100597985|FG001|Overall Study|Protocol Violation|0|||
33188162|NCT02643251|100597984|FG000|Overall Study|PI Decision to terminate patient|1|||
33188163|NCT02643251|100597985|FG001|Overall Study|PI Decision to terminate patient|0|||
33188164|NCT00086580|100597986|FG000|Treatment Period|Disease progression|9|||
33188165|NCT00086580|100597987|FG001|Treatment Period|Disease progression|8|||
33188166|NCT00086580|100597986|FG000|Treatment Period|Unable to comply with protocol|3|||
33188167|NCT00086580|100597987|FG001|Treatment Period|Unable to comply with protocol|1|||
33188168|NCT00086580|100597986|FG000|Treatment Period|Withdrawal by Subject|7|||
33188169|NCT00086580|100597987|FG001|Treatment Period|Withdrawal by Subject|8|||
33188170|NCT00086580|100597986|FG000|Treatment Period|Physician Decision|13|||
33188171|NCT00086580|100597987|FG001|Treatment Period|Physician Decision|7|||
33188172|NCT00086580|100597986|FG000|Treatment Period|AE - not treatment related|7|||
33188173|NCT00086580|100597987|FG001|Treatment Period|AE - not treatment related|7|||
33188174|NCT00086580|100597986|FG000|Treatment Period|Toxicity - treatment related|15|||
33188175|NCT00086580|100597987|FG001|Treatment Period|Toxicity - treatment related|15|||
33188176|NCT00086580|100597986|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
33188177|NCT00086580|100597987|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
33188178|NCT00086580|100597986|FG000|Treatment Period|Death|5|||
33188179|NCT00086580|100597987|FG001|Treatment Period|Death|7|||
33188180|NCT00086580|100597986|FG000|Treatment Period|Other|5|||
33188181|NCT00086580|100597987|FG001|Treatment Period|Other|3|||
33188182|NCT00086580|100597986|FG000|Follow-up Period|Disease progression|72|||
33188183|NCT00086580|100597987|FG001|Follow-up Period|Disease progression|99|||
33188184|NCT00086580|100597986|FG000|Follow-up Period|Unable to comply with protocol|5|||
33188185|NCT00086580|100597987|FG001|Follow-up Period|Unable to comply with protocol|0|||
33188186|NCT00086580|100597986|FG000|Follow-up Period|Withdrawal by Subject|6|||
33188187|NCT00086580|100597987|FG001|Follow-up Period|Withdrawal by Subject|6|||
33188188|NCT00086580|100597986|FG000|Follow-up Period|Physician Decision|0|||
33188189|NCT00086580|100597987|FG001|Follow-up Period|Physician Decision|1|||
33188190|NCT00086580|100597986|FG000|Follow-up Period|AE - not related|1|||
33188191|NCT00086580|100597987|FG001|Follow-up Period|AE - not related|0|||
33188192|NCT00086580|100597986|FG000|Follow-up Period|Death|13|||
33188193|NCT00086580|100597987|FG001|Follow-up Period|Death|7|||
33289963|NCT01813305|100959003|FG000|Overall Study|Physician Decision|4|||
33289964|NCT01813305|100959004|FG001|Overall Study|Physician Decision|0|||
33289965|NCT01813305|100959003|FG000|Overall Study|Lost to Follow-up|3|||
33289966|NCT01813305|100959004|FG001|Overall Study|Lost to Follow-up|1|||
33289967|NCT01813305|100959003|FG000|Overall Study|Protocol Violation|1|||
33289968|NCT01813305|100959004|FG001|Overall Study|Protocol Violation|0|||
33289969|NCT01813305|100959003|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
33289970|NCT01813305|100959004|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
33188194|NCT00086580|100597986|FG000|Follow-up Period|Other|7|||
33289971|NCT00927901|100959005|FG000|Treatment Period 1|Subject withdrew consent|0|||
33289972|NCT00927901|100959006|FG001|Treatment Period 1|Subject withdrew consent|0|||
33188195|NCT00086580|100597987|FG001|Follow-up Period|Other|6|||
33188196|NCT00086580|100597986|FG000|Observation Period|Unable to comply with protocol|1|||
33188197|NCT00086580|100597987|FG001|Observation Period|Unable to comply with protocol|1|||
33188198|NCT00086580|100597986|FG000|Observation Period|Withdrawal by Subject|4|||
33188199|NCT00086580|100597987|FG001|Observation Period|Withdrawal by Subject|2|||
33188200|NCT00086580|100597986|FG000|Observation Period|Death|33|||
33188201|NCT00086580|100597987|FG001|Observation Period|Death|55|||
33188202|NCT00086580|100597986|FG000|Observation Period|Other|8|||
33188203|NCT00086580|100597987|FG001|Observation Period|Other|7|||
33188204|NCT05091528|100597988|FG000|Overall Study|Study Termination by Sponsor|0|||
33188205|NCT05091528|100597989|FG001|Overall Study|Study Termination by Sponsor|1|||
33188206|NCT05091528|100597990|FG002|Overall Study|Study Termination by Sponsor|0|||
33289973|NCT00927901|100959007|FG002|Treatment Period 1|Subject withdrew consent|1|||
33289974|NCT00927901|100959008|FG003|Treatment Period 1|Subject withdrew consent|0|||
33289975|NCT00927901|100959005|FG000|Treatment Period 4|Adverse Event|0|||
33289976|NCT00927901|100959006|FG001|Treatment Period 4|Adverse Event|0|||
33289977|NCT00927901|100959007|FG002|Treatment Period 4|Adverse Event|0|||
33289978|NCT00927901|100959008|FG003|Treatment Period 4|Adverse Event|1|||
33289979|NCT00927901|100959005|FG000|Treatment Period 4|Subject withdrew consent|0|||
33289980|NCT00927901|100959006|FG001|Treatment Period 4|Subject withdrew consent|0|||
33289981|NCT00927901|100959007|FG002|Treatment Period 4|Subject withdrew consent|1|||
33289982|NCT00927901|100959008|FG003|Treatment Period 4|Subject withdrew consent|0|||
33289983|NCT01585298|100959014|FG000|Overall Study|Study completion was not documented.|1|||
33289984|NCT01585298|100959014|FG000|Overall Study|Protocol deviation|1|||
33289985|NCT01585298|100959014|FG000|Overall Study|Administrative problems|4|||
33289986|NCT01585298|100959014|FG000|Overall Study|Lost to Follow-up|2|||
33289987|NCT01585298|100959014|FG000|Overall Study|Withdrawal by Subject|4|||
33289988|NCT01585298|100959014|FG000|Overall Study|Abnormal test procedure results|1|||
33289989|NCT01585298|100959014|FG000|Overall Study|Adverse Event|24|||
33289990|NCT02466243|100959015|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
33289991|NCT02466243|100959016|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
33289992|NCT02466243|100959015|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
33289993|NCT02466243|100959016|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
33289994|NCT02466243|100959015|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
33289995|NCT02466243|100959016|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
33289996|NCT02466243|100959015|FG000|Part B Open-label Treatment Period|Missing|2|||
33289997|NCT02466243|100959016|FG001|Part B Open-label Treatment Period|Missing|2|||
33289998|NCT01151423|100959017|FG000|Overall Study|Study terminated by Sponsor|9|||
33289999|NCT01151423|100959018|FG001|Overall Study|Study terminated by Sponsor|10|||
33290000|NCT01151423|100959017|FG000|Overall Study|Protocol Violation|0|||
33290001|NCT01151423|100959018|FG001|Overall Study|Protocol Violation|1|||
33290002|NCT01151423|100959017|FG000|Overall Study|Physician Decision|1|||
33290003|NCT01151423|100959018|FG001|Overall Study|Physician Decision|1|||
33290004|NCT01151423|100959017|FG000|Overall Study|Pregnancy|0|||
33290005|NCT01151423|100959018|FG001|Overall Study|Pregnancy|1|||
33290006|NCT01151423|100959017|FG000|Overall Study|Death|0|||
33290007|NCT01151423|100959018|FG001|Overall Study|Death|1|||
33290008|NCT01151423|100959017|FG000|Overall Study|Adverse Event|3|||
33290009|NCT01151423|100959018|FG001|Overall Study|Adverse Event|0|||
33290010|NCT01151423|100959017|FG000|Overall Study|Withdrawal by Subject|1|||
33290011|NCT01151423|100959018|FG001|Overall Study|Withdrawal by Subject|3|||
33290012|NCT01151423|100959017|FG000|Overall Study|Lost to Follow-up|1|||
33290013|NCT01151423|100959018|FG001|Overall Study|Lost to Follow-up|0|||
33290014|NCT01151423|100959017|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
33290015|NCT01151423|100959018|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
33290016|NCT01151423|100959017|FG000|Overall Study|Participated in other clinical trial|1|||
33290017|NCT01151423|100959018|FG001|Overall Study|Participated in other clinical trial|0|||
33290018|NCT01466790|100959019|FG000|Overall Study|Adverse Event|1|||
33290019|NCT01466790|100959020|FG001|Overall Study|Adverse Event|0|||
33290020|NCT01466790|100959021|FG002|Overall Study|Adverse Event|0|||
33290021|NCT01466790|100959022|FG003|Overall Study|Adverse Event|0|||
33290022|NCT01466790|100959023|FG004|Overall Study|Adverse Event|2|||
33290023|NCT01466790|100959024|FG005|Overall Study|Adverse Event|0|||
33290024|NCT01466790|100959025|FG006|Overall Study|Adverse Event|0|||
33290025|NCT01466790|100959026|FG007|Overall Study|Adverse Event|0|||
33290026|NCT01466790|100959019|FG000|Overall Study|Lost to Follow-up|2|||
33391725|NCT02959190|101321852|FG000|Post Treatment Follow Up|Adverse Event|1|||
33290027|NCT01466790|100959020|FG001|Overall Study|Lost to Follow-up|0|||
33188207|NCT05091528|100597991|FG003|Overall Study|Study Termination by Sponsor|1|||
33290028|NCT01466790|100959021|FG002|Overall Study|Lost to Follow-up|0|||
33290029|NCT01466790|100959022|FG003|Overall Study|Lost to Follow-up|0|||
33290030|NCT01466790|100959023|FG004|Overall Study|Lost to Follow-up|0|||
33290031|NCT01466790|100959024|FG005|Overall Study|Lost to Follow-up|0|||
33290032|NCT01466790|100959025|FG006|Overall Study|Lost to Follow-up|0|||
33290033|NCT01466790|100959026|FG007|Overall Study|Lost to Follow-up|0|||
33290034|NCT01466790|100959019|FG000|Overall Study|Withdrawal by Subject|1|||
33290035|NCT01466790|100959020|FG001|Overall Study|Withdrawal by Subject|1|||
33290036|NCT01466790|100959021|FG002|Overall Study|Withdrawal by Subject|0|||
33290037|NCT01466790|100959022|FG003|Overall Study|Withdrawal by Subject|0|||
33290038|NCT01466790|100959023|FG004|Overall Study|Withdrawal by Subject|1|||
33290039|NCT01466790|100959024|FG005|Overall Study|Withdrawal by Subject|0|||
33290040|NCT01466790|100959025|FG006|Overall Study|Withdrawal by Subject|1|||
33290041|NCT01466790|100959026|FG007|Overall Study|Withdrawal by Subject|1|||
33290042|NCT02520310|100959029|FG000|At 6 Months Clinical Follow-up|Death|1|||
33290043|NCT02520310|100959029|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
33290044|NCT02520310|100959029|FG000|AT 3 Year Clinical Follow-up|Death|2|||
33290045|NCT02520310|100959029|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
33290046|NCT02520310|100959029|FG000|AT 4 Year Clinical Follow-up|Death|1|||
33290047|NCT02520310|100959029|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
33290048|NCT02132117|100959030|FG000|Overall Study|Adverse Event|6|||
33290049|NCT02132117|100959031|FG001|Overall Study|Adverse Event|1|||
33290050|NCT02132117|100959030|FG000|Overall Study|Lost to Follow-up|2|||
33290051|NCT02132117|100959031|FG001|Overall Study|Lost to Follow-up|2|||
33290052|NCT02132117|100959030|FG000|Overall Study|Personal Reasons|1|||
33290053|NCT02132117|100959031|FG001|Overall Study|Personal Reasons|2|||
33290054|NCT02132117|100959030|FG000|Overall Study|Other Miscellaneous Reasons|2|||
33290055|NCT02132117|100959031|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33290056|NCT03596242|100959032|FG000|Overall Study|Lost to Follow-up|2|||
33290057|NCT03596242|100959033|FG001|Overall Study|Lost to Follow-up|2|||
33290058|NCT00307164|100959034|FG000|Overall Study|Death|1|||
33290059|NCT00307164|100959035|FG001|Overall Study|Death|0|||
33290060|NCT00307164|100959034|FG000|Overall Study|Severe debilitation, unable to continue|1|||
33290061|NCT00307164|100959035|FG001|Overall Study|Severe debilitation, unable to continue|0|||
33290062|NCT00307164|100959034|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
33290063|NCT00307164|100959035|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
33290064|NCT00307164|100959034|FG000|Overall Study|Withdrawal by Subject|1|||
33290065|NCT00307164|100959035|FG001|Overall Study|Withdrawal by Subject|8|||
33290066|NCT00307164|100959034|FG000|Overall Study|Not compliant with requirements|4|||
33290067|NCT00307164|100959035|FG001|Overall Study|Not compliant with requirements|4|||
33290068|NCT00307164|100959034|FG000|Overall Study|Lost to Follow-up|6|||
33290069|NCT00307164|100959035|FG001|Overall Study|Lost to Follow-up|1|||
33290070|NCT03443414|100959036|FG000|Overall Study|Adverse Event|6|||
33290071|NCT03443414|100959037|FG001|Overall Study|Adverse Event|0|||
33290072|NCT03443414|100959038|FG002|Overall Study|Adverse Event|4|||
33290073|NCT03443414|100959039|FG003|Overall Study|Adverse Event|2|||
33290074|NCT03443414|100959040|FG004|Overall Study|Adverse Event|3|||
33290075|NCT03443414|100959036|FG000|Overall Study|Withdrawal by Subject|3|||
33290076|NCT03443414|100959037|FG001|Overall Study|Withdrawal by Subject|2|||
33290077|NCT03443414|100959038|FG002|Overall Study|Withdrawal by Subject|2|||
33290078|NCT03443414|100959039|FG003|Overall Study|Withdrawal by Subject|2|||
33290079|NCT03443414|100959040|FG004|Overall Study|Withdrawal by Subject|1|||
33290080|NCT03443414|100959036|FG000|Overall Study|Death|0|||
33290081|NCT03443414|100959037|FG001|Overall Study|Death|1|||
33290082|NCT03443414|100959038|FG002|Overall Study|Death|0|||
33290083|NCT03443414|100959039|FG003|Overall Study|Death|1|||
33290084|NCT03443414|100959040|FG004|Overall Study|Death|0|||
33290085|NCT03443414|100959036|FG000|Overall Study|Reason not specified|2|||
33290086|NCT03443414|100959037|FG001|Overall Study|Reason not specified|0|||
33290087|NCT03443414|100959038|FG002|Overall Study|Reason not specified|0|||
33290088|NCT03443414|100959039|FG003|Overall Study|Reason not specified|0|||
33391726|NCT02959190|101321853|FG001|Post Treatment Follow Up|Adverse Event|1|||
33391727|NCT02959190|101321854|FG002|Post Treatment Follow Up|Adverse Event|0|||
33599043|NCT01822535|102081816|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
33290089|NCT03443414|100959040|FG004|Overall Study|Reason not specified|1|||
33290090|NCT01777490|100959041|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
33290091|NCT01777490|100959042|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
33290092|NCT01777490|100959043|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
33290093|NCT01777490|100959044|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
33290094|NCT00412880|100959045|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
33290095|NCT00412880|100959045|FG000|Overall Study|Consent withdrawn|1|||
33290096|NCT00412880|100959045|FG000|Overall Study|Adverse Event|1|||
33290097|NCT00412880|100959045|FG000|Overall Study|Progressive disease|20|||
33290098|NCT01242371|100959046|FG000|Overall Study|Withdrawal by Subject|2|||
33290099|NCT01242371|100959047|FG001|Overall Study|Withdrawal by Subject|2|||
33290100|NCT01242371|100959046|FG000|Overall Study|Protocol Violation|0|||
33290101|NCT01242371|100959047|FG001|Overall Study|Protocol Violation|3|||
33290102|NCT03634839|100959050|FG000|First Intervention (2 Hours)|Adverse Event|0|||
33290103|NCT03634839|100959051|FG001|First Intervention (2 Hours)|Adverse Event|2|||
33290104|NCT00621192|100959052|FG000|Overall Study|Withdrawal by Subject|0|||
33290105|NCT00621192|100959053|FG001|Overall Study|Withdrawal by Subject|0|||
33290106|NCT00621192|100959054|FG002|Overall Study|Withdrawal by Subject|2|||
33290107|NCT00621192|100959055|FG003|Overall Study|Withdrawal by Subject|0|||
33290108|NCT00621192|100959052|FG000|Overall Study|Physician Decision|1|||
33290109|NCT00621192|100959053|FG001|Overall Study|Physician Decision|3|||
33290110|NCT00621192|100959054|FG002|Overall Study|Physician Decision|0|||
33290111|NCT00621192|100959055|FG003|Overall Study|Physician Decision|0|||
33290112|NCT00621192|100959052|FG000|Overall Study|Protocol Violation|1|||
33290113|NCT00621192|100959053|FG001|Overall Study|Protocol Violation|0|||
33290114|NCT00621192|100959054|FG002|Overall Study|Protocol Violation|0|||
33290115|NCT00621192|100959055|FG003|Overall Study|Protocol Violation|1|||
33290116|NCT00621192|100959052|FG000|Overall Study|Adverse Event|0|||
33290117|NCT00621192|100959053|FG001|Overall Study|Adverse Event|1|||
33290118|NCT00621192|100959054|FG002|Overall Study|Adverse Event|0|||
33290119|NCT00621192|100959055|FG003|Overall Study|Adverse Event|1|||
33290120|NCT00621192|100959052|FG000|Overall Study|Death|2|||
33290121|NCT00621192|100959053|FG001|Overall Study|Death|5|||
33290122|NCT00621192|100959054|FG002|Overall Study|Death|0|||
33290123|NCT00621192|100959055|FG003|Overall Study|Death|0|||
33290124|NCT00621192|100959052|FG000|Overall Study|Final Assessments not Completed|0|||
33290125|NCT00621192|100959053|FG001|Overall Study|Final Assessments not Completed|0|||
33290126|NCT00621192|100959054|FG002|Overall Study|Final Assessments not Completed|3|||
33290127|NCT00621192|100959055|FG003|Overall Study|Final Assessments not Completed|1|||
33290128|NCT00664105|100959056|FG000|Overall Study|Death|3|||
33290129|NCT00664105|100959056|FG000|Overall Study|Withdrawal by Subject|5|||
33290130|NCT00664105|100959056|FG000|Overall Study|Adverse Event|9|||
33290131|NCT00664105|100959056|FG000|Overall Study|Disease progression|7|||
33290132|NCT00030823|100959063|FG000|Overall Study|Withdrawal by Subject|1|||
33290133|NCT00761956|100959066|FG000|Overall Study|Lost to Follow-up|6|||
33290134|NCT00761956|100959067|FG001|Overall Study|Lost to Follow-up|11|||
33290135|NCT00761956|100959066|FG000|Overall Study|Withdrawal by Subject|3|||
33290136|NCT00761956|100959067|FG001|Overall Study|Withdrawal by Subject|8|||
33290137|NCT00761956|100959066|FG000|Overall Study|Death|0|||
33290138|NCT00761956|100959067|FG001|Overall Study|Death|1|||
33290139|NCT00761956|100959066|FG000|Overall Study|Adverse Event|26|||
33290140|NCT00761956|100959067|FG001|Overall Study|Adverse Event|34|||
33290141|NCT02706951|100959068|FG000|Period 1|Adverse Event|1|||
33290142|NCT02706951|100959069|FG001|Period 1|Adverse Event|5|||
33290143|NCT02706951|100959070|FG002|Period 1|Adverse Event|3|||
33290144|NCT02706951|100959071|FG003|Period 1|Adverse Event|0|||
33290145|NCT02706951|100959072|FG004|Period 1|Adverse Event|0|||
33290146|NCT02706951|100959068|FG000|Period 1|Withdrawal by Subject|10|||
33290147|NCT02706951|100959069|FG001|Period 1|Withdrawal by Subject|6|||
33290148|NCT02706951|100959070|FG002|Period 1|Withdrawal by Subject|6|||
33290149|NCT02706951|100959071|FG003|Period 1|Withdrawal by Subject|0|||
33290150|NCT02706951|100959072|FG004|Period 1|Withdrawal by Subject|0|||
33290151|NCT02706951|100959068|FG000|Period 1|Lost to Follow-up|0|||
33290152|NCT02706951|100959069|FG001|Period 1|Lost to Follow-up|4|||
33290153|NCT02706951|100959070|FG002|Period 1|Lost to Follow-up|1|||
33290154|NCT02706951|100959071|FG003|Period 1|Lost to Follow-up|0|||
33290155|NCT02706951|100959072|FG004|Period 1|Lost to Follow-up|0|||
33290156|NCT02706951|100959068|FG000|Period 1|Other|2|||
33290157|NCT02706951|100959069|FG001|Period 1|Other|1|||
33290158|NCT02706951|100959070|FG002|Period 1|Other|0|||
33290159|NCT02706951|100959071|FG003|Period 1|Other|0|||
33290160|NCT02706951|100959072|FG004|Period 1|Other|0|||
33290161|NCT02706951|100959068|FG000|Period 2|Adverse Event|0|||
33290162|NCT02706951|100959069|FG001|Period 2|Adverse Event|0|||
33290163|NCT02706951|100959070|FG002|Period 2|Adverse Event|0|||
33290164|NCT02706951|100959071|FG003|Period 2|Adverse Event|25|||
33290165|NCT02706951|100959072|FG004|Period 2|Adverse Event|34|||
33290166|NCT02706951|100959068|FG000|Period 2|Withdrawal by Subject|0|||
33290167|NCT02706951|100959069|FG001|Period 2|Withdrawal by Subject|0|||
33290168|NCT02706951|100959070|FG002|Period 2|Withdrawal by Subject|0|||
33290169|NCT02706951|100959071|FG003|Period 2|Withdrawal by Subject|38|||
33290170|NCT02706951|100959072|FG004|Period 2|Withdrawal by Subject|44|||
33290171|NCT02706951|100959068|FG000|Period 2|Lost to Follow-up|0|||
33290172|NCT02706951|100959069|FG001|Period 2|Lost to Follow-up|0|||
33391728|NCT02959190|101321855|FG003|Post Treatment Follow Up|Adverse Event|0|||
33391729|NCT02959190|101321852|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
33391730|NCT02959190|101321853|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
33290173|NCT02706951|100959070|FG002|Period 2|Lost to Follow-up|0|||
33290174|NCT02706951|100959071|FG003|Period 2|Lost to Follow-up|17|||
33290175|NCT02706951|100959072|FG004|Period 2|Lost to Follow-up|9|||
33290176|NCT02706951|100959068|FG000|Period 2|COVID-19 Related|0|||
33290177|NCT02706951|100959069|FG001|Period 2|COVID-19 Related|0|||
33290178|NCT02706951|100959070|FG002|Period 2|COVID-19 Related|0|||
33290179|NCT02706951|100959071|FG003|Period 2|COVID-19 Related|1|||
33290180|NCT02706951|100959072|FG004|Period 2|COVID-19 Related|2|||
33290181|NCT02706951|100959068|FG000|Period 2|Other|0|||
33290182|NCT02706951|100959069|FG001|Period 2|Other|0|||
33290183|NCT02706951|100959070|FG002|Period 2|Other|0|||
33290184|NCT02706951|100959071|FG003|Period 2|Other|37|||
33290185|NCT02706951|100959072|FG004|Period 2|Other|31|||
33290186|NCT00936598|100959074|FG000|Overall Study|Withdrawal by Subject|1|||
33290187|NCT00936598|100959075|FG001|Overall Study|Withdrawal by Subject|0|||
33290188|NCT00936598|100959074|FG000|Overall Study|Ineligible after consent|1|||
33290189|NCT00936598|100959075|FG001|Overall Study|Ineligible after consent|0|||
33290190|NCT01103232|100959078|FG000|Overall Study|Withdrawal by Subject|1|||
33290191|NCT01103232|100959079|FG001|Overall Study|Withdrawal by Subject|1|||
33290192|NCT01103232|100959078|FG000|Overall Study|Protocol Violation|0|||
33290193|NCT01103232|100959079|FG001|Overall Study|Protocol Violation|1|||
33290194|NCT02161406|100959082|FG000|Overall Study|Death|2|||
33290195|NCT02161406|100959083|FG001|Overall Study|Death|1|||
33290196|NCT02161406|100959082|FG000|Overall Study|Lost to Follow-up|2|||
33290197|NCT02161406|100959083|FG001|Overall Study|Lost to Follow-up|1|||
33290198|NCT02161406|100959082|FG000|Overall Study|Withdrawal by Subject|2|||
33290199|NCT02161406|100959083|FG001|Overall Study|Withdrawal by Subject|4|||
33290200|NCT02161406|100959082|FG000|Overall Study|investigator withdrew subject|3|||
33290201|NCT02161406|100959083|FG001|Overall Study|investigator withdrew subject|1|||
33290202|NCT02161406|100959082|FG000|Overall Study|Lack of Efficacy|1|||
33290203|NCT02161406|100959083|FG001|Overall Study|Lack of Efficacy|1|||
33290204|NCT02161406|100959082|FG000|Overall Study|relocation|0|||
33290205|NCT02161406|100959083|FG001|Overall Study|relocation|1|||
33290206|NCT00684203|100959084|FG000|Overall Study|Adverse Event|6|||
33290207|NCT00684203|100959085|FG001|Overall Study|Adverse Event|4|||
33290208|NCT00684203|100959086|FG002|Overall Study|Adverse Event|8|||
33290209|NCT00684203|100959087|FG003|Overall Study|Adverse Event|0|||
33290210|NCT00684203|100959088|FG004|Overall Study|Adverse Event|0|||
33290211|NCT00684203|100959089|FG005|Overall Study|Adverse Event|0|||
33290212|NCT00684203|100959084|FG000|Overall Study|Protocol-defined clinical event|3|||
33290213|NCT00684203|100959085|FG001|Overall Study|Protocol-defined clinical event|1|||
33290214|NCT00684203|100959086|FG002|Overall Study|Protocol-defined clinical event|0|||
33290215|NCT00684203|100959087|FG003|Overall Study|Protocol-defined clinical event|0|||
33290216|NCT00684203|100959088|FG004|Overall Study|Protocol-defined clinical event|0|||
33290217|NCT00684203|100959089|FG005|Overall Study|Protocol-defined clinical event|0|||
33290218|NCT00684203|100959084|FG000|Overall Study|Withdrawal by Subject|0|||
33290219|NCT00684203|100959085|FG001|Overall Study|Withdrawal by Subject|2|||
33290220|NCT00684203|100959086|FG002|Overall Study|Withdrawal by Subject|1|||
33290221|NCT00684203|100959087|FG003|Overall Study|Withdrawal by Subject|0|||
33290222|NCT00684203|100959088|FG004|Overall Study|Withdrawal by Subject|0|||
33290223|NCT00684203|100959089|FG005|Overall Study|Withdrawal by Subject|0|||
33290224|NCT00684203|100959084|FG000|Overall Study|Did not meet protocol eligibility|0|||
33290225|NCT00684203|100959085|FG001|Overall Study|Did not meet protocol eligibility|1|||
33290226|NCT00684203|100959086|FG002|Overall Study|Did not meet protocol eligibility|0|||
33290227|NCT00684203|100959087|FG003|Overall Study|Did not meet protocol eligibility|0|||
33290228|NCT00684203|100959088|FG004|Overall Study|Did not meet protocol eligibility|0|||
33290229|NCT00684203|100959089|FG005|Overall Study|Did not meet protocol eligibility|0|||
33290230|NCT04147195|100959092|FG000|Overall Study|Adverse Event|0|||
33290231|NCT04147195|100959093|FG001|Overall Study|Adverse Event|3|||
33290232|NCT04147195|100959092|FG000|Overall Study|Study Terminated by Sponsor|4|||
33290233|NCT04147195|100959093|FG001|Overall Study|Study Terminated by Sponsor|2|||
33290234|NCT04147195|100959092|FG000|Overall Study|Withdrawal by Subject|0|||
33290235|NCT04147195|100959093|FG001|Overall Study|Withdrawal by Subject|1|||
33290236|NCT04016805|100959094|FG000|Overall Study|Sponsor's Discretion|30|||
33290237|NCT04016805|100959095|FG001|Overall Study|Sponsor's Discretion|6|||
33290238|NCT04016805|100959096|FG002|Overall Study|Sponsor's Discretion|5|||
33290239|NCT03128671|100959101|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
33290240|NCT03128671|100959102|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
33290241|NCT03128671|100959101|FG000|Allocation|Death|1|||
33290242|NCT03128671|100959102|FG001|Allocation|Death|0|||
33290243|NCT03128671|100959101|FG000|Allocation|Withdrawal by Subject|4|||
33290244|NCT03128671|100959102|FG001|Allocation|Withdrawal by Subject|0|||
33290245|NCT03128671|100959101|FG000|Intervention|Withdrawal by Subject|11|||
33290246|NCT03128671|100959102|FG001|Intervention|Withdrawal by Subject|10|||
33290247|NCT03128671|100959101|FG000|Intervention|Palliative/hospice care initiated|9|||
33290248|NCT03128671|100959102|FG001|Intervention|Palliative/hospice care initiated|10|||
33290249|NCT03128671|100959101|FG000|Intervention|Death|13|||
33290250|NCT03128671|100959102|FG001|Intervention|Death|11|||
33290251|NCT03128671|100959101|FG000|Intervention|Interrupted by hurricane|1|||
33290252|NCT03128671|100959102|FG001|Intervention|Interrupted by hurricane|0|||
33290253|NCT03128671|100959101|FG000|Intervention|Physician Decision|2|||
33290254|NCT03128671|100959102|FG001|Intervention|Physician Decision|3|||
33290255|NCT03616964|100959103|FG000|Overall Study|Adverse Event|15|||
33290256|NCT03616964|100959104|FG001|Overall Study|Adverse Event|10|||
33290257|NCT03616964|100959105|FG002|Overall Study|Adverse Event|16|||
33290258|NCT03616964|100959103|FG000|Overall Study|Death|3|||
33290259|NCT03616964|100959104|FG001|Overall Study|Death|0|||
33290260|NCT03616964|100959105|FG002|Overall Study|Death|4|||
33290261|NCT03616964|100959103|FG000|Overall Study|Lack of Efficacy|4|||
33290262|NCT03616964|100959104|FG001|Overall Study|Lack of Efficacy|8|||
33290263|NCT03616964|100959105|FG002|Overall Study|Lack of Efficacy|8|||
33290264|NCT03616964|100959103|FG000|Overall Study|Lost to Follow-up|2|||
33290265|NCT03616964|100959104|FG001|Overall Study|Lost to Follow-up|1|||
33290266|NCT03616964|100959105|FG002|Overall Study|Lost to Follow-up|3|||
33290267|NCT03616964|100959103|FG000|Overall Study|Withdrawal by Subject|18|||
33290268|NCT03616964|100959104|FG001|Overall Study|Withdrawal by Subject|14|||
33290269|NCT03616964|100959105|FG002|Overall Study|Withdrawal by Subject|21|||
33290270|NCT03616964|100959103|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
33290271|NCT03616964|100959104|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
33290272|NCT03616964|100959105|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
33290273|NCT03616964|100959103|FG000|Overall Study|Sponsor's Decision|1|||
33290274|NCT03616964|100959104|FG001|Overall Study|Sponsor's Decision|0|||
33290275|NCT03616964|100959105|FG002|Overall Study|Sponsor's Decision|0|||
33290276|NCT03616964|100959103|FG000|Overall Study|Physician Decision|0|||
33290277|NCT03616964|100959104|FG001|Overall Study|Physician Decision|2|||
33290278|NCT03616964|100959105|FG002|Overall Study|Physician Decision|0|||
33290279|NCT03616964|100959103|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
33290280|NCT03616964|100959104|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
33290281|NCT03616964|100959105|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
33290282|NCT03616964|100959103|FG000|Overall Study|Protocol Violation|0|||
33290283|NCT03616964|100959104|FG001|Overall Study|Protocol Violation|1|||
33290284|NCT03616964|100959105|FG002|Overall Study|Protocol Violation|0|||
33290285|NCT03616964|100959103|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
33290286|NCT03616964|100959104|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
33290287|NCT03616964|100959105|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
33290288|NCT03616964|100959103|FG000|Overall Study|Randomized but Never Treated|1|||
33290289|NCT03616964|100959104|FG001|Overall Study|Randomized but Never Treated|1|||
33290290|NCT03616964|100959105|FG002|Overall Study|Randomized but Never Treated|1|||
33290291|NCT00988533|100959108|FG000|Overall Study|Lost to Follow-up|3|||
33290292|NCT03713320|100959109|FG000|Randomized Period|Adverse Event|1|||
33290293|NCT03713320|100959110|FG001|Randomized Period|Adverse Event|5|||
33290294|NCT03713320|100959111|FG002|Randomized Period|Adverse Event|0|||
33290295|NCT03713320|100959109|FG000|Randomized Period|Physician Decision|1|||
33290296|NCT03713320|100959110|FG001|Randomized Period|Physician Decision|1|||
33290297|NCT03713320|100959111|FG002|Randomized Period|Physician Decision|0|||
33290298|NCT03713320|100959109|FG000|Randomized Period|Withdrawal by Subject|4|||
33290299|NCT03713320|100959110|FG001|Randomized Period|Withdrawal by Subject|0|||
33290300|NCT03713320|100959111|FG002|Randomized Period|Withdrawal by Subject|0|||
33290301|NCT03713320|100959109|FG000|Randomized Period|Participant decision|3|||
33290302|NCT03713320|100959110|FG001|Randomized Period|Participant decision|1|||
33290303|NCT03713320|100959111|FG002|Randomized Period|Participant decision|0|||
33290304|NCT03713320|100959109|FG000|Randomized Period|Study terminated by sponsor|6|||
33290305|NCT03713320|100959110|FG001|Randomized Period|Study terminated by sponsor|3|||
33290306|NCT03713320|100959111|FG002|Randomized Period|Study terminated by sponsor|0|||
33290307|NCT03713320|100959109|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
33290308|NCT03713320|100959110|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
33290309|NCT03713320|100959111|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
33290310|NCT03713320|100959109|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
33290311|NCT03713320|100959110|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
33290312|NCT03713320|100959111|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
33290313|NCT01774305|100959115|FG000|Overall Study|Physician Decision|1|||
33290314|NCT01774305|100959116|FG001|Overall Study|Physician Decision|0|||
33290315|NCT02895360|100959117|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
33290316|NCT02895360|100959118|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
33290317|NCT02895360|100959119|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
33290318|NCT02895360|100959120|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
33290319|NCT02895360|100959121|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
33290320|NCT02895360|100959122|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
33290321|NCT02895360|100959117|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
33290322|NCT02895360|100959118|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
33290323|NCT02895360|100959119|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
33290324|NCT02895360|100959120|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
33290325|NCT02895360|100959121|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
33290326|NCT02895360|100959122|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
33290327|NCT02895360|100959117|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
33290328|NCT02895360|100959118|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
33290329|NCT02895360|100959119|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
33290330|NCT02895360|100959120|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
33290331|NCT02895360|100959121|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
33290332|NCT02895360|100959122|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
33290333|NCT02895360|100959117|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
33290334|NCT02895360|100959118|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
33290335|NCT02895360|100959119|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
33290336|NCT02895360|100959120|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
33290337|NCT02895360|100959121|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
33290338|NCT02895360|100959122|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
33290339|NCT02895360|100959117|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
33290340|NCT02895360|100959118|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
33290341|NCT02895360|100959119|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
33290342|NCT02895360|100959120|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
33290343|NCT02895360|100959121|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
33290344|NCT02895360|100959122|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
33290345|NCT02895360|100959117|FG000|Phase 2a|Adverse Event|0|||
33290346|NCT02895360|100959118|FG001|Phase 2a|Adverse Event|0|||
33290347|NCT02895360|100959119|FG002|Phase 2a|Adverse Event|0|||
33290348|NCT02895360|100959120|FG003|Phase 2a|Adverse Event|0|||
33290349|NCT02895360|100959121|FG004|Phase 2a|Adverse Event|0|||
33290350|NCT02895360|100959122|FG005|Phase 2a|Adverse Event|1|||
33290351|NCT02895360|100959117|FG000|Phase 2a|Progressive disease|0|||
33290352|NCT02895360|100959118|FG001|Phase 2a|Progressive disease|0|||
33290353|NCT02895360|100959119|FG002|Phase 2a|Progressive disease|0|||
33290354|NCT02895360|100959120|FG003|Phase 2a|Progressive disease|0|||
33290355|NCT02895360|100959121|FG004|Phase 2a|Progressive disease|11|||
33290356|NCT02895360|100959122|FG005|Phase 2a|Progressive disease|11|||
33290357|NCT02599688|100959123|FG000|Overall Study|Lack of Efficacy|1|||
33290358|NCT02599688|100959123|FG000|Overall Study|Withdrawal by Subject|1|||
33290359|NCT02599688|100959123|FG000|Overall Study|Termination by Sponsor|2|||
33290360|NCT02781311|100959126|FG000|Overall Study|Adverse Event|2|||
33290361|NCT02781311|100959127|FG001|Overall Study|Adverse Event|6|||
33290362|NCT02781311|100959128|FG002|Overall Study|Adverse Event|1|||
33290363|NCT02781311|100959126|FG000|Overall Study|Withdrawal of Consent|11|||
33290364|NCT02781311|100959127|FG001|Overall Study|Withdrawal of Consent|12|||
33290365|NCT02781311|100959128|FG002|Overall Study|Withdrawal of Consent|2|||
33290366|NCT02781311|100959126|FG000|Overall Study|Lost to Follow-up|11|||
33290367|NCT02781311|100959127|FG001|Overall Study|Lost to Follow-up|8|||
33290368|NCT02781311|100959128|FG002|Overall Study|Lost to Follow-up|1|||
33290369|NCT02781311|100959126|FG000|Overall Study|Non-Compliance with Study Drug|2|||
33290370|NCT02781311|100959127|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33290371|NCT02781311|100959128|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33290372|NCT00632021|100959129|FG000|Overall Study|Withdrawal/death|4|||
33290373|NCT00632021|100959130|FG001|Overall Study|Withdrawal/death|7|||
33290374|NCT01649557|100959131|FG000|Overall Study|Lost to Follow-up|5|||
33290375|NCT01649557|100959132|FG001|Overall Study|Lost to Follow-up|0|||
33290376|NCT01649557|100959133|FG002|Overall Study|Lost to Follow-up|3|||
33290377|NCT01649557|100959131|FG000|Overall Study|Adverse Event|7|||
33290378|NCT01649557|100959132|FG001|Overall Study|Adverse Event|5|||
33290379|NCT01649557|100959133|FG002|Overall Study|Adverse Event|1|||
33290380|NCT01649557|100959131|FG000|Overall Study|Met withdrawal criteria|4|||
33290381|NCT01649557|100959132|FG001|Overall Study|Met withdrawal criteria|0|||
33290382|NCT01649557|100959133|FG002|Overall Study|Met withdrawal criteria|0|||
33290383|NCT01649557|100959131|FG000|Overall Study|Physician Decision|8|||
33290384|NCT01649557|100959132|FG001|Overall Study|Physician Decision|2|||
33290385|NCT01649557|100959133|FG002|Overall Study|Physician Decision|1|||
33290386|NCT01649557|100959131|FG000|Overall Study|Withdrawal by Subject|15|||
33290387|NCT01649557|100959132|FG001|Overall Study|Withdrawal by Subject|5|||
33290388|NCT01649557|100959133|FG002|Overall Study|Withdrawal by Subject|4|||
33290389|NCT01649557|100959131|FG000|Overall Study|Protocol deviation|0|||
33290390|NCT01649557|100959132|FG001|Overall Study|Protocol deviation|2|||
33290391|NCT01649557|100959133|FG002|Overall Study|Protocol deviation|0|||
33290392|NCT01649557|100959131|FG000|Overall Study|Lack of Efficacy|5|||
33290393|NCT01649557|100959132|FG001|Overall Study|Lack of Efficacy|0|||
33290394|NCT01649557|100959133|FG002|Overall Study|Lack of Efficacy|0|||
33290395|NCT01190644|100959134|FG000|Overall Study|Death|2|||
33290396|NCT01190644|100959134|FG000|Overall Study|Disease progression|1|||
33290397|NCT01536171|100959139|FG000|Overall Study|Withdrawal by Subject|1|||
33290398|NCT02581059|100962659|FG000|Study Treatment|Disease Progression|1|||
33290399|NCT02581059|100962660|FG001|Study Treatment|Disease Progression|1|||
33290400|NCT02581059|100962659|FG000|Study Treatment|Adverse Event|2|||
33290401|NCT02581059|100962660|FG001|Study Treatment|Adverse Event|1|||
33290402|NCT02581059|100962659|FG000|Study Treatment|Death|1|||
33290403|NCT02581059|100962660|FG001|Study Treatment|Death|1|||
33290404|NCT02581059|100962659|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
33290405|NCT02581059|100962660|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
33290406|NCT02581059|100962659|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
33290407|NCT02581059|100962660|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
33290408|NCT02581059|100962659|FG000|Follow up|Death|1|||
33290409|NCT02581059|100962660|FG001|Follow up|Death|3|||
33290410|NCT02581059|100962659|FG000|Follow up|study terminated|1|||
33290411|NCT02581059|100962660|FG001|Follow up|study terminated|1|||
33290412|NCT02581059|100962659|FG000|Follow up|screen failure|0|||
33290413|NCT02581059|100962660|FG001|Follow up|screen failure|1|||
33290414|NCT02581059|100962659|FG000|Follow up|Patient started new clinical trial|1|||
33290415|NCT02581059|100962660|FG001|Follow up|Patient started new clinical trial|0|||
33290416|NCT04120376|100962661|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
33290417|NCT04120376|100962662|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
33290418|NCT03229486|100962663|FG000|Overall Study|Protocol Violation|0|||
33290419|NCT03229486|100962664|FG001|Overall Study|Protocol Violation|1|||
33290420|NCT01834586|100962665|FG000|Overall Study|Adverse Event|1|||
33290421|NCT02684123|100962666|FG000|Phase 1|Lack of Efficacy|5|||
33290422|NCT02684123|100962667|FG001|Phase 1|Lack of Efficacy|0|||
33290423|NCT02684123|100962666|FG000|Phase 1|Adverse Event|3|||
33290424|NCT02684123|100962667|FG001|Phase 1|Adverse Event|0|||
33290425|NCT02684123|100962666|FG000|Phase 1|Lost to Follow-up|0|||
33290426|NCT02684123|100962667|FG001|Phase 1|Lost to Follow-up|1|||
33290427|NCT02684123|100962666|FG000|Phase 2|Lack of Efficacy|1|||
33290428|NCT02684123|100962667|FG001|Phase 2|Lack of Efficacy|8|||
33290429|NCT01628692|100962670|FG000|Overall Study|Lack of Efficacy|4|||
33290430|NCT01628692|100962671|FG001|Overall Study|Lack of Efficacy|4|||
33290431|NCT01628692|100962672|FG002|Overall Study|Lack of Efficacy|5|||
33290432|NCT01628692|100962673|FG003|Overall Study|Lack of Efficacy|1|||
33290433|NCT01628692|100962674|FG004|Overall Study|Lack of Efficacy|4|||
33290434|NCT01628692|100962675|FG005|Overall Study|Lack of Efficacy|7|||
33290435|NCT01628692|100962670|FG000|Overall Study|Adverse Event|2|||
33290436|NCT01628692|100962671|FG001|Overall Study|Adverse Event|0|||
33290437|NCT01628692|100962672|FG002|Overall Study|Adverse Event|2|||
33290438|NCT01628692|100962673|FG003|Overall Study|Adverse Event|0|||
33290439|NCT01628692|100962674|FG004|Overall Study|Adverse Event|0|||
33290440|NCT01628692|100962675|FG005|Overall Study|Adverse Event|0|||
33290441|NCT01628692|100962670|FG000|Overall Study|Withdrawal by Subject|0|||
33290442|NCT01628692|100962671|FG001|Overall Study|Withdrawal by Subject|1|||
33290443|NCT01628692|100962672|FG002|Overall Study|Withdrawal by Subject|1|||
33290444|NCT01628692|100962673|FG003|Overall Study|Withdrawal by Subject|0|||
33290445|NCT01628692|100962674|FG004|Overall Study|Withdrawal by Subject|0|||
33290446|NCT01628692|100962675|FG005|Overall Study|Withdrawal by Subject|0|||
33290447|NCT01628692|100962670|FG000|Overall Study|Death|0|||
33290448|NCT01628692|100962671|FG001|Overall Study|Death|1|||
33290449|NCT01628692|100962672|FG002|Overall Study|Death|0|||
33290450|NCT01628692|100962673|FG003|Overall Study|Death|0|||
33290451|NCT01628692|100962674|FG004|Overall Study|Death|0|||
33290452|NCT01628692|100962675|FG005|Overall Study|Death|0|||
33290453|NCT01628692|100962670|FG000|Overall Study|Poor compliance/noncompliance|1|||
33290454|NCT01628692|100962671|FG001|Overall Study|Poor compliance/noncompliance|0|||
33290455|NCT01628692|100962672|FG002|Overall Study|Poor compliance/noncompliance|0|||
33290456|NCT01628692|100962673|FG003|Overall Study|Poor compliance/noncompliance|0|||
33290457|NCT01628692|100962674|FG004|Overall Study|Poor compliance/noncompliance|0|||
33290458|NCT01628692|100962675|FG005|Overall Study|Poor compliance/noncompliance|0|||
33290459|NCT01628692|100962670|FG000|Overall Study|Administrative reason by sponsor|0|||
33290460|NCT01628692|100962671|FG001|Overall Study|Administrative reason by sponsor|0|||
33290461|NCT01628692|100962672|FG002|Overall Study|Administrative reason by sponsor|0|||
33290462|NCT01628692|100962673|FG003|Overall Study|Administrative reason by sponsor|0|||
33290463|NCT01628692|100962674|FG004|Overall Study|Administrative reason by sponsor|0|||
33290464|NCT01628692|100962675|FG005|Overall Study|Administrative reason by sponsor|1|||
33290465|NCT01628692|100962670|FG000|Overall Study|Completed 12 Week only|0|||
33290466|NCT01628692|100962671|FG001|Overall Study|Completed 12 Week only|0|||
33290467|NCT01628692|100962672|FG002|Overall Study|Completed 12 Week only|0|||
33290468|NCT01628692|100962673|FG003|Overall Study|Completed 12 Week only|0|||
33290469|NCT01628692|100962674|FG004|Overall Study|Completed 12 Week only|0|||
33290470|NCT01628692|100962675|FG005|Overall Study|Completed 12 Week only|1|||
33290471|NCT00944229|100962676|FG000|Overall Study|Withdrawal by Subject|11|||
33290472|NCT00944229|100962676|FG000|Overall Study|Physician Decision|14|||
33290473|NCT01333111|100962680|FG000|Overall Study|patient undergoing major surgery|0|||
33290474|NCT01333111|100962681|FG001|Overall Study|patient undergoing major surgery|2|||
33290475|NCT01333111|100962682|FG002|Overall Study|patient undergoing major surgery|0|||
33290476|NCT01333111|100962680|FG000|Overall Study|personal reasons|0|||
33290477|NCT01333111|100962681|FG001|Overall Study|personal reasons|0|||
33290478|NCT01333111|100962682|FG002|Overall Study|personal reasons|1|||
33290479|NCT01333111|100962680|FG000|Overall Study|unclassified|1|||
33290480|NCT01333111|100962681|FG001|Overall Study|unclassified|0|||
33290481|NCT01333111|100962682|FG002|Overall Study|unclassified|0|||
33290482|NCT01333111|100962680|FG000|Overall Study|withdrawal criteria|0|||
33290483|NCT01333111|100962681|FG001|Overall Study|withdrawal criteria|1|||
33290484|NCT01333111|100962682|FG002|Overall Study|withdrawal criteria|0|||
33290485|NCT01333111|100962680|FG000|Overall Study|Non-compliance|1|||
33290486|NCT01333111|100962681|FG001|Overall Study|Non-compliance|0|||
33290487|NCT01333111|100962682|FG002|Overall Study|Non-compliance|0|||
33290488|NCT01333111|100962680|FG000|Overall Study|Ineffective therapy|0|||
33290489|NCT01333111|100962681|FG001|Overall Study|Ineffective therapy|0|||
33290490|NCT01333111|100962682|FG002|Overall Study|Ineffective therapy|1|||
33290491|NCT02548078|100962684|FG000|Overall Study|Serious adverse event/Adverse event|1|||
33290492|NCT02548078|100962685|FG001|Overall Study|Serious adverse event/Adverse event|0|||
33290493|NCT02548078|100962684|FG000|Overall Study|Moved from study area|3|||
33290494|NCT02548078|100962685|FG001|Overall Study|Moved from study area|3|||
33290495|NCT02548078|100962684|FG000|Overall Study|Lost to Follow-up|1|||
33290496|NCT02548078|100962685|FG001|Overall Study|Lost to Follow-up|3|||
33290497|NCT00243022|100962686|FG000|Overall Study|Withdrawal by Subject|1|||
33290498|NCT00243022|100962687|FG001|Overall Study|Withdrawal by Subject|0|||
33290499|NCT00243022|100962686|FG000|Overall Study|Death|1|||
33290500|NCT00243022|100962687|FG001|Overall Study|Death|0|||
33290501|NCT00243022|100962686|FG000|Overall Study|Difficult Travel Distance|0|||
33290502|NCT00243022|100962687|FG001|Overall Study|Difficult Travel Distance|1|||
33290503|NCT04009629|100962688|FG000|Overall Study|Withdrawal by Subject|2|||
33290504|NCT04009629|100962689|FG001|Overall Study|Withdrawal by Subject|0|||
33290505|NCT04042077|100962690|FG000|Overall Study|Adverse Event|0|||
33290506|NCT04042077|100962691|FG001|Overall Study|Adverse Event|1|||
33290507|NCT04042077|100962690|FG000|Overall Study|Death|2|||
33290508|NCT04042077|100962691|FG001|Overall Study|Death|1|||
33290509|NCT04042077|100962690|FG000|Overall Study|Physician Decision|2|||
33290510|NCT04042077|100962691|FG001|Overall Study|Physician Decision|0|||
33290511|NCT04042077|100962690|FG000|Overall Study|Withdrawal by Subject|3|||
33290512|NCT04042077|100962691|FG001|Overall Study|Withdrawal by Subject|2|||
33290513|NCT04042077|100962690|FG000|Overall Study|Lack of Efficacy|0|||
33290514|NCT04042077|100962691|FG001|Overall Study|Lack of Efficacy|1|||
33290515|NCT01667549|100962692|FG000|Overall Study|Withdrawal by Subject|3|||
33290516|NCT01667549|100962693|FG001|Overall Study|Withdrawal by Subject|5|||
33290517|NCT01667549|100962694|FG002|Overall Study|Withdrawal by Subject|7|||
33290518|NCT01667549|100962695|FG003|Overall Study|Withdrawal by Subject|6|||
33290519|NCT01667549|100962696|FG004|Overall Study|Withdrawal by Subject|1|||
33290520|NCT01150045|100962703|FG000|Overall Study|Protocol Violation|0|||
33290521|NCT01150045|100962704|FG001|Overall Study|Protocol Violation|1|||
33290522|NCT01150045|100962705|FG002|Overall Study|Protocol Violation|0|||
33290523|NCT01150045|100962706|FG003|Overall Study|Protocol Violation|1|||
33290524|NCT00013611|100962707|FG000|Overall Study|Lost to Follow-up|91|||
33290525|NCT00013611|100962708|FG001|Overall Study|Lost to Follow-up|100|||
33290526|NCT03783689|100962709|FG000|Overall Study|Adverse Event|2|||
33290527|NCT03783689|100962710|FG001|Overall Study|Adverse Event|0|||
33290528|NCT03783689|100962709|FG000|Overall Study|Lost to Follow-up|2|||
33290529|NCT03783689|100962710|FG001|Overall Study|Lost to Follow-up|1|||
33290530|NCT03783689|100962709|FG000|Overall Study|Physician Decision|2|||
33290531|NCT03783689|100962710|FG001|Overall Study|Physician Decision|1|||
33290532|NCT03783689|100962709|FG000|Overall Study|Withdrawal by Subject|3|||
33290533|NCT03783689|100962710|FG001|Overall Study|Withdrawal by Subject|3|||
33290534|NCT01010204|100962712|FG000|Overall Study|Lost to Follow-up|2|||
33290535|NCT01010204|100962713|FG001|Overall Study|Lost to Follow-up|2|||
33290536|NCT01010204|100962712|FG000|Overall Study|Adverse Event|1|||
33290537|NCT01010204|100962713|FG001|Overall Study|Adverse Event|3|||
33290538|NCT01010204|100962712|FG000|Overall Study|Withdrawal by Subject|2|||
33290539|NCT01010204|100962713|FG001|Overall Study|Withdrawal by Subject|3|||
33290540|NCT01010204|100962712|FG000|Overall Study|psychiatric hospitalization|2|||
33290541|NCT01010204|100962713|FG001|Overall Study|psychiatric hospitalization|1|||
33290542|NCT03062449|100962717|FG000|Overall Study|Withdrawal by Subject|7|||
33290543|NCT03062449|100962718|FG001|Overall Study|Withdrawal by Subject|1|||
33290544|NCT01375751|100962719|FG000|Overall Study|Other|0|||
33290545|NCT01375751|100962720|FG001|Overall Study|Other|1|||
33290546|NCT01375751|100962721|FG002|Overall Study|Other|0|||
33290547|NCT00079339|100962722|FG000|Overall Study|Adverse Event|1|||
33290548|NCT00079339|100962723|FG001|Overall Study|Adverse Event|7|||
33290549|NCT00079339|100962724|FG002|Overall Study|Adverse Event|2|||
33290550|NCT00079339|100962722|FG000|Overall Study|Death|1|||
33290551|NCT00079339|100962723|FG001|Overall Study|Death|0|||
33290552|NCT00079339|100962724|FG002|Overall Study|Death|0|||
33290553|NCT00079339|100962722|FG000|Overall Study|Non-compliance|0|||
33290554|NCT00079339|100962723|FG001|Overall Study|Non-compliance|0|||
33290555|NCT00079339|100962724|FG002|Overall Study|Non-compliance|1|||
33290556|NCT00079339|100962722|FG000|Overall Study|Withdrawal by Subject|0|||
33290557|NCT00079339|100962723|FG001|Overall Study|Withdrawal by Subject|4|||
33290558|NCT00079339|100962724|FG002|Overall Study|Withdrawal by Subject|1|||
33290559|NCT00079339|100962722|FG000|Overall Study|Disease progression|3|||
33290560|NCT00079339|100962723|FG001|Overall Study|Disease progression|28|||
33290561|NCT00079339|100962724|FG002|Overall Study|Disease progression|2|||
33290562|NCT00755417|100962725|FG000|Overall Study|Adverse Event|28|||
33290563|NCT00755417|100962726|FG001|Overall Study|Adverse Event|20|||
33290564|NCT00755417|100962727|FG002|Overall Study|Adverse Event|7|||
33290565|NCT00755417|100962725|FG000|Overall Study|Lack of Efficacy|8|||
33290566|NCT00755417|100962726|FG001|Overall Study|Lack of Efficacy|4|||
33290567|NCT00755417|100962727|FG002|Overall Study|Lack of Efficacy|9|||
33290568|NCT00755417|100962725|FG000|Overall Study|Protocol Violation|2|||
33290569|NCT00755417|100962726|FG001|Overall Study|Protocol Violation|1|||
33290570|NCT00755417|100962727|FG002|Overall Study|Protocol Violation|1|||
33290571|NCT00755417|100962725|FG000|Overall Study|Lost to Follow-up|3|||
33290572|NCT00755417|100962726|FG001|Overall Study|Lost to Follow-up|0|||
33290573|NCT00755417|100962727|FG002|Overall Study|Lost to Follow-up|1|||
33290574|NCT00755417|100962725|FG000|Overall Study|Withdrawal by Subject|12|||
33290575|NCT00755417|100962726|FG001|Overall Study|Withdrawal by Subject|12|||
33290576|NCT00755417|100962727|FG002|Overall Study|Withdrawal by Subject|12|||
33290577|NCT00755417|100962725|FG000|Overall Study|Not specified or missing data|9|||
33290578|NCT00755417|100962726|FG001|Overall Study|Not specified or missing data|18|||
33290579|NCT00755417|100962727|FG002|Overall Study|Not specified or missing data|12|||
33290580|NCT03546816|100962728|FG000|Overall Study|Adverse Event|5|||
33290581|NCT03546816|100962729|FG001|Overall Study|Adverse Event|3|||
33290582|NCT03546816|100962728|FG000|Overall Study|Lack of Efficacy|2|||
33290583|NCT03546816|100962729|FG001|Overall Study|Lack of Efficacy|4|||
33290584|NCT03546816|100962728|FG000|Overall Study|Pregnancy|1|||
33290585|NCT03546816|100962729|FG001|Overall Study|Pregnancy|0|||
33290586|NCT03546816|100962728|FG000|Overall Study|Physician Decision|2|||
33290587|NCT03546816|100962729|FG001|Overall Study|Physician Decision|0|||
33290588|NCT03546816|100962728|FG000|Overall Study|Withdrawal by Subject|8|||
33290589|NCT03546816|100962729|FG001|Overall Study|Withdrawal by Subject|10|||
33290590|NCT03546816|100962728|FG000|Overall Study|Lost to Follow-up|3|||
33290591|NCT03546816|100962729|FG001|Overall Study|Lost to Follow-up|2|||
33290592|NCT00368641|100962730|FG000|Overall Study|Adverse Event|2|||
33290593|NCT00368641|100962731|FG001|Overall Study|Adverse Event|1|||
33290594|NCT00368641|100962730|FG000|Overall Study|Death|1|||
33290595|NCT00368641|100962731|FG001|Overall Study|Death|0|||
33290596|NCT00368641|100962730|FG000|Overall Study|Withdrawal by Subject|1|||
33290597|NCT00368641|100962731|FG001|Overall Study|Withdrawal by Subject|0|||
33290598|NCT00368641|100962730|FG000|Overall Study|Sponsor decision to terminate study|2|||
33290599|NCT00368641|100962731|FG001|Overall Study|Sponsor decision to terminate study|5|||
33290600|NCT03672175|100962737|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
33290601|NCT03672175|100962738|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
33290602|NCT03672175|100962739|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
33290603|NCT03672175|100962737|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
33290604|NCT03672175|100962738|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
33290605|NCT03672175|100962739|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
33290606|NCT03672175|100962737|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
33290607|NCT03672175|100962738|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
33290608|NCT03672175|100962739|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
33290609|NCT03672175|100962737|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
33290610|NCT03672175|100962738|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
33290611|NCT03672175|100962739|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
33290612|NCT03672175|100962737|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
33290613|NCT03672175|100962738|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
33290614|NCT03672175|100962739|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
33290615|NCT03672175|100962737|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
33290616|NCT03672175|100962738|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
33290617|NCT03672175|100962739|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
33290618|NCT03672175|100962737|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
33290619|NCT03672175|100962738|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
33290620|NCT03672175|100962739|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
33290621|NCT03672175|100962737|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
33290622|NCT03672175|100962738|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
33290623|NCT03672175|100962739|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
33290624|NCT03672175|100962737|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
33290625|NCT03672175|100962738|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
33290626|NCT03672175|100962739|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
33290627|NCT03672175|100962737|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
33290628|NCT03672175|100962738|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
33290629|NCT03672175|100962739|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
33290630|NCT03672175|100962737|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
33290631|NCT03672175|100962738|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
33290632|NCT03672175|100962739|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
33290633|NCT03672175|100962737|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
33290634|NCT03672175|100962738|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
33290635|NCT03672175|100962739|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
33290636|NCT01214421|100962740|FG000|Overall Study|Lost to Follow-up|7|||
33290637|NCT01214421|100962741|FG001|Overall Study|Lost to Follow-up|3|||
33290638|NCT01214421|100962742|FG002|Overall Study|Lost to Follow-up|7|||
33290639|NCT01214421|100962743|FG003|Overall Study|Lost to Follow-up|3|||
33290640|NCT01214421|100962740|FG000|Overall Study|Adverse Event|16|||
33290641|NCT01214421|100962741|FG001|Overall Study|Adverse Event|35|||
33290642|NCT01214421|100962742|FG002|Overall Study|Adverse Event|14|||
33290643|NCT01214421|100962743|FG003|Overall Study|Adverse Event|3|||
33290644|NCT01214421|100962740|FG000|Overall Study|Sponsor Discontinued Site|1|||
33290645|NCT01214421|100962741|FG001|Overall Study|Sponsor Discontinued Site|2|||
33290646|NCT01214421|100962742|FG002|Overall Study|Sponsor Discontinued Site|0|||
33290647|NCT01214421|100962743|FG003|Overall Study|Sponsor Discontinued Site|0|||
33290648|NCT01214421|100962740|FG000|Overall Study|Withdrawal Criteria Met|3|||
33290649|NCT01214421|100962741|FG001|Overall Study|Withdrawal Criteria Met|0|||
33290650|NCT01214421|100962742|FG002|Overall Study|Withdrawal Criteria Met|2|||
33290651|NCT01214421|100962743|FG003|Overall Study|Withdrawal Criteria Met|1|||
33290652|NCT01214421|100962740|FG000|Overall Study|Physician Decision|2|||
33290653|NCT01214421|100962741|FG001|Overall Study|Physician Decision|0|||
33290654|NCT01214421|100962742|FG002|Overall Study|Physician Decision|4|||
33290655|NCT01214421|100962743|FG003|Overall Study|Physician Decision|0|||
33290656|NCT01214421|100962740|FG000|Overall Study|Withdrawal by Subject|21|||
33290657|NCT01214421|100962741|FG001|Overall Study|Withdrawal by Subject|18|||
33290658|NCT01214421|100962742|FG002|Overall Study|Withdrawal by Subject|11|||
33290659|NCT01214421|100962743|FG003|Overall Study|Withdrawal by Subject|2|||
33290660|NCT02689453|100962744|FG000|Overall Study|Progressive disease|0|||
33290661|NCT02689453|100962745|FG001|Overall Study|Progressive disease|1|||
33290662|NCT02689453|100962746|FG002|Overall Study|Progressive disease|1|||
33290663|NCT02284009|100962748|FG000|Overall Study|Adverse Event|3|||
33290664|NCT02284009|100962749|FG001|Overall Study|Adverse Event|0|||
33290665|NCT02284009|100962748|FG000|Overall Study|Lost to Follow-up|1|||
33290666|NCT02284009|100962749|FG001|Overall Study|Lost to Follow-up|3|||
33290667|NCT02284009|100962748|FG000|Overall Study|Physician Decision|0|||
33290668|NCT02284009|100962749|FG001|Overall Study|Physician Decision|2|||
33290669|NCT02284009|100962748|FG000|Overall Study|Withdrawal by Subject|2|||
33290670|NCT02284009|100962749|FG001|Overall Study|Withdrawal by Subject|5|||
33290671|NCT01124097|100962760|FG000|Overall Study|Withdrawal by Subject|4|||
33290672|NCT01124097|100962761|FG001|Overall Study|Withdrawal by Subject|3|||
33290673|NCT01124097|100962762|FG002|Overall Study|Withdrawal by Subject|2|||
33290674|NCT01124097|100962763|FG003|Overall Study|Withdrawal by Subject|3|||
33290675|NCT01124097|100962760|FG000|Overall Study|Lack of Efficacy|2|||
33290676|NCT01124097|100962761|FG001|Overall Study|Lack of Efficacy|3|||
33290677|NCT01124097|100962762|FG002|Overall Study|Lack of Efficacy|1|||
33290678|NCT01124097|100962763|FG003|Overall Study|Lack of Efficacy|3|||
33290679|NCT01124097|100962760|FG000|Overall Study|Adverse Event|24|||
33290680|NCT01124097|100962761|FG001|Overall Study|Adverse Event|15|||
33290681|NCT01124097|100962762|FG002|Overall Study|Adverse Event|15|||
33290682|NCT01124097|100962763|FG003|Overall Study|Adverse Event|7|||
33290683|NCT01124097|100962760|FG000|Overall Study|Protocol Violation|2|||
33290684|NCT01124097|100962761|FG001|Overall Study|Protocol Violation|0|||
33290685|NCT01124097|100962762|FG002|Overall Study|Protocol Violation|2|||
33290686|NCT01124097|100962763|FG003|Overall Study|Protocol Violation|1|||
33290687|NCT01124097|100962760|FG000|Overall Study|Physician Decision|2|||
33290688|NCT01124097|100962761|FG001|Overall Study|Physician Decision|1|||
33290689|NCT01124097|100962762|FG002|Overall Study|Physician Decision|0|||
33290690|NCT01124097|100962763|FG003|Overall Study|Physician Decision|0|||
33290691|NCT00612352|100962764|FG000|Overall Study|Adverse Event|1|||
33290692|NCT00612352|100962765|FG001|Overall Study|Adverse Event|0|||
33290693|NCT00612352|100962764|FG000|Overall Study|Withdrawal by Subject|3|||
33290694|NCT00612352|100962765|FG001|Overall Study|Withdrawal by Subject|5|||
33290695|NCT00612352|100962764|FG000|Overall Study|moved out of state|1|||
33290696|NCT00612352|100962765|FG001|Overall Study|moved out of state|0|||
33290697|NCT00612352|100962764|FG000|Overall Study|didn't return calls/show up on test date|4|||
33290698|NCT00612352|100962765|FG001|Overall Study|didn't return calls/show up on test date|1|||
33290699|NCT04732871|100962770|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
33290700|NCT04732871|100962771|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
33290701|NCT04732871|100962772|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
33290702|NCT04732871|100962770|FG000|Overall Study|Lost to Follow-up|7|||
33290703|NCT04732871|100962771|FG001|Overall Study|Lost to Follow-up|4|||
33290704|NCT04732871|100962772|FG002|Overall Study|Lost to Follow-up|3|||
33290705|NCT04732871|100962770|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
33290706|NCT04732871|100962771|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
33290707|NCT04732871|100962772|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
33290708|NCT04732871|100962770|FG000|Overall Study|Migrated / moved from the study area|5|||
33290709|NCT04732871|100962771|FG001|Overall Study|Migrated / moved from the study area|0|||
33290710|NCT04732871|100962772|FG002|Overall Study|Migrated / moved from the study area|0|||
33290711|NCT04732871|100962770|FG000|Overall Study|Other|1|||
33290712|NCT04732871|100962771|FG001|Overall Study|Other|0|||
33290713|NCT04732871|100962772|FG002|Overall Study|Other|1|||
33290714|NCT04732871|100962770|FG000|Overall Study|Ongoing|6|||
33290715|NCT04732871|100962771|FG001|Overall Study|Ongoing|0|||
33290716|NCT04732871|100962772|FG002|Overall Study|Ongoing|1|||
33290717|NCT04732871|100962770|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
33290718|NCT04732871|100962771|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
33290719|NCT04732871|100962772|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
33290720|NCT00916305|100962773|FG000|Overall Study|Lost to Follow-up|21|||
33290721|NCT00916305|100962774|FG001|Overall Study|Lost to Follow-up|27|||
33290722|NCT00916305|100962773|FG000|Overall Study|Withdrawal by Subject|0|||
33290723|NCT00916305|100962774|FG001|Overall Study|Withdrawal by Subject|1|||
33290724|NCT03409731|100962775|FG000|Overall Study|Withdrawal by Subject|17|||
33290725|NCT03409731|100962775|FG000|Overall Study|Death|4|||
33290726|NCT04140266|100962778|FG000|Overall Study|Physician Decision|2|||
33290727|NCT04140266|100962779|FG001|Overall Study|Physician Decision|0|||
33290728|NCT04140266|100962778|FG000|Overall Study|Withdrawal by Subject|4|||
33290729|NCT04140266|100962779|FG001|Overall Study|Withdrawal by Subject|2|||
33290730|NCT01261247|100962780|FG000|Overall Study|Ineligible|2|||
33290731|NCT01841697|100962781|FG000|Overall Study|Death|0|||
33290732|NCT01841697|100962782|FG001|Overall Study|Death|1|||
33290733|NCT01841697|100962781|FG000|Overall Study|Lost to Follow-up|4|||
33290734|NCT01841697|100962782|FG001|Overall Study|Lost to Follow-up|1|||
33290735|NCT01841697|100962781|FG000|Overall Study|Withdrawal by Subject|16|||
33290736|NCT01841697|100962782|FG001|Overall Study|Withdrawal by Subject|16|||
33290737|NCT01270828|100962783|FG000|Pregabalin CR SB|Reason Unspecified|0|||
33290738|NCT01270828|100962784|FG001|Pregabalin CR SB|Reason Unspecified|0|||
33290739|NCT01270828|100962785|FG002|Pregabalin CR SB|Reason Unspecified|8|||
33290740|NCT01270828|100962783|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
33290741|NCT01270828|100962784|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
33290742|NCT01270828|100962785|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
33290743|NCT01270828|100962783|FG000|Pregabalin CR SB|Related adverse event|0|||
33290744|NCT01270828|100962784|FG001|Pregabalin CR SB|Related adverse event|0|||
33290745|NCT01270828|100962785|FG002|Pregabalin CR SB|Related adverse event|46|||
33290746|NCT01270828|100962783|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
33290747|NCT01270828|100962784|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
33290748|NCT01270828|100962785|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
33290749|NCT01270828|100962783|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
33290750|NCT01270828|100962784|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
33290751|NCT01270828|100962785|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
33290752|NCT01270828|100962783|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
33290753|NCT01270828|100962784|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
33290754|NCT01270828|100962785|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
33290755|NCT01270828|100962783|FG000|Pregabalin CR SB|Unrelated AE|0|||
33290756|NCT01270828|100962784|FG001|Pregabalin CR SB|Unrelated AE|0|||
33290757|NCT01270828|100962785|FG002|Pregabalin CR SB|Unrelated AE|8|||
33290758|NCT01270828|100962783|FG000|Pregabalin CR SB|Protocol Violation|0|||
33290759|NCT01270828|100962784|FG001|Pregabalin CR SB|Protocol Violation|0|||
33290760|NCT01270828|100962785|FG002|Pregabalin CR SB|Protocol Violation|8|||
33290761|NCT01270828|100962783|FG000|Double Blind Phase|Death|0|||
33290762|NCT01270828|100962784|FG001|Double Blind Phase|Death|1|||
33290763|NCT01270828|100962785|FG002|Double Blind Phase|Death|0|||
33290764|NCT01270828|100962783|FG000|Double Blind Phase|Protocol Violation|0|||
33290765|NCT01270828|100962784|FG001|Double Blind Phase|Protocol Violation|1|||
33290766|NCT01270828|100962785|FG002|Double Blind Phase|Protocol Violation|0|||
33290767|NCT01270828|100962783|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
33290768|NCT01270828|100962784|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
33290769|NCT01270828|100962785|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
33290770|NCT01270828|100962783|FG000|Double Blind Phase|Reason Unspecified|7|||
33290771|NCT01270828|100962784|FG001|Double Blind Phase|Reason Unspecified|4|||
33290772|NCT01270828|100962785|FG002|Double Blind Phase|Reason Unspecified|0|||
33290773|NCT01270828|100962783|FG000|Double Blind Phase|Withdrawal by Subject|6|||
33290774|NCT01270828|100962784|FG001|Double Blind Phase|Withdrawal by Subject|15|||
33290775|NCT01270828|100962785|FG002|Double Blind Phase|Withdrawal by Subject|0|||
33290776|NCT01270828|100962783|FG000|Double Blind Phase|Lost to Follow-up|1|||
33290777|NCT01270828|100962784|FG001|Double Blind Phase|Lost to Follow-up|2|||
33290778|NCT01270828|100962785|FG002|Double Blind Phase|Lost to Follow-up|0|||
33290779|NCT01270828|100962783|FG000|Double Blind Phase|Lack of Efficacy|2|||
33290780|NCT01270828|100962784|FG001|Double Blind Phase|Lack of Efficacy|11|||
33290781|NCT01270828|100962785|FG002|Double Blind Phase|Lack of Efficacy|0|||
33290782|NCT01270828|100962783|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
33290783|NCT01270828|100962784|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
33290784|NCT01270828|100962785|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
33290785|NCT01270828|100962783|FG000|Double Blind Phase|Adverse event related to study drug|5|||
33290786|NCT01270828|100962784|FG001|Double Blind Phase|Adverse event related to study drug|7|||
33290787|NCT01270828|100962785|FG002|Double Blind Phase|Adverse event related to study drug|0|||
33290788|NCT03174782|100962787|FG000|Overall Study|Protocol Violation|1|||
33290789|NCT03174782|100962788|FG001|Overall Study|Protocol Violation|0|||
33290790|NCT03174782|100962787|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
33290791|NCT03174782|100962788|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
33290792|NCT00464945|100962789|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
33290793|NCT00464945|100962790|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
33290794|NCT00464945|100962789|FG000|Infant Series|Protocol Violation|1|||
33290795|NCT00464945|100962790|FG001|Infant Series|Protocol Violation|0|||
33290796|NCT00464945|100962789|FG000|Infant Series|Lost to Follow-up|1|||
33290797|NCT00464945|100962790|FG001|Infant Series|Lost to Follow-up|0|||
33290798|NCT00464945|100962789|FG000|After Infant Series|Withdrawal by Subject|0|||
33290799|NCT00464945|100962790|FG001|After Infant Series|Withdrawal by Subject|2|||
33290800|NCT00464945|100962789|FG000|Toddler Dose|Lost to Follow-up|0|||
33290801|NCT00464945|100962790|FG001|Toddler Dose|Lost to Follow-up|1|||
33290802|NCT00926575|100962791|FG000|Overall Study|Adverse Event|1|||
33290803|NCT00926575|100962792|FG001|Overall Study|Adverse Event|1|||
33290804|NCT00926575|100962791|FG000|Overall Study|Death|4|||
33290805|NCT00926575|100962792|FG001|Overall Study|Death|4|||
33290806|NCT00926575|100962791|FG000|Overall Study|Lost to Follow-up|1|||
33290807|NCT00926575|100962792|FG001|Overall Study|Lost to Follow-up|1|||
33290808|NCT00926575|100962791|FG000|Overall Study|Physician Decision|1|||
33290809|NCT00926575|100962792|FG001|Overall Study|Physician Decision|2|||
33290810|NCT00926575|100962791|FG000|Overall Study|Protocol Violation|1|||
33290811|NCT00926575|100962792|FG001|Overall Study|Protocol Violation|0|||
33290812|NCT00926575|100962791|FG000|Overall Study|Withdrawal by Subject|8|||
33290813|NCT00926575|100962792|FG001|Overall Study|Withdrawal by Subject|9|||
33290814|NCT02706847|100962800|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
33290815|NCT02706847|100962801|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
33290816|NCT02706847|100962802|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
33290817|NCT02706847|100962803|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
33290818|NCT02706847|100962800|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
33290819|NCT02706847|100962801|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
33290820|NCT02706847|100962802|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
33290821|NCT02706847|100962803|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
33290822|NCT02706847|100962800|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
33290823|NCT02706847|100962801|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
33290824|NCT02706847|100962802|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
33290825|NCT02706847|100962803|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
33290826|NCT02706847|100962800|FG000|Period 1: Day 1 to Week 12|Other|4|||
33290827|NCT02706847|100962801|FG001|Period 1: Day 1 to Week 12|Other|4|||
33290828|NCT02706847|100962802|FG002|Period 1: Day 1 to Week 12|Other|2|||
33290829|NCT02706847|100962803|FG003|Period 1: Day 1 to Week 12|Other|2|||
33290830|NCT02706847|100962800|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
33290831|NCT02706847|100962801|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
33290832|NCT02706847|100962802|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
33290833|NCT02706847|100962803|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
33290834|NCT02706847|100962800|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
33290835|NCT02706847|100962801|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
33290836|NCT02706847|100962802|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
33290837|NCT02706847|100962803|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
33290838|NCT02706847|100962800|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
33391731|NCT02959190|101321854|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
33290839|NCT02706847|100962801|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
33290840|NCT02706847|100962802|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
33290841|NCT02706847|100962803|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
33290842|NCT02706847|100962800|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
33290843|NCT02706847|100962801|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
33290844|NCT02706847|100962802|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
33290845|NCT02706847|100962803|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
33290846|NCT02706847|100962800|FG000|Period 1: Week 12 to Week 24|Other|1|||
33290847|NCT02706847|100962801|FG001|Period 1: Week 12 to Week 24|Other|0|||
33290848|NCT02706847|100962802|FG002|Period 1: Week 12 to Week 24|Other|1|||
33290849|NCT02706847|100962803|FG003|Period 1: Week 12 to Week 24|Other|4|||
33290850|NCT02706847|100962800|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
33290851|NCT02706847|100962801|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
33290852|NCT02706847|100962802|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
33290853|NCT02706847|100962803|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
33290854|NCT02706847|100962800|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
33290855|NCT02706847|100962801|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
33290856|NCT02706847|100962802|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
33290857|NCT02706847|100962803|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
33290858|NCT02706847|100962800|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
33290859|NCT02706847|100962801|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
33290860|NCT02706847|100962802|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
33290861|NCT02706847|100962803|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
33290862|NCT02706847|100962800|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
33290863|NCT02706847|100962801|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
33290864|NCT02706847|100962802|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
33290865|NCT02706847|100962803|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
33290866|NCT02706847|100962800|FG000|Period 2: Week 24 to Week 260|Other|8|||
33290867|NCT02706847|100962801|FG001|Period 2: Week 24 to Week 260|Other|5|||
33290868|NCT02706847|100962802|FG002|Period 2: Week 24 to Week 260|Other|15|||
33290869|NCT02706847|100962803|FG003|Period 2: Week 24 to Week 260|Other|15|||
33290870|NCT00516139|100962808|FG000|Overall Study|Adverse Event|27|||
33290871|NCT00516139|100962808|FG000|Overall Study|Lost to Follow-up|1|||
33290872|NCT00516139|100962808|FG000|Overall Study|Protocol Violation|1|||
33290873|NCT00516139|100962808|FG000|Overall Study|Withdrawal by Subject|8|||
33290874|NCT00516139|100962808|FG000|Overall Study|Lack of Efficacy|1|||
33290875|NCT01845805|100962809|FG000|Overall Study|Withdrawal by Subject|1|||
33290876|NCT01845805|100962810|FG001|Overall Study|Withdrawal by Subject|2|||
33290877|NCT01845805|100962809|FG000|Overall Study|Disease Progression|13|||
33290878|NCT01845805|100962810|FG001|Overall Study|Disease Progression|14|||
33290879|NCT01845805|100962809|FG000|Overall Study|Drug-related Toxicity|4|||
33290880|NCT01845805|100962810|FG001|Overall Study|Drug-related Toxicity|0|||
33290881|NCT04544865|100962811|FG000|Overall Study|Death|0|||
33290882|NCT04544865|100962812|FG001|Overall Study|Death|2|||
33290883|NCT04544865|100962811|FG000|Overall Study|Lost to Follow-up|11|||
33290884|NCT04544865|100962812|FG001|Overall Study|Lost to Follow-up|7|||
33290885|NCT04544865|100962811|FG000|Overall Study|Withdrawal by Subject|0|||
33290886|NCT04544865|100962812|FG001|Overall Study|Withdrawal by Subject|1|||
33290887|NCT04544865|100962811|FG000|Overall Study|Other|0|||
33290888|NCT04544865|100962812|FG001|Overall Study|Other|1|||
33290889|NCT02485899|100962813|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
33290890|NCT02485899|100962814|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33290891|NCT02485899|100962813|FG000|Overall Study|Withdrawal by Subject|1|||
33290892|NCT02485899|100962814|FG001|Overall Study|Withdrawal by Subject|0|||
33290893|NCT02485899|100962813|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
33290894|NCT02485899|100962814|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
33290895|NCT00798304|100962815|FG000|Overall Study|Adverse Event|0|||
33290896|NCT00798304|100962816|FG001|Overall Study|Adverse Event|1|||
33290897|NCT00798304|100962817|FG002|Overall Study|Adverse Event|1|||
33290898|NCT00798304|100962815|FG000|Overall Study|Discontinuation by Sponsor|14|||
33290899|NCT00798304|100962816|FG001|Overall Study|Discontinuation by Sponsor|21|||
33290900|NCT00798304|100962817|FG002|Overall Study|Discontinuation by Sponsor|9|||
33290901|NCT00174447|100962819|FG000|Overall Study|Adverse Event|19|||
33290902|NCT00174447|100962819|FG000|Overall Study|Withdrawal by Subject|15|||
33290903|NCT00174447|100962819|FG000|Overall Study|Protocol Violation|1|||
33290904|NCT00174447|100962819|FG000|Overall Study|Lack of Efficacy|1|||
33290905|NCT00174447|100962819|FG000|Overall Study|Administrative reason/Other|2|||
33290906|NCT04594733|100962820|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
33290907|NCT04594733|100962821|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
33290908|NCT04594733|100962820|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
33290909|NCT04594733|100962821|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
33290910|NCT04594733|100962820|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
33290911|NCT04594733|100962821|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
33290912|NCT01289210|100962823|FG000|Overall Study|Adverse Event|1|||
33290913|NCT01266018|100962825|FG000|Overall Study|Physician Decision|1|||
33290914|NCT01266018|100962826|FG001|Overall Study|Physician Decision|0|||
33290915|NCT01266018|100962825|FG000|Overall Study|Progressive disease|0|||
33290916|NCT01266018|100962826|FG001|Overall Study|Progressive disease|1|||
33290917|NCT00443209|100962827|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
33290918|NCT00443209|100962828|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
33290919|NCT00443209|100962827|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
33290920|NCT00443209|100962828|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
33290921|NCT00443209|100962827|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
33290922|NCT00443209|100962828|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
33290923|NCT00443209|100962827|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
33290924|NCT00443209|100962828|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
33290925|NCT00443209|100962827|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
33290926|NCT00443209|100962828|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
33290927|NCT00443209|100962827|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
33290928|NCT00443209|100962828|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
33290929|NCT00443209|100962827|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
33290930|NCT00443209|100962828|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
33290931|NCT00443209|100962827|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
33290932|NCT00443209|100962828|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
33290933|NCT00443209|100962827|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
33290934|NCT00443209|100962828|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
33290935|NCT00443209|100962827|FG000|Months 1 to 12 Treatment Period|Missing|2|||
33290936|NCT00443209|100962828|FG001|Months 1 to 12 Treatment Period|Missing|1|||
33290937|NCT00443209|100962827|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
33290938|NCT00443209|100962828|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
33290939|NCT00443209|100962827|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
33290940|NCT00443209|100962828|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
33290941|NCT00443209|100962827|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
33290942|NCT00443209|100962828|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
33599044|NCT01822535|102081817|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
33599045|NCT01822535|102081816|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
33599046|NCT01822535|102081817|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
33599047|NCT01165320|102081818|FG000|Overall Study|Clinical adverse experience|2|||
33599048|NCT01165320|102081819|FG001|Overall Study|Clinical adverse experience|1|||
33599049|NCT01165320|102081820|FG002|Overall Study|Clinical adverse experience|0|||
33290943|NCT00443209|100962827|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
33290944|NCT00443209|100962828|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
33599050|NCT01165320|102081818|FG000|Overall Study|Laboratory adverse experience|1|||
33599051|NCT01165320|102081819|FG001|Overall Study|Laboratory adverse experience|0|||
33599052|NCT01165320|102081820|FG002|Overall Study|Laboratory adverse experience|0|||
33599053|NCT01165320|102081818|FG000|Overall Study|Lack of Efficacy|0|||
33599054|NCT01165320|102081819|FG001|Overall Study|Lack of Efficacy|2|||
33599055|NCT01165320|102081820|FG002|Overall Study|Lack of Efficacy|0|||
33599056|NCT01165320|102081818|FG000|Overall Study|Reason unknown|0|||
33599057|NCT01165320|102081819|FG001|Overall Study|Reason unknown|1|||
33599058|NCT01165320|102081820|FG002|Overall Study|Reason unknown|0|||
33599059|NCT04224272|102081821|FG000|Part 1 - Dose Finding|Death|4|||
33599060|NCT04224272|102081821|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
33599061|NCT04224272|102081821|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
33599062|NCT04224272|102081821|FG000|Part 2 - Dose Expansion|Death|10|||
33599063|NCT04224272|102081821|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
33599064|NCT00541099|102081822|FG000|Overall Study|Ineligible|3|||
33599065|NCT01300819|102084754|FG000|Overall Study|Adverse Event|9|||
33599066|NCT01300819|102084755|FG001|Overall Study|Adverse Event|27|||
33599067|NCT01300819|102084754|FG000|Overall Study|Lack of Efficacy|2|||
33599068|NCT01300819|102084755|FG001|Overall Study|Lack of Efficacy|1|||
33599069|NCT01300819|102084754|FG000|Overall Study|Withdrawal by Subject|10|||
33599070|NCT01300819|102084755|FG001|Overall Study|Withdrawal by Subject|12|||
33290945|NCT00443209|100962827|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
33290946|NCT00443209|100962828|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
33290947|NCT00443209|100962827|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
33290948|NCT00443209|100962828|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
33290949|NCT00443209|100962827|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
33290950|NCT00443209|100962828|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
33290951|NCT02559310|100962832|FG000|Overall Study|Death|4|||
33290952|NCT02559310|100962833|FG001|Overall Study|Death|3|||
33599071|NCT01300819|102084754|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
33599072|NCT01300819|102084755|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
33599073|NCT01300819|102084754|FG000|Overall Study|Refusal to down titrate study drug|0|||
33599074|NCT01300819|102084755|FG001|Overall Study|Refusal to down titrate study drug|1|||
33599075|NCT01300819|102084754|FG000|Overall Study|Administrative reason|0|||
33599076|NCT01300819|102084755|FG001|Overall Study|Administrative reason|1|||
33599077|NCT01300819|102084754|FG000|Overall Study|Safety follow up not done by mistake|0|||
33599078|NCT01300819|102084755|FG001|Overall Study|Safety follow up not done by mistake|1|||
33599079|NCT01300819|102084754|FG000|Overall Study|Follow up call was not done|1|||
33599080|NCT01300819|102084755|FG001|Overall Study|Follow up call was not done|0|||
33599081|NCT01170598|102084758|FG000|Overall Study|Withdrawal by Subject|1|||
33599082|NCT01170598|102084758|FG000|Overall Study|Death|3|||
33599083|NCT01170598|102084758|FG000|Overall Study|Lost to Follow-up|1|||
33599084|NCT01170598|102084758|FG000|Overall Study|Refused|1|||
33599085|NCT04465877|102084759|FG000|Overall Study|Noncompliant with study requirements|0|||
33599086|NCT04465877|102084760|FG001|Overall Study|Noncompliant with study requirements|0|||
33599087|NCT04465877|102084761|FG002|Overall Study|Noncompliant with study requirements|1|||
33599088|NCT04465877|102084762|FG003|Overall Study|Noncompliant with study requirements|0|||
33599089|NCT01852825|102084763|FG000|Overall Study|Withdrawal by Subject|2|||
33599090|NCT01852825|102084764|FG001|Overall Study|Withdrawal by Subject|0|||
33599091|NCT01852825|102084765|FG002|Overall Study|Withdrawal by Subject|0|||
33599092|NCT00933244|102084766|FG000|Overall Study|Withdrawal by Subject|5|||
33599093|NCT00933244|102084767|FG001|Overall Study|Withdrawal by Subject|1|||
33599094|NCT00933244|102084768|FG002|Overall Study|Withdrawal by Subject|3|||
33599095|NCT04863248|102084769|FG000|Overall Study|Sponsor Terminated|4|||
33599096|NCT04863248|102084770|FG001|Overall Study|Sponsor Terminated|1|||
33599097|NCT04863248|102084769|FG000|Overall Study|Death|0|||
33599098|NCT04863248|102084770|FG001|Overall Study|Death|1|||
33599099|NCT04863248|102084769|FG000|Overall Study|Withdrawal by Subject|0|||
33599100|NCT04863248|102084770|FG001|Overall Study|Withdrawal by Subject|1|||
33599101|NCT02836873|102084771|FG000|Overall Study|Protocol Violation|0|||
33599102|NCT02836873|102084772|FG001|Overall Study|Protocol Violation|1|||
33599103|NCT02836873|102084771|FG000|Overall Study|Adverse Event|1|||
33599104|NCT02836873|102084772|FG001|Overall Study|Adverse Event|4|||
33599105|NCT02836873|102084771|FG000|Overall Study|Withdrawal by Subject|2|||
33599106|NCT02836873|102084772|FG001|Overall Study|Withdrawal by Subject|2|||
33599107|NCT02836873|102084771|FG000|Overall Study|Lost to Follow-up|1|||
33599108|NCT02836873|102084772|FG001|Overall Study|Lost to Follow-up|3|||
33599109|NCT02836873|102084771|FG000|Overall Study|Physician Decision|0|||
33599110|NCT02836873|102084772|FG001|Overall Study|Physician Decision|1|||
33599111|NCT02836873|102084771|FG000|Overall Study|Other|1|||
33599112|NCT02836873|102084772|FG001|Overall Study|Other|0|||
33599113|NCT02118597|102084779|FG000|Overall Study|Sponsor terminated the study|14|||
33599114|NCT02118597|102084779|FG000|Overall Study|Serious Adverse Event|1|||
33599115|NCT02118597|102084779|FG000|Overall Study|Investigator's decision|1|||
33599116|NCT00303446|102084780|FG000|Overall Study|Withdrawal by Subject|2|||
33599117|NCT00303446|102084781|FG001|Overall Study|Withdrawal by Subject|2|||
33599118|NCT00303446|102084780|FG000|Overall Study|Death|0|||
33599119|NCT00303446|102084781|FG001|Overall Study|Death|1|||
33599120|NCT00303446|102084780|FG000|Overall Study|Physician Decision|0|||
33599121|NCT00303446|102084781|FG001|Overall Study|Physician Decision|1|||
33599122|NCT00354107|102084782|FG000|Overall Study|Adverse Event|2|||
33599123|NCT00354107|102084782|FG000|Overall Study|Physician Decision|2|||
33599124|NCT00354107|102084782|FG000|Overall Study|Withdrawal by Subject|1|||
33599125|NCT00966719|102084783|FG000|Overall Study|Lost to Follow-up|6|||
33599126|NCT00966719|102084784|FG001|Overall Study|Lost to Follow-up|11|||
33599127|NCT01958021|102084785|FG000|Overall Study|Progressive disease|87|||
33599128|NCT01958021|102084786|FG001|Overall Study|Progressive disease|146|||
33599129|NCT01958021|102084785|FG000|Overall Study|Adverse Event|25|||
33599130|NCT01958021|102084786|FG001|Overall Study|Adverse Event|7|||
33599131|NCT01958021|102084785|FG000|Overall Study|Subject/guardian decision|12|||
33290953|NCT02559310|100962832|FG000|Overall Study|Lost to Follow-up|5|||
33290954|NCT02559310|100962833|FG001|Overall Study|Lost to Follow-up|3|||
33188208|NCT01652716|100597992|FG000|Overall Study|Loss of glucose control|1|||
33290955|NCT02559310|100962832|FG000|Overall Study|Physician Decision|2|||
33290956|NCT02559310|100962833|FG001|Overall Study|Physician Decision|1|||
33599132|NCT01958021|102084786|FG001|Overall Study|Subject/guardian decision|13|||
33599133|NCT01958021|102084785|FG000|Overall Study|Physician Decision|10|||
33599134|NCT01958021|102084786|FG001|Overall Study|Physician Decision|13|||
33599135|NCT01958021|102084785|FG000|Overall Study|Protocol Violation|3|||
33599136|NCT01958021|102084786|FG001|Overall Study|Protocol Violation|1|||
33599137|NCT01958021|102084785|FG000|Overall Study|Death|2|||
33599138|NCT01958021|102084786|FG001|Overall Study|Death|0|||
33599139|NCT04584346|102084794|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
33599140|NCT04584346|102084795|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
33599141|NCT02387164|102084796|FG000|Overall Study|Lost to Follow-up|2|||
33599142|NCT02387164|102084797|FG001|Overall Study|Lost to Follow-up|0|||
33188209|NCT01652716|100597993|FG001|Overall Study|Loss of glucose control|0|||
33290957|NCT02559310|100962832|FG000|Overall Study|Withdrawal by Subject|13|||
33290958|NCT02559310|100962833|FG001|Overall Study|Withdrawal by Subject|9|||
33290959|NCT02559310|100962832|FG000|Overall Study|Sponsor Decision|0|||
33599143|NCT02387164|102084796|FG000|Overall Study|Diagnosed|1|||
33599144|NCT02387164|102084797|FG001|Overall Study|Diagnosed|2|||
33290960|NCT02559310|100962833|FG001|Overall Study|Sponsor Decision|1|||
33599145|NCT03383783|102084798|FG000|Overall Study|Withdrawal by Subject|2|||
33290961|NCT02559310|100962832|FG000|Overall Study|Randomized but not treated|3|||
33290962|NCT02559310|100962833|FG001|Overall Study|Randomized but not treated|2|||
33290963|NCT04211389|100962840|FG000|Overall Study|Adverse Event|1|||
33290964|NCT04211389|100962841|FG001|Overall Study|Adverse Event|2|||
33290965|NCT04211389|100962840|FG000|Overall Study|Lost to Follow-up|15|||
33290966|NCT04211389|100962841|FG001|Overall Study|Lost to Follow-up|7|||
33290967|NCT04211389|100962840|FG000|Overall Study|Protocol Violation|0|||
33290968|NCT04211389|100962841|FG001|Overall Study|Protocol Violation|1|||
33290969|NCT04211389|100962840|FG000|Overall Study|Withdrawal by Subject|10|||
33290970|NCT04211389|100962841|FG001|Overall Study|Withdrawal by Subject|11|||
33290971|NCT01639742|100962842|FG000|Overall Study|Study Ongoing|17|||
33290972|NCT01639742|100962842|FG000|Overall Study|Lost to Follow-up|1|||
33290973|NCT05382039|100962847|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
33290974|NCT05382039|100962848|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
33290975|NCT05382039|100962849|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
33290976|NCT05382039|100962847|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
33290977|NCT05382039|100962848|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
33290978|NCT05382039|100962849|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
33290979|NCT05382039|100962847|FG000|Overall Study|waiting for confirmation|0|||
33290980|NCT05382039|100962848|FG001|Overall Study|waiting for confirmation|0|||
33290981|NCT05382039|100962849|FG002|Overall Study|waiting for confirmation|1|||
33290982|NCT03432390|100962864|FG000|Apnea Period|Protocol Violation|2|||
33290983|NCT03432390|100962865|FG001|Apnea Period|Protocol Violation|2|||
33290984|NCT00943787|100962866|FG000|Overall Study|Physician Decision|4|||
33290985|NCT00943787|100962866|FG000|Overall Study|Withdrawal by Subject|3|||
33290986|NCT04092452|100962867|FG000|Overall Study|Adverse Event|1|||
33290987|NCT04092452|100962868|FG001|Overall Study|Adverse Event|3|||
33290988|NCT04092452|100962869|FG002|Overall Study|Adverse Event|3|||
33290989|NCT04092452|100962870|FG003|Overall Study|Adverse Event|7|||
33290990|NCT04092452|100962867|FG000|Overall Study|Lack of Efficacy|1|||
33290991|NCT04092452|100962868|FG001|Overall Study|Lack of Efficacy|1|||
33290992|NCT04092452|100962869|FG002|Overall Study|Lack of Efficacy|1|||
33290993|NCT04092452|100962870|FG003|Overall Study|Lack of Efficacy|0|||
33290994|NCT04092452|100962867|FG000|Overall Study|Lost to Follow-up|4|||
33290995|NCT04092452|100962868|FG001|Overall Study|Lost to Follow-up|3|||
33290996|NCT04092452|100962869|FG002|Overall Study|Lost to Follow-up|5|||
33290997|NCT04092452|100962870|FG003|Overall Study|Lost to Follow-up|1|||
33290998|NCT04092452|100962867|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33290999|NCT04092452|100962868|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33291000|NCT04092452|100962869|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33291001|NCT04092452|100962870|FG003|Overall Study|Non-Compliance With Study Drug|1|||
33291002|NCT04092452|100962867|FG000|Overall Study|Physician Decision|1|||
33291003|NCT04092452|100962868|FG001|Overall Study|Physician Decision|0|||
33391732|NCT02959190|101321855|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
33391733|NCT01098032|101321856|FG000|Overall Study|Withdrawal by Subject|1|||
33391734|NCT01098032|101321857|FG001|Overall Study|Withdrawal by Subject|1|||
33599146|NCT03372551|102084812|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
33599147|NCT03372551|102084813|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
33599148|NCT00794365|102084814|FG000|Overall Study|Lost to Follow-up|38|||
33599149|NCT00794365|102084814|FG000|Overall Study|Other|17|||
33599150|NCT00794365|102084814|FG000|Overall Study|Poor Compliance|11|||
33599151|NCT00794365|102084814|FG000|Overall Study|Adverse Event|10|||
33599152|NCT00794365|102084814|FG000|Overall Study|Lack of Efficacy|3|||
33599153|NCT00919867|102084815|FG000|First Intervention|Withdrawal by Subject|0|||
33599154|NCT00919867|102084816|FG001|First Intervention|Withdrawal by Subject|0|||
33599155|NCT00919867|102084817|FG002|First Intervention|Withdrawal by Subject|1|||
33599156|NCT00919867|102084818|FG003|First Intervention|Withdrawal by Subject|0|||
33599157|NCT00919867|102084819|FG004|First Intervention|Withdrawal by Subject|0|||
33599158|NCT00919867|102084820|FG005|First Intervention|Withdrawal by Subject|0|||
33599159|NCT00919867|102084815|FG000|First Intervention|Physician Decision|0|||
33599160|NCT00919867|102084816|FG001|First Intervention|Physician Decision|0|||
33391735|NCT01135394|101321861|FG000|Screening|Lost to Follow-up|2|||
33391736|NCT01135394|101321861|FG000|Screening|Withdrawal by Subject|10|||
33391737|NCT01135394|101321861|FG000|Screening|Screening failure|16|||
33391738|NCT01135394|101321861|FG000|Screening|Physician Decision|5|||
33391739|NCT01135394|101321861|FG000|Baseline Assessment|Withdrawal by Subject|9|||
33391740|NCT01135394|101321861|FG000|Baseline Assessment|Physician Decision|3|||
33291004|NCT04092452|100962869|FG002|Overall Study|Physician Decision|1|||
33291005|NCT04092452|100962870|FG003|Overall Study|Physician Decision|0|||
33291006|NCT04092452|100962867|FG000|Overall Study|Pregnancy|2|||
33291007|NCT04092452|100962868|FG001|Overall Study|Pregnancy|0|||
33291008|NCT04092452|100962869|FG002|Overall Study|Pregnancy|0|||
33291009|NCT04092452|100962870|FG003|Overall Study|Pregnancy|0|||
33291010|NCT04092452|100962867|FG000|Overall Study|Protocol Deviation|1|||
33291011|NCT04092452|100962868|FG001|Overall Study|Protocol Deviation|0|||
33291012|NCT04092452|100962869|FG002|Overall Study|Protocol Deviation|0|||
33291013|NCT04092452|100962870|FG003|Overall Study|Protocol Deviation|0|||
33291014|NCT04092452|100962867|FG000|Overall Study|Withdrawal by Subject|3|||
33291015|NCT04092452|100962868|FG001|Overall Study|Withdrawal by Subject|10|||
33291016|NCT04092452|100962869|FG002|Overall Study|Withdrawal by Subject|3|||
33291017|NCT04092452|100962870|FG003|Overall Study|Withdrawal by Subject|5|||
33291018|NCT04092452|100962867|FG000|Overall Study|Other|0|||
33291019|NCT04092452|100962868|FG001|Overall Study|Other|0|||
33291020|NCT04092452|100962869|FG002|Overall Study|Other|1|||
33291021|NCT04092452|100962870|FG003|Overall Study|Other|2|||
33291022|NCT00302159|100962872|FG000|Overall Study|pt declined before treatment started|1|||
33291023|NCT00302159|100962872|FG000|Overall Study|pt started Avastin|1|||
33291024|NCT02643628|100962876|FG000|Overall Study|Lost to Follow-up|1|||
33291025|NCT02643628|100962877|FG001|Overall Study|Lost to Follow-up|4|||
33291026|NCT02643628|100962876|FG000|Overall Study|Withdrawal by Subject|0|||
33291027|NCT02643628|100962877|FG001|Overall Study|Withdrawal by Subject|1|||
33291028|NCT02643628|100962876|FG000|Overall Study|Relocated out of state|0|||
33291029|NCT02643628|100962877|FG001|Overall Study|Relocated out of state|1|||
33291030|NCT01952847|100962878|FG000|Overall Study|Ineligible|1|||
33291031|NCT01952847|100962879|FG001|Overall Study|Ineligible|0|||
33291032|NCT01952847|100962880|FG002|Overall Study|Ineligible|0|||
33291033|NCT01952847|100962881|FG003|Overall Study|Ineligible|0|||
33291034|NCT01952847|100962878|FG000|Overall Study|Lack of Insurance Coverage|0|||
33291035|NCT01952847|100962879|FG001|Overall Study|Lack of Insurance Coverage|1|||
33291036|NCT01952847|100962880|FG002|Overall Study|Lack of Insurance Coverage|0|||
33291037|NCT01952847|100962881|FG003|Overall Study|Lack of Insurance Coverage|0|||
33291038|NCT01952847|100962878|FG000|Overall Study|Withdrawal by Subject|1|||
33291039|NCT01952847|100962879|FG001|Overall Study|Withdrawal by Subject|1|||
33291040|NCT01952847|100962880|FG002|Overall Study|Withdrawal by Subject|0|||
33291041|NCT01952847|100962881|FG003|Overall Study|Withdrawal by Subject|1|||
33291042|NCT00992992|100962882|FG000|Overall Study|Lost to Follow-up|3|||
33291043|NCT00992992|100962882|FG000|Overall Study|Death|16|||
33291044|NCT00992992|100962882|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
33291045|NCT00992992|100962882|FG000|Overall Study|Sponsor Closed the Study|4|||
33291046|NCT02719743|100962883|FG000|Overall Study|Consent withdrawal|0|||
33291047|NCT02719743|100962884|FG001|Overall Study|Consent withdrawal|2|||
33291048|NCT02719743|100962885|FG002|Overall Study|Consent withdrawal|0|||
33291049|NCT02719743|100962886|FG003|Overall Study|Consent withdrawal|1|||
33291050|NCT02719743|100962887|FG004|Overall Study|Consent withdrawal|0|||
33291051|NCT02719743|100962883|FG000|Overall Study|Migrated/moved from study area|0|||
33291052|NCT02719743|100962884|FG001|Overall Study|Migrated/moved from study area|0|||
33291053|NCT02719743|100962885|FG002|Overall Study|Migrated/moved from study area|0|||
33291054|NCT02719743|100962886|FG003|Overall Study|Migrated/moved from study area|0|||
33291055|NCT02719743|100962887|FG004|Overall Study|Migrated/moved from study area|2|||
33291056|NCT02719743|100962883|FG000|Overall Study|Lost to Follow-up|1|||
33291057|NCT02719743|100962884|FG001|Overall Study|Lost to Follow-up|1|||
33291058|NCT02719743|100962885|FG002|Overall Study|Lost to Follow-up|0|||
33291059|NCT02719743|100962886|FG003|Overall Study|Lost to Follow-up|0|||
33291060|NCT02719743|100962887|FG004|Overall Study|Lost to Follow-up|0|||
33291061|NCT00113269|100962892|FG000|Overall Study|Not transplanted, donor issues|4|||
33291062|NCT00113269|100962893|FG001|Overall Study|Not transplanted, donor issues|0|||
33291063|NCT00113269|100962894|FG002|Overall Study|Not transplanted, donor issues|2|||
33291064|NCT00113269|100962895|FG003|Overall Study|Not transplanted, donor issues|2|||
33291065|NCT00113269|100962892|FG000|Overall Study|Not transplanted, recipient issues|2|||
33291066|NCT00113269|100962893|FG001|Overall Study|Not transplanted, recipient issues|1|||
33291067|NCT00113269|100962894|FG002|Overall Study|Not transplanted, recipient issues|7|||
33291068|NCT00113269|100962895|FG003|Overall Study|Not transplanted, recipient issues|4|||
33291069|NCT00113269|100962892|FG000|Overall Study|Early graft loss, technical|0|||
33291070|NCT00113269|100962893|FG001|Overall Study|Early graft loss, technical|0|||
33291071|NCT00113269|100962894|FG002|Overall Study|Early graft loss, technical|2|||
33291072|NCT00113269|100962895|FG003|Overall Study|Early graft loss, technical|0|||
33291073|NCT00113269|100962892|FG000|Overall Study|Death in operating room|0|||
33291074|NCT00113269|100962893|FG001|Overall Study|Death in operating room|0|||
33291075|NCT00113269|100962894|FG002|Overall Study|Death in operating room|0|||
33291076|NCT00113269|100962895|FG003|Overall Study|Death in operating room|1|||
33291077|NCT00113269|100962892|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
33291078|NCT00113269|100962893|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
33291079|NCT00113269|100962894|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
33599161|NCT00919867|102084817|FG002|First Intervention|Physician Decision|0|||
33291080|NCT00113269|100962895|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
33291081|NCT00113269|100962892|FG000|Overall Study|Adverse Event|2|||
33291082|NCT00113269|100962893|FG001|Overall Study|Adverse Event|7|||
33291083|NCT00113269|100962894|FG002|Overall Study|Adverse Event|11|||
33291084|NCT00113269|100962895|FG003|Overall Study|Adverse Event|7|||
33291085|NCT00113269|100962892|FG000|Overall Study|Withdrawal by Subject|4|||
33291086|NCT00113269|100962893|FG001|Overall Study|Withdrawal by Subject|3|||
33291087|NCT00113269|100962894|FG002|Overall Study|Withdrawal by Subject|4|||
33291088|NCT00113269|100962895|FG003|Overall Study|Withdrawal by Subject|2|||
33291089|NCT00113269|100962892|FG000|Overall Study|Graft loss|6|||
33291090|NCT00113269|100962893|FG001|Overall Study|Graft loss|6|||
33291091|NCT00113269|100962894|FG002|Overall Study|Graft loss|4|||
33291092|NCT00113269|100962895|FG003|Overall Study|Graft loss|9|||
33291093|NCT00113269|100962892|FG000|Overall Study|Protocol Violation|1|||
33291094|NCT00113269|100962893|FG001|Overall Study|Protocol Violation|0|||
33291095|NCT00113269|100962894|FG002|Overall Study|Protocol Violation|4|||
33291096|NCT00113269|100962895|FG003|Overall Study|Protocol Violation|2|||
33291097|NCT00113269|100962892|FG000|Overall Study|Lost to Follow-up|2|||
33291098|NCT00113269|100962893|FG001|Overall Study|Lost to Follow-up|3|||
33291099|NCT00113269|100962894|FG002|Overall Study|Lost to Follow-up|6|||
33291100|NCT00113269|100962895|FG003|Overall Study|Lost to Follow-up|3|||
33291101|NCT00113269|100962892|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
33291102|NCT00113269|100962893|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
33291103|NCT00113269|100962894|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
33291104|NCT00113269|100962895|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
33291105|NCT00113269|100962892|FG000|Overall Study|Discontinued due to rejection|0|||
33291106|NCT00113269|100962893|FG001|Overall Study|Discontinued due to rejection|0|||
33291107|NCT00113269|100962894|FG002|Overall Study|Discontinued due to rejection|1|||
33291108|NCT00113269|100962895|FG003|Overall Study|Discontinued due to rejection|0|||
33291109|NCT00113269|100962892|FG000|Overall Study|Moved|0|||
33291110|NCT00113269|100962893|FG001|Overall Study|Moved|1|||
33291111|NCT00113269|100962894|FG002|Overall Study|Moved|0|||
33291112|NCT00113269|100962895|FG003|Overall Study|Moved|3|||
33291113|NCT00113269|100962892|FG000|Overall Study|Received pancreas transplant|0|||
33291114|NCT00113269|100962893|FG001|Overall Study|Received pancreas transplant|0|||
33291115|NCT00113269|100962894|FG002|Overall Study|Received pancreas transplant|0|||
33291116|NCT00113269|100962895|FG003|Overall Study|Received pancreas transplant|2|||
33291117|NCT00113269|100962892|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
33291118|NCT00113269|100962893|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
33291119|NCT00113269|100962894|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
33291120|NCT00113269|100962895|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
33291121|NCT00113269|100962892|FG000|Overall Study|Did not meet eligibility criteria|1|||
33291122|NCT00113269|100962893|FG001|Overall Study|Did not meet eligibility criteria|0|||
33291123|NCT00113269|100962894|FG002|Overall Study|Did not meet eligibility criteria|0|||
33291124|NCT00113269|100962895|FG003|Overall Study|Did not meet eligibility criteria|1|||
33291125|NCT00113269|100962892|FG000|Overall Study|Unable to return for follow up|2|||
33291126|NCT00113269|100962893|FG001|Overall Study|Unable to return for follow up|1|||
33291127|NCT00113269|100962894|FG002|Overall Study|Unable to return for follow up|0|||
33291128|NCT00113269|100962895|FG003|Overall Study|Unable to return for follow up|0|||
33188210|NCT01652716|100597992|FG000|Overall Study|Administrative|0|||
33291129|NCT00784147|100962896|FG000|Overall Study|Lost to Follow-up|2|||
33291130|NCT00784147|100962897|FG001|Overall Study|Lost to Follow-up|4|||
33291131|NCT00784147|100962896|FG000|Overall Study|Withdrawal by Subject|1|||
33291132|NCT00784147|100962897|FG001|Overall Study|Withdrawal by Subject|3|||
33291133|NCT00784147|100962896|FG000|Overall Study|Physician Decision|2|||
33291134|NCT00784147|100962897|FG001|Overall Study|Physician Decision|1|||
33291135|NCT00784147|100962896|FG000|Overall Study|Protocol Violation|1|||
33291136|NCT00784147|100962897|FG001|Overall Study|Protocol Violation|1|||
33291137|NCT00784147|100962896|FG000|Overall Study|Death|2|||
33291138|NCT00784147|100962897|FG001|Overall Study|Death|0|||
33291139|NCT02636608|100962898|FG000|Overall Study|Failure to Return|4|||
33291140|NCT02636608|100962898|FG000|Overall Study|Insufficient Virological Response|1|||
33391741|NCT01135394|101321861|FG000|Baseline Assessment|Lost to Follow-up|2|||
33391742|NCT01135394|101321861|FG000|Baseline Assessment|Adverse Event|1|||
33291141|NCT02636608|100962898|FG000|Overall Study|Death|3|||
33291142|NCT02636608|100962898|FG000|Overall Study|Other|2|||
33291143|NCT02636608|100962898|FG000|Overall Study|Did Not Receive Treatment|1|||
33291144|NCT00250432|100962899|FG000|Overall Study|Adverse Event|25|||
33291145|NCT00250432|100962900|FG001|Overall Study|Adverse Event|29|||
33291146|NCT00250432|100962899|FG000|Overall Study|Lack of Efficacy|2|||
33291147|NCT00250432|100962900|FG001|Overall Study|Lack of Efficacy|1|||
33291148|NCT00250432|100962899|FG000|Overall Study|Lost to Follow-up|6|||
33291149|NCT00250432|100962900|FG001|Overall Study|Lost to Follow-up|5|||
33291150|NCT00250432|100962899|FG000|Overall Study|Patient Moved|0|||
33291151|NCT00250432|100962900|FG001|Overall Study|Patient Moved|1|||
33291152|NCT00250432|100962899|FG000|Overall Study|Protocol Violation|0|||
33291153|NCT00250432|100962900|FG001|Overall Study|Protocol Violation|3|||
33291154|NCT00250432|100962899|FG000|Overall Study|Withdrawal by Subject|6|||
33291155|NCT00250432|100962900|FG001|Overall Study|Withdrawal by Subject|2|||
33291156|NCT00250432|100962899|FG000|Overall Study|Pt died out of posttherapy report period|6|||
33291157|NCT00250432|100962900|FG001|Overall Study|Pt died out of posttherapy report period|5|||
33291158|NCT00250432|100962899|FG000|Overall Study|Pt was considered untreatable|0|||
33291159|NCT00250432|100962900|FG001|Overall Study|Pt was considered untreatable|1|||
33291160|NCT00511836|100962901|FG000|Double-blind Period|Lost to Follow-up|1|||
33291161|NCT00511836|100962902|FG001|Double-blind Period|Lost to Follow-up|0|||
33291162|NCT01130168|100962903|FG000|Period 1|Withdrawal by Subject|0|||
33291163|NCT01130168|100962904|FG001|Period 1|Withdrawal by Subject|1|||
33291164|NCT01130168|100962905|FG002|Period 1|Withdrawal by Subject|0|||
33291165|NCT01130168|100962906|FG003|Period 1|Withdrawal by Subject|1|||
33291166|NCT01130168|100962907|FG004|Period 1|Withdrawal by Subject|0|||
33291167|NCT01130168|100962908|FG005|Period 1|Withdrawal by Subject|0|||
33291168|NCT01130168|100962903|FG000|Period 1|Discontinued For Other Reason|0|||
33291169|NCT01130168|100962904|FG001|Period 1|Discontinued For Other Reason|0|||
33291170|NCT01130168|100962905|FG002|Period 1|Discontinued For Other Reason|1|||
33291171|NCT01130168|100962906|FG003|Period 1|Discontinued For Other Reason|1|||
33291172|NCT01130168|100962907|FG004|Period 1|Discontinued For Other Reason|0|||
33291173|NCT01130168|100962908|FG005|Period 1|Discontinued For Other Reason|0|||
33291174|NCT01130168|100962903|FG000|Period 1|Adverse Event|0|||
33291175|NCT01130168|100962904|FG001|Period 1|Adverse Event|0|||
33291176|NCT01130168|100962905|FG002|Period 1|Adverse Event|0|||
33291177|NCT01130168|100962906|FG003|Period 1|Adverse Event|1|||
33291178|NCT01130168|100962907|FG004|Period 1|Adverse Event|0|||
33291179|NCT01130168|100962908|FG005|Period 1|Adverse Event|0|||
33291180|NCT01390441|100962912|FG000|Treatment Period|Protocol Violation|0|||
33291181|NCT01390441|100962913|FG001|Treatment Period|Protocol Violation|1|||
33291182|NCT01390441|100962914|FG002|Treatment Period|Protocol Violation|0|||
33291183|NCT01390441|100962915|FG003|Treatment Period|Protocol Violation|0|||
33291184|NCT01390441|100962916|FG004|Treatment Period|Protocol Violation|0|||
33291185|NCT01390441|100962912|FG000|Treatment Period|Physician Decision|0|||
33291186|NCT01390441|100962913|FG001|Treatment Period|Physician Decision|0|||
33291187|NCT01390441|100962914|FG002|Treatment Period|Physician Decision|0|||
33291188|NCT01390441|100962915|FG003|Treatment Period|Physician Decision|1|||
33291189|NCT01390441|100962916|FG004|Treatment Period|Physician Decision|0|||
33291190|NCT01390441|100962912|FG000|Treatment Period|Lack of Efficacy|0|||
33291191|NCT01390441|100962913|FG001|Treatment Period|Lack of Efficacy|0|||
33291192|NCT01390441|100962914|FG002|Treatment Period|Lack of Efficacy|0|||
33291193|NCT01390441|100962915|FG003|Treatment Period|Lack of Efficacy|0|||
33291194|NCT01390441|100962916|FG004|Treatment Period|Lack of Efficacy|1|||
33291195|NCT01390441|100962912|FG000|Treatment Period|Unknown due to early stopping of study|0|||
33291196|NCT01390441|100962913|FG001|Treatment Period|Unknown due to early stopping of study|0|||
33291197|NCT01390441|100962914|FG002|Treatment Period|Unknown due to early stopping of study|8|||
33291198|NCT01390441|100962915|FG003|Treatment Period|Unknown due to early stopping of study|11|||
33291199|NCT01390441|100962916|FG004|Treatment Period|Unknown due to early stopping of study|7|||
33291200|NCT01390441|100962912|FG000|Treatment Period|Adverse Event|0|||
33291201|NCT01390441|100962913|FG001|Treatment Period|Adverse Event|0|||
33291202|NCT01390441|100962914|FG002|Treatment Period|Adverse Event|1|||
33291203|NCT01390441|100962915|FG003|Treatment Period|Adverse Event|1|||
33291204|NCT01390441|100962916|FG004|Treatment Period|Adverse Event|2|||
33291205|NCT01390441|100962912|FG000|Treatment Period|Withdrawal by Subject|0|||
33291206|NCT01390441|100962913|FG001|Treatment Period|Withdrawal by Subject|0|||
33291207|NCT01390441|100962914|FG002|Treatment Period|Withdrawal by Subject|1|||
33291208|NCT01390441|100962915|FG003|Treatment Period|Withdrawal by Subject|0|||
33291209|NCT01390441|100962916|FG004|Treatment Period|Withdrawal by Subject|1|||
33291210|NCT01390441|100962912|FG000|Treatment Period|Lost to Follow-up|1|||
33291211|NCT01390441|100962913|FG001|Treatment Period|Lost to Follow-up|0|||
33291212|NCT01390441|100962914|FG002|Treatment Period|Lost to Follow-up|0|||
33291213|NCT01390441|100962915|FG003|Treatment Period|Lost to Follow-up|0|||
33291214|NCT01390441|100962916|FG004|Treatment Period|Lost to Follow-up|0|||
33291215|NCT01390441|100962912|FG000|Extension Period|Protocol Violation|3|||
33291216|NCT01390441|100962913|FG001|Extension Period|Protocol Violation|1|||
33291217|NCT01390441|100962914|FG002|Extension Period|Protocol Violation|0|||
33291218|NCT01390441|100962915|FG003|Extension Period|Protocol Violation|1|||
33291219|NCT01390441|100962916|FG004|Extension Period|Protocol Violation|0|||
33291220|NCT00543062|100962917|FG000|Overall Study|Withdrawal by Subject|1|||
33291221|NCT00543062|100962918|FG001|Overall Study|Withdrawal by Subject|0|||
33291222|NCT00543062|100962919|FG002|Overall Study|Withdrawal by Subject|2|||
33291223|NCT00543062|100962920|FG003|Overall Study|Withdrawal by Subject|0|||
33291224|NCT00543062|100962917|FG000|Overall Study|Adverse Event|0|||
33291225|NCT00543062|100962918|FG001|Overall Study|Adverse Event|1|||
33291226|NCT00543062|100962919|FG002|Overall Study|Adverse Event|1|||
33291227|NCT00543062|100962920|FG003|Overall Study|Adverse Event|1|||
33291228|NCT00543062|100962917|FG000|Overall Study|Protocol Violation|1|||
33291229|NCT00543062|100962918|FG001|Overall Study|Protocol Violation|0|||
33291230|NCT00543062|100962919|FG002|Overall Study|Protocol Violation|0|||
33291231|NCT00543062|100962920|FG003|Overall Study|Protocol Violation|0|||
33291232|NCT01236352|100962925|FG000|Overall Study|Death|0|||
33291233|NCT01236352|100962926|FG001|Overall Study|Death|0|||
33291234|NCT01236352|100962927|FG002|Overall Study|Death|0|||
33291235|NCT01236352|100962928|FG003|Overall Study|Death|0|||
33291236|NCT01236352|100962929|FG004|Overall Study|Death|0|||
33291237|NCT01236352|100962930|FG005|Overall Study|Death|0|||
33291238|NCT01236352|100962931|FG006|Overall Study|Death|0|||
33291239|NCT01236352|100962932|FG007|Overall Study|Death|1|||
33291240|NCT01236352|100962933|FG008|Overall Study|Death|0|||
33291241|NCT01236352|100962934|FG009|Overall Study|Death|0|||
33291242|NCT01236352|100962935|FG010|Overall Study|Death|0|||
33291243|NCT01236352|100962925|FG000|Overall Study|Withdrawal by Subject|0|||
33291244|NCT01236352|100962926|FG001|Overall Study|Withdrawal by Subject|0|||
33291245|NCT01236352|100962927|FG002|Overall Study|Withdrawal by Subject|0|||
33291246|NCT01236352|100962928|FG003|Overall Study|Withdrawal by Subject|0|||
33291247|NCT01236352|100962929|FG004|Overall Study|Withdrawal by Subject|0|||
33291248|NCT01236352|100962930|FG005|Overall Study|Withdrawal by Subject|0|||
33291249|NCT01236352|100962931|FG006|Overall Study|Withdrawal by Subject|0|||
33291250|NCT01236352|100962932|FG007|Overall Study|Withdrawal by Subject|0|||
33291251|NCT01236352|100962933|FG008|Overall Study|Withdrawal by Subject|0|||
33291252|NCT01236352|100962934|FG009|Overall Study|Withdrawal by Subject|2|||
33291253|NCT01236352|100962935|FG010|Overall Study|Withdrawal by Subject|1|||
33291254|NCT01236352|100962925|FG000|Overall Study|Adverse Event|0|||
33291255|NCT01236352|100962926|FG001|Overall Study|Adverse Event|0|||
33291256|NCT01236352|100962927|FG002|Overall Study|Adverse Event|0|||
33291257|NCT01236352|100962928|FG003|Overall Study|Adverse Event|0|||
33291258|NCT01236352|100962929|FG004|Overall Study|Adverse Event|0|||
33291259|NCT01236352|100962930|FG005|Overall Study|Adverse Event|0|||
33291260|NCT01236352|100962931|FG006|Overall Study|Adverse Event|2|||
33291261|NCT01236352|100962932|FG007|Overall Study|Adverse Event|0|||
33291262|NCT01236352|100962933|FG008|Overall Study|Adverse Event|0|||
33291263|NCT01236352|100962934|FG009|Overall Study|Adverse Event|4|||
33291264|NCT01236352|100962935|FG010|Overall Study|Adverse Event|1|||
33291265|NCT01236352|100962925|FG000|Overall Study|Study drug toxicity|0|||
33291266|NCT01236352|100962926|FG001|Overall Study|Study drug toxicity|0|||
33291267|NCT01236352|100962927|FG002|Overall Study|Study drug toxicity|0|||
33291268|NCT01236352|100962928|FG003|Overall Study|Study drug toxicity|0|||
33291269|NCT01236352|100962929|FG004|Overall Study|Study drug toxicity|0|||
33291270|NCT01236352|100962930|FG005|Overall Study|Study drug toxicity|1|||
33291271|NCT01236352|100962931|FG006|Overall Study|Study drug toxicity|1|||
33291272|NCT01236352|100962932|FG007|Overall Study|Study drug toxicity|0|||
33291273|NCT01236352|100962933|FG008|Overall Study|Study drug toxicity|0|||
33291274|NCT01236352|100962934|FG009|Overall Study|Study drug toxicity|2|||
33291275|NCT01236352|100962935|FG010|Overall Study|Study drug toxicity|2|||
33291276|NCT01236352|100962925|FG000|Overall Study|Disease progression|1|||
33291277|NCT01236352|100962926|FG001|Overall Study|Disease progression|2|||
33291278|NCT01236352|100962927|FG002|Overall Study|Disease progression|1|||
33291279|NCT01236352|100962928|FG003|Overall Study|Disease progression|2|||
33291280|NCT01236352|100962929|FG004|Overall Study|Disease progression|2|||
33291281|NCT01236352|100962930|FG005|Overall Study|Disease progression|2|||
33291282|NCT01236352|100962931|FG006|Overall Study|Disease progression|1|||
33291283|NCT01236352|100962932|FG007|Overall Study|Disease progression|3|||
33291284|NCT01236352|100962933|FG008|Overall Study|Disease progression|2|||
33291285|NCT01236352|100962934|FG009|Overall Study|Disease progression|2|||
33291286|NCT01236352|100962935|FG010|Overall Study|Disease progression|2|||
33291287|NCT01236352|100962925|FG000|Overall Study|Poor/Non-compliance|1|||
33291288|NCT01236352|100962926|FG001|Overall Study|Poor/Non-compliance|0|||
33291289|NCT01236352|100962927|FG002|Overall Study|Poor/Non-compliance|0|||
33291290|NCT01236352|100962928|FG003|Overall Study|Poor/Non-compliance|0|||
33291291|NCT01236352|100962929|FG004|Overall Study|Poor/Non-compliance|0|||
33291292|NCT01236352|100962930|FG005|Overall Study|Poor/Non-compliance|0|||
33291293|NCT01236352|100962931|FG006|Overall Study|Poor/Non-compliance|0|||
33291294|NCT01236352|100962932|FG007|Overall Study|Poor/Non-compliance|0|||
33291295|NCT01236352|100962933|FG008|Overall Study|Poor/Non-compliance|0|||
33291296|NCT01236352|100962934|FG009|Overall Study|Poor/Non-compliance|0|||
33291297|NCT01236352|100962935|FG010|Overall Study|Poor/Non-compliance|0|||
33291298|NCT01236352|100962925|FG000|Overall Study|Maximum clinical benefit|1|||
33291299|NCT01236352|100962926|FG001|Overall Study|Maximum clinical benefit|1|||
33291300|NCT01236352|100962927|FG002|Overall Study|Maximum clinical benefit|1|||
33291301|NCT01236352|100962928|FG003|Overall Study|Maximum clinical benefit|0|||
33291302|NCT01236352|100962929|FG004|Overall Study|Maximum clinical benefit|2|||
33291303|NCT01236352|100962930|FG005|Overall Study|Maximum clinical benefit|0|||
33391743|NCT01135394|101321861|FG000|Study Treatment|Withdrawal by Subject|1|||
33291304|NCT01236352|100962931|FG006|Overall Study|Maximum clinical benefit|3|||
33291305|NCT01236352|100962932|FG007|Overall Study|Maximum clinical benefit|1|||
33291306|NCT01236352|100962933|FG008|Overall Study|Maximum clinical benefit|1|||
33291307|NCT01236352|100962934|FG009|Overall Study|Maximum clinical benefit|4|||
33291308|NCT01236352|100962935|FG010|Overall Study|Maximum clinical benefit|2|||
33291309|NCT01236352|100962925|FG000|Overall Study|Subject request to discontinue treatment|0|||
33291310|NCT01236352|100962926|FG001|Overall Study|Subject request to discontinue treatment|0|||
33291311|NCT01236352|100962927|FG002|Overall Study|Subject request to discontinue treatment|1|||
33291312|NCT01236352|100962928|FG003|Overall Study|Subject request to discontinue treatment|1|||
33291313|NCT01236352|100962929|FG004|Overall Study|Subject request to discontinue treatment|0|||
33291314|NCT01236352|100962930|FG005|Overall Study|Subject request to discontinue treatment|1|||
33291315|NCT01236352|100962931|FG006|Overall Study|Subject request to discontinue treatment|0|||
33291316|NCT01236352|100962932|FG007|Overall Study|Subject request to discontinue treatment|0|||
33291317|NCT01236352|100962933|FG008|Overall Study|Subject request to discontinue treatment|0|||
33291318|NCT01236352|100962934|FG009|Overall Study|Subject request to discontinue treatment|1|||
33291319|NCT01236352|100962935|FG010|Overall Study|Subject request to discontinue treatment|4|||
33291320|NCT01236352|100962925|FG000|Overall Study|Subject to receive drug via EAP|1|||
33291321|NCT01236352|100962926|FG001|Overall Study|Subject to receive drug via EAP|1|||
33291322|NCT01236352|100962927|FG002|Overall Study|Subject to receive drug via EAP|1|||
33291323|NCT01236352|100962928|FG003|Overall Study|Subject to receive drug via EAP|0|||
33291324|NCT01236352|100962929|FG004|Overall Study|Subject to receive drug via EAP|0|||
33291325|NCT01236352|100962930|FG005|Overall Study|Subject to receive drug via EAP|0|||
33291326|NCT01236352|100962931|FG006|Overall Study|Subject to receive drug via EAP|0|||
33291327|NCT01236352|100962932|FG007|Overall Study|Subject to receive drug via EAP|2|||
33291328|NCT01236352|100962933|FG008|Overall Study|Subject to receive drug via EAP|0|||
33291329|NCT01236352|100962934|FG009|Overall Study|Subject to receive drug via EAP|4|||
33291330|NCT01236352|100962935|FG010|Overall Study|Subject to receive drug via EAP|0|||
33291331|NCT01236352|100962925|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
33291332|NCT01236352|100962926|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
33291333|NCT01236352|100962927|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
33291334|NCT01236352|100962928|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
33291335|NCT01236352|100962929|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
33291336|NCT01236352|100962930|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
33291337|NCT01236352|100962931|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
33291338|NCT01236352|100962932|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
33291339|NCT01236352|100962933|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
33291340|NCT01236352|100962934|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
33291341|NCT01236352|100962935|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
33291342|NCT01236352|100962925|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33291343|NCT01236352|100962926|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33291344|NCT01236352|100962927|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33291345|NCT01236352|100962928|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33291346|NCT01236352|100962929|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33291347|NCT01236352|100962930|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33291348|NCT01236352|100962931|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33291349|NCT01236352|100962932|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33291350|NCT01236352|100962933|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33291351|NCT01236352|100962934|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
33291352|NCT01236352|100962935|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
33291353|NCT01236352|100962925|FG000|Overall Study|Lack of response to drug|0|||
33291354|NCT01236352|100962926|FG001|Overall Study|Lack of response to drug|0|||
33291355|NCT01236352|100962927|FG002|Overall Study|Lack of response to drug|0|||
33291356|NCT01236352|100962928|FG003|Overall Study|Lack of response to drug|0|||
33291357|NCT01236352|100962929|FG004|Overall Study|Lack of response to drug|0|||
33291358|NCT01236352|100962930|FG005|Overall Study|Lack of response to drug|0|||
33291359|NCT01236352|100962931|FG006|Overall Study|Lack of response to drug|0|||
33291360|NCT01236352|100962932|FG007|Overall Study|Lack of response to drug|0|||
33291361|NCT01236352|100962933|FG008|Overall Study|Lack of response to drug|0|||
33291362|NCT01236352|100962934|FG009|Overall Study|Lack of response to drug|1|||
33291363|NCT01236352|100962935|FG010|Overall Study|Lack of response to drug|1|||
33291364|NCT01236352|100962925|FG000|Overall Study|Patient transferred to IST|0|||
33291365|NCT01236352|100962926|FG001|Overall Study|Patient transferred to IST|0|||
33291366|NCT01236352|100962927|FG002|Overall Study|Patient transferred to IST|0|||
33291367|NCT01236352|100962928|FG003|Overall Study|Patient transferred to IST|0|||
33291368|NCT01236352|100962929|FG004|Overall Study|Patient transferred to IST|0|||
33291369|NCT01236352|100962930|FG005|Overall Study|Patient transferred to IST|0|||
33291370|NCT01236352|100962931|FG006|Overall Study|Patient transferred to IST|0|||
33291371|NCT01236352|100962932|FG007|Overall Study|Patient transferred to IST|0|||
33291372|NCT01236352|100962933|FG008|Overall Study|Patient transferred to IST|0|||
33291373|NCT01236352|100962934|FG009|Overall Study|Patient transferred to IST|2|||
33291374|NCT01236352|100962935|FG010|Overall Study|Patient transferred to IST|6|||
33291375|NCT01322009|100962936|FG000|Overall Study|Death|0|||
33291376|NCT01322009|100962937|FG001|Overall Study|Death|1|||
33291377|NCT01322009|100962936|FG000|Overall Study|Adverse Event|0|||
33291378|NCT01322009|100962937|FG001|Overall Study|Adverse Event|1|||
33291379|NCT01322009|100962936|FG000|Overall Study|ng tube discontinued|0|||
33291380|NCT01322009|100962937|FG001|Overall Study|ng tube discontinued|1|||
33291381|NCT03178045|100962938|FG000|Overall Study|Withdrawal by Subject|5|||
33291382|NCT03178045|100962939|FG001|Overall Study|Withdrawal by Subject|7|||
33291383|NCT03178045|100962938|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
33291384|NCT03178045|100962939|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
33291385|NCT03178045|100962938|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
33291386|NCT03178045|100962939|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
33291387|NCT03113383|100962940|FG000|Overall Study|Death|4|||
33291388|NCT03113383|100962941|FG001|Overall Study|Death|0|||
33291389|NCT00909532|100962942|FG000|Overall Study|Adverse Event|4|||
33291390|NCT00909532|100962943|FG001|Overall Study|Adverse Event|1|||
33291391|NCT00909532|100962942|FG000|Overall Study|Pregnancy|0|||
33291392|NCT00909532|100962943|FG001|Overall Study|Pregnancy|1|||
33291393|NCT00909532|100962942|FG000|Overall Study|Prohibited Medication|2|||
33291394|NCT00909532|100962943|FG001|Overall Study|Prohibited Medication|1|||
33291395|NCT00909532|100962942|FG000|Overall Study|Withdrawal of Consent|1|||
33291396|NCT00909532|100962943|FG001|Overall Study|Withdrawal of Consent|1|||
33291397|NCT00909532|100962942|FG000|Overall Study|Noncompliance with Study Requirements|0|||
33291398|NCT00909532|100962943|FG001|Overall Study|Noncompliance with Study Requirements|2|||
33291399|NCT00909532|100962942|FG000|Overall Study|Physician Decision|1|||
33291400|NCT00909532|100962943|FG001|Overall Study|Physician Decision|0|||
33291401|NCT00909532|100962942|FG000|Overall Study|Wrong Genotype|1|||
33291402|NCT00909532|100962943|FG001|Overall Study|Wrong Genotype|0|||
33291403|NCT00909532|100962942|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
33291404|NCT00909532|100962943|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
33291405|NCT02630706|100962944|FG000|Overall Study|Adverse Event|2|||
33291406|NCT02630706|100962945|FG001|Overall Study|Adverse Event|1|||
33291407|NCT02630706|100962946|FG002|Overall Study|Adverse Event|1|||
33291408|NCT02630706|100962944|FG000|Overall Study|Lost to Follow-up|0|||
33291409|NCT02630706|100962945|FG001|Overall Study|Lost to Follow-up|1|||
33291410|NCT02630706|100962946|FG002|Overall Study|Lost to Follow-up|2|||
33291411|NCT02630706|100962944|FG000|Overall Study|Physician Decision|1|||
33291412|NCT02630706|100962945|FG001|Overall Study|Physician Decision|1|||
33291413|NCT02630706|100962946|FG002|Overall Study|Physician Decision|0|||
33291414|NCT02630706|100962944|FG000|Overall Study|Pregnancy|0|||
33291415|NCT02630706|100962945|FG001|Overall Study|Pregnancy|1|||
33291416|NCT02630706|100962946|FG002|Overall Study|Pregnancy|0|||
33291417|NCT02630706|100962944|FG000|Overall Study|Withdrawal by Subject|4|||
33291418|NCT02630706|100962945|FG001|Overall Study|Withdrawal by Subject|5|||
33291419|NCT02630706|100962946|FG002|Overall Study|Withdrawal by Subject|7|||
33291420|NCT01262092|100962947|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
33291421|NCT01262092|100962948|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
33291422|NCT01262092|100962947|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
33291423|NCT01262092|100962948|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
33291424|NCT01262092|100962947|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
33291425|NCT01262092|100962948|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
33291426|NCT01262092|100962947|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
33291427|NCT01262092|100962948|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
33291428|NCT00727506|100962949|FG000|Overall Study|Adverse Event|0|||
33291429|NCT00727506|100962950|FG001|Overall Study|Adverse Event|0|||
33291430|NCT00727506|100962951|FG002|Overall Study|Adverse Event|4|||
33291431|NCT00727506|100962952|FG003|Overall Study|Adverse Event|4|||
33291432|NCT00727506|100962953|FG004|Overall Study|Adverse Event|1|||
33291433|NCT00727506|100962954|FG005|Overall Study|Adverse Event|8|||
33291434|NCT00727506|100962949|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
33291435|NCT00727506|100962950|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33291436|NCT00727506|100962951|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
33291437|NCT00727506|100962952|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33599162|NCT00919867|102084818|FG003|First Intervention|Physician Decision|0|||
33291438|NCT00727506|100962953|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33291439|NCT00727506|100962954|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33291440|NCT00727506|100962949|FG000|Overall Study|Progressive disease|4|||
33291441|NCT00727506|100962950|FG001|Overall Study|Progressive disease|7|||
33291442|NCT00727506|100962951|FG002|Overall Study|Progressive disease|9|||
33291443|NCT00727506|100962952|FG003|Overall Study|Progressive disease|28|||
33291444|NCT00727506|100962953|FG004|Overall Study|Progressive disease|38|||
33291445|NCT00727506|100962954|FG005|Overall Study|Progressive disease|28|||
33291446|NCT00727506|100962949|FG000|Overall Study|Refused to continue medication|0|||
33291447|NCT00727506|100962950|FG001|Overall Study|Refused to continue medication|1|||
33291448|NCT00727506|100962951|FG002|Overall Study|Refused to continue medication|2|||
33291449|NCT00727506|100962952|FG003|Overall Study|Refused to continue medication|3|||
33291450|NCT00727506|100962953|FG004|Overall Study|Refused to continue medication|1|||
33291451|NCT00727506|100962954|FG005|Overall Study|Refused to continue medication|2|||
33291452|NCT00727506|100962949|FG000|Overall Study|Other reason not described above|0|||
33291453|NCT00727506|100962950|FG001|Overall Study|Other reason not described above|0|||
33291454|NCT00727506|100962951|FG002|Overall Study|Other reason not described above|1|||
33291455|NCT00727506|100962952|FG003|Overall Study|Other reason not described above|4|||
33291456|NCT00727506|100962953|FG004|Overall Study|Other reason not described above|1|||
33291457|NCT00727506|100962954|FG005|Overall Study|Other reason not described above|1|||
33291458|NCT03024996|100962955|FG000|Overall Study|Death|57|||
33291459|NCT03024996|100962956|FG001|Overall Study|Death|55|||
33291460|NCT03024996|100962955|FG000|Overall Study|Disease relapse|1|||
33291461|NCT03024996|100962956|FG001|Overall Study|Disease relapse|0|||
33291462|NCT03024996|100962955|FG000|Overall Study|Lost to Follow-up|5|||
33291463|NCT03024996|100962956|FG001|Overall Study|Lost to Follow-up|10|||
33291464|NCT03024996|100962955|FG000|Overall Study|Other|3|||
33291465|NCT03024996|100962956|FG001|Overall Study|Other|3|||
33291466|NCT03024996|100962955|FG000|Overall Study|Physician Decision|0|||
33291467|NCT03024996|100962956|FG001|Overall Study|Physician Decision|1|||
33291468|NCT03024996|100962955|FG000|Overall Study|Study terminated by sponsor|303|||
33291469|NCT03024996|100962956|FG001|Overall Study|Study terminated by sponsor|283|||
33291470|NCT03024996|100962955|FG000|Overall Study|Withdrawal by Subject|21|||
33291471|NCT03024996|100962956|FG001|Overall Study|Withdrawal by Subject|36|||
33291472|NCT01174264|100962957|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
33291473|NCT01174264|100962958|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
33599163|NCT00919867|102084819|FG004|First Intervention|Physician Decision|0|||
33291474|NCT01174264|100962959|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
33291475|NCT01174264|100962957|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
33291476|NCT01174264|100962958|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
33291477|NCT01174264|100962959|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
33291478|NCT01174264|100962957|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
33291479|NCT01174264|100962958|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
33291480|NCT01174264|100962959|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
33291481|NCT00358644|100962962|FG000|Overall Study|Progressive Disease|21|||
33291482|NCT00358644|100962962|FG000|Overall Study|Adverse Event|7|||
33291483|NCT00358644|100962962|FG000|Overall Study|Death|11|||
33291484|NCT00358644|100962962|FG000|Overall Study|Withdrawal by Subject|4|||
33291485|NCT00358644|100962962|FG000|Overall Study|Physician Decision|6|||
33291486|NCT00358644|100962962|FG000|Overall Study|Patient not eligible for study|1|||
33291487|NCT00447590|100962965|FG000|Overall Study|Withdrawal by Subject|26|||
33291488|NCT00447590|100962965|FG000|Overall Study|Lost to Follow-up|24|||
33291489|NCT00447590|100962965|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
33291490|NCT01929876|100966585|FG000|Period 2|Non-Compliance|1|||
33291491|NCT02561247|100966586|FG000|Overall Study|Protocol Violation|1|||
33291492|NCT02561247|100966586|FG000|Overall Study|Withdrawal by Subject|1|||
33291493|NCT02561247|100966586|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
33291494|NCT01209598|100966587|FG000|Overall Study|Withdrawal by Subject|1|||
33291495|NCT01209598|100966588|FG001|Overall Study|Withdrawal by Subject|0|||
33291496|NCT01821937|100966589|FG000|Overall Study|Adverse Event|0|||
33291497|NCT01821937|100966590|FG001|Overall Study|Adverse Event|3|||
33291498|NCT00583947|100966591|FG000|Cross-over Period|Adverse Event|2|||
33291499|NCT00583947|100966592|FG001|Cross-over Period|Adverse Event|0|||
33291500|NCT00583947|100966591|FG000|Cross-over Period|Withdrawal by Subject|2|||
33291501|NCT00583947|100966592|FG001|Cross-over Period|Withdrawal by Subject|0|||
33291502|NCT00583947|100966591|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
33291503|NCT00583947|100966592|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
33291504|NCT00583947|100966591|FG000|Cross-over Period|Other|1|||
33291505|NCT00583947|100966592|FG001|Cross-over Period|Other|1|||
33291506|NCT02209181|100966593|FG000|Overall Study|Adverse Event|1|||
33291507|NCT02209181|100966594|FG001|Overall Study|Adverse Event|0|||
33291508|NCT02209181|100966595|FG002|Overall Study|Adverse Event|1|||
33291509|NCT02209181|100966596|FG003|Overall Study|Adverse Event|0|||
33291510|NCT02209181|100966593|FG000|Overall Study|Withdrawal by Subject|0|||
33291511|NCT02209181|100966594|FG001|Overall Study|Withdrawal by Subject|1|||
33291512|NCT02209181|100966595|FG002|Overall Study|Withdrawal by Subject|0|||
33291513|NCT02209181|100966596|FG003|Overall Study|Withdrawal by Subject|0|||
33291514|NCT04468230|100966597|FG000|Overall Study|Adverse Event|2|||
33599164|NCT00919867|102084820|FG005|First Intervention|Physician Decision|1|||
33291515|NCT01646385|100966601|FG000|Overall Study|Death|202|||
33291516|NCT01646385|100966602|FG001|Overall Study|Death|222|||
33291517|NCT01646385|100966601|FG000|Overall Study|Switched to alternate biologic|636|||
33291518|NCT01646385|100966602|FG001|Overall Study|Switched to alternate biologic|649|||
33291519|NCT00490698|100966604|FG000|Overall Study|Withdrawal by Subject|1|||
33291520|NCT00490698|100966604|FG000|Overall Study|Disease Progression|7|||
33291521|NCT00490698|100966604|FG000|Overall Study|Physician Decision|2|||
33291522|NCT02287233|100966606|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
33291523|NCT02287233|100966607|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
33291524|NCT02287233|100966608|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
33291525|NCT02287233|100966606|FG000|Overall Study|Adverse Event Related to Progression|0|||
33291526|NCT02287233|100966607|FG001|Overall Study|Adverse Event Related to Progression|2|||
33291527|NCT02287233|100966608|FG002|Overall Study|Adverse Event Related to Progression|8|||
33291528|NCT02287233|100966606|FG000|Overall Study|Physician Decision|1|||
33291529|NCT02287233|100966607|FG001|Overall Study|Physician Decision|2|||
33291530|NCT02287233|100966608|FG002|Overall Study|Physician Decision|4|||
33291531|NCT02287233|100966606|FG000|Overall Study|Progressive Disease with Death|0|||
33291532|NCT02287233|100966607|FG001|Overall Study|Progressive Disease with Death|0|||
33291533|NCT02287233|100966608|FG002|Overall Study|Progressive Disease with Death|10|||
33291534|NCT02287233|100966606|FG000|Overall Study|Progressive Disease Without Death|2|||
33291535|NCT02287233|100966607|FG001|Overall Study|Progressive Disease Without Death|3|||
33291536|NCT02287233|100966608|FG002|Overall Study|Progressive Disease Without Death|20|||
33291537|NCT02287233|100966606|FG000|Overall Study|Withdrawal by Subject|1|||
33291538|NCT02287233|100966607|FG001|Overall Study|Withdrawal by Subject|1|||
33291539|NCT02287233|100966608|FG002|Overall Study|Withdrawal by Subject|7|||
33291540|NCT02287233|100966606|FG000|Overall Study|Other|3|||
33291541|NCT02287233|100966607|FG001|Overall Study|Other|0|||
33291542|NCT02287233|100966608|FG002|Overall Study|Other|15|||
33291543|NCT02287233|100966606|FG000|Overall Study|Did Not Receive Treatment|0|||
33291544|NCT02287233|100966607|FG001|Overall Study|Did Not Receive Treatment|0|||
33291545|NCT02287233|100966608|FG002|Overall Study|Did Not Receive Treatment|2|||
33291546|NCT03602586|100966609|FG000|Overall Study|Withdrawal by Subject|3|||
33291547|NCT00853372|100966612|FG000|Overall Study|Death|30|||
33291548|NCT00853372|100966613|FG001|Overall Study|Death|26|||
33291549|NCT00853372|100966612|FG000|Overall Study|Lost to Follow-up|1|||
33291550|NCT00853372|100966613|FG001|Overall Study|Lost to Follow-up|2|||
33291551|NCT00853372|100966612|FG000|Overall Study|Full Consent Withdrawn|1|||
33291552|NCT00853372|100966613|FG001|Overall Study|Full Consent Withdrawn|1|||
33291553|NCT02980523|100966614|FG000|Overall Study|Lost to Follow-up|1|||
33291554|NCT02980523|100966615|FG001|Overall Study|Lost to Follow-up|4|||
33291555|NCT02980523|100966616|FG002|Overall Study|Lost to Follow-up|1|||
33291556|NCT02980523|100966617|FG003|Overall Study|Lost to Follow-up|2|||
33291557|NCT02980523|100966618|FG004|Overall Study|Lost to Follow-up|1|||
33291558|NCT02980523|100966614|FG000|Overall Study|Excluded from analysis|1|||
33291559|NCT02980523|100966615|FG001|Overall Study|Excluded from analysis|3|||
33291560|NCT02980523|100966616|FG002|Overall Study|Excluded from analysis|1|||
33291561|NCT02980523|100966617|FG003|Overall Study|Excluded from analysis|1|||
33291562|NCT02980523|100966618|FG004|Overall Study|Excluded from analysis|1|||
33291563|NCT02980523|100966614|FG000|Overall Study|Lack of Efficacy|1|||
33291564|NCT02980523|100966615|FG001|Overall Study|Lack of Efficacy|4|||
33291565|NCT02980523|100966616|FG002|Overall Study|Lack of Efficacy|4|||
33291566|NCT02980523|100966617|FG003|Overall Study|Lack of Efficacy|5|||
33291567|NCT02980523|100966618|FG004|Overall Study|Lack of Efficacy|8|||
33291568|NCT02980523|100966614|FG000|Overall Study|Did not receive intervention|0|||
33291569|NCT02980523|100966615|FG001|Overall Study|Did not receive intervention|0|||
33291570|NCT02980523|100966616|FG002|Overall Study|Did not receive intervention|0|||
33291571|NCT02980523|100966617|FG003|Overall Study|Did not receive intervention|1|||
33291572|NCT02980523|100966618|FG004|Overall Study|Did not receive intervention|0|||
33291573|NCT00856245|100966622|FG000|Overall Study|Was not transplanted|5|||
33291574|NCT01772563|100966623|FG000|Cycle 1|Dose limiting toxicity|2|||
33291575|NCT01772563|100966623|FG000|Cycle 1|Progressive disease|2|||
33291576|NCT01772563|100966623|FG000|Cycle 2 and Beyond|Progressive disease|17|||
33291577|NCT01772563|100966623|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
33291578|NCT01772563|100966623|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
33291579|NCT00575042|100966629|FG000|Overall Study|Adverse Event|2|||
33291580|NCT00575042|100966629|FG000|Overall Study|Lost to Follow-up|1|||
33291581|NCT00632502|100966630|FG000|Overall Study|Adverse Event|0|||
33291582|NCT00632502|100966631|FG001|Overall Study|Adverse Event|1|||
33291583|NCT00632502|100966630|FG000|Overall Study|Randomized not treated|3|||
33291584|NCT00632502|100966631|FG001|Overall Study|Randomized not treated|0|||
33291585|NCT02786004|100966632|FG000|Overall Study|Withdrawal by Subject|0|||
33291586|NCT02786004|100966633|FG001|Overall Study|Withdrawal by Subject|1|||
33291587|NCT01336205|100966635|FG000|Overall Study|Other|22|||
33291588|NCT01336205|100966636|FG001|Overall Study|Other|9|||
33291589|NCT01336205|100966635|FG000|Overall Study|Lost to Follow-up|40|||
33291590|NCT01336205|100966636|FG001|Overall Study|Lost to Follow-up|20|||
33291591|NCT01336205|100966635|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
33291592|NCT01336205|100966636|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
33291593|NCT01336205|100966635|FG000|Overall Study|Lack of Efficacy|4|||
33291594|NCT01336205|100966636|FG001|Overall Study|Lack of Efficacy|0|||
33291595|NCT01336205|100966635|FG000|Overall Study|Severe noncompliance with protocol|9|||
33291596|NCT01336205|100966636|FG001|Overall Study|Severe noncompliance with protocol|2|||
33291597|NCT01336205|100966635|FG000|Overall Study|Adverse Event|56|||
33291598|NCT01336205|100966636|FG001|Overall Study|Adverse Event|6|||
33291599|NCT01336205|100966635|FG000|Overall Study|Death|1|||
33291600|NCT01336205|100966636|FG001|Overall Study|Death|1|||
33291601|NCT01336205|100966635|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
33291602|NCT01336205|100966636|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
33291603|NCT01336205|100966635|FG000|Overall Study|Withdrawal by Subject|72|||
33291604|NCT01336205|100966636|FG001|Overall Study|Withdrawal by Subject|38|||
33291605|NCT01336205|100966635|FG000|Overall Study|Did not receive treatment|4|||
33291606|NCT01336205|100966636|FG001|Overall Study|Did not receive treatment|0|||
33291607|NCT04147858|100966639|FG000|Overall Study|Adverse Event|6|||
33291608|NCT04147858|100966640|FG001|Overall Study|Adverse Event|6|||
33599165|NCT00609791|102084824|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
33599166|NCT01440517|102084825|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
33599167|NCT01442064|102084826|FG000|Overall Study|Adverse Event|2|||
33599168|NCT01442064|102084827|FG001|Overall Study|Adverse Event|2|||
33599169|NCT01442064|102084828|FG002|Overall Study|Adverse Event|2|||
33599170|NCT01442064|102084829|FG003|Overall Study|Adverse Event|1|||
33599171|NCT01442064|102084830|FG004|Overall Study|Adverse Event|2|||
33599172|NCT01442064|102084831|FG005|Overall Study|Adverse Event|0|||
33599173|NCT01442064|102084826|FG000|Overall Study|Death|0|||
33599174|NCT01442064|102084827|FG001|Overall Study|Death|1|||
33599175|NCT01442064|102084828|FG002|Overall Study|Death|3|||
33599176|NCT01442064|102084829|FG003|Overall Study|Death|3|||
33599177|NCT01442064|102084830|FG004|Overall Study|Death|1|||
33599178|NCT01442064|102084831|FG005|Overall Study|Death|3|||
33599179|NCT01442064|102084826|FG000|Overall Study|Lost to Follow-up|5|||
33599180|NCT01442064|102084827|FG001|Overall Study|Lost to Follow-up|5|||
33599181|NCT01442064|102084828|FG002|Overall Study|Lost to Follow-up|1|||
33599182|NCT01442064|102084829|FG003|Overall Study|Lost to Follow-up|1|||
33599183|NCT01442064|102084830|FG004|Overall Study|Lost to Follow-up|3|||
33599184|NCT01442064|102084831|FG005|Overall Study|Lost to Follow-up|3|||
33599185|NCT01442064|102084826|FG000|Overall Study|Physician Decision|1|||
33599186|NCT01442064|102084827|FG001|Overall Study|Physician Decision|1|||
33188211|NCT01652716|100597993|FG001|Overall Study|Administrative|2|||
33291609|NCT04147858|100966641|FG002|Overall Study|Adverse Event|6|||
33291610|NCT04147858|100966639|FG000|Overall Study|Lack of Efficacy|3|||
33291611|NCT04147858|100966640|FG001|Overall Study|Lack of Efficacy|3|||
33291612|NCT04147858|100966641|FG002|Overall Study|Lack of Efficacy|1|||
33291613|NCT04147858|100966639|FG000|Overall Study|Lost to Follow-up|1|||
33291614|NCT04147858|100966640|FG001|Overall Study|Lost to Follow-up|6|||
33291615|NCT04147858|100966641|FG002|Overall Study|Lost to Follow-up|2|||
33291616|NCT04147858|100966639|FG000|Overall Study|Withdrawal by Subject|3|||
33291617|NCT04147858|100966640|FG001|Overall Study|Withdrawal by Subject|4|||
33291618|NCT04147858|100966641|FG002|Overall Study|Withdrawal by Subject|10|||
33291619|NCT04147858|100966639|FG000|Overall Study|Subject Noncompliance, Other|4|||
33291620|NCT04147858|100966640|FG001|Overall Study|Subject Noncompliance, Other|3|||
33291621|NCT04147858|100966641|FG002|Overall Study|Subject Noncompliance, Other|1|||
33291622|NCT00891046|100966642|FG000|Overall Study|Protocol Violation|1|||
33291623|NCT00891046|100966643|FG001|Overall Study|Protocol Violation|1|||
33291624|NCT00891046|100966644|FG002|Overall Study|Protocol Violation|0|||
33291625|NCT00891046|100966645|FG003|Overall Study|Protocol Violation|0|||
33291626|NCT00891046|100966646|FG004|Overall Study|Protocol Violation|1|||
33291627|NCT00891046|100966642|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
33291628|NCT00891046|100966643|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33291629|NCT00891046|100966644|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
33291630|NCT00891046|100966645|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
33291631|NCT00891046|100966646|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
33291632|NCT00891046|100966642|FG000|Overall Study|Administrative problems|0|||
33291633|NCT00891046|100966643|FG001|Overall Study|Administrative problems|0|||
33291634|NCT00891046|100966644|FG002|Overall Study|Administrative problems|0|||
33291635|NCT00891046|100966645|FG003|Overall Study|Administrative problems|0|||
33291636|NCT00891046|100966646|FG004|Overall Study|Administrative problems|1|||
33291637|NCT00891046|100966642|FG000|Overall Study|Participant no longer required drug|0|||
33291638|NCT00891046|100966643|FG001|Overall Study|Participant no longer required drug|2|||
33291639|NCT00891046|100966644|FG002|Overall Study|Participant no longer required drug|0|||
33291640|NCT00891046|100966645|FG003|Overall Study|Participant no longer required drug|0|||
33291641|NCT00891046|100966646|FG004|Overall Study|Participant no longer required drug|1|||
33291642|NCT00891046|100966642|FG000|Overall Study|Adverse Event|4|||
33291643|NCT00891046|100966643|FG001|Overall Study|Adverse Event|3|||
33291644|NCT00891046|100966644|FG002|Overall Study|Adverse Event|2|||
33291645|NCT00891046|100966645|FG003|Overall Study|Adverse Event|0|||
33291646|NCT00891046|100966646|FG004|Overall Study|Adverse Event|14|||
33291647|NCT00891046|100966642|FG000|Overall Study|Withdrawal by Subject|2|||
33291648|NCT00891046|100966643|FG001|Overall Study|Withdrawal by Subject|1|||
33291649|NCT00891046|100966644|FG002|Overall Study|Withdrawal by Subject|2|||
33291650|NCT00891046|100966645|FG003|Overall Study|Withdrawal by Subject|1|||
33291651|NCT00891046|100966646|FG004|Overall Study|Withdrawal by Subject|1|||
33291652|NCT00891046|100966642|FG000|Overall Study|Lost to Follow-up|0|||
33291653|NCT00891046|100966643|FG001|Overall Study|Lost to Follow-up|0|||
33291654|NCT00891046|100966644|FG002|Overall Study|Lost to Follow-up|0|||
33291655|NCT00891046|100966645|FG003|Overall Study|Lost to Follow-up|0|||
33291656|NCT00891046|100966646|FG004|Overall Study|Lost to Follow-up|1|||
33291657|NCT01453023|100966647|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
33291658|NCT01453023|100966648|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
33291659|NCT01453023|100966647|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
33291660|NCT01453023|100966648|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
33291661|NCT01453023|100966647|FG000|Treatment Period 2|Protocol Violation|0|||
33291662|NCT01453023|100966648|FG001|Treatment Period 2|Protocol Violation|1|||
33291663|NCT00823836|100966651|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
33291664|NCT00823836|100966652|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
33291665|NCT00823836|100966651|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
33291666|NCT00823836|100966652|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
33291667|NCT00823836|100966651|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
33291668|NCT00823836|100966652|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
33291669|NCT00823836|100966651|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
33291670|NCT00823836|100966652|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
33291671|NCT00823836|100966651|FG000|Long-term Phase|Adverse Event|3|||
33291672|NCT00823836|100966652|FG001|Long-term Phase|Adverse Event|2|||
33291673|NCT00823836|100966651|FG000|Long-term Phase|Physician Decision|1|||
33291674|NCT00823836|100966652|FG001|Long-term Phase|Physician Decision|2|||
33291675|NCT00823836|100966651|FG000|Long-term Phase|Withdrawal by Subject|1|||
33291676|NCT00823836|100966652|FG001|Long-term Phase|Withdrawal by Subject|1|||
33291677|NCT00356811|100966653|FG000|Overall Study|Death|35|||
33291678|NCT00356811|100966653|FG000|Overall Study|Lost to Follow-up|2|||
33291679|NCT00356811|100966653|FG000|Overall Study|Withdrawal by Subject|6|||
33599187|NCT01442064|102084828|FG002|Overall Study|Physician Decision|2|||
33291680|NCT00356811|100966653|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
33291681|NCT00356811|100966653|FG000|Overall Study|Study Is Terminating|3|||
33291682|NCT00356811|100966653|FG000|Overall Study|Site Closed during Follow-up|2|||
33291683|NCT02577003|100966654|FG000|Overall Study|Adverse Event|2|||
33291684|NCT02577003|100966655|FG001|Overall Study|Adverse Event|4|||
33291685|NCT02577003|100966654|FG000|Overall Study|Withdrawal by Subject|0|||
33291686|NCT02577003|100966655|FG001|Overall Study|Withdrawal by Subject|1|||
33291687|NCT02818998|100966656|FG000|Overall Study|Adverse Event|3|||
33291688|NCT02818998|100966657|FG001|Overall Study|Adverse Event|2|||
33291689|NCT02818998|100966658|FG002|Overall Study|Adverse Event|1|||
33291690|NCT02818998|100966656|FG000|Overall Study|Lost to Follow-up|4|||
33291691|NCT02818998|100966657|FG001|Overall Study|Lost to Follow-up|1|||
33291692|NCT02818998|100966658|FG002|Overall Study|Lost to Follow-up|2|||
33291693|NCT02818998|100966656|FG000|Overall Study|Withdrawal by sponsor|0|||
33291694|NCT02818998|100966657|FG001|Overall Study|Withdrawal by sponsor|1|||
33291695|NCT02818998|100966658|FG002|Overall Study|Withdrawal by sponsor|1|||
33291696|NCT02818998|100966656|FG000|Overall Study|Death|3|||
33291697|NCT02818998|100966657|FG001|Overall Study|Death|6|||
33291698|NCT02818998|100966658|FG002|Overall Study|Death|8|||
33291699|NCT02818998|100966656|FG000|Overall Study|Withdrawal by Subject|7|||
33291700|NCT02818998|100966657|FG001|Overall Study|Withdrawal by Subject|6|||
33291701|NCT02818998|100966658|FG002|Overall Study|Withdrawal by Subject|6|||
33291702|NCT02818998|100966656|FG000|Overall Study|Physician Decision|1|||
33291703|NCT02818998|100966657|FG001|Overall Study|Physician Decision|0|||
33291704|NCT02818998|100966658|FG002|Overall Study|Physician Decision|0|||
33291705|NCT01210651|100966659|FG000|Overall Study|Lost to Follow-up|1|||
33291706|NCT01210651|100966660|FG001|Overall Study|Lost to Follow-up|1|||
33291707|NCT01210651|100966659|FG000|Overall Study|schedule conflicts|1|||
33291708|NCT01210651|100966660|FG001|Overall Study|schedule conflicts|5|||
33291709|NCT01210651|100966659|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
33291710|NCT01210651|100966660|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
33291711|NCT01210651|100966659|FG000|Overall Study|Withdrawal by Subject|1|||
33291712|NCT01210651|100966660|FG001|Overall Study|Withdrawal by Subject|1|||
33291713|NCT01210651|100966659|FG000|Overall Study|Injury outside study|2|||
33291714|NCT01210651|100966660|FG001|Overall Study|Injury outside study|0|||
33291715|NCT01677299|100966662|FG000|Overall Study|Adverse Event|0|||
33291716|NCT01677299|100966663|FG001|Overall Study|Adverse Event|2|||
33291717|NCT01677299|100966664|FG002|Overall Study|Adverse Event|1|||
33291718|NCT01677299|100966665|FG003|Overall Study|Adverse Event|0|||
33291719|NCT01677299|100966662|FG000|Overall Study|Withdrawal by Subject|0|||
33291720|NCT01677299|100966663|FG001|Overall Study|Withdrawal by Subject|1|||
33291721|NCT01677299|100966664|FG002|Overall Study|Withdrawal by Subject|0|||
33291722|NCT01677299|100966665|FG003|Overall Study|Withdrawal by Subject|1|||
33291723|NCT01090011|100966666|FG000|Overall Study|Progressive disease|128|||
33291724|NCT01090011|100966666|FG000|Overall Study|Adverse Event|32|||
33291725|NCT01090011|100966666|FG000|Overall Study|Protocol Violation|1|||
33291726|NCT01090011|100966666|FG000|Overall Study|Refusal to start/continue medication|5|||
33291727|NCT01090011|100966666|FG000|Overall Study|Other reason not defined above|5|||
33291728|NCT02498236|100966670|FG000|Overall Study|Did not show for testing|1|||
33291729|NCT02498236|100966671|FG001|Overall Study|Did not show for testing|0|||
33291730|NCT02498236|100966672|FG002|Overall Study|Did not show for testing|0|||
33291731|NCT02498236|100966673|FG003|Overall Study|Did not show for testing|0|||
33291732|NCT02498236|100966674|FG004|Overall Study|Did not show for testing|0|||
33291733|NCT02498236|100966675|FG005|Overall Study|Did not show for testing|0|||
33291734|NCT02498236|100966676|FG006|Overall Study|Did not show for testing|0|||
33291735|NCT02498236|100966677|FG007|Overall Study|Did not show for testing|1|||
33291736|NCT02498236|100966670|FG000|Overall Study|Equipment failure|0|||
33291737|NCT02498236|100966671|FG001|Overall Study|Equipment failure|0|||
33291738|NCT02498236|100966672|FG002|Overall Study|Equipment failure|0|||
33291739|NCT02498236|100966673|FG003|Overall Study|Equipment failure|0|||
33291740|NCT02498236|100966674|FG004|Overall Study|Equipment failure|0|||
33291741|NCT02498236|100966675|FG005|Overall Study|Equipment failure|0|||
33291742|NCT02498236|100966676|FG006|Overall Study|Equipment failure|1|||
33291743|NCT02498236|100966677|FG007|Overall Study|Equipment failure|0|||
33291744|NCT02498236|100966670|FG000|Overall Study|Withdrawal by Subject|0|||
33291745|NCT02498236|100966671|FG001|Overall Study|Withdrawal by Subject|0|||
33291746|NCT02498236|100966672|FG002|Overall Study|Withdrawal by Subject|0|||
33291747|NCT02498236|100966673|FG003|Overall Study|Withdrawal by Subject|0|||
33291748|NCT02498236|100966674|FG004|Overall Study|Withdrawal by Subject|1|||
33291749|NCT02498236|100966675|FG005|Overall Study|Withdrawal by Subject|0|||
33291750|NCT02498236|100966676|FG006|Overall Study|Withdrawal by Subject|0|||
33291751|NCT02498236|100966677|FG007|Overall Study|Withdrawal by Subject|0|||
33291752|NCT02825251|100966680|FG000|Overall Study|Adverse Event|0|||
33291753|NCT02825251|100966681|FG001|Overall Study|Adverse Event|1|||
33291754|NCT02825251|100966680|FG000|Overall Study|Lost to Follow-up|0|||
33291755|NCT02825251|100966681|FG001|Overall Study|Lost to Follow-up|1|||
33291756|NCT02825251|100966680|FG000|Overall Study|Withdrawal by Subject|1|||
33291757|NCT02825251|100966681|FG001|Overall Study|Withdrawal by Subject|4|||
33291758|NCT02825251|100966680|FG000|Overall Study|Unclassified|2|||
33291759|NCT02825251|100966681|FG001|Overall Study|Unclassified|0|||
33291760|NCT02994784|100966682|FG000|6 Months Follow-up|Lost to Follow-up|3|||
33291761|NCT00520845|100966685|FG000|Overall Study|Death|3|||
33291762|NCT00520845|100966685|FG000|Overall Study|Adverse Event|4|||
33291763|NCT00520845|100966685|FG000|Overall Study|Disease Progression, relapse|13|||
33291764|NCT00520845|100966685|FG000|Overall Study|Withdrawal by Subject|1|||
33291765|NCT00520845|100966685|FG000|Overall Study|Alternative Therapy|1|||
33291766|NCT04292470|100966686|FG000|Overall Study|Withdrawal by Subject|0|||
33291767|NCT04292470|100966687|FG001|Overall Study|Withdrawal by Subject|1|||
33291768|NCT01426347|100966688|FG000|Overall Study|Lost to Follow-up|0|||
33291769|NCT01426347|100966689|FG001|Overall Study|Lost to Follow-up|3|||
33291770|NCT01426347|100966688|FG000|Overall Study|Protocol Violation|2|||
33291771|NCT01426347|100966689|FG001|Overall Study|Protocol Violation|0|||
33291772|NCT01426347|100966688|FG000|Overall Study|Withdrawal by Subject|5|||
33291773|NCT01426347|100966689|FG001|Overall Study|Withdrawal by Subject|0|||
33291774|NCT02906020|100966690|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
33291775|NCT02906020|100966691|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
33291776|NCT02906020|100966692|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
33291777|NCT02906020|100966693|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
33291778|NCT02906020|100966694|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
33291779|NCT02906020|100966695|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
33291780|NCT02906020|100966696|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
33291781|NCT02906020|100966697|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
33291782|NCT02906020|100966698|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
33291783|NCT02906020|100966699|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
33291784|NCT02906020|100966700|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
33291785|NCT02906020|100966701|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
33291786|NCT02906020|100966702|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
33291787|NCT02906020|100966703|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
33291788|NCT02906020|100966704|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
33291789|NCT02906020|100966705|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
33291790|NCT02906020|100966690|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33291791|NCT02906020|100966691|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33291792|NCT02906020|100966692|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33291793|NCT02906020|100966693|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33291794|NCT02906020|100966694|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33291795|NCT02906020|100966695|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33291796|NCT02906020|100966696|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33291797|NCT02906020|100966697|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33291798|NCT02906020|100966698|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
33291799|NCT02906020|100966699|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
33291800|NCT02906020|100966700|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33291801|NCT02906020|100966701|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33291802|NCT02906020|100966702|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33291803|NCT02906020|100966703|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33291804|NCT02906020|100966704|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33291805|NCT02906020|100966705|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
33291806|NCT02906020|100966690|FG000|Part 2: Double-blind Treatment Period|Other|0|||
33291807|NCT02906020|100966691|FG001|Part 2: Double-blind Treatment Period|Other|0|||
33291808|NCT02906020|100966692|FG002|Part 2: Double-blind Treatment Period|Other|0|||
33291809|NCT02906020|100966693|FG003|Part 2: Double-blind Treatment Period|Other|0|||
33291810|NCT02906020|100966694|FG004|Part 2: Double-blind Treatment Period|Other|0|||
33291811|NCT02906020|100966695|FG005|Part 2: Double-blind Treatment Period|Other|0|||
33291812|NCT02906020|100966696|FG006|Part 2: Double-blind Treatment Period|Other|0|||
33291813|NCT02906020|100966697|FG007|Part 2: Double-blind Treatment Period|Other|0|||
33291814|NCT02906020|100966698|FG008|Part 2: Double-blind Treatment Period|Other|6|||
33291815|NCT02906020|100966699|FG009|Part 2: Double-blind Treatment Period|Other|10|||
33291816|NCT02906020|100966700|FG010|Part 2: Double-blind Treatment Period|Other|0|||
33291817|NCT02906020|100966701|FG011|Part 2: Double-blind Treatment Period|Other|0|||
33291818|NCT02906020|100966702|FG012|Part 2: Double-blind Treatment Period|Other|0|||
33291819|NCT02906020|100966703|FG013|Part 2: Double-blind Treatment Period|Other|0|||
33291820|NCT02906020|100966704|FG014|Part 2: Double-blind Treatment Period|Other|0|||
33291821|NCT02906020|100966705|FG015|Part 2: Double-blind Treatment Period|Other|0|||
33291822|NCT02906020|100966690|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33291823|NCT02906020|100966691|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33291824|NCT02906020|100966692|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33291825|NCT02906020|100966693|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33291826|NCT02906020|100966694|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33291827|NCT02906020|100966695|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33291828|NCT02906020|100966696|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33291829|NCT02906020|100966697|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33291830|NCT02906020|100966698|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33291831|NCT02906020|100966699|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33291832|NCT02906020|100966700|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33291833|NCT02906020|100966701|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33291834|NCT02906020|100966702|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
33291835|NCT02906020|100966703|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
33291836|NCT02906020|100966704|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33291837|NCT02906020|100966705|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
33291838|NCT02906020|100966690|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33291839|NCT02906020|100966691|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33291840|NCT02906020|100966692|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33291841|NCT02906020|100966693|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33291842|NCT02906020|100966694|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33291843|NCT02906020|100966695|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33291844|NCT02906020|100966696|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33291845|NCT02906020|100966697|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33291846|NCT02906020|100966698|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33291847|NCT02906020|100966699|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33291848|NCT02906020|100966700|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33291849|NCT02906020|100966701|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33291850|NCT02906020|100966702|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
33291851|NCT02906020|100966703|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
33291852|NCT02906020|100966704|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
33291853|NCT02906020|100966705|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
33291854|NCT02906020|100966690|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33291855|NCT02906020|100966691|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33291856|NCT02906020|100966692|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33291857|NCT02906020|100966693|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33291858|NCT02906020|100966694|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33291859|NCT02906020|100966695|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33291860|NCT02906020|100966696|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33291861|NCT02906020|100966697|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33291862|NCT02906020|100966698|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33291863|NCT02906020|100966699|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33291864|NCT02906020|100966700|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33291865|NCT02906020|100966701|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33291866|NCT02906020|100966702|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
33291867|NCT02906020|100966703|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
33291868|NCT02906020|100966704|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33291869|NCT02906020|100966705|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
33291870|NCT02906020|100966690|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33291871|NCT02906020|100966691|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33291872|NCT02906020|100966692|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33291873|NCT02906020|100966693|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33291874|NCT02906020|100966694|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33291875|NCT02906020|100966695|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33291876|NCT02906020|100966696|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33291877|NCT02906020|100966697|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33291878|NCT02906020|100966698|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33291879|NCT02906020|100966699|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33291880|NCT02906020|100966700|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33291881|NCT02906020|100966701|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33291882|NCT02906020|100966702|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
33291883|NCT02906020|100966703|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
33291884|NCT02906020|100966704|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33291885|NCT02906020|100966705|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
33291886|NCT02906020|100966690|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33291887|NCT02906020|100966691|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33291888|NCT02906020|100966692|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33291889|NCT02906020|100966693|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33291890|NCT02906020|100966694|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33291891|NCT02906020|100966695|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33291892|NCT02906020|100966696|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33599188|NCT01442064|102084829|FG003|Overall Study|Physician Decision|3|||
33291893|NCT02906020|100966697|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33291894|NCT02906020|100966698|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33291895|NCT02906020|100966699|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33291896|NCT02906020|100966700|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33291897|NCT02906020|100966701|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
33291898|NCT02906020|100966702|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
33291899|NCT02906020|100966703|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
33291900|NCT02906020|100966704|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
33291901|NCT02906020|100966705|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
33291902|NCT02906020|100966690|FG000|Part 2: Long-term Follow-up Period|Other|0|||
33291903|NCT02906020|100966691|FG001|Part 2: Long-term Follow-up Period|Other|0|||
33291904|NCT02906020|100966692|FG002|Part 2: Long-term Follow-up Period|Other|0|||
33291905|NCT02906020|100966693|FG003|Part 2: Long-term Follow-up Period|Other|0|||
33291906|NCT02906020|100966694|FG004|Part 2: Long-term Follow-up Period|Other|0|||
33291907|NCT02906020|100966695|FG005|Part 2: Long-term Follow-up Period|Other|0|||
33291908|NCT02906020|100966696|FG006|Part 2: Long-term Follow-up Period|Other|0|||
33291909|NCT02906020|100966697|FG007|Part 2: Long-term Follow-up Period|Other|0|||
33291910|NCT02906020|100966698|FG008|Part 2: Long-term Follow-up Period|Other|0|||
33291911|NCT02906020|100966699|FG009|Part 2: Long-term Follow-up Period|Other|0|||
33291912|NCT02906020|100966700|FG010|Part 2: Long-term Follow-up Period|Other|0|||
33291913|NCT02906020|100966701|FG011|Part 2: Long-term Follow-up Period|Other|0|||
33291914|NCT02906020|100966702|FG012|Part 2: Long-term Follow-up Period|Other|13|||
33291915|NCT02906020|100966703|FG013|Part 2: Long-term Follow-up Period|Other|8|||
33291916|NCT02906020|100966704|FG014|Part 2: Long-term Follow-up Period|Other|3|||
33291917|NCT02906020|100966705|FG015|Part 2: Long-term Follow-up Period|Other|2|||
33291918|NCT01814072|100966706|FG000|Overall Study|Lost to Follow-up|2|||
33291919|NCT01814072|100966707|FG001|Overall Study|Lost to Follow-up|2|||
33291920|NCT01814072|100966708|FG002|Overall Study|Lost to Follow-up|2|||
33291921|NCT01814072|100966709|FG003|Overall Study|Lost to Follow-up|0|||
33291922|NCT01814072|100966710|FG004|Overall Study|Lost to Follow-up|2|||
33291923|NCT01814072|100966711|FG005|Overall Study|Lost to Follow-up|3|||
33291924|NCT01814072|100966712|FG006|Overall Study|Lost to Follow-up|3|||
33291925|NCT01814072|100966713|FG007|Overall Study|Lost to Follow-up|1|||
33291926|NCT01814072|100966714|FG008|Overall Study|Lost to Follow-up|2|||
33291927|NCT01814072|100966715|FG009|Overall Study|Lost to Follow-up|3|||
33291928|NCT01814072|100966716|FG010|Overall Study|Lost to Follow-up|1|||
33291929|NCT01814072|100966717|FG011|Overall Study|Lost to Follow-up|2|||
33291930|NCT01814072|100966718|FG012|Overall Study|Lost to Follow-up|2|||
33291931|NCT01814072|100966719|FG013|Overall Study|Lost to Follow-up|1|||
33291932|NCT01814072|100966720|FG014|Overall Study|Lost to Follow-up|2|||
33291933|NCT01814072|100966721|FG015|Overall Study|Lost to Follow-up|1|||
33291934|NCT01814072|100966722|FG016|Overall Study|Lost to Follow-up|3|||
33291935|NCT01814072|100966723|FG017|Overall Study|Lost to Follow-up|1|||
33291936|NCT01814072|100966724|FG018|Overall Study|Lost to Follow-up|3|||
33291937|NCT01814072|100966725|FG019|Overall Study|Lost to Follow-up|3|||
33291938|NCT01814072|100966726|FG020|Overall Study|Lost to Follow-up|2|||
33291939|NCT01814072|100966727|FG021|Overall Study|Lost to Follow-up|1|||
33291940|NCT01814072|100966728|FG022|Overall Study|Lost to Follow-up|3|||
33291941|NCT01814072|100966729|FG023|Overall Study|Lost to Follow-up|1|||
33291942|NCT01814072|100966730|FG024|Overall Study|Lost to Follow-up|4|||
33291943|NCT01814072|100966731|FG025|Overall Study|Lost to Follow-up|1|||
33291944|NCT01814072|100966732|FG026|Overall Study|Lost to Follow-up|1|||
33291945|NCT01814072|100966733|FG027|Overall Study|Lost to Follow-up|2|||
33291946|NCT01814072|100966734|FG028|Overall Study|Lost to Follow-up|3|||
33291947|NCT01814072|100966735|FG029|Overall Study|Lost to Follow-up|3|||
33291948|NCT01814072|100966736|FG030|Overall Study|Lost to Follow-up|2|||
33291949|NCT01814072|100966737|FG031|Overall Study|Lost to Follow-up|0|||
33291950|NCT01814072|100966706|FG000|Overall Study|Withdrawal by Subject|2|||
33291951|NCT01814072|100966707|FG001|Overall Study|Withdrawal by Subject|0|||
33291952|NCT01814072|100966708|FG002|Overall Study|Withdrawal by Subject|1|||
33291953|NCT01814072|100966709|FG003|Overall Study|Withdrawal by Subject|0|||
33291954|NCT01814072|100966710|FG004|Overall Study|Withdrawal by Subject|2|||
33291955|NCT01814072|100966711|FG005|Overall Study|Withdrawal by Subject|3|||
33291956|NCT01814072|100966712|FG006|Overall Study|Withdrawal by Subject|1|||
33291957|NCT01814072|100966713|FG007|Overall Study|Withdrawal by Subject|0|||
33291958|NCT01814072|100966714|FG008|Overall Study|Withdrawal by Subject|1|||
33291959|NCT01814072|100966715|FG009|Overall Study|Withdrawal by Subject|2|||
33291960|NCT01814072|100966716|FG010|Overall Study|Withdrawal by Subject|0|||
33291961|NCT01814072|100966717|FG011|Overall Study|Withdrawal by Subject|0|||
33291962|NCT01814072|100966718|FG012|Overall Study|Withdrawal by Subject|1|||
33291963|NCT01814072|100966719|FG013|Overall Study|Withdrawal by Subject|1|||
33291964|NCT01814072|100966720|FG014|Overall Study|Withdrawal by Subject|1|||
33291965|NCT01814072|100966721|FG015|Overall Study|Withdrawal by Subject|1|||
33291966|NCT01814072|100966722|FG016|Overall Study|Withdrawal by Subject|0|||
33291967|NCT01814072|100966723|FG017|Overall Study|Withdrawal by Subject|0|||
33291968|NCT01814072|100966724|FG018|Overall Study|Withdrawal by Subject|0|||
33291969|NCT01814072|100966725|FG019|Overall Study|Withdrawal by Subject|2|||
33291970|NCT01814072|100966726|FG020|Overall Study|Withdrawal by Subject|0|||
33291971|NCT01814072|100966727|FG021|Overall Study|Withdrawal by Subject|0|||
33291972|NCT01814072|100966728|FG022|Overall Study|Withdrawal by Subject|1|||
33291973|NCT01814072|100966729|FG023|Overall Study|Withdrawal by Subject|0|||
33291974|NCT01814072|100966730|FG024|Overall Study|Withdrawal by Subject|2|||
33291975|NCT01814072|100966731|FG025|Overall Study|Withdrawal by Subject|1|||
33291976|NCT01814072|100966732|FG026|Overall Study|Withdrawal by Subject|1|||
33291977|NCT01814072|100966733|FG027|Overall Study|Withdrawal by Subject|2|||
33291978|NCT01814072|100966734|FG028|Overall Study|Withdrawal by Subject|1|||
33291979|NCT01814072|100966735|FG029|Overall Study|Withdrawal by Subject|0|||
33291980|NCT01814072|100966736|FG030|Overall Study|Withdrawal by Subject|0|||
33291981|NCT01814072|100966737|FG031|Overall Study|Withdrawal by Subject|0|||
33291982|NCT00825305|100966739|FG000|Overall Study|Adverse Event|1|||
33291983|NCT00825305|100966740|FG001|Overall Study|Adverse Event|1|||
33291984|NCT00825305|100966739|FG000|Overall Study|Withdrawal by Subject|6|||
33291985|NCT00825305|100966740|FG001|Overall Study|Withdrawal by Subject|12|||
33291986|NCT00825305|100966739|FG000|Overall Study|Inappropriate inclusion|1|||
33291987|NCT00825305|100966740|FG001|Overall Study|Inappropriate inclusion|0|||
33291988|NCT00825305|100966739|FG000|Overall Study|Protocol Violation|9|||
33291989|NCT00825305|100966740|FG001|Overall Study|Protocol Violation|9|||
33291990|NCT00825305|100966739|FG000|Overall Study|Can not be classified|0|||
33291991|NCT00825305|100966740|FG001|Overall Study|Can not be classified|1|||
33291992|NCT02242643|100966741|FG000|Overall Study|Protocol Violation|1|||
33291993|NCT02242643|100966742|FG001|Overall Study|Protocol Violation|2|||
33291994|NCT02242643|100966741|FG000|Overall Study|Withdrawal by Subject|15|||
33291995|NCT02242643|100966742|FG001|Overall Study|Withdrawal by Subject|10|||
33291996|NCT02242643|100966741|FG000|Overall Study|Migrated/moved from study area|1|||
33291997|NCT02242643|100966742|FG001|Overall Study|Migrated/moved from study area|3|||
33291998|NCT02242643|100966741|FG000|Overall Study|Lost to Follow-up|54|||
33291999|NCT02242643|100966742|FG001|Overall Study|Lost to Follow-up|61|||
33292000|NCT02242643|100966741|FG000|Overall Study|Child placed in foster care by family|0|||
33292001|NCT02242643|100966742|FG001|Overall Study|Child placed in foster care by family|1|||
33292002|NCT02242643|100966741|FG000|Overall Study|Non-compliance|1|||
33292003|NCT02242643|100966742|FG001|Overall Study|Non-compliance|0|||
33292004|NCT02242643|100966741|FG000|Overall Study|Consent withdrawal by parent|1|||
33292005|NCT02242643|100966742|FG001|Overall Study|Consent withdrawal by parent|0|||
33292006|NCT02242643|100966741|FG000|Overall Study|Protocol requirements not followed|1|||
33292007|NCT02242643|100966742|FG001|Overall Study|Protocol requirements not followed|0|||
33292008|NCT02242643|100966741|FG000|Overall Study|Language barrier|1|||
33292009|NCT02242643|100966742|FG001|Overall Study|Language barrier|0|||
33292010|NCT02242643|100966741|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
33292011|NCT02242643|100966742|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
33292012|NCT00356759|100966744|FG000|Overall Study|Death|5|||
33292013|NCT00356759|100966745|FG001|Overall Study|Death|2|||
33292014|NCT00356759|100966744|FG000|Overall Study|Withdrawal by Subject|2|||
33292015|NCT00356759|100966745|FG001|Overall Study|Withdrawal by Subject|2|||
33292016|NCT00356759|100966744|FG000|Overall Study|Adverse Event|1|||
33292017|NCT00356759|100966745|FG001|Overall Study|Adverse Event|3|||
33292018|NCT00356759|100966744|FG000|Overall Study|Lost to Follow-up|1|||
33292019|NCT00356759|100966745|FG001|Overall Study|Lost to Follow-up|1|||
33292020|NCT00356759|100966744|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
33292021|NCT00356759|100966745|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
33292022|NCT02106195|100966746|FG000|Overall Study|Adverse Event|2|||
33292023|NCT02106195|100966746|FG000|Overall Study|Protocol Violation|1|||
33292024|NCT03054337|100966747|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
33292025|NCT03054337|100966748|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
33292026|NCT03054337|100966749|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
33292027|NCT03054337|100966750|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
33292028|NCT03054337|100966751|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
33292029|NCT03054337|100966752|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
33292030|NCT02080403|100966753|FG000|Overall Study|Adverse Event|5|||
33292031|NCT02080403|100966754|FG001|Overall Study|Adverse Event|1|||
33292032|NCT02080403|100966753|FG000|Overall Study|Death|0|||
33292033|NCT02080403|100966754|FG001|Overall Study|Death|2|||
33292034|NCT02080403|100966753|FG000|Overall Study|Lost to Follow-up|2|||
33292035|NCT02080403|100966754|FG001|Overall Study|Lost to Follow-up|0|||
33292036|NCT02080403|100966753|FG000|Overall Study|Pregnancy|0|||
33292037|NCT02080403|100966754|FG001|Overall Study|Pregnancy|1|||
33292038|NCT02080403|100966753|FG000|Overall Study|Protocol Violation|3|||
33292039|NCT02080403|100966754|FG001|Overall Study|Protocol Violation|7|||
33292040|NCT02080403|100966753|FG000|Overall Study|Withdrawal by Subject|5|||
33292041|NCT02080403|100966754|FG001|Overall Study|Withdrawal by Subject|1|||
33292042|NCT02547441|100966755|FG000|Double-Blind Study Period|Adverse Event|4|||
33292043|NCT02547441|100966756|FG001|Double-Blind Study Period|Adverse Event|9|||
33292044|NCT02547441|100966755|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
33292045|NCT02547441|100966756|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
33292046|NCT02547441|100966755|FG000|Double-Blind Study Period|Physician Decision|1|||
33292047|NCT02547441|100966756|FG001|Double-Blind Study Period|Physician Decision|0|||
33292048|NCT02547441|100966755|FG000|Double-Blind Study Period|Protocol Violation|1|||
33292049|NCT02547441|100966756|FG001|Double-Blind Study Period|Protocol Violation|2|||
33292050|NCT02547441|100966755|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
33292051|NCT02547441|100966756|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
33292052|NCT02547441|100966755|FG000|Double-Blind Study Period|Sponsor Decision|1|||
33292053|NCT02547441|100966756|FG001|Double-Blind Study Period|Sponsor Decision|0|||
33292054|NCT02547441|100966755|FG000|Open-Label Study Period|Adverse Event|10|||
33292055|NCT02547441|100966756|FG001|Open-Label Study Period|Adverse Event|11|||
33292056|NCT02547441|100966755|FG000|Open-Label Study Period|Lack of Efficacy|3|||
33292057|NCT02547441|100966756|FG001|Open-Label Study Period|Lack of Efficacy|2|||
33292058|NCT02547441|100966755|FG000|Open-Label Study Period|Lost to Follow-up|7|||
33292059|NCT02547441|100966756|FG001|Open-Label Study Period|Lost to Follow-up|8|||
33292060|NCT02547441|100966755|FG000|Open-Label Study Period|Physician Decision|1|||
33292061|NCT02547441|100966756|FG001|Open-Label Study Period|Physician Decision|0|||
33292062|NCT02547441|100966755|FG000|Open-Label Study Period|Protocol Violation|2|||
33292063|NCT02547441|100966756|FG001|Open-Label Study Period|Protocol Violation|0|||
33292064|NCT02547441|100966755|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
33292065|NCT02547441|100966756|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
33292066|NCT02547441|100966755|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
33292067|NCT02547441|100966756|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
33292068|NCT02872012|100966757|FG000|Overall Study|Withdrawal by Subject|1|||
33292069|NCT02872012|100966758|FG001|Overall Study|Withdrawal by Subject|0|||
33292070|NCT02872012|100966759|FG002|Overall Study|Withdrawal by Subject|0|||
33292071|NCT02872012|100966760|FG003|Overall Study|Withdrawal by Subject|0|||
33292072|NCT02872012|100966761|FG004|Overall Study|Withdrawal by Subject|0|||
33292073|NCT03004404|100966762|FG000|Period 2|Adverse Event|0|||
33292074|NCT03004404|100966763|FG001|Period 2|Adverse Event|0|||
33292075|NCT03004404|100966764|FG002|Period 2|Adverse Event|0|||
33292076|NCT03004404|100966765|FG003|Period 2|Adverse Event|0|||
33292077|NCT03004404|100966766|FG004|Period 2|Adverse Event|0|||
33292078|NCT03004404|100966767|FG005|Period 2|Adverse Event|0|||
33292079|NCT03004404|100966768|FG006|Period 2|Adverse Event|0|||
33292080|NCT03004404|100966769|FG007|Period 2|Adverse Event|0|||
33292081|NCT03004404|100966770|FG008|Period 2|Adverse Event|1|||
33292082|NCT03004404|100966771|FG009|Period 2|Adverse Event|0|||
33292083|NCT03004404|100966772|FG010|Period 2|Adverse Event|0|||
33292084|NCT03004404|100966773|FG011|Period 2|Adverse Event|0|||
33292085|NCT03004404|100966774|FG012|Period 2|Adverse Event|0|||
33292086|NCT03004404|100966775|FG013|Period 2|Adverse Event|0|||
33292087|NCT03004404|100966776|FG014|Period 2|Adverse Event|0|||
33292088|NCT03004404|100966777|FG015|Period 2|Adverse Event|1|||
33292089|NCT03865953|100966780|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
33292090|NCT03865953|100966781|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
33292091|NCT03865953|100966780|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
33292092|NCT03865953|100966781|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
33292093|NCT03865953|100966780|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
33292094|NCT03865953|100966781|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
33292095|NCT02386839|100966782|FG000|Overall Study|Death|1|||
33292096|NCT02386839|100966783|FG001|Overall Study|Death|0|||
33292097|NCT02386839|100966782|FG000|Overall Study|Withdrawal by Subject|9|||
33292098|NCT02386839|100966783|FG001|Overall Study|Withdrawal by Subject|10|||
33292099|NCT02386839|100966782|FG000|Overall Study|Lost to Follow-up|4|||
33292100|NCT02386839|100966783|FG001|Overall Study|Lost to Follow-up|4|||
33292101|NCT02386839|100966782|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
33292102|NCT02386839|100966783|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
33292103|NCT02386839|100966782|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
33292104|NCT02386839|100966783|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
33292105|NCT02386839|100966782|FG000|Overall Study|Other (unspecified)|1|||
33292106|NCT02386839|100966783|FG001|Overall Study|Other (unspecified)|0|||
33292107|NCT00738283|100966784|FG000|Overall Study|Death|1|||
33292108|NCT00738283|100966784|FG000|Overall Study|Transfer to another facility|2|||
33292109|NCT00738283|100966784|FG000|Overall Study|Discharge home prior to end of study|1|||
33292110|NCT01844726|100966788|FG000|Overall Study|Withdrawal by Subject|0|||
33292111|NCT01844726|100966789|FG001|Overall Study|Withdrawal by Subject|1|||
33292112|NCT01844726|100966788|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
33292113|NCT01844726|100966789|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
33292114|NCT01256671|100966790|FG000|Overall Study|Adverse Event|29|||
33292115|NCT01256671|100966790|FG000|Overall Study|Lost to Follow-up|16|||
33292116|NCT01256671|100966790|FG000|Overall Study|Withdrawal by Subject|31|||
33292117|NCT01256671|100966790|FG000|Overall Study|Physician Decision|3|||
33292118|NCT01256671|100966790|FG000|Overall Study|Lack of Efficacy|4|||
33292119|NCT01256671|100966790|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
33292120|NCT01843777|100966791|FG000|Overall Study|Withdrawal by Subject|1|||
33292121|NCT01843777|100966792|FG001|Overall Study|Withdrawal by Subject|0|||
33292122|NCT01468077|100966793|FG000|Overall Study|Adverse Event|2|||
33292123|NCT01468077|100966794|FG001|Overall Study|Adverse Event|2|||
33292124|NCT01468077|100966793|FG000|Overall Study|Lack of Efficacy|1|||
33292125|NCT01468077|100966794|FG001|Overall Study|Lack of Efficacy|1|||
33292126|NCT01468077|100966793|FG000|Overall Study|Physician Decision|1|||
33292127|NCT01468077|100966794|FG001|Overall Study|Physician Decision|0|||
33292128|NCT00844597|100966796|FG000|Overall Study|Adverse Event|0|||
33292129|NCT00844597|100966797|FG001|Overall Study|Adverse Event|0|||
33292130|NCT00844597|100966798|FG002|Overall Study|Adverse Event|0|||
33292131|NCT00844597|100966799|FG003|Overall Study|Adverse Event|1|||
33292132|NCT00844597|100966800|FG004|Overall Study|Adverse Event|0|||
33292133|NCT00844597|100966801|FG005|Overall Study|Adverse Event|0|||
33292134|NCT02312206|100966808|FG000|Overall Study|Adverse Event|3|||
33292135|NCT02312206|100966809|FG001|Overall Study|Adverse Event|6|||
33292136|NCT02312206|100966808|FG000|Overall Study|Withdrawal by Subject|6|||
33292137|NCT02312206|100966809|FG001|Overall Study|Withdrawal by Subject|6|||
33292138|NCT02312206|100966808|FG000|Overall Study|Physician Decision|7|||
33292139|NCT02312206|100966809|FG001|Overall Study|Physician Decision|6|||
33292140|NCT02312206|100966808|FG000|Overall Study|Death|31|||
33292141|NCT02312206|100966809|FG001|Overall Study|Death|36|||
33292142|NCT02312206|100966808|FG000|Overall Study|Study Terminated by Sponsor|81|||
33292143|NCT02312206|100966809|FG001|Overall Study|Study Terminated by Sponsor|74|||
33292144|NCT02312206|100966808|FG000|Overall Study|Patient transferred to hospice|0|||
33292145|NCT02312206|100966809|FG001|Overall Study|Patient transferred to hospice|1|||
33292146|NCT02312206|100966808|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
33292147|NCT02312206|100966809|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
33292148|NCT02312206|100966808|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
33292149|NCT02312206|100966809|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
33292150|NCT02312206|100966808|FG000|Overall Study|Disease Progression|1|||
33292151|NCT02312206|100966809|FG001|Overall Study|Disease Progression|0|||
33292152|NCT01240915|100966810|FG000|Overall Study|Adverse Event|0|||
33292153|NCT01240915|100966811|FG001|Overall Study|Adverse Event|0|||
33292154|NCT01240915|100966812|FG002|Overall Study|Adverse Event|0|||
33292155|NCT01240915|100966813|FG003|Overall Study|Adverse Event|1|||
33292156|NCT01240915|100966814|FG004|Overall Study|Adverse Event|0|||
33292157|NCT01240915|100966815|FG005|Overall Study|Adverse Event|2|||
33292158|NCT01240915|100966816|FG006|Overall Study|Adverse Event|0|||
33292159|NCT01240915|100966817|FG007|Overall Study|Adverse Event|0|||
33292160|NCT01240915|100966818|FG008|Overall Study|Adverse Event|1|||
33292161|NCT01240915|100966810|FG000|Overall Study|Lost to Follow-up|0|||
33292162|NCT01240915|100966811|FG001|Overall Study|Lost to Follow-up|0|||
33292163|NCT01240915|100966812|FG002|Overall Study|Lost to Follow-up|0|||
33292164|NCT01240915|100966813|FG003|Overall Study|Lost to Follow-up|0|||
33292165|NCT01240915|100966814|FG004|Overall Study|Lost to Follow-up|1|||
33292166|NCT01240915|100966815|FG005|Overall Study|Lost to Follow-up|1|||
33292167|NCT01240915|100966816|FG006|Overall Study|Lost to Follow-up|0|||
33292168|NCT01240915|100966817|FG007|Overall Study|Lost to Follow-up|1|||
33292169|NCT01240915|100966818|FG008|Overall Study|Lost to Follow-up|1|||
33292170|NCT01240915|100966810|FG000|Overall Study|Withdrawal by Subject|2|||
33292171|NCT01240915|100966811|FG001|Overall Study|Withdrawal by Subject|1|||
33292172|NCT01240915|100966812|FG002|Overall Study|Withdrawal by Subject|0|||
33292173|NCT01240915|100966813|FG003|Overall Study|Withdrawal by Subject|2|||
33292174|NCT01240915|100966814|FG004|Overall Study|Withdrawal by Subject|0|||
33292175|NCT01240915|100966815|FG005|Overall Study|Withdrawal by Subject|4|||
33292176|NCT01240915|100966816|FG006|Overall Study|Withdrawal by Subject|2|||
33292177|NCT01240915|100966817|FG007|Overall Study|Withdrawal by Subject|3|||
33292178|NCT01240915|100966818|FG008|Overall Study|Withdrawal by Subject|3|||
33292179|NCT01240915|100966810|FG000|Overall Study|Other|0|||
33292180|NCT01240915|100966811|FG001|Overall Study|Other|0|||
33292181|NCT01240915|100966812|FG002|Overall Study|Other|0|||
33292182|NCT01240915|100966813|FG003|Overall Study|Other|0|||
33292183|NCT01240915|100966814|FG004|Overall Study|Other|2|||
33292184|NCT01240915|100966815|FG005|Overall Study|Other|0|||
33292185|NCT01240915|100966816|FG006|Overall Study|Other|0|||
33292186|NCT01240915|100966817|FG007|Overall Study|Other|0|||
33292187|NCT01240915|100966818|FG008|Overall Study|Other|0|||
33292188|NCT01240915|100966810|FG000|Overall Study|Insufficient Clinical Response|0|||
33292189|NCT01240915|100966811|FG001|Overall Study|Insufficient Clinical Response|0|||
33292190|NCT01240915|100966812|FG002|Overall Study|Insufficient Clinical Response|0|||
33292191|NCT01240915|100966813|FG003|Overall Study|Insufficient Clinical Response|0|||
33292192|NCT01240915|100966814|FG004|Overall Study|Insufficient Clinical Response|1|||
33292193|NCT01240915|100966815|FG005|Overall Study|Insufficient Clinical Response|3|||
33292194|NCT01240915|100966816|FG006|Overall Study|Insufficient Clinical Response|6|||
33292195|NCT01240915|100966817|FG007|Overall Study|Insufficient Clinical Response|0|||
33292196|NCT01240915|100966818|FG008|Overall Study|Insufficient Clinical Response|3|||
33292197|NCT01807182|100966825|FG000|Overall Study|Death|1|||
33292198|NCT01807182|100966825|FG000|Overall Study|New therapy|1|||
33292199|NCT01807182|100966825|FG000|Overall Study|Moved to hospice care|1|||
33292200|NCT00966264|100966826|FG000|Overall Study|Lost to Follow-up|4|||
33292201|NCT00966264|100966827|FG001|Overall Study|Lost to Follow-up|3|||
33292202|NCT01318876|100966833|FG000|Day 8 Survey|email address invalid|96|||
33599189|NCT01442064|102084830|FG004|Overall Study|Physician Decision|3|||
33599190|NCT01442064|102084831|FG005|Overall Study|Physician Decision|1|||
33599191|NCT01442064|102084826|FG000|Overall Study|Withdrawal by Subject|6|||
33599192|NCT01442064|102084827|FG001|Overall Study|Withdrawal by Subject|3|||
33599193|NCT01442064|102084828|FG002|Overall Study|Withdrawal by Subject|2|||
33599194|NCT01442064|102084829|FG003|Overall Study|Withdrawal by Subject|2|||
33599195|NCT01442064|102084830|FG004|Overall Study|Withdrawal by Subject|2|||
33599196|NCT01442064|102084831|FG005|Overall Study|Withdrawal by Subject|1|||
33599197|NCT01442064|102084826|FG000|Overall Study|Sponsor decision|82|||
33599198|NCT01442064|102084827|FG001|Overall Study|Sponsor decision|88|||
33599199|NCT01442064|102084828|FG002|Overall Study|Sponsor decision|92|||
33599200|NCT01442064|102084829|FG003|Overall Study|Sponsor decision|88|||
33599201|NCT01442064|102084830|FG004|Overall Study|Sponsor decision|95|||
33599202|NCT01442064|102084831|FG005|Overall Study|Sponsor decision|87|||
33599203|NCT01442064|102084826|FG000|Overall Study|Subject non-compliance|0|||
33599204|NCT01442064|102084827|FG001|Overall Study|Subject non-compliance|0|||
33599205|NCT01442064|102084828|FG002|Overall Study|Subject non-compliance|0|||
33599206|NCT01442064|102084829|FG003|Overall Study|Subject non-compliance|0|||
33599207|NCT01442064|102084830|FG004|Overall Study|Subject non-compliance|0|||
33599208|NCT01442064|102084831|FG005|Overall Study|Subject non-compliance|2|||
33599209|NCT01442064|102084826|FG000|Overall Study|Condition mandated other intervention|1|||
33599210|NCT01442064|102084827|FG001|Overall Study|Condition mandated other intervention|1|||
33292203|NCT01318876|100966833|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
33292204|NCT01318876|100966833|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
33292205|NCT00455741|100966834|FG000|Overall Study|Physician Decision|0|||
33292206|NCT00455741|100966835|FG001|Overall Study|Physician Decision|1|||
33292207|NCT01015677|100966836|FG000|Overall Study|Adverse Event|0|||
33292208|NCT01015677|100966837|FG001|Overall Study|Adverse Event|1|||
33292209|NCT01015677|100966838|FG002|Overall Study|Adverse Event|0|||
33292210|NCT01015677|100966836|FG000|Overall Study|Lack of Efficacy|0|||
33292211|NCT01015677|100966837|FG001|Overall Study|Lack of Efficacy|1|||
33292212|NCT01015677|100966838|FG002|Overall Study|Lack of Efficacy|0|||
33292213|NCT01015677|100966836|FG000|Overall Study|Protocol Violation|0|||
33292214|NCT01015677|100966837|FG001|Overall Study|Protocol Violation|1|||
33292215|NCT01015677|100966838|FG002|Overall Study|Protocol Violation|0|||
33292216|NCT01015677|100966836|FG000|Overall Study|Withdrawal by Subject|1|||
33292217|NCT01015677|100966837|FG001|Overall Study|Withdrawal by Subject|1|||
33292218|NCT01015677|100966838|FG002|Overall Study|Withdrawal by Subject|0|||
33292219|NCT02153905|100966842|FG000|Overall Study|Death|1|||
33292220|NCT02153905|100966843|FG001|Overall Study|Death|0|||
33292221|NCT02367352|100966846|FG000|Overall Study|Progressive disease|7|||
33599211|NCT01442064|102084828|FG002|Overall Study|Condition mandated other intervention|2|||
33599212|NCT01442064|102084829|FG003|Overall Study|Condition mandated other intervention|0|||
33599213|NCT01442064|102084830|FG004|Overall Study|Condition mandated other intervention|0|||
33599214|NCT01442064|102084831|FG005|Overall Study|Condition mandated other intervention|2|||
33599215|NCT02075632|102084832|FG000|Overall Study|Adverse Event|1|||
33599216|NCT02075632|102084833|FG001|Overall Study|Adverse Event|1|||
33599217|NCT02075632|102084832|FG000|Overall Study|Lost to Follow-up|0|||
33599218|NCT02075632|102084833|FG001|Overall Study|Lost to Follow-up|3|||
33599219|NCT02075632|102084832|FG000|Overall Study|Withdrawal by Subject|0|||
33599220|NCT02075632|102084833|FG001|Overall Study|Withdrawal by Subject|1|||
33599221|NCT03554772|102084835|FG000|Overall Study|Lost to Follow-up|0|||
33599222|NCT03554772|102084836|FG001|Overall Study|Lost to Follow-up|0|||
33599223|NCT03554772|102084837|FG002|Overall Study|Lost to Follow-up|0|||
33599224|NCT03554772|102084838|FG003|Overall Study|Lost to Follow-up|2|||
33599225|NCT02075047|102084840|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
33599226|NCT02075047|102084841|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
33599227|NCT02075047|102084840|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
33599228|NCT02075047|102084841|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
33599229|NCT02075047|102084840|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
33599230|NCT02075047|102084841|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
33292222|NCT02367352|100966847|FG001|Overall Study|Progressive disease|0|||
33292223|NCT02367352|100966848|FG002|Overall Study|Progressive disease|0|||
33292224|NCT02367352|100966846|FG000|Overall Study|Participant Received Alternative Therapy|1|||
33292225|NCT02367352|100966847|FG001|Overall Study|Participant Received Alternative Therapy|0|||
33292226|NCT02367352|100966848|FG002|Overall Study|Participant Received Alternative Therapy|0|||
33292227|NCT02367352|100966846|FG000|Overall Study|Adverse Event|1|||
33599231|NCT02075047|102084840|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
33599232|NCT02075047|102084841|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
33599233|NCT02075047|102084840|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
33599234|NCT02075047|102084841|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
33599235|NCT02075047|102084840|FG000|Treatment Phase (4 Weeks)|Other|1|||
33599236|NCT02075047|102084841|FG001|Treatment Phase (4 Weeks)|Other|1|||
33599237|NCT02075047|102084840|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
33599238|NCT02075047|102084841|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
33599239|NCT02075047|102084840|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
33599240|NCT02075047|102084841|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
33599241|NCT02075047|102084840|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
33599242|NCT02075047|102084841|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
33599243|NCT02075047|102084840|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
33599244|NCT02075047|102084841|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
33599245|NCT02075047|102084840|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
33599246|NCT02075047|102084841|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
33599247|NCT02075047|102084840|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
33599248|NCT02075047|102084841|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
33599249|NCT02075047|102084840|FG000|Follow up Phase (5 Weeks)|Other|1|||
33599250|NCT02075047|102084841|FG001|Follow up Phase (5 Weeks)|Other|2|||
33599251|NCT02075047|102084840|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
33599252|NCT02075047|102084841|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
33599253|NCT04612842|102084842|FG000|Overall Study|Lost to Follow-up|20|||
33599254|NCT04612842|102084843|FG001|Overall Study|Lost to Follow-up|11|||
33599255|NCT04612842|102084842|FG000|Overall Study|Withdrawal by Subject|26|||
33599256|NCT04612842|102084843|FG001|Overall Study|Withdrawal by Subject|15|||
33599257|NCT04612842|102084842|FG000|Overall Study|Death|2|||
33599258|NCT04612842|102084843|FG001|Overall Study|Death|2|||
33599259|NCT00089986|102084844|FG000|Overall Study|Adverse Event|6|||
33599260|NCT00089986|102084845|FG001|Overall Study|Adverse Event|9|||
33599261|NCT00089986|102084846|FG002|Overall Study|Adverse Event|6|||
33599262|NCT00089986|102084844|FG000|Overall Study|Lost to Follow-up|3|||
33599263|NCT00089986|102084845|FG001|Overall Study|Lost to Follow-up|1|||
33599264|NCT00089986|102084846|FG002|Overall Study|Lost to Follow-up|1|||
33599265|NCT00089986|102084844|FG000|Overall Study|Protocol Violation|0|||
33599266|NCT00089986|102084845|FG001|Overall Study|Protocol Violation|1|||
33599267|NCT00089986|102084846|FG002|Overall Study|Protocol Violation|0|||
33599268|NCT00089986|102084844|FG000|Overall Study|Patient transferred to another hospital|2|||
33599269|NCT00089986|102084845|FG001|Overall Study|Patient transferred to another hospital|1|||
33599270|NCT00089986|102084846|FG002|Overall Study|Patient transferred to another hospital|0|||
33599271|NCT00089986|102084844|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
33599272|NCT00089986|102084845|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
33599273|NCT00089986|102084846|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
33599274|NCT00089986|102084844|FG000|Overall Study|Hemohlobin stopping rule|0|||
33599275|NCT00089986|102084845|FG001|Overall Study|Hemohlobin stopping rule|1|||
33599276|NCT00089986|102084846|FG002|Overall Study|Hemohlobin stopping rule|0|||
33599277|NCT00089986|102084844|FG000|Overall Study|Investigator decision to withdrew|0|||
33599278|NCT00089986|102084845|FG001|Overall Study|Investigator decision to withdrew|1|||
33599279|NCT00089986|102084846|FG002|Overall Study|Investigator decision to withdrew|0|||
33599280|NCT00089986|102084844|FG000|Overall Study|Enrollment in another study|0|||
33599281|NCT00089986|102084845|FG001|Overall Study|Enrollment in another study|1|||
33599282|NCT00089986|102084846|FG002|Overall Study|Enrollment in another study|0|||
33599283|NCT00089986|102084844|FG000|Overall Study|Family decision|0|||
33599284|NCT00089986|102084845|FG001|Overall Study|Family decision|1|||
33599285|NCT00089986|102084846|FG002|Overall Study|Family decision|0|||
33599286|NCT00089986|102084844|FG000|Overall Study|Do not resuscitate (DNR)|0|||
33599287|NCT00089986|102084845|FG001|Overall Study|Do not resuscitate (DNR)|0|||
33599288|NCT00089986|102084846|FG002|Overall Study|Do not resuscitate (DNR)|1|||
33599289|NCT00089986|102084844|FG000|Overall Study|Withdrawal by Subject|3|||
33599290|NCT00089986|102084845|FG001|Overall Study|Withdrawal by Subject|6|||
33599291|NCT00089986|102084846|FG002|Overall Study|Withdrawal by Subject|2|||
33599292|NCT01484834|102084855|FG000|Overall Study|Lost to Follow-up|5|||
33599293|NCT01484834|102084856|FG001|Overall Study|Lost to Follow-up|8|||
33599294|NCT01484834|102084857|FG002|Overall Study|Lost to Follow-up|1|||
33599295|NCT01484834|102084858|FG003|Overall Study|Lost to Follow-up|4|||
33599296|NCT03762616|102084859|FG000|Overall Study|Protocol Violation|2|||
33599297|NCT00357656|102084864|FG000|Overall Study|Other, No surgery performed|0|||
33599298|NCT00357656|102084865|FG001|Overall Study|Other, No surgery performed|3|||
33599299|NCT02680574|102084872|FG000|Overall Study|Death|137|||
33599300|NCT02680574|102084873|FG001|Overall Study|Death|137|||
33599301|NCT02680574|102084872|FG000|Overall Study|Withdrawal by Subject|17|||
33599302|NCT02680574|102084873|FG001|Overall Study|Withdrawal by Subject|9|||
33599303|NCT02680574|102084872|FG000|Overall Study|Lost to Follow-up|4|||
33599304|NCT02680574|102084873|FG001|Overall Study|Lost to Follow-up|6|||
33599305|NCT02226198|102084874|FG000|Lead-in Phase|Protocol Violation|1|||
33599306|NCT02226198|102084875|FG001|Lead-in Phase|Protocol Violation|0|||
33599307|NCT02226198|102084876|FG002|Lead-in Phase|Protocol Violation|0|||
33599308|NCT02226198|102084874|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
33631263|NCT01231906|102202897|FG000|Overall Study|Withdrawal by Subject|0|||
33599309|NCT02226198|102084875|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
33599310|NCT02226198|102084876|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
33599311|NCT00791557|102084877|FG000|Overall Study|Adverse Event|1|||
33599312|NCT02251717|102084878|FG000|Overall Study|Adverse Event|0|||
33599313|NCT02251717|102084879|FG001|Overall Study|Adverse Event|1|||
33599314|NCT02251717|102084878|FG000|Overall Study|Withdrew Consent|1|||
33599315|NCT02251717|102084879|FG001|Overall Study|Withdrew Consent|0|||
33599316|NCT02982018|102084882|FG000|Overall Study|Incorrect Lens Dispensed|1|||
33599317|NCT02982018|102084883|FG001|Overall Study|Incorrect Lens Dispensed|0|||
33599318|NCT02982018|102084882|FG000|Overall Study|Protocol Violation|1|||
33599319|NCT02982018|102084883|FG001|Overall Study|Protocol Violation|1|||
33599320|NCT02982018|102084882|FG000|Overall Study|Adverse Event|1|||
33599321|NCT02982018|102084883|FG001|Overall Study|Adverse Event|1|||
33599322|NCT02982018|102084882|FG000|Overall Study|Lens Discomfort|2|||
33599323|NCT02982018|102084883|FG001|Overall Study|Lens Discomfort|0|||
33599324|NCT02982018|102084882|FG000|Overall Study|Withdrawal by Subject|0|||
33599325|NCT02982018|102084883|FG001|Overall Study|Withdrawal by Subject|1|||
33599326|NCT03515941|102084884|FG000|Overall Study|Adverse Event|1|||
33599327|NCT03515941|102084885|FG001|Overall Study|Adverse Event|0|||
33599328|NCT00431951|102084889|FG000|Overall Study|Inability to follow study procedures|1|||
33599329|NCT00431951|102084890|FG001|Overall Study|Inability to follow study procedures|0|||
33599330|NCT00431951|102084891|FG002|Overall Study|Inability to follow study procedures|1|||
33599331|NCT00431951|102084892|FG003|Overall Study|Inability to follow study procedures|2|||
33599332|NCT00431951|102084889|FG000|Overall Study|Lost to Follow-up|0|||
33599333|NCT00431951|102084890|FG001|Overall Study|Lost to Follow-up|1|||
33599334|NCT00431951|102084891|FG002|Overall Study|Lost to Follow-up|0|||
33599335|NCT00431951|102084892|FG003|Overall Study|Lost to Follow-up|0|||
33599336|NCT00431951|102084889|FG000|Overall Study|Withdrawal by Subject|0|||
33599337|NCT00431951|102084890|FG001|Overall Study|Withdrawal by Subject|1|||
33599338|NCT00431951|102084891|FG002|Overall Study|Withdrawal by Subject|0|||
33599339|NCT00431951|102084892|FG003|Overall Study|Withdrawal by Subject|0|||
33599340|NCT00431951|102084889|FG000|Overall Study|Adverse Event|0|||
33599341|NCT00431951|102084890|FG001|Overall Study|Adverse Event|0|||
33599342|NCT00431951|102084891|FG002|Overall Study|Adverse Event|1|||
33599343|NCT00431951|102084892|FG003|Overall Study|Adverse Event|0|||
33292228|NCT02367352|100966847|FG001|Overall Study|Adverse Event|0|||
33599344|NCT01739933|102084895|FG000|Overall Study|Death|89|||
33599345|NCT01739933|102084896|FG001|Overall Study|Death|86|||
33599346|NCT01739933|102084895|FG000|Overall Study|Withdrawal by Subject|10|||
33599347|NCT01739933|102084896|FG001|Overall Study|Withdrawal by Subject|8|||
33599348|NCT01739933|102084895|FG000|Overall Study|Lost to Follow-up|3|||
33599349|NCT01739933|102084896|FG001|Overall Study|Lost to Follow-up|10|||
33292229|NCT02367352|100966848|FG002|Overall Study|Adverse Event|0|||
33292230|NCT01013961|100966849|FG000|Overall Study|Adverse Event|2|||
33599350|NCT01739933|102084895|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
33599351|NCT01739933|102084896|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
33599352|NCT02351349|102084900|FG000|Overall Study|Withdrawal by Subject|2|||
33599353|NCT02351349|102084901|FG001|Overall Study|Withdrawal by Subject|3|||
33599354|NCT00098722|102084902|FG000|Double Blind Phase|Adverse Event|7|||
33599355|NCT00098722|102084903|FG001|Double Blind Phase|Adverse Event|7|||
33599356|NCT00098722|102084904|FG002|Double Blind Phase|Adverse Event|3|||
33599357|NCT00098722|102084905|FG003|Double Blind Phase|Adverse Event|0|||
33599358|NCT00098722|102084906|FG004|Double Blind Phase|Adverse Event|0|||
33599359|NCT00098722|102084907|FG005|Double Blind Phase|Adverse Event|0|||
33599360|NCT00098722|102084908|FG006|Double Blind Phase|Adverse Event|0|||
33599361|NCT00098722|102084902|FG000|Double Blind Phase|Death|2|||
33599362|NCT00098722|102084903|FG001|Double Blind Phase|Death|5|||
33599363|NCT00098722|102084904|FG002|Double Blind Phase|Death|0|||
33599364|NCT00098722|102084905|FG003|Double Blind Phase|Death|0|||
33599365|NCT00098722|102084906|FG004|Double Blind Phase|Death|0|||
33599366|NCT00098722|102084907|FG005|Double Blind Phase|Death|0|||
33599367|NCT00098722|102084908|FG006|Double Blind Phase|Death|0|||
33599368|NCT00098722|102084902|FG000|Double Blind Phase|Lack of Efficacy|21|||
33599369|NCT00098722|102084903|FG001|Double Blind Phase|Lack of Efficacy|23|||
33599370|NCT00098722|102084904|FG002|Double Blind Phase|Lack of Efficacy|15|||
33599371|NCT00098722|102084905|FG003|Double Blind Phase|Lack of Efficacy|0|||
33599372|NCT00098722|102084906|FG004|Double Blind Phase|Lack of Efficacy|0|||
33599373|NCT00098722|102084907|FG005|Double Blind Phase|Lack of Efficacy|0|||
33599374|NCT00098722|102084908|FG006|Double Blind Phase|Lack of Efficacy|0|||
33599375|NCT00098722|102084902|FG000|Double Blind Phase|Participant defaulted|16|||
33599376|NCT00098722|102084903|FG001|Double Blind Phase|Participant defaulted|11|||
33599377|NCT00098722|102084904|FG002|Double Blind Phase|Participant defaulted|9|||
33599378|NCT00098722|102084905|FG003|Double Blind Phase|Participant defaulted|0|||
33599379|NCT00098722|102084906|FG004|Double Blind Phase|Participant defaulted|0|||
33599380|NCT00098722|102084907|FG005|Double Blind Phase|Participant defaulted|0|||
33599381|NCT00098722|102084908|FG006|Double Blind Phase|Participant defaulted|0|||
33599382|NCT00098722|102084902|FG000|Double Blind Phase|Pregnancy|1|||
33599383|NCT00098722|102084903|FG001|Double Blind Phase|Pregnancy|0|||
33599384|NCT00098722|102084904|FG002|Double Blind Phase|Pregnancy|0|||
33599385|NCT00098722|102084905|FG003|Double Blind Phase|Pregnancy|0|||
33599386|NCT00098722|102084906|FG004|Double Blind Phase|Pregnancy|0|||
33599387|NCT00098722|102084907|FG005|Double Blind Phase|Pregnancy|0|||
33599388|NCT00098722|102084908|FG006|Double Blind Phase|Pregnancy|0|||
33292231|NCT01013961|100966850|FG001|Overall Study|Adverse Event|2|||
33599389|NCT00098722|102084902|FG000|Double Blind Phase|Randomized, not treated|4|||
33599390|NCT00098722|102084903|FG001|Double Blind Phase|Randomized, not treated|3|||
33599391|NCT00098722|102084904|FG002|Double Blind Phase|Randomized, not treated|3|||
33599392|NCT00098722|102084905|FG003|Double Blind Phase|Randomized, not treated|0|||
33599393|NCT00098722|102084906|FG004|Double Blind Phase|Randomized, not treated|0|||
33599394|NCT00098722|102084907|FG005|Double Blind Phase|Randomized, not treated|0|||
33599395|NCT00098722|102084908|FG006|Double Blind Phase|Randomized, not treated|0|||
33599396|NCT00098722|102084902|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
33599397|NCT00098722|102084903|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
33599398|NCT00098722|102084904|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
33599399|NCT00098722|102084905|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
33599400|NCT00098722|102084906|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
33599401|NCT00098722|102084907|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
33599402|NCT00098722|102084908|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
33599403|NCT00098722|102084902|FG000|Double Blind Phase|Other|7|||
33599404|NCT00098722|102084903|FG001|Double Blind Phase|Other|8|||
33599405|NCT00098722|102084904|FG002|Double Blind Phase|Other|7|||
33599406|NCT00098722|102084905|FG003|Double Blind Phase|Other|0|||
33599407|NCT00098722|102084906|FG004|Double Blind Phase|Other|0|||
33599408|NCT00098722|102084907|FG005|Double Blind Phase|Other|0|||
33599409|NCT00098722|102084908|FG006|Double Blind Phase|Other|0|||
33599410|NCT00098722|102084902|FG000|Open Label Phase|Adverse Event|0|||
33599411|NCT00098722|102084903|FG001|Open Label Phase|Adverse Event|0|||
33599412|NCT00098722|102084904|FG002|Open Label Phase|Adverse Event|0|||
33599413|NCT00098722|102084905|FG003|Open Label Phase|Adverse Event|5|||
33599414|NCT00098722|102084906|FG004|Open Label Phase|Adverse Event|0|||
33292232|NCT01013961|100966849|FG000|Overall Study|Withdrawal by Subject|1|||
33292233|NCT01013961|100966850|FG001|Overall Study|Withdrawal by Subject|0|||
33292234|NCT01013961|100966849|FG000|Overall Study|Physician Decision|0|||
33292235|NCT01013961|100966850|FG001|Overall Study|Physician Decision|1|||
33292236|NCT02586415|100966851|FG000|Overall Study|Death|13|||
33292237|NCT02586415|100966852|FG001|Overall Study|Death|23|||
33292238|NCT02586415|100966851|FG000|Overall Study|Lost to Follow-up|1|||
33292239|NCT02586415|100966852|FG001|Overall Study|Lost to Follow-up|2|||
33292240|NCT00475644|100966853|FG000|Overall Study|Protocol Violation|13|||
33292241|NCT01536587|100966854|FG000|Overall Study|Adverse Event|2|||
33292242|NCT01288209|100966855|FG000|Overall Study|Withdrawal by Subject|1|||
33292243|NCT01288209|100966856|FG001|Overall Study|Withdrawal by Subject|3|||
33599415|NCT00098722|102084907|FG005|Open Label Phase|Adverse Event|0|||
33599416|NCT00098722|102084908|FG006|Open Label Phase|Adverse Event|0|||
33599417|NCT00098722|102084902|FG000|Open Label Phase|Death|0|||
33599418|NCT00098722|102084903|FG001|Open Label Phase|Death|0|||
33599419|NCT00098722|102084904|FG002|Open Label Phase|Death|0|||
33599420|NCT00098722|102084905|FG003|Open Label Phase|Death|2|||
33599421|NCT00098722|102084906|FG004|Open Label Phase|Death|0|||
33599422|NCT00098722|102084907|FG005|Open Label Phase|Death|0|||
33599423|NCT00098722|102084908|FG006|Open Label Phase|Death|0|||
33599424|NCT00098722|102084902|FG000|Open Label Phase|Lack of Efficacy|0|||
33599425|NCT00098722|102084903|FG001|Open Label Phase|Lack of Efficacy|0|||
33599426|NCT00098722|102084904|FG002|Open Label Phase|Lack of Efficacy|0|||
33599427|NCT00098722|102084905|FG003|Open Label Phase|Lack of Efficacy|8|||
33599428|NCT00098722|102084906|FG004|Open Label Phase|Lack of Efficacy|0|||
33599429|NCT00098722|102084907|FG005|Open Label Phase|Lack of Efficacy|0|||
33599430|NCT00098722|102084908|FG006|Open Label Phase|Lack of Efficacy|0|||
33599431|NCT00098722|102084902|FG000|Open Label Phase|Pregnancy|0|||
33599432|NCT00098722|102084903|FG001|Open Label Phase|Pregnancy|0|||
33599433|NCT00098722|102084904|FG002|Open Label Phase|Pregnancy|0|||
33599434|NCT00098722|102084905|FG003|Open Label Phase|Pregnancy|1|||
33599435|NCT00098722|102084906|FG004|Open Label Phase|Pregnancy|0|||
33599436|NCT00098722|102084907|FG005|Open Label Phase|Pregnancy|0|||
33599437|NCT00098722|102084908|FG006|Open Label Phase|Pregnancy|0|||
33599438|NCT00098722|102084902|FG000|Open Label Phase|Participant defaulted|0|||
33599439|NCT00098722|102084903|FG001|Open Label Phase|Participant defaulted|0|||
33599440|NCT00098722|102084904|FG002|Open Label Phase|Participant defaulted|0|||
33599441|NCT00098722|102084905|FG003|Open Label Phase|Participant defaulted|18|||
33599442|NCT00098722|102084906|FG004|Open Label Phase|Participant defaulted|0|||
33599443|NCT00098722|102084907|FG005|Open Label Phase|Participant defaulted|0|||
33599444|NCT00098722|102084908|FG006|Open Label Phase|Participant defaulted|0|||
33599445|NCT00098722|102084902|FG000|Open Label Phase|Ongoing at cut-off date|0|||
33599446|NCT00098722|102084903|FG001|Open Label Phase|Ongoing at cut-off date|0|||
33292244|NCT01288209|100966855|FG000|Overall Study|Other|1|||
33599447|NCT00098722|102084904|FG002|Open Label Phase|Ongoing at cut-off date|0|||
33599448|NCT00098722|102084905|FG003|Open Label Phase|Ongoing at cut-off date|220|||
33599449|NCT00098722|102084906|FG004|Open Label Phase|Ongoing at cut-off date|50|||
33599450|NCT00098722|102084907|FG005|Open Label Phase|Ongoing at cut-off date|0|||
33599451|NCT00098722|102084908|FG006|Open Label Phase|Ongoing at cut-off date|0|||
33599452|NCT00098722|102084902|FG000|Open Label Phase|Other|0|||
33599453|NCT00098722|102084903|FG001|Open Label Phase|Other|0|||
33599454|NCT00098722|102084904|FG002|Open Label Phase|Other|0|||
33599455|NCT00098722|102084905|FG003|Open Label Phase|Other|18|||
33599456|NCT00098722|102084906|FG004|Open Label Phase|Other|0|||
33599457|NCT00098722|102084907|FG005|Open Label Phase|Other|0|||
33599458|NCT00098722|102084908|FG006|Open Label Phase|Other|0|||
33599459|NCT00098722|102084902|FG000|Observation Phase|Death|0|||
33292245|NCT01288209|100966856|FG001|Overall Study|Other|0|||
33599460|NCT00098722|102084903|FG001|Observation Phase|Death|0|||
33292246|NCT02419417|100966857|FG000|Overall Study|Disease progression|5|||
33292247|NCT02419417|100966858|FG001|Overall Study|Disease progression|4|||
33292248|NCT02419417|100966859|FG002|Overall Study|Disease progression|13|||
33292249|NCT02419417|100966860|FG003|Overall Study|Disease progression|10|||
33292250|NCT02419417|100966861|FG004|Overall Study|Disease progression|10|||
33292251|NCT02419417|100966862|FG005|Overall Study|Disease progression|3|||
33292252|NCT02419417|100966863|FG006|Overall Study|Disease progression|4|||
33292253|NCT02419417|100966864|FG007|Overall Study|Disease progression|5|||
33292254|NCT02419417|100966865|FG008|Overall Study|Disease progression|13|||
33292255|NCT02419417|100966866|FG009|Overall Study|Disease progression|9|||
33292256|NCT02419417|100966867|FG010|Overall Study|Disease progression|0|||
33292257|NCT02419417|100966857|FG000|Overall Study|Study drug toxicity|0|||
33292258|NCT02419417|100966858|FG001|Overall Study|Study drug toxicity|0|||
33292259|NCT02419417|100966859|FG002|Overall Study|Study drug toxicity|0|||
33292260|NCT02419417|100966860|FG003|Overall Study|Study drug toxicity|0|||
33292261|NCT02419417|100966861|FG004|Overall Study|Study drug toxicity|1|||
33599461|NCT00098722|102084904|FG002|Observation Phase|Death|0|||
33599462|NCT00098722|102084905|FG003|Observation Phase|Death|0|||
33599463|NCT00098722|102084906|FG004|Observation Phase|Death|0|||
33599464|NCT00098722|102084907|FG005|Observation Phase|Death|5|||
33599465|NCT00098722|102084908|FG006|Observation Phase|Death|3|||
33599466|NCT00098722|102084902|FG000|Observation Phase|Lack of Efficacy|0|||
33599467|NCT00098722|102084903|FG001|Observation Phase|Lack of Efficacy|0|||
33599468|NCT00098722|102084904|FG002|Observation Phase|Lack of Efficacy|0|||
33599469|NCT00098722|102084905|FG003|Observation Phase|Lack of Efficacy|0|||
33599470|NCT00098722|102084906|FG004|Observation Phase|Lack of Efficacy|0|||
33599471|NCT00098722|102084907|FG005|Observation Phase|Lack of Efficacy|2|||
33599472|NCT00098722|102084908|FG006|Observation Phase|Lack of Efficacy|0|||
33599473|NCT00098722|102084902|FG000|Observation Phase|Participant defaulted|0|||
33599474|NCT00098722|102084903|FG001|Observation Phase|Participant defaulted|0|||
33599475|NCT00098722|102084904|FG002|Observation Phase|Participant defaulted|0|||
33599476|NCT00098722|102084905|FG003|Observation Phase|Participant defaulted|0|||
33599477|NCT00098722|102084906|FG004|Observation Phase|Participant defaulted|0|||
33599478|NCT00098722|102084907|FG005|Observation Phase|Participant defaulted|17|||
33599479|NCT00098722|102084908|FG006|Observation Phase|Participant defaulted|4|||
33599480|NCT00098722|102084902|FG000|Observation Phase|Other|0|||
33599481|NCT00098722|102084903|FG001|Observation Phase|Other|0|||
33599482|NCT00098722|102084904|FG002|Observation Phase|Other|0|||
33599483|NCT00098722|102084905|FG003|Observation Phase|Other|0|||
33599484|NCT00098722|102084906|FG004|Observation Phase|Other|0|||
33599485|NCT00098722|102084907|FG005|Observation Phase|Other|21|||
33599486|NCT00098722|102084908|FG006|Observation Phase|Other|10|||
33599487|NCT00490139|102084923|FG000|Overall Study|Death|106|||
33599488|NCT00490139|102084924|FG001|Overall Study|Death|119|||
33292262|NCT02419417|100966862|FG005|Overall Study|Study drug toxicity|0|||
33292263|NCT02419417|100966863|FG006|Overall Study|Study drug toxicity|0|||
33292264|NCT02419417|100966864|FG007|Overall Study|Study drug toxicity|0|||
33292265|NCT02419417|100966865|FG008|Overall Study|Study drug toxicity|0|||
33292266|NCT02419417|100966866|FG009|Overall Study|Study drug toxicity|0|||
33292267|NCT02419417|100966867|FG010|Overall Study|Study drug toxicity|0|||
33292268|NCT02419417|100966857|FG000|Overall Study|Adverse event unrelated to study drug|0|||
33292269|NCT02419417|100966858|FG001|Overall Study|Adverse event unrelated to study drug|0|||
33292270|NCT02419417|100966859|FG002|Overall Study|Adverse event unrelated to study drug|0|||
33292271|NCT02419417|100966860|FG003|Overall Study|Adverse event unrelated to study drug|0|||
33599489|NCT00490139|102084925|FG002|Overall Study|Death|168|||
33599490|NCT00490139|102084926|FG003|Overall Study|Death|135|||
33599491|NCT00490139|102084923|FG000|Overall Study|Lost to Follow-up|56|||
33599492|NCT00490139|102084924|FG001|Overall Study|Lost to Follow-up|46|||
33599493|NCT00490139|102084925|FG002|Overall Study|Lost to Follow-up|58|||
33599494|NCT00490139|102084926|FG003|Overall Study|Lost to Follow-up|56|||
33599495|NCT00490139|102084923|FG000|Overall Study|Participant Withdrew Consent|146|||
33599496|NCT00490139|102084924|FG001|Overall Study|Participant Withdrew Consent|110|||
33599497|NCT00490139|102084925|FG002|Overall Study|Participant Withdrew Consent|208|||
33599498|NCT00490139|102084926|FG003|Overall Study|Participant Withdrew Consent|116|||
33292272|NCT02419417|100966861|FG004|Overall Study|Adverse event unrelated to study drug|2|||
33292273|NCT02419417|100966862|FG005|Overall Study|Adverse event unrelated to study drug|1|||
33292274|NCT02419417|100966863|FG006|Overall Study|Adverse event unrelated to study drug|0|||
33292275|NCT02419417|100966864|FG007|Overall Study|Adverse event unrelated to study drug|1|||
33292276|NCT02419417|100966865|FG008|Overall Study|Adverse event unrelated to study drug|0|||
33292277|NCT02419417|100966866|FG009|Overall Study|Adverse event unrelated to study drug|0|||
33292278|NCT02419417|100966867|FG010|Overall Study|Adverse event unrelated to study drug|0|||
33292279|NCT02419417|100966857|FG000|Overall Study|Participant request to discontinue|0|||
33292280|NCT02419417|100966858|FG001|Overall Study|Participant request to discontinue|0|||
33292281|NCT02419417|100966859|FG002|Overall Study|Participant request to discontinue|0|||
33292282|NCT02419417|100966860|FG003|Overall Study|Participant request to discontinue|0|||
33292283|NCT02419417|100966861|FG004|Overall Study|Participant request to discontinue|0|||
33292284|NCT02419417|100966862|FG005|Overall Study|Participant request to discontinue|0|||
33292285|NCT02419417|100966863|FG006|Overall Study|Participant request to discontinue|0|||
33292286|NCT02419417|100966864|FG007|Overall Study|Participant request to discontinue|0|||
33292287|NCT02419417|100966865|FG008|Overall Study|Participant request to discontinue|0|||
33292288|NCT02419417|100966866|FG009|Overall Study|Participant request to discontinue|1|||
33292289|NCT02419417|100966867|FG010|Overall Study|Participant request to discontinue|0|||
33292290|NCT02419417|100966857|FG000|Overall Study|Withdrawal by Subject|0|||
33292291|NCT02419417|100966858|FG001|Overall Study|Withdrawal by Subject|0|||
33292292|NCT02419417|100966859|FG002|Overall Study|Withdrawal by Subject|0|||
33292293|NCT02419417|100966860|FG003|Overall Study|Withdrawal by Subject|0|||
33292294|NCT02419417|100966861|FG004|Overall Study|Withdrawal by Subject|0|||
33292295|NCT02419417|100966862|FG005|Overall Study|Withdrawal by Subject|0|||
33292296|NCT02419417|100966863|FG006|Overall Study|Withdrawal by Subject|0|||
33292297|NCT02419417|100966864|FG007|Overall Study|Withdrawal by Subject|0|||
33292298|NCT02419417|100966865|FG008|Overall Study|Withdrawal by Subject|0|||
33292299|NCT02419417|100966866|FG009|Overall Study|Withdrawal by Subject|0|||
33292300|NCT02419417|100966867|FG010|Overall Study|Withdrawal by Subject|1|||
33292301|NCT01660256|100966868|FG000|Overall Study|Adverse Event|4|||
33292302|NCT01660256|100966869|FG001|Overall Study|Adverse Event|0|||
33292303|NCT01660256|100966870|FG002|Overall Study|Adverse Event|2|||
33292304|NCT01660256|100966868|FG000|Overall Study|Withdrawal by Subject|1|||
33292305|NCT01660256|100966869|FG001|Overall Study|Withdrawal by Subject|0|||
33292306|NCT01660256|100966870|FG002|Overall Study|Withdrawal by Subject|2|||
33292307|NCT01784523|100966871|FG000|Overall Study|Study closed early|7|||
33292308|NCT01784523|100966872|FG001|Overall Study|Study closed early|4|||
33292309|NCT00760747|100966873|FG000|Study Period II|Adverse Event|3|||
33292310|NCT00760747|100966874|FG001|Study Period II|Adverse Event|4|||
33292311|NCT00760747|100966873|FG000|Study Period II|Lack of Efficacy|0|||
33292312|NCT00760747|100966874|FG001|Study Period II|Lack of Efficacy|6|||
33292313|NCT00760747|100966873|FG000|Study Period II|Parent/Caregiver Decision|3|||
33292314|NCT00760747|100966874|FG001|Study Period II|Parent/Caregiver Decision|0|||
33292315|NCT00760747|100966873|FG000|Study Period II|Protocol Violation|6|||
33292316|NCT00760747|100966874|FG001|Study Period II|Protocol Violation|3|||
33292317|NCT00760747|100966873|FG000|Study Period II|Withdrawal by Subject|1|||
33292318|NCT00760747|100966874|FG001|Study Period II|Withdrawal by Subject|0|||
33292319|NCT00760747|100966873|FG000|Study Period II|No drug administered|0|||
33292320|NCT00760747|100966874|FG001|Study Period II|No drug administered|1|||
33292321|NCT00760747|100966873|FG000|Study Period III|Adverse Event|1|||
33292322|NCT00760747|100966874|FG001|Study Period III|Adverse Event|0|||
33292323|NCT00760747|100966873|FG000|Study Period III|Lack of Efficacy|1|||
33292324|NCT00760747|100966874|FG001|Study Period III|Lack of Efficacy|0|||
33292325|NCT00760747|100966873|FG000|Study Period III|Parent/Caregiver Decision|0|||
33292326|NCT00760747|100966874|FG001|Study Period III|Parent/Caregiver Decision|1|||
33391744|NCT01135394|101321861|FG000|Study Treatment|Physician Decision|1|||
33292327|NCT00760747|100966873|FG000|Study Period III|Protocol Violation|1|||
33292328|NCT00760747|100966874|FG001|Study Period III|Protocol Violation|1|||
33292329|NCT00760747|100966873|FG000|Study Period III|Physician Decision|0|||
33292330|NCT00760747|100966874|FG001|Study Period III|Physician Decision|1|||
33292331|NCT00617929|100966875|FG000|Overall Study|Physician Decision|1|||
33292332|NCT01689363|100966878|FG000|Overall Study|Protocol Violation|0|||
33292333|NCT01689363|100966879|FG001|Overall Study|Protocol Violation|1|||
33292334|NCT01689363|100966880|FG002|Overall Study|Protocol Violation|0|||
33599499|NCT02358044|102084928|FG000|Overall Study|Adverse Event|0|||
33292335|NCT01689363|100966881|FG003|Overall Study|Protocol Violation|0|||
33292336|NCT01689363|100966882|FG004|Overall Study|Protocol Violation|0|||
33292337|NCT01689363|100966883|FG005|Overall Study|Protocol Violation|0|||
33292338|NCT01689363|100966884|FG006|Overall Study|Protocol Violation|0|||
33292339|NCT01689363|100966885|FG007|Overall Study|Protocol Violation|0|||
33292340|NCT00590564|100966886|FG000|Overall Study|Withdrawal by Subject|4|||
33292341|NCT00590564|100966886|FG000|Overall Study|Lost to Follow-up|6|||
33292342|NCT00590564|100966886|FG000|Overall Study|Protocol Violation|1|||
33292343|NCT00590564|100966886|FG000|Overall Study|Patient Found to be Ineligible|1|||
33292344|NCT00590564|100966886|FG000|Overall Study|Patient Non-compliance|6|||
33292345|NCT01111240|100966887|FG000|Overall Study|Adverse Event|190|||
33292346|NCT01111240|100966887|FG000|Overall Study|Lack of Efficacy|545|||
33292347|NCT01111240|100966887|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
33292348|NCT01111240|100966887|FG000|Overall Study|Other|312|||
33292349|NCT01496365|100966896|FG000|Overall Study|Adverse Event|2|||
33292350|NCT01496365|100966897|FG001|Overall Study|Adverse Event|3|||
33599500|NCT02358044|102084929|FG001|Overall Study|Adverse Event|1|||
33599501|NCT02358044|102084928|FG000|Overall Study|Lost to Follow-up|2|||
33599502|NCT02358044|102084929|FG001|Overall Study|Lost to Follow-up|1|||
33599503|NCT02358044|102084928|FG000|Overall Study|Physician Decision|0|||
33599504|NCT02358044|102084929|FG001|Overall Study|Physician Decision|1|||
33599505|NCT02358044|102084928|FG000|Overall Study|Withdrawal by Subject|0|||
33599506|NCT02358044|102084929|FG001|Overall Study|Withdrawal by Subject|4|||
33599507|NCT01416441|102084934|FG000|Overall Study|Lost to Follow-up|5|||
33599508|NCT01416441|102084934|FG000|Overall Study|Adverse Event|6|||
33599509|NCT01416441|102084934|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
33599510|NCT01416441|102084934|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
33599511|NCT01416441|102084934|FG000|Overall Study|Investigator Withdrew Subject|2|||
33599512|NCT01416441|102084934|FG000|Overall Study|Subject Withdrew Consent|12|||
33599513|NCT01416441|102084934|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
33292351|NCT01496365|100966898|FG002|Overall Study|Adverse Event|3|||
33292352|NCT01496365|100966899|FG003|Overall Study|Adverse Event|2|||
33292353|NCT01496365|100966900|FG004|Overall Study|Adverse Event|5|||
33599514|NCT00837876|102084935|FG000|Overall Study|Death|2|||
33599515|NCT00837876|102084935|FG000|Overall Study|Adverse Event|7|||
33599516|NCT00837876|102084935|FG000|Overall Study|Physician Decision|1|||
33599517|NCT00837876|102084935|FG000|Overall Study|Withdrawal by Subject|3|||
33599518|NCT00837876|102084935|FG000|Overall Study|disease progression|24|||
33599519|NCT01994863|102084942|FG000|Period 1|Adverse Event|4|||
33599520|NCT01994863|102084943|FG001|Period 1|Adverse Event|0|||
33599521|NCT01994863|102084942|FG000|Period 1|Withdrawal by Subject|1|||
33599522|NCT01994863|102084943|FG001|Period 1|Withdrawal by Subject|0|||
33599523|NCT01994863|102084942|FG000|Period 1|Trial stopped by sponsor|1|||
33599524|NCT01994863|102084943|FG001|Period 1|Trial stopped by sponsor|3|||
33599525|NCT01994863|102084942|FG000|Period 1|Lack of Efficacy|1|||
33599526|NCT01994863|102084943|FG001|Period 1|Lack of Efficacy|0|||
33599527|NCT01994863|102084942|FG000|Period 2|Adverse Event|0|||
33599528|NCT01994863|102084943|FG001|Period 2|Adverse Event|1|||
33599529|NCT01994863|102084942|FG000|Period 2|Lack of Efficacy|0|||
33292354|NCT01496365|100966901|FG005|Overall Study|Adverse Event|6|||
33292355|NCT01496365|100966902|FG006|Overall Study|Adverse Event|4|||
33292356|NCT01496365|100966896|FG000|Overall Study|Withdrawal by Subject|6|||
33292357|NCT01496365|100966897|FG001|Overall Study|Withdrawal by Subject|6|||
33599530|NCT01994863|102084943|FG001|Period 2|Lack of Efficacy|2|||
33599531|NCT01994863|102084942|FG000|Period 2|Withdrawal by Subject|1|||
33599532|NCT01994863|102084943|FG001|Period 2|Withdrawal by Subject|1|||
33599533|NCT00413374|102084944|FG000|Overall Study|Ineligible due to screening criteria.|3|||
33599534|NCT00413374|102084945|FG001|Overall Study|Ineligible due to screening criteria.|0|||
33599535|NCT00413374|102084944|FG000|Overall Study|Adverse Event|1|||
33599536|NCT00413374|102084945|FG001|Overall Study|Adverse Event|0|||
33599537|NCT00413374|102084944|FG000|Overall Study|Lost to Follow-up|1|||
33599538|NCT00413374|102084945|FG001|Overall Study|Lost to Follow-up|0|||
33599539|NCT00413374|102084944|FG000|Overall Study|Surgery|1|||
33599540|NCT00413374|102084945|FG001|Overall Study|Surgery|0|||
33599541|NCT03582813|102084950|FG000|Overall Study|Lost to Follow-up|18|||
33599542|NCT03582813|102084951|FG001|Overall Study|Lost to Follow-up|21|||
33599543|NCT03582813|102084950|FG000|Overall Study|Withdrawal by Subject|1|||
33599544|NCT03582813|102084951|FG001|Overall Study|Withdrawal by Subject|0|||
33599545|NCT02536300|102084952|FG000|Overall Study|Investigator's Discretion|17|||
33599546|NCT02536300|102084953|FG001|Overall Study|Investigator's Discretion|11|||
33599547|NCT02536300|102084954|FG002|Overall Study|Investigator's Discretion|2|||
33599548|NCT02536300|102084952|FG000|Overall Study|Progressive Disease|11|||
33599549|NCT02536300|102084953|FG001|Overall Study|Progressive Disease|7|||
33599550|NCT02536300|102084954|FG002|Overall Study|Progressive Disease|6|||
33599551|NCT02536300|102084952|FG000|Overall Study|Study Terminated by Sponsor|6|||
33599552|NCT02536300|102084953|FG001|Overall Study|Study Terminated by Sponsor|4|||
33599553|NCT02536300|102084954|FG002|Overall Study|Study Terminated by Sponsor|7|||
33292358|NCT01496365|100966898|FG002|Overall Study|Withdrawal by Subject|0|||
33292359|NCT01496365|100966899|FG003|Overall Study|Withdrawal by Subject|1|||
33292360|NCT01496365|100966900|FG004|Overall Study|Withdrawal by Subject|3|||
33292361|NCT01496365|100966901|FG005|Overall Study|Withdrawal by Subject|2|||
33599554|NCT02536300|102084952|FG000|Overall Study|Death|7|||
33599555|NCT02536300|102084953|FG001|Overall Study|Death|0|||
33599556|NCT02536300|102084954|FG002|Overall Study|Death|5|||
33599557|NCT02536300|102084952|FG000|Overall Study|Withdrew Consent|4|||
33599558|NCT02536300|102084953|FG001|Overall Study|Withdrew Consent|2|||
33599559|NCT02536300|102084954|FG002|Overall Study|Withdrew Consent|0|||
33599560|NCT02536300|102084952|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
33599561|NCT02536300|102084953|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
33599562|NCT02536300|102084954|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
33599563|NCT02536300|102084952|FG000|Overall Study|Enrolled but Never Treated|0|||
33599564|NCT02536300|102084953|FG001|Overall Study|Enrolled but Never Treated|0|||
33599565|NCT02536300|102084954|FG002|Overall Study|Enrolled but Never Treated|1|||
33599566|NCT02536300|102084952|FG000|Overall Study|Non-compliance With Study Drug|1|||
33599567|NCT02536300|102084953|FG001|Overall Study|Non-compliance With Study Drug|0|||
33599568|NCT02536300|102084954|FG002|Overall Study|Non-compliance With Study Drug|0|||
33599569|NCT02536300|102084952|FG000|Overall Study|Protocol Violation|0|||
33599570|NCT02536300|102084953|FG001|Overall Study|Protocol Violation|1|||
33599571|NCT02536300|102084954|FG002|Overall Study|Protocol Violation|0|||
33599572|NCT01066780|102084955|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
33599573|NCT01066780|102084956|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
33599574|NCT00740714|102084961|FG000|Overall Study|Withdrawal by Subject|17|||
33599575|NCT00740714|102084962|FG001|Overall Study|Withdrawal by Subject|19|||
33599576|NCT00740714|102084963|FG002|Overall Study|Withdrawal by Subject|29|||
33599577|NCT01945775|102084965|FG000|Overall Study|Death|214|||
33599578|NCT01945775|102084966|FG001|Overall Study|Death|98|||
33599579|NCT01945775|102084965|FG000|Overall Study|Lost to Follow-up|12|||
33599580|NCT01945775|102084966|FG001|Overall Study|Lost to Follow-up|7|||
33599581|NCT01945775|102084965|FG000|Overall Study|Withdrawal by Subject|11|||
33599582|NCT01945775|102084966|FG001|Overall Study|Withdrawal by Subject|21|||
33599583|NCT01945775|102084965|FG000|Overall Study|Other|50|||
33599584|NCT01945775|102084966|FG001|Overall Study|Other|18|||
33599585|NCT00747344|102084967|FG000|Controlled Period|Adverse Event|3|||
33599586|NCT00747344|102084968|FG001|Controlled Period|Adverse Event|0|||
33292362|NCT01496365|100966902|FG006|Overall Study|Withdrawal by Subject|1|||
33292363|NCT01496365|100966896|FG000|Overall Study|Protocol Violation|2|||
33292364|NCT01496365|100966897|FG001|Overall Study|Protocol Violation|1|||
33292365|NCT01496365|100966898|FG002|Overall Study|Protocol Violation|1|||
33292366|NCT01496365|100966899|FG003|Overall Study|Protocol Violation|0|||
33292367|NCT01496365|100966900|FG004|Overall Study|Protocol Violation|0|||
33292368|NCT01496365|100966901|FG005|Overall Study|Protocol Violation|1|||
33292369|NCT01496365|100966902|FG006|Overall Study|Protocol Violation|0|||
33292370|NCT01496365|100966896|FG000|Overall Study|Lack of Efficacy|1|||
33292371|NCT01496365|100966897|FG001|Overall Study|Lack of Efficacy|0|||
33292372|NCT01496365|100966898|FG002|Overall Study|Lack of Efficacy|0|||
33292373|NCT01496365|100966899|FG003|Overall Study|Lack of Efficacy|0|||
33292374|NCT01496365|100966900|FG004|Overall Study|Lack of Efficacy|0|||
33292375|NCT01496365|100966901|FG005|Overall Study|Lack of Efficacy|1|||
33292376|NCT01496365|100966902|FG006|Overall Study|Lack of Efficacy|0|||
33292377|NCT01496365|100966896|FG000|Overall Study|Lost to Follow-up|0|||
33292378|NCT01496365|100966897|FG001|Overall Study|Lost to Follow-up|1|||
33292379|NCT01496365|100966898|FG002|Overall Study|Lost to Follow-up|0|||
33292380|NCT01496365|100966899|FG003|Overall Study|Lost to Follow-up|0|||
33292381|NCT01496365|100966900|FG004|Overall Study|Lost to Follow-up|2|||
33292382|NCT01496365|100966901|FG005|Overall Study|Lost to Follow-up|0|||
33292383|NCT01496365|100966902|FG006|Overall Study|Lost to Follow-up|0|||
33292384|NCT01496365|100966896|FG000|Overall Study|Other|4|||
33292385|NCT01496365|100966897|FG001|Overall Study|Other|4|||
33292386|NCT01496365|100966898|FG002|Overall Study|Other|2|||
33292387|NCT01496365|100966899|FG003|Overall Study|Other|1|||
33292388|NCT01496365|100966900|FG004|Overall Study|Other|3|||
33292389|NCT01496365|100966901|FG005|Overall Study|Other|0|||
33292390|NCT01496365|100966902|FG006|Overall Study|Other|1|||
33292391|NCT01458522|100966905|FG000|Overall Study|Withdrawal by Subject|2|||
33292392|NCT01458522|100966906|FG001|Overall Study|Withdrawal by Subject|2|||
33292393|NCT01458522|100966905|FG000|Overall Study|Physician Decision|1|||
33292394|NCT01458522|100966906|FG001|Overall Study|Physician Decision|9|||
33292395|NCT03194867|100966907|FG000|Overall Study|Incorrect completion of end of study form|0|||
33292396|NCT03194867|100966908|FG001|Overall Study|Incorrect completion of end of study form|0|||
33292397|NCT03194867|100966909|FG002|Overall Study|Incorrect completion of end of study form|1|||
33292398|NCT03194867|100966910|FG003|Overall Study|Incorrect completion of end of study form|0|||
33292399|NCT01443923|100966915|FG000|Overall Study|Adverse Event|1|||
33292400|NCT01443923|100966916|FG001|Overall Study|Adverse Event|0|||
33292401|NCT02990468|100966917|FG000|Phase 2: MTD|Change in treatment|0|||
33292402|NCT02990468|100966918|FG001|Phase 2: MTD|Change in treatment|0|||
33292403|NCT02990468|100966919|FG002|Phase 2: MTD|Change in treatment|1|||
33292404|NCT02595372|100966920|FG000|Overall Study|Adverse Event|6|||
33292405|NCT02595372|100966920|FG000|Overall Study|Physician Decision|2|||
33292406|NCT02595372|100966920|FG000|Overall Study|Disease Progression|1|||
33292407|NCT01791413|100970690|FG000|Overall Study|Lost to Follow-up|5|||
33292408|NCT01791413|100970691|FG001|Overall Study|Lost to Follow-up|1|||
33292409|NCT03566979|100970692|FG000|Overall Study|Withdrawal by Subject|2|||
33292410|NCT03566979|100970693|FG001|Overall Study|Withdrawal by Subject|0|||
33292411|NCT03566979|100970694|FG002|Overall Study|Withdrawal by Subject|1|||
33292412|NCT03566979|100970695|FG003|Overall Study|Withdrawal by Subject|1|||
33292413|NCT03566979|100970692|FG000|Overall Study|Lost to Follow-up|2|||
33292414|NCT03566979|100970693|FG001|Overall Study|Lost to Follow-up|7|||
33292415|NCT03566979|100970694|FG002|Overall Study|Lost to Follow-up|9|||
33292416|NCT03566979|100970695|FG003|Overall Study|Lost to Follow-up|5|||
33292417|NCT03566979|100970692|FG000|Overall Study|Adverse Event|1|||
33292418|NCT03566979|100970693|FG001|Overall Study|Adverse Event|0|||
33292419|NCT03566979|100970694|FG002|Overall Study|Adverse Event|0|||
33292420|NCT03566979|100970695|FG003|Overall Study|Adverse Event|0|||
33292421|NCT01602510|100970696|FG000|Open Label Phase|Adverse Event|46|||
33292422|NCT01602510|100970697|FG001|Open Label Phase|Adverse Event|0|||
33292423|NCT01602510|100970698|FG002|Open Label Phase|Adverse Event|0|||
33292424|NCT01602510|100970696|FG000|Open Label Phase|Lack of Efficacy|22|||
33292425|NCT01602510|100970697|FG001|Open Label Phase|Lack of Efficacy|0|||
33292426|NCT01602510|100970698|FG002|Open Label Phase|Lack of Efficacy|0|||
33292427|NCT01602510|100970696|FG000|Open Label Phase|Protocol Violation|15|||
33292428|NCT01602510|100970697|FG001|Open Label Phase|Protocol Violation|0|||
33292429|NCT01602510|100970698|FG002|Open Label Phase|Protocol Violation|0|||
33292430|NCT01602510|100970696|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
33292431|NCT01602510|100970697|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
33292432|NCT01602510|100970698|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
33292433|NCT01602510|100970696|FG000|Open Label Phase|Lost to Follow-up|22|||
33292434|NCT01602510|100970697|FG001|Open Label Phase|Lost to Follow-up|0|||
33292435|NCT01602510|100970698|FG002|Open Label Phase|Lost to Follow-up|0|||
33292436|NCT01602510|100970696|FG000|Open Label Phase|Physician Decision|19|||
33292437|NCT01602510|100970697|FG001|Open Label Phase|Physician Decision|0|||
33292438|NCT01602510|100970698|FG002|Open Label Phase|Physician Decision|0|||
33292439|NCT01602510|100970696|FG000|Open Label Phase|Withdrawal by Subject|57|||
33599587|NCT00747344|102084969|FG002|Controlled Period|Adverse Event|0|||
33599588|NCT00747344|102084970|FG003|Controlled Period|Adverse Event|0|||
33292440|NCT01602510|100970697|FG001|Open Label Phase|Withdrawal by Subject|0|||
33292441|NCT01602510|100970698|FG002|Open Label Phase|Withdrawal by Subject|0|||
33292442|NCT01602510|100970696|FG000|Randomized Phase|Adverse Event|0|||
33292443|NCT01602510|100970697|FG001|Randomized Phase|Adverse Event|2|||
33292444|NCT01602510|100970698|FG002|Randomized Phase|Adverse Event|6|||
33292445|NCT01602510|100970696|FG000|Randomized Phase|Lack of Efficacy|0|||
33292446|NCT01602510|100970697|FG001|Randomized Phase|Lack of Efficacy|4|||
33292447|NCT01602510|100970698|FG002|Randomized Phase|Lack of Efficacy|4|||
33292448|NCT01602510|100970696|FG000|Randomized Phase|Protocol Violation|0|||
33292449|NCT01602510|100970697|FG001|Randomized Phase|Protocol Violation|3|||
33292450|NCT01602510|100970698|FG002|Randomized Phase|Protocol Violation|3|||
33292451|NCT01602510|100970696|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
33292452|NCT01602510|100970697|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
33292453|NCT01602510|100970698|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
33599589|NCT00747344|102084967|FG000|Controlled Period|Lack of Efficacy|2|||
33599590|NCT00747344|102084968|FG001|Controlled Period|Lack of Efficacy|1|||
33599591|NCT00747344|102084969|FG002|Controlled Period|Lack of Efficacy|0|||
33599592|NCT00747344|102084970|FG003|Controlled Period|Lack of Efficacy|0|||
33599593|NCT00747344|102084967|FG000|Controlled Period|Other|0|||
33599594|NCT00747344|102084968|FG001|Controlled Period|Other|3|||
33292454|NCT01602510|100970696|FG000|Randomized Phase|Lost to Follow-up|0|||
33292455|NCT01602510|100970697|FG001|Randomized Phase|Lost to Follow-up|1|||
33599595|NCT00747344|102084969|FG002|Controlled Period|Other|0|||
33292456|NCT01602510|100970698|FG002|Randomized Phase|Lost to Follow-up|3|||
33292457|NCT01602510|100970696|FG000|Randomized Phase|Physician Decision|0|||
33292458|NCT01602510|100970697|FG001|Randomized Phase|Physician Decision|0|||
33292459|NCT01602510|100970698|FG002|Randomized Phase|Physician Decision|2|||
33292460|NCT01602510|100970696|FG000|Randomized Phase|Withdrawal by Subject|0|||
33292461|NCT01602510|100970697|FG001|Randomized Phase|Withdrawal by Subject|6|||
33292462|NCT01602510|100970698|FG002|Randomized Phase|Withdrawal by Subject|7|||
33292463|NCT04547023|100970701|FG000|Overall Study|Did Not Receive Intervention|3|||
33292464|NCT04547023|100970702|FG001|Overall Study|Did Not Receive Intervention|2|||
33292465|NCT04547023|100970701|FG000|Overall Study|Lost to Follow-up|1|||
33292466|NCT04547023|100970702|FG001|Overall Study|Lost to Follow-up|1|||
33292467|NCT00127842|100970703|FG000|Overall Study|Adverse Event|15|||
33292468|NCT00127842|100970703|FG000|Overall Study|Withdrawal by Subject|3|||
33292469|NCT00127842|100970703|FG000|Overall Study|Lost to Follow-up|1|||
33292470|NCT00127842|100970703|FG000|Overall Study|Lack of Efficacy|12|||
33292471|NCT00127842|100970703|FG000|Overall Study|Noncompliance|2|||
33292472|NCT00127842|100970703|FG000|Overall Study|Protocol Violation|1|||
33292473|NCT00127842|100970703|FG000|Overall Study|Other|5|||
33292474|NCT00362375|100970704|FG000|Overall Study|Lost to Follow-up|40|||
33292475|NCT00362375|100970705|FG001|Overall Study|Lost to Follow-up|35|||
33292476|NCT02375347|100970706|FG000|Overall Study|Protocol Violation|1|||
33292477|NCT01790295|100970707|FG000|Overall Study|Adverse Event|1|||
33292478|NCT01790295|100970707|FG000|Overall Study|Death|4|||
33292479|NCT01790295|100970707|FG000|Overall Study|Lack of Efficacy|2|||
33292480|NCT01790295|100970707|FG000|Overall Study|Study closure|4|||
33292481|NCT00905034|100970711|FG000|Overall Study|Withdrawal by Subject|1|||
33292482|NCT00913523|100970714|FG000|Overall Study|Withdrawal by Subject|3|||
33292483|NCT00913523|100970715|FG001|Overall Study|Withdrawal by Subject|2|||
33292484|NCT00913523|100970716|FG002|Overall Study|Withdrawal by Subject|2|||
33292485|NCT00913523|100970714|FG000|Overall Study|Lost to Follow-up|1|||
33292486|NCT00913523|100970715|FG001|Overall Study|Lost to Follow-up|1|||
33292487|NCT00913523|100970716|FG002|Overall Study|Lost to Follow-up|1|||
33292488|NCT00913523|100970714|FG000|Overall Study|Adverse Event|1|||
33292489|NCT00913523|100970715|FG001|Overall Study|Adverse Event|0|||
33292490|NCT00913523|100970716|FG002|Overall Study|Adverse Event|0|||
33292491|NCT00913523|100970714|FG000|Overall Study|Protocol Violation|5|||
33292492|NCT00913523|100970715|FG001|Overall Study|Protocol Violation|8|||
33292493|NCT00913523|100970716|FG002|Overall Study|Protocol Violation|8|||
33292494|NCT00913523|100970714|FG000|Overall Study|Pregnancy|1|||
33292495|NCT00913523|100970715|FG001|Overall Study|Pregnancy|3|||
33292496|NCT00913523|100970716|FG002|Overall Study|Pregnancy|0|||
33292497|NCT00913523|100970714|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
33292498|NCT00913523|100970715|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
33292499|NCT00913523|100970716|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
33292500|NCT02232399|100970717|FG000|Overall Study|Adverse Event|1|||
33292501|NCT02232399|100970718|FG001|Overall Study|Adverse Event|0|||
33292502|NCT02232399|100970717|FG000|Overall Study|Withdrawal by Subject|0|||
33292503|NCT02232399|100970718|FG001|Overall Study|Withdrawal by Subject|1|||
33599596|NCT00747344|102084970|FG003|Controlled Period|Other|0|||
33599597|NCT00747344|102084967|FG000|After Controlled Period|Adverse Event|0|||
33599598|NCT00747344|102084968|FG001|After Controlled Period|Adverse Event|0|||
33599599|NCT00747344|102084969|FG002|After Controlled Period|Adverse Event|0|||
33599600|NCT00747344|102084970|FG003|After Controlled Period|Adverse Event|1|||
33599601|NCT01081301|102084978|FG000|Overall Study|Bereaved|3|||
33599602|NCT01081301|102084978|FG000|Overall Study|Too busy|5|||
33599603|NCT01081301|102084978|FG000|Overall Study|Patient too ill|2|||
33599604|NCT01081301|102084978|FG000|Overall Study|Lost to Follow-up|4|||
33599605|NCT00520013|102084980|FG000|Overall Study|Withdrawal by Subject|0|||
33599606|NCT00520013|102084981|FG001|Overall Study|Withdrawal by Subject|0|||
33599607|NCT00520013|102084982|FG002|Overall Study|Withdrawal by Subject|1|||
33599608|NCT00520013|102084980|FG000|Overall Study|Adverse Event|2|||
33599609|NCT00520013|102084981|FG001|Overall Study|Adverse Event|10|||
33599610|NCT00520013|102084982|FG002|Overall Study|Adverse Event|7|||
33599611|NCT00520013|102084980|FG000|Overall Study|Progressive Disease|7|||
33599612|NCT00520013|102084981|FG001|Overall Study|Progressive Disease|3|||
33599613|NCT00520013|102084982|FG002|Overall Study|Progressive Disease|0|||
33599614|NCT00520013|102084980|FG000|Overall Study|Clinical Progression|3|||
33599615|NCT00520013|102084981|FG001|Overall Study|Clinical Progression|1|||
33599616|NCT00520013|102084982|FG002|Overall Study|Clinical Progression|0|||
33599617|NCT00520013|102084980|FG000|Overall Study|Death|0|||
33599618|NCT00520013|102084981|FG001|Overall Study|Death|1|||
33599619|NCT00520013|102084982|FG002|Overall Study|Death|0|||
33599620|NCT00520013|102084980|FG000|Overall Study|Physician Decision|0|||
33292504|NCT01781832|100970719|FG000|Overall Study|Withdrawal by Subject|1|||
33599621|NCT00520013|102084981|FG001|Overall Study|Physician Decision|0|||
33599622|NCT00520013|102084982|FG002|Overall Study|Physician Decision|3|||
33599623|NCT02741570|102084983|FG000|Pre-Treatment Period|Other reasons|0|||
33599624|NCT02741570|102084984|FG001|Pre-Treatment Period|Other reasons|3|||
33599625|NCT02741570|102084983|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
33292505|NCT01939353|100970720|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
33292506|NCT01939353|100970720|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
33292507|NCT01939353|100970720|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
33292508|NCT01939353|100970720|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
33292509|NCT01939353|100970720|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
33292510|NCT01163474|100970722|FG000|Overall Study|Withdrawal by Subject|1|||
33292511|NCT01163474|100970722|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
33292512|NCT01163474|100970722|FG000|Overall Study|Lost to Follow-up|3|||
33292513|NCT00781937|100970726|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
33292514|NCT00781937|100970727|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
33292515|NCT00781937|100970726|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
33292516|NCT00781937|100970727|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
33292517|NCT00781937|100970726|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
33292518|NCT00781937|100970727|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
33292519|NCT00781937|100970726|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
33599626|NCT02741570|102084984|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
33599627|NCT02741570|102084983|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
33599628|NCT02741570|102084984|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
33599629|NCT02741570|102084983|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
33599630|NCT02741570|102084984|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
33599631|NCT02741570|102084983|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
33599632|NCT02741570|102084984|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
33599633|NCT02741570|102084983|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
33599634|NCT02741570|102084984|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
33599635|NCT02741570|102084983|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
33599636|NCT02741570|102084984|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33599637|NCT02741570|102084983|FG000|Pre-Treatment Period|Death|0|||
33599638|NCT02741570|102084984|FG001|Pre-Treatment Period|Death|1|||
33599639|NCT02741570|102084983|FG000|Pre-Treatment Period|Disease progression|0|||
33599640|NCT02741570|102084984|FG001|Pre-Treatment Period|Disease progression|1|||
33599641|NCT02741570|102084983|FG000|Treatment Period|Other reasons|47|||
33599642|NCT02741570|102084984|FG001|Treatment Period|Other reasons|12|||
33599643|NCT02741570|102084983|FG000|Treatment Period|Poor/non-compliance|0|||
33599644|NCT02741570|102084984|FG001|Treatment Period|Poor/non-compliance|2|||
33599645|NCT02741570|102084983|FG000|Treatment Period|Maximum clinical benefit|4|||
33599646|NCT02741570|102084984|FG001|Treatment Period|Maximum clinical benefit|6|||
33599647|NCT02741570|102084983|FG000|Treatment Period|Lost to Follow-up|1|||
33599648|NCT02741570|102084984|FG001|Treatment Period|Lost to Follow-up|3|||
33599649|NCT02741570|102084983|FG000|Treatment Period|Participant withdrew consent|9|||
33599650|NCT02741570|102084984|FG001|Treatment Period|Participant withdrew consent|13|||
33292520|NCT00781937|100970727|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
33292521|NCT00781937|100970726|FG000|Main Trial Period Through Week 56|Unclassified|10|||
33292522|NCT00781937|100970727|FG001|Main Trial Period Through Week 56|Unclassified|15|||
33292523|NCT00781937|100970726|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
33292524|NCT00781937|100970727|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
33292525|NCT00781937|100970726|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
33292526|NCT00781937|100970727|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
33292527|NCT03513068|100970728|FG000|Overall Study|Death|1|||
33292528|NCT03513068|100970729|FG001|Overall Study|Death|0|||
33292529|NCT03513068|100970728|FG000|Overall Study|Withdrawal by Subject|4|||
33292530|NCT03513068|100970729|FG001|Overall Study|Withdrawal by Subject|6|||
33292531|NCT00633945|100970730|FG000|Overall Study|Physician Decision|2|||
33292532|NCT01296555|100970731|FG000|Overall Study|Adverse Event|0|||
33292533|NCT01296555|100970732|FG001|Overall Study|Adverse Event|0|||
33292534|NCT01296555|100970733|FG002|Overall Study|Adverse Event|1|||
33292535|NCT01296555|100970734|FG003|Overall Study|Adverse Event|1|||
33292536|NCT01296555|100970735|FG004|Overall Study|Adverse Event|2|||
33292537|NCT01296555|100970736|FG005|Overall Study|Adverse Event|4|||
33292538|NCT01296555|100970737|FG006|Overall Study|Adverse Event|1|||
33292539|NCT01296555|100970738|FG007|Overall Study|Adverse Event|4|||
33292540|NCT01296555|100970739|FG008|Overall Study|Adverse Event|3|||
33292541|NCT01296555|100970740|FG009|Overall Study|Adverse Event|1|||
33292542|NCT01296555|100970741|FG010|Overall Study|Adverse Event|0|||
33292543|NCT01296555|100970742|FG011|Overall Study|Adverse Event|4|||
33292544|NCT01296555|100970743|FG012|Overall Study|Adverse Event|1|||
33292545|NCT01296555|100970744|FG013|Overall Study|Adverse Event|4|||
33292546|NCT01296555|100970745|FG014|Overall Study|Adverse Event|0|||
33292547|NCT01296555|100970746|FG015|Overall Study|Adverse Event|0|||
33292548|NCT01296555|100970747|FG016|Overall Study|Adverse Event|0|||
33292549|NCT01296555|100970748|FG017|Overall Study|Adverse Event|0|||
33292550|NCT01296555|100970749|FG018|Overall Study|Adverse Event|0|||
33292551|NCT01296555|100970750|FG019|Overall Study|Adverse Event|1|||
33292552|NCT01296555|100970751|FG020|Overall Study|Adverse Event|0|||
33292553|NCT01296555|100970752|FG021|Overall Study|Adverse Event|0|||
33292554|NCT01296555|100970753|FG022|Overall Study|Adverse Event|0|||
33292555|NCT01296555|100970754|FG023|Overall Study|Adverse Event|0|||
33292556|NCT01296555|100970755|FG024|Overall Study|Adverse Event|0|||
33292557|NCT01296555|100970756|FG025|Overall Study|Adverse Event|0|||
33292558|NCT01296555|100970757|FG026|Overall Study|Adverse Event|0|||
33292559|NCT01296555|100970758|FG027|Overall Study|Adverse Event|0|||
33292560|NCT01296555|100970759|FG028|Overall Study|Adverse Event|0|||
33292561|NCT01296555|100970731|FG000|Overall Study|Reason Not Specified|0|||
33292562|NCT01296555|100970732|FG001|Overall Study|Reason Not Specified|0|||
33292563|NCT01296555|100970733|FG002|Overall Study|Reason Not Specified|0|||
33292564|NCT01296555|100970734|FG003|Overall Study|Reason Not Specified|0|||
33292565|NCT01296555|100970735|FG004|Overall Study|Reason Not Specified|0|||
33292566|NCT01296555|100970736|FG005|Overall Study|Reason Not Specified|0|||
33292567|NCT01296555|100970737|FG006|Overall Study|Reason Not Specified|0|||
33292568|NCT01296555|100970738|FG007|Overall Study|Reason Not Specified|0|||
33292569|NCT01296555|100970739|FG008|Overall Study|Reason Not Specified|0|||
33292570|NCT01296555|100970740|FG009|Overall Study|Reason Not Specified|0|||
33292571|NCT01296555|100970741|FG010|Overall Study|Reason Not Specified|0|||
33391745|NCT01135394|101321861|FG000|Study Treatment|Adverse Event|2|||
33292572|NCT01296555|100970742|FG011|Overall Study|Reason Not Specified|0|||
33292573|NCT01296555|100970743|FG012|Overall Study|Reason Not Specified|0|||
33292574|NCT01296555|100970744|FG013|Overall Study|Reason Not Specified|1|||
33292575|NCT01296555|100970745|FG014|Overall Study|Reason Not Specified|2|||
33292576|NCT01296555|100970746|FG015|Overall Study|Reason Not Specified|3|||
33292577|NCT01296555|100970747|FG016|Overall Study|Reason Not Specified|7|||
33292578|NCT01296555|100970748|FG017|Overall Study|Reason Not Specified|4|||
33292579|NCT01296555|100970749|FG018|Overall Study|Reason Not Specified|3|||
33292580|NCT01296555|100970750|FG019|Overall Study|Reason Not Specified|7|||
33292581|NCT01296555|100970751|FG020|Overall Study|Reason Not Specified|11|||
33292582|NCT01296555|100970752|FG021|Overall Study|Reason Not Specified|5|||
33292583|NCT01296555|100970753|FG022|Overall Study|Reason Not Specified|5|||
33292584|NCT01296555|100970754|FG023|Overall Study|Reason Not Specified|7|||
33292585|NCT01296555|100970755|FG024|Overall Study|Reason Not Specified|2|||
33292586|NCT01296555|100970756|FG025|Overall Study|Reason Not Specified|2|||
33292587|NCT01296555|100970757|FG026|Overall Study|Reason Not Specified|19|||
33292588|NCT01296555|100970758|FG027|Overall Study|Reason Not Specified|11|||
33292589|NCT01296555|100970759|FG028|Overall Study|Reason Not Specified|9|||
33292590|NCT01296555|100970731|FG000|Overall Study|Physician Decision|0|||
33292591|NCT01296555|100970732|FG001|Overall Study|Physician Decision|0|||
33292592|NCT01296555|100970733|FG002|Overall Study|Physician Decision|0|||
33292593|NCT01296555|100970734|FG003|Overall Study|Physician Decision|0|||
33292594|NCT01296555|100970735|FG004|Overall Study|Physician Decision|1|||
33292595|NCT01296555|100970736|FG005|Overall Study|Physician Decision|0|||
33292596|NCT01296555|100970737|FG006|Overall Study|Physician Decision|0|||
33292597|NCT01296555|100970738|FG007|Overall Study|Physician Decision|0|||
33292598|NCT01296555|100970739|FG008|Overall Study|Physician Decision|0|||
33292599|NCT01296555|100970740|FG009|Overall Study|Physician Decision|0|||
33292600|NCT01296555|100970741|FG010|Overall Study|Physician Decision|0|||
33292601|NCT01296555|100970742|FG011|Overall Study|Physician Decision|0|||
33292602|NCT01296555|100970743|FG012|Overall Study|Physician Decision|0|||
33292603|NCT01296555|100970744|FG013|Overall Study|Physician Decision|1|||
33292604|NCT01296555|100970745|FG014|Overall Study|Physician Decision|0|||
33292605|NCT01296555|100970746|FG015|Overall Study|Physician Decision|0|||
33292606|NCT01296555|100970747|FG016|Overall Study|Physician Decision|0|||
33292607|NCT01296555|100970748|FG017|Overall Study|Physician Decision|0|||
33292608|NCT01296555|100970749|FG018|Overall Study|Physician Decision|0|||
33292609|NCT01296555|100970750|FG019|Overall Study|Physician Decision|1|||
33292610|NCT01296555|100970751|FG020|Overall Study|Physician Decision|0|||
33292611|NCT01296555|100970752|FG021|Overall Study|Physician Decision|0|||
33292612|NCT01296555|100970753|FG022|Overall Study|Physician Decision|0|||
33292613|NCT01296555|100970754|FG023|Overall Study|Physician Decision|0|||
33292614|NCT01296555|100970755|FG024|Overall Study|Physician Decision|0|||
33292615|NCT01296555|100970756|FG025|Overall Study|Physician Decision|0|||
33292616|NCT01296555|100970757|FG026|Overall Study|Physician Decision|0|||
33292617|NCT01296555|100970758|FG027|Overall Study|Physician Decision|0|||
33292618|NCT01296555|100970759|FG028|Overall Study|Physician Decision|0|||
33292619|NCT01296555|100970731|FG000|Overall Study|Progressive Disease|6|||
33292620|NCT01296555|100970732|FG001|Overall Study|Progressive Disease|3|||
33292621|NCT01296555|100970733|FG002|Overall Study|Progressive Disease|3|||
33292622|NCT01296555|100970734|FG003|Overall Study|Progressive Disease|7|||
33292623|NCT01296555|100970735|FG004|Overall Study|Progressive Disease|6|||
33292624|NCT01296555|100970736|FG005|Overall Study|Progressive Disease|16|||
33292625|NCT01296555|100970737|FG006|Overall Study|Progressive Disease|16|||
33292626|NCT01296555|100970738|FG007|Overall Study|Progressive Disease|8|||
33292627|NCT01296555|100970739|FG008|Overall Study|Progressive Disease|7|||
33292628|NCT01296555|100970740|FG009|Overall Study|Progressive Disease|18|||
33292629|NCT01296555|100970741|FG010|Overall Study|Progressive Disease|7|||
33292630|NCT01296555|100970742|FG011|Overall Study|Progressive Disease|14|||
33292631|NCT01296555|100970743|FG012|Overall Study|Progressive Disease|5|||
33292632|NCT01296555|100970744|FG013|Overall Study|Progressive Disease|12|||
33292633|NCT01296555|100970745|FG014|Overall Study|Progressive Disease|1|||
33292634|NCT01296555|100970746|FG015|Overall Study|Progressive Disease|1|||
33292635|NCT01296555|100970747|FG016|Overall Study|Progressive Disease|0|||
33292636|NCT01296555|100970748|FG017|Overall Study|Progressive Disease|0|||
33292637|NCT01296555|100970749|FG018|Overall Study|Progressive Disease|0|||
33292638|NCT01296555|100970750|FG019|Overall Study|Progressive Disease|1|||
33292639|NCT01296555|100970751|FG020|Overall Study|Progressive Disease|0|||
33292640|NCT01296555|100970752|FG021|Overall Study|Progressive Disease|0|||
33292641|NCT01296555|100970753|FG022|Overall Study|Progressive Disease|0|||
33292642|NCT01296555|100970754|FG023|Overall Study|Progressive Disease|0|||
33292643|NCT01296555|100970755|FG024|Overall Study|Progressive Disease|1|||
33292644|NCT01296555|100970756|FG025|Overall Study|Progressive Disease|0|||
33292645|NCT01296555|100970757|FG026|Overall Study|Progressive Disease|5|||
33292646|NCT01296555|100970758|FG027|Overall Study|Progressive Disease|1|||
33292647|NCT01296555|100970759|FG028|Overall Study|Progressive Disease|0|||
33292648|NCT01296555|100970731|FG000|Overall Study|Protocol Violation|0|||
33292649|NCT01296555|100970732|FG001|Overall Study|Protocol Violation|0|||
33292650|NCT01296555|100970733|FG002|Overall Study|Protocol Violation|0|||
33292651|NCT01296555|100970734|FG003|Overall Study|Protocol Violation|0|||
33292652|NCT01296555|100970735|FG004|Overall Study|Protocol Violation|0|||
33292653|NCT01296555|100970736|FG005|Overall Study|Protocol Violation|0|||
33292654|NCT01296555|100970737|FG006|Overall Study|Protocol Violation|0|||
33292655|NCT01296555|100970738|FG007|Overall Study|Protocol Violation|0|||
33292656|NCT01296555|100970739|FG008|Overall Study|Protocol Violation|0|||
33292657|NCT01296555|100970740|FG009|Overall Study|Protocol Violation|0|||
33292658|NCT01296555|100970741|FG010|Overall Study|Protocol Violation|0|||
33292659|NCT01296555|100970742|FG011|Overall Study|Protocol Violation|0|||
33599651|NCT02741570|102084983|FG000|Treatment Period|Participant request to discontinue treatment|8|||
33599652|NCT02741570|102084984|FG001|Treatment Period|Participant request to discontinue treatment|23|||
33292660|NCT01296555|100970743|FG012|Overall Study|Protocol Violation|0|||
33292661|NCT01296555|100970744|FG013|Overall Study|Protocol Violation|1|||
33292662|NCT01296555|100970745|FG014|Overall Study|Protocol Violation|0|||
33292663|NCT01296555|100970746|FG015|Overall Study|Protocol Violation|0|||
33292664|NCT01296555|100970747|FG016|Overall Study|Protocol Violation|0|||
33292665|NCT01296555|100970748|FG017|Overall Study|Protocol Violation|0|||
33292666|NCT01296555|100970749|FG018|Overall Study|Protocol Violation|0|||
33292667|NCT01296555|100970750|FG019|Overall Study|Protocol Violation|0|||
33292668|NCT01296555|100970751|FG020|Overall Study|Protocol Violation|0|||
33292669|NCT01296555|100970752|FG021|Overall Study|Protocol Violation|0|||
33292670|NCT01296555|100970753|FG022|Overall Study|Protocol Violation|0|||
33292671|NCT01296555|100970754|FG023|Overall Study|Protocol Violation|0|||
33292672|NCT01296555|100970755|FG024|Overall Study|Protocol Violation|0|||
33292673|NCT01296555|100970756|FG025|Overall Study|Protocol Violation|0|||
33292674|NCT01296555|100970757|FG026|Overall Study|Protocol Violation|0|||
33292675|NCT01296555|100970758|FG027|Overall Study|Protocol Violation|0|||
33292676|NCT01296555|100970759|FG028|Overall Study|Protocol Violation|0|||
33292677|NCT01296555|100970731|FG000|Overall Study|Study Terminated By Sponsor|0|||
33292678|NCT01296555|100970732|FG001|Overall Study|Study Terminated By Sponsor|0|||
33292679|NCT01296555|100970733|FG002|Overall Study|Study Terminated By Sponsor|0|||
33292680|NCT01296555|100970734|FG003|Overall Study|Study Terminated By Sponsor|0|||
33292681|NCT01296555|100970735|FG004|Overall Study|Study Terminated By Sponsor|0|||
33292682|NCT01296555|100970736|FG005|Overall Study|Study Terminated By Sponsor|0|||
33292683|NCT01296555|100970737|FG006|Overall Study|Study Terminated By Sponsor|0|||
33292684|NCT01296555|100970738|FG007|Overall Study|Study Terminated By Sponsor|0|||
33292685|NCT01296555|100970739|FG008|Overall Study|Study Terminated By Sponsor|0|||
33292686|NCT01296555|100970740|FG009|Overall Study|Study Terminated By Sponsor|0|||
33292687|NCT01296555|100970741|FG010|Overall Study|Study Terminated By Sponsor|0|||
33292688|NCT01296555|100970742|FG011|Overall Study|Study Terminated By Sponsor|0|||
33292689|NCT01296555|100970743|FG012|Overall Study|Study Terminated By Sponsor|0|||
33292690|NCT01296555|100970744|FG013|Overall Study|Study Terminated By Sponsor|0|||
33292691|NCT01296555|100970745|FG014|Overall Study|Study Terminated By Sponsor|0|||
33292692|NCT01296555|100970746|FG015|Overall Study|Study Terminated By Sponsor|0|||
33292693|NCT01296555|100970747|FG016|Overall Study|Study Terminated By Sponsor|0|||
33292694|NCT01296555|100970748|FG017|Overall Study|Study Terminated By Sponsor|0|||
33292695|NCT01296555|100970749|FG018|Overall Study|Study Terminated By Sponsor|0|||
33292696|NCT01296555|100970750|FG019|Overall Study|Study Terminated By Sponsor|0|||
33292697|NCT01296555|100970751|FG020|Overall Study|Study Terminated By Sponsor|0|||
33292698|NCT01296555|100970752|FG021|Overall Study|Study Terminated By Sponsor|0|||
33292699|NCT01296555|100970753|FG022|Overall Study|Study Terminated By Sponsor|0|||
33292700|NCT01296555|100970754|FG023|Overall Study|Study Terminated By Sponsor|0|||
33292701|NCT01296555|100970755|FG024|Overall Study|Study Terminated By Sponsor|0|||
33292702|NCT01296555|100970756|FG025|Overall Study|Study Terminated By Sponsor|1|||
33292703|NCT01296555|100970757|FG026|Overall Study|Study Terminated By Sponsor|0|||
33292704|NCT01296555|100970758|FG027|Overall Study|Study Terminated By Sponsor|0|||
33292705|NCT01296555|100970759|FG028|Overall Study|Study Terminated By Sponsor|0|||
33292706|NCT01296555|100970731|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292707|NCT01296555|100970732|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292708|NCT01296555|100970733|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292709|NCT01296555|100970734|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292710|NCT01296555|100970735|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292711|NCT01296555|100970736|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292712|NCT01296555|100970737|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292713|NCT01296555|100970738|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292714|NCT01296555|100970739|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292715|NCT01296555|100970740|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292716|NCT01296555|100970741|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292717|NCT01296555|100970742|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292718|NCT01296555|100970743|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292719|NCT01296555|100970744|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292720|NCT01296555|100970745|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292721|NCT01296555|100970746|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292722|NCT01296555|100970747|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292723|NCT01296555|100970748|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292724|NCT01296555|100970749|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292725|NCT01296555|100970750|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
33292726|NCT01296555|100970751|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292727|NCT01296555|100970752|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292728|NCT01296555|100970753|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292729|NCT01296555|100970754|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292730|NCT01296555|100970755|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292731|NCT01296555|100970756|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292732|NCT01296555|100970757|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292733|NCT01296555|100970758|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292734|NCT01296555|100970759|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
33292735|NCT01296555|100970731|FG000|Overall Study|Death|0|||
33292736|NCT01296555|100970732|FG001|Overall Study|Death|0|||
33292737|NCT01296555|100970733|FG002|Overall Study|Death|0|||
33292738|NCT01296555|100970734|FG003|Overall Study|Death|2|||
33292739|NCT01296555|100970735|FG004|Overall Study|Death|1|||
33292740|NCT01296555|100970736|FG005|Overall Study|Death|0|||
33292741|NCT01296555|100970737|FG006|Overall Study|Death|2|||
33292742|NCT01296555|100970738|FG007|Overall Study|Death|0|||
33292743|NCT01296555|100970739|FG008|Overall Study|Death|0|||
33292744|NCT01296555|100970740|FG009|Overall Study|Death|1|||
33292745|NCT01296555|100970741|FG010|Overall Study|Death|0|||
33292746|NCT01296555|100970742|FG011|Overall Study|Death|1|||
33292747|NCT01296555|100970743|FG012|Overall Study|Death|0|||
33292748|NCT01296555|100970744|FG013|Overall Study|Death|2|||
33292749|NCT01296555|100970745|FG014|Overall Study|Death|27|||
33292750|NCT01296555|100970746|FG015|Overall Study|Death|15|||
33292751|NCT01296555|100970747|FG016|Overall Study|Death|11|||
33292752|NCT01296555|100970748|FG017|Overall Study|Death|11|||
33292753|NCT01296555|100970749|FG018|Overall Study|Death|17|||
33292754|NCT01296555|100970750|FG019|Overall Study|Death|12|||
33292755|NCT01296555|100970751|FG020|Overall Study|Death|13|||
33292756|NCT01296555|100970752|FG021|Overall Study|Death|12|||
33292757|NCT01296555|100970753|FG022|Overall Study|Death|12|||
33292758|NCT01296555|100970754|FG023|Overall Study|Death|13|||
33292759|NCT01296555|100970755|FG024|Overall Study|Death|7|||
33292760|NCT01296555|100970756|FG025|Overall Study|Death|7|||
33292761|NCT01296555|100970757|FG026|Overall Study|Death|35|||
33292762|NCT01296555|100970758|FG027|Overall Study|Death|92|||
33292763|NCT01296555|100970759|FG028|Overall Study|Death|44|||
33292764|NCT01296555|100970731|FG000|Overall Study|Lost to Follow-up|0|||
33599653|NCT02741570|102084983|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
33599654|NCT02741570|102084984|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
33599655|NCT02741570|102084983|FG000|Treatment Period|Death|9|||
33292765|NCT01296555|100970732|FG001|Overall Study|Lost to Follow-up|0|||
33292766|NCT01296555|100970733|FG002|Overall Study|Lost to Follow-up|0|||
33292767|NCT01296555|100970734|FG003|Overall Study|Lost to Follow-up|0|||
33292768|NCT01296555|100970735|FG004|Overall Study|Lost to Follow-up|0|||
33292769|NCT01296555|100970736|FG005|Overall Study|Lost to Follow-up|0|||
33292770|NCT01296555|100970737|FG006|Overall Study|Lost to Follow-up|0|||
33292771|NCT01296555|100970738|FG007|Overall Study|Lost to Follow-up|0|||
33292772|NCT01296555|100970739|FG008|Overall Study|Lost to Follow-up|0|||
33292773|NCT01296555|100970740|FG009|Overall Study|Lost to Follow-up|0|||
33292774|NCT01296555|100970741|FG010|Overall Study|Lost to Follow-up|0|||
33599656|NCT02741570|102084984|FG001|Treatment Period|Death|7|||
33599657|NCT02741570|102084983|FG000|Treatment Period|Study drug toxicity|55|||
33599658|NCT02741570|102084984|FG001|Treatment Period|Study drug toxicity|47|||
33599659|NCT02741570|102084983|FG000|Treatment Period|Disease progression|294|||
33599660|NCT02741570|102084984|FG001|Treatment Period|Disease progression|301|||
33599661|NCT02741570|102084983|FG000|Treatment Period|Administrative reason by sponsor|0|||
33599662|NCT02741570|102084984|FG001|Treatment Period|Administrative reason by sponsor|1|||
33599663|NCT00033540|102084985|FG000|Overall Study|Adverse Event|14|||
33599664|NCT00033540|102084985|FG000|Overall Study|Death|1|||
33599665|NCT00033540|102084985|FG000|Overall Study|Progression|26|||
33292775|NCT01296555|100970742|FG011|Overall Study|Lost to Follow-up|0|||
33292776|NCT01296555|100970743|FG012|Overall Study|Lost to Follow-up|0|||
33292777|NCT01296555|100970744|FG013|Overall Study|Lost to Follow-up|0|||
33292778|NCT01296555|100970745|FG014|Overall Study|Lost to Follow-up|2|||
33292779|NCT01296555|100970746|FG015|Overall Study|Lost to Follow-up|1|||
33599666|NCT00033540|102084985|FG000|Overall Study|Withdrawal by Subject|6|||
33292780|NCT01296555|100970747|FG016|Overall Study|Lost to Follow-up|0|||
33599667|NCT00033540|102084985|FG000|Overall Study|Other|5|||
33599668|NCT00033540|102084985|FG000|Overall Study|Ineligible|3|||
33599669|NCT00033540|102084985|FG000|Overall Study|Never received treatment|2|||
33599670|NCT02689076|102084986|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
33599671|NCT02689076|102084987|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
33599672|NCT02689076|102084988|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
33599673|NCT02689076|102084986|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
33599674|NCT02689076|102084987|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
33599675|NCT02689076|102084988|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
33599676|NCT02689076|102084986|FG000|Overall Study|Did not have an HIE match|2|||
33599677|NCT02689076|102084987|FG001|Overall Study|Did not have an HIE match|0|||
33599678|NCT02689076|102084988|FG002|Overall Study|Did not have an HIE match|0|||
33599679|NCT02689076|102084986|FG000|Overall Study|Death during non-VA encounter|2|||
33599680|NCT02689076|102084987|FG001|Overall Study|Death during non-VA encounter|5|||
33599681|NCT02689076|102084988|FG002|Overall Study|Death during non-VA encounter|0|||
33599682|NCT02689076|102084986|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
33599683|NCT02689076|102084987|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
33599684|NCT02689076|102084988|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
33599685|NCT02689076|102084986|FG000|Overall Study|Participant no longer active in VA system|1|||
33599686|NCT02689076|102084987|FG001|Overall Study|Participant no longer active in VA system|0|||
33599687|NCT02689076|102084988|FG002|Overall Study|Participant no longer active in VA system|0|||
33599688|NCT02689076|102084986|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
33599689|NCT02689076|102084987|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
33599690|NCT02689076|102084988|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
33599691|NCT03356977|102084991|FG000|Overall Study|Lost to Follow-up|3|||
33599692|NCT03356977|102084991|FG000|Overall Study|Withdrawal by parent/guardian|2|||
33599693|NCT02608450|102084993|FG000|Overall Study|Lost to Follow-up|39|||
33599694|NCT02608450|102084994|FG001|Overall Study|Lost to Follow-up|32|||
33599695|NCT02608450|102084993|FG000|Overall Study|Withdrawal by Subject|21|||
33599696|NCT02608450|102084994|FG001|Overall Study|Withdrawal by Subject|15|||
33599697|NCT02608450|102084993|FG000|Overall Study|Adverse Event|3|||
33599698|NCT02608450|102084994|FG001|Overall Study|Adverse Event|6|||
33599699|NCT02608450|102084993|FG000|Overall Study|Withdrawal by parent|2|||
33599700|NCT02608450|102084994|FG001|Overall Study|Withdrawal by parent|3|||
33599701|NCT02608450|102084993|FG000|Overall Study|Lack of Efficacy|0|||
33599702|NCT02608450|102084994|FG001|Overall Study|Lack of Efficacy|3|||
33599703|NCT02608450|102084993|FG000|Overall Study|Noncompliance with study drug|0|||
33599704|NCT02608450|102084994|FG001|Overall Study|Noncompliance with study drug|2|||
33599705|NCT02608450|102084993|FG000|Overall Study|Physician Decision|0|||
33599706|NCT02608450|102084994|FG001|Overall Study|Physician Decision|1|||
33599707|NCT02608450|102084993|FG000|Overall Study|Pregnancy|0|||
33599708|NCT02608450|102084994|FG001|Overall Study|Pregnancy|1|||
33599709|NCT02608450|102084993|FG000|Overall Study|Progressive disease|1|||
33599710|NCT02608450|102084994|FG001|Overall Study|Progressive disease|0|||
33599711|NCT02608450|102084993|FG000|Overall Study|Multiple reasons|0|||
33599712|NCT02608450|102084994|FG001|Overall Study|Multiple reasons|2|||
33599713|NCT02366767|102084995|FG000|Overall Study|left for home after 1 day at camp|1|||
33599714|NCT02366767|102084996|FG001|Overall Study|left for home after 1 day at camp|0|||
33599715|NCT00353873|102084997|FG000|Overall Study|Protocol Violation|1|||
33599716|NCT00353873|102084998|FG001|Overall Study|Protocol Violation|2|||
33599717|NCT00353873|102084997|FG000|Overall Study|Exacerbation|1|||
33599718|NCT00353873|102084998|FG001|Overall Study|Exacerbation|0|||
33599719|NCT00353873|102084997|FG000|Overall Study|Adverse Event|1|||
33599720|NCT00353873|102084998|FG001|Overall Study|Adverse Event|0|||
33599721|NCT00353873|102084997|FG000|Overall Study|Physician Decision|2|||
33599722|NCT00353873|102084998|FG001|Overall Study|Physician Decision|0|||
33599723|NCT00353873|102084997|FG000|Overall Study|Withdrawal by Subject|1|||
33599724|NCT00353873|102084998|FG001|Overall Study|Withdrawal by Subject|1|||
33599725|NCT00787137|102084999|FG000|Overall Study|Study Termination|0|||
33599726|NCT00787137|102085000|FG001|Overall Study|Study Termination|0|||
33599727|NCT00787137|102085001|FG002|Overall Study|Study Termination|1|||
33599728|NCT02078102|102085002|FG000|Overall Study|Adverse Event|1|||
33599729|NCT02078102|102085003|FG001|Overall Study|Adverse Event|0|||
33599730|NCT02078102|102085002|FG000|Overall Study|Withdrawal by Subject|1|||
33599731|NCT02078102|102085003|FG001|Overall Study|Withdrawal by Subject|0|||
33599732|NCT02078102|102085002|FG000|Overall Study|Physician Decision|0|||
33599733|NCT02078102|102085003|FG001|Overall Study|Physician Decision|1|||
33599734|NCT01999218|102085006|FG000|Overall Study|Hyperglycemia|18|||
33599735|NCT01999218|102085007|FG001|Overall Study|Hyperglycemia|17|||
33599736|NCT01999218|102085008|FG002|Overall Study|Hyperglycemia|17|||
33599737|NCT01999218|102085006|FG000|Overall Study|Lack of Efficacy|1|||
33599738|NCT01999218|102085007|FG001|Overall Study|Lack of Efficacy|0|||
33599739|NCT01999218|102085008|FG002|Overall Study|Lack of Efficacy|1|||
33599740|NCT01999218|102085006|FG000|Overall Study|Lost to Follow-up|22|||
33599741|NCT01999218|102085007|FG001|Overall Study|Lost to Follow-up|17|||
33599742|NCT01999218|102085008|FG002|Overall Study|Lost to Follow-up|18|||
33599743|NCT01999218|102085006|FG000|Overall Study|Non-Compliance With Study Drug|6|||
33599744|NCT01999218|102085007|FG001|Overall Study|Non-Compliance With Study Drug|4|||
33599745|NCT01999218|102085008|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33599746|NCT01999218|102085006|FG000|Overall Study|Physician Decision|1|||
33599747|NCT01999218|102085007|FG001|Overall Study|Physician Decision|4|||
33599748|NCT01999218|102085008|FG002|Overall Study|Physician Decision|6|||
33599749|NCT01999218|102085006|FG000|Overall Study|Protocol Violation|4|||
33599750|NCT01999218|102085007|FG001|Overall Study|Protocol Violation|5|||
33599751|NCT01999218|102085008|FG002|Overall Study|Protocol Violation|4|||
33599752|NCT01999218|102085006|FG000|Overall Study|Screen failure|0|||
33599753|NCT01999218|102085007|FG001|Overall Study|Screen failure|1|||
33599754|NCT01999218|102085008|FG002|Overall Study|Screen failure|0|||
33599755|NCT01999218|102085006|FG000|Overall Study|Study Terminated By Sponsor|7|||
33599756|NCT01999218|102085007|FG001|Overall Study|Study Terminated By Sponsor|5|||
33599757|NCT01999218|102085008|FG002|Overall Study|Study Terminated By Sponsor|12|||
33599758|NCT01999218|102085006|FG000|Overall Study|Participant moves|2|||
33599759|NCT01999218|102085007|FG001|Overall Study|Participant moves|5|||
33599760|NCT01999218|102085008|FG002|Overall Study|Participant moves|3|||
33599761|NCT01999218|102085006|FG000|Overall Study|Withdrawal by Subject|28|||
33599762|NCT01999218|102085007|FG001|Overall Study|Withdrawal by Subject|29|||
33599763|NCT01999218|102085008|FG002|Overall Study|Withdrawal by Subject|34|||
33599764|NCT01999218|102085006|FG000|Overall Study|Creatinine/eGFR|0|||
33599765|NCT01999218|102085007|FG001|Overall Study|Creatinine/eGFR|0|||
33599766|NCT01999218|102085008|FG002|Overall Study|Creatinine/eGFR|1|||
33599767|NCT01999218|102085006|FG000|Overall Study|Death|7|||
33599768|NCT01999218|102085007|FG001|Overall Study|Death|1|||
33599769|NCT01999218|102085008|FG002|Overall Study|Death|2|||
33292781|NCT01296555|100970748|FG017|Overall Study|Lost to Follow-up|2|||
33292782|NCT01296555|100970749|FG018|Overall Study|Lost to Follow-up|0|||
33292783|NCT01296555|100970750|FG019|Overall Study|Lost to Follow-up|2|||
33292784|NCT01296555|100970751|FG020|Overall Study|Lost to Follow-up|3|||
33292785|NCT01296555|100970752|FG021|Overall Study|Lost to Follow-up|2|||
33292786|NCT01296555|100970753|FG022|Overall Study|Lost to Follow-up|0|||
33292787|NCT01296555|100970754|FG023|Overall Study|Lost to Follow-up|0|||
33292788|NCT01296555|100970755|FG024|Overall Study|Lost to Follow-up|0|||
33292789|NCT01296555|100970756|FG025|Overall Study|Lost to Follow-up|0|||
33292790|NCT01296555|100970757|FG026|Overall Study|Lost to Follow-up|3|||
33292791|NCT01296555|100970758|FG027|Overall Study|Lost to Follow-up|13|||
33292792|NCT01296555|100970759|FG028|Overall Study|Lost to Follow-up|5|||
33292793|NCT01296555|100970731|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33292794|NCT01296555|100970732|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33292795|NCT01296555|100970733|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33292796|NCT01296555|100970734|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33292797|NCT01296555|100970735|FG004|Overall Study|Non-Compliance With Study Drug|0|||
33292798|NCT01296555|100970736|FG005|Overall Study|Non-Compliance With Study Drug|0|||
33292799|NCT01296555|100970737|FG006|Overall Study|Non-Compliance With Study Drug|0|||
33292800|NCT01296555|100970738|FG007|Overall Study|Non-Compliance With Study Drug|1|||
33292801|NCT01296555|100970739|FG008|Overall Study|Non-Compliance With Study Drug|0|||
33292802|NCT01296555|100970740|FG009|Overall Study|Non-Compliance With Study Drug|0|||
33292803|NCT01296555|100970741|FG010|Overall Study|Non-Compliance With Study Drug|0|||
33292804|NCT01296555|100970742|FG011|Overall Study|Non-Compliance With Study Drug|0|||
33292805|NCT01296555|100970743|FG012|Overall Study|Non-Compliance With Study Drug|0|||
33292806|NCT01296555|100970744|FG013|Overall Study|Non-Compliance With Study Drug|0|||
33292807|NCT01296555|100970745|FG014|Overall Study|Non-Compliance With Study Drug|0|||
33292808|NCT01296555|100970746|FG015|Overall Study|Non-Compliance With Study Drug|0|||
33292809|NCT01296555|100970747|FG016|Overall Study|Non-Compliance With Study Drug|0|||
33292810|NCT01296555|100970748|FG017|Overall Study|Non-Compliance With Study Drug|0|||
33292811|NCT01296555|100970749|FG018|Overall Study|Non-Compliance With Study Drug|0|||
33292812|NCT01296555|100970750|FG019|Overall Study|Non-Compliance With Study Drug|0|||
33292813|NCT01296555|100970751|FG020|Overall Study|Non-Compliance With Study Drug|0|||
33292814|NCT01296555|100970752|FG021|Overall Study|Non-Compliance With Study Drug|0|||
33292815|NCT01296555|100970753|FG022|Overall Study|Non-Compliance With Study Drug|0|||
33292816|NCT01296555|100970754|FG023|Overall Study|Non-Compliance With Study Drug|0|||
33292817|NCT01296555|100970755|FG024|Overall Study|Non-Compliance With Study Drug|0|||
33292818|NCT01296555|100970756|FG025|Overall Study|Non-Compliance With Study Drug|0|||
33292819|NCT01296555|100970757|FG026|Overall Study|Non-Compliance With Study Drug|0|||
33292820|NCT01296555|100970758|FG027|Overall Study|Non-Compliance With Study Drug|0|||
33292821|NCT01296555|100970759|FG028|Overall Study|Non-Compliance With Study Drug|0|||
33292822|NCT01296555|100970731|FG000|Overall Study|Withdrawal by Subject|0|||
33292823|NCT01296555|100970732|FG001|Overall Study|Withdrawal by Subject|0|||
33292824|NCT01296555|100970733|FG002|Overall Study|Withdrawal by Subject|0|||
33292825|NCT01296555|100970734|FG003|Overall Study|Withdrawal by Subject|0|||
33292826|NCT01296555|100970735|FG004|Overall Study|Withdrawal by Subject|1|||
33292827|NCT01296555|100970736|FG005|Overall Study|Withdrawal by Subject|0|||
33292828|NCT01296555|100970737|FG006|Overall Study|Withdrawal by Subject|1|||
33292829|NCT01296555|100970738|FG007|Overall Study|Withdrawal by Subject|0|||
33292830|NCT01296555|100970739|FG008|Overall Study|Withdrawal by Subject|0|||
33292831|NCT01296555|100970740|FG009|Overall Study|Withdrawal by Subject|0|||
33292832|NCT01296555|100970741|FG010|Overall Study|Withdrawal by Subject|1|||
33292833|NCT01296555|100970742|FG011|Overall Study|Withdrawal by Subject|1|||
33599770|NCT01999218|102085006|FG000|Overall Study|Excluded Medication|1|||
33599771|NCT01999218|102085007|FG001|Overall Study|Excluded Medication|1|||
33599772|NCT01999218|102085008|FG002|Overall Study|Excluded Medication|2|||
33599773|NCT01999218|102085006|FG000|Overall Study|Adverse Event|9|||
33599774|NCT01999218|102085007|FG001|Overall Study|Adverse Event|7|||
33599775|NCT01999218|102085008|FG002|Overall Study|Adverse Event|7|||
33599776|NCT01999218|102085006|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
33599777|NCT01999218|102085007|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
33599778|NCT01999218|102085008|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
33599779|NCT00289198|102085009|FG000|Overall Study|Adverse Event|0|||
33599780|NCT00289198|102085010|FG001|Overall Study|Adverse Event|2|||
33599781|NCT00289198|102085009|FG000|Overall Study|Protocol Violation|2|||
33599782|NCT00289198|102085010|FG001|Overall Study|Protocol Violation|1|||
33599783|NCT00289198|102085009|FG000|Overall Study|Withdrawal by Subject|4|||
33599784|NCT00289198|102085010|FG001|Overall Study|Withdrawal by Subject|1|||
33599785|NCT00289198|102085009|FG000|Overall Study|Lack of Efficacy|2|||
33599786|NCT00289198|102085010|FG001|Overall Study|Lack of Efficacy|0|||
33599787|NCT00289198|102085009|FG000|Overall Study|Other: Low compliance|0|||
33599788|NCT00289198|102085010|FG001|Overall Study|Other: Low compliance|1|||
33599789|NCT00289198|102085009|FG000|Overall Study|Other: Physician's decision|0|||
33292834|NCT01296555|100970743|FG012|Overall Study|Withdrawal by Subject|0|||
33292835|NCT01296555|100970744|FG013|Overall Study|Withdrawal by Subject|0|||
33292836|NCT01296555|100970745|FG014|Overall Study|Withdrawal by Subject|3|||
33292837|NCT01296555|100970746|FG015|Overall Study|Withdrawal by Subject|0|||
33292838|NCT01296555|100970747|FG016|Overall Study|Withdrawal by Subject|2|||
33292839|NCT01296555|100970748|FG017|Overall Study|Withdrawal by Subject|1|||
33292840|NCT01296555|100970749|FG018|Overall Study|Withdrawal by Subject|0|||
33292841|NCT01296555|100970750|FG019|Overall Study|Withdrawal by Subject|1|||
33292842|NCT01296555|100970751|FG020|Overall Study|Withdrawal by Subject|1|||
33292843|NCT01296555|100970752|FG021|Overall Study|Withdrawal by Subject|1|||
33292844|NCT01296555|100970753|FG022|Overall Study|Withdrawal by Subject|3|||
33292845|NCT01296555|100970754|FG023|Overall Study|Withdrawal by Subject|0|||
33292846|NCT01296555|100970755|FG024|Overall Study|Withdrawal by Subject|0|||
33292847|NCT01296555|100970756|FG025|Overall Study|Withdrawal by Subject|0|||
33292848|NCT01296555|100970757|FG026|Overall Study|Withdrawal by Subject|8|||
33292849|NCT01296555|100970758|FG027|Overall Study|Withdrawal by Subject|4|||
33292850|NCT01296555|100970759|FG028|Overall Study|Withdrawal by Subject|2|||
33292851|NCT02229227|100970762|FG000|Overall Study|Adverse Event|14|||
33292852|NCT02229227|100970763|FG001|Overall Study|Adverse Event|9|||
33292853|NCT02229227|100970762|FG000|Overall Study|Lack of Efficacy|3|||
33292854|NCT02229227|100970763|FG001|Overall Study|Lack of Efficacy|3|||
33292855|NCT02229227|100970762|FG000|Overall Study|Protocol Violation|6|||
33292856|NCT02229227|100970763|FG001|Overall Study|Protocol Violation|8|||
33292857|NCT02229227|100970762|FG000|Overall Study|Protocol defined stopping criteria|1|||
33292858|NCT02229227|100970763|FG001|Overall Study|Protocol defined stopping criteria|3|||
33292859|NCT02229227|100970762|FG000|Overall Study|Lost to Follow-up|3|||
33292860|NCT02229227|100970763|FG001|Overall Study|Lost to Follow-up|3|||
33292861|NCT02229227|100970762|FG000|Overall Study|Study terminated by sponsor|11|||
33292862|NCT02229227|100970763|FG001|Overall Study|Study terminated by sponsor|11|||
33292863|NCT02229227|100970762|FG000|Overall Study|Withdrawal by Subject|8|||
33292864|NCT02229227|100970763|FG001|Overall Study|Withdrawal by Subject|12|||
33292865|NCT02229227|100970762|FG000|Overall Study|Other|0|||
33292866|NCT02229227|100970763|FG001|Overall Study|Other|1|||
33292867|NCT02229227|100970762|FG000|Overall Study|Physician Decision|5|||
33292868|NCT02229227|100970763|FG001|Overall Study|Physician Decision|12|||
33292869|NCT01889069|100970764|FG000|Overall Study|Death|18|||
33292870|NCT01889069|100970764|FG000|Overall Study|Progression of Disease|14|||
33292871|NCT01889069|100970764|FG000|Overall Study|Lost to Follow-up|6|||
33292872|NCT01889069|100970764|FG000|Overall Study|Other|4|||
33292873|NCT01889069|100970764|FG000|Overall Study|Consent Withdrawal|3|||
33292874|NCT01077128|100970765|FG000|Overall Study|Adverse Event|8|||
33292875|NCT01077128|100970765|FG000|Overall Study|Lack of Efficacy|1|||
33292876|NCT01077128|100970765|FG000|Overall Study|Disease exacerbation|1|||
33292877|NCT01077128|100970765|FG000|Overall Study|Adverse event and consent withdrawal|1|||
33292878|NCT01077128|100970765|FG000|Overall Study|Adverse event and disease exacerbation|1|||
33292879|NCT01077128|100970765|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
33292880|NCT01077128|100970765|FG000|Overall Study|Other|54|||
33292881|NCT02659098|100970773|FG000|Overall Study|Withdrawal by Subject|7|||
33292882|NCT01850030|100970777|FG000|Overall Study|Adverse Event|64|||
33292883|NCT01850030|100970778|FG001|Overall Study|Adverse Event|82|||
33292884|NCT01850030|100970777|FG000|Overall Study|Lack of Efficacy|3|||
33292885|NCT01850030|100970778|FG001|Overall Study|Lack of Efficacy|1|||
33292886|NCT01850030|100970777|FG000|Overall Study|Lost to Follow-up|5|||
33292887|NCT01850030|100970778|FG001|Overall Study|Lost to Follow-up|5|||
33292888|NCT01850030|100970777|FG000|Overall Study|Withdrawal by Subject|3|||
33292889|NCT01850030|100970778|FG001|Overall Study|Withdrawal by Subject|4|||
33292890|NCT01850030|100970777|FG000|Overall Study|Protocol Violation|24|||
33292891|NCT01850030|100970778|FG001|Overall Study|Protocol Violation|28|||
33292892|NCT01850030|100970777|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
33292893|NCT01850030|100970778|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
33292894|NCT01896726|100970779|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
33292895|NCT01896726|100970779|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
33292896|NCT00798434|100970782|FG000|Double-Blind|Adverse Event|22|||
33292897|NCT00798434|100970783|FG001|Double-Blind|Adverse Event|46|||
33292898|NCT00798434|100970782|FG000|Double-Blind|Death|0|||
33292899|NCT00798434|100970783|FG001|Double-Blind|Death|1|||
33292900|NCT00798434|100970782|FG000|Double-Blind|Lost to Follow-up|1|||
33292901|NCT00798434|100970783|FG001|Double-Blind|Lost to Follow-up|0|||
33292902|NCT00798434|100970782|FG000|Double-Blind|Lack of Efficacy|8|||
33292903|NCT00798434|100970783|FG001|Double-Blind|Lack of Efficacy|12|||
33292904|NCT00798434|100970782|FG000|Double-Blind|Withdrawal by Subject|17|||
33292905|NCT00798434|100970783|FG001|Double-Blind|Withdrawal by Subject|14|||
33292906|NCT00798434|100970782|FG000|Double-Blind|Protocol Violation|1|||
33292907|NCT00798434|100970783|FG001|Double-Blind|Protocol Violation|4|||
33292908|NCT00798434|100970782|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
33292909|NCT00798434|100970783|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
33292910|NCT00798434|100970782|FG000|Double-Blind|Other|1|||
33292911|NCT00798434|100970783|FG001|Double-Blind|Other|0|||
33292912|NCT00798434|100970782|FG000|Double-Blind|Not Treated|3|||
33292913|NCT00798434|100970783|FG001|Double-Blind|Not Treated|6|||
33292914|NCT00798434|100970782|FG000|Open-Label|Adverse Event|33|||
33292915|NCT00798434|100970783|FG001|Open-Label|Adverse Event|11|||
33292916|NCT00798434|100970782|FG000|Open-Label|Lack of Efficacy|5|||
33292917|NCT00798434|100970783|FG001|Open-Label|Lack of Efficacy|11|||
33292918|NCT00798434|100970782|FG000|Open-Label|Withdrawal by Subject|2|||
33292919|NCT00798434|100970783|FG001|Open-Label|Withdrawal by Subject|7|||
33292920|NCT00798434|100970782|FG000|Open-Label|Protocol Violation|1|||
33292921|NCT00798434|100970783|FG001|Open-Label|Protocol Violation|0|||
33292922|NCT00798434|100970782|FG000|Open-Label|Other|1|||
33292923|NCT00798434|100970783|FG001|Open-Label|Other|2|||
33292924|NCT00798434|100970782|FG000|Open-Label|Not Treated|0|||
33292925|NCT00798434|100970783|FG001|Open-Label|Not Treated|1|||
33292926|NCT04367480|100970784|FG000|Overall Study|Adverse Event|1|||
33292927|NCT04367480|100970785|FG001|Overall Study|Adverse Event|1|||
33599790|NCT00289198|102085010|FG001|Overall Study|Other: Physician's decision|1|||
33599791|NCT00289198|102085009|FG000|Overall Study|Other: Unable to attend on schedule|2|||
33292928|NCT04367480|100970784|FG000|Overall Study|Death|1|||
33292929|NCT04367480|100970785|FG001|Overall Study|Death|0|||
33292930|NCT04367480|100970784|FG000|Overall Study|Lost to Follow-up|1|||
33292931|NCT04367480|100970785|FG001|Overall Study|Lost to Follow-up|1|||
33292932|NCT04367480|100970784|FG000|Overall Study|Withdrawal by Subject|0|||
33292933|NCT04367480|100970785|FG001|Overall Study|Withdrawal by Subject|3|||
33292934|NCT04367480|100970784|FG000|Overall Study|App glitch during the study|1|||
33292935|NCT04367480|100970785|FG001|Overall Study|App glitch during the study|0|||
33292936|NCT04367480|100970784|FG000|Overall Study|Device Distribution Error|0|||
33292937|NCT04367480|100970785|FG001|Overall Study|Device Distribution Error|2|||
33292938|NCT04367480|100970784|FG000|Overall Study|Ineligible after Randomization|0|||
33292939|NCT04367480|100970785|FG001|Overall Study|Ineligible after Randomization|1|||
33292940|NCT04367480|100970784|FG000|Overall Study|Other Medical Reasons|0|||
33292941|NCT04367480|100970785|FG001|Overall Study|Other Medical Reasons|2|||
33292942|NCT02094898|100970786|FG000|Overall Study|Clinical Worsening|2|||
33292943|NCT02094898|100970786|FG000|Overall Study|Adverse Event|2|||
33292944|NCT02094898|100970786|FG000|Overall Study|Lack of Efficacy|1|||
33292945|NCT02844777|100970787|FG000|Overall Study|Withdrawal by Subject|2|||
33292946|NCT02844777|100970788|FG001|Overall Study|Withdrawal by Subject|0|||
33292947|NCT02844777|100970789|FG002|Overall Study|Withdrawal by Subject|0|||
33292948|NCT00351377|100970790|FG000|Overall Study|Adverse Event|5|||
33292949|NCT00351377|100970790|FG000|Overall Study|Death|1|||
33292950|NCT00351377|100970790|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33292951|NCT01080300|100970791|FG000|Overall Study|Adverse Event|49|||
33292952|NCT01080300|100970792|FG001|Overall Study|Adverse Event|35|||
33292953|NCT01080300|100970791|FG000|Overall Study|Lack of Efficacy|12|||
33292954|NCT01080300|100970792|FG001|Overall Study|Lack of Efficacy|15|||
33292955|NCT01080300|100970791|FG000|Overall Study|Protocol Violation|7|||
33599792|NCT00289198|102085010|FG001|Overall Study|Other: Unable to attend on schedule|1|||
33599793|NCT00289198|102085009|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
33292956|NCT01080300|100970792|FG001|Overall Study|Protocol Violation|13|||
33292957|NCT01080300|100970791|FG000|Overall Study|Lost to Follow-up|10|||
33292958|NCT01080300|100970792|FG001|Overall Study|Lost to Follow-up|6|||
33292959|NCT01080300|100970791|FG000|Overall Study|Death|0|||
33292960|NCT01080300|100970792|FG001|Overall Study|Death|1|||
33292961|NCT01080300|100970791|FG000|Overall Study|Withdrawal by Subject|12|||
33292962|NCT01080300|100970792|FG001|Overall Study|Withdrawal by Subject|28|||
33292963|NCT01080300|100970791|FG000|Overall Study|Reasons not specified|4|||
33292964|NCT01080300|100970792|FG001|Overall Study|Reasons not specified|6|||
33292965|NCT02397447|100970797|FG000|Overall Study|Lost to Follow-up|2|||
33292966|NCT02397447|100970798|FG001|Overall Study|Lost to Follow-up|2|||
33292967|NCT02127125|100970799|FG000|Overall Study|Lost to Follow-up|0|||
33292968|NCT02127125|100970800|FG001|Overall Study|Lost to Follow-up|0|||
33292969|NCT02127125|100970801|FG002|Overall Study|Lost to Follow-up|0|||
33292970|NCT02127125|100970802|FG003|Overall Study|Lost to Follow-up|0|||
33292971|NCT02127125|100970803|FG004|Overall Study|Lost to Follow-up|2|||
33292972|NCT02127125|100970804|FG005|Overall Study|Lost to Follow-up|1|||
33292973|NCT02127125|100970805|FG006|Overall Study|Lost to Follow-up|0|||
33292974|NCT02127125|100970806|FG007|Overall Study|Lost to Follow-up|0|||
33292975|NCT02127125|100970807|FG008|Overall Study|Lost to Follow-up|0|||
33292976|NCT02127125|100970799|FG000|Overall Study|Withdrawal by Subject|0|||
33292977|NCT02127125|100970800|FG001|Overall Study|Withdrawal by Subject|0|||
33292978|NCT02127125|100970801|FG002|Overall Study|Withdrawal by Subject|0|||
33292979|NCT02127125|100970802|FG003|Overall Study|Withdrawal by Subject|1|||
33292980|NCT02127125|100970803|FG004|Overall Study|Withdrawal by Subject|0|||
33292981|NCT02127125|100970804|FG005|Overall Study|Withdrawal by Subject|0|||
33292982|NCT02127125|100970805|FG006|Overall Study|Withdrawal by Subject|0|||
33292983|NCT02127125|100970806|FG007|Overall Study|Withdrawal by Subject|0|||
33292984|NCT02127125|100970807|FG008|Overall Study|Withdrawal by Subject|0|||
33292985|NCT02127125|100970799|FG000|Overall Study|Physician Decision|0|||
33292986|NCT02127125|100970800|FG001|Overall Study|Physician Decision|0|||
33292987|NCT02127125|100970801|FG002|Overall Study|Physician Decision|1|||
33292988|NCT02127125|100970802|FG003|Overall Study|Physician Decision|0|||
33292989|NCT02127125|100970803|FG004|Overall Study|Physician Decision|1|||
33292990|NCT02127125|100970804|FG005|Overall Study|Physician Decision|2|||
33292991|NCT02127125|100970805|FG006|Overall Study|Physician Decision|0|||
33292992|NCT02127125|100970806|FG007|Overall Study|Physician Decision|0|||
33292993|NCT02127125|100970807|FG008|Overall Study|Physician Decision|0|||
33292994|NCT04978090|100970824|FG000|Overall Study|unable to adequately fit device|2|||
33292995|NCT01263509|100970829|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
33292996|NCT01263509|100970830|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
33292997|NCT01263509|100970831|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
33292998|NCT01263509|100970832|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
33292999|NCT01263509|100970829|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
33293000|NCT01263509|100970830|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
33293001|NCT01263509|100970831|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
33293002|NCT01263509|100970832|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
33293003|NCT01263509|100970829|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33293004|NCT01263509|100970830|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33293005|NCT01263509|100970831|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
33293006|NCT01263509|100970832|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
33293007|NCT01263509|100970829|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
33293008|NCT01263509|100970830|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
33293009|NCT01263509|100970831|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33293010|NCT01263509|100970832|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33293011|NCT01263509|100970829|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
33293012|NCT01263509|100970830|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
33293013|NCT01263509|100970831|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
33293014|NCT01263509|100970832|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
33293015|NCT02838134|100970833|FG000|Overall Study|Lost to Follow-up|1|||
33293016|NCT02838134|100970834|FG001|Overall Study|Lost to Follow-up|2|||
33293017|NCT02838134|100970833|FG000|Overall Study|logistic problems|1|||
33293018|NCT02838134|100970834|FG001|Overall Study|logistic problems|1|||
33293019|NCT04351269|100970835|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
33293020|NCT04351269|100970836|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
33293021|NCT04351269|100970837|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
33293022|NCT04351269|100970835|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
33293023|NCT04351269|100970836|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
33293024|NCT04351269|100970837|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
33293025|NCT04351269|100970835|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
33293026|NCT04351269|100970836|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
33293027|NCT04351269|100970837|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
33293028|NCT04351269|100970835|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
33293029|NCT04351269|100970836|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
33293030|NCT04351269|100970837|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
33293031|NCT04351269|100970835|FG000|Overall Study|Lost to Follow-up|1|||
33293032|NCT04351269|100970836|FG001|Overall Study|Lost to Follow-up|3|||
33293033|NCT04351269|100970837|FG002|Overall Study|Lost to Follow-up|0|||
33293034|NCT03682185|100970838|FG000|Overall Study|Lost to Follow-up|4|||
33293035|NCT03682185|100970839|FG001|Overall Study|Lost to Follow-up|7|||
33293036|NCT03682185|100970840|FG002|Overall Study|Lost to Follow-up|4|||
33293037|NCT03682185|100970841|FG003|Overall Study|Lost to Follow-up|7|||
33293038|NCT03682185|100970842|FG004|Overall Study|Lost to Follow-up|1|||
33293039|NCT03682185|100970838|FG000|Overall Study|Withdrawal by Subject|7|||
33293040|NCT03682185|100970839|FG001|Overall Study|Withdrawal by Subject|3|||
33293041|NCT03682185|100970840|FG002|Overall Study|Withdrawal by Subject|7|||
33293042|NCT03682185|100970841|FG003|Overall Study|Withdrawal by Subject|3|||
33293043|NCT03682185|100970842|FG004|Overall Study|Withdrawal by Subject|0|||
33293044|NCT00935532|100970843|FG000|Overall Study|Adverse Event|11|||
33293045|NCT00935532|100970844|FG001|Overall Study|Adverse Event|6|||
33293046|NCT00935532|100970843|FG000|Overall Study|Death|1|||
33293047|NCT00935532|100970844|FG001|Overall Study|Death|0|||
33293048|NCT00935532|100970843|FG000|Overall Study|Lost to Follow-up|1|||
33293049|NCT00935532|100970844|FG001|Overall Study|Lost to Follow-up|0|||
33293050|NCT00935532|100970843|FG000|Overall Study|Physician Decision|1|||
33293051|NCT00935532|100970844|FG001|Overall Study|Physician Decision|2|||
33293052|NCT00935532|100970843|FG000|Overall Study|Protocol Violation|2|||
33293053|NCT00935532|100970844|FG001|Overall Study|Protocol Violation|1|||
33293054|NCT00935532|100970843|FG000|Overall Study|Subject Decision|2|||
33293055|NCT00935532|100970844|FG001|Overall Study|Subject Decision|1|||
33293056|NCT00935532|100970843|FG000|Overall Study|Sponsor Decision|0|||
33293057|NCT00935532|100970844|FG001|Overall Study|Sponsor Decision|1|||
33293058|NCT00935532|100970843|FG000|Overall Study|Loss Glucose Control|4|||
33293059|NCT00935532|100970844|FG001|Overall Study|Loss Glucose Control|0|||
33293060|NCT05144945|100970848|FG000|Overall Study|Withdrawal by Subject|1|||
33293061|NCT05144945|100970849|FG001|Overall Study|Withdrawal by Subject|0|||
33293062|NCT04650698|100970850|FG000|Overall Study|Protocol Violation|2|||
33293063|NCT04650698|100970851|FG001|Overall Study|Protocol Violation|1|||
33293064|NCT04650698|100970850|FG000|Overall Study|Withdrawal by Subject|0|||
33293065|NCT04650698|100970851|FG001|Overall Study|Withdrawal by Subject|1|||
33293066|NCT01485120|100970852|FG000|Overall Study|Withdrawal by Subject|2|||
33293067|NCT02641587|100970853|FG000|Confinement Period|Adverse Event|1|||
33599794|NCT00289198|102085010|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
33599795|NCT00289198|102085009|FG000|Overall Study|Other: Impossible to come on visit|0|||
33599796|NCT00289198|102085010|FG001|Overall Study|Other: Impossible to come on visit|1|||
33599797|NCT00526110|102085013|FG000|Overall Study|Adverse Event|2|||
33599798|NCT00526110|102085014|FG001|Overall Study|Adverse Event|9|||
33599799|NCT00526110|102085013|FG000|Overall Study|Disease Progression|0|||
33599800|NCT00526110|102085014|FG001|Overall Study|Disease Progression|19|||
33599801|NCT00526110|102085013|FG000|Overall Study|Maximal Response|0|||
33599802|NCT00526110|102085014|FG001|Overall Study|Maximal Response|6|||
33599803|NCT00526110|102085013|FG000|Overall Study|Withdrawal by Subject|0|||
33599804|NCT00526110|102085014|FG001|Overall Study|Withdrawal by Subject|2|||
33599805|NCT00526110|102085013|FG000|Overall Study|Poor Tolerance|0|||
33599806|NCT00526110|102085014|FG001|Overall Study|Poor Tolerance|5|||
33599807|NCT01816906|102085015|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
33599808|NCT01816906|102085016|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
33599809|NCT01816906|102085015|FG000|Six Months|Lost to Follow-up|14|||
33599810|NCT01816906|102085016|FG001|Six Months|Lost to Follow-up|16|||
33599811|NCT01816906|102085015|FG000|12 Months|Adverse Event|2|||
33599812|NCT01816906|102085016|FG001|12 Months|Adverse Event|2|||
33599813|NCT01816906|102085015|FG000|12 Months|Death|0|||
33599814|NCT01816906|102085016|FG001|12 Months|Death|2|||
33599815|NCT01816906|102085015|FG000|12 Months|Lost to Follow-up|2|||
33599816|NCT01816906|102085016|FG001|12 Months|Lost to Follow-up|1|||
33293068|NCT02641587|100970854|FG001|Confinement Period|Adverse Event|0|||
33293069|NCT02641587|100970853|FG000|Confinement Period|Withdrawal by Subject|2|||
33599817|NCT00700102|102085017|FG000|Overall Study|Died|394|||
33599818|NCT00700102|102085018|FG001|Overall Study|Died|385|||
33599819|NCT00700102|102085017|FG000|Overall Study|Lost to Follow-up|8|||
33599820|NCT00700102|102085018|FG001|Overall Study|Lost to Follow-up|10|||
33293070|NCT02641587|100970854|FG001|Confinement Period|Withdrawal by Subject|1|||
33293071|NCT02641587|100970853|FG000|Ambulatory Period|Withdrawal by Subject|1|||
33293072|NCT02641587|100970854|FG001|Ambulatory Period|Withdrawal by Subject|0|||
33293073|NCT04411186|100970856|FG000|Overall Study|Withdrawn due to protocol violation|0|||
33293074|NCT04411186|100970857|FG001|Overall Study|Withdrawn due to protocol violation|1|||
33293075|NCT00121667|100970859|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
33293076|NCT00121667|100970860|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
33293077|NCT00121667|100970861|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
33293078|NCT00121667|100970862|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
33293079|NCT00121667|100970859|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
33293080|NCT00121667|100970860|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
33293081|NCT00121667|100970861|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
33293082|NCT00121667|100970862|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
33293083|NCT00121667|100970859|FG000|Short Term (ST) Period|Adverse Event|5|||
33293084|NCT00121667|100970860|FG001|Short Term (ST) Period|Adverse Event|6|||
33293085|NCT00121667|100970861|FG002|Short Term (ST) Period|Adverse Event|5|||
33293086|NCT00121667|100970862|FG003|Short Term (ST) Period|Adverse Event|3|||
33293087|NCT00121667|100970859|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
33293088|NCT00121667|100970860|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
33293089|NCT00121667|100970861|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
33293090|NCT00121667|100970862|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
33293091|NCT00121667|100970859|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
33293092|NCT00121667|100970860|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
33293093|NCT00121667|100970861|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
33293094|NCT00121667|100970862|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
33293095|NCT00121667|100970859|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
33293096|NCT00121667|100970860|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
33293097|NCT00121667|100970861|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
33293098|NCT00121667|100970862|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
33293099|NCT00121667|100970859|FG000|Short Term (ST) Period|Other Reason|3|||
33293100|NCT00121667|100970860|FG001|Short Term (ST) Period|Other Reason|0|||
33293101|NCT00121667|100970861|FG002|Short Term (ST) Period|Other Reason|0|||
33293102|NCT00121667|100970862|FG003|Short Term (ST) Period|Other Reason|0|||
33293103|NCT00121667|100970859|FG000|Short Term (ST) Period|Death|0|||
33293104|NCT00121667|100970860|FG001|Short Term (ST) Period|Death|0|||
33293105|NCT00121667|100970861|FG002|Short Term (ST) Period|Death|0|||
33293106|NCT00121667|100970862|FG003|Short Term (ST) Period|Death|1|||
33293107|NCT00121667|100970859|FG000|Short Term (ST) Period|Pregnancy|0|||
33293108|NCT00121667|100970860|FG001|Short Term (ST) Period|Pregnancy|0|||
33293109|NCT00121667|100970861|FG002|Short Term (ST) Period|Pregnancy|0|||
33293110|NCT00121667|100970862|FG003|Short Term (ST) Period|Pregnancy|1|||
33293111|NCT00121667|100970859|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
33293112|NCT00121667|100970860|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
33293113|NCT00121667|100970861|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
33293114|NCT00121667|100970862|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
33293115|NCT00121667|100970859|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
33293116|NCT00121667|100970860|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
33293117|NCT00121667|100970861|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
33293118|NCT00121667|100970862|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
33293119|NCT00121667|100970859|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
33293120|NCT00121667|100970860|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
33293121|NCT00121667|100970861|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
33293122|NCT00121667|100970862|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
33293123|NCT00121667|100970859|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
33293124|NCT00121667|100970860|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
33293125|NCT00121667|100970861|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
33293126|NCT00121667|100970862|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
33293127|NCT00121667|100970859|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
33293128|NCT00121667|100970860|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
33293129|NCT00121667|100970861|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
33293130|NCT00121667|100970862|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
33293131|NCT00121667|100970859|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
33293132|NCT00121667|100970860|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
33293133|NCT00121667|100970861|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
33293134|NCT00121667|100970862|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
33293135|NCT00121667|100970859|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
33293136|NCT00121667|100970860|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
33293137|NCT00121667|100970861|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
33293138|NCT00121667|100970862|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
33293139|NCT00121667|100970859|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
33293140|NCT00121667|100970860|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
33293141|NCT00121667|100970861|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
33293142|NCT00121667|100970862|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
33293143|NCT00121667|100970859|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
33293144|NCT00121667|100970860|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
33293145|NCT00121667|100970861|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
33293146|NCT00121667|100970862|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
33293147|NCT01437423|100970865|FG000|Overall Study|Lost to Follow-up|12|||
33293148|NCT01437423|100970865|FG000|Overall Study|Off label usage|3|||
33293149|NCT00150618|100970866|FG000|Overall Study|Adverse Event|2|||
33293150|NCT00150618|100970867|FG001|Overall Study|Adverse Event|2|||
33293151|NCT00150618|100970868|FG002|Overall Study|Adverse Event|6|||
33293152|NCT00150618|100970869|FG003|Overall Study|Adverse Event|9|||
33293153|NCT00150618|100970870|FG004|Overall Study|Adverse Event|5|||
33293154|NCT00150618|100970866|FG000|Overall Study|Withdrawal by Subject|6|||
33293155|NCT00150618|100970867|FG001|Overall Study|Withdrawal by Subject|8|||
33293156|NCT00150618|100970868|FG002|Overall Study|Withdrawal by Subject|8|||
33293157|NCT00150618|100970869|FG003|Overall Study|Withdrawal by Subject|4|||
33293158|NCT00150618|100970870|FG004|Overall Study|Withdrawal by Subject|5|||
33293159|NCT00150618|100970866|FG000|Overall Study|Lost to Follow-up|4|||
33293160|NCT00150618|100970867|FG001|Overall Study|Lost to Follow-up|1|||
33293161|NCT00150618|100970868|FG002|Overall Study|Lost to Follow-up|5|||
33293162|NCT00150618|100970869|FG003|Overall Study|Lost to Follow-up|8|||
33293163|NCT00150618|100970870|FG004|Overall Study|Lost to Follow-up|4|||
33293164|NCT00150618|100970866|FG000|Overall Study|Protocol Violation|1|||
33293165|NCT00150618|100970867|FG001|Overall Study|Protocol Violation|0|||
33293166|NCT00150618|100970868|FG002|Overall Study|Protocol Violation|0|||
33293167|NCT00150618|100970869|FG003|Overall Study|Protocol Violation|0|||
33293168|NCT00150618|100970870|FG004|Overall Study|Protocol Violation|1|||
33293169|NCT00150618|100970866|FG000|Overall Study|Lack of Efficacy|1|||
33293170|NCT00150618|100970867|FG001|Overall Study|Lack of Efficacy|4|||
33293171|NCT00150618|100970868|FG002|Overall Study|Lack of Efficacy|7|||
33293172|NCT00150618|100970869|FG003|Overall Study|Lack of Efficacy|4|||
33293173|NCT00150618|100970870|FG004|Overall Study|Lack of Efficacy|6|||
33293174|NCT00150618|100970866|FG000|Overall Study|No study meds|0|||
33293175|NCT00150618|100970867|FG001|Overall Study|No study meds|0|||
33293176|NCT00150618|100970868|FG002|Overall Study|No study meds|0|||
33293177|NCT00150618|100970869|FG003|Overall Study|No study meds|0|||
33293178|NCT00150618|100970870|FG004|Overall Study|No study meds|2|||
33293179|NCT00150618|100970866|FG000|Overall Study|Physician Decision|0|||
33293180|NCT00150618|100970867|FG001|Overall Study|Physician Decision|2|||
33293181|NCT00150618|100970868|FG002|Overall Study|Physician Decision|0|||
33293182|NCT00150618|100970869|FG003|Overall Study|Physician Decision|0|||
33293183|NCT00150618|100970870|FG004|Overall Study|Physician Decision|1|||
33293184|NCT00150618|100970866|FG000|Overall Study|Lack of compliance|2|||
33293185|NCT00150618|100970867|FG001|Overall Study|Lack of compliance|1|||
33293186|NCT00150618|100970868|FG002|Overall Study|Lack of compliance|1|||
33293187|NCT00150618|100970869|FG003|Overall Study|Lack of compliance|0|||
33293188|NCT00150618|100970870|FG004|Overall Study|Lack of compliance|1|||
33293189|NCT00150618|100970866|FG000|Overall Study|Abnormal ECG|1|||
33293190|NCT00150618|100970867|FG001|Overall Study|Abnormal ECG|0|||
33293191|NCT00150618|100970868|FG002|Overall Study|Abnormal ECG|0|||
33293192|NCT00150618|100970869|FG003|Overall Study|Abnormal ECG|0|||
33293193|NCT00150618|100970870|FG004|Overall Study|Abnormal ECG|0|||
33293194|NCT00150618|100970866|FG000|Overall Study|Sponsor's decision|0|||
33293195|NCT00150618|100970867|FG001|Overall Study|Sponsor's decision|0|||
33293196|NCT00150618|100970868|FG002|Overall Study|Sponsor's decision|0|||
33293197|NCT00150618|100970869|FG003|Overall Study|Sponsor's decision|1|||
33293198|NCT00150618|100970870|FG004|Overall Study|Sponsor's decision|0|||
33293199|NCT00958711|100970871|FG000|Overall Study|Withdrawal by Subject|0|||
33293200|NCT00958711|100970872|FG001|Overall Study|Withdrawal by Subject|4|||
33293201|NCT00958711|100970871|FG000|Overall Study|Physician Decision|5|||
33293202|NCT00958711|100970872|FG001|Overall Study|Physician Decision|7|||
33293203|NCT00958711|100970871|FG000|Overall Study|Lost to Follow-up|4|||
33293204|NCT00958711|100970872|FG001|Overall Study|Lost to Follow-up|1|||
33293205|NCT00958711|100970871|FG000|Overall Study|Other|2|||
33293206|NCT00958711|100970872|FG001|Overall Study|Other|5|||
33293207|NCT00958711|100970871|FG000|Overall Study|Death|1|||
33293208|NCT00958711|100970872|FG001|Overall Study|Death|2|||
33293209|NCT00958711|100970871|FG000|Overall Study|Adverse Event|1|||
33293210|NCT00958711|100970872|FG001|Overall Study|Adverse Event|2|||
33293211|NCT04949802|100970875|FG000|Overall Study|Lost to Follow-up|3|||
33293212|NCT00307047|100970876|FG000|Overall Study|Lost to Follow-up|35|||
33293213|NCT00307047|100970877|FG001|Overall Study|Lost to Follow-up|24|||
33293214|NCT00307047|100970876|FG000|Overall Study|Withdrawal by Subject|6|||
33293215|NCT00307047|100970877|FG001|Overall Study|Withdrawal by Subject|6|||
33293216|NCT00307047|100970876|FG000|Overall Study|Physician Decision|1|||
33293217|NCT00307047|100970877|FG001|Overall Study|Physician Decision|2|||
33293218|NCT00307047|100970876|FG000|Overall Study|Lost to follow-up for other reasons|0|||
33293219|NCT00307047|100970877|FG001|Overall Study|Lost to follow-up for other reasons|1|||
33293220|NCT00307047|100970876|FG000|Overall Study|All death, all MI, all Revascularization|27|||
33293221|NCT00307047|100970877|FG001|Overall Study|All death, all MI, all Revascularization|16|||
33293222|NCT03197766|100970880|FG000|Overall Study|Withdrawal by Subject|2|||
33293223|NCT03197766|100970881|FG001|Overall Study|Withdrawal by Subject|0|||
33293224|NCT00770588|100970882|FG000|Overall Study|Adverse Event|9|||
33293225|NCT00770588|100970883|FG001|Overall Study|Adverse Event|2|||
33293226|NCT00770588|100970882|FG000|Overall Study|Death caused by progression of disease|70|||
33293227|NCT00770588|100970883|FG001|Overall Study|Death caused by progression of disease|91|||
33293228|NCT00770588|100970882|FG000|Overall Study|Lost to Follow-up|1|||
33293229|NCT00770588|100970883|FG001|Overall Study|Lost to Follow-up|1|||
33293230|NCT00770588|100970882|FG000|Overall Study|Withdrawal by Subject|1|||
33293231|NCT00770588|100970883|FG001|Overall Study|Withdrawal by Subject|1|||
33293232|NCT01191008|100970884|FG000|Overall Study|Protocol Violation|7|||
33293233|NCT01191008|100970884|FG000|Overall Study|Lost to Follow-up|8|||
33293234|NCT02514551|100970885|FG000|Overall Study|Lost to Follow-up|0|||
33293235|NCT02514551|100970886|FG001|Overall Study|Lost to Follow-up|1|||
33293236|NCT02514551|100970885|FG000|Overall Study|Participant Never Treated|0|||
33293237|NCT02514551|100970886|FG001|Overall Study|Participant Never Treated|2|||
33293238|NCT03784820|100970890|FG000|Overall Study|Lost to Follow-up|5|||
33293239|NCT03784820|100970891|FG001|Overall Study|Lost to Follow-up|5|||
33293240|NCT03784820|100970892|FG002|Overall Study|Lost to Follow-up|3|||
33293241|NCT03784820|100970893|FG003|Overall Study|Lost to Follow-up|3|||
33293242|NCT03126110|100970894|FG000|Phase 1|Death|2|||
33293243|NCT03126110|100970895|FG001|Phase 1|Death|2|||
33293244|NCT03126110|100970896|FG002|Phase 1|Death|4|||
33293245|NCT03126110|100970897|FG003|Phase 1|Death|3|||
33293246|NCT03126110|100970898|FG004|Phase 1|Death|4|||
33293247|NCT03126110|100970899|FG005|Phase 1|Death|4|||
33293248|NCT03126110|100970900|FG006|Phase 1|Death|3|||
33293249|NCT03126110|100970901|FG007|Phase 1|Death|4|||
33293250|NCT03126110|100970902|FG008|Phase 1|Death|5|||
33293251|NCT03126110|100970903|FG009|Phase 1|Death|2|||
33293252|NCT03126110|100970904|FG010|Phase 1|Death|6|||
33293253|NCT03126110|100970905|FG011|Phase 1|Death|0|||
33293254|NCT03126110|100970906|FG012|Phase 1|Death|0|||
33293255|NCT03126110|100970907|FG013|Phase 1|Death|0|||
33293256|NCT03126110|100970908|FG014|Phase 1|Death|0|||
33293257|NCT03126110|100970909|FG015|Phase 1|Death|0|||
33293258|NCT03126110|100970910|FG016|Phase 1|Death|0|||
33293259|NCT03126110|100970894|FG000|Phase 1|Lost to Follow-up|0|||
33293260|NCT03126110|100970895|FG001|Phase 1|Lost to Follow-up|1|||
33293261|NCT03126110|100970896|FG002|Phase 1|Lost to Follow-up|0|||
33293262|NCT03126110|100970897|FG003|Phase 1|Lost to Follow-up|0|||
33293263|NCT03126110|100970898|FG004|Phase 1|Lost to Follow-up|0|||
33293264|NCT03126110|100970899|FG005|Phase 1|Lost to Follow-up|0|||
33293265|NCT03126110|100970900|FG006|Phase 1|Lost to Follow-up|0|||
33293266|NCT03126110|100970901|FG007|Phase 1|Lost to Follow-up|0|||
33293267|NCT03126110|100970902|FG008|Phase 1|Lost to Follow-up|1|||
33293268|NCT03126110|100970903|FG009|Phase 1|Lost to Follow-up|0|||
33293269|NCT03126110|100970904|FG010|Phase 1|Lost to Follow-up|0|||
33599821|NCT01565941|102085024|FG000|Overall Study|Withdrawn by parent/guardian|3|||
33293270|NCT03126110|100970905|FG011|Phase 1|Lost to Follow-up|0|||
33293271|NCT03126110|100970906|FG012|Phase 1|Lost to Follow-up|0|||
33293272|NCT03126110|100970907|FG013|Phase 1|Lost to Follow-up|0|||
33293273|NCT03126110|100970908|FG014|Phase 1|Lost to Follow-up|0|||
33599822|NCT01565941|102085025|FG001|Overall Study|Withdrawn by parent/guardian|2|||
33599823|NCT01565941|102085024|FG000|Overall Study|Randomized; did not receive intevention|8|||
33599824|NCT01565941|102085025|FG001|Overall Study|Randomized; did not receive intevention|2|||
33599825|NCT00235391|102085031|FG000|Overall Study|Adverse Event|4|||
33599826|NCT00235391|102085032|FG001|Overall Study|Adverse Event|5|||
33599827|NCT00235391|102085033|FG002|Overall Study|Adverse Event|10|||
33599828|NCT00235391|102085034|FG003|Overall Study|Adverse Event|72|||
33599829|NCT00235391|102085035|FG004|Overall Study|Adverse Event|5|||
33599830|NCT00235391|102085036|FG005|Overall Study|Adverse Event|2|||
33599831|NCT00235391|102085031|FG000|Overall Study|Abnormal laboratory value(s)|3|||
33599832|NCT00235391|102085032|FG001|Overall Study|Abnormal laboratory value(s)|5|||
33599833|NCT00235391|102085033|FG002|Overall Study|Abnormal laboratory value(s)|4|||
33599834|NCT00235391|102085034|FG003|Overall Study|Abnormal laboratory value(s)|27|||
33599835|NCT00235391|102085035|FG004|Overall Study|Abnormal laboratory value(s)|1|||
33599836|NCT00235391|102085036|FG005|Overall Study|Abnormal laboratory value(s)|2|||
33599837|NCT00235391|102085031|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33599838|NCT00235391|102085032|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33599839|NCT00235391|102085033|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
33599840|NCT00235391|102085034|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
33599841|NCT00235391|102085035|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
33599842|NCT00235391|102085036|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
33599843|NCT00235391|102085031|FG000|Overall Study|Condition no longer requires treatment|3|||
33599844|NCT00235391|102085032|FG001|Overall Study|Condition no longer requires treatment|0|||
33599845|NCT00235391|102085033|FG002|Overall Study|Condition no longer requires treatment|0|||
33599846|NCT00235391|102085034|FG003|Overall Study|Condition no longer requires treatment|11|||
33599847|NCT00235391|102085035|FG004|Overall Study|Condition no longer requires treatment|1|||
33599848|NCT00235391|102085036|FG005|Overall Study|Condition no longer requires treatment|0|||
33599849|NCT00235391|102085031|FG000|Overall Study|Protocol deviation|0|||
33599850|NCT00235391|102085032|FG001|Overall Study|Protocol deviation|0|||
33599851|NCT00235391|102085033|FG002|Overall Study|Protocol deviation|1|||
33599852|NCT00235391|102085034|FG003|Overall Study|Protocol deviation|11|||
33599853|NCT00235391|102085035|FG004|Overall Study|Protocol deviation|0|||
33599854|NCT00235391|102085036|FG005|Overall Study|Protocol deviation|0|||
33599855|NCT00235391|102085031|FG000|Overall Study|Withdrawal by Subject|2|||
33599856|NCT00235391|102085032|FG001|Overall Study|Withdrawal by Subject|3|||
33293274|NCT03126110|100970909|FG015|Phase 1|Lost to Follow-up|0|||
33293275|NCT03126110|100970910|FG016|Phase 1|Lost to Follow-up|0|||
33293276|NCT03126110|100970894|FG000|Phase 1|Withdrawal by Subject|1|||
33293277|NCT03126110|100970895|FG001|Phase 1|Withdrawal by Subject|0|||
33293278|NCT03126110|100970896|FG002|Phase 1|Withdrawal by Subject|0|||
33293279|NCT03126110|100970897|FG003|Phase 1|Withdrawal by Subject|1|||
33293280|NCT03126110|100970898|FG004|Phase 1|Withdrawal by Subject|1|||
33293281|NCT03126110|100970899|FG005|Phase 1|Withdrawal by Subject|0|||
33293282|NCT03126110|100970900|FG006|Phase 1|Withdrawal by Subject|0|||
33293283|NCT03126110|100970901|FG007|Phase 1|Withdrawal by Subject|0|||
33293284|NCT03126110|100970902|FG008|Phase 1|Withdrawal by Subject|2|||
33293285|NCT03126110|100970903|FG009|Phase 1|Withdrawal by Subject|1|||
33293286|NCT03126110|100970904|FG010|Phase 1|Withdrawal by Subject|0|||
33293287|NCT03126110|100970905|FG011|Phase 1|Withdrawal by Subject|0|||
33293288|NCT03126110|100970906|FG012|Phase 1|Withdrawal by Subject|0|||
33293289|NCT03126110|100970907|FG013|Phase 1|Withdrawal by Subject|0|||
33293290|NCT03126110|100970908|FG014|Phase 1|Withdrawal by Subject|0|||
33293291|NCT03126110|100970909|FG015|Phase 1|Withdrawal by Subject|0|||
33293292|NCT03126110|100970910|FG016|Phase 1|Withdrawal by Subject|0|||
33293293|NCT03126110|100970894|FG000|Phase 1|Safety follow-up no longer necessary|1|||
33293294|NCT03126110|100970895|FG001|Phase 1|Safety follow-up no longer necessary|0|||
33293295|NCT03126110|100970896|FG002|Phase 1|Safety follow-up no longer necessary|0|||
33293296|NCT03126110|100970897|FG003|Phase 1|Safety follow-up no longer necessary|0|||
33293297|NCT03126110|100970898|FG004|Phase 1|Safety follow-up no longer necessary|0|||
33293298|NCT03126110|100970899|FG005|Phase 1|Safety follow-up no longer necessary|0|||
33293299|NCT03126110|100970900|FG006|Phase 1|Safety follow-up no longer necessary|0|||
33293300|NCT03126110|100970901|FG007|Phase 1|Safety follow-up no longer necessary|0|||
33293301|NCT03126110|100970902|FG008|Phase 1|Safety follow-up no longer necessary|0|||
33293302|NCT03126110|100970903|FG009|Phase 1|Safety follow-up no longer necessary|0|||
33293303|NCT03126110|100970904|FG010|Phase 1|Safety follow-up no longer necessary|0|||
33293304|NCT03126110|100970905|FG011|Phase 1|Safety follow-up no longer necessary|0|||
33293305|NCT03126110|100970906|FG012|Phase 1|Safety follow-up no longer necessary|0|||
33293306|NCT03126110|100970907|FG013|Phase 1|Safety follow-up no longer necessary|0|||
33293307|NCT03126110|100970908|FG014|Phase 1|Safety follow-up no longer necessary|0|||
33293308|NCT03126110|100970909|FG015|Phase 1|Safety follow-up no longer necessary|0|||
33293309|NCT03126110|100970910|FG016|Phase 1|Safety follow-up no longer necessary|0|||
33293310|NCT03126110|100970894|FG000|Phase 1|Survival follow-up no longer necessary|0|||
33293311|NCT03126110|100970895|FG001|Phase 1|Survival follow-up no longer necessary|0|||
33293312|NCT03126110|100970896|FG002|Phase 1|Survival follow-up no longer necessary|1|||
33293313|NCT03126110|100970897|FG003|Phase 1|Survival follow-up no longer necessary|0|||
33293314|NCT03126110|100970898|FG004|Phase 1|Survival follow-up no longer necessary|0|||
33293315|NCT03126110|100970899|FG005|Phase 1|Survival follow-up no longer necessary|0|||
33293316|NCT03126110|100970900|FG006|Phase 1|Survival follow-up no longer necessary|0|||
33293317|NCT03126110|100970901|FG007|Phase 1|Survival follow-up no longer necessary|0|||
33293318|NCT03126110|100970902|FG008|Phase 1|Survival follow-up no longer necessary|0|||
33293319|NCT03126110|100970903|FG009|Phase 1|Survival follow-up no longer necessary|0|||
33293320|NCT03126110|100970904|FG010|Phase 1|Survival follow-up no longer necessary|0|||
33293321|NCT03126110|100970905|FG011|Phase 1|Survival follow-up no longer necessary|0|||
33293322|NCT03126110|100970906|FG012|Phase 1|Survival follow-up no longer necessary|0|||
33293323|NCT03126110|100970907|FG013|Phase 1|Survival follow-up no longer necessary|0|||
33293324|NCT03126110|100970908|FG014|Phase 1|Survival follow-up no longer necessary|0|||
33293325|NCT03126110|100970909|FG015|Phase 1|Survival follow-up no longer necessary|0|||
33293326|NCT03126110|100970910|FG016|Phase 1|Survival follow-up no longer necessary|0|||
33293327|NCT03126110|100970894|FG000|Phase 2|Study terminated by the sponsor|0|||
33293328|NCT03126110|100970895|FG001|Phase 2|Study terminated by the sponsor|0|||
33293329|NCT03126110|100970896|FG002|Phase 2|Study terminated by the sponsor|0|||
33293330|NCT03126110|100970897|FG003|Phase 2|Study terminated by the sponsor|0|||
33293331|NCT03126110|100970898|FG004|Phase 2|Study terminated by the sponsor|0|||
33293332|NCT03126110|100970899|FG005|Phase 2|Study terminated by the sponsor|0|||
33293333|NCT03126110|100970900|FG006|Phase 2|Study terminated by the sponsor|0|||
33293334|NCT03126110|100970901|FG007|Phase 2|Study terminated by the sponsor|0|||
33293335|NCT03126110|100970902|FG008|Phase 2|Study terminated by the sponsor|0|||
33293336|NCT03126110|100970903|FG009|Phase 2|Study terminated by the sponsor|0|||
33293337|NCT03126110|100970904|FG010|Phase 2|Study terminated by the sponsor|0|||
33293338|NCT03126110|100970905|FG011|Phase 2|Study terminated by the sponsor|0|||
33293339|NCT03126110|100970906|FG012|Phase 2|Study terminated by the sponsor|0|||
33293340|NCT03126110|100970907|FG013|Phase 2|Study terminated by the sponsor|4|||
33293341|NCT03126110|100970908|FG014|Phase 2|Study terminated by the sponsor|0|||
33293342|NCT03126110|100970909|FG015|Phase 2|Study terminated by the sponsor|0|||
33293343|NCT03126110|100970910|FG016|Phase 2|Study terminated by the sponsor|0|||
33293344|NCT03126110|100970894|FG000|Phase 2|Withdrawal by Subject|0|||
33293345|NCT03126110|100970895|FG001|Phase 2|Withdrawal by Subject|0|||
33293346|NCT03126110|100970896|FG002|Phase 2|Withdrawal by Subject|0|||
33293347|NCT03126110|100970897|FG003|Phase 2|Withdrawal by Subject|0|||
33293348|NCT03126110|100970898|FG004|Phase 2|Withdrawal by Subject|0|||
33293349|NCT03126110|100970899|FG005|Phase 2|Withdrawal by Subject|0|||
33293350|NCT03126110|100970900|FG006|Phase 2|Withdrawal by Subject|0|||
33293351|NCT03126110|100970901|FG007|Phase 2|Withdrawal by Subject|0|||
33293352|NCT03126110|100970902|FG008|Phase 2|Withdrawal by Subject|0|||
33293353|NCT03126110|100970903|FG009|Phase 2|Withdrawal by Subject|0|||
33293354|NCT03126110|100970904|FG010|Phase 2|Withdrawal by Subject|0|||
33293355|NCT03126110|100970905|FG011|Phase 2|Withdrawal by Subject|1|||
33293356|NCT03126110|100970906|FG012|Phase 2|Withdrawal by Subject|3|||
33293357|NCT03126110|100970907|FG013|Phase 2|Withdrawal by Subject|3|||
33293358|NCT03126110|100970908|FG014|Phase 2|Withdrawal by Subject|2|||
33293359|NCT03126110|100970909|FG015|Phase 2|Withdrawal by Subject|1|||
33293360|NCT03126110|100970910|FG016|Phase 2|Withdrawal by Subject|0|||
33293361|NCT03126110|100970894|FG000|Phase 2|Lost to Follow-up|0|||
33293362|NCT03126110|100970895|FG001|Phase 2|Lost to Follow-up|0|||
33293363|NCT03126110|100970896|FG002|Phase 2|Lost to Follow-up|0|||
33293364|NCT03126110|100970897|FG003|Phase 2|Lost to Follow-up|0|||
33293365|NCT03126110|100970898|FG004|Phase 2|Lost to Follow-up|0|||
33293366|NCT03126110|100970899|FG005|Phase 2|Lost to Follow-up|0|||
33293367|NCT03126110|100970900|FG006|Phase 2|Lost to Follow-up|0|||
33293368|NCT03126110|100970901|FG007|Phase 2|Lost to Follow-up|0|||
33293369|NCT03126110|100970902|FG008|Phase 2|Lost to Follow-up|0|||
33293370|NCT03126110|100970903|FG009|Phase 2|Lost to Follow-up|0|||
33293371|NCT03126110|100970904|FG010|Phase 2|Lost to Follow-up|0|||
33293372|NCT03126110|100970905|FG011|Phase 2|Lost to Follow-up|1|||
33293373|NCT03126110|100970906|FG012|Phase 2|Lost to Follow-up|1|||
33293374|NCT03126110|100970907|FG013|Phase 2|Lost to Follow-up|1|||
33293375|NCT03126110|100970908|FG014|Phase 2|Lost to Follow-up|2|||
33293376|NCT03126110|100970909|FG015|Phase 2|Lost to Follow-up|0|||
33293377|NCT03126110|100970910|FG016|Phase 2|Lost to Follow-up|0|||
33293378|NCT03126110|100970894|FG000|Phase 2|Death|0|||
33293379|NCT03126110|100970895|FG001|Phase 2|Death|0|||
33293380|NCT03126110|100970896|FG002|Phase 2|Death|0|||
33293381|NCT03126110|100970897|FG003|Phase 2|Death|0|||
33293382|NCT03126110|100970898|FG004|Phase 2|Death|0|||
33293383|NCT03126110|100970899|FG005|Phase 2|Death|0|||
33293384|NCT03126110|100970900|FG006|Phase 2|Death|0|||
33293385|NCT03126110|100970901|FG007|Phase 2|Death|0|||
33293386|NCT03126110|100970902|FG008|Phase 2|Death|0|||
33293387|NCT03126110|100970903|FG009|Phase 2|Death|0|||
33293388|NCT03126110|100970904|FG010|Phase 2|Death|0|||
33293389|NCT03126110|100970905|FG011|Phase 2|Death|6|||
33293390|NCT03126110|100970906|FG012|Phase 2|Death|12|||
33293391|NCT03126110|100970907|FG013|Phase 2|Death|25|||
33293392|NCT03126110|100970908|FG014|Phase 2|Death|11|||
33293393|NCT03126110|100970909|FG015|Phase 2|Death|3|||
33293394|NCT03126110|100970910|FG016|Phase 2|Death|2|||
33293395|NCT03126110|100970894|FG000|Phase 2|Progressive Disease|0|||
33293396|NCT03126110|100970895|FG001|Phase 2|Progressive Disease|0|||
33293397|NCT03126110|100970896|FG002|Phase 2|Progressive Disease|0|||
33293398|NCT03126110|100970897|FG003|Phase 2|Progressive Disease|0|||
33293399|NCT03126110|100970898|FG004|Phase 2|Progressive Disease|0|||
33293400|NCT03126110|100970899|FG005|Phase 2|Progressive Disease|0|||
33293401|NCT03126110|100970900|FG006|Phase 2|Progressive Disease|0|||
33293402|NCT03126110|100970901|FG007|Phase 2|Progressive Disease|0|||
33293403|NCT03126110|100970902|FG008|Phase 2|Progressive Disease|0|||
33293404|NCT03126110|100970903|FG009|Phase 2|Progressive Disease|0|||
33293405|NCT03126110|100970904|FG010|Phase 2|Progressive Disease|0|||
33293406|NCT03126110|100970905|FG011|Phase 2|Progressive Disease|0|||
33293407|NCT03126110|100970906|FG012|Phase 2|Progressive Disease|0|||
33293408|NCT03126110|100970907|FG013|Phase 2|Progressive Disease|1|||
33293409|NCT03126110|100970908|FG014|Phase 2|Progressive Disease|0|||
33293410|NCT03126110|100970909|FG015|Phase 2|Progressive Disease|0|||
33293411|NCT03126110|100970910|FG016|Phase 2|Progressive Disease|0|||
33293412|NCT03126110|100970894|FG000|Phase 2|Started new treatment|0|||
33293413|NCT03126110|100970895|FG001|Phase 2|Started new treatment|0|||
33293414|NCT03126110|100970896|FG002|Phase 2|Started new treatment|0|||
33293415|NCT03126110|100970897|FG003|Phase 2|Started new treatment|0|||
33293416|NCT03126110|100970898|FG004|Phase 2|Started new treatment|0|||
33293417|NCT03126110|100970899|FG005|Phase 2|Started new treatment|0|||
33293418|NCT03126110|100970900|FG006|Phase 2|Started new treatment|0|||
33293419|NCT03126110|100970901|FG007|Phase 2|Started new treatment|0|||
33293420|NCT03126110|100970902|FG008|Phase 2|Started new treatment|0|||
33293421|NCT03126110|100970903|FG009|Phase 2|Started new treatment|0|||
33293422|NCT03126110|100970904|FG010|Phase 2|Started new treatment|0|||
33293423|NCT03126110|100970905|FG011|Phase 2|Started new treatment|0|||
33293424|NCT03126110|100970906|FG012|Phase 2|Started new treatment|0|||
33293425|NCT03126110|100970907|FG013|Phase 2|Started new treatment|0|||
33293426|NCT03126110|100970908|FG014|Phase 2|Started new treatment|1|||
33293427|NCT03126110|100970909|FG015|Phase 2|Started new treatment|0|||
33293428|NCT03126110|100970910|FG016|Phase 2|Started new treatment|0|||
33293429|NCT00731133|100970911|FG000|Overall Study|Withdrawal by Subject|10|||
33293430|NCT00967005|100970917|FG000|Overall Study|Lost to Follow-up|7|||
33293431|NCT00967005|100970918|FG001|Overall Study|Lost to Follow-up|10|||
33293432|NCT00208325|100970919|FG000|Overall Study|Death|18|||
33293433|NCT00208325|100970920|FG001|Overall Study|Death|19|||
33293434|NCT00208325|100970921|FG002|Overall Study|Death|7|||
33293435|NCT00208325|100970922|FG003|Overall Study|Death|5|||
33293436|NCT00208325|100970919|FG000|Overall Study|Withdrawal by Subject|0|||
33293437|NCT00208325|100970920|FG001|Overall Study|Withdrawal by Subject|1|||
33293438|NCT00208325|100970921|FG002|Overall Study|Withdrawal by Subject|0|||
33293439|NCT00208325|100970922|FG003|Overall Study|Withdrawal by Subject|0|||
33293440|NCT00208325|100970919|FG000|Overall Study|Revision|4|||
33293441|NCT00208325|100970920|FG001|Overall Study|Revision|1|||
33293442|NCT00208325|100970921|FG002|Overall Study|Revision|0|||
33293443|NCT00208325|100970922|FG003|Overall Study|Revision|4|||
33293444|NCT00208325|100970919|FG000|Overall Study|Lost to Follow-up|1|||
33293445|NCT00208325|100970920|FG001|Overall Study|Lost to Follow-up|0|||
33293446|NCT00208325|100970921|FG002|Overall Study|Lost to Follow-up|2|||
33293447|NCT00208325|100970922|FG003|Overall Study|Lost to Follow-up|0|||
33293448|NCT00208325|100970919|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
33293449|NCT00208325|100970920|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
33293450|NCT00208325|100970921|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
33293451|NCT00208325|100970922|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
33293452|NCT00208325|100970919|FG000|Overall Study|Does not wish to Continue in Study|5|||
33293453|NCT00208325|100970920|FG001|Overall Study|Does not wish to Continue in Study|8|||
33293454|NCT00208325|100970921|FG002|Overall Study|Does not wish to Continue in Study|3|||
33293455|NCT00208325|100970922|FG003|Overall Study|Does not wish to Continue in Study|2|||
33293456|NCT00208325|100970919|FG000|Overall Study|Other|2|||
33599857|NCT00235391|102085033|FG002|Overall Study|Withdrawal by Subject|3|||
33599858|NCT00235391|102085034|FG003|Overall Study|Withdrawal by Subject|61|||
33599859|NCT00235391|102085035|FG004|Overall Study|Withdrawal by Subject|5|||
33599860|NCT00235391|102085036|FG005|Overall Study|Withdrawal by Subject|0|||
33599861|NCT00235391|102085031|FG000|Overall Study|Lost to Follow-up|0|||
33599862|NCT00235391|102085032|FG001|Overall Study|Lost to Follow-up|3|||
33599863|NCT00235391|102085033|FG002|Overall Study|Lost to Follow-up|3|||
33599864|NCT00235391|102085034|FG003|Overall Study|Lost to Follow-up|16|||
33599865|NCT00235391|102085035|FG004|Overall Study|Lost to Follow-up|0|||
33599866|NCT00235391|102085036|FG005|Overall Study|Lost to Follow-up|0|||
33599867|NCT00235391|102085031|FG000|Overall Study|Administrative problems|0|||
33599868|NCT00235391|102085032|FG001|Overall Study|Administrative problems|0|||
33599869|NCT00235391|102085033|FG002|Overall Study|Administrative problems|0|||
33599870|NCT00235391|102085034|FG003|Overall Study|Administrative problems|1|||
33599871|NCT00235391|102085035|FG004|Overall Study|Administrative problems|0|||
33599872|NCT00235391|102085036|FG005|Overall Study|Administrative problems|0|||
33599873|NCT00235391|102085031|FG000|Overall Study|Death|0|||
33599874|NCT00235391|102085032|FG001|Overall Study|Death|0|||
33599875|NCT00235391|102085033|FG002|Overall Study|Death|1|||
33599876|NCT00235391|102085034|FG003|Overall Study|Death|4|||
33599877|NCT00235391|102085035|FG004|Overall Study|Death|0|||
33599878|NCT00235391|102085036|FG005|Overall Study|Death|0|||
33599879|NCT02463032|102085037|FG000|Overall Study|Lack of Efficacy|61|||
33599880|NCT02463032|102085038|FG001|Overall Study|Lack of Efficacy|50|||
33599881|NCT02463032|102085037|FG000|Overall Study|Death|8|||
33599882|NCT02463032|102085038|FG001|Overall Study|Death|8|||
33599883|NCT02463032|102085037|FG000|Overall Study|Adverse Event|2|||
33599884|NCT02463032|102085038|FG001|Overall Study|Adverse Event|6|||
33599885|NCT00385723|102085040|FG000|Overall Study|Lost to Follow-up|1|||
33599886|NCT00385723|102085041|FG001|Overall Study|Lost to Follow-up|1|||
33599887|NCT00385723|102085042|FG002|Overall Study|Lost to Follow-up|0|||
33599888|NCT00385723|102085040|FG000|Overall Study|Withdrawal by Subject|1|||
33599889|NCT00385723|102085041|FG001|Overall Study|Withdrawal by Subject|0|||
33599890|NCT00385723|102085042|FG002|Overall Study|Withdrawal by Subject|2|||
33599891|NCT04962230|102085049|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
33599892|NCT04962230|102085049|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
33599893|NCT01318070|102085052|FG000|Overall Study|Adverse Event|1|||
33599894|NCT01318070|102085053|FG001|Overall Study|Adverse Event|1|||
33599895|NCT01318070|102085054|FG002|Overall Study|Adverse Event|5|||
33599896|NCT01318070|102085052|FG000|Overall Study|Withdrawal by Subject|0|||
33599897|NCT01318070|102085053|FG001|Overall Study|Withdrawal by Subject|1|||
33599898|NCT01318070|102085054|FG002|Overall Study|Withdrawal by Subject|1|||
33599899|NCT01318070|102085052|FG000|Overall Study|Lack of Efficacy|0|||
33599900|NCT01318070|102085053|FG001|Overall Study|Lack of Efficacy|0|||
33599901|NCT01318070|102085054|FG002|Overall Study|Lack of Efficacy|1|||
33599902|NCT01318070|102085052|FG000|Overall Study|Principal Investigator Discretion|1|||
33599903|NCT01318070|102085053|FG001|Overall Study|Principal Investigator Discretion|0|||
33599904|NCT01318070|102085054|FG002|Overall Study|Principal Investigator Discretion|0|||
33599905|NCT01891344|102085055|FG000|Overall Study|Ongoing|6|||
33599906|NCT01891344|102085056|FG001|Overall Study|Ongoing|2|||
33599907|NCT01891344|102085057|FG002|Overall Study|Ongoing|0|||
33599908|NCT01891344|102085058|FG003|Overall Study|Ongoing|1|||
33293457|NCT00208325|100970920|FG001|Overall Study|Other|1|||
33293458|NCT00208325|100970921|FG002|Overall Study|Other|1|||
33293459|NCT00208325|100970922|FG003|Overall Study|Other|0|||
33293460|NCT00208325|100970919|FG000|Overall Study|Mis-Randomized|17|||
33293461|NCT00208325|100970920|FG001|Overall Study|Mis-Randomized|20|||
33293462|NCT00208325|100970921|FG002|Overall Study|Mis-Randomized|0|||
33293463|NCT00208325|100970922|FG003|Overall Study|Mis-Randomized|0|||
33293464|NCT02593123|100970923|FG000|Overall Study|Physician Decision|2|||
33293465|NCT02593123|100970924|FG001|Overall Study|Physician Decision|1|||
33293466|NCT02593123|100970923|FG000|Overall Study|Relapse|1|||
33293467|NCT02593123|100970924|FG001|Overall Study|Relapse|1|||
33293468|NCT00422734|100970925|FG000|Overall Study|Physician Decision|1|||
33293469|NCT00422734|100970926|FG001|Overall Study|Physician Decision|1|||
33293470|NCT00422734|100970925|FG000|Overall Study|Protocol Violation|1|||
33293471|NCT00422734|100970926|FG001|Overall Study|Protocol Violation|6|||
33293472|NCT00422734|100970925|FG000|Overall Study|Withdrawal by Subject|12|||
33293473|NCT00422734|100970926|FG001|Overall Study|Withdrawal by Subject|8|||
33293474|NCT00422734|100970925|FG000|Overall Study|Adverse Event|0|||
33293475|NCT00422734|100970926|FG001|Overall Study|Adverse Event|3|||
33293476|NCT00422734|100970925|FG000|Overall Study|Partner Decision|0|||
33293477|NCT00422734|100970926|FG001|Overall Study|Partner Decision|3|||
33293478|NCT02820597|100970927|FG000|Overall Study|Lost to Follow-up|12|||
33293479|NCT01216072|100970930|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
33293480|NCT01216072|100970931|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
33293481|NCT01216072|100970930|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
33293482|NCT01216072|100970931|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
33293483|NCT01216072|100970930|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
33293484|NCT01216072|100970931|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
33293485|NCT01216072|100970930|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
33293486|NCT01216072|100970931|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
33293487|NCT01216072|100970930|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
33293488|NCT01216072|100970931|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
33293489|NCT01216072|100970930|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
33293490|NCT01216072|100970931|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
33293491|NCT01216072|100970930|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
33293492|NCT01216072|100970931|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
33293493|NCT01216072|100970930|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
33293494|NCT01216072|100970931|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
33293495|NCT01216072|100970930|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
33293496|NCT01216072|100970931|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
33293497|NCT01216072|100970930|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
33293498|NCT01216072|100970931|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
33293499|NCT03023722|100970932|FG000|Overall Study|No follow-up assessment|4|||
33293500|NCT03482752|100970933|FG000|Overall Study|Withdrawal by Subject|2|||
33293501|NCT03482752|100970933|FG000|Overall Study|Lost to Follow-up|1|||
33293502|NCT03482752|100970933|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
33293503|NCT02392104|100970934|FG000|Overall Study|discontinuation of warfarin|3|||
33293504|NCT02392104|100970934|FG000|Overall Study|bleeding event|1|||
33293505|NCT02392104|100970934|FG000|Overall Study|transferred care to another doctor|2|||
33293506|NCT02392104|100970934|FG000|Overall Study|INR goal range changed|1|||
33293507|NCT02392104|100970934|FG000|Overall Study|admitted to skilled nursing facility|3|||
33293508|NCT02392104|100970934|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
33293509|NCT00979953|100970935|FG000|Overall Study|Adverse Event|5|||
33293510|NCT00979953|100970936|FG001|Overall Study|Adverse Event|2|||
33293511|NCT00979953|100970937|FG002|Overall Study|Adverse Event|17|||
33293512|NCT00979953|100970938|FG003|Overall Study|Adverse Event|4|||
33599909|NCT01891344|102085059|FG004|Overall Study|Ongoing|4|||
33293513|NCT00979953|100970935|FG000|Overall Study|Lack of Efficacy|1|||
33293514|NCT00979953|100970936|FG001|Overall Study|Lack of Efficacy|2|||
33293515|NCT00979953|100970937|FG002|Overall Study|Lack of Efficacy|0|||
33599910|NCT01891344|102085060|FG005|Overall Study|Ongoing|1|||
33293516|NCT00979953|100970938|FG003|Overall Study|Lack of Efficacy|0|||
33293517|NCT00979953|100970935|FG000|Overall Study|Lost to Follow-up|1|||
33293518|NCT00979953|100970936|FG001|Overall Study|Lost to Follow-up|1|||
33293519|NCT00979953|100970937|FG002|Overall Study|Lost to Follow-up|1|||
33293520|NCT00979953|100970938|FG003|Overall Study|Lost to Follow-up|0|||
33293521|NCT00979953|100970935|FG000|Overall Study|Withdrawal by Subject|0|||
33293522|NCT00979953|100970936|FG001|Overall Study|Withdrawal by Subject|0|||
33293523|NCT00979953|100970937|FG002|Overall Study|Withdrawal by Subject|2|||
33293524|NCT00979953|100970938|FG003|Overall Study|Withdrawal by Subject|1|||
33293525|NCT00979953|100970935|FG000|Overall Study|Protocol Violation|1|||
33293526|NCT00979953|100970936|FG001|Overall Study|Protocol Violation|0|||
33293527|NCT00979953|100970937|FG002|Overall Study|Protocol Violation|2|||
33293528|NCT00979953|100970938|FG003|Overall Study|Protocol Violation|2|||
33293529|NCT02034162|100970940|FG000|Double-blind|Lost to Follow-up|3|||
33293530|NCT02034162|100970941|FG001|Double-blind|Lost to Follow-up|0|||
33293531|NCT02034162|100970942|FG002|Double-blind|Lost to Follow-up|0|||
33293532|NCT02034162|100970940|FG000|Double-blind|Physician Decision|1|||
33293533|NCT02034162|100970941|FG001|Double-blind|Physician Decision|0|||
33293534|NCT02034162|100970942|FG002|Double-blind|Physician Decision|0|||
33293535|NCT02034162|100970940|FG000|Double-blind|Protocol Violation|0|||
33293536|NCT02034162|100970941|FG001|Double-blind|Protocol Violation|1|||
33293537|NCT02034162|100970942|FG002|Double-blind|Protocol Violation|0|||
33293538|NCT02034162|100970940|FG000|Double-blind|Withdrawal by Subject|5|||
33293539|NCT02034162|100970941|FG001|Double-blind|Withdrawal by Subject|7|||
33293540|NCT02034162|100970942|FG002|Double-blind|Withdrawal by Subject|0|||
33293541|NCT04463680|100970946|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
33293542|NCT04463680|100970946|FG000|Overall Study|Not eligible due to implant duration of use|1|||
33293543|NCT04463680|100970946|FG000|Overall Study|Withdrawal by Subject|3|||
33293544|NCT00383123|100970954|FG000|Overall Study|Adverse Event|1|||
33293545|NCT00383123|100970955|FG001|Overall Study|Adverse Event|0|||
33293546|NCT00383123|100970954|FG000|Overall Study|Lost to Follow-up|68|||
33293547|NCT00383123|100970955|FG001|Overall Study|Lost to Follow-up|61|||
33293548|NCT00383123|100970954|FG000|Overall Study|Protocol Violation|5|||
33293549|NCT00383123|100970955|FG001|Overall Study|Protocol Violation|1|||
33293550|NCT00383123|100970954|FG000|Overall Study|Withdrawal by Subject|27|||
33293551|NCT00383123|100970955|FG001|Overall Study|Withdrawal by Subject|18|||
33599911|NCT01891344|102085061|FG006|Overall Study|Ongoing|0|||
33293552|NCT00383123|100970954|FG000|Overall Study|Other reason|10|||
33599912|NCT01891344|102085062|FG007|Overall Study|Ongoing|0|||
33599913|NCT03538444|102085063|FG000|Overall Study|opioid withdrawal|1|||
33599914|NCT03538444|102085064|FG001|Overall Study|opioid withdrawal|0|||
33599915|NCT02278614|102085065|FG000|Overall Study|Withdrawal by Subject|3|||
33599916|NCT02278614|102085066|FG001|Overall Study|Withdrawal by Subject|5|||
33599917|NCT02278614|102085065|FG000|Overall Study|Adverse Event|1|||
33599918|NCT02278614|102085066|FG001|Overall Study|Adverse Event|0|||
33599919|NCT02278614|102085065|FG000|Overall Study|left eye was not eligible|1|||
33599920|NCT02278614|102085066|FG001|Overall Study|left eye was not eligible|0|||
33599921|NCT02395055|102085067|FG000|Overall Study|Withdrawal by Subject|7|||
33599922|NCT02395055|102085068|FG001|Overall Study|Withdrawal by Subject|3|||
33599923|NCT02649855|102088475|FG000|Overall Study|Refused further treatment|2|||
33599924|NCT02649855|102088476|FG001|Overall Study|Refused further treatment|1|||
33599925|NCT02649855|102088477|FG002|Overall Study|Refused further treatment|1|||
33599926|NCT02649855|102088475|FG000|Overall Study|Withdrew consent|0|||
33599927|NCT02649855|102088476|FG001|Overall Study|Withdrew consent|1|||
33599928|NCT02649855|102088477|FG002|Overall Study|Withdrew consent|0|||
33599929|NCT02649855|102088475|FG000|Overall Study|Switched to alternative treatment|0|||
33599930|NCT02649855|102088476|FG001|Overall Study|Switched to alternative treatment|1|||
33599931|NCT02649855|102088477|FG002|Overall Study|Switched to alternative treatment|1|||
33599932|NCT02649855|102088475|FG000|Overall Study|Principal investigator discretion|0|||
33599933|NCT02649855|102088476|FG001|Overall Study|Principal investigator discretion|1|||
33599934|NCT02649855|102088477|FG002|Overall Study|Principal investigator discretion|1|||
33599935|NCT02649855|102088475|FG000|Overall Study|No treatment, per protocol|1|||
33599936|NCT02649855|102088476|FG001|Overall Study|No treatment, per protocol|0|||
33599937|NCT02649855|102088477|FG002|Overall Study|No treatment, per protocol|0|||
33599938|NCT02649855|102088475|FG000|Overall Study|Initiate new treatment|1|||
33599939|NCT02649855|102088476|FG001|Overall Study|Initiate new treatment|0|||
33599940|NCT02649855|102088477|FG002|Overall Study|Initiate new treatment|0|||
33599941|NCT02688088|102088481|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
33599942|NCT02688088|102088482|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
33599943|NCT02688088|102088483|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
33599944|NCT02688088|102088484|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
33599945|NCT02688088|102088485|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
33599946|NCT02688088|102088481|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
33599947|NCT02688088|102088482|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
33599948|NCT02688088|102088483|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
33599949|NCT02688088|102088484|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
33599950|NCT02688088|102088485|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
33599951|NCT02688088|102088481|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
33599952|NCT02688088|102088482|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
33599953|NCT02688088|102088483|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
33599954|NCT02688088|102088484|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
33599955|NCT02688088|102088485|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
33599956|NCT02688088|102088481|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
33599957|NCT02688088|102088482|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
33599958|NCT02688088|102088483|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
33599959|NCT02688088|102088484|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
33599960|NCT02688088|102088485|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
33599961|NCT02688088|102088481|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
33599962|NCT02688088|102088482|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
33599963|NCT02688088|102088483|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
33599964|NCT02688088|102088484|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
33599965|NCT02688088|102088485|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
33293553|NCT00383123|100970955|FG001|Overall Study|Other reason|6|||
33293554|NCT01131104|100970956|FG000|Overall Study|Withdrawal by Subject|3|||
33293555|NCT01131104|100970956|FG000|Overall Study|Physician Decision|4|||
33293556|NCT01131104|100970956|FG000|Overall Study|Information Not Available|5|||
33293557|NCT01131104|100970956|FG000|Overall Study|No Information on Index Date of Onset|1|||
33293558|NCT01151215|100970957|FG000|Overall Study|Worsening of condition under study|1|||
33293559|NCT01151215|100970958|FG001|Overall Study|Worsening of condition under study|1|||
33293560|NCT01151215|100970959|FG002|Overall Study|Worsening of condition under study|1|||
33293561|NCT01151215|100970957|FG000|Overall Study|Death|16|||
33293562|NCT01151215|100970958|FG001|Overall Study|Death|20|||
33293563|NCT01151215|100970959|FG002|Overall Study|Death|11|||
33293564|NCT01151215|100970957|FG000|Overall Study|Lost to Follow-up|0|||
33293565|NCT01151215|100970958|FG001|Overall Study|Lost to Follow-up|0|||
33293566|NCT01151215|100970959|FG002|Overall Study|Lost to Follow-up|3|||
33293567|NCT01151215|100970957|FG000|Overall Study|Withdrawal by Subject|3|||
33293568|NCT01151215|100970958|FG001|Overall Study|Withdrawal by Subject|1|||
33293569|NCT01151215|100970959|FG002|Overall Study|Withdrawal by Subject|2|||
33293570|NCT01151215|100970957|FG000|Overall Study|Disease progression|0|||
33293571|NCT01151215|100970958|FG001|Overall Study|Disease progression|1|||
33293572|NCT01151215|100970959|FG002|Overall Study|Disease progression|1|||
33293573|NCT01151215|100970957|FG000|Overall Study|Safety as judged by the investigator|0|||
33293574|NCT01151215|100970958|FG001|Overall Study|Safety as judged by the investigator|0|||
33293575|NCT01151215|100970959|FG002|Overall Study|Safety as judged by the investigator|1|||
33293576|NCT01436305|100970960|FG000|Overall Study|Death|1|||
33293577|NCT01436305|100970961|FG001|Overall Study|Death|0|||
33293578|NCT01436305|100970962|FG002|Overall Study|Death|0|||
33293579|NCT01436305|100970960|FG000|Overall Study|Lost to Follow-up|0|||
33293580|NCT01436305|100970961|FG001|Overall Study|Lost to Follow-up|1|||
33293581|NCT01436305|100970962|FG002|Overall Study|Lost to Follow-up|0|||
33293582|NCT01436305|100970960|FG000|Overall Study|Withdrawal by Subject|1|||
33293583|NCT01436305|100970961|FG001|Overall Study|Withdrawal by Subject|3|||
33293584|NCT01436305|100970962|FG002|Overall Study|Withdrawal by Subject|0|||
33293585|NCT00547534|100970967|FG000|Overall Study|Adverse Event|7|||
33293586|NCT00547534|100970967|FG000|Overall Study|Disease Progression|4|||
33293587|NCT02688530|100970968|FG000|Overall Study|Withdrawal by Subject|0|||
33293588|NCT02688530|100970969|FG001|Overall Study|Withdrawal by Subject|1|||
33293589|NCT02688530|100970970|FG002|Overall Study|Withdrawal by Subject|0|||
33293590|NCT02688530|100970971|FG003|Overall Study|Withdrawal by Subject|0|||
33293591|NCT02688530|100970968|FG000|Overall Study|Lost to Follow-up|0|||
33293592|NCT02688530|100970969|FG001|Overall Study|Lost to Follow-up|0|||
33293593|NCT02688530|100970970|FG002|Overall Study|Lost to Follow-up|2|||
33293594|NCT02688530|100970971|FG003|Overall Study|Lost to Follow-up|0|||
33293595|NCT04936685|100970972|FG000|Overall Study|Protocol Violation|1|||
33293596|NCT04936685|100970973|FG001|Overall Study|Protocol Violation|0|||
33293597|NCT02615509|100970990|FG000|Overall Study|Lost to Follow-up|134|||
33293598|NCT02615509|100970990|FG000|Overall Study|Death|4|||
33293599|NCT02615509|100970990|FG000|Overall Study|Withdrawal by Subject|8|||
33293600|NCT01948076|100970992|FG000|Overall Study|Withdrawal by Subject|0|||
33293601|NCT01948076|100970993|FG001|Overall Study|Withdrawal by Subject|1|||
33293602|NCT00667459|100970997|FG000|Overall Study|Death|0|||
33293603|NCT00667459|100970998|FG001|Overall Study|Death|2|||
33293604|NCT00667459|100970997|FG000|Overall Study|Lost to Follow-up|8|||
33293605|NCT00667459|100970998|FG001|Overall Study|Lost to Follow-up|43|||
33293606|NCT02536742|100970999|FG000|Overall Study|Did not start protocol therapy|1|||
33293607|NCT02536742|100970999|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
33293608|NCT00839956|100971000|FG000|Overall Study|Adverse Event|2|||
33293609|NCT00839956|100971000|FG000|Overall Study|Lack of Efficacy|6|||
33293610|NCT00839956|100971000|FG000|Overall Study|Physician Decision|1|||
33293611|NCT00839956|100971000|FG000|Overall Study|Withdrawal by Subject|3|||
33293612|NCT00334542|100971001|FG000|Overall Study|Adverse Event|3|||
33293613|NCT00334542|100971001|FG000|Overall Study|Withdrawal by Subject|1|||
33293614|NCT00334542|100971001|FG000|Overall Study|New cancer diagnosis|1|||
33293615|NCT01107899|100971002|FG000|Overall Study|Physician Decision|5|||
33293616|NCT01107899|100971003|FG001|Overall Study|Physician Decision|0|||
33293617|NCT01107899|100971004|FG002|Overall Study|Physician Decision|3|||
33293618|NCT01107899|100971002|FG000|Overall Study|Withdrawal by Subject|0|||
33293619|NCT01107899|100971003|FG001|Overall Study|Withdrawal by Subject|0|||
33293620|NCT01107899|100971004|FG002|Overall Study|Withdrawal by Subject|1|||
33293621|NCT03334253|100971013|FG000|Overall Study|Withdrawal by Subject|1|||
33293622|NCT03334253|100971014|FG001|Overall Study|Withdrawal by Subject|0|||
33293623|NCT03334253|100971013|FG000|Overall Study|Lost to Follow-up|4|||
33293624|NCT03334253|100971014|FG001|Overall Study|Lost to Follow-up|3|||
33293625|NCT03334253|100971013|FG000|Overall Study|Moved residence|2|||
33293626|NCT03334253|100971014|FG001|Overall Study|Moved residence|2|||
33293627|NCT00416598|100971020|FG000|Induction & Intensification|Adverse Event|38|||
33293628|NCT00416598|100971020|FG000|Induction & Intensification|Death|32|||
33293629|NCT00416598|100971020|FG000|Induction & Intensification|Withdrawal by Subject|46|||
33293630|NCT00416598|100971020|FG000|Induction & Intensification|Alternative Treatment|135|||
33293631|NCT00416598|100971020|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
33293632|NCT00416598|100971020|FG000|Induction & Intensification|Relapse/progression|29|||
33293633|NCT00416598|100971020|FG000|Induction & Intensification|Failed induction|87|||
33293634|NCT00416598|100971020|FG000|Decitabine Maintenance|Adverse Event|5|||
33293635|NCT00416598|100971020|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
33293636|NCT00416598|100971020|FG000|Decitabine Maintenance|Progression/relapse|38|||
33293637|NCT00416598|100971020|FG000|Decitabine Maintenance|Alternative treatment|2|||
33293638|NCT00416598|100971020|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
33293639|NCT00263211|100971021|FG000|Overall Study|Death|1|||
33293640|NCT00263211|100971022|FG001|Overall Study|Death|0|||
33293641|NCT00263211|100971021|FG000|Overall Study|Withdrawal by Subject|3|||
33293642|NCT00263211|100971022|FG001|Overall Study|Withdrawal by Subject|0|||
33293643|NCT00263211|100971021|FG000|Overall Study|Protocol Violation|1|||
33293644|NCT00263211|100971022|FG001|Overall Study|Protocol Violation|0|||
33293645|NCT00263211|100971021|FG000|Overall Study|Disease Progression|0|||
33293646|NCT00263211|100971022|FG001|Overall Study|Disease Progression|1|||
33293647|NCT01986114|100971023|FG000|Overall Study|Adverse Event|59|||
33293648|NCT01986114|100971023|FG000|Overall Study|Lack of Efficacy|23|||
33293649|NCT01986114|100971023|FG000|Overall Study|Withdrawal by Subject|58|||
33293650|NCT01986114|100971023|FG000|Overall Study|Noncompliance|3|||
33293651|NCT01986114|100971023|FG000|Overall Study|Protocol Violation|1|||
33293652|NCT01986114|100971023|FG000|Overall Study|Lost to Follow-up|5|||
33293653|NCT01986114|100971023|FG000|Overall Study|Other reason|7|||
33293654|NCT04596995|100971024|FG000|Overall Study|Lack of Efficacy|8|||
33293655|NCT04596995|100971024|FG000|Overall Study|Lost to Follow-up|3|||
33293656|NCT04596995|100971024|FG000|Overall Study|Withdrawal by Subject|12|||
33293657|NCT04596995|100971024|FG000|Overall Study|Sponsor decision|3|||
33293658|NCT04596995|100971024|FG000|Overall Study|Enrolled in managed access program|3|||
33293659|NCT03080493|100971029|FG000|Overall Study|Did not provide NRS pain results|1|||
33293660|NCT03080493|100971030|FG001|Overall Study|Did not provide NRS pain results|0|||
33293661|NCT03080493|100971029|FG000|Overall Study|Adverse Event|0|||
33293662|NCT03080493|100971030|FG001|Overall Study|Adverse Event|1|||
33293663|NCT03080493|100971029|FG000|Overall Study|Randomization error (parity group)|0|||
33293664|NCT03080493|100971030|FG001|Overall Study|Randomization error (parity group)|1|||
33293665|NCT00478205|100971031|FG000|Overall Study|Adverse Event|182|||
33293666|NCT00478205|100971032|FG001|Overall Study|Adverse Event|39|||
33293667|NCT00478205|100971031|FG000|Overall Study|Medication Non-compliance|9|||
33599966|NCT02688088|102088481|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
33599967|NCT02688088|102088482|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
33599968|NCT02688088|102088483|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
33599969|NCT02688088|102088484|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
33599970|NCT02688088|102088485|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
33599971|NCT02688088|102088481|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
33599972|NCT02688088|102088482|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
33599973|NCT02688088|102088483|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
33599974|NCT02688088|102088484|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
33599975|NCT02688088|102088485|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
33293668|NCT00478205|100971032|FG001|Overall Study|Medication Non-compliance|4|||
33293669|NCT00478205|100971031|FG000|Overall Study|Protocol Violation|15|||
33293670|NCT00478205|100971032|FG001|Overall Study|Protocol Violation|5|||
33293671|NCT00478205|100971031|FG000|Overall Study|Request of Investigator or Sponsor|4|||
33293672|NCT00478205|100971032|FG001|Overall Study|Request of Investigator or Sponsor|5|||
33293673|NCT00478205|100971031|FG000|Overall Study|Withdrawal by Subject|61|||
33293674|NCT00478205|100971032|FG001|Overall Study|Withdrawal by Subject|22|||
33293675|NCT00478205|100971031|FG000|Overall Study|Lack of Efficacy|1|||
33293676|NCT00478205|100971032|FG001|Overall Study|Lack of Efficacy|0|||
33293677|NCT00478205|100971031|FG000|Overall Study|Other|24|||
33293678|NCT00478205|100971032|FG001|Overall Study|Other|12|||
33293679|NCT01732549|100971033|FG000|Overall Study|Adverse Event|13|||
33293680|NCT01732549|100971034|FG001|Overall Study|Adverse Event|3|||
33293681|NCT01732549|100971033|FG000|Overall Study|Consent withdrawn|13|||
33293682|NCT01732549|100971034|FG001|Overall Study|Consent withdrawn|6|||
33293683|NCT01732549|100971033|FG000|Overall Study|Disease progression|37|||
33293684|NCT01732549|100971034|FG001|Overall Study|Disease progression|50|||
33293685|NCT01732549|100971033|FG000|Overall Study|Other|8|||
33293686|NCT01732549|100971034|FG001|Overall Study|Other|14|||
33293687|NCT00475228|100971035|FG000|Overall Study|Lost to Follow-up|17|||
33293688|NCT00475228|100971036|FG001|Overall Study|Lost to Follow-up|17|||
33293689|NCT00882115|100975217|FG000|Overall Study|Withdrawal by Subject|3|||
33293690|NCT00882115|100975217|FG000|Overall Study|did not respond to DEP challe|6|||
33293691|NCT00193479|100975218|FG000|Induction Chemotherapy|Adverse Event|2|||
33293692|NCT00193479|100975218|FG000|Induction Chemotherapy|Disease Progression|1|||
33293693|NCT00193479|100975218|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
33293694|NCT00193479|100975218|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
33293695|NCT04210843|100975219|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
33293696|NCT04210843|100975220|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
33293697|NCT04210843|100975219|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
33293698|NCT04210843|100975220|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
33293699|NCT04210843|100975219|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
33293700|NCT04210843|100975220|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
33293701|NCT04210843|100975219|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
33293702|NCT04210843|100975220|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
33293703|NCT04210843|100975219|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
33293704|NCT04210843|100975220|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
33293705|NCT04210843|100975219|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
33293706|NCT04210843|100975220|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
33293707|NCT04210843|100975219|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
33293708|NCT04210843|100975220|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
33599976|NCT02688088|102088481|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
33599977|NCT02688088|102088482|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
33599978|NCT02688088|102088483|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
33599979|NCT02688088|102088484|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
33599980|NCT02688088|102088485|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
33599981|NCT02688088|102088481|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
33599982|NCT02688088|102088482|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
33599983|NCT02688088|102088483|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
33599984|NCT02688088|102088484|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
33599985|NCT02688088|102088485|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
33599986|NCT02576860|102088494|FG000|Overall Study|Adverse Event|6|||
33599987|NCT02576860|102088495|FG001|Overall Study|Adverse Event|6|||
33599988|NCT02576860|102088494|FG000|Overall Study|Lost to Follow-up|5|||
33599989|NCT02576860|102088495|FG001|Overall Study|Lost to Follow-up|7|||
33599990|NCT02576860|102088494|FG000|Overall Study|Physician Decision|0|||
33599991|NCT02576860|102088495|FG001|Overall Study|Physician Decision|1|||
33599992|NCT02576860|102088494|FG000|Overall Study|Protocol Violation|0|||
33599993|NCT02576860|102088495|FG001|Overall Study|Protocol Violation|2|||
33599994|NCT02576860|102088494|FG000|Overall Study|Withdrawal by Subject|13|||
33599995|NCT02576860|102088495|FG001|Overall Study|Withdrawal by Subject|8|||
33293709|NCT04210843|100975219|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
33293710|NCT04210843|100975220|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
33293711|NCT04210843|100975219|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
33293712|NCT04210843|100975220|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
33293713|NCT04210843|100975219|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
33293714|NCT04210843|100975220|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
33293715|NCT04210843|100975219|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
33293716|NCT04210843|100975220|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
33293717|NCT04210843|100975219|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
33293718|NCT04210843|100975220|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
33293719|NCT04210843|100975219|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
33293720|NCT04210843|100975220|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
33293721|NCT04210843|100975219|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
33293722|NCT04210843|100975220|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
33293723|NCT04210843|100975219|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
33293724|NCT04210843|100975220|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
33293725|NCT04210843|100975219|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
33293726|NCT04210843|100975220|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
33293727|NCT04210843|100975219|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
33293728|NCT04210843|100975220|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
33293729|NCT04210843|100975219|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
33293730|NCT04210843|100975220|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
33293731|NCT04210843|100975219|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
33293732|NCT04210843|100975220|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
33293733|NCT04210843|100975219|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
33293734|NCT04210843|100975220|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
33293735|NCT04210843|100975219|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
33293736|NCT04210843|100975220|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
33293737|NCT04210843|100975219|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
33293738|NCT04210843|100975220|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
33293739|NCT04210843|100975219|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
33293740|NCT04210843|100975220|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
33293741|NCT04210843|100975219|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
33293742|NCT04210843|100975220|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
33293743|NCT02366143|100975224|FG000|Overall Study|Death|307|||
33293744|NCT02366143|100975225|FG001|Overall Study|Death|278|||
33293745|NCT02366143|100975226|FG002|Overall Study|Death|280|||
33293746|NCT02366143|100975224|FG000|Overall Study|Lost to Follow-up|2|||
33293747|NCT02366143|100975225|FG001|Overall Study|Lost to Follow-up|4|||
33293748|NCT02366143|100975226|FG002|Overall Study|Lost to Follow-up|2|||
33293749|NCT02366143|100975224|FG000|Overall Study|Physician Decision|1|||
33293750|NCT02366143|100975225|FG001|Overall Study|Physician Decision|2|||
33293751|NCT02366143|100975226|FG002|Overall Study|Physician Decision|1|||
33293752|NCT02366143|100975224|FG000|Overall Study|Protocol Violation|0|||
33293753|NCT02366143|100975225|FG001|Overall Study|Protocol Violation|0|||
33293754|NCT02366143|100975226|FG002|Overall Study|Protocol Violation|2|||
33293755|NCT02366143|100975224|FG000|Overall Study|Withdrawal by Subject|16|||
33293756|NCT02366143|100975225|FG001|Overall Study|Withdrawal by Subject|17|||
33293757|NCT02366143|100975226|FG002|Overall Study|Withdrawal by Subject|22|||
33293758|NCT02366143|100975224|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
33293759|NCT02366143|100975225|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
33293760|NCT02366143|100975226|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
33293761|NCT02366143|100975224|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
33293762|NCT02366143|100975225|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
33293763|NCT02366143|100975226|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
33293764|NCT02366143|100975224|FG000|Overall Study|Randomization Error|1|||
33293765|NCT02366143|100975225|FG001|Overall Study|Randomization Error|0|||
33293766|NCT02366143|100975226|FG002|Overall Study|Randomization Error|0|||
33293767|NCT02366143|100975224|FG000|Overall Study|PI Move and Site Closure|1|||
33293768|NCT02366143|100975225|FG001|Overall Study|PI Move and Site Closure|0|||
33293769|NCT02366143|100975226|FG002|Overall Study|PI Move and Site Closure|1|||
33293770|NCT02366143|100975224|FG000|Overall Study|Study Terminated By Sponsor|0|||
33293771|NCT02366143|100975225|FG001|Overall Study|Study Terminated By Sponsor|0|||
33293772|NCT02366143|100975226|FG002|Overall Study|Study Terminated By Sponsor|2|||
33293773|NCT02366143|100975224|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
33293774|NCT02366143|100975225|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
33293775|NCT02366143|100975226|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
33293776|NCT02366143|100975224|FG000|Overall Study|Patient moved to roll-over study|1|||
33293777|NCT02366143|100975225|FG001|Overall Study|Patient moved to roll-over study|19|||
33293778|NCT02366143|100975226|FG002|Overall Study|Patient moved to roll-over study|28|||
33293779|NCT02366143|100975224|FG000|Overall Study|Patient moved to commercial stock|0|||
33293780|NCT02366143|100975225|FG001|Overall Study|Patient moved to commercial stock|0|||
33293781|NCT02366143|100975226|FG002|Overall Study|Patient moved to commercial stock|1|||
33293782|NCT02366143|100975224|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
33293783|NCT02366143|100975225|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
33293784|NCT02366143|100975226|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
33293785|NCT02366143|100975224|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
33293786|NCT02366143|100975225|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
33391746|NCT03807778|101321862|FG000|Overall Study|Adverse Event|0|||
33293787|NCT02366143|100975226|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
33293788|NCT02366143|100975224|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
33293789|NCT02366143|100975225|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
33293790|NCT02366143|100975226|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
33293791|NCT02366143|100975224|FG000|Overall Study|Requester's instructions|1|||
33293792|NCT02366143|100975225|FG001|Overall Study|Requester's instructions|1|||
33293793|NCT02366143|100975226|FG002|Overall Study|Requester's instructions|1|||
33293794|NCT02366143|100975224|FG000|Overall Study|Uneligible|0|||
33293795|NCT02366143|100975225|FG001|Overall Study|Uneligible|1|||
33293796|NCT02366143|100975226|FG002|Overall Study|Uneligible|0|||
33293797|NCT02366143|100975224|FG000|Overall Study|Post Trial Migration|0|||
33293798|NCT02366143|100975225|FG001|Overall Study|Post Trial Migration|1|||
33293799|NCT02366143|100975226|FG002|Overall Study|Post Trial Migration|0|||
33293800|NCT02366143|100975224|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
33293801|NCT02366143|100975225|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
33293802|NCT02366143|100975226|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
33293803|NCT02366143|100975224|FG000|Overall Study|Patient switched to PTAP|0|||
33293804|NCT02366143|100975225|FG001|Overall Study|Patient switched to PTAP|1|||
33293805|NCT02366143|100975226|FG002|Overall Study|Patient switched to PTAP|0|||
33293806|NCT02366143|100975224|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
33293807|NCT02366143|100975225|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
33293808|NCT02366143|100975226|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
33293809|NCT00706654|100975233|FG000|Conversion Phase|Lost to Follow-up|4|||
33293810|NCT00706654|100975234|FG001|Conversion Phase|Lost to Follow-up|0|||
33293811|NCT00706654|100975235|FG002|Conversion Phase|Lost to Follow-up|0|||
33293812|NCT00706654|100975236|FG003|Conversion Phase|Lost to Follow-up|0|||
33293813|NCT00706654|100975233|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
33293814|NCT00706654|100975234|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
33293815|NCT00706654|100975235|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
33293816|NCT00706654|100975236|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
33293817|NCT00706654|100975233|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
33293818|NCT00706654|100975234|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
33293819|NCT00706654|100975235|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
33293820|NCT00706654|100975236|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
33293821|NCT00706654|100975233|FG000|Conversion Phase|Withdrawn by Investigator|14|||
33293822|NCT00706654|100975234|FG001|Conversion Phase|Withdrawn by Investigator|0|||
33293823|NCT00706654|100975235|FG002|Conversion Phase|Withdrawn by Investigator|0|||
33293824|NCT00706654|100975236|FG003|Conversion Phase|Withdrawn by Investigator|0|||
33293825|NCT00706654|100975233|FG000|Conversion Phase|Withdrew Consent|38|||
33293826|NCT00706654|100975234|FG001|Conversion Phase|Withdrew Consent|0|||
33293827|NCT00706654|100975235|FG002|Conversion Phase|Withdrew Consent|0|||
33293828|NCT00706654|100975236|FG003|Conversion Phase|Withdrew Consent|0|||
33293829|NCT00706654|100975233|FG000|Conversion Phase|Adverse Event|18|||
33293830|NCT00706654|100975234|FG001|Conversion Phase|Adverse Event|0|||
33293831|NCT00706654|100975235|FG002|Conversion Phase|Adverse Event|0|||
33293832|NCT00706654|100975236|FG003|Conversion Phase|Adverse Event|0|||
33293833|NCT00706654|100975233|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
33293834|NCT00706654|100975234|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
33599996|NCT02576860|102088494|FG000|Overall Study|Disallowed medication|1|||
33293835|NCT00706654|100975235|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
33293836|NCT00706654|100975236|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
33293837|NCT00706654|100975233|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
33293838|NCT00706654|100975234|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
33293839|NCT00706654|100975235|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
33293840|NCT00706654|100975236|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
33293841|NCT00706654|100975233|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
33293842|NCT00706654|100975234|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
33293843|NCT00706654|100975235|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
33293844|NCT00706654|100975236|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
33293845|NCT00706654|100975233|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
33293846|NCT00706654|100975234|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
33293847|NCT00706654|100975235|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
33293848|NCT00706654|100975236|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
33293849|NCT00706654|100975233|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
33293850|NCT00706654|100975234|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
33293851|NCT00706654|100975235|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
33293852|NCT00706654|100975236|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
33293853|NCT00706654|100975233|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
33293854|NCT00706654|100975234|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
33293855|NCT00706654|100975235|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
33293856|NCT00706654|100975236|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
33293857|NCT00706654|100975233|FG000|Oral Stabilization Phase|Withdrew consent|55|||
33293858|NCT00706654|100975234|FG001|Oral Stabilization Phase|Withdrew consent|0|||
33293859|NCT00706654|100975235|FG002|Oral Stabilization Phase|Withdrew consent|0|||
33293860|NCT00706654|100975236|FG003|Oral Stabilization Phase|Withdrew consent|0|||
33293861|NCT00706654|100975233|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
33293862|NCT00706654|100975234|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
33293863|NCT00706654|100975235|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
33293864|NCT00706654|100975236|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
33293865|NCT00706654|100975233|FG000|Oral Stabilization Phase|Adverse Event|21|||
33293866|NCT00706654|100975234|FG001|Oral Stabilization Phase|Adverse Event|0|||
33293867|NCT00706654|100975235|FG002|Oral Stabilization Phase|Adverse Event|0|||
33293868|NCT00706654|100975236|FG003|Oral Stabilization Phase|Adverse Event|0|||
33293869|NCT00706654|100975233|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
33293870|NCT00706654|100975234|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
33293871|NCT00706654|100975235|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
33293872|NCT00706654|100975236|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
33293873|NCT00706654|100975233|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
33293874|NCT00706654|100975234|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
33293875|NCT00706654|100975235|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
33293876|NCT00706654|100975236|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
33293877|NCT00706654|100975233|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
33293878|NCT00706654|100975234|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
33293879|NCT00706654|100975235|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
33391747|NCT03807778|101321863|FG001|Overall Study|Adverse Event|0|||
33391748|NCT03807778|101321864|FG002|Overall Study|Adverse Event|3|||
33599997|NCT02576860|102088495|FG001|Overall Study|Disallowed medication|0|||
33293880|NCT00706654|100975236|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
33293881|NCT00706654|100975233|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
33293882|NCT00706654|100975234|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
33293883|NCT00706654|100975235|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
33293884|NCT00706654|100975236|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
33293885|NCT00706654|100975233|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
33293886|NCT00706654|100975234|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
33293887|NCT00706654|100975235|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
33293888|NCT00706654|100975236|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
33293889|NCT00706654|100975233|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
33293890|NCT00706654|100975234|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
33293891|NCT00706654|100975235|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
33293892|NCT00706654|100975236|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
33293893|NCT00706654|100975233|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
33293894|NCT00706654|100975234|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
33293895|NCT00706654|100975235|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
33293896|NCT00706654|100975236|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
33293897|NCT00706654|100975233|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
33293898|NCT00706654|100975234|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
33293899|NCT00706654|100975235|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
33293900|NCT00706654|100975236|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
33293901|NCT00706654|100975233|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
33599998|NCT04493684|102088498|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
33599999|NCT04493684|102088499|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33600000|NCT04493684|102088500|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
33600001|NCT04493684|102088501|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33600002|NCT04493684|102088502|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33600003|NCT04493684|102088503|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
33600004|NCT04493684|102088504|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33600005|NCT04493684|102088505|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33600006|NCT04493684|102088506|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33600007|NCT04493684|102088507|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33600008|NCT04493684|102088508|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33600009|NCT04493684|102088509|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33600010|NCT04493684|102088510|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33600011|NCT04493684|102088511|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33600012|NCT04493684|102088512|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33600013|NCT04493684|102088513|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33600014|NCT04493684|102088514|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
33600015|NCT04493684|102088498|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
33600016|NCT04493684|102088499|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33600017|NCT04493684|102088500|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33600018|NCT04493684|102088501|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33600019|NCT04493684|102088502|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33600020|NCT04493684|102088503|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33600021|NCT04493684|102088504|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33600022|NCT04493684|102088505|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33600023|NCT04493684|102088506|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33600024|NCT04493684|102088507|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33600025|NCT04493684|102088508|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33600026|NCT04493684|102088509|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33600027|NCT04493684|102088510|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33293902|NCT00706654|100975234|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
33293903|NCT00706654|100975235|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
33293904|NCT00706654|100975236|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
33293905|NCT00706654|100975233|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
33293906|NCT00706654|100975234|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
33293907|NCT00706654|100975235|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
33293908|NCT00706654|100975236|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
33293909|NCT01594827|100975237|FG000|Overall Study|Adverse Event|1|||
33293910|NCT01594827|100975238|FG001|Overall Study|Adverse Event|0|||
33293911|NCT01594827|100975237|FG000|Overall Study|Physician Decision|3|||
33293912|NCT01594827|100975238|FG001|Overall Study|Physician Decision|0|||
33293913|NCT00504075|100975243|FG000|Overall Study|Adverse Event|1|||
33293914|NCT00504075|100975243|FG000|Overall Study|Lost to Follow-up|5|||
33293915|NCT00504075|100975243|FG000|Overall Study|Withdrawal by Subject|1|||
33293916|NCT00504075|100975243|FG000|Overall Study|Required other therapeutic intervention|1|||
33293917|NCT04160988|100975244|FG000|Overall Study|poor image quality|28|||
33293918|NCT00132678|100975245|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
33293919|NCT00132678|100975246|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
33293920|NCT00132678|100975247|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
33293921|NCT00132678|100975245|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
33293922|NCT00132678|100975246|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
33293923|NCT00132678|100975247|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
33293924|NCT00132678|100975245|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
33293925|NCT00132678|100975246|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
33293926|NCT00132678|100975247|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
33293927|NCT00132678|100975245|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
33600028|NCT04493684|102088511|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33600029|NCT04493684|102088512|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33293928|NCT00132678|100975246|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
33293929|NCT00132678|100975247|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
33293930|NCT00132678|100975245|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
33293931|NCT00132678|100975246|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
33600030|NCT04493684|102088513|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33600031|NCT04493684|102088514|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
33600032|NCT04493684|102088498|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33600033|NCT04493684|102088499|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33600034|NCT04493684|102088500|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33600035|NCT04493684|102088501|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33600036|NCT04493684|102088502|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33600037|NCT04493684|102088503|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33293932|NCT00132678|100975247|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
33293933|NCT00132678|100975245|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
33293934|NCT00132678|100975246|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
33293935|NCT00132678|100975247|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
33293936|NCT00132678|100975245|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
33293937|NCT00132678|100975246|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
33293938|NCT00132678|100975247|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
33293939|NCT00132678|100975245|FG000|Period III (Open-Label Stabilization)|Death|2|||
33293940|NCT00132678|100975246|FG001|Period III (Open-Label Stabilization)|Death|0|||
33293941|NCT00132678|100975247|FG002|Period III (Open-Label Stabilization)|Death|0|||
33293942|NCT00132678|100975245|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
33293943|NCT00132678|100975246|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
33293944|NCT00132678|100975247|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
33293945|NCT00132678|100975245|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
33293946|NCT00132678|100975246|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
33293947|NCT00132678|100975247|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
33293948|NCT00132678|100975245|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
33293949|NCT00132678|100975246|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
33293950|NCT00132678|100975247|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
33293951|NCT00132678|100975245|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
33293952|NCT00132678|100975246|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
33293953|NCT00132678|100975247|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
33293954|NCT00132678|100975245|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
33293955|NCT00132678|100975246|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
33293956|NCT00132678|100975247|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
33293957|NCT00132678|100975245|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
33293958|NCT00132678|100975246|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
33293959|NCT00132678|100975247|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
33293960|NCT00132678|100975245|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
33293961|NCT00132678|100975246|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
33293962|NCT00132678|100975247|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
33293963|NCT00132678|100975245|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
33293964|NCT00132678|100975246|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
33293965|NCT00132678|100975247|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
33293966|NCT00132678|100975245|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
33293967|NCT00132678|100975246|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
33293968|NCT00132678|100975247|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
33293969|NCT00132678|100975245|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
33293970|NCT00132678|100975246|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
33293971|NCT00132678|100975247|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
33293972|NCT00132678|100975245|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
33293973|NCT00132678|100975246|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
33293974|NCT00132678|100975247|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
33293975|NCT00132678|100975245|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
33293976|NCT00132678|100975246|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
33293977|NCT00132678|100975247|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
33293978|NCT00132678|100975245|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
33293979|NCT00132678|100975246|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
33293980|NCT00132678|100975247|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
33293981|NCT00132678|100975245|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
33293982|NCT00132678|100975246|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
33293983|NCT00132678|100975247|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
33293984|NCT00132678|100975245|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
33293985|NCT00132678|100975246|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
33600038|NCT04493684|102088504|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
33600039|NCT04493684|102088505|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33600040|NCT04493684|102088506|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33600041|NCT04493684|102088507|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33293986|NCT00132678|100975247|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
33293987|NCT01067846|100975249|FG000|Overall Study|Lost to Follow-up|17|||
33293988|NCT01067846|100975250|FG001|Overall Study|Lost to Follow-up|19|||
33600042|NCT04493684|102088508|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33600043|NCT04493684|102088509|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33600044|NCT04493684|102088510|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33600045|NCT04493684|102088511|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33600046|NCT04493684|102088512|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33600047|NCT04493684|102088513|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33600048|NCT04493684|102088514|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
33293989|NCT01067846|100975249|FG000|Overall Study|Withdrawal by Subject|1|||
33293990|NCT01067846|100975250|FG001|Overall Study|Withdrawal by Subject|0|||
33293991|NCT01067846|100975249|FG000|Overall Study|participation in other tx study|1|||
33293992|NCT01067846|100975250|FG001|Overall Study|participation in other tx study|0|||
33600049|NCT04493684|102088498|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
33600050|NCT04493684|102088499|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600051|NCT04493684|102088500|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600052|NCT04493684|102088501|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600053|NCT04493684|102088502|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600054|NCT04493684|102088503|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600055|NCT04493684|102088504|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600056|NCT04493684|102088505|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600057|NCT04493684|102088506|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33293993|NCT00847626|100975256|FG000|Overall Study|Adverse Event|10|||
33600058|NCT04493684|102088507|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600059|NCT04493684|102088508|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600060|NCT04493684|102088509|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600061|NCT04493684|102088510|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600062|NCT04493684|102088511|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600063|NCT04493684|102088512|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600064|NCT04493684|102088513|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600065|NCT04493684|102088514|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
33600066|NCT04493684|102088498|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600067|NCT04493684|102088499|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600068|NCT04493684|102088500|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600069|NCT04493684|102088501|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600070|NCT04493684|102088502|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600071|NCT04493684|102088503|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
33600072|NCT04493684|102088504|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600073|NCT04493684|102088505|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600074|NCT04493684|102088506|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600075|NCT04493684|102088507|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600076|NCT04493684|102088508|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600077|NCT04493684|102088509|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600078|NCT04493684|102088510|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600079|NCT04493684|102088511|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600080|NCT04493684|102088512|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600081|NCT04493684|102088513|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33293994|NCT00847626|100975257|FG001|Overall Study|Adverse Event|10|||
33188212|NCT01652716|100597992|FG000|Overall Study|Investigator decision|1|||
33188213|NCT01652716|100597993|FG001|Overall Study|Investigator decision|4|||
33188214|NCT01652716|100597992|FG000|Overall Study|Lost to Follow-up|12|||
33188215|NCT01652716|100597993|FG001|Overall Study|Lost to Follow-up|11|||
33188216|NCT01652716|100597992|FG000|Overall Study|Protocol Violation|2|||
33188217|NCT01652716|100597993|FG001|Overall Study|Protocol Violation|1|||
33188218|NCT01652716|100597992|FG000|Overall Study|Adverse Event|7|||
33188219|NCT01652716|100597993|FG001|Overall Study|Adverse Event|10|||
33188220|NCT01652716|100597992|FG000|Overall Study|Withdrawal by Subject|33|||
33188221|NCT01652716|100597993|FG001|Overall Study|Withdrawal by Subject|18|||
33188222|NCT02884089|100597994|FG000|Period 1|Dosing error|2|||
33188223|NCT02884089|100597995|FG001|Period 1|Dosing error|2|||
33188224|NCT02884089|100597996|FG002|Period 1|Dosing error|0|||
33188225|NCT02884089|100597997|FG003|Period 1|Dosing error|0|||
33188226|NCT02884089|100597994|FG000|Washout Period 1|Lost to Follow-up|0|||
33293995|NCT00847626|100975258|FG002|Overall Study|Adverse Event|6|||
33293996|NCT00847626|100975259|FG003|Overall Study|Adverse Event|19|||
33293997|NCT00847626|100975260|FG004|Overall Study|Adverse Event|11|||
33293998|NCT00847626|100975261|FG005|Overall Study|Adverse Event|22|||
33293999|NCT00847626|100975262|FG006|Overall Study|Adverse Event|4|||
33294000|NCT00847626|100975263|FG007|Overall Study|Adverse Event|6|||
33294001|NCT00847626|100975264|FG008|Overall Study|Adverse Event|3|||
33294002|NCT00847626|100975265|FG009|Overall Study|Adverse Event|6|||
33294003|NCT00847626|100975266|FG010|Overall Study|Adverse Event|6|||
33391749|NCT03807778|101321865|FG003|Overall Study|Adverse Event|5|||
33294004|NCT00847626|100975256|FG000|Overall Study|Protocol Violation|2|||
33391750|NCT03807778|101321862|FG000|Overall Study|Progressive Disease|4|||
33391751|NCT03807778|101321863|FG001|Overall Study|Progressive Disease|2|||
33294005|NCT00847626|100975257|FG001|Overall Study|Protocol Violation|1|||
33391752|NCT03807778|101321864|FG002|Overall Study|Progressive Disease|8|||
33294006|NCT00847626|100975258|FG002|Overall Study|Protocol Violation|2|||
33294007|NCT00847626|100975259|FG003|Overall Study|Protocol Violation|1|||
33294008|NCT00847626|100975260|FG004|Overall Study|Protocol Violation|1|||
33294009|NCT00847626|100975261|FG005|Overall Study|Protocol Violation|1|||
33294010|NCT00847626|100975262|FG006|Overall Study|Protocol Violation|1|||
33294011|NCT00847626|100975263|FG007|Overall Study|Protocol Violation|1|||
33294012|NCT00847626|100975264|FG008|Overall Study|Protocol Violation|0|||
33294013|NCT00847626|100975265|FG009|Overall Study|Protocol Violation|1|||
33294014|NCT00847626|100975266|FG010|Overall Study|Protocol Violation|1|||
33294015|NCT00847626|100975256|FG000|Overall Study|Lost to Follow-up|0|||
33294016|NCT00847626|100975257|FG001|Overall Study|Lost to Follow-up|1|||
33294017|NCT00847626|100975258|FG002|Overall Study|Lost to Follow-up|1|||
33294018|NCT00847626|100975259|FG003|Overall Study|Lost to Follow-up|1|||
33294019|NCT00847626|100975260|FG004|Overall Study|Lost to Follow-up|0|||
33294020|NCT00847626|100975261|FG005|Overall Study|Lost to Follow-up|3|||
33294021|NCT00847626|100975262|FG006|Overall Study|Lost to Follow-up|1|||
33294022|NCT00847626|100975263|FG007|Overall Study|Lost to Follow-up|3|||
33294023|NCT00847626|100975264|FG008|Overall Study|Lost to Follow-up|1|||
33294024|NCT00847626|100975265|FG009|Overall Study|Lost to Follow-up|0|||
33294025|NCT00847626|100975266|FG010|Overall Study|Lost to Follow-up|1|||
33294026|NCT00847626|100975256|FG000|Overall Study|Withdrawal by Subject|5|||
33294027|NCT00847626|100975257|FG001|Overall Study|Withdrawal by Subject|5|||
33294028|NCT00847626|100975258|FG002|Overall Study|Withdrawal by Subject|3|||
33294029|NCT00847626|100975259|FG003|Overall Study|Withdrawal by Subject|8|||
33294030|NCT00847626|100975260|FG004|Overall Study|Withdrawal by Subject|12|||
33294031|NCT00847626|100975261|FG005|Overall Study|Withdrawal by Subject|9|||
33294032|NCT00847626|100975262|FG006|Overall Study|Withdrawal by Subject|8|||
33294033|NCT00847626|100975263|FG007|Overall Study|Withdrawal by Subject|4|||
33294034|NCT00847626|100975264|FG008|Overall Study|Withdrawal by Subject|4|||
33294035|NCT00847626|100975265|FG009|Overall Study|Withdrawal by Subject|5|||
33294036|NCT00847626|100975266|FG010|Overall Study|Withdrawal by Subject|2|||
33294037|NCT00847626|100975256|FG000|Overall Study|Lack of Efficacy|3|||
33294038|NCT00847626|100975257|FG001|Overall Study|Lack of Efficacy|1|||
33294039|NCT00847626|100975258|FG002|Overall Study|Lack of Efficacy|0|||
33294040|NCT00847626|100975259|FG003|Overall Study|Lack of Efficacy|1|||
33294041|NCT00847626|100975260|FG004|Overall Study|Lack of Efficacy|2|||
33294042|NCT00847626|100975261|FG005|Overall Study|Lack of Efficacy|0|||
33294043|NCT00847626|100975262|FG006|Overall Study|Lack of Efficacy|6|||
33294044|NCT00847626|100975263|FG007|Overall Study|Lack of Efficacy|2|||
33294045|NCT00847626|100975264|FG008|Overall Study|Lack of Efficacy|5|||
33294046|NCT00847626|100975265|FG009|Overall Study|Lack of Efficacy|1|||
33294047|NCT00847626|100975266|FG010|Overall Study|Lack of Efficacy|7|||
33294048|NCT00847626|100975256|FG000|Overall Study|Other|1|||
33294049|NCT00847626|100975257|FG001|Overall Study|Other|5|||
33294050|NCT00847626|100975258|FG002|Overall Study|Other|4|||
33294051|NCT00847626|100975259|FG003|Overall Study|Other|1|||
33294052|NCT00847626|100975260|FG004|Overall Study|Other|2|||
33294053|NCT00847626|100975261|FG005|Overall Study|Other|2|||
33294054|NCT00847626|100975262|FG006|Overall Study|Other|2|||
33294055|NCT00847626|100975263|FG007|Overall Study|Other|3|||
33294056|NCT00847626|100975264|FG008|Overall Study|Other|1|||
33294057|NCT00847626|100975265|FG009|Overall Study|Other|1|||
33294058|NCT00847626|100975266|FG010|Overall Study|Other|3|||
33294059|NCT02563548|100975267|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
33294060|NCT02563548|100975268|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
33294061|NCT02563548|100975269|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
33294062|NCT02563548|100975270|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
33294063|NCT02563548|100975271|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
33294064|NCT02563548|100975272|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
33294065|NCT02563548|100975267|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
33294066|NCT02563548|100975268|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
33294067|NCT02563548|100975269|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
33294068|NCT02563548|100975270|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
33294069|NCT02563548|100975271|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
33294070|NCT02563548|100975272|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
33294071|NCT02563548|100975267|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
33294072|NCT02563548|100975268|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
33294073|NCT02563548|100975269|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
33294074|NCT02563548|100975270|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
33294075|NCT02563548|100975271|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
33294076|NCT02563548|100975272|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
33294077|NCT02563548|100975267|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
33294078|NCT02563548|100975268|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
33294079|NCT02563548|100975269|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
33294080|NCT02563548|100975270|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
33294081|NCT02563548|100975271|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
33294082|NCT02563548|100975272|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
33294083|NCT02563548|100975267|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
33294084|NCT02563548|100975268|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
33294085|NCT02563548|100975269|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
33294086|NCT02563548|100975270|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
33294087|NCT02563548|100975271|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
33294088|NCT02563548|100975272|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
33294089|NCT02563548|100975267|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
33294090|NCT02563548|100975268|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
33294091|NCT02563548|100975269|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
33294092|NCT02563548|100975270|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
33294093|NCT02563548|100975271|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
33391753|NCT03807778|101321865|FG003|Overall Study|Progressive Disease|15|||
33391754|NCT03807778|101321862|FG000|Overall Study|Symptomatic Deterioration|0|||
33391755|NCT03807778|101321863|FG001|Overall Study|Symptomatic Deterioration|1|||
33391756|NCT03807778|101321864|FG002|Overall Study|Symptomatic Deterioration|0|||
33391757|NCT03807778|101321865|FG003|Overall Study|Symptomatic Deterioration|1|||
33391758|NCT03807778|101321862|FG000|Overall Study|Withdrawal by Subject|0|||
33391759|NCT03807778|101321863|FG001|Overall Study|Withdrawal by Subject|1|||
33391760|NCT03807778|101321864|FG002|Overall Study|Withdrawal by Subject|0|||
33391761|NCT03807778|101321865|FG003|Overall Study|Withdrawal by Subject|1|||
33391762|NCT03807778|101321862|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
33391763|NCT03807778|101321863|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
33294094|NCT02563548|100975272|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
33294095|NCT02563548|100975267|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
33294096|NCT02563548|100975268|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
33294097|NCT02563548|100975269|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
33294098|NCT02563548|100975270|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
33294099|NCT02563548|100975271|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
33294100|NCT02563548|100975272|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
33294101|NCT02563548|100975267|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
33294102|NCT02563548|100975268|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
33294103|NCT02563548|100975269|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
33294104|NCT02563548|100975270|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
33294105|NCT02563548|100975271|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
33294106|NCT02563548|100975272|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
33294107|NCT02563548|100975267|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
33294108|NCT02563548|100975268|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
33294109|NCT02563548|100975269|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
33294110|NCT02563548|100975270|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
33294111|NCT02563548|100975271|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
33294112|NCT02563548|100975272|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
33294113|NCT02563548|100975267|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
33188227|NCT02884089|100597995|FG001|Washout Period 1|Lost to Follow-up|1|||
33294114|NCT02563548|100975268|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
33294115|NCT02563548|100975269|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
33294116|NCT02563548|100975270|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
33294117|NCT02563548|100975271|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
33294118|NCT02563548|100975272|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
33294119|NCT02563548|100975267|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
33294120|NCT02563548|100975268|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
33294121|NCT02563548|100975269|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
33294122|NCT02563548|100975270|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
33294123|NCT02563548|100975271|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
33294124|NCT02563548|100975272|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
33294125|NCT02563548|100975267|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
33294126|NCT02563548|100975268|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
33294127|NCT02563548|100975269|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
33294128|NCT02563548|100975270|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
33294129|NCT02563548|100975271|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
33294130|NCT02563548|100975272|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
33294131|NCT01867047|100975273|FG000|Overall Study|Lost to Follow-up|3|||
33294132|NCT01867047|100975274|FG001|Overall Study|Lost to Follow-up|3|||
33294133|NCT01867047|100975273|FG000|Overall Study|Withdrawal by Subject|2|||
33294134|NCT01867047|100975274|FG001|Overall Study|Withdrawal by Subject|0|||
33294135|NCT01867047|100975273|FG000|Overall Study|Physician Decision|2|||
33294136|NCT01867047|100975274|FG001|Overall Study|Physician Decision|0|||
33294137|NCT01867047|100975273|FG000|Overall Study|surgery not indicated in protocol|1|||
33294138|NCT01867047|100975274|FG001|Overall Study|surgery not indicated in protocol|2|||
33294139|NCT03325777|100975275|FG000|Overall Study|Lost to Follow-up|9|||
33294140|NCT03325777|100975276|FG001|Overall Study|Lost to Follow-up|12|||
33294141|NCT02344342|100975277|FG000|Overall Study|Industry partner dropped out|11|||
33294142|NCT02344342|100975278|FG001|Overall Study|Industry partner dropped out|9|||
33294143|NCT02344342|100975279|FG002|Overall Study|Industry partner dropped out|14|||
33294144|NCT02344342|100975280|FG003|Overall Study|Industry partner dropped out|10|||
33294145|NCT02493946|100975285|FG000|DB Period|Withdrawal by Subject|8|||
33294146|NCT02493946|100975286|FG001|DB Period|Withdrawal by Subject|5|||
33294147|NCT02493946|100975287|FG002|DB Period|Withdrawal by Subject|0|||
33294148|NCT02493946|100975285|FG000|Open Label Period|Withdrawal by Subject|0|||
33294149|NCT02493946|100975286|FG001|Open Label Period|Withdrawal by Subject|0|||
33391764|NCT03807778|101321864|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
33294150|NCT02493946|100975287|FG002|Open Label Period|Withdrawal by Subject|74|||
33294151|NCT02493946|100975285|FG000|Open Label Period|Adverse Event|0|||
33294152|NCT02493946|100975286|FG001|Open Label Period|Adverse Event|0|||
33294153|NCT02493946|100975287|FG002|Open Label Period|Adverse Event|4|||
33294154|NCT02493946|100975285|FG000|Open Label Period|Lost to Follow-up|0|||
33294155|NCT02493946|100975286|FG001|Open Label Period|Lost to Follow-up|0|||
33294156|NCT02493946|100975287|FG002|Open Label Period|Lost to Follow-up|1|||
33294157|NCT02493946|100975285|FG000|Open Label Period|Investigator decision, non-compliance|0|||
33294158|NCT02493946|100975286|FG001|Open Label Period|Investigator decision, non-compliance|0|||
33294159|NCT02493946|100975287|FG002|Open Label Period|Investigator decision, non-compliance|2|||
33294160|NCT02493946|100975285|FG000|Open Label Period|Investigator decision, non-availability|0|||
33294161|NCT02493946|100975286|FG001|Open Label Period|Investigator decision, non-availability|0|||
33294162|NCT02493946|100975287|FG002|Open Label Period|Investigator decision, non-availability|1|||
33294163|NCT02493946|100975285|FG000|Open Label Period|Pregnancy|0|||
33294164|NCT02493946|100975286|FG001|Open Label Period|Pregnancy|0|||
33294165|NCT02493946|100975287|FG002|Open Label Period|Pregnancy|3|||
33294166|NCT02493946|100975285|FG000|Open Label Period|Site error|0|||
33294167|NCT02493946|100975286|FG001|Open Label Period|Site error|0|||
33294168|NCT02493946|100975287|FG002|Open Label Period|Site error|1|||
33294169|NCT00572533|100975290|FG000|Overall Study|Death|4|||
33294170|NCT00572533|100975291|FG001|Overall Study|Death|1|||
33294171|NCT00572533|100975290|FG000|Overall Study|Received Kidney Transplant|2|||
33294172|NCT00572533|100975291|FG001|Overall Study|Received Kidney Transplant|1|||
33294173|NCT00572533|100975290|FG000|Overall Study|Social Issues|1|||
33294174|NCT00572533|100975291|FG001|Overall Study|Social Issues|0|||
33294175|NCT00572533|100975290|FG000|Overall Study|Transfer out of Facility|0|||
33294176|NCT00572533|100975291|FG001|Overall Study|Transfer out of Facility|1|||
33294177|NCT01327612|100975292|FG000|Overall Study|Withdrawal by Subject|0|||
33294178|NCT01327612|100975293|FG001|Overall Study|Withdrawal by Subject|0|||
33294179|NCT01327612|100975294|FG002|Overall Study|Withdrawal by Subject|0|||
33294180|NCT01327612|100975295|FG003|Overall Study|Withdrawal by Subject|0|||
33294181|NCT01327612|100975296|FG004|Overall Study|Withdrawal by Subject|0|||
33294182|NCT01327612|100975297|FG005|Overall Study|Withdrawal by Subject|1|||
33294183|NCT01327612|100975298|FG006|Overall Study|Withdrawal by Subject|0|||
33294184|NCT01327612|100975292|FG000|Overall Study|Disease Progression|1|||
33294185|NCT01327612|100975293|FG001|Overall Study|Disease Progression|1|||
33391765|NCT03807778|101321865|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
33391766|NCT02327078|101321866|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
33391767|NCT02327078|101321867|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
33294186|NCT01327612|100975294|FG002|Overall Study|Disease Progression|1|||
33294187|NCT01327612|100975295|FG003|Overall Study|Disease Progression|0|||
33294188|NCT01327612|100975296|FG004|Overall Study|Disease Progression|1|||
33294189|NCT01327612|100975297|FG005|Overall Study|Disease Progression|2|||
33294190|NCT01327612|100975298|FG006|Overall Study|Disease Progression|2|||
33294191|NCT01327612|100975292|FG000|Overall Study|Administrative Decision|0|||
33294192|NCT01327612|100975293|FG001|Overall Study|Administrative Decision|0|||
33294193|NCT01327612|100975294|FG002|Overall Study|Administrative Decision|0|||
33294194|NCT01327612|100975295|FG003|Overall Study|Administrative Decision|1|||
33294195|NCT01327612|100975296|FG004|Overall Study|Administrative Decision|0|||
33294196|NCT01327612|100975297|FG005|Overall Study|Administrative Decision|0|||
33294197|NCT01327612|100975298|FG006|Overall Study|Administrative Decision|0|||
33294198|NCT01327612|100975292|FG000|Overall Study|Death|0|||
33294199|NCT01327612|100975293|FG001|Overall Study|Death|0|||
33294200|NCT01327612|100975294|FG002|Overall Study|Death|0|||
33294201|NCT01327612|100975295|FG003|Overall Study|Death|0|||
33294202|NCT01327612|100975296|FG004|Overall Study|Death|1|||
33294203|NCT01327612|100975297|FG005|Overall Study|Death|0|||
33294204|NCT01327612|100975298|FG006|Overall Study|Death|0|||
33294205|NCT01199068|100975299|FG000|Overall Study|Unacceptable toxicity|0|||
33294206|NCT01199068|100975300|FG001|Overall Study|Unacceptable toxicity|0|||
33294207|NCT01199068|100975301|FG002|Overall Study|Unacceptable toxicity|2|||
33294208|NCT01199068|100975299|FG000|Overall Study|Progressive disease|3|||
33294209|NCT01199068|100975300|FG001|Overall Study|Progressive disease|3|||
33294210|NCT01199068|100975301|FG002|Overall Study|Progressive disease|6|||
33294211|NCT01199068|100975299|FG000|Overall Study|Withdrawal by Subject|0|||
33294212|NCT01199068|100975300|FG001|Overall Study|Withdrawal by Subject|0|||
33294213|NCT01199068|100975301|FG002|Overall Study|Withdrawal by Subject|1|||
33294214|NCT00978562|100975304|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
33294215|NCT02522728|100975305|FG000|Overall Study|Withdrawal by Subject|6|||
33294216|NCT02522728|100975306|FG001|Overall Study|Withdrawal by Subject|6|||
33294217|NCT02522728|100975305|FG000|Overall Study|Death|4|||
33294218|NCT02522728|100975306|FG001|Overall Study|Death|3|||
33294219|NCT02522728|100975305|FG000|Overall Study|Adverse Event|2|||
33294220|NCT02522728|100975306|FG001|Overall Study|Adverse Event|1|||
33294221|NCT02522728|100975305|FG000|Overall Study|Did not receive randomized study device|0|||
33294222|NCT02522728|100975306|FG001|Overall Study|Did not receive randomized study device|1|||
33294223|NCT00725712|100975307|FG000|Overall Study|Withdrawal by Subject|2|||
33294224|NCT00725712|100975308|FG001|Overall Study|Withdrawal by Subject|1|||
33294225|NCT00725712|100975307|FG000|Overall Study|Protocol Violation|1|||
33294226|NCT00725712|100975308|FG001|Overall Study|Protocol Violation|0|||
33294227|NCT00725712|100975307|FG000|Overall Study|Progressive disease|37|||
33294228|NCT00725712|100975308|FG001|Overall Study|Progressive disease|16|||
33294229|NCT00725712|100975307|FG000|Overall Study|Clinical progression not based on RECIST|0|||
33294230|NCT00725712|100975308|FG001|Overall Study|Clinical progression not based on RECIST|3|||
33294231|NCT00725712|100975307|FG000|Overall Study|Adverse Event|5|||
33294232|NCT00725712|100975308|FG001|Overall Study|Adverse Event|5|||
33294233|NCT00725712|100975307|FG000|Overall Study|Death|2|||
33294234|NCT00725712|100975308|FG001|Overall Study|Death|0|||
33294235|NCT00725712|100975307|FG000|Overall Study|Other: Death|1|||
33294236|NCT00725712|100975308|FG001|Overall Study|Other: Death|0|||
33294237|NCT00725712|100975307|FG000|Overall Study|Hospitalized, unable to continue|0|||
33294238|NCT00725712|100975308|FG001|Overall Study|Hospitalized, unable to continue|1|||
33294239|NCT03721705|100975309|FG000|Overall Study|Adverse Event|2|||
33294240|NCT03721705|100975310|FG001|Overall Study|Adverse Event|0|||
33294241|NCT03721705|100975309|FG000|Overall Study|Withdrawal by Subject|4|||
33294242|NCT03721705|100975310|FG001|Overall Study|Withdrawal by Subject|10|||
33294243|NCT03721705|100975309|FG000|Overall Study|No Suitable Study Partner|1|||
33294244|NCT03721705|100975310|FG001|Overall Study|No Suitable Study Partner|0|||
33294245|NCT03721705|100975309|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
33294246|NCT03721705|100975310|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
33294247|NCT03721705|100975309|FG000|Overall Study|Death|0|||
33294248|NCT03721705|100975310|FG001|Overall Study|Death|1|||
33294249|NCT01572740|100975311|FG000|Overall Study|Adverse Event|1|||
33294250|NCT01572740|100975312|FG001|Overall Study|Adverse Event|1|||
33294251|NCT01572740|100975311|FG000|Overall Study|Withdrawal by Subject|1|||
33294252|NCT01572740|100975312|FG001|Overall Study|Withdrawal by Subject|1|||
33294253|NCT01572740|100975311|FG000|Overall Study|unclassified|4|||
33294254|NCT01572740|100975312|FG001|Overall Study|unclassified|3|||
33294255|NCT00267098|100975313|FG000|Overall Study|Death|0|||
33294256|NCT00267098|100975314|FG001|Overall Study|Death|0|||
33294257|NCT00267098|100975315|FG002|Overall Study|Death|57|||
33294258|NCT00267098|100975316|FG003|Overall Study|Death|66|||
33294259|NCT00267098|100975317|FG004|Overall Study|Death|14|||
33294260|NCT00267098|100975318|FG005|Overall Study|Death|23|||
33294261|NCT00267098|100975319|FG006|Overall Study|Death|28|||
33294262|NCT00267098|100975320|FG007|Overall Study|Death|9|||
33294263|NCT00267098|100975313|FG000|Overall Study|Lost to Follow-up|0|||
33294264|NCT00267098|100975314|FG001|Overall Study|Lost to Follow-up|0|||
33294265|NCT00267098|100975315|FG002|Overall Study|Lost to Follow-up|6|||
33294266|NCT00267098|100975316|FG003|Overall Study|Lost to Follow-up|5|||
33294267|NCT00267098|100975317|FG004|Overall Study|Lost to Follow-up|2|||
33294268|NCT00267098|100975318|FG005|Overall Study|Lost to Follow-up|3|||
33294269|NCT00267098|100975319|FG006|Overall Study|Lost to Follow-up|1|||
33294270|NCT00267098|100975320|FG007|Overall Study|Lost to Follow-up|1|||
33294271|NCT00267098|100975313|FG000|Overall Study|Withdrawal by Subject|8|||
33294272|NCT00267098|100975314|FG001|Overall Study|Withdrawal by Subject|0|||
33294273|NCT00267098|100975315|FG002|Overall Study|Withdrawal by Subject|24|||
33294274|NCT00267098|100975316|FG003|Overall Study|Withdrawal by Subject|21|||
33294275|NCT00267098|100975317|FG004|Overall Study|Withdrawal by Subject|12|||
33294276|NCT00267098|100975318|FG005|Overall Study|Withdrawal by Subject|9|||
33294277|NCT00267098|100975319|FG006|Overall Study|Withdrawal by Subject|12|||
33294278|NCT00267098|100975320|FG007|Overall Study|Withdrawal by Subject|5|||
33294279|NCT00267098|100975313|FG000|Overall Study|Physician Decision|5|||
33294280|NCT00267098|100975314|FG001|Overall Study|Physician Decision|0|||
33294281|NCT00267098|100975315|FG002|Overall Study|Physician Decision|7|||
33294282|NCT00267098|100975316|FG003|Overall Study|Physician Decision|11|||
33294283|NCT00267098|100975317|FG004|Overall Study|Physician Decision|5|||
33294284|NCT00267098|100975318|FG005|Overall Study|Physician Decision|4|||
33294285|NCT00267098|100975319|FG006|Overall Study|Physician Decision|3|||
33294286|NCT00267098|100975320|FG007|Overall Study|Physician Decision|0|||
33294287|NCT00267098|100975313|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
33294288|NCT00267098|100975314|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33294289|NCT00267098|100975315|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33294290|NCT00267098|100975316|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33294291|NCT00267098|100975317|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
33294292|NCT00267098|100975318|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33294293|NCT00267098|100975319|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33294294|NCT00267098|100975320|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33294295|NCT00267098|100975313|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
33294296|NCT00267098|100975314|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
33294297|NCT00267098|100975315|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
33294298|NCT00267098|100975316|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
33294299|NCT00267098|100975317|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
33294300|NCT00267098|100975318|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
33294301|NCT00267098|100975319|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
33294302|NCT00267098|100975320|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
33294303|NCT00267098|100975313|FG000|Overall Study|Site closure|0|||
33294304|NCT00267098|100975314|FG001|Overall Study|Site closure|0|||
33294305|NCT00267098|100975315|FG002|Overall Study|Site closure|0|||
33294306|NCT00267098|100975316|FG003|Overall Study|Site closure|1|||
33294307|NCT00267098|100975317|FG004|Overall Study|Site closure|0|||
33294308|NCT00267098|100975318|FG005|Overall Study|Site closure|1|||
33294309|NCT00267098|100975319|FG006|Overall Study|Site closure|1|||
33294310|NCT00267098|100975320|FG007|Overall Study|Site closure|0|||
33294311|NCT00267098|100975313|FG000|Overall Study|Explanted Medtronic device|0|||
33294312|NCT00267098|100975314|FG001|Overall Study|Explanted Medtronic device|0|||
33294313|NCT00267098|100975315|FG002|Overall Study|Explanted Medtronic device|0|||
33294314|NCT00267098|100975316|FG003|Overall Study|Explanted Medtronic device|1|||
33294315|NCT00267098|100975317|FG004|Overall Study|Explanted Medtronic device|0|||
33294316|NCT00267098|100975318|FG005|Overall Study|Explanted Medtronic device|0|||
33294317|NCT00267098|100975319|FG006|Overall Study|Explanted Medtronic device|0|||
33417153|NCT04449354|101420217|FG000|Overall Study|Withdrawal by Subject|1|||
33294318|NCT00267098|100975320|FG007|Overall Study|Explanted Medtronic device|0|||
33294319|NCT00267098|100975313|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
33294320|NCT00267098|100975314|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
33294321|NCT00267098|100975315|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
33294322|NCT00267098|100975316|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
33294323|NCT00267098|100975317|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
33294324|NCT00267098|100975318|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
33294325|NCT00267098|100975319|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
33294326|NCT00267098|100975320|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
33294327|NCT00267098|100975313|FG000|Overall Study|Subject listed for heart transplant|0|||
33294328|NCT00267098|100975314|FG001|Overall Study|Subject listed for heart transplant|0|||
33294329|NCT00267098|100975315|FG002|Overall Study|Subject listed for heart transplant|0|||
33294330|NCT00267098|100975316|FG003|Overall Study|Subject listed for heart transplant|0|||
33294331|NCT00267098|100975317|FG004|Overall Study|Subject listed for heart transplant|0|||
33294332|NCT00267098|100975318|FG005|Overall Study|Subject listed for heart transplant|0|||
33294333|NCT00267098|100975319|FG006|Overall Study|Subject listed for heart transplant|1|||
33294334|NCT00267098|100975320|FG007|Overall Study|Subject listed for heart transplant|0|||
33294335|NCT00267098|100975313|FG000|Overall Study|Sponsor withdrew subject|0|||
33294336|NCT00267098|100975314|FG001|Overall Study|Sponsor withdrew subject|0|||
33294337|NCT00267098|100975315|FG002|Overall Study|Sponsor withdrew subject|0|||
33294338|NCT00267098|100975316|FG003|Overall Study|Sponsor withdrew subject|1|||
33294339|NCT00267098|100975317|FG004|Overall Study|Sponsor withdrew subject|0|||
33417154|NCT01861717|101420218|FG000|Overall Study|Lost to Follow-up|1|||
33294340|NCT00267098|100975318|FG005|Overall Study|Sponsor withdrew subject|0|||
33294341|NCT00267098|100975319|FG006|Overall Study|Sponsor withdrew subject|0|||
33294342|NCT00267098|100975320|FG007|Overall Study|Sponsor withdrew subject|0|||
33294343|NCT00203268|100975322|FG000|Early Treatment|only treated one headache|2|||
33294344|NCT00203268|100975322|FG000|Early Treatment|Lost to Follow-up|1|||
33294345|NCT00203268|100975322|FG000|Early Treatment|Withdrawal by Subject|1|||
33294346|NCT01513330|100975324|FG000|SenSura Mio First,|Adverse Event|2|||
33294347|NCT01513330|100975325|FG001|SenSura Mio First,|Adverse Event|0|||
33294348|NCT01513330|100975324|FG000|SenSura Mio First,|Lack of Efficacy|0|||
33294349|NCT01513330|100975325|FG001|SenSura Mio First,|Lack of Efficacy|1|||
33294350|NCT01513330|100975324|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
33294351|NCT01513330|100975325|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
33294352|NCT01513330|100975324|FG000|SenSura Mio First,|Other|1|||
33294353|NCT01513330|100975325|FG001|SenSura Mio First,|Other|0|||
33294354|NCT01513330|100975324|FG000|Standard Care First,|Lack of Efficacy|2|||
33294355|NCT01513330|100975325|FG001|Standard Care First,|Lack of Efficacy|2|||
33294356|NCT01513330|100975324|FG000|Standard Care First,|Withdrawal by Subject|1|||
33294357|NCT01513330|100975325|FG001|Standard Care First,|Withdrawal by Subject|2|||
33294358|NCT01513330|100975324|FG000|Standard Care First,|Other|1|||
33294359|NCT01513330|100975325|FG001|Standard Care First,|Other|0|||
33294360|NCT01304498|100975326|FG000|Overall Study|Adverse Event|1|||
33294361|NCT01304498|100975327|FG001|Overall Study|Adverse Event|1|||
33294362|NCT01304498|100975326|FG000|Overall Study|Withdrawal by Subject|2|||
33294363|NCT01304498|100975327|FG001|Overall Study|Withdrawal by Subject|3|||
33294364|NCT01304498|100975326|FG000|Overall Study|Protocol Violation|1|||
33294365|NCT01304498|100975327|FG001|Overall Study|Protocol Violation|0|||
33294366|NCT01304498|100975326|FG000|Overall Study|Lost to Follow-up|2|||
33294367|NCT01304498|100975327|FG001|Overall Study|Lost to Follow-up|1|||
33294368|NCT03768336|100975328|FG000|Overall Study|Lost to Follow-up|3|||
33294369|NCT03768336|100975329|FG001|Overall Study|Lost to Follow-up|2|||
33294370|NCT03768336|100975328|FG000|Overall Study|Became Ineligible|2|||
33294371|NCT03768336|100975329|FG001|Overall Study|Became Ineligible|0|||
33294372|NCT03768336|100975328|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
33294373|NCT03768336|100975329|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
33294374|NCT03768336|100975328|FG000|Overall Study|Missed final survey (post-treatment|0|||
33294375|NCT03768336|100975329|FG001|Overall Study|Missed final survey (post-treatment|1|||
33294376|NCT00277095|100975330|FG000|Overall Study|Death|2|||
33294377|NCT00277095|100975330|FG000|Overall Study|Explanted|7|||
33294378|NCT00277095|100975330|FG000|Overall Study|Lost to Follow-up|2|||
33294379|NCT00277095|100975330|FG000|Overall Study|Missed Follow-up|9|||
33294380|NCT00277095|100975330|FG000|Overall Study|Physician Decision|1|||
33294381|NCT02638103|100975331|FG000|Overall Study|Adverse Event|13|||
33294382|NCT02638103|100975332|FG001|Overall Study|Adverse Event|12|||
33294383|NCT02638103|100975333|FG002|Overall Study|Adverse Event|19|||
33294384|NCT02638103|100975334|FG003|Overall Study|Adverse Event|12|||
33294385|NCT02638103|100975331|FG000|Overall Study|Withdrawal by Subject|43|||
33294386|NCT02638103|100975332|FG001|Overall Study|Withdrawal by Subject|53|||
33294387|NCT02638103|100975333|FG002|Overall Study|Withdrawal by Subject|30|||
33294388|NCT02638103|100975334|FG003|Overall Study|Withdrawal by Subject|61|||
33294389|NCT02638103|100975331|FG000|Overall Study|Protocol Violation|1|||
33294390|NCT02638103|100975332|FG001|Overall Study|Protocol Violation|2|||
33294391|NCT02638103|100975333|FG002|Overall Study|Protocol Violation|1|||
33294392|NCT02638103|100975334|FG003|Overall Study|Protocol Violation|4|||
33294393|NCT02638103|100975331|FG000|Overall Study|Pregnancy|2|||
33294394|NCT02638103|100975332|FG001|Overall Study|Pregnancy|3|||
33294395|NCT02638103|100975333|FG002|Overall Study|Pregnancy|0|||
33294396|NCT02638103|100975334|FG003|Overall Study|Pregnancy|1|||
33294397|NCT02638103|100975331|FG000|Overall Study|Non-compliance to Study Procedures|2|||
33294398|NCT02638103|100975332|FG001|Overall Study|Non-compliance to Study Procedures|1|||
33294399|NCT02638103|100975333|FG002|Overall Study|Non-compliance to Study Procedures|1|||
33294400|NCT02638103|100975334|FG003|Overall Study|Non-compliance to Study Procedures|1|||
33294401|NCT02638103|100975331|FG000|Overall Study|Lost to Follow-up|26|||
33294402|NCT02638103|100975332|FG001|Overall Study|Lost to Follow-up|33|||
33294403|NCT02638103|100975333|FG002|Overall Study|Lost to Follow-up|20|||
33294404|NCT02638103|100975334|FG003|Overall Study|Lost to Follow-up|37|||
33294405|NCT02638103|100975331|FG000|Overall Study|Lack of Efficacy|14|||
33294406|NCT02638103|100975332|FG001|Overall Study|Lack of Efficacy|10|||
33294407|NCT02638103|100975333|FG002|Overall Study|Lack of Efficacy|12|||
33294408|NCT02638103|100975334|FG003|Overall Study|Lack of Efficacy|22|||
33294409|NCT02638103|100975331|FG000|Overall Study|Other than specified|5|||
33294410|NCT02638103|100975332|FG001|Overall Study|Other than specified|4|||
33294411|NCT02638103|100975333|FG002|Overall Study|Other than specified|2|||
33294412|NCT02638103|100975334|FG003|Overall Study|Other than specified|4|||
33294413|NCT02763215|100975335|FG000|Overall Study|Participants withdrew from study|3|||
33294414|NCT02763215|100975335|FG000|Overall Study|Missed visit|1|||
33294415|NCT02763215|100975335|FG000|Overall Study|Visit outside visit-window|1|||
33294416|NCT02763215|100975335|FG000|Overall Study|Death|1|||
33294417|NCT02763215|100975335|FG000|Overall Study|Lost to Follow-up|1|||
33294418|NCT03819634|100975336|FG000|Overall Study|Physician Decision|2|||
33294419|NCT00425607|100975337|FG000|Overall Study|Death|1|||
33294420|NCT00425607|100975337|FG000|Overall Study|Withdrawal by Subject|1|||
33294421|NCT01377389|100975338|FG000|Overall Study|Withdrawal by Subject|1|||
33294422|NCT01377389|100975338|FG000|Overall Study|Screen failure|2|||
33294423|NCT01077518|100975339|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
33294424|NCT01077518|100975340|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
33294425|NCT01077518|100975341|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
33294426|NCT01077518|100975339|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
33294427|NCT01077518|100975340|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
33294428|NCT01077518|100975341|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
33294429|NCT01077518|100975339|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
33294430|NCT01077518|100975340|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
33294431|NCT01077518|100975341|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
33294432|NCT01077518|100975339|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
33294433|NCT01077518|100975340|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
33294434|NCT01077518|100975341|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
33294435|NCT01077518|100975339|FG000|Optional Ofa Phase|Physician Decision|0|||
33294436|NCT01077518|100975340|FG001|Optional Ofa Phase|Physician Decision|0|||
33294437|NCT01077518|100975341|FG002|Optional Ofa Phase|Physician Decision|1|||
33294438|NCT01077518|100975339|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
33294439|NCT01077518|100975340|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
33294440|NCT01077518|100975341|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
33294441|NCT01077518|100975339|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
33294442|NCT01077518|100975340|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
33294443|NCT01077518|100975341|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
33294444|NCT01721954|100975342|FG000|Overall Study|Death|58|||
33294445|NCT01721954|100975343|FG001|Overall Study|Death|64|||
33294446|NCT01721954|100975342|FG000|Overall Study|Withdrawal by Subject|8|||
33294447|NCT01721954|100975343|FG001|Overall Study|Withdrawal by Subject|4|||
33294448|NCT01721954|100975342|FG000|Overall Study|Adverse Event|2|||
33294449|NCT01721954|100975343|FG001|Overall Study|Adverse Event|0|||
33294450|NCT01721954|100975342|FG000|Overall Study|Lost to Follow-up|2|||
33294451|NCT01721954|100975343|FG001|Overall Study|Lost to Follow-up|1|||
33294452|NCT05186311|100975347|FG000|Part A: Serum|Withdrawal by Subject|1|||
33294453|NCT01658020|100975348|FG000|Overall Study|Adverse Event|3|||
33294454|NCT01658020|100975349|FG001|Overall Study|Adverse Event|3|||
33294455|NCT01658020|100975348|FG000|Overall Study|Lost to Follow-up|1|||
33294456|NCT01658020|100975349|FG001|Overall Study|Lost to Follow-up|0|||
33294457|NCT01658020|100975348|FG000|Overall Study|Withdrawal by Subject|4|||
33294458|NCT01658020|100975349|FG001|Overall Study|Withdrawal by Subject|5|||
33600082|NCT04493684|102088514|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
33600083|NCT04493684|102088498|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33294459|NCT01658020|100975348|FG000|Overall Study|Protocol Violation|0|||
33294460|NCT01658020|100975349|FG001|Overall Study|Protocol Violation|1|||
33294461|NCT01417104|100975351|FG000|Overall Study|Withdrawal by Subject|5|||
33294462|NCT01417104|100975352|FG001|Overall Study|Withdrawal by Subject|1|||
33294463|NCT01417104|100975351|FG000|Overall Study|Failure to make contact|0|||
33294464|NCT01417104|100975352|FG001|Overall Study|Failure to make contact|1|||
33294465|NCT01417104|100975351|FG000|Overall Study|Adverse Event|1|||
33294466|NCT01417104|100975352|FG001|Overall Study|Adverse Event|0|||
33294467|NCT00379769|100975353|FG000|Main Study|Death|57|||
33294468|NCT00379769|100975354|FG001|Main Study|Death|67|||
33294469|NCT00379769|100975355|FG002|Main Study|Death|54|||
33294470|NCT00379769|100975356|FG003|Main Study|Death|72|||
33294471|NCT00379769|100975357|FG004|Main Study|Death|0|||
33294472|NCT00379769|100975358|FG005|Main Study|Death|0|||
33294473|NCT00379769|100975353|FG000|Main Study|Adverse Event|5|||
33294474|NCT00379769|100975354|FG001|Main Study|Adverse Event|8|||
33294475|NCT00379769|100975355|FG002|Main Study|Adverse Event|10|||
33294476|NCT00379769|100975356|FG003|Main Study|Adverse Event|11|||
33294477|NCT00379769|100975357|FG004|Main Study|Adverse Event|0|||
33294478|NCT00379769|100975358|FG005|Main Study|Adverse Event|0|||
33294479|NCT00379769|100975353|FG000|Main Study|Lost to Follow-up|29|||
33294480|NCT00379769|100975354|FG001|Main Study|Lost to Follow-up|29|||
33294481|NCT00379769|100975355|FG002|Main Study|Lost to Follow-up|25|||
33294482|NCT00379769|100975356|FG003|Main Study|Lost to Follow-up|26|||
33294483|NCT00379769|100975357|FG004|Main Study|Lost to Follow-up|0|||
33294484|NCT00379769|100975358|FG005|Main Study|Lost to Follow-up|0|||
33294485|NCT00379769|100975353|FG000|Main Study|Withdrawal by Subject|46|||
33294486|NCT00379769|100975354|FG001|Main Study|Withdrawal by Subject|56|||
33294487|NCT00379769|100975355|FG002|Main Study|Withdrawal by Subject|72|||
33294488|NCT00379769|100975356|FG003|Main Study|Withdrawal by Subject|70|||
33294489|NCT00379769|100975357|FG004|Main Study|Withdrawal by Subject|0|||
33294490|NCT00379769|100975358|FG005|Main Study|Withdrawal by Subject|0|||
33294491|NCT00379769|100975353|FG000|Main Study|Moved to survival status follow-up only|27|||
33294492|NCT00379769|100975354|FG001|Main Study|Moved to survival status follow-up only|25|||
33294493|NCT00379769|100975355|FG002|Main Study|Moved to survival status follow-up only|32|||
33294494|NCT00379769|100975356|FG003|Main Study|Moved to survival status follow-up only|36|||
33294495|NCT00379769|100975357|FG004|Main Study|Moved to survival status follow-up only|0|||
33294496|NCT00379769|100975358|FG005|Main Study|Moved to survival status follow-up only|0|||
33294497|NCT00379769|100975353|FG000|Main Study|Participant moved|3|||
33294498|NCT00379769|100975354|FG001|Main Study|Participant moved|2|||
33294499|NCT00379769|100975355|FG002|Main Study|Participant moved|3|||
33294500|NCT00379769|100975356|FG003|Main Study|Participant moved|3|||
33294501|NCT00379769|100975357|FG004|Main Study|Participant moved|0|||
33294502|NCT00379769|100975358|FG005|Main Study|Participant moved|0|||
33294503|NCT00379769|100975353|FG000|Main Study|Poor compliance|3|||
33294504|NCT00379769|100975354|FG001|Main Study|Poor compliance|2|||
33294505|NCT00379769|100975355|FG002|Main Study|Poor compliance|2|||
33188228|NCT02884089|100597996|FG002|Washout Period 1|Lost to Follow-up|0|||
33188229|NCT02884089|100597997|FG003|Washout Period 1|Lost to Follow-up|1|||
33294506|NCT00379769|100975356|FG003|Main Study|Poor compliance|1|||
33294507|NCT00379769|100975357|FG004|Main Study|Poor compliance|0|||
33294508|NCT00379769|100975358|FG005|Main Study|Poor compliance|0|||
33294509|NCT00379769|100975353|FG000|Main Study|Prohibited glucose lowering medication|0|||
33294510|NCT00379769|100975354|FG001|Main Study|Prohibited glucose lowering medication|3|||
33294511|NCT00379769|100975355|FG002|Main Study|Prohibited glucose lowering medication|0|||
33294512|NCT00379769|100975356|FG003|Main Study|Prohibited glucose lowering medication|1|||
33294513|NCT00379769|100975357|FG004|Main Study|Prohibited glucose lowering medication|0|||
33294514|NCT00379769|100975358|FG005|Main Study|Prohibited glucose lowering medication|0|||
33294515|NCT00379769|100975353|FG000|Main Study|Site closed|4|||
33294516|NCT00379769|100975354|FG001|Main Study|Site closed|4|||
33294517|NCT00379769|100975355|FG002|Main Study|Site closed|4|||
33294518|NCT00379769|100975356|FG003|Main Study|Site closed|8|||
33294519|NCT00379769|100975357|FG004|Main Study|Site closed|0|||
33294520|NCT00379769|100975358|FG005|Main Study|Site closed|0|||
33294521|NCT00379769|100975353|FG000|Main Study|Entry criteria violation|0|||
33294522|NCT00379769|100975354|FG001|Main Study|Entry criteria violation|0|||
33294523|NCT00379769|100975355|FG002|Main Study|Entry criteria violation|1|||
33294524|NCT00379769|100975356|FG003|Main Study|Entry criteria violation|1|||
33294525|NCT00379769|100975357|FG004|Main Study|Entry criteria violation|0|||
33294526|NCT00379769|100975358|FG005|Main Study|Entry criteria violation|0|||
33294527|NCT00379769|100975353|FG000|Main Study|Participant did not take study drug|0|||
33294528|NCT00379769|100975354|FG001|Main Study|Participant did not take study drug|0|||
33294529|NCT00379769|100975355|FG002|Main Study|Participant did not take study drug|1|||
33294530|NCT00379769|100975356|FG003|Main Study|Participant did not take study drug|0|||
33294531|NCT00379769|100975357|FG004|Main Study|Participant did not take study drug|0|||
33294532|NCT00379769|100975358|FG005|Main Study|Participant did not take study drug|0|||
33294533|NCT00379769|100975353|FG000|Main Study|Physician Decision|2|||
33294534|NCT00379769|100975354|FG001|Main Study|Physician Decision|2|||
33294535|NCT00379769|100975355|FG002|Main Study|Physician Decision|1|||
33294536|NCT00379769|100975356|FG003|Main Study|Physician Decision|1|||
33294537|NCT00379769|100975357|FG004|Main Study|Physician Decision|0|||
33294538|NCT00379769|100975358|FG005|Main Study|Physician Decision|0|||
33294539|NCT00379769|100975353|FG000|Main Study|Participant completed study at visit 27|1|||
33294540|NCT00379769|100975354|FG001|Main Study|Participant completed study at visit 27|0|||
33294541|NCT00379769|100975355|FG002|Main Study|Participant completed study at visit 27|0|||
33294542|NCT00379769|100975356|FG003|Main Study|Participant completed study at visit 27|0|||
33294543|NCT00379769|100975357|FG004|Main Study|Participant completed study at visit 27|0|||
33294544|NCT00379769|100975358|FG005|Main Study|Participant completed study at visit 27|0|||
33294545|NCT00379769|100975353|FG000|Main Study|Personal reasons|1|||
33294546|NCT00379769|100975354|FG001|Main Study|Personal reasons|0|||
33294547|NCT00379769|100975355|FG002|Main Study|Personal reasons|0|||
33294548|NCT00379769|100975356|FG003|Main Study|Personal reasons|0|||
33294549|NCT00379769|100975357|FG004|Main Study|Personal reasons|0|||
33294550|NCT00379769|100975358|FG005|Main Study|Personal reasons|0|||
33294551|NCT00379769|100975353|FG000|Main Study|Risk of heart failure|0|||
33294552|NCT00379769|100975354|FG001|Main Study|Risk of heart failure|1|||
33294553|NCT00379769|100975355|FG002|Main Study|Risk of heart failure|0|||
33294554|NCT00379769|100975356|FG003|Main Study|Risk of heart failure|0|||
33294555|NCT00379769|100975357|FG004|Main Study|Risk of heart failure|0|||
33294556|NCT00379769|100975358|FG005|Main Study|Risk of heart failure|0|||
33294557|NCT00379769|100975353|FG000|Main Study|Investigator refused to log temperature|0|||
33600084|NCT04493684|102088499|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33600085|NCT04493684|102088500|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33600086|NCT04493684|102088501|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33600087|NCT04493684|102088502|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33600088|NCT04493684|102088503|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33600089|NCT04493684|102088504|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33600090|NCT04493684|102088505|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33600091|NCT04493684|102088506|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33600092|NCT04493684|102088507|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33600093|NCT04493684|102088508|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33600094|NCT04493684|102088509|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
33600095|NCT04493684|102088510|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33600096|NCT04493684|102088511|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33294558|NCT00379769|100975354|FG001|Main Study|Investigator refused to log temperature|0|||
33294559|NCT00379769|100975355|FG002|Main Study|Investigator refused to log temperature|1|||
33294560|NCT00379769|100975356|FG003|Main Study|Investigator refused to log temperature|0|||
33294561|NCT00379769|100975357|FG004|Main Study|Investigator refused to log temperature|0|||
33294562|NCT00379769|100975358|FG005|Main Study|Investigator refused to log temperature|0|||
33294563|NCT00379769|100975353|FG000|Main Study|Reason unspecified|0|||
33294564|NCT00379769|100975354|FG001|Main Study|Reason unspecified|0|||
33294565|NCT00379769|100975355|FG002|Main Study|Reason unspecified|1|||
33294566|NCT00379769|100975356|FG003|Main Study|Reason unspecified|0|||
33294567|NCT00379769|100975357|FG004|Main Study|Reason unspecified|0|||
33294568|NCT00379769|100975358|FG005|Main Study|Reason unspecified|0|||
33294569|NCT00379769|100975353|FG000|Observational Follow-up|Death|0|||
33294570|NCT00379769|100975354|FG001|Observational Follow-up|Death|0|||
33294571|NCT00379769|100975355|FG002|Observational Follow-up|Death|0|||
33294572|NCT00379769|100975356|FG003|Observational Follow-up|Death|0|||
33294573|NCT00379769|100975357|FG004|Observational Follow-up|Death|78|||
33294574|NCT00379769|100975358|FG005|Observational Follow-up|Death|70|||
33294575|NCT00379769|100975353|FG000|Observational Follow-up|Adverse Event|0|||
33294576|NCT00379769|100975354|FG001|Observational Follow-up|Adverse Event|0|||
33294577|NCT00379769|100975355|FG002|Observational Follow-up|Adverse Event|0|||
33294578|NCT00379769|100975356|FG003|Observational Follow-up|Adverse Event|0|||
33294579|NCT00379769|100975357|FG004|Observational Follow-up|Adverse Event|1|||
33294580|NCT00379769|100975358|FG005|Observational Follow-up|Adverse Event|0|||
33294581|NCT00379769|100975353|FG000|Observational Follow-up|Lost to Follow-up|0|||
33294582|NCT00379769|100975354|FG001|Observational Follow-up|Lost to Follow-up|0|||
33294583|NCT00379769|100975355|FG002|Observational Follow-up|Lost to Follow-up|0|||
33294584|NCT00379769|100975356|FG003|Observational Follow-up|Lost to Follow-up|0|||
33294585|NCT00379769|100975357|FG004|Observational Follow-up|Lost to Follow-up|25|||
33294586|NCT00379769|100975358|FG005|Observational Follow-up|Lost to Follow-up|27|||
33294587|NCT00379769|100975353|FG000|Observational Follow-up|Withdrawal by Subject|0|||
33294588|NCT00379769|100975354|FG001|Observational Follow-up|Withdrawal by Subject|0|||
33294589|NCT00379769|100975355|FG002|Observational Follow-up|Withdrawal by Subject|0|||
33294590|NCT00379769|100975356|FG003|Observational Follow-up|Withdrawal by Subject|0|||
33294591|NCT00379769|100975357|FG004|Observational Follow-up|Withdrawal by Subject|12|||
33294592|NCT00379769|100975358|FG005|Observational Follow-up|Withdrawal by Subject|12|||
33294593|NCT00379769|100975353|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
33294594|NCT00379769|100975354|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
33294595|NCT00379769|100975355|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
33294596|NCT00379769|100975356|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
33294597|NCT00379769|100975357|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
33294598|NCT00379769|100975358|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
33294599|NCT00379769|100975353|FG000|Observational Follow-up|Physician Decision|0|||
33294600|NCT00379769|100975354|FG001|Observational Follow-up|Physician Decision|0|||
33294601|NCT00379769|100975355|FG002|Observational Follow-up|Physician Decision|0|||
33294602|NCT00379769|100975356|FG003|Observational Follow-up|Physician Decision|0|||
33294603|NCT00379769|100975357|FG004|Observational Follow-up|Physician Decision|8|||
33294604|NCT00379769|100975358|FG005|Observational Follow-up|Physician Decision|8|||
33294605|NCT00379769|100975353|FG000|Observational Follow-up|Site Closed Early|0|||
33294606|NCT00379769|100975354|FG001|Observational Follow-up|Site Closed Early|0|||
33294607|NCT00379769|100975355|FG002|Observational Follow-up|Site Closed Early|0|||
33294608|NCT00379769|100975356|FG003|Observational Follow-up|Site Closed Early|0|||
33600097|NCT04493684|102088512|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33294609|NCT00379769|100975357|FG004|Observational Follow-up|Site Closed Early|6|||
33294610|NCT00379769|100975358|FG005|Observational Follow-up|Site Closed Early|7|||
33294611|NCT00379769|100975353|FG000|Observational Follow-up|Participant Moved|0|||
33294612|NCT00379769|100975354|FG001|Observational Follow-up|Participant Moved|0|||
33294613|NCT00379769|100975355|FG002|Observational Follow-up|Participant Moved|0|||
33294614|NCT00379769|100975356|FG003|Observational Follow-up|Participant Moved|0|||
33294615|NCT00379769|100975357|FG004|Observational Follow-up|Participant Moved|0|||
33294616|NCT00379769|100975358|FG005|Observational Follow-up|Participant Moved|1|||
33294617|NCT00379769|100975353|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
33294618|NCT00379769|100975354|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
33294619|NCT00379769|100975355|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
33294620|NCT00379769|100975356|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
33294621|NCT00379769|100975357|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
33294622|NCT00379769|100975358|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
33294623|NCT05262751|100975361|FG000|Washout Period 2|Adverse Event|1|||
33294624|NCT05262751|100975362|FG001|Washout Period 2|Adverse Event|0|||
33294625|NCT05262751|100975363|FG002|Washout Period 2|Adverse Event|0|||
33294626|NCT05262751|100975364|FG003|Washout Period 2|Adverse Event|0|||
33294627|NCT05262751|100975365|FG004|Washout Period 2|Adverse Event|0|||
33294628|NCT05262751|100975366|FG005|Washout Period 2|Adverse Event|0|||
33294629|NCT05262751|100975361|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
33294630|NCT05262751|100975362|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
33294631|NCT05262751|100975363|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
33294632|NCT05262751|100975364|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
33294633|NCT05262751|100975365|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
33294634|NCT05262751|100975366|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
33294635|NCT00412607|100975367|FG000|Overall Study|Withdrawal by Subject|9|||
33294636|NCT00412607|100975367|FG000|Overall Study|Lost to Follow-up|19|||
33294637|NCT00412607|100975367|FG000|Overall Study|Death|61|||
33294638|NCT00412607|100975367|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
33294639|NCT03552523|100975368|FG000|Overall Study|Withdrawal by Subject|1|||
33294640|NCT03552523|100975369|FG001|Overall Study|Withdrawal by Subject|1|||
33294641|NCT01735175|100975370|FG000|Overall Study|Withdrawal by Subject|9|||
33294642|NCT01735175|100975371|FG001|Overall Study|Withdrawal by Subject|2|||
33294643|NCT01735175|100975370|FG000|Overall Study|Lost to Follow-up|4|||
33294644|NCT01735175|100975371|FG001|Overall Study|Lost to Follow-up|2|||
33294645|NCT01735175|100975370|FG000|Overall Study|Death|3|||
33294646|NCT01735175|100975371|FG001|Overall Study|Death|2|||
33294647|NCT01735175|100975370|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
33294648|NCT01735175|100975371|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
33294649|NCT02833077|100975372|FG000|Overall Study|Adverse Event|1|||
33294650|NCT02833077|100975373|FG001|Overall Study|Adverse Event|2|||
33294651|NCT02833077|100975372|FG000|Overall Study|Lost to Follow-up|10|||
33294652|NCT02833077|100975373|FG001|Overall Study|Lost to Follow-up|1|||
33294653|NCT02833077|100975372|FG000|Overall Study|Personal Reasons|6|||
33294654|NCT02833077|100975373|FG001|Overall Study|Personal Reasons|4|||
33294655|NCT02833077|100975372|FG000|Overall Study|Protocol Deviation|0|||
33294656|NCT02833077|100975373|FG001|Overall Study|Protocol Deviation|1|||
33294657|NCT00940875|100975374|FG000|Treatment Phase|Adverse Event|9|||
33294658|NCT00940875|100975375|FG001|Treatment Phase|Adverse Event|3|||
33294659|NCT00940875|100975374|FG000|Treatment Phase|Death|3|||
33294660|NCT00940875|100975375|FG001|Treatment Phase|Death|5|||
33294661|NCT00940875|100975374|FG000|Treatment Phase|Lack of Efficacy|1|||
33294662|NCT00940875|100975375|FG001|Treatment Phase|Lack of Efficacy|0|||
33294663|NCT00940875|100975374|FG000|Treatment Phase|Withdrawal by Subject|3|||
33294664|NCT00940875|100975375|FG001|Treatment Phase|Withdrawal by Subject|0|||
33294665|NCT00940875|100975374|FG000|Treatment Phase|Disease progression|9|||
33294666|NCT00940875|100975375|FG001|Treatment Phase|Disease progression|11|||
33294667|NCT00940875|100975374|FG000|Treatment Phase|Physician Decision|1|||
33294668|NCT00940875|100975375|FG001|Treatment Phase|Physician Decision|0|||
33294669|NCT00940875|100975374|FG000|Post-Study Treatment|Death|0|||
33294670|NCT00940875|100975375|FG001|Post-Study Treatment|Death|1|||
33294671|NCT00940875|100975374|FG000|Post-Study Treatment|Disease Progression|0|||
33294672|NCT00940875|100975375|FG001|Post-Study Treatment|Disease Progression|2|||
33294673|NCT01154140|100975376|FG000|Overall Study|Death|71|||
33294674|NCT01154140|100975377|FG001|Overall Study|Death|81|||
33294675|NCT01154140|100975376|FG000|Overall Study|Lost to Follow-up|4|||
33294676|NCT01154140|100975377|FG001|Overall Study|Lost to Follow-up|5|||
33294677|NCT01154140|100975376|FG000|Overall Study|Withdrawal by Subject|12|||
33294678|NCT01154140|100975377|FG001|Overall Study|Withdrawal by Subject|13|||
33294679|NCT01154140|100975376|FG000|Overall Study|Other|3|||
33294680|NCT01154140|100975377|FG001|Overall Study|Other|1|||
33294681|NCT01154140|100975376|FG000|Overall Study|Randomized but not treated|1|||
33294682|NCT01154140|100975377|FG001|Overall Study|Randomized but not treated|2|||
33294683|NCT01896557|100975378|FG000|Clopidogrel Alone|Adverse Event|1|||
33294684|NCT01896557|100975379|FG001|Clopidogrel Alone|Adverse Event|0|||
33294685|NCT01896557|100975378|FG000|Clopidogrel + GI Protector|low adherence|1|||
33294686|NCT01896557|100975379|FG001|Clopidogrel + GI Protector|low adherence|1|||
33294687|NCT01896557|100975378|FG000|Clopidogrel + GI Protector|Reading error|1|||
33294688|NCT01896557|100975379|FG001|Clopidogrel + GI Protector|Reading error|3|||
33294689|NCT02388347|100975380|FG000|Overall Study|Withdrawal by Subject|0|||
33294690|NCT02388347|100975381|FG001|Overall Study|Withdrawal by Subject|0|||
33294691|NCT02388347|100975382|FG002|Overall Study|Withdrawal by Subject|1|||
33294692|NCT02388347|100975383|FG003|Overall Study|Withdrawal by Subject|0|||
33294693|NCT02388347|100975384|FG004|Overall Study|Withdrawal by Subject|0|||
33294694|NCT01736189|100975385|FG000|Overall Study|Violation of registration criteria|41|||
33294695|NCT01736189|100975385|FG000|Overall Study|Protocol Violation|4|||
33294696|NCT01736189|100975385|FG000|Overall Study|Criteria and protocol violations|1|||
33294697|NCT02358668|100975386|FG000|Overall Study|Adverse Event|2|||
33294698|NCT02358668|100975387|FG001|Overall Study|Adverse Event|0|||
33294699|NCT02358668|100975388|FG002|Overall Study|Adverse Event|0|||
33294700|NCT02358668|100975386|FG000|Overall Study|Withdrawal by Subject|0|||
33294701|NCT02358668|100975387|FG001|Overall Study|Withdrawal by Subject|1|||
33294702|NCT02358668|100975388|FG002|Overall Study|Withdrawal by Subject|0|||
33294703|NCT00243074|100975391|FG000|Overall Study|Ineligible|6|||
33294704|NCT00243074|100975391|FG000|Overall Study|Adverse Event|6|||
33294705|NCT00243074|100975391|FG000|Overall Study|Withdrawal by Subject|2|||
33294706|NCT00243074|100975391|FG000|Overall Study|Lack of Efficacy|36|||
33294707|NCT00243074|100975391|FG000|Overall Study|Death|2|||
33294708|NCT00243074|100975391|FG000|Overall Study|not protocol specified|1|||
33294709|NCT00243074|100975391|FG000|Overall Study|Did not receive any treatment|1|||
33294710|NCT00401258|100975392|FG000|Overall Study|Adverse Event|7|||
33294711|NCT01730378|100975393|FG000|Overall Study|Lost to Follow-up|1|||
33294712|NCT01730378|100975394|FG001|Overall Study|Lost to Follow-up|0|||
33294713|NCT00281320|100975395|FG000|Overall Study|Adverse Event|12|||
33294714|NCT00281320|100975396|FG001|Overall Study|Adverse Event|9|||
33294715|NCT00281320|100975395|FG000|Overall Study|Lack of Efficacy|4|||
33294716|NCT00281320|100975396|FG001|Overall Study|Lack of Efficacy|3|||
33294717|NCT00281320|100975395|FG000|Overall Study|Withdrawal by Subject|5|||
33600098|NCT04493684|102088513|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33600099|NCT04493684|102088514|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
33600100|NCT04493684|102088498|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33294718|NCT00281320|100975396|FG001|Overall Study|Withdrawal by Subject|6|||
33294719|NCT00281320|100975395|FG000|Overall Study|Lost to Follow-up|1|||
33294720|NCT00281320|100975396|FG001|Overall Study|Lost to Follow-up|2|||
33294721|NCT00281320|100975395|FG000|Overall Study|Other|3|||
33294722|NCT00281320|100975396|FG001|Overall Study|Other|1|||
33294723|NCT02567708|100975397|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
33294724|NCT02567708|100975398|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
33294725|NCT02567708|100975397|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
33294726|NCT02567708|100975398|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
33294727|NCT02567708|100975397|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
33294728|NCT02567708|100975398|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
33294729|NCT02567708|100975397|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
33294730|NCT02567708|100975398|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
33294731|NCT02370251|100975399|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
33294732|NCT02370251|100975399|FG000|Overall Study|Death|4|||
33294733|NCT01712061|100975400|FG000|Overall Study|Adverse Event|4|||
33294734|NCT01712061|100975401|FG001|Overall Study|Adverse Event|9|||
33294735|NCT01712061|100975402|FG002|Overall Study|Adverse Event|5|||
33294736|NCT01712061|100975400|FG000|Overall Study|Death|0|||
33294737|NCT01712061|100975401|FG001|Overall Study|Death|0|||
33294738|NCT01712061|100975402|FG002|Overall Study|Death|1|||
33294739|NCT01712061|100975400|FG000|Overall Study|Lost to Follow-up|1|||
33294740|NCT01712061|100975401|FG001|Overall Study|Lost to Follow-up|0|||
33600101|NCT04493684|102088499|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33600102|NCT04493684|102088500|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33600103|NCT04493684|102088501|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33294741|NCT01712061|100975402|FG002|Overall Study|Lost to Follow-up|1|||
33294742|NCT01712061|100975400|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
33294743|NCT01712061|100975401|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
33294744|NCT01712061|100975402|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
33294745|NCT01712061|100975400|FG000|Overall Study|Medication Error Without Associated AE|0|||
33294746|NCT01712061|100975401|FG001|Overall Study|Medication Error Without Associated AE|1|||
33294747|NCT01712061|100975402|FG002|Overall Study|Medication Error Without Associated AE|0|||
33294748|NCT01712061|100975400|FG000|Overall Study|Withdrawal by Subject|1|||
33294749|NCT01712061|100975401|FG001|Overall Study|Withdrawal by Subject|7|||
33294750|NCT01712061|100975402|FG002|Overall Study|Withdrawal by Subject|1|||
33294751|NCT01712061|100975400|FG000|Overall Study|Other|0|||
33294752|NCT01712061|100975401|FG001|Overall Study|Other|3|||
33294753|NCT01712061|100975402|FG002|Overall Study|Other|0|||
33294754|NCT01053247|100975403|FG000|Overall Study|Withdrawal by Subject|9|||
33294755|NCT01053247|100975404|FG001|Overall Study|Withdrawal by Subject|4|||
33294756|NCT01053247|100975405|FG002|Overall Study|Withdrawal by Subject|15|||
33294757|NCT01053247|100975403|FG000|Overall Study|Lack of Efficacy|1|||
33294758|NCT01053247|100975404|FG001|Overall Study|Lack of Efficacy|0|||
33294759|NCT01053247|100975405|FG002|Overall Study|Lack of Efficacy|1|||
33294760|NCT01053247|100975403|FG000|Overall Study|Protocol Violation|2|||
33294761|NCT01053247|100975404|FG001|Overall Study|Protocol Violation|1|||
33294762|NCT01053247|100975405|FG002|Overall Study|Protocol Violation|2|||
33294763|NCT01053247|100975403|FG000|Overall Study|Lost to Follow-up|8|||
33294764|NCT01053247|100975404|FG001|Overall Study|Lost to Follow-up|5|||
33294765|NCT01053247|100975405|FG002|Overall Study|Lost to Follow-up|7|||
33294766|NCT01053247|100975403|FG000|Overall Study|Adverse Event|0|||
33294767|NCT01053247|100975404|FG001|Overall Study|Adverse Event|9|||
33294768|NCT01053247|100975405|FG002|Overall Study|Adverse Event|3|||
33294769|NCT00701909|100975410|FG000|Overall Study|Withdrawal by Subject|0|||
33294770|NCT00701909|100975411|FG001|Overall Study|Withdrawal by Subject|1|||
33294771|NCT03933462|100975412|FG000|Overall Study|Adverse Event|2|||
33294772|NCT03933462|100975413|FG001|Overall Study|Adverse Event|0|||
33294773|NCT03017742|100975414|FG000|Overall Study|Protocol Violation|36|||
33294774|NCT03017742|100975414|FG000|Overall Study|Withdrawal by Subject|37|||
33294775|NCT00848484|100975415|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
33294776|NCT00848484|100975416|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
33294777|NCT00848484|100975415|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
33294778|NCT00848484|100975416|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
33294779|NCT00848484|100975415|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
33294780|NCT00848484|100975416|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
33294781|NCT00848484|100975415|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
33294782|NCT00848484|100975416|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
33294783|NCT00848484|100975415|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
33294784|NCT00848484|100975416|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
33294785|NCT00983749|100975417|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
33294786|NCT00983749|100975418|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
33294787|NCT00965497|100975419|FG000|Overall Study|Physician Decision|1|||
33294788|NCT01454739|100975423|FG000|Overall Study|Protocol Violation|2|||
33294789|NCT01454739|100975424|FG001|Overall Study|Protocol Violation|3|||
33294790|NCT01454739|100975423|FG000|Overall Study|Withdrawal by Subject|2|||
33294791|NCT01454739|100975424|FG001|Overall Study|Withdrawal by Subject|6|||
33294792|NCT01454739|100975423|FG000|Overall Study|Other|3|||
33294793|NCT01454739|100975424|FG001|Overall Study|Other|5|||
33294794|NCT01454739|100975423|FG000|Overall Study|Physician Decision|0|||
33294795|NCT01454739|100975424|FG001|Overall Study|Physician Decision|5|||
33294796|NCT01454739|100975423|FG000|Overall Study|Lost to Follow-up|0|||
33294797|NCT01454739|100975424|FG001|Overall Study|Lost to Follow-up|1|||
33294798|NCT01454739|100975423|FG000|Overall Study|Adverse Event|0|||
33294799|NCT01454739|100975424|FG001|Overall Study|Adverse Event|1|||
33294800|NCT00972322|100975427|FG000|Overall Study|Adverse Event|2|||
33294801|NCT00972322|100975428|FG001|Overall Study|Adverse Event|1|||
33294802|NCT00972322|100975427|FG000|Overall Study|Positive drug screen|0|||
33294803|NCT00972322|100975428|FG001|Overall Study|Positive drug screen|1|||
33294804|NCT00972322|100975427|FG000|Overall Study|Lost to Follow-up|0|||
33294805|NCT00972322|100975428|FG001|Overall Study|Lost to Follow-up|1|||
33294806|NCT00972322|100975427|FG000|Overall Study|Consistently high glucose values|1|||
33294807|NCT00972322|100975428|FG001|Overall Study|Consistently high glucose values|0|||
33294808|NCT00402051|100975429|FG000|Overall Study|Progressive Disease|13|||
33294809|NCT00402051|100975430|FG001|Overall Study|Progressive Disease|20|||
33294810|NCT00402051|100975429|FG000|Overall Study|Adverse Event|11|||
33294811|NCT00402051|100975430|FG001|Overall Study|Adverse Event|4|||
33294812|NCT00402051|100975429|FG000|Overall Study|Physician Decision|7|||
33294813|NCT00402051|100975430|FG001|Overall Study|Physician Decision|3|||
33294814|NCT00402051|100975429|FG000|Overall Study|Withdrawal by Subject|3|||
33294815|NCT00402051|100975430|FG001|Overall Study|Withdrawal by Subject|3|||
33294816|NCT00402051|100975429|FG000|Overall Study|Death - Related to Study Drug|1|||
33294817|NCT00402051|100975430|FG001|Overall Study|Death - Related to Study Drug|2|||
33294818|NCT00402051|100975429|FG000|Overall Study|Death Due to Study Disease|2|||
33294819|NCT00402051|100975430|FG001|Overall Study|Death Due to Study Disease|1|||
33294820|NCT00402051|100975429|FG000|Overall Study|Death Due to Adverse Event|0|||
33294821|NCT00402051|100975430|FG001|Overall Study|Death Due to Adverse Event|2|||
33294822|NCT00402051|100975429|FG000|Overall Study|Lost to Follow-up|1|||
33294823|NCT00402051|100975430|FG001|Overall Study|Lost to Follow-up|0|||
33294824|NCT02552147|100975434|FG000|First Intervention (7 Days)|Protocol Violation|1|||
33496235|NCT02013817|101710042|FG000|Overall Study|Withdrawal by Subject|4|||
33294825|NCT02552147|100975435|FG001|First Intervention (7 Days)|Protocol Violation|0|||
33294826|NCT02552147|100975434|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
33294827|NCT02552147|100975435|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
33294828|NCT02406248|100975438|FG000|Overall Study|Death|7|||
33294829|NCT02406248|100975438|FG000|Overall Study|Withdrawal by Subject|2|||
33294830|NCT02353468|100975445|FG000|Overall Study|Study terminated|3|||
33294831|NCT00762476|100975446|FG000|Overall Study|Adverse Event|7|||
33294832|NCT00762476|100975447|FG001|Overall Study|Adverse Event|1|||
33294833|NCT00762476|100975446|FG000|Overall Study|Lost to Follow-up|2|||
33294834|NCT00762476|100975447|FG001|Overall Study|Lost to Follow-up|0|||
33294835|NCT00762476|100975446|FG000|Overall Study|Protocol Violation|5|||
33294836|NCT00762476|100975447|FG001|Overall Study|Protocol Violation|6|||
33600104|NCT04493684|102088502|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33294837|NCT00762476|100975446|FG000|Overall Study|Physician Decision|2|||
33294838|NCT00762476|100975447|FG001|Overall Study|Physician Decision|14|||
33294839|NCT00762476|100975446|FG000|Overall Study|Withdrawal by Subject|6|||
33294840|NCT00762476|100975447|FG001|Overall Study|Withdrawal by Subject|12|||
33188230|NCT02884089|100597994|FG000|Washout Period 1|Withdrawal by Subject|0|||
33188231|NCT02884089|100597995|FG001|Washout Period 1|Withdrawal by Subject|1|||
33188232|NCT02884089|100597996|FG002|Washout Period 1|Withdrawal by Subject|0|||
33188233|NCT02884089|100597997|FG003|Washout Period 1|Withdrawal by Subject|0|||
33188234|NCT02884089|100597994|FG000|Period 2|Adverse Event|1|||
33188235|NCT02884089|100597995|FG001|Period 2|Adverse Event|0|||
33188236|NCT02884089|100597996|FG002|Period 2|Adverse Event|0|||
33188237|NCT02884089|100597997|FG003|Period 2|Adverse Event|0|||
33188238|NCT02884089|100597994|FG000|Period 3|Withdrawal by Subject|0|||
33188239|NCT02884089|100597995|FG001|Period 3|Withdrawal by Subject|0|||
33188240|NCT02884089|100597996|FG002|Period 3|Withdrawal by Subject|1|||
33188241|NCT02884089|100597997|FG003|Period 3|Withdrawal by Subject|0|||
33188242|NCT02884089|100597994|FG000|Washout Period 3|Withdrawal by Subject|0|||
33188243|NCT02884089|100597995|FG001|Washout Period 3|Withdrawal by Subject|0|||
33188244|NCT02884089|100597996|FG002|Washout Period 3|Withdrawal by Subject|1|||
33188245|NCT02884089|100597997|FG003|Washout Period 3|Withdrawal by Subject|0|||
33188246|NCT02884089|100597994|FG000|Washout Period 3|Lost to Follow-up|0|||
33188247|NCT02884089|100597995|FG001|Washout Period 3|Lost to Follow-up|0|||
33188248|NCT02884089|100597996|FG002|Washout Period 3|Lost to Follow-up|0|||
33188249|NCT02884089|100597997|FG003|Washout Period 3|Lost to Follow-up|1|||
33188250|NCT02884089|100597994|FG000|Period 4|Withdrawal by Subject|0|||
33188251|NCT02884089|100597995|FG001|Period 4|Withdrawal by Subject|1|||
33188252|NCT02884089|100597996|FG002|Period 4|Withdrawal by Subject|0|||
33188253|NCT02884089|100597997|FG003|Period 4|Withdrawal by Subject|0|||
33188254|NCT02884089|100597994|FG000|Period 4|Lost to Follow-up|1|||
33188255|NCT02884089|100597995|FG001|Period 4|Lost to Follow-up|0|||
33188256|NCT02884089|100597996|FG002|Period 4|Lost to Follow-up|0|||
33188257|NCT02884089|100597997|FG003|Period 4|Lost to Follow-up|0|||
33188258|NCT02884089|100597994|FG000|Follow-up Visit|Withdrawal by Subject|1|||
33188259|NCT02884089|100597995|FG001|Follow-up Visit|Withdrawal by Subject|0|||
33188260|NCT02884089|100597996|FG002|Follow-up Visit|Withdrawal by Subject|0|||
33188261|NCT02884089|100597997|FG003|Follow-up Visit|Withdrawal by Subject|1|||
33188262|NCT03925324|100597998|FG000|Overall Study|Death|1|||
33188263|NCT03925324|100597999|FG001|Overall Study|Death|1|||
33188264|NCT03450707|100598005|FG000|Overall Study|Outside enrollment window|4|||
33188265|NCT03450707|100598006|FG001|Overall Study|Outside enrollment window|1|||
33188266|NCT03450707|100598005|FG000|Overall Study|Death|1|||
33188267|NCT03450707|100598006|FG001|Overall Study|Death|0|||
33188268|NCT03450707|100598005|FG000|Overall Study|Indication for thiamine|1|||
33188269|NCT03450707|100598006|FG001|Overall Study|Indication for thiamine|1|||
33188270|NCT03450707|100598005|FG000|Overall Study|Evidence of traumatic brain injury|1|||
33188271|NCT03450707|100598006|FG001|Overall Study|Evidence of traumatic brain injury|0|||
33188272|NCT03450707|100598005|FG000|Overall Study|Following commands|0|||
33188273|NCT03450707|100598006|FG001|Overall Study|Following commands|3|||
33188274|NCT03450707|100598005|FG000|Overall Study|Lactate < 3.5|0|||
33188275|NCT03450707|100598006|FG001|Overall Study|Lactate < 3.5|2|||
33188276|NCT03450707|100598005|FG000|Overall Study|Rearrest with ECMO|0|||
33188277|NCT03450707|100598006|FG001|Overall Study|Rearrest with ECMO|1|||
33188278|NCT03450707|100598005|FG000|Overall Study|Indication for thiamine + head CT results|0|||
33294841|NCT00762476|100975446|FG000|Overall Study|antibiotic use|0|||
33294842|NCT00762476|100975447|FG001|Overall Study|antibiotic use|1|||
33294843|NCT00762476|100975446|FG000|Overall Study|non-compliance with study visits|0|||
33294844|NCT00762476|100975447|FG001|Overall Study|non-compliance with study visits|2|||
33294845|NCT00762476|100975446|FG000|Overall Study|Seasonal allergies|1|||
33294846|NCT00762476|100975447|FG001|Overall Study|Seasonal allergies|0|||
33294847|NCT01516749|100975448|FG000|Active Therapy|Lost to Follow-up|1|||
33294848|NCT01516749|100975448|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
33188279|NCT03450707|100598006|FG001|Overall Study|Indication for thiamine + head CT results|1|||
33188280|NCT03450707|100598005|FG000|Overall Study|Family/patient goals of care|0|||
33188281|NCT03450707|100598006|FG001|Overall Study|Family/patient goals of care|1|||
33188282|NCT00418691|100598008|FG000|Overall Study|Lost to Follow-up|1|||
33188283|NCT00418691|100598009|FG001|Overall Study|Lost to Follow-up|2|||
33188284|NCT00418691|100598010|FG002|Overall Study|Lost to Follow-up|3|||
33188285|NCT00418691|100598008|FG000|Overall Study|Started new medication voiding entry|0|||
33188286|NCT00418691|100598009|FG001|Overall Study|Started new medication voiding entry|0|||
33188287|NCT00418691|100598010|FG002|Overall Study|Started new medication voiding entry|1|||
33188288|NCT00418691|100598008|FG000|Overall Study|Progressive Disease|1|||
33188289|NCT00418691|100598009|FG001|Overall Study|Progressive Disease|0|||
33188290|NCT00418691|100598010|FG002|Overall Study|Progressive Disease|1|||
33188291|NCT02806726|100598011|FG000|Overall Study|Lost to Follow-up|1|||
33188292|NCT00850395|100598012|FG000|Overall Study|Death|1|||
33188293|NCT00850395|100598012|FG000|Overall Study|Adverse Event|1|||
33188294|NCT00850395|100598012|FG000|Overall Study|Insufficient clinical response|3|||
33188295|NCT00850395|100598012|FG000|Overall Study|Other|5|||
33188296|NCT02953821|100598014|FG000|Overall Study|Adverse Event|0|||
33188297|NCT02953821|100598015|FG001|Overall Study|Adverse Event|4|||
33188298|NCT02953821|100598014|FG000|Overall Study|Death|1|||
33188299|NCT02953821|100598015|FG001|Overall Study|Death|0|||
33188300|NCT02953821|100598014|FG000|Overall Study|Progressive Disease|5|||
33188301|NCT02953821|100598015|FG001|Overall Study|Progressive Disease|1|||
33188302|NCT02953821|100598014|FG000|Overall Study|Lost to Follow-up|2|||
33188303|NCT02953821|100598015|FG001|Overall Study|Lost to Follow-up|0|||
33188304|NCT02953821|100598014|FG000|Overall Study|Physician Decision|1|||
33188305|NCT02953821|100598015|FG001|Overall Study|Physician Decision|1|||
33188306|NCT02953821|100598014|FG000|Overall Study|Withdrawal by Subject|3|||
33188307|NCT02953821|100598015|FG001|Overall Study|Withdrawal by Subject|3|||
33188308|NCT02953821|100598014|FG000|Overall Study|Change of address|0|||
33188309|NCT02953821|100598015|FG001|Overall Study|Change of address|1|||
33188310|NCT02953821|100598014|FG000|Overall Study|Lack of Efficacy|1|||
33188311|NCT02953821|100598015|FG001|Overall Study|Lack of Efficacy|0|||
33188312|NCT02953821|100598014|FG000|Overall Study|Out of state for indeterminate time|0|||
33188313|NCT02953821|100598015|FG001|Overall Study|Out of state for indeterminate time|1|||
33188314|NCT02953821|100598014|FG000|Overall Study|No improvement|0|||
33188315|NCT02953821|100598015|FG001|Overall Study|No improvement|1|||
33188316|NCT02953821|100598014|FG000|Overall Study|Refused follow-up visit|2|||
33188317|NCT02953821|100598015|FG001|Overall Study|Refused follow-up visit|1|||
33188318|NCT02350309|100598016|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
33188319|NCT02350309|100598017|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
33188320|NCT02350309|100598018|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
33188321|NCT02350309|100598019|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
33294849|NCT00634842|100975449|FG000|Overall Study|Adverse Event|2|||
33294850|NCT00634842|100975450|FG001|Overall Study|Adverse Event|3|||
33294851|NCT00634842|100975449|FG000|Overall Study|Protocol Violation|8|||
33294852|NCT00634842|100975450|FG001|Overall Study|Protocol Violation|4|||
33294853|NCT00634842|100975449|FG000|Overall Study|Move to another state|1|||
33294854|NCT00634842|100975450|FG001|Overall Study|Move to another state|0|||
33294855|NCT00634842|100975449|FG000|Overall Study|Inclusion criteria were not met|1|||
33294856|NCT00634842|100975450|FG001|Overall Study|Inclusion criteria were not met|0|||
33294857|NCT00634842|100975449|FG000|Overall Study|Lost to Follow-up|1|||
33294858|NCT00634842|100975450|FG001|Overall Study|Lost to Follow-up|2|||
33294859|NCT00634842|100975449|FG000|Overall Study|Physician Decision|1|||
33294860|NCT00634842|100975450|FG001|Overall Study|Physician Decision|0|||
33294861|NCT00634842|100975449|FG000|Overall Study|Withdrawal by Subject|1|||
33294862|NCT00634842|100975450|FG001|Overall Study|Withdrawal by Subject|3|||
33294863|NCT00634842|100975449|FG000|Overall Study|Lack of time and intolerance to drug|0|||
33294864|NCT00634842|100975450|FG001|Overall Study|Lack of time and intolerance to drug|1|||
33294865|NCT00634842|100975449|FG000|Overall Study|Discontinued due to injection|0|||
33188322|NCT02350309|100598020|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
33188323|NCT02350309|100598021|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
33294866|NCT00634842|100975450|FG001|Overall Study|Discontinued due to injection|2|||
33294867|NCT00634842|100975449|FG000|Overall Study|No need of study drug to treat diabetes|0|||
33188324|NCT02350309|100598016|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
33188325|NCT02350309|100598017|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
33188326|NCT02350309|100598018|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
33188327|NCT02350309|100598019|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
33188328|NCT02350309|100598020|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
33188329|NCT02350309|100598021|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
33188330|NCT01009099|100598022|FG000|Overall Study|Lost to Follow-up|1|||
33188331|NCT01009099|100598023|FG001|Overall Study|Lost to Follow-up|0|||
33294868|NCT00634842|100975450|FG001|Overall Study|No need of study drug to treat diabetes|1|||
33294869|NCT00634842|100975449|FG000|Overall Study|No wish to keep taking Avandia|0|||
33294870|NCT00634842|100975450|FG001|Overall Study|No wish to keep taking Avandia|1|||
33188332|NCT01009099|100598022|FG000|Overall Study|Physician Decision|3|||
33188333|NCT01009099|100598023|FG001|Overall Study|Physician Decision|2|||
33188334|NCT01009099|100598022|FG000|Overall Study|Withdrawal by Subject|1|||
33188335|NCT01009099|100598023|FG001|Overall Study|Withdrawal by Subject|1|||
33188336|NCT01009099|100598022|FG000|Overall Study|Death|0|||
33188337|NCT01009099|100598023|FG001|Overall Study|Death|1|||
33188338|NCT01231581|100598024|FG000|Overall Study|Lost to Follow-up|2|||
33188339|NCT01231581|100598025|FG001|Overall Study|Lost to Follow-up|2|||
33188340|NCT01231581|100598024|FG000|Overall Study|Withdrawal by Subject|6|||
33188341|NCT01231581|100598025|FG001|Overall Study|Withdrawal by Subject|9|||
33188342|NCT01231581|100598024|FG000|Overall Study|Study Closed/Terminated|6|||
33188343|NCT01231581|100598025|FG001|Overall Study|Study Closed/Terminated|5|||
33188344|NCT01231581|100598024|FG000|Overall Study|Death|65|||
33188345|NCT01231581|100598025|FG001|Overall Study|Death|64|||
33188346|NCT01231581|100598024|FG000|Overall Study|Ongoing|1|||
33188347|NCT01231581|100598025|FG001|Overall Study|Ongoing|0|||
33188348|NCT01158222|100598026|FG000|Overall Study|Not eligible for intermediate phase|17|||
33188349|NCT01557400|100598031|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
33188350|NCT01557400|100598031|FG000|Overall Study|Adverse Event|3|||
33188351|NCT01557400|100598031|FG000|Overall Study|Lost to Follow-up|5|||
33188352|NCT01557400|100598031|FG000|Overall Study|Withdrawal by Subject|9|||
33188353|NCT02774681|100598043|FG000|Treatment on Study|Progressive Disease|7|||
33188354|NCT02774681|100598043|FG000|Follow-Up for 3 Years|Death|11|||
33188355|NCT02774681|100598043|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
33188356|NCT02603809|100598046|FG000|Overall Study|Withdrawal by Subject|4|||
33188357|NCT02603809|100598047|FG001|Overall Study|Withdrawal by Subject|1|||
33188358|NCT02603809|100598048|FG002|Overall Study|Withdrawal by Subject|2|||
33188359|NCT02603809|100598049|FG003|Overall Study|Withdrawal by Subject|3|||
33188360|NCT02603809|100598050|FG004|Overall Study|Withdrawal by Subject|3|||
33188361|NCT02603809|100598051|FG005|Overall Study|Withdrawal by Subject|4|||
33188362|NCT02603809|100598046|FG000|Overall Study|Lost to Follow-up|2|||
33294871|NCT00634842|100975449|FG000|Overall Study|Subject off study drug for too long|0|||
33294872|NCT00634842|100975450|FG001|Overall Study|Subject off study drug for too long|1|||
33294873|NCT02270671|100975451|FG000|Overall Study|Withdrawal by Subject|1|||
33294874|NCT02270671|100975452|FG001|Overall Study|Withdrawal by Subject|1|||
33294875|NCT02270671|100975451|FG000|Overall Study|Protocol Violation|0|||
33294876|NCT02270671|100975452|FG001|Overall Study|Protocol Violation|1|||
33294877|NCT02270671|100975451|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
33294878|NCT02270671|100975452|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
33294879|NCT02270671|100975451|FG000|Overall Study|Lost to Follow-up|2|||
33294880|NCT02270671|100975452|FG001|Overall Study|Lost to Follow-up|1|||
33294881|NCT03809039|100975456|FG000|Part 1|Withdrawal by Subject|1|||
33294882|NCT03809039|100975457|FG001|Part 1|Withdrawal by Subject|0|||
33294883|NCT03809039|100975458|FG002|Part 1|Withdrawal by Subject|0|||
33294884|NCT03809039|100975459|FG003|Part 1|Withdrawal by Subject|1|||
33294885|NCT03809039|100975460|FG004|Part 1|Withdrawal by Subject|0|||
33294886|NCT03809039|100975461|FG005|Part 1|Withdrawal by Subject|0|||
33188363|NCT02603809|100598047|FG001|Overall Study|Lost to Follow-up|3|||
33188364|NCT02603809|100598048|FG002|Overall Study|Lost to Follow-up|1|||
33188365|NCT02603809|100598049|FG003|Overall Study|Lost to Follow-up|4|||
33188366|NCT02603809|100598050|FG004|Overall Study|Lost to Follow-up|2|||
33188367|NCT02603809|100598051|FG005|Overall Study|Lost to Follow-up|2|||
33188368|NCT02603809|100598046|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
33294887|NCT03809039|100975462|FG006|Part 1|Withdrawal by Subject|0|||
33294888|NCT03809039|100975463|FG007|Part 1|Withdrawal by Subject|0|||
33294889|NCT03809039|100975464|FG008|Part 1|Withdrawal by Subject|0|||
33294890|NCT03809039|100975456|FG000|Part 3|Withdrawn by study termination|0|||
33294891|NCT03809039|100975457|FG001|Part 3|Withdrawn by study termination|0|||
33188369|NCT02603809|100598047|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
33294892|NCT03809039|100975458|FG002|Part 3|Withdrawn by study termination|0|||
33294893|NCT03809039|100975459|FG003|Part 3|Withdrawn by study termination|0|||
33294894|NCT03809039|100975460|FG004|Part 3|Withdrawn by study termination|0|||
33294895|NCT03809039|100975461|FG005|Part 3|Withdrawn by study termination|0|||
33294896|NCT03809039|100975462|FG006|Part 3|Withdrawn by study termination|0|||
33294897|NCT03809039|100975463|FG007|Part 3|Withdrawn by study termination|2|||
33294898|NCT03809039|100975464|FG008|Part 3|Withdrawn by study termination|6|||
33294899|NCT00730015|100975465|FG000|Overall Study|Adverse Event|11|||
33294900|NCT00730015|100975466|FG001|Overall Study|Adverse Event|10|||
33294901|NCT00730015|100975467|FG002|Overall Study|Adverse Event|8|||
33294902|NCT00730015|100975465|FG000|Overall Study|Protocol Violation|2|||
33294903|NCT00730015|100975466|FG001|Overall Study|Protocol Violation|6|||
33294904|NCT00730015|100975467|FG002|Overall Study|Protocol Violation|4|||
33294905|NCT00730015|100975465|FG000|Overall Study|Withdrawal by Subject|12|||
33188370|NCT02603809|100598048|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
33188371|NCT02603809|100598049|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
33188372|NCT02603809|100598050|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
33188373|NCT02603809|100598051|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
33188374|NCT02603809|100598046|FG000|Overall Study|Physician Decision|0|||
33188375|NCT02603809|100598047|FG001|Overall Study|Physician Decision|0|||
33188376|NCT02603809|100598048|FG002|Overall Study|Physician Decision|0|||
33188377|NCT02603809|100598049|FG003|Overall Study|Physician Decision|1|||
33188378|NCT02603809|100598050|FG004|Overall Study|Physician Decision|2|||
33188379|NCT02603809|100598051|FG005|Overall Study|Physician Decision|1|||
33188380|NCT02603809|100598046|FG000|Overall Study|Adverse Event|3|||
33188381|NCT02603809|100598047|FG001|Overall Study|Adverse Event|0|||
33188382|NCT02603809|100598048|FG002|Overall Study|Adverse Event|2|||
33188383|NCT02603809|100598049|FG003|Overall Study|Adverse Event|2|||
33188384|NCT02603809|100598050|FG004|Overall Study|Adverse Event|1|||
33188385|NCT02603809|100598051|FG005|Overall Study|Adverse Event|1|||
33188386|NCT02603809|100598046|FG000|Overall Study|Lack of Efficacy|0|||
33188387|NCT02603809|100598047|FG001|Overall Study|Lack of Efficacy|1|||
33188388|NCT02603809|100598048|FG002|Overall Study|Lack of Efficacy|0|||
33188389|NCT02603809|100598049|FG003|Overall Study|Lack of Efficacy|0|||
33188390|NCT02603809|100598050|FG004|Overall Study|Lack of Efficacy|0|||
33188391|NCT02603809|100598051|FG005|Overall Study|Lack of Efficacy|1|||
33188392|NCT02214121|100598052|FG000|Part A|Patient decision|2|||
33188393|NCT02214121|100598053|FG001|Part A|Patient decision|0|||
33188394|NCT02214121|100598054|FG002|Part A|Patient decision|0|||
33188395|NCT02214121|100598052|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
33188396|NCT02214121|100598053|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
33188397|NCT02214121|100598054|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
33188398|NCT02214121|100598052|FG000|Part A|Other|1|||
33188399|NCT02214121|100598053|FG001|Part A|Other|0|||
33188400|NCT02214121|100598054|FG002|Part A|Other|0|||
33188401|NCT02214121|100598052|FG000|Part B|Patient decision|0|||
33188402|NCT02214121|100598053|FG001|Part B|Patient decision|1|||
33188403|NCT02214121|100598054|FG002|Part B|Patient decision|0|||
33188404|NCT02214121|100598052|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
33188405|NCT02214121|100598053|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
33188406|NCT02214121|100598054|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
33188407|NCT02214121|100598052|FG000|Part B|Lost to Follow-up|0|||
33294906|NCT00730015|100975466|FG001|Overall Study|Withdrawal by Subject|12|||
33294907|NCT00730015|100975467|FG002|Overall Study|Withdrawal by Subject|8|||
33188408|NCT02214121|100598053|FG001|Part B|Lost to Follow-up|0|||
33188409|NCT02214121|100598054|FG002|Part B|Lost to Follow-up|1|||
33188410|NCT01467076|100598057|FG000|Overall Study|Lost to Follow-up|1|||
33188411|NCT01467076|100598058|FG001|Overall Study|Lost to Follow-up|0|||
33188412|NCT01467076|100598059|FG002|Overall Study|Lost to Follow-up|0|||
33188413|NCT00684424|100598070|FG000|Overall Study|Adverse Event|1|||
33188414|NCT00684424|100598070|FG000|Overall Study|Lost to Follow-up|2|||
33294908|NCT00730015|100975465|FG000|Overall Study|Lost to Follow-up|4|||
33294909|NCT00730015|100975466|FG001|Overall Study|Lost to Follow-up|10|||
33294910|NCT00730015|100975467|FG002|Overall Study|Lost to Follow-up|3|||
33294911|NCT00730015|100975465|FG000|Overall Study|Lack of Efficacy|1|||
33188415|NCT00684424|100598070|FG000|Overall Study|Other|2|||
33188416|NCT03467425|100598074|FG000|Overall Study|Adverse Event|9|||
33188417|NCT03467425|100598075|FG001|Overall Study|Adverse Event|9|||
33391768|NCT02327078|101321868|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
33188418|NCT03467425|100598074|FG000|Overall Study|Lack of Efficacy|3|||
33188419|NCT03467425|100598075|FG001|Overall Study|Lack of Efficacy|1|||
33188420|NCT03467425|100598074|FG000|Overall Study|Protocol Violation|0|||
33188421|NCT03467425|100598075|FG001|Overall Study|Protocol Violation|1|||
33188422|NCT03467425|100598074|FG000|Overall Study|Lost to Follow-up|18|||
33188423|NCT03467425|100598075|FG001|Overall Study|Lost to Follow-up|25|||
33188424|NCT03467425|100598074|FG000|Overall Study|Physician Decision|2|||
33188425|NCT03467425|100598075|FG001|Overall Study|Physician Decision|1|||
33188426|NCT03467425|100598074|FG000|Overall Study|Withdrawal by Subject|15|||
33417155|NCT01861717|101420218|FG000|Overall Study|Withdrawal by Subject|1|||
33188427|NCT03467425|100598075|FG001|Overall Study|Withdrawal by Subject|17|||
33188428|NCT02256891|100598080|FG000|Overall Study|Death|0|||
33188429|NCT02256891|100598081|FG001|Overall Study|Death|2|||
33188430|NCT02256891|100598080|FG000|Overall Study|Lost to Follow-up|0|||
33188431|NCT02256891|100598081|FG001|Overall Study|Lost to Follow-up|3|||
33188432|NCT02256891|100598080|FG000|Overall Study|Physician Decision|7|||
33188433|NCT02256891|100598081|FG001|Overall Study|Physician Decision|3|||
33188434|NCT02256891|100598080|FG000|Overall Study|Screen Fail|5|||
33188435|NCT02256891|100598081|FG001|Overall Study|Screen Fail|4|||
33188436|NCT02256891|100598080|FG000|Overall Study|Equipment Malfunction|0|||
33188437|NCT02256891|100598081|FG001|Overall Study|Equipment Malfunction|1|||
33188438|NCT02365636|100598082|FG000|Overall Study|Adverse Event|3|||
33294912|NCT00730015|100975466|FG001|Overall Study|Lack of Efficacy|2|||
33188439|NCT02365636|100598083|FG001|Overall Study|Adverse Event|3|||
33188440|NCT02365636|100598084|FG002|Overall Study|Adverse Event|2|||
33188441|NCT02365636|100598082|FG000|Overall Study|Protocol Violation|1|||
33188442|NCT02365636|100598083|FG001|Overall Study|Protocol Violation|4|||
33188443|NCT02365636|100598084|FG002|Overall Study|Protocol Violation|0|||
33188444|NCT02365636|100598082|FG000|Overall Study|Lost to Follow-up|0|||
33188445|NCT02365636|100598083|FG001|Overall Study|Lost to Follow-up|0|||
33188446|NCT02365636|100598084|FG002|Overall Study|Lost to Follow-up|1|||
33188447|NCT02365636|100598082|FG000|Overall Study|Other|2|||
33188448|NCT02365636|100598083|FG001|Overall Study|Other|0|||
33188449|NCT02365636|100598084|FG002|Overall Study|Other|0|||
33188450|NCT02510794|100598085|FG000|Overall Study|Adverse Event|0|||
33188451|NCT02510794|100598086|FG001|Overall Study|Adverse Event|1|||
33188452|NCT02510794|100598087|FG002|Overall Study|Adverse Event|0|||
33188453|NCT02510794|100598088|FG003|Overall Study|Adverse Event|0|||
33188454|NCT02510794|100598085|FG000|Overall Study|Death|1|||
33188455|NCT02510794|100598086|FG001|Overall Study|Death|2|||
33188456|NCT02510794|100598087|FG002|Overall Study|Death|1|||
33188457|NCT02510794|100598088|FG003|Overall Study|Death|1|||
33188458|NCT02510794|100598085|FG000|Overall Study|Lack of Efficacy|3|||
33188459|NCT02510794|100598086|FG001|Overall Study|Lack of Efficacy|1|||
33188460|NCT02510794|100598087|FG002|Overall Study|Lack of Efficacy|1|||
33188461|NCT02510794|100598088|FG003|Overall Study|Lack of Efficacy|0|||
33188462|NCT02510794|100598085|FG000|Overall Study|Participant moved out of the area|0|||
33188463|NCT02510794|100598086|FG001|Overall Study|Participant moved out of the area|0|||
33188464|NCT02510794|100598087|FG002|Overall Study|Participant moved out of the area|0|||
33188465|NCT02510794|100598088|FG003|Overall Study|Participant moved out of the area|1|||
33188466|NCT02510794|100598085|FG000|Overall Study|Physician Decision|3|||
33188467|NCT02510794|100598086|FG001|Overall Study|Physician Decision|0|||
33188468|NCT02510794|100598087|FG002|Overall Study|Physician Decision|0|||
33188469|NCT02510794|100598088|FG003|Overall Study|Physician Decision|0|||
33188470|NCT02510794|100598085|FG000|Overall Study|Protocol Violation|0|||
33188471|NCT02510794|100598086|FG001|Overall Study|Protocol Violation|0|||
33188472|NCT02510794|100598087|FG002|Overall Study|Protocol Violation|1|||
33188473|NCT02510794|100598088|FG003|Overall Study|Protocol Violation|0|||
33188474|NCT02510794|100598085|FG000|Overall Study|Withdrawal by Subject|1|||
33188475|NCT02510794|100598086|FG001|Overall Study|Withdrawal by Subject|2|||
33188476|NCT02510794|100598087|FG002|Overall Study|Withdrawal by Subject|4|||
33188477|NCT02510794|100598088|FG003|Overall Study|Withdrawal by Subject|3|||
33188478|NCT02272413|100598095|FG000|Randomized Through Treatment Start|Not treated|3|||
33188479|NCT02272413|100598096|FG001|Randomized Through Treatment Start|Not treated|5|||
33188480|NCT02272413|100598095|FG000|Pre-switch Period|Adverse Event|38|||
33188481|NCT02272413|100598096|FG001|Pre-switch Period|Adverse Event|37|||
33188482|NCT02272413|100598095|FG000|Pre-switch Period|Death|26|||
33188483|NCT02272413|100598096|FG001|Pre-switch Period|Death|26|||
33188484|NCT02272413|100598095|FG000|Pre-switch Period|Withdrawal by Subject|27|||
33188485|NCT02272413|100598096|FG001|Pre-switch Period|Withdrawal by Subject|15|||
33188486|NCT02272413|100598095|FG000|Pre-switch Period|Physician Decision|6|||
33188487|NCT02272413|100598096|FG001|Pre-switch Period|Physician Decision|18|||
33188488|NCT02272413|100598095|FG000|Pre-switch Period|Progressive disease|185|||
33188489|NCT02272413|100598096|FG001|Pre-switch Period|Progressive disease|173|||
33188490|NCT02272413|100598095|FG000|Pre-switch Period|Lost to Follow-up|0|||
33188491|NCT02272413|100598096|FG001|Pre-switch Period|Lost to Follow-up|2|||
33188492|NCT02272413|100598095|FG000|Pre-switch Period|Protocol Violation|1|||
33188493|NCT02272413|100598096|FG001|Pre-switch Period|Protocol Violation|0|||
33188494|NCT02272413|100598095|FG000|Pre-switch Period|Other than listed|10|||
33294913|NCT00730015|100975467|FG002|Overall Study|Lack of Efficacy|8|||
33188495|NCT02272413|100598096|FG001|Pre-switch Period|Other than listed|11|||
33188496|NCT02272413|100598095|FG000|Post-switch Period|Adverse Event|4|||
33188497|NCT02272413|100598096|FG001|Post-switch Period|Adverse Event|4|||
33188498|NCT02272413|100598095|FG000|Post-switch Period|Death|3|||
33188499|NCT02272413|100598096|FG001|Post-switch Period|Death|2|||
33188500|NCT02272413|100598095|FG000|Post-switch Period|Withdrawal by Subject|1|||
33188501|NCT02272413|100598096|FG001|Post-switch Period|Withdrawal by Subject|2|||
33188502|NCT02272413|100598095|FG000|Post-switch Period|Physician Decision|1|||
33188503|NCT02272413|100598096|FG001|Post-switch Period|Physician Decision|1|||
33188504|NCT02272413|100598095|FG000|Post-switch Period|Progressive disease|21|||
33188505|NCT02272413|100598096|FG001|Post-switch Period|Progressive disease|21|||
33188506|NCT02272413|100598095|FG000|Post-switch Period|Study terminated by sponsor|8|||
33188507|NCT02272413|100598096|FG001|Post-switch Period|Study terminated by sponsor|11|||
33188508|NCT02272413|100598095|FG000|Post-switch Period|Other than listed|4|||
33188509|NCT02272413|100598096|FG001|Post-switch Period|Other than listed|5|||
33188510|NCT02547129|100598097|FG000|Overall Study|Difficulty with ongoing infection|1|||
33188511|NCT02547129|100598098|FG001|Overall Study|Difficulty with ongoing infection|0|||
33188512|NCT04365699|100598099|FG000|Overall Study|Death|2|||
33188513|NCT04365699|100598100|FG001|Overall Study|Death|5|||
33188514|NCT04365699|100598101|FG002|Overall Study|Death|15|||
33188515|NCT01577758|100598102|FG000|Dose Escalation Phase|Adverse Event|0|||
33188516|NCT01577758|100598103|FG001|Dose Escalation Phase|Adverse Event|0|||
33188517|NCT01577758|100598104|FG002|Dose Escalation Phase|Adverse Event|0|||
33188518|NCT01577758|100598105|FG003|Dose Escalation Phase|Adverse Event|0|||
33188519|NCT01577758|100598106|FG004|Dose Escalation Phase|Adverse Event|0|||
33188520|NCT01577758|100598107|FG005|Dose Escalation Phase|Adverse Event|2|||
33188521|NCT01577758|100598108|FG006|Dose Escalation Phase|Adverse Event|1|||
33188522|NCT01577758|100598109|FG007|Dose Escalation Phase|Adverse Event|0|||
33188523|NCT01577758|100598102|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
33188524|NCT01577758|100598103|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
33188525|NCT01577758|100598104|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
33188526|NCT01577758|100598105|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
33188527|NCT01577758|100598106|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
33188528|NCT01577758|100598107|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
33188529|NCT01577758|100598108|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
33188530|NCT01577758|100598109|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
33188531|NCT01577758|100598102|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
33188532|NCT01577758|100598103|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
33188533|NCT01577758|100598104|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
33188534|NCT01577758|100598105|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
33188535|NCT01577758|100598106|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
33188536|NCT01577758|100598107|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
33188537|NCT01577758|100598108|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
33188538|NCT01577758|100598109|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
33188539|NCT01577758|100598102|FG000|Dose Escalation Phase|Progression Disease|2|||
33188540|NCT01577758|100598103|FG001|Dose Escalation Phase|Progression Disease|2|||
33294914|NCT00730015|100975465|FG000|Overall Study|Other Reason|1|||
33294915|NCT00730015|100975466|FG001|Overall Study|Other Reason|0|||
33294916|NCT00730015|100975467|FG002|Overall Study|Other Reason|1|||
33294917|NCT05071313|100975470|FG000|Overall Study|Lost to Follow-up|17|||
33294918|NCT05071313|100975471|FG001|Overall Study|Lost to Follow-up|10|||
33294919|NCT05071313|100975470|FG000|Overall Study|Physician Decision|1|||
33294920|NCT05071313|100975471|FG001|Overall Study|Physician Decision|6|||
33294921|NCT05071313|100975470|FG000|Overall Study|Death|1|||
33294922|NCT05071313|100975471|FG001|Overall Study|Death|0|||
33294923|NCT05071313|100975470|FG000|Overall Study|Withdrawal by Subject|10|||
33294924|NCT05071313|100975471|FG001|Overall Study|Withdrawal by Subject|15|||
33294925|NCT05071313|100975470|FG000|Overall Study|Other|1|||
33294926|NCT05071313|100975471|FG001|Overall Study|Other|0|||
33294927|NCT05071313|100975470|FG000|Overall Study|Randomized but not vaccinated|4|||
33294928|NCT05071313|100975471|FG001|Overall Study|Randomized but not vaccinated|2|||
33294929|NCT03358238|100975472|FG000|Overall Study|Withdrawal by Subject|0|||
33294930|NCT03358238|100975473|FG001|Overall Study|Withdrawal by Subject|1|||
33294931|NCT02614183|100975474|FG000|Double Blind Treatment Phase|Adverse Event|10|||
33294932|NCT02614183|100975475|FG001|Double Blind Treatment Phase|Adverse Event|9|||
33294933|NCT02614183|100975476|FG002|Double Blind Treatment Phase|Adverse Event|7|||
33294934|NCT02614183|100975474|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
33294935|NCT02614183|100975475|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
33294936|NCT02614183|100975476|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
33294937|NCT02614183|100975474|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
33294938|NCT02614183|100975475|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
33294939|NCT02614183|100975476|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
33294940|NCT02614183|100975474|FG000|Double Blind Treatment Phase|Physician Decision|7|||
33294941|NCT02614183|100975475|FG001|Double Blind Treatment Phase|Physician Decision|3|||
33391769|NCT02327078|101321869|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
33391770|NCT02327078|101321870|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
33391771|NCT02327078|101321871|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
33294942|NCT02614183|100975476|FG002|Double Blind Treatment Phase|Physician Decision|2|||
33294943|NCT02614183|100975474|FG000|Double Blind Treatment Phase|Pregnancy|2|||
33294944|NCT02614183|100975475|FG001|Double Blind Treatment Phase|Pregnancy|1|||
33294945|NCT02614183|100975476|FG002|Double Blind Treatment Phase|Pregnancy|3|||
33294946|NCT02614183|100975474|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
33294947|NCT02614183|100975475|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
33294948|NCT02614183|100975476|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
33294949|NCT02614183|100975474|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
33294950|NCT02614183|100975475|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
33294951|NCT02614183|100975476|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
33294952|NCT02614183|100975474|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
33294953|NCT02614183|100975475|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
33294954|NCT02614183|100975476|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
33294955|NCT02614183|100975474|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
33294956|NCT02614183|100975475|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
33294957|NCT02614183|100975476|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
33294958|NCT02614183|100975474|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
33294959|NCT02614183|100975475|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
33294960|NCT02614183|100975476|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
33294961|NCT02614183|100975474|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
33294962|NCT02614183|100975475|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
33294963|NCT02614183|100975476|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
33294964|NCT02614183|100975474|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
33294965|NCT02614183|100975475|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
33294966|NCT02614183|100975476|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
33294967|NCT01663506|100975477|FG000|Overall Study|Lack of Efficacy|3|||
33294968|NCT01663506|100975477|FG000|Overall Study|Consent Withdrawal by Subject|1|||
33294969|NCT01663506|100975477|FG000|Overall Study|Lost to Follow-up|1|||
33294970|NCT01663506|100975477|FG000|Overall Study|Adverse Event|1|||
33294971|NCT01663506|100975477|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
33294972|NCT01999972|100975478|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
33294973|NCT01999972|100975479|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
33391772|NCT02327078|101321872|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
33391773|NCT02327078|101321873|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
33391774|NCT02327078|101321874|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
33294974|NCT01999972|100975480|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
33294975|NCT01999972|100975481|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
33294976|NCT01999972|100975482|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
33294977|NCT01999972|100975483|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
33294978|NCT01999972|100975478|FG000|Dose Escalation Part|Death|0|||
33294979|NCT01999972|100975479|FG001|Dose Escalation Part|Death|1|||
33294980|NCT01999972|100975480|FG002|Dose Escalation Part|Death|0|||
33294981|NCT01999972|100975481|FG003|Dose Escalation Part|Death|0|||
33294982|NCT01999972|100975482|FG004|Dose Escalation Part|Death|0|||
33294983|NCT01999972|100975483|FG005|Dose Escalation Part|Death|0|||
33294984|NCT01999972|100975478|FG000|Dose Escalation Part|Enrolled but not treated|0|||
33294985|NCT01999972|100975479|FG001|Dose Escalation Part|Enrolled but not treated|0|||
33294986|NCT01999972|100975480|FG002|Dose Escalation Part|Enrolled but not treated|1|||
33294987|NCT01999972|100975481|FG003|Dose Escalation Part|Enrolled but not treated|1|||
33294988|NCT01999972|100975482|FG004|Dose Escalation Part|Enrolled but not treated|0|||
33294989|NCT01999972|100975483|FG005|Dose Escalation Part|Enrolled but not treated|0|||
33294990|NCT01999972|100975478|FG000|Dose Escalation Part|Disease progression|3|||
33294991|NCT01999972|100975479|FG001|Dose Escalation Part|Disease progression|2|||
33294992|NCT01999972|100975480|FG002|Dose Escalation Part|Disease progression|3|||
33294993|NCT01999972|100975481|FG003|Dose Escalation Part|Disease progression|6|||
33294994|NCT01999972|100975482|FG004|Dose Escalation Part|Disease progression|0|||
33294995|NCT01999972|100975483|FG005|Dose Escalation Part|Disease progression|0|||
33294996|NCT01999972|100975478|FG000|Dose Escalation Part|Adverse Event|0|||
33294997|NCT01999972|100975479|FG001|Dose Escalation Part|Adverse Event|0|||
33294998|NCT01999972|100975480|FG002|Dose Escalation Part|Adverse Event|0|||
33294999|NCT01999972|100975481|FG003|Dose Escalation Part|Adverse Event|2|||
33295000|NCT01999972|100975482|FG004|Dose Escalation Part|Adverse Event|0|||
33295001|NCT01999972|100975483|FG005|Dose Escalation Part|Adverse Event|0|||
33295002|NCT01999972|100975478|FG000|Dose Escalation Part|Global deterioration of health status|1|||
33295003|NCT01999972|100975479|FG001|Dose Escalation Part|Global deterioration of health status|0|||
33295004|NCT01999972|100975480|FG002|Dose Escalation Part|Global deterioration of health status|0|||
33295005|NCT01999972|100975481|FG003|Dose Escalation Part|Global deterioration of health status|1|||
33295006|NCT01999972|100975482|FG004|Dose Escalation Part|Global deterioration of health status|0|||
33295007|NCT01999972|100975483|FG005|Dose Escalation Part|Global deterioration of health status|0|||
33295008|NCT01999972|100975478|FG000|Dose Expansion Part|Death|0|||
33295009|NCT01999972|100975479|FG001|Dose Expansion Part|Death|0|||
33295010|NCT01999972|100975480|FG002|Dose Expansion Part|Death|0|||
33295011|NCT01999972|100975481|FG003|Dose Expansion Part|Death|0|||
33295012|NCT01999972|100975482|FG004|Dose Expansion Part|Death|2|||
33295013|NCT01999972|100975483|FG005|Dose Expansion Part|Death|1|||
33295014|NCT01999972|100975478|FG000|Dose Expansion Part|Disease progression|0|||
33295015|NCT01999972|100975479|FG001|Dose Expansion Part|Disease progression|0|||
33295016|NCT01999972|100975480|FG002|Dose Expansion Part|Disease progression|0|||
33295017|NCT01999972|100975481|FG003|Dose Expansion Part|Disease progression|0|||
33295018|NCT01999972|100975482|FG004|Dose Expansion Part|Disease progression|9|||
33295019|NCT01999972|100975483|FG005|Dose Expansion Part|Disease progression|3|||
33295020|NCT01999972|100975478|FG000|Dose Expansion Part|Sponsor decision|0|||
33295021|NCT01999972|100975479|FG001|Dose Expansion Part|Sponsor decision|0|||
33295022|NCT01999972|100975480|FG002|Dose Expansion Part|Sponsor decision|0|||
33295023|NCT01999972|100975481|FG003|Dose Expansion Part|Sponsor decision|0|||
33295024|NCT01999972|100975482|FG004|Dose Expansion Part|Sponsor decision|1|||
33295025|NCT01999972|100975483|FG005|Dose Expansion Part|Sponsor decision|0|||
33295026|NCT01999972|100975478|FG000|Dose Expansion Part|Adverse Event|0|||
33295027|NCT01999972|100975479|FG001|Dose Expansion Part|Adverse Event|0|||
33295028|NCT01999972|100975480|FG002|Dose Expansion Part|Adverse Event|0|||
33295029|NCT01999972|100975481|FG003|Dose Expansion Part|Adverse Event|0|||
33295030|NCT01999972|100975482|FG004|Dose Expansion Part|Adverse Event|4|||
33295031|NCT01999972|100975483|FG005|Dose Expansion Part|Adverse Event|2|||
33295032|NCT01999972|100975478|FG000|Dose Expansion Part|Participant's non-compliance|0|||
33295033|NCT01999972|100975479|FG001|Dose Expansion Part|Participant's non-compliance|0|||
33295034|NCT01999972|100975480|FG002|Dose Expansion Part|Participant's non-compliance|0|||
33295035|NCT01999972|100975481|FG003|Dose Expansion Part|Participant's non-compliance|0|||
33295036|NCT01999972|100975482|FG004|Dose Expansion Part|Participant's non-compliance|0|||
33295037|NCT01999972|100975483|FG005|Dose Expansion Part|Participant's non-compliance|1|||
33295038|NCT01999972|100975478|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
33295039|NCT01999972|100975479|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
33295040|NCT01999972|100975480|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
33295041|NCT01999972|100975481|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
33391775|NCT02327078|101321866|FG000|Overall Study|Death|2|||
33295042|NCT01999972|100975482|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
33295043|NCT01999972|100975483|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
33295044|NCT01999972|100975478|FG000|Dose Expansion Part|Changed to standard of care|0|||
33295045|NCT01999972|100975479|FG001|Dose Expansion Part|Changed to standard of care|0|||
33295046|NCT01999972|100975480|FG002|Dose Expansion Part|Changed to standard of care|0|||
33295047|NCT01999972|100975481|FG003|Dose Expansion Part|Changed to standard of care|0|||
33295048|NCT01999972|100975482|FG004|Dose Expansion Part|Changed to standard of care|1|||
33295049|NCT01999972|100975483|FG005|Dose Expansion Part|Changed to standard of care|0|||
33295050|NCT00971997|100975486|FG000|Overall Study|Adverse Event|2|||
33295051|NCT00971997|100975486|FG000|Overall Study|Death|1|||
33295052|NCT00971997|100975486|FG000|Overall Study|Protocol Violation|4|||
33295053|NCT00971997|100975486|FG000|Overall Study|Withdrawal by Subject|5|||
33391776|NCT02327078|101321867|FG001|Overall Study|Death|4|||
33391777|NCT02327078|101321868|FG002|Overall Study|Death|10|||
33391778|NCT02327078|101321869|FG003|Overall Study|Death|6|||
33391779|NCT02327078|101321870|FG004|Overall Study|Death|4|||
33391780|NCT02327078|101321871|FG005|Overall Study|Death|3|||
33391781|NCT02327078|101321872|FG006|Overall Study|Death|2|||
33391782|NCT02327078|101321873|FG007|Overall Study|Death|51|||
33391783|NCT02327078|101321874|FG008|Overall Study|Death|97|||
33391784|NCT02327078|101321866|FG000|Overall Study|Lost to Follow-up|0|||
33391785|NCT02327078|101321867|FG001|Overall Study|Lost to Follow-up|1|||
33391786|NCT02327078|101321868|FG002|Overall Study|Lost to Follow-up|1|||
33391787|NCT02327078|101321869|FG003|Overall Study|Lost to Follow-up|0|||
33391788|NCT02327078|101321870|FG004|Overall Study|Lost to Follow-up|0|||
33391789|NCT02327078|101321871|FG005|Overall Study|Lost to Follow-up|0|||
33391790|NCT02327078|101321872|FG006|Overall Study|Lost to Follow-up|0|||
33391791|NCT02327078|101321873|FG007|Overall Study|Lost to Follow-up|2|||
33391792|NCT02327078|101321874|FG008|Overall Study|Lost to Follow-up|5|||
33391793|NCT02327078|101321866|FG000|Overall Study|Site Terminated by Sponsor|1|||
33295054|NCT00971997|100975486|FG000|Overall Study|Physician Decision|7|||
33295055|NCT00570908|100975487|FG000|Overall Study|Adverse Event|5|||
33295056|NCT00570908|100975487|FG000|Overall Study|Withdrawal by Subject|2|||
33295057|NCT02336425|100975492|FG000|Overall Study|Study terminated.|2|||
33295058|NCT02336425|100975493|FG001|Overall Study|Study terminated.|2|||
33295059|NCT02336425|100975494|FG002|Overall Study|Study terminated.|3|||
33295060|NCT02336425|100975495|FG003|Overall Study|Study terminated.|3|||
33295061|NCT00955708|100975496|FG000|Overall Study|Death|269|||
33295062|NCT00955708|100975496|FG000|Overall Study|Lost to Follow-up|72|||
33295063|NCT00955708|100975496|FG000|Overall Study|Physician Decision|36|||
33295064|NCT00955708|100975496|FG000|Overall Study|Protocol Violation|134|||
33295065|NCT00955708|100975496|FG000|Overall Study|Registry Conclusion|186|||
33391794|NCT02327078|101321867|FG001|Overall Study|Site Terminated by Sponsor|0|||
33391795|NCT02327078|101321868|FG002|Overall Study|Site Terminated by Sponsor|1|||
33391796|NCT02327078|101321869|FG003|Overall Study|Site Terminated by Sponsor|4|||
33391797|NCT02327078|101321870|FG004|Overall Study|Site Terminated by Sponsor|0|||
33391798|NCT02327078|101321871|FG005|Overall Study|Site Terminated by Sponsor|0|||
33391799|NCT02327078|101321872|FG006|Overall Study|Site Terminated by Sponsor|0|||
33391800|NCT02327078|101321873|FG007|Overall Study|Site Terminated by Sponsor|11|||
33391801|NCT02327078|101321874|FG008|Overall Study|Site Terminated by Sponsor|25|||
33391802|NCT02327078|101321866|FG000|Overall Study|Physician Decision|0|||
33391803|NCT02327078|101321867|FG001|Overall Study|Physician Decision|0|||
33391804|NCT02327078|101321868|FG002|Overall Study|Physician Decision|0|||
33391805|NCT02327078|101321869|FG003|Overall Study|Physician Decision|1|||
33391806|NCT02327078|101321870|FG004|Overall Study|Physician Decision|0|||
33188541|NCT01577758|100598104|FG002|Dose Escalation Phase|Progression Disease|1|||
33188542|NCT01577758|100598105|FG003|Dose Escalation Phase|Progression Disease|2|||
33188543|NCT01577758|100598106|FG004|Dose Escalation Phase|Progression Disease|5|||
33188544|NCT01577758|100598107|FG005|Dose Escalation Phase|Progression Disease|0|||
33188545|NCT01577758|100598108|FG006|Dose Escalation Phase|Progression Disease|0|||
33188546|NCT01577758|100598109|FG007|Dose Escalation Phase|Progression Disease|0|||
33188547|NCT01577758|100598102|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
33188548|NCT01577758|100598103|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
33188549|NCT01577758|100598104|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
33188550|NCT01577758|100598105|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
33188551|NCT01577758|100598106|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
33188552|NCT01577758|100598107|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
33188553|NCT01577758|100598108|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
33188554|NCT01577758|100598109|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
33188555|NCT01577758|100598102|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
33295066|NCT00955708|100975496|FG000|Overall Study|Product removed from service|94|||
33391807|NCT02327078|101321871|FG005|Overall Study|Physician Decision|0|||
33188556|NCT01577758|100598103|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
33188557|NCT01577758|100598104|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
33188558|NCT01577758|100598105|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
33188559|NCT01577758|100598106|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
33391808|NCT02327078|101321872|FG006|Overall Study|Physician Decision|0|||
33391809|NCT02327078|101321873|FG007|Overall Study|Physician Decision|0|||
33391810|NCT02327078|101321874|FG008|Overall Study|Physician Decision|1|||
33391811|NCT02327078|101321866|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
33391812|NCT02327078|101321867|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
33391813|NCT02327078|101321868|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
33391814|NCT02327078|101321869|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
33391815|NCT02327078|101321870|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
33391816|NCT02327078|101321871|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
33391817|NCT02327078|101321872|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
33391818|NCT02327078|101321873|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
33391819|NCT02327078|101321874|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
33391820|NCT02327078|101321866|FG000|Overall Study|Reason not Specified|0|||
33391821|NCT02327078|101321867|FG001|Overall Study|Reason not Specified|0|||
33391822|NCT02327078|101321868|FG002|Overall Study|Reason not Specified|0|||
33391823|NCT02327078|101321869|FG003|Overall Study|Reason not Specified|0|||
33391824|NCT02327078|101321870|FG004|Overall Study|Reason not Specified|0|||
33600105|NCT04493684|102088503|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33600106|NCT04493684|102088504|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33600107|NCT04493684|102088505|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33600108|NCT04493684|102088506|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33600109|NCT04493684|102088507|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33600110|NCT04493684|102088508|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33600111|NCT04493684|102088509|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33600112|NCT04493684|102088510|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33600113|NCT04493684|102088511|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33600114|NCT04493684|102088512|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33600115|NCT04493684|102088513|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
33600116|NCT04493684|102088514|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
33600117|NCT04493684|102088498|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33600118|NCT04493684|102088499|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33600119|NCT04493684|102088500|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33600120|NCT04493684|102088501|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33600121|NCT04493684|102088502|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33600122|NCT04493684|102088503|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33391825|NCT02327078|101321871|FG005|Overall Study|Reason not Specified|0|||
33188560|NCT01577758|100598107|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
33188561|NCT01577758|100598108|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
33188562|NCT01577758|100598109|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
33188563|NCT01577758|100598102|FG000|mCRC Expansion Phase|Progression Disease|0|||
33188564|NCT01577758|100598103|FG001|mCRC Expansion Phase|Progression Disease|0|||
33188565|NCT01577758|100598104|FG002|mCRC Expansion Phase|Progression Disease|0|||
33188566|NCT01577758|100598105|FG003|mCRC Expansion Phase|Progression Disease|0|||
33188567|NCT01577758|100598106|FG004|mCRC Expansion Phase|Progression Disease|0|||
33188568|NCT01577758|100598107|FG005|mCRC Expansion Phase|Progression Disease|0|||
33188569|NCT01577758|100598108|FG006|mCRC Expansion Phase|Progression Disease|0|||
33188570|NCT01577758|100598109|FG007|mCRC Expansion Phase|Progression Disease|19|||
33188571|NCT00952341|100598110|FG000|Cycle 1|Adverse Event|4|||
33188572|NCT00952341|100598111|FG001|Cycle 1|Adverse Event|1|||
33188573|NCT00952341|100598110|FG000|Cycle 1|Withdrawal by Subject|3|||
33188574|NCT00952341|100598111|FG001|Cycle 1|Withdrawal by Subject|8|||
33188575|NCT00952341|100598110|FG000|Cycle 1|Protocol Violation|2|||
33188576|NCT00952341|100598111|FG001|Cycle 1|Protocol Violation|1|||
33188577|NCT00952341|100598110|FG000|Cycle 1|Lost to Follow-up|11|||
33391826|NCT02327078|101321872|FG006|Overall Study|Reason not Specified|0|||
33391827|NCT02327078|101321873|FG007|Overall Study|Reason not Specified|5|||
33391828|NCT02327078|101321874|FG008|Overall Study|Reason not Specified|12|||
33188578|NCT00952341|100598111|FG001|Cycle 1|Lost to Follow-up|2|||
33188579|NCT00952341|100598110|FG000|Cycle 1|Physician Decision|0|||
33188580|NCT00952341|100598111|FG001|Cycle 1|Physician Decision|1|||
33188581|NCT00952341|100598110|FG000|Cycle 2|Withdrawal by Subject|1|||
33188582|NCT00952341|100598111|FG001|Cycle 2|Withdrawal by Subject|1|||
33188583|NCT00952341|100598110|FG000|Cycle 2|Protocol Violation|1|||
33188584|NCT00952341|100598111|FG001|Cycle 2|Protocol Violation|0|||
33188585|NCT00952341|100598110|FG000|Cycle 2|Lost to Follow-up|6|||
33188586|NCT00952341|100598111|FG001|Cycle 2|Lost to Follow-up|9|||
33188587|NCT00952341|100598110|FG000|Cycle 2|Physician Decision|1|||
33188588|NCT00952341|100598111|FG001|Cycle 2|Physician Decision|1|||
33188589|NCT00952341|100598110|FG000|Cycle 2|Progressive Disease|0|||
33188590|NCT00952341|100598111|FG001|Cycle 2|Progressive Disease|1|||
33188591|NCT04238728|100598114|FG000|Overall Study|Withdrawal by Subject|1|||
33188592|NCT04238728|100598114|FG000|Overall Study|Lost to Follow-up|2|||
33188593|NCT01190254|100598115|FG000|Overall Study|Adverse Event|3|||
33188594|NCT01190254|100598116|FG001|Overall Study|Adverse Event|6|||
33188595|NCT01190254|100598117|FG002|Overall Study|Adverse Event|8|||
33188596|NCT01190254|100598115|FG000|Overall Study|Lack of Efficacy|7|||
33188597|NCT01190254|100598116|FG001|Overall Study|Lack of Efficacy|4|||
33188598|NCT01190254|100598117|FG002|Overall Study|Lack of Efficacy|5|||
33188599|NCT01190254|100598115|FG000|Overall Study|Lost to Follow-up|4|||
33188600|NCT01190254|100598116|FG001|Overall Study|Lost to Follow-up|2|||
33188601|NCT01190254|100598117|FG002|Overall Study|Lost to Follow-up|0|||
33188602|NCT01190254|100598115|FG000|Overall Study|Withdrawal by Subject|4|||
33188603|NCT01190254|100598116|FG001|Overall Study|Withdrawal by Subject|5|||
33188604|NCT01190254|100598117|FG002|Overall Study|Withdrawal by Subject|7|||
33188605|NCT01190254|100598115|FG000|Overall Study|Protocol Violation|2|||
33188606|NCT01190254|100598116|FG001|Overall Study|Protocol Violation|0|||
33188607|NCT01190254|100598117|FG002|Overall Study|Protocol Violation|2|||
33188608|NCT01190254|100598115|FG000|Overall Study|Did not meet protocol eligibility|1|||
33188609|NCT01190254|100598116|FG001|Overall Study|Did not meet protocol eligibility|0|||
33188610|NCT01190254|100598117|FG002|Overall Study|Did not meet protocol eligibility|0|||
33188611|NCT04019041|100598121|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
33188612|NCT04019041|100598122|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
33188613|NCT04019041|100598123|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
33188614|NCT04019041|100598124|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
33188615|NCT04019041|100598125|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
33188616|NCT04019041|100598126|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
33188617|NCT04019041|100598121|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
33188618|NCT04019041|100598122|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
33188619|NCT04019041|100598123|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
33188620|NCT04019041|100598124|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
33188621|NCT04019041|100598125|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
33188622|NCT04019041|100598126|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
33188623|NCT04019041|100598121|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
33188624|NCT04019041|100598122|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
33188625|NCT04019041|100598123|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
33188626|NCT04019041|100598124|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
33391829|NCT00373880|101321878|FG000|Overall Study|Physician Decision|3|||
33188627|NCT04019041|100598125|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
33188628|NCT04019041|100598126|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
33188629|NCT04019041|100598121|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
33391830|NCT00373880|101321878|FG000|Overall Study|Arrested|1|||
33188630|NCT04019041|100598122|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
33188631|NCT04019041|100598123|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
33188632|NCT04019041|100598124|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
33188633|NCT04019041|100598125|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
33188634|NCT04019041|100598126|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
33188635|NCT04019041|100598121|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
33188636|NCT04019041|100598122|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
33391831|NCT00373880|101321878|FG000|Overall Study|Protocol Violation|14|||
33188637|NCT04019041|100598123|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
33188638|NCT04019041|100598124|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
33188639|NCT04019041|100598125|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
33188640|NCT04019041|100598126|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
33188641|NCT04019041|100598121|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
33188642|NCT04019041|100598122|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
33188643|NCT04019041|100598123|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
33188644|NCT04019041|100598124|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
33188645|NCT04019041|100598125|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
33188646|NCT04019041|100598126|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
33188647|NCT04019041|100598121|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
33188648|NCT04019041|100598122|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
33188649|NCT04019041|100598123|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
33188650|NCT04019041|100598124|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
33188651|NCT04019041|100598125|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
33188652|NCT04019041|100598126|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
33188653|NCT04019041|100598121|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
33188654|NCT04019041|100598122|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
33188655|NCT04019041|100598123|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
33188656|NCT04019041|100598124|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
33188657|NCT04019041|100598125|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
33188658|NCT04019041|100598126|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
33295067|NCT00955708|100975496|FG000|Overall Study|Patient Refused to participate further|116|||
33295068|NCT00955708|100975496|FG000|Overall Study|Closure of study location|60|||
33295069|NCT00955708|100975496|FG000|Overall Study|Patient changed care provider/moved|91|||
33295070|NCT01165177|100975504|FG000|Overall Study|Serious Adverse Event|227|||
33295071|NCT01165177|100975505|FG001|Overall Study|Serious Adverse Event|235|||
33295072|NCT01165177|100975504|FG000|Overall Study|Withdrawal by Subject|368|||
33391832|NCT02470429|101321881|FG000|Overall Study|Adverse Event|1|||
33391833|NCT02470429|101321882|FG001|Overall Study|Adverse Event|0|||
33391834|NCT02470429|101321881|FG000|Overall Study|Withdrawal by Subject|1|||
33391835|NCT02470429|101321882|FG001|Overall Study|Withdrawal by Subject|0|||
33391836|NCT02623699|101321885|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33295073|NCT01165177|100975505|FG001|Overall Study|Withdrawal by Subject|354|||
33295074|NCT01165177|100975504|FG000|Overall Study|Protocol Violation|19|||
33295075|NCT01165177|100975505|FG001|Overall Study|Protocol Violation|21|||
33295076|NCT01165177|100975504|FG000|Overall Study|Non-serious adverse event|30|||
33295077|NCT01165177|100975505|FG001|Overall Study|Non-serious adverse event|18|||
33295078|NCT01165177|100975504|FG000|Overall Study|Other unspecified reasons|47|||
33295079|NCT01165177|100975505|FG001|Overall Study|Other unspecified reasons|35|||
33295080|NCT01165177|100975504|FG000|Overall Study|Suspected HZ episode|0|||
33295081|NCT01165177|100975505|FG001|Overall Study|Suspected HZ episode|2|||
33295082|NCT01165177|100975504|FG000|Overall Study|Lost to Follow-up|183|||
33295083|NCT01165177|100975505|FG001|Overall Study|Lost to Follow-up|194|||
33295084|NCT01165177|100975504|FG000|Overall Study|Migrated/ moved from study area|48|||
33295085|NCT01165177|100975505|FG001|Overall Study|Migrated/ moved from study area|43|||
33295086|NCT03614676|100975506|FG000|Overall Study|Delivery before planned visit|2|||
33295087|NCT03614676|100975507|FG001|Overall Study|Delivery before planned visit|0|||
33295088|NCT03614676|100975506|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
33295089|NCT03614676|100975507|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
33295090|NCT03614676|100975506|FG000|Overall Study|Migrated / moved from the study area|30|||
33295091|NCT03614676|100975507|FG001|Overall Study|Migrated / moved from the study area|22|||
33295092|NCT03614676|100975506|FG000|Overall Study|Lost to Follow-up|17|||
33295093|NCT03614676|100975507|FG001|Overall Study|Lost to Follow-up|42|||
33295094|NCT03614676|100975506|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
33295095|NCT03614676|100975507|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
33295096|NCT03614676|100975506|FG000|Overall Study|Other|16|||
33295097|NCT03614676|100975507|FG001|Overall Study|Other|47|||
33391837|NCT02623699|101321886|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
33391838|NCT02623699|101321887|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33391839|NCT02623699|101321888|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33391840|NCT02623699|101321889|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33188659|NCT04019041|100598121|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
33188660|NCT04019041|100598122|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
33188661|NCT04019041|100598123|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
33188662|NCT04019041|100598124|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
33188663|NCT04019041|100598125|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
33188664|NCT04019041|100598126|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
33188665|NCT00025883|100598127|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
33188666|NCT00025883|100598127|FG000|Overall Study|no baseline data|1|||
33188667|NCT00025883|100598127|FG000|Overall Study|Death|1|||
33188668|NCT00025883|100598127|FG000|Overall Study|Adverse Event|1|||
33188669|NCT00025883|100598127|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
33188670|NCT01247090|100598128|FG000|Overall Study|Physician Decision|1|||
33188671|NCT01247090|100598129|FG001|Overall Study|Physician Decision|0|||
33188672|NCT01247090|100598130|FG002|Overall Study|Physician Decision|0|||
33295098|NCT03614676|100975506|FG000|Overall Study|Protocol Violation|0|||
33391841|NCT02623699|101321890|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33391842|NCT02623699|101321891|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33391843|NCT02623699|101321892|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33391844|NCT02623699|101321893|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33391845|NCT02623699|101321894|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33391846|NCT02623699|101321895|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33391847|NCT02623699|101321896|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
33391848|NCT02623699|101321885|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33391849|NCT02623699|101321886|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33391850|NCT02623699|101321887|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33391851|NCT02623699|101321888|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33391852|NCT02623699|101321889|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33391853|NCT02623699|101321890|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33391854|NCT02623699|101321891|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
33391855|NCT02623699|101321892|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33391856|NCT02623699|101321893|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33391857|NCT02623699|101321894|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33391858|NCT02623699|101321895|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33391859|NCT02623699|101321896|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
33391860|NCT02623699|101321885|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33391861|NCT02623699|101321886|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33391862|NCT02623699|101321887|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33391863|NCT02623699|101321888|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33391864|NCT02623699|101321889|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33391865|NCT02623699|101321890|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
33391866|NCT02623699|101321891|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33391867|NCT02623699|101321892|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33391868|NCT02623699|101321893|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33391869|NCT02623699|101321894|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33391870|NCT02623699|101321895|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33391871|NCT02623699|101321896|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
33391872|NCT02623699|101321885|FG000|Part B (Up to 289 Days)|Death|0|||
33391873|NCT02623699|101321886|FG001|Part B (Up to 289 Days)|Death|0|||
33391874|NCT02623699|101321887|FG002|Part B (Up to 289 Days)|Death|0|||
33391875|NCT02623699|101321888|FG003|Part B (Up to 289 Days)|Death|0|||
33391876|NCT02623699|101321889|FG004|Part B (Up to 289 Days)|Death|0|||
33391877|NCT02623699|101321890|FG005|Part B (Up to 289 Days)|Death|1|||
33391878|NCT02623699|101321891|FG006|Part B (Up to 289 Days)|Death|1|||
33391879|NCT02623699|101321892|FG007|Part B (Up to 289 Days)|Death|0|||
33391880|NCT02623699|101321893|FG008|Part B (Up to 289 Days)|Death|1|||
33391881|NCT02623699|101321894|FG009|Part B (Up to 289 Days)|Death|0|||
33391882|NCT02623699|101321895|FG010|Part B (Up to 289 Days)|Death|0|||
33391883|NCT02623699|101321896|FG011|Part B (Up to 289 Days)|Death|0|||
33391884|NCT02623699|101321885|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
33391885|NCT02623699|101321886|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
33391886|NCT02623699|101321887|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
33391887|NCT02623699|101321888|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
33295099|NCT03614676|100975507|FG001|Overall Study|Protocol Violation|2|||
33295100|NCT03614676|100975506|FG000|Overall Study|Neonatal event of interest|0|||
33295101|NCT03614676|100975507|FG001|Overall Study|Neonatal event of interest|6|||
33295102|NCT03614676|100975506|FG000|Overall Study|Death in infant greater than 28 days old|0|||
33295103|NCT03614676|100975507|FG001|Overall Study|Death in infant greater than 28 days old|12|||
33295104|NCT03614676|100975506|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
33295105|NCT03614676|100975507|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
33295106|NCT02579772|100975508|FG000|Overall Study|Withdrawal by Subject|0|||
33295107|NCT02579772|100975509|FG001|Overall Study|Withdrawal by Subject|1|||
33295108|NCT02579772|100975508|FG000|Overall Study|Usage of additional antioxidants|1|||
33295109|NCT02579772|100975509|FG001|Overall Study|Usage of additional antioxidants|0|||
33295110|NCT02579772|100975508|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
33295111|NCT02579772|100975509|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
33295112|NCT03690427|100975512|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
33391888|NCT02623699|101321889|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
33295113|NCT03690427|100975513|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
33295114|NCT04206085|100975514|FG000|Overall Study|Lost to Follow-up|0|||
33295115|NCT04206085|100975515|FG001|Overall Study|Lost to Follow-up|1|||
33295116|NCT04206085|100975516|FG002|Overall Study|Lost to Follow-up|0|||
33295117|NCT04206085|100975514|FG000|Overall Study|Lost to Follow-up|0|||
33295118|NCT04206085|100975515|FG001|Overall Study|Lost to Follow-up|0|||
33295119|NCT04206085|100975516|FG002|Overall Study|Lost to Follow-up|1|||
33295120|NCT01592045|100975517|FG000|Overall Study|Disease Progression|1|||
33295121|NCT01592045|100975518|FG001|Overall Study|Disease Progression|1|||
33295122|NCT01592045|100975517|FG000|Overall Study|Adverse Event|1|||
33295123|NCT01592045|100975518|FG001|Overall Study|Adverse Event|1|||
33295124|NCT01592045|100975517|FG000|Overall Study|Withdrawal by Subject|1|||
33295125|NCT01592045|100975518|FG001|Overall Study|Withdrawal by Subject|0|||
33295126|NCT01592045|100975517|FG000|Overall Study|Moved out of country|2|||
33295127|NCT01592045|100975518|FG001|Overall Study|Moved out of country|0|||
33295128|NCT00203047|100975520|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
33295129|NCT00203047|100975521|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
33295130|NCT00203047|100975520|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
33295131|NCT00203047|100975521|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
33295132|NCT00203047|100975520|FG000|Overall Study|Withdrawal by Subject|13|||
33295133|NCT00203047|100975521|FG001|Overall Study|Withdrawal by Subject|47|||
33295134|NCT00203047|100975520|FG000|Overall Study|Teva requested participant withdrawal|1|||
33295135|NCT00203047|100975521|FG001|Overall Study|Teva requested participant withdrawal|1|||
33295136|NCT00203047|100975520|FG000|Overall Study|Physician Decision|8|||
33295137|NCT00203047|100975521|FG001|Overall Study|Physician Decision|7|||
33295138|NCT00203047|100975520|FG000|Overall Study|Non-compliance|4|||
33295139|NCT00203047|100975521|FG001|Overall Study|Non-compliance|8|||
33295140|NCT00203047|100975520|FG000|Overall Study|Protocol Violation|1|||
33295141|NCT00203047|100975521|FG001|Overall Study|Protocol Violation|0|||
33295142|NCT00203047|100975520|FG000|Overall Study|Lost to Follow-up|11|||
33295143|NCT00203047|100975521|FG001|Overall Study|Lost to Follow-up|5|||
33295144|NCT00203047|100975520|FG000|Overall Study|Adverse Event|8|||
33295145|NCT00203047|100975521|FG001|Overall Study|Adverse Event|18|||
33295146|NCT00203047|100975520|FG000|Overall Study|Death|1|||
33188673|NCT01247090|100598128|FG000|Overall Study|Withdrawal by Subject|0|||
33188674|NCT01247090|100598129|FG001|Overall Study|Withdrawal by Subject|1|||
33188675|NCT01247090|100598130|FG002|Overall Study|Withdrawal by Subject|0|||
33188676|NCT00749775|100598131|FG000|Overall Study|Protocol Violation|24|||
33188677|NCT00749775|100598131|FG000|Overall Study|Lost to Follow-up|36|||
33188678|NCT00749775|100598131|FG000|Overall Study|No visit after first day of treatment|44|||
33188679|NCT00749775|100598131|FG000|Overall Study|No drug administration|3|||
33188680|NCT01399593|100598136|FG000|Overall Study|Physician Decision|1|||
33188681|NCT01399593|100598137|FG001|Overall Study|Physician Decision|0|||
33188682|NCT01399593|100598136|FG000|Overall Study|Adverse Event|1|||
33188683|NCT01399593|100598137|FG001|Overall Study|Adverse Event|0|||
33188684|NCT01399593|100598136|FG000|Overall Study|Death|1|||
33188685|NCT01399593|100598137|FG001|Overall Study|Death|1|||
33188686|NCT01399593|100598136|FG000|Overall Study|Transplantectomy|0|||
33188687|NCT01399593|100598137|FG001|Overall Study|Transplantectomy|1|||
33188688|NCT01120210|100598138|FG000|MAIN INFUSION|Adverse Event|1|||
33188689|NCT01120210|100598139|FG001|MAIN INFUSION|Adverse Event|0|||
33295147|NCT00203047|100975521|FG001|Overall Study|Death|2|||
33295148|NCT00203047|100975520|FG000|Overall Study|Pregnancy|3|||
33295149|NCT00203047|100975521|FG001|Overall Study|Pregnancy|0|||
33295150|NCT00203047|100975520|FG000|Overall Study|Other|5|||
33295151|NCT00203047|100975521|FG001|Overall Study|Other|5|||
33188690|NCT01120210|100598138|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
33188691|NCT01120210|100598139|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
33188692|NCT04091646|100598140|FG000|Overall Study|Adverse Event|2|||
33188693|NCT04091646|100598141|FG001|Overall Study|Adverse Event|1|||
33188694|NCT04091646|100598140|FG000|Overall Study|Lost to Follow-up|6|||
33188695|NCT04091646|100598141|FG001|Overall Study|Lost to Follow-up|2|||
33188696|NCT04091646|100598140|FG000|Overall Study|Protocol Violation|0|||
33188697|NCT04091646|100598141|FG001|Overall Study|Protocol Violation|1|||
33188698|NCT04091646|100598140|FG000|Overall Study|Withdrawal by Subject|4|||
33188699|NCT04091646|100598141|FG001|Overall Study|Withdrawal by Subject|1|||
33188700|NCT04091646|100598140|FG000|Overall Study|Participant Incarcerated|1|||
33188701|NCT04091646|100598141|FG001|Overall Study|Participant Incarcerated|0|||
33188702|NCT02487394|100598142|FG000|Phase 1|Withdrawal by Subject|0|||
33188703|NCT02487394|100598143|FG001|Phase 1|Withdrawal by Subject|1|||
33188704|NCT01344369|100598144|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
33188705|NCT01344369|100598145|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
33188706|NCT01344369|100598144|FG000|Washout of 28 Days|Physician Decision|0|||
33188707|NCT01344369|100598145|FG001|Washout of 28 Days|Physician Decision|1|||
33188708|NCT01344369|100598144|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
33188709|NCT01344369|100598145|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
33188710|NCT00245765|100598149|FG000|Overall Study|Adverse Event|1|||
33188711|NCT00245765|100598150|FG001|Overall Study|Adverse Event|1|||
33188712|NCT00245765|100598151|FG002|Overall Study|Adverse Event|0|||
33188713|NCT00245765|100598149|FG000|Overall Study|Lack of Efficacy|14|||
33188714|NCT00245765|100598150|FG001|Overall Study|Lack of Efficacy|7|||
33188715|NCT00245765|100598151|FG002|Overall Study|Lack of Efficacy|0|||
33188716|NCT00245765|100598149|FG000|Overall Study|Lost to Follow-up|1|||
33188717|NCT00245765|100598150|FG001|Overall Study|Lost to Follow-up|2|||
33188718|NCT00245765|100598151|FG002|Overall Study|Lost to Follow-up|0|||
33188719|NCT00245765|100598149|FG000|Overall Study|Withdrawal by Subject|1|||
33188720|NCT00245765|100598150|FG001|Overall Study|Withdrawal by Subject|0|||
33188721|NCT00245765|100598151|FG002|Overall Study|Withdrawal by Subject|3|||
33188722|NCT00245765|100598149|FG000|Overall Study|Other reason|2|||
33188723|NCT00245765|100598150|FG001|Overall Study|Other reason|0|||
33188724|NCT00245765|100598151|FG002|Overall Study|Other reason|1|||
33188725|NCT00245765|100598149|FG000|Overall Study|Other|13|||
33188726|NCT00245765|100598150|FG001|Overall Study|Other|4|||
33188727|NCT00245765|100598151|FG002|Overall Study|Other|4|||
33188728|NCT00159588|100601338|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
33188729|NCT00159588|100601339|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
33188730|NCT00159588|100601340|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
33188731|NCT00430092|100601341|FG000|Overall Study|Adverse Event|0|||
33188732|NCT00430092|100601342|FG001|Overall Study|Adverse Event|0|||
33188733|NCT00430092|100601343|FG002|Overall Study|Adverse Event|1|||
33188734|NCT00430092|100601341|FG000|Overall Study|Lack of Efficacy|5|||
33188735|NCT00430092|100601342|FG001|Overall Study|Lack of Efficacy|2|||
33188736|NCT00430092|100601343|FG002|Overall Study|Lack of Efficacy|54|||
33188737|NCT00430092|100601341|FG000|Overall Study|Lost to Follow-up|1|||
33188738|NCT00430092|100601342|FG001|Overall Study|Lost to Follow-up|0|||
33188739|NCT00430092|100601343|FG002|Overall Study|Lost to Follow-up|0|||
33188740|NCT00430092|100601341|FG000|Overall Study|Protocol Violation|0|||
33188741|NCT00430092|100601342|FG001|Overall Study|Protocol Violation|1|||
33188742|NCT00430092|100601343|FG002|Overall Study|Protocol Violation|1|||
33188743|NCT00430092|100601341|FG000|Overall Study|Withdrawal by Subject|0|||
33188744|NCT00430092|100601342|FG001|Overall Study|Withdrawal by Subject|1|||
33188745|NCT00430092|100601343|FG002|Overall Study|Withdrawal by Subject|1|||
33188746|NCT04999111|100601344|FG000|Overall Study|Lost to Follow-up|21|||
33188747|NCT04999111|100601345|FG001|Overall Study|Lost to Follow-up|16|||
33188748|NCT04999111|100601346|FG002|Overall Study|Lost to Follow-up|2|||
33188749|NCT04999111|100601347|FG003|Overall Study|Lost to Follow-up|26|||
33188750|NCT04999111|100601348|FG004|Overall Study|Lost to Follow-up|30|||
33188751|NCT04999111|100601349|FG005|Overall Study|Lost to Follow-up|6|||
33188752|NCT04999111|100601344|FG000|Overall Study|Physician Decision|1|||
33188753|NCT04999111|100601345|FG001|Overall Study|Physician Decision|3|||
33188754|NCT04999111|100601346|FG002|Overall Study|Physician Decision|0|||
33188755|NCT04999111|100601347|FG003|Overall Study|Physician Decision|1|||
33188756|NCT04999111|100601348|FG004|Overall Study|Physician Decision|2|||
33188757|NCT04999111|100601349|FG005|Overall Study|Physician Decision|0|||
33188758|NCT04999111|100601344|FG000|Overall Study|Withdrawal by Subject|23|||
33188759|NCT04999111|100601345|FG001|Overall Study|Withdrawal by Subject|29|||
33188760|NCT04999111|100601346|FG002|Overall Study|Withdrawal by Subject|15|||
33188761|NCT04999111|100601347|FG003|Overall Study|Withdrawal by Subject|30|||
33188762|NCT04999111|100601348|FG004|Overall Study|Withdrawal by Subject|35|||
33188763|NCT04999111|100601349|FG005|Overall Study|Withdrawal by Subject|10|||
33188764|NCT04999111|100601344|FG000|Overall Study|Other|6|||
33188765|NCT04999111|100601345|FG001|Overall Study|Other|6|||
33188766|NCT04999111|100601346|FG002|Overall Study|Other|3|||
33188767|NCT04999111|100601347|FG003|Overall Study|Other|8|||
33188768|NCT04999111|100601348|FG004|Overall Study|Other|8|||
33188769|NCT04999111|100601349|FG005|Overall Study|Other|5|||
33188770|NCT04999111|100601344|FG000|Overall Study|Non-compliance with study schedule|1|||
33188771|NCT04999111|100601345|FG001|Overall Study|Non-compliance with study schedule|0|||
33391889|NCT02623699|101321890|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
33391890|NCT02623699|101321891|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
33391891|NCT02623699|101321892|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
33391892|NCT02623699|101321893|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
33391893|NCT02623699|101321894|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
33391894|NCT02623699|101321895|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
33391895|NCT02623699|101321896|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
33391896|NCT02623699|101321885|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33391897|NCT02623699|101321886|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33391898|NCT02623699|101321887|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33391899|NCT02623699|101321888|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33188772|NCT04999111|100601346|FG002|Overall Study|Non-compliance with study schedule|0|||
33188773|NCT04999111|100601347|FG003|Overall Study|Non-compliance with study schedule|1|||
33188774|NCT04999111|100601348|FG004|Overall Study|Non-compliance with study schedule|1|||
33188775|NCT04999111|100601349|FG005|Overall Study|Non-compliance with study schedule|1|||
33188776|NCT04999111|100601344|FG000|Overall Study|Randomized but not vaccinated|1|||
33188777|NCT04999111|100601345|FG001|Overall Study|Randomized but not vaccinated|2|||
33188778|NCT04999111|100601346|FG002|Overall Study|Randomized but not vaccinated|0|||
33188779|NCT04999111|100601347|FG003|Overall Study|Randomized but not vaccinated|3|||
33188780|NCT04999111|100601348|FG004|Overall Study|Randomized but not vaccinated|3|||
33188781|NCT04999111|100601349|FG005|Overall Study|Randomized but not vaccinated|0|||
33188782|NCT04999111|100601344|FG000|Overall Study|Adverse Event|1|||
33188783|NCT04999111|100601345|FG001|Overall Study|Adverse Event|1|||
33188784|NCT04999111|100601346|FG002|Overall Study|Adverse Event|0|||
33188785|NCT04999111|100601347|FG003|Overall Study|Adverse Event|0|||
33188786|NCT04999111|100601348|FG004|Overall Study|Adverse Event|0|||
33188787|NCT04999111|100601349|FG005|Overall Study|Adverse Event|0|||
33188788|NCT04999111|100601344|FG000|Overall Study|Initiated prohibited medication|0|||
33188789|NCT04999111|100601345|FG001|Overall Study|Initiated prohibited medication|0|||
33188790|NCT04999111|100601346|FG002|Overall Study|Initiated prohibited medication|0|||
33188791|NCT04999111|100601347|FG003|Overall Study|Initiated prohibited medication|0|||
33188792|NCT04999111|100601348|FG004|Overall Study|Initiated prohibited medication|1|||
33188793|NCT04999111|100601349|FG005|Overall Study|Initiated prohibited medication|0|||
33188794|NCT00701129|100601350|FG000|Overall Study|Death|2|||
33188795|NCT03554291|100601351|FG000|Overall Study|Death|2|||
33188796|NCT03554291|100601352|FG001|Overall Study|Death|1|||
33188797|NCT03554291|100601351|FG000|Overall Study|Lost to Follow-up|1|||
33188798|NCT03554291|100601352|FG001|Overall Study|Lost to Follow-up|0|||
33188799|NCT03554291|100601351|FG000|Overall Study|Withdrawal by Subject|1|||
33188800|NCT03554291|100601352|FG001|Overall Study|Withdrawal by Subject|0|||
33188801|NCT03554291|100601351|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
33188802|NCT03554291|100601352|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
33188803|NCT03216850|100601356|FG000|Overall Study|Pre-analytical error|6|||
33188804|NCT00637195|100601357|FG000|Overall Study|Lost to Follow-up|1|||
33188805|NCT00637195|100601358|FG001|Overall Study|Lost to Follow-up|0|||
33295152|NCT00497874|100975522|FG000|Overall Study|Withdrawal by Subject|48|||
33295153|NCT00497874|100975523|FG001|Overall Study|Withdrawal by Subject|17|||
33295154|NCT00497874|100975522|FG000|Overall Study|Illness|8|||
33295155|NCT00497874|100975523|FG001|Overall Study|Illness|4|||
33295156|NCT00497874|100975522|FG000|Overall Study|Death|2|||
33295157|NCT00497874|100975523|FG001|Overall Study|Death|4|||
33295158|NCT00497874|100975522|FG000|Overall Study|Unable to contact|52|||
33295159|NCT00497874|100975523|FG001|Overall Study|Unable to contact|67|||
33295160|NCT00497874|100975522|FG000|Overall Study|Unable to schedule|37|||
33295161|NCT00497874|100975523|FG001|Overall Study|Unable to schedule|24|||
33295162|NCT00658606|100975524|FG000|Overall Study|Adverse Event|2|||
33295163|NCT00658606|100975525|FG001|Overall Study|Adverse Event|1|||
33295164|NCT00658606|100975524|FG000|Overall Study|Lack of Efficacy|6|||
33295165|NCT00658606|100975525|FG001|Overall Study|Lack of Efficacy|3|||
33295166|NCT00658606|100975524|FG000|Overall Study|Lost to Follow-up|1|||
33295167|NCT00658606|100975525|FG001|Overall Study|Lost to Follow-up|0|||
33295168|NCT00658606|100975524|FG000|Overall Study|Withdrawal by Subject|7|||
33295169|NCT00658606|100975525|FG001|Overall Study|Withdrawal by Subject|16|||
33295170|NCT00658606|100975524|FG000|Overall Study|Lack of Compliance|0|||
33295171|NCT00658606|100975525|FG001|Overall Study|Lack of Compliance|3|||
33391900|NCT02623699|101321889|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33391901|NCT02623699|101321890|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33391902|NCT02623699|101321891|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33391903|NCT02623699|101321892|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33188806|NCT00637195|100601357|FG000|Overall Study|Other|2|||
33188807|NCT00637195|100601358|FG001|Overall Study|Other|0|||
33188808|NCT00637195|100601357|FG000|Overall Study|Withdrawal by Subject|0|||
33188809|NCT00637195|100601358|FG001|Overall Study|Withdrawal by Subject|1|||
33417156|NCT00038467|101420219|FG000|Overall Study|Adverse Event|170|||
33188810|NCT00096044|100601364|FG000|Overall Study|Withdrawal by Subject|9|||
33391904|NCT02623699|101321893|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33391905|NCT02623699|101321894|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
33391906|NCT02623699|101321895|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
33188811|NCT00096044|100601364|FG000|Overall Study|Adverse Event|21|||
33188812|NCT00096044|100601364|FG000|Overall Study|Disease Progression|4|||
33188813|NCT03385239|100601366|FG000|Overall Study|Voluntary Withdrawal|2|||
33188814|NCT03385239|100601367|FG001|Overall Study|Voluntary Withdrawal|3|||
33188815|NCT03385239|100601368|FG002|Overall Study|Voluntary Withdrawal|2|||
33188816|NCT03385239|100601369|FG003|Overall Study|Voluntary Withdrawal|3|||
33188817|NCT03385239|100601370|FG004|Overall Study|Voluntary Withdrawal|0|||
33188818|NCT03385239|100601366|FG000|Overall Study|Adverse Event|0|||
33188819|NCT03385239|100601367|FG001|Overall Study|Adverse Event|0|||
33188820|NCT03385239|100601368|FG002|Overall Study|Adverse Event|1|||
33188821|NCT03385239|100601369|FG003|Overall Study|Adverse Event|0|||
33188822|NCT03385239|100601370|FG004|Overall Study|Adverse Event|0|||
33188823|NCT03385239|100601366|FG000|Overall Study|Other|0|||
33188824|NCT03385239|100601367|FG001|Overall Study|Other|0|||
33391907|NCT02623699|101321896|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
33391908|NCT02623699|101321885|FG000|Part C (Up to 236 Days)|Death|0|||
33391909|NCT02623699|101321886|FG001|Part C (Up to 236 Days)|Death|0|||
33391910|NCT02623699|101321887|FG002|Part C (Up to 236 Days)|Death|0|||
33391911|NCT02623699|101321888|FG003|Part C (Up to 236 Days)|Death|0|||
33391912|NCT02623699|101321889|FG004|Part C (Up to 236 Days)|Death|0|||
33391913|NCT02623699|101321890|FG005|Part C (Up to 236 Days)|Death|0|||
33391914|NCT02623699|101321891|FG006|Part C (Up to 236 Days)|Death|0|||
33391915|NCT02623699|101321892|FG007|Part C (Up to 236 Days)|Death|0|||
33391916|NCT02623699|101321893|FG008|Part C (Up to 236 Days)|Death|0|||
33391917|NCT02623699|101321894|FG009|Part C (Up to 236 Days)|Death|0|||
33391918|NCT02623699|101321895|FG010|Part C (Up to 236 Days)|Death|0|||
33391919|NCT02623699|101321896|FG011|Part C (Up to 236 Days)|Death|1|||
33391920|NCT02623699|101321885|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
33391921|NCT02623699|101321886|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
33391922|NCT02623699|101321887|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
33391923|NCT02623699|101321888|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
33391924|NCT02623699|101321889|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
33391925|NCT02623699|101321890|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
33391926|NCT02623699|101321891|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
33188825|NCT03385239|100601368|FG002|Overall Study|Other|0|||
33188826|NCT03385239|100601369|FG003|Overall Study|Other|1|||
33188827|NCT03385239|100601370|FG004|Overall Study|Other|0|||
33188828|NCT01957475|100601371|FG000|Test Period 1|Withdrawal by Subject|1|||
33188829|NCT01957475|100601372|FG001|Test Period 1|Withdrawal by Subject|0|||
33188830|NCT01957475|100601371|FG000|Test Period 1|Other|1|||
33188831|NCT01957475|100601372|FG001|Test Period 1|Other|0|||
33188832|NCT01957475|100601371|FG000|Test Period 1|Lack of Efficacy|0|||
33188833|NCT01957475|100601372|FG001|Test Period 1|Lack of Efficacy|1|||
33188834|NCT01957475|100601371|FG000|Test Period 2|Adverse Event|1|||
33188835|NCT01957475|100601372|FG001|Test Period 2|Adverse Event|0|||
33295172|NCT00760513|100975526|FG000|Overall Study|Withdrawal by Subject|5|||
33295173|NCT00760513|100975527|FG001|Overall Study|Withdrawal by Subject|7|||
33295174|NCT00486252|100975528|FG000|Overall Study|Adverse Event|7|||
33295175|NCT00486252|100975528|FG000|Overall Study|Lack of Efficacy|9|||
33295176|NCT00486252|100975528|FG000|Overall Study|Lost to Follow-up|24|||
33295177|NCT00486252|100975528|FG000|Overall Study|Other|18|||
33295178|NCT01012947|100975529|FG000|Overall Study|Lost to Follow-up|131|||
33295179|NCT01012947|100975530|FG001|Overall Study|Lost to Follow-up|135|||
33295180|NCT01012947|100975531|FG002|Overall Study|Lost to Follow-up|130|||
33295181|NCT01012947|100975532|FG003|Overall Study|Lost to Follow-up|118|||
33295182|NCT01012947|100975533|FG004|Overall Study|Lost to Follow-up|142|||
33295183|NCT02417441|100975535|FG000|Overall Study|Inconclusive due to missing data|52|||
33295184|NCT02417441|100975536|FG001|Overall Study|Inconclusive due to missing data|19|||
33295185|NCT01327846|100975537|FG000|Core Phase|Subject decision (vital status: missing)|1|||
33295186|NCT01327846|100975538|FG001|Core Phase|Subject decision (vital status: missing)|2|||
33295187|NCT01327846|100975539|FG002|Core Phase|Subject decision (vital status: missing)|2|||
33295188|NCT01327846|100975540|FG003|Core Phase|Subject decision (vital status: missing)|1|||
33295189|NCT01327846|100975537|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
33295190|NCT01327846|100975538|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
33295191|NCT01327846|100975539|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
33295192|NCT01327846|100975540|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
33295193|NCT01327846|100975537|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
33295194|NCT01327846|100975538|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
33295195|NCT01327846|100975539|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
33295196|NCT01327846|100975540|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
33295197|NCT01327846|100975537|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
33295198|NCT01327846|100975538|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
33295199|NCT01327846|100975539|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
33295200|NCT01327846|100975540|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
33295201|NCT01327846|100975537|FG000|Core Phase|Lost to Follow-up|3|||
33391927|NCT02623699|101321892|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
33391928|NCT02623699|101321893|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
33391929|NCT02623699|101321894|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
33391930|NCT02623699|101321895|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
33600123|NCT04493684|102088504|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33188836|NCT03277261|100601377|FG000|Overall Study|Adverse Event|17|||
33391931|NCT02623699|101321896|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
33391932|NCT00804986|101321898|FG000|Overall Study|Adverse Event|0|||
33391933|NCT00804986|101321899|FG001|Overall Study|Adverse Event|1|||
33391934|NCT00804986|101321900|FG002|Overall Study|Adverse Event|2|||
33188837|NCT03277261|100601378|FG001|Overall Study|Adverse Event|1|||
33188838|NCT03277261|100601377|FG000|Overall Study|Participant Withdrawal of Consent|6|||
33295202|NCT01327846|100975538|FG001|Core Phase|Lost to Follow-up|3|||
33295203|NCT01327846|100975539|FG002|Core Phase|Lost to Follow-up|4|||
33295204|NCT01327846|100975540|FG003|Core Phase|Lost to Follow-up|5|||
33188839|NCT03277261|100601378|FG001|Overall Study|Participant Withdrawal of Consent|15|||
33188840|NCT03277261|100601377|FG000|Overall Study|Investigator / Sponsor Decision|4|||
33188841|NCT03277261|100601378|FG001|Overall Study|Investigator / Sponsor Decision|2|||
33188842|NCT03277261|100601377|FG000|Overall Study|Pregnancy|2|||
33188843|NCT03277261|100601378|FG001|Overall Study|Pregnancy|0|||
33188844|NCT03277261|100601377|FG000|Overall Study|Lost to Follow-up|2|||
33188845|NCT03277261|100601378|FG001|Overall Study|Lost to Follow-up|2|||
33188846|NCT03277261|100601377|FG000|Overall Study|Lack of Efficacy|2|||
33188847|NCT03277261|100601378|FG001|Overall Study|Lack of Efficacy|2|||
33188848|NCT03277261|100601377|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
33188849|NCT03277261|100601378|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
33188850|NCT01600586|100601379|FG000|Overall Study|Physician Decision|3|||
33188851|NCT01600586|100601380|FG001|Overall Study|Physician Decision|3|||
33188852|NCT00934544|100601382|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
33188853|NCT00934544|100601383|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
33188854|NCT00934544|100601384|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
33188855|NCT00934544|100601382|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
33188856|NCT00934544|100601383|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
33188857|NCT00934544|100601384|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
33188858|NCT00934544|100601382|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
33188859|NCT00934544|100601383|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
33188860|NCT00934544|100601384|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
33188861|NCT00934544|100601382|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
33188862|NCT00934544|100601383|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
33188863|NCT00934544|100601384|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
33188864|NCT00934544|100601382|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
33188865|NCT00934544|100601383|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
33188866|NCT00934544|100601384|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
33188867|NCT00934544|100601382|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
33188868|NCT00934544|100601383|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
33188869|NCT00934544|100601384|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
33188870|NCT00934544|100601382|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
33188871|NCT00934544|100601383|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
33188872|NCT00934544|100601384|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
33188873|NCT00934544|100601382|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
33188874|NCT00934544|100601383|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
33188875|NCT00934544|100601384|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
33188876|NCT00934544|100601382|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
33188877|NCT00934544|100601383|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
33188878|NCT00934544|100601384|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
33188879|NCT00934544|100601382|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
33188880|NCT00934544|100601383|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
33188881|NCT00934544|100601384|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
33188882|NCT00934544|100601382|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
33188883|NCT00934544|100601383|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
33188884|NCT00934544|100601384|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
33188885|NCT00934544|100601382|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
33188886|NCT00934544|100601383|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
33188887|NCT00934544|100601384|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
33188888|NCT00934544|100601382|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
33391935|NCT00804986|101321901|FG003|Overall Study|Adverse Event|1|||
33188889|NCT00934544|100601383|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
33188890|NCT00934544|100601384|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
33188891|NCT00934544|100601382|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
33188892|NCT00934544|100601383|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
33188893|NCT00934544|100601384|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
33188894|NCT00934544|100601382|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
33391936|NCT00804986|101321902|FG004|Overall Study|Adverse Event|3|||
33391937|NCT00804986|101321903|FG005|Overall Study|Adverse Event|0|||
33391938|NCT00804986|101321898|FG000|Overall Study|Lack of Efficacy|0|||
33391939|NCT00804986|101321899|FG001|Overall Study|Lack of Efficacy|0|||
33391940|NCT00804986|101321900|FG002|Overall Study|Lack of Efficacy|0|||
33391941|NCT00804986|101321901|FG003|Overall Study|Lack of Efficacy|1|||
33391942|NCT00804986|101321902|FG004|Overall Study|Lack of Efficacy|0|||
33295205|NCT01327846|100975537|FG000|Extension Phase|Study terminated by sponsor|1073|||
33295206|NCT01327846|100975538|FG001|Extension Phase|Study terminated by sponsor|1124|||
33295207|NCT01327846|100975539|FG002|Extension Phase|Study terminated by sponsor|1067|||
33295208|NCT01327846|100975540|FG003|Extension Phase|Study terminated by sponsor|1660|||
33295209|NCT01327846|100975537|FG000|Extension Phase|Withdrawal by Subject|20|||
33295210|NCT01327846|100975538|FG001|Extension Phase|Withdrawal by Subject|13|||
33295211|NCT01327846|100975539|FG002|Extension Phase|Withdrawal by Subject|19|||
33295212|NCT01327846|100975540|FG003|Extension Phase|Withdrawal by Subject|37|||
33295213|NCT01327846|100975537|FG000|Extension Phase|Lost to Follow-up|4|||
33295214|NCT01327846|100975538|FG001|Extension Phase|Lost to Follow-up|3|||
33391943|NCT00804986|101321903|FG005|Overall Study|Lack of Efficacy|3|||
33391944|NCT00804986|101321898|FG000|Overall Study|Lost to Follow-up|0|||
33391945|NCT00804986|101321899|FG001|Overall Study|Lost to Follow-up|0|||
33391946|NCT00804986|101321900|FG002|Overall Study|Lost to Follow-up|0|||
33391947|NCT00804986|101321901|FG003|Overall Study|Lost to Follow-up|1|||
33391948|NCT00804986|101321902|FG004|Overall Study|Lost to Follow-up|1|||
33391949|NCT00804986|101321903|FG005|Overall Study|Lost to Follow-up|3|||
33391950|NCT00804986|101321898|FG000|Overall Study|Protocol Violation|0|||
33391951|NCT00804986|101321899|FG001|Overall Study|Protocol Violation|1|||
33391952|NCT00804986|101321900|FG002|Overall Study|Protocol Violation|0|||
33391953|NCT00804986|101321901|FG003|Overall Study|Protocol Violation|1|||
33391954|NCT00804986|101321902|FG004|Overall Study|Protocol Violation|0|||
33391955|NCT00804986|101321903|FG005|Overall Study|Protocol Violation|0|||
33391956|NCT00804986|101321898|FG000|Overall Study|Withdrawal by Subject|0|||
33391957|NCT00804986|101321899|FG001|Overall Study|Withdrawal by Subject|3|||
33391958|NCT00804986|101321900|FG002|Overall Study|Withdrawal by Subject|0|||
33391959|NCT00804986|101321901|FG003|Overall Study|Withdrawal by Subject|3|||
33391960|NCT00804986|101321902|FG004|Overall Study|Withdrawal by Subject|5|||
33391961|NCT00804986|101321903|FG005|Overall Study|Withdrawal by Subject|3|||
33391962|NCT00804986|101321898|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
33391963|NCT00804986|101321899|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
33391964|NCT00804986|101321900|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
33391965|NCT00804986|101321901|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
33391966|NCT00804986|101321902|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
33188895|NCT00934544|100601383|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
33295215|NCT01327846|100975539|FG002|Extension Phase|Lost to Follow-up|4|||
33295216|NCT01327846|100975540|FG003|Extension Phase|Lost to Follow-up|7|||
33188896|NCT00934544|100601384|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
33188897|NCT00934544|100601382|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
33295217|NCT01327846|100975537|FG000|Extension Phase|Technical Problems|2|||
33295218|NCT01327846|100975538|FG001|Extension Phase|Technical Problems|4|||
33295219|NCT01327846|100975539|FG002|Extension Phase|Technical Problems|2|||
33295220|NCT01327846|100975540|FG003|Extension Phase|Technical Problems|2|||
33295221|NCT03210519|100975545|FG000|Overall Study|Adverse Event|2|||
33391967|NCT00804986|101321903|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
33391968|NCT00804986|101321898|FG000|Overall Study|Sponsor Decision|0|||
33391969|NCT00804986|101321899|FG001|Overall Study|Sponsor Decision|1|||
33391970|NCT00804986|101321900|FG002|Overall Study|Sponsor Decision|0|||
33295222|NCT03210519|100975546|FG001|Overall Study|Adverse Event|0|||
33295223|NCT00983853|100975549|FG000|Overall Study|Lost to Follow-up|1|||
33295224|NCT00983853|100975550|FG001|Overall Study|Lost to Follow-up|1|||
33295225|NCT00983853|100975551|FG002|Overall Study|Lost to Follow-up|2|||
33295226|NCT00983853|100975552|FG003|Overall Study|Lost to Follow-up|2|||
33391971|NCT00804986|101321901|FG003|Overall Study|Sponsor Decision|0|||
33391972|NCT00804986|101321902|FG004|Overall Study|Sponsor Decision|0|||
33391973|NCT00804986|101321903|FG005|Overall Study|Sponsor Decision|0|||
33391974|NCT00804986|101321898|FG000|Overall Study|Physician Decision|1|||
33391975|NCT00804986|101321899|FG001|Overall Study|Physician Decision|0|||
33391976|NCT00804986|101321900|FG002|Overall Study|Physician Decision|0|||
33391977|NCT00804986|101321901|FG003|Overall Study|Physician Decision|0|||
33391978|NCT00804986|101321902|FG004|Overall Study|Physician Decision|0|||
33391979|NCT00804986|101321903|FG005|Overall Study|Physician Decision|0|||
33391980|NCT02583711|101321904|FG000|Overall Study|Withdrawal by Subject|0|||
33295227|NCT00983853|100975553|FG004|Overall Study|Lost to Follow-up|2|||
33295228|NCT00983853|100975554|FG005|Overall Study|Lost to Follow-up|1|||
33295229|NCT00983853|100975549|FG000|Overall Study|Withdrawal by Subject|0|||
33295230|NCT00983853|100975550|FG001|Overall Study|Withdrawal by Subject|0|||
33295231|NCT00983853|100975551|FG002|Overall Study|Withdrawal by Subject|1|||
33295232|NCT00983853|100975552|FG003|Overall Study|Withdrawal by Subject|0|||
33295233|NCT00983853|100975553|FG004|Overall Study|Withdrawal by Subject|1|||
33295234|NCT00983853|100975554|FG005|Overall Study|Withdrawal by Subject|0|||
33295235|NCT00983853|100975549|FG000|Overall Study|Unable to come to study follow-up visits|0|||
33295236|NCT00983853|100975550|FG001|Overall Study|Unable to come to study follow-up visits|1|||
33295237|NCT00983853|100975551|FG002|Overall Study|Unable to come to study follow-up visits|0|||
33295238|NCT00983853|100975552|FG003|Overall Study|Unable to come to study follow-up visits|0|||
33295239|NCT00983853|100975553|FG004|Overall Study|Unable to come to study follow-up visits|0|||
33295240|NCT00983853|100975554|FG005|Overall Study|Unable to come to study follow-up visits|0|||
33295241|NCT03327831|100975555|FG000|Overall Study|Lost to Follow-up|2|||
33295242|NCT00725543|100975556|FG000|Overall Study|Adverse Event|10|||
33295243|NCT00725543|100975556|FG000|Overall Study|Lack of Efficacy|3|||
33295244|NCT00725543|100975556|FG000|Overall Study|Withdrawal by Subject|10|||
33295245|NCT00725543|100975556|FG000|Overall Study|Physician Decision|5|||
33295246|NCT00725543|100975556|FG000|Overall Study|Lost to Follow-up|4|||
33391981|NCT02583711|101321905|FG001|Overall Study|Withdrawal by Subject|10|||
33391982|NCT02583711|101321906|FG002|Overall Study|Withdrawal by Subject|0|||
33391983|NCT02224274|101321907|FG000|Overall Study|Death|1|||
33391984|NCT02224274|101321908|FG001|Overall Study|Death|0|||
33391985|NCT02707601|101321921|FG000|Overall Study|Death|0|||
33391986|NCT02707601|101321922|FG001|Overall Study|Death|1|||
33391987|NCT02707601|101321921|FG000|Overall Study|Lack of Efficacy|0|||
33391988|NCT02707601|101321922|FG001|Overall Study|Lack of Efficacy|1|||
33391989|NCT02707601|101321921|FG000|Overall Study|Investigator's Discretion|1|||
33391990|NCT02707601|101321922|FG001|Overall Study|Investigator's Discretion|0|||
33391991|NCT02707601|101321921|FG000|Overall Study|Withdrew Consent|0|||
33391992|NCT02707601|101321922|FG001|Overall Study|Withdrew Consent|1|||
33391993|NCT02707601|101321921|FG000|Overall Study|Lost to Follow-up|1|||
33295247|NCT00725543|100975556|FG000|Overall Study|Non-compliance|2|||
33295248|NCT00725543|100975556|FG000|Overall Study|Other|119|||
33391994|NCT02707601|101321922|FG001|Overall Study|Lost to Follow-up|1|||
33391995|NCT02707601|101321921|FG000|Overall Study|Participants Randomized but Not Treated|2|||
33391996|NCT02707601|101321922|FG001|Overall Study|Participants Randomized but Not Treated|0|||
33391997|NCT00560794|101321923|FG000|Overall Study|Adverse Event|2|||
33391998|NCT00560794|101321923|FG000|Overall Study|Patient was not Compliant|1|||
33391999|NCT00560794|101321923|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
33392000|NCT00560794|101321923|FG000|Overall Study|Hematological Relapse|1|||
33392001|NCT00560794|101321923|FG000|Overall Study|Received Bone Marrow Transplant|6|||
33392002|NCT00246376|101321924|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
33392003|NCT00246376|101321925|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
33392004|NCT00246376|101321926|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
33392005|NCT00246376|101321927|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
33392006|NCT00246376|101321928|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
33392007|NCT00246376|101321924|FG000|Overall Study|Adverse Event|2|||
33392008|NCT00246376|101321925|FG001|Overall Study|Adverse Event|3|||
33295249|NCT01371708|100975557|FG000|Overall Study|Insufficient clinical response|3|||
33295250|NCT01371708|100975558|FG001|Overall Study|Insufficient clinical response|2|||
33295251|NCT01371708|100975559|FG002|Overall Study|Insufficient clinical response|0|||
33295252|NCT01371708|100975557|FG000|Overall Study|Lost to Follow-up|5|||
33295253|NCT01371708|100975558|FG001|Overall Study|Lost to Follow-up|9|||
33295254|NCT01371708|100975559|FG002|Overall Study|Lost to Follow-up|7|||
33295255|NCT01371708|100975557|FG000|Overall Study|Protocol Violation|2|||
33295256|NCT01371708|100975558|FG001|Overall Study|Protocol Violation|1|||
33392009|NCT00246376|101321926|FG002|Overall Study|Adverse Event|1|||
33392010|NCT00246376|101321927|FG003|Overall Study|Adverse Event|3|||
33392011|NCT00246376|101321928|FG004|Overall Study|Adverse Event|1|||
33392012|NCT00246376|101321924|FG000|Overall Study|Lost to Follow-up|2|||
33392013|NCT00246376|101321925|FG001|Overall Study|Lost to Follow-up|11|||
33392014|NCT00246376|101321926|FG002|Overall Study|Lost to Follow-up|11|||
33392015|NCT00246376|101321927|FG003|Overall Study|Lost to Follow-up|16|||
33392016|NCT00246376|101321928|FG004|Overall Study|Lost to Follow-up|13|||
33392017|NCT00666536|101321929|FG000|Overall Study|Adverse Event|9|||
33392018|NCT00666536|101321930|FG001|Overall Study|Adverse Event|19|||
33392019|NCT00666536|101321929|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33392020|NCT00666536|101321930|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33392021|NCT00666536|101321929|FG000|Overall Study|Protocol deviation(s)|8|||
33392022|NCT00666536|101321930|FG001|Overall Study|Protocol deviation(s)|6|||
33392023|NCT00666536|101321929|FG000|Overall Study|Withdrawal by Subject|10|||
33392024|NCT00666536|101321930|FG001|Overall Study|Withdrawal by Subject|9|||
33392025|NCT00666536|101321929|FG000|Overall Study|Lost to Follow-up|4|||
33392026|NCT00666536|101321930|FG001|Overall Study|Lost to Follow-up|3|||
33392027|NCT02260388|101321931|FG000|Overall Study|Lost to Follow-up|2|||
33392028|NCT02260388|101321932|FG001|Overall Study|Lost to Follow-up|8|||
33392029|NCT02260388|101321933|FG002|Overall Study|Lost to Follow-up|3|||
33392030|NCT02260388|101321934|FG003|Overall Study|Lost to Follow-up|4|||
33392031|NCT00333970|101321937|FG000|Overall Study|Withdrawal by Subject|13|||
33392032|NCT00333970|101321938|FG001|Overall Study|Withdrawal by Subject|7|||
33392033|NCT01300767|101321944|FG000|Overall Study|Discomfort|2|||
33392034|NCT01300767|101321944|FG000|Overall Study|Biomicroscopy|1|||
33295257|NCT01371708|100975559|FG002|Overall Study|Protocol Violation|2|||
33295258|NCT01371708|100975557|FG000|Overall Study|No longer willing to participate|7|||
33295259|NCT01371708|100975558|FG001|Overall Study|No longer willing to participate|7|||
33295260|NCT01371708|100975559|FG002|Overall Study|No longer willing to participate|13|||
33295261|NCT01371708|100975557|FG000|Overall Study|Medication error/not related to AE|0|||
33295262|NCT01371708|100975558|FG001|Overall Study|Medication error/not related to AE|1|||
33295263|NCT01371708|100975559|FG002|Overall Study|Medication error/not related to AE|0|||
33295264|NCT01371708|100975557|FG000|Overall Study|Other|3|||
33295265|NCT01371708|100975558|FG001|Overall Study|Other|2|||
33295266|NCT01371708|100975559|FG002|Overall Study|Other|4|||
33392035|NCT01300767|101321944|FG000|Overall Study|Unacceptable fit|1|||
33392036|NCT02708966|101321946|FG000|Overall Study|Lost to Follow-up|2|||
33392037|NCT02708966|101321947|FG001|Overall Study|Lost to Follow-up|2|||
33392038|NCT01249157|101321949|FG000|Overall Study|Withdrawal by Subject|1|||
33392039|NCT01922739|101321950|FG000|Titration/Adjustment Period|Adverse Event|3|||
33392040|NCT01922739|101321950|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
33295267|NCT01371708|100975557|FG000|Overall Study|Adverse Event|5|||
33392041|NCT01922739|101321950|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
33392042|NCT01922739|101321950|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
33392043|NCT01922739|101321950|FG000|Open-label Treatment Period|Adverse Event|6|||
33295268|NCT01371708|100975558|FG001|Overall Study|Adverse Event|8|||
33392044|NCT01922739|101321950|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
33392045|NCT01922739|101321950|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
33392046|NCT01922739|101321950|FG000|Open-label Treatment Period|Protocol Violation|5|||
33392047|NCT01922739|101321950|FG000|Open-label Treatment Period|Pregnancy|1|||
33392048|NCT01922739|101321950|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
33392049|NCT01922739|101321950|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
33392050|NCT01922739|101321950|FG000|Open-label Treatment Period|Physician Decision|1|||
33392051|NCT01922739|101321950|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
33392052|NCT01929018|101321951|FG000|Overall Study|Lost to Follow-up|1|||
33392053|NCT01929018|101321952|FG001|Overall Study|Lost to Follow-up|0|||
33392054|NCT01929018|101321951|FG000|Overall Study|Hospitalization|0|||
33392055|NCT01929018|101321952|FG001|Overall Study|Hospitalization|1|||
33392056|NCT01405027|101321954|FG000|Overall Study|Withdrawn consent|3|||
33392057|NCT01405027|101321955|FG001|Overall Study|Withdrawn consent|0|||
33392058|NCT01405027|101321954|FG000|Overall Study|Lost to Follow-up|16|||
33392059|NCT01405027|101321955|FG001|Overall Study|Lost to Follow-up|24|||
33392060|NCT01405027|101321954|FG000|Overall Study|Investigator judgement|0|||
33392061|NCT01405027|101321955|FG001|Overall Study|Investigator judgement|2|||
33392062|NCT01405027|101321954|FG000|Overall Study|Death|1|||
33392063|NCT01405027|101321955|FG001|Overall Study|Death|0|||
33392064|NCT01405027|101321954|FG000|Overall Study|Other or Unknown|12|||
33392065|NCT01405027|101321955|FG001|Overall Study|Other or Unknown|25|||
33392066|NCT01224106|101321956|FG000|Double-Blind Treatment Phase|Death|3|||
33392067|NCT01224106|101321957|FG001|Double-Blind Treatment Phase|Death|0|||
33392068|NCT01224106|101321958|FG002|Double-Blind Treatment Phase|Death|0|||
33392069|NCT01224106|101321959|FG003|Double-Blind Treatment Phase|Death|0|||
33392070|NCT01224106|101321960|FG004|Double-Blind Treatment Phase|Death|0|||
33392071|NCT01224106|101321956|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
33392072|NCT01224106|101321957|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
33392073|NCT01224106|101321958|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
33392074|NCT01224106|101321959|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
33392075|NCT01224106|101321960|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
33392076|NCT01224106|101321956|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
33392077|NCT01224106|101321957|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
33392078|NCT01224106|101321958|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
33392079|NCT01224106|101321959|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
33392080|NCT01224106|101321960|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
33392081|NCT01224106|101321956|FG000|Double-Blind Treatment Phase|Other|0|||
33392082|NCT01224106|101321957|FG001|Double-Blind Treatment Phase|Other|0|||
33392083|NCT01224106|101321958|FG002|Double-Blind Treatment Phase|Other|1|||
33392084|NCT01224106|101321959|FG003|Double-Blind Treatment Phase|Other|0|||
33496236|NCT02013817|101710042|FG000|Overall Study|Death|2|||
33295269|NCT01371708|100975559|FG002|Overall Study|Adverse Event|12|||
33295270|NCT01371708|100975557|FG000|Overall Study|Started but did not receive treatment|1|||
33295271|NCT01371708|100975558|FG001|Overall Study|Started but did not receive treatment|0|||
33295272|NCT01371708|100975559|FG002|Overall Study|Started but did not receive treatment|1|||
33295273|NCT00794924|100975563|FG000|Overall Study|Lost to Follow-up|6|||
33295274|NCT00794924|100975564|FG001|Overall Study|Lost to Follow-up|8|||
33295275|NCT00794924|100975563|FG000|Overall Study|Withdrawal by Subject|48|||
33295276|NCT00794924|100975564|FG001|Overall Study|Withdrawal by Subject|60|||
33295277|NCT00794924|100975563|FG000|Overall Study|Adverse Event|6|||
33295278|NCT00794924|100975564|FG001|Overall Study|Adverse Event|2|||
33295279|NCT01174446|100975566|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
33295280|NCT01174446|100975567|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
33295281|NCT01174446|100975568|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
33295282|NCT01174446|100975569|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
33295283|NCT01174446|100975566|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
33295284|NCT01174446|100975567|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
33295285|NCT01174446|100975568|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
33295286|NCT01174446|100975569|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
33392085|NCT01224106|101321960|FG004|Double-Blind Treatment Phase|Other|0|||
33392086|NCT01224106|101321956|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
33392087|NCT01224106|101321957|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
33392088|NCT01224106|101321958|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
33392089|NCT01224106|101321959|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
33392090|NCT01224106|101321960|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
33392091|NCT01224106|101321956|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
33392092|NCT01224106|101321957|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
33392093|NCT01224106|101321958|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
33392094|NCT01224106|101321959|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
33392095|NCT01224106|101321960|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
33392096|NCT01224106|101321956|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
33392097|NCT01224106|101321957|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33392098|NCT01224106|101321958|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
33496237|NCT02013817|101710042|FG000|Overall Study|Other|9|||
33295287|NCT01174446|100975566|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
33295288|NCT01174446|100975567|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
33295289|NCT01174446|100975568|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
33295290|NCT01174446|100975569|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
33392099|NCT01224106|101321959|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33392100|NCT01224106|101321960|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33392101|NCT01224106|101321956|FG000|Open-Label Extension (OLE) Phase|Death|0|||
33295291|NCT01174446|100975566|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
33295292|NCT01174446|100975567|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
33295293|NCT01174446|100975568|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
33295294|NCT01174446|100975569|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
33364869|NCT00726323|101223670|FG000|Overall Study|Clinical progression|0|||
33364870|NCT00726323|101223671|FG001|Overall Study|Clinical progression|3|||
33364871|NCT00726323|101223670|FG000|Overall Study|Adverse Event|9|||
33364872|NCT00726323|101223671|FG001|Overall Study|Adverse Event|9|||
33364873|NCT00726323|101223670|FG000|Overall Study|Death|1|||
33364874|NCT00726323|101223671|FG001|Overall Study|Death|0|||
33364875|NCT00726323|101223670|FG000|Overall Study|Participant wished to discontinue|0|||
33364876|NCT00726323|101223671|FG001|Overall Study|Participant wished to discontinue|1|||
33364877|NCT00726323|101223670|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
33364878|NCT00726323|101223671|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
33364879|NCT01844700|101223672|FG000|Overall Study|Lack of Efficacy|1|||
33364880|NCT01844700|101223673|FG001|Overall Study|Lack of Efficacy|0|||
33364881|NCT01844700|101223672|FG000|Overall Study|refused medication switch|1|||
33364882|NCT01844700|101223673|FG001|Overall Study|refused medication switch|0|||
33364883|NCT01844700|101223672|FG000|Overall Study|Withdrawal by Subject|1|||
33364884|NCT01844700|101223673|FG001|Overall Study|Withdrawal by Subject|0|||
33364885|NCT01844700|101223672|FG000|Overall Study|stopped taking meds|0|||
33364886|NCT01844700|101223673|FG001|Overall Study|stopped taking meds|1|||
33364887|NCT02805907|101223674|FG000|Overall Study|Lost to Follow-up|3|||
33364888|NCT02805907|101223675|FG001|Overall Study|Lost to Follow-up|3|||
33364889|NCT01520324|101223676|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
33364890|NCT00077623|101223677|FG000|Overall Study|Adverse Event|1|||
33364891|NCT00077623|101223678|FG001|Overall Study|Adverse Event|0|||
33364892|NCT00077623|101223679|FG002|Overall Study|Adverse Event|1|||
33364893|NCT00077623|101223677|FG000|Overall Study|Withdrawal by Subject|2|||
33364894|NCT00077623|101223678|FG001|Overall Study|Withdrawal by Subject|10|||
33364895|NCT00077623|101223679|FG002|Overall Study|Withdrawal by Subject|1|||
33364896|NCT00077623|101223677|FG000|Overall Study|Other-Non safety reason|18|||
33364897|NCT00077623|101223678|FG001|Overall Study|Other-Non safety reason|15|||
33364898|NCT00077623|101223679|FG002|Overall Study|Other-Non safety reason|19|||
33364899|NCT00077623|101223677|FG000|Overall Study|Insufficient therapeutic response|2|||
33364900|NCT00077623|101223678|FG001|Overall Study|Insufficient therapeutic response|0|||
33364901|NCT00077623|101223679|FG002|Overall Study|Insufficient therapeutic response|0|||
33364902|NCT00077623|101223677|FG000|Overall Study|Death|12|||
33364903|NCT00077623|101223678|FG001|Overall Study|Death|18|||
33392102|NCT01224106|101321957|FG001|Open-Label Extension (OLE) Phase|Death|0|||
33392103|NCT01224106|101321958|FG002|Open-Label Extension (OLE) Phase|Death|0|||
33392104|NCT01224106|101321959|FG003|Open-Label Extension (OLE) Phase|Death|1|||
33496238|NCT02166333|101710046|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
33188898|NCT00934544|100601383|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
33188899|NCT00934544|100601384|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
33188900|NCT02023151|100601385|FG000|Overall Study|Lost to Follow-up|4|||
33188901|NCT04033003|100601386|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
33188902|NCT04033003|100601387|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
33188903|NCT04033003|100601386|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
33188904|NCT04033003|100601387|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
33392105|NCT01224106|101321960|FG004|Open-Label Extension (OLE) Phase|Death|3|||
33188905|NCT04033003|100601386|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
33188906|NCT04033003|100601387|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
33188907|NCT04033003|100601386|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
33188908|NCT04033003|100601387|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
33188909|NCT04033003|100601386|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
33188910|NCT04033003|100601387|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
33188911|NCT04033003|100601386|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
33188912|NCT04033003|100601387|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
33188913|NCT04033003|100601386|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
33188914|NCT04033003|100601387|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
33295295|NCT03898700|100978434|FG000|Overall Study|Withdrawal by Subject|2|||
33295296|NCT01483144|100978435|FG000|Overall Study|Adverse Event|9|||
33392106|NCT01224106|101321956|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
33188915|NCT04033003|100601386|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
33188916|NCT04033003|100601387|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
33188917|NCT04033003|100601386|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
33188918|NCT04033003|100601387|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
33188919|NCT04033003|100601386|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
33188920|NCT04033003|100601387|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
33188921|NCT04033003|100601386|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
33392107|NCT01224106|101321957|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
33392108|NCT01224106|101321958|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
33392109|NCT01224106|101321959|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
33392110|NCT01224106|101321960|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
33392111|NCT01224106|101321956|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
33392112|NCT01224106|101321957|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
33392113|NCT01224106|101321958|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
33392114|NCT01224106|101321959|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
33392115|NCT01224106|101321960|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
33392116|NCT01224106|101321956|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
33392117|NCT01224106|101321957|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
33392118|NCT01224106|101321958|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
33392119|NCT01224106|101321959|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
33392120|NCT01224106|101321960|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
33392121|NCT01224106|101321956|FG000|Open-Label Extension (OLE) Phase|Other|0|||
33392122|NCT01224106|101321957|FG001|Open-Label Extension (OLE) Phase|Other|0|||
33392123|NCT01224106|101321958|FG002|Open-Label Extension (OLE) Phase|Other|0|||
33188922|NCT04033003|100601387|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
33188923|NCT04033003|100601386|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
33188924|NCT04033003|100601387|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
33188925|NCT04033003|100601386|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
33188926|NCT04033003|100601387|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
33188927|NCT00378703|100601388|FG000|Overall Study|Disease progression|59|||
33188928|NCT00378703|100601389|FG001|Overall Study|Disease progression|43|||
33188929|NCT00378703|100601390|FG002|Overall Study|Disease progression|48|||
33188930|NCT00378703|100601391|FG003|Overall Study|Disease progression|49|||
33188931|NCT00378703|100601388|FG000|Overall Study|Adverse Event|11|||
33188932|NCT00378703|100601389|FG001|Overall Study|Adverse Event|17|||
33188933|NCT00378703|100601390|FG002|Overall Study|Adverse Event|20|||
33188934|NCT00378703|100601391|FG003|Overall Study|Adverse Event|18|||
33188935|NCT00378703|100601388|FG000|Overall Study|Death|2|||
33188936|NCT00378703|100601389|FG001|Overall Study|Death|2|||
33188937|NCT00378703|100601390|FG002|Overall Study|Death|4|||
33188938|NCT00378703|100601391|FG003|Overall Study|Death|3|||
33188939|NCT00378703|100601388|FG000|Overall Study|Withdrawal by Subject|4|||
33188940|NCT00378703|100601389|FG001|Overall Study|Withdrawal by Subject|8|||
33295297|NCT01483144|100978436|FG001|Overall Study|Adverse Event|4|||
33295298|NCT01483144|100978437|FG002|Overall Study|Adverse Event|6|||
33295299|NCT01483144|100978435|FG000|Overall Study|Withdrawal by Subject|0|||
33295300|NCT01483144|100978436|FG001|Overall Study|Withdrawal by Subject|2|||
33295301|NCT01483144|100978437|FG002|Overall Study|Withdrawal by Subject|5|||
33295302|NCT01483144|100978435|FG000|Overall Study|Physician Decision|1|||
33188941|NCT00378703|100601390|FG002|Overall Study|Withdrawal by Subject|5|||
33188942|NCT00378703|100601391|FG003|Overall Study|Withdrawal by Subject|7|||
33295303|NCT01483144|100978436|FG001|Overall Study|Physician Decision|0|||
33392124|NCT01224106|101321959|FG003|Open-Label Extension (OLE) Phase|Other|5|||
33392125|NCT01224106|101321960|FG004|Open-Label Extension (OLE) Phase|Other|3|||
33392126|NCT02120469|101321963|FG000|Overall Study|HER-2/neu-amplified|1|||
33392127|NCT02120469|101321964|FG001|Overall Study|HER-2/neu-amplified|0|||
33600124|NCT04493684|102088505|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33188943|NCT00378703|100601388|FG000|Overall Study|Physician Decision|1|||
33188944|NCT00378703|100601389|FG001|Overall Study|Physician Decision|4|||
33188945|NCT00378703|100601390|FG002|Overall Study|Physician Decision|1|||
33188946|NCT00378703|100601391|FG003|Overall Study|Physician Decision|0|||
33188947|NCT00378703|100601388|FG000|Overall Study|Alternative therapy|4|||
33188948|NCT00378703|100601389|FG001|Overall Study|Alternative therapy|2|||
33188949|NCT00378703|100601390|FG002|Overall Study|Alternative therapy|0|||
33188950|NCT00378703|100601391|FG003|Overall Study|Alternative therapy|0|||
33188951|NCT00378703|100601388|FG000|Overall Study|Other complicated disease|0|||
33188952|NCT00378703|100601389|FG001|Overall Study|Other complicated disease|2|||
33188953|NCT00378703|100601390|FG002|Overall Study|Other complicated disease|2|||
33188954|NCT00378703|100601391|FG003|Overall Study|Other complicated disease|0|||
33188955|NCT00378703|100601388|FG000|Overall Study|Symptomatic deterioration|0|||
33188956|NCT00378703|100601389|FG001|Overall Study|Symptomatic deterioration|1|||
33188957|NCT00378703|100601390|FG002|Overall Study|Symptomatic deterioration|0|||
33188958|NCT00378703|100601391|FG003|Overall Study|Symptomatic deterioration|2|||
33188959|NCT00378703|100601388|FG000|Overall Study|Surgery|1|||
33188960|NCT00378703|100601389|FG001|Overall Study|Surgery|0|||
33188961|NCT00378703|100601390|FG002|Overall Study|Surgery|0|||
33188962|NCT00378703|100601391|FG003|Overall Study|Surgery|1|||
33188963|NCT00378703|100601388|FG000|Overall Study|Joint decision of physician and patient|1|||
33188964|NCT00378703|100601389|FG001|Overall Study|Joint decision of physician and patient|0|||
33188965|NCT00378703|100601390|FG002|Overall Study|Joint decision of physician and patient|0|||
33188966|NCT00378703|100601391|FG003|Overall Study|Joint decision of physician and patient|0|||
33188967|NCT00378703|100601388|FG000|Overall Study|Adverse events and progressive disease|0|||
33188968|NCT00378703|100601389|FG001|Overall Study|Adverse events and progressive disease|0|||
33188969|NCT00378703|100601390|FG002|Overall Study|Adverse events and progressive disease|0|||
33188970|NCT00378703|100601391|FG003|Overall Study|Adverse events and progressive disease|1|||
33188971|NCT00378703|100601388|FG000|Overall Study|Relocation|0|||
33188972|NCT00378703|100601389|FG001|Overall Study|Relocation|0|||
33188973|NCT00378703|100601390|FG002|Overall Study|Relocation|1|||
33188974|NCT00378703|100601391|FG003|Overall Study|Relocation|0|||
33188975|NCT00378703|100601388|FG000|Overall Study|Ineligible|4|||
33188976|NCT00378703|100601389|FG001|Overall Study|Ineligible|7|||
33188977|NCT00378703|100601390|FG002|Overall Study|Ineligible|7|||
33188978|NCT00378703|100601391|FG003|Overall Study|Ineligible|7|||
33188979|NCT00378703|100601388|FG000|Overall Study|Never started treatment|1|||
33188980|NCT00378703|100601389|FG001|Overall Study|Never started treatment|4|||
33188981|NCT00378703|100601390|FG002|Overall Study|Never started treatment|0|||
33188982|NCT00378703|100601391|FG003|Overall Study|Never started treatment|0|||
33188983|NCT00378703|100601388|FG000|Overall Study|Other|1|||
33188984|NCT00378703|100601389|FG001|Overall Study|Other|1|||
33188985|NCT00378703|100601390|FG002|Overall Study|Other|2|||
33188986|NCT00378703|100601391|FG003|Overall Study|Other|3|||
33188987|NCT03044197|100601393|FG000|Overall Study|Withdrawal by Subject|3|||
33188988|NCT03044197|100601394|FG001|Overall Study|Withdrawal by Subject|1|||
33188989|NCT00715793|100601395|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
33188990|NCT00715793|100601396|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
33188991|NCT00715793|100601395|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
33188992|NCT00715793|100601396|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
33188993|NCT02126969|100601397|FG000|Overall Study|Withdrawal by Subject|1|||
33188994|NCT02126969|100601398|FG001|Overall Study|Withdrawal by Subject|2|||
33188995|NCT02404311|100601401|FG000|Part A: Month 0-18|Death|2|||
33188996|NCT02404311|100601402|FG001|Part A: Month 0-18|Death|0|||
33188997|NCT02404311|100601403|FG002|Part A: Month 0-18|Death|0|||
33188998|NCT02404311|100601404|FG003|Part A: Month 0-18|Death|0|||
33188999|NCT02404311|100601405|FG004|Part A: Month 0-18|Death|0|||
33189000|NCT02404311|100601401|FG000|Part A: Month 0-18|Physician Decision|1|||
33189001|NCT02404311|100601402|FG001|Part A: Month 0-18|Physician Decision|0|||
33189002|NCT02404311|100601403|FG002|Part A: Month 0-18|Physician Decision|0|||
33189003|NCT02404311|100601404|FG003|Part A: Month 0-18|Physician Decision|0|||
33189004|NCT02404311|100601405|FG004|Part A: Month 0-18|Physician Decision|0|||
33189005|NCT02404311|100601401|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
33189006|NCT02404311|100601402|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
33189007|NCT02404311|100601403|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
33189008|NCT02404311|100601404|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
33189009|NCT02404311|100601405|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
33189010|NCT02404311|100601401|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
33189011|NCT02404311|100601402|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
33189012|NCT02404311|100601403|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
33189013|NCT02404311|100601404|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
33189014|NCT02404311|100601405|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
33189015|NCT02404311|100601401|FG000|Part A: Month 0-18|HIV Infection|6|||
33189016|NCT02404311|100601402|FG001|Part A: Month 0-18|HIV Infection|2|||
33189017|NCT02404311|100601403|FG002|Part A: Month 0-18|HIV Infection|0|||
33189018|NCT02404311|100601404|FG003|Part A: Month 0-18|HIV Infection|0|||
33189019|NCT02404311|100601405|FG004|Part A: Month 0-18|HIV Infection|0|||
33189020|NCT02404311|100601401|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
33189021|NCT02404311|100601402|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
33295304|NCT01483144|100978437|FG002|Overall Study|Physician Decision|0|||
33295305|NCT01483144|100978435|FG000|Overall Study|Lost to Follow-up|2|||
33295306|NCT01483144|100978436|FG001|Overall Study|Lost to Follow-up|4|||
33295307|NCT01483144|100978437|FG002|Overall Study|Lost to Follow-up|1|||
33295308|NCT01483144|100978435|FG000|Overall Study|Protocol Violation|3|||
33295309|NCT01483144|100978436|FG001|Overall Study|Protocol Violation|3|||
33295310|NCT01483144|100978437|FG002|Overall Study|Protocol Violation|3|||
33295311|NCT01667926|100978438|FG000|Overall Study|Withdrawal by Subject|1|||
33295312|NCT01667926|100978439|FG001|Overall Study|Withdrawal by Subject|2|||
33295313|NCT01667926|100978440|FG002|Overall Study|Withdrawal by Subject|2|||
33295314|NCT01667926|100978438|FG000|Overall Study|Physician Decision|0|||
33295315|NCT01667926|100978439|FG001|Overall Study|Physician Decision|0|||
33392128|NCT02120469|101321965|FG002|Overall Study|HER-2/neu-amplified|1|||
33189022|NCT02404311|100601403|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
33189023|NCT02404311|100601404|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
33189024|NCT02404311|100601405|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
33189025|NCT03277846|100601408|FG000|Overall Study|Inpatient stay too brief|12|||
33189026|NCT03277846|100601409|FG001|Overall Study|Inpatient stay too brief|11|||
33189027|NCT01720069|100601414|FG000|Overall Study|Could not use e-diary correctly|0|||
33189028|NCT01720069|100601415|FG001|Overall Study|Could not use e-diary correctly|1|||
33189029|NCT01720069|100601416|FG002|Overall Study|Could not use e-diary correctly|1|||
33189030|NCT01720069|100601414|FG000|Overall Study|Randomised without baseline values|0|||
33189031|NCT01720069|100601415|FG001|Overall Study|Randomised without baseline values|0|||
33189032|NCT01720069|100601416|FG002|Overall Study|Randomised without baseline values|1|||
33189033|NCT01720069|100601414|FG000|Overall Study|Adverse Event|0|||
33189034|NCT01720069|100601415|FG001|Overall Study|Adverse Event|0|||
33189035|NCT01720069|100601416|FG002|Overall Study|Adverse Event|1|||
33189036|NCT01720069|100601414|FG000|Overall Study|Lack of Efficacy|0|||
33189037|NCT01720069|100601415|FG001|Overall Study|Lack of Efficacy|4|||
33392129|NCT00948428|101325150|FG000|Overall Study|Withdrawal by Subject|6|||
33392130|NCT00948428|101325151|FG001|Overall Study|Withdrawal by Subject|12|||
33392131|NCT00948428|101325152|FG002|Overall Study|Withdrawal by Subject|7|||
33392132|NCT00948428|101325150|FG000|Overall Study|Adverse Event|6|||
33392133|NCT00948428|101325151|FG001|Overall Study|Adverse Event|3|||
33392134|NCT00948428|101325152|FG002|Overall Study|Adverse Event|0|||
33392135|NCT00948428|101325150|FG000|Overall Study|Lost to Follow-up|2|||
33392136|NCT00948428|101325151|FG001|Overall Study|Lost to Follow-up|1|||
33392137|NCT00948428|101325152|FG002|Overall Study|Lost to Follow-up|1|||
33392138|NCT00948428|101325150|FG000|Overall Study|Death|2|||
33392139|NCT00948428|101325151|FG001|Overall Study|Death|0|||
33392140|NCT00948428|101325152|FG002|Overall Study|Death|0|||
33392141|NCT00948428|101325150|FG000|Overall Study|Intercurrent Illness|1|||
33392142|NCT00948428|101325151|FG001|Overall Study|Intercurrent Illness|0|||
33392143|NCT00948428|101325152|FG002|Overall Study|Intercurrent Illness|0|||
33392144|NCT00948428|101325150|FG000|Overall Study|Non-compliance|1|||
33392145|NCT00948428|101325151|FG001|Overall Study|Non-compliance|2|||
33392146|NCT00948428|101325152|FG002|Overall Study|Non-compliance|0|||
33392147|NCT00552344|101325153|FG000|Overall Study|Lack of Efficacy|55|||
33392148|NCT00552344|101325153|FG000|Overall Study|Loss of efficacy|75|||
33392149|NCT00552344|101325153|FG000|Overall Study|Lost to Follow-up|8|||
33392150|NCT00552344|101325153|FG000|Overall Study|Withdrawal by Subject|48|||
33392151|NCT00552344|101325153|FG000|Overall Study|SAE, non-fatal|6|||
33392152|NCT00552344|101325153|FG000|Overall Study|AE, non-serious non-fatal|38|||
33392153|NCT00552344|101325153|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
33392154|NCT00552344|101325153|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
33392155|NCT00552344|101325153|FG000|Overall Study|Other Reason|22|||
33392156|NCT01201967|101325154|FG000|Overall Study|Lost to Follow-up|6|||
33392157|NCT01201967|101325155|FG001|Overall Study|Lost to Follow-up|5|||
33295316|NCT01667926|100978440|FG002|Overall Study|Physician Decision|1|||
33295317|NCT01667926|100978438|FG000|Overall Study|Time committment|0|||
33295318|NCT01667926|100978439|FG001|Overall Study|Time committment|0|||
33295319|NCT01667926|100978440|FG002|Overall Study|Time committment|2|||
33392158|NCT04159701|101325160|FG000|Period 1: Treatment Period|Pregnancy|1|||
33392159|NCT04159701|101325161|FG001|Period 1: Treatment Period|Pregnancy|0|||
33392160|NCT04159701|101325160|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
33392161|NCT04159701|101325161|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
33392162|NCT04159701|101325160|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
33392163|NCT04159701|101325161|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
33392164|NCT04159701|101325160|FG000|Washout Period|site terminated by sponsor|0|||
33189038|NCT01720069|100601416|FG002|Overall Study|Lack of Efficacy|0|||
33295320|NCT01667926|100978438|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
33392165|NCT04159701|101325161|FG001|Washout Period|site terminated by sponsor|1|||
33392166|NCT04159701|101325160|FG000|Washout Period|study terminated by sponsor|10|||
33392167|NCT04159701|101325161|FG001|Washout Period|study terminated by sponsor|3|||
33392168|NCT04159701|101325160|FG000|Washout Period|Withdrawal by Subject|1|||
33392169|NCT04159701|101325161|FG001|Washout Period|Withdrawal by Subject|0|||
33392170|NCT04159701|101325160|FG000|Washout Period|Inadvertent Enrollment|1|||
33392171|NCT04159701|101325161|FG001|Washout Period|Inadvertent Enrollment|0|||
33392172|NCT04159701|101325160|FG000|Washout Period|Miscellaneous|1|||
33392173|NCT04159701|101325161|FG001|Washout Period|Miscellaneous|0|||
33392174|NCT04159701|101325160|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
33392175|NCT04159701|101325161|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
33392176|NCT04159701|101325160|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
33392177|NCT04159701|101325161|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
33392178|NCT04159701|101325160|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
33189039|NCT01720069|100601414|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
33189040|NCT01720069|100601415|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
33189041|NCT01720069|100601416|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
33189042|NCT01720069|100601414|FG000|Overall Study|Withdrawal by Subject|0|||
33189043|NCT01720069|100601415|FG001|Overall Study|Withdrawal by Subject|2|||
33189044|NCT01720069|100601416|FG002|Overall Study|Withdrawal by Subject|1|||
33189045|NCT01720069|100601414|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
33189046|NCT01720069|100601415|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
33189047|NCT01720069|100601416|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
33189048|NCT01720069|100601414|FG000|Overall Study|Non-compliance on using e-diary|0|||
33189049|NCT01720069|100601415|FG001|Overall Study|Non-compliance on using e-diary|0|||
33189050|NCT01720069|100601416|FG002|Overall Study|Non-compliance on using e-diary|1|||
33189051|NCT01720069|100601414|FG000|Overall Study|Lost to Follow-up|0|||
33189052|NCT01720069|100601415|FG001|Overall Study|Lost to Follow-up|0|||
33189053|NCT01720069|100601416|FG002|Overall Study|Lost to Follow-up|1|||
33189054|NCT03102918|100601417|FG000|Overall Study|Protocol Violation|1|||
33189055|NCT03102918|100601418|FG001|Overall Study|Protocol Violation|0|||
33189056|NCT00482391|100601422|FG000|Overall Study|Withdrawal by Subject|1|||
33189057|NCT00482391|100601422|FG000|Overall Study|Adverse Event|1|||
33189058|NCT00482391|100601422|FG000|Overall Study|Death|1|||
33295321|NCT01667926|100978439|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
33295322|NCT01667926|100978440|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
33295323|NCT01667926|100978438|FG000|Overall Study|Lost to Follow-up|1|||
33295324|NCT01667926|100978439|FG001|Overall Study|Lost to Follow-up|2|||
33600125|NCT04493684|102088506|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33295325|NCT01667926|100978440|FG002|Overall Study|Lost to Follow-up|1|||
33295326|NCT01667926|100978438|FG000|Overall Study|Side effects|3|||
33295327|NCT01667926|100978439|FG001|Overall Study|Side effects|0|||
33295328|NCT01667926|100978440|FG002|Overall Study|Side effects|0|||
33295329|NCT00350727|100978442|FG000|Phase I: Dose Escalation|Adverse Event|4|||
33295330|NCT00350727|100978443|FG001|Phase I: Dose Escalation|Adverse Event|0|||
33295331|NCT00350727|100978444|FG002|Phase I: Dose Escalation|Adverse Event|0|||
33295332|NCT00350727|100978442|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
33295333|NCT00350727|100978443|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
33295334|NCT00350727|100978444|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
33295335|NCT00350727|100978442|FG000|Phase I: Dose Escalation|Death|1|||
33295336|NCT00350727|100978443|FG001|Phase I: Dose Escalation|Death|0|||
33295337|NCT00350727|100978444|FG002|Phase I: Dose Escalation|Death|0|||
33364904|NCT00077623|101223679|FG002|Overall Study|Death|11|||
33392179|NCT04159701|101325161|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
33392180|NCT04159701|101325160|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
33392181|NCT04159701|101325161|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
33189059|NCT02346240|100601427|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189060|NCT02346240|100601428|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
33189061|NCT02346240|100601429|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
33189062|NCT02346240|100601430|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
33189063|NCT02346240|100601431|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189064|NCT02346240|100601432|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189065|NCT02346240|100601433|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189066|NCT02346240|100601434|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189067|NCT02346240|100601435|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189068|NCT02346240|100601436|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189069|NCT02346240|100601437|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189070|NCT02346240|100601438|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189071|NCT02346240|100601439|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189072|NCT02346240|100601440|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189073|NCT02346240|100601441|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33295338|NCT00350727|100978442|FG000|Phase I: Dose Escalation|Physician Decision|1|||
33295339|NCT00350727|100978443|FG001|Phase I: Dose Escalation|Physician Decision|0|||
33295340|NCT00350727|100978444|FG002|Phase I: Dose Escalation|Physician Decision|0|||
33295341|NCT00350727|100978442|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
33295342|NCT00350727|100978443|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
33295343|NCT00350727|100978444|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
33295344|NCT00350727|100978442|FG000|Phase II|Disease Progression|0|||
33392182|NCT04159701|101325160|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
33392183|NCT04159701|101325161|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
33392184|NCT01804842|101325162|FG000|Overall Study|Adverse Event|1|||
33392185|NCT01804842|101325163|FG001|Overall Study|Adverse Event|1|||
33392186|NCT01804842|101325164|FG002|Overall Study|Adverse Event|0|||
33392187|NCT01804842|101325162|FG000|Overall Study|Lost to Follow-up|1|||
33392188|NCT01804842|101325163|FG001|Overall Study|Lost to Follow-up|0|||
33392189|NCT01804842|101325164|FG002|Overall Study|Lost to Follow-up|0|||
33392190|NCT01804842|101325162|FG000|Overall Study|Non-Compliance|1|||
33392191|NCT01804842|101325163|FG001|Overall Study|Non-Compliance|1|||
33392192|NCT01804842|101325164|FG002|Overall Study|Non-Compliance|0|||
33392193|NCT01804842|101325162|FG000|Overall Study|Personal Reason|0|||
33189074|NCT02346240|100601442|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189075|NCT02346240|100601443|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189076|NCT02346240|100601444|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189077|NCT02346240|100601445|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189078|NCT02346240|100601446|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189079|NCT02346240|100601447|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33295345|NCT00350727|100978443|FG001|Phase II|Disease Progression|15|||
33295346|NCT00350727|100978444|FG002|Phase II|Disease Progression|16|||
33295347|NCT00350727|100978442|FG000|Phase II|Clinical Deterioration|0|||
33295348|NCT00350727|100978443|FG001|Phase II|Clinical Deterioration|1|||
33295349|NCT00350727|100978444|FG002|Phase II|Clinical Deterioration|0|||
33295350|NCT00350727|100978442|FG000|Phase II|Withdrawal by Subject|0|||
33295351|NCT00350727|100978443|FG001|Phase II|Withdrawal by Subject|2|||
33295352|NCT00350727|100978444|FG002|Phase II|Withdrawal by Subject|1|||
33295353|NCT00350727|100978442|FG000|Phase II|Adverse Event|0|||
33295354|NCT00350727|100978443|FG001|Phase II|Adverse Event|1|||
33295355|NCT00350727|100978444|FG002|Phase II|Adverse Event|1|||
33295356|NCT00350727|100978442|FG000|Phase II|Death|0|||
33189080|NCT02346240|100601448|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189081|NCT02346240|100601449|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33189082|NCT02346240|100601450|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
33295357|NCT00350727|100978443|FG001|Phase II|Death|0|||
33392194|NCT01804842|101325163|FG001|Overall Study|Personal Reason|0|||
33392195|NCT01804842|101325164|FG002|Overall Study|Personal Reason|1|||
33295358|NCT00350727|100978444|FG002|Phase II|Death|2|||
33392196|NCT03325010|101325166|FG000|Overall Study|Adverse Event|3|||
33392197|NCT03325010|101325167|FG001|Overall Study|Adverse Event|8|||
33600126|NCT04493684|102088507|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33295359|NCT00350727|100978442|FG000|Phase II|Sponsor Terminated Study|0|||
33295360|NCT00350727|100978443|FG001|Phase II|Sponsor Terminated Study|0|||
33295361|NCT00350727|100978444|FG002|Phase II|Sponsor Terminated Study|1|||
33189083|NCT02346240|100601427|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189084|NCT02346240|100601428|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
33189085|NCT02346240|100601429|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189086|NCT02346240|100601430|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189087|NCT02346240|100601431|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189088|NCT02346240|100601432|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189089|NCT02346240|100601433|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189090|NCT02346240|100601434|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33392198|NCT03325010|101325166|FG000|Overall Study|Protocol Violation|1|||
33392199|NCT03325010|101325167|FG001|Overall Study|Protocol Violation|8|||
33392200|NCT03325010|101325166|FG000|Overall Study|Withdrawal by Subject|1|||
33392201|NCT03325010|101325167|FG001|Overall Study|Withdrawal by Subject|3|||
33392202|NCT03325010|101325166|FG000|Overall Study|Lost to Follow-up|1|||
33392203|NCT03325010|101325167|FG001|Overall Study|Lost to Follow-up|0|||
33392204|NCT03325010|101325166|FG000|Overall Study|Physician Decision|1|||
33392205|NCT03325010|101325167|FG001|Overall Study|Physician Decision|1|||
33392206|NCT03325010|101325166|FG000|Overall Study|Lack of Efficacy|2|||
33392207|NCT03325010|101325167|FG001|Overall Study|Lack of Efficacy|0|||
33392208|NCT02903368|101325170|FG000|Part 1|Adverse Event|3|||
33392209|NCT02903368|101325171|FG001|Part 1|Adverse Event|0|||
33392210|NCT02903368|101325172|FG002|Part 1|Adverse Event|0|||
33392211|NCT02903368|101325173|FG003|Part 1|Adverse Event|0|||
33189091|NCT02346240|100601435|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33295362|NCT00350727|100978442|FG000|Phase II|Enrolled in Rollover Study|0|||
33295363|NCT00350727|100978443|FG001|Phase II|Enrolled in Rollover Study|0|||
33295364|NCT00350727|100978444|FG002|Phase II|Enrolled in Rollover Study|1|||
33295365|NCT01246999|100978447|FG000|Overall Study|Lost to Follow-up|0|||
33295366|NCT01246999|100978448|FG001|Overall Study|Lost to Follow-up|1|||
33295367|NCT01246999|100978449|FG002|Overall Study|Lost to Follow-up|0|||
33295368|NCT01246999|100978450|FG003|Overall Study|Lost to Follow-up|0|||
33295369|NCT01246999|100978447|FG000|Overall Study|Withdrawal by Subject|0|||
33392212|NCT02903368|101325170|FG000|Part 1|Withdrawal by Subject|1|||
33392213|NCT02903368|101325171|FG001|Part 1|Withdrawal by Subject|0|||
33392214|NCT02903368|101325172|FG002|Part 1|Withdrawal by Subject|0|||
33392215|NCT02903368|101325173|FG003|Part 1|Withdrawal by Subject|0|||
33392216|NCT02903368|101325170|FG000|Part 2|Adverse Event|0|||
33392217|NCT02903368|101325171|FG001|Part 2|Adverse Event|0|||
33392218|NCT02903368|101325172|FG002|Part 2|Adverse Event|5|||
33392219|NCT02903368|101325173|FG003|Part 2|Adverse Event|0|||
33392220|NCT02903368|101325170|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
33392221|NCT02903368|101325171|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
33392222|NCT02903368|101325172|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
33392223|NCT02903368|101325173|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
33392224|NCT02903368|101325170|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
33392225|NCT02903368|101325171|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
33392226|NCT02903368|101325172|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
33392227|NCT02903368|101325173|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
33392228|NCT02903368|101325170|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
33392229|NCT02903368|101325171|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
33392230|NCT02903368|101325172|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
33392231|NCT02903368|101325173|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
33392232|NCT04268303|101325174|FG000|Overall Study|Lost to Follow-up|1|||
33392233|NCT04268303|101325175|FG001|Overall Study|Lost to Follow-up|1|||
33392234|NCT04268303|101325176|FG002|Overall Study|Lost to Follow-up|2|||
33392235|NCT04268303|101325174|FG000|Overall Study|Withdrawal by Subject|0|||
33392236|NCT04268303|101325175|FG001|Overall Study|Withdrawal by Subject|1|||
33392237|NCT04268303|101325176|FG002|Overall Study|Withdrawal by Subject|1|||
33392238|NCT04268303|101325174|FG000|Overall Study|Adverse Event|2|||
33295370|NCT01246999|100978448|FG001|Overall Study|Withdrawal by Subject|0|||
33295371|NCT01246999|100978449|FG002|Overall Study|Withdrawal by Subject|0|||
33392239|NCT04268303|101325175|FG001|Overall Study|Adverse Event|0|||
33392240|NCT04268303|101325176|FG002|Overall Study|Adverse Event|0|||
33392241|NCT00595868|101325177|FG000|Overall Study|Lost to Follow-up|45|||
33392242|NCT00595868|101325178|FG001|Overall Study|Lost to Follow-up|50|||
33392243|NCT01041404|101325179|FG000|Overall Study|Adverse Event|45|||
33392244|NCT01041404|101325180|FG001|Overall Study|Adverse Event|35|||
33295372|NCT01246999|100978450|FG003|Overall Study|Withdrawal by Subject|2|||
33295373|NCT01439867|100978451|FG000|Overall Study|Non-compliance|0|||
33295374|NCT01439867|100978452|FG001|Overall Study|Non-compliance|1|||
33295375|NCT01439867|100978451|FG000|Overall Study|Withdrawal by Subject|1|||
33295376|NCT01439867|100978452|FG001|Overall Study|Withdrawal by Subject|2|||
33295377|NCT01439867|100978451|FG000|Overall Study|Administrative Decision|4|||
33295378|NCT01439867|100978452|FG001|Overall Study|Administrative Decision|5|||
33295379|NCT01439867|100978451|FG000|Overall Study|Protocol-specified Criteria|1|||
33295380|NCT01439867|100978452|FG001|Overall Study|Protocol-specified Criteria|0|||
33392245|NCT01041404|101325179|FG000|Overall Study|Lack of Efficacy|200|||
33392246|NCT01041404|101325180|FG001|Overall Study|Lack of Efficacy|210|||
33392247|NCT01041404|101325179|FG000|Overall Study|Violation of Selection Criteria|0|||
33392248|NCT01041404|101325180|FG001|Overall Study|Violation of Selection Criteria|1|||
33392249|NCT01041404|101325179|FG000|Overall Study|Protocol Violation|4|||
33392250|NCT01041404|101325180|FG001|Overall Study|Protocol Violation|0|||
33392251|NCT01041404|101325179|FG000|Overall Study|Withdrawal by Subject|29|||
33189092|NCT02346240|100601436|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189093|NCT02346240|100601437|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189094|NCT02346240|100601438|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189095|NCT02346240|100601439|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189096|NCT02346240|100601440|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189097|NCT02346240|100601441|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189098|NCT02346240|100601442|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189099|NCT02346240|100601443|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189100|NCT02346240|100601444|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189101|NCT02346240|100601445|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189102|NCT02346240|100601446|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189103|NCT02346240|100601447|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189104|NCT02346240|100601448|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189105|NCT02346240|100601449|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189106|NCT02346240|100601450|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
33189107|NCT02346240|100601427|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189108|NCT02346240|100601428|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
33189109|NCT02346240|100601429|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189110|NCT02346240|100601430|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189111|NCT02346240|100601431|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189112|NCT02346240|100601432|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189113|NCT02346240|100601433|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189114|NCT02346240|100601434|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189115|NCT02346240|100601435|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189116|NCT02346240|100601436|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189117|NCT02346240|100601437|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189118|NCT02346240|100601438|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189119|NCT02346240|100601439|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189120|NCT02346240|100601440|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33295381|NCT00879775|100978453|FG000|Overall Study|Lost to Follow-up|2|||
33295382|NCT00879775|100978454|FG001|Overall Study|Lost to Follow-up|1|||
33295383|NCT04593823|100978455|FG000|Overall Study|Withdrawal by Subject|1|||
33392252|NCT01041404|101325180|FG001|Overall Study|Withdrawal by Subject|23|||
33392253|NCT01041404|101325179|FG000|Overall Study|Failure to Return|1|||
33364905|NCT00077623|101223677|FG000|Overall Study|Failure to return|1|||
33392254|NCT01041404|101325180|FG001|Overall Study|Failure to Return|2|||
33392255|NCT01041404|101325179|FG000|Overall Study|Other|11|||
33392256|NCT01041404|101325180|FG001|Overall Study|Other|23|||
33189121|NCT02346240|100601441|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189122|NCT02346240|100601442|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189123|NCT02346240|100601443|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189124|NCT02346240|100601444|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189125|NCT02346240|100601445|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33392257|NCT02971007|101325185|FG000|Overall Study|Adverse Event|1|||
33392258|NCT02971007|101325186|FG001|Overall Study|Adverse Event|0|||
33392259|NCT02971007|101325187|FG002|Overall Study|Adverse Event|0|||
33392260|NCT02971007|101325185|FG000|Overall Study|Lost to Follow-up|0|||
33392261|NCT02971007|101325186|FG001|Overall Study|Lost to Follow-up|1|||
33392262|NCT02971007|101325187|FG002|Overall Study|Lost to Follow-up|1|||
33392263|NCT02971007|101325185|FG000|Overall Study|Withdrawal by Subject|0|||
33392264|NCT02971007|101325186|FG001|Overall Study|Withdrawal by Subject|1|||
33392265|NCT02971007|101325187|FG002|Overall Study|Withdrawal by Subject|0|||
33392266|NCT02971007|101325185|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
33392267|NCT02971007|101325186|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
33392268|NCT02971007|101325187|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
33392269|NCT02971007|101325185|FG000|Overall Study|Patient discontinued study drug|0|||
33392270|NCT02971007|101325186|FG001|Overall Study|Patient discontinued study drug|1|||
33392271|NCT02971007|101325187|FG002|Overall Study|Patient discontinued study drug|0|||
33392272|NCT00741260|101325188|FG000|Overall Study|Disease Progression|3|||
33392273|NCT00741260|101325189|FG001|Overall Study|Disease Progression|5|||
33392274|NCT00741260|101325190|FG002|Overall Study|Disease Progression|3|||
33392275|NCT00741260|101325191|FG003|Overall Study|Disease Progression|3|||
33392276|NCT00741260|101325192|FG004|Overall Study|Disease Progression|5|||
33392277|NCT00741260|101325193|FG005|Overall Study|Disease Progression|37|||
33392278|NCT00741260|101325194|FG006|Overall Study|Disease Progression|4|||
33392279|NCT00741260|101325188|FG000|Overall Study|Death|0|||
33392280|NCT00741260|101325189|FG001|Overall Study|Death|1|||
33392281|NCT00741260|101325190|FG002|Overall Study|Death|0|||
33392282|NCT00741260|101325191|FG003|Overall Study|Death|1|||
33392283|NCT00741260|101325192|FG004|Overall Study|Death|2|||
33392284|NCT00741260|101325193|FG005|Overall Study|Death|2|||
33189126|NCT02346240|100601446|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189127|NCT02346240|100601447|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189128|NCT02346240|100601448|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189129|NCT02346240|100601449|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189130|NCT02346240|100601450|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
33189131|NCT02346240|100601427|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
33189132|NCT02346240|100601428|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
33295384|NCT04593823|100978456|FG001|Overall Study|Withdrawal by Subject|1|||
33295385|NCT04593823|100978455|FG000|Overall Study|Lost to Follow-up|0|||
33295386|NCT04593823|100978456|FG001|Overall Study|Lost to Follow-up|1|||
33295387|NCT03445533|100978457|FG000|Overall Study|Progressive Disease|48|||
33295388|NCT03445533|100978458|FG001|Overall Study|Progressive Disease|81|||
33295389|NCT03445533|100978457|FG000|Overall Study|Adverse Event|60|||
33392285|NCT00741260|101325194|FG006|Overall Study|Death|1|||
33392286|NCT00741260|101325188|FG000|Overall Study|Withdrawal by Subject|0|||
33392287|NCT00741260|101325189|FG001|Overall Study|Withdrawal by Subject|0|||
33392288|NCT00741260|101325190|FG002|Overall Study|Withdrawal by Subject|0|||
33392289|NCT00741260|101325191|FG003|Overall Study|Withdrawal by Subject|0|||
33392290|NCT00741260|101325192|FG004|Overall Study|Withdrawal by Subject|1|||
33392291|NCT00741260|101325193|FG005|Overall Study|Withdrawal by Subject|3|||
33392292|NCT00741260|101325194|FG006|Overall Study|Withdrawal by Subject|1|||
33189133|NCT02346240|100601429|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
33295390|NCT03445533|100978458|FG001|Overall Study|Adverse Event|64|||
33295391|NCT03445533|100978457|FG000|Overall Study|Death|9|||
33295392|NCT03445533|100978458|FG001|Overall Study|Death|19|||
33295393|NCT03445533|100978457|FG000|Overall Study|Miscellaneous|0|||
33295394|NCT03445533|100978458|FG001|Overall Study|Miscellaneous|16|||
33295395|NCT03445533|100978457|FG000|Overall Study|Withdrawal by Subject|3|||
33392293|NCT00741260|101325188|FG000|Overall Study|Physician Decision|1|||
33392294|NCT00741260|101325189|FG001|Overall Study|Physician Decision|1|||
33392295|NCT00741260|101325190|FG002|Overall Study|Physician Decision|0|||
33392296|NCT00741260|101325191|FG003|Overall Study|Physician Decision|0|||
33392297|NCT00741260|101325192|FG004|Overall Study|Physician Decision|0|||
33392298|NCT00741260|101325193|FG005|Overall Study|Physician Decision|0|||
33392299|NCT00741260|101325194|FG006|Overall Study|Physician Decision|0|||
33392300|NCT00741260|101325188|FG000|Overall Study|Other|2|||
33392301|NCT00741260|101325189|FG001|Overall Study|Other|1|||
33392302|NCT00741260|101325190|FG002|Overall Study|Other|1|||
33392303|NCT00741260|101325191|FG003|Overall Study|Other|2|||
33392304|NCT00741260|101325192|FG004|Overall Study|Other|1|||
33392305|NCT00741260|101325193|FG005|Overall Study|Other|3|||
33392306|NCT00741260|101325194|FG006|Overall Study|Other|1|||
33392307|NCT03954704|101325195|FG000|Overall Study|Death|1|||
33392308|NCT03954704|101325196|FG001|Overall Study|Death|1|||
33392309|NCT03954704|101325197|FG002|Overall Study|Death|1|||
33392310|NCT03954704|101325198|FG003|Overall Study|Death|3|||
33392311|NCT03954704|101325199|FG004|Overall Study|Death|2|||
33392312|NCT03954704|101325200|FG005|Overall Study|Death|2|||
33392313|NCT03954704|101325201|FG006|Overall Study|Death|0|||
33392314|NCT03954704|101325195|FG000|Overall Study|Withdrew Consent|0|||
33392315|NCT03954704|101325196|FG001|Overall Study|Withdrew Consent|0|||
33392316|NCT03954704|101325197|FG002|Overall Study|Withdrew Consent|1|||
33392317|NCT03954704|101325198|FG003|Overall Study|Withdrew Consent|0|||
33392318|NCT03954704|101325199|FG004|Overall Study|Withdrew Consent|0|||
33392319|NCT03954704|101325200|FG005|Overall Study|Withdrew Consent|1|||
33392320|NCT03954704|101325201|FG006|Overall Study|Withdrew Consent|0|||
33392321|NCT03954704|101325195|FG000|Overall Study|Lost to Follow-up|0|||
33392322|NCT03954704|101325196|FG001|Overall Study|Lost to Follow-up|0|||
33392323|NCT03954704|101325197|FG002|Overall Study|Lost to Follow-up|0|||
33392324|NCT03954704|101325198|FG003|Overall Study|Lost to Follow-up|0|||
33392325|NCT03954704|101325199|FG004|Overall Study|Lost to Follow-up|0|||
33392326|NCT03954704|101325200|FG005|Overall Study|Lost to Follow-up|0|||
33392327|NCT03954704|101325201|FG006|Overall Study|Lost to Follow-up|1|||
33392328|NCT03954704|101325195|FG000|Overall Study|Study Terminated by Sponsor|0|||
33392329|NCT03954704|101325196|FG001|Overall Study|Study Terminated by Sponsor|0|||
33392330|NCT03954704|101325197|FG002|Overall Study|Study Terminated by Sponsor|1|||
33392331|NCT03954704|101325198|FG003|Overall Study|Study Terminated by Sponsor|0|||
33392332|NCT03954704|101325199|FG004|Overall Study|Study Terminated by Sponsor|1|||
33392333|NCT03954704|101325200|FG005|Overall Study|Study Terminated by Sponsor|4|||
33392334|NCT03954704|101325201|FG006|Overall Study|Study Terminated by Sponsor|2|||
33392335|NCT03954704|101325195|FG000|Overall Study|Enrolled but not Treated|0|||
33392336|NCT03954704|101325196|FG001|Overall Study|Enrolled but not Treated|0|||
33392337|NCT03954704|101325197|FG002|Overall Study|Enrolled but not Treated|0|||
33392338|NCT03954704|101325198|FG003|Overall Study|Enrolled but not Treated|0|||
33392339|NCT03954704|101325199|FG004|Overall Study|Enrolled but not Treated|0|||
33392340|NCT03954704|101325200|FG005|Overall Study|Enrolled but not Treated|1|||
33392341|NCT03954704|101325201|FG006|Overall Study|Enrolled but not Treated|0|||
33392342|NCT02000219|101325205|FG000|14-Week Study Period|Physician Decision|1|||
33392343|NCT02000219|101325205|FG000|14-Week Study Period|Adverse Event|1|||
33392344|NCT02000219|101325205|FG000|14-Week Study Period|Underwent transplantation|1|||
33392345|NCT02000219|101325205|FG000|Continuation Period|Withdrawal by Subject|1|||
33392346|NCT02000219|101325205|FG000|Continuation Period|Had liver transplant|2|||
33392347|NCT02000219|101325205|FG000|Continuation Period|Non-compliance with study drug|2|||
33392348|NCT01553591|101325206|FG000|Overall Study|Voluntarily withdrew|94|||
33392349|NCT01553591|101325207|FG001|Overall Study|Voluntarily withdrew|79|||
33392350|NCT01553591|101325208|FG002|Overall Study|Voluntarily withdrew|96|||
33392351|NCT01553591|101325206|FG000|Overall Study|Adverse Event|36|||
33392352|NCT01553591|101325207|FG001|Overall Study|Adverse Event|45|||
33392353|NCT01553591|101325208|FG002|Overall Study|Adverse Event|16|||
33392354|NCT01553591|101325206|FG000|Overall Study|Lost to Follow-up|25|||
33392355|NCT01553591|101325207|FG001|Overall Study|Lost to Follow-up|23|||
33392356|NCT01553591|101325208|FG002|Overall Study|Lost to Follow-up|16|||
33392357|NCT01553591|101325206|FG000|Overall Study|Physician decision: other|11|||
33392358|NCT01553591|101325207|FG001|Overall Study|Physician decision: other|14|||
33392359|NCT01553591|101325208|FG002|Overall Study|Physician decision: other|16|||
33392360|NCT01553591|101325206|FG000|Overall Study|Physician decision: lack of efficacy|2|||
33392361|NCT01553591|101325207|FG001|Overall Study|Physician decision: lack of efficacy|3|||
33392362|NCT01553591|101325208|FG002|Overall Study|Physician decision: lack of efficacy|7|||
33392363|NCT01553591|101325206|FG000|Overall Study|Protocol Violation|3|||
33392364|NCT01553591|101325207|FG001|Overall Study|Protocol Violation|4|||
33392365|NCT01553591|101325208|FG002|Overall Study|Protocol Violation|4|||
33392366|NCT01553591|101325206|FG000|Overall Study|Sponsor decision|1|||
33392367|NCT01553591|101325207|FG001|Overall Study|Sponsor decision|0|||
33392368|NCT01553591|101325208|FG002|Overall Study|Sponsor decision|3|||
33392369|NCT01553591|101325206|FG000|Overall Study|Randomized and never dispensed drug|0|||
33392370|NCT01553591|101325207|FG001|Overall Study|Randomized and never dispensed drug|1|||
33392371|NCT01553591|101325208|FG002|Overall Study|Randomized and never dispensed drug|0|||
33392372|NCT04737759|101325209|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
33392373|NCT04737759|101325210|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
33392374|NCT04737759|101325209|FG000|Overall Study|Death|2|||
33392375|NCT04737759|101325210|FG001|Overall Study|Death|0|||
33392376|NCT04737759|101325209|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
33392377|NCT04737759|101325210|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
33392378|NCT04737759|101325209|FG000|Overall Study|Lost to Follow-up|4|||
33392379|NCT04737759|101325210|FG001|Overall Study|Lost to Follow-up|12|||
33392380|NCT00796224|101325213|FG000|Overall Study|Adverse Event|1|||
33392381|NCT00796224|101325214|FG001|Overall Study|Adverse Event|0|||
33392382|NCT00796224|101325213|FG000|Overall Study|Protocol Violation|0|||
33392383|NCT00796224|101325214|FG001|Overall Study|Protocol Violation|1|||
33392384|NCT02774291|101325215|FG000|Overall Study|Lost to Follow-up|1|||
33392385|NCT04362189|101325216|FG000|Overall Study|Lost to Follow-up|0|||
33392386|NCT04362189|101325217|FG001|Overall Study|Lost to Follow-up|1|||
33392387|NCT04362189|101325216|FG000|Overall Study|Withdrawal by Subject|1|||
33392388|NCT04362189|101325217|FG001|Overall Study|Withdrawal by Subject|0|||
33392389|NCT04362189|101325216|FG000|Overall Study|FDA Clinical Hold|7|||
33392390|NCT04362189|101325217|FG001|Overall Study|FDA Clinical Hold|2|||
33392391|NCT04362189|101325216|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
33392392|NCT04362189|101325217|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
33392393|NCT04362189|101325216|FG000|Overall Study|Adverse Event|0|||
33392394|NCT04362189|101325217|FG001|Overall Study|Adverse Event|2|||
33392395|NCT04362189|101325216|FG000|Overall Study|Death|4|||
33295396|NCT03445533|100978458|FG001|Overall Study|Withdrawal by Subject|4|||
33295397|NCT03445533|100978457|FG000|Overall Study|Physician Decision|1|||
33295398|NCT03445533|100978458|FG001|Overall Study|Physician Decision|3|||
33295399|NCT03445533|100978457|FG000|Overall Study|Sponsor Decision|0|||
33295400|NCT03445533|100978458|FG001|Overall Study|Sponsor Decision|1|||
33295401|NCT03445533|100978457|FG000|Overall Study|Lost to Follow-up|0|||
33392396|NCT04362189|101325217|FG001|Overall Study|Death|1|||
33392397|NCT03788967|101325218|FG000|Overall Study|Lost to Follow-up|14|||
33392398|NCT03788967|101325219|FG001|Overall Study|Lost to Follow-up|10|||
33392399|NCT03788967|101325218|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
33392400|NCT03788967|101325219|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
33392401|NCT03788967|101325218|FG000|Overall Study|Participant Withdrawal of Consent|13|||
33392402|NCT03788967|101325219|FG001|Overall Study|Participant Withdrawal of Consent|5|||
33392403|NCT03788967|101325218|FG000|Overall Study|Adverse Event|1|||
33392404|NCT03788967|101325219|FG001|Overall Study|Adverse Event|1|||
33392405|NCT03788967|101325218|FG000|Overall Study|COVID-19|1|||
33392406|NCT03788967|101325219|FG001|Overall Study|COVID-19|2|||
33392407|NCT01838213|101325220|FG000|Overall Study|Ineligible|166|||
33392408|NCT01838213|101325221|FG001|Overall Study|Ineligible|191|||
33392409|NCT01826448|101325222|FG000|Overall Study|Adverse Event|1|||
33189134|NCT02346240|100601430|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
33295402|NCT03445533|100978458|FG001|Overall Study|Lost to Follow-up|1|||
33295403|NCT03445533|100978457|FG000|Overall Study|Never Received any Study Treatment|7|||
33295404|NCT03445533|100978458|FG001|Overall Study|Never Received any Study Treatment|4|||
33295405|NCT02601209|100978468|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
33295406|NCT02601209|100978469|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
33295407|NCT02601209|100978470|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
33295408|NCT02601209|100978471|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
33295409|NCT02601209|100978472|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
33295410|NCT02601209|100978473|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
33295411|NCT02601209|100978474|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
33392410|NCT01826448|101325223|FG001|Overall Study|Adverse Event|3|||
33392411|NCT01826448|101325222|FG000|Overall Study|Disease progression|2|||
33392412|NCT01826448|101325223|FG001|Overall Study|Disease progression|4|||
33392413|NCT01826448|101325222|FG000|Overall Study|Withdrawal by Subject|1|||
33189135|NCT02346240|100601431|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189136|NCT02346240|100601432|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189137|NCT02346240|100601433|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189138|NCT02346240|100601434|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33392414|NCT01826448|101325223|FG001|Overall Study|Withdrawal by Subject|0|||
33392415|NCT01826448|101325222|FG000|Overall Study|Physician Decision|0|||
33189139|NCT02346240|100601435|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189140|NCT02346240|100601436|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189141|NCT02346240|100601437|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189142|NCT02346240|100601438|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189143|NCT02346240|100601439|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189144|NCT02346240|100601440|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189145|NCT02346240|100601441|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189146|NCT02346240|100601442|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189147|NCT02346240|100601443|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189148|NCT02346240|100601444|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189149|NCT02346240|100601445|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189150|NCT02346240|100601446|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33295412|NCT02601209|100978475|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
33295413|NCT02601209|100978476|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
33295414|NCT02601209|100978468|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
33295415|NCT02601209|100978469|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
33295416|NCT02601209|100978470|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
33295417|NCT02601209|100978471|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
33295418|NCT02601209|100978472|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
33295419|NCT02601209|100978473|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
33295420|NCT02601209|100978474|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
33295421|NCT02601209|100978475|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
33295422|NCT02601209|100978476|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
33295423|NCT01001390|100978477|FG000|Overall Study|Failure to wear AFO device|2|||
33295424|NCT01001390|100978478|FG001|Overall Study|Failure to wear AFO device|0|||
33295425|NCT03721172|100978481|FG000|Placebo-controlled Phase|Adverse Event|7|||
33295426|NCT03721172|100978482|FG001|Placebo-controlled Phase|Adverse Event|7|||
33295427|NCT03721172|100978483|FG002|Placebo-controlled Phase|Adverse Event|0|||
33295428|NCT03721172|100978481|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
33295429|NCT03721172|100978482|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
33295430|NCT03721172|100978483|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
33295431|NCT03721172|100978481|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
33295432|NCT03721172|100978482|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
33295433|NCT03721172|100978483|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
33295434|NCT03721172|100978481|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
33295435|NCT03721172|100978482|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
33295436|NCT03721172|100978483|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
33189151|NCT02346240|100601447|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189152|NCT02346240|100601448|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189153|NCT02346240|100601449|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33189154|NCT02346240|100601450|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
33295437|NCT03721172|100978481|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
33295438|NCT03721172|100978482|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
33295439|NCT03721172|100978483|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
33189155|NCT02346240|100601427|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
33295440|NCT03721172|100978481|FG000|Placebo-controlled Phase|Other|3|||
33392416|NCT01826448|101325223|FG001|Overall Study|Physician Decision|1|||
33189156|NCT02346240|100601428|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
33189157|NCT02346240|100601429|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
33189158|NCT02346240|100601430|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
33189159|NCT02346240|100601431|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189160|NCT02346240|100601432|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189161|NCT02346240|100601433|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189162|NCT02346240|100601434|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189163|NCT02346240|100601435|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189164|NCT02346240|100601436|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189165|NCT02346240|100601437|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189166|NCT02346240|100601438|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189167|NCT02346240|100601439|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189168|NCT02346240|100601440|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189169|NCT02346240|100601441|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189170|NCT02346240|100601442|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189171|NCT02346240|100601443|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189172|NCT02346240|100601444|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189173|NCT02346240|100601445|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189174|NCT02346240|100601446|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189175|NCT02346240|100601447|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189176|NCT02346240|100601448|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189177|NCT02346240|100601449|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33189178|NCT02346240|100601450|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
33392417|NCT01826448|101325222|FG000|Overall Study|2 active cancers|0|||
33392418|NCT01826448|101325223|FG001|Overall Study|2 active cancers|1|||
33392419|NCT04228445|101325224|FG000|Overall Study|Lost to Follow-up|1|||
33392420|NCT04228445|101325225|FG001|Overall Study|Lost to Follow-up|1|||
33392421|NCT04228445|101325224|FG000|Overall Study|Physician Decision|1|||
33392422|NCT04228445|101325225|FG001|Overall Study|Physician Decision|2|||
33392423|NCT04228445|101325224|FG000|Overall Study|Withdrawal by Subject|0|||
33189179|NCT02346240|100601427|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189180|NCT02346240|100601428|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
33189181|NCT02346240|100601429|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189182|NCT02346240|100601430|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
33189183|NCT02346240|100601431|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189184|NCT02346240|100601432|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189185|NCT02346240|100601433|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189186|NCT02346240|100601434|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33392424|NCT04228445|101325225|FG001|Overall Study|Withdrawal by Subject|1|||
33392425|NCT04228445|101325224|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
33392426|NCT04228445|101325225|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
33392427|NCT01505114|101325226|FG000|Overall Study|Withdrawal by Subject|5|||
33392428|NCT01505114|101325227|FG001|Overall Study|Withdrawal by Subject|4|||
33392429|NCT01505114|101325228|FG002|Overall Study|Withdrawal by Subject|4|||
33392430|NCT01505114|101325229|FG003|Overall Study|Withdrawal by Subject|7|||
33392431|NCT01505114|101325226|FG000|Overall Study|Death|1|||
33392432|NCT01505114|101325227|FG001|Overall Study|Death|0|||
33496239|NCT02166333|101710047|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
33189187|NCT02346240|100601435|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33392433|NCT01505114|101325228|FG002|Overall Study|Death|0|||
33392434|NCT01505114|101325229|FG003|Overall Study|Death|1|||
33392435|NCT01505114|101325226|FG000|Overall Study|unable to adhere to visit schedule|3|||
33392436|NCT01505114|101325227|FG001|Overall Study|unable to adhere to visit schedule|2|||
33392437|NCT01505114|101325228|FG002|Overall Study|unable to adhere to visit schedule|3|||
33392438|NCT01505114|101325229|FG003|Overall Study|unable to adhere to visit schedule|3|||
33392439|NCT01505114|101325226|FG000|Overall Study|Lost to Follow-up|11|||
33392440|NCT01505114|101325227|FG001|Overall Study|Lost to Follow-up|5|||
33392441|NCT01505114|101325228|FG002|Overall Study|Lost to Follow-up|8|||
33392442|NCT01505114|101325229|FG003|Overall Study|Lost to Follow-up|7|||
33392443|NCT01505114|101325226|FG000|Overall Study|relocated|4|||
33392444|NCT01505114|101325227|FG001|Overall Study|relocated|2|||
33392445|NCT01505114|101325228|FG002|Overall Study|relocated|2|||
33392446|NCT01505114|101325229|FG003|Overall Study|relocated|3|||
33392447|NCT01505114|101325226|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
33392448|NCT01505114|101325227|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
33392449|NCT01505114|101325228|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
33392450|NCT01505114|101325229|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
33392451|NCT01505114|101325226|FG000|Overall Study|staff safety concerns|0|||
33392452|NCT01505114|101325227|FG001|Overall Study|staff safety concerns|0|||
33392453|NCT01505114|101325228|FG002|Overall Study|staff safety concerns|0|||
33392454|NCT01505114|101325229|FG003|Overall Study|staff safety concerns|1|||
33392455|NCT01505114|101325226|FG000|Overall Study|investigator decision|1|||
33392456|NCT01505114|101325227|FG001|Overall Study|investigator decision|0|||
33392457|NCT01505114|101325228|FG002|Overall Study|investigator decision|1|||
33392458|NCT01505114|101325229|FG003|Overall Study|investigator decision|0|||
33392459|NCT01226472|101325230|FG000|Overall Study|Progressive Disease|1|||
33392460|NCT03991936|101325234|FG000|Overall Study|Lost to Follow-up|1|||
33392461|NCT03991936|101325235|FG001|Overall Study|Lost to Follow-up|1|||
33392462|NCT03991936|101325236|FG002|Overall Study|Lost to Follow-up|1|||
33189188|NCT02346240|100601436|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189189|NCT02346240|100601437|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189190|NCT02346240|100601438|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189191|NCT02346240|100601439|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189192|NCT02346240|100601440|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189193|NCT02346240|100601441|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189194|NCT02346240|100601442|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189195|NCT02346240|100601443|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189196|NCT02346240|100601444|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189197|NCT02346240|100601445|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189198|NCT02346240|100601446|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33295441|NCT03721172|100978482|FG001|Placebo-controlled Phase|Other|0|||
33295442|NCT03721172|100978483|FG002|Placebo-controlled Phase|Other|0|||
33189199|NCT02346240|100601447|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189200|NCT02346240|100601448|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33295443|NCT03721172|100978481|FG000|Apremilast Extension Phase|Adverse Event|0|||
33295444|NCT03721172|100978482|FG001|Apremilast Extension Phase|Adverse Event|0|||
33295445|NCT03721172|100978483|FG002|Apremilast Extension Phase|Adverse Event|10|||
33295446|NCT03721172|100978481|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
33295447|NCT03721172|100978482|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
33295448|NCT03721172|100978483|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
33295449|NCT03721172|100978481|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
33295450|NCT03721172|100978482|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
33295451|NCT03721172|100978483|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
33295452|NCT03721172|100978481|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
33295453|NCT03721172|100978482|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
33295454|NCT03721172|100978483|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
33295455|NCT03721172|100978481|FG000|Apremilast Extension Phase|Protocol Violation|0|||
33295456|NCT03721172|100978482|FG001|Apremilast Extension Phase|Protocol Violation|0|||
33295457|NCT03721172|100978483|FG002|Apremilast Extension Phase|Protocol Violation|1|||
33295458|NCT03721172|100978481|FG000|Apremilast Extension Phase|Physician Decision|0|||
33295459|NCT03721172|100978482|FG001|Apremilast Extension Phase|Physician Decision|0|||
33295460|NCT03721172|100978483|FG002|Apremilast Extension Phase|Physician Decision|1|||
33295461|NCT03721172|100978481|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
33295462|NCT03721172|100978482|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
33295463|NCT03721172|100978483|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
33295464|NCT03721172|100978481|FG000|Apremilast Extension Phase|Other|0|||
33295465|NCT03721172|100978482|FG001|Apremilast Extension Phase|Other|0|||
33295466|NCT03721172|100978483|FG002|Apremilast Extension Phase|Other|3|||
33295467|NCT03721172|100978481|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
33295468|NCT03721172|100978482|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
33189201|NCT02346240|100601449|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189202|NCT02346240|100601450|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
33189203|NCT02346240|100601427|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189204|NCT02346240|100601428|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189205|NCT02346240|100601429|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
33189206|NCT02346240|100601430|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189207|NCT02346240|100601431|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189208|NCT02346240|100601432|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189209|NCT02346240|100601433|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189210|NCT02346240|100601434|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189211|NCT02346240|100601435|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189212|NCT02346240|100601436|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189213|NCT02346240|100601437|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189214|NCT02346240|100601438|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189215|NCT02346240|100601439|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189216|NCT02346240|100601440|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189217|NCT02346240|100601441|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189218|NCT02346240|100601442|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189219|NCT02346240|100601443|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189220|NCT02346240|100601444|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189221|NCT02346240|100601445|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189222|NCT02346240|100601446|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189223|NCT02346240|100601447|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189224|NCT02346240|100601448|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189225|NCT02346240|100601449|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189226|NCT02346240|100601450|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
33189227|NCT02346240|100601427|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189228|NCT02346240|100601428|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189229|NCT02346240|100601429|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189230|NCT02346240|100601430|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189231|NCT02346240|100601431|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189232|NCT02346240|100601432|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189233|NCT02346240|100601433|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189234|NCT02346240|100601434|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
33189235|NCT02346240|100601435|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
33189236|NCT02346240|100601436|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33295469|NCT03721172|100978483|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
33295470|NCT02402322|100978484|FG000|Pretreatment|Withdrawal by Subject|3|||
33295471|NCT02402322|100978485|FG001|Pretreatment|Withdrawal by Subject|1|||
33295472|NCT02402322|100978486|FG002|Pretreatment|Withdrawal by Subject|1|||
33295473|NCT02402322|100978484|FG000|Follow-up|Withdrawal by Subject|6|||
33295474|NCT02402322|100978485|FG001|Follow-up|Withdrawal by Subject|3|||
33295475|NCT02402322|100978486|FG002|Follow-up|Withdrawal by Subject|24|||
33295476|NCT04829747|100978487|FG000|Overall Study|Protocol Violation|1|||
33295477|NCT01432626|100978488|FG000|Overall Study|LV function recovered|2|||
33295478|NCT01432626|100978488|FG000|Overall Study|Withdrawal by Subject|2|||
33295479|NCT01432626|100978488|FG000|Overall Study|Only 1 image competed|2|||
33295480|NCT01432626|100978488|FG000|Overall Study|Imaging agent not available|1|||
33295481|NCT03332784|100978489|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295482|NCT03332784|100978490|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
33295483|NCT03332784|100978491|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295484|NCT03332784|100978492|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295485|NCT03332784|100978493|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295486|NCT03332784|100978494|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295487|NCT03332784|100978495|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295488|NCT03332784|100978496|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295489|NCT03332784|100978497|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295490|NCT03332784|100978498|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295491|NCT03332784|100978499|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295492|NCT03332784|100978500|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295493|NCT03332784|100978501|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33189237|NCT02346240|100601437|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189238|NCT02346240|100601438|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189239|NCT02346240|100601439|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33295494|NCT03332784|100978502|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295495|NCT03332784|100978503|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
33295496|NCT03332784|100978504|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295497|NCT03332784|100978505|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295498|NCT03332784|100978506|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295499|NCT03332784|100978507|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295500|NCT03332784|100978508|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
33295501|NCT00953147|100978509|FG000|Overall Study|Adverse Event|8|||
33295502|NCT00953147|100978510|FG001|Overall Study|Adverse Event|16|||
33295503|NCT00953147|100978511|FG002|Overall Study|Adverse Event|6|||
33295504|NCT00953147|100978509|FG000|Overall Study|Protocol Violation|2|||
33295505|NCT00953147|100978510|FG001|Overall Study|Protocol Violation|8|||
33295506|NCT00953147|100978511|FG002|Overall Study|Protocol Violation|4|||
33295507|NCT00953147|100978509|FG000|Overall Study|Withdrawal by Subject|13|||
33295508|NCT00953147|100978510|FG001|Overall Study|Withdrawal by Subject|15|||
33295509|NCT00953147|100978511|FG002|Overall Study|Withdrawal by Subject|12|||
33295510|NCT00953147|100978509|FG000|Overall Study|Lost to Follow-up|8|||
33295511|NCT00953147|100978510|FG001|Overall Study|Lost to Follow-up|9|||
33295512|NCT00953147|100978511|FG002|Overall Study|Lost to Follow-up|4|||
33295513|NCT00953147|100978509|FG000|Overall Study|Physician Decision|2|||
33295514|NCT00953147|100978510|FG001|Overall Study|Physician Decision|7|||
33295515|NCT00953147|100978511|FG002|Overall Study|Physician Decision|3|||
33295516|NCT00953147|100978509|FG000|Overall Study|Other|4|||
33295517|NCT00953147|100978510|FG001|Overall Study|Other|11|||
33295518|NCT00953147|100978511|FG002|Overall Study|Other|13|||
33295519|NCT01358331|100978512|FG000|Overall Study|Lost to Follow-up|0|||
33295520|NCT01358331|100978513|FG001|Overall Study|Lost to Follow-up|0|||
33295521|NCT01358331|100978514|FG002|Overall Study|Lost to Follow-up|0|||
33295522|NCT01358331|100978515|FG003|Overall Study|Lost to Follow-up|1|||
33295523|NCT01358331|100978516|FG004|Overall Study|Lost to Follow-up|0|||
33295524|NCT01358331|100978517|FG005|Overall Study|Lost to Follow-up|0|||
33295525|NCT01358331|100978512|FG000|Overall Study|Withdrawal by Subject|0|||
33295526|NCT01358331|100978513|FG001|Overall Study|Withdrawal by Subject|0|||
33295527|NCT01358331|100978514|FG002|Overall Study|Withdrawal by Subject|0|||
33295528|NCT01358331|100978515|FG003|Overall Study|Withdrawal by Subject|1|||
33295529|NCT01358331|100978516|FG004|Overall Study|Withdrawal by Subject|1|||
33295530|NCT01358331|100978517|FG005|Overall Study|Withdrawal by Subject|1|||
33295531|NCT01358331|100978512|FG000|Overall Study|Adverse Events|1|||
33295532|NCT01358331|100978513|FG001|Overall Study|Adverse Events|1|||
33295533|NCT01358331|100978514|FG002|Overall Study|Adverse Events|1|||
33295534|NCT01358331|100978515|FG003|Overall Study|Adverse Events|0|||
33295535|NCT01358331|100978516|FG004|Overall Study|Adverse Events|1|||
33295536|NCT01358331|100978517|FG005|Overall Study|Adverse Events|5|||
33295537|NCT01358331|100978512|FG000|Overall Study|Symptomatic Deterioration|0|||
33295538|NCT01358331|100978513|FG001|Overall Study|Symptomatic Deterioration|0|||
33295539|NCT01358331|100978514|FG002|Overall Study|Symptomatic Deterioration|0|||
33295540|NCT01358331|100978515|FG003|Overall Study|Symptomatic Deterioration|0|||
33295541|NCT01358331|100978516|FG004|Overall Study|Symptomatic Deterioration|1|||
33295542|NCT01358331|100978517|FG005|Overall Study|Symptomatic Deterioration|0|||
33295543|NCT01358331|100978512|FG000|Overall Study|Participants did not wish to continue|0|||
33295544|NCT01358331|100978513|FG001|Overall Study|Participants did not wish to continue|0|||
33295545|NCT01358331|100978514|FG002|Overall Study|Participants did not wish to continue|0|||
33295546|NCT01358331|100978515|FG003|Overall Study|Participants did not wish to continue|0|||
33295547|NCT01358331|100978516|FG004|Overall Study|Participants did not wish to continue|1|||
33392463|NCT03991936|101325237|FG003|Overall Study|Lost to Follow-up|1|||
33392464|NCT03991936|101325238|FG004|Overall Study|Lost to Follow-up|1|||
33392465|NCT04728815|101325239|FG000|Overall Study|Lost to Follow-up|3|||
33189240|NCT02346240|100601440|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
33189241|NCT02346240|100601441|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
33189242|NCT02346240|100601442|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
33189243|NCT02346240|100601443|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
33189244|NCT02346240|100601444|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189245|NCT02346240|100601445|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189246|NCT02346240|100601446|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189247|NCT02346240|100601447|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189248|NCT02346240|100601448|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189249|NCT02346240|100601449|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33295548|NCT01358331|100978517|FG005|Overall Study|Participants did not wish to continue|0|||
33295549|NCT01358331|100978512|FG000|Overall Study|Progress of disease under investigation|1|||
33295550|NCT01358331|100978513|FG001|Overall Study|Progress of disease under investigation|2|||
33295551|NCT01358331|100978514|FG002|Overall Study|Progress of disease under investigation|3|||
33295552|NCT01358331|100978515|FG003|Overall Study|Progress of disease under investigation|1|||
33295553|NCT01358331|100978516|FG004|Overall Study|Progress of disease under investigation|3|||
33295554|NCT01358331|100978517|FG005|Overall Study|Progress of disease under investigation|0|||
33295555|NCT03603639|100978520|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
33295556|NCT03603639|100978521|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
33295557|NCT03603639|100978522|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
33189250|NCT02346240|100601450|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33189251|NCT02346240|100601427|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189252|NCT02346240|100601428|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189253|NCT02346240|100601429|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189254|NCT02346240|100601430|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189255|NCT02346240|100601431|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189256|NCT02346240|100601432|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189257|NCT02346240|100601433|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189258|NCT02346240|100601434|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189259|NCT02346240|100601435|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189260|NCT02346240|100601436|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189261|NCT02346240|100601437|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189262|NCT02346240|100601438|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33295558|NCT03603639|100978523|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
33295559|NCT03603639|100978524|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
33295560|NCT03603639|100978525|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
33295561|NCT03603639|100978520|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
33295562|NCT03603639|100978521|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
33295563|NCT03603639|100978522|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
33295564|NCT03603639|100978523|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
33295565|NCT03603639|100978524|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
33295566|NCT03603639|100978525|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
33295567|NCT00790400|100978526|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
33295568|NCT00790400|100978527|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
33295569|NCT00790400|100978526|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
33295570|NCT00790400|100978527|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
33295571|NCT00790400|100978526|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
33295572|NCT00790400|100978527|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
33295573|NCT00790400|100978526|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
33295574|NCT00790400|100978527|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
33295575|NCT00790400|100978526|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
33295576|NCT00790400|100978527|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
33295577|NCT00790400|100978526|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
33295578|NCT00790400|100978527|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
33295579|NCT00790400|100978526|FG000|Double-blind Period (Core Phase)|Death|1|||
33295580|NCT00790400|100978527|FG001|Double-blind Period (Core Phase)|Death|0|||
33295581|NCT00790400|100978526|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
33295582|NCT00790400|100978527|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
33295583|NCT00790400|100978526|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
33295584|NCT00790400|100978527|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
33295585|NCT00790400|100978526|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
33295586|NCT00790400|100978527|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
33295587|NCT00790400|100978526|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
33295588|NCT00790400|100978527|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
33295589|NCT00790400|100978526|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
33295590|NCT00790400|100978527|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
33295591|NCT00790400|100978526|FG000|Everolimus Period (Core or Extension)|Death|1|||
33295592|NCT00790400|100978527|FG001|Everolimus Period (Core or Extension)|Death|0|||
33295593|NCT00790400|100978526|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
33295594|NCT00790400|100978527|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
33295595|NCT00790400|100978526|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
33295596|NCT00790400|100978527|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
33295597|NCT00790400|100978526|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
33295598|NCT00790400|100978527|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
33295599|NCT02671500|100978528|FG000|Overall Study|Lack of Efficacy|12|||
33295600|NCT02671500|100978528|FG000|Overall Study|Lost to Follow-up|2|||
33295601|NCT03167151|100978532|FG000|Overall Study|Withdrawal by Subject|1|||
33295602|NCT03167151|100978533|FG001|Overall Study|Withdrawal by Subject|0|||
33295603|NCT03167151|100978534|FG002|Overall Study|Withdrawal by Subject|0|||
33295604|NCT03167151|100978532|FG000|Overall Study|No evidence of tumour at surgery|0|||
33392466|NCT04728815|101325240|FG001|Overall Study|Lost to Follow-up|0|||
33392467|NCT04728815|101325241|FG002|Overall Study|Lost to Follow-up|0|||
33295605|NCT03167151|100978533|FG001|Overall Study|No evidence of tumour at surgery|1|||
33295606|NCT03167151|100978534|FG002|Overall Study|No evidence of tumour at surgery|1|||
33295607|NCT01371825|100978535|FG000|Overall Study|Death|4|||
33295608|NCT02229578|100978536|FG000|Overall Study|Withdrawal by Subject|1|||
33295609|NCT02229578|100978537|FG001|Overall Study|Withdrawal by Subject|3|||
33295610|NCT02229578|100978536|FG000|Overall Study|Protocol Violation|2|||
33295611|NCT02229578|100978537|FG001|Overall Study|Protocol Violation|0|||
33295612|NCT04843579|100978545|FG000|Overall Study|Adverse Event|1|||
33295613|NCT04843579|100978545|FG000|Overall Study|Disease Progression|1|||
33295614|NCT00903760|100978546|FG000|Overall Study|Disease Progression/Death|8|||
33295615|NCT00903760|100978547|FG001|Overall Study|Disease Progression/Death|6|||
33295616|NCT00903760|100978546|FG000|Overall Study|Stem Cell Transplant|8|||
33295617|NCT00903760|100978547|FG001|Overall Study|Stem Cell Transplant|4|||
33295618|NCT00903760|100978546|FG000|Overall Study|Physician Decision|1|||
33295619|NCT00903760|100978547|FG001|Overall Study|Physician Decision|2|||
33295620|NCT00903760|100978546|FG000|Overall Study|Death|0|||
33295621|NCT00903760|100978547|FG001|Overall Study|Death|1|||
33295622|NCT00903760|100978546|FG000|Overall Study|Lost to Follow-up|1|||
33295623|NCT00903760|100978547|FG001|Overall Study|Lost to Follow-up|0|||
33295624|NCT00903760|100978546|FG000|Overall Study|Withdrawal by Subject|1|||
33189263|NCT02346240|100601439|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189264|NCT02346240|100601440|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
33189265|NCT02346240|100601441|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33295625|NCT00903760|100978547|FG001|Overall Study|Withdrawal by Subject|2|||
33295626|NCT00903760|100978546|FG000|Overall Study|Off treatment for long period|0|||
33295627|NCT00903760|100978547|FG001|Overall Study|Off treatment for long period|1|||
33295628|NCT01250509|100978548|FG000|Overall Study|Lost to Follow-up|5|||
33295629|NCT01250509|100978549|FG001|Overall Study|Lost to Follow-up|2|||
33295630|NCT03994731|100978550|FG000|Pegloticase + IMM Period|Death|2|||
33295631|NCT03994731|100978551|FG001|Pegloticase + IMM Period|Death|0|||
33295632|NCT03994731|100978550|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
33295633|NCT03994731|100978551|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
33189266|NCT02346240|100601442|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
33189267|NCT02346240|100601443|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189268|NCT02346240|100601444|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189269|NCT02346240|100601445|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189270|NCT02346240|100601446|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189271|NCT02346240|100601447|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189272|NCT02346240|100601448|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189273|NCT02346240|100601449|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189274|NCT02346240|100601450|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33189275|NCT02346240|100601427|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189276|NCT02346240|100601428|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189277|NCT02346240|100601429|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189278|NCT02346240|100601430|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189279|NCT02346240|100601431|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189280|NCT02346240|100601432|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189281|NCT02346240|100601433|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189282|NCT02346240|100601434|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189283|NCT02346240|100601435|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189284|NCT02346240|100601436|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189285|NCT02346240|100601437|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189286|NCT02346240|100601438|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189287|NCT02346240|100601439|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189288|NCT02346240|100601440|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189289|NCT02346240|100601441|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
33189290|NCT02346240|100601442|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189291|NCT02346240|100601443|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189292|NCT02346240|100601444|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189293|NCT02346240|100601445|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189294|NCT02346240|100601446|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189295|NCT02346240|100601447|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189296|NCT02346240|100601448|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189297|NCT02346240|100601449|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189298|NCT02346240|100601450|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33189299|NCT02346240|100601427|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33189300|NCT02346240|100601428|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33295634|NCT03994731|100978550|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
33295635|NCT03994731|100978551|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
33295636|NCT02947100|100978556|FG000|Overall Study|study terminated early|3|||
33295637|NCT02947100|100978556|FG000|Overall Study|did not meet inclusion criteria|1|||
33295638|NCT00600613|100978563|FG000|Overall Study|Protocol Deviation|1|||
33295639|NCT03041792|100978564|FG000|Overall Study|Adverse Event|4|||
33295640|NCT03041792|100978565|FG001|Overall Study|Adverse Event|0|||
33392468|NCT04728815|101325242|FG003|Overall Study|Lost to Follow-up|1|||
33295641|NCT03041792|100978564|FG000|Overall Study|Death in the family|0|||
33295642|NCT03041792|100978565|FG001|Overall Study|Death in the family|2|||
33295643|NCT03041792|100978564|FG000|Overall Study|Randomized but not treated|0|||
33295644|NCT03041792|100978565|FG001|Overall Study|Randomized but not treated|1|||
33295645|NCT00368875|100978567|FG000|Overall Study|Adverse Event|0|||
33295646|NCT00368875|100978568|FG001|Overall Study|Adverse Event|12|||
33295647|NCT00368875|100978567|FG000|Overall Study|Progressive disease|3|||
33295648|NCT00368875|100978568|FG001|Overall Study|Progressive disease|27|||
33295649|NCT00368875|100978567|FG000|Overall Study|Withdrawal by Subject|2|||
33295650|NCT00368875|100978568|FG001|Overall Study|Withdrawal by Subject|6|||
33295651|NCT00368875|100978567|FG000|Overall Study|Other Reason|0|||
33295652|NCT00368875|100978568|FG001|Overall Study|Other Reason|2|||
33295653|NCT00368875|100978567|FG000|Overall Study|Alternative Therapy|1|||
33295654|NCT00368875|100978568|FG001|Overall Study|Alternative Therapy|1|||
33295655|NCT00108745|100978569|FG000|Overall Study|Withdrawal by Subject|19|||
33295656|NCT00108745|100978570|FG001|Overall Study|Withdrawal by Subject|12|||
33295657|NCT00108745|100978571|FG002|Overall Study|Withdrawal by Subject|12|||
33295658|NCT00108745|100978569|FG000|Overall Study|Never Treated|8|||
33295659|NCT00108745|100978570|FG001|Overall Study|Never Treated|10|||
33295660|NCT00108745|100978571|FG002|Overall Study|Never Treated|12|||
33295661|NCT00108745|100978569|FG000|Overall Study|Ineligible|7|||
33295662|NCT00108745|100978570|FG001|Overall Study|Ineligible|13|||
33295663|NCT00108745|100978571|FG002|Overall Study|Ineligible|13|||
33295664|NCT03548220|100978572|FG000|Overall Study|Lost to Follow-up|1|||
33295665|NCT03548220|100978573|FG001|Overall Study|Lost to Follow-up|0|||
33295666|NCT03548220|100978574|FG002|Overall Study|Lost to Follow-up|0|||
33295667|NCT03548220|100978575|FG003|Overall Study|Lost to Follow-up|0|||
33295668|NCT00842244|100978576|FG000|Overall Study|Death|3|||
33295669|NCT00842244|100978576|FG000|Overall Study|Withdrawal by Subject|1|||
33295670|NCT00842244|100978576|FG000|Overall Study|Other|17|||
33295671|NCT03238963|100978579|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
33295672|NCT03238963|100978580|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
33295673|NCT03238963|100978579|FG000|Overall Study|Withdrawal by Subject|1|||
33295674|NCT03238963|100978580|FG001|Overall Study|Withdrawal by Subject|1|||
33295675|NCT03238963|100978579|FG000|Overall Study|Lost to Follow-up|1|||
33295676|NCT03238963|100978580|FG001|Overall Study|Lost to Follow-up|0|||
33295677|NCT03238963|100978579|FG000|Overall Study|Protocol Violation|1|||
33295678|NCT03238963|100978580|FG001|Overall Study|Protocol Violation|1|||
33295679|NCT03238963|100978579|FG000|Overall Study|Adverse Event|1|||
33295680|NCT03238963|100978580|FG001|Overall Study|Adverse Event|0|||
33295681|NCT00609947|100978583|FG000|Overall Study|Death|1|||
33295682|NCT01183390|100978584|FG000|First Intervention|Adverse Event|0|||
33295683|NCT01183390|100978585|FG001|First Intervention|Adverse Event|1|||
33295684|NCT02227992|100978586|FG000|Overall Study|Lost to Follow-up|1|||
33295685|NCT02227992|100978587|FG001|Overall Study|Lost to Follow-up|1|||
33295686|NCT01989169|100978588|FG000|Period 2|Adverse Event|0|||
33295687|NCT01989169|100978589|FG001|Period 2|Adverse Event|1|||
33295688|NCT01411241|100978592|FG000|Overall Study|Protocol Violation|0|||
33295689|NCT01411241|100978593|FG001|Overall Study|Protocol Violation|5|||
33295690|NCT01411241|100978592|FG000|Overall Study|Withdrawal by Subject|9|||
33295691|NCT01411241|100978593|FG001|Overall Study|Withdrawal by Subject|10|||
33295692|NCT01411241|100978592|FG000|Overall Study|Serious Adverse Event|0|||
33295693|NCT01411241|100978593|FG001|Overall Study|Serious Adverse Event|3|||
33295694|NCT01411241|100978592|FG000|Overall Study|Lost to Follow-up|2|||
33295695|NCT01411241|100978593|FG001|Overall Study|Lost to Follow-up|4|||
33295696|NCT01217437|100978595|FG000|Overall Study|Adverse Event|0|||
33295697|NCT01217437|100978596|FG001|Overall Study|Adverse Event|8|||
33295698|NCT01217437|100978595|FG000|Overall Study|Death|5|||
33295699|NCT01217437|100978596|FG001|Overall Study|Death|0|||
33295700|NCT01217437|100978595|FG000|Overall Study|Lack of Efficacy|29|||
33295701|NCT01217437|100978596|FG001|Overall Study|Lack of Efficacy|25|||
33295702|NCT01217437|100978595|FG000|Overall Study|Physician Decision|8|||
33295703|NCT01217437|100978596|FG001|Overall Study|Physician Decision|5|||
33295704|NCT01217437|100978595|FG000|Overall Study|Withdrawal by Subject|0|||
33295705|NCT01217437|100978596|FG001|Overall Study|Withdrawal by Subject|2|||
33295706|NCT01217437|100978595|FG000|Overall Study|Ineligible|1|||
33189301|NCT02346240|100601429|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33295707|NCT01217437|100978596|FG001|Overall Study|Ineligible|1|||
33295708|NCT00895895|100978597|FG000|Period 1|Adverse Event|7|||
33295709|NCT00895895|100978598|FG001|Period 1|Adverse Event|6|||
33189302|NCT02346240|100601430|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33295710|NCT00895895|100978599|FG002|Period 1|Adverse Event|4|||
33295711|NCT00895895|100978600|FG003|Period 1|Adverse Event|6|||
33295712|NCT00895895|100978601|FG004|Period 1|Adverse Event|7|||
33295713|NCT00895895|100978597|FG000|Period 1|Death|0|||
33295714|NCT00895895|100978598|FG001|Period 1|Death|0|||
33295715|NCT00895895|100978599|FG002|Period 1|Death|0|||
33295716|NCT00895895|100978600|FG003|Period 1|Death|0|||
33295717|NCT00895895|100978601|FG004|Period 1|Death|1|||
33295718|NCT00895895|100978597|FG000|Period 1|discontinued by sponsor|2|||
33295719|NCT00895895|100978598|FG001|Period 1|discontinued by sponsor|1|||
33295720|NCT00895895|100978599|FG002|Period 1|discontinued by sponsor|2|||
33295721|NCT00895895|100978600|FG003|Period 1|discontinued by sponsor|1|||
33295722|NCT00895895|100978601|FG004|Period 1|discontinued by sponsor|1|||
33295723|NCT00895895|100978597|FG000|Period 1|failed to return|0|||
33295724|NCT00895895|100978598|FG001|Period 1|failed to return|0|||
33295725|NCT00895895|100978599|FG002|Period 1|failed to return|1|||
33295726|NCT00895895|100978600|FG003|Period 1|failed to return|0|||
33295727|NCT00895895|100978601|FG004|Period 1|failed to return|1|||
33295728|NCT00895895|100978597|FG000|Period 1|investigator request|0|||
33295729|NCT00895895|100978598|FG001|Period 1|investigator request|1|||
33295730|NCT00895895|100978599|FG002|Period 1|investigator request|0|||
33295731|NCT00895895|100978600|FG003|Period 1|investigator request|0|||
33295732|NCT00895895|100978601|FG004|Period 1|investigator request|0|||
33295733|NCT00895895|100978597|FG000|Period 1|Lost to Follow-up|2|||
33295734|NCT00895895|100978598|FG001|Period 1|Lost to Follow-up|1|||
33189303|NCT02346240|100601431|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33189304|NCT02346240|100601432|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33189305|NCT02346240|100601433|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33189306|NCT02346240|100601434|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33189307|NCT02346240|100601435|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33189308|NCT02346240|100601436|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33295735|NCT00895895|100978599|FG002|Period 1|Lost to Follow-up|3|||
33295736|NCT00895895|100978600|FG003|Period 1|Lost to Follow-up|2|||
33295737|NCT00895895|100978601|FG004|Period 1|Lost to Follow-up|3|||
33295738|NCT00895895|100978597|FG000|Period 1|Other|1|||
33295739|NCT00895895|100978598|FG001|Period 1|Other|2|||
33295740|NCT00895895|100978599|FG002|Period 1|Other|1|||
33295741|NCT00895895|100978600|FG003|Period 1|Other|1|||
33295742|NCT00895895|100978601|FG004|Period 1|Other|1|||
33295743|NCT00895895|100978597|FG000|Period 1|Protocol Violation|0|||
33295744|NCT00895895|100978598|FG001|Period 1|Protocol Violation|1|||
33295745|NCT00895895|100978599|FG002|Period 1|Protocol Violation|0|||
33295746|NCT00895895|100978600|FG003|Period 1|Protocol Violation|0|||
33295747|NCT00895895|100978601|FG004|Period 1|Protocol Violation|0|||
33295748|NCT00895895|100978597|FG000|Period 1|Withdrawal by Subject|6|||
33295749|NCT00895895|100978598|FG001|Period 1|Withdrawal by Subject|6|||
33295750|NCT00895895|100978599|FG002|Period 1|Withdrawal by Subject|8|||
33295751|NCT00895895|100978600|FG003|Period 1|Withdrawal by Subject|2|||
33295752|NCT00895895|100978601|FG004|Period 1|Withdrawal by Subject|4|||
33392469|NCT04728815|101325243|FG004|Overall Study|Lost to Follow-up|1|||
33392470|NCT04728815|101325244|FG005|Overall Study|Lost to Follow-up|0|||
33189309|NCT02346240|100601437|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33189310|NCT02346240|100601438|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
33189311|NCT02346240|100601439|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33189312|NCT02346240|100601440|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
33295753|NCT00895895|100978597|FG000|Period 1|unsatisfactory response-efficacy|2|||
33189313|NCT02346240|100601441|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
33189314|NCT02346240|100601442|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
33295754|NCT00895895|100978598|FG001|Period 1|unsatisfactory response-efficacy|0|||
33295755|NCT00895895|100978599|FG002|Period 1|unsatisfactory response-efficacy|0|||
33295756|NCT00895895|100978600|FG003|Period 1|unsatisfactory response-efficacy|0|||
33295757|NCT00895895|100978601|FG004|Period 1|unsatisfactory response-efficacy|0|||
33295758|NCT00895895|100978597|FG000|Period 1|randomized and not treated|1|||
33295759|NCT00895895|100978598|FG001|Period 1|randomized and not treated|3|||
33295760|NCT00895895|100978599|FG002|Period 1|randomized and not treated|1|||
33295761|NCT00895895|100978600|FG003|Period 1|randomized and not treated|1|||
33295762|NCT00895895|100978601|FG004|Period 1|randomized and not treated|2|||
33392471|NCT04728815|101325245|FG006|Overall Study|Lost to Follow-up|2|||
33295763|NCT00895895|100978597|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
33295764|NCT00895895|100978598|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
33295765|NCT00895895|100978599|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
33295766|NCT00895895|100978600|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
33295767|NCT00895895|100978601|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
33295768|NCT00895895|100978597|FG000|After Period 1, Prior to Period 2|Other|0|||
33295769|NCT00895895|100978598|FG001|After Period 1, Prior to Period 2|Other|0|||
33295770|NCT00895895|100978599|FG002|After Period 1, Prior to Period 2|Other|1|||
33295771|NCT00895895|100978600|FG003|After Period 1, Prior to Period 2|Other|0|||
33295772|NCT00895895|100978601|FG004|After Period 1, Prior to Period 2|Other|0|||
33295773|NCT00895895|100978597|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
33295774|NCT00895895|100978598|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
33295775|NCT00895895|100978599|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
33295776|NCT00895895|100978600|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
33295777|NCT00895895|100978601|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
33295778|NCT00895895|100978597|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
33295779|NCT00895895|100978598|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
33295780|NCT00895895|100978599|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
33295781|NCT00895895|100978600|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
33295782|NCT00895895|100978601|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
33295783|NCT00895895|100978597|FG000|Period 2|Adverse Event|3|||
33295784|NCT00895895|100978598|FG001|Period 2|Adverse Event|3|||
33295785|NCT00895895|100978599|FG002|Period 2|Adverse Event|5|||
33295786|NCT00895895|100978600|FG003|Period 2|Adverse Event|2|||
33295787|NCT00895895|100978601|FG004|Period 2|Adverse Event|5|||
33295788|NCT00895895|100978597|FG000|Period 2|Death|0|||
33295789|NCT00895895|100978598|FG001|Period 2|Death|0|||
33295790|NCT00895895|100978599|FG002|Period 2|Death|1|||
33295791|NCT00895895|100978600|FG003|Period 2|Death|0|||
33295792|NCT00895895|100978601|FG004|Period 2|Death|0|||
33295793|NCT00895895|100978597|FG000|Period 2|discontinued by sponsor|44|||
33295794|NCT00895895|100978598|FG001|Period 2|discontinued by sponsor|44|||
33295795|NCT00895895|100978599|FG002|Period 2|discontinued by sponsor|38|||
33295796|NCT00895895|100978600|FG003|Period 2|discontinued by sponsor|46|||
33295797|NCT00895895|100978601|FG004|Period 2|discontinued by sponsor|37|||
33295798|NCT00895895|100978597|FG000|Period 2|failed to return|2|||
33295799|NCT00895895|100978598|FG001|Period 2|failed to return|0|||
33295800|NCT00895895|100978599|FG002|Period 2|failed to return|0|||
33295801|NCT00895895|100978600|FG003|Period 2|failed to return|0|||
33295802|NCT00895895|100978601|FG004|Period 2|failed to return|0|||
33295803|NCT00895895|100978597|FG000|Period 2|investigator request|2|||
33295804|NCT00895895|100978598|FG001|Period 2|investigator request|0|||
33295805|NCT00895895|100978599|FG002|Period 2|investigator request|0|||
33295806|NCT00895895|100978600|FG003|Period 2|investigator request|0|||
33295807|NCT00895895|100978601|FG004|Period 2|investigator request|0|||
33295808|NCT00895895|100978597|FG000|Period 2|Lost to Follow-up|1|||
33295809|NCT00895895|100978598|FG001|Period 2|Lost to Follow-up|2|||
33295810|NCT00895895|100978599|FG002|Period 2|Lost to Follow-up|1|||
33295811|NCT00895895|100978600|FG003|Period 2|Lost to Follow-up|1|||
33295812|NCT00895895|100978601|FG004|Period 2|Lost to Follow-up|0|||
33295813|NCT00895895|100978597|FG000|Period 2|Other|1|||
33295814|NCT00895895|100978598|FG001|Period 2|Other|1|||
33295815|NCT00895895|100978599|FG002|Period 2|Other|3|||
33295816|NCT00895895|100978600|FG003|Period 2|Other|1|||
33295817|NCT00895895|100978601|FG004|Period 2|Other|1|||
33295818|NCT00895895|100978597|FG000|Period 2|Protocol Violation|1|||
33295819|NCT00895895|100978598|FG001|Period 2|Protocol Violation|0|||
33295820|NCT00895895|100978599|FG002|Period 2|Protocol Violation|1|||
33295821|NCT00895895|100978600|FG003|Period 2|Protocol Violation|1|||
33295822|NCT00895895|100978601|FG004|Period 2|Protocol Violation|1|||
33295823|NCT00895895|100978597|FG000|Period 2|Withdrawal by Subject|0|||
33295824|NCT00895895|100978598|FG001|Period 2|Withdrawal by Subject|2|||
33295825|NCT00895895|100978599|FG002|Period 2|Withdrawal by Subject|0|||
33295826|NCT00895895|100978600|FG003|Period 2|Withdrawal by Subject|3|||
33295827|NCT00895895|100978601|FG004|Period 2|Withdrawal by Subject|5|||
33295828|NCT00895895|100978597|FG000|Period 2|unsatisfactory response-efficacy|2|||
33295829|NCT00895895|100978598|FG001|Period 2|unsatisfactory response-efficacy|1|||
33295830|NCT00895895|100978599|FG002|Period 2|unsatisfactory response-efficacy|0|||
33295831|NCT00895895|100978600|FG003|Period 2|unsatisfactory response-efficacy|0|||
33295832|NCT00895895|100978601|FG004|Period 2|unsatisfactory response-efficacy|0|||
33189315|NCT02346240|100601443|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33295833|NCT00078377|100978603|FG000|Overall Study|Adverse Event|2|||
33295834|NCT00078377|100978604|FG001|Overall Study|Adverse Event|5|||
33295835|NCT00078377|100978605|FG002|Overall Study|Adverse Event|1|||
33295836|NCT00078377|100978603|FG000|Overall Study|Lack of Efficacy|2|||
33295837|NCT00078377|100978604|FG001|Overall Study|Lack of Efficacy|0|||
33295838|NCT00078377|100978605|FG002|Overall Study|Lack of Efficacy|2|||
33295839|NCT00078377|100978603|FG000|Overall Study|Lost to Follow-up|0|||
33295840|NCT00078377|100978604|FG001|Overall Study|Lost to Follow-up|1|||
33295841|NCT00078377|100978605|FG002|Overall Study|Lost to Follow-up|1|||
33295842|NCT00078377|100978603|FG000|Overall Study|Physician Decision|2|||
33295843|NCT00078377|100978604|FG001|Overall Study|Physician Decision|0|||
33295844|NCT00078377|100978605|FG002|Overall Study|Physician Decision|0|||
33295845|NCT00078377|100978603|FG000|Overall Study|Withdrawal by Subject|3|||
33295846|NCT00078377|100978604|FG001|Overall Study|Withdrawal by Subject|4|||
33295847|NCT00078377|100978605|FG002|Overall Study|Withdrawal by Subject|4|||
33295848|NCT00078377|100978603|FG000|Overall Study|Miscellaneous|2|||
33295849|NCT00078377|100978604|FG001|Overall Study|Miscellaneous|6|||
33295850|NCT00078377|100978605|FG002|Overall Study|Miscellaneous|1|||
33295851|NCT01240551|100978608|FG000|Overall Study|Refused further treatment|3|||
33295852|NCT01240551|100978609|FG001|Overall Study|Refused further treatment|2|||
33295853|NCT01240551|100978608|FG000|Overall Study|Lost to Follow-up|1|||
33295854|NCT01240551|100978609|FG001|Overall Study|Lost to Follow-up|1|||
33295855|NCT02993406|100978610|FG000|Overall Study|Withdrawal by Subject|170|||
33295856|NCT02993406|100978611|FG001|Overall Study|Withdrawal by Subject|196|||
33295857|NCT02993406|100978610|FG000|Overall Study|Physician Decision|3|||
33295858|NCT02993406|100978611|FG001|Overall Study|Physician Decision|5|||
33295859|NCT02993406|100978610|FG000|Overall Study|Lost to Follow-up|12|||
33295860|NCT02993406|100978611|FG001|Overall Study|Lost to Follow-up|13|||
33295861|NCT02993406|100978610|FG000|Overall Study|Unclassifiable Response|105|||
33295862|NCT02993406|100978611|FG001|Overall Study|Unclassifiable Response|139|||
33295863|NCT02993406|100978610|FG000|Overall Study|Administrative decision|1|||
33295864|NCT02993406|100978611|FG001|Overall Study|Administrative decision|0|||
33295865|NCT02993406|100978610|FG000|Overall Study|Sponsor decision|4|||
33295866|NCT02993406|100978611|FG001|Overall Study|Sponsor decision|5|||
33295867|NCT00822770|100978612|FG000|Overall Study|Not treated|1|||
33295868|NCT00822770|100978613|FG001|Overall Study|Not treated|0|||
33295869|NCT00822770|100978612|FG000|Overall Study|Complication/Incomplete treatment|1|||
33295870|NCT00822770|100978613|FG001|Overall Study|Complication/Incomplete treatment|0|||
33295871|NCT00822770|100978612|FG000|Overall Study|Death|1|||
33295872|NCT00822770|100978613|FG001|Overall Study|Death|1|||
33295873|NCT01250925|100978616|FG000|Overall Study|Lost to Follow-up|1|||
33295874|NCT01250925|100978617|FG001|Overall Study|Lost to Follow-up|1|||
33295875|NCT01250925|100978618|FG002|Overall Study|Lost to Follow-up|0|||
33295876|NCT01250925|100978616|FG000|Overall Study|Withdrawal by Subject|2|||
33295877|NCT01250925|100978617|FG001|Overall Study|Withdrawal by Subject|0|||
33295878|NCT01250925|100978618|FG002|Overall Study|Withdrawal by Subject|0|||
33295879|NCT01250925|100978616|FG000|Overall Study|Protocol Violation|2|||
33295880|NCT01250925|100978617|FG001|Overall Study|Protocol Violation|0|||
33295881|NCT01250925|100978618|FG002|Overall Study|Protocol Violation|0|||
33295882|NCT01250925|100978616|FG000|Overall Study|Physician Decision|0|||
33295883|NCT01250925|100978617|FG001|Overall Study|Physician Decision|2|||
33295884|NCT01250925|100978618|FG002|Overall Study|Physician Decision|1|||
33295885|NCT01250925|100978616|FG000|Overall Study|Adverse Event|0|||
33295886|NCT01250925|100978617|FG001|Overall Study|Adverse Event|0|||
33295887|NCT01250925|100978618|FG002|Overall Study|Adverse Event|1|||
33295888|NCT02125279|100978624|FG000|Overall Study|Lack of Efficacy|2|||
33295889|NCT02125279|100978624|FG000|Overall Study|Withdrawal by Subject|6|||
33295890|NCT02125279|100978624|FG000|Overall Study|Protocol Violation|1|||
33295891|NCT02125279|100978624|FG000|Overall Study|Lost to Follow-up|4|||
33295892|NCT02637323|100978628|FG000|Overall Study|Lost to Follow-up|2|||
33295893|NCT02637323|100978629|FG001|Overall Study|Lost to Follow-up|0|||
33295894|NCT02637323|100978628|FG000|Overall Study|Protocol Violation|0|||
33295895|NCT02637323|100978629|FG001|Overall Study|Protocol Violation|1|||
33295896|NCT00504777|100978630|FG000|Overall Study|Adverse Event|1|||
33295897|NCT01040169|100978631|FG000|Overall Study|Lost to Follow-up|3|||
33295898|NCT01040169|100978632|FG001|Overall Study|Lost to Follow-up|8|||
33295899|NCT01932762|100978633|FG000|Overall Study|Withdrawal by Subject|1|||
33295900|NCT01932762|100978634|FG001|Overall Study|Withdrawal by Subject|2|||
33295901|NCT01932762|100978635|FG002|Overall Study|Withdrawal by Subject|0|||
33295902|NCT01932762|100978636|FG003|Overall Study|Withdrawal by Subject|0|||
33295903|NCT01932762|100978633|FG000|Overall Study|Lost to Follow-up|4|||
33295904|NCT01932762|100978634|FG001|Overall Study|Lost to Follow-up|0|||
33295905|NCT01932762|100978635|FG002|Overall Study|Lost to Follow-up|0|||
33295906|NCT01932762|100978636|FG003|Overall Study|Lost to Follow-up|1|||
33295907|NCT01932762|100978633|FG000|Overall Study|Physician Decision|1|||
33295908|NCT01932762|100978634|FG001|Overall Study|Physician Decision|0|||
33295909|NCT01932762|100978635|FG002|Overall Study|Physician Decision|0|||
33295910|NCT01932762|100978636|FG003|Overall Study|Physician Decision|0|||
33295911|NCT04887506|100978637|FG000|Overall Study|Death|1|||
33295912|NCT04887506|100978638|FG001|Overall Study|Death|1|||
33295913|NCT04887506|100978637|FG000|Overall Study|Withdrawal by Subject|0|||
33295914|NCT04887506|100978638|FG001|Overall Study|Withdrawal by Subject|3|||
33295915|NCT04887506|100978637|FG000|Overall Study|Adverse Event|4|||
33295916|NCT04887506|100978638|FG001|Overall Study|Adverse Event|3|||
33295917|NCT04887506|100978637|FG000|Overall Study|Other - Not Reported|1|||
33295918|NCT04887506|100978638|FG001|Overall Study|Other - Not Reported|1|||
33295919|NCT03834519|100978641|FG000|Overall Study|Ongoing|234|||
33295920|NCT03834519|100978642|FG001|Overall Study|Ongoing|111|||
33295921|NCT03834519|100978641|FG000|Overall Study|Withdrawal by Subject|4|||
33295922|NCT03834519|100978642|FG001|Overall Study|Withdrawal by Subject|7|||
33295923|NCT03834519|100978641|FG000|Overall Study|Death|291|||
33295924|NCT03834519|100978642|FG001|Overall Study|Death|146|||
33295925|NCT02879383|100978650|FG000|First 24 Weeks|Physician Decision|0|||
33295926|NCT02879383|100978651|FG001|First 24 Weeks|Physician Decision|1|||
33295927|NCT02879383|100978652|FG002|First 24 Weeks|Physician Decision|0|||
33295928|NCT02879383|100978653|FG003|First 24 Weeks|Physician Decision|0|||
33295929|NCT00681668|100978654|FG000|Overall Study|Protocol Violation|1|||
33295930|NCT00681668|100978654|FG000|Overall Study|Withdrawal by Subject|1|||
33295931|NCT01777334|100978655|FG000|Overall Study|Adverse Event|18|||
33295932|NCT01777334|100978656|FG001|Overall Study|Adverse Event|14|||
33295933|NCT01777334|100978655|FG000|Overall Study|Lack of Efficacy|15|||
33295934|NCT01777334|100978656|FG001|Overall Study|Lack of Efficacy|29|||
33295935|NCT01777334|100978655|FG000|Overall Study|Protocol Violation|3|||
33295936|NCT01777334|100978656|FG001|Overall Study|Protocol Violation|7|||
33295937|NCT01777334|100978655|FG000|Overall Study|Lost to Follow-up|3|||
33295938|NCT01777334|100978656|FG001|Overall Study|Lost to Follow-up|2|||
33295939|NCT01777334|100978655|FG000|Overall Study|Withdrawal by Subject|14|||
33295940|NCT01777334|100978656|FG001|Overall Study|Withdrawal by Subject|11|||
33189316|NCT02346240|100601444|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33189317|NCT02346240|100601445|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33189318|NCT02346240|100601446|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33295941|NCT03510455|100978660|FG000|Overall Study|Physician Decision|1|||
33189319|NCT02346240|100601447|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33189320|NCT02346240|100601448|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33189321|NCT02346240|100601449|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33189322|NCT02346240|100601450|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33189323|NCT02346240|100601427|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189324|NCT02346240|100601428|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189325|NCT02346240|100601429|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189326|NCT02346240|100601430|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189327|NCT02346240|100601431|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189328|NCT02346240|100601432|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189329|NCT02346240|100601433|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189330|NCT02346240|100601434|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189331|NCT02346240|100601435|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189332|NCT02346240|100601436|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189333|NCT02346240|100601437|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189334|NCT02346240|100601438|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189335|NCT02346240|100601439|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189336|NCT02346240|100601440|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
33189337|NCT02346240|100601441|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
33189338|NCT02346240|100601442|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
33189339|NCT02346240|100601443|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
33189340|NCT02346240|100601444|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189341|NCT02346240|100601445|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189342|NCT02346240|100601446|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189343|NCT02346240|100601447|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189344|NCT02346240|100601448|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189345|NCT02346240|100601449|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189346|NCT02346240|100601450|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33189347|NCT02346240|100601427|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189348|NCT02346240|100601428|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189349|NCT02346240|100601429|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189350|NCT02346240|100601430|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189351|NCT02346240|100601431|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33295942|NCT01736540|100978661|FG000|Overall Study|Did not complete scan within 45 days|2|||
33295943|NCT01736540|100978661|FG000|Overall Study|Death|1|||
33295944|NCT01736540|100978661|FG000|Overall Study|Abnormal test procedure|1|||
33295945|NCT01736540|100978661|FG000|Overall Study|Withdrawal by Subject|5|||
33295946|NCT01736540|100978661|FG000|Overall Study|Protocol Violation|1|||
33295947|NCT01736540|100978661|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
33295948|NCT01736540|100978661|FG000|Overall Study|No show for MRI appointment|1|||
33295949|NCT01736540|100978661|FG000|Overall Study|Unable to make MRI appointment|3|||
33295950|NCT00126659|100978662|FG000|Overall Study|Adverse Event|0|||
33295951|NCT00126659|100978663|FG001|Overall Study|Adverse Event|0|||
33295952|NCT00126659|100978664|FG002|Overall Study|Adverse Event|2|||
33295953|NCT01081886|100978665|FG000|Overall Study|Study termination|11|||
33295954|NCT01081886|100978666|FG001|Overall Study|Study termination|13|||
33392472|NCT04728815|101325246|FG007|Overall Study|Lost to Follow-up|0|||
33392473|NCT04728815|101325239|FG000|Overall Study|Physician Decision|0|||
33295955|NCT01234883|100978667|FG000|Overall Study|Early treatment release|8|||
33295956|NCT01234883|100978668|FG001|Overall Study|Early treatment release|10|||
33295957|NCT01234883|100978667|FG000|Overall Study|Parent/guardian withdrew consent|1|||
33295958|NCT01234883|100978668|FG001|Overall Study|Parent/guardian withdrew consent|2|||
33295959|NCT01234883|100978667|FG000|Overall Study|Technical difficulties with IV infusion|0|||
33295960|NCT01234883|100978668|FG001|Overall Study|Technical difficulties with IV infusion|1|||
33295961|NCT01234883|100978667|FG000|Overall Study|Inclusion/exclusion failure|1|||
33295962|NCT01234883|100978668|FG001|Overall Study|Inclusion/exclusion failure|0|||
33295963|NCT02035696|100978669|FG000|Overall Study|Lost to Follow-up|0|||
33295964|NCT02035696|100978670|FG001|Overall Study|Lost to Follow-up|3|||
33295965|NCT02035696|100978671|FG002|Overall Study|Lost to Follow-up|1|||
33295966|NCT02035696|100978672|FG003|Overall Study|Lost to Follow-up|2|||
33295967|NCT02035696|100978669|FG000|Overall Study|Withdrawal by Subject|3|||
33295968|NCT02035696|100978670|FG001|Overall Study|Withdrawal by Subject|0|||
33295969|NCT02035696|100978671|FG002|Overall Study|Withdrawal by Subject|2|||
33295970|NCT02035696|100978672|FG003|Overall Study|Withdrawal by Subject|1|||
33295971|NCT01647542|100978675|FG000|Overall Study|Major Protocol Deviation|1|||
33295972|NCT01647542|100978676|FG001|Overall Study|Major Protocol Deviation|0|||
33295973|NCT01647542|100978677|FG002|Overall Study|Major Protocol Deviation|0|||
33295974|NCT01647542|100978675|FG000|Overall Study|Adverse Event|4|||
33295975|NCT01647542|100978676|FG001|Overall Study|Adverse Event|5|||
33295976|NCT01647542|100978677|FG002|Overall Study|Adverse Event|4|||
33295977|NCT01647542|100978675|FG000|Overall Study|Lost to Follow-up|0|||
33295978|NCT01647542|100978676|FG001|Overall Study|Lost to Follow-up|2|||
33295979|NCT01647542|100978677|FG002|Overall Study|Lost to Follow-up|2|||
33295980|NCT01647542|100978675|FG000|Overall Study|Withdrawal by Subject|6|||
33295981|NCT01647542|100978676|FG001|Overall Study|Withdrawal by Subject|4|||
33295982|NCT01647542|100978677|FG002|Overall Study|Withdrawal by Subject|0|||
33295983|NCT01647542|100978675|FG000|Overall Study|Study Termination|64|||
33392474|NCT04728815|101325240|FG001|Overall Study|Physician Decision|0|||
33392475|NCT04728815|101325241|FG002|Overall Study|Physician Decision|1|||
33392476|NCT04728815|101325242|FG003|Overall Study|Physician Decision|0|||
33392477|NCT04728815|101325243|FG004|Overall Study|Physician Decision|0|||
33392478|NCT04728815|101325244|FG005|Overall Study|Physician Decision|0|||
33392479|NCT04728815|101325245|FG006|Overall Study|Physician Decision|0|||
33189352|NCT02346240|100601432|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189353|NCT02346240|100601433|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
33189354|NCT02346240|100601434|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189355|NCT02346240|100601435|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189356|NCT02346240|100601436|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189357|NCT02346240|100601437|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189358|NCT02346240|100601438|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189359|NCT02346240|100601439|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189360|NCT02346240|100601440|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189361|NCT02346240|100601441|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189362|NCT02346240|100601442|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189363|NCT02346240|100601443|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33295984|NCT01647542|100978676|FG001|Overall Study|Study Termination|61|||
33295985|NCT01647542|100978677|FG002|Overall Study|Study Termination|65|||
33295986|NCT01647542|100978675|FG000|Overall Study|Lack of Efficacy|1|||
33295987|NCT01647542|100978676|FG001|Overall Study|Lack of Efficacy|1|||
33295988|NCT01647542|100978677|FG002|Overall Study|Lack of Efficacy|0|||
33295989|NCT01647542|100978675|FG000|Overall Study|Death|0|||
33189364|NCT02346240|100601444|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189365|NCT02346240|100601445|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189366|NCT02346240|100601446|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189367|NCT02346240|100601447|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189368|NCT02346240|100601448|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189369|NCT02346240|100601449|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33295990|NCT01647542|100978676|FG001|Overall Study|Death|0|||
33295991|NCT01647542|100978677|FG002|Overall Study|Death|1|||
33295992|NCT01967069|100978678|FG000|Overall Study|Adverse Event|2|||
33295993|NCT01967069|100978679|FG001|Overall Study|Adverse Event|2|||
33295994|NCT01967069|100978678|FG000|Overall Study|Lost to Follow-up|5|||
33295995|NCT01967069|100978679|FG001|Overall Study|Lost to Follow-up|2|||
33295996|NCT01967069|100978678|FG000|Overall Study|Withdrawal by Subject|1|||
33295997|NCT01967069|100978679|FG001|Overall Study|Withdrawal by Subject|3|||
33295998|NCT01967069|100978678|FG000|Overall Study|Lack of Efficacy|0|||
33295999|NCT01967069|100978679|FG001|Overall Study|Lack of Efficacy|1|||
33392480|NCT04728815|101325246|FG007|Overall Study|Physician Decision|0|||
33296000|NCT01144377|100978680|FG000|52 Week Treatment Period|Adverse Event|0|||
33296001|NCT01144377|100978681|FG001|52 Week Treatment Period|Adverse Event|0|||
33392481|NCT04728815|101325239|FG000|Overall Study|Treatment drop|0|||
33296002|NCT01144377|100978682|FG002|52 Week Treatment Period|Adverse Event|3|||
33296003|NCT01144377|100978683|FG003|52 Week Treatment Period|Adverse Event|2|||
33296004|NCT01144377|100978684|FG004|52 Week Treatment Period|Adverse Event|1|||
33296005|NCT01144377|100978680|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
33296006|NCT01144377|100978681|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
33296007|NCT01144377|100978682|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
33296008|NCT01144377|100978683|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
33296009|NCT01144377|100978684|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
33296010|NCT01144377|100978680|FG000|52 Week Treatment Period|Protocol Violation|0|||
33296011|NCT01144377|100978681|FG001|52 Week Treatment Period|Protocol Violation|0|||
33296012|NCT01144377|100978682|FG002|52 Week Treatment Period|Protocol Violation|0|||
33296013|NCT01144377|100978683|FG003|52 Week Treatment Period|Protocol Violation|0|||
33296014|NCT01144377|100978684|FG004|52 Week Treatment Period|Protocol Violation|1|||
33392482|NCT04728815|101325240|FG001|Overall Study|Treatment drop|2|||
33392483|NCT04728815|101325241|FG002|Overall Study|Treatment drop|1|||
33392484|NCT04728815|101325242|FG003|Overall Study|Treatment drop|0|||
33392485|NCT04728815|101325243|FG004|Overall Study|Treatment drop|3|||
33392486|NCT04728815|101325244|FG005|Overall Study|Treatment drop|1|||
33392487|NCT04728815|101325245|FG006|Overall Study|Treatment drop|3|||
33392488|NCT04728815|101325246|FG007|Overall Study|Treatment drop|0|||
33392489|NCT04728815|101325239|FG000|Overall Study|Study drop|0|||
33392490|NCT04728815|101325240|FG001|Overall Study|Study drop|3|||
33392491|NCT04728815|101325241|FG002|Overall Study|Study drop|3|||
33392492|NCT04728815|101325242|FG003|Overall Study|Study drop|0|||
33392493|NCT04728815|101325243|FG004|Overall Study|Study drop|0|||
33392494|NCT04728815|101325244|FG005|Overall Study|Study drop|0|||
33296015|NCT01144377|100978680|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
33296016|NCT01144377|100978681|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
33296017|NCT01144377|100978682|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
33296018|NCT01144377|100978683|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
33296019|NCT01144377|100978684|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
33296020|NCT01144377|100978680|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
33296021|NCT01144377|100978681|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
33296022|NCT01144377|100978682|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
33296023|NCT01144377|100978683|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
33296024|NCT01144377|100978684|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
33296025|NCT01144377|100978680|FG000|52 Week Treatment Period|Sponsor Decision|0|||
33296026|NCT01144377|100978681|FG001|52 Week Treatment Period|Sponsor Decision|0|||
33296027|NCT01144377|100978682|FG002|52 Week Treatment Period|Sponsor Decision|0|||
33296028|NCT01144377|100978683|FG003|52 Week Treatment Period|Sponsor Decision|0|||
33296029|NCT01144377|100978684|FG004|52 Week Treatment Period|Sponsor Decision|1|||
33296030|NCT01144377|100978680|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
33296031|NCT01144377|100978681|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
33296032|NCT01144377|100978682|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
33296033|NCT01144377|100978683|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
33296034|NCT01144377|100978684|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
33296035|NCT01144377|100978680|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
33296036|NCT01144377|100978681|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
33296037|NCT01144377|100978682|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
33296038|NCT01144377|100978683|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
33296039|NCT01144377|100978684|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
33296040|NCT01144377|100978680|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
33296041|NCT01144377|100978681|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
33296042|NCT01144377|100978682|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
33296043|NCT01144377|100978683|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
33296044|NCT01144377|100978684|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
33296045|NCT01564277|100978685|FG000|Overall Study|Protocol Violation|0|||
33296046|NCT01564277|100978686|FG001|Overall Study|Protocol Violation|1|||
33296047|NCT01564277|100978685|FG000|Overall Study|Physician Decision|1|||
33296048|NCT01564277|100978686|FG001|Overall Study|Physician Decision|0|||
33296049|NCT01475461|100978689|FG000|Run-in Period|Not meet eligibility criteria|16|||
33296050|NCT01475461|100978690|FG001|Run-in Period|Not meet eligibility criteria|0|||
33296051|NCT01475461|100978691|FG002|Run-in Period|Not meet eligibility criteria|0|||
33296052|NCT01475461|100978692|FG003|Run-in Period|Not meet eligibility criteria|0|||
33296053|NCT01475461|100978693|FG004|Run-in Period|Not meet eligibility criteria|0|||
33296054|NCT01475461|100978694|FG005|Run-in Period|Not meet eligibility criteria|0|||
33296055|NCT01475461|100978695|FG006|Run-in Period|Not meet eligibility criteria|0|||
33296056|NCT01475461|100978689|FG000|Run-in Period|Lost to Follow-up|7|||
33392495|NCT04728815|101325245|FG006|Overall Study|Study drop|7|||
33392496|NCT04728815|101325246|FG007|Overall Study|Study drop|0|||
33392497|NCT01624467|101325247|FG000|Overall Study|Withdrawal by Subject|2|||
33392498|NCT01624467|101325247|FG000|Overall Study|Lost to Follow-up|1|||
33392499|NCT01624467|101325247|FG000|Overall Study|Adverse Event|7|||
33296057|NCT01475461|100978690|FG001|Run-in Period|Lost to Follow-up|0|||
33296058|NCT01475461|100978691|FG002|Run-in Period|Lost to Follow-up|0|||
33296059|NCT01475461|100978692|FG003|Run-in Period|Lost to Follow-up|0|||
33296060|NCT01475461|100978693|FG004|Run-in Period|Lost to Follow-up|0|||
33296061|NCT01475461|100978694|FG005|Run-in Period|Lost to Follow-up|0|||
33296062|NCT01475461|100978695|FG006|Run-in Period|Lost to Follow-up|0|||
33296063|NCT01475461|100978689|FG000|Run-in Period|Withdrawal by Subject|11|||
33296064|NCT01475461|100978690|FG001|Run-in Period|Withdrawal by Subject|0|||
33296065|NCT01475461|100978691|FG002|Run-in Period|Withdrawal by Subject|0|||
33296066|NCT01475461|100978692|FG003|Run-in Period|Withdrawal by Subject|0|||
33296067|NCT01475461|100978693|FG004|Run-in Period|Withdrawal by Subject|0|||
33296068|NCT01475461|100978694|FG005|Run-in Period|Withdrawal by Subject|0|||
33296069|NCT01475461|100978695|FG006|Run-in Period|Withdrawal by Subject|0|||
33296070|NCT01475461|100978689|FG000|Run-in Period|Other|3|||
33296071|NCT01475461|100978690|FG001|Run-in Period|Other|0|||
33296072|NCT01475461|100978691|FG002|Run-in Period|Other|0|||
33296073|NCT01475461|100978692|FG003|Run-in Period|Other|0|||
33296074|NCT01475461|100978693|FG004|Run-in Period|Other|0|||
33296075|NCT01475461|100978694|FG005|Run-in Period|Other|0|||
33296076|NCT01475461|100978695|FG006|Run-in Period|Other|0|||
33296077|NCT01475461|100978689|FG000|Run-in Period|Protocol Violation|4|||
33296078|NCT01475461|100978690|FG001|Run-in Period|Protocol Violation|0|||
33296079|NCT01475461|100978691|FG002|Run-in Period|Protocol Violation|0|||
33296080|NCT01475461|100978692|FG003|Run-in Period|Protocol Violation|0|||
33296081|NCT01475461|100978693|FG004|Run-in Period|Protocol Violation|0|||
33296082|NCT01475461|100978694|FG005|Run-in Period|Protocol Violation|0|||
33296083|NCT01475461|100978695|FG006|Run-in Period|Protocol Violation|0|||
33296084|NCT01475461|100978689|FG000|Treatment Period|Death|0|||
33296085|NCT01475461|100978690|FG001|Treatment Period|Death|0|||
33296086|NCT01475461|100978691|FG002|Treatment Period|Death|0|||
33296087|NCT01475461|100978692|FG003|Treatment Period|Death|1|||
33392500|NCT01624467|101325247|FG000|Overall Study|Progressive Disease|19|||
33392501|NCT01624467|101325247|FG000|Overall Study|Per Sponsor Requirement|1|||
33392502|NCT01624467|101325247|FG000|Overall Study|Subject Withdrew from Treatment|1|||
33392503|NCT01764022|101325248|FG000|Overall Study|Death|3|||
33392504|NCT01764022|101325249|FG001|Overall Study|Death|5|||
33392505|NCT01764022|101325248|FG000|Overall Study|Withdrawal by Subject|2|||
33392506|NCT01764022|101325249|FG001|Overall Study|Withdrawal by Subject|6|||
33392507|NCT01764022|101325248|FG000|Overall Study|Lack of Efficacy|0|||
33392508|NCT01764022|101325249|FG001|Overall Study|Lack of Efficacy|1|||
33392509|NCT01764022|101325248|FG000|Overall Study|Physician Decision|0|||
33392510|NCT01764022|101325249|FG001|Overall Study|Physician Decision|2|||
33392511|NCT01764022|101325248|FG000|Overall Study|Lost to Follow-up|2|||
33392512|NCT01764022|101325249|FG001|Overall Study|Lost to Follow-up|0|||
33392513|NCT01764022|101325248|FG000|Overall Study|Protocol Violation|1|||
33392514|NCT01764022|101325249|FG001|Overall Study|Protocol Violation|0|||
33392515|NCT00415623|101325252|FG000|Overall Study|Adverse Event|3|||
33392516|NCT00415623|101325253|FG001|Overall Study|Adverse Event|4|||
33392517|NCT00415623|101325252|FG000|Overall Study|Death|1|||
33392518|NCT00415623|101325253|FG001|Overall Study|Death|0|||
33392519|NCT00415623|101325252|FG000|Overall Study|Withdrawal by Subject|1|||
33392520|NCT00415623|101325253|FG001|Overall Study|Withdrawal by Subject|1|||
33392521|NCT02977507|101325254|FG000|Overall Study|Protocol Deviation|1|||
33392522|NCT02977507|101325255|FG001|Overall Study|Protocol Deviation|0|||
33392523|NCT02977507|101325254|FG000|Overall Study|Lost to Follow-up|1|||
33392524|NCT02977507|101325255|FG001|Overall Study|Lost to Follow-up|0|||
33392525|NCT03342404|101325256|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
33392526|NCT03342404|101325257|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
33392527|NCT03342404|101325256|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
33392528|NCT03342404|101325257|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
33392529|NCT03342404|101325256|FG000|Blinded Treatment Phase|Adverse Event|5|||
33392530|NCT03342404|101325257|FG001|Blinded Treatment Phase|Adverse Event|4|||
33392531|NCT03342404|101325256|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
33392532|NCT03342404|101325257|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
33392533|NCT03342404|101325256|FG000|Blinded Treatment Phase|Other reasons|1|||
33392534|NCT03342404|101325257|FG001|Blinded Treatment Phase|Other reasons|0|||
33392535|NCT03342404|101325256|FG000|Blinded Treatment Phase|Physician Decision|1|||
33392536|NCT03342404|101325257|FG001|Blinded Treatment Phase|Physician Decision|0|||
33392537|NCT03342404|101325256|FG000|Blinded Treatment Phase|Death|1|||
33392538|NCT03342404|101325257|FG001|Blinded Treatment Phase|Death|0|||
33392539|NCT03342404|101325256|FG000|Open-Label Phase|Lost to Follow-up|0|||
33296088|NCT01475461|100978693|FG004|Treatment Period|Death|0|||
33296089|NCT01475461|100978694|FG005|Treatment Period|Death|0|||
33296090|NCT01475461|100978695|FG006|Treatment Period|Death|0|||
33296091|NCT01475461|100978689|FG000|Treatment Period|Lost to Follow-up|0|||
33296092|NCT01475461|100978690|FG001|Treatment Period|Lost to Follow-up|3|||
33296093|NCT01475461|100978691|FG002|Treatment Period|Lost to Follow-up|2|||
33296094|NCT01475461|100978692|FG003|Treatment Period|Lost to Follow-up|3|||
33296095|NCT01475461|100978693|FG004|Treatment Period|Lost to Follow-up|1|||
33392540|NCT03342404|101325257|FG001|Open-Label Phase|Lost to Follow-up|1|||
33392541|NCT03342404|101325256|FG000|Open-Label Phase|Other reasons|0|||
33392542|NCT03342404|101325257|FG001|Open-Label Phase|Other reasons|1|||
33392543|NCT03342404|101325256|FG000|Open-Label Phase|Adverse Event|0|||
33392544|NCT03342404|101325257|FG001|Open-Label Phase|Adverse Event|3|||
33392545|NCT03342404|101325256|FG000|Open-Label Phase|Withdrawal by Subject|0|||
33392546|NCT03342404|101325257|FG001|Open-Label Phase|Withdrawal by Subject|6|||
33392547|NCT01025232|101325264|FG000|Overall Study|Study drug no longer available|3|||
33392548|NCT01025232|101325265|FG001|Overall Study|Study drug no longer available|6|||
33392549|NCT03074318|101325266|FG000|Overall Study|Adverse Event|0|||
33392550|NCT03074318|101325267|FG001|Overall Study|Adverse Event|1|||
33392551|NCT03074318|101325268|FG002|Overall Study|Adverse Event|1|||
33392552|NCT03074318|101325269|FG003|Overall Study|Adverse Event|1|||
33392553|NCT03074318|101325266|FG000|Overall Study|Death|1|||
33392554|NCT03074318|101325267|FG001|Overall Study|Death|0|||
33392555|NCT03074318|101325268|FG002|Overall Study|Death|0|||
33392556|NCT03074318|101325269|FG003|Overall Study|Death|0|||
33392557|NCT03074318|101325266|FG000|Overall Study|Withdrawal by Subject|1|||
33392558|NCT03074318|101325267|FG001|Overall Study|Withdrawal by Subject|2|||
33392559|NCT03074318|101325268|FG002|Overall Study|Withdrawal by Subject|2|||
33392560|NCT03074318|101325269|FG003|Overall Study|Withdrawal by Subject|4|||
33392561|NCT03074318|101325266|FG000|Overall Study|Trial Closure|2|||
33392562|NCT03074318|101325267|FG001|Overall Study|Trial Closure|2|||
33392563|NCT03074318|101325268|FG002|Overall Study|Trial Closure|3|||
33392564|NCT03074318|101325269|FG003|Overall Study|Trial Closure|11|||
33392565|NCT02756845|101325272|FG000|Overall Study|Death|12|||
33392566|NCT02756845|101325273|FG001|Overall Study|Death|2|||
33392567|NCT02756845|101325272|FG000|Overall Study|Withdrawal by Subject|1|||
33392568|NCT02756845|101325273|FG001|Overall Study|Withdrawal by Subject|0|||
33392569|NCT02996500|101325275|FG000|Overall Study|Adverse Event|1|||
33392570|NCT02996500|101325276|FG001|Overall Study|Adverse Event|1|||
33392571|NCT02996500|101325277|FG002|Overall Study|Adverse Event|4|||
33392572|NCT02996500|101325278|FG003|Overall Study|Adverse Event|3|||
33392573|NCT02996500|101325279|FG004|Overall Study|Adverse Event|1|||
33392574|NCT02996500|101325280|FG005|Overall Study|Adverse Event|2|||
33392575|NCT02996500|101325275|FG000|Overall Study|Lack of Efficacy|0|||
33392576|NCT02996500|101325276|FG001|Overall Study|Lack of Efficacy|0|||
33392577|NCT02996500|101325277|FG002|Overall Study|Lack of Efficacy|0|||
33392578|NCT02996500|101325278|FG003|Overall Study|Lack of Efficacy|0|||
33392579|NCT02996500|101325279|FG004|Overall Study|Lack of Efficacy|2|||
33392580|NCT02996500|101325280|FG005|Overall Study|Lack of Efficacy|0|||
33392581|NCT02996500|101325275|FG000|Overall Study|Lost to Follow-up|1|||
33392582|NCT02996500|101325276|FG001|Overall Study|Lost to Follow-up|0|||
33392583|NCT02996500|101325277|FG002|Overall Study|Lost to Follow-up|0|||
33392584|NCT02996500|101325278|FG003|Overall Study|Lost to Follow-up|0|||
33392585|NCT02996500|101325279|FG004|Overall Study|Lost to Follow-up|0|||
33392586|NCT02996500|101325280|FG005|Overall Study|Lost to Follow-up|1|||
33392587|NCT02996500|101325275|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33392588|NCT02996500|101325276|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33392589|NCT02996500|101325277|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
33392590|NCT02996500|101325278|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
33392591|NCT02996500|101325279|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
33392592|NCT02996500|101325280|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
33392593|NCT02996500|101325275|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33392594|NCT02996500|101325276|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33392595|NCT02996500|101325277|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33392596|NCT02996500|101325278|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33392597|NCT02996500|101325279|FG004|Overall Study|Non-Compliance With Study Drug|0|||
33392598|NCT02996500|101325280|FG005|Overall Study|Non-Compliance With Study Drug|1|||
33392599|NCT02996500|101325275|FG000|Overall Study|Progressive Disease|1|||
33392600|NCT02996500|101325276|FG001|Overall Study|Progressive Disease|0|||
33392601|NCT02996500|101325277|FG002|Overall Study|Progressive Disease|0|||
33392602|NCT02996500|101325278|FG003|Overall Study|Progressive Disease|0|||
33392603|NCT02996500|101325279|FG004|Overall Study|Progressive Disease|0|||
33392604|NCT02996500|101325280|FG005|Overall Study|Progressive Disease|0|||
33392605|NCT02996500|101325275|FG000|Overall Study|Other|2|||
33392606|NCT02996500|101325276|FG001|Overall Study|Other|0|||
33392607|NCT02996500|101325277|FG002|Overall Study|Other|2|||
33392608|NCT02996500|101325278|FG003|Overall Study|Other|0|||
33392609|NCT02996500|101325279|FG004|Overall Study|Other|0|||
33392610|NCT02996500|101325280|FG005|Overall Study|Other|0|||
33392611|NCT02996500|101325275|FG000|Overall Study|Protocol Violation|0|||
33392612|NCT02996500|101325276|FG001|Overall Study|Protocol Violation|0|||
33392613|NCT02996500|101325277|FG002|Overall Study|Protocol Violation|0|||
33392614|NCT02996500|101325278|FG003|Overall Study|Protocol Violation|1|||
33392615|NCT02996500|101325279|FG004|Overall Study|Protocol Violation|0|||
33392616|NCT02996500|101325280|FG005|Overall Study|Protocol Violation|0|||
33392617|NCT02996500|101325275|FG000|Overall Study|Withdrawal by Subject|3|||
33296096|NCT01475461|100978694|FG005|Treatment Period|Lost to Follow-up|2|||
33296097|NCT01475461|100978695|FG006|Treatment Period|Lost to Follow-up|1|||
33296098|NCT01475461|100978689|FG000|Treatment Period|Withdrawal by Subject|0|||
33296099|NCT01475461|100978690|FG001|Treatment Period|Withdrawal by Subject|2|||
33296100|NCT01475461|100978691|FG002|Treatment Period|Withdrawal by Subject|2|||
33296101|NCT01475461|100978692|FG003|Treatment Period|Withdrawal by Subject|0|||
33296102|NCT01475461|100978693|FG004|Treatment Period|Withdrawal by Subject|2|||
33296103|NCT01475461|100978694|FG005|Treatment Period|Withdrawal by Subject|2|||
33296104|NCT01475461|100978695|FG006|Treatment Period|Withdrawal by Subject|0|||
33296105|NCT01475461|100978689|FG000|Treatment Period|Other|0|||
33296106|NCT01475461|100978690|FG001|Treatment Period|Other|1|||
33296107|NCT01475461|100978691|FG002|Treatment Period|Other|0|||
33296108|NCT01475461|100978692|FG003|Treatment Period|Other|0|||
33296109|NCT01475461|100978693|FG004|Treatment Period|Other|0|||
33296110|NCT01475461|100978694|FG005|Treatment Period|Other|0|||
33296111|NCT01475461|100978695|FG006|Treatment Period|Other|0|||
33296112|NCT01475461|100978689|FG000|Treatment Period|Protocol Violation|0|||
33296113|NCT01475461|100978690|FG001|Treatment Period|Protocol Violation|1|||
33296114|NCT01475461|100978691|FG002|Treatment Period|Protocol Violation|0|||
33296115|NCT01475461|100978692|FG003|Treatment Period|Protocol Violation|0|||
33296116|NCT01475461|100978693|FG004|Treatment Period|Protocol Violation|0|||
33296117|NCT01475461|100978694|FG005|Treatment Period|Protocol Violation|0|||
33296118|NCT01475461|100978695|FG006|Treatment Period|Protocol Violation|1|||
33296119|NCT01475461|100978689|FG000|Treatment Period|Lack of Efficacy|0|||
33296120|NCT01475461|100978690|FG001|Treatment Period|Lack of Efficacy|2|||
33296121|NCT01475461|100978691|FG002|Treatment Period|Lack of Efficacy|0|||
33296122|NCT01475461|100978692|FG003|Treatment Period|Lack of Efficacy|2|||
33296123|NCT01475461|100978693|FG004|Treatment Period|Lack of Efficacy|1|||
33296124|NCT01475461|100978694|FG005|Treatment Period|Lack of Efficacy|1|||
33296125|NCT01475461|100978695|FG006|Treatment Period|Lack of Efficacy|0|||
33296126|NCT01475461|100978689|FG000|Treatment Period|Medication Error|0|||
33296127|NCT01475461|100978690|FG001|Treatment Period|Medication Error|0|||
33296128|NCT01475461|100978691|FG002|Treatment Period|Medication Error|0|||
33296129|NCT01475461|100978692|FG003|Treatment Period|Medication Error|1|||
33296130|NCT01475461|100978693|FG004|Treatment Period|Medication Error|0|||
33296131|NCT01475461|100978694|FG005|Treatment Period|Medication Error|0|||
33296132|NCT01475461|100978695|FG006|Treatment Period|Medication Error|0|||
33296133|NCT01475461|100978689|FG000|Treatment Period|Adverse Event|0|||
33296134|NCT01475461|100978690|FG001|Treatment Period|Adverse Event|0|||
33296135|NCT01475461|100978691|FG002|Treatment Period|Adverse Event|0|||
33296136|NCT01475461|100978692|FG003|Treatment Period|Adverse Event|1|||
33296137|NCT01475461|100978693|FG004|Treatment Period|Adverse Event|0|||
33296138|NCT01475461|100978694|FG005|Treatment Period|Adverse Event|0|||
33296139|NCT01475461|100978695|FG006|Treatment Period|Adverse Event|0|||
33296140|NCT02975102|100978698|FG000|Overall Study|Adverse Event|2|||
33296141|NCT02975102|100978699|FG001|Overall Study|Adverse Event|1|||
33296142|NCT01727505|100978702|FG000|First 24 Hours|Adverse Event|0|||
33296143|NCT01727505|100978703|FG001|First 24 Hours|Adverse Event|1|||
33296144|NCT01727505|100978702|FG000|Second 24 Hours|Missing data|0|||
33296145|NCT01727505|100978703|FG001|Second 24 Hours|Missing data|1|||
33296146|NCT02172911|100978707|FG000|Overall Study|Serious Adverse Event|0|||
33392618|NCT02996500|101325276|FG001|Overall Study|Withdrawal by Subject|0|||
33392619|NCT02996500|101325277|FG002|Overall Study|Withdrawal by Subject|3|||
33392620|NCT02996500|101325278|FG003|Overall Study|Withdrawal by Subject|0|||
33392621|NCT02996500|101325279|FG004|Overall Study|Withdrawal by Subject|2|||
33392622|NCT02996500|101325280|FG005|Overall Study|Withdrawal by Subject|0|||
33296147|NCT02172911|100978708|FG001|Overall Study|Serious Adverse Event|1|||
33296148|NCT02172911|100978707|FG000|Overall Study|Progression of Disease|0|||
33296149|NCT02172911|100978708|FG001|Overall Study|Progression of Disease|1|||
33392623|NCT04350372|101325281|FG000|Overall Study|Death|1|||
33392624|NCT02741310|101325284|FG000|Overall Study|Sponsor Decision|2|||
33296150|NCT02172911|100978707|FG000|Overall Study|Loss of insurance coverage|1|||
33296151|NCT02172911|100978708|FG001|Overall Study|Loss of insurance coverage|0|||
33296152|NCT00862836|100978711|FG000|Overall Study|Withdrawal by Subject|1|||
33296153|NCT01228175|100978714|FG000|Overall Study|Lost to Follow-up|64|||
33296154|NCT01228175|100978715|FG001|Overall Study|Lost to Follow-up|50|||
33296155|NCT01228175|100978714|FG000|Overall Study|Withdrawal by Subject|1|||
33296156|NCT01228175|100978715|FG001|Overall Study|Withdrawal by Subject|2|||
33296157|NCT01228175|100978714|FG000|Overall Study|Physician Decision|1|||
33296158|NCT01228175|100978715|FG001|Overall Study|Physician Decision|1|||
33296159|NCT02870972|100978716|FG000|Overall Study|Adverse Event|1|||
33392625|NCT02741310|101325285|FG001|Overall Study|Sponsor Decision|2|||
33392626|NCT01833806|101325286|FG000|Overall Study|Alternative treatment|2|||
33392627|NCT01833806|101325286|FG000|Overall Study|Death|5|||
33392628|NCT01833806|101325286|FG000|Overall Study|Physician Decision|1|||
33392629|NCT01833806|101325286|FG000|Overall Study|Lost to Follow-up|1|||
33189370|NCT02346240|100601450|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
33189371|NCT02346240|100601427|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189372|NCT02346240|100601428|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189373|NCT02346240|100601429|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189374|NCT02346240|100601430|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189375|NCT02346240|100601431|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189376|NCT02346240|100601432|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189377|NCT02346240|100601433|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189378|NCT02346240|100601434|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189379|NCT02346240|100601435|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
33189380|NCT02346240|100601436|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189381|NCT02346240|100601437|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189382|NCT02346240|100601438|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
33189383|NCT02346240|100601439|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189384|NCT02346240|100601440|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
33189385|NCT02346240|100601441|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
33189386|NCT02346240|100601442|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189387|NCT02346240|100601443|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189388|NCT02346240|100601444|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189389|NCT02346240|100601445|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189390|NCT02346240|100601446|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189391|NCT02346240|100601447|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189392|NCT02346240|100601448|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189393|NCT02346240|100601449|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189394|NCT02346240|100601450|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
33189395|NCT02346240|100601427|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189396|NCT02346240|100601428|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189397|NCT02346240|100601429|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189398|NCT02346240|100601430|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189399|NCT02346240|100601431|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189400|NCT02346240|100601432|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189401|NCT02346240|100601433|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189402|NCT02346240|100601434|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189403|NCT02346240|100601435|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189404|NCT02346240|100601436|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
33189405|NCT02346240|100601437|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189406|NCT02346240|100601438|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189407|NCT02346240|100601439|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189408|NCT02346240|100601440|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189409|NCT02346240|100601441|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189410|NCT02346240|100601442|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189411|NCT02346240|100601443|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189412|NCT02346240|100601444|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189413|NCT02346240|100601445|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33296160|NCT02870972|100978717|FG001|Overall Study|Adverse Event|0|||
33392630|NCT02667236|101325289|FG000|Overall Study|Adverse Event|1|||
33392631|NCT02667236|101325290|FG001|Overall Study|Adverse Event|1|||
33392632|NCT02667236|101325289|FG000|Overall Study|Withdrawal by Subject|2|||
33392633|NCT02667236|101325290|FG001|Overall Study|Withdrawal by Subject|0|||
33392634|NCT03128307|101325293|FG000|Overall Study|Lost to Follow-up|29|||
33392635|NCT03128307|101325293|FG000|Overall Study|Withdrawal by Subject|5|||
33392636|NCT01156363|101325295|FG000|Overall Study|Adverse Event|6|||
33392637|NCT01156363|101325295|FG000|Overall Study|Insufficient Therapeutic Response|5|||
33392638|NCT01156363|101325295|FG000|Overall Study|Failure to Return|1|||
33392639|NCT01156363|101325295|FG000|Overall Study|Refused Treatment|4|||
33392640|NCT01156363|101325295|FG000|Overall Study|Other|6|||
33392641|NCT02408484|101325296|FG000|Overall Study|Withdrawal by Subject|3|||
33392642|NCT02408484|101325296|FG000|Overall Study|Not treated during study period|1|||
33392643|NCT02253992|101325301|FG000|Overall Study|Study drug toxicity|1|||
33600127|NCT04493684|102088508|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33189414|NCT02346240|100601446|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189415|NCT02346240|100601447|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189416|NCT02346240|100601448|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189417|NCT02346240|100601449|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189418|NCT02346240|100601450|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
33189419|NCT02346240|100601427|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33392644|NCT02253992|101325302|FG001|Overall Study|Study drug toxicity|0|||
33392645|NCT02253992|101325303|FG002|Overall Study|Study drug toxicity|10|||
33392646|NCT02253992|101325301|FG000|Overall Study|Disease progression|4|||
33392647|NCT02253992|101325302|FG001|Overall Study|Disease progression|3|||
33392648|NCT02253992|101325303|FG002|Overall Study|Disease progression|98|||
33392649|NCT02253992|101325301|FG000|Overall Study|Withdrawal by Subject|0|||
33392650|NCT02253992|101325302|FG001|Overall Study|Withdrawal by Subject|0|||
33392651|NCT02253992|101325303|FG002|Overall Study|Withdrawal by Subject|3|||
33392652|NCT02253992|101325301|FG000|Overall Study|Adverse Event|0|||
33392653|NCT02253992|101325302|FG001|Overall Study|Adverse Event|0|||
33392654|NCT02253992|101325303|FG002|Overall Study|Adverse Event|8|||
33392655|NCT02253992|101325301|FG000|Overall Study|Death|0|||
33392656|NCT02253992|101325302|FG001|Overall Study|Death|0|||
33392657|NCT02253992|101325303|FG002|Overall Study|Death|1|||
33392658|NCT02253992|101325301|FG000|Overall Study|Subject discontinued study drug|1|||
33189420|NCT02346240|100601428|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189421|NCT02346240|100601429|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189422|NCT02346240|100601430|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189423|NCT02346240|100601431|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189424|NCT02346240|100601432|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189425|NCT02346240|100601433|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189426|NCT02346240|100601434|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189427|NCT02346240|100601435|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189428|NCT02346240|100601436|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189429|NCT02346240|100601437|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
33189430|NCT02346240|100601438|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189431|NCT02346240|100601439|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189432|NCT02346240|100601440|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189433|NCT02346240|100601441|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189434|NCT02346240|100601442|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189435|NCT02346240|100601443|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189436|NCT02346240|100601444|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189437|NCT02346240|100601445|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189438|NCT02346240|100601446|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189439|NCT02346240|100601447|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189440|NCT02346240|100601448|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189441|NCT02346240|100601449|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189442|NCT02346240|100601450|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
33189443|NCT02346240|100601427|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189444|NCT02346240|100601428|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189445|NCT02346240|100601429|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189446|NCT02346240|100601430|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189447|NCT02346240|100601431|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189448|NCT02346240|100601432|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33296161|NCT02870972|100978718|FG002|Overall Study|Adverse Event|0|||
33296162|NCT02870972|100978719|FG003|Overall Study|Adverse Event|0|||
33296163|NCT02870972|100978720|FG004|Overall Study|Adverse Event|0|||
33296164|NCT00664534|100978722|FG000|Overall Study|Adverse Event|2|||
33296165|NCT00664534|100978723|FG001|Overall Study|Adverse Event|3|||
33296166|NCT00664534|100978722|FG000|Overall Study|Lost to Follow-up|6|||
33296167|NCT00664534|100978723|FG001|Overall Study|Lost to Follow-up|10|||
33296168|NCT00664534|100978722|FG000|Overall Study|Protocol Violation|10|||
33392659|NCT02253992|101325302|FG001|Overall Study|Subject discontinued study drug|0|||
33392660|NCT02253992|101325303|FG002|Overall Study|Subject discontinued study drug|1|||
33392661|NCT02253992|101325301|FG000|Overall Study|Completed treatment as per protocol|0|||
33392662|NCT02253992|101325302|FG001|Overall Study|Completed treatment as per protocol|1|||
33392663|NCT02253992|101325303|FG002|Overall Study|Completed treatment as per protocol|22|||
33296169|NCT00664534|100978723|FG001|Overall Study|Protocol Violation|8|||
33296170|NCT00664534|100978722|FG000|Overall Study|Withdrawal by Subject|7|||
33296171|NCT00664534|100978723|FG001|Overall Study|Withdrawal by Subject|6|||
33296172|NCT00664534|100978722|FG000|Overall Study|Physician Decision|8|||
33296173|NCT00664534|100978723|FG001|Overall Study|Physician Decision|0|||
33296174|NCT00664534|100978722|FG000|Overall Study|Sponsor decision|8|||
33296175|NCT00664534|100978723|FG001|Overall Study|Sponsor decision|6|||
33296176|NCT00129935|100981682|FG000|Overall Study|Adverse Event|18|||
33296177|NCT00129935|100981683|FG001|Overall Study|Adverse Event|56|||
33296178|NCT00129935|100981682|FG000|Overall Study|Death|1|||
33296179|NCT00129935|100981683|FG001|Overall Study|Death|1|||
33296180|NCT00129935|100981682|FG000|Overall Study|Withdrawal by Subject|7|||
33296181|NCT00129935|100981683|FG001|Overall Study|Withdrawal by Subject|20|||
33296182|NCT00129935|100981682|FG000|Overall Study|Protocol Violation|0|||
33296183|NCT00129935|100981683|FG001|Overall Study|Protocol Violation|4|||
33296184|NCT00129935|100981682|FG000|Overall Study|Physician Decision|3|||
33296185|NCT00129935|100981683|FG001|Overall Study|Physician Decision|4|||
33296186|NCT00129935|100981682|FG000|Overall Study|Recurrence|1|||
33296187|NCT00129935|100981683|FG001|Overall Study|Recurrence|3|||
33296188|NCT00129935|100981682|FG000|Overall Study|Second primary|0|||
33296189|NCT00129935|100981683|FG001|Overall Study|Second primary|1|||
33296190|NCT00129935|100981682|FG000|Overall Study|Other|3|||
33296191|NCT00129935|100981683|FG001|Overall Study|Other|2|||
33296192|NCT00129935|100981682|FG000|Overall Study|Crossed to the other arm|2|||
33296193|NCT00129935|100981683|FG001|Overall Study|Crossed to the other arm|1|||
33296194|NCT00129935|100981682|FG000|Overall Study|Incorrect study treatment|1|||
33392664|NCT02253992|101325301|FG000|Overall Study|Other|0|||
33392665|NCT02253992|101325302|FG001|Overall Study|Other|0|||
33392666|NCT02253992|101325303|FG002|Overall Study|Other|1|||
33392667|NCT04259346|101325304|FG000|Overall Study|Lost to Follow-up|1|||
33392668|NCT04259346|101325305|FG001|Overall Study|Lost to Follow-up|3|||
33392669|NCT04259346|101325304|FG000|Overall Study|Protocol Violation|1|||
33392670|NCT04259346|101325305|FG001|Overall Study|Protocol Violation|0|||
33392671|NCT04259346|101325304|FG000|Overall Study|Withdrawal by Subject|1|||
33392672|NCT04259346|101325305|FG001|Overall Study|Withdrawal by Subject|0|||
33392673|NCT04259346|101325304|FG000|Overall Study|Adverse Event|1|||
33392674|NCT04259346|101325305|FG001|Overall Study|Adverse Event|1|||
33392675|NCT02688153|101325306|FG000|Overall Study|Death|7|||
33296195|NCT00129935|100981683|FG001|Overall Study|Incorrect study treatment|0|||
33296196|NCT01907906|100981685|FG000|Overall Study|Withdrawal by Subject|1|||
33392676|NCT02688153|101325307|FG001|Overall Study|Death|5|||
33392677|NCT02688153|101325306|FG000|Overall Study|Withdrawal by Subject|4|||
33392678|NCT02688153|101325307|FG001|Overall Study|Withdrawal by Subject|2|||
33392679|NCT02688153|101325306|FG000|Overall Study|Valve Explant|1|||
33392680|NCT02688153|101325307|FG001|Overall Study|Valve Explant|0|||
33392681|NCT02688153|101325306|FG000|Overall Study|Conversion to Commercial Valve|3|||
33392682|NCT02688153|101325307|FG001|Overall Study|Conversion to Commercial Valve|0|||
33392683|NCT02809118|101325308|FG000|Overall Study|Withdrawal by Subject|0|||
33392684|NCT02809118|101325309|FG001|Overall Study|Withdrawal by Subject|1|||
33392685|NCT02809118|101325310|FG002|Overall Study|Withdrawal by Subject|1|||
33392686|NCT04973085|101325311|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
33392687|NCT04973085|101325312|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
33392688|NCT01976624|101325318|FG000|Overall Study|Participants contraindicated|2|||
33392689|NCT01976624|101325318|FG000|Overall Study|Participants age less than 19 years|12|||
33392690|NCT01194414|101325319|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
33296197|NCT01907906|100981686|FG001|Overall Study|Withdrawal by Subject|0|||
33296198|NCT01907906|100981685|FG000|Overall Study|Physician Decision|3|||
33296199|NCT01907906|100981686|FG001|Overall Study|Physician Decision|1|||
33296200|NCT02920970|100981687|FG000|First Intervention|Protocol Violation|0|||
33296201|NCT02920970|100981688|FG001|First Intervention|Protocol Violation|1|||
33296202|NCT02920970|100981687|FG000|First Intervention|Adverse Event|0|||
33296203|NCT02920970|100981688|FG001|First Intervention|Adverse Event|1|||
33296204|NCT02920970|100981687|FG000|Second Intervention|Poor Lens Fit|1|||
33296205|NCT02920970|100981688|FG001|Second Intervention|Poor Lens Fit|0|||
33296206|NCT02473965|100981689|FG000|Overall Study|Adverse Event|6|||
33296207|NCT02473965|100981690|FG001|Overall Study|Adverse Event|4|||
33296208|NCT02473965|100981689|FG000|Overall Study|MG worsening|4|||
33296209|NCT02473965|100981690|FG001|Overall Study|MG worsening|1|||
33296210|NCT02473965|100981689|FG000|Overall Study|Withdrawal by Subject|2|||
33296211|NCT02473965|100981690|FG001|Overall Study|Withdrawal by Subject|3|||
33392691|NCT01194414|101325320|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
33392692|NCT01194414|101325321|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
33392693|NCT01194414|101325322|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
33296212|NCT02473965|100981689|FG000|Overall Study|Physician Decision|0|||
33296213|NCT02473965|100981690|FG001|Overall Study|Physician Decision|2|||
33296214|NCT01825577|100981691|FG000|Overall Study|Physician Decision|2|||
33296215|NCT01825577|100981691|FG000|Overall Study|Withdrawal by Subject|1|||
33392694|NCT01194414|101325319|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
33296216|NCT01825577|100981691|FG000|Overall Study|Withdrawn by family members|2|||
33296217|NCT01825577|100981691|FG000|Overall Study|Lack of Efficacy|3|||
33296218|NCT01594970|100981692|FG000|Overall Study|Non-Adverse Event Related|4|||
33296219|NCT01594970|100981693|FG001|Overall Study|Non-Adverse Event Related|5|||
33296220|NCT01594970|100981694|FG002|Overall Study|Non-Adverse Event Related|6|||
33296221|NCT01594970|100981692|FG000|Overall Study|Adverse Event|17|||
33296222|NCT01594970|100981693|FG001|Overall Study|Adverse Event|23|||
33296223|NCT01594970|100981694|FG002|Overall Study|Adverse Event|23|||
33296224|NCT01594970|100981692|FG000|Overall Study|Lost to Follow-up|54|||
33296225|NCT01594970|100981693|FG001|Overall Study|Lost to Follow-up|54|||
33296226|NCT01594970|100981694|FG002|Overall Study|Lost to Follow-up|37|||
33296227|NCT02336451|100981696|FG000|Overall Study|Adverse Event|1|||
33296228|NCT02336451|100981697|FG001|Overall Study|Adverse Event|2|||
33296229|NCT02336451|100981698|FG002|Overall Study|Adverse Event|0|||
33296230|NCT02336451|100981699|FG003|Overall Study|Adverse Event|6|||
33296231|NCT02336451|100981700|FG004|Overall Study|Adverse Event|4|||
33296232|NCT02336451|100981696|FG000|Overall Study|Death|6|||
33296233|NCT02336451|100981697|FG001|Overall Study|Death|2|||
33296234|NCT02336451|100981698|FG002|Overall Study|Death|3|||
33392695|NCT01194414|101325320|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
33392696|NCT01194414|101325321|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
33392697|NCT01194414|101325322|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
33392698|NCT01194414|101325319|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
33392699|NCT01194414|101325320|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
33392700|NCT01194414|101325321|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
33392701|NCT01194414|101325322|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
33392702|NCT01194414|101325319|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
33392703|NCT01194414|101325320|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
33392704|NCT01194414|101325321|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
33392705|NCT01194414|101325322|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
33392706|NCT01194414|101325319|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
33392707|NCT01194414|101325320|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
33392708|NCT01194414|101325321|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
33392709|NCT01194414|101325322|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
33392710|NCT01194414|101325319|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
33392711|NCT01194414|101325320|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
33392712|NCT01194414|101325321|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
33392713|NCT01194414|101325322|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
33392714|NCT01194414|101325319|FG000|24 Weeks Double Blind Period|Other|0|||
33392715|NCT01194414|101325320|FG001|24 Weeks Double Blind Period|Other|1|||
33392716|NCT01194414|101325321|FG002|24 Weeks Double Blind Period|Other|0|||
33392717|NCT01194414|101325322|FG003|24 Weeks Double Blind Period|Other|0|||
33392718|NCT01194414|101325319|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
33392719|NCT01194414|101325320|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
33296235|NCT02336451|100981699|FG003|Overall Study|Death|6|||
33296236|NCT02336451|100981700|FG004|Overall Study|Death|6|||
33296237|NCT02336451|100981696|FG000|Overall Study|Physician Decision|9|||
33296238|NCT02336451|100981697|FG001|Overall Study|Physician Decision|6|||
33296239|NCT02336451|100981698|FG002|Overall Study|Physician Decision|7|||
33296240|NCT02336451|100981699|FG003|Overall Study|Physician Decision|16|||
33296241|NCT02336451|100981700|FG004|Overall Study|Physician Decision|3|||
33296242|NCT02336451|100981696|FG000|Overall Study|Progressive disease|23|||
33296243|NCT02336451|100981697|FG001|Overall Study|Progressive disease|26|||
33296244|NCT02336451|100981698|FG002|Overall Study|Progressive disease|2|||
33392720|NCT01194414|101325321|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
33392721|NCT01194414|101325322|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
33296245|NCT02336451|100981699|FG003|Overall Study|Progressive disease|14|||
33296246|NCT02336451|100981700|FG004|Overall Study|Progressive disease|4|||
33296247|NCT02336451|100981696|FG000|Overall Study|Protocol Violation|1|||
33296248|NCT02336451|100981697|FG001|Overall Study|Protocol Violation|0|||
33296249|NCT02336451|100981698|FG002|Overall Study|Protocol Violation|0|||
33296250|NCT02336451|100981699|FG003|Overall Study|Protocol Violation|0|||
33296251|NCT02336451|100981700|FG004|Overall Study|Protocol Violation|0|||
33296252|NCT02336451|100981696|FG000|Overall Study|Patient/guardian decision|2|||
33296253|NCT02336451|100981697|FG001|Overall Study|Patient/guardian decision|4|||
33296254|NCT02336451|100981698|FG002|Overall Study|Patient/guardian decision|0|||
33296255|NCT02336451|100981699|FG003|Overall Study|Patient/guardian decision|2|||
33296256|NCT02336451|100981700|FG004|Overall Study|Patient/guardian decision|1|||
33296257|NCT02980042|100981702|FG000|Overall Study|Lost to Follow-up|5|||
33296258|NCT02980042|100981703|FG001|Overall Study|Lost to Follow-up|0|||
33296259|NCT02980042|100981702|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
33296260|NCT02980042|100981703|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
33296261|NCT01241604|100981711|FG000|Screening Period|Screen Failure|3|||
33296262|NCT01241604|100981712|FG001|Screening Period|Screen Failure|0|||
33296263|NCT01241604|100981713|FG002|Screening Period|Screen Failure|0|||
33296264|NCT00245960|100981714|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
33296265|NCT00245960|100981715|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
33296266|NCT00245960|100981714|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
33296267|NCT00245960|100981715|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
33296268|NCT00245960|100981714|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
33296269|NCT00245960|100981715|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
33296270|NCT00245960|100981714|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
33296271|NCT00245960|100981715|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
33296272|NCT00245960|100981714|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
33296273|NCT00245960|100981715|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
33296274|NCT00245960|100981714|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
33296275|NCT00245960|100981715|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
33296276|NCT00245960|100981714|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
33296277|NCT00245960|100981715|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
33296278|NCT00245960|100981714|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
33296279|NCT00245960|100981715|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
33296280|NCT00245960|100981714|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
33296281|NCT00245960|100981715|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
33296282|NCT00245960|100981714|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
33296283|NCT00245960|100981715|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
33296284|NCT00245960|100981714|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
33296285|NCT00245960|100981715|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
33296286|NCT00245960|100981714|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
33296287|NCT00245960|100981715|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
33296288|NCT01575873|100981720|FG000|Overall Study|Withdrawal by Subject|15|||
33296289|NCT01575873|100981721|FG001|Overall Study|Withdrawal by Subject|20|||
33296290|NCT01575873|100981722|FG002|Overall Study|Withdrawal by Subject|34|||
33296291|NCT01575873|100981723|FG003|Overall Study|Withdrawal by Subject|34|||
33296292|NCT01575873|100981720|FG000|Overall Study|Adverse Event|7|||
33296293|NCT01575873|100981721|FG001|Overall Study|Adverse Event|7|||
33296294|NCT01575873|100981722|FG002|Overall Study|Adverse Event|9|||
33296295|NCT01575873|100981723|FG003|Overall Study|Adverse Event|12|||
33296296|NCT01575873|100981720|FG000|Overall Study|Lost to Follow-up|1|||
33296297|NCT01575873|100981721|FG001|Overall Study|Lost to Follow-up|3|||
33296298|NCT01575873|100981722|FG002|Overall Study|Lost to Follow-up|13|||
33296299|NCT01575873|100981723|FG003|Overall Study|Lost to Follow-up|5|||
33296300|NCT01575873|100981720|FG000|Overall Study|Death|3|||
33296301|NCT01575873|100981721|FG001|Overall Study|Death|2|||
33296302|NCT01575873|100981722|FG002|Overall Study|Death|8|||
33296303|NCT01575873|100981723|FG003|Overall Study|Death|9|||
33296304|NCT01575873|100981720|FG000|Overall Study|Noncompliance|1|||
33296305|NCT01575873|100981721|FG001|Overall Study|Noncompliance|2|||
33296306|NCT01575873|100981722|FG002|Overall Study|Noncompliance|4|||
33296307|NCT01575873|100981723|FG003|Overall Study|Noncompliance|3|||
33296308|NCT01575873|100981720|FG000|Overall Study|Administrative decision|1|||
33296309|NCT01575873|100981721|FG001|Overall Study|Administrative decision|1|||
33296310|NCT01575873|100981722|FG002|Overall Study|Administrative decision|1|||
33296311|NCT01575873|100981723|FG003|Overall Study|Administrative decision|0|||
33296312|NCT01575873|100981720|FG000|Overall Study|Protocol deviation|0|||
33296313|NCT01575873|100981721|FG001|Overall Study|Protocol deviation|1|||
33296314|NCT01575873|100981722|FG002|Overall Study|Protocol deviation|0|||
33296315|NCT01575873|100981723|FG003|Overall Study|Protocol deviation|1|||
33296316|NCT01575873|100981720|FG000|Overall Study|Requirement for Alternative Therapy|0|||
33296317|NCT01575873|100981721|FG001|Overall Study|Requirement for Alternative Therapy|0|||
33296318|NCT01575873|100981722|FG002|Overall Study|Requirement for Alternative Therapy|1|||
33296319|NCT01575873|100981723|FG003|Overall Study|Requirement for Alternative Therapy|1|||
33296320|NCT01575873|100981720|FG000|Overall Study|Other|0|||
33296321|NCT01575873|100981721|FG001|Overall Study|Other|0|||
33296322|NCT01575873|100981722|FG002|Overall Study|Other|4|||
33296323|NCT01575873|100981723|FG003|Overall Study|Other|2|||
33296324|NCT01931098|100981730|FG000|Overall Study|Withdrawal by Subject|0|||
33296325|NCT01931098|100981731|FG001|Overall Study|Withdrawal by Subject|1|||
33296326|NCT01931098|100981730|FG000|Overall Study|Enrolled in different protocol|0|||
33296327|NCT01931098|100981731|FG001|Overall Study|Enrolled in different protocol|1|||
33296328|NCT01931098|100981730|FG000|Overall Study|Unable to begin trmt:active infection|0|||
33392722|NCT01194414|101325319|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
33296329|NCT01931098|100981731|FG001|Overall Study|Unable to begin trmt:active infection|1|||
33296330|NCT01931098|100981730|FG000|Overall Study|Refused further treatment|0|||
33296331|NCT01931098|100981731|FG001|Overall Study|Refused further treatment|1|||
33296332|NCT01162486|100981735|FG000|Overall Study|low ANC|1|||
33296333|NCT01162486|100981736|FG001|Overall Study|low ANC|0|||
33296334|NCT01162486|100981737|FG002|Overall Study|low ANC|0|||
33296335|NCT01162486|100981738|FG003|Overall Study|low ANC|0|||
33296336|NCT01162486|100981739|FG004|Overall Study|low ANC|0|||
33392723|NCT01194414|101325320|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
33392724|NCT01194414|101325321|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
33392725|NCT01194414|101325322|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
33392726|NCT01194414|101325319|FG000|24 Weeks Double Blind Period|Death|0|||
33392727|NCT01194414|101325320|FG001|24 Weeks Double Blind Period|Death|1|||
33392728|NCT01194414|101325321|FG002|24 Weeks Double Blind Period|Death|0|||
33189449|NCT02346240|100601433|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189450|NCT02346240|100601434|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189451|NCT02346240|100601435|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189452|NCT02346240|100601436|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189453|NCT02346240|100601437|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189454|NCT02346240|100601438|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189455|NCT02346240|100601439|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189456|NCT02346240|100601440|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189457|NCT02346240|100601441|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
33189458|NCT02346240|100601442|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189459|NCT02346240|100601443|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189460|NCT02346240|100601444|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189461|NCT02346240|100601445|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189462|NCT02346240|100601446|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189463|NCT02346240|100601447|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189464|NCT02346240|100601448|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189465|NCT02346240|100601449|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189466|NCT02346240|100601450|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
33189467|NCT02346240|100601427|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189468|NCT02346240|100601428|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189469|NCT02346240|100601429|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189470|NCT02346240|100601430|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189471|NCT02346240|100601431|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189472|NCT02346240|100601432|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189473|NCT02346240|100601433|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33296337|NCT01162486|100981735|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
33392729|NCT01194414|101325322|FG003|24 Weeks Double Blind Period|Death|0|||
33296338|NCT01162486|100981736|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
33296339|NCT01162486|100981737|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
33296340|NCT01162486|100981738|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
33296341|NCT01162486|100981739|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
33296342|NCT01162486|100981735|FG000|Overall Study|elevated LFTs|0|||
33296343|NCT01162486|100981736|FG001|Overall Study|elevated LFTs|0|||
33296344|NCT01162486|100981737|FG002|Overall Study|elevated LFTs|1|||
33296345|NCT01162486|100981738|FG003|Overall Study|elevated LFTs|0|||
33296346|NCT01162486|100981739|FG004|Overall Study|elevated LFTs|0|||
33296347|NCT01162486|100981735|FG000|Overall Study|Pregnancy|0|||
33296348|NCT01162486|100981736|FG001|Overall Study|Pregnancy|0|||
33296349|NCT01162486|100981737|FG002|Overall Study|Pregnancy|0|||
33296350|NCT01162486|100981738|FG003|Overall Study|Pregnancy|1|||
33296351|NCT01162486|100981739|FG004|Overall Study|Pregnancy|0|||
33296352|NCT00581477|100981740|FG000|Overall Study|Physician Decision|2|||
33296353|NCT01367847|100981741|FG000|Overall Study|Withdrawal by Subject|2|||
33296354|NCT01367847|100981742|FG001|Overall Study|Withdrawal by Subject|2|||
33296355|NCT04276051|100981753|FG000|Overall Study|Lost to Follow-up|0|||
33296356|NCT04276051|100981754|FG001|Overall Study|Lost to Follow-up|1|||
33296357|NCT04276051|100981753|FG000|Overall Study|Physician Decision|0|||
33296358|NCT04276051|100981754|FG001|Overall Study|Physician Decision|1|||
33296359|NCT04276051|100981753|FG000|Overall Study|Withdrawal by Subject|1|||
33296360|NCT04276051|100981754|FG001|Overall Study|Withdrawal by Subject|1|||
33296361|NCT02808975|100981755|FG000|Overall Study|Adverse Event|3|||
33296362|NCT02808975|100981756|FG001|Overall Study|Adverse Event|4|||
33296363|NCT02808975|100981755|FG000|Overall Study|Withdrew consent|9|||
33296364|NCT02808975|100981756|FG001|Overall Study|Withdrew consent|8|||
33392730|NCT01194414|101325319|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
33392731|NCT01194414|101325320|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
33392732|NCT01194414|101325321|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
33392733|NCT01194414|101325322|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
33392734|NCT01194414|101325319|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
33392735|NCT01194414|101325320|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
33296365|NCT02808975|100981755|FG000|Overall Study|Lost to Follow-up|4|||
33296366|NCT02808975|100981756|FG001|Overall Study|Lost to Follow-up|6|||
33296367|NCT02808975|100981755|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
33189474|NCT02346240|100601434|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189475|NCT02346240|100601435|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189476|NCT02346240|100601436|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189477|NCT02346240|100601437|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189478|NCT02346240|100601438|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189479|NCT02346240|100601439|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189480|NCT02346240|100601440|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189481|NCT02346240|100601441|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
33189482|NCT02346240|100601442|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189483|NCT02346240|100601443|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189484|NCT02346240|100601444|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189485|NCT02346240|100601445|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189486|NCT02346240|100601446|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189487|NCT02346240|100601447|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189488|NCT02346240|100601448|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189489|NCT02346240|100601449|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189490|NCT02346240|100601450|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
33189491|NCT02346240|100601427|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189492|NCT02346240|100601428|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189493|NCT02346240|100601429|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189494|NCT02346240|100601430|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189495|NCT02346240|100601431|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189496|NCT02346240|100601432|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189497|NCT02346240|100601433|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189498|NCT02346240|100601434|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189499|NCT02346240|100601435|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189500|NCT02346240|100601436|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189501|NCT02346240|100601437|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189502|NCT02346240|100601438|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189503|NCT02346240|100601439|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189504|NCT02346240|100601440|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189505|NCT02346240|100601441|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
33189506|NCT02346240|100601442|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189507|NCT02346240|100601443|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189508|NCT02346240|100601444|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189509|NCT02346240|100601445|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189510|NCT02346240|100601446|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189511|NCT02346240|100601447|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189512|NCT02346240|100601448|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189513|NCT02346240|100601449|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189514|NCT02346240|100601450|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
33189515|NCT02346240|100601427|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189516|NCT02346240|100601428|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189517|NCT02346240|100601429|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189518|NCT02346240|100601430|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189519|NCT02346240|100601431|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189520|NCT02346240|100601432|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189521|NCT02346240|100601433|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189522|NCT02346240|100601434|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189523|NCT02346240|100601435|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189524|NCT02346240|100601436|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189525|NCT02346240|100601437|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189526|NCT02346240|100601438|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189527|NCT02346240|100601439|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33296368|NCT02808975|100981756|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
33296369|NCT02808975|100981755|FG000|Overall Study|Other, not specified|5|||
33296370|NCT02808975|100981756|FG001|Overall Study|Other, not specified|1|||
33296371|NCT01920477|100981760|FG000|Overall Study|Adverse Event|0|||
33296372|NCT01920477|100981761|FG001|Overall Study|Adverse Event|1|||
33296373|NCT01920477|100981760|FG000|Overall Study|Lack of Efficacy|1|||
33296374|NCT01920477|100981761|FG001|Overall Study|Lack of Efficacy|0|||
33296375|NCT01920477|100981760|FG000|Overall Study|Study closed/terminated|14|||
33296376|NCT01920477|100981761|FG001|Overall Study|Study closed/terminated|15|||
33296377|NCT01920477|100981760|FG000|Overall Study|Withdrawal by Subject|0|||
33296378|NCT01920477|100981761|FG001|Overall Study|Withdrawal by Subject|1|||
33296379|NCT01607476|100981762|FG000|Overall Study|Withdrawal by Subject|1|||
33296380|NCT01607476|100981763|FG001|Overall Study|Withdrawal by Subject|0|||
33296381|NCT01607476|100981764|FG002|Overall Study|Withdrawal by Subject|1|||
33296382|NCT01607476|100981762|FG000|Overall Study|Lost to Follow-up|0|||
33296383|NCT01607476|100981763|FG001|Overall Study|Lost to Follow-up|0|||
33296384|NCT01607476|100981764|FG002|Overall Study|Lost to Follow-up|2|||
33296385|NCT03149042|100981765|FG000|Overall Study|Invasive FFR not performed|21|||
33296386|NCT03149042|100981765|FG000|Overall Study|Poor CT Image Quality|1|||
33296387|NCT03149042|100981765|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
33296388|NCT01195623|100981770|FG000|Overall Study|Lost to Follow-up|35|||
33296389|NCT01195623|100981771|FG001|Overall Study|Lost to Follow-up|37|||
33296390|NCT04071301|100981772|FG000|Overall Study|Withdrawal by Subject|6|||
33296391|NCT04071301|100981772|FG000|Overall Study|Death|1|||
33296392|NCT00335140|100981774|FG000|Overall Study|Ineligible|1|||
33296393|NCT01747551|100981776|FG000|Overall Study|Progressive Disease|24|||
33296394|NCT01747551|100981777|FG001|Overall Study|Progressive Disease|17|||
33296395|NCT01747551|100981776|FG000|Overall Study|Death|3|||
33296396|NCT01747551|100981777|FG001|Overall Study|Death|1|||
33296397|NCT01747551|100981776|FG000|Overall Study|Adverse Event|7|||
33296398|NCT01747551|100981777|FG001|Overall Study|Adverse Event|1|||
33296399|NCT01747551|100981776|FG000|Overall Study|Prolonged Treatment Delay|2|||
33296400|NCT01747551|100981777|FG001|Overall Study|Prolonged Treatment Delay|0|||
33296401|NCT01747551|100981776|FG000|Overall Study|Withdrawal by Subject|3|||
33296402|NCT01747551|100981777|FG001|Overall Study|Withdrawal by Subject|1|||
33296403|NCT01747551|100981776|FG000|Overall Study|Physician Decision|2|||
33296404|NCT01747551|100981777|FG001|Overall Study|Physician Decision|1|||
33392736|NCT01194414|101325321|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
33392737|NCT01194414|101325322|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
33392738|NCT01194414|101325319|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
33392739|NCT01194414|101325320|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
33392740|NCT01194414|101325321|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
33392741|NCT01194414|101325322|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
33392742|NCT01194414|101325319|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
33392743|NCT01194414|101325320|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
33392744|NCT01194414|101325321|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
33392745|NCT01194414|101325322|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
33392746|NCT01194414|101325319|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
33392747|NCT01194414|101325320|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
33392748|NCT01194414|101325321|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
33392749|NCT01194414|101325322|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
33392750|NCT01194414|101325319|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
33392751|NCT01194414|101325320|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
33392752|NCT01194414|101325321|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
33392753|NCT01194414|101325322|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
33392754|NCT01194414|101325319|FG000|72 Weeks Open Label Extension|Other|2|||
33392755|NCT01194414|101325320|FG001|72 Weeks Open Label Extension|Other|1|||
33392756|NCT01194414|101325321|FG002|72 Weeks Open Label Extension|Other|0|||
33392757|NCT01194414|101325322|FG003|72 Weeks Open Label Extension|Other|0|||
33392758|NCT01194414|101325319|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
33392759|NCT01194414|101325320|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
33392760|NCT01194414|101325321|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
33392761|NCT01194414|101325322|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
33392762|NCT01194414|101325319|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
33392763|NCT01194414|101325320|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
33392764|NCT01194414|101325321|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
33296405|NCT01747551|100981776|FG000|Overall Study|Other|2|||
33296406|NCT01747551|100981777|FG001|Overall Study|Other|0|||
33296407|NCT03406078|100981783|FG000|Overall Study|Death|1|||
33296408|NCT03406078|100981784|FG001|Overall Study|Death|0|||
33296409|NCT03406078|100981783|FG000|Overall Study|Lost to Follow-up|0|||
33296410|NCT03406078|100981784|FG001|Overall Study|Lost to Follow-up|1|||
33296411|NCT03406078|100981783|FG000|Overall Study|Withdrawal by Subject|5|||
33296412|NCT03406078|100981784|FG001|Overall Study|Withdrawal by Subject|2|||
33296413|NCT00078338|100981785|FG000|Overall Study|Adverse Event|31|||
33296414|NCT00078338|100981786|FG001|Overall Study|Adverse Event|24|||
33392765|NCT01194414|101325322|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
33392766|NCT01194414|101325319|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
33392767|NCT01194414|101325320|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
33392768|NCT01194414|101325321|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
33392769|NCT01194414|101325322|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
33392770|NCT01194414|101325319|FG000|72 Weeks Open Label Extension|Death|1|||
33392771|NCT01194414|101325320|FG001|72 Weeks Open Label Extension|Death|2|||
33392772|NCT01194414|101325321|FG002|72 Weeks Open Label Extension|Death|0|||
33392773|NCT01194414|101325322|FG003|72 Weeks Open Label Extension|Death|2|||
33392774|NCT04624672|101325329|FG000|Overall Study|Early Study Closure|2|||
33392775|NCT04624672|101325330|FG001|Overall Study|Early Study Closure|1|||
33392776|NCT00511108|101325331|FG000|Overall Study|Adverse Event|2|||
33392777|NCT00511108|101325332|FG001|Overall Study|Adverse Event|0|||
33392778|NCT00511108|101325333|FG002|Overall Study|Adverse Event|1|||
33392779|NCT00511108|101325334|FG003|Overall Study|Adverse Event|2|||
33392780|NCT00511108|101325331|FG000|Overall Study|Lost to Follow-up|0|||
33392781|NCT00511108|101325332|FG001|Overall Study|Lost to Follow-up|2|||
33392782|NCT00511108|101325333|FG002|Overall Study|Lost to Follow-up|1|||
33392783|NCT00511108|101325334|FG003|Overall Study|Lost to Follow-up|0|||
33392784|NCT00511108|101325331|FG000|Overall Study|Physician Decision|0|||
33392785|NCT00511108|101325332|FG001|Overall Study|Physician Decision|0|||
33392786|NCT00511108|101325333|FG002|Overall Study|Physician Decision|0|||
33392787|NCT00511108|101325334|FG003|Overall Study|Physician Decision|1|||
33392788|NCT00511108|101325331|FG000|Overall Study|Withdrawal by Subject|4|||
33392789|NCT00511108|101325332|FG001|Overall Study|Withdrawal by Subject|0|||
33392790|NCT00511108|101325333|FG002|Overall Study|Withdrawal by Subject|3|||
33392791|NCT00511108|101325334|FG003|Overall Study|Withdrawal by Subject|2|||
33392792|NCT02465489|101325335|FG000|Overall Study|Adverse Event|5|||
33392793|NCT00887068|101325336|FG000|Overall Study|Withdrawal by Subject|2|||
33392794|NCT00887068|101325337|FG001|Overall Study|Withdrawal by Subject|0|||
33392795|NCT00887068|101325336|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
33392796|NCT00887068|101325337|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
33296415|NCT00078338|100981785|FG000|Overall Study|Lost to Follow-up|17|||
33296416|NCT00078338|100981786|FG001|Overall Study|Lost to Follow-up|2|||
33296417|NCT00078338|100981785|FG000|Overall Study|Protocol Violation|2|||
33296418|NCT00078338|100981786|FG001|Overall Study|Protocol Violation|2|||
33296419|NCT00078338|100981785|FG000|Overall Study|Disease Progression|4|||
33296420|NCT00078338|100981786|FG001|Overall Study|Disease Progression|7|||
33296421|NCT00078338|100981785|FG000|Overall Study|Other|28|||
33296422|NCT00078338|100981786|FG001|Overall Study|Other|16|||
33296423|NCT00078338|100981785|FG000|Overall Study|Subjects randomized, but not treated|3|||
33296424|NCT00078338|100981786|FG001|Overall Study|Subjects randomized, but not treated|3|||
33296425|NCT01031628|100981787|FG000|Overall Study|Study terminated early|0|||
33296426|NCT01031628|100981788|FG001|Overall Study|Study terminated early|1|||
33296427|NCT01031628|100981789|FG002|Overall Study|Study terminated early|3|||
33296428|NCT01031628|100981790|FG003|Overall Study|Study terminated early|0|||
33296429|NCT00945672|100981791|FG000|Overall Study|Withdrawal by Subject|0|||
33296430|NCT00945672|100981792|FG001|Overall Study|Withdrawal by Subject|0|||
33296431|NCT00945672|100981793|FG002|Overall Study|Withdrawal by Subject|0|||
33296432|NCT00945672|100981794|FG003|Overall Study|Withdrawal by Subject|1|||
33296433|NCT01008553|100981795|FG000|Period 1 (Titration Period)|Physician Decision|2|||
33296434|NCT01008553|100981796|FG001|Period 1 (Titration Period)|Physician Decision|0|||
33296435|NCT01008553|100981797|FG002|Period 1 (Titration Period)|Physician Decision|0|||
33296436|NCT01008553|100981795|FG000|Period 1 (Titration Period)|Adverse Event|33|||
33296437|NCT01008553|100981796|FG001|Period 1 (Titration Period)|Adverse Event|0|||
33296438|NCT01008553|100981797|FG002|Period 1 (Titration Period)|Adverse Event|0|||
33296439|NCT01008553|100981795|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
33296440|NCT01008553|100981796|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
33296441|NCT01008553|100981797|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
33296442|NCT01008553|100981795|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
33296443|NCT01008553|100981796|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
33392797|NCT02109744|101325338|FG000|Overall Study|Death|1|||
33392798|NCT02109744|101325339|FG001|Overall Study|Death|1|||
33392799|NCT02109744|101325338|FG000|Overall Study|no marrow exam|1|||
33392800|NCT02109744|101325339|FG001|Overall Study|no marrow exam|0|||
33392801|NCT00479167|101325344|FG000|Overall Study|Withdrawal by Subject|1|||
33392802|NCT00369278|101325350|FG000|Overall Study|Adverse Event|14|||
33296444|NCT01008553|100981797|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
33296445|NCT01008553|100981795|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
33392803|NCT00369278|101325351|FG001|Overall Study|Adverse Event|11|||
33392804|NCT00369278|101325350|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33392805|NCT00369278|101325351|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
33392806|NCT00369278|101325350|FG000|Overall Study|Protocol Violation|2|||
33392807|NCT00369278|101325351|FG001|Overall Study|Protocol Violation|1|||
33392808|NCT00369278|101325350|FG000|Overall Study|Withdrawal by Subject|2|||
33296446|NCT01008553|100981796|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
33296447|NCT01008553|100981797|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
33296448|NCT01008553|100981795|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
33296449|NCT01008553|100981796|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
33296450|NCT01008553|100981797|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
33296451|NCT01008553|100981795|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
33296452|NCT01008553|100981796|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
33296453|NCT01008553|100981797|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
33296454|NCT01008553|100981795|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
33296455|NCT01008553|100981796|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
33296456|NCT01008553|100981797|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
33296457|NCT01008553|100981795|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
33296458|NCT01008553|100981796|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
33296459|NCT01008553|100981797|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
33296460|NCT01008553|100981795|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
33392809|NCT00369278|101325351|FG001|Overall Study|Withdrawal by Subject|2|||
33189528|NCT02346240|100601440|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33392810|NCT00369278|101325350|FG000|Overall Study|Lost to Follow-up|1|||
33392811|NCT00369278|101325351|FG001|Overall Study|Lost to Follow-up|0|||
33189529|NCT02346240|100601441|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189530|NCT02346240|100601442|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189531|NCT02346240|100601443|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
33189532|NCT02346240|100601444|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
33189533|NCT02346240|100601445|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
33189534|NCT02346240|100601446|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
33189535|NCT02346240|100601447|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
33189536|NCT02346240|100601448|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
33189537|NCT02346240|100601449|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
33189538|NCT02346240|100601450|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
33189539|NCT02346240|100601427|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189540|NCT02346240|100601428|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189541|NCT02346240|100601429|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189542|NCT02346240|100601430|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189543|NCT02346240|100601431|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189544|NCT02346240|100601432|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189545|NCT02346240|100601433|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189546|NCT02346240|100601434|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189547|NCT02346240|100601435|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189548|NCT02346240|100601436|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189549|NCT02346240|100601437|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189550|NCT02346240|100601438|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189551|NCT02346240|100601439|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189552|NCT02346240|100601440|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189553|NCT02346240|100601441|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189554|NCT02346240|100601442|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189555|NCT02346240|100601443|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189556|NCT02346240|100601444|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189557|NCT02346240|100601445|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
33296461|NCT01008553|100981796|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
33392812|NCT00369278|101325350|FG000|Overall Study|Graft loss|1|||
33392813|NCT00369278|101325351|FG001|Overall Study|Graft loss|2|||
33392814|NCT04539262|101325352|FG000|Overall Study|Adverse Event|0|||
33392815|NCT04539262|101325353|FG001|Overall Study|Adverse Event|0|||
33392816|NCT04539262|101325354|FG002|Overall Study|Adverse Event|1|||
33392817|NCT04539262|101325355|FG003|Overall Study|Adverse Event|0|||
33392818|NCT04539262|101325356|FG004|Overall Study|Adverse Event|0|||
33189558|NCT02346240|100601446|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
33189559|NCT02346240|100601447|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189560|NCT02346240|100601448|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
33189561|NCT02346240|100601449|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189562|NCT02346240|100601450|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
33189563|NCT02346240|100601427|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189564|NCT02346240|100601428|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189565|NCT02346240|100601429|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189566|NCT02346240|100601430|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189567|NCT02346240|100601431|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189568|NCT02346240|100601432|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189569|NCT02346240|100601433|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33392819|NCT04539262|101325357|FG005|Overall Study|Adverse Event|0|||
33392820|NCT04539262|101325358|FG006|Overall Study|Adverse Event|0|||
33392821|NCT04539262|101325359|FG007|Overall Study|Adverse Event|0|||
33392822|NCT04539262|101325352|FG000|Overall Study|Withdrew Consent|0|||
33392823|NCT04539262|101325353|FG001|Overall Study|Withdrew Consent|0|||
33392824|NCT04539262|101325354|FG002|Overall Study|Withdrew Consent|0|||
33392825|NCT04539262|101325355|FG003|Overall Study|Withdrew Consent|1|||
33392826|NCT04539262|101325356|FG004|Overall Study|Withdrew Consent|0|||
33392827|NCT04539262|101325357|FG005|Overall Study|Withdrew Consent|0|||
33392828|NCT04539262|101325358|FG006|Overall Study|Withdrew Consent|0|||
33189570|NCT02346240|100601434|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189571|NCT02346240|100601435|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33392829|NCT04539262|101325359|FG007|Overall Study|Withdrew Consent|0|||
33392830|NCT04539262|101325352|FG000|Overall Study|Randomized, Not treated|0|||
33392831|NCT04539262|101325353|FG001|Overall Study|Randomized, Not treated|1|||
33392832|NCT04539262|101325354|FG002|Overall Study|Randomized, Not treated|0|||
33392833|NCT04539262|101325355|FG003|Overall Study|Randomized, Not treated|0|||
33392834|NCT04539262|101325356|FG004|Overall Study|Randomized, Not treated|0|||
33392835|NCT04539262|101325357|FG005|Overall Study|Randomized, Not treated|0|||
33392836|NCT04539262|101325358|FG006|Overall Study|Randomized, Not treated|1|||
33189572|NCT02346240|100601436|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189573|NCT02346240|100601437|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189574|NCT02346240|100601438|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189575|NCT02346240|100601439|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189576|NCT02346240|100601440|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189577|NCT02346240|100601441|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189578|NCT02346240|100601442|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189579|NCT02346240|100601443|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189580|NCT02346240|100601444|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189581|NCT02346240|100601445|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
33189582|NCT02346240|100601446|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189583|NCT02346240|100601447|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189584|NCT02346240|100601448|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
33189585|NCT02346240|100601449|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189586|NCT02346240|100601450|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33189587|NCT02346240|100601427|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189588|NCT02346240|100601428|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189589|NCT02346240|100601429|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189590|NCT02346240|100601430|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189591|NCT02346240|100601431|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189592|NCT02346240|100601432|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189593|NCT02346240|100601433|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189594|NCT02346240|100601434|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33296462|NCT01008553|100981797|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
33296463|NCT01008553|100981795|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
33296464|NCT01008553|100981796|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
33296465|NCT01008553|100981797|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
33296466|NCT01008553|100981795|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
33296467|NCT01008553|100981796|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
33296468|NCT01008553|100981797|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
33296469|NCT01008553|100981795|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
33296470|NCT01008553|100981796|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
33296471|NCT01008553|100981797|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
33296472|NCT01008553|100981795|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
33296473|NCT01008553|100981796|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
33296474|NCT01008553|100981797|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
33296475|NCT00264303|100981799|FG000|Overall Study|Adverse Event|4|||
33296476|NCT00264303|100981800|FG001|Overall Study|Adverse Event|3|||
33296477|NCT00264303|100981799|FG000|Overall Study|Lack of Efficacy|10|||
33296478|NCT00264303|100981800|FG001|Overall Study|Lack of Efficacy|13|||
33296479|NCT00264303|100981799|FG000|Overall Study|Lost to Follow-up|3|||
33296480|NCT00264303|100981800|FG001|Overall Study|Lost to Follow-up|3|||
33296481|NCT00264303|100981799|FG000|Overall Study|Withdrawal by Subject|2|||
33296482|NCT00264303|100981800|FG001|Overall Study|Withdrawal by Subject|3|||
33392837|NCT04539262|101325359|FG007|Overall Study|Randomized, Not treated|0|||
33189595|NCT02346240|100601435|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33392838|NCT01641081|101325360|FG000|Period 1|Sponsor request (potential unblinding)|0|||
33392839|NCT01641081|101325361|FG001|Period 1|Sponsor request (potential unblinding)|0|||
33392840|NCT01641081|101325362|FG002|Period 1|Sponsor request (potential unblinding)|0|||
33296483|NCT00264303|100981799|FG000|Overall Study|Various reasons listed in study report|6|||
33296484|NCT00264303|100981800|FG001|Overall Study|Various reasons listed in study report|7|||
33296485|NCT02878603|100981801|FG000|Overall Study|Lost to Follow-up|4|||
33296486|NCT02878603|100981802|FG001|Overall Study|Lost to Follow-up|1|||
33296487|NCT02878603|100981801|FG000|Overall Study|Withdrawal by Subject|1|||
33296488|NCT02878603|100981802|FG001|Overall Study|Withdrawal by Subject|1|||
33296489|NCT02878603|100981801|FG000|Overall Study|Death|1|||
33296490|NCT02878603|100981802|FG001|Overall Study|Death|0|||
33296491|NCT02878603|100981801|FG000|Overall Study|Physician Decision|0|||
33296492|NCT02878603|100981802|FG001|Overall Study|Physician Decision|3|||
33296493|NCT00680992|100981804|FG000|Overall Study|Complete Resection (as per protocol)|25|||
33296494|NCT00680992|100981805|FG001|Overall Study|Complete Resection (as per protocol)|121|||
33296495|NCT00680992|100981806|FG002|Overall Study|Complete Resection (as per protocol)|0|||
33296496|NCT00680992|100981804|FG000|Overall Study|Administrative Decision|83|||
33296497|NCT00680992|100981805|FG001|Overall Study|Administrative Decision|42|||
33296498|NCT00680992|100981806|FG002|Overall Study|Administrative Decision|5|||
33296499|NCT00680992|100981804|FG000|Overall Study|End of Trial|32|||
33296500|NCT00680992|100981805|FG001|Overall Study|End of Trial|12|||
33296501|NCT00680992|100981806|FG002|Overall Study|End of Trial|3|||
33296502|NCT00680992|100981804|FG000|Overall Study|Withdrawal by Subject|33|||
33296503|NCT00680992|100981805|FG001|Overall Study|Withdrawal by Subject|11|||
33296504|NCT00680992|100981806|FG002|Overall Study|Withdrawal by Subject|1|||
33189596|NCT02346240|100601436|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33296505|NCT00680992|100981804|FG000|Overall Study|Adverse Event|21|||
33296506|NCT00680992|100981805|FG001|Overall Study|Adverse Event|19|||
33296507|NCT00680992|100981806|FG002|Overall Study|Adverse Event|1|||
33296508|NCT00680992|100981804|FG000|Overall Study|Other|19|||
33296509|NCT00680992|100981805|FG001|Overall Study|Other|14|||
33296510|NCT00680992|100981806|FG002|Overall Study|Other|1|||
33296511|NCT00680992|100981804|FG000|Overall Study|Disease Progression|21|||
33296512|NCT00680992|100981805|FG001|Overall Study|Disease Progression|9|||
33296513|NCT00680992|100981806|FG002|Overall Study|Disease Progression|0|||
33296514|NCT00680992|100981804|FG000|Overall Study|Lost to Follow-up|12|||
33296515|NCT00680992|100981805|FG001|Overall Study|Lost to Follow-up|14|||
33296516|NCT00680992|100981806|FG002|Overall Study|Lost to Follow-up|0|||
33296517|NCT00680992|100981804|FG000|Overall Study|Noncompliance|4|||
33296518|NCT00680992|100981805|FG001|Overall Study|Noncompliance|6|||
33296519|NCT00680992|100981806|FG002|Overall Study|Noncompliance|0|||
33296520|NCT00680992|100981804|FG000|Overall Study|Requirement for Alternative Therapy|8|||
33296521|NCT00680992|100981805|FG001|Overall Study|Requirement for Alternative Therapy|2|||
33296522|NCT00680992|100981806|FG002|Overall Study|Requirement for Alternative Therapy|0|||
33296523|NCT00680992|100981804|FG000|Overall Study|Pregnancy|5|||
33296524|NCT00680992|100981805|FG001|Overall Study|Pregnancy|0|||
33296525|NCT00680992|100981806|FG002|Overall Study|Pregnancy|1|||
33296526|NCT00680992|100981804|FG000|Overall Study|Death|5|||
33296527|NCT00680992|100981805|FG001|Overall Study|Death|1|||
33296528|NCT00680992|100981806|FG002|Overall Study|Death|0|||
33296529|NCT00680992|100981804|FG000|Overall Study|Ineligibility Determined|0|||
33296530|NCT00680992|100981805|FG001|Overall Study|Ineligibility Determined|1|||
33392841|NCT01641081|101325363|FG003|Period 1|Sponsor request (potential unblinding)|0|||
33392842|NCT01641081|101325364|FG004|Period 1|Sponsor request (potential unblinding)|0|||
33392843|NCT01641081|101325365|FG005|Period 1|Sponsor request (potential unblinding)|0|||
33392844|NCT01641081|101325366|FG006|Period 1|Sponsor request (potential unblinding)|1|||
33392845|NCT01641081|101325367|FG007|Period 1|Sponsor request (potential unblinding)|0|||
33392846|NCT01641081|101325368|FG008|Period 1|Sponsor request (potential unblinding)|0|||
33392847|NCT01641081|101325369|FG009|Period 1|Sponsor request (potential unblinding)|0|||
33392848|NCT01641081|101325360|FG000|Period 1|Protocol Violation|0|||
33392849|NCT01641081|101325361|FG001|Period 1|Protocol Violation|0|||
33392850|NCT01641081|101325362|FG002|Period 1|Protocol Violation|0|||
33392851|NCT01641081|101325363|FG003|Period 1|Protocol Violation|0|||
33392852|NCT01641081|101325364|FG004|Period 1|Protocol Violation|1|||
33392853|NCT01641081|101325365|FG005|Period 1|Protocol Violation|0|||
33392854|NCT01641081|101325366|FG006|Period 1|Protocol Violation|0|||
33392855|NCT01641081|101325367|FG007|Period 1|Protocol Violation|1|||
33392856|NCT01641081|101325368|FG008|Period 1|Protocol Violation|0|||
33392857|NCT01641081|101325369|FG009|Period 1|Protocol Violation|0|||
33392858|NCT01641081|101325360|FG000|Period 1|Adverse Event|1|||
33392859|NCT01641081|101325361|FG001|Period 1|Adverse Event|0|||
33392860|NCT01641081|101325362|FG002|Period 1|Adverse Event|0|||
33392861|NCT01641081|101325363|FG003|Period 1|Adverse Event|0|||
33392862|NCT01641081|101325364|FG004|Period 1|Adverse Event|0|||
33392863|NCT01641081|101325365|FG005|Period 1|Adverse Event|0|||
33392864|NCT01641081|101325366|FG006|Period 1|Adverse Event|0|||
33296531|NCT00680992|100981806|FG002|Overall Study|Ineligibility Determined|0|||
33296532|NCT01200290|100981811|FG000|Treatment Period|Adverse Event|1|||
33364906|NCT00077623|101223678|FG001|Overall Study|Failure to return|0|||
33392865|NCT01641081|101325367|FG007|Period 1|Adverse Event|2|||
33392866|NCT01641081|101325368|FG008|Period 1|Adverse Event|0|||
33392867|NCT01641081|101325369|FG009|Period 1|Adverse Event|0|||
33392868|NCT01641081|101325360|FG000|Period 2|Adverse Event|0|||
33392869|NCT01641081|101325361|FG001|Period 2|Adverse Event|0|||
33392870|NCT01641081|101325362|FG002|Period 2|Adverse Event|0|||
33392871|NCT01641081|101325363|FG003|Period 2|Adverse Event|0|||
33392872|NCT01641081|101325364|FG004|Period 2|Adverse Event|0|||
33392873|NCT01641081|101325365|FG005|Period 2|Adverse Event|1|||
33392874|NCT01641081|101325366|FG006|Period 2|Adverse Event|0|||
33392875|NCT01641081|101325367|FG007|Period 2|Adverse Event|0|||
33392876|NCT01641081|101325368|FG008|Period 2|Adverse Event|0|||
33392877|NCT01641081|101325369|FG009|Period 2|Adverse Event|0|||
33392878|NCT01641081|101325360|FG000|Period 2|Withdrawal by Subject|0|||
33392879|NCT01641081|101325361|FG001|Period 2|Withdrawal by Subject|0|||
33392880|NCT01641081|101325362|FG002|Period 2|Withdrawal by Subject|0|||
33392881|NCT01641081|101325363|FG003|Period 2|Withdrawal by Subject|1|||
33392882|NCT01641081|101325364|FG004|Period 2|Withdrawal by Subject|0|||
33392883|NCT01641081|101325365|FG005|Period 2|Withdrawal by Subject|0|||
33392884|NCT01641081|101325366|FG006|Period 2|Withdrawal by Subject|2|||
33392885|NCT01641081|101325367|FG007|Period 2|Withdrawal by Subject|0|||
33392886|NCT01641081|101325368|FG008|Period 2|Withdrawal by Subject|0|||
33392887|NCT01641081|101325369|FG009|Period 2|Withdrawal by Subject|0|||
33392888|NCT01641081|101325360|FG000|Period 2|Protocol Violation|1|||
33392889|NCT01641081|101325361|FG001|Period 2|Protocol Violation|0|||
33392890|NCT01641081|101325362|FG002|Period 2|Protocol Violation|0|||
33392891|NCT01641081|101325363|FG003|Period 2|Protocol Violation|0|||
33392892|NCT01641081|101325364|FG004|Period 2|Protocol Violation|0|||
33392893|NCT01641081|101325365|FG005|Period 2|Protocol Violation|0|||
33392894|NCT01641081|101325366|FG006|Period 2|Protocol Violation|0|||
33392895|NCT01641081|101325367|FG007|Period 2|Protocol Violation|0|||
33392896|NCT01641081|101325368|FG008|Period 2|Protocol Violation|0|||
33189597|NCT02346240|100601437|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33392897|NCT01641081|101325369|FG009|Period 2|Protocol Violation|0|||
33392898|NCT01641081|101325360|FG000|Period 3|Adverse Event|0|||
33392899|NCT01641081|101325361|FG001|Period 3|Adverse Event|0|||
33392900|NCT01641081|101325362|FG002|Period 3|Adverse Event|1|||
33189598|NCT02346240|100601438|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189599|NCT02346240|100601439|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189600|NCT02346240|100601440|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189601|NCT02346240|100601441|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189602|NCT02346240|100601442|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189603|NCT02346240|100601443|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33296533|NCT01200290|100981811|FG000|Post-Treatment Follow-Up Period|Death|2|||
33296534|NCT00953615|100981815|FG000|Overall Study|Adverse Event|1|||
33296535|NCT01252355|100981817|FG000|Overall Study|Adverse Event|9|||
33296536|NCT01252355|100981818|FG001|Overall Study|Adverse Event|17|||
33296537|NCT01252355|100981819|FG002|Overall Study|Adverse Event|22|||
33296538|NCT01252355|100981817|FG000|Overall Study|Lack of Efficacy|6|||
33296539|NCT01252355|100981818|FG001|Overall Study|Lack of Efficacy|4|||
33296540|NCT01252355|100981819|FG002|Overall Study|Lack of Efficacy|2|||
33296541|NCT01252355|100981817|FG000|Overall Study|Lost to Follow-up|0|||
33296542|NCT01252355|100981818|FG001|Overall Study|Lost to Follow-up|0|||
33296543|NCT01252355|100981819|FG002|Overall Study|Lost to Follow-up|1|||
33296544|NCT01252355|100981817|FG000|Overall Study|Poor Compliance to Protocol|1|||
33296545|NCT01252355|100981818|FG001|Overall Study|Poor Compliance to Protocol|1|||
33296546|NCT01252355|100981819|FG002|Overall Study|Poor Compliance to Protocol|1|||
33296547|NCT01252355|100981817|FG000|Overall Study|Progressive Disease|2|||
33296548|NCT01252355|100981818|FG001|Overall Study|Progressive Disease|0|||
33296549|NCT01252355|100981819|FG002|Overall Study|Progressive Disease|0|||
33296550|NCT01252355|100981817|FG000|Overall Study|Sponsor Early Termination of Study|149|||
33296551|NCT01252355|100981818|FG001|Overall Study|Sponsor Early Termination of Study|149|||
33296552|NCT01252355|100981819|FG002|Overall Study|Sponsor Early Termination of Study|146|||
33296553|NCT01252355|100981817|FG000|Overall Study|Randomized but not Treated|2|||
33296554|NCT01252355|100981818|FG001|Overall Study|Randomized but not Treated|0|||
33296555|NCT01252355|100981819|FG002|Overall Study|Randomized but not Treated|0|||
33296556|NCT01252355|100981817|FG000|Overall Study|Other Than Above|8|||
33392901|NCT01641081|101325363|FG003|Period 3|Adverse Event|0|||
33392902|NCT01641081|101325364|FG004|Period 3|Adverse Event|0|||
33392903|NCT01641081|101325365|FG005|Period 3|Adverse Event|0|||
33392904|NCT01641081|101325366|FG006|Period 3|Adverse Event|0|||
33392905|NCT01641081|101325367|FG007|Period 3|Adverse Event|0|||
33392906|NCT01641081|101325368|FG008|Period 3|Adverse Event|0|||
33392907|NCT01641081|101325369|FG009|Period 3|Adverse Event|0|||
33392908|NCT01641081|101325360|FG000|Period 3|Withdrawal by Subject|0|||
33296557|NCT01252355|100981818|FG001|Overall Study|Other Than Above|7|||
33296558|NCT01252355|100981819|FG002|Overall Study|Other Than Above|7|||
33392909|NCT01641081|101325361|FG001|Period 3|Withdrawal by Subject|0|||
33392910|NCT01641081|101325362|FG002|Period 3|Withdrawal by Subject|0|||
33392911|NCT01641081|101325363|FG003|Period 3|Withdrawal by Subject|0|||
33392912|NCT01641081|101325364|FG004|Period 3|Withdrawal by Subject|0|||
33392913|NCT01641081|101325365|FG005|Period 3|Withdrawal by Subject|0|||
33392914|NCT01641081|101325366|FG006|Period 3|Withdrawal by Subject|0|||
33392915|NCT01641081|101325367|FG007|Period 3|Withdrawal by Subject|0|||
33392916|NCT01641081|101325368|FG008|Period 3|Withdrawal by Subject|1|||
33392917|NCT01641081|101325369|FG009|Period 3|Withdrawal by Subject|0|||
33392918|NCT01641081|101325360|FG000|Period 4|Adverse Event|0|||
33392919|NCT01641081|101325361|FG001|Period 4|Adverse Event|1|||
33189604|NCT02346240|100601444|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33296559|NCT02737826|100981822|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
33296560|NCT02737826|100981823|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
33296561|NCT02737826|100981824|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
33296562|NCT02525692|100981825|FG000|Overall Study|Withdrawal by Subject|1|||
33296563|NCT02525692|100981826|FG001|Overall Study|Withdrawal by Subject|1|||
33296564|NCT02525692|100981827|FG002|Overall Study|Withdrawal by Subject|0|||
33296565|NCT02525692|100981828|FG003|Overall Study|Withdrawal by Subject|5|||
33296566|NCT02525692|100981829|FG004|Overall Study|Withdrawal by Subject|0|||
33296567|NCT02525692|100981830|FG005|Overall Study|Withdrawal by Subject|1|||
33296568|NCT02525692|100981825|FG000|Overall Study|Death|16|||
33296569|NCT02525692|100981826|FG001|Overall Study|Death|18|||
33296570|NCT02525692|100981827|FG002|Overall Study|Death|7|||
33296571|NCT02525692|100981828|FG003|Overall Study|Death|20|||
33296572|NCT02525692|100981829|FG004|Overall Study|Death|3|||
33296573|NCT02525692|100981830|FG005|Overall Study|Death|6|||
33296574|NCT02525692|100981825|FG000|Overall Study|Lost to Follow-up|0|||
33296575|NCT02525692|100981826|FG001|Overall Study|Lost to Follow-up|0|||
33296576|NCT02525692|100981827|FG002|Overall Study|Lost to Follow-up|1|||
33296577|NCT02525692|100981828|FG003|Overall Study|Lost to Follow-up|5|||
33296578|NCT02525692|100981829|FG004|Overall Study|Lost to Follow-up|0|||
33296579|NCT02525692|100981830|FG005|Overall Study|Lost to Follow-up|0|||
33296580|NCT01294436|100981831|FG000|Overall Study|Adverse Event|10|||
33296581|NCT01294436|100981832|FG001|Overall Study|Adverse Event|17|||
33296582|NCT01294436|100981831|FG000|Overall Study|Withdrawal by Subject|11|||
33296583|NCT01294436|100981832|FG001|Overall Study|Withdrawal by Subject|28|||
33296584|NCT01294436|100981831|FG000|Overall Study|subject no longer meets study criteria|5|||
33296585|NCT01294436|100981832|FG001|Overall Study|subject no longer meets study criteria|20|||
33296586|NCT01294436|100981831|FG000|Overall Study|poor/non-compliance|2|||
33296587|NCT01294436|100981832|FG001|Overall Study|poor/non-compliance|5|||
33296588|NCT03519204|100981838|FG000|Overall Study|Lost to Follow-up|3|||
33296589|NCT03519204|100981839|FG001|Overall Study|Lost to Follow-up|8|||
33296590|NCT03519204|100981838|FG000|Overall Study|Withdrawal by Subject|9|||
33296591|NCT03519204|100981839|FG001|Overall Study|Withdrawal by Subject|7|||
33296592|NCT03519204|100981838|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33296593|NCT03519204|100981839|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33296594|NCT01987895|100981840|FG000|Overall Study|Withdrawal by Subject|12|||
33296595|NCT01987895|100981841|FG001|Overall Study|Withdrawal by Subject|7|||
33296596|NCT01987895|100981840|FG000|Overall Study|Physician Decision|8|||
33296597|NCT01987895|100981841|FG001|Overall Study|Physician Decision|10|||
33296598|NCT01987895|100981840|FG000|Overall Study|Death|7|||
33296599|NCT01987895|100981841|FG001|Overall Study|Death|7|||
33296600|NCT01987895|100981840|FG000|Overall Study|Lost to Follow-up|3|||
33296601|NCT01987895|100981841|FG001|Overall Study|Lost to Follow-up|5|||
33296602|NCT01987895|100981840|FG000|Overall Study|randomized before giving IC|0|||
33296603|NCT01987895|100981841|FG001|Overall Study|randomized before giving IC|1|||
33296604|NCT01294397|100981842|FG000|Overall Study|Withdrawal by Subject|1|||
33296605|NCT01294397|100981842|FG000|Overall Study|Administrative Decision|1|||
33296606|NCT01782690|100981845|FG000|Overall Study|Not reported|7|||
33296607|NCT01782690|100981845|FG000|Overall Study|Toxicity of gemcitabine|1|||
33296608|NCT01782690|100981845|FG000|Overall Study|Toxicity of erlotinib|1|||
33296609|NCT01782690|100981845|FG000|Overall Study|Lost to Follow-up|31|||
33392920|NCT01641081|101325362|FG002|Period 4|Adverse Event|0|||
33392921|NCT01641081|101325363|FG003|Period 4|Adverse Event|1|||
33392922|NCT01641081|101325364|FG004|Period 4|Adverse Event|0|||
33392923|NCT01641081|101325365|FG005|Period 4|Adverse Event|0|||
33392924|NCT01641081|101325366|FG006|Period 4|Adverse Event|0|||
33392925|NCT01641081|101325367|FG007|Period 4|Adverse Event|0|||
33392926|NCT01641081|101325368|FG008|Period 4|Adverse Event|0|||
33392927|NCT01641081|101325369|FG009|Period 4|Adverse Event|0|||
33392928|NCT01641081|101325360|FG000|Period 5|Adverse Event|0|||
33392929|NCT01641081|101325361|FG001|Period 5|Adverse Event|0|||
33392930|NCT01641081|101325362|FG002|Period 5|Adverse Event|2|||
33189605|NCT02346240|100601445|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33296610|NCT01782690|100981845|FG000|Overall Study|Withdrawal of informed consent|2|||
33296611|NCT01782690|100981845|FG000|Overall Study|Absent rash|9|||
33296612|NCT01782690|100981845|FG000|Overall Study|Physician Decision|13|||
33296613|NCT01782690|100981845|FG000|Overall Study|Patient's wish|21|||
33296614|NCT01782690|100981845|FG000|Overall Study|Tumor progression|74|||
33296615|NCT01782690|100981845|FG000|Overall Study|Death|133|||
33392931|NCT01641081|101325363|FG003|Period 5|Adverse Event|0|||
33392932|NCT01641081|101325364|FG004|Period 5|Adverse Event|0|||
33392933|NCT01641081|101325365|FG005|Period 5|Adverse Event|0|||
33392934|NCT01641081|101325366|FG006|Period 5|Adverse Event|0|||
33392935|NCT01641081|101325367|FG007|Period 5|Adverse Event|0|||
33392936|NCT01641081|101325368|FG008|Period 5|Adverse Event|0|||
33296616|NCT01782690|100981845|FG000|Overall Study|Study completion unknown|7|||
33296617|NCT02807883|100981849|FG000|Overall Study|Withdrawal by Subject|2|||
33296618|NCT03057847|100981850|FG000|Overall Study|Lost to Follow-up|16|||
33296619|NCT00487825|100981851|FG000|Overall Study|Adverse Event|2|||
33296620|NCT00487825|100981852|FG001|Overall Study|Adverse Event|2|||
33296621|NCT00487825|100981851|FG000|Overall Study|Lack of Efficacy|1|||
33296622|NCT00487825|100981852|FG001|Overall Study|Lack of Efficacy|1|||
33296623|NCT00487825|100981851|FG000|Overall Study|Other|3|||
33296624|NCT00487825|100981852|FG001|Overall Study|Other|2|||
33296625|NCT02389764|100981854|FG000|Overall Study|Lack of Efficacy|9|||
33296626|NCT03853551|100981860|FG000|Overall Study|Death|2|||
33296627|NCT03853551|100981860|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
33296628|NCT01261000|100981861|FG000|Overall Study|Screen failure|1|||
33296629|NCT01305408|100981862|FG000|Overall Study|Adverse Event|10|||
33296630|NCT01305408|100981863|FG001|Overall Study|Adverse Event|7|||
33296631|NCT01305408|100981862|FG000|Overall Study|Lack of Efficacy|3|||
33189606|NCT02346240|100601446|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189607|NCT02346240|100601447|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189608|NCT02346240|100601448|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
33189609|NCT02346240|100601449|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189610|NCT02346240|100601450|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
33189611|NCT02346240|100601427|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189612|NCT02346240|100601428|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189613|NCT02346240|100601429|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189614|NCT02346240|100601430|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189615|NCT02346240|100601431|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189616|NCT02346240|100601432|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189617|NCT02346240|100601433|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189618|NCT02346240|100601434|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189619|NCT02346240|100601435|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189620|NCT02346240|100601436|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189621|NCT02346240|100601437|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189622|NCT02346240|100601438|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189623|NCT02346240|100601439|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189624|NCT02346240|100601440|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189625|NCT02346240|100601441|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189626|NCT02346240|100601442|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189627|NCT02346240|100601443|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189628|NCT02346240|100601444|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
33189629|NCT02346240|100601445|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
33189630|NCT02346240|100601446|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
33189631|NCT02346240|100601447|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33189632|NCT02346240|100601448|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
33189633|NCT02346240|100601449|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
33189634|NCT02346240|100601450|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
33189635|NCT02346240|100601427|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189636|NCT02346240|100601428|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189637|NCT02346240|100601429|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189638|NCT02346240|100601430|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189639|NCT02346240|100601431|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189640|NCT02346240|100601432|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189641|NCT02346240|100601433|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189642|NCT02346240|100601434|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189643|NCT02346240|100601435|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189644|NCT02346240|100601436|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189645|NCT02346240|100601437|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33296632|NCT01305408|100981863|FG001|Overall Study|Lack of Efficacy|4|||
33296633|NCT01305408|100981862|FG000|Overall Study|Withdrawal by Subject|9|||
33392937|NCT01641081|101325369|FG009|Period 5|Adverse Event|0|||
33189646|NCT02346240|100601438|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189647|NCT02346240|100601439|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189648|NCT02346240|100601440|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189649|NCT02346240|100601441|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33296634|NCT01305408|100981863|FG001|Overall Study|Withdrawal by Subject|9|||
33296635|NCT01305408|100981862|FG000|Overall Study|Protocol Violation|4|||
33392938|NCT00633360|101325372|FG000|Overall Study|Lost to Follow-up|1|||
33296636|NCT01305408|100981863|FG001|Overall Study|Protocol Violation|6|||
33296637|NCT01305408|100981862|FG000|Overall Study|Lost to Follow-up|5|||
33296638|NCT01305408|100981863|FG001|Overall Study|Lost to Follow-up|3|||
33296639|NCT01305408|100981862|FG000|Overall Study|Noncompliance with study medication|0|||
33296640|NCT01305408|100981863|FG001|Overall Study|Noncompliance with study medication|1|||
33392939|NCT00633360|101325373|FG001|Overall Study|Lost to Follow-up|1|||
33392940|NCT00633360|101325372|FG000|Overall Study|Adverse Event|3|||
33392941|NCT00633360|101325373|FG001|Overall Study|Adverse Event|1|||
33392942|NCT00633360|101325372|FG000|Overall Study|Protocol Violation|0|||
33392943|NCT00633360|101325373|FG001|Overall Study|Protocol Violation|1|||
33392944|NCT02910089|101325376|FG000|Overall Study|Lost insurance eligibility|22|||
33392945|NCT02910089|101325377|FG001|Overall Study|Lost insurance eligibility|16|||
33392946|NCT02201472|101325378|FG000|Overall Study|Lack of Efficacy|2|||
33189650|NCT02346240|100601442|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189651|NCT02346240|100601443|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189652|NCT02346240|100601444|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189653|NCT02346240|100601445|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
33189654|NCT02346240|100601446|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
33189655|NCT02346240|100601447|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33189656|NCT02346240|100601448|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
33189657|NCT02346240|100601449|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
33189658|NCT02346240|100601450|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
33189659|NCT02346240|100601427|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189660|NCT02346240|100601428|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189661|NCT02346240|100601429|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189662|NCT02346240|100601430|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189663|NCT02346240|100601431|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189664|NCT02346240|100601432|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189665|NCT02346240|100601433|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189666|NCT02346240|100601434|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189667|NCT02346240|100601435|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189668|NCT02346240|100601436|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189669|NCT02346240|100601437|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189670|NCT02346240|100601438|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189671|NCT02346240|100601439|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189672|NCT02346240|100601440|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189673|NCT02346240|100601441|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189674|NCT02346240|100601442|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189675|NCT02346240|100601443|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189676|NCT02346240|100601444|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189677|NCT02346240|100601445|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
33189678|NCT02346240|100601446|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189679|NCT02346240|100601447|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
33189680|NCT02346240|100601448|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
33189681|NCT02346240|100601449|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
33189682|NCT02346240|100601450|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
33189683|NCT02346240|100601427|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189684|NCT02346240|100601428|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189685|NCT02346240|100601429|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189686|NCT02346240|100601430|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189687|NCT02346240|100601431|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189688|NCT02346240|100601432|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189689|NCT02346240|100601433|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189690|NCT02346240|100601434|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189691|NCT02346240|100601435|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189692|NCT02346240|100601436|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189693|NCT02346240|100601437|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189694|NCT02346240|100601438|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33296641|NCT01305408|100981862|FG000|Overall Study|Noncompliance with study procedures|0|||
33296642|NCT01305408|100981863|FG001|Overall Study|Noncompliance with study procedures|1|||
33296643|NCT01305408|100981862|FG000|Overall Study|Other|1|||
33296644|NCT01305408|100981863|FG001|Overall Study|Other|0|||
33392947|NCT00633893|101325381|FG000|Overall Study|Death|1|||
33392948|NCT00633893|101325382|FG001|Overall Study|Death|3|||
33392949|NCT00633893|101325383|FG002|Overall Study|Death|9|||
33392950|NCT00633893|101325381|FG000|Overall Study|Adverse Event|65|||
33392951|NCT00633893|101325382|FG001|Overall Study|Adverse Event|58|||
33392952|NCT00633893|101325383|FG002|Overall Study|Adverse Event|126|||
33392953|NCT00633893|101325381|FG000|Overall Study|Withdrawal by Subject|7|||
33392954|NCT00633893|101325382|FG001|Overall Study|Withdrawal by Subject|12|||
33392955|NCT00633893|101325383|FG002|Overall Study|Withdrawal by Subject|6|||
33392956|NCT00633893|101325381|FG000|Overall Study|Lost to Follow-up|2|||
33392957|NCT00633893|101325382|FG001|Overall Study|Lost to Follow-up|4|||
33392958|NCT00633893|101325383|FG002|Overall Study|Lost to Follow-up|8|||
33392959|NCT00633893|101325381|FG000|Overall Study|Poor/non-compliance|5|||
33392960|NCT00633893|101325382|FG001|Overall Study|Poor/non-compliance|12|||
33392961|NCT00633893|101325383|FG002|Overall Study|Poor/non-compliance|3|||
33392962|NCT00633893|101325381|FG000|Overall Study|Pregnancy|2|||
33392963|NCT00633893|101325382|FG001|Overall Study|Pregnancy|1|||
33392964|NCT00633893|101325383|FG002|Overall Study|Pregnancy|1|||
33392965|NCT00633893|101325381|FG000|Overall Study|Not meet/no longer meets criteria|4|||
33392966|NCT00633893|101325382|FG001|Overall Study|Not meet/no longer meets criteria|6|||
33392967|NCT00633893|101325383|FG002|Overall Study|Not meet/no longer meets criteria|4|||
33392968|NCT00633893|101325381|FG000|Overall Study|Other|28|||
33392969|NCT00633893|101325382|FG001|Overall Study|Other|33|||
33392970|NCT00633893|101325383|FG002|Overall Study|Other|31|||
33392971|NCT05179057|101325384|FG000|Overall Study|Adverse Event|3|||
33392972|NCT05179057|101325385|FG001|Overall Study|Adverse Event|2|||
33392973|NCT05179057|101325384|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
33392974|NCT05179057|101325385|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
33392975|NCT05179057|101325384|FG000|Overall Study|Study terminated|13|||
33392976|NCT05179057|101325385|FG001|Overall Study|Study terminated|7|||
33392977|NCT05179057|101325384|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
33392978|NCT05179057|101325385|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
33392979|NCT05179057|101325384|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
33392980|NCT05179057|101325385|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
33392981|NCT02244619|101325392|FG000|Overall Study|Did not receive study intervention|8|||
33392982|NCT02244619|101325393|FG001|Overall Study|Did not receive study intervention|21|||
33392983|NCT02940860|101325394|FG000|Overall Study|Non-serious AE|1|||
33392984|NCT02940860|101325395|FG001|Overall Study|Non-serious AE|2|||
33392985|NCT02940860|101325394|FG000|Overall Study|Serious AE|7|||
33392986|NCT02940860|101325395|FG001|Overall Study|Serious AE|3|||
33392987|NCT02940860|101325394|FG000|Overall Study|Withdrawal by Subject|19|||
33392988|NCT02940860|101325395|FG001|Overall Study|Withdrawal by Subject|9|||
33392989|NCT02940860|101325394|FG000|Overall Study|Lost to Follow-up|13|||
33392990|NCT02940860|101325395|FG001|Overall Study|Lost to Follow-up|7|||
33392991|NCT02940860|101325394|FG000|Overall Study|Physician Decision|5|||
33392992|NCT02940860|101325395|FG001|Overall Study|Physician Decision|3|||
33392993|NCT02940860|101325394|FG000|Overall Study|Sponsor Decision|0|||
33392994|NCT02940860|101325395|FG001|Overall Study|Sponsor Decision|1|||
33392995|NCT02940860|101325394|FG000|Overall Study|Protocol Violation|0|||
33392996|NCT02940860|101325395|FG001|Overall Study|Protocol Violation|2|||
33392997|NCT02940860|101325394|FG000|Overall Study|Death|3|||
33189695|NCT02346240|100601439|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189696|NCT02346240|100601440|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33392998|NCT02940860|101325395|FG001|Overall Study|Death|2|||
33392999|NCT02940860|101325394|FG000|Overall Study|Moved, poor venous access, transport|6|||
33600128|NCT04493684|102088509|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33189697|NCT02346240|100601441|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189698|NCT02346240|100601442|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189699|NCT02346240|100601443|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189700|NCT02346240|100601444|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189701|NCT02346240|100601445|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
33189702|NCT02346240|100601446|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189703|NCT02346240|100601447|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189704|NCT02346240|100601448|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33393000|NCT02940860|101325395|FG001|Overall Study|Moved, poor venous access, transport|4|||
33393001|NCT02940860|101325394|FG000|Overall Study|Not treated|2|||
33393002|NCT02940860|101325395|FG001|Overall Study|Not treated|2|||
33393003|NCT02972593|101325396|FG000|Overall Study|Lost to Follow-up|19|||
33393004|NCT02972593|101325397|FG001|Overall Study|Lost to Follow-up|15|||
33393005|NCT02972593|101325396|FG000|Overall Study|Protocol Violation|1|||
33393006|NCT02972593|101325397|FG001|Overall Study|Protocol Violation|0|||
33393007|NCT04095793|101325403|FG000|Overall Study|Adverse Event|3|||
33393008|NCT04095793|101325403|FG000|Overall Study|Study Terminated by Sponsor|103|||
33393009|NCT04095793|101325403|FG000|Overall Study|Withdrawal by Subject|4|||
33393010|NCT03006926|101325405|FG000|Overall Study|Adverse Event|0|||
33393011|NCT03006926|101325406|FG001|Overall Study|Adverse Event|27|||
33600129|NCT04493684|102088510|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33393012|NCT03006926|101325405|FG000|Overall Study|Withdrawal by Subject|0|||
33393013|NCT03006926|101325406|FG001|Overall Study|Withdrawal by Subject|1|||
33393014|NCT03006926|101325405|FG000|Overall Study|Radiological Disease Progression|0|||
33393015|NCT03006926|101325406|FG001|Overall Study|Radiological Disease Progression|52|||
33393016|NCT03006926|101325405|FG000|Overall Study|Clinical Disease Progression|0|||
33393017|NCT03006926|101325406|FG001|Overall Study|Clinical Disease Progression|10|||
33393018|NCT03006926|101325405|FG000|Overall Study|Other|0|||
33393019|NCT03006926|101325406|FG001|Overall Study|Other|8|||
33393020|NCT01235507|101325407|FG000|Overall Study|Adverse Event|1|||
33393021|NCT01235507|101325407|FG000|Overall Study|Withdrawal by Subject|1|||
33393022|NCT00441012|101325408|FG000|Overall Study|Adverse Event|0|||
33393023|NCT00441012|101325409|FG001|Overall Study|Adverse Event|1|||
33296645|NCT00534495|100981864|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
33296646|NCT00534495|100981865|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
33296647|NCT00534495|100981866|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
33296648|NCT00534495|100981864|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
33296649|NCT00534495|100981865|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
33296650|NCT00534495|100981866|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
33296651|NCT00534495|100981864|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
33296652|NCT00534495|100981865|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
33296653|NCT00534495|100981866|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
33296654|NCT00534495|100981864|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
33296655|NCT00534495|100981865|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
33296656|NCT00534495|100981866|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
33296657|NCT00534495|100981864|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
33296658|NCT00534495|100981865|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
33296659|NCT00534495|100981866|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
33296660|NCT00534495|100981864|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
33296661|NCT00534495|100981865|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
33296662|NCT00534495|100981866|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
33296663|NCT00534495|100981864|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
33296664|NCT00534495|100981865|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
33296665|NCT00534495|100981866|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
33296666|NCT00534495|100981864|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
33296667|NCT00534495|100981865|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
33296668|NCT00534495|100981866|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
33296669|NCT00534495|100981864|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
33296670|NCT00534495|100981865|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
33296671|NCT00534495|100981866|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
33296672|NCT00416195|100981869|FG000|Overall Study|Adverse Event|1|||
33296673|NCT00416195|100981870|FG001|Overall Study|Adverse Event|2|||
33296674|NCT00416195|100981869|FG000|Overall Study|Protocol Violation|1|||
33393024|NCT00441012|101325408|FG000|Overall Study|Lost to Follow-up|3|||
33393025|NCT00441012|101325409|FG001|Overall Study|Lost to Follow-up|3|||
33393026|NCT00441012|101325408|FG000|Overall Study|Protocol Violation|10|||
33393027|NCT00441012|101325409|FG001|Overall Study|Protocol Violation|9|||
33393028|NCT00441012|101325408|FG000|Overall Study|Withdrawal by Subject|4|||
33393029|NCT00441012|101325409|FG001|Overall Study|Withdrawal by Subject|0|||
33393030|NCT00441012|101325408|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
33393031|NCT00441012|101325409|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
33393032|NCT04067011|101325410|FG000|Overall Study|Not Treated|8|||
33393033|NCT04067011|101325411|FG001|Overall Study|Not Treated|7|||
33393034|NCT04067011|101325412|FG002|Overall Study|Not Treated|5|||
33393035|NCT04067011|101325410|FG000|Overall Study|Adverse Event|2|||
33393036|NCT04067011|101325411|FG001|Overall Study|Adverse Event|1|||
33393037|NCT04067011|101325412|FG002|Overall Study|Adverse Event|0|||
33393038|NCT04067011|101325410|FG000|Overall Study|Withdrawal by Subject|6|||
33296675|NCT00416195|100981870|FG001|Overall Study|Protocol Violation|1|||
33296676|NCT00416195|100981869|FG000|Overall Study|Other|0|||
33296677|NCT00416195|100981870|FG001|Overall Study|Other|1|||
33393039|NCT04067011|101325411|FG001|Overall Study|Withdrawal by Subject|2|||
33296678|NCT01375673|100981871|FG000|Overall Study|Withdrawal by Subject|0|||
33296679|NCT01375673|100981872|FG001|Overall Study|Withdrawal by Subject|1|||
33296680|NCT01251770|100981877|FG000|Overall Study|Protocol Violation|13|||
33296681|NCT01251770|100981878|FG001|Overall Study|Protocol Violation|7|||
33296682|NCT01661205|100981881|FG000|Overall Study|Physician Decision|2|||
33393040|NCT04067011|101325412|FG002|Overall Study|Withdrawal by Subject|1|||
33393041|NCT04067011|101325410|FG000|Overall Study|Lost to Follow-up|0|||
33393042|NCT04067011|101325411|FG001|Overall Study|Lost to Follow-up|0|||
33393043|NCT04067011|101325412|FG002|Overall Study|Lost to Follow-up|1|||
33393044|NCT04067011|101325410|FG000|Overall Study|Physician Decision|1|||
33393045|NCT04067011|101325411|FG001|Overall Study|Physician Decision|1|||
33393046|NCT04067011|101325412|FG002|Overall Study|Physician Decision|0|||
33393047|NCT04067011|101325410|FG000|Overall Study|Other Reasons|2|||
33393048|NCT04067011|101325411|FG001|Overall Study|Other Reasons|0|||
33393049|NCT04067011|101325412|FG002|Overall Study|Other Reasons|1|||
33393050|NCT04067011|101325410|FG000|Overall Study|Missing|0|||
33393051|NCT04067011|101325411|FG001|Overall Study|Missing|2|||
33393052|NCT04067011|101325412|FG002|Overall Study|Missing|0|||
33393053|NCT00744991|101325416|FG000|Overall Study|Progressive Disease|11|||
33393054|NCT00744991|101325416|FG000|Overall Study|Withdrawal by Subject|8|||
33393055|NCT00744991|101325416|FG000|Overall Study|Physician Decision|3|||
33393056|NCT00744991|101325416|FG000|Overall Study|Adverse Event|2|||
33393057|NCT00744991|101325416|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
33393058|NCT00839436|101325417|FG000|Overall Study|Developed exclusionary condition|1|||
33393059|NCT00839436|101325418|FG001|Overall Study|Developed exclusionary condition|0|||
33393060|NCT00839436|101325419|FG002|Overall Study|Developed exclusionary condition|0|||
33393061|NCT00839436|101325417|FG000|Overall Study|Withdrawal by Subject|0|||
33393062|NCT00839436|101325418|FG001|Overall Study|Withdrawal by Subject|1|||
33393063|NCT00839436|101325419|FG002|Overall Study|Withdrawal by Subject|0|||
33296683|NCT01370655|100981883|FG000|Period 1|Adverse Event|2|||
33296684|NCT01370655|100981884|FG001|Period 1|Adverse Event|0|||
33296685|NCT01370655|100981885|FG002|Period 1|Adverse Event|0|||
33296686|NCT01370655|100981886|FG003|Period 1|Adverse Event|0|||
33296687|NCT01370655|100981887|FG004|Period 1|Adverse Event|0|||
33296688|NCT01370655|100981888|FG005|Period 1|Adverse Event|0|||
33296689|NCT01370655|100981889|FG006|Period 1|Adverse Event|1|||
33296690|NCT01370655|100981890|FG007|Period 1|Adverse Event|0|||
33296691|NCT01370655|100981891|FG008|Period 1|Adverse Event|0|||
33296692|NCT01370655|100981892|FG009|Period 1|Adverse Event|0|||
33296693|NCT01370655|100981893|FG010|Period 1|Adverse Event|0|||
33296694|NCT01370655|100981894|FG011|Period 1|Adverse Event|0|||
33296695|NCT01370655|100981883|FG000|Period 2|Adverse Event|0|||
33296696|NCT01370655|100981884|FG001|Period 2|Adverse Event|0|||
33296697|NCT01370655|100981885|FG002|Period 2|Adverse Event|1|||
33296698|NCT01370655|100981886|FG003|Period 2|Adverse Event|0|||
33296699|NCT01370655|100981887|FG004|Period 2|Adverse Event|1|||
33296700|NCT01370655|100981888|FG005|Period 2|Adverse Event|0|||
33296701|NCT01370655|100981889|FG006|Period 2|Adverse Event|0|||
33296702|NCT01370655|100981890|FG007|Period 2|Adverse Event|1|||
33296703|NCT01370655|100981891|FG008|Period 2|Adverse Event|0|||
33296704|NCT01370655|100981892|FG009|Period 2|Adverse Event|0|||
33296705|NCT01370655|100981893|FG010|Period 2|Adverse Event|0|||
33296706|NCT01370655|100981894|FG011|Period 2|Adverse Event|0|||
33296707|NCT01370655|100981883|FG000|Period 2|met protocol specified stopping criteria|0|||
33296708|NCT01370655|100981884|FG001|Period 2|met protocol specified stopping criteria|0|||
33296709|NCT01370655|100981885|FG002|Period 2|met protocol specified stopping criteria|1|||
33296710|NCT01370655|100981886|FG003|Period 2|met protocol specified stopping criteria|0|||
33296711|NCT01370655|100981887|FG004|Period 2|met protocol specified stopping criteria|0|||
33296712|NCT01370655|100981888|FG005|Period 2|met protocol specified stopping criteria|0|||
33296713|NCT01370655|100981889|FG006|Period 2|met protocol specified stopping criteria|1|||
33296714|NCT01370655|100981890|FG007|Period 2|met protocol specified stopping criteria|0|||
33296715|NCT01370655|100981891|FG008|Period 2|met protocol specified stopping criteria|1|||
33296716|NCT01370655|100981892|FG009|Period 2|met protocol specified stopping criteria|0|||
33296717|NCT01370655|100981893|FG010|Period 2|met protocol specified stopping criteria|1|||
33296718|NCT01370655|100981894|FG011|Period 2|met protocol specified stopping criteria|0|||
33296719|NCT01370655|100981883|FG000|Period 2|Withdrawal by Subject|0|||
33296720|NCT01370655|100981884|FG001|Period 2|Withdrawal by Subject|0|||
33296721|NCT01370655|100981885|FG002|Period 2|Withdrawal by Subject|0|||
33296722|NCT01370655|100981886|FG003|Period 2|Withdrawal by Subject|0|||
33296723|NCT01370655|100981887|FG004|Period 2|Withdrawal by Subject|0|||
33296724|NCT01370655|100981888|FG005|Period 2|Withdrawal by Subject|0|||
33296725|NCT01370655|100981889|FG006|Period 2|Withdrawal by Subject|0|||
33393064|NCT00839436|101325417|FG000|Overall Study|Study drug no longer available|0|||
33393065|NCT00839436|101325418|FG001|Overall Study|Study drug no longer available|0|||
33393066|NCT00839436|101325419|FG002|Overall Study|Study drug no longer available|1|||
33393067|NCT02724111|101325420|FG000|Overall Study|Protocol Violation|2|||
33393068|NCT02724111|101325421|FG001|Overall Study|Protocol Violation|5|||
33393069|NCT01473355|101325422|FG000|Overall Study|Protocol Violation|2|||
33296726|NCT01370655|100981890|FG007|Period 2|Withdrawal by Subject|0|||
33296727|NCT01370655|100981891|FG008|Period 2|Withdrawal by Subject|1|||
33296728|NCT01370655|100981892|FG009|Period 2|Withdrawal by Subject|0|||
33296729|NCT01370655|100981893|FG010|Period 2|Withdrawal by Subject|0|||
33296730|NCT01370655|100981894|FG011|Period 2|Withdrawal by Subject|0|||
33296731|NCT01441635|100981895|FG000|Overall Study|Adverse Event|4|||
33296732|NCT01441635|100981896|FG001|Overall Study|Adverse Event|3|||
33296733|NCT01441635|100981897|FG002|Overall Study|Adverse Event|1|||
33393070|NCT01473355|101325422|FG000|Overall Study|Adverse Event|2|||
33393071|NCT01473355|101325422|FG000|Overall Study|Lost to Follow-up|2|||
33296734|NCT01441635|100981898|FG003|Overall Study|Adverse Event|5|||
33296735|NCT01441635|100981899|FG004|Overall Study|Adverse Event|1|||
33296736|NCT01441635|100981900|FG005|Overall Study|Adverse Event|2|||
33296737|NCT01441635|100981901|FG006|Overall Study|Adverse Event|2|||
33296738|NCT01441635|100981902|FG007|Overall Study|Adverse Event|2|||
33296739|NCT01441635|100981903|FG008|Overall Study|Adverse Event|1|||
33296740|NCT01441635|100981904|FG009|Overall Study|Adverse Event|0|||
33296741|NCT01441635|100981895|FG000|Overall Study|Withdrawal by Subject|1|||
33296742|NCT01441635|100981896|FG001|Overall Study|Withdrawal by Subject|1|||
33296743|NCT01441635|100981897|FG002|Overall Study|Withdrawal by Subject|0|||
33296744|NCT01441635|100981898|FG003|Overall Study|Withdrawal by Subject|1|||
33296745|NCT01441635|100981899|FG004|Overall Study|Withdrawal by Subject|0|||
33296746|NCT01441635|100981900|FG005|Overall Study|Withdrawal by Subject|0|||
33296747|NCT01441635|100981901|FG006|Overall Study|Withdrawal by Subject|2|||
33296748|NCT01441635|100981902|FG007|Overall Study|Withdrawal by Subject|0|||
33296749|NCT01441635|100981903|FG008|Overall Study|Withdrawal by Subject|1|||
33296750|NCT01441635|100981904|FG009|Overall Study|Withdrawal by Subject|1|||
33296751|NCT01441635|100981895|FG000|Overall Study|Lost to Follow-up|0|||
33296752|NCT01441635|100981896|FG001|Overall Study|Lost to Follow-up|1|||
33296753|NCT01441635|100981897|FG002|Overall Study|Lost to Follow-up|1|||
33296754|NCT01441635|100981898|FG003|Overall Study|Lost to Follow-up|1|||
33296755|NCT01441635|100981899|FG004|Overall Study|Lost to Follow-up|1|||
33296756|NCT01441635|100981900|FG005|Overall Study|Lost to Follow-up|3|||
33296757|NCT01441635|100981901|FG006|Overall Study|Lost to Follow-up|1|||
33296758|NCT01441635|100981902|FG007|Overall Study|Lost to Follow-up|1|||
33296759|NCT01441635|100981903|FG008|Overall Study|Lost to Follow-up|0|||
33296760|NCT01441635|100981904|FG009|Overall Study|Lost to Follow-up|1|||
33296761|NCT01441635|100981895|FG000|Overall Study|Noncompliance|0|||
33296762|NCT01441635|100981896|FG001|Overall Study|Noncompliance|1|||
33296763|NCT01441635|100981897|FG002|Overall Study|Noncompliance|0|||
33296764|NCT01441635|100981898|FG003|Overall Study|Noncompliance|0|||
33296765|NCT01441635|100981899|FG004|Overall Study|Noncompliance|0|||
33296766|NCT01441635|100981900|FG005|Overall Study|Noncompliance|0|||
33296767|NCT01441635|100981901|FG006|Overall Study|Noncompliance|1|||
33296768|NCT01441635|100981902|FG007|Overall Study|Noncompliance|0|||
33296769|NCT01441635|100981903|FG008|Overall Study|Noncompliance|0|||
33296770|NCT01441635|100981904|FG009|Overall Study|Noncompliance|0|||
33296771|NCT01441635|100981895|FG000|Overall Study|Surgery or Invasive Intervention|0|||
33296772|NCT01441635|100981896|FG001|Overall Study|Surgery or Invasive Intervention|0|||
33296773|NCT01441635|100981897|FG002|Overall Study|Surgery or Invasive Intervention|1|||
33296774|NCT01441635|100981898|FG003|Overall Study|Surgery or Invasive Intervention|0|||
33296775|NCT01441635|100981899|FG004|Overall Study|Surgery or Invasive Intervention|0|||
33296776|NCT01441635|100981900|FG005|Overall Study|Surgery or Invasive Intervention|0|||
33296777|NCT01441635|100981901|FG006|Overall Study|Surgery or Invasive Intervention|0|||
33296778|NCT01441635|100981902|FG007|Overall Study|Surgery or Invasive Intervention|0|||
33296779|NCT01441635|100981903|FG008|Overall Study|Surgery or Invasive Intervention|0|||
33296780|NCT01441635|100981904|FG009|Overall Study|Surgery or Invasive Intervention|0|||
33296781|NCT01441635|100981895|FG000|Overall Study|Received Exclusionary Medication|1|||
33296782|NCT01441635|100981896|FG001|Overall Study|Received Exclusionary Medication|0|||
33296783|NCT01441635|100981897|FG002|Overall Study|Received Exclusionary Medication|0|||
33296784|NCT01441635|100981898|FG003|Overall Study|Received Exclusionary Medication|0|||
33296785|NCT01441635|100981899|FG004|Overall Study|Received Exclusionary Medication|0|||
33296786|NCT01441635|100981900|FG005|Overall Study|Received Exclusionary Medication|0|||
33296787|NCT01441635|100981901|FG006|Overall Study|Received Exclusionary Medication|0|||
33296788|NCT01441635|100981902|FG007|Overall Study|Received Exclusionary Medication|0|||
33296789|NCT01441635|100981903|FG008|Overall Study|Received Exclusionary Medication|0|||
33296790|NCT01441635|100981904|FG009|Overall Study|Received Exclusionary Medication|0|||
33296791|NCT01441635|100981895|FG000|Overall Study|Other|0|||
33296792|NCT01441635|100981896|FG001|Overall Study|Other|0|||
33296793|NCT01441635|100981897|FG002|Overall Study|Other|0|||
33296794|NCT01441635|100981898|FG003|Overall Study|Other|0|||
33296795|NCT01441635|100981899|FG004|Overall Study|Other|0|||
33296796|NCT01441635|100981900|FG005|Overall Study|Other|0|||
33296797|NCT01441635|100981901|FG006|Overall Study|Other|0|||
33296798|NCT01441635|100981902|FG007|Overall Study|Other|1|||
33296799|NCT01441635|100981903|FG008|Overall Study|Other|0|||
33296800|NCT01441635|100981904|FG009|Overall Study|Other|0|||
33296801|NCT00340704|100981906|FG000|PK Study|Adverse Event|0|||
33296802|NCT00340704|100981907|FG001|PK Study|Adverse Event|1|||
33296803|NCT00340704|100981908|FG002|PK Study|Adverse Event|0|||
33296804|NCT00340704|100981909|FG003|PK Study|Adverse Event|0|||
33296805|NCT00340704|100981910|FG004|PK Study|Adverse Event|0|||
33296806|NCT00340704|100981911|FG005|PK Study|Adverse Event|0|||
33296807|NCT00340704|100981912|FG006|PK Study|Adverse Event|0|||
33296808|NCT00340704|100981913|FG007|PK Study|Adverse Event|0|||
33296809|NCT00340704|100981914|FG008|PK Study|Adverse Event|0|||
33296810|NCT00340704|100981906|FG000|PK Study|Not treated|0|||
33296811|NCT00340704|100981907|FG001|PK Study|Not treated|0|||
33296812|NCT00340704|100981908|FG002|PK Study|Not treated|1|||
33296813|NCT00340704|100981909|FG003|PK Study|Not treated|0|||
33296814|NCT00340704|100981910|FG004|PK Study|Not treated|0|||
33296815|NCT00340704|100981911|FG005|PK Study|Not treated|0|||
33296816|NCT00340704|100981912|FG006|PK Study|Not treated|0|||
33393072|NCT00606294|101325425|FG000|Overall Study|Withdrawal by Subject|36|||
33393073|NCT00606294|101325426|FG001|Overall Study|Withdrawal by Subject|0|||
33393074|NCT02143141|101325427|FG000|Overall Study|pain scores at 24 hours not collected|1|||
33393075|NCT02143141|101325428|FG001|Overall Study|pain scores at 24 hours not collected|0|||
33296817|NCT00340704|100981913|FG007|PK Study|Not treated|0|||
33296818|NCT00340704|100981914|FG008|PK Study|Not treated|0|||
33296819|NCT00340704|100981906|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
33296820|NCT00340704|100981907|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
33296821|NCT00340704|100981908|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
33296822|NCT00340704|100981909|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
33296823|NCT00340704|100981910|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
33296824|NCT00340704|100981911|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
33296825|NCT00340704|100981912|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
33296826|NCT00340704|100981913|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
33296827|NCT00340704|100981914|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
33296828|NCT00340704|100981906|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33296829|NCT00340704|100981907|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33296830|NCT00340704|100981908|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33296831|NCT00340704|100981909|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33296832|NCT00340704|100981910|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33296833|NCT00340704|100981911|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
33296834|NCT00340704|100981912|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33296835|NCT00340704|100981913|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33296836|NCT00340704|100981914|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
33296837|NCT00340704|100981906|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
33296838|NCT00340704|100981907|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
33296839|NCT00340704|100981908|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
33296840|NCT00340704|100981909|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
33296841|NCT00340704|100981910|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
33296842|NCT00340704|100981911|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
33296843|NCT00340704|100981912|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
33296844|NCT00340704|100981913|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
33296845|NCT00340704|100981914|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
33296846|NCT00340704|100981906|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
33296847|NCT00340704|100981907|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
33296848|NCT00340704|100981908|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
33296849|NCT00340704|100981909|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
33296850|NCT00340704|100981910|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
33296851|NCT00340704|100981911|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
33296852|NCT00340704|100981912|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
33296853|NCT00340704|100981913|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
33296854|NCT00340704|100981914|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
33296855|NCT00332462|100981915|FG000|Overall Study|Adverse Event|5|||
33296856|NCT00332462|100981915|FG000|Overall Study|Abnormal Lab Value|1|||
33296857|NCT00332462|100981915|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33296858|NCT00332462|100981915|FG000|Overall Study|no longer requires study drug|1|||
33296859|NCT00332462|100981915|FG000|Overall Study|Death|3|||
33296860|NCT00332462|100981915|FG000|Overall Study|Graft Loss|2|||
33296861|NCT03995316|100981919|FG000|Overall Study|Lost to Follow-up|10|||
33296862|NCT03995316|100981920|FG001|Overall Study|Lost to Follow-up|3|||
33296863|NCT00246090|100981921|FG000|Overall Study|Adverse Event|25|||
33296864|NCT00246090|100981921|FG000|Overall Study|Withdrawal by Subject|7|||
33296865|NCT00246090|100981921|FG000|Overall Study|Progressive Disease|212|||
33296866|NCT00246090|100981921|FG000|Overall Study|Clinical Progression|30|||
33296867|NCT00246090|100981921|FG000|Overall Study|Physician Decision|11|||
33296868|NCT00246090|100981921|FG000|Overall Study|Not Otherwise Specified|10|||
33296869|NCT00643617|100981922|FG000|Overall Study|Death|6|||
33296870|NCT00643617|100981923|FG001|Overall Study|Death|9|||
33296871|NCT00643617|100981922|FG000|Overall Study|Lost to Follow-up|42|||
33296872|NCT00643617|100981923|FG001|Overall Study|Lost to Follow-up|51|||
33296873|NCT02202785|100981925|FG000|Overall Study|Study Terminated by Sponsor|1|||
33296874|NCT02202785|100981926|FG001|Overall Study|Study Terminated by Sponsor|6|||
33296875|NCT02202785|100981927|FG002|Overall Study|Study Terminated by Sponsor|4|||
33296876|NCT02202785|100981925|FG000|Overall Study|Withdrawal by Subject|0|||
33393076|NCT04063865|101328353|FG000|Overall Study|Physician Decision|1|||
33393077|NCT04063865|101328354|FG001|Overall Study|Physician Decision|3|||
33393078|NCT04063865|101328353|FG000|Overall Study|Study Closed Prior to Completion|4|||
33393079|NCT04063865|101328354|FG001|Overall Study|Study Closed Prior to Completion|4|||
33296877|NCT02202785|100981926|FG001|Overall Study|Withdrawal by Subject|1|||
33296878|NCT02202785|100981927|FG002|Overall Study|Withdrawal by Subject|0|||
33296879|NCT02202785|100981925|FG000|Overall Study|Lost to Follow-up|0|||
33296880|NCT02202785|100981926|FG001|Overall Study|Lost to Follow-up|1|||
33296881|NCT02202785|100981927|FG002|Overall Study|Lost to Follow-up|0|||
33296882|NCT02202785|100981925|FG000|Overall Study|Reason not Specified|10|||
33189705|NCT02346240|100601449|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33189706|NCT02346240|100601450|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
33296883|NCT02202785|100981926|FG001|Overall Study|Reason not Specified|7|||
33296884|NCT02202785|100981927|FG002|Overall Study|Reason not Specified|13|||
33296885|NCT00527787|100981929|FG000|Overall Study|Adverse Event|14|||
33296886|NCT00527787|100981930|FG001|Overall Study|Adverse Event|24|||
33296887|NCT00527787|100981929|FG000|Overall Study|Withdrawal by Subject|13|||
33189707|NCT02840877|100601451|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
33189708|NCT02840877|100601451|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
33189709|NCT02840877|100601451|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
33189710|NCT02840877|100601451|FG000|Baseline to 12 Weeks|Death|1|||
33189711|NCT02840877|100601451|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
33189712|NCT02840877|100601451|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
33189713|NCT02840877|100601451|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
33189714|NCT02840877|100601451|FG000|12 Weeks to 6 Months|Treatment failure|1|||
33189715|NCT02840877|100601451|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
33189716|NCT02840877|100601451|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
33189717|NCT02840877|100601451|FG000|12 Weeks to 6 Months|Death|1|||
33189718|NCT02840877|100601451|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
33189719|NCT02840877|100601451|FG000|6 Months to 18 Months|Treatment failure|7|||
33189720|NCT02840877|100601451|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
33189721|NCT02840877|100601451|FG000|6 Months to 18 Months|Moved/transferred out|6|||
33189722|NCT02840877|100601451|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
33189723|NCT02840877|100601451|FG000|6 Months to 18 Months|Death|4|||
33189724|NCT02840877|100601451|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
33189725|NCT02840877|100601451|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
33189726|NCT02840877|100601451|FG000|6 Months to 18 Months|Still in study.|14|||
33189727|NCT03019627|100601452|FG000|Overall Study|Adverse Event|8|||
33189728|NCT03019627|100601453|FG001|Overall Study|Adverse Event|0|||
33189729|NCT03019627|100601452|FG000|Overall Study|Unrelated to adverse event|1|||
33189730|NCT03019627|100601453|FG001|Overall Study|Unrelated to adverse event|3|||
33189731|NCT03019627|100601452|FG000|Overall Study|Lost to Follow-up|2|||
33189732|NCT03019627|100601453|FG001|Overall Study|Lost to Follow-up|1|||
33189733|NCT03019627|100601452|FG000|Overall Study|not compliance|2|||
33189734|NCT03019627|100601453|FG001|Overall Study|not compliance|2|||
33189735|NCT03019627|100601452|FG000|Overall Study|Other|2|||
33189736|NCT03019627|100601453|FG001|Overall Study|Other|2|||
33189737|NCT03945981|100601457|FG000|Overall Study|Lost to Follow-up|12|||
33189738|NCT03945981|100601457|FG000|Overall Study|Physician Decision|4|||
33189739|NCT03945981|100601457|FG000|Overall Study|Withdrawal by Subject|6|||
33189740|NCT03945981|100601457|FG000|Overall Study|Protocol Violation|1|||
33189741|NCT01393743|100601458|FG000|Core Study|Adverse Event|5|||
33189742|NCT01393743|100601459|FG001|Core Study|Adverse Event|9|||
33189743|NCT01393743|100601460|FG002|Core Study|Adverse Event|0|||
33189744|NCT01393743|100601458|FG000|Core Study|Lost to Follow-up|1|||
33189745|NCT01393743|100601459|FG001|Core Study|Lost to Follow-up|1|||
33189746|NCT01393743|100601460|FG002|Core Study|Lost to Follow-up|0|||
33189747|NCT01393743|100601458|FG000|Core Study|Participant's Choice|2|||
33189748|NCT01393743|100601459|FG001|Core Study|Participant's Choice|3|||
33189749|NCT01393743|100601460|FG002|Core Study|Participant's Choice|0|||
33189750|NCT01393743|100601458|FG000|Core Study|Inadequate therapeutic effect|2|||
33189751|NCT01393743|100601459|FG001|Core Study|Inadequate therapeutic effect|0|||
33189752|NCT01393743|100601460|FG002|Core Study|Inadequate therapeutic effect|0|||
33189753|NCT01393743|100601458|FG000|Extension Phase|Adverse Event|0|||
33189754|NCT01393743|100601459|FG001|Extension Phase|Adverse Event|0|||
33189755|NCT01393743|100601460|FG002|Extension Phase|Adverse Event|12|||
33189756|NCT01393743|100601458|FG000|Extension Phase|Lost to Follow-up|0|||
33189757|NCT01393743|100601459|FG001|Extension Phase|Lost to Follow-up|0|||
33189758|NCT01393743|100601460|FG002|Extension Phase|Lost to Follow-up|2|||
33189759|NCT01393743|100601458|FG000|Extension Phase|Participant choice|0|||
33189760|NCT01393743|100601459|FG001|Extension Phase|Participant choice|0|||
33189761|NCT01393743|100601460|FG002|Extension Phase|Participant choice|16|||
33189762|NCT01393743|100601458|FG000|Extension Phase|Inadequate therapeutic effect|0|||
33189763|NCT01393743|100601459|FG001|Extension Phase|Inadequate therapeutic effect|0|||
33189764|NCT01393743|100601460|FG002|Extension Phase|Inadequate therapeutic effect|7|||
33296888|NCT00527787|100981930|FG001|Overall Study|Withdrawal by Subject|25|||
33296889|NCT00527787|100981929|FG000|Overall Study|Lost to Follow-up|5|||
33296890|NCT00527787|100981930|FG001|Overall Study|Lost to Follow-up|2|||
33296891|NCT00527787|100981929|FG000|Overall Study|Duodenal Ulcer|1|||
33296892|NCT00527787|100981930|FG001|Overall Study|Duodenal Ulcer|10|||
33296893|NCT00527787|100981929|FG000|Overall Study|misc|5|||
33296894|NCT00527787|100981930|FG001|Overall Study|misc|2|||
33296895|NCT00863512|100981931|FG000|Overall Study|Adverse Event|2|||
33296896|NCT00863512|100981932|FG001|Overall Study|Adverse Event|0|||
33296897|NCT00863512|100981931|FG000|Overall Study|Withdrawal by Subject|11|||
33296898|NCT00863512|100981932|FG001|Overall Study|Withdrawal by Subject|0|||
33296899|NCT00863512|100981931|FG000|Overall Study|Physician Decision|1|||
33296900|NCT00863512|100981932|FG001|Overall Study|Physician Decision|0|||
33296901|NCT00611975|100981933|FG000|Overall Study|Withdrawal by Subject|3|||
33296902|NCT00611975|100981934|FG001|Overall Study|Withdrawal by Subject|7|||
33296903|NCT00611975|100981933|FG000|Overall Study|Pregnancy|2|||
33296904|NCT00611975|100981934|FG001|Overall Study|Pregnancy|1|||
33296905|NCT02053610|100981935|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
33296906|NCT02053610|100981936|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
33296907|NCT02053610|100981935|FG000|Overall Study|Withdrew Consent|2|||
33296908|NCT02053610|100981936|FG001|Overall Study|Withdrew Consent|9|||
33296909|NCT02053610|100981935|FG000|Overall Study|Death|5|||
33296910|NCT02053610|100981936|FG001|Overall Study|Death|5|||
33296911|NCT02053610|100981935|FG000|Overall Study|Administrative/Other|1|||
33296912|NCT02053610|100981936|FG001|Overall Study|Administrative/Other|1|||
33296913|NCT02053610|100981935|FG000|Overall Study|Disease Progression|2|||
33296914|NCT02053610|100981936|FG001|Overall Study|Disease Progression|3|||
33296915|NCT02053610|100981935|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
33296916|NCT02053610|100981936|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
33296917|NCT02053610|100981935|FG000|Overall Study|Did not Receive Treatment|4|||
33296918|NCT02053610|100981936|FG001|Overall Study|Did not Receive Treatment|2|||
33296919|NCT02053610|100981935|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33296920|NCT02053610|100981936|FG001|Overall Study|Insufficient Therapeutic Response|1|||
33296921|NCT02053610|100981935|FG000|Overall Study|Violation of Selection Criteria|1|||
33296922|NCT02053610|100981936|FG001|Overall Study|Violation of Selection Criteria|0|||
33296923|NCT02269423|100981937|FG000|Overall Study|Discontinued due to change in residence|0|||
33296924|NCT02269423|100981938|FG001|Overall Study|Discontinued due to change in residence|1|||
33296925|NCT02269423|100981939|FG002|Overall Study|Discontinued due to change in residence|0|||
33296926|NCT02269423|100981940|FG003|Overall Study|Discontinued due to change in residence|1|||
33296927|NCT01465763|100981941|FG000|Overall Study|Withdrawal by Subject|4|||
33296928|NCT01465763|100981942|FG001|Overall Study|Withdrawal by Subject|0|||
33296929|NCT01465763|100981943|FG002|Overall Study|Withdrawal by Subject|1|||
33296930|NCT01465763|100981941|FG000|Overall Study|Insufficient Clinical Response|11|||
33296931|NCT01465763|100981942|FG001|Overall Study|Insufficient Clinical Response|0|||
33296932|NCT01465763|100981943|FG002|Overall Study|Insufficient Clinical Response|1|||
33296933|NCT01465763|100981941|FG000|Overall Study|Adverse Event|9|||
33296934|NCT01465763|100981942|FG001|Overall Study|Adverse Event|0|||
33296935|NCT01465763|100981943|FG002|Overall Study|Adverse Event|1|||
33296936|NCT01465763|100981941|FG000|Overall Study|Other|2|||
33296937|NCT01465763|100981942|FG001|Overall Study|Other|0|||
33296938|NCT01465763|100981943|FG002|Overall Study|Other|0|||
33296939|NCT01465763|100981941|FG000|Overall Study|Protocol Violation|4|||
33296940|NCT01465763|100981942|FG001|Overall Study|Protocol Violation|1|||
33296941|NCT01465763|100981943|FG002|Overall Study|Protocol Violation|1|||
33296942|NCT01465763|100981941|FG000|Overall Study|Death|1|||
33296943|NCT01465763|100981942|FG001|Overall Study|Death|0|||
33296944|NCT01465763|100981943|FG002|Overall Study|Death|0|||
33296945|NCT00667394|100981947|FG000|Overall Study|Adverse Event|3|||
33296946|NCT00667394|100981948|FG001|Overall Study|Adverse Event|0|||
33296947|NCT00667394|100981947|FG000|Overall Study|Progressive disease|1|||
33296948|NCT00667394|100981948|FG001|Overall Study|Progressive disease|0|||
33296949|NCT02354651|100981952|FG000|Overall Study|Withdrawal by Subject|2|||
33296950|NCT02354651|100981952|FG000|Overall Study|Physician Decision|1|||
33296951|NCT01443403|100981953|FG000|Overall Study|Adverse Event|1|||
33296952|NCT01443403|100981954|FG001|Overall Study|Adverse Event|1|||
33296953|NCT01443403|100981955|FG002|Overall Study|Adverse Event|4|||
33296954|NCT01443403|100981956|FG003|Overall Study|Adverse Event|5|||
33296955|NCT01443403|100981953|FG000|Overall Study|Withdrawal by Subject|0|||
33296956|NCT01443403|100981954|FG001|Overall Study|Withdrawal by Subject|1|||
33296957|NCT01443403|100981955|FG002|Overall Study|Withdrawal by Subject|2|||
33296958|NCT01443403|100981956|FG003|Overall Study|Withdrawal by Subject|1|||
33296959|NCT01443403|100981953|FG000|Overall Study|Lost to Follow-up|0|||
33296960|NCT01443403|100981954|FG001|Overall Study|Lost to Follow-up|0|||
33296961|NCT01443403|100981955|FG002|Overall Study|Lost to Follow-up|0|||
33296962|NCT01443403|100981956|FG003|Overall Study|Lost to Follow-up|1|||
33296963|NCT01443403|100981953|FG000|Overall Study|Protocol Violation|2|||
33296964|NCT01443403|100981954|FG001|Overall Study|Protocol Violation|1|||
33296965|NCT01443403|100981955|FG002|Overall Study|Protocol Violation|1|||
33296966|NCT01443403|100981956|FG003|Overall Study|Protocol Violation|1|||
33296967|NCT01443403|100981953|FG000|Overall Study|Use of Prohibited Treatment|2|||
33296968|NCT01443403|100981954|FG001|Overall Study|Use of Prohibited Treatment|3|||
33296969|NCT01443403|100981955|FG002|Overall Study|Use of Prohibited Treatment|0|||
33296970|NCT01443403|100981956|FG003|Overall Study|Use of Prohibited Treatment|0|||
33296971|NCT01443403|100981953|FG000|Overall Study|Other - Miscellaneous|1|||
33296972|NCT01443403|100981954|FG001|Overall Study|Other - Miscellaneous|0|||
33296973|NCT01443403|100981955|FG002|Overall Study|Other - Miscellaneous|0|||
33296974|NCT01443403|100981956|FG003|Overall Study|Other - Miscellaneous|1|||
33296975|NCT01888874|100981961|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
33296976|NCT01888874|100981962|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
33296977|NCT01888874|100981963|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
33296978|NCT01888874|100981964|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
33296979|NCT01888874|100981965|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
33296980|NCT01888874|100981966|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
33296981|NCT01888874|100981967|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
33296982|NCT01888874|100981961|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
33296983|NCT01888874|100981962|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
33296984|NCT01888874|100981963|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
33296985|NCT01888874|100981964|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
33296986|NCT01888874|100981965|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
33296987|NCT01888874|100981966|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
33296988|NCT01888874|100981967|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
33296989|NCT01888874|100981961|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
33296990|NCT01888874|100981962|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
33296991|NCT01888874|100981963|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
33296992|NCT01888874|100981964|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
33296993|NCT01888874|100981965|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
33296994|NCT01888874|100981966|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
33296995|NCT01888874|100981967|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
33296996|NCT01888874|100981961|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
33296997|NCT01888874|100981962|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
33296998|NCT01888874|100981963|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
33296999|NCT01888874|100981964|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
33297000|NCT01888874|100981965|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
33297001|NCT01888874|100981966|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
33297002|NCT01888874|100981967|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
33297003|NCT01888874|100981961|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33297004|NCT01888874|100981962|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33297005|NCT01888874|100981963|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33297006|NCT01888874|100981964|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33297007|NCT01888874|100981965|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
33297008|NCT01888874|100981966|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33297009|NCT01888874|100981967|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33297010|NCT01888874|100981961|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
33297011|NCT01888874|100981962|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
33297012|NCT01888874|100981963|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
33297013|NCT01888874|100981964|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
33297014|NCT01888874|100981965|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
33297015|NCT01888874|100981966|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
33297016|NCT01888874|100981967|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
33297017|NCT01888874|100981961|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
33297018|NCT01888874|100981962|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
33297019|NCT01888874|100981963|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
33297020|NCT01888874|100981964|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
33297021|NCT01888874|100981965|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
33297022|NCT01888874|100981966|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
33297023|NCT01888874|100981967|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
33297024|NCT01888874|100981961|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
33297025|NCT01888874|100981962|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
33297026|NCT01888874|100981963|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
33297027|NCT01888874|100981964|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
33297028|NCT01888874|100981965|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
33297029|NCT01888874|100981966|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
33297030|NCT01888874|100981967|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
33297031|NCT01888874|100981961|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
33297032|NCT01888874|100981962|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
33297033|NCT01888874|100981963|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
33297034|NCT01888874|100981964|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
33297035|NCT01888874|100981965|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
33297036|NCT01888874|100981966|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
33297037|NCT01888874|100981967|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
33297038|NCT01888874|100981961|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
33297039|NCT01888874|100981962|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
33297040|NCT01888874|100981963|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
33297041|NCT01888874|100981964|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
33297042|NCT01888874|100981965|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
33297043|NCT01888874|100981966|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
33297044|NCT01888874|100981967|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
33297045|NCT01888874|100981961|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
33297046|NCT01888874|100981962|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
33189765|NCT01393743|100601458|FG000|Extension Phase|Withdrawal by Subject|0|||
33189766|NCT01393743|100601459|FG001|Extension Phase|Withdrawal by Subject|0|||
33189767|NCT01393743|100601460|FG002|Extension Phase|Withdrawal by Subject|8|||
33189768|NCT01393743|100601458|FG000|Extension Phase|Pregnancy|0|||
33189769|NCT01393743|100601459|FG001|Extension Phase|Pregnancy|0|||
33189770|NCT01393743|100601460|FG002|Extension Phase|Pregnancy|1|||
33189771|NCT01393743|100601458|FG000|Extension Phase|Other|0|||
33189772|NCT01393743|100601459|FG001|Extension Phase|Other|0|||
33189773|NCT01393743|100601460|FG002|Extension Phase|Other|14|||
33189774|NCT01762943|100601461|FG000|Overall Study|Physician Decision|1|||
33189775|NCT01762943|100601462|FG001|Overall Study|Physician Decision|1|||
33189776|NCT01762943|100601461|FG000|Overall Study|Protocol Violation|1|||
33189777|NCT01762943|100601462|FG001|Overall Study|Protocol Violation|0|||
33189778|NCT01762943|100601461|FG000|Overall Study|Withdrawal by Subject|2|||
33189779|NCT01762943|100601462|FG001|Overall Study|Withdrawal by Subject|1|||
33189780|NCT00655564|100601465|FG000|Overall Study|Adverse Event|1|||
33189781|NCT00655564|100601465|FG000|Overall Study|Lost to Follow-up|1|||
33189782|NCT00655564|100601465|FG000|Overall Study|Desired Alternate Therapy|1|||
33189783|NCT00499603|100601469|FG000|Overall Study|Adverse Event|0|||
33189784|NCT00499603|100601470|FG001|Overall Study|Adverse Event|1|||
33189785|NCT02457325|100601473|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
33189786|NCT02457325|100601474|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
33189787|NCT01971346|100601475|FG000|Overall Study|Protocol Violation|3|||
33189788|NCT01971346|100601475|FG000|Overall Study|Lost to Follow-up|2|||
33189789|NCT01971346|100601475|FG000|Overall Study|Withdrawal by Subject|2|||
33189790|NCT01971346|100601475|FG000|Overall Study|Physician Decision|1|||
33189791|NCT05091307|100601479|FG000|Overall Study|Death|0|||
33189792|NCT05091307|100601480|FG001|Overall Study|Death|0|||
33189793|NCT05091307|100601481|FG002|Overall Study|Death|1|||
33189794|NCT05091307|100601482|FG003|Overall Study|Death|0|||
33189795|NCT05091307|100601479|FG000|Overall Study|Lost to Follow-up|33|||
33189796|NCT05091307|100601480|FG001|Overall Study|Lost to Follow-up|33|||
33189797|NCT05091307|100601481|FG002|Overall Study|Lost to Follow-up|2|||
33189798|NCT05091307|100601482|FG003|Overall Study|Lost to Follow-up|0|||
33189799|NCT05091307|100601479|FG000|Overall Study|Physician Decision|1|||
33189800|NCT05091307|100601480|FG001|Overall Study|Physician Decision|0|||
33189801|NCT05091307|100601481|FG002|Overall Study|Physician Decision|0|||
33189802|NCT05091307|100601482|FG003|Overall Study|Physician Decision|0|||
33189803|NCT05091307|100601479|FG000|Overall Study|Protocol Violation|1|||
33189804|NCT05091307|100601480|FG001|Overall Study|Protocol Violation|0|||
33189805|NCT05091307|100601481|FG002|Overall Study|Protocol Violation|0|||
33189806|NCT05091307|100601482|FG003|Overall Study|Protocol Violation|0|||
33189807|NCT05091307|100601479|FG000|Overall Study|Withdrawal by Subject|16|||
33189808|NCT05091307|100601480|FG001|Overall Study|Withdrawal by Subject|16|||
33189809|NCT05091307|100601481|FG002|Overall Study|Withdrawal by Subject|0|||
33189810|NCT05091307|100601482|FG003|Overall Study|Withdrawal by Subject|1|||
33189811|NCT05091307|100601479|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
33189812|NCT05091307|100601480|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
33189813|NCT05091307|100601481|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
33189814|NCT05091307|100601482|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
33189815|NCT05091307|100601479|FG000|Overall Study|Initiated Prohibited Medication|1|||
33189816|NCT05091307|100601480|FG001|Overall Study|Initiated Prohibited Medication|0|||
33189817|NCT05091307|100601481|FG002|Overall Study|Initiated Prohibited Medication|0|||
33189818|NCT05091307|100601482|FG003|Overall Study|Initiated Prohibited Medication|0|||
33189819|NCT05091307|100601479|FG000|Overall Study|Other|4|||
33189820|NCT05091307|100601480|FG001|Overall Study|Other|4|||
33189821|NCT05091307|100601481|FG002|Overall Study|Other|0|||
33189822|NCT05091307|100601482|FG003|Overall Study|Other|0|||
33189823|NCT05091307|100601479|FG000|Overall Study|Randomized but not vaccinated|0|||
33189824|NCT05091307|100601480|FG001|Overall Study|Randomized but not vaccinated|2|||
33189825|NCT05091307|100601481|FG002|Overall Study|Randomized but not vaccinated|0|||
33189826|NCT05091307|100601482|FG003|Overall Study|Randomized but not vaccinated|0|||
33189827|NCT00838201|100601485|FG000|Overall Study|Investigator decision, or other reasons|2|||
33297047|NCT01888874|100981963|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
33297048|NCT01888874|100981964|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
33297049|NCT01888874|100981965|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
33297050|NCT01888874|100981966|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
33297051|NCT01888874|100981967|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
33297052|NCT01888874|100981961|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
33297053|NCT01888874|100981962|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
33297054|NCT01888874|100981963|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
33297055|NCT01888874|100981964|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
33297056|NCT01888874|100981965|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
33297057|NCT01888874|100981966|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
33297058|NCT01888874|100981967|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
33297059|NCT01888874|100981961|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
33297060|NCT01888874|100981962|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
33297061|NCT01888874|100981963|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
33297062|NCT01888874|100981964|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
33297063|NCT01888874|100981965|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
33297064|NCT01888874|100981966|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
33297065|NCT01888874|100981967|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
33297066|NCT02817906|100981968|FG000|Overall Study|Adverse Event|3|||
33297067|NCT02817906|100981969|FG001|Overall Study|Adverse Event|0|||
33297068|NCT02817906|100981968|FG000|Overall Study|Lack of Efficacy|1|||
33297069|NCT02817906|100981969|FG001|Overall Study|Lack of Efficacy|0|||
33297070|NCT02817906|100981968|FG000|Overall Study|Protocol Violation|1|||
33297071|NCT02817906|100981969|FG001|Overall Study|Protocol Violation|1|||
33297072|NCT02817906|100981968|FG000|Overall Study|Study Terminated by Sponsor|2|||
33297073|NCT02817906|100981969|FG001|Overall Study|Study Terminated by Sponsor|2|||
33297074|NCT02817906|100981968|FG000|Overall Study|Withdrawal by Subject|7|||
33297075|NCT02817906|100981969|FG001|Overall Study|Withdrawal by Subject|0|||
33297076|NCT02817906|100981968|FG000|Overall Study|Other|2|||
33297077|NCT02817906|100981969|FG001|Overall Study|Other|2|||
33297078|NCT03274453|100981970|FG000|Overall Study|Lost to Follow-up|2|||
33297079|NCT03274453|100981971|FG001|Overall Study|Lost to Follow-up|5|||
33297080|NCT03274453|100981972|FG002|Overall Study|Lost to Follow-up|4|||
33297081|NCT03274453|100981973|FG003|Overall Study|Lost to Follow-up|1|||
33297082|NCT03274453|100981970|FG000|Overall Study|Physician Decision|2|||
33297083|NCT03274453|100981971|FG001|Overall Study|Physician Decision|0|||
33297084|NCT03274453|100981972|FG002|Overall Study|Physician Decision|0|||
33297085|NCT03274453|100981973|FG003|Overall Study|Physician Decision|3|||
33297086|NCT03274453|100981970|FG000|Overall Study|Surgery Cancelled|0|||
33297087|NCT03274453|100981971|FG001|Overall Study|Surgery Cancelled|1|||
33297088|NCT03274453|100981972|FG002|Overall Study|Surgery Cancelled|0|||
33297089|NCT03274453|100981973|FG003|Overall Study|Surgery Cancelled|0|||
33297090|NCT01825798|100981976|FG000|Overall Study|Adverse Event|1|||
33297091|NCT01825798|100981977|FG001|Overall Study|Adverse Event|5|||
33297092|NCT01825798|100981976|FG000|Overall Study|Lost to Follow-up|1|||
33297093|NCT01825798|100981977|FG001|Overall Study|Lost to Follow-up|0|||
33297094|NCT01850589|100981980|FG000|Overall Study|Withdrawal by Subject|8|||
33297095|NCT01850589|100981981|FG001|Overall Study|Withdrawal by Subject|0|||
33297096|NCT00607724|100984588|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
33297097|NCT00607724|100984589|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
33297098|NCT00607724|100984590|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
33297099|NCT00607724|100984591|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
33297100|NCT00607724|100984592|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
33297101|NCT00607724|100984593|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
33297102|NCT00607724|100984594|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
33297103|NCT00607724|100984588|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
33297104|NCT00607724|100984589|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
33297105|NCT00607724|100984590|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
33297106|NCT00607724|100984591|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
33297107|NCT00607724|100984592|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
33297108|NCT00607724|100984593|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
33297109|NCT00607724|100984594|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
33297110|NCT00607724|100984588|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
33297111|NCT00607724|100984589|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
33297112|NCT00607724|100984590|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
33297113|NCT00607724|100984591|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
33393080|NCT04063865|101328353|FG000|Overall Study|Withdrawal by Subject|1|||
33393081|NCT04063865|101328354|FG001|Overall Study|Withdrawal by Subject|1|||
33297114|NCT00607724|100984592|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
33393082|NCT00707486|101328355|FG000|Overall Study|Withdrawal by Subject|1|||
33297115|NCT00607724|100984593|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
33297116|NCT00607724|100984594|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
33297117|NCT00607724|100984588|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
33297118|NCT00607724|100984589|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
33297119|NCT00607724|100984590|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
33297120|NCT00607724|100984591|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
33297121|NCT00607724|100984592|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
33297122|NCT00607724|100984593|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
33297123|NCT00607724|100984594|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
33297124|NCT00607724|100984588|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
33297125|NCT00607724|100984589|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
33297126|NCT00607724|100984590|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
33297127|NCT00607724|100984591|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
33297128|NCT00607724|100984592|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
33297129|NCT00607724|100984593|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
33297130|NCT00607724|100984594|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
33297131|NCT00694109|100984595|FG000|Overall Study|Physician Decision|3|||
33297132|NCT00694109|100984595|FG000|Overall Study|Adverse Event|74|||
33297133|NCT00694109|100984595|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
33297134|NCT00694109|100984595|FG000|Overall Study|Lack of Efficacy|2|||
33297135|NCT00694109|100984595|FG000|Overall Study|Withdrawal by Subject|13|||
33297136|NCT00694109|100984595|FG000|Overall Study|Pregnancy|1|||
33297137|NCT00694109|100984595|FG000|Overall Study|Enrolled but not treated|1|||
33297138|NCT00694109|100984595|FG000|Overall Study|Other|2|||
33297139|NCT00694109|100984595|FG000|Overall Study|Consented but no additional treatment|3|||
33297140|NCT00755105|100984596|FG000|Overall Study|Withdrawal by Subject|9|||
33297141|NCT00755105|100984597|FG001|Overall Study|Withdrawal by Subject|11|||
33297142|NCT00755105|100984598|FG002|Overall Study|Withdrawal by Subject|4|||
33297143|NCT01099917|100984599|FG000|Overall Study|Adverse Event|3|||
33297144|NCT01099917|100984599|FG000|Overall Study|Not Treated|24|||
33297145|NCT02159040|100984602|FG000|Overall Study|Death|1|||
33297146|NCT01646177|100984603|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
33297147|NCT01646177|100984604|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
33297148|NCT01646177|100984605|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
33297149|NCT01646177|100984606|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
33297150|NCT01646177|100984607|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33297151|NCT01646177|100984608|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33297152|NCT01646177|100984609|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33297153|NCT01646177|100984610|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33297154|NCT01646177|100984611|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33297155|NCT01646177|100984612|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33297156|NCT01646177|100984613|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33297157|NCT01646177|100984614|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
33297158|NCT01646177|100984603|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
33297159|NCT01646177|100984604|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
33297160|NCT01646177|100984605|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
33297161|NCT01646177|100984606|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
33297162|NCT01646177|100984607|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33297163|NCT01646177|100984608|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33297164|NCT01646177|100984609|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33297165|NCT01646177|100984610|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33297166|NCT01646177|100984611|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33297167|NCT01646177|100984612|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33297168|NCT01646177|100984613|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33297169|NCT01646177|100984614|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
33297170|NCT01646177|100984603|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
33297171|NCT01646177|100984604|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
33297172|NCT01646177|100984605|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
33297173|NCT01646177|100984606|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
33297174|NCT01646177|100984607|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33297175|NCT01646177|100984608|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33297176|NCT01646177|100984609|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33297177|NCT01646177|100984610|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33297178|NCT01646177|100984611|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33393083|NCT01060124|101328358|FG000|Overall Study|Other|16|||
33393084|NCT01060124|101328358|FG000|Overall Study|Adverse Event|14|||
33297179|NCT01646177|100984612|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33297180|NCT01646177|100984613|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33297181|NCT01646177|100984614|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
33393085|NCT01060124|101328358|FG000|Overall Study|Withdrawal by Subject|7|||
33393086|NCT00486889|101328362|FG000|Overall Study|Death|3|||
33297182|NCT01646177|100984603|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
33297183|NCT01646177|100984604|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
33297184|NCT01646177|100984605|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
33297185|NCT01646177|100984606|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
33297186|NCT01646177|100984607|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33297187|NCT01646177|100984608|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33297188|NCT01646177|100984609|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33297189|NCT01646177|100984610|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33297190|NCT01646177|100984611|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33297191|NCT01646177|100984612|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33297192|NCT01646177|100984613|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33297193|NCT01646177|100984614|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
33297194|NCT01646177|100984603|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33297195|NCT01646177|100984604|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33297196|NCT01646177|100984605|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
33297197|NCT01646177|100984606|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
33297198|NCT01646177|100984607|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33297199|NCT01646177|100984608|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33297200|NCT01646177|100984609|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33297201|NCT01646177|100984610|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33297202|NCT01646177|100984611|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33297203|NCT01646177|100984612|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33297204|NCT01646177|100984613|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33297205|NCT01646177|100984614|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
33297206|NCT01646177|100984603|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
33297207|NCT01646177|100984604|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
33297208|NCT01646177|100984605|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
33297209|NCT01646177|100984606|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33297210|NCT01646177|100984607|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33297211|NCT01646177|100984608|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33297212|NCT01646177|100984609|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33297213|NCT01646177|100984610|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33297214|NCT01646177|100984611|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33297215|NCT01646177|100984612|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33297216|NCT01646177|100984613|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33297217|NCT01646177|100984614|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
33297218|NCT01646177|100984603|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33297219|NCT01646177|100984604|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33297220|NCT01646177|100984605|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33297221|NCT01646177|100984606|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33297222|NCT01646177|100984607|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
33297223|NCT01646177|100984608|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
33297224|NCT01646177|100984609|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
33297225|NCT01646177|100984610|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
33297226|NCT01646177|100984611|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33297227|NCT01646177|100984612|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33297228|NCT01646177|100984613|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33297229|NCT01646177|100984614|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
33297230|NCT01646177|100984603|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33297231|NCT01646177|100984604|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33297232|NCT01646177|100984605|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33297233|NCT01646177|100984606|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33297234|NCT01646177|100984607|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
33297235|NCT01646177|100984608|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
33297236|NCT01646177|100984609|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
33297237|NCT01646177|100984610|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
33297238|NCT01646177|100984611|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33297239|NCT01646177|100984612|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33364907|NCT00077623|101223679|FG002|Overall Study|Failure to return|0|||
33393087|NCT00486889|101328362|FG000|Overall Study|Non-compliant|2|||
33393088|NCT00486889|101328362|FG000|Overall Study|Withdrawal by Subject|6|||
33393089|NCT02044822|101328370|FG000|Overall Study|Study Terminated by Sponsor|77|||
33393090|NCT02044822|101328370|FG000|Overall Study|Investigator's Discretion|10|||
33393091|NCT02044822|101328370|FG000|Overall Study|Withdrew Consent|3|||
33393092|NCT02044822|101328370|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
33393093|NCT02044822|101328370|FG000|Overall Study|Lost to Follow-up|1|||
33297240|NCT01646177|100984613|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33297241|NCT01646177|100984614|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
33297242|NCT01646177|100984603|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33297243|NCT01646177|100984604|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33297244|NCT01646177|100984605|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33297245|NCT01646177|100984606|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33297246|NCT01646177|100984607|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
33297247|NCT01646177|100984608|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
33297248|NCT01646177|100984609|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
33297249|NCT01646177|100984610|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
33297250|NCT01646177|100984611|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33297251|NCT01646177|100984612|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33297252|NCT01646177|100984613|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33297253|NCT01646177|100984614|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
33297254|NCT01646177|100984603|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33297255|NCT01646177|100984604|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33297256|NCT01646177|100984605|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33297257|NCT01646177|100984606|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33297258|NCT01646177|100984607|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
33297259|NCT01646177|100984608|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
33297260|NCT01646177|100984609|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
33297261|NCT01646177|100984610|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
33297262|NCT01646177|100984611|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33297263|NCT01646177|100984612|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33297264|NCT01646177|100984613|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33297265|NCT01646177|100984614|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
33297266|NCT01646177|100984603|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33297267|NCT01646177|100984604|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33297268|NCT01646177|100984605|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33297269|NCT01646177|100984606|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33297270|NCT01646177|100984607|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
33297271|NCT01646177|100984608|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
33297272|NCT01646177|100984609|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
33297273|NCT01646177|100984610|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
33297274|NCT01646177|100984611|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33297275|NCT01646177|100984612|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33297276|NCT01646177|100984613|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33297277|NCT01646177|100984614|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
33297278|NCT01646177|100984603|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33297279|NCT01646177|100984604|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33297280|NCT01646177|100984605|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33297281|NCT01646177|100984606|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33297282|NCT01646177|100984607|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
33297283|NCT01646177|100984608|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
33297284|NCT01646177|100984609|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33393094|NCT00446797|101328371|FG000|Overall Study|Lack of Efficacy|0|||
33393095|NCT00446797|101328372|FG001|Overall Study|Lack of Efficacy|2|||
33393096|NCT00446797|101328371|FG000|Overall Study|Lost to Follow-up|5|||
33393097|NCT00446797|101328372|FG001|Overall Study|Lost to Follow-up|3|||
33189828|NCT00838201|100601486|FG001|Overall Study|Investigator decision, or other reasons|3|||
33189829|NCT00838201|100601485|FG000|Overall Study|Noncompliance|0|||
33189830|NCT00838201|100601486|FG001|Overall Study|Noncompliance|1|||
33189831|NCT00838201|100601485|FG000|Overall Study|Administrative decision|1|||
33189832|NCT00838201|100601486|FG001|Overall Study|Administrative decision|2|||
33189833|NCT00838201|100601485|FG000|Overall Study|Disease progression|3|||
33189834|NCT00838201|100601486|FG001|Overall Study|Disease progression|3|||
33189835|NCT00838201|100601485|FG000|Overall Study|Consent withdrawn|16|||
33189836|NCT00838201|100601486|FG001|Overall Study|Consent withdrawn|19|||
33189837|NCT00838201|100601485|FG000|Overall Study|Lost to Follow-up|4|||
33189838|NCT00838201|100601486|FG001|Overall Study|Lost to Follow-up|3|||
33189839|NCT00838201|100601485|FG000|Overall Study|Adverse Event|5|||
33189840|NCT00838201|100601486|FG001|Overall Study|Adverse Event|9|||
33189841|NCT00838201|100601485|FG000|Overall Study|Death|11|||
33189842|NCT00838201|100601486|FG001|Overall Study|Death|13|||
33189843|NCT01849588|100601491|FG000|Overall Study|Lack of Efficacy|3|||
33189844|NCT00354172|100601492|FG000|Overall Study|Did not receive transplant|1|||
33297285|NCT01646177|100984610|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
33297286|NCT01646177|100984611|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33297287|NCT01646177|100984612|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33297288|NCT01646177|100984613|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33297289|NCT01646177|100984614|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
33297290|NCT01646177|100984603|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33297291|NCT01646177|100984604|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33297292|NCT01646177|100984605|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33297293|NCT01646177|100984606|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33297294|NCT01646177|100984607|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
33297295|NCT01646177|100984608|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
33297296|NCT01646177|100984609|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
33297297|NCT01646177|100984610|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
33297298|NCT01646177|100984611|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33297299|NCT01646177|100984612|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33297300|NCT01646177|100984613|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33297301|NCT01646177|100984614|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
33297302|NCT01646177|100984603|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
33297303|NCT01646177|100984604|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
33297304|NCT01646177|100984605|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
33297305|NCT01646177|100984606|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
33297306|NCT01646177|100984607|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
33297307|NCT01646177|100984608|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
33297308|NCT01646177|100984609|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
33297309|NCT01646177|100984610|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
33297310|NCT01646177|100984611|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
33297311|NCT01646177|100984612|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
33297312|NCT01646177|100984613|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
33297313|NCT01646177|100984614|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
33297314|NCT01646177|100984603|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33297315|NCT01646177|100984604|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33297316|NCT01646177|100984605|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33297317|NCT01646177|100984606|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33297318|NCT01646177|100984607|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
33297319|NCT01646177|100984608|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
33297320|NCT01646177|100984609|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
33297321|NCT01646177|100984610|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
33297322|NCT01646177|100984611|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33297323|NCT01646177|100984612|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33297324|NCT01646177|100984613|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33297325|NCT01646177|100984614|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
33297326|NCT01646177|100984603|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33297327|NCT01646177|100984604|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33297328|NCT01646177|100984605|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33297329|NCT01646177|100984606|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33297330|NCT01646177|100984607|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33297331|NCT01646177|100984608|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33297332|NCT01646177|100984609|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33297333|NCT01646177|100984610|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
33297334|NCT01646177|100984611|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33297335|NCT01646177|100984612|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33297336|NCT01646177|100984613|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33297337|NCT01646177|100984614|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
33297338|NCT01646177|100984603|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33297339|NCT01646177|100984604|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33297340|NCT01646177|100984605|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33297341|NCT01646177|100984606|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33297342|NCT01646177|100984607|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33297343|NCT01646177|100984608|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
33297344|NCT01646177|100984609|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
33393098|NCT00446797|101328371|FG000|Overall Study|Withdrawal by Subject|2|||
33297345|NCT01646177|100984610|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
33297346|NCT01646177|100984611|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33297347|NCT01646177|100984612|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33297348|NCT01646177|100984613|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33297349|NCT01646177|100984614|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
33297350|NCT01646177|100984603|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33297351|NCT01646177|100984604|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33297352|NCT01646177|100984605|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33297353|NCT01646177|100984606|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33297354|NCT01646177|100984607|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33297355|NCT01646177|100984608|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33297356|NCT01646177|100984609|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33297357|NCT01646177|100984610|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
33297358|NCT01646177|100984611|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
33297359|NCT01646177|100984612|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
33297360|NCT01646177|100984613|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
33297361|NCT01646177|100984614|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
33297362|NCT01646177|100984603|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33297363|NCT01646177|100984604|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33393099|NCT00446797|101328372|FG001|Overall Study|Withdrawal by Subject|2|||
33393100|NCT00446797|101328371|FG000|Overall Study|Protocol Violation|1|||
33393101|NCT00446797|101328372|FG001|Overall Study|Protocol Violation|3|||
33393102|NCT00446797|101328371|FG000|Overall Study|subject entered at another site|0|||
33393103|NCT00446797|101328372|FG001|Overall Study|subject entered at another site|1|||
33393104|NCT00446797|101328371|FG000|Overall Study|did not meet entrance criteria|0|||
33393105|NCT00446797|101328372|FG001|Overall Study|did not meet entrance criteria|1|||
33393106|NCT01600105|101328373|FG000|Total Participants|Withdrawal by Subject|1|||
33393107|NCT01600105|101328374|FG001|Total Participants|Withdrawal by Subject|0|||
33393108|NCT01600105|101328373|FG000|Total Participants|No images in PACS|10|||
33393109|NCT01600105|101328374|FG001|Total Participants|No images in PACS|0|||
33393110|NCT01600105|101328373|FG000|Total Participants|Insufficient image quality|30|||
33393111|NCT01600105|101328374|FG001|Total Participants|Insufficient image quality|10|||
33393112|NCT01600105|101328373|FG000|Sub Study I|Insufficient image quality|0|||
33393113|NCT01600105|101328374|FG001|Sub Study I|Insufficient image quality|10|||
33393114|NCT01600105|101328373|FG000|Sub Study II|Withdrawal by Subject|1|||
33393115|NCT01600105|101328374|FG001|Sub Study II|Withdrawal by Subject|0|||
33393116|NCT01600105|101328373|FG000|Sub Study II|No images in PACS|1|||
33393117|NCT01600105|101328374|FG001|Sub Study II|No images in PACS|0|||
33189845|NCT00205712|100601493|FG000|Overall Study|Lost to Follow-up|0|||
33189846|NCT00205712|100601494|FG001|Overall Study|Lost to Follow-up|1|||
33189847|NCT00360334|100601495|FG000|Overall Study|Adverse Event|7|||
33189848|NCT00360334|100601496|FG001|Overall Study|Adverse Event|4|||
33189849|NCT00360334|100601495|FG000|Overall Study|Protocol Violation|1|||
33189850|NCT00360334|100601496|FG001|Overall Study|Protocol Violation|1|||
33189851|NCT00360334|100601495|FG000|Overall Study|Physician Decision|2|||
33189852|NCT00360334|100601496|FG001|Overall Study|Physician Decision|3|||
33189853|NCT00360334|100601495|FG000|Overall Study|Lack of Efficacy|0|||
33189854|NCT00360334|100601496|FG001|Overall Study|Lack of Efficacy|1|||
33189855|NCT00360334|100601495|FG000|Overall Study|Entry criterion not met|1|||
33189856|NCT00360334|100601496|FG001|Overall Study|Entry criterion not met|2|||
33189857|NCT00360334|100601495|FG000|Overall Study|Subject decision|8|||
33189858|NCT00360334|100601496|FG001|Overall Study|Subject decision|2|||
33189859|NCT04013191|100601497|FG000|Overall Study|Adverse Event|1|||
33189860|NCT04013191|100601498|FG001|Overall Study|Adverse Event|0|||
33189861|NCT01603875|100601499|FG000|Overall Study|Preexisting rabies antibody|3|||
33189862|NCT01603875|100601500|FG001|Overall Study|Preexisting rabies antibody|4|||
33189863|NCT01603875|100601501|FG002|Overall Study|Preexisting rabies antibody|3|||
33189864|NCT01603875|100601499|FG000|Overall Study|Lost to Follow-up|4|||
33189865|NCT01603875|100601500|FG001|Overall Study|Lost to Follow-up|3|||
33189866|NCT01603875|100601501|FG002|Overall Study|Lost to Follow-up|6|||
33189867|NCT01603875|100601499|FG000|Overall Study|Protocol Violation|0|||
33189868|NCT01603875|100601500|FG001|Overall Study|Protocol Violation|1|||
33189869|NCT01603875|100601501|FG002|Overall Study|Protocol Violation|0|||
33189870|NCT00720941|100601502|FG000|Overall Study|Death|334|||
33189871|NCT00720941|100601503|FG001|Overall Study|Death|335|||
33189872|NCT00720941|100601502|FG000|Overall Study|Protocol Violation|0|||
33189873|NCT00720941|100601503|FG001|Overall Study|Protocol Violation|2|||
33189874|NCT00720941|100601502|FG000|Overall Study|Lost to Follow-up|17|||
33189875|NCT00720941|100601503|FG001|Overall Study|Lost to Follow-up|15|||
33393118|NCT01600105|101328373|FG000|Sub Study II|Insufficient image quality|3|||
33393119|NCT01600105|101328374|FG001|Sub Study II|Insufficient image quality|0|||
33393120|NCT01600105|101328373|FG000|Sub Study III|Insufficient image quality|5|||
33417157|NCT00038467|101420220|FG001|Overall Study|Adverse Event|145|||
33189876|NCT00720941|100601502|FG000|Overall Study|Physician Decision|1|||
33189877|NCT00720941|100601503|FG001|Overall Study|Physician Decision|5|||
33189878|NCT00720941|100601502|FG000|Overall Study|Withdrawal by Subject|27|||
33189879|NCT00720941|100601503|FG001|Overall Study|Withdrawal by Subject|35|||
33189880|NCT00720941|100601502|FG000|Overall Study|Ongoing|34|||
33297364|NCT01646177|100984605|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33297365|NCT01646177|100984606|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33297366|NCT01646177|100984607|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33297367|NCT01646177|100984608|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33297368|NCT01646177|100984609|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33297369|NCT01646177|100984610|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
33297370|NCT01646177|100984611|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
33297371|NCT01646177|100984612|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
33297372|NCT01646177|100984613|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
33297373|NCT01646177|100984614|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
33297374|NCT01646177|100984603|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33297375|NCT01646177|100984604|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33297376|NCT01646177|100984605|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33297377|NCT01646177|100984606|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33297378|NCT01646177|100984607|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33297379|NCT01646177|100984608|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33297380|NCT01646177|100984609|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33297381|NCT01646177|100984610|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
33297382|NCT01646177|100984611|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
33297383|NCT01646177|100984612|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
33297384|NCT01646177|100984613|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
33297385|NCT01646177|100984614|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
33297386|NCT01646177|100984603|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33297387|NCT01646177|100984604|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33297388|NCT01646177|100984605|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33297389|NCT01646177|100984606|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33297390|NCT01646177|100984607|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33297391|NCT01646177|100984608|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33297392|NCT01646177|100984609|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33297393|NCT01646177|100984610|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
33297394|NCT01646177|100984611|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
33297395|NCT01646177|100984612|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
33297396|NCT01646177|100984613|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
33297397|NCT01646177|100984614|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
33297398|NCT01646177|100984603|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33297399|NCT01646177|100984604|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33297400|NCT01646177|100984605|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33297401|NCT01646177|100984606|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33297402|NCT01646177|100984607|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33297403|NCT01646177|100984608|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33297404|NCT01646177|100984609|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33297405|NCT01646177|100984610|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
33297406|NCT01646177|100984611|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
33297407|NCT01646177|100984612|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
33297408|NCT01646177|100984613|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
33297409|NCT01646177|100984614|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
33297410|NCT01646177|100984603|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33297411|NCT01646177|100984604|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33297412|NCT01646177|100984605|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33297413|NCT01646177|100984606|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33297414|NCT01646177|100984607|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33297415|NCT01646177|100984608|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33297416|NCT01646177|100984609|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33297417|NCT01646177|100984610|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
33393121|NCT01600105|101328374|FG001|Sub Study III|Insufficient image quality|0|||
33393122|NCT01600105|101328373|FG000|Sub Study V|Poor Image Quality|2|||
33393123|NCT01600105|101328374|FG001|Sub Study V|Poor Image Quality|0|||
33393124|NCT04005755|101328375|FG000|Overall Study|Adverse Event|6|||
33297418|NCT01646177|100984611|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
33297419|NCT01646177|100984612|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
33297420|NCT01646177|100984613|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
33297421|NCT01646177|100984614|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
33393125|NCT04005755|101328375|FG000|Overall Study|Physician Decision|3|||
33393126|NCT04005755|101328375|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
33393127|NCT04005755|101328375|FG000|Overall Study|Withdrawal by Subject|3|||
33393128|NCT04005755|101328375|FG000|Overall Study|Lost to Follow-up|1|||
33393129|NCT02635867|101328378|FG000|Overall Study|Lost to Follow-up|4|||
33297422|NCT01646177|100984603|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33297423|NCT01646177|100984604|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33297424|NCT01646177|100984605|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33393130|NCT02635867|101328379|FG001|Overall Study|Lost to Follow-up|3|||
33297425|NCT01646177|100984606|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33297426|NCT01646177|100984607|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33297427|NCT01646177|100984608|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33297428|NCT01646177|100984609|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33297429|NCT01646177|100984610|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33297430|NCT01646177|100984611|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
33297431|NCT01646177|100984612|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
33297432|NCT01646177|100984613|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
33297433|NCT01646177|100984614|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
33297434|NCT01646177|100984603|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33297435|NCT01646177|100984604|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33297436|NCT01646177|100984605|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33297437|NCT01646177|100984606|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33297438|NCT01646177|100984607|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33297439|NCT01646177|100984608|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33297440|NCT01646177|100984609|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33297441|NCT01646177|100984610|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33297442|NCT01646177|100984611|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
33297443|NCT01646177|100984612|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
33297444|NCT01646177|100984613|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
33297445|NCT01646177|100984614|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
33297446|NCT01646177|100984603|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33297447|NCT01646177|100984604|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33297448|NCT01646177|100984605|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33297449|NCT01646177|100984606|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33297450|NCT01646177|100984607|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33297451|NCT01646177|100984608|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33297452|NCT01646177|100984609|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33297453|NCT01646177|100984610|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33297454|NCT01646177|100984611|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
33297455|NCT01646177|100984612|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
33297456|NCT01646177|100984613|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
33297457|NCT01646177|100984614|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
33297458|NCT01646177|100984603|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33297459|NCT01646177|100984604|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33297460|NCT01646177|100984605|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33297461|NCT01646177|100984606|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33297462|NCT01646177|100984607|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33297463|NCT01646177|100984608|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33297464|NCT01646177|100984609|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33297465|NCT01646177|100984610|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33297466|NCT01646177|100984611|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33297467|NCT01646177|100984612|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
33297468|NCT01646177|100984613|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
33297469|NCT01646177|100984614|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
33297470|NCT00763451|100984617|FG000|Overall Study|Adverse Event|4|||
33297471|NCT00763451|100984618|FG001|Overall Study|Adverse Event|6|||
33297472|NCT00763451|100984619|FG002|Overall Study|Adverse Event|19|||
33297473|NCT00763451|100984620|FG003|Overall Study|Adverse Event|14|||
33297474|NCT00763451|100984617|FG000|Overall Study|Lack of Efficacy|1|||
33297475|NCT00763451|100984618|FG001|Overall Study|Lack of Efficacy|4|||
33297476|NCT00763451|100984619|FG002|Overall Study|Lack of Efficacy|3|||
33297477|NCT00763451|100984620|FG003|Overall Study|Lack of Efficacy|2|||
33297478|NCT00763451|100984617|FG000|Overall Study|Withdrawal by Subject|1|||
33297479|NCT00763451|100984618|FG001|Overall Study|Withdrawal by Subject|6|||
33297480|NCT00763451|100984619|FG002|Overall Study|Withdrawal by Subject|9|||
33393131|NCT02635867|101328380|FG002|Overall Study|Lost to Follow-up|3|||
33393132|NCT02635867|101328381|FG003|Overall Study|Lost to Follow-up|4|||
33393133|NCT02635867|101328382|FG004|Overall Study|Lost to Follow-up|1|||
33393134|NCT01974440|101328383|FG000|Overall Study|Lost to Follow-up|7|||
33393135|NCT01974440|101328384|FG001|Overall Study|Lost to Follow-up|7|||
33393136|NCT01974440|101328383|FG000|Overall Study|Withdrawal by Subject|24|||
33393137|NCT01974440|101328384|FG001|Overall Study|Withdrawal by Subject|20|||
33393138|NCT01974440|101328383|FG000|Overall Study|Sponsor decision|109|||
33393139|NCT01974440|101328384|FG001|Overall Study|Sponsor decision|110|||
33297481|NCT00763451|100984620|FG003|Overall Study|Withdrawal by Subject|7|||
33297482|NCT00763451|100984617|FG000|Overall Study|Protocol Violation|0|||
33297483|NCT00763451|100984618|FG001|Overall Study|Protocol Violation|0|||
33297484|NCT00763451|100984619|FG002|Overall Study|Protocol Violation|1|||
33297485|NCT00763451|100984620|FG003|Overall Study|Protocol Violation|0|||
33297486|NCT00763451|100984617|FG000|Overall Study|Poor Compliance to Protocol|1|||
33297487|NCT00763451|100984618|FG001|Overall Study|Poor Compliance to Protocol|1|||
33297488|NCT00763451|100984619|FG002|Overall Study|Poor Compliance to Protocol|2|||
33297489|NCT00763451|100984620|FG003|Overall Study|Poor Compliance to Protocol|2|||
33297490|NCT00763451|100984617|FG000|Overall Study|Familial and Personal Reasons|5|||
33297491|NCT00763451|100984618|FG001|Overall Study|Familial and Personal Reasons|3|||
33297492|NCT00763451|100984619|FG002|Overall Study|Familial and Personal Reasons|5|||
33297493|NCT00763451|100984620|FG003|Overall Study|Familial and Personal Reasons|4|||
33297494|NCT00763451|100984617|FG000|Overall Study|Randomized but not Treated|1|||
33297495|NCT00763451|100984618|FG001|Overall Study|Randomized but not Treated|1|||
33297496|NCT00763451|100984619|FG002|Overall Study|Randomized but not Treated|0|||
33297497|NCT00763451|100984620|FG003|Overall Study|Randomized but not Treated|0|||
33297498|NCT00763451|100984617|FG000|Overall Study|Study Site Reason|0|||
33297499|NCT00763451|100984618|FG001|Overall Study|Study Site Reason|1|||
33297500|NCT00763451|100984619|FG002|Overall Study|Study Site Reason|1|||
33297501|NCT00763451|100984620|FG003|Overall Study|Study Site Reason|1|||
33297502|NCT01271504|100984629|FG000|Overall Study|Death|7|||
33297503|NCT01271504|100984630|FG001|Overall Study|Death|6|||
33297504|NCT01271504|100984631|FG002|Overall Study|Death|32|||
33297505|NCT01271504|100984632|FG003|Overall Study|Death|32|||
33297506|NCT01271504|100984629|FG000|Overall Study|Lost to Follow-up|0|||
33297507|NCT01271504|100984630|FG001|Overall Study|Lost to Follow-up|1|||
33297508|NCT01271504|100984631|FG002|Overall Study|Lost to Follow-up|3|||
33297509|NCT01271504|100984632|FG003|Overall Study|Lost to Follow-up|1|||
33297510|NCT01271504|100984629|FG000|Overall Study|Protocol Violation|0|||
33297511|NCT01271504|100984630|FG001|Overall Study|Protocol Violation|0|||
33297512|NCT01271504|100984631|FG002|Overall Study|Protocol Violation|0|||
33297513|NCT01271504|100984632|FG003|Overall Study|Protocol Violation|2|||
33297514|NCT01271504|100984629|FG000|Overall Study|Administrative Reasons|0|||
33297515|NCT01271504|100984630|FG001|Overall Study|Administrative Reasons|0|||
33297516|NCT01271504|100984631|FG002|Overall Study|Administrative Reasons|6|||
33297517|NCT01271504|100984632|FG003|Overall Study|Administrative Reasons|5|||
33297518|NCT01271504|100984629|FG000|Overall Study|Withdrawal by Subject|0|||
33297519|NCT01271504|100984630|FG001|Overall Study|Withdrawal by Subject|0|||
33297520|NCT01271504|100984631|FG002|Overall Study|Withdrawal by Subject|1|||
33297521|NCT01271504|100984632|FG003|Overall Study|Withdrawal by Subject|3|||
33297522|NCT01271504|100984629|FG000|Overall Study|Other|0|||
33297523|NCT01271504|100984630|FG001|Overall Study|Other|1|||
33297524|NCT01271504|100984631|FG002|Overall Study|Other|2|||
33297525|NCT01271504|100984632|FG003|Overall Study|Other|0|||
33297526|NCT02963090|100984635|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
33297527|NCT02963090|100984636|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
33297528|NCT00678301|100984637|FG000|Overall Study|Non-compliance with study procedures|0|||
33297529|NCT00678301|100984638|FG001|Overall Study|Non-compliance with study procedures|1|||
33297530|NCT00678301|100984637|FG000|Overall Study|Adverse Event|1|||
33297531|NCT00678301|100984638|FG001|Overall Study|Adverse Event|0|||
33297532|NCT00678301|100984637|FG000|Overall Study|Withdrawal by Subject|4|||
33297533|NCT00678301|100984638|FG001|Overall Study|Withdrawal by Subject|0|||
33297534|NCT00678301|100984637|FG000|Overall Study|Lost to Follow-up|3|||
33297535|NCT00678301|100984638|FG001|Overall Study|Lost to Follow-up|1|||
33297536|NCT04674189|100984639|FG000|Overall Study|Adverse Event|0|||
33393140|NCT02289833|101328385|FG000|Overall Study|Study discontinuation|0|||
33393141|NCT02289833|101328386|FG001|Overall Study|Study discontinuation|1|||
33393142|NCT02289833|101328385|FG000|Overall Study|Lost to Follow-up|4|||
33297537|NCT04674189|100984640|FG001|Overall Study|Adverse Event|0|||
33297538|NCT04674189|100984641|FG002|Overall Study|Adverse Event|1|||
33297539|NCT04674189|100984639|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
33297540|NCT04674189|100984640|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
33297541|NCT04674189|100984641|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
33393143|NCT02289833|101328386|FG001|Overall Study|Lost to Follow-up|0|||
33393144|NCT02289833|101328385|FG000|Overall Study|Death|23|||
33297542|NCT04674189|100984639|FG000|Overall Study|Physician Decision|1|||
33297543|NCT04674189|100984640|FG001|Overall Study|Physician Decision|0|||
33297544|NCT04674189|100984641|FG002|Overall Study|Physician Decision|0|||
33297545|NCT04674189|100984639|FG000|Overall Study|Withdrawal by Participant|83|||
33297546|NCT04674189|100984640|FG001|Overall Study|Withdrawal by Participant|71|||
33297547|NCT04674189|100984641|FG002|Overall Study|Withdrawal by Participant|142|||
33297548|NCT04674189|100984639|FG000|Overall Study|Lost to Follow-up|55|||
33297549|NCT04674189|100984640|FG001|Overall Study|Lost to Follow-up|53|||
33297550|NCT04674189|100984641|FG002|Overall Study|Lost to Follow-up|44|||
33297551|NCT04674189|100984639|FG000|Overall Study|Miscellaneous|27|||
33297552|NCT04674189|100984640|FG001|Overall Study|Miscellaneous|23|||
33297553|NCT04674189|100984641|FG002|Overall Study|Miscellaneous|207|||
33297554|NCT04674189|100984639|FG000|Overall Study|Did Not Receive Treatment|3|||
33297555|NCT04674189|100984640|FG001|Overall Study|Did Not Receive Treatment|1|||
33297556|NCT04674189|100984641|FG002|Overall Study|Did Not Receive Treatment|2|||
33297557|NCT02412735|100984649|FG000|Overall Study|Adverse Event|0|||
33297558|NCT02412735|100984650|FG001|Overall Study|Adverse Event|1|||
33297559|NCT02412735|100984651|FG002|Overall Study|Adverse Event|2|||
33297560|NCT02412735|100984649|FG000|Overall Study|Withdrawal by Subject|23|||
33297561|NCT02412735|100984650|FG001|Overall Study|Withdrawal by Subject|27|||
33297562|NCT02412735|100984651|FG002|Overall Study|Withdrawal by Subject|22|||
33297563|NCT02412735|100984649|FG000|Overall Study|Investigator Decision|3|||
33297564|NCT02412735|100984650|FG001|Overall Study|Investigator Decision|3|||
33297565|NCT02412735|100984651|FG002|Overall Study|Investigator Decision|2|||
33297566|NCT02412735|100984649|FG000|Overall Study|Lost to Follow-up|17|||
33297567|NCT02412735|100984650|FG001|Overall Study|Lost to Follow-up|11|||
33297568|NCT02412735|100984651|FG002|Overall Study|Lost to Follow-up|18|||
33297569|NCT02412735|100984649|FG000|Overall Study|Reason not Specified|3|||
33297570|NCT02412735|100984650|FG001|Overall Study|Reason not Specified|2|||
33297571|NCT02412735|100984651|FG002|Overall Study|Reason not Specified|2|||
33297572|NCT00996606|100984652|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
33297573|NCT00996606|100984652|FG000|Overall Study|Insufficient Therapeutic Response|2|||
33297574|NCT00996606|100984652|FG000|Overall Study|Protocol Violation|1|||
33297575|NCT00996606|100984652|FG000|Overall Study|Withdrawal by Subject|3|||
33297576|NCT01754753|100984653|FG000|Overall Study|Study close|43|||
33297577|NCT01754753|100984654|FG001|Overall Study|Study close|44|||
33297578|NCT01754753|100984653|FG000|Overall Study|Lost to Follow-up|9|||
33297579|NCT01754753|100984654|FG001|Overall Study|Lost to Follow-up|5|||
33297580|NCT01689857|100984666|FG000|Overall Study|Lost to Follow-up|5|||
33297581|NCT01689857|100984667|FG001|Overall Study|Lost to Follow-up|2|||
33297582|NCT00426127|100984668|FG000|Overall Study|Adverse Event|1|||
33297583|NCT00426127|100984668|FG000|Overall Study|Removed due to disease progression|1|||
33297584|NCT01068665|100984669|FG000|Overall Study|Adverse Event|5|||
33297585|NCT01068665|100984670|FG001|Overall Study|Adverse Event|4|||
33297586|NCT01068665|100984669|FG000|Overall Study|Lack of Efficacy|0|||
33297587|NCT01068665|100984670|FG001|Overall Study|Lack of Efficacy|2|||
33297588|NCT01068665|100984669|FG000|Overall Study|Protocol Violation|5|||
33297589|NCT01068665|100984670|FG001|Overall Study|Protocol Violation|2|||
33297590|NCT01068665|100984669|FG000|Overall Study|Withdrawal Criteria|3|||
33297591|NCT01068665|100984670|FG001|Overall Study|Withdrawal Criteria|9|||
33297592|NCT01068665|100984669|FG000|Overall Study|Other|17|||
33297593|NCT01068665|100984670|FG001|Overall Study|Other|12|||
33297594|NCT05383508|100984675|FG000|Overall Study|Withdrawal by Subject|1|||
33297595|NCT05383508|100984676|FG001|Overall Study|Withdrawal by Subject|0|||
33297596|NCT05383508|100984677|FG002|Overall Study|Withdrawal by Subject|1|||
33297597|NCT05383508|100984678|FG003|Overall Study|Withdrawal by Subject|1|||
33297598|NCT05383508|100984679|FG004|Overall Study|Withdrawal by Subject|2|||
33297599|NCT05383508|100984680|FG005|Overall Study|Withdrawal by Subject|0|||
33297600|NCT01080326|100984685|FG000|Overall Study|Patient deterioration prior to procedure|3|||
33297601|NCT01080326|100984685|FG000|Overall Study|Surgeon decision|1|||
33297602|NCT02145468|100984691|FG000|Overall Study|Withdrawal by Subject|5|||
33297603|NCT02145468|100984692|FG001|Overall Study|Withdrawal by Subject|8|||
33297604|NCT01810939|100984693|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
33297605|NCT01810939|100984694|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
33297606|NCT01810939|100984695|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
33297607|NCT01810939|100984693|FG000|Part A Treatment Period|Protocol Violation|2|||
33297608|NCT01810939|100984694|FG001|Part A Treatment Period|Protocol Violation|0|||
33297609|NCT01810939|100984695|FG002|Part A Treatment Period|Protocol Violation|0|||
33297610|NCT01810939|100984693|FG000|Part A Treatment Period|Adverse Event|10|||
33297611|NCT01810939|100984694|FG001|Part A Treatment Period|Adverse Event|0|||
33297612|NCT01810939|100984695|FG002|Part A Treatment Period|Adverse Event|0|||
33297613|NCT01810939|100984693|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
33297614|NCT01810939|100984694|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
33297615|NCT01810939|100984695|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
33297616|NCT01810939|100984693|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
33297617|NCT01810939|100984694|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
33297618|NCT01810939|100984695|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
33297619|NCT01810939|100984693|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
33297620|NCT01810939|100984694|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
33297621|NCT01810939|100984695|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
33297622|NCT01810939|100984693|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
33297623|NCT01810939|100984694|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
33297624|NCT01810939|100984695|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
33297625|NCT01810939|100984693|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
33297626|NCT01810939|100984694|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
33297627|NCT01810939|100984695|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
33297628|NCT01810939|100984693|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
33189881|NCT00720941|100601503|FG001|Overall Study|Ongoing|23|||
33189882|NCT01218516|100601504|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
33297629|NCT01810939|100984694|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
33297630|NCT01810939|100984695|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
33297631|NCT01810939|100984693|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
33297632|NCT01810939|100984694|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
33297633|NCT01810939|100984695|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
33297634|NCT01810939|100984693|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
33297635|NCT01810939|100984694|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
33297636|NCT01810939|100984695|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
33297637|NCT01810939|100984693|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
33393145|NCT02289833|101328386|FG001|Overall Study|Death|16|||
33393146|NCT03050307|101328388|FG000|Overall Study|Adverse Event|4|||
33189883|NCT01218516|100601505|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
33189884|NCT01218516|100601506|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
33189885|NCT01218516|100601507|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
33189886|NCT01218516|100601504|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
33189887|NCT01218516|100601505|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
33189888|NCT01218516|100601506|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
33189889|NCT01218516|100601507|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
33189890|NCT01218516|100601504|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
33189891|NCT01218516|100601505|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
33189892|NCT01218516|100601506|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
33189893|NCT01218516|100601507|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
33189894|NCT01218516|100601504|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
33189895|NCT01218516|100601505|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
33189896|NCT01218516|100601506|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
33189897|NCT01218516|100601507|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
33189898|NCT01218516|100601504|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
33189899|NCT01218516|100601505|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
33189900|NCT01218516|100601506|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
33189901|NCT01218516|100601507|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
33189902|NCT01218516|100601504|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
33189903|NCT01218516|100601505|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
33189904|NCT01218516|100601506|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
33189905|NCT01218516|100601507|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
33189906|NCT01218516|100601504|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
33189907|NCT01218516|100601505|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
33189908|NCT01218516|100601506|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
33189909|NCT01218516|100601507|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
33189910|NCT01218516|100601504|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
33189911|NCT01218516|100601505|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
33189912|NCT01218516|100601506|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
33189913|NCT01218516|100601507|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
33189914|NCT01218516|100601504|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
33189915|NCT01218516|100601505|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
33189916|NCT01218516|100601506|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
33189917|NCT01218516|100601507|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
33189918|NCT01218516|100601504|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
33189919|NCT01218516|100601505|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
33189920|NCT01218516|100601506|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
33189921|NCT01218516|100601507|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
33189922|NCT01218516|100601504|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
33189923|NCT01218516|100601505|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
33189924|NCT01218516|100601506|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
33189925|NCT01218516|100601507|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
33189926|NCT01218516|100601504|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
33297638|NCT01810939|100984694|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
33297639|NCT01810939|100984695|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
33364908|NCT01790438|101223682|FG000|Overall Study|Adverse Event|3|||
33393147|NCT03050307|101328389|FG001|Overall Study|Adverse Event|2|||
33393148|NCT03050307|101328388|FG000|Overall Study|Significant Protocol Deviation|0|||
33393149|NCT03050307|101328389|FG001|Overall Study|Significant Protocol Deviation|1|||
33393150|NCT03050307|101328388|FG000|Overall Study|Lost to Follow-up|0|||
33393151|NCT03050307|101328389|FG001|Overall Study|Lost to Follow-up|1|||
33393152|NCT03050307|101328388|FG000|Overall Study|Voluntary Withdrawal|3|||
33393153|NCT03050307|101328389|FG001|Overall Study|Voluntary Withdrawal|4|||
33393154|NCT03050307|101328388|FG000|Overall Study|Reason not Specified|1|||
33600130|NCT04493684|102088511|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33600131|NCT04493684|102088512|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33600132|NCT04493684|102088513|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
33600133|NCT04493684|102088514|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
33189927|NCT01218516|100601505|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
33189928|NCT01218516|100601506|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
33393155|NCT03050307|101328389|FG001|Overall Study|Reason not Specified|1|||
33189929|NCT01218516|100601507|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
33189930|NCT00997503|100601509|FG000|Overall Study|Death|53|||
33189931|NCT00997503|100601509|FG000|Overall Study|Withdrawal by Subject|76|||
33189932|NCT00997503|100601509|FG000|Overall Study|Lost to Follow-up|33|||
33189933|NCT00997503|100601509|FG000|Overall Study|Adverse Event|3|||
33189934|NCT00997503|100601509|FG000|Overall Study|Physician Decision|10|||
33189935|NCT00997503|100601509|FG000|Overall Study|Missed 12-month follow-up|85|||
33189936|NCT00997503|100601509|FG000|Overall Study|Other reason|13|||
33189937|NCT03325166|100601510|FG000|Overall Study|Adverse Event|1|||
33189938|NCT00004412|100601520|FG000|Randomized Period|Moved to Crossover Period|3|||
33189939|NCT00004412|100601521|FG001|Randomized Period|Moved to Crossover Period|0|||
33189940|NCT00004412|100601522|FG002|Randomized Period|Moved to Crossover Period|0|||
33189941|NCT00111228|100601523|FG000|Overall Study|Withdrawal by Subject|5|||
33189942|NCT00111228|100601524|FG001|Overall Study|Withdrawal by Subject|1|||
33189943|NCT00111228|100601525|FG002|Overall Study|Withdrawal by Subject|0|||
33189944|NCT01371656|100601526|FG000|Overall Study|Death|7|||
33189945|NCT01371656|100601527|FG001|Overall Study|Death|4|||
33189946|NCT01371656|100601526|FG000|Overall Study|Physician Decision|46|||
33189947|NCT01371656|100601527|FG001|Overall Study|Physician Decision|7|||
33189948|NCT01371656|100601526|FG000|Overall Study|Withdrawal by Subject|7|||
33189949|NCT01371656|100601527|FG001|Overall Study|Withdrawal by Subject|0|||
33189950|NCT01371656|100601526|FG000|Overall Study|Ineligible|4|||
33189951|NCT01371656|100601527|FG001|Overall Study|Ineligible|3|||
33189952|NCT01539226|100601528|FG000|Overall Study|Withdrawal by Subject|24|||
33189953|NCT01539226|100601529|FG001|Overall Study|Withdrawal by Subject|54|||
33189954|NCT01539226|100601528|FG000|Overall Study|Lost to Follow-up|20|||
33189955|NCT01539226|100601529|FG001|Overall Study|Lost to Follow-up|54|||
33189956|NCT01539226|100601528|FG000|Overall Study|Death|1|||
33189957|NCT01539226|100601529|FG001|Overall Study|Death|2|||
33189958|NCT01539226|100601528|FG000|Overall Study|Adverse Event|2|||
33189959|NCT01539226|100601529|FG001|Overall Study|Adverse Event|0|||
33189960|NCT01539226|100601528|FG000|Overall Study|Pregnancy|13|||
33189961|NCT01539226|100601529|FG001|Overall Study|Pregnancy|29|||
33189962|NCT01539226|100601528|FG000|Overall Study|inappropriate enrollment|0|||
33189963|NCT01539226|100601529|FG001|Overall Study|inappropriate enrollment|1|||
33189964|NCT01539226|100601528|FG000|Overall Study|Multiple Reasons|3|||
33189965|NCT01539226|100601529|FG001|Overall Study|Multiple Reasons|1|||
33189966|NCT01539226|100601528|FG000|Overall Study|not HIV seroconversion-related|93|||
33189967|NCT01539226|100601529|FG001|Overall Study|not HIV seroconversion-related|176|||
33189968|NCT01539226|100601528|FG000|Overall Study|HIV seroconversion-related|55|||
33189969|NCT01539226|100601529|FG001|Overall Study|HIV seroconversion-related|80|||
33189970|NCT01539226|100601528|FG000|Overall Study|Non-compliance|6|||
33189971|NCT01539226|100601529|FG001|Overall Study|Non-compliance|8|||
33189972|NCT04074317|100601532|FG000|Third Period|Withdrawal by Subject|0|||
33189973|NCT04074317|100601533|FG001|Third Period|Withdrawal by Subject|0|||
33189974|NCT04074317|100601534|FG002|Third Period|Withdrawal by Subject|0|||
33189975|NCT04074317|100601535|FG003|Third Period|Withdrawal by Subject|1|||
33189976|NCT04074317|100601536|FG004|Third Period|Withdrawal by Subject|0|||
33189977|NCT04074317|100601537|FG005|Third Period|Withdrawal by Subject|0|||
33189978|NCT01069289|100601538|FG000|Overall Study|Withdrawal by Subject|15|||
33189979|NCT01069289|100601539|FG001|Overall Study|Withdrawal by Subject|26|||
33189980|NCT01069289|100601538|FG000|Overall Study|Adverse Event|21|||
33189981|NCT01069289|100601539|FG001|Overall Study|Adverse Event|28|||
33189982|NCT01069289|100601538|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33189983|NCT01069289|100601539|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33189984|NCT01069289|100601538|FG000|Overall Study|Severe non-compliance to protocol|3|||
33189985|NCT01069289|100601539|FG001|Overall Study|Severe non-compliance to protocol|2|||
33189986|NCT01069289|100601538|FG000|Overall Study|Due to deteriorating health condition|1|||
33189987|NCT01069289|100601539|FG001|Overall Study|Due to deteriorating health condition|0|||
33393156|NCT01849562|101328391|FG000|Overall Study|Lost to Follow-up|1|||
33393157|NCT01849562|101328392|FG001|Overall Study|Lost to Follow-up|0|||
33297640|NCT01810939|100984693|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
33297641|NCT01810939|100984694|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
33297642|NCT01810939|100984695|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
33297643|NCT01810939|100984693|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
33297644|NCT01810939|100984694|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
33297645|NCT01810939|100984695|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
33297646|NCT01810939|100984693|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
33297647|NCT01810939|100984694|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
33297648|NCT01810939|100984695|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
33297649|NCT01810939|100984693|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
33297650|NCT01810939|100984694|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
33297651|NCT01810939|100984695|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
33297652|NCT01810939|100984693|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
33297653|NCT01810939|100984694|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
33297654|NCT01810939|100984695|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
33297655|NCT03192462|100984702|FG000|Overall Study|Death|13|||
33297656|NCT03192462|100984703|FG001|Overall Study|Death|11|||
33297657|NCT03192462|100984704|FG002|Overall Study|Death|9|||
33297658|NCT03192462|100984702|FG000|Overall Study|Lost to Follow-up|0|||
33297659|NCT03192462|100984703|FG001|Overall Study|Lost to Follow-up|1|||
33297660|NCT03192462|100984704|FG002|Overall Study|Lost to Follow-up|0|||
33297661|NCT03192462|100984702|FG000|Overall Study|On follow up|0|||
33297662|NCT03192462|100984703|FG001|Overall Study|On follow up|0|||
33297663|NCT03192462|100984704|FG002|Overall Study|On follow up|3|||
33297664|NCT02956837|100984706|FG000|Overall Study|Serious Adverse Events|0|||
33297665|NCT02956837|100984707|FG001|Overall Study|Serious Adverse Events|1|||
33297666|NCT02956837|100984708|FG002|Overall Study|Serious Adverse Events|0|||
33297667|NCT02956837|100984709|FG003|Overall Study|Serious Adverse Events|0|||
33297668|NCT02956837|100984706|FG000|Overall Study|Withdrawal by Subject|0|||
33297669|NCT02956837|100984707|FG001|Overall Study|Withdrawal by Subject|1|||
33297670|NCT02956837|100984708|FG002|Overall Study|Withdrawal by Subject|0|||
33297671|NCT02956837|100984709|FG003|Overall Study|Withdrawal by Subject|3|||
33297672|NCT02956837|100984706|FG000|Overall Study|Lost to Follow-up|0|||
33297673|NCT02956837|100984707|FG001|Overall Study|Lost to Follow-up|1|||
33297674|NCT02956837|100984708|FG002|Overall Study|Lost to Follow-up|2|||
33297675|NCT02956837|100984709|FG003|Overall Study|Lost to Follow-up|0|||
33297676|NCT01711853|100984710|FG000|Overall Study|Not treated|3|||
33297677|NCT01696955|100984713|FG000|Main Study|Protocol Violation|1|||
33297678|NCT01696955|100984714|FG001|Main Study|Protocol Violation|0|||
33297679|NCT01696955|100984713|FG000|Main Study|Withdrawal by Subject|1|||
33297680|NCT01696955|100984714|FG001|Main Study|Withdrawal by Subject|1|||
33393158|NCT01849562|101328393|FG002|Overall Study|Lost to Follow-up|0|||
33393159|NCT01849562|101328391|FG000|Overall Study|Non-compliance with Study Drug|1|||
33189988|NCT00419562|100601540|FG000|Overall Study|Lost to Follow-up|12|||
33189989|NCT00419562|100601541|FG001|Overall Study|Lost to Follow-up|13|||
33189990|NCT00419562|100601540|FG000|Overall Study|Withdrawal by Subject|20|||
33189991|NCT00419562|100601541|FG001|Overall Study|Withdrawal by Subject|18|||
33189992|NCT00419562|100601540|FG000|Overall Study|Participant Institutionalized|1|||
33189993|NCT00419562|100601541|FG001|Overall Study|Participant Institutionalized|0|||
33189994|NCT01565291|100601543|FG000|Overall Study|Withdrawal by Subject|1|||
33189995|NCT01565291|100601544|FG001|Overall Study|Withdrawal by Subject|0|||
33189996|NCT04709575|100601545|FG000|Overall Study|Withdrawal by Subject|6|||
33189997|NCT04709575|100601546|FG001|Overall Study|Withdrawal by Subject|2|||
33189998|NCT04709575|100601545|FG000|Overall Study|Lost to Follow-up|2|||
33297681|NCT02416453|100984715|FG000|Overall Study|Adverse Event|0|||
33297682|NCT02416453|100984716|FG001|Overall Study|Adverse Event|0|||
33297683|NCT02416453|100984717|FG002|Overall Study|Adverse Event|0|||
33297684|NCT02416453|100984718|FG003|Overall Study|Adverse Event|2|||
33297685|NCT02416453|100984719|FG004|Overall Study|Adverse Event|0|||
33297686|NCT02416453|100984720|FG005|Overall Study|Adverse Event|1|||
33297687|NCT02416453|100984721|FG006|Overall Study|Adverse Event|0|||
33297688|NCT02416453|100984722|FG007|Overall Study|Adverse Event|0|||
33297689|NCT02416453|100984723|FG008|Overall Study|Adverse Event|0|||
33297690|NCT02416453|100984724|FG009|Overall Study|Adverse Event|0|||
33297691|NCT02416453|100984725|FG010|Overall Study|Adverse Event|0|||
33297692|NCT02416453|100984715|FG000|Overall Study|Lost to Follow-up|1|||
33393160|NCT01849562|101328392|FG001|Overall Study|Non-compliance with Study Drug|0|||
33393161|NCT01849562|101328393|FG002|Overall Study|Non-compliance with Study Drug|0|||
33393162|NCT00981292|101328394|FG000|Day 1|Protocol Violation|1|||
33393163|NCT00981292|101328395|FG001|Day 1|Protocol Violation|0|||
33393164|NCT00981292|101328396|FG002|Day 1|Protocol Violation|0|||
33189999|NCT04709575|100601546|FG001|Overall Study|Lost to Follow-up|2|||
33190000|NCT04709575|100601545|FG000|Overall Study|Adverse Event|1|||
33190001|NCT04709575|100601546|FG001|Overall Study|Adverse Event|0|||
33190002|NCT04709575|100601545|FG000|Overall Study|Protocol Violation|1|||
33190003|NCT04709575|100601546|FG001|Overall Study|Protocol Violation|1|||
33190004|NCT00218543|100601547|FG000|Overall Study|Lost to Follow-up|8|||
33190005|NCT00218543|100601547|FG000|Overall Study|relocated|1|||
33190006|NCT00218543|100601547|FG000|Overall Study|Withdrawal by Subject|1|||
33190007|NCT00218543|100601547|FG000|Overall Study|Physician Decision|3|||
33190008|NCT00218543|100601547|FG000|Overall Study|Adverse Event|2|||
33190009|NCT00654381|100601548|FG000|1st Stage|Adverse Event|3|||
33190010|NCT00654381|100601549|FG001|1st Stage|Adverse Event|3|||
33190011|NCT00654381|100601550|FG002|1st Stage|Adverse Event|3|||
33190012|NCT00654381|100601551|FG003|1st Stage|Adverse Event|3|||
33190013|NCT00654381|100601552|FG004|1st Stage|Adverse Event|2|||
33190014|NCT00654381|100601553|FG005|1st Stage|Adverse Event|1|||
33190015|NCT00654381|100601548|FG000|1st Stage|Withdrawal by Subject|0|||
33190016|NCT00654381|100601549|FG001|1st Stage|Withdrawal by Subject|0|||
33190017|NCT00654381|100601550|FG002|1st Stage|Withdrawal by Subject|0|||
33190018|NCT00654381|100601551|FG003|1st Stage|Withdrawal by Subject|1|||
33190019|NCT00654381|100601552|FG004|1st Stage|Withdrawal by Subject|0|||
33190020|NCT00654381|100601553|FG005|1st Stage|Withdrawal by Subject|1|||
33190021|NCT00654381|100601548|FG000|1st Stage|Investigator's decision|0|||
33190022|NCT00654381|100601549|FG001|1st Stage|Investigator's decision|0|||
33190023|NCT00654381|100601550|FG002|1st Stage|Investigator's decision|0|||
33190024|NCT00654381|100601551|FG003|1st Stage|Investigator's decision|1|||
33190025|NCT00654381|100601552|FG004|1st Stage|Investigator's decision|0|||
33190026|NCT00654381|100601553|FG005|1st Stage|Investigator's decision|0|||
33190027|NCT00654381|100601548|FG000|2nd Stage|Adverse Event|2|||
33190028|NCT00654381|100601549|FG001|2nd Stage|Adverse Event|0|||
33190029|NCT00654381|100601550|FG002|2nd Stage|Adverse Event|2|||
33190030|NCT00654381|100601551|FG003|2nd Stage|Adverse Event|3|||
33190031|NCT00654381|100601552|FG004|2nd Stage|Adverse Event|7|||
33190032|NCT00654381|100601553|FG005|2nd Stage|Adverse Event|2|||
33190033|NCT00654381|100601548|FG000|2nd Stage|Withdrawal by Subject|0|||
33190034|NCT00654381|100601549|FG001|2nd Stage|Withdrawal by Subject|0|||
33190035|NCT00654381|100601550|FG002|2nd Stage|Withdrawal by Subject|0|||
33190036|NCT00654381|100601551|FG003|2nd Stage|Withdrawal by Subject|0|||
33190037|NCT00654381|100601552|FG004|2nd Stage|Withdrawal by Subject|1|||
33190038|NCT00654381|100601553|FG005|2nd Stage|Withdrawal by Subject|1|||
33190039|NCT00654381|100601548|FG000|2nd Stage|Investigator's decision|0|||
33190040|NCT00654381|100601549|FG001|2nd Stage|Investigator's decision|0|||
33190041|NCT00654381|100601550|FG002|2nd Stage|Investigator's decision|1|||
33190042|NCT00654381|100601551|FG003|2nd Stage|Investigator's decision|1|||
33190043|NCT00654381|100601552|FG004|2nd Stage|Investigator's decision|0|||
33190044|NCT00654381|100601553|FG005|2nd Stage|Investigator's decision|0|||
33190045|NCT00654381|100601548|FG000|Extension Stage|Adverse Event|1|||
33190046|NCT00654381|100601549|FG001|Extension Stage|Adverse Event|2|||
33190047|NCT00654381|100601550|FG002|Extension Stage|Adverse Event|9|||
33190048|NCT00654381|100601551|FG003|Extension Stage|Adverse Event|7|||
33190049|NCT00654381|100601552|FG004|Extension Stage|Adverse Event|1|||
33190050|NCT00654381|100601553|FG005|Extension Stage|Adverse Event|1|||
33190051|NCT00654381|100601548|FG000|Extension Stage|Protocol Violation|0|||
33190052|NCT00654381|100601549|FG001|Extension Stage|Protocol Violation|0|||
33190053|NCT00654381|100601550|FG002|Extension Stage|Protocol Violation|0|||
33190054|NCT00654381|100601551|FG003|Extension Stage|Protocol Violation|1|||
33190055|NCT00654381|100601552|FG004|Extension Stage|Protocol Violation|0|||
33190056|NCT00654381|100601553|FG005|Extension Stage|Protocol Violation|0|||
33190057|NCT00654381|100601548|FG000|Extension Stage|Lack of Efficacy|0|||
33190058|NCT00654381|100601549|FG001|Extension Stage|Lack of Efficacy|0|||
33190059|NCT00654381|100601550|FG002|Extension Stage|Lack of Efficacy|1|||
33190060|NCT00654381|100601551|FG003|Extension Stage|Lack of Efficacy|0|||
33190061|NCT00654381|100601552|FG004|Extension Stage|Lack of Efficacy|0|||
33393165|NCT00981292|101328397|FG003|Day 1|Protocol Violation|0|||
33393166|NCT00981292|101328398|FG004|Day 1|Protocol Violation|0|||
33600134|NCT05239221|102088515|FG000|Overall Study|Adverse Event|0|||
33600135|NCT05239221|102088516|FG001|Overall Study|Adverse Event|0|||
33600136|NCT05239221|102088517|FG002|Overall Study|Adverse Event|0|||
33600137|NCT05239221|102088518|FG003|Overall Study|Adverse Event|0|||
33190062|NCT00654381|100601553|FG005|Extension Stage|Lack of Efficacy|0|||
33190063|NCT00654381|100601548|FG000|Extension Stage|Withdrawal by Subject|0|||
33190064|NCT00654381|100601549|FG001|Extension Stage|Withdrawal by Subject|0|||
33190065|NCT00654381|100601550|FG002|Extension Stage|Withdrawal by Subject|1|||
33190066|NCT00654381|100601551|FG003|Extension Stage|Withdrawal by Subject|1|||
33190067|NCT00654381|100601552|FG004|Extension Stage|Withdrawal by Subject|1|||
33190068|NCT00654381|100601553|FG005|Extension Stage|Withdrawal by Subject|1|||
33393167|NCT00981292|101328399|FG005|Day 1|Protocol Violation|2|||
33393168|NCT00981292|101328394|FG000|Day 2|Protocol Violation|2|||
33297693|NCT02416453|100984716|FG001|Overall Study|Lost to Follow-up|3|||
33297694|NCT02416453|100984717|FG002|Overall Study|Lost to Follow-up|0|||
33297695|NCT02416453|100984718|FG003|Overall Study|Lost to Follow-up|8|||
33297696|NCT02416453|100984719|FG004|Overall Study|Lost to Follow-up|0|||
33297697|NCT02416453|100984720|FG005|Overall Study|Lost to Follow-up|5|||
33297698|NCT02416453|100984721|FG006|Overall Study|Lost to Follow-up|1|||
33297699|NCT02416453|100984722|FG007|Overall Study|Lost to Follow-up|3|||
33297700|NCT02416453|100984723|FG008|Overall Study|Lost to Follow-up|1|||
33297701|NCT02416453|100984724|FG009|Overall Study|Lost to Follow-up|0|||
33297702|NCT02416453|100984725|FG010|Overall Study|Lost to Follow-up|0|||
33297703|NCT02416453|100984715|FG000|Overall Study|Physician Decision|0|||
33297704|NCT02416453|100984716|FG001|Overall Study|Physician Decision|0|||
33297705|NCT02416453|100984717|FG002|Overall Study|Physician Decision|0|||
33297706|NCT02416453|100984718|FG003|Overall Study|Physician Decision|0|||
33297707|NCT02416453|100984719|FG004|Overall Study|Physician Decision|0|||
33297708|NCT02416453|100984720|FG005|Overall Study|Physician Decision|1|||
33297709|NCT02416453|100984721|FG006|Overall Study|Physician Decision|1|||
33297710|NCT02416453|100984722|FG007|Overall Study|Physician Decision|1|||
33297711|NCT02416453|100984723|FG008|Overall Study|Physician Decision|0|||
33297712|NCT02416453|100984724|FG009|Overall Study|Physician Decision|0|||
33297713|NCT02416453|100984725|FG010|Overall Study|Physician Decision|0|||
33297714|NCT02416453|100984715|FG000|Overall Study|Withdrawal by Subject|2|||
33297715|NCT02416453|100984716|FG001|Overall Study|Withdrawal by Subject|0|||
33297716|NCT02416453|100984717|FG002|Overall Study|Withdrawal by Subject|0|||
33297717|NCT02416453|100984718|FG003|Overall Study|Withdrawal by Subject|5|||
33297718|NCT02416453|100984719|FG004|Overall Study|Withdrawal by Subject|1|||
33297719|NCT02416453|100984720|FG005|Overall Study|Withdrawal by Subject|8|||
33297720|NCT02416453|100984721|FG006|Overall Study|Withdrawal by Subject|0|||
33297721|NCT02416453|100984722|FG007|Overall Study|Withdrawal by Subject|8|||
33297722|NCT02416453|100984723|FG008|Overall Study|Withdrawal by Subject|4|||
33297723|NCT02416453|100984724|FG009|Overall Study|Withdrawal by Subject|0|||
33297724|NCT02416453|100984725|FG010|Overall Study|Withdrawal by Subject|0|||
33297725|NCT02416453|100984715|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33297726|NCT02416453|100984716|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33297727|NCT02416453|100984717|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
33297728|NCT02416453|100984718|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33297729|NCT02416453|100984719|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33297730|NCT02416453|100984720|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33297731|NCT02416453|100984721|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33297732|NCT02416453|100984722|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33297733|NCT02416453|100984723|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33297734|NCT02416453|100984724|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33297735|NCT02416453|100984725|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
33297736|NCT02416453|100984715|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33297737|NCT02416453|100984716|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33297738|NCT02416453|100984717|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33297739|NCT02416453|100984718|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33297740|NCT02416453|100984719|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33297741|NCT02416453|100984720|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
33297742|NCT02416453|100984721|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33297743|NCT02416453|100984722|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33297744|NCT02416453|100984723|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33297745|NCT02416453|100984724|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33297746|NCT02416453|100984725|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
33297747|NCT01706705|100984729|FG000|Overall Study|Death|1|||
33297748|NCT01706705|100984729|FG000|Overall Study|Lack of Efficacy|13|||
33297749|NCT01706705|100984729|FG000|Overall Study|Non-clinical|6|||
33297750|NCT04707664|100984735|FG000|Overall Study|Adverse Event|2|||
33297751|NCT04707664|100984736|FG001|Overall Study|Adverse Event|0|||
33297752|NCT04707664|100984735|FG000|Overall Study|Death|1|||
33297753|NCT04707664|100984736|FG001|Overall Study|Death|2|||
33297754|NCT04707664|100984735|FG000|Overall Study|Withdrawal by Subject|13|||
33297755|NCT04707664|100984736|FG001|Overall Study|Withdrawal by Subject|21|||
33297756|NCT04707664|100984735|FG000|Overall Study|Lost to Follow-up|11|||
33297757|NCT04707664|100984736|FG001|Overall Study|Lost to Follow-up|13|||
33297758|NCT04707664|100984735|FG000|Overall Study|Not treated|2|||
33297759|NCT04707664|100984736|FG001|Overall Study|Not treated|0|||
33297760|NCT00911768|100984744|FG000|Overall Study|Protocol Violation|5|||
33297761|NCT00911768|100984745|FG001|Overall Study|Protocol Violation|4|||
33297762|NCT00911768|100984744|FG000|Overall Study|Withdrawal by Subject|1|||
33297763|NCT00911768|100984745|FG001|Overall Study|Withdrawal by Subject|0|||
33297764|NCT04954326|100984746|FG000|Overall Study|Protocol Violation|0|||
33297765|NCT04954326|100984747|FG001|Overall Study|Protocol Violation|1|||
33297766|NCT04954326|100984746|FG000|Overall Study|Death|0|||
33297767|NCT04954326|100984747|FG001|Overall Study|Death|2|||
33297768|NCT04954326|100984746|FG000|Overall Study|Physician Decision|0|||
33297769|NCT04954326|100984747|FG001|Overall Study|Physician Decision|1|||
33297770|NCT03559062|100984748|FG000|Overall Study|Other|0|||
33297771|NCT03559062|100984749|FG001|Overall Study|Other|1|||
33297772|NCT03559062|100984750|FG002|Overall Study|Other|0|||
33297773|NCT01637077|100984751|FG000|Overall Study|Cancel|1|||
33297774|NCT01637077|100984752|FG001|Overall Study|Cancel|1|||
33297775|NCT01637077|100984751|FG000|Overall Study|Withdrawal by Subject|1|||
33297776|NCT01637077|100984752|FG001|Overall Study|Withdrawal by Subject|0|||
33297777|NCT01637077|100984751|FG000|Overall Study|No cycle 1 questionnaire data|2|||
33297778|NCT01637077|100984752|FG001|Overall Study|No cycle 1 questionnaire data|0|||
33297779|NCT01133418|100984754|FG000|Overall Study|Lost to Follow-up|5|||
33297780|NCT01133418|100984755|FG001|Overall Study|Lost to Follow-up|6|||
33297781|NCT03381339|100984756|FG000|Overall Study|Protocol Violation|4|||
33297782|NCT03381339|100984757|FG001|Overall Study|Protocol Violation|3|||
33297783|NCT03381339|100984756|FG000|Overall Study|Lost to Follow-up|0|||
33297784|NCT03381339|100984757|FG001|Overall Study|Lost to Follow-up|1|||
33297785|NCT01385748|100984758|FG000|Overall Study|Withdrawal by Subject|7|||
33297786|NCT01385748|100984759|FG001|Overall Study|Withdrawal by Subject|4|||
33297787|NCT01385748|100984760|FG002|Overall Study|Withdrawal by Subject|5|||
33297788|NCT01385748|100984758|FG000|Overall Study|Noncompliance|3|||
33297789|NCT01385748|100984759|FG001|Overall Study|Noncompliance|1|||
33297790|NCT01385748|100984760|FG002|Overall Study|Noncompliance|6|||
33297791|NCT01385748|100984758|FG000|Overall Study|Other|1|||
33297792|NCT01385748|100984759|FG001|Overall Study|Other|7|||
33297793|NCT01385748|100984760|FG002|Overall Study|Other|1|||
33297794|NCT01385748|100984758|FG000|Overall Study|Adverse Event|4|||
33297795|NCT01385748|100984759|FG001|Overall Study|Adverse Event|2|||
33297796|NCT01385748|100984760|FG002|Overall Study|Adverse Event|1|||
33297797|NCT02687035|100984761|FG000|Overall Study|Withdrawal by Subject|1|||
33297798|NCT02687035|100984761|FG000|Overall Study|Death|87|||
33297799|NCT02687035|100984761|FG000|Overall Study|Lost to Follow-up|1|||
33297800|NCT02687035|100984761|FG000|Overall Study|Missed Visit|87|||
33297801|NCT02687035|100984761|FG000|Overall Study|Did not receive Study Device|8|||
33297802|NCT03838731|100984764|FG000|Overall Study|Pregnancy|0|||
33297803|NCT03838731|100984765|FG001|Overall Study|Pregnancy|1|||
33297804|NCT03838731|100984764|FG000|Overall Study|Withdrawal of consent|1|||
33393169|NCT00981292|101328395|FG001|Day 2|Protocol Violation|0|||
33393170|NCT00981292|101328396|FG002|Day 2|Protocol Violation|0|||
33393171|NCT00981292|101328397|FG003|Day 2|Protocol Violation|0|||
33393172|NCT00981292|101328398|FG004|Day 2|Protocol Violation|0|||
33297805|NCT03838731|100984765|FG001|Overall Study|Withdrawal of consent|0|||
33297806|NCT01436253|100984766|FG000|Overall Study|Lost to Follow-up|182|||
33297807|NCT01436253|100984766|FG000|Overall Study|Not meeting all eligibility criteria|117|||
33297808|NCT02489968|100984769|FG000|Open-label Treatment Period|Adverse Event|14|||
33297809|NCT02489968|100984770|FG001|Open-label Treatment Period|Adverse Event|7|||
33297810|NCT02489968|100984771|FG002|Open-label Treatment Period|Adverse Event|0|||
33297811|NCT02489968|100984772|FG003|Open-label Treatment Period|Adverse Event|0|||
33297812|NCT02489968|100984773|FG004|Open-label Treatment Period|Adverse Event|0|||
33297813|NCT02489968|100984774|FG005|Open-label Treatment Period|Adverse Event|0|||
33297814|NCT02489968|100984769|FG000|Open-label Treatment Period|Protocol Violation|2|||
33297815|NCT02489968|100984770|FG001|Open-label Treatment Period|Protocol Violation|2|||
33297816|NCT02489968|100984771|FG002|Open-label Treatment Period|Protocol Violation|0|||
33297817|NCT02489968|100984772|FG003|Open-label Treatment Period|Protocol Violation|0|||
33393173|NCT00981292|101328399|FG005|Day 2|Protocol Violation|0|||
33393174|NCT00981292|101328394|FG000|Day 3|Protocol Violation|0|||
33393175|NCT00981292|101328395|FG001|Day 3|Protocol Violation|0|||
33393176|NCT00981292|101328396|FG002|Day 3|Protocol Violation|0|||
33393177|NCT00981292|101328397|FG003|Day 3|Protocol Violation|0|||
33393178|NCT00981292|101328398|FG004|Day 3|Protocol Violation|0|||
33393179|NCT00981292|101328399|FG005|Day 3|Protocol Violation|1|||
33393180|NCT01462045|101328400|FG000|Overall Study|Family matter|0|||
33393181|NCT01462045|101328401|FG001|Overall Study|Family matter|1|||
33393182|NCT01462045|101328402|FG002|Overall Study|Family matter|0|||
33393183|NCT02692560|101328403|FG000|Overall Study|Withdrawal by Subject|0|||
33393184|NCT02692560|101328404|FG001|Overall Study|Withdrawal by Subject|6|||
33393185|NCT04847141|101328411|FG000|Overall Study|Adverse Event|1|||
33393186|NCT04847141|101328412|FG001|Overall Study|Adverse Event|0|||
33393187|NCT04847141|101328413|FG002|Overall Study|Adverse Event|1|||
33393188|NCT04847141|101328411|FG000|Overall Study|Withdrawal by Subject|2|||
33393189|NCT04847141|101328412|FG001|Overall Study|Withdrawal by Subject|4|||
33393190|NCT04847141|101328413|FG002|Overall Study|Withdrawal by Subject|3|||
33297818|NCT02489968|100984773|FG004|Open-label Treatment Period|Protocol Violation|0|||
33297819|NCT02489968|100984774|FG005|Open-label Treatment Period|Protocol Violation|0|||
33297820|NCT02489968|100984769|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
33393191|NCT04847141|101328411|FG000|Overall Study|Lost to Follow-up|7|||
33393192|NCT04847141|101328412|FG001|Overall Study|Lost to Follow-up|5|||
33600138|NCT05239221|102088519|FG004|Overall Study|Adverse Event|0|||
33393193|NCT04847141|101328413|FG002|Overall Study|Lost to Follow-up|7|||
33393194|NCT04847141|101328411|FG000|Overall Study|Reason not Specified|0|||
33297821|NCT02489968|100984770|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
33297822|NCT02489968|100984771|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
33297823|NCT02489968|100984772|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
33297824|NCT02489968|100984773|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
33297825|NCT02489968|100984774|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
33297826|NCT02489968|100984769|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
33297827|NCT02489968|100984770|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
33297828|NCT02489968|100984771|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
33297829|NCT02489968|100984772|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
33297830|NCT02489968|100984773|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
33297831|NCT02489968|100984774|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
33297832|NCT02489968|100984769|FG000|Open-label Treatment Period|Other than specified above|204|||
33297833|NCT02489968|100984770|FG001|Open-label Treatment Period|Other than specified above|189|||
33297834|NCT02489968|100984771|FG002|Open-label Treatment Period|Other than specified above|0|||
33297835|NCT02489968|100984772|FG003|Open-label Treatment Period|Other than specified above|0|||
33297836|NCT02489968|100984773|FG004|Open-label Treatment Period|Other than specified above|0|||
33297837|NCT02489968|100984774|FG005|Open-label Treatment Period|Other than specified above|0|||
33297838|NCT02489968|100984769|FG000|Double-blind Treatment Period|Adverse Event|0|||
33297839|NCT02489968|100984770|FG001|Double-blind Treatment Period|Adverse Event|0|||
33297840|NCT02489968|100984771|FG002|Double-blind Treatment Period|Adverse Event|2|||
33297841|NCT02489968|100984772|FG003|Double-blind Treatment Period|Adverse Event|6|||
33297842|NCT02489968|100984773|FG004|Double-blind Treatment Period|Adverse Event|4|||
33297843|NCT02489968|100984774|FG005|Double-blind Treatment Period|Adverse Event|5|||
33297844|NCT02489968|100984769|FG000|Double-blind Treatment Period|Protocol Violation|0|||
33297845|NCT02489968|100984770|FG001|Double-blind Treatment Period|Protocol Violation|0|||
33297846|NCT02489968|100984771|FG002|Double-blind Treatment Period|Protocol Violation|0|||
33297847|NCT02489968|100984772|FG003|Double-blind Treatment Period|Protocol Violation|0|||
33297848|NCT02489968|100984773|FG004|Double-blind Treatment Period|Protocol Violation|1|||
33297849|NCT02489968|100984774|FG005|Double-blind Treatment Period|Protocol Violation|1|||
33297850|NCT02489968|100984769|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
33297851|NCT02489968|100984770|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
33297852|NCT02489968|100984771|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33297853|NCT02489968|100984772|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
33393195|NCT04847141|101328412|FG001|Overall Study|Reason not Specified|1|||
33393196|NCT04847141|101328413|FG002|Overall Study|Reason not Specified|0|||
33393197|NCT01117181|101328416|FG000|Overall Study|Lost to Follow-up|1|||
33393198|NCT01117181|101328417|FG001|Overall Study|Lost to Follow-up|0|||
33393199|NCT01117181|101328416|FG000|Overall Study|Withdrawal by Subject|0|||
33393200|NCT01117181|101328417|FG001|Overall Study|Withdrawal by Subject|2|||
33393201|NCT03573804|101328418|FG000|Overall Study|claustrophobia or MRI table problems|10|||
33297854|NCT02489968|100984773|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
33393202|NCT00880100|101328419|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
33393203|NCT00880100|101328419|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
33393204|NCT00880100|101328419|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
33393205|NCT02147691|101328420|FG000|Overall Study|Withdrawal by Subject|2|||
33393206|NCT02147691|101328421|FG001|Overall Study|Withdrawal by Subject|0|||
33393207|NCT02147691|101328420|FG000|Overall Study|Adverse Event|2|||
33393208|NCT02147691|101328421|FG001|Overall Study|Adverse Event|0|||
33393209|NCT02147691|101328420|FG000|Overall Study|Lost to Follow-up|0|||
33393210|NCT02147691|101328421|FG001|Overall Study|Lost to Follow-up|1|||
33393211|NCT01291511|101328422|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
33393212|NCT01291511|101328423|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
33393213|NCT01291511|101328422|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
33393214|NCT01291511|101328423|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
33393215|NCT01291511|101328422|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
33393216|NCT01291511|101328423|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
33393217|NCT01291511|101328422|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
33393218|NCT01291511|101328423|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
33297855|NCT02489968|100984774|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
33297856|NCT02489968|100984769|FG000|Double-blind Treatment Period|Other than specified above|0|||
33297857|NCT02489968|100984770|FG001|Double-blind Treatment Period|Other than specified above|0|||
33297858|NCT02489968|100984771|FG002|Double-blind Treatment Period|Other than specified above|0|||
33297859|NCT02489968|100984772|FG003|Double-blind Treatment Period|Other than specified above|0|||
33297860|NCT02489968|100984773|FG004|Double-blind Treatment Period|Other than specified above|1|||
33297861|NCT02489968|100984774|FG005|Double-blind Treatment Period|Other than specified above|0|||
33297862|NCT00846807|100984775|FG000|Overall Study|Adverse Event|270|||
33297863|NCT00846807|100984775|FG000|Overall Study|Lost to Follow-up|94|||
33297864|NCT00846807|100984775|FG000|Overall Study|Withdrawal by Subject|56|||
33364909|NCT01790438|101223683|FG001|Overall Study|Adverse Event|2|||
33297865|NCT00846807|100984775|FG000|Overall Study|Non compliant with European label|7|||
33297866|NCT00846807|100984775|FG000|Overall Study|Switch to other anticoagulants|89|||
33297867|NCT00846807|100984775|FG000|Overall Study|No prescription after hospital discharge|56|||
33297868|NCT00846807|100984775|FG000|Overall Study|Other|60|||
33297869|NCT02609672|100984776|FG000|Overall Study|Lost to Follow-up|3|||
33393219|NCT01291511|101328422|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
33393220|NCT01291511|101328423|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
33297870|NCT02609672|100984777|FG001|Overall Study|Lost to Follow-up|1|||
33297871|NCT02993523|100984780|FG000|Overall Study|Withdrew Consent|0|||
33297872|NCT02993523|100984781|FG001|Overall Study|Withdrew Consent|0|||
33297873|NCT02993523|100984782|FG002|Overall Study|Withdrew Consent|2|||
33297874|NCT02993523|100984783|FG003|Overall Study|Withdrew Consent|9|||
33297875|NCT02993523|100984784|FG004|Overall Study|Withdrew Consent|0|||
33393221|NCT01291511|101328422|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
33190069|NCT00654381|100601548|FG000|Extension Stage|Closure of the trial site|0|||
33190070|NCT00654381|100601549|FG001|Extension Stage|Closure of the trial site|0|||
33190071|NCT00654381|100601550|FG002|Extension Stage|Closure of the trial site|0|||
33190072|NCT00654381|100601551|FG003|Extension Stage|Closure of the trial site|0|||
33190073|NCT00654381|100601552|FG004|Extension Stage|Closure of the trial site|1|||
33190074|NCT00654381|100601553|FG005|Extension Stage|Closure of the trial site|1|||
33190075|NCT00640510|100601557|FG000|Overall Study|Lack of Efficacy|0|||
33190076|NCT00640510|100601558|FG001|Overall Study|Lack of Efficacy|1|||
33190077|NCT00640510|100601557|FG000|Overall Study|Protocol Violation|1|||
33190078|NCT00640510|100601558|FG001|Overall Study|Protocol Violation|0|||
33190079|NCT00640510|100601557|FG000|Overall Study|Physician Decision|0|||
33190080|NCT00640510|100601558|FG001|Overall Study|Physician Decision|1|||
33190081|NCT01176292|100601560|FG000|Overall Study|Lost to Follow-up|2|||
33190082|NCT01176292|100601561|FG001|Overall Study|Lost to Follow-up|4|||
33190083|NCT01176292|100601560|FG000|Overall Study|Adverse Event|1|||
33190084|NCT01176292|100601561|FG001|Overall Study|Adverse Event|1|||
33190085|NCT01176292|100601560|FG000|Overall Study|Physician Decision|0|||
33393222|NCT01291511|101328423|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
33393223|NCT01291511|101328422|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
33393224|NCT01291511|101328423|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
33393225|NCT01291511|101328422|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
33393226|NCT01291511|101328423|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
33393227|NCT01291511|101328422|FG000|Cross-Titration and Stabilization Phase|Death|1|||
33393228|NCT01291511|101328423|FG001|Cross-Titration and Stabilization Phase|Death|0|||
33393229|NCT01291511|101328422|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
33393230|NCT01291511|101328423|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
33393231|NCT01291511|101328422|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
33393232|NCT01291511|101328423|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
33393233|NCT01291511|101328422|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
33393234|NCT01291511|101328423|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
33393235|NCT01291511|101328422|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
33393236|NCT01291511|101328423|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
33393237|NCT01291511|101328422|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
33393238|NCT01291511|101328423|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
33393239|NCT01291511|101328422|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
33393240|NCT01291511|101328423|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
33393241|NCT01291511|101328422|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
33393242|NCT01291511|101328423|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
33393243|NCT01291511|101328422|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
33393244|NCT01291511|101328423|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
33393245|NCT01291511|101328422|FG000|Double-blind Relapse Prevention Phase|Death|1|||
33393246|NCT01291511|101328423|FG001|Double-blind Relapse Prevention Phase|Death|0|||
33393247|NCT01237223|101328430|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
33393248|NCT01237223|101328431|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
33393249|NCT01237223|101328432|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
33190086|NCT01176292|100601561|FG001|Overall Study|Physician Decision|2|||
33190087|NCT01176292|100601560|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
33190088|NCT01176292|100601561|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
33190089|NCT00207142|100601568|FG000|Induction Phase|Adverse Event|9|||
33393250|NCT01237223|101328433|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
33190090|NCT00207142|100601569|FG001|Induction Phase|Adverse Event|0|||
33190091|NCT00207142|100601570|FG002|Induction Phase|Adverse Event|0|||
33190092|NCT00207142|100601571|FG003|Induction Phase|Adverse Event|0|||
33190093|NCT00207142|100601568|FG000|Induction Phase|Death|1|||
33190094|NCT00207142|100601569|FG001|Induction Phase|Death|0|||
33190095|NCT00207142|100601570|FG002|Induction Phase|Death|0|||
33297876|NCT02993523|100984780|FG000|Overall Study|Lost to Follow-up|0|||
33297877|NCT02993523|100984781|FG001|Overall Study|Lost to Follow-up|0|||
33297878|NCT02993523|100984782|FG002|Overall Study|Lost to Follow-up|3|||
33297879|NCT02993523|100984783|FG003|Overall Study|Lost to Follow-up|6|||
33297880|NCT02993523|100984784|FG004|Overall Study|Lost to Follow-up|0|||
33297881|NCT02993523|100984780|FG000|Overall Study|Death|1|||
33297882|NCT02993523|100984781|FG001|Overall Study|Death|1|||
33297883|NCT02993523|100984782|FG002|Overall Study|Death|138|||
33297884|NCT02993523|100984783|FG003|Overall Study|Death|222|||
33297885|NCT02993523|100984784|FG004|Overall Study|Death|6|||
33297886|NCT02993523|100984780|FG000|Overall Study|Reason not Specified|0|||
33297887|NCT02993523|100984781|FG001|Overall Study|Reason not Specified|0|||
33297888|NCT02993523|100984782|FG002|Overall Study|Reason not Specified|1|||
33297889|NCT02993523|100984783|FG003|Overall Study|Reason not Specified|1|||
33297890|NCT02993523|100984784|FG004|Overall Study|Reason not Specified|0|||
33297891|NCT01435772|100984785|FG000|Overall Study|Adverse Event|1|||
33297892|NCT01435772|100984786|FG001|Overall Study|Adverse Event|0|||
33297893|NCT01435772|100984787|FG002|Overall Study|Adverse Event|2|||
33297894|NCT01435772|100984785|FG000|Overall Study|Withdrawal by Subject|0|||
33297895|NCT01435772|100984786|FG001|Overall Study|Withdrawal by Subject|1|||
33297896|NCT01435772|100984787|FG002|Overall Study|Withdrawal by Subject|3|||
33297897|NCT01435772|100984785|FG000|Overall Study|Other - study termination|2|||
33297898|NCT01435772|100984786|FG001|Overall Study|Other - study termination|2|||
33297899|NCT01435772|100984787|FG002|Overall Study|Other - study termination|10|||
33297900|NCT04343976|100984788|FG000|Overall Study|Withdrawal by Subject|0|||
33297901|NCT04343976|100984789|FG001|Overall Study|Withdrawal by Subject|1|||
33297902|NCT03019640|100984790|FG000|Overall Study|Screen Failures|4|||
33297903|NCT03019640|100984790|FG000|Overall Study|Adverse Event|3|||
33297904|NCT03019640|100984790|FG000|Overall Study|Participant Relapsed|1|||
33297905|NCT02493062|100984791|FG000|Overall Study|Physician Decision|12|||
33297906|NCT04043143|100984793|FG000|Overall Study|Lost to Follow-up|5|||
33297907|NCT04043143|100984794|FG001|Overall Study|Lost to Follow-up|5|||
33297908|NCT04043143|100984793|FG000|Overall Study|screen failure|1|||
33297909|NCT04043143|100984794|FG001|Overall Study|screen failure|0|||
33297910|NCT01110408|100984795|FG000|Overall Study|Protocol Violation|1|||
33297911|NCT01110408|100984796|FG001|Overall Study|Protocol Violation|0|||
33297912|NCT01638390|100984797|FG000|Overall Study|screening failures|21|||
33297913|NCT01132820|100984798|FG000|Overall Study|Ineligible: wrong cell type|1|||
33297914|NCT01132820|100984798|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
33297915|NCT01132820|100984798|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
33393251|NCT01237223|101328434|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
33393252|NCT01237223|101328435|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
33393253|NCT01237223|101328430|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
33393254|NCT01237223|101328431|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
33393255|NCT01237223|101328432|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
33393256|NCT01237223|101328433|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
33393257|NCT01237223|101328434|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
33393258|NCT01237223|101328435|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
33393259|NCT01237223|101328430|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
33393260|NCT01237223|101328431|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
33393261|NCT01237223|101328432|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
33393262|NCT01237223|101328433|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
33393263|NCT01237223|101328434|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
33393264|NCT01237223|101328435|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
33393265|NCT01237223|101328430|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
33393266|NCT01237223|101328431|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
33393267|NCT01237223|101328432|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
33393268|NCT01237223|101328433|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
33393269|NCT01237223|101328434|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
33393270|NCT01237223|101328435|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
33393271|NCT01237223|101328430|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
33393272|NCT01237223|101328431|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
33393273|NCT01237223|101328432|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
33297916|NCT01132820|100984798|FG000|Overall Study|Never treated|1|||
33297917|NCT01132820|100984798|FG000|Overall Study|Inadequate data|1|||
33297918|NCT00513708|100984809|FG000|Overall Study|Lost to Follow-up|4|||
33297919|NCT00513708|100984810|FG001|Overall Study|Lost to Follow-up|4|||
33297920|NCT00513708|100984811|FG002|Overall Study|Lost to Follow-up|4|||
33297921|NCT01413503|100984815|FG000|Overall Study|Lost to Follow-up|1|||
33297922|NCT03101462|100984816|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
33297923|NCT03101462|100984817|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
33297924|NCT00757627|100984820|FG000|Overall Study|Adverse Event|15|||
33297925|NCT00757627|100984820|FG000|Overall Study|Lack of Efficacy|10|||
33297926|NCT00757627|100984820|FG000|Overall Study|Lost to Follow-up|28|||
33393274|NCT01237223|101328433|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
33393275|NCT01237223|101328434|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
33393276|NCT01237223|101328435|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
33393277|NCT01237223|101328430|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
33393278|NCT01237223|101328431|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
33393279|NCT01237223|101328432|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
33393280|NCT01237223|101328433|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
33393281|NCT01237223|101328434|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
33393282|NCT01237223|101328435|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
33393283|NCT01237223|101328430|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
33393284|NCT01237223|101328431|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
33393285|NCT01237223|101328432|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
33393286|NCT01237223|101328433|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
33393287|NCT01237223|101328434|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
33393288|NCT01237223|101328435|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
33393289|NCT01237223|101328430|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
33393290|NCT01237223|101328431|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
33393291|NCT01237223|101328432|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
33393292|NCT01237223|101328433|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
33393293|NCT01237223|101328434|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
33393294|NCT01237223|101328435|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
33393295|NCT01237223|101328430|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
33393296|NCT01237223|101328431|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
33393297|NCT01237223|101328432|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
33393298|NCT01237223|101328433|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
33393299|NCT01237223|101328434|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
33393300|NCT01237223|101328435|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
33393301|NCT01237223|101328430|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
33393302|NCT01237223|101328431|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
33393303|NCT01237223|101328432|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
33393304|NCT01237223|101328433|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
33393305|NCT01237223|101328434|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
33393306|NCT01237223|101328435|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
33393307|NCT01010776|101328436|FG000|Main Phase|Withdrawal by Subject|14|||
33393308|NCT01010776|101328436|FG000|Main Phase|Lack of Efficacy|8|||
33393309|NCT01010776|101328436|FG000|Main Phase|Adverse Event|7|||
33393310|NCT01010776|101328436|FG000|Main Phase|Lost to Follow-up|6|||
33393311|NCT01010776|101328436|FG000|Main Phase|Non-compliance to study medication|5|||
33393312|NCT01010776|101328436|FG000|Main Phase|Selection failure|2|||
33393313|NCT01010776|101328436|FG000|Main Phase|Inform consent withdrawal|1|||
33393314|NCT01010776|101328436|FG000|Main Phase|Other|1|||
33393315|NCT01010776|101328436|FG000|Main Phase|Did not received study medication|5|||
33393316|NCT01010776|101328436|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
33393317|NCT01010776|101328436|FG000|Extension Phase|Other|3|||
33393318|NCT02603172|101328439|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
33393319|NCT02603172|101328440|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
33393320|NCT02603172|101328441|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
33393321|NCT02603172|101328442|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
33393322|NCT02603172|101328443|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
33393323|NCT02603172|101328444|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
33393324|NCT02603172|101328445|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
33393325|NCT02603172|101328446|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
33393326|NCT00959699|101328447|FG000|Treatment Period|Adverse Event|3|||
33393327|NCT00959699|101328448|FG001|Treatment Period|Adverse Event|13|||
33393328|NCT00959699|101328447|FG000|Treatment Period|Lack of Efficacy|15|||
33393329|NCT00959699|101328448|FG001|Treatment Period|Lack of Efficacy|6|||
33393330|NCT00959699|101328447|FG000|Treatment Period|Lost to Follow-up|0|||
33393331|NCT00959699|101328448|FG001|Treatment Period|Lost to Follow-up|1|||
33393332|NCT00959699|101328447|FG000|Treatment Period|Withdrawal by Subject|1|||
33393333|NCT00959699|101328448|FG001|Treatment Period|Withdrawal by Subject|3|||
33393334|NCT00959699|101328447|FG000|Treatment Period|Non-Compliance with Protocol|0|||
33393335|NCT00959699|101328448|FG001|Treatment Period|Non-Compliance with Protocol|1|||
33393336|NCT00959699|101328447|FG000|Treatment Period|Did not receive treatment|0|||
33393337|NCT00959699|101328448|FG001|Treatment Period|Did not receive treatment|1|||
33393338|NCT00959699|101328447|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
33393339|NCT00959699|101328448|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
33393340|NCT00959699|101328447|FG000|Follow-up Period|Lost to Follow-up|3|||
33393341|NCT00959699|101328448|FG001|Follow-up Period|Lost to Follow-up|2|||
33190096|NCT00207142|100601571|FG003|Induction Phase|Death|0|||
33297927|NCT00757627|100984820|FG000|Overall Study|Withdrawal by Subject|27|||
33297928|NCT00757627|100984820|FG000|Overall Study|Other|1|||
33297929|NCT02472145|100984822|FG000|Overall Study|Death|10|||
33297930|NCT02472145|100984823|FG001|Overall Study|Death|101|||
33297931|NCT02472145|100984824|FG002|Overall Study|Death|99|||
33297932|NCT02472145|100984822|FG000|Overall Study|Lost to Follow-up|0|||
33297933|NCT02472145|100984823|FG001|Overall Study|Lost to Follow-up|1|||
33297934|NCT02472145|100984824|FG002|Overall Study|Lost to Follow-up|0|||
33297935|NCT02472145|100984822|FG000|Overall Study|Withdrawal by Subject|0|||
33297936|NCT02472145|100984823|FG001|Overall Study|Withdrawal by Subject|9|||
33297937|NCT02472145|100984824|FG002|Overall Study|Withdrawal by Subject|13|||
33297938|NCT02472145|100984822|FG000|Overall Study|Sponsor decision|0|||
33297939|NCT02472145|100984823|FG001|Overall Study|Sponsor decision|3|||
33297940|NCT02472145|100984824|FG002|Overall Study|Sponsor decision|2|||
33297941|NCT02472145|100984822|FG000|Overall Study|Other|0|||
33297942|NCT02472145|100984823|FG001|Overall Study|Other|45|||
33297943|NCT02472145|100984824|FG002|Overall Study|Other|43|||
33297944|NCT03392168|100984825|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
33297945|NCT03392168|100984826|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
33297946|NCT03392168|100984827|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
33297947|NCT03392168|100984828|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
33297948|NCT03392168|100984825|FG000|Period 2: Cohort 2|Other|0|||
33297949|NCT03392168|100984826|FG001|Period 2: Cohort 2|Other|1|||
33297950|NCT03392168|100984827|FG002|Period 2: Cohort 2|Other|0|||
33297951|NCT03392168|100984828|FG003|Period 2: Cohort 2|Other|0|||
33297952|NCT01424813|100984829|FG000|Overall Study|Withdrawal by Subject|3|||
33297953|NCT01424813|100984830|FG001|Overall Study|Withdrawal by Subject|0|||
33297954|NCT01424813|100984829|FG000|Overall Study|Protocol Violation|1|||
33297955|NCT01424813|100984830|FG001|Overall Study|Protocol Violation|0|||
33297956|NCT01424813|100984829|FG000|Overall Study|Other|1|||
33297957|NCT01424813|100984830|FG001|Overall Study|Other|2|||
33297958|NCT00863681|100984831|FG000|Overall Study|Other|2|||
33297959|NCT00863681|100984832|FG001|Overall Study|Other|0|||
33297960|NCT00863681|100984833|FG002|Overall Study|Other|0|||
33297961|NCT00863681|100984831|FG000|Overall Study|Missing|1|||
33297962|NCT00863681|100984832|FG001|Overall Study|Missing|0|||
33297963|NCT00863681|100984833|FG002|Overall Study|Missing|0|||
33297964|NCT00863681|100984831|FG000|Overall Study|Death|40|||
33297965|NCT00863681|100984832|FG001|Overall Study|Death|23|||
33393342|NCT00959699|101328447|FG000|Follow-up Period|Withdrawal by Subject|3|||
33190097|NCT00207142|100601568|FG000|Induction Phase|Lack of Efficacy|1|||
33190098|NCT00207142|100601569|FG001|Induction Phase|Lack of Efficacy|0|||
33190099|NCT00207142|100601570|FG002|Induction Phase|Lack of Efficacy|0|||
33190100|NCT00207142|100601571|FG003|Induction Phase|Lack of Efficacy|0|||
33190101|NCT00207142|100601568|FG000|Induction Phase|Lost to Follow-up|5|||
33190102|NCT00207142|100601569|FG001|Induction Phase|Lost to Follow-up|0|||
33190103|NCT00207142|100601570|FG002|Induction Phase|Lost to Follow-up|0|||
33190104|NCT00207142|100601571|FG003|Induction Phase|Lost to Follow-up|0|||
33190105|NCT00207142|100601568|FG000|Induction Phase|Physician Decision|2|||
33190106|NCT00207142|100601569|FG001|Induction Phase|Physician Decision|0|||
33190107|NCT00207142|100601570|FG002|Induction Phase|Physician Decision|0|||
33190108|NCT00207142|100601571|FG003|Induction Phase|Physician Decision|0|||
33190109|NCT00207142|100601568|FG000|Induction Phase|Poor/noncompliance|2|||
33190110|NCT00207142|100601569|FG001|Induction Phase|Poor/noncompliance|0|||
33190111|NCT00207142|100601570|FG002|Induction Phase|Poor/noncompliance|0|||
33190112|NCT00207142|100601571|FG003|Induction Phase|Poor/noncompliance|0|||
33190113|NCT00207142|100601568|FG000|Induction Phase|Pregnancy|1|||
33190114|NCT00207142|100601569|FG001|Induction Phase|Pregnancy|0|||
33190115|NCT00207142|100601570|FG002|Induction Phase|Pregnancy|0|||
33190116|NCT00207142|100601571|FG003|Induction Phase|Pregnancy|0|||
33190117|NCT00207142|100601568|FG000|Induction Phase|Subject no longer meets study criteria|3|||
33190118|NCT00207142|100601569|FG001|Induction Phase|Subject no longer meets study criteria|0|||
33190119|NCT00207142|100601570|FG002|Induction Phase|Subject no longer meets study criteria|0|||
33190120|NCT00207142|100601571|FG003|Induction Phase|Subject no longer meets study criteria|0|||
33190121|NCT00207142|100601568|FG000|Induction Phase|Withdrawal by Subject|4|||
33297966|NCT00863681|100984833|FG002|Overall Study|Death|6|||
33297967|NCT00863681|100984831|FG000|Overall Study|Withdrawal by Subject|12|||
33297968|NCT00863681|100984832|FG001|Overall Study|Withdrawal by Subject|5|||
33297969|NCT00863681|100984833|FG002|Overall Study|Withdrawal by Subject|2|||
33297970|NCT00863681|100984831|FG000|Overall Study|Protocol Violation|2|||
33297971|NCT00863681|100984832|FG001|Overall Study|Protocol Violation|0|||
33297972|NCT00863681|100984833|FG002|Overall Study|Protocol Violation|0|||
33297973|NCT00863681|100984831|FG000|Overall Study|Lost to Follow-up|3|||
33297974|NCT00863681|100984832|FG001|Overall Study|Lost to Follow-up|0|||
33297975|NCT00863681|100984833|FG002|Overall Study|Lost to Follow-up|3|||
33297976|NCT00863681|100984831|FG000|Overall Study|Adverse Event|28|||
33297977|NCT00863681|100984832|FG001|Overall Study|Adverse Event|10|||
33297978|NCT00863681|100984833|FG002|Overall Study|Adverse Event|6|||
33297979|NCT00863681|100984831|FG000|Overall Study|Lack of Efficacy|2|||
33297980|NCT00863681|100984832|FG001|Overall Study|Lack of Efficacy|2|||
33297981|NCT00863681|100984833|FG002|Overall Study|Lack of Efficacy|1|||
33297982|NCT00863681|100984831|FG000|Overall Study|Non-compliance with study drug|1|||
33297983|NCT00863681|100984832|FG001|Overall Study|Non-compliance with study drug|3|||
33297984|NCT00863681|100984833|FG002|Overall Study|Non-compliance with study drug|0|||
33297985|NCT00737477|100984834|FG000|Overall Study|Adverse Event|9|||
33297986|NCT00737477|100984834|FG000|Overall Study|Death|9|||
33297987|NCT00737477|100984834|FG000|Overall Study|Treatment Refusal|1|||
33297988|NCT00737477|100984834|FG000|Overall Study|Withdrawal by Subject|1|||
33297989|NCT00737477|100984834|FG000|Overall Study|Renal Transplantation|10|||
33297990|NCT00737477|100984834|FG000|Overall Study|Other|4|||
33297991|NCT01399918|100984845|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
33297992|NCT00820170|100984846|FG000|Overall Study|Adverse Event|0|||
33297993|NCT00820170|100984847|FG001|Overall Study|Adverse Event|0|||
33297994|NCT00820170|100984848|FG002|Overall Study|Adverse Event|0|||
33297995|NCT00820170|100984849|FG003|Overall Study|Adverse Event|0|||
33297996|NCT00820170|100984850|FG004|Overall Study|Adverse Event|2|||
33297997|NCT00820170|100984846|FG000|Overall Study|Progressive Disease|0|||
33297998|NCT00820170|100984847|FG001|Overall Study|Progressive Disease|0|||
33297999|NCT00820170|100984848|FG002|Overall Study|Progressive Disease|0|||
33298000|NCT00820170|100984849|FG003|Overall Study|Progressive Disease|0|||
33298001|NCT00820170|100984850|FG004|Overall Study|Progressive Disease|2|||
33298002|NCT01038427|100984852|FG000|Overall Study|Lost to follow up|1|||
33298003|NCT01038427|100984853|FG001|Overall Study|Lost to follow up|1|||
33298004|NCT01038427|100984854|FG002|Overall Study|Lost to follow up|0|||
33298005|NCT01038427|100984852|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
33298006|NCT01038427|100984853|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
33298007|NCT01038427|100984854|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
33298008|NCT01038427|100984852|FG000|Overall Study|Withdrew consent|0|||
33298009|NCT01038427|100984853|FG001|Overall Study|Withdrew consent|0|||
33298010|NCT01038427|100984854|FG002|Overall Study|Withdrew consent|1|||
33298011|NCT01038427|100984852|FG000|Overall Study|Adverse Event|2|||
33298012|NCT01038427|100984853|FG001|Overall Study|Adverse Event|2|||
33298013|NCT01038427|100984854|FG002|Overall Study|Adverse Event|1|||
33298014|NCT01038427|100984852|FG000|Overall Study|Enrolled in error|0|||
33298015|NCT01038427|100984853|FG001|Overall Study|Enrolled in error|1|||
33298016|NCT01038427|100984854|FG002|Overall Study|Enrolled in error|1|||
33298017|NCT01038427|100984852|FG000|Overall Study|Other|0|||
33298018|NCT01038427|100984853|FG001|Overall Study|Other|2|||
33298019|NCT01038427|100984854|FG002|Overall Study|Other|0|||
33298020|NCT00589303|100984858|FG000|Overall Study|Withdrawal by Subject|2|||
33298021|NCT00589303|100984859|FG001|Overall Study|Withdrawal by Subject|1|||
33298022|NCT02271984|100984860|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33298023|NCT02271984|100984861|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33298024|NCT02271984|100984862|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33298025|NCT02271984|100984863|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33298026|NCT02271984|100984864|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33298027|NCT02271984|100984865|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
33298028|NCT02271984|100984866|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33298029|NCT02271984|100984867|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
33298030|NCT02271984|100984868|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33298031|NCT02271984|100984869|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33298032|NCT02271984|100984870|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33298033|NCT02271984|100984871|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33298034|NCT04577001|100984872|FG000|Overall Study|Subject became ineligible|0|||
33298035|NCT04577001|100984873|FG001|Overall Study|Subject became ineligible|1|||
33298036|NCT00623805|100984874|FG000|Overall Study|Adverse Event|9|||
33298037|NCT00623805|100984875|FG001|Overall Study|Adverse Event|6|||
33298038|NCT00623805|100984874|FG000|Overall Study|Death|2|||
33298039|NCT00623805|100984875|FG001|Overall Study|Death|0|||
33298040|NCT00623805|100984874|FG000|Overall Study|Lack of Efficacy|3|||
33298041|NCT00623805|100984875|FG001|Overall Study|Lack of Efficacy|7|||
33298042|NCT00623805|100984874|FG000|Overall Study|Lost to Follow-up|2|||
33298043|NCT00623805|100984875|FG001|Overall Study|Lost to Follow-up|2|||
33298044|NCT00623805|100984874|FG000|Overall Study|Protocol Violation|1|||
33298045|NCT00623805|100984875|FG001|Overall Study|Protocol Violation|1|||
33298046|NCT00623805|100984874|FG000|Overall Study|Reason not Specified|3|||
33298047|NCT00623805|100984875|FG001|Overall Study|Reason not Specified|6|||
33298048|NCT01299480|100984876|FG000|Overall Study|No longer willing to participate|19|||
33298049|NCT01299480|100984877|FG001|Overall Study|No longer willing to participate|17|||
33298050|NCT01299480|100984878|FG002|Overall Study|No longer willing to participate|14|||
33298051|NCT01299480|100984879|FG003|Overall Study|No longer willing to participate|13|||
33298052|NCT01299480|100984880|FG004|Overall Study|No longer willing to participate|10|||
33298053|NCT01299480|100984876|FG000|Overall Study|Protocol Violation|7|||
33298054|NCT01299480|100984877|FG001|Overall Study|Protocol Violation|5|||
33298055|NCT01299480|100984878|FG002|Overall Study|Protocol Violation|8|||
33298056|NCT01299480|100984879|FG003|Overall Study|Protocol Violation|1|||
33298057|NCT01299480|100984880|FG004|Overall Study|Protocol Violation|1|||
33298058|NCT01299480|100984876|FG000|Overall Study|Withdrawal by Subject|3|||
33298059|NCT01299480|100984877|FG001|Overall Study|Withdrawal by Subject|4|||
33298060|NCT01299480|100984878|FG002|Overall Study|Withdrawal by Subject|7|||
33298061|NCT01299480|100984879|FG003|Overall Study|Withdrawal by Subject|3|||
33298062|NCT01299480|100984880|FG004|Overall Study|Withdrawal by Subject|4|||
33298063|NCT01299480|100984876|FG000|Overall Study|Adverse Event|6|||
33298064|NCT01299480|100984877|FG001|Overall Study|Adverse Event|4|||
33298065|NCT01299480|100984878|FG002|Overall Study|Adverse Event|5|||
33298066|NCT01299480|100984879|FG003|Overall Study|Adverse Event|4|||
33298067|NCT01299480|100984880|FG004|Overall Study|Adverse Event|0|||
33298068|NCT01299480|100984876|FG000|Overall Study|Withdrawal due to pregnancy|0|||
33298069|NCT01299480|100984877|FG001|Overall Study|Withdrawal due to pregnancy|1|||
33298070|NCT01299480|100984878|FG002|Overall Study|Withdrawal due to pregnancy|1|||
33298071|NCT01299480|100984879|FG003|Overall Study|Withdrawal due to pregnancy|0|||
33298072|NCT01299480|100984880|FG004|Overall Study|Withdrawal due to pregnancy|0|||
33298073|NCT01299480|100984876|FG000|Overall Study|Physician Decision|1|||
33298074|NCT01299480|100984877|FG001|Overall Study|Physician Decision|1|||
33298075|NCT01299480|100984878|FG002|Overall Study|Physician Decision|0|||
33298076|NCT01299480|100984879|FG003|Overall Study|Physician Decision|2|||
33298077|NCT01299480|100984880|FG004|Overall Study|Physician Decision|0|||
33298078|NCT01299480|100984876|FG000|Overall Study|Lost to Follow-up|3|||
33298079|NCT01299480|100984877|FG001|Overall Study|Lost to Follow-up|1|||
33298080|NCT01299480|100984878|FG002|Overall Study|Lost to Follow-up|2|||
33298081|NCT01299480|100984879|FG003|Overall Study|Lost to Follow-up|1|||
33298082|NCT01299480|100984880|FG004|Overall Study|Lost to Follow-up|2|||
33298083|NCT01299480|100984876|FG000|Overall Study|Other|3|||
33298084|NCT01299480|100984877|FG001|Overall Study|Other|2|||
33298085|NCT01299480|100984878|FG002|Overall Study|Other|3|||
33298086|NCT01299480|100984879|FG003|Overall Study|Other|0|||
33298087|NCT01299480|100984880|FG004|Overall Study|Other|3|||
33298088|NCT01299480|100984876|FG000|Overall Study|Started, but not vaccinated|0|||
33298089|NCT01299480|100984877|FG001|Overall Study|Started, but not vaccinated|0|||
33298090|NCT01299480|100984878|FG002|Overall Study|Started, but not vaccinated|1|||
33298091|NCT01299480|100984879|FG003|Overall Study|Started, but not vaccinated|1|||
33298092|NCT01299480|100984880|FG004|Overall Study|Started, but not vaccinated|0|||
33298093|NCT00338962|100988298|FG000|Overall Study|Lost to Follow-up|3|||
33298094|NCT00338962|100988299|FG001|Overall Study|Lost to Follow-up|3|||
33298095|NCT00338962|100988300|FG002|Overall Study|Lost to Follow-up|2|||
33298096|NCT00338962|100988301|FG003|Overall Study|Lost to Follow-up|3|||
33298097|NCT00338962|100988298|FG000|Overall Study|Withdrawal by Subject|1|||
33298098|NCT00338962|100988299|FG001|Overall Study|Withdrawal by Subject|0|||
33298099|NCT00338962|100988300|FG002|Overall Study|Withdrawal by Subject|0|||
33298100|NCT00338962|100988301|FG003|Overall Study|Withdrawal by Subject|0|||
33298101|NCT00338962|100988298|FG000|Overall Study|No Transportation|2|||
33298102|NCT00338962|100988299|FG001|Overall Study|No Transportation|0|||
33298103|NCT00338962|100988300|FG002|Overall Study|No Transportation|0|||
33298104|NCT00338962|100988301|FG003|Overall Study|No Transportation|0|||
33298105|NCT00338962|100988298|FG000|Overall Study|Time Constraint|2|||
33298106|NCT00338962|100988299|FG001|Overall Study|Time Constraint|0|||
33298107|NCT00338962|100988300|FG002|Overall Study|Time Constraint|0|||
33298108|NCT00338962|100988301|FG003|Overall Study|Time Constraint|0|||
33298109|NCT00338962|100988298|FG000|Overall Study|Moved|0|||
33298110|NCT00338962|100988299|FG001|Overall Study|Moved|1|||
33298111|NCT00338962|100988300|FG002|Overall Study|Moved|0|||
33298112|NCT00338962|100988301|FG003|Overall Study|Moved|0|||
33298113|NCT00338962|100988298|FG000|Overall Study|Adverse Event|0|||
33298114|NCT00338962|100988299|FG001|Overall Study|Adverse Event|0|||
33298115|NCT00338962|100988300|FG002|Overall Study|Adverse Event|2|||
33298116|NCT00338962|100988301|FG003|Overall Study|Adverse Event|0|||
33298117|NCT00338962|100988298|FG000|Overall Study|Poor Compliance|0|||
33298118|NCT00338962|100988299|FG001|Overall Study|Poor Compliance|0|||
33298119|NCT00338962|100988300|FG002|Overall Study|Poor Compliance|2|||
33298120|NCT00338962|100988301|FG003|Overall Study|Poor Compliance|0|||
33393343|NCT00959699|101328448|FG001|Follow-up Period|Withdrawal by Subject|4|||
33600139|NCT05239221|102088520|FG005|Overall Study|Adverse Event|0|||
33600140|NCT05239221|102088521|FG006|Overall Study|Adverse Event|1|||
33190122|NCT00207142|100601569|FG001|Induction Phase|Withdrawal by Subject|0|||
33190123|NCT00207142|100601570|FG002|Induction Phase|Withdrawal by Subject|0|||
33298121|NCT02229851|100988302|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
33298122|NCT02229851|100988303|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
33298123|NCT02229851|100988304|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
33298124|NCT02229851|100988305|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
33298125|NCT02229851|100988306|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
33298126|NCT02229851|100988307|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
33298127|NCT02229851|100988308|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
33298128|NCT02229851|100988302|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
33393344|NCT01355497|101328451|FG000|Overall Study|Death|19|||
33393345|NCT01355497|101328452|FG001|Overall Study|Death|18|||
33393346|NCT01355497|101328451|FG000|Overall Study|Lost to Follow-up|3|||
33393347|NCT01355497|101328452|FG001|Overall Study|Lost to Follow-up|0|||
33393348|NCT01355497|101328451|FG000|Overall Study|Protocol Violation|0|||
33393349|NCT01355497|101328452|FG001|Overall Study|Protocol Violation|1|||
33393350|NCT01355497|101328451|FG000|Overall Study|other-not provided|9|||
33393351|NCT01355497|101328452|FG001|Overall Study|other-not provided|4|||
33393352|NCT01355497|101328451|FG000|Overall Study|Withdrawal by Subject|12|||
33393353|NCT01355497|101328452|FG001|Overall Study|Withdrawal by Subject|20|||
33393354|NCT01355497|101328451|FG000|Overall Study|noncompliance|1|||
33393355|NCT01355497|101328452|FG001|Overall Study|noncompliance|2|||
33393356|NCT01355497|101328451|FG000|Overall Study|progressive disease|11|||
33393357|NCT01355497|101328452|FG001|Overall Study|progressive disease|8|||
33393358|NCT01355497|101328451|FG000|Overall Study|Adverse Event|11|||
33393359|NCT01355497|101328452|FG001|Overall Study|Adverse Event|10|||
33393360|NCT00285649|101328453|FG000|Overall Study|Lost to Follow-up|6|||
33393361|NCT00285649|101328454|FG001|Overall Study|Lost to Follow-up|4|||
33393362|NCT00285649|101328455|FG002|Overall Study|Lost to Follow-up|4|||
33393363|NCT00285649|101328453|FG000|Overall Study|Withdrawal by Subject|3|||
33393364|NCT00285649|101328454|FG001|Overall Study|Withdrawal by Subject|2|||
33393365|NCT00285649|101328455|FG002|Overall Study|Withdrawal by Subject|2|||
33393366|NCT00126425|101328459|FG000|Overall Study|Withdrawal by Subject|17|||
33393367|NCT00126425|101328460|FG001|Overall Study|Withdrawal by Subject|1|||
33393368|NCT00126425|101328459|FG000|Overall Study|Lost to Follow-up|8|||
33393369|NCT00126425|101328460|FG001|Overall Study|Lost to Follow-up|4|||
33393370|NCT00126425|101328459|FG000|Overall Study|Protocol Violation|9|||
33393371|NCT00126425|101328460|FG001|Overall Study|Protocol Violation|6|||
33393372|NCT00126425|101328459|FG000|Overall Study|Adverse Event|1|||
33393373|NCT00126425|101328460|FG001|Overall Study|Adverse Event|0|||
33393374|NCT00126425|101328459|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
33393375|NCT00126425|101328460|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
33393376|NCT00126425|101328459|FG000|Overall Study|Other|5|||
33393377|NCT00126425|101328460|FG001|Overall Study|Other|0|||
33393378|NCT00320190|101328462|FG000|First 12 Months|Completed but did not enter extension|5|||
33393379|NCT00320190|101328463|FG001|First 12 Months|Completed but did not enter extension|3|||
33393380|NCT00320190|101328462|FG000|First 12 Months|Sponsor terminated study|2|||
33393381|NCT00320190|101328463|FG001|First 12 Months|Sponsor terminated study|2|||
33393382|NCT00320190|101328462|FG000|First 12 Months|Lost to Follow-up|0|||
33393383|NCT00320190|101328463|FG001|First 12 Months|Lost to Follow-up|1|||
33393384|NCT00320190|101328462|FG000|First 12 Months|Enrollment failure|0|||
33393385|NCT00320190|101328463|FG001|First 12 Months|Enrollment failure|1|||
33393386|NCT00320190|101328462|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
33393387|NCT00320190|101328463|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
33393388|NCT00320190|101328462|FG000|First 12 Months|Investigator request|0|||
33393389|NCT00320190|101328463|FG001|First 12 Months|Investigator request|1|||
33393390|NCT00320190|101328462|FG000|First 12 Months|Study drug toxicity|0|||
33393391|NCT00320190|101328463|FG001|First 12 Months|Study drug toxicity|1|||
33393392|NCT00320190|101328462|FG000|First 12 Months|Withdrawal by Subject|0|||
33393393|NCT00320190|101328463|FG001|First 12 Months|Withdrawal by Subject|1|||
33393394|NCT00320190|101328462|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
33393395|NCT00320190|101328463|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
33393396|NCT00320190|101328462|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
33393397|NCT00320190|101328463|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
33393398|NCT00320190|101328462|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
33393399|NCT00320190|101328463|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
33393400|NCT03051217|101328465|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
33393401|NCT03051217|101328466|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33496240|NCT02166333|101710048|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
33496241|NCT02166333|101710049|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
33496242|NCT02166333|101710050|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
33496243|NCT02166333|101710051|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
33496244|NCT02166333|101710046|FG000|Stage 1|Death|4|||
33496245|NCT02166333|101710047|FG001|Stage 1|Death|0|||
33496246|NCT02166333|101710048|FG002|Stage 1|Death|2|||
33496247|NCT02166333|101710049|FG003|Stage 1|Death|0|||
33496248|NCT02166333|101710050|FG004|Stage 1|Death|3|||
33496249|NCT02166333|101710051|FG005|Stage 1|Death|2|||
33190124|NCT00207142|100601571|FG003|Induction Phase|Withdrawal by Subject|0|||
33190125|NCT00207142|100601568|FG000|Induction Phase|Incarceration|1|||
33393402|NCT03051217|101328467|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
33393403|NCT03051217|101328468|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33393404|NCT03051217|101328469|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33393405|NCT03051217|101328470|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33496250|NCT02166333|101710046|FG000|Stage 1|Lost to Follow-up|12|||
33496251|NCT02166333|101710047|FG001|Stage 1|Lost to Follow-up|0|||
33496252|NCT02166333|101710048|FG002|Stage 1|Lost to Follow-up|6|||
33496253|NCT02166333|101710049|FG003|Stage 1|Lost to Follow-up|0|||
33496254|NCT02166333|101710050|FG004|Stage 1|Lost to Follow-up|3|||
33496255|NCT02166333|101710051|FG005|Stage 1|Lost to Follow-up|3|||
33496256|NCT02166333|101710046|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
33496257|NCT02166333|101710047|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
33496258|NCT02166333|101710048|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
33496259|NCT02166333|101710049|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
33298129|NCT02229851|100988303|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
33298130|NCT02229851|100988304|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
33298131|NCT02229851|100988305|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
33298132|NCT02229851|100988306|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
33298133|NCT02229851|100988307|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
33298134|NCT02229851|100988308|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
33298135|NCT02229851|100988302|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
33298136|NCT02229851|100988303|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
33298137|NCT02229851|100988304|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
33298138|NCT02229851|100988305|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
33298139|NCT02229851|100988306|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
33298140|NCT02229851|100988307|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
33298141|NCT02229851|100988308|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
33298142|NCT02229851|100988302|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
33298143|NCT02229851|100988303|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
33298144|NCT02229851|100988304|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
33298145|NCT02229851|100988305|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
33298146|NCT02229851|100988306|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
33298147|NCT02229851|100988307|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
33298148|NCT02229851|100988308|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
33298149|NCT02229851|100988302|FG000|Main Phase (Double-blind Phase)|Death|1|||
33298150|NCT02229851|100988303|FG001|Main Phase (Double-blind Phase)|Death|1|||
33298151|NCT02229851|100988304|FG002|Main Phase (Double-blind Phase)|Death|0|||
33298152|NCT02229851|100988305|FG003|Main Phase (Double-blind Phase)|Death|0|||
33298153|NCT02229851|100988306|FG004|Main Phase (Double-blind Phase)|Death|0|||
33298154|NCT02229851|100988307|FG005|Main Phase (Double-blind Phase)|Death|0|||
33298155|NCT02229851|100988308|FG006|Main Phase (Double-blind Phase)|Death|0|||
33298156|NCT02229851|100988302|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
33298157|NCT02229851|100988303|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
33496260|NCT02166333|101710050|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
33496261|NCT02166333|101710051|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
33496262|NCT02166333|101710046|FG000|Stage 2|Death|4|||
33496263|NCT02166333|101710047|FG001|Stage 2|Death|2|||
33496264|NCT02166333|101710048|FG002|Stage 2|Death|1|||
33496265|NCT02166333|101710049|FG003|Stage 2|Death|0|||
33496266|NCT02166333|101710050|FG004|Stage 2|Death|0|||
33496267|NCT02166333|101710051|FG005|Stage 2|Death|1|||
33496268|NCT02166333|101710046|FG000|Stage 2|Lost to Follow-up|23|||
33496269|NCT02166333|101710047|FG001|Stage 2|Lost to Follow-up|4|||
33496270|NCT02166333|101710048|FG002|Stage 2|Lost to Follow-up|11|||
33496271|NCT02166333|101710049|FG003|Stage 2|Lost to Follow-up|9|||
33496272|NCT02166333|101710050|FG004|Stage 2|Lost to Follow-up|3|||
33496273|NCT02166333|101710051|FG005|Stage 2|Lost to Follow-up|6|||
33496274|NCT04846569|101710052|FG000|Overall Study|Withdrawal by Subject|3|||
33496275|NCT04846569|101710053|FG001|Overall Study|Withdrawal by Subject|1|||
33496276|NCT00564850|101710057|FG000|Overall Study|Protocol Violation|2|||
33496277|NCT02220764|101710058|FG000|Overall Study|Lost to Follow-up|3|||
33496278|NCT02220764|101710059|FG001|Overall Study|Lost to Follow-up|1|||
33496279|NCT02220764|101710058|FG000|Overall Study|Death|1|||
33496280|NCT02220764|101710059|FG001|Overall Study|Death|0|||
33496281|NCT04515147|101710061|FG000|Overall Study|Withdrawal by Subject|1|||
33496282|NCT04515147|101710062|FG001|Overall Study|Withdrawal by Subject|0|||
33496283|NCT04515147|101710063|FG002|Overall Study|Withdrawal by Subject|10|||
33298158|NCT02229851|100988304|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
33298159|NCT02229851|100988305|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
33496284|NCT04515147|101710064|FG003|Overall Study|Withdrawal by Subject|18|||
33496285|NCT04515147|101710065|FG004|Overall Study|Withdrawal by Subject|1|||
33496286|NCT04515147|101710066|FG005|Overall Study|Withdrawal by Subject|8|||
33496287|NCT04515147|101710061|FG000|Overall Study|Lost to Follow-up|0|||
33496288|NCT04515147|101710062|FG001|Overall Study|Lost to Follow-up|1|||
33496289|NCT04515147|101710063|FG002|Overall Study|Lost to Follow-up|5|||
33496290|NCT04515147|101710064|FG003|Overall Study|Lost to Follow-up|6|||
33496291|NCT04515147|101710065|FG004|Overall Study|Lost to Follow-up|2|||
33600141|NCT05239221|102088522|FG007|Overall Study|Adverse Event|0|||
33496292|NCT04515147|101710066|FG005|Overall Study|Lost to Follow-up|1|||
33496293|NCT04515147|101710061|FG000|Overall Study|Adverse Event|0|||
33496294|NCT04515147|101710062|FG001|Overall Study|Adverse Event|0|||
33496295|NCT04515147|101710063|FG002|Overall Study|Adverse Event|0|||
33496296|NCT04515147|101710064|FG003|Overall Study|Adverse Event|2|||
33496297|NCT04515147|101710065|FG004|Overall Study|Adverse Event|0|||
33496298|NCT04515147|101710066|FG005|Overall Study|Adverse Event|0|||
33496299|NCT04515147|101710061|FG000|Overall Study|Miscellaneous|0|||
33496300|NCT04515147|101710062|FG001|Overall Study|Miscellaneous|0|||
33496301|NCT04515147|101710063|FG002|Overall Study|Miscellaneous|0|||
33496302|NCT04515147|101710064|FG003|Overall Study|Miscellaneous|1|||
33298160|NCT02229851|100988306|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
33298161|NCT02229851|100988307|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
33298162|NCT02229851|100988308|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
33298163|NCT02229851|100988302|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
33298164|NCT02229851|100988303|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
33298165|NCT02229851|100988304|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
33298166|NCT02229851|100988305|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
33298167|NCT02229851|100988306|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
33298168|NCT02229851|100988307|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
33298169|NCT02229851|100988308|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
33496303|NCT04515147|101710065|FG004|Overall Study|Miscellaneous|0|||
33496304|NCT04515147|101710066|FG005|Overall Study|Miscellaneous|1|||
33496305|NCT01515423|101710067|FG000|Open Label Phase|Adverse Event|57|||
33496306|NCT01515423|101710068|FG001|Open Label Phase|Adverse Event|0|||
33496307|NCT01515423|101710069|FG002|Open Label Phase|Adverse Event|0|||
33496308|NCT01515423|101710067|FG000|Open Label Phase|Death|2|||
33496309|NCT01515423|101710068|FG001|Open Label Phase|Death|0|||
33496310|NCT01515423|101710069|FG002|Open Label Phase|Death|0|||
33496311|NCT01515423|101710067|FG000|Open Label Phase|Lack of Efficacy|117|||
33496312|NCT01515423|101710068|FG001|Open Label Phase|Lack of Efficacy|0|||
33496313|NCT01515423|101710069|FG002|Open Label Phase|Lack of Efficacy|0|||
33496314|NCT01515423|101710067|FG000|Open Label Phase|Lost to Follow-up|21|||
33496315|NCT01515423|101710068|FG001|Open Label Phase|Lost to Follow-up|0|||
33496316|NCT01515423|101710069|FG002|Open Label Phase|Lost to Follow-up|0|||
33496317|NCT01515423|101710067|FG000|Open Label Phase|Withdrawal by Subject|118|||
33496318|NCT01515423|101710068|FG001|Open Label Phase|Withdrawal by Subject|0|||
33496319|NCT01515423|101710069|FG002|Open Label Phase|Withdrawal by Subject|0|||
33496320|NCT01515423|101710067|FG000|Open Label Phase|excluded from DB Phase|70|||
33496321|NCT01515423|101710068|FG001|Open Label Phase|excluded from DB Phase|0|||
33496322|NCT01515423|101710069|FG002|Open Label Phase|excluded from DB Phase|0|||
33496323|NCT01515423|101710067|FG000|Open Label Phase|Other|28|||
33496324|NCT01515423|101710068|FG001|Open Label Phase|Other|0|||
33496325|NCT01515423|101710069|FG002|Open Label Phase|Other|0|||
33496326|NCT01515423|101710067|FG000|DOUBLE BLIND|Adverse Event|0|||
33496327|NCT01515423|101710068|FG001|DOUBLE BLIND|Adverse Event|15|||
33496328|NCT01515423|101710069|FG002|DOUBLE BLIND|Adverse Event|13|||
33496329|NCT01515423|101710067|FG000|DOUBLE BLIND|Death|0|||
33496330|NCT01515423|101710068|FG001|DOUBLE BLIND|Death|1|||
33496331|NCT01515423|101710069|FG002|DOUBLE BLIND|Death|2|||
33496332|NCT01515423|101710067|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
33298170|NCT02229851|100988302|FG000|Extension Phase (Open-label Phase)|Death|0|||
33298171|NCT02229851|100988303|FG001|Extension Phase (Open-label Phase)|Death|0|||
33298172|NCT02229851|100988304|FG002|Extension Phase (Open-label Phase)|Death|0|||
33298173|NCT02229851|100988305|FG003|Extension Phase (Open-label Phase)|Death|1|||
33298174|NCT02229851|100988306|FG004|Extension Phase (Open-label Phase)|Death|0|||
33298175|NCT02229851|100988307|FG005|Extension Phase (Open-label Phase)|Death|1|||
33298176|NCT02229851|100988308|FG006|Extension Phase (Open-label Phase)|Death|1|||
33298177|NCT00477490|100988309|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
33496333|NCT01515423|101710068|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
33496334|NCT01515423|101710069|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
33496335|NCT01515423|101710067|FG000|DOUBLE BLIND|Pregnancy|0|||
33496336|NCT01515423|101710068|FG001|DOUBLE BLIND|Pregnancy|2|||
33496337|NCT01515423|101710069|FG002|DOUBLE BLIND|Pregnancy|0|||
33298178|NCT00477490|100988310|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
33298179|NCT00477490|100988311|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
33298180|NCT00477490|100988312|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
33298181|NCT00477490|100988313|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
33496338|NCT01515423|101710067|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
33496339|NCT01515423|101710068|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
33496340|NCT01515423|101710069|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
33496341|NCT01515423|101710067|FG000|DOUBLE BLIND|Other|0|||
33496342|NCT01515423|101710068|FG001|DOUBLE BLIND|Other|6|||
33496343|NCT01515423|101710069|FG002|DOUBLE BLIND|Other|12|||
33496344|NCT01515423|101710067|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
33496345|NCT01515423|101710068|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
33496346|NCT01515423|101710069|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
33298182|NCT00477490|100988314|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
33298183|NCT00477490|100988315|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
33298184|NCT00477490|100988316|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
33298185|NCT00477490|100988317|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
33298186|NCT00477490|100988309|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
33298187|NCT00477490|100988310|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
33298188|NCT00477490|100988311|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
33298189|NCT00477490|100988312|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
33298190|NCT00477490|100988313|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
33298191|NCT00477490|100988314|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
33298192|NCT00477490|100988315|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
33298193|NCT00477490|100988316|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
33298194|NCT00477490|100988317|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
33298195|NCT00477490|100988309|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
33298196|NCT00477490|100988310|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
33298197|NCT00477490|100988311|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
33298198|NCT00477490|100988312|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
33298199|NCT00477490|100988313|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
33298200|NCT00477490|100988314|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
33298201|NCT00477490|100988315|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
33298202|NCT00477490|100988316|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
33298203|NCT00477490|100988317|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
33298204|NCT00477490|100988309|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
33298205|NCT00477490|100988310|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
33298206|NCT00477490|100988311|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
33298207|NCT00477490|100988312|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
33298208|NCT00477490|100988313|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
33298209|NCT00477490|100988314|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
33298210|NCT00477490|100988315|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
33298211|NCT00477490|100988316|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
33298212|NCT00477490|100988317|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
33298213|NCT00477490|100988309|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
33298214|NCT00477490|100988310|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
33298215|NCT00477490|100988311|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
33298216|NCT00477490|100988312|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
33298217|NCT00477490|100988313|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
33298218|NCT00477490|100988314|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
33298219|NCT00477490|100988315|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
33298220|NCT00477490|100988316|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
33298221|NCT00477490|100988317|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
33298222|NCT00477490|100988309|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
33298223|NCT00477490|100988310|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
33298224|NCT00477490|100988311|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
33298225|NCT00477490|100988312|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
33298226|NCT00477490|100988313|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
33298227|NCT00477490|100988314|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
33298228|NCT00477490|100988315|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
33298229|NCT00477490|100988316|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
33298230|NCT00477490|100988317|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
33298231|NCT00477490|100988309|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
33298232|NCT00477490|100988310|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
33298233|NCT00477490|100988311|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
33298234|NCT00477490|100988312|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
33298235|NCT00477490|100988313|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
33298236|NCT00477490|100988314|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
33298237|NCT00477490|100988315|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
33298238|NCT00477490|100988316|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
33298239|NCT00477490|100988317|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
33298240|NCT00477490|100988309|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
33298241|NCT00477490|100988310|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
33298242|NCT00477490|100988311|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
33298243|NCT00477490|100988312|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
33298244|NCT00477490|100988313|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
33298245|NCT00477490|100988314|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
33298246|NCT00477490|100988315|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
33298247|NCT00477490|100988316|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
33298248|NCT00477490|100988317|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
33298249|NCT00477490|100988309|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
33298250|NCT00477490|100988310|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
33393406|NCT03051217|101328471|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33298251|NCT00477490|100988311|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
33298252|NCT00477490|100988312|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
33298253|NCT00477490|100988313|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
33298254|NCT00477490|100988314|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
33298255|NCT00477490|100988315|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
33298256|NCT00477490|100988316|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
33298257|NCT00477490|100988317|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
33298258|NCT00477490|100988309|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
33298259|NCT00477490|100988310|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
33298260|NCT00477490|100988311|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
33298261|NCT00477490|100988312|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
33298262|NCT00477490|100988313|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
33298263|NCT00477490|100988314|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
33298264|NCT00477490|100988315|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
33298265|NCT00477490|100988316|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
33298266|NCT00477490|100988317|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
33298267|NCT00477490|100988309|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
33298268|NCT00477490|100988310|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
33298269|NCT00477490|100988311|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
33298270|NCT00477490|100988312|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
33298271|NCT00477490|100988313|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
33298272|NCT00477490|100988314|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
33298273|NCT00477490|100988315|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
33298274|NCT00477490|100988316|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
33298275|NCT00477490|100988317|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
33298276|NCT00477490|100988309|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33298277|NCT00477490|100988310|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
33298278|NCT00477490|100988311|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33298279|NCT00477490|100988312|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33190126|NCT00207142|100601569|FG001|Induction Phase|Incarceration|0|||
33190127|NCT00207142|100601570|FG002|Induction Phase|Incarceration|0|||
33298280|NCT00477490|100988313|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33298281|NCT00477490|100988314|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33298282|NCT00477490|100988315|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33298283|NCT00477490|100988316|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33298284|NCT00477490|100988317|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
33298285|NCT00477490|100988309|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
33298286|NCT00477490|100988310|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
33298287|NCT00477490|100988311|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
33298288|NCT00477490|100988312|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
33298289|NCT00477490|100988313|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
33298290|NCT00477490|100988314|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
33393407|NCT03051217|101328465|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
33393408|NCT03051217|101328466|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
33393409|NCT03051217|101328467|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
33393410|NCT03051217|101328468|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
33393411|NCT03051217|101328469|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
33393412|NCT03051217|101328470|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
33393413|NCT03051217|101328471|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
33393414|NCT03051217|101328465|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
33496347|NCT01778855|101710070|FG000|Overall Study|Death|0|||
33496348|NCT01778855|101710071|FG001|Overall Study|Death|1|||
33496349|NCT03885661|101710072|FG000|Overall Study|Withdrawal by Subject|0|||
33393415|NCT03051217|101328466|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
33393416|NCT03051217|101328467|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
33393417|NCT03051217|101328468|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33393418|NCT03051217|101328469|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33393419|NCT03051217|101328470|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33393420|NCT03051217|101328471|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33393421|NCT03051217|101328465|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
33496350|NCT03885661|101710073|FG001|Overall Study|Withdrawal by Subject|1|||
33496351|NCT03885661|101710072|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
33298291|NCT00477490|100988315|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
33298292|NCT00477490|100988316|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
33298293|NCT00477490|100988317|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
33298294|NCT00477490|100988309|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
33298295|NCT00477490|100988310|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
33298296|NCT00477490|100988311|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
33298297|NCT00477490|100988312|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
33298298|NCT00477490|100988313|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
33298299|NCT00477490|100988314|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
33298300|NCT00477490|100988315|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
33298301|NCT00477490|100988316|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
33298302|NCT00477490|100988317|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
33298303|NCT01254747|100988318|FG000|Overall Study|Unacceptable subjective vision|0|||
33298304|NCT01254747|100988319|FG001|Overall Study|Unacceptable subjective vision|0|||
33298305|NCT01254747|100988320|FG002|Overall Study|Unacceptable subjective vision|0|||
33298306|NCT01254747|100988321|FG003|Overall Study|Unacceptable subjective vision|2|||
33298307|NCT01254747|100988318|FG000|Overall Study|Difficult removal handling|0|||
33298308|NCT01254747|100988319|FG001|Overall Study|Difficult removal handling|0|||
33298309|NCT01254747|100988320|FG002|Overall Study|Difficult removal handling|1|||
33298310|NCT01254747|100988321|FG003|Overall Study|Difficult removal handling|0|||
33298311|NCT01254747|100988318|FG000|Overall Study|Symptoms and problems|0|||
33298312|NCT01254747|100988319|FG001|Overall Study|Symptoms and problems|2|||
33298313|NCT01254747|100988320|FG002|Overall Study|Symptoms and problems|1|||
33298314|NCT01254747|100988321|FG003|Overall Study|Symptoms and problems|0|||
33298315|NCT01254747|100988318|FG000|Overall Study|Lost to Follow-up|0|||
33298316|NCT01254747|100988319|FG001|Overall Study|Lost to Follow-up|0|||
33298317|NCT01254747|100988320|FG002|Overall Study|Lost to Follow-up|1|||
33298318|NCT01254747|100988321|FG003|Overall Study|Lost to Follow-up|0|||
33298319|NCT01254747|100988318|FG000|Overall Study|Biomicroscopy|0|||
33298320|NCT01254747|100988319|FG001|Overall Study|Biomicroscopy|0|||
33298321|NCT01254747|100988320|FG002|Overall Study|Biomicroscopy|1|||
33298322|NCT01254747|100988321|FG003|Overall Study|Biomicroscopy|0|||
33298323|NCT01254747|100988318|FG000|Overall Study|Discomfort|0|||
33298324|NCT01254747|100988319|FG001|Overall Study|Discomfort|4|||
33298325|NCT01254747|100988320|FG002|Overall Study|Discomfort|0|||
33298326|NCT01254747|100988321|FG003|Overall Study|Discomfort|0|||
33298327|NCT02460575|100988323|FG000|Overall Study|Lost to Follow-up|1|||
33298328|NCT02460575|100988324|FG001|Overall Study|Lost to Follow-up|0|||
33298329|NCT02628028|100988325|FG000|Dosing Period|Withdrawal by Subject|0|||
33298330|NCT02628028|100988326|FG001|Dosing Period|Withdrawal by Subject|0|||
33298331|NCT02628028|100988327|FG002|Dosing Period|Withdrawal by Subject|1|||
33298332|NCT02628028|100988328|FG003|Dosing Period|Withdrawal by Subject|0|||
33298333|NCT02628028|100988329|FG004|Dosing Period|Withdrawal by Subject|2|||
33298334|NCT02628028|100988330|FG005|Dosing Period|Withdrawal by Subject|4|||
33298335|NCT02628028|100988331|FG006|Dosing Period|Withdrawal by Subject|1|||
33298336|NCT02628028|100988332|FG007|Dosing Period|Withdrawal by Subject|1|||
33298337|NCT02628028|100988325|FG000|Dosing Period|Adverse Event|0|||
33298338|NCT02628028|100988326|FG001|Dosing Period|Adverse Event|0|||
33298339|NCT02628028|100988327|FG002|Dosing Period|Adverse Event|0|||
33298340|NCT02628028|100988328|FG003|Dosing Period|Adverse Event|0|||
33298341|NCT02628028|100988329|FG004|Dosing Period|Adverse Event|2|||
33298342|NCT02628028|100988330|FG005|Dosing Period|Adverse Event|1|||
33298343|NCT02628028|100988331|FG006|Dosing Period|Adverse Event|3|||
33298344|NCT02628028|100988332|FG007|Dosing Period|Adverse Event|2|||
33298345|NCT02628028|100988325|FG000|Dosing Period|Death|0|||
33298346|NCT02628028|100988326|FG001|Dosing Period|Death|0|||
33298347|NCT02628028|100988327|FG002|Dosing Period|Death|0|||
33298348|NCT02628028|100988328|FG003|Dosing Period|Death|0|||
33298349|NCT02628028|100988329|FG004|Dosing Period|Death|0|||
33298350|NCT02628028|100988330|FG005|Dosing Period|Death|0|||
33298351|NCT02628028|100988331|FG006|Dosing Period|Death|0|||
33298352|NCT02628028|100988332|FG007|Dosing Period|Death|1|||
33298353|NCT02628028|100988325|FG000|Dosing Period|Lack of Efficacy|0|||
33298354|NCT02628028|100988326|FG001|Dosing Period|Lack of Efficacy|0|||
33298355|NCT02628028|100988327|FG002|Dosing Period|Lack of Efficacy|0|||
33298356|NCT02628028|100988328|FG003|Dosing Period|Lack of Efficacy|0|||
33298357|NCT02628028|100988329|FG004|Dosing Period|Lack of Efficacy|3|||
33190128|NCT00207142|100601571|FG003|Induction Phase|Incarceration|0|||
33298358|NCT02628028|100988330|FG005|Dosing Period|Lack of Efficacy|0|||
33298359|NCT02628028|100988331|FG006|Dosing Period|Lack of Efficacy|1|||
33298360|NCT02628028|100988332|FG007|Dosing Period|Lack of Efficacy|0|||
33298361|NCT02628028|100988325|FG000|Dosing Period|Study Terminated by Sponsor|0|||
33298362|NCT02628028|100988326|FG001|Dosing Period|Study Terminated by Sponsor|0|||
33298363|NCT02628028|100988327|FG002|Dosing Period|Study Terminated by Sponsor|0|||
33496352|NCT03885661|101710073|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
33496353|NCT03518008|101710076|FG000|Period 2, Second Week of Wear|Family emergency|0|||
33298364|NCT02628028|100988328|FG003|Dosing Period|Study Terminated by Sponsor|0|||
33298365|NCT02628028|100988329|FG004|Dosing Period|Study Terminated by Sponsor|7|||
33298366|NCT02628028|100988330|FG005|Dosing Period|Study Terminated by Sponsor|6|||
33298367|NCT02628028|100988331|FG006|Dosing Period|Study Terminated by Sponsor|7|||
33298368|NCT02628028|100988332|FG007|Dosing Period|Study Terminated by Sponsor|7|||
33298369|NCT02628028|100988325|FG000|Dosing Period|Physician Decision|0|||
33298370|NCT02628028|100988326|FG001|Dosing Period|Physician Decision|0|||
33496354|NCT03518008|101710077|FG001|Period 2, Second Week of Wear|Family emergency|1|||
33496355|NCT02088177|101710078|FG000|Overall Study|Lost to Follow-up|3|||
33496356|NCT05064397|101710079|FG000|Overall Study|Adverse Event|4|||
33496357|NCT05064397|101710079|FG000|Overall Study|Lack of Efficacy|12|||
33496358|NCT05064397|101710079|FG000|Overall Study|Withdrawal by Subject|3|||
33496359|NCT05064397|101710079|FG000|Overall Study|Lost to Follow-up|1|||
33496360|NCT05064397|101710079|FG000|Overall Study|Other reasons|3|||
33496361|NCT02503540|101710080|FG000|Overall Study|Death|2|||
33496362|NCT02503540|101710080|FG000|Overall Study|Withdrawal by Subject|1|||
33496363|NCT04011722|101710082|FG000|30 Days|Death|5|||
33496364|NCT04011722|101710083|FG001|30 Days|Death|1|||
33496365|NCT04011722|101710082|FG000|1 Year|Death|13|||
33496366|NCT04011722|101710083|FG001|1 Year|Death|5|||
33496367|NCT04011722|101710082|FG000|1 Year|Withdrawal by Subject|8|||
33496368|NCT04011722|101710083|FG001|1 Year|Withdrawal by Subject|2|||
33190129|NCT00207142|100601568|FG000|Induction Phase|Missing lab data|1|||
33190130|NCT00207142|100601569|FG001|Induction Phase|Missing lab data|0|||
33190131|NCT00207142|100601570|FG002|Induction Phase|Missing lab data|0|||
33190132|NCT00207142|100601571|FG003|Induction Phase|Missing lab data|0|||
33190133|NCT00207142|100601568|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
33190134|NCT00207142|100601569|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
33190135|NCT00207142|100601570|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
33190136|NCT00207142|100601571|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
33190137|NCT00207142|100601568|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
33190138|NCT00207142|100601569|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
33190139|NCT00207142|100601570|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
33190140|NCT00207142|100601571|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
33190141|NCT00207142|100601568|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
33190142|NCT00207142|100601569|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
33190143|NCT00207142|100601570|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
33190144|NCT00207142|100601571|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
33190145|NCT00207142|100601568|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
33190146|NCT00207142|100601569|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
33190147|NCT00207142|100601570|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
33190148|NCT00207142|100601571|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
33190149|NCT00207142|100601568|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
33190150|NCT00207142|100601569|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
33190151|NCT00207142|100601570|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
33190152|NCT00207142|100601571|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
33190153|NCT00207142|100601568|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
33190154|NCT00207142|100601569|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
33190155|NCT00207142|100601570|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
33190156|NCT00207142|100601571|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
33190157|NCT00207142|100601568|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
33190158|NCT00207142|100601569|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
33190159|NCT00207142|100601570|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
33298371|NCT02628028|100988327|FG002|Dosing Period|Physician Decision|0|||
33190160|NCT00207142|100601571|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
33190161|NCT00207142|100601568|FG000|Maintenance Phase/Rescue Phase|Death|0|||
33496369|NCT04011722|101710082|FG000|1 Year|Missed Visit|6|||
33496370|NCT04011722|101710083|FG001|1 Year|Missed Visit|1|||
33496371|NCT04011722|101710082|FG000|1 Year|Pending Visit|0|||
33298372|NCT02628028|100988328|FG003|Dosing Period|Physician Decision|0|||
33298373|NCT02628028|100988329|FG004|Dosing Period|Physician Decision|0|||
33298374|NCT02628028|100988330|FG005|Dosing Period|Physician Decision|1|||
33298375|NCT02628028|100988331|FG006|Dosing Period|Physician Decision|0|||
33298376|NCT02628028|100988332|FG007|Dosing Period|Physician Decision|0|||
33298377|NCT02628028|100988325|FG000|Dosing Period|Site Terminated by Sponsor|0|||
33298378|NCT02628028|100988326|FG001|Dosing Period|Site Terminated by Sponsor|0|||
33298379|NCT02628028|100988327|FG002|Dosing Period|Site Terminated by Sponsor|0|||
33298380|NCT02628028|100988328|FG003|Dosing Period|Site Terminated by Sponsor|0|||
33298381|NCT02628028|100988329|FG004|Dosing Period|Site Terminated by Sponsor|0|||
33298382|NCT02628028|100988330|FG005|Dosing Period|Site Terminated by Sponsor|1|||
33298383|NCT02628028|100988331|FG006|Dosing Period|Site Terminated by Sponsor|1|||
33298384|NCT02628028|100988332|FG007|Dosing Period|Site Terminated by Sponsor|0|||
33298385|NCT02628028|100988325|FG000|Dosing Period|Lost to Follow-up|0|||
33298386|NCT02628028|100988326|FG001|Dosing Period|Lost to Follow-up|0|||
33298387|NCT02628028|100988327|FG002|Dosing Period|Lost to Follow-up|0|||
33298388|NCT02628028|100988328|FG003|Dosing Period|Lost to Follow-up|0|||
33298389|NCT02628028|100988329|FG004|Dosing Period|Lost to Follow-up|0|||
33298390|NCT02628028|100988330|FG005|Dosing Period|Lost to Follow-up|0|||
33298391|NCT02628028|100988331|FG006|Dosing Period|Lost to Follow-up|1|||
33298392|NCT02628028|100988332|FG007|Dosing Period|Lost to Follow-up|0|||
33298393|NCT02628028|100988325|FG000|Dosing Period|Other|0|||
33298394|NCT02628028|100988326|FG001|Dosing Period|Other|0|||
33298395|NCT02628028|100988327|FG002|Dosing Period|Other|0|||
33298396|NCT02628028|100988328|FG003|Dosing Period|Other|0|||
33298397|NCT02628028|100988329|FG004|Dosing Period|Other|2|||
33298398|NCT02628028|100988330|FG005|Dosing Period|Other|1|||
33298399|NCT02628028|100988331|FG006|Dosing Period|Other|2|||
33298400|NCT02628028|100988332|FG007|Dosing Period|Other|4|||
33298401|NCT02628028|100988325|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
33298402|NCT02628028|100988326|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
33298403|NCT02628028|100988327|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
33298404|NCT02628028|100988328|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
33298405|NCT02628028|100988329|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
33298406|NCT02628028|100988330|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
33298407|NCT02628028|100988331|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
33298408|NCT02628028|100988332|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
33298409|NCT02628028|100988325|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
33298410|NCT02628028|100988326|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
33298411|NCT02628028|100988327|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
33298412|NCT02628028|100988328|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
33298413|NCT02628028|100988329|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
33298414|NCT02628028|100988330|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
33298415|NCT02628028|100988331|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
33298416|NCT02628028|100988332|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
33298417|NCT02628028|100988325|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
33298418|NCT02628028|100988326|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
33298419|NCT02628028|100988327|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
33298420|NCT02628028|100988328|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
33298421|NCT02628028|100988329|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
33298422|NCT02628028|100988330|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
33298423|NCT02628028|100988331|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
33298424|NCT02628028|100988332|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
33298425|NCT02628028|100988325|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
33298426|NCT02628028|100988326|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
33298427|NCT02628028|100988327|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
33298428|NCT02628028|100988328|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
33298429|NCT02628028|100988329|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
33298430|NCT02628028|100988330|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
33298431|NCT02628028|100988331|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
33298432|NCT02628028|100988332|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
33298433|NCT02628028|100988325|FG000|Long-term Extension (LTE) Period|Other|0|||
33298434|NCT02628028|100988326|FG001|Long-term Extension (LTE) Period|Other|0|||
33298435|NCT02628028|100988327|FG002|Long-term Extension (LTE) Period|Other|0|||
33298436|NCT02628028|100988328|FG003|Long-term Extension (LTE) Period|Other|0|||
33298437|NCT02628028|100988329|FG004|Long-term Extension (LTE) Period|Other|0|||
33298438|NCT02628028|100988330|FG005|Long-term Extension (LTE) Period|Other|3|||
33298439|NCT02628028|100988331|FG006|Long-term Extension (LTE) Period|Other|4|||
33298440|NCT02628028|100988332|FG007|Long-term Extension (LTE) Period|Other|3|||
33298441|NCT02568397|100988338|FG000|Period 2|Withdrawal by Subject|0|||
33298442|NCT02568397|100988339|FG001|Period 2|Withdrawal by Subject|1|||
33298443|NCT02568397|100988338|FG000|Period 2|Physician Decision|0|||
33298444|NCT02568397|100988339|FG001|Period 2|Physician Decision|1|||
33364910|NCT01790438|101223682|FG000|Overall Study|Death|4|||
33298445|NCT00633880|100988341|FG000|Open Label Titration|Lack of Efficacy|1|||
33298446|NCT00633880|100988342|FG001|Open Label Titration|Lack of Efficacy|0|||
33298447|NCT00633880|100988343|FG002|Open Label Titration|Lack of Efficacy|0|||
33298448|NCT00633880|100988341|FG000|Open Label Titration|Adverse Event|13|||
33298449|NCT00633880|100988342|FG001|Open Label Titration|Adverse Event|0|||
33298450|NCT00633880|100988343|FG002|Open Label Titration|Adverse Event|0|||
33298451|NCT00633880|100988341|FG000|Open Label Titration|Treatment Failure|55|||
33298452|NCT00633880|100988342|FG001|Open Label Titration|Treatment Failure|0|||
33298453|NCT00633880|100988343|FG002|Open Label Titration|Treatment Failure|0|||
33298454|NCT00633880|100988341|FG000|Open Label Titration|Protocol Violation|6|||
33298455|NCT00633880|100988342|FG001|Open Label Titration|Protocol Violation|0|||
33298456|NCT00633880|100988343|FG002|Open Label Titration|Protocol Violation|0|||
33298457|NCT00633880|100988341|FG000|Open Label Titration|Physician Decision|1|||
33298458|NCT00633880|100988342|FG001|Open Label Titration|Physician Decision|0|||
33298459|NCT00633880|100988343|FG002|Open Label Titration|Physician Decision|0|||
33298460|NCT00633880|100988341|FG000|Open Label Titration|Withdrawal by Subject|4|||
33298461|NCT00633880|100988342|FG001|Open Label Titration|Withdrawal by Subject|0|||
33298462|NCT00633880|100988343|FG002|Open Label Titration|Withdrawal by Subject|0|||
33298463|NCT03551691|100988346|FG000|Overall Study|Withdrawal by Subject|3|||
33298464|NCT03551691|100988347|FG001|Overall Study|Withdrawal by Subject|3|||
33298465|NCT00567567|100988352|FG000|Overall Study|Adverse Event|0|||
33298466|NCT00567567|100988353|FG001|Overall Study|Adverse Event|2|||
33298467|NCT00567567|100988354|FG002|Overall Study|Adverse Event|5|||
33298468|NCT00567567|100988352|FG000|Overall Study|Death|8|||
33298469|NCT00567567|100988353|FG001|Overall Study|Death|1|||
33298470|NCT00567567|100988354|FG002|Overall Study|Death|5|||
33298471|NCT00567567|100988352|FG000|Overall Study|Lack of Efficacy|16|||
33298472|NCT00567567|100988353|FG001|Overall Study|Lack of Efficacy|17|||
33298473|NCT00567567|100988354|FG002|Overall Study|Lack of Efficacy|48|||
33298474|NCT00567567|100988352|FG000|Overall Study|Lost to Follow-up|0|||
33298475|NCT00567567|100988353|FG001|Overall Study|Lost to Follow-up|0|||
33298476|NCT00567567|100988354|FG002|Overall Study|Lost to Follow-up|1|||
33298477|NCT00567567|100988352|FG000|Overall Study|Physician Decision|16|||
33298478|NCT00567567|100988353|FG001|Overall Study|Physician Decision|18|||
33298479|NCT00567567|100988354|FG002|Overall Study|Physician Decision|84|||
33298480|NCT00567567|100988352|FG000|Overall Study|Withdrawal by Subject|0|||
33298481|NCT00567567|100988353|FG001|Overall Study|Withdrawal by Subject|0|||
33298482|NCT00567567|100988354|FG002|Overall Study|Withdrawal by Subject|2|||
33298483|NCT00567567|100988352|FG000|Overall Study|Ineligible|4|||
33298484|NCT00567567|100988353|FG001|Overall Study|Ineligible|0|||
33298485|NCT00567567|100988354|FG002|Overall Study|Ineligible|9|||
33298486|NCT00567567|100988352|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
33298487|NCT00567567|100988353|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
33298488|NCT00567567|100988354|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
33298489|NCT00567567|100988352|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
33298490|NCT00567567|100988353|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
33298491|NCT00567567|100988354|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
33298492|NCT00567567|100988352|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
33298493|NCT00567567|100988353|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
33298494|NCT00567567|100988354|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
33298495|NCT01606670|100988355|FG000|Overall Study|Adverse Event|6|||
33298496|NCT01606670|100988355|FG000|Overall Study|Lack of Efficacy|2|||
33298497|NCT01606670|100988355|FG000|Overall Study|Lost to Follow-up|3|||
33496372|NCT04011722|101710083|FG001|1 Year|Pending Visit|11|||
33496373|NCT04011722|101710082|FG000|1 Year|Not Yet Due|0|||
33298498|NCT01606670|100988355|FG000|Overall Study|Withdrawal by Subject|3|||
33496374|NCT04011722|101710083|FG001|1 Year|Not Yet Due|9|||
33496375|NCT04011722|101710082|FG000|2 Year|Death|16|||
33298499|NCT01606670|100988355|FG000|Overall Study|Other Reason|2|||
33298500|NCT01147536|100988361|FG000|Overall Study|Administrative study close|2|||
33298501|NCT01147536|100988361|FG000|Overall Study|Death|1|||
33298502|NCT00968526|100988362|FG000|Overall Study|Adverse Event|2|||
33298503|NCT00968526|100988363|FG001|Overall Study|Adverse Event|0|||
33298504|NCT00968526|100988362|FG000|Overall Study|Migrated/moved from study area|1|||
33298505|NCT00968526|100988363|FG001|Overall Study|Migrated/moved from study area|0|||
33298506|NCT02592876|100988364|FG000|Overall Study|Withdrawal by Subject|3|||
33298507|NCT02592876|100988365|FG001|Overall Study|Withdrawal by Subject|3|||
33298508|NCT02592876|100988364|FG000|Overall Study|Study Termination by Sponsor|32|||
33298509|NCT02592876|100988365|FG001|Overall Study|Study Termination by Sponsor|27|||
33298510|NCT02592876|100988364|FG000|Overall Study|Lost to Follow-up|0|||
33298511|NCT02592876|100988365|FG001|Overall Study|Lost to Follow-up|1|||
33298512|NCT02592876|100988364|FG000|Overall Study|Death|6|||
33298513|NCT02592876|100988365|FG001|Overall Study|Death|9|||
33298514|NCT01213524|100988366|FG000|Baseline|Withdrawal by Subject|5|||
33298515|NCT01213524|100988366|FG000|Baseline|high breath alcohol levels|1|||
33298516|NCT01213524|100988366|FG000|Baseline|Physician Decision|1|||
33496376|NCT04011722|101710083|FG001|2 Year|Death|1|||
33298517|NCT01213524|100988366|FG000|Session 2|Withdrawal by Subject|5|||
33298518|NCT01213524|100988366|FG000|Session 3|Withdrawal by Subject|4|||
33298519|NCT01213524|100988366|FG000|Session 4|Physician Decision|1|||
33298520|NCT01213524|100988366|FG000|Session 4|Withdrawal by Subject|2|||
33298521|NCT02056626|100988367|FG000|Overall Study|patient did not follow directions|3|||
33298522|NCT02056626|100988368|FG001|Overall Study|patient did not follow directions|1|||
33298523|NCT02056626|100988369|FG002|Overall Study|patient did not follow directions|0|||
33298524|NCT02056626|100988370|FG003|Overall Study|patient did not follow directions|0|||
33298525|NCT01114880|100988374|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
33298526|NCT01114880|100988375|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
33298527|NCT01114880|100988374|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
33298528|NCT01114880|100988375|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
33298529|NCT01114880|100988374|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
33298530|NCT01114880|100988375|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
33298531|NCT01114880|100988374|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
33298532|NCT01114880|100988375|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
33298533|NCT01114880|100988374|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
33298534|NCT01114880|100988375|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
33298535|NCT01114880|100988374|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
33298536|NCT01114880|100988375|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
33298537|NCT04055090|100988378|FG000|Overall Study|screen failure|1|||
33298538|NCT04055090|100988379|FG001|Overall Study|screen failure|0|||
33298539|NCT04055090|100988378|FG000|Overall Study|Withdrawal by Subject|1|||
33298540|NCT04055090|100988379|FG001|Overall Study|Withdrawal by Subject|0|||
33298541|NCT02922023|100988380|FG000|Overall Study|Lost to Follow-up|2|||
33298542|NCT02922023|100988381|FG001|Overall Study|Lost to Follow-up|0|||
33298543|NCT02473289|100988382|FG000|Overall Study|Adverse Event|2|||
33298544|NCT02473289|100988383|FG001|Overall Study|Adverse Event|3|||
33298545|NCT02473289|100988382|FG000|Overall Study|Lost to Follow-up|1|||
33298546|NCT02473289|100988383|FG001|Overall Study|Lost to Follow-up|1|||
33298547|NCT02473289|100988382|FG000|Overall Study|Protocol Violation|0|||
33298548|NCT02473289|100988383|FG001|Overall Study|Protocol Violation|1|||
33298549|NCT02473289|100988382|FG000|Overall Study|Withdrawal of consent|6|||
33298550|NCT02473289|100988383|FG001|Overall Study|Withdrawal of consent|7|||
33298551|NCT02473289|100988382|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
33298552|NCT02473289|100988383|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
33298553|NCT02473289|100988382|FG000|Overall Study|Other|2|||
33298554|NCT02473289|100988383|FG001|Overall Study|Other|0|||
33298555|NCT03812029|100988384|FG000|Overall Study|Protocol Violation|1|||
33298556|NCT03812029|100988385|FG001|Overall Study|Protocol Violation|0|||
33298557|NCT03812029|100988386|FG002|Overall Study|Protocol Violation|0|||
33298558|NCT03812029|100988387|FG003|Overall Study|Protocol Violation|1|||
33298559|NCT03812029|100988388|FG004|Overall Study|Protocol Violation|0|||
33298560|NCT03812029|100988384|FG000|Overall Study|Withdrawal by Subject|1|||
33298561|NCT03812029|100988385|FG001|Overall Study|Withdrawal by Subject|0|||
33298562|NCT03812029|100988386|FG002|Overall Study|Withdrawal by Subject|0|||
33298563|NCT03812029|100988387|FG003|Overall Study|Withdrawal by Subject|2|||
33298564|NCT03812029|100988388|FG004|Overall Study|Withdrawal by Subject|2|||
33298565|NCT03812029|100988384|FG000|Overall Study|Stopping rules|0|||
33298566|NCT03812029|100988385|FG001|Overall Study|Stopping rules|1|||
33298567|NCT03812029|100988386|FG002|Overall Study|Stopping rules|0|||
33298568|NCT03812029|100988387|FG003|Overall Study|Stopping rules|0|||
33600142|NCT05239221|102088523|FG008|Overall Study|Adverse Event|0|||
33600143|NCT05239221|102088524|FG009|Overall Study|Adverse Event|0|||
33190162|NCT00207142|100601569|FG001|Maintenance Phase/Rescue Phase|Death|0|||
33190163|NCT00207142|100601570|FG002|Maintenance Phase/Rescue Phase|Death|0|||
33298569|NCT03812029|100988388|FG004|Overall Study|Stopping rules|0|||
33298570|NCT03812029|100988384|FG000|Overall Study|Adverse Event|0|||
33298571|NCT03812029|100988385|FG001|Overall Study|Adverse Event|9|||
33298572|NCT03812029|100988386|FG002|Overall Study|Adverse Event|0|||
33298573|NCT03812029|100988387|FG003|Overall Study|Adverse Event|3|||
33298574|NCT03812029|100988388|FG004|Overall Study|Adverse Event|5|||
33298575|NCT03812029|100988384|FG000|Overall Study|Lost to Follow-up|0|||
33298576|NCT03812029|100988385|FG001|Overall Study|Lost to Follow-up|0|||
33298577|NCT03812029|100988386|FG002|Overall Study|Lost to Follow-up|0|||
33298578|NCT03812029|100988387|FG003|Overall Study|Lost to Follow-up|0|||
33298579|NCT03812029|100988388|FG004|Overall Study|Lost to Follow-up|3|||
33298580|NCT00214019|100988389|FG000|Overall Study|Lost to Follow-up|11|||
33298581|NCT00214019|100988389|FG000|Overall Study|Withdrawal by Subject|2|||
33298582|NCT00214019|100988389|FG000|Overall Study|Screen Failed prior to randomization|17|||
33298583|NCT03258723|100988390|FG000|Overall Study|COVID Interruption of study|54|||
33298584|NCT03258723|100988390|FG000|Overall Study|Lost to Follow-up|8|||
33600144|NCT05239221|102088525|FG010|Overall Study|Adverse Event|1|||
33298585|NCT02206061|100988391|FG000|Overall Study|Withdrawal by Subject|4|||
33298586|NCT02206061|100988392|FG001|Overall Study|Withdrawal by Subject|7|||
33298587|NCT02206061|100988393|FG002|Overall Study|Withdrawal by Subject|1|||
33298588|NCT02206061|100988391|FG000|Overall Study|Lost to Follow-up|14|||
33298589|NCT02206061|100988392|FG001|Overall Study|Lost to Follow-up|7|||
33298590|NCT02206061|100988393|FG002|Overall Study|Lost to Follow-up|20|||
33298591|NCT01011868|100988394|FG000|After Week 18 Follow-up|Adverse Event|8|||
33298592|NCT01011868|100988395|FG001|After Week 18 Follow-up|Adverse Event|6|||
33298593|NCT01011868|100988396|FG002|After Week 18 Follow-up|Adverse Event|13|||
33298594|NCT01011868|100988394|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
33298595|NCT01011868|100988395|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
33298596|NCT01011868|100988396|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
33298597|NCT01011868|100988394|FG000|After Week 18 Follow-up|Protocol Violation|1|||
33298598|NCT01011868|100988395|FG001|After Week 18 Follow-up|Protocol Violation|1|||
33298599|NCT01011868|100988396|FG002|After Week 18 Follow-up|Protocol Violation|1|||
33298600|NCT01011868|100988394|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
33298601|NCT01011868|100988395|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
33298602|NCT01011868|100988396|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
33298603|NCT01011868|100988394|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
33298604|NCT01011868|100988395|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
33298605|NCT01011868|100988396|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
33298606|NCT01011868|100988394|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
33298607|NCT01011868|100988395|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
33298608|NCT01011868|100988396|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
33298609|NCT01011868|100988394|FG000|After Week 78 Follow-up|Adverse Event|14|||
33298610|NCT01011868|100988395|FG001|After Week 78 Follow-up|Adverse Event|18|||
33298611|NCT01011868|100988396|FG002|After Week 78 Follow-up|Adverse Event|21|||
33298612|NCT01011868|100988394|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
33298613|NCT01011868|100988395|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
33298614|NCT01011868|100988396|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
33298615|NCT01011868|100988394|FG000|After Week 78 Follow-up|Protocol Violation|9|||
33298616|NCT01011868|100988395|FG001|After Week 78 Follow-up|Protocol Violation|1|||
33496377|NCT04011722|101710082|FG000|2 Year|Withdrawal by Subject|10|||
33496378|NCT04011722|101710083|FG001|2 Year|Withdrawal by Subject|1|||
33496379|NCT04011722|101710082|FG000|2 Year|Missed Visit|9|||
33496380|NCT04011722|101710083|FG001|2 Year|Missed Visit|0|||
33496381|NCT04011722|101710082|FG000|2 Year|Visit Pending|1|||
33496382|NCT04011722|101710083|FG001|2 Year|Visit Pending|3|||
33496383|NCT04011722|101710082|FG000|2 Year|Not Yet Due|43|||
33496384|NCT04011722|101710083|FG001|2 Year|Not Yet Due|54|||
33496385|NCT04011722|101710082|FG000|3 Year|Death|10|||
33298617|NCT01011868|100988396|FG002|After Week 78 Follow-up|Protocol Violation|2|||
33298618|NCT01011868|100988394|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
33298619|NCT01011868|100988395|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
33298620|NCT01011868|100988396|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
33298621|NCT01011868|100988394|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
33298622|NCT01011868|100988395|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
33298623|NCT01011868|100988396|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
33298624|NCT01011868|100988394|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
33298625|NCT01011868|100988395|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
33298626|NCT01011868|100988396|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
33298627|NCT00737698|100988397|FG000|Overall Study|Withdrawal by Subject|6|||
33298628|NCT00737698|100988398|FG001|Overall Study|Withdrawal by Subject|5|||
33298629|NCT00737698|100988399|FG002|Overall Study|Withdrawal by Subject|3|||
33496386|NCT04011722|101710083|FG001|3 Year|Death|0|||
33600145|NCT05239221|102088526|FG011|Overall Study|Adverse Event|1|||
33298630|NCT00737698|100988397|FG000|Overall Study|Death|0|||
33298631|NCT00737698|100988398|FG001|Overall Study|Death|0|||
33298632|NCT00737698|100988399|FG002|Overall Study|Death|1|||
33298633|NCT02807272|100988400|FG000|Overall Study|Death|9|||
33298634|NCT02807272|100988401|FG001|Overall Study|Death|5|||
33298635|NCT02807272|100988402|FG002|Overall Study|Death|2|||
33298636|NCT02807272|100988403|FG003|Overall Study|Death|0|||
33298637|NCT02807272|100988404|FG004|Overall Study|Death|1|||
33298638|NCT02807272|100988400|FG000|Overall Study|Lost to Follow-up|1|||
33298639|NCT02807272|100988401|FG001|Overall Study|Lost to Follow-up|0|||
33298640|NCT02807272|100988402|FG002|Overall Study|Lost to Follow-up|0|||
33298641|NCT02807272|100988403|FG003|Overall Study|Lost to Follow-up|0|||
33298642|NCT02807272|100988404|FG004|Overall Study|Lost to Follow-up|0|||
33298643|NCT02807272|100988400|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
33298644|NCT02807272|100988401|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
33298645|NCT02807272|100988402|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
33364911|NCT01790438|101223683|FG001|Overall Study|Death|0|||
33496387|NCT04011722|101710082|FG000|3 Year|Withdrawal by Subject|2|||
33496388|NCT04011722|101710083|FG001|3 Year|Withdrawal by Subject|0|||
33496389|NCT04011722|101710082|FG000|3 Year|Missed Visit|2|||
33298646|NCT02807272|100988403|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
33298647|NCT02807272|100988404|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
33298648|NCT02807272|100988400|FG000|Overall Study|Protocol-defined Disease Progression|0|||
33298649|NCT02807272|100988401|FG001|Overall Study|Protocol-defined Disease Progression|1|||
33298650|NCT02807272|100988402|FG002|Overall Study|Protocol-defined Disease Progression|0|||
33298651|NCT02807272|100988403|FG003|Overall Study|Protocol-defined Disease Progression|0|||
33298652|NCT02807272|100988404|FG004|Overall Study|Protocol-defined Disease Progression|1|||
33298653|NCT02807272|100988400|FG000|Overall Study|Study Terminated by Sponsor|1|||
33298654|NCT02807272|100988401|FG001|Overall Study|Study Terminated by Sponsor|0|||
33298655|NCT02807272|100988402|FG002|Overall Study|Study Terminated by Sponsor|0|||
33298656|NCT02807272|100988403|FG003|Overall Study|Study Terminated by Sponsor|1|||
33600146|NCT05239221|102088527|FG012|Overall Study|Adverse Event|0|||
33600147|NCT05239221|102088528|FG013|Overall Study|Adverse Event|0|||
33190164|NCT00207142|100601571|FG003|Maintenance Phase/Rescue Phase|Death|1|||
33190165|NCT00207142|100601568|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
33190166|NCT00207142|100601569|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
33190167|NCT00207142|100601570|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
33190168|NCT00207142|100601571|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
33190169|NCT01067352|100601572|FG000|Overall Study|Withdrawal by Subject|1|||
33190170|NCT01067352|100601573|FG001|Overall Study|Withdrawal by Subject|2|||
33190171|NCT01067352|100601574|FG002|Overall Study|Withdrawal by Subject|1|||
33190172|NCT01067352|100601572|FG000|Overall Study|Physician Decision|0|||
33190173|NCT01067352|100601573|FG001|Overall Study|Physician Decision|1|||
33190174|NCT01067352|100601574|FG002|Overall Study|Physician Decision|0|||
33190175|NCT00515827|100601576|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
33190176|NCT00515827|100601577|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
33190177|NCT00515827|100601576|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
33190178|NCT00515827|100601577|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
33600148|NCT05239221|102088529|FG014|Overall Study|Adverse Event|0|||
33600149|NCT05239221|102088530|FG015|Overall Study|Adverse Event|0|||
33600150|NCT05239221|102088515|FG000|Overall Study|Withdrawal by Subject|0|||
33600151|NCT05239221|102088516|FG001|Overall Study|Withdrawal by Subject|0|||
33600152|NCT05239221|102088517|FG002|Overall Study|Withdrawal by Subject|0|||
33600153|NCT05239221|102088518|FG003|Overall Study|Withdrawal by Subject|0|||
33600154|NCT05239221|102088519|FG004|Overall Study|Withdrawal by Subject|0|||
33600155|NCT05239221|102088520|FG005|Overall Study|Withdrawal by Subject|0|||
33190179|NCT02586012|100601581|FG000|Overall Study|Withdrawal by Subject|1|||
33298657|NCT02807272|100988404|FG004|Overall Study|Study Terminated by Sponsor|0|||
33298658|NCT02807272|100988400|FG000|Overall Study|Other|1|||
33298659|NCT02807272|100988401|FG001|Overall Study|Other|0|||
33298660|NCT02807272|100988402|FG002|Overall Study|Other|0|||
33298661|NCT02807272|100988403|FG003|Overall Study|Other|0|||
33298662|NCT02807272|100988404|FG004|Overall Study|Other|1|||
33298663|NCT00384397|100988405|FG000|Overall Study|Adverse Event|0|||
33298664|NCT00384397|100988406|FG001|Overall Study|Adverse Event|1|||
33298665|NCT00384397|100988407|FG002|Overall Study|Adverse Event|2|||
33298666|NCT00384397|100988405|FG000|Overall Study|Protocol Violation|7|||
33298667|NCT00384397|100988406|FG001|Overall Study|Protocol Violation|15|||
33298668|NCT00384397|100988407|FG002|Overall Study|Protocol Violation|13|||
33298669|NCT00384397|100988405|FG000|Overall Study|Lost to Follow-up|11|||
33298670|NCT00384397|100988406|FG001|Overall Study|Lost to Follow-up|13|||
33298671|NCT00384397|100988407|FG002|Overall Study|Lost to Follow-up|3|||
33298672|NCT00384397|100988405|FG000|Overall Study|Withdrawal by Subject|14|||
33298673|NCT00384397|100988406|FG001|Overall Study|Withdrawal by Subject|17|||
33298674|NCT00384397|100988407|FG002|Overall Study|Withdrawal by Subject|15|||
33298675|NCT00368927|100988408|FG000|Overall Study|Lost to Follow-up|2|||
33298676|NCT00368927|100988409|FG001|Overall Study|Lost to Follow-up|0|||
33298677|NCT00368927|100988408|FG000|Overall Study|Adverse Event|1|||
33298678|NCT00368927|100988409|FG001|Overall Study|Adverse Event|1|||
33298679|NCT00368927|100988408|FG000|Overall Study|Withdrawal by Subject|1|||
33298680|NCT00368927|100988409|FG001|Overall Study|Withdrawal by Subject|2|||
33298681|NCT00368927|100988408|FG000|Overall Study|Physician Decision|1|||
33298682|NCT00368927|100988409|FG001|Overall Study|Physician Decision|0|||
33298683|NCT00747227|100988411|FG000|Overall Study|Death|3|||
33298684|NCT00747227|100988412|FG001|Overall Study|Death|1|||
33298685|NCT00747227|100988411|FG000|Overall Study|Withdrawal by Subject|1|||
33298686|NCT00747227|100988412|FG001|Overall Study|Withdrawal by Subject|0|||
33298687|NCT00747227|100988411|FG000|Overall Study|Lost to Follow-up|1|||
33298688|NCT00747227|100988412|FG001|Overall Study|Lost to Follow-up|2|||
33298689|NCT00747227|100988411|FG000|Overall Study|Illness|1|||
33298690|NCT00747227|100988412|FG001|Overall Study|Illness|1|||
33298691|NCT03301155|100988413|FG000|Overall Study|Сompliance with exclusion criteria|8|||
33298692|NCT03301155|100988414|FG001|Overall Study|Сompliance with exclusion criteria|7|||
33298693|NCT01912404|100988416|FG000|Overall Study|Due to personal reasons|1|||
33298694|NCT01912404|100988417|FG001|Overall Study|Due to personal reasons|0|||
33298695|NCT01381575|100988418|FG000|Overall Study|Serious Adverse Event|1|||
33298696|NCT01381575|100988419|FG001|Overall Study|Serious Adverse Event|0|||
33298697|NCT01381575|100988420|FG002|Overall Study|Serious Adverse Event|0|||
33298698|NCT01381575|100988418|FG000|Overall Study|Non-Serious Adverse Event|0|||
33298699|NCT01381575|100988419|FG001|Overall Study|Non-Serious Adverse Event|0|||
33298700|NCT01381575|100988420|FG002|Overall Study|Non-Serious Adverse Event|1|||
33298701|NCT01381575|100988418|FG000|Overall Study|Protocol Violation|0|||
33298702|NCT01381575|100988419|FG001|Overall Study|Protocol Violation|1|||
33298703|NCT01381575|100988420|FG002|Overall Study|Protocol Violation|1|||
33298704|NCT01381575|100988418|FG000|Overall Study|Withdrawal by Subject|15|||
33298705|NCT01381575|100988419|FG001|Overall Study|Withdrawal by Subject|9|||
33496390|NCT04011722|101710083|FG001|3 Year|Missed Visit|0|||
33496391|NCT04011722|101710082|FG000|3 Year|Pending Visit|34|||
33496392|NCT04011722|101710083|FG001|3 Year|Pending Visit|0|||
33496393|NCT04011722|101710082|FG000|3 Year|Not Yet Due|99|||
33496394|NCT04011722|101710083|FG001|3 Year|Not Yet Due|0|||
33496395|NCT01293695|101710084|FG000|Overall Study|Withdrawal by Subject|7|||
33496396|NCT01293695|101710085|FG001|Overall Study|Withdrawal by Subject|1|||
33496397|NCT01293695|101710084|FG000|Overall Study|Lost to Follow-up|8|||
33298706|NCT01381575|100988420|FG002|Overall Study|Withdrawal by Subject|7|||
33298707|NCT01381575|100988418|FG000|Overall Study|Migrated/moved from study area|2|||
33298708|NCT01381575|100988419|FG001|Overall Study|Migrated/moved from study area|12|||
33298709|NCT01381575|100988420|FG002|Overall Study|Migrated/moved from study area|2|||
33298710|NCT01381575|100988418|FG000|Overall Study|Lost to Follow-up|8|||
33298711|NCT01381575|100988419|FG001|Overall Study|Lost to Follow-up|17|||
33298712|NCT01381575|100988420|FG002|Overall Study|Lost to Follow-up|9|||
33298713|NCT03192475|100988424|FG000|Overall Study|Death|0|||
33298714|NCT03192475|100988425|FG001|Overall Study|Death|1|||
33298715|NCT03192475|100988424|FG000|Overall Study|Lost to Follow-up|13|||
33298716|NCT03192475|100988425|FG001|Overall Study|Lost to Follow-up|8|||
33298717|NCT00669877|100988430|FG000|Overall Study|Disease Progression/Death|4|||
33298718|NCT03926195|100988431|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
33298719|NCT03926195|100988432|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
33298720|NCT03926195|100988431|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
33298721|NCT03926195|100988432|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
33298722|NCT03926195|100988431|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
33298723|NCT03926195|100988432|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
33298724|NCT03926195|100988431|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
33298725|NCT03926195|100988432|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
33364912|NCT01790438|101223682|FG000|Overall Study|Lost to Follow-up|5|||
33496398|NCT01293695|101710085|FG001|Overall Study|Lost to Follow-up|6|||
33298726|NCT03926195|100988431|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
33496399|NCT01205269|101710086|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
33496400|NCT01205269|101710087|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
33496401|NCT01205269|101710088|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
33496402|NCT01205269|101710089|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
33496403|NCT01205269|101710090|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
33496404|NCT01205269|101710091|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
33496405|NCT00848718|101710092|FG000|Overall Study|Adverse Event|2|||
33496406|NCT00848718|101710093|FG001|Overall Study|Adverse Event|2|||
33496407|NCT00848718|101710094|FG002|Overall Study|Adverse Event|1|||
33496408|NCT00848718|101710095|FG003|Overall Study|Adverse Event|1|||
33496409|NCT00848718|101710096|FG004|Overall Study|Adverse Event|1|||
33496410|NCT00848718|101710097|FG005|Overall Study|Adverse Event|0|||
33298727|NCT03926195|100988432|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
33393422|NCT03051217|101328466|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
33393423|NCT03051217|101328467|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
33298728|NCT03926195|100988431|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
33298729|NCT03926195|100988432|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
33298730|NCT01156376|100988433|FG000|Overall Study|Adverse Event|1|||
33298731|NCT01156376|100988434|FG001|Overall Study|Adverse Event|0|||
33298732|NCT01156376|100988435|FG002|Overall Study|Adverse Event|1|||
33298733|NCT01156376|100988433|FG000|Overall Study|Withdrawal by Subject|0|||
33298734|NCT01156376|100988434|FG001|Overall Study|Withdrawal by Subject|0|||
33298735|NCT01156376|100988435|FG002|Overall Study|Withdrawal by Subject|3|||
33298736|NCT01016262|100988437|FG000|Double-blind Phase|Adverse Event|0|||
33298737|NCT01016262|100988438|FG001|Double-blind Phase|Adverse Event|0|||
33298738|NCT01016262|100988439|FG002|Double-blind Phase|Adverse Event|1|||
33298739|NCT01016262|100988440|FG003|Double-blind Phase|Adverse Event|0|||
33298740|NCT01016262|100988441|FG004|Double-blind Phase|Adverse Event|0|||
33298741|NCT01016262|100988442|FG005|Double-blind Phase|Adverse Event|0|||
33298742|NCT01016262|100988437|FG000|Double-blind Phase|Lack of Efficacy|1|||
33298743|NCT01016262|100988438|FG001|Double-blind Phase|Lack of Efficacy|0|||
33298744|NCT01016262|100988439|FG002|Double-blind Phase|Lack of Efficacy|5|||
33298745|NCT01016262|100988440|FG003|Double-blind Phase|Lack of Efficacy|0|||
33298746|NCT01016262|100988441|FG004|Double-blind Phase|Lack of Efficacy|0|||
33298747|NCT01016262|100988442|FG005|Double-blind Phase|Lack of Efficacy|0|||
33298748|NCT01016262|100988437|FG000|Double-blind Phase|Disease Progression|0|||
33298749|NCT01016262|100988438|FG001|Double-blind Phase|Disease Progression|1|||
33298750|NCT01016262|100988439|FG002|Double-blind Phase|Disease Progression|2|||
33298751|NCT01016262|100988440|FG003|Double-blind Phase|Disease Progression|0|||
33298752|NCT01016262|100988441|FG004|Double-blind Phase|Disease Progression|0|||
33298753|NCT01016262|100988442|FG005|Double-blind Phase|Disease Progression|0|||
33298754|NCT01016262|100988437|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
33298755|NCT01016262|100988438|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
33298756|NCT01016262|100988439|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
33298757|NCT01016262|100988440|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
33298758|NCT01016262|100988441|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
33298759|NCT01016262|100988442|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
33298760|NCT01016262|100988437|FG000|Open-Label Phase|Adverse Event|0|||
33298761|NCT01016262|100988438|FG001|Open-Label Phase|Adverse Event|0|||
33298762|NCT01016262|100988439|FG002|Open-Label Phase|Adverse Event|0|||
33298763|NCT01016262|100988440|FG003|Open-Label Phase|Adverse Event|1|||
33298764|NCT01016262|100988441|FG004|Open-Label Phase|Adverse Event|0|||
33298765|NCT01016262|100988442|FG005|Open-Label Phase|Adverse Event|0|||
33298766|NCT01016262|100988437|FG000|Open-Label Phase|Lost to Follow-up|0|||
33298767|NCT01016262|100988438|FG001|Open-Label Phase|Lost to Follow-up|0|||
33298768|NCT01016262|100988439|FG002|Open-Label Phase|Lost to Follow-up|0|||
33298769|NCT01016262|100988440|FG003|Open-Label Phase|Lost to Follow-up|0|||
33298770|NCT01016262|100988441|FG004|Open-Label Phase|Lost to Follow-up|1|||
33298771|NCT01016262|100988442|FG005|Open-Label Phase|Lost to Follow-up|0|||
33393424|NCT03051217|101328468|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
33393425|NCT03051217|101328469|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
33393426|NCT03051217|101328470|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
33393427|NCT03051217|101328471|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
33393428|NCT03051217|101328465|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
33298772|NCT01016262|100988437|FG000|Open-Label Phase|Lack of Efficacy|0|||
33298773|NCT01016262|100988438|FG001|Open-Label Phase|Lack of Efficacy|0|||
33298774|NCT01016262|100988439|FG002|Open-Label Phase|Lack of Efficacy|0|||
33298775|NCT01016262|100988440|FG003|Open-Label Phase|Lack of Efficacy|1|||
33298776|NCT01016262|100988441|FG004|Open-Label Phase|Lack of Efficacy|0|||
33298777|NCT01016262|100988442|FG005|Open-Label Phase|Lack of Efficacy|0|||
33298778|NCT01016262|100988437|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
33298779|NCT01016262|100988438|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
33298780|NCT01016262|100988439|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
33298781|NCT01016262|100988440|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
33298782|NCT01016262|100988441|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
33298783|NCT01016262|100988442|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
33298784|NCT00438672|100988443|FG000|Overall Study|Lost to Follow-up|7|||
33298785|NCT00438672|100988444|FG001|Overall Study|Lost to Follow-up|9|||
33298786|NCT00581893|100988445|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
33298787|NCT00581893|100988446|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
33298788|NCT02815579|100988447|FG000|Overall Study|Non-payment of loan down-payment|16|||
33298789|NCT02815579|100988448|FG001|Overall Study|Non-payment of loan down-payment|0|||
33298790|NCT02815579|100988447|FG000|Overall Study|Withdrawal by Subject|7|||
33298791|NCT02815579|100988448|FG001|Overall Study|Withdrawal by Subject|1|||
33298792|NCT02815579|100988447|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
33298793|NCT02815579|100988448|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
33298794|NCT02815579|100988447|FG000|Overall Study|Lost to Follow-up|7|||
33298795|NCT02815579|100988448|FG001|Overall Study|Lost to Follow-up|4|||
33298796|NCT02815579|100988447|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
33298797|NCT02815579|100988448|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
33298798|NCT02815579|100988447|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
33298799|NCT02815579|100988448|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
33298800|NCT02815579|100988447|FG000|Overall Study|Death|5|||
33298801|NCT02815579|100988448|FG001|Overall Study|Death|4|||
33298802|NCT02815579|100988447|FG000|Overall Study|Imprisoned|0|||
33298803|NCT02815579|100988448|FG001|Overall Study|Imprisoned|2|||
33298804|NCT02815579|100988447|FG000|Overall Study|Did not meet enrollment criteria|0|||
33298805|NCT02815579|100988448|FG001|Overall Study|Did not meet enrollment criteria|1|||
33298806|NCT02783573|100988456|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
33298807|NCT02783573|100988457|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
33298808|NCT02783573|100988458|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
33298809|NCT02783573|100988456|FG000|Placebo-Controlled Treatment Period|Death|4|||
33298810|NCT02783573|100988457|FG001|Placebo-Controlled Treatment Period|Death|2|||
33298811|NCT02783573|100988458|FG002|Placebo-Controlled Treatment Period|Death|3|||
33298812|NCT02783573|100988456|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
33298813|NCT02783573|100988457|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
33298814|NCT02783573|100988458|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
33298815|NCT02783573|100988456|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
33298816|NCT02783573|100988457|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
33298817|NCT02783573|100988458|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
33298818|NCT02783573|100988456|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
33298819|NCT02783573|100988457|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
33298820|NCT02783573|100988458|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
33298821|NCT02783573|100988456|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
33298822|NCT02783573|100988457|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
33298823|NCT02783573|100988458|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
33298824|NCT02783573|100988456|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
33298825|NCT02783573|100988457|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
33298826|NCT02783573|100988458|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
33298827|NCT02783573|100988456|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
33298828|NCT02783573|100988457|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
33298829|NCT02783573|100988458|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
33298830|NCT02783573|100988456|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
33298831|NCT02783573|100988457|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
33298832|NCT02783573|100988458|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
33298833|NCT02783573|100988456|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
33298834|NCT02783573|100988457|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
33298835|NCT02783573|100988458|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
33298836|NCT02783573|100988456|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
33298837|NCT02783573|100988457|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
33298838|NCT02783573|100988458|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
33298839|NCT02783573|100988456|FG000|Delayed-Start Period|Sponsor Decision|0|||
33298840|NCT02783573|100988457|FG001|Delayed-Start Period|Sponsor Decision|17|||
33298841|NCT02783573|100988458|FG002|Delayed-Start Period|Sponsor Decision|12|||
33298842|NCT00734591|100988459|FG000|Screening for Prospective Period|Site did not participate|1604|||
33298843|NCT00734591|100988460|FG001|Screening for Prospective Period|Site did not participate|1488|||
33298844|NCT00734591|100988459|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
33298845|NCT00734591|100988460|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
33364913|NCT01790438|101223683|FG001|Overall Study|Lost to Follow-up|2|||
33393429|NCT03051217|101328466|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
33496411|NCT00848718|101710098|FG006|Overall Study|Adverse Event|0|||
33393430|NCT03051217|101328467|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
33393431|NCT03051217|101328468|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
33393432|NCT03051217|101328469|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
33298846|NCT00734591|100988459|FG000|Prospective Period|Withdrawal by Subject|11|||
33393433|NCT03051217|101328470|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
33393434|NCT03051217|101328471|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
33393435|NCT03051217|101328465|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
33496412|NCT00848718|101710099|FG007|Overall Study|Adverse Event|1|||
33496413|NCT00848718|101710100|FG008|Overall Study|Adverse Event|1|||
33496414|NCT00848718|101710101|FG009|Overall Study|Adverse Event|0|||
33496415|NCT00848718|101710102|FG010|Overall Study|Adverse Event|0|||
33496416|NCT00848718|101710103|FG011|Overall Study|Adverse Event|0|||
33496417|NCT00848718|101710104|FG012|Overall Study|Adverse Event|2|||
33496418|NCT00848718|101710092|FG000|Overall Study|Lack of Efficacy|0|||
33298847|NCT00734591|100988460|FG001|Prospective Period|Withdrawal by Subject|9|||
33298848|NCT00734591|100988459|FG000|Prospective Period|Lost to Follow-up|37|||
33298849|NCT00734591|100988460|FG001|Prospective Period|Lost to Follow-up|33|||
33298850|NCT00734591|100988459|FG000|Prospective Period|Study Terminated|1|||
33298851|NCT00734591|100988460|FG001|Prospective Period|Study Terminated|0|||
33298852|NCT00734591|100988459|FG000|Prospective Period|Other|2|||
33298853|NCT00734591|100988460|FG001|Prospective Period|Other|2|||
33298854|NCT05262517|100988461|FG000|Overall Study|Randomized but not treated|5|||
33298855|NCT05262517|100988462|FG001|Overall Study|Randomized but not treated|11|||
33298856|NCT04458922|100988471|FG000|Overall Study|Withdrawal by Subject|1|||
33298857|NCT04458922|100988472|FG001|Overall Study|Withdrawal by Subject|0|||
33298858|NCT04458922|100988473|FG002|Overall Study|Withdrawal by Subject|2|||
33298859|NCT04458922|100988471|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
33298860|NCT04458922|100988472|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
33298861|NCT04458922|100988473|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
33298862|NCT04458922|100988471|FG000|Overall Study|Adverse Event|1|||
33298863|NCT04458922|100988472|FG001|Overall Study|Adverse Event|0|||
33298864|NCT04458922|100988473|FG002|Overall Study|Adverse Event|0|||
33298865|NCT04458922|100988471|FG000|Overall Study|Started new study|0|||
33496419|NCT00848718|101710093|FG001|Overall Study|Lack of Efficacy|0|||
33496420|NCT00848718|101710094|FG002|Overall Study|Lack of Efficacy|1|||
33496421|NCT00848718|101710095|FG003|Overall Study|Lack of Efficacy|0|||
33496422|NCT00848718|101710096|FG004|Overall Study|Lack of Efficacy|0|||
33496423|NCT00848718|101710097|FG005|Overall Study|Lack of Efficacy|0|||
33496424|NCT00848718|101710098|FG006|Overall Study|Lack of Efficacy|1|||
33496425|NCT00848718|101710099|FG007|Overall Study|Lack of Efficacy|0|||
33496426|NCT00848718|101710100|FG008|Overall Study|Lack of Efficacy|0|||
33496427|NCT00848718|101710101|FG009|Overall Study|Lack of Efficacy|0|||
33298866|NCT04458922|100988472|FG001|Overall Study|Started new study|0|||
33298867|NCT04458922|100988473|FG002|Overall Study|Started new study|1|||
33298868|NCT04458922|100988471|FG000|Overall Study|Progressive disease|6|||
33298869|NCT04458922|100988472|FG001|Overall Study|Progressive disease|8|||
33298870|NCT04458922|100988473|FG002|Overall Study|Progressive disease|2|||
33298871|NCT04458922|100988471|FG000|Overall Study|Death|1|||
33298872|NCT04458922|100988472|FG001|Overall Study|Death|0|||
33298873|NCT04458922|100988473|FG002|Overall Study|Death|2|||
33298874|NCT04458922|100988471|FG000|Overall Study|Participant started chemotherapy|0|||
33298875|NCT04458922|100988472|FG001|Overall Study|Participant started chemotherapy|1|||
33298876|NCT04458922|100988473|FG002|Overall Study|Participant started chemotherapy|0|||
33298877|NCT03686423|100988474|FG000|Overall Study|Withdrawal by Subject|9|||
33298878|NCT03686423|100988474|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
33298879|NCT01397422|100988478|FG000|Overall Study|Adverse Event|0|||
33298880|NCT01397422|100988479|FG001|Overall Study|Adverse Event|3|||
33298881|NCT01397422|100988480|FG002|Overall Study|Adverse Event|3|||
33298882|NCT01397422|100988481|FG003|Overall Study|Adverse Event|8|||
33298883|NCT01397422|100988478|FG000|Overall Study|Withdrawal by Subject|1|||
33298884|NCT01397422|100988479|FG001|Overall Study|Withdrawal by Subject|0|||
33496428|NCT00848718|101710102|FG010|Overall Study|Lack of Efficacy|0|||
33496429|NCT00848718|101710103|FG011|Overall Study|Lack of Efficacy|0|||
33496430|NCT00848718|101710104|FG012|Overall Study|Lack of Efficacy|0|||
33298885|NCT01397422|100988480|FG002|Overall Study|Withdrawal by Subject|0|||
33496431|NCT00848718|101710092|FG000|Overall Study|Physician Decision|0|||
33600156|NCT05239221|102088521|FG006|Overall Study|Withdrawal by Subject|0|||
33600157|NCT05239221|102088522|FG007|Overall Study|Withdrawal by Subject|0|||
33600158|NCT05239221|102088523|FG008|Overall Study|Withdrawal by Subject|0|||
33600159|NCT05239221|102088524|FG009|Overall Study|Withdrawal by Subject|0|||
33600160|NCT05239221|102088525|FG010|Overall Study|Withdrawal by Subject|1|||
33600161|NCT05239221|102088526|FG011|Overall Study|Withdrawal by Subject|0|||
33298886|NCT01397422|100988481|FG003|Overall Study|Withdrawal by Subject|0|||
33298887|NCT01397422|100988478|FG000|Overall Study|Increased bradykinesia related to PD|1|||
33298888|NCT01397422|100988479|FG001|Overall Study|Increased bradykinesia related to PD|0|||
33298889|NCT01397422|100988480|FG002|Overall Study|Increased bradykinesia related to PD|0|||
33298890|NCT01397422|100988481|FG003|Overall Study|Increased bradykinesia related to PD|0|||
33298891|NCT04497389|100988487|FG000|Overall Study|Withdrawal by Subject|1|||
33298892|NCT04497389|100988488|FG001|Overall Study|Withdrawal by Subject|0|||
33298893|NCT01208103|100988489|FG000|Overall Study|Adverse Event|1|||
33298894|NCT01208103|100988489|FG000|Overall Study|Withdrawal by Subject|1|||
33298895|NCT02979249|100988490|FG000|Overall Study|Lost to Follow-up|2|||
33298896|NCT02979249|100988490|FG000|Overall Study|Withdrawal by Subject|4|||
33298897|NCT00756457|100988491|FG000|Overall Study|Lost to Follow-up|1|||
33298898|NCT00756457|100988492|FG001|Overall Study|Lost to Follow-up|2|||
33298899|NCT00604708|100988495|FG000|Overall Study|Withdrawal by Subject|9|||
33298900|NCT00604708|100988496|FG001|Overall Study|Withdrawal by Subject|10|||
33298901|NCT00604708|100988495|FG000|Overall Study|Protocol Violation|2|||
33298902|NCT00604708|100988496|FG001|Overall Study|Protocol Violation|8|||
33298903|NCT00604708|100988495|FG000|Overall Study|Lost to Follow-up|5|||
33298904|NCT00604708|100988496|FG001|Overall Study|Lost to Follow-up|5|||
33298905|NCT00604708|100988495|FG000|Overall Study|administrative reasons|9|||
33298906|NCT00604708|100988496|FG001|Overall Study|administrative reasons|11|||
33298907|NCT00604708|100988495|FG000|Overall Study|Adverse Event|6|||
33298908|NCT00604708|100988496|FG001|Overall Study|Adverse Event|6|||
33298909|NCT01277887|100988497|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
33298910|NCT01277887|100988498|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
33298911|NCT01277887|100988497|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
33298912|NCT01277887|100988498|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
33298913|NCT01277887|100988497|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
33298914|NCT01277887|100988498|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
33298915|NCT00594880|100988499|FG000|Overall Study|Withdrawal by Subject|1|||
33298916|NCT00594880|100988500|FG001|Overall Study|Withdrawal by Subject|1|||
33298917|NCT00594880|100988499|FG000|Overall Study|Lost to Follow-up|1|||
33298918|NCT00594880|100988500|FG001|Overall Study|Lost to Follow-up|0|||
33298919|NCT04942366|100988501|FG000|Overall Study|Withdrawal by Subject|5|||
33298920|NCT04942366|100988502|FG001|Overall Study|Withdrawal by Subject|5|||
33298921|NCT02666664|100988505|FG000|Overall Study|Physician Decision|0|||
33298922|NCT02666664|100988506|FG001|Overall Study|Physician Decision|1|||
33298923|NCT02666664|100988505|FG000|Overall Study|Protocol Violation|0|||
33298924|NCT02666664|100988506|FG001|Overall Study|Protocol Violation|2|||
33298925|NCT02666664|100988505|FG000|Overall Study|Other|0|||
33298926|NCT02666664|100988506|FG001|Overall Study|Other|1|||
33298927|NCT02666664|100988505|FG000|Overall Study|Adverse Event|12|||
33298928|NCT02666664|100988506|FG001|Overall Study|Adverse Event|37|||
33298929|NCT02666664|100988505|FG000|Overall Study|Withdrawal by participant|23|||
33298930|NCT02666664|100988506|FG001|Overall Study|Withdrawal by participant|40|||
33298931|NCT02666664|100988505|FG000|Overall Study|Sponsor decision|0|||
33298932|NCT02666664|100988506|FG001|Overall Study|Sponsor decision|1|||
33298933|NCT02666664|100988505|FG000|Overall Study|Lost to Follow-up|1|||
33298934|NCT02666664|100988506|FG001|Overall Study|Lost to Follow-up|2|||
33298935|NCT00288639|100988507|FG000|Overall Study|Adverse Event|5|||
33298936|NCT00288639|100988507|FG000|Overall Study|Lack of Efficacy|4|||
33298937|NCT00288639|100988507|FG000|Overall Study|Withdrawal by Subject|2|||
33298938|NCT00288639|100988507|FG000|Overall Study|Other|1|||
33298939|NCT01245374|100988508|FG000|Overall Study|Protocol Violation|1|||
33298940|NCT01245374|100988508|FG000|Overall Study|Withdrawal by Subject|3|||
33298941|NCT01934790|100988510|FG000|Treatment|Adverse Event|3|||
33298942|NCT01934790|100988510|FG000|Treatment|Clinical progression|6|||
33298943|NCT01934790|100988510|FG000|Treatment|Radiological progression|4|||
33298944|NCT01934790|100988510|FG000|Treatment|Withdrawal by Subject|2|||
33298945|NCT01934790|100988510|FG000|Treatment|Study drug never administered|1|||
33298946|NCT01934790|100988510|FG000|Active Follow up|Death|20|||
33298947|NCT01934790|100988510|FG000|Active Follow up|Physician Decision|2|||
33298948|NCT01934790|100988510|FG000|Active Follow up|Progressive disease|1|||
33298949|NCT01934790|100988510|FG000|Active Follow up|Other reason|1|||
33298950|NCT03031496|100988516|FG000|Period 1|Adverse Event|2|||
33298951|NCT03031496|100988517|FG001|Period 1|Adverse Event|0|||
33298952|NCT03031496|100988516|FG000|Period 1|Withdrawal by Subject|0|||
33298953|NCT03031496|100988517|FG001|Period 1|Withdrawal by Subject|2|||
33298954|NCT01886287|100988518|FG000|Overall Study|Radiographic disease progression|1|||
33298955|NCT01886287|100988518|FG000|Overall Study|Clinical progression due to disease|1|||
33496432|NCT00848718|101710093|FG001|Overall Study|Physician Decision|1|||
33298956|NCT03232931|100988523|FG000|Overall Study|Physician Decision|1|||
33298957|NCT03232931|100988524|FG001|Overall Study|Physician Decision|1|||
33298958|NCT03232931|100988523|FG000|Overall Study|Withdrawal by Subject|6|||
33298959|NCT03232931|100988524|FG001|Overall Study|Withdrawal by Subject|0|||
33298960|NCT03232931|100988523|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
33298961|NCT03232931|100988524|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
33298962|NCT03232931|100988523|FG000|Overall Study|Parent did not record voice|1|||
33298963|NCT03232931|100988524|FG001|Overall Study|Parent did not record voice|2|||
33298964|NCT03232931|100988523|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
33298965|NCT03232931|100988524|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
33298966|NCT00780559|100988525|FG000|Overall Study|Lost to Follow-up|2|||
33298967|NCT00780559|100988526|FG001|Overall Study|Lost to Follow-up|7|||
33298968|NCT00780559|100988525|FG000|Overall Study|Death|1|||
33298969|NCT00780559|100988526|FG001|Overall Study|Death|0|||
33298970|NCT02071290|100988530|FG000|Overall Study|Death|1|||
33298971|NCT02071290|100988531|FG001|Overall Study|Death|0|||
33298972|NCT02071290|100988530|FG000|Overall Study|Withdrawal by Subject|0|||
33298973|NCT02071290|100988531|FG001|Overall Study|Withdrawal by Subject|1|||
33298974|NCT02071290|100988530|FG000|Overall Study|Protocol Violation|3|||
33298975|NCT02071290|100988531|FG001|Overall Study|Protocol Violation|5|||
33298976|NCT02071290|100988530|FG000|Overall Study|Physician Decision|0|||
33496433|NCT00848718|101710094|FG002|Overall Study|Physician Decision|0|||
33496434|NCT00848718|101710095|FG003|Overall Study|Physician Decision|0|||
33298977|NCT02071290|100988531|FG001|Overall Study|Physician Decision|1|||
33298978|NCT01681992|100988534|FG000|Overall Study|Adverse Event|3|||
33298979|NCT01681992|100988535|FG001|Overall Study|Adverse Event|2|||
33298980|NCT01681992|100988536|FG002|Overall Study|Adverse Event|3|||
33298981|NCT01681992|100988534|FG000|Overall Study|Lost to Follow-up|36|||
33298982|NCT01681992|100988535|FG001|Overall Study|Lost to Follow-up|38|||
33298983|NCT01681992|100988536|FG002|Overall Study|Lost to Follow-up|53|||
33298984|NCT01681992|100988534|FG000|Overall Study|As Per Sponsor Decision|0|||
33298985|NCT01681992|100988535|FG001|Overall Study|As Per Sponsor Decision|0|||
33298986|NCT01681992|100988536|FG002|Overall Study|As Per Sponsor Decision|1|||
33298987|NCT01681992|100988534|FG000|Overall Study|Protocol Violation|0|||
33298988|NCT01681992|100988535|FG001|Overall Study|Protocol Violation|0|||
33298989|NCT01681992|100988536|FG002|Overall Study|Protocol Violation|1|||
33298990|NCT01681992|100988534|FG000|Overall Study|Withdrawal by Subject|27|||
33298991|NCT01681992|100988535|FG001|Overall Study|Withdrawal by Subject|30|||
33298992|NCT01681992|100988536|FG002|Overall Study|Withdrawal by Subject|25|||
33298993|NCT00677534|100988537|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
33298994|NCT00677534|100988537|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
33298995|NCT00677534|100988537|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
33298996|NCT03762200|100988548|FG000|Overall Study|Death|2|||
33298997|NCT03274895|100988549|FG000|Overall Study|Lack of Efficacy|1|||
33298998|NCT03274895|100988550|FG001|Overall Study|Lack of Efficacy|0|||
33298999|NCT03274895|100988549|FG000|Overall Study|Adverse Event|8|||
33393436|NCT03051217|101328466|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
33393437|NCT03051217|101328467|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
33393438|NCT03051217|101328468|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
33393439|NCT03051217|101328469|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
33393440|NCT03051217|101328470|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
33393441|NCT03051217|101328471|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
33393442|NCT03051217|101328465|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
33393443|NCT03051217|101328466|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
33393444|NCT03051217|101328467|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
33393445|NCT03051217|101328468|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
33496435|NCT00848718|101710096|FG004|Overall Study|Physician Decision|1|||
33299000|NCT03274895|100988550|FG001|Overall Study|Adverse Event|7|||
33299001|NCT03274895|100988549|FG000|Overall Study|Lost to Follow-up|1|||
33299002|NCT03274895|100988550|FG001|Overall Study|Lost to Follow-up|0|||
33299003|NCT03274895|100988549|FG000|Overall Study|Diagnosis not confirmed|3|||
33299004|NCT03274895|100988550|FG001|Overall Study|Diagnosis not confirmed|4|||
33299005|NCT00790205|100988563|FG000|Overall Study|Lost to Follow-up|61|||
33299006|NCT00790205|100988564|FG001|Overall Study|Lost to Follow-up|71|||
33299007|NCT00790205|100988563|FG000|Overall Study|Withdrawal by Subject|299|||
33299008|NCT00790205|100988564|FG001|Overall Study|Withdrawal by Subject|363|||
33299009|NCT00874731|100988565|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
33299010|NCT00874731|100988566|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
33299011|NCT00874731|100988567|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
33299012|NCT00874731|100988565|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
33299013|NCT00874731|100988566|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
33299014|NCT00874731|100988567|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
33299015|NCT00874731|100988565|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
33299016|NCT00874731|100988566|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
33299017|NCT00874731|100988567|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
33299018|NCT02138786|100988568|FG000|Overall Study|Adverse Event|0|||
33299019|NCT02138786|100988569|FG001|Overall Study|Adverse Event|2|||
33299020|NCT02138786|100988570|FG002|Overall Study|Adverse Event|1|||
33299021|NCT02138786|100988568|FG000|Overall Study|Death|1|||
33299022|NCT02138786|100988569|FG001|Overall Study|Death|7|||
33299023|NCT02138786|100988570|FG002|Overall Study|Death|2|||
33299024|NCT02138786|100988568|FG000|Overall Study|Disease Progression|1|||
33299025|NCT02138786|100988569|FG001|Overall Study|Disease Progression|1|||
33299026|NCT02138786|100988570|FG002|Overall Study|Disease Progression|3|||
33299027|NCT02138786|100988568|FG000|Overall Study|Withdrawal by Subject|1|||
33299028|NCT02138786|100988569|FG001|Overall Study|Withdrawal by Subject|2|||
33299029|NCT02138786|100988570|FG002|Overall Study|Withdrawal by Subject|0|||
33299030|NCT02138786|100988568|FG000|Overall Study|Patient's Wish|0|||
33299031|NCT02138786|100988569|FG001|Overall Study|Patient's Wish|2|||
33299032|NCT02138786|100988570|FG002|Overall Study|Patient's Wish|0|||
33299033|NCT02138786|100988568|FG000|Overall Study|Sponsor Terminated Study|0|||
33299034|NCT02138786|100988569|FG001|Overall Study|Sponsor Terminated Study|1|||
33299035|NCT02138786|100988570|FG002|Overall Study|Sponsor Terminated Study|1|||
33299036|NCT02138786|100988568|FG000|Overall Study|Non-Compliance|0|||
33299037|NCT02138786|100988569|FG001|Overall Study|Non-Compliance|0|||
33299038|NCT02138786|100988570|FG002|Overall Study|Non-Compliance|1|||
33299039|NCT04531904|100988571|FG000|Overall Study|Lost to Follow-up|1|||
33299040|NCT04531904|100988571|FG000|Overall Study|Death|14|||
33299041|NCT01609062|100988574|FG000|Extension Phase|Terminated by Sponsor|14|||
33299042|NCT01609062|100988575|FG001|Extension Phase|Terminated by Sponsor|9|||
33299043|NCT01609062|100988574|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
33299044|NCT01609062|100988575|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
33299045|NCT01609062|100988574|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
33299046|NCT01609062|100988575|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
33299047|NCT03738475|100988576|FG000|Overall Study|Participant Non-Compliance|1|||
33299048|NCT03738475|100988577|FG001|Overall Study|Participant Non-Compliance|0|||
33299049|NCT00387426|100988580|FG000|Overall Study|Lack of Response|7|||
33299050|NCT00387426|100988580|FG000|Overall Study|Toxicities|4|||
33299051|NCT00387426|100988580|FG000|Overall Study|Disease Progression|3|||
33299052|NCT01585155|100988581|FG000|Overall Study|Adverse Event|1|||
33299053|NCT01585155|100988581|FG000|Overall Study|Lack of Efficacy|2|||
33299054|NCT01585155|100988581|FG000|Overall Study|Worsening ulcerative colitis|2|||
33299055|NCT00941070|100988583|FG000|Overall Study|Patient non-compliant|1|||
33299056|NCT01681277|100988584|FG000|Overall Study|Adverse Event|1|||
33299057|NCT01681277|100988585|FG001|Overall Study|Adverse Event|0|||
33299058|NCT01681277|100988586|FG002|Overall Study|Adverse Event|0|||
33299059|NCT01681277|100988587|FG003|Overall Study|Adverse Event|0|||
33299060|NCT01681277|100988588|FG004|Overall Study|Adverse Event|0|||
33299061|NCT01509547|100988591|FG000|Overall Study|Lost to Follow-up|24|||
33299062|NCT01509547|100988592|FG001|Overall Study|Lost to Follow-up|14|||
33299063|NCT01509547|100988591|FG000|Overall Study|Withdrawal by Subject|11|||
33299064|NCT01509547|100988592|FG001|Overall Study|Withdrawal by Subject|24|||
33299065|NCT01509547|100988591|FG000|Overall Study|Physician Decision|0|||
33299066|NCT01509547|100988592|FG001|Overall Study|Physician Decision|1|||
33299067|NCT01827046|100988595|FG000|Overall Study|Lost to Follow-up|1|||
33299068|NCT01827046|100988596|FG001|Overall Study|Lost to Follow-up|5|||
33299069|NCT01827046|100988595|FG000|Overall Study|Withdrawal by Subject|0|||
33299070|NCT01827046|100988596|FG001|Overall Study|Withdrawal by Subject|4|||
33299071|NCT03026075|100991930|FG000|Overall Study|Physician Decision|1|||
33299072|NCT03149549|100991938|FG000|Study Discontinuation--Treatment Period|Death|0|||
33299073|NCT03149549|100991939|FG001|Study Discontinuation--Treatment Period|Death|0|||
33299074|NCT03149549|100991940|FG002|Study Discontinuation--Treatment Period|Death|0|||
33299075|NCT03149549|100991941|FG003|Study Discontinuation--Treatment Period|Death|1|||
33299076|NCT03149549|100991942|FG004|Study Discontinuation--Treatment Period|Death|2|||
33299077|NCT03149549|100991943|FG005|Study Discontinuation--Treatment Period|Death|1|||
33299078|NCT03149549|100991944|FG006|Study Discontinuation--Treatment Period|Death|1|||
33299079|NCT03149549|100991945|FG007|Study Discontinuation--Treatment Period|Death|2|||
33299080|NCT03149549|100991946|FG008|Study Discontinuation--Treatment Period|Death|4|||
33299081|NCT03149549|100991947|FG009|Study Discontinuation--Treatment Period|Death|1|||
33299082|NCT03149549|100991948|FG010|Study Discontinuation--Treatment Period|Death|0|||
33299083|NCT03149549|100991949|FG011|Study Discontinuation--Treatment Period|Death|0|||
33299084|NCT03149549|100991950|FG012|Study Discontinuation--Treatment Period|Death|1|||
33299085|NCT03149549|100991938|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
33299086|NCT03149549|100991939|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
33299087|NCT03149549|100991940|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
33299088|NCT03149549|100991941|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
33299089|NCT03149549|100991942|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
33299090|NCT03149549|100991943|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
33299091|NCT03149549|100991944|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
33299092|NCT03149549|100991945|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
33299093|NCT03149549|100991946|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
33299094|NCT03149549|100991947|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
33299095|NCT03149549|100991948|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
33299096|NCT03149549|100991949|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
33299097|NCT03149549|100991950|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
33299098|NCT03149549|100991938|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
33299099|NCT03149549|100991939|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
33299100|NCT03149549|100991940|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
33299101|NCT03149549|100991941|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
33299102|NCT03149549|100991942|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
33299103|NCT03149549|100991943|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
33299104|NCT03149549|100991944|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
33299105|NCT03149549|100991945|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
33299106|NCT03149549|100991946|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
33299107|NCT03149549|100991947|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
33299108|NCT03149549|100991948|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
33299109|NCT03149549|100991949|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
33299110|NCT03149549|100991950|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
33299111|NCT03149549|100991938|FG000|Study Discontinuation--Treatment Period|Other|0|||
33299112|NCT03149549|100991939|FG001|Study Discontinuation--Treatment Period|Other|0|||
33299113|NCT03149549|100991940|FG002|Study Discontinuation--Treatment Period|Other|0|||
33299114|NCT03149549|100991941|FG003|Study Discontinuation--Treatment Period|Other|0|||
33299115|NCT03149549|100991942|FG004|Study Discontinuation--Treatment Period|Other|0|||
33299116|NCT03149549|100991943|FG005|Study Discontinuation--Treatment Period|Other|0|||
33299117|NCT03149549|100991944|FG006|Study Discontinuation--Treatment Period|Other|0|||
33299118|NCT03149549|100991945|FG007|Study Discontinuation--Treatment Period|Other|1|||
33299119|NCT03149549|100991946|FG008|Study Discontinuation--Treatment Period|Other|0|||
33299120|NCT03149549|100991947|FG009|Study Discontinuation--Treatment Period|Other|1|||
33299121|NCT03149549|100991948|FG010|Study Discontinuation--Treatment Period|Other|0|||
33299122|NCT03149549|100991949|FG011|Study Discontinuation--Treatment Period|Other|0|||
33299123|NCT03149549|100991950|FG012|Study Discontinuation--Treatment Period|Other|0|||
33299124|NCT03149549|100991938|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
33299125|NCT03149549|100991939|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
33299126|NCT03149549|100991940|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
33299127|NCT03149549|100991941|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
33299128|NCT03149549|100991942|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
33299129|NCT03149549|100991943|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
33299130|NCT03149549|100991944|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
33299131|NCT03149549|100991945|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
33299132|NCT03149549|100991946|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
33299133|NCT03149549|100991947|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
33299134|NCT03149549|100991948|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
33299135|NCT03149549|100991949|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
33299136|NCT03149549|100991950|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
33299137|NCT03149549|100991938|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
33299138|NCT03149549|100991939|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
33299139|NCT03149549|100991940|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
33496436|NCT00848718|101710097|FG005|Overall Study|Physician Decision|1|||
33190180|NCT02586012|100601582|FG001|Overall Study|Withdrawal by Subject|1|||
33496437|NCT00848718|101710098|FG006|Overall Study|Physician Decision|0|||
33496438|NCT00848718|101710099|FG007|Overall Study|Physician Decision|0|||
33496439|NCT00848718|101710100|FG008|Overall Study|Physician Decision|1|||
33496440|NCT00848718|101710101|FG009|Overall Study|Physician Decision|2|||
33496441|NCT00848718|101710102|FG010|Overall Study|Physician Decision|0|||
33496442|NCT00848718|101710103|FG011|Overall Study|Physician Decision|0|||
33496443|NCT00848718|101710104|FG012|Overall Study|Physician Decision|1|||
33496444|NCT00848718|101710092|FG000|Overall Study|Progressive disease before treatment|1|||
33496445|NCT00848718|101710093|FG001|Overall Study|Progressive disease before treatment|5|||
33496446|NCT00848718|101710094|FG002|Overall Study|Progressive disease before treatment|1|||
33496447|NCT00848718|101710095|FG003|Overall Study|Progressive disease before treatment|3|||
33496448|NCT00848718|101710096|FG004|Overall Study|Progressive disease before treatment|4|||
33496449|NCT00848718|101710097|FG005|Overall Study|Progressive disease before treatment|4|||
33190181|NCT02586012|100601583|FG002|Overall Study|Withdrawal by Subject|0|||
33190182|NCT02586012|100601584|FG003|Overall Study|Withdrawal by Subject|1|||
33496450|NCT00848718|101710098|FG006|Overall Study|Progressive disease before treatment|2|||
33299140|NCT03149549|100991941|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
33299141|NCT03149549|100991942|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
33299142|NCT03149549|100991943|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
33299143|NCT03149549|100991944|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
33299144|NCT03149549|100991945|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
33496451|NCT00848718|101710099|FG007|Overall Study|Progressive disease before treatment|1|||
33496452|NCT00848718|101710100|FG008|Overall Study|Progressive disease before treatment|2|||
33496453|NCT00848718|101710101|FG009|Overall Study|Progressive disease before treatment|7|||
33496454|NCT00848718|101710102|FG010|Overall Study|Progressive disease before treatment|3|||
33496455|NCT00848718|101710103|FG011|Overall Study|Progressive disease before treatment|6|||
33496456|NCT00848718|101710104|FG012|Overall Study|Progressive disease before treatment|2|||
33496457|NCT00848718|101710092|FG000|Overall Study|Protocol Violation|0|||
33496458|NCT00848718|101710093|FG001|Overall Study|Protocol Violation|1|||
33299145|NCT03149549|100991946|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
33299146|NCT03149549|100991947|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
33299147|NCT03149549|100991948|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
33299148|NCT03149549|100991949|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
33299149|NCT03149549|100991950|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
33299150|NCT03149549|100991938|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
33299151|NCT03149549|100991939|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
33299152|NCT03149549|100991940|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
33299153|NCT03149549|100991941|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
33299154|NCT03149549|100991942|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
33299155|NCT03149549|100991943|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
33299156|NCT03149549|100991944|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
33299157|NCT03149549|100991945|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
33299158|NCT03149549|100991946|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
33299159|NCT03149549|100991947|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
33299160|NCT03149549|100991948|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
33299161|NCT03149549|100991949|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
33299162|NCT03149549|100991950|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
33299163|NCT03149549|100991938|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
33299164|NCT03149549|100991939|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
33299165|NCT03149549|100991940|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
33299166|NCT03149549|100991941|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
33299167|NCT03149549|100991942|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
33299168|NCT03149549|100991943|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
33299169|NCT03149549|100991944|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
33299170|NCT03149549|100991945|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
33299171|NCT03149549|100991946|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
33496459|NCT00848718|101710094|FG002|Overall Study|Protocol Violation|0|||
33496460|NCT00848718|101710095|FG003|Overall Study|Protocol Violation|0|||
33496461|NCT00848718|101710096|FG004|Overall Study|Protocol Violation|0|||
33496462|NCT00848718|101710097|FG005|Overall Study|Protocol Violation|0|||
33496463|NCT00848718|101710098|FG006|Overall Study|Protocol Violation|0|||
33496464|NCT00848718|101710099|FG007|Overall Study|Protocol Violation|1|||
33496465|NCT00848718|101710100|FG008|Overall Study|Protocol Violation|0|||
33496466|NCT00848718|101710101|FG009|Overall Study|Protocol Violation|0|||
33496467|NCT00848718|101710102|FG010|Overall Study|Protocol Violation|0|||
33496468|NCT00848718|101710103|FG011|Overall Study|Protocol Violation|0|||
33496469|NCT00848718|101710104|FG012|Overall Study|Protocol Violation|1|||
33496470|NCT00848718|101710092|FG000|Overall Study|Withdrawal by Subject|1|||
33496471|NCT00848718|101710093|FG001|Overall Study|Withdrawal by Subject|0|||
33496472|NCT00848718|101710094|FG002|Overall Study|Withdrawal by Subject|0|||
33496473|NCT00848718|101710095|FG003|Overall Study|Withdrawal by Subject|1|||
33496474|NCT00848718|101710096|FG004|Overall Study|Withdrawal by Subject|0|||
33496475|NCT00848718|101710097|FG005|Overall Study|Withdrawal by Subject|0|||
33496476|NCT00848718|101710098|FG006|Overall Study|Withdrawal by Subject|0|||
33496477|NCT00848718|101710099|FG007|Overall Study|Withdrawal by Subject|0|||
33496478|NCT00848718|101710100|FG008|Overall Study|Withdrawal by Subject|0|||
33299172|NCT03149549|100991947|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
33299173|NCT03149549|100991948|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
33496479|NCT00848718|101710101|FG009|Overall Study|Withdrawal by Subject|0|||
33299174|NCT03149549|100991949|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
33496480|NCT00848718|101710102|FG010|Overall Study|Withdrawal by Subject|1|||
33496481|NCT00848718|101710103|FG011|Overall Study|Withdrawal by Subject|0|||
33496482|NCT00848718|101710104|FG012|Overall Study|Withdrawal by Subject|0|||
33496483|NCT00848718|101710092|FG000|Overall Study|Progressive disease during treatment|3|||
33496484|NCT00848718|101710093|FG001|Overall Study|Progressive disease during treatment|0|||
33496485|NCT00848718|101710094|FG002|Overall Study|Progressive disease during treatment|3|||
33496486|NCT00848718|101710095|FG003|Overall Study|Progressive disease during treatment|0|||
33496487|NCT00848718|101710096|FG004|Overall Study|Progressive disease during treatment|0|||
33496488|NCT00848718|101710097|FG005|Overall Study|Progressive disease during treatment|0|||
33496489|NCT00848718|101710098|FG006|Overall Study|Progressive disease during treatment|0|||
33496490|NCT00848718|101710099|FG007|Overall Study|Progressive disease during treatment|2|||
33496491|NCT00848718|101710100|FG008|Overall Study|Progressive disease during treatment|0|||
33496492|NCT00848718|101710101|FG009|Overall Study|Progressive disease during treatment|0|||
33496493|NCT00848718|101710102|FG010|Overall Study|Progressive disease during treatment|0|||
33496494|NCT00848718|101710103|FG011|Overall Study|Progressive disease during treatment|0|||
33496495|NCT00848718|101710104|FG012|Overall Study|Progressive disease during treatment|2|||
33299175|NCT03149549|100991950|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
33299176|NCT03149549|100991938|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
33299177|NCT03149549|100991939|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
33299178|NCT03149549|100991940|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
33299179|NCT03149549|100991941|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
33299180|NCT03149549|100991942|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
33299181|NCT03149549|100991943|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
33299182|NCT03149549|100991944|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
33299183|NCT03149549|100991945|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
33299184|NCT03149549|100991946|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
33299185|NCT03149549|100991947|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
33299186|NCT03149549|100991948|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
33299187|NCT03149549|100991949|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
33299188|NCT03149549|100991950|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
33299189|NCT03433677|100991953|FG000|Period 1|Protocol Violation|1|||
33299190|NCT03433677|100991954|FG001|Period 1|Protocol Violation|0|||
33299191|NCT03433677|100991953|FG000|Period 2|Withdrawal by Subject|1|||
33299192|NCT03433677|100991954|FG001|Period 2|Withdrawal by Subject|1|||
33299193|NCT02631577|100991957|FG000|Overall Study|Death|1|||
33299194|NCT02631577|100991958|FG001|Overall Study|Death|7|||
33299195|NCT02631577|100991957|FG000|Overall Study|Withdrawal by Subject|0|||
33299196|NCT02631577|100991958|FG001|Overall Study|Withdrawal by Subject|3|||
33299197|NCT00552929|100991963|FG000|Overall Study|Lost to Follow-up|0|||
33299198|NCT00552929|100991964|FG001|Overall Study|Lost to Follow-up|0|||
33299199|NCT00552929|100991965|FG002|Overall Study|Lost to Follow-up|0|||
33299200|NCT00552929|100991966|FG003|Overall Study|Lost to Follow-up|0|||
33299201|NCT00552929|100991967|FG004|Overall Study|Lost to Follow-up|0|||
33299202|NCT00552929|100991968|FG005|Overall Study|Lost to Follow-up|0|||
33299203|NCT00552929|100991969|FG006|Overall Study|Lost to Follow-up|0|||
33299204|NCT00552929|100991970|FG007|Overall Study|Lost to Follow-up|0|||
33299205|NCT00552929|100991971|FG008|Overall Study|Lost to Follow-up|1|||
33299206|NCT00552929|100991972|FG009|Overall Study|Lost to Follow-up|0|||
33299207|NCT00552929|100991963|FG000|Overall Study|Not Eligible|0|||
33299208|NCT00552929|100991964|FG001|Overall Study|Not Eligible|0|||
33299209|NCT00552929|100991965|FG002|Overall Study|Not Eligible|0|||
33393446|NCT03051217|101328469|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
33393447|NCT03051217|101328470|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
33393448|NCT03051217|101328471|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
33393449|NCT03051217|101328465|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
33393450|NCT03051217|101328466|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
33393451|NCT03051217|101328467|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
33393452|NCT03051217|101328468|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
33393453|NCT03051217|101328469|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
33393454|NCT03051217|101328470|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
33393455|NCT03051217|101328471|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
33496496|NCT01567462|101710107|FG000|Overall Study|Withdrawal by Subject|4|||
33496497|NCT01567462|101710108|FG001|Overall Study|Withdrawal by Subject|7|||
33299210|NCT00552929|100991966|FG003|Overall Study|Not Eligible|0|||
33299211|NCT00552929|100991967|FG004|Overall Study|Not Eligible|0|||
33299212|NCT00552929|100991968|FG005|Overall Study|Not Eligible|1|||
33299213|NCT00552929|100991969|FG006|Overall Study|Not Eligible|0|||
33299214|NCT00552929|100991970|FG007|Overall Study|Not Eligible|0|||
33299215|NCT00552929|100991971|FG008|Overall Study|Not Eligible|0|||
33299216|NCT00552929|100991972|FG009|Overall Study|Not Eligible|0|||
33299217|NCT00902746|100991977|FG000|Overall Study|Protocol Violation|7|||
33299218|NCT00902746|100991977|FG000|Overall Study|Withdrawal by Subject|16|||
33299219|NCT00902746|100991977|FG000|Overall Study|Adverse Event|8|||
33299220|NCT00902746|100991977|FG000|Overall Study|Lost to Follow-up|3|||
33299221|NCT00902746|100991977|FG000|Overall Study|Physician Decision|2|||
33299222|NCT00603525|100991978|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
33299223|NCT00603525|100991979|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
33299224|NCT00603525|100991980|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
33299225|NCT00603525|100991978|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
33299226|NCT00603525|100991979|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
33299227|NCT00603525|100991980|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
33299228|NCT00603525|100991978|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
33299229|NCT00603525|100991979|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
33299230|NCT00603525|100991980|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
33299231|NCT00603525|100991978|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
33299232|NCT00603525|100991979|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
33299233|NCT00603525|100991980|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33299234|NCT00603525|100991978|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
33299235|NCT00603525|100991979|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
33299236|NCT00603525|100991980|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33299237|NCT00603525|100991978|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
33299238|NCT00603525|100991979|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
33299239|NCT00603525|100991980|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
33299240|NCT00603525|100991978|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
33299241|NCT00603525|100991979|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
33299242|NCT00603525|100991980|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
33299243|NCT00603525|100991978|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
33299244|NCT00603525|100991979|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
33299245|NCT00603525|100991980|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
33299246|NCT00603525|100991978|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
33299247|NCT00603525|100991979|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
33299248|NCT00603525|100991980|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
33299249|NCT00603525|100991978|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
33299250|NCT00603525|100991979|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
33299251|NCT00603525|100991980|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
33299252|NCT00603525|100991978|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
33299253|NCT00603525|100991979|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
33299254|NCT00603525|100991980|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
33299255|NCT00603525|100991978|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
33299256|NCT00603525|100991979|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
33299257|NCT00603525|100991980|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
33299258|NCT00603525|100991978|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
33299259|NCT00603525|100991979|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
33299260|NCT00603525|100991980|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
33299261|NCT00603525|100991978|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
33299262|NCT00603525|100991979|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
33299263|NCT00603525|100991980|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
33299264|NCT00603525|100991978|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
33299265|NCT00603525|100991979|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
33299266|NCT00603525|100991980|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
33299267|NCT01840410|100991983|FG000|Overall Study|Physician Decision|1|||
33299268|NCT01840410|100991984|FG001|Overall Study|Physician Decision|2|||
33299269|NCT01840410|100991983|FG000|Overall Study|Pregnancy|1|||
33299270|NCT01840410|100991984|FG001|Overall Study|Pregnancy|0|||
33299271|NCT01840410|100991983|FG000|Overall Study|Protocol deviation|1|||
33299272|NCT01840410|100991984|FG001|Overall Study|Protocol deviation|0|||
33299273|NCT01840410|100991983|FG000|Overall Study|Lost to Follow-up|1|||
33299274|NCT01840410|100991984|FG001|Overall Study|Lost to Follow-up|0|||
33299275|NCT01840410|100991983|FG000|Overall Study|Withdrawal by Subject|2|||
33299276|NCT01840410|100991984|FG001|Overall Study|Withdrawal by Subject|1|||
33299277|NCT01840410|100991983|FG000|Overall Study|Adverse Event|1|||
33299278|NCT01840410|100991984|FG001|Overall Study|Adverse Event|1|||
33299279|NCT02091206|100991992|FG000|Treatment Period|Adverse Event|0|||
33299280|NCT02091206|100991993|FG001|Treatment Period|Adverse Event|1|||
33299281|NCT02091206|100991994|FG002|Treatment Period|Adverse Event|0|||
33299282|NCT02091206|100991995|FG003|Treatment Period|Adverse Event|0|||
33299283|NCT02091206|100991992|FG000|Treatment Period|Met withdrawal criteria|0|||
33299284|NCT02091206|100991993|FG001|Treatment Period|Met withdrawal criteria|0|||
33393456|NCT00959894|101328473|FG000|Overall Study|Lost to Follow-up|10|||
33299285|NCT02091206|100991994|FG002|Treatment Period|Met withdrawal criteria|1|||
33299286|NCT02091206|100991995|FG003|Treatment Period|Met withdrawal criteria|0|||
33299287|NCT02091206|100991992|FG000|Taper Period|Participant refused study drug|1|||
33299288|NCT02091206|100991993|FG001|Taper Period|Participant refused study drug|0|||
33299289|NCT02091206|100991994|FG002|Taper Period|Participant refused study drug|0|||
33299290|NCT02091206|100991995|FG003|Taper Period|Participant refused study drug|1|||
33299291|NCT02091206|100991992|FG000|Taper Period|Lost to Follow-up|0|||
33299292|NCT02091206|100991993|FG001|Taper Period|Lost to Follow-up|0|||
33299293|NCT02091206|100991994|FG002|Taper Period|Lost to Follow-up|0|||
33299294|NCT02091206|100991995|FG003|Taper Period|Lost to Follow-up|1|||
33299295|NCT05172050|100991996|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
33299296|NCT05172050|100991997|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
33299297|NCT05172050|100991998|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
33299298|NCT05172050|100991996|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
33299299|NCT05172050|100991997|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
33299300|NCT05172050|100991998|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
33299301|NCT05172050|100991996|FG000|Overall Study|Other|2|||
33299302|NCT05172050|100991997|FG001|Overall Study|Other|2|||
33299303|NCT05172050|100991998|FG002|Overall Study|Other|1|||
33299304|NCT00479882|100991999|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
33299305|NCT00479882|100992000|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
33299306|NCT00479882|100992001|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
33299307|NCT00479882|100992002|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
33299308|NCT00479882|100991999|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
33299309|NCT00479882|100992000|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
33299310|NCT00479882|100992001|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
33299311|NCT00479882|100992002|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
33299312|NCT00479882|100991999|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
33299313|NCT00479882|100992000|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
33299314|NCT00479882|100992001|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
33299315|NCT00479882|100992002|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
33299316|NCT00479882|100991999|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
33299317|NCT00479882|100992000|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
33299318|NCT00479882|100992001|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
33299319|NCT00479882|100992002|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
33299320|NCT00479882|100991999|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
33299321|NCT00479882|100992000|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
33299322|NCT00479882|100992001|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
33299323|NCT00479882|100992002|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
33299324|NCT00479882|100991999|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
33299325|NCT00479882|100992000|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
33299326|NCT00479882|100992001|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
33299327|NCT00479882|100992002|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
33299328|NCT00479882|100991999|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
33190183|NCT02586012|100601585|FG004|Overall Study|Withdrawal by Subject|0|||
33190184|NCT02586012|100601586|FG005|Overall Study|Withdrawal by Subject|2|||
33190185|NCT02586012|100601581|FG000|Overall Study|Protocol Violation|0|||
33190186|NCT02586012|100601582|FG001|Overall Study|Protocol Violation|0|||
33190187|NCT02586012|100601583|FG002|Overall Study|Protocol Violation|0|||
33190188|NCT02586012|100601584|FG003|Overall Study|Protocol Violation|0|||
33190189|NCT02586012|100601585|FG004|Overall Study|Protocol Violation|0|||
33190190|NCT02586012|100601586|FG005|Overall Study|Protocol Violation|1|||
33190191|NCT02586012|100601581|FG000|Overall Study|study terminated|0|||
33299329|NCT00479882|100992000|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
33299330|NCT00479882|100992001|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
33299331|NCT00479882|100992002|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
33299332|NCT00479882|100991999|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
33299333|NCT00479882|100992000|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
33190192|NCT02586012|100601582|FG001|Overall Study|study terminated|2|||
33190193|NCT02586012|100601583|FG002|Overall Study|study terminated|1|||
33190194|NCT02586012|100601584|FG003|Overall Study|study terminated|1|||
33190195|NCT02586012|100601585|FG004|Overall Study|study terminated|1|||
33299334|NCT00479882|100992001|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
33299335|NCT00479882|100992002|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
33299336|NCT00479882|100991999|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
33299337|NCT00479882|100992000|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
33299338|NCT00479882|100992001|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
33299339|NCT00479882|100992002|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
33299340|NCT00479882|100991999|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
33299341|NCT00479882|100992000|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
33299342|NCT00479882|100992001|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
33299343|NCT00479882|100992002|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
33299344|NCT00479882|100991999|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
33299345|NCT00479882|100992000|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
33299346|NCT00479882|100992001|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
33299347|NCT00479882|100992002|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
33299348|NCT00479882|100991999|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
33299349|NCT00479882|100992000|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
33299350|NCT00479882|100992001|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
33299351|NCT00479882|100992002|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
33299352|NCT00479882|100991999|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
33299353|NCT00479882|100992000|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
33299354|NCT00479882|100992001|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
33299355|NCT00479882|100992002|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
33299356|NCT00479882|100991999|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
33299357|NCT00479882|100992000|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
33299358|NCT00479882|100992001|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
33299359|NCT00479882|100992002|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
33299360|NCT02440425|100992003|FG000|Overall Study|Death likely due to disease progression|1|||
33299361|NCT02440425|100992003|FG000|Overall Study|Withdrawal by Subject|2|||
33299362|NCT02440425|100992003|FG000|Overall Study|Adverse Event|1|||
33299363|NCT02440425|100992003|FG000|Overall Study|Adverse Event/Ineligible|1|||
33299364|NCT03338296|100992013|FG000|Overall Study|Adverse Event|0|||
33299365|NCT03338296|100992014|FG001|Overall Study|Adverse Event|1|||
33299366|NCT03338296|100992013|FG000|Overall Study|Withdrawal by Subject|14|||
33299367|NCT03338296|100992014|FG001|Overall Study|Withdrawal by Subject|13|||
33299368|NCT03338296|100992013|FG000|Overall Study|Lost to Follow-up|10|||
33299369|NCT03338296|100992014|FG001|Overall Study|Lost to Follow-up|10|||
33299370|NCT03338296|100992013|FG000|Overall Study|Study Terminated by Sponsor|77|||
33299371|NCT03338296|100992014|FG001|Overall Study|Study Terminated by Sponsor|76|||
33299372|NCT03338296|100992013|FG000|Overall Study|Other|2|||
33299373|NCT03338296|100992014|FG001|Overall Study|Other|7|||
33299374|NCT03338296|100992013|FG000|Overall Study|Missing|0|||
33299375|NCT03338296|100992014|FG001|Overall Study|Missing|1|||
33496498|NCT02837731|101710109|FG000|Allocation|Admitted to General Floor|3|||
33496499|NCT02837731|101710110|FG001|Allocation|Admitted to General Floor|4|||
33299376|NCT01430468|100992015|FG000|Overall Study|Physician Decision|2|||
33299377|NCT01430468|100992016|FG001|Overall Study|Physician Decision|1|||
33299378|NCT01430468|100992015|FG000|Overall Study|Withdrawal by Subject|5|||
33299379|NCT01430468|100992016|FG001|Overall Study|Withdrawal by Subject|5|||
33299380|NCT03361605|100992017|FG000|Overall Study|Analyzable data not available|3|||
33299381|NCT01696045|100992018|FG000|Overall Study|Study drug toxicity|1|||
33299382|NCT01696045|100992019|FG001|Overall Study|Study drug toxicity|5|||
33299383|NCT01696045|100992018|FG000|Overall Study|Disease progression|2|||
33299384|NCT01696045|100992019|FG001|Overall Study|Disease progression|2|||
33299385|NCT01023958|100992022|FG000|Overall Study|Progressive disease|48|||
33299386|NCT01023958|100992022|FG000|Overall Study|Other adverse event|1|||
33299387|NCT01023958|100992022|FG000|Overall Study|Refused to continue medication|1|||
33299388|NCT01200342|100992023|FG000|Overall Study|Disease Progression|1|||
33299389|NCT01730950|100992024|FG000|Overall Study|Protocol Violation|6|||
33299390|NCT01730950|100992025|FG001|Overall Study|Protocol Violation|6|||
33299391|NCT00513305|100992026|FG000|Overall Study|Adverse Event|6|||
33299392|NCT00513305|100992027|FG001|Overall Study|Adverse Event|2|||
33299393|NCT00513305|100992026|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
33299394|NCT00513305|100992027|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
33299395|NCT00513305|100992026|FG000|Overall Study|Lack of Efficacy|8|||
33299396|NCT00513305|100992027|FG001|Overall Study|Lack of Efficacy|13|||
33393457|NCT00959894|101328473|FG000|Overall Study|Adverse Event|3|||
33496500|NCT02837731|101710109|FG000|Allocation|Immediate surgery/withdrew|2|||
33190196|NCT02586012|100601586|FG005|Overall Study|study terminated|0|||
33299397|NCT00513305|100992026|FG000|Overall Study|Withdrawal by Subject|1|||
33299398|NCT00513305|100992027|FG001|Overall Study|Withdrawal by Subject|2|||
33299399|NCT00513305|100992026|FG000|Overall Study|Disease progression|8|||
33299400|NCT00513305|100992027|FG001|Overall Study|Disease progression|5|||
33299401|NCT00513305|100992026|FG000|Overall Study|Eligible for stem cell transplant|1|||
33299402|NCT00513305|100992027|FG001|Overall Study|Eligible for stem cell transplant|0|||
33299403|NCT00513305|100992026|FG000|Overall Study|Hematologic counts did not recover|1|||
33299404|NCT00513305|100992027|FG001|Overall Study|Hematologic counts did not recover|0|||
33299405|NCT00513305|100992026|FG000|Overall Study|Physician Decision|1|||
33299406|NCT00513305|100992027|FG001|Overall Study|Physician Decision|0|||
33299407|NCT00513305|100992026|FG000|Overall Study|Persistent hypocellularity|0|||
33299408|NCT00513305|100992027|FG001|Overall Study|Persistent hypocellularity|1|||
33299409|NCT00513305|100992026|FG000|Overall Study|Sponsor Decision|0|||
33299410|NCT00513305|100992027|FG001|Overall Study|Sponsor Decision|2|||
33299411|NCT01468181|100992028|FG000|Overall Study|Adverse Event|8|||
33299412|NCT01468181|100992029|FG001|Overall Study|Adverse Event|1|||
33299413|NCT01468181|100992030|FG002|Overall Study|Adverse Event|6|||
33299414|NCT01468181|100992031|FG003|Overall Study|Adverse Event|2|||
33299415|NCT01468181|100992032|FG004|Overall Study|Adverse Event|2|||
33299416|NCT01468181|100992028|FG000|Overall Study|Protocol Violation|2|||
33299417|NCT01468181|100992029|FG001|Overall Study|Protocol Violation|0|||
33299418|NCT01468181|100992030|FG002|Overall Study|Protocol Violation|1|||
33299419|NCT01468181|100992031|FG003|Overall Study|Protocol Violation|0|||
33299420|NCT01468181|100992032|FG004|Overall Study|Protocol Violation|1|||
33299421|NCT01468181|100992028|FG000|Overall Study|Physician Decision|0|||
33299422|NCT01468181|100992029|FG001|Overall Study|Physician Decision|0|||
33299423|NCT01468181|100992030|FG002|Overall Study|Physician Decision|0|||
33299424|NCT01468181|100992031|FG003|Overall Study|Physician Decision|1|||
33299425|NCT01468181|100992032|FG004|Overall Study|Physician Decision|1|||
33299426|NCT01468181|100992028|FG000|Overall Study|Lost to Follow-up|0|||
33299427|NCT01468181|100992029|FG001|Overall Study|Lost to Follow-up|0|||
33299428|NCT01468181|100992030|FG002|Overall Study|Lost to Follow-up|1|||
33299429|NCT01468181|100992031|FG003|Overall Study|Lost to Follow-up|0|||
33299430|NCT01468181|100992032|FG004|Overall Study|Lost to Follow-up|1|||
33299431|NCT01468181|100992028|FG000|Overall Study|Withdrawal by Subject|0|||
33299432|NCT01468181|100992029|FG001|Overall Study|Withdrawal by Subject|1|||
33299433|NCT01468181|100992030|FG002|Overall Study|Withdrawal by Subject|0|||
33299434|NCT01468181|100992031|FG003|Overall Study|Withdrawal by Subject|0|||
33299435|NCT01468181|100992032|FG004|Overall Study|Withdrawal by Subject|0|||
33299436|NCT05110690|100992033|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
33299437|NCT05110690|100992033|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
33299438|NCT05110690|100992033|FG000|Completion of Intervention|Lost to Follow-up|1|||
33299439|NCT05110690|100992033|FG000|Completion of Intervention|Death|1|||
33299440|NCT05110690|100992033|FG000|Completion of Intervention|Withdrawal by Subject|2|||
33299441|NCT04148651|100992040|FG000|Overall Study|Lost to Follow-up|2|||
33299442|NCT02476175|100992041|FG000|Overall Study|Adverse Event|2|||
33299443|NCT03683823|100992047|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
33299444|NCT03683823|100992048|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
33299445|NCT03683823|100992047|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
33299446|NCT03683823|100992048|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
33299447|NCT03683823|100992047|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
33299448|NCT03683823|100992048|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
33299449|NCT02235311|100992050|FG000|Overall Study|Lost to Follow-up|0|||
33299450|NCT02235311|100992051|FG001|Overall Study|Lost to Follow-up|1|||
33299451|NCT02235311|100992050|FG000|Overall Study|Protocol Violation|0|||
33299452|NCT02235311|100992051|FG001|Overall Study|Protocol Violation|1|||
33299453|NCT01969851|100992052|FG000|Overall Study|Adverse Event|0|||
33299454|NCT01969851|100992053|FG001|Overall Study|Adverse Event|0|||
33299455|NCT01969851|100992054|FG002|Overall Study|Adverse Event|3|||
33299456|NCT01969851|100992052|FG000|Overall Study|Lack of Efficacy|0|||
33299457|NCT01969851|100992053|FG001|Overall Study|Lack of Efficacy|3|||
33299458|NCT01969851|100992054|FG002|Overall Study|Lack of Efficacy|1|||
33299459|NCT01969851|100992052|FG000|Overall Study|Withdrawal by Subject|1|||
33299460|NCT01969851|100992053|FG001|Overall Study|Withdrawal by Subject|0|||
33299461|NCT01969851|100992054|FG002|Overall Study|Withdrawal by Subject|1|||
33299462|NCT01969851|100992052|FG000|Overall Study|No effective dose in Titration period|0|||
33393458|NCT00959894|101328473|FG000|Overall Study|Withdrawal by Subject|1|||
33299463|NCT01969851|100992053|FG001|Overall Study|No effective dose in Titration period|0|||
33299464|NCT01969851|100992054|FG002|Overall Study|No effective dose in Titration period|1|||
33299465|NCT01969851|100992052|FG000|Overall Study|Sponsor decision|0|||
33299466|NCT01969851|100992053|FG001|Overall Study|Sponsor decision|0|||
33299467|NCT01969851|100992054|FG002|Overall Study|Sponsor decision|1|||
33299468|NCT00573859|100992055|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
33299469|NCT00573859|100992055|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
33299470|NCT00709228|100992056|FG000|Overall Study|Not treated|14|||
33299471|NCT00709228|100992056|FG000|Overall Study|Eligibility criteria not met|281|||
33299472|NCT00709228|100992056|FG000|Overall Study|Adverse events|2|||
33299473|NCT00709228|100992056|FG000|Overall Study|Discontinued treatment|14|||
33299474|NCT00709228|100992056|FG000|Overall Study|Did not enter follow-up|4|||
33299475|NCT00709228|100992056|FG000|Overall Study|Discontinued follow-up|5|||
33299476|NCT00709228|100992056|FG000|Overall Study|Disease progression|1|||
33496501|NCT02837731|101710110|FG001|Allocation|Immediate surgery/withdrew|0|||
33496502|NCT02837731|101710109|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
33496503|NCT02837731|101710110|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
33496504|NCT02837731|101710109|FG000|Allocation|Withdrawal by Subject|2|||
33496505|NCT02837731|101710110|FG001|Allocation|Withdrawal by Subject|0|||
33496506|NCT02837731|101710109|FG000|Allocation|Device not available|1|||
33190197|NCT02722928|100601588|FG000|Overall Study|Standard CT was not as required per prot|5|||
33190198|NCT02722928|100601589|FG001|Overall Study|Standard CT was not as required per prot|13|||
33190199|NCT02722928|100601588|FG000|Overall Study|Required Intraoperative MRI|5|||
33190200|NCT02722928|100601589|FG001|Overall Study|Required Intraoperative MRI|7|||
33190201|NCT01256710|100601590|FG000|Overall Study|Death|449|||
33190202|NCT01256710|100601590|FG000|Overall Study|System Explant|67|||
33190203|NCT01256710|100601590|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
33190204|NCT01256710|100601590|FG000|Overall Study|Lost to Follow-up|67|||
33190205|NCT01256710|100601590|FG000|Overall Study|Withdrawal by Subject|29|||
33190206|NCT01256710|100601590|FG000|Overall Study|Physician Decision|9|||
33190207|NCT01256710|100601590|FG000|Overall Study|Subject Noncompliance|2|||
33190208|NCT01256710|100601590|FG000|Overall Study|Study Terminated by Sponsor|273|||
33190209|NCT03548584|100601591|FG000|Overall Study|Lost to Follow-up|0|||
33190210|NCT03548584|100601592|FG001|Overall Study|Lost to Follow-up|0|||
33190211|NCT03548584|100601593|FG002|Overall Study|Lost to Follow-up|1|||
33190212|NCT03548584|100601591|FG000|Overall Study|Adverse Event|1|||
33190213|NCT03548584|100601592|FG001|Overall Study|Adverse Event|11|||
33190214|NCT03548584|100601593|FG002|Overall Study|Adverse Event|5|||
33190215|NCT03548584|100601591|FG000|Overall Study|Site Terminated by Sponsor|1|||
33190216|NCT03548584|100601592|FG001|Overall Study|Site Terminated by Sponsor|3|||
33190217|NCT03548584|100601593|FG002|Overall Study|Site Terminated by Sponsor|2|||
33190218|NCT03548584|100601591|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
33190219|NCT03548584|100601592|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
33190220|NCT03548584|100601593|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
33190221|NCT03548584|100601591|FG000|Overall Study|Lack of Efficacy|0|||
33190222|NCT03548584|100601592|FG001|Overall Study|Lack of Efficacy|1|||
33190223|NCT03548584|100601593|FG002|Overall Study|Lack of Efficacy|0|||
33190224|NCT03548584|100601591|FG000|Overall Study|Non-compliance with Study Drug|0|||
33190225|NCT03548584|100601592|FG001|Overall Study|Non-compliance with Study Drug|1|||
33190226|NCT03548584|100601593|FG002|Overall Study|Non-compliance with Study Drug|0|||
33190227|NCT03548584|100601591|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
33190228|NCT03548584|100601592|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
33190229|NCT03548584|100601593|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
33190230|NCT03643562|100601594|FG000|Overall Study|Adverse Event|1|||
33190231|NCT03643562|100601595|FG001|Overall Study|Adverse Event|0|||
33190232|NCT03643562|100601594|FG000|Overall Study|Lack of Efficacy|0|||
33190233|NCT03643562|100601595|FG001|Overall Study|Lack of Efficacy|1|||
33190234|NCT03643562|100601594|FG000|Overall Study|Physician Decision|0|||
33190235|NCT03643562|100601595|FG001|Overall Study|Physician Decision|1|||
33190236|NCT03643562|100601594|FG000|Overall Study|Study Terminated by Sponsor|2|||
33190237|NCT03643562|100601595|FG001|Overall Study|Study Terminated by Sponsor|10|||
33190238|NCT03643562|100601594|FG000|Overall Study|Withdrawal by Subject|2|||
33190239|NCT03643562|100601595|FG001|Overall Study|Withdrawal by Subject|2|||
33190240|NCT03643562|100601594|FG000|Overall Study|Other than specified|3|||
33190241|NCT03643562|100601595|FG001|Overall Study|Other than specified|2|||
33190242|NCT01096784|100601596|FG000|Overall Study|Withdrawal by Subject|2|||
33190243|NCT01096784|100601597|FG001|Overall Study|Withdrawal by Subject|1|||
33190244|NCT01096784|100601596|FG000|Overall Study|Adverse Event|11|||
33190245|NCT01096784|100601597|FG001|Overall Study|Adverse Event|9|||
33190246|NCT01096784|100601596|FG000|Overall Study|Protocol Deviation|2|||
33190247|NCT01096784|100601597|FG001|Overall Study|Protocol Deviation|2|||
33190248|NCT01096784|100601596|FG000|Overall Study|Administrative Decision|0|||
33299477|NCT00709228|100992056|FG000|Overall Study|Lost to Follow-up|6|||
33299478|NCT00709228|100992056|FG000|Overall Study|Non-compliance|5|||
33299479|NCT01365481|100992057|FG000|Overall Study|Adverse Event|6|||
33299480|NCT01365481|100992058|FG001|Overall Study|Adverse Event|9|||
33393459|NCT00959894|101328473|FG000|Overall Study|Need for contraindicated medication|1|||
33496507|NCT02837731|101710110|FG001|Allocation|Device not available|0|||
33496508|NCT02837731|101710109|FG000|Allocation|Protocol not implemented|7|||
33190249|NCT01096784|100601597|FG001|Overall Study|Administrative Decision|1|||
33190250|NCT01096784|100601596|FG000|Overall Study|Other Unspecified|0|||
33190251|NCT01096784|100601597|FG001|Overall Study|Other Unspecified|1|||
33190252|NCT03029624|100601599|FG000|Overall Study|Adverse Event|1|||
33190253|NCT03029624|100601599|FG000|Overall Study|Withdrawal by Subject|1|||
33190254|NCT03029624|100601599|FG000|Overall Study|Lack of Efficacy|1|||
33190255|NCT03029624|100601599|FG000|Overall Study|MRI need|2|||
33299481|NCT01365481|100992059|FG002|Overall Study|Adverse Event|0|||
33299482|NCT01365481|100992060|FG003|Overall Study|Adverse Event|2|||
33299483|NCT01365481|100992057|FG000|Overall Study|Withdrawal by Subject|0|||
33299484|NCT01365481|100992058|FG001|Overall Study|Withdrawal by Subject|2|||
33299485|NCT01365481|100992059|FG002|Overall Study|Withdrawal by Subject|1|||
33299486|NCT01365481|100992060|FG003|Overall Study|Withdrawal by Subject|1|||
33299487|NCT01365481|100992057|FG000|Overall Study|Lost to Follow-up|1|||
33299488|NCT01365481|100992058|FG001|Overall Study|Lost to Follow-up|1|||
33299489|NCT01365481|100992059|FG002|Overall Study|Lost to Follow-up|2|||
33299490|NCT01365481|100992060|FG003|Overall Study|Lost to Follow-up|3|||
33299491|NCT01365481|100992057|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33299492|NCT01365481|100992058|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33299493|NCT01365481|100992059|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33299494|NCT01365481|100992060|FG003|Overall Study|Abnormal laboratory value(s)|0|||
33299495|NCT01365481|100992057|FG000|Overall Study|Administrative problems|0|||
33299496|NCT01365481|100992058|FG001|Overall Study|Administrative problems|1|||
33299497|NCT01365481|100992059|FG002|Overall Study|Administrative problems|0|||
33299498|NCT01365481|100992060|FG003|Overall Study|Administrative problems|0|||
33299499|NCT01365481|100992057|FG000|Overall Study|Protocol deviation|0|||
33299500|NCT01365481|100992058|FG001|Overall Study|Protocol deviation|1|||
33299501|NCT01365481|100992059|FG002|Overall Study|Protocol deviation|0|||
33299502|NCT01365481|100992060|FG003|Overall Study|Protocol deviation|1|||
33299503|NCT01365481|100992057|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33299504|NCT01365481|100992058|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33299505|NCT01365481|100992059|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
33299506|NCT01365481|100992060|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
33299507|NCT00943852|100992065|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33299508|NCT00943852|100992066|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33299509|NCT00943852|100992067|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33299510|NCT00943852|100992068|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
33299511|NCT00943852|100992069|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33299512|NCT00943852|100992070|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33299513|NCT00943852|100992071|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33496509|NCT02837731|101710110|FG001|Allocation|Protocol not implemented|0|||
33496510|NCT02837731|101710109|FG000|Allocation|Moribund/Do not resuscitate|2|||
33496511|NCT02837731|101710110|FG001|Allocation|Moribund/Do not resuscitate|0|||
33496512|NCT02837731|101710109|FG000|Allocation|Did not meet sepsis criteria|1|||
33496513|NCT02837731|101710110|FG001|Allocation|Did not meet sepsis criteria|2|||
33496514|NCT02837731|101710109|FG000|Allocation|Known aortic abnormalities|0|||
33496515|NCT02837731|101710110|FG001|Allocation|Known aortic abnormalities|1|||
33496516|NCT00395629|101710111|FG000|Core Study|Adverse Event|0|||
33190256|NCT02563028|100601600|FG000|Overall Study|Lack of equipment|1|||
33190257|NCT02563028|100601600|FG000|Overall Study|Unable to elicit VEP post induction|1|||
33190258|NCT00727714|100601601|FG000|Overall Study|Lost to Follow-up|2|||
33299514|NCT00943852|100992072|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33299515|NCT00943852|100992073|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33299516|NCT00943852|100992074|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
33299517|NCT00943852|100992065|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33496517|NCT00395629|101710112|FG001|Core Study|Adverse Event|3|||
33190259|NCT02696096|100601602|FG000|Overall Study|ruled out at screening|1|||
33190260|NCT02696096|100601602|FG000|Overall Study|did not attend second fMRI|1|||
33299518|NCT00943852|100992066|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33496518|NCT00395629|101710113|FG002|Core Study|Adverse Event|4|||
33496519|NCT00395629|101710111|FG000|Core Study|Abnormal laboratory value(s)|0|||
33393460|NCT00959894|101328473|FG000|Overall Study|Subject moved out of town|1|||
33190261|NCT01428193|100601603|FG000|Overall Study|Physician Decision|1|||
33190262|NCT01428193|100601603|FG000|Overall Study|Elevated screening liver enzymes|1|||
33190263|NCT00969553|100601606|FG000|Overall Study|Progressive disease (PD)|2|||
33190264|NCT00969553|100601607|FG001|Overall Study|Progressive disease (PD)|2|||
33190265|NCT00969553|100601608|FG002|Overall Study|Progressive disease (PD)|6|||
33190266|NCT00969553|100601609|FG003|Overall Study|Progressive disease (PD)|9|||
33190267|NCT00969553|100601610|FG004|Overall Study|Progressive disease (PD)|2|||
33190268|NCT00969553|100601611|FG005|Overall Study|Progressive disease (PD)|4|||
33190269|NCT00969553|100601612|FG006|Overall Study|Progressive disease (PD)|2|||
33190270|NCT00969553|100601613|FG007|Overall Study|Progressive disease (PD)|12|||
33190271|NCT00969553|100601614|FG008|Overall Study|Progressive disease (PD)|3|||
33190272|NCT00969553|100601606|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
33190273|NCT00969553|100601607|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
33190274|NCT00969553|100601608|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
33190275|NCT00969553|100601609|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
33190276|NCT00969553|100601610|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
33190277|NCT00969553|100601611|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
33190278|NCT00969553|100601612|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
33190279|NCT00969553|100601613|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
33190280|NCT00969553|100601614|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
33190281|NCT00969553|100601606|FG000|Overall Study|Other Adverse Event|0|||
33190282|NCT00969553|100601607|FG001|Overall Study|Other Adverse Event|0|||
33190283|NCT00969553|100601608|FG002|Overall Study|Other Adverse Event|0|||
33190284|NCT00969553|100601609|FG003|Overall Study|Other Adverse Event|1|||
33190285|NCT00969553|100601610|FG004|Overall Study|Other Adverse Event|0|||
33190286|NCT00969553|100601611|FG005|Overall Study|Other Adverse Event|0|||
33190287|NCT00969553|100601612|FG006|Overall Study|Other Adverse Event|1|||
33190288|NCT00969553|100601613|FG007|Overall Study|Other Adverse Event|0|||
33190289|NCT00969553|100601614|FG008|Overall Study|Other Adverse Event|0|||
33190290|NCT00969553|100601606|FG000|Overall Study|Refused cont. medication|1|||
33190291|NCT00969553|100601607|FG001|Overall Study|Refused cont. medication|1|||
33190292|NCT00969553|100601608|FG002|Overall Study|Refused cont. medication|0|||
33190293|NCT00969553|100601609|FG003|Overall Study|Refused cont. medication|2|||
33190294|NCT00969553|100601610|FG004|Overall Study|Refused cont. medication|0|||
33190295|NCT00969553|100601611|FG005|Overall Study|Refused cont. medication|0|||
33190296|NCT00969553|100601612|FG006|Overall Study|Refused cont. medication|0|||
33190297|NCT00969553|100601613|FG007|Overall Study|Refused cont. medication|1|||
33190298|NCT00969553|100601614|FG008|Overall Study|Refused cont. medication|0|||
33393461|NCT01510028|101328474|FG000|Overall Study|Lack of Efficacy|1|||
33496520|NCT00395629|101710112|FG001|Core Study|Abnormal laboratory value(s)|0|||
33190299|NCT00969553|100601606|FG000|Overall Study|Not specified above|0|||
33190300|NCT00969553|100601607|FG001|Overall Study|Not specified above|0|||
33190301|NCT00969553|100601608|FG002|Overall Study|Not specified above|0|||
33190302|NCT00969553|100601609|FG003|Overall Study|Not specified above|4|||
33190303|NCT00969553|100601610|FG004|Overall Study|Not specified above|0|||
33190304|NCT00969553|100601611|FG005|Overall Study|Not specified above|0|||
33190305|NCT00969553|100601612|FG006|Overall Study|Not specified above|1|||
33190306|NCT00969553|100601613|FG007|Overall Study|Not specified above|1|||
33190307|NCT00969553|100601614|FG008|Overall Study|Not specified above|0|||
33190308|NCT03254134|100601620|FG000|Overall Study|Not eligible patients|599|||
33190309|NCT03254134|100601621|FG001|Overall Study|Not eligible patients|3630|||
33190310|NCT00358527|100601624|FG000|Overall Study|Adverse Event|4|||
33190311|NCT00358527|100601625|FG001|Overall Study|Adverse Event|0|||
33190312|NCT00358527|100601624|FG000|Overall Study|Withdrawal by Subject|1|||
33190313|NCT00358527|100601625|FG001|Overall Study|Withdrawal by Subject|1|||
33299519|NCT00943852|100992067|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33299520|NCT00943852|100992068|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33299521|NCT00943852|100992069|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33299522|NCT00943852|100992070|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
33299523|NCT00943852|100992071|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33299524|NCT00943852|100992072|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33299525|NCT00943852|100992073|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33299526|NCT00943852|100992074|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
33299527|NCT00943852|100992065|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33299528|NCT00943852|100992066|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33299529|NCT00943852|100992067|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33299530|NCT00943852|100992068|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33299531|NCT00943852|100992069|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33299532|NCT00943852|100992070|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33299533|NCT00943852|100992071|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
33299534|NCT00943852|100992072|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33299535|NCT00943852|100992073|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33299536|NCT00943852|100992074|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
33299537|NCT00943852|100992065|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33299538|NCT00943852|100992066|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33299539|NCT00943852|100992067|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33299540|NCT00943852|100992068|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33299541|NCT00943852|100992069|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33299542|NCT00943852|100992070|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33299543|NCT00943852|100992071|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33299544|NCT00943852|100992072|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
33299545|NCT00943852|100992073|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33299546|NCT00943852|100992074|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
33299547|NCT00943852|100992065|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
33299548|NCT00943852|100992066|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
33299549|NCT00943852|100992067|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
33299550|NCT00943852|100992068|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
33299551|NCT00943852|100992069|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
33299552|NCT00943852|100992070|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
33299553|NCT00943852|100992071|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
33299554|NCT00943852|100992072|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
33299555|NCT00943852|100992073|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
33299556|NCT00943852|100992074|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
33299557|NCT03015129|100992082|FG000|Overall Study|Death|2|||
33299558|NCT03015129|100992083|FG001|Overall Study|Death|2|||
33299559|NCT03015129|100992082|FG000|Overall Study|Lost to Follow-up|0|||
33299560|NCT03015129|100992083|FG001|Overall Study|Lost to Follow-up|1|||
33299561|NCT03015129|100992082|FG000|Overall Study|Progression of disease|38|||
33299562|NCT03015129|100992083|FG001|Overall Study|Progression of disease|33|||
33299563|NCT03015129|100992082|FG000|Overall Study|Adverse Event|0|||
33299564|NCT03015129|100992083|FG001|Overall Study|Adverse Event|4|||
33299565|NCT00461981|100992084|FG000|Overall Study|Lost to Follow-up|9|||
33299566|NCT00461981|100992085|FG001|Overall Study|Lost to Follow-up|6|||
33299567|NCT00461981|100992084|FG000|Overall Study|Withdrawal by Subject|2|||
33299568|NCT00461981|100992085|FG001|Overall Study|Withdrawal by Subject|3|||
33299569|NCT02179177|100992090|FG000|Overall Study|Lost to Follow-up|1|||
33299570|NCT02179177|100992091|FG001|Overall Study|Lost to Follow-up|1|||
33299571|NCT02179177|100992090|FG000|Overall Study|Withdrawal by Subject|1|||
33299572|NCT02179177|100992091|FG001|Overall Study|Withdrawal by Subject|1|||
33299573|NCT00406692|100992094|FG000|Overall Study|Withdrawal by Subject|4|||
33299574|NCT00406692|100992094|FG000|Overall Study|Physician Decision|1|||
33299575|NCT00406692|100992094|FG000|Overall Study|Adverse Event|1|||
33299576|NCT00406692|100992094|FG000|Overall Study|Lack of Efficacy|1|||
33299577|NCT00523640|100992095|FG000|Overall Study|Death|1|||
33299578|NCT01228318|100992096|FG000|Overall Study|Clinic no show to receive intervention|1|||
33299579|NCT01228318|100992097|FG001|Overall Study|Clinic no show to receive intervention|0|||
33299580|NCT01228318|100992096|FG000|Overall Study|Unable to contact|2|||
33299581|NCT01228318|100992097|FG001|Overall Study|Unable to contact|5|||
33299582|NCT01228318|100992096|FG000|Overall Study|Moved|0|||
33299583|NCT01228318|100992097|FG001|Overall Study|Moved|2|||
33299584|NCT01228318|100992096|FG000|Overall Study|Incarcerated|1|||
33299585|NCT01228318|100992097|FG001|Overall Study|Incarcerated|0|||
33299586|NCT02703259|100992098|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
33299587|NCT02703259|100992099|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
33299588|NCT02703259|100992098|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
33299589|NCT02703259|100992099|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
33299590|NCT02703259|100992098|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
33299591|NCT02703259|100992099|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
33299592|NCT00667225|100992100|FG000|Overall Study|Subject had no more lesions to treat.|1|||
33299593|NCT00667225|100992101|FG001|Overall Study|Subject had no more lesions to treat.|0|||
33299594|NCT00667225|100992100|FG000|Overall Study|Lost to Follow-up|0|||
33299595|NCT00667225|100992101|FG001|Overall Study|Lost to Follow-up|1|||
33299596|NCT03174431|100992105|FG000|Overall Study|Withdrawal by Subject|14|||
33299597|NCT03174431|100992106|FG001|Overall Study|Withdrawal by Subject|11|||
33299598|NCT03174431|100992105|FG000|Overall Study|alternative treatment|2|||
33299599|NCT03174431|100992106|FG001|Overall Study|alternative treatment|0|||
33299600|NCT03174431|100992105|FG000|Overall Study|Lost to Follow-up|1|||
33299601|NCT03174431|100992106|FG001|Overall Study|Lost to Follow-up|5|||
33299602|NCT02406677|100992117|FG000|Overall Study|Death|16|||
33299603|NCT02406677|100992118|FG001|Overall Study|Death|8|||
33299604|NCT02406677|100992117|FG000|Overall Study|Discharged without P2Y12|1|||
33299605|NCT02406677|100992118|FG001|Overall Study|Discharged without P2Y12|3|||
33299606|NCT02406677|100992117|FG000|Overall Study|Discharged on prasugrel|283|||
33299607|NCT02406677|100992118|FG001|Overall Study|Discharged on prasugrel|587|||
33299608|NCT02406677|100992117|FG000|Overall Study|Withdrawal by Subject|1|||
33496521|NCT00395629|101710113|FG002|Core Study|Abnormal laboratory value(s)|1|||
33496522|NCT00395629|101710111|FG000|Core Study|Protocol Violation|1|||
33496523|NCT00395629|101710112|FG001|Core Study|Protocol Violation|0|||
33496524|NCT00395629|101710113|FG002|Core Study|Protocol Violation|0|||
33496525|NCT00395629|101710111|FG000|Core Study|Withdrawal by Subject|0|||
33496526|NCT00395629|101710112|FG001|Core Study|Withdrawal by Subject|1|||
33496527|NCT00395629|101710113|FG002|Core Study|Withdrawal by Subject|1|||
33496528|NCT00395629|101710111|FG000|Core Study|Lost to Follow-up|0|||
33496529|NCT00395629|101710112|FG001|Core Study|Lost to Follow-up|0|||
33496530|NCT00395629|101710113|FG002|Core Study|Lost to Follow-up|1|||
33496531|NCT00395629|101710111|FG000|Extension Study|Adverse Event|0|||
33496532|NCT00395629|101710112|FG001|Extension Study|Adverse Event|0|||
33496533|NCT00395629|101710113|FG002|Extension Study|Adverse Event|2|||
33496534|NCT00395629|101710111|FG000|Extension Study|Administrative problems|0|||
33496535|NCT00395629|101710112|FG001|Extension Study|Administrative problems|0|||
33496536|NCT00395629|101710113|FG002|Extension Study|Administrative problems|1|||
33496537|NCT03743051|101710116|FG000|Overall Study|Adverse Event|5|||
33496538|NCT03743051|101710117|FG001|Overall Study|Adverse Event|9|||
33496539|NCT03743051|101710116|FG000|Overall Study|Death|27|||
33496540|NCT03743051|101710117|FG001|Overall Study|Death|26|||
33496541|NCT03743051|101710116|FG000|Overall Study|Lost to Follow-up|4|||
33496542|NCT03743051|101710117|FG001|Overall Study|Lost to Follow-up|8|||
33496543|NCT03743051|101710116|FG000|Overall Study|Withdrawal by Subject|32|||
33496544|NCT03743051|101710117|FG001|Overall Study|Withdrawal by Subject|19|||
33496545|NCT03743051|101710116|FG000|Overall Study|Physician Decision|10|||
33496546|NCT03743051|101710117|FG001|Overall Study|Physician Decision|15|||
33496547|NCT03743051|101710116|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
33190314|NCT00358527|100601624|FG000|Overall Study|Non-compliance with protocol|6|||
33190315|NCT00358527|100601625|FG001|Overall Study|Non-compliance with protocol|1|||
33190316|NCT00358527|100601624|FG000|Overall Study|Administrative|2|||
33190317|NCT00358527|100601625|FG001|Overall Study|Administrative|1|||
33190318|NCT00964392|100601627|FG000|Overall Study|Withdrawal by Subject|4|||
33190319|NCT00964392|100601628|FG001|Overall Study|Withdrawal by Subject|6|||
33190320|NCT00964392|100601627|FG000|Overall Study|Lost to Follow-up|4|||
33190321|NCT00964392|100601628|FG001|Overall Study|Lost to Follow-up|10|||
33190322|NCT00964392|100601627|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
33190323|NCT00964392|100601628|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
33190324|NCT00964392|100601627|FG000|Overall Study|Not completed|44|||
33190325|NCT00964392|100601628|FG001|Overall Study|Not completed|168|||
33190326|NCT01077960|100601634|FG000|Overall Study|Adverse Event|6|||
33190327|NCT01077960|100601634|FG000|Overall Study|Protocol Violation|3|||
33496548|NCT03743051|101710117|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
33190328|NCT01077960|100601634|FG000|Overall Study|Lost to Follow-up|5|||
33190329|NCT01077960|100601634|FG000|Overall Study|Subject decision|1|||
33190330|NCT01077960|100601634|FG000|Overall Study|Reason unspecified|1|||
33299609|NCT02406677|100992118|FG001|Overall Study|Withdrawal by Subject|0|||
33299610|NCT01259089|100992119|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
33299611|NCT01259089|100992120|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
33299612|NCT01259089|100992121|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
33496549|NCT01890122|101710120|FG000|Overall Study|Adverse Event|1|||
33299613|NCT01259089|100992122|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
33299614|NCT01259089|100992123|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
33299615|NCT01259089|100992124|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
33299616|NCT01259089|100992119|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
33299617|NCT01259089|100992120|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
33299618|NCT01259089|100992121|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
33299619|NCT01259089|100992122|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
33299620|NCT01259089|100992123|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
33299621|NCT01259089|100992124|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
33299622|NCT01259089|100992119|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
33299623|NCT01259089|100992120|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
33299624|NCT01259089|100992121|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
33299625|NCT01259089|100992122|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
33299626|NCT01259089|100992123|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
33299627|NCT01259089|100992124|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
33299628|NCT01259089|100992119|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
33496550|NCT01890122|101710121|FG001|Overall Study|Adverse Event|1|||
33496551|NCT01890122|101710122|FG002|Overall Study|Adverse Event|1|||
33496552|NCT01890122|101710123|FG003|Overall Study|Adverse Event|2|||
33496553|NCT01890122|101710120|FG000|Overall Study|Major Protocol Deviation|3|||
33496554|NCT01890122|101710121|FG001|Overall Study|Major Protocol Deviation|1|||
33496555|NCT01890122|101710122|FG002|Overall Study|Major Protocol Deviation|0|||
33496556|NCT01890122|101710123|FG003|Overall Study|Major Protocol Deviation|1|||
33496557|NCT01890122|101710120|FG000|Overall Study|Lost to Follow-up|0|||
33496558|NCT01890122|101710121|FG001|Overall Study|Lost to Follow-up|1|||
33496559|NCT01890122|101710122|FG002|Overall Study|Lost to Follow-up|2|||
33496560|NCT01890122|101710123|FG003|Overall Study|Lost to Follow-up|2|||
33496561|NCT01890122|101710120|FG000|Overall Study|Voluntary Withdrawal|8|||
33496562|NCT01890122|101710121|FG001|Overall Study|Voluntary Withdrawal|8|||
33496563|NCT01890122|101710122|FG002|Overall Study|Voluntary Withdrawal|2|||
33496564|NCT01890122|101710123|FG003|Overall Study|Voluntary Withdrawal|11|||
33496565|NCT01890122|101710120|FG000|Overall Study|Lack of Efficacy|14|||
33496566|NCT01890122|101710121|FG001|Overall Study|Lack of Efficacy|24|||
33496567|NCT01890122|101710122|FG002|Overall Study|Lack of Efficacy|7|||
33496568|NCT01890122|101710123|FG003|Overall Study|Lack of Efficacy|41|||
33496569|NCT01890122|101710120|FG000|Overall Study|Reason not Specified|0|||
33496570|NCT01890122|101710121|FG001|Overall Study|Reason not Specified|1|||
33496571|NCT01890122|101710122|FG002|Overall Study|Reason not Specified|1|||
33496572|NCT01890122|101710123|FG003|Overall Study|Reason not Specified|2|||
33496573|NCT01890122|101710120|FG000|Overall Study|Randomized but not Treated|1|||
33496574|NCT01890122|101710121|FG001|Overall Study|Randomized but not Treated|1|||
33496575|NCT01890122|101710122|FG002|Overall Study|Randomized but not Treated|0|||
33496576|NCT01890122|101710123|FG003|Overall Study|Randomized but not Treated|0|||
33496577|NCT02394600|101710124|FG000|Overall Study|Adverse Event|3|||
33496578|NCT02394600|101710125|FG001|Overall Study|Adverse Event|0|||
33496579|NCT02394600|101710124|FG000|Overall Study|Lost to Follow-up|0|||
33496580|NCT02394600|101710125|FG001|Overall Study|Lost to Follow-up|1|||
33299629|NCT01259089|100992120|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
33299630|NCT01259089|100992121|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
33299631|NCT01259089|100992122|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
33299632|NCT01259089|100992123|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
33299633|NCT01259089|100992124|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
33299634|NCT01259089|100992119|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
33299635|NCT01259089|100992120|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
33299636|NCT01259089|100992121|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
33299637|NCT01259089|100992122|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
33299638|NCT01259089|100992123|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
33299639|NCT01259089|100992124|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
33299640|NCT01259089|100992119|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
33299641|NCT01259089|100992120|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
33299642|NCT01259089|100992121|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
33299643|NCT01259089|100992122|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
33496581|NCT02394600|101710124|FG000|Overall Study|Withdrawal by Subject|0|||
33496582|NCT02394600|101710125|FG001|Overall Study|Withdrawal by Subject|1|||
33600162|NCT05239221|102088527|FG012|Overall Study|Withdrawal by Subject|0|||
33299644|NCT01259089|100992123|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
33299645|NCT01259089|100992124|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
33299646|NCT01259089|100992119|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
33496583|NCT02394600|101710124|FG000|Overall Study|Protocol Violation|1|||
33496584|NCT02394600|101710125|FG001|Overall Study|Protocol Violation|0|||
33496585|NCT00350207|101710126|FG000|Overall Study|Adverse Event|5|||
33496586|NCT00350207|101710127|FG001|Overall Study|Adverse Event|2|||
33496587|NCT00350207|101710128|FG002|Overall Study|Adverse Event|2|||
33299647|NCT01259089|100992120|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
33299648|NCT01259089|100992121|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
33299649|NCT01259089|100992122|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
33299650|NCT01259089|100992123|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
33299651|NCT01259089|100992124|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
33299652|NCT01259089|100992119|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
33299653|NCT01259089|100992120|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
33299654|NCT01259089|100992121|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
33496588|NCT00350207|101710126|FG000|Overall Study|Lack of Efficacy|1|||
33496589|NCT00350207|101710127|FG001|Overall Study|Lack of Efficacy|0|||
33496590|NCT00350207|101710128|FG002|Overall Study|Lack of Efficacy|2|||
33496591|NCT00350207|101710126|FG000|Overall Study|Lost to Follow-up|1|||
33496592|NCT00350207|101710127|FG001|Overall Study|Lost to Follow-up|0|||
33496593|NCT00350207|101710128|FG002|Overall Study|Lost to Follow-up|1|||
33496594|NCT00350207|101710126|FG000|Overall Study|Withdrawal by Subject|0|||
33496595|NCT00350207|101710127|FG001|Overall Study|Withdrawal by Subject|1|||
33496596|NCT00350207|101710128|FG002|Overall Study|Withdrawal by Subject|1|||
33496597|NCT00350207|101710126|FG000|Overall Study|Other|1|||
33496598|NCT00350207|101710127|FG001|Overall Study|Other|3|||
33496599|NCT00350207|101710128|FG002|Overall Study|Other|1|||
33496600|NCT02137252|101710130|FG000|Overall Study|trial terminated early|2|||
33496601|NCT02137252|101710131|FG001|Overall Study|trial terminated early|1|||
33496602|NCT01922037|101710132|FG000|Overall Study|Withdrawal by Subject|2|||
33496603|NCT01922037|101710133|FG001|Overall Study|Withdrawal by Subject|44|||
33496604|NCT01922037|101710132|FG000|Overall Study|Adverse Event|1|||
33496605|NCT01922037|101710133|FG001|Overall Study|Adverse Event|7|||
33496606|NCT01922037|101710132|FG000|Overall Study|Death|0|||
33496607|NCT01922037|101710133|FG001|Overall Study|Death|5|||
33496608|NCT01922037|101710132|FG000|Overall Study|Pregnancy|0|||
33496609|NCT01922037|101710133|FG001|Overall Study|Pregnancy|2|||
33496610|NCT01922037|101710132|FG000|Overall Study|Participant non-compliance|4|||
33496611|NCT01922037|101710133|FG001|Overall Study|Participant non-compliance|46|||
33496612|NCT01922037|101710132|FG000|Overall Study|Investigator/Sponsor decision|1|||
33496613|NCT01922037|101710133|FG001|Overall Study|Investigator/Sponsor decision|4|||
33190331|NCT01239368|100601635|FG000|Overall Study|Principal investigator discretion|1|||
33190332|NCT01239368|100601636|FG001|Overall Study|Principal investigator discretion|0|||
33190333|NCT01239368|100601637|FG002|Overall Study|Principal investigator discretion|0|||
33190334|NCT01239368|100601638|FG003|Overall Study|Principal investigator discretion|0|||
33190335|NCT01239368|100601639|FG004|Overall Study|Principal investigator discretion|1|||
33190336|NCT01239368|100601640|FG005|Overall Study|Principal investigator discretion|2|||
33190337|NCT01239368|100601641|FG006|Overall Study|Principal investigator discretion|0|||
33190338|NCT01239368|100601642|FG007|Overall Study|Principal investigator discretion|0|||
33190339|NCT01239368|100601643|FG008|Overall Study|Principal investigator discretion|0|||
33190340|NCT01239368|100601644|FG009|Overall Study|Principal investigator discretion|1|||
33190341|NCT01239368|100601635|FG000|Overall Study|Disease progression on study|1|||
33190342|NCT01239368|100601636|FG001|Overall Study|Disease progression on study|1|||
33190343|NCT01239368|100601637|FG002|Overall Study|Disease progression on study|1|||
33190344|NCT01239368|100601638|FG003|Overall Study|Disease progression on study|1|||
33190345|NCT01239368|100601639|FG004|Overall Study|Disease progression on study|4|||
33190346|NCT01239368|100601640|FG005|Overall Study|Disease progression on study|2|||
33190347|NCT01239368|100601641|FG006|Overall Study|Disease progression on study|5|||
33190348|NCT01239368|100601642|FG007|Overall Study|Disease progression on study|0|||
33190349|NCT01239368|100601643|FG008|Overall Study|Disease progression on study|0|||
33190350|NCT01239368|100601644|FG009|Overall Study|Disease progression on study|2|||
33190351|NCT01239368|100601635|FG000|Overall Study|Refused further treatment|0|||
33190352|NCT01239368|100601636|FG001|Overall Study|Refused further treatment|0|||
33190353|NCT01239368|100601637|FG002|Overall Study|Refused further treatment|0|||
33190354|NCT01239368|100601638|FG003|Overall Study|Refused further treatment|0|||
33190355|NCT01239368|100601639|FG004|Overall Study|Refused further treatment|0|||
33190356|NCT01239368|100601640|FG005|Overall Study|Refused further treatment|0|||
33190357|NCT01239368|100601641|FG006|Overall Study|Refused further treatment|0|||
33190358|NCT01239368|100601642|FG007|Overall Study|Refused further treatment|0|||
33299655|NCT01259089|100992122|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
33299656|NCT01259089|100992123|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
33496614|NCT01922037|101710132|FG000|Overall Study|Other unspecified|2|||
33496615|NCT01922037|101710133|FG001|Overall Study|Other unspecified|66|||
33496616|NCT02418949|101710134|FG000|Overall Study|Withdrawal by Subject|1|||
33496617|NCT02418949|101710135|FG001|Overall Study|Withdrawal by Subject|0|||
33190359|NCT01239368|100601643|FG008|Overall Study|Refused further treatment|0|||
33190360|NCT01239368|100601644|FG009|Overall Study|Refused further treatment|1|||
33496618|NCT02418949|101710136|FG002|Overall Study|Withdrawal by Subject|1|||
33496619|NCT02418949|101710137|FG003|Overall Study|Withdrawal by Subject|1|||
33496620|NCT02418949|101710134|FG000|Overall Study|Lost to Follow-up|1|||
33496621|NCT02418949|101710135|FG001|Overall Study|Lost to Follow-up|0|||
33496622|NCT02418949|101710136|FG002|Overall Study|Lost to Follow-up|1|||
33496623|NCT02418949|101710137|FG003|Overall Study|Lost to Follow-up|0|||
33496624|NCT02418949|101710134|FG000|Overall Study|Physician Decision|1|||
33496625|NCT02418949|101710135|FG001|Overall Study|Physician Decision|1|||
33496626|NCT02418949|101710136|FG002|Overall Study|Physician Decision|1|||
33496627|NCT02418949|101710137|FG003|Overall Study|Physician Decision|0|||
33496628|NCT01217112|101710138|FG000|Overall Study|Adverse Event|0|||
33496629|NCT01217112|101710139|FG001|Overall Study|Adverse Event|2|||
33496630|NCT01217112|101710140|FG002|Overall Study|Adverse Event|0|||
33496631|NCT01217112|101710141|FG003|Overall Study|Adverse Event|2|||
33496632|NCT01217112|101710142|FG004|Overall Study|Adverse Event|0|||
33496633|NCT01217112|101710138|FG000|Overall Study|Withdrawal by Subject|0|||
33496634|NCT01217112|101710139|FG001|Overall Study|Withdrawal by Subject|0|||
33496635|NCT01217112|101710140|FG002|Overall Study|Withdrawal by Subject|1|||
33496636|NCT01217112|101710141|FG003|Overall Study|Withdrawal by Subject|0|||
33496637|NCT01217112|101710142|FG004|Overall Study|Withdrawal by Subject|0|||
33496638|NCT01217112|101710138|FG000|Overall Study|Physician Decision|0|||
33496639|NCT01217112|101710139|FG001|Overall Study|Physician Decision|0|||
33496640|NCT01217112|101710140|FG002|Overall Study|Physician Decision|0|||
33496641|NCT01217112|101710141|FG003|Overall Study|Physician Decision|0|||
33496642|NCT01217112|101710142|FG004|Overall Study|Physician Decision|1|||
33496643|NCT00615550|101710143|FG000|Overall Study|Lost to Follow-up|6|||
33496644|NCT00615550|101710144|FG001|Overall Study|Lost to Follow-up|1|||
33496645|NCT03655405|101710145|FG000|Overall Study|Death after initial data collection|4|||
33496646|NCT03655405|101710146|FG001|Overall Study|Death after initial data collection|2|||
33496647|NCT03655405|101710145|FG000|Overall Study|Died before initial data collection|1|||
33496648|NCT03655405|101710146|FG001|Overall Study|Died before initial data collection|2|||
33496649|NCT03655405|101710145|FG000|Overall Study|Protocol Violation|0|||
33496650|NCT03655405|101710146|FG001|Overall Study|Protocol Violation|1|||
33496651|NCT02505217|101710147|FG000|Overall Study|Withdrawal by Subject|1|||
33496652|NCT02505217|101710148|FG001|Overall Study|Withdrawal by Subject|2|||
33496653|NCT03620708|101710149|FG000|Overall Study|Lost to Follow-up|1|||
33496654|NCT03620708|101710150|FG001|Overall Study|Lost to Follow-up|1|||
33496655|NCT03620708|101710151|FG002|Overall Study|Lost to Follow-up|2|||
33299657|NCT01259089|100992124|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
33299658|NCT01259089|100992119|FG000|Survival Follow up for Two Years|Death|3|||
33299659|NCT01259089|100992120|FG001|Survival Follow up for Two Years|Death|2|||
33299660|NCT01259089|100992121|FG002|Survival Follow up for Two Years|Death|2|||
33299661|NCT01259089|100992122|FG003|Survival Follow up for Two Years|Death|3|||
33299662|NCT01259089|100992123|FG004|Survival Follow up for Two Years|Death|6|||
33299663|NCT01259089|100992124|FG005|Survival Follow up for Two Years|Death|13|||
33299664|NCT01259089|100992119|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
33299665|NCT01259089|100992120|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
33299666|NCT01259089|100992121|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
33299667|NCT01259089|100992122|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
33299668|NCT01259089|100992123|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
33299669|NCT01259089|100992124|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
33299670|NCT01259089|100992119|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
33299671|NCT01259089|100992120|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
33299672|NCT01259089|100992121|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
33299673|NCT01259089|100992122|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
33299674|NCT01259089|100992123|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
33299675|NCT01259089|100992124|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
33299676|NCT01495598|100992125|FG000|Overall Study|Death during follow up period|2|||
33299677|NCT01495598|100992125|FG000|Overall Study|Death on study|1|||
33299678|NCT01495598|100992125|FG000|Overall Study|Lost to Follow-up|3|||
33299679|NCT01495598|100992125|FG000|Overall Study|Physician Decision|8|||
33299680|NCT01593787|100992126|FG000|Overall Study|Adverse Event|1|||
33299681|NCT01593787|100992127|FG001|Overall Study|Adverse Event|0|||
33299682|NCT01593787|100992128|FG002|Overall Study|Adverse Event|0|||
33299683|NCT04400487|100992129|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
33299684|NCT04400487|100992129|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
33600163|NCT05239221|102088528|FG013|Overall Study|Withdrawal by Subject|0|||
33299685|NCT04400487|100992129|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
33299686|NCT02037477|100992130|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
33299687|NCT02037477|100992131|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
33496656|NCT03620708|101710149|FG000|Overall Study|Withdrawal by Subject|0|||
33496657|NCT03620708|101710150|FG001|Overall Study|Withdrawal by Subject|0|||
33496658|NCT03620708|101710151|FG002|Overall Study|Withdrawal by Subject|1|||
33496659|NCT03877068|101710152|FG000|Overall Study|Physician Decision|9|||
33496660|NCT03877068|101710153|FG001|Overall Study|Physician Decision|3|||
33496661|NCT00654095|101710154|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
33299688|NCT02037477|100992132|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
33299689|NCT02037477|100992133|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
33299690|NCT04655027|100992136|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
33299691|NCT04655027|100992137|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
33299692|NCT01214642|100992143|FG000|Overall Study|Progressive Disease|3|||
33299693|NCT01214642|100992144|FG001|Overall Study|Progressive Disease|2|||
33299694|NCT01214642|100992145|FG002|Overall Study|Progressive Disease|3|||
33299695|NCT01214642|100992146|FG003|Overall Study|Progressive Disease|5|||
33299696|NCT01214642|100992147|FG004|Overall Study|Progressive Disease|5|||
33299697|NCT01214642|100992148|FG005|Overall Study|Progressive Disease|3|||
33299698|NCT01214642|100992149|FG006|Overall Study|Progressive Disease|5|||
33299699|NCT01214642|100992150|FG007|Overall Study|Progressive Disease|3|||
33299700|NCT01214642|100992151|FG008|Overall Study|Progressive Disease|10|||
33299701|NCT01214642|100992152|FG009|Overall Study|Progressive Disease|2|||
33299702|NCT01214642|100992153|FG010|Overall Study|Progressive Disease|1|||
33299703|NCT01214642|100992154|FG011|Overall Study|Progressive Disease|4|||
33299704|NCT01214642|100992143|FG000|Overall Study|Adverse Event|0|||
33299705|NCT01214642|100992144|FG001|Overall Study|Adverse Event|1|||
33299706|NCT01214642|100992145|FG002|Overall Study|Adverse Event|0|||
33299707|NCT01214642|100992146|FG003|Overall Study|Adverse Event|0|||
33299708|NCT01214642|100992147|FG004|Overall Study|Adverse Event|0|||
33299709|NCT01214642|100992148|FG005|Overall Study|Adverse Event|0|||
33299710|NCT01214642|100992149|FG006|Overall Study|Adverse Event|1|||
33299711|NCT01214642|100992150|FG007|Overall Study|Adverse Event|0|||
33299712|NCT01214642|100992151|FG008|Overall Study|Adverse Event|0|||
33299713|NCT01214642|100992152|FG009|Overall Study|Adverse Event|1|||
33299714|NCT01214642|100992153|FG010|Overall Study|Adverse Event|1|||
33299715|NCT01214642|100992154|FG011|Overall Study|Adverse Event|0|||
33299716|NCT01214642|100992143|FG000|Overall Study|Death|0|||
33299717|NCT01214642|100992144|FG001|Overall Study|Death|0|||
33299718|NCT01214642|100992145|FG002|Overall Study|Death|1|||
33299719|NCT01214642|100992146|FG003|Overall Study|Death|0|||
33299720|NCT01214642|100992147|FG004|Overall Study|Death|0|||
33299721|NCT01214642|100992148|FG005|Overall Study|Death|0|||
33299722|NCT01214642|100992149|FG006|Overall Study|Death|0|||
33299723|NCT01214642|100992150|FG007|Overall Study|Death|0|||
33299724|NCT01214642|100992151|FG008|Overall Study|Death|0|||
33299725|NCT01214642|100992152|FG009|Overall Study|Death|0|||
33299726|NCT01214642|100992153|FG010|Overall Study|Death|1|||
33299727|NCT01214642|100992154|FG011|Overall Study|Death|0|||
33299728|NCT01214642|100992143|FG000|Overall Study|Withdrawal by Subject|0|||
33299729|NCT01214642|100992144|FG001|Overall Study|Withdrawal by Subject|0|||
33299730|NCT01214642|100992145|FG002|Overall Study|Withdrawal by Subject|1|||
33299731|NCT01214642|100992146|FG003|Overall Study|Withdrawal by Subject|0|||
33299732|NCT01214642|100992147|FG004|Overall Study|Withdrawal by Subject|0|||
33299733|NCT01214642|100992148|FG005|Overall Study|Withdrawal by Subject|0|||
33299734|NCT01214642|100992149|FG006|Overall Study|Withdrawal by Subject|0|||
33299735|NCT01214642|100992150|FG007|Overall Study|Withdrawal by Subject|0|||
33299736|NCT01214642|100992151|FG008|Overall Study|Withdrawal by Subject|3|||
33299737|NCT01214642|100992152|FG009|Overall Study|Withdrawal by Subject|1|||
33299738|NCT01214642|100992153|FG010|Overall Study|Withdrawal by Subject|1|||
33299739|NCT01214642|100992154|FG011|Overall Study|Withdrawal by Subject|0|||
33299740|NCT01214642|100992143|FG000|Overall Study|Physician Decision|0|||
33299741|NCT01214642|100992144|FG001|Overall Study|Physician Decision|0|||
33393462|NCT01510028|101328475|FG001|Overall Study|Lack of Efficacy|0|||
33190361|NCT01239368|100601635|FG000|Overall Study|Death|0|||
33299742|NCT01214642|100992145|FG002|Overall Study|Physician Decision|1|||
33299743|NCT01214642|100992146|FG003|Overall Study|Physician Decision|1|||
33299744|NCT01214642|100992147|FG004|Overall Study|Physician Decision|1|||
33299745|NCT01214642|100992148|FG005|Overall Study|Physician Decision|0|||
33299746|NCT01214642|100992149|FG006|Overall Study|Physician Decision|0|||
33299747|NCT01214642|100992150|FG007|Overall Study|Physician Decision|0|||
33299748|NCT01214642|100992151|FG008|Overall Study|Physician Decision|0|||
33299749|NCT01214642|100992152|FG009|Overall Study|Physician Decision|0|||
33299750|NCT01214642|100992153|FG010|Overall Study|Physician Decision|0|||
33299751|NCT01214642|100992154|FG011|Overall Study|Physician Decision|2|||
33299752|NCT01020877|100992158|FG000|Second Intervention|Withdrawal by Subject|1|||
33299753|NCT01020877|100992159|FG001|Second Intervention|Withdrawal by Subject|0|||
33299754|NCT01152814|100992160|FG000|Overall Study|Lost to Follow-up|2|||
33299755|NCT02797522|100992161|FG000|Overall Study|Study Terminated by Sponsor|0|||
33299756|NCT02797522|100992162|FG001|Overall Study|Study Terminated by Sponsor|0|||
33299757|NCT02797522|100992163|FG002|Overall Study|Study Terminated by Sponsor|0|||
33299758|NCT02797522|100992164|FG003|Overall Study|Study Terminated by Sponsor|0|||
33299759|NCT02797522|100992165|FG004|Overall Study|Study Terminated by Sponsor|0|||
33299760|NCT02797522|100992166|FG005|Overall Study|Study Terminated by Sponsor|0|||
33299761|NCT02797522|100992167|FG006|Overall Study|Study Terminated by Sponsor|0|||
33299762|NCT02797522|100992168|FG007|Overall Study|Study Terminated by Sponsor|4|||
33299763|NCT02797522|100992169|FG008|Overall Study|Study Terminated by Sponsor|2|||
33299764|NCT02797522|100992170|FG009|Overall Study|Study Terminated by Sponsor|4|||
33299765|NCT02797522|100992171|FG010|Overall Study|Study Terminated by Sponsor|1|||
33299766|NCT04145700|100992172|FG000|Overall Study|Withdrawal by Subject|8|||
33299767|NCT04145700|100992173|FG001|Overall Study|Withdrawal by Subject|3|||
33299768|NCT03248882|100992178|FG000|Overall Study|Adverse Event|3|||
33299769|NCT03248882|100992179|FG001|Overall Study|Adverse Event|3|||
33299770|NCT03248882|100992180|FG002|Overall Study|Adverse Event|2|||
33299771|NCT03248882|100992181|FG003|Overall Study|Adverse Event|6|||
33299772|NCT03248882|100992182|FG004|Overall Study|Adverse Event|9|||
33496662|NCT00654095|101710154|FG000|Overall Study|Elevated triglyceride level (2)|1|||
33496663|NCT00654095|101710154|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
33496664|NCT00654095|101710154|FG000|Overall Study|Adverse Event|11|||
33299773|NCT03248882|100992178|FG000|Overall Study|Lost to Follow-up|0|||
33299774|NCT03248882|100992179|FG001|Overall Study|Lost to Follow-up|0|||
33299775|NCT03248882|100992180|FG002|Overall Study|Lost to Follow-up|0|||
33299776|NCT03248882|100992181|FG003|Overall Study|Lost to Follow-up|0|||
33299777|NCT03248882|100992182|FG004|Overall Study|Lost to Follow-up|1|||
33299778|NCT03248882|100992178|FG000|Overall Study|Protocol Violation|2|||
33299779|NCT03248882|100992179|FG001|Overall Study|Protocol Violation|0|||
33299780|NCT03248882|100992180|FG002|Overall Study|Protocol Violation|2|||
33299781|NCT03248882|100992181|FG003|Overall Study|Protocol Violation|0|||
33299782|NCT03248882|100992182|FG004|Overall Study|Protocol Violation|1|||
33299783|NCT03248882|100992178|FG000|Overall Study|Withdrawal by Subject|2|||
33299784|NCT03248882|100992179|FG001|Overall Study|Withdrawal by Subject|2|||
33299785|NCT03248882|100992180|FG002|Overall Study|Withdrawal by Subject|3|||
33299786|NCT03248882|100992181|FG003|Overall Study|Withdrawal by Subject|4|||
33299787|NCT03248882|100992182|FG004|Overall Study|Withdrawal by Subject|2|||
33299788|NCT01923467|100992183|FG000|Overall Study|Lost to Follow-up|62|||
33299789|NCT01923467|100992183|FG000|Overall Study|Subject non-interest|479|||
33299790|NCT02574845|100992184|FG000|Overall Study|Consent withdrawn further participation|0|||
33299791|NCT02574845|100992185|FG001|Overall Study|Consent withdrawn further participation|0|||
33299792|NCT02574845|100992186|FG002|Overall Study|Consent withdrawn further participation|0|||
33299793|NCT02574845|100992187|FG003|Overall Study|Consent withdrawn further participation|0|||
33299794|NCT02574845|100992188|FG004|Overall Study|Consent withdrawn further participation|1|||
33299795|NCT02574845|100992189|FG005|Overall Study|Consent withdrawn further participation|0|||
33299796|NCT02574845|100992184|FG000|Overall Study|Adverse Event|0|||
33299797|NCT02574845|100992185|FG001|Overall Study|Adverse Event|1|||
33299798|NCT02574845|100992186|FG002|Overall Study|Adverse Event|0|||
33299799|NCT02574845|100992187|FG003|Overall Study|Adverse Event|0|||
33299800|NCT02574845|100992188|FG004|Overall Study|Adverse Event|0|||
33299801|NCT02574845|100992189|FG005|Overall Study|Adverse Event|1|||
33299802|NCT03106753|100992190|FG000|Overall Study|Withdrawal by Subject|0|||
33299803|NCT03106753|100992191|FG001|Overall Study|Withdrawal by Subject|1|||
33299804|NCT01006980|100992194|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
33299805|NCT01006980|100992195|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
33299806|NCT01006980|100992194|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
33299807|NCT01006980|100992195|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
33299808|NCT01006980|100992194|FG000|Vemurafenib and Dacarbazine|Death|13|||
33299809|NCT01006980|100992195|FG001|Vemurafenib and Dacarbazine|Death|12|||
33299810|NCT01006980|100992194|FG000|Vemurafenib and Dacarbazine|Progression|257|||
33299811|NCT01006980|100992195|FG001|Vemurafenib and Dacarbazine|Progression|218|||
33299812|NCT01006980|100992194|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
33299813|NCT01006980|100992195|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
33299814|NCT01006980|100992194|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
33496665|NCT00654095|101710154|FG000|Overall Study|Withdrawal by Subject|5|||
33496666|NCT00654095|101710154|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
33496667|NCT00654095|101710154|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
33496668|NCT00654095|101710154|FG000|Overall Study|Did not meet inclusion criteria|1|||
33496669|NCT01418378|101710157|FG000|Overall Study|Death|1|||
33299815|NCT01006980|100992195|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
33299816|NCT01006980|100992194|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
33299817|NCT01006980|100992195|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
33299818|NCT01006980|100992194|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
33299819|NCT01006980|100992195|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
33299820|NCT01006980|100992194|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
33299821|NCT01006980|100992195|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
33299822|NCT01006980|100992194|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
33496670|NCT01418378|101710158|FG001|Overall Study|Death|2|||
33496671|NCT01418378|101710157|FG000|Overall Study|Physician Decision|0|||
33496672|NCT01418378|101710158|FG001|Overall Study|Physician Decision|1|||
33496673|NCT01418378|101710157|FG000|Overall Study|ligament imbalance|0|||
33496674|NCT01418378|101710158|FG001|Overall Study|ligament imbalance|1|||
33496675|NCT01418378|101710157|FG000|Overall Study|developed chronic myopathy|0|||
33496676|NCT01418378|101710158|FG001|Overall Study|developed chronic myopathy|1|||
33496677|NCT03711188|101710159|FG000|Overall Study|Disease progression|11|||
33496678|NCT03711188|101710159|FG000|Overall Study|Adverse Event|1|||
33496679|NCT01402570|101710166|FG000|Overall Study|Adverse Event|1|||
33496680|NCT01962103|101710172|FG000|Phase 1|Adverse Event|4|||
33496681|NCT01962103|101710173|FG001|Phase 1|Adverse Event|0|||
33496682|NCT01962103|101710174|FG002|Phase 1|Adverse Event|2|||
33496683|NCT01962103|101710175|FG003|Phase 1|Adverse Event|1|||
33496684|NCT01962103|101710176|FG004|Phase 1|Adverse Event|2|||
33496685|NCT01962103|101710177|FG005|Phase 1|Adverse Event|2|||
33496686|NCT01962103|101710178|FG006|Phase 1|Adverse Event|0|||
33496687|NCT01962103|101710179|FG007|Phase 1|Adverse Event|0|||
33496688|NCT01962103|101710180|FG008|Phase 1|Adverse Event|0|||
33496689|NCT01962103|101710172|FG000|Phase 1|Progressive Disease|8|||
33496690|NCT01962103|101710173|FG001|Phase 1|Progressive Disease|6|||
33496691|NCT01962103|101710174|FG002|Phase 1|Progressive Disease|8|||
33496692|NCT01962103|101710175|FG003|Phase 1|Progressive Disease|4|||
33496693|NCT01962103|101710176|FG004|Phase 1|Progressive Disease|5|||
33496694|NCT01962103|101710177|FG005|Phase 1|Progressive Disease|4|||
33496695|NCT01962103|101710178|FG006|Phase 1|Progressive Disease|0|||
33496696|NCT01962103|101710179|FG007|Phase 1|Progressive Disease|0|||
33496697|NCT01962103|101710180|FG008|Phase 1|Progressive Disease|0|||
33496698|NCT01962103|101710172|FG000|Phase 1|Withdrawal by Subject|0|||
33496699|NCT01962103|101710173|FG001|Phase 1|Withdrawal by Subject|0|||
33496700|NCT01962103|101710174|FG002|Phase 1|Withdrawal by Subject|0|||
33496701|NCT01962103|101710175|FG003|Phase 1|Withdrawal by Subject|2|||
33496702|NCT01962103|101710176|FG004|Phase 1|Withdrawal by Subject|0|||
33496703|NCT01962103|101710177|FG005|Phase 1|Withdrawal by Subject|0|||
33496704|NCT01962103|101710178|FG006|Phase 1|Withdrawal by Subject|0|||
33496705|NCT01962103|101710179|FG007|Phase 1|Withdrawal by Subject|0|||
33299823|NCT01006980|100992195|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
33299824|NCT01006980|100992194|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
33299825|NCT01006980|100992195|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
33299826|NCT01006980|100992194|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
33299827|NCT01006980|100992195|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
33299828|NCT01006980|100992194|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
33299829|NCT01006980|100992195|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
33299830|NCT04617275|100992198|FG000|Treatment Period|Adverse Event|1|||
33299831|NCT04617275|100992199|FG001|Treatment Period|Adverse Event|6|||
33299832|NCT04617275|100992200|FG002|Treatment Period|Adverse Event|4|||
33299833|NCT04617275|100992201|FG003|Treatment Period|Adverse Event|6|||
33299834|NCT04617275|100992202|FG004|Treatment Period|Adverse Event|7|||
33299835|NCT04617275|100992203|FG005|Treatment Period|Adverse Event|8|||
33299836|NCT04617275|100992204|FG006|Treatment Period|Adverse Event|0|||
33299837|NCT04617275|100992205|FG007|Treatment Period|Adverse Event|12|||
33299838|NCT04617275|100992198|FG000|Treatment Period|Lost to Follow-up|0|||
33299839|NCT04617275|100992199|FG001|Treatment Period|Lost to Follow-up|0|||
33299840|NCT04617275|100992200|FG002|Treatment Period|Lost to Follow-up|2|||
33299841|NCT04617275|100992201|FG003|Treatment Period|Lost to Follow-up|0|||
33299842|NCT04617275|100992202|FG004|Treatment Period|Lost to Follow-up|0|||
33299843|NCT04617275|100992203|FG005|Treatment Period|Lost to Follow-up|3|||
33299844|NCT04617275|100992204|FG006|Treatment Period|Lost to Follow-up|0|||
33299845|NCT04617275|100992205|FG007|Treatment Period|Lost to Follow-up|2|||
33299846|NCT04617275|100992198|FG000|Treatment Period|No longer meets eligibility criteria|0|||
33299847|NCT04617275|100992199|FG001|Treatment Period|No longer meets eligibility criteria|0|||
33496706|NCT01962103|101710180|FG008|Phase 1|Withdrawal by Subject|0|||
33299848|NCT04617275|100992200|FG002|Treatment Period|No longer meets eligibility criteria|0|||
33496707|NCT01962103|101710172|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
33496708|NCT01962103|101710173|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
33496709|NCT01962103|101710174|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
33496710|NCT01962103|101710175|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
33496711|NCT01962103|101710176|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
33299849|NCT04617275|100992201|FG003|Treatment Period|No longer meets eligibility criteria|1|||
33299850|NCT04617275|100992202|FG004|Treatment Period|No longer meets eligibility criteria|0|||
33299851|NCT04617275|100992203|FG005|Treatment Period|No longer meets eligibility criteria|0|||
33393463|NCT01510028|101328476|FG002|Overall Study|Lack of Efficacy|0|||
33496712|NCT01962103|101710177|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
33496713|NCT01962103|101710178|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
33496714|NCT01962103|101710179|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
33496715|NCT01962103|101710180|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
33496716|NCT01962103|101710172|FG000|Phase 1|Physician Decision|0|||
33496717|NCT01962103|101710173|FG001|Phase 1|Physician Decision|0|||
33299852|NCT04617275|100992204|FG006|Treatment Period|No longer meets eligibility criteria|0|||
33299853|NCT04617275|100992205|FG007|Treatment Period|No longer meets eligibility criteria|0|||
33299854|NCT04617275|100992198|FG000|Treatment Period|Other|0|||
33299855|NCT04617275|100992199|FG001|Treatment Period|Other|1|||
33299856|NCT04617275|100992200|FG002|Treatment Period|Other|0|||
33299857|NCT04617275|100992201|FG003|Treatment Period|Other|0|||
33299858|NCT04617275|100992202|FG004|Treatment Period|Other|0|||
33299859|NCT04617275|100992203|FG005|Treatment Period|Other|0|||
33299860|NCT04617275|100992204|FG006|Treatment Period|Other|0|||
33299861|NCT04617275|100992205|FG007|Treatment Period|Other|0|||
33299862|NCT04617275|100992198|FG000|Treatment Period|Withdrawal by Subject|2|||
33393464|NCT01510028|101328477|FG003|Overall Study|Lack of Efficacy|0|||
33496718|NCT01962103|101710174|FG002|Phase 1|Physician Decision|0|||
33496719|NCT01962103|101710175|FG003|Phase 1|Physician Decision|1|||
33496720|NCT01962103|101710176|FG004|Phase 1|Physician Decision|0|||
33496721|NCT01962103|101710177|FG005|Phase 1|Physician Decision|0|||
33496722|NCT01962103|101710178|FG006|Phase 1|Physician Decision|0|||
33496723|NCT01962103|101710179|FG007|Phase 1|Physician Decision|0|||
33496724|NCT01962103|101710180|FG008|Phase 1|Physician Decision|0|||
33496725|NCT01962103|101710172|FG000|Phase 1|Symptomatic Deterioration|3|||
33496726|NCT01962103|101710173|FG001|Phase 1|Symptomatic Deterioration|2|||
33496727|NCT01962103|101710174|FG002|Phase 1|Symptomatic Deterioration|2|||
33496728|NCT01962103|101710175|FG003|Phase 1|Symptomatic Deterioration|2|||
33496729|NCT01962103|101710176|FG004|Phase 1|Symptomatic Deterioration|1|||
33496730|NCT01962103|101710177|FG005|Phase 1|Symptomatic Deterioration|1|||
33496731|NCT01962103|101710178|FG006|Phase 1|Symptomatic Deterioration|0|||
33496732|NCT01962103|101710179|FG007|Phase 1|Symptomatic Deterioration|0|||
33496733|NCT01962103|101710180|FG008|Phase 1|Symptomatic Deterioration|0|||
33496734|NCT01962103|101710172|FG000|Phase 1|Miscellaneous|1|||
33496735|NCT01962103|101710173|FG001|Phase 1|Miscellaneous|0|||
33496736|NCT01962103|101710174|FG002|Phase 1|Miscellaneous|0|||
33496737|NCT01962103|101710175|FG003|Phase 1|Miscellaneous|0|||
33496738|NCT01962103|101710176|FG004|Phase 1|Miscellaneous|0|||
33190362|NCT01239368|100601636|FG001|Overall Study|Death|0|||
33190363|NCT01239368|100601637|FG002|Overall Study|Death|0|||
33190364|NCT01239368|100601638|FG003|Overall Study|Death|0|||
33190365|NCT01239368|100601639|FG004|Overall Study|Death|0|||
33190366|NCT01239368|100601640|FG005|Overall Study|Death|0|||
33190367|NCT01239368|100601641|FG006|Overall Study|Death|1|||
33190368|NCT01239368|100601642|FG007|Overall Study|Death|0|||
33190369|NCT01239368|100601643|FG008|Overall Study|Death|0|||
33190370|NCT01239368|100601644|FG009|Overall Study|Death|0|||
33190371|NCT00989833|100601645|FG000|Overall Study|Lost to Follow-up|0|||
33190372|NCT00989833|100601646|FG001|Overall Study|Lost to Follow-up|1|||
33190373|NCT00989833|100601647|FG002|Overall Study|Lost to Follow-up|0|||
33190374|NCT00989833|100601645|FG000|Overall Study|Protocol Violation|1|||
33190375|NCT00989833|100601646|FG001|Overall Study|Protocol Violation|2|||
33190376|NCT00989833|100601647|FG002|Overall Study|Protocol Violation|1|||
33190377|NCT00989833|100601645|FG000|Overall Study|Withdrawal by Subject|0|||
33190378|NCT00989833|100601646|FG001|Overall Study|Withdrawal by Subject|0|||
33190379|NCT00989833|100601647|FG002|Overall Study|Withdrawal by Subject|1|||
33190380|NCT00989833|100601645|FG000|Overall Study|Incorrectly randomized|1|||
33190381|NCT00989833|100601646|FG001|Overall Study|Incorrectly randomized|0|||
33190382|NCT00989833|100601647|FG002|Overall Study|Incorrectly randomized|0|||
33190383|NCT03878134|100601648|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
33190384|NCT01494610|100601649|FG000|Period 1|Withdrawal by Subject|1|||
33190385|NCT01494610|100601650|FG001|Period 1|Withdrawal by Subject|1|||
33190386|NCT01494610|100601649|FG000|Period 3|Adverse Event|1|||
33190387|NCT01494610|100601650|FG001|Period 3|Adverse Event|0|||
33190388|NCT01494610|100601649|FG000|Period 3|Withdrawal by Subject|1|||
33190389|NCT01494610|100601650|FG001|Period 3|Withdrawal by Subject|0|||
33190390|NCT01494610|100601649|FG000|Period 4|Protocol Violation|1|||
33190391|NCT01494610|100601650|FG001|Period 4|Protocol Violation|0|||
33190392|NCT02673775|100601657|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
33299863|NCT04617275|100992199|FG001|Treatment Period|Withdrawal by Subject|0|||
33393465|NCT01102140|101328478|FG000|Overall Study|Lost to Follow-up|1|||
33496739|NCT01962103|101710177|FG005|Phase 1|Miscellaneous|0|||
33496740|NCT01962103|101710178|FG006|Phase 1|Miscellaneous|0|||
33496741|NCT01962103|101710179|FG007|Phase 1|Miscellaneous|0|||
33496742|NCT01962103|101710180|FG008|Phase 1|Miscellaneous|0|||
33190393|NCT02673775|100601658|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
33190394|NCT02673775|100601657|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
33190395|NCT02673775|100601658|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
33190396|NCT02673775|100601657|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
33190397|NCT02673775|100601658|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
33190398|NCT02673775|100601657|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
33299864|NCT04617275|100992200|FG002|Treatment Period|Withdrawal by Subject|0|||
33496743|NCT01962103|101710172|FG000|Phase 2|Adverse Event|0|||
33496744|NCT01962103|101710173|FG001|Phase 2|Adverse Event|0|||
33496745|NCT01962103|101710174|FG002|Phase 2|Adverse Event|0|||
33393466|NCT01102140|101328479|FG001|Overall Study|Lost to Follow-up|0|||
33299865|NCT04617275|100992201|FG003|Treatment Period|Withdrawal by Subject|2|||
33299866|NCT04617275|100992202|FG004|Treatment Period|Withdrawal by Subject|2|||
33299867|NCT04617275|100992203|FG005|Treatment Period|Withdrawal by Subject|0|||
33299868|NCT04617275|100992204|FG006|Treatment Period|Withdrawal by Subject|1|||
33299869|NCT04617275|100992205|FG007|Treatment Period|Withdrawal by Subject|2|||
33299870|NCT04617275|100992198|FG000|Follow-up Period|Adverse Event|1|||
33299871|NCT04617275|100992199|FG001|Follow-up Period|Adverse Event|1|||
33299872|NCT04617275|100992200|FG002|Follow-up Period|Adverse Event|2|||
33299873|NCT04617275|100992201|FG003|Follow-up Period|Adverse Event|3|||
33299874|NCT04617275|100992202|FG004|Follow-up Period|Adverse Event|4|||
33299875|NCT04617275|100992203|FG005|Follow-up Period|Adverse Event|3|||
33299876|NCT04617275|100992204|FG006|Follow-up Period|Adverse Event|0|||
33299877|NCT04617275|100992205|FG007|Follow-up Period|Adverse Event|3|||
33299878|NCT04617275|100992198|FG000|Follow-up Period|Lost to Follow-up|0|||
33299879|NCT04617275|100992199|FG001|Follow-up Period|Lost to Follow-up|1|||
33299880|NCT04617275|100992200|FG002|Follow-up Period|Lost to Follow-up|2|||
33496746|NCT01962103|101710175|FG003|Phase 2|Adverse Event|0|||
33496747|NCT01962103|101710176|FG004|Phase 2|Adverse Event|0|||
33496748|NCT01962103|101710177|FG005|Phase 2|Adverse Event|0|||
33496749|NCT01962103|101710178|FG006|Phase 2|Adverse Event|1|||
33496750|NCT01962103|101710179|FG007|Phase 2|Adverse Event|0|||
33496751|NCT01962103|101710180|FG008|Phase 2|Adverse Event|3|||
33496752|NCT01962103|101710172|FG000|Phase 2|Progressive Disease|0|||
33496753|NCT01962103|101710173|FG001|Phase 2|Progressive Disease|0|||
33496754|NCT01962103|101710174|FG002|Phase 2|Progressive Disease|0|||
33496755|NCT01962103|101710175|FG003|Phase 2|Progressive Disease|0|||
33496756|NCT01962103|101710176|FG004|Phase 2|Progressive Disease|0|||
33496757|NCT01962103|101710177|FG005|Phase 2|Progressive Disease|0|||
33496758|NCT01962103|101710178|FG006|Phase 2|Progressive Disease|11|||
33299881|NCT04617275|100992201|FG003|Follow-up Period|Lost to Follow-up|0|||
33299882|NCT04617275|100992202|FG004|Follow-up Period|Lost to Follow-up|0|||
33299883|NCT04617275|100992203|FG005|Follow-up Period|Lost to Follow-up|4|||
33299884|NCT04617275|100992204|FG006|Follow-up Period|Lost to Follow-up|0|||
33299885|NCT04617275|100992205|FG007|Follow-up Period|Lost to Follow-up|3|||
33299886|NCT04617275|100992198|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
33299887|NCT04617275|100992199|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
33299888|NCT04617275|100992200|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
33299889|NCT04617275|100992201|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
33299890|NCT04617275|100992202|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
33299891|NCT04617275|100992203|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
33299892|NCT04617275|100992204|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
33299893|NCT04617275|100992205|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
33299894|NCT04617275|100992198|FG000|Follow-up Period|Other|0|||
33299895|NCT04617275|100992199|FG001|Follow-up Period|Other|1|||
33299896|NCT04617275|100992200|FG002|Follow-up Period|Other|0|||
33299897|NCT04617275|100992201|FG003|Follow-up Period|Other|0|||
33299898|NCT04617275|100992202|FG004|Follow-up Period|Other|0|||
33299899|NCT04617275|100992203|FG005|Follow-up Period|Other|0|||
33299900|NCT04617275|100992204|FG006|Follow-up Period|Other|0|||
33299901|NCT04617275|100992205|FG007|Follow-up Period|Other|0|||
33299902|NCT04617275|100992198|FG000|Follow-up Period|Withdrawal by Subject|2|||
33299903|NCT04617275|100992199|FG001|Follow-up Period|Withdrawal by Subject|0|||
33299904|NCT04617275|100992200|FG002|Follow-up Period|Withdrawal by Subject|0|||
33299905|NCT04617275|100992201|FG003|Follow-up Period|Withdrawal by Subject|2|||
33299906|NCT04617275|100992202|FG004|Follow-up Period|Withdrawal by Subject|2|||
33299907|NCT04617275|100992203|FG005|Follow-up Period|Withdrawal by Subject|0|||
33299908|NCT04617275|100992204|FG006|Follow-up Period|Withdrawal by Subject|1|||
33299909|NCT04617275|100992205|FG007|Follow-up Period|Withdrawal by Subject|2|||
33299910|NCT00436605|100992206|FG000|Overall Study|Protocol Violation|3|||
33299911|NCT03117998|100992207|FG000|Overall Study|Adverse Event|1|||
33299912|NCT03117998|100992208|FG001|Overall Study|Adverse Event|0|||
33299913|NCT03117998|100992209|FG002|Overall Study|Adverse Event|0|||
33299914|NCT03117998|100992210|FG003|Overall Study|Adverse Event|0|||
33299915|NCT03117998|100992211|FG004|Overall Study|Adverse Event|0|||
33496759|NCT01962103|101710179|FG007|Phase 2|Progressive Disease|12|||
33496760|NCT01962103|101710180|FG008|Phase 2|Progressive Disease|11|||
33496761|NCT01962103|101710172|FG000|Phase 2|Symptomatic Deterioration|0|||
33496762|NCT01962103|101710173|FG001|Phase 2|Symptomatic Deterioration|0|||
33299916|NCT03117998|100992212|FG005|Overall Study|Adverse Event|0|||
33299917|NCT03117998|100992207|FG000|Overall Study|Withdrawal by Subject|0|||
33299918|NCT03117998|100992208|FG001|Overall Study|Withdrawal by Subject|0|||
33299919|NCT03117998|100992209|FG002|Overall Study|Withdrawal by Subject|2|||
33299920|NCT03117998|100992210|FG003|Overall Study|Withdrawal by Subject|3|||
33299921|NCT03117998|100992211|FG004|Overall Study|Withdrawal by Subject|3|||
33299922|NCT03117998|100992212|FG005|Overall Study|Withdrawal by Subject|0|||
33496763|NCT01962103|101710174|FG002|Phase 2|Symptomatic Deterioration|0|||
33496764|NCT01962103|101710175|FG003|Phase 2|Symptomatic Deterioration|0|||
33299923|NCT03117998|100992207|FG000|Overall Study|Physician Decision|0|||
33299924|NCT03117998|100992208|FG001|Overall Study|Physician Decision|1|||
33299925|NCT03117998|100992209|FG002|Overall Study|Physician Decision|1|||
33299926|NCT03117998|100992210|FG003|Overall Study|Physician Decision|0|||
33299927|NCT03117998|100992211|FG004|Overall Study|Physician Decision|0|||
33299928|NCT03117998|100992212|FG005|Overall Study|Physician Decision|0|||
33299929|NCT03117998|100992207|FG000|Overall Study|Lost to Follow-up|0|||
33299930|NCT03117998|100992208|FG001|Overall Study|Lost to Follow-up|0|||
33299931|NCT03117998|100992209|FG002|Overall Study|Lost to Follow-up|0|||
33299932|NCT03117998|100992210|FG003|Overall Study|Lost to Follow-up|1|||
33299933|NCT03117998|100992211|FG004|Overall Study|Lost to Follow-up|4|||
33299934|NCT03117998|100992212|FG005|Overall Study|Lost to Follow-up|0|||
33299935|NCT03117998|100992207|FG000|Overall Study|Subject noncompliance|0|||
33299936|NCT03117998|100992208|FG001|Overall Study|Subject noncompliance|0|||
33299937|NCT03117998|100992209|FG002|Overall Study|Subject noncompliance|1|||
33299938|NCT03117998|100992210|FG003|Overall Study|Subject noncompliance|0|||
33299939|NCT03117998|100992211|FG004|Overall Study|Subject noncompliance|0|||
33496765|NCT01962103|101710176|FG004|Phase 2|Symptomatic Deterioration|0|||
33496766|NCT01962103|101710177|FG005|Phase 2|Symptomatic Deterioration|0|||
33496767|NCT01962103|101710178|FG006|Phase 2|Symptomatic Deterioration|2|||
33496768|NCT01962103|101710179|FG007|Phase 2|Symptomatic Deterioration|2|||
33496769|NCT01962103|101710180|FG008|Phase 2|Symptomatic Deterioration|0|||
33496770|NCT01134939|101710181|FG000|Overall Study|Adverse Event|9|||
33496771|NCT01134939|101710182|FG001|Overall Study|Adverse Event|3|||
33496772|NCT01134939|101710183|FG002|Overall Study|Adverse Event|4|||
33496773|NCT01134939|101710184|FG003|Overall Study|Adverse Event|5|||
33496774|NCT01134939|101710185|FG004|Overall Study|Adverse Event|5|||
33600164|NCT05239221|102088529|FG014|Overall Study|Withdrawal by Subject|0|||
33299940|NCT03117998|100992212|FG005|Overall Study|Subject noncompliance|2|||
33299941|NCT03117998|100992207|FG000|Overall Study|Protocol Violation|0|||
33299942|NCT03117998|100992208|FG001|Overall Study|Protocol Violation|0|||
33299943|NCT03117998|100992209|FG002|Overall Study|Protocol Violation|0|||
33299944|NCT03117998|100992210|FG003|Overall Study|Protocol Violation|0|||
33299945|NCT03117998|100992211|FG004|Overall Study|Protocol Violation|0|||
33299946|NCT03117998|100992212|FG005|Overall Study|Protocol Violation|1|||
33299947|NCT01818531|100992230|FG000|Overall Study|Withdrawn for case delay after block|1|||
33299948|NCT01818531|100992231|FG001|Overall Study|Withdrawn for case delay after block|0|||
33299949|NCT01818531|100992230|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
33299950|NCT01818531|100992231|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
33299951|NCT01818531|100992230|FG000|Overall Study|Withdrawn for failure to place block|0|||
33299952|NCT01818531|100992231|FG001|Overall Study|Withdrawn for failure to place block|1|||
33299953|NCT02224703|100992233|FG000|Overall Study|Adverse Event|0|||
33299954|NCT02224703|100992234|FG001|Overall Study|Adverse Event|5|||
33299955|NCT02224703|100992235|FG002|Overall Study|Adverse Event|0|||
33299956|NCT02224703|100992233|FG000|Overall Study|Withdrawn by investigator|1|||
33299957|NCT02224703|100992234|FG001|Overall Study|Withdrawn by investigator|0|||
33299958|NCT02224703|100992235|FG002|Overall Study|Withdrawn by investigator|0|||
33299959|NCT02224703|100992233|FG000|Overall Study|Advised by medical monitor|1|||
33299960|NCT02224703|100992234|FG001|Overall Study|Advised by medical monitor|0|||
33299961|NCT02224703|100992235|FG002|Overall Study|Advised by medical monitor|0|||
33299962|NCT02224703|100992233|FG000|Overall Study|Withdrawn by parent/guardian|0|||
33299963|NCT02224703|100992234|FG001|Overall Study|Withdrawn by parent/guardian|1|||
33299964|NCT02224703|100992235|FG002|Overall Study|Withdrawn by parent/guardian|0|||
33299965|NCT02224703|100992233|FG000|Overall Study|Lack of Efficacy|1|||
33299966|NCT02224703|100992234|FG001|Overall Study|Lack of Efficacy|0|||
33299967|NCT02224703|100992235|FG002|Overall Study|Lack of Efficacy|0|||
33299968|NCT02597712|100992238|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
33299969|NCT02597712|100992239|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
33393467|NCT01102140|101328478|FG000|Overall Study|Investigator terminated study|2|||
33393468|NCT01102140|101328479|FG001|Overall Study|Investigator terminated study|2|||
33299970|NCT02597712|100992238|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
33299971|NCT02597712|100992239|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
33299972|NCT02597712|100992238|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
33299973|NCT02597712|100992239|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
33299974|NCT03752970|100992240|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
33299975|NCT03752970|100992241|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
33299976|NCT03752970|100992242|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
33299977|NCT03752970|100992240|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
33393469|NCT01899768|101328480|FG000|Part A|Adverse Event|2|||
33393470|NCT01899768|101328480|FG000|Part A|Withdrawal by Subject|1|||
33393471|NCT01899768|101328480|FG000|Part B|Adverse Event|1|||
33393472|NCT01899768|101328480|FG000|Part B|Withdrawal by Subject|1|||
33496775|NCT01134939|101710186|FG005|Overall Study|Adverse Event|5|||
33496776|NCT01134939|101710187|FG006|Overall Study|Adverse Event|1|||
33496777|NCT01134939|101710188|FG007|Overall Study|Adverse Event|0|||
33299978|NCT03752970|100992241|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
33299979|NCT03752970|100992242|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
33299980|NCT03752970|100992240|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
33299981|NCT03752970|100992241|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
33299982|NCT03752970|100992242|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
33299983|NCT03752970|100992240|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
33299984|NCT03752970|100992241|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
33299985|NCT03752970|100992242|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
33299986|NCT03752970|100992240|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
33299987|NCT03752970|100992241|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
33299988|NCT03752970|100992242|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
33299989|NCT01498887|100992243|FG000|Overall Study|Administrative problems|1|||
33299990|NCT01498887|100992244|FG001|Overall Study|Administrative problems|0|||
33190399|NCT02673775|100601658|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
33190400|NCT01786629|100601667|FG000|Overall Study|Lack of Efficacy|0|||
33190401|NCT01786629|100601668|FG001|Overall Study|Lack of Efficacy|4|||
33190402|NCT01786629|100601667|FG000|Overall Study|Adverse Event|0|||
33190403|NCT01786629|100601668|FG001|Overall Study|Adverse Event|1|||
33190404|NCT00436748|100601669|FG000|Overall Study|Ineligibility Determined|1|||
33190405|NCT00436748|100601670|FG001|Overall Study|Ineligibility Determined|1|||
33190406|NCT00436748|100601669|FG000|Overall Study|Adverse Event|0|||
33190407|NCT00436748|100601670|FG001|Overall Study|Adverse Event|2|||
33190408|NCT00436748|100601669|FG000|Overall Study|Consent Withdrawn|1|||
33190409|NCT00436748|100601670|FG001|Overall Study|Consent Withdrawn|4|||
33190410|NCT00436748|100601669|FG000|Overall Study|Administrative Decision|1|||
33190411|NCT00436748|100601670|FG001|Overall Study|Administrative Decision|0|||
33190412|NCT00436748|100601669|FG000|Overall Study|Lost to Follow-up|0|||
33190413|NCT00436748|100601670|FG001|Overall Study|Lost to Follow-up|1|||
33190414|NCT00436748|100601669|FG000|Overall Study|Protocol-specified Criteria|5|||
33190415|NCT00436748|100601670|FG001|Overall Study|Protocol-specified Criteria|4|||
33190416|NCT00436748|100601669|FG000|Overall Study|Other|3|||
33190417|NCT00436748|100601670|FG001|Overall Study|Other|0|||
33299991|NCT01498887|100992243|FG000|Overall Study|Lost to Follow-up|1|||
33190418|NCT00326612|100601675|FG000|Overall Study|They did not have a seizure requiring tx|129|||
33190419|NCT00326612|100601676|FG001|Overall Study|They did not have a seizure requiring tx|137|||
33190420|NCT01537783|100601680|FG000|Overall Study|Lost to Follow-up|11|||
33190421|NCT01537783|100601681|FG001|Overall Study|Lost to Follow-up|2|||
33190422|NCT02940691|100601684|FG000|Overall Study|Lost to Follow-up|5|||
33496778|NCT01134939|101710181|FG000|Overall Study|Lack of Efficacy|2|||
33496779|NCT01134939|101710182|FG001|Overall Study|Lack of Efficacy|5|||
33496780|NCT01134939|101710183|FG002|Overall Study|Lack of Efficacy|1|||
33496781|NCT01134939|101710184|FG003|Overall Study|Lack of Efficacy|0|||
33496782|NCT01134939|101710185|FG004|Overall Study|Lack of Efficacy|3|||
33496783|NCT01134939|101710186|FG005|Overall Study|Lack of Efficacy|0|||
33496784|NCT01134939|101710187|FG006|Overall Study|Lack of Efficacy|1|||
33496785|NCT01134939|101710188|FG007|Overall Study|Lack of Efficacy|0|||
33496786|NCT01134939|101710181|FG000|Overall Study|Lost to Follow-up|2|||
33496787|NCT01134939|101710182|FG001|Overall Study|Lost to Follow-up|3|||
33496788|NCT01134939|101710183|FG002|Overall Study|Lost to Follow-up|0|||
33496789|NCT01134939|101710184|FG003|Overall Study|Lost to Follow-up|1|||
33496790|NCT01134939|101710185|FG004|Overall Study|Lost to Follow-up|2|||
33496791|NCT01134939|101710186|FG005|Overall Study|Lost to Follow-up|1|||
33496792|NCT01134939|101710187|FG006|Overall Study|Lost to Follow-up|0|||
33496793|NCT01134939|101710188|FG007|Overall Study|Lost to Follow-up|0|||
33496794|NCT01134939|101710181|FG000|Overall Study|Death|0|||
33496795|NCT01134939|101710182|FG001|Overall Study|Death|1|||
33496796|NCT01134939|101710183|FG002|Overall Study|Death|0|||
33496797|NCT01134939|101710184|FG003|Overall Study|Death|0|||
33299992|NCT01498887|100992244|FG001|Overall Study|Lost to Follow-up|1|||
33299993|NCT01498887|100992243|FG000|Overall Study|Withdrawal by Subject|1|||
33299994|NCT01498887|100992244|FG001|Overall Study|Withdrawal by Subject|0|||
33299995|NCT01498887|100992243|FG000|Overall Study|Protocol Violation|1|||
33299996|NCT01498887|100992244|FG001|Overall Study|Protocol Violation|3|||
33299997|NCT01498887|100992243|FG000|Overall Study|Lack of Efficacy|5|||
33299998|NCT01498887|100992244|FG001|Overall Study|Lack of Efficacy|3|||
33299999|NCT01498887|100992243|FG000|Overall Study|Abnormal result from test procedure|1|||
33300000|NCT01498887|100992244|FG001|Overall Study|Abnormal result from test procedure|1|||
33300001|NCT01498887|100992243|FG000|Overall Study|Abnormal laboratory value|2|||
33300002|NCT01498887|100992244|FG001|Overall Study|Abnormal laboratory value|2|||
33300003|NCT01498887|100992243|FG000|Overall Study|Adverse Event|4|||
33300004|NCT01498887|100992244|FG001|Overall Study|Adverse Event|1|||
33300005|NCT04546425|100992245|FG000|Overall Study|Protocol Violation|1|||
33300006|NCT04546425|100992246|FG001|Overall Study|Protocol Violation|1|||
33300007|NCT04546425|100992247|FG002|Overall Study|Protocol Violation|0|||
33300008|NCT04546425|100992248|FG003|Overall Study|Protocol Violation|0|||
33300009|NCT04546425|100992245|FG000|Overall Study|Adverse Event|3|||
33300010|NCT04546425|100992246|FG001|Overall Study|Adverse Event|0|||
33300011|NCT04546425|100992247|FG002|Overall Study|Adverse Event|0|||
33300012|NCT04546425|100992248|FG003|Overall Study|Adverse Event|0|||
33300013|NCT04546425|100992245|FG000|Overall Study|Lost to Follow-up|5|||
33300014|NCT04546425|100992246|FG001|Overall Study|Lost to Follow-up|4|||
33300015|NCT04546425|100992247|FG002|Overall Study|Lost to Follow-up|0|||
33300016|NCT04546425|100992248|FG003|Overall Study|Lost to Follow-up|0|||
33300017|NCT04546425|100992245|FG000|Overall Study|No Longer met eligibility criteria|3|||
33300018|NCT04546425|100992246|FG001|Overall Study|No Longer met eligibility criteria|3|||
33300019|NCT04546425|100992247|FG002|Overall Study|No Longer met eligibility criteria|1|||
33300020|NCT04546425|100992248|FG003|Overall Study|No Longer met eligibility criteria|1|||
33300021|NCT04546425|100992245|FG000|Overall Study|Withdrawal by parent/guardian|6|||
33300022|NCT04546425|100992246|FG001|Overall Study|Withdrawal by parent/guardian|5|||
33300023|NCT04546425|100992247|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33300024|NCT04546425|100992248|FG003|Overall Study|Withdrawal by parent/guardian|1|||
33300025|NCT02088957|100992250|FG000|Overall Study|Lack of Efficacy|1|||
33300026|NCT02088957|100992251|FG001|Overall Study|Lack of Efficacy|0|||
33300027|NCT01607879|100992254|FG000|Overall Study|Death|1|||
33300028|NCT01607879|100992255|FG001|Overall Study|Death|0|||
33300029|NCT01559129|100992257|FG000|Treatment Phase|Adverse Event|0|||
33300030|NCT01559129|100992258|FG001|Treatment Phase|Adverse Event|2|||
33300031|NCT01559129|100992257|FG000|Treatment Phase|Progressive Disease|1|||
33300032|NCT01559129|100992258|FG001|Treatment Phase|Progressive Disease|1|||
33300033|NCT01559129|100992257|FG000|Treatment Phase|Lack of Efficacy|0|||
33300034|NCT01559129|100992258|FG001|Treatment Phase|Lack of Efficacy|1|||
33300035|NCT01559129|100992257|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
33300036|NCT01559129|100992258|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
33300037|NCT01559129|100992257|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
33300038|NCT01559129|100992258|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
33496798|NCT01134939|101710185|FG004|Overall Study|Death|0|||
33496799|NCT01134939|101710186|FG005|Overall Study|Death|0|||
33300039|NCT01559129|100992257|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
33300040|NCT01559129|100992258|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
33300041|NCT01559129|100992257|FG000|Open-label Extension Period|Adverse Event|1|||
33300042|NCT01559129|100992258|FG001|Open-label Extension Period|Adverse Event|0|||
33300043|NCT01559129|100992257|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
33300044|NCT01559129|100992258|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
33496800|NCT01134939|101710187|FG006|Overall Study|Death|0|||
33496801|NCT01134939|101710188|FG007|Overall Study|Death|0|||
33496802|NCT01134939|101710181|FG000|Overall Study|Termination page not available|4|||
33300045|NCT00515671|100992259|FG000|Overall Study|Lost to Follow-up|13|||
33300046|NCT00515671|100992260|FG001|Overall Study|Lost to Follow-up|10|||
33300047|NCT00515671|100992259|FG000|Overall Study|Withdrawal by Subject|3|||
33300048|NCT00515671|100992260|FG001|Overall Study|Withdrawal by Subject|5|||
33300049|NCT00515671|100992259|FG000|Overall Study|incarcerated|1|||
33300050|NCT00515671|100992260|FG001|Overall Study|incarcerated|2|||
33300051|NCT00974259|100992263|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
33300052|NCT00974259|100992264|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
33300053|NCT00283244|100992265|FG000|Overall Study|Adverse Event|0|||
33300054|NCT00283244|100992266|FG001|Overall Study|Adverse Event|8|||
33300055|NCT00283244|100992267|FG002|Overall Study|Adverse Event|11|||
33300056|NCT00283244|100992265|FG000|Overall Study|Death|4|||
33300057|NCT00283244|100992266|FG001|Overall Study|Death|3|||
33300058|NCT00283244|100992267|FG002|Overall Study|Death|2|||
33300059|NCT00283244|100992265|FG000|Overall Study|Lack of Efficacy|8|||
33300060|NCT00283244|100992266|FG001|Overall Study|Lack of Efficacy|32|||
33300061|NCT00283244|100992267|FG002|Overall Study|Lack of Efficacy|26|||
33300062|NCT00283244|100992265|FG000|Overall Study|Withdrawal by Subject|1|||
33300063|NCT00283244|100992266|FG001|Overall Study|Withdrawal by Subject|2|||
33300064|NCT00283244|100992267|FG002|Overall Study|Withdrawal by Subject|2|||
33300065|NCT00283244|100992265|FG000|Overall Study|Physician Decision|0|||
33300066|NCT00283244|100992266|FG001|Overall Study|Physician Decision|0|||
33300067|NCT00283244|100992267|FG002|Overall Study|Physician Decision|1|||
33300068|NCT00283244|100992265|FG000|Overall Study|Medical illness (other complicating dz)|4|||
33300069|NCT00283244|100992266|FG001|Overall Study|Medical illness (other complicating dz)|3|||
33300070|NCT00283244|100992267|FG002|Overall Study|Medical illness (other complicating dz)|6|||
33300071|NCT00283244|100992265|FG000|Overall Study|Clinical deterioration|1|||
33300072|NCT00283244|100992266|FG001|Overall Study|Clinical deterioration|3|||
33300073|NCT00283244|100992267|FG002|Overall Study|Clinical deterioration|3|||
33300074|NCT00568178|100992268|FG000|Double Blind Base Study|Adverse Event|0|||
33300075|NCT00568178|100992269|FG001|Double Blind Base Study|Adverse Event|2|||
33300076|NCT00568178|100992270|FG002|Double Blind Base Study|Adverse Event|1|||
33300077|NCT00568178|100992271|FG003|Double Blind Base Study|Adverse Event|2|||
33300078|NCT00568178|100992272|FG004|Double Blind Base Study|Adverse Event|0|||
33300079|NCT00568178|100992273|FG005|Double Blind Base Study|Adverse Event|0|||
33300080|NCT00568178|100992268|FG000|Double Blind Base Study|Lost to Follow-up|1|||
33300081|NCT00568178|100992269|FG001|Double Blind Base Study|Lost to Follow-up|0|||
33300082|NCT00568178|100992270|FG002|Double Blind Base Study|Lost to Follow-up|0|||
33300083|NCT00568178|100992271|FG003|Double Blind Base Study|Lost to Follow-up|1|||
33300084|NCT00568178|100992272|FG004|Double Blind Base Study|Lost to Follow-up|0|||
33300085|NCT00568178|100992273|FG005|Double Blind Base Study|Lost to Follow-up|0|||
33300086|NCT00568178|100992268|FG000|Double Blind Base Study|Physician Decision|1|||
33300087|NCT00568178|100992269|FG001|Double Blind Base Study|Physician Decision|1|||
33300088|NCT00568178|100992270|FG002|Double Blind Base Study|Physician Decision|0|||
33300089|NCT00568178|100992271|FG003|Double Blind Base Study|Physician Decision|1|||
33300090|NCT00568178|100992272|FG004|Double Blind Base Study|Physician Decision|0|||
33300091|NCT00568178|100992273|FG005|Double Blind Base Study|Physician Decision|0|||
33300092|NCT00568178|100992268|FG000|Double Blind Base Study|Protocol Violation|3|||
33300093|NCT00568178|100992269|FG001|Double Blind Base Study|Protocol Violation|2|||
33300094|NCT00568178|100992270|FG002|Double Blind Base Study|Protocol Violation|0|||
33300095|NCT00568178|100992271|FG003|Double Blind Base Study|Protocol Violation|0|||
33300096|NCT00568178|100992272|FG004|Double Blind Base Study|Protocol Violation|0|||
33300097|NCT00568178|100992273|FG005|Double Blind Base Study|Protocol Violation|0|||
33300098|NCT00568178|100992268|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
33300099|NCT00568178|100992269|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
33300100|NCT00568178|100992270|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
33300101|NCT00568178|100992271|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
33393473|NCT03424044|101328484|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33190423|NCT02940691|100601684|FG000|Overall Study|Incarceration|1|||
33300102|NCT00568178|100992272|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
33300103|NCT00568178|100992273|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
33300104|NCT00568178|100992268|FG000|Double Blind Base Study|Progressive Disease|0|||
33300105|NCT00568178|100992269|FG001|Double Blind Base Study|Progressive Disease|0|||
33300106|NCT00568178|100992270|FG002|Double Blind Base Study|Progressive Disease|0|||
33300107|NCT00568178|100992271|FG003|Double Blind Base Study|Progressive Disease|1|||
33300108|NCT00568178|100992272|FG004|Double Blind Base Study|Progressive Disease|0|||
33300109|NCT00568178|100992273|FG005|Double Blind Base Study|Progressive Disease|0|||
33300110|NCT00568178|100992268|FG000|Open Label Extension|Adverse Event|0|||
33300111|NCT00568178|100992269|FG001|Open Label Extension|Adverse Event|0|||
33300112|NCT00568178|100992270|FG002|Open Label Extension|Adverse Event|0|||
33496803|NCT01134939|101710182|FG001|Overall Study|Termination page not available|6|||
33496804|NCT01134939|101710183|FG002|Overall Study|Termination page not available|5|||
33496805|NCT01134939|101710184|FG003|Overall Study|Termination page not available|8|||
33496806|NCT01134939|101710185|FG004|Overall Study|Termination page not available|0|||
33496807|NCT01134939|101710186|FG005|Overall Study|Termination page not available|3|||
33496808|NCT01134939|101710187|FG006|Overall Study|Termination page not available|7|||
33496809|NCT01134939|101710188|FG007|Overall Study|Termination page not available|0|||
33496810|NCT04537078|101710189|FG000|Overall Study|Protocol Violation|3|||
33496811|NCT04537078|101710190|FG001|Overall Study|Protocol Violation|2|||
33496812|NCT04537078|101710189|FG000|Overall Study|Lost to Follow-up|1|||
33496813|NCT04537078|101710190|FG001|Overall Study|Lost to Follow-up|0|||
33496814|NCT04537078|101710189|FG000|Overall Study|Withdrawal by Subject|0|||
33496815|NCT04537078|101710190|FG001|Overall Study|Withdrawal by Subject|1|||
33496816|NCT00793871|101710199|FG000|Overall Study|Death|50|||
33496817|NCT00793871|101710199|FG000|Overall Study|Lost to Follow-up|3|||
33496818|NCT00793871|101710199|FG000|Overall Study|Study terminated by the Sponsor|7|||
33496819|NCT03313180|101710200|FG000|Overall Study|Adverse Event|120|||
33496820|NCT03313180|101710200|FG000|Overall Study|Lost to Follow-up|3|||
33496821|NCT03313180|101710200|FG000|Overall Study|Withdrawal by Subject|39|||
33496822|NCT03313180|101710200|FG000|Overall Study|Other than listed above|15|||
33496823|NCT03313180|101710200|FG000|Overall Study|Covid-19 related|2|||
33496824|NCT00722137|101710203|FG000|Overall Study|Overt Disease Progression|5|||
33496825|NCT00722137|101710204|FG001|Overall Study|Overt Disease Progression|4|||
33496826|NCT00722137|101710203|FG000|Overall Study|Adverse Event|17|||
33496827|NCT00722137|101710204|FG001|Overall Study|Adverse Event|21|||
33496828|NCT00722137|101710203|FG000|Overall Study|Death|12|||
33496829|NCT00722137|101710204|FG001|Overall Study|Death|7|||
33496830|NCT00722137|101710203|FG000|Overall Study|Withdrawal by Subject|6|||
33496831|NCT00722137|101710204|FG001|Overall Study|Withdrawal by Subject|9|||
33300113|NCT00568178|100992271|FG003|Open Label Extension|Adverse Event|0|||
33300114|NCT00568178|100992272|FG004|Open Label Extension|Adverse Event|11|||
33300115|NCT00568178|100992273|FG005|Open Label Extension|Adverse Event|8|||
33300116|NCT00568178|100992268|FG000|Open Label Extension|Protocol Violation|0|||
33300117|NCT00568178|100992269|FG001|Open Label Extension|Protocol Violation|0|||
33300118|NCT00568178|100992270|FG002|Open Label Extension|Protocol Violation|0|||
33300119|NCT00568178|100992271|FG003|Open Label Extension|Protocol Violation|0|||
33300120|NCT00568178|100992272|FG004|Open Label Extension|Protocol Violation|1|||
33300121|NCT00568178|100992273|FG005|Open Label Extension|Protocol Violation|0|||
33300122|NCT00568178|100992268|FG000|Open Label Extension|Lost to Follow-up|0|||
33300123|NCT00568178|100992269|FG001|Open Label Extension|Lost to Follow-up|0|||
33300124|NCT00568178|100992270|FG002|Open Label Extension|Lost to Follow-up|0|||
33300125|NCT00568178|100992271|FG003|Open Label Extension|Lost to Follow-up|0|||
33300126|NCT00568178|100992272|FG004|Open Label Extension|Lost to Follow-up|6|||
33300127|NCT00568178|100992273|FG005|Open Label Extension|Lost to Follow-up|11|||
33300128|NCT00568178|100992268|FG000|Open Label Extension|Physician Decision|0|||
33300129|NCT00568178|100992269|FG001|Open Label Extension|Physician Decision|0|||
33300130|NCT00568178|100992270|FG002|Open Label Extension|Physician Decision|0|||
33300131|NCT00568178|100992271|FG003|Open Label Extension|Physician Decision|0|||
33300132|NCT00568178|100992272|FG004|Open Label Extension|Physician Decision|9|||
33300133|NCT00568178|100992273|FG005|Open Label Extension|Physician Decision|8|||
33300134|NCT00568178|100992268|FG000|Open Label Extension|Pregnancy|0|||
33300135|NCT00568178|100992269|FG001|Open Label Extension|Pregnancy|0|||
33300136|NCT00568178|100992270|FG002|Open Label Extension|Pregnancy|0|||
33300137|NCT00568178|100992271|FG003|Open Label Extension|Pregnancy|0|||
33300138|NCT00568178|100992272|FG004|Open Label Extension|Pregnancy|0|||
33300139|NCT00568178|100992273|FG005|Open Label Extension|Pregnancy|1|||
33300140|NCT00568178|100992268|FG000|Open Label Extension|Progressive Disease|0|||
33300141|NCT00568178|100992269|FG001|Open Label Extension|Progressive Disease|0|||
33300142|NCT00568178|100992270|FG002|Open Label Extension|Progressive Disease|0|||
33300143|NCT00568178|100992271|FG003|Open Label Extension|Progressive Disease|0|||
33300144|NCT00568178|100992272|FG004|Open Label Extension|Progressive Disease|3|||
33300145|NCT00568178|100992273|FG005|Open Label Extension|Progressive Disease|1|||
33300146|NCT00568178|100992268|FG000|Open Label Extension|Termination of Trial|0|||
33300147|NCT00568178|100992269|FG001|Open Label Extension|Termination of Trial|0|||
33300148|NCT00568178|100992270|FG002|Open Label Extension|Termination of Trial|0|||
33300149|NCT00568178|100992271|FG003|Open Label Extension|Termination of Trial|0|||
33496832|NCT00722137|101710203|FG000|Overall Study|Other Reason Unknown|3|||
33496833|NCT00722137|101710204|FG001|Overall Study|Other Reason Unknown|4|||
33300150|NCT00568178|100992272|FG004|Open Label Extension|Termination of Trial|45|||
33300151|NCT00568178|100992273|FG005|Open Label Extension|Termination of Trial|47|||
33300152|NCT00568178|100992268|FG000|Open Label Extension|Withdrawal by Subject|0|||
33300153|NCT00568178|100992269|FG001|Open Label Extension|Withdrawal by Subject|0|||
33496834|NCT00722137|101710203|FG000|Overall Study|Randomized But Not Treated|2|||
33496835|NCT00722137|101710204|FG001|Overall Study|Randomized But Not Treated|3|||
33300154|NCT00568178|100992270|FG002|Open Label Extension|Withdrawal by Subject|0|||
33300155|NCT00568178|100992271|FG003|Open Label Extension|Withdrawal by Subject|0|||
33300156|NCT00568178|100992272|FG004|Open Label Extension|Withdrawal by Subject|4|||
33300157|NCT00568178|100992273|FG005|Open Label Extension|Withdrawal by Subject|4|||
33300158|NCT00635661|100992274|FG000|Overall Study|Withdrawal by Subject|4|||
33300159|NCT03846453|100992275|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
33300160|NCT03846453|100992276|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
33300161|NCT03846453|100992277|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
33300162|NCT03846453|100992275|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
33300163|NCT03846453|100992276|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
33300164|NCT03846453|100992277|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
33300165|NCT03846453|100992275|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
33300166|NCT03846453|100992276|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
33300167|NCT03846453|100992277|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
33300168|NCT03846453|100992275|FG000|Placebo Run-in (14 Days)|Other|2|||
33300169|NCT03846453|100992276|FG001|Placebo Run-in (14 Days)|Other|0|||
33300170|NCT03846453|100992277|FG002|Placebo Run-in (14 Days)|Other|0|||
33300171|NCT03846453|100992275|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
33300172|NCT03846453|100992276|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
33300173|NCT03846453|100992277|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
33300174|NCT03846453|100992275|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
33300175|NCT03846453|100992276|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
33300176|NCT03846453|100992277|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
33300177|NCT03846453|100992275|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
33300178|NCT03846453|100992276|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
33300179|NCT03846453|100992277|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
33300180|NCT03846453|100992275|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
33300181|NCT03846453|100992276|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
33300182|NCT03846453|100992277|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
33300183|NCT03846453|100992275|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
33300184|NCT03846453|100992276|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
33300185|NCT03846453|100992277|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
33300186|NCT01461811|100992278|FG000|Overall Study|Adverse Event|2|||
33300187|NCT01461811|100992279|FG001|Overall Study|Adverse Event|1|||
33300188|NCT01461811|100992278|FG000|Overall Study|Subject decision unrelated to an AE|1|||
33300189|NCT01461811|100992279|FG001|Overall Study|Subject decision unrelated to an AE|1|||
33300190|NCT01461811|100992278|FG000|Overall Study|Noncompliance|1|||
33300191|NCT01461811|100992279|FG001|Overall Study|Noncompliance|1|||
33300192|NCT01865747|100992280|FG000|Overall Study (ITT)|Adverse Event|32|||
33300193|NCT01865747|100992281|FG001|Overall Study (ITT)|Adverse Event|31|||
33300194|NCT01865747|100992280|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
33300195|NCT01865747|100992281|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
33300196|NCT01865747|100992280|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
33300197|NCT01865747|100992281|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
33300198|NCT01865747|100992280|FG000|Overall Study (ITT)|Protocol Violation|1|||
33300199|NCT01865747|100992281|FG001|Overall Study (ITT)|Protocol Violation|1|||
33496836|NCT03351608|101710205|FG000|Overall Study|Lost to Follow-up|0|||
33300200|NCT01865747|100992280|FG000|Overall Study (ITT)|Physician Decision|5|||
33300201|NCT01865747|100992281|FG001|Overall Study (ITT)|Physician Decision|2|||
33300202|NCT01865747|100992280|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
33300203|NCT01865747|100992281|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
33300204|NCT01865747|100992280|FG000|Overall Study (ITT)|Sponsor Decision|0|||
33300205|NCT01865747|100992281|FG001|Overall Study (ITT)|Sponsor Decision|1|||
33300206|NCT01865747|100992280|FG000|Overall Study (ITT)|Progressive Disease|122|||
33300207|NCT01865747|100992281|FG001|Overall Study (ITT)|Progressive Disease|158|||
33300208|NCT01865747|100992280|FG000|Overall Study (ITT)|Reason Not Provided|0|||
33300209|NCT01865747|100992281|FG001|Overall Study (ITT)|Reason Not Provided|1|||
33300210|NCT01865747|100992280|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
33300211|NCT01865747|100992281|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
33300212|NCT01865747|100992280|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
33300213|NCT01865747|100992281|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
33300214|NCT01865747|100992280|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
33300215|NCT01865747|100992281|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
33300216|NCT01865747|100992280|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
33300217|NCT01865747|100992281|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
33300218|NCT01865747|100992280|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
33496837|NCT03351608|101710206|FG001|Overall Study|Lost to Follow-up|1|||
33496838|NCT03351608|101710207|FG002|Overall Study|Lost to Follow-up|1|||
33300219|NCT01865747|100992281|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
33300220|NCT01865747|100992280|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
33496839|NCT03351608|101710208|FG003|Overall Study|Lost to Follow-up|1|||
33300221|NCT01865747|100992281|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
33300222|NCT01865747|100992280|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
33300223|NCT01865747|100992281|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
33496840|NCT03351608|101710209|FG004|Overall Study|Lost to Follow-up|1|||
33496841|NCT03351608|101710205|FG000|Overall Study|Physician Decision|1|||
33496842|NCT03351608|101710206|FG001|Overall Study|Physician Decision|0|||
33496843|NCT03351608|101710207|FG002|Overall Study|Physician Decision|0|||
33496844|NCT03351608|101710208|FG003|Overall Study|Physician Decision|2|||
33496845|NCT03351608|101710209|FG004|Overall Study|Physician Decision|1|||
33496846|NCT03351608|101710205|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
33496847|NCT03351608|101710206|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
33496848|NCT03351608|101710207|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
33496849|NCT03351608|101710208|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
33496850|NCT03351608|101710209|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
33496851|NCT03351608|101710205|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33496852|NCT03351608|101710206|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33496853|NCT03351608|101710207|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33496854|NCT03351608|101710208|FG003|Overall Study|Withdrawal by parent/guardian|1|||
33496855|NCT03351608|101710209|FG004|Overall Study|Withdrawal by parent/guardian|0|||
33496856|NCT03351608|101710205|FG000|Overall Study|Other|0|||
33496857|NCT03351608|101710206|FG001|Overall Study|Other|1|||
33496858|NCT03351608|101710207|FG002|Overall Study|Other|1|||
33496859|NCT03351608|101710208|FG003|Overall Study|Other|3|||
33496860|NCT03351608|101710209|FG004|Overall Study|Other|0|||
33300224|NCT01865747|100992280|FG000|Primary Intent to Treat (PITT)|Other|0|||
33300225|NCT01865747|100992281|FG001|Primary Intent to Treat (PITT)|Other|1|||
33300226|NCT02510040|100992282|FG000|Overall Study|Deemed no longer eligible|18|||
33300227|NCT02510040|100992283|FG001|Overall Study|Deemed no longer eligible|3|||
33300228|NCT02510040|100992284|FG002|Overall Study|Deemed no longer eligible|1|||
33300229|NCT02731690|100992285|FG000|Overall Study|Adverse Event|1|||
33300230|NCT02731690|100992285|FG000|Overall Study|Withdrawal by Subject|3|||
33300231|NCT02731690|100992285|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
33300232|NCT01245140|100992286|FG000|Overall Study|Adverse Event|1|||
33300233|NCT01245140|100992287|FG001|Overall Study|Adverse Event|3|||
33300234|NCT01245140|100992286|FG000|Overall Study|Lack of Efficacy|2|||
33300235|NCT01245140|100992287|FG001|Overall Study|Lack of Efficacy|4|||
33300236|NCT01245140|100992286|FG000|Overall Study|Protocol Violation|0|||
33300237|NCT01245140|100992287|FG001|Overall Study|Protocol Violation|1|||
33300238|NCT01245140|100992286|FG000|Overall Study|Withdrawal by Subject|0|||
33300239|NCT01245140|100992287|FG001|Overall Study|Withdrawal by Subject|1|||
33300240|NCT01245140|100992286|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
33300241|NCT01245140|100992287|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
33300242|NCT04157400|100996156|FG000|Overall Study|Withdrawal by Subject|1|||
33300243|NCT04157400|100996156|FG000|Overall Study|Lost to Follow-up|3|||
33300244|NCT00233480|100996158|FG000|Overall Study|Underwent status II heart transplant|0|||
33300245|NCT00233480|100996159|FG001|Overall Study|Underwent status II heart transplant|1|||
33300246|NCT03480932|100996160|FG000|Overall Study|Death|1|||
33300247|NCT03480932|100996161|FG001|Overall Study|Death|1|||
33300248|NCT03480932|100996162|FG002|Overall Study|Death|0|||
33300249|NCT03480932|100996160|FG000|Overall Study|Lost to Follow-up|0|||
33300250|NCT03480932|100996161|FG001|Overall Study|Lost to Follow-up|2|||
33300251|NCT03480932|100996162|FG002|Overall Study|Lost to Follow-up|3|||
33300252|NCT03480932|100996160|FG000|Overall Study|Incarcerated|2|||
33300253|NCT03480932|100996161|FG001|Overall Study|Incarcerated|2|||
33300254|NCT03480932|100996162|FG002|Overall Study|Incarcerated|2|||
33300255|NCT02546921|100996163|FG000|Overall Study|Adverse Event|0|||
33496861|NCT02857816|101710218|FG000|Overall Study|Screen Failure|33|||
33496862|NCT02857816|101710218|FG000|Overall Study|Withdrawal by Subject|4|||
33496863|NCT02857816|101710218|FG000|Overall Study|Lost to Follow-up|1|||
33496864|NCT00391768|101710219|FG000|Overall Study|Withdrawal by Subject|0|||
33496865|NCT00391768|101710220|FG001|Overall Study|Withdrawal by Subject|0|||
33496866|NCT00391768|101710221|FG002|Overall Study|Withdrawal by Subject|1|||
33496867|NCT00391768|101710222|FG003|Overall Study|Withdrawal by Subject|0|||
33496868|NCT00391768|101710223|FG004|Overall Study|Withdrawal by Subject|0|||
33496869|NCT00391768|101710224|FG005|Overall Study|Withdrawal by Subject|1|||
33496870|NCT00391768|101710225|FG006|Overall Study|Withdrawal by Subject|1|||
33190424|NCT00213148|100601685|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
33300256|NCT02546921|100996164|FG001|Overall Study|Adverse Event|5|||
33300257|NCT02546921|100996165|FG002|Overall Study|Adverse Event|2|||
33300258|NCT02546921|100996166|FG003|Overall Study|Adverse Event|0|||
33300259|NCT02546921|100996167|FG004|Overall Study|Adverse Event|0|||
33300260|NCT02546921|100996168|FG005|Overall Study|Adverse Event|0|||
33300261|NCT02546921|100996169|FG006|Overall Study|Adverse Event|0|||
33300262|NCT02546921|100996163|FG000|Overall Study|Evidence of Disease Progression|1|||
33496871|NCT00391768|101710219|FG000|Overall Study|Lost to Follow-up|0|||
33496872|NCT00391768|101710220|FG001|Overall Study|Lost to Follow-up|0|||
33496873|NCT00391768|101710221|FG002|Overall Study|Lost to Follow-up|0|||
33496874|NCT00391768|101710222|FG003|Overall Study|Lost to Follow-up|1|||
33496875|NCT00391768|101710223|FG004|Overall Study|Lost to Follow-up|2|||
33496876|NCT00391768|101710224|FG005|Overall Study|Lost to Follow-up|2|||
33496877|NCT00391768|101710225|FG006|Overall Study|Lost to Follow-up|3|||
33496878|NCT03751098|101710226|FG000|Overall Study|Withdrawal by Subject|0|||
33496879|NCT03751098|101710227|FG001|Overall Study|Withdrawal by Subject|1|||
33496880|NCT01787292|101710236|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
33496881|NCT01787292|101710237|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
33496882|NCT01787292|101710236|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
33496883|NCT01787292|101710237|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
33496884|NCT04871776|101710238|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
33496885|NCT04871776|101710239|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
33496886|NCT04871776|101710240|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
33496887|NCT04871776|101710238|FG000|Overall Study|Did not meet eligibility criteria|1|||
33496888|NCT04871776|101710239|FG001|Overall Study|Did not meet eligibility criteria|1|||
33496889|NCT04871776|101710240|FG002|Overall Study|Did not meet eligibility criteria|1|||
33496890|NCT01198470|101713760|FG000|Overall Study|Adverse Event|2|||
33496891|NCT01791894|101713761|FG000|Overall Study|Adverse Event|1|||
33496892|NCT02946463|101713767|FG000|Primary Evaluation Period|Physician Decision|0|||
33496893|NCT02946463|101713768|FG001|Primary Evaluation Period|Physician Decision|1|||
33496894|NCT02946463|101713769|FG002|Primary Evaluation Period|Physician Decision|0|||
33496895|NCT02946463|101713770|FG003|Primary Evaluation Period|Physician Decision|0|||
33496896|NCT02946463|101713767|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
33496897|NCT02946463|101713768|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
33496898|NCT02946463|101713769|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
33496899|NCT02946463|101713770|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
33496900|NCT02946463|101713767|FG000|Extension Period|Death|4|||
33496901|NCT02946463|101713768|FG001|Extension Period|Death|4|||
33496902|NCT02946463|101713769|FG002|Extension Period|Death|0|||
33496903|NCT02946463|101713770|FG003|Extension Period|Death|0|||
33496904|NCT02946463|101713767|FG000|Extension Period|Withdrawal by Subject|4|||
33496905|NCT02946463|101713768|FG001|Extension Period|Withdrawal by Subject|3|||
33496906|NCT02946463|101713769|FG002|Extension Period|Withdrawal by Subject|0|||
33496907|NCT02946463|101713770|FG003|Extension Period|Withdrawal by Subject|0|||
33190425|NCT00213148|100601686|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
33190426|NCT00213148|100601687|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
33190427|NCT00213148|100601688|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
33300263|NCT02546921|100996164|FG001|Overall Study|Evidence of Disease Progression|0|||
33393474|NCT03424044|101328485|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33496908|NCT02946463|101713767|FG000|Extension Period|Other than specified|2|||
33496909|NCT02946463|101713768|FG001|Extension Period|Other than specified|3|||
33600165|NCT05239221|102088530|FG015|Overall Study|Withdrawal by Subject|1|||
33600166|NCT01414205|102088531|FG000|Overall Study|Death|5|||
33600167|NCT01414205|102088532|FG001|Overall Study|Death|1|||
33600168|NCT01414205|102088531|FG000|Overall Study|Lost to Follow-up|1|||
33600169|NCT01414205|102088532|FG001|Overall Study|Lost to Follow-up|4|||
33600170|NCT01414205|102088531|FG000|Overall Study|Physician Decision|0|||
33600171|NCT01414205|102088532|FG001|Overall Study|Physician Decision|1|||
33600172|NCT01414205|102088531|FG000|Overall Study|Randomized but not Treated|1|||
33600173|NCT01414205|102088532|FG001|Overall Study|Randomized but not Treated|1|||
33600174|NCT03242772|102088536|FG000|Overall Study|Lost to Follow-up|2|||
33600175|NCT03242772|102088537|FG001|Overall Study|Lost to Follow-up|0|||
33600176|NCT03242772|102088536|FG000|Overall Study|Physician Decision|0|||
33600177|NCT03242772|102088537|FG001|Overall Study|Physician Decision|1|||
33600178|NCT03242772|102088536|FG000|Overall Study|Withdrawal by Subject|1|||
33600179|NCT03242772|102088537|FG001|Overall Study|Withdrawal by Subject|0|||
33600180|NCT02914548|102088538|FG000|Overall Study|Adverse Event|15|||
33600181|NCT02914548|102088539|FG001|Overall Study|Adverse Event|7|||
33600182|NCT02914548|102088540|FG002|Overall Study|Adverse Event|15|||
33600183|NCT02914548|102088538|FG000|Overall Study|Physician Decision|2|||
33300264|NCT02546921|100996165|FG002|Overall Study|Evidence of Disease Progression|0|||
33300265|NCT02546921|100996166|FG003|Overall Study|Evidence of Disease Progression|0|||
33300266|NCT02546921|100996167|FG004|Overall Study|Evidence of Disease Progression|1|||
33300267|NCT02546921|100996168|FG005|Overall Study|Evidence of Disease Progression|0|||
33300268|NCT02546921|100996169|FG006|Overall Study|Evidence of Disease Progression|0|||
33300269|NCT02546921|100996163|FG000|Overall Study|Patient Choice|0|||
33300270|NCT02546921|100996164|FG001|Overall Study|Patient Choice|1|||
33300271|NCT02546921|100996165|FG002|Overall Study|Patient Choice|0|||
33300272|NCT02546921|100996166|FG003|Overall Study|Patient Choice|0|||
33300273|NCT02546921|100996167|FG004|Overall Study|Patient Choice|0|||
33300274|NCT02546921|100996168|FG005|Overall Study|Patient Choice|1|||
33300275|NCT02546921|100996169|FG006|Overall Study|Patient Choice|0|||
33300276|NCT02310100|100996173|FG000|Overall Study|Physician Decision|3|||
33300277|NCT02310100|100996173|FG000|Overall Study|Withdrawal by Subject|10|||
33300278|NCT02310100|100996173|FG000|Overall Study|Enrollment closure|1|||
33300279|NCT02310100|100996173|FG000|Overall Study|Unapproved ablation operator|1|||
33300280|NCT02310100|100996173|FG000|Overall Study|Visit compliance|1|||
33300281|NCT02310100|100996173|FG000|Overall Study|Lost to Follow-up|2|||
33300282|NCT04531098|100996174|FG000|Stage I|Adverse Event|0|||
33300283|NCT04531098|100996175|FG001|Stage I|Adverse Event|0|||
33300284|NCT04531098|100996176|FG002|Stage I|Adverse Event|3|||
33300285|NCT04531098|100996174|FG000|Stage I|Protocol Violation|0|||
33300286|NCT04531098|100996175|FG001|Stage I|Protocol Violation|0|||
33300287|NCT04531098|100996176|FG002|Stage I|Protocol Violation|5|||
33300288|NCT04531098|100996174|FG000|Stage I|Withdrawal by Subject|0|||
33300289|NCT04531098|100996175|FG001|Stage I|Withdrawal by Subject|5|||
33300290|NCT04531098|100996176|FG002|Stage I|Withdrawal by Subject|10|||
33300291|NCT04531098|100996174|FG000|Stage II|Adverse Event|1|||
33300292|NCT04531098|100996175|FG001|Stage II|Adverse Event|2|||
33300293|NCT04531098|100996176|FG002|Stage II|Adverse Event|0|||
33300294|NCT04531098|100996174|FG000|Stage II|Protocol Violation|1|||
33300295|NCT04531098|100996175|FG001|Stage II|Protocol Violation|2|||
33300296|NCT04531098|100996176|FG002|Stage II|Protocol Violation|0|||
33300297|NCT04531098|100996174|FG000|Stage II|Withdrawal by Subject|3|||
33300298|NCT04531098|100996175|FG001|Stage II|Withdrawal by Subject|1|||
33300299|NCT04531098|100996176|FG002|Stage II|Withdrawal by Subject|0|||
33300300|NCT04531098|100996174|FG000|Stage II|Moved from study area|8|||
33300301|NCT04531098|100996175|FG001|Stage II|Moved from study area|5|||
33300302|NCT04531098|100996176|FG002|Stage II|Moved from study area|0|||
33300303|NCT04276415|100996178|FG000|Overall Study|Adverse Event|0|||
33300304|NCT04276415|100996179|FG001|Overall Study|Adverse Event|0|||
33300305|NCT04276415|100996180|FG002|Overall Study|Adverse Event|0|||
33300306|NCT04276415|100996181|FG003|Overall Study|Adverse Event|3|||
33300307|NCT04276415|100996182|FG004|Overall Study|Adverse Event|0|||
33300308|NCT04276415|100996183|FG005|Overall Study|Adverse Event|0|||
33300309|NCT04276415|100996178|FG000|Overall Study|Clinical progression|1|||
33300310|NCT04276415|100996179|FG001|Overall Study|Clinical progression|1|||
33300311|NCT04276415|100996180|FG002|Overall Study|Clinical progression|0|||
33300312|NCT04276415|100996181|FG003|Overall Study|Clinical progression|0|||
33496910|NCT02946463|101713769|FG002|Extension Period|Other than specified|2|||
33496911|NCT02946463|101713770|FG003|Extension Period|Other than specified|0|||
33496912|NCT02946463|101713767|FG000|Extension Period|Physician Decision|1|||
33496913|NCT02946463|101713768|FG001|Extension Period|Physician Decision|4|||
33300313|NCT04276415|100996182|FG004|Overall Study|Clinical progression|1|||
33300314|NCT04276415|100996183|FG005|Overall Study|Clinical progression|0|||
33300315|NCT04276415|100996178|FG000|Overall Study|Other|0|||
33496914|NCT02946463|101713769|FG002|Extension Period|Physician Decision|0|||
33496915|NCT02946463|101713770|FG003|Extension Period|Physician Decision|0|||
33190428|NCT00213148|100601689|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
33190429|NCT00213148|100601685|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
33300316|NCT04276415|100996179|FG001|Overall Study|Other|0|||
33300317|NCT04276415|100996180|FG002|Overall Study|Other|0|||
33300318|NCT04276415|100996181|FG003|Overall Study|Other|1|||
33300319|NCT04276415|100996182|FG004|Overall Study|Other|0|||
33300320|NCT04276415|100996183|FG005|Overall Study|Other|0|||
33300321|NCT04276415|100996178|FG000|Overall Study|Physician Decision|0|||
33300322|NCT04276415|100996179|FG001|Overall Study|Physician Decision|0|||
33300323|NCT04276415|100996180|FG002|Overall Study|Physician Decision|1|||
33300324|NCT04276415|100996181|FG003|Overall Study|Physician Decision|3|||
33300325|NCT04276415|100996182|FG004|Overall Study|Physician Decision|2|||
33300326|NCT04276415|100996183|FG005|Overall Study|Physician Decision|0|||
33300327|NCT04276415|100996178|FG000|Overall Study|Progressive disease|3|||
33300328|NCT04276415|100996179|FG001|Overall Study|Progressive disease|3|||
33300329|NCT04276415|100996180|FG002|Overall Study|Progressive disease|4|||
33300330|NCT04276415|100996181|FG003|Overall Study|Progressive disease|5|||
33300331|NCT04276415|100996182|FG004|Overall Study|Progressive disease|1|||
33300332|NCT04276415|100996183|FG005|Overall Study|Progressive disease|2|||
33300333|NCT04276415|100996178|FG000|Overall Study|Withdrawal by patient|0|||
33300334|NCT04276415|100996179|FG001|Overall Study|Withdrawal by patient|0|||
33600184|NCT02914548|102088539|FG001|Overall Study|Physician Decision|2|||
33300335|NCT04276415|100996180|FG002|Overall Study|Withdrawal by patient|0|||
33300336|NCT04276415|100996181|FG003|Overall Study|Withdrawal by patient|1|||
33300337|NCT04276415|100996182|FG004|Overall Study|Withdrawal by patient|2|||
33300338|NCT04276415|100996183|FG005|Overall Study|Withdrawal by patient|0|||
33300339|NCT03284203|100996184|FG000|Overall Study|Lost to Follow-up|3|||
33300340|NCT03449901|100996187|FG000|Overall Study|Progression|57|||
33300341|NCT03449901|100996188|FG001|Overall Study|Progression|12|||
33300342|NCT03449901|100996187|FG000|Overall Study|Adverse Event|3|||
33300343|NCT03449901|100996188|FG001|Overall Study|Adverse Event|0|||
33300344|NCT03449901|100996187|FG000|Overall Study|Death|6|||
33300345|NCT03449901|100996188|FG001|Overall Study|Death|2|||
33300346|NCT03449901|100996187|FG000|Overall Study|Withdrawal by Subject|12|||
33300347|NCT03449901|100996188|FG001|Overall Study|Withdrawal by Subject|1|||
33300348|NCT03449901|100996187|FG000|Overall Study|Physician Decision|1|||
33300349|NCT03449901|100996188|FG001|Overall Study|Physician Decision|0|||
33300350|NCT03449901|100996187|FG000|Overall Study|Patient elected for surgical intervention|1|||
33300351|NCT03449901|100996188|FG001|Overall Study|Patient elected for surgical intervention|0|||
33300352|NCT03449901|100996187|FG000|Overall Study|Patient off for other complicating disease|1|||
33300353|NCT03449901|100996188|FG001|Overall Study|Patient off for other complicating disease|0|||
33300354|NCT00293059|100996189|FG000|Overall Study|Adverse Event|12|||
33300355|NCT00293059|100996190|FG001|Overall Study|Adverse Event|4|||
33300356|NCT00293059|100996189|FG000|Overall Study|Lack of Efficacy|2|||
33300357|NCT00293059|100996190|FG001|Overall Study|Lack of Efficacy|0|||
33300358|NCT00293059|100996189|FG000|Overall Study|Lost to Follow-up|2|||
33300359|NCT00293059|100996190|FG001|Overall Study|Lost to Follow-up|3|||
33300360|NCT00293059|100996189|FG000|Overall Study|Pregnancy|1|||
33300361|NCT00293059|100996190|FG001|Overall Study|Pregnancy|1|||
33300362|NCT00293059|100996189|FG000|Overall Study|Protocol Violation|2|||
33300363|NCT00293059|100996190|FG001|Overall Study|Protocol Violation|0|||
33300364|NCT00293059|100996189|FG000|Overall Study|Withdrawal by Subject|11|||
33300365|NCT00293059|100996190|FG001|Overall Study|Withdrawal by Subject|5|||
33300366|NCT00293059|100996189|FG000|Overall Study|Participant moved out of state|1|||
33300367|NCT00293059|100996190|FG001|Overall Study|Participant moved out of state|0|||
33300368|NCT00293059|100996189|FG000|Overall Study|Participant stopped study drug|1|||
33300369|NCT00293059|100996190|FG001|Overall Study|Participant stopped study drug|0|||
33300370|NCT00293059|100996189|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
33300371|NCT00293059|100996190|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
33300372|NCT00293059|100996189|FG000|Overall Study|missing|3|||
33300373|NCT00293059|100996190|FG001|Overall Study|missing|5|||
33300374|NCT04076943|100996191|FG000|Overall Study|Withdrawal by Subject|12|||
33300375|NCT04076943|100996191|FG000|Overall Study|Adverse Event|1|||
33300376|NCT04076943|100996191|FG000|Overall Study|Progressive Disease|2|||
33300377|NCT04076943|100996191|FG000|Overall Study|Death|13|||
33300378|NCT04076943|100996191|FG000|Overall Study|Other than specified|6|||
33300379|NCT01232738|100996192|FG000|Overall Study|Death|3|||
33300380|NCT01232738|100996192|FG000|Overall Study|Physician Decision|2|||
33300381|NCT01232738|100996192|FG000|Overall Study|Lost to Follow-up|1|||
33300382|NCT01232738|100996192|FG000|Overall Study|Withdrawal by Subject|2|||
33300383|NCT01232738|100996192|FG000|Overall Study|Adverse Event|5|||
33300384|NCT00685698|100996194|FG000|Overall Study|Withdrawal by Subject|1|||
33300385|NCT00685698|100996194|FG000|Overall Study|Protocol Violation|6|||
33300386|NCT00685698|100996194|FG000|Overall Study|Adverse Event|3|||
33300387|NCT00685698|100996194|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
33300388|NCT00685698|100996194|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
33300389|NCT00685698|100996194|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
33300390|NCT00392925|100996195|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
33300391|NCT00392925|100996196|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
33300392|NCT00392925|100996197|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
33300393|NCT00392925|100996198|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
33300394|NCT00392925|100996195|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
33300395|NCT00392925|100996196|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
33300396|NCT00392925|100996197|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
33300397|NCT00392925|100996198|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
33300398|NCT00392925|100996195|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
33300399|NCT00392925|100996196|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
33300400|NCT00392925|100996197|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
33300401|NCT00392925|100996198|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
33300402|NCT00392925|100996195|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
33300403|NCT00392925|100996196|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
33300404|NCT00392925|100996197|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
33300405|NCT00392925|100996198|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
33300406|NCT00392925|100996195|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
33300407|NCT00392925|100996196|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
33496916|NCT02946463|101713767|FG000|Extension Period|Pregnancy|3|||
33496917|NCT02946463|101713768|FG001|Extension Period|Pregnancy|1|||
33496918|NCT02946463|101713769|FG002|Extension Period|Pregnancy|0|||
33496919|NCT02946463|101713770|FG003|Extension Period|Pregnancy|0|||
33496920|NCT02946463|101713767|FG000|Extension Period|Adverse Event|1|||
33496921|NCT02946463|101713768|FG001|Extension Period|Adverse Event|2|||
33496922|NCT02946463|101713769|FG002|Extension Period|Adverse Event|0|||
33496923|NCT02946463|101713770|FG003|Extension Period|Adverse Event|0|||
33496924|NCT02946463|101713767|FG000|Extension Period|Lost to Follow-up|1|||
33496925|NCT02946463|101713768|FG001|Extension Period|Lost to Follow-up|0|||
33496926|NCT02946463|101713769|FG002|Extension Period|Lost to Follow-up|0|||
33496927|NCT02946463|101713770|FG003|Extension Period|Lost to Follow-up|0|||
33496928|NCT01445730|101713772|FG000|Overall Study|Adverse Event|1|||
33496929|NCT01445730|101713772|FG000|Overall Study|For the advice of a dentist|1|||
33496930|NCT01445730|101713772|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
33496931|NCT00360282|101713773|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
33496932|NCT00360282|101713774|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
33300408|NCT00392925|100996197|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
33300409|NCT00392925|100996198|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
33300410|NCT00392925|100996195|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
33300411|NCT00392925|100996196|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
33300412|NCT00392925|100996197|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
33300413|NCT00392925|100996198|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
33300414|NCT00392925|100996195|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
33300415|NCT00392925|100996196|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
33300416|NCT00392925|100996197|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
33300417|NCT00392925|100996198|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
33300418|NCT00392925|100996195|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
33300419|NCT00392925|100996196|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
33300420|NCT00392925|100996197|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
33300421|NCT00392925|100996198|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
33300422|NCT00392925|100996195|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
33300423|NCT00392925|100996196|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
33300424|NCT00392925|100996197|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
33300425|NCT00392925|100996198|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
33300426|NCT01088984|100996199|FG000|Phase 1|Death|2|||
33300427|NCT01088984|100996200|FG001|Phase 1|Death|1|||
33300428|NCT01088984|100996199|FG000|Phase 1|Disease Progression|2|||
33300429|NCT01088984|100996200|FG001|Phase 1|Disease Progression|4|||
33300430|NCT01088984|100996199|FG000|Phase 1|Other|1|||
33300431|NCT01088984|100996200|FG001|Phase 1|Other|1|||
33300432|NCT01088984|100996199|FG000|Phase 2|Death|0|||
33300433|NCT01088984|100996200|FG001|Phase 2|Death|5|||
33300434|NCT01088984|100996199|FG000|Phase 2|Withdrawal by Subject|0|||
33300435|NCT01088984|100996200|FG001|Phase 2|Withdrawal by Subject|1|||
33300436|NCT01088984|100996199|FG000|Phase 2|DIsease Progression|0|||
33300437|NCT01088984|100996200|FG001|Phase 2|DIsease Progression|25|||
33300438|NCT01088984|100996199|FG000|Phase 2|Other|0|||
33300439|NCT01088984|100996200|FG001|Phase 2|Other|1|||
33300440|NCT01940939|100996202|FG000|Overall Study|Withdrawal by Subject|2|||
33300441|NCT01940939|100996203|FG001|Overall Study|Withdrawal by Subject|8|||
33300442|NCT03635099|100996206|FG000|Period 1|Adverse Event|1|||
33300443|NCT03635099|100996207|FG001|Period 1|Adverse Event|0|||
33300444|NCT03635099|100996208|FG002|Period 1|Adverse Event|0|||
33300445|NCT03635099|100996209|FG003|Period 1|Adverse Event|1|||
33300446|NCT03635099|100996210|FG004|Period 1|Adverse Event|0|||
33300447|NCT03635099|100996211|FG005|Period 1|Adverse Event|0|||
33300448|NCT03635099|100996212|FG006|Period 1|Adverse Event|0|||
33300449|NCT03635099|100996213|FG007|Period 1|Adverse Event|0|||
33300450|NCT03635099|100996206|FG000|Period 1|Protocol Violation|0|||
33300451|NCT03635099|100996207|FG001|Period 1|Protocol Violation|0|||
33300452|NCT03635099|100996208|FG002|Period 1|Protocol Violation|1|||
33300453|NCT03635099|100996209|FG003|Period 1|Protocol Violation|0|||
33300454|NCT03635099|100996210|FG004|Period 1|Protocol Violation|0|||
33300455|NCT03635099|100996211|FG005|Period 1|Protocol Violation|0|||
33300456|NCT03635099|100996212|FG006|Period 1|Protocol Violation|0|||
33300457|NCT03635099|100996213|FG007|Period 1|Protocol Violation|0|||
33300458|NCT03635099|100996206|FG000|Period 1|Lost to Follow-up|0|||
33300459|NCT03635099|100996207|FG001|Period 1|Lost to Follow-up|0|||
33300460|NCT03635099|100996208|FG002|Period 1|Lost to Follow-up|1|||
33300461|NCT03635099|100996209|FG003|Period 1|Lost to Follow-up|2|||
33300462|NCT03635099|100996210|FG004|Period 1|Lost to Follow-up|1|||
33300463|NCT03635099|100996211|FG005|Period 1|Lost to Follow-up|0|||
33496933|NCT00360282|101713775|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
33496934|NCT00360282|101713776|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
33300464|NCT03635099|100996212|FG006|Period 1|Lost to Follow-up|1|||
33300465|NCT03635099|100996213|FG007|Period 1|Lost to Follow-up|2|||
33300466|NCT03635099|100996206|FG000|Period 1|Withdrawal by Subject|3|||
33300467|NCT03635099|100996207|FG001|Period 1|Withdrawal by Subject|3|||
33300468|NCT03635099|100996208|FG002|Period 1|Withdrawal by Subject|5|||
33300469|NCT03635099|100996209|FG003|Period 1|Withdrawal by Subject|2|||
33300470|NCT03635099|100996210|FG004|Period 1|Withdrawal by Subject|2|||
33300471|NCT03635099|100996211|FG005|Period 1|Withdrawal by Subject|0|||
33300472|NCT03635099|100996212|FG006|Period 1|Withdrawal by Subject|3|||
33300473|NCT03635099|100996213|FG007|Period 1|Withdrawal by Subject|0|||
33300474|NCT03635099|100996206|FG000|Period 1|History of suicidal ideation|0|||
33300475|NCT03635099|100996207|FG001|Period 1|History of suicidal ideation|0|||
33300476|NCT03635099|100996208|FG002|Period 1|History of suicidal ideation|1|||
33300477|NCT03635099|100996209|FG003|Period 1|History of suicidal ideation|0|||
33300478|NCT03635099|100996210|FG004|Period 1|History of suicidal ideation|0|||
33300479|NCT03635099|100996211|FG005|Period 1|History of suicidal ideation|0|||
33300480|NCT03635099|100996212|FG006|Period 1|History of suicidal ideation|0|||
33300481|NCT03635099|100996213|FG007|Period 1|History of suicidal ideation|0|||
33300482|NCT03635099|100996206|FG000|Period 1|pursue other treatment options|0|||
33300483|NCT03635099|100996207|FG001|Period 1|pursue other treatment options|0|||
33393475|NCT03424044|101328486|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
33393476|NCT03424044|101328487|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33393477|NCT03424044|101328488|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33393478|NCT03424044|101328489|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33393479|NCT03424044|101328490|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33393480|NCT03424044|101328491|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33393481|NCT03424044|101328492|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
33393482|NCT03424044|101328484|FG000|First Intervention (76 Hours)|Adverse Event|0|||
33393483|NCT03424044|101328485|FG001|First Intervention (76 Hours)|Adverse Event|0|||
33393484|NCT03424044|101328486|FG002|First Intervention (76 Hours)|Adverse Event|0|||
33393485|NCT03424044|101328487|FG003|First Intervention (76 Hours)|Adverse Event|0|||
33393486|NCT03424044|101328488|FG004|First Intervention (76 Hours)|Adverse Event|1|||
33393487|NCT03424044|101328489|FG005|First Intervention (76 Hours)|Adverse Event|0|||
33393488|NCT03424044|101328490|FG006|First Intervention (76 Hours)|Adverse Event|0|||
33393489|NCT03424044|101328491|FG007|First Intervention (76 Hours)|Adverse Event|0|||
33393490|NCT03424044|101328492|FG008|First Intervention (76 Hours)|Adverse Event|0|||
33393491|NCT03424044|101328484|FG000|First Intervention (76 Hours)|device issues|0|||
33393492|NCT03424044|101328485|FG001|First Intervention (76 Hours)|device issues|0|||
33393493|NCT03424044|101328486|FG002|First Intervention (76 Hours)|device issues|0|||
33393494|NCT03424044|101328487|FG003|First Intervention (76 Hours)|device issues|0|||
33393495|NCT03424044|101328488|FG004|First Intervention (76 Hours)|device issues|0|||
33393496|NCT03424044|101328489|FG005|First Intervention (76 Hours)|device issues|0|||
33393497|NCT03424044|101328490|FG006|First Intervention (76 Hours)|device issues|1|||
33393498|NCT03424044|101328491|FG007|First Intervention (76 Hours)|device issues|1|||
33393499|NCT03424044|101328492|FG008|First Intervention (76 Hours)|device issues|1|||
33393500|NCT03424044|101328484|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
33393501|NCT03424044|101328485|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
33393502|NCT03424044|101328486|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
33393503|NCT03424044|101328487|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
33393504|NCT03424044|101328488|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
33393505|NCT03424044|101328489|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
33393506|NCT03424044|101328490|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
33393507|NCT03424044|101328491|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
33393508|NCT03424044|101328492|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
33393509|NCT03424044|101328484|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33393510|NCT03424044|101328485|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33393511|NCT03424044|101328486|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33393512|NCT03424044|101328487|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
33393513|NCT03424044|101328488|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33393514|NCT03424044|101328489|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33393515|NCT03424044|101328490|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33393516|NCT03424044|101328491|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33393517|NCT03424044|101328492|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
33393518|NCT03924427|101328495|FG000|Overall Study|Adverse Event|4|||
33393519|NCT03924427|101328495|FG000|Overall Study|Lack of Efficacy|1|||
33300484|NCT03635099|100996208|FG002|Period 1|pursue other treatment options|0|||
33300485|NCT03635099|100996209|FG003|Period 1|pursue other treatment options|0|||
33393520|NCT03924427|101328495|FG000|Overall Study|Withdrawal by Subject|1|||
33393521|NCT01843205|101328496|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
33393522|NCT01843205|101328497|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
33393523|NCT05116683|101328502|FG000|Overall Study|Physician Decision|4|||
33393524|NCT01047436|101328503|FG000|Overall Study|Protocol Violation|1|||
33393525|NCT01047436|101328504|FG001|Overall Study|Protocol Violation|0|||
33300486|NCT03635099|100996210|FG004|Period 1|pursue other treatment options|0|||
33300487|NCT03635099|100996211|FG005|Period 1|pursue other treatment options|1|||
33300488|NCT03635099|100996212|FG006|Period 1|pursue other treatment options|0|||
33300489|NCT03635099|100996213|FG007|Period 1|pursue other treatment options|0|||
33300490|NCT03635099|100996206|FG000|Not Eligible for Period 2|Pregnancy|0|||
33300491|NCT03635099|100996207|FG001|Not Eligible for Period 2|Pregnancy|0|||
33300492|NCT03635099|100996208|FG002|Not Eligible for Period 2|Pregnancy|0|||
33300493|NCT03635099|100996209|FG003|Not Eligible for Period 2|Pregnancy|1|||
33300494|NCT03635099|100996210|FG004|Not Eligible for Period 2|Pregnancy|0|||
33300495|NCT03635099|100996211|FG005|Not Eligible for Period 2|Pregnancy|0|||
33300496|NCT03635099|100996212|FG006|Not Eligible for Period 2|Pregnancy|0|||
33300497|NCT03635099|100996213|FG007|Not Eligible for Period 2|Pregnancy|0|||
33300498|NCT03635099|100996206|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
33300499|NCT03635099|100996207|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
33300500|NCT03635099|100996208|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
33300501|NCT03635099|100996209|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
33300502|NCT03635099|100996210|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
33300503|NCT03635099|100996211|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
33300504|NCT03635099|100996212|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
33300505|NCT03635099|100996213|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
33300506|NCT03635099|100996206|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
33300507|NCT03635099|100996207|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
33300508|NCT03635099|100996208|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
33300509|NCT03635099|100996209|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
33300510|NCT03635099|100996210|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
33300511|NCT03635099|100996211|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
33300512|NCT03635099|100996212|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
33300513|NCT03635099|100996213|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
33300514|NCT03635099|100996206|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
33300515|NCT03635099|100996207|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
33300516|NCT03635099|100996208|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
33300517|NCT03635099|100996209|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
33300518|NCT03635099|100996210|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
33300519|NCT03635099|100996211|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
33300520|NCT03635099|100996212|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
33300521|NCT03635099|100996213|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
33300522|NCT03635099|100996206|FG000|Period 2|Adverse Event|0|||
33300523|NCT03635099|100996207|FG001|Period 2|Adverse Event|0|||
33300524|NCT03635099|100996208|FG002|Period 2|Adverse Event|1|||
33300525|NCT03635099|100996209|FG003|Period 2|Adverse Event|0|||
33300526|NCT03635099|100996210|FG004|Period 2|Adverse Event|1|||
33300527|NCT03635099|100996211|FG005|Period 2|Adverse Event|0|||
33300528|NCT03635099|100996212|FG006|Period 2|Adverse Event|0|||
33300529|NCT03635099|100996213|FG007|Period 2|Adverse Event|0|||
33300530|NCT03635099|100996206|FG000|Period 2|Lost to Follow-up|0|||
33300531|NCT03635099|100996207|FG001|Period 2|Lost to Follow-up|0|||
33300532|NCT03635099|100996208|FG002|Period 2|Lost to Follow-up|1|||
33300533|NCT03635099|100996209|FG003|Period 2|Lost to Follow-up|0|||
33300534|NCT03635099|100996210|FG004|Period 2|Lost to Follow-up|4|||
33300535|NCT03635099|100996211|FG005|Period 2|Lost to Follow-up|0|||
33300536|NCT03635099|100996212|FG006|Period 2|Lost to Follow-up|0|||
33300537|NCT03635099|100996213|FG007|Period 2|Lost to Follow-up|0|||
33300538|NCT03635099|100996206|FG000|Period 2|Withdrawal by Subject|0|||
33300539|NCT03635099|100996207|FG001|Period 2|Withdrawal by Subject|0|||
33300540|NCT03635099|100996208|FG002|Period 2|Withdrawal by Subject|7|||
33300541|NCT03635099|100996209|FG003|Period 2|Withdrawal by Subject|4|||
33300542|NCT03635099|100996210|FG004|Period 2|Withdrawal by Subject|7|||
33300543|NCT03635099|100996211|FG005|Period 2|Withdrawal by Subject|0|||
33300544|NCT03635099|100996212|FG006|Period 2|Withdrawal by Subject|0|||
33300545|NCT03635099|100996213|FG007|Period 2|Withdrawal by Subject|0|||
33300546|NCT03772587|100996214|FG000|Overall Study|COVID-19|0|||
33300547|NCT03772587|100996215|FG001|Overall Study|COVID-19|0|||
33300548|NCT03772587|100996216|FG002|Overall Study|COVID-19|1|||
33300549|NCT03772587|100996217|FG003|Overall Study|COVID-19|1|||
33300550|NCT03772587|100996218|FG004|Overall Study|COVID-19|0|||
33300551|NCT03772587|100996214|FG000|Overall Study|Withdrawal by Subject|1|||
33300552|NCT03772587|100996215|FG001|Overall Study|Withdrawal by Subject|0|||
33300553|NCT03772587|100996216|FG002|Overall Study|Withdrawal by Subject|0|||
33300554|NCT03772587|100996217|FG003|Overall Study|Withdrawal by Subject|0|||
33300555|NCT03772587|100996218|FG004|Overall Study|Withdrawal by Subject|0|||
33300556|NCT01255631|100996219|FG000|Overall Study|poor enrollment, no data analyzed|9|||
33300557|NCT01255631|100996220|FG001|Overall Study|poor enrollment, no data analyzed|6|||
33300558|NCT04445987|100996221|FG000|Overall Study|Adverse Event|0|||
33300559|NCT04445987|100996222|FG001|Overall Study|Adverse Event|0|||
33300560|NCT04445987|100996223|FG002|Overall Study|Adverse Event|1|||
33300561|NCT04445987|100996224|FG003|Overall Study|Adverse Event|0|||
33300562|NCT04445987|100996225|FG004|Overall Study|Adverse Event|4|||
33300563|NCT04445987|100996226|FG005|Overall Study|Adverse Event|0|||
33300564|NCT04445987|100996221|FG000|Overall Study|Lost to Follow-up|4|||
33300565|NCT04445987|100996222|FG001|Overall Study|Lost to Follow-up|3|||
33300566|NCT04445987|100996223|FG002|Overall Study|Lost to Follow-up|1|||
33300567|NCT04445987|100996224|FG003|Overall Study|Lost to Follow-up|1|||
33300568|NCT04445987|100996225|FG004|Overall Study|Lost to Follow-up|29|||
33300569|NCT04445987|100996226|FG005|Overall Study|Lost to Follow-up|0|||
33300570|NCT04445987|100996221|FG000|Overall Study|Physician Decision|0|||
33300571|NCT04445987|100996222|FG001|Overall Study|Physician Decision|0|||
33300572|NCT04445987|100996223|FG002|Overall Study|Physician Decision|0|||
33300573|NCT04445987|100996224|FG003|Overall Study|Physician Decision|0|||
33300574|NCT04445987|100996225|FG004|Overall Study|Physician Decision|1|||
33300575|NCT04445987|100996226|FG005|Overall Study|Physician Decision|0|||
33300576|NCT04445987|100996221|FG000|Overall Study|Protocol Violation|1|||
33300577|NCT04445987|100996222|FG001|Overall Study|Protocol Violation|0|||
33300578|NCT04445987|100996223|FG002|Overall Study|Protocol Violation|0|||
33300579|NCT04445987|100996224|FG003|Overall Study|Protocol Violation|0|||
33300580|NCT04445987|100996225|FG004|Overall Study|Protocol Violation|2|||
33300581|NCT04445987|100996226|FG005|Overall Study|Protocol Violation|0|||
33300582|NCT04445987|100996221|FG000|Overall Study|Withdrawal by Subject|4|||
33300583|NCT04445987|100996222|FG001|Overall Study|Withdrawal by Subject|0|||
33300584|NCT04445987|100996223|FG002|Overall Study|Withdrawal by Subject|1|||
33300585|NCT04445987|100996224|FG003|Overall Study|Withdrawal by Subject|0|||
33300586|NCT04445987|100996225|FG004|Overall Study|Withdrawal by Subject|18|||
33300587|NCT04445987|100996226|FG005|Overall Study|Withdrawal by Subject|1|||
33300588|NCT04445987|100996221|FG000|Overall Study|Other reason|0|||
33300589|NCT04445987|100996222|FG001|Overall Study|Other reason|0|||
33300590|NCT04445987|100996223|FG002|Overall Study|Other reason|1|||
33300591|NCT04445987|100996224|FG003|Overall Study|Other reason|0|||
33300592|NCT04445987|100996225|FG004|Overall Study|Other reason|2|||
33300593|NCT04445987|100996226|FG005|Overall Study|Other reason|0|||
33300594|NCT02535091|100996227|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
33300595|NCT02535091|100996228|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
33300596|NCT02535091|100996229|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
33300597|NCT02535091|100996227|FG000|Overall Study|Withdrawal by Subject|14|||
33300598|NCT02535091|100996228|FG001|Overall Study|Withdrawal by Subject|5|||
33300599|NCT02535091|100996229|FG002|Overall Study|Withdrawal by Subject|121|||
33300600|NCT02535091|100996227|FG000|Overall Study|Adverse Event|9|||
33300601|NCT02535091|100996228|FG001|Overall Study|Adverse Event|4|||
33300602|NCT02535091|100996229|FG002|Overall Study|Adverse Event|170|||
33300603|NCT02535091|100996227|FG000|Overall Study|Other|4|||
33300604|NCT02535091|100996228|FG001|Overall Study|Other|3|||
33300605|NCT02535091|100996229|FG002|Overall Study|Other|81|||
33300606|NCT02535091|100996227|FG000|Overall Study|Lost to Follow-up|0|||
33300607|NCT02535091|100996228|FG001|Overall Study|Lost to Follow-up|1|||
33300608|NCT02535091|100996229|FG002|Overall Study|Lost to Follow-up|19|||
33300609|NCT02535091|100996227|FG000|Overall Study|Protocol Violation|0|||
33300610|NCT02535091|100996228|FG001|Overall Study|Protocol Violation|1|||
33300611|NCT02535091|100996229|FG002|Overall Study|Protocol Violation|11|||
33300612|NCT02535091|100996227|FG000|Overall Study|Pregnancy|0|||
33300613|NCT02535091|100996228|FG001|Overall Study|Pregnancy|0|||
33300614|NCT02535091|100996229|FG002|Overall Study|Pregnancy|7|||
33300615|NCT00320528|100996230|FG000|Study Period II|Adverse Event|3|||
33300616|NCT00320528|100996231|FG001|Study Period II|Adverse Event|4|||
33300617|NCT00320528|100996232|FG002|Study Period II|Adverse Event|8|||
33300618|NCT00320528|100996230|FG000|Study Period II|Parent/Caregiver Decision|8|||
33496935|NCT00360282|101713773|FG000|Second Intervention|Adverse Event|0|||
33496936|NCT00360282|101713774|FG001|Second Intervention|Adverse Event|1|||
33600185|NCT02914548|102088540|FG002|Overall Study|Physician Decision|0|||
33300619|NCT00320528|100996231|FG001|Study Period II|Parent/Caregiver Decision|3|||
33300620|NCT00320528|100996232|FG002|Study Period II|Parent/Caregiver Decision|11|||
33300621|NCT00320528|100996230|FG000|Study Period II|Withdrawal by Subject|0|||
33300622|NCT00320528|100996231|FG001|Study Period II|Withdrawal by Subject|1|||
33300623|NCT00320528|100996232|FG002|Study Period II|Withdrawal by Subject|1|||
33300624|NCT00320528|100996230|FG000|Study Period II|Entry Criteria Exclusion|0|||
33300625|NCT00320528|100996231|FG001|Study Period II|Entry Criteria Exclusion|2|||
33600186|NCT02914548|102088538|FG000|Overall Study|Protocol Violation|1|||
33300626|NCT00320528|100996232|FG002|Study Period II|Entry Criteria Exclusion|2|||
33300627|NCT00320528|100996230|FG000|Study Period III|Adverse Event|1|||
33300628|NCT00320528|100996231|FG001|Study Period III|Adverse Event|0|||
33300629|NCT00320528|100996232|FG002|Study Period III|Adverse Event|0|||
33300630|NCT00320528|100996230|FG000|Study Period III|Lost to Follow-up|1|||
33300631|NCT00320528|100996231|FG001|Study Period III|Lost to Follow-up|0|||
33496937|NCT00360282|101713775|FG002|Second Intervention|Adverse Event|0|||
33300632|NCT00320528|100996232|FG002|Study Period III|Lost to Follow-up|0|||
33300633|NCT00320528|100996230|FG000|Study Period III|Withdrawal by Subject|1|||
33300634|NCT00320528|100996231|FG001|Study Period III|Withdrawal by Subject|1|||
33300635|NCT00320528|100996232|FG002|Study Period III|Withdrawal by Subject|2|||
33300636|NCT00320528|100996230|FG000|Study Period III|Lack of Efficacy|2|||
33300637|NCT00320528|100996231|FG001|Study Period III|Lack of Efficacy|0|||
33300638|NCT00320528|100996232|FG002|Study Period III|Lack of Efficacy|0|||
33300639|NCT00320528|100996230|FG000|Study Period III|Parent/Caregiver Decision|14|||
33300640|NCT00320528|100996231|FG001|Study Period III|Parent/Caregiver Decision|3|||
33300641|NCT00320528|100996232|FG002|Study Period III|Parent/Caregiver Decision|11|||
33300642|NCT00320528|100996230|FG000|Study Period III|Protocol Violation|0|||
33300643|NCT00320528|100996231|FG001|Study Period III|Protocol Violation|1|||
33300644|NCT00320528|100996232|FG002|Study Period III|Protocol Violation|0|||
33300645|NCT00320528|100996230|FG000|Study Period III|Physician Decision|0|||
33300646|NCT00320528|100996231|FG001|Study Period III|Physician Decision|1|||
33300647|NCT00320528|100996232|FG002|Study Period III|Physician Decision|2|||
33300648|NCT00320528|100996230|FG000|Study Period III|Sponsor Decision|0|||
33300649|NCT00320528|100996231|FG001|Study Period III|Sponsor Decision|0|||
33300650|NCT00320528|100996232|FG002|Study Period III|Sponsor Decision|1|||
33300651|NCT00320528|100996230|FG000|Study Period III|Atomoxetine Commercially Available|68|||
33300652|NCT00320528|100996231|FG001|Study Period III|Atomoxetine Commercially Available|25|||
33300653|NCT00320528|100996232|FG002|Study Period III|Atomoxetine Commercially Available|90|||
33300654|NCT03682302|100996234|FG000|Overall Study|Lost to Follow-up|1|||
33300655|NCT03682302|100996235|FG001|Overall Study|Lost to Follow-up|2|||
33300656|NCT03682302|100996236|FG002|Overall Study|Lost to Follow-up|0|||
33300657|NCT03682302|100996237|FG003|Overall Study|Lost to Follow-up|1|||
33300658|NCT03682302|100996234|FG000|Overall Study|Study drug was not administered|0|||
33300659|NCT03682302|100996235|FG001|Overall Study|Study drug was not administered|0|||
33300660|NCT03682302|100996236|FG002|Overall Study|Study drug was not administered|1|||
33300661|NCT03682302|100996237|FG003|Overall Study|Study drug was not administered|1|||
33300662|NCT02233803|100996238|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
33300663|NCT02233803|100996239|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
33300664|NCT02233803|100996238|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
33300665|NCT02233803|100996239|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
33300666|NCT02233803|100996238|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
33300667|NCT02233803|100996239|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
33300668|NCT02233803|100996238|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
33300669|NCT02233803|100996239|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
33300670|NCT02233803|100996238|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
33300671|NCT02233803|100996239|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
33300672|NCT02233803|100996238|FG000|Washout Period (4-Wks)|Physician Decision|1|||
33300673|NCT02233803|100996239|FG001|Washout Period (4-Wks)|Physician Decision|0|||
33300674|NCT02233803|100996238|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
33300675|NCT02233803|100996239|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
33300676|NCT02233803|100996238|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
33300677|NCT02233803|100996239|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
33300678|NCT02233803|100996238|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
33300679|NCT02233803|100996239|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
33300680|NCT02626455|100996240|FG000|Overall Study|Other|1|||
33300681|NCT02626455|100996241|FG001|Overall Study|Other|1|||
33300682|NCT02626455|100996242|FG002|Overall Study|Other|0|||
33300683|NCT02626455|100996243|FG003|Overall Study|Other|0|||
33300684|NCT02626455|100996244|FG004|Overall Study|Other|0|||
33300685|NCT02626455|100996245|FG005|Overall Study|Other|17|||
33300686|NCT02626455|100996246|FG006|Overall Study|Other|23|||
33300687|NCT02626455|100996240|FG000|Overall Study|Withdrawal by Subject|1|||
33300688|NCT02626455|100996241|FG001|Overall Study|Withdrawal by Subject|0|||
33300689|NCT02626455|100996242|FG002|Overall Study|Withdrawal by Subject|0|||
33300690|NCT02626455|100996243|FG003|Overall Study|Withdrawal by Subject|0|||
33300691|NCT02626455|100996244|FG004|Overall Study|Withdrawal by Subject|0|||
33300692|NCT02626455|100996245|FG005|Overall Study|Withdrawal by Subject|10|||
33300693|NCT02626455|100996246|FG006|Overall Study|Withdrawal by Subject|6|||
33300694|NCT02626455|100996240|FG000|Overall Study|Physician Decision|0|||
33300695|NCT02626455|100996241|FG001|Overall Study|Physician Decision|2|||
33300696|NCT02626455|100996242|FG002|Overall Study|Physician Decision|2|||
33300697|NCT02626455|100996243|FG003|Overall Study|Physician Decision|2|||
33300698|NCT02626455|100996244|FG004|Overall Study|Physician Decision|1|||
33300699|NCT02626455|100996245|FG005|Overall Study|Physician Decision|10|||
33300700|NCT02626455|100996246|FG006|Overall Study|Physician Decision|3|||
33300701|NCT02626455|100996240|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
33300702|NCT02626455|100996241|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
33300703|NCT02626455|100996242|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
33300704|NCT02626455|100996243|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
33300705|NCT02626455|100996244|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
33300706|NCT02626455|100996245|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
33393526|NCT00117572|101328505|FG000|Overall Study|Site withdrew before starting treatment|2|||
33300707|NCT02626455|100996246|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
33300708|NCT02626455|100996240|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
33300709|NCT02626455|100996241|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
33300710|NCT02626455|100996242|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
33300711|NCT02626455|100996243|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
33300712|NCT02626455|100996244|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
33300713|NCT02626455|100996245|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
33300714|NCT02626455|100996246|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
33300715|NCT02626455|100996240|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
33300716|NCT02626455|100996241|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
33300717|NCT02626455|100996242|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
33300718|NCT02626455|100996243|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
33300719|NCT02626455|100996244|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
33300720|NCT02626455|100996245|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
33300721|NCT02626455|100996246|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
33300722|NCT02626455|100996240|FG000|Overall Study|Patient decision|0|||
33300723|NCT02626455|100996241|FG001|Overall Study|Patient decision|1|||
33300724|NCT02626455|100996242|FG002|Overall Study|Patient decision|0|||
33300725|NCT02626455|100996243|FG003|Overall Study|Patient decision|0|||
33300726|NCT02626455|100996244|FG004|Overall Study|Patient decision|1|||
33300727|NCT02626455|100996245|FG005|Overall Study|Patient decision|36|||
33300728|NCT02626455|100996246|FG006|Overall Study|Patient decision|22|||
33300729|NCT02626455|100996240|FG000|Overall Study|Protocol Violation|0|||
33300730|NCT02626455|100996241|FG001|Overall Study|Protocol Violation|0|||
33300731|NCT02626455|100996242|FG002|Overall Study|Protocol Violation|0|||
33300732|NCT02626455|100996243|FG003|Overall Study|Protocol Violation|0|||
33300733|NCT02626455|100996244|FG004|Overall Study|Protocol Violation|0|||
33300734|NCT02626455|100996245|FG005|Overall Study|Protocol Violation|0|||
33300735|NCT02626455|100996246|FG006|Overall Study|Protocol Violation|1|||
33300736|NCT02626455|100996240|FG000|Overall Study|Progressive disease - radiological progression|0|||
33300737|NCT02626455|100996241|FG001|Overall Study|Progressive disease - radiological progression|0|||
33300738|NCT02626455|100996242|FG002|Overall Study|Progressive disease - radiological progression|0|||
33300739|NCT02626455|100996243|FG003|Overall Study|Progressive disease - radiological progression|0|||
33300740|NCT02626455|100996244|FG004|Overall Study|Progressive disease - radiological progression|0|||
33300741|NCT02626455|100996245|FG005|Overall Study|Progressive disease - radiological progression|11|||
33300742|NCT02626455|100996246|FG006|Overall Study|Progressive disease - radiological progression|22|||
33300743|NCT02626455|100996240|FG000|Overall Study|Progressive disease - clinical progression|0|||
33300744|NCT02626455|100996241|FG001|Overall Study|Progressive disease - clinical progression|0|||
33300745|NCT02626455|100996242|FG002|Overall Study|Progressive disease - clinical progression|0|||
33300746|NCT02626455|100996243|FG003|Overall Study|Progressive disease - clinical progression|0|||
33300747|NCT02626455|100996244|FG004|Overall Study|Progressive disease - clinical progression|0|||
33300748|NCT02626455|100996245|FG005|Overall Study|Progressive disease - clinical progression|1|||
33300749|NCT02626455|100996246|FG006|Overall Study|Progressive disease - clinical progression|2|||
33300750|NCT02626455|100996240|FG000|Overall Study|Lost to Follow-up|0|||
33300751|NCT02626455|100996241|FG001|Overall Study|Lost to Follow-up|0|||
33300752|NCT02626455|100996242|FG002|Overall Study|Lost to Follow-up|0|||
33300753|NCT02626455|100996243|FG003|Overall Study|Lost to Follow-up|0|||
33300754|NCT02626455|100996244|FG004|Overall Study|Lost to Follow-up|0|||
33300755|NCT02626455|100996245|FG005|Overall Study|Lost to Follow-up|1|||
33300756|NCT02626455|100996246|FG006|Overall Study|Lost to Follow-up|0|||
33300757|NCT02626455|100996240|FG000|Overall Study|AE not associated with clinical disease progression|1|||
33300758|NCT02626455|100996241|FG001|Overall Study|AE not associated with clinical disease progression|1|||
33300759|NCT02626455|100996242|FG002|Overall Study|AE not associated with clinical disease progression|0|||
33300760|NCT02626455|100996243|FG003|Overall Study|AE not associated with clinical disease progression|2|||
33300761|NCT02626455|100996244|FG004|Overall Study|AE not associated with clinical disease progression|1|||
33300762|NCT02626455|100996245|FG005|Overall Study|AE not associated with clinical disease progression|65|||
33300763|NCT02626455|100996246|FG006|Overall Study|AE not associated with clinical disease progression|21|||
33300764|NCT02626455|100996240|FG000|Overall Study|AE associated with clinical disease progression|0|||
33496938|NCT00360282|101713776|FG003|Second Intervention|Adverse Event|0|||
33300765|NCT02626455|100996241|FG001|Overall Study|AE associated with clinical disease progression|0|||
33300766|NCT02626455|100996242|FG002|Overall Study|AE associated with clinical disease progression|0|||
33300767|NCT02626455|100996243|FG003|Overall Study|AE associated with clinical disease progression|0|||
33300768|NCT02626455|100996244|FG004|Overall Study|AE associated with clinical disease progression|0|||
33300769|NCT02626455|100996245|FG005|Overall Study|AE associated with clinical disease progression|1|||
33300770|NCT02626455|100996246|FG006|Overall Study|AE associated with clinical disease progression|2|||
33300771|NCT02626455|100996240|FG000|Overall Study|Study intervention never administered|0|||
33300772|NCT02626455|100996241|FG001|Overall Study|Study intervention never administered|0|||
33496939|NCT02570308|101713779|FG000|Overall Study|Death|1|||
33300773|NCT02626455|100996242|FG002|Overall Study|Study intervention never administered|0|||
33300774|NCT02626455|100996243|FG003|Overall Study|Study intervention never administered|0|||
33300775|NCT02626455|100996244|FG004|Overall Study|Study intervention never administered|0|||
33300776|NCT02626455|100996245|FG005|Overall Study|Study intervention never administered|1|||
33300777|NCT02626455|100996246|FG006|Overall Study|Study intervention never administered|3|||
33300778|NCT00403767|100996247|FG000|Overall Study|Adverse Event|993|||
33300779|NCT00403767|100996248|FG001|Overall Study|Adverse Event|919|||
33300780|NCT00403767|100996247|FG000|Overall Study|Non-compliant with study medication|134|||
33300781|NCT00403767|100996248|FG001|Overall Study|Non-compliant with study medication|164|||
33300782|NCT00403767|100996247|FG000|Overall Study|Consent withdrawn|671|||
33300783|NCT00403767|100996248|FG001|Overall Study|Consent withdrawn|673|||
33300784|NCT00403767|100996247|FG000|Overall Study|Investigator dec./not protocol-related|191|||
33300785|NCT00403767|100996248|FG001|Overall Study|Investigator dec./not protocol-related|178|||
33300786|NCT00403767|100996247|FG000|Overall Study|Lost to Follow-up|6|||
33300787|NCT00403767|100996248|FG001|Overall Study|Lost to Follow-up|8|||
33300788|NCT00403767|100996247|FG000|Overall Study|Protocol Violation|142|||
33300789|NCT00403767|100996248|FG001|Overall Study|Protocol Violation|124|||
33300790|NCT00403767|100996247|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
33300791|NCT00403767|100996248|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
33300792|NCT00403767|100996247|FG000|Overall Study|Study terminated by sponsor|82|||
33300793|NCT00403767|100996248|FG001|Overall Study|Study terminated by sponsor|69|||
33300794|NCT00403767|100996247|FG000|Overall Study|Missing/incomplete data|1|||
33300795|NCT00403767|100996248|FG001|Overall Study|Missing/incomplete data|1|||
33300796|NCT00415051|100996251|FG000|Overall Study|Protocol Violation|1|||
33300797|NCT00357110|100996254|FG000|Overall Study|Early study termination|5|||
33300798|NCT00357110|100996255|FG001|Overall Study|Early study termination|5|||
33300799|NCT01641159|100996256|FG000|Overall Study|Lost to Follow-up|2|||
33300800|NCT01641159|100996257|FG001|Overall Study|Lost to Follow-up|1|||
33300801|NCT01641159|100996256|FG000|Overall Study|Withdrawal by Subject|0|||
33300802|NCT01641159|100996257|FG001|Overall Study|Withdrawal by Subject|1|||
33300803|NCT05330676|100996258|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
33300804|NCT05330676|100996259|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
33300805|NCT00789360|100996260|FG000|Overall Study|Protocol Violation|3|||
33300806|NCT00789360|100996261|FG001|Overall Study|Protocol Violation|1|||
33300807|NCT04230122|100996270|FG000|Overall Study|Lost to Follow-up|1|||
33300808|NCT04230122|100996271|FG001|Overall Study|Lost to Follow-up|0|||
33300809|NCT01525238|100996273|FG000|Overall Study|Withdrawal by Subject|1|||
33300810|NCT01525238|100996274|FG001|Overall Study|Withdrawal by Subject|0|||
33300811|NCT01525238|100996275|FG002|Overall Study|Withdrawal by Subject|0|||
33300812|NCT03046121|100996280|FG000|Overall Study|Death|32|||
33300813|NCT03046121|100996281|FG001|Overall Study|Death|60|||
33300814|NCT03046121|100996280|FG000|Overall Study|Withdrawal by Subject|14|||
33300815|NCT03046121|100996281|FG001|Overall Study|Withdrawal by Subject|12|||
33300816|NCT01374568|100996284|FG000|Overall Study|Lab unable to analyze BTM|0|||
33300817|NCT01374568|100996285|FG001|Overall Study|Lab unable to analyze BTM|2|||
33300818|NCT01182441|100996286|FG000|Overall Study|Patient Still in Follow-up|152|||
33300819|NCT01182441|100996287|FG001|Overall Study|Patient Still in Follow-up|72|||
33300820|NCT01182441|100996286|FG000|Overall Study|Death|37|||
33300821|NCT01182441|100996287|FG001|Overall Study|Death|25|||
33300822|NCT01182441|100996286|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
33300823|NCT01182441|100996287|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
33300824|NCT01182441|100996286|FG000|Overall Study|Lost to Follow-up|5|||
33496940|NCT02570308|101713780|FG001|Overall Study|Death|5|||
33496941|NCT02570308|101713781|FG002|Overall Study|Death|4|||
33496942|NCT02570308|101713782|FG003|Overall Study|Death|4|||
33496943|NCT02570308|101713783|FG004|Overall Study|Death|69|||
33496944|NCT02570308|101713779|FG000|Overall Study|Lost to Follow-up|0|||
33300825|NCT01182441|100996287|FG001|Overall Study|Lost to Follow-up|8|||
33300826|NCT01182441|100996286|FG000|Overall Study|Withdrawal by Subject|6|||
33300827|NCT01182441|100996287|FG001|Overall Study|Withdrawal by Subject|13|||
33300828|NCT01182441|100996286|FG000|Overall Study|Implant Not Attempted|4|||
33300829|NCT01182441|100996287|FG001|Overall Study|Implant Not Attempted|0|||
33300830|NCT01182441|100996286|FG000|Overall Study|Adverse Event|2|||
33300831|NCT01182441|100996287|FG001|Overall Study|Adverse Event|0|||
33300832|NCT01182441|100996286|FG000|Overall Study|Physician Decision|1|||
33300833|NCT01182441|100996287|FG001|Overall Study|Physician Decision|1|||
33300834|NCT00565773|100996288|FG000|Overall Study|Withdrawal by Subject|1|||
33300835|NCT00565773|100996288|FG000|Overall Study|Physician Decision|1|||
33300836|NCT02136134|100996289|FG000|Overall Study|Death|170|||
33300837|NCT02136134|100996290|FG001|Overall Study|Death|148|||
33300838|NCT02136134|100996289|FG000|Overall Study|Withdrawal by Subject|19|||
33496945|NCT02570308|101713780|FG001|Overall Study|Lost to Follow-up|0|||
33496946|NCT02570308|101713781|FG002|Overall Study|Lost to Follow-up|0|||
33300839|NCT02136134|100996290|FG001|Overall Study|Withdrawal by Subject|10|||
33300840|NCT02136134|100996289|FG000|Overall Study|Lost to Follow-up|3|||
33496947|NCT02570308|101713782|FG003|Overall Study|Lost to Follow-up|0|||
33496948|NCT02570308|101713783|FG004|Overall Study|Lost to Follow-up|2|||
33300841|NCT02136134|100996290|FG001|Overall Study|Lost to Follow-up|3|||
33300842|NCT02136134|100996289|FG000|Overall Study|Uspecified|55|||
33300843|NCT02136134|100996290|FG001|Overall Study|Uspecified|90|||
33300844|NCT02949362|100996293|FG000|Retrospective Period|Inform consent not signed by participant|4|||
33300845|NCT02949362|100996294|FG001|Retrospective Period|Inform consent not signed by participant|1|||
33300846|NCT02949362|100996295|FG002|Retrospective Period|Inform consent not signed by participant|0|||
33300847|NCT02949362|100996296|FG003|Retrospective Period|Inform consent not signed by participant|0|||
33300848|NCT02949362|100996293|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
33300849|NCT02949362|100996294|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
33300850|NCT02949362|100996295|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
33300851|NCT02949362|100996296|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
33300852|NCT02949362|100996293|FG000|Prospective Period|Other|0|||
33300853|NCT02949362|100996294|FG001|Prospective Period|Other|0|||
33300854|NCT02949362|100996295|FG002|Prospective Period|Other|0|||
33300855|NCT02949362|100996296|FG003|Prospective Period|Other|4|||
33300856|NCT01892540|100996297|FG000|Overall Study|Did not complete PET/MRI|0|||
33300857|NCT01892540|100996298|FG001|Overall Study|Did not complete PET/MRI|0|||
33300858|NCT01892540|100996299|FG002|Overall Study|Did not complete PET/MRI|2|||
33300859|NCT01892540|100996297|FG000|Overall Study|Did not fit in scanner|0|||
33300860|NCT01892540|100996298|FG001|Overall Study|Did not fit in scanner|0|||
33300861|NCT01892540|100996299|FG002|Overall Study|Did not fit in scanner|1|||
33300862|NCT02175641|100996300|FG000|Overall Study|Death|3|||
33300863|NCT02175641|100996301|FG001|Overall Study|Death|4|||
33300864|NCT02175641|100996300|FG000|Overall Study|Lost to Follow-up|4|||
33300865|NCT02175641|100996301|FG001|Overall Study|Lost to Follow-up|4|||
33300866|NCT02175641|100996300|FG000|Overall Study|Withdrawal by Subject|7|||
33300867|NCT02175641|100996301|FG001|Overall Study|Withdrawal by Subject|4|||
33300868|NCT02175641|100996300|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
33300869|NCT02175641|100996301|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
33300870|NCT02175641|100996300|FG000|Overall Study|Developed Contraindicated Condition|8|||
33300871|NCT02175641|100996301|FG001|Overall Study|Developed Contraindicated Condition|0|||
33300872|NCT02248818|100996305|FG000|Screening|Protocol Violation|0|||
33300873|NCT02248818|100996306|FG001|Screening|Protocol Violation|0|||
33300874|NCT02248818|100996307|FG002|Screening|Protocol Violation|0|||
33300875|NCT02248818|100996308|FG003|Screening|Protocol Violation|0|||
33300876|NCT02248818|100996309|FG004|Screening|Protocol Violation|0|||
33300877|NCT02248818|100996310|FG005|Screening|Protocol Violation|0|||
33300878|NCT02248818|100996311|FG006|Screening|Protocol Violation|0|||
33300879|NCT02248818|100996312|FG007|Screening|Protocol Violation|0|||
33300880|NCT02248818|100996313|FG008|Screening|Protocol Violation|7|||
33300881|NCT02248818|100996305|FG000|Screening|Study fully enrolled|0|||
33300882|NCT02248818|100996306|FG001|Screening|Study fully enrolled|0|||
33300883|NCT02248818|100996307|FG002|Screening|Study fully enrolled|0|||
33300884|NCT02248818|100996308|FG003|Screening|Study fully enrolled|0|||
33300885|NCT02248818|100996309|FG004|Screening|Study fully enrolled|0|||
33300886|NCT02248818|100996310|FG005|Screening|Study fully enrolled|0|||
33300887|NCT02248818|100996311|FG006|Screening|Study fully enrolled|0|||
33300888|NCT02248818|100996312|FG007|Screening|Study fully enrolled|0|||
33300889|NCT02248818|100996313|FG008|Screening|Study fully enrolled|14|||
33300890|NCT02248818|100996305|FG000|Screening|Physician Decision|0|||
33300891|NCT02248818|100996306|FG001|Screening|Physician Decision|0|||
33300892|NCT02248818|100996307|FG002|Screening|Physician Decision|0|||
33300893|NCT02248818|100996308|FG003|Screening|Physician Decision|0|||
33300894|NCT02248818|100996309|FG004|Screening|Physician Decision|0|||
33300895|NCT02248818|100996310|FG005|Screening|Physician Decision|0|||
33300896|NCT02248818|100996311|FG006|Screening|Physician Decision|0|||
33300897|NCT02248818|100996312|FG007|Screening|Physician Decision|0|||
33300898|NCT02248818|100996313|FG008|Screening|Physician Decision|73|||
33300899|NCT02248818|100996305|FG000|Screening|Withdrawal by Subject|0|||
33300900|NCT02248818|100996306|FG001|Screening|Withdrawal by Subject|0|||
33300901|NCT02248818|100996307|FG002|Screening|Withdrawal by Subject|0|||
33300902|NCT02248818|100996308|FG003|Screening|Withdrawal by Subject|0|||
33300903|NCT02248818|100996309|FG004|Screening|Withdrawal by Subject|0|||
33300904|NCT02248818|100996310|FG005|Screening|Withdrawal by Subject|0|||
33300905|NCT02248818|100996311|FG006|Screening|Withdrawal by Subject|0|||
33190430|NCT00213148|100601686|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
33300906|NCT02248818|100996312|FG007|Screening|Withdrawal by Subject|0|||
33496949|NCT02570308|101713779|FG000|Overall Study|Withdrawal by Subject|0|||
33300907|NCT02248818|100996313|FG008|Screening|Withdrawal by Subject|6|||
33300908|NCT02248818|100996305|FG000|Screening|Lost to Follow-up|0|||
33300909|NCT02248818|100996306|FG001|Screening|Lost to Follow-up|0|||
33300910|NCT02248818|100996307|FG002|Screening|Lost to Follow-up|0|||
33300911|NCT02248818|100996308|FG003|Screening|Lost to Follow-up|0|||
33300912|NCT02248818|100996309|FG004|Screening|Lost to Follow-up|0|||
33300913|NCT02248818|100996310|FG005|Screening|Lost to Follow-up|0|||
33300914|NCT02248818|100996311|FG006|Screening|Lost to Follow-up|0|||
33300915|NCT02248818|100996312|FG007|Screening|Lost to Follow-up|0|||
33300916|NCT02248818|100996313|FG008|Screening|Lost to Follow-up|7|||
33300917|NCT02248818|100996305|FG000|Randomised Study|Administrative - randomization error|0|||
33300918|NCT02248818|100996306|FG001|Randomised Study|Administrative - randomization error|0|||
33300919|NCT02248818|100996307|FG002|Randomised Study|Administrative - randomization error|0|||
33300920|NCT02248818|100996308|FG003|Randomised Study|Administrative - randomization error|0|||
33300921|NCT02248818|100996309|FG004|Randomised Study|Administrative - randomization error|0|||
33300922|NCT02248818|100996310|FG005|Randomised Study|Administrative - randomization error|8|||
33300923|NCT02248818|100996311|FG006|Randomised Study|Administrative - randomization error|0|||
33300924|NCT02248818|100996312|FG007|Randomised Study|Administrative - randomization error|0|||
33300925|NCT02248818|100996313|FG008|Randomised Study|Administrative - randomization error|0|||
33300926|NCT01281839|100996318|FG000|Overall Study|Lost to Follow-up|6|||
33300927|NCT01281839|100996319|FG001|Overall Study|Lost to Follow-up|3|||
33300928|NCT01281839|100996318|FG000|Overall Study|Withdrawal by Subject|4|||
33300929|NCT01281839|100996319|FG001|Overall Study|Withdrawal by Subject|10|||
33300930|NCT01281839|100996318|FG000|Overall Study|Reason not specified|0|||
33300931|NCT01281839|100996319|FG001|Overall Study|Reason not specified|1|||
33300932|NCT01305239|100996322|FG000|Overall Study|Adverse Event|22|||
33300933|NCT01305239|100996322|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
33300934|NCT00324116|100996323|FG000|Overall Study|Adverse Event|5|||
33300935|NCT00324116|100996323|FG000|Overall Study|Lack of Efficacy|17|||
33300936|NCT00324116|100996323|FG000|Overall Study|Withdrawal by Subject|5|||
33300937|NCT00324116|100996323|FG000|Overall Study|Other|5|||
33300938|NCT03921723|100996325|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
33300939|NCT03921723|100996325|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
33300940|NCT00951015|100996326|FG000|Randomization Phase 96 Week|Adverse Event|1|||
33300941|NCT00951015|100996327|FG001|Randomization Phase 96 Week|Adverse Event|1|||
33300942|NCT00951015|100996328|FG002|Randomization Phase 96 Week|Adverse Event|2|||
33300943|NCT00951015|100996329|FG003|Randomization Phase 96 Week|Adverse Event|5|||
33300944|NCT00951015|100996330|FG004|Randomization Phase 96 Week|Adverse Event|0|||
33300945|NCT00951015|100996326|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
33300946|NCT00951015|100996327|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
33300947|NCT00951015|100996328|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
33300948|NCT00951015|100996329|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
33300949|NCT00951015|100996330|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
33300950|NCT00951015|100996326|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
33300951|NCT00951015|100996327|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
33300952|NCT00951015|100996328|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
33300953|NCT00951015|100996329|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
33300954|NCT00951015|100996330|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
33300955|NCT00951015|100996326|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
33300956|NCT00951015|100996327|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
33300957|NCT00951015|100996328|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
33300958|NCT00951015|100996329|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
33300959|NCT00951015|100996330|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
33300960|NCT00951015|100996326|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
33300961|NCT00951015|100996327|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
33300962|NCT00951015|100996328|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
33300963|NCT00951015|100996329|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
33300964|NCT00951015|100996330|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
33300965|NCT00951015|100996326|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
33300966|NCT00951015|100996327|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
33300967|NCT00951015|100996328|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
33300968|NCT00951015|100996329|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
33300969|NCT00951015|100996330|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
33300970|NCT00951015|100996326|FG000|Open-label Phase|Adverse Event|0|||
33300971|NCT00951015|100996327|FG001|Open-label Phase|Adverse Event|0|||
33300972|NCT00951015|100996328|FG002|Open-label Phase|Adverse Event|0|||
33300973|NCT00951015|100996329|FG003|Open-label Phase|Adverse Event|0|||
33300974|NCT00951015|100996330|FG004|Open-label Phase|Adverse Event|3|||
33300975|NCT00951015|100996326|FG000|Open-label Phase|Lack of Efficacy|0|||
33300976|NCT00951015|100996327|FG001|Open-label Phase|Lack of Efficacy|0|||
33300977|NCT00951015|100996328|FG002|Open-label Phase|Lack of Efficacy|0|||
33300978|NCT00951015|100996329|FG003|Open-label Phase|Lack of Efficacy|0|||
33300979|NCT00951015|100996330|FG004|Open-label Phase|Lack of Efficacy|1|||
33300980|NCT00951015|100996326|FG000|Open-label Phase|Protocol Violation|0|||
33300981|NCT00951015|100996327|FG001|Open-label Phase|Protocol Violation|0|||
33300982|NCT00951015|100996328|FG002|Open-label Phase|Protocol Violation|0|||
33300983|NCT00951015|100996329|FG003|Open-label Phase|Protocol Violation|0|||
33300984|NCT00951015|100996330|FG004|Open-label Phase|Protocol Violation|12|||
33300985|NCT00951015|100996326|FG000|Open-label Phase|Lost to Follow-up|0|||
33300986|NCT00951015|100996327|FG001|Open-label Phase|Lost to Follow-up|0|||
33300987|NCT00951015|100996328|FG002|Open-label Phase|Lost to Follow-up|0|||
33300988|NCT00951015|100996329|FG003|Open-label Phase|Lost to Follow-up|0|||
33300989|NCT00951015|100996330|FG004|Open-label Phase|Lost to Follow-up|12|||
33300990|NCT00951015|100996326|FG000|Open-label Phase|Withdrawal by Subject|0|||
33300991|NCT00951015|100996327|FG001|Open-label Phase|Withdrawal by Subject|0|||
33300992|NCT00951015|100996328|FG002|Open-label Phase|Withdrawal by Subject|0|||
33300993|NCT00951015|100996329|FG003|Open-label Phase|Withdrawal by Subject|0|||
33300994|NCT00951015|100996330|FG004|Open-label Phase|Withdrawal by Subject|14|||
33300995|NCT00951015|100996326|FG000|Open-label Phase|Physician Decision|0|||
33300996|NCT00951015|100996327|FG001|Open-label Phase|Physician Decision|0|||
33300997|NCT00951015|100996328|FG002|Open-label Phase|Physician Decision|0|||
33300998|NCT00951015|100996329|FG003|Open-label Phase|Physician Decision|0|||
33300999|NCT00951015|100996330|FG004|Open-label Phase|Physician Decision|8|||
33301000|NCT02971761|100996331|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
33301001|NCT04927247|100996332|FG000|Overall Study|Other|2|||
33301002|NCT04927247|100996333|FG001|Overall Study|Other|1|||
33301003|NCT04927247|100996332|FG000|Overall Study|Physician Decision|0|||
33301004|NCT04927247|100996333|FG001|Overall Study|Physician Decision|1|||
33301005|NCT04927247|100996332|FG000|Overall Study|Adverse Event|1|||
33301006|NCT04927247|100996333|FG001|Overall Study|Adverse Event|0|||
33301007|NCT01399697|100996334|FG000|Overall Study|Adverse Event|13|||
33301008|NCT01399697|100996335|FG001|Overall Study|Adverse Event|3|||
33301009|NCT01399697|100996336|FG002|Overall Study|Adverse Event|1|||
33301010|NCT01399697|100996334|FG000|Overall Study|Lost to Follow-up|2|||
33301011|NCT01399697|100996335|FG001|Overall Study|Lost to Follow-up|0|||
33301012|NCT01399697|100996336|FG002|Overall Study|Lost to Follow-up|0|||
33301013|NCT01399697|100996334|FG000|Overall Study|Withdrawal by Subject|8|||
33301014|NCT01399697|100996335|FG001|Overall Study|Withdrawal by Subject|0|||
33301015|NCT01399697|100996336|FG002|Overall Study|Withdrawal by Subject|0|||
33301016|NCT01399697|100996334|FG000|Overall Study|Investigator Decisión|1|||
33301017|NCT01399697|100996335|FG001|Overall Study|Investigator Decisión|0|||
33301018|NCT01399697|100996336|FG002|Overall Study|Investigator Decisión|2|||
33301019|NCT01399697|100996334|FG000|Overall Study|Lack of Efficacy|9|||
33301020|NCT01399697|100996335|FG001|Overall Study|Lack of Efficacy|0|||
33301021|NCT01399697|100996336|FG002|Overall Study|Lack of Efficacy|1|||
33301022|NCT01399697|100996334|FG000|Overall Study|Protocol Violation|2|||
33301023|NCT01399697|100996335|FG001|Overall Study|Protocol Violation|0|||
33301024|NCT01399697|100996336|FG002|Overall Study|Protocol Violation|0|||
33301025|NCT01399697|100996334|FG000|Overall Study|Non-Compliant|1|||
33301026|NCT01399697|100996335|FG001|Overall Study|Non-Compliant|0|||
33301027|NCT01399697|100996336|FG002|Overall Study|Non-Compliant|0|||
33301028|NCT01399697|100996334|FG000|Overall Study|Inclusion Error|2|||
33301029|NCT01399697|100996335|FG001|Overall Study|Inclusion Error|0|||
33301030|NCT01399697|100996336|FG002|Overall Study|Inclusion Error|0|||
33301031|NCT01399697|100996334|FG000|Overall Study|Positive result for hepatitis B|1|||
33301032|NCT01399697|100996335|FG001|Overall Study|Positive result for hepatitis B|0|||
33301033|NCT01399697|100996336|FG002|Overall Study|Positive result for hepatitis B|0|||
33301034|NCT01399697|100996334|FG000|Overall Study|Clinical RA remission|1|||
33301035|NCT01399697|100996335|FG001|Overall Study|Clinical RA remission|0|||
33301036|NCT01399697|100996336|FG002|Overall Study|Clinical RA remission|0|||
33301037|NCT01399697|100996334|FG000|Overall Study|Sponsor Decision|1|||
33301038|NCT01399697|100996335|FG001|Overall Study|Sponsor Decision|0|||
33301039|NCT01399697|100996336|FG002|Overall Study|Sponsor Decision|0|||
33301040|NCT00127205|100996337|FG000|Overall Study|Adverse Event|228|||
33496950|NCT02570308|101713780|FG001|Overall Study|Withdrawal by Subject|0|||
33496951|NCT02570308|101713781|FG002|Overall Study|Withdrawal by Subject|0|||
33496952|NCT02570308|101713782|FG003|Overall Study|Withdrawal by Subject|0|||
33496953|NCT02570308|101713783|FG004|Overall Study|Withdrawal by Subject|1|||
33496954|NCT02570308|101713779|FG000|Overall Study|Other|0|||
33496955|NCT02570308|101713780|FG001|Overall Study|Other|0|||
33496956|NCT02570308|101713781|FG002|Overall Study|Other|0|||
33496957|NCT02570308|101713782|FG003|Overall Study|Other|0|||
33301041|NCT00127205|100996338|FG001|Overall Study|Adverse Event|387|||
33301042|NCT00127205|100996339|FG002|Overall Study|Adverse Event|273|||
33301043|NCT00127205|100996337|FG000|Overall Study|Death|8|||
33301044|NCT00127205|100996338|FG001|Overall Study|Death|6|||
33496958|NCT02570308|101713783|FG004|Overall Study|Other|2|||
33301045|NCT00127205|100996339|FG002|Overall Study|Death|5|||
33301046|NCT00127205|100996337|FG000|Overall Study|Withdrawal by Subject|318|||
33301047|NCT00127205|100996338|FG001|Overall Study|Withdrawal by Subject|310|||
33301048|NCT00127205|100996339|FG002|Overall Study|Withdrawal by Subject|172|||
33496959|NCT00365794|101713784|FG000|Overall Study|Withdrawal by Subject|2|||
33496960|NCT02712320|101713785|FG000|Overall Study|Lost to Follow-up|1|||
33301049|NCT00127205|100996337|FG000|Overall Study|Other-non protocol specified|142|||
33301050|NCT00127205|100996338|FG001|Overall Study|Other-non protocol specified|129|||
33301051|NCT00127205|100996339|FG002|Overall Study|Other-non protocol specified|77|||
33301052|NCT00127205|100996337|FG000|Overall Study|Data not reported|6|||
33600187|NCT02914548|102088539|FG001|Overall Study|Protocol Violation|0|||
33301053|NCT00127205|100996338|FG001|Overall Study|Data not reported|10|||
33301054|NCT00127205|100996339|FG002|Overall Study|Data not reported|1|||
33301055|NCT00127205|100996337|FG000|Overall Study|Progression|127|||
33301056|NCT00127205|100996338|FG001|Overall Study|Progression|131|||
33301057|NCT00127205|100996339|FG002|Overall Study|Progression|84|||
33301058|NCT02001064|100996340|FG000|Overall Study|Withdrawal by Subject|2|||
33301059|NCT02001064|100996341|FG001|Overall Study|Withdrawal by Subject|1|||
33301060|NCT01401153|100996345|FG000|First Test Day|Learning disabilities; illness|1|||
33301061|NCT01401153|100996346|FG001|First Test Day|Learning disabilities; illness|10|||
33301062|NCT01401153|100996345|FG000|Second Test Day|illness|0|||
33301063|NCT01401153|100996346|FG001|Second Test Day|illness|5|||
33301064|NCT03868787|100996354|FG000|Overall Study|Withdrawal by Subject|2|||
33301065|NCT03868787|100996355|FG001|Overall Study|Withdrawal by Subject|1|||
33301066|NCT01977677|100996358|FG000|Overall Study|Unrelated Adverse Event|0|||
33301067|NCT01977677|100996359|FG001|Overall Study|Unrelated Adverse Event|0|||
33301068|NCT01977677|100996360|FG002|Overall Study|Unrelated Adverse Event|1|||
33301069|NCT01137578|100996365|FG000|Overall Study|Participant requested to Discontinue|3|||
33301070|NCT01137578|100996366|FG001|Overall Study|Participant requested to Discontinue|0|||
33301071|NCT01137578|100996367|FG002|Overall Study|Participant requested to Discontinue|0|||
33301072|NCT01137578|100996365|FG000|Overall Study|Withdrawal by Subject|1|||
33301073|NCT01137578|100996366|FG001|Overall Study|Withdrawal by Subject|0|||
33301074|NCT01137578|100996367|FG002|Overall Study|Withdrawal by Subject|0|||
33301075|NCT01137578|100996365|FG000|Overall Study|Other|12|||
33301076|NCT01137578|100996366|FG001|Overall Study|Other|2|||
33301077|NCT01137578|100996367|FG002|Overall Study|Other|6|||
33301078|NCT01598662|100996371|FG000|Overall Study|Lost to Follow-up|10|||
33301079|NCT01598662|100996372|FG001|Overall Study|Lost to Follow-up|17|||
33301080|NCT01598662|100996371|FG000|Overall Study|Physician Decision|1|||
33301081|NCT01598662|100996372|FG001|Overall Study|Physician Decision|2|||
33301082|NCT01598662|100996371|FG000|Overall Study|IUD expelled before month 6|0|||
33301083|NCT01598662|100996372|FG001|Overall Study|IUD expelled before month 6|2|||
33301084|NCT03738423|100996373|FG000|Overall Study|Withdrawal by Subject|9|||
33301085|NCT03738423|100996374|FG001|Overall Study|Withdrawal by Subject|12|||
33301086|NCT03738423|100996375|FG002|Overall Study|Withdrawal by Subject|9|||
33301087|NCT03738423|100996376|FG003|Overall Study|Withdrawal by Subject|12|||
33301088|NCT03738423|100996377|FG004|Overall Study|Withdrawal by Subject|10|||
33301089|NCT03738423|100996373|FG000|Overall Study|Lack of Efficacy|3|||
33301090|NCT03738423|100996374|FG001|Overall Study|Lack of Efficacy|1|||
33301091|NCT03738423|100996375|FG002|Overall Study|Lack of Efficacy|1|||
33301092|NCT03738423|100996376|FG003|Overall Study|Lack of Efficacy|1|||
33301093|NCT03738423|100996377|FG004|Overall Study|Lack of Efficacy|2|||
33301094|NCT03738423|100996373|FG000|Overall Study|Lost to Follow-up|1|||
33301095|NCT03738423|100996374|FG001|Overall Study|Lost to Follow-up|0|||
33301096|NCT03738423|100996375|FG002|Overall Study|Lost to Follow-up|1|||
33301097|NCT03738423|100996376|FG003|Overall Study|Lost to Follow-up|1|||
33301098|NCT03738423|100996377|FG004|Overall Study|Lost to Follow-up|0|||
33301099|NCT03738423|100996373|FG000|Overall Study|Protocol Violation|1|||
33301100|NCT03738423|100996374|FG001|Overall Study|Protocol Violation|0|||
33301101|NCT03738423|100996375|FG002|Overall Study|Protocol Violation|0|||
33301102|NCT03738423|100996376|FG003|Overall Study|Protocol Violation|0|||
33301103|NCT03738423|100996377|FG004|Overall Study|Protocol Violation|1|||
33301104|NCT03738423|100996373|FG000|Overall Study|Physician Decision|0|||
33301105|NCT03738423|100996374|FG001|Overall Study|Physician Decision|0|||
33301106|NCT03738423|100996375|FG002|Overall Study|Physician Decision|1|||
33301107|NCT03738423|100996376|FG003|Overall Study|Physician Decision|0|||
33301108|NCT03738423|100996377|FG004|Overall Study|Physician Decision|1|||
33301109|NCT03738423|100996373|FG000|Overall Study|Death|0|||
33301110|NCT03738423|100996374|FG001|Overall Study|Death|0|||
33301111|NCT03738423|100996375|FG002|Overall Study|Death|0|||
33301112|NCT03738423|100996376|FG003|Overall Study|Death|0|||
33393527|NCT00117572|101328506|FG001|Overall Study|Site withdrew before starting treatment|3|||
33393528|NCT00117572|101328505|FG000|Overall Study|Withdrawal by Subject|3|||
33393529|NCT00117572|101328506|FG001|Overall Study|Withdrawal by Subject|3|||
33301113|NCT03738423|100996377|FG004|Overall Study|Death|1|||
33301114|NCT03738423|100996373|FG000|Overall Study|Randomized but never treated|0|||
33301115|NCT03738423|100996374|FG001|Overall Study|Randomized but never treated|0|||
33301116|NCT03738423|100996375|FG002|Overall Study|Randomized but never treated|1|||
33301117|NCT03738423|100996376|FG003|Overall Study|Randomized but never treated|1|||
33301118|NCT03738423|100996377|FG004|Overall Study|Randomized but never treated|0|||
33301119|NCT01725126|100996382|FG000|Overall Study|Protocol Violation|0|||
33301120|NCT01725126|100996383|FG001|Overall Study|Protocol Violation|1|||
33301121|NCT01725126|100996384|FG002|Overall Study|Protocol Violation|0|||
33393530|NCT00117572|101328505|FG000|Overall Study|Protocol Violation|1|||
33301122|NCT01725126|100996385|FG003|Overall Study|Protocol Violation|0|||
33301123|NCT01725126|100996386|FG004|Overall Study|Protocol Violation|0|||
33301124|NCT01725126|100996387|FG005|Overall Study|Protocol Violation|0|||
33301125|NCT01725126|100996382|FG000|Overall Study|Withdrawal by Subject|0|||
33393531|NCT00117572|101328506|FG001|Overall Study|Protocol Violation|0|||
33301126|NCT01725126|100996383|FG001|Overall Study|Withdrawal by Subject|0|||
33301127|NCT01725126|100996384|FG002|Overall Study|Withdrawal by Subject|0|||
33301128|NCT01725126|100996385|FG003|Overall Study|Withdrawal by Subject|1|||
33301129|NCT01725126|100996386|FG004|Overall Study|Withdrawal by Subject|0|||
33301130|NCT01725126|100996387|FG005|Overall Study|Withdrawal by Subject|0|||
33301131|NCT02591953|100996388|FG000|Overall Study|Lost to Follow-up|6|||
33301132|NCT02591953|100996389|FG001|Overall Study|Lost to Follow-up|6|||
33301133|NCT02383940|100996395|FG000|Overall Study|Adverse Event|1|||
33301134|NCT02383940|100996396|FG001|Overall Study|Adverse Event|0|||
33301135|NCT02383940|100996395|FG000|Overall Study|Lost to Follow-up|2|||
33301136|NCT02383940|100996396|FG001|Overall Study|Lost to Follow-up|2|||
33301137|NCT02383940|100996395|FG000|Overall Study|Physician Decision|2|||
33301138|NCT02383940|100996396|FG001|Overall Study|Physician Decision|0|||
33301139|NCT02383940|100996395|FG000|Overall Study|Withdrawal by Subject|1|||
33301140|NCT02383940|100996396|FG001|Overall Study|Withdrawal by Subject|1|||
33301141|NCT02383940|100996395|FG000|Overall Study|Randomized but not treated|2|||
33301142|NCT02383940|100996396|FG001|Overall Study|Randomized but not treated|0|||
33301143|NCT02383940|100996395|FG000|Overall Study|Other than specified above|1|||
33301144|NCT02383940|100996396|FG001|Overall Study|Other than specified above|0|||
33301145|NCT01484431|100996397|FG000|Period 1: High Dose|Physician Decision|0|||
33301146|NCT01484431|100996398|FG001|Period 1: High Dose|Physician Decision|1|||
33301147|NCT01484431|100996399|FG002|Period 1: High Dose|Physician Decision|0|||
33301148|NCT01484431|100996397|FG000|Period 2|Death|0|||
33301149|NCT01484431|100996398|FG001|Period 2|Death|1|||
33301150|NCT01484431|100996399|FG002|Period 2|Death|1|||
33301151|NCT01484431|100996397|FG000|Period 2|Physician Decision|0|||
33301152|NCT01484431|100996398|FG001|Period 2|Physician Decision|0|||
33301153|NCT01484431|100996399|FG002|Period 2|Physician Decision|1|||
33301154|NCT01484431|100996397|FG000|Period 2|Non-Compliance with Study Drug|1|||
33301155|NCT01484431|100996398|FG001|Period 2|Non-Compliance with Study Drug|0|||
33301156|NCT01484431|100996399|FG002|Period 2|Non-Compliance with Study Drug|0|||
33301157|NCT00316017|100996401|FG000|Overall Study|Protocol Violation|11|||
33301158|NCT00316017|100996402|FG001|Overall Study|Protocol Violation|13|||
33301159|NCT00316017|100996403|FG002|Overall Study|Protocol Violation|19|||
33301160|NCT02311673|100996404|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
33301161|NCT02311673|100996405|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
33301162|NCT02311673|100996406|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
33301163|NCT02311673|100996407|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
33301164|NCT01685229|100996408|FG000|Overall Study|Subjects missing Study Exit form|3|||
33301165|NCT01685229|100996409|FG001|Overall Study|Subjects missing Study Exit form|1|||
33301166|NCT01685229|100996408|FG000|Overall Study|Lost to Follow-up|16|||
33301167|NCT01685229|100996409|FG001|Overall Study|Lost to Follow-up|10|||
33301168|NCT01685229|100996408|FG000|Overall Study|Withdrawal by Subject|6|||
33301169|NCT01685229|100996409|FG001|Overall Study|Withdrawal by Subject|5|||
33301170|NCT01685229|100996408|FG000|Overall Study|Death|1|||
33301171|NCT01685229|100996409|FG001|Overall Study|Death|0|||
33301172|NCT04307940|100996414|FG000|Overall Study|Adverse Event|1|||
33301173|NCT04307940|100996415|FG001|Overall Study|Adverse Event|0|||
33301174|NCT04307940|100996416|FG002|Overall Study|Adverse Event|0|||
33301175|NCT04307940|100996414|FG000|Overall Study|Withdrawal by Subject|2|||
33301176|NCT04307940|100996415|FG001|Overall Study|Withdrawal by Subject|3|||
33301177|NCT04307940|100996416|FG002|Overall Study|Withdrawal by Subject|1|||
33301178|NCT04307940|100996414|FG000|Overall Study|Lost to Follow-up|2|||
33301179|NCT04307940|100996415|FG001|Overall Study|Lost to Follow-up|0|||
33301180|NCT04307940|100996416|FG002|Overall Study|Lost to Follow-up|1|||
33301181|NCT02706405|100996417|FG000|Overall Study|Death|3|||
33301182|NCT02706405|100996418|FG001|Overall Study|Death|2|||
33301183|NCT02706405|100996419|FG002|Overall Study|Death|0|||
33301184|NCT02706405|100996420|FG003|Overall Study|Death|1|||
33301185|NCT02706405|100996421|FG004|Overall Study|Death|0|||
33301186|NCT02706405|100996422|FG005|Overall Study|Death|0|||
33190431|NCT00213148|100601687|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
33190432|NCT00213148|100601688|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
33301187|NCT02706405|100996423|FG006|Overall Study|Death|3|||
33301188|NCT02706405|100996424|FG007|Overall Study|Death|4|||
33301189|NCT02706405|100996417|FG000|Overall Study|Disease progression|0|||
33301190|NCT02706405|100996418|FG001|Overall Study|Disease progression|0|||
33301191|NCT02706405|100996419|FG002|Overall Study|Disease progression|0|||
33301192|NCT02706405|100996420|FG003|Overall Study|Disease progression|0|||
33301193|NCT02706405|100996421|FG004|Overall Study|Disease progression|0|||
33301194|NCT02706405|100996422|FG005|Overall Study|Disease progression|0|||
33301195|NCT02706405|100996423|FG006|Overall Study|Disease progression|0|||
33301196|NCT02706405|100996424|FG007|Overall Study|Disease progression|1|||
33301197|NCT02706405|100996417|FG000|Overall Study|Pt moved to new therapy|0|||
33301198|NCT02706405|100996418|FG001|Overall Study|Pt moved to new therapy|0|||
33190433|NCT00213148|100601689|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
33301199|NCT02706405|100996419|FG002|Overall Study|Pt moved to new therapy|0|||
33301200|NCT02706405|100996420|FG003|Overall Study|Pt moved to new therapy|0|||
33301201|NCT02706405|100996421|FG004|Overall Study|Pt moved to new therapy|0|||
33301202|NCT02706405|100996422|FG005|Overall Study|Pt moved to new therapy|1|||
33301203|NCT02706405|100996423|FG006|Overall Study|Pt moved to new therapy|0|||
33301204|NCT02706405|100996424|FG007|Overall Study|Pt moved to new therapy|1|||
33301205|NCT02706405|100996417|FG000|Overall Study|Physician Decision|1|||
33301206|NCT02706405|100996418|FG001|Overall Study|Physician Decision|0|||
33301207|NCT02706405|100996419|FG002|Overall Study|Physician Decision|0|||
33301208|NCT02706405|100996420|FG003|Overall Study|Physician Decision|0|||
33301209|NCT02706405|100996421|FG004|Overall Study|Physician Decision|0|||
33301210|NCT02706405|100996422|FG005|Overall Study|Physician Decision|0|||
33301211|NCT02706405|100996423|FG006|Overall Study|Physician Decision|0|||
33301212|NCT02706405|100996424|FG007|Overall Study|Physician Decision|0|||
33301213|NCT02242097|100996429|FG000|Ibrutinib Treatment|Adverse Event|16|||
33301214|NCT02242097|100996429|FG000|Ibrutinib Treatment|Physician Decision|1|||
33301215|NCT02242097|100996429|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
33301216|NCT02242097|100996429|FG000|Ibrutinib Treatment|Death|1|||
33301217|NCT02242097|100996429|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
33301218|NCT02242097|100996429|FG000|Post Therapy Follow Up|Death|3|||
33301219|NCT02242097|100996429|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
33301220|NCT02672852|100996430|FG000|Part A1|Disease Worsening|1|||
33301221|NCT02672852|100996431|FG001|Part A1|Disease Worsening|0|||
33301222|NCT02672852|100996432|FG002|Part A1|Disease Worsening|0|||
33301223|NCT02672852|100996433|FG003|Part A1|Disease Worsening|0|||
33301224|NCT02672852|100996434|FG004|Part A1|Disease Worsening|0|||
33301225|NCT02672852|100996435|FG005|Part A1|Disease Worsening|0|||
33301226|NCT02672852|100996436|FG006|Part A1|Disease Worsening|0|||
33301227|NCT02672852|100996430|FG000|Part A1|Adverse Event|0|||
33301228|NCT02672852|100996431|FG001|Part A1|Adverse Event|1|||
33301229|NCT02672852|100996432|FG002|Part A1|Adverse Event|0|||
33301230|NCT02672852|100996433|FG003|Part A1|Adverse Event|0|||
33301231|NCT02672852|100996434|FG004|Part A1|Adverse Event|0|||
33301232|NCT02672852|100996435|FG005|Part A1|Adverse Event|0|||
33301233|NCT02672852|100996436|FG006|Part A1|Adverse Event|0|||
33301234|NCT02672852|100996430|FG000|Part A1|Lost to Follow-up|1|||
33301235|NCT02672852|100996431|FG001|Part A1|Lost to Follow-up|2|||
33301236|NCT02672852|100996432|FG002|Part A1|Lost to Follow-up|0|||
33301237|NCT02672852|100996433|FG003|Part A1|Lost to Follow-up|0|||
33301238|NCT02672852|100996434|FG004|Part A1|Lost to Follow-up|0|||
33301239|NCT02672852|100996435|FG005|Part A1|Lost to Follow-up|0|||
33301240|NCT02672852|100996436|FG006|Part A1|Lost to Follow-up|0|||
33301241|NCT02672852|100996430|FG000|Part A1|Withdrawal by Subject|1|||
33301242|NCT02672852|100996431|FG001|Part A1|Withdrawal by Subject|1|||
33301243|NCT02672852|100996432|FG002|Part A1|Withdrawal by Subject|0|||
33301244|NCT02672852|100996433|FG003|Part A1|Withdrawal by Subject|0|||
33301245|NCT02672852|100996434|FG004|Part A1|Withdrawal by Subject|0|||
33301246|NCT02672852|100996435|FG005|Part A1|Withdrawal by Subject|0|||
33301247|NCT02672852|100996436|FG006|Part A1|Withdrawal by Subject|0|||
33301248|NCT02672852|100996430|FG000|Part A2|Disease worsening|0|||
33301249|NCT02672852|100996431|FG001|Part A2|Disease worsening|0|||
33301250|NCT02672852|100996432|FG002|Part A2|Disease worsening|1|||
33301251|NCT02672852|100996433|FG003|Part A2|Disease worsening|0|||
33301252|NCT02672852|100996434|FG004|Part A2|Disease worsening|0|||
33301253|NCT02672852|100996435|FG005|Part A2|Disease worsening|0|||
33301254|NCT02672852|100996436|FG006|Part A2|Disease worsening|0|||
33301255|NCT02672852|100996430|FG000|Part A2|Adverse Event|0|||
33301256|NCT02672852|100996431|FG001|Part A2|Adverse Event|0|||
33301257|NCT02672852|100996432|FG002|Part A2|Adverse Event|3|||
33301258|NCT02672852|100996433|FG003|Part A2|Adverse Event|0|||
33301259|NCT02672852|100996434|FG004|Part A2|Adverse Event|0|||
33301260|NCT02672852|100996435|FG005|Part A2|Adverse Event|0|||
33301261|NCT02672852|100996436|FG006|Part A2|Adverse Event|0|||
33190434|NCT00213148|100601685|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
33301262|NCT02672852|100996430|FG000|Part A2|Lost to Follow-up|0|||
33301263|NCT02672852|100996431|FG001|Part A2|Lost to Follow-up|0|||
33301264|NCT02672852|100996432|FG002|Part A2|Lost to Follow-up|2|||
33301265|NCT02672852|100996433|FG003|Part A2|Lost to Follow-up|0|||
33301266|NCT02672852|100996434|FG004|Part A2|Lost to Follow-up|0|||
33190435|NCT00213148|100601686|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
33190436|NCT00213148|100601687|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
33190437|NCT00213148|100601688|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
33190438|NCT00213148|100601689|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
33190439|NCT00213148|100601685|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
33301267|NCT02672852|100996435|FG005|Part A2|Lost to Follow-up|0|||
33301268|NCT02672852|100996436|FG006|Part A2|Lost to Follow-up|0|||
33301269|NCT02672852|100996430|FG000|Part A2|Withdrawal by Subject|0|||
33301270|NCT02672852|100996431|FG001|Part A2|Withdrawal by Subject|0|||
33190440|NCT00213148|100601686|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
33301271|NCT02672852|100996432|FG002|Part A2|Withdrawal by Subject|1|||
33301272|NCT02672852|100996433|FG003|Part A2|Withdrawal by Subject|0|||
33301273|NCT02672852|100996434|FG004|Part A2|Withdrawal by Subject|0|||
33301274|NCT02672852|100996435|FG005|Part A2|Withdrawal by Subject|0|||
33301275|NCT02672852|100996436|FG006|Part A2|Withdrawal by Subject|0|||
33301276|NCT02672852|100996430|FG000|Part A2|Other|0|||
33301277|NCT02672852|100996431|FG001|Part A2|Other|0|||
33301278|NCT02672852|100996432|FG002|Part A2|Other|3|||
33301279|NCT02672852|100996433|FG003|Part A2|Other|0|||
33301280|NCT02672852|100996434|FG004|Part A2|Other|0|||
33301281|NCT02672852|100996435|FG005|Part A2|Other|0|||
33301282|NCT02672852|100996436|FG006|Part A2|Other|0|||
33301283|NCT02672852|100996430|FG000|Part A2|Not entered in Part B|0|||
33301284|NCT02672852|100996431|FG001|Part A2|Not entered in Part B|0|||
33301285|NCT02672852|100996432|FG002|Part A2|Not entered in Part B|0|||
33301286|NCT02672852|100996433|FG003|Part A2|Not entered in Part B|4|||
33301287|NCT02672852|100996434|FG004|Part A2|Not entered in Part B|0|||
33301288|NCT02672852|100996435|FG005|Part A2|Not entered in Part B|0|||
33301289|NCT02672852|100996436|FG006|Part A2|Not entered in Part B|0|||
33301290|NCT02672852|100996430|FG000|Part B|Disease worsening|0|||
33301291|NCT02672852|100996431|FG001|Part B|Disease worsening|0|||
33496961|NCT02712320|101713785|FG000|Overall Study|Withdrawal by Subject|1|||
33496962|NCT02712320|101713785|FG000|Overall Study|Transferred to another facility|1|||
33496963|NCT02712320|101713785|FG000|Overall Study|Treating with the prohibited medications|2|||
33496964|NCT00523848|101713786|FG000|Overall Study|Adverse Event|11|||
33496965|NCT00523848|101713786|FG000|Overall Study|Withdrawal by Subject|2|||
33496966|NCT00523848|101713786|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
33496967|NCT00523848|101713786|FG000|Overall Study|Disease Progression|5|||
33496968|NCT00523848|101713786|FG000|Overall Study|Other, unspecified|4|||
33496969|NCT03817853|101713790|FG000|Induction Phase|Adverse Event|5|||
33496970|NCT03817853|101713791|FG001|Induction Phase|Adverse Event|0|||
33496971|NCT03817853|101713792|FG002|Induction Phase|Adverse Event|0|||
33496972|NCT03817853|101713790|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
33496973|NCT03817853|101713791|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
33301292|NCT02672852|100996432|FG002|Part B|Disease worsening|0|||
33301293|NCT02672852|100996433|FG003|Part B|Disease worsening|0|||
33301294|NCT02672852|100996434|FG004|Part B|Disease worsening|1|||
33301295|NCT02672852|100996435|FG005|Part B|Disease worsening|0|||
33496974|NCT03817853|101713792|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
33496975|NCT03817853|101713790|FG000|Induction Phase|Physician Decision|2|||
33496976|NCT03817853|101713791|FG001|Induction Phase|Physician Decision|0|||
33496977|NCT03817853|101713792|FG002|Induction Phase|Physician Decision|0|||
33496978|NCT03817853|101713790|FG000|Induction Phase|Progressive Disease|6|||
33496979|NCT03817853|101713791|FG001|Induction Phase|Progressive Disease|0|||
33496980|NCT03817853|101713792|FG002|Induction Phase|Progressive Disease|0|||
33496981|NCT03817853|101713790|FG000|Induction Phase|Withdrawal by Subject|4|||
33496982|NCT03817853|101713791|FG001|Induction Phase|Withdrawal by Subject|0|||
33496983|NCT03817853|101713792|FG002|Induction Phase|Withdrawal by Subject|0|||
33496984|NCT03817853|101713790|FG000|Maintenance Phase|Adverse Event|0|||
33496985|NCT03817853|101713791|FG001|Maintenance Phase|Adverse Event|8|||
33496986|NCT03817853|101713792|FG002|Maintenance Phase|Adverse Event|0|||
33496987|NCT03817853|101713790|FG000|Maintenance Phase|Death|0|||
33496988|NCT03817853|101713791|FG001|Maintenance Phase|Death|5|||
33496989|NCT03817853|101713792|FG002|Maintenance Phase|Death|0|||
33496990|NCT03817853|101713790|FG000|Maintenance Phase|Progressive Disease|0|||
33496991|NCT03817853|101713791|FG001|Maintenance Phase|Progressive Disease|7|||
33496992|NCT03817853|101713792|FG002|Maintenance Phase|Progressive Disease|0|||
33496993|NCT03817853|101713790|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33496994|NCT03817853|101713791|FG001|Maintenance Phase|Withdrawal by Subject|2|||
33496995|NCT03817853|101713792|FG002|Maintenance Phase|Withdrawal by Subject|0|||
33496996|NCT03817853|101713790|FG000|Maintenance Phase|Physician Decision|0|||
33496997|NCT03817853|101713791|FG001|Maintenance Phase|Physician Decision|1|||
33496998|NCT03817853|101713792|FG002|Maintenance Phase|Physician Decision|0|||
33496999|NCT03817853|101713790|FG000|Maintenance Phase|Various reasons|0|||
33497000|NCT03817853|101713791|FG001|Maintenance Phase|Various reasons|4|||
33497001|NCT03817853|101713792|FG002|Maintenance Phase|Various reasons|0|||
33497002|NCT03817853|101713790|FG000|Maintenance Phase|Protocol Deviation|0|||
33497003|NCT03817853|101713791|FG001|Maintenance Phase|Protocol Deviation|1|||
33497004|NCT03817853|101713792|FG002|Maintenance Phase|Protocol Deviation|0|||
33190441|NCT00213148|100601687|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
33301296|NCT02672852|100996436|FG006|Part B|Disease worsening|1|||
33497005|NCT03817853|101713790|FG000|Follow-up Phase|Adverse Event|0|||
33301297|NCT02672852|100996430|FG000|Part B|Worsening pre-existing condition|0|||
33497006|NCT03817853|101713791|FG001|Follow-up Phase|Adverse Event|0|||
33497007|NCT03817853|101713792|FG002|Follow-up Phase|Adverse Event|2|||
33301298|NCT02672852|100996431|FG001|Part B|Worsening pre-existing condition|0|||
33301299|NCT02672852|100996432|FG002|Part B|Worsening pre-existing condition|0|||
33301300|NCT02672852|100996433|FG003|Part B|Worsening pre-existing condition|0|||
33497008|NCT03817853|101713790|FG000|Follow-up Phase|Death|0|||
33301301|NCT02672852|100996434|FG004|Part B|Worsening pre-existing condition|0|||
33301302|NCT02672852|100996435|FG005|Part B|Worsening pre-existing condition|1|||
33301303|NCT02672852|100996436|FG006|Part B|Worsening pre-existing condition|0|||
33497009|NCT03817853|101713791|FG001|Follow-up Phase|Death|0|||
33497010|NCT03817853|101713792|FG002|Follow-up Phase|Death|1|||
33497011|NCT03817853|101713790|FG000|Follow-up Phase|Progressive Disease|0|||
33497012|NCT03817853|101713791|FG001|Follow-up Phase|Progressive Disease|0|||
33497013|NCT03817853|101713792|FG002|Follow-up Phase|Progressive Disease|3|||
33497014|NCT03817853|101713790|FG000|Follow-up Phase|Withdrawal by Subject|0|||
33497015|NCT03817853|101713791|FG001|Follow-up Phase|Withdrawal by Subject|0|||
33497016|NCT03817853|101713792|FG002|Follow-up Phase|Withdrawal by Subject|1|||
33497017|NCT02389829|101713793|FG000|Overall Study|Lost to Follow-up|0|||
33497018|NCT02389829|101713794|FG001|Overall Study|Lost to Follow-up|1|||
33497019|NCT03170362|101713795|FG000|Overall Study|Death|2|||
33497020|NCT03170362|101713796|FG001|Overall Study|Death|2|||
33497021|NCT03170362|101713795|FG000|Overall Study|Withdrawal by Subject|23|||
33497022|NCT03170362|101713796|FG001|Overall Study|Withdrawal by Subject|22|||
33497023|NCT03170362|101713795|FG000|Overall Study|Lost to Follow-up|187|||
33497024|NCT03170362|101713796|FG001|Overall Study|Lost to Follow-up|167|||
33497025|NCT04620746|101713797|FG000|Overall Study|Adverse Event|2|||
33497026|NCT04620746|101713798|FG001|Overall Study|Adverse Event|0|||
33497027|NCT04620746|101713797|FG000|Overall Study|Uniterpretable skin test|1|||
33497028|NCT04620746|101713798|FG001|Overall Study|Uniterpretable skin test|0|||
33497029|NCT04620746|101713797|FG000|Overall Study|Withdrawal by Subject|0|||
33497030|NCT04620746|101713798|FG001|Overall Study|Withdrawal by Subject|1|||
33497031|NCT00063934|101713799|FG000|Overall Study|Ineligible|1|||
33497032|NCT02375971|101713801|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
33497033|NCT02375971|101713802|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
33497034|NCT02375971|101713803|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
33497035|NCT02375971|101713801|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
33497036|NCT02375971|101713802|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
33497037|NCT02375971|101713803|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
33497038|NCT02375971|101713801|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
33497039|NCT02375971|101713802|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
33497040|NCT02375971|101713803|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
33497041|NCT02375971|101713801|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
33497042|NCT02375971|101713802|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
33497043|NCT02375971|101713803|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
33497044|NCT02375971|101713801|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
33497045|NCT02375971|101713802|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
33497046|NCT02375971|101713803|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
33497047|NCT02375971|101713801|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
33497048|NCT02375971|101713802|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
33393532|NCT01347840|101328507|FG000|Overall Study|Withdrawal by Subject|1|||
33393533|NCT02903966|101328508|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
33497049|NCT02375971|101713803|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
33497050|NCT02375971|101713801|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
33497051|NCT02375971|101713802|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
33497052|NCT02375971|101713803|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
33497053|NCT02375971|101713801|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
33497054|NCT02375971|101713802|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
33497055|NCT02375971|101713803|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
33497056|NCT01882985|101713805|FG000|Overall Study|Lost to Follow-up|1|||
33497057|NCT01882985|101713805|FG000|Overall Study|Withdrawal by Subject|1|||
33497058|NCT01167140|101713806|FG000|Overall Study|Withdrawal by Subject|1|||
33497059|NCT00502242|101713809|FG000|Overall Study|Lack of Efficacy|1|||
33497060|NCT00502242|101713810|FG001|Overall Study|Lack of Efficacy|11|||
33497061|NCT00502242|101713809|FG000|Overall Study|Adverse Event|31|||
33497062|NCT00502242|101713810|FG001|Overall Study|Adverse Event|20|||
33497063|NCT00502242|101713809|FG000|Overall Study|Physician Decision|2|||
33497064|NCT00502242|101713810|FG001|Overall Study|Physician Decision|3|||
33497065|NCT00502242|101713809|FG000|Overall Study|Other - Unspecified|8|||
33497066|NCT00502242|101713810|FG001|Overall Study|Other - Unspecified|14|||
33497067|NCT00502242|101713809|FG000|Overall Study|Protocol Violation|3|||
33497068|NCT00502242|101713810|FG001|Overall Study|Protocol Violation|1|||
33497069|NCT00502242|101713809|FG000|Overall Study|Withdrawal by Subject|6|||
33497070|NCT00502242|101713810|FG001|Overall Study|Withdrawal by Subject|7|||
33497071|NCT00712712|101713813|FG000|Overall Study|Protocol Violation|11|||
33497072|NCT00712712|101713813|FG000|Overall Study|Radiofrequency not done|3|||
33497073|NCT00712712|101713813|FG000|Overall Study|Death|8|||
33497074|NCT00712712|101713813|FG000|Overall Study|Withdrawal by Subject|1|||
33497075|NCT01082328|101713814|FG000|Overall Study|Adverse Event|1|||
33497076|NCT01532934|101713815|FG000|Overall Study|Lost to Follow-up|11|||
33497077|NCT01532934|101713816|FG001|Overall Study|Lost to Follow-up|11|||
33600188|NCT02914548|102088540|FG002|Overall Study|Protocol Violation|0|||
33190442|NCT00213148|100601688|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
33190443|NCT00213148|100601689|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
33301304|NCT02672852|100996430|FG000|Part B|Other adverse event|0|||
33190444|NCT00213148|100601685|FG000|Cycle 1 (1 Month)|Other|3|||
33497078|NCT01532934|101713815|FG000|Overall Study|In controlled environment|3|||
33497079|NCT01532934|101713816|FG001|Overall Study|In controlled environment|2|||
33497080|NCT00778817|101713819|FG000|Overall Study|Adverse Event|2|||
33497081|NCT00778817|101713819|FG000|Overall Study|Withdrawal by Subject|2|||
33497082|NCT02714218|101713822|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33497083|NCT02714218|101713823|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
33497084|NCT02714218|101713824|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33497085|NCT02714218|101713822|FG000|Pre-Treatment Period|Other reasons|0|||
33497086|NCT02714218|101713823|FG001|Pre-Treatment Period|Other reasons|1|||
33497087|NCT02714218|101713824|FG002|Pre-Treatment Period|Other reasons|0|||
33497088|NCT02714218|101713822|FG000|Treatment Period|Disease Progression|55|||
33497089|NCT02714218|101713823|FG001|Treatment Period|Disease Progression|52|||
33497090|NCT02714218|101713824|FG002|Treatment Period|Disease Progression|14|||
33497091|NCT02714218|101713822|FG000|Treatment Period|Study drug toxicity|46|||
33497092|NCT02714218|101713823|FG001|Treatment Period|Study drug toxicity|70|||
33497093|NCT02714218|101713824|FG002|Treatment Period|Study drug toxicity|6|||
33497094|NCT02714218|101713822|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
33497095|NCT02714218|101713823|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
33497096|NCT02714218|101713824|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
33497097|NCT02714218|101713822|FG000|Treatment Period|Request to discontinue treatment|1|||
33497098|NCT02714218|101713823|FG001|Treatment Period|Request to discontinue treatment|4|||
33497099|NCT02714218|101713824|FG002|Treatment Period|Request to discontinue treatment|1|||
33497100|NCT02714218|101713822|FG000|Treatment Period|Participant withdrew consent|2|||
33497101|NCT02714218|101713823|FG001|Treatment Period|Participant withdrew consent|2|||
33497102|NCT02714218|101713824|FG002|Treatment Period|Participant withdrew consent|0|||
33497103|NCT02714218|101713822|FG000|Treatment Period|Maximum clinical benefit|4|||
33497104|NCT02714218|101713823|FG001|Treatment Period|Maximum clinical benefit|2|||
33497105|NCT02714218|101713824|FG002|Treatment Period|Maximum clinical benefit|0|||
33497106|NCT02714218|101713822|FG000|Treatment Period|Administrative reason by sponsor|2|||
33497107|NCT02714218|101713823|FG001|Treatment Period|Administrative reason by sponsor|1|||
33497108|NCT02714218|101713824|FG002|Treatment Period|Administrative reason by sponsor|0|||
33497109|NCT02714218|101713822|FG000|Treatment Period|Other reasons|6|||
33497110|NCT02714218|101713823|FG001|Treatment Period|Other reasons|6|||
33497111|NCT02714218|101713824|FG002|Treatment Period|Other reasons|0|||
33497112|NCT02714218|101713822|FG000|Treatment Period|Completed treatment as per protocol|36|||
33497113|NCT02714218|101713823|FG001|Treatment Period|Completed treatment as per protocol|27|||
33497114|NCT02714218|101713824|FG002|Treatment Period|Completed treatment as per protocol|3|||
33497115|NCT02714218|101713822|FG000|Treatment Period|Not reported|9|||
33497116|NCT02714218|101713823|FG001|Treatment Period|Not reported|6|||
33497117|NCT02714218|101713824|FG002|Treatment Period|Not reported|0|||
33497118|NCT02157376|101713825|FG000|Overall Study|Death|10|||
33497119|NCT02157376|101713826|FG001|Overall Study|Death|4|||
33497120|NCT02157376|101713825|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33497121|NCT02157376|101713826|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33497122|NCT02157376|101713825|FG000|Overall Study|Withdrawal by Subject|3|||
33497123|NCT02157376|101713826|FG001|Overall Study|Withdrawal by Subject|8|||
33497124|NCT02157376|101713825|FG000|Overall Study|Not treated|8|||
33497125|NCT02157376|101713826|FG001|Overall Study|Not treated|3|||
33497126|NCT02157376|101713825|FG000|Overall Study|Investigator's misjudgement|1|||
33497127|NCT02157376|101713826|FG001|Overall Study|Investigator's misjudgement|2|||
33497128|NCT01343043|101713827|FG000|Overall Study|Disease progression before treatment|1|||
33497129|NCT01343043|101713828|FG001|Overall Study|Disease progression before treatment|0|||
33497130|NCT01343043|101713829|FG002|Overall Study|Disease progression before treatment|0|||
33497131|NCT01343043|101713830|FG003|Overall Study|Disease progression before treatment|0|||
33497132|NCT01343043|101713827|FG000|Overall Study|Withdrawal by Subject|1|||
33497133|NCT01343043|101713828|FG001|Overall Study|Withdrawal by Subject|0|||
33497134|NCT01343043|101713829|FG002|Overall Study|Withdrawal by Subject|0|||
33301305|NCT02672852|100996431|FG001|Part B|Other adverse event|0|||
33497135|NCT01343043|101713830|FG003|Overall Study|Withdrawal by Subject|0|||
33497136|NCT01343043|101713827|FG000|Overall Study|Death|1|||
33497137|NCT01343043|101713828|FG001|Overall Study|Death|1|||
33497138|NCT01343043|101713829|FG002|Overall Study|Death|0|||
33497139|NCT01343043|101713830|FG003|Overall Study|Death|1|||
33497140|NCT01611883|101713831|FG000|Overall Study|Adverse Event|1|||
33497141|NCT01611883|101713832|FG001|Overall Study|Adverse Event|1|||
33497142|NCT02182843|101713833|FG000|Overall Study|Withdrawal by Subject|7|||
33497143|NCT02182843|101713833|FG000|Overall Study|Lost to Follow-up|2|||
33497144|NCT02182843|101713833|FG000|Overall Study|Adverse Event|1|||
33497145|NCT00014495|101713837|FG000|Overall Study|Death|0|||
33497146|NCT00014495|101713838|FG001|Overall Study|Death|0|||
33497147|NCT00014495|101713839|FG002|Overall Study|Death|1|||
33497148|NCT00014495|101713840|FG003|Overall Study|Death|0|||
33497149|NCT00014495|101713837|FG000|Overall Study|Clinical deterioration|0|||
33497150|NCT00014495|101713838|FG001|Overall Study|Clinical deterioration|0|||
33301306|NCT02672852|100996432|FG002|Part B|Other adverse event|0|||
33497151|NCT00014495|101713839|FG002|Overall Study|Clinical deterioration|0|||
33497152|NCT00014495|101713840|FG003|Overall Study|Clinical deterioration|1|||
33497153|NCT00455403|101713841|FG000|Overall Study|Lost to Follow-up|2|||
33497154|NCT00455403|101713842|FG001|Overall Study|Lost to Follow-up|1|||
33497155|NCT00455403|101713841|FG000|Overall Study|Withdrawal by Subject|1|||
33497156|NCT00455403|101713842|FG001|Overall Study|Withdrawal by Subject|3|||
33497157|NCT00455403|101713841|FG000|Overall Study|Protocol Violation|0|||
33497158|NCT00455403|101713842|FG001|Overall Study|Protocol Violation|2|||
33497159|NCT00856193|101713843|FG000|Period 2|Abnormal test procedure results|0|||
33497160|NCT00856193|101713844|FG001|Period 2|Abnormal test procedure results|1|||
33497161|NCT00856193|101713843|FG000|Period 2|Lost to Follow-up|0|||
33497162|NCT00856193|101713844|FG001|Period 2|Lost to Follow-up|1|||
33497163|NCT00958828|101713847|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
33497164|NCT00958828|101713848|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
33497165|NCT00958828|101713847|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
33497166|NCT00958828|101713848|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
33497167|NCT00669669|101713853|FG000|Overall Study|To late to start treatment|1|||
33497168|NCT00594165|101713886|FG000|Overall Study|Major protocol violation|1|||
33497169|NCT00594165|101713886|FG000|Overall Study|Lack of Efficacy|12|||
33497170|NCT00594165|101713886|FG000|Overall Study|Adverse Event|52|||
33497171|NCT00594165|101713886|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
33497172|NCT00594165|101713886|FG000|Overall Study|Subject withdrew consent|27|||
33497173|NCT00594165|101713886|FG000|Overall Study|Study ended per sponsor|102|||
33497174|NCT00594165|101713886|FG000|Overall Study|Lost to Follow-up|4|||
33497175|NCT00594165|101713886|FG000|Overall Study|Other: PI discretion|5|||
33497176|NCT00594165|101713886|FG000|Overall Study|Other: Subject moving|3|||
33497177|NCT00594165|101713886|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
33497178|NCT00594165|101713886|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
33497179|NCT00594165|101713886|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
33497180|NCT00594165|101713886|FG000|Overall Study|Other: Site terminated participation|2|||
33497181|NCT04200651|101713887|FG000|Overall Study|Moved to another country during follow-up|2|||
33497182|NCT04200651|101713888|FG001|Overall Study|Moved to another country during follow-up|2|||
33497183|NCT04200651|101713887|FG000|Overall Study|Lost to Follow-up|1|||
33497184|NCT04200651|101713888|FG001|Overall Study|Lost to Follow-up|3|||
33497185|NCT04909853|101713891|FG000|Part 1|Assigned but not treated|0|||
33497186|NCT04909853|101713892|FG001|Part 1|Assigned but not treated|0|||
33497187|NCT04909853|101713893|FG002|Part 1|Assigned but not treated|1|||
33497188|NCT04909853|101713894|FG003|Part 1|Assigned but not treated|0|||
33497189|NCT04909853|101713891|FG000|Part 2|Adverse Event|0|||
33497190|NCT04909853|101713892|FG001|Part 2|Adverse Event|0|||
33497191|NCT04909853|101713893|FG002|Part 2|Adverse Event|0|||
33497192|NCT04909853|101713894|FG003|Part 2|Adverse Event|1|||
33497193|NCT04421131|101713895|FG000|Overall Study|Lost to Follow-up|1|||
33497194|NCT04421131|101713895|FG000|Overall Study|Protocol Violation|2|||
33497195|NCT04421131|101713895|FG000|Overall Study|App crashed|5|||
33190445|NCT00213148|100601686|FG001|Cycle 1 (1 Month)|Other|0|||
33190446|NCT00213148|100601687|FG002|Cycle 1 (1 Month)|Other|2|||
33190447|NCT00213148|100601688|FG003|Cycle 1 (1 Month)|Other|2|||
33190448|NCT00213148|100601689|FG004|Cycle 1 (1 Month)|Other|7|||
33190449|NCT00213148|100601685|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33190450|NCT00213148|100601686|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33190451|NCT00213148|100601687|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33190452|NCT00213148|100601688|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
33190453|NCT00213148|100601689|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33190454|NCT00213148|100601685|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
33190455|NCT00213148|100601686|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
33190456|NCT00213148|100601687|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
33190457|NCT00213148|100601688|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
33190458|NCT00213148|100601689|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
33190459|NCT00213148|100601685|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
33190460|NCT00213148|100601686|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
33190461|NCT00213148|100601687|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
33190462|NCT00213148|100601688|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
33190463|NCT00213148|100601689|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
33190464|NCT00213148|100601685|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
33190465|NCT00213148|100601686|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
33190466|NCT00213148|100601687|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
33190467|NCT00213148|100601688|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
33497196|NCT05370040|101713896|FG000|Overall Study|Lost to Follow-up|0|||
33497197|NCT05370040|101713897|FG001|Overall Study|Lost to Follow-up|0|||
33497198|NCT05370040|101713898|FG002|Overall Study|Lost to Follow-up|1|||
33497199|NCT05370040|101713899|FG003|Overall Study|Lost to Follow-up|0|||
33497200|NCT05370040|101713900|FG004|Overall Study|Lost to Follow-up|1|||
33497201|NCT05370040|101713901|FG005|Overall Study|Lost to Follow-up|0|||
33497202|NCT01960413|101713902|FG000|Overall Study|Withdrawal by Subject|1|||
33497203|NCT01960413|101713903|FG001|Overall Study|Withdrawal by Subject|1|||
33497204|NCT01960413|101713902|FG000|Overall Study|Physician Decision|1|||
33497205|NCT01960413|101713903|FG001|Overall Study|Physician Decision|0|||
33497206|NCT01960413|101713902|FG000|Overall Study|Lost to Follow-up|2|||
33497207|NCT01960413|101713903|FG001|Overall Study|Lost to Follow-up|0|||
33497208|NCT01842438|101713906|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
33497209|NCT01842438|101713907|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
33497210|NCT01842438|101713906|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
33497211|NCT01842438|101713907|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
33497212|NCT01842438|101713906|FG000|T2: 6month Follow-up|Death|0|||
33497213|NCT01842438|101713907|FG001|T2: 6month Follow-up|Death|1|||
33497214|NCT03850483|101713912|FG000|Treatment for Stage 1|Adverse Event|1|||
33497215|NCT03850483|101713913|FG001|Treatment for Stage 1|Adverse Event|1|||
33497216|NCT03850483|101713914|FG002|Treatment for Stage 1|Adverse Event|3|||
33497217|NCT03850483|101713915|FG003|Treatment for Stage 1|Adverse Event|0|||
33497218|NCT03850483|101713916|FG004|Treatment for Stage 1|Adverse Event|2|||
33497219|NCT03850483|101713917|FG005|Treatment for Stage 1|Adverse Event|0|||
33497220|NCT03850483|101713918|FG006|Treatment for Stage 1|Adverse Event|2|||
33497221|NCT03850483|101713919|FG007|Treatment for Stage 1|Adverse Event|2|||
33497222|NCT03850483|101713920|FG008|Treatment for Stage 1|Adverse Event|0|||
33497223|NCT03850483|101713921|FG009|Treatment for Stage 1|Adverse Event|0|||
33497224|NCT03850483|101713912|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
33497225|NCT03850483|101713913|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
33497226|NCT03850483|101713914|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
33497227|NCT03850483|101713915|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
33497228|NCT03850483|101713916|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
33497229|NCT03850483|101713917|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
33497230|NCT03850483|101713918|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
33497231|NCT03850483|101713919|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
33497232|NCT03850483|101713920|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
33497233|NCT03850483|101713921|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
33497234|NCT03850483|101713912|FG000|Treatment for Stage 1|Protocol Violation|1|||
33497235|NCT03850483|101713913|FG001|Treatment for Stage 1|Protocol Violation|0|||
33497236|NCT03850483|101713914|FG002|Treatment for Stage 1|Protocol Violation|0|||
33497237|NCT03850483|101713915|FG003|Treatment for Stage 1|Protocol Violation|0|||
33497238|NCT03850483|101713916|FG004|Treatment for Stage 1|Protocol Violation|0|||
33497239|NCT03850483|101713917|FG005|Treatment for Stage 1|Protocol Violation|0|||
33497240|NCT03850483|101713918|FG006|Treatment for Stage 1|Protocol Violation|1|||
33497241|NCT03850483|101713919|FG007|Treatment for Stage 1|Protocol Violation|0|||
33497242|NCT03850483|101713920|FG008|Treatment for Stage 1|Protocol Violation|0|||
33497243|NCT03850483|101713921|FG009|Treatment for Stage 1|Protocol Violation|0|||
33497244|NCT03850483|101713912|FG000|Treatment for Stage 1|Physician Decision|0|||
33497245|NCT03850483|101713913|FG001|Treatment for Stage 1|Physician Decision|0|||
33497246|NCT03850483|101713914|FG002|Treatment for Stage 1|Physician Decision|0|||
33497247|NCT03850483|101713915|FG003|Treatment for Stage 1|Physician Decision|0|||
33497248|NCT03850483|101713916|FG004|Treatment for Stage 1|Physician Decision|0|||
33497249|NCT03850483|101713917|FG005|Treatment for Stage 1|Physician Decision|1|||
33497250|NCT03850483|101713918|FG006|Treatment for Stage 1|Physician Decision|0|||
33497251|NCT03850483|101713919|FG007|Treatment for Stage 1|Physician Decision|0|||
33497252|NCT03850483|101713920|FG008|Treatment for Stage 1|Physician Decision|0|||
33497253|NCT03850483|101713921|FG009|Treatment for Stage 1|Physician Decision|0|||
33497254|NCT03850483|101713912|FG000|Treatment for Stage 1|Other|0|||
33497255|NCT03850483|101713913|FG001|Treatment for Stage 1|Other|0|||
33600189|NCT02914548|102088538|FG000|Overall Study|Withdrawal by Subject|3|||
33600190|NCT02914548|102088539|FG001|Overall Study|Withdrawal by Subject|4|||
33600191|NCT02914548|102088540|FG002|Overall Study|Withdrawal by Subject|4|||
33600192|NCT02914548|102088538|FG000|Overall Study|>40% of body surface area|0|||
33600193|NCT02914548|102088539|FG001|Overall Study|>40% of body surface area|1|||
33600194|NCT02914548|102088540|FG002|Overall Study|>40% of body surface area|1|||
33600195|NCT03444766|102088541|FG000|Overall Study|Other Reasons|2|||
33600196|NCT03444766|102088541|FG000|Overall Study|Participant Withdrew Consent|5|||
33600197|NCT03444766|102088541|FG000|Overall Study|Lost to Follow-up|2|||
33600198|NCT03444766|102088541|FG000|Overall Study|Death|2|||
33600199|NCT03444766|102088541|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
33600200|NCT03444766|102088541|FG000|Overall Study|Disease Progression|49|||
33600201|NCT01596335|102088542|FG000|Overall Study|exacerbation of primary disease|5|||
33600202|NCT01596335|102088543|FG001|Overall Study|exacerbation of primary disease|9|||
33600203|NCT04035564|102088544|FG000|Overall Study|Protocol Violation|1|||
33497256|NCT03850483|101713914|FG002|Treatment for Stage 1|Other|0|||
33497257|NCT03850483|101713915|FG003|Treatment for Stage 1|Other|0|||
33497258|NCT03850483|101713916|FG004|Treatment for Stage 1|Other|2|||
33497259|NCT03850483|101713917|FG005|Treatment for Stage 1|Other|1|||
33497260|NCT03850483|101713918|FG006|Treatment for Stage 1|Other|0|||
33497261|NCT03850483|101713919|FG007|Treatment for Stage 1|Other|0|||
33497262|NCT03850483|101713920|FG008|Treatment for Stage 1|Other|0|||
33301307|NCT02672852|100996433|FG003|Part B|Other adverse event|0|||
33301308|NCT02672852|100996434|FG004|Part B|Other adverse event|3|||
33301309|NCT02672852|100996435|FG005|Part B|Other adverse event|5|||
33301310|NCT02672852|100996436|FG006|Part B|Other adverse event|1|||
33301311|NCT02672852|100996430|FG000|Part B|Lost to Follow-up|0|||
33301312|NCT02672852|100996431|FG001|Part B|Lost to Follow-up|0|||
33301313|NCT02672852|100996432|FG002|Part B|Lost to Follow-up|0|||
33301314|NCT02672852|100996433|FG003|Part B|Lost to Follow-up|0|||
33301315|NCT02672852|100996434|FG004|Part B|Lost to Follow-up|3|||
33301316|NCT02672852|100996435|FG005|Part B|Lost to Follow-up|4|||
33301317|NCT02672852|100996436|FG006|Part B|Lost to Follow-up|1|||
33301318|NCT02672852|100996430|FG000|Part B|Withdrawal by Subject|0|||
33301319|NCT02672852|100996431|FG001|Part B|Withdrawal by Subject|0|||
33301320|NCT02672852|100996432|FG002|Part B|Withdrawal by Subject|0|||
33301321|NCT02672852|100996433|FG003|Part B|Withdrawal by Subject|0|||
33301322|NCT02672852|100996434|FG004|Part B|Withdrawal by Subject|5|||
33301323|NCT02672852|100996435|FG005|Part B|Withdrawal by Subject|0|||
33301324|NCT02672852|100996436|FG006|Part B|Withdrawal by Subject|7|||
33301325|NCT02672852|100996430|FG000|Part B|Other|0|||
33301326|NCT02672852|100996431|FG001|Part B|Other|0|||
33301327|NCT02672852|100996432|FG002|Part B|Other|0|||
33301328|NCT02672852|100996433|FG003|Part B|Other|0|||
33301329|NCT02672852|100996434|FG004|Part B|Other|4|||
33301330|NCT02672852|100996435|FG005|Part B|Other|1|||
33301331|NCT02672852|100996436|FG006|Part B|Other|2|||
33301332|NCT01605019|100996437|FG000|Overall Study|pt did not meet transplant endpoint|3|||
33301333|NCT01605019|100996438|FG001|Overall Study|pt did not meet transplant endpoint|0|||
33301334|NCT01519089|100996439|FG000|Overall Study|Adverse Event|4|||
33301335|NCT01519089|100996440|FG001|Overall Study|Adverse Event|4|||
33301336|NCT01519089|100996439|FG000|Overall Study|Lack of Efficacy|0|||
33301337|NCT01519089|100996440|FG001|Overall Study|Lack of Efficacy|2|||
33301338|NCT01519089|100996439|FG000|Overall Study|Lost to Follow-up|1|||
33301339|NCT01519089|100996440|FG001|Overall Study|Lost to Follow-up|0|||
33497263|NCT03850483|101713921|FG009|Treatment for Stage 1|Other|0|||
33497264|NCT03850483|101713912|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33497265|NCT03850483|101713913|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33497266|NCT03850483|101713914|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
33497267|NCT03850483|101713915|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33497268|NCT03850483|101713916|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33497269|NCT03850483|101713917|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33497270|NCT03850483|101713918|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33301340|NCT01519089|100996439|FG000|Overall Study|Withdrawal by Subject|0|||
33301341|NCT01519089|100996440|FG001|Overall Study|Withdrawal by Subject|2|||
33301342|NCT01519089|100996439|FG000|Overall Study|Other|2|||
33301343|NCT01519089|100996440|FG001|Overall Study|Other|6|||
33301344|NCT01519089|100996439|FG000|Overall Study|Not received study drug|0|||
33301345|NCT01519089|100996440|FG001|Overall Study|Not received study drug|1|||
33301346|NCT03538938|100996441|FG000|Overall Study|Death|0|||
33301347|NCT03538938|100996442|FG001|Overall Study|Death|0|||
33301348|NCT03538938|100996443|FG002|Overall Study|Death|2|||
33301349|NCT03538938|100996444|FG003|Overall Study|Death|0|||
33497271|NCT03850483|101713919|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33497272|NCT03850483|101713920|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33600204|NCT04035564|102088545|FG001|Overall Study|Protocol Violation|2|||
33600205|NCT04035564|102088544|FG000|Overall Study|No laboratory available|2|||
33600206|NCT04035564|102088545|FG001|Overall Study|No laboratory available|2|||
33600207|NCT04035564|102088544|FG000|Overall Study|Guardian declined consent|1|||
33600208|NCT04035564|102088545|FG001|Overall Study|Guardian declined consent|2|||
33600209|NCT01328041|102088546|FG000|Overall Study|Adverse Event|7|||
33301350|NCT03538938|100996445|FG004|Overall Study|Death|0|||
33301351|NCT03538938|100996446|FG005|Overall Study|Death|1|||
33497273|NCT03850483|101713921|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
33497274|NCT03850483|101713912|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33497275|NCT03850483|101713913|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33497276|NCT03850483|101713914|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33497277|NCT03850483|101713915|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33301352|NCT03538938|100996447|FG006|Overall Study|Death|0|||
33497278|NCT03850483|101713916|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33600210|NCT01328041|102088546|FG000|Overall Study|Lack of Efficacy|27|||
33600211|NCT01328041|102088546|FG000|Overall Study|Protocol Violation|7|||
33301353|NCT03538938|100996448|FG007|Overall Study|Death|1|||
33301354|NCT03538938|100996449|FG008|Overall Study|Death|1|||
33301355|NCT03538938|100996450|FG009|Overall Study|Death|1|||
33301356|NCT03538938|100996451|FG010|Overall Study|Death|0|||
33301357|NCT03538938|100996452|FG011|Overall Study|Death|0|||
33301358|NCT03538938|100996453|FG012|Overall Study|Death|1|||
33301359|NCT03538938|100996454|FG013|Overall Study|Death|1|||
33301360|NCT03538938|100996455|FG014|Overall Study|Death|0|||
33301361|NCT03538938|100996456|FG015|Overall Study|Death|1|||
33301362|NCT03538938|100996441|FG000|Overall Study|Withdrawal by Subject|4|||
33497279|NCT03850483|101713917|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
33497280|NCT03850483|101713918|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33497281|NCT03850483|101713919|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33497282|NCT03850483|101713920|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33497283|NCT03850483|101713921|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
33497284|NCT03850483|101713912|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
33497285|NCT03850483|101713913|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
33497286|NCT03850483|101713914|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
33497287|NCT03850483|101713915|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
33497288|NCT03850483|101713916|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
33497289|NCT03850483|101713917|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
33497290|NCT03850483|101713918|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
33497291|NCT03850483|101713919|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
33497292|NCT03850483|101713920|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
33497293|NCT03850483|101713921|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
33497294|NCT03850483|101713912|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
33497295|NCT03850483|101713913|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
33497296|NCT03850483|101713914|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
33497297|NCT03850483|101713915|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
33497298|NCT03850483|101713916|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
33497299|NCT03850483|101713917|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
33301363|NCT03538938|100996442|FG001|Overall Study|Withdrawal by Subject|6|||
33301364|NCT03538938|100996443|FG002|Overall Study|Withdrawal by Subject|5|||
33301365|NCT03538938|100996444|FG003|Overall Study|Withdrawal by Subject|3|||
33301366|NCT03538938|100996445|FG004|Overall Study|Withdrawal by Subject|0|||
33301367|NCT03538938|100996446|FG005|Overall Study|Withdrawal by Subject|0|||
33301368|NCT03538938|100996447|FG006|Overall Study|Withdrawal by Subject|3|||
33301369|NCT03538938|100996448|FG007|Overall Study|Withdrawal by Subject|1|||
33301370|NCT03538938|100996449|FG008|Overall Study|Withdrawal by Subject|5|||
33301371|NCT03538938|100996450|FG009|Overall Study|Withdrawal by Subject|1|||
33301372|NCT03538938|100996451|FG010|Overall Study|Withdrawal by Subject|2|||
33301373|NCT03538938|100996452|FG011|Overall Study|Withdrawal by Subject|1|||
33301374|NCT03538938|100996453|FG012|Overall Study|Withdrawal by Subject|3|||
33301375|NCT03538938|100996454|FG013|Overall Study|Withdrawal by Subject|0|||
33301376|NCT03538938|100996455|FG014|Overall Study|Withdrawal by Subject|2|||
33301377|NCT03538938|100996456|FG015|Overall Study|Withdrawal by Subject|4|||
33301378|NCT03538938|100996441|FG000|Overall Study|Incarcerated|0|||
33301379|NCT03538938|100996442|FG001|Overall Study|Incarcerated|0|||
33301380|NCT03538938|100996443|FG002|Overall Study|Incarcerated|0|||
33301381|NCT03538938|100996444|FG003|Overall Study|Incarcerated|0|||
33301382|NCT03538938|100996445|FG004|Overall Study|Incarcerated|0|||
33301383|NCT03538938|100996446|FG005|Overall Study|Incarcerated|0|||
33301384|NCT03538938|100996447|FG006|Overall Study|Incarcerated|0|||
33301385|NCT03538938|100996448|FG007|Overall Study|Incarcerated|0|||
33301386|NCT03538938|100996449|FG008|Overall Study|Incarcerated|0|||
33301387|NCT03538938|100996450|FG009|Overall Study|Incarcerated|0|||
33301388|NCT03538938|100996451|FG010|Overall Study|Incarcerated|0|||
33301389|NCT03538938|100996452|FG011|Overall Study|Incarcerated|1|||
33301390|NCT03538938|100996453|FG012|Overall Study|Incarcerated|0|||
33301391|NCT03538938|100996454|FG013|Overall Study|Incarcerated|0|||
33301392|NCT03538938|100996455|FG014|Overall Study|Incarcerated|0|||
33301393|NCT03538938|100996456|FG015|Overall Study|Incarcerated|0|||
33301394|NCT00604825|100996459|FG000|Overall Study|Adverse Event|2|||
33301395|NCT00604825|100996460|FG001|Overall Study|Adverse Event|6|||
33301396|NCT00604825|100996461|FG002|Overall Study|Adverse Event|7|||
33301397|NCT00604825|100996462|FG003|Overall Study|Adverse Event|4|||
33301398|NCT00604825|100996459|FG000|Overall Study|Lost to Follow-up|0|||
33301399|NCT00604825|100996460|FG001|Overall Study|Lost to Follow-up|3|||
33301400|NCT00604825|100996461|FG002|Overall Study|Lost to Follow-up|1|||
33301401|NCT00604825|100996462|FG003|Overall Study|Lost to Follow-up|0|||
33301402|NCT00604825|100996459|FG000|Overall Study|Protocol Violation|0|||
33301403|NCT00604825|100996460|FG001|Overall Study|Protocol Violation|1|||
33301404|NCT00604825|100996461|FG002|Overall Study|Protocol Violation|0|||
33301405|NCT00604825|100996462|FG003|Overall Study|Protocol Violation|0|||
33600212|NCT01328041|102088546|FG000|Overall Study|Lost to Follow-up|7|||
33600213|NCT01328041|102088546|FG000|Overall Study|Physician Decision|2|||
33301406|NCT00604825|100996459|FG000|Overall Study|Withdrawal by Subject|4|||
33301407|NCT00604825|100996460|FG001|Overall Study|Withdrawal by Subject|3|||
33301408|NCT00604825|100996461|FG002|Overall Study|Withdrawal by Subject|5|||
33301409|NCT00604825|100996462|FG003|Overall Study|Withdrawal by Subject|5|||
33301410|NCT00604825|100996459|FG000|Overall Study|Lack of Efficacy|3|||
33301411|NCT00604825|100996460|FG001|Overall Study|Lack of Efficacy|2|||
33301412|NCT00604825|100996461|FG002|Overall Study|Lack of Efficacy|1|||
33301413|NCT00604825|100996462|FG003|Overall Study|Lack of Efficacy|0|||
33497300|NCT03850483|101713918|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
33497301|NCT03850483|101713919|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
33301414|NCT00604825|100996459|FG000|Overall Study|Did not meet eligibility criteria|0|||
33301415|NCT00604825|100996460|FG001|Overall Study|Did not meet eligibility criteria|0|||
33301416|NCT00604825|100996461|FG002|Overall Study|Did not meet eligibility criteria|2|||
33301417|NCT00604825|100996462|FG003|Overall Study|Did not meet eligibility criteria|0|||
33301418|NCT00604825|100996459|FG000|Overall Study|Physician Decision|0|||
33301419|NCT00604825|100996460|FG001|Overall Study|Physician Decision|0|||
33301420|NCT00604825|100996461|FG002|Overall Study|Physician Decision|0|||
33301421|NCT00604825|100996462|FG003|Overall Study|Physician Decision|1|||
33301422|NCT00604825|100996459|FG000|Overall Study|Exclusion criterion met|0|||
33301423|NCT00604825|100996460|FG001|Overall Study|Exclusion criterion met|0|||
33497302|NCT03850483|101713920|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
33497303|NCT03850483|101713921|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
33301424|NCT00604825|100996461|FG002|Overall Study|Exclusion criterion met|0|||
33301425|NCT00604825|100996462|FG003|Overall Study|Exclusion criterion met|1|||
33301426|NCT00702962|100996463|FG000|Overall Study|Progressive disease|0|||
33301427|NCT00702962|100996464|FG001|Overall Study|Progressive disease|1|||
33301428|NCT00702962|100996463|FG000|Overall Study|Hospitalized for other health disorder|1|||
33301429|NCT00702962|100996464|FG001|Overall Study|Hospitalized for other health disorder|0|||
33301430|NCT00925353|100996468|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
33301431|NCT03653208|100996469|FG000|Overall Study|Withdrawal by Subject|0|||
33301432|NCT03653208|100996470|FG001|Overall Study|Withdrawal by Subject|0|||
33301433|NCT03653208|100996471|FG002|Overall Study|Withdrawal by Subject|0|||
33301434|NCT03653208|100996472|FG003|Overall Study|Withdrawal by Subject|0|||
33301435|NCT03653208|100996473|FG004|Overall Study|Withdrawal by Subject|1|||
33301436|NCT03653208|100996474|FG005|Overall Study|Withdrawal by Subject|0|||
33301437|NCT03653208|100996475|FG006|Overall Study|Withdrawal by Subject|0|||
33301438|NCT03653208|100996476|FG007|Overall Study|Withdrawal by Subject|1|||
33301439|NCT03653208|100996477|FG008|Overall Study|Withdrawal by Subject|1|||
33301440|NCT02643472|100996478|FG000|Overall Study|Death|2|||
33301441|NCT02643472|100996479|FG001|Overall Study|Death|5|||
33301442|NCT02643472|100996478|FG000|Overall Study|Withdrawal by Subject|3|||
33301443|NCT02643472|100996479|FG001|Overall Study|Withdrawal by Subject|2|||
33301444|NCT02643472|100996478|FG000|Overall Study|Protocol Violation|0|||
33301445|NCT02643472|100996479|FG001|Overall Study|Protocol Violation|1|||
33301446|NCT02643472|100996478|FG000|Overall Study|Lost to Follow-up|22|||
33301447|NCT02643472|100996479|FG001|Overall Study|Lost to Follow-up|26|||
33301448|NCT04608773|100996482|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
33301449|NCT04608773|100996483|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
33301450|NCT04608773|100996482|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
33301451|NCT04608773|100996483|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
33301452|NCT04608773|100996482|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
33301453|NCT04608773|100996483|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
33301454|NCT04608773|100996482|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
33301455|NCT04608773|100996483|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
33497304|NCT03850483|101713912|FG000|Treatment for Stage 1|Death|0|||
33301456|NCT04608773|100996482|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
33301457|NCT04608773|100996483|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
33301458|NCT00953771|100996484|FG000|Overall Study|Death|1|||
33301459|NCT00953771|100996485|FG001|Overall Study|Death|0|||
33301460|NCT00743431|100996486|FG000|Overall Study|Toxicity|6|||
33301461|NCT00743431|100996486|FG000|Overall Study|Tumor progression|56|||
33301462|NCT00743431|100996486|FG000|Overall Study|Withdrawal by Subject|13|||
33301463|NCT00743431|100996486|FG000|Overall Study|Death|9|||
33301464|NCT00743431|100996486|FG000|Overall Study|Reason for discontinuation not specified|29|||
33301465|NCT00743431|100996486|FG000|Overall Study|No documentation available|13|||
33301466|NCT01125046|100996489|FG000|First 6 Months of Treatment|Death|1|||
33301467|NCT01125046|100996489|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
33301468|NCT01125046|100996489|FG000|First 6 Months of Treatment|Non-compliance|1|||
33301469|NCT01125046|100996489|FG000|First 6 Months of Treatment|Surgery|1|||
33301470|NCT01125046|100996489|FG000|First 6 Months of Treatment|Progressive Disease|7|||
33301471|NCT01125046|100996489|FG000|First 6 Months of Treatment|Adverse Event|2|||
33301472|NCT01125046|100996489|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
33301473|NCT01125046|100996489|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
33301474|NCT01125046|100996489|FG000|Follow-up/Data Cut Off Point|Death|29|||
33301475|NCT01125046|100996489|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
33301476|NCT00126503|100999647|FG000|Overall Study|disease progression|23|||
33301477|NCT00126503|100999648|FG001|Overall Study|disease progression|14|||
33497305|NCT03850483|101713913|FG001|Treatment for Stage 1|Death|0|||
33497306|NCT03850483|101713914|FG002|Treatment for Stage 1|Death|0|||
33497307|NCT03850483|101713915|FG003|Treatment for Stage 1|Death|0|||
33301478|NCT00126503|100999647|FG000|Overall Study|Withdrawal by Subject|0|||
33301479|NCT00126503|100999648|FG001|Overall Study|Withdrawal by Subject|1|||
33301480|NCT00126503|100999647|FG000|Overall Study|alternative therapy|1|||
33301481|NCT00126503|100999648|FG001|Overall Study|alternative therapy|1|||
33301482|NCT00126503|100999647|FG000|Overall Study|other complicating disease|4|||
33301483|NCT00126503|100999648|FG001|Overall Study|other complicating disease|1|||
33497308|NCT03850483|101713916|FG004|Treatment for Stage 1|Death|0|||
33497309|NCT03850483|101713917|FG005|Treatment for Stage 1|Death|1|||
33497310|NCT03850483|101713918|FG006|Treatment for Stage 1|Death|0|||
33497311|NCT03850483|101713919|FG007|Treatment for Stage 1|Death|0|||
33497312|NCT03850483|101713920|FG008|Treatment for Stage 1|Death|0|||
33497313|NCT03850483|101713921|FG009|Treatment for Stage 1|Death|0|||
33497314|NCT03850483|101713912|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
33497315|NCT03850483|101713913|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
33497316|NCT03850483|101713914|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
33497317|NCT03850483|101713915|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
33497318|NCT03850483|101713916|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
33497319|NCT03850483|101713917|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
33497320|NCT03850483|101713918|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
33497321|NCT03850483|101713919|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
33497322|NCT03850483|101713920|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
33497323|NCT03850483|101713921|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
33497324|NCT03850483|101713912|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
33301484|NCT00126503|100999647|FG000|Overall Study|Death|3|||
33301485|NCT00126503|100999648|FG001|Overall Study|Death|0|||
33301486|NCT00126503|100999647|FG000|Overall Study|Adverse Event|13|||
33301487|NCT00126503|100999648|FG001|Overall Study|Adverse Event|3|||
33301488|NCT00126503|100999647|FG000|Overall Study|non-compliant|1|||
33301489|NCT00126503|100999648|FG001|Overall Study|non-compliant|0|||
33301490|NCT00126503|100999647|FG000|Overall Study|Physician Decision|2|||
33301491|NCT00126503|100999648|FG001|Overall Study|Physician Decision|1|||
33301492|NCT01643044|100999649|FG000|Overall Study|Lost to Follow-up|1|||
33301493|NCT01643044|100999650|FG001|Overall Study|Lost to Follow-up|1|||
33301494|NCT01643044|100999649|FG000|Overall Study|Miscarried baby|2|||
33301495|NCT01643044|100999650|FG001|Overall Study|Miscarried baby|2|||
33301496|NCT01643044|100999649|FG000|Overall Study|Delivered outside of hospital|1|||
33301497|NCT01643044|100999650|FG001|Overall Study|Delivered outside of hospital|2|||
33301498|NCT00821587|100999654|FG000|Overall Study|Physician Decision|0|||
33301499|NCT00821587|100999655|FG001|Overall Study|Physician Decision|1|||
33301500|NCT01677767|100999656|FG000|Overall Study|Adverse Event|1|||
33301501|NCT01677767|100999656|FG000|Overall Study|Death|4|||
33301502|NCT01677767|100999656|FG000|Overall Study|Protocol Violation|4|||
33301503|NCT01677767|100999656|FG000|Overall Study|Withdrawal by Subject|10|||
33301504|NCT01677767|100999656|FG000|Overall Study|Non-compliance by the participants|3|||
33301505|NCT02898077|100999657|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
33301506|NCT02898077|100999658|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
33301507|NCT02898077|100999657|FG000|Overall Study|Lost to Follow-up|4|||
33301508|NCT02898077|100999658|FG001|Overall Study|Lost to Follow-up|3|||
33301509|NCT02898077|100999657|FG000|Overall Study|Physician Decision|0|||
33301510|NCT02898077|100999658|FG001|Overall Study|Physician Decision|2|||
33301511|NCT02898077|100999657|FG000|Overall Study|Sponsor Decision|32|||
33301512|NCT02898077|100999658|FG001|Overall Study|Sponsor Decision|13|||
33301513|NCT02898077|100999657|FG000|Overall Study|Withdrawal by Subject|6|||
33497325|NCT03850483|101713913|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
33497326|NCT03850483|101713914|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
33497327|NCT03850483|101713915|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
33497328|NCT03850483|101713916|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
33497329|NCT03850483|101713917|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
33497330|NCT03850483|101713918|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
33497331|NCT03850483|101713919|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
33497332|NCT03850483|101713920|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
33497333|NCT03850483|101713921|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
33497334|NCT03850483|101713912|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
33497335|NCT03850483|101713913|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
33497336|NCT03850483|101713914|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
33497337|NCT03850483|101713915|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
33497338|NCT03850483|101713916|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
33497339|NCT03850483|101713917|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
33301514|NCT02898077|100999658|FG001|Overall Study|Withdrawal by Subject|3|||
33301515|NCT02898077|100999657|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
33301516|NCT02898077|100999658|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
33301517|NCT02898077|100999657|FG000|Overall Study|Ended extension period|3|||
33301518|NCT02898077|100999658|FG001|Overall Study|Ended extension period|0|||
33301519|NCT00918879|100999660|FG000|Overall Study|Withdrawal by Subject|4|||
33301520|NCT00918879|100999661|FG001|Overall Study|Withdrawal by Subject|4|||
33301521|NCT00918879|100999660|FG000|Overall Study|Lost to Follow-up|1|||
33301522|NCT00918879|100999661|FG001|Overall Study|Lost to Follow-up|1|||
33301523|NCT00918879|100999660|FG000|Overall Study|Severe non-compliance to protocol|1|||
33301524|NCT00918879|100999661|FG001|Overall Study|Severe non-compliance to protocol|1|||
33301525|NCT01669577|100999665|FG000|Overall Study|Death|22|||
33301526|NCT01669577|100999665|FG000|Overall Study|Lost to Follow-up|78|||
33497340|NCT03850483|101713918|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
33497341|NCT03850483|101713919|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
33497342|NCT03850483|101713920|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
33497343|NCT03850483|101713921|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
33497344|NCT03850483|101713912|FG000|Follow-up for Stage 1|Physician Decision|0|||
33497345|NCT03850483|101713913|FG001|Follow-up for Stage 1|Physician Decision|0|||
33497346|NCT03850483|101713914|FG002|Follow-up for Stage 1|Physician Decision|0|||
33497347|NCT03850483|101713915|FG003|Follow-up for Stage 1|Physician Decision|0|||
33497348|NCT03850483|101713916|FG004|Follow-up for Stage 1|Physician Decision|1|||
33497349|NCT03850483|101713917|FG005|Follow-up for Stage 1|Physician Decision|0|||
33497350|NCT03850483|101713918|FG006|Follow-up for Stage 1|Physician Decision|1|||
33497351|NCT03850483|101713919|FG007|Follow-up for Stage 1|Physician Decision|0|||
33497352|NCT03850483|101713920|FG008|Follow-up for Stage 1|Physician Decision|0|||
33497353|NCT03850483|101713921|FG009|Follow-up for Stage 1|Physician Decision|0|||
33497354|NCT03850483|101713912|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
33497355|NCT03850483|101713913|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
33497356|NCT03850483|101713914|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
33497357|NCT03850483|101713915|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
33497358|NCT03850483|101713916|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
33497359|NCT03850483|101713917|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
33497360|NCT03850483|101713918|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
33497361|NCT03850483|101713919|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
33497362|NCT03850483|101713920|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
33497363|NCT03850483|101713921|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
33497364|NCT03850483|101713912|FG000|Follow-up for Stage 1|Adverse Event|0|||
33497365|NCT03850483|101713913|FG001|Follow-up for Stage 1|Adverse Event|0|||
33497366|NCT03850483|101713914|FG002|Follow-up for Stage 1|Adverse Event|1|||
33497367|NCT03850483|101713915|FG003|Follow-up for Stage 1|Adverse Event|0|||
33497368|NCT03850483|101713916|FG004|Follow-up for Stage 1|Adverse Event|0|||
33497369|NCT03850483|101713917|FG005|Follow-up for Stage 1|Adverse Event|1|||
33301527|NCT01669577|100999665|FG000|Overall Study|Physician Decision|34|||
33301528|NCT00742326|100999666|FG000|Overall Study|Physician Decision|0|||
33301529|NCT00742326|100999667|FG001|Overall Study|Physician Decision|1|||
33301530|NCT00224887|100999668|FG000|Overall Study|Pregnancy|6|||
33301531|NCT00224887|100999669|FG001|Overall Study|Pregnancy|6|||
33301532|NCT02232243|100999670|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
33301533|NCT02232243|100999671|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
33301534|NCT02232243|100999672|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
33301535|NCT01499303|100999673|FG000|Overall Study|Ongoing|2|||
33301536|NCT01499303|100999674|FG001|Overall Study|Ongoing|1|||
33301537|NCT01499303|100999673|FG000|Overall Study|Withdrawal by Subject|0|||
33301538|NCT01499303|100999674|FG001|Overall Study|Withdrawal by Subject|1|||
33301539|NCT01499303|100999673|FG000|Overall Study|Adverse Event|1|||
33301540|NCT01499303|100999674|FG001|Overall Study|Adverse Event|4|||
33301541|NCT01499303|100999673|FG000|Overall Study|Other|0|||
33301542|NCT01499303|100999674|FG001|Overall Study|Other|1|||
33301543|NCT01022112|100999677|FG000|Overall Study|Adverse Event|1|||
33301544|NCT01022112|100999678|FG001|Overall Study|Adverse Event|2|||
33301545|NCT01022112|100999679|FG002|Overall Study|Adverse Event|0|||
33301546|NCT01022112|100999680|FG003|Overall Study|Adverse Event|1|||
33301547|NCT01022112|100999681|FG004|Overall Study|Adverse Event|0|||
33497370|NCT03850483|101713918|FG006|Follow-up for Stage 1|Adverse Event|0|||
33497371|NCT03850483|101713919|FG007|Follow-up for Stage 1|Adverse Event|0|||
33497372|NCT03850483|101713920|FG008|Follow-up for Stage 1|Adverse Event|0|||
33497373|NCT03850483|101713921|FG009|Follow-up for Stage 1|Adverse Event|0|||
33497374|NCT03850483|101713912|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
33497375|NCT03850483|101713913|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
33497376|NCT03850483|101713914|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
33497377|NCT03850483|101713915|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
33497378|NCT03850483|101713916|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
33497379|NCT03850483|101713917|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
33497380|NCT03850483|101713918|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
33497381|NCT03850483|101713919|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
33497382|NCT03850483|101713920|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
33497383|NCT03850483|101713921|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
33301548|NCT01022112|100999677|FG000|Overall Study|Lack of Efficacy|1|||
33301549|NCT01022112|100999678|FG001|Overall Study|Lack of Efficacy|0|||
33301550|NCT01022112|100999679|FG002|Overall Study|Lack of Efficacy|0|||
33301551|NCT01022112|100999680|FG003|Overall Study|Lack of Efficacy|0|||
33301552|NCT01022112|100999681|FG004|Overall Study|Lack of Efficacy|1|||
33301553|NCT01022112|100999677|FG000|Overall Study|Physician Decision|0|||
33301554|NCT01022112|100999678|FG001|Overall Study|Physician Decision|0|||
33301555|NCT01022112|100999679|FG002|Overall Study|Physician Decision|1|||
33301556|NCT01022112|100999680|FG003|Overall Study|Physician Decision|0|||
33301557|NCT01022112|100999681|FG004|Overall Study|Physician Decision|1|||
33301558|NCT01022112|100999677|FG000|Overall Study|Withdrawal by Subject|0|||
33301559|NCT01022112|100999678|FG001|Overall Study|Withdrawal by Subject|1|||
33301560|NCT01022112|100999679|FG002|Overall Study|Withdrawal by Subject|2|||
33301561|NCT01022112|100999680|FG003|Overall Study|Withdrawal by Subject|2|||
33301562|NCT01022112|100999681|FG004|Overall Study|Withdrawal by Subject|1|||
33301563|NCT01022112|100999677|FG000|Overall Study|Fasting plasma glucose level increased|1|||
33301564|NCT01022112|100999678|FG001|Overall Study|Fasting plasma glucose level increased|0|||
33301565|NCT01022112|100999679|FG002|Overall Study|Fasting plasma glucose level increased|0|||
33301566|NCT01022112|100999680|FG003|Overall Study|Fasting plasma glucose level increased|0|||
33301567|NCT01022112|100999681|FG004|Overall Study|Fasting plasma glucose level increased|7|||
33301568|NCT00663702|100999682|FG000|Overall Study|Adverse Event|8|||
33301569|NCT00663702|100999683|FG001|Overall Study|Adverse Event|4|||
33301570|NCT00663702|100999682|FG000|Overall Study|Withdrawal by Subject|3|||
33301571|NCT00663702|100999683|FG001|Overall Study|Withdrawal by Subject|1|||
33301572|NCT00663702|100999682|FG000|Overall Study|Pregnancy|0|||
33301573|NCT00663702|100999683|FG001|Overall Study|Pregnancy|1|||
33301574|NCT00663702|100999682|FG000|Overall Study|Lost to Follow-up|3|||
33301575|NCT00663702|100999683|FG001|Overall Study|Lost to Follow-up|0|||
33301576|NCT00663702|100999682|FG000|Overall Study|Death|1|||
33301577|NCT00663702|100999683|FG001|Overall Study|Death|1|||
33301578|NCT00663702|100999682|FG000|Overall Study|Lack of Efficacy|3|||
33301579|NCT00663702|100999683|FG001|Overall Study|Lack of Efficacy|3|||
33301580|NCT02530970|100999684|FG000|Overall Study|Adverse Event|8|||
33301581|NCT02530970|100999684|FG000|Overall Study|Lost to Follow-up|88|||
33301582|NCT02530970|100999684|FG000|Overall Study|Physician Decision|5|||
33301583|NCT02530970|100999684|FG000|Overall Study|Withdrawal by Subject|14|||
33301584|NCT02530970|100999684|FG000|Overall Study|Death|6|||
33301585|NCT02530970|100999684|FG000|Overall Study|Hospitalization|1|||
33301586|NCT02530970|100999684|FG000|Overall Study|Insurance|2|||
33301587|NCT02530970|100999684|FG000|Overall Study|Explant|2|||
33301588|NCT02530970|100999684|FG000|Overall Study|Change in Provider|5|||
33301589|NCT02530970|100999684|FG000|Overall Study|Relocation|3|||
33301590|NCT05917470|100999689|FG000|Overall Study|Progressive Disease|1|||
33301591|NCT05917470|100999690|FG001|Overall Study|Progressive Disease|1|||
33301592|NCT05917470|100999691|FG002|Overall Study|Progressive Disease|2|||
33301593|NCT05917470|100999692|FG003|Overall Study|Progressive Disease|3|||
33301594|NCT05917470|100999693|FG004|Overall Study|Progressive Disease|1|||
33301595|NCT05917470|100999694|FG005|Overall Study|Progressive Disease|1|||
33301596|NCT05917470|100999695|FG006|Overall Study|Progressive Disease|0|||
33301597|NCT05917470|100999696|FG007|Overall Study|Progressive Disease|0|||
33301598|NCT05917470|100999689|FG000|Overall Study|Withdrawal by Subject|0|||
33301599|NCT05917470|100999690|FG001|Overall Study|Withdrawal by Subject|0|||
33301600|NCT05917470|100999691|FG002|Overall Study|Withdrawal by Subject|1|||
33301601|NCT05917470|100999692|FG003|Overall Study|Withdrawal by Subject|0|||
33301602|NCT05917470|100999693|FG004|Overall Study|Withdrawal by Subject|0|||
33301603|NCT05917470|100999694|FG005|Overall Study|Withdrawal by Subject|0|||
33301604|NCT05917470|100999695|FG006|Overall Study|Withdrawal by Subject|0|||
33301605|NCT05917470|100999696|FG007|Overall Study|Withdrawal by Subject|0|||
33301606|NCT05917470|100999689|FG000|Overall Study|Sponsor Decision|0|||
33301607|NCT05917470|100999690|FG001|Overall Study|Sponsor Decision|0|||
33301608|NCT05917470|100999691|FG002|Overall Study|Sponsor Decision|1|||
33301609|NCT05917470|100999692|FG003|Overall Study|Sponsor Decision|0|||
33301610|NCT05917470|100999693|FG004|Overall Study|Sponsor Decision|2|||
33301611|NCT05917470|100999694|FG005|Overall Study|Sponsor Decision|1|||
33301612|NCT05917470|100999695|FG006|Overall Study|Sponsor Decision|3|||
33301613|NCT05917470|100999696|FG007|Overall Study|Sponsor Decision|3|||
33301614|NCT05917470|100999689|FG000|Overall Study|Adverse Event|0|||
33301615|NCT05917470|100999690|FG001|Overall Study|Adverse Event|0|||
33301616|NCT05917470|100999691|FG002|Overall Study|Adverse Event|0|||
33301617|NCT05917470|100999692|FG003|Overall Study|Adverse Event|0|||
33301618|NCT05917470|100999693|FG004|Overall Study|Adverse Event|0|||
33301619|NCT05917470|100999694|FG005|Overall Study|Adverse Event|1|||
33301620|NCT05917470|100999695|FG006|Overall Study|Adverse Event|0|||
33301621|NCT05917470|100999696|FG007|Overall Study|Adverse Event|0|||
33301622|NCT00772330|100999701|FG000|Overall Study|Lost to Follow-up|3|||
33301623|NCT03562975|100999709|FG000|Overall Study|Death|1|||
33301624|NCT03562975|100999709|FG000|Overall Study|Lost to Follow-up|1|||
33301625|NCT03562975|100999709|FG000|Overall Study|Withdrawal by Subject|1|||
33301626|NCT04491877|100999711|FG000|Overall Study|Protocol Deviation|1|||
33301627|NCT04491877|100999712|FG001|Overall Study|Protocol Deviation|0|||
33301628|NCT04491877|100999713|FG002|Overall Study|Protocol Deviation|2|||
33301629|NCT04491877|100999714|FG003|Overall Study|Protocol Deviation|0|||
33301630|NCT04491877|100999715|FG004|Overall Study|Protocol Deviation|0|||
33301631|NCT04491877|100999716|FG005|Overall Study|Protocol Deviation|0|||
33301632|NCT04491877|100999717|FG006|Overall Study|Protocol Deviation|1|||
33301633|NCT04491877|100999718|FG007|Overall Study|Protocol Deviation|1|||
33301634|NCT04491877|100999719|FG008|Overall Study|Protocol Deviation|0|||
33301635|NCT04491877|100999711|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33301636|NCT04491877|100999712|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33301637|NCT04491877|100999713|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
33301638|NCT04491877|100999714|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
33301639|NCT04491877|100999715|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
33301640|NCT04491877|100999716|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
33301641|NCT04491877|100999717|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
33301642|NCT04491877|100999718|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
33497384|NCT03850483|101713912|FG000|Follow-up for Stage 1|Other|0|||
33497385|NCT03850483|101713913|FG001|Follow-up for Stage 1|Other|2|||
33497386|NCT03850483|101713914|FG002|Follow-up for Stage 1|Other|0|||
33497387|NCT03850483|101713915|FG003|Follow-up for Stage 1|Other|2|||
33497388|NCT03850483|101713916|FG004|Follow-up for Stage 1|Other|0|||
33497389|NCT03850483|101713917|FG005|Follow-up for Stage 1|Other|1|||
33497390|NCT03850483|101713918|FG006|Follow-up for Stage 1|Other|0|||
33497391|NCT03850483|101713919|FG007|Follow-up for Stage 1|Other|0|||
33497392|NCT03850483|101713920|FG008|Follow-up for Stage 1|Other|0|||
33497393|NCT03850483|101713921|FG009|Follow-up for Stage 1|Other|0|||
33497394|NCT03850483|101713912|FG000|Treatment for Stage 2|Adverse Event|0|||
33497395|NCT03850483|101713913|FG001|Treatment for Stage 2|Adverse Event|0|||
33497396|NCT03850483|101713914|FG002|Treatment for Stage 2|Adverse Event|0|||
33497397|NCT03850483|101713915|FG003|Treatment for Stage 2|Adverse Event|0|||
33497398|NCT03850483|101713916|FG004|Treatment for Stage 2|Adverse Event|0|||
33497399|NCT03850483|101713917|FG005|Treatment for Stage 2|Adverse Event|0|||
33497400|NCT03850483|101713918|FG006|Treatment for Stage 2|Adverse Event|0|||
33497401|NCT03850483|101713919|FG007|Treatment for Stage 2|Adverse Event|0|||
33497402|NCT03850483|101713920|FG008|Treatment for Stage 2|Adverse Event|0|||
33497403|NCT03850483|101713921|FG009|Treatment for Stage 2|Adverse Event|1|||
33497404|NCT03850483|101713912|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
33497405|NCT03850483|101713913|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
33497406|NCT03850483|101713914|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
33497407|NCT03850483|101713915|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
33497408|NCT03850483|101713916|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
33497409|NCT03850483|101713917|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
33497410|NCT03850483|101713918|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
33497411|NCT03850483|101713919|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
33497412|NCT03850483|101713920|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
33497413|NCT03850483|101713921|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
33497414|NCT03850483|101713912|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
33497415|NCT03850483|101713913|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
33497416|NCT03850483|101713914|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
33497417|NCT03850483|101713915|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
33497418|NCT03850483|101713916|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
33497419|NCT03850483|101713917|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
33497420|NCT03850483|101713918|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
33497421|NCT03850483|101713919|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
33497422|NCT03850483|101713920|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
33497423|NCT03850483|101713921|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
33497424|NCT03850483|101713912|FG000|Treatment for Stage 2|Physician Decision|0|||
33497425|NCT03850483|101713913|FG001|Treatment for Stage 2|Physician Decision|0|||
33497426|NCT03850483|101713914|FG002|Treatment for Stage 2|Physician Decision|0|||
33497427|NCT03850483|101713915|FG003|Treatment for Stage 2|Physician Decision|0|||
33301643|NCT04491877|100999719|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
33301644|NCT04491877|100999711|FG000|Overall Study|Lost to Follow-up|0|||
33301645|NCT04491877|100999712|FG001|Overall Study|Lost to Follow-up|2|||
33301646|NCT04491877|100999713|FG002|Overall Study|Lost to Follow-up|0|||
33301647|NCT04491877|100999714|FG003|Overall Study|Lost to Follow-up|0|||
33393534|NCT02903966|101328509|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
33497428|NCT03850483|101713916|FG004|Treatment for Stage 2|Physician Decision|0|||
33497429|NCT03850483|101713917|FG005|Treatment for Stage 2|Physician Decision|0|||
33497430|NCT03850483|101713918|FG006|Treatment for Stage 2|Physician Decision|0|||
33497431|NCT03850483|101713919|FG007|Treatment for Stage 2|Physician Decision|0|||
33497432|NCT03850483|101713920|FG008|Treatment for Stage 2|Physician Decision|0|||
33497433|NCT03850483|101713921|FG009|Treatment for Stage 2|Physician Decision|1|||
33497434|NCT03850483|101713912|FG000|Treatment for Stage 2|Protocol Violation|0|||
33497435|NCT03850483|101713913|FG001|Treatment for Stage 2|Protocol Violation|0|||
33497436|NCT03850483|101713914|FG002|Treatment for Stage 2|Protocol Violation|0|||
33497437|NCT03850483|101713915|FG003|Treatment for Stage 2|Protocol Violation|0|||
33497438|NCT03850483|101713916|FG004|Treatment for Stage 2|Protocol Violation|0|||
33497439|NCT03850483|101713917|FG005|Treatment for Stage 2|Protocol Violation|0|||
33497440|NCT03850483|101713918|FG006|Treatment for Stage 2|Protocol Violation|0|||
33497441|NCT03850483|101713919|FG007|Treatment for Stage 2|Protocol Violation|0|||
33497442|NCT03850483|101713920|FG008|Treatment for Stage 2|Protocol Violation|1|||
33497443|NCT03850483|101713921|FG009|Treatment for Stage 2|Protocol Violation|0|||
33497444|NCT03850483|101713912|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
33301648|NCT04491877|100999715|FG004|Overall Study|Lost to Follow-up|0|||
33301649|NCT04491877|100999716|FG005|Overall Study|Lost to Follow-up|0|||
33497445|NCT03850483|101713913|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
33497446|NCT03850483|101713914|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
33497447|NCT03850483|101713915|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
33497448|NCT03850483|101713916|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
33497449|NCT03850483|101713917|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
33497450|NCT03850483|101713918|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
33497451|NCT03850483|101713919|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
33497452|NCT03850483|101713920|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
33497453|NCT03850483|101713921|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
33497454|NCT03850483|101713912|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33497455|NCT03850483|101713913|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33497456|NCT03850483|101713914|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33497457|NCT03850483|101713915|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33497458|NCT03850483|101713916|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33497459|NCT03850483|101713917|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33497460|NCT03850483|101713918|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33497461|NCT03850483|101713919|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33301650|NCT04491877|100999717|FG006|Overall Study|Lost to Follow-up|2|||
33301651|NCT04491877|100999718|FG007|Overall Study|Lost to Follow-up|1|||
33301652|NCT04491877|100999719|FG008|Overall Study|Lost to Follow-up|1|||
33301653|NCT00798590|100999720|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
33301654|NCT00798590|100999721|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
33301655|NCT01370590|100999729|FG000|Period 1|Adverse Event|8|||
33497462|NCT03850483|101713920|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
33497463|NCT03850483|101713921|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
33497464|NCT03850483|101713912|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
33497465|NCT03850483|101713913|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
33497466|NCT03850483|101713914|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
33497467|NCT03850483|101713915|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
33497468|NCT03850483|101713916|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
33497469|NCT03850483|101713917|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
33497470|NCT03850483|101713918|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
33497471|NCT03850483|101713919|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
33497472|NCT03850483|101713920|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
33497473|NCT03850483|101713921|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
33497474|NCT03850483|101713912|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
33497475|NCT03850483|101713913|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
33497476|NCT03850483|101713914|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
33497477|NCT03850483|101713915|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
33497478|NCT03850483|101713916|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
33497479|NCT03850483|101713917|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
33497480|NCT03850483|101713918|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
33497481|NCT03850483|101713919|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
33497482|NCT03850483|101713920|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
33497483|NCT03850483|101713921|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
33497484|NCT03850483|101713912|FG000|Follow-up For Stage 2|Other|0|||
33497485|NCT03850483|101713913|FG001|Follow-up For Stage 2|Other|0|||
33497486|NCT03850483|101713914|FG002|Follow-up For Stage 2|Other|0|||
33497487|NCT03850483|101713915|FG003|Follow-up For Stage 2|Other|0|||
33497488|NCT03850483|101713916|FG004|Follow-up For Stage 2|Other|0|||
33497489|NCT03850483|101713917|FG005|Follow-up For Stage 2|Other|0|||
33497490|NCT03850483|101713918|FG006|Follow-up For Stage 2|Other|0|||
33497491|NCT03850483|101713919|FG007|Follow-up For Stage 2|Other|0|||
33497492|NCT03850483|101713920|FG008|Follow-up For Stage 2|Other|0|||
33497493|NCT03850483|101713921|FG009|Follow-up For Stage 2|Other|1|||
33497494|NCT03926117|101713923|FG000|Overall Study|Unclassified|1|||
33497495|NCT03926117|101713924|FG001|Overall Study|Unclassified|4|||
33497496|NCT03926117|101713925|FG002|Overall Study|Unclassified|1|||
33497497|NCT03926117|101713926|FG003|Overall Study|Unclassified|4|||
33497498|NCT03926117|101713923|FG000|Overall Study|Withdrawal by Subject|3|||
33497499|NCT03926117|101713924|FG001|Overall Study|Withdrawal by Subject|0|||
33301656|NCT01370590|100999730|FG001|Period 1|Adverse Event|4|||
33497500|NCT03926117|101713925|FG002|Overall Study|Withdrawal by Subject|1|||
33497501|NCT03926117|101713926|FG003|Overall Study|Withdrawal by Subject|1|||
33497502|NCT03926117|101713923|FG000|Overall Study|Lost to Follow-up|0|||
33497503|NCT03926117|101713924|FG001|Overall Study|Lost to Follow-up|2|||
33497504|NCT03926117|101713925|FG002|Overall Study|Lost to Follow-up|1|||
33497505|NCT03926117|101713926|FG003|Overall Study|Lost to Follow-up|0|||
33497506|NCT03926117|101713923|FG000|Overall Study|Adverse Event|1|||
33497507|NCT03926117|101713924|FG001|Overall Study|Adverse Event|2|||
33497508|NCT03926117|101713925|FG002|Overall Study|Adverse Event|3|||
33301657|NCT01370590|100999729|FG000|Period 1|Lost to Follow-up|2|||
33301658|NCT01370590|100999730|FG001|Period 1|Lost to Follow-up|2|||
33497509|NCT03926117|101713926|FG003|Overall Study|Adverse Event|1|||
33497510|NCT03926117|101713923|FG000|Overall Study|Randomized but not treated|1|||
33497511|NCT03926117|101713924|FG001|Overall Study|Randomized but not treated|1|||
33497512|NCT03926117|101713925|FG002|Overall Study|Randomized but not treated|0|||
33497513|NCT03926117|101713926|FG003|Overall Study|Randomized but not treated|1|||
33497514|NCT01277601|101713927|FG000|Overall Study|Adverse Event|5|||
33497515|NCT01277601|101713928|FG001|Overall Study|Adverse Event|3|||
33497516|NCT01277601|101713929|FG002|Overall Study|Adverse Event|0|||
33497517|NCT01277601|101713930|FG003|Overall Study|Adverse Event|7|||
33497518|NCT01277601|101713927|FG000|Overall Study|Withdrawal by Subject|18|||
33497519|NCT01277601|101713928|FG001|Overall Study|Withdrawal by Subject|21|||
33497520|NCT01277601|101713929|FG002|Overall Study|Withdrawal by Subject|8|||
33497521|NCT01277601|101713930|FG003|Overall Study|Withdrawal by Subject|17|||
33497522|NCT01277601|101713927|FG000|Overall Study|Lost to Follow-up|7|||
33497523|NCT01277601|101713928|FG001|Overall Study|Lost to Follow-up|9|||
33497524|NCT01277601|101713929|FG002|Overall Study|Lost to Follow-up|4|||
33497525|NCT01277601|101713930|FG003|Overall Study|Lost to Follow-up|2|||
33497526|NCT01277601|101713927|FG000|Overall Study|Physician Decision|3|||
33497527|NCT01277601|101713928|FG001|Overall Study|Physician Decision|5|||
33497528|NCT01277601|101713929|FG002|Overall Study|Physician Decision|1|||
33497529|NCT01277601|101713930|FG003|Overall Study|Physician Decision|6|||
33497530|NCT01277601|101713927|FG000|Overall Study|Pregnancy|2|||
33497531|NCT01277601|101713928|FG001|Overall Study|Pregnancy|2|||
33497532|NCT01277601|101713929|FG002|Overall Study|Pregnancy|4|||
33497533|NCT01277601|101713930|FG003|Overall Study|Pregnancy|1|||
33497534|NCT01277601|101713927|FG000|Overall Study|Noncompliance with Study Drug|1|||
33497535|NCT01277601|101713928|FG001|Overall Study|Noncompliance with Study Drug|3|||
33497536|NCT01277601|101713929|FG002|Overall Study|Noncompliance with Study Drug|2|||
33497537|NCT01277601|101713930|FG003|Overall Study|Noncompliance with Study Drug|0|||
33497538|NCT01277601|101713927|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
33497539|NCT01277601|101713928|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
33600214|NCT01328041|102088546|FG000|Overall Study|Withdrawal by Subject|7|||
33600215|NCT03968159|102088547|FG000|Overall Study|Adverse Event|4|||
33600216|NCT03968159|102088548|FG001|Overall Study|Adverse Event|4|||
33600217|NCT03968159|102088547|FG000|Overall Study|Lost to Follow-up|1|||
33600218|NCT03968159|102088548|FG001|Overall Study|Lost to Follow-up|1|||
33600219|NCT03968159|102088547|FG000|Overall Study|Use of prohibited medication|0|||
33600220|NCT03968159|102088548|FG001|Overall Study|Use of prohibited medication|1|||
33600221|NCT03968159|102088547|FG000|Overall Study|Protocol Violation|2|||
33600222|NCT03968159|102088548|FG001|Overall Study|Protocol Violation|2|||
33600223|NCT03968159|102088547|FG000|Overall Study|Withdrawal by Subject|4|||
33600224|NCT03968159|102088548|FG001|Overall Study|Withdrawal by Subject|6|||
33600225|NCT03968159|102088547|FG000|Overall Study|Lack of Efficacy|0|||
33600226|NCT03968159|102088548|FG001|Overall Study|Lack of Efficacy|1|||
33600227|NCT03968159|102088547|FG000|Overall Study|Not further specified|2|||
33600228|NCT03968159|102088548|FG001|Overall Study|Not further specified|0|||
33600229|NCT02437409|102088555|FG000|Overall Study|Withdrawal by Subject|3|||
33600230|NCT02437409|102088555|FG000|Overall Study|Screening failure|12|||
33600231|NCT02410824|102088556|FG000|First Intervention (One Week)|Headache|0|||
33600232|NCT02410824|102088557|FG001|First Intervention (One Week)|Headache|1|||
33600233|NCT00434759|102088560|FG000|Overall Study|Lack of Efficacy|5|||
33600234|NCT00434759|102088561|FG001|Overall Study|Lack of Efficacy|4|||
33600235|NCT00434759|102088560|FG000|Overall Study|Withdrawal by Subject|17|||
33600236|NCT00434759|102088561|FG001|Overall Study|Withdrawal by Subject|1|||
33600237|NCT00434759|102088560|FG000|Overall Study|family affairs|2|||
33600238|NCT00434759|102088561|FG001|Overall Study|family affairs|0|||
33600239|NCT00149994|102088566|FG000|Overall Study|Administrative problems:|1|||
33600240|NCT00149994|102088567|FG001|Overall Study|Administrative problems:|0|||
33497540|NCT01277601|101713929|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
33497541|NCT01277601|101713930|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
33497542|NCT01277601|101713927|FG000|Overall Study|Protocol Violation|0|||
33497543|NCT01277601|101713928|FG001|Overall Study|Protocol Violation|2|||
33600241|NCT00149994|102088566|FG000|Overall Study|Protocol Violation|0|||
33600242|NCT00149994|102088567|FG001|Overall Study|Protocol Violation|1|||
33600243|NCT00543296|102088572|FG000|Overall Study|Physician Decision|7|||
33600244|NCT02753127|102088575|FG000|Overall Study|Lost to Follow-up|13|||
33600245|NCT02753127|102088576|FG001|Overall Study|Lost to Follow-up|11|||
33600246|NCT02753127|102088575|FG000|Overall Study|Withdrawal by Subject|37|||
33497544|NCT01277601|101713929|FG002|Overall Study|Protocol Violation|5|||
33497545|NCT01277601|101713930|FG003|Overall Study|Protocol Violation|0|||
33497546|NCT01277601|101713927|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
33497547|NCT01277601|101713928|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
33497548|NCT01277601|101713929|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
33497549|NCT01277601|101713930|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
33497550|NCT01804946|101713931|FG000|Overall Study|Protocol Violation|1|||
33497551|NCT01804946|101713932|FG001|Overall Study|Protocol Violation|0|||
33600247|NCT02753127|102088576|FG001|Overall Study|Withdrawal by Subject|47|||
33600248|NCT02753127|102088575|FG000|Overall Study|Other|3|||
33600249|NCT02753127|102088576|FG001|Overall Study|Other|8|||
33301659|NCT01370590|100999729|FG000|Period 1|Protocol Violation|2|||
33301660|NCT01370590|100999730|FG001|Period 1|Protocol Violation|2|||
33301661|NCT01370590|100999729|FG000|Period 1|Withdrawal by Subject|4|||
33301662|NCT01370590|100999730|FG001|Period 1|Withdrawal by Subject|2|||
33301663|NCT01370590|100999729|FG000|Period 1|Could not access randomization system|0|||
33301664|NCT01370590|100999730|FG001|Period 1|Could not access randomization system|1|||
33301665|NCT01370590|100999729|FG000|Crossover Washout Period|Adverse Event|1|||
33301666|NCT01370590|100999730|FG001|Crossover Washout Period|Adverse Event|4|||
33301667|NCT01370590|100999729|FG000|Crossover Washout Period|Lost to Follow-up|2|||
33301668|NCT01370590|100999730|FG001|Crossover Washout Period|Lost to Follow-up|0|||
33301669|NCT01370590|100999729|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
33301670|NCT01370590|100999730|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
33301671|NCT01370590|100999729|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
33301672|NCT01370590|100999730|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
33301673|NCT01370590|100999729|FG000|Period 2|Adverse Event|0|||
33301674|NCT01370590|100999730|FG001|Period 2|Adverse Event|1|||
33301675|NCT01370590|100999729|FG000|Period 2|Withdrawal by Subject|1|||
33301676|NCT01370590|100999730|FG001|Period 2|Withdrawal by Subject|1|||
33301677|NCT03541200|100999744|FG000|Overall Study|Adverse Event|19|||
33301678|NCT03541200|100999744|FG000|Overall Study|Death|1|||
33301679|NCT03541200|100999744|FG000|Overall Study|Lost to Follow-up|10|||
33301680|NCT03541200|100999744|FG000|Overall Study|Physician Decision|1|||
33301681|NCT03541200|100999744|FG000|Overall Study|Protocol Violation|51|||
33301682|NCT03541200|100999744|FG000|Overall Study|Withdrawal by Subject|23|||
33301683|NCT03541200|100999744|FG000|Overall Study|other|8|||
33301684|NCT00589121|100999745|FG000|Overall Study|Protocol Violation|2|||
33301685|NCT00589121|100999746|FG001|Overall Study|Protocol Violation|6|||
33301686|NCT00589121|100999745|FG000|Overall Study|No protocol treatment received|0|||
33301687|NCT00589121|100999746|FG001|Overall Study|No protocol treatment received|1|||
33301688|NCT02766777|100999747|FG000|Overall Study|Adverse Event|12|||
33301689|NCT02766777|100999747|FG000|Overall Study|Lost to Follow-up|16|||
33301690|NCT02766777|100999747|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33301691|NCT02766777|100999747|FG000|Overall Study|Protocol Violation|1|||
33301692|NCT02766777|100999747|FG000|Overall Study|Withdrawal by Subject|4|||
33301693|NCT00299494|100999748|FG000|Overall Study|Withdrawal by Subject|0|||
33301694|NCT00299494|100999749|FG001|Overall Study|Withdrawal by Subject|0|||
33301695|NCT00299494|100999750|FG002|Overall Study|Withdrawal by Subject|0|||
33301696|NCT00299494|100999751|FG003|Overall Study|Withdrawal by Subject|3|||
33301697|NCT00299494|100999752|FG004|Overall Study|Withdrawal by Subject|1|||
33301698|NCT00299494|100999753|FG005|Overall Study|Withdrawal by Subject|4|||
33301699|NCT00299494|100999748|FG000|Overall Study|Physician Decision|0|||
33301700|NCT00299494|100999749|FG001|Overall Study|Physician Decision|0|||
33301701|NCT00299494|100999750|FG002|Overall Study|Physician Decision|0|||
33301702|NCT00299494|100999751|FG003|Overall Study|Physician Decision|0|||
33301703|NCT00299494|100999752|FG004|Overall Study|Physician Decision|1|||
33301704|NCT00299494|100999753|FG005|Overall Study|Physician Decision|0|||
33301705|NCT00299494|100999748|FG000|Overall Study|Death|3|||
33301706|NCT00299494|100999749|FG001|Overall Study|Death|1|||
33497552|NCT01804946|101713931|FG000|Overall Study|Adverse Event|0|||
33497553|NCT01804946|101713932|FG001|Overall Study|Adverse Event|1|||
33497554|NCT01804946|101713931|FG000|Overall Study|Insufficient data available|0|||
33497555|NCT01804946|101713932|FG001|Overall Study|Insufficient data available|1|||
33497556|NCT01804946|101713931|FG000|Overall Study|Do not meet inclusion criteria|1|||
33497557|NCT01804946|101713932|FG001|Overall Study|Do not meet inclusion criteria|2|||
33497558|NCT01205776|101713936|FG000|Overall Study|Lost to Follow-up|53|||
33497559|NCT01205776|101713937|FG001|Overall Study|Lost to Follow-up|61|||
33497560|NCT01205776|101713936|FG000|Overall Study|Withdrawal by Subject|11|||
33497561|NCT01205776|101713937|FG001|Overall Study|Withdrawal by Subject|34|||
33497562|NCT05000164|101713938|FG000|Overall Study|Adverse Event|1|||
33600250|NCT02753127|102088575|FG000|Overall Study|Hospice|0|||
33600251|NCT02753127|102088576|FG001|Overall Study|Hospice|2|||
33600252|NCT03627065|102088578|FG000|Overall Study|Study Terminated by sponsor|1|||
33497563|NCT05000164|101713938|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
33497564|NCT05000164|101713938|FG000|Overall Study|Lens Discomfort|3|||
33301707|NCT00299494|100999750|FG002|Overall Study|Death|4|||
33301708|NCT00299494|100999751|FG003|Overall Study|Death|6|||
33301709|NCT00299494|100999752|FG004|Overall Study|Death|18|||
33301710|NCT00299494|100999753|FG005|Overall Study|Death|19|||
33301711|NCT00299494|100999748|FG000|Overall Study|Lost to Follow-up|0|||
33301712|NCT00299494|100999749|FG001|Overall Study|Lost to Follow-up|0|||
33301713|NCT00299494|100999750|FG002|Overall Study|Lost to Follow-up|0|||
33301714|NCT00299494|100999751|FG003|Overall Study|Lost to Follow-up|0|||
33301715|NCT00299494|100999752|FG004|Overall Study|Lost to Follow-up|3|||
33301716|NCT00299494|100999753|FG005|Overall Study|Lost to Follow-up|1|||
33301717|NCT00299494|100999748|FG000|Overall Study|Other - Unspecified|0|||
33301718|NCT00299494|100999749|FG001|Overall Study|Other - Unspecified|0|||
33301719|NCT00299494|100999750|FG002|Overall Study|Other - Unspecified|0|||
33301720|NCT00299494|100999751|FG003|Overall Study|Other - Unspecified|0|||
33301721|NCT00299494|100999752|FG004|Overall Study|Other - Unspecified|3|||
33301722|NCT00299494|100999753|FG005|Overall Study|Other - Unspecified|1|||
33301723|NCT00299494|100999748|FG000|Overall Study|Other - site closure|0|||
33301724|NCT00299494|100999749|FG001|Overall Study|Other - site closure|0|||
33301725|NCT00299494|100999750|FG002|Overall Study|Other - site closure|0|||
33301726|NCT00299494|100999751|FG003|Overall Study|Other - site closure|1|||
33301727|NCT00299494|100999752|FG004|Overall Study|Other - site closure|1|||
33301728|NCT00299494|100999753|FG005|Overall Study|Other - site closure|1|||
33301729|NCT02760498|100999754|FG000|Overall Study|Adverse Event|3|||
33301730|NCT02760498|100999755|FG001|Overall Study|Adverse Event|3|||
33301731|NCT02760498|100999756|FG002|Overall Study|Adverse Event|1|||
33301732|NCT02760498|100999757|FG003|Overall Study|Adverse Event|1|||
33301733|NCT02760498|100999758|FG004|Overall Study|Adverse Event|0|||
33301734|NCT02760498|100999759|FG005|Overall Study|Adverse Event|6|||
33301735|NCT02760498|100999754|FG000|Overall Study|Death|7|||
33301736|NCT02760498|100999755|FG001|Overall Study|Death|5|||
33301737|NCT02760498|100999756|FG002|Overall Study|Death|5|||
33301738|NCT02760498|100999757|FG003|Overall Study|Death|7|||
33301739|NCT02760498|100999758|FG004|Overall Study|Death|0|||
33301740|NCT02760498|100999759|FG005|Overall Study|Death|23|||
33301741|NCT02760498|100999754|FG000|Overall Study|Lost to Follow-up|0|||
33301742|NCT02760498|100999755|FG001|Overall Study|Lost to Follow-up|0|||
33301743|NCT02760498|100999756|FG002|Overall Study|Lost to Follow-up|0|||
33301744|NCT02760498|100999757|FG003|Overall Study|Lost to Follow-up|0|||
33301745|NCT02760498|100999758|FG004|Overall Study|Lost to Follow-up|0|||
33301746|NCT02760498|100999759|FG005|Overall Study|Lost to Follow-up|3|||
33301747|NCT02760498|100999754|FG000|Overall Study|Non-compliance with study drug|0|||
33301748|NCT02760498|100999755|FG001|Overall Study|Non-compliance with study drug|2|||
33301749|NCT02760498|100999756|FG002|Overall Study|Non-compliance with study drug|0|||
33301750|NCT02760498|100999757|FG003|Overall Study|Non-compliance with study drug|0|||
33301751|NCT02760498|100999758|FG004|Overall Study|Non-compliance with study drug|0|||
33301752|NCT02760498|100999759|FG005|Overall Study|Non-compliance with study drug|0|||
33301753|NCT02760498|100999754|FG000|Overall Study|Participant decision|1|||
33301754|NCT02760498|100999755|FG001|Overall Study|Participant decision|4|||
33301755|NCT02760498|100999756|FG002|Overall Study|Participant decision|2|||
33301756|NCT02760498|100999757|FG003|Overall Study|Participant decision|2|||
33301757|NCT02760498|100999758|FG004|Overall Study|Participant decision|1|||
33301758|NCT02760498|100999759|FG005|Overall Study|Participant decision|6|||
33301759|NCT02760498|100999754|FG000|Overall Study|Sponsor decision|0|||
33301760|NCT02760498|100999755|FG001|Overall Study|Sponsor decision|0|||
33301761|NCT02760498|100999756|FG002|Overall Study|Sponsor decision|0|||
33301762|NCT02760498|100999757|FG003|Overall Study|Sponsor decision|3|||
33301763|NCT02760498|100999758|FG004|Overall Study|Sponsor decision|0|||
33301764|NCT02760498|100999759|FG005|Overall Study|Sponsor decision|0|||
33301765|NCT02760498|100999754|FG000|Overall Study|Physician Decision|3|||
33301766|NCT02760498|100999755|FG001|Overall Study|Physician Decision|4|||
33301767|NCT02760498|100999756|FG002|Overall Study|Physician Decision|1|||
33301768|NCT02760498|100999757|FG003|Overall Study|Physician Decision|4|||
33301769|NCT02760498|100999758|FG004|Overall Study|Physician Decision|0|||
33301770|NCT02760498|100999759|FG005|Overall Study|Physician Decision|2|||
33301771|NCT02760498|100999754|FG000|Overall Study|Disease progression|21|||
33301772|NCT02760498|100999755|FG001|Overall Study|Disease progression|19|||
33301773|NCT02760498|100999756|FG002|Overall Study|Disease progression|20|||
33301774|NCT02760498|100999757|FG003|Overall Study|Disease progression|18|||
33301775|NCT02760498|100999758|FG004|Overall Study|Disease progression|4|||
33301776|NCT02760498|100999759|FG005|Overall Study|Disease progression|55|||
33301777|NCT02760498|100999754|FG000|Overall Study|Withdrawal by Subject|4|||
33301778|NCT02760498|100999755|FG001|Overall Study|Withdrawal by Subject|7|||
33301779|NCT02760498|100999756|FG002|Overall Study|Withdrawal by Subject|5|||
33301780|NCT02760498|100999757|FG003|Overall Study|Withdrawal by Subject|1|||
33301781|NCT02760498|100999758|FG004|Overall Study|Withdrawal by Subject|0|||
33301782|NCT02760498|100999759|FG005|Overall Study|Withdrawal by Subject|6|||
33301783|NCT02760498|100999754|FG000|Overall Study|Other than specified|1|||
33301784|NCT02760498|100999755|FG001|Overall Study|Other than specified|6|||
33301785|NCT02760498|100999756|FG002|Overall Study|Other than specified|0|||
33301786|NCT02760498|100999757|FG003|Overall Study|Other than specified|3|||
33301787|NCT02760498|100999758|FG004|Overall Study|Other than specified|1|||
33301788|NCT02760498|100999759|FG005|Overall Study|Other than specified|0|||
33301789|NCT02760498|100999754|FG000|Overall Study|Not treated|0|||
33301790|NCT02760498|100999755|FG001|Overall Study|Not treated|0|||
33301791|NCT02760498|100999756|FG002|Overall Study|Not treated|0|||
33301792|NCT02760498|100999757|FG003|Overall Study|Not treated|0|||
33301793|NCT02760498|100999758|FG004|Overall Study|Not treated|0|||
33301794|NCT02760498|100999759|FG005|Overall Study|Not treated|2|||
33301795|NCT05000931|100999760|FG000|Overall Study|Lost to Follow-up|1|||
33301796|NCT04806373|100999761|FG000|Overall Study|Withdrawal by Subject|1|||
33301797|NCT04806373|100999762|FG001|Overall Study|Withdrawal by Subject|1|||
33301798|NCT02550938|100999763|FG000|Overall Study|Lost to Follow-up|8|||
33301799|NCT02550938|100999764|FG001|Overall Study|Lost to Follow-up|7|||
33301800|NCT02550938|100999765|FG002|Overall Study|Lost to Follow-up|12|||
33301801|NCT02550938|100999766|FG003|Overall Study|Lost to Follow-up|11|||
33301802|NCT02842151|100999770|FG000|Overall Study|Adverse Event|1|||
33301803|NCT02842151|100999770|FG000|Overall Study|Subject moved too far away|1|||
33301804|NCT00964886|100999771|FG000|Overall Study|Lost to Follow-up|2|||
33301805|NCT00964886|100999772|FG001|Overall Study|Lost to Follow-up|2|||
33301806|NCT00964886|100999773|FG002|Overall Study|Lost to Follow-up|6|||
33301807|NCT00964886|100999774|FG003|Overall Study|Lost to Follow-up|4|||
33301808|NCT00964886|100999771|FG000|Overall Study|Withdrawal by Subject|6|||
33301809|NCT00964886|100999772|FG001|Overall Study|Withdrawal by Subject|2|||
33301810|NCT00964886|100999773|FG002|Overall Study|Withdrawal by Subject|5|||
33301811|NCT00964886|100999774|FG003|Overall Study|Withdrawal by Subject|3|||
33301812|NCT00964886|100999771|FG000|Overall Study|Adverse Event|3|||
33301813|NCT00964886|100999772|FG001|Overall Study|Adverse Event|1|||
33301814|NCT00964886|100999773|FG002|Overall Study|Adverse Event|5|||
33497565|NCT05000164|101713938|FG000|Overall Study|Withdrew Consent during Study|2|||
33497566|NCT05000164|101713938|FG000|Overall Study|Subject Withdrawn by PI|2|||
33497567|NCT05000164|101713938|FG000|Overall Study|Other Fractured Test Article|1|||
33497568|NCT01686373|101713940|FG000|Overall Study|Lost to Follow-up|3|||
33497569|NCT01686373|101713941|FG001|Overall Study|Lost to Follow-up|0|||
33497570|NCT01686373|101713940|FG000|Overall Study|Withdrawal by Subject|0|||
33497571|NCT01686373|101713941|FG001|Overall Study|Withdrawal by Subject|1|||
33497572|NCT01686373|101713940|FG000|Overall Study|Adverse Event|0|||
33497573|NCT01686373|101713941|FG001|Overall Study|Adverse Event|1|||
33600253|NCT03627065|102088578|FG000|Overall Study|Withdrawal by Subject|2|||
33301815|NCT00964886|100999774|FG003|Overall Study|Adverse Event|2|||
33301816|NCT00964886|100999771|FG000|Overall Study|Protocol Violation|0|||
33301817|NCT00964886|100999772|FG001|Overall Study|Protocol Violation|2|||
33301818|NCT00964886|100999773|FG002|Overall Study|Protocol Violation|0|||
33301819|NCT00964886|100999774|FG003|Overall Study|Protocol Violation|0|||
33301820|NCT04869358|100999775|FG000|Overall Study|Wish to have children.|1|||
33301821|NCT04869358|100999776|FG001|Overall Study|Wish to have children.|0|||
33301822|NCT04869358|100999777|FG002|Overall Study|Wish to have children.|0|||
33301823|NCT04869358|100999778|FG003|Overall Study|Wish to have children.|0|||
33301824|NCT04889209|100999779|FG000|All Cohorts Except 15E|Adverse Event|0|||
33301825|NCT04889209|100999780|FG001|All Cohorts Except 15E|Adverse Event|0|||
33301826|NCT04889209|100999781|FG002|All Cohorts Except 15E|Adverse Event|0|||
33301827|NCT04889209|100999782|FG003|All Cohorts Except 15E|Adverse Event|0|||
33301828|NCT04889209|100999783|FG004|All Cohorts Except 15E|Adverse Event|0|||
33301829|NCT04889209|100999784|FG005|All Cohorts Except 15E|Adverse Event|0|||
33301830|NCT04889209|100999785|FG006|All Cohorts Except 15E|Adverse Event|1|||
33301831|NCT04889209|100999786|FG007|All Cohorts Except 15E|Adverse Event|0|||
33301832|NCT04889209|100999787|FG008|All Cohorts Except 15E|Adverse Event|0|||
33301833|NCT04889209|100999788|FG009|All Cohorts Except 15E|Adverse Event|0|||
33301834|NCT04889209|100999789|FG010|All Cohorts Except 15E|Adverse Event|0|||
33301835|NCT04889209|100999790|FG011|All Cohorts Except 15E|Adverse Event|0|||
33301836|NCT04889209|100999791|FG012|All Cohorts Except 15E|Adverse Event|0|||
33301837|NCT04889209|100999792|FG013|All Cohorts Except 15E|Adverse Event|0|||
33301838|NCT04889209|100999793|FG014|All Cohorts Except 15E|Adverse Event|0|||
33301839|NCT04889209|100999794|FG015|All Cohorts Except 15E|Adverse Event|0|||
33301840|NCT04889209|100999795|FG016|All Cohorts Except 15E|Adverse Event|0|||
33301841|NCT04889209|100999796|FG017|All Cohorts Except 15E|Adverse Event|0|||
33301842|NCT04889209|100999779|FG000|All Cohorts Except 15E|Death|0|||
33301843|NCT04889209|100999780|FG001|All Cohorts Except 15E|Death|1|||
33190468|NCT00213148|100601689|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
33301844|NCT04889209|100999781|FG002|All Cohorts Except 15E|Death|0|||
33301845|NCT04889209|100999782|FG003|All Cohorts Except 15E|Death|0|||
33301846|NCT04889209|100999783|FG004|All Cohorts Except 15E|Death|0|||
33301847|NCT04889209|100999784|FG005|All Cohorts Except 15E|Death|0|||
33301848|NCT04889209|100999785|FG006|All Cohorts Except 15E|Death|0|||
33301849|NCT04889209|100999786|FG007|All Cohorts Except 15E|Death|0|||
33301850|NCT04889209|100999787|FG008|All Cohorts Except 15E|Death|0|||
33497574|NCT01973439|101713944|FG000|Overall Study|Lost samples from one PK Day|2|||
33497575|NCT01973439|101713944|FG000|Overall Study|Vomiting after commencing once daily|1|||
33301851|NCT04889209|100999788|FG009|All Cohorts Except 15E|Death|0|||
33301852|NCT04889209|100999789|FG010|All Cohorts Except 15E|Death|0|||
33301853|NCT04889209|100999790|FG011|All Cohorts Except 15E|Death|0|||
33301854|NCT04889209|100999791|FG012|All Cohorts Except 15E|Death|0|||
33301855|NCT04889209|100999792|FG013|All Cohorts Except 15E|Death|0|||
33301856|NCT04889209|100999793|FG014|All Cohorts Except 15E|Death|0|||
33301857|NCT04889209|100999794|FG015|All Cohorts Except 15E|Death|0|||
33301858|NCT04889209|100999795|FG016|All Cohorts Except 15E|Death|0|||
33301859|NCT04889209|100999796|FG017|All Cohorts Except 15E|Death|0|||
33497576|NCT01973439|101713944|FG000|Overall Study|PK curve incomplete|2|||
33497577|NCT00808210|101713945|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
33600254|NCT01765426|102088582|FG000|Overall Study|Lost to Follow-up|0|||
33301860|NCT04889209|100999779|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
33301861|NCT04889209|100999780|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
33301862|NCT04889209|100999781|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
33301863|NCT04889209|100999782|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
33301864|NCT04889209|100999783|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
33301865|NCT04889209|100999784|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
33301866|NCT04889209|100999785|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
33301867|NCT04889209|100999786|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
33301868|NCT04889209|100999787|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
33301869|NCT04889209|100999788|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
33301870|NCT04889209|100999789|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
33301871|NCT04889209|100999790|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
33301872|NCT04889209|100999791|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
33301873|NCT04889209|100999792|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
33301874|NCT04889209|100999793|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
33301875|NCT04889209|100999794|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
33301876|NCT04889209|100999795|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
33301877|NCT04889209|100999796|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
33301878|NCT04889209|100999779|FG000|All Cohorts Except 15E|Physician Decision|0|||
33301879|NCT04889209|100999780|FG001|All Cohorts Except 15E|Physician Decision|0|||
33301880|NCT04889209|100999781|FG002|All Cohorts Except 15E|Physician Decision|0|||
33301881|NCT04889209|100999782|FG003|All Cohorts Except 15E|Physician Decision|0|||
33301882|NCT04889209|100999783|FG004|All Cohorts Except 15E|Physician Decision|1|||
33301883|NCT04889209|100999784|FG005|All Cohorts Except 15E|Physician Decision|0|||
33301884|NCT04889209|100999785|FG006|All Cohorts Except 15E|Physician Decision|0|||
33301885|NCT04889209|100999786|FG007|All Cohorts Except 15E|Physician Decision|1|||
33301886|NCT04889209|100999787|FG008|All Cohorts Except 15E|Physician Decision|0|||
33301887|NCT04889209|100999788|FG009|All Cohorts Except 15E|Physician Decision|1|||
33301888|NCT04889209|100999789|FG010|All Cohorts Except 15E|Physician Decision|0|||
33301889|NCT04889209|100999790|FG011|All Cohorts Except 15E|Physician Decision|1|||
33301890|NCT04889209|100999791|FG012|All Cohorts Except 15E|Physician Decision|1|||
33497578|NCT00808210|101713946|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
33497579|NCT00808210|101713945|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
33190469|NCT00213148|100601685|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
33190470|NCT00213148|100601686|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
33190471|NCT00213148|100601687|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
33190472|NCT00213148|100601688|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
33301891|NCT04889209|100999792|FG013|All Cohorts Except 15E|Physician Decision|0|||
33301892|NCT04889209|100999793|FG014|All Cohorts Except 15E|Physician Decision|0|||
33301893|NCT04889209|100999794|FG015|All Cohorts Except 15E|Physician Decision|0|||
33301894|NCT04889209|100999795|FG016|All Cohorts Except 15E|Physician Decision|0|||
33301895|NCT04889209|100999796|FG017|All Cohorts Except 15E|Physician Decision|0|||
33301896|NCT04889209|100999779|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
33301897|NCT04889209|100999780|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
33301898|NCT04889209|100999781|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
33497580|NCT00808210|101713946|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
33497581|NCT00808210|101713945|FG000|Double-Blind TX Period|Adverse Event|0|||
33497582|NCT00808210|101713946|FG001|Double-Blind TX Period|Adverse Event|1|||
33497583|NCT00808210|101713945|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
33497584|NCT00808210|101713946|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
33301899|NCT04889209|100999782|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
33301900|NCT04889209|100999783|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
33301901|NCT04889209|100999784|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
33301902|NCT04889209|100999785|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
33301903|NCT04889209|100999786|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
33301904|NCT04889209|100999787|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
33301905|NCT04889209|100999788|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
33301906|NCT04889209|100999789|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
33301907|NCT04889209|100999790|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
33301908|NCT04889209|100999791|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
33301909|NCT04889209|100999792|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
33301910|NCT04889209|100999793|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
33301911|NCT04889209|100999794|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
33497585|NCT00808210|101713945|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
33497586|NCT00808210|101713946|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
33497587|NCT00808210|101713945|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
33497588|NCT00808210|101713946|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
33497589|NCT03442751|101713948|FG000|Overall Study|Withdrawal by Subject|3|||
33497590|NCT03442751|101713949|FG001|Overall Study|Withdrawal by Subject|1|||
33497591|NCT03442751|101713948|FG000|Overall Study|Lost to Follow-up|3|||
33497592|NCT03442751|101713949|FG001|Overall Study|Lost to Follow-up|0|||
33497593|NCT01283464|101713950|FG000|Overall Study|Lost to Follow-up|0|||
33497594|NCT01283464|101713951|FG001|Overall Study|Lost to Follow-up|1|||
33497595|NCT01283464|101713950|FG000|Overall Study|Withdrawal by Subject|1|||
33497596|NCT01283464|101713951|FG001|Overall Study|Withdrawal by Subject|0|||
33497597|NCT01283464|101713950|FG000|Overall Study|Physician Decision|1|||
33497598|NCT01283464|101713951|FG001|Overall Study|Physician Decision|0|||
33497599|NCT01928472|101713956|FG000|Overall Study|Death|0|||
33497600|NCT01928472|101713957|FG001|Overall Study|Death|0|||
33497601|NCT01928472|101713958|FG002|Overall Study|Death|1|||
33497602|NCT01928472|101713959|FG003|Overall Study|Death|0|||
33497603|NCT01928472|101713956|FG000|Overall Study|Withdrawal by Subject|4|||
33497604|NCT01928472|101713957|FG001|Overall Study|Withdrawal by Subject|4|||
33497605|NCT01928472|101713958|FG002|Overall Study|Withdrawal by Subject|1|||
33497606|NCT01928472|101713959|FG003|Overall Study|Withdrawal by Subject|2|||
33497607|NCT01928472|101713956|FG000|Overall Study|Lost to Follow-up|2|||
33497608|NCT01928472|101713957|FG001|Overall Study|Lost to Follow-up|3|||
33497609|NCT01928472|101713958|FG002|Overall Study|Lost to Follow-up|4|||
33497610|NCT01928472|101713959|FG003|Overall Study|Lost to Follow-up|0|||
33497611|NCT01928472|101713956|FG000|Overall Study|Administrative Reason|2|||
33497612|NCT01928472|101713957|FG001|Overall Study|Administrative Reason|1|||
33497613|NCT01928472|101713958|FG002|Overall Study|Administrative Reason|0|||
33497614|NCT01928472|101713959|FG003|Overall Study|Administrative Reason|0|||
33497615|NCT01928472|101713956|FG000|Overall Study|Unclassified|0|||
33497616|NCT01928472|101713957|FG001|Overall Study|Unclassified|0|||
33497617|NCT01928472|101713958|FG002|Overall Study|Unclassified|1|||
33497618|NCT01928472|101713959|FG003|Overall Study|Unclassified|0|||
33497619|NCT00444535|101713960|FG000|Overall Study|Withdrawal by Subject|5|||
33497620|NCT00444535|101713960|FG000|Overall Study|Physician Decision|5|||
33497621|NCT00444535|101713960|FG000|Overall Study|progressive disease|1|||
33497622|NCT00444535|101713960|FG000|Overall Study|Adverse Event|2|||
33497623|NCT02259010|101713961|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
33497624|NCT01730053|101713962|FG000|Overall Study|Participant moved|0|||
33497625|NCT01730053|101713963|FG001|Overall Study|Participant moved|0|||
33497626|NCT01730053|101713964|FG002|Overall Study|Participant moved|1|||
33497627|NCT01730053|101713965|FG003|Overall Study|Participant moved|0|||
33497628|NCT01730053|101713966|FG004|Overall Study|Participant moved|0|||
33497629|NCT01730053|101713967|FG005|Overall Study|Participant moved|0|||
33497630|NCT01730053|101713962|FG000|Overall Study|Physician Decision|0|||
33497631|NCT01730053|101713963|FG001|Overall Study|Physician Decision|0|||
33497632|NCT01730053|101713964|FG002|Overall Study|Physician Decision|0|||
33497633|NCT01730053|101713965|FG003|Overall Study|Physician Decision|1|||
33497634|NCT01730053|101713966|FG004|Overall Study|Physician Decision|0|||
33600255|NCT01765426|102088583|FG001|Overall Study|Lost to Follow-up|1|||
33600256|NCT01765426|102088584|FG002|Overall Study|Lost to Follow-up|0|||
33600257|NCT01765426|102088585|FG003|Overall Study|Lost to Follow-up|0|||
33600258|NCT02827500|102088586|FG000|Overall Study|Death|7|||
33190473|NCT00213148|100601689|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
33190474|NCT00213148|100601685|FG000|Cycle 2 (1 Month)|Other|2|||
33190475|NCT00213148|100601686|FG001|Cycle 2 (1 Month)|Other|1|||
33190476|NCT00213148|100601687|FG002|Cycle 2 (1 Month)|Other|2|||
33497635|NCT01730053|101713967|FG005|Overall Study|Physician Decision|0|||
33497636|NCT01730053|101713962|FG000|Overall Study|Adverse Event|2|||
33497637|NCT01730053|101713963|FG001|Overall Study|Adverse Event|6|||
33497638|NCT01730053|101713964|FG002|Overall Study|Adverse Event|3|||
33497639|NCT01730053|101713965|FG003|Overall Study|Adverse Event|3|||
33497640|NCT01730053|101713966|FG004|Overall Study|Adverse Event|2|||
33497641|NCT01730053|101713967|FG005|Overall Study|Adverse Event|2|||
33497642|NCT01730053|101713962|FG000|Overall Study|Poor compliance to protocol|1|||
33497643|NCT01730053|101713963|FG001|Overall Study|Poor compliance to protocol|2|||
33497644|NCT01730053|101713964|FG002|Overall Study|Poor compliance to protocol|2|||
33497645|NCT01730053|101713965|FG003|Overall Study|Poor compliance to protocol|0|||
33497646|NCT01730053|101713966|FG004|Overall Study|Poor compliance to protocol|0|||
33497647|NCT01730053|101713967|FG005|Overall Study|Poor compliance to protocol|2|||
33497648|NCT01730053|101713962|FG000|Overall Study|Other than specified|2|||
33497649|NCT01730053|101713963|FG001|Overall Study|Other than specified|6|||
33497650|NCT01730053|101713964|FG002|Overall Study|Other than specified|5|||
33497651|NCT01730053|101713965|FG003|Overall Study|Other than specified|4|||
33497652|NCT01730053|101713966|FG004|Overall Study|Other than specified|7|||
33497653|NCT01730053|101713967|FG005|Overall Study|Other than specified|9|||
33190477|NCT00213148|100601688|FG003|Cycle 2 (1 Month)|Other|8|||
33190478|NCT00213148|100601689|FG004|Cycle 2 (1 Month)|Other|7|||
33497654|NCT01068860|101713968|FG000|Overall Study|Withdrawal by Subject|0|||
33600259|NCT02827500|102088587|FG001|Overall Study|Death|3|||
33497655|NCT01068860|101713969|FG001|Overall Study|Withdrawal by Subject|0|||
33301912|NCT04889209|100999795|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
33301913|NCT04889209|100999796|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
33301914|NCT04889209|100999779|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
33301915|NCT04889209|100999780|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
33301916|NCT04889209|100999781|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
33301917|NCT04889209|100999782|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
33301918|NCT04889209|100999783|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
33301919|NCT04889209|100999784|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
33301920|NCT04889209|100999785|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
33301921|NCT04889209|100999786|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
33301922|NCT04889209|100999787|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
33301923|NCT04889209|100999788|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
33301924|NCT04889209|100999789|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
33301925|NCT04889209|100999790|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
33301926|NCT04889209|100999791|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
33301927|NCT04889209|100999792|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
33301928|NCT04889209|100999793|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
33301929|NCT04889209|100999794|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
33301930|NCT04889209|100999795|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
33301931|NCT04889209|100999796|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
33301932|NCT04889209|100999779|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301933|NCT04889209|100999780|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301934|NCT04889209|100999781|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301935|NCT04889209|100999782|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
33301936|NCT04889209|100999783|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301937|NCT04889209|100999784|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301938|NCT04889209|100999785|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301939|NCT04889209|100999786|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301940|NCT04889209|100999787|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301941|NCT04889209|100999788|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301942|NCT04889209|100999789|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301943|NCT04889209|100999790|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301944|NCT04889209|100999791|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301945|NCT04889209|100999792|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301946|NCT04889209|100999793|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301947|NCT04889209|100999794|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301948|NCT04889209|100999795|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301949|NCT04889209|100999796|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
33301950|NCT04889209|100999779|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
33301951|NCT04889209|100999780|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
33301952|NCT04889209|100999781|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
33301953|NCT04889209|100999782|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
33301954|NCT04889209|100999783|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
33301955|NCT04889209|100999784|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
33301956|NCT04889209|100999785|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
33301957|NCT04889209|100999786|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
33301958|NCT04889209|100999787|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
33301959|NCT04889209|100999788|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
33301960|NCT04889209|100999789|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
33301961|NCT04889209|100999790|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
33301962|NCT04889209|100999791|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
33301963|NCT04889209|100999792|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
33301964|NCT04889209|100999793|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
33497656|NCT01068860|101713970|FG002|Overall Study|Withdrawal by Subject|0|||
33497657|NCT01068860|101713971|FG003|Overall Study|Withdrawal by Subject|0|||
33497658|NCT01068860|101713972|FG004|Overall Study|Withdrawal by Subject|0|||
33497659|NCT01068860|101713973|FG005|Overall Study|Withdrawal by Subject|2|||
33497660|NCT01068860|101713974|FG006|Overall Study|Withdrawal by Subject|0|||
33497661|NCT01068860|101713975|FG007|Overall Study|Withdrawal by Subject|0|||
33497662|NCT01068860|101713976|FG008|Overall Study|Withdrawal by Subject|0|||
33497663|NCT01068860|101713977|FG009|Overall Study|Withdrawal by Subject|3|||
33497664|NCT01068860|101713968|FG000|Overall Study|Administrative problems; misrandomized|0|||
33497665|NCT01068860|101713969|FG001|Overall Study|Administrative problems; misrandomized|0|||
33497666|NCT01068860|101713970|FG002|Overall Study|Administrative problems; misrandomized|0|||
33497667|NCT01068860|101713971|FG003|Overall Study|Administrative problems; misrandomized|1|||
33497668|NCT01068860|101713972|FG004|Overall Study|Administrative problems; misrandomized|0|||
33497669|NCT01068860|101713973|FG005|Overall Study|Administrative problems; misrandomized|0|||
33497670|NCT01068860|101713974|FG006|Overall Study|Administrative problems; misrandomized|0|||
33301965|NCT04889209|100999794|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
33301966|NCT04889209|100999795|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
33301967|NCT04889209|100999796|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
33301968|NCT04889209|100999779|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301969|NCT04889209|100999780|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301970|NCT04889209|100999781|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301971|NCT04889209|100999782|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301972|NCT04889209|100999783|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301973|NCT04889209|100999784|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301974|NCT04889209|100999785|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301975|NCT04889209|100999786|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301976|NCT04889209|100999787|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301977|NCT04889209|100999788|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301978|NCT04889209|100999789|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301979|NCT04889209|100999790|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301980|NCT04889209|100999791|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301981|NCT04889209|100999792|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301982|NCT04889209|100999793|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301983|NCT04889209|100999794|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301984|NCT04889209|100999795|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
33301985|NCT04889209|100999796|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
33301986|NCT04889209|100999779|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33301987|NCT04889209|100999780|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33301988|NCT04889209|100999781|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33301989|NCT04889209|100999782|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33301990|NCT04889209|100999783|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33301991|NCT04889209|100999784|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33301992|NCT04889209|100999785|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33301993|NCT04889209|100999786|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33301994|NCT04889209|100999787|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33301995|NCT04889209|100999788|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33301996|NCT04889209|100999789|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33301997|NCT04889209|100999790|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33301998|NCT04889209|100999791|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33301999|NCT04889209|100999792|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33302000|NCT04889209|100999793|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33302001|NCT04889209|100999794|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33302002|NCT04889209|100999795|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
33302003|NCT04889209|100999796|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
33302004|NCT04889209|100999779|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33302005|NCT04889209|100999780|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33302006|NCT04889209|100999781|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33302007|NCT04889209|100999782|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33302008|NCT04889209|100999783|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33497671|NCT01068860|101713975|FG007|Overall Study|Administrative problems; misrandomized|0|||
33302009|NCT04889209|100999784|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33497672|NCT01068860|101713976|FG008|Overall Study|Administrative problems; misrandomized|0|||
33497673|NCT01068860|101713977|FG009|Overall Study|Administrative problems; misrandomized|1|||
33497674|NCT01068860|101713968|FG000|Overall Study|Lost to Follow-up|0|||
33497675|NCT01068860|101713969|FG001|Overall Study|Lost to Follow-up|1|||
33497676|NCT01068860|101713970|FG002|Overall Study|Lost to Follow-up|0|||
33600260|NCT02827500|102088586|FG000|Overall Study|Lost to Follow-up|1|||
33497677|NCT01068860|101713971|FG003|Overall Study|Lost to Follow-up|0|||
33497678|NCT01068860|101713972|FG004|Overall Study|Lost to Follow-up|0|||
33497679|NCT01068860|101713973|FG005|Overall Study|Lost to Follow-up|0|||
33497680|NCT01068860|101713974|FG006|Overall Study|Lost to Follow-up|0|||
33497681|NCT01068860|101713975|FG007|Overall Study|Lost to Follow-up|0|||
33497682|NCT01068860|101713976|FG008|Overall Study|Lost to Follow-up|0|||
33497683|NCT01068860|101713977|FG009|Overall Study|Lost to Follow-up|0|||
33497684|NCT00739882|101713978|FG000|Double-blind Period|Adverse Event|1|||
33497685|NCT00739882|101713979|FG001|Double-blind Period|Adverse Event|2|||
33497686|NCT00739882|101713978|FG000|Double-blind Period|Protocol Violation|1|||
33497687|NCT00739882|101713979|FG001|Double-blind Period|Protocol Violation|0|||
33497688|NCT00739882|101713978|FG000|Double-blind Period|Lack of Efficacy|1|||
33497689|NCT00739882|101713979|FG001|Double-blind Period|Lack of Efficacy|1|||
33497690|NCT00739882|101713978|FG000|Double-blind Period|Other|16|||
33497691|NCT00739882|101713979|FG001|Double-blind Period|Other|8|||
33497692|NCT00739882|101713978|FG000|Open-label Period|Adverse Event|1|||
33497693|NCT00739882|101713979|FG001|Open-label Period|Adverse Event|0|||
33497694|NCT00739882|101713978|FG000|Open-label Period|Other|9|||
33302010|NCT04889209|100999785|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33190479|NCT00213148|100601685|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33302011|NCT04889209|100999786|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33302012|NCT04889209|100999787|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33302013|NCT04889209|100999788|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33302014|NCT04889209|100999789|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33302015|NCT04889209|100999790|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33302016|NCT04889209|100999791|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33302017|NCT04889209|100999792|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33302018|NCT04889209|100999793|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
33302019|NCT04889209|100999794|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33302020|NCT04889209|100999795|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33302021|NCT04889209|100999796|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
33302022|NCT03139604|100999797|FG000|Overall Study|Other|7|||
33302023|NCT03139604|100999798|FG001|Overall Study|Other|3|||
33302024|NCT03139604|100999797|FG000|Overall Study|Withdrawal by Subject|16|||
33302025|NCT03139604|100999798|FG001|Overall Study|Withdrawal by Subject|17|||
33302026|NCT03139604|100999797|FG000|Overall Study|Physician Decision|1|||
33302027|NCT03139604|100999798|FG001|Overall Study|Physician Decision|2|||
33302028|NCT03139604|100999797|FG000|Overall Study|Lost to Follow-up|3|||
33393535|NCT02903966|101328508|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
33393536|NCT02903966|101328509|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
33393537|NCT02903966|101328508|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
33393538|NCT02903966|101328509|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
33393539|NCT02985684|101328510|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
33393540|NCT02985684|101328510|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
33393541|NCT02985684|101328510|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
33497695|NCT00739882|101713979|FG001|Open-label Period|Other|5|||
33600261|NCT02827500|102088587|FG001|Overall Study|Lost to Follow-up|1|||
33600262|NCT02827500|102088586|FG000|Overall Study|Withdrawal by Subject|3|||
33600263|NCT02827500|102088587|FG001|Overall Study|Withdrawal by Subject|1|||
33600264|NCT02827500|102088586|FG000|Overall Study|Missing primary endpoint data|3|||
33600265|NCT02827500|102088587|FG001|Overall Study|Missing primary endpoint data|1|||
33600266|NCT02827500|102088586|FG000|Overall Study|Other|5|||
33600267|NCT02827500|102088587|FG001|Overall Study|Other|1|||
33600268|NCT00554619|102088588|FG000|Overall Study|Adverse Event|1|||
33600269|NCT00554619|102088588|FG000|Overall Study|Physician Decision|1|||
33600270|NCT00554619|102088588|FG000|Overall Study|Liver Function Test Abnormality|1|||
33600271|NCT00657371|102088589|FG000|Overall Study|Poor bowel preparation|15|||
33600272|NCT00657371|102088589|FG000|Overall Study|Unable to intubate the cecum|5|||
33190480|NCT00213148|100601686|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
33190481|NCT00213148|100601687|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33190482|NCT00213148|100601688|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33190483|NCT00213148|100601689|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
33497696|NCT00110396|101713980|FG000|Overall Study|Adverse Event|15|||
33393542|NCT03073200|101328511|FG000|Double Blind Treatment Period|Protocol Violation|1|||
33600273|NCT00657371|102088589|FG000|Overall Study|Protocol Violation|2|||
33497697|NCT00110396|101713980|FG000|Overall Study|Lost to Follow-up|1|||
33497698|NCT00110396|101713980|FG000|Overall Study|Administration of plasmapheresis|1|||
33600274|NCT00657371|102088589|FG000|Overall Study|Device- related reasons|13|||
33600275|NCT00657371|102088589|FG000|Overall Study|Pre-existing medical condition|4|||
33600276|NCT03697993|102088590|FG000|Overall Study|Became Ineligible after Enrollment|1|||
33600277|NCT03697993|102088591|FG001|Overall Study|Became Ineligible after Enrollment|3|||
33190484|NCT00213148|100601685|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
33497699|NCT00110396|101713980|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
33600278|NCT03697993|102088590|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
33600279|NCT03697993|102088591|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
33600280|NCT03697993|102088590|FG000|Overall Study|Lost to Follow-up|3|||
33600281|NCT03697993|102088591|FG001|Overall Study|Lost to Follow-up|0|||
33600282|NCT03697993|102088590|FG000|Overall Study|Physician Decision|4|||
33600283|NCT03697993|102088591|FG001|Overall Study|Physician Decision|0|||
33600284|NCT03697993|102088590|FG000|Overall Study|Initial Urine Culture Negative|0|||
33600285|NCT03697993|102088591|FG001|Overall Study|Initial Urine Culture Negative|1|||
33600286|NCT01149486|102088595|FG000|First Intervention|Adverse Event|0|||
33600287|NCT01149486|102088596|FG001|First Intervention|Adverse Event|1|||
33600288|NCT02370095|102088597|FG000|Overall Study|Withdrawal by Subject|0|||
33600289|NCT02370095|102088598|FG001|Overall Study|Withdrawal by Subject|1|||
33600290|NCT04126564|102088601|FG000|Overall Study|Withdrawal by Subject|0|||
33600291|NCT04126564|102088602|FG001|Overall Study|Withdrawal by Subject|2|||
33600292|NCT04126564|102088601|FG000|Overall Study|Lost to Follow-up|0|||
33600293|NCT04126564|102088602|FG001|Overall Study|Lost to Follow-up|1|||
33600294|NCT03812185|102088603|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
33600295|NCT01636713|102088604|FG000|Overall Study|Adverse Event|16|||
33600296|NCT01636713|102088605|FG001|Overall Study|Adverse Event|16|||
33600297|NCT01636713|102088606|FG002|Overall Study|Adverse Event|7|||
33600298|NCT01636713|102088604|FG000|Overall Study|Lack of Efficacy|6|||
33600299|NCT01636713|102088605|FG001|Overall Study|Lack of Efficacy|6|||
33600300|NCT01636713|102088606|FG002|Overall Study|Lack of Efficacy|2|||
33600301|NCT01636713|102088604|FG000|Overall Study|Protocol Violation|3|||
33600302|NCT01636713|102088605|FG001|Overall Study|Protocol Violation|0|||
33600303|NCT01636713|102088606|FG002|Overall Study|Protocol Violation|1|||
33600304|NCT01636713|102088604|FG000|Overall Study|Lost to Follow-up|0|||
33600305|NCT01636713|102088605|FG001|Overall Study|Lost to Follow-up|0|||
33190485|NCT00213148|100601686|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
33190486|NCT00213148|100601687|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
33497700|NCT00110396|101713980|FG000|Overall Study|Lack of Efficacy|1|||
33497701|NCT00110396|101713980|FG000|Overall Study|Decided not to continue treatment|1|||
33497702|NCT00110396|101713980|FG000|Overall Study|Patient non-compliance|1|||
33497703|NCT00110396|101713980|FG000|Overall Study|Patient refused to continue|1|||
33497704|NCT00110396|101713980|FG000|Overall Study|Patient refused to participate|1|||
33497705|NCT00110396|101713980|FG000|Overall Study|Patient will|1|||
33497706|NCT00110396|101713980|FG000|Overall Study|Patient's decision|1|||
33497707|NCT00110396|101713980|FG000|Overall Study|Participation in MS vaccine study|1|||
33497708|NCT00110396|101713980|FG000|Overall Study|Pregnancy|1|||
33497709|NCT00110396|101713980|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
33497710|NCT00110396|101713980|FG000|Overall Study|Protocol Violation|2|||
33497711|NCT00110396|101713980|FG000|Overall Study|Patient refused to come back|1|||
33497712|NCT00110396|101713980|FG000|Overall Study|The patient has refused|2|||
33497713|NCT00110396|101713980|FG000|Overall Study|The patient has refused to visit site|1|||
33497714|NCT00110396|101713980|FG000|Overall Study|Patient is to be administered copaxone|1|||
33497715|NCT03207815|101713981|FG000|Overall Study|Protocol Violation|3|||
33497716|NCT03207815|101713982|FG001|Overall Study|Protocol Violation|1|||
33497717|NCT03207815|101713981|FG000|Overall Study|Adverse Event|1|||
33497718|NCT03207815|101713982|FG001|Overall Study|Adverse Event|2|||
33497719|NCT03207815|101713981|FG000|Overall Study|Lost to Follow-up|1|||
33190487|NCT00213148|100601688|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
33190488|NCT00213148|100601689|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
33190489|NCT00213148|100601685|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
33190490|NCT00213148|100601686|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
33190491|NCT00213148|100601687|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
33190492|NCT00213148|100601688|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
33190493|NCT00213148|100601689|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
33190494|NCT00213148|100601685|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
33190495|NCT00213148|100601686|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
33190496|NCT00213148|100601687|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
33190497|NCT00213148|100601688|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
33190498|NCT00213148|100601689|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
33190499|NCT00213148|100601685|FG000|Cycle 3 (1 Month)|Other|0|||
33497720|NCT03207815|101713982|FG001|Overall Study|Lost to Follow-up|2|||
33497721|NCT03207815|101713981|FG000|Overall Study|Investigator's Discretion|1|||
33190500|NCT00213148|100601686|FG001|Cycle 3 (1 Month)|Other|0|||
33497722|NCT03207815|101713982|FG001|Overall Study|Investigator's Discretion|1|||
33497723|NCT03207815|101713981|FG000|Overall Study|Lack of Efficacy|0|||
33600306|NCT01636713|102088606|FG002|Overall Study|Lost to Follow-up|1|||
33600307|NCT01636713|102088604|FG000|Overall Study|Withdrawal by Subject|5|||
33600308|NCT01636713|102088605|FG001|Overall Study|Withdrawal by Subject|4|||
33497724|NCT03207815|101713982|FG001|Overall Study|Lack of Efficacy|1|||
33497725|NCT03207815|101713981|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
33497726|NCT03207815|101713982|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
33497727|NCT03207815|101713981|FG000|Overall Study|Withdrew Consent|1|||
33497728|NCT03207815|101713982|FG001|Overall Study|Withdrew Consent|0|||
33497729|NCT01662635|101713983|FG000|Overall Study|scarce samples for evaluation|30|||
33497730|NCT01801865|101713984|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
33497731|NCT01801865|101713984|FG000|Overall Study|Physician Decision|7|||
33497732|NCT00460811|101713985|FG000|Overall Study|Adverse Event|4|||
33497733|NCT00460811|101713986|FG001|Overall Study|Adverse Event|6|||
33497734|NCT00460811|101713987|FG002|Overall Study|Adverse Event|3|||
33497735|NCT00460811|101713988|FG003|Overall Study|Adverse Event|10|||
33497736|NCT00460811|101713989|FG004|Overall Study|Adverse Event|2|||
33497737|NCT00460811|101713985|FG000|Overall Study|Noncompliance|1|||
33497738|NCT00460811|101713986|FG001|Overall Study|Noncompliance|0|||
33497739|NCT00460811|101713987|FG002|Overall Study|Noncompliance|0|||
33497740|NCT00460811|101713988|FG003|Overall Study|Noncompliance|2|||
33497741|NCT00460811|101713989|FG004|Overall Study|Noncompliance|1|||
33497742|NCT00460811|101713985|FG000|Overall Study|Withdrawal by Subject|7|||
33497743|NCT00460811|101713986|FG001|Overall Study|Withdrawal by Subject|7|||
33497744|NCT00460811|101713987|FG002|Overall Study|Withdrawal by Subject|6|||
33497745|NCT00460811|101713988|FG003|Overall Study|Withdrawal by Subject|3|||
33497746|NCT00460811|101713989|FG004|Overall Study|Withdrawal by Subject|11|||
33497747|NCT00460811|101713985|FG000|Overall Study|Physician Decision|1|||
33497748|NCT00460811|101713986|FG001|Overall Study|Physician Decision|0|||
33497749|NCT00460811|101713987|FG002|Overall Study|Physician Decision|0|||
33497750|NCT00460811|101713988|FG003|Overall Study|Physician Decision|0|||
33497751|NCT00460811|101713989|FG004|Overall Study|Physician Decision|0|||
33497752|NCT00460811|101713985|FG000|Overall Study|Lost to Follow-up|3|||
33600309|NCT01636713|102088606|FG002|Overall Study|Withdrawal by Subject|8|||
33600310|NCT01636713|102088604|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
33600311|NCT01636713|102088605|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
33600312|NCT01636713|102088606|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
33600313|NCT03461406|102088607|FG000|Overall Study|Death|1|||
33600314|NCT03461406|102088608|FG001|Overall Study|Death|2|||
33600315|NCT03461406|102088607|FG000|Overall Study|Consent Withdrawn by Participant|0|||
33600316|NCT03461406|102088608|FG001|Overall Study|Consent Withdrawn by Participant|1|||
33600317|NCT03461406|102088607|FG000|Overall Study|Screen Failure|3|||
33600318|NCT03461406|102088608|FG001|Overall Study|Screen Failure|1|||
33497753|NCT00460811|101713986|FG001|Overall Study|Lost to Follow-up|2|||
33497754|NCT00460811|101713987|FG002|Overall Study|Lost to Follow-up|5|||
33497755|NCT00460811|101713988|FG003|Overall Study|Lost to Follow-up|3|||
33497756|NCT00460811|101713989|FG004|Overall Study|Lost to Follow-up|6|||
33497757|NCT02630251|101713990|FG000|Overall Study|Physician Decision|0|||
33497758|NCT02630251|101713991|FG001|Overall Study|Physician Decision|0|||
33497759|NCT02630251|101713992|FG002|Overall Study|Physician Decision|1|||
33497760|NCT02630251|101713993|FG003|Overall Study|Physician Decision|0|||
33497761|NCT00489918|101713994|FG000|Overall Study|Withdrawal by Subject|2|||
33497762|NCT00489918|101713995|FG001|Overall Study|Withdrawal by Subject|1|||
33497763|NCT00489918|101713996|FG002|Overall Study|Withdrawal by Subject|1|||
33497764|NCT00489918|101713997|FG003|Overall Study|Withdrawal by Subject|0|||
33497765|NCT00489918|101713998|FG004|Overall Study|Withdrawal by Subject|1|||
33497766|NCT00489918|101713994|FG000|Overall Study|Adverse Event|0|||
33497767|NCT00489918|101713995|FG001|Overall Study|Adverse Event|1|||
33497768|NCT00489918|101713996|FG002|Overall Study|Adverse Event|1|||
33497769|NCT00489918|101713997|FG003|Overall Study|Adverse Event|0|||
33497770|NCT00489918|101713998|FG004|Overall Study|Adverse Event|0|||
33497771|NCT00489918|101713994|FG000|Overall Study|Lost to Follow-up|0|||
33600319|NCT03461406|102088607|FG000|Overall Study|Reason not Specified|1|||
33600320|NCT03461406|102088608|FG001|Overall Study|Reason not Specified|3|||
33600321|NCT03461406|102088607|FG000|Overall Study|Lost to Follow-up|3|||
33190501|NCT00213148|100601687|FG002|Cycle 3 (1 Month)|Other|1|||
33190502|NCT00213148|100601688|FG003|Cycle 3 (1 Month)|Other|1|||
33190503|NCT00213148|100601689|FG004|Cycle 3 (1 Month)|Other|0|||
33190504|NCT03181542|100601692|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
33190505|NCT03181542|100601693|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
33190506|NCT01944059|100604911|FG000|Overall Study|Lost to Follow-up|1|||
33497772|NCT00489918|101713995|FG001|Overall Study|Lost to Follow-up|0|||
33497773|NCT00489918|101713996|FG002|Overall Study|Lost to Follow-up|1|||
33497774|NCT00489918|101713997|FG003|Overall Study|Lost to Follow-up|1|||
33497775|NCT00489918|101713998|FG004|Overall Study|Lost to Follow-up|0|||
33497776|NCT00489918|101713994|FG000|Overall Study|Physician Decision|0|||
33600322|NCT03461406|102088608|FG001|Overall Study|Lost to Follow-up|0|||
33600323|NCT01460407|102088609|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
33600324|NCT01460407|102088610|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
33190507|NCT01944059|100604911|FG000|Overall Study|Physician Decision|3|||
33497777|NCT00489918|101713995|FG001|Overall Study|Physician Decision|0|||
33600325|NCT01224821|102088612|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
33600326|NCT01224821|102088612|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
33600327|NCT01224821|102088612|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
33600328|NCT01224821|102088612|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
33600329|NCT01224821|102088612|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
33600330|NCT01224821|102088612|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
33600331|NCT01224821|102088612|FG000|Long-Term Follow-Up|Death|2|||
33600332|NCT01224821|102088612|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
33600333|NCT02525094|102088613|FG000|Overall Study|Lost to Follow-up|2|||
33600334|NCT02525094|102088614|FG001|Overall Study|Lost to Follow-up|1|||
33600335|NCT02525094|102088613|FG000|Overall Study|Withdrawal by Subject|5|||
33600336|NCT02525094|102088614|FG001|Overall Study|Withdrawal by Subject|6|||
33600337|NCT02525094|102088613|FG000|Overall Study|Not Treated|1|||
33600338|NCT02525094|102088614|FG001|Overall Study|Not Treated|1|||
33600339|NCT01100528|102088616|FG000|Overall Study|Death|1|||
33600340|NCT01100528|102088616|FG000|Overall Study|Withdrawal by Subject|2|||
33600341|NCT04047420|102088618|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
33600342|NCT04047420|102088618|FG000|Washout Period|Refused Participation|2|||
33600343|NCT03002623|102088625|FG000|Overall Study|Lost to Follow-up|1|||
33600344|NCT03002623|102088626|FG001|Overall Study|Lost to Follow-up|0|||
33600345|NCT03002623|102088625|FG000|Overall Study|Physician Decision|1|||
33600346|NCT03002623|102088626|FG001|Overall Study|Physician Decision|1|||
33600347|NCT03691779|102088627|FG000|Part B (24 Weeks)|Adverse Event|0|||
33600348|NCT03691779|102088628|FG001|Part B (24 Weeks)|Adverse Event|1|||
33302029|NCT03139604|100999798|FG001|Overall Study|Lost to Follow-up|1|||
33302030|NCT03139604|100999797|FG000|Overall Study|Death|65|||
33302031|NCT03139604|100999798|FG001|Overall Study|Death|67|||
33302032|NCT03139604|100999797|FG000|Overall Study|Study Terminated by Sponsor|122|||
33302033|NCT03139604|100999798|FG001|Overall Study|Study Terminated by Sponsor|127|||
33302034|NCT03139604|100999797|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
33302035|NCT03139604|100999798|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
33302036|NCT03816761|100999799|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
33302037|NCT03816761|100999800|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
33302038|NCT03816761|100999801|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
33302039|NCT03816761|100999802|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
33302040|NCT03816761|100999803|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
33302041|NCT03816761|100999804|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
33302042|NCT03816761|100999799|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
33302043|NCT03816761|100999800|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
33302044|NCT03816761|100999801|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
33302045|NCT03816761|100999802|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
33302046|NCT03816761|100999803|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
33302047|NCT03816761|100999804|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
33302048|NCT01142115|100999811|FG000|First Intervention|Lack of Efficacy|1|||
33302049|NCT01142115|100999812|FG001|First Intervention|Lack of Efficacy|1|||
33302050|NCT01142115|100999811|FG000|First Intervention|Adverse Event|1|||
33302051|NCT01142115|100999812|FG001|First Intervention|Adverse Event|0|||
33302052|NCT01803282|100999813|FG000|Overall Study|Progressive Disease|4|||
33302053|NCT01803282|100999814|FG001|Overall Study|Progressive Disease|3|||
33302054|NCT01803282|100999815|FG002|Overall Study|Progressive Disease|6|||
33302055|NCT01803282|100999816|FG003|Overall Study|Progressive Disease|22|||
33302056|NCT01803282|100999817|FG004|Overall Study|Progressive Disease|5|||
33302057|NCT01803282|100999818|FG005|Overall Study|Progressive Disease|8|||
33302058|NCT01803282|100999819|FG006|Overall Study|Progressive Disease|23|||
33302059|NCT01803282|100999820|FG007|Overall Study|Progressive Disease|24|||
33302060|NCT01803282|100999821|FG008|Overall Study|Progressive Disease|3|||
33302061|NCT01803282|100999822|FG009|Overall Study|Progressive Disease|29|||
33302062|NCT01803282|100999823|FG010|Overall Study|Progressive Disease|6|||
33302063|NCT01803282|100999824|FG011|Overall Study|Progressive Disease|11|||
33302064|NCT01803282|100999813|FG000|Overall Study|Death|0|||
33302065|NCT01803282|100999814|FG001|Overall Study|Death|0|||
33302066|NCT01803282|100999815|FG002|Overall Study|Death|0|||
33302067|NCT01803282|100999816|FG003|Overall Study|Death|0|||
33302068|NCT01803282|100999817|FG004|Overall Study|Death|2|||
33302069|NCT01803282|100999818|FG005|Overall Study|Death|1|||
33302070|NCT01803282|100999819|FG006|Overall Study|Death|1|||
33393543|NCT03073200|101328512|FG001|Double Blind Treatment Period|Protocol Violation|0|||
33302071|NCT01803282|100999820|FG007|Overall Study|Death|5|||
33302072|NCT01803282|100999821|FG008|Overall Study|Death|1|||
33302073|NCT01803282|100999822|FG009|Overall Study|Death|1|||
33302074|NCT01803282|100999823|FG010|Overall Study|Death|0|||
33600349|NCT03691779|102088627|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
33600350|NCT03691779|102088628|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
33600351|NCT03757130|102088629|FG000|Overall Study|Lost to Follow-up|0|||
33600352|NCT03757130|102088630|FG001|Overall Study|Lost to Follow-up|0|||
33497778|NCT00489918|101713996|FG002|Overall Study|Physician Decision|1|||
33497779|NCT00489918|101713997|FG003|Overall Study|Physician Decision|0|||
33497780|NCT00489918|101713998|FG004|Overall Study|Physician Decision|0|||
33497781|NCT01812109|101714008|FG000|Overall Study|research personnel delay|16|||
33497782|NCT01812109|101714008|FG000|Overall Study|NIRS Unattainable|17|||
33497783|NCT03652051|101714009|FG000|Stage 1|Adverse Event|0|||
33497784|NCT03652051|101714010|FG001|Stage 1|Adverse Event|5|||
33497785|NCT03652051|101714011|FG002|Stage 1|Adverse Event|7|||
33497786|NCT03652051|101714012|FG003|Stage 1|Adverse Event|1|||
33497787|NCT03652051|101714009|FG000|Stage 1|Withdrawal by Subject|0|||
33497788|NCT03652051|101714010|FG001|Stage 1|Withdrawal by Subject|0|||
33497789|NCT03652051|101714011|FG002|Stage 1|Withdrawal by Subject|1|||
33497790|NCT03652051|101714012|FG003|Stage 1|Withdrawal by Subject|0|||
33497791|NCT03652051|101714009|FG000|Stage 2|Adverse Event|0|||
33497792|NCT03652051|101714010|FG001|Stage 2|Adverse Event|2|||
33497793|NCT03652051|101714011|FG002|Stage 2|Adverse Event|1|||
33497794|NCT03652051|101714012|FG003|Stage 2|Adverse Event|0|||
33497795|NCT03652051|101714009|FG000|Stage 2|Protocol Violation|0|||
33497796|NCT03652051|101714010|FG001|Stage 2|Protocol Violation|1|||
33497797|NCT03652051|101714011|FG002|Stage 2|Protocol Violation|6|||
33497798|NCT03652051|101714012|FG003|Stage 2|Protocol Violation|0|||
33497799|NCT03652051|101714009|FG000|Stage 2|Lost to Follow-up|0|||
33497800|NCT03652051|101714010|FG001|Stage 2|Lost to Follow-up|2|||
33497801|NCT03652051|101714011|FG002|Stage 2|Lost to Follow-up|0|||
33497802|NCT03652051|101714012|FG003|Stage 2|Lost to Follow-up|3|||
33497803|NCT03652051|101714009|FG000|Stage 2|Withdrawal by Subject|0|||
33497804|NCT03652051|101714010|FG001|Stage 2|Withdrawal by Subject|11|||
33497805|NCT03652051|101714011|FG002|Stage 2|Withdrawal by Subject|9|||
33497806|NCT03652051|101714012|FG003|Stage 2|Withdrawal by Subject|3|||
33497807|NCT01131455|101714013|FG000|Overall Study|Death of PI|6|||
33600353|NCT03757130|102088631|FG002|Overall Study|Lost to Follow-up|0|||
33600354|NCT03757130|102088632|FG003|Overall Study|Lost to Follow-up|1|||
33600355|NCT03757130|102088633|FG004|Overall Study|Lost to Follow-up|0|||
33600356|NCT03757130|102088634|FG005|Overall Study|Lost to Follow-up|0|||
33600357|NCT03757130|102088635|FG006|Overall Study|Lost to Follow-up|0|||
33600358|NCT03757130|102088636|FG007|Overall Study|Lost to Follow-up|1|||
33600359|NCT03757130|102088629|FG000|Overall Study|Withdrawal by Subject|0|||
33600360|NCT03757130|102088630|FG001|Overall Study|Withdrawal by Subject|0|||
33600361|NCT03757130|102088631|FG002|Overall Study|Withdrawal by Subject|0|||
33190508|NCT01944059|100604911|FG000|Overall Study|Withdrawal by Subject|1|||
33190509|NCT01944059|100604911|FG000|Overall Study|Adverse Event|2|||
33190510|NCT01227512|100604920|FG000|Overall Study|Physician Decision|6|||
33190511|NCT01227512|100604921|FG001|Overall Study|Physician Decision|6|||
33190512|NCT01227512|100604920|FG000|Overall Study|Adverse Event|4|||
33190513|NCT01227512|100604921|FG001|Overall Study|Adverse Event|3|||
33190514|NCT01227512|100604920|FG000|Overall Study|Withdrawal by Subject|3|||
33190515|NCT01227512|100604921|FG001|Overall Study|Withdrawal by Subject|0|||
33190516|NCT01227512|100604920|FG000|Overall Study|Participant met withdrawal criteria|0|||
33190517|NCT01227512|100604921|FG001|Overall Study|Participant met withdrawal criteria|1|||
33190518|NCT00403273|100604926|FG000|Overall Study|Lost to Follow-up|3|||
33190519|NCT00403273|100604927|FG001|Overall Study|Lost to Follow-up|2|||
33190520|NCT00403273|100604926|FG000|Overall Study|Physician Decision|0|||
33190521|NCT00403273|100604927|FG001|Overall Study|Physician Decision|1|||
33190522|NCT00403273|100604926|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
33190523|NCT00403273|100604927|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
33190524|NCT02554656|100604928|FG000|Overall Study|Protocol Violation|3|||
33190525|NCT02852265|100604929|FG000|3-month Follow-up|Lost to Follow-up|1|||
33190526|NCT02852265|100604930|FG001|3-month Follow-up|Lost to Follow-up|1|||
33190527|NCT01072201|100604931|FG000|Overall Study|Lost to Follow-up|0|||
33190528|NCT01072201|100604932|FG001|Overall Study|Lost to Follow-up|1|||
33190529|NCT01481116|100604933|FG000|Overall Study|Adverse Event|26|||
33190530|NCT01481116|100604934|FG001|Overall Study|Adverse Event|26|||
33190531|NCT01481116|100604935|FG002|Overall Study|Adverse Event|42|||
33190532|NCT01481116|100604933|FG000|Overall Study|Major Protocol Deviation|3|||
33190533|NCT01481116|100604934|FG001|Overall Study|Major Protocol Deviation|7|||
33190534|NCT01481116|100604935|FG002|Overall Study|Major Protocol Deviation|1|||
33190535|NCT01481116|100604933|FG000|Overall Study|Lost to Follow-up|8|||
33497808|NCT01131455|101714014|FG001|Overall Study|Death of PI|4|||
33497809|NCT01131455|101714015|FG002|Overall Study|Death of PI|0|||
33497810|NCT05005507|101714019|FG000|Overall Study|Premature termination of study|1|||
33497811|NCT02064816|101714022|FG000|Overall Study|Adverse Event|3|||
33497812|NCT02064816|101714023|FG001|Overall Study|Adverse Event|2|||
33497813|NCT02064816|101714022|FG000|Overall Study|Withdrawal by Subject|2|||
33497814|NCT02064816|101714023|FG001|Overall Study|Withdrawal by Subject|1|||
33600362|NCT03757130|102088632|FG003|Overall Study|Withdrawal by Subject|0|||
33190536|NCT01481116|100604934|FG001|Overall Study|Lost to Follow-up|12|||
33190537|NCT01481116|100604935|FG002|Overall Study|Lost to Follow-up|11|||
33190538|NCT01481116|100604933|FG000|Overall Study|Withdrawal by Subject|37|||
33190539|NCT01481116|100604934|FG001|Overall Study|Withdrawal by Subject|33|||
33302075|NCT01803282|100999824|FG011|Overall Study|Death|0|||
33302076|NCT01803282|100999813|FG000|Overall Study|Withdrew Consent|0|||
33302077|NCT01803282|100999814|FG001|Overall Study|Withdrew Consent|0|||
33302078|NCT01803282|100999815|FG002|Overall Study|Withdrew Consent|0|||
33302079|NCT01803282|100999816|FG003|Overall Study|Withdrew Consent|6|||
33302080|NCT01803282|100999817|FG004|Overall Study|Withdrew Consent|1|||
33302081|NCT01803282|100999818|FG005|Overall Study|Withdrew Consent|0|||
33302082|NCT01803282|100999819|FG006|Overall Study|Withdrew Consent|8|||
33302083|NCT01803282|100999820|FG007|Overall Study|Withdrew Consent|3|||
33302084|NCT01803282|100999821|FG008|Overall Study|Withdrew Consent|1|||
33497815|NCT02064816|101714022|FG000|Overall Study|Lost to Follow-up|2|||
33497816|NCT02064816|101714023|FG001|Overall Study|Lost to Follow-up|1|||
33497817|NCT02064816|101714022|FG000|Overall Study|Therapeutic failure|0|||
33302085|NCT01803282|100999822|FG009|Overall Study|Withdrew Consent|5|||
33302086|NCT01803282|100999823|FG010|Overall Study|Withdrew Consent|0|||
33302087|NCT01803282|100999824|FG011|Overall Study|Withdrew Consent|1|||
33302088|NCT01803282|100999813|FG000|Overall Study|Investigator's Discretion|0|||
33302089|NCT01803282|100999814|FG001|Overall Study|Investigator's Discretion|0|||
33302090|NCT01803282|100999815|FG002|Overall Study|Investigator's Discretion|0|||
33302091|NCT01803282|100999816|FG003|Overall Study|Investigator's Discretion|7|||
33302092|NCT01803282|100999817|FG004|Overall Study|Investigator's Discretion|2|||
33302093|NCT01803282|100999818|FG005|Overall Study|Investigator's Discretion|1|||
33302094|NCT01803282|100999819|FG006|Overall Study|Investigator's Discretion|7|||
33302095|NCT01803282|100999820|FG007|Overall Study|Investigator's Discretion|10|||
33302096|NCT01803282|100999821|FG008|Overall Study|Investigator's Discretion|6|||
33302097|NCT01803282|100999822|FG009|Overall Study|Investigator's Discretion|7|||
33302098|NCT01803282|100999823|FG010|Overall Study|Investigator's Discretion|1|||
33302099|NCT01803282|100999824|FG011|Overall Study|Investigator's Discretion|0|||
33302100|NCT01803282|100999813|FG000|Overall Study|Adverse Event|0|||
33302101|NCT01803282|100999814|FG001|Overall Study|Adverse Event|0|||
33302102|NCT01803282|100999815|FG002|Overall Study|Adverse Event|0|||
33302103|NCT01803282|100999816|FG003|Overall Study|Adverse Event|0|||
33302104|NCT01803282|100999817|FG004|Overall Study|Adverse Event|0|||
33302105|NCT01803282|100999818|FG005|Overall Study|Adverse Event|0|||
33302106|NCT01803282|100999819|FG006|Overall Study|Adverse Event|1|||
33302107|NCT01803282|100999820|FG007|Overall Study|Adverse Event|2|||
33302108|NCT01803282|100999821|FG008|Overall Study|Adverse Event|0|||
33302109|NCT01803282|100999822|FG009|Overall Study|Adverse Event|1|||
33302110|NCT01803282|100999823|FG010|Overall Study|Adverse Event|0|||
33302111|NCT01803282|100999824|FG011|Overall Study|Adverse Event|3|||
33302112|NCT01803282|100999813|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33302113|NCT01803282|100999814|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33302114|NCT01803282|100999815|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33302115|NCT01803282|100999816|FG003|Overall Study|Non-Compliance with Study Drug|1|||
33302116|NCT01803282|100999817|FG004|Overall Study|Non-Compliance with Study Drug|0|||
33302117|NCT01803282|100999818|FG005|Overall Study|Non-Compliance with Study Drug|0|||
33302118|NCT01803282|100999819|FG006|Overall Study|Non-Compliance with Study Drug|0|||
33302119|NCT01803282|100999820|FG007|Overall Study|Non-Compliance with Study Drug|0|||
33302120|NCT01803282|100999821|FG008|Overall Study|Non-Compliance with Study Drug|0|||
33302121|NCT01803282|100999822|FG009|Overall Study|Non-Compliance with Study Drug|0|||
33302122|NCT01803282|100999823|FG010|Overall Study|Non-Compliance with Study Drug|0|||
33302123|NCT01803282|100999824|FG011|Overall Study|Non-Compliance with Study Drug|0|||
33302124|NCT01803282|100999813|FG000|Overall Study|Unknown Reason|0|||
33302125|NCT01803282|100999814|FG001|Overall Study|Unknown Reason|0|||
33497818|NCT02064816|101714023|FG001|Overall Study|Therapeutic failure|1|||
33497819|NCT02064816|101714022|FG000|Overall Study|Other|1|||
33497820|NCT02064816|101714023|FG001|Overall Study|Other|3|||
33497821|NCT02314026|101714025|FG000|Overall Study|Protocol Violation|28|||
33497822|NCT01422889|101714027|FG000|Overall Study|No Data Entered for Study Stent|9|||
33497823|NCT00113763|101714029|FG000|Overall Study|Adverse Event|5|||
33497824|NCT00113763|101714030|FG001|Overall Study|Adverse Event|2|||
33497825|NCT00113763|101714029|FG000|Overall Study|Disease Progression|28|||
33497826|NCT00113763|101714030|FG001|Overall Study|Disease Progression|14|||
33497827|NCT00113763|101714029|FG000|Overall Study|Lost to Follow-up|10|||
33497828|NCT00113763|101714030|FG001|Overall Study|Lost to Follow-up|0|||
33302126|NCT01803282|100999815|FG002|Overall Study|Unknown Reason|0|||
33302127|NCT01803282|100999816|FG003|Overall Study|Unknown Reason|0|||
33302128|NCT01803282|100999817|FG004|Overall Study|Unknown Reason|0|||
33302129|NCT01803282|100999818|FG005|Overall Study|Unknown Reason|0|||
33302130|NCT01803282|100999819|FG006|Overall Study|Unknown Reason|0|||
33302131|NCT01803282|100999820|FG007|Overall Study|Unknown Reason|1|||
33302132|NCT01803282|100999821|FG008|Overall Study|Unknown Reason|0|||
33302133|NCT01803282|100999822|FG009|Overall Study|Unknown Reason|0|||
33302134|NCT01803282|100999823|FG010|Overall Study|Unknown Reason|0|||
33302135|NCT01803282|100999824|FG011|Overall Study|Unknown Reason|0|||
33302136|NCT01803282|100999813|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
33302137|NCT01803282|100999814|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
33497829|NCT00113763|101714029|FG000|Overall Study|Withdrawal by Subject|1|||
33497830|NCT00113763|101714030|FG001|Overall Study|Withdrawal by Subject|4|||
33302138|NCT01803282|100999815|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
33302139|NCT01803282|100999816|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
33302140|NCT01803282|100999817|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
33302141|NCT01803282|100999818|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
33302142|NCT01803282|100999819|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
33302143|NCT01803282|100999820|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
33302144|NCT01803282|100999821|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
33302145|NCT01803282|100999822|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
33302146|NCT01803282|100999823|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
33302147|NCT01803282|100999824|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
33302148|NCT01803282|100999813|FG000|Overall Study|Enrolled but Never Treated|0|||
33393544|NCT03073200|101328513|FG002|Double Blind Treatment Period|Protocol Violation|0|||
33393545|NCT03073200|101328514|FG003|Double Blind Treatment Period|Protocol Violation|0|||
33393546|NCT03073200|101328515|FG004|Double Blind Treatment Period|Protocol Violation|0|||
33393547|NCT03073200|101328516|FG005|Double Blind Treatment Period|Protocol Violation|0|||
33393548|NCT03073200|101328517|FG006|Double Blind Treatment Period|Protocol Violation|0|||
33393549|NCT03073200|101328518|FG007|Double Blind Treatment Period|Protocol Violation|0|||
33393550|NCT03073200|101328519|FG008|Double Blind Treatment Period|Protocol Violation|0|||
33393551|NCT03073200|101328520|FG009|Double Blind Treatment Period|Protocol Violation|0|||
33393552|NCT03073200|101328521|FG010|Double Blind Treatment Period|Protocol Violation|0|||
33393553|NCT03073200|101328522|FG011|Double Blind Treatment Period|Protocol Violation|0|||
33393554|NCT03073200|101328523|FG012|Double Blind Treatment Period|Protocol Violation|0|||
33393555|NCT03073200|101328524|FG013|Double Blind Treatment Period|Protocol Violation|0|||
33393556|NCT03073200|101328525|FG014|Double Blind Treatment Period|Protocol Violation|0|||
33393557|NCT03073200|101328511|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33393558|NCT03073200|101328512|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
33393559|NCT03073200|101328513|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33393560|NCT03073200|101328514|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33393561|NCT03073200|101328515|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33497831|NCT00113763|101714029|FG000|Overall Study|Other|27|||
33497832|NCT00113763|101714030|FG001|Overall Study|Other|6|||
33497833|NCT00113763|101714029|FG000|Overall Study|Non-compliance|1|||
33497834|NCT00113763|101714030|FG001|Overall Study|Non-compliance|0|||
33497835|NCT00113763|101714029|FG000|Overall Study|Ongoing|1|||
33497836|NCT00113763|101714030|FG001|Overall Study|Ongoing|0|||
33497837|NCT01956773|101714034|FG000|Overall Study|Lost to Follow-up|628|||
33497838|NCT01956773|101714035|FG001|Overall Study|Lost to Follow-up|1|||
33497839|NCT01431716|101714042|FG000|Overall Study|Withdrawal of consent|1|||
33497840|NCT04526288|101714043|FG000|Overall Study|Disease Progression|1|||
33497841|NCT04526288|101714044|FG001|Overall Study|Disease Progression|0|||
33497842|NCT05344560|101714045|FG000|Period 1|Subject out of visit window|1|||
33190540|NCT01481116|100604935|FG002|Overall Study|Withdrawal by Subject|37|||
33190541|NCT01481116|100604933|FG000|Overall Study|Study Termination|730|||
33190542|NCT01481116|100604934|FG001|Overall Study|Study Termination|729|||
33190543|NCT01481116|100604935|FG002|Overall Study|Study Termination|713|||
33190544|NCT01481116|100604933|FG000|Overall Study|Pregnancy|0|||
33190545|NCT01481116|100604934|FG001|Overall Study|Pregnancy|0|||
33190546|NCT01481116|100604935|FG002|Overall Study|Pregnancy|1|||
33190547|NCT01481116|100604933|FG000|Overall Study|Lack of Efficacy|3|||
33190548|NCT01481116|100604934|FG001|Overall Study|Lack of Efficacy|3|||
33190549|NCT01481116|100604935|FG002|Overall Study|Lack of Efficacy|1|||
33190550|NCT01481116|100604933|FG000|Overall Study|Contraindications|1|||
33190551|NCT01481116|100604934|FG001|Overall Study|Contraindications|1|||
33190552|NCT01481116|100604935|FG002|Overall Study|Contraindications|0|||
33190553|NCT01481116|100604933|FG000|Overall Study|Other|1|||
33190554|NCT01481116|100604934|FG001|Overall Study|Other|1|||
33190555|NCT01481116|100604935|FG002|Overall Study|Other|0|||
33190556|NCT01481116|100604933|FG000|Overall Study|Participant Started Taking Glipizide|1|||
33190557|NCT01481116|100604934|FG001|Overall Study|Participant Started Taking Glipizide|0|||
33190558|NCT01481116|100604935|FG002|Overall Study|Participant Started Taking Glipizide|0|||
33190559|NCT01481116|100604933|FG000|Overall Study|Participant Moved Out of Area|2|||
33190560|NCT01481116|100604934|FG001|Overall Study|Participant Moved Out of Area|0|||
33190561|NCT01481116|100604935|FG002|Overall Study|Participant Moved Out of Area|1|||
33190562|NCT01481116|100604933|FG000|Overall Study|Participant Moved Out of Country|1|||
33190563|NCT01481116|100604934|FG001|Overall Study|Participant Moved Out of Country|0|||
33302149|NCT01803282|100999814|FG001|Overall Study|Enrolled but Never Treated|0|||
33393562|NCT03073200|101328516|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33190564|NCT01481116|100604935|FG002|Overall Study|Participant Moved Out of Country|1|||
33190565|NCT01481116|100604933|FG000|Overall Study|Investigator Decision|3|||
33190566|NCT01481116|100604934|FG001|Overall Study|Investigator Decision|2|||
33190567|NCT01481116|100604935|FG002|Overall Study|Investigator Decision|1|||
33190568|NCT01481116|100604933|FG000|Overall Study|Sponsor Decision|0|||
33190569|NCT01481116|100604934|FG001|Overall Study|Sponsor Decision|1|||
33302150|NCT01803282|100999815|FG002|Overall Study|Enrolled but Never Treated|0|||
33497843|NCT05344560|101714046|FG001|Period 1|Subject out of visit window|1|||
33497844|NCT05344560|101714045|FG000|Period 2|Covid-19 Related|1|||
33497845|NCT05344560|101714046|FG001|Period 2|Covid-19 Related|0|||
33497846|NCT05344560|101714045|FG000|Period 2|Adverse Event|1|||
33497847|NCT05344560|101714046|FG001|Period 2|Adverse Event|0|||
33497848|NCT05344560|101714045|FG000|Period 2|Subject out of visit window|1|||
33497849|NCT05344560|101714046|FG001|Period 2|Subject out of visit window|1|||
33497850|NCT05344560|101714045|FG000|Period 3|Subject out of visit window|1|||
33302151|NCT01803282|100999816|FG003|Overall Study|Enrolled but Never Treated|0|||
33302152|NCT01803282|100999817|FG004|Overall Study|Enrolled but Never Treated|1|||
33302153|NCT01803282|100999818|FG005|Overall Study|Enrolled but Never Treated|0|||
33302154|NCT01803282|100999819|FG006|Overall Study|Enrolled but Never Treated|1|||
33302155|NCT01803282|100999820|FG007|Overall Study|Enrolled but Never Treated|1|||
33302156|NCT01803282|100999821|FG008|Overall Study|Enrolled but Never Treated|0|||
33302157|NCT01803282|100999822|FG009|Overall Study|Enrolled but Never Treated|1|||
33302158|NCT01803282|100999823|FG010|Overall Study|Enrolled but Never Treated|0|||
33497851|NCT05344560|101714046|FG001|Period 3|Subject out of visit window|0|||
33302159|NCT01803282|100999824|FG011|Overall Study|Enrolled but Never Treated|0|||
33302160|NCT01769326|100999825|FG000|Overall Study|Lost to Follow-up|1|||
33302161|NCT01769326|100999826|FG001|Overall Study|Lost to Follow-up|2|||
33302162|NCT01769326|100999827|FG002|Overall Study|Lost to Follow-up|0|||
33302163|NCT01769326|100999828|FG003|Overall Study|Lost to Follow-up|0|||
33302164|NCT01769326|100999825|FG000|Overall Study|unrelated injry|1|||
33302165|NCT01769326|100999826|FG001|Overall Study|unrelated injry|1|||
33302166|NCT01769326|100999827|FG002|Overall Study|unrelated injry|0|||
33302167|NCT01769326|100999828|FG003|Overall Study|unrelated injry|0|||
33302168|NCT01769326|100999825|FG000|Overall Study|got a job|0|||
33302169|NCT01769326|100999826|FG001|Overall Study|got a job|1|||
33302170|NCT01769326|100999827|FG002|Overall Study|got a job|0|||
33302171|NCT01769326|100999828|FG003|Overall Study|got a job|0|||
33302172|NCT01769326|100999825|FG000|Overall Study|Got sick and could not complete study|0|||
33302173|NCT01769326|100999826|FG001|Overall Study|Got sick and could not complete study|0|||
33302174|NCT01769326|100999827|FG002|Overall Study|Got sick and could not complete study|1|||
33302175|NCT01769326|100999828|FG003|Overall Study|Got sick and could not complete study|0|||
33302176|NCT00586612|100999831|FG000|Primary Phase|Protocol Violation|1|||
33302177|NCT00586612|100999832|FG001|Primary Phase|Protocol Violation|0|||
33302178|NCT00586612|100999831|FG000|Primary Phase|Lost to Follow-up|0|||
33302179|NCT00586612|100999832|FG001|Primary Phase|Lost to Follow-up|1|||
33302180|NCT00586612|100999831|FG000|Primary Phase|Withdrawal by Subject|0|||
33302181|NCT00586612|100999832|FG001|Primary Phase|Withdrawal by Subject|2|||
33302182|NCT00586612|100999831|FG000|Booster Phase|Lost to Follow-up|3|||
33302183|NCT00586612|100999832|FG001|Booster Phase|Lost to Follow-up|1|||
33302184|NCT02683785|100999837|FG000|Overall Study|Withdrawal by Subject|1|||
33302185|NCT02683785|100999838|FG001|Overall Study|Withdrawal by Subject|1|||
33302186|NCT02683785|100999837|FG000|Overall Study|Lost to Follow-up|0|||
33302187|NCT02683785|100999838|FG001|Overall Study|Lost to Follow-up|1|||
33302188|NCT02683785|100999837|FG000|Overall Study|Adverse Event|0|||
33302189|NCT02683785|100999838|FG001|Overall Study|Adverse Event|2|||
33302190|NCT00890695|100999839|FG000|Overall Study|Protocol Violation|1|||
33302191|NCT00890695|100999840|FG001|Overall Study|Protocol Violation|0|||
33302192|NCT01518153|100999841|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
33302193|NCT01518153|100999842|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
33302194|NCT01518153|100999843|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
33302195|NCT01518153|100999841|FG000|Stem Cell Transplant|Death|2|||
33302196|NCT01518153|100999842|FG001|Stem Cell Transplant|Death|0|||
33302197|NCT01518153|100999843|FG002|Stem Cell Transplant|Death|0|||
33302198|NCT01518153|100999841|FG000|Stem Cell Transplant|Secondary graft failure|1|||
33302199|NCT01518153|100999842|FG001|Stem Cell Transplant|Secondary graft failure|0|||
33302200|NCT01518153|100999843|FG002|Stem Cell Transplant|Secondary graft failure|0|||
33302201|NCT01518153|100999841|FG000|Stem Cell Transplant|Adverse Event|1|||
33302202|NCT01518153|100999842|FG001|Stem Cell Transplant|Adverse Event|0|||
33302203|NCT01518153|100999843|FG002|Stem Cell Transplant|Adverse Event|0|||
33497852|NCT03749330|101714047|FG000|Overall Study|Clinicians left work in the CICU|0|||
33302204|NCT01518153|100999841|FG000|Donor Lymphocyte Infusion|Death|0|||
33302205|NCT01518153|100999842|FG001|Donor Lymphocyte Infusion|Death|2|||
33302206|NCT01518153|100999843|FG002|Donor Lymphocyte Infusion|Death|1|||
33302207|NCT02060370|100999846|FG000|Overall Study|Physician Decision|1|||
33302208|NCT03377699|100999847|FG000|Overall Study|Withdrawal by Subject|2|||
33302209|NCT03377699|100999848|FG001|Overall Study|Withdrawal by Subject|9|||
33302210|NCT03377699|100999847|FG000|Overall Study|Lost to Follow-up|1|||
33302211|NCT03377699|100999848|FG001|Overall Study|Lost to Follow-up|1|||
33302212|NCT03377699|100999847|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
33302213|NCT03377699|100999848|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
33302214|NCT03377699|100999847|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
33497853|NCT03749330|101714048|FG001|Overall Study|Clinicians left work in the CICU|2|||
33302215|NCT03377699|100999848|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
33302216|NCT03377699|100999847|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
33302217|NCT03377699|100999848|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
33302218|NCT03377699|100999847|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
33302219|NCT03377699|100999848|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
33302220|NCT01905150|100999856|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
33302221|NCT01905150|100999857|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
33302222|NCT00468559|100999858|FG000|Open-label Treatment Phase|Adverse Event|5|||
33302223|NCT00468559|100999859|FG001|Open-label Treatment Phase|Adverse Event|0|||
33302224|NCT00468559|100999860|FG002|Open-label Treatment Phase|Adverse Event|0|||
33302225|NCT00468559|100999858|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
33302226|NCT00468559|100999859|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
33302227|NCT00468559|100999860|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
33302228|NCT00468559|100999858|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
33302229|NCT00468559|100999859|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
33302230|NCT00468559|100999860|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
33302231|NCT00468559|100999858|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
33302232|NCT00468559|100999859|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
33302233|NCT00468559|100999860|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
33302234|NCT00468559|100999858|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
33302235|NCT00468559|100999859|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
33302236|NCT00468559|100999860|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
33302237|NCT01075958|100999863|FG000|Overall Study|Blood sample could not be obtained|44|||
33302238|NCT00095056|100999864|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
33302239|NCT00095056|100999865|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
33302240|NCT00095056|100999864|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
33302241|NCT00095056|100999865|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
33302242|NCT00095056|100999864|FG000|Phase A (Weeks 0-12)|Death|1|||
33302243|NCT00095056|100999865|FG001|Phase A (Weeks 0-12)|Death|0|||
33302244|NCT00095056|100999864|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
33302245|NCT00095056|100999865|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
33302246|NCT00095056|100999864|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
33302247|NCT00095056|100999865|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
33302248|NCT00095056|100999864|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
33302249|NCT00095056|100999865|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
33302250|NCT00095056|100999864|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
33302251|NCT00095056|100999865|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
33302252|NCT00095056|100999864|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
33302253|NCT00095056|100999865|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
33302254|NCT00095056|100999864|FG000|Phase B (Weeks 12-54)|Death|3|||
33302255|NCT00095056|100999865|FG001|Phase B (Weeks 12-54)|Death|1|||
33302256|NCT00095056|100999864|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
33302257|NCT00095056|100999865|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
33302258|NCT00095056|100999864|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
33302259|NCT00095056|100999865|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
33302260|NCT03014479|100999866|FG000|Overall Study|Adverse Event|0|||
33302261|NCT03014479|100999867|FG001|Overall Study|Adverse Event|1|||
33302262|NCT03014479|100999866|FG000|Overall Study|Voluntary Withdrawal|0|||
33302263|NCT03014479|100999867|FG001|Overall Study|Voluntary Withdrawal|2|||
33497854|NCT03749330|101714049|FG002|Overall Study|Clinicians left work in the CICU|0|||
33497855|NCT03749330|101714050|FG003|Overall Study|Clinicians left work in the CICU|0|||
33497856|NCT03749330|101714051|FG004|Overall Study|Clinicians left work in the CICU|0|||
33497857|NCT03749330|101714052|FG005|Overall Study|Clinicians left work in the CICU|0|||
33497858|NCT03711786|101714053|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
33497859|NCT03711786|101714054|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
33497860|NCT03711786|101714053|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
33497861|NCT03711786|101714054|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
33497862|NCT03711786|101714053|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
33497863|NCT03711786|101714054|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
33302264|NCT03014479|100999866|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
33302265|NCT03014479|100999867|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
33302266|NCT04828837|100999869|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
33302267|NCT04828837|100999870|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
33302268|NCT04828837|100999869|FG000|Overall Study|Lost to Follow-up|2|||
33302269|NCT04828837|100999870|FG001|Overall Study|Lost to Follow-up|6|||
33302270|NCT04828837|100999869|FG000|Overall Study|Lack of Efficacy|1|||
33302271|NCT04828837|100999870|FG001|Overall Study|Lack of Efficacy|0|||
33302272|NCT04828837|100999869|FG000|Overall Study|Admitted due to pneumothorax.|1|||
33302273|NCT04828837|100999870|FG001|Overall Study|Admitted due to pneumothorax.|0|||
33302274|NCT04828837|100999869|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
33302275|NCT04828837|100999870|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
33302276|NCT01280357|100999872|FG000|Overall Study|Excluded no internal monitoring|14|||
33302277|NCT01280357|100999872|FG000|Overall Study|IInsufficient data/No data supplied|12|||
33302278|NCT05543707|100999876|FG000|Overall Study|Study drug non-compliance/|5|||
33302279|NCT05543707|100999877|FG001|Overall Study|Study drug non-compliance/|0|||
33302280|NCT05543707|100999876|FG000|Overall Study|Withdrawal by Subject|1|||
33302281|NCT05543707|100999877|FG001|Overall Study|Withdrawal by Subject|1|||
33302282|NCT05543707|100999876|FG000|Overall Study|Adverse Event|1|||
33302283|NCT05543707|100999877|FG001|Overall Study|Adverse Event|0|||
33497864|NCT03711786|101714053|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
33497865|NCT03711786|101714054|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
33497866|NCT03711786|101714053|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
33497867|NCT03711786|101714054|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
33497868|NCT03711786|101714053|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
33497869|NCT03711786|101714054|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
33497870|NCT03428152|101714055|FG000|Overall Study|Physician Decision|4|||
33497871|NCT03428152|101714056|FG001|Overall Study|Physician Decision|2|||
33497872|NCT03428152|101714055|FG000|Overall Study|Protocol Violation|3|||
33497873|NCT03428152|101714056|FG001|Overall Study|Protocol Violation|5|||
33497874|NCT03428152|101714055|FG000|Overall Study|Lack of Efficacy|0|||
33497875|NCT03428152|101714056|FG001|Overall Study|Lack of Efficacy|4|||
33497876|NCT01537042|101714057|FG000|Overall Study|Adverse Event|0|||
33497877|NCT01537042|101714058|FG001|Overall Study|Adverse Event|2|||
33497878|NCT01537042|101714057|FG000|Overall Study|Lack of Efficacy|0|||
33497879|NCT01537042|101714058|FG001|Overall Study|Lack of Efficacy|1|||
33497880|NCT01537042|101714057|FG000|Overall Study|Protocol Violation|0|||
33497881|NCT01537042|101714058|FG001|Overall Study|Protocol Violation|1|||
33497882|NCT01537042|101714057|FG000|Overall Study|Other|0|||
33497883|NCT01537042|101714058|FG001|Overall Study|Other|1|||
33497884|NCT02502149|101714065|FG000|Intermediate|Discontinued prematurely|1|||
33497885|NCT02502149|101714066|FG001|Intermediate|Discontinued prematurely|0|||
33497886|NCT02502149|101714067|FG002|Intermediate|Discontinued prematurely|0|||
33497887|NCT02502149|101714068|FG003|Intermediate|Discontinued prematurely|0|||
33497888|NCT02502149|101714069|FG004|Intermediate|Discontinued prematurely|0|||
33497889|NCT00513695|101714072|FG000|Overall Study|Discontinued therapy|2|||
33497890|NCT00513695|101714072|FG000|Overall Study|Progression prior to surgery|3|||
33302284|NCT05543707|100999876|FG000|Overall Study|concurrent illness|0|||
33302285|NCT05543707|100999877|FG001|Overall Study|concurrent illness|1|||
33302286|NCT05543707|100999876|FG000|Overall Study|Pregnancy|1|||
33302287|NCT05543707|100999877|FG001|Overall Study|Pregnancy|1|||
33302288|NCT01427725|100999882|FG000|Overall Study|Lost to Follow-up|17|||
33302289|NCT01427725|100999882|FG000|Overall Study|Protocol Violation|1|||
33302290|NCT01427725|100999882|FG000|Overall Study|Drug not administered|1|||
33302291|NCT01427725|100999882|FG000|Overall Study|Failure to visit|7|||
33302292|NCT01427725|100999882|FG000|Overall Study|Adverse Event|46|||
33302293|NCT01427725|100999882|FG000|Overall Study|Failure to visit after administration|40|||
33302294|NCT01427725|100999882|FG000|Overall Study|Patient's rejection|27|||
33302295|NCT01427725|100999882|FG000|Overall Study|Transfer to a different hospital|17|||
33302296|NCT01427725|100999882|FG000|Overall Study|Lack of Efficacy|8|||
33302297|NCT01427725|100999882|FG000|Overall Study|Death|7|||
33302298|NCT01427725|100999882|FG000|Overall Study|Symptom improvement|6|||
33302299|NCT01427725|100999882|FG000|Overall Study|AE and Patient's rejection|5|||
33302300|NCT01427725|100999882|FG000|Overall Study|Physician Decision|5|||
33302301|NCT01427725|100999882|FG000|Overall Study|Exacerbation of underlying disease|5|||
33302302|NCT01427725|100999882|FG000|Overall Study|Oral feeding difficulty|5|||
33302303|NCT01427725|100999882|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
33302304|NCT01427725|100999882|FG000|Overall Study|Forgetting prescription|1|||
33393563|NCT03073200|101328517|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33497891|NCT02418182|101714083|FG000|Overall Study|Unable to re-consent|18|||
33497892|NCT02418182|101714084|FG001|Overall Study|Unable to re-consent|15|||
33497893|NCT02418182|101714083|FG000|Overall Study|Lost to Follow-up|0|||
33393564|NCT03073200|101328518|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33497894|NCT02418182|101714084|FG001|Overall Study|Lost to Follow-up|2|||
33497895|NCT00315458|101714085|FG000|Overall Study|Administrative|0|||
33497896|NCT00315458|101714086|FG001|Overall Study|Administrative|3|||
33497897|NCT00315458|101714087|FG002|Overall Study|Administrative|8|||
33600363|NCT03757130|102088633|FG004|Overall Study|Withdrawal by Subject|0|||
33302305|NCT01427725|100999882|FG000|Overall Study|Other|2|||
33302306|NCT02108964|100999884|FG000|Overall Study|Progressive disease|15|||
33302307|NCT02108964|100999885|FG001|Overall Study|Progressive disease|31|||
33302308|NCT02108964|100999886|FG002|Overall Study|Progressive disease|54|||
33302309|NCT02108964|100999887|FG003|Overall Study|Progressive disease|7|||
33302310|NCT02108964|100999888|FG004|Overall Study|Progressive disease|20|||
33302311|NCT02108964|100999889|FG005|Overall Study|Progressive disease|4|||
33302312|NCT02108964|100999890|FG006|Overall Study|Progressive disease|6|||
33302313|NCT02108964|100999891|FG007|Overall Study|Progressive disease|33|||
33302314|NCT02108964|100999884|FG000|Overall Study|Physician Decision|1|||
33302315|NCT02108964|100999885|FG001|Overall Study|Physician Decision|5|||
33497898|NCT00315458|101714088|FG003|Overall Study|Administrative|21|||
33497899|NCT00315458|101714085|FG000|Overall Study|Adverse Event|2|||
33497900|NCT00315458|101714086|FG001|Overall Study|Adverse Event|4|||
33497901|NCT00315458|101714087|FG002|Overall Study|Adverse Event|23|||
33497902|NCT00315458|101714088|FG003|Overall Study|Adverse Event|3|||
33497903|NCT00315458|101714085|FG000|Overall Study|Lost to Follow-up|1|||
33497904|NCT00315458|101714086|FG001|Overall Study|Lost to Follow-up|2|||
33497905|NCT00315458|101714087|FG002|Overall Study|Lost to Follow-up|0|||
33497906|NCT00315458|101714088|FG003|Overall Study|Lost to Follow-up|2|||
33497907|NCT00315458|101714085|FG000|Overall Study|Withdrawal by Subject|0|||
33497908|NCT00315458|101714086|FG001|Overall Study|Withdrawal by Subject|3|||
33497909|NCT00315458|101714087|FG002|Overall Study|Withdrawal by Subject|0|||
33497910|NCT00315458|101714088|FG003|Overall Study|Withdrawal by Subject|2|||
33497911|NCT00315458|101714085|FG000|Overall Study|Lack of Efficacy|0|||
33600364|NCT03757130|102088634|FG005|Overall Study|Withdrawal by Subject|0|||
33600365|NCT03757130|102088635|FG006|Overall Study|Withdrawal by Subject|1|||
33302316|NCT02108964|100999886|FG002|Overall Study|Physician Decision|7|||
33302317|NCT02108964|100999887|FG003|Overall Study|Physician Decision|1|||
33302318|NCT02108964|100999888|FG004|Overall Study|Physician Decision|2|||
33302319|NCT02108964|100999889|FG005|Overall Study|Physician Decision|1|||
33302320|NCT02108964|100999890|FG006|Overall Study|Physician Decision|1|||
33302321|NCT02108964|100999891|FG007|Overall Study|Physician Decision|3|||
33302322|NCT02108964|100999884|FG000|Overall Study|Adverse Event|0|||
33302323|NCT02108964|100999885|FG001|Overall Study|Adverse Event|0|||
33302324|NCT02108964|100999886|FG002|Overall Study|Adverse Event|4|||
33302325|NCT02108964|100999887|FG003|Overall Study|Adverse Event|0|||
33302326|NCT02108964|100999888|FG004|Overall Study|Adverse Event|1|||
33302327|NCT02108964|100999889|FG005|Overall Study|Adverse Event|0|||
33302328|NCT02108964|100999890|FG006|Overall Study|Adverse Event|3|||
33302329|NCT02108964|100999891|FG007|Overall Study|Adverse Event|2|||
33302330|NCT02108964|100999884|FG000|Overall Study|Death|1|||
33302331|NCT02108964|100999885|FG001|Overall Study|Death|1|||
33302332|NCT02108964|100999886|FG002|Overall Study|Death|4|||
33302333|NCT02108964|100999887|FG003|Overall Study|Death|0|||
33302334|NCT02108964|100999888|FG004|Overall Study|Death|3|||
33302335|NCT02108964|100999889|FG005|Overall Study|Death|0|||
33302336|NCT02108964|100999890|FG006|Overall Study|Death|0|||
33302337|NCT02108964|100999891|FG007|Overall Study|Death|2|||
33302338|NCT02108964|100999884|FG000|Overall Study|Subject/Guardian decision|0|||
33302339|NCT02108964|100999885|FG001|Overall Study|Subject/Guardian decision|1|||
33302340|NCT02108964|100999886|FG002|Overall Study|Subject/Guardian decision|4|||
33302341|NCT02108964|100999887|FG003|Overall Study|Subject/Guardian decision|0|||
33302342|NCT02108964|100999888|FG004|Overall Study|Subject/Guardian decision|2|||
33302343|NCT02108964|100999889|FG005|Overall Study|Subject/Guardian decision|0|||
33302344|NCT02108964|100999890|FG006|Overall Study|Subject/Guardian decision|1|||
33302345|NCT02108964|100999891|FG007|Overall Study|Subject/Guardian decision|2|||
33302346|NCT02108964|100999884|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
33302347|NCT02108964|100999885|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
33302348|NCT02108964|100999886|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
33302349|NCT02108964|100999887|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
33302350|NCT02108964|100999888|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
33302351|NCT02108964|100999889|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
33302352|NCT02108964|100999890|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
33302353|NCT02108964|100999891|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
33302354|NCT03940703|100999892|FG000|Overall Study|Still under treatment|31|||
33302355|NCT03940703|100999893|FG001|Overall Study|Still under treatment|0|||
33393565|NCT03073200|101328519|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33393566|NCT03073200|101328520|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33393567|NCT03073200|101328521|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33393568|NCT03073200|101328522|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33393569|NCT03073200|101328523|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33497912|NCT00315458|101714086|FG001|Overall Study|Lack of Efficacy|0|||
33600366|NCT03757130|102088636|FG007|Overall Study|Withdrawal by Subject|0|||
33302356|NCT04939701|100999901|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
33302357|NCT04939701|100999902|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
33302358|NCT04939701|100999903|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
33393570|NCT03073200|101328524|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33302359|NCT04939701|100999901|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
33302360|NCT04939701|100999902|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
33302361|NCT04939701|100999903|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
33302362|NCT04939701|100999901|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
33302363|NCT04939701|100999902|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
33302364|NCT04939701|100999903|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
33302365|NCT04939701|100999901|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
33302366|NCT04939701|100999902|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
33302367|NCT04939701|100999903|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
33497913|NCT00315458|101714087|FG002|Overall Study|Lack of Efficacy|20|||
33497914|NCT00315458|101714088|FG003|Overall Study|Lack of Efficacy|1|||
33497915|NCT00315458|101714085|FG000|Overall Study|Did not qualify|0|||
33302368|NCT04939701|100999901|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
33302369|NCT04939701|100999902|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
33302370|NCT04939701|100999903|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
33302371|NCT04939701|100999901|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
33302372|NCT04939701|100999902|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
33302373|NCT04939701|100999903|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
33302374|NCT04939701|100999901|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
33302375|NCT04939701|100999902|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
33302376|NCT04939701|100999903|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
33302377|NCT02992691|100999904|FG000|Overall Study|Adverse Event|2|||
33302378|NCT02992691|100999904|FG000|Overall Study|Withdrawal by Subject|1|||
33302379|NCT01638429|100999909|FG000|Overall Study|Withdrawal by Subject|1|||
33302380|NCT00818779|101002974|FG000|Overall Study|Protocol Violation|1|||
33302381|NCT00818779|101002975|FG001|Overall Study|Protocol Violation|0|||
33302382|NCT00818779|101002974|FG000|Overall Study|Lost to Follow-up|1|||
33302383|NCT00818779|101002975|FG001|Overall Study|Lost to Follow-up|0|||
33302384|NCT00818779|101002974|FG000|Overall Study|Adverse Event|4|||
33302385|NCT00818779|101002975|FG001|Overall Study|Adverse Event|1|||
33302386|NCT02218606|101002976|FG000|Overall Study|Adverse Event|1|||
33302387|NCT02218606|101002977|FG001|Overall Study|Adverse Event|1|||
33302388|NCT02218606|101002976|FG000|Overall Study|Death|15|||
33302389|NCT02218606|101002977|FG001|Overall Study|Death|28|||
33302390|NCT02218606|101002976|FG000|Overall Study|Physician Decision|0|||
33302391|NCT02218606|101002977|FG001|Overall Study|Physician Decision|1|||
33302392|NCT02218606|101002976|FG000|Overall Study|Withdrawal by Subject|4|||
33302393|NCT02218606|101002977|FG001|Overall Study|Withdrawal by Subject|0|||
33302394|NCT02218606|101002976|FG000|Overall Study|Noncompliance|1|||
33302395|NCT02218606|101002977|FG001|Overall Study|Noncompliance|0|||
33302396|NCT02218606|101002976|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
33302397|NCT02218606|101002977|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
33302398|NCT02218606|101002976|FG000|Overall Study|Other|2|||
33302399|NCT02218606|101002977|FG001|Overall Study|Other|1|||
33302400|NCT02218606|101002976|FG000|Overall Study|Never started treatment|0|||
33302401|NCT02218606|101002977|FG001|Overall Study|Never started treatment|1|||
33302402|NCT03002220|101002980|FG000|Overall Study|Lack of Efficacy|2|||
33302403|NCT03002220|101002980|FG000|Overall Study|Withdrawal by Subject|3|||
33302404|NCT03002220|101002980|FG000|Overall Study|Adverse Event|2|||
33302405|NCT03002220|101002980|FG000|Overall Study|Disease progression|13|||
33302406|NCT03002220|101002980|FG000|Overall Study|Physician Decision|1|||
33302407|NCT02797080|101002981|FG000|Overall Study|Lost to Follow-up|1|||
33302408|NCT02797080|101002981|FG000|Overall Study|Withdrawal by Subject|1|||
33302409|NCT01072630|101002982|FG000|Overall Study|Adverse Event|11|||
33302410|NCT01072630|101002983|FG001|Overall Study|Adverse Event|19|||
33302411|NCT01072630|101002984|FG002|Overall Study|Adverse Event|2|||
33302412|NCT01072630|101002982|FG000|Overall Study|Lack of Efficacy|10|||
33302413|NCT01072630|101002983|FG001|Overall Study|Lack of Efficacy|10|||
33302414|NCT01072630|101002984|FG002|Overall Study|Lack of Efficacy|1|||
33302415|NCT01072630|101002982|FG000|Overall Study|Withdrawal by Subject|8|||
33497916|NCT00315458|101714086|FG001|Overall Study|Did not qualify|0|||
33497917|NCT00315458|101714087|FG002|Overall Study|Did not qualify|1|||
33497918|NCT00315458|101714088|FG003|Overall Study|Did not qualify|0|||
33302416|NCT01072630|101002983|FG001|Overall Study|Withdrawal by Subject|7|||
33302417|NCT01072630|101002984|FG002|Overall Study|Withdrawal by Subject|2|||
33302418|NCT01072630|101002982|FG000|Overall Study|Protocol Violation|10|||
33302419|NCT01072630|101002983|FG001|Overall Study|Protocol Violation|8|||
33302420|NCT01072630|101002984|FG002|Overall Study|Protocol Violation|4|||
33302421|NCT01072630|101002982|FG000|Overall Study|Lost to Follow-up|11|||
33302422|NCT01072630|101002983|FG001|Overall Study|Lost to Follow-up|11|||
33497919|NCT03922321|101714089|FG000|Overall Study|Participant Moved|1|||
33302423|NCT01072630|101002984|FG002|Overall Study|Lost to Follow-up|1|||
33302424|NCT01072630|101002982|FG000|Overall Study|Noncompliance with study medication|1|||
33302425|NCT01072630|101002983|FG001|Overall Study|Noncompliance with study medication|1|||
33302426|NCT01072630|101002984|FG002|Overall Study|Noncompliance with study medication|1|||
33302427|NCT01072630|101002982|FG000|Overall Study|Noncompliance with study procedures|1|||
33302428|NCT01072630|101002983|FG001|Overall Study|Noncompliance with study procedures|2|||
33302429|NCT01072630|101002984|FG002|Overall Study|Noncompliance with study procedures|1|||
33302430|NCT01072630|101002982|FG000|Overall Study|Other|3|||
33302431|NCT01072630|101002983|FG001|Overall Study|Other|2|||
33302432|NCT01072630|101002984|FG002|Overall Study|Other|1|||
33302433|NCT03047395|101002987|FG000|Overall Study|Adverse Event|142|||
33302434|NCT03047395|101002987|FG000|Overall Study|Withdrawal by Subject|155|||
33302435|NCT03047395|101002987|FG000|Overall Study|Lost to Follow-up|144|||
33302436|NCT03047395|101002987|FG000|Overall Study|COVID-19 Infection|2|||
33302437|NCT03047395|101002987|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
33302438|NCT03047395|101002987|FG000|Overall Study|Other, Not Specified|117|||
33302439|NCT03596762|101002988|FG000|Overall Study|Protocol Violation|0|||
33302440|NCT03596762|101002989|FG001|Overall Study|Protocol Violation|0|||
33302441|NCT03596762|101002990|FG002|Overall Study|Protocol Violation|0|||
33302442|NCT03596762|101002991|FG003|Overall Study|Protocol Violation|0|||
33302443|NCT03596762|101002992|FG004|Overall Study|Protocol Violation|1|||
33302444|NCT03596762|101002988|FG000|Overall Study|Adverse Event|2|||
33393571|NCT03073200|101328525|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
33497920|NCT03922321|101714089|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
33497921|NCT01415518|101714090|FG000|Overall Study|Withdrawal by Subject|2|||
33497922|NCT01415518|101714091|FG001|Overall Study|Withdrawal by Subject|12|||
33497923|NCT01415518|101714090|FG000|Overall Study|Protocol Violation|6|||
33497924|NCT01415518|101714091|FG001|Overall Study|Protocol Violation|8|||
33497925|NCT01415518|101714090|FG000|Overall Study|Lost to Follow-up|3|||
33497926|NCT01415518|101714091|FG001|Overall Study|Lost to Follow-up|5|||
33497927|NCT01415518|101714090|FG000|Overall Study|Adverse Event|3|||
33497928|NCT01415518|101714091|FG001|Overall Study|Adverse Event|4|||
33497929|NCT01415518|101714090|FG000|Overall Study|Death|1|||
33497930|NCT01415518|101714091|FG001|Overall Study|Death|1|||
33497931|NCT01415518|101714090|FG000|Overall Study|Condition under Investigation Worsened|1|||
33497932|NCT01415518|101714091|FG001|Overall Study|Condition under Investigation Worsened|1|||
33497933|NCT00114140|101714093|FG000|Overall Study|Protocol Violation|7|||
33393572|NCT03073200|101328511|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
33393573|NCT03073200|101328512|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
33393574|NCT03073200|101328513|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
33393575|NCT03073200|101328514|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
33393576|NCT03073200|101328515|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
33393577|NCT03073200|101328516|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
33393578|NCT03073200|101328517|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
33393579|NCT03073200|101328518|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
33393580|NCT03073200|101328519|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
33393581|NCT03073200|101328520|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
33393582|NCT03073200|101328521|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
33393583|NCT03073200|101328522|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
33393584|NCT03073200|101328523|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
33393585|NCT03073200|101328524|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
33393586|NCT03073200|101328525|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
33393587|NCT03073200|101328511|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
33393588|NCT03073200|101328512|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
33393589|NCT03073200|101328513|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
33393590|NCT03073200|101328514|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
33393591|NCT03073200|101328515|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
33393592|NCT03073200|101328516|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
33393593|NCT03073200|101328517|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
33393594|NCT03073200|101328518|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
33393595|NCT03073200|101328519|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
33393596|NCT03073200|101328520|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
33393597|NCT03073200|101328521|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
33393598|NCT03073200|101328522|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
33393599|NCT03073200|101328523|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
33393600|NCT03073200|101328524|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
33393601|NCT03073200|101328525|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
33393602|NCT03073200|101328511|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
33393603|NCT03073200|101328512|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
33393604|NCT03073200|101328513|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
33497934|NCT00226499|101714094|FG000|Overall Study|Adverse Event|10|||
33497935|NCT00226499|101714095|FG001|Overall Study|Adverse Event|6|||
33497936|NCT00226499|101714096|FG002|Overall Study|Adverse Event|3|||
33302445|NCT03596762|101002989|FG001|Overall Study|Adverse Event|0|||
33302446|NCT03596762|101002990|FG002|Overall Study|Adverse Event|1|||
33302447|NCT03596762|101002991|FG003|Overall Study|Adverse Event|0|||
33302448|NCT03596762|101002992|FG004|Overall Study|Adverse Event|5|||
33497937|NCT00226499|101714094|FG000|Overall Study|Others|1064|||
33497938|NCT00226499|101714095|FG001|Overall Study|Others|1066|||
33497939|NCT00226499|101714096|FG002|Overall Study|Others|356|||
33497940|NCT01554527|101714097|FG000|Overall Study|Withdrawal by Subject|1|||
33497941|NCT01554527|101714098|FG001|Overall Study|Withdrawal by Subject|0|||
33497942|NCT01554527|101714099|FG002|Overall Study|Withdrawal by Subject|3|||
33302449|NCT03596762|101002988|FG000|Overall Study|Withdrawal by Subject|2|||
33302450|NCT03596762|101002989|FG001|Overall Study|Withdrawal by Subject|1|||
33497943|NCT01554527|101714097|FG000|Overall Study|Lost to Follow-up|0|||
33302451|NCT03596762|101002990|FG002|Overall Study|Withdrawal by Subject|0|||
33302452|NCT03596762|101002991|FG003|Overall Study|Withdrawal by Subject|1|||
33302453|NCT03596762|101002992|FG004|Overall Study|Withdrawal by Subject|1|||
33302454|NCT05017103|101002995|FG000|Overall Study|Death|2|||
33302455|NCT00616902|101002996|FG000|Overall Study|Termination of study|6|||
33302456|NCT00616902|101002997|FG001|Overall Study|Termination of study|6|||
33302457|NCT02636725|101002998|FG000|Overall Study|Adverse Event|1|||
33302458|NCT06390839|101002999|FG000|Overall Study|Ineligible|2|||
33302459|NCT06390839|101002999|FG000|Overall Study|Never start protocol therapy|3|||
33302460|NCT06390839|101002999|FG000|Overall Study|Adverse Event|1|||
33302461|NCT06390839|101002999|FG000|Overall Study|Alternative therapy|2|||
33302462|NCT06390839|101002999|FG000|Overall Study|Death|3|||
33302463|NCT06390839|101002999|FG000|Overall Study|Disease progression|28|||
33302464|NCT06390839|101002999|FG000|Overall Study|Withdrawal by Subject|2|||
33302465|NCT06390839|101002999|FG000|Overall Study|Complicating disease|1|||
33302466|NCT06390839|101002999|FG000|Overall Study|Noncompliance|1|||
33302467|NCT00859222|101003000|FG000|Overall Study|Adverse Event|2|||
33302468|NCT00859222|101003001|FG001|Overall Study|Adverse Event|3|||
33302469|NCT00859222|101003002|FG002|Overall Study|Adverse Event|6|||
33302470|NCT00859222|101003003|FG003|Overall Study|Adverse Event|24|||
33302471|NCT00859222|101003004|FG004|Overall Study|Adverse Event|15|||
33302472|NCT00859222|101003000|FG000|Overall Study|DLT|1|||
33302473|NCT00859222|101003001|FG001|Overall Study|DLT|0|||
33302474|NCT00859222|101003002|FG002|Overall Study|DLT|0|||
33302475|NCT00859222|101003003|FG003|Overall Study|DLT|0|||
33302476|NCT00859222|101003004|FG004|Overall Study|DLT|0|||
33302477|NCT00565851|101003005|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
33302478|NCT00565851|101003006|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
33302479|NCT00565851|101003007|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
33302480|NCT00565851|101003008|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
33302481|NCT00565851|101003009|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
33302482|NCT00565851|101003010|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
33302483|NCT00565851|101003011|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
33302484|NCT00565851|101003012|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
33302485|NCT00565851|101003005|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
33302486|NCT00565851|101003006|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
33302487|NCT00565851|101003007|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
33302488|NCT00565851|101003008|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
33302489|NCT00565851|101003009|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
33302490|NCT00565851|101003010|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
33302491|NCT00565851|101003011|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
33302492|NCT00565851|101003012|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
33302493|NCT00037830|101003013|FG000|Overall Study|Adverse Event|2|||
33302494|NCT00037830|101003014|FG001|Overall Study|Adverse Event|0|||
33302495|NCT00037830|101003015|FG002|Overall Study|Adverse Event|0|||
33393605|NCT03073200|101328514|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
33393606|NCT03073200|101328515|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
33393607|NCT03073200|101328516|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
33393608|NCT03073200|101328517|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
33393609|NCT03073200|101328518|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
33393610|NCT03073200|101328519|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
33393611|NCT03073200|101328520|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
33393612|NCT03073200|101328521|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
33393613|NCT03073200|101328522|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
33393614|NCT03073200|101328523|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
33393615|NCT03073200|101328524|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
33393616|NCT03073200|101328525|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
33393617|NCT03073200|101328511|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
33393618|NCT03073200|101328512|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
33393619|NCT03073200|101328513|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
33393620|NCT03073200|101328514|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
33393621|NCT03073200|101328515|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
33497944|NCT01554527|101714098|FG001|Overall Study|Lost to Follow-up|0|||
33497945|NCT01554527|101714099|FG002|Overall Study|Lost to Follow-up|4|||
33497946|NCT01554527|101714097|FG000|Overall Study|Physician Decision|0|||
33302496|NCT00037830|101003013|FG000|Overall Study|Withdrawal by Subject|4|||
33302497|NCT00037830|101003014|FG001|Overall Study|Withdrawal by Subject|5|||
33302498|NCT00037830|101003015|FG002|Overall Study|Withdrawal by Subject|1|||
33302499|NCT00037830|101003013|FG000|Overall Study|Protocol Violation|2|||
33302500|NCT00037830|101003014|FG001|Overall Study|Protocol Violation|2|||
33302501|NCT00037830|101003015|FG002|Overall Study|Protocol Violation|0|||
33302502|NCT00037830|101003013|FG000|Overall Study|Unrelated Medical Problem|2|||
33302503|NCT00037830|101003014|FG001|Overall Study|Unrelated Medical Problem|0|||
33302504|NCT00037830|101003015|FG002|Overall Study|Unrelated Medical Problem|0|||
33302505|NCT01162863|101003016|FG000|Overall Study|Lack of Efficacy|1|||
33302506|NCT01162863|101003017|FG001|Overall Study|Lack of Efficacy|0|||
33302507|NCT01162863|101003018|FG002|Overall Study|Lack of Efficacy|0|||
33302508|NCT01162863|101003016|FG000|Overall Study|Adverse Event|0|||
33302509|NCT01162863|101003017|FG001|Overall Study|Adverse Event|1|||
33302510|NCT01162863|101003018|FG002|Overall Study|Adverse Event|0|||
33302511|NCT02787044|101003019|FG000|Overall Study|Lost to Follow-up|15|||
33302512|NCT02787044|101003020|FG001|Overall Study|Lost to Follow-up|19|||
33302513|NCT00468143|101003021|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
33302514|NCT00468143|101003022|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
33302515|NCT00468143|101003021|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
33302516|NCT00468143|101003022|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
33302517|NCT00316602|101003023|FG000|Overall Study|Withdrawal by Subject|3|||
33302518|NCT00316602|101003024|FG001|Overall Study|Withdrawal by Subject|2|||
33302519|NCT00316602|101003023|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
33302520|NCT00316602|101003024|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
33302521|NCT00316602|101003023|FG000|Overall Study|Adverse Event|1|||
33302522|NCT00316602|101003024|FG001|Overall Study|Adverse Event|0|||
33302523|NCT00316602|101003023|FG000|Overall Study|Other|3|||
33302524|NCT00316602|101003024|FG001|Overall Study|Other|6|||
33302525|NCT00867308|101003025|FG000|Overall Study|Death|1|||
33302526|NCT00867308|101003026|FG001|Overall Study|Death|0|||
33302527|NCT00867308|101003025|FG000|Overall Study|Adverse Event|1|||
33302528|NCT00867308|101003026|FG001|Overall Study|Adverse Event|4|||
33302529|NCT00867308|101003025|FG000|Overall Study|Lack of Efficacy|6|||
33302530|NCT00867308|101003026|FG001|Overall Study|Lack of Efficacy|12|||
33302531|NCT00867308|101003025|FG000|Overall Study|Withdrawal by Subject|1|||
33302532|NCT00867308|101003026|FG001|Overall Study|Withdrawal by Subject|2|||
33302533|NCT00474526|101003027|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
33302534|NCT00474526|101003028|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
33302535|NCT00474526|101003029|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
33302536|NCT00474526|101003030|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
33302537|NCT00474526|101003031|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
33302538|NCT00474526|101003032|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
33302539|NCT00474526|101003033|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
33302540|NCT00474526|101003034|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
33302541|NCT00474526|101003035|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
33302542|NCT00474526|101003036|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
33302543|NCT00474526|101003037|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
33302544|NCT00474526|101003038|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
33302545|NCT00474526|101003039|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
33302546|NCT00474526|101003040|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
33302547|NCT00474526|101003041|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
33302548|NCT00474526|101003042|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
33302549|NCT00474526|101003043|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
33302550|NCT00474526|101003027|FG000|Overall Study|Adverse Event|2|||
33302551|NCT00474526|101003028|FG001|Overall Study|Adverse Event|0|||
33302552|NCT00474526|101003029|FG002|Overall Study|Adverse Event|2|||
33497947|NCT01554527|101714098|FG001|Overall Study|Physician Decision|0|||
33497948|NCT01554527|101714099|FG002|Overall Study|Physician Decision|1|||
33497949|NCT02568189|101717193|FG000|Overall Study|Protocol Violation|0|||
33497950|NCT02568189|101717194|FG001|Overall Study|Protocol Violation|0|||
33600367|NCT02581930|102088637|FG000|Overall Study|Withdrawal by Subject|1|||
33302553|NCT00474526|101003030|FG003|Overall Study|Adverse Event|4|||
33302554|NCT00474526|101003031|FG004|Overall Study|Adverse Event|2|||
33302555|NCT00474526|101003032|FG005|Overall Study|Adverse Event|1|||
33302556|NCT00474526|101003033|FG006|Overall Study|Adverse Event|1|||
33302557|NCT00474526|101003034|FG007|Overall Study|Adverse Event|0|||
33302558|NCT00474526|101003035|FG008|Overall Study|Adverse Event|0|||
33302559|NCT00474526|101003036|FG009|Overall Study|Adverse Event|0|||
33302560|NCT00474526|101003037|FG010|Overall Study|Adverse Event|0|||
33302561|NCT00474526|101003038|FG011|Overall Study|Adverse Event|0|||
33302562|NCT00474526|101003039|FG012|Overall Study|Adverse Event|0|||
33302563|NCT00474526|101003040|FG013|Overall Study|Adverse Event|0|||
33302564|NCT00474526|101003041|FG014|Overall Study|Adverse Event|1|||
33302565|NCT00474526|101003042|FG015|Overall Study|Adverse Event|1|||
33600368|NCT02581930|102088637|FG000|Overall Study|patient declined further treatment|1|||
33302566|NCT00474526|101003043|FG016|Overall Study|Adverse Event|0|||
33497951|NCT02568189|101717195|FG002|Overall Study|Protocol Violation|19|||
33302567|NCT00474526|101003027|FG000|Overall Study|Death|0|||
33302568|NCT00474526|101003028|FG001|Overall Study|Death|0|||
33302569|NCT00474526|101003029|FG002|Overall Study|Death|0|||
33302570|NCT00474526|101003030|FG003|Overall Study|Death|0|||
33302571|NCT00474526|101003031|FG004|Overall Study|Death|0|||
33302572|NCT00474526|101003032|FG005|Overall Study|Death|0|||
33302573|NCT00474526|101003033|FG006|Overall Study|Death|0|||
33302574|NCT00474526|101003034|FG007|Overall Study|Death|0|||
33302575|NCT00474526|101003035|FG008|Overall Study|Death|0|||
33302576|NCT00474526|101003036|FG009|Overall Study|Death|0|||
33302577|NCT00474526|101003037|FG010|Overall Study|Death|0|||
33302578|NCT00474526|101003038|FG011|Overall Study|Death|0|||
33302579|NCT00474526|101003039|FG012|Overall Study|Death|0|||
33302580|NCT00474526|101003040|FG013|Overall Study|Death|3|||
33302581|NCT00474526|101003041|FG014|Overall Study|Death|0|||
33302582|NCT00474526|101003042|FG015|Overall Study|Death|0|||
33302583|NCT00474526|101003043|FG016|Overall Study|Death|0|||
33302584|NCT00474526|101003027|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33302585|NCT00474526|101003028|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
33302586|NCT00474526|101003029|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33302587|NCT00474526|101003030|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
33302588|NCT00474526|101003031|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
33302589|NCT00474526|101003032|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33302590|NCT00474526|101003033|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33302591|NCT00474526|101003034|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33302592|NCT00474526|101003035|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33302593|NCT00474526|101003036|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33302594|NCT00474526|101003037|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33302595|NCT00474526|101003038|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33302596|NCT00474526|101003039|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33302597|NCT00474526|101003040|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
33302598|NCT00474526|101003041|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
33302599|NCT00474526|101003042|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33302600|NCT00474526|101003043|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
33302601|NCT00474526|101003027|FG000|Overall Study|Lost to Follow-up|8|||
33302602|NCT00474526|101003028|FG001|Overall Study|Lost to Follow-up|6|||
33302603|NCT00474526|101003029|FG002|Overall Study|Lost to Follow-up|13|||
33302604|NCT00474526|101003030|FG003|Overall Study|Lost to Follow-up|29|||
33302605|NCT00474526|101003031|FG004|Overall Study|Lost to Follow-up|11|||
33302606|NCT00474526|101003032|FG005|Overall Study|Lost to Follow-up|5|||
33302607|NCT00474526|101003033|FG006|Overall Study|Lost to Follow-up|8|||
33302608|NCT00474526|101003034|FG007|Overall Study|Lost to Follow-up|1|||
33302609|NCT00474526|101003035|FG008|Overall Study|Lost to Follow-up|0|||
33302610|NCT00474526|101003036|FG009|Overall Study|Lost to Follow-up|6|||
33302611|NCT00474526|101003037|FG010|Overall Study|Lost to Follow-up|2|||
33302612|NCT00474526|101003038|FG011|Overall Study|Lost to Follow-up|4|||
33302613|NCT00474526|101003039|FG012|Overall Study|Lost to Follow-up|6|||
33302614|NCT00474526|101003040|FG013|Overall Study|Lost to Follow-up|74|||
33302615|NCT00474526|101003041|FG014|Overall Study|Lost to Follow-up|29|||
33302616|NCT00474526|101003042|FG015|Overall Study|Lost to Follow-up|4|||
33302617|NCT00474526|101003043|FG016|Overall Study|Lost to Follow-up|5|||
33302618|NCT00474526|101003027|FG000|Overall Study|Protocol Violation|2|||
33302619|NCT00474526|101003028|FG001|Overall Study|Protocol Violation|6|||
33302620|NCT00474526|101003029|FG002|Overall Study|Protocol Violation|4|||
33302621|NCT00474526|101003030|FG003|Overall Study|Protocol Violation|12|||
33302622|NCT00474526|101003031|FG004|Overall Study|Protocol Violation|3|||
33302623|NCT00474526|101003032|FG005|Overall Study|Protocol Violation|1|||
33302624|NCT00474526|101003033|FG006|Overall Study|Protocol Violation|3|||
33302625|NCT00474526|101003034|FG007|Overall Study|Protocol Violation|0|||
33302626|NCT00474526|101003035|FG008|Overall Study|Protocol Violation|0|||
33302627|NCT00474526|101003036|FG009|Overall Study|Protocol Violation|4|||
33302628|NCT00474526|101003037|FG010|Overall Study|Protocol Violation|2|||
33302629|NCT00474526|101003038|FG011|Overall Study|Protocol Violation|2|||
33302630|NCT00474526|101003039|FG012|Overall Study|Protocol Violation|4|||
33302631|NCT00474526|101003040|FG013|Overall Study|Protocol Violation|19|||
33302632|NCT00474526|101003041|FG014|Overall Study|Protocol Violation|9|||
33497952|NCT02568189|101717196|FG003|Overall Study|Protocol Violation|18|||
33302633|NCT00474526|101003042|FG015|Overall Study|Protocol Violation|6|||
33302634|NCT00474526|101003043|FG016|Overall Study|Protocol Violation|2|||
33302635|NCT00474526|101003027|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
33302636|NCT00474526|101003028|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
33302637|NCT00474526|101003029|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
33302638|NCT00474526|101003030|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
33302639|NCT00474526|101003031|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
33302640|NCT00474526|101003032|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
33302641|NCT00474526|101003033|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
33302642|NCT00474526|101003034|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
33302643|NCT00474526|101003035|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
33302644|NCT00474526|101003036|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
33302645|NCT00474526|101003037|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
33302646|NCT00474526|101003038|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
33302647|NCT00474526|101003039|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
33302648|NCT00474526|101003040|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
33302649|NCT00474526|101003041|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
33302650|NCT00474526|101003042|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
33302651|NCT00474526|101003043|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
33302652|NCT00474526|101003027|FG000|Overall Study|Withdrawal by Subject|9|||
33302653|NCT00474526|101003028|FG001|Overall Study|Withdrawal by Subject|24|||
33302654|NCT00474526|101003029|FG002|Overall Study|Withdrawal by Subject|21|||
33302655|NCT00474526|101003030|FG003|Overall Study|Withdrawal by Subject|52|||
33302656|NCT00474526|101003031|FG004|Overall Study|Withdrawal by Subject|38|||
33302657|NCT00474526|101003032|FG005|Overall Study|Withdrawal by Subject|6|||
33302658|NCT00474526|101003033|FG006|Overall Study|Withdrawal by Subject|12|||
33302659|NCT00474526|101003034|FG007|Overall Study|Withdrawal by Subject|4|||
33302660|NCT00474526|101003035|FG008|Overall Study|Withdrawal by Subject|4|||
33302661|NCT00474526|101003036|FG009|Overall Study|Withdrawal by Subject|13|||
33302662|NCT00474526|101003037|FG010|Overall Study|Withdrawal by Subject|5|||
33302663|NCT00474526|101003038|FG011|Overall Study|Withdrawal by Subject|4|||
33302664|NCT00474526|101003039|FG012|Overall Study|Withdrawal by Subject|4|||
33302665|NCT00474526|101003040|FG013|Overall Study|Withdrawal by Subject|37|||
33302666|NCT00474526|101003041|FG014|Overall Study|Withdrawal by Subject|22|||
33302667|NCT00474526|101003042|FG015|Overall Study|Withdrawal by Subject|1|||
33302668|NCT00474526|101003043|FG016|Overall Study|Withdrawal by Subject|1|||
33302669|NCT00608868|101003044|FG000|Overall Study|Withdrawal by Subject|7|||
33302670|NCT00608868|101003044|FG000|Overall Study|Protocol Violation|3|||
33302671|NCT00608868|101003044|FG000|Overall Study|Lost to Follow-up|2|||
33302672|NCT00608868|101003044|FG000|Overall Study|Adverse Event|1|||
33302673|NCT00608868|101003044|FG000|Overall Study|Physician Decision|2|||
33302674|NCT02412371|101003045|FG000|Overall Study|Withdrawal by Subject|0|||
33302675|NCT02412371|101003046|FG001|Overall Study|Withdrawal by Subject|2|||
33302676|NCT02412371|101003047|FG002|Overall Study|Withdrawal by Subject|0|||
33302677|NCT02412371|101003048|FG003|Overall Study|Withdrawal by Subject|1|||
33302678|NCT02412371|101003049|FG004|Overall Study|Withdrawal by Subject|1|||
33302679|NCT02412371|101003050|FG005|Overall Study|Withdrawal by Subject|0|||
33302680|NCT02412371|101003045|FG000|Overall Study|Sponsor Discontinued Study|1|||
33302681|NCT02412371|101003046|FG001|Overall Study|Sponsor Discontinued Study|4|||
33302682|NCT02412371|101003047|FG002|Overall Study|Sponsor Discontinued Study|6|||
33302683|NCT02412371|101003048|FG003|Overall Study|Sponsor Discontinued Study|4|||
33302684|NCT02412371|101003049|FG004|Overall Study|Sponsor Discontinued Study|5|||
33302685|NCT02412371|101003050|FG005|Overall Study|Sponsor Discontinued Study|0|||
33302686|NCT02412371|101003045|FG000|Overall Study|Death|4|||
33302687|NCT02412371|101003046|FG001|Overall Study|Death|2|||
33302688|NCT02412371|101003047|FG002|Overall Study|Death|1|||
33302689|NCT02412371|101003048|FG003|Overall Study|Death|3|||
33302690|NCT02412371|101003049|FG004|Overall Study|Death|5|||
33302691|NCT02412371|101003050|FG005|Overall Study|Death|2|||
33302692|NCT02412371|101003045|FG000|Overall Study|Other|2|||
33302693|NCT02412371|101003046|FG001|Overall Study|Other|1|||
33302694|NCT02412371|101003047|FG002|Overall Study|Other|0|||
33302695|NCT02412371|101003048|FG003|Overall Study|Other|0|||
33302696|NCT02412371|101003049|FG004|Overall Study|Other|1|||
33302697|NCT02412371|101003050|FG005|Overall Study|Other|3|||
33302698|NCT01528345|101003051|FG000|Overall Study|Adverse Event|10|||
33302699|NCT01528345|101003052|FG001|Overall Study|Adverse Event|1|||
33302700|NCT01528345|101003051|FG000|Overall Study|Death|1|||
33302701|NCT01528345|101003052|FG001|Overall Study|Death|1|||
33302702|NCT01528345|101003051|FG000|Overall Study|Non-compliance with study treatment|1|||
33302703|NCT01528345|101003052|FG001|Overall Study|Non-compliance with study treatment|0|||
33302704|NCT01528345|101003051|FG000|Overall Study|Progressive Disease|26|||
33302705|NCT01528345|101003052|FG001|Overall Study|Progressive Disease|40|||
33302706|NCT01528345|101003051|FG000|Overall Study|Study Terminated by Sponsor|4|||
33302707|NCT01528345|101003052|FG001|Overall Study|Study Terminated by Sponsor|8|||
33302708|NCT01528345|101003051|FG000|Overall Study|Subject/Guardian Decision|5|||
33302709|NCT01528345|101003052|FG001|Overall Study|Subject/Guardian Decision|0|||
33600369|NCT01400243|102088638|FG000|Overall Study|Protocol Violation|8|||
33600370|NCT01400243|102088639|FG001|Overall Study|Protocol Violation|11|||
33302710|NCT00700778|101003053|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
33190570|NCT01481116|100604935|FG002|Overall Study|Sponsor Decision|3|||
33302711|NCT03775486|101003054|FG000|Initial Therapy Phase|Other reason provided|0|||
33302712|NCT03775486|101003055|FG001|Initial Therapy Phase|Other reason provided|15|||
33302713|NCT03775486|101003054|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
33302714|NCT03775486|101003055|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
33302715|NCT03775486|101003054|FG000|Initial Therapy Phase|Protocol Violation|0|||
33302716|NCT03775486|101003055|FG001|Initial Therapy Phase|Protocol Violation|2|||
33600371|NCT01688739|102088640|FG000|Overall Study|Administrative Decision|1|||
33190571|NCT01481116|100604933|FG000|Overall Study|Non-Compliant With Study Drug|0|||
33302717|NCT03775486|101003054|FG000|Initial Therapy Phase|Adverse Event|0|||
33302718|NCT03775486|101003055|FG001|Initial Therapy Phase|Adverse Event|34|||
33497953|NCT02157935|101717197|FG000|Overall Study|Withdrawal by Subject|25|||
33497954|NCT02157935|101717198|FG001|Overall Study|Withdrawal by Subject|39|||
33497955|NCT02157935|101717197|FG000|Overall Study|Screen failure|1|||
33302719|NCT03775486|101003054|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
33302720|NCT03775486|101003055|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
33302721|NCT03775486|101003054|FG000|Maintenance Phase|Withdrawal by Subject|13|||
33302722|NCT03775486|101003055|FG001|Maintenance Phase|Withdrawal by Subject|12|||
33302723|NCT03775486|101003054|FG000|Maintenance Phase|Death|44|||
33302724|NCT03775486|101003055|FG001|Maintenance Phase|Death|45|||
33302725|NCT05597787|101003056|FG000|Overall Study|Withdrawal by Subject|0|||
33302726|NCT05597787|101003057|FG001|Overall Study|Withdrawal by Subject|0|||
33302727|NCT05597787|101003058|FG002|Overall Study|Withdrawal by Subject|1|||
33302728|NCT00588692|101003059|FG000|Overall Study|Withdrawal by Subject|4|||
33302729|NCT00588692|101003060|FG001|Overall Study|Withdrawal by Subject|2|||
33302730|NCT00588692|101003059|FG000|Overall Study|Hip Surgery|0|||
33302731|NCT00588692|101003060|FG001|Overall Study|Hip Surgery|1|||
33302732|NCT00588692|101003059|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
33302733|NCT00588692|101003060|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
33302734|NCT00588692|101003059|FG000|Overall Study|Cancer|1|||
33302735|NCT00588692|101003060|FG001|Overall Study|Cancer|0|||
33302736|NCT00588692|101003059|FG000|Overall Study|Death|1|||
33302737|NCT00588692|101003060|FG001|Overall Study|Death|0|||
33302738|NCT04514510|101003061|FG000|Overall Study|Lost to Follow-up|0|||
33302739|NCT04514510|101003062|FG001|Overall Study|Lost to Follow-up|1|||
33302740|NCT04514510|101003061|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
33302741|NCT04514510|101003062|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
33302742|NCT04476251|101003063|FG000|Overall Study|Not treated|1|||
33302743|NCT03563157|101003066|FG000|Overall Study|Progressive Disease|2|||
33302744|NCT03896152|101003067|FG000|Overall Study|Patient/guardian decision|1|||
33302745|NCT03896152|101003068|FG001|Overall Study|Patient/guardian decision|1|||
33302746|NCT03896152|101003067|FG000|Overall Study|Adverse Event|0|||
33302747|NCT03896152|101003068|FG001|Overall Study|Adverse Event|1|||
33302748|NCT03896152|101003067|FG000|Overall Study|Physician Decision|1|||
33302749|NCT03896152|101003068|FG001|Overall Study|Physician Decision|0|||
33302750|NCT03896152|101003067|FG000|Overall Study|Technical problems|1|||
33302751|NCT03896152|101003068|FG001|Overall Study|Technical problems|0|||
33302752|NCT03668223|101003070|FG000|Overall Study|Death|10|||
33302753|NCT03668223|101003071|FG001|Overall Study|Death|5|||
33302754|NCT03668223|101003070|FG000|Overall Study|Lost to Follow-up|12|||
33302755|NCT03668223|101003071|FG001|Overall Study|Lost to Follow-up|12|||
33302756|NCT03668223|101003070|FG000|Overall Study|Withdrawal by Subject|8|||
33302757|NCT03668223|101003071|FG001|Overall Study|Withdrawal by Subject|3|||
33302758|NCT02236988|101003072|FG000|Overall Study|Lost to Follow-up|0|||
33302759|NCT02236988|101003073|FG001|Overall Study|Lost to Follow-up|0|||
33302760|NCT02236988|101003074|FG002|Overall Study|Lost to Follow-up|0|||
33302761|NCT02236988|101003075|FG003|Overall Study|Lost to Follow-up|1|||
33302762|NCT02236988|101003072|FG000|Overall Study|Unable to Comply with Study Visits|0|||
33302763|NCT02236988|101003073|FG001|Overall Study|Unable to Comply with Study Visits|0|||
33302764|NCT02236988|101003074|FG002|Overall Study|Unable to Comply with Study Visits|0|||
33302765|NCT02236988|101003075|FG003|Overall Study|Unable to Comply with Study Visits|2|||
33302766|NCT05269966|101003076|FG000|Overall Study|Adverse Event|4|||
33302767|NCT05269966|101003076|FG000|Overall Study|Withdrawal by Subject|1|||
33302768|NCT05269966|101003076|FG000|Overall Study|Lost to Follow-up|4|||
33302769|NCT05269966|101003076|FG000|Overall Study|Physician Decision|1|||
33302770|NCT03231800|101003080|FG000|Overall Study|Lost to Follow-up|0|||
33302771|NCT03231800|101003081|FG001|Overall Study|Lost to Follow-up|2|||
33302772|NCT03231800|101003080|FG000|Overall Study|Protocol Violation|1|||
33302773|NCT03231800|101003081|FG001|Overall Study|Protocol Violation|1|||
33302774|NCT03231800|101003080|FG000|Overall Study|reason not provided|2|||
33302775|NCT03231800|101003081|FG001|Overall Study|reason not provided|0|||
33302776|NCT05618912|101003082|FG000|Overall Study|Lost to Follow-up|14|||
33302777|NCT05618912|101003083|FG001|Overall Study|Lost to Follow-up|19|||
33302778|NCT04500769|101003084|FG000|Overall Study|Withdrawal by Subject|5|||
33497956|NCT02157935|101717198|FG001|Overall Study|Screen failure|2|||
33497957|NCT02157935|101717197|FG000|Overall Study|Protocol Violation|1|||
33190572|NCT01481116|100604934|FG001|Overall Study|Non-Compliant With Study Drug|1|||
33302779|NCT02304705|101003085|FG000|Overall Study|Withdrawal by Subject|2|||
33190573|NCT01481116|100604935|FG002|Overall Study|Non-Compliant With Study Drug|1|||
33497958|NCT02157935|101717198|FG001|Overall Study|Protocol Violation|0|||
33302780|NCT02304705|101003086|FG001|Overall Study|Withdrawal by Subject|0|||
33302781|NCT02304705|101003085|FG000|Overall Study|Physician Decision|2|||
33302782|NCT02304705|101003086|FG001|Overall Study|Physician Decision|4|||
33302783|NCT02304705|101003085|FG000|Overall Study|Death|0|||
33302784|NCT02304705|101003086|FG001|Overall Study|Death|1|||
33302785|NCT02304705|101003085|FG000|Overall Study|Lost to Follow-up|0|||
33302786|NCT02304705|101003086|FG001|Overall Study|Lost to Follow-up|2|||
33302787|NCT00488475|101003087|FG000|Overall Study|Other|1754|||
33302788|NCT00704405|101003098|FG000|Overall Study (NC Population)|Adverse Event|1|||
33497959|NCT02157935|101717197|FG000|Overall Study|Progressive disease|0|||
33302789|NCT00704405|101003099|FG001|Overall Study (NC Population)|Adverse Event|0|||
33302790|NCT00704405|101003100|FG002|Overall Study (NC Population)|Adverse Event|0|||
33302791|NCT00704405|101003101|FG003|Overall Study (NC Population)|Adverse Event|0|||
33302792|NCT00704405|101003102|FG004|Overall Study (NC Population)|Adverse Event|0|||
33302793|NCT00704405|101003098|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
33302794|NCT00704405|101003099|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
33302795|NCT00704405|101003100|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
33302796|NCT00704405|101003101|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
33302797|NCT00704405|101003102|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
33302798|NCT00704405|101003098|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
33302799|NCT00704405|101003099|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
33302800|NCT00704405|101003100|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
33302801|NCT00704405|101003101|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
33302802|NCT00704405|101003102|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
33302803|NCT00704405|101003098|FG000|Overall Study (NC Population)|Other|0|||
33302804|NCT00704405|101003099|FG001|Overall Study (NC Population)|Other|0|||
33302805|NCT00704405|101003100|FG002|Overall Study (NC Population)|Other|0|||
33302806|NCT00704405|101003101|FG003|Overall Study (NC Population)|Other|0|||
33302807|NCT00704405|101003102|FG004|Overall Study (NC Population)|Other|1|||
33302808|NCT00704405|101003098|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
33302809|NCT00704405|101003099|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
33302810|NCT00704405|101003100|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
33302811|NCT00704405|101003101|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
33302812|NCT00704405|101003102|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
33302813|NCT00704405|101003098|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
33302814|NCT00704405|101003099|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
33302815|NCT00704405|101003100|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
33302816|NCT00704405|101003101|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
33302817|NCT00704405|101003102|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
33302818|NCT00979576|101003103|FG000|Combination Treatment Phase|Progressive disease|3|||
33302819|NCT00979576|101003104|FG001|Combination Treatment Phase|Progressive disease|1|||
33302820|NCT00979576|101003105|FG002|Combination Treatment Phase|Progressive disease|5|||
33302821|NCT00979576|101003103|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
33302822|NCT00979576|101003104|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
33302823|NCT00979576|101003105|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
33302824|NCT00979576|101003103|FG000|Combination Treatment Phase|Adverse Event|0|||
33302825|NCT00979576|101003104|FG001|Combination Treatment Phase|Adverse Event|2|||
33302826|NCT00979576|101003105|FG002|Combination Treatment Phase|Adverse Event|2|||
33302827|NCT00979576|101003103|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
33302828|NCT00979576|101003104|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
33302829|NCT00979576|101003105|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
33302830|NCT01879553|101003110|FG000|Overall Study|Withdrawal by Subject|1|||
33302831|NCT01879553|101003111|FG001|Overall Study|Withdrawal by Subject|0|||
33302832|NCT04020185|101003112|FG000|Overall Study|Death|0|||
33302833|NCT04020185|101003113|FG001|Overall Study|Death|0|||
33302834|NCT04020185|101003114|FG002|Overall Study|Death|1|||
33302835|NCT04020185|101003115|FG003|Overall Study|Death|2|||
33302836|NCT04020185|101003116|FG004|Overall Study|Death|1|||
33302837|NCT04020185|101003117|FG005|Overall Study|Death|0|||
33302838|NCT04020185|101003118|FG006|Overall Study|Death|1|||
33302839|NCT04020185|101003119|FG007|Overall Study|Death|0|||
33302840|NCT04020185|101003112|FG000|Overall Study|Consent withdrawn|1|||
33302841|NCT04020185|101003113|FG001|Overall Study|Consent withdrawn|0|||
33302842|NCT04020185|101003114|FG002|Overall Study|Consent withdrawn|0|||
33302843|NCT04020185|101003115|FG003|Overall Study|Consent withdrawn|0|||
33302844|NCT04020185|101003116|FG004|Overall Study|Consent withdrawn|2|||
33302845|NCT04020185|101003117|FG005|Overall Study|Consent withdrawn|0|||
33302846|NCT04020185|101003118|FG006|Overall Study|Consent withdrawn|1|||
33302847|NCT04020185|101003119|FG007|Overall Study|Consent withdrawn|1|||
33302848|NCT04020185|101003112|FG000|Overall Study|Patient in hospice|0|||
33600372|NCT01688739|102088641|FG001|Overall Study|Administrative Decision|0|||
33600373|NCT01688739|102088642|FG002|Overall Study|Administrative Decision|0|||
33600374|NCT01688739|102088643|FG003|Overall Study|Administrative Decision|0|||
33600375|NCT01688739|102088644|FG004|Overall Study|Administrative Decision|0|||
33600376|NCT01688739|102088645|FG005|Overall Study|Administrative Decision|0|||
33600377|NCT01688739|102088646|FG006|Overall Study|Administrative Decision|0|||
33600378|NCT01688739|102088647|FG007|Overall Study|Administrative Decision|0|||
33600379|NCT01688739|102088648|FG008|Overall Study|Administrative Decision|0|||
33302849|NCT04020185|101003113|FG001|Overall Study|Patient in hospice|1|||
33302850|NCT04020185|101003114|FG002|Overall Study|Patient in hospice|0|||
33302851|NCT04020185|101003115|FG003|Overall Study|Patient in hospice|0|||
33302852|NCT04020185|101003116|FG004|Overall Study|Patient in hospice|0|||
33302853|NCT04020185|101003117|FG005|Overall Study|Patient in hospice|0|||
33302854|NCT04020185|101003118|FG006|Overall Study|Patient in hospice|0|||
33302855|NCT04020185|101003119|FG007|Overall Study|Patient in hospice|0|||
33302856|NCT04020185|101003112|FG000|Overall Study|Continuing on expanded access|0|||
33302857|NCT04020185|101003113|FG001|Overall Study|Continuing on expanded access|0|||
33302858|NCT04020185|101003114|FG002|Overall Study|Continuing on expanded access|0|||
33302859|NCT04020185|101003115|FG003|Overall Study|Continuing on expanded access|0|||
33302860|NCT04020185|101003116|FG004|Overall Study|Continuing on expanded access|0|||
33302861|NCT04020185|101003117|FG005|Overall Study|Continuing on expanded access|0|||
33302862|NCT04020185|101003118|FG006|Overall Study|Continuing on expanded access|1|||
33302863|NCT04020185|101003119|FG007|Overall Study|Continuing on expanded access|1|||
33302864|NCT01036438|101003122|FG000|Overall Study|Adverse Event|7|||
33302865|NCT01036438|101003123|FG001|Overall Study|Adverse Event|8|||
33302866|NCT01036438|101003122|FG000|Overall Study|Death|0|||
33302867|NCT01036438|101003123|FG001|Overall Study|Death|1|||
33302868|NCT01036438|101003122|FG000|Overall Study|No effect of study treatment|3|||
33302869|NCT01036438|101003123|FG001|Overall Study|No effect of study treatment|1|||
33302870|NCT00384189|101003124|FG000|Overall Study|Reason Not Specified|50|||
33302871|NCT00384189|101003125|FG001|Overall Study|Reason Not Specified|57|||
33302872|NCT00384189|101003126|FG002|Overall Study|Reason Not Specified|58|||
33302873|NCT00384189|101003127|FG003|Overall Study|Reason Not Specified|40|||
33302874|NCT01253135|101003128|FG000|Original Protocol|Protocol Amendment|15|||
33302875|NCT01253135|101003128|FG000|Amended Protocol|Non-compliance|1|||
33302876|NCT04996004|101003129|FG000|Phase I|Death|1|||
33302877|NCT04996004|101003130|FG001|Phase I|Death|2|||
33302878|NCT04996004|101003131|FG002|Phase I|Death|1|||
33302879|NCT04996004|101003132|FG003|Phase I|Death|0|||
33302880|NCT04996004|101003133|FG004|Phase I|Death|0|||
33302881|NCT04996004|101003134|FG005|Phase I|Death|0|||
33497960|NCT02157935|101717198|FG001|Overall Study|Progressive disease|2|||
33497961|NCT02157935|101717197|FG000|Overall Study|Other|5|||
33497962|NCT02157935|101717198|FG001|Overall Study|Other|12|||
33497963|NCT02157935|101717197|FG000|Overall Study|Lack of Efficacy|0|||
33497964|NCT02157935|101717198|FG001|Overall Study|Lack of Efficacy|1|||
33497965|NCT02157935|101717197|FG000|Overall Study|Death|4|||
33497966|NCT02157935|101717198|FG001|Overall Study|Death|4|||
33497967|NCT02157935|101717197|FG000|Overall Study|Adverse Event|3|||
33497968|NCT02157935|101717198|FG001|Overall Study|Adverse Event|5|||
33497969|NCT01958437|101717202|FG000|Overall Study|Incidental MRI findings|0|||
33497970|NCT01958437|101717203|FG001|Overall Study|Incidental MRI findings|0|||
33497971|NCT01958437|101717204|FG002|Overall Study|Incidental MRI findings|1|||
33497972|NCT01958437|101717205|FG003|Overall Study|Incidental MRI findings|1|||
33497973|NCT02965573|101717206|FG000|Overall Study|Lack of Efficacy|1|||
33302882|NCT04996004|101003129|FG000|Phase I|Study terminated by sponsor|2|||
33302883|NCT04996004|101003130|FG001|Phase I|Study terminated by sponsor|1|||
33302884|NCT04996004|101003131|FG002|Phase I|Study terminated by sponsor|2|||
33302885|NCT04996004|101003132|FG003|Phase I|Study terminated by sponsor|0|||
33302886|NCT04996004|101003133|FG004|Phase I|Study terminated by sponsor|0|||
33302887|NCT04996004|101003134|FG005|Phase I|Study terminated by sponsor|0|||
33302888|NCT04996004|101003129|FG000|Phase II|Study terminated by sponsor|0|||
33302889|NCT04996004|101003130|FG001|Phase II|Study terminated by sponsor|0|||
33302890|NCT04996004|101003131|FG002|Phase II|Study terminated by sponsor|0|||
33302891|NCT04996004|101003132|FG003|Phase II|Study terminated by sponsor|20|||
33302892|NCT04996004|101003133|FG004|Phase II|Study terminated by sponsor|10|||
33302893|NCT04996004|101003134|FG005|Phase II|Study terminated by sponsor|10|||
33302894|NCT04996004|101003129|FG000|Phase II|Withdrawal by Subject|0|||
33302895|NCT04996004|101003130|FG001|Phase II|Withdrawal by Subject|0|||
33302896|NCT04996004|101003131|FG002|Phase II|Withdrawal by Subject|0|||
33302897|NCT04996004|101003132|FG003|Phase II|Withdrawal by Subject|0|||
33302898|NCT04996004|101003133|FG004|Phase II|Withdrawal by Subject|1|||
33302899|NCT04996004|101003134|FG005|Phase II|Withdrawal by Subject|2|||
33302900|NCT04996004|101003129|FG000|Phase II|Death|0|||
33302901|NCT04996004|101003130|FG001|Phase II|Death|0|||
33302902|NCT04996004|101003131|FG002|Phase II|Death|0|||
33302903|NCT04996004|101003132|FG003|Phase II|Death|12|||
33302904|NCT04996004|101003133|FG004|Phase II|Death|2|||
33302905|NCT04996004|101003134|FG005|Phase II|Death|9|||
33302906|NCT04996004|101003129|FG000|Phase II|Other|0|||
33497974|NCT02965573|101717207|FG001|Overall Study|Lack of Efficacy|0|||
33497975|NCT01930162|101717208|FG000|Overall Study|Abnormal test procedure result(s)|4|||
33302907|NCT04996004|101003130|FG001|Phase II|Other|0|||
33497976|NCT01930162|101717208|FG000|Overall Study|Death|1|||
33497977|NCT03187301|101717209|FG000|Titration Period|Adverse Event|0|||
33302908|NCT04996004|101003131|FG002|Phase II|Other|0|||
33302909|NCT04996004|101003132|FG003|Phase II|Other|0|||
33302910|NCT04996004|101003133|FG004|Phase II|Other|0|||
33302911|NCT04996004|101003134|FG005|Phase II|Other|1|||
33302912|NCT03031470|101003135|FG000|Overall Study|Adverse Event|3|||
33302913|NCT03031470|101003136|FG001|Overall Study|Adverse Event|0|||
33302914|NCT03031470|101003135|FG000|Overall Study|Death|3|||
33497978|NCT03187301|101717210|FG001|Titration Period|Adverse Event|0|||
33497979|NCT03187301|101717211|FG002|Titration Period|Adverse Event|0|||
33497980|NCT03187301|101717212|FG003|Titration Period|Adverse Event|0|||
33302915|NCT03031470|101003136|FG001|Overall Study|Death|1|||
33302916|NCT03031470|101003135|FG000|Overall Study|Lost to Follow-up|1|||
33302917|NCT03031470|101003136|FG001|Overall Study|Lost to Follow-up|1|||
33302918|NCT03031470|101003135|FG000|Overall Study|Withdrawal by Subject|1|||
33302919|NCT03031470|101003136|FG001|Overall Study|Withdrawal by Subject|0|||
33302920|NCT03031470|101003135|FG000|Overall Study|Protocol entry criteria not met|0|||
33497981|NCT03187301|101717213|FG004|Titration Period|Adverse Event|0|||
33497982|NCT03187301|101717214|FG005|Titration Period|Adverse Event|0|||
33497983|NCT03187301|101717215|FG006|Titration Period|Adverse Event|5|||
33497984|NCT03187301|101717209|FG000|Titration Period|Withdrawal by Subject|0|||
33302921|NCT03031470|101003136|FG001|Overall Study|Protocol entry criteria not met|1|||
33302922|NCT03031470|101003135|FG000|Overall Study|Cancel the operation|0|||
33302923|NCT03031470|101003136|FG001|Overall Study|Cancel the operation|1|||
33302924|NCT00699153|101003142|FG000|Overall Study|Lost to Follow-up|1|||
33302925|NCT00699153|101003143|FG001|Overall Study|Lost to Follow-up|0|||
33302926|NCT00699153|101003142|FG000|Overall Study|Adverse Event|0|||
33302927|NCT00699153|101003143|FG001|Overall Study|Adverse Event|2|||
33302928|NCT00699153|101003142|FG000|Overall Study|Protocol Violation|1|||
33302929|NCT00699153|101003143|FG001|Overall Study|Protocol Violation|0|||
33302930|NCT00699153|101003142|FG000|Overall Study|Travel Problem|1|||
33302931|NCT00699153|101003143|FG001|Overall Study|Travel Problem|0|||
33302932|NCT02387970|101003144|FG000|Overall Study|Did not complete 1-year follow up|1|||
33302933|NCT02387970|101003145|FG001|Overall Study|Did not complete 1-year follow up|2|||
33302934|NCT05038163|101003154|FG000|Stage 1|Did not complete survey|374|||
33302935|NCT05038163|101003155|FG001|Stage 1|Did not complete survey|0|||
33302936|NCT05038163|101003156|FG002|Stage 1|Did not complete survey|0|||
33302937|NCT05038163|101003157|FG003|Stage 1|Did not complete survey|0|||
33302938|NCT05038163|101003158|FG004|Stage 1|Did not complete survey|0|||
33302939|NCT05038163|101003159|FG005|Stage 1|Did not complete survey|0|||
33302940|NCT05038163|101003154|FG000|Stage 2|Did not complete Stage 2 survey|0|||
33302941|NCT05038163|101003155|FG001|Stage 2|Did not complete Stage 2 survey|29|||
33302942|NCT05038163|101003156|FG002|Stage 2|Did not complete Stage 2 survey|30|||
33302943|NCT05038163|101003157|FG003|Stage 2|Did not complete Stage 2 survey|24|||
33302944|NCT05038163|101003158|FG004|Stage 2|Did not complete Stage 2 survey|21|||
33302945|NCT05038163|101003159|FG005|Stage 2|Did not complete Stage 2 survey|100|||
33302946|NCT00400725|101003160|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
33302947|NCT00400725|101003161|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
33302948|NCT00400725|101003162|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
33302949|NCT00400725|101003160|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
33302950|NCT00400725|101003161|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
33302951|NCT00400725|101003162|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
33302952|NCT00400725|101003160|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
33302953|NCT00400725|101003161|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
33302954|NCT00400725|101003162|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
33302955|NCT00400725|101003160|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
33302956|NCT00400725|101003161|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
33302957|NCT00400725|101003162|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
33302958|NCT00400725|101003160|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
33302959|NCT00400725|101003161|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
33302960|NCT00400725|101003162|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
33302961|NCT00400725|101003160|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
33302962|NCT00400725|101003161|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
33302963|NCT00400725|101003162|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
33302964|NCT00400725|101003160|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
33302965|NCT00400725|101003161|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
33302966|NCT00400725|101003162|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
33302967|NCT00400725|101003160|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
33302968|NCT00400725|101003161|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
33302969|NCT00400725|101003162|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
33302970|NCT00400725|101003160|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
33302971|NCT00400725|101003161|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
33302972|NCT00400725|101003162|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
33302973|NCT01283152|101003167|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
33497985|NCT03187301|101717210|FG001|Titration Period|Withdrawal by Subject|0|||
33497986|NCT03187301|101717211|FG002|Titration Period|Withdrawal by Subject|0|||
33302974|NCT01283152|101003168|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
33302975|NCT01283152|101003167|FG000|Overall Study|Refused HESA|1|||
33302976|NCT01283152|101003168|FG001|Overall Study|Refused HESA|0|||
33302977|NCT05327816|101003169|FG000|Overall Study|Lost to Follow-up|1|||
33497987|NCT03187301|101717212|FG003|Titration Period|Withdrawal by Subject|0|||
33302978|NCT05327816|101003170|FG001|Overall Study|Lost to Follow-up|0|||
33302979|NCT05327816|101003171|FG002|Overall Study|Lost to Follow-up|0|||
33302980|NCT05327816|101003172|FG003|Overall Study|Lost to Follow-up|0|||
33302981|NCT05327816|101003173|FG004|Overall Study|Lost to Follow-up|0|||
33302982|NCT05327816|101003174|FG005|Overall Study|Lost to Follow-up|0|||
33302983|NCT05327816|101003175|FG006|Overall Study|Lost to Follow-up|0|||
33302984|NCT05327816|101003176|FG007|Overall Study|Lost to Follow-up|0|||
33302985|NCT05327816|101003177|FG008|Overall Study|Lost to Follow-up|0|||
33302986|NCT05327816|101003178|FG009|Overall Study|Lost to Follow-up|1|||
33302987|NCT05327816|101003179|FG010|Overall Study|Lost to Follow-up|0|||
33302988|NCT05327816|101003169|FG000|Overall Study|Withdrawal by Subject|0|||
33302989|NCT05327816|101003170|FG001|Overall Study|Withdrawal by Subject|0|||
33302990|NCT05327816|101003171|FG002|Overall Study|Withdrawal by Subject|0|||
33302991|NCT05327816|101003172|FG003|Overall Study|Withdrawal by Subject|0|||
33302992|NCT05327816|101003173|FG004|Overall Study|Withdrawal by Subject|1|||
33302993|NCT05327816|101003174|FG005|Overall Study|Withdrawal by Subject|1|||
33302994|NCT05327816|101003175|FG006|Overall Study|Withdrawal by Subject|0|||
33302995|NCT05327816|101003176|FG007|Overall Study|Withdrawal by Subject|0|||
33302996|NCT05327816|101003177|FG008|Overall Study|Withdrawal by Subject|0|||
33302997|NCT05327816|101003178|FG009|Overall Study|Withdrawal by Subject|0|||
33302998|NCT05327816|101003179|FG010|Overall Study|Withdrawal by Subject|0|||
33302999|NCT05327816|101003169|FG000|Overall Study|Study Terminated by Sponsor|11|||
33303000|NCT05327816|101003170|FG001|Overall Study|Study Terminated by Sponsor|12|||
33303001|NCT05327816|101003171|FG002|Overall Study|Study Terminated by Sponsor|12|||
33303002|NCT05327816|101003172|FG003|Overall Study|Study Terminated by Sponsor|12|||
33303003|NCT05327816|101003173|FG004|Overall Study|Study Terminated by Sponsor|11|||
33303004|NCT05327816|101003174|FG005|Overall Study|Study Terminated by Sponsor|11|||
33303005|NCT05327816|101003175|FG006|Overall Study|Study Terminated by Sponsor|11|||
33303006|NCT05327816|101003176|FG007|Overall Study|Study Terminated by Sponsor|11|||
33303007|NCT05327816|101003177|FG008|Overall Study|Study Terminated by Sponsor|11|||
33303008|NCT05327816|101003178|FG009|Overall Study|Study Terminated by Sponsor|11|||
33303009|NCT05327816|101003179|FG010|Overall Study|Study Terminated by Sponsor|12|||
33303010|NCT05327816|101003169|FG000|Overall Study|Randomized but not treated|0|||
33303011|NCT05327816|101003170|FG001|Overall Study|Randomized but not treated|0|||
33303012|NCT05327816|101003171|FG002|Overall Study|Randomized but not treated|0|||
33303013|NCT05327816|101003172|FG003|Overall Study|Randomized but not treated|0|||
33303014|NCT05327816|101003173|FG004|Overall Study|Randomized but not treated|0|||
33303015|NCT05327816|101003174|FG005|Overall Study|Randomized but not treated|0|||
33303016|NCT05327816|101003175|FG006|Overall Study|Randomized but not treated|1|||
33303017|NCT05327816|101003176|FG007|Overall Study|Randomized but not treated|1|||
33303018|NCT05327816|101003177|FG008|Overall Study|Randomized but not treated|1|||
33303019|NCT05327816|101003178|FG009|Overall Study|Randomized but not treated|0|||
33303020|NCT05327816|101003179|FG010|Overall Study|Randomized but not treated|0|||
33497988|NCT03187301|101717213|FG004|Titration Period|Withdrawal by Subject|0|||
33497989|NCT03187301|101717214|FG005|Titration Period|Withdrawal by Subject|0|||
33497990|NCT03187301|101717215|FG006|Titration Period|Withdrawal by Subject|1|||
33497991|NCT03187301|101717209|FG000|Titration Period|Exclusion Criteria Met|0|||
33497992|NCT03187301|101717210|FG001|Titration Period|Exclusion Criteria Met|0|||
33497993|NCT03187301|101717211|FG002|Titration Period|Exclusion Criteria Met|0|||
33497994|NCT03187301|101717212|FG003|Titration Period|Exclusion Criteria Met|0|||
33497995|NCT03187301|101717213|FG004|Titration Period|Exclusion Criteria Met|0|||
33497996|NCT03187301|101717214|FG005|Titration Period|Exclusion Criteria Met|0|||
33497997|NCT03187301|101717215|FG006|Titration Period|Exclusion Criteria Met|1|||
33497998|NCT03187301|101717209|FG000|Pre-Intervention|Withdrawal by Subject|1|||
33497999|NCT03187301|101717210|FG001|Pre-Intervention|Withdrawal by Subject|0|||
33498000|NCT03187301|101717211|FG002|Pre-Intervention|Withdrawal by Subject|0|||
33498001|NCT03187301|101717212|FG003|Pre-Intervention|Withdrawal by Subject|0|||
33498002|NCT03187301|101717213|FG004|Pre-Intervention|Withdrawal by Subject|0|||
33498003|NCT03187301|101717214|FG005|Pre-Intervention|Withdrawal by Subject|0|||
33498004|NCT03187301|101717215|FG006|Pre-Intervention|Withdrawal by Subject|0|||
33498005|NCT01703260|101717217|FG000|Overall Study|Adverse Event|1|||
33498006|NCT01703260|101717218|FG001|Overall Study|Adverse Event|2|||
33498007|NCT01703260|101717219|FG002|Overall Study|Adverse Event|2|||
33498008|NCT01703260|101717217|FG000|Overall Study|Lost to Follow-up|1|||
33498009|NCT01703260|101717218|FG001|Overall Study|Lost to Follow-up|0|||
33498010|NCT01703260|101717219|FG002|Overall Study|Lost to Follow-up|0|||
33498011|NCT01703260|101717217|FG000|Overall Study|Withdrawal by Subject|0|||
33498012|NCT01703260|101717218|FG001|Overall Study|Withdrawal by Subject|0|||
33303021|NCT05775991|101003180|FG000|Overall Study|Withdrawal by Subject|0|||
33303022|NCT05775991|101003181|FG001|Overall Study|Withdrawal by Subject|0|||
33303023|NCT05775991|101003182|FG002|Overall Study|Withdrawal by Subject|2|||
33303024|NCT02770612|101003185|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
33498013|NCT01703260|101717219|FG002|Overall Study|Withdrawal by Subject|1|||
33303025|NCT01743989|101003186|FG000|Treatment Phase|Unstable MR4.0|0|||
33303026|NCT01743989|101003187|FG001|Treatment Phase|Unstable MR4.0|6|||
33303027|NCT01743989|101003188|FG002|Treatment Phase|Unstable MR4.0|263|||
33303028|NCT01743989|101003186|FG000|Treatment Phase|Adverse Event|0|||
33303029|NCT01743989|101003187|FG001|Treatment Phase|Adverse Event|4|||
33303030|NCT01743989|101003188|FG002|Treatment Phase|Adverse Event|67|||
33498014|NCT01703260|101717217|FG000|Overall Study|Study Termination|1|||
33498015|NCT01703260|101717218|FG001|Overall Study|Study Termination|2|||
33498016|NCT01703260|101717219|FG002|Overall Study|Study Termination|0|||
33498017|NCT05393037|101717220|FG000|Overall Study|Death|1|||
33303031|NCT01743989|101003186|FG000|Treatment Phase|Withdrawal by Subject|1|||
33303032|NCT01743989|101003187|FG001|Treatment Phase|Withdrawal by Subject|3|||
33303033|NCT01743989|101003188|FG002|Treatment Phase|Withdrawal by Subject|28|||
33303034|NCT01743989|101003186|FG000|Treatment Phase|Death|0|||
33498018|NCT05393037|101717221|FG001|Overall Study|Death|0|||
33498019|NCT05393037|101717220|FG000|Overall Study|Lost to Follow-up|1|||
33498020|NCT05393037|101717221|FG001|Overall Study|Lost to Follow-up|1|||
33498021|NCT05393037|101717220|FG000|Overall Study|Withdrawal by Subject|2|||
33498022|NCT05393037|101717221|FG001|Overall Study|Withdrawal by Subject|4|||
33498023|NCT05393037|101717220|FG000|Overall Study|Ongoing|152|||
33498024|NCT05393037|101717221|FG001|Overall Study|Ongoing|0|||
33498025|NCT01966120|101717224|FG000|Overall Study|Withdrawal by Subject|0|||
33498026|NCT01966120|101717225|FG001|Overall Study|Withdrawal by Subject|5|||
33498027|NCT01966120|101717224|FG000|Overall Study|Lost to Follow-up|1|||
33498028|NCT01966120|101717225|FG001|Overall Study|Lost to Follow-up|1|||
33498029|NCT01557504|101717236|FG000|Overall Study|Physician Decision|1|||
33498030|NCT01557504|101717237|FG001|Overall Study|Physician Decision|0|||
33498031|NCT00571727|101717238|FG000|Overall Study|Did not enter in this study|1|||
33498032|NCT00571727|101717238|FG000|Overall Study|Non-compliance|4|||
33498033|NCT00571727|101717238|FG000|Overall Study|Lost to Follow-up|30|||
33498034|NCT00571727|101717238|FG000|Overall Study|Poor growth|1|||
33498035|NCT00571727|101717238|FG000|Overall Study|Parent/patient decision|2|||
33498036|NCT00571727|101717238|FG000|Overall Study|Participant transferred to commercial drug|14|||
33498037|NCT00571727|101717238|FG000|Overall Study|Unable to provide study drug|6|||
33498038|NCT00571727|101717238|FG000|Overall Study|On-treatment at end of study|8|||
33303035|NCT01743989|101003187|FG001|Treatment Phase|Death|1|||
33303036|NCT01743989|101003188|FG002|Treatment Phase|Death|3|||
33303037|NCT01743989|101003186|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
33498039|NCT02872714|101717239|FG000|Overall Study|Progressive Disease|1|||
33303038|NCT01743989|101003187|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
33303039|NCT01743989|101003188|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
33303040|NCT01743989|101003186|FG000|Treatment Phase|Protocol deviation|0|||
33303041|NCT01743989|101003187|FG001|Treatment Phase|Protocol deviation|0|||
33303042|NCT01743989|101003188|FG002|Treatment Phase|Protocol deviation|3|||
33303043|NCT01743989|101003186|FG000|Treatment Phase|Pregnancy|0|||
33303044|NCT01743989|101003187|FG001|Treatment Phase|Pregnancy|0|||
33303045|NCT01743989|101003188|FG002|Treatment Phase|Pregnancy|2|||
33303046|NCT01743989|101003186|FG000|Treatment Phase|Lost to Follow-up|0|||
33303047|NCT01743989|101003187|FG001|Treatment Phase|Lost to Follow-up|0|||
33303048|NCT01743989|101003188|FG002|Treatment Phase|Lost to Follow-up|2|||
33303049|NCT01743989|101003186|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
33303050|NCT01743989|101003187|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
33303051|NCT01743989|101003188|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
33303052|NCT01743989|101003186|FG000|Treatment Phase|Administrative problems|0|||
33303053|NCT01743989|101003187|FG001|Treatment Phase|Administrative problems|0|||
33303054|NCT01743989|101003188|FG002|Treatment Phase|Administrative problems|1|||
33303055|NCT01743989|101003186|FG000|Treatment Phase|New cancer (CML) therapy|0|||
33303056|NCT01743989|101003187|FG001|Treatment Phase|New cancer (CML) therapy|1|||
33303057|NCT01743989|101003188|FG002|Treatment Phase|New cancer (CML) therapy|0|||
33303058|NCT01743989|101003186|FG000|Treatment Phase|Physician Decision|0|||
33303059|NCT01743989|101003187|FG001|Treatment Phase|Physician Decision|0|||
33303060|NCT01743989|101003188|FG002|Treatment Phase|Physician Decision|3|||
33303061|NCT01743989|101003186|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
33303062|NCT01743989|101003187|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
33303063|NCT01743989|101003188|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
33303064|NCT01743989|101003186|FG000|Treatment Phase|Not randomized by mistake|0|||
33303065|NCT01743989|101003187|FG001|Treatment Phase|Not randomized by mistake|0|||
33303066|NCT01743989|101003188|FG002|Treatment Phase|Not randomized by mistake|1|||
33303067|NCT01743989|101003186|FG000|Treatment Phase|Included by mistake|0|||
33498040|NCT02872714|101717240|FG001|Overall Study|Progressive Disease|2|||
33498041|NCT02872714|101717241|FG002|Overall Study|Progressive Disease|0|||
33498042|NCT02872714|101717242|FG003|Overall Study|Progressive Disease|0|||
33498043|NCT02872714|101717243|FG004|Overall Study|Progressive Disease|0|||
33498044|NCT02872714|101717239|FG000|Overall Study|Death|87|||
33303068|NCT01743989|101003187|FG001|Treatment Phase|Included by mistake|0|||
33303069|NCT01743989|101003188|FG002|Treatment Phase|Included by mistake|1|||
33303070|NCT01743989|101003186|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
33303071|NCT01743989|101003187|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
33303072|NCT01743989|101003188|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
33498045|NCT02872714|101717240|FG001|Overall Study|Death|36|||
33498046|NCT02872714|101717241|FG002|Overall Study|Death|8|||
33303073|NCT01743989|101003186|FG000|TFR Phase|Adverse Event|0|||
33303074|NCT01743989|101003187|FG001|TFR Phase|Adverse Event|1|||
33303075|NCT01743989|101003188|FG002|TFR Phase|Adverse Event|0|||
33498047|NCT02872714|101717242|FG003|Overall Study|Death|81|||
33498048|NCT02872714|101717243|FG004|Overall Study|Death|2|||
33498049|NCT02872714|101717239|FG000|Overall Study|Lost to Follow-up|2|||
33498050|NCT02872714|101717240|FG001|Overall Study|Lost to Follow-up|1|||
33498051|NCT02872714|101717241|FG002|Overall Study|Lost to Follow-up|0|||
33498052|NCT02872714|101717242|FG003|Overall Study|Lost to Follow-up|3|||
33498053|NCT02872714|101717243|FG004|Overall Study|Lost to Follow-up|0|||
33498054|NCT02872714|101717239|FG000|Overall Study|Physician Decision|0|||
33498055|NCT02872714|101717240|FG001|Overall Study|Physician Decision|0|||
33498056|NCT02872714|101717241|FG002|Overall Study|Physician Decision|0|||
33498057|NCT02872714|101717242|FG003|Overall Study|Physician Decision|1|||
33498058|NCT02872714|101717243|FG004|Overall Study|Physician Decision|0|||
33498059|NCT02872714|101717239|FG000|Overall Study|Withdrawal by Subject|1|||
33498060|NCT02872714|101717240|FG001|Overall Study|Withdrawal by Subject|3|||
33498061|NCT02872714|101717241|FG002|Overall Study|Withdrawal by Subject|0|||
33498062|NCT02872714|101717242|FG003|Overall Study|Withdrawal by Subject|2|||
33498063|NCT02872714|101717243|FG004|Overall Study|Withdrawal by Subject|0|||
33498064|NCT02872714|101717239|FG000|Overall Study|Captured as Other|2|||
33498065|NCT02872714|101717240|FG001|Overall Study|Captured as Other|0|||
33498066|NCT02872714|101717241|FG002|Overall Study|Captured as Other|0|||
33498067|NCT02872714|101717242|FG003|Overall Study|Captured as Other|1|||
33498068|NCT02872714|101717243|FG004|Overall Study|Captured as Other|0|||
33498069|NCT01592786|101717244|FG000|Overall Study|Adverse Event|60|||
33303076|NCT01743989|101003186|FG000|TFR Phase|Lost to Follow-up|0|||
33303077|NCT01743989|101003187|FG001|TFR Phase|Lost to Follow-up|2|||
33303078|NCT01743989|101003188|FG002|TFR Phase|Lost to Follow-up|0|||
33303079|NCT01743989|101003186|FG000|TFR Phase|Physician Decision|0|||
33303080|NCT01743989|101003187|FG001|TFR Phase|Physician Decision|1|||
33303081|NCT01743989|101003188|FG002|TFR Phase|Physician Decision|0|||
33303082|NCT01743989|101003186|FG000|TFR Phase|Logistical problems|0|||
33303083|NCT01743989|101003187|FG001|TFR Phase|Logistical problems|2|||
33303084|NCT01743989|101003188|FG002|TFR Phase|Logistical problems|0|||
33303085|NCT01743989|101003186|FG000|TFR Phase|Protocol deviation|0|||
33303086|NCT01743989|101003187|FG001|TFR Phase|Protocol deviation|1|||
33303087|NCT01743989|101003188|FG002|TFR Phase|Protocol deviation|0|||
33303088|NCT01743989|101003186|FG000|TFR Phase|Withdrawal by Subject|0|||
33303089|NCT01743989|101003187|FG001|TFR Phase|Withdrawal by Subject|2|||
33303090|NCT01743989|101003188|FG002|TFR Phase|Withdrawal by Subject|0|||
33303091|NCT01743989|101003186|FG000|Re-treatment Phase|Adverse Event|8|||
33303092|NCT01743989|101003187|FG001|Re-treatment Phase|Adverse Event|4|||
33303093|NCT01743989|101003188|FG002|Re-treatment Phase|Adverse Event|0|||
33303094|NCT01743989|101003186|FG000|Re-treatment Phase|Death|1|||
33303095|NCT01743989|101003187|FG001|Re-treatment Phase|Death|1|||
33303096|NCT01743989|101003188|FG002|Re-treatment Phase|Death|0|||
33303097|NCT01743989|101003186|FG000|Re-treatment Phase|Administrative problems|1|||
33303098|NCT01743989|101003187|FG001|Re-treatment Phase|Administrative problems|1|||
33303099|NCT01743989|101003188|FG002|Re-treatment Phase|Administrative problems|0|||
33303100|NCT01743989|101003186|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
33303101|NCT01743989|101003187|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
33303102|NCT01743989|101003188|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
33303103|NCT01743989|101003186|FG000|Re-treatment Phase|Unstable MR|1|||
33303104|NCT01743989|101003187|FG001|Re-treatment Phase|Unstable MR|0|||
33303105|NCT01743989|101003188|FG002|Re-treatment Phase|Unstable MR|0|||
33303106|NCT01743989|101003186|FG000|Re-treatment Phase|Physician Decision|0|||
33303107|NCT01743989|101003187|FG001|Re-treatment Phase|Physician Decision|1|||
33303108|NCT01743989|101003188|FG002|Re-treatment Phase|Physician Decision|0|||
33303109|NCT01743989|101003186|FG000|Re-treatment Phase|Lost to Follow-up|0|||
33303110|NCT01743989|101003187|FG001|Re-treatment Phase|Lost to Follow-up|1|||
33498070|NCT01592786|101717244|FG000|Overall Study|Lack of Efficacy|19|||
33498071|NCT01592786|101717244|FG000|Overall Study|Protocol Violation|14|||
33498072|NCT01592786|101717244|FG000|Overall Study|Withdrawal by Subject|23|||
33303111|NCT01743989|101003188|FG002|Re-treatment Phase|Lost to Follow-up|0|||
33303112|NCT01853475|101003189|FG000|Overall Study|Withdrawal by Subject|0|||
33303113|NCT01853475|101003190|FG001|Overall Study|Withdrawal by Subject|1|||
33303114|NCT01853475|101003191|FG002|Overall Study|Withdrawal by Subject|0|||
33303115|NCT01531673|101003192|FG000|Overall Study|Non-Compliance|0|||
33303116|NCT01531673|101003193|FG001|Overall Study|Non-Compliance|0|||
33303117|NCT01531673|101003194|FG002|Overall Study|Non-Compliance|0|||
33498073|NCT01592786|101717244|FG000|Overall Study|Lost to Follow-up|19|||
33498074|NCT01592786|101717244|FG000|Overall Study|Other|3|||
33498075|NCT02268916|101717245|FG000|Overall Study|Lost to Follow-up|1|||
33498076|NCT02268916|101717246|FG001|Overall Study|Lost to Follow-up|1|||
33303118|NCT01531673|101003195|FG003|Overall Study|Non-Compliance|0|||
33303119|NCT01531673|101003196|FG004|Overall Study|Non-Compliance|0|||
33303120|NCT01531673|101003197|FG005|Overall Study|Non-Compliance|1|||
33303121|NCT01531673|101003198|FG006|Overall Study|Non-Compliance|0|||
33303122|NCT01531673|101003199|FG007|Overall Study|Non-Compliance|0|||
33303123|NCT01531673|101003200|FG008|Overall Study|Non-Compliance|0|||
33303124|NCT01531673|101003201|FG009|Overall Study|Non-Compliance|0|||
33303125|NCT01531673|101003202|FG010|Overall Study|Non-Compliance|0|||
33303126|NCT01531673|101003203|FG011|Overall Study|Non-Compliance|0|||
33303127|NCT01531673|101003204|FG012|Overall Study|Non-Compliance|0|||
33303128|NCT01531673|101003192|FG000|Overall Study|Adverse Event|0|||
33303129|NCT01531673|101003193|FG001|Overall Study|Adverse Event|1|||
33303130|NCT01531673|101003194|FG002|Overall Study|Adverse Event|0|||
33303131|NCT01531673|101003195|FG003|Overall Study|Adverse Event|0|||
33303132|NCT01531673|101003196|FG004|Overall Study|Adverse Event|0|||
33303133|NCT01531673|101003197|FG005|Overall Study|Adverse Event|0|||
33303134|NCT01531673|101003198|FG006|Overall Study|Adverse Event|0|||
33303135|NCT01531673|101003199|FG007|Overall Study|Adverse Event|0|||
33303136|NCT01531673|101003200|FG008|Overall Study|Adverse Event|0|||
33303137|NCT01531673|101003201|FG009|Overall Study|Adverse Event|0|||
33303138|NCT01531673|101003202|FG010|Overall Study|Adverse Event|0|||
33303139|NCT01531673|101003203|FG011|Overall Study|Adverse Event|0|||
33303140|NCT01531673|101003204|FG012|Overall Study|Adverse Event|0|||
33303141|NCT01531673|101003192|FG000|Overall Study|Lost to Follow-up|0|||
33303142|NCT01531673|101003193|FG001|Overall Study|Lost to Follow-up|0|||
33303143|NCT01531673|101003194|FG002|Overall Study|Lost to Follow-up|0|||
33303144|NCT01531673|101003195|FG003|Overall Study|Lost to Follow-up|0|||
33303145|NCT01531673|101003196|FG004|Overall Study|Lost to Follow-up|1|||
33303146|NCT01531673|101003197|FG005|Overall Study|Lost to Follow-up|0|||
33303147|NCT01531673|101003198|FG006|Overall Study|Lost to Follow-up|0|||
33303148|NCT01531673|101003199|FG007|Overall Study|Lost to Follow-up|0|||
33303149|NCT01531673|101003200|FG008|Overall Study|Lost to Follow-up|0|||
33303150|NCT01531673|101003201|FG009|Overall Study|Lost to Follow-up|0|||
33303151|NCT01531673|101003202|FG010|Overall Study|Lost to Follow-up|0|||
33303152|NCT01531673|101003203|FG011|Overall Study|Lost to Follow-up|0|||
33303153|NCT01531673|101003204|FG012|Overall Study|Lost to Follow-up|0|||
33303154|NCT01531673|101003192|FG000|Overall Study|Other|0|||
33303155|NCT01531673|101003193|FG001|Overall Study|Other|0|||
33303156|NCT01531673|101003194|FG002|Overall Study|Other|0|||
33303157|NCT01531673|101003195|FG003|Overall Study|Other|1|||
33303158|NCT01531673|101003196|FG004|Overall Study|Other|0|||
33303159|NCT01531673|101003197|FG005|Overall Study|Other|0|||
33303160|NCT01531673|101003198|FG006|Overall Study|Other|0|||
33303161|NCT01531673|101003199|FG007|Overall Study|Other|0|||
33303162|NCT01531673|101003200|FG008|Overall Study|Other|0|||
33303163|NCT01531673|101003201|FG009|Overall Study|Other|1|||
33303164|NCT01531673|101003202|FG010|Overall Study|Other|0|||
33303165|NCT01531673|101003203|FG011|Overall Study|Other|0|||
33303166|NCT01531673|101003204|FG012|Overall Study|Other|0|||
33303167|NCT03241927|101003205|FG000|Overall Study|study terminated|1|||
33303168|NCT03241927|101003206|FG001|Overall Study|study terminated|0|||
33303169|NCT05560243|101003207|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
33303170|NCT00545753|101003211|FG000|Overall Study|Withdrawal by Subject|0|||
33303171|NCT00545753|101003212|FG001|Overall Study|Withdrawal by Subject|1|||
33303172|NCT00545753|101003213|FG002|Overall Study|Withdrawal by Subject|10|||
33303173|NCT00545753|101003211|FG000|Overall Study|Lost to Follow-up|13|||
33303174|NCT00545753|101003212|FG001|Overall Study|Lost to Follow-up|3|||
33303175|NCT00545753|101003213|FG002|Overall Study|Lost to Follow-up|12|||
33303176|NCT00545753|101003211|FG000|Overall Study|Protocol Violation|3|||
33303177|NCT00545753|101003212|FG001|Overall Study|Protocol Violation|1|||
33303178|NCT00545753|101003213|FG002|Overall Study|Protocol Violation|4|||
33303179|NCT01758900|101003214|FG000|Overall Study|difficulty for further intubation|7|||
33303180|NCT01758900|101003215|FG001|Overall Study|difficulty for further intubation|8|||
33303181|NCT02656706|101003216|FG000|Overall Study|Insurance Denial|1|||
33303182|NCT04032613|101003223|FG000|Overall Study|Did not complete post-program assessment|5|||
33303183|NCT04032613|101003224|FG001|Overall Study|Did not complete post-program assessment|2|||
33303184|NCT01656200|101003230|FG000|Overall Study|Withdrawal by Subject|1|||
33303185|NCT05096221|101003231|FG000|Part 2|Ongoing in Part 2 of the Study|63|||
33303186|NCT05096221|101003232|FG001|Part 2|Ongoing in Part 2 of the Study|62|||
33303187|NCT03592745|101003233|FG000|Overall Study|Adverse Event|0|||
33303188|NCT03592745|101003234|FG001|Overall Study|Adverse Event|2|||
33303189|NCT03592745|101003233|FG000|Overall Study|Lost to Follow-up|2|||
33303190|NCT03592745|101003234|FG001|Overall Study|Lost to Follow-up|0|||
33303191|NCT03592745|101003233|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
33303192|NCT03592745|101003234|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
33303193|NCT03465904|101003235|FG000|Overall Study|Withdrawal by Subject|9|||
33303194|NCT03465904|101003236|FG001|Overall Study|Withdrawal by Subject|5|||
33303195|NCT03465904|101003235|FG000|Overall Study|Lost to Follow-up|11|||
33303196|NCT03465904|101003236|FG001|Overall Study|Lost to Follow-up|9|||
33303197|NCT03465904|101003235|FG000|Overall Study|Protocol Violation|20|||
33303198|NCT03465904|101003236|FG001|Overall Study|Protocol Violation|15|||
33303199|NCT04546217|101003245|FG000|Overall Study|Withdrawal by Subject|2|||
33303200|NCT04546217|101003246|FG001|Overall Study|Withdrawal by Subject|0|||
33303201|NCT04546217|101003245|FG000|Overall Study|Uncontrolled hypertension|1|||
33303202|NCT04546217|101003246|FG001|Overall Study|Uncontrolled hypertension|0|||
33303203|NCT05384938|101003247|FG000|Overall Study|Withdrawal by Subject|8|||
33303204|NCT05384938|101003247|FG000|Overall Study|Lost to Follow-up|6|||
33303205|NCT05384938|101003247|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
33303206|NCT02559895|101003252|FG000|Overall Study|Adverse Event|3|||
33303207|NCT02559895|101003253|FG001|Overall Study|Adverse Event|3|||
33303208|NCT02559895|101003254|FG002|Overall Study|Adverse Event|2|||
33303209|NCT02559895|101003255|FG003|Overall Study|Adverse Event|1|||
33303210|NCT02559895|101003252|FG000|Overall Study|Lack of Efficacy|2|||
33303211|NCT02559895|101003253|FG001|Overall Study|Lack of Efficacy|3|||
33303212|NCT02559895|101003254|FG002|Overall Study|Lack of Efficacy|2|||
33303213|NCT02559895|101003255|FG003|Overall Study|Lack of Efficacy|8|||
33303214|NCT02559895|101003252|FG000|Overall Study|Lost to Follow-up|22|||
33303215|NCT02559895|101003253|FG001|Overall Study|Lost to Follow-up|16|||
33303216|NCT02559895|101003254|FG002|Overall Study|Lost to Follow-up|12|||
33303217|NCT02559895|101003255|FG003|Overall Study|Lost to Follow-up|17|||
33303218|NCT02559895|101003252|FG000|Overall Study|Physician Decision|1|||
33303219|NCT02559895|101003253|FG001|Overall Study|Physician Decision|1|||
33303220|NCT02559895|101003254|FG002|Overall Study|Physician Decision|3|||
33303221|NCT02559895|101003255|FG003|Overall Study|Physician Decision|0|||
33303222|NCT02559895|101003252|FG000|Overall Study|Withdrawal by Subject|16|||
33303223|NCT02559895|101003253|FG001|Overall Study|Withdrawal by Subject|9|||
33303224|NCT02559895|101003254|FG002|Overall Study|Withdrawal by Subject|20|||
33303225|NCT02559895|101003255|FG003|Overall Study|Withdrawal by Subject|9|||
33303226|NCT02559895|101003252|FG000|Overall Study|Study Burden|10|||
33303227|NCT02559895|101003253|FG001|Overall Study|Study Burden|16|||
33303228|NCT02559895|101003254|FG002|Overall Study|Study Burden|12|||
33303229|NCT02559895|101003255|FG003|Overall Study|Study Burden|22|||
33303230|NCT02559895|101003252|FG000|Overall Study|Other|1|||
33303231|NCT02559895|101003253|FG001|Overall Study|Other|5|||
33303232|NCT02559895|101003254|FG002|Overall Study|Other|3|||
33303233|NCT02559895|101003255|FG003|Overall Study|Other|3|||
33303234|NCT04958200|101003256|FG000|Overall Study|Withdrawal by Subject|0|||
33303235|NCT04958200|101003257|FG001|Overall Study|Withdrawal by Subject|2|||
33303236|NCT04958200|101003256|FG000|Overall Study|Lost to Follow-up|3|||
33303237|NCT04958200|101003257|FG001|Overall Study|Lost to Follow-up|2|||
33303238|NCT05038800|101003260|FG000|Overall Study|Death|1|||
33303239|NCT05038800|101003261|FG001|Overall Study|Death|1|||
33303240|NCT05038800|101003262|FG002|Overall Study|Death|5|||
33303241|NCT05038800|101003263|FG003|Overall Study|Death|3|||
33303242|NCT05038800|101003264|FG004|Overall Study|Death|1|||
33303243|NCT05038800|101003260|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33303244|NCT05038800|101003261|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33303245|NCT05038800|101003262|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33303246|NCT05038800|101003263|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33303247|NCT05038800|101003264|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
33303248|NCT05038800|101003260|FG000|Overall Study|Lack of Efficacy|0|||
33303249|NCT05038800|101003261|FG001|Overall Study|Lack of Efficacy|0|||
33303250|NCT05038800|101003262|FG002|Overall Study|Lack of Efficacy|0|||
33303251|NCT05038800|101003263|FG003|Overall Study|Lack of Efficacy|0|||
33303252|NCT05038800|101003264|FG004|Overall Study|Lack of Efficacy|1|||
33303253|NCT03214640|101003268|FG000|Overall Study|Protocol Violation|1|||
33303254|NCT03214640|101003269|FG001|Overall Study|Protocol Violation|2|||
33303255|NCT03214640|101003270|FG002|Overall Study|Protocol Violation|1|||
33303256|NCT03214640|101003271|FG003|Overall Study|Protocol Violation|4|||
33303257|NCT03208036|101003272|FG000|Baseline Assessment|Withdrawal by Subject|1|||
33303258|NCT03208036|101003273|FG001|Baseline Assessment|Withdrawal by Subject|1|||
33303259|NCT03208036|101003272|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
33303260|NCT03208036|101003273|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
33303261|NCT03208036|101003272|FG000|Intervention|Withdrawal by Subject|3|||
33303262|NCT03208036|101003273|FG001|Intervention|Withdrawal by Subject|2|||
33303263|NCT03208036|101003272|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
33303264|NCT03208036|101003273|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
33303265|NCT04958642|101003277|FG000|Overall Study|Transferred to OLEX program|3|||
33303266|NCT04958642|101003278|FG001|Overall Study|Transferred to OLEX program|0|||
33303267|NCT04958642|101003279|FG002|Overall Study|Transferred to OLEX program|5|||
33303268|NCT04958642|101003277|FG000|Overall Study|Death|0|||
33303269|NCT04958642|101003278|FG001|Overall Study|Death|0|||
33303270|NCT04958642|101003279|FG002|Overall Study|Death|1|||
33303271|NCT04958642|101003277|FG000|Overall Study|Withdrawal by Subject|4|||
33303272|NCT04958642|101003278|FG001|Overall Study|Withdrawal by Subject|9|||
33303273|NCT04958642|101003279|FG002|Overall Study|Withdrawal by Subject|13|||
33303274|NCT04958642|101003277|FG000|Overall Study|Investigator's Decision|0|||
33303275|NCT04958642|101003278|FG001|Overall Study|Investigator's Decision|0|||
33303276|NCT04958642|101003279|FG002|Overall Study|Investigator's Decision|1|||
33303277|NCT04958642|101003277|FG000|Overall Study|Adverse Event|1|||
33303278|NCT04958642|101003278|FG001|Overall Study|Adverse Event|0|||
33303279|NCT04958642|101003279|FG002|Overall Study|Adverse Event|1|||
33303280|NCT04958642|101003277|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
33303281|NCT04958642|101003278|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
33303282|NCT04958642|101003279|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
33303283|NCT04958642|101003277|FG000|Overall Study|Lost to Follow-up|1|||
33303284|NCT04958642|101003278|FG001|Overall Study|Lost to Follow-up|0|||
33303285|NCT04958642|101003279|FG002|Overall Study|Lost to Follow-up|0|||
33303286|NCT04958642|101003277|FG000|Overall Study|Transferred to EAP following study termination|0|||
33303287|NCT04958642|101003278|FG001|Overall Study|Transferred to EAP following study termination|0|||
33303288|NCT04958642|101003279|FG002|Overall Study|Transferred to EAP following study termination|1|||
33303289|NCT04958642|101003277|FG000|Overall Study|Transferred to Expanded Access Program|1|||
33303290|NCT04958642|101003278|FG001|Overall Study|Transferred to Expanded Access Program|0|||
33303291|NCT04958642|101003279|FG002|Overall Study|Transferred to Expanded Access Program|0|||
33303292|NCT01202903|101003280|FG000|Overall Study|Administrative Probelms|1|||
33303293|NCT01202903|101003281|FG001|Overall Study|Administrative Probelms|4|||
33303294|NCT01202903|101003280|FG000|Overall Study|Protocol Violation|0|||
33303295|NCT01202903|101003281|FG001|Overall Study|Protocol Violation|1|||
33303296|NCT01202903|101003280|FG000|Overall Study|Death|1|||
33303297|NCT01202903|101003281|FG001|Overall Study|Death|0|||
33303298|NCT01202903|101003280|FG000|Overall Study|Lost to Follow-up|1|||
33303299|NCT01202903|101003281|FG001|Overall Study|Lost to Follow-up|1|||
33303300|NCT01202903|101003280|FG000|Overall Study|Lack of Efficacy|1|||
33303301|NCT01202903|101003281|FG001|Overall Study|Lack of Efficacy|3|||
33303302|NCT01202903|101003280|FG000|Overall Study|Adverse Event|3|||
33303303|NCT01202903|101003281|FG001|Overall Study|Adverse Event|3|||
33303304|NCT01202903|101003280|FG000|Overall Study|Withdrawal by Subject|4|||
33303305|NCT01202903|101003281|FG001|Overall Study|Withdrawal by Subject|4|||
33303306|NCT04927884|101003282|FG000|Overall Study|Progressive Disease|2|||
33303307|NCT00529958|101003286|FG000|2-Year Follow-up|Lost to Follow-up|1|||
33303308|NCT00529958|101003287|FG001|2-Year Follow-up|Lost to Follow-up|2|||
33303309|NCT00529958|101003288|FG002|2-Year Follow-up|Lost to Follow-up|2|||
33303310|NCT00529958|101003286|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
33303311|NCT00529958|101003287|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
33303312|NCT00529958|101003288|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
33303313|NCT00529958|101003286|FG000|5-Year Follow-up|Lost to Follow-up|2|||
33303314|NCT00529958|101003287|FG001|5-Year Follow-up|Lost to Follow-up|3|||
33303315|NCT00529958|101003288|FG002|5-Year Follow-up|Lost to Follow-up|1|||
33303316|NCT00529958|101003286|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
33303317|NCT00529958|101003287|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
33303318|NCT00529958|101003288|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
33303319|NCT01012414|101003289|FG000|Overall Study|Withdrawal by Subject|2|||
33303320|NCT01012414|101003289|FG000|Overall Study|Lost to Follow-up|1|||
33303321|NCT01012414|101003289|FG000|Overall Study|Trial was stopped before completed|7|||
33303322|NCT01332630|101003293|FG000|Overall Study|Withdrawal by Subject|3|||
33303323|NCT02113124|101007043|FG000|Overall Study|Unable to retrieve blood sample|1|||
33303324|NCT02113124|101007044|FG001|Overall Study|Unable to retrieve blood sample|1|||
33303325|NCT01305200|101007045|FG000|Overall Study|Physician Decision|4|||
33303326|NCT01305200|101007046|FG001|Overall Study|Physician Decision|6|||
33303327|NCT01305200|101007047|FG002|Overall Study|Physician Decision|1|||
33303328|NCT01305200|101007045|FG000|Overall Study|Withdrawal by Subject|24|||
33303329|NCT01305200|101007046|FG001|Overall Study|Withdrawal by Subject|21|||
33303330|NCT01305200|101007047|FG002|Overall Study|Withdrawal by Subject|1|||
33303331|NCT01305200|101007045|FG000|Overall Study|Ineligible|1|||
33303332|NCT01305200|101007046|FG001|Overall Study|Ineligible|2|||
33303333|NCT01305200|101007047|FG002|Overall Study|Ineligible|1|||
33303334|NCT01305200|101007045|FG000|Overall Study|Death|0|||
33303335|NCT01305200|101007046|FG001|Overall Study|Death|2|||
33303336|NCT01305200|101007047|FG002|Overall Study|Death|0|||
33303337|NCT02389452|101007048|FG000|Overall Study|Lost to Follow-up|13|||
33303338|NCT02389452|101007048|FG000|Overall Study|Adverse Event|1|||
33303339|NCT02389452|101007048|FG000|Overall Study|Withdrawal by Subject|5|||
33303340|NCT02389452|101007048|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
33303341|NCT00635427|101007049|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
33303342|NCT00635427|101007050|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
33303343|NCT00635427|101007051|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
33303344|NCT00635427|101007052|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
33303345|NCT00635427|101007053|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
33303346|NCT00635427|101007049|FG000|Overall Study|Death|0|||
33303347|NCT00635427|101007050|FG001|Overall Study|Death|0|||
33303348|NCT00635427|101007051|FG002|Overall Study|Death|0|||
33303349|NCT00635427|101007052|FG003|Overall Study|Death|1|||
33303350|NCT00635427|101007053|FG004|Overall Study|Death|0|||
33303351|NCT00635427|101007049|FG000|Overall Study|Termination Of Study By Sponsor|12|||
33303352|NCT00635427|101007050|FG001|Overall Study|Termination Of Study By Sponsor|6|||
33303353|NCT00635427|101007051|FG002|Overall Study|Termination Of Study By Sponsor|10|||
33303354|NCT00635427|101007052|FG003|Overall Study|Termination Of Study By Sponsor|6|||
33303355|NCT00635427|101007053|FG004|Overall Study|Termination Of Study By Sponsor|6|||
33303356|NCT00635427|101007049|FG000|Overall Study|Withdrawal Of Consent|0|||
33303357|NCT00635427|101007050|FG001|Overall Study|Withdrawal Of Consent|0|||
33303358|NCT00635427|101007051|FG002|Overall Study|Withdrawal Of Consent|0|||
33303359|NCT00635427|101007052|FG003|Overall Study|Withdrawal Of Consent|2|||
33303360|NCT00635427|101007053|FG004|Overall Study|Withdrawal Of Consent|2|||
33303361|NCT05602727|101007057|FG000|Overall Study|Physician Decision|0|||
33303362|NCT05602727|101007058|FG001|Overall Study|Physician Decision|1|||
33303363|NCT05602727|101007059|FG002|Overall Study|Physician Decision|0|||
33303364|NCT05602727|101007057|FG000|Overall Study|Randomized by mistake without study medication|1|||
33303365|NCT05602727|101007058|FG001|Overall Study|Randomized by mistake without study medication|0|||
33303366|NCT05602727|101007059|FG002|Overall Study|Randomized by mistake without study medication|0|||
33303367|NCT05602727|101007057|FG000|Overall Study|Study termination by Sponsor|18|||
33303368|NCT05602727|101007058|FG001|Overall Study|Study termination by Sponsor|15|||
33303369|NCT05602727|101007059|FG002|Overall Study|Study termination by Sponsor|19|||
33303370|NCT05602727|101007057|FG000|Overall Study|Withdrawal by Subject|2|||
33303371|NCT05602727|101007058|FG001|Overall Study|Withdrawal by Subject|1|||
33303372|NCT05602727|101007059|FG002|Overall Study|Withdrawal by Subject|1|||
33303373|NCT05602727|101007057|FG000|Overall Study|Various reasons|1|||
33303374|NCT05602727|101007058|FG001|Overall Study|Various reasons|6|||
33303375|NCT05602727|101007059|FG002|Overall Study|Various reasons|1|||
33303376|NCT01552603|101007064|FG000|Overall Study|Physician Decision|1|||
33303377|NCT05653427|101007065|FG000|Overall Study|Study Terminated by Sponsor|13|||
33303378|NCT00503139|101007066|FG000|Overall Study|Case Report Forms were not collected|4|||
33303379|NCT00503139|101007066|FG000|Overall Study|Protocol Violation|4|||
33303380|NCT01253018|101007067|FG000|Overall Study|Lost to Follow-up|1|||
33303381|NCT01253018|101007068|FG001|Overall Study|Lost to Follow-up|1|||
33303382|NCT01253018|101007067|FG000|Overall Study|Robot Repair Issues|2|||
33303383|NCT01253018|101007068|FG001|Overall Study|Robot Repair Issues|0|||
33303384|NCT01253018|101007067|FG000|Overall Study|Withdrawal by Subject|1|||
33303385|NCT01253018|101007068|FG001|Overall Study|Withdrawal by Subject|1|||
33303386|NCT02180243|101007069|FG000|Overall Study|Withdrawal by Subject|12|||
33303387|NCT02180243|101007070|FG001|Overall Study|Withdrawal by Subject|12|||
33303388|NCT02180243|101007069|FG000|Overall Study|Lost to Follow-up|12|||
33303389|NCT02180243|101007070|FG001|Overall Study|Lost to Follow-up|2|||
33303390|NCT02738853|101007071|FG000|Enrollment|Inclusion/Exclusion not met|21|||
33303391|NCT02738853|101007071|FG000|Enrollment|Withdrawal by Subject|3|||
33303392|NCT02738853|101007071|FG000|Enrollment|Subject treated with commercially available device|6|||
33303393|NCT02738853|101007071|FG000|Enrollment|Study Enrollment Closed|3|||
33303394|NCT02738853|101007071|FG000|Procedure|Death|1|||
33303395|NCT02738853|101007071|FG000|1 Month|Death|2|||
33303396|NCT02738853|101007071|FG000|6 Month|Death|4|||
33303397|NCT02738853|101007071|FG000|6 Month|Withdrawal by Subject|2|||
33303398|NCT02738853|101007071|FG000|1 Year|Death|6|||
33303399|NCT02738853|101007071|FG000|1 Year|Withdrawal by Subject|1|||
33303400|NCT02738853|101007071|FG000|2 Year|Death|2|||
33303401|NCT02738853|101007071|FG000|2 Year|Lost to Follow-up|1|||
33303402|NCT02738853|101007071|FG000|3 Year|Death|2|||
33303403|NCT02738853|101007071|FG000|3 Year|Withdrawal by Subject|1|||
33303404|NCT02738853|101007071|FG000|4 Year|Death|9|||
33303405|NCT02738853|101007071|FG000|5 Year|Lost to Follow-up|4|||
33303406|NCT03333876|101007072|FG000|Screening Period|Screen Failure|4|||
33303407|NCT03333876|101007072|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
33303408|NCT03333876|101007072|FG000|Mandibular Advancement|Adverse Event|2|||
33303409|NCT03333876|101007072|FG000|Mandibular Advancement|Product Damage|2|||
33303410|NCT04165031|101007073|FG000|Overall Study|Adverse Event|1|||
33303411|NCT04165031|101007074|FG001|Overall Study|Adverse Event|1|||
33303412|NCT04165031|101007075|FG002|Overall Study|Adverse Event|0|||
33303413|NCT04165031|101007076|FG003|Overall Study|Adverse Event|0|||
33303414|NCT04165031|101007077|FG004|Overall Study|Adverse Event|0|||
33303415|NCT04165031|101007078|FG005|Overall Study|Adverse Event|0|||
33303416|NCT04165031|101007073|FG000|Overall Study|Withdrawal by Subject|0|||
33303417|NCT04165031|101007074|FG001|Overall Study|Withdrawal by Subject|0|||
33303418|NCT04165031|101007075|FG002|Overall Study|Withdrawal by Subject|1|||
33303419|NCT04165031|101007076|FG003|Overall Study|Withdrawal by Subject|0|||
33303420|NCT04165031|101007077|FG004|Overall Study|Withdrawal by Subject|0|||
33303421|NCT04165031|101007078|FG005|Overall Study|Withdrawal by Subject|0|||
33303422|NCT01373151|101007079|FG000|Period 1|Lack of Efficacy|3|||
33303423|NCT01373151|101007080|FG001|Period 1|Lack of Efficacy|0|||
33303424|NCT01373151|101007081|FG002|Period 1|Lack of Efficacy|0|||
33303425|NCT01373151|101007082|FG003|Period 1|Lack of Efficacy|0|||
33303426|NCT01373151|101007083|FG004|Period 1|Lack of Efficacy|1|||
33303427|NCT01373151|101007084|FG005|Period 1|Lack of Efficacy|0|||
33303428|NCT01373151|101007085|FG006|Period 1|Lack of Efficacy|0|||
33303429|NCT01373151|101007079|FG000|Period 1|Adverse Event|0|||
33303430|NCT01373151|101007080|FG001|Period 1|Adverse Event|0|||
33303431|NCT01373151|101007081|FG002|Period 1|Adverse Event|1|||
33303432|NCT01373151|101007082|FG003|Period 1|Adverse Event|0|||
33303433|NCT01373151|101007083|FG004|Period 1|Adverse Event|4|||
33303434|NCT01373151|101007084|FG005|Period 1|Adverse Event|3|||
33303435|NCT01373151|101007085|FG006|Period 1|Adverse Event|0|||
33303436|NCT01373151|101007079|FG000|Period 1|Withdrawal by Subject|2|||
33303437|NCT01373151|101007080|FG001|Period 1|Withdrawal by Subject|0|||
33303438|NCT01373151|101007081|FG002|Period 1|Withdrawal by Subject|3|||
33303439|NCT01373151|101007082|FG003|Period 1|Withdrawal by Subject|1|||
33303440|NCT01373151|101007083|FG004|Period 1|Withdrawal by Subject|0|||
33303441|NCT01373151|101007084|FG005|Period 1|Withdrawal by Subject|1|||
33303442|NCT01373151|101007085|FG006|Period 1|Withdrawal by Subject|0|||
33303443|NCT01373151|101007079|FG000|Period 2|Lack of Efficacy|9|||
33303444|NCT01373151|101007080|FG001|Period 2|Lack of Efficacy|0|||
33303445|NCT01373151|101007081|FG002|Period 2|Lack of Efficacy|0|||
33303446|NCT01373151|101007082|FG003|Period 2|Lack of Efficacy|1|||
33303447|NCT01373151|101007083|FG004|Period 2|Lack of Efficacy|2|||
33303448|NCT01373151|101007084|FG005|Period 2|Lack of Efficacy|0|||
33303449|NCT01373151|101007085|FG006|Period 2|Lack of Efficacy|3|||
33303450|NCT01373151|101007079|FG000|Period 2|Adverse Event|0|||
33303451|NCT01373151|101007080|FG001|Period 2|Adverse Event|0|||
33303452|NCT01373151|101007081|FG002|Period 2|Adverse Event|3|||
33303453|NCT01373151|101007082|FG003|Period 2|Adverse Event|3|||
33303454|NCT01373151|101007083|FG004|Period 2|Adverse Event|0|||
33303455|NCT01373151|101007084|FG005|Period 2|Adverse Event|0|||
33303456|NCT01373151|101007085|FG006|Period 2|Adverse Event|1|||
33303457|NCT01373151|101007079|FG000|Period 2|subject request to discontinue|0|||
33303458|NCT01373151|101007080|FG001|Period 2|subject request to discontinue|1|||
33303459|NCT01373151|101007081|FG002|Period 2|subject request to discontinue|0|||
33303460|NCT01373151|101007082|FG003|Period 2|subject request to discontinue|0|||
33303461|NCT01373151|101007083|FG004|Period 2|subject request to discontinue|0|||
33303462|NCT01373151|101007084|FG005|Period 2|subject request to discontinue|0|||
33303463|NCT01373151|101007085|FG006|Period 2|subject request to discontinue|0|||
33303464|NCT01373151|101007079|FG000|Period 2|Withdrawal by Subject|0|||
33303465|NCT01373151|101007080|FG001|Period 2|Withdrawal by Subject|0|||
33303466|NCT01373151|101007081|FG002|Period 2|Withdrawal by Subject|0|||
33303467|NCT01373151|101007082|FG003|Period 2|Withdrawal by Subject|1|||
33303468|NCT01373151|101007083|FG004|Period 2|Withdrawal by Subject|0|||
33303469|NCT01373151|101007084|FG005|Period 2|Withdrawal by Subject|0|||
33303470|NCT01373151|101007085|FG006|Period 2|Withdrawal by Subject|0|||
33303471|NCT01373151|101007079|FG000|Period 2|Other|0|||
33303472|NCT01373151|101007080|FG001|Period 2|Other|0|||
33303473|NCT01373151|101007081|FG002|Period 2|Other|1|||
33303474|NCT01373151|101007082|FG003|Period 2|Other|0|||
33303475|NCT01373151|101007083|FG004|Period 2|Other|0|||
33303476|NCT01373151|101007084|FG005|Period 2|Other|0|||
33303477|NCT01373151|101007085|FG006|Period 2|Other|1|||
33303478|NCT04860297|101007086|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
33303479|NCT04860297|101007087|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
33303480|NCT04860297|101007088|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
33303481|NCT04860297|101007089|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
33303482|NCT04860297|101007090|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
33303483|NCT04860297|101007091|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
33303484|NCT04860297|101007092|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
33303485|NCT04860297|101007093|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
33498077|NCT02268916|101717245|FG000|Overall Study|Withdrawal by Subject|6|||
33498078|NCT02268916|101717246|FG001|Overall Study|Withdrawal by Subject|5|||
33303486|NCT04860297|101007086|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
33303487|NCT04860297|101007087|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
33303488|NCT04860297|101007088|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
33303489|NCT04860297|101007089|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
33303490|NCT04860297|101007090|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
33303491|NCT04860297|101007091|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
33303492|NCT04860297|101007092|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
33303493|NCT04860297|101007093|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
33303494|NCT04860297|101007086|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
33303495|NCT04860297|101007087|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
33498079|NCT02268916|101717245|FG000|Overall Study|Participant did not have diabetes|1|||
33303496|NCT04860297|101007088|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
33303497|NCT04860297|101007089|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
33303498|NCT04860297|101007090|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
33303499|NCT04860297|101007091|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
33303500|NCT04860297|101007092|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
33303501|NCT04860297|101007093|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
33303502|NCT04860297|101007086|FG000|Part B (Booster Dose)|Other Than Specified|0|||
33303503|NCT04860297|101007087|FG001|Part B (Booster Dose)|Other Than Specified|0|||
33303504|NCT04860297|101007088|FG002|Part B (Booster Dose)|Other Than Specified|0|||
33303505|NCT04860297|101007089|FG003|Part B (Booster Dose)|Other Than Specified|0|||
33303506|NCT04860297|101007090|FG004|Part B (Booster Dose)|Other Than Specified|0|||
33303507|NCT04860297|101007091|FG005|Part B (Booster Dose)|Other Than Specified|1|||
33303508|NCT04860297|101007092|FG006|Part B (Booster Dose)|Other Than Specified|1|||
33303509|NCT04860297|101007093|FG007|Part B (Booster Dose)|Other Than Specified|0|||
33303510|NCT04860297|101007086|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
33303511|NCT04860297|101007087|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
33303512|NCT04860297|101007088|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
33303513|NCT04860297|101007089|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
33303514|NCT04860297|101007090|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
33303515|NCT04860297|101007091|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
33303516|NCT04860297|101007092|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
33303517|NCT04860297|101007093|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
33303518|NCT04860297|101007086|FG000|Part B (Booster Dose)|Death|0|||
33303519|NCT04860297|101007087|FG001|Part B (Booster Dose)|Death|0|||
33303520|NCT04860297|101007088|FG002|Part B (Booster Dose)|Death|0|||
33303521|NCT04860297|101007089|FG003|Part B (Booster Dose)|Death|0|||
33303522|NCT04860297|101007090|FG004|Part B (Booster Dose)|Death|1|||
33303523|NCT04860297|101007091|FG005|Part B (Booster Dose)|Death|2|||
33303524|NCT04860297|101007092|FG006|Part B (Booster Dose)|Death|1|||
33303525|NCT04860297|101007093|FG007|Part B (Booster Dose)|Death|0|||
33303526|NCT04860297|101007086|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
33303527|NCT04860297|101007087|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
33303528|NCT04860297|101007088|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
33303529|NCT04860297|101007089|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
33303530|NCT04860297|101007090|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
33303531|NCT04860297|101007091|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
33303532|NCT04860297|101007092|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
33303533|NCT04860297|101007093|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
33303534|NCT01008410|101007094|FG000|Overall Study|Adverse Event|13|||
33303535|NCT01008410|101007095|FG001|Overall Study|Adverse Event|7|||
33303536|NCT01008410|101007094|FG000|Overall Study|Withdrawal by Subject|6|||
33303537|NCT01008410|101007095|FG001|Overall Study|Withdrawal by Subject|2|||
33303538|NCT01008410|101007094|FG000|Overall Study|Lost to Follow-up|1|||
33303539|NCT01008410|101007095|FG001|Overall Study|Lost to Follow-up|0|||
33303540|NCT01008410|101007094|FG000|Overall Study|Noncompliance|1|||
33303541|NCT01008410|101007095|FG001|Overall Study|Noncompliance|0|||
33303542|NCT01008410|101007094|FG000|Overall Study|Low Cortisol|2|||
33303543|NCT01008410|101007095|FG001|Overall Study|Low Cortisol|0|||
33303544|NCT01008410|101007094|FG000|Overall Study|Lack of Efficacy|2|||
33303545|NCT01008410|101007095|FG001|Overall Study|Lack of Efficacy|6|||
33303546|NCT01008410|101007094|FG000|Overall Study|Met Exclusion Criterion|0|||
33303547|NCT01008410|101007095|FG001|Overall Study|Met Exclusion Criterion|1|||
33303548|NCT00886795|101007096|FG000|Overall Study|Lack of Efficacy|1|||
33303549|NCT03181789|101007097|FG000|Overall Study|Withdrawal by Subject|0|||
33303550|NCT03181789|101007098|FG001|Overall Study|Withdrawal by Subject|1|||
33303551|NCT03181789|101007099|FG002|Overall Study|Withdrawal by Subject|1|||
33303552|NCT03181789|101007100|FG003|Overall Study|Withdrawal by Subject|0|||
33303553|NCT03181789|101007097|FG000|Overall Study|Lost to Follow-up|7|||
33303554|NCT03181789|101007098|FG001|Overall Study|Lost to Follow-up|1|||
33303555|NCT03181789|101007099|FG002|Overall Study|Lost to Follow-up|0|||
33303556|NCT03181789|101007100|FG003|Overall Study|Lost to Follow-up|0|||
33303557|NCT03181789|101007097|FG000|Overall Study|Participant unable to adhere to visit|0|||
33303558|NCT03181789|101007098|FG001|Overall Study|Participant unable to adhere to visit|1|||
33303559|NCT03181789|101007099|FG002|Overall Study|Participant unable to adhere to visit|0|||
33303560|NCT03181789|101007100|FG003|Overall Study|Participant unable to adhere to visit|0|||
33303561|NCT02019667|101007101|FG000|First Intervention (6 Months)|Adverse Event|0|||
33303562|NCT02019667|101007102|FG001|First Intervention (6 Months)|Adverse Event|1|||
33303563|NCT02019667|101007101|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
33303564|NCT02019667|101007102|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
33303565|NCT02019667|101007101|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
33303566|NCT02019667|101007102|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
33303567|NCT03525392|101007103|FG000|Overall Study|Adverse Event|1|||
33303568|NCT03525392|101007104|FG001|Overall Study|Adverse Event|0|||
33303569|NCT03525392|101007105|FG002|Overall Study|Adverse Event|2|||
33303570|NCT03525392|101007106|FG003|Overall Study|Adverse Event|0|||
33303571|NCT03525392|101007107|FG004|Overall Study|Adverse Event|0|||
33303572|NCT03525392|101007103|FG000|Overall Study|Progressive disease|0|||
33303573|NCT03525392|101007104|FG001|Overall Study|Progressive disease|1|||
33303574|NCT03525392|101007105|FG002|Overall Study|Progressive disease|1|||
33303575|NCT03525392|101007106|FG003|Overall Study|Progressive disease|3|||
33303576|NCT03525392|101007107|FG004|Overall Study|Progressive disease|1|||
33303577|NCT00591851|101007108|FG000|Overall Study|Withdrawal by Subject|3|||
33303578|NCT00591851|101007108|FG000|Overall Study|Adverse Event|2|||
33303579|NCT00591851|101007108|FG000|Overall Study|Progressive Disease|1|||
33303580|NCT00548262|101007109|FG000|Overall Study|Death|21|||
33303581|NCT00548262|101007109|FG000|Overall Study|Adverse Event|2|||
33303582|NCT00548262|101007109|FG000|Overall Study|Lack of Efficacy|4|||
33303583|NCT00548262|101007109|FG000|Overall Study|Lost to Follow-up|1|||
33303584|NCT00548262|101007109|FG000|Overall Study|Other|3|||
33303585|NCT00548262|101007109|FG000|Overall Study|Withdrawal by Subject|1|||
33303586|NCT02124811|101007110|FG000|Overall Study|Early termination|2|||
33303587|NCT02124811|101007111|FG001|Overall Study|Early termination|2|||
33190574|NCT01481116|100604933|FG000|Overall Study|Investigator's Discretion|2|||
33190575|NCT01481116|100604934|FG001|Overall Study|Investigator's Discretion|0|||
33303588|NCT02124811|101007110|FG000|Overall Study|Withdrawal by Subject|1|||
33303589|NCT02124811|101007111|FG001|Overall Study|Withdrawal by Subject|0|||
33303590|NCT01327495|101007112|FG000|Overall Study|Adverse Event|2|||
33303591|NCT01327495|101007113|FG001|Overall Study|Adverse Event|1|||
33303592|NCT01327495|101007114|FG002|Overall Study|Adverse Event|1|||
33303593|NCT01327495|101007115|FG003|Overall Study|Adverse Event|0|||
33303594|NCT01327495|101007116|FG004|Overall Study|Adverse Event|0|||
33303595|NCT01327495|101007117|FG005|Overall Study|Adverse Event|2|||
33303596|NCT01327495|101007112|FG000|Overall Study|Withdrawal by Subject|0|||
33303597|NCT01327495|101007113|FG001|Overall Study|Withdrawal by Subject|1|||
33303598|NCT01327495|101007114|FG002|Overall Study|Withdrawal by Subject|1|||
33303599|NCT01327495|101007115|FG003|Overall Study|Withdrawal by Subject|0|||
33303600|NCT01327495|101007116|FG004|Overall Study|Withdrawal by Subject|1|||
33303601|NCT01327495|101007117|FG005|Overall Study|Withdrawal by Subject|0|||
33303602|NCT01327495|101007112|FG000|Overall Study|Physician Decision|0|||
33303603|NCT01327495|101007113|FG001|Overall Study|Physician Decision|0|||
33303604|NCT01327495|101007114|FG002|Overall Study|Physician Decision|0|||
33303605|NCT01327495|101007115|FG003|Overall Study|Physician Decision|0|||
33303606|NCT01327495|101007116|FG004|Overall Study|Physician Decision|2|||
33303607|NCT01327495|101007117|FG005|Overall Study|Physician Decision|0|||
33303608|NCT02755818|101007120|FG000|Overall Study|Withdrawal by Subject|0|||
33303609|NCT02755818|101007121|FG001|Overall Study|Withdrawal by Subject|0|||
33303610|NCT02755818|101007122|FG002|Overall Study|Withdrawal by Subject|0|||
33303611|NCT02755818|101007123|FG003|Overall Study|Withdrawal by Subject|2|||
33303612|NCT02755818|101007120|FG000|Overall Study|withdrawal by PI|0|||
33303613|NCT02755818|101007121|FG001|Overall Study|withdrawal by PI|0|||
33303614|NCT02755818|101007122|FG002|Overall Study|withdrawal by PI|1|||
33303615|NCT02755818|101007123|FG003|Overall Study|withdrawal by PI|1|||
33303616|NCT02544451|101007125|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
33303617|NCT02544451|101007126|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
33303618|NCT02544451|101007127|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
33600380|NCT01688739|102088649|FG009|Overall Study|Administrative Decision|0|||
33303619|NCT02544451|101007128|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
33303620|NCT02544451|101007125|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
33600381|NCT03421743|102088655|FG000|Overall Study|Lack of Efficacy|1|||
33600382|NCT03421743|102088656|FG001|Overall Study|Lack of Efficacy|0|||
33600383|NCT03421743|102088655|FG000|Overall Study|Adverse Event|2|||
33600384|NCT03421743|102088656|FG001|Overall Study|Adverse Event|1|||
33600385|NCT03421743|102088655|FG000|Overall Study|Withdrawal by Subject|0|||
33600386|NCT03421743|102088656|FG001|Overall Study|Withdrawal by Subject|1|||
33600387|NCT04021524|102088663|FG000|Overall Study|Change in surgical intervention|0|||
33600388|NCT04021524|102088664|FG001|Overall Study|Change in surgical intervention|1|||
33600389|NCT00810901|102088665|FG000|Overall Study|Lost to Follow-up|88|||
33600390|NCT00810901|102088666|FG001|Overall Study|Lost to Follow-up|58|||
33600391|NCT03541187|102088672|FG000|Overall Study|Lost to Follow-up|2|||
33190576|NCT01481116|100604935|FG002|Overall Study|Investigator's Discretion|0|||
33303621|NCT02544451|101007126|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
33303622|NCT02544451|101007127|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
33600392|NCT03541187|102088673|FG001|Overall Study|Lost to Follow-up|6|||
33303623|NCT02544451|101007128|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
33498080|NCT02268916|101717246|FG001|Overall Study|Participant did not have diabetes|0|||
33498081|NCT02268916|101717245|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
33498082|NCT02268916|101717246|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
33498083|NCT01790984|101717251|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
33498084|NCT01790984|101717252|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
33498085|NCT01790984|101717253|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
33498086|NCT01790984|101717254|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
33498087|NCT02859337|101717257|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
33303624|NCT02544451|101007125|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
33303625|NCT02544451|101007126|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
33303626|NCT02544451|101007127|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
33498088|NCT02859337|101717258|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
33498089|NCT02859337|101717259|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
33498090|NCT02859337|101717257|FG000|Overall Study|Withdrawal by Subject|3|||
33190577|NCT01481116|100604933|FG000|Overall Study|Death|2|||
33303627|NCT02544451|101007128|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
33303628|NCT02544451|101007125|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
33303629|NCT02544451|101007126|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
33303630|NCT02544451|101007127|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
33303631|NCT02544451|101007128|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
33303632|NCT02544451|101007125|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
33303633|NCT02544451|101007126|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
33303634|NCT02544451|101007127|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
33303635|NCT02544451|101007128|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
33498091|NCT02859337|101717258|FG001|Overall Study|Withdrawal by Subject|1|||
33600393|NCT03541187|102088672|FG000|Overall Study|Pregnancy|0|||
33190578|NCT01481116|100604934|FG001|Overall Study|Death|1|||
33190579|NCT01481116|100604935|FG002|Overall Study|Death|0|||
33190580|NCT01481116|100604933|FG000|Overall Study|Hypoglycemic Event|4|||
33190581|NCT01481116|100604934|FG001|Overall Study|Hypoglycemic Event|0|||
33190582|NCT01481116|100604935|FG002|Overall Study|Hypoglycemic Event|0|||
33190583|NCT00706966|100604940|FG000|Overall Study|Adverse Event|1|||
33190584|NCT03139916|100604941|FG000|Overall Study|Withdrawal by Subject|2|||
33190585|NCT03139916|100604941|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
33190586|NCT00958776|100604942|FG000|Overall Study|Adverse Event|0|||
33190587|NCT00958776|100604943|FG001|Overall Study|Adverse Event|1|||
33190588|NCT00958776|100604942|FG000|Overall Study|Physician Decision|1|||
33190589|NCT00958776|100604943|FG001|Overall Study|Physician Decision|0|||
33190590|NCT00958776|100604942|FG000|Overall Study|Lost to Follow-up|2|||
33190591|NCT00958776|100604943|FG001|Overall Study|Lost to Follow-up|6|||
33303636|NCT02544451|101007125|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
33303637|NCT02544451|101007126|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
33303638|NCT02544451|101007127|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
33600394|NCT03541187|102088673|FG001|Overall Study|Pregnancy|1|||
33600395|NCT03541187|102088672|FG000|Overall Study|Withdrawal by Subject|6|||
33190592|NCT00958776|100604942|FG000|Overall Study|Withdrawal by Subject|7|||
33190593|NCT00958776|100604943|FG001|Overall Study|Withdrawal by Subject|16|||
33303639|NCT02544451|101007128|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
33303640|NCT01631227|101007134|FG000|Overall Study|withdrawn consent|27|||
33303641|NCT01631227|101007135|FG001|Overall Study|withdrawn consent|21|||
33303642|NCT01631227|101007134|FG000|Overall Study|Adverse Event|1|||
33303643|NCT01631227|101007135|FG001|Overall Study|Adverse Event|0|||
33303644|NCT01631227|101007134|FG000|Overall Study|administrative|2|||
33303645|NCT01631227|101007135|FG001|Overall Study|administrative|1|||
33303646|NCT02285153|101007137|FG000|Overall Study|Adverse Event|1|||
33303647|NCT02285153|101007138|FG001|Overall Study|Adverse Event|0|||
33303648|NCT01283516|101007139|FG000|Overall Study|Adverse Event|0|||
33303649|NCT01283516|101007140|FG001|Overall Study|Adverse Event|0|||
33303650|NCT01283516|101007141|FG002|Overall Study|Adverse Event|0|||
33303651|NCT01283516|101007142|FG003|Overall Study|Adverse Event|0|||
33303652|NCT01283516|101007143|FG004|Overall Study|Adverse Event|0|||
33303653|NCT01283516|101007144|FG005|Overall Study|Adverse Event|0|||
33303654|NCT01283516|101007145|FG006|Overall Study|Adverse Event|2|||
33303655|NCT01283516|101007146|FG007|Overall Study|Adverse Event|0|||
33190594|NCT00958776|100604942|FG000|Overall Study|Protocol Violation|1|||
33303656|NCT01283516|101007147|FG008|Overall Study|Adverse Event|28|||
33303657|NCT01283516|101007139|FG000|Overall Study|Death|0|||
33303658|NCT01283516|101007140|FG001|Overall Study|Death|0|||
33303659|NCT01283516|101007141|FG002|Overall Study|Death|0|||
33303660|NCT01283516|101007142|FG003|Overall Study|Death|0|||
33303661|NCT01283516|101007143|FG004|Overall Study|Death|0|||
33303662|NCT01283516|101007144|FG005|Overall Study|Death|1|||
33303663|NCT01283516|101007145|FG006|Overall Study|Death|0|||
33303664|NCT01283516|101007146|FG007|Overall Study|Death|1|||
33303665|NCT01283516|101007147|FG008|Overall Study|Death|12|||
33303666|NCT01283516|101007139|FG000|Overall Study|Disease Progression|2|||
33393622|NCT03073200|101328516|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
33498092|NCT02859337|101717259|FG002|Overall Study|Withdrawal by Subject|0|||
33498093|NCT02859337|101717257|FG000|Overall Study|Lost to Follow-up|1|||
33498094|NCT02859337|101717258|FG001|Overall Study|Lost to Follow-up|0|||
33498095|NCT02859337|101717259|FG002|Overall Study|Lost to Follow-up|0|||
33498096|NCT01074268|101717262|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
33498097|NCT01074268|101717263|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
33498098|NCT01074268|101717262|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
33600396|NCT03541187|102088673|FG001|Overall Study|Withdrawal by Subject|2|||
33600397|NCT03541187|102088672|FG000|Overall Study|Moved out of town|1|||
33600398|NCT03541187|102088673|FG001|Overall Study|Moved out of town|0|||
33600399|NCT03541187|102088672|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
33600400|NCT03541187|102088673|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
33600401|NCT03541187|102088672|FG000|Overall Study|Did not meet randomization criteria|1|||
33600402|NCT03541187|102088673|FG001|Overall Study|Did not meet randomization criteria|1|||
33600403|NCT03541187|102088672|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
33600404|NCT03541187|102088673|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
33600405|NCT03541187|102088672|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
33600406|NCT03541187|102088673|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
33600407|NCT00661388|102088674|FG000|Overall Study|Adverse Event|14|||
33600408|NCT00661388|102088674|FG000|Overall Study|Protocol Violation|7|||
33600409|NCT00661388|102088674|FG000|Overall Study|Renal transplantation|1|||
33600410|NCT00661388|102088674|FG000|Overall Study|Dialysis initiation|1|||
33600411|NCT00661388|102088674|FG000|Overall Study|Administrative reasons|1|||
33600412|NCT04258995|102088675|FG000|Overall Study|Lost to Follow-up|1|||
33600413|NCT04258995|102088676|FG001|Overall Study|Lost to Follow-up|1|||
33600414|NCT00746733|102088680|FG000|Second Intervention|Adverse Event|1|||
33600415|NCT00746733|102088681|FG001|Second Intervention|Adverse Event|0|||
33600416|NCT00746733|102088680|FG000|Third Intervention|Withdrawal by Subject|1|||
33393623|NCT03073200|101328517|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
33393624|NCT03073200|101328518|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
33393625|NCT03073200|101328519|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
33393626|NCT03073200|101328520|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
33393627|NCT03073200|101328521|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
33393628|NCT03073200|101328522|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
33393629|NCT03073200|101328523|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
33393630|NCT03073200|101328524|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
33393631|NCT03073200|101328525|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
33393632|NCT03073200|101328511|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33393633|NCT03073200|101328512|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33393634|NCT03073200|101328513|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33393635|NCT03073200|101328514|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
33393636|NCT03073200|101328515|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
33393637|NCT03073200|101328516|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33393638|NCT03073200|101328517|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33393639|NCT03073200|101328518|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33393640|NCT03073200|101328519|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33393641|NCT03073200|101328520|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33393642|NCT03073200|101328521|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33393643|NCT03073200|101328522|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33393644|NCT03073200|101328523|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33393645|NCT03073200|101328524|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33393646|NCT03073200|101328525|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
33393647|NCT03073200|101328511|FG000|Extension Period|Lost to Follow-up|0|||
33393648|NCT03073200|101328512|FG001|Extension Period|Lost to Follow-up|0|||
33393649|NCT03073200|101328513|FG002|Extension Period|Lost to Follow-up|0|||
33600417|NCT00746733|102088681|FG001|Third Intervention|Withdrawal by Subject|1|||
33600418|NCT04135859|102088682|FG000|Overall Study|Withdrawal by Subject|1|||
33303667|NCT01283516|101007140|FG001|Overall Study|Disease Progression|2|||
33498099|NCT01074268|101717263|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
33498100|NCT01074268|101717262|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
33498101|NCT01074268|101717263|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
33498102|NCT01074268|101717262|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
33498103|NCT01074268|101717263|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
33498104|NCT01074268|101717262|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
33498105|NCT01074268|101717263|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
33498106|NCT01074268|101717262|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
33498107|NCT01074268|101717263|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
33498108|NCT01074268|101717262|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
33498109|NCT01074268|101717263|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
33498110|NCT01074268|101717262|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
33498111|NCT01074268|101717263|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
33498112|NCT01074268|101717262|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
33498113|NCT01074268|101717263|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
33498114|NCT00915018|101717266|FG000|Overall Study|Death|75|||
33498115|NCT00915018|101717267|FG001|Overall Study|Death|70|||
33498116|NCT00915018|101717266|FG000|Overall Study|Lost to Follow-up|10|||
33498117|NCT00915018|101717267|FG001|Overall Study|Lost to Follow-up|5|||
33498118|NCT00915018|101717266|FG000|Overall Study|Withdrawal by Subject|38|||
33600419|NCT04135859|102088683|FG001|Overall Study|Withdrawal by Subject|0|||
33600420|NCT04135859|102088682|FG000|Overall Study|Withdrawal due to screening failure|1|||
33600421|NCT04135859|102088683|FG001|Overall Study|Withdrawal due to screening failure|2|||
33600422|NCT04135859|102088682|FG000|Overall Study|Did not complete stress test|3|||
33600423|NCT04135859|102088683|FG001|Overall Study|Did not complete stress test|3|||
33600424|NCT04135859|102088682|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
33600425|NCT04135859|102088683|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
33600426|NCT04676867|102088685|FG000|Overall Study|Screen failure|0|||
33600427|NCT04676867|102088686|FG001|Overall Study|Screen failure|0|||
33600428|NCT04676867|102088687|FG002|Overall Study|Screen failure|6|||
33600429|NCT04676867|102088688|FG003|Overall Study|Screen failure|2|||
33600430|NCT04676867|102088685|FG000|Overall Study|Death|0|||
33600431|NCT04676867|102088686|FG001|Overall Study|Death|0|||
33600432|NCT04676867|102088687|FG002|Overall Study|Death|1|||
33600433|NCT04676867|102088688|FG003|Overall Study|Death|0|||
33600434|NCT04676867|102088685|FG000|Overall Study|Withdrawal by Subject|2|||
33600435|NCT04676867|102088686|FG001|Overall Study|Withdrawal by Subject|2|||
33600436|NCT04676867|102088687|FG002|Overall Study|Withdrawal by Subject|4|||
33600437|NCT04676867|102088688|FG003|Overall Study|Withdrawal by Subject|4|||
33600438|NCT04676867|102088685|FG000|Overall Study|Lost to Follow-up|1|||
33600439|NCT04676867|102088686|FG001|Overall Study|Lost to Follow-up|0|||
33600440|NCT04676867|102088687|FG002|Overall Study|Lost to Follow-up|0|||
33600441|NCT04676867|102088688|FG003|Overall Study|Lost to Follow-up|0|||
33600442|NCT03602885|102088692|FG000|Overall Study|Lost to Follow-up|3|||
33600443|NCT03602885|102088693|FG001|Overall Study|Lost to Follow-up|0|||
33600444|NCT01998893|102088694|FG000|Overall Study|Adverse Event|2|||
33600445|NCT01998893|102088694|FG000|Overall Study|Death|1|||
33600446|NCT01998893|102088694|FG000|Overall Study|Lost to Follow-up|8|||
33600447|NCT01998893|102088694|FG000|Overall Study|Physician Decision|2|||
33600448|NCT01998893|102088694|FG000|Overall Study|Protocol Violation|2|||
33600449|NCT01998893|102088694|FG000|Overall Study|Withdrawal by Subject|1|||
33600450|NCT01998893|102088694|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
33600451|NCT02485925|102088695|FG000|Overall Study|Withdrawal by Subject|3|||
33600452|NCT02485925|102088695|FG000|Overall Study|Death|1|||
33600453|NCT02485925|102088695|FG000|Overall Study|Lost to Follow-up|11|||
33600454|NCT01974752|102088696|FG000|Overall Study|Death|33|||
33600455|NCT01974752|102088697|FG001|Overall Study|Death|11|||
33600456|NCT01974752|102088696|FG000|Overall Study|Lost to Follow-up|2|||
33600457|NCT01974752|102088697|FG001|Overall Study|Lost to Follow-up|0|||
33600458|NCT01974752|102088696|FG000|Overall Study|Withdrawal by Subject|2|||
33600459|NCT01974752|102088697|FG001|Overall Study|Withdrawal by Subject|3|||
33600460|NCT01974752|102088696|FG000|Overall Study|Other Eligibility Criteria|0|||
33600461|NCT01974752|102088697|FG001|Overall Study|Other Eligibility Criteria|1|||
33600462|NCT03464422|102088698|FG000|Overall Study|Lost to Follow-up|2|||
33600463|NCT03464422|102088698|FG000|Overall Study|Withdrawal by Subject|2|||
33600464|NCT00364533|102088699|FG000|Overall Study|Adverse Event|8|||
33600465|NCT00364533|102088700|FG001|Overall Study|Adverse Event|7|||
33600466|NCT00364533|102088701|FG002|Overall Study|Adverse Event|15|||
33600467|NCT00364533|102088702|FG003|Overall Study|Adverse Event|5|||
33600468|NCT00364533|102088703|FG004|Overall Study|Adverse Event|2|||
33600469|NCT00364533|102088699|FG000|Overall Study|Withdrawal by Subject|4|||
33600470|NCT00364533|102088700|FG001|Overall Study|Withdrawal by Subject|8|||
33600471|NCT00364533|102088701|FG002|Overall Study|Withdrawal by Subject|6|||
33600472|NCT00364533|102088702|FG003|Overall Study|Withdrawal by Subject|6|||
33600473|NCT00364533|102088703|FG004|Overall Study|Withdrawal by Subject|6|||
33498119|NCT00915018|101717267|FG001|Overall Study|Withdrawal by Subject|27|||
33498120|NCT00915018|101717266|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
33498121|NCT00915018|101717267|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
33498122|NCT00733421|101717276|FG000|Overall Study|Withdrawal by Subject|1|||
33498123|NCT00733421|101717277|FG001|Overall Study|Withdrawal by Subject|1|||
33498124|NCT01671007|101717278|FG000|Overall Study|Other reasons than listed|166|||
33498125|NCT01671007|101717279|FG001|Overall Study|Other reasons than listed|373|||
33498126|NCT01671007|101717280|FG002|Overall Study|Other reasons than listed|197|||
33190595|NCT00958776|100604943|FG001|Overall Study|Protocol Violation|1|||
33190596|NCT00958776|100604942|FG000|Overall Study|Death|2|||
33190597|NCT00958776|100604943|FG001|Overall Study|Death|1|||
33190598|NCT00958776|100604942|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
33498127|NCT01671007|101717281|FG003|Overall Study|Other reasons than listed|228|||
33498128|NCT01671007|101717282|FG004|Overall Study|Other reasons than listed|14|||
33498129|NCT01671007|101717283|FG005|Overall Study|Other reasons than listed|71|||
33498130|NCT01671007|101717284|FG006|Overall Study|Other reasons than listed|17|||
33190599|NCT00958776|100604943|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
33190600|NCT00958776|100604942|FG000|Overall Study|Missing|1|||
33190601|NCT00958776|100604943|FG001|Overall Study|Missing|1|||
33498131|NCT01671007|101717285|FG007|Overall Study|Other reasons than listed|66|||
33190602|NCT01559311|100604946|FG000|Overall Study|Protocol Violation|0|||
33190603|NCT01559311|100604947|FG001|Overall Study|Protocol Violation|0|||
33190604|NCT01559311|100604948|FG002|Overall Study|Protocol Violation|2|||
33190605|NCT01559311|100604946|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
33190606|NCT01559311|100604947|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
33190607|NCT01559311|100604948|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
33190608|NCT01559311|100604946|FG000|Overall Study|Withdrawal by Subject|2|||
33190609|NCT01559311|100604947|FG001|Overall Study|Withdrawal by Subject|1|||
33190610|NCT01559311|100604948|FG002|Overall Study|Withdrawal by Subject|0|||
33190611|NCT01559311|100604946|FG000|Overall Study|Death|0|||
33190612|NCT01559311|100604947|FG001|Overall Study|Death|2|||
33190613|NCT01559311|100604948|FG002|Overall Study|Death|3|||
33190614|NCT01559311|100604946|FG000|Overall Study|Lost to Follow-up|0|||
33190615|NCT01559311|100604947|FG001|Overall Study|Lost to Follow-up|3|||
33190616|NCT01559311|100604948|FG002|Overall Study|Lost to Follow-up|2|||
33190617|NCT01559311|100604946|FG000|Overall Study|Adverse Event|0|||
33190618|NCT01559311|100604947|FG001|Overall Study|Adverse Event|0|||
33600474|NCT00364533|102088699|FG000|Overall Study|Lack of Efficacy|22|||
33600475|NCT00364533|102088700|FG001|Overall Study|Lack of Efficacy|22|||
33600476|NCT00364533|102088701|FG002|Overall Study|Lack of Efficacy|21|||
33600477|NCT00364533|102088702|FG003|Overall Study|Lack of Efficacy|17|||
33600478|NCT00364533|102088703|FG004|Overall Study|Lack of Efficacy|42|||
33600479|NCT00364533|102088699|FG000|Overall Study|Subject discharged from hospital|4|||
33600480|NCT00364533|102088700|FG001|Overall Study|Subject discharged from hospital|1|||
33600481|NCT00364533|102088701|FG002|Overall Study|Subject discharged from hospital|2|||
33600482|NCT00364533|102088702|FG003|Overall Study|Subject discharged from hospital|3|||
33600483|NCT00364533|102088703|FG004|Overall Study|Subject discharged from hospital|1|||
33600484|NCT00364533|102088699|FG000|Overall Study|Variations in drug compliance|2|||
33600485|NCT00364533|102088700|FG001|Overall Study|Variations in drug compliance|1|||
33190619|NCT01559311|100604948|FG002|Overall Study|Adverse Event|1|||
33190620|NCT01302392|100604949|FG000|Overall Study|Lost to Follow-up|1|||
33190621|NCT01302392|100604950|FG001|Overall Study|Lost to Follow-up|0|||
33190622|NCT01302392|100604949|FG000|Overall Study|Withdrawal by Subject|6|||
33190623|NCT01302392|100604950|FG001|Overall Study|Withdrawal by Subject|1|||
33190624|NCT01940120|100604951|FG000|Overall Study|Death|40|||
33190625|NCT01940120|100604951|FG000|Overall Study|Withdrawal by Subject|8|||
33190626|NCT00833924|100604952|FG000|Overall Study|Death|21|||
33190627|NCT00833924|100604952|FG000|Overall Study|Conversion|2|||
33190628|NCT00833924|100604952|FG000|Overall Study|Lost to Follow-up|2|||
33190629|NCT00833924|100604952|FG000|Overall Study|Withdrawal by Subject|13|||
33190630|NCT00833924|100604952|FG000|Overall Study|In study follow-up|71|||
33498132|NCT01671007|101717286|FG008|Overall Study|Other reasons than listed|0|||
33498133|NCT01671007|101717278|FG000|Overall Study|Withdrawal by Subject|36|||
33498134|NCT01671007|101717279|FG001|Overall Study|Withdrawal by Subject|59|||
33498135|NCT01671007|101717280|FG002|Overall Study|Withdrawal by Subject|53|||
33498136|NCT01671007|101717281|FG003|Overall Study|Withdrawal by Subject|58|||
33498137|NCT01671007|101717282|FG004|Overall Study|Withdrawal by Subject|4|||
33498138|NCT01671007|101717283|FG005|Overall Study|Withdrawal by Subject|15|||
33498139|NCT01671007|101717284|FG006|Overall Study|Withdrawal by Subject|1|||
33498140|NCT01671007|101717285|FG007|Overall Study|Withdrawal by Subject|19|||
33498141|NCT01671007|101717286|FG008|Overall Study|Withdrawal by Subject|0|||
33498142|NCT01671007|101717278|FG000|Overall Study|Lost to Follow-up|93|||
33498143|NCT01671007|101717279|FG001|Overall Study|Lost to Follow-up|142|||
33498144|NCT01671007|101717280|FG002|Overall Study|Lost to Follow-up|91|||
33498145|NCT01671007|101717281|FG003|Overall Study|Lost to Follow-up|63|||
33498146|NCT01671007|101717282|FG004|Overall Study|Lost to Follow-up|7|||
33190631|NCT01828034|100604957|FG000|Overall Study|Withdrawal by Subject|0|||
33190632|NCT01828034|100604958|FG001|Overall Study|Withdrawal by Subject|0|||
33190633|NCT01828034|100604959|FG002|Overall Study|Withdrawal by Subject|0|||
33190634|NCT01828034|100604960|FG003|Overall Study|Withdrawal by Subject|1|||
33190635|NCT00670228|100604961|FG000|Overall Study|Adverse Event|1|||
33190636|NCT00670228|100604962|FG001|Overall Study|Adverse Event|0|||
33190637|NCT00670228|100604961|FG000|Overall Study|Death or MACE|0|||
33190638|NCT00670228|100604962|FG001|Overall Study|Death or MACE|1|||
33498147|NCT01671007|101717283|FG005|Overall Study|Lost to Follow-up|20|||
33498148|NCT01671007|101717284|FG006|Overall Study|Lost to Follow-up|2|||
33498149|NCT01671007|101717285|FG007|Overall Study|Lost to Follow-up|28|||
33498150|NCT01671007|101717286|FG008|Overall Study|Lost to Follow-up|0|||
33498151|NCT01671007|101717278|FG000|Overall Study|No end of study case report form|3|||
33498152|NCT01671007|101717279|FG001|Overall Study|No end of study case report form|1|||
33498153|NCT01671007|101717280|FG002|Overall Study|No end of study case report form|0|||
33190639|NCT00670228|100604961|FG000|Overall Study|Not treated|2|||
33190640|NCT00670228|100604962|FG001|Overall Study|Not treated|2|||
33190641|NCT00670228|100604961|FG000|Overall Study|Not meeting the selection criteria|2|||
33190642|NCT00670228|100604962|FG001|Overall Study|Not meeting the selection criteria|0|||
33498154|NCT01671007|101717281|FG003|Overall Study|No end of study case report form|2|||
33190643|NCT01541826|100604963|FG000|Overall Study|Lost to Follow-up|2|||
33190644|NCT01541826|100604964|FG001|Overall Study|Lost to Follow-up|3|||
33190645|NCT01541826|100604965|FG002|Overall Study|Lost to Follow-up|0|||
33190646|NCT01541826|100604963|FG000|Overall Study|Withdrawal by Subject|2|||
33190647|NCT01541826|100604964|FG001|Overall Study|Withdrawal by Subject|0|||
33190648|NCT01541826|100604965|FG002|Overall Study|Withdrawal by Subject|0|||
33190649|NCT04399161|100604966|FG000|Overall Study|Withdrawal by Subject|1|||
33190650|NCT04399161|100604967|FG001|Overall Study|Withdrawal by Subject|0|||
33190651|NCT04399161|100604968|FG002|Overall Study|Withdrawal by Subject|2|||
33190652|NCT04399161|100604966|FG000|Overall Study|Protocol Violation|1|||
33190653|NCT04399161|100604967|FG001|Overall Study|Protocol Violation|2|||
33190654|NCT04399161|100604968|FG002|Overall Study|Protocol Violation|0|||
33190655|NCT02075320|100604969|FG000|Overall Study|Withdrawal by Subject|2|||
33190656|NCT01485861|100604970|FG000|Phase Ib|Death|1|||
33190657|NCT01485861|100604971|FG001|Phase Ib|Death|0|||
33190658|NCT01485861|100604972|FG002|Phase Ib|Death|0|||
33190659|NCT01485861|100604973|FG003|Phase Ib|Death|0|||
33190660|NCT01485861|100604974|FG004|Phase Ib|Death|0|||
33190661|NCT01485861|100604975|FG005|Phase Ib|Death|0|||
33190662|NCT01485861|100604970|FG000|Phase Ib|Physician Decision|1|||
33190663|NCT01485861|100604971|FG001|Phase Ib|Physician Decision|1|||
33190664|NCT01485861|100604972|FG002|Phase Ib|Physician Decision|0|||
33190665|NCT01485861|100604973|FG003|Phase Ib|Physician Decision|0|||
33190666|NCT01485861|100604974|FG004|Phase Ib|Physician Decision|0|||
33190667|NCT01485861|100604975|FG005|Phase Ib|Physician Decision|0|||
33190668|NCT01485861|100604970|FG000|Phase Ib|Adverse Event|0|||
33190669|NCT01485861|100604971|FG001|Phase Ib|Adverse Event|4|||
33190670|NCT01485861|100604972|FG002|Phase Ib|Adverse Event|0|||
33190671|NCT01485861|100604973|FG003|Phase Ib|Adverse Event|0|||
33498155|NCT01671007|101717282|FG004|Overall Study|No end of study case report form|0|||
33498156|NCT01671007|101717283|FG005|Overall Study|No end of study case report form|0|||
33498157|NCT01671007|101717284|FG006|Overall Study|No end of study case report form|0|||
33498158|NCT01671007|101717285|FG007|Overall Study|No end of study case report form|0|||
33498159|NCT01671007|101717286|FG008|Overall Study|No end of study case report form|0|||
33190672|NCT01485861|100604974|FG004|Phase Ib|Adverse Event|0|||
33190673|NCT01485861|100604975|FG005|Phase Ib|Adverse Event|0|||
33190674|NCT01485861|100604970|FG000|Phase Ib|Progression of disease|5|||
33190675|NCT01485861|100604971|FG001|Phase Ib|Progression of disease|0|||
33190676|NCT01485861|100604972|FG002|Phase Ib|Progression of disease|0|||
33190677|NCT01485861|100604973|FG003|Phase Ib|Progression of disease|0|||
33190678|NCT01485861|100604974|FG004|Phase Ib|Progression of disease|0|||
33190679|NCT01485861|100604975|FG005|Phase Ib|Progression of disease|0|||
33190680|NCT01485861|100604970|FG000|Phase Ib|Other|3|||
33190681|NCT01485861|100604971|FG001|Phase Ib|Other|0|||
33190682|NCT01485861|100604972|FG002|Phase Ib|Other|0|||
33190683|NCT01485861|100604973|FG003|Phase Ib|Other|0|||
33190684|NCT01485861|100604974|FG004|Phase Ib|Other|0|||
33190685|NCT01485861|100604975|FG005|Phase Ib|Other|0|||
33190686|NCT01485861|100604970|FG000|Phase Ib|Withdrawal by Subject|4|||
33190687|NCT01485861|100604971|FG001|Phase Ib|Withdrawal by Subject|1|||
33393650|NCT03073200|101328514|FG003|Extension Period|Lost to Follow-up|0|||
33393651|NCT03073200|101328515|FG004|Extension Period|Lost to Follow-up|0|||
33498160|NCT01671007|101717278|FG000|Overall Study|Not eligible|23|||
33190688|NCT01485861|100604972|FG002|Phase Ib|Withdrawal by Subject|0|||
33190689|NCT01485861|100604973|FG003|Phase Ib|Withdrawal by Subject|0|||
33190690|NCT01485861|100604974|FG004|Phase Ib|Withdrawal by Subject|0|||
33190691|NCT01485861|100604975|FG005|Phase Ib|Withdrawal by Subject|0|||
33190692|NCT01485861|100604970|FG000|Phase II|Death|0|||
33190693|NCT01485861|100604971|FG001|Phase II|Death|0|||
33190694|NCT01485861|100604972|FG002|Phase II|Death|67|||
33190695|NCT01485861|100604973|FG003|Phase II|Death|71|||
33190696|NCT01485861|100604974|FG004|Phase II|Death|68|||
33190697|NCT01485861|100604975|FG005|Phase II|Death|0|||
33190698|NCT01485861|100604970|FG000|Phase II|Progression of Disease|0|||
33190699|NCT01485861|100604971|FG001|Phase II|Progression of Disease|0|||
33190700|NCT01485861|100604972|FG002|Phase II|Progression of Disease|1|||
33190701|NCT01485861|100604973|FG003|Phase II|Progression of Disease|0|||
33190702|NCT01485861|100604974|FG004|Phase II|Progression of Disease|0|||
33190703|NCT01485861|100604975|FG005|Phase II|Progression of Disease|0|||
33190704|NCT01485861|100604970|FG000|Phase II|Other|0|||
33190705|NCT01485861|100604971|FG001|Phase II|Other|0|||
33190706|NCT01485861|100604972|FG002|Phase II|Other|0|||
33190707|NCT01485861|100604973|FG003|Phase II|Other|1|||
33190708|NCT01485861|100604974|FG004|Phase II|Other|0|||
33190709|NCT01485861|100604975|FG005|Phase II|Other|0|||
33498161|NCT01671007|101717279|FG001|Overall Study|Not eligible|76|||
33498162|NCT01671007|101717280|FG002|Overall Study|Not eligible|25|||
33498163|NCT01671007|101717281|FG003|Overall Study|Not eligible|17|||
33498164|NCT01671007|101717282|FG004|Overall Study|Not eligible|0|||
33190710|NCT01485861|100604970|FG000|Phase II|Withdrawal by Subject|0|||
33190711|NCT01485861|100604971|FG001|Phase II|Withdrawal by Subject|0|||
33190712|NCT01485861|100604972|FG002|Phase II|Withdrawal by Subject|6|||
33190713|NCT01485861|100604973|FG003|Phase II|Withdrawal by Subject|3|||
33190714|NCT01485861|100604974|FG004|Phase II|Withdrawal by Subject|4|||
33190715|NCT01485861|100604975|FG005|Phase II|Withdrawal by Subject|0|||
33190716|NCT01485861|100604970|FG000|Phase II|Lost to Follow-up|0|||
33190717|NCT01485861|100604971|FG001|Phase II|Lost to Follow-up|0|||
33190718|NCT01485861|100604972|FG002|Phase II|Lost to Follow-up|2|||
33190719|NCT01485861|100604973|FG003|Phase II|Lost to Follow-up|3|||
33190720|NCT01485861|100604974|FG004|Phase II|Lost to Follow-up|5|||
33190721|NCT01485861|100604975|FG005|Phase II|Lost to Follow-up|0|||
33190722|NCT01485861|100604970|FG000|Phase II|Study Ended|0|||
33190723|NCT01485861|100604971|FG001|Phase II|Study Ended|0|||
33190724|NCT01485861|100604972|FG002|Phase II|Study Ended|7|||
33190725|NCT01485861|100604973|FG003|Phase II|Study Ended|8|||
33190726|NCT01485861|100604974|FG004|Phase II|Study Ended|6|||
33190727|NCT01485861|100604975|FG005|Phase II|Study Ended|0|||
33190728|NCT01485861|100604970|FG000|Safety Phase|Death|0|||
33190729|NCT01485861|100604971|FG001|Safety Phase|Death|0|||
33190730|NCT01485861|100604972|FG002|Safety Phase|Death|0|||
33498165|NCT01671007|101717283|FG005|Overall Study|Not eligible|6|||
33190731|NCT01485861|100604973|FG003|Safety Phase|Death|0|||
33190732|NCT01485861|100604974|FG004|Safety Phase|Death|0|||
33190733|NCT01485861|100604975|FG005|Safety Phase|Death|2|||
33190734|NCT01485861|100604970|FG000|Safety Phase|Adverse Event|0|||
33190735|NCT01485861|100604971|FG001|Safety Phase|Adverse Event|0|||
33190736|NCT01485861|100604972|FG002|Safety Phase|Adverse Event|0|||
33498166|NCT01671007|101717284|FG006|Overall Study|Not eligible|1|||
33190737|NCT01485861|100604973|FG003|Safety Phase|Adverse Event|0|||
33190738|NCT01485861|100604974|FG004|Safety Phase|Adverse Event|0|||
33190739|NCT01485861|100604975|FG005|Safety Phase|Adverse Event|1|||
33498167|NCT01671007|101717285|FG007|Overall Study|Not eligible|19|||
33303668|NCT01283516|101007141|FG002|Overall Study|Disease Progression|3|||
33303669|NCT01283516|101007142|FG003|Overall Study|Disease Progression|3|||
33303670|NCT01283516|101007143|FG004|Overall Study|Disease Progression|13|||
33303671|NCT01283516|101007144|FG005|Overall Study|Disease Progression|8|||
33303672|NCT01283516|101007145|FG006|Overall Study|Disease Progression|6|||
33303673|NCT01283516|101007146|FG007|Overall Study|Disease Progression|3|||
33303674|NCT01283516|101007147|FG008|Overall Study|Disease Progression|139|||
33303675|NCT01283516|101007139|FG000|Overall Study|Withdrawal by Subject|0|||
33303676|NCT01283516|101007140|FG001|Overall Study|Withdrawal by Subject|0|||
33303677|NCT01283516|101007141|FG002|Overall Study|Withdrawal by Subject|0|||
33303678|NCT01283516|101007142|FG003|Overall Study|Withdrawal by Subject|0|||
33303679|NCT01283516|101007143|FG004|Overall Study|Withdrawal by Subject|1|||
33303680|NCT01283516|101007144|FG005|Overall Study|Withdrawal by Subject|0|||
33303681|NCT01283516|101007145|FG006|Overall Study|Withdrawal by Subject|1|||
33303682|NCT01283516|101007146|FG007|Overall Study|Withdrawal by Subject|0|||
33303683|NCT01283516|101007147|FG008|Overall Study|Withdrawal by Subject|36|||
33303684|NCT01283516|101007139|FG000|Overall Study|Administrative problems|0|||
33303685|NCT01283516|101007140|FG001|Overall Study|Administrative problems|0|||
33303686|NCT01283516|101007141|FG002|Overall Study|Administrative problems|0|||
33303687|NCT01283516|101007142|FG003|Overall Study|Administrative problems|0|||
33303688|NCT01283516|101007143|FG004|Overall Study|Administrative problems|0|||
33303689|NCT01283516|101007144|FG005|Overall Study|Administrative problems|1|||
33303690|NCT01283516|101007145|FG006|Overall Study|Administrative problems|1|||
33303691|NCT01283516|101007146|FG007|Overall Study|Administrative problems|1|||
33303692|NCT01283516|101007147|FG008|Overall Study|Administrative problems|39|||
33303693|NCT01283516|101007139|FG000|Overall Study|Lost to Follow-up|0|||
33303694|NCT01283516|101007140|FG001|Overall Study|Lost to Follow-up|0|||
33303695|NCT01283516|101007141|FG002|Overall Study|Lost to Follow-up|0|||
33303696|NCT01283516|101007142|FG003|Overall Study|Lost to Follow-up|0|||
33303697|NCT01283516|101007143|FG004|Overall Study|Lost to Follow-up|0|||
33303698|NCT01283516|101007144|FG005|Overall Study|Lost to Follow-up|0|||
33303699|NCT01283516|101007145|FG006|Overall Study|Lost to Follow-up|0|||
33303700|NCT01283516|101007146|FG007|Overall Study|Lost to Follow-up|0|||
33303701|NCT01283516|101007147|FG008|Overall Study|Lost to Follow-up|1|||
33303702|NCT01901419|101007148|FG000|Overall Study|Protocol Violation|2|||
33303703|NCT01901419|101007149|FG001|Overall Study|Protocol Violation|6|||
33303704|NCT01901419|101007148|FG000|Overall Study|unavailable researchers|6|||
33303705|NCT01901419|101007149|FG001|Overall Study|unavailable researchers|3|||
33303706|NCT03900416|101007154|FG000|Six Week Follow-up|Lost to Follow-up|1|||
33303707|NCT03900416|101007155|FG001|Six Week Follow-up|Lost to Follow-up|0|||
33303708|NCT03900416|101007154|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
33303709|NCT03900416|101007155|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
33303710|NCT03900416|101007154|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
33303711|NCT03900416|101007155|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
33303712|NCT03900416|101007154|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
33303713|NCT03900416|101007155|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
33303714|NCT03900416|101007154|FG000|Twelve Week Follow-up|Adverse Event|1|||
33303715|NCT03900416|101007155|FG001|Twelve Week Follow-up|Adverse Event|1|||
33303716|NCT03900416|101007154|FG000|Six Month Follow-up|Lost to Follow-up|4|||
33303717|NCT03900416|101007155|FG001|Six Month Follow-up|Lost to Follow-up|3|||
33303718|NCT03900416|101007154|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
33303719|NCT03900416|101007155|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
33303720|NCT01205152|101007160|FG000|Overall Study|Death|1|||
33303721|NCT01493427|101007161|FG000|Overall Study|Adverse Event|10|||
33303722|NCT01493427|101007161|FG000|Overall Study|Personal Reasons|4|||
33303723|NCT01493427|101007161|FG000|Overall Study|Lost to Follow-up|2|||
33303724|NCT01493427|101007161|FG000|Overall Study|Inability to Follow Instructions|2|||
33498168|NCT01671007|101717286|FG008|Overall Study|Not eligible|0|||
33498169|NCT00739661|101717287|FG000|Overall Study|Adverse Event|2|||
33498170|NCT00739661|101717288|FG001|Overall Study|Adverse Event|0|||
33498171|NCT00739661|101717287|FG000|Overall Study|Physician decision to withdraw patient|1|||
33498172|NCT00739661|101717288|FG001|Overall Study|Physician decision to withdraw patient|0|||
33600486|NCT00364533|102088701|FG002|Overall Study|Variations in drug compliance|1|||
33600487|NCT00364533|102088702|FG003|Overall Study|Variations in drug compliance|0|||
33600488|NCT00364533|102088703|FG004|Overall Study|Variations in drug compliance|0|||
33303725|NCT01493427|101007161|FG000|Overall Study|Other|2|||
33303726|NCT03538301|101007164|FG000|Overall Study|Adverse Event|1|||
33303727|NCT03538301|101007165|FG001|Overall Study|Adverse Event|4|||
33303728|NCT03538301|101007166|FG002|Overall Study|Adverse Event|4|||
33303729|NCT03538301|101007164|FG000|Overall Study|Death|1|||
33303730|NCT03538301|101007165|FG001|Overall Study|Death|1|||
33303731|NCT03538301|101007166|FG002|Overall Study|Death|0|||
33600489|NCT00364533|102088699|FG000|Overall Study|Non-compliance|1|||
33303732|NCT03538301|101007164|FG000|Overall Study|Physician Decision|0|||
33303733|NCT03538301|101007165|FG001|Overall Study|Physician Decision|1|||
33498173|NCT00739661|101717287|FG000|Overall Study|Patient decision to withdraw|9|||
33498174|NCT00739661|101717288|FG001|Overall Study|Patient decision to withdraw|4|||
33498175|NCT00739661|101717287|FG000|Overall Study|Disease progression, radiographic|33|||
33498176|NCT00739661|101717288|FG001|Overall Study|Disease progression, radiographic|37|||
33498177|NCT00739661|101717287|FG000|Overall Study|Reason for discontinuation not available|1|||
33498178|NCT00739661|101717288|FG001|Overall Study|Reason for discontinuation not available|1|||
33498179|NCT02445248|101717289|FG000|Overall Study|Death|45|||
33498180|NCT02445248|101717290|FG001|Overall Study|Death|12|||
33498181|NCT02445248|101717289|FG000|Overall Study|Progressive disease|13|||
33498182|NCT02445248|101717290|FG001|Overall Study|Progressive disease|1|||
33303734|NCT03538301|101007166|FG002|Overall Study|Physician Decision|0|||
33303735|NCT03538301|101007164|FG000|Overall Study|Protocol Violation|0|||
33303736|NCT03538301|101007165|FG001|Overall Study|Protocol Violation|0|||
33303737|NCT03538301|101007166|FG002|Overall Study|Protocol Violation|1|||
33303738|NCT03538301|101007164|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
33303739|NCT03538301|101007165|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
33303740|NCT03538301|101007166|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
33303741|NCT01732822|101007167|FG000|Overall Study|Withdrawal by Subject|123|||
33303742|NCT01732822|101007168|FG001|Overall Study|Withdrawal by Subject|113|||
33303743|NCT01302080|101007169|FG000|Overall Study|Withdrew Consent|92|||
33303744|NCT01302080|101007170|FG001|Overall Study|Withdrew Consent|39|||
33303745|NCT01302080|101007169|FG000|Overall Study|Patient/Family Moved|28|||
33303746|NCT01302080|101007170|FG001|Overall Study|Patient/Family Moved|3|||
33303747|NCT01302080|101007169|FG000|Overall Study|Lost to Follow-up|192|||
33303748|NCT01302080|101007170|FG001|Overall Study|Lost to Follow-up|93|||
33303749|NCT01302080|101007169|FG000|Overall Study|Death|1|||
33303750|NCT01302080|101007170|FG001|Overall Study|Death|0|||
33303751|NCT01302080|101007169|FG000|Overall Study|Other|52|||
33303752|NCT01302080|101007170|FG001|Overall Study|Other|8|||
33303753|NCT01302080|101007169|FG000|Overall Study|Reason Missing For Discontinuation|1|||
33303754|NCT01302080|101007170|FG001|Overall Study|Reason Missing For Discontinuation|0|||
33303755|NCT01012817|101007171|FG000|Overall Study|Withdrawal by Subject|0|||
33303756|NCT01012817|101007172|FG001|Overall Study|Withdrawal by Subject|0|||
33303757|NCT01012817|101007173|FG002|Overall Study|Withdrawal by Subject|0|||
33303758|NCT01012817|101007174|FG003|Overall Study|Withdrawal by Subject|1|||
33303759|NCT01012817|101007175|FG004|Overall Study|Withdrawal by Subject|0|||
33303760|NCT01012817|101007176|FG005|Overall Study|Withdrawal by Subject|0|||
33303761|NCT01012817|101007177|FG006|Overall Study|Withdrawal by Subject|0|||
33303762|NCT01012817|101007178|FG007|Overall Study|Withdrawal by Subject|1|||
33303763|NCT01012817|101007179|FG008|Overall Study|Withdrawal by Subject|0|||
33303764|NCT01012817|101007180|FG009|Overall Study|Withdrawal by Subject|0|||
33303765|NCT01012817|101007181|FG010|Overall Study|Withdrawal by Subject|1|||
33303766|NCT01012817|101007182|FG011|Overall Study|Withdrawal by Subject|1|||
33303767|NCT01012817|101007183|FG012|Overall Study|Withdrawal by Subject|0|||
33303768|NCT01012817|101007184|FG013|Overall Study|Withdrawal by Subject|1|||
33303769|NCT01012817|101007171|FG000|Overall Study|Adverse Event|0|||
33303770|NCT01012817|101007172|FG001|Overall Study|Adverse Event|0|||
33303771|NCT01012817|101007173|FG002|Overall Study|Adverse Event|0|||
33303772|NCT01012817|101007174|FG003|Overall Study|Adverse Event|0|||
33303773|NCT01012817|101007175|FG004|Overall Study|Adverse Event|0|||
33303774|NCT01012817|101007176|FG005|Overall Study|Adverse Event|1|||
33303775|NCT01012817|101007177|FG006|Overall Study|Adverse Event|0|||
33303776|NCT01012817|101007178|FG007|Overall Study|Adverse Event|0|||
33303777|NCT01012817|101007179|FG008|Overall Study|Adverse Event|0|||
33498183|NCT02445248|101717289|FG000|Overall Study|Subject decision|8|||
33498184|NCT02445248|101717290|FG001|Overall Study|Subject decision|0|||
33498185|NCT02445248|101717289|FG000|Overall Study|Physician Decision|5|||
33498186|NCT02445248|101717290|FG001|Overall Study|Physician Decision|0|||
33498187|NCT02445248|101717289|FG000|Overall Study|Adverse Event|1|||
33498188|NCT02445248|101717290|FG001|Overall Study|Adverse Event|0|||
33498189|NCT02445248|101717289|FG000|Overall Study|Lost to Follow-up|1|||
33498190|NCT02445248|101717290|FG001|Overall Study|Lost to Follow-up|0|||
33498191|NCT04855760|101717293|FG000|Overall Study|Adverse Event|21|||
33498192|NCT04855760|101717293|FG000|Overall Study|Withdrawal by Subject|116|||
33498193|NCT04855760|101717293|FG000|Overall Study|Lack of Efficacy|21|||
33600490|NCT00364533|102088700|FG001|Overall Study|Non-compliance|0|||
33498194|NCT04855760|101717293|FG000|Overall Study|Lost to Follow-up|49|||
33498195|NCT04855760|101717293|FG000|Overall Study|Protocol Violation|2|||
33498196|NCT04855760|101717293|FG000|Overall Study|Physician Decision|5|||
33498197|NCT04855760|101717293|FG000|Overall Study|Pregnancy|1|||
33303778|NCT01012817|101007180|FG009|Overall Study|Adverse Event|0|||
33303779|NCT01012817|101007181|FG010|Overall Study|Adverse Event|1|||
33303780|NCT01012817|101007182|FG011|Overall Study|Adverse Event|0|||
33303781|NCT01012817|101007183|FG012|Overall Study|Adverse Event|0|||
33303782|NCT01012817|101007184|FG013|Overall Study|Adverse Event|1|||
33303783|NCT03122223|101007185|FG000|Overall Study|Withdrawal by Subject|2|||
33303784|NCT03122223|101007186|FG001|Overall Study|Withdrawal by Subject|2|||
33303785|NCT03122223|101007187|FG002|Overall Study|Withdrawal by Subject|1|||
33303786|NCT03122223|101007188|FG003|Overall Study|Withdrawal by Subject|0|||
33303787|NCT03122223|101007185|FG000|Overall Study|Lost to Follow-up|0|||
33303788|NCT03122223|101007186|FG001|Overall Study|Lost to Follow-up|2|||
33303789|NCT03122223|101007187|FG002|Overall Study|Lost to Follow-up|2|||
33303790|NCT03122223|101007188|FG003|Overall Study|Lost to Follow-up|0|||
33303791|NCT03122223|101007185|FG000|Overall Study|Participant unable to adhere|1|||
33303792|NCT03122223|101007186|FG001|Overall Study|Participant unable to adhere|1|||
33303793|NCT03122223|101007187|FG002|Overall Study|Participant unable to adhere|1|||
33303794|NCT03122223|101007188|FG003|Overall Study|Participant unable to adhere|0|||
33303795|NCT01395888|101007189|FG000|2-week Run-in Period|Adverse Event|2|||
33498198|NCT04855760|101717293|FG000|Overall Study|Non-Compliance with Study Drug|11|||
33498199|NCT04855760|101717293|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
33498200|NCT04855760|101717293|FG000|Overall Study|Study Completed by Sponsor|202|||
33498201|NCT04855760|101717293|FG000|Overall Study|Other|13|||
33498202|NCT01058642|101717294|FG000|Treatment Period 1|Adverse Event|0|||
33498203|NCT01058642|101717295|FG001|Treatment Period 1|Adverse Event|1|||
33498204|NCT01058642|101717296|FG002|Treatment Period 1|Adverse Event|1|||
33498205|NCT01058642|101717297|FG003|Treatment Period 1|Adverse Event|0|||
33498206|NCT01058642|101717294|FG000|Treatment Period 1|Physician Decision|0|||
33498207|NCT01058642|101717295|FG001|Treatment Period 1|Physician Decision|0|||
33303796|NCT01395888|101007190|FG001|2-week Run-in Period|Adverse Event|0|||
33303797|NCT01395888|101007191|FG002|2-week Run-in Period|Adverse Event|0|||
33303798|NCT01395888|101007189|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
33303799|NCT01395888|101007190|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
33303800|NCT01395888|101007191|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
33303801|NCT01395888|101007189|FG000|2-week Run-in Period|Lost to Follow-up|1|||
33303802|NCT01395888|101007190|FG001|2-week Run-in Period|Lost to Follow-up|0|||
33303803|NCT01395888|101007191|FG002|2-week Run-in Period|Lost to Follow-up|0|||
33303804|NCT01395888|101007189|FG000|2-week Run-in Period|Protocol Violation|2|||
33303805|NCT01395888|101007190|FG001|2-week Run-in Period|Protocol Violation|0|||
33303806|NCT01395888|101007191|FG002|2-week Run-in Period|Protocol Violation|0|||
33303807|NCT01395888|101007189|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
33303808|NCT01395888|101007190|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
33303809|NCT01395888|101007191|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
33303810|NCT01395888|101007189|FG000|Treatment Period (TP)|Adverse Event|0|||
33303811|NCT01395888|101007190|FG001|Treatment Period (TP)|Adverse Event|7|||
33303812|NCT01395888|101007191|FG002|Treatment Period (TP)|Adverse Event|6|||
33303813|NCT01395888|101007189|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
33303814|NCT01395888|101007190|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
33303815|NCT01395888|101007191|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
33303816|NCT01395888|101007189|FG000|Treatment Period (TP)|Protocol Violation|0|||
33303817|NCT01395888|101007190|FG001|Treatment Period (TP)|Protocol Violation|1|||
33303818|NCT01395888|101007191|FG002|Treatment Period (TP)|Protocol Violation|5|||
33303819|NCT01395888|101007189|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
33303820|NCT01395888|101007190|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
33498208|NCT01058642|101717296|FG002|Treatment Period 1|Physician Decision|1|||
33498209|NCT01058642|101717297|FG003|Treatment Period 1|Physician Decision|0|||
33498210|NCT01058642|101717294|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33498211|NCT01058642|101717295|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33498212|NCT01058642|101717296|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33498213|NCT01058642|101717297|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33498214|NCT01058642|101717294|FG000|Treatment Period 1|Lack of Efficacy|0|||
33498215|NCT01058642|101717295|FG001|Treatment Period 1|Lack of Efficacy|0|||
33498216|NCT01058642|101717296|FG002|Treatment Period 1|Lack of Efficacy|0|||
33498217|NCT01058642|101717297|FG003|Treatment Period 1|Lack of Efficacy|1|||
33498218|NCT01058642|101717294|FG000|Treatment Period 1|Protocol Violation|0|||
33498219|NCT01058642|101717295|FG001|Treatment Period 1|Protocol Violation|0|||
33498220|NCT01058642|101717296|FG002|Treatment Period 1|Protocol Violation|0|||
33498221|NCT01058642|101717297|FG003|Treatment Period 1|Protocol Violation|1|||
33498222|NCT01058642|101717294|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
33498223|NCT01058642|101717295|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
33498224|NCT01058642|101717296|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
33498225|NCT01058642|101717297|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
33303821|NCT01395888|101007191|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
33303822|NCT01395888|101007189|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
33498226|NCT03270657|101717298|FG000|Overall Study|Withdrawal by Subject|1|||
33498227|NCT03283566|101717301|FG000|Overall Study|Lost to Follow-up|1|||
33498228|NCT03283566|101717302|FG001|Overall Study|Lost to Follow-up|2|||
33498229|NCT03762265|101717303|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
33303823|NCT01395888|101007190|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
33303824|NCT01395888|101007191|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
33190740|NCT01485861|100604970|FG000|Safety Phase|Other|0|||
33498230|NCT03762265|101717304|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
33498231|NCT03762265|101717303|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
33498232|NCT03762265|101717304|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
33498233|NCT03762265|101717303|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
33498234|NCT03762265|101717304|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
33498235|NCT03762265|101717303|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
33303825|NCT00958841|101007192|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33303826|NCT00958841|101007192|FG000|Overall Study|Abnormal test procedure result(s)|3|||
33303827|NCT00958841|101007192|FG000|Overall Study|Administrative problems|1|||
33303828|NCT00958841|101007192|FG000|Overall Study|Adverse Event|8|||
33498236|NCT03762265|101717304|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
33303829|NCT00958841|101007192|FG000|Overall Study|New cancer therapy|5|||
33303830|NCT00958841|101007192|FG000|Overall Study|Withdrawal by Subject|1|||
33498237|NCT03762265|101717303|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
33498238|NCT03762265|101717304|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
33498239|NCT03762265|101717303|FG000|BT Period: Weeks 1 to 37|Other|0|||
33498240|NCT03762265|101717304|FG001|BT Period: Weeks 1 to 37|Other|1|||
33498241|NCT03762265|101717303|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
33498242|NCT03762265|101717304|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
33498243|NCT03762265|101717303|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
33498244|NCT03762265|101717304|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
33498245|NCT03762265|101717303|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
33498246|NCT03762265|101717304|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
33498247|NCT03762265|101717303|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
33498248|NCT03762265|101717304|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
33498249|NCT03762265|101717303|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
33498250|NCT03762265|101717304|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
33498251|NCT03762265|101717303|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
33498252|NCT03762265|101717304|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
33498253|NCT03762265|101717303|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
33498254|NCT03762265|101717304|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
33498255|NCT03762265|101717303|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
33498256|NCT03762265|101717304|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
33498257|NCT03762265|101717303|FG000|LTE Period: Weeks 61 to 109|Other|1|||
33498258|NCT03762265|101717304|FG001|LTE Period: Weeks 61 to 109|Other|0|||
33498259|NCT02712554|101717305|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
33498260|NCT02712554|101717306|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
33498261|NCT02712554|101717305|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
33498262|NCT02712554|101717306|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
33498263|NCT02712554|101717305|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
33303831|NCT00958841|101007192|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
33303832|NCT00958841|101007192|FG000|Overall Study|Completed M6/did not enter extension|27|||
33303833|NCT00958841|101007192|FG000|Overall Study|Discontinued prior to M*|28|||
33303834|NCT02580305|101007193|FG000|Overall Study|Adverse Event|15|||
33303835|NCT02580305|101007194|FG001|Overall Study|Adverse Event|19|||
33303836|NCT02580305|101007195|FG002|Overall Study|Adverse Event|10|||
33303837|NCT02580305|101007193|FG000|Overall Study|Lack of Efficacy|5|||
33303838|NCT02580305|101007194|FG001|Overall Study|Lack of Efficacy|0|||
33303839|NCT02580305|101007195|FG002|Overall Study|Lack of Efficacy|2|||
33303840|NCT02580305|101007193|FG000|Overall Study|Protocol Violation|4|||
33600491|NCT00364533|102088701|FG002|Overall Study|Non-compliance|0|||
33190741|NCT01485861|100604971|FG001|Safety Phase|Other|0|||
33190742|NCT01485861|100604972|FG002|Safety Phase|Other|0|||
33190743|NCT01485861|100604973|FG003|Safety Phase|Other|0|||
33190744|NCT01485861|100604974|FG004|Safety Phase|Other|0|||
33190745|NCT01485861|100604975|FG005|Safety Phase|Other|5|||
33190746|NCT01485861|100604970|FG000|Safety Phase|Progression of Disease|0|||
33190747|NCT01485861|100604971|FG001|Safety Phase|Progression of Disease|0|||
33190748|NCT01485861|100604972|FG002|Safety Phase|Progression of Disease|0|||
33190749|NCT01485861|100604973|FG003|Safety Phase|Progression of Disease|0|||
33190750|NCT01485861|100604974|FG004|Safety Phase|Progression of Disease|0|||
33190751|NCT01485861|100604975|FG005|Safety Phase|Progression of Disease|9|||
33190752|NCT01485861|100604970|FG000|Safety Phase|Withdrawal by Subject|0|||
33190753|NCT01485861|100604971|FG001|Safety Phase|Withdrawal by Subject|0|||
33190754|NCT01485861|100604972|FG002|Safety Phase|Withdrawal by Subject|0|||
33303841|NCT02580305|101007194|FG001|Overall Study|Protocol Violation|9|||
33600492|NCT00364533|102088702|FG003|Overall Study|Non-compliance|0|||
33190755|NCT01485861|100604973|FG003|Safety Phase|Withdrawal by Subject|0|||
33190756|NCT01485861|100604974|FG004|Safety Phase|Withdrawal by Subject|0|||
33190757|NCT01485861|100604975|FG005|Safety Phase|Withdrawal by Subject|6|||
33190758|NCT01485861|100604970|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
33303842|NCT02580305|101007195|FG002|Overall Study|Protocol Violation|6|||
33303843|NCT02580305|101007193|FG000|Overall Study|Lost to Follow-up|4|||
33498264|NCT02712554|101717306|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
33498265|NCT02712554|101717305|FG000|Part B: Qualification Phase|Adverse Event|0|||
33498266|NCT02712554|101717306|FG001|Part B: Qualification Phase|Adverse Event|1|||
33303844|NCT02580305|101007194|FG001|Overall Study|Lost to Follow-up|4|||
33303845|NCT02580305|101007195|FG002|Overall Study|Lost to Follow-up|2|||
33303846|NCT02580305|101007193|FG000|Overall Study|Withdrawal by Subject|11|||
33303847|NCT02580305|101007194|FG001|Overall Study|Withdrawal by Subject|9|||
33303848|NCT02580305|101007195|FG002|Overall Study|Withdrawal by Subject|7|||
33303849|NCT02580305|101007193|FG000|Overall Study|Randomized in error and never treated|4|||
33303850|NCT02580305|101007194|FG001|Overall Study|Randomized in error and never treated|8|||
33303851|NCT02580305|101007195|FG002|Overall Study|Randomized in error and never treated|5|||
33498267|NCT02712554|101717305|FG000|Part B: Treatment Phase|Adverse Event|0|||
33498268|NCT02712554|101717306|FG001|Part B: Treatment Phase|Adverse Event|1|||
33498269|NCT02712554|101717305|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
33498270|NCT02712554|101717306|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
33498271|NCT02712554|101717305|FG000|Part B: Treatment Phase|Other|0|||
33498272|NCT02712554|101717306|FG001|Part B: Treatment Phase|Other|1|||
33498273|NCT00568451|101717313|FG000|Overall Study|Disease Progression|0|||
33498274|NCT00568451|101717314|FG001|Overall Study|Disease Progression|0|||
33498275|NCT00568451|101717315|FG002|Overall Study|Disease Progression|2|||
33498276|NCT00568451|101717316|FG003|Overall Study|Disease Progression|7|||
33498277|NCT00086619|101717317|FG000|Overall Study|Withdrawal by Subject|6|||
33498278|NCT00086619|101717318|FG001|Overall Study|Withdrawal by Subject|6|||
33498279|NCT00086619|101717317|FG000|Overall Study|Adverse Event|8|||
33498280|NCT00086619|101717318|FG001|Overall Study|Adverse Event|10|||
33498281|NCT00086619|101717317|FG000|Overall Study|Protocol Violation|1|||
33498282|NCT00086619|101717318|FG001|Overall Study|Protocol Violation|1|||
33498283|NCT00603473|101717321|FG000|Overall Study|Adverse Event|4|||
33498284|NCT00603473|101717321|FG000|Overall Study|Lack of Efficacy|4|||
33498285|NCT00603473|101717321|FG000|Overall Study|Protocol Violation|1|||
33498286|NCT01823328|101717324|FG000|Overall Study|Withdrawal by Subject|8|||
33498287|NCT01823328|101717325|FG001|Overall Study|Withdrawal by Subject|6|||
33498288|NCT02996968|101717326|FG000|Overall Study|Withdrawal by Subject|1|||
33498289|NCT02996968|101717327|FG001|Overall Study|Withdrawal by Subject|0|||
33498290|NCT01796392|101717328|FG000|Overall Study|Withdrawal by Subject|2|||
33498291|NCT01796392|101717329|FG001|Overall Study|Withdrawal by Subject|0|||
33498292|NCT01796392|101717328|FG000|Overall Study|Death|5|||
33498293|NCT01796392|101717329|FG001|Overall Study|Death|1|||
33498294|NCT01796392|101717328|FG000|Overall Study|Excluded for medical reasons|1|||
33498295|NCT01796392|101717329|FG001|Overall Study|Excluded for medical reasons|2|||
33498296|NCT01796392|101717328|FG000|Overall Study|Lost to Follow-up|1|||
33498297|NCT01796392|101717329|FG001|Overall Study|Lost to Follow-up|0|||
33498298|NCT02640664|101717338|FG000|Epoch 1|Withdrawal of informed consent|1|||
33498299|NCT02640664|101717339|FG001|Epoch 1|Withdrawal of informed consent|0|||
33498300|NCT02640664|101717340|FG002|Epoch 1|Withdrawal of informed consent|0|||
33498301|NCT02640664|101717338|FG000|Epoch 1|Death|0|||
33498302|NCT02640664|101717339|FG001|Epoch 1|Death|0|||
33498303|NCT02640664|101717340|FG002|Epoch 1|Death|1|||
33190759|NCT01485861|100604971|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
33190760|NCT01485861|100604972|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
33190761|NCT01485861|100604973|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
33190762|NCT01485861|100604974|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
33190763|NCT01485861|100604975|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
33190764|NCT00931307|100604982|FG000|Overall Study|Lack of Efficacy|12|||
33190765|NCT00931307|100604982|FG000|Overall Study|Biomicroscopy|1|||
33190766|NCT00261716|100604985|FG000|Overall Study|Withdrawal by Subject|6|||
33190767|NCT00261716|100604986|FG001|Overall Study|Withdrawal by Subject|8|||
33190768|NCT00261716|100604985|FG000|Overall Study|Lost to Follow-up|0|||
33190769|NCT00261716|100604986|FG001|Overall Study|Lost to Follow-up|2|||
33190770|NCT01604343|100604988|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
33190771|NCT01604343|100604989|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
33190772|NCT01604343|100604990|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
33190773|NCT01604343|100604991|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
33190774|NCT01604343|100604992|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
33190775|NCT01604343|100604988|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
33498304|NCT02640664|101717338|FG000|Epoch 2|Withdrawal of informed consent|3|||
33498305|NCT02640664|101717339|FG001|Epoch 2|Withdrawal of informed consent|4|||
33498306|NCT02640664|101717340|FG002|Epoch 2|Withdrawal of informed consent|2|||
33498307|NCT02640664|101717338|FG000|Epoch 2|Subject/guardian decision|0|||
33498308|NCT02640664|101717339|FG001|Epoch 2|Subject/guardian decision|2|||
33498309|NCT02640664|101717340|FG002|Epoch 2|Subject/guardian decision|2|||
33498310|NCT02640664|101717338|FG000|Epoch 2|Lost to Follow-up|3|||
33498311|NCT02640664|101717339|FG001|Epoch 2|Lost to Follow-up|4|||
33498312|NCT02640664|101717340|FG002|Epoch 2|Lost to Follow-up|1|||
33498313|NCT02640664|101717338|FG000|Epoch 2|Death|0|||
33498314|NCT02640664|101717339|FG001|Epoch 2|Death|0|||
33498315|NCT02640664|101717340|FG002|Epoch 2|Death|1|||
33303852|NCT01262027|101007196|FG000|Overall Study|Adverse Event|1|||
33303853|NCT01262027|101007196|FG000|Overall Study|Withdrawal by Subject|3|||
33303854|NCT01262027|101007196|FG000|Overall Study|Protocol Violation|1|||
33303855|NCT00727311|101007197|FG000|Overall Study|Did not receive drug|316|||
33303856|NCT00727311|101007197|FG000|Overall Study|Missing end of therapy data|205|||
33303857|NCT00727311|101007197|FG000|Overall Study|Adverse Event|58|||
33303858|NCT00727311|101007197|FG000|Overall Study|Lack of Efficacy|242|||
33303859|NCT00727311|101007197|FG000|Overall Study|Lost to Follow-up|73|||
33303860|NCT00727311|101007197|FG000|Overall Study|Withdrawal by Subject|77|||
33303861|NCT00727311|101007197|FG000|Overall Study|Other|97|||
33303862|NCT00727311|101007197|FG000|Overall Study|Multiple reasons|39|||
33303863|NCT02712905|101007200|FG000|Monotherapy|Death|2|||
33303864|NCT02712905|101007201|FG001|Monotherapy|Death|5|||
33600493|NCT00364533|102088703|FG004|Overall Study|Non-compliance|0|||
33600494|NCT00364533|102088699|FG000|Overall Study|Protocol Violation|1|||
33600495|NCT00364533|102088700|FG001|Overall Study|Protocol Violation|1|||
33600496|NCT00364533|102088701|FG002|Overall Study|Protocol Violation|0|||
33600497|NCT00364533|102088702|FG003|Overall Study|Protocol Violation|0|||
33600498|NCT00364533|102088703|FG004|Overall Study|Protocol Violation|0|||
33303865|NCT02712905|101007202|FG002|Monotherapy|Death|0|||
33303866|NCT02712905|101007203|FG003|Monotherapy|Death|3|||
33303867|NCT02712905|101007204|FG004|Monotherapy|Death|15|||
33303868|NCT02712905|101007205|FG005|Monotherapy|Death|1|||
33303869|NCT02712905|101007206|FG006|Monotherapy|Death|3|||
33303870|NCT02712905|101007207|FG007|Monotherapy|Death|3|||
33303871|NCT02712905|101007208|FG008|Monotherapy|Death|0|||
33303872|NCT02712905|101007209|FG009|Monotherapy|Death|27|||
33303873|NCT02712905|101007210|FG010|Monotherapy|Death|2|||
33303874|NCT02712905|101007211|FG011|Monotherapy|Death|5|||
33303875|NCT02712905|101007212|FG012|Monotherapy|Death|0|||
33303876|NCT02712905|101007213|FG013|Monotherapy|Death|0|||
33303877|NCT02712905|101007214|FG014|Monotherapy|Death|0|||
33303878|NCT02712905|101007215|FG015|Monotherapy|Death|0|||
33303879|NCT02712905|101007216|FG016|Monotherapy|Death|0|||
33303880|NCT02712905|101007217|FG017|Monotherapy|Death|0|||
33498316|NCT01290068|101717352|FG000|Overall Study|Adverse Event|1|||
33303881|NCT02712905|101007200|FG000|Monotherapy|Lost to Follow-up|0|||
33303882|NCT02712905|101007201|FG001|Monotherapy|Lost to Follow-up|1|||
33303883|NCT02712905|101007202|FG002|Monotherapy|Lost to Follow-up|0|||
33303884|NCT02712905|101007203|FG003|Monotherapy|Lost to Follow-up|1|||
33303885|NCT02712905|101007204|FG004|Monotherapy|Lost to Follow-up|0|||
33498317|NCT01290068|101717353|FG001|Overall Study|Adverse Event|3|||
33498318|NCT01290068|101717352|FG000|Overall Study|Lost to Follow-up|3|||
33498319|NCT01290068|101717353|FG001|Overall Study|Lost to Follow-up|0|||
33498320|NCT01290068|101717352|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
33498321|NCT01290068|101717353|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
33498322|NCT01290068|101717352|FG000|Overall Study|Other|3|||
33498323|NCT01290068|101717353|FG001|Overall Study|Other|1|||
33498324|NCT02356588|101717359|FG000|Overall Study|Lack of Efficacy|4|||
33498325|NCT02356588|101717360|FG001|Overall Study|Lack of Efficacy|10|||
33498326|NCT02356588|101717359|FG000|Overall Study|Adverse Event|0|||
33498327|NCT02356588|101717360|FG001|Overall Study|Adverse Event|2|||
33498328|NCT02356588|101717359|FG000|Overall Study|Withdrawal by Subject|1|||
33498329|NCT02356588|101717360|FG001|Overall Study|Withdrawal by Subject|0|||
33498330|NCT02356588|101717359|FG000|Overall Study|Protocol Violation|0|||
33498331|NCT02356588|101717360|FG001|Overall Study|Protocol Violation|1|||
33498332|NCT01006122|101717361|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
33498333|NCT01006122|101717362|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
33498334|NCT01006122|101717361|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
33498335|NCT01006122|101717362|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
33498336|NCT01006122|101717361|FG000|First Double-blind Intervention Period|Pregnancy|0|||
33600499|NCT01241760|102088707|FG000|Overall Study|Adverse Event|1|||
33600500|NCT01241760|102088708|FG001|Overall Study|Adverse Event|0|||
33498337|NCT01006122|101717362|FG001|First Double-blind Intervention Period|Pregnancy|1|||
33498338|NCT01006122|101717361|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
33303886|NCT02712905|101007205|FG005|Monotherapy|Lost to Follow-up|0|||
33303887|NCT02712905|101007206|FG006|Monotherapy|Lost to Follow-up|0|||
33303888|NCT02712905|101007207|FG007|Monotherapy|Lost to Follow-up|0|||
33393652|NCT03073200|101328516|FG005|Extension Period|Lost to Follow-up|0|||
33498339|NCT01006122|101717362|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
33498340|NCT01006122|101717361|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
33498341|NCT01006122|101717362|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
33498342|NCT01006122|101717361|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
33600501|NCT01241760|102088707|FG000|Overall Study|Lost to Follow-up|18|||
33600502|NCT01241760|102088708|FG001|Overall Study|Lost to Follow-up|22|||
33303889|NCT02712905|101007208|FG008|Monotherapy|Lost to Follow-up|0|||
33600503|NCT01241760|102088707|FG000|Overall Study|Withdrawal by Subject|13|||
33303890|NCT02712905|101007209|FG009|Monotherapy|Lost to Follow-up|2|||
33303891|NCT02712905|101007210|FG010|Monotherapy|Lost to Follow-up|0|||
33303892|NCT02712905|101007211|FG011|Monotherapy|Lost to Follow-up|0|||
33498343|NCT01006122|101717362|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
33498344|NCT01006122|101717361|FG000|First Double-blind Intervention Period|Other|3|||
33498345|NCT01006122|101717362|FG001|First Double-blind Intervention Period|Other|0|||
33498346|NCT01006122|101717361|FG000|First Double-blind Intervention Period|Adverse Event|0|||
33498347|NCT01006122|101717362|FG001|First Double-blind Intervention Period|Adverse Event|4|||
33498348|NCT01006122|101717361|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
33498349|NCT01006122|101717362|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
33498350|NCT01006122|101717361|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
33498351|NCT01006122|101717362|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
33498352|NCT01006122|101717361|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
33498353|NCT01006122|101717362|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
33498354|NCT01006122|101717361|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
33498355|NCT01006122|101717362|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
33498356|NCT01006122|101717361|FG000|Second Double-blind Intervention Period|Death|0|||
33498357|NCT01006122|101717362|FG001|Second Double-blind Intervention Period|Death|1|||
33498358|NCT01568892|101717363|FG000|Open-label Phase|Adverse Event|2|||
33498359|NCT01568892|101717364|FG001|Open-label Phase|Adverse Event|0|||
33498360|NCT01568892|101717363|FG000|Open-label Phase|Lack of Efficacy|4|||
33498361|NCT01568892|101717364|FG001|Open-label Phase|Lack of Efficacy|2|||
33498362|NCT01568892|101717363|FG000|Open-label Phase|Lost to Follow-up|0|||
33498363|NCT01568892|101717364|FG001|Open-label Phase|Lost to Follow-up|1|||
33498364|NCT02285361|101717365|FG000|Overall Study|Protocol Violation|43|||
33498365|NCT02285361|101717365|FG000|Overall Study|Lost to Follow-up|5|||
33498366|NCT02285361|101717365|FG000|Overall Study|Not taken GIOTRIF|2|||
33498367|NCT02285361|101717365|FG000|Overall Study|Consented prior to the contract date|1|||
33498368|NCT00420420|101717366|FG000|Overall Study|Adverse Event|5|||
33498369|NCT00420420|101717367|FG001|Overall Study|Adverse Event|3|||
33498370|NCT00420420|101717366|FG000|Overall Study|Protocol Violation|1|||
33498371|NCT00420420|101717367|FG001|Overall Study|Protocol Violation|1|||
33303893|NCT02712905|101007212|FG012|Monotherapy|Lost to Follow-up|0|||
33303894|NCT02712905|101007213|FG013|Monotherapy|Lost to Follow-up|0|||
33303895|NCT02712905|101007214|FG014|Monotherapy|Lost to Follow-up|0|||
33498372|NCT00420420|101717366|FG000|Overall Study|Withdrawal by Subject|1|||
33498373|NCT00420420|101717367|FG001|Overall Study|Withdrawal by Subject|0|||
33600504|NCT01241760|102088708|FG001|Overall Study|Withdrawal by Subject|13|||
33600505|NCT01241760|102088707|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
33600506|NCT01241760|102088708|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
33600507|NCT01241760|102088707|FG000|Overall Study|Other|1|||
33498374|NCT00420420|101717366|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
33498375|NCT00420420|101717367|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
33498376|NCT00488644|101717368|FG000|Overall Study|Not Eligible|1|||
33498377|NCT00488644|101717368|FG000|Overall Study|Not Evaluable|1|||
33498378|NCT01591096|101717369|FG000|Overall Study|Adverse Event|1|||
33498379|NCT00191477|101717371|FG000|Overall Study|Tumor Recurrence|49|||
33498380|NCT00191477|101717372|FG001|Overall Study|Tumor Recurrence|48|||
33498381|NCT00191477|101717371|FG000|Overall Study|Death, Study Disease|1|||
33498382|NCT00191477|101717372|FG001|Overall Study|Death, Study Disease|1|||
33498383|NCT00191477|101717371|FG000|Overall Study|Death, Other Cause|3|||
33498384|NCT00191477|101717372|FG001|Overall Study|Death, Other Cause|6|||
33498385|NCT00191477|101717371|FG000|Overall Study|Lost to Follow-up|23|||
33498386|NCT00191477|101717372|FG001|Overall Study|Lost to Follow-up|21|||
33498387|NCT00191477|101717371|FG000|Overall Study|Protocol Violation|1|||
33498388|NCT00191477|101717372|FG001|Overall Study|Protocol Violation|1|||
33498389|NCT00191477|101717371|FG000|Overall Study|Treatment Change|2|||
33498390|NCT00191477|101717372|FG001|Overall Study|Treatment Change|0|||
33498391|NCT00191477|101717371|FG000|Overall Study|Withdrawal by Subject|2|||
33498392|NCT00191477|101717372|FG001|Overall Study|Withdrawal by Subject|0|||
33498393|NCT00191477|101717371|FG000|Overall Study|Other|2|||
33600508|NCT01241760|102088708|FG001|Overall Study|Other|1|||
33600509|NCT04284813|102088709|FG000|Overall Study|Withdrawal by Subject|1|||
33600510|NCT03958656|102088713|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
33498394|NCT00191477|101717372|FG001|Overall Study|Other|0|||
33498395|NCT00191477|101717371|FG000|Overall Study|Not Eligible|41|||
33498396|NCT00191477|101717372|FG001|Overall Study|Not Eligible|38|||
33303896|NCT02712905|101007215|FG015|Monotherapy|Lost to Follow-up|0|||
33498397|NCT00191477|101717371|FG000|Overall Study|Pathological Specimen Lost|1|||
33498398|NCT00191477|101717372|FG001|Overall Study|Pathological Specimen Lost|0|||
33498399|NCT00191477|101717371|FG000|Overall Study|Discontinued Prior to Instillation|13|||
33498400|NCT00191477|101717372|FG001|Overall Study|Discontinued Prior to Instillation|14|||
33498401|NCT01067105|101717373|FG000|Overall Study|Adverse Event|14|||
33303897|NCT02712905|101007216|FG016|Monotherapy|Lost to Follow-up|0|||
33600511|NCT03958656|102088714|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
33498402|NCT01067105|101717373|FG000|Overall Study|Protocol Violation|48|||
33498403|NCT01067105|101717373|FG000|Overall Study|Withdrawal by Subject|36|||
33498404|NCT01067105|101717373|FG000|Overall Study|Lost to Follow-up|6|||
33498405|NCT01067105|101717373|FG000|Overall Study|Physician Decision|6|||
33498406|NCT01067105|101717373|FG000|Overall Study|Other|31|||
33498407|NCT00298272|101717374|FG000|Double-blind Phase|Adverse Event|2|||
33498408|NCT00298272|101717375|FG001|Double-blind Phase|Adverse Event|0|||
33498409|NCT00298272|101717374|FG000|Double-blind Phase|Failure to Return|2|||
33498410|NCT00298272|101717375|FG001|Double-blind Phase|Failure to Return|0|||
33498411|NCT00298272|101717374|FG000|Double-blind Phase|Protocol Violation|2|||
33498412|NCT00298272|101717375|FG001|Double-blind Phase|Protocol Violation|0|||
33498413|NCT00298272|101717374|FG000|Double-blind Phase|Withdrawal by Subject|2|||
33498414|NCT00298272|101717375|FG001|Double-blind Phase|Withdrawal by Subject|0|||
33498415|NCT00298272|101717374|FG000|Open Label Retreatment Phase|Adverse Event|1|||
33498416|NCT00298272|101717375|FG001|Open Label Retreatment Phase|Adverse Event|2|||
33498417|NCT00298272|101717374|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
33303898|NCT02712905|101007217|FG017|Monotherapy|Lost to Follow-up|0|||
33303899|NCT02712905|101007200|FG000|Monotherapy|Physician Decision|1|||
33498418|NCT00298272|101717375|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
33498419|NCT00298272|101717374|FG000|Open Label Retreatment Phase|Failure to Return|1|||
33498420|NCT00298272|101717375|FG001|Open Label Retreatment Phase|Failure to Return|0|||
33498421|NCT00298272|101717374|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
33498422|NCT00298272|101717375|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
33498423|NCT00298272|101717374|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
33303900|NCT02712905|101007201|FG001|Monotherapy|Physician Decision|0|||
33303901|NCT02712905|101007202|FG002|Monotherapy|Physician Decision|0|||
33303902|NCT02712905|101007203|FG003|Monotherapy|Physician Decision|1|||
33303903|NCT02712905|101007204|FG004|Monotherapy|Physician Decision|0|||
33303904|NCT02712905|101007205|FG005|Monotherapy|Physician Decision|0|||
33303905|NCT02712905|101007206|FG006|Monotherapy|Physician Decision|0|||
33303906|NCT02712905|101007207|FG007|Monotherapy|Physician Decision|0|||
33303907|NCT02712905|101007208|FG008|Monotherapy|Physician Decision|0|||
33303908|NCT02712905|101007209|FG009|Monotherapy|Physician Decision|1|||
33303909|NCT02712905|101007210|FG010|Monotherapy|Physician Decision|0|||
33303910|NCT02712905|101007211|FG011|Monotherapy|Physician Decision|0|||
33303911|NCT02712905|101007212|FG012|Monotherapy|Physician Decision|0|||
33303912|NCT02712905|101007213|FG013|Monotherapy|Physician Decision|0|||
33303913|NCT02712905|101007214|FG014|Monotherapy|Physician Decision|0|||
33303914|NCT02712905|101007215|FG015|Monotherapy|Physician Decision|0|||
33303915|NCT02712905|101007216|FG016|Monotherapy|Physician Decision|0|||
33303916|NCT02712905|101007217|FG017|Monotherapy|Physician Decision|0|||
33303917|NCT02712905|101007200|FG000|Monotherapy|Study Terminated by Sponsor|0|||
33303918|NCT02712905|101007201|FG001|Monotherapy|Study Terminated by Sponsor|0|||
33303919|NCT02712905|101007202|FG002|Monotherapy|Study Terminated by Sponsor|0|||
33303920|NCT02712905|101007203|FG003|Monotherapy|Study Terminated by Sponsor|0|||
33303921|NCT02712905|101007204|FG004|Monotherapy|Study Terminated by Sponsor|1|||
33303922|NCT02712905|101007205|FG005|Monotherapy|Study Terminated by Sponsor|0|||
33303923|NCT02712905|101007206|FG006|Monotherapy|Study Terminated by Sponsor|0|||
33303924|NCT02712905|101007207|FG007|Monotherapy|Study Terminated by Sponsor|0|||
33303925|NCT02712905|101007208|FG008|Monotherapy|Study Terminated by Sponsor|0|||
33303926|NCT02712905|101007209|FG009|Monotherapy|Study Terminated by Sponsor|2|||
33303927|NCT02712905|101007210|FG010|Monotherapy|Study Terminated by Sponsor|0|||
33303928|NCT02712905|101007211|FG011|Monotherapy|Study Terminated by Sponsor|0|||
33303929|NCT02712905|101007212|FG012|Monotherapy|Study Terminated by Sponsor|0|||
33303930|NCT02712905|101007213|FG013|Monotherapy|Study Terminated by Sponsor|0|||
33303931|NCT02712905|101007214|FG014|Monotherapy|Study Terminated by Sponsor|0|||
33303932|NCT02712905|101007215|FG015|Monotherapy|Study Terminated by Sponsor|0|||
33303933|NCT02712905|101007216|FG016|Monotherapy|Study Terminated by Sponsor|0|||
33303934|NCT02712905|101007217|FG017|Monotherapy|Study Terminated by Sponsor|0|||
33303935|NCT02712905|101007200|FG000|Monotherapy|Withdrawal by Subject|0|||
33303936|NCT02712905|101007201|FG001|Monotherapy|Withdrawal by Subject|0|||
33303937|NCT02712905|101007202|FG002|Monotherapy|Withdrawal by Subject|1|||
33303938|NCT02712905|101007203|FG003|Monotherapy|Withdrawal by Subject|0|||
33303939|NCT02712905|101007204|FG004|Monotherapy|Withdrawal by Subject|2|||
33303940|NCT02712905|101007205|FG005|Monotherapy|Withdrawal by Subject|0|||
33303941|NCT02712905|101007206|FG006|Monotherapy|Withdrawal by Subject|0|||
33303942|NCT02712905|101007207|FG007|Monotherapy|Withdrawal by Subject|0|||
33303943|NCT02712905|101007208|FG008|Monotherapy|Withdrawal by Subject|0|||
33303944|NCT02712905|101007209|FG009|Monotherapy|Withdrawal by Subject|4|||
33498424|NCT00298272|101717375|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
33303945|NCT02712905|101007210|FG010|Monotherapy|Withdrawal by Subject|1|||
33303946|NCT02712905|101007211|FG011|Monotherapy|Withdrawal by Subject|2|||
33303947|NCT02712905|101007212|FG012|Monotherapy|Withdrawal by Subject|0|||
33498425|NCT00298272|101717374|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
33498426|NCT00298272|101717375|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
33498427|NCT00298272|101717374|FG000|Safety Follow-up Phase|Failure to Return|1|||
33303948|NCT02712905|101007213|FG013|Monotherapy|Withdrawal by Subject|0|||
33498428|NCT00298272|101717375|FG001|Safety Follow-up Phase|Failure to Return|1|||
33600512|NCT03958656|102088715|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
33600513|NCT03958656|102088716|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
33600514|NCT03958656|102088713|FG000|Overall Study|No longer meets eligibility criteria|0|||
33600515|NCT03958656|102088714|FG001|Overall Study|No longer meets eligibility criteria|0|||
33600516|NCT03958656|102088715|FG002|Overall Study|No longer meets eligibility criteria|1|||
33600517|NCT03958656|102088716|FG003|Overall Study|No longer meets eligibility criteria|0|||
33600518|NCT03958656|102088713|FG000|Overall Study|Started anti-cancer treatment|0|||
33600519|NCT03958656|102088714|FG001|Overall Study|Started anti-cancer treatment|0|||
33600520|NCT03958656|102088715|FG002|Overall Study|Started anti-cancer treatment|1|||
33600521|NCT03958656|102088716|FG003|Overall Study|Started anti-cancer treatment|0|||
33303949|NCT02712905|101007214|FG014|Monotherapy|Withdrawal by Subject|0|||
33303950|NCT02712905|101007215|FG015|Monotherapy|Withdrawal by Subject|0|||
33303951|NCT02712905|101007216|FG016|Monotherapy|Withdrawal by Subject|0|||
33303952|NCT02712905|101007217|FG017|Monotherapy|Withdrawal by Subject|0|||
33303953|NCT02712905|101007200|FG000|Monotherapy|Started New Cancer Drug|0|||
33303954|NCT02712905|101007201|FG001|Monotherapy|Started New Cancer Drug|0|||
33393653|NCT03073200|101328517|FG006|Extension Period|Lost to Follow-up|1|||
33393654|NCT03073200|101328518|FG007|Extension Period|Lost to Follow-up|1|||
33393655|NCT03073200|101328519|FG008|Extension Period|Lost to Follow-up|0|||
33393656|NCT03073200|101328520|FG009|Extension Period|Lost to Follow-up|0|||
33393657|NCT03073200|101328521|FG010|Extension Period|Lost to Follow-up|0|||
33393658|NCT03073200|101328522|FG011|Extension Period|Lost to Follow-up|0|||
33393659|NCT03073200|101328523|FG012|Extension Period|Lost to Follow-up|0|||
33393660|NCT03073200|101328524|FG013|Extension Period|Lost to Follow-up|0|||
33393661|NCT03073200|101328525|FG014|Extension Period|Lost to Follow-up|0|||
33393662|NCT03073200|101328511|FG000|Extension Period|Sponsor Decision|0|||
33393663|NCT03073200|101328512|FG001|Extension Period|Sponsor Decision|0|||
33393664|NCT03073200|101328513|FG002|Extension Period|Sponsor Decision|0|||
33393665|NCT03073200|101328514|FG003|Extension Period|Sponsor Decision|0|||
33393666|NCT03073200|101328515|FG004|Extension Period|Sponsor Decision|0|||
33393667|NCT03073200|101328516|FG005|Extension Period|Sponsor Decision|0|||
33393668|NCT03073200|101328517|FG006|Extension Period|Sponsor Decision|0|||
33393669|NCT03073200|101328518|FG007|Extension Period|Sponsor Decision|0|||
33393670|NCT03073200|101328519|FG008|Extension Period|Sponsor Decision|1|||
33393671|NCT03073200|101328520|FG009|Extension Period|Sponsor Decision|0|||
33393672|NCT03073200|101328521|FG010|Extension Period|Sponsor Decision|0|||
33393673|NCT03073200|101328522|FG011|Extension Period|Sponsor Decision|0|||
33393674|NCT03073200|101328523|FG012|Extension Period|Sponsor Decision|0|||
33393675|NCT03073200|101328524|FG013|Extension Period|Sponsor Decision|0|||
33393676|NCT03073200|101328525|FG014|Extension Period|Sponsor Decision|0|||
33393677|NCT03073200|101328511|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
33393678|NCT03073200|101328512|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
33393679|NCT03073200|101328513|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
33393680|NCT03073200|101328514|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
33393681|NCT03073200|101328515|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
33393682|NCT03073200|101328516|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
33393683|NCT03073200|101328517|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
33393684|NCT03073200|101328518|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
33393685|NCT03073200|101328519|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
33393686|NCT03073200|101328520|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
33393687|NCT03073200|101328521|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
33393688|NCT03073200|101328522|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
33393689|NCT03073200|101328523|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
33393690|NCT03073200|101328524|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
33393691|NCT03073200|101328525|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
33393692|NCT03073200|101328511|FG000|Extension Period|Withdrawal by Subject|0|||
33303955|NCT02712905|101007202|FG002|Monotherapy|Started New Cancer Drug|0|||
33303956|NCT02712905|101007203|FG003|Monotherapy|Started New Cancer Drug|0|||
33303957|NCT02712905|101007204|FG004|Monotherapy|Started New Cancer Drug|0|||
33303958|NCT02712905|101007205|FG005|Monotherapy|Started New Cancer Drug|1|||
33303959|NCT02712905|101007206|FG006|Monotherapy|Started New Cancer Drug|0|||
33303960|NCT02712905|101007207|FG007|Monotherapy|Started New Cancer Drug|0|||
33303961|NCT02712905|101007208|FG008|Monotherapy|Started New Cancer Drug|0|||
33303962|NCT02712905|101007209|FG009|Monotherapy|Started New Cancer Drug|0|||
33303963|NCT02712905|101007210|FG010|Monotherapy|Started New Cancer Drug|0|||
33303964|NCT02712905|101007211|FG011|Monotherapy|Started New Cancer Drug|0|||
33303965|NCT02712905|101007212|FG012|Monotherapy|Started New Cancer Drug|0|||
33303966|NCT02712905|101007213|FG013|Monotherapy|Started New Cancer Drug|0|||
33303967|NCT02712905|101007214|FG014|Monotherapy|Started New Cancer Drug|0|||
33303968|NCT02712905|101007215|FG015|Monotherapy|Started New Cancer Drug|0|||
33303969|NCT02712905|101007216|FG016|Monotherapy|Started New Cancer Drug|0|||
33303970|NCT02712905|101007217|FG017|Monotherapy|Started New Cancer Drug|0|||
33303971|NCT02712905|101007200|FG000|Monotherapy|Adverse Event|0|||
33303972|NCT02712905|101007201|FG001|Monotherapy|Adverse Event|0|||
33303973|NCT02712905|101007202|FG002|Monotherapy|Adverse Event|0|||
33303974|NCT02712905|101007203|FG003|Monotherapy|Adverse Event|0|||
33303975|NCT02712905|101007204|FG004|Monotherapy|Adverse Event|0|||
33303976|NCT02712905|101007205|FG005|Monotherapy|Adverse Event|0|||
33303977|NCT02712905|101007206|FG006|Monotherapy|Adverse Event|0|||
33303978|NCT02712905|101007207|FG007|Monotherapy|Adverse Event|0|||
33303979|NCT02712905|101007208|FG008|Monotherapy|Adverse Event|1|||
33303980|NCT02712905|101007209|FG009|Monotherapy|Adverse Event|0|||
33303981|NCT02712905|101007210|FG010|Monotherapy|Adverse Event|0|||
33303982|NCT02712905|101007211|FG011|Monotherapy|Adverse Event|0|||
33303983|NCT02712905|101007212|FG012|Monotherapy|Adverse Event|0|||
33303984|NCT02712905|101007213|FG013|Monotherapy|Adverse Event|0|||
33303985|NCT02712905|101007214|FG014|Monotherapy|Adverse Event|0|||
33303986|NCT02712905|101007215|FG015|Monotherapy|Adverse Event|0|||
33303987|NCT02712905|101007216|FG016|Monotherapy|Adverse Event|0|||
33303988|NCT02712905|101007217|FG017|Monotherapy|Adverse Event|0|||
33303989|NCT02712905|101007200|FG000|Combination Therapy|Death|0|||
33303990|NCT02712905|101007201|FG001|Combination Therapy|Death|0|||
33303991|NCT02712905|101007202|FG002|Combination Therapy|Death|0|||
33303992|NCT02712905|101007203|FG003|Combination Therapy|Death|0|||
33303993|NCT02712905|101007204|FG004|Combination Therapy|Death|0|||
33303994|NCT02712905|101007205|FG005|Combination Therapy|Death|0|||
33303995|NCT02712905|101007206|FG006|Combination Therapy|Death|0|||
33303996|NCT02712905|101007207|FG007|Combination Therapy|Death|0|||
33303997|NCT02712905|101007208|FG008|Combination Therapy|Death|0|||
33303998|NCT02712905|101007209|FG009|Combination Therapy|Death|0|||
33303999|NCT02712905|101007210|FG010|Combination Therapy|Death|0|||
33304000|NCT02712905|101007211|FG011|Combination Therapy|Death|0|||
33304001|NCT02712905|101007212|FG012|Combination Therapy|Death|5|||
33304002|NCT02712905|101007213|FG013|Combination Therapy|Death|6|||
33304003|NCT02712905|101007214|FG014|Combination Therapy|Death|1|||
33304004|NCT02712905|101007215|FG015|Combination Therapy|Death|3|||
33304005|NCT02712905|101007216|FG016|Combination Therapy|Death|1|||
33304006|NCT02712905|101007217|FG017|Combination Therapy|Death|3|||
33304007|NCT02712905|101007200|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
33304008|NCT02712905|101007201|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
33304009|NCT02712905|101007202|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
33304010|NCT02712905|101007203|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
33304011|NCT02712905|101007204|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
33304012|NCT02712905|101007205|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
33304013|NCT02712905|101007206|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
33304014|NCT02712905|101007207|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
33304015|NCT02712905|101007208|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
33304016|NCT02712905|101007209|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
33304017|NCT02712905|101007210|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
33304018|NCT02712905|101007211|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
33304019|NCT02712905|101007212|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
33304020|NCT02712905|101007213|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
33304021|NCT02712905|101007214|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
33304022|NCT02712905|101007215|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
33304023|NCT02712905|101007216|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
33304024|NCT02712905|101007217|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
33304025|NCT02712905|101007200|FG000|Combination Therapy|Withdrawal by Subject|0|||
33304026|NCT02712905|101007201|FG001|Combination Therapy|Withdrawal by Subject|0|||
33304027|NCT02712905|101007202|FG002|Combination Therapy|Withdrawal by Subject|0|||
33304028|NCT02712905|101007203|FG003|Combination Therapy|Withdrawal by Subject|0|||
33304029|NCT02712905|101007204|FG004|Combination Therapy|Withdrawal by Subject|0|||
33304030|NCT02712905|101007205|FG005|Combination Therapy|Withdrawal by Subject|0|||
33304031|NCT02712905|101007206|FG006|Combination Therapy|Withdrawal by Subject|0|||
33304032|NCT02712905|101007207|FG007|Combination Therapy|Withdrawal by Subject|0|||
33304033|NCT02712905|101007208|FG008|Combination Therapy|Withdrawal by Subject|0|||
33304034|NCT02712905|101007209|FG009|Combination Therapy|Withdrawal by Subject|0|||
33304035|NCT02712905|101007210|FG010|Combination Therapy|Withdrawal by Subject|0|||
33304036|NCT02712905|101007211|FG011|Combination Therapy|Withdrawal by Subject|0|||
33304037|NCT02712905|101007212|FG012|Combination Therapy|Withdrawal by Subject|0|||
33304038|NCT02712905|101007213|FG013|Combination Therapy|Withdrawal by Subject|0|||
33304039|NCT02712905|101007214|FG014|Combination Therapy|Withdrawal by Subject|0|||
33304040|NCT02712905|101007215|FG015|Combination Therapy|Withdrawal by Subject|1|||
33304041|NCT02712905|101007216|FG016|Combination Therapy|Withdrawal by Subject|0|||
33304042|NCT02712905|101007217|FG017|Combination Therapy|Withdrawal by Subject|2|||
33304043|NCT02712905|101007200|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304044|NCT02712905|101007201|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304045|NCT02712905|101007202|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304046|NCT02712905|101007203|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304047|NCT02712905|101007204|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304048|NCT02712905|101007205|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304049|NCT02712905|101007206|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304050|NCT02712905|101007207|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304051|NCT02712905|101007208|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304052|NCT02712905|101007209|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304053|NCT02712905|101007210|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33600522|NCT03759041|102088717|FG000|Overall Study|Withdrawal by Subject|4|||
33600523|NCT03759041|102088718|FG001|Overall Study|Withdrawal by Subject|10|||
33600524|NCT03759041|102088719|FG002|Overall Study|Withdrawal by Subject|10|||
33600525|NCT03759041|102088717|FG000|Overall Study|Adverse Event|1|||
33600526|NCT03759041|102088718|FG001|Overall Study|Adverse Event|3|||
33600527|NCT03759041|102088719|FG002|Overall Study|Adverse Event|4|||
33600528|NCT03759041|102088717|FG000|Overall Study|Lack of Efficacy|0|||
33600529|NCT03759041|102088718|FG001|Overall Study|Lack of Efficacy|0|||
33600530|NCT03759041|102088719|FG002|Overall Study|Lack of Efficacy|1|||
33600531|NCT03759041|102088717|FG000|Overall Study|Study Terminated by Sponsor|15|||
33600532|NCT03759041|102088718|FG001|Overall Study|Study Terminated by Sponsor|16|||
33304054|NCT02712905|101007211|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304055|NCT02712905|101007212|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304056|NCT02712905|101007213|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304057|NCT02712905|101007214|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304058|NCT02712905|101007215|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
33304059|NCT02712905|101007216|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304060|NCT02712905|101007217|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
33304061|NCT05148962|101007220|FG000|Overall Study|Withdrawal by Subject|1|||
33304062|NCT05148962|101007221|FG001|Overall Study|Withdrawal by Subject|1|||
33304063|NCT05148962|101007222|FG002|Overall Study|Withdrawal by Subject|0|||
33304064|NCT05148962|101007223|FG003|Overall Study|Withdrawal by Subject|1|||
33304065|NCT05148962|101007224|FG004|Overall Study|Withdrawal by Subject|0|||
33304066|NCT05148962|101007220|FG000|Overall Study|Participant was early terminated per protocol|0|||
33304067|NCT05148962|101007221|FG001|Overall Study|Participant was early terminated per protocol|0|||
33304068|NCT05148962|101007222|FG002|Overall Study|Participant was early terminated per protocol|3|||
33304069|NCT05148962|101007223|FG003|Overall Study|Participant was early terminated per protocol|5|||
33304070|NCT05148962|101007224|FG004|Overall Study|Participant was early terminated per protocol|2|||
33304071|NCT05148962|101007220|FG000|Overall Study|Miscellaneous|0|||
33304072|NCT05148962|101007221|FG001|Overall Study|Miscellaneous|0|||
33304073|NCT05148962|101007222|FG002|Overall Study|Miscellaneous|0|||
33304074|NCT05148962|101007223|FG003|Overall Study|Miscellaneous|1|||
33304075|NCT05148962|101007224|FG004|Overall Study|Miscellaneous|0|||
33304076|NCT03582943|101007225|FG000|Allocated to Groups|Withdrawal by Subject|1|||
33304077|NCT03582943|101007226|FG001|Allocated to Groups|Withdrawal by Subject|1|||
33304078|NCT03582943|101007225|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
33304079|NCT03582943|101007226|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
33304080|NCT03582943|101007225|FG000|Analyzed|Protocol Violation|4|||
33304081|NCT03582943|101007226|FG001|Analyzed|Protocol Violation|1|||
33498429|NCT00298272|101717374|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
33498430|NCT00298272|101717375|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
33498431|NCT00298272|101717374|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
33498432|NCT00298272|101717375|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
33498433|NCT04335123|101717376|FG000|Overall Study|Withdrawal by Subject|2|||
33498434|NCT04335123|101717377|FG001|Overall Study|Withdrawal by Subject|0|||
33498435|NCT04335123|101717376|FG000|Overall Study|Physician Decision|2|||
33498436|NCT04335123|101717377|FG001|Overall Study|Physician Decision|0|||
33498437|NCT00806403|101717378|FG000|Overall Study|Death|4|||
33498438|NCT00806403|101717379|FG001|Overall Study|Death|3|||
33600533|NCT03759041|102088719|FG002|Overall Study|Study Terminated by Sponsor|10|||
33600534|NCT03759041|102088717|FG000|Overall Study|Other reason for discontinuation|0|||
33600535|NCT03759041|102088718|FG001|Overall Study|Other reason for discontinuation|2|||
33600536|NCT03759041|102088719|FG002|Overall Study|Other reason for discontinuation|1|||
33600537|NCT03759041|102088717|FG000|Overall Study|Lost to Follow-up|7|||
33304082|NCT03339245|101007227|FG000|Overall Study|Adverse Event|1|||
33304083|NCT03339245|101007228|FG001|Overall Study|Adverse Event|1|||
33304084|NCT03339245|101007227|FG000|Overall Study|Withdrawal by Subject|1|||
33304085|NCT03339245|101007228|FG001|Overall Study|Withdrawal by Subject|0|||
33304086|NCT03828747|101007229|FG000|Double-Blind Treatment Period|Adverse Event|6|||
33304087|NCT03828747|101007230|FG001|Double-Blind Treatment Period|Adverse Event|6|||
33304088|NCT03828747|101007229|FG000|Double-Blind Treatment Period|Death|1|||
33304089|NCT03828747|101007230|FG001|Double-Blind Treatment Period|Death|1|||
33304090|NCT03828747|101007229|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33304091|NCT03828747|101007230|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
33304092|NCT03828747|101007229|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
33304093|NCT03828747|101007230|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
33304094|NCT03828747|101007229|FG000|Double-Blind Treatment Period|Physician Decision|1|||
33304095|NCT03828747|101007230|FG001|Double-Blind Treatment Period|Physician Decision|4|||
33304096|NCT03828747|101007229|FG000|Double-Blind Treatment Period|Various reasons|5|||
33304097|NCT03828747|101007230|FG001|Double-Blind Treatment Period|Various reasons|3|||
33304098|NCT03828747|101007229|FG000|Open-Label Extension|Adverse Event|9|||
33304099|NCT03828747|101007230|FG001|Open-Label Extension|Adverse Event|7|||
33304100|NCT03828747|101007229|FG000|Open-Label Extension|Death|0|||
33304101|NCT03828747|101007230|FG001|Open-Label Extension|Death|2|||
33304102|NCT03828747|101007229|FG000|Open-Label Extension|Lost to Follow-up|4|||
33304103|NCT03828747|101007230|FG001|Open-Label Extension|Lost to Follow-up|0|||
33304104|NCT03828747|101007229|FG000|Open-Label Extension|Withdrawal by Subject|31|||
33304105|NCT03828747|101007230|FG001|Open-Label Extension|Withdrawal by Subject|30|||
33304106|NCT03828747|101007229|FG000|Open-Label Extension|Various reasons|4|||
33304107|NCT03828747|101007230|FG001|Open-Label Extension|Various reasons|4|||
33304108|NCT03828747|101007229|FG000|Open-Label Extension|Physician Decision|6|||
33304109|NCT03828747|101007230|FG001|Open-Label Extension|Physician Decision|2|||
33304110|NCT02942277|101007231|FG000|Year 1|Withdrawal by Subject|0|||
33304111|NCT02942277|101007232|FG001|Year 1|Withdrawal by Subject|0|||
33304112|NCT02942277|101007233|FG002|Year 1|Withdrawal by Subject|0|||
33304113|NCT02942277|101007234|FG003|Year 1|Withdrawal by Subject|0|||
33304114|NCT02942277|101007235|FG004|Year 1|Withdrawal by Subject|1|||
33304115|NCT02942277|101007236|FG005|Year 1|Withdrawal by Subject|3|||
33304116|NCT02942277|101007237|FG006|Year 1|Withdrawal by Subject|0|||
33304117|NCT02942277|101007238|FG007|Year 1|Withdrawal by Subject|1|||
33304118|NCT02942277|101007239|FG008|Year 1|Withdrawal by Subject|0|||
33304119|NCT02942277|101007240|FG009|Year 1|Withdrawal by Subject|0|||
33304120|NCT02942277|101007241|FG010|Year 1|Withdrawal by Subject|3|||
33304121|NCT02942277|101007231|FG000|Year 1|Travel|0|||
33304122|NCT02942277|101007232|FG001|Year 1|Travel|1|||
33304123|NCT02942277|101007233|FG002|Year 1|Travel|0|||
33304124|NCT02942277|101007234|FG003|Year 1|Travel|0|||
33304125|NCT02942277|101007235|FG004|Year 1|Travel|4|||
33304126|NCT02942277|101007236|FG005|Year 1|Travel|5|||
33304127|NCT02942277|101007237|FG006|Year 1|Travel|0|||
33304128|NCT02942277|101007238|FG007|Year 1|Travel|0|||
33304129|NCT02942277|101007239|FG008|Year 1|Travel|0|||
33304130|NCT02942277|101007240|FG009|Year 1|Travel|0|||
33304131|NCT02942277|101007241|FG010|Year 1|Travel|8|||
33304132|NCT02942277|101007231|FG000|Year 1|Joined Army|0|||
33304133|NCT02942277|101007232|FG001|Year 1|Joined Army|1|||
33304134|NCT02942277|101007233|FG002|Year 1|Joined Army|0|||
33304135|NCT02942277|101007234|FG003|Year 1|Joined Army|0|||
33304136|NCT02942277|101007235|FG004|Year 1|Joined Army|0|||
33304137|NCT02942277|101007236|FG005|Year 1|Joined Army|0|||
33304138|NCT02942277|101007237|FG006|Year 1|Joined Army|0|||
33304139|NCT02942277|101007238|FG007|Year 1|Joined Army|0|||
33304140|NCT02942277|101007239|FG008|Year 1|Joined Army|0|||
33304141|NCT02942277|101007240|FG009|Year 1|Joined Army|0|||
33304142|NCT02942277|101007241|FG010|Year 1|Joined Army|0|||
33304143|NCT02942277|101007231|FG000|Year 1|Subject met withdrawal criteria|0|||
33304144|NCT02942277|101007232|FG001|Year 1|Subject met withdrawal criteria|0|||
33304145|NCT02942277|101007233|FG002|Year 1|Subject met withdrawal criteria|0|||
33304146|NCT02942277|101007234|FG003|Year 1|Subject met withdrawal criteria|1|||
33304147|NCT02942277|101007235|FG004|Year 1|Subject met withdrawal criteria|0|||
33304148|NCT02942277|101007236|FG005|Year 1|Subject met withdrawal criteria|0|||
33498439|NCT02454608|101717380|FG000|Double-Blind Period|Lack of Efficacy|0|||
33304149|NCT02942277|101007237|FG006|Year 1|Subject met withdrawal criteria|0|||
33304150|NCT02942277|101007238|FG007|Year 1|Subject met withdrawal criteria|0|||
33304151|NCT02942277|101007239|FG008|Year 1|Subject met withdrawal criteria|0|||
33304152|NCT02942277|101007240|FG009|Year 1|Subject met withdrawal criteria|0|||
33304153|NCT02942277|101007241|FG010|Year 1|Subject met withdrawal criteria|0|||
33304154|NCT02942277|101007231|FG000|Year 1|Lost to Follow-up|0|||
33304155|NCT02942277|101007232|FG001|Year 1|Lost to Follow-up|0|||
33304156|NCT02942277|101007233|FG002|Year 1|Lost to Follow-up|0|||
33304157|NCT02942277|101007234|FG003|Year 1|Lost to Follow-up|0|||
33304158|NCT02942277|101007235|FG004|Year 1|Lost to Follow-up|1|||
33304159|NCT02942277|101007236|FG005|Year 1|Lost to Follow-up|0|||
33304160|NCT02942277|101007237|FG006|Year 1|Lost to Follow-up|0|||
33600538|NCT03759041|102088718|FG001|Overall Study|Lost to Follow-up|2|||
33600539|NCT03759041|102088719|FG002|Overall Study|Lost to Follow-up|2|||
33600540|NCT03759041|102088717|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
33600541|NCT03759041|102088718|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
33304161|NCT02942277|101007238|FG007|Year 1|Lost to Follow-up|0|||
33304162|NCT02942277|101007239|FG008|Year 1|Lost to Follow-up|0|||
33304163|NCT02942277|101007240|FG009|Year 1|Lost to Follow-up|0|||
33304164|NCT02942277|101007241|FG010|Year 1|Lost to Follow-up|2|||
33304165|NCT02942277|101007231|FG000|Year 1|Protocol Violation|0|||
33304166|NCT02942277|101007232|FG001|Year 1|Protocol Violation|0|||
33304167|NCT02942277|101007233|FG002|Year 1|Protocol Violation|0|||
33304168|NCT02942277|101007234|FG003|Year 1|Protocol Violation|0|||
33304169|NCT02942277|101007235|FG004|Year 1|Protocol Violation|1|||
33304170|NCT02942277|101007236|FG005|Year 1|Protocol Violation|1|||
33304171|NCT02942277|101007237|FG006|Year 1|Protocol Violation|0|||
33304172|NCT02942277|101007238|FG007|Year 1|Protocol Violation|0|||
33304173|NCT02942277|101007239|FG008|Year 1|Protocol Violation|0|||
33304174|NCT02942277|101007240|FG009|Year 1|Protocol Violation|0|||
33304175|NCT02942277|101007241|FG010|Year 1|Protocol Violation|2|||
33304176|NCT02942277|101007231|FG000|Year 1|Pregnancy|0|||
33304177|NCT02942277|101007232|FG001|Year 1|Pregnancy|0|||
33304178|NCT02942277|101007233|FG002|Year 1|Pregnancy|0|||
33304179|NCT02942277|101007234|FG003|Year 1|Pregnancy|0|||
33304180|NCT02942277|101007235|FG004|Year 1|Pregnancy|0|||
33304181|NCT02942277|101007236|FG005|Year 1|Pregnancy|1|||
33304182|NCT02942277|101007237|FG006|Year 1|Pregnancy|0|||
33304183|NCT02942277|101007238|FG007|Year 1|Pregnancy|0|||
33304184|NCT02942277|101007239|FG008|Year 1|Pregnancy|0|||
33304185|NCT02942277|101007240|FG009|Year 1|Pregnancy|0|||
33304186|NCT02942277|101007241|FG010|Year 1|Pregnancy|0|||
33304187|NCT02942277|101007231|FG000|Year 2|Lost to Follow-up|0|||
33304188|NCT02942277|101007232|FG001|Year 2|Lost to Follow-up|0|||
33304189|NCT02942277|101007233|FG002|Year 2|Lost to Follow-up|0|||
33304190|NCT02942277|101007234|FG003|Year 2|Lost to Follow-up|0|||
33304191|NCT02942277|101007235|FG004|Year 2|Lost to Follow-up|2|||
33304192|NCT02942277|101007236|FG005|Year 2|Lost to Follow-up|1|||
33304193|NCT02942277|101007237|FG006|Year 2|Lost to Follow-up|0|||
33304194|NCT02942277|101007238|FG007|Year 2|Lost to Follow-up|0|||
33304195|NCT02942277|101007239|FG008|Year 2|Lost to Follow-up|0|||
33304196|NCT02942277|101007240|FG009|Year 2|Lost to Follow-up|0|||
33304197|NCT02942277|101007241|FG010|Year 2|Lost to Follow-up|0|||
33304198|NCT02942277|101007231|FG000|Year 2|Did not rescreen|0|||
33304199|NCT02942277|101007232|FG001|Year 2|Did not rescreen|0|||
33304200|NCT02942277|101007233|FG002|Year 2|Did not rescreen|1|||
33304201|NCT02942277|101007234|FG003|Year 2|Did not rescreen|1|||
33304202|NCT02942277|101007235|FG004|Year 2|Did not rescreen|9|||
33304203|NCT02942277|101007236|FG005|Year 2|Did not rescreen|6|||
33304204|NCT02942277|101007237|FG006|Year 2|Did not rescreen|0|||
33304205|NCT02942277|101007238|FG007|Year 2|Did not rescreen|1|||
33304206|NCT02942277|101007239|FG008|Year 2|Did not rescreen|0|||
33304207|NCT02942277|101007240|FG009|Year 2|Did not rescreen|0|||
33304208|NCT02942277|101007241|FG010|Year 2|Did not rescreen|21|||
33304209|NCT02942277|101007231|FG000|Year 2|Met withdrawal criteria|0|||
33304210|NCT02942277|101007232|FG001|Year 2|Met withdrawal criteria|0|||
33304211|NCT02942277|101007233|FG002|Year 2|Met withdrawal criteria|0|||
33304212|NCT02942277|101007234|FG003|Year 2|Met withdrawal criteria|0|||
33393693|NCT03073200|101328512|FG001|Extension Period|Withdrawal by Subject|0|||
33600542|NCT03759041|102088719|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
33600543|NCT03276052|102088720|FG000|Overall Study|Withdrawal by Subject|5|||
33600544|NCT03276052|102088720|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
33304213|NCT02942277|101007235|FG004|Year 2|Met withdrawal criteria|1|||
33304214|NCT02942277|101007236|FG005|Year 2|Met withdrawal criteria|2|||
33393694|NCT03073200|101328513|FG002|Extension Period|Withdrawal by Subject|0|||
33393695|NCT03073200|101328514|FG003|Extension Period|Withdrawal by Subject|0|||
33304215|NCT02942277|101007237|FG006|Year 2|Met withdrawal criteria|0|||
33304216|NCT02942277|101007238|FG007|Year 2|Met withdrawal criteria|0|||
33304217|NCT02942277|101007239|FG008|Year 2|Met withdrawal criteria|0|||
33304218|NCT02942277|101007240|FG009|Year 2|Met withdrawal criteria|0|||
33304219|NCT02942277|101007241|FG010|Year 2|Met withdrawal criteria|1|||
33304220|NCT02942277|101007231|FG000|Year 2|Travel|0|||
33304221|NCT02942277|101007232|FG001|Year 2|Travel|1|||
33304222|NCT02942277|101007233|FG002|Year 2|Travel|0|||
33304223|NCT02942277|101007234|FG003|Year 2|Travel|0|||
33304224|NCT02942277|101007235|FG004|Year 2|Travel|0|||
33304225|NCT02942277|101007236|FG005|Year 2|Travel|1|||
33304226|NCT02942277|101007237|FG006|Year 2|Travel|0|||
33304227|NCT02942277|101007238|FG007|Year 2|Travel|0|||
33304228|NCT02942277|101007239|FG008|Year 2|Travel|0|||
33304229|NCT02942277|101007240|FG009|Year 2|Travel|1|||
33304230|NCT02942277|101007241|FG010|Year 2|Travel|3|||
33304231|NCT02942277|101007231|FG000|Year 2|Non-compliant|0|||
33304232|NCT02942277|101007232|FG001|Year 2|Non-compliant|0|||
33600545|NCT03242018|102088723|FG000|Overall Study|Adverse Event|7|||
33600546|NCT03242018|102088724|FG001|Overall Study|Adverse Event|7|||
33600547|NCT03242018|102088725|FG002|Overall Study|Adverse Event|6|||
33600548|NCT03242018|102088723|FG000|Overall Study|Lost to Follow-up|2|||
33600549|NCT03242018|102088724|FG001|Overall Study|Lost to Follow-up|2|||
33600550|NCT03242018|102088725|FG002|Overall Study|Lost to Follow-up|2|||
33600551|NCT03242018|102088723|FG000|Overall Study|At the Participant's Own Request|5|||
33600552|NCT03242018|102088724|FG001|Overall Study|At the Participant's Own Request|1|||
33600553|NCT03242018|102088725|FG002|Overall Study|At the Participant's Own Request|4|||
33600554|NCT03242018|102088723|FG000|Overall Study|Reason Not Specified|3|||
33304233|NCT02942277|101007233|FG002|Year 2|Non-compliant|0|||
33304234|NCT02942277|101007234|FG003|Year 2|Non-compliant|0|||
33304235|NCT02942277|101007235|FG004|Year 2|Non-compliant|1|||
33304236|NCT02942277|101007236|FG005|Year 2|Non-compliant|1|||
33304237|NCT02942277|101007237|FG006|Year 2|Non-compliant|0|||
33304238|NCT02942277|101007238|FG007|Year 2|Non-compliant|0|||
33304239|NCT02942277|101007239|FG008|Year 2|Non-compliant|0|||
33304240|NCT02942277|101007240|FG009|Year 2|Non-compliant|0|||
33304241|NCT02942277|101007241|FG010|Year 2|Non-compliant|0|||
33304242|NCT02942277|101007231|FG000|Year 2|Withdrawal by Subject|0|||
33304243|NCT02942277|101007232|FG001|Year 2|Withdrawal by Subject|0|||
33304244|NCT02942277|101007233|FG002|Year 2|Withdrawal by Subject|0|||
33304245|NCT02942277|101007234|FG003|Year 2|Withdrawal by Subject|0|||
33304246|NCT02942277|101007235|FG004|Year 2|Withdrawal by Subject|0|||
33304247|NCT02942277|101007236|FG005|Year 2|Withdrawal by Subject|0|||
33304248|NCT02942277|101007237|FG006|Year 2|Withdrawal by Subject|1|||
33304249|NCT02942277|101007238|FG007|Year 2|Withdrawal by Subject|0|||
33304250|NCT02942277|101007239|FG008|Year 2|Withdrawal by Subject|0|||
33304251|NCT02942277|101007240|FG009|Year 2|Withdrawal by Subject|0|||
33304252|NCT02942277|101007241|FG010|Year 2|Withdrawal by Subject|0|||
33304253|NCT01081132|101007244|FG000|Overall Study|Lack of Efficacy|25|||
33304254|NCT01081132|101007245|FG001|Overall Study|Lack of Efficacy|9|||
33304255|NCT01081132|101007244|FG000|Overall Study|Withdrawal by Subject|13|||
33304256|NCT01081132|101007245|FG001|Overall Study|Withdrawal by Subject|16|||
33304257|NCT01081132|101007244|FG000|Overall Study|Lost to Follow-up|4|||
33304258|NCT01081132|101007245|FG001|Overall Study|Lost to Follow-up|11|||
33304259|NCT01081132|101007244|FG000|Overall Study|Adverse Event|3|||
33304260|NCT01081132|101007245|FG001|Overall Study|Adverse Event|9|||
33304261|NCT01081132|101007244|FG000|Overall Study|Non Compliance|4|||
33304262|NCT01081132|101007245|FG001|Overall Study|Non Compliance|2|||
33304263|NCT01081132|101007244|FG000|Overall Study|Lack Of Compliance|0|||
33304264|NCT01081132|101007245|FG001|Overall Study|Lack Of Compliance|1|||
33498440|NCT02454608|101717381|FG001|Double-Blind Period|Lack of Efficacy|2|||
33498441|NCT02454608|101717382|FG002|Double-Blind Period|Lack of Efficacy|0|||
33498442|NCT02454608|101717380|FG000|Open Label Period|Lost to Follow-up|0|||
33498443|NCT02454608|101717381|FG001|Open Label Period|Lost to Follow-up|0|||
33498444|NCT02454608|101717382|FG002|Open Label Period|Lost to Follow-up|11|||
33498445|NCT02454608|101717380|FG000|Open Label Period|Withdrawal by Subject|0|||
33498446|NCT02454608|101717381|FG001|Open Label Period|Withdrawal by Subject|0|||
33498447|NCT02454608|101717382|FG002|Open Label Period|Withdrawal by Subject|8|||
33498448|NCT01408303|101717385|FG000|Overall Study|Adverse Event|3|||
33498449|NCT01408303|101717386|FG001|Overall Study|Adverse Event|7|||
33498450|NCT01408303|101717387|FG002|Overall Study|Adverse Event|2|||
33498451|NCT01408303|101717385|FG000|Overall Study|Lost to Follow-up|0|||
33498452|NCT01408303|101717386|FG001|Overall Study|Lost to Follow-up|1|||
33498453|NCT01408303|101717387|FG002|Overall Study|Lost to Follow-up|2|||
33498454|NCT01408303|101717385|FG000|Overall Study|Withdrawal by Subject|2|||
33498455|NCT01408303|101717386|FG001|Overall Study|Withdrawal by Subject|3|||
33498456|NCT01408303|101717387|FG002|Overall Study|Withdrawal by Subject|1|||
33498457|NCT01408303|101717385|FG000|Overall Study|Protocol Violation|0|||
33498458|NCT01408303|101717386|FG001|Overall Study|Protocol Violation|1|||
33498459|NCT01408303|101717387|FG002|Overall Study|Protocol Violation|0|||
33498460|NCT01408303|101717385|FG000|Overall Study|Noncompliance|1|||
33498461|NCT01408303|101717386|FG001|Overall Study|Noncompliance|0|||
33600555|NCT03242018|102088724|FG001|Overall Study|Reason Not Specified|4|||
33600556|NCT03242018|102088725|FG002|Overall Study|Reason Not Specified|1|||
33600557|NCT03242018|102088723|FG000|Overall Study|Study Terminated by Sponsor|1|||
33304265|NCT01081132|101007244|FG000|Overall Study|Missed Visits|1|||
33600558|NCT03242018|102088724|FG001|Overall Study|Study Terminated by Sponsor|0|||
33304266|NCT01081132|101007245|FG001|Overall Study|Missed Visits|1|||
33304267|NCT01081132|101007244|FG000|Overall Study|Stopped Taking Meds|2|||
33304268|NCT01081132|101007245|FG001|Overall Study|Stopped Taking Meds|0|||
33304269|NCT01081132|101007244|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
33304270|NCT01081132|101007245|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
33498462|NCT01408303|101717387|FG002|Overall Study|Noncompliance|1|||
33498463|NCT04630002|101717388|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
33498464|NCT04630002|101717389|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
33498465|NCT04630002|101717390|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
33304271|NCT01081132|101007244|FG000|Overall Study|Declined Taper Phase|0|||
33304272|NCT01081132|101007245|FG001|Overall Study|Declined Taper Phase|1|||
33304273|NCT01081132|101007244|FG000|Overall Study|Protocol Violation|3|||
33304274|NCT01081132|101007245|FG001|Overall Study|Protocol Violation|1|||
33304275|NCT00528931|101007246|FG000|Overall Study|Lost to Follow-up|1|||
33304276|NCT01258595|101007247|FG000|Overall Study|Lost to Follow-up|1|||
33304277|NCT01258595|101007248|FG001|Overall Study|Lost to Follow-up|0|||
33304278|NCT01258595|101007247|FG000|Overall Study|Withdrawal by Subject|0|||
33304279|NCT01258595|101007248|FG001|Overall Study|Withdrawal by Subject|1|||
33304280|NCT04772898|101007256|FG000|Overall Study|Withdrawal by Subject|0|||
33304281|NCT04772898|101007257|FG001|Overall Study|Withdrawal by Subject|1|||
33304282|NCT01076647|101007258|FG000|Overall Study|Adverse Event|4|||
33304283|NCT01076647|101007259|FG001|Overall Study|Adverse Event|1|||
33304284|NCT01076647|101007258|FG000|Overall Study|Lack of Efficacy|0|||
33304285|NCT01076647|101007259|FG001|Overall Study|Lack of Efficacy|1|||
33304286|NCT01076647|101007258|FG000|Overall Study|Protocol Violation|7|||
33304287|NCT01076647|101007259|FG001|Overall Study|Protocol Violation|9|||
33304288|NCT01076647|101007258|FG000|Overall Study|Withdrawal criteria|2|||
33304289|NCT01076647|101007259|FG001|Overall Study|Withdrawal criteria|2|||
33304290|NCT01076647|101007258|FG000|Overall Study|Unclassified|12|||
33304291|NCT01076647|101007259|FG001|Overall Study|Unclassified|12|||
33304292|NCT02182947|101007260|FG000|Overall Study|Withdrawal by Subject|7|||
33304293|NCT02182947|101007260|FG000|Overall Study|Lost to Follow-up|3|||
33304294|NCT02182947|101007260|FG000|Overall Study|Failed screening activities|8|||
33304295|NCT00506441|101007262|FG000|Period 1; Open-label Period|Adverse Event|21|||
33304296|NCT00506441|101007263|FG001|Period 1; Open-label Period|Adverse Event|0|||
33304297|NCT00506441|101007262|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
33304298|NCT00506441|101007263|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
33304299|NCT00506441|101007262|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
33304300|NCT00506441|101007263|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
33304301|NCT00506441|101007262|FG000|Period 1; Open-label Period|Physician Decision|5|||
33304302|NCT00506441|101007263|FG001|Period 1; Open-label Period|Physician Decision|0|||
33304303|NCT00506441|101007262|FG000|Period 1; Open-label Period|Protocol Violation|9|||
33304304|NCT00506441|101007263|FG001|Period 1; Open-label Period|Protocol Violation|0|||
33304305|NCT00506441|101007262|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
33304306|NCT00506441|101007263|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
33304307|NCT00506441|101007262|FG000|Period 1; Open-label Period|Other Reasons|13|||
33304308|NCT00506441|101007263|FG001|Period 1; Open-label Period|Other Reasons|0|||
33304309|NCT00506441|101007262|FG000|Period 2; Double-blind Period|Adverse Event|0|||
33304310|NCT00506441|101007263|FG001|Period 2; Double-blind Period|Adverse Event|1|||
33304311|NCT00506441|101007262|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
33304312|NCT00506441|101007263|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
33304313|NCT00506441|101007262|FG000|Period 2; Double-blind Period|Physician Decision|1|||
33304314|NCT00506441|101007263|FG001|Period 2; Double-blind Period|Physician Decision|1|||
33304315|NCT00506441|101007262|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
33304316|NCT00506441|101007263|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
33304317|NCT00506441|101007262|FG000|Period 2; Double-blind Period|Other Reason|1|||
33304318|NCT00506441|101007263|FG001|Period 2; Double-blind Period|Other Reason|1|||
33304319|NCT04101318|101007264|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
33304320|NCT04101318|101007265|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
33304321|NCT04101318|101007264|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
33304322|NCT04101318|101007265|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
33304323|NCT04101318|101007264|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
33304324|NCT04101318|101007265|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
33304325|NCT00910039|101007266|FG000|Overall Study|Physician Decision|1|||
33304326|NCT01129102|101007270|FG000|Overall Study|No study drug treatment|2|||
33304327|NCT01129102|101007271|FG001|Overall Study|No study drug treatment|3|||
33304328|NCT01129102|101007272|FG002|Overall Study|No study drug treatment|1|||
33304329|NCT01129102|101007270|FG000|Overall Study|Withdrawal by Subject|2|||
33304330|NCT01129102|101007271|FG001|Overall Study|Withdrawal by Subject|0|||
33304331|NCT01129102|101007272|FG002|Overall Study|Withdrawal by Subject|3|||
33304332|NCT01129102|101007270|FG000|Overall Study|Protocol Violation|0|||
33304333|NCT01129102|101007271|FG001|Overall Study|Protocol Violation|1|||
33304334|NCT01129102|101007272|FG002|Overall Study|Protocol Violation|1|||
33304335|NCT01129102|101007270|FG000|Overall Study|Pregnancy|0|||
33304336|NCT01129102|101007271|FG001|Overall Study|Pregnancy|0|||
33304337|NCT01129102|101007272|FG002|Overall Study|Pregnancy|1|||
33304338|NCT01129102|101007270|FG000|Overall Study|Adverse Event|2|||
33304339|NCT01129102|101007271|FG001|Overall Study|Adverse Event|2|||
33304340|NCT01129102|101007272|FG002|Overall Study|Adverse Event|1|||
33304341|NCT01129102|101007270|FG000|Overall Study|Lost to Follow-up|2|||
33304342|NCT01129102|101007271|FG001|Overall Study|Lost to Follow-up|0|||
33498466|NCT04630002|101717388|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
33498467|NCT04630002|101717389|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
33498468|NCT04630002|101717390|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
33498469|NCT04630002|101717388|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
33498470|NCT04630002|101717389|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
33498471|NCT04630002|101717390|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
33498472|NCT04630002|101717388|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
33498473|NCT04630002|101717389|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
33498474|NCT04630002|101717390|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
33498475|NCT04630002|101717388|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
33498476|NCT04630002|101717389|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
33498477|NCT04630002|101717390|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
33498478|NCT04630002|101717388|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
33498479|NCT04630002|101717389|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
33498480|NCT04630002|101717390|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
33498481|NCT04630002|101717388|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
33498482|NCT04630002|101717389|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
33498483|NCT04630002|101717390|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
33498484|NCT04630002|101717388|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
33498485|NCT04630002|101717389|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
33498486|NCT04630002|101717390|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
33498487|NCT00529087|101717392|FG000|Overall Study|Adverse Event|10|||
33498488|NCT00529087|101717393|FG001|Overall Study|Adverse Event|13|||
33498489|NCT00529087|101717394|FG002|Overall Study|Adverse Event|4|||
33498490|NCT00529087|101717392|FG000|Overall Study|Lost to Follow-up|6|||
33498491|NCT00529087|101717393|FG001|Overall Study|Lost to Follow-up|4|||
33498492|NCT00529087|101717394|FG002|Overall Study|Lost to Follow-up|1|||
33498493|NCT00529087|101717392|FG000|Overall Study|Protocol Violation|8|||
33498494|NCT00529087|101717393|FG001|Overall Study|Protocol Violation|7|||
33498495|NCT00529087|101717394|FG002|Overall Study|Protocol Violation|6|||
33498496|NCT00529087|101717392|FG000|Overall Study|Withdrawal by Subject|3|||
33498497|NCT00529087|101717393|FG001|Overall Study|Withdrawal by Subject|3|||
33498498|NCT00529087|101717394|FG002|Overall Study|Withdrawal by Subject|3|||
33498499|NCT00529087|101717392|FG000|Overall Study|Protocol deviation|1|||
33498500|NCT00529087|101717393|FG001|Overall Study|Protocol deviation|1|||
33498501|NCT00529087|101717394|FG002|Overall Study|Protocol deviation|2|||
33498502|NCT00449865|101717397|FG000|Overall Study|Withdrawal by Subject|110|||
33498503|NCT00449865|101717398|FG001|Overall Study|Withdrawal by Subject|110|||
33498504|NCT00449865|101717397|FG000|Overall Study|Lost to Follow-up|36|||
33498505|NCT00449865|101717398|FG001|Overall Study|Lost to Follow-up|37|||
33498506|NCT00449865|101717397|FG000|Overall Study|Physician Decision|13|||
33498507|NCT00449865|101717398|FG001|Overall Study|Physician Decision|12|||
33498508|NCT00449865|101717397|FG000|Overall Study|Death|31|||
33498509|NCT00449865|101717398|FG001|Overall Study|Death|40|||
33304343|NCT01129102|101007272|FG002|Overall Study|Lost to Follow-up|0|||
33304344|NCT04738292|101007273|FG000|Overall Study|Death|1|||
33304345|NCT00266227|101007274|FG000|Initial Treatment|Adverse Event|0|||
33304346|NCT00266227|101007275|FG001|Initial Treatment|Adverse Event|0|||
33304347|NCT00266227|101007276|FG002|Initial Treatment|Adverse Event|13|||
33393696|NCT03073200|101328515|FG004|Extension Period|Withdrawal by Subject|0|||
33498510|NCT00449865|101717397|FG000|Overall Study|Protocol Violation|8|||
33498511|NCT00449865|101717398|FG001|Overall Study|Protocol Violation|7|||
33498512|NCT00449865|101717397|FG000|Overall Study|Study was stopped|324|||
33498513|NCT00449865|101717398|FG001|Overall Study|Study was stopped|328|||
33498514|NCT01113892|101717400|FG000|Overall Study|Lost to Follow-up|2|||
33498515|NCT01113892|101717401|FG001|Overall Study|Lost to Follow-up|2|||
33498516|NCT01113892|101717400|FG000|Overall Study|Withdrawal by Subject|1|||
33304348|NCT00266227|101007274|FG000|Initial Treatment|Lost to Follow-up|0|||
33498517|NCT01113892|101717401|FG001|Overall Study|Withdrawal by Subject|1|||
33498518|NCT01113892|101717400|FG000|Overall Study|Death|2|||
33498519|NCT01113892|101717401|FG001|Overall Study|Death|4|||
33498520|NCT01113892|101717400|FG000|Overall Study|Graft no longer evaluable|9|||
33498521|NCT01113892|101717401|FG001|Overall Study|Graft no longer evaluable|9|||
33498522|NCT02044302|101717409|FG000|Overall Study|study terminated|2|||
33498523|NCT02044302|101717410|FG001|Overall Study|study terminated|0|||
33498524|NCT00320710|101717414|FG000|Overall Study|Disease progression|24|||
33498525|NCT00320710|101717415|FG001|Overall Study|Disease progression|19|||
33498526|NCT00320710|101717416|FG002|Overall Study|Disease progression|2|||
33498527|NCT00320710|101717414|FG000|Overall Study|Death|10|||
33498528|NCT00320710|101717415|FG001|Overall Study|Death|7|||
33498529|NCT00320710|101717416|FG002|Overall Study|Death|1|||
33498530|NCT00320710|101717414|FG000|Overall Study|Administrative problems|1|||
33498531|NCT00320710|101717415|FG001|Overall Study|Administrative problems|2|||
33498532|NCT00320710|101717416|FG002|Overall Study|Administrative problems|0|||
33498533|NCT00320710|101717414|FG000|Overall Study|Withdrawal by Subject|20|||
33498534|NCT00320710|101717415|FG001|Overall Study|Withdrawal by Subject|26|||
33498535|NCT00320710|101717416|FG002|Overall Study|Withdrawal by Subject|1|||
33498536|NCT00320710|101717414|FG000|Overall Study|Protocol Violation|6|||
33498537|NCT00320710|101717415|FG001|Overall Study|Protocol Violation|5|||
33498538|NCT00320710|101717416|FG002|Overall Study|Protocol Violation|0|||
33498539|NCT00320710|101717414|FG000|Overall Study|Abnormal test procedure result(s)|2|||
33498540|NCT00320710|101717415|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33498541|NCT00320710|101717416|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33498542|NCT00320710|101717414|FG000|Overall Study|Abnormal laboratory value(s)|12|||
33498543|NCT00320710|101717415|FG001|Overall Study|Abnormal laboratory value(s)|3|||
33498544|NCT00320710|101717416|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33498545|NCT00320710|101717414|FG000|Overall Study|Adverse Event|18|||
33498546|NCT00320710|101717415|FG001|Overall Study|Adverse Event|14|||
33498547|NCT00320710|101717416|FG002|Overall Study|Adverse Event|1|||
33498548|NCT00320710|101717414|FG000|Overall Study|Lost to Follow-up|1|||
33498549|NCT00320710|101717415|FG001|Overall Study|Lost to Follow-up|0|||
33393697|NCT03073200|101328516|FG005|Extension Period|Withdrawal by Subject|0|||
33498550|NCT00320710|101717416|FG002|Overall Study|Lost to Follow-up|0|||
33498551|NCT02062450|101717421|FG000|Overall Study|No follow-up visit|124|||
33498552|NCT00634803|101717422|FG000|Overall Study|Lost to Follow-up|6|||
33498553|NCT00634803|101717423|FG001|Overall Study|Lost to Follow-up|7|||
33498554|NCT00634803|101717424|FG002|Overall Study|Lost to Follow-up|7|||
33498555|NCT02509507|101717425|FG000|Overall Study|Death|21|||
33498556|NCT02509507|101717426|FG001|Overall Study|Death|3|||
33498557|NCT02509507|101717427|FG002|Overall Study|Death|22|||
33498558|NCT02509507|101717428|FG003|Overall Study|Death|14|||
33498559|NCT02509507|101717429|FG004|Overall Study|Death|8|||
33498560|NCT02509507|101717430|FG005|Overall Study|Death|12|||
33498561|NCT02509507|101717431|FG006|Overall Study|Death|5|||
33498562|NCT02509507|101717432|FG007|Overall Study|Death|4|||
33498563|NCT02509507|101717433|FG008|Overall Study|Death|8|||
33498564|NCT02509507|101717425|FG000|Overall Study|Lost to Follow-up|0|||
33498565|NCT02509507|101717426|FG001|Overall Study|Lost to Follow-up|1|||
33498566|NCT02509507|101717427|FG002|Overall Study|Lost to Follow-up|0|||
33498567|NCT02509507|101717428|FG003|Overall Study|Lost to Follow-up|0|||
33498568|NCT02509507|101717429|FG004|Overall Study|Lost to Follow-up|0|||
33498569|NCT02509507|101717430|FG005|Overall Study|Lost to Follow-up|2|||
33498570|NCT02509507|101717431|FG006|Overall Study|Lost to Follow-up|0|||
33498571|NCT02509507|101717432|FG007|Overall Study|Lost to Follow-up|0|||
33498572|NCT02509507|101717433|FG008|Overall Study|Lost to Follow-up|0|||
33498573|NCT02509507|101717425|FG000|Overall Study|Withdrawal by Subject|2|||
33393698|NCT03073200|101328517|FG006|Extension Period|Withdrawal by Subject|1|||
33393699|NCT03073200|101328518|FG007|Extension Period|Withdrawal by Subject|2|||
33393700|NCT03073200|101328519|FG008|Extension Period|Withdrawal by Subject|0|||
33393701|NCT03073200|101328520|FG009|Extension Period|Withdrawal by Subject|0|||
33393702|NCT03073200|101328521|FG010|Extension Period|Withdrawal by Subject|0|||
33393703|NCT03073200|101328522|FG011|Extension Period|Withdrawal by Subject|0|||
33393704|NCT03073200|101328523|FG012|Extension Period|Withdrawal by Subject|0|||
33393705|NCT03073200|101328524|FG013|Extension Period|Withdrawal by Subject|0|||
33393706|NCT03073200|101328525|FG014|Extension Period|Withdrawal by Subject|0|||
33393707|NCT03073200|101328511|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
33393708|NCT03073200|101328512|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
33393709|NCT03073200|101328513|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
33393710|NCT03073200|101328514|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
33393711|NCT03073200|101328515|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
33393712|NCT03073200|101328516|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
33393713|NCT03073200|101328517|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
33393714|NCT03073200|101328518|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
33393715|NCT03073200|101328519|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
33393716|NCT03073200|101328520|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
33393717|NCT03073200|101328521|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
33498574|NCT02509507|101717426|FG001|Overall Study|Withdrawal by Subject|0|||
33498575|NCT02509507|101717427|FG002|Overall Study|Withdrawal by Subject|1|||
33498576|NCT02509507|101717428|FG003|Overall Study|Withdrawal by Subject|4|||
33498577|NCT02509507|101717429|FG004|Overall Study|Withdrawal by Subject|1|||
33498578|NCT02509507|101717430|FG005|Overall Study|Withdrawal by Subject|3|||
33498579|NCT02509507|101717431|FG006|Overall Study|Withdrawal by Subject|4|||
33498580|NCT02509507|101717432|FG007|Overall Study|Withdrawal by Subject|0|||
33498581|NCT02509507|101717433|FG008|Overall Study|Withdrawal by Subject|1|||
33498582|NCT01286467|101717434|FG000|Overall Study|Death|1|||
33498583|NCT01286467|101717435|FG001|Overall Study|Death|1|||
33498584|NCT01286467|101717436|FG002|Overall Study|Death|1|||
33498585|NCT01286467|101717437|FG003|Overall Study|Death|0|||
33498586|NCT01286467|101717434|FG000|Overall Study|Lost to Follow-up|0|||
33498587|NCT01286467|101717435|FG001|Overall Study|Lost to Follow-up|0|||
33498588|NCT01286467|101717436|FG002|Overall Study|Lost to Follow-up|0|||
33498589|NCT01286467|101717437|FG003|Overall Study|Lost to Follow-up|1|||
33498590|NCT01286467|101717434|FG000|Overall Study|Withdrawal by Subject|0|||
33498591|NCT01286467|101717435|FG001|Overall Study|Withdrawal by Subject|0|||
33498592|NCT01286467|101717436|FG002|Overall Study|Withdrawal by Subject|1|||
33498593|NCT01286467|101717437|FG003|Overall Study|Withdrawal by Subject|0|||
33498594|NCT01286467|101717434|FG000|Overall Study|Physician Decision|0|||
33498595|NCT01286467|101717435|FG001|Overall Study|Physician Decision|0|||
33498596|NCT01286467|101717436|FG002|Overall Study|Physician Decision|0|||
33498597|NCT01286467|101717437|FG003|Overall Study|Physician Decision|1|||
33498598|NCT01286467|101717434|FG000|Overall Study|Disease progression|3|||
33498599|NCT01286467|101717435|FG001|Overall Study|Disease progression|2|||
33498600|NCT01286467|101717436|FG002|Overall Study|Disease progression|2|||
33498601|NCT01286467|101717437|FG003|Overall Study|Disease progression|3|||
33498602|NCT01286467|101717434|FG000|Overall Study|Adverse Event|0|||
33498603|NCT01286467|101717435|FG001|Overall Study|Adverse Event|1|||
33498604|NCT01286467|101717436|FG002|Overall Study|Adverse Event|2|||
33498605|NCT01286467|101717437|FG003|Overall Study|Adverse Event|3|||
33498606|NCT01286467|101717434|FG000|Overall Study|Study drug stop longer than 14 days|0|||
33498607|NCT01286467|101717435|FG001|Overall Study|Study drug stop longer than 14 days|0|||
33498608|NCT01286467|101717436|FG002|Overall Study|Study drug stop longer than 14 days|1|||
33498609|NCT01286467|101717437|FG003|Overall Study|Study drug stop longer than 14 days|0|||
33498610|NCT03379727|101717438|FG000|Overall Study|Lack of Efficacy|73|||
33498611|NCT03379727|101717438|FG000|Overall Study|Adverse Event|32|||
33498612|NCT03379727|101717438|FG000|Overall Study|Death|18|||
33498613|NCT03379727|101717438|FG000|Overall Study|Patient/guardian decision|17|||
33498614|NCT03379727|101717438|FG000|Overall Study|Physician Decision|104|||
33498615|NCT03379727|101717438|FG000|Overall Study|Protocol Violation|4|||
33498616|NCT03379727|101717438|FG000|Overall Study|Lost to Follow-up|1|||
33304349|NCT00266227|101007275|FG001|Initial Treatment|Lost to Follow-up|0|||
33498617|NCT03526861|101717441|FG000|Initial Treatment Period|Not dosed|1|||
33498618|NCT03526861|101717442|FG001|Initial Treatment Period|Not dosed|1|||
33498619|NCT03526861|101717443|FG002|Initial Treatment Period|Not dosed|1|||
33498620|NCT03526861|101717444|FG003|Initial Treatment Period|Not dosed|0|||
33498621|NCT03526861|101717445|FG004|Initial Treatment Period|Not dosed|0|||
33498622|NCT03526861|101717446|FG005|Initial Treatment Period|Not dosed|0|||
33304350|NCT00266227|101007276|FG002|Initial Treatment|Lost to Follow-up|6|||
33304351|NCT00266227|101007274|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
33304352|NCT00266227|101007275|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
33304353|NCT00266227|101007276|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
33304354|NCT00266227|101007274|FG000|Initial Treatment|Physician decision to withdraw|0|||
33304355|NCT00266227|101007275|FG001|Initial Treatment|Physician decision to withdraw|0|||
33304356|NCT00266227|101007276|FG002|Initial Treatment|Physician decision to withdraw|12|||
33304357|NCT00266227|101007274|FG000|Initial Treatment|Pregnancy|0|||
33304358|NCT00266227|101007275|FG001|Initial Treatment|Pregnancy|0|||
33304359|NCT00266227|101007276|FG002|Initial Treatment|Pregnancy|1|||
33304360|NCT00266227|101007274|FG000|Retreatment: Up to Week 48|Death|1|||
33304361|NCT00266227|101007275|FG001|Retreatment: Up to Week 48|Death|0|||
33304362|NCT00266227|101007276|FG002|Retreatment: Up to Week 48|Death|0|||
33304363|NCT00266227|101007274|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
33304364|NCT00266227|101007275|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
33304365|NCT00266227|101007276|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
33498623|NCT03526861|101717447|FG006|Initial Treatment Period|Not dosed|0|||
33498624|NCT03526861|101717448|FG007|Initial Treatment Period|Not dosed|0|||
33498625|NCT03526861|101717449|FG008|Initial Treatment Period|Not dosed|0|||
33498626|NCT03526861|101717441|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
33498627|NCT03526861|101717442|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
33498628|NCT03526861|101717443|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
33498629|NCT03526861|101717444|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498630|NCT03526861|101717445|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498631|NCT03526861|101717446|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498632|NCT03526861|101717447|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498633|NCT03526861|101717448|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498634|NCT03526861|101717449|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498635|NCT03526861|101717441|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
33498636|NCT03526861|101717442|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
33498637|NCT03526861|101717443|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
33498638|NCT03526861|101717444|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
33498639|NCT03526861|101717445|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
33498640|NCT03526861|101717446|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
33498641|NCT03526861|101717447|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
33498642|NCT03526861|101717448|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
33498643|NCT03526861|101717449|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
33498644|NCT03526861|101717441|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33498645|NCT03526861|101717442|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33498646|NCT03526861|101717443|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33498647|NCT03526861|101717444|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
33498648|NCT03526861|101717445|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
33498649|NCT03526861|101717446|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33498650|NCT03526861|101717447|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
33498651|NCT03526861|101717448|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33498652|NCT03526861|101717449|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33498653|NCT03526861|101717441|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
33498654|NCT03526861|101717442|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
33498655|NCT03526861|101717443|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
33498656|NCT03526861|101717444|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
33498657|NCT03526861|101717445|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
33498658|NCT03526861|101717446|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
33498659|NCT03526861|101717447|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
33498660|NCT03526861|101717448|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
33498661|NCT03526861|101717449|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
33498662|NCT03526861|101717441|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498663|NCT03526861|101717442|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498664|NCT03526861|101717443|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498665|NCT03526861|101717444|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
33498666|NCT03526861|101717445|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498667|NCT03526861|101717446|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498668|NCT03526861|101717447|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498669|NCT03526861|101717448|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498670|NCT03526861|101717449|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498671|NCT03526861|101717441|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33498672|NCT03526861|101717442|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33498673|NCT03526861|101717443|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33498674|NCT03526861|101717444|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33498675|NCT03526861|101717445|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33498676|NCT03526861|101717446|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33498677|NCT03526861|101717447|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33498678|NCT03526861|101717448|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
33498679|NCT03526861|101717449|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
33498680|NCT03526861|101717441|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33304366|NCT00266227|101007274|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
33304367|NCT00266227|101007275|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
33304368|NCT00266227|101007276|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
33304369|NCT00266227|101007274|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
33304370|NCT00266227|101007275|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
33304371|NCT00266227|101007276|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
33304372|NCT00266227|101007274|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
33304373|NCT00266227|101007275|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
33498681|NCT03526861|101717442|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33498682|NCT03526861|101717443|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33304374|NCT00266227|101007276|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
33304375|NCT00266227|101007274|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
33304376|NCT00266227|101007275|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
33304377|NCT00266227|101007276|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
33304378|NCT00266227|101007274|FG000|Retreatment: Week 48 to Week 72|Death|1|||
33304379|NCT00266227|101007275|FG001|Retreatment: Week 48 to Week 72|Death|1|||
33304380|NCT00266227|101007276|FG002|Retreatment: Week 48 to Week 72|Death|0|||
33304381|NCT00266227|101007274|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
33304382|NCT00266227|101007275|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
33304383|NCT00266227|101007276|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
33304384|NCT00266227|101007274|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
33304385|NCT00266227|101007275|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
33304386|NCT00266227|101007276|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
33304387|NCT00266227|101007274|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
33304388|NCT00266227|101007275|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
33304389|NCT00266227|101007276|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
33304390|NCT00266227|101007274|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
33304391|NCT00266227|101007275|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
33304392|NCT00266227|101007276|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
33304393|NCT03056300|101007280|FG000|Overall Study|Surgical reason per study protocol|3|||
33304394|NCT02735577|101007281|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
33304395|NCT02735577|101007281|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
33304396|NCT03651622|101007283|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
33304397|NCT03651622|101007284|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
33304398|NCT03651622|101007285|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
33304399|NCT03651622|101007283|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
33304400|NCT03651622|101007284|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
33304401|NCT03651622|101007285|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
33304402|NCT03651622|101007283|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
33304403|NCT03651622|101007284|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
33304404|NCT03651622|101007285|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
33304405|NCT03651622|101007283|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
33304406|NCT03651622|101007284|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
33304407|NCT03651622|101007285|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
33304408|NCT03651622|101007283|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
33304409|NCT03651622|101007284|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
33304410|NCT03651622|101007285|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
33304411|NCT02217475|101007286|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
33304412|NCT02217475|101007287|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
33304413|NCT02217475|101007288|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
33304414|NCT02217475|101007286|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
33304415|NCT02217475|101007287|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
33304416|NCT02217475|101007288|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
33304417|NCT02217475|101007286|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
33304418|NCT02217475|101007287|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
33304419|NCT02217475|101007288|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
33304420|NCT02217475|101007286|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
33304421|NCT02217475|101007287|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
33304422|NCT02217475|101007288|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
33304423|NCT02217475|101007286|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
33304424|NCT02217475|101007287|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
33304425|NCT02217475|101007288|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
33304426|NCT02217475|101007286|FG000|Discontinued After Period 1|Adverse Event|1|||
33304427|NCT02217475|101007287|FG001|Discontinued After Period 1|Adverse Event|2|||
33304428|NCT02217475|101007288|FG002|Discontinued After Period 1|Adverse Event|0|||
33304429|NCT02217475|101007286|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
33304430|NCT02217475|101007287|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
33498683|NCT03526861|101717444|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33498684|NCT03526861|101717445|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33304431|NCT02217475|101007288|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
33304432|NCT02217475|101007286|FG000|Discontinued After Period 1|Physician Decision|0|||
33304433|NCT02217475|101007287|FG001|Discontinued After Period 1|Physician Decision|0|||
33304434|NCT02217475|101007288|FG002|Discontinued After Period 1|Physician Decision|1|||
33304435|NCT02217475|101007286|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
33304436|NCT02217475|101007287|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
33304437|NCT02217475|101007288|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
33304438|NCT02217475|101007286|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
33304439|NCT02217475|101007287|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
33304440|NCT02217475|101007288|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
33304441|NCT02217475|101007286|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
33304442|NCT02217475|101007287|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
33304443|NCT02217475|101007288|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
33304444|NCT02217475|101007286|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
33304445|NCT02217475|101007287|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
33304446|NCT02217475|101007288|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
33304447|NCT02217475|101007286|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
33304448|NCT02217475|101007287|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
33304449|NCT02217475|101007288|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
33304450|NCT01517295|101007291|FG000|Overall Study|Physician Decision|1|||
33304451|NCT01517295|101007292|FG001|Overall Study|Physician Decision|0|||
33304452|NCT02495792|101007294|FG000|Overall Study|Lost to Follow-up|5|||
33304453|NCT02495792|101007295|FG001|Overall Study|Lost to Follow-up|9|||
33304454|NCT02495792|101007294|FG000|Overall Study|Protocol Violation|32|||
33304455|NCT02495792|101007295|FG001|Overall Study|Protocol Violation|31|||
33304456|NCT01416389|101007296|FG000|Overall Study|Lost to Follow-up|1|||
33304457|NCT01416389|101007297|FG001|Overall Study|Lost to Follow-up|0|||
33304458|NCT01416389|101007296|FG000|Overall Study|Started New Therapy|2|||
33304459|NCT01416389|101007297|FG001|Overall Study|Started New Therapy|0|||
33304460|NCT00350103|101007301|FG000|Overall Study|Adverse Event|12|||
33304461|NCT00350103|101007302|FG001|Overall Study|Adverse Event|29|||
33304462|NCT00350103|101007303|FG002|Overall Study|Adverse Event|17|||
33304463|NCT00350103|101007301|FG000|Overall Study|Lack of Efficacy|5|||
33304464|NCT00350103|101007302|FG001|Overall Study|Lack of Efficacy|1|||
33304465|NCT00350103|101007303|FG002|Overall Study|Lack of Efficacy|3|||
33304466|NCT00350103|101007301|FG000|Overall Study|Withdrawal by Subject|6|||
33304467|NCT00350103|101007302|FG001|Overall Study|Withdrawal by Subject|6|||
33304468|NCT00350103|101007303|FG002|Overall Study|Withdrawal by Subject|8|||
33304469|NCT00350103|101007301|FG000|Overall Study|Protocol Violation|0|||
33304470|NCT00350103|101007302|FG001|Overall Study|Protocol Violation|0|||
33304471|NCT00350103|101007303|FG002|Overall Study|Protocol Violation|1|||
33304472|NCT00350103|101007301|FG000|Overall Study|Unsatisfactory Compliance|2|||
33304473|NCT00350103|101007302|FG001|Overall Study|Unsatisfactory Compliance|2|||
33304474|NCT00350103|101007303|FG002|Overall Study|Unsatisfactory Compliance|1|||
33304475|NCT00350103|101007301|FG000|Overall Study|Investigator´s decision|1|||
33304476|NCT00350103|101007302|FG001|Overall Study|Investigator´s decision|1|||
33304477|NCT00350103|101007303|FG002|Overall Study|Investigator´s decision|0|||
33304478|NCT00350103|101007301|FG000|Overall Study|Exclusion criteria met|0|||
33304479|NCT00350103|101007302|FG001|Overall Study|Exclusion criteria met|0|||
33304480|NCT00350103|101007303|FG002|Overall Study|Exclusion criteria met|1|||
33304481|NCT00350103|101007301|FG000|Overall Study|Patient relocated|0|||
33304482|NCT00350103|101007302|FG001|Overall Study|Patient relocated|0|||
33304483|NCT00350103|101007303|FG002|Overall Study|Patient relocated|1|||
33304484|NCT00350103|101007301|FG000|Overall Study|Need for prohibited medication|1|||
33304485|NCT00350103|101007302|FG001|Overall Study|Need for prohibited medication|0|||
33304486|NCT00350103|101007303|FG002|Overall Study|Need for prohibited medication|0|||
33304487|NCT00350103|101007301|FG000|Overall Study|Personal reasons|0|||
33304488|NCT00350103|101007302|FG001|Overall Study|Personal reasons|0|||
33304489|NCT00350103|101007303|FG002|Overall Study|Personal reasons|1|||
33498685|NCT03526861|101717446|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33498686|NCT03526861|101717447|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33600559|NCT03242018|102088725|FG002|Overall Study|Study Terminated by Sponsor|1|||
33600560|NCT00882908|102088726|FG000|Overall Study|Adverse Event|0|||
33304490|NCT00350103|101007301|FG000|Overall Study|Patient stopped feeling pain|1|||
33304491|NCT00350103|101007302|FG001|Overall Study|Patient stopped feeling pain|0|||
33498687|NCT03526861|101717448|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
33498688|NCT03526861|101717449|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
33498689|NCT03526861|101717441|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498690|NCT03526861|101717442|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498691|NCT03526861|101717443|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498692|NCT03526861|101717444|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498693|NCT03526861|101717445|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498694|NCT03526861|101717446|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498695|NCT03526861|101717447|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33498696|NCT03526861|101717448|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
33567578|NCT02723955|101973176|FG007|Crossover/ Re-treatment Phase|Death|0|||
33600561|NCT00882908|102088727|FG001|Overall Study|Adverse Event|0|||
33600562|NCT00882908|102088728|FG002|Overall Study|Adverse Event|1|||
33304492|NCT00350103|101007303|FG002|Overall Study|Patient stopped feeling pain|0|||
33304493|NCT00350103|101007301|FG000|Overall Study|PR greater than 250ms|0|||
33304494|NCT00350103|101007302|FG001|Overall Study|PR greater than 250ms|0|||
33304495|NCT00350103|101007303|FG002|Overall Study|PR greater than 250ms|1|||
33304496|NCT00350103|101007301|FG000|Overall Study|Wrong calculation of QT interval|0|||
33304497|NCT00350103|101007302|FG001|Overall Study|Wrong calculation of QT interval|0|||
33304498|NCT00350103|101007303|FG002|Overall Study|Wrong calculation of QT interval|1|||
33304499|NCT00350103|101007301|FG000|Overall Study|Sponsor mistake|1|||
33304500|NCT00350103|101007302|FG001|Overall Study|Sponsor mistake|0|||
33304501|NCT00350103|101007303|FG002|Overall Study|Sponsor mistake|0|||
33304502|NCT00350103|101007301|FG000|Overall Study|Randomization mistake|0|||
33304503|NCT00350103|101007302|FG001|Overall Study|Randomization mistake|1|||
33190776|NCT01604343|100604989|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
33190777|NCT01604343|100604990|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
33190778|NCT01604343|100604991|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
33304504|NCT00350103|101007303|FG002|Overall Study|Randomization mistake|1|||
33304505|NCT00350103|101007301|FG000|Overall Study|Sponsor´s decision|0|||
33304506|NCT00350103|101007302|FG001|Overall Study|Sponsor´s decision|1|||
33304507|NCT00350103|101007303|FG002|Overall Study|Sponsor´s decision|0|||
33304508|NCT00350103|101007301|FG000|Overall Study|Lost, Reason unknown|1|||
33304509|NCT00350103|101007302|FG001|Overall Study|Lost, Reason unknown|1|||
33304510|NCT00350103|101007303|FG002|Overall Study|Lost, Reason unknown|0|||
33304511|NCT00132873|101007306|FG000|Overall Study|Adverse Event|3|||
33304512|NCT00132873|101007306|FG000|Overall Study|Lost to Follow-up|1|||
33304513|NCT00132873|101007306|FG000|Overall Study|Lack of Efficacy|1|||
33304514|NCT00132873|101007306|FG000|Overall Study|Withdrawal by Subject|3|||
33304515|NCT00132873|101007306|FG000|Overall Study|Planned Pregnancy|1|||
33304516|NCT02053792|101007307|FG000|Overall Study|Physician Decision|0|||
33304517|NCT02053792|101007308|FG001|Overall Study|Physician Decision|1|||
33304518|NCT02053792|101007307|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
33304519|NCT02053792|101007308|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
33304520|NCT02053792|101007307|FG000|Overall Study|Lack of Efficacy|1|||
33304521|NCT02053792|101007308|FG001|Overall Study|Lack of Efficacy|0|||
33304522|NCT02053792|101007307|FG000|Overall Study|Adverse Event|1|||
33304523|NCT02053792|101007308|FG001|Overall Study|Adverse Event|0|||
33304524|NCT02053792|101007307|FG000|Overall Study|Withdrawal by Subject|2|||
33304525|NCT02053792|101007308|FG001|Overall Study|Withdrawal by Subject|2|||
33304526|NCT02053792|101007307|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
33304527|NCT02053792|101007308|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
33304528|NCT02053792|101007307|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
33304529|NCT02053792|101007308|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
33304530|NCT00022659|101007309|FG000|Overall Study|Ineligible: wrong primary|1|||
33304531|NCT00022659|101007309|FG000|Overall Study|Never treated|1|||
33304532|NCT05032872|101007310|FG000|Overall Study|Adverse Event|1|||
33304533|NCT05032872|101007311|FG001|Overall Study|Adverse Event|0|||
33304534|NCT05032872|101007310|FG000|Overall Study|Lost to Follow-up|2|||
33304535|NCT05032872|101007311|FG001|Overall Study|Lost to Follow-up|4|||
33304536|NCT05032872|101007310|FG000|Overall Study|Withdrawal by Subject|4|||
33304537|NCT05032872|101007311|FG001|Overall Study|Withdrawal by Subject|3|||
33304538|NCT03345576|101007312|FG000|Overall Study|Withdrawal by Subject|2|||
33190779|NCT01604343|100604992|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
33190780|NCT01604343|100604988|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
33190781|NCT01604343|100604989|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
33190782|NCT01604343|100604990|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
33190783|NCT01604343|100604991|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
33190784|NCT01604343|100604992|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
33190785|NCT01604343|100604988|FG000|Prior to W52 Administration(Through W52)|Death|5|||
33190786|NCT01604343|100604989|FG001|Prior to W52 Administration(Through W52)|Death|0|||
33190787|NCT01604343|100604990|FG002|Prior to W52 Administration(Through W52)|Death|2|||
33190788|NCT01604343|100604991|FG003|Prior to W52 Administration(Through W52)|Death|0|||
33190789|NCT01604343|100604992|FG004|Prior to W52 Administration(Through W52)|Death|4|||
33190790|NCT01604343|100604988|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
33190791|NCT01604343|100604989|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
33190792|NCT01604343|100604990|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
33190793|NCT01604343|100604991|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
33190794|NCT01604343|100604992|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
33190795|NCT01604343|100604988|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
33190796|NCT01604343|100604989|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
33190797|NCT01604343|100604990|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
33190798|NCT01604343|100604991|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
33190799|NCT01604343|100604992|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
33190800|NCT01604343|100604988|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
33190801|NCT01604343|100604989|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
33190802|NCT01604343|100604990|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
33190803|NCT01604343|100604991|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
33190804|NCT01604343|100604992|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
33190805|NCT01604343|100604988|FG000|Prior to W52 Administration(Through W52)|Other|15|||
33190806|NCT01604343|100604989|FG001|Prior to W52 Administration(Through W52)|Other|0|||
33190807|NCT01604343|100604990|FG002|Prior to W52 Administration(Through W52)|Other|10|||
33190808|NCT01604343|100604991|FG003|Prior to W52 Administration(Through W52)|Other|0|||
33190809|NCT01604343|100604992|FG004|Prior to W52 Administration(Through W52)|Other|6|||
33190810|NCT01604343|100604988|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
33190811|NCT01604343|100604989|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
33190812|NCT01604343|100604990|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
33190813|NCT01604343|100604991|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
33190814|NCT01604343|100604992|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
33190815|NCT01604343|100604988|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
33190816|NCT01604343|100604989|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
33498697|NCT03526861|101717449|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
33498698|NCT00696423|101717450|FG000|Overall Study|Lost to Follow-up|0|||
33498699|NCT00696423|101717451|FG001|Overall Study|Lost to Follow-up|5|||
33498700|NCT02512302|101717454|FG000|Period 1|Adverse Event|0|||
33190817|NCT01604343|100604990|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
33190818|NCT01604343|100604991|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
33190819|NCT01604343|100604992|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
33190820|NCT01604343|100604988|FG000|Week 52 to Week 104|Adverse Event|0|||
33190821|NCT01604343|100604989|FG001|Week 52 to Week 104|Adverse Event|12|||
33190822|NCT01604343|100604990|FG002|Week 52 to Week 104|Adverse Event|26|||
33190823|NCT01604343|100604991|FG003|Week 52 to Week 104|Adverse Event|21|||
33190824|NCT01604343|100604992|FG004|Week 52 to Week 104|Adverse Event|27|||
33190825|NCT01604343|100604988|FG000|Week 52 to Week 104|Death|0|||
33190826|NCT01604343|100604989|FG001|Week 52 to Week 104|Death|4|||
33190827|NCT01604343|100604990|FG002|Week 52 to Week 104|Death|2|||
33498701|NCT02512302|101717455|FG001|Period 1|Adverse Event|1|||
33498702|NCT02512302|101717456|FG002|Period 1|Adverse Event|0|||
33498703|NCT02512302|101717457|FG003|Period 1|Adverse Event|0|||
33498704|NCT02512302|101717458|FG004|Period 1|Adverse Event|0|||
33498705|NCT02512302|101717459|FG005|Period 1|Adverse Event|0|||
33498706|NCT02512302|101717460|FG006|Period 1|Adverse Event|0|||
33498707|NCT02512302|101717461|FG007|Period 1|Adverse Event|0|||
33498708|NCT02512302|101717462|FG008|Period 1|Adverse Event|0|||
33498709|NCT02512302|101717463|FG009|Period 1|Adverse Event|0|||
33498710|NCT02512302|101717454|FG000|Period 2|Adverse Event|0|||
33600563|NCT00882908|102088729|FG003|Overall Study|Adverse Event|0|||
33190828|NCT01604343|100604991|FG003|Week 52 to Week 104|Death|5|||
33190829|NCT01604343|100604992|FG004|Week 52 to Week 104|Death|0|||
33393718|NCT03073200|101328522|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
33393719|NCT03073200|101328523|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
33190830|NCT01604343|100604988|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
33190831|NCT01604343|100604989|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
33190832|NCT01604343|100604990|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
33190833|NCT01604343|100604991|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
33190834|NCT01604343|100604992|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
33498711|NCT02512302|101717455|FG001|Period 2|Adverse Event|0|||
33498712|NCT02512302|101717456|FG002|Period 2|Adverse Event|0|||
33498713|NCT02512302|101717457|FG003|Period 2|Adverse Event|0|||
33498714|NCT02512302|101717458|FG004|Period 2|Adverse Event|0|||
33498715|NCT02512302|101717459|FG005|Period 2|Adverse Event|0|||
33498716|NCT02512302|101717460|FG006|Period 2|Adverse Event|0|||
33498717|NCT02512302|101717461|FG007|Period 2|Adverse Event|0|||
33498718|NCT02512302|101717462|FG008|Period 2|Adverse Event|0|||
33498719|NCT02512302|101717463|FG009|Period 2|Adverse Event|1|||
33498720|NCT02512302|101717454|FG000|Period 3|Lost to Follow-up|0|||
33498721|NCT02512302|101717455|FG001|Period 3|Lost to Follow-up|0|||
33498722|NCT02512302|101717456|FG002|Period 3|Lost to Follow-up|1|||
33190835|NCT01604343|100604988|FG000|Week 52 to Week 104|Physician Decision|0|||
33190836|NCT01604343|100604989|FG001|Week 52 to Week 104|Physician Decision|1|||
33304539|NCT03345576|101007313|FG001|Overall Study|Withdrawal by Subject|2|||
33304540|NCT03345576|101007312|FG000|Overall Study|Adverse Event|1|||
33498723|NCT02512302|101717457|FG003|Period 3|Lost to Follow-up|0|||
33190837|NCT01604343|100604990|FG002|Week 52 to Week 104|Physician Decision|0|||
33190838|NCT01604343|100604991|FG003|Week 52 to Week 104|Physician Decision|0|||
33498724|NCT02512302|101717458|FG004|Period 3|Lost to Follow-up|0|||
33498725|NCT02512302|101717459|FG005|Period 3|Lost to Follow-up|0|||
33190839|NCT01604343|100604992|FG004|Week 52 to Week 104|Physician Decision|2|||
33190840|NCT01604343|100604988|FG000|Week 52 to Week 104|Pregnancy|0|||
33190841|NCT01604343|100604989|FG001|Week 52 to Week 104|Pregnancy|0|||
33190842|NCT01604343|100604990|FG002|Week 52 to Week 104|Pregnancy|1|||
33190843|NCT01604343|100604991|FG003|Week 52 to Week 104|Pregnancy|2|||
33190844|NCT01604343|100604992|FG004|Week 52 to Week 104|Pregnancy|1|||
33190845|NCT01604343|100604988|FG000|Week 52 to Week 104|Other|0|||
33304541|NCT03345576|101007313|FG001|Overall Study|Adverse Event|0|||
33304542|NCT04833127|101007316|FG000|Overall Study|Lost to Follow-up|1|||
33190846|NCT01604343|100604989|FG001|Week 52 to Week 104|Other|11|||
33190847|NCT01604343|100604990|FG002|Week 52 to Week 104|Other|11|||
33190848|NCT01604343|100604991|FG003|Week 52 to Week 104|Other|6|||
33190849|NCT01604343|100604992|FG004|Week 52 to Week 104|Other|3|||
33190850|NCT01604343|100604988|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
33190851|NCT01604343|100604989|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
33190852|NCT01604343|100604990|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
33190853|NCT01604343|100604991|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
33190854|NCT01604343|100604992|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
33190855|NCT01604343|100604988|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
33190856|NCT01604343|100604989|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
33190857|NCT01604343|100604990|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
33190858|NCT01604343|100604991|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
33190859|NCT01604343|100604992|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
33190860|NCT01604343|100604988|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
33190861|NCT01604343|100604989|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
33190862|NCT01604343|100604990|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
33190863|NCT01604343|100604991|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
33190864|NCT01604343|100604992|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
33190865|NCT00749463|100604997|FG000|Overall Study|Adverse Event|0|||
33190866|NCT00749463|100604998|FG001|Overall Study|Adverse Event|4|||
33190867|NCT00749463|100604999|FG002|Overall Study|Adverse Event|1|||
33190868|NCT00749463|100604997|FG000|Overall Study|Withdrawal by Subject|1|||
33190869|NCT00749463|100604998|FG001|Overall Study|Withdrawal by Subject|0|||
33190870|NCT00749463|100604999|FG002|Overall Study|Withdrawal by Subject|0|||
33190871|NCT01533246|100605009|FG000|Overall Study|Adverse Event|1|||
33190872|NCT01533246|100605009|FG000|Overall Study|Withdrawal by Subject|1|||
33190873|NCT01020019|100605022|FG000|Overall Study|Lost to Follow-up|21|||
33190874|NCT01020019|100605023|FG001|Overall Study|Lost to Follow-up|18|||
33190875|NCT01020019|100605022|FG000|Overall Study|Adverse Event|1|||
33190876|NCT01020019|100605023|FG001|Overall Study|Adverse Event|5|||
33190877|NCT01020019|100605022|FG000|Overall Study|not interested in treatment|4|||
33304543|NCT04833127|101007317|FG001|Overall Study|Lost to Follow-up|1|||
33304544|NCT03330405|101007318|FG000|Overall Study|Other|1|||
33304545|NCT03330405|101007319|FG001|Overall Study|Other|3|||
33304546|NCT03330405|101007320|FG002|Overall Study|Other|1|||
33304547|NCT03330405|101007321|FG003|Overall Study|Other|0|||
33190878|NCT01020019|100605023|FG001|Overall Study|not interested in treatment|4|||
33304548|NCT03330405|101007322|FG004|Overall Study|Other|2|||
33498726|NCT02512302|101717460|FG006|Period 3|Lost to Follow-up|0|||
33600564|NCT00882908|102088730|FG004|Overall Study|Adverse Event|1|||
33190879|NCT01020019|100605022|FG000|Overall Study|moving|0|||
33190880|NCT01020019|100605023|FG001|Overall Study|moving|2|||
33190881|NCT00953329|100605024|FG000|Overall Study|Lack of Efficacy|1|||
33304549|NCT03330405|101007323|FG005|Overall Study|Other|0|||
33304550|NCT03330405|101007324|FG006|Overall Study|Other|1|||
33304551|NCT03330405|101007325|FG007|Overall Study|Other|0|||
33498727|NCT02512302|101717461|FG007|Period 3|Lost to Follow-up|0|||
33498728|NCT02512302|101717462|FG008|Period 3|Lost to Follow-up|0|||
33498729|NCT02512302|101717463|FG009|Period 3|Lost to Follow-up|0|||
33498730|NCT02512302|101717454|FG000|Period 4|Adverse Event|0|||
33304552|NCT03330405|101007326|FG008|Overall Study|Other|0|||
33304553|NCT03330405|101007327|FG009|Overall Study|Other|0|||
33304554|NCT03330405|101007328|FG010|Overall Study|Other|0|||
33304555|NCT03330405|101007318|FG000|Overall Study|Progressive disease|8|||
33304556|NCT03330405|101007319|FG001|Overall Study|Progressive disease|27|||
33304557|NCT03330405|101007320|FG002|Overall Study|Progressive disease|4|||
33304558|NCT03330405|101007321|FG003|Overall Study|Progressive disease|18|||
33304559|NCT03330405|101007322|FG004|Overall Study|Progressive disease|16|||
33304560|NCT03330405|101007323|FG005|Overall Study|Progressive disease|14|||
33304561|NCT03330405|101007324|FG006|Overall Study|Progressive disease|7|||
33304562|NCT03330405|101007325|FG007|Overall Study|Progressive disease|29|||
33304563|NCT03330405|101007326|FG008|Overall Study|Progressive disease|9|||
33304564|NCT03330405|101007327|FG009|Overall Study|Progressive disease|11|||
33304565|NCT03330405|101007328|FG010|Overall Study|Progressive disease|5|||
33304566|NCT03330405|101007318|FG000|Overall Study|Withdrawal by Subject|1|||
33304567|NCT03330405|101007319|FG001|Overall Study|Withdrawal by Subject|4|||
33304568|NCT03330405|101007320|FG002|Overall Study|Withdrawal by Subject|0|||
33304569|NCT03330405|101007321|FG003|Overall Study|Withdrawal by Subject|1|||
33304570|NCT03330405|101007322|FG004|Overall Study|Withdrawal by Subject|1|||
33498731|NCT02512302|101717455|FG001|Period 4|Adverse Event|0|||
33498732|NCT02512302|101717456|FG002|Period 4|Adverse Event|0|||
33498733|NCT02512302|101717457|FG003|Period 4|Adverse Event|0|||
33498734|NCT02512302|101717458|FG004|Period 4|Adverse Event|0|||
33498735|NCT02512302|101717459|FG005|Period 4|Adverse Event|0|||
33498736|NCT02512302|101717460|FG006|Period 4|Adverse Event|1|||
33498737|NCT02512302|101717461|FG007|Period 4|Adverse Event|0|||
33498738|NCT02512302|101717462|FG008|Period 4|Adverse Event|0|||
33498739|NCT02512302|101717463|FG009|Period 4|Adverse Event|0|||
33498740|NCT03776357|101717468|FG000|Overall Study|Lost to Follow-up|3|||
33498741|NCT00840749|101717469|FG000|Overall Study|Death|1|||
33498742|NCT00840749|101717470|FG001|Overall Study|Death|2|||
33498743|NCT00840749|101717469|FG000|Overall Study|not treated on study arm|11|||
33190882|NCT02178475|100605025|FG000|Overall Study|Withdrawal by Subject|7|||
33190883|NCT02178475|100605025|FG000|Overall Study|Lost to Follow-up|10|||
33190884|NCT02178475|100605025|FG000|Overall Study|Death|13|||
33190885|NCT02178475|100605025|FG000|Overall Study|Protocol-specified Criteria|99|||
33190886|NCT04587193|100605026|FG000|Overall Study|Screen failure after consent|3|||
33190887|NCT04587193|100605027|FG001|Overall Study|Screen failure after consent|0|||
33190888|NCT04587193|100605026|FG000|Overall Study|Device broke during study|3|||
33190889|NCT04587193|100605027|FG001|Overall Study|Device broke during study|2|||
33190890|NCT01454934|100605033|FG000|Overall Study|Clinical progression|28|||
33190891|NCT01454934|100605034|FG001|Overall Study|Clinical progression|25|||
33190892|NCT01454934|100605033|FG000|Overall Study|Other|6|||
33190893|NCT01454934|100605034|FG001|Overall Study|Other|17|||
33190894|NCT01454934|100605033|FG000|Overall Study|Adverse Event|28|||
33190895|NCT01454934|100605034|FG001|Overall Study|Adverse Event|24|||
33190896|NCT01454934|100605033|FG000|Overall Study|Withdrawn consent|2|||
33190897|NCT01454934|100605034|FG001|Overall Study|Withdrawn consent|5|||
33190898|NCT01454934|100605033|FG000|Overall Study|Withdrawal by Subject|11|||
33190899|NCT01454934|100605034|FG001|Overall Study|Withdrawal by Subject|15|||
33190900|NCT01454934|100605033|FG000|Overall Study|Disease progression|194|||
33190901|NCT01454934|100605034|FG001|Overall Study|Disease progression|181|||
33190902|NCT01454934|100605033|FG000|Overall Study|Lost to Follow-up|0|||
33190903|NCT01454934|100605034|FG001|Overall Study|Lost to Follow-up|1|||
33190904|NCT01454934|100605033|FG000|Overall Study|Not treated|1|||
33190905|NCT01454934|100605034|FG001|Overall Study|Not treated|2|||
33190906|NCT01252290|100605038|FG000|Overall Study|Withdrawal by Subject|1|||
33190907|NCT01632891|100605039|FG000|Overall Study|Lost to Follow-up|0|||
33190908|NCT01632891|100605040|FG001|Overall Study|Lost to Follow-up|1|||
33190909|NCT01632891|100605039|FG000|Overall Study|Withdrawal by Subject|1|||
33190910|NCT01632891|100605040|FG001|Overall Study|Withdrawal by Subject|0|||
33190911|NCT04144166|100605043|FG000|Overall Study|Discharged before study start|1|||
33190912|NCT04144166|100605043|FG000|Overall Study|Pregnancy|1|||
33190913|NCT04144166|100605043|FG000|Overall Study|Nail polish could not be removed from finger|1|||
33190914|NCT01183975|100605044|FG000|Overall Study|Lost to Follow-up|73|||
33190915|NCT01660711|100605045|FG000|Overall Study|Adverse Event|7|||
33190916|NCT01660711|100605045|FG000|Overall Study|Withdrawal by Subject|1|||
33190917|NCT01639040|100605046|FG000|Overall Study|Adverse Event|1|||
33190918|NCT01639040|100605047|FG001|Overall Study|Adverse Event|0|||
33190919|NCT00376168|100605054|FG000|Overall Study|Adverse Event|1|||
33304571|NCT03330405|101007323|FG005|Overall Study|Withdrawal by Subject|1|||
33190920|NCT00376168|100605055|FG001|Overall Study|Adverse Event|1|||
33304572|NCT03330405|101007324|FG006|Overall Study|Withdrawal by Subject|0|||
33304573|NCT03330405|101007325|FG007|Overall Study|Withdrawal by Subject|2|||
33304574|NCT03330405|101007326|FG008|Overall Study|Withdrawal by Subject|2|||
33304575|NCT03330405|101007327|FG009|Overall Study|Withdrawal by Subject|1|||
33498744|NCT00840749|101717470|FG001|Overall Study|not treated on study arm|11|||
33498745|NCT00840749|101717469|FG000|Overall Study|study closed|19|||
33498746|NCT00840749|101717470|FG001|Overall Study|study closed|14|||
33498747|NCT02755103|101717471|FG000|Overall Study|Lost to Follow-up|17|||
33498748|NCT02755103|101717472|FG001|Overall Study|Lost to Follow-up|15|||
33498749|NCT02755103|101717471|FG000|Overall Study|Death|0|||
33498750|NCT02755103|101717472|FG001|Overall Study|Death|1|||
33498751|NCT02755103|101717471|FG000|Overall Study|Physician Decision|0|||
33498752|NCT02755103|101717472|FG001|Overall Study|Physician Decision|1|||
33498753|NCT02755103|101717471|FG000|Overall Study|Pregnancy|0|||
33498754|NCT02755103|101717472|FG001|Overall Study|Pregnancy|1|||
33498755|NCT02755103|101717471|FG000|Overall Study|Withdrawal by Subject|3|||
33498756|NCT02755103|101717472|FG001|Overall Study|Withdrawal by Subject|0|||
33498757|NCT01321749|101717476|FG000|Overall Study|Lost to Follow-up|4|||
33498758|NCT01321749|101717477|FG001|Overall Study|Lost to Follow-up|11|||
33498759|NCT01321749|101717476|FG000|Overall Study|Protocol Violation|4|||
33498760|NCT01321749|101717477|FG001|Overall Study|Protocol Violation|7|||
33498761|NCT01321749|101717476|FG000|Overall Study|Withdrawal by Subject|5|||
33498762|NCT01321749|101717477|FG001|Overall Study|Withdrawal by Subject|4|||
33498763|NCT01620138|101717479|FG000|Overall Study|Withdrawal by Subject|3|||
33498764|NCT01620138|101717480|FG001|Overall Study|Withdrawal by Subject|0|||
33304576|NCT03330405|101007328|FG010|Overall Study|Withdrawal by Subject|1|||
33304577|NCT03330405|101007318|FG000|Overall Study|Global deterioration of health status|2|||
33304578|NCT03330405|101007319|FG001|Overall Study|Global deterioration of health status|3|||
33304579|NCT03330405|101007320|FG002|Overall Study|Global deterioration of health status|0|||
33304580|NCT03330405|101007321|FG003|Overall Study|Global deterioration of health status|2|||
33304581|NCT03330405|101007322|FG004|Overall Study|Global deterioration of health status|3|||
33304582|NCT03330405|101007323|FG005|Overall Study|Global deterioration of health status|3|||
33304583|NCT03330405|101007324|FG006|Overall Study|Global deterioration of health status|0|||
33304584|NCT03330405|101007325|FG007|Overall Study|Global deterioration of health status|2|||
33304585|NCT03330405|101007326|FG008|Overall Study|Global deterioration of health status|8|||
33304586|NCT03330405|101007327|FG009|Overall Study|Global deterioration of health status|4|||
33304587|NCT03330405|101007328|FG010|Overall Study|Global deterioration of health status|1|||
33304588|NCT03330405|101007318|FG000|Overall Study|Adverse Event|0|||
33304589|NCT03330405|101007319|FG001|Overall Study|Adverse Event|1|||
33304590|NCT03330405|101007320|FG002|Overall Study|Adverse Event|0|||
33304591|NCT03330405|101007321|FG003|Overall Study|Adverse Event|1|||
33304592|NCT03330405|101007322|FG004|Overall Study|Adverse Event|1|||
33304593|NCT03330405|101007323|FG005|Overall Study|Adverse Event|1|||
33304594|NCT03330405|101007324|FG006|Overall Study|Adverse Event|3|||
33304595|NCT03330405|101007325|FG007|Overall Study|Adverse Event|4|||
33304596|NCT03330405|101007326|FG008|Overall Study|Adverse Event|2|||
33498765|NCT01620138|101717479|FG000|Overall Study|Lack of Efficacy|1|||
33498766|NCT01620138|101717480|FG001|Overall Study|Lack of Efficacy|0|||
33498767|NCT01620138|101717479|FG000|Overall Study|Adverse Event|2|||
33304597|NCT03330405|101007327|FG009|Overall Study|Adverse Event|2|||
33304598|NCT03330405|101007328|FG010|Overall Study|Adverse Event|2|||
33304599|NCT03330405|101007318|FG000|Overall Study|Death|0|||
33304600|NCT03330405|101007319|FG001|Overall Study|Death|4|||
33304601|NCT03330405|101007320|FG002|Overall Study|Death|0|||
33304602|NCT03330405|101007321|FG003|Overall Study|Death|0|||
33304603|NCT03330405|101007322|FG004|Overall Study|Death|0|||
33304604|NCT03330405|101007323|FG005|Overall Study|Death|1|||
33304605|NCT03330405|101007324|FG006|Overall Study|Death|0|||
33304606|NCT03330405|101007325|FG007|Overall Study|Death|2|||
33304607|NCT03330405|101007326|FG008|Overall Study|Death|0|||
33304608|NCT03330405|101007327|FG009|Overall Study|Death|0|||
33304609|NCT03330405|101007328|FG010|Overall Study|Death|0|||
33304610|NCT03330405|101007318|FG000|Overall Study|Physician Decision|0|||
33304611|NCT03330405|101007319|FG001|Overall Study|Physician Decision|0|||
33304612|NCT03330405|101007320|FG002|Overall Study|Physician Decision|0|||
33304613|NCT03330405|101007321|FG003|Overall Study|Physician Decision|0|||
33304614|NCT03330405|101007322|FG004|Overall Study|Physician Decision|0|||
33304615|NCT03330405|101007323|FG005|Overall Study|Physician Decision|0|||
33304616|NCT03330405|101007324|FG006|Overall Study|Physician Decision|0|||
33304617|NCT03330405|101007325|FG007|Overall Study|Physician Decision|1|||
33304618|NCT03330405|101007326|FG008|Overall Study|Physician Decision|0|||
33600565|NCT00882908|102088726|FG000|Overall Study|Lost to Follow-up|3|||
33600566|NCT00882908|102088727|FG001|Overall Study|Lost to Follow-up|5|||
33304619|NCT03330405|101007327|FG009|Overall Study|Physician Decision|0|||
33600567|NCT00882908|102088728|FG002|Overall Study|Lost to Follow-up|3|||
33304620|NCT03330405|101007328|FG010|Overall Study|Physician Decision|0|||
33304621|NCT02576587|101007330|FG000|Baseline|Equipment failure|0|||
33304622|NCT02576587|101007331|FG001|Baseline|Equipment failure|1|||
33304623|NCT02576587|101007330|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
33304624|NCT02576587|101007331|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
33304625|NCT02576587|101007330|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
33498768|NCT01620138|101717480|FG001|Overall Study|Adverse Event|0|||
33498769|NCT04305327|101717482|FG000|Overall Study|Study early termination|2|||
33498770|NCT04305327|101717483|FG001|Overall Study|Study early termination|5|||
33498771|NCT04305327|101717484|FG002|Overall Study|Study early termination|2|||
33498772|NCT04305327|101717485|FG003|Overall Study|Study early termination|2|||
33304626|NCT02576587|101007331|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
33498773|NCT04305327|101717482|FG000|Overall Study|Withdrawal by Subject|0|||
33498774|NCT04305327|101717483|FG001|Overall Study|Withdrawal by Subject|1|||
33498775|NCT04305327|101717484|FG002|Overall Study|Withdrawal by Subject|0|||
33498776|NCT04305327|101717485|FG003|Overall Study|Withdrawal by Subject|0|||
33498777|NCT02059135|101720203|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
33498778|NCT02059135|101720204|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
33498779|NCT02059135|101720203|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
33498780|NCT02059135|101720204|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
33498781|NCT02059135|101720203|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
33498782|NCT02059135|101720204|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
33498783|NCT02059135|101720203|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
33498784|NCT02059135|101720204|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
33498785|NCT02059135|101720203|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
33498786|NCT02059135|101720204|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
33498787|NCT02059135|101720203|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
33498788|NCT02059135|101720204|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
33498789|NCT02059135|101720203|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
33498790|NCT02059135|101720204|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
33498791|NCT02059135|101720203|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
33190921|NCT00376168|100605054|FG000|Overall Study|Pregnancy|1|||
33190922|NCT00376168|100605055|FG001|Overall Study|Pregnancy|0|||
33190923|NCT01140477|100605063|FG000|Overall Study|Lost to Follow-up|4|||
33190924|NCT01140477|100605064|FG001|Overall Study|Lost to Follow-up|0|||
33190925|NCT01140477|100605063|FG000|Overall Study|Withdrawal by Subject|1|||
33190926|NCT01140477|100605064|FG001|Overall Study|Withdrawal by Subject|4|||
33190927|NCT01140477|100605063|FG000|Overall Study|Surgical complication preventing implant|2|||
33190928|NCT01140477|100605064|FG001|Overall Study|Surgical complication preventing implant|0|||
33190929|NCT01140477|100605063|FG000|Overall Study|Death|1|||
33190930|NCT01140477|100605064|FG001|Overall Study|Death|1|||
33190931|NCT01140477|100605063|FG000|Overall Study|Subject explanted|0|||
33190932|NCT01140477|100605064|FG001|Overall Study|Subject explanted|1|||
33190933|NCT01641367|100605065|FG000|Cohorts|Death|18|||
33190934|NCT01641367|100605066|FG001|Cohorts|Death|1|||
33190935|NCT01641367|100605067|FG002|Cohorts|Death|2|||
33190936|NCT01641367|100605068|FG003|Cohorts|Death|0|||
33190937|NCT01641367|100605069|FG004|Cohorts|Death|1|||
33190938|NCT01641367|100605070|FG005|Cohorts|Death|1|||
33190939|NCT01641367|100605071|FG006|Cohorts|Death|0|||
33498792|NCT02059135|101720204|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
33190940|NCT01641367|100605072|FG007|Cohorts|Death|0|||
33190941|NCT01641367|100605065|FG000|Cohorts|Lost to Follow-up|16|||
33190942|NCT01641367|100605066|FG001|Cohorts|Lost to Follow-up|0|||
33190943|NCT01641367|100605067|FG002|Cohorts|Lost to Follow-up|2|||
33190944|NCT01641367|100605068|FG003|Cohorts|Lost to Follow-up|0|||
33190945|NCT01641367|100605069|FG004|Cohorts|Lost to Follow-up|2|||
33190946|NCT01641367|100605070|FG005|Cohorts|Lost to Follow-up|0|||
33190947|NCT01641367|100605071|FG006|Cohorts|Lost to Follow-up|0|||
33190948|NCT01641367|100605072|FG007|Cohorts|Lost to Follow-up|0|||
33190949|NCT01641367|100605065|FG000|Randomized Adherence Intervention|Death|0|||
33190950|NCT01641367|100605066|FG001|Randomized Adherence Intervention|Death|0|||
33190951|NCT01641367|100605067|FG002|Randomized Adherence Intervention|Death|0|||
33190952|NCT01641367|100605068|FG003|Randomized Adherence Intervention|Death|0|||
33190953|NCT01641367|100605069|FG004|Randomized Adherence Intervention|Death|0|||
33304627|NCT02576587|101007330|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
33304628|NCT02576587|101007331|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
33304629|NCT01081665|101007332|FG000|Overall Study|Death|41|||
33304630|NCT01081665|101007332|FG000|Overall Study|Lost to Follow-up|18|||
33304631|NCT01081665|101007332|FG000|Overall Study|Withdrawal by Subject|17|||
33304632|NCT01081665|101007332|FG000|Overall Study|Change of dialysis unit|10|||
33304633|NCT01081665|101007332|FG000|Overall Study|Regulation of iPTH|5|||
33304634|NCT01081665|101007332|FG000|Overall Study|Change in renal replacement therapy|2|||
33393720|NCT03073200|101328524|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
33393721|NCT03073200|101328525|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
33498793|NCT00984542|101720207|FG000|Overall Study|disease progression|19|||
33190954|NCT01641367|100605070|FG005|Randomized Adherence Intervention|Death|0|||
33190955|NCT01641367|100605071|FG006|Randomized Adherence Intervention|Death|11|||
33190956|NCT01641367|100605072|FG007|Randomized Adherence Intervention|Death|12|||
33190957|NCT01641367|100605065|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
33190958|NCT01641367|100605066|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
33190959|NCT01641367|100605067|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
33190960|NCT01641367|100605068|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
33190961|NCT01641367|100605069|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
33190962|NCT01641367|100605070|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
33304635|NCT01081665|101007332|FG000|Overall Study|Adverse Event|1|||
33304636|NCT01081665|101007332|FG000|Overall Study|Lack of Efficacy|1|||
33304637|NCT00659880|101007333|FG000|Overall Study|Lost to Follow-up|5|||
33304638|NCT00287690|101007334|FG000|Overall Study|Protocol Violation|20|||
33304639|NCT00287690|101007335|FG001|Overall Study|Protocol Violation|26|||
33304640|NCT03435692|101007336|FG000|Overall Study|Lack of Efficacy|2|||
33304641|NCT03435692|101007337|FG001|Overall Study|Lack of Efficacy|2|||
33304642|NCT03435692|101007338|FG002|Overall Study|Lack of Efficacy|0|||
33304643|NCT02081417|101007339|FG000|Overall Study|Lost to Follow-up|26|||
33304644|NCT02081417|101007340|FG001|Overall Study|Lost to Follow-up|23|||
33304645|NCT02081417|101007339|FG000|Overall Study|Moved Away|1|||
33304646|NCT02081417|101007340|FG001|Overall Study|Moved Away|2|||
33304647|NCT02081417|101007339|FG000|Overall Study|Incarcerated|2|||
33304648|NCT02081417|101007340|FG001|Overall Study|Incarcerated|2|||
33304649|NCT02081417|101007339|FG000|Overall Study|Death|4|||
33304650|NCT02081417|101007340|FG001|Overall Study|Death|3|||
33304651|NCT02081417|101007339|FG000|Overall Study|Withdrawal by Subject|4|||
33304652|NCT02081417|101007340|FG001|Overall Study|Withdrawal by Subject|0|||
33304653|NCT02081417|101007339|FG000|Overall Study|Admitted to Residential Treatment|2|||
33304654|NCT02081417|101007340|FG001|Overall Study|Admitted to Residential Treatment|0|||
33304655|NCT02081417|101007339|FG000|Overall Study|Did not start treatment|17|||
33304656|NCT02081417|101007340|FG001|Overall Study|Did not start treatment|21|||
33304657|NCT01144052|101007343|FG000|Overall Study|Withdrawal by Subject|1|||
33304658|NCT01144052|101007344|FG001|Overall Study|Withdrawal by Subject|1|||
33304659|NCT03053518|101007348|FG000|Overall Study|Withdrawal by Subject|3|||
33304660|NCT03053518|101007348|FG000|Overall Study|Lost to Follow-up|2|||
33304661|NCT03053518|101007348|FG000|Overall Study|Ineligible|5|||
33304662|NCT00862719|101010350|FG000|Overall Study|Disease Progression|5|||
33304663|NCT00862719|101010351|FG001|Overall Study|Disease Progression|0|||
33304664|NCT00862719|101010352|FG002|Overall Study|Disease Progression|1|||
33498794|NCT00984542|101720207|FG000|Overall Study|toxicity|7|||
33498795|NCT00984542|101720207|FG000|Overall Study|Death|7|||
33498796|NCT00984542|101720207|FG000|Overall Study|complicating disease|3|||
33304665|NCT00862719|101010353|FG003|Overall Study|Disease Progression|0|||
33498797|NCT00984542|101720207|FG000|Overall Study|Withdrawal by Subject|3|||
33304666|NCT00862719|101010350|FG000|Overall Study|Death|5|||
33304667|NCT00862719|101010351|FG001|Overall Study|Death|6|||
33304668|NCT00862719|101010352|FG002|Overall Study|Death|1|||
33304669|NCT00862719|101010353|FG003|Overall Study|Death|1|||
33304670|NCT00862719|101010350|FG000|Overall Study|Engraftment failure|0|||
33304671|NCT00862719|101010351|FG001|Overall Study|Engraftment failure|0|||
33498798|NCT00984542|101720207|FG000|Overall Study|clinical deterioration|2|||
33498799|NCT00828568|101720208|FG000|Randomized|Withdrawal by Subject|1|||
33498800|NCT00828568|101720209|FG001|Randomized|Withdrawal by Subject|0|||
33498801|NCT00828568|101720210|FG002|Randomized|Withdrawal by Subject|2|||
33498802|NCT00828568|101720208|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
33498803|NCT00828568|101720209|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
33498804|NCT00828568|101720210|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
33498805|NCT00828568|101720208|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
33498806|NCT00828568|101720209|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
33498807|NCT00828568|101720210|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
33498808|NCT00828568|101720208|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
33498809|NCT00828568|101720209|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
33498810|NCT00828568|101720210|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
33498811|NCT00828568|101720208|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
33498812|NCT00828568|101720209|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
33498813|NCT00828568|101720210|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
33498814|NCT01870973|101720217|FG000|Overall Study|Lost to Follow-up|10|||
33498815|NCT01870973|101720218|FG001|Overall Study|Lost to Follow-up|3|||
33498816|NCT04762160|101720219|FG000|Overall Study|Study terminated early due to business reasons|5|||
33498817|NCT00314340|101720220|FG000|Overall Study|lost interest|1|||
33498818|NCT03588910|101720221|FG000|Overall Study|Withdrawal by Subject|1|||
33498819|NCT03588910|101720222|FG001|Overall Study|Withdrawal by Subject|0|||
33498820|NCT03588910|101720221|FG000|Overall Study|Allergy|2|||
33304672|NCT00862719|101010352|FG002|Overall Study|Engraftment failure|1|||
33304673|NCT00862719|101010353|FG003|Overall Study|Engraftment failure|0|||
33304674|NCT00862719|101010350|FG000|Overall Study|Veno-Occlusive Disease|0|||
33304675|NCT00862719|101010351|FG001|Overall Study|Veno-Occlusive Disease|0|||
33304676|NCT00862719|101010352|FG002|Overall Study|Veno-Occlusive Disease|1|||
33304677|NCT00862719|101010353|FG003|Overall Study|Veno-Occlusive Disease|0|||
33304678|NCT03141905|101010359|FG000|Overall Study|Death|3|||
33304679|NCT03141905|101010360|FG001|Overall Study|Death|2|||
33393722|NCT03073200|101328511|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33304680|NCT03141905|101010359|FG000|Overall Study|Withdrawal by Subject|1|||
33498821|NCT03588910|101720222|FG001|Overall Study|Allergy|0|||
33498822|NCT03588910|101720221|FG000|Overall Study|Protocol Violation|0|||
33304681|NCT03141905|101010360|FG001|Overall Study|Withdrawal by Subject|0|||
33304682|NCT03141905|101010359|FG000|Overall Study|Lost to Follow-up|3|||
33304683|NCT03141905|101010360|FG001|Overall Study|Lost to Follow-up|7|||
33304684|NCT03141905|101010359|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
33304685|NCT03141905|101010360|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
33304686|NCT03980808|101010361|FG000|Overall Study|Lost to Follow-up|2|||
33304687|NCT03980808|101010362|FG001|Overall Study|Lost to Follow-up|2|||
33304688|NCT03775434|101010368|FG000|Overall Study|Adverse Event|2|||
33304689|NCT03775434|101010368|FG000|Overall Study|Withdrawal by Subject|1|||
33304690|NCT02112708|101010369|FG000|Baseline|Physician Decision|16|||
33304691|NCT02112708|101010370|FG001|Baseline|Physician Decision|11|||
33304692|NCT02112708|101010369|FG000|Baseline|Lost to Follow-up|12|||
33304693|NCT02112708|101010370|FG001|Baseline|Lost to Follow-up|0|||
33304694|NCT02112708|101010369|FG000|4 Month|Death|0|||
33304695|NCT02112708|101010370|FG001|4 Month|Death|1|||
33304696|NCT02112708|101010369|FG000|4 Month|Withdrawal by Subject|12|||
33304697|NCT02112708|101010370|FG001|4 Month|Withdrawal by Subject|0|||
33304698|NCT00929110|101010381|FG000|Overall Study|Adverse Event|40|||
33304699|NCT00929110|101010382|FG001|Overall Study|Adverse Event|29|||
33498823|NCT03588910|101720222|FG001|Overall Study|Protocol Violation|3|||
33498824|NCT03588910|101720221|FG000|Overall Study|Did not complete Day 1 Survey|5|||
33498825|NCT03588910|101720222|FG001|Overall Study|Did not complete Day 1 Survey|10|||
33600568|NCT00882908|102088729|FG003|Overall Study|Lost to Follow-up|1|||
33600569|NCT00882908|102088730|FG004|Overall Study|Lost to Follow-up|2|||
33600570|NCT00882908|102088726|FG000|Overall Study|Protocol Violation|0|||
33304700|NCT00929110|101010383|FG002|Overall Study|Adverse Event|18|||
33304701|NCT00929110|101010381|FG000|Overall Study|Subject withdrew consent|40|||
33304702|NCT00929110|101010382|FG001|Overall Study|Subject withdrew consent|23|||
33304703|NCT00929110|101010383|FG002|Overall Study|Subject withdrew consent|26|||
33304704|NCT00929110|101010381|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
33304705|NCT00929110|101010382|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
33304706|NCT00929110|101010383|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
33498826|NCT03588910|101720221|FG000|Overall Study|Did not complete Day 7 Survey|5|||
33498827|NCT03588910|101720222|FG001|Overall Study|Did not complete Day 7 Survey|2|||
33498828|NCT01420068|101720223|FG000|Overall Study|Administrative problems|1|||
33498829|NCT01420068|101720224|FG001|Overall Study|Administrative problems|3|||
33498830|NCT01420068|101720223|FG000|Overall Study|Withdrawal by Subject|1|||
33498831|NCT01420068|101720224|FG001|Overall Study|Withdrawal by Subject|2|||
33600571|NCT00882908|102088727|FG001|Overall Study|Protocol Violation|1|||
33304707|NCT00929110|101010381|FG000|Overall Study|Lost to Follow-up|7|||
33304708|NCT00929110|101010382|FG001|Overall Study|Lost to Follow-up|7|||
33600572|NCT00882908|102088728|FG002|Overall Study|Protocol Violation|0|||
33600573|NCT00882908|102088729|FG003|Overall Study|Protocol Violation|0|||
33600574|NCT00882908|102088730|FG004|Overall Study|Protocol Violation|0|||
33600575|NCT00882908|102088726|FG000|Overall Study|Withdrawal by Subject|0|||
33600576|NCT00882908|102088727|FG001|Overall Study|Withdrawal by Subject|0|||
33600577|NCT00882908|102088728|FG002|Overall Study|Withdrawal by Subject|3|||
33600578|NCT00882908|102088729|FG003|Overall Study|Withdrawal by Subject|5|||
33600579|NCT00882908|102088730|FG004|Overall Study|Withdrawal by Subject|2|||
33600580|NCT00882908|102088726|FG000|Overall Study|Subject reached a virologic endpoint|0|||
33600581|NCT00882908|102088727|FG001|Overall Study|Subject reached a virologic endpoint|0|||
33600582|NCT00882908|102088728|FG002|Overall Study|Subject reached a virologic endpoint|0|||
33600583|NCT00882908|102088729|FG003|Overall Study|Subject reached a virologic endpoint|0|||
33600584|NCT00882908|102088730|FG004|Overall Study|Subject reached a virologic endpoint|1|||
33600585|NCT00882908|102088726|FG000|Overall Study|Study terminated in error|0|||
33304709|NCT00929110|101010383|FG002|Overall Study|Lost to Follow-up|3|||
33304710|NCT00929110|101010381|FG000|Overall Study|Protocol deviation|5|||
33600586|NCT00882908|102088727|FG001|Overall Study|Study terminated in error|0|||
33600587|NCT00882908|102088728|FG002|Overall Study|Study terminated in error|0|||
33600588|NCT00882908|102088729|FG003|Overall Study|Study terminated in error|1|||
33600589|NCT00882908|102088730|FG004|Overall Study|Study terminated in error|0|||
33600590|NCT03285958|102088737|FG000|Overall Study|Lost to Follow-up|1|||
33304711|NCT00929110|101010382|FG001|Overall Study|Protocol deviation|2|||
33304712|NCT00929110|101010383|FG002|Overall Study|Protocol deviation|4|||
33304713|NCT00929110|101010381|FG000|Overall Study|Administrative problems|4|||
33304714|NCT00929110|101010382|FG001|Overall Study|Administrative problems|1|||
33304715|NCT00929110|101010383|FG002|Overall Study|Administrative problems|2|||
33304716|NCT00929110|101010381|FG000|Overall Study|Death|2|||
33304717|NCT00929110|101010382|FG001|Overall Study|Death|2|||
33304718|NCT00929110|101010383|FG002|Overall Study|Death|2|||
33304719|NCT00929110|101010381|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33304720|NCT00929110|101010382|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33304721|NCT00929110|101010383|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33304722|NCT00929110|101010381|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33304723|NCT00929110|101010382|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33304724|NCT00929110|101010383|FG002|Overall Study|Abnormal test procedure result(s)|1|||
33304725|NCT00929110|101010381|FG000|Overall Study|Patient inability to use the device|0|||
33304726|NCT00929110|101010382|FG001|Overall Study|Patient inability to use the device|1|||
33304727|NCT00929110|101010383|FG002|Overall Study|Patient inability to use the device|0|||
33304728|NCT01806623|101010384|FG000|Overall Study|Withdrawal by Subject|1|||
33304729|NCT01806623|101010384|FG000|Overall Study|Adverse Event|1|||
33304730|NCT01806623|101010384|FG000|Overall Study|Did not meet the inclusion criteria|56|||
33304731|NCT01014208|101010387|FG000|Overall Study|Lost to Follow-up|2|||
33304732|NCT01014208|101010388|FG001|Overall Study|Lost to Follow-up|5|||
33304733|NCT01014208|101010387|FG000|Overall Study|Participant Withdrew Consent|12|||
33304734|NCT01014208|101010388|FG001|Overall Study|Participant Withdrew Consent|12|||
33304735|NCT01014208|101010387|FG000|Overall Study|Did Not Receive Study Drug|2|||
33304736|NCT01014208|101010388|FG001|Overall Study|Did Not Receive Study Drug|0|||
33304737|NCT01014208|101010387|FG000|Overall Study|Study Closed/terminated|78|||
33304738|NCT01014208|101010388|FG001|Overall Study|Study Closed/terminated|83|||
33304739|NCT00939822|101010389|FG000|Overall Study|Lost to Follow-up|1|||
33304740|NCT00939822|101010390|FG001|Overall Study|Lost to Follow-up|0|||
33304741|NCT00939822|101010389|FG000|Overall Study|withdrew from study due to busy schedule|1|||
33304742|NCT00939822|101010390|FG001|Overall Study|withdrew from study due to busy schedule|1|||
33600591|NCT03285958|102088738|FG001|Overall Study|Lost to Follow-up|1|||
33304743|NCT00939822|101010389|FG000|Overall Study|Mental health issues|0|||
33304744|NCT00939822|101010390|FG001|Overall Study|Mental health issues|2|||
33304745|NCT00710021|101010394|FG000|Overall Study|Lost to Follow-up|1|||
33304746|NCT00710021|101010395|FG001|Overall Study|Lost to Follow-up|0|||
33304747|NCT00710021|101010396|FG002|Overall Study|Lost to Follow-up|0|||
33304748|NCT00710021|101010394|FG000|Overall Study|Subject's Decision|0|||
33304749|NCT00710021|101010395|FG001|Overall Study|Subject's Decision|1|||
33304750|NCT00710021|101010396|FG002|Overall Study|Subject's Decision|0|||
33304751|NCT00710021|101010394|FG000|Overall Study|Subject misrandomized|0|||
33304752|NCT00710021|101010395|FG001|Overall Study|Subject misrandomized|1|||
33304753|NCT00710021|101010396|FG002|Overall Study|Subject misrandomized|1|||
33304754|NCT00710021|101010394|FG000|Overall Study|Physician Decision|0|||
33600592|NCT03285958|102088737|FG000|Overall Study|Withdrawal by Subject|1|||
33600593|NCT03285958|102088738|FG001|Overall Study|Withdrawal by Subject|0|||
33600594|NCT03285958|102088737|FG000|Overall Study|Not able to attend required orientation|3|||
33600595|NCT03285958|102088738|FG001|Overall Study|Not able to attend required orientation|0|||
33600596|NCT01344629|102088740|FG000|Crossover Period 2|Withdrawal by Subject|0|||
33600597|NCT01344629|102088741|FG001|Crossover Period 2|Withdrawal by Subject|1|||
33600598|NCT01420627|102088742|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
33600599|NCT03077698|102088744|FG000|Progestin Monotherapy|Stable Disease|8|||
33600600|NCT03077698|102088745|FG001|Progestin Monotherapy|Stable Disease|0|||
33600601|NCT03077698|102088744|FG000|Progestin Monotherapy|Adverse Event|1|||
33600602|NCT03077698|102088745|FG001|Progestin Monotherapy|Adverse Event|0|||
33600603|NCT03077698|102088744|FG000|Progestin Monotherapy|Death|1|||
33600604|NCT03077698|102088745|FG001|Progestin Monotherapy|Death|0|||
33600605|NCT03077698|102088744|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
33304755|NCT00710021|101010395|FG001|Overall Study|Physician Decision|1|||
33304756|NCT00710021|101010396|FG002|Overall Study|Physician Decision|0|||
33304757|NCT00490724|101010398|FG000|Period I|Physician Decision|0|||
33304758|NCT00490724|101010399|FG001|Period I|Physician Decision|0|||
33304759|NCT00490724|101010400|FG002|Period I|Physician Decision|1|||
33304760|NCT00490724|101010398|FG000|Period II|Treatment Discontinuation|3|||
33600606|NCT03077698|102088745|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
33600607|NCT03077698|102088744|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
33304761|NCT00490724|101010399|FG001|Period II|Treatment Discontinuation|1|||
33304762|NCT00490724|101010400|FG002|Period II|Treatment Discontinuation|3|||
33304763|NCT00831129|101010403|FG000|Overall Study|Adverse Event|0|||
33304764|NCT00831129|101010404|FG001|Overall Study|Adverse Event|1|||
33304765|NCT00831129|101010403|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
33304766|NCT00831129|101010404|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
33304767|NCT02595073|101010406|FG000|Overall Study|Progressive Disease|0|||
33304768|NCT02595073|101010407|FG001|Overall Study|Progressive Disease|1|||
33304769|NCT02595073|101010406|FG000|Overall Study|Protocol Violation|2|||
33304770|NCT02595073|101010407|FG001|Overall Study|Protocol Violation|0|||
33498832|NCT04185220|101720227|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
33498833|NCT04185220|101720228|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
33498834|NCT04185220|101720227|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
33498835|NCT04185220|101720228|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
33498836|NCT00428246|101720230|FG000|Overall Study|Withdrawal by Subject|0|||
33498837|NCT00428246|101720231|FG001|Overall Study|Withdrawal by Subject|0|||
33498838|NCT00428246|101720232|FG002|Overall Study|Withdrawal by Subject|1|||
33498839|NCT00428246|101720230|FG000|Overall Study|Adverse Event|1|||
33498840|NCT00428246|101720231|FG001|Overall Study|Adverse Event|0|||
33498841|NCT00428246|101720232|FG002|Overall Study|Adverse Event|0|||
33498842|NCT00359424|101720233|FG000|Overall Study|Death|99|||
33498843|NCT00359424|101720234|FG001|Overall Study|Death|58|||
33498844|NCT00359424|101720233|FG000|Overall Study|Lost to Follow-up|19|||
33498845|NCT00359424|101720234|FG001|Overall Study|Lost to Follow-up|7|||
33498846|NCT00359424|101720233|FG000|Overall Study|Withdrawal by Subject|10|||
33498847|NCT00359424|101720234|FG001|Overall Study|Withdrawal by Subject|2|||
33498848|NCT00359424|101720233|FG000|Overall Study|follow up not conducted|2|||
33498849|NCT00359424|101720234|FG001|Overall Study|follow up not conducted|0|||
33498850|NCT01697748|101720237|FG000|Overall Study|ineligible skin incision|1|||
33498851|NCT01697748|101720238|FG001|Overall Study|ineligible skin incision|2|||
33498852|NCT01697748|101720237|FG000|Overall Study|ineligible uterine incision|4|||
33498853|NCT01697748|101720238|FG001|Overall Study|ineligible uterine incision|1|||
33498854|NCT01697748|101720237|FG000|Overall Study|Lost to Follow-up|53|||
33498855|NCT01697748|101720238|FG001|Overall Study|Lost to Follow-up|65|||
33498856|NCT04577404|101720239|FG000|Overall Study|Adverse Event|31|||
33498857|NCT04577404|101720239|FG000|Overall Study|Death|1|||
33498858|NCT04577404|101720239|FG000|Overall Study|Lack of Efficacy|3|||
33600608|NCT03077698|102088745|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
33304771|NCT02233543|101010411|FG000|Period 1|Withdrawal by Subject|1|||
33304772|NCT02233543|101010412|FG001|Period 1|Withdrawal by Subject|0|||
33498859|NCT04577404|101720239|FG000|Overall Study|Physician Decision|7|||
33498860|NCT04577404|101720239|FG000|Overall Study|Withdrawal by Subject|21|||
33600609|NCT03077698|102088744|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
33600610|NCT03077698|102088745|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
33600611|NCT03077698|102088744|FG000|Safety Follow Up|Withdrawal by Subject|2|||
33600612|NCT03077698|102088745|FG001|Safety Follow Up|Withdrawal by Subject|1|||
33600613|NCT03077698|102088744|FG000|Safety Follow Up|Transfer of care to hospice|1|||
33600614|NCT03077698|102088745|FG001|Safety Follow Up|Transfer of care to hospice|0|||
33600615|NCT00654004|102088747|FG000|Overall Study|Lost to Follow-up|1|||
33600616|NCT00654004|102088748|FG001|Overall Study|Lost to Follow-up|0|||
33600617|NCT04912895|102088749|FG000|Overall Study|Unable to provide specimen|2|||
33600618|NCT04912895|102088750|FG001|Overall Study|Unable to provide specimen|0|||
33600619|NCT04912895|102088751|FG002|Overall Study|Unable to provide specimen|0|||
33600620|NCT03906656|102088757|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
33600621|NCT03906656|102088758|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
33600622|NCT03906656|102088757|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
33600623|NCT03906656|102088758|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
33600624|NCT03906656|102088757|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
33600625|NCT03906656|102088758|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
33600626|NCT03906656|102088757|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
33190963|NCT01641367|100605071|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
33190964|NCT01641367|100605072|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
33190965|NCT04545515|100605073|FG000|Overall Study|Adverse Event|1|||
33190966|NCT04545515|100605073|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
33190967|NCT04545515|100605073|FG000|Overall Study|Commercial drug is available for participant|7|||
33304773|NCT02233543|101010411|FG000|Period 1|Participants required other treatment.|2|||
33498861|NCT04577404|101720239|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
33600627|NCT03906656|102088758|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
33600628|NCT03906656|102088757|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
33600629|NCT03906656|102088758|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
33600630|NCT03906656|102088757|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
33304774|NCT02233543|101010412|FG001|Period 1|Participants required other treatment.|3|||
33304775|NCT02233543|101010411|FG000|Period 2|Adverse Event|1|||
33498862|NCT02729025|101720240|FG000|Overall Study|Sponsor Decision|0|||
33498863|NCT02729025|101720241|FG001|Overall Study|Sponsor Decision|1|||
33498864|NCT00105079|101720242|FG000|Overall Study|Adverse Event|5|||
33498865|NCT00105079|101720243|FG001|Overall Study|Adverse Event|12|||
33498866|NCT00105079|101720242|FG000|Overall Study|Death|3|||
33498867|NCT00105079|101720243|FG001|Overall Study|Death|1|||
33498868|NCT00105079|101720242|FG000|Overall Study|Lost to Follow-up|12|||
33498869|NCT00105079|101720243|FG001|Overall Study|Lost to Follow-up|12|||
33498870|NCT00105079|101720242|FG000|Overall Study|Lack of Efficacy|9|||
33498871|NCT00105079|101720243|FG001|Overall Study|Lack of Efficacy|3|||
33498872|NCT00105079|101720242|FG000|Overall Study|Refused treatment|6|||
33498873|NCT00105079|101720243|FG001|Overall Study|Refused treatment|4|||
33498874|NCT00105079|101720242|FG000|Overall Study|Violation of selection criteria at entry|0|||
33498875|NCT00105079|101720243|FG001|Overall Study|Violation of selection criteria at entry|2|||
33190968|NCT00519649|100605077|FG000|Overall Study|Withdrawal by Subject|1|||
33190969|NCT00974571|100605078|FG000|Overall Study|Adverse Event|31|||
33190970|NCT00974571|100605079|FG001|Overall Study|Adverse Event|4|||
33190971|NCT00974571|100605080|FG002|Overall Study|Adverse Event|27|||
33190972|NCT00974571|100605078|FG000|Overall Study|Lack of Efficacy|3|||
33190973|NCT00974571|100605079|FG001|Overall Study|Lack of Efficacy|2|||
33190974|NCT00974571|100605080|FG002|Overall Study|Lack of Efficacy|9|||
33190975|NCT00974571|100605078|FG000|Overall Study|Lost to Follow-up|2|||
33190976|NCT00974571|100605079|FG001|Overall Study|Lost to Follow-up|1|||
33190977|NCT00974571|100605080|FG002|Overall Study|Lost to Follow-up|2|||
33190978|NCT00974571|100605078|FG000|Overall Study|Protocol Violation|13|||
33190979|NCT00974571|100605079|FG001|Overall Study|Protocol Violation|4|||
33190980|NCT00974571|100605080|FG002|Overall Study|Protocol Violation|18|||
33304776|NCT02233543|101010412|FG001|Period 2|Adverse Event|0|||
33304777|NCT02233543|101010411|FG000|Period 2|Participant required other treatment.|0|||
33304778|NCT02233543|101010412|FG001|Period 2|Participant required other treatment.|1|||
33498876|NCT00105079|101720242|FG000|Overall Study|Protocol Violation|1|||
33498877|NCT00105079|101720243|FG001|Overall Study|Protocol Violation|0|||
33498878|NCT00105079|101720242|FG000|Overall Study|Other|3|||
33498879|NCT00105079|101720243|FG001|Overall Study|Other|1|||
33498880|NCT05506046|101720246|FG000|Overall Study|Lost to Follow-up|89|||
33304779|NCT02233543|101010411|FG000|Period 2|COPD exacerbation|1|||
33304780|NCT02233543|101010412|FG001|Period 2|COPD exacerbation|0|||
33304781|NCT03339583|101010413|FG000|First Intervention (14 Days)|Adverse Event|1|||
33304782|NCT03339583|101010414|FG001|First Intervention (14 Days)|Adverse Event|0|||
33304783|NCT03339583|101010413|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
33304784|NCT03339583|101010414|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
33304785|NCT03339583|101010413|FG000|Second Intervention (14 Days)|Adverse Event|0|||
33304786|NCT03339583|101010414|FG001|Second Intervention (14 Days)|Adverse Event|1|||
33304787|NCT03339583|101010413|FG000|Follow-up (14 Days)|Physician Decision|6|||
33304788|NCT03339583|101010414|FG001|Follow-up (14 Days)|Physician Decision|3|||
33304789|NCT02399254|101010415|FG000|Overall Study|Physician Decision|2|||
33304790|NCT01253304|101010416|FG000|Overall Study|Adverse Event|0|||
33304791|NCT01253304|101010417|FG001|Overall Study|Adverse Event|0|||
33304792|NCT01253304|101010418|FG002|Overall Study|Adverse Event|0|||
33304793|NCT01253304|101010419|FG003|Overall Study|Adverse Event|1|||
33304794|NCT02297139|101010420|FG000|Overall Study|Disease progression|0|||
33304795|NCT02297139|101010421|FG001|Overall Study|Disease progression|1|||
33304796|NCT02297139|101010420|FG000|Overall Study|Study drug toxicity|0|||
33304797|NCT02297139|101010421|FG001|Overall Study|Study drug toxicity|4|||
33498881|NCT05506046|101720247|FG001|Overall Study|Lost to Follow-up|101|||
33498882|NCT05506046|101720248|FG002|Overall Study|Lost to Follow-up|102|||
33190981|NCT00974571|100605078|FG000|Overall Study|Withdrawal by Subject|14|||
33190982|NCT00974571|100605079|FG001|Overall Study|Withdrawal by Subject|5|||
33190983|NCT00974571|100605080|FG002|Overall Study|Withdrawal by Subject|16|||
33304798|NCT02297139|101010420|FG000|Overall Study|Participant request to discontinue study treatment|0|||
33498883|NCT05506046|101720249|FG003|Overall Study|Lost to Follow-up|99|||
33498884|NCT00031590|101720250|FG000|Overall Study|Adverse Event|1|||
33190984|NCT00974571|100605078|FG000|Overall Study|Patient Moved|1|||
33498885|NCT00031590|101720250|FG000|Overall Study|Withdrawal by parents|2|||
33498886|NCT00506415|101720251|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
33304799|NCT02297139|101010421|FG001|Overall Study|Participant request to discontinue study treatment|1|||
33304800|NCT02297139|101010420|FG000|Overall Study|Maximum clinical benefit|1|||
33304801|NCT02297139|101010421|FG001|Overall Study|Maximum clinical benefit|0|||
33304802|NCT02297139|101010420|FG000|Overall Study|Administrative reason by sponsor|0|||
33304803|NCT02297139|101010421|FG001|Overall Study|Administrative reason by sponsor|2|||
33304804|NCT02297139|101010420|FG000|Overall Study|Other reasons|0|||
33304805|NCT02297139|101010421|FG001|Overall Study|Other reasons|8|||
33304806|NCT02964325|101010422|FG000|Overall Study|Lost to Follow-up|3|||
33304807|NCT02964325|101010423|FG001|Overall Study|Lost to Follow-up|3|||
33304808|NCT02964325|101010422|FG000|Overall Study|Physician Decision|5|||
33304809|NCT02964325|101010423|FG001|Overall Study|Physician Decision|4|||
33304810|NCT02964325|101010422|FG000|Overall Study|Death|1|||
33304811|NCT02964325|101010423|FG001|Overall Study|Death|3|||
33304812|NCT02964325|101010422|FG000|Overall Study|Withdrawal by Subject|2|||
33304813|NCT02964325|101010423|FG001|Overall Study|Withdrawal by Subject|1|||
33304814|NCT02964325|101010422|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
33304815|NCT02964325|101010423|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
33304816|NCT00446043|101010427|FG000|Overall Study|Adverse Event|9|||
33304817|NCT00446043|101010427|FG000|Overall Study|Withdrawal by Subject|70|||
33304818|NCT00446043|101010427|FG000|Overall Study|Protocol Violation|2|||
33304819|NCT00446043|101010427|FG000|Overall Study|Lost to Follow-up|42|||
33304820|NCT00446043|101010427|FG000|Overall Study|Pregnancy|2|||
33304821|NCT02781090|101010430|FG000|3-Month Follow-Up|Missed Visit|20|||
33304822|NCT02781090|101010431|FG001|3-Month Follow-Up|Missed Visit|20|||
33304823|NCT02781090|101010430|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
33304824|NCT02781090|101010431|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
33304825|NCT02781090|101010430|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
33304826|NCT02781090|101010431|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
33190985|NCT00974571|100605079|FG001|Overall Study|Patient Moved|0|||
33190986|NCT00974571|100605080|FG002|Overall Study|Patient Moved|1|||
33190987|NCT00974571|100605078|FG000|Overall Study|Other|4|||
33190988|NCT00974571|100605079|FG001|Overall Study|Other|0|||
33190989|NCT00974571|100605080|FG002|Overall Study|Other|10|||
33190990|NCT00006184|100605081|FG000|Overall Study|Death|1|||
33190991|NCT00006184|100605082|FG001|Overall Study|Death|0|||
33190992|NCT00355238|100605083|FG000|Overall Study|Adverse event unrelated to study drug|2|||
33190993|NCT00355238|100605084|FG001|Overall Study|Adverse event unrelated to study drug|2|||
33190994|NCT00355238|100605085|FG002|Overall Study|Adverse event unrelated to study drug|0|||
33190995|NCT00355238|100605086|FG003|Overall Study|Adverse event unrelated to study drug|1|||
33190996|NCT00355238|100605083|FG000|Overall Study|Death|1|||
33190997|NCT00355238|100605084|FG001|Overall Study|Death|0|||
33190998|NCT00355238|100605085|FG002|Overall Study|Death|0|||
33190999|NCT00355238|100605086|FG003|Overall Study|Death|0|||
33191000|NCT00355238|100605083|FG000|Overall Study|Disease progression|37|||
33191001|NCT00355238|100605084|FG001|Overall Study|Disease progression|36|||
33191002|NCT00355238|100605085|FG002|Overall Study|Disease progression|16|||
33191003|NCT00355238|100605086|FG003|Overall Study|Disease progression|11|||
33191004|NCT00355238|100605083|FG000|Overall Study|Study drug toxicity|11|||
33191005|NCT00355238|100605084|FG001|Overall Study|Study drug toxicity|7|||
33191006|NCT00355238|100605085|FG002|Overall Study|Study drug toxicity|5|||
33191007|NCT00355238|100605086|FG003|Overall Study|Study drug toxicity|2|||
33191008|NCT00355238|100605083|FG000|Overall Study|Participant withdrew consent|3|||
33191009|NCT00355238|100605084|FG001|Overall Study|Participant withdrew consent|1|||
33191010|NCT00355238|100605085|FG002|Overall Study|Participant withdrew consent|0|||
33191011|NCT00355238|100605086|FG003|Overall Study|Participant withdrew consent|0|||
33191012|NCT00355238|100605083|FG000|Overall Study|Participant request to discontinue study treatment|1|||
33191013|NCT00355238|100605084|FG001|Overall Study|Participant request to discontinue study treatment|0|||
33191014|NCT00355238|100605085|FG002|Overall Study|Participant request to discontinue study treatment|1|||
33191015|NCT00355238|100605086|FG003|Overall Study|Participant request to discontinue study treatment|0|||
33304827|NCT02781090|101010430|FG000|3-Month Follow-Up|Death|1|||
33304828|NCT02781090|101010431|FG001|3-Month Follow-Up|Death|0|||
33304829|NCT02781090|101010430|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
33304830|NCT02781090|101010431|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
33304831|NCT02781090|101010430|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
33304832|NCT02781090|101010431|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
33304833|NCT02781090|101010430|FG000|6-Month Follow-Up|Death|0|||
33304834|NCT02781090|101010431|FG001|6-Month Follow-Up|Death|1|||
33191016|NCT00670800|100605089|FG000|Overall Study|2 controls were insulin resistant|0|||
33191017|NCT00670800|100605090|FG001|Overall Study|2 controls were insulin resistant|2|||
33191018|NCT02375672|100605091|FG000|Overall Study|remain on follow up|20|||
33191019|NCT03852316|100605093|FG000|Overall Study|Protocol Violation|1|||
33304835|NCT01215188|101010432|FG000|Overall Study|Lost to Follow-up|22|||
33191020|NCT03852316|100605093|FG000|Overall Study|Withdrawal by Subject|2|||
33191021|NCT03852316|100605093|FG000|Overall Study|Enrolled but Device not Utilized|1|||
33191022|NCT01987427|100605094|FG000|Overall Study|Adverse Event|4|||
33304836|NCT01215188|101010433|FG001|Overall Study|Lost to Follow-up|22|||
33304837|NCT01215188|101010434|FG002|Overall Study|Lost to Follow-up|16|||
33304838|NCT01215188|101010432|FG000|Overall Study|Adverse Event|1|||
33304839|NCT01215188|101010433|FG001|Overall Study|Adverse Event|1|||
33304840|NCT01215188|101010434|FG002|Overall Study|Adverse Event|3|||
33304841|NCT01215188|101010432|FG000|Overall Study|Physician Decision|2|||
33304842|NCT01215188|101010433|FG001|Overall Study|Physician Decision|1|||
33304843|NCT01215188|101010434|FG002|Overall Study|Physician Decision|0|||
33304844|NCT01215188|101010432|FG000|Overall Study|Lack of Efficacy|0|||
33304845|NCT01215188|101010433|FG001|Overall Study|Lack of Efficacy|0|||
33304846|NCT01215188|101010434|FG002|Overall Study|Lack of Efficacy|1|||
33304847|NCT01215188|101010432|FG000|Overall Study|Protocol Violation|1|||
33304848|NCT01215188|101010433|FG001|Overall Study|Protocol Violation|1|||
33304849|NCT01215188|101010434|FG002|Overall Study|Protocol Violation|1|||
33304850|NCT01215188|101010432|FG000|Overall Study|Withdrawal by Subject|32|||
33304851|NCT01215188|101010433|FG001|Overall Study|Withdrawal by Subject|34|||
33304852|NCT01215188|101010434|FG002|Overall Study|Withdrawal by Subject|31|||
33304853|NCT00998790|101010435|FG000|Overall Study|Withdrawal by Subject|21|||
33304854|NCT02766465|101010436|FG000|Overall Study|Withdrawal by Subject|0|||
33304855|NCT02766465|101010437|FG001|Overall Study|Withdrawal by Subject|10|||
33304856|NCT00151281|101010438|FG000|Overall Study|Not evaluable|3|||
33304857|NCT00564889|101010441|FG000|Overall Study|Death|7|||
33304858|NCT00564889|101010441|FG000|Overall Study|Adverse Event|12|||
33304859|NCT00564889|101010441|FG000|Overall Study|Alternative treatment|3|||
33304860|NCT00564889|101010441|FG000|Overall Study|Disease progression|3|||
33304861|NCT00564889|101010441|FG000|Overall Study|Other, not specified|4|||
33304862|NCT00201643|101010443|FG000|Overall Study|Withdrawal by Subject|5|||
33304863|NCT00201643|101010444|FG001|Overall Study|Withdrawal by Subject|4|||
33304864|NCT00626990|101010445|FG000|Overall Study|Lack of Efficacy|6|||
33304865|NCT00626990|101010446|FG001|Overall Study|Lack of Efficacy|7|||
33304866|NCT00626990|101010447|FG002|Overall Study|Lack of Efficacy|49|||
33304867|NCT00626990|101010448|FG003|Overall Study|Lack of Efficacy|40|||
33304868|NCT00626990|101010445|FG000|Overall Study|Adverse Event|1|||
33304869|NCT00626990|101010446|FG001|Overall Study|Adverse Event|7|||
33304870|NCT00626990|101010447|FG002|Overall Study|Adverse Event|14|||
33304871|NCT00626990|101010448|FG003|Overall Study|Adverse Event|28|||
33304872|NCT00626990|101010445|FG000|Overall Study|Death|0|||
33304873|NCT00626990|101010446|FG001|Overall Study|Death|1|||
33304874|NCT00626990|101010447|FG002|Overall Study|Death|0|||
33304875|NCT00626990|101010448|FG003|Overall Study|Death|0|||
33304876|NCT00626990|101010445|FG000|Overall Study|Withdrawal by Subject|3|||
33304877|NCT00626990|101010446|FG001|Overall Study|Withdrawal by Subject|1|||
33304878|NCT00626990|101010447|FG002|Overall Study|Withdrawal by Subject|5|||
33600631|NCT03906656|102088758|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
33600632|NCT03906656|102088757|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
33600633|NCT03906656|102088758|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
33600634|NCT03906656|102088757|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
33600635|NCT03906656|102088758|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
33600636|NCT03906656|102088757|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
33600637|NCT03906656|102088758|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
33600638|NCT03906656|102088757|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
33600639|NCT03906656|102088758|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
33600640|NCT03906656|102088757|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
33600641|NCT03906656|102088758|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
33600642|NCT03906656|102088757|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
33600643|NCT03906656|102088758|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
33600644|NCT03906656|102088757|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
33600645|NCT03906656|102088758|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
33600646|NCT03906656|102088757|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
33600647|NCT03906656|102088758|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
33600648|NCT03906656|102088757|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
33600649|NCT03906656|102088758|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
33600650|NCT03906656|102088757|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
33600651|NCT03906656|102088758|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
33600652|NCT03906656|102088757|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
33304879|NCT00626990|101010448|FG003|Overall Study|Withdrawal by Subject|11|||
33600653|NCT03906656|102088758|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
33600654|NCT03906656|102088757|FG000|Home Use 2 (3 Months)|Death|2|||
33600655|NCT03906656|102088758|FG001|Home Use 2 (3 Months)|Death|0|||
33304880|NCT00626990|101010445|FG000|Overall Study|Protocol Violation|0|||
33304881|NCT00626990|101010446|FG001|Overall Study|Protocol Violation|1|||
33304882|NCT00626990|101010447|FG002|Overall Study|Protocol Violation|1|||
33304883|NCT00626990|101010448|FG003|Overall Study|Protocol Violation|0|||
33304884|NCT00626990|101010445|FG000|Overall Study|Various different reasons/missing|4|||
33304885|NCT00626990|101010446|FG001|Overall Study|Various different reasons/missing|8|||
33600656|NCT03906656|102088757|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
33600657|NCT03906656|102088758|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
33191023|NCT01987427|100605095|FG001|Overall Study|Adverse Event|2|||
33191024|NCT01987427|100605096|FG002|Overall Study|Adverse Event|8|||
33191025|NCT01987427|100605094|FG000|Overall Study|Lost to Follow-up|6|||
33191026|NCT01987427|100605095|FG001|Overall Study|Lost to Follow-up|6|||
33191027|NCT01987427|100605096|FG002|Overall Study|Lost to Follow-up|9|||
33191028|NCT01987427|100605094|FG000|Overall Study|Withdrawal by Subject|2|||
33191029|NCT01987427|100605095|FG001|Overall Study|Withdrawal by Subject|1|||
33191030|NCT01987427|100605096|FG002|Overall Study|Withdrawal by Subject|3|||
33191031|NCT01987427|100605094|FG000|Overall Study|Lack of Efficacy|1|||
33191032|NCT01987427|100605095|FG001|Overall Study|Lack of Efficacy|0|||
33191033|NCT01987427|100605096|FG002|Overall Study|Lack of Efficacy|0|||
33304886|NCT00626990|101010447|FG002|Overall Study|Various different reasons/missing|8|||
33304887|NCT00626990|101010448|FG003|Overall Study|Various different reasons/missing|16|||
33304888|NCT02317432|101010451|FG000|Overall Study|Death|4|||
33304889|NCT02317432|101010452|FG001|Overall Study|Death|1|||
33191034|NCT01987427|100605094|FG000|Overall Study|Other|1|||
33191035|NCT01987427|100605095|FG001|Overall Study|Other|1|||
33304890|NCT02317432|101010451|FG000|Overall Study|Lost to Follow-up|0|||
33304891|NCT02317432|101010452|FG001|Overall Study|Lost to Follow-up|5|||
33304892|NCT02317432|101010451|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
33304893|NCT02317432|101010452|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
33304894|NCT00721149|101010453|FG000|Overall Study|Physician Decision|1|||
33304895|NCT03284229|101010454|FG000|Overall Study|Lost to Follow-up|3|||
33304896|NCT01011153|101010455|FG000|Overall Study|Less than 78 cases completed|8|||
33304897|NCT01011153|101010456|FG001|Overall Study|Less than 78 cases completed|11|||
33304898|NCT01011153|101010457|FG002|Overall Study|Less than 78 cases completed|9|||
33304899|NCT02008877|101010458|FG000|Overall Study|Inevaluable|0|||
33304900|NCT02008877|101010459|FG001|Overall Study|Inevaluable|1|||
33304901|NCT02008877|101010460|FG002|Overall Study|Inevaluable|0|||
33304902|NCT01361594|101010461|FG000|Overall Study|Withdrawal by Subject|1|||
33304903|NCT01361594|101010462|FG001|Overall Study|Withdrawal by Subject|2|||
33304904|NCT03845140|101010463|FG000|Overall Study|Participant travelled outside study area|0|||
33304905|NCT03845140|101010464|FG001|Overall Study|Participant travelled outside study area|1|||
33304906|NCT03845140|101010465|FG002|Overall Study|Participant travelled outside study area|0|||
33304907|NCT03845140|101010466|FG003|Overall Study|Participant travelled outside study area|0|||
33304908|NCT03845140|101010467|FG004|Overall Study|Participant travelled outside study area|0|||
33304909|NCT03845140|101010468|FG005|Overall Study|Participant travelled outside study area|0|||
33304910|NCT05114473|101010469|FG000|Overall Study|Lost to Follow-up|2|||
33304911|NCT05114473|101010470|FG001|Overall Study|Lost to Follow-up|2|||
33304912|NCT05114473|101010471|FG002|Overall Study|Lost to Follow-up|0|||
33304913|NCT03140280|101010474|FG000|Overall Study|Physician Decision|5|||
33304914|NCT00738894|101010475|FG000|Overall Study|Lost to Follow-up|23|||
33304915|NCT00738894|101010476|FG001|Overall Study|Lost to Follow-up|13|||
33304916|NCT00738894|101010475|FG000|Overall Study|Withdrawal by Subject|10|||
33304917|NCT00738894|101010476|FG001|Overall Study|Withdrawal by Subject|15|||
33304918|NCT00738894|101010475|FG000|Overall Study|Physician Decision|4|||
33304919|NCT00738894|101010476|FG001|Overall Study|Physician Decision|5|||
33304920|NCT00738894|101010475|FG000|Overall Study|Death|2|||
33304921|NCT00738894|101010476|FG001|Overall Study|Death|0|||
33304922|NCT01964924|101010477|FG000|Trametinib Monotherapy|Progression|19|||
33498887|NCT00506415|101720252|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
33498888|NCT00506415|101720253|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
33498889|NCT00506415|101720254|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
33498890|NCT00506415|101720251|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
33498891|NCT00506415|101720252|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
33498892|NCT00506415|101720253|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
33498893|NCT00506415|101720254|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
33498894|NCT00506415|101720251|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
33498895|NCT00506415|101720252|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
33498896|NCT00506415|101720253|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
33498897|NCT00506415|101720254|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
33498898|NCT00506415|101720251|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
33498899|NCT00506415|101720252|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
33304923|NCT01964924|101010478|FG001|Trametinib Monotherapy|Progression|0|||
33304924|NCT05180500|101010479|FG000|Overall Study|Adverse Event|1|||
33304925|NCT05180500|101010480|FG001|Overall Study|Adverse Event|0|||
33304926|NCT05180500|101010479|FG000|Overall Study|Withdrawal by Subject|2|||
33304927|NCT05180500|101010480|FG001|Overall Study|Withdrawal by Subject|0|||
33191036|NCT01987427|100605096|FG002|Overall Study|Other|0|||
33191037|NCT02624284|100605099|FG000|Overall Study|Withdrawal by Subject|3|||
33191038|NCT02624284|100605100|FG001|Overall Study|Withdrawal by Subject|6|||
33191039|NCT02624284|100605101|FG002|Overall Study|Withdrawal by Subject|3|||
33498900|NCT00506415|101720253|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
33498901|NCT00506415|101720254|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
33498902|NCT00506415|101720251|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
33498903|NCT00506415|101720252|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
33498904|NCT00506415|101720253|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
33304928|NCT01153321|101010484|FG000|Overall Study|Development of study withdrawal criteria|0|||
33304929|NCT01153321|101010485|FG001|Overall Study|Development of study withdrawal criteria|1|||
33304930|NCT01153321|101010484|FG000|Overall Study|Withdrawal by Subject|0|||
33304931|NCT01153321|101010485|FG001|Overall Study|Withdrawal by Subject|1|||
33304932|NCT01153321|101010484|FG000|Overall Study|Adverse Event|1|||
33304933|NCT01153321|101010485|FG001|Overall Study|Adverse Event|1|||
33304934|NCT02665338|101010488|FG000|Overall Study|Withdrawal by Subject|0|||
33304935|NCT02665338|101010489|FG001|Overall Study|Withdrawal by Subject|1|||
33304936|NCT01195948|101010494|FG000|Overall Study|Lost to Follow-up|0|||
33304937|NCT01195948|101010495|FG001|Overall Study|Lost to Follow-up|1|||
33304938|NCT01195948|101010496|FG002|Overall Study|Lost to Follow-up|2|||
33304939|NCT03245151|101010497|FG000|Overall Study|Withdrawal by Subject|2|||
33304940|NCT03245151|101010498|FG001|Overall Study|Withdrawal by Subject|0|||
33304941|NCT03245151|101010499|FG002|Overall Study|Withdrawal by Subject|0|||
33304942|NCT03245151|101010500|FG003|Overall Study|Withdrawal by Subject|2|||
33304943|NCT03245151|101010501|FG004|Overall Study|Withdrawal by Subject|1|||
33304944|NCT03245151|101010497|FG000|Overall Study|Death|3|||
33304945|NCT03245151|101010498|FG001|Overall Study|Death|14|||
33304946|NCT03245151|101010499|FG002|Overall Study|Death|9|||
33304947|NCT03245151|101010500|FG003|Overall Study|Death|16|||
33304948|NCT03245151|101010501|FG004|Overall Study|Death|7|||
33304949|NCT03245151|101010497|FG000|Overall Study|Sponsor's decision|0|||
33304950|NCT03245151|101010498|FG001|Overall Study|Sponsor's decision|1|||
33304951|NCT03245151|101010499|FG002|Overall Study|Sponsor's decision|0|||
33304952|NCT03245151|101010500|FG003|Overall Study|Sponsor's decision|0|||
33304953|NCT03245151|101010501|FG004|Overall Study|Sponsor's decision|0|||
33304954|NCT00864253|101010502|FG000|Overall Study|Adverse Event|56|||
33304955|NCT00864253|101010503|FG001|Overall Study|Adverse Event|11|||
33304956|NCT00864253|101010502|FG000|Overall Study|Unrelated Adverse Event|3|||
33304957|NCT00864253|101010503|FG001|Overall Study|Unrelated Adverse Event|1|||
33304958|NCT00864253|101010502|FG000|Overall Study|Physician Decision|11|||
33304959|NCT00864253|101010503|FG001|Overall Study|Physician Decision|15|||
33304960|NCT00864253|101010502|FG000|Overall Study|Protocol Violation|0|||
33304961|NCT00864253|101010503|FG001|Overall Study|Protocol Violation|2|||
33304962|NCT00864253|101010502|FG000|Overall Study|Lost to Follow-up|1|||
33304963|NCT00864253|101010503|FG001|Overall Study|Lost to Follow-up|1|||
33304964|NCT00864253|101010502|FG000|Overall Study|Withdrawal by Subject|18|||
33304965|NCT00864253|101010503|FG001|Overall Study|Withdrawal by Subject|18|||
33304966|NCT00864253|101010502|FG000|Overall Study|Death|1|||
33304967|NCT00864253|101010503|FG001|Overall Study|Death|0|||
33304968|NCT00864253|101010502|FG000|Overall Study|Ongoing|2|||
33304969|NCT00864253|101010503|FG001|Overall Study|Ongoing|3|||
33304970|NCT00864253|101010502|FG000|Overall Study|Untreated|7|||
33304971|NCT00864253|101010503|FG001|Overall Study|Untreated|7|||
33304972|NCT02349425|101010511|FG000|Period 1|Adverse Event|1|||
33304973|NCT02349425|101010512|FG001|Period 1|Adverse Event|1|||
33304974|NCT02349425|101010513|FG002|Period 1|Adverse Event|0|||
33304975|NCT02349425|101010514|FG003|Period 1|Adverse Event|0|||
33304976|NCT02349425|101010511|FG000|Period 2|Adverse Event|0|||
33304977|NCT02349425|101010512|FG001|Period 2|Adverse Event|1|||
33304978|NCT02349425|101010513|FG002|Period 2|Adverse Event|1|||
33304979|NCT02349425|101010514|FG003|Period 2|Adverse Event|0|||
33304980|NCT00953745|101010523|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
33304981|NCT00953745|101010524|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
33304982|NCT00953745|101010523|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
33304983|NCT00953745|101010524|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
33304984|NCT00953745|101010523|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
33498905|NCT00506415|101720254|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
33600658|NCT03906656|102088757|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
33600659|NCT03906656|102088758|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
33304985|NCT00953745|101010524|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
33393723|NCT03073200|101328512|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33191040|NCT02624284|100605099|FG000|Overall Study|Protocol Violation|9|||
33304986|NCT00953745|101010523|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
33304987|NCT00953745|101010524|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
33304988|NCT00953745|101010523|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
33304989|NCT00953745|101010524|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
33304990|NCT00953745|101010523|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
33304991|NCT00953745|101010524|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
33393724|NCT03073200|101328513|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33304992|NCT01871805|101010525|FG000|Phase I|Death|7|||
33304993|NCT01871805|101010526|FG001|Phase I|Death|4|||
33304994|NCT01871805|101010527|FG002|Phase I|Death|6|||
33304995|NCT01871805|101010528|FG003|Phase I|Death|2|||
33304996|NCT01871805|101010529|FG004|Phase I|Death|9|||
33304997|NCT01871805|101010530|FG005|Phase I|Death|0|||
33304998|NCT01871805|101010525|FG000|Phase I|Alive in Survival Follow-up|0|||
33304999|NCT01871805|101010526|FG001|Phase I|Alive in Survival Follow-up|2|||
33305000|NCT01871805|101010527|FG002|Phase I|Alive in Survival Follow-up|4|||
33305001|NCT01871805|101010528|FG003|Phase I|Alive in Survival Follow-up|5|||
33305002|NCT01871805|101010529|FG004|Phase I|Alive in Survival Follow-up|4|||
33305003|NCT01871805|101010530|FG005|Phase I|Alive in Survival Follow-up|0|||
33305004|NCT01871805|101010525|FG000|Phase I|Lost to Follow-up|0|||
33305005|NCT01871805|101010526|FG001|Phase I|Lost to Follow-up|1|||
33305006|NCT01871805|101010527|FG002|Phase I|Lost to Follow-up|3|||
33305007|NCT01871805|101010528|FG003|Phase I|Lost to Follow-up|0|||
33305008|NCT01871805|101010529|FG004|Phase I|Lost to Follow-up|0|||
33305009|NCT01871805|101010530|FG005|Phase I|Lost to Follow-up|0|||
33305010|NCT01871805|101010525|FG000|Phase II|Death|0|||
33305011|NCT01871805|101010526|FG001|Phase II|Death|0|||
33498906|NCT00506415|101720251|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
33498907|NCT00506415|101720252|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
33498908|NCT00506415|101720253|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
33498909|NCT00506415|101720254|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
33498910|NCT00506415|101720251|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
33305012|NCT01871805|101010527|FG002|Phase II|Death|0|||
33305013|NCT01871805|101010528|FG003|Phase II|Death|0|||
33305014|NCT01871805|101010529|FG004|Phase II|Death|0|||
33305015|NCT01871805|101010530|FG005|Phase II|Death|45|||
33305016|NCT01871805|101010525|FG000|Phase II|Alive in Survival Follow-up|0|||
33305017|NCT01871805|101010526|FG001|Phase II|Alive in Survival Follow-up|0|||
33305018|NCT01871805|101010527|FG002|Phase II|Alive in Survival Follow-up|0|||
33305019|NCT01871805|101010528|FG003|Phase II|Alive in Survival Follow-up|0|||
33305020|NCT01871805|101010529|FG004|Phase II|Alive in Survival Follow-up|0|||
33305021|NCT01871805|101010530|FG005|Phase II|Alive in Survival Follow-up|29|||
33305022|NCT01871805|101010525|FG000|Phase II|Lost to Follow-up|0|||
33305023|NCT01871805|101010526|FG001|Phase II|Lost to Follow-up|0|||
33305024|NCT01871805|101010527|FG002|Phase II|Lost to Follow-up|0|||
33305025|NCT01871805|101010528|FG003|Phase II|Lost to Follow-up|0|||
33305026|NCT01871805|101010529|FG004|Phase II|Lost to Follow-up|0|||
33305027|NCT01871805|101010530|FG005|Phase II|Lost to Follow-up|13|||
33305028|NCT04737187|101010531|FG000|Overall Study|Switched to marketed drug|32|||
33305029|NCT04737187|101010532|FG001|Overall Study|Switched to marketed drug|4|||
33305030|NCT04737187|101010531|FG000|Overall Study|Radiological Progressive Disease|145|||
33305031|NCT04737187|101010532|FG001|Overall Study|Radiological Progressive Disease|146|||
33305032|NCT04737187|101010531|FG000|Overall Study|Clinical Progressive Disease|20|||
33305033|NCT04737187|101010532|FG001|Overall Study|Clinical Progressive Disease|20|||
33305034|NCT04737187|101010531|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
33305035|NCT04737187|101010532|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
33498911|NCT00506415|101720252|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
33498912|NCT00506415|101720253|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
33191041|NCT02624284|100605100|FG001|Overall Study|Protocol Violation|10|||
33191042|NCT02624284|100605101|FG002|Overall Study|Protocol Violation|7|||
33600660|NCT01632241|102088759|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
33305036|NCT04737187|101010531|FG000|Overall Study|Adverse Event|16|||
33305037|NCT04737187|101010532|FG001|Overall Study|Adverse Event|16|||
33305038|NCT04737187|101010531|FG000|Overall Study|Physician Decision|2|||
33305039|NCT04737187|101010532|FG001|Overall Study|Physician Decision|0|||
33305040|NCT04737187|101010531|FG000|Overall Study|Withdrawal by Subject|5|||
33305041|NCT04737187|101010532|FG001|Overall Study|Withdrawal by Subject|8|||
33305042|NCT00992225|101010533|FG000|Overall Study|Entry Criteria Not Met|8|||
33305043|NCT00992225|101010533|FG000|Overall Study|Adverse Event|2|||
33305044|NCT00626197|101010535|FG000|Overall Study|Did not cooperate|2|||
33305045|NCT00626197|101010536|FG001|Overall Study|Did not cooperate|6|||
33305046|NCT00626197|101010537|FG002|Overall Study|Did not cooperate|1|||
33305047|NCT00626197|101010535|FG000|Overall Study|Failure to return|6|||
33305048|NCT00626197|101010536|FG001|Overall Study|Failure to return|5|||
33305049|NCT00626197|101010537|FG002|Overall Study|Failure to return|6|||
33305050|NCT00626197|101010535|FG000|Overall Study|Adverse event, serious fatal|3|||
33305051|NCT00626197|101010536|FG001|Overall Study|Adverse event, serious fatal|6|||
33305052|NCT00626197|101010537|FG002|Overall Study|Adverse event, serious fatal|6|||
33305053|NCT00626197|101010535|FG000|Overall Study|Adverse Event|1|||
33305054|NCT00626197|101010536|FG001|Overall Study|Adverse Event|1|||
33305055|NCT00626197|101010537|FG002|Overall Study|Adverse Event|2|||
33305056|NCT00626197|101010535|FG000|Overall Study|Withdrawal by Subject|17|||
33305057|NCT00626197|101010536|FG001|Overall Study|Withdrawal by Subject|17|||
33305058|NCT00626197|101010537|FG002|Overall Study|Withdrawal by Subject|7|||
33305059|NCT00626197|101010535|FG000|Overall Study|Administrative reasons|15|||
33305060|NCT00626197|101010536|FG001|Overall Study|Administrative reasons|19|||
33305061|NCT00626197|101010537|FG002|Overall Study|Administrative reasons|55|||
33305062|NCT01994837|101010538|FG000|Overall Study|Progressive disease per protocol|23|||
33305063|NCT01994837|101010538|FG000|Overall Study|Adv event related to progressive disease|3|||
33305064|NCT01994837|101010538|FG000|Overall Study|Fatal progressive disease|2|||
33305065|NCT01994837|101010538|FG000|Overall Study|Adverse event not related to progression|1|||
33305066|NCT01994837|101010538|FG000|Overall Study|Chose palliative care|1|||
33305067|NCT01994837|101010538|FG000|Overall Study|Proceeded to transplant|1|||
33305068|NCT01994837|101010538|FG000|Overall Study|Removed from study due to no response|1|||
33305069|NCT01276379|101010539|FG000|Overall Study|Screening failure|40|||
33305070|NCT00652327|101010542|FG000|Overall Study|Adverse Event|0|||
33305071|NCT00652327|101010543|FG001|Overall Study|Adverse Event|2|||
33305072|NCT00652327|101010542|FG000|Overall Study|Lost to Follow-up|0|||
33305073|NCT00652327|101010543|FG001|Overall Study|Lost to Follow-up|3|||
33305074|NCT01342341|101010544|FG000|Overall Study|Lost to Follow-up|4|||
33305075|NCT01342341|101010545|FG001|Overall Study|Lost to Follow-up|4|||
33305076|NCT02153073|101010546|FG000|Overall Study|Case Report Forms Uncollected|230|||
33305077|NCT02153073|101010546|FG000|Overall Study|Protocol Deviation|68|||
33305078|NCT02217501|101010547|FG000|Overall Study|Death|3|||
33305079|NCT02217501|101010548|FG001|Overall Study|Death|4|||
33305080|NCT00888927|101010549|FG000|Overall Study|Adverse Event|0|||
33305081|NCT00888927|101010550|FG001|Overall Study|Adverse Event|0|||
33305082|NCT00888927|101010551|FG002|Overall Study|Adverse Event|0|||
33305083|NCT00888927|101010552|FG003|Overall Study|Adverse Event|1|||
33305084|NCT00888927|101010549|FG000|Overall Study|Withdrawal of consent|0|||
33305085|NCT00888927|101010550|FG001|Overall Study|Withdrawal of consent|0|||
33305086|NCT00888927|101010551|FG002|Overall Study|Withdrawal of consent|0|||
33305087|NCT00888927|101010552|FG003|Overall Study|Withdrawal of consent|1|||
33305088|NCT03889704|101010553|FG000|Overall Study|Study terminated due to pandemic|1|||
33305089|NCT03507777|101010556|FG000|Overall Study|Lost to Follow-up|5|||
33305090|NCT03507777|101010557|FG001|Overall Study|Lost to Follow-up|7|||
33305091|NCT03507777|101010556|FG000|Overall Study|Withdrawal by Subject|6|||
33305092|NCT03507777|101010557|FG001|Overall Study|Withdrawal by Subject|11|||
33305093|NCT03507777|101010556|FG000|Overall Study|Death|30|||
33305094|NCT03507777|101010557|FG001|Overall Study|Death|44|||
33305095|NCT03507777|101010556|FG000|Overall Study|Other Reasons|3|||
33305096|NCT03507777|101010557|FG001|Overall Study|Other Reasons|8|||
33191043|NCT02624284|100605099|FG000|Overall Study|Revealed exclusionary condition|2|||
33305097|NCT01307579|101010558|FG000|Overall Study|Death|3|||
33305098|NCT01307579|101010559|FG001|Overall Study|Death|6|||
33305099|NCT01307579|101010558|FG000|Overall Study|Physician Decision|26|||
33305100|NCT01307579|101010559|FG001|Overall Study|Physician Decision|29|||
33305101|NCT01307579|101010558|FG000|Overall Study|Withdrawal by Subject|7|||
33305102|NCT01307579|101010559|FG001|Overall Study|Withdrawal by Subject|3|||
33305103|NCT01307579|101010558|FG000|Overall Study|Institutional diagnosis of IFD|21|||
33305104|NCT01307579|101010559|FG001|Overall Study|Institutional diagnosis of IFD|36|||
33305105|NCT01307579|101010558|FG000|Overall Study|Begin conditioning for HSCT|42|||
33305106|NCT01307579|101010559|FG001|Overall Study|Begin conditioning for HSCT|44|||
33305107|NCT01307579|101010558|FG000|Overall Study|Refractory or relapsed AML|38|||
33305108|NCT01307579|101010559|FG001|Overall Study|Refractory or relapsed AML|23|||
33305109|NCT01307579|101010558|FG000|Overall Study|Ineligible|3|||
33498913|NCT00506415|101720254|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
33498914|NCT00506415|101720251|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
33305110|NCT01307579|101010559|FG001|Overall Study|Ineligible|4|||
33305111|NCT01204710|101010560|FG000|Randomization Treatment|Lost to Follow-up|1|||
33305112|NCT01204710|101010561|FG001|Randomization Treatment|Lost to Follow-up|0|||
33305113|NCT01204710|101010560|FG000|Randomization Treatment|Withdrawal by Subject|6|||
33305114|NCT01204710|101010561|FG001|Randomization Treatment|Withdrawal by Subject|5|||
33305115|NCT01204710|101010560|FG000|Randomization Treatment|Physician Decision|3|||
33305116|NCT01204710|101010561|FG001|Randomization Treatment|Physician Decision|2|||
33305117|NCT01204710|101010560|FG000|Randomization Treatment|Entry criteria not met|0|||
33305118|NCT01204710|101010561|FG001|Randomization Treatment|Entry criteria not met|1|||
33305119|NCT01204710|101010560|FG000|Randomization Treatment|Adverse Event|4|||
33305120|NCT01204710|101010561|FG001|Randomization Treatment|Adverse Event|2|||
33305121|NCT01204710|101010560|FG000|Randomization Treatment|Sponsor Decision|0|||
33305122|NCT01204710|101010561|FG001|Randomization Treatment|Sponsor Decision|1|||
33305123|NCT01204710|101010560|FG000|Randomization Treatment|Worsening of General condition|0|||
33305124|NCT01204710|101010561|FG001|Randomization Treatment|Worsening of General condition|1|||
33305125|NCT01204710|101010560|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
33305126|NCT01204710|101010561|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
33305127|NCT01204710|101010560|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
33305128|NCT01204710|101010561|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
33305129|NCT01204710|101010560|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
33305130|NCT01204710|101010561|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
33305131|NCT01204710|101010560|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
33305132|NCT01204710|101010561|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
33305133|NCT01699503|101010563|FG000|Overall Study|Death|31|||
33305134|NCT01699503|101010564|FG001|Overall Study|Death|40|||
33305135|NCT01699503|101010563|FG000|Overall Study|Withdrawal by Subject|65|||
33305136|NCT01699503|101010564|FG001|Overall Study|Withdrawal by Subject|57|||
33305137|NCT01699503|101010563|FG000|Overall Study|Lost to Follow-up|121|||
33305138|NCT01699503|101010564|FG001|Overall Study|Lost to Follow-up|117|||
33305139|NCT01699503|101010563|FG000|Overall Study|Excluded due to quality|783|||
33305140|NCT01699503|101010564|FG001|Overall Study|Excluded due to quality|791|||
33305141|NCT01163292|101010565|FG000|Overall Study|Lack of Efficacy|9|||
33305142|NCT01163292|101010566|FG001|Overall Study|Lack of Efficacy|0|||
33305143|NCT01163292|101010565|FG000|Overall Study|Adverse Event|6|||
33305144|NCT01163292|101010566|FG001|Overall Study|Adverse Event|0|||
33305145|NCT01163292|101010565|FG000|Overall Study|Initiation of biological therapy|0|||
33305146|NCT01163292|101010566|FG001|Overall Study|Initiation of biological therapy|15|||
33305147|NCT01163292|101010565|FG000|Overall Study|Sufficient response to adalimumab|8|||
33305148|NCT01163292|101010566|FG001|Overall Study|Sufficient response to adalimumab|0|||
33305149|NCT01163292|101010565|FG000|Overall Study|Refusal to receive adalimumab|7|||
33305150|NCT01163292|101010566|FG001|Overall Study|Refusal to receive adalimumab|0|||
33305151|NCT01163292|101010565|FG000|Overall Study|Economic reasons|6|||
33305152|NCT01163292|101010566|FG001|Overall Study|Economic reasons|0|||
33305153|NCT01163292|101010565|FG000|Overall Study|No further visits|5|||
33305154|NCT01163292|101010566|FG001|Overall Study|No further visits|7|||
33305155|NCT02075476|101010567|FG000|Overall Study|Death|2|||
33305156|NCT02075476|101010568|FG001|Overall Study|Death|2|||
33305157|NCT02075476|101010567|FG000|Overall Study|Lost to Follow-up|1|||
33305158|NCT02075476|101010568|FG001|Overall Study|Lost to Follow-up|3|||
33305159|NCT04664400|101010569|FG000|Overall Study|Withdrawal by Subject|2|||
33305160|NCT00515853|101010570|FG000|Overall Study|Lost to Follow-up|9|||
33305161|NCT00515853|101010571|FG001|Overall Study|Lost to Follow-up|13|||
33305162|NCT00515853|101010570|FG000|Overall Study|Withdrawal by Subject|6|||
33305163|NCT00515853|101010571|FG001|Overall Study|Withdrawal by Subject|4|||
33305164|NCT00185965|101010572|FG000|Overall Study|Adverse Event|0|||
33305165|NCT00185965|101010573|FG001|Overall Study|Adverse Event|1|||
33305166|NCT02207569|101010574|FG000|1-Month|Death|6|||
33305167|NCT02207569|101010574|FG000|1-Month|Withdrawal by Subject|2|||
33305168|NCT02207569|101010574|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
33305169|NCT02207569|101010574|FG000|6-Month|Death|8|||
33305170|NCT02207569|101010574|FG000|6-Month|Withdrawal by Subject|2|||
33305171|NCT02207569|101010574|FG000|12-Month|Death|14|||
33305172|NCT02207569|101010574|FG000|12-Month|Withdrawal by Subject|2|||
33305173|NCT02207569|101010574|FG000|24-Month|Death|23|||
33305174|NCT02207569|101010574|FG000|24-Month|Withdrawal by Subject|3|||
33305175|NCT02207569|101010574|FG000|36-Month|Death|23|||
33305176|NCT02207569|101010574|FG000|36-Month|Withdrawal by Subject|4|||
33305177|NCT02207569|101010574|FG000|48-Month|Death|25|||
33305178|NCT02207569|101010574|FG000|48-Month|Withdrawal by Subject|2|||
33498915|NCT00506415|101720252|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
33305179|NCT02207569|101010574|FG000|48-Month|Lost to Follow-up|4|||
33305180|NCT02207569|101010574|FG000|60-Month|Death|1|||
33305181|NCT02207569|101010574|FG000|60-Month|Lost to Follow-up|1|||
33305182|NCT02207569|101010574|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
33305183|NCT02207569|101010574|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
33305184|NCT03932812|101010575|FG000|Overall Study|Lost to Follow-up|12|||
33498916|NCT00506415|101720253|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
33305185|NCT03932812|101010576|FG001|Overall Study|Lost to Follow-up|14|||
33498917|NCT00506415|101720254|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
33305186|NCT03932812|101010575|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
33305187|NCT03932812|101010576|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
33305188|NCT04606771|101010577|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
33305189|NCT04606771|101010578|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
33305190|NCT04606771|101010577|FG000|Overall Study|Death|5|||
33305191|NCT04606771|101010578|FG001|Overall Study|Death|6|||
33305192|NCT04606771|101010577|FG000|Overall Study|Wrong randomisation|0|||
33305193|NCT04606771|101010578|FG001|Overall Study|Wrong randomisation|1|||
33305194|NCT03590366|101010579|FG000|Overall Study|Adverse Event|0|||
33305195|NCT03590366|101010580|FG001|Overall Study|Adverse Event|3|||
33305196|NCT03590366|101010579|FG000|Overall Study|Lost to Follow-up|3|||
33305197|NCT03590366|101010580|FG001|Overall Study|Lost to Follow-up|3|||
33305198|NCT03590366|101010579|FG000|Overall Study|Withdrawal by Subject|0|||
33305199|NCT03590366|101010580|FG001|Overall Study|Withdrawal by Subject|2|||
33305200|NCT01127763|101010581|FG000|Overall Study|Adverse Event|2|||
33305201|NCT01127763|101010581|FG000|Overall Study|Withdrawal by Subject|1|||
33305202|NCT01127763|101010581|FG000|Overall Study|Physician Decision|2|||
33305203|NCT02045875|101010587|FG000|Overall Study|Lost to Follow-up|3|||
33305204|NCT02045875|101010588|FG001|Overall Study|Lost to Follow-up|0|||
33305205|NCT02045875|101010587|FG000|Overall Study|Withdrawal by Subject|4|||
33305206|NCT02045875|101010588|FG001|Overall Study|Withdrawal by Subject|3|||
33305207|NCT01470001|101010590|FG000|Overall Study|Lost to Follow-up|1|||
33305208|NCT01470001|101010591|FG001|Overall Study|Lost to Follow-up|1|||
33305209|NCT01470001|101010590|FG000|Overall Study|Physician Decision|2|||
33305210|NCT01470001|101010591|FG001|Overall Study|Physician Decision|0|||
33305211|NCT01470001|101010590|FG000|Overall Study|Withdrawal by Subject|2|||
33305212|NCT01470001|101010591|FG001|Overall Study|Withdrawal by Subject|1|||
33305213|NCT00858364|101010596|FG000|Overall Study|Administrative Decision|3|||
33305214|NCT00858364|101010597|FG001|Overall Study|Administrative Decision|2|||
33305215|NCT00858364|101010596|FG000|Overall Study|Adverse Event|5|||
33305216|NCT00858364|101010597|FG001|Overall Study|Adverse Event|2|||
33305217|NCT00858364|101010596|FG000|Overall Study|Withdrawal by Subject|44|||
33305218|NCT00858364|101010597|FG001|Overall Study|Withdrawal by Subject|118|||
33305219|NCT00858364|101010596|FG000|Overall Study|Ineligibility Determined|1|||
33305220|NCT00858364|101010597|FG001|Overall Study|Ineligibility Determined|10|||
33305221|NCT00858364|101010596|FG000|Overall Study|Lost to Follow-up|24|||
33305222|NCT00858364|101010597|FG001|Overall Study|Lost to Follow-up|54|||
33305223|NCT00858364|101010596|FG000|Overall Study|Noncompliance|3|||
33305224|NCT00858364|101010597|FG001|Overall Study|Noncompliance|4|||
33305225|NCT00858364|101010596|FG000|Overall Study|Protocol Deviation|0|||
33305226|NCT00858364|101010597|FG001|Overall Study|Protocol Deviation|2|||
33305227|NCT00858364|101010596|FG000|Overall Study|Other|9|||
33305228|NCT00858364|101010597|FG001|Overall Study|Other|17|||
33305229|NCT00858364|101010596|FG000|Overall Study|Missing|1|||
33305230|NCT00858364|101010597|FG001|Overall Study|Missing|1|||
33305231|NCT00858364|101010596|FG000|Overall Study|Still on-study|114|||
33305232|NCT00858364|101010597|FG001|Overall Study|Still on-study|247|||
33305233|NCT04155047|101010598|FG000|Overall Study|Adverse Event|1|||
33305234|NCT04155047|101010599|FG001|Overall Study|Adverse Event|0|||
33305235|NCT04155047|101010598|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
33305236|NCT04155047|101010599|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
33305237|NCT02141620|101010600|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
33305238|NCT02141620|101010601|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
33305239|NCT03207451|101010602|FG000|Overall Study|scheduling conflict|1|||
33305240|NCT03207451|101010603|FG001|Overall Study|scheduling conflict|0|||
33305241|NCT03207451|101010604|FG002|Overall Study|scheduling conflict|2|||
33305242|NCT03207451|101010605|FG003|Overall Study|scheduling conflict|2|||
33305243|NCT03207451|101010602|FG000|Overall Study|Adverse Event|0|||
33305244|NCT03207451|101010603|FG001|Overall Study|Adverse Event|0|||
33305245|NCT03207451|101010604|FG002|Overall Study|Adverse Event|0|||
33305246|NCT03207451|101010605|FG003|Overall Study|Adverse Event|1|||
33305247|NCT00837694|101010610|FG000|Overall Study|Lost to Follow-up|2|||
33305248|NCT00837694|101010611|FG001|Overall Study|Lost to Follow-up|0|||
33305249|NCT00837694|101010612|FG002|Overall Study|Lost to Follow-up|2|||
33305250|NCT00837694|101010613|FG003|Overall Study|Lost to Follow-up|1|||
33305251|NCT00837694|101010614|FG004|Overall Study|Lost to Follow-up|1|||
33305252|NCT00837694|101010615|FG005|Overall Study|Lost to Follow-up|1|||
33305253|NCT02601300|101010618|FG000|Induction Phase|Lack of Efficacy|2|||
33305254|NCT02601300|101010618|FG000|Induction Phase|Protocol Violation|1|||
33305255|NCT02601300|101010618|FG000|Extension Phase|Withdrawal by Subject|3|||
33305256|NCT02601300|101010618|FG000|Extension Phase|Adverse Event|4|||
33305257|NCT02601300|101010618|FG000|Extension Phase|Lack of Efficacy|10|||
33305258|NCT00774930|101010621|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
33305259|NCT00774930|101010622|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
33305260|NCT00774930|101010621|FG000|DB Phase|Adverse Event|1|||
33305261|NCT00774930|101010622|FG001|DB Phase|Adverse Event|2|||
33305262|NCT00774930|101010621|FG000|DB Phase|Subject Decision|1|||
33305263|NCT00774930|101010622|FG001|DB Phase|Subject Decision|5|||
33498918|NCT00506415|101720251|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
33498919|NCT00506415|101720252|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
33305264|NCT00774930|101010621|FG000|DB Phase|Sponsor Decision|0|||
33305265|NCT00774930|101010622|FG001|DB Phase|Sponsor Decision|1|||
33305266|NCT00774930|101010621|FG000|DB Phase|Disease Progression|1|||
33305267|NCT00774930|101010622|FG001|DB Phase|Disease Progression|1|||
33498920|NCT00506415|101720253|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
33498921|NCT00506415|101720254|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
33498922|NCT00506415|101720251|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
33498923|NCT00506415|101720252|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
33498924|NCT00506415|101720253|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
33498925|NCT00506415|101720254|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
33498926|NCT00506415|101720251|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
33498927|NCT00506415|101720252|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
33498928|NCT00506415|101720253|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
33498929|NCT00506415|101720254|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
33498930|NCT00506415|101720251|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
33498931|NCT00506415|101720252|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
33498932|NCT00506415|101720253|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
33305268|NCT00774930|101010621|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
33305269|NCT00774930|101010622|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
33305270|NCT00774930|101010621|FG000|IOL Phase|Adverse Event|1|||
33305271|NCT00774930|101010622|FG001|IOL Phase|Adverse Event|1|||
33305272|NCT00774930|101010621|FG000|IOL Phase|Subject Decision|4|||
33305273|NCT00774930|101010622|FG001|IOL Phase|Subject Decision|3|||
33305274|NCT00774930|101010621|FG000|IOL Phase|Physician Decision|3|||
33305275|NCT00774930|101010622|FG001|IOL Phase|Physician Decision|2|||
33305276|NCT00774930|101010621|FG000|IOL Phase|Sponsor Decision|1|||
33305277|NCT00774930|101010622|FG001|IOL Phase|Sponsor Decision|0|||
33305278|NCT00774930|101010621|FG000|IOL Phase|Disease Progression|2|||
33305279|NCT00774930|101010622|FG001|IOL Phase|Disease Progression|1|||
33305280|NCT00774930|101010621|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
33305281|NCT00774930|101010622|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
33305282|NCT00774930|101010621|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
33305283|NCT00774930|101010622|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
33305284|NCT00774930|101010621|FG000|IOL Phase|Other|1|||
33305285|NCT00774930|101010622|FG001|IOL Phase|Other|0|||
33305286|NCT00774930|101010621|FG000|IOL Phase|Brain radiation|0|||
33305287|NCT00774930|101010622|FG001|IOL Phase|Brain radiation|1|||
33305288|NCT00774930|101010621|FG000|LTOLE Phase|Adverse Event|7|||
33305289|NCT00774930|101010622|FG001|LTOLE Phase|Adverse Event|3|||
33305290|NCT00774930|101010621|FG000|LTOLE Phase|Subject decision|0|||
33305291|NCT00774930|101010622|FG001|LTOLE Phase|Subject decision|5|||
33305292|NCT00774930|101010621|FG000|LTOLE Phase|Physician Decision|4|||
33305293|NCT00774930|101010622|FG001|LTOLE Phase|Physician Decision|1|||
33305294|NCT00774930|101010621|FG000|LTOLE Phase|Sponsor decision|2|||
33305295|NCT00774930|101010622|FG001|LTOLE Phase|Sponsor decision|1|||
33305296|NCT00774930|101010621|FG000|LTOLE Phase|Disease Progression|2|||
33305297|NCT00774930|101010622|FG001|LTOLE Phase|Disease Progression|5|||
33305298|NCT00774930|101010621|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
33305299|NCT00774930|101010622|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
33305300|NCT00774930|101010621|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
33305301|NCT00774930|101010622|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
33305302|NCT00291642|101010623|FG000|Overall Study|Adverse Event|1|||
33305303|NCT00291642|101010624|FG001|Overall Study|Adverse Event|0|||
33305304|NCT00291642|101010625|FG002|Overall Study|Adverse Event|1|||
33305305|NCT00291642|101010626|FG003|Overall Study|Adverse Event|0|||
33305306|NCT00291642|101010627|FG004|Overall Study|Adverse Event|1|||
33305307|NCT00291642|101010623|FG000|Overall Study|Patient missed visit|0|||
33305308|NCT00291642|101010624|FG001|Overall Study|Patient missed visit|0|||
33305309|NCT00291642|101010625|FG002|Overall Study|Patient missed visit|1|||
33305310|NCT00291642|101010626|FG003|Overall Study|Patient missed visit|0|||
33305311|NCT00291642|101010627|FG004|Overall Study|Patient missed visit|0|||
33305312|NCT00291642|101010623|FG000|Overall Study|Intake of prohibited medication|1|||
33305313|NCT00291642|101010624|FG001|Overall Study|Intake of prohibited medication|0|||
33305314|NCT00291642|101010625|FG002|Overall Study|Intake of prohibited medication|0|||
33305315|NCT00291642|101010626|FG003|Overall Study|Intake of prohibited medication|0|||
33498933|NCT00506415|101720254|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
33305316|NCT00291642|101010627|FG004|Overall Study|Intake of prohibited medication|0|||
33305317|NCT01123070|101010628|FG000|Part B Double Blind Period|Protocol Violation|0|||
33305318|NCT01123070|101010629|FG001|Part B Double Blind Period|Protocol Violation|0|||
33498934|NCT00506415|101720251|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
33305319|NCT01123070|101010630|FG002|Part B Double Blind Period|Protocol Violation|0|||
33305320|NCT01123070|101010631|FG003|Part B Double Blind Period|Protocol Violation|1|||
33305321|NCT01123070|101010628|FG000|Part B Double Blind Period|Adverse Event|0|||
33498935|NCT00506415|101720252|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
33498936|NCT00506415|101720253|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
33498937|NCT00506415|101720254|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
33498938|NCT00506415|101720251|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
33498939|NCT00506415|101720252|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
33498940|NCT00506415|101720253|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
33498941|NCT00506415|101720254|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
33498942|NCT00506415|101720251|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
33498943|NCT00506415|101720252|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
33498944|NCT00506415|101720253|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
33498945|NCT00506415|101720254|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
33498946|NCT00506415|101720251|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
33305322|NCT01123070|101010629|FG001|Part B Double Blind Period|Adverse Event|0|||
33305323|NCT01123070|101010630|FG002|Part B Double Blind Period|Adverse Event|2|||
33305324|NCT01123070|101010631|FG003|Part B Double Blind Period|Adverse Event|0|||
33305325|NCT01123070|101010628|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
33305326|NCT01123070|101010629|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
33305327|NCT01123070|101010630|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
33305328|NCT01123070|101010631|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
33305329|NCT01323972|101010632|FG000|Overall Study|Withdrawal by Subject|1|||
33305330|NCT01323972|101010633|FG001|Overall Study|Withdrawal by Subject|0|||
33305331|NCT01323972|101010634|FG002|Overall Study|Withdrawal by Subject|1|||
33305332|NCT01323972|101010635|FG003|Overall Study|Withdrawal by Subject|0|||
33305333|NCT01323972|101010632|FG000|Overall Study|Migrated/moved from study area|1|||
33305334|NCT01323972|101010633|FG001|Overall Study|Migrated/moved from study area|2|||
33305335|NCT01323972|101010634|FG002|Overall Study|Migrated/moved from study area|0|||
33305336|NCT01323972|101010635|FG003|Overall Study|Migrated/moved from study area|0|||
33498947|NCT00506415|101720252|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
33498948|NCT00506415|101720253|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
33498949|NCT00506415|101720254|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
33600661|NCT01632241|102088760|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
33600662|NCT01632241|102088759|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
33600663|NCT01632241|102088760|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
33600664|NCT01632241|102088759|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
33600665|NCT01632241|102088760|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
33600666|NCT01632241|102088759|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
33600667|NCT01632241|102088760|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
33600668|NCT01632241|102088759|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
33600669|NCT01632241|102088760|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
33600670|NCT01632241|102088759|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
33600671|NCT01632241|102088760|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
33600672|NCT01632241|102088759|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
33600673|NCT01632241|102088760|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
33600674|NCT01632241|102088759|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
33600675|NCT01632241|102088760|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
33600676|NCT01632241|102088759|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
33600677|NCT01632241|102088760|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
33600678|NCT01632241|102088759|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
33600679|NCT01632241|102088760|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
33600680|NCT01632241|102088759|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
33600681|NCT01632241|102088760|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
33600682|NCT01632241|102088759|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
33600683|NCT01632241|102088760|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
33600684|NCT01632241|102088759|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
33600685|NCT01632241|102088760|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
33600686|NCT01632241|102088759|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
33600687|NCT01632241|102088760|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
33600688|NCT02084238|102088761|FG000|Overall Study|Lost to Follow-up|2|||
33600689|NCT00973102|102088762|FG000|Overall Study|Protocol Violation|1|||
33600690|NCT00973102|102088763|FG001|Overall Study|Protocol Violation|0|||
33600691|NCT00973102|102088762|FG000|Overall Study|Prisoner|0|||
33305337|NCT01323972|101010632|FG000|Overall Study|Lost to Follow-up|0|||
33600692|NCT00973102|102088763|FG001|Overall Study|Prisoner|1|||
33600693|NCT01288612|102088766|FG000|Overall Study|Unable to contact|11|||
33305338|NCT01323972|101010633|FG001|Overall Study|Lost to Follow-up|1|||
33498950|NCT00506415|101720251|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
33600694|NCT01288612|102088767|FG001|Overall Study|Unable to contact|16|||
33600695|NCT01288612|102088768|FG002|Overall Study|Unable to contact|20|||
33600696|NCT01288612|102088766|FG000|Overall Study|Declined|78|||
33600697|NCT01288612|102088767|FG001|Overall Study|Declined|63|||
33600698|NCT01288612|102088768|FG002|Overall Study|Declined|62|||
33305339|NCT01323972|101010634|FG002|Overall Study|Lost to Follow-up|1|||
33305340|NCT01323972|101010635|FG003|Overall Study|Lost to Follow-up|1|||
33305341|NCT02514239|101010636|FG000|Overall Study|Refused to continue trial medication|0|||
33305342|NCT02514239|101010637|FG001|Overall Study|Refused to continue trial medication|0|||
33305343|NCT02514239|101010638|FG002|Overall Study|Refused to continue trial medication|0|||
33305344|NCT02514239|101010639|FG003|Overall Study|Refused to continue trial medication|0|||
33305345|NCT02514239|101010640|FG004|Overall Study|Refused to continue trial medication|0|||
33305346|NCT02514239|101010641|FG005|Overall Study|Refused to continue trial medication|0|||
33305347|NCT02514239|101010642|FG006|Overall Study|Refused to continue trial medication|0|||
33305348|NCT02514239|101010643|FG007|Overall Study|Refused to continue trial medication|0|||
33305349|NCT02514239|101010644|FG008|Overall Study|Refused to continue trial medication|0|||
33305350|NCT02514239|101010645|FG009|Overall Study|Refused to continue trial medication|1|||
33305351|NCT02514239|101010636|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
33305352|NCT02514239|101010637|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
33305353|NCT02514239|101010638|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
33305354|NCT02514239|101010639|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
33305355|NCT02514239|101010640|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
33305356|NCT02514239|101010641|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
33305357|NCT02514239|101010642|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
33305358|NCT02514239|101010643|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
33305359|NCT02514239|101010644|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
33305360|NCT02514239|101010645|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
33305361|NCT02514239|101010636|FG000|Overall Study|Not treated|0|||
33305362|NCT02514239|101010637|FG001|Overall Study|Not treated|1|||
33305363|NCT02514239|101010638|FG002|Overall Study|Not treated|0|||
33305364|NCT02514239|101010639|FG003|Overall Study|Not treated|0|||
33305365|NCT02514239|101010640|FG004|Overall Study|Not treated|0|||
33305366|NCT02514239|101010641|FG005|Overall Study|Not treated|0|||
33305367|NCT02514239|101010642|FG006|Overall Study|Not treated|0|||
33305368|NCT02514239|101010643|FG007|Overall Study|Not treated|0|||
33305369|NCT02514239|101010644|FG008|Overall Study|Not treated|0|||
33305370|NCT02514239|101010645|FG009|Overall Study|Not treated|0|||
33305371|NCT02514239|101010636|FG000|Overall Study|Other Adverse Events|2|||
33305372|NCT02514239|101010637|FG001|Overall Study|Other Adverse Events|0|||
33305373|NCT02514239|101010638|FG002|Overall Study|Other Adverse Events|0|||
33305374|NCT02514239|101010639|FG003|Overall Study|Other Adverse Events|1|||
33305375|NCT02514239|101010640|FG004|Overall Study|Other Adverse Events|0|||
33305376|NCT02514239|101010641|FG005|Overall Study|Other Adverse Events|1|||
33305377|NCT02514239|101010642|FG006|Overall Study|Other Adverse Events|0|||
33305378|NCT02514239|101010643|FG007|Overall Study|Other Adverse Events|1|||
33305379|NCT02514239|101010644|FG008|Overall Study|Other Adverse Events|2|||
33305380|NCT02514239|101010645|FG009|Overall Study|Other Adverse Events|0|||
33305381|NCT02514239|101010636|FG000|Overall Study|Progressive disease|3|||
33305382|NCT02514239|101010637|FG001|Overall Study|Progressive disease|3|||
33305383|NCT02514239|101010638|FG002|Overall Study|Progressive disease|2|||
33305384|NCT02514239|101010639|FG003|Overall Study|Progressive disease|2|||
33305385|NCT02514239|101010640|FG004|Overall Study|Progressive disease|3|||
33305386|NCT02514239|101010641|FG005|Overall Study|Progressive disease|3|||
33305387|NCT02514239|101010642|FG006|Overall Study|Progressive disease|4|||
33305388|NCT02514239|101010643|FG007|Overall Study|Progressive disease|2|||
33305389|NCT02514239|101010644|FG008|Overall Study|Progressive disease|5|||
33305390|NCT02514239|101010645|FG009|Overall Study|Progressive disease|0|||
33305391|NCT02643303|101014066|FG000|Overall Study|Progressive Disease|4|||
33305392|NCT02643303|101014067|FG001|Overall Study|Progressive Disease|4|||
33305393|NCT02643303|101014068|FG002|Overall Study|Progressive Disease|1|||
33305394|NCT02643303|101014069|FG003|Overall Study|Progressive Disease|12|||
33305395|NCT02643303|101014070|FG004|Overall Study|Progressive Disease|6|||
33305396|NCT02643303|101014071|FG005|Overall Study|Progressive Disease|4|||
33305397|NCT02643303|101014072|FG006|Overall Study|Progressive Disease|8|||
33305398|NCT02643303|101014073|FG007|Overall Study|Progressive Disease|2|||
33305399|NCT02643303|101014074|FG008|Overall Study|Progressive Disease|6|||
33305400|NCT02643303|101014066|FG000|Overall Study|Adverse Event|0|||
33305401|NCT02643303|101014067|FG001|Overall Study|Adverse Event|1|||
33305402|NCT02643303|101014068|FG002|Overall Study|Adverse Event|0|||
33305403|NCT02643303|101014069|FG003|Overall Study|Adverse Event|0|||
33305404|NCT02643303|101014070|FG004|Overall Study|Adverse Event|1|||
33305405|NCT02643303|101014071|FG005|Overall Study|Adverse Event|0|||
33305406|NCT02643303|101014072|FG006|Overall Study|Adverse Event|0|||
33305407|NCT02643303|101014073|FG007|Overall Study|Adverse Event|0|||
33305408|NCT02643303|101014074|FG008|Overall Study|Adverse Event|0|||
33305409|NCT02643303|101014066|FG000|Overall Study|Withdrawal by Subject|0|||
33305410|NCT02643303|101014067|FG001|Overall Study|Withdrawal by Subject|0|||
33305411|NCT02643303|101014068|FG002|Overall Study|Withdrawal by Subject|0|||
33305412|NCT02643303|101014069|FG003|Overall Study|Withdrawal by Subject|1|||
33305413|NCT02643303|101014070|FG004|Overall Study|Withdrawal by Subject|0|||
33600699|NCT01288612|102088766|FG000|Overall Study|Unable to intubate|0|||
33498951|NCT00506415|101720252|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
33498952|NCT00506415|101720253|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
33498953|NCT00506415|101720254|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
33498954|NCT00506415|101720251|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
33498955|NCT00506415|101720252|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
33498956|NCT00506415|101720253|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
33498957|NCT00506415|101720254|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
33498958|NCT00506415|101720251|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
33498959|NCT00506415|101720252|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
33498960|NCT00506415|101720253|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
33498961|NCT00506415|101720254|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
33498962|NCT00506415|101720251|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
33498963|NCT00506415|101720252|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
33498964|NCT00506415|101720253|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
33498965|NCT00506415|101720254|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
33498966|NCT00506415|101720251|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
33498967|NCT00506415|101720252|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
33498968|NCT00506415|101720253|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
33498969|NCT00506415|101720254|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
33498970|NCT00506415|101720251|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
33498971|NCT00506415|101720252|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
33498972|NCT00506415|101720253|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
33498973|NCT00506415|101720254|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
33498974|NCT00506415|101720251|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
33498975|NCT00506415|101720252|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
33498976|NCT00506415|101720253|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
33498977|NCT00506415|101720254|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
33498978|NCT00506415|101720251|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
33498979|NCT00506415|101720252|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
33498980|NCT00506415|101720253|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
33498981|NCT00506415|101720254|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
33498982|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
33498983|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
33498984|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
33498985|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
33498986|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
33498987|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
33498988|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
33498989|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
33498990|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
33498991|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
33498992|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
33498993|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
33498994|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
33498995|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
33498996|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
33498997|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
33498998|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
33498999|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
33499000|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
33499001|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
33499002|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
33499003|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
33499004|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
33499005|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
33499006|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
33499007|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
33600700|NCT01288612|102088767|FG001|Overall Study|Unable to intubate|3|||
33600701|NCT01288612|102088768|FG002|Overall Study|Unable to intubate|0|||
33600702|NCT03780959|102088771|FG000|Part 1|Adverse Event|1|||
33600703|NCT03780959|102088772|FG001|Part 1|Adverse Event|0|||
33600704|NCT03780959|102088773|FG002|Part 1|Adverse Event|0|||
33600705|NCT03780959|102088771|FG000|Part 1|Withdrawal by Subject|1|||
33600706|NCT03780959|102088772|FG001|Part 1|Withdrawal by Subject|0|||
33600707|NCT03780959|102088773|FG002|Part 1|Withdrawal by Subject|0|||
33600708|NCT03780959|102088771|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
33499008|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
33305414|NCT02643303|101014071|FG005|Overall Study|Withdrawal by Subject|0|||
33305415|NCT02643303|101014072|FG006|Overall Study|Withdrawal by Subject|1|||
33305416|NCT02643303|101014073|FG007|Overall Study|Withdrawal by Subject|1|||
33305417|NCT02643303|101014074|FG008|Overall Study|Withdrawal by Subject|1|||
33305418|NCT04540887|101014075|FG000|Overall Study|Withdrawal by Subject|2|||
33305419|NCT03014011|101014076|FG000|First Intervention|Withdrawal by Subject|1|||
33305420|NCT03014011|101014077|FG001|First Intervention|Withdrawal by Subject|0|||
33305421|NCT03014011|101014076|FG000|Washout|Withdrawal by Subject|1|||
33305422|NCT03014011|101014077|FG001|Washout|Withdrawal by Subject|0|||
33305423|NCT01877239|101014078|FG000|Overall Study|Adverse Event|4|||
33305424|NCT01877239|101014078|FG000|Overall Study|Disease Remission|1|||
33305425|NCT01877239|101014078|FG000|Overall Study|Withdrawal by Subject|4|||
33305426|NCT01877239|101014078|FG000|Overall Study|Other|2|||
33305427|NCT01877239|101014078|FG000|Overall Study|Lack of Efficacy|4|||
33305428|NCT01877239|101014078|FG000|Overall Study|Data not available|35|||
33305429|NCT03482466|101014080|FG000|Overall Study|Protocol Violation|2|||
33305430|NCT00658788|101014087|FG000|Overall Study|Adverse Event|11|||
33305431|NCT00658788|101014087|FG000|Overall Study|Withdrawal by Subject|13|||
33305432|NCT00658788|101014087|FG000|Overall Study|Lost to Follow-up|18|||
33305433|NCT00658788|101014087|FG000|Overall Study|Treatment Discontinuation|32|||
33305434|NCT00436852|101014088|FG000|Overall Study|Death|23|||
33305435|NCT00436852|101014089|FG001|Overall Study|Death|34|||
33305436|NCT00436852|101014088|FG000|Overall Study|Lack of Efficacy|9|||
33305437|NCT00436852|101014089|FG001|Overall Study|Lack of Efficacy|7|||
33305438|NCT00436852|101014088|FG000|Overall Study|Withdrawal by Subject|2|||
33305439|NCT00436852|101014089|FG001|Overall Study|Withdrawal by Subject|4|||
33305440|NCT00436852|101014088|FG000|Overall Study|Ineligible|1|||
33305441|NCT00436852|101014089|FG001|Overall Study|Ineligible|0|||
33305442|NCT01451827|101014105|FG000|Overall Study|Adverse Event|2|||
33305443|NCT01451827|101014106|FG001|Overall Study|Adverse Event|0|||
33305444|NCT01451827|101014107|FG002|Overall Study|Adverse Event|1|||
33305445|NCT01451827|101014108|FG003|Overall Study|Adverse Event|1|||
33305446|NCT01451827|101014105|FG000|Overall Study|Protocol deviation|1|||
33305447|NCT01451827|101014106|FG001|Overall Study|Protocol deviation|0|||
33305448|NCT01451827|101014107|FG002|Overall Study|Protocol deviation|0|||
33305449|NCT01451827|101014108|FG003|Overall Study|Protocol deviation|0|||
33305450|NCT01451827|101014105|FG000|Overall Study|Lost to Follow-up|0|||
33305451|NCT01451827|101014106|FG001|Overall Study|Lost to Follow-up|3|||
33305452|NCT01451827|101014107|FG002|Overall Study|Lost to Follow-up|0|||
33305453|NCT01451827|101014108|FG003|Overall Study|Lost to Follow-up|2|||
33305454|NCT01451827|101014105|FG000|Overall Study|Participant met withdrawal criteria|0|||
33305455|NCT01451827|101014106|FG001|Overall Study|Participant met withdrawal criteria|2|||
33305456|NCT01451827|101014107|FG002|Overall Study|Participant met withdrawal criteria|0|||
33305457|NCT01451827|101014108|FG003|Overall Study|Participant met withdrawal criteria|0|||
33305458|NCT01451827|101014105|FG000|Overall Study|Withdrawal by Subject|0|||
33305459|NCT01451827|101014106|FG001|Overall Study|Withdrawal by Subject|0|||
33305460|NCT01451827|101014107|FG002|Overall Study|Withdrawal by Subject|1|||
33305461|NCT01451827|101014108|FG003|Overall Study|Withdrawal by Subject|1|||
33305462|NCT00490490|101014112|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
33305463|NCT00490490|101014112|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
33305464|NCT02624791|101014124|FG000|Overall Study|Withdrawal by Subject|2|||
33305465|NCT02624791|101014125|FG001|Overall Study|Withdrawal by Subject|0|||
33305466|NCT02624791|101014126|FG002|Overall Study|Withdrawal by Subject|0|||
33305467|NCT02624791|101014127|FG003|Overall Study|Withdrawal by Subject|0|||
33305468|NCT02624791|101014128|FG004|Overall Study|Withdrawal by Subject|0|||
33305469|NCT02624791|101014129|FG005|Overall Study|Withdrawal by Subject|0|||
33305470|NCT04488770|101014130|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33305471|NCT04488770|101014131|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33305472|NCT04488770|101014132|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33305473|NCT04488770|101014133|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
33305474|NCT04488770|101014134|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33305475|NCT04488770|101014135|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33305476|NCT04488770|101014136|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33305477|NCT04488770|101014137|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33305478|NCT04488770|101014138|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33305479|NCT04488770|101014139|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33305480|NCT04488770|101014140|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33305481|NCT04488770|101014141|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33305482|NCT04488770|101014142|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
33305483|NCT04488770|101014130|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
33305484|NCT04488770|101014131|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33305485|NCT04488770|101014132|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33305486|NCT04488770|101014133|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33305487|NCT04488770|101014134|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33499009|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
33499010|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
33499011|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
33499012|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
33499013|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
33499014|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
33499015|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
33600709|NCT03780959|102088772|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
33305488|NCT04488770|101014135|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33305489|NCT04488770|101014136|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33305490|NCT04488770|101014137|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33305491|NCT04488770|101014138|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33600710|NCT03780959|102088773|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
33600711|NCT03780959|102088771|FG000|Part 1|Response Status|2|||
33600712|NCT03780959|102088772|FG001|Part 1|Response Status|0|||
33600713|NCT03780959|102088773|FG002|Part 1|Response Status|0|||
33600714|NCT03780959|102088771|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
33600715|NCT03780959|102088772|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
33600716|NCT03780959|102088773|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
33600717|NCT03780959|102088771|FG000|Part 2|Response Status|0|||
33600718|NCT03780959|102088772|FG001|Part 2|Response Status|18|||
33600719|NCT03780959|102088773|FG002|Part 2|Response Status|6|||
33600720|NCT01439074|102088776|FG000|Overall Study|Lost to Follow-up|3|||
33600721|NCT01439074|102088777|FG001|Overall Study|Lost to Follow-up|4|||
33600722|NCT01439074|102088776|FG000|Overall Study|Subject shedding|1|||
33600723|NCT01439074|102088777|FG001|Overall Study|Subject shedding|0|||
33600724|NCT01439074|102088776|FG000|Overall Study|Withdrawal by Subject|1|||
33600725|NCT01439074|102088777|FG001|Overall Study|Withdrawal by Subject|5|||
33600726|NCT01439074|102088776|FG000|Overall Study|Other|4|||
33600727|NCT01439074|102088777|FG001|Overall Study|Other|4|||
33600728|NCT00378599|102088778|FG000|Overall Study|Adverse Event|38|||
33600729|NCT00378599|102088778|FG000|Overall Study|Protocol Violation|2|||
33600730|NCT00378599|102088778|FG000|Overall Study|Treatment failure|7|||
33600731|NCT00378599|102088778|FG000|Overall Study|Withdrawal by Subject|5|||
33600732|NCT00996801|102088790|FG000|Overall Study|Adverse Event|6|||
33600733|NCT00996801|102088791|FG001|Overall Study|Adverse Event|4|||
33600734|NCT00996801|102088792|FG002|Overall Study|Adverse Event|12|||
33600735|NCT00996801|102088793|FG003|Overall Study|Adverse Event|17|||
33600736|NCT00996801|102088794|FG004|Overall Study|Adverse Event|31|||
33600737|NCT00996801|102088795|FG005|Overall Study|Adverse Event|3|||
33600738|NCT00996801|102088790|FG000|Overall Study|Lack of Efficacy|3|||
33600739|NCT00996801|102088791|FG001|Overall Study|Lack of Efficacy|0|||
33600740|NCT00996801|102088792|FG002|Overall Study|Lack of Efficacy|1|||
33600741|NCT00996801|102088793|FG003|Overall Study|Lack of Efficacy|3|||
33600742|NCT00996801|102088794|FG004|Overall Study|Lack of Efficacy|0|||
33600743|NCT00996801|102088795|FG005|Overall Study|Lack of Efficacy|1|||
33600744|NCT00996801|102088790|FG000|Overall Study|Lost to Follow-up|0|||
33600745|NCT00996801|102088791|FG001|Overall Study|Lost to Follow-up|0|||
33600746|NCT00996801|102088792|FG002|Overall Study|Lost to Follow-up|0|||
33600747|NCT00996801|102088793|FG003|Overall Study|Lost to Follow-up|3|||
33600748|NCT00996801|102088794|FG004|Overall Study|Lost to Follow-up|3|||
33600749|NCT00996801|102088795|FG005|Overall Study|Lost to Follow-up|2|||
33600750|NCT00996801|102088790|FG000|Overall Study|Physician Decision|0|||
33600751|NCT00996801|102088791|FG001|Overall Study|Physician Decision|0|||
33600752|NCT00996801|102088792|FG002|Overall Study|Physician Decision|0|||
33600753|NCT00996801|102088793|FG003|Overall Study|Physician Decision|1|||
33600754|NCT00996801|102088794|FG004|Overall Study|Physician Decision|0|||
33600755|NCT00996801|102088795|FG005|Overall Study|Physician Decision|0|||
33600756|NCT00996801|102088790|FG000|Overall Study|Progressive Disease|0|||
33600757|NCT00996801|102088791|FG001|Overall Study|Progressive Disease|1|||
33600758|NCT00996801|102088792|FG002|Overall Study|Progressive Disease|0|||
33600759|NCT00996801|102088793|FG003|Overall Study|Progressive Disease|0|||
33305492|NCT04488770|101014139|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33305493|NCT04488770|101014140|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33600760|NCT00996801|102088794|FG004|Overall Study|Progressive Disease|0|||
33600761|NCT00996801|102088795|FG005|Overall Study|Progressive Disease|0|||
33600762|NCT00996801|102088790|FG000|Overall Study|Protocol Violation|3|||
33600763|NCT00996801|102088791|FG001|Overall Study|Protocol Violation|4|||
33600764|NCT00996801|102088792|FG002|Overall Study|Protocol Violation|1|||
33600765|NCT00996801|102088793|FG003|Overall Study|Protocol Violation|2|||
33600766|NCT00996801|102088794|FG004|Overall Study|Protocol Violation|3|||
33305494|NCT04488770|101014141|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33305495|NCT04488770|101014142|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
33305496|NCT04488770|101014130|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33305497|NCT04488770|101014131|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33305498|NCT04488770|101014132|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33305499|NCT04488770|101014133|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33305500|NCT04488770|101014134|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33305501|NCT04488770|101014135|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
33305502|NCT04488770|101014136|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
33305503|NCT04488770|101014137|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33305504|NCT04488770|101014138|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33305505|NCT04488770|101014139|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33305506|NCT04488770|101014140|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33305507|NCT04488770|101014141|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33305508|NCT04488770|101014142|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33393725|NCT03073200|101328514|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33393726|NCT03073200|101328515|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33600767|NCT00996801|102088795|FG005|Overall Study|Protocol Violation|4|||
33600768|NCT00996801|102088790|FG000|Overall Study|Study Terminated by Sponsor|0|||
33600769|NCT00996801|102088791|FG001|Overall Study|Study Terminated by Sponsor|1|||
33600770|NCT00996801|102088792|FG002|Overall Study|Study Terminated by Sponsor|0|||
33600771|NCT00996801|102088793|FG003|Overall Study|Study Terminated by Sponsor|0|||
33600772|NCT00996801|102088794|FG004|Overall Study|Study Terminated by Sponsor|46|||
33600773|NCT00996801|102088795|FG005|Overall Study|Study Terminated by Sponsor|0|||
33600774|NCT00996801|102088790|FG000|Overall Study|Withdrawal by Subject|8|||
33600775|NCT00996801|102088791|FG001|Overall Study|Withdrawal by Subject|6|||
33600776|NCT00996801|102088792|FG002|Overall Study|Withdrawal by Subject|9|||
33600777|NCT00996801|102088793|FG003|Overall Study|Withdrawal by Subject|5|||
33600778|NCT00996801|102088794|FG004|Overall Study|Withdrawal by Subject|5|||
33600779|NCT00996801|102088795|FG005|Overall Study|Withdrawal by Subject|9|||
33600780|NCT00857948|102088796|FG000|Overall Study|Withdrawal by Subject|2|||
33600781|NCT00857948|102088797|FG001|Overall Study|Withdrawal by Subject|0|||
33600782|NCT00857948|102088798|FG002|Overall Study|Withdrawal by Subject|0|||
33600783|NCT00857948|102088799|FG003|Overall Study|Withdrawal by Subject|0|||
33600784|NCT00857948|102088796|FG000|Overall Study|Protocol Violation|1|||
33600785|NCT00857948|102088797|FG001|Overall Study|Protocol Violation|0|||
33600786|NCT00857948|102088798|FG002|Overall Study|Protocol Violation|1|||
33600787|NCT00857948|102088799|FG003|Overall Study|Protocol Violation|0|||
33600788|NCT00524589|102088800|FG000|Overall Study|Withdrawal by Subject|2|||
33600789|NCT00524589|102088800|FG000|Overall Study|Disease Progression|16|||
33600790|NCT02788201|102088806|FG000|Overall Study|Death|1|||
33600791|NCT02788201|102088807|FG001|Overall Study|Death|1|||
33600792|NCT02788201|102088808|FG002|Overall Study|Death|1|||
33600793|NCT02788201|102088809|FG003|Overall Study|Death|1|||
33600794|NCT02788201|102088810|FG004|Overall Study|Death|0|||
33305509|NCT04488770|101014130|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33305510|NCT04488770|101014131|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33393727|NCT03073200|101328516|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33600795|NCT02788201|102088811|FG005|Overall Study|Death|1|||
33600796|NCT02788201|102088806|FG000|Overall Study|Ineligible|0|||
33600797|NCT02788201|102088807|FG001|Overall Study|Ineligible|0|||
33305511|NCT04488770|101014132|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33305512|NCT04488770|101014133|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33305513|NCT04488770|101014134|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
33305514|NCT04488770|101014135|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33305515|NCT04488770|101014136|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33305516|NCT04488770|101014137|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33305517|NCT04488770|101014138|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33305518|NCT04488770|101014139|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33305519|NCT04488770|101014140|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33305520|NCT04488770|101014141|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33305521|NCT04488770|101014142|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
33305522|NCT00128102|101014143|FG000|Overall Study|Site Discontinued|3|||
33305523|NCT00128102|101014144|FG001|Overall Study|Site Discontinued|6|||
33305524|NCT00128102|101014143|FG000|Overall Study|Other|0|||
33305525|NCT00128102|101014144|FG001|Overall Study|Other|1|||
33305526|NCT00128102|101014143|FG000|Overall Study|Progressive Disease|255|||
33305527|NCT00128102|101014144|FG001|Overall Study|Progressive Disease|285|||
33305528|NCT00128102|101014143|FG000|Overall Study|Adverse Event|34|||
33305529|NCT00128102|101014144|FG001|Overall Study|Adverse Event|11|||
33305530|NCT00128102|101014143|FG000|Overall Study|Death|12|||
33305531|NCT00128102|101014144|FG001|Overall Study|Death|13|||
33305532|NCT00128102|101014143|FG000|Overall Study|Physician Decision|3|||
33305533|NCT00128102|101014144|FG001|Overall Study|Physician Decision|3|||
33305534|NCT00128102|101014143|FG000|Overall Study|Withdrawal by Subject|19|||
33305535|NCT00128102|101014144|FG001|Overall Study|Withdrawal by Subject|11|||
33305536|NCT00128102|101014143|FG000|Overall Study|Protocol Violation|2|||
33305537|NCT00128102|101014144|FG001|Overall Study|Protocol Violation|2|||
33305538|NCT01056718|101014146|FG000|Overall Study|Withdrawal by Subject|2|||
33305539|NCT01056718|101014146|FG000|Overall Study|Ischemia on baseline stress test|1|||
33305540|NCT01859988|101014147|FG000|Overall Study|Withdrawal by Subject|6|||
33305541|NCT01859988|101014148|FG001|Overall Study|Withdrawal by Subject|3|||
33305542|NCT01859988|101014149|FG002|Overall Study|Withdrawal by Subject|4|||
33305543|NCT01859988|101014150|FG003|Overall Study|Withdrawal by Subject|3|||
33305544|NCT01859988|101014151|FG004|Overall Study|Withdrawal by Subject|2|||
33305545|NCT01859988|101014152|FG005|Overall Study|Withdrawal by Subject|2|||
33305546|NCT01859988|101014147|FG000|Overall Study|Lack of Efficacy|1|||
33305547|NCT01859988|101014148|FG001|Overall Study|Lack of Efficacy|1|||
33305548|NCT01859988|101014149|FG002|Overall Study|Lack of Efficacy|5|||
33305549|NCT01859988|101014150|FG003|Overall Study|Lack of Efficacy|0|||
33305550|NCT01859988|101014151|FG004|Overall Study|Lack of Efficacy|7|||
33305551|NCT01859988|101014152|FG005|Overall Study|Lack of Efficacy|9|||
33305552|NCT01859988|101014147|FG000|Overall Study|Physician Decision|1|||
33305553|NCT01859988|101014148|FG001|Overall Study|Physician Decision|3|||
33305554|NCT01859988|101014149|FG002|Overall Study|Physician Decision|1|||
33305555|NCT01859988|101014150|FG003|Overall Study|Physician Decision|3|||
33305556|NCT01859988|101014151|FG004|Overall Study|Physician Decision|4|||
33305557|NCT01859988|101014152|FG005|Overall Study|Physician Decision|1|||
33305558|NCT01859988|101014147|FG000|Overall Study|Adverse Event|2|||
33305559|NCT01859988|101014148|FG001|Overall Study|Adverse Event|1|||
33305560|NCT01859988|101014149|FG002|Overall Study|Adverse Event|3|||
33305561|NCT01859988|101014150|FG003|Overall Study|Adverse Event|1|||
33305562|NCT01859988|101014151|FG004|Overall Study|Adverse Event|2|||
33305563|NCT01859988|101014152|FG005|Overall Study|Adverse Event|2|||
33305564|NCT01859988|101014147|FG000|Overall Study|Lost to Follow-up|1|||
33305565|NCT01859988|101014148|FG001|Overall Study|Lost to Follow-up|2|||
33305566|NCT01859988|101014149|FG002|Overall Study|Lost to Follow-up|3|||
33305567|NCT01859988|101014150|FG003|Overall Study|Lost to Follow-up|0|||
33305568|NCT01859988|101014151|FG004|Overall Study|Lost to Follow-up|3|||
33305569|NCT01859988|101014152|FG005|Overall Study|Lost to Follow-up|2|||
33305570|NCT01859988|101014147|FG000|Overall Study|Protocol Violation|0|||
33305571|NCT01859988|101014148|FG001|Overall Study|Protocol Violation|0|||
33305572|NCT01859988|101014149|FG002|Overall Study|Protocol Violation|1|||
33305573|NCT01859988|101014150|FG003|Overall Study|Protocol Violation|0|||
33305574|NCT01859988|101014151|FG004|Overall Study|Protocol Violation|0|||
33305575|NCT01859988|101014152|FG005|Overall Study|Protocol Violation|0|||
33305576|NCT01859988|101014147|FG000|Overall Study|Other than specified above|0|||
33305577|NCT01859988|101014148|FG001|Overall Study|Other than specified above|2|||
33305578|NCT01859988|101014149|FG002|Overall Study|Other than specified above|11|||
33305579|NCT01859988|101014150|FG003|Overall Study|Other than specified above|3|||
33305580|NCT01859988|101014151|FG004|Overall Study|Other than specified above|5|||
33305581|NCT01859988|101014152|FG005|Overall Study|Other than specified above|3|||
33305582|NCT03554629|101014153|FG000|Overall Study|Inadequate data|6|||
33305583|NCT03218397|101014156|FG000|Overall Study|Prior positive blood culture|8|||
33305584|NCT03218397|101014157|FG001|Overall Study|Prior positive blood culture|13|||
33305585|NCT03218397|101014156|FG000|Overall Study|Comfort care|8|||
33305586|NCT03218397|101014157|FG001|Overall Study|Comfort care|5|||
33499016|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
33499017|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
33499018|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
33499019|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
33499020|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
33499021|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
33499022|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
33499023|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
33499024|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
33499025|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
33499026|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
33499027|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
33499028|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
33499029|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
33499030|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
33499031|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
33499032|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
33499033|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
33499034|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Site closed|0|||
33499035|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Site closed|0|||
33600798|NCT02788201|102088808|FG002|Overall Study|Ineligible|0|||
33499036|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Site closed|1|||
33600799|NCT02788201|102088809|FG003|Overall Study|Ineligible|0|||
33600800|NCT02788201|102088810|FG004|Overall Study|Ineligible|0|||
33600801|NCT02788201|102088811|FG005|Overall Study|Ineligible|1|||
33600802|NCT02788201|102088806|FG000|Overall Study|Withdrawal by Subject|0|||
33600803|NCT02788201|102088807|FG001|Overall Study|Withdrawal by Subject|0|||
33600804|NCT02788201|102088808|FG002|Overall Study|Withdrawal by Subject|0|||
33600805|NCT02788201|102088809|FG003|Overall Study|Withdrawal by Subject|0|||
33600806|NCT02788201|102088810|FG004|Overall Study|Withdrawal by Subject|0|||
33600807|NCT02788201|102088811|FG005|Overall Study|Withdrawal by Subject|1|||
33600808|NCT02558400|102088812|FG000|Overall Study|Adverse Event|47|||
33600809|NCT02558400|102088813|FG001|Overall Study|Adverse Event|53|||
33600810|NCT02558400|102088814|FG002|Overall Study|Adverse Event|4|||
33600811|NCT02558400|102088812|FG000|Overall Study|Withdrawal by Subject|13|||
33600812|NCT02558400|102088813|FG001|Overall Study|Withdrawal by Subject|9|||
33600813|NCT02558400|102088814|FG002|Overall Study|Withdrawal by Subject|8|||
33600814|NCT02558400|102088812|FG000|Overall Study|Non-Compliant|0|||
33600815|NCT02558400|102088813|FG001|Overall Study|Non-Compliant|1|||
33600816|NCT02558400|102088814|FG002|Overall Study|Non-Compliant|3|||
33600817|NCT02558400|102088812|FG000|Overall Study|Lost to Follow-up|5|||
33600818|NCT02558400|102088813|FG001|Overall Study|Lost to Follow-up|5|||
33600819|NCT02558400|102088814|FG002|Overall Study|Lost to Follow-up|4|||
33600820|NCT02558400|102088812|FG000|Overall Study|Lack of Efficacy|0|||
33600821|NCT02558400|102088813|FG001|Overall Study|Lack of Efficacy|13|||
33600822|NCT02558400|102088814|FG002|Overall Study|Lack of Efficacy|1|||
33600823|NCT02558400|102088812|FG000|Overall Study|Disallowed Concurrent Medication|6|||
33600824|NCT02558400|102088813|FG001|Overall Study|Disallowed Concurrent Medication|7|||
33600825|NCT02558400|102088814|FG002|Overall Study|Disallowed Concurrent Medication|5|||
33499037|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Site closed|0|||
33600826|NCT02558400|102088812|FG000|Overall Study|Physician Decision|2|||
33600827|NCT02558400|102088813|FG001|Overall Study|Physician Decision|2|||
33600828|NCT02558400|102088814|FG002|Overall Study|Physician Decision|0|||
33600829|NCT02558400|102088812|FG000|Overall Study|Protocol Violation|6|||
33600830|NCT02558400|102088813|FG001|Overall Study|Protocol Violation|3|||
33600831|NCT02558400|102088814|FG002|Overall Study|Protocol Violation|8|||
33600832|NCT02558400|102088812|FG000|Overall Study|Death|0|||
33600833|NCT02558400|102088813|FG001|Overall Study|Death|1|||
33600834|NCT02558400|102088814|FG002|Overall Study|Death|0|||
33600835|NCT02558400|102088812|FG000|Overall Study|Ineligible for the study|0|||
33600836|NCT02558400|102088813|FG001|Overall Study|Ineligible for the study|2|||
33305587|NCT03218397|101014156|FG000|Overall Study|Comfort care and positive blood culture|1|||
33305588|NCT03218397|101014157|FG001|Overall Study|Comfort care and positive blood culture|0|||
33305589|NCT03218397|101014156|FG000|Overall Study|Comfort care and mixed culture|0|||
33305590|NCT03218397|101014157|FG001|Overall Study|Comfort care and mixed culture|1|||
33305591|NCT03218397|101014156|FG000|Overall Study|Mixed culture|2|||
33305592|NCT03218397|101014157|FG001|Overall Study|Mixed culture|2|||
33305593|NCT03218397|101014156|FG000|Overall Study|Inaccessible hospital records|2|||
33305594|NCT03218397|101014157|FG001|Overall Study|Inaccessible hospital records|5|||
33305595|NCT03218397|101014156|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
33305596|NCT03218397|101014157|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
33305597|NCT03218397|101014156|FG000|Overall Study|Randomized during laboratory off hours|2|||
33305598|NCT03218397|101014157|FG001|Overall Study|Randomized during laboratory off hours|1|||
33393728|NCT03073200|101328517|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33393729|NCT03073200|101328518|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33393730|NCT03073200|101328519|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33305599|NCT03020576|101014158|FG000|Overall Study|Withdrawal by Subject|1|||
33305600|NCT03020576|101014159|FG001|Overall Study|Withdrawal by Subject|2|||
33305601|NCT00760474|101014160|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
33305602|NCT00760474|101014161|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
33305603|NCT00760474|101014160|FG000|Placebo Washout Period|Other|0|||
33305604|NCT00760474|101014161|FG001|Placebo Washout Period|Other|1|||
33305605|NCT00760474|101014160|FG000|Period 2 (P2)|Lost to Follow-up|1|||
33305606|NCT00760474|101014161|FG001|Period 2 (P2)|Lost to Follow-up|0|||
33305607|NCT00760474|101014160|FG000|Period 2 (P2)|Adverse Event|0|||
33305608|NCT00760474|101014161|FG001|Period 2 (P2)|Adverse Event|1|||
33305609|NCT03319849|101014162|FG000|Overall Study|Adverse Event|1|||
33305610|NCT03319849|101014163|FG001|Overall Study|Adverse Event|0|||
33305611|NCT03319849|101014162|FG000|Overall Study|Physician Decision|0|||
33305612|NCT03319849|101014163|FG001|Overall Study|Physician Decision|1|||
33305613|NCT03319849|101014162|FG000|Overall Study|Withdrawal by Subject|0|||
33305614|NCT03319849|101014163|FG001|Overall Study|Withdrawal by Subject|1|||
33305615|NCT03319849|101014162|FG000|Overall Study|COVID-19|0|||
33305616|NCT03319849|101014163|FG001|Overall Study|COVID-19|1|||
33305617|NCT03319849|101014162|FG000|Overall Study|Other|1|||
33305618|NCT03319849|101014163|FG001|Overall Study|Other|2|||
33305619|NCT03319849|101014162|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
33305620|NCT03319849|101014163|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
33305621|NCT03319849|101014162|FG000|Overall Study|Lost to Follow-up|0|||
33305622|NCT03319849|101014163|FG001|Overall Study|Lost to Follow-up|2|||
33305623|NCT03534284|101014169|FG000|Overall Study|Death|2|||
33305624|NCT03534284|101014170|FG001|Overall Study|Death|3|||
33305625|NCT03534284|101014171|FG002|Overall Study|Death|3|||
33305626|NCT03534284|101014169|FG000|Overall Study|Withdrawal by Subject|5|||
33305627|NCT03534284|101014170|FG001|Overall Study|Withdrawal by Subject|0|||
33305628|NCT03534284|101014171|FG002|Overall Study|Withdrawal by Subject|0|||
33305629|NCT03981861|101014172|FG000|Overall Study|Withdrawal by Subject|3|||
33305630|NCT05086276|101014179|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
33305631|NCT05086276|101014180|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
33305632|NCT01177800|101014181|FG000|Overall Study|Adverse Event|9|||
33305633|NCT01177800|101014182|FG001|Overall Study|Adverse Event|3|||
33305634|NCT01177800|101014181|FG000|Overall Study|Protocol Violation|0|||
33305635|NCT01177800|101014182|FG001|Overall Study|Protocol Violation|1|||
33305636|NCT01177800|101014181|FG000|Overall Study|Physician Decision|1|||
33305637|NCT01177800|101014182|FG001|Overall Study|Physician Decision|0|||
33305638|NCT01177800|101014181|FG000|Overall Study|Withdrawal of informed consent|0|||
33305639|NCT01177800|101014182|FG001|Overall Study|Withdrawal of informed consent|1|||
33305640|NCT03291288|101014183|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
33305641|NCT03291288|101014184|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
33305642|NCT03291288|101014183|FG000|Drug-drug Interaction Phase|Disease progression|1|||
33305643|NCT03291288|101014184|FG001|Drug-drug Interaction Phase|Disease progression|0|||
33305644|NCT03291288|101014183|FG000|Drug-drug Interaction Phase|Other|3|||
33305645|NCT03291288|101014184|FG001|Drug-drug Interaction Phase|Other|0|||
33305646|NCT03291288|101014183|FG000|Pexidartinib Only|Ongoing|0|||
33305647|NCT03291288|101014184|FG001|Pexidartinib Only|Ongoing|2|||
33305648|NCT02751320|101014185|FG000|Overall Study|Adverse Event|2|||
33305649|NCT02751320|101014185|FG000|Overall Study|Withdrawal by Subject|1|||
33305650|NCT02432196|101014186|FG000|Overall Study|Exit - did not receive study device|1|||
33305651|NCT02432196|101014186|FG000|Overall Study|Death|2|||
33305652|NCT02432196|101014186|FG000|Overall Study|Reoperation|3|||
33305653|NCT02030002|101014187|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
33305654|NCT02030002|101014187|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
33305655|NCT02030002|101014187|FG000|Follow-up|Lost to Follow-up|2|||
33305656|NCT03965351|101014188|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
33305657|NCT03965351|101014189|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
33305658|NCT03965351|101014188|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
33305659|NCT03965351|101014189|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
33305660|NCT01076153|101014190|FG000|Overall Study|Symptoms improved/resolved|10|||
33305661|NCT01076153|101014190|FG000|Overall Study|Adverse Event|1|||
33305662|NCT01239043|101014192|FG000|Overall Study|Protocol Violation|2|||
33305663|NCT01239043|101014193|FG001|Overall Study|Protocol Violation|1|||
33305664|NCT00943111|101014199|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
33305665|NCT00943111|101014200|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
33305666|NCT00943111|101014201|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
33305667|NCT00943111|101014199|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
33305668|NCT00943111|101014200|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
33305669|NCT00943111|101014201|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
33305670|NCT00943111|101014199|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
33305671|NCT00943111|101014200|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
33305672|NCT00943111|101014201|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
33305673|NCT00943111|101014199|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
33305674|NCT00943111|101014200|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
33305675|NCT00943111|101014201|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
33305676|NCT00943111|101014199|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
33305677|NCT00943111|101014200|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
33305678|NCT00943111|101014201|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
33305679|NCT00943111|101014199|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
33305680|NCT00943111|101014200|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
33305681|NCT00943111|101014201|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
33305682|NCT00943111|101014199|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
33305683|NCT00943111|101014200|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
33305684|NCT00943111|101014201|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
33305685|NCT00943111|101014199|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
33305686|NCT00943111|101014200|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
33305687|NCT00943111|101014201|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
33305688|NCT01655693|101014203|FG000|Overall Study|Progression of Disease|92|||
33305689|NCT01655693|101014204|FG001|Overall Study|Progression of Disease|76|||
33305690|NCT01655693|101014205|FG002|Overall Study|Progression of Disease|58|||
33305691|NCT01655693|101014203|FG000|Overall Study|Death|8|||
33305692|NCT01655693|101014204|FG001|Overall Study|Death|9|||
33305693|NCT01655693|101014205|FG002|Overall Study|Death|12|||
33305694|NCT01655693|101014203|FG000|Overall Study|Serious Adverse Event|3|||
33305695|NCT01655693|101014204|FG001|Overall Study|Serious Adverse Event|15|||
33305696|NCT01655693|101014205|FG002|Overall Study|Serious Adverse Event|11|||
33305697|NCT01655693|101014203|FG000|Overall Study|Withdrawal by Subject|3|||
33305698|NCT01655693|101014204|FG001|Overall Study|Withdrawal by Subject|2|||
33305699|NCT01655693|101014205|FG002|Overall Study|Withdrawal by Subject|20|||
33305700|NCT01655693|101014203|FG000|Overall Study|Adverse Event|3|||
33305701|NCT01655693|101014204|FG001|Overall Study|Adverse Event|11|||
33305702|NCT01655693|101014205|FG002|Overall Study|Adverse Event|3|||
33305703|NCT01655693|101014203|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
33305704|NCT01655693|101014204|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
33305705|NCT01655693|101014205|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
33305706|NCT01655693|101014203|FG000|Overall Study|Non-Compliance|0|||
33305707|NCT01655693|101014204|FG001|Overall Study|Non-Compliance|0|||
33305708|NCT01655693|101014205|FG002|Overall Study|Non-Compliance|7|||
33305709|NCT01655693|101014203|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
33305710|NCT01655693|101014204|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
33305711|NCT01655693|101014205|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
33305712|NCT01655693|101014203|FG000|Overall Study|Protocol Violation|1|||
33305713|NCT01655693|101014204|FG001|Overall Study|Protocol Violation|0|||
33305714|NCT01655693|101014205|FG002|Overall Study|Protocol Violation|3|||
33305715|NCT01655693|101014203|FG000|Overall Study|Lost to Follow-up|1|||
33305716|NCT01655693|101014204|FG001|Overall Study|Lost to Follow-up|0|||
33305717|NCT01655693|101014205|FG002|Overall Study|Lost to Follow-up|1|||
33305718|NCT01655693|101014203|FG000|Overall Study|Screening Failure|1|||
33305719|NCT01655693|101014204|FG001|Overall Study|Screening Failure|0|||
33305720|NCT01655693|101014205|FG002|Overall Study|Screening Failure|0|||
33305721|NCT01655693|101014203|FG000|Overall Study|Other|8|||
33305722|NCT01655693|101014204|FG001|Overall Study|Other|6|||
33305723|NCT01655693|101014205|FG002|Overall Study|Other|15|||
33305724|NCT01346475|101014206|FG000|First Intervention|Lost to Follow-up|4|||
33305725|NCT01346475|101014207|FG001|First Intervention|Lost to Follow-up|3|||
33305726|NCT03309813|101014208|FG000|Main Randomized Study|Withdrawal by Subject|1|||
33305727|NCT03309813|101014209|FG001|Main Randomized Study|Withdrawal by Subject|0|||
33305728|NCT01901432|101014210|FG000|Overall Study|Adverse Event|0|||
33305729|NCT01901432|101014211|FG001|Overall Study|Adverse Event|1|||
33305730|NCT01901432|101014212|FG002|Overall Study|Adverse Event|1|||
33305731|NCT01901432|101014213|FG003|Overall Study|Adverse Event|0|||
33305732|NCT01901432|101014214|FG004|Overall Study|Adverse Event|1|||
33305733|NCT01901432|101014210|FG000|Overall Study|Withdrawal by Subject|0|||
33305734|NCT01901432|101014211|FG001|Overall Study|Withdrawal by Subject|0|||
33305735|NCT01901432|101014212|FG002|Overall Study|Withdrawal by Subject|1|||
33305736|NCT01901432|101014213|FG003|Overall Study|Withdrawal by Subject|0|||
33305737|NCT01901432|101014214|FG004|Overall Study|Withdrawal by Subject|5|||
33305738|NCT01901432|101014210|FG000|Overall Study|Physician Decision|0|||
33305739|NCT01901432|101014211|FG001|Overall Study|Physician Decision|0|||
33191044|NCT02624284|100605100|FG001|Overall Study|Revealed exclusionary condition|2|||
33191045|NCT02624284|100605101|FG002|Overall Study|Revealed exclusionary condition|0|||
33191046|NCT02624284|100605099|FG000|Overall Study|Adverse Event|0|||
33191047|NCT02624284|100605100|FG001|Overall Study|Adverse Event|0|||
33191048|NCT02624284|100605101|FG002|Overall Study|Adverse Event|1|||
33191049|NCT02388997|100605104|FG000|Overall Study|Adverse Event|1|||
33191050|NCT02388997|100605105|FG001|Overall Study|Adverse Event|2|||
33191051|NCT02388997|100605104|FG000|Overall Study|Withdrawal by Subject|2|||
33191052|NCT02388997|100605105|FG001|Overall Study|Withdrawal by Subject|1|||
33191053|NCT02388997|100605104|FG000|Overall Study|Lung function exclusion criteria|0|||
33191054|NCT02388997|100605105|FG001|Overall Study|Lung function exclusion criteria|2|||
33305740|NCT01901432|101014212|FG002|Overall Study|Physician Decision|0|||
33305741|NCT01901432|101014213|FG003|Overall Study|Physician Decision|0|||
33305742|NCT01901432|101014214|FG004|Overall Study|Physician Decision|2|||
33305743|NCT01901432|101014210|FG000|Overall Study|Patient decision to stop study drug|0|||
33305744|NCT01901432|101014211|FG001|Overall Study|Patient decision to stop study drug|0|||
33305745|NCT01901432|101014212|FG002|Overall Study|Patient decision to stop study drug|0|||
33305746|NCT01901432|101014213|FG003|Overall Study|Patient decision to stop study drug|0|||
33191055|NCT02388997|100605104|FG000|Overall Study|Tested positive for virus during run-in|0|||
33191056|NCT02388997|100605105|FG001|Overall Study|Tested positive for virus during run-in|1|||
33191057|NCT01469065|100605110|FG000|Overall Study|Lack of Efficacy|0|||
33191058|NCT01469065|100605111|FG001|Overall Study|Lack of Efficacy|0|||
33191059|NCT01469065|100605112|FG002|Overall Study|Lack of Efficacy|0|||
33191060|NCT01469065|100605113|FG003|Overall Study|Lack of Efficacy|0|||
33191061|NCT01469065|100605114|FG004|Overall Study|Lack of Efficacy|1|||
33191062|NCT01469065|100605110|FG000|Overall Study|Other|0|||
33191063|NCT01469065|100605111|FG001|Overall Study|Other|1|||
33191064|NCT01469065|100605112|FG002|Overall Study|Other|0|||
33191065|NCT01469065|100605113|FG003|Overall Study|Other|0|||
33191066|NCT01469065|100605114|FG004|Overall Study|Other|0|||
33191067|NCT02412631|100605116|FG000|Overall Study|Adverse Event|1|||
33191068|NCT02412631|100605117|FG001|Overall Study|Adverse Event|2|||
33191069|NCT02412631|100605116|FG000|Overall Study|Lost to Follow-up|5|||
33191070|NCT02412631|100605117|FG001|Overall Study|Lost to Follow-up|9|||
33191071|NCT02412631|100605116|FG000|Overall Study|Withdrawal by Subject|9|||
33191072|NCT02412631|100605117|FG001|Overall Study|Withdrawal by Subject|3|||
33191073|NCT02412631|100605116|FG000|Overall Study|Early stop by FDA|5|||
33191074|NCT02412631|100605117|FG001|Overall Study|Early stop by FDA|2|||
33191075|NCT02412631|100605116|FG000|Overall Study|Unspecified reason|6|||
33191076|NCT02412631|100605117|FG001|Overall Study|Unspecified reason|8|||
33191077|NCT02474199|100605118|FG000|Overall Study|Lost to Follow-up|1|||
33191078|NCT02474199|100605119|FG001|Overall Study|Lost to Follow-up|0|||
33191079|NCT02474199|100605120|FG002|Overall Study|Lost to Follow-up|0|||
33191080|NCT02474199|100605121|FG003|Overall Study|Lost to Follow-up|0|||
33191081|NCT02474199|100605118|FG000|Overall Study|Withdrawal by Subject|1|||
33305747|NCT01901432|101014214|FG004|Overall Study|Patient decision to stop study drug|1|||
33305748|NCT01125514|101014215|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
33305749|NCT01125514|101014215|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
33305750|NCT01125514|101014215|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
33305751|NCT01125514|101014215|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
33393731|NCT03073200|101328520|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33191082|NCT02474199|100605119|FG001|Overall Study|Withdrawal by Subject|2|||
33191083|NCT02474199|100605120|FG002|Overall Study|Withdrawal by Subject|0|||
33191084|NCT02474199|100605121|FG003|Overall Study|Withdrawal by Subject|1|||
33191085|NCT02474199|100605118|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
33191086|NCT02474199|100605119|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
33191087|NCT02474199|100605120|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
33600837|NCT02558400|102088814|FG002|Overall Study|Ineligible for the study|0|||
33600838|NCT01527383|102088815|FG000|Overall Study|Adverse Event|5|||
33600839|NCT01527383|102088816|FG001|Overall Study|Adverse Event|0|||
33600840|NCT01527383|102088815|FG000|Overall Study|Lost to Follow-up|3|||
33600841|NCT01527383|102088816|FG001|Overall Study|Lost to Follow-up|0|||
33600842|NCT01527383|102088815|FG000|Overall Study|Physician Decision|2|||
33600843|NCT01527383|102088816|FG001|Overall Study|Physician Decision|0|||
33600844|NCT01527383|102088815|FG000|Overall Study|Pregnancy|1|||
33600845|NCT01527383|102088816|FG001|Overall Study|Pregnancy|0|||
33600846|NCT01527383|102088815|FG000|Overall Study|Protocol Violation|1|||
33600847|NCT01527383|102088816|FG001|Overall Study|Protocol Violation|0|||
33600848|NCT01527383|102088815|FG000|Overall Study|Screen failure|1|||
33600849|NCT01527383|102088816|FG001|Overall Study|Screen failure|0|||
33600850|NCT01527383|102088815|FG000|Overall Study|Participant moved|0|||
33600851|NCT01527383|102088816|FG001|Overall Study|Participant moved|1|||
33600852|NCT01527383|102088815|FG000|Overall Study|Withdrawal by Subject|2|||
33600853|NCT01527383|102088816|FG001|Overall Study|Withdrawal by Subject|3|||
33305752|NCT01125514|101014215|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
33305753|NCT01125514|101014215|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
33305754|NCT05593445|101014216|FG000|12-Week DBVC Period|Adverse Event|1|||
33305755|NCT05593445|101014217|FG001|12-Week DBVC Period|Adverse Event|0|||
33305756|NCT05593445|101014218|FG002|12-Week DBVC Period|Adverse Event|0|||
33305757|NCT05593445|101014219|FG003|12-Week DBVC Period|Adverse Event|0|||
33305758|NCT05593445|101014216|FG000|12-Week DBVC Period|Physician Decision|0|||
33305759|NCT05593445|101014217|FG001|12-Week DBVC Period|Physician Decision|1|||
33305760|NCT05593445|101014218|FG002|12-Week DBVC Period|Physician Decision|0|||
33305761|NCT05593445|101014219|FG003|12-Week DBVC Period|Physician Decision|0|||
33305762|NCT05593445|101014216|FG000|12-Week DBVC Period|Protocol Violation|0|||
33305763|NCT05593445|101014217|FG001|12-Week DBVC Period|Protocol Violation|1|||
33305764|NCT05593445|101014218|FG002|12-Week DBVC Period|Protocol Violation|0|||
33305765|NCT05593445|101014219|FG003|12-Week DBVC Period|Protocol Violation|0|||
33393732|NCT03073200|101328521|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33600854|NCT01036529|102088817|FG000|Overall Study|Adverse Event|0|||
33600855|NCT01036529|102088818|FG001|Overall Study|Adverse Event|1|||
33600856|NCT01036529|102088817|FG000|Overall Study|Lost to Follow-up|0|||
33600857|NCT01036529|102088818|FG001|Overall Study|Lost to Follow-up|1|||
33600858|NCT01036529|102088817|FG000|Overall Study|Physician Decision|1|||
33224220|NCT03489057|100721757|FG002|Overall Study|Withdrawal by Subject|8|||
33224221|NCT03489057|100721758|FG003|Overall Study|Withdrawal by Subject|8|||
33224222|NCT03489057|100721755|FG000|Overall Study|Protocol Violation|7|||
33224223|NCT03489057|100721756|FG001|Overall Study|Protocol Violation|7|||
33224224|NCT03489057|100721757|FG002|Overall Study|Protocol Violation|2|||
33224225|NCT03489057|100721758|FG003|Overall Study|Protocol Violation|2|||
33224226|NCT00927355|100721759|FG000|Overall Study|Adverse Event|1|||
33224227|NCT00927355|100721760|FG001|Overall Study|Adverse Event|1|||
33224228|NCT02696564|100721761|FG000|Overall Study|Death|1|||
33224229|NCT02696564|100721762|FG001|Overall Study|Death|2|||
33224230|NCT02696564|100721761|FG000|Overall Study|Withdrawal by Subject|3|||
33224231|NCT02696564|100721762|FG001|Overall Study|Withdrawal by Subject|2|||
33224232|NCT02696564|100721761|FG000|Overall Study|Lost to Follow-up|3|||
33224233|NCT02696564|100721762|FG001|Overall Study|Lost to Follow-up|3|||
33224234|NCT02696564|100721761|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
33224235|NCT02696564|100721762|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
33224236|NCT02696564|100721761|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
33224237|NCT02696564|100721762|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
33224238|NCT02696564|100721761|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
33224239|NCT02696564|100721762|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
33224240|NCT02696564|100721761|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
33224241|NCT02696564|100721762|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
33224242|NCT02696564|100721761|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
33224243|NCT02696564|100721762|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
33224244|NCT01672853|100721764|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
33224245|NCT01672853|100721765|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
33224246|NCT01672853|100721766|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
33224247|NCT01672853|100721764|FG000|Overall Study|Pregnancy|0|||
33224248|NCT01672853|100721765|FG001|Overall Study|Pregnancy|1|||
33224249|NCT01672853|100721766|FG002|Overall Study|Pregnancy|0|||
33224250|NCT01672853|100721764|FG000|Overall Study|Investigator's Discretion|1|||
33224251|NCT01672853|100721765|FG001|Overall Study|Investigator's Discretion|0|||
33224252|NCT01672853|100721766|FG002|Overall Study|Investigator's Discretion|0|||
33305766|NCT05593445|101014216|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
33305767|NCT05593445|101014217|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
33305768|NCT05593445|101014218|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
33305769|NCT05593445|101014219|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
33305770|NCT05593445|101014216|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
33305771|NCT05593445|101014217|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
33305772|NCT05593445|101014218|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
33305773|NCT05593445|101014219|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
33305774|NCT05593445|101014216|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
33305775|NCT05593445|101014217|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
33305776|NCT05593445|101014218|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
33305777|NCT05593445|101014219|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
33305778|NCT05593445|101014216|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
33305779|NCT05593445|101014217|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
33305780|NCT05593445|101014218|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
33305781|NCT05593445|101014219|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
33305782|NCT05593445|101014216|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33305783|NCT05593445|101014217|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33305784|NCT05593445|101014218|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
33305785|NCT05593445|101014219|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33305786|NCT00777088|101014223|FG000|Overall Study|PED Treatment not attempted|1|||
33305787|NCT02101385|101014226|FG000|Study Treatment|Disease Progression|9|||
33499038|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
33499039|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
33499040|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
33499041|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
33499042|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
33499043|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
33499044|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
33499045|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
33499046|NCT00838903|101720256|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
33499047|NCT00838903|101720257|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
33499048|NCT00838903|101720258|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
33305788|NCT02101385|101014227|FG001|Study Treatment|Disease Progression|3|||
33305789|NCT02101385|101014226|FG000|Study Treatment|Alternative therapy|0|||
33305790|NCT02101385|101014227|FG001|Study Treatment|Alternative therapy|1|||
33305791|NCT02101385|101014226|FG000|Study Treatment|No treatment, per protocol criteria|0|||
33305792|NCT02101385|101014227|FG001|Study Treatment|No treatment, per protocol criteria|4|||
33305793|NCT02101385|101014226|FG000|Study Treatment|Patient Non compliance|0|||
33305794|NCT02101385|101014227|FG001|Study Treatment|Patient Non compliance|2|||
33305795|NCT02101385|101014226|FG000|Study Treatment|Withdrawal by Subject|5|||
33305796|NCT02101385|101014227|FG001|Study Treatment|Withdrawal by Subject|2|||
33305797|NCT02101385|101014226|FG000|Study Treatment|screen failure|1|||
33305798|NCT02101385|101014227|FG001|Study Treatment|screen failure|0|||
33305799|NCT02101385|101014226|FG000|Study Treatment|AE/Side Effects/Complications|8|||
33305800|NCT02101385|101014227|FG001|Study Treatment|AE/Side Effects/Complications|0|||
33305801|NCT02101385|101014226|FG000|Study Treatment|Lost to Follow-up|1|||
33305802|NCT02101385|101014227|FG001|Study Treatment|Lost to Follow-up|0|||
33305803|NCT02101385|101014226|FG000|Study Treatment|Disease Progression before treatment|1|||
33305804|NCT02101385|101014227|FG001|Study Treatment|Disease Progression before treatment|0|||
33305805|NCT02101385|101014226|FG000|Study Treatment|Death|1|||
33305806|NCT02101385|101014227|FG001|Study Treatment|Death|0|||
33305807|NCT02101385|101014226|FG000|Follow up|Lost to Follow-up|4|||
33305808|NCT02101385|101014227|FG001|Follow up|Lost to Follow-up|9|||
33305809|NCT02101385|101014226|FG000|Follow up|Refused to follow up|5|||
33305810|NCT02101385|101014227|FG001|Follow up|Refused to follow up|4|||
33305811|NCT02101385|101014226|FG000|Follow up|Death|21|||
33305812|NCT02101385|101014227|FG001|Follow up|Death|39|||
33305813|NCT02101385|101014226|FG000|Follow up|study completed|33|||
33305814|NCT02101385|101014227|FG001|Follow up|study completed|52|||
33305815|NCT02101385|101014226|FG000|Follow up|screen failure|2|||
33305816|NCT02101385|101014227|FG001|Follow up|screen failure|0|||
33499049|NCT00838903|101720259|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
33499050|NCT00838903|101720256|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
33305817|NCT02101385|101014226|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
33600859|NCT01036529|102088818|FG001|Overall Study|Physician Decision|0|||
33224253|NCT01672853|100721764|FG000|Overall Study|Withdrew Consent|5|||
33305818|NCT02101385|101014227|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
33305819|NCT02101385|101014226|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
33305820|NCT02101385|101014227|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
33305821|NCT02101385|101014226|FG000|Follow up|Withdrawal by Subject|2|||
33305822|NCT02101385|101014227|FG001|Follow up|Withdrawal by Subject|2|||
33305823|NCT02101385|101014226|FG000|Follow up|PI requested closure of site|0|||
33305824|NCT02101385|101014227|FG001|Follow up|PI requested closure of site|5|||
33305825|NCT00006011|101014236|FG000|Overall Study|Disease progression|13|||
33305826|NCT00006011|101014237|FG001|Overall Study|Disease progression|6|||
33305827|NCT00006011|101014238|FG002|Overall Study|Disease progression|26|||
33305828|NCT00006011|101014236|FG000|Overall Study|Refused further treatment|15|||
33305829|NCT00006011|101014237|FG001|Overall Study|Refused further treatment|13|||
33305830|NCT00006011|101014238|FG002|Overall Study|Refused further treatment|26|||
33305831|NCT00006011|101014236|FG000|Overall Study|Adverse Event|15|||
33305832|NCT00006011|101014237|FG001|Overall Study|Adverse Event|39|||
33305833|NCT00006011|101014238|FG002|Overall Study|Adverse Event|5|||
33305834|NCT00006011|101014236|FG000|Overall Study|Death|0|||
33305835|NCT00006011|101014237|FG001|Overall Study|Death|1|||
33305836|NCT00006011|101014238|FG002|Overall Study|Death|2|||
33305837|NCT00006011|101014236|FG000|Overall Study|Other|4|||
33305838|NCT00006011|101014237|FG001|Overall Study|Other|2|||
33305839|NCT00006011|101014238|FG002|Overall Study|Other|5|||
33305840|NCT00006011|101014236|FG000|Overall Study|Ineligible|18|||
33305841|NCT00006011|101014237|FG001|Overall Study|Ineligible|16|||
33305842|NCT00006011|101014238|FG002|Overall Study|Ineligible|9|||
33305843|NCT01097707|101014239|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
33305844|NCT01097707|101014240|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
33305845|NCT01097707|101014241|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
33305846|NCT01097707|101014242|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
33305847|NCT01097707|101014243|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
33305848|NCT01097707|101014239|FG000|Overall Study|Adverse Event|4|||
33305849|NCT01097707|101014240|FG001|Overall Study|Adverse Event|2|||
33305850|NCT01097707|101014241|FG002|Overall Study|Adverse Event|3|||
33305851|NCT01097707|101014242|FG003|Overall Study|Adverse Event|1|||
33305852|NCT01097707|101014243|FG004|Overall Study|Adverse Event|3|||
33305853|NCT01097707|101014239|FG000|Overall Study|Entry Criteria Not Met|2|||
33305854|NCT01097707|101014240|FG001|Overall Study|Entry Criteria Not Met|1|||
33305855|NCT01097707|101014241|FG002|Overall Study|Entry Criteria Not Met|1|||
33305856|NCT01097707|101014242|FG003|Overall Study|Entry Criteria Not Met|0|||
33305857|NCT01097707|101014243|FG004|Overall Study|Entry Criteria Not Met|1|||
33305858|NCT01097707|101014239|FG000|Overall Study|Lack of Efficacy|1|||
33305859|NCT01097707|101014240|FG001|Overall Study|Lack of Efficacy|0|||
33305860|NCT01097707|101014241|FG002|Overall Study|Lack of Efficacy|0|||
33305861|NCT01097707|101014242|FG003|Overall Study|Lack of Efficacy|1|||
33305862|NCT01097707|101014243|FG004|Overall Study|Lack of Efficacy|0|||
33305863|NCT01097707|101014239|FG000|Overall Study|Lost to Follow-up|1|||
33305864|NCT01097707|101014240|FG001|Overall Study|Lost to Follow-up|1|||
33305865|NCT01097707|101014241|FG002|Overall Study|Lost to Follow-up|2|||
33305866|NCT01097707|101014242|FG003|Overall Study|Lost to Follow-up|0|||
33305867|NCT01097707|101014243|FG004|Overall Study|Lost to Follow-up|3|||
33305868|NCT01097707|101014239|FG000|Overall Study|Protocol Violation|2|||
33305869|NCT01097707|101014240|FG001|Overall Study|Protocol Violation|2|||
33305870|NCT01097707|101014241|FG002|Overall Study|Protocol Violation|3|||
33305871|NCT01097707|101014242|FG003|Overall Study|Protocol Violation|2|||
33305872|NCT01097707|101014243|FG004|Overall Study|Protocol Violation|2|||
33305873|NCT01097707|101014239|FG000|Overall Study|Sponsor Decision|31|||
33305874|NCT01097707|101014240|FG001|Overall Study|Sponsor Decision|31|||
33305875|NCT01097707|101014241|FG002|Overall Study|Sponsor Decision|34|||
33305876|NCT01097707|101014242|FG003|Overall Study|Sponsor Decision|35|||
33305877|NCT01097707|101014243|FG004|Overall Study|Sponsor Decision|36|||
33305878|NCT01097707|101014239|FG000|Overall Study|Withdrawal by Subject|3|||
33305879|NCT01097707|101014240|FG001|Overall Study|Withdrawal by Subject|6|||
33305880|NCT01097707|101014241|FG002|Overall Study|Withdrawal by Subject|1|||
33305881|NCT01097707|101014242|FG003|Overall Study|Withdrawal by Subject|4|||
33305882|NCT01097707|101014243|FG004|Overall Study|Withdrawal by Subject|3|||
33305883|NCT01097707|101014239|FG000|Overall Study|Reason unknown|0|||
33305884|NCT01097707|101014240|FG001|Overall Study|Reason unknown|0|||
33305885|NCT01097707|101014241|FG002|Overall Study|Reason unknown|0|||
33305886|NCT01097707|101014242|FG003|Overall Study|Reason unknown|0|||
33305887|NCT01097707|101014243|FG004|Overall Study|Reason unknown|1|||
33305888|NCT03001076|101014246|FG000|Overall Study|Withdrawal by patient|2|||
33305889|NCT03001076|101014247|FG001|Overall Study|Withdrawal by patient|0|||
33305890|NCT03001076|101014246|FG000|Overall Study|Other|1|||
33305891|NCT03001076|101014247|FG001|Overall Study|Other|0|||
33305892|NCT03001076|101014246|FG000|Overall Study|Adverse Event|3|||
33305893|NCT03001076|101014247|FG001|Overall Study|Adverse Event|3|||
33305894|NCT03001076|101014246|FG000|Overall Study|Sponsor decision|1|||
33305895|NCT03001076|101014247|FG001|Overall Study|Sponsor decision|0|||
33305896|NCT03001076|101014246|FG000|Overall Study|Lost to Follow-up|0|||
33305897|NCT03001076|101014247|FG001|Overall Study|Lost to Follow-up|2|||
33305898|NCT00847808|101014248|FG000|Overall Study|Adverse Event|7|||
33305899|NCT00847808|101014248|FG000|Overall Study|Protocol Violation|1|||
33305900|NCT00847808|101014248|FG000|Overall Study|Lost to Follow-up|1|||
33305901|NCT00847808|101014248|FG000|Overall Study|Withdrawal by Subject|4|||
33305902|NCT00847808|101014248|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
33305903|NCT00847808|101014248|FG000|Overall Study|Participant Took Excluded Medication|1|||
33305904|NCT02996474|101014249|FG000|Overall Study|Physician Decision|5|||
33305905|NCT01034163|101014250|FG000|Overall Study|Treatment completed as per protocol|8|||
33305906|NCT01034163|101014251|FG001|Overall Study|Treatment completed as per protocol|7|||
33305907|NCT01034163|101014250|FG000|Overall Study|Withdrawal by Subject|8|||
33305908|NCT01034163|101014251|FG001|Overall Study|Withdrawal by Subject|2|||
33305909|NCT01034163|101014250|FG000|Overall Study|Protocol deviation|1|||
33305910|NCT01034163|101014251|FG001|Overall Study|Protocol deviation|0|||
33305911|NCT01034163|101014250|FG000|Overall Study|Disease progression|3|||
33305912|NCT01034163|101014251|FG001|Overall Study|Disease progression|4|||
33305913|NCT01034163|101014250|FG000|Overall Study|Adverse Event|6|||
33305914|NCT01034163|101014251|FG001|Overall Study|Adverse Event|0|||
33305915|NCT01034163|101014250|FG000|Overall Study|Administrative problems|0|||
33305916|NCT01034163|101014251|FG001|Overall Study|Administrative problems|1|||
33305917|NCT01034163|101014250|FG000|Overall Study|Abnormal laboratory value|1|||
33305918|NCT01034163|101014251|FG001|Overall Study|Abnormal laboratory value|0|||
33305919|NCT04510090|101014254|FG000|FE-HS|Withdrawal by Subject|0|||
33305920|NCT04510090|101014255|FG001|FE-HS|Withdrawal by Subject|0|||
33305921|NCT04510090|101014256|FG002|FE-HS|Withdrawal by Subject|0|||
33305922|NCT04510090|101014257|FG003|FE-HS|Withdrawal by Subject|0|||
33305923|NCT04510090|101014258|FG004|FE-HS|Withdrawal by Subject|1|||
33305924|NCT04510090|101014259|FG005|FE-HS|Withdrawal by Subject|0|||
33305925|NCT04510090|101014260|FG006|FE-HS|Withdrawal by Subject|0|||
33305926|NCT04510090|101014261|FG007|FE-HS|Withdrawal by Subject|0|||
33305927|NCT02040259|101014265|FG000|Overall Study|Death|280|||
33305928|NCT02040259|101014265|FG000|Overall Study|Lost to Follow-up|76|||
33305929|NCT02040259|101014265|FG000|Overall Study|Assessment not completed|3|||
33305930|NCT02040259|101014265|FG000|Overall Study|Withdrawal by Subject|4|||
33305931|NCT02929329|101014266|FG000|Overall Study|Withdrawal by Subject|24|||
33305932|NCT02929329|101014267|FG001|Overall Study|Withdrawal by Subject|21|||
33305933|NCT02929329|101014266|FG000|Overall Study|Lost to Follow-up|26|||
33305934|NCT02929329|101014267|FG001|Overall Study|Lost to Follow-up|20|||
33305935|NCT02929329|101014266|FG000|Overall Study|Death|1054|||
33305936|NCT02929329|101014267|FG001|Overall Study|Death|1051|||
33305937|NCT00770029|101014268|FG000|Overall Study|Lost to Follow-up|2|||
33305938|NCT00770029|101014269|FG001|Overall Study|Lost to Follow-up|0|||
33305939|NCT00770029|101014268|FG000|Overall Study|Withdrawal by Subject|3|||
33305940|NCT00770029|101014269|FG001|Overall Study|Withdrawal by Subject|3|||
33305941|NCT00770029|101014268|FG000|Overall Study|Adverse Event|1|||
33305942|NCT00770029|101014269|FG001|Overall Study|Adverse Event|0|||
33305943|NCT00603304|101014270|FG000|Overall Study|Lost to Follow-up|5|||
33305944|NCT00603304|101014271|FG001|Overall Study|Lost to Follow-up|7|||
33305945|NCT00603304|101014270|FG000|Overall Study|Withdrawal by Subject|8|||
33305946|NCT00603304|101014271|FG001|Overall Study|Withdrawal by Subject|5|||
33305947|NCT00603304|101014270|FG000|Overall Study|Protocol Violation|1|||
33305948|NCT00603304|101014271|FG001|Overall Study|Protocol Violation|0|||
33305949|NCT00603304|101014270|FG000|Overall Study|Adverse Event|4|||
33305950|NCT00603304|101014271|FG001|Overall Study|Adverse Event|2|||
33305951|NCT00603304|101014270|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
33305952|NCT00603304|101014271|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
33600860|NCT01036529|102088817|FG000|Overall Study|Withdrawal by Subject|1|||
33600861|NCT01036529|102088818|FG001|Overall Study|Withdrawal by Subject|1|||
33600862|NCT01036529|102088817|FG000|Overall Study|Sponsor study termination|11|||
33305953|NCT00603304|101014270|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
33305954|NCT00603304|101014271|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
33305955|NCT00603304|101014270|FG000|Overall Study|Exclusionary Medication|2|||
33305956|NCT00603304|101014271|FG001|Overall Study|Exclusionary Medication|3|||
33600863|NCT01036529|102088818|FG001|Overall Study|Sponsor study termination|12|||
33305957|NCT00603304|101014270|FG000|Overall Study|Non-Compliant|0|||
33305958|NCT00603304|101014271|FG001|Overall Study|Non-Compliant|1|||
33305959|NCT00603304|101014270|FG000|Overall Study|Moved Away|0|||
33305960|NCT00603304|101014271|FG001|Overall Study|Moved Away|2|||
33305961|NCT00603304|101014270|FG000|Overall Study|Other|2|||
33305962|NCT00603304|101014271|FG001|Overall Study|Other|0|||
33305963|NCT00603304|101014270|FG000|Overall Study|Patient Decision|2|||
33305964|NCT00603304|101014271|FG001|Overall Study|Patient Decision|0|||
33305965|NCT00356408|101014272|FG000|Overall Study|Adverse Event|9|||
33305966|NCT00356408|101014272|FG000|Overall Study|Lack of Efficacy|36|||
33305967|NCT00356408|101014272|FG000|Overall Study|Lost to Follow-up|2|||
33305968|NCT00356408|101014272|FG000|Overall Study|Withdrawal by Subject|6|||
33600864|NCT00350623|102088822|FG000|Overall Study|Lost to Follow-up|8|||
33600865|NCT00350623|102088823|FG001|Overall Study|Lost to Follow-up|3|||
33600866|NCT00350623|102088824|FG002|Overall Study|Lost to Follow-up|4|||
33600867|NCT00350623|102088822|FG000|Overall Study|Withdrawal by Subject|0|||
33600868|NCT00350623|102088823|FG001|Overall Study|Withdrawal by Subject|1|||
33600869|NCT00350623|102088824|FG002|Overall Study|Withdrawal by Subject|1|||
33600870|NCT00350623|102088822|FG000|Overall Study|patient traveling outside the country|0|||
33600871|NCT00350623|102088823|FG001|Overall Study|patient traveling outside the country|0|||
33600872|NCT00350623|102088824|FG002|Overall Study|patient traveling outside the country|1|||
33600873|NCT00392808|102091710|FG000|Overall Study|Lost to Follow-up|3|||
33600874|NCT00392808|102091711|FG001|Overall Study|Lost to Follow-up|2|||
33600875|NCT00392808|102091712|FG002|Overall Study|Lost to Follow-up|1|||
33600876|NCT00392808|102091713|FG003|Overall Study|Lost to Follow-up|2|||
33305969|NCT00356408|101014272|FG000|Overall Study|Other: Principal investigator discretion|3|||
33305970|NCT00356408|101014272|FG000|Overall Study|Other: Sponsor request|1|||
33305971|NCT00356408|101014272|FG000|Overall Study|Other: Azathioprine stopped|1|||
33305972|NCT00356408|101014272|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
33305973|NCT00356408|101014272|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
33305974|NCT00818168|101014273|FG000|Overall Study|Lack of Efficacy|18|||
33305975|NCT00818168|101014273|FG000|Overall Study|Pregnancy|2|||
33305976|NCT00818168|101014273|FG000|Overall Study|Withdrawal by Subject|16|||
33305977|NCT00818168|101014273|FG000|Overall Study|Lost to Follow-up|7|||
33305978|NCT00818168|101014273|FG000|Overall Study|Adverse Event|19|||
33305979|NCT00818168|101014273|FG000|Overall Study|Reason for Non-completion Not reported|6|||
33305980|NCT00818168|101014273|FG000|Overall Study|Participant Moved|2|||
33305981|NCT03167359|101014274|FG000|Overall Study|Physician Decision|1|||
33305982|NCT03167359|101014274|FG000|Overall Study|Lost to Follow-up|1|||
33305983|NCT04313608|101014275|FG000|Overall Study|Death|12|||
33305984|NCT04313608|101014276|FG001|Overall Study|Death|3|||
33305985|NCT01099215|101014279|FG000|Overall Study|Withdrawal by Subject|1|||
33305986|NCT01099215|101014280|FG001|Overall Study|Withdrawal by Subject|0|||
33305987|NCT01099215|101014279|FG000|Overall Study|Adverse Event|0|||
33305988|NCT01099215|101014280|FG001|Overall Study|Adverse Event|1|||
33305989|NCT02187159|101014281|FG000|Overall Study|Protocol Violation|4|||
33305990|NCT02187159|101014282|FG001|Overall Study|Protocol Violation|6|||
33305991|NCT02187159|101014283|FG002|Overall Study|Protocol Violation|3|||
33305992|NCT02187159|101014284|FG003|Overall Study|Protocol Violation|4|||
33305993|NCT02187159|101014281|FG000|Overall Study|Lack of Efficacy|10|||
33305994|NCT02187159|101014282|FG001|Overall Study|Lack of Efficacy|5|||
33305995|NCT02187159|101014283|FG002|Overall Study|Lack of Efficacy|4|||
33305996|NCT02187159|101014284|FG003|Overall Study|Lack of Efficacy|7|||
33305997|NCT02187159|101014281|FG000|Overall Study|Adverse Event|28|||
33305998|NCT02187159|101014282|FG001|Overall Study|Adverse Event|33|||
33305999|NCT02187159|101014283|FG002|Overall Study|Adverse Event|42|||
33306000|NCT02187159|101014284|FG003|Overall Study|Adverse Event|50|||
33306001|NCT02187159|101014281|FG000|Overall Study|Withdrawal by Subject|24|||
33600877|NCT00392808|102091710|FG000|Overall Study|Unable to withdraw blood|3|||
33600878|NCT00392808|102091711|FG001|Overall Study|Unable to withdraw blood|1|||
33600879|NCT00392808|102091712|FG002|Overall Study|Unable to withdraw blood|1|||
33600880|NCT00392808|102091713|FG003|Overall Study|Unable to withdraw blood|2|||
33600881|NCT01100567|102091714|FG000|Overall Study|Withdrawal by Subject|5|||
33600882|NCT01100567|102091715|FG001|Overall Study|Withdrawal by Subject|8|||
33600883|NCT01100567|102091714|FG000|Overall Study|Early Hospital Discharge|6|||
33600884|NCT01100567|102091715|FG001|Overall Study|Early Hospital Discharge|4|||
33600885|NCT01100567|102091714|FG000|Overall Study|Lost to Follow-up|1|||
33600886|NCT01100567|102091715|FG001|Overall Study|Lost to Follow-up|2|||
33600887|NCT01100567|102091714|FG000|Overall Study|Physician Decision|0|||
33600888|NCT01100567|102091715|FG001|Overall Study|Physician Decision|1|||
33600889|NCT01100567|102091714|FG000|Overall Study|Deemed ineligible after consent|0|||
33600890|NCT01100567|102091715|FG001|Overall Study|Deemed ineligible after consent|1|||
33306002|NCT02187159|101014282|FG001|Overall Study|Withdrawal by Subject|28|||
33306003|NCT02187159|101014283|FG002|Overall Study|Withdrawal by Subject|25|||
33306004|NCT02187159|101014284|FG003|Overall Study|Withdrawal by Subject|26|||
33306005|NCT02187159|101014281|FG000|Overall Study|Other|3|||
33306006|NCT02187159|101014282|FG001|Overall Study|Other|7|||
33306007|NCT02187159|101014283|FG002|Overall Study|Other|3|||
33306008|NCT02187159|101014284|FG003|Overall Study|Other|9|||
33306009|NCT00444275|101014285|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
33306010|NCT00444275|101014286|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
33306011|NCT00444275|101014287|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
33600891|NCT00283868|102091716|FG000|Overall Study|Lost to Follow-up|7|||
33306012|NCT00444275|101014288|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
33306013|NCT00444275|101014289|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
33306014|NCT00444275|101014285|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
33306015|NCT00444275|101014286|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
33600892|NCT00283868|102091717|FG001|Overall Study|Lost to Follow-up|8|||
33224254|NCT01672853|100721765|FG001|Overall Study|Withdrew Consent|5|||
33600893|NCT00554099|102091720|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
33600894|NCT00554099|102091721|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
33600895|NCT00554099|102091722|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
33600896|NCT00554099|102091720|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
33600897|NCT00554099|102091721|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
33600898|NCT00554099|102091722|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
33600899|NCT00554099|102091720|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
33600900|NCT00554099|102091721|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
33600901|NCT00554099|102091722|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
33600902|NCT00554099|102091720|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
33600903|NCT00554099|102091721|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
33600904|NCT00554099|102091722|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
33600905|NCT00554099|102091720|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
33600906|NCT00554099|102091721|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
33600907|NCT00554099|102091722|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
33600908|NCT00554099|102091720|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
33600909|NCT00554099|102091721|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
33600910|NCT00554099|102091722|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
33600911|NCT00554099|102091720|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
33600912|NCT00554099|102091721|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
33600913|NCT00554099|102091722|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
33600914|NCT00554099|102091720|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
33600915|NCT00554099|102091721|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
33600916|NCT00554099|102091722|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
33600917|NCT00554099|102091720|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
33600918|NCT00554099|102091721|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
33306016|NCT00444275|101014287|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
33306017|NCT00444275|101014288|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
33600919|NCT00554099|102091722|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
33600920|NCT02772978|102091725|FG000|Overall Study|Withdrawal by Subject|1|||
33600921|NCT02772978|102091726|FG001|Overall Study|Withdrawal by Subject|1|||
33600922|NCT00680368|102091734|FG000|Overall Study|not supervised, not eligible|15|||
33600923|NCT00428220|102091735|FG000|Overall Study|Participant died|8|||
33600924|NCT00428220|102091735|FG000|Overall Study|Global deterioration of health status|7|||
33600925|NCT00428220|102091735|FG000|Overall Study|Lost to Follow-up|4|||
33600926|NCT00428220|102091735|FG000|Overall Study|Objective progression or relapse|123|||
33600927|NCT00428220|102091735|FG000|Overall Study|Participant refused continued treatment|7|||
33600928|NCT00428220|102091735|FG000|Overall Study|Adverse Event|51|||
33600929|NCT00428220|102091735|FG000|Overall Study|Other|23|||
33600930|NCT02365285|102091736|FG000|Overall Study|Physician Decision|0|||
33600931|NCT02365285|102091737|FG001|Overall Study|Physician Decision|1|||
33600932|NCT02365285|102091738|FG002|Overall Study|Physician Decision|1|||
33600933|NCT02365285|102091739|FG003|Overall Study|Physician Decision|0|||
33600934|NCT02365285|102091736|FG000|Overall Study|Adverse Event|0|||
33600935|NCT02365285|102091737|FG001|Overall Study|Adverse Event|0|||
33600936|NCT02365285|102091738|FG002|Overall Study|Adverse Event|0|||
33600937|NCT02365285|102091739|FG003|Overall Study|Adverse Event|2|||
33600938|NCT00623545|102091740|FG000|Overall Study|Adverse Event|6|||
33600939|NCT00623545|102091740|FG000|Overall Study|Withdrawal by Subject|4|||
33600940|NCT02513823|102091743|FG000|Overall Study|Lost to Follow-up|4|||
33600941|NCT02513823|102091743|FG000|Overall Study|Physician Decision|1|||
33191088|NCT02474199|100605121|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
33191089|NCT02474199|100605118|FG000|Overall Study|Did not meet eligibility criteria|0|||
33191090|NCT02474199|100605119|FG001|Overall Study|Did not meet eligibility criteria|0|||
33191091|NCT02474199|100605120|FG002|Overall Study|Did not meet eligibility criteria|2|||
33306018|NCT00444275|101014289|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
33306019|NCT00444275|101014285|FG000|Maintenance Treatment Phase|Adverse Event|0|||
33306020|NCT00444275|101014286|FG001|Maintenance Treatment Phase|Adverse Event|0|||
33306021|NCT00444275|101014287|FG002|Maintenance Treatment Phase|Adverse Event|3|||
33306022|NCT00444275|101014288|FG003|Maintenance Treatment Phase|Adverse Event|2|||
33306023|NCT00444275|101014289|FG004|Maintenance Treatment Phase|Adverse Event|13|||
33306024|NCT00444275|101014285|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
33306025|NCT00444275|101014286|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
33600942|NCT01591863|102091744|FG000|Overall Study|Adverse Event|3|||
33600943|NCT01591863|102091744|FG000|Overall Study|Withdrawal by Subject|1|||
33600944|NCT01591863|102091744|FG000|Overall Study|recurrence|9|||
33600945|NCT01591863|102091744|FG000|Overall Study|Lack of Efficacy|1|||
33600946|NCT03322423|102091745|FG000|Period 1|Subject no longer eligible|0|||
33600947|NCT03322423|102091746|FG001|Period 1|Subject no longer eligible|1|||
33499051|NCT00838903|101720257|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
33499052|NCT00838903|101720258|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
33499053|NCT00838903|101720259|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
33499054|NCT00838903|101720256|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
33499055|NCT00838903|101720257|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
33499056|NCT00838903|101720258|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
33499057|NCT00838903|101720259|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
33499058|NCT00838903|101720256|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
33499059|NCT00838903|101720257|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
33499060|NCT00838903|101720258|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
33499061|NCT00838903|101720259|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
33499062|NCT00838903|101720256|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
33499063|NCT00838903|101720257|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
33499064|NCT00838903|101720258|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
33499065|NCT00838903|101720259|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
33306026|NCT00444275|101014287|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
33306027|NCT00444275|101014288|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
33306028|NCT00444275|101014289|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
33306029|NCT00444275|101014285|FG000|Maintenance Treatment Phase|Patient's wish|0|||
33306030|NCT00444275|101014286|FG001|Maintenance Treatment Phase|Patient's wish|0|||
33306031|NCT00444275|101014287|FG002|Maintenance Treatment Phase|Patient's wish|19|||
33306032|NCT00444275|101014288|FG003|Maintenance Treatment Phase|Patient's wish|9|||
33499066|NCT00838903|101720256|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
33499067|NCT00838903|101720257|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
33499068|NCT00838903|101720258|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
33499069|NCT00838903|101720259|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
33499070|NCT00838903|101720256|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
33306033|NCT00444275|101014289|FG004|Maintenance Treatment Phase|Patient's wish|20|||
33306034|NCT00444275|101014285|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
33499071|NCT00838903|101720257|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
33499072|NCT00838903|101720258|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
33499073|NCT00838903|101720259|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
33499074|NCT00838903|101720256|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
33600948|NCT03322423|102091745|FG000|Period 1|Withdrawal by Subject|0|||
33600949|NCT03322423|102091746|FG001|Period 1|Withdrawal by Subject|1|||
33600950|NCT03322423|102091745|FG000|Period 1|Incorrect Lens Dispensed|1|||
33600951|NCT03322423|102091746|FG001|Period 1|Incorrect Lens Dispensed|0|||
33600952|NCT03322423|102091745|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
33600953|NCT03322423|102091746|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
33600954|NCT03322423|102091745|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
33600955|NCT03322423|102091746|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
33600956|NCT03322423|102091745|FG000|Period 2|Protocol Violation|1|||
33600957|NCT03322423|102091746|FG001|Period 2|Protocol Violation|0|||
33600958|NCT03322423|102091745|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
33600959|NCT03322423|102091746|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
33600960|NCT01667562|102091748|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
33600961|NCT01667562|102091749|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
33600962|NCT01667562|102091748|FG000|Erlotinib Phase|Lost to Follow-up|0|||
33600963|NCT01667562|102091749|FG001|Erlotinib Phase|Lost to Follow-up|1|||
33600964|NCT01667562|102091748|FG000|Erlotinib Phase|Adverse Event|0|||
33600965|NCT01667562|102091749|FG001|Erlotinib Phase|Adverse Event|1|||
33600966|NCT01667562|102091748|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
33600967|NCT01667562|102091749|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
33600968|NCT04342689|102091755|FG000|Overall Study|Withdrawal by Subject|32|||
33600969|NCT04342689|102091756|FG001|Overall Study|Withdrawal by Subject|33|||
33600970|NCT04342689|102091755|FG000|Overall Study|Lost to Follow-up|10|||
33600971|NCT04342689|102091756|FG001|Overall Study|Lost to Follow-up|12|||
33600972|NCT02847858|102091759|FG000|Overall Study|Lost to Follow-up|401|||
33600973|NCT02847858|102091760|FG001|Overall Study|Lost to Follow-up|269|||
33600974|NCT02654236|102091765|FG000|Overall Study|Withdrawal by Subject|0|||
33600975|NCT02654236|102091766|FG001|Overall Study|Withdrawal by Subject|0|||
33600976|NCT02654236|102091767|FG002|Overall Study|Withdrawal by Subject|2|||
33600977|NCT00316888|102091768|FG000|Overall Study|Adverse Event|4|||
33600978|NCT00316888|102091769|FG001|Overall Study|Adverse Event|5|||
33600979|NCT00316888|102091768|FG000|Overall Study|Withdrawal by Subject|2|||
33600980|NCT00316888|102091769|FG001|Overall Study|Withdrawal by Subject|2|||
33499075|NCT00838903|101720257|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
33600981|NCT00316888|102091768|FG000|Overall Study|Not start protocol therapy|0|||
33600982|NCT00316888|102091769|FG001|Overall Study|Not start protocol therapy|1|||
33600983|NCT03405935|102091770|FG000|Overall Study|Adverse Event|3|||
33600984|NCT03405935|102091770|FG000|Overall Study|Death|2|||
33600985|NCT03405935|102091770|FG000|Overall Study|Withdrawal by Subject|1|||
33600986|NCT03405935|102091770|FG000|Overall Study|Lost to Follow-up|2|||
33600987|NCT02130986|102091772|FG000|Overall Study|Withdrawal by Subject|4|||
33600988|NCT02130986|102091773|FG001|Overall Study|Withdrawal by Subject|4|||
33191092|NCT02474199|100605121|FG003|Overall Study|Did not meet eligibility criteria|2|||
33306035|NCT00444275|101014286|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
33393733|NCT03073200|101328522|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
33499076|NCT00838903|101720258|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
33499077|NCT00838903|101720259|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
33499078|NCT00838903|101720256|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
33499079|NCT00838903|101720257|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
33499080|NCT00838903|101720258|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
33499081|NCT00838903|101720259|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
33600989|NCT02130986|102091772|FG000|Overall Study|Lost to Follow-up|151|||
33600990|NCT02130986|102091773|FG001|Overall Study|Lost to Follow-up|160|||
33600991|NCT02120365|102091774|FG000|Overall Study|Withdrawal by Subject|0|||
33600992|NCT02120365|102091775|FG001|Overall Study|Withdrawal by Subject|0|||
33600993|NCT02120365|102091776|FG002|Overall Study|Withdrawal by Subject|2|||
33600994|NCT02120365|102091777|FG003|Overall Study|Withdrawal by Subject|4|||
33600995|NCT02120365|102091778|FG004|Overall Study|Withdrawal by Subject|0|||
33600996|NCT02120365|102091779|FG005|Overall Study|Withdrawal by Subject|2|||
33393734|NCT03073200|101328523|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33393735|NCT03073200|101328524|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33393736|NCT03073200|101328525|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
33393737|NCT03073200|101328511|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33393738|NCT03073200|101328512|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33499082|NCT00838903|101720256|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
33499083|NCT00838903|101720257|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
33499084|NCT00838903|101720258|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
33499085|NCT00838903|101720259|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
33499086|NCT00838903|101720256|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
33499087|NCT00838903|101720257|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
33499088|NCT00838903|101720258|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
33499089|NCT00838903|101720259|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
33499090|NCT00838903|101720256|FG000|Follow-up Period (8 Weeks)|Missing|1|||
33499091|NCT00838903|101720257|FG001|Follow-up Period (8 Weeks)|Missing|2|||
33499092|NCT00838903|101720258|FG002|Follow-up Period (8 Weeks)|Missing|1|||
33499093|NCT00838903|101720259|FG003|Follow-up Period (8 Weeks)|Missing|1|||
33499094|NCT00288626|101720260|FG000|Overall Study|Death|3|||
33499095|NCT00288626|101720260|FG000|Overall Study|Withdrawal by Subject|4|||
33499096|NCT00364923|101720265|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
33499097|NCT00364923|101720265|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
33499098|NCT03181633|101720266|FG000|Overall Study|Withdrawal by Subject|1|||
33499099|NCT03181633|101720266|FG000|Overall Study|Missing follow-up visit|1|||
33499100|NCT04152837|101720267|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
33499101|NCT04152837|101720267|FG000|Maintenance Period|Adverse Event|1|||
33499102|NCT04152837|101720267|FG000|Maintenance Period|Withdrawal by Subject|1|||
33499103|NCT04152837|101720267|FG000|Maintenance Period|Sponsor Termination of Study|2|||
33499104|NCT00403481|101720278|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
33499105|NCT00403481|101720278|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
33499106|NCT00403481|101720278|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
33499107|NCT00403481|101720278|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
33600997|NCT01145053|102091780|FG000|Overall Study|Adverse Event|22|||
33600998|NCT01145053|102091780|FG000|Overall Study|Lost to Follow-up|28|||
33393739|NCT03073200|101328513|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33393740|NCT03073200|101328514|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33393741|NCT03073200|101328515|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33393742|NCT03073200|101328516|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33393743|NCT03073200|101328517|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33393744|NCT03073200|101328518|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33393745|NCT03073200|101328519|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33393746|NCT03073200|101328520|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33393747|NCT03073200|101328521|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
33393748|NCT03073200|101328522|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
33393749|NCT03073200|101328523|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33393750|NCT03073200|101328524|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33393751|NCT03073200|101328525|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33393752|NCT03073200|101328511|FG000|Randomized Withdrawal Period|Adverse Event|0|||
33393753|NCT03073200|101328512|FG001|Randomized Withdrawal Period|Adverse Event|0|||
33499108|NCT00403481|101720278|FG000|Olm 40 mg|Adverse Event|2|||
33499109|NCT00403481|101720278|FG000|Olm 40 mg|Protocol Violation|1|||
33499110|NCT00403481|101720278|FG000|Olm 40 mg|Withdrawal by Subject|1|||
33499111|NCT00403481|101720278|FG000|Olm 40 mg|Other|1|||
33499112|NCT00403481|101720278|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
33499113|NCT00403481|101720278|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
33499114|NCT00403481|101720278|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
33499115|NCT00403481|101720278|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
33191093|NCT00678561|100605122|FG000|Overall Study|Adverse Event|0|||
33191094|NCT00678561|100605123|FG001|Overall Study|Adverse Event|1|||
33191095|NCT00678561|100605124|FG002|Overall Study|Adverse Event|1|||
33191096|NCT00678561|100605125|FG003|Overall Study|Adverse Event|0|||
33191097|NCT00678561|100605126|FG004|Overall Study|Adverse Event|1|||
33191098|NCT00678561|100605127|FG005|Overall Study|Adverse Event|0|||
33191099|NCT00678561|100605128|FG006|Overall Study|Adverse Event|0|||
33191100|NCT00678561|100605129|FG007|Overall Study|Adverse Event|0|||
33191101|NCT00678561|100605122|FG000|Overall Study|Protocol Violation|0|||
33191102|NCT00678561|100605123|FG001|Overall Study|Protocol Violation|0|||
33191103|NCT00678561|100605124|FG002|Overall Study|Protocol Violation|0|||
33499116|NCT00403481|101720278|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
33191104|NCT00678561|100605125|FG003|Overall Study|Protocol Violation|0|||
33191105|NCT00678561|100605126|FG004|Overall Study|Protocol Violation|1|||
33191106|NCT00678561|100605127|FG005|Overall Study|Protocol Violation|1|||
33191107|NCT00678561|100605128|FG006|Overall Study|Protocol Violation|0|||
33499117|NCT00403481|101720278|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
33191108|NCT00678561|100605129|FG007|Overall Study|Protocol Violation|0|||
33191109|NCT00678561|100605122|FG000|Overall Study|Withdrawal by Subject|0|||
33191110|NCT00678561|100605123|FG001|Overall Study|Withdrawal by Subject|0|||
33191111|NCT00678561|100605124|FG002|Overall Study|Withdrawal by Subject|0|||
33191112|NCT00678561|100605125|FG003|Overall Study|Withdrawal by Subject|0|||
33191113|NCT00678561|100605126|FG004|Overall Study|Withdrawal by Subject|0|||
33191114|NCT00678561|100605127|FG005|Overall Study|Withdrawal by Subject|0|||
33191115|NCT00678561|100605128|FG006|Overall Study|Withdrawal by Subject|0|||
33191116|NCT00678561|100605129|FG007|Overall Study|Withdrawal by Subject|1|||
33191117|NCT00298831|100605132|FG000|Overall Study|Adverse Event|1|||
33191118|NCT00298831|100605132|FG000|Overall Study|Lost to Follow-up|3|||
33191119|NCT00298831|100605132|FG000|Overall Study|Withdrawal by Subject|1|||
33191120|NCT00298831|100605132|FG000|Overall Study|Participants did not receive treatment|27|||
33306036|NCT00444275|101014287|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
33306037|NCT00444275|101014288|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
33306038|NCT00444275|101014289|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
33191121|NCT01631474|100605133|FG000|Overall Study|Lost to Follow-up|8|||
33191122|NCT01631474|100605134|FG001|Overall Study|Lost to Follow-up|5|||
33191123|NCT01631474|100605135|FG002|Overall Study|Lost to Follow-up|7|||
33191124|NCT01631474|100605136|FG003|Overall Study|Lost to Follow-up|5|||
33191125|NCT01631474|100605137|FG004|Overall Study|Lost to Follow-up|5|||
33191126|NCT01631474|100605133|FG000|Overall Study|Withdrawal by Subject|4|||
33191127|NCT01631474|100605134|FG001|Overall Study|Withdrawal by Subject|4|||
33191128|NCT01631474|100605135|FG002|Overall Study|Withdrawal by Subject|2|||
33306039|NCT00444275|101014285|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
33306040|NCT00444275|101014286|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
33499118|NCT01051960|101720279|FG000|Overall Study|Adverse Event|1|||
33600999|NCT01145053|102091780|FG000|Overall Study|Withdrawal by Subject|25|||
33601000|NCT01145053|102091780|FG000|Overall Study|Other|18|||
33601001|NCT00240110|102091781|FG000|Overall Study|Lost to Follow-up|6|||
33601002|NCT00240110|102091782|FG001|Overall Study|Lost to Follow-up|7|||
33601003|NCT00391391|102091783|FG000|Overall Study|Adverse Event|0|||
33601004|NCT00391391|102091784|FG001|Overall Study|Adverse Event|0|||
33601005|NCT00391391|102091785|FG002|Overall Study|Adverse Event|0|||
33601006|NCT00391391|102091786|FG003|Overall Study|Adverse Event|1|||
33601007|NCT00391391|102091783|FG000|Overall Study|Lost to Follow-up|1|||
33601008|NCT00391391|102091784|FG001|Overall Study|Lost to Follow-up|3|||
33601009|NCT00391391|102091785|FG002|Overall Study|Lost to Follow-up|7|||
33601010|NCT00391391|102091786|FG003|Overall Study|Lost to Follow-up|4|||
33601011|NCT00391391|102091783|FG000|Overall Study|Protocol Violation|2|||
33601012|NCT00391391|102091784|FG001|Overall Study|Protocol Violation|3|||
33601013|NCT00391391|102091785|FG002|Overall Study|Protocol Violation|6|||
33601014|NCT00391391|102091786|FG003|Overall Study|Protocol Violation|7|||
33601015|NCT00391391|102091783|FG000|Overall Study|Withdrawal by Subject|6|||
33601016|NCT00391391|102091784|FG001|Overall Study|Withdrawal by Subject|4|||
33191129|NCT01631474|100605136|FG003|Overall Study|Withdrawal by Subject|6|||
33306041|NCT00444275|101014287|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
33601017|NCT00391391|102091785|FG002|Overall Study|Withdrawal by Subject|10|||
33601018|NCT00391391|102091786|FG003|Overall Study|Withdrawal by Subject|7|||
33601019|NCT00969436|102091788|FG000|Overall Study|Protocol Violation|1|||
33601020|NCT00969436|102091789|FG001|Overall Study|Protocol Violation|3|||
33601021|NCT00969436|102091790|FG002|Overall Study|Protocol Violation|0|||
33306042|NCT00444275|101014288|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
33306043|NCT00444275|101014289|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
33306044|NCT01415531|101014292|FG000|Overall Study|Adverse Event|7|||
33306045|NCT01415531|101014293|FG001|Overall Study|Adverse Event|10|||
33306046|NCT01415531|101014292|FG000|Overall Study|Lack of Efficacy|3|||
33306047|NCT01415531|101014293|FG001|Overall Study|Lack of Efficacy|2|||
33306048|NCT01415531|101014292|FG000|Overall Study|Protocol Violation|0|||
33306049|NCT01415531|101014293|FG001|Overall Study|Protocol Violation|1|||
33306050|NCT01415531|101014292|FG000|Overall Study|Withdrawal by Subject|5|||
33499119|NCT03493854|101720280|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
33499120|NCT03493854|101720281|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
33499121|NCT03493854|101720280|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
33499122|NCT03493854|101720281|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
33499123|NCT03493854|101720280|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
33499124|NCT03493854|101720281|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
33499125|NCT03493854|101720280|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
33499126|NCT03493854|101720281|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
33499127|NCT03493854|101720280|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
33499128|NCT03493854|101720281|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
33499129|NCT03493854|101720280|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
33499130|NCT03493854|101720281|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
33499131|NCT03493854|101720280|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
33499132|NCT03493854|101720281|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
33499133|NCT03493854|101720280|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
33499134|NCT03493854|101720281|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
33499135|NCT03493854|101720280|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
33499136|NCT03493854|101720281|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
33499137|NCT03493854|101720280|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
33499138|NCT03493854|101720281|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
33499139|NCT03493854|101720280|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
33499140|NCT03493854|101720281|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
33499141|NCT03493854|101720280|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
33306051|NCT01415531|101014293|FG001|Overall Study|Withdrawal by Subject|4|||
33306052|NCT01415531|101014292|FG000|Overall Study|Lost to Follow-up|6|||
33306053|NCT01415531|101014293|FG001|Overall Study|Lost to Follow-up|14|||
33499142|NCT03493854|101720281|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
33499143|NCT03493854|101720280|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
33499144|NCT03493854|101720281|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
33499145|NCT03493854|101720280|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
33499146|NCT03493854|101720281|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
33499147|NCT03493854|101720280|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
33499148|NCT03493854|101720281|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
33499149|NCT03493854|101720280|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
33499150|NCT03493854|101720281|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
33499151|NCT03493854|101720280|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
33499152|NCT03493854|101720281|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
33499153|NCT03493854|101720280|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
33499154|NCT03493854|101720281|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
33499155|NCT02547428|101720282|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
33499156|NCT02547428|101720283|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
33499157|NCT02547428|101720282|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
33499158|NCT02547428|101720283|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
33499159|NCT02547428|101720282|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
33499160|NCT02547428|101720283|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
33499161|NCT02547428|101720282|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
33499162|NCT02547428|101720283|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
33499163|NCT02547428|101720282|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
33306054|NCT01415531|101014292|FG000|Overall Study|Lack of Compliance|1|||
33306055|NCT01415531|101014293|FG001|Overall Study|Lack of Compliance|4|||
33306056|NCT01415531|101014292|FG000|Overall Study|Other Reasons|3|||
33499164|NCT02547428|101720283|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
33499165|NCT02547428|101720282|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
33499166|NCT02547428|101720283|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
33499167|NCT02547428|101720282|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
33499168|NCT02547428|101720283|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
33306057|NCT01415531|101014293|FG001|Overall Study|Other Reasons|2|||
33306058|NCT01242800|101014294|FG000|Overall Study|Patient refusal|0|||
33306059|NCT01242800|101014295|FG001|Overall Study|Patient refusal|10|||
33306060|NCT01242800|101014294|FG000|Overall Study|Physician Decision|0|||
33306061|NCT01242800|101014295|FG001|Overall Study|Physician Decision|1|||
33306062|NCT01242800|101014294|FG000|Overall Study|Disease progression|0|||
33306063|NCT01242800|101014295|FG001|Overall Study|Disease progression|3|||
33306064|NCT01242800|101014294|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
33306065|NCT01242800|101014295|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
33306066|NCT01242800|101014294|FG000|Overall Study|Reasons not reported|0|||
33306067|NCT01242800|101014295|FG001|Overall Study|Reasons not reported|4|||
33306068|NCT02738203|101014296|FG000|Overall Study|Failed IUD Insertion|2|||
33306069|NCT02738203|101014297|FG001|Overall Study|Failed IUD Insertion|2|||
33306070|NCT02738203|101014296|FG000|Overall Study|Protocol Violation|0|||
33306071|NCT02738203|101014297|FG001|Overall Study|Protocol Violation|1|||
33306072|NCT01888900|101014298|FG000|Overall Study|failed treatment|0|||
33306073|NCT01888900|101014299|FG001|Overall Study|failed treatment|2|||
33306074|NCT00307684|101014300|FG000|Open Label Phase|Lack of Efficacy|0|||
33306075|NCT00307684|101014301|FG001|Open Label Phase|Lack of Efficacy|0|||
33306076|NCT00307684|101014302|FG002|Open Label Phase|Lack of Efficacy|3|||
33306077|NCT00307684|101014300|FG000|Open Label Phase|Adverse Event|0|||
33306078|NCT00307684|101014301|FG001|Open Label Phase|Adverse Event|0|||
33601022|NCT00969436|102091788|FG000|Overall Study|Migrated/moved from study area|12|||
33601023|NCT00969436|102091789|FG001|Overall Study|Migrated/moved from study area|10|||
33601024|NCT00969436|102091790|FG002|Overall Study|Migrated/moved from study area|2|||
33601025|NCT00969436|102091788|FG000|Overall Study|Father - serious health problem|0|||
33306079|NCT00307684|101014302|FG002|Open Label Phase|Adverse Event|16|||
33306080|NCT00307684|101014300|FG000|Open Label Phase|Withdrawal by Subject|0|||
33306081|NCT00307684|101014301|FG001|Open Label Phase|Withdrawal by Subject|0|||
33499169|NCT02547428|101720282|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
33499170|NCT02547428|101720283|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
33499171|NCT01753310|101720284|FG000|Overall Study|Entered into open label extension study|25|||
33499172|NCT01753310|101720285|FG001|Overall Study|Entered into open label extension study|22|||
33499173|NCT01753310|101720284|FG000|Overall Study|Adverse Event|1|||
33499174|NCT01753310|101720285|FG001|Overall Study|Adverse Event|0|||
33499175|NCT01753310|101720284|FG000|Overall Study|Lost to Follow-up|2|||
33499176|NCT01753310|101720285|FG001|Overall Study|Lost to Follow-up|0|||
33499177|NCT01753310|101720284|FG000|Overall Study|Subject decision|2|||
33499178|NCT01753310|101720285|FG001|Overall Study|Subject decision|2|||
33499179|NCT01753310|101720284|FG000|Overall Study|Sponsor decision|1|||
33499180|NCT01753310|101720285|FG001|Overall Study|Sponsor decision|0|||
33499181|NCT01753310|101720284|FG000|Overall Study|Withdrawal by Subject|1|||
33499182|NCT01753310|101720285|FG001|Overall Study|Withdrawal by Subject|0|||
33499183|NCT01017874|101720287|FG000|Overall Study|Withdrawal by Subject|23|||
33601026|NCT00969436|102091789|FG001|Overall Study|Father - serious health problem|0|||
33306082|NCT00307684|101014302|FG002|Open Label Phase|Withdrawal by Subject|15|||
33306083|NCT00307684|101014300|FG000|Open Label Phase|Lost to Follow-up|0|||
33306084|NCT00307684|101014301|FG001|Open Label Phase|Lost to Follow-up|0|||
33306085|NCT00307684|101014302|FG002|Open Label Phase|Lost to Follow-up|11|||
33306086|NCT00307684|101014300|FG000|Open Label Phase|non compliance|0|||
33306087|NCT00307684|101014301|FG001|Open Label Phase|non compliance|0|||
33306088|NCT00307684|101014302|FG002|Open Label Phase|non compliance|5|||
33306089|NCT00307684|101014300|FG000|Open Label Phase|other|0|||
33306090|NCT00307684|101014301|FG001|Open Label Phase|other|0|||
33306091|NCT00307684|101014302|FG002|Open Label Phase|other|6|||
33306092|NCT00307684|101014300|FG000|Double Blind Phase|Lack of Efficacy|2|||
33306093|NCT00307684|101014301|FG001|Double Blind Phase|Lack of Efficacy|5|||
33306094|NCT00307684|101014302|FG002|Double Blind Phase|Lack of Efficacy|0|||
33306095|NCT01080716|101014303|FG000|Part 1|Physician Decision|1|||
33499184|NCT01017874|101720288|FG001|Overall Study|Withdrawal by Subject|20|||
33499185|NCT01017874|101720287|FG000|Overall Study|Sponsor decision|3|||
33499186|NCT01017874|101720288|FG001|Overall Study|Sponsor decision|1|||
33499187|NCT01017874|101720287|FG000|Overall Study|Lost to Follow-up|3|||
33306096|NCT01080716|101014304|FG001|Part 1|Physician Decision|0|||
33306097|NCT01080716|101014305|FG002|Part 1|Physician Decision|0|||
33306098|NCT01080716|101014306|FG003|Part 1|Physician Decision|0|||
33306099|NCT02930226|101014307|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
33306100|NCT02930226|101014308|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
33306101|NCT02930226|101014309|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
33306102|NCT02930226|101014310|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
33499188|NCT01017874|101720288|FG001|Overall Study|Lost to Follow-up|2|||
33499189|NCT01017874|101720287|FG000|Overall Study|Physician Decision|1|||
33499190|NCT01017874|101720288|FG001|Overall Study|Physician Decision|3|||
33499191|NCT01120184|101720293|FG000|Overall Study|Adverse Event|0|||
33499192|NCT01120184|101720294|FG001|Overall Study|Adverse Event|1|||
33499193|NCT01120184|101720295|FG002|Overall Study|Adverse Event|0|||
33499194|NCT01120184|101720293|FG000|Overall Study|Lost to Follow-up|13|||
33499195|NCT01120184|101720294|FG001|Overall Study|Lost to Follow-up|13|||
33499196|NCT01120184|101720295|FG002|Overall Study|Lost to Follow-up|11|||
33499197|NCT01120184|101720293|FG000|Overall Study|Physician Decision|9|||
33499198|NCT01120184|101720294|FG001|Overall Study|Physician Decision|1|||
33499199|NCT01120184|101720295|FG002|Overall Study|Physician Decision|3|||
33499200|NCT01120184|101720293|FG000|Overall Study|Reason not Specified|8|||
33499201|NCT01120184|101720294|FG001|Overall Study|Reason not Specified|3|||
33499202|NCT01120184|101720295|FG002|Overall Study|Reason not Specified|12|||
33306103|NCT02930226|101014311|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
33306104|NCT02930226|101014312|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
33306105|NCT04289051|101014313|FG000|Overall Study|Lost to Follow-up|0|||
33306106|NCT04289051|101014314|FG001|Overall Study|Lost to Follow-up|0|||
33306107|NCT04289051|101014315|FG002|Overall Study|Lost to Follow-up|2|||
33306108|NCT01879722|101014317|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33306109|NCT01879722|101014318|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
33306110|NCT01879722|101014319|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
33499203|NCT01120184|101720293|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
33499204|NCT01120184|101720294|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
33499205|NCT01120184|101720295|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
33499206|NCT01120184|101720293|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
33499207|NCT01120184|101720294|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
33499208|NCT01120184|101720295|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
33499209|NCT01120184|101720293|FG000|Overall Study|Death|170|||
33499210|NCT01120184|101720294|FG001|Overall Study|Death|176|||
33499211|NCT01120184|101720295|FG002|Overall Study|Death|169|||
33499212|NCT01954056|101720296|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
33306111|NCT01879722|101014320|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
33306112|NCT01879722|101014321|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
33306113|NCT01879722|101014322|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
33306114|NCT01879722|101014323|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
33499213|NCT01954056|101720297|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
33499214|NCT01297517|101720299|FG000|Overall Study|Adverse Event|21|||
33499215|NCT01297517|101720300|FG001|Overall Study|Adverse Event|7|||
33499216|NCT01297517|101720301|FG002|Overall Study|Adverse Event|16|||
33499217|NCT01297517|101720299|FG000|Overall Study|Lost to Follow-up|1|||
33499218|NCT01297517|101720300|FG001|Overall Study|Lost to Follow-up|0|||
33499219|NCT01297517|101720301|FG002|Overall Study|Lost to Follow-up|1|||
33499220|NCT01297517|101720299|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
33499221|NCT01297517|101720300|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
33499222|NCT01297517|101720301|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
33499223|NCT01297517|101720299|FG000|Overall Study|Noncompliance|1|||
33499224|NCT01297517|101720300|FG001|Overall Study|Noncompliance|0|||
33499225|NCT01297517|101720301|FG002|Overall Study|Noncompliance|0|||
33499226|NCT01297517|101720299|FG000|Overall Study|Protocol Violation|1|||
33499227|NCT01297517|101720300|FG001|Overall Study|Protocol Violation|1|||
33499228|NCT01297517|101720301|FG002|Overall Study|Protocol Violation|1|||
33499229|NCT01297517|101720299|FG000|Overall Study|Inadequate Control of IOP|1|||
33499230|NCT01297517|101720300|FG001|Overall Study|Inadequate Control of IOP|1|||
33499231|NCT01297517|101720301|FG002|Overall Study|Inadequate Control of IOP|2|||
33499232|NCT00396656|101720302|FG000|First Treatment Period|Withdrawal by Subject|0|||
33499233|NCT00396656|101720303|FG001|First Treatment Period|Withdrawal by Subject|2|||
33499234|NCT00396656|101720302|FG000|Second Treatment Period|Adverse Event|0|||
33499235|NCT00396656|101720303|FG001|Second Treatment Period|Adverse Event|1|||
33499236|NCT03448419|101720304|FG000|Overall Study|Adverse Event|10|||
33499237|NCT03448419|101720305|FG001|Overall Study|Adverse Event|9|||
33601027|NCT00969436|102091790|FG002|Overall Study|Father - serious health problem|1|||
33601028|NCT00969436|102091788|FG000|Overall Study|Parents personal problem|0|||
33601029|NCT00969436|102091789|FG001|Overall Study|Parents personal problem|0|||
33601030|NCT00969436|102091790|FG002|Overall Study|Parents personal problem|1|||
33601031|NCT00969436|102091788|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
33601032|NCT00969436|102091789|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
33601033|NCT00969436|102091790|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
33601034|NCT00969436|102091788|FG000|Overall Study|Withdrawal by Subject|3|||
33601035|NCT00969436|102091789|FG001|Overall Study|Withdrawal by Subject|0|||
33601036|NCT00969436|102091790|FG002|Overall Study|Withdrawal by Subject|2|||
33601037|NCT00969436|102091788|FG000|Overall Study|Lost to Follow-up|8|||
33601038|NCT00969436|102091789|FG001|Overall Study|Lost to Follow-up|8|||
33601039|NCT00969436|102091790|FG002|Overall Study|Lost to Follow-up|5|||
33601040|NCT00613080|102091795|FG000|Overall Study|Ineligible / no protocol treatment|11|||
33601041|NCT01253265|102091796|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
33601042|NCT01253265|102091797|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
33601043|NCT01253265|102091798|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
33601044|NCT01253265|102091799|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
33601045|NCT01253265|102091800|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
33601046|NCT01253265|102091796|FG000|Overall Study|Withdrawal by Subject|0|||
33601047|NCT01253265|102091797|FG001|Overall Study|Withdrawal by Subject|0|||
33601048|NCT01253265|102091798|FG002|Overall Study|Withdrawal by Subject|0|||
33601049|NCT01253265|102091799|FG003|Overall Study|Withdrawal by Subject|0|||
33601050|NCT01253265|102091800|FG004|Overall Study|Withdrawal by Subject|1|||
33601051|NCT00946322|102091801|FG000|Pre-treatment|participant failure to follow up|1|||
33601052|NCT00946322|102091801|FG000|Post-treatment|participant failure to follow up|2|||
33601053|NCT00711113|102091802|FG000|Overall Study|Lost to Follow-up|9|||
33601054|NCT00711113|102091802|FG000|Overall Study|Implant lost|2|||
33601055|NCT00886119|102091803|FG000|Period 1|Did not meet inclusion criteria|1|||
33601056|NCT00886119|102091804|FG001|Period 1|Did not meet inclusion criteria|0|||
33601057|NCT00320372|102091805|FG000|Overall Study|Physician Decision|4|||
33601058|NCT00320372|102091806|FG001|Overall Study|Physician Decision|7|||
33601059|NCT00320372|102091805|FG000|Overall Study|Death|7|||
33601060|NCT00320372|102091806|FG001|Overall Study|Death|8|||
33224255|NCT01672853|100721766|FG002|Overall Study|Withdrew Consent|5|||
33306115|NCT01879722|101014324|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
33306116|NCT01879722|101014325|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
33306117|NCT01879722|101014326|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
33499238|NCT03448419|101720304|FG000|Overall Study|Lost to Follow-up|0|||
33499239|NCT03448419|101720305|FG001|Overall Study|Lost to Follow-up|2|||
33499240|NCT03448419|101720304|FG000|Overall Study|Withdrawal by Subject|3|||
33499241|NCT03448419|101720305|FG001|Overall Study|Withdrawal by Subject|1|||
33499242|NCT03448419|101720304|FG000|Overall Study|Not treated|0|||
33499243|NCT03448419|101720305|FG001|Overall Study|Not treated|1|||
33499244|NCT03448419|101720304|FG000|Overall Study|Patient did not attend all visits|0|||
33601061|NCT00320372|102091805|FG000|Overall Study|Withdrawal by Subject|55|||
33499245|NCT03448419|101720305|FG001|Overall Study|Patient did not attend all visits|2|||
33499246|NCT03448419|101720304|FG000|Overall Study|Withdrawn by Sponsor|0|||
33499247|NCT03448419|101720305|FG001|Overall Study|Withdrawn by Sponsor|1|||
33499248|NCT02169271|101720306|FG000|Overall Study|Protocol Violation|1|||
33499249|NCT02169271|101720307|FG001|Overall Study|Protocol Violation|2|||
33499250|NCT00318474|101720310|FG000|Overall Study|Adverse Event|1|||
33306118|NCT01879722|101014317|FG000|Overall Study|Voluntary Withdrawal|0|||
33306119|NCT01879722|101014318|FG001|Overall Study|Voluntary Withdrawal|0|||
33191130|NCT01631474|100605137|FG004|Overall Study|Withdrawal by Subject|5|||
33191131|NCT01631474|100605133|FG000|Overall Study|Lack of Efficacy|2|||
33191132|NCT01631474|100605134|FG001|Overall Study|Lack of Efficacy|2|||
33191133|NCT01631474|100605135|FG002|Overall Study|Lack of Efficacy|0|||
33191134|NCT01631474|100605136|FG003|Overall Study|Lack of Efficacy|0|||
33191135|NCT01631474|100605137|FG004|Overall Study|Lack of Efficacy|2|||
33191136|NCT01631474|100605133|FG000|Overall Study|Noncompliance with Study Drug|0|||
33191137|NCT01631474|100605134|FG001|Overall Study|Noncompliance with Study Drug|0|||
33191138|NCT01631474|100605135|FG002|Overall Study|Noncompliance with Study Drug|0|||
33191139|NCT01631474|100605136|FG003|Overall Study|Noncompliance with Study Drug|0|||
33191140|NCT01631474|100605137|FG004|Overall Study|Noncompliance with Study Drug|1|||
33191141|NCT01631474|100605133|FG000|Overall Study|Adverse Event|0|||
33191142|NCT01631474|100605134|FG001|Overall Study|Adverse Event|1|||
33191143|NCT01631474|100605135|FG002|Overall Study|Adverse Event|0|||
33191144|NCT01631474|100605136|FG003|Overall Study|Adverse Event|0|||
33191145|NCT01631474|100605137|FG004|Overall Study|Adverse Event|0|||
33191146|NCT01340976|100605138|FG000|Overall Study|Physician Decision|2|||
33191147|NCT01340976|100605139|FG001|Overall Study|Physician Decision|0|||
33191148|NCT01340976|100605140|FG002|Overall Study|Physician Decision|1|||
33306120|NCT01879722|101014319|FG002|Overall Study|Voluntary Withdrawal|0|||
33306121|NCT01879722|101014320|FG003|Overall Study|Voluntary Withdrawal|0|||
33306122|NCT01879722|101014321|FG004|Overall Study|Voluntary Withdrawal|0|||
33306123|NCT01879722|101014322|FG005|Overall Study|Voluntary Withdrawal|0|||
33306124|NCT01879722|101014323|FG006|Overall Study|Voluntary Withdrawal|0|||
33306125|NCT01879722|101014324|FG007|Overall Study|Voluntary Withdrawal|0|||
33306126|NCT01879722|101014325|FG008|Overall Study|Voluntary Withdrawal|1|||
33306127|NCT01879722|101014326|FG009|Overall Study|Voluntary Withdrawal|0|||
33306128|NCT01757197|101014327|FG000|Overall Study|Death|2|||
33306129|NCT01302067|101014328|FG000|Overall Study|Death|0|||
33306130|NCT01302067|101014329|FG001|Overall Study|Death|0|||
33306131|NCT01302067|101014330|FG002|Overall Study|Death|1|||
33306132|NCT01302067|101014328|FG000|Overall Study|Physician Decision|9|||
33306133|NCT01302067|101014329|FG001|Overall Study|Physician Decision|5|||
33306134|NCT01302067|101014330|FG002|Overall Study|Physician Decision|14|||
33306135|NCT01302067|101014328|FG000|Overall Study|Lack of Efficacy|8|||
33306136|NCT01302067|101014329|FG001|Overall Study|Lack of Efficacy|4|||
33306137|NCT01302067|101014330|FG002|Overall Study|Lack of Efficacy|2|||
33306138|NCT01302067|101014328|FG000|Overall Study|Lost to Follow-up|9|||
33306139|NCT01302067|101014329|FG001|Overall Study|Lost to Follow-up|4|||
33499251|NCT00318474|101720311|FG001|Overall Study|Adverse Event|1|||
33499252|NCT00318474|101720310|FG000|Overall Study|Lost to Follow-up|0|||
33499253|NCT00318474|101720311|FG001|Overall Study|Lost to Follow-up|1|||
33499254|NCT00318474|101720310|FG000|Overall Study|Pregnancy|0|||
33499255|NCT00318474|101720311|FG001|Overall Study|Pregnancy|2|||
33499256|NCT00318474|101720310|FG000|Overall Study|Protocol Violation|1|||
33499257|NCT00318474|101720311|FG001|Overall Study|Protocol Violation|0|||
33499258|NCT00318474|101720310|FG000|Overall Study|Withdrawal by Subject|3|||
33499259|NCT00318474|101720311|FG001|Overall Study|Withdrawal by Subject|2|||
33306140|NCT01302067|101014330|FG002|Overall Study|Lost to Follow-up|15|||
33306141|NCT01302067|101014328|FG000|Overall Study|Withdrawal by Subject|13|||
33191149|NCT01340976|100605141|FG003|Overall Study|Physician Decision|1|||
33306142|NCT01302067|101014329|FG001|Overall Study|Withdrawal by Subject|6|||
33191150|NCT01340976|100605142|FG004|Overall Study|Physician Decision|1|||
33306143|NCT01302067|101014330|FG002|Overall Study|Withdrawal by Subject|10|||
33499260|NCT00318474|101720310|FG000|Overall Study|Fall in GFR|3|||
33499261|NCT00318474|101720311|FG001|Overall Study|Fall in GFR|3|||
33499262|NCT00318474|101720310|FG000|Overall Study|Post-therapy hyperflycemia|0|||
33499263|NCT00318474|101720311|FG001|Overall Study|Post-therapy hyperflycemia|1|||
33306144|NCT01302067|101014328|FG000|Overall Study|Other|1|||
33306145|NCT01302067|101014329|FG001|Overall Study|Other|1|||
33306146|NCT01302067|101014330|FG002|Overall Study|Other|3|||
33306147|NCT01302067|101014328|FG000|Overall Study|Protocol Violation|11|||
33306148|NCT01302067|101014329|FG001|Overall Study|Protocol Violation|0|||
33306149|NCT01302067|101014330|FG002|Overall Study|Protocol Violation|8|||
33306150|NCT01302067|101014328|FG000|Overall Study|Adverse Event|27|||
33306151|NCT01302067|101014329|FG001|Overall Study|Adverse Event|14|||
33306152|NCT01302067|101014330|FG002|Overall Study|Adverse Event|45|||
33306153|NCT01796548|101014331|FG000|Overall Study|Lost to Follow-up|1|||
33306154|NCT01796548|101014331|FG000|Overall Study|Other|2|||
33306155|NCT01353859|101014332|FG000|Overall Study|Adverse Event|3|||
33306156|NCT01353859|101014332|FG000|Overall Study|Lack of Efficacy|1|||
33306157|NCT00297427|101014333|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
33306158|NCT00297427|101014334|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
33306159|NCT00297427|101014333|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
33306160|NCT00297427|101014334|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
33306161|NCT00297427|101014333|FG000|Phase 1: Initial Intervention|Death|0|||
33306162|NCT00297427|101014334|FG001|Phase 1: Initial Intervention|Death|1|||
33306163|NCT00297427|101014333|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
33306164|NCT00297427|101014334|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
33306165|NCT00297427|101014333|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
33306166|NCT00297427|101014334|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
33306167|NCT00297427|101014333|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
33306168|NCT00297427|101014334|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
33306169|NCT00297427|101014333|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
33306170|NCT00297427|101014334|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
33306171|NCT00297427|101014333|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
33306172|NCT00297427|101014334|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
33499264|NCT00318474|101720310|FG000|Overall Study|Trial terminated|10|||
33499265|NCT00318474|101720311|FG001|Overall Study|Trial terminated|7|||
33499266|NCT00824772|101720312|FG000|Overall Study|Withdrawal by Subject|8|||
33499267|NCT02572570|101720316|FG000|Overall Study|Study Terminated|27|||
33499268|NCT04565145|101720322|FG000|Overall Study|Withdrawal by Subject|1|||
33499269|NCT04565145|101720323|FG001|Overall Study|Withdrawal by Subject|1|||
33499270|NCT02801617|101720325|FG000|Overall Study|Protocol Violation|2|||
33499271|NCT02801617|101720326|FG001|Overall Study|Protocol Violation|6|||
33499272|NCT04021914|101720327|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
33499273|NCT00813150|101720328|FG000|Treatment Period|Adverse Event|16|||
33306173|NCT04811131|101014335|FG000|Overall Study|Adverse Event|0|||
33306174|NCT04811131|101014336|FG001|Overall Study|Adverse Event|0|||
33306175|NCT04811131|101014337|FG002|Overall Study|Adverse Event|1|||
33306176|NCT04811131|101014338|FG003|Overall Study|Adverse Event|0|||
33306177|NCT04811131|101014335|FG000|Overall Study|Lack of Efficacy|0|||
33306178|NCT04811131|101014336|FG001|Overall Study|Lack of Efficacy|0|||
33499274|NCT00813150|101720329|FG001|Treatment Period|Adverse Event|15|||
33306179|NCT04811131|101014337|FG002|Overall Study|Lack of Efficacy|0|||
33306180|NCT04811131|101014338|FG003|Overall Study|Lack of Efficacy|1|||
33306181|NCT04811131|101014335|FG000|Overall Study|Lost to Follow-up|0|||
33306182|NCT04811131|101014336|FG001|Overall Study|Lost to Follow-up|1|||
33306183|NCT04811131|101014337|FG002|Overall Study|Lost to Follow-up|0|||
33306184|NCT04811131|101014338|FG003|Overall Study|Lost to Follow-up|0|||
33306185|NCT04811131|101014335|FG000|Overall Study|Sponsor request|31|||
33306186|NCT04811131|101014336|FG001|Overall Study|Sponsor request|35|||
33306187|NCT04811131|101014337|FG002|Overall Study|Sponsor request|27|||
33306188|NCT04811131|101014338|FG003|Overall Study|Sponsor request|10|||
33306189|NCT04811131|101014335|FG000|Overall Study|Withdrawal by Subject|3|||
33306190|NCT04811131|101014336|FG001|Overall Study|Withdrawal by Subject|1|||
33306191|NCT04811131|101014337|FG002|Overall Study|Withdrawal by Subject|3|||
33306192|NCT04811131|101014338|FG003|Overall Study|Withdrawal by Subject|1|||
33393754|NCT03073200|101328513|FG002|Randomized Withdrawal Period|Adverse Event|0|||
33393755|NCT03073200|101328514|FG003|Randomized Withdrawal Period|Adverse Event|0|||
33306193|NCT00836745|101014339|FG000|Overall Study|Death|2|||
33306194|NCT00836745|101014339|FG000|Overall Study|Lost to Follow-up|10|||
33393756|NCT03073200|101328515|FG004|Randomized Withdrawal Period|Adverse Event|0|||
33306195|NCT00836745|101014339|FG000|Overall Study|Adverse Event|3|||
33306196|NCT00836745|101014339|FG000|Overall Study|Objective progression or relapse|4|||
33306197|NCT00836745|101014339|FG000|Overall Study|Other|2|||
33306198|NCT00621777|101014340|FG000|Open Phase|Adverse Event|20|||
33306199|NCT00621777|101014341|FG001|Open Phase|Adverse Event|0|||
33306200|NCT00621777|101014340|FG000|Open Phase|Did not abstain during open phase|56|||
33306201|NCT00621777|101014341|FG001|Open Phase|Did not abstain during open phase|0|||
33393757|NCT03073200|101328516|FG005|Randomized Withdrawal Period|Adverse Event|0|||
33393758|NCT03073200|101328517|FG006|Randomized Withdrawal Period|Adverse Event|0|||
33393759|NCT03073200|101328518|FG007|Randomized Withdrawal Period|Adverse Event|0|||
33306202|NCT00621777|101014340|FG000|Open Phase|Withdrawal by Subject|17|||
33306203|NCT00621777|101014341|FG001|Open Phase|Withdrawal by Subject|0|||
33306204|NCT00621777|101014340|FG000|Open Phase|administrative|13|||
33306205|NCT00621777|101014341|FG001|Open Phase|administrative|0|||
33306206|NCT00621777|101014340|FG000|Open Phase|Lost to Follow-up|10|||
33601062|NCT00320372|102091806|FG001|Overall Study|Withdrawal by Subject|37|||
33601063|NCT00320372|102091805|FG000|Overall Study|Non-Compliance|40|||
33191151|NCT01340976|100605143|FG005|Overall Study|Physician Decision|0|||
33191152|NCT01340976|100605138|FG000|Overall Study|Death|0|||
33191153|NCT01340976|100605139|FG001|Overall Study|Death|1|||
33191154|NCT01340976|100605140|FG002|Overall Study|Death|0|||
33191155|NCT01340976|100605141|FG003|Overall Study|Death|0|||
33191156|NCT01340976|100605142|FG004|Overall Study|Death|0|||
33191157|NCT01340976|100605143|FG005|Overall Study|Death|0|||
33191158|NCT01340976|100605138|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
33191159|NCT01340976|100605139|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
33191160|NCT01340976|100605140|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
33191161|NCT01340976|100605141|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
33191162|NCT01340976|100605142|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
33191163|NCT01340976|100605143|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
33191164|NCT01340976|100605138|FG000|Overall Study|Withdrawal by Subject|0|||
33191165|NCT01340976|100605139|FG001|Overall Study|Withdrawal by Subject|0|||
33191166|NCT01340976|100605140|FG002|Overall Study|Withdrawal by Subject|0|||
33191167|NCT01340976|100605141|FG003|Overall Study|Withdrawal by Subject|1|||
33191168|NCT01340976|100605142|FG004|Overall Study|Withdrawal by Subject|1|||
33191169|NCT01340976|100605143|FG005|Overall Study|Withdrawal by Subject|0|||
33191170|NCT01340976|100605138|FG000|Overall Study|Other anemia treatment|1|||
33191171|NCT01340976|100605139|FG001|Overall Study|Other anemia treatment|0|||
33191172|NCT01340976|100605140|FG002|Overall Study|Other anemia treatment|2|||
33191173|NCT01340976|100605141|FG003|Overall Study|Other anemia treatment|1|||
33191174|NCT01340976|100605142|FG004|Overall Study|Other anemia treatment|0|||
33191175|NCT01340976|100605143|FG005|Overall Study|Other anemia treatment|1|||
33191176|NCT01340976|100605138|FG000|Overall Study|Adverse Event|0|||
33191177|NCT01340976|100605139|FG001|Overall Study|Adverse Event|1|||
33191178|NCT01340976|100605140|FG002|Overall Study|Adverse Event|0|||
33191179|NCT01340976|100605141|FG003|Overall Study|Adverse Event|0|||
33191180|NCT01340976|100605142|FG004|Overall Study|Adverse Event|0|||
33191181|NCT01340976|100605143|FG005|Overall Study|Adverse Event|0|||
33191182|NCT01723228|100605144|FG000|Overall Study|Adverse Event|2|||
33191183|NCT01723228|100605145|FG001|Overall Study|Adverse Event|6|||
33191184|NCT01723228|100605144|FG000|Overall Study|Withdrawal by Subject|2|||
33191185|NCT01723228|100605145|FG001|Overall Study|Withdrawal by Subject|1|||
33191186|NCT01723228|100605144|FG000|Overall Study|Protocol Violation|0|||
33191187|NCT01723228|100605145|FG001|Overall Study|Protocol Violation|2|||
33191188|NCT01723228|100605144|FG000|Overall Study|Lost to Follow-up|2|||
33306207|NCT00621777|101014341|FG001|Open Phase|Lost to Follow-up|0|||
33601064|NCT00320372|102091806|FG001|Overall Study|Non-Compliance|39|||
33601065|NCT00320372|102091805|FG000|Overall Study|Did not Meet (I/E)|3|||
33601066|NCT00320372|102091806|FG001|Overall Study|Did not Meet (I/E)|1|||
33191189|NCT01723228|100605145|FG001|Overall Study|Lost to Follow-up|1|||
33191190|NCT01723228|100605144|FG000|Overall Study|Other|2|||
33306208|NCT00621777|101014340|FG000|Randomized Phase|Adverse Event|3|||
33306209|NCT00621777|101014341|FG001|Randomized Phase|Adverse Event|3|||
33306210|NCT00621777|101014340|FG000|Randomized Phase|Lost to Follow-up|3|||
33601067|NCT00320372|102091805|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
33601068|NCT00320372|102091806|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
33601069|NCT00711802|102091807|FG000|Overall Study|Not treated (no further detail)|2|||
33601070|NCT00711802|102091808|FG001|Overall Study|Not treated (no further detail)|1|||
33601071|NCT00711802|102091809|FG002|Overall Study|Not treated (no further detail)|2|||
33601072|NCT00711802|102091810|FG003|Overall Study|Not treated (no further detail)|0|||
33601073|NCT00711802|102091811|FG004|Overall Study|Not treated (no further detail)|2|||
33601074|NCT00711802|102091812|FG005|Overall Study|Not treated (no further detail)|0|||
33191191|NCT01723228|100605145|FG001|Overall Study|Other|1|||
33191192|NCT00480636|100605146|FG000|Overall Study|Death|12|||
33191193|NCT00480636|100605146|FG000|Overall Study|Lost to Follow-up|4|||
33306211|NCT00621777|101014341|FG001|Randomized Phase|Lost to Follow-up|3|||
33306212|NCT00621777|101014340|FG000|Randomized Phase|Withdrawal by Subject|1|||
33306213|NCT00621777|101014341|FG001|Randomized Phase|Withdrawal by Subject|9|||
33306214|NCT00621777|101014340|FG000|Randomized Phase|administrative|0|||
33306215|NCT00621777|101014341|FG001|Randomized Phase|administrative|3|||
33306216|NCT00621777|101014340|FG000|Randomized Phase|Death|0|||
33499275|NCT00813150|101720328|FG000|Treatment Period|Death|2|||
33499276|NCT00813150|101720329|FG001|Treatment Period|Death|0|||
33499277|NCT00813150|101720328|FG000|Treatment Period|Progressive disease|1|||
33499278|NCT00813150|101720329|FG001|Treatment Period|Progressive disease|0|||
33499279|NCT00813150|101720328|FG000|Treatment Period|Complete response|0|||
33499280|NCT00813150|101720329|FG001|Treatment Period|Complete response|1|||
33499281|NCT00813150|101720328|FG000|Treatment Period|Stable disease|1|||
33499282|NCT00813150|101720329|FG001|Treatment Period|Stable disease|2|||
33499283|NCT00813150|101720328|FG000|Treatment Period|Protocol Violation|3|||
33499284|NCT00813150|101720329|FG001|Treatment Period|Protocol Violation|4|||
33499285|NCT00813150|101720328|FG000|Treatment Period|Withdrawal by Subject|5|||
33499286|NCT00813150|101720329|FG001|Treatment Period|Withdrawal by Subject|3|||
33499287|NCT00813150|101720328|FG000|Treatment Period|Non compliance|0|||
33499288|NCT00813150|101720329|FG001|Treatment Period|Non compliance|1|||
33499289|NCT00813150|101720328|FG000|Treatment Period|Reason not specified|3|||
33499290|NCT00813150|101720329|FG001|Treatment Period|Reason not specified|4|||
33191194|NCT00480636|100605146|FG000|Overall Study|Other|2|||
33191195|NCT00480636|100605146|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
33191196|NCT00463060|100605147|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
33191197|NCT00463060|100605147|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
33191198|NCT01921829|100605148|FG000|Overall Study|Withdrawal by Subject|0|||
33191199|NCT01921829|100605149|FG001|Overall Study|Withdrawal by Subject|1|||
33191200|NCT03400033|100605154|FG000|Overall Study|Withdrawal by Subject|1|||
33191201|NCT03400033|100605155|FG001|Overall Study|Withdrawal by Subject|2|||
33191202|NCT04497987|100605156|FG000|Overall Study|Adverse Event|1|||
33191203|NCT04497987|100605157|FG001|Overall Study|Adverse Event|0|||
33191204|NCT04497987|100605156|FG000|Overall Study|Death|21|||
33499291|NCT00813150|101720328|FG000|Treatment Period|Data not available|1|||
33499292|NCT00813150|101720329|FG001|Treatment Period|Data not available|2|||
33499293|NCT00813150|101720328|FG000|Long Term Follow-up|Death|0|||
33499294|NCT00813150|101720329|FG001|Long Term Follow-up|Death|4|||
33191205|NCT04497987|100605157|FG001|Overall Study|Death|13|||
33191206|NCT04497987|100605156|FG000|Overall Study|Lost to Follow-up|19|||
33191207|NCT04497987|100605157|FG001|Overall Study|Lost to Follow-up|17|||
33191208|NCT04497987|100605156|FG000|Overall Study|Other - as reported by the investigator|22|||
33191209|NCT04497987|100605157|FG001|Overall Study|Other - as reported by the investigator|16|||
33191210|NCT04497987|100605156|FG000|Overall Study|Physician Decision|1|||
33191211|NCT04497987|100605157|FG001|Overall Study|Physician Decision|0|||
33191212|NCT04497987|100605156|FG000|Overall Study|Withdrawal by Subject|35|||
33191213|NCT04497987|100605157|FG001|Overall Study|Withdrawal by Subject|21|||
33191214|NCT02711800|100605161|FG000|Overall Study|Lost to Follow-up|1|||
33191215|NCT02711800|100605161|FG000|Overall Study|Withdrawal by Subject|1|||
33191216|NCT00699972|100605165|FG000|Overall Study|Adverse Event|7|||
33191217|NCT00699972|100605166|FG001|Overall Study|Adverse Event|9|||
33191218|NCT00699972|100605167|FG002|Overall Study|Adverse Event|24|||
33191219|NCT00699972|100605165|FG000|Overall Study|Lost to Follow-up|0|||
33191220|NCT00699972|100605166|FG001|Overall Study|Lost to Follow-up|2|||
33191221|NCT00699972|100605167|FG002|Overall Study|Lost to Follow-up|0|||
33191222|NCT00699972|100605165|FG000|Overall Study|Withdrawal by Subject|3|||
33191223|NCT00699972|100605166|FG001|Overall Study|Withdrawal by Subject|7|||
33191224|NCT00699972|100605167|FG002|Overall Study|Withdrawal by Subject|4|||
33191225|NCT00699972|100605165|FG000|Overall Study|Lack of Efficacy|2|||
33191226|NCT00699972|100605166|FG001|Overall Study|Lack of Efficacy|0|||
33191227|NCT00699972|100605167|FG002|Overall Study|Lack of Efficacy|2|||
33191228|NCT00699972|100605165|FG000|Overall Study|Administrative/Other|3|||
33191229|NCT00699972|100605166|FG001|Overall Study|Administrative/Other|1|||
33191230|NCT00699972|100605167|FG002|Overall Study|Administrative/Other|4|||
33191231|NCT00699972|100605165|FG000|Overall Study|Randomized, Not Treated|1|||
33191232|NCT00699972|100605166|FG001|Overall Study|Randomized, Not Treated|0|||
33191233|NCT00699972|100605167|FG002|Overall Study|Randomized, Not Treated|1|||
33191234|NCT03491150|100605168|FG000|Overall Study|Adverse Event|1|||
33191235|NCT03491150|100605169|FG001|Overall Study|Adverse Event|0|||
33191236|NCT03491150|100605168|FG000|Overall Study|Study Terminated by Sponsor|74|||
33306217|NCT00621777|101014341|FG001|Randomized Phase|Death|1|||
33306218|NCT00379288|101014343|FG000|Overall Study|Adverse Event|5|||
33499295|NCT00813150|101720328|FG000|Long Term Follow-up|Other|0|||
33499296|NCT00813150|101720329|FG001|Long Term Follow-up|Other|3|||
33191237|NCT03491150|100605169|FG001|Overall Study|Study Terminated by Sponsor|70|||
33191238|NCT03491150|100605168|FG000|Overall Study|Other|0|||
33191239|NCT03491150|100605169|FG001|Overall Study|Other|1|||
33499297|NCT00813150|101720328|FG000|Long Term Follow-up|Lost to Follow-up|2|||
33306219|NCT00379288|101014344|FG001|Overall Study|Adverse Event|6|||
33306220|NCT00379288|101014345|FG002|Overall Study|Adverse Event|2|||
33306221|NCT00379288|101014346|FG003|Overall Study|Adverse Event|0|||
33306222|NCT00379288|101014343|FG000|Overall Study|Treatment Failure|0|||
33306223|NCT00379288|101014344|FG001|Overall Study|Treatment Failure|1|||
33306224|NCT00379288|101014345|FG002|Overall Study|Treatment Failure|0|||
33306225|NCT00379288|101014346|FG003|Overall Study|Treatment Failure|1|||
33306226|NCT00379288|101014343|FG000|Overall Study|Lost to Follow-up|3|||
33306227|NCT00379288|101014344|FG001|Overall Study|Lost to Follow-up|3|||
33306228|NCT00379288|101014345|FG002|Overall Study|Lost to Follow-up|2|||
33306229|NCT00379288|101014346|FG003|Overall Study|Lost to Follow-up|0|||
33306230|NCT00379288|101014343|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
33306231|NCT00379288|101014344|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
33306232|NCT00379288|101014345|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
33306233|NCT00379288|101014346|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
33306234|NCT00379288|101014343|FG000|Overall Study|Subject withdrew-related to study drug|1|||
33306235|NCT00379288|101014344|FG001|Overall Study|Subject withdrew-related to study drug|0|||
33306236|NCT00379288|101014345|FG002|Overall Study|Subject withdrew-related to study drug|0|||
33306237|NCT00379288|101014346|FG003|Overall Study|Subject withdrew-related to study drug|1|||
33306238|NCT00379288|101014343|FG000|Overall Study|Noncompliance with protocol|8|||
33306239|NCT00379288|101014344|FG001|Overall Study|Noncompliance with protocol|6|||
33306240|NCT00379288|101014345|FG002|Overall Study|Noncompliance with protocol|2|||
33306241|NCT00379288|101014346|FG003|Overall Study|Noncompliance with protocol|1|||
33306242|NCT00379288|101014343|FG000|Overall Study|Did not meet protocol eligibility|0|||
33306243|NCT00379288|101014344|FG001|Overall Study|Did not meet protocol eligibility|1|||
33306244|NCT00379288|101014345|FG002|Overall Study|Did not meet protocol eligibility|0|||
33306245|NCT00379288|101014346|FG003|Overall Study|Did not meet protocol eligibility|2|||
33306246|NCT00379288|101014343|FG000|Overall Study|Administrative|2|||
33306247|NCT00379288|101014344|FG001|Overall Study|Administrative|2|||
33306248|NCT00379288|101014345|FG002|Overall Study|Administrative|0|||
33306249|NCT00379288|101014346|FG003|Overall Study|Administrative|1|||
33306250|NCT03248492|101014347|FG000|Overall Study|Ongoing|23|||
33306251|NCT03248492|101014348|FG001|Overall Study|Ongoing|26|||
33306252|NCT03248492|101014349|FG002|Overall Study|Ongoing|3|||
33306253|NCT03248492|101014350|FG003|Overall Study|Ongoing|85|||
33306254|NCT03248492|101014351|FG004|Overall Study|Ongoing|2|||
33306255|NCT03248492|101014347|FG000|Overall Study|Progressive disease per RECIST v1.1|16|||
33306256|NCT03248492|101014348|FG001|Overall Study|Progressive disease per RECIST v1.1|12|||
33306257|NCT03248492|101014349|FG002|Overall Study|Progressive disease per RECIST v1.1|9|||
33306258|NCT03248492|101014350|FG003|Overall Study|Progressive disease per RECIST v1.1|22|||
33306259|NCT03248492|101014351|FG004|Overall Study|Progressive disease per RECIST v1.1|0|||
33306260|NCT03248492|101014347|FG000|Overall Study|Adverse Event|6|||
33306261|NCT03248492|101014348|FG001|Overall Study|Adverse Event|6|||
33306262|NCT03248492|101014349|FG002|Overall Study|Adverse Event|8|||
33191240|NCT03491150|100605168|FG000|Overall Study|Withdrawal by Subject|1|||
33191241|NCT03491150|100605169|FG001|Overall Study|Withdrawal by Subject|2|||
33191242|NCT01337297|100605170|FG000|Overall Study|They entered to single anodal tDCS|4|||
33191243|NCT01337297|100605171|FG001|Overall Study|They entered to single anodal tDCS|3|||
33191244|NCT01337297|100605170|FG000|Overall Study|Lost to Follow-up|1|||
33191245|NCT01337297|100605171|FG001|Overall Study|Lost to Follow-up|3|||
33191246|NCT00094653|100605172|FG000|Overall Study|Death|306|||
33191247|NCT00094653|100605173|FG001|Overall Study|Death|100|||
33191248|NCT00094653|100605174|FG002|Overall Study|Death|119|||
33191249|NCT00094653|100605172|FG000|Overall Study|Subject Withdrew Consent|10|||
33191250|NCT00094653|100605173|FG001|Overall Study|Subject Withdrew Consent|2|||
33191251|NCT00094653|100605174|FG002|Overall Study|Subject Withdrew Consent|3|||
33191252|NCT00094653|100605172|FG000|Overall Study|Other|2|||
33191253|NCT00094653|100605173|FG001|Overall Study|Other|2|||
33191254|NCT00094653|100605174|FG002|Overall Study|Other|2|||
33191255|NCT00094653|100605172|FG000|Overall Study|Lost to Follow-up|3|||
33191256|NCT00094653|100605173|FG001|Overall Study|Lost to Follow-up|2|||
33191257|NCT00094653|100605174|FG002|Overall Study|Lost to Follow-up|1|||
33191258|NCT00094653|100605172|FG000|Overall Study|Protocol Violation|0|||
33191259|NCT00094653|100605173|FG001|Overall Study|Protocol Violation|0|||
33191260|NCT00094653|100605174|FG002|Overall Study|Protocol Violation|1|||
33499298|NCT00813150|101720329|FG001|Long Term Follow-up|Lost to Follow-up|0|||
33191261|NCT00528528|100605175|FG000|Overall Study|Lost to Follow-up|0|||
33306263|NCT03248492|101014350|FG003|Overall Study|Adverse Event|8|||
33306264|NCT03248492|101014351|FG004|Overall Study|Adverse Event|1|||
33306265|NCT03248492|101014347|FG000|Overall Study|Withdrawal by Subject|3|||
33306266|NCT03248492|101014348|FG001|Overall Study|Withdrawal by Subject|3|||
33306267|NCT03248492|101014349|FG002|Overall Study|Withdrawal by Subject|0|||
33306268|NCT03248492|101014350|FG003|Overall Study|Withdrawal by Subject|3|||
33306269|NCT03248492|101014351|FG004|Overall Study|Withdrawal by Subject|1|||
33306270|NCT03248492|101014347|FG000|Overall Study|Physician Decision|1|||
33191262|NCT00528528|100605176|FG001|Overall Study|Lost to Follow-up|0|||
33306271|NCT03248492|101014348|FG001|Overall Study|Physician Decision|0|||
33306272|NCT03248492|101014349|FG002|Overall Study|Physician Decision|1|||
33306273|NCT03248492|101014350|FG003|Overall Study|Physician Decision|2|||
33306274|NCT03248492|101014351|FG004|Overall Study|Physician Decision|0|||
33306275|NCT03248492|101014347|FG000|Overall Study|Death|1|||
33306276|NCT03248492|101014348|FG001|Overall Study|Death|0|||
33306277|NCT03248492|101014349|FG002|Overall Study|Death|0|||
33306278|NCT03248492|101014350|FG003|Overall Study|Death|6|||
33306279|NCT03248492|101014351|FG004|Overall Study|Death|0|||
33306280|NCT03248492|101014347|FG000|Overall Study|Other|0|||
33306281|NCT03248492|101014348|FG001|Overall Study|Other|1|||
33306282|NCT03248492|101014349|FG002|Overall Study|Other|0|||
33306283|NCT03248492|101014350|FG003|Overall Study|Other|4|||
33306284|NCT03248492|101014351|FG004|Overall Study|Other|0|||
33306285|NCT05132127|101014352|FG000|Overall Study|Adverse Event|1|||
33306286|NCT04552899|101014353|FG000|Overall Study|Adverse Event|4|||
33306287|NCT04552899|101014354|FG001|Overall Study|Adverse Event|3|||
33306288|NCT04552899|101014353|FG000|Overall Study|Death|4|||
33306289|NCT04552899|101014354|FG001|Overall Study|Death|4|||
33306290|NCT04552899|101014353|FG000|Overall Study|Lost to Follow-up|8|||
33306291|NCT04552899|101014354|FG001|Overall Study|Lost to Follow-up|13|||
33306292|NCT04552899|101014353|FG000|Overall Study|Lung Transplant|4|||
33306293|NCT04552899|101014354|FG001|Overall Study|Lung Transplant|3|||
33306294|NCT04552899|101014353|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
33306295|NCT04552899|101014354|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
33306296|NCT04552899|101014353|FG000|Overall Study|Physician Decision|3|||
33306297|NCT04552899|101014354|FG001|Overall Study|Physician Decision|4|||
33306298|NCT04552899|101014353|FG000|Overall Study|Study Terminated By Sponsor|237|||
33306299|NCT04552899|101014354|FG001|Overall Study|Study Terminated By Sponsor|239|||
33306300|NCT04552899|101014353|FG000|Overall Study|Withdrawal by Subject|15|||
33306301|NCT04552899|101014354|FG001|Overall Study|Withdrawal by Subject|17|||
33306302|NCT00439231|101014355|FG000|Overall Study|Lack of Efficacy|28|||
33306303|NCT02549196|101014356|FG000|Overall Study|Protocol Violation|0|||
33306304|NCT02549196|101014357|FG001|Overall Study|Protocol Violation|0|||
33306305|NCT02549196|101014358|FG002|Overall Study|Protocol Violation|0|||
33306306|NCT02549196|101014359|FG003|Overall Study|Protocol Violation|1|||
33306307|NCT02549196|101014356|FG000|Overall Study|Withdrawal by Subject|1|||
33306308|NCT02549196|101014357|FG001|Overall Study|Withdrawal by Subject|0|||
33306309|NCT02549196|101014358|FG002|Overall Study|Withdrawal by Subject|1|||
33306310|NCT02549196|101014359|FG003|Overall Study|Withdrawal by Subject|0|||
33306311|NCT01691768|101014360|FG000|Overall Study|Death|0|||
33306312|NCT01691768|101014361|FG001|Overall Study|Death|2|||
33306313|NCT01691768|101014360|FG000|Overall Study|Lost to Follow-up|4|||
33306314|NCT01691768|101014361|FG001|Overall Study|Lost to Follow-up|3|||
33306315|NCT01691768|101014360|FG000|Overall Study|Withdrawal by Subject|10|||
33306316|NCT01691768|101014361|FG001|Overall Study|Withdrawal by Subject|9|||
33306317|NCT01691768|101014360|FG000|Overall Study|Relocated|0|||
33306318|NCT01691768|101014361|FG001|Overall Study|Relocated|1|||
33306319|NCT01691768|101014360|FG000|Overall Study|Investigator decision|1|||
33306320|NCT01691768|101014361|FG001|Overall Study|Investigator decision|1|||
33306321|NCT01605916|101014362|FG000|Overall Study|Adverse Event|1|||
33306322|NCT01605916|101014363|FG001|Overall Study|Adverse Event|0|||
33306323|NCT01605916|101014364|FG002|Overall Study|Adverse Event|0|||
33306324|NCT01605916|101014365|FG003|Overall Study|Adverse Event|1|||
33306325|NCT01605916|101014366|FG004|Overall Study|Adverse Event|0|||
33306326|NCT01605916|101014362|FG000|Overall Study|Lack of Efficacy|2|||
33306327|NCT01605916|101014363|FG001|Overall Study|Lack of Efficacy|3|||
33306328|NCT01605916|101014364|FG002|Overall Study|Lack of Efficacy|3|||
33306329|NCT01605916|101014365|FG003|Overall Study|Lack of Efficacy|5|||
33306330|NCT01605916|101014366|FG004|Overall Study|Lack of Efficacy|4|||
33306331|NCT01605916|101014362|FG000|Overall Study|Withdrawal by Subject|1|||
33306332|NCT01605916|101014363|FG001|Overall Study|Withdrawal by Subject|1|||
33306333|NCT01605916|101014364|FG002|Overall Study|Withdrawal by Subject|0|||
33306334|NCT01605916|101014365|FG003|Overall Study|Withdrawal by Subject|0|||
33306335|NCT01605916|101014366|FG004|Overall Study|Withdrawal by Subject|2|||
33306336|NCT03223662|101014367|FG000|Overall Study|Physician Decision|1|||
33306337|NCT03223662|101014367|FG000|Overall Study|Study closure|1|||
33306338|NCT01145898|101014370|FG000|3-year Treatment|medication change by treating physician|3|||
33306339|NCT01145898|101014371|FG001|3-year Treatment|medication change by treating physician|16|||
33306340|NCT01200589|101014372|FG000|Overall Study|Withdrawal by Subject|13|||
33306341|NCT01200589|101014373|FG001|Overall Study|Withdrawal by Subject|11|||
33306342|NCT01200589|101014372|FG000|Overall Study|Physician Decision|2|||
33306343|NCT01200589|101014373|FG001|Overall Study|Physician Decision|2|||
33306344|NCT01200589|101014372|FG000|Overall Study|Lost to Follow-up|5|||
33306345|NCT01200589|101014373|FG001|Overall Study|Lost to Follow-up|4|||
33306346|NCT01200589|101014372|FG000|Overall Study|Study terminated|170|||
33306347|NCT01200589|101014373|FG001|Overall Study|Study terminated|172|||
33306348|NCT02581631|101017026|FG000|Overall Study|Disease progression|29|||
33306349|NCT02581631|101017027|FG001|Overall Study|Disease progression|19|||
33306350|NCT02581631|101017028|FG002|Overall Study|Disease progression|13|||
33306351|NCT02581631|101017029|FG003|Overall Study|Disease progression|5|||
33306352|NCT02581631|101017030|FG004|Overall Study|Disease progression|8|||
33306353|NCT02581631|101017026|FG000|Overall Study|Study drug toxicity|4|||
33306354|NCT02581631|101017027|FG001|Overall Study|Study drug toxicity|6|||
33306355|NCT02581631|101017028|FG002|Overall Study|Study drug toxicity|7|||
33306356|NCT02581631|101017029|FG003|Overall Study|Study drug toxicity|0|||
33306357|NCT02581631|101017030|FG004|Overall Study|Study drug toxicity|3|||
33306358|NCT02581631|101017026|FG000|Overall Study|AE unrelated to study drug|3|||
33306359|NCT02581631|101017027|FG001|Overall Study|AE unrelated to study drug|1|||
33306360|NCT02581631|101017028|FG002|Overall Study|AE unrelated to study drug|1|||
33306361|NCT02581631|101017029|FG003|Overall Study|AE unrelated to study drug|0|||
33306362|NCT02581631|101017030|FG004|Overall Study|AE unrelated to study drug|2|||
33306363|NCT02581631|101017026|FG000|Overall Study|Request to discontinue|1|||
33306364|NCT02581631|101017027|FG001|Overall Study|Request to discontinue|0|||
33306365|NCT02581631|101017028|FG002|Overall Study|Request to discontinue|3|||
33306366|NCT02581631|101017029|FG003|Overall Study|Request to discontinue|0|||
33306367|NCT02581631|101017030|FG004|Overall Study|Request to discontinue|1|||
33306368|NCT02581631|101017026|FG000|Overall Study|participant withdrew consent|3|||
33306369|NCT02581631|101017027|FG001|Overall Study|participant withdrew consent|0|||
33306370|NCT02581631|101017028|FG002|Overall Study|participant withdrew consent|1|||
33306371|NCT02581631|101017029|FG003|Overall Study|participant withdrew consent|0|||
33306372|NCT02581631|101017030|FG004|Overall Study|participant withdrew consent|0|||
33306373|NCT02581631|101017026|FG000|Overall Study|Maximum clinical benefit|1|||
33306374|NCT02581631|101017027|FG001|Overall Study|Maximum clinical benefit|7|||
33306375|NCT02581631|101017028|FG002|Overall Study|Maximum clinical benefit|1|||
33306376|NCT02581631|101017029|FG003|Overall Study|Maximum clinical benefit|3|||
33306377|NCT02581631|101017030|FG004|Overall Study|Maximum clinical benefit|13|||
33306378|NCT02581631|101017026|FG000|Overall Study|Other Reasons|1|||
33306379|NCT02581631|101017027|FG001|Overall Study|Other Reasons|0|||
33306380|NCT02581631|101017028|FG002|Overall Study|Other Reasons|2|||
33306381|NCT02581631|101017029|FG003|Overall Study|Other Reasons|2|||
33306382|NCT02581631|101017030|FG004|Overall Study|Other Reasons|3|||
33306383|NCT02581631|101017026|FG000|Overall Study|Poor/Non-Compliance|0|||
33306384|NCT02581631|101017027|FG001|Overall Study|Poor/Non-Compliance|0|||
33306385|NCT02581631|101017028|FG002|Overall Study|Poor/Non-Compliance|1|||
33306386|NCT02581631|101017029|FG003|Overall Study|Poor/Non-Compliance|0|||
33306387|NCT02581631|101017030|FG004|Overall Study|Poor/Non-Compliance|0|||
33306388|NCT00924027|101017033|FG000|Overall Study|Lost to Further Follow-Up|4|||
33306389|NCT00924027|101017034|FG001|Overall Study|Lost to Further Follow-Up|0|||
33306390|NCT00924027|101017035|FG002|Overall Study|Lost to Further Follow-Up|0|||
33306391|NCT00924027|101017036|FG003|Overall Study|Lost to Further Follow-Up|0|||
33306392|NCT00924027|101017033|FG000|Overall Study|Physician Decision|1|||
33306393|NCT00924027|101017034|FG001|Overall Study|Physician Decision|0|||
33306394|NCT00924027|101017035|FG002|Overall Study|Physician Decision|0|||
33601075|NCT00711802|102091813|FG006|Overall Study|Not treated (no further detail)|0|||
33601076|NCT00711802|102091814|FG007|Overall Study|Not treated (no further detail)|0|||
33601077|NCT00711802|102091807|FG000|Overall Study|Adverse Event|0|||
33601078|NCT00711802|102091808|FG001|Overall Study|Adverse Event|0|||
33601079|NCT00711802|102091809|FG002|Overall Study|Adverse Event|0|||
33601080|NCT00711802|102091810|FG003|Overall Study|Adverse Event|0|||
33601081|NCT00711802|102091811|FG004|Overall Study|Adverse Event|1|||
33601082|NCT00711802|102091812|FG005|Overall Study|Adverse Event|1|||
33306395|NCT00924027|101017036|FG003|Overall Study|Physician Decision|1|||
33306396|NCT00924027|101017033|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
33306397|NCT00924027|101017034|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
33306398|NCT00924027|101017035|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
33306399|NCT00924027|101017036|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
33306400|NCT00924027|101017033|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
33306401|NCT00924027|101017034|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
33306402|NCT00924027|101017035|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
33306403|NCT00924027|101017036|FG003|Overall Study|Withdrawal: Refused to start treatment|1|||
33306404|NCT00924027|101017033|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
33306405|NCT00924027|101017034|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
33601083|NCT00711802|102091813|FG006|Overall Study|Adverse Event|0|||
33306406|NCT00924027|101017035|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
33601084|NCT00711802|102091814|FG007|Overall Study|Adverse Event|0|||
33306407|NCT00924027|101017036|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
33306408|NCT00688870|101017038|FG000|Infant Series|Parent or legal guardian request|4|||
33306409|NCT00688870|101017039|FG001|Infant Series|Parent or legal guardian request|0|||
33306410|NCT04677179|101017040|FG000|Induction Treatment Period|Adverse Event|1|||
33306411|NCT04677179|101017041|FG001|Induction Treatment Period|Adverse Event|0|||
33306412|NCT04677179|101017042|FG002|Induction Treatment Period|Adverse Event|0|||
33306413|NCT04677179|101017043|FG003|Induction Treatment Period|Adverse Event|0|||
33306414|NCT04677179|101017044|FG004|Induction Treatment Period|Adverse Event|0|||
33601085|NCT00711802|102091807|FG000|Overall Study|Microbiological failure|0|||
33306415|NCT04677179|101017045|FG005|Induction Treatment Period|Adverse Event|0|||
33306416|NCT04677179|101017046|FG006|Induction Treatment Period|Adverse Event|0|||
33306417|NCT04677179|101017047|FG007|Induction Treatment Period|Adverse Event|0|||
33306418|NCT04677179|101017048|FG008|Induction Treatment Period|Adverse Event|0|||
33306419|NCT04677179|101017049|FG009|Induction Treatment Period|Adverse Event|0|||
33306420|NCT04677179|101017040|FG000|Induction Treatment Period|Physician Decision|1|||
33306421|NCT04677179|101017041|FG001|Induction Treatment Period|Physician Decision|0|||
33306422|NCT04677179|101017042|FG002|Induction Treatment Period|Physician Decision|1|||
33306423|NCT04677179|101017043|FG003|Induction Treatment Period|Physician Decision|0|||
33306424|NCT04677179|101017044|FG004|Induction Treatment Period|Physician Decision|0|||
33306425|NCT04677179|101017045|FG005|Induction Treatment Period|Physician Decision|0|||
33306426|NCT04677179|101017046|FG006|Induction Treatment Period|Physician Decision|0|||
33306427|NCT04677179|101017047|FG007|Induction Treatment Period|Physician Decision|0|||
33306428|NCT04677179|101017048|FG008|Induction Treatment Period|Physician Decision|0|||
33306429|NCT04677179|101017049|FG009|Induction Treatment Period|Physician Decision|0|||
33306430|NCT04677179|101017040|FG000|Induction Treatment Period|Protocol Violation|0|||
33306431|NCT04677179|101017041|FG001|Induction Treatment Period|Protocol Violation|1|||
33306432|NCT04677179|101017042|FG002|Induction Treatment Period|Protocol Violation|0|||
33306433|NCT04677179|101017043|FG003|Induction Treatment Period|Protocol Violation|0|||
33306434|NCT04677179|101017044|FG004|Induction Treatment Period|Protocol Violation|0|||
33306435|NCT04677179|101017045|FG005|Induction Treatment Period|Protocol Violation|0|||
33306436|NCT04677179|101017046|FG006|Induction Treatment Period|Protocol Violation|0|||
33306437|NCT04677179|101017047|FG007|Induction Treatment Period|Protocol Violation|0|||
33306438|NCT04677179|101017048|FG008|Induction Treatment Period|Protocol Violation|0|||
33306439|NCT04677179|101017049|FG009|Induction Treatment Period|Protocol Violation|0|||
33306440|NCT04677179|101017040|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
33306441|NCT04677179|101017041|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
33306442|NCT04677179|101017042|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
33306443|NCT04677179|101017043|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
33306444|NCT04677179|101017044|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
33306445|NCT04677179|101017045|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
33306446|NCT04677179|101017046|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
33306447|NCT04677179|101017047|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
33306448|NCT04677179|101017048|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
33306449|NCT04677179|101017049|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
33499299|NCT00813150|101720328|FG000|Long Term Follow-up|Progression/Relapse|22|||
33499300|NCT00813150|101720329|FG001|Long Term Follow-up|Progression/Relapse|24|||
33499301|NCT00765336|101720332|FG000|Overall Study|Protocol Violation|4|||
33306450|NCT04677179|101017040|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
33306451|NCT04677179|101017041|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
33306452|NCT04677179|101017042|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
33306453|NCT04677179|101017043|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
33306454|NCT04677179|101017044|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
33306455|NCT04677179|101017045|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
33306456|NCT04677179|101017046|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
33306457|NCT04677179|101017047|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
33306458|NCT04677179|101017048|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
33306459|NCT04677179|101017049|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
33306460|NCT04677179|101017040|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
33306461|NCT04677179|101017041|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
33499302|NCT00765336|101720333|FG001|Overall Study|Protocol Violation|2|||
33499303|NCT00765336|101720332|FG000|Overall Study|Withdrawal by Subject|6|||
33499304|NCT00765336|101720333|FG001|Overall Study|Withdrawal by Subject|4|||
33499305|NCT00765336|101720332|FG000|Overall Study|Lost to Follow-up|7|||
33601086|NCT00711802|102091808|FG001|Overall Study|Microbiological failure|1|||
33601087|NCT00711802|102091809|FG002|Overall Study|Microbiological failure|0|||
33499306|NCT00765336|101720333|FG001|Overall Study|Lost to Follow-up|9|||
33499307|NCT00765336|101720332|FG000|Overall Study|Adverse Event|2|||
33499308|NCT00765336|101720333|FG001|Overall Study|Adverse Event|1|||
33601088|NCT00711802|102091810|FG003|Overall Study|Microbiological failure|0|||
33601089|NCT00711802|102091811|FG004|Overall Study|Microbiological failure|0|||
33601090|NCT00711802|102091812|FG005|Overall Study|Microbiological failure|1|||
33499309|NCT02513160|101720337|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
33601091|NCT00711802|102091813|FG006|Overall Study|Microbiological failure|0|||
33601092|NCT00711802|102091814|FG007|Overall Study|Microbiological failure|0|||
33306462|NCT04677179|101017042|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
33306463|NCT04677179|101017043|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
33306464|NCT04677179|101017044|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
33306465|NCT04677179|101017045|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
33499310|NCT02513160|101720338|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
33499311|NCT02513160|101720339|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
33499312|NCT02513160|101720340|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
33499313|NCT02513160|101720337|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
33499314|NCT02513160|101720338|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
33499315|NCT02513160|101720339|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
33499316|NCT02513160|101720340|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
33499317|NCT02513160|101720337|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
33499318|NCT02513160|101720338|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
33601093|NCT00711802|102091807|FG000|Overall Study|Protocol Violation|0|||
33601094|NCT00711802|102091808|FG001|Overall Study|Protocol Violation|0|||
33601095|NCT00711802|102091809|FG002|Overall Study|Protocol Violation|0|||
33601096|NCT00711802|102091810|FG003|Overall Study|Protocol Violation|1|||
33601097|NCT00711802|102091811|FG004|Overall Study|Protocol Violation|0|||
33601098|NCT00711802|102091812|FG005|Overall Study|Protocol Violation|0|||
33601099|NCT00711802|102091813|FG006|Overall Study|Protocol Violation|0|||
33601100|NCT00711802|102091814|FG007|Overall Study|Protocol Violation|0|||
33601101|NCT00711802|102091807|FG000|Overall Study|Physician Decision|0|||
33601102|NCT00711802|102091808|FG001|Overall Study|Physician Decision|2|||
33601103|NCT00711802|102091809|FG002|Overall Study|Physician Decision|0|||
33601104|NCT00711802|102091810|FG003|Overall Study|Physician Decision|0|||
33601105|NCT00711802|102091811|FG004|Overall Study|Physician Decision|0|||
33601106|NCT00711802|102091812|FG005|Overall Study|Physician Decision|0|||
33601107|NCT00711802|102091813|FG006|Overall Study|Physician Decision|0|||
33601108|NCT00711802|102091814|FG007|Overall Study|Physician Decision|0|||
33601109|NCT00711802|102091807|FG000|Overall Study|Withdrawal by Subject|0|||
33601110|NCT00711802|102091808|FG001|Overall Study|Withdrawal by Subject|1|||
33601111|NCT00711802|102091809|FG002|Overall Study|Withdrawal by Subject|0|||
33601112|NCT00711802|102091810|FG003|Overall Study|Withdrawal by Subject|1|||
33601113|NCT00711802|102091811|FG004|Overall Study|Withdrawal by Subject|0|||
33601114|NCT00711802|102091812|FG005|Overall Study|Withdrawal by Subject|0|||
33601115|NCT00711802|102091813|FG006|Overall Study|Withdrawal by Subject|0|||
33601116|NCT00711802|102091814|FG007|Overall Study|Withdrawal by Subject|0|||
33601117|NCT00711802|102091807|FG000|Overall Study|Lost to Follow-up|0|||
33601118|NCT00711802|102091808|FG001|Overall Study|Lost to Follow-up|0|||
33601119|NCT00711802|102091809|FG002|Overall Study|Lost to Follow-up|3|||
33601120|NCT00711802|102091810|FG003|Overall Study|Lost to Follow-up|1|||
33601121|NCT00711802|102091811|FG004|Overall Study|Lost to Follow-up|10|||
33601122|NCT00711802|102091812|FG005|Overall Study|Lost to Follow-up|6|||
33499319|NCT02513160|101720339|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
33499320|NCT02513160|101720340|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
33601123|NCT00711802|102091813|FG006|Overall Study|Lost to Follow-up|4|||
33601124|NCT00711802|102091814|FG007|Overall Study|Lost to Follow-up|2|||
33601125|NCT00711802|102091807|FG000|Overall Study|Reason not reported|0|||
33601126|NCT00711802|102091808|FG001|Overall Study|Reason not reported|1|||
33499321|NCT02513160|101720337|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
33499322|NCT02513160|101720338|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
33499323|NCT02513160|101720339|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
33499324|NCT02513160|101720340|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
33499325|NCT02513160|101720337|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
33499326|NCT02513160|101720338|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
33499327|NCT02513160|101720339|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
33306466|NCT04677179|101017046|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
33306467|NCT04677179|101017047|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
33306468|NCT04677179|101017048|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
33306469|NCT04677179|101017049|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
33306470|NCT04677179|101017040|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
33306471|NCT04677179|101017041|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
33306472|NCT04677179|101017042|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
33306473|NCT04677179|101017043|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
33306474|NCT04677179|101017044|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
33306475|NCT04677179|101017045|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
33306476|NCT04677179|101017046|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
33306477|NCT04677179|101017047|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
33306478|NCT04677179|101017048|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
33306479|NCT04677179|101017049|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
33306480|NCT04677179|101017040|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
33306481|NCT04677179|101017041|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
33306482|NCT04677179|101017042|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
33306483|NCT04677179|101017043|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
33306484|NCT04677179|101017044|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
33306485|NCT04677179|101017045|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
33306486|NCT04677179|101017046|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
33306487|NCT04677179|101017047|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
33306488|NCT04677179|101017048|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
33306489|NCT04677179|101017049|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
33393760|NCT03073200|101328519|FG008|Randomized Withdrawal Period|Adverse Event|0|||
33393761|NCT03073200|101328520|FG009|Randomized Withdrawal Period|Adverse Event|0|||
33393762|NCT03073200|101328521|FG010|Randomized Withdrawal Period|Adverse Event|1|||
33393763|NCT03073200|101328522|FG011|Randomized Withdrawal Period|Adverse Event|0|||
33393764|NCT03073200|101328523|FG012|Randomized Withdrawal Period|Adverse Event|0|||
33393765|NCT03073200|101328524|FG013|Randomized Withdrawal Period|Adverse Event|0|||
33393766|NCT03073200|101328525|FG014|Randomized Withdrawal Period|Adverse Event|0|||
33393767|NCT03073200|101328511|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
33393768|NCT03073200|101328512|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
33393769|NCT03073200|101328513|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
33393770|NCT03073200|101328514|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
33393771|NCT03073200|101328515|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
33306490|NCT04677179|101017040|FG000|Extension Treatment Period|Lack of Efficacy|0|||
33306491|NCT04677179|101017041|FG001|Extension Treatment Period|Lack of Efficacy|0|||
33306492|NCT04677179|101017042|FG002|Extension Treatment Period|Lack of Efficacy|0|||
33306493|NCT04677179|101017043|FG003|Extension Treatment Period|Lack of Efficacy|0|||
33306494|NCT04677179|101017044|FG004|Extension Treatment Period|Lack of Efficacy|0|||
33306495|NCT04677179|101017045|FG005|Extension Treatment Period|Lack of Efficacy|0|||
33306496|NCT04677179|101017046|FG006|Extension Treatment Period|Lack of Efficacy|6|||
33306497|NCT04677179|101017047|FG007|Extension Treatment Period|Lack of Efficacy|0|||
33306498|NCT04677179|101017048|FG008|Extension Treatment Period|Lack of Efficacy|0|||
33499328|NCT02513160|101720340|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
33499329|NCT02513160|101720337|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
33499330|NCT02513160|101720338|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
33499331|NCT02513160|101720339|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
33499332|NCT02513160|101720340|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
33499333|NCT02513160|101720337|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
33499334|NCT02513160|101720338|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
33499335|NCT02513160|101720339|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
33499336|NCT02513160|101720340|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
33306499|NCT04677179|101017049|FG009|Extension Treatment Period|Lack of Efficacy|0|||
33499337|NCT02513160|101720337|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
33499338|NCT02513160|101720338|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
33601127|NCT00711802|102091809|FG002|Overall Study|Reason not reported|1|||
33499339|NCT02513160|101720339|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
33499340|NCT02513160|101720340|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
33499341|NCT02513160|101720337|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
33499342|NCT02513160|101720338|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
33499343|NCT02513160|101720339|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
33499344|NCT02513160|101720340|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
33499345|NCT02513160|101720337|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
33499346|NCT02513160|101720338|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
33499347|NCT02513160|101720339|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
33499348|NCT02513160|101720340|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
33499349|NCT02513160|101720337|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
33499350|NCT02513160|101720338|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
33499351|NCT02513160|101720339|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
33499352|NCT02513160|101720340|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
33499353|NCT02513160|101720337|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
33499354|NCT02513160|101720338|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
33499355|NCT02513160|101720339|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
33499356|NCT02513160|101720340|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
33499357|NCT01173523|101720341|FG000|Overall Study|Clinical Progression|1|||
33499358|NCT01173523|101720342|FG001|Overall Study|Clinical Progression|1|||
33499359|NCT01173523|101720341|FG000|Overall Study|Progressive Disease|10|||
33499360|NCT01173523|101720342|FG001|Overall Study|Progressive Disease|8|||
33499361|NCT01173523|101720341|FG000|Overall Study|Other|2|||
33499362|NCT01173523|101720342|FG001|Overall Study|Other|3|||
33499363|NCT03376789|101720343|FG000|Overall Study|Withdrawal by Subject|3|||
33499364|NCT03376789|101720344|FG001|Overall Study|Withdrawal by Subject|5|||
33499365|NCT03376789|101720343|FG000|Overall Study|Protocol Violation|0|||
33499366|NCT03376789|101720344|FG001|Overall Study|Protocol Violation|1|||
33499367|NCT03376789|101720343|FG000|Overall Study|Adverse Event|0|||
33499368|NCT03376789|101720344|FG001|Overall Study|Adverse Event|1|||
33499369|NCT03376789|101720343|FG000|Overall Study|Lost to Follow-up|1|||
33499370|NCT03376789|101720344|FG001|Overall Study|Lost to Follow-up|1|||
33499371|NCT03376789|101720343|FG000|Overall Study|Per sponsor due to noncompliance|1|||
33601128|NCT00711802|102091810|FG003|Overall Study|Reason not reported|0|||
33601129|NCT00711802|102091811|FG004|Overall Study|Reason not reported|1|||
33601130|NCT00711802|102091812|FG005|Overall Study|Reason not reported|0|||
33601131|NCT00711802|102091813|FG006|Overall Study|Reason not reported|1|||
33601132|NCT00711802|102091814|FG007|Overall Study|Reason not reported|0|||
33601133|NCT00432744|102091815|FG000|Months 0-6|Withdrawal by Subject|4|||
33601134|NCT00432744|102091816|FG001|Months 0-6|Withdrawal by Subject|4|||
33601135|NCT00432744|102091815|FG000|Months 0-6|Too disabled to score|1|||
33601136|NCT00432744|102091816|FG001|Months 0-6|Too disabled to score|0|||
33191263|NCT00528528|100605177|FG002|Overall Study|Lost to Follow-up|1|||
33191264|NCT00528528|100605178|FG003|Overall Study|Lost to Follow-up|1|||
33191265|NCT00528528|100605175|FG000|Overall Study|Ineligible to continue the trial|0|||
33191266|NCT00528528|100605176|FG001|Overall Study|Ineligible to continue the trial|0|||
33601137|NCT00432744|102091815|FG000|Months 7 - 12|Withdrawal by Subject|1|||
33601138|NCT00432744|102091816|FG001|Months 7 - 12|Withdrawal by Subject|0|||
33191267|NCT00528528|100605177|FG002|Overall Study|Ineligible to continue the trial|0|||
33306500|NCT04677179|101017040|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
33306501|NCT04677179|101017041|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
33191268|NCT00528528|100605178|FG003|Overall Study|Ineligible to continue the trial|1|||
33191269|NCT00528528|100605175|FG000|Overall Study|Other|0|||
33191270|NCT00528528|100605176|FG001|Overall Study|Other|1|||
33191271|NCT00528528|100605177|FG002|Overall Study|Other|0|||
33306502|NCT04677179|101017042|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
33499372|NCT03376789|101720344|FG001|Overall Study|Per sponsor due to noncompliance|0|||
33499373|NCT03376789|101720343|FG000|Overall Study|Subject off study medication|0|||
33499374|NCT03376789|101720344|FG001|Overall Study|Subject off study medication|1|||
33499375|NCT02172664|101720345|FG000|Overall Study|Lost to Follow-up|4|||
33499376|NCT02172664|101720346|FG001|Overall Study|Lost to Follow-up|4|||
33499377|NCT02172664|101720345|FG000|Overall Study|Death|1|||
33601139|NCT00432744|102091815|FG000|Months 7 - 12|Too disabled to score|0|||
33601140|NCT00432744|102091816|FG001|Months 7 - 12|Too disabled to score|1|||
33601141|NCT02644356|102091817|FG000|Overall Study|Withdrawal by Subject|2|||
33306503|NCT04677179|101017043|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
33306504|NCT04677179|101017044|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
33306505|NCT04677179|101017045|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
33306506|NCT04677179|101017046|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
33306507|NCT04677179|101017047|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
33306508|NCT04677179|101017048|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
33306509|NCT04677179|101017049|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
33306510|NCT04677179|101017040|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
33306511|NCT04677179|101017041|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
33306512|NCT04677179|101017042|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
33306513|NCT04677179|101017043|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
33306514|NCT04677179|101017044|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
33306515|NCT04677179|101017045|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
33306516|NCT04677179|101017046|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
33306517|NCT04677179|101017047|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
33306518|NCT04677179|101017048|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
33306519|NCT04677179|101017049|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
33306520|NCT04677179|101017040|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
33306521|NCT04677179|101017041|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
33306522|NCT04677179|101017042|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
33306523|NCT04677179|101017043|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
33306524|NCT04677179|101017044|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
33306525|NCT04677179|101017045|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
33306526|NCT04677179|101017046|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
33306527|NCT04677179|101017047|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
33306528|NCT04677179|101017048|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
33306529|NCT04677179|101017049|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
33306530|NCT04677179|101017040|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33499378|NCT02172664|101720346|FG001|Overall Study|Death|1|||
33499379|NCT02172664|101720345|FG000|Overall Study|Moved out of area|1|||
33499380|NCT02172664|101720346|FG001|Overall Study|Moved out of area|1|||
33499381|NCT02907177|101720347|FG000|Overall Study|Death|0|||
33306531|NCT04677179|101017041|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33306532|NCT04677179|101017042|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33306533|NCT04677179|101017043|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33306534|NCT04677179|101017044|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33499382|NCT02907177|101720348|FG001|Overall Study|Death|1|||
33499383|NCT02907177|101720347|FG000|Overall Study|Physician Decision|3|||
33499384|NCT02907177|101720348|FG001|Overall Study|Physician Decision|3|||
33499385|NCT02907177|101720347|FG000|Overall Study|Withdrawal by Subject|15|||
33499386|NCT02907177|101720348|FG001|Overall Study|Withdrawal by Subject|7|||
33499387|NCT02907177|101720347|FG000|Overall Study|Sponsor's Decision|50|||
33499388|NCT02907177|101720348|FG001|Overall Study|Sponsor's Decision|57|||
33499389|NCT05061693|101720349|FG000|Overall Study|Adverse Event|1|||
33499390|NCT05061693|101720350|FG001|Overall Study|Adverse Event|1|||
33499391|NCT05061693|101720351|FG002|Overall Study|Adverse Event|1|||
33499392|NCT05061693|101720352|FG003|Overall Study|Adverse Event|0|||
33499393|NCT05061693|101720349|FG000|Overall Study|Death|0|||
33499394|NCT05061693|101720350|FG001|Overall Study|Death|1|||
33306535|NCT04677179|101017045|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33306536|NCT04677179|101017046|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33306537|NCT04677179|101017047|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
33306538|NCT04677179|101017048|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
33306539|NCT04677179|101017049|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
33306540|NCT04677179|101017040|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33306541|NCT04677179|101017041|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33306542|NCT04677179|101017042|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33306543|NCT04677179|101017043|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33499395|NCT05061693|101720351|FG002|Overall Study|Death|0|||
33499396|NCT05061693|101720352|FG003|Overall Study|Death|0|||
33499397|NCT05061693|101720349|FG000|Overall Study|Lack of Efficacy|1|||
33191272|NCT00528528|100605178|FG003|Overall Study|Other|0|||
33191273|NCT00528528|100605175|FG000|Overall Study|Withdrawal by Subject|3|||
33306544|NCT04677179|101017044|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33306545|NCT04677179|101017045|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33306546|NCT04677179|101017046|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33499398|NCT05061693|101720350|FG001|Overall Study|Lack of Efficacy|0|||
33499399|NCT05061693|101720351|FG002|Overall Study|Lack of Efficacy|0|||
33499400|NCT05061693|101720352|FG003|Overall Study|Lack of Efficacy|0|||
33499401|NCT05061693|101720349|FG000|Overall Study|Lost to Follow-up|0|||
33306547|NCT04677179|101017047|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
33306548|NCT04677179|101017048|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33499402|NCT05061693|101720350|FG001|Overall Study|Lost to Follow-up|0|||
33306549|NCT04677179|101017049|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33306550|NCT04677179|101017040|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33306551|NCT04677179|101017041|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33306552|NCT04677179|101017042|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33306553|NCT04677179|101017043|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33306554|NCT04677179|101017044|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33306555|NCT04677179|101017045|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33306556|NCT04677179|101017046|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33306557|NCT04677179|101017047|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
33306558|NCT04677179|101017048|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
33306559|NCT04677179|101017049|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33306560|NCT04677179|101017040|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
33306561|NCT04677179|101017041|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
33306562|NCT04677179|101017042|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
33306563|NCT04677179|101017043|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
33306564|NCT04677179|101017044|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
33306565|NCT04677179|101017045|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
33306566|NCT04677179|101017046|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
33306567|NCT04677179|101017047|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
33306568|NCT04677179|101017048|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
33306569|NCT04677179|101017049|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
33306570|NCT00532493|101017050|FG000|Overall Study|Death|1|||
33306571|NCT00532493|101017051|FG001|Overall Study|Death|1|||
33306572|NCT00532493|101017050|FG000|Overall Study|Lost to Follow-up|10|||
33306573|NCT00532493|101017051|FG001|Overall Study|Lost to Follow-up|7|||
33306574|NCT00532493|101017050|FG000|Overall Study|Withdrawal by Subject|7|||
33306575|NCT00532493|101017051|FG001|Overall Study|Withdrawal by Subject|9|||
33306576|NCT00532493|101017050|FG000|Overall Study|Physician Decision|1|||
33306577|NCT00532493|101017051|FG001|Overall Study|Physician Decision|6|||
33306578|NCT00532493|101017050|FG000|Overall Study|Adverse Event|6|||
33306579|NCT00532493|101017051|FG001|Overall Study|Adverse Event|5|||
33306580|NCT00532493|101017050|FG000|Overall Study|Protocol Deviation|1|||
33306581|NCT00532493|101017051|FG001|Overall Study|Protocol Deviation|0|||
33306582|NCT00532493|101017050|FG000|Overall Study|Subject Moved Away|3|||
33306583|NCT00532493|101017051|FG001|Overall Study|Subject Moved Away|1|||
33306584|NCT00532493|101017050|FG000|Overall Study|Contraindicative Medication|1|||
33306585|NCT00532493|101017051|FG001|Overall Study|Contraindicative Medication|0|||
33306586|NCT01050790|101017052|FG000|Overall Study|Adverse Event|1|||
33306587|NCT00473265|101017053|FG000|Overall Study|Unrelated adverse event|5|||
33306588|NCT00473265|101017053|FG000|Overall Study|Off treatment early|15|||
33306589|NCT05007080|101017057|FG000|Overall Study|Lost to Follow-up|0|||
33306590|NCT05007080|101017058|FG001|Overall Study|Lost to Follow-up|1|||
33306591|NCT05007080|101017059|FG002|Overall Study|Lost to Follow-up|0|||
33306592|NCT05007080|101017060|FG003|Overall Study|Lost to Follow-up|1|||
33306593|NCT05007080|101017061|FG004|Overall Study|Lost to Follow-up|1|||
33306594|NCT05007080|101017062|FG005|Overall Study|Lost to Follow-up|1|||
33306595|NCT05007080|101017057|FG000|Overall Study|Death|0|||
33306596|NCT05007080|101017058|FG001|Overall Study|Death|1|||
33306597|NCT05007080|101017059|FG002|Overall Study|Death|0|||
33306598|NCT05007080|101017060|FG003|Overall Study|Death|0|||
33306599|NCT05007080|101017061|FG004|Overall Study|Death|0|||
33306600|NCT05007080|101017062|FG005|Overall Study|Death|0|||
33306601|NCT05007080|101017057|FG000|Overall Study|Withdrawal by Subject|1|||
33306602|NCT05007080|101017058|FG001|Overall Study|Withdrawal by Subject|2|||
33499403|NCT05061693|101720351|FG002|Overall Study|Lost to Follow-up|1|||
33499404|NCT05061693|101720352|FG003|Overall Study|Lost to Follow-up|0|||
33499405|NCT05061693|101720349|FG000|Overall Study|Protocol Violation|1|||
33499406|NCT05061693|101720350|FG001|Overall Study|Protocol Violation|1|||
33499407|NCT05061693|101720351|FG002|Overall Study|Protocol Violation|1|||
33499408|NCT05061693|101720352|FG003|Overall Study|Protocol Violation|2|||
33224256|NCT01672853|100721764|FG000|Overall Study|Adverse Event|4|||
33306603|NCT05007080|101017059|FG002|Overall Study|Withdrawal by Subject|0|||
33306604|NCT05007080|101017060|FG003|Overall Study|Withdrawal by Subject|2|||
33306605|NCT05007080|101017061|FG004|Overall Study|Withdrawal by Subject|1|||
33306606|NCT05007080|101017062|FG005|Overall Study|Withdrawal by Subject|1|||
33306607|NCT05007080|101017057|FG000|Overall Study|Other|1|||
33306608|NCT05007080|101017058|FG001|Overall Study|Other|0|||
33306609|NCT05007080|101017059|FG002|Overall Study|Other|1|||
33306610|NCT05007080|101017060|FG003|Overall Study|Other|1|||
33306611|NCT05007080|101017061|FG004|Overall Study|Other|0|||
33306612|NCT05007080|101017062|FG005|Overall Study|Other|2|||
33306613|NCT05007080|101017057|FG000|Overall Study|Randomized not vaccinated|0|||
33306614|NCT05007080|101017058|FG001|Overall Study|Randomized not vaccinated|0|||
33306615|NCT05007080|101017059|FG002|Overall Study|Randomized not vaccinated|0|||
33306616|NCT05007080|101017060|FG003|Overall Study|Randomized not vaccinated|0|||
33306617|NCT05007080|101017061|FG004|Overall Study|Randomized not vaccinated|0|||
33306618|NCT05007080|101017062|FG005|Overall Study|Randomized not vaccinated|1|||
33306619|NCT01034176|101017065|FG000|Overall Study|Physician Decision|2|||
33306620|NCT01034176|101017066|FG001|Overall Study|Physician Decision|0|||
33306621|NCT01034176|101017065|FG000|Overall Study|Withdrawal by Subject|0|||
33306622|NCT01034176|101017066|FG001|Overall Study|Withdrawal by Subject|1|||
33306623|NCT01034176|101017065|FG000|Overall Study|Lost to Follow-up|0|||
33306624|NCT01034176|101017066|FG001|Overall Study|Lost to Follow-up|1|||
33306625|NCT00935818|101017073|FG000|Overall Study|Withdrawal by Subject|45|||
33306626|NCT00935818|101017074|FG001|Overall Study|Withdrawal by Subject|50|||
33306627|NCT00935818|101017073|FG000|Overall Study|Lost to Follow-up|40|||
33306628|NCT00935818|101017074|FG001|Overall Study|Lost to Follow-up|42|||
33306629|NCT00935818|101017073|FG000|Overall Study|Adverse Event|6|||
33306630|NCT00935818|101017074|FG001|Overall Study|Adverse Event|7|||
33306631|NCT00935818|101017073|FG000|Overall Study|Physician Decision|0|||
33306632|NCT00935818|101017074|FG001|Overall Study|Physician Decision|1|||
33306633|NCT01639560|101017075|FG000|Overall Study|Withdrawal by Subject|9|||
33306634|NCT01639560|101017076|FG001|Overall Study|Withdrawal by Subject|14|||
33306635|NCT01639560|101017075|FG000|Overall Study|Lack of Efficacy|1|||
33306636|NCT01639560|101017076|FG001|Overall Study|Lack of Efficacy|2|||
33306637|NCT01639560|101017075|FG000|Overall Study|Lost to Follow-up|9|||
33306638|NCT01639560|101017076|FG001|Overall Study|Lost to Follow-up|11|||
33306639|NCT01639560|101017075|FG000|Overall Study|Adverse Event|0|||
33306640|NCT01639560|101017076|FG001|Overall Study|Adverse Event|2|||
33306641|NCT00872989|101017077|FG000|Overall Study|Adverse Event|7|||
33306642|NCT00872989|101017078|FG001|Overall Study|Adverse Event|15|||
33306643|NCT00872989|101017077|FG000|Overall Study|Withdrawal by Subject|8|||
33306644|NCT00872989|101017078|FG001|Overall Study|Withdrawal by Subject|5|||
33306645|NCT00872989|101017077|FG000|Overall Study|Progression/relapse|47|||
33306646|NCT00872989|101017078|FG001|Overall Study|Progression/relapse|35|||
33306647|NCT00872989|101017077|FG000|Overall Study|Not protocol specified|3|||
33306648|NCT00872989|101017078|FG001|Overall Study|Not protocol specified|8|||
33306649|NCT04189952|101017079|FG000|Follow-up Period|Death|1|||
33306650|NCT04189952|101017079|FG000|Follow-up Period|Withdrawal by Subject|1|||
33306651|NCT02334423|101017084|FG000|Overall Study|Protocol Violation|10|||
33306652|NCT02334423|101017085|FG001|Overall Study|Protocol Violation|3|||
33306653|NCT00414908|101017088|FG000|Overall Study|Protocol Violation|1|||
33306654|NCT00414908|101017089|FG001|Overall Study|Protocol Violation|1|||
33306655|NCT04138576|101017092|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
33306656|NCT03466073|101017093|FG000|Overall Study|Death|1|||
33306657|NCT03466073|101017094|FG001|Overall Study|Death|0|||
33306658|NCT03466073|101017095|FG002|Overall Study|Death|0|||
33306659|NCT03466073|101017096|FG003|Overall Study|Death|0|||
33306660|NCT03466073|101017097|FG004|Overall Study|Death|0|||
33306661|NCT03466073|101017098|FG005|Overall Study|Death|1|||
33306662|NCT02314780|101017099|FG000|Overall Study|organizational reasons|0|||
33306663|NCT02314780|101017100|FG001|Overall Study|organizational reasons|2|||
33306664|NCT02314780|101017101|FG002|Overall Study|organizational reasons|0|||
33306665|NCT02314780|101017099|FG000|Overall Study|Adverse Event|0|||
33306666|NCT02314780|101017100|FG001|Overall Study|Adverse Event|1|||
33306667|NCT02314780|101017101|FG002|Overall Study|Adverse Event|0|||
33306668|NCT01394978|101017108|FG000|Overall Study|Withdrawal by Subject|2|||
33306669|NCT01394978|101017109|FG001|Overall Study|Withdrawal by Subject|4|||
33306670|NCT01394978|101017108|FG000|Overall Study|Lost to Follow-up|13|||
33306671|NCT01394978|101017109|FG001|Overall Study|Lost to Follow-up|20|||
33306672|NCT01394978|101017108|FG000|Overall Study|Death|6|||
33306673|NCT01394978|101017109|FG001|Overall Study|Death|7|||
33499409|NCT05061693|101720349|FG000|Overall Study|Withdrawal by Subject|2|||
33499410|NCT05061693|101720350|FG001|Overall Study|Withdrawal by Subject|4|||
33601142|NCT02713529|102091818|FG000|Overall Study|Withdrawal by Subject|3|||
33306674|NCT01910181|101017114|FG000|Overall Study|Death|37|||
33306675|NCT01910181|101017114|FG000|Overall Study|Lost to Follow-up|3|||
33306676|NCT01910181|101017114|FG000|Overall Study|Study Terminated by Sponsor|6|||
33306677|NCT03446781|101017117|FG000|Overall Study|Lost to Follow-up|11|||
33306678|NCT03446781|101017118|FG001|Overall Study|Lost to Follow-up|5|||
33499411|NCT05061693|101720351|FG002|Overall Study|Withdrawal by Subject|2|||
33306679|NCT03446781|101017117|FG000|Overall Study|Withdrawal by Subject|9|||
33306680|NCT03446781|101017118|FG001|Overall Study|Withdrawal by Subject|7|||
33306681|NCT03446781|101017117|FG000|Overall Study|Adverse Event|8|||
33306682|NCT03446781|101017118|FG001|Overall Study|Adverse Event|2|||
33306683|NCT03446781|101017117|FG000|Overall Study|Protocol Violation|0|||
33306684|NCT03446781|101017118|FG001|Overall Study|Protocol Violation|3|||
33306685|NCT03432260|101017122|FG000|Overall Study|Lost to Follow-up|1|||
33306686|NCT03432260|101017123|FG001|Overall Study|Lost to Follow-up|1|||
33499412|NCT05061693|101720352|FG003|Overall Study|Withdrawal by Subject|2|||
33499413|NCT02644668|101720356|FG000|Overall Study|Adverse Event|2|||
33499414|NCT02644668|101720357|FG001|Overall Study|Adverse Event|0|||
33499415|NCT02644668|101720358|FG002|Overall Study|Adverse Event|1|||
33499416|NCT02644668|101720356|FG000|Overall Study|Protocol Violation|0|||
33499417|NCT02644668|101720357|FG001|Overall Study|Protocol Violation|0|||
33499418|NCT02644668|101720358|FG002|Overall Study|Protocol Violation|1|||
33499419|NCT02644668|101720356|FG000|Overall Study|Withdrawal by Subject|0|||
33499420|NCT02644668|101720357|FG001|Overall Study|Withdrawal by Subject|0|||
33499421|NCT02644668|101720358|FG002|Overall Study|Withdrawal by Subject|1|||
33499422|NCT03335475|101720359|FG000|Overall Study|Did not wear accelerometer|4|||
33499423|NCT03335475|101720360|FG001|Overall Study|Did not wear accelerometer|0|||
33499424|NCT03335475|101720359|FG000|Overall Study|Withdrawal by Subject|0|||
33499425|NCT03335475|101720360|FG001|Overall Study|Withdrawal by Subject|1|||
33499426|NCT00782626|101720365|FG000|Overall Study|Adverse Event|1|||
33499427|NCT00782626|101720365|FG000|Overall Study|Progressive Disease|5|||
33499428|NCT00782626|101720365|FG000|Overall Study|Other Complicating Disease|1|||
33499429|NCT03889418|101720366|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
33499430|NCT03889418|101720367|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
33499431|NCT03889418|101720368|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
33499432|NCT03889418|101720369|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
33499433|NCT03889418|101720370|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
33499434|NCT03889418|101720371|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
33499435|NCT03889418|101720372|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
33499436|NCT03889418|101720373|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
33499437|NCT03889418|101720374|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
33499438|NCT03889418|101720375|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
33499439|NCT03889418|101720366|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
33499440|NCT03889418|101720367|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
33499441|NCT03889418|101720368|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
33499442|NCT03889418|101720369|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
33499443|NCT03889418|101720370|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
33499444|NCT03889418|101720371|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
33499445|NCT03889418|101720372|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
33499446|NCT03889418|101720373|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
33499447|NCT03889418|101720374|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
33499448|NCT03889418|101720375|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
33306687|NCT03432260|101017124|FG002|Overall Study|Lost to Follow-up|0|||
33306688|NCT03432260|101017125|FG003|Overall Study|Lost to Follow-up|0|||
33306689|NCT03432260|101017126|FG004|Overall Study|Lost to Follow-up|1|||
33306690|NCT01427751|101017127|FG000|Overall Study|Adverse Event|18|||
33306691|NCT01427751|101017128|FG001|Overall Study|Adverse Event|2|||
33306692|NCT01427751|101017127|FG000|Overall Study|No further treatment benefit expected|5|||
33306693|NCT01427751|101017128|FG001|Overall Study|No further treatment benefit expected|1|||
33601143|NCT02713529|102091819|FG001|Overall Study|Withdrawal by Subject|1|||
33601144|NCT02713529|102091820|FG002|Overall Study|Withdrawal by Subject|4|||
33601145|NCT02713529|102091821|FG003|Overall Study|Withdrawal by Subject|2|||
33601146|NCT02713529|102091822|FG004|Overall Study|Withdrawal by Subject|0|||
33601147|NCT02713529|102091823|FG005|Overall Study|Withdrawal by Subject|1|||
33306694|NCT01427751|101017127|FG000|Overall Study|Lost to Follow-up|3|||
33306695|NCT01427751|101017128|FG001|Overall Study|Lost to Follow-up|1|||
33306696|NCT01427751|101017127|FG000|Overall Study|Withdrawal of consent|2|||
33306697|NCT01427751|101017128|FG001|Overall Study|Withdrawal of consent|2|||
33306698|NCT01427751|101017127|FG000|Overall Study|Protocol Violation|6|||
33306699|NCT01427751|101017128|FG001|Overall Study|Protocol Violation|4|||
33306700|NCT01427751|101017127|FG000|Overall Study|Death|2|||
33306701|NCT01427751|101017128|FG001|Overall Study|Death|0|||
33306702|NCT01427751|101017127|FG000|Overall Study|Other miscellaneous reasons|6|||
33306703|NCT01427751|101017128|FG001|Overall Study|Other miscellaneous reasons|4|||
33306704|NCT00653523|101017129|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
33306705|NCT00653523|101017129|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
33306706|NCT00653523|101017129|FG000|Overall Study|Adverse Event|7|||
33306707|NCT00653523|101017129|FG000|Overall Study|Withdrawal by Subject|6|||
33499449|NCT03889418|101720366|FG000|October-December 2019 (Month 7-9)|Death|0|||
33499450|NCT03889418|101720367|FG001|October-December 2019 (Month 7-9)|Death|0|||
33499451|NCT03889418|101720368|FG002|October-December 2019 (Month 7-9)|Death|0|||
33499452|NCT03889418|101720369|FG003|October-December 2019 (Month 7-9)|Death|0|||
33306708|NCT00653523|101017129|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
33306709|NCT00653523|101017129|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
33499453|NCT03889418|101720370|FG004|October-December 2019 (Month 7-9)|Death|0|||
33306710|NCT00467285|101017135|FG000|Overall Study|Lost to Follow-up|4|||
33601148|NCT02713529|102091824|FG006|Overall Study|Withdrawal by Subject|1|||
33601149|NCT02713529|102091818|FG000|Overall Study|Lost to Follow-up|1|||
33499454|NCT03889418|101720371|FG005|October-December 2019 (Month 7-9)|Death|0|||
33499455|NCT03889418|101720372|FG006|October-December 2019 (Month 7-9)|Death|0|||
33499456|NCT03889418|101720373|FG007|October-December 2019 (Month 7-9)|Death|0|||
33499457|NCT03889418|101720374|FG008|October-December 2019 (Month 7-9)|Death|1|||
33499458|NCT03889418|101720375|FG009|October-December 2019 (Month 7-9)|Death|0|||
33499459|NCT03889418|101720366|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
33499460|NCT03889418|101720367|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
33499461|NCT03889418|101720368|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
33499462|NCT03889418|101720369|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
33499463|NCT03889418|101720370|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
33499464|NCT03889418|101720371|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
33499465|NCT03889418|101720372|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
33499466|NCT03889418|101720373|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
33499467|NCT03889418|101720374|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
33499468|NCT03889418|101720375|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
33499469|NCT03889418|101720366|FG000|April - June 2020 (Month 13-15)|Death|0|||
33499470|NCT03889418|101720367|FG001|April - June 2020 (Month 13-15)|Death|1|||
33499471|NCT03889418|101720368|FG002|April - June 2020 (Month 13-15)|Death|0|||
33499472|NCT03889418|101720369|FG003|April - June 2020 (Month 13-15)|Death|0|||
33499473|NCT03889418|101720370|FG004|April - June 2020 (Month 13-15)|Death|0|||
33499474|NCT03889418|101720371|FG005|April - June 2020 (Month 13-15)|Death|0|||
33499475|NCT03889418|101720372|FG006|April - June 2020 (Month 13-15)|Death|0|||
33499476|NCT03889418|101720373|FG007|April - June 2020 (Month 13-15)|Death|0|||
33499477|NCT03889418|101720374|FG008|April - June 2020 (Month 13-15)|Death|0|||
33499478|NCT03889418|101720375|FG009|April - June 2020 (Month 13-15)|Death|0|||
33499479|NCT03889418|101720366|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
33499480|NCT03889418|101720367|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
33499481|NCT03889418|101720368|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
33499482|NCT03889418|101720369|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
33499483|NCT03889418|101720370|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
33499484|NCT03889418|101720371|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
33499485|NCT03889418|101720372|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
33499486|NCT03889418|101720373|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
33499487|NCT03889418|101720374|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
33499488|NCT03889418|101720375|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
33499489|NCT03889418|101720366|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
33499490|NCT03889418|101720367|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
33499491|NCT03889418|101720368|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
33499492|NCT03889418|101720369|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
33499493|NCT03889418|101720370|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
33499494|NCT03889418|101720371|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
33499495|NCT03889418|101720372|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
33499496|NCT03889418|101720373|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
33499497|NCT03889418|101720374|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
33499498|NCT03889418|101720375|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
33499499|NCT03889418|101720366|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
33499500|NCT03889418|101720367|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
33499501|NCT03889418|101720368|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
33499502|NCT03889418|101720369|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
33499503|NCT03889418|101720370|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
33499504|NCT03889418|101720371|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
33499505|NCT03889418|101720372|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
33499506|NCT03889418|101720373|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
33499507|NCT03889418|101720374|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
33499508|NCT03889418|101720375|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
33499509|NCT00347958|101720378|FG000|Overall Study|Adverse Event|1|||
33499510|NCT00347958|101720378|FG000|Overall Study|Protocol Violation|2|||
33499511|NCT00347958|101720378|FG000|Overall Study|Withdrawal by Subject|1|||
33499512|NCT00507455|101720383|FG000|Overall Study|Adverse Event|3|||
33499513|NCT00507455|101720384|FG001|Overall Study|Adverse Event|3|||
33499514|NCT00507455|101720385|FG002|Overall Study|Adverse Event|6|||
33499515|NCT00507455|101720383|FG000|Overall Study|Withdrawal by Subject|2|||
33499516|NCT00507455|101720384|FG001|Overall Study|Withdrawal by Subject|1|||
33499517|NCT00507455|101720385|FG002|Overall Study|Withdrawal by Subject|2|||
33499518|NCT00507455|101720383|FG000|Overall Study|Protocol Violation|4|||
33499519|NCT00507455|101720384|FG001|Overall Study|Protocol Violation|1|||
33499520|NCT00507455|101720385|FG002|Overall Study|Protocol Violation|1|||
33499521|NCT00507455|101720383|FG000|Overall Study|Lost to Follow-up|2|||
33601150|NCT02713529|102091819|FG001|Overall Study|Lost to Follow-up|0|||
33224257|NCT01672853|100721765|FG001|Overall Study|Adverse Event|6|||
33499522|NCT00507455|101720384|FG001|Overall Study|Lost to Follow-up|0|||
33601151|NCT02713529|102091820|FG002|Overall Study|Lost to Follow-up|1|||
33601152|NCT02713529|102091821|FG003|Overall Study|Lost to Follow-up|0|||
33601153|NCT02713529|102091822|FG004|Overall Study|Lost to Follow-up|0|||
33601154|NCT02713529|102091823|FG005|Overall Study|Lost to Follow-up|0|||
33601155|NCT02713529|102091824|FG006|Overall Study|Lost to Follow-up|0|||
33601156|NCT02713529|102091818|FG000|Overall Study|Death|3|||
33601157|NCT02713529|102091819|FG001|Overall Study|Death|3|||
33499523|NCT00507455|101720385|FG002|Overall Study|Lost to Follow-up|2|||
33601158|NCT02713529|102091820|FG002|Overall Study|Death|26|||
33601159|NCT02713529|102091821|FG003|Overall Study|Death|27|||
33601160|NCT02713529|102091822|FG004|Overall Study|Death|3|||
33601161|NCT02713529|102091823|FG005|Overall Study|Death|13|||
33601162|NCT02713529|102091824|FG006|Overall Study|Death|3|||
33601163|NCT02241187|102091829|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
33601164|NCT00186537|102091832|FG000|Overall Study|Withdrawal by Subject|4|||
33601165|NCT00186537|102091833|FG001|Overall Study|Withdrawal by Subject|0|||
33601166|NCT00186537|102091834|FG002|Overall Study|Withdrawal by Subject|3|||
33601167|NCT00186537|102091832|FG000|Overall Study|ALT > 1.5 x ULN|3|||
33601168|NCT00186537|102091833|FG001|Overall Study|ALT > 1.5 x ULN|0|||
33601169|NCT00186537|102091834|FG002|Overall Study|ALT > 1.5 x ULN|0|||
33601170|NCT02809053|102091835|FG000|Overall Study|Death|0|||
33601171|NCT02809053|102091836|FG001|Overall Study|Death|1|||
33601172|NCT02809053|102091835|FG000|Overall Study|Lost to Follow-up|3|||
33601173|NCT02809053|102091836|FG001|Overall Study|Lost to Follow-up|1|||
33601174|NCT02809053|102091835|FG000|Overall Study|Withdrawal by Subject|2|||
33601175|NCT02809053|102091836|FG001|Overall Study|Withdrawal by Subject|3|||
33306711|NCT00467285|101017136|FG001|Overall Study|Lost to Follow-up|4|||
33499524|NCT00507455|101720383|FG000|Overall Study|Lack of Efficacy|0|||
33499525|NCT00507455|101720384|FG001|Overall Study|Lack of Efficacy|1|||
33499526|NCT00507455|101720385|FG002|Overall Study|Lack of Efficacy|0|||
33499527|NCT00507455|101720383|FG000|Overall Study|Other - miscellaneous reason|1|||
33499528|NCT00507455|101720384|FG001|Overall Study|Other - miscellaneous reason|0|||
33499529|NCT00507455|101720385|FG002|Overall Study|Other - miscellaneous reason|1|||
33499530|NCT01778530|101720386|FG000|Overall Study|Progression on study|1|||
33499531|NCT01778530|101720386|FG000|Overall Study|Adverse event/side effect|1|||
33499532|NCT00855894|101720388|FG000|Overall Study|Death|31|||
33499533|NCT00855894|101720388|FG000|Overall Study|Patient's decision|1|||
33499534|NCT00855894|101720388|FG000|Overall Study|Disease progression|1|||
33499535|NCT00030901|101720389|FG000|Initial Registration|Ineligible|167|||
33499536|NCT00030901|101720390|FG001|Initial Registration|Ineligible|0|||
33499537|NCT00030901|101720391|FG002|Initial Registration|Ineligible|0|||
33499538|NCT00030901|101720389|FG000|Randomization|Adverse Event|0|||
33499539|NCT00030901|101720390|FG001|Randomization|Adverse Event|11|||
33499540|NCT00030901|101720391|FG002|Randomization|Adverse Event|7|||
33499541|NCT00030901|101720389|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
33499542|NCT00030901|101720390|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
33499543|NCT00030901|101720391|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
33499544|NCT00030901|101720389|FG000|Randomization|Progression/Relapse|0|||
33499545|NCT00030901|101720390|FG001|Randomization|Progression/Relapse|22|||
33499546|NCT00030901|101720391|FG002|Randomization|Progression/Relapse|21|||
33499547|NCT00030901|101720389|FG000|Randomization|Death|0|||
33499548|NCT00030901|101720390|FG001|Randomization|Death|1|||
33499549|NCT00030901|101720391|FG002|Randomization|Death|3|||
33499550|NCT00030901|101720389|FG000|Randomization|Other|0|||
33306712|NCT03836716|101017141|FG000|Overall Study|Adverse Event|3|||
33306713|NCT03836716|101017141|FG000|Overall Study|Death|22|||
33499551|NCT00030901|101720390|FG001|Randomization|Other|36|||
33601176|NCT02809053|102091835|FG000|Overall Study|Disease Progression|2|||
33601177|NCT02809053|102091836|FG001|Overall Study|Disease Progression|1|||
33499552|NCT00030901|101720391|FG002|Randomization|Other|33|||
33499553|NCT00030901|101720389|FG000|Randomization|Ineligible|0|||
33499554|NCT00030901|101720390|FG001|Randomization|Ineligible|15|||
33499555|NCT00030901|101720391|FG002|Randomization|Ineligible|14|||
33499556|NCT01164579|101720392|FG000|Overall Study|Lack of Efficacy|0|||
33499557|NCT01164579|101720393|FG001|Overall Study|Lack of Efficacy|0|||
33499558|NCT01164579|101720394|FG002|Overall Study|Lack of Efficacy|6|||
33499559|NCT01164579|101720392|FG000|Overall Study|Lost to Follow-up|1|||
33601178|NCT01522404|102091840|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
33601179|NCT01522404|102091841|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
33499560|NCT01164579|101720393|FG001|Overall Study|Lost to Follow-up|1|||
33499561|NCT01164579|101720394|FG002|Overall Study|Lost to Follow-up|0|||
33499562|NCT01164579|101720392|FG000|Overall Study|Withdrawal by Subject|2|||
33499563|NCT01164579|101720393|FG001|Overall Study|Withdrawal by Subject|5|||
33499564|NCT01164579|101720394|FG002|Overall Study|Withdrawal by Subject|3|||
33499565|NCT01164579|101720392|FG000|Overall Study|Protocol Violation|0|||
33499566|NCT01164579|101720393|FG001|Overall Study|Protocol Violation|1|||
33499567|NCT01164579|101720394|FG002|Overall Study|Protocol Violation|2|||
33499568|NCT01164579|101720392|FG000|Overall Study|Adverse Event|4|||
33306714|NCT03836716|101017141|FG000|Overall Study|Withdrawal by Subject|8|||
33306715|NCT03836716|101017141|FG000|Overall Study|Study terminated by sponsor|87|||
33499569|NCT01164579|101720393|FG001|Overall Study|Adverse Event|2|||
33499570|NCT01164579|101720394|FG002|Overall Study|Adverse Event|5|||
33499571|NCT01164579|101720392|FG000|Overall Study|Reason not specified|1|||
33499572|NCT01164579|101720393|FG001|Overall Study|Reason not specified|0|||
33499573|NCT01164579|101720394|FG002|Overall Study|Reason not specified|0|||
33499574|NCT00789854|101720395|FG000|Overall Study|Adverse Event|28|||
33601180|NCT01522404|102091840|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
33601181|NCT01522404|102091841|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
33601182|NCT01522404|102091840|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
33601183|NCT01522404|102091841|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
33601184|NCT02230683|102091842|FG000|Overall Study|Adverse Event|1|||
33601185|NCT03761394|102091843|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
33601186|NCT03761394|102091844|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
33601187|NCT03761394|102091845|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
33499575|NCT00789854|101720396|FG001|Overall Study|Adverse Event|23|||
33499576|NCT00789854|101720397|FG002|Overall Study|Adverse Event|18|||
33601188|NCT03761394|102091846|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
33601189|NCT03761394|102091843|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
33601190|NCT03761394|102091844|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
33306716|NCT01983254|101017148|FG000|Overall Study|Death|6|||
33306717|NCT01983254|101017149|FG001|Overall Study|Death|6|||
33499577|NCT00789854|101720395|FG000|Overall Study|Lost to Follow-up|1|||
33499578|NCT00789854|101720396|FG001|Overall Study|Lost to Follow-up|1|||
33499579|NCT00789854|101720397|FG002|Overall Study|Lost to Follow-up|4|||
33499580|NCT00789854|101720395|FG000|Overall Study|Withdrawal by Subject|9|||
33499581|NCT00789854|101720396|FG001|Overall Study|Withdrawal by Subject|6|||
33499582|NCT00789854|101720397|FG002|Overall Study|Withdrawal by Subject|17|||
33499583|NCT00789854|101720395|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33499584|NCT00789854|101720396|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
33499585|NCT00789854|101720397|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
33499586|NCT00789854|101720395|FG000|Overall Study|Severe non-compliance to the protocol|3|||
33499587|NCT00789854|101720396|FG001|Overall Study|Severe non-compliance to the protocol|0|||
33499588|NCT00789854|101720397|FG002|Overall Study|Severe non-compliance to the protocol|0|||
33499589|NCT00789854|101720395|FG000|Overall Study|Safety reasons|0|||
33499590|NCT00789854|101720396|FG001|Overall Study|Safety reasons|0|||
33499591|NCT00789854|101720397|FG002|Overall Study|Safety reasons|2|||
33499592|NCT00789854|101720395|FG000|Overall Study|Other|6|||
33499593|NCT00789854|101720396|FG001|Overall Study|Other|0|||
33499594|NCT00789854|101720397|FG002|Overall Study|Other|5|||
33499595|NCT02588612|101720401|FG000|Overall Study|Physician Decision|1|||
33499596|NCT02588612|101720401|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
33499597|NCT02588612|101720401|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
33499598|NCT02588612|101720401|FG000|Overall Study|Death prior to T-cell infusion|1|||
33499599|NCT00351468|101720402|FG000|Overall Study|Adverse Event|42|||
33499600|NCT00351468|101720402|FG000|Overall Study|Withdrawal by Subject|39|||
33601191|NCT03761394|102091845|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
33306718|NCT01983254|101017148|FG000|Overall Study|Lost to Follow-up|17|||
33499601|NCT00351468|101720402|FG000|Overall Study|Various -follow up w clinical team|39|||
33499602|NCT00351468|101720402|FG000|Overall Study|Lack of Efficacy|32|||
33499603|NCT00351468|101720402|FG000|Overall Study|Non-compliance|8|||
33499604|NCT00351468|101720402|FG000|Overall Study|Lost to Follow-up|4|||
33499605|NCT00351468|101720402|FG000|Overall Study|Protocol Violation|3|||
33499606|NCT00832455|101720403|FG000|Overall Study|Adverse Event|13|||
33499607|NCT00832455|101720403|FG000|Overall Study|Lost to Follow-up|26|||
33499608|NCT00832455|101720403|FG000|Overall Study|Protocol Violation|4|||
33499609|NCT00832455|101720403|FG000|Overall Study|Withdrawal by Subject|17|||
33499610|NCT00832455|101720403|FG000|Overall Study|Screening Failure|2|||
33499611|NCT00832455|101720403|FG000|Overall Study|Stopped Medication|4|||
33601192|NCT03761394|102091846|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
33601193|NCT03761394|102091843|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
33499612|NCT00832455|101720403|FG000|Overall Study|Parent misunderstood study|1|||
33499613|NCT00832455|101720403|FG000|Overall Study|Parent dissatisfied|1|||
33499614|NCT00832455|101720403|FG000|Overall Study|No improvement|3|||
33499615|NCT00832455|101720403|FG000|Overall Study|Patient moved|1|||
33499616|NCT00077207|101720404|FG000|Overall Study|Adverse Event|5|||
33499617|NCT00077207|101720404|FG000|Overall Study|Lack of Efficacy|12|||
33499618|NCT00077207|101720404|FG000|Overall Study|Physician Decision|6|||
33499619|NCT00077207|101720404|FG000|Overall Study|Withdrawal by Subject|6|||
33499620|NCT00077207|101720404|FG000|Overall Study|Ineligible|1|||
33499621|NCT04830969|101720406|FG000|Overall Study|Withdrawal by Subject|6|||
33499622|NCT04830969|101720407|FG001|Overall Study|Withdrawal by Subject|2|||
33499623|NCT04830969|101720406|FG000|Overall Study|Protocol Violation|3|||
33499624|NCT04830969|101720407|FG001|Overall Study|Protocol Violation|9|||
33499625|NCT04830969|101720406|FG000|Overall Study|Lost to Follow-up|4|||
33499626|NCT04830969|101720407|FG001|Overall Study|Lost to Follow-up|4|||
33499627|NCT03922308|101720408|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
33499628|NCT03922308|101720409|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
33499629|NCT03922308|101720410|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
33499630|NCT03922308|101720408|FG000|Overall Study|Lost to Follow-up|1|||
33499631|NCT03922308|101720409|FG001|Overall Study|Lost to Follow-up|0|||
33499632|NCT03922308|101720410|FG002|Overall Study|Lost to Follow-up|0|||
33499633|NCT03922308|101720408|FG000|Overall Study|Reason not Specified|0|||
33499634|NCT03922308|101720409|FG001|Overall Study|Reason not Specified|2|||
33499635|NCT03922308|101720410|FG002|Overall Study|Reason not Specified|1|||
33499636|NCT00734994|101720411|FG000|Overall Study|Withdrawal by Subject|1|||
33499637|NCT02431676|101720414|FG000|Overall Study|no lab obtained|0|||
33499638|NCT02431676|101720415|FG001|Overall Study|no lab obtained|1|||
33499639|NCT02431676|101720416|FG002|Overall Study|no lab obtained|2|||
33499640|NCT00764660|101720419|FG000|Overall Study|Adverse Event|6|||
33499641|NCT00764660|101720420|FG001|Overall Study|Adverse Event|3|||
33499642|NCT00764660|101720419|FG000|Overall Study|Lost to Follow-up|3|||
33499643|NCT00764660|101720420|FG001|Overall Study|Lost to Follow-up|4|||
33499644|NCT00764660|101720419|FG000|Overall Study|Withdrawal by Subject|7|||
33499645|NCT00764660|101720420|FG001|Overall Study|Withdrawal by Subject|3|||
33499646|NCT00764660|101720419|FG000|Overall Study|Noncompliance With Protocol|5|||
33499647|NCT00764660|101720420|FG001|Overall Study|Noncompliance With Protocol|1|||
33499648|NCT00764660|101720419|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
33499649|NCT00764660|101720420|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
33499650|NCT00595920|101720423|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
33499651|NCT03570619|101720424|FG000|Overall Study|Adverse Event|2|||
33499652|NCT03570619|101720425|FG001|Overall Study|Adverse Event|0|||
33499653|NCT03570619|101720426|FG002|Overall Study|Adverse Event|1|||
33499654|NCT03570619|101720424|FG000|Overall Study|new diagnosis of new malignancy|1|||
33499655|NCT03570619|101720425|FG001|Overall Study|new diagnosis of new malignancy|0|||
33499656|NCT03570619|101720426|FG002|Overall Study|new diagnosis of new malignancy|0|||
33499657|NCT03570619|101720424|FG000|Overall Study|Physician Decision|1|||
33499658|NCT03570619|101720425|FG001|Overall Study|Physician Decision|1|||
33499659|NCT03570619|101720426|FG002|Overall Study|Physician Decision|0|||
33499660|NCT03570619|101720424|FG000|Overall Study|Withdrawal by Subject|0|||
33499661|NCT03570619|101720425|FG001|Overall Study|Withdrawal by Subject|2|||
33499662|NCT03570619|101720426|FG002|Overall Study|Withdrawal by Subject|0|||
33499663|NCT01303172|101720427|FG000|Overall Study|Physician Decision|9|||
33499664|NCT01303172|101720428|FG001|Overall Study|Physician Decision|6|||
33499665|NCT01303172|101720427|FG000|Overall Study|Adverse Event|5|||
33601194|NCT03761394|102091844|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
33601195|NCT03761394|102091845|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
33601196|NCT03761394|102091846|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
33601197|NCT03761394|102091843|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
33601198|NCT03761394|102091844|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
33601199|NCT03761394|102091845|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
33499666|NCT01303172|101720428|FG001|Overall Study|Adverse Event|2|||
33499667|NCT01303172|101720427|FG000|Overall Study|Withdrawal by Subject|4|||
33499668|NCT01303172|101720428|FG001|Overall Study|Withdrawal by Subject|2|||
33601200|NCT03761394|102091846|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
33499669|NCT01303172|101720427|FG000|Overall Study|Death|20|||
33499670|NCT01303172|101720428|FG001|Overall Study|Death|7|||
33499671|NCT01303172|101720427|FG000|Overall Study|Lack of Efficacy|25|||
33499672|NCT01303172|101720428|FG001|Overall Study|Lack of Efficacy|17|||
33499673|NCT03103152|101720429|FG000|Overall Study|Physician Decision|5|||
33499674|NCT03103152|101720430|FG001|Overall Study|Physician Decision|2|||
33499675|NCT03103152|101720431|FG002|Overall Study|Physician Decision|6|||
33499676|NCT03103152|101720432|FG003|Overall Study|Physician Decision|3|||
33499677|NCT03103152|101720433|FG004|Overall Study|Physician Decision|3|||
33499678|NCT03103152|101720434|FG005|Overall Study|Physician Decision|1|||
33499679|NCT03103152|101720429|FG000|Overall Study|Protocol Violation|2|||
33499680|NCT03103152|101720430|FG001|Overall Study|Protocol Violation|2|||
33499681|NCT03103152|101720431|FG002|Overall Study|Protocol Violation|1|||
33499682|NCT03103152|101720432|FG003|Overall Study|Protocol Violation|2|||
33499683|NCT03103152|101720433|FG004|Overall Study|Protocol Violation|1|||
33499684|NCT03103152|101720434|FG005|Overall Study|Protocol Violation|1|||
33499685|NCT03103152|101720429|FG000|Overall Study|Inter-current illness|0|||
33499686|NCT03103152|101720430|FG001|Overall Study|Inter-current illness|0|||
33499687|NCT03103152|101720431|FG002|Overall Study|Inter-current illness|1|||
33499688|NCT03103152|101720432|FG003|Overall Study|Inter-current illness|0|||
33499689|NCT03103152|101720433|FG004|Overall Study|Inter-current illness|0|||
33499690|NCT03103152|101720434|FG005|Overall Study|Inter-current illness|0|||
33499691|NCT03103152|101720429|FG000|Overall Study|Death|0|||
33191274|NCT00528528|100605176|FG001|Overall Study|Withdrawal by Subject|2|||
33191275|NCT00528528|100605177|FG002|Overall Study|Withdrawal by Subject|1|||
33191276|NCT00528528|100605178|FG003|Overall Study|Withdrawal by Subject|1|||
33191277|NCT00528528|100605175|FG000|Overall Study|Ongoing participant|0|||
33191278|NCT00528528|100605176|FG001|Overall Study|Ongoing participant|0|||
33191279|NCT00528528|100605177|FG002|Overall Study|Ongoing participant|1|||
33191280|NCT00528528|100605178|FG003|Overall Study|Ongoing participant|0|||
33191281|NCT02059148|100605179|FG000|Treatment 1|Protocol Violation|0|||
33191282|NCT02059148|100605180|FG001|Treatment 1|Protocol Violation|0|||
33191283|NCT02059148|100605181|FG002|Treatment 1|Protocol Violation|0|||
33191284|NCT02059148|100605182|FG003|Treatment 1|Protocol Violation|0|||
33191285|NCT02059148|100605183|FG004|Treatment 1|Protocol Violation|0|||
33191286|NCT02059148|100605184|FG005|Treatment 1|Protocol Violation|1|||
33191287|NCT00826267|100605185|FG000|Overall Study|Other Adverse Event|1|||
33191288|NCT00826267|100605186|FG001|Overall Study|Other Adverse Event|0|||
33191289|NCT00826267|100605187|FG002|Overall Study|Other Adverse Event|0|||
33191290|NCT01700179|100605192|FG000|Overall Study|Physician Decision|2|||
33191291|NCT00502697|100605193|FG000|Overall Study|Withdrawal by Subject|3|||
33191292|NCT00502697|100605194|FG001|Overall Study|Withdrawal by Subject|1|||
33191293|NCT00502697|100605193|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
33191294|NCT00502697|100605194|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
33191295|NCT00502697|100605193|FG000|Overall Study|found not to meet eligibility criteria|3|||
33499692|NCT03103152|101720430|FG001|Overall Study|Death|1|||
33499693|NCT03103152|101720431|FG002|Overall Study|Death|0|||
33191296|NCT00502697|100605194|FG001|Overall Study|found not to meet eligibility criteria|4|||
33191297|NCT00502697|100605193|FG000|Overall Study|did not meet assignment criteria|4|||
33191298|NCT00502697|100605194|FG001|Overall Study|did not meet assignment criteria|2|||
33191299|NCT01387607|100605201|FG000|Overall Study|Adverse Event|23|||
33191300|NCT01387607|100605202|FG001|Overall Study|Adverse Event|11|||
33191301|NCT01387607|100605201|FG000|Overall Study|Lack of Efficacy|8|||
33191302|NCT01387607|100605202|FG001|Overall Study|Lack of Efficacy|6|||
33191303|NCT01387607|100605201|FG000|Overall Study|Lost to Follow-up|2|||
33191304|NCT01387607|100605202|FG001|Overall Study|Lost to Follow-up|1|||
33191305|NCT01387607|100605201|FG000|Overall Study|No longer meets eligibility criteria|0|||
33191306|NCT01387607|100605202|FG001|Overall Study|No longer meets eligibility criteria|1|||
33191307|NCT01387607|100605201|FG000|Overall Study|Protocol Violation|1|||
33306719|NCT01983254|101017149|FG001|Overall Study|Lost to Follow-up|16|||
33306720|NCT01983254|101017148|FG000|Overall Study|too ill|11|||
33306721|NCT01983254|101017149|FG001|Overall Study|too ill|8|||
33306722|NCT01867333|101017150|FG000|Overall Study|Withdrawal by Subject|1|||
33306723|NCT01867333|101017151|FG001|Overall Study|Withdrawal by Subject|0|||
33499694|NCT03103152|101720432|FG003|Overall Study|Death|0|||
33499695|NCT03103152|101720433|FG004|Overall Study|Death|0|||
33601201|NCT02616393|102091847|FG000|Overall Study|Death|5|||
33601202|NCT02616393|102091848|FG001|Overall Study|Death|12|||
33191308|NCT01387607|100605202|FG001|Overall Study|Protocol Violation|5|||
33191309|NCT01387607|100605201|FG000|Overall Study|Withdrawal by Subject|13|||
33191310|NCT01387607|100605202|FG001|Overall Study|Withdrawal by Subject|14|||
33191311|NCT01387607|100605201|FG000|Overall Study|Other|1|||
33306724|NCT01867333|101017150|FG000|Overall Study|Adverse Event|1|||
33306725|NCT01867333|101017151|FG001|Overall Study|Adverse Event|0|||
33499696|NCT03103152|101720434|FG005|Overall Study|Death|0|||
33499697|NCT03103152|101720429|FG000|Overall Study|Adverse Event|0|||
33499698|NCT03103152|101720430|FG001|Overall Study|Adverse Event|0|||
33499699|NCT03103152|101720431|FG002|Overall Study|Adverse Event|1|||
33499700|NCT03103152|101720432|FG003|Overall Study|Adverse Event|0|||
33499701|NCT03103152|101720433|FG004|Overall Study|Adverse Event|0|||
33499702|NCT03103152|101720434|FG005|Overall Study|Adverse Event|1|||
33499703|NCT03103152|101720429|FG000|Overall Study|Withdrawal by Subject|1|||
33499704|NCT03103152|101720430|FG001|Overall Study|Withdrawal by Subject|0|||
33499705|NCT03103152|101720431|FG002|Overall Study|Withdrawal by Subject|1|||
33499706|NCT03103152|101720432|FG003|Overall Study|Withdrawal by Subject|1|||
33499707|NCT03103152|101720433|FG004|Overall Study|Withdrawal by Subject|1|||
33499708|NCT03103152|101720434|FG005|Overall Study|Withdrawal by Subject|1|||
33499709|NCT03103152|101720429|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
33191312|NCT01387607|100605202|FG001|Overall Study|Other|1|||
33191313|NCT01387607|100605201|FG000|Overall Study|Randomized, not treated|3|||
33191314|NCT01387607|100605202|FG001|Overall Study|Randomized, not treated|6|||
33191315|NCT01852292|100605203|FG000|Overall Study|Untreated - did not receive study drug|3|||
33191316|NCT01852292|100605204|FG001|Overall Study|Untreated - did not receive study drug|1|||
33191317|NCT01852292|100605203|FG000|Overall Study|Death|9|||
33191318|NCT01852292|100605204|FG001|Overall Study|Death|8|||
33191319|NCT01852292|100605203|FG000|Overall Study|Patient/guardian decision|8|||
33191320|NCT01852292|100605204|FG001|Overall Study|Patient/guardian decision|4|||
33191321|NCT01852292|100605203|FG000|Overall Study|Adverse Event|8|||
33191322|NCT01852292|100605204|FG001|Overall Study|Adverse Event|11|||
33191323|NCT01852292|100605203|FG000|Overall Study|Physician Decision|6|||
33191324|NCT01852292|100605204|FG001|Overall Study|Physician Decision|2|||
33191325|NCT01852292|100605203|FG000|Overall Study|Protocol Violation|2|||
33191326|NCT01852292|100605204|FG001|Overall Study|Protocol Violation|0|||
33191327|NCT01852292|100605203|FG000|Overall Study|Non-compliance with study treatment|1|||
33191328|NCT01852292|100605204|FG001|Overall Study|Non-compliance with study treatment|0|||
33191329|NCT01852292|100605203|FG000|Overall Study|Study terminated by Sponsor|0|||
33191330|NCT01852292|100605204|FG001|Overall Study|Study terminated by Sponsor|1|||
33191331|NCT01852292|100605203|FG000|Overall Study|Progressive disease|42|||
33191332|NCT01852292|100605204|FG001|Overall Study|Progressive disease|52|||
33191333|NCT00004031|100605205|FG000|Overall Study|Adverse Event|5|||
33191334|NCT00004031|100605206|FG001|Overall Study|Adverse Event|0|||
33191335|NCT00004031|100605205|FG000|Overall Study|Refusal unrelated to adverse events|2|||
33191336|NCT00004031|100605206|FG001|Overall Study|Refusal unrelated to adverse events|11|||
33191337|NCT00004031|100605205|FG000|Overall Study|Progression/relapse|9|||
33191338|NCT00004031|100605206|FG001|Overall Study|Progression/relapse|4|||
33191339|NCT00004031|100605205|FG000|Overall Study|Death|3|||
33191340|NCT00004031|100605206|FG001|Overall Study|Death|1|||
33191341|NCT00004031|100605205|FG000|Overall Study|Other- not protocol specified|3|||
33191342|NCT00004031|100605206|FG001|Overall Study|Other- not protocol specified|3|||
33191343|NCT00004031|100605205|FG000|Overall Study|Reason under review|3|||
33191344|NCT00004031|100605206|FG001|Overall Study|Reason under review|2|||
33191345|NCT01782313|100605207|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
33191346|NCT01782313|100605207|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
33191347|NCT01782313|100605207|FG000|Treated Cycle 3|Progressive Disease|21|||
33191348|NCT01782313|100605207|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
33191349|NCT01782313|100605207|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
33191350|NCT01782313|100605207|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
33191351|NCT01782313|100605207|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
33191352|NCT01782313|100605207|FG000|Survival Follow up|Lost to Follow-up|1|||
33191353|NCT03568942|100605208|FG000|Overall Study|Family emergency|1|||
33191354|NCT03568942|100605208|FG000|Overall Study|Lost to Follow-up|1|||
33191355|NCT02287896|100605209|FG000|Second Injection Visit|Withdrawal by Subject|0|||
33191356|NCT02287896|100605210|FG001|Second Injection Visit|Withdrawal by Subject|1|||
33191357|NCT02434770|100605212|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
33191358|NCT02434770|100605213|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
33191359|NCT02434770|100605214|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
33191360|NCT02434770|100605212|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
33191361|NCT02434770|100605213|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
33191362|NCT02434770|100605214|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
33191363|NCT02434770|100605212|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
33499710|NCT03103152|101720430|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
33499711|NCT03103152|101720431|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
33499712|NCT03103152|101720432|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
33191364|NCT02434770|100605213|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
33191365|NCT02434770|100605214|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
33306726|NCT01867333|101017150|FG000|Overall Study|Participant choice|1|||
33601203|NCT02616393|102091849|FG002|Overall Study|Death|1|||
33191366|NCT02434770|100605212|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
33499713|NCT03103152|101720433|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
33601204|NCT02616393|102091847|FG000|Overall Study|Termination by Sponsor|4|||
33191367|NCT02434770|100605213|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
33191368|NCT02434770|100605214|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
33191369|NCT02434770|100605212|FG000|Week 1 to Week 18|Death|1|||
33191370|NCT02434770|100605213|FG001|Week 1 to Week 18|Death|0|||
33191371|NCT02434770|100605214|FG002|Week 1 to Week 18|Death|0|||
33191372|NCT02434770|100605212|FG000|Week 18 to Week|Lost to Follow-up|2|||
33191373|NCT02434770|100605213|FG001|Week 18 to Week|Lost to Follow-up|2|||
33191374|NCT02434770|100605214|FG002|Week 18 to Week|Lost to Follow-up|1|||
33191375|NCT02434770|100605212|FG000|Week 18 to Week|Withdrawal by Subject|0|||
33191376|NCT02434770|100605213|FG001|Week 18 to Week|Withdrawal by Subject|0|||
33191377|NCT02434770|100605214|FG002|Week 18 to Week|Withdrawal by Subject|2|||
33191378|NCT02434770|100605212|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
33191379|NCT02434770|100605213|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
33191380|NCT02434770|100605214|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
33191381|NCT02388737|100605215|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
33191382|NCT02388737|100605216|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
33191383|NCT02388737|100605217|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
33191384|NCT02388737|100605215|FG000|Overall Study|Major Protocol Deviation|18|||
33191385|NCT02388737|100605216|FG001|Overall Study|Major Protocol Deviation|25|||
33191386|NCT02388737|100605217|FG002|Overall Study|Major Protocol Deviation|22|||
33499714|NCT03103152|101720434|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
33499715|NCT03103152|101720429|FG000|Overall Study|Unacceptable side effects|0|||
33499716|NCT03103152|101720430|FG001|Overall Study|Unacceptable side effects|0|||
33499717|NCT03103152|101720431|FG002|Overall Study|Unacceptable side effects|0|||
33499718|NCT03103152|101720432|FG003|Overall Study|Unacceptable side effects|0|||
33499719|NCT03103152|101720433|FG004|Overall Study|Unacceptable side effects|0|||
33499720|NCT03103152|101720434|FG005|Overall Study|Unacceptable side effects|1|||
33499721|NCT03103152|101720429|FG000|Overall Study|Lost to Follow-up|0|||
33499722|NCT03103152|101720430|FG001|Overall Study|Lost to Follow-up|1|||
33499723|NCT03103152|101720431|FG002|Overall Study|Lost to Follow-up|0|||
33499724|NCT03103152|101720432|FG003|Overall Study|Lost to Follow-up|1|||
33499725|NCT03103152|101720433|FG004|Overall Study|Lost to Follow-up|0|||
33601205|NCT02616393|102091848|FG001|Overall Study|Termination by Sponsor|5|||
33601206|NCT02616393|102091849|FG002|Overall Study|Termination by Sponsor|2|||
33499726|NCT03103152|101720434|FG005|Overall Study|Lost to Follow-up|1|||
33499727|NCT03103152|101720429|FG000|Overall Study|Testicular pain|0|||
33499728|NCT03103152|101720430|FG001|Overall Study|Testicular pain|0|||
33499729|NCT03103152|101720431|FG002|Overall Study|Testicular pain|0|||
33601207|NCT02616393|102091847|FG000|Overall Study|Other|3|||
33601208|NCT02616393|102091848|FG001|Overall Study|Other|0|||
33601209|NCT02616393|102091849|FG002|Overall Study|Other|0|||
33601210|NCT02616393|102091847|FG000|Overall Study|Withdrawal by Subject|1|||
33601211|NCT02616393|102091848|FG001|Overall Study|Withdrawal by Subject|1|||
33601212|NCT02616393|102091849|FG002|Overall Study|Withdrawal by Subject|0|||
33601213|NCT02616393|102091847|FG000|Overall Study|Lost to Follow-up|0|||
33601214|NCT02616393|102091848|FG001|Overall Study|Lost to Follow-up|2|||
33601215|NCT02616393|102091849|FG002|Overall Study|Lost to Follow-up|0|||
33601216|NCT04032080|102091851|FG000|Overall Study|Death|6|||
33601217|NCT03099148|102091852|FG000|Wash-out|scheduling conflict|0|||
33601218|NCT03099148|102091853|FG001|Wash-out|scheduling conflict|1|||
33601219|NCT03099148|102091854|FG002|Wash-out|scheduling conflict|0|||
33601220|NCT03099148|102091855|FG003|Wash-out|scheduling conflict|0|||
33601221|NCT03099148|102091852|FG000|Wash-out|Adverse Event|0|||
33601222|NCT03099148|102091853|FG001|Wash-out|Adverse Event|1|||
33601223|NCT03099148|102091854|FG002|Wash-out|Adverse Event|0|||
33601224|NCT03099148|102091855|FG003|Wash-out|Adverse Event|0|||
33601225|NCT03361189|102091858|FG000|Overall Study|Received heart transplant|1|||
33601226|NCT03361189|102091859|FG001|Overall Study|Received heart transplant|0|||
33601227|NCT03361189|102091858|FG000|Overall Study|Pacemake replacement|0|||
33601228|NCT03361189|102091859|FG001|Overall Study|Pacemake replacement|1|||
33601229|NCT00687609|102091860|FG000|Overall Study|Physician Decision|1|||
33601230|NCT00687609|102091860|FG000|Overall Study|Withdrawal by Subject|2|||
33191387|NCT02388737|100605215|FG000|Overall Study|Lost to Follow-up|5|||
33191388|NCT02388737|100605216|FG001|Overall Study|Lost to Follow-up|1|||
33306727|NCT01867333|101017151|FG001|Overall Study|Participant choice|2|||
33499730|NCT03103152|101720432|FG003|Overall Study|Testicular pain|1|||
33601231|NCT02771626|102091861|FG000|Overall Study|Adverse Event|1|||
33601232|NCT02771626|102091862|FG001|Overall Study|Adverse Event|5|||
33601233|NCT02771626|102091863|FG002|Overall Study|Adverse Event|3|||
33601234|NCT02771626|102091864|FG003|Overall Study|Adverse Event|0|||
33601235|NCT02771626|102091865|FG004|Overall Study|Adverse Event|1|||
33306728|NCT01867333|101017150|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
33499731|NCT03103152|101720433|FG004|Overall Study|Testicular pain|0|||
33499732|NCT03103152|101720434|FG005|Overall Study|Testicular pain|0|||
33499733|NCT02861807|101720435|FG000|Overall Study|Lost to Follow-up|7|||
33601236|NCT02771626|102091866|FG005|Overall Study|Adverse Event|1|||
33191389|NCT02388737|100605217|FG002|Overall Study|Lost to Follow-up|4|||
33601237|NCT02771626|102091861|FG000|Overall Study|Radiologic Disease Progression|6|||
33191390|NCT02388737|100605215|FG000|Overall Study|Voluntary Withdrawal|10|||
33601238|NCT02771626|102091862|FG001|Overall Study|Radiologic Disease Progression|13|||
33601239|NCT02771626|102091863|FG002|Overall Study|Radiologic Disease Progression|10|||
33601240|NCT02771626|102091864|FG003|Overall Study|Radiologic Disease Progression|7|||
33191391|NCT02388737|100605216|FG001|Overall Study|Voluntary Withdrawal|18|||
33191392|NCT02388737|100605217|FG002|Overall Study|Voluntary Withdrawal|17|||
33191393|NCT02388737|100605215|FG000|Overall Study|Lack of Efficacy|3|||
33191394|NCT02388737|100605216|FG001|Overall Study|Lack of Efficacy|0|||
33306729|NCT01867333|101017151|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
33306730|NCT01867333|101017150|FG000|Overall Study|Death|0|||
33306731|NCT01867333|101017151|FG001|Overall Study|Death|1|||
33306732|NCT01867333|101017150|FG000|Overall Study|Physician Decision|3|||
33306733|NCT01867333|101017151|FG001|Overall Study|Physician Decision|2|||
33306734|NCT01867333|101017150|FG000|Overall Study|Switched to alternative treatment|1|||
33306735|NCT01867333|101017151|FG001|Overall Study|Switched to alternative treatment|0|||
33306736|NCT01789567|101017152|FG000|Overall Study|Death|6|||
33306737|NCT01967147|101017153|FG000|Overall Study|Adverse Event|5|||
33306738|NCT01967147|101017154|FG001|Overall Study|Adverse Event|2|||
33306739|NCT01967147|101017153|FG000|Overall Study|Lack of Efficacy|1|||
33306740|NCT01967147|101017154|FG001|Overall Study|Lack of Efficacy|4|||
33306741|NCT01967147|101017153|FG000|Overall Study|Lost to Follow-up|1|||
33306742|NCT01967147|101017154|FG001|Overall Study|Lost to Follow-up|2|||
33306743|NCT01967147|101017153|FG000|Overall Study|Withdrawal by Subject|2|||
33306744|NCT01967147|101017154|FG001|Overall Study|Withdrawal by Subject|4|||
33306745|NCT01967147|101017153|FG000|Overall Study|Non-compliance with Study Drug|0|||
33306746|NCT01967147|101017154|FG001|Overall Study|Non-compliance with Study Drug|3|||
33306747|NCT01967147|101017153|FG000|Overall Study|Other|4|||
33306748|NCT01967147|101017154|FG001|Overall Study|Other|5|||
33306749|NCT00141219|101017155|FG000|Overall Study|Protocol violations|5|||
33306750|NCT00141219|101017156|FG001|Overall Study|Protocol violations|4|||
33306751|NCT00141219|101017155|FG000|Overall Study|Adverse Event|8|||
33306752|NCT00141219|101017156|FG001|Overall Study|Adverse Event|6|||
33306753|NCT00141219|101017155|FG000|Overall Study|Lack of Efficacy|5|||
33306754|NCT00141219|101017156|FG001|Overall Study|Lack of Efficacy|4|||
33306755|NCT00141219|101017155|FG000|Overall Study|Withdrawal by Subject|6|||
33306756|NCT00141219|101017156|FG001|Overall Study|Withdrawal by Subject|2|||
33306757|NCT02075073|101017158|FG000|Overall Study|Withdrawal by Subject|0|||
33306758|NCT02075073|101017159|FG001|Overall Study|Withdrawal by Subject|1|||
33306759|NCT02075073|101017160|FG002|Overall Study|Withdrawal by Subject|0|||
33306760|NCT00657020|101017161|FG000|PERIOD 1|Adverse Event|0|||
33306761|NCT00657020|101017162|FG001|PERIOD 1|Adverse Event|1|||
33306762|NCT00296400|101017167|FG000|Overall Study|Adverse Event|7|||
33306763|NCT00296400|101017168|FG001|Overall Study|Adverse Event|7|||
33306764|NCT00296400|101017169|FG002|Overall Study|Adverse Event|7|||
33306765|NCT00296400|101017167|FG000|Overall Study|Withdrawal by Subject|5|||
33191395|NCT02388737|100605217|FG002|Overall Study|Lack of Efficacy|3|||
33191396|NCT02388737|100605215|FG000|Overall Study|Reason Not Specified|5|||
33191397|NCT02388737|100605216|FG001|Overall Study|Reason Not Specified|5|||
33191398|NCT02388737|100605217|FG002|Overall Study|Reason Not Specified|4|||
33306766|NCT00296400|101017168|FG001|Overall Study|Withdrawal by Subject|6|||
33306767|NCT00296400|101017169|FG002|Overall Study|Withdrawal by Subject|2|||
33306768|NCT00296400|101017167|FG000|Overall Study|Incorrect enrollment|2|||
33306769|NCT00296400|101017168|FG001|Overall Study|Incorrect enrollment|0|||
33306770|NCT00296400|101017169|FG002|Overall Study|Incorrect enrollment|0|||
33306771|NCT00296400|101017167|FG000|Overall Study|Protocol Violation|1|||
33306772|NCT00296400|101017168|FG001|Overall Study|Protocol Violation|1|||
33499734|NCT02861807|101720436|FG001|Overall Study|Lost to Follow-up|6|||
33191399|NCT00240071|100605218|FG000|Overall Study|Withdrawal by Subject|3|||
33306773|NCT00296400|101017169|FG002|Overall Study|Protocol Violation|1|||
33306774|NCT00296400|101017167|FG000|Overall Study|Lost to Follow-up|1|||
33306775|NCT00296400|101017168|FG001|Overall Study|Lost to Follow-up|1|||
33306776|NCT00296400|101017169|FG002|Overall Study|Lost to Follow-up|2|||
33224258|NCT01672853|100721766|FG002|Overall Study|Adverse Event|8|||
33306777|NCT00296400|101017167|FG000|Overall Study|Study specific discontinuation criteria|0|||
33499735|NCT02861807|101720435|FG000|Overall Study|Withdrawal by Subject|5|||
33499736|NCT02861807|101720436|FG001|Overall Study|Withdrawal by Subject|8|||
33499737|NCT02841995|101720444|FG000|Overall Study|Disease progression|5|||
33499738|NCT02841995|101720445|FG001|Overall Study|Disease progression|11|||
33499739|NCT02841995|101720446|FG002|Overall Study|Disease progression|8|||
33499740|NCT02841995|101720444|FG000|Overall Study|Withdrawal by Subject|2|||
33499741|NCT02841995|101720445|FG001|Overall Study|Withdrawal by Subject|4|||
33499742|NCT02841995|101720446|FG002|Overall Study|Withdrawal by Subject|4|||
33499743|NCT02841995|101720444|FG000|Overall Study|Adverse Event|2|||
33499744|NCT02841995|101720445|FG001|Overall Study|Adverse Event|0|||
33499745|NCT02841995|101720446|FG002|Overall Study|Adverse Event|1|||
33499746|NCT02841995|101720444|FG000|Overall Study|Investigator decision|2|||
33499747|NCT02841995|101720445|FG001|Overall Study|Investigator decision|0|||
33499748|NCT02841995|101720446|FG002|Overall Study|Investigator decision|1|||
33306778|NCT00296400|101017168|FG001|Overall Study|Study specific discontinuation criteria|0|||
33306779|NCT00296400|101017169|FG002|Overall Study|Study specific discontinuation criteria|1|||
33306780|NCT00296400|101017167|FG000|Overall Study|Visit 10 was performed earlier|0|||
33306781|NCT00296400|101017168|FG001|Overall Study|Visit 10 was performed earlier|1|||
33306782|NCT00296400|101017169|FG002|Overall Study|Visit 10 was performed earlier|0|||
33306783|NCT00296400|101017167|FG000|Overall Study|Pregnancy|1|||
33306784|NCT00296400|101017168|FG001|Overall Study|Pregnancy|2|||
33306785|NCT00296400|101017169|FG002|Overall Study|Pregnancy|0|||
33306786|NCT00470366|101017170|FG000|Overall Study|Adverse Event|3|||
33306787|NCT00470366|101017170|FG000|Overall Study|Poor compliance|1|||
33306788|NCT01171807|101017173|FG000|Overall Study|Treatment failure|2|||
33306789|NCT01171807|101017174|FG001|Overall Study|Treatment failure|4|||
33306790|NCT01171807|101017173|FG000|Overall Study|Non compliance|1|||
33306791|NCT01171807|101017174|FG001|Overall Study|Non compliance|0|||
33499749|NCT02841995|101720444|FG000|Overall Study|Death|0|||
33499750|NCT02841995|101720445|FG001|Overall Study|Death|0|||
33499751|NCT02841995|101720446|FG002|Overall Study|Death|2|||
33499752|NCT02841995|101720444|FG000|Overall Study|Noncompliance to protocol|1|||
33499753|NCT02841995|101720445|FG001|Overall Study|Noncompliance to protocol|0|||
33499754|NCT02841995|101720446|FG002|Overall Study|Noncompliance to protocol|0|||
33499755|NCT02841995|101720444|FG000|Overall Study|Sponsor decision|1|||
33499756|NCT02841995|101720445|FG001|Overall Study|Sponsor decision|0|||
33499757|NCT02841995|101720446|FG002|Overall Study|Sponsor decision|0|||
33499758|NCT02841995|101720444|FG000|Overall Study|Other|4|||
33499759|NCT02841995|101720445|FG001|Overall Study|Other|1|||
33499760|NCT02841995|101720446|FG002|Overall Study|Other|5|||
33499761|NCT02522884|101720449|FG000|Overall Study|Withdrawal by Subject|6|||
33306792|NCT01171807|101017173|FG000|Overall Study|Lost to Follow-up|3|||
33306793|NCT01171807|101017174|FG001|Overall Study|Lost to Follow-up|0|||
33306794|NCT01131182|101017175|FG000|Overall Study|Withdrawal by Subject|1|||
33499762|NCT02522884|101720449|FG000|Overall Study|Death|3|||
33499763|NCT02522884|101720449|FG000|Overall Study|Missed 12-month Follow-up|9|||
33499764|NCT00954941|101720456|FG000|Overall Study|Received treatment at home|1|||
33499765|NCT00954941|101720457|FG001|Overall Study|Received treatment at home|0|||
33306795|NCT01131182|101017176|FG001|Overall Study|Withdrawal by Subject|1|||
33306796|NCT01131182|101017175|FG000|Overall Study|Lost to Follow-up|14|||
33306797|NCT01131182|101017176|FG001|Overall Study|Lost to Follow-up|15|||
33499766|NCT00954941|101720456|FG000|Overall Study|Withdrawal by Subject|1|||
33499767|NCT00954941|101720457|FG001|Overall Study|Withdrawal by Subject|0|||
33499768|NCT00954941|101720456|FG000|Overall Study|Insurance Denial|2|||
33306798|NCT01131182|101017175|FG000|Overall Study|Other Reason|1|||
33306799|NCT01131182|101017176|FG001|Overall Study|Other Reason|0|||
33306800|NCT02704754|101017177|FG000|Overall Study|Lost to Follow-up|1|||
33306801|NCT02704754|101017178|FG001|Overall Study|Lost to Follow-up|1|||
33306802|NCT02704754|101017177|FG000|Overall Study|Lack of Efficacy|1|||
33306803|NCT02704754|101017178|FG001|Overall Study|Lack of Efficacy|0|||
33306804|NCT02704754|101017177|FG000|Overall Study|Withdrawal by Subject|1|||
33306805|NCT02704754|101017178|FG001|Overall Study|Withdrawal by Subject|0|||
33306806|NCT00925132|101017179|FG000|Overall Study|Withdrawal by Subject|2|||
33306807|NCT00925132|101017180|FG001|Overall Study|Withdrawal by Subject|0|||
33306808|NCT00925132|101017181|FG002|Overall Study|Withdrawal by Subject|0|||
33306809|NCT00925132|101017182|FG003|Overall Study|Withdrawal by Subject|0|||
33306810|NCT00925132|101017183|FG004|Overall Study|Withdrawal by Subject|1|||
33306811|NCT00925132|101017179|FG000|Overall Study|Removed due to disease progression|0|||
33306812|NCT00925132|101017180|FG001|Overall Study|Removed due to disease progression|0|||
33306813|NCT00925132|101017181|FG002|Overall Study|Removed due to disease progression|0|||
33306814|NCT00925132|101017182|FG003|Overall Study|Removed due to disease progression|0|||
33499769|NCT00954941|101720457|FG001|Overall Study|Insurance Denial|2|||
33499770|NCT00954941|101720456|FG000|Overall Study|Physician Decision|2|||
33499771|NCT00954941|101720457|FG001|Overall Study|Physician Decision|2|||
33499772|NCT00954941|101720456|FG000|Overall Study|Ineligible|2|||
33499773|NCT00954941|101720457|FG001|Overall Study|Ineligible|2|||
33601241|NCT02771626|102091865|FG004|Overall Study|Radiologic Disease Progression|28|||
33601242|NCT02771626|102091866|FG005|Overall Study|Radiologic Disease Progression|15|||
33306815|NCT00925132|101017183|FG004|Overall Study|Removed due to disease progression|4|||
33306816|NCT03705832|101017184|FG000|Overall Study|Physician Decision|0|||
33306817|NCT03705832|101017185|FG001|Overall Study|Physician Decision|1|||
33306818|NCT03705832|101017184|FG000|Overall Study|Withdrawal by Subject|1|||
33499774|NCT00954941|101720456|FG000|Overall Study|Adverse Event|0|||
33499775|NCT00954941|101720457|FG001|Overall Study|Adverse Event|1|||
33601243|NCT02771626|102091861|FG000|Overall Study|Symptomatic Deterioration|0|||
33601244|NCT02771626|102091862|FG001|Overall Study|Symptomatic Deterioration|4|||
33306819|NCT03705832|101017185|FG001|Overall Study|Withdrawal by Subject|0|||
33306820|NCT00423943|101017186|FG000|Overall Study|Withdrawal by Subject|3|||
33306821|NCT00423943|101017187|FG001|Overall Study|Withdrawal by Subject|1|||
33499776|NCT02019472|101720463|FG000|Overall Study|Adverse Event|14|||
33499777|NCT02019472|101720464|FG001|Overall Study|Adverse Event|23|||
33306822|NCT01895101|101017190|FG000|Overall Study|OPCAB procedure|1|||
33306823|NCT01895101|101017191|FG001|Overall Study|OPCAB procedure|1|||
33306824|NCT01895101|101017192|FG002|Overall Study|OPCAB procedure|3|||
33306825|NCT01895101|101017190|FG000|Overall Study|Withdrawal by Subject|0|||
33306826|NCT01895101|101017191|FG001|Overall Study|Withdrawal by Subject|1|||
33306827|NCT01895101|101017192|FG002|Overall Study|Withdrawal by Subject|2|||
33306828|NCT01895101|101017190|FG000|Overall Study|another study, enrolled in other study|0|||
33306829|NCT01895101|101017191|FG001|Overall Study|another study, enrolled in other study|1|||
33306830|NCT01895101|101017192|FG002|Overall Study|another study, enrolled in other study|0|||
33306831|NCT01895101|101017190|FG000|Overall Study|Death|0|||
33306832|NCT01895101|101017191|FG001|Overall Study|Death|1|||
33306833|NCT01895101|101017192|FG002|Overall Study|Death|0|||
33306834|NCT01895101|101017190|FG000|Overall Study|coagulation disorder|0|||
33306835|NCT01895101|101017191|FG001|Overall Study|coagulation disorder|1|||
33306836|NCT01895101|101017192|FG002|Overall Study|coagulation disorder|0|||
33306837|NCT00581555|101017193|FG000|Overall Study|Adverse Event|4|||
33306838|NCT00581555|101017194|FG001|Overall Study|Adverse Event|3|||
33306839|NCT00581555|101017193|FG000|Overall Study|Physician Decision|3|||
33306840|NCT00581555|101017194|FG001|Overall Study|Physician Decision|2|||
33306841|NCT00581555|101017193|FG000|Overall Study|Withdrawal by Subject|18|||
33306842|NCT00581555|101017194|FG001|Overall Study|Withdrawal by Subject|9|||
33224259|NCT01672853|100721764|FG000|Overall Study|Lost to Follow-up|0|||
33306843|NCT00581555|101017193|FG000|Overall Study|Lost to Follow-up|2|||
33306844|NCT00581555|101017194|FG001|Overall Study|Lost to Follow-up|2|||
33306845|NCT00581555|101017193|FG000|Overall Study|Other reasons|16|||
33306846|NCT00581555|101017194|FG001|Overall Study|Other reasons|4|||
33306847|NCT04343872|101017199|FG000|Overall Study|Lost to Follow-up|6|||
33306848|NCT04343872|101017200|FG001|Overall Study|Lost to Follow-up|3|||
33306849|NCT01139580|101017202|FG000|Overall Study|Adverse Event|5|||
33306850|NCT01139580|101017203|FG001|Overall Study|Adverse Event|4|||
33306851|NCT01139580|101017202|FG000|Overall Study|Lost to Follow-up|9|||
33306852|NCT01139580|101017203|FG001|Overall Study|Lost to Follow-up|1|||
33306853|NCT01139580|101017202|FG000|Overall Study|Lack of Efficacy|0|||
33306854|NCT01139580|101017203|FG001|Overall Study|Lack of Efficacy|2|||
33306855|NCT01139580|101017202|FG000|Overall Study|Withdrawal by Subject|6|||
33306856|NCT01139580|101017203|FG001|Overall Study|Withdrawal by Subject|9|||
33306857|NCT01139580|101017202|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
33306858|NCT01139580|101017203|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
33306859|NCT01139580|101017202|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
33306860|NCT01139580|101017203|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
33306861|NCT01139580|101017202|FG000|Overall Study|Misrandomized|1|||
33306862|NCT01139580|101017203|FG001|Overall Study|Misrandomized|0|||
33306863|NCT01139580|101017202|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
33499778|NCT02019472|101720465|FG002|Overall Study|Adverse Event|17|||
33499779|NCT02019472|101720463|FG000|Overall Study|Death|0|||
33499780|NCT02019472|101720464|FG001|Overall Study|Death|1|||
33499781|NCT02019472|101720465|FG002|Overall Study|Death|1|||
33499782|NCT02019472|101720463|FG000|Overall Study|Lack of Efficacy|7|||
33306864|NCT01139580|101017203|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
33499783|NCT02019472|101720464|FG001|Overall Study|Lack of Efficacy|4|||
33499784|NCT02019472|101720465|FG002|Overall Study|Lack of Efficacy|4|||
33499785|NCT02019472|101720463|FG000|Overall Study|Lost to Follow-up|0|||
33499786|NCT02019472|101720464|FG001|Overall Study|Lost to Follow-up|2|||
33306865|NCT01139580|101017202|FG000|Overall Study|Participant Randomization in Error|0|||
33306866|NCT01139580|101017203|FG001|Overall Study|Participant Randomization in Error|1|||
33306867|NCT00116753|101017207|FG000|Overall Study|Adverse Event|16|||
33306868|NCT00116753|101017208|FG001|Overall Study|Adverse Event|10|||
33306869|NCT00116753|101017209|FG002|Overall Study|Adverse Event|7|||
33306870|NCT00116753|101017207|FG000|Overall Study|Withdrawal by Subject|11|||
33499787|NCT02019472|101720465|FG002|Overall Study|Lost to Follow-up|1|||
33499788|NCT02019472|101720463|FG000|Overall Study|Physician Decision|1|||
33306871|NCT00116753|101017208|FG001|Overall Study|Withdrawal by Subject|12|||
33306872|NCT00116753|101017209|FG002|Overall Study|Withdrawal by Subject|8|||
33306873|NCT00116753|101017207|FG000|Overall Study|Lost to Follow-up|0|||
33306874|NCT00116753|101017208|FG001|Overall Study|Lost to Follow-up|2|||
33306875|NCT00116753|101017209|FG002|Overall Study|Lost to Follow-up|1|||
33306876|NCT00116753|101017207|FG000|Overall Study|Protocol Violation|0|||
33306877|NCT00116753|101017208|FG001|Overall Study|Protocol Violation|0|||
33306878|NCT00116753|101017209|FG002|Overall Study|Protocol Violation|1|||
33306879|NCT00116753|101017207|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
33306880|NCT00116753|101017208|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
33306881|NCT00116753|101017209|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
33306882|NCT00116753|101017207|FG000|Overall Study|Disease Progression|3|||
33306883|NCT00116753|101017208|FG001|Overall Study|Disease Progression|4|||
33306884|NCT00116753|101017209|FG002|Overall Study|Disease Progression|3|||
33306885|NCT00116753|101017207|FG000|Overall Study|Abnormal Echocardiogram|0|||
33306886|NCT00116753|101017208|FG001|Overall Study|Abnormal Echocardiogram|0|||
33306887|NCT00116753|101017209|FG002|Overall Study|Abnormal Echocardiogram|1|||
33306888|NCT00116753|101017207|FG000|Overall Study|Progressive Parkinson's Disease|1|||
33306889|NCT00116753|101017208|FG001|Overall Study|Progressive Parkinson's Disease|0|||
33306890|NCT00116753|101017209|FG002|Overall Study|Progressive Parkinson's Disease|0|||
33306891|NCT00116753|101017207|FG000|Overall Study|Dosing Error|0|||
33306892|NCT00116753|101017208|FG001|Overall Study|Dosing Error|1|||
33306893|NCT00116753|101017209|FG002|Overall Study|Dosing Error|0|||
33306894|NCT00620282|101017211|FG000|Overall Study|Adverse Event|0|||
33306895|NCT00620282|101017212|FG001|Overall Study|Adverse Event|1|||
33306896|NCT00620282|101017213|FG002|Overall Study|Adverse Event|0|||
33306897|NCT00620282|101017211|FG000|Overall Study|Arterial line unable to be placed|0|||
33306898|NCT00620282|101017212|FG001|Overall Study|Arterial line unable to be placed|0|||
33306899|NCT00620282|101017213|FG002|Overall Study|Arterial line unable to be placed|1|||
33306900|NCT00620282|101017211|FG000|Overall Study|Withdrawal by Subject|0|||
33306901|NCT00620282|101017212|FG001|Overall Study|Withdrawal by Subject|1|||
33306902|NCT00620282|101017213|FG002|Overall Study|Withdrawal by Subject|0|||
33306903|NCT01850446|101017218|FG000|Overall Study|Lack of Efficacy|1|||
33306904|NCT01850446|101017219|FG001|Overall Study|Lack of Efficacy|0|||
33306905|NCT01850446|101017218|FG000|Overall Study|Withdrawal by Subject|4|||
33306906|NCT01850446|101017219|FG001|Overall Study|Withdrawal by Subject|0|||
33306907|NCT01850446|101017218|FG000|Overall Study|Protocol Violation|0|||
33306908|NCT01850446|101017219|FG001|Overall Study|Protocol Violation|2|||
33306909|NCT00412061|101017220|FG000|Double Blind Phase|Disease Progression|101|||
33306910|NCT00412061|101017221|FG001|Double Blind Phase|Disease Progression|154|||
33306911|NCT00412061|101017220|FG000|Double Blind Phase|Adverse Event|61|||
33306912|NCT00412061|101017221|FG001|Double Blind Phase|Adverse Event|16|||
33306913|NCT00412061|101017220|FG000|Double Blind Phase|Final Primary Analysis|26|||
33306914|NCT00412061|101017221|FG001|Double Blind Phase|Final Primary Analysis|14|||
33306915|NCT00412061|101017220|FG000|Double Blind Phase|Withdrawal by Subject|18|||
33306916|NCT00412061|101017221|FG001|Double Blind Phase|Withdrawal by Subject|20|||
33306917|NCT00412061|101017220|FG000|Double Blind Phase|Death|6|||
33306918|NCT00412061|101017221|FG001|Double Blind Phase|Death|3|||
33306919|NCT00412061|101017220|FG000|Double Blind Phase|Protocol Violation|3|||
33306920|NCT00412061|101017221|FG001|Double Blind Phase|Protocol Violation|4|||
33306921|NCT00412061|101017220|FG000|Double Blind Phase|New Cander Therapy|1|||
33306922|NCT00412061|101017221|FG001|Double Blind Phase|New Cander Therapy|1|||
33306923|NCT00412061|101017220|FG000|Double Blind Phase|Lost to Follow-up|0|||
33306924|NCT00412061|101017221|FG001|Double Blind Phase|Lost to Follow-up|1|||
33306925|NCT00412061|101017220|FG000|Open Label Phase|Disease Progression|0|||
33306926|NCT00412061|101017221|FG001|Open Label Phase|Disease Progression|86|||
33306927|NCT00412061|101017220|FG000|Open Label Phase|Adverse Event|0|||
33306928|NCT00412061|101017221|FG001|Open Label Phase|Adverse Event|46|||
33306929|NCT00412061|101017220|FG000|Open Label Phase|Withdrawal by Subject|0|||
33306930|NCT00412061|101017221|FG001|Open Label Phase|Withdrawal by Subject|15|||
33306931|NCT00412061|101017220|FG000|Open Label Phase|Administrative Problems|0|||
33306932|NCT00412061|101017221|FG001|Open Label Phase|Administrative Problems|13|||
33306933|NCT00412061|101017220|FG000|Open Label Phase|Death|0|||
33306934|NCT00412061|101017221|FG001|Open Label Phase|Death|7|||
33306935|NCT00412061|101017220|FG000|Open Label Phase|Lost to Follow-up|0|||
33306936|NCT00412061|101017221|FG001|Open Label Phase|Lost to Follow-up|2|||
33306937|NCT00412061|101017220|FG000|Open Label Phase|New Cancer Therapy|0|||
33306938|NCT00412061|101017221|FG001|Open Label Phase|New Cancer Therapy|1|||
33306939|NCT03292432|101017222|FG000|Overall Study|Lost to Follow-up|11|||
33306940|NCT03292432|101017223|FG001|Overall Study|Lost to Follow-up|8|||
33306941|NCT03292432|101017222|FG000|Overall Study|Death|2|||
33306942|NCT03292432|101017223|FG001|Overall Study|Death|1|||
33306943|NCT03292432|101017222|FG000|Overall Study|Withdrawal by Subject|1|||
33306944|NCT03292432|101017223|FG001|Overall Study|Withdrawal by Subject|2|||
33306945|NCT03292432|101017222|FG000|Overall Study|Site closed before any data collected|1|||
33306946|NCT03292432|101017223|FG001|Overall Study|Site closed before any data collected|0|||
33306947|NCT01621568|101017227|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
33306948|NCT01621568|101017228|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
33306949|NCT01621568|101017227|FG000|Week 5-6 No Treatment|Death|1|||
33306950|NCT01621568|101017228|FG001|Week 5-6 No Treatment|Death|0|||
33306951|NCT01712659|101017229|FG000|Dose Escalation|Physician Decision|0|||
33306952|NCT01712659|101017230|FG001|Dose Escalation|Physician Decision|1|||
33306953|NCT01712659|101017231|FG002|Dose Escalation|Physician Decision|0|||
33306954|NCT01712659|101017232|FG003|Dose Escalation|Physician Decision|0|||
33306955|NCT01712659|101017233|FG004|Dose Escalation|Physician Decision|0|||
33306956|NCT01712659|101017229|FG000|Dose Escalation|Unable to take study drug|0|||
33306957|NCT01712659|101017230|FG001|Dose Escalation|Unable to take study drug|1|||
33306958|NCT01712659|101017231|FG002|Dose Escalation|Unable to take study drug|0|||
33306959|NCT01712659|101017232|FG003|Dose Escalation|Unable to take study drug|0|||
33306960|NCT01712659|101017233|FG004|Dose Escalation|Unable to take study drug|0|||
33306961|NCT01712659|101017229|FG000|Dose Expansion|Early disease progression|1|||
33306962|NCT01712659|101017230|FG001|Dose Expansion|Early disease progression|0|||
33306963|NCT01712659|101017231|FG002|Dose Expansion|Early disease progression|0|||
33306964|NCT01712659|101017232|FG003|Dose Expansion|Early disease progression|0|||
33306965|NCT01712659|101017233|FG004|Dose Expansion|Early disease progression|0|||
33306966|NCT01712659|101017229|FG000|Dose Expansion|Physician Decision|1|||
33306967|NCT01712659|101017230|FG001|Dose Expansion|Physician Decision|0|||
33306968|NCT01712659|101017231|FG002|Dose Expansion|Physician Decision|0|||
33306969|NCT01712659|101017232|FG003|Dose Expansion|Physician Decision|0|||
33306970|NCT01712659|101017233|FG004|Dose Expansion|Physician Decision|0|||
33306971|NCT01014143|101017234|FG000|Second Intervention|Lost to Follow-up|2|||
33306972|NCT01014143|101017235|FG001|Second Intervention|Lost to Follow-up|0|||
33306973|NCT01014143|101017236|FG002|Second Intervention|Lost to Follow-up|0|||
33306974|NCT01182194|101017241|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
33306975|NCT01182194|101017242|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
33306976|NCT04371198|101017243|FG000|Overall Study|inadequate sample|4|||
33306977|NCT03500159|101017247|FG000|Overall Study|Study Terminated|2|||
33306978|NCT03500159|101017248|FG001|Overall Study|Study Terminated|1|||
33306979|NCT00381615|101017249|FG000|Overall Study|Withdrawal by Subject|1|||
33306980|NCT00381615|101017250|FG001|Overall Study|Withdrawal by Subject|3|||
33306981|NCT00381615|101017251|FG002|Overall Study|Withdrawal by Subject|0|||
33306982|NCT00381615|101017252|FG003|Overall Study|Withdrawal by Subject|1|||
33306983|NCT00381615|101017249|FG000|Overall Study|Lost to Follow-up|3|||
33306984|NCT00381615|101017250|FG001|Overall Study|Lost to Follow-up|2|||
33306985|NCT00381615|101017251|FG002|Overall Study|Lost to Follow-up|0|||
33306986|NCT00381615|101017252|FG003|Overall Study|Lost to Follow-up|1|||
33306987|NCT00381615|101017249|FG000|Overall Study|Protocol Violation|0|||
33306988|NCT00381615|101017250|FG001|Overall Study|Protocol Violation|0|||
33306989|NCT00381615|101017251|FG002|Overall Study|Protocol Violation|1|||
33306990|NCT00381615|101017252|FG003|Overall Study|Protocol Violation|0|||
33306991|NCT05062759|101017253|FG000|Overall Study|Death|0|||
33306992|NCT05062759|101017254|FG001|Overall Study|Death|1|||
33306993|NCT05062759|101017253|FG000|Overall Study|Lost to Follow-up|1|||
33306994|NCT05062759|101017254|FG001|Overall Study|Lost to Follow-up|0|||
33306995|NCT02224690|101017255|FG000|Overall Study|Adverse Event|8|||
33306996|NCT02224690|101017256|FG001|Overall Study|Adverse Event|1|||
33306997|NCT02224690|101017255|FG000|Overall Study|Met Withdrawal Criteria|4|||
33306998|NCT02224690|101017256|FG001|Overall Study|Met Withdrawal Criteria|0|||
33306999|NCT02224690|101017255|FG000|Overall Study|Use of G-tube|1|||
33307000|NCT02224690|101017256|FG001|Overall Study|Use of G-tube|0|||
33307001|NCT02224690|101017255|FG000|Overall Study|Did not meet eligibility criteria|1|||
33307002|NCT02224690|101017256|FG001|Overall Study|Did not meet eligibility criteria|0|||
33307003|NCT05398237|101017257|FG000|Overall Study|Withdrawal by Subject|1|||
33307004|NCT00577577|101017258|FG000|Overall Study|Adverse Event|3|||
33307005|NCT00577577|101017259|FG001|Overall Study|Adverse Event|2|||
33307006|NCT00577577|101017258|FG000|Overall Study|Lost to Follow-up|1|||
33307007|NCT00577577|101017259|FG001|Overall Study|Lost to Follow-up|0|||
33307008|NCT00577577|101017258|FG000|Overall Study|Protocol Violation|0|||
33307009|NCT00577577|101017259|FG001|Overall Study|Protocol Violation|3|||
33307010|NCT00577577|101017258|FG000|Overall Study|Transportation|1|||
33307011|NCT00577577|101017259|FG001|Overall Study|Transportation|0|||
33307012|NCT01942590|101017260|FG000|Overall Study|Withdrawal by Subject|0|||
33307013|NCT01942590|101017261|FG001|Overall Study|Withdrawal by Subject|1|||
33499789|NCT02019472|101720464|FG001|Overall Study|Physician Decision|2|||
33499790|NCT02019472|101720465|FG002|Overall Study|Physician Decision|0|||
33499791|NCT02019472|101720463|FG000|Overall Study|Pregnancy|1|||
33601245|NCT02771626|102091863|FG002|Overall Study|Symptomatic Deterioration|2|||
33307014|NCT01942590|101017260|FG000|Overall Study|Adverse Event|1|||
33307015|NCT01942590|101017261|FG001|Overall Study|Adverse Event|0|||
33307016|NCT01142232|101017263|FG000|Overall Study|Adverse Event|1|||
33307017|NCT01142232|101017264|FG001|Overall Study|Adverse Event|2|||
33307018|NCT01142232|101017265|FG002|Overall Study|Adverse Event|1|||
33307019|NCT01142232|101017266|FG003|Overall Study|Adverse Event|0|||
33307020|NCT01142232|101017267|FG004|Overall Study|Adverse Event|4|||
33307021|NCT01142232|101017263|FG000|Overall Study|Death|0|||
33307022|NCT01142232|101017264|FG001|Overall Study|Death|0|||
33307023|NCT01142232|101017265|FG002|Overall Study|Death|0|||
33307024|NCT01142232|101017266|FG003|Overall Study|Death|0|||
33307025|NCT01142232|101017267|FG004|Overall Study|Death|1|||
33601246|NCT02771626|102091864|FG003|Overall Study|Symptomatic Deterioration|0|||
33601247|NCT02771626|102091865|FG004|Overall Study|Symptomatic Deterioration|5|||
33601248|NCT02771626|102091866|FG005|Overall Study|Symptomatic Deterioration|2|||
33601249|NCT02771626|102091861|FG000|Overall Study|Participant Request|0|||
33601250|NCT02771626|102091862|FG001|Overall Study|Participant Request|1|||
33601251|NCT02771626|102091863|FG002|Overall Study|Participant Request|0|||
33601252|NCT02771626|102091864|FG003|Overall Study|Participant Request|2|||
33601253|NCT02771626|102091865|FG004|Overall Study|Participant Request|0|||
33601254|NCT02771626|102091866|FG005|Overall Study|Participant Request|1|||
33601255|NCT02771626|102091861|FG000|Overall Study|Investigator Decision|0|||
33601256|NCT02771626|102091862|FG001|Overall Study|Investigator Decision|1|||
33601257|NCT02771626|102091863|FG002|Overall Study|Investigator Decision|0|||
33601258|NCT02771626|102091864|FG003|Overall Study|Investigator Decision|0|||
33601259|NCT02771626|102091865|FG004|Overall Study|Investigator Decision|1|||
33601260|NCT02771626|102091866|FG005|Overall Study|Investigator Decision|0|||
33601261|NCT02771626|102091861|FG000|Overall Study|Study Termination by Sponsor|0|||
33601262|NCT02771626|102091862|FG001|Overall Study|Study Termination by Sponsor|2|||
33601263|NCT02771626|102091863|FG002|Overall Study|Study Termination by Sponsor|1|||
33601264|NCT02771626|102091864|FG003|Overall Study|Study Termination by Sponsor|0|||
33601265|NCT02771626|102091865|FG004|Overall Study|Study Termination by Sponsor|1|||
33601266|NCT02771626|102091866|FG005|Overall Study|Study Termination by Sponsor|0|||
33601267|NCT02771626|102091861|FG000|Overall Study|Informed Consent Withdrawn|0|||
33601268|NCT02771626|102091862|FG001|Overall Study|Informed Consent Withdrawn|0|||
33601269|NCT02771626|102091863|FG002|Overall Study|Informed Consent Withdrawn|1|||
33601270|NCT02771626|102091864|FG003|Overall Study|Informed Consent Withdrawn|0|||
33307026|NCT01142232|101017263|FG000|Overall Study|Disease Progression|2|||
33307027|NCT01142232|101017264|FG001|Overall Study|Disease Progression|0|||
33307028|NCT01142232|101017265|FG002|Overall Study|Disease Progression|1|||
33307029|NCT01142232|101017266|FG003|Overall Study|Disease Progression|2|||
33601271|NCT02771626|102091865|FG004|Overall Study|Informed Consent Withdrawn|1|||
33601272|NCT02771626|102091866|FG005|Overall Study|Informed Consent Withdrawn|1|||
33601273|NCT02771626|102091861|FG000|Overall Study|Other, Not Specified|1|||
33601274|NCT02771626|102091862|FG001|Overall Study|Other, Not Specified|0|||
33601275|NCT02771626|102091863|FG002|Overall Study|Other, Not Specified|0|||
33601276|NCT02771626|102091864|FG003|Overall Study|Other, Not Specified|0|||
33601277|NCT02771626|102091865|FG004|Overall Study|Other, Not Specified|0|||
33601278|NCT02771626|102091866|FG005|Overall Study|Other, Not Specified|1|||
33601279|NCT00334282|102091867|FG000|Overall Study|Lost to Follow-up|11|||
33601280|NCT00334282|102091868|FG001|Overall Study|Lost to Follow-up|5|||
33601281|NCT00334282|102091867|FG000|Overall Study|Withdrawal by Subject|17|||
33601282|NCT00334282|102091868|FG001|Overall Study|Withdrawal by Subject|3|||
33601283|NCT00334282|102091867|FG000|Overall Study|Death|194|||
33601284|NCT00334282|102091868|FG001|Overall Study|Death|100|||
33601285|NCT01853072|102091869|FG000|Overall Study|Adverse event prior to treatment|0|||
33601286|NCT01853072|102091870|FG001|Overall Study|Adverse event prior to treatment|1|||
33601287|NCT01853072|102091869|FG000|Overall Study|Adverse Event|0|||
33601288|NCT01853072|102091870|FG001|Overall Study|Adverse Event|3|||
33601289|NCT01853072|102091869|FG000|Overall Study|Death|1|||
33601290|NCT01853072|102091870|FG001|Overall Study|Death|4|||
33601291|NCT01853072|102091869|FG000|Overall Study|Lost to Follow-up|0|||
33601292|NCT01853072|102091870|FG001|Overall Study|Lost to Follow-up|3|||
33601293|NCT01853072|102091869|FG000|Overall Study|Non-compliance with study drug|0|||
33601294|NCT01853072|102091870|FG001|Overall Study|Non-compliance with study drug|1|||
33601295|NCT01853072|102091869|FG000|Overall Study|Physician Decision|1|||
33601296|NCT01853072|102091870|FG001|Overall Study|Physician Decision|1|||
33601297|NCT01853072|102091869|FG000|Overall Study|Withdrawal by Subject|1|||
33601298|NCT01853072|102091870|FG001|Overall Study|Withdrawal by Subject|2|||
33601299|NCT01853072|102091869|FG000|Overall Study|Reason not specified|9|||
33307030|NCT01142232|101017267|FG004|Overall Study|Disease Progression|12|||
33307031|NCT01142232|101017263|FG000|Overall Study|Withdrawal by Subject|0|||
33601300|NCT01853072|102091870|FG001|Overall Study|Reason not specified|6|||
33601301|NCT00581828|102091871|FG000|Overall Study|Protocol Violation|1|||
33601302|NCT01920152|102091872|FG000|Overall Study|Withdrawal by Subject|1|||
33601303|NCT01920152|102091873|FG001|Overall Study|Withdrawal by Subject|2|||
33601304|NCT00489736|102091876|FG000|Overall Study|Lack of Efficacy|53|||
33601305|NCT00489736|102091877|FG001|Overall Study|Lack of Efficacy|14|||
33601306|NCT00489736|102091876|FG000|Overall Study|Adverse Event|32|||
33601307|NCT00489736|102091877|FG001|Overall Study|Adverse Event|45|||
33307032|NCT01142232|101017264|FG001|Overall Study|Withdrawal by Subject|0|||
33499792|NCT02019472|101720464|FG001|Overall Study|Pregnancy|2|||
33601308|NCT00489736|102091876|FG000|Overall Study|Poor compliance|6|||
33601309|NCT00489736|102091877|FG001|Overall Study|Poor compliance|2|||
33601310|NCT00489736|102091876|FG000|Overall Study|Not coded/ Not pre-specified|5|||
33601311|NCT00489736|102091877|FG001|Overall Study|Not coded/ Not pre-specified|8|||
33601312|NCT03474081|102091881|FG000|Overall Study|Adverse Event|6|||
33601313|NCT03474081|102091882|FG001|Overall Study|Adverse Event|3|||
33601314|NCT03474081|102091881|FG000|Overall Study|Lost to Follow-up|2|||
33307033|NCT01142232|101017265|FG002|Overall Study|Withdrawal by Subject|0|||
33307034|NCT01142232|101017266|FG003|Overall Study|Withdrawal by Subject|1|||
33307035|NCT01142232|101017267|FG004|Overall Study|Withdrawal by Subject|3|||
33307036|NCT01142232|101017263|FG000|Overall Study|Physician Decision|0|||
33307037|NCT01142232|101017264|FG001|Overall Study|Physician Decision|1|||
33307038|NCT01142232|101017265|FG002|Overall Study|Physician Decision|0|||
33307039|NCT01142232|101017266|FG003|Overall Study|Physician Decision|2|||
33307040|NCT01142232|101017267|FG004|Overall Study|Physician Decision|10|||
33307041|NCT01142232|101017263|FG000|Overall Study|Alternative Therapy|0|||
33307042|NCT01142232|101017264|FG001|Overall Study|Alternative Therapy|1|||
33307043|NCT01142232|101017265|FG002|Overall Study|Alternative Therapy|1|||
33307044|NCT01142232|101017266|FG003|Overall Study|Alternative Therapy|0|||
33307045|NCT01142232|101017267|FG004|Overall Study|Alternative Therapy|1|||
33307046|NCT01142232|101017263|FG000|Overall Study|Off Trt for other complicating disease|0|||
33307047|NCT01142232|101017264|FG001|Overall Study|Off Trt for other complicating disease|0|||
33307048|NCT01142232|101017265|FG002|Overall Study|Off Trt for other complicating disease|0|||
33307049|NCT01142232|101017266|FG003|Overall Study|Off Trt for other complicating disease|0|||
33307050|NCT01142232|101017267|FG004|Overall Study|Off Trt for other complicating disease|1|||
33307051|NCT01142232|101017263|FG000|Overall Study|Noncompliance|0|||
33307052|NCT01142232|101017264|FG001|Overall Study|Noncompliance|0|||
33601315|NCT03474081|102091882|FG001|Overall Study|Lost to Follow-up|1|||
33601316|NCT03474081|102091881|FG000|Overall Study|Physician Decision|3|||
33601317|NCT03474081|102091882|FG001|Overall Study|Physician Decision|2|||
33601318|NCT03474081|102091881|FG000|Overall Study|Withdrawal by Subject|5|||
33601319|NCT03474081|102091882|FG001|Overall Study|Withdrawal by Subject|7|||
33307053|NCT01142232|101017265|FG002|Overall Study|Noncompliance|0|||
33307054|NCT01142232|101017266|FG003|Overall Study|Noncompliance|0|||
33307055|NCT01142232|101017267|FG004|Overall Study|Noncompliance|2|||
33307056|NCT00371683|101017272|FG000|DB Treatment Period-Randomized Patients|Death|1|||
33307057|NCT00371683|101017273|FG001|DB Treatment Period-Randomized Patients|Death|1|||
33307058|NCT00371683|101017272|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
33307059|NCT00371683|101017273|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
33307060|NCT00371683|101017272|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
33307061|NCT00371683|101017273|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
33307062|NCT00371683|101017272|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
33307063|NCT00371683|101017273|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
33307064|NCT00371683|101017272|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
33307065|NCT00371683|101017273|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
33307066|NCT00371683|101017272|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
33307067|NCT00371683|101017273|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
33307068|NCT00371683|101017272|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
33307069|NCT00371683|101017273|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
33307070|NCT00371683|101017272|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
33307071|NCT00371683|101017273|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
33601320|NCT03474081|102091881|FG000|Overall Study|Investigator site closed|1|||
33307072|NCT00371683|101017272|FG000|Follow-Up Period - Randomized Patients|Death|0|||
33307073|NCT00371683|101017273|FG001|Follow-Up Period - Randomized Patients|Death|2|||
33307074|NCT00371683|101017272|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
33307075|NCT00371683|101017273|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
33307076|NCT00371683|101017272|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
33307077|NCT00371683|101017273|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
33307078|NCT02150343|101017274|FG000|Overall Study|Adverse Event|2|||
33307079|NCT02150343|101017275|FG001|Overall Study|Adverse Event|0|||
33307080|NCT02150343|101017276|FG002|Overall Study|Adverse Event|1|||
33307081|NCT02150343|101017277|FG003|Overall Study|Adverse Event|1|||
33307082|NCT02150343|101017274|FG000|Overall Study|Withdrawal by Subject|13|||
33601321|NCT03474081|102091882|FG001|Overall Study|Investigator site closed|0|||
33307083|NCT02150343|101017275|FG001|Overall Study|Withdrawal by Subject|10|||
33601322|NCT00260065|102091884|FG000|Overall Study|Progressive Disease|22|||
33601323|NCT00260065|102091884|FG000|Overall Study|Adverse Event|17|||
33601324|NCT00260065|102091884|FG000|Overall Study|Death|13|||
33307084|NCT02150343|101017276|FG002|Overall Study|Withdrawal by Subject|9|||
33307085|NCT02150343|101017277|FG003|Overall Study|Withdrawal by Subject|4|||
33307086|NCT02150343|101017274|FG000|Overall Study|Lost to Follow-up|4|||
33601325|NCT00260065|102091884|FG000|Overall Study|Withdrawal by Subject|13|||
33601326|NCT00260065|102091884|FG000|Overall Study|Physician Decision|19|||
33601327|NCT00260065|102091884|FG000|Overall Study|Not otherwise specified|8|||
33307087|NCT02150343|101017275|FG001|Overall Study|Lost to Follow-up|4|||
33307088|NCT02150343|101017276|FG002|Overall Study|Lost to Follow-up|2|||
33307089|NCT02150343|101017277|FG003|Overall Study|Lost to Follow-up|3|||
33307090|NCT02150343|101017274|FG000|Overall Study|Other|2|||
33307091|NCT02150343|101017275|FG001|Overall Study|Other|6|||
33307092|NCT02150343|101017276|FG002|Overall Study|Other|0|||
33307093|NCT02150343|101017277|FG003|Overall Study|Other|2|||
33307094|NCT01278173|101017285|FG000|Overall Study|Lack of Efficacy|13|||
33307095|NCT01278173|101017285|FG000|Overall Study|Adverse Event|8|||
33307096|NCT01278173|101017285|FG000|Overall Study|Administrative or other reason|4|||
33307097|NCT01278173|101017285|FG000|Overall Study|Protocol Violation|1|||
33307098|NCT01278173|101017285|FG000|Overall Study|Withdrawal by Subject|1|||
33307099|NCT01445301|101017294|FG000|Overall Study|Adverse Event|15|||
33307100|NCT01445301|101017295|FG001|Overall Study|Adverse Event|25|||
33307101|NCT01445301|101017296|FG002|Overall Study|Adverse Event|4|||
33307102|NCT01445301|101017294|FG000|Overall Study|Lack of Efficacy|0|||
33307103|NCT01445301|101017295|FG001|Overall Study|Lack of Efficacy|1|||
33499793|NCT02019472|101720465|FG002|Overall Study|Pregnancy|2|||
33499794|NCT02019472|101720463|FG000|Overall Study|Withdrawal by Subject|11|||
33499795|NCT02019472|101720464|FG001|Overall Study|Withdrawal by Subject|10|||
33499796|NCT02019472|101720465|FG002|Overall Study|Withdrawal by Subject|11|||
33499797|NCT02019472|101720463|FG000|Overall Study|Other|3|||
33499798|NCT02019472|101720464|FG001|Overall Study|Other|8|||
33499799|NCT02019472|101720465|FG002|Overall Study|Other|6|||
33499800|NCT01383707|101720466|FG000|Overall Study|Consent withdrawal|6|||
33499801|NCT01383707|101720466|FG000|Overall Study|Death|19|||
33499802|NCT01383707|101720466|FG000|Overall Study|Other|8|||
33499803|NCT01383707|101720466|FG000|Overall Study|Sponsor's decision|2|||
33499804|NCT01383707|101720466|FG000|Overall Study|Adverse Event|14|||
33499805|NCT01383707|101720466|FG000|Overall Study|Progressive disease|23|||
33499806|NCT03511105|101720467|FG000|Overall Study|Adverse Event|1|||
33499807|NCT03511105|101720468|FG001|Overall Study|Adverse Event|0|||
33499808|NCT03511105|101720467|FG000|Overall Study|Withdrew consent|1|||
33499809|NCT03511105|101720468|FG001|Overall Study|Withdrew consent|0|||
33499810|NCT01256450|101720481|FG000|Open-label Titration|Adverse Event|39|||
33499811|NCT01256450|101720482|FG001|Open-label Titration|Adverse Event|0|||
33499812|NCT01256450|101720483|FG002|Open-label Titration|Adverse Event|0|||
33499813|NCT01256450|101720481|FG000|Open-label Titration|Lost to Follow-up|7|||
33499814|NCT01256450|101720482|FG001|Open-label Titration|Lost to Follow-up|0|||
33499815|NCT01256450|101720483|FG002|Open-label Titration|Lost to Follow-up|0|||
33499816|NCT01256450|101720481|FG000|Open-label Titration|Lack of analgesic effect|30|||
33499817|NCT01256450|101720482|FG001|Open-label Titration|Lack of analgesic effect|0|||
33499818|NCT01256450|101720483|FG002|Open-label Titration|Lack of analgesic effect|0|||
33499819|NCT01256450|101720481|FG000|Open-label Titration|Non-compliance|9|||
33499820|NCT01256450|101720482|FG001|Open-label Titration|Non-compliance|0|||
33307104|NCT01445301|101017296|FG002|Overall Study|Lack of Efficacy|0|||
33307105|NCT01445301|101017294|FG000|Overall Study|Protocol Violation|1|||
33499821|NCT01256450|101720483|FG002|Open-label Titration|Non-compliance|0|||
33499822|NCT01256450|101720481|FG000|Open-label Titration|Screen failure|1|||
33499823|NCT01256450|101720482|FG001|Open-label Titration|Screen failure|0|||
33499824|NCT01256450|101720483|FG002|Open-label Titration|Screen failure|0|||
33499825|NCT01256450|101720481|FG000|Open-label Titration|Other|13|||
33499826|NCT01256450|101720482|FG001|Open-label Titration|Other|0|||
33499827|NCT01256450|101720483|FG002|Open-label Titration|Other|0|||
33499828|NCT01256450|101720481|FG000|Double-blind Treatment|Adverse Event|0|||
33499829|NCT01256450|101720482|FG001|Double-blind Treatment|Adverse Event|8|||
33499830|NCT01256450|101720483|FG002|Double-blind Treatment|Adverse Event|6|||
33499831|NCT01256450|101720481|FG000|Double-blind Treatment|Lost to Follow-up|0|||
33499832|NCT01256450|101720482|FG001|Double-blind Treatment|Lost to Follow-up|1|||
33499833|NCT01256450|101720483|FG002|Double-blind Treatment|Lost to Follow-up|7|||
33499834|NCT01256450|101720481|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
33499835|NCT01256450|101720482|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
33499836|NCT01256450|101720483|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
33499837|NCT01256450|101720481|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
33307106|NCT01445301|101017295|FG001|Overall Study|Protocol Violation|0|||
33307107|NCT01445301|101017296|FG002|Overall Study|Protocol Violation|0|||
33499838|NCT01256450|101720482|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
33499839|NCT01256450|101720483|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
33499840|NCT01256450|101720481|FG000|Double-blind Treatment|Non-compliance|0|||
33499841|NCT01256450|101720482|FG001|Double-blind Treatment|Non-compliance|5|||
33499842|NCT01256450|101720483|FG002|Double-blind Treatment|Non-compliance|4|||
33307108|NCT01445301|101017294|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
33499843|NCT01256450|101720481|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
33499844|NCT01256450|101720482|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
33307109|NCT01445301|101017295|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
33499845|NCT01256450|101720483|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
33499846|NCT01256450|101720481|FG000|Double-blind Treatment|Other|0|||
33499847|NCT01256450|101720482|FG001|Double-blind Treatment|Other|9|||
33499848|NCT01256450|101720483|FG002|Double-blind Treatment|Other|12|||
33499849|NCT04387435|101720484|FG000|Overall Study|Physician Decision|1|||
33499850|NCT04615403|101720487|FG000|Overall Study|Death|1|||
33499851|NCT03096314|101720488|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
33499852|NCT03096314|101720489|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
33499853|NCT00591565|101724456|FG000|Overall Study|lost follow up, withdrawn|5|||
33499854|NCT02547220|101724457|FG000|Overall Study|Withdrawal by Subject|1|||
33499855|NCT02547220|101724458|FG001|Overall Study|Withdrawal by Subject|0|||
33499856|NCT02547220|101724457|FG000|Overall Study|Study terminated by sponsor|18|||
33499857|NCT02547220|101724458|FG001|Overall Study|Study terminated by sponsor|20|||
33499858|NCT02025725|101724462|FG000|Overall Study|Adverse Event|5|||
33499859|NCT02025725|101724463|FG001|Overall Study|Adverse Event|0|||
33499860|NCT02025725|101724462|FG000|Overall Study|Lost to Follow-up|2|||
33499861|NCT02025725|101724463|FG001|Overall Study|Lost to Follow-up|0|||
33499862|NCT02025725|101724462|FG000|Overall Study|Protocol Violation|1|||
33499863|NCT02025725|101724463|FG001|Overall Study|Protocol Violation|1|||
33499864|NCT02025725|101724462|FG000|Overall Study|Withdrawal by Subject|3|||
33499865|NCT02025725|101724463|FG001|Overall Study|Withdrawal by Subject|2|||
33499866|NCT02025725|101724462|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
33499867|NCT02025725|101724463|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
33499868|NCT01276756|101724464|FG000|Overall Study|Lost to Follow-up|2|||
33499869|NCT01276756|101724465|FG001|Overall Study|Lost to Follow-up|0|||
33499870|NCT01276756|101724464|FG000|Overall Study|Adverse Event|3|||
33499871|NCT01276756|101724465|FG001|Overall Study|Adverse Event|2|||
33499872|NCT01464593|101724469|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
33499873|NCT03192488|101724470|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
33499874|NCT03192488|101724471|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
33499875|NCT03192488|101724472|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
33499876|NCT03192488|101724473|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
33499877|NCT03192488|101724474|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
33499878|NCT03192488|101724475|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
33499879|NCT03192488|101724470|FG000|Third Intervention (d1)|Adverse Event|0|||
33499880|NCT03192488|101724471|FG001|Third Intervention (d1)|Adverse Event|0|||
33499881|NCT03192488|101724472|FG002|Third Intervention (d1)|Adverse Event|0|||
33499882|NCT03192488|101724473|FG003|Third Intervention (d1)|Adverse Event|0|||
33499883|NCT03192488|101724474|FG004|Third Intervention (d1)|Adverse Event|1|||
33499884|NCT03192488|101724475|FG005|Third Intervention (d1)|Adverse Event|0|||
33499885|NCT00558467|101724476|FG000|Overall Study|Adverse Event|1|||
33499886|NCT00558467|101724477|FG001|Overall Study|Adverse Event|2|||
33499887|NCT00558467|101724476|FG000|Overall Study|Lack of Efficacy|0|||
33499888|NCT00558467|101724477|FG001|Overall Study|Lack of Efficacy|1|||
33499889|NCT00558467|101724476|FG000|Overall Study|Patient moving out of state|0|||
33499890|NCT00558467|101724477|FG001|Overall Study|Patient moving out of state|1|||
33499891|NCT02962648|101724478|FG000|Overall Study|Withdrawal by Subject|3|||
33499892|NCT02962648|101724478|FG000|Overall Study|Lost to Follow-up|3|||
33499893|NCT02962648|101724478|FG000|Overall Study|Physician Decision|1|||
33499894|NCT02962648|101724478|FG000|Overall Study|Subject had problems with transportation|2|||
33499895|NCT02151851|101724479|FG000|Overall Study|Lack of Efficacy|67|||
33499896|NCT02151851|101724480|FG001|Overall Study|Lack of Efficacy|94|||
33499897|NCT02151851|101724479|FG000|Overall Study|Protocol Violation|0|||
33499898|NCT02151851|101724480|FG001|Overall Study|Protocol Violation|1|||
33499899|NCT02151851|101724479|FG000|Overall Study|Withdrawal by Subject|2|||
33499900|NCT02151851|101724480|FG001|Overall Study|Withdrawal by Subject|5|||
33499901|NCT02151851|101724479|FG000|Overall Study|Medical impairment|1|||
33499902|NCT02151851|101724480|FG001|Overall Study|Medical impairment|0|||
33499903|NCT02151851|101724479|FG000|Overall Study|Low compliance to study visits|0|||
33499904|NCT02151851|101724480|FG001|Overall Study|Low compliance to study visits|1|||
33191400|NCT01454726|100605219|FG000|Overall Study|Withdrawal by Subject|0|||
33499905|NCT02151851|101724479|FG000|Overall Study|Subject entered into study in error|0|||
33499906|NCT02151851|101724480|FG001|Overall Study|Subject entered into study in error|1|||
33499907|NCT02151851|101724479|FG000|Overall Study|Adverse Event|6|||
33499908|NCT02151851|101724480|FG001|Overall Study|Adverse Event|28|||
33499909|NCT00462709|101724481|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
33499910|NCT00462709|101724481|FG000|Overall Study|Lost to Follow-up|10|||
33499911|NCT00462709|101724481|FG000|Overall Study|Withdrawal by Subject|8|||
33499912|NCT00462709|101724481|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
33499913|NCT00462709|101724481|FG000|Overall Study|Death|2|||
33499914|NCT00462709|101724481|FG000|Overall Study|Logistical reasons|2|||
33499915|NCT00462709|101724481|FG000|Overall Study|Physician Decision|1|||
33499916|NCT00462709|101724481|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
33499917|NCT02525783|101724482|FG000|Overall Study|Lost to Follow-up|10|||
33499918|NCT03123393|101724483|FG000|Overall Study|Study Terminated by Sponsor|6|||
33499919|NCT03123393|101724484|FG001|Overall Study|Study Terminated by Sponsor|9|||
33499920|NCT03123393|101724483|FG000|Overall Study|Withdrawal by Subject|2|||
33499921|NCT03123393|101724484|FG001|Overall Study|Withdrawal by Subject|1|||
33499922|NCT03123393|101724483|FG000|Overall Study|Reason not Specified|13|||
33499923|NCT03123393|101724484|FG001|Overall Study|Reason not Specified|13|||
33499924|NCT01051791|101724485|FG000|Overall Study|Failed screening|3|||
33499925|NCT01051791|101724485|FG000|Overall Study|Withdrawal by Subject|1|||
33499926|NCT02887183|101724489|FG000|Overall Study|Adverse Event|44|||
33499927|NCT02887183|101724489|FG000|Overall Study|Death|30|||
33499928|NCT02887183|101724489|FG000|Overall Study|Pregnancy|1|||
33499929|NCT02887183|101724489|FG000|Overall Study|Protocol Violation|6|||
33499930|NCT02887183|101724489|FG000|Overall Study|Technical Problems|2|||
33499931|NCT02887183|101724489|FG000|Overall Study|Lost to Follow-up|13|||
33499932|NCT02887183|101724489|FG000|Overall Study|Physician Decision|10|||
33499933|NCT02887183|101724489|FG000|Overall Study|Withdrawal by Subject|35|||
33499934|NCT03340454|101724490|FG000|Overall Study|Lost to Follow-up|0|||
33499935|NCT03340454|101724491|FG001|Overall Study|Lost to Follow-up|4|||
33499936|NCT00536939|101724494|FG000|Overall Study|Withdrawal by Subject|1|||
33499937|NCT00536939|101724495|FG001|Overall Study|Withdrawal by Subject|0|||
33499938|NCT00536939|101724494|FG000|Overall Study|Other Complicating Disease|1|||
33499939|NCT00536939|101724495|FG001|Overall Study|Other Complicating Disease|0|||
33499940|NCT00386360|101724496|FG000|Overall Study|Adverse Event|4|||
33499941|NCT00386360|101724497|FG001|Overall Study|Adverse Event|2|||
33499942|NCT00386360|101724496|FG000|Overall Study|Physician Decision|2|||
33499943|NCT00386360|101724497|FG001|Overall Study|Physician Decision|2|||
33499944|NCT00386360|101724496|FG000|Overall Study|Lost to Follow-up|0|||
33499945|NCT00386360|101724497|FG001|Overall Study|Lost to Follow-up|2|||
33499946|NCT00386360|101724496|FG000|Overall Study|Protocol Violation|0|||
33499947|NCT00386360|101724497|FG001|Overall Study|Protocol Violation|3|||
33499948|NCT00386360|101724496|FG000|Overall Study|Withdrawal by Subject|3|||
33499949|NCT00386360|101724497|FG001|Overall Study|Withdrawal by Subject|6|||
33499950|NCT00386360|101724496|FG000|Overall Study|Did not take any study medication|0|||
33499951|NCT00386360|101724497|FG001|Overall Study|Did not take any study medication|2|||
33499952|NCT01002989|101724498|FG000|Overall Study|exclusion criteria, no consent|5|||
33499953|NCT02898597|101724499|FG000|Overall Study|Protocol Violation|4|||
33499954|NCT02898597|101724500|FG001|Overall Study|Protocol Violation|2|||
33499955|NCT02898597|101724499|FG000|Overall Study|Lost to Follow-up|0|||
33499956|NCT02898597|101724500|FG001|Overall Study|Lost to Follow-up|9|||
33499957|NCT02898597|101724499|FG000|Overall Study|Death|0|||
33499958|NCT02898597|101724500|FG001|Overall Study|Death|1|||
33499959|NCT00245466|101724502|FG000|Overall Study|Adverse Event|2|||
33499960|NCT00245466|101724503|FG001|Overall Study|Adverse Event|8|||
33499961|NCT00245466|101724504|FG002|Overall Study|Adverse Event|4|||
33499962|NCT00245466|101724502|FG000|Overall Study|Low prostate specific antigen suppr|16|||
33499963|NCT00245466|101724503|FG001|Overall Study|Low prostate specific antigen suppr|14|||
33499964|NCT00245466|101724504|FG002|Overall Study|Low prostate specific antigen suppr|5|||
33499965|NCT00245466|101724502|FG000|Overall Study|Insufficient testosterone suppr|12|||
33499966|NCT00245466|101724503|FG001|Overall Study|Insufficient testosterone suppr|12|||
33499967|NCT00245466|101724504|FG002|Overall Study|Insufficient testosterone suppr|21|||
33499968|NCT00245466|101724502|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
33499969|NCT00245466|101724503|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
33499970|NCT00245466|101724504|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
33499971|NCT00245466|101724502|FG000|Overall Study|Withdrawal by Subject|2|||
33499972|NCT00245466|101724503|FG001|Overall Study|Withdrawal by Subject|2|||
33499973|NCT00245466|101724504|FG002|Overall Study|Withdrawal by Subject|1|||
33499974|NCT00245466|101724502|FG000|Overall Study|Lost to Follow-up|3|||
33499975|NCT00245466|101724503|FG001|Overall Study|Lost to Follow-up|0|||
33499976|NCT00245466|101724504|FG002|Overall Study|Lost to Follow-up|0|||
33499977|NCT00245466|101724502|FG000|Overall Study|Disease progression|0|||
33499978|NCT00245466|101724503|FG001|Overall Study|Disease progression|3|||
33499979|NCT00245466|101724504|FG002|Overall Study|Disease progression|1|||
33499980|NCT00245466|101724502|FG000|Overall Study|Protocol Violation|1|||
33499981|NCT00245466|101724503|FG001|Overall Study|Protocol Violation|2|||
33499982|NCT00245466|101724504|FG002|Overall Study|Protocol Violation|2|||
33499983|NCT00245466|101724502|FG000|Overall Study|Death|0|||
33499984|NCT00245466|101724503|FG001|Overall Study|Death|2|||
33499985|NCT00245466|101724504|FG002|Overall Study|Death|0|||
33499986|NCT00245466|101724502|FG000|Overall Study|Administrative reasons|0|||
33499987|NCT00245466|101724503|FG001|Overall Study|Administrative reasons|1|||
33499988|NCT00245466|101724504|FG002|Overall Study|Administrative reasons|0|||
33499989|NCT01609296|101724505|FG000|Overall Study|Death|253|||
33499990|NCT01609296|101724505|FG000|Overall Study|Withdrawal by Subject|151|||
33499991|NCT01609296|101724505|FG000|Overall Study|Lost to Follow-up|21|||
33499992|NCT01609296|101724505|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
33499993|NCT01609296|101724505|FG000|Overall Study|missed visit but known to be alive|28|||
33499994|NCT02198664|101724506|FG000|Overall Study|Adverse Event|2|||
33499995|NCT02198664|101724507|FG001|Overall Study|Adverse Event|0|||
33499996|NCT02198664|101724506|FG000|Overall Study|Withdrawal by Subject|11|||
33499997|NCT02198664|101724507|FG001|Overall Study|Withdrawal by Subject|8|||
33499998|NCT02198664|101724506|FG000|Overall Study|Failure to tolerate|2|||
33499999|NCT02198664|101724507|FG001|Overall Study|Failure to tolerate|0|||
33500000|NCT02198664|101724506|FG000|Overall Study|Not stated|1|||
33500001|NCT02198664|101724507|FG001|Overall Study|Not stated|0|||
33500002|NCT01464333|101724508|FG000|Overall Study|Adverse Event|34|||
33500003|NCT01464333|101724508|FG000|Overall Study|Lack of Efficacy|72|||
33500004|NCT01464333|101724508|FG000|Overall Study|Withdrawal by Subject|11|||
33500005|NCT01464333|101724508|FG000|Overall Study|Other|4|||
33500006|NCT01464333|101724508|FG000|Overall Study|No Hospital Visit|42|||
33500007|NCT02569801|101724510|FG000|Overall Study|Withdrawal by Subject|9|||
33500008|NCT02569801|101724511|FG001|Overall Study|Withdrawal by Subject|9|||
33500009|NCT02569801|101724510|FG000|Overall Study|Sponsor Decision|13|||
33500010|NCT02569801|101724511|FG001|Overall Study|Sponsor Decision|14|||
33500011|NCT02569801|101724510|FG000|Overall Study|Progressive Disease|2|||
33500012|NCT02569801|101724511|FG001|Overall Study|Progressive Disease|7|||
33500013|NCT02569801|101724510|FG000|Overall Study|Lost to Follow-up|0|||
33500014|NCT02569801|101724511|FG001|Overall Study|Lost to Follow-up|1|||
33500015|NCT02569801|101724510|FG000|Overall Study|Death|12|||
33500016|NCT02569801|101724511|FG001|Overall Study|Death|4|||
33500017|NCT02176655|101724512|FG000|Overall Study|Subjects did not treat|6|||
33500018|NCT00818766|101724515|FG000|Overall Study|Could not be Contacted on Day 28|11|||
33500019|NCT00818766|101724516|FG001|Overall Study|Could not be Contacted on Day 28|10|||
33500020|NCT00818766|101724515|FG000|Overall Study|Death|1|||
33500021|NCT00818766|101724516|FG001|Overall Study|Death|0|||
33500022|NCT00818766|101724515|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
33500023|NCT00818766|101724516|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
33500024|NCT04548193|101724517|FG000|Overall Study|Lost to Follow-up|0|||
33500025|NCT04548193|101724518|FG001|Overall Study|Lost to Follow-up|1|||
33500026|NCT04548193|101724517|FG000|Overall Study|Death|0|||
33500027|NCT04548193|101724518|FG001|Overall Study|Death|1|||
33500028|NCT04548193|101724517|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
33500029|NCT04548193|101724518|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
33500030|NCT04548193|101724517|FG000|Overall Study|Withdrawal by Subject|2|||
33500031|NCT04548193|101724518|FG001|Overall Study|Withdrawal by Subject|2|||
33500032|NCT04031846|101724519|FG000|Overall Study|Lost to Follow-up|4|||
33500033|NCT04031846|101724520|FG001|Overall Study|Lost to Follow-up|4|||
33500034|NCT04031846|101724519|FG000|Overall Study|Physician Decision|0|||
33500035|NCT04031846|101724520|FG001|Overall Study|Physician Decision|1|||
33500036|NCT04031846|101724519|FG000|Overall Study|Protocol Violation|1|||
33500037|NCT04031846|101724520|FG001|Overall Study|Protocol Violation|1|||
33500038|NCT04031846|101724519|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
33500039|NCT04031846|101724520|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
33307110|NCT01445301|101017296|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
33307111|NCT01445301|101017294|FG000|Overall Study|Physician Decision|0|||
33307112|NCT01445301|101017295|FG001|Overall Study|Physician Decision|2|||
33307113|NCT01445301|101017296|FG002|Overall Study|Physician Decision|0|||
33307114|NCT01445301|101017294|FG000|Overall Study|Withdrawal by Subject|5|||
33307115|NCT01445301|101017295|FG001|Overall Study|Withdrawal by Subject|6|||
33307116|NCT01445301|101017296|FG002|Overall Study|Withdrawal by Subject|4|||
33307117|NCT03282240|101017298|FG000|Overall Study|Adverse Event|2|||
33307118|NCT03282240|101017299|FG001|Overall Study|Adverse Event|2|||
33307119|NCT03282240|101017300|FG002|Overall Study|Adverse Event|0|||
33307120|NCT03282240|101017298|FG000|Overall Study|Lost to Follow-up|3|||
33307121|NCT03282240|101017299|FG001|Overall Study|Lost to Follow-up|0|||
33307122|NCT03282240|101017300|FG002|Overall Study|Lost to Follow-up|0|||
33307123|NCT03282240|101017298|FG000|Overall Study|Protocol Deviation|4|||
33307124|NCT03282240|101017299|FG001|Overall Study|Protocol Deviation|1|||
33307125|NCT03282240|101017300|FG002|Overall Study|Protocol Deviation|2|||
33307126|NCT03282240|101017298|FG000|Overall Study|Withdrawal by Subject|1|||
33307127|NCT03282240|101017299|FG001|Overall Study|Withdrawal by Subject|0|||
33307128|NCT03282240|101017300|FG002|Overall Study|Withdrawal by Subject|1|||
33307129|NCT01901341|101017301|FG000|Overall Study|Adverse Event|4|||
33500040|NCT03051100|101724521|FG000|Overall Study|Withdrawal by Subject|1|||
33500041|NCT03051100|101724522|FG001|Overall Study|Withdrawal by Subject|0|||
33500042|NCT00684411|101724523|FG000|Overall Study|New Primary Cancer|1|||
33500043|NCT00684411|101724523|FG000|Overall Study|Disease Progression|10|||
33500044|NCT00684411|101724523|FG000|Overall Study|Adverse Event|1|||
33500045|NCT01996241|101724528|FG000|Overall Study|Lost to Follow-up|252|||
33307130|NCT01901341|101017302|FG001|Overall Study|Adverse Event|2|||
33307131|NCT01901341|101017301|FG000|Overall Study|Lack of Efficacy|0|||
33307132|NCT01901341|101017302|FG001|Overall Study|Lack of Efficacy|2|||
33307133|NCT01901341|101017301|FG000|Overall Study|Lost to Follow-up|0|||
33500046|NCT01996241|101724529|FG001|Overall Study|Lost to Follow-up|235|||
33500047|NCT01100086|101724530|FG000|Period 1|Withdrawal by Subject|1|||
33500048|NCT01100086|101724531|FG001|Period 1|Withdrawal by Subject|0|||
33500049|NCT01479465|101724532|FG000|Overall Study|Disease Progression|9|||
33500050|NCT01479465|101724533|FG001|Overall Study|Disease Progression|61|||
33500051|NCT01479465|101724534|FG002|Overall Study|Disease Progression|65|||
33500052|NCT01479465|101724535|FG003|Overall Study|Disease Progression|70|||
33500053|NCT01479465|101724532|FG000|Overall Study|Study Discontinued by Sponsor|0|||
33500054|NCT01479465|101724533|FG001|Overall Study|Study Discontinued by Sponsor|7|||
33500055|NCT01479465|101724534|FG002|Overall Study|Study Discontinued by Sponsor|5|||
33500056|NCT01479465|101724535|FG003|Overall Study|Study Discontinued by Sponsor|3|||
33500057|NCT01479465|101724532|FG000|Overall Study|Adverse Event|0|||
33500058|NCT01479465|101724533|FG001|Overall Study|Adverse Event|3|||
33500059|NCT01479465|101724534|FG002|Overall Study|Adverse Event|6|||
33500060|NCT01479465|101724535|FG003|Overall Study|Adverse Event|4|||
33500061|NCT01479465|101724532|FG000|Overall Study|Investigator Discretion|1|||
33500062|NCT01479465|101724533|FG001|Overall Study|Investigator Discretion|4|||
33500063|NCT01479465|101724534|FG002|Overall Study|Investigator Discretion|2|||
33500064|NCT01479465|101724535|FG003|Overall Study|Investigator Discretion|4|||
33500065|NCT01479465|101724532|FG000|Overall Study|Subject Request|1|||
33500066|NCT01479465|101724533|FG001|Overall Study|Subject Request|3|||
33500067|NCT01479465|101724534|FG002|Overall Study|Subject Request|4|||
33500068|NCT01479465|101724535|FG003|Overall Study|Subject Request|2|||
33500069|NCT01479465|101724532|FG000|Overall Study|Subject Withdrew Consent|0|||
33500070|NCT01479465|101724533|FG001|Overall Study|Subject Withdrew Consent|5|||
33500071|NCT01479465|101724534|FG002|Overall Study|Subject Withdrew Consent|2|||
33500072|NCT01479465|101724535|FG003|Overall Study|Subject Withdrew Consent|1|||
33500073|NCT01479465|101724532|FG000|Overall Study|Protocol Violation|0|||
33500074|NCT01479465|101724533|FG001|Overall Study|Protocol Violation|1|||
33191401|NCT01454726|100605220|FG001|Overall Study|Withdrawal by Subject|1|||
33191402|NCT02410811|100605221|FG000|Overall Study|Withdrawal by Subject|0|||
33191403|NCT02410811|100605222|FG001|Overall Study|Withdrawal by Subject|0|||
33191404|NCT02410811|100605223|FG002|Overall Study|Withdrawal by Subject|1|||
33191405|NCT02410811|100605224|FG003|Overall Study|Withdrawal by Subject|0|||
33191406|NCT02896400|100605225|FG000|1 Month Follow-up|Lost to Follow-up|7|||
33191407|NCT02896400|100605226|FG001|1 Month Follow-up|Lost to Follow-up|7|||
33500075|NCT01479465|101724534|FG002|Overall Study|Protocol Violation|1|||
33500076|NCT01479465|101724535|FG003|Overall Study|Protocol Violation|0|||
33500077|NCT01479465|101724532|FG000|Overall Study|Death|0|||
33500078|NCT01479465|101724533|FG001|Overall Study|Death|0|||
33191408|NCT02896400|100605227|FG002|1 Month Follow-up|Lost to Follow-up|5|||
33191409|NCT02896400|100605228|FG003|1 Month Follow-up|Lost to Follow-up|8|||
33191410|NCT02896400|100605229|FG004|1 Month Follow-up|Lost to Follow-up|9|||
33191411|NCT02896400|100605230|FG005|1 Month Follow-up|Lost to Follow-up|6|||
33191412|NCT02896400|100605231|FG006|1 Month Follow-up|Lost to Follow-up|5|||
33191413|NCT02896400|100605232|FG007|1 Month Follow-up|Lost to Follow-up|6|||
33191414|NCT02896400|100605233|FG008|1 Month Follow-up|Lost to Follow-up|4|||
33191415|NCT02896400|100605234|FG009|1 Month Follow-up|Lost to Follow-up|7|||
33191416|NCT02896400|100605235|FG010|1 Month Follow-up|Lost to Follow-up|5|||
33191417|NCT02896400|100605236|FG011|1 Month Follow-up|Lost to Follow-up|5|||
33191418|NCT02896400|100605237|FG012|1 Month Follow-up|Lost to Follow-up|3|||
33191419|NCT02896400|100605238|FG013|1 Month Follow-up|Lost to Follow-up|4|||
33191420|NCT02896400|100605239|FG014|1 Month Follow-up|Lost to Follow-up|1|||
33191421|NCT02896400|100605240|FG015|1 Month Follow-up|Lost to Follow-up|2|||
33191422|NCT02896400|100605225|FG000|1 Month Follow-up|Death|0|||
33191423|NCT02896400|100605226|FG001|1 Month Follow-up|Death|0|||
33191424|NCT02896400|100605227|FG002|1 Month Follow-up|Death|0|||
33191425|NCT02896400|100605228|FG003|1 Month Follow-up|Death|0|||
33191426|NCT02896400|100605229|FG004|1 Month Follow-up|Death|0|||
33191427|NCT02896400|100605230|FG005|1 Month Follow-up|Death|0|||
33191428|NCT02896400|100605231|FG006|1 Month Follow-up|Death|0|||
33191429|NCT02896400|100605232|FG007|1 Month Follow-up|Death|0|||
33191430|NCT02896400|100605233|FG008|1 Month Follow-up|Death|0|||
33191431|NCT02896400|100605234|FG009|1 Month Follow-up|Death|0|||
33191432|NCT02896400|100605235|FG010|1 Month Follow-up|Death|0|||
33191433|NCT02896400|100605236|FG011|1 Month Follow-up|Death|0|||
33191434|NCT02896400|100605237|FG012|1 Month Follow-up|Death|0|||
33191435|NCT02896400|100605238|FG013|1 Month Follow-up|Death|0|||
33191436|NCT02896400|100605239|FG014|1 Month Follow-up|Death|0|||
33191437|NCT02896400|100605240|FG015|1 Month Follow-up|Death|1|||
33191438|NCT02896400|100605225|FG000|3 Month Follow-up|Lost to Follow-up|6|||
33191439|NCT02896400|100605226|FG001|3 Month Follow-up|Lost to Follow-up|3|||
33191440|NCT02896400|100605227|FG002|3 Month Follow-up|Lost to Follow-up|6|||
33191441|NCT02896400|100605228|FG003|3 Month Follow-up|Lost to Follow-up|11|||
33191442|NCT02896400|100605229|FG004|3 Month Follow-up|Lost to Follow-up|12|||
33191443|NCT02896400|100605230|FG005|3 Month Follow-up|Lost to Follow-up|6|||
33191444|NCT02896400|100605231|FG006|3 Month Follow-up|Lost to Follow-up|4|||
33191445|NCT02896400|100605232|FG007|3 Month Follow-up|Lost to Follow-up|3|||
33191446|NCT02896400|100605233|FG008|3 Month Follow-up|Lost to Follow-up|6|||
33191447|NCT02896400|100605234|FG009|3 Month Follow-up|Lost to Follow-up|5|||
33191448|NCT02896400|100605235|FG010|3 Month Follow-up|Lost to Follow-up|6|||
33191449|NCT02896400|100605236|FG011|3 Month Follow-up|Lost to Follow-up|6|||
33191450|NCT02896400|100605237|FG012|3 Month Follow-up|Lost to Follow-up|3|||
33191451|NCT02896400|100605238|FG013|3 Month Follow-up|Lost to Follow-up|5|||
33191452|NCT02896400|100605239|FG014|3 Month Follow-up|Lost to Follow-up|3|||
33191453|NCT02896400|100605240|FG015|3 Month Follow-up|Lost to Follow-up|2|||
33191454|NCT02896400|100605225|FG000|3 Month Follow-up|Death|0|||
33191455|NCT02896400|100605226|FG001|3 Month Follow-up|Death|0|||
33191456|NCT02896400|100605227|FG002|3 Month Follow-up|Death|0|||
33191457|NCT02896400|100605228|FG003|3 Month Follow-up|Death|0|||
33191458|NCT02896400|100605229|FG004|3 Month Follow-up|Death|0|||
33191459|NCT02896400|100605230|FG005|3 Month Follow-up|Death|0|||
33191460|NCT02896400|100605231|FG006|3 Month Follow-up|Death|0|||
33191461|NCT02896400|100605232|FG007|3 Month Follow-up|Death|0|||
33191462|NCT02896400|100605233|FG008|3 Month Follow-up|Death|0|||
33191463|NCT02896400|100605234|FG009|3 Month Follow-up|Death|0|||
33191464|NCT02896400|100605235|FG010|3 Month Follow-up|Death|0|||
33191465|NCT02896400|100605236|FG011|3 Month Follow-up|Death|0|||
33191466|NCT02896400|100605237|FG012|3 Month Follow-up|Death|0|||
33191467|NCT02896400|100605238|FG013|3 Month Follow-up|Death|1|||
33191468|NCT02896400|100605239|FG014|3 Month Follow-up|Death|1|||
33191469|NCT02896400|100605240|FG015|3 Month Follow-up|Death|0|||
33191470|NCT02896400|100605225|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33191471|NCT02896400|100605226|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
33191472|NCT02896400|100605227|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33191473|NCT02896400|100605228|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33191474|NCT02896400|100605229|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
33191475|NCT02896400|100605230|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33191476|NCT02896400|100605231|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
33191477|NCT02896400|100605232|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
33191478|NCT02896400|100605233|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33191479|NCT02896400|100605234|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33500079|NCT01479465|101724534|FG002|Overall Study|Death|0|||
33191480|NCT02896400|100605235|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
33191481|NCT02896400|100605236|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
33191482|NCT02896400|100605237|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33191483|NCT02896400|100605238|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
33191484|NCT02896400|100605239|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
33191485|NCT02896400|100605240|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
33191486|NCT02896400|100605225|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
33191487|NCT02896400|100605226|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
33191488|NCT02896400|100605227|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
33191489|NCT02896400|100605228|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
33191490|NCT02896400|100605229|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
33601328|NCT00260065|102091884|FG000|Overall Study|Medication Noncompliance|1|||
33601329|NCT01304329|102091885|FG000|Third Intervention (3 Days)|Adverse Event|0|||
33601330|NCT01304329|102091886|FG001|Third Intervention (3 Days)|Adverse Event|1|||
33601331|NCT01304329|102091887|FG002|Third Intervention (3 Days)|Adverse Event|0|||
33191491|NCT02896400|100605230|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
33191492|NCT02896400|100605231|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
33191493|NCT02896400|100605232|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
33191494|NCT02896400|100605233|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
33191495|NCT02896400|100605234|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
33191496|NCT02896400|100605235|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
33191497|NCT02896400|100605236|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
33191498|NCT02896400|100605237|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
33191499|NCT02896400|100605238|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
33191500|NCT02896400|100605239|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
33191501|NCT02896400|100605240|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
33191502|NCT01610791|100605241|FG000|Overall Study|Lost to Follow-up|7|||
33191503|NCT01610791|100605241|FG000|Overall Study|Adverse Event|6|||
33191504|NCT01610791|100605241|FG000|Overall Study|Physician Decision|1|||
33191505|NCT01610791|100605241|FG000|Overall Study|Adverse event and Investigator decision|1|||
33191506|NCT01610791|100605241|FG000|Overall Study|Death|1|||
33191507|NCT01610791|100605241|FG000|Overall Study|Not determined|5|||
33191508|NCT00235989|100605242|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
33191509|NCT00235989|100605243|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
33191510|NCT00235989|100605244|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
33191511|NCT00235989|100605245|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
33191512|NCT00235989|100605246|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
33191513|NCT00235989|100605247|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
33191514|NCT00235989|100605242|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
33191515|NCT00235989|100605243|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
33191516|NCT00235989|100605244|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
33191517|NCT00235989|100605245|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
33191518|NCT00235989|100605246|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
33191519|NCT00235989|100605247|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
33191520|NCT00235989|100605242|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
33191521|NCT00235989|100605243|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
33191522|NCT00235989|100605244|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
33191523|NCT00235989|100605245|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
33191524|NCT00235989|100605246|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
33500080|NCT01479465|101724535|FG003|Overall Study|Death|1|||
33500081|NCT01479465|101724532|FG000|Overall Study|Lost to Follow-up|0|||
33500082|NCT01479465|101724533|FG001|Overall Study|Lost to Follow-up|0|||
33500083|NCT01479465|101724534|FG002|Overall Study|Lost to Follow-up|1|||
33500084|NCT01479465|101724535|FG003|Overall Study|Lost to Follow-up|0|||
33500085|NCT03150719|101724536|FG000|Overall Study|Adverse Event|0|||
33500086|NCT03150719|101724537|FG001|Overall Study|Adverse Event|1|||
33500087|NCT03150719|101724536|FG000|Overall Study|Death|0|||
33500088|NCT03150719|101724537|FG001|Overall Study|Death|1|||
33500089|NCT03150719|101724536|FG000|Overall Study|Other|1|||
33500090|NCT03150719|101724537|FG001|Overall Study|Other|0|||
33500091|NCT03682848|101724538|FG000|Overall Study|Withdrawal by Subject|2|||
33500092|NCT03682848|101724538|FG000|Overall Study|Site closed|5|||
33500093|NCT03682848|101724538|FG000|Overall Study|Protocol Deviation|1|||
33500094|NCT03682848|101724538|FG000|Overall Study|Adverse Event|1|||
33500095|NCT02593097|101724539|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
33500096|NCT02593097|101724540|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
33601332|NCT01304329|102091888|FG003|Third Intervention (3 Days)|Adverse Event|0|||
33601333|NCT01304329|102091889|FG004|Third Intervention (3 Days)|Adverse Event|0|||
33601334|NCT01304329|102091890|FG005|Third Intervention (3 Days)|Adverse Event|0|||
33224260|NCT01672853|100721765|FG001|Overall Study|Lost to Follow-up|1|||
33500097|NCT02593097|101724539|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
33500098|NCT02593097|101724540|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
33500099|NCT02593097|101724539|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
33500100|NCT02593097|101724540|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
33500101|NCT02593097|101724539|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
33500102|NCT02593097|101724540|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
33500103|NCT02593097|101724539|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
33500104|NCT02593097|101724540|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
33500105|NCT00917852|101724541|FG000|Overall Study|Death|6|||
33500106|NCT01464424|101724542|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
33500107|NCT01464424|101724543|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
33500108|NCT02518048|101724544|FG000|Overall Study|Withdrawal by Subject|1|||
33601335|NCT00823212|102091891|FG000|Overall Study|Death|8|||
33191525|NCT00235989|100605247|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
33191526|NCT00235989|100605242|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
33191527|NCT00235989|100605243|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
33191528|NCT00235989|100605244|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
33191529|NCT00235989|100605245|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
33191530|NCT00235989|100605246|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
33191531|NCT00235989|100605247|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
33191532|NCT00235989|100605242|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
33191533|NCT00235989|100605243|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
33191534|NCT00235989|100605244|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
33191535|NCT00235989|100605245|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
33191536|NCT00235989|100605246|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
33191537|NCT00235989|100605247|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
33191538|NCT04380857|100605250|FG000|Overall Study|Lost to Follow-up|3|||
33307134|NCT01901341|101017302|FG001|Overall Study|Lost to Follow-up|1|||
33307135|NCT01901341|101017301|FG000|Overall Study|Protocol Violation|2|||
33307136|NCT01901341|101017302|FG001|Overall Study|Protocol Violation|0|||
33307137|NCT01901341|101017301|FG000|Overall Study|Study Terminated by Sponsor|13|||
33307138|NCT01901341|101017302|FG001|Overall Study|Study Terminated by Sponsor|15|||
33307139|NCT01901341|101017301|FG000|Overall Study|Withdrawal by Subject|1|||
33307140|NCT01901341|101017302|FG001|Overall Study|Withdrawal by Subject|1|||
33307141|NCT02874924|101021367|FG000|Overall Study|Adverse Event|2|||
33307142|NCT02874924|101021368|FG001|Overall Study|Adverse Event|0|||
33307143|NCT02874924|101021369|FG002|Overall Study|Adverse Event|0|||
33307144|NCT02874924|101021367|FG000|Overall Study|Withdrawal by Subject|1|||
33307145|NCT02874924|101021368|FG001|Overall Study|Withdrawal by Subject|0|||
33307146|NCT02874924|101021369|FG002|Overall Study|Withdrawal by Subject|0|||
33307147|NCT01737827|101021370|FG000|Overall Study|Adverse Event|3|||
33307148|NCT01737827|101021371|FG001|Overall Study|Adverse Event|6|||
33307149|NCT01737827|101021372|FG002|Overall Study|Adverse Event|0|||
33307150|NCT01737827|101021370|FG000|Overall Study|Lost to Follow-up|0|||
33307151|NCT01737827|101021371|FG001|Overall Study|Lost to Follow-up|1|||
33307152|NCT01737827|101021372|FG002|Overall Study|Lost to Follow-up|0|||
33307153|NCT01737827|101021370|FG000|Overall Study|Physician Decision|0|||
33307154|NCT01737827|101021371|FG001|Overall Study|Physician Decision|2|||
33307155|NCT01737827|101021372|FG002|Overall Study|Physician Decision|0|||
33307156|NCT01737827|101021370|FG000|Overall Study|Progressive Disease|5|||
33307157|NCT01737827|101021371|FG001|Overall Study|Progressive Disease|16|||
33307158|NCT01737827|101021372|FG002|Overall Study|Progressive Disease|2|||
33307159|NCT01737827|101021370|FG000|Overall Study|Study Terminated by Sponsor|0|||
33307160|NCT01737827|101021371|FG001|Overall Study|Study Terminated by Sponsor|1|||
33307161|NCT01737827|101021372|FG002|Overall Study|Study Terminated by Sponsor|0|||
33307162|NCT01737827|101021370|FG000|Overall Study|Subject/Guardian Decision|0|||
33307163|NCT01737827|101021371|FG001|Overall Study|Subject/Guardian Decision|2|||
33307164|NCT01737827|101021372|FG002|Overall Study|Subject/Guardian Decision|0|||
33307165|NCT01293487|101021374|FG000|Overall Study|Lost to Follow-up|0|||
33307166|NCT01293487|101021375|FG001|Overall Study|Lost to Follow-up|0|||
33307167|NCT01293487|101021376|FG002|Overall Study|Lost to Follow-up|0|||
33307168|NCT01293487|101021377|FG003|Overall Study|Lost to Follow-up|1|||
33191539|NCT04380857|100605251|FG001|Overall Study|Lost to Follow-up|3|||
33191540|NCT01448850|100605253|FG000|Overall Study|Death|3|||
33191541|NCT01448850|100605254|FG001|Overall Study|Death|6|||
33191542|NCT01448850|100605253|FG000|Overall Study|Withdrawal by Subject|13|||
33191543|NCT01448850|100605254|FG001|Overall Study|Withdrawal by Subject|21|||
33191544|NCT01448850|100605253|FG000|Overall Study|Lost to Follow-up|3|||
33307169|NCT01293487|101021378|FG004|Overall Study|Lost to Follow-up|0|||
33307170|NCT01293487|101021379|FG005|Overall Study|Lost to Follow-up|0|||
33307171|NCT01293487|101021380|FG006|Overall Study|Lost to Follow-up|0|||
33307172|NCT01293487|101021381|FG007|Overall Study|Lost to Follow-up|0|||
33601336|NCT00823212|102091892|FG001|Overall Study|Death|10|||
33191545|NCT01448850|100605254|FG001|Overall Study|Lost to Follow-up|1|||
33307173|NCT01293487|101021374|FG000|Overall Study|Withdrawal by Subject|0|||
33307174|NCT01293487|101021375|FG001|Overall Study|Withdrawal by Subject|0|||
33307175|NCT01293487|101021376|FG002|Overall Study|Withdrawal by Subject|0|||
33307176|NCT01293487|101021377|FG003|Overall Study|Withdrawal by Subject|0|||
33500109|NCT00611923|101724545|FG000|Overall Study|Withdrawal by Subject|2|||
33500110|NCT00611923|101724546|FG001|Overall Study|Withdrawal by Subject|2|||
33307177|NCT01293487|101021378|FG004|Overall Study|Withdrawal by Subject|0|||
33307178|NCT01293487|101021379|FG005|Overall Study|Withdrawal by Subject|0|||
33307179|NCT01293487|101021380|FG006|Overall Study|Withdrawal by Subject|0|||
33307180|NCT01293487|101021381|FG007|Overall Study|Withdrawal by Subject|2|||
33307181|NCT01679405|101021389|FG000|Overall Study|Death|2|||
33307182|NCT01679405|101021390|FG001|Overall Study|Death|5|||
33307183|NCT00572039|101021391|FG000|Overall Study|Withdrawal by Subject|9|||
33307184|NCT00572039|101021392|FG001|Overall Study|Withdrawal by Subject|6|||
33307185|NCT00572039|101021391|FG000|Overall Study|Death|2|||
33307186|NCT00572039|101021392|FG001|Overall Study|Death|3|||
33307187|NCT00572039|101021391|FG000|Overall Study|Ill|5|||
33307188|NCT00572039|101021392|FG001|Overall Study|Ill|1|||
33307189|NCT03656510|101021393|FG000|Overall Study|Lost to Follow-up|1|||
33307190|NCT03656510|101021394|FG001|Overall Study|Lost to Follow-up|0|||
33307191|NCT03656510|101021395|FG002|Overall Study|Lost to Follow-up|0|||
33307192|NCT03656510|101021396|FG003|Overall Study|Lost to Follow-up|0|||
33307193|NCT03656510|101021397|FG004|Overall Study|Lost to Follow-up|0|||
33307194|NCT03656510|101021398|FG005|Overall Study|Lost to Follow-up|0|||
33307195|NCT03656510|101021393|FG000|Overall Study|Withdrawal by Subject|1|||
33307196|NCT03656510|101021394|FG001|Overall Study|Withdrawal by Subject|1|||
33307197|NCT03656510|101021395|FG002|Overall Study|Withdrawal by Subject|0|||
33307198|NCT03656510|101021396|FG003|Overall Study|Withdrawal by Subject|1|||
33307199|NCT03656510|101021397|FG004|Overall Study|Withdrawal by Subject|0|||
33307200|NCT03656510|101021398|FG005|Overall Study|Withdrawal by Subject|0|||
33307201|NCT05718466|101021399|FG000|Overall Study|Withdrawal by Subject|1|||
33307202|NCT05718466|101021400|FG001|Overall Study|Withdrawal by Subject|2|||
33307203|NCT05718466|101021399|FG000|Overall Study|Death|0|||
33307204|NCT05718466|101021400|FG001|Overall Study|Death|1|||
33307205|NCT01768637|101021401|FG000|Overall Study|Lost to Follow-up|2|||
33307206|NCT01768637|101021402|FG001|Overall Study|Lost to Follow-up|7|||
33307207|NCT01768637|101021401|FG000|Overall Study|Difficult blood draw|1|||
33307208|NCT01768637|101021402|FG001|Overall Study|Difficult blood draw|0|||
33307209|NCT05020327|101021403|FG000|Overall Study|Physician Decision|3|||
33307210|NCT05020327|101021404|FG001|Overall Study|Physician Decision|0|||
33307211|NCT05020327|101021405|FG002|Overall Study|Physician Decision|0|||
33307212|NCT05020327|101021403|FG000|Overall Study|Withdrawal by Subject|1|||
33307213|NCT05020327|101021404|FG001|Overall Study|Withdrawal by Subject|1|||
33307214|NCT05020327|101021405|FG002|Overall Study|Withdrawal by Subject|0|||
33307215|NCT05020327|101021403|FG000|Overall Study|personal/cultural, ineligible|12|||
33500111|NCT00757042|101724549|FG000|Overall Study|Lost to Follow-up|0|||
33307216|NCT05020327|101021404|FG001|Overall Study|personal/cultural, ineligible|0|||
33307217|NCT05020327|101021405|FG002|Overall Study|personal/cultural, ineligible|0|||
33307218|NCT00540046|101021410|FG000|Overall Study|Lost to Follow-up|33|||
33307219|NCT00540046|101021411|FG001|Overall Study|Lost to Follow-up|23|||
33307220|NCT01151410|101021412|FG000|Overall Study|Withdrawal by Subject|3|||
33307221|NCT01151410|101021413|FG001|Overall Study|Withdrawal by Subject|5|||
33307222|NCT01151410|101021412|FG000|Overall Study|Lost to Follow-up|3|||
33500112|NCT00757042|101724550|FG001|Overall Study|Lost to Follow-up|0|||
33500113|NCT00757042|101724551|FG002|Overall Study|Lost to Follow-up|0|||
33500114|NCT00757042|101724552|FG003|Overall Study|Lost to Follow-up|0|||
33500115|NCT00757042|101724553|FG004|Overall Study|Lost to Follow-up|0|||
33307223|NCT01151410|101021413|FG001|Overall Study|Lost to Follow-up|4|||
33307224|NCT01151410|101021412|FG000|Overall Study|Adverse Event|1|||
33307225|NCT01151410|101021413|FG001|Overall Study|Adverse Event|2|||
33307226|NCT01151410|101021412|FG000|Overall Study|Protocol deviation|2|||
33307227|NCT01151410|101021413|FG001|Overall Study|Protocol deviation|1|||
33307228|NCT01151410|101021412|FG000|Overall Study|Administrative problems|1|||
33307229|NCT01151410|101021413|FG001|Overall Study|Administrative problems|1|||
33307230|NCT01151410|101021412|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33307231|NCT01151410|101021413|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33307232|NCT01151410|101021412|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33307233|NCT01151410|101021413|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33307234|NCT00215137|101021414|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
33601337|NCT00823212|102091891|FG000|Overall Study|Withdrawal by Subject|6|||
33601338|NCT00823212|102091892|FG001|Overall Study|Withdrawal by Subject|1|||
33601339|NCT00823212|102091891|FG000|Overall Study|Incarcerated|0|||
33601340|NCT00823212|102091892|FG001|Overall Study|Incarcerated|1|||
33601341|NCT00823212|102091891|FG000|Overall Study|Missed 12-month visit|21|||
33601342|NCT00823212|102091892|FG001|Overall Study|Missed 12-month visit|21|||
33601343|NCT01444027|102091899|FG000|Overall Study|Withdrawal by Subject|4|||
33601344|NCT01444027|102091900|FG001|Overall Study|Withdrawal by Subject|10|||
33601345|NCT01444027|102091901|FG002|Overall Study|Withdrawal by Subject|24|||
33601346|NCT01444027|102091899|FG000|Overall Study|Lost to Follow-up|26|||
33307235|NCT00215137|101021415|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
33307236|NCT00215137|101021416|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
33307237|NCT00215137|101021414|FG000|Randomization Period|Lost to Follow-up|0|||
33307238|NCT00215137|101021415|FG001|Randomization Period|Lost to Follow-up|1|||
33307239|NCT00215137|101021416|FG002|Randomization Period|Lost to Follow-up|0|||
33307240|NCT00215137|101021414|FG000|Randomization Period|Withdrawal by Subject|0|||
33307241|NCT00215137|101021415|FG001|Randomization Period|Withdrawal by Subject|1|||
33307242|NCT00215137|101021416|FG002|Randomization Period|Withdrawal by Subject|0|||
33307243|NCT01204398|101021419|FG000|Overall Study|Adverse Event|1|||
33307244|NCT01146782|101021420|FG000|Screening Cohort|Screen Failure|187|||
33307245|NCT01146782|101021420|FG000|Screening Cohort|Lost to Follow-up|4|||
33307246|NCT01146782|101021420|FG000|Screening Cohort|Physician Decision|1|||
33307247|NCT01146782|101021420|FG000|Screening Cohort|Withdrawal by Subject|29|||
33307248|NCT01146782|101021420|FG000|Safety Cohort|Screen Failure|61|||
33307249|NCT01146782|101021420|FG000|Safety Cohort|Withdrawal by Subject|4|||
33307250|NCT01146782|101021420|FG000|Safety Cohort|Control AHI <5|4|||
33307251|NCT01146782|101021420|FG000|Safety Cohort|TST <4 hrs|14|||
33307252|NCT01146782|101021420|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
33307253|NCT01146782|101021420|FG000|Primary Endpoint Cohort|Physician Decision|1|||
33307254|NCT02914275|101021421|FG000|Overall Study|Lost to Follow-up|84|||
33500116|NCT00757042|101724554|FG005|Overall Study|Lost to Follow-up|0|||
33500117|NCT00757042|101724555|FG006|Overall Study|Lost to Follow-up|0|||
33500118|NCT00757042|101724556|FG007|Overall Study|Lost to Follow-up|0|||
33500119|NCT00757042|101724557|FG008|Overall Study|Lost to Follow-up|1|||
33500120|NCT00757042|101724558|FG009|Overall Study|Lost to Follow-up|0|||
33500121|NCT00757042|101724559|FG010|Overall Study|Lost to Follow-up|0|||
33500122|NCT00757042|101724549|FG000|Overall Study|Ineligibility Determined|0|||
33500123|NCT00757042|101724550|FG001|Overall Study|Ineligibility Determined|0|||
33500124|NCT00757042|101724551|FG002|Overall Study|Ineligibility Determined|0|||
33500125|NCT00757042|101724552|FG003|Overall Study|Ineligibility Determined|0|||
33500126|NCT00757042|101724553|FG004|Overall Study|Ineligibility Determined|0|||
33500127|NCT00757042|101724554|FG005|Overall Study|Ineligibility Determined|0|||
33500128|NCT00757042|101724555|FG006|Overall Study|Ineligibility Determined|0|||
33500129|NCT00757042|101724556|FG007|Overall Study|Ineligibility Determined|0|||
33500130|NCT00757042|101724557|FG008|Overall Study|Ineligibility Determined|0|||
33500131|NCT00757042|101724558|FG009|Overall Study|Ineligibility Determined|0|||
33500132|NCT00757042|101724559|FG010|Overall Study|Ineligibility Determined|1|||
33500133|NCT00757042|101724549|FG000|Overall Study|Withdrawal by Subject|0|||
33500134|NCT00757042|101724550|FG001|Overall Study|Withdrawal by Subject|0|||
33500135|NCT00757042|101724551|FG002|Overall Study|Withdrawal by Subject|0|||
33500136|NCT00757042|101724552|FG003|Overall Study|Withdrawal by Subject|0|||
33500137|NCT00757042|101724553|FG004|Overall Study|Withdrawal by Subject|0|||
33307255|NCT02914275|101021422|FG001|Overall Study|Lost to Follow-up|29|||
33307256|NCT02914275|101021421|FG000|Overall Study|Withdrawal by Subject|26|||
33307257|NCT02914275|101021422|FG001|Overall Study|Withdrawal by Subject|10|||
33307258|NCT02914275|101021421|FG000|Overall Study|Protocol Violation|1|||
33307259|NCT02914275|101021422|FG001|Overall Study|Protocol Violation|1|||
33393772|NCT03073200|101328516|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
33500138|NCT00757042|101724554|FG005|Overall Study|Withdrawal by Subject|0|||
33393773|NCT03073200|101328517|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
33393774|NCT03073200|101328518|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
33500139|NCT00757042|101724555|FG006|Overall Study|Withdrawal by Subject|0|||
33500140|NCT00757042|101724556|FG007|Overall Study|Withdrawal by Subject|0|||
33500141|NCT00757042|101724557|FG008|Overall Study|Withdrawal by Subject|0|||
33500142|NCT00757042|101724558|FG009|Overall Study|Withdrawal by Subject|1|||
33601347|NCT01444027|102091900|FG001|Overall Study|Lost to Follow-up|20|||
33601348|NCT01444027|102091901|FG002|Overall Study|Lost to Follow-up|14|||
33601349|NCT05291936|102091902|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
33307260|NCT02914275|101021421|FG000|Overall Study|Physician Decision|3|||
33307261|NCT02914275|101021422|FG001|Overall Study|Physician Decision|1|||
33307262|NCT02914275|101021421|FG000|Overall Study|Other|4|||
33307263|NCT02914275|101021422|FG001|Overall Study|Other|1|||
33307264|NCT02914275|101021421|FG000|Overall Study|Excluded due to invalid informed consent|3|||
33307265|NCT02914275|101021422|FG001|Overall Study|Excluded due to invalid informed consent|0|||
33500143|NCT00757042|101724559|FG010|Overall Study|Withdrawal by Subject|0|||
33500144|NCT01295827|101724562|FG000|Overall Study|Adverse Event|1|||
33500145|NCT01295827|101724563|FG001|Overall Study|Adverse Event|2|||
33500146|NCT01295827|101724564|FG002|Overall Study|Adverse Event|2|||
33500147|NCT01295827|101724565|FG003|Overall Study|Adverse Event|1|||
33500148|NCT01295827|101724566|FG004|Overall Study|Adverse Event|1|||
33500149|NCT01295827|101724567|FG005|Overall Study|Adverse Event|4|||
33500150|NCT01295827|101724568|FG006|Overall Study|Adverse Event|15|||
33500151|NCT01295827|101724569|FG007|Overall Study|Adverse Event|49|||
33500152|NCT01295827|101724570|FG008|Overall Study|Adverse Event|22|||
33500153|NCT01295827|101724571|FG009|Overall Study|Adverse Event|7|||
33500154|NCT01295827|101724572|FG010|Overall Study|Adverse Event|50|||
33500155|NCT01295827|101724573|FG011|Overall Study|Adverse Event|21|||
33500156|NCT01295827|101724574|FG012|Overall Study|Adverse Event|0|||
33500157|NCT01295827|101724575|FG013|Overall Study|Adverse Event|0|||
33500158|NCT01295827|101724576|FG014|Overall Study|Adverse Event|0|||
33500159|NCT01295827|101724562|FG000|Overall Study|Lost to Follow-up|0|||
33500160|NCT01295827|101724563|FG001|Overall Study|Lost to Follow-up|0|||
33500161|NCT01295827|101724564|FG002|Overall Study|Lost to Follow-up|3|||
33500162|NCT01295827|101724565|FG003|Overall Study|Lost to Follow-up|0|||
33500163|NCT01295827|101724566|FG004|Overall Study|Lost to Follow-up|1|||
33500164|NCT01295827|101724567|FG005|Overall Study|Lost to Follow-up|0|||
33500165|NCT01295827|101724568|FG006|Overall Study|Lost to Follow-up|4|||
33500166|NCT01295827|101724569|FG007|Overall Study|Lost to Follow-up|8|||
33500167|NCT01295827|101724570|FG008|Overall Study|Lost to Follow-up|7|||
33500168|NCT01295827|101724571|FG009|Overall Study|Lost to Follow-up|4|||
33500169|NCT01295827|101724572|FG010|Overall Study|Lost to Follow-up|7|||
33500170|NCT01295827|101724573|FG011|Overall Study|Lost to Follow-up|3|||
33500171|NCT01295827|101724574|FG012|Overall Study|Lost to Follow-up|0|||
33500172|NCT01295827|101724575|FG013|Overall Study|Lost to Follow-up|0|||
33500173|NCT01295827|101724576|FG014|Overall Study|Lost to Follow-up|0|||
33500174|NCT01295827|101724562|FG000|Overall Study|Not Reported|0|||
33500175|NCT01295827|101724563|FG001|Overall Study|Not Reported|0|||
33500176|NCT01295827|101724564|FG002|Overall Study|Not Reported|0|||
33500177|NCT01295827|101724565|FG003|Overall Study|Not Reported|1|||
33500178|NCT01295827|101724566|FG004|Overall Study|Not Reported|0|||
33500179|NCT01295827|101724567|FG005|Overall Study|Not Reported|0|||
33500180|NCT01295827|101724568|FG006|Overall Study|Not Reported|24|||
33500181|NCT01295827|101724569|FG007|Overall Study|Not Reported|58|||
33500182|NCT01295827|101724570|FG008|Overall Study|Not Reported|41|||
33500183|NCT01295827|101724571|FG009|Overall Study|Not Reported|2|||
33500184|NCT01295827|101724572|FG010|Overall Study|Not Reported|23|||
33500185|NCT01295827|101724573|FG011|Overall Study|Not Reported|13|||
33500186|NCT01295827|101724574|FG012|Overall Study|Not Reported|0|||
33500187|NCT01295827|101724575|FG013|Overall Study|Not Reported|0|||
33500188|NCT01295827|101724576|FG014|Overall Study|Not Reported|0|||
33500189|NCT01295827|101724562|FG000|Overall Study|Progressive Disease|2|||
33500190|NCT01295827|101724563|FG001|Overall Study|Progressive Disease|1|||
33500191|NCT01295827|101724564|FG002|Overall Study|Progressive Disease|5|||
33500192|NCT01295827|101724565|FG003|Overall Study|Progressive Disease|2|||
33500193|NCT01295827|101724566|FG004|Overall Study|Progressive Disease|0|||
33500194|NCT01295827|101724567|FG005|Overall Study|Progressive Disease|1|||
33500195|NCT01295827|101724568|FG006|Overall Study|Progressive Disease|87|||
33500196|NCT01295827|101724569|FG007|Overall Study|Progressive Disease|144|||
33500197|NCT01295827|101724570|FG008|Overall Study|Progressive Disease|85|||
33500198|NCT01295827|101724571|FG009|Overall Study|Progressive Disease|40|||
33500199|NCT01295827|101724572|FG010|Overall Study|Progressive Disease|175|||
33500200|NCT01295827|101724573|FG011|Overall Study|Progressive Disease|136|||
33500201|NCT01295827|101724574|FG012|Overall Study|Progressive Disease|0|||
33500202|NCT01295827|101724575|FG013|Overall Study|Progressive Disease|0|||
33500203|NCT01295827|101724576|FG014|Overall Study|Progressive Disease|0|||
33500204|NCT01295827|101724562|FG000|Overall Study|Screen Failure|0|||
33500205|NCT01295827|101724563|FG001|Overall Study|Screen Failure|0|||
33500206|NCT01295827|101724564|FG002|Overall Study|Screen Failure|0|||
33500207|NCT01295827|101724565|FG003|Overall Study|Screen Failure|0|||
33500208|NCT01295827|101724566|FG004|Overall Study|Screen Failure|0|||
33500209|NCT01295827|101724567|FG005|Overall Study|Screen Failure|0|||
33500210|NCT01295827|101724568|FG006|Overall Study|Screen Failure|2|||
33500211|NCT01295827|101724569|FG007|Overall Study|Screen Failure|2|||
33500212|NCT01295827|101724570|FG008|Overall Study|Screen Failure|2|||
33500213|NCT01295827|101724571|FG009|Overall Study|Screen Failure|0|||
33500214|NCT01295827|101724572|FG010|Overall Study|Screen Failure|1|||
33500215|NCT01295827|101724573|FG011|Overall Study|Screen Failure|0|||
33500216|NCT01295827|101724574|FG012|Overall Study|Screen Failure|0|||
33500217|NCT01295827|101724575|FG013|Overall Study|Screen Failure|0|||
33500218|NCT01295827|101724576|FG014|Overall Study|Screen Failure|0|||
33500219|NCT01295827|101724562|FG000|Overall Study|Withdrawal by Subject|1|||
33500220|NCT01295827|101724563|FG001|Overall Study|Withdrawal by Subject|0|||
33500221|NCT01295827|101724564|FG002|Overall Study|Withdrawal by Subject|2|||
33500222|NCT01295827|101724565|FG003|Overall Study|Withdrawal by Subject|0|||
33500223|NCT01295827|101724566|FG004|Overall Study|Withdrawal by Subject|0|||
33191546|NCT01448850|100605253|FG000|Overall Study|Other|15|||
33191547|NCT01448850|100605254|FG001|Overall Study|Other|12|||
33191548|NCT03571516|100605259|FG000|Overall Study|Severe diarrhea|1|||
33191549|NCT03571516|100605260|FG001|Overall Study|Severe diarrhea|0|||
33191550|NCT03571516|100605259|FG000|Overall Study|Withdrawal by Subject|0|||
33191551|NCT03571516|100605260|FG001|Overall Study|Withdrawal by Subject|1|||
33224261|NCT01672853|100721766|FG002|Overall Study|Lost to Follow-up|0|||
33224262|NCT01672853|100721764|FG000|Overall Study|Randomized but Never Treated|0|||
33307266|NCT01021215|101021423|FG000|Overall Study|Lost to Follow-up|3|||
33307267|NCT01021215|101021424|FG001|Overall Study|Lost to Follow-up|0|||
33307268|NCT00484289|101021425|FG000|Long Term Phase|Adverse Event|1|||
33307269|NCT00484289|101021426|FG001|Long Term Phase|Adverse Event|17|||
33307270|NCT00484289|101021427|FG002|Long Term Phase|Adverse Event|5|||
33307271|NCT00484289|101021425|FG000|Long Term Phase|Withdrawal by Subject|0|||
33307272|NCT00484289|101021426|FG001|Long Term Phase|Withdrawal by Subject|7|||
33307273|NCT00484289|101021427|FG002|Long Term Phase|Withdrawal by Subject|6|||
33500224|NCT01295827|101724567|FG005|Overall Study|Withdrawal by Subject|1|||
33500225|NCT01295827|101724568|FG006|Overall Study|Withdrawal by Subject|13|||
33224263|NCT01672853|100721765|FG001|Overall Study|Randomized but Never Treated|0|||
33224264|NCT01672853|100721766|FG002|Overall Study|Randomized but Never Treated|1|||
33224265|NCT02739347|100721767|FG000|Overall Study|Adverse Event|3|||
33224266|NCT02739347|100721768|FG001|Overall Study|Adverse Event|0|||
33224267|NCT02739347|100721767|FG000|Overall Study|Protocol Violation|0|||
33224268|NCT02739347|100721768|FG001|Overall Study|Protocol Violation|1|||
33224269|NCT02739347|100721767|FG000|Overall Study|Lost to Follow-up|0|||
33307274|NCT00484289|101021425|FG000|Long Term Phase|Inadequate response|2|||
33500226|NCT01295827|101724569|FG007|Overall Study|Withdrawal by Subject|35|||
33500227|NCT01295827|101724570|FG008|Overall Study|Withdrawal by Subject|11|||
33500228|NCT01295827|101724571|FG009|Overall Study|Withdrawal by Subject|2|||
33500229|NCT01295827|101724572|FG010|Overall Study|Withdrawal by Subject|18|||
33601350|NCT05291936|102091903|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
33601351|NCT05291936|102091902|FG000|Period 1|Withdrew Consent during study|1|||
33601352|NCT05291936|102091903|FG001|Period 1|Withdrew Consent during study|0|||
33601353|NCT05291936|102091902|FG000|Period 2|Adverse Event|0|||
33601354|NCT05291936|102091903|FG001|Period 2|Adverse Event|1|||
33601355|NCT05291936|102091902|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
33601356|NCT05291936|102091903|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
33601357|NCT00330928|102091904|FG000|Overall Study|Lost to Follow-up|6|||
33601358|NCT00330928|102091904|FG000|Overall Study|Physician Decision|9|||
33601359|NCT00330928|102091904|FG000|Overall Study|Death|1|||
33601360|NCT00330928|102091904|FG000|Overall Study|IVUS could not be performed.|1|||
33601361|NCT00652899|102091906|FG000|Overall Study|Death|1|||
33601362|NCT00652899|102091906|FG000|Overall Study|Treating physician decision|1|||
33601363|NCT00806442|102091907|FG000|Overall Study|Lost to Follow-up|3|||
33601364|NCT00806442|102091908|FG001|Overall Study|Lost to Follow-up|2|||
33224270|NCT02739347|100721768|FG001|Overall Study|Lost to Follow-up|2|||
33224271|NCT04737109|100721769|FG000|Study Treatment|Disease Progression|5|||
33224272|NCT04737109|100721770|FG001|Study Treatment|Disease Progression|0|||
33601365|NCT00806442|102091907|FG000|Overall Study|Withdrawal by Subject|1|||
33601366|NCT00806442|102091908|FG001|Overall Study|Withdrawal by Subject|5|||
33307275|NCT00484289|101021426|FG001|Long Term Phase|Inadequate response|7|||
33601367|NCT01842581|102091910|FG000|Overall Study|Adverse Event|6|||
33601368|NCT01842581|102091911|FG001|Overall Study|Adverse Event|4|||
33500230|NCT01295827|101724573|FG011|Overall Study|Withdrawal by Subject|13|||
33500231|NCT01295827|101724574|FG012|Overall Study|Withdrawal by Subject|0|||
33500232|NCT01295827|101724575|FG013|Overall Study|Withdrawal by Subject|0|||
33500233|NCT01295827|101724576|FG014|Overall Study|Withdrawal by Subject|0|||
33500234|NCT01295827|101724562|FG000|Overall Study|Other|0|||
33500235|NCT01295827|101724563|FG001|Overall Study|Other|0|||
33500236|NCT01295827|101724564|FG002|Overall Study|Other|0|||
33500237|NCT01295827|101724565|FG003|Overall Study|Other|0|||
33500238|NCT01295827|101724566|FG004|Overall Study|Other|0|||
33500239|NCT01295827|101724567|FG005|Overall Study|Other|0|||
33500240|NCT01295827|101724568|FG006|Overall Study|Other|1|||
33500241|NCT01295827|101724569|FG007|Overall Study|Other|1|||
33500242|NCT01295827|101724570|FG008|Overall Study|Other|1|||
33500243|NCT01295827|101724571|FG009|Overall Study|Other|0|||
33500244|NCT01295827|101724572|FG010|Overall Study|Other|2|||
33500245|NCT01295827|101724573|FG011|Overall Study|Other|0|||
33500246|NCT01295827|101724574|FG012|Overall Study|Other|0|||
33500247|NCT01295827|101724575|FG013|Overall Study|Other|0|||
33500248|NCT01295827|101724576|FG014|Overall Study|Other|0|||
33500249|NCT02877004|101724577|FG000|Overall Study|Pregnancy|0|||
33307276|NCT00484289|101021427|FG002|Long Term Phase|Inadequate response|4|||
33307277|NCT00484289|101021425|FG000|Long Term Phase|Other Reason|0|||
33307278|NCT00484289|101021426|FG001|Long Term Phase|Other Reason|5|||
33500250|NCT02877004|101724578|FG001|Overall Study|Pregnancy|0|||
33500251|NCT02877004|101724579|FG002|Overall Study|Pregnancy|1|||
33307279|NCT00484289|101021427|FG002|Long Term Phase|Other Reason|1|||
33307280|NCT00484289|101021425|FG000|Post Marketing Phase|Adverse Event|0|||
33307281|NCT00484289|101021426|FG001|Post Marketing Phase|Adverse Event|1|||
33307282|NCT00484289|101021427|FG002|Post Marketing Phase|Adverse Event|0|||
33307283|NCT05559476|101021428|FG000|Overall Study|Adverse Event|2|||
33307284|NCT05559476|101021429|FG001|Overall Study|Adverse Event|0|||
33307285|NCT05559476|101021428|FG000|Overall Study|Lost to Follow-up|13|||
33307286|NCT05559476|101021429|FG001|Overall Study|Lost to Follow-up|12|||
33307287|NCT05559476|101021428|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
33307288|NCT05559476|101021429|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
33307289|NCT05559476|101021428|FG000|Overall Study|Other|0|||
33307290|NCT05559476|101021429|FG001|Overall Study|Other|2|||
33307291|NCT00232544|101021430|FG000|Overall Study|Lost to Follow-up|20|||
33307292|NCT00232544|101021431|FG001|Overall Study|Lost to Follow-up|15|||
33307293|NCT01238900|101021432|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
33307294|NCT01238900|101021432|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
33307295|NCT01775475|101021441|FG000|Overall Study|Death|3|||
33307296|NCT01775475|101021442|FG001|Overall Study|Death|3|||
33307297|NCT03189745|101021443|FG000|Overall Study|Conflict in work schedule of participant|1|||
33307298|NCT03189745|101021444|FG001|Overall Study|Conflict in work schedule of participant|1|||
33307299|NCT03965689|101021449|FG000|Overall Study|Too sick to get study intervention|2|||
33307300|NCT01775124|101021450|FG000|Core Period|Disease Progression|0|||
33307301|NCT01775124|101021451|FG001|Core Period|Disease Progression|1|||
33307302|NCT01775124|101021450|FG000|Core Period|Physician Decision|1|||
33307303|NCT01775124|101021451|FG001|Core Period|Physician Decision|1|||
33307304|NCT01775124|101021450|FG000|Core Period|Death|0|||
33307305|NCT01775124|101021451|FG001|Core Period|Death|1|||
33307306|NCT01775124|101021450|FG000|Core Period|Administrative problems|1|||
33500252|NCT02019264|101724580|FG000|Overall Study|Not treated|6|||
33500253|NCT02019264|101724581|FG001|Overall Study|Not treated|4|||
33500254|NCT02019264|101724580|FG000|Overall Study|Lost to Follow-up|50|||
33601369|NCT01842581|102091910|FG000|Overall Study|HE breakthrough|26|||
33500255|NCT02019264|101724581|FG001|Overall Study|Lost to Follow-up|47|||
33307307|NCT01775124|101021451|FG001|Core Period|Administrative problems|0|||
33307308|NCT01775124|101021450|FG000|Core Period|Withdrawal by Subject|4|||
33307309|NCT01775124|101021451|FG001|Core Period|Withdrawal by Subject|2|||
33307310|NCT01775124|101021450|FG000|Core Period|Adverse Event|5|||
33307311|NCT01775124|101021451|FG001|Core Period|Adverse Event|5|||
33307312|NCT01775124|101021450|FG000|Extension Period|Adverse Event|3|||
33307313|NCT01775124|101021451|FG001|Extension Period|Adverse Event|2|||
33500256|NCT02019264|101724580|FG000|Overall Study|Withdrawal by Subject|142|||
33500257|NCT02019264|101724581|FG001|Overall Study|Withdrawal by Subject|117|||
33500258|NCT02019264|101724580|FG000|Overall Study|Administrative reason|36|||
33500259|NCT02019264|101724581|FG001|Overall Study|Administrative reason|28|||
33500260|NCT02019264|101724580|FG000|Overall Study|Missing|14|||
33500261|NCT02019264|101724581|FG001|Overall Study|Missing|11|||
33500262|NCT00791778|101724590|FG000|Double-blind Treatment|Adverse Event|49|||
33500263|NCT00791778|101724591|FG001|Double-blind Treatment|Adverse Event|9|||
33500264|NCT00791778|101724590|FG000|Double-blind Treatment|Physician Decision|6|||
33500265|NCT00791778|101724591|FG001|Double-blind Treatment|Physician Decision|26|||
33500266|NCT00791778|101724590|FG000|Double-blind Treatment|Protocol Violation|0|||
33500267|NCT00791778|101724591|FG001|Double-blind Treatment|Protocol Violation|4|||
33500268|NCT00791778|101724590|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
33500269|NCT00791778|101724591|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
33500270|NCT00791778|101724590|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
33500271|NCT00791778|101724591|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
33500272|NCT00791778|101724590|FG000|Follow-up|Withdrawal by Subject|3|||
33500273|NCT00791778|101724591|FG001|Follow-up|Withdrawal by Subject|0|||
33500274|NCT00791778|101724590|FG000|Follow-up|Lost to Follow-up|2|||
33500275|NCT00791778|101724591|FG001|Follow-up|Lost to Follow-up|1|||
33500276|NCT00461630|101724592|FG000|Overall Study|Death|798|||
33500277|NCT00461630|101724593|FG001|Overall Study|Death|732|||
33307314|NCT01775124|101021450|FG000|Extension Period|Physician Decision|0|||
33307315|NCT01775124|101021451|FG001|Extension Period|Physician Decision|2|||
33307316|NCT01775124|101021450|FG000|Extension Period|Administrative problems|0|||
33307317|NCT01775124|101021451|FG001|Extension Period|Administrative problems|1|||
33500278|NCT00461630|101724592|FG000|Overall Study|Lost to Follow-up|108|||
33500279|NCT00461630|101724593|FG001|Overall Study|Lost to Follow-up|95|||
33500280|NCT01467713|101724597|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
33500281|NCT01467713|101724598|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
33500282|NCT01467713|101724599|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
33500283|NCT01467713|101724600|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
33500284|NCT01467713|101724597|FG000|Overall Study|Major Protocol Deviation|2|||
33500285|NCT01467713|101724598|FG001|Overall Study|Major Protocol Deviation|4|||
33500286|NCT01467713|101724599|FG002|Overall Study|Major Protocol Deviation|4|||
33500287|NCT01467713|101724600|FG003|Overall Study|Major Protocol Deviation|1|||
33500288|NCT01467713|101724597|FG000|Overall Study|Lost to Follow-up|9|||
33500289|NCT01467713|101724598|FG001|Overall Study|Lost to Follow-up|12|||
33500290|NCT01467713|101724599|FG002|Overall Study|Lost to Follow-up|6|||
33500291|NCT01467713|101724600|FG003|Overall Study|Lost to Follow-up|9|||
33500292|NCT01467713|101724597|FG000|Overall Study|Voluntary Withdrawal|18|||
33500293|NCT01467713|101724598|FG001|Overall Study|Voluntary Withdrawal|14|||
33500294|NCT01467713|101724599|FG002|Overall Study|Voluntary Withdrawal|21|||
33500295|NCT01467713|101724600|FG003|Overall Study|Voluntary Withdrawal|20|||
33500296|NCT01467713|101724597|FG000|Overall Study|Study Termination|23|||
33500297|NCT01467713|101724598|FG001|Overall Study|Study Termination|33|||
33500298|NCT01467713|101724599|FG002|Overall Study|Study Termination|28|||
33500299|NCT01467713|101724600|FG003|Overall Study|Study Termination|29|||
33500300|NCT01467713|101724597|FG000|Overall Study|Pregnancy|0|||
33500301|NCT01467713|101724598|FG001|Overall Study|Pregnancy|1|||
33500302|NCT01467713|101724599|FG002|Overall Study|Pregnancy|1|||
33500303|NCT01467713|101724600|FG003|Overall Study|Pregnancy|3|||
33500304|NCT01467713|101724597|FG000|Overall Study|Relapse|35|||
33500305|NCT01467713|101724598|FG001|Overall Study|Relapse|25|||
33500306|NCT01467713|101724599|FG002|Overall Study|Relapse|28|||
33500307|NCT01467713|101724600|FG003|Overall Study|Relapse|35|||
33500308|NCT01467713|101724597|FG000|Overall Study|Reason not Specified|6|||
33500309|NCT01467713|101724598|FG001|Overall Study|Reason not Specified|11|||
33500310|NCT01467713|101724599|FG002|Overall Study|Reason not Specified|8|||
33500311|NCT01467713|101724600|FG003|Overall Study|Reason not Specified|7|||
33500312|NCT01627574|101724603|FG000|Overall Study|Withdrawal by Subject|8|||
33500313|NCT01627574|101724604|FG001|Overall Study|Withdrawal by Subject|5|||
33500314|NCT01627574|101724603|FG000|Overall Study|Lost to Follow-up|13|||
33500315|NCT01627574|101724604|FG001|Overall Study|Lost to Follow-up|13|||
33500316|NCT00961350|101724605|FG000|Overall Study|Adverse Event|18|||
33500317|NCT00961350|101724606|FG001|Overall Study|Adverse Event|33|||
33601370|NCT01842581|102091911|FG001|Overall Study|HE breakthrough|13|||
33601371|NCT01842581|102091910|FG000|Overall Study|Liver transplant|2|||
33601372|NCT01842581|102091911|FG001|Overall Study|Liver transplant|0|||
33601373|NCT01842581|102091910|FG000|Overall Study|Lost to Follow-up|2|||
33601374|NCT01842581|102091911|FG001|Overall Study|Lost to Follow-up|5|||
33601375|NCT01842581|102091910|FG000|Overall Study|Withdrawal by Subject|5|||
33307318|NCT01775124|101021450|FG000|Extension Period|Lost to Follow-up|0|||
33500318|NCT00961350|101724605|FG000|Overall Study|Withdrawal by Subject|10|||
33500319|NCT00961350|101724606|FG001|Overall Study|Withdrawal by Subject|10|||
33500320|NCT00961350|101724605|FG000|Overall Study|Lost to Follow-up|3|||
33601376|NCT01842581|102091911|FG001|Overall Study|Withdrawal by Subject|7|||
33601377|NCT01842581|102091910|FG000|Overall Study|Other than specified|3|||
33500321|NCT00961350|101724606|FG001|Overall Study|Lost to Follow-up|3|||
33500322|NCT00961350|101724605|FG000|Overall Study|Misc|16|||
33500323|NCT00961350|101724606|FG001|Overall Study|Misc|21|||
33500324|NCT01314872|101724607|FG000|Treatment Period 1|Protocol Violation|2|||
33500325|NCT01314872|101724608|FG001|Treatment Period 1|Protocol Violation|1|||
33500326|NCT01314872|101724609|FG002|Treatment Period 1|Protocol Violation|1|||
33500327|NCT01314872|101724610|FG003|Treatment Period 1|Protocol Violation|0|||
33500328|NCT01314872|101724611|FG004|Treatment Period 1|Protocol Violation|1|||
33500329|NCT01314872|101724612|FG005|Treatment Period 1|Protocol Violation|0|||
33500330|NCT01314872|101724613|FG006|Treatment Period 1|Protocol Violation|0|||
33500331|NCT01314872|101724614|FG007|Treatment Period 1|Protocol Violation|0|||
33500332|NCT01314872|101724615|FG008|Treatment Period 1|Protocol Violation|0|||
33500333|NCT01314872|101724616|FG009|Treatment Period 1|Protocol Violation|1|||
33500334|NCT01314872|101724617|FG010|Treatment Period 1|Protocol Violation|1|||
33500335|NCT01314872|101724618|FG011|Treatment Period 1|Protocol Violation|0|||
33500336|NCT01314872|101724619|FG012|Treatment Period 1|Protocol Violation|0|||
33500337|NCT01314872|101724620|FG013|Treatment Period 1|Protocol Violation|0|||
33500338|NCT01314872|101724621|FG014|Treatment Period 1|Protocol Violation|0|||
33191552|NCT00782210|100608399|FG000|Overall Study|Adverse Event|21|||
33191553|NCT00782210|100608400|FG001|Overall Study|Adverse Event|17|||
33191554|NCT00782210|100608401|FG002|Overall Study|Adverse Event|16|||
33191555|NCT00782210|100608399|FG000|Overall Study|Lost to Follow-up|2|||
33191556|NCT00782210|100608400|FG001|Overall Study|Lost to Follow-up|1|||
33191557|NCT00782210|100608401|FG002|Overall Study|Lost to Follow-up|2|||
33191558|NCT00782210|100608399|FG000|Overall Study|Withdrawal by Subject|11|||
33191559|NCT00782210|100608400|FG001|Overall Study|Withdrawal by Subject|8|||
33191560|NCT00782210|100608401|FG002|Overall Study|Withdrawal by Subject|11|||
33191561|NCT00782210|100608399|FG000|Overall Study|Non compliance with protocol|0|||
33191562|NCT00782210|100608400|FG001|Overall Study|Non compliance with protocol|3|||
33191563|NCT00782210|100608401|FG002|Overall Study|Non compliance with protocol|2|||
33191564|NCT00782210|100608399|FG000|Overall Study|Lack of Efficacy|13|||
33191565|NCT00782210|100608400|FG001|Overall Study|Lack of Efficacy|4|||
33191566|NCT00782210|100608401|FG002|Overall Study|Lack of Efficacy|1|||
33191567|NCT00782210|100608399|FG000|Overall Study|Other reason not described above|3|||
33191568|NCT00782210|100608400|FG001|Overall Study|Other reason not described above|2|||
33191569|NCT00782210|100608401|FG002|Overall Study|Other reason not described above|3|||
33191570|NCT00325234|100608403|FG000|Overall Study|Adverse Event|10|||
33307319|NCT01775124|101021451|FG001|Extension Period|Lost to Follow-up|1|||
33307320|NCT01775124|101021450|FG000|Extension Period|Withdrawal by Subject|9|||
33307321|NCT01775124|101021451|FG001|Extension Period|Withdrawal by Subject|12|||
33307322|NCT04410523|101021452|FG000|Overall Study|Study terminated by sponsor|1|||
33307323|NCT04410523|101021453|FG001|Overall Study|Study terminated by sponsor|3|||
33307324|NCT04410523|101021454|FG002|Overall Study|Study terminated by sponsor|2|||
33307325|NCT04410523|101021455|FG003|Overall Study|Study terminated by sponsor|6|||
33500339|NCT01314872|101724607|FG000|Treatment Period 1|Physician Decision|0|||
33500340|NCT01314872|101724608|FG001|Treatment Period 1|Physician Decision|1|||
33500341|NCT01314872|101724609|FG002|Treatment Period 1|Physician Decision|0|||
33500342|NCT01314872|101724610|FG003|Treatment Period 1|Physician Decision|1|||
33500343|NCT01314872|101724611|FG004|Treatment Period 1|Physician Decision|0|||
33500344|NCT01314872|101724612|FG005|Treatment Period 1|Physician Decision|0|||
33601378|NCT01842581|102091911|FG001|Overall Study|Other than specified|1|||
33601379|NCT01460719|102091912|FG000|Overall Study|Adverse Event|1|||
33191571|NCT00325234|100608404|FG001|Overall Study|Adverse Event|7|||
33191572|NCT00325234|100608403|FG000|Overall Study|Death due to Study Disease|1|||
33307326|NCT04410523|101021456|FG004|Overall Study|Study terminated by sponsor|3|||
33307327|NCT04410523|101021457|FG005|Overall Study|Study terminated by sponsor|4|||
33500345|NCT01314872|101724613|FG006|Treatment Period 1|Physician Decision|0|||
33601380|NCT01460719|102091912|FG000|Overall Study|Withdrawal by Subject|1|||
33191573|NCT00325234|100608404|FG001|Overall Study|Death due to Study Disease|0|||
33191574|NCT00325234|100608403|FG000|Overall Study|Entry Criteria Not Met|1|||
33191575|NCT00325234|100608404|FG001|Overall Study|Entry Criteria Not Met|2|||
33191576|NCT00325234|100608403|FG000|Overall Study|Subject Decision|6|||
33191577|NCT00325234|100608404|FG001|Overall Study|Subject Decision|8|||
33191578|NCT00325234|100608403|FG000|Overall Study|Physician Decision|17|||
33191579|NCT00325234|100608404|FG001|Overall Study|Physician Decision|12|||
33191580|NCT00325234|100608403|FG000|Overall Study|Progressive Disease|34|||
33191581|NCT00325234|100608404|FG001|Overall Study|Progressive Disease|37|||
33191582|NCT04476030|100608416|FG000|Overall Study|Withdrawal by Subject|20|||
33191583|NCT04476030|100608417|FG001|Overall Study|Withdrawal by Subject|16|||
33191584|NCT04476030|100608416|FG000|Overall Study|Adverse Event|10|||
33191585|NCT04476030|100608417|FG001|Overall Study|Adverse Event|11|||
33191586|NCT04476030|100608416|FG000|Overall Study|Lost to Follow-up|7|||
33191587|NCT04476030|100608417|FG001|Overall Study|Lost to Follow-up|4|||
33191588|NCT04476030|100608416|FG000|Overall Study|Physician Decision|1|||
33191589|NCT04476030|100608417|FG001|Overall Study|Physician Decision|1|||
33191590|NCT04476030|100608416|FG000|Overall Study|Protocol Deviation|2|||
33191591|NCT04476030|100608417|FG001|Overall Study|Protocol Deviation|0|||
33191592|NCT04476030|100608416|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
33191593|NCT04476030|100608417|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
33191594|NCT04476030|100608416|FG000|Overall Study|Randomized but not Dosed|2|||
33191595|NCT04476030|100608417|FG001|Overall Study|Randomized but not Dosed|8|||
33191596|NCT00700011|100608420|FG000|Overall Study|Death|0|||
33191597|NCT00700011|100608421|FG001|Overall Study|Death|1|||
33191598|NCT03304379|100608422|FG000|Overall Study|Protocol Violation|8|||
33191599|NCT03304379|100608423|FG001|Overall Study|Protocol Violation|10|||
33191600|NCT03304379|100608424|FG002|Overall Study|Protocol Violation|5|||
33191601|NCT03304379|100608425|FG003|Overall Study|Protocol Violation|0|||
33191602|NCT03304379|100608426|FG004|Overall Study|Protocol Violation|2|||
33191603|NCT03304379|100608422|FG000|Overall Study|Adverse Event|4|||
33191604|NCT03304379|100608423|FG001|Overall Study|Adverse Event|20|||
33191605|NCT03304379|100608424|FG002|Overall Study|Adverse Event|17|||
33191606|NCT03304379|100608425|FG003|Overall Study|Adverse Event|1|||
33191607|NCT03304379|100608426|FG004|Overall Study|Adverse Event|0|||
33191608|NCT03304379|100608422|FG000|Overall Study|Lack of Efficacy|17|||
33191609|NCT03304379|100608423|FG001|Overall Study|Lack of Efficacy|16|||
33191610|NCT03304379|100608424|FG002|Overall Study|Lack of Efficacy|20|||
33191611|NCT03304379|100608425|FG003|Overall Study|Lack of Efficacy|0|||
33191612|NCT03304379|100608426|FG004|Overall Study|Lack of Efficacy|0|||
33191613|NCT03304379|100608422|FG000|Overall Study|Physician Decision|6|||
33191614|NCT03304379|100608423|FG001|Overall Study|Physician Decision|10|||
33191615|NCT03304379|100608424|FG002|Overall Study|Physician Decision|6|||
33191616|NCT03304379|100608425|FG003|Overall Study|Physician Decision|9|||
33191617|NCT03304379|100608426|FG004|Overall Study|Physician Decision|10|||
33191618|NCT03304379|100608422|FG000|Overall Study|Withdrawal by Subject|26|||
33191619|NCT03304379|100608423|FG001|Overall Study|Withdrawal by Subject|58|||
33191620|NCT03304379|100608424|FG002|Overall Study|Withdrawal by Subject|66|||
33191621|NCT03304379|100608425|FG003|Overall Study|Withdrawal by Subject|3|||
33191622|NCT03304379|100608426|FG004|Overall Study|Withdrawal by Subject|5|||
33191623|NCT03304379|100608422|FG000|Overall Study|Lost to Follow-up|8|||
33191624|NCT03304379|100608423|FG001|Overall Study|Lost to Follow-up|24|||
33191625|NCT03304379|100608424|FG002|Overall Study|Lost to Follow-up|35|||
33191626|NCT03304379|100608425|FG003|Overall Study|Lost to Follow-up|4|||
33191627|NCT03304379|100608426|FG004|Overall Study|Lost to Follow-up|0|||
33191628|NCT03304379|100608422|FG000|Overall Study|Death|1|||
33191629|NCT03304379|100608423|FG001|Overall Study|Death|2|||
33191630|NCT03304379|100608424|FG002|Overall Study|Death|0|||
33191631|NCT03304379|100608425|FG003|Overall Study|Death|0|||
33191632|NCT03304379|100608426|FG004|Overall Study|Death|0|||
33191633|NCT03304379|100608422|FG000|Overall Study|Other|0|||
33601381|NCT01519674|102091913|FG000|Overall Study|Adverse Event|3|||
33601382|NCT01519674|102091914|FG001|Overall Study|Adverse Event|3|||
33191634|NCT03304379|100608423|FG001|Overall Study|Other|1|||
33191635|NCT03304379|100608424|FG002|Overall Study|Other|0|||
33191636|NCT03304379|100608425|FG003|Overall Study|Other|0|||
33191637|NCT03304379|100608426|FG004|Overall Study|Other|0|||
33191638|NCT01306617|100608427|FG000|Overall Study|Adverse Event|1|||
33393775|NCT03073200|101328519|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
33191639|NCT01306617|100608428|FG001|Overall Study|Adverse Event|0|||
33191640|NCT01306617|100608429|FG002|Overall Study|Adverse Event|0|||
33191641|NCT01306617|100608427|FG000|Overall Study|Virologic Failure|0|||
33191642|NCT01306617|100608428|FG001|Overall Study|Virologic Failure|0|||
33191643|NCT01306617|100608429|FG002|Overall Study|Virologic Failure|5|||
33191644|NCT01306617|100608427|FG000|Overall Study|Non-compliance|0|||
33191645|NCT01306617|100608428|FG001|Overall Study|Non-compliance|1|||
33191646|NCT01306617|100608429|FG002|Overall Study|Non-compliance|0|||
33191647|NCT00437034|100608430|FG000|Overall Study|Adverse Event|1|||
33191648|NCT00437034|100608430|FG000|Overall Study|Disease progression during treatment|5|||
33191649|NCT03256552|100608431|FG000|Overall Study|Protocol Violation|1|||
33191650|NCT03256552|100608431|FG000|Overall Study|Physician Decision|1|||
33191651|NCT03256552|100608431|FG000|Overall Study|Adverse Event|1|||
33191652|NCT03256552|100608431|FG000|Overall Study|Withdrawal by Subject|2|||
33191653|NCT01886833|100608432|FG000|Overall Study|IgA not available from both periods|204|||
33191654|NCT05074433|100608434|FG000|Overall Study|Adverse Event|0|||
33191655|NCT05074433|100608435|FG001|Overall Study|Adverse Event|2|||
33191656|NCT05074433|100608436|FG002|Overall Study|Adverse Event|0|||
33191657|NCT05074433|100608437|FG003|Overall Study|Adverse Event|1|||
33191658|NCT05074433|100608434|FG000|Overall Study|Sponsor Request|0|||
33191659|NCT05074433|100608435|FG001|Overall Study|Sponsor Request|1|||
33191660|NCT05074433|100608436|FG002|Overall Study|Sponsor Request|1|||
33191661|NCT05074433|100608437|FG003|Overall Study|Sponsor Request|0|||
33191662|NCT05074433|100608434|FG000|Overall Study|Death|1|||
33191663|NCT05074433|100608435|FG001|Overall Study|Death|0|||
33191664|NCT05074433|100608436|FG002|Overall Study|Death|0|||
33191665|NCT05074433|100608437|FG003|Overall Study|Death|0|||
33191666|NCT05074433|100608434|FG000|Overall Study|Lost to Follow-up|0|||
33191667|NCT05074433|100608435|FG001|Overall Study|Lost to Follow-up|0|||
33191668|NCT05074433|100608436|FG002|Overall Study|Lost to Follow-up|2|||
33191669|NCT05074433|100608437|FG003|Overall Study|Lost to Follow-up|0|||
33191670|NCT05074433|100608434|FG000|Overall Study|Subject Decision|8|||
33307328|NCT04410523|101021452|FG000|Overall Study|Adverse Event|1|||
33307329|NCT04410523|101021453|FG001|Overall Study|Adverse Event|0|||
33307330|NCT04410523|101021454|FG002|Overall Study|Adverse Event|0|||
33307331|NCT04410523|101021455|FG003|Overall Study|Adverse Event|0|||
33307332|NCT04410523|101021456|FG004|Overall Study|Adverse Event|0|||
33307333|NCT04410523|101021457|FG005|Overall Study|Adverse Event|2|||
33307334|NCT04410523|101021452|FG000|Overall Study|Lost to Follow-up|0|||
33307335|NCT04410523|101021453|FG001|Overall Study|Lost to Follow-up|1|||
33307336|NCT04410523|101021454|FG002|Overall Study|Lost to Follow-up|0|||
33307337|NCT04410523|101021455|FG003|Overall Study|Lost to Follow-up|0|||
33307338|NCT04410523|101021456|FG004|Overall Study|Lost to Follow-up|0|||
33307339|NCT04410523|101021457|FG005|Overall Study|Lost to Follow-up|0|||
33307340|NCT04410523|101021452|FG000|Overall Study|Physician Decision|0|||
33307341|NCT04410523|101021453|FG001|Overall Study|Physician Decision|1|||
33307342|NCT04410523|101021454|FG002|Overall Study|Physician Decision|0|||
33307343|NCT04410523|101021455|FG003|Overall Study|Physician Decision|0|||
33307344|NCT04410523|101021456|FG004|Overall Study|Physician Decision|0|||
33307345|NCT04410523|101021457|FG005|Overall Study|Physician Decision|0|||
33307346|NCT04410523|101021452|FG000|Overall Study|Pregnancy|0|||
33307347|NCT04410523|101021453|FG001|Overall Study|Pregnancy|0|||
33307348|NCT04410523|101021454|FG002|Overall Study|Pregnancy|0|||
33307349|NCT04410523|101021455|FG003|Overall Study|Pregnancy|0|||
33191671|NCT05074433|100608435|FG001|Overall Study|Subject Decision|6|||
33191672|NCT05074433|100608436|FG002|Overall Study|Subject Decision|4|||
33191673|NCT05074433|100608437|FG003|Overall Study|Subject Decision|5|||
33191674|NCT00071812|100608438|FG000|24-Week Double-Blind Period|Adverse Event|2|||
33191675|NCT00071812|100608439|FG001|24-Week Double-Blind Period|Adverse Event|3|||
33307350|NCT04410523|101021456|FG004|Overall Study|Pregnancy|0|||
33191676|NCT00071812|100608440|FG002|24-Week Double-Blind Period|Adverse Event|4|||
33307351|NCT04410523|101021457|FG005|Overall Study|Pregnancy|1|||
33191677|NCT00071812|100608441|FG003|24-Week Double-Blind Period|Adverse Event|4|||
33191678|NCT00071812|100608438|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
33191679|NCT00071812|100608439|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
33191680|NCT00071812|100608440|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
33191681|NCT00071812|100608441|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
33191682|NCT00071812|100608438|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
33191683|NCT00071812|100608439|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
33500346|NCT01314872|101724614|FG007|Treatment Period 1|Physician Decision|0|||
33500347|NCT01314872|101724615|FG008|Treatment Period 1|Physician Decision|0|||
33500348|NCT01314872|101724616|FG009|Treatment Period 1|Physician Decision|1|||
33500349|NCT01314872|101724617|FG010|Treatment Period 1|Physician Decision|0|||
33500350|NCT01314872|101724618|FG011|Treatment Period 1|Physician Decision|0|||
33500351|NCT01314872|101724619|FG012|Treatment Period 1|Physician Decision|0|||
33500352|NCT01314872|101724620|FG013|Treatment Period 1|Physician Decision|0|||
33500353|NCT01314872|101724621|FG014|Treatment Period 1|Physician Decision|0|||
33500354|NCT01314872|101724607|FG000|Treatment Period 1|Lack of Efficacy|1|||
33191684|NCT00071812|100608440|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
33307352|NCT04410523|101021452|FG000|Overall Study|Protocol deviation|0|||
33191685|NCT00071812|100608441|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
33191686|NCT00071812|100608438|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
33307353|NCT04410523|101021453|FG001|Overall Study|Protocol deviation|0|||
33307354|NCT04410523|101021454|FG002|Overall Study|Protocol deviation|0|||
33307355|NCT04410523|101021455|FG003|Overall Study|Protocol deviation|0|||
33307356|NCT04410523|101021456|FG004|Overall Study|Protocol deviation|0|||
33307357|NCT04410523|101021457|FG005|Overall Study|Protocol deviation|2|||
33307358|NCT04410523|101021452|FG000|Overall Study|Subject decision|2|||
33307359|NCT04410523|101021453|FG001|Overall Study|Subject decision|0|||
33307360|NCT04410523|101021454|FG002|Overall Study|Subject decision|0|||
33307361|NCT04410523|101021455|FG003|Overall Study|Subject decision|1|||
33307362|NCT04410523|101021456|FG004|Overall Study|Subject decision|0|||
33500355|NCT01314872|101724608|FG001|Treatment Period 1|Lack of Efficacy|0|||
33500356|NCT01314872|101724609|FG002|Treatment Period 1|Lack of Efficacy|0|||
33191687|NCT00071812|100608439|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
33191688|NCT00071812|100608440|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
33191689|NCT00071812|100608441|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
33191690|NCT00071812|100608438|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
33191691|NCT00071812|100608439|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
33191692|NCT00071812|100608440|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
33191693|NCT00071812|100608441|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
33191694|NCT00071812|100608438|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
33191695|NCT00071812|100608439|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
33191696|NCT00071812|100608440|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
33191697|NCT00071812|100608441|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
33191698|NCT00071812|100608438|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
33191699|NCT00071812|100608439|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
33191700|NCT00071812|100608440|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
33191701|NCT00071812|100608441|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
33191702|NCT00071812|100608438|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
33191703|NCT00071812|100608439|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
33191704|NCT00071812|100608440|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
33191705|NCT00071812|100608441|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
33191706|NCT00071812|100608438|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33191707|NCT00071812|100608439|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33191708|NCT00071812|100608440|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33191709|NCT00071812|100608441|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
33191710|NCT00071812|100608438|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
33191711|NCT00071812|100608439|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
33191712|NCT00071812|100608440|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
33191713|NCT00071812|100608441|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
33191714|NCT01712984|100608442|FG000|Overall Study|Adverse Event|0|||
33191715|NCT01712984|100608443|FG001|Overall Study|Adverse Event|0|||
33191716|NCT01712984|100608444|FG002|Overall Study|Adverse Event|1|||
33191717|NCT01712984|100608442|FG000|Overall Study|Protocol Violation|2|||
33191718|NCT01712984|100608443|FG001|Overall Study|Protocol Violation|0|||
33191719|NCT01712984|100608444|FG002|Overall Study|Protocol Violation|1|||
33191720|NCT01712984|100608442|FG000|Overall Study|Lost to Follow-up|8|||
33500357|NCT01314872|101724610|FG003|Treatment Period 1|Lack of Efficacy|0|||
33191721|NCT01712984|100608443|FG001|Overall Study|Lost to Follow-up|10|||
33191722|NCT01712984|100608444|FG002|Overall Study|Lost to Follow-up|1|||
33191723|NCT01712984|100608442|FG000|Overall Study|Withdrawal by Subject|6|||
33307363|NCT04410523|101021457|FG005|Overall Study|Subject decision|1|||
33307364|NCT03459443|101021458|FG000|Overall Study|Lack of Efficacy|3|||
33307365|NCT03459443|101021458|FG000|Overall Study|Adverse Event|1|||
33307366|NCT03459443|101021458|FG000|Overall Study|Sponsor's decision to close the study|18|||
33307367|NCT01590082|101021461|FG000|Overall Study|Withdrawal by Subject|1|||
33307368|NCT01590082|101021462|FG001|Overall Study|Withdrawal by Subject|0|||
33307369|NCT01590082|101021461|FG000|Overall Study|Ineligible|1|||
33307370|NCT01590082|101021462|FG001|Overall Study|Ineligible|0|||
33307371|NCT00993668|101021463|FG000|Single-Blind Period|Adverse Event|1|||
33307372|NCT00993668|101021464|FG001|Single-Blind Period|Adverse Event|1|||
33307373|NCT00993668|101021463|FG000|Single-Blind Period|Lack of Efficacy|0|||
33307374|NCT00993668|101021464|FG001|Single-Blind Period|Lack of Efficacy|1|||
33601383|NCT01519674|102091915|FG002|Overall Study|Adverse Event|0|||
33601384|NCT01519674|102091913|FG000|Overall Study|Lack of Efficacy|1|||
33191724|NCT01712984|100608443|FG001|Overall Study|Withdrawal by Subject|6|||
33191725|NCT01712984|100608444|FG002|Overall Study|Withdrawal by Subject|7|||
33191726|NCT00378014|100608445|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
33191727|NCT00378014|100608446|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
33191728|NCT00378014|100608445|FG000|Core (Randomization to Month 11)|Graft loss|1|||
33191729|NCT00378014|100608446|FG001|Core (Randomization to Month 11)|Graft loss|2|||
33191730|NCT00378014|100608445|FG000|Core (Randomization to Month 11)|Death|5|||
33191731|NCT00378014|100608446|FG001|Core (Randomization to Month 11)|Death|3|||
33191732|NCT00378014|100608445|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
33191733|NCT00378014|100608446|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
33191734|NCT00378014|100608445|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
33191735|NCT00378014|100608446|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
33191736|NCT00378014|100608445|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
33191737|NCT00378014|100608446|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
33191738|NCT00378014|100608445|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
33191739|NCT00378014|100608446|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
33191740|NCT00378014|100608445|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
33191741|NCT00378014|100608446|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
33191742|NCT00378014|100608445|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
33191743|NCT00378014|100608446|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
33191744|NCT00378014|100608445|FG000|Extension (Month 12 to Month 59)|Death|1|||
33191745|NCT00378014|100608446|FG001|Extension (Month 12 to Month 59)|Death|2|||
33191746|NCT00378014|100608445|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
33191747|NCT00378014|100608446|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
33191748|NCT00378014|100608445|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
33191749|NCT00378014|100608446|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
33191750|NCT00378014|100608445|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
33191751|NCT00378014|100608446|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
33191752|NCT00378014|100608445|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
33191753|NCT00378014|100608446|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
33191754|NCT01633944|100608447|FG000|Open-label Titration Phase|Adverse Event|109|||
33191755|NCT01633944|100608448|FG001|Open-label Titration Phase|Adverse Event|0|||
33191756|NCT01633944|100608449|FG002|Open-label Titration Phase|Adverse Event|0|||
33191757|NCT01633944|100608447|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
33191758|NCT01633944|100608448|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
33191759|NCT01633944|100608449|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
33191760|NCT01633944|100608447|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
33191761|NCT01633944|100608448|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
33191762|NCT01633944|100608449|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
33191763|NCT01633944|100608447|FG000|Open-label Titration Phase|Protocol Violation|24|||
33191764|NCT01633944|100608448|FG001|Open-label Titration Phase|Protocol Violation|0|||
33191765|NCT01633944|100608449|FG002|Open-label Titration Phase|Protocol Violation|0|||
33191766|NCT01633944|100608447|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
33191767|NCT01633944|100608448|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
33601385|NCT01519674|102091914|FG001|Overall Study|Lack of Efficacy|1|||
33191768|NCT01633944|100608449|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
33191769|NCT01633944|100608447|FG000|Open-label Titration Phase|Other|68|||
33191770|NCT01633944|100608448|FG001|Open-label Titration Phase|Other|0|||
33191771|NCT01633944|100608449|FG002|Open-label Titration Phase|Other|0|||
33307375|NCT00993668|101021463|FG000|Single-Blind Period|Lost to Follow-up|3|||
33307376|NCT00993668|101021464|FG001|Single-Blind Period|Lost to Follow-up|1|||
33307377|NCT00993668|101021463|FG000|Open-Label Period|Adverse Event|9|||
33307378|NCT00993668|101021464|FG001|Open-Label Period|Adverse Event|8|||
33601386|NCT01519674|102091915|FG002|Overall Study|Lack of Efficacy|1|||
33191772|NCT01633944|100608447|FG000|Double-blind Treatment Phase|Adverse Event|0|||
33191773|NCT01633944|100608448|FG001|Double-blind Treatment Phase|Adverse Event|13|||
33191774|NCT01633944|100608449|FG002|Double-blind Treatment Phase|Adverse Event|7|||
33191775|NCT01633944|100608447|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
33191776|NCT01633944|100608448|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
33191777|NCT01633944|100608449|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
33191778|NCT01633944|100608447|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33191779|NCT01633944|100608448|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
33191780|NCT01633944|100608449|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
33191781|NCT01633944|100608447|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
33191782|NCT01633944|100608448|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
33191783|NCT01633944|100608449|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
33191784|NCT01633944|100608447|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
33191785|NCT01633944|100608448|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
33307379|NCT00993668|101021463|FG000|Open-Label Period|Lack of Efficacy|4|||
33307380|NCT00993668|101021464|FG001|Open-Label Period|Lack of Efficacy|3|||
33307381|NCT00993668|101021463|FG000|Open-Label Period|Withdrawal by Subject|4|||
33307382|NCT00993668|101021464|FG001|Open-Label Period|Withdrawal by Subject|3|||
33307383|NCT00993668|101021463|FG000|Open-Label Period|Lost to Follow-up|6|||
33307384|NCT00993668|101021464|FG001|Open-Label Period|Lost to Follow-up|1|||
33307385|NCT02663518|101021465|FG000|Part 1: Phase 1a Escalation|Death|0|||
33307386|NCT02663518|101021466|FG001|Part 1: Phase 1a Escalation|Death|0|||
33307387|NCT02663518|101021467|FG002|Part 1: Phase 1a Escalation|Death|1|||
33307388|NCT02663518|101021468|FG003|Part 1: Phase 1a Escalation|Death|0|||
33307389|NCT02663518|101021469|FG004|Part 1: Phase 1a Escalation|Death|0|||
33307390|NCT02663518|101021470|FG005|Part 1: Phase 1a Escalation|Death|0|||
33307391|NCT02663518|101021471|FG006|Part 1: Phase 1a Escalation|Death|0|||
33307392|NCT02663518|101021472|FG007|Part 1: Phase 1a Escalation|Death|0|||
33307393|NCT02663518|101021473|FG008|Part 1: Phase 1a Escalation|Death|0|||
33307394|NCT02663518|101021474|FG009|Part 1: Phase 1a Escalation|Death|0|||
33307395|NCT02663518|101021475|FG010|Part 1: Phase 1a Escalation|Death|0|||
33307396|NCT02663518|101021476|FG011|Part 1: Phase 1a Escalation|Death|0|||
33307397|NCT02663518|101021477|FG012|Part 1: Phase 1a Escalation|Death|0|||
33307398|NCT02663518|101021478|FG013|Part 1: Phase 1a Escalation|Death|0|||
33307399|NCT02663518|101021465|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
33307400|NCT02663518|101021466|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
33307401|NCT02663518|101021467|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
33307402|NCT02663518|101021468|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
33307403|NCT02663518|101021469|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
33307404|NCT02663518|101021470|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
33307405|NCT02663518|101021471|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
33307406|NCT02663518|101021472|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
33307407|NCT02663518|101021473|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
33307408|NCT02663518|101021474|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
33307409|NCT02663518|101021475|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
33307410|NCT02663518|101021476|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
33307411|NCT02663518|101021477|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
33307412|NCT02663518|101021478|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
33307413|NCT02663518|101021465|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
33307414|NCT02663518|101021466|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
33307415|NCT02663518|101021467|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
33307416|NCT02663518|101021468|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
33307417|NCT02663518|101021469|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
33307418|NCT02663518|101021470|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
33191786|NCT01633944|100608449|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
33191787|NCT01633944|100608447|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
33191788|NCT01633944|100608448|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
33307419|NCT02663518|101021471|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
33307420|NCT02663518|101021472|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
33307421|NCT02663518|101021473|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
33307422|NCT02663518|101021474|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
33307423|NCT02663518|101021475|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
33307424|NCT02663518|101021476|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
33307425|NCT02663518|101021477|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
33307426|NCT02663518|101021478|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
33307427|NCT02663518|101021465|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
33307428|NCT02663518|101021466|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
33307429|NCT02663518|101021467|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
33307430|NCT02663518|101021468|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
33307431|NCT02663518|101021469|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
33307432|NCT02663518|101021470|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
33307433|NCT02663518|101021471|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
33307434|NCT02663518|101021472|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
33307435|NCT02663518|101021473|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
33307436|NCT02663518|101021474|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
33307437|NCT02663518|101021475|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
33307438|NCT02663518|101021476|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
33307439|NCT02663518|101021477|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
33307440|NCT02663518|101021478|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
33307441|NCT02663518|101021465|FG000|Part 1: Phase 1a Escalation|Other|0|||
33307442|NCT02663518|101021466|FG001|Part 1: Phase 1a Escalation|Other|0|||
33307443|NCT02663518|101021467|FG002|Part 1: Phase 1a Escalation|Other|2|||
33307444|NCT02663518|101021468|FG003|Part 1: Phase 1a Escalation|Other|0|||
33307445|NCT02663518|101021469|FG004|Part 1: Phase 1a Escalation|Other|0|||
33307446|NCT02663518|101021470|FG005|Part 1: Phase 1a Escalation|Other|0|||
33307447|NCT02663518|101021471|FG006|Part 1: Phase 1a Escalation|Other|0|||
33307448|NCT02663518|101021472|FG007|Part 1: Phase 1a Escalation|Other|0|||
33307449|NCT02663518|101021473|FG008|Part 1: Phase 1a Escalation|Other|0|||
33307450|NCT02663518|101021474|FG009|Part 1: Phase 1a Escalation|Other|0|||
33307451|NCT02663518|101021475|FG010|Part 1: Phase 1a Escalation|Other|0|||
33307452|NCT02663518|101021476|FG011|Part 1: Phase 1a Escalation|Other|0|||
33307453|NCT02663518|101021477|FG012|Part 1: Phase 1a Escalation|Other|0|||
33307454|NCT02663518|101021478|FG013|Part 1: Phase 1a Escalation|Other|0|||
33601387|NCT01519674|102091913|FG000|Overall Study|Protocol Violation|0|||
33307455|NCT02663518|101021465|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
33307456|NCT02663518|101021466|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
33307457|NCT02663518|101021467|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
33307458|NCT02663518|101021468|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
33307459|NCT02663518|101021469|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
33601388|NCT01519674|102091914|FG001|Overall Study|Protocol Violation|3|||
33307460|NCT02663518|101021470|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
33307461|NCT02663518|101021471|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
33307462|NCT02663518|101021472|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
33307463|NCT02663518|101021473|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
33307464|NCT02663518|101021474|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
33307465|NCT02663518|101021475|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
33307466|NCT02663518|101021476|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
33307467|NCT02663518|101021477|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
33307468|NCT02663518|101021478|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
33307469|NCT02663518|101021465|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
33307470|NCT02663518|101021466|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
33307471|NCT02663518|101021467|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
33307472|NCT02663518|101021468|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
33307473|NCT02663518|101021469|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
33307474|NCT02663518|101021470|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
33307475|NCT02663518|101021471|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
33307476|NCT02663518|101021472|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
33307477|NCT02663518|101021473|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
33307478|NCT02663518|101021474|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
33307479|NCT02663518|101021475|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
33500358|NCT01314872|101724611|FG004|Treatment Period 1|Lack of Efficacy|0|||
33500359|NCT01314872|101724612|FG005|Treatment Period 1|Lack of Efficacy|1|||
33601389|NCT01519674|102091915|FG002|Overall Study|Protocol Violation|1|||
33601390|NCT01519674|102091913|FG000|Overall Study|Withdrawal Criteria|7|||
33601391|NCT01519674|102091914|FG001|Overall Study|Withdrawal Criteria|2|||
33601392|NCT01519674|102091915|FG002|Overall Study|Withdrawal Criteria|7|||
33601393|NCT01519674|102091913|FG000|Overall Study|Unsclassified|10|||
33601394|NCT01519674|102091914|FG001|Overall Study|Unsclassified|4|||
33500360|NCT01314872|101724613|FG006|Treatment Period 1|Lack of Efficacy|0|||
33500361|NCT01314872|101724614|FG007|Treatment Period 1|Lack of Efficacy|2|||
33500362|NCT01314872|101724615|FG008|Treatment Period 1|Lack of Efficacy|0|||
33500363|NCT01314872|101724616|FG009|Treatment Period 1|Lack of Efficacy|0|||
33500364|NCT01314872|101724617|FG010|Treatment Period 1|Lack of Efficacy|0|||
33500365|NCT01314872|101724618|FG011|Treatment Period 1|Lack of Efficacy|0|||
33500366|NCT01314872|101724619|FG012|Treatment Period 1|Lack of Efficacy|0|||
33500367|NCT01314872|101724620|FG013|Treatment Period 1|Lack of Efficacy|0|||
33500368|NCT01314872|101724621|FG014|Treatment Period 1|Lack of Efficacy|0|||
33500369|NCT01314872|101724607|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
33500370|NCT01314872|101724608|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
33601395|NCT01519674|102091915|FG002|Overall Study|Unsclassified|3|||
33191789|NCT01633944|100608449|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
33307480|NCT02663518|101021476|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
33307481|NCT02663518|101021477|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
33307482|NCT02663518|101021478|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
33500371|NCT01314872|101724609|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
33500372|NCT01314872|101724610|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
33500373|NCT01314872|101724611|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
33601396|NCT03734029|102091916|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
33307483|NCT02663518|101021465|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
33500374|NCT01314872|101724612|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
33500375|NCT01314872|101724613|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
33500376|NCT01314872|101724614|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
33500377|NCT01314872|101724615|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
33500378|NCT01314872|101724616|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
33500379|NCT01314872|101724617|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
33500380|NCT01314872|101724618|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
33500381|NCT01314872|101724619|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
33500382|NCT01314872|101724620|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
33500383|NCT01314872|101724621|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
33500384|NCT01314872|101724607|FG000|Treatment Period 1|Withdrawal by Subject|3|||
33500385|NCT01314872|101724608|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33500386|NCT01314872|101724609|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33500387|NCT01314872|101724610|FG003|Treatment Period 1|Withdrawal by Subject|2|||
33500388|NCT01314872|101724611|FG004|Treatment Period 1|Withdrawal by Subject|3|||
33500389|NCT01314872|101724612|FG005|Treatment Period 1|Withdrawal by Subject|1|||
33500390|NCT01314872|101724613|FG006|Treatment Period 1|Withdrawal by Subject|3|||
33500391|NCT01314872|101724614|FG007|Treatment Period 1|Withdrawal by Subject|2|||
33500392|NCT01314872|101724615|FG008|Treatment Period 1|Withdrawal by Subject|2|||
33500393|NCT01314872|101724616|FG009|Treatment Period 1|Withdrawal by Subject|2|||
33500394|NCT01314872|101724617|FG010|Treatment Period 1|Withdrawal by Subject|1|||
33500395|NCT01314872|101724618|FG011|Treatment Period 1|Withdrawal by Subject|0|||
33500396|NCT01314872|101724619|FG012|Treatment Period 1|Withdrawal by Subject|0|||
33500397|NCT01314872|101724620|FG013|Treatment Period 1|Withdrawal by Subject|0|||
33500398|NCT01314872|101724621|FG014|Treatment Period 1|Withdrawal by Subject|0|||
33500399|NCT01314872|101724607|FG000|Treatment Period 1|Lost to Follow-up|0|||
33500400|NCT01314872|101724608|FG001|Treatment Period 1|Lost to Follow-up|1|||
33500401|NCT01314872|101724609|FG002|Treatment Period 1|Lost to Follow-up|2|||
33500402|NCT01314872|101724610|FG003|Treatment Period 1|Lost to Follow-up|2|||
33500403|NCT01314872|101724611|FG004|Treatment Period 1|Lost to Follow-up|1|||
33500404|NCT01314872|101724612|FG005|Treatment Period 1|Lost to Follow-up|1|||
33500405|NCT01314872|101724613|FG006|Treatment Period 1|Lost to Follow-up|1|||
33500406|NCT01314872|101724614|FG007|Treatment Period 1|Lost to Follow-up|1|||
33500407|NCT01314872|101724615|FG008|Treatment Period 1|Lost to Follow-up|1|||
33500408|NCT01314872|101724616|FG009|Treatment Period 1|Lost to Follow-up|0|||
33500409|NCT01314872|101724617|FG010|Treatment Period 1|Lost to Follow-up|0|||
33500410|NCT01314872|101724618|FG011|Treatment Period 1|Lost to Follow-up|0|||
33500411|NCT01314872|101724619|FG012|Treatment Period 1|Lost to Follow-up|0|||
33500412|NCT01314872|101724620|FG013|Treatment Period 1|Lost to Follow-up|0|||
33500413|NCT01314872|101724621|FG014|Treatment Period 1|Lost to Follow-up|0|||
33500414|NCT01314872|101724607|FG000|Period 2|Protocol Violation|0|||
33500415|NCT01314872|101724608|FG001|Period 2|Protocol Violation|0|||
33500416|NCT01314872|101724609|FG002|Period 2|Protocol Violation|0|||
33500417|NCT01314872|101724610|FG003|Period 2|Protocol Violation|0|||
33500418|NCT01314872|101724611|FG004|Period 2|Protocol Violation|0|||
33500419|NCT01314872|101724612|FG005|Period 2|Protocol Violation|0|||
33500420|NCT01314872|101724613|FG006|Period 2|Protocol Violation|0|||
33500421|NCT01314872|101724614|FG007|Period 2|Protocol Violation|0|||
33500422|NCT01314872|101724615|FG008|Period 2|Protocol Violation|0|||
33500423|NCT01314872|101724616|FG009|Period 2|Protocol Violation|0|||
33500424|NCT01314872|101724617|FG010|Period 2|Protocol Violation|0|||
33500425|NCT01314872|101724618|FG011|Period 2|Protocol Violation|3|||
33500426|NCT01314872|101724619|FG012|Period 2|Protocol Violation|3|||
33500427|NCT01314872|101724620|FG013|Period 2|Protocol Violation|2|||
33500428|NCT01314872|101724621|FG014|Period 2|Protocol Violation|0|||
33500429|NCT01314872|101724607|FG000|Period 2|Non-compliance with study drug|0|||
33191790|NCT01633944|100608447|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
33191791|NCT01633944|100608448|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
33191792|NCT01633944|100608449|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
33191793|NCT01633944|100608447|FG000|Double-blind Treatment Phase|Other|0|||
33191794|NCT01633944|100608448|FG001|Double-blind Treatment Phase|Other|7|||
33307484|NCT02663518|101021466|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
33307485|NCT02663518|101021467|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
33307486|NCT02663518|101021468|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
33500430|NCT01314872|101724608|FG001|Period 2|Non-compliance with study drug|0|||
33500431|NCT01314872|101724609|FG002|Period 2|Non-compliance with study drug|0|||
33500432|NCT01314872|101724610|FG003|Period 2|Non-compliance with study drug|0|||
33500433|NCT01314872|101724611|FG004|Period 2|Non-compliance with study drug|0|||
33500434|NCT01314872|101724612|FG005|Period 2|Non-compliance with study drug|0|||
33500435|NCT01314872|101724613|FG006|Period 2|Non-compliance with study drug|0|||
33500436|NCT01314872|101724614|FG007|Period 2|Non-compliance with study drug|0|||
33500437|NCT01314872|101724615|FG008|Period 2|Non-compliance with study drug|0|||
33191795|NCT01633944|100608449|FG002|Double-blind Treatment Phase|Other|0|||
33307487|NCT02663518|101021469|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
33307488|NCT02663518|101021470|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
33307489|NCT02663518|101021471|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
33307490|NCT02663518|101021472|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
33307491|NCT02663518|101021473|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
33307492|NCT02663518|101021474|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
33307493|NCT02663518|101021475|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
33307494|NCT02663518|101021476|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
33307495|NCT02663518|101021477|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
33601397|NCT03734029|102091917|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
33601398|NCT03734029|102091916|FG000|Overall Study|Adverse Event|60|||
33601399|NCT03734029|102091917|FG001|Overall Study|Adverse Event|14|||
33191796|NCT00779766|100608452|FG000|Month 24|Serious Adverse Event|2|||
33191797|NCT00779766|100608453|FG001|Month 24|Serious Adverse Event|3|||
33191798|NCT00779766|100608452|FG000|Month 24|Adverse Event|3|||
33191799|NCT00779766|100608453|FG001|Month 24|Adverse Event|3|||
33191800|NCT00779766|100608452|FG000|Month 24|Protocol Violation|3|||
33191801|NCT00779766|100608453|FG001|Month 24|Protocol Violation|1|||
33191802|NCT00779766|100608452|FG000|Month 24|Withdrawal by Subject|159|||
33191803|NCT00779766|100608453|FG001|Month 24|Withdrawal by Subject|127|||
33191804|NCT00779766|100608452|FG000|Month 24|Migrated/moved from study area|138|||
33191805|NCT00779766|100608453|FG001|Month 24|Migrated/moved from study area|162|||
33191806|NCT00779766|100608452|FG000|Month 24|Lost to Follow-up|9|||
33191807|NCT00779766|100608453|FG001|Month 24|Lost to Follow-up|9|||
33191808|NCT00779766|100608452|FG000|Month 24|Other|18|||
33307496|NCT02663518|101021478|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
33307497|NCT02663518|101021465|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
33307498|NCT02663518|101021466|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
33307499|NCT02663518|101021467|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
33500438|NCT01314872|101724616|FG009|Period 2|Non-compliance with study drug|0|||
33500439|NCT01314872|101724617|FG010|Period 2|Non-compliance with study drug|0|||
33500440|NCT01314872|101724618|FG011|Period 2|Non-compliance with study drug|3|||
33500441|NCT01314872|101724619|FG012|Period 2|Non-compliance with study drug|3|||
33500442|NCT01314872|101724620|FG013|Period 2|Non-compliance with study drug|1|||
33500443|NCT01314872|101724621|FG014|Period 2|Non-compliance with study drug|2|||
33500444|NCT01314872|101724607|FG000|Period 2|Lack of Efficacy|0|||
33500445|NCT01314872|101724608|FG001|Period 2|Lack of Efficacy|0|||
33500446|NCT01314872|101724609|FG002|Period 2|Lack of Efficacy|0|||
33500447|NCT01314872|101724610|FG003|Period 2|Lack of Efficacy|0|||
33500448|NCT01314872|101724611|FG004|Period 2|Lack of Efficacy|0|||
33500449|NCT01314872|101724612|FG005|Period 2|Lack of Efficacy|0|||
33500450|NCT01314872|101724613|FG006|Period 2|Lack of Efficacy|0|||
33500451|NCT01314872|101724614|FG007|Period 2|Lack of Efficacy|0|||
33601400|NCT03734029|102091916|FG000|Overall Study|Withdrawal by Subject|12|||
33601401|NCT03734029|102091917|FG001|Overall Study|Withdrawal by Subject|11|||
33601402|NCT03734029|102091916|FG000|Overall Study|Clinical progression by investigator|10|||
33601403|NCT03734029|102091917|FG001|Overall Study|Clinical progression by investigator|8|||
33601404|NCT03734029|102091916|FG000|Overall Study|Death|5|||
33601405|NCT03734029|102091917|FG001|Overall Study|Death|2|||
33601406|NCT03734029|102091916|FG000|Overall Study|Physician Decision|4|||
33601407|NCT03734029|102091917|FG001|Overall Study|Physician Decision|3|||
33601408|NCT03734029|102091916|FG000|Overall Study|Other|2|||
33601409|NCT03734029|102091917|FG001|Overall Study|Other|0|||
33601410|NCT03734029|102091916|FG000|Overall Study|Lost to Follow-up|0|||
33601411|NCT03734029|102091917|FG001|Overall Study|Lost to Follow-up|1|||
33601412|NCT03734029|102091916|FG000|Overall Study|Randomized, but not treated|2|||
33601413|NCT03734029|102091917|FG001|Overall Study|Randomized, but not treated|12|||
33601414|NCT03426631|102091924|FG000|Overall Study|Lost to Follow-up|0|||
33601415|NCT03426631|102091925|FG001|Overall Study|Lost to Follow-up|1|||
33601416|NCT04384107|102091928|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
33601417|NCT04384107|102091929|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
33307500|NCT02663518|101021468|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
33500452|NCT01314872|101724615|FG008|Period 2|Lack of Efficacy|0|||
33500453|NCT01314872|101724616|FG009|Period 2|Lack of Efficacy|0|||
33500454|NCT01314872|101724617|FG010|Period 2|Lack of Efficacy|0|||
33601418|NCT04384107|102091928|FG000|Overall Study|Lost to Follow-up|1|||
33601419|NCT04384107|102091929|FG001|Overall Study|Lost to Follow-up|0|||
33601420|NCT01219933|102091933|FG000|Overall Study|Adverse Event|8|||
33500455|NCT01314872|101724618|FG011|Period 2|Lack of Efficacy|7|||
33601421|NCT01219933|102091933|FG000|Overall Study|No LDA reached|5|||
33191809|NCT00779766|100608453|FG001|Month 24|Other|27|||
33191810|NCT00779766|100608452|FG000|Month 48|Withdrawal by Subject|68|||
33500456|NCT01314872|101724619|FG012|Period 2|Lack of Efficacy|12|||
33500457|NCT01314872|101724620|FG013|Period 2|Lack of Efficacy|9|||
33601422|NCT01219933|102091933|FG000|Overall Study|No LDA maintained|7|||
33601423|NCT01219933|102091933|FG000|Overall Study|Lost to Follow-up|3|||
33191811|NCT00779766|100608453|FG001|Month 48|Withdrawal by Subject|63|||
33307501|NCT02663518|101021469|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
33307502|NCT02663518|101021470|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
33307503|NCT02663518|101021471|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
33307504|NCT02663518|101021472|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
33500458|NCT01314872|101724621|FG014|Period 2|Lack of Efficacy|2|||
33500459|NCT01314872|101724607|FG000|Period 2|Pregnancy|0|||
33500460|NCT01314872|101724608|FG001|Period 2|Pregnancy|0|||
33500461|NCT01314872|101724609|FG002|Period 2|Pregnancy|0|||
33500462|NCT01314872|101724610|FG003|Period 2|Pregnancy|0|||
33500463|NCT01314872|101724611|FG004|Period 2|Pregnancy|0|||
33500464|NCT01314872|101724612|FG005|Period 2|Pregnancy|0|||
33500465|NCT01314872|101724613|FG006|Period 2|Pregnancy|0|||
33500466|NCT01314872|101724614|FG007|Period 2|Pregnancy|0|||
33500467|NCT01314872|101724615|FG008|Period 2|Pregnancy|0|||
33500468|NCT01314872|101724616|FG009|Period 2|Pregnancy|0|||
33500469|NCT01314872|101724617|FG010|Period 2|Pregnancy|0|||
33500470|NCT01314872|101724618|FG011|Period 2|Pregnancy|0|||
33500471|NCT01314872|101724619|FG012|Period 2|Pregnancy|0|||
33500472|NCT01314872|101724620|FG013|Period 2|Pregnancy|0|||
33500473|NCT01314872|101724621|FG014|Period 2|Pregnancy|1|||
33500474|NCT01314872|101724607|FG000|Period 2|Study terminated by Sponsor|0|||
33500475|NCT01314872|101724608|FG001|Period 2|Study terminated by Sponsor|0|||
33307505|NCT02663518|101021473|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
33307506|NCT02663518|101021474|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
33307507|NCT02663518|101021475|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
33307508|NCT02663518|101021476|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
33307509|NCT02663518|101021477|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
33307510|NCT02663518|101021478|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
33307511|NCT02663518|101021465|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
33307512|NCT02663518|101021466|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
33307513|NCT02663518|101021467|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
33307514|NCT02663518|101021468|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
33307515|NCT02663518|101021469|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
33307516|NCT02663518|101021470|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
33307517|NCT02663518|101021471|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
33500476|NCT01314872|101724609|FG002|Period 2|Study terminated by Sponsor|0|||
33500477|NCT01314872|101724610|FG003|Period 2|Study terminated by Sponsor|0|||
33500478|NCT01314872|101724611|FG004|Period 2|Study terminated by Sponsor|0|||
33500479|NCT01314872|101724612|FG005|Period 2|Study terminated by Sponsor|0|||
33500480|NCT01314872|101724613|FG006|Period 2|Study terminated by Sponsor|0|||
33191812|NCT00779766|100608452|FG000|Month 48|Migrated/moved from study area|76|||
33500481|NCT01314872|101724614|FG007|Period 2|Study terminated by Sponsor|0|||
33500482|NCT01314872|101724615|FG008|Period 2|Study terminated by Sponsor|0|||
33500483|NCT01314872|101724616|FG009|Period 2|Study terminated by Sponsor|0|||
33191813|NCT00779766|100608453|FG001|Month 48|Migrated/moved from study area|75|||
33191814|NCT00779766|100608452|FG000|Month 48|Lost to Follow-up|29|||
33191815|NCT00779766|100608453|FG001|Month 48|Lost to Follow-up|30|||
33191816|NCT00779766|100608452|FG000|Month 48|Other|1|||
33191817|NCT00779766|100608453|FG001|Month 48|Other|0|||
33191818|NCT00779766|100608452|FG000|Month 72|Withdrawal by Subject|55|||
33191819|NCT00779766|100608453|FG001|Month 72|Withdrawal by Subject|71|||
33191820|NCT00779766|100608452|FG000|Month 72|Migrated/moved from study area|124|||
33191821|NCT00779766|100608453|FG001|Month 72|Migrated/moved from study area|109|||
33191822|NCT00779766|100608452|FG000|Month 72|Lost to Follow-up|6|||
33191823|NCT00779766|100608453|FG001|Month 72|Lost to Follow-up|8|||
33191824|NCT00779766|100608452|FG000|Month 72|Other|0|||
33191825|NCT00779766|100608453|FG001|Month 72|Other|1|||
33191826|NCT00280566|100608454|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
33191827|NCT00280566|100608455|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
33307518|NCT02663518|101021472|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
33307519|NCT02663518|101021473|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
33500484|NCT01314872|101724617|FG010|Period 2|Study terminated by Sponsor|0|||
33601424|NCT01219933|102091933|FG000|Overall Study|GC free|1|||
33601425|NCT01219933|102091933|FG000|Overall Study|Withdrawal by Subject|5|||
33601426|NCT01219933|102091933|FG000|Overall Study|Protocol Violation|8|||
33191828|NCT00280566|100608456|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
33307520|NCT02663518|101021474|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
33307521|NCT02663518|101021475|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
33500485|NCT01314872|101724618|FG011|Period 2|Study terminated by Sponsor|2|||
33500486|NCT01314872|101724619|FG012|Period 2|Study terminated by Sponsor|2|||
33601427|NCT01219933|102091933|FG000|Overall Study|Lack of Efficacy|1|||
33500487|NCT01314872|101724620|FG013|Period 2|Study terminated by Sponsor|3|||
33500488|NCT01314872|101724621|FG014|Period 2|Study terminated by Sponsor|0|||
33191829|NCT00280566|100608454|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
33191830|NCT00280566|100608455|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
33191831|NCT00280566|100608456|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
33500489|NCT01314872|101724607|FG000|Period 2|Adverse event, non-fatal|0|||
33500490|NCT01314872|101724608|FG001|Period 2|Adverse event, non-fatal|0|||
33500491|NCT01314872|101724609|FG002|Period 2|Adverse event, non-fatal|0|||
33500492|NCT01314872|101724610|FG003|Period 2|Adverse event, non-fatal|0|||
33500493|NCT01314872|101724611|FG004|Period 2|Adverse event, non-fatal|0|||
33500494|NCT01314872|101724612|FG005|Period 2|Adverse event, non-fatal|0|||
33500495|NCT01314872|101724613|FG006|Period 2|Adverse event, non-fatal|0|||
33500496|NCT01314872|101724614|FG007|Period 2|Adverse event, non-fatal|0|||
33500497|NCT01314872|101724615|FG008|Period 2|Adverse event, non-fatal|0|||
33500498|NCT01314872|101724616|FG009|Period 2|Adverse event, non-fatal|0|||
33500499|NCT01314872|101724617|FG010|Period 2|Adverse event, non-fatal|0|||
33500500|NCT01314872|101724618|FG011|Period 2|Adverse event, non-fatal|13|||
33500501|NCT01314872|101724619|FG012|Period 2|Adverse event, non-fatal|16|||
33500502|NCT01314872|101724620|FG013|Period 2|Adverse event, non-fatal|24|||
33500503|NCT01314872|101724621|FG014|Period 2|Adverse event, non-fatal|9|||
33500504|NCT01314872|101724607|FG000|Period 2|Withdrawal by Subject|0|||
33500505|NCT01314872|101724608|FG001|Period 2|Withdrawal by Subject|0|||
33500506|NCT01314872|101724609|FG002|Period 2|Withdrawal by Subject|0|||
33500507|NCT01314872|101724610|FG003|Period 2|Withdrawal by Subject|0|||
33500508|NCT01314872|101724611|FG004|Period 2|Withdrawal by Subject|0|||
33500509|NCT01314872|101724612|FG005|Period 2|Withdrawal by Subject|0|||
33500510|NCT01314872|101724613|FG006|Period 2|Withdrawal by Subject|0|||
33500511|NCT01314872|101724614|FG007|Period 2|Withdrawal by Subject|0|||
33500512|NCT01314872|101724615|FG008|Period 2|Withdrawal by Subject|0|||
33500513|NCT01314872|101724616|FG009|Period 2|Withdrawal by Subject|0|||
33500514|NCT01314872|101724617|FG010|Period 2|Withdrawal by Subject|0|||
33500515|NCT01314872|101724618|FG011|Period 2|Withdrawal by Subject|14|||
33500516|NCT01314872|101724619|FG012|Period 2|Withdrawal by Subject|17|||
33500517|NCT01314872|101724620|FG013|Period 2|Withdrawal by Subject|12|||
33500518|NCT01314872|101724621|FG014|Period 2|Withdrawal by Subject|4|||
33500519|NCT01314872|101724607|FG000|Period 2|Lost to Follow-up|0|||
33500520|NCT01314872|101724608|FG001|Period 2|Lost to Follow-up|0|||
33500521|NCT01314872|101724609|FG002|Period 2|Lost to Follow-up|0|||
33500522|NCT01314872|101724610|FG003|Period 2|Lost to Follow-up|0|||
33307522|NCT02663518|101021476|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
33307523|NCT02663518|101021477|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
33307524|NCT02663518|101021478|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
33307525|NCT02663518|101021465|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
33307526|NCT02663518|101021466|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
33307527|NCT02663518|101021467|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
33307528|NCT02663518|101021468|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
33307529|NCT02663518|101021469|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
33307530|NCT02663518|101021470|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
33307531|NCT02663518|101021471|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
33307532|NCT02663518|101021472|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
33307533|NCT02663518|101021473|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
33307534|NCT02663518|101021474|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
33307535|NCT02663518|101021475|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
33307536|NCT02663518|101021476|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
33307537|NCT02663518|101021477|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
33307538|NCT02663518|101021478|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
33307539|NCT02663518|101021465|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
33307540|NCT02663518|101021466|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
33307541|NCT02663518|101021467|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
33307542|NCT02663518|101021468|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
33307543|NCT02663518|101021469|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
33307544|NCT02663518|101021470|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
33307545|NCT02663518|101021471|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
33307546|NCT02663518|101021472|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
33307547|NCT02663518|101021473|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
33307548|NCT02663518|101021474|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
33307549|NCT02663518|101021475|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
33307550|NCT02663518|101021476|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
33307551|NCT02663518|101021477|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
33307552|NCT02663518|101021478|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
33307553|NCT02663518|101021465|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
33307554|NCT02663518|101021466|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
33500523|NCT01314872|101724611|FG004|Period 2|Lost to Follow-up|0|||
33500524|NCT01314872|101724612|FG005|Period 2|Lost to Follow-up|0|||
33500525|NCT01314872|101724613|FG006|Period 2|Lost to Follow-up|0|||
33500526|NCT01314872|101724614|FG007|Period 2|Lost to Follow-up|0|||
33500527|NCT01314872|101724615|FG008|Period 2|Lost to Follow-up|0|||
33500528|NCT01314872|101724616|FG009|Period 2|Lost to Follow-up|0|||
33500529|NCT01314872|101724617|FG010|Period 2|Lost to Follow-up|0|||
33500530|NCT01314872|101724618|FG011|Period 2|Lost to Follow-up|6|||
33500531|NCT01314872|101724619|FG012|Period 2|Lost to Follow-up|7|||
33500532|NCT01314872|101724620|FG013|Period 2|Lost to Follow-up|2|||
33500533|NCT01314872|101724621|FG014|Period 2|Lost to Follow-up|6|||
33307555|NCT02663518|101021467|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
33307556|NCT02663518|101021468|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
33307557|NCT02663518|101021469|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
33307558|NCT02663518|101021470|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
33307559|NCT02663518|101021471|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
33500534|NCT00630825|101724622|FG000|Overall Study|Adverse Event|4|||
33601428|NCT01545050|102091934|FG000|Overall Study|Lack of Efficacy|0|||
33601429|NCT01545050|102091935|FG001|Overall Study|Lack of Efficacy|0|||
33601430|NCT01545050|102091936|FG002|Overall Study|Lack of Efficacy|0|||
33601431|NCT01545050|102091937|FG003|Overall Study|Lack of Efficacy|3|||
33601432|NCT01545050|102091938|FG004|Overall Study|Lack of Efficacy|2|||
33601433|NCT01545050|102091934|FG000|Overall Study|Adverse Event|1|||
33601434|NCT01545050|102091935|FG001|Overall Study|Adverse Event|1|||
33601435|NCT01545050|102091936|FG002|Overall Study|Adverse Event|2|||
33601436|NCT01545050|102091937|FG003|Overall Study|Adverse Event|2|||
33601437|NCT01545050|102091938|FG004|Overall Study|Adverse Event|0|||
33601438|NCT01545050|102091934|FG000|Overall Study|Discontinued study treatment|1|||
33601439|NCT01545050|102091935|FG001|Overall Study|Discontinued study treatment|0|||
33601440|NCT01545050|102091936|FG002|Overall Study|Discontinued study treatment|0|||
33601441|NCT01545050|102091937|FG003|Overall Study|Discontinued study treatment|0|||
33601442|NCT01545050|102091938|FG004|Overall Study|Discontinued study treatment|0|||
33601443|NCT01545050|102091934|FG000|Overall Study|Withdrawal by Subject|1|||
33601444|NCT01545050|102091935|FG001|Overall Study|Withdrawal by Subject|0|||
33601445|NCT01545050|102091936|FG002|Overall Study|Withdrawal by Subject|0|||
33601446|NCT01545050|102091937|FG003|Overall Study|Withdrawal by Subject|2|||
33601447|NCT01545050|102091938|FG004|Overall Study|Withdrawal by Subject|1|||
33601448|NCT01545050|102091934|FG000|Overall Study|Participant no longer meets study criteria|0|||
33601449|NCT01545050|102091935|FG001|Overall Study|Participant no longer meets study criteria|2|||
33191832|NCT00280566|100608454|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
33191833|NCT00280566|100608455|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
33191834|NCT00280566|100608456|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
33191835|NCT00280566|100608454|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
33191836|NCT00280566|100608455|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
33307560|NCT02663518|101021472|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
33500535|NCT00630825|101724623|FG001|Overall Study|Adverse Event|4|||
33500536|NCT00630825|101724624|FG002|Overall Study|Adverse Event|3|||
33500537|NCT00630825|101724625|FG003|Overall Study|Adverse Event|1|||
33500538|NCT00630825|101724622|FG000|Overall Study|Entry Criteria Not Met|1|||
33500539|NCT00630825|101724623|FG001|Overall Study|Entry Criteria Not Met|0|||
33500540|NCT00630825|101724624|FG002|Overall Study|Entry Criteria Not Met|2|||
33601450|NCT01545050|102091936|FG002|Overall Study|Participant no longer meets study criteria|0|||
33601451|NCT01545050|102091937|FG003|Overall Study|Participant no longer meets study criteria|0|||
33601452|NCT01545050|102091938|FG004|Overall Study|Participant no longer meets study criteria|1|||
33500541|NCT00630825|101724625|FG003|Overall Study|Entry Criteria Not Met|1|||
33500542|NCT00630825|101724622|FG000|Overall Study|Lost to Follow-up|1|||
33500543|NCT00630825|101724623|FG001|Overall Study|Lost to Follow-up|1|||
33500544|NCT00630825|101724624|FG002|Overall Study|Lost to Follow-up|1|||
33500545|NCT00630825|101724625|FG003|Overall Study|Lost to Follow-up|1|||
33500546|NCT00630825|101724622|FG000|Overall Study|Physician Decision|1|||
33307561|NCT02663518|101021473|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
33307562|NCT02663518|101021474|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
33307563|NCT02663518|101021475|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
33307564|NCT02663518|101021476|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
33500547|NCT00630825|101724623|FG001|Overall Study|Physician Decision|0|||
33500548|NCT00630825|101724624|FG002|Overall Study|Physician Decision|0|||
33307565|NCT02663518|101021477|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
33307566|NCT02663518|101021478|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
33307567|NCT02663518|101021465|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
33500549|NCT00630825|101724625|FG003|Overall Study|Physician Decision|0|||
33500550|NCT00630825|101724622|FG000|Overall Study|Withdrawal by Subject|2|||
33500551|NCT00630825|101724623|FG001|Overall Study|Withdrawal by Subject|2|||
33500552|NCT00630825|101724624|FG002|Overall Study|Withdrawal by Subject|2|||
33500553|NCT00630825|101724625|FG003|Overall Study|Withdrawal by Subject|3|||
33500554|NCT04090060|101724626|FG000|Overall Study|Lost to Follow-up|76|||
33500555|NCT04090060|101724627|FG001|Overall Study|Lost to Follow-up|77|||
33500556|NCT00866281|101724628|FG000|Overall Study|Adverse Event|1|||
33500557|NCT00866281|101724629|FG001|Overall Study|Adverse Event|0|||
33500558|NCT00866281|101724628|FG000|Overall Study|Withdrawal by participants|3|||
33500559|NCT00866281|101724629|FG001|Overall Study|Withdrawal by participants|0|||
33500560|NCT00866281|101724628|FG000|Overall Study|Disease progression|3|||
33500561|NCT00866281|101724629|FG001|Overall Study|Disease progression|11|||
33500562|NCT00866281|101724628|FG000|Overall Study|New cancer therapy|0|||
33500563|NCT00866281|101724629|FG001|Overall Study|New cancer therapy|4|||
33500564|NCT02362360|101724630|FG000|Period 1|Lack of Efficacy|1|||
33500565|NCT02362360|101724631|FG001|Period 1|Lack of Efficacy|0|||
33500566|NCT02362360|101724630|FG000|Period 1|Withdrawal by Subject|2|||
33500567|NCT02362360|101724631|FG001|Period 1|Withdrawal by Subject|1|||
33500568|NCT01749826|101724647|FG000|Overall Study|Study Terminated|20|||
33500569|NCT01749826|101724648|FG001|Overall Study|Study Terminated|0|||
33500570|NCT03048747|101724649|FG000|Overall Study|Adverse Event|2|||
33500571|NCT03048747|101724649|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
33500572|NCT03048747|101724649|FG000|Overall Study|Physician Decision|1|||
33500573|NCT01806051|101724650|FG000|Overall Study|Withdrawal by Subject|6|||
33500574|NCT03852472|101724651|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
33500575|NCT03852472|101724652|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
33500576|NCT03852472|101724653|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
33500577|NCT03852472|101724654|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
33500578|NCT03852472|101724655|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
33500579|NCT03852472|101724651|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
33500580|NCT03852472|101724652|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
33500581|NCT03852472|101724653|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
33500582|NCT03852472|101724654|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
33500583|NCT03852472|101724655|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
33500584|NCT03852472|101724651|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
33500585|NCT03852472|101724652|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
33500586|NCT03852472|101724653|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
33500587|NCT03852472|101724654|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
33500588|NCT03852472|101724655|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
33500589|NCT03852472|101724651|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
33500590|NCT03852472|101724652|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
33500591|NCT03852472|101724653|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
33500592|NCT03852472|101724654|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
33500593|NCT03852472|101724655|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
33500594|NCT03852472|101724651|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
33500595|NCT03852472|101724652|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
33500596|NCT03852472|101724653|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
33500597|NCT03852472|101724654|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
33500598|NCT03852472|101724655|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
33500599|NCT03852472|101724651|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
33500600|NCT03852472|101724652|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
33500601|NCT03852472|101724653|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
33500602|NCT03852472|101724654|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
33500603|NCT03852472|101724655|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
33500604|NCT03852472|101724651|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
33500605|NCT03852472|101724652|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
33307568|NCT02663518|101021466|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
33307569|NCT02663518|101021467|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
33307570|NCT02663518|101021468|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
33307571|NCT02663518|101021469|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
33307572|NCT02663518|101021470|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
33307573|NCT02663518|101021471|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
33307574|NCT02663518|101021472|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
33307575|NCT02663518|101021473|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
33307576|NCT02663518|101021474|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
33307577|NCT02663518|101021475|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
33307578|NCT02663518|101021476|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
33307579|NCT02663518|101021477|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
33307580|NCT02663518|101021478|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
33307581|NCT02663518|101021465|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
33307582|NCT02663518|101021466|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
33307583|NCT02663518|101021467|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
33307584|NCT02663518|101021468|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
33307585|NCT02663518|101021469|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
33307586|NCT02663518|101021470|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
33500606|NCT03852472|101724653|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
33191837|NCT00280566|100608456|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
33307587|NCT02663518|101021471|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
33307588|NCT02663518|101021472|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
33307589|NCT02663518|101021473|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
33307590|NCT02663518|101021474|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
33307591|NCT02663518|101021475|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
33307592|NCT02663518|101021476|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
33307593|NCT02663518|101021477|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
33307594|NCT02663518|101021478|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
33307595|NCT02663518|101021465|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
33307596|NCT02663518|101021466|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
33307597|NCT02663518|101021467|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
33601453|NCT01545050|102091934|FG000|Overall Study|Administrative reason by sponsor|4|||
33307598|NCT02663518|101021468|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
33307599|NCT02663518|101021469|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
33307600|NCT02663518|101021470|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
33307601|NCT02663518|101021471|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
33307602|NCT02663518|101021472|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
33307603|NCT02663518|101021473|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
33307604|NCT02663518|101021474|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
33307605|NCT02663518|101021475|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
33307606|NCT02663518|101021476|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
33307607|NCT02663518|101021477|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
33307608|NCT02663518|101021478|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
33307609|NCT02663518|101021465|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
33307610|NCT02663518|101021466|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
33307611|NCT02663518|101021467|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
33500607|NCT03852472|101724654|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
33500608|NCT03852472|101724655|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
33500609|NCT03852472|101724651|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
33601454|NCT01545050|102091935|FG001|Overall Study|Administrative reason by sponsor|2|||
33601455|NCT01545050|102091936|FG002|Overall Study|Administrative reason by sponsor|3|||
33601456|NCT01545050|102091937|FG003|Overall Study|Administrative reason by sponsor|5|||
33601457|NCT01545050|102091938|FG004|Overall Study|Administrative reason by sponsor|5|||
33601458|NCT02598128|102091939|FG000|Period A: Days -7 to -1|Adverse Event|1|||
33601459|NCT02598128|102091940|FG001|Period A: Days -7 to -1|Adverse Event|0|||
33601460|NCT02598128|102091941|FG002|Period A: Days -7 to -1|Adverse Event|0|||
33601461|NCT02598128|102091942|FG003|Period A: Days -7 to -1|Adverse Event|0|||
33601462|NCT01299571|102091944|FG000|Overall Study|Protocol Violation|107|||
33601463|NCT01595581|102091945|FG000|Overall Study|Withdrawal by Subject|1|||
33601464|NCT01595581|102091946|FG001|Overall Study|Withdrawal by Subject|0|||
33191838|NCT00280566|100608454|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
33307612|NCT02663518|101021468|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
33307613|NCT02663518|101021469|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
33307614|NCT02663518|101021470|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
33307615|NCT02663518|101021471|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
33307616|NCT02663518|101021472|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
33307617|NCT02663518|101021473|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
33307618|NCT02663518|101021474|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
33307619|NCT02663518|101021475|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
33307620|NCT02663518|101021476|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
33307621|NCT02663518|101021477|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
33307622|NCT02663518|101021478|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
33307623|NCT00752557|101021481|FG000|Overall Study|Withdrawal by Subject|4|||
33307624|NCT00752557|101021482|FG001|Overall Study|Withdrawal by Subject|3|||
33307625|NCT00752557|101021483|FG002|Overall Study|Withdrawal by Subject|3|||
33307626|NCT00752557|101021481|FG000|Overall Study|Unspecified resaons|0|||
33307627|NCT00752557|101021482|FG001|Overall Study|Unspecified resaons|2|||
33307628|NCT00752557|101021483|FG002|Overall Study|Unspecified resaons|2|||
33307629|NCT00752557|101021481|FG000|Overall Study|Lost to Follow-up|1|||
33307630|NCT00752557|101021482|FG001|Overall Study|Lost to Follow-up|0|||
33307631|NCT00752557|101021483|FG002|Overall Study|Lost to Follow-up|1|||
33307632|NCT02656329|101021484|FG000|Overall Study|Lost to Follow-up|2|||
33307633|NCT02656329|101021485|FG001|Overall Study|Lost to Follow-up|3|||
33307634|NCT02656329|101021484|FG000|Overall Study|Withdrawal by Subject|7|||
33307635|NCT02656329|101021485|FG001|Overall Study|Withdrawal by Subject|6|||
33307636|NCT02656329|101021484|FG000|Overall Study|Study termination by Sponsor|150|||
33307637|NCT02656329|101021485|FG001|Overall Study|Study termination by Sponsor|142|||
33307638|NCT02656329|101021484|FG000|Overall Study|Other than specified above|5|||
33307639|NCT02656329|101021485|FG001|Overall Study|Other than specified above|6|||
33307640|NCT01156792|101021486|FG000|Overall Study|Adverse Event|1|||
33307641|NCT01156792|101021486|FG000|Overall Study|Lack of Efficacy|36|||
33307642|NCT01156792|101021486|FG000|Overall Study|Protocol Violation|6|||
33307643|NCT01156792|101021486|FG000|Overall Study|Lost to Follow-up|3|||
33307644|NCT01156792|101021486|FG000|Overall Study|Physician Decision|3|||
33307645|NCT01156792|101021486|FG000|Overall Study|Withdrawal by Subject|9|||
33307646|NCT01156792|101021486|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
33307647|NCT01920854|101021489|FG000|Overall Study|Withdrawal by Subject|1|||
33307648|NCT01920854|101021490|FG001|Overall Study|Withdrawal by Subject|0|||
33307649|NCT01920854|101021491|FG002|Overall Study|Withdrawal by Subject|0|||
33307650|NCT01920854|101021492|FG003|Overall Study|Withdrawal by Subject|0|||
33191839|NCT00280566|100608455|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
33191840|NCT00280566|100608456|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
33191841|NCT00280566|100608454|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
33191842|NCT00280566|100608455|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
33191843|NCT00280566|100608456|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
33191844|NCT00280566|100608454|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
33191845|NCT00280566|100608455|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
33191846|NCT00280566|100608456|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
33191847|NCT00280566|100608454|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
33191848|NCT00280566|100608455|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
33191849|NCT00280566|100608456|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
33307651|NCT01920854|101021493|FG004|Overall Study|Withdrawal by Subject|1|||
33307652|NCT01920854|101021494|FG005|Overall Study|Withdrawal by Subject|0|||
33307653|NCT01920854|101021495|FG006|Overall Study|Withdrawal by Subject|1|||
33307654|NCT00833833|101021496|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
33307655|NCT00833833|101021497|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
33307656|NCT00833833|101021498|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
33307657|NCT00833833|101021499|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
33307658|NCT00833833|101021500|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
33307659|NCT00833833|101021501|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
33307660|NCT00833833|101021496|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
33307661|NCT00833833|101021497|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
33307662|NCT00833833|101021498|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
33307663|NCT00833833|101021499|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
33307664|NCT00833833|101021500|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
33307665|NCT00833833|101021501|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
33307666|NCT00833833|101021496|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
33191850|NCT00280566|100608454|FG000|Period 2 Double Blind|Adverse Event|0|||
33191851|NCT00280566|100608455|FG001|Period 2 Double Blind|Adverse Event|11|||
33191852|NCT00280566|100608456|FG002|Period 2 Double Blind|Adverse Event|15|||
33191853|NCT00280566|100608454|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
33191854|NCT00280566|100608455|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
33191855|NCT00280566|100608456|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
33191856|NCT00280566|100608454|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
33191857|NCT00280566|100608455|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
33191858|NCT00280566|100608456|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
33191859|NCT00280566|100608454|FG000|Period 2 Double Blind|miscellaneous|0|||
33191860|NCT00280566|100608455|FG001|Period 2 Double Blind|miscellaneous|10|||
33191861|NCT00280566|100608456|FG002|Period 2 Double Blind|miscellaneous|5|||
33191862|NCT01114516|100608459|FG000|Overall Study|Lost to Follow-up|2|||
33191863|NCT01114516|100608460|FG001|Overall Study|Lost to Follow-up|1|||
33191864|NCT01207778|100608461|FG000|Overall Study|Lost to Follow-up|0|||
33191865|NCT01207778|100608462|FG001|Overall Study|Lost to Follow-up|3|||
33191866|NCT01207778|100608463|FG002|Overall Study|Lost to Follow-up|3|||
33191867|NCT02684006|100608468|FG000|Overall Study|Ongoing|31|||
33191868|NCT02684006|100608469|FG001|Overall Study|Ongoing|10|||
33191869|NCT02684006|100608468|FG000|Overall Study|Other|7|||
33191870|NCT02684006|100608469|FG001|Overall Study|Other|6|||
33191871|NCT02684006|100608468|FG000|Overall Study|Protocol Violation|2|||
33191872|NCT02684006|100608469|FG001|Overall Study|Protocol Violation|1|||
33191873|NCT02684006|100608468|FG000|Overall Study|Non-compliance with study drug|1|||
33191874|NCT02684006|100608469|FG001|Overall Study|Non-compliance with study drug|1|||
33191875|NCT02684006|100608468|FG000|Overall Study|No longer meets eligibility criteria|6|||
33191876|NCT02684006|100608469|FG001|Overall Study|No longer meets eligibility criteria|2|||
33191877|NCT02684006|100608468|FG000|Overall Study|Lost to Follow-up|0|||
33191878|NCT02684006|100608469|FG001|Overall Study|Lost to Follow-up|1|||
33191879|NCT02684006|100608468|FG000|Overall Study|Death|24|||
33307667|NCT00833833|101021497|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
33307668|NCT00833833|101021498|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
33307669|NCT00833833|101021499|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
33307670|NCT00833833|101021500|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
33307671|NCT00833833|101021501|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
33307672|NCT00833833|101021496|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
33307673|NCT00833833|101021497|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
33307674|NCT00833833|101021498|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
33307675|NCT00833833|101021499|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
33307676|NCT00833833|101021500|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
33307677|NCT00833833|101021501|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
33307678|NCT00833833|101021496|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
33307679|NCT00833833|101021497|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33601465|NCT02360293|102091947|FG000|Overall Study|Lost to Follow-up|73|||
33601466|NCT02360293|102091948|FG001|Overall Study|Lost to Follow-up|95|||
33601467|NCT02360293|102091947|FG000|Overall Study|Withdrawal by Subject|2|||
33601468|NCT02360293|102091948|FG001|Overall Study|Withdrawal by Subject|1|||
33601469|NCT02360293|102091947|FG000|Overall Study|Excluded|1|||
33601470|NCT02360293|102091948|FG001|Overall Study|Excluded|0|||
33601471|NCT00657150|102091949|FG000|Overall Study|Adverse Event|19|||
33601472|NCT00657150|102091950|FG001|Overall Study|Adverse Event|10|||
33601473|NCT00657150|102091949|FG000|Overall Study|Non-compliant with protocol|5|||
33601474|NCT00657150|102091950|FG001|Overall Study|Non-compliant with protocol|9|||
33191880|NCT02684006|100608469|FG001|Overall Study|Death|22|||
33393776|NCT03073200|101328520|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
33601475|NCT00657150|102091949|FG000|Overall Study|Lost to Follow-up|2|||
33601476|NCT00657150|102091950|FG001|Overall Study|Lost to Follow-up|0|||
33191881|NCT02684006|100608468|FG000|Overall Study|Global deterioration of health status|18|||
33191882|NCT02684006|100608469|FG001|Overall Study|Global deterioration of health status|20|||
33191883|NCT02684006|100608468|FG000|Overall Study|Physician Decision|14|||
33191884|NCT02684006|100608469|FG001|Overall Study|Physician Decision|9|||
33191885|NCT02684006|100608468|FG000|Overall Study|Adverse Event|74|||
33307680|NCT00833833|101021498|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
33307681|NCT00833833|101021499|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33307682|NCT00833833|101021500|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33307683|NCT00833833|101021501|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33307684|NCT00833833|101021496|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
33307685|NCT00833833|101021497|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
33307686|NCT00833833|101021498|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
33307687|NCT00833833|101021499|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
33307688|NCT00833833|101021500|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
33307689|NCT00833833|101021501|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
33307690|NCT00833833|101021496|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
33307691|NCT00833833|101021497|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
33307692|NCT00833833|101021498|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
33307693|NCT00833833|101021499|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
33307694|NCT00833833|101021500|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
33307695|NCT00833833|101021501|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
33191886|NCT02684006|100608469|FG001|Overall Study|Adverse Event|65|||
33191887|NCT02684006|100608468|FG000|Overall Study|Withdrawal by Subject|29|||
33191888|NCT02684006|100608469|FG001|Overall Study|Withdrawal by Subject|41|||
33191889|NCT02684006|100608468|FG000|Overall Study|Progressive disease|236|||
33191890|NCT02684006|100608469|FG001|Overall Study|Progressive disease|266|||
33191891|NCT01516879|100608470|FG000|Overall Study|Withdrawal by Subject|9|||
33191892|NCT01516879|100608471|FG001|Overall Study|Withdrawal by Subject|11|||
33191893|NCT01516879|100608470|FG000|Overall Study|Death|0|||
33191894|NCT01516879|100608471|FG001|Overall Study|Death|2|||
33191895|NCT01516879|100608470|FG000|Overall Study|Lost to Follow-up|2|||
33191896|NCT01516879|100608471|FG001|Overall Study|Lost to Follow-up|11|||
33307696|NCT00833833|101021496|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
33307697|NCT00833833|101021497|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
33307698|NCT00833833|101021498|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
33307699|NCT00833833|101021499|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
33307700|NCT00833833|101021500|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
33307701|NCT00833833|101021501|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
33307702|NCT00833833|101021496|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
33307703|NCT00833833|101021497|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
33307704|NCT00833833|101021498|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
33307705|NCT00833833|101021499|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
33307706|NCT00833833|101021500|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
33307707|NCT00833833|101021501|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
33307708|NCT00833833|101021496|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33307709|NCT00833833|101021497|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33307710|NCT00833833|101021498|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33307711|NCT00833833|101021499|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
33307712|NCT00833833|101021500|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
33307713|NCT00833833|101021501|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
33307714|NCT00833833|101021496|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
33307715|NCT00833833|101021497|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
33307716|NCT00833833|101021498|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
33307717|NCT00833833|101021499|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
33307718|NCT00833833|101021500|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
33307719|NCT00833833|101021501|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
33191897|NCT01516879|100608470|FG000|Overall Study|Other|5|||
33191898|NCT01516879|100608471|FG001|Overall Study|Other|10|||
33307720|NCT00833833|101021496|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
33307721|NCT00833833|101021497|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
33307722|NCT00833833|101021498|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
33191899|NCT00589108|100608480|FG000|Overall Study|Lost to Follow-up|1|||
33191900|NCT00589108|100608481|FG001|Overall Study|Lost to Follow-up|1|||
33191901|NCT00589108|100608482|FG002|Overall Study|Lost to Follow-up|1|||
33307723|NCT00833833|101021499|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
33307724|NCT00833833|101021500|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
33307725|NCT00833833|101021501|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
33307726|NCT00833833|101021496|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
33307727|NCT00833833|101021497|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
33307728|NCT00833833|101021498|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
33307729|NCT00833833|101021499|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
33307730|NCT00833833|101021500|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
33307731|NCT00833833|101021501|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
33307732|NCT02516332|101021502|FG000|Overall Study|Withdrawal by Subject|2|||
33307733|NCT02516332|101021503|FG001|Overall Study|Withdrawal by Subject|1|||
33307734|NCT02516332|101021504|FG002|Overall Study|Withdrawal by Subject|2|||
33307735|NCT04279392|101021512|FG000|Overall Study|Physician Decision|1|||
33307736|NCT04279392|101021513|FG001|Overall Study|Physician Decision|0|||
33307737|NCT00998335|101021527|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
33307738|NCT00998335|101021528|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
33307739|NCT00744757|101021530|FG000|Overall Study|Objective disease progression|7|||
33307740|NCT00744757|101021530|FG000|Overall Study|Physician Decision|5|||
33307741|NCT00744757|101021530|FG000|Overall Study|Withdrawal by Subject|1|||
33307742|NCT00744757|101021530|FG000|Overall Study|Death|6|||
33307743|NCT00744757|101021530|FG000|Overall Study|Adverse Event|2|||
33307744|NCT00166712|101021531|FG000|Overall Study|Death|0|||
33307745|NCT00166712|101021532|FG001|Overall Study|Death|1|||
33307746|NCT00166712|101021531|FG000|Overall Study|Adverse Event|1|||
33307747|NCT00166712|101021532|FG001|Overall Study|Adverse Event|0|||
33307748|NCT00166712|101021531|FG000|Overall Study|Withdrawal by Subject|1|||
33307749|NCT00166712|101021532|FG001|Overall Study|Withdrawal by Subject|2|||
33307750|NCT00166712|101021531|FG000|Overall Study|Physician Decision|0|||
33307751|NCT00166712|101021532|FG001|Overall Study|Physician Decision|2|||
33307752|NCT04602221|101021533|FG000|Overall Study|Discontinuation of trial treatment|0|||
33307753|NCT04602221|101021534|FG001|Overall Study|Discontinuation of trial treatment|0|||
33307754|NCT04602221|101021535|FG002|Overall Study|Discontinuation of trial treatment|1|||
33307755|NCT04602221|101021536|FG003|Overall Study|Discontinuation of trial treatment|0|||
33307756|NCT04602221|101021537|FG004|Overall Study|Discontinuation of trial treatment|0|||
33307757|NCT04602221|101021538|FG005|Overall Study|Discontinuation of trial treatment|0|||
33307758|NCT04602221|101021539|FG006|Overall Study|Discontinuation of trial treatment|0|||
33307759|NCT04602221|101021540|FG007|Overall Study|Discontinuation of trial treatment|0|||
33191902|NCT00589108|100608480|FG000|Overall Study|Death|3|||
33191903|NCT00589108|100608481|FG001|Overall Study|Death|3|||
33191904|NCT00589108|100608482|FG002|Overall Study|Death|4|||
33307760|NCT04602221|101021541|FG008|Overall Study|Discontinuation of trial treatment|0|||
33307761|NCT04602221|101021542|FG009|Overall Study|Discontinuation of trial treatment|0|||
33307762|NCT04602221|101021543|FG010|Overall Study|Discontinuation of trial treatment|0|||
33307763|NCT04602221|101021544|FG011|Overall Study|Discontinuation of trial treatment|0|||
33307764|NCT04602221|101021545|FG012|Overall Study|Discontinuation of trial treatment|0|||
33307765|NCT04602221|101021546|FG013|Overall Study|Discontinuation of trial treatment|0|||
33307766|NCT04602221|101021547|FG014|Overall Study|Discontinuation of trial treatment|0|||
33307767|NCT04602221|101021548|FG015|Overall Study|Discontinuation of trial treatment|0|||
33307768|NCT04602221|101021549|FG016|Overall Study|Discontinuation of trial treatment|0|||
33307769|NCT04602221|101021550|FG017|Overall Study|Discontinuation of trial treatment|0|||
33307770|NCT04602221|101021533|FG000|Overall Study|Other than listed|0|||
33307771|NCT04602221|101021534|FG001|Overall Study|Other than listed|0|||
33307772|NCT04602221|101021535|FG002|Overall Study|Other than listed|0|||
33307773|NCT04602221|101021536|FG003|Overall Study|Other than listed|0|||
33307774|NCT04602221|101021537|FG004|Overall Study|Other than listed|0|||
33307775|NCT04602221|101021538|FG005|Overall Study|Other than listed|0|||
33307776|NCT04602221|101021539|FG006|Overall Study|Other than listed|0|||
33307777|NCT04602221|101021540|FG007|Overall Study|Other than listed|0|||
33307778|NCT04602221|101021541|FG008|Overall Study|Other than listed|0|||
33307779|NCT04602221|101021542|FG009|Overall Study|Other than listed|0|||
33307780|NCT04602221|101021543|FG010|Overall Study|Other than listed|0|||
33307781|NCT04602221|101021544|FG011|Overall Study|Other than listed|0|||
33307782|NCT04602221|101021545|FG012|Overall Study|Other than listed|0|||
33307783|NCT04602221|101021546|FG013|Overall Study|Other than listed|0|||
33307784|NCT04602221|101021547|FG014|Overall Study|Other than listed|0|||
33307785|NCT04602221|101021548|FG015|Overall Study|Other than listed|1|||
33307786|NCT04602221|101021549|FG016|Overall Study|Other than listed|0|||
33307787|NCT04602221|101021550|FG017|Overall Study|Other than listed|1|||
33307788|NCT04602221|101021533|FG000|Overall Study|Withdrawal by Subject|0|||
33307789|NCT04602221|101021534|FG001|Overall Study|Withdrawal by Subject|0|||
33191905|NCT02141516|100608483|FG000|Overall Study|Adverse Event|0|||
33307790|NCT04602221|101021535|FG002|Overall Study|Withdrawal by Subject|0|||
33393777|NCT03073200|101328521|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
33191906|NCT02141516|100608484|FG001|Overall Study|Adverse Event|1|||
33307791|NCT04602221|101021536|FG003|Overall Study|Withdrawal by Subject|0|||
33307792|NCT04602221|101021537|FG004|Overall Study|Withdrawal by Subject|0|||
33500610|NCT03852472|101724652|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
33500611|NCT03852472|101724653|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
33500612|NCT03852472|101724654|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
33191907|NCT02141516|100608485|FG002|Overall Study|Adverse Event|0|||
33500613|NCT03852472|101724655|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
33500614|NCT03852472|101724651|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
33500615|NCT03852472|101724652|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
33500616|NCT03852472|101724653|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
33500617|NCT03852472|101724654|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
33307793|NCT04602221|101021538|FG005|Overall Study|Withdrawal by Subject|0|||
33307794|NCT04602221|101021539|FG006|Overall Study|Withdrawal by Subject|0|||
33307795|NCT04602221|101021540|FG007|Overall Study|Withdrawal by Subject|0|||
33307796|NCT04602221|101021541|FG008|Overall Study|Withdrawal by Subject|0|||
33307797|NCT04602221|101021542|FG009|Overall Study|Withdrawal by Subject|0|||
33307798|NCT04602221|101021543|FG010|Overall Study|Withdrawal by Subject|0|||
33307799|NCT04602221|101021544|FG011|Overall Study|Withdrawal by Subject|0|||
33307800|NCT04602221|101021545|FG012|Overall Study|Withdrawal by Subject|1|||
33307801|NCT04602221|101021546|FG013|Overall Study|Withdrawal by Subject|0|||
33307802|NCT04602221|101021547|FG014|Overall Study|Withdrawal by Subject|0|||
33307803|NCT04602221|101021548|FG015|Overall Study|Withdrawal by Subject|0|||
33307804|NCT04602221|101021549|FG016|Overall Study|Withdrawal by Subject|0|||
33307805|NCT04602221|101021550|FG017|Overall Study|Withdrawal by Subject|0|||
33307806|NCT04602221|101021533|FG000|Overall Study|Lost to Follow-up|0|||
33307807|NCT04602221|101021534|FG001|Overall Study|Lost to Follow-up|0|||
33307808|NCT04602221|101021535|FG002|Overall Study|Lost to Follow-up|0|||
33307809|NCT04602221|101021536|FG003|Overall Study|Lost to Follow-up|0|||
33307810|NCT04602221|101021537|FG004|Overall Study|Lost to Follow-up|0|||
33307811|NCT04602221|101021538|FG005|Overall Study|Lost to Follow-up|1|||
33307812|NCT04602221|101021539|FG006|Overall Study|Lost to Follow-up|0|||
33307813|NCT04602221|101021540|FG007|Overall Study|Lost to Follow-up|0|||
33307814|NCT04602221|101021541|FG008|Overall Study|Lost to Follow-up|0|||
33307815|NCT04602221|101021542|FG009|Overall Study|Lost to Follow-up|0|||
33307816|NCT04602221|101021543|FG010|Overall Study|Lost to Follow-up|0|||
33307817|NCT04602221|101021544|FG011|Overall Study|Lost to Follow-up|0|||
33307818|NCT04602221|101021545|FG012|Overall Study|Lost to Follow-up|0|||
33307819|NCT04602221|101021546|FG013|Overall Study|Lost to Follow-up|0|||
33307820|NCT04602221|101021547|FG014|Overall Study|Lost to Follow-up|0|||
33307821|NCT04602221|101021548|FG015|Overall Study|Lost to Follow-up|0|||
33307822|NCT04602221|101021549|FG016|Overall Study|Lost to Follow-up|0|||
33307823|NCT04602221|101021550|FG017|Overall Study|Lost to Follow-up|0|||
33500618|NCT03852472|101724655|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
33500619|NCT03852472|101724651|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
33500620|NCT03852472|101724652|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
33500621|NCT03852472|101724653|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
33601477|NCT00657150|102091949|FG000|Overall Study|Withdrawal by Subject|51|||
33601478|NCT00657150|102091950|FG001|Overall Study|Withdrawal by Subject|36|||
33601479|NCT00657150|102091949|FG000|Overall Study|Other|38|||
33191908|NCT02141516|100608483|FG000|Overall Study|Lost to Follow-up|0|||
33191909|NCT02141516|100608484|FG001|Overall Study|Lost to Follow-up|1|||
33307824|NCT00928018|101021551|FG000|Overall Study|Withdrawal by Subject|1|||
33307825|NCT00928018|101021552|FG001|Overall Study|Withdrawal by Subject|0|||
33307826|NCT00700427|101021557|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
33307827|NCT00700427|101021558|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
33307828|NCT00700427|101021559|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
33307829|NCT00700427|101021560|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
33601480|NCT00657150|102091950|FG001|Overall Study|Other|38|||
33601481|NCT00657150|102091949|FG000|Treatment|Adverse Event|60|||
33601482|NCT00657150|102091950|FG001|Treatment|Adverse Event|53|||
33601483|NCT00657150|102091949|FG000|Treatment|Non-compliant with protocol|10|||
33601484|NCT00657150|102091950|FG001|Treatment|Non-compliant with protocol|9|||
33601485|NCT00657150|102091949|FG000|Treatment|Lost to Follow-up|1|||
33601486|NCT00657150|102091950|FG001|Treatment|Lost to Follow-up|0|||
33307830|NCT00700427|101021561|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
33307831|NCT00700427|101021557|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
33307832|NCT00700427|101021558|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
33601487|NCT00657150|102091949|FG000|Treatment|Withdrawal by Subject|23|||
33601488|NCT00657150|102091950|FG001|Treatment|Withdrawal by Subject|20|||
33601489|NCT00657150|102091949|FG000|Treatment|Other|13|||
33601490|NCT00657150|102091950|FG001|Treatment|Other|15|||
33191910|NCT02141516|100608485|FG002|Overall Study|Lost to Follow-up|0|||
33191911|NCT02141516|100608483|FG000|Overall Study|Other|0|||
33191912|NCT02141516|100608484|FG001|Overall Study|Other|3|||
33191913|NCT02141516|100608485|FG002|Overall Study|Other|0|||
33191914|NCT01205165|100608491|FG000|Overall Study|Lost to Follow-up|2|||
33191915|NCT00720876|100608492|FG000|Overall Study|found to be ineligible after starting tx|2|||
33191916|NCT01234467|100608494|FG000|Overall Study|Adverse Event|3|||
33191917|NCT01234467|100608494|FG000|Overall Study|Death|2|||
33191918|NCT01234467|100608494|FG000|Overall Study|Withdrawal by Subject|2|||
33191919|NCT01234467|100608494|FG000|Overall Study|Disease Progression|2|||
33307833|NCT00700427|101021559|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
33307834|NCT00700427|101021560|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
33307835|NCT00700427|101021561|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
33307836|NCT00700427|101021557|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
33191920|NCT01234467|100608494|FG000|Overall Study|Clinical deterioration|1|||
33191921|NCT01234467|100608494|FG000|Overall Study|Physician Decision|1|||
33307837|NCT00700427|101021558|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
33307838|NCT00700427|101021559|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
33307839|NCT00700427|101021560|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
33307840|NCT00700427|101021561|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
33307841|NCT00700427|101021557|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
33307842|NCT00700427|101021558|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
33307843|NCT00700427|101021559|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
33307844|NCT00700427|101021560|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
33307845|NCT00700427|101021561|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
33307846|NCT00700427|101021557|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
33307847|NCT00700427|101021558|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
33307848|NCT00700427|101021559|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
33307849|NCT00700427|101021560|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
33307850|NCT00700427|101021561|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
33307851|NCT00700427|101021557|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
33307852|NCT00700427|101021558|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
33307853|NCT00700427|101021559|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
33307854|NCT00700427|101021560|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
33307855|NCT00700427|101021561|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
33307856|NCT00700427|101021557|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
33307857|NCT00700427|101021558|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
33307858|NCT00700427|101021559|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
33307859|NCT00700427|101021560|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
33307860|NCT00700427|101021561|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
33307861|NCT00700427|101021557|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
33307862|NCT00700427|101021558|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
33307863|NCT00700427|101021559|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
33307864|NCT00700427|101021560|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
33307865|NCT00700427|101021561|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
33307866|NCT00700427|101021557|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
33307867|NCT00700427|101021558|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
33307868|NCT00700427|101021559|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
33307869|NCT00700427|101021560|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
33307870|NCT00700427|101021561|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
33307871|NCT00700427|101021557|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
33307872|NCT00700427|101021558|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
33307873|NCT00700427|101021559|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
33307874|NCT00700427|101021560|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
33307875|NCT00700427|101021561|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
33307876|NCT00700427|101021557|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
33307877|NCT00700427|101021558|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
33307878|NCT00700427|101021559|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
33307879|NCT00700427|101021560|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
33307880|NCT00700427|101021561|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
33307881|NCT00700427|101021557|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
33307882|NCT00700427|101021558|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
33307883|NCT00700427|101021559|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
33307884|NCT00700427|101021560|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
33307885|NCT00700427|101021561|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
33307886|NCT00700427|101021557|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
33307887|NCT00700427|101021558|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
33307888|NCT00700427|101021559|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
33307889|NCT00700427|101021560|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
33307890|NCT00700427|101021561|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
33307891|NCT00700427|101021557|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
33307892|NCT00700427|101021558|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
33307893|NCT00700427|101021559|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
33307894|NCT00700427|101021560|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
33307895|NCT00700427|101021561|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
33307896|NCT00700427|101021557|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
33307897|NCT00700427|101021558|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
33307898|NCT00700427|101021559|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
33307899|NCT00700427|101021560|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
33307900|NCT00700427|101021561|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
33307901|NCT00700427|101021557|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
33307902|NCT00700427|101021558|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
33307903|NCT00700427|101021559|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
33307904|NCT00700427|101021560|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
33307905|NCT00700427|101021561|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
33307906|NCT00700427|101021557|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
33307907|NCT00700427|101021558|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
33307908|NCT00700427|101021559|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
33393778|NCT03073200|101328522|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
33393779|NCT03073200|101328523|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
33393780|NCT03073200|101328524|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
33393781|NCT03073200|101328525|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
33307909|NCT00700427|101021560|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
33393782|NCT03073200|101328511|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33307910|NCT00700427|101021561|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
33307911|NCT00700427|101021557|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
33307912|NCT00700427|101021558|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
33307913|NCT00700427|101021559|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
33307914|NCT00700427|101021560|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
33307915|NCT00700427|101021561|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
33307916|NCT00700427|101021557|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
33307917|NCT00700427|101021558|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
33307918|NCT00700427|101021559|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
33307919|NCT00700427|101021560|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
33307920|NCT00700427|101021561|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
33307921|NCT00700427|101021557|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
33307922|NCT00700427|101021558|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
33307923|NCT00700427|101021559|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
33307924|NCT00700427|101021560|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
33307925|NCT00700427|101021561|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
33307926|NCT00700427|101021557|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
33307927|NCT00700427|101021558|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
33307928|NCT00700427|101021559|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
33307929|NCT00700427|101021560|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
33307930|NCT00700427|101021561|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
33307931|NCT00700427|101021557|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
33307932|NCT00700427|101021558|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
33307933|NCT00700427|101021559|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
33307934|NCT00700427|101021560|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
33307935|NCT00700427|101021561|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
33307936|NCT00700427|101021557|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
33307937|NCT00700427|101021558|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
33307938|NCT00700427|101021559|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
33307939|NCT00700427|101021560|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
33307940|NCT00700427|101021561|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
33307941|NCT00700427|101021557|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
33307942|NCT00700427|101021558|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
33307943|NCT00700427|101021559|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
33307944|NCT00700427|101021560|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
33307945|NCT00700427|101021561|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
33307946|NCT00700427|101021557|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
33307947|NCT00700427|101021558|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
33307948|NCT00700427|101021559|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
33307949|NCT00700427|101021560|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
33307950|NCT00700427|101021561|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
33307951|NCT00700427|101021557|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
33307952|NCT00700427|101021558|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
33307953|NCT00700427|101021559|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
33307954|NCT00700427|101021560|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
33307955|NCT00700427|101021561|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
33307956|NCT00700427|101021557|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
33307957|NCT00700427|101021558|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
33307958|NCT00700427|101021559|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
33307959|NCT00700427|101021560|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
33307960|NCT00700427|101021561|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
33307961|NCT00700427|101021557|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
33307962|NCT00700427|101021558|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
33307963|NCT00700427|101021559|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
33307964|NCT00700427|101021560|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
33307965|NCT00700427|101021561|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
33601491|NCT02776033|102091951|FG000|Overall Study|Withdrawal by Subject|0|||
33601492|NCT02776033|102091952|FG001|Overall Study|Withdrawal by Subject|0|||
33601493|NCT02776033|102091953|FG002|Overall Study|Withdrawal by Subject|2|||
33601494|NCT02776033|102091951|FG000|Overall Study|Physician Decision|2|||
33601495|NCT02776033|102091952|FG001|Overall Study|Physician Decision|0|||
33601496|NCT02776033|102091953|FG002|Overall Study|Physician Decision|0|||
33307966|NCT00700427|101021557|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
33307967|NCT00700427|101021558|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
33601497|NCT02776033|102091951|FG000|Overall Study|Lost to Follow-up|1|||
33307968|NCT00700427|101021559|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
33307969|NCT00700427|101021560|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
33307970|NCT00700427|101021561|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
33307971|NCT00700427|101021557|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
33307972|NCT00700427|101021558|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
33307973|NCT00700427|101021559|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
33307974|NCT00700427|101021560|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
33307975|NCT00700427|101021561|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
33307976|NCT00700427|101021557|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
33307977|NCT00700427|101021558|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
33307978|NCT00700427|101021559|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
33307979|NCT00700427|101021560|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
33307980|NCT00700427|101021561|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
33307981|NCT00700427|101021557|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
33307982|NCT00700427|101021558|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
33307983|NCT00700427|101021559|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
33307984|NCT00700427|101021560|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
33307985|NCT00700427|101021561|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
33307986|NCT00700427|101021557|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
33307987|NCT00700427|101021558|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
33307988|NCT00700427|101021559|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
33307989|NCT00700427|101021560|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
33307990|NCT00700427|101021561|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
33307991|NCT00700427|101021557|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
33307992|NCT00700427|101021558|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
33307993|NCT00700427|101021559|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
33307994|NCT00700427|101021560|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
33307995|NCT00700427|101021561|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
33307996|NCT00700427|101021557|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
33307997|NCT00700427|101021558|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
33307998|NCT00700427|101021559|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
33307999|NCT00700427|101021560|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
33308000|NCT00700427|101021561|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
33308001|NCT00700427|101021557|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
33308002|NCT00700427|101021558|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
33308003|NCT00700427|101021559|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
33308004|NCT00700427|101021560|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
33308005|NCT00700427|101021561|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
33308006|NCT00700427|101021557|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
33308007|NCT00700427|101021558|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
33308008|NCT00700427|101021559|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
33308009|NCT00700427|101021560|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
33308010|NCT00700427|101021561|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
33308011|NCT00700427|101021557|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
33308012|NCT00700427|101021558|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
33308013|NCT00700427|101021559|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
33308014|NCT00700427|101021560|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
33308015|NCT00700427|101021561|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
33308016|NCT03412747|101021565|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
33308017|NCT03412747|101021566|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
33308018|NCT03412747|101021567|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
33308019|NCT03412747|101021565|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
33308020|NCT03412747|101021566|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
33308021|NCT03412747|101021567|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
33308022|NCT03412747|101021565|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
33308023|NCT03412747|101021566|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
33308024|NCT03412747|101021567|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
33308025|NCT03412747|101021565|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
33308026|NCT03412747|101021566|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
33308027|NCT03412747|101021567|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
33308028|NCT03412747|101021565|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
33308029|NCT03412747|101021566|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
33308030|NCT03412747|101021567|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
33393783|NCT03073200|101328512|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33393784|NCT03073200|101328513|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33601498|NCT02776033|102091952|FG001|Overall Study|Lost to Follow-up|0|||
33601499|NCT02776033|102091953|FG002|Overall Study|Lost to Follow-up|0|||
33393785|NCT03073200|101328514|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33393786|NCT03073200|101328515|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33393787|NCT03073200|101328516|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33393788|NCT03073200|101328517|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33393789|NCT03073200|101328518|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33308031|NCT03412747|101021565|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
33308032|NCT03412747|101021566|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
33308033|NCT03412747|101021567|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
33308034|NCT03412747|101021565|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
33308035|NCT03412747|101021566|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
33308036|NCT03412747|101021567|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
33308037|NCT03412747|101021565|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
33393790|NCT03073200|101328519|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33393791|NCT03073200|101328520|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33393792|NCT03073200|101328521|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33393793|NCT03073200|101328522|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33393794|NCT03073200|101328523|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33393795|NCT03073200|101328524|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
33393796|NCT03073200|101328525|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33393797|NCT03073200|101328511|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33393798|NCT03073200|101328512|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33393799|NCT03073200|101328513|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33393800|NCT03073200|101328514|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33393801|NCT03073200|101328515|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33393802|NCT03073200|101328516|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33393803|NCT03073200|101328517|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33393804|NCT03073200|101328518|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33308038|NCT03412747|101021566|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
33308039|NCT03412747|101021567|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
33308040|NCT03412747|101021565|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
33308041|NCT03412747|101021566|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
33308042|NCT03412747|101021567|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
33308043|NCT03412747|101021565|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
33308044|NCT03412747|101021566|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
33308045|NCT03412747|101021567|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
33308046|NCT03412747|101021565|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
33308047|NCT03412747|101021566|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
33308048|NCT03412747|101021567|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
33601500|NCT02776033|102091951|FG000|Overall Study|Adverse Event|1|||
33601501|NCT02776033|102091952|FG001|Overall Study|Adverse Event|2|||
33393805|NCT03073200|101328519|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33393806|NCT03073200|101328520|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33393807|NCT03073200|101328521|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33393808|NCT03073200|101328522|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33393809|NCT03073200|101328523|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33393810|NCT03073200|101328524|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
33393811|NCT03073200|101328525|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
33393812|NCT03073200|101328511|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33393813|NCT03073200|101328512|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33393814|NCT03073200|101328513|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33393815|NCT03073200|101328514|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33393816|NCT03073200|101328515|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33393817|NCT03073200|101328516|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33393818|NCT03073200|101328517|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33393819|NCT03073200|101328518|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33393820|NCT03073200|101328519|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33393821|NCT03073200|101328520|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33393822|NCT03073200|101328521|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33393823|NCT03073200|101328522|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33393824|NCT03073200|101328523|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33393825|NCT03073200|101328524|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
33393826|NCT03073200|101328525|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33500622|NCT03852472|101724654|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
33500623|NCT03852472|101724655|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
33601502|NCT02776033|102091953|FG002|Overall Study|Adverse Event|0|||
33601503|NCT02124772|102091956|FG000|Overall Study|Lack of Efficacy|2|||
33393827|NCT03073200|101328511|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33393828|NCT03073200|101328512|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33393829|NCT03073200|101328513|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33393830|NCT03073200|101328514|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33393831|NCT03073200|101328515|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33393832|NCT03073200|101328516|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33393833|NCT03073200|101328517|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33393834|NCT03073200|101328518|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33393835|NCT03073200|101328519|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33393836|NCT03073200|101328520|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33393837|NCT03073200|101328521|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33393838|NCT03073200|101328522|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33393839|NCT03073200|101328523|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33393840|NCT03073200|101328524|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
33393841|NCT03073200|101328525|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
33393842|NCT03073200|101328511|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33393843|NCT03073200|101328512|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33393844|NCT03073200|101328513|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33393845|NCT03073200|101328514|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33393846|NCT03073200|101328515|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33393847|NCT03073200|101328516|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33393848|NCT03073200|101328517|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33393849|NCT03073200|101328518|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33393850|NCT03073200|101328519|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33393851|NCT03073200|101328520|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33393852|NCT03073200|101328521|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33393853|NCT03073200|101328522|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33393854|NCT03073200|101328523|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33393855|NCT03073200|101328524|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
33393856|NCT03073200|101328525|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
33393857|NCT03073200|101328511|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33308049|NCT03412747|101021565|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
33308050|NCT03412747|101021566|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
33393858|NCT03073200|101328512|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33308051|NCT03412747|101021567|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
33308052|NCT03412747|101021565|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
33308053|NCT03412747|101021566|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
33308054|NCT03412747|101021567|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
33308055|NCT03412747|101021565|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
33308056|NCT03412747|101021566|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
33308057|NCT03412747|101021567|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
33308058|NCT03412747|101021565|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
33308059|NCT03412747|101021566|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
33308060|NCT03412747|101021567|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
33308061|NCT03412747|101021565|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
33308062|NCT03412747|101021566|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
33308063|NCT03412747|101021567|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
33308064|NCT00979134|101021569|FG000|Overall Study|Disease progression|18|||
33308065|NCT00979134|101021570|FG001|Overall Study|Disease progression|2|||
33308066|NCT00979134|101021571|FG002|Overall Study|Disease progression|5|||
33308067|NCT00979134|101021569|FG000|Overall Study|Adverse Event|0|||
33308068|NCT00979134|101021570|FG001|Overall Study|Adverse Event|0|||
33308069|NCT00979134|101021571|FG002|Overall Study|Adverse Event|2|||
33308070|NCT00979134|101021569|FG000|Overall Study|Withdrawal by Subject|1|||
33308071|NCT00979134|101021570|FG001|Overall Study|Withdrawal by Subject|1|||
33308072|NCT00979134|101021571|FG002|Overall Study|Withdrawal by Subject|2|||
33308073|NCT00979134|101021569|FG000|Overall Study|Lost to Follow-up|2|||
33308074|NCT00979134|101021570|FG001|Overall Study|Lost to Follow-up|2|||
33308075|NCT00979134|101021571|FG002|Overall Study|Lost to Follow-up|0|||
33308076|NCT00979134|101021569|FG000|Overall Study|Death|4|||
33308077|NCT00979134|101021570|FG001|Overall Study|Death|0|||
33393859|NCT03073200|101328513|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33393860|NCT03073200|101328514|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33393861|NCT03073200|101328515|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33308078|NCT00979134|101021571|FG002|Overall Study|Death|26|||
33308079|NCT00979134|101021569|FG000|Overall Study|Other|8|||
33308080|NCT00979134|101021570|FG001|Overall Study|Other|1|||
33308081|NCT00979134|101021571|FG002|Overall Study|Other|5|||
33308082|NCT00735475|101021572|FG000|Overall Study|Adverse Event|0|||
33308083|NCT00735475|101021573|FG001|Overall Study|Adverse Event|1|||
33308084|NCT00735475|101021572|FG000|Overall Study|Death|1|||
33308085|NCT00735475|101021573|FG001|Overall Study|Death|1|||
33308086|NCT00735475|101021572|FG000|Overall Study|Lost to Follow-up|3|||
33308087|NCT00735475|101021573|FG001|Overall Study|Lost to Follow-up|3|||
33308088|NCT00735475|101021572|FG000|Overall Study|Physician Decision|0|||
33308089|NCT00735475|101021573|FG001|Overall Study|Physician Decision|1|||
33308090|NCT00735475|101021572|FG000|Overall Study|Withdrawal by Subject|4|||
33308091|NCT00735475|101021573|FG001|Overall Study|Withdrawal by Subject|5|||
33308092|NCT04075994|101021574|FG000|Overall Study|Withdrawal by Subject|8|||
33308093|NCT04075994|101021575|FG001|Overall Study|Withdrawal by Subject|9|||
33308094|NCT04075994|101021574|FG000|Overall Study|Adverse Event|2|||
33308095|NCT04075994|101021575|FG001|Overall Study|Adverse Event|2|||
33308096|NCT04075994|101021574|FG000|Overall Study|Investigator withdrew|3|||
33308097|NCT04075994|101021575|FG001|Overall Study|Investigator withdrew|1|||
33308098|NCT04725240|101021576|FG000|Overall Study|Adverse Event|2|||
33308099|NCT00923260|101021583|FG000|Overall Study|Lost to Follow-up|1|||
33308100|NCT00923260|101021584|FG001|Overall Study|Lost to Follow-up|1|||
33308101|NCT01844687|101021585|FG000|Visit 1|Protocol Violation|3|||
33308102|NCT01844687|101021585|FG000|Visit 1|Lost to Follow-up|5|||
33308103|NCT01844687|101021585|FG000|Visit 2|Withdrawal by Subject|1|||
33308104|NCT01844687|101021585|FG000|Visit 2|Protocol Violation|1|||
33308105|NCT01844687|101021585|FG000|Visit 3|Lost to Follow-up|1|||
33308106|NCT01844687|101021585|FG000|Visit 3|Withdrawal by Subject|3|||
33308107|NCT01844687|101021585|FG000|Visit 3|child care problems|1|||
33308108|NCT01844687|101021585|FG000|Visit 4|Pregnancy|1|||
33308109|NCT01844687|101021585|FG000|Visit 4|Lost to Follow-up|1|||
33308110|NCT01844687|101021585|FG000|Visit 4|Withdrawal by Subject|2|||
33308111|NCT01004848|101021589|FG000|Overall Study|Lost to Follow-up|55|||
33308112|NCT01004848|101021590|FG001|Overall Study|Lost to Follow-up|45|||
33308113|NCT01281969|101021595|FG000|Overall Study|not randomized didn't meet criteria|0|||
33308114|NCT01281969|101021596|FG001|Overall Study|not randomized didn't meet criteria|0|||
33308115|NCT01281969|101021597|FG002|Overall Study|not randomized didn't meet criteria|7|||
33308116|NCT01281969|101021595|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
33308117|NCT01281969|101021596|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
33393862|NCT03073200|101328516|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33393863|NCT03073200|101328517|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33393864|NCT03073200|101328518|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33393865|NCT03073200|101328519|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33393866|NCT03073200|101328520|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33393867|NCT03073200|101328521|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33393868|NCT03073200|101328522|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33393869|NCT03073200|101328523|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33393870|NCT03073200|101328524|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
33393871|NCT03073200|101328525|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33393872|NCT03073200|101328511|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33393873|NCT03073200|101328512|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33393874|NCT03073200|101328513|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33393875|NCT03073200|101328514|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33393876|NCT03073200|101328515|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33393877|NCT03073200|101328516|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33393878|NCT03073200|101328517|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33393879|NCT03073200|101328518|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33393880|NCT03073200|101328519|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33393881|NCT03073200|101328520|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33393882|NCT03073200|101328521|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33500624|NCT03852472|101724651|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
33500625|NCT03852472|101724652|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
33601504|NCT02124772|102091957|FG001|Overall Study|Lack of Efficacy|0|||
33601505|NCT02124772|102091958|FG002|Overall Study|Lack of Efficacy|0|||
33308118|NCT01281969|101021597|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
33308119|NCT01281969|101021595|FG000|Overall Study|not randomized, child consent not given|0|||
33308120|NCT01281969|101021596|FG001|Overall Study|not randomized, child consent not given|0|||
33308121|NCT01281969|101021597|FG002|Overall Study|not randomized, child consent not given|2|||
33308122|NCT00903006|101021602|FG000|Overall Study|Withdrawal by Subject|2|||
33308123|NCT00903006|101021603|FG001|Overall Study|Withdrawal by Subject|0|||
33308124|NCT00903006|101021604|FG002|Overall Study|Withdrawal by Subject|0|||
33308125|NCT00903006|101021605|FG003|Overall Study|Withdrawal by Subject|0|||
33308126|NCT00903006|101021602|FG000|Overall Study|Progressive Disease|0|||
33500626|NCT03852472|101724653|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
33393883|NCT03073200|101328522|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33308127|NCT00903006|101021603|FG001|Overall Study|Progressive Disease|3|||
33308128|NCT00903006|101021604|FG002|Overall Study|Progressive Disease|1|||
33308129|NCT00903006|101021605|FG003|Overall Study|Progressive Disease|0|||
33308130|NCT00895154|101021606|FG000|Overall Study|Lost to Follow-up|1|||
33308131|NCT00895154|101021607|FG001|Overall Study|Lost to Follow-up|1|||
33308132|NCT00895154|101021606|FG000|Overall Study|Withdrawal by Subject|0|||
33308133|NCT00895154|101021607|FG001|Overall Study|Withdrawal by Subject|1|||
33308134|NCT02047903|101021608|FG000|Overall Study|Adverse Event|14|||
33308135|NCT02047903|101021608|FG000|Overall Study|Serious adverse event|10|||
33308136|NCT02047903|101021608|FG000|Overall Study|Withdrawal by Subject|16|||
33308137|NCT02047903|101021608|FG000|Overall Study|Lost to Follow-up|4|||
33308138|NCT02047903|101021608|FG000|Overall Study|Reason not listed|6|||
33308139|NCT02047903|101021608|FG000|Overall Study|Not Treated|9|||
33308140|NCT03702231|101021609|FG000|Overall Study|Withdrawal by Subject|1|||
33308141|NCT03702231|101021610|FG001|Overall Study|Withdrawal by Subject|0|||
33308142|NCT03702231|101021611|FG002|Overall Study|Withdrawal by Subject|0|||
33308143|NCT03702231|101021609|FG000|Overall Study|Protocol Violation|0|||
33308144|NCT03702231|101021610|FG001|Overall Study|Protocol Violation|0|||
33308145|NCT03702231|101021611|FG002|Overall Study|Protocol Violation|1|||
33308146|NCT03702231|101021609|FG000|Overall Study|Change in CLL Treatment|0|||
33308147|NCT03702231|101021610|FG001|Overall Study|Change in CLL Treatment|0|||
33308148|NCT03702231|101021611|FG002|Overall Study|Change in CLL Treatment|1|||
33308149|NCT03702231|101021609|FG000|Overall Study|COVID Pandemic|1|||
33308150|NCT03702231|101021610|FG001|Overall Study|COVID Pandemic|4|||
33308151|NCT03702231|101021611|FG002|Overall Study|COVID Pandemic|1|||
33308152|NCT03702231|101021609|FG000|Overall Study|Non-compliance|0|||
33308153|NCT03702231|101021610|FG001|Overall Study|Non-compliance|0|||
33308154|NCT03702231|101021611|FG002|Overall Study|Non-compliance|1|||
33308155|NCT03527550|101021612|FG000|Overall Study|Lost to Follow-up|4|||
33308156|NCT03527550|101021613|FG001|Overall Study|Lost to Follow-up|2|||
33308157|NCT03527550|101021612|FG000|Overall Study|Withdrawal by Subject|4|||
33308158|NCT03527550|101021613|FG001|Overall Study|Withdrawal by Subject|1|||
33308159|NCT03527550|101021612|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
33308160|NCT03527550|101021613|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
33308161|NCT03426605|101021620|FG000|Overall Study|AML relapse or progression|2|||
33308162|NCT03426605|101021621|FG001|Overall Study|AML relapse or progression|1|||
33308163|NCT03426605|101021622|FG002|Overall Study|AML relapse or progression|2|||
33308164|NCT03426605|101021623|FG003|Overall Study|AML relapse or progression|2|||
33308165|NCT03426605|101021620|FG000|Overall Study|Treatment failure|3|||
33308166|NCT03426605|101021621|FG001|Overall Study|Treatment failure|2|||
33308167|NCT03426605|101021622|FG002|Overall Study|Treatment failure|0|||
33308168|NCT03426605|101021623|FG003|Overall Study|Treatment failure|0|||
33308169|NCT03426605|101021620|FG000|Overall Study|Adverse Event|1|||
33308170|NCT03426605|101021621|FG001|Overall Study|Adverse Event|0|||
33308171|NCT03426605|101021622|FG002|Overall Study|Adverse Event|1|||
33308172|NCT03426605|101021623|FG003|Overall Study|Adverse Event|1|||
33308173|NCT03426605|101021620|FG000|Overall Study|Withdrawal by Subject|0|||
33308174|NCT03426605|101021621|FG001|Overall Study|Withdrawal by Subject|0|||
33308175|NCT03426605|101021622|FG002|Overall Study|Withdrawal by Subject|1|||
33308176|NCT03426605|101021623|FG003|Overall Study|Withdrawal by Subject|1|||
33308177|NCT01191268|101021624|FG000|Overall Study|Withdrawal by Subject|19|||
33308178|NCT01191268|101021625|FG001|Overall Study|Withdrawal by Subject|25|||
33308179|NCT01191268|101021626|FG002|Overall Study|Withdrawal by Subject|21|||
33308180|NCT01191268|101021624|FG000|Overall Study|Adverse Event|21|||
33308181|NCT01191268|101021625|FG001|Overall Study|Adverse Event|13|||
33308182|NCT01191268|101021626|FG002|Overall Study|Adverse Event|8|||
33308183|NCT01191268|101021624|FG000|Overall Study|Physician Decision|6|||
33308184|NCT01191268|101021625|FG001|Overall Study|Physician Decision|8|||
33308185|NCT01191268|101021626|FG002|Overall Study|Physician Decision|9|||
33308186|NCT01191268|101021624|FG000|Overall Study|Lost to Follow-up|8|||
33308187|NCT01191268|101021625|FG001|Overall Study|Lost to Follow-up|5|||
33308188|NCT01191268|101021626|FG002|Overall Study|Lost to Follow-up|9|||
33308189|NCT01191268|101021624|FG000|Overall Study|Entry Criteria Not Met|3|||
33308190|NCT01191268|101021625|FG001|Overall Study|Entry Criteria Not Met|1|||
33601506|NCT02124772|102091959|FG003|Overall Study|Lack of Efficacy|1|||
33601507|NCT02124772|102091960|FG004|Overall Study|Lack of Efficacy|2|||
33308191|NCT01191268|101021626|FG002|Overall Study|Entry Criteria Not Met|1|||
33308192|NCT01191268|101021624|FG000|Overall Study|Death|0|||
33308193|NCT01191268|101021625|FG001|Overall Study|Death|1|||
33308194|NCT01191268|101021626|FG002|Overall Study|Death|3|||
33308195|NCT01191268|101021624|FG000|Overall Study|Protocol Violation|1|||
33308196|NCT01191268|101021625|FG001|Overall Study|Protocol Violation|0|||
33601508|NCT02124772|102091961|FG005|Overall Study|Lack of Efficacy|3|||
33601509|NCT02124772|102091962|FG006|Overall Study|Lack of Efficacy|0|||
33601510|NCT02124772|102091963|FG007|Overall Study|Lack of Efficacy|2|||
33308197|NCT01191268|101021626|FG002|Overall Study|Protocol Violation|1|||
33308198|NCT01191268|101021624|FG000|Overall Study|Sponsor Decision|0|||
33308199|NCT01191268|101021625|FG001|Overall Study|Sponsor Decision|2|||
33308200|NCT01191268|101021626|FG002|Overall Study|Sponsor Decision|0|||
33308201|NCT01942785|101021627|FG000|Overall Study|Adverse Event|2|||
33308202|NCT01942785|101021627|FG000|Overall Study|Withdrawal by Subject|1|||
33308203|NCT01942785|101021627|FG000|Overall Study|Protocol Violation|1|||
33308204|NCT05543187|101021628|FG000|Overall Study|Ongoing|3|||
33308205|NCT05543187|101021629|FG001|Overall Study|Ongoing|2|||
33308206|NCT00844532|101021630|FG000|Overall Study|Death|16|||
33308207|NCT00844532|101021630|FG000|Overall Study|Withdrawal by Subject|16|||
33308208|NCT00844532|101021630|FG000|Overall Study|Lost to Follow-up|7|||
33308209|NCT00766363|101021631|FG000|Overall Study|Withdrawal by Subject|1|||
33308210|NCT00766363|101021632|FG001|Overall Study|Withdrawal by Subject|0|||
33308211|NCT00766363|101021633|FG002|Overall Study|Withdrawal by Subject|0|||
33308212|NCT00766363|101021634|FG003|Overall Study|Withdrawal by Subject|0|||
33308213|NCT00766363|101021631|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
33308214|NCT00766363|101021632|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
33308215|NCT00766363|101021633|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
33308216|NCT00766363|101021634|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
33308217|NCT02884908|101021635|FG000|Overall Study|Lost to Follow-up|13|||
33308218|NCT02884908|101021636|FG001|Overall Study|Lost to Follow-up|18|||
33308219|NCT04797650|101021637|FG000|Overall Study|Reason Not Specified|5|||
33308220|NCT04797650|101021638|FG001|Overall Study|Reason Not Specified|12|||
33308221|NCT04797650|101021639|FG002|Overall Study|Reason Not Specified|5|||
33308222|NCT04797650|101021637|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
33308223|NCT04797650|101021638|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
33308224|NCT04797650|101021639|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
33308225|NCT04797650|101021637|FG000|Overall Study|Lack of Efficacy|1|||
33308226|NCT04797650|101021638|FG001|Overall Study|Lack of Efficacy|0|||
33308227|NCT04797650|101021639|FG002|Overall Study|Lack of Efficacy|1|||
33308228|NCT04797650|101021637|FG000|Overall Study|Non-compliance with Study Drug|0|||
33308229|NCT04797650|101021638|FG001|Overall Study|Non-compliance with Study Drug|0|||
33308230|NCT04797650|101021639|FG002|Overall Study|Non-compliance with Study Drug|2|||
33308231|NCT04797650|101021637|FG000|Overall Study|Lost to Follow-up|4|||
33308232|NCT04797650|101021638|FG001|Overall Study|Lost to Follow-up|6|||
33308233|NCT04797650|101021639|FG002|Overall Study|Lost to Follow-up|1|||
33308234|NCT01993927|101021640|FG000|Overall Study|Case Report Forms Uncollected|18|||
33308235|NCT01993927|101021640|FG000|Overall Study|Protocol Violation|11|||
33308236|NCT02523599|101021641|FG000|Overall Study|Adverse Event|1|||
33308237|NCT02523599|101021642|FG001|Overall Study|Adverse Event|0|||
33308238|NCT02523599|101021641|FG000|Overall Study|Physician Decision|1|||
33308239|NCT02523599|101021642|FG001|Overall Study|Physician Decision|0|||
33308240|NCT02523599|101021641|FG000|Overall Study|Lost to Follow-up|4|||
33308241|NCT02523599|101021642|FG001|Overall Study|Lost to Follow-up|1|||
33308242|NCT02523599|101021641|FG000|Overall Study|Did not return for Day 30 visit|2|||
33308243|NCT02523599|101021642|FG001|Overall Study|Did not return for Day 30 visit|0|||
33308244|NCT01160289|101021643|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
33308245|NCT01160289|101021644|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
33308246|NCT01160289|101021645|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
33308247|NCT01160289|101021646|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
33308248|NCT01160289|101021647|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
33308249|NCT01160289|101021648|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
33308250|NCT01160289|101021643|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
33308251|NCT01160289|101021644|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
33308252|NCT01160289|101021645|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
33308253|NCT01160289|101021646|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
33308254|NCT01160289|101021647|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
33308255|NCT01160289|101021648|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
33308256|NCT01160289|101021643|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
33308257|NCT01160289|101021644|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
33308258|NCT01160289|101021645|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
33308259|NCT01160289|101021646|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
33308260|NCT01160289|101021647|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
33308261|NCT01160289|101021648|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
33308262|NCT01160289|101021643|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
33601511|NCT02124772|102091964|FG008|Overall Study|Lack of Efficacy|0|||
33308263|NCT01160289|101021644|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
33308264|NCT01160289|101021645|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
33308265|NCT01160289|101021646|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
33308266|NCT01160289|101021647|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
33308267|NCT01160289|101021648|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
33601512|NCT02124772|102091965|FG009|Overall Study|Lack of Efficacy|1|||
33601513|NCT02124772|102091966|FG010|Overall Study|Lack of Efficacy|0|||
33308268|NCT01160289|101021643|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
33308269|NCT01160289|101021644|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
33308270|NCT01160289|101021645|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
33308271|NCT01160289|101021646|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
33308272|NCT01160289|101021647|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
33308273|NCT01160289|101021648|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
33308274|NCT01160289|101021643|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
33308275|NCT01160289|101021644|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
33308276|NCT01160289|101021645|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
33308277|NCT01160289|101021646|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
33308278|NCT01160289|101021647|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
33308279|NCT01160289|101021648|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
33308280|NCT01160289|101021643|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
33308281|NCT01160289|101021644|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
33308282|NCT01160289|101021645|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
33308283|NCT01160289|101021646|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
33308284|NCT01160289|101021647|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
33308285|NCT01160289|101021648|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
33308286|NCT01160289|101021643|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
33308287|NCT01160289|101021644|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
33308288|NCT01160289|101021645|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
33308289|NCT01160289|101021646|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
33308290|NCT01160289|101021647|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
33308291|NCT01160289|101021648|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
33308292|NCT01160289|101021643|FG000|Post-Randomization Period|Adverse Event|0|||
33308293|NCT01160289|101021644|FG001|Post-Randomization Period|Adverse Event|4|||
33308294|NCT01160289|101021645|FG002|Post-Randomization Period|Adverse Event|4|||
33308295|NCT01160289|101021646|FG003|Post-Randomization Period|Adverse Event|2|||
33308296|NCT01160289|101021647|FG004|Post-Randomization Period|Adverse Event|0|||
33308297|NCT01160289|101021648|FG005|Post-Randomization Period|Adverse Event|0|||
33308298|NCT01160289|101021643|FG000|Post-Randomization Period|Death|0|||
33308299|NCT01160289|101021644|FG001|Post-Randomization Period|Death|0|||
33308300|NCT01160289|101021645|FG002|Post-Randomization Period|Death|0|||
33308301|NCT01160289|101021646|FG003|Post-Randomization Period|Death|1|||
33308302|NCT01160289|101021647|FG004|Post-Randomization Period|Death|0|||
33308303|NCT01160289|101021648|FG005|Post-Randomization Period|Death|0|||
33308304|NCT01160289|101021643|FG000|Post-Randomization Period|Lack of Efficacy|0|||
33308305|NCT01160289|101021644|FG001|Post-Randomization Period|Lack of Efficacy|1|||
33308306|NCT01160289|101021645|FG002|Post-Randomization Period|Lack of Efficacy|0|||
33308307|NCT01160289|101021646|FG003|Post-Randomization Period|Lack of Efficacy|3|||
33308308|NCT01160289|101021647|FG004|Post-Randomization Period|Lack of Efficacy|0|||
33308309|NCT01160289|101021648|FG005|Post-Randomization Period|Lack of Efficacy|0|||
33308310|NCT01160289|101021643|FG000|Post-Randomization Period|Lost to Follow-up|0|||
33308311|NCT01160289|101021644|FG001|Post-Randomization Period|Lost to Follow-up|3|||
33308312|NCT01160289|101021645|FG002|Post-Randomization Period|Lost to Follow-up|2|||
33308313|NCT01160289|101021646|FG003|Post-Randomization Period|Lost to Follow-up|5|||
33308314|NCT01160289|101021647|FG004|Post-Randomization Period|Lost to Follow-up|3|||
33308315|NCT01160289|101021648|FG005|Post-Randomization Period|Lost to Follow-up|4|||
33308316|NCT01160289|101021643|FG000|Post-Randomization Period|Physician Decision|0|||
33308317|NCT01160289|101021644|FG001|Post-Randomization Period|Physician Decision|0|||
33308318|NCT01160289|101021645|FG002|Post-Randomization Period|Physician Decision|1|||
33308319|NCT01160289|101021646|FG003|Post-Randomization Period|Physician Decision|0|||
33308320|NCT01160289|101021647|FG004|Post-Randomization Period|Physician Decision|0|||
33308321|NCT01160289|101021648|FG005|Post-Randomization Period|Physician Decision|0|||
33308322|NCT01160289|101021643|FG000|Post-Randomization Period|Protocol Violation|0|||
33308323|NCT01160289|101021644|FG001|Post-Randomization Period|Protocol Violation|4|||
33308324|NCT01160289|101021645|FG002|Post-Randomization Period|Protocol Violation|2|||
33308325|NCT01160289|101021646|FG003|Post-Randomization Period|Protocol Violation|0|||
33308326|NCT01160289|101021647|FG004|Post-Randomization Period|Protocol Violation|1|||
33308327|NCT01160289|101021648|FG005|Post-Randomization Period|Protocol Violation|3|||
33308328|NCT01160289|101021643|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
33308329|NCT01160289|101021644|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
33601514|NCT02124772|102091967|FG011|Overall Study|Lack of Efficacy|0|||
33601515|NCT02124772|102091968|FG012|Overall Study|Lack of Efficacy|1|||
33308330|NCT01160289|101021645|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
33308331|NCT01160289|101021646|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
33308332|NCT01160289|101021647|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
33601516|NCT02124772|102091956|FG000|Overall Study|Adverse Event|1|||
33601517|NCT02124772|102091957|FG001|Overall Study|Adverse Event|4|||
33191922|NCT01234467|100608494|FG000|Overall Study|Other complicating disease (stroke)|1|||
33191923|NCT04300296|100608495|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
33191924|NCT04300296|100608496|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
33191925|NCT04300296|100608497|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
33191926|NCT04300296|100608498|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
33191927|NCT04300296|100608499|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
33191928|NCT04300296|100608500|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
33191929|NCT04300296|100608495|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
33191930|NCT04300296|100608496|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
33191931|NCT04300296|100608497|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
33191932|NCT04300296|100608498|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
33191933|NCT04300296|100608499|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
33191934|NCT04300296|100608500|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
33191935|NCT04300296|100608495|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
33191936|NCT04300296|100608496|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
33191937|NCT04300296|100608497|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
33191938|NCT04300296|100608498|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
33191939|NCT04300296|100608499|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
33191940|NCT04300296|100608500|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
33191941|NCT04300296|100608495|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
33191942|NCT04300296|100608496|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
33191943|NCT04300296|100608497|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
33191944|NCT04300296|100608498|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
33191945|NCT04300296|100608499|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
33191946|NCT04300296|100608500|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
33191947|NCT04300296|100608495|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
33191948|NCT04300296|100608496|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
33191949|NCT04300296|100608497|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
33191950|NCT04300296|100608498|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
33191951|NCT04300296|100608499|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
33191952|NCT04300296|100608500|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
33191953|NCT04300296|100608495|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
33191954|NCT04300296|100608496|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
33191955|NCT04300296|100608497|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
33191956|NCT04300296|100608498|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
33191957|NCT04300296|100608499|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
33191958|NCT04300296|100608500|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
33191959|NCT04300296|100608495|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
33191960|NCT04300296|100608496|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
33191961|NCT04300296|100608497|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
33191962|NCT04300296|100608498|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
33191963|NCT04300296|100608499|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
33191964|NCT04300296|100608500|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
33191965|NCT03075644|100608501|FG000|Overall Study|Withdrawal by Subject|1|||
33191966|NCT03075644|100608502|FG001|Overall Study|Withdrawal by Subject|1|||
33191967|NCT03364049|100608508|FG000|Overall Study|Death|6|||
33191968|NCT03364049|100608509|FG001|Overall Study|Death|4|||
33191969|NCT03364049|100608510|FG002|Overall Study|Death|5|||
33191970|NCT03364049|100608511|FG003|Overall Study|Death|14|||
33191971|NCT03364049|100608508|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
33191972|NCT03364049|100608509|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
33191973|NCT03364049|100608510|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
33191974|NCT03364049|100608511|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
33191975|NCT03364049|100608508|FG000|Overall Study|Withdrawal by Subject|0|||
33191976|NCT03364049|100608509|FG001|Overall Study|Withdrawal by Subject|1|||
33191977|NCT03364049|100608510|FG002|Overall Study|Withdrawal by Subject|1|||
33191978|NCT03364049|100608511|FG003|Overall Study|Withdrawal by Subject|1|||
33191979|NCT01706250|100608512|FG000|Overall Study|Lost to Follow-up|2|||
33191980|NCT00577122|100608513|FG000|Overall Study|Adverse Event|0|||
33191981|NCT00577122|100608514|FG001|Overall Study|Adverse Event|2|||
33191982|NCT00577122|100608513|FG000|Overall Study|Progression, relapse during active trt|6|||
33191983|NCT00577122|100608514|FG001|Overall Study|Progression, relapse during active trt|8|||
33191984|NCT00577122|100608513|FG000|Overall Study|Prog, refract disease during active trt|8|||
33191985|NCT00577122|100608514|FG001|Overall Study|Prog, refract disease during active trt|5|||
33601518|NCT02124772|102091958|FG002|Overall Study|Adverse Event|1|||
33393884|NCT03073200|101328523|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33393885|NCT03073200|101328524|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
33393886|NCT03073200|101328525|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
33393887|NCT02736929|101328526|FG000|Main Study|Lost to Follow-up|7|||
33393888|NCT02736929|101328527|FG001|Main Study|Lost to Follow-up|1|||
33393889|NCT02736929|101328528|FG002|Main Study|Lost to Follow-up|0|||
33393890|NCT02736929|101328526|FG000|Main Study|Withdrawal by Subject|1|||
33393891|NCT02736929|101328527|FG001|Main Study|Withdrawal by Subject|1|||
33393892|NCT02736929|101328528|FG002|Main Study|Withdrawal by Subject|0|||
33393893|NCT02736929|101328526|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
33393894|NCT02736929|101328527|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
33393895|NCT02736929|101328528|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
33393896|NCT01305941|101328529|FG000|Overall Study|Adverse Event|6|||
33393897|NCT01305941|101328529|FG000|Overall Study|Clinical decline|2|||
33393898|NCT01305941|101328529|FG000|Overall Study|Withdrawal by Subject|1|||
33393899|NCT01305941|101328529|FG000|Overall Study|Death|1|||
33393900|NCT00537771|101328531|FG000|Overall Study|Withdrawal by Subject|6|||
33393901|NCT00537771|101328532|FG001|Overall Study|Withdrawal by Subject|23|||
33393902|NCT00537771|101328531|FG000|Overall Study|Adverse Event|8|||
33393903|NCT00537771|101328532|FG001|Overall Study|Adverse Event|15|||
33393904|NCT00537771|101328531|FG000|Overall Study|Lost to Follow-up|9|||
33393905|NCT00537771|101328532|FG001|Overall Study|Lost to Follow-up|15|||
33393906|NCT00537771|101328531|FG000|Overall Study|Protocol Violation|2|||
33393907|NCT00537771|101328532|FG001|Overall Study|Protocol Violation|6|||
33393908|NCT00537771|101328531|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
33393909|NCT00537771|101328532|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
33393910|NCT01708915|101328540|FG000|Overall Study|Adverse Event|1|||
33393911|NCT01708915|101328541|FG001|Overall Study|Adverse Event|0|||
33393912|NCT01708915|101328542|FG002|Overall Study|Adverse Event|9|||
33393913|NCT01708915|101328543|FG003|Overall Study|Adverse Event|13|||
33393914|NCT01708915|101328540|FG000|Overall Study|Lack of Efficacy|84|||
33393915|NCT01708915|101328541|FG001|Overall Study|Lack of Efficacy|60|||
33393916|NCT01708915|101328542|FG002|Overall Study|Lack of Efficacy|35|||
33601519|NCT02124772|102091959|FG003|Overall Study|Adverse Event|5|||
33308333|NCT01160289|101021648|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
33308334|NCT01160289|101021643|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
33308335|NCT01160289|101021644|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
33308336|NCT01160289|101021645|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
33308337|NCT01160289|101021646|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
33308338|NCT01160289|101021647|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
33308339|NCT01160289|101021648|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
33308340|NCT01160289|101021643|FG000|Post-Randomization Period|Sponsor Decision|0|||
33308341|NCT01160289|101021644|FG001|Post-Randomization Period|Sponsor Decision|1|||
33308342|NCT01160289|101021645|FG002|Post-Randomization Period|Sponsor Decision|0|||
33308343|NCT01160289|101021646|FG003|Post-Randomization Period|Sponsor Decision|0|||
33308344|NCT01160289|101021647|FG004|Post-Randomization Period|Sponsor Decision|0|||
33308345|NCT01160289|101021648|FG005|Post-Randomization Period|Sponsor Decision|0|||
33308346|NCT00700258|101021649|FG000|Overall Study|Premature discontinuation of documentation|136|||
33308347|NCT00700258|101021649|FG000|Overall Study|Type of study end not documented|1|||
33308348|NCT00700258|101021649|FG000|Overall Study|Lost to Follow-up|81|||
33308349|NCT00700258|101021649|FG000|Overall Study|Premature discontinuation of therapy|1013|||
33308350|NCT02724969|101021650|FG000|Overall Study|Lost to Follow-up|12|||
33308351|NCT02724969|101021651|FG001|Overall Study|Lost to Follow-up|6|||
33308352|NCT02724969|101021650|FG000|Overall Study|Withdrawal by Subject|3|||
33308353|NCT02724969|101021651|FG001|Overall Study|Withdrawal by Subject|3|||
33308354|NCT02724969|101021650|FG000|Overall Study|Infant demise|0|||
33308355|NCT02724969|101021651|FG001|Overall Study|Infant demise|2|||
33308356|NCT03256851|101021652|FG000|Overall Study|Withdrawal by Subject|1|||
33308357|NCT03256851|101021653|FG001|Overall Study|Withdrawal by Subject|0|||
33308358|NCT02424734|101021654|FG000|Overall Study|Treatment stopped to be discharged home|2|||
33308359|NCT02424734|101021655|FG001|Overall Study|Treatment stopped to be discharged home|2|||
33601520|NCT02124772|102091960|FG004|Overall Study|Adverse Event|2|||
33308360|NCT02424734|101021656|FG002|Overall Study|Treatment stopped to be discharged home|0|||
33393917|NCT01708915|101328543|FG003|Overall Study|Lack of Efficacy|15|||
33393918|NCT01708915|101328540|FG000|Overall Study|Protocol Violation|0|||
33393919|NCT01708915|101328541|FG001|Overall Study|Protocol Violation|0|||
33393920|NCT01708915|101328542|FG002|Overall Study|Protocol Violation|0|||
33393921|NCT01708915|101328543|FG003|Overall Study|Protocol Violation|1|||
33393922|NCT01708915|101328540|FG000|Overall Study|Withdrawal by Subject|0|||
33601521|NCT02124772|102091961|FG005|Overall Study|Adverse Event|1|||
33308361|NCT01077271|101021657|FG000|Overall Study|Parental desire|8|||
33308362|NCT01077271|101021657|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
33393923|NCT01708915|101328541|FG001|Overall Study|Withdrawal by Subject|1|||
33393924|NCT01708915|101328542|FG002|Overall Study|Withdrawal by Subject|2|||
33393925|NCT01708915|101328543|FG003|Overall Study|Withdrawal by Subject|2|||
33500627|NCT03852472|101724654|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
33500628|NCT03852472|101724655|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
33500629|NCT03852472|101724651|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
33308363|NCT01077271|101021657|FG000|Overall Study|Noncompliance|2|||
33308364|NCT01077271|101021657|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
33191986|NCT00577122|100608513|FG000|Overall Study|Alternative Therapy|0|||
33191987|NCT00577122|100608514|FG001|Overall Study|Alternative Therapy|1|||
33191988|NCT00458484|100608517|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
33191989|NCT00458484|100608518|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
33191990|NCT00458484|100608519|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
33191991|NCT00458484|100608520|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
33191992|NCT00458484|100608521|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
33191993|NCT00458484|100608522|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
33191994|NCT00458484|100608523|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
33191995|NCT02043015|100608526|FG000|Overall Study|Lost to Follow-up|4|||
33191996|NCT02043015|100608526|FG000|Overall Study|Withdrawal by Subject|4|||
33191997|NCT02043015|100608526|FG000|Overall Study|Removed once target enrollment reached|15|||
33191998|NCT02043015|100608526|FG000|Overall Study|Participant moved away from study city|4|||
33191999|NCT02043015|100608526|FG000|Overall Study|Incarceration|1|||
33192000|NCT01430585|100608527|FG000|Overall Study|Death|1|||
33308365|NCT01077271|101021657|FG000|Overall Study|Changed doctors|2|||
33308366|NCT01077271|101021657|FG000|Overall Study|Parents thought too many injections|2|||
33308367|NCT01077271|101021657|FG000|Overall Study|End of RSV season nearly reached|1|||
33308368|NCT01077271|101021657|FG000|Overall Study|Mother unconvinced of the necessity|1|||
33308369|NCT02545933|101021661|FG000|Overall Study|Adverse Event|3|||
33308370|NCT02545933|101021662|FG001|Overall Study|Adverse Event|0|||
33308371|NCT02545933|101021663|FG002|Overall Study|Adverse Event|0|||
33308372|NCT02545933|101021661|FG000|Overall Study|Withdrawal by Subject|2|||
33308373|NCT02545933|101021662|FG001|Overall Study|Withdrawal by Subject|3|||
33308374|NCT02545933|101021663|FG002|Overall Study|Withdrawal by Subject|3|||
33308375|NCT02545933|101021661|FG000|Overall Study|Protocol Violation|1|||
33308376|NCT02545933|101021662|FG001|Overall Study|Protocol Violation|0|||
33308377|NCT02545933|101021663|FG002|Overall Study|Protocol Violation|1|||
33500630|NCT03852472|101724652|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
33500631|NCT03852472|101724653|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
33601522|NCT02124772|102091962|FG006|Overall Study|Adverse Event|1|||
33192001|NCT01430585|100608527|FG000|Overall Study|Objective Progression or Relapse|3|||
33601523|NCT02124772|102091963|FG007|Overall Study|Adverse Event|5|||
33192002|NCT01430585|100608527|FG000|Overall Study|Study Terminated by Sponsor|3|||
33192003|NCT01430585|100608527|FG000|Overall Study|Other|7|||
33192004|NCT00353366|100608528|FG000|Overall Study|Adverse Event|8|||
33308378|NCT04227704|101021666|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
33308379|NCT04227704|101021667|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
33308380|NCT04227704|101021668|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
33192005|NCT00353366|100608528|FG000|Overall Study|Protocol Violation|12|||
33192006|NCT00353366|100608528|FG000|Overall Study|Withdrawal by Subject|12|||
33192007|NCT00353366|100608528|FG000|Overall Study|Lost to Follow-up|92|||
33308381|NCT04227704|101021666|FG000|Overall Study|due to C/S being cancelled|1|||
33308382|NCT04227704|101021667|FG001|Overall Study|due to C/S being cancelled|0|||
33308383|NCT04227704|101021668|FG002|Overall Study|due to C/S being cancelled|0|||
33308384|NCT01820585|101021672|FG000|Overall Study|Adverse Event|9|||
33308385|NCT01820585|101021673|FG001|Overall Study|Adverse Event|13|||
33192008|NCT00353366|100608528|FG000|Overall Study|Other|19|||
33192009|NCT03265119|100608529|FG000|Overall Study|Adverse Event|2|||
33192010|NCT03265119|100608530|FG001|Overall Study|Adverse Event|1|||
33192011|NCT03265119|100608529|FG000|Overall Study|Lack of Efficacy|3|||
33192012|NCT03265119|100608530|FG001|Overall Study|Lack of Efficacy|0|||
33192013|NCT03265119|100608529|FG000|Overall Study|Protocol Violation|1|||
33192014|NCT03265119|100608530|FG001|Overall Study|Protocol Violation|2|||
33192015|NCT03265119|100608529|FG000|Overall Study|Withdrawal by Subject|2|||
33192016|NCT03265119|100608530|FG001|Overall Study|Withdrawal by Subject|4|||
33192017|NCT03265119|100608529|FG000|Overall Study|Lost to Follow-up|1|||
33308386|NCT01820585|101021674|FG002|Overall Study|Adverse Event|23|||
33308387|NCT01820585|101021675|FG003|Overall Study|Adverse Event|34|||
33308388|NCT01820585|101021672|FG000|Overall Study|Lack of Efficacy|9|||
33308389|NCT01820585|101021673|FG001|Overall Study|Lack of Efficacy|7|||
33308390|NCT01820585|101021674|FG002|Overall Study|Lack of Efficacy|5|||
33308391|NCT01820585|101021675|FG003|Overall Study|Lack of Efficacy|1|||
33308392|NCT01820585|101021672|FG000|Overall Study|Withdrawal by Subject|3|||
33308393|NCT01820585|101021673|FG001|Overall Study|Withdrawal by Subject|7|||
33393926|NCT01708915|101328540|FG000|Overall Study|Other reasons than stated above|1|||
33393927|NCT01708915|101328541|FG001|Overall Study|Other reasons than stated above|1|||
33393928|NCT01708915|101328542|FG002|Overall Study|Other reasons than stated above|0|||
33393929|NCT01708915|101328543|FG003|Overall Study|Other reasons than stated above|2|||
33393930|NCT02728206|101328544|FG000|Overall Study|Death|1|||
33393931|NCT04897594|101328548|FG000|Overall Study|Lost to Follow-up|0|||
33393932|NCT04897594|101328549|FG001|Overall Study|Lost to Follow-up|1|||
33393933|NCT04897594|101328550|FG002|Overall Study|Lost to Follow-up|1|||
33393934|NCT04897594|101328548|FG000|Overall Study|Sponsor Decision|0|||
33393935|NCT04897594|101328549|FG001|Overall Study|Sponsor Decision|0|||
33393936|NCT04897594|101328550|FG002|Overall Study|Sponsor Decision|1|||
33393937|NCT04897594|101328548|FG000|Overall Study|Withdrawal by Subject|1|||
33500632|NCT03852472|101724654|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
33393938|NCT04897594|101328549|FG001|Overall Study|Withdrawal by Subject|0|||
33393939|NCT04897594|101328550|FG002|Overall Study|Withdrawal by Subject|1|||
33393940|NCT01474889|101328551|FG000|Overall Study|Physician Decision|1|||
33393941|NCT01474889|101328552|FG001|Overall Study|Physician Decision|0|||
33393942|NCT01474889|101328553|FG002|Overall Study|Physician Decision|0|||
33500633|NCT03852472|101724655|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
33500634|NCT03852472|101724651|FG000|Period 2 - Week 44|Adverse Event|0|||
33500635|NCT03852472|101724652|FG001|Period 2 - Week 44|Adverse Event|3|||
33500636|NCT03852472|101724653|FG002|Period 2 - Week 44|Adverse Event|1|||
33500637|NCT03852472|101724654|FG003|Period 2 - Week 44|Adverse Event|2|||
33500638|NCT03852472|101724655|FG004|Period 2 - Week 44|Adverse Event|2|||
33500639|NCT03852472|101724651|FG000|Period 2 - Week 44|COVID-19 Related|0|||
33500640|NCT03852472|101724652|FG001|Period 2 - Week 44|COVID-19 Related|0|||
33500641|NCT03852472|101724653|FG002|Period 2 - Week 44|COVID-19 Related|0|||
33500642|NCT03852472|101724654|FG003|Period 2 - Week 44|COVID-19 Related|1|||
33601524|NCT02124772|102091964|FG008|Overall Study|Adverse Event|0|||
33192018|NCT03265119|100608530|FG001|Overall Study|Lost to Follow-up|0|||
33192019|NCT03265119|100608529|FG000|Overall Study|Lack of Compliance|1|||
33192020|NCT03265119|100608530|FG001|Overall Study|Lack of Compliance|0|||
33192021|NCT00578565|100608540|FG000|Overall Study|Adverse Event|3|||
33308394|NCT01820585|101021674|FG002|Overall Study|Withdrawal by Subject|3|||
33308395|NCT01820585|101021675|FG003|Overall Study|Withdrawal by Subject|8|||
33308396|NCT01820585|101021672|FG000|Overall Study|Lost to Follow-up|3|||
33308397|NCT01820585|101021673|FG001|Overall Study|Lost to Follow-up|3|||
33393943|NCT01474889|101328551|FG000|Overall Study|Did not meet inclusion|1|||
33393944|NCT01474889|101328552|FG001|Overall Study|Did not meet inclusion|0|||
33393945|NCT01474889|101328553|FG002|Overall Study|Did not meet inclusion|0|||
33393946|NCT01474889|101328551|FG000|Overall Study|Withdrawal by Subject|0|||
33393947|NCT01474889|101328552|FG001|Overall Study|Withdrawal by Subject|1|||
33393948|NCT01474889|101328553|FG002|Overall Study|Withdrawal by Subject|0|||
33393949|NCT00711412|101328556|FG000|Induction Treatment|Death|2|||
33393950|NCT00711412|101328556|FG000|Induction Treatment|Adverse Event|1|||
33393951|NCT00711412|101328556|FG000|Induction Treatment|Other|1|||
33192022|NCT01451424|100608541|FG000|Overall Study|Withdrawal by Subject|1|||
33192023|NCT01451424|100608542|FG001|Overall Study|Withdrawal by Subject|1|||
33192024|NCT01451424|100608543|FG002|Overall Study|Withdrawal by Subject|0|||
33192025|NCT01451424|100608544|FG003|Overall Study|Withdrawal by Subject|2|||
33308398|NCT01820585|101021674|FG002|Overall Study|Lost to Follow-up|0|||
33308399|NCT01820585|101021675|FG003|Overall Study|Lost to Follow-up|3|||
33192026|NCT01451424|100608541|FG000|Overall Study|Lost to Follow-up|0|||
33192027|NCT01451424|100608542|FG001|Overall Study|Lost to Follow-up|1|||
33192028|NCT01451424|100608543|FG002|Overall Study|Lost to Follow-up|0|||
33192029|NCT01451424|100608544|FG003|Overall Study|Lost to Follow-up|1|||
33192030|NCT01451424|100608541|FG000|Overall Study|Physician Decision|0|||
33192031|NCT01451424|100608542|FG001|Overall Study|Physician Decision|0|||
33192032|NCT01451424|100608543|FG002|Overall Study|Physician Decision|1|||
33192033|NCT01451424|100608544|FG003|Overall Study|Physician Decision|1|||
33192034|NCT01451424|100608541|FG000|Overall Study|Adverse Event|0|||
33192035|NCT01451424|100608542|FG001|Overall Study|Adverse Event|0|||
33192036|NCT01451424|100608543|FG002|Overall Study|Adverse Event|0|||
33192037|NCT01451424|100608544|FG003|Overall Study|Adverse Event|1|||
33192038|NCT02907359|100608545|FG000|Overall Study|Death|234|||
33192039|NCT02907359|100608546|FG001|Overall Study|Death|117|||
33192040|NCT02907359|100608545|FG000|Overall Study|Withdrawal by Subject|6|||
33192041|NCT02907359|100608546|FG001|Overall Study|Withdrawal by Subject|11|||
33192042|NCT02907359|100608545|FG000|Overall Study|Lost to Follow-up|1|||
33192043|NCT02907359|100608546|FG001|Overall Study|Lost to Follow-up|0|||
33192044|NCT01864291|100608547|FG000|Overall Study|need for revision surgery|2|||
33192045|NCT02553421|100608550|FG000|Overall Study|Lost to Follow-up|21|||
33192046|NCT02553421|100608551|FG001|Overall Study|Lost to Follow-up|1|||
33192047|NCT02553421|100608550|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
33192048|NCT02553421|100608551|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
33308400|NCT01820585|101021672|FG000|Overall Study|Protocol Violation|3|||
33308401|NCT01820585|101021673|FG001|Overall Study|Protocol Violation|1|||
33308402|NCT01820585|101021674|FG002|Overall Study|Protocol Violation|1|||
33308403|NCT01820585|101021675|FG003|Overall Study|Protocol Violation|1|||
33308404|NCT01820585|101021672|FG000|Overall Study|Subject non-compliance|0|||
33308405|NCT01820585|101021673|FG001|Overall Study|Subject non-compliance|0|||
33308406|NCT01820585|101021674|FG002|Overall Study|Subject non-compliance|1|||
33308407|NCT01820585|101021675|FG003|Overall Study|Subject non-compliance|2|||
33308408|NCT01820585|101021672|FG000|Overall Study|at sponsor request|0|||
33308409|NCT01820585|101021673|FG001|Overall Study|at sponsor request|0|||
33308410|NCT01820585|101021674|FG002|Overall Study|at sponsor request|1|||
33308411|NCT01820585|101021675|FG003|Overall Study|at sponsor request|0|||
33308412|NCT01820585|101021672|FG000|Overall Study|Pregnancy|0|||
33308413|NCT01820585|101021673|FG001|Overall Study|Pregnancy|1|||
33308414|NCT01820585|101021674|FG002|Overall Study|Pregnancy|0|||
33308415|NCT01820585|101021675|FG003|Overall Study|Pregnancy|0|||
33308416|NCT03647488|101021676|FG000|Overall Study|Progressive disease|10|||
33308417|NCT03647488|101021677|FG001|Overall Study|Progressive disease|0|||
33308418|NCT03647488|101021678|FG002|Overall Study|Progressive disease|0|||
33308419|NCT03647488|101021676|FG000|Overall Study|Adverse Event|5|||
33308420|NCT03647488|101021677|FG001|Overall Study|Adverse Event|0|||
33308421|NCT03647488|101021678|FG002|Overall Study|Adverse Event|0|||
33308422|NCT03647488|101021676|FG000|Overall Study|Clinical progression|2|||
33308423|NCT03647488|101021677|FG001|Overall Study|Clinical progression|0|||
33308424|NCT03647488|101021678|FG002|Overall Study|Clinical progression|0|||
33308425|NCT03647488|101021676|FG000|Overall Study|Participant refused to take investigational product|1|||
33308426|NCT03647488|101021677|FG001|Overall Study|Participant refused to take investigational product|0|||
33308427|NCT03647488|101021678|FG002|Overall Study|Participant refused to take investigational product|0|||
33308428|NCT05326815|101021681|FG000|Overall Study|Withdrawal by Subject|3|||
33192049|NCT02553421|100608550|FG000|Overall Study|Improper Device Placement|3|||
33192050|NCT02553421|100608551|FG001|Overall Study|Improper Device Placement|0|||
33308429|NCT05326815|101021681|FG000|Overall Study|Did not complete required labs|6|||
33308430|NCT05326815|101021681|FG000|Overall Study|Screen fail- abnormal labs|5|||
33308431|NCT01290029|101021682|FG000|Overall Study|Other|2|||
33308432|NCT00574873|101021684|FG000|Overall Study|Withdrawal by Subject|18|||
33308433|NCT00574873|101021685|FG001|Overall Study|Withdrawal by Subject|19|||
33308434|NCT00574873|101021684|FG000|Overall Study|Investigator request|18|||
33308435|NCT00574873|101021685|FG001|Overall Study|Investigator request|8|||
33308436|NCT00574873|101021684|FG000|Overall Study|Death|15|||
33308437|NCT00574873|101021685|FG001|Overall Study|Death|14|||
33308438|NCT00574873|101021684|FG000|Overall Study|Lost to Follow-up|14|||
33308439|NCT00574873|101021685|FG001|Overall Study|Lost to Follow-up|5|||
33308440|NCT00574873|101021684|FG000|Overall Study|Other|40|||
33308441|NCT00574873|101021685|FG001|Overall Study|Other|4|||
33308442|NCT00574873|101021684|FG000|Overall Study|Discontinuation of study by sponsor|5|||
33192051|NCT00646204|100608552|FG000|Overall Study|Adverse Event|3|||
33192052|NCT00646204|100608553|FG001|Overall Study|Adverse Event|0|||
33192053|NCT00646204|100608552|FG000|Overall Study|Withdrawal by Subject|1|||
33192054|NCT00646204|100608553|FG001|Overall Study|Withdrawal by Subject|0|||
33308443|NCT00574873|101021685|FG001|Overall Study|Discontinuation of study by sponsor|199|||
33308444|NCT00574873|101021684|FG000|Overall Study|Blank, site closed per local regulations|2|||
33308445|NCT00574873|101021685|FG001|Overall Study|Blank, site closed per local regulations|2|||
33308446|NCT00574873|101021684|FG000|Overall Study|Extension Study|126|||
33308447|NCT00574873|101021685|FG001|Overall Study|Extension Study|0|||
33192055|NCT04171414|100608556|FG000|Overall Study|Death|1|||
33308448|NCT00948766|101021686|FG000|Core Study|Adverse Event|73|||
33308449|NCT00948766|101021687|FG001|Core Study|Adverse Event|51|||
33308450|NCT00948766|101021686|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
33308451|NCT00948766|101021687|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
33308452|NCT00948766|101021686|FG000|Core Study|Patient Withdrew Consent|27|||
33308453|NCT00948766|101021687|FG001|Core Study|Patient Withdrew Consent|46|||
33308454|NCT00948766|101021686|FG000|Core Study|Lost to Follow-up|3|||
33308455|NCT00948766|101021687|FG001|Core Study|Lost to Follow-up|2|||
33308456|NCT00948766|101021686|FG000|Core Study|Administrative Problems|2|||
33308457|NCT00948766|101021687|FG001|Core Study|Administrative Problems|2|||
33308458|NCT00948766|101021686|FG000|Core Study|Death|1|||
33308459|NCT00948766|101021687|FG001|Core Study|Death|1|||
33308460|NCT00948766|101021686|FG000|Core Study|Protocol Deviation|8|||
33308461|NCT00948766|101021687|FG001|Core Study|Protocol Deviation|10|||
33308462|NCT00948766|101021686|FG000|Extension Study|Adverse Event|43|||
33308463|NCT00948766|101021687|FG001|Extension Study|Adverse Event|0|||
33308464|NCT00948766|101021686|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
33308465|NCT00948766|101021687|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
33308466|NCT00948766|101021686|FG000|Extension Study|Study Drug No Longer Required|1|||
33308467|NCT00948766|101021687|FG001|Extension Study|Study Drug No Longer Required|0|||
33308468|NCT00948766|101021686|FG000|Extension Study|Patient Withdrew Consent|32|||
33308469|NCT00948766|101021687|FG001|Extension Study|Patient Withdrew Consent|0|||
33308470|NCT00948766|101021686|FG000|Extension Study|Lost to Follow-up|8|||
33308471|NCT00948766|101021687|FG001|Extension Study|Lost to Follow-up|0|||
33308472|NCT00948766|101021686|FG000|Extension Study|Administrative Problems|1|||
33308473|NCT00948766|101021687|FG001|Extension Study|Administrative Problems|0|||
33308474|NCT00948766|101021686|FG000|Extension Study|Death|4|||
33308475|NCT00948766|101021687|FG001|Extension Study|Death|0|||
33308476|NCT03484273|101021689|FG000|Overall Study|Equipment Malfunction|1|||
33308477|NCT03484273|101021689|FG000|Overall Study|Data excluded from analysis|1|||
33308478|NCT00734097|101021690|FG000|Screening|Protocol Violation|12|||
33308479|NCT00734097|101021690|FG000|Screening|Withdrawal by Subject|5|||
33308480|NCT00734097|101021690|FG000|Screening|Lost to Follow-up|2|||
33308481|NCT00734097|101021690|FG000|Screening|Unconfirmed pregnancy|1|||
33308482|NCT00734097|101021690|FG000|Open Label|Lost to Follow-up|7|||
33308483|NCT00734097|101021690|FG000|Open Label|Withdrawal by Subject|5|||
33308484|NCT00734097|101021690|FG000|Open Label|Protocol Violation|4|||
33308485|NCT00833261|101021694|FG000|Overall Study|Withdrawal by Subject|4|||
33308486|NCT01656733|101026115|FG000|Overall Study|No permission to collect birth outcomes|0|||
33308487|NCT01656733|101026116|FG001|Overall Study|No permission to collect birth outcomes|1|||
33308488|NCT01656733|101026115|FG000|Overall Study|Delivery at another hospital|0|||
33308489|NCT01656733|101026116|FG001|Overall Study|Delivery at another hospital|2|||
33308490|NCT01656733|101026115|FG000|Overall Study|Spontaneous abortion|0|||
33308491|NCT01656733|101026116|FG001|Overall Study|Spontaneous abortion|1|||
33308492|NCT00297232|101026117|FG000|Overall Study|Lack of Efficacy|7|||
33308493|NCT00297232|101026117|FG000|Overall Study|Lost to Follow-up|10|||
33308494|NCT00297232|101026117|FG000|Overall Study|Adverse Event|63|||
33308495|NCT00297232|101026117|FG000|Overall Study|Voluntary Withdrawal|120|||
33308496|NCT00297232|101026117|FG000|Overall Study|Subject was Noncompliant|9|||
33308497|NCT00297232|101026117|FG000|Overall Study|Death|9|||
33308498|NCT00297232|101026117|FG000|Overall Study|Anti-natalizumab Positive|8|||
33308499|NCT00297232|101026117|FG000|Overall Study|Switched to Commercial Tysabri|22|||
33308500|NCT00297232|101026117|FG000|Overall Study|Disease Progression|8|||
33308501|NCT00297232|101026117|FG000|Overall Study|Fear of PML|10|||
33308502|NCT00297232|101026117|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
33308503|NCT00297232|101026117|FG000|Overall Study|Miscellaneous|5|||
33308504|NCT00297232|101026117|FG000|Overall Study|Sponsor Decision|34|||
33308505|NCT00297232|101026117|FG000|Overall Study|Subject Relocated|7|||
33308506|NCT00297232|101026117|FG000|Overall Study|Subject Withdrew Consent|37|||
33393952|NCT00711412|101328556|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
33393953|NCT00711412|101328556|FG000|Evaluated for Combination Treatment|Death|1|||
33601525|NCT02124772|102091965|FG009|Overall Study|Adverse Event|3|||
33192056|NCT04171414|100608556|FG000|Overall Study|Withdrawal by Subject|1|||
33192057|NCT01420081|100608558|FG000|Overall Study|Death|1|||
33192058|NCT01420081|100608559|FG001|Overall Study|Death|0|||
33308507|NCT00297232|101026117|FG000|Overall Study|Persistently Positive Antibodies|11|||
33393954|NCT00711412|101328556|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
33308508|NCT00297232|101026117|FG000|Overall Study|Investigator Withdrew From Program|19|||
33308509|NCT00297232|101026117|FG000|Overall Study|Did Not Enroll to Week 264|34|||
33308510|NCT00297232|101026117|FG000|Overall Study|Did Not Enroll to Week 480|17|||
33308511|NCT00297232|101026117|FG000|Overall Study|No data available after Week 264|161|||
33308512|NCT00297232|101026117|FG000|Overall Study|Other|1|||
33308513|NCT00069108|101026118|FG000|Overall Study|Withdrawal by Subject|5|||
33308514|NCT00069108|101026119|FG001|Overall Study|Withdrawal by Subject|9|||
33308515|NCT00069108|101026118|FG000|Overall Study|Adverse Event|64|||
33308516|NCT00069108|101026119|FG001|Overall Study|Adverse Event|42|||
33308517|NCT00069108|101026118|FG000|Overall Study|Death|6|||
33308518|NCT00069108|101026119|FG001|Overall Study|Death|6|||
33393955|NCT00711412|101328556|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
33393956|NCT00711412|101328556|FG000|Combination Treatment|Progressive Disease|1|||
33393957|NCT00711412|101328556|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
33393958|NCT00711412|101328556|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
33393959|NCT00711412|101328556|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
33308519|NCT00069108|101026118|FG000|Overall Study|Administration|15|||
33308520|NCT00069108|101026119|FG001|Overall Study|Administration|4|||
33308521|NCT00069108|101026118|FG000|Overall Study|Insufficient therapy|117|||
33308522|NCT00069108|101026119|FG001|Overall Study|Insufficient therapy|144|||
33308523|NCT00069108|101026118|FG000|Overall Study|Violation criteria|1|||
33308524|NCT00069108|101026119|FG001|Overall Study|Violation criteria|4|||
33308525|NCT00069108|101026118|FG000|Overall Study|Refused treatment|5|||
33308526|NCT00069108|101026119|FG001|Overall Study|Refused treatment|10|||
33308527|NCT02433340|101026120|FG000|Overall Study|Adverse Event|0|||
33308528|NCT02433340|101026121|FG001|Overall Study|Adverse Event|0|||
33308529|NCT02433340|101026122|FG002|Overall Study|Adverse Event|1|||
33308530|NCT02433340|101026123|FG003|Overall Study|Adverse Event|0|||
33308531|NCT02433340|101026120|FG000|Overall Study|Withdrawal by Subject|1|||
33308532|NCT02433340|101026121|FG001|Overall Study|Withdrawal by Subject|0|||
33308533|NCT02433340|101026122|FG002|Overall Study|Withdrawal by Subject|1|||
33308534|NCT02433340|101026123|FG003|Overall Study|Withdrawal by Subject|2|||
33308535|NCT02433340|101026120|FG000|Overall Study|Lost to Follow-up|0|||
33308536|NCT02433340|101026121|FG001|Overall Study|Lost to Follow-up|1|||
33308537|NCT02433340|101026122|FG002|Overall Study|Lost to Follow-up|0|||
33308538|NCT02433340|101026123|FG003|Overall Study|Lost to Follow-up|0|||
33308539|NCT02433340|101026120|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
33308540|NCT02433340|101026121|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
33308541|NCT02433340|101026122|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
33308542|NCT02433340|101026123|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
33308543|NCT02433340|101026120|FG000|Overall Study|Other|0|||
33308544|NCT02433340|101026121|FG001|Overall Study|Other|1|||
33308545|NCT02433340|101026122|FG002|Overall Study|Other|0|||
33308546|NCT02433340|101026123|FG003|Overall Study|Other|0|||
33308547|NCT03261700|101026127|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
33308548|NCT03261700|101026128|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
33308549|NCT00600886|101026129|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
33308550|NCT00600886|101026130|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
33308551|NCT00600886|101026129|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
33308552|NCT00600886|101026130|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
33308553|NCT00600886|101026129|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
33308554|NCT00600886|101026130|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
33308555|NCT00600886|101026129|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
33308556|NCT00600886|101026130|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
33308557|NCT00600886|101026129|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
33308558|NCT00600886|101026130|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
33308559|NCT00600886|101026129|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
33308560|NCT00600886|101026130|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
33308561|NCT00600886|101026129|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
33308562|NCT00600886|101026130|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
33308563|NCT00600886|101026129|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
33308564|NCT00600886|101026130|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
33308565|NCT00600886|101026129|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
33308566|NCT00600886|101026130|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
33308567|NCT00600886|101026129|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
33308568|NCT00600886|101026130|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
33308569|NCT00600886|101026129|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
33308570|NCT00600886|101026130|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
33308571|NCT00600886|101026129|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
33308572|NCT00600886|101026130|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
33308573|NCT00600886|101026129|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
33308574|NCT00600886|101026130|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
33308575|NCT00600886|101026129|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
33308576|NCT00600886|101026130|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
33308577|NCT00600886|101026129|FG000|Extension - Same Treatment (FAS)|Death|1|||
33308578|NCT00600886|101026130|FG001|Extension - Same Treatment (FAS)|Death|1|||
33308579|NCT00600886|101026129|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
33601526|NCT02124772|102091966|FG010|Overall Study|Adverse Event|1|||
33601527|NCT02124772|102091967|FG011|Overall Study|Adverse Event|3|||
33308580|NCT00600886|101026130|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
33308581|NCT00600886|101026129|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
33393960|NCT00711412|101328556|FG000|Evaluation for Response and Surgery|Death|1|||
33393961|NCT00711412|101328556|FG000|Survival Follow up Until Death|Other|12|||
33393962|NCT01634100|101328562|FG000|Overall Study|Withdrawal by Subject|1|||
33393963|NCT01634100|101328563|FG001|Overall Study|Withdrawal by Subject|0|||
33393964|NCT01634100|101328564|FG002|Overall Study|Withdrawal by Subject|1|||
33308582|NCT00600886|101026130|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
33308583|NCT00600886|101026129|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
33308584|NCT00600886|101026130|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
33308585|NCT00600886|101026129|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
33308586|NCT00600886|101026130|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
33308587|NCT00600886|101026129|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
33308588|NCT00600886|101026130|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
33308589|NCT00600886|101026129|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
33308590|NCT00600886|101026130|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
33308591|NCT00600886|101026129|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
33393965|NCT01634100|101328565|FG003|Overall Study|Withdrawal by Subject|0|||
33393966|NCT01634100|101328566|FG004|Overall Study|Withdrawal by Subject|0|||
33393967|NCT01634100|101328567|FG005|Overall Study|Withdrawal by Subject|0|||
33393968|NCT03938636|101328568|FG000|Overall Study|Protocol Violation|0|||
33393969|NCT03938636|101328569|FG001|Overall Study|Protocol Violation|1|||
33393970|NCT03938636|101328570|FG002|Overall Study|Protocol Violation|1|||
33393971|NCT03938636|101328568|FG000|Overall Study|Subject withdrew due to death in family|0|||
33393972|NCT03938636|101328569|FG001|Overall Study|Subject withdrew due to death in family|1|||
33393973|NCT03938636|101328570|FG002|Overall Study|Subject withdrew due to death in family|0|||
33393974|NCT03938636|101328568|FG000|Overall Study|Missed visit|0|||
33393975|NCT03938636|101328569|FG001|Overall Study|Missed visit|1|||
33393976|NCT03938636|101328570|FG002|Overall Study|Missed visit|0|||
33393977|NCT03938636|101328568|FG000|Overall Study|Adverse Event|0|||
33393978|NCT03938636|101328569|FG001|Overall Study|Adverse Event|0|||
33393979|NCT03938636|101328570|FG002|Overall Study|Adverse Event|1|||
33393980|NCT03938636|101328568|FG000|Overall Study|Lost to Follow-up|0|||
33393981|NCT03938636|101328569|FG001|Overall Study|Lost to Follow-up|0|||
33393982|NCT03938636|101328570|FG002|Overall Study|Lost to Follow-up|1|||
33393983|NCT00790218|101328571|FG000|Overall Study|Death|1|||
33393984|NCT00790218|101328572|FG001|Overall Study|Death|0|||
33393985|NCT00790218|101328573|FG002|Overall Study|Death|0|||
33393986|NCT00608244|101328578|FG000|Overall Study|Adverse Event|1|||
33393987|NCT00608244|101328578|FG000|Overall Study|Low trough levels|1|||
33393988|NCT01975376|101328581|FG000|Overall Study|Adverse Event|5|||
33393989|NCT01975376|101328582|FG001|Overall Study|Adverse Event|5|||
33393990|NCT01975376|101328581|FG000|Overall Study|Death|65|||
33393991|NCT01975376|101328582|FG001|Overall Study|Death|72|||
33393992|NCT01975376|101328581|FG000|Overall Study|Lost to Follow-up|70|||
33393993|NCT01975376|101328582|FG001|Overall Study|Lost to Follow-up|66|||
33393994|NCT01975376|101328581|FG000|Overall Study|Withdrew consent|68|||
33308592|NCT00600886|101026130|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
33308593|NCT00600886|101026129|FG000|Extension - After Crossover (CAS)|Death|1|||
33308594|NCT00600886|101026130|FG001|Extension - After Crossover (CAS)|Death|0|||
33308595|NCT01886378|101026131|FG000|Overall Study|Adverse Event|1|||
33308596|NCT01886378|101026131|FG000|Overall Study|Withdrawal by Subject|4|||
33308597|NCT00712673|101026132|FG000|Overall Study|Adverse Event|3|||
33308598|NCT00712673|101026133|FG001|Overall Study|Adverse Event|3|||
33308599|NCT00712673|101026134|FG002|Overall Study|Adverse Event|21|||
33308600|NCT00712673|101026135|FG003|Overall Study|Adverse Event|26|||
33308601|NCT00712673|101026132|FG000|Overall Study|Lack of Efficacy|2|||
33308602|NCT00712673|101026133|FG001|Overall Study|Lack of Efficacy|8|||
33308603|NCT00712673|101026134|FG002|Overall Study|Lack of Efficacy|8|||
33308604|NCT00712673|101026135|FG003|Overall Study|Lack of Efficacy|6|||
33308605|NCT00712673|101026132|FG000|Overall Study|Poor Compliance to Protocol|3|||
33308606|NCT00712673|101026133|FG001|Overall Study|Poor Compliance to Protocol|3|||
33308607|NCT00712673|101026134|FG002|Overall Study|Poor Compliance to Protocol|4|||
33308608|NCT00712673|101026135|FG003|Overall Study|Poor Compliance to Protocol|16|||
33308609|NCT00712673|101026132|FG000|Overall Study|Lost to Follow-up|1|||
33308610|NCT00712673|101026133|FG001|Overall Study|Lost to Follow-up|0|||
33308611|NCT00712673|101026134|FG002|Overall Study|Lost to Follow-up|2|||
33393995|NCT01975376|101328582|FG001|Overall Study|Withdrew consent|62|||
33308612|NCT00712673|101026135|FG003|Overall Study|Lost to Follow-up|0|||
33393996|NCT01975376|101328581|FG000|Overall Study|Other|2|||
33393997|NCT01975376|101328582|FG001|Overall Study|Other|4|||
33393998|NCT01975376|101328581|FG000|Overall Study|Randomized, Not Treated|16|||
33393999|NCT01975376|101328582|FG001|Overall Study|Randomized, Not Treated|8|||
33394000|NCT02640755|101328583|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
33308613|NCT00712673|101026132|FG000|Overall Study|Withdrawal by Subject|6|||
33308614|NCT00712673|101026133|FG001|Overall Study|Withdrawal by Subject|7|||
33394001|NCT02640755|101328584|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
33417158|NCT00038467|101420219|FG000|Overall Study|Withdrawal by Subject|150|||
33394002|NCT02640755|101328583|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
33308615|NCT00712673|101026134|FG002|Overall Study|Withdrawal by Subject|15|||
33308616|NCT00712673|101026135|FG003|Overall Study|Withdrawal by Subject|20|||
33308617|NCT00712673|101026132|FG000|Overall Study|Familial and Personal Reasons|5|||
33308618|NCT00712673|101026133|FG001|Overall Study|Familial and Personal Reasons|0|||
33308619|NCT00712673|101026134|FG002|Overall Study|Familial and Personal Reasons|5|||
33308620|NCT00712673|101026135|FG003|Overall Study|Familial and Personal Reasons|2|||
33394003|NCT02640755|101328584|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
33394004|NCT02640755|101328583|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
33394005|NCT02640755|101328584|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
33394006|NCT00844415|101328585|FG000|Overall Study|Withdrawal by Subject|1|||
33394007|NCT01365091|101328592|FG000|Period 1|Adverse Event|1|||
33394008|NCT01365091|101328593|FG001|Period 1|Adverse Event|0|||
33394009|NCT01365091|101328594|FG002|Period 1|Adverse Event|2|||
33394010|NCT01365091|101328595|FG003|Period 1|Adverse Event|3|||
33394011|NCT01365091|101328592|FG000|Period 1|Positive test result for drugs of abuse|1|||
33394012|NCT01365091|101328593|FG001|Period 1|Positive test result for drugs of abuse|0|||
33394013|NCT01365091|101328594|FG002|Period 1|Positive test result for drugs of abuse|0|||
33394014|NCT01365091|101328595|FG003|Period 1|Positive test result for drugs of abuse|0|||
33394015|NCT01365091|101328592|FG000|Period 1|No longer met study criteria|0|||
33394016|NCT01365091|101328593|FG001|Period 1|No longer met study criteria|1|||
33394017|NCT01365091|101328594|FG002|Period 1|No longer met study criteria|0|||
33394018|NCT01365091|101328595|FG003|Period 1|No longer met study criteria|0|||
33394019|NCT01365091|101328592|FG000|Period 1|Withdrawal by Subject|0|||
33394020|NCT01365091|101328593|FG001|Period 1|Withdrawal by Subject|1|||
33394021|NCT01365091|101328594|FG002|Period 1|Withdrawal by Subject|0|||
33394022|NCT01365091|101328595|FG003|Period 1|Withdrawal by Subject|0|||
33394023|NCT01365091|101328592|FG000|Period 1|Personal reasons|0|||
33394024|NCT01365091|101328593|FG001|Period 1|Personal reasons|0|||
33394025|NCT01365091|101328594|FG002|Period 1|Personal reasons|1|||
33394026|NCT01365091|101328595|FG003|Period 1|Personal reasons|0|||
33394027|NCT01365091|101328592|FG000|Period 2|Withdrawal by Subject|1|||
33394028|NCT01365091|101328593|FG001|Period 2|Withdrawal by Subject|0|||
33394029|NCT01365091|101328594|FG002|Period 2|Withdrawal by Subject|0|||
33394030|NCT01365091|101328595|FG003|Period 2|Withdrawal by Subject|0|||
33394031|NCT01365091|101328592|FG000|Period 2|Adverse Event|0|||
33394032|NCT01365091|101328593|FG001|Period 2|Adverse Event|0|||
33394033|NCT01365091|101328594|FG002|Period 2|Adverse Event|1|||
33394034|NCT01365091|101328595|FG003|Period 2|Adverse Event|0|||
33394035|NCT02691468|101328596|FG000|Overall Study|Bronchial blocker use|2|||
33394036|NCT02691468|101328597|FG001|Overall Study|Bronchial blocker use|1|||
33394037|NCT02691468|101328596|FG000|Overall Study|Lost to Follow-up|2|||
33308621|NCT00712673|101026132|FG000|Overall Study|Investigator's Decision|1|||
33308622|NCT00712673|101026133|FG001|Overall Study|Investigator's Decision|0|||
33308623|NCT00712673|101026134|FG002|Overall Study|Investigator's Decision|0|||
33308624|NCT00712673|101026135|FG003|Overall Study|Investigator's Decision|0|||
33308625|NCT00712673|101026132|FG000|Overall Study|Protocol Violation|0|||
33308626|NCT00712673|101026133|FG001|Overall Study|Protocol Violation|0|||
33394038|NCT02691468|101328597|FG001|Overall Study|Lost to Follow-up|1|||
33394039|NCT02691468|101328596|FG000|Overall Study|Failure to advance FOB|2|||
33394040|NCT02691468|101328597|FG001|Overall Study|Failure to advance FOB|0|||
33394041|NCT01819194|101328613|FG000|Overall Study|Loss of study articles|2|||
33394042|NCT02668692|101328616|FG000|Overall Study|Adverse Event|1|||
33394043|NCT02668692|101328617|FG001|Overall Study|Adverse Event|0|||
33394044|NCT00209092|101328618|FG000|Overall Study|Progression of disease|7|||
33500643|NCT03852472|101724655|FG004|Period 2 - Week 44|COVID-19 Related|0|||
33500644|NCT03852472|101724651|FG000|Period 2 - Week 44|Reason not stated|0|||
33394045|NCT00209092|101328619|FG001|Overall Study|Progression of disease|1|||
33394046|NCT00209092|101328618|FG000|Overall Study|Adverse Event|0|||
33394047|NCT00209092|101328619|FG001|Overall Study|Adverse Event|1|||
33500645|NCT03852472|101724652|FG001|Period 2 - Week 44|Reason not stated|0|||
33500646|NCT03852472|101724653|FG002|Period 2 - Week 44|Reason not stated|0|||
33500647|NCT03852472|101724654|FG003|Period 2 - Week 44|Reason not stated|0|||
33500648|NCT03852472|101724655|FG004|Period 2 - Week 44|Reason not stated|1|||
33500649|NCT03809663|101724656|FG000|Overall Study|Decision by sponsor|24|||
33500650|NCT03809663|101724657|FG001|Overall Study|Decision by sponsor|18|||
33500651|NCT03809663|101724658|FG002|Overall Study|Decision by sponsor|20|||
33500652|NCT03809663|101724659|FG003|Overall Study|Decision by sponsor|20|||
33500653|NCT03809663|101724660|FG004|Overall Study|Decision by sponsor|0|||
33500654|NCT03809663|101724661|FG005|Overall Study|Decision by sponsor|0|||
33500655|NCT03809663|101724656|FG000|Overall Study|Withdrawal by Subject|26|||
33308627|NCT00712673|101026134|FG002|Overall Study|Protocol Violation|2|||
33394048|NCT00209092|101328618|FG000|Overall Study|Withdrawal by Subject|1|||
33308628|NCT00712673|101026135|FG003|Overall Study|Protocol Violation|0|||
33500656|NCT03809663|101724657|FG001|Overall Study|Withdrawal by Subject|22|||
33500657|NCT03809663|101724658|FG002|Overall Study|Withdrawal by Subject|27|||
33308629|NCT00309959|101026136|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
33394049|NCT00209092|101328619|FG001|Overall Study|Withdrawal by Subject|0|||
33394050|NCT00693420|101328620|FG000|Overall Study|Adverse Event|4|||
33394051|NCT00693420|101328621|FG001|Overall Study|Adverse Event|4|||
33394052|NCT00693420|101328620|FG000|Overall Study|Lost to Follow-up|0|||
33394053|NCT00693420|101328621|FG001|Overall Study|Lost to Follow-up|3|||
33394054|NCT00693420|101328620|FG000|Overall Study|Withdrawal by Subject|1|||
33394055|NCT00693420|101328621|FG001|Overall Study|Withdrawal by Subject|0|||
33394056|NCT00693420|101328620|FG000|Overall Study|Protocol Violation|0|||
33394057|NCT00693420|101328621|FG001|Overall Study|Protocol Violation|2|||
33394058|NCT00693420|101328620|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
33394059|NCT00693420|101328621|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
33394060|NCT00693420|101328620|FG000|Overall Study|Personal Reasons|1|||
33394061|NCT00693420|101328621|FG001|Overall Study|Personal Reasons|4|||
33394062|NCT03418376|101328622|FG000|Overall Study|Musculoskeletal injury|1|||
33394063|NCT03418376|101328623|FG001|Overall Study|Musculoskeletal injury|2|||
33394064|NCT03418376|101328624|FG002|Overall Study|Musculoskeletal injury|1|||
33394065|NCT03418376|101328625|FG003|Overall Study|Musculoskeletal injury|0|||
33394066|NCT03418376|101328622|FG000|Overall Study|Personal reasons|0|||
33394067|NCT03418376|101328623|FG001|Overall Study|Personal reasons|2|||
33394068|NCT03418376|101328624|FG002|Overall Study|Personal reasons|2|||
33394069|NCT03418376|101328625|FG003|Overall Study|Personal reasons|1|||
33394070|NCT03418376|101328622|FG000|Overall Study|Exacerbation|0|||
33394071|NCT03418376|101328623|FG001|Overall Study|Exacerbation|1|||
33394072|NCT03418376|101328624|FG002|Overall Study|Exacerbation|0|||
33394073|NCT03418376|101328625|FG003|Overall Study|Exacerbation|0|||
33394074|NCT01387074|101328626|FG000|Overall Study|Lost to Follow-up|7|||
33394075|NCT01387074|101328626|FG000|Overall Study|Lack of Efficacy|1|||
33394076|NCT03878160|101328636|FG000|Overall Study|Lost to Follow-up|1|||
33394077|NCT03878160|101328637|FG001|Overall Study|Lost to Follow-up|1|||
33394078|NCT03878160|101328638|FG002|Overall Study|Lost to Follow-up|1|||
33394079|NCT03878160|101328636|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
33394080|NCT03878160|101328637|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
33394081|NCT03878160|101328638|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
33394082|NCT04489940|101328640|FG000|Overall Study|Other|2|||
33394083|NCT04489940|101328640|FG000|Overall Study|Withdrawal by Subject|2|||
33394084|NCT04489940|101328640|FG000|Overall Study|Death|5|||
33394085|NCT04489940|101328640|FG000|Overall Study|Lost to Follow-up|1|||
33394086|NCT03152110|101328641|FG000|Overall Study|Withdrawal by Subject|3|||
33394087|NCT01625611|101328644|FG000|Overall Study|No adlib drinks Lab 1|3|||
33394088|NCT01625611|101328645|FG001|Overall Study|No adlib drinks Lab 1|0|||
33394089|NCT01625611|101328644|FG000|Overall Study|Technical issues with PET|1|||
33394090|NCT01625611|101328645|FG001|Overall Study|Technical issues with PET|0|||
33394091|NCT01625611|101328644|FG000|Overall Study|Unable to complete study procedures|1|||
33394092|NCT01625611|101328645|FG001|Overall Study|Unable to complete study procedures|0|||
33192059|NCT01420081|100608560|FG002|Overall Study|Death|8|||
33192060|NCT01420081|100608561|FG003|Overall Study|Death|0|||
33394093|NCT01625611|101328644|FG000|Overall Study|Withdrawal by Subject|3|||
33394094|NCT01625611|101328645|FG001|Overall Study|Withdrawal by Subject|0|||
33394095|NCT00441727|101328646|FG000|Overall Study|Protocol Violation|19|||
33394096|NCT00441727|101328647|FG001|Overall Study|Protocol Violation|28|||
33394097|NCT00441727|101328648|FG002|Overall Study|Protocol Violation|32|||
33394098|NCT00441727|101328646|FG000|Overall Study|Adverse Event|26|||
33394099|NCT00441727|101328647|FG001|Overall Study|Adverse Event|33|||
33394100|NCT00441727|101328648|FG002|Overall Study|Adverse Event|28|||
33394101|NCT00441727|101328646|FG000|Overall Study|Lack of Efficacy|7|||
33192061|NCT01420081|100608562|FG004|Overall Study|Death|7|||
33192062|NCT01420081|100608563|FG005|Overall Study|Death|12|||
33192063|NCT01420081|100608564|FG006|Overall Study|Death|0|||
33192064|NCT01420081|100608565|FG007|Overall Study|Death|1|||
33192065|NCT01420081|100608566|FG008|Overall Study|Death|1|||
33394102|NCT00441727|101328647|FG001|Overall Study|Lack of Efficacy|8|||
33394103|NCT00441727|101328648|FG002|Overall Study|Lack of Efficacy|48|||
33394104|NCT00441727|101328646|FG000|Overall Study|Withdrawal by Subject|40|||
33394105|NCT00441727|101328647|FG001|Overall Study|Withdrawal by Subject|34|||
33394106|NCT00441727|101328648|FG002|Overall Study|Withdrawal by Subject|47|||
33394107|NCT00441727|101328646|FG000|Overall Study|Lost to Follow-up|5|||
33394108|NCT00441727|101328647|FG001|Overall Study|Lost to Follow-up|6|||
33394109|NCT00441727|101328648|FG002|Overall Study|Lost to Follow-up|5|||
33394110|NCT00441727|101328646|FG000|Overall Study|Safety Reasons|3|||
33394111|NCT00441727|101328647|FG001|Overall Study|Safety Reasons|1|||
33394112|NCT00441727|101328648|FG002|Overall Study|Safety Reasons|3|||
33394113|NCT00441727|101328646|FG000|Overall Study|Various reason specified|6|||
33394114|NCT00441727|101328647|FG001|Overall Study|Various reason specified|8|||
33394115|NCT00441727|101328648|FG002|Overall Study|Various reason specified|5|||
33394116|NCT02853123|101328649|FG000|Treatment Period 1|Adverse Event|0|||
33394117|NCT02853123|101328650|FG001|Treatment Period 1|Adverse Event|3|||
33192066|NCT01420081|100608558|FG000|Overall Study|Lost to Follow-up|0|||
33192067|NCT01420081|100608559|FG001|Overall Study|Lost to Follow-up|0|||
33308630|NCT04493502|101026137|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
33308631|NCT04493502|101026138|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
33308632|NCT04493502|101026137|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
33308633|NCT04493502|101026138|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
33308634|NCT04493502|101026137|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
33308635|NCT04493502|101026138|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
33308636|NCT04493502|101026137|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
33308637|NCT04493502|101026138|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
33308638|NCT04493502|101026137|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
33308639|NCT04493502|101026138|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
33308640|NCT04493502|101026137|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
33308641|NCT04493502|101026138|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
33394118|NCT02853123|101328649|FG000|Washout Period|Worsening of COPD|0|||
33308642|NCT04493502|101026137|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
33308643|NCT04493502|101026138|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
33308644|NCT04493502|101026137|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
33308645|NCT04493502|101026138|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
33308646|NCT04493502|101026137|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
33308647|NCT04493502|101026138|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
33308648|NCT04493502|101026137|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
33308649|NCT04493502|101026138|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
33308650|NCT04493502|101026137|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
33308651|NCT04493502|101026138|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
33308652|NCT04493502|101026137|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
33308653|NCT04493502|101026138|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
33308654|NCT04493502|101026137|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
33308655|NCT04493502|101026138|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
33308656|NCT00688103|101026144|FG000|Overall Study|Adverse Event|4|||
33308657|NCT00688103|101026145|FG001|Overall Study|Adverse Event|1|||
33308658|NCT00688103|101026144|FG000|Overall Study|Lack of Efficacy|11|||
33308659|NCT00688103|101026145|FG001|Overall Study|Lack of Efficacy|1|||
33308660|NCT00688103|101026144|FG000|Overall Study|Withdrawal by Subject|4|||
33308661|NCT00688103|101026145|FG001|Overall Study|Withdrawal by Subject|2|||
33308662|NCT00688103|101026144|FG000|Overall Study|complex reasons|11|||
33308663|NCT00688103|101026145|FG001|Overall Study|complex reasons|9|||
33308664|NCT03866473|101026146|FG000|Phase 1|Death|1|||
33308665|NCT03866473|101026147|FG001|Phase 1|Death|0|||
33308666|NCT03866473|101026146|FG000|Phase 2|Death|0|||
33308667|NCT03866473|101026147|FG001|Phase 2|Death|2|||
33308668|NCT03866473|101026146|FG000|Phase 2|Dropped|1|||
33308669|NCT03866473|101026147|FG001|Phase 2|Dropped|1|||
33308670|NCT03866473|101026146|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
33308671|NCT03866473|101026147|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
33308672|NCT00598273|101026148|FG000|Overall Study|Adverse Event|4|||
33308673|NCT00598273|101026149|FG001|Overall Study|Adverse Event|5|||
33308674|NCT00598273|101026150|FG002|Overall Study|Adverse Event|2|||
33308675|NCT00598273|101026148|FG000|Overall Study|Death|6|||
33308676|NCT00598273|101026149|FG001|Overall Study|Death|12|||
33308677|NCT00598273|101026150|FG002|Overall Study|Death|8|||
33308678|NCT00598273|101026148|FG000|Overall Study|Lost to Follow-up|8|||
33308679|NCT00598273|101026149|FG001|Overall Study|Lost to Follow-up|3|||
33308680|NCT00598273|101026150|FG002|Overall Study|Lost to Follow-up|5|||
33308681|NCT00598273|101026148|FG000|Overall Study|Physician Decision|0|||
33308682|NCT00598273|101026149|FG001|Overall Study|Physician Decision|0|||
33394119|NCT02853123|101328650|FG001|Washout Period|Worsening of COPD|3|||
33394120|NCT02853123|101328649|FG000|Washout Period|Adverse Event|1|||
33192068|NCT01420081|100608560|FG002|Overall Study|Lost to Follow-up|0|||
33308683|NCT00598273|101026150|FG002|Overall Study|Physician Decision|1|||
33308684|NCT00598273|101026148|FG000|Overall Study|Withdrawal by Subject|12|||
33308685|NCT00598273|101026149|FG001|Overall Study|Withdrawal by Subject|10|||
33308686|NCT00598273|101026150|FG002|Overall Study|Withdrawal by Subject|10|||
33308687|NCT00598273|101026148|FG000|Overall Study|Noncompliance|3|||
33308688|NCT00598273|101026149|FG001|Overall Study|Noncompliance|2|||
33308689|NCT00598273|101026150|FG002|Overall Study|Noncompliance|3|||
33308690|NCT00598273|101026148|FG000|Overall Study|Relocation|0|||
33308691|NCT00598273|101026149|FG001|Overall Study|Relocation|2|||
33308692|NCT00598273|101026150|FG002|Overall Study|Relocation|4|||
33308693|NCT00598273|101026148|FG000|Overall Study|Renal transplant|1|||
33308694|NCT00598273|101026149|FG001|Overall Study|Renal transplant|0|||
33308695|NCT00598273|101026150|FG002|Overall Study|Renal transplant|1|||
33308696|NCT00598273|101026148|FG000|Overall Study|Site elected to close|1|||
33308697|NCT00598273|101026149|FG001|Overall Study|Site elected to close|0|||
33308698|NCT00598273|101026150|FG002|Overall Study|Site elected to close|0|||
33394121|NCT02853123|101328650|FG001|Washout Period|Adverse Event|0|||
33394122|NCT03369704|101328651|FG000|Treatment Epoch|technical problems|1|||
33394123|NCT03369704|101328652|FG001|Treatment Epoch|technical problems|0|||
33394124|NCT03369704|101328651|FG000|Treatment Epoch|Protocol Violation|1|||
33308699|NCT00598273|101026148|FG000|Overall Study|Started dialysis|6|||
33308700|NCT00598273|101026149|FG001|Overall Study|Started dialysis|4|||
33308701|NCT00598273|101026150|FG002|Overall Study|Started dialysis|5|||
33308702|NCT01049217|101026151|FG000|Overall Study|Adverse Event|2|||
33308703|NCT01049217|101026152|FG001|Overall Study|Adverse Event|1|||
33308704|NCT01049217|101026151|FG000|Overall Study|Lack of Efficacy|1|||
33308705|NCT01049217|101026152|FG001|Overall Study|Lack of Efficacy|1|||
33308706|NCT01049217|101026151|FG000|Overall Study|Lost to Follow-up|3|||
33308707|NCT01049217|101026152|FG001|Overall Study|Lost to Follow-up|8|||
33308708|NCT01049217|101026151|FG000|Overall Study|Withdrawal by Subject|4|||
33308709|NCT01049217|101026152|FG001|Overall Study|Withdrawal by Subject|3|||
33308710|NCT01049217|101026151|FG000|Overall Study|Protocol Violation|1|||
33308711|NCT01049217|101026152|FG001|Overall Study|Protocol Violation|3|||
33308712|NCT01049217|101026151|FG000|Overall Study|Pregnancy|1|||
33308713|NCT01049217|101026152|FG001|Overall Study|Pregnancy|0|||
33308714|NCT01049217|101026151|FG000|Overall Study|Study Terminated by Sponsor|43|||
33308715|NCT01049217|101026152|FG001|Overall Study|Study Terminated by Sponsor|43|||
33308716|NCT01049217|101026151|FG000|Overall Study|Other|1|||
33308717|NCT01049217|101026152|FG001|Overall Study|Other|2|||
33308718|NCT01049217|101026151|FG000|Overall Study|Randomized but not Treated|0|||
33308719|NCT01049217|101026152|FG001|Overall Study|Randomized but not Treated|2|||
33308720|NCT02842827|101026155|FG000|Overall Study|Adverse Event|0|||
33308721|NCT02842827|101026156|FG001|Overall Study|Adverse Event|1|||
33308722|NCT02842827|101026157|FG002|Overall Study|Adverse Event|0|||
33308723|NCT02842827|101026158|FG003|Overall Study|Adverse Event|1|||
33308724|NCT02842827|101026159|FG004|Overall Study|Adverse Event|0|||
33308725|NCT02842827|101026160|FG005|Overall Study|Adverse Event|1|||
33308726|NCT02842827|101026161|FG006|Overall Study|Adverse Event|0|||
33308727|NCT02842827|101026162|FG007|Overall Study|Adverse Event|0|||
33308728|NCT02842827|101026155|FG000|Overall Study|Death|1|||
33308729|NCT02842827|101026156|FG001|Overall Study|Death|0|||
33308730|NCT02842827|101026157|FG002|Overall Study|Death|2|||
33308731|NCT02842827|101026158|FG003|Overall Study|Death|3|||
33308732|NCT02842827|101026159|FG004|Overall Study|Death|2|||
33308733|NCT02842827|101026160|FG005|Overall Study|Death|1|||
33308734|NCT02842827|101026161|FG006|Overall Study|Death|0|||
33308735|NCT02842827|101026162|FG007|Overall Study|Death|4|||
33308736|NCT02842827|101026155|FG000|Overall Study|Physician Decision|1|||
33308737|NCT02842827|101026156|FG001|Overall Study|Physician Decision|3|||
33308738|NCT02842827|101026157|FG002|Overall Study|Physician Decision|0|||
33308739|NCT02842827|101026158|FG003|Overall Study|Physician Decision|0|||
33308740|NCT02842827|101026159|FG004|Overall Study|Physician Decision|1|||
33308741|NCT02842827|101026160|FG005|Overall Study|Physician Decision|4|||
33308742|NCT02842827|101026161|FG006|Overall Study|Physician Decision|2|||
33308743|NCT02842827|101026162|FG007|Overall Study|Physician Decision|1|||
33308744|NCT02842827|101026155|FG000|Overall Study|Protocol Defined Disease Progression|0|||
33308745|NCT02842827|101026156|FG001|Overall Study|Protocol Defined Disease Progression|0|||
33308746|NCT02842827|101026157|FG002|Overall Study|Protocol Defined Disease Progression|0|||
33308747|NCT02842827|101026158|FG003|Overall Study|Protocol Defined Disease Progression|0|||
33308748|NCT02842827|101026159|FG004|Overall Study|Protocol Defined Disease Progression|0|||
33308749|NCT02842827|101026160|FG005|Overall Study|Protocol Defined Disease Progression|1|||
33308750|NCT02842827|101026161|FG006|Overall Study|Protocol Defined Disease Progression|0|||
33308751|NCT02842827|101026162|FG007|Overall Study|Protocol Defined Disease Progression|0|||
33308752|NCT02842827|101026155|FG000|Overall Study|Participant Withdrawal of Consent|1|||
33394125|NCT03369704|101328652|FG001|Treatment Epoch|Protocol Violation|0|||
33394126|NCT03369704|101328651|FG000|Treatment Epoch|Lost to Follow-up|0|||
33308753|NCT02842827|101026156|FG001|Overall Study|Participant Withdrawal of Consent|2|||
33308754|NCT02842827|101026157|FG002|Overall Study|Participant Withdrawal of Consent|2|||
33308755|NCT02842827|101026158|FG003|Overall Study|Participant Withdrawal of Consent|2|||
33394127|NCT03369704|101328652|FG001|Treatment Epoch|Lost to Follow-up|1|||
33394128|NCT03369704|101328651|FG000|Treatment Epoch|Lack of Efficacy|0|||
33394129|NCT03369704|101328652|FG001|Treatment Epoch|Lack of Efficacy|2|||
33394130|NCT03369704|101328651|FG000|Treatment Epoch|Adverse Event|2|||
33394131|NCT03369704|101328652|FG001|Treatment Epoch|Adverse Event|0|||
33394132|NCT03369704|101328651|FG000|Follow-up Epoch|Lost to Follow-up|1|||
33394133|NCT03369704|101328652|FG001|Follow-up Epoch|Lost to Follow-up|0|||
33394134|NCT01681836|101328653|FG000|Second Intervention|Withdrawal by Subject|0|||
33394135|NCT01681836|101328654|FG001|Second Intervention|Withdrawal by Subject|1|||
33394136|NCT01431521|101331659|FG000|Overall Study|Withdrawal by Subject|0|||
33394137|NCT01431521|101331660|FG001|Overall Study|Withdrawal by Subject|0|||
33394138|NCT01431521|101331661|FG002|Overall Study|Withdrawal by Subject|1|||
33394139|NCT01431521|101331662|FG003|Overall Study|Withdrawal by Subject|0|||
33394140|NCT01782885|101331663|FG000|Overall Study|Lost to Follow-up|4|||
33601528|NCT02124772|102091968|FG012|Overall Study|Adverse Event|1|||
33308756|NCT02842827|101026159|FG004|Overall Study|Participant Withdrawal of Consent|2|||
33308757|NCT02842827|101026160|FG005|Overall Study|Participant Withdrawal of Consent|1|||
33308758|NCT02842827|101026161|FG006|Overall Study|Participant Withdrawal of Consent|2|||
33308759|NCT02842827|101026162|FG007|Overall Study|Participant Withdrawal of Consent|1|||
33308760|NCT00522873|101026165|FG000|Overall Study|Adverse Event|41|||
33308761|NCT00522873|101026166|FG001|Overall Study|Adverse Event|26|||
33308762|NCT00522873|101026165|FG000|Overall Study|Withdrawal by Subject|20|||
33308763|NCT00522873|101026166|FG001|Overall Study|Withdrawal by Subject|9|||
33308764|NCT00522873|101026165|FG000|Overall Study|Protocol Violation|14|||
33308765|NCT00522873|101026166|FG001|Overall Study|Protocol Violation|4|||
33308766|NCT00522873|101026165|FG000|Overall Study|Lost to Follow-up|11|||
33308767|NCT00522873|101026166|FG001|Overall Study|Lost to Follow-up|3|||
33308768|NCT00522873|101026165|FG000|Overall Study|Personal Reasons|8|||
33308769|NCT00522873|101026166|FG001|Overall Study|Personal Reasons|1|||
33308770|NCT00522873|101026165|FG000|Overall Study|Medication Errors|1|||
33308771|NCT00522873|101026166|FG001|Overall Study|Medication Errors|1|||
33308772|NCT00522873|101026165|FG000|Overall Study|Never Received Medication|1|||
33308773|NCT00522873|101026166|FG001|Overall Study|Never Received Medication|0|||
33308774|NCT00461032|101026167|FG000|Overall Study|Adverse Event|5|||
33308775|NCT00461032|101026168|FG001|Overall Study|Adverse Event|6|||
33394141|NCT01782885|101331664|FG001|Overall Study|Lost to Follow-up|6|||
33394142|NCT00430027|101331667|FG000|Overall Study|Study terminated|8|||
33394143|NCT01040728|101331668|FG000|Overall Study|Adverse Event|4|||
33601529|NCT02124772|102091956|FG000|Overall Study|Withdrawal consent|0|||
33601530|NCT02124772|102091957|FG001|Overall Study|Withdrawal consent|1|||
33601531|NCT02124772|102091958|FG002|Overall Study|Withdrawal consent|1|||
33601532|NCT02124772|102091959|FG003|Overall Study|Withdrawal consent|1|||
33601533|NCT02124772|102091960|FG004|Overall Study|Withdrawal consent|0|||
33601534|NCT02124772|102091961|FG005|Overall Study|Withdrawal consent|1|||
33601535|NCT02124772|102091962|FG006|Overall Study|Withdrawal consent|1|||
33601536|NCT02124772|102091963|FG007|Overall Study|Withdrawal consent|0|||
33601537|NCT02124772|102091964|FG008|Overall Study|Withdrawal consent|0|||
33601538|NCT02124772|102091965|FG009|Overall Study|Withdrawal consent|1|||
33601539|NCT02124772|102091966|FG010|Overall Study|Withdrawal consent|0|||
33601540|NCT02124772|102091967|FG011|Overall Study|Withdrawal consent|1|||
33308776|NCT00461032|101026167|FG000|Overall Study|Lack of Efficacy|5|||
33308777|NCT00461032|101026168|FG001|Overall Study|Lack of Efficacy|1|||
33394144|NCT01040728|101331669|FG001|Overall Study|Adverse Event|8|||
33500658|NCT03809663|101724659|FG003|Overall Study|Withdrawal by Subject|26|||
33500659|NCT03809663|101724660|FG004|Overall Study|Withdrawal by Subject|0|||
33500660|NCT03809663|101724661|FG005|Overall Study|Withdrawal by Subject|0|||
33500661|NCT03809663|101724656|FG000|Overall Study|Lost to Follow-up|1|||
33500662|NCT03809663|101724657|FG001|Overall Study|Lost to Follow-up|4|||
33500663|NCT03809663|101724658|FG002|Overall Study|Lost to Follow-up|1|||
33500664|NCT03809663|101724659|FG003|Overall Study|Lost to Follow-up|1|||
33500665|NCT03809663|101724660|FG004|Overall Study|Lost to Follow-up|0|||
33500666|NCT03809663|101724661|FG005|Overall Study|Lost to Follow-up|0|||
33500667|NCT00171210|101724666|FG000|Overall Study|Adverse Event|16|||
33500668|NCT00171210|101724667|FG001|Overall Study|Adverse Event|27|||
33394145|NCT01040728|101331670|FG002|Overall Study|Adverse Event|0|||
33394146|NCT01040728|101331671|FG003|Overall Study|Adverse Event|4|||
33394147|NCT01040728|101331668|FG000|Overall Study|Withdrawal by Subject|0|||
33394148|NCT01040728|101331669|FG001|Overall Study|Withdrawal by Subject|1|||
33394149|NCT01040728|101331670|FG002|Overall Study|Withdrawal by Subject|1|||
33394150|NCT01040728|101331671|FG003|Overall Study|Withdrawal by Subject|0|||
33394151|NCT01040728|101331668|FG000|Overall Study|Protocol Violation|0|||
33394152|NCT01040728|101331669|FG001|Overall Study|Protocol Violation|0|||
33394153|NCT01040728|101331670|FG002|Overall Study|Protocol Violation|0|||
33394154|NCT01040728|101331671|FG003|Overall Study|Protocol Violation|1|||
33394155|NCT01040728|101331668|FG000|Overall Study|Lack of Efficacy|0|||
33394156|NCT01040728|101331669|FG001|Overall Study|Lack of Efficacy|1|||
33394157|NCT01040728|101331670|FG002|Overall Study|Lack of Efficacy|0|||
33394158|NCT01040728|101331671|FG003|Overall Study|Lack of Efficacy|1|||
33394159|NCT01040728|101331668|FG000|Overall Study|Other reasons not listed above|0|||
33394160|NCT01040728|101331669|FG001|Overall Study|Other reasons not listed above|1|||
33394161|NCT01040728|101331670|FG002|Overall Study|Other reasons not listed above|0|||
33394162|NCT01040728|101331671|FG003|Overall Study|Other reasons not listed above|0|||
33394163|NCT00149890|101331675|FG000|Overall Study|Adverse Event|1|||
33394164|NCT00149890|101331676|FG001|Overall Study|Adverse Event|8|||
33500669|NCT00171210|101724666|FG000|Overall Study|Abnormal laboratory value(s)|6|||
33192069|NCT01420081|100608561|FG003|Overall Study|Lost to Follow-up|0|||
33394165|NCT00149890|101331675|FG000|Overall Study|Lack of Efficacy|8|||
33394166|NCT00149890|101331676|FG001|Overall Study|Lack of Efficacy|9|||
33394167|NCT00149890|101331675|FG000|Overall Study|Protocol Violation|1|||
33394168|NCT00149890|101331676|FG001|Overall Study|Protocol Violation|0|||
33394169|NCT00149890|101331675|FG000|Overall Study|Lost to Follow-up|1|||
33394170|NCT00149890|101331676|FG001|Overall Study|Lost to Follow-up|0|||
33394171|NCT00149890|101331675|FG000|Overall Study|Graft Loss|2|||
33500670|NCT00171210|101724667|FG001|Overall Study|Abnormal laboratory value(s)|3|||
33500671|NCT00171210|101724666|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33394172|NCT00149890|101331676|FG001|Overall Study|Graft Loss|1|||
33601541|NCT02124772|102091968|FG012|Overall Study|Withdrawal consent|0|||
33601542|NCT02124772|102091956|FG000|Overall Study|Investigator discretion|0|||
33601543|NCT02124772|102091957|FG001|Overall Study|Investigator discretion|2|||
33601544|NCT02124772|102091958|FG002|Overall Study|Investigator discretion|2|||
33601545|NCT02124772|102091959|FG003|Overall Study|Investigator discretion|1|||
33601546|NCT02124772|102091960|FG004|Overall Study|Investigator discretion|1|||
33601547|NCT02124772|102091961|FG005|Overall Study|Investigator discretion|0|||
33601548|NCT02124772|102091962|FG006|Overall Study|Investigator discretion|1|||
33601549|NCT02124772|102091963|FG007|Overall Study|Investigator discretion|0|||
33601550|NCT02124772|102091964|FG008|Overall Study|Investigator discretion|0|||
33601551|NCT02124772|102091965|FG009|Overall Study|Investigator discretion|1|||
33601552|NCT02124772|102091966|FG010|Overall Study|Investigator discretion|0|||
33601553|NCT02124772|102091967|FG011|Overall Study|Investigator discretion|1|||
33601554|NCT02124772|102091968|FG012|Overall Study|Investigator discretion|0|||
33601555|NCT02124772|102091956|FG000|Overall Study|Progressive disease|0|||
33601556|NCT02124772|102091957|FG001|Overall Study|Progressive disease|0|||
33601557|NCT02124772|102091958|FG002|Overall Study|Progressive disease|0|||
33601558|NCT02124772|102091959|FG003|Overall Study|Progressive disease|0|||
33601559|NCT02124772|102091960|FG004|Overall Study|Progressive disease|0|||
33601560|NCT02124772|102091961|FG005|Overall Study|Progressive disease|0|||
33601561|NCT02124772|102091962|FG006|Overall Study|Progressive disease|1|||
33601562|NCT02124772|102091963|FG007|Overall Study|Progressive disease|1|||
33601563|NCT02124772|102091964|FG008|Overall Study|Progressive disease|0|||
33601564|NCT02124772|102091965|FG009|Overall Study|Progressive disease|0|||
33601565|NCT02124772|102091966|FG010|Overall Study|Progressive disease|0|||
33601566|NCT02124772|102091967|FG011|Overall Study|Progressive disease|0|||
33601567|NCT02124772|102091968|FG012|Overall Study|Progressive disease|0|||
33601568|NCT02124772|102091956|FG000|Overall Study|Other|0|||
33601569|NCT02124772|102091957|FG001|Overall Study|Other|7|||
33601570|NCT02124772|102091958|FG002|Overall Study|Other|2|||
33601571|NCT02124772|102091959|FG003|Overall Study|Other|5|||
33601572|NCT02124772|102091960|FG004|Overall Study|Other|4|||
33601573|NCT02124772|102091961|FG005|Overall Study|Other|3|||
33601574|NCT02124772|102091962|FG006|Overall Study|Other|4|||
33601575|NCT02124772|102091963|FG007|Overall Study|Other|1|||
33601576|NCT02124772|102091964|FG008|Overall Study|Other|1|||
33601577|NCT02124772|102091965|FG009|Overall Study|Other|1|||
33601578|NCT02124772|102091966|FG010|Overall Study|Other|1|||
33601579|NCT02124772|102091967|FG011|Overall Study|Other|1|||
33601580|NCT02124772|102091968|FG012|Overall Study|Other|0|||
33601581|NCT00831701|102091969|FG000|Overall Study|Withdrawal by Subject|2|||
33601582|NCT00831701|102091970|FG001|Overall Study|Withdrawal by Subject|0|||
33601583|NCT00831701|102091969|FG000|Overall Study|Stone expulsion before first medication|2|||
33601584|NCT00831701|102091970|FG001|Overall Study|Stone expulsion before first medication|2|||
33601585|NCT00831701|102091969|FG000|Overall Study|Lost to Follow-up|1|||
33601586|NCT00831701|102091970|FG001|Overall Study|Lost to Follow-up|3|||
33601587|NCT01739803|102091972|FG000|Overall Study|Lost to Follow-up|9|||
33601588|NCT01739803|102091973|FG001|Overall Study|Lost to Follow-up|6|||
33601589|NCT03369431|102091974|FG000|Overall Study|Lost to Follow-up|1|||
33601590|NCT03369431|102091975|FG001|Overall Study|Lost to Follow-up|3|||
33601591|NCT03369431|102091974|FG000|Overall Study|Withdrawal by Subject|2|||
33601592|NCT03369431|102091975|FG001|Overall Study|Withdrawal by Subject|3|||
33601593|NCT03369431|102091974|FG000|Overall Study|Protocol Violation|1|||
33601594|NCT03369431|102091975|FG001|Overall Study|Protocol Violation|1|||
33601595|NCT04376827|102091976|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
33601596|NCT04376827|102091977|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
33601597|NCT04376827|102091976|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
33601598|NCT04376827|102091977|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
33601599|NCT04376827|102091976|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
33601600|NCT04376827|102091977|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
33601601|NCT04376827|102091976|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
33601602|NCT04376827|102091977|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
33601603|NCT04376827|102091976|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
33601604|NCT04376827|102091977|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
33601605|NCT01116427|102091978|FG000|Core Phase|Adverse Event|0|||
33601606|NCT01116427|102091979|FG001|Core Phase|Adverse Event|1|||
33601607|NCT01116427|102091978|FG000|Core Phase|Lost to Follow-up|1|||
33601608|NCT01116427|102091979|FG001|Core Phase|Lost to Follow-up|0|||
33601609|NCT01116427|102091978|FG000|Core Phase|Withdrawal by Subject|3|||
33601610|NCT01116427|102091979|FG001|Core Phase|Withdrawal by Subject|0|||
33601611|NCT01116427|102091978|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
33192070|NCT01420081|100608562|FG004|Overall Study|Lost to Follow-up|1|||
33192071|NCT01420081|100608563|FG005|Overall Study|Lost to Follow-up|1|||
33192072|NCT01420081|100608564|FG006|Overall Study|Lost to Follow-up|0|||
33192073|NCT01420081|100608565|FG007|Overall Study|Lost to Follow-up|0|||
33192074|NCT01420081|100608566|FG008|Overall Study|Lost to Follow-up|0|||
33192075|NCT01420081|100608558|FG000|Overall Study|Study Terminated by Sponsor|2|||
33192076|NCT01420081|100608559|FG001|Overall Study|Study Terminated by Sponsor|1|||
33192077|NCT01420081|100608560|FG002|Overall Study|Study Terminated by Sponsor|1|||
33192078|NCT01420081|100608561|FG003|Overall Study|Study Terminated by Sponsor|3|||
33192079|NCT01420081|100608562|FG004|Overall Study|Study Terminated by Sponsor|11|||
33192080|NCT01420081|100608563|FG005|Overall Study|Study Terminated by Sponsor|7|||
33192081|NCT01420081|100608564|FG006|Overall Study|Study Terminated by Sponsor|3|||
33192082|NCT01420081|100608565|FG007|Overall Study|Study Terminated by Sponsor|2|||
33192083|NCT01420081|100608566|FG008|Overall Study|Study Terminated by Sponsor|2|||
33192084|NCT01420081|100608558|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
33192085|NCT01420081|100608559|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
33192086|NCT01420081|100608560|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
33192087|NCT01420081|100608561|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
33192088|NCT01420081|100608562|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
33192089|NCT01420081|100608563|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
33192090|NCT01420081|100608564|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
33192091|NCT01420081|100608565|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
33192092|NCT01420081|100608566|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
33192093|NCT01420081|100608558|FG000|Overall Study|Other Reasons|0|||
33192094|NCT01420081|100608559|FG001|Overall Study|Other Reasons|0|||
33192095|NCT01420081|100608560|FG002|Overall Study|Other Reasons|1|||
33192096|NCT01420081|100608561|FG003|Overall Study|Other Reasons|0|||
33192097|NCT01420081|100608562|FG004|Overall Study|Other Reasons|0|||
33192098|NCT01420081|100608563|FG005|Overall Study|Other Reasons|0|||
33192099|NCT01420081|100608564|FG006|Overall Study|Other Reasons|0|||
33192100|NCT01420081|100608565|FG007|Overall Study|Other Reasons|0|||
33192101|NCT01420081|100608566|FG008|Overall Study|Other Reasons|0|||
33192102|NCT02310672|100608567|FG000|Overall Study|Death|1|||
33192103|NCT02310672|100608567|FG000|Overall Study|Lost to Follow-up|1|||
33192104|NCT02310672|100608567|FG000|Overall Study|Withdrawal by Subject|1|||
33192105|NCT02310672|100608567|FG000|Overall Study|Sponsor's decision|12|||
33308778|NCT00461032|101026167|FG000|Overall Study|Lost to Follow-up|7|||
33308779|NCT00461032|101026168|FG001|Overall Study|Lost to Follow-up|12|||
33394173|NCT00985738|101331677|FG000|Overall Study|Study closed prematurely|8|||
33394174|NCT00985738|101331678|FG001|Overall Study|Study closed prematurely|8|||
33308780|NCT00461032|101026167|FG000|Overall Study|Protocol Violation|4|||
33394175|NCT02415595|101331680|FG000|Overall Study|Administrative reason by sponsor|39|||
33192106|NCT00101101|100608572|FG000|Overall Study|never received vaccine|20|||
33192107|NCT00689481|100608573|FG000|Overall Study|Adverse Event|7|||
33192108|NCT00689481|100608574|FG001|Overall Study|Adverse Event|1|||
33192109|NCT00689481|100608573|FG000|Overall Study|Lost to Follow-up|4|||
33308781|NCT00461032|101026168|FG001|Overall Study|Protocol Violation|4|||
33192110|NCT00689481|100608574|FG001|Overall Study|Lost to Follow-up|3|||
33192111|NCT00689481|100608573|FG000|Overall Study|Lack of Efficacy|4|||
33192112|NCT00689481|100608574|FG001|Overall Study|Lack of Efficacy|3|||
33192113|NCT00689481|100608573|FG000|Overall Study|Non-compliance with study treatment|1|||
33192114|NCT00689481|100608574|FG001|Overall Study|Non-compliance with study treatment|1|||
33192115|NCT00689481|100608573|FG000|Overall Study|Withdrawal by Subject|8|||
33192116|NCT00689481|100608574|FG001|Overall Study|Withdrawal by Subject|4|||
33192117|NCT00689481|100608573|FG000|Overall Study|Excluded medication started during study|0|||
33192118|NCT00689481|100608574|FG001|Overall Study|Excluded medication started during study|1|||
33192119|NCT00689481|100608573|FG000|Overall Study|Subject early term, left on vacation|0|||
33192120|NCT00689481|100608574|FG001|Overall Study|Subject early term, left on vacation|1|||
33192121|NCT03417141|100608578|FG000|Overall Study|Withdrawal by Subject|1|||
33192122|NCT03417141|100608578|FG000|Overall Study|Protocol Violation|3|||
33192123|NCT03027466|100608581|FG000|Overall Study|Opting out of the app|1869|||
33192124|NCT03027466|100608582|FG001|Overall Study|Opting out of the app|1819|||
33192125|NCT03027466|100608583|FG002|Overall Study|Opting out of the app|1743|||
33192126|NCT03027466|100608584|FG003|Overall Study|Opting out of the app|1821|||
33192127|NCT01109316|100608585|FG000|Study Period 1|Adverse Event|0|||
33192128|NCT01109316|100608586|FG001|Study Period 1|Adverse Event|0|||
33192129|NCT01109316|100608587|FG002|Study Period 1|Adverse Event|1|||
33308782|NCT00461032|101026167|FG000|Overall Study|Withdrawal by Subject|7|||
33308783|NCT00461032|101026168|FG001|Overall Study|Withdrawal by Subject|15|||
33308784|NCT00461032|101026167|FG000|Overall Study|Patient Moved or Relocated|2|||
33308785|NCT00461032|101026168|FG001|Overall Study|Patient Moved or Relocated|1|||
33308786|NCT00461032|101026167|FG000|Overall Study|Other|7|||
33308787|NCT00461032|101026168|FG001|Overall Study|Other|5|||
33308788|NCT02390245|101026170|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
33308789|NCT02390245|101026171|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
33308790|NCT02390245|101026172|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
33308791|NCT02390245|101026170|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
33308792|NCT02390245|101026171|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
33308793|NCT02390245|101026172|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
33308794|NCT00560066|101026175|FG000|Overall Study|Death|2|||
33308795|NCT00560066|101026176|FG001|Overall Study|Death|1|||
33308796|NCT00560066|101026175|FG000|Overall Study|Withdrawal by Subject|0|||
33394176|NCT02415595|101331681|FG001|Overall Study|Administrative reason by sponsor|40|||
33394177|NCT02415595|101331682|FG002|Overall Study|Administrative reason by sponsor|41|||
33394178|NCT02415595|101331683|FG003|Overall Study|Administrative reason by sponsor|39|||
33394179|NCT02415595|101331680|FG000|Overall Study|Adverse Event|1|||
33394180|NCT02415595|101331681|FG001|Overall Study|Adverse Event|3|||
33394181|NCT02415595|101331682|FG002|Overall Study|Adverse Event|5|||
33308797|NCT00560066|101026176|FG001|Overall Study|Withdrawal by Subject|3|||
33308798|NCT00560066|101026175|FG000|Overall Study|Lost to Follow-up|4|||
33308799|NCT00560066|101026176|FG001|Overall Study|Lost to Follow-up|10|||
33394182|NCT02415595|101331683|FG003|Overall Study|Adverse Event|10|||
33394183|NCT02415595|101331680|FG000|Overall Study|Lack of Efficacy|4|||
33394184|NCT02415595|101331681|FG001|Overall Study|Lack of Efficacy|4|||
33394185|NCT02415595|101331682|FG002|Overall Study|Lack of Efficacy|0|||
33394186|NCT02415595|101331683|FG003|Overall Study|Lack of Efficacy|0|||
33394187|NCT02415595|101331680|FG000|Overall Study|Lost to Follow-up|1|||
33394188|NCT02415595|101331681|FG001|Overall Study|Lost to Follow-up|3|||
33394189|NCT02415595|101331682|FG002|Overall Study|Lost to Follow-up|1|||
33394190|NCT02415595|101331683|FG003|Overall Study|Lost to Follow-up|1|||
33394191|NCT02415595|101331680|FG000|Overall Study|Poor/Non-compliance|1|||
33394192|NCT02415595|101331681|FG001|Overall Study|Poor/Non-compliance|0|||
33394193|NCT02415595|101331682|FG002|Overall Study|Poor/Non-compliance|1|||
33394194|NCT02415595|101331683|FG003|Overall Study|Poor/Non-compliance|0|||
33394195|NCT02415595|101331680|FG000|Overall Study|Reached stopping criteria|0|||
33394196|NCT02415595|101331681|FG001|Overall Study|Reached stopping criteria|1|||
33394197|NCT02415595|101331682|FG002|Overall Study|Reached stopping criteria|1|||
33394198|NCT02415595|101331683|FG003|Overall Study|Reached stopping criteria|0|||
33394199|NCT02415595|101331680|FG000|Overall Study|Withdrawal by Subject|4|||
33394200|NCT02415595|101331681|FG001|Overall Study|Withdrawal by Subject|0|||
33394201|NCT02415595|101331682|FG002|Overall Study|Withdrawal by Subject|1|||
33394202|NCT02415595|101331683|FG003|Overall Study|Withdrawal by Subject|3|||
33394203|NCT02415595|101331680|FG000|Overall Study|Other|0|||
33394204|NCT02415595|101331681|FG001|Overall Study|Other|1|||
33394205|NCT02415595|101331682|FG002|Overall Study|Other|1|||
33394206|NCT02415595|101331683|FG003|Overall Study|Other|0|||
33394207|NCT05307523|101331685|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
33394208|NCT05307523|101331686|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
33394209|NCT05307523|101331685|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
33394210|NCT05307523|101331686|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
33394211|NCT02513394|101331687|FG000|Overall Study|Withdrawal by Subject|11|||
33394212|NCT02513394|101331688|FG001|Overall Study|Withdrawal by Subject|23|||
33308800|NCT00560066|101026175|FG000|Overall Study|Protocol Violation|0|||
33308801|NCT00560066|101026176|FG001|Overall Study|Protocol Violation|1|||
33308802|NCT00560066|101026175|FG000|Overall Study|Administrative reason|0|||
33308803|NCT00560066|101026176|FG001|Overall Study|Administrative reason|5|||
33394213|NCT02513394|101331687|FG000|Overall Study|Ineligible|1|||
33394214|NCT02513394|101331688|FG001|Overall Study|Ineligible|0|||
33394215|NCT00863317|101331691|FG000|Overall Study|Lost to Follow-up|8|||
33394216|NCT00863317|101331692|FG001|Overall Study|Lost to Follow-up|9|||
33394217|NCT00609167|101331695|FG000|Overall Study|Withdrawal by Subject|1|||
33308804|NCT00560066|101026175|FG000|Overall Study|Missing primary reason|0|||
33394218|NCT00609167|101331696|FG001|Overall Study|Withdrawal by Subject|0|||
33394219|NCT00609167|101331695|FG000|Overall Study|Lack of Efficacy|1|||
33394220|NCT00609167|101331696|FG001|Overall Study|Lack of Efficacy|0|||
33394221|NCT00609167|101331695|FG000|Overall Study|Adverse Event|5|||
33394222|NCT00609167|101331696|FG001|Overall Study|Adverse Event|1|||
33394223|NCT00609167|101331695|FG000|Overall Study|Disease Progression|1|||
33394224|NCT00609167|101331696|FG001|Overall Study|Disease Progression|0|||
33394225|NCT00609167|101331695|FG000|Overall Study|Stem Cell Transplant|0|||
33394226|NCT00609167|101331696|FG001|Overall Study|Stem Cell Transplant|6|||
33394227|NCT03745989|101331699|FG000|Overall Study|Death|3|||
33394228|NCT03745989|101331700|FG001|Overall Study|Death|7|||
33394229|NCT03745989|101331701|FG002|Overall Study|Death|4|||
33394230|NCT03745989|101331699|FG000|Overall Study|Lost to Follow-up|0|||
33394231|NCT03745989|101331700|FG001|Overall Study|Lost to Follow-up|2|||
33394232|NCT03745989|101331701|FG002|Overall Study|Lost to Follow-up|0|||
33394233|NCT03745989|101331699|FG000|Overall Study|Sponsor Decision|0|||
33394234|NCT03745989|101331700|FG001|Overall Study|Sponsor Decision|2|||
33394235|NCT03745989|101331701|FG002|Overall Study|Sponsor Decision|8|||
33394236|NCT03745989|101331699|FG000|Overall Study|Withdrawal by Subject|0|||
33394237|NCT03745989|101331700|FG001|Overall Study|Withdrawal by Subject|1|||
33394238|NCT03745989|101331701|FG002|Overall Study|Withdrawal by Subject|3|||
33394239|NCT02252588|101331702|FG000|Overall Study|Withdrawal by Subject|4|||
33394240|NCT02252588|101331703|FG001|Overall Study|Withdrawal by Subject|0|||
33394241|NCT00471315|101331704|FG000|Overall Study|Adverse Event|7|||
33394242|NCT00471315|101331704|FG000|Overall Study|Withdrawal by Subject|1|||
33394243|NCT02038790|101331711|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
33394244|NCT02038790|101331712|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
33394245|NCT00952419|101331713|FG000|Overall Study|Adverse Event|2|||
33394246|NCT00952419|101331714|FG001|Overall Study|Adverse Event|0|||
33394247|NCT00952419|101331715|FG002|Overall Study|Adverse Event|0|||
33394248|NCT00952419|101331713|FG000|Overall Study|Protocol Violation|3|||
33394249|NCT00952419|101331714|FG001|Overall Study|Protocol Violation|7|||
33394250|NCT00952419|101331715|FG002|Overall Study|Protocol Violation|0|||
33394251|NCT00952419|101331713|FG000|Overall Study|Withdrawal by Subject|1|||
33394252|NCT00952419|101331714|FG001|Overall Study|Withdrawal by Subject|3|||
33394253|NCT00952419|101331715|FG002|Overall Study|Withdrawal by Subject|0|||
33394254|NCT00063986|101331722|FG000|Overall Study|Withdrawal by Subject|1|||
33394255|NCT00063986|101331722|FG000|Overall Study|Ineligible|1|||
33394256|NCT00063986|101331722|FG000|Overall Study|Intra-operatively ineligible|4|||
33394257|NCT02431793|101331725|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
33394258|NCT02431793|101331726|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
33394259|NCT02431793|101331727|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
33394260|NCT02431793|101331725|FG000|Overall Study|Withdrawal by Subject|7|||
33394261|NCT02431793|101331726|FG001|Overall Study|Withdrawal by Subject|5|||
33394262|NCT02431793|101331727|FG002|Overall Study|Withdrawal by Subject|5|||
33394263|NCT02431793|101331725|FG000|Overall Study|Lost to Follow-up|101|||
33394264|NCT02431793|101331726|FG001|Overall Study|Lost to Follow-up|122|||
33394265|NCT02431793|101331727|FG002|Overall Study|Lost to Follow-up|104|||
33394266|NCT02182999|101331728|FG000|Overall Study|Adverse Event|4|||
33394267|NCT02182999|101331729|FG001|Overall Study|Adverse Event|3|||
33394268|NCT02182999|101331728|FG000|Overall Study|Physician Decision|1|||
33601612|NCT01116427|102091979|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
33601613|NCT01116427|102091978|FG000|Extension Phase|Adverse Event|1|||
33601614|NCT01116427|102091979|FG001|Extension Phase|Adverse Event|1|||
33601615|NCT01116427|102091978|FG000|Extension Phase|Lost to Follow-up|2|||
33601616|NCT01116427|102091979|FG001|Extension Phase|Lost to Follow-up|0|||
33601617|NCT01116427|102091978|FG000|Extension Phase|Withdrawal by Subject|5|||
33601618|NCT01116427|102091979|FG001|Extension Phase|Withdrawal by Subject|1|||
33394269|NCT02182999|101331729|FG001|Overall Study|Physician Decision|0|||
33394270|NCT02705755|101331730|FG000|Part A (6 Days)|Adverse Event|1|||
33394271|NCT02705755|101331731|FG001|Part A (6 Days)|Adverse Event|0|||
33394272|NCT02705755|101331732|FG002|Part A (6 Days)|Adverse Event|0|||
33394273|NCT02705755|101331733|FG003|Part A (6 Days)|Adverse Event|0|||
33394274|NCT02705755|101331730|FG000|Part A (6 Days)|Physician Decision|3|||
33394275|NCT02705755|101331731|FG001|Part A (6 Days)|Physician Decision|0|||
33394276|NCT02705755|101331732|FG002|Part A (6 Days)|Physician Decision|0|||
33394277|NCT02705755|101331733|FG003|Part A (6 Days)|Physician Decision|0|||
33394278|NCT02705755|101331730|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
33601619|NCT01116427|102091978|FG000|Extension Phase|Not using appropriate birth control|1|||
33394279|NCT02705755|101331731|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
33394280|NCT02705755|101331732|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
33394281|NCT02705755|101331733|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
33394282|NCT02705755|101331730|FG000|Part C (20 Weeks)|Physician Decision|0|||
33394283|NCT02705755|101331731|FG001|Part C (20 Weeks)|Physician Decision|0|||
33394284|NCT02705755|101331732|FG002|Part C (20 Weeks)|Physician Decision|0|||
33394285|NCT02705755|101331733|FG003|Part C (20 Weeks)|Physician Decision|2|||
33394286|NCT02705755|101331730|FG000|Part C (20 Weeks)|Adverse Event|0|||
33601620|NCT01116427|102091979|FG001|Extension Phase|Not using appropriate birth control|0|||
33394287|NCT02705755|101331731|FG001|Part C (20 Weeks)|Adverse Event|0|||
33601621|NCT03899064|102091980|FG000|Overall Study|Lost to Follow-up|1|||
33394288|NCT02705755|101331732|FG002|Part C (20 Weeks)|Adverse Event|0|||
33394289|NCT02705755|101331733|FG003|Part C (20 Weeks)|Adverse Event|6|||
33394290|NCT02705755|101331730|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
33394291|NCT02705755|101331731|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
33394292|NCT02705755|101331732|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
33394293|NCT02705755|101331733|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
33394294|NCT03099304|101331734|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
33394295|NCT03099304|101331735|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
33394296|NCT03099304|101331736|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
33394297|NCT03099304|101331737|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
33394298|NCT03099304|101331738|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
33394299|NCT03099304|101331739|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
33394300|NCT03099304|101331734|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
33394301|NCT03099304|101331735|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
33394302|NCT03099304|101331736|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
33394303|NCT03099304|101331737|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
33394304|NCT03099304|101331738|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
33394305|NCT03099304|101331739|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
33394306|NCT03099304|101331734|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
33394307|NCT03099304|101331735|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
33394308|NCT03099304|101331736|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
33394309|NCT03099304|101331737|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
33394310|NCT03099304|101331738|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
33394311|NCT03099304|101331739|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
33394312|NCT03099304|101331734|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
33394313|NCT03099304|101331735|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
33394314|NCT03099304|101331736|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
33394315|NCT03099304|101331737|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
33394316|NCT03099304|101331738|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
33394317|NCT03099304|101331739|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
33394318|NCT03099304|101331734|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
33394319|NCT03099304|101331735|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
33394320|NCT03099304|101331736|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
33394321|NCT03099304|101331737|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
33394322|NCT03099304|101331738|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
33500672|NCT00171210|101724667|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33500673|NCT00171210|101724666|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
33500674|NCT00171210|101724667|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
33500675|NCT00171210|101724666|FG000|Overall Study|Protocol Violation|0|||
33500676|NCT00171210|101724667|FG001|Overall Study|Protocol Violation|2|||
33500677|NCT00171210|101724666|FG000|Overall Study|Withdrawal by Subject|32|||
33500678|NCT00171210|101724667|FG001|Overall Study|Withdrawal by Subject|30|||
33500679|NCT00171210|101724666|FG000|Overall Study|Lost to Follow-up|1|||
33500680|NCT00171210|101724667|FG001|Overall Study|Lost to Follow-up|0|||
33500681|NCT00171210|101724666|FG000|Overall Study|Administrative problems|1|||
33500682|NCT00171210|101724667|FG001|Overall Study|Administrative problems|1|||
33500683|NCT00171210|101724666|FG000|Overall Study|Death|2|||
33500684|NCT00171210|101724667|FG001|Overall Study|Death|3|||
33500685|NCT00171210|101724666|FG000|Overall Study|Stopped at end of core|0|||
33500686|NCT00171210|101724667|FG001|Overall Study|Stopped at end of core|32|||
33500687|NCT00171210|101724666|FG000|Overall Study|Stopped at end of extension 1|0|||
33500688|NCT00171210|101724667|FG001|Overall Study|Stopped at end of extension 1|1|||
33500689|NCT02626026|101724668|FG000|Overall Study|Randomized but Never Treated|0|||
33500690|NCT02626026|101724669|FG001|Overall Study|Randomized but Never Treated|0|||
33500691|NCT02626026|101724670|FG002|Overall Study|Randomized but Never Treated|0|||
33500692|NCT02626026|101724671|FG003|Overall Study|Randomized but Never Treated|0|||
33500693|NCT02626026|101724672|FG004|Overall Study|Randomized but Never Treated|1|||
33500694|NCT02626026|101724673|FG005|Overall Study|Randomized but Never Treated|0|||
33500695|NCT03349060|101724674|FG000|Overall Study|Adverse Event|9|||
33500696|NCT03349060|101724675|FG001|Overall Study|Adverse Event|9|||
33500697|NCT03349060|101724676|FG002|Overall Study|Adverse Event|7|||
33500698|NCT03349060|101724674|FG000|Overall Study|Lack of Efficacy|1|||
33500699|NCT03349060|101724675|FG001|Overall Study|Lack of Efficacy|0|||
33500700|NCT03349060|101724676|FG002|Overall Study|Lack of Efficacy|2|||
33394323|NCT03099304|101331739|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
33500701|NCT03349060|101724674|FG000|Overall Study|Lost to Follow-up|2|||
33500702|NCT03349060|101724675|FG001|Overall Study|Lost to Follow-up|1|||
33500703|NCT03349060|101724676|FG002|Overall Study|Lost to Follow-up|1|||
33500704|NCT03349060|101724674|FG000|Overall Study|Protocol Violation|2|||
33500705|NCT03349060|101724675|FG001|Overall Study|Protocol Violation|2|||
33394324|NCT03099304|101331734|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
33394325|NCT03099304|101331735|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
33394326|NCT03099304|101331736|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
33394327|NCT03099304|101331737|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
33394328|NCT03099304|101331738|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
33394329|NCT03099304|101331739|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
33394330|NCT03099304|101331734|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
33500706|NCT03349060|101724676|FG002|Overall Study|Protocol Violation|1|||
33500707|NCT03349060|101724674|FG000|Overall Study|Withdrawal by Subject|5|||
33500708|NCT03349060|101724675|FG001|Overall Study|Withdrawal by Subject|3|||
33500709|NCT03349060|101724676|FG002|Overall Study|Withdrawal by Subject|4|||
33394331|NCT03099304|101331735|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
33500710|NCT03349060|101724674|FG000|Overall Study|Medication error,no linked adverse event|0|||
33500711|NCT03349060|101724675|FG001|Overall Study|Medication error,no linked adverse event|0|||
33500712|NCT03349060|101724676|FG002|Overall Study|Medication error,no linked adverse event|1|||
33500713|NCT03349060|101724674|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
33500714|NCT03349060|101724675|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
33500715|NCT03349060|101724676|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
33500716|NCT03349060|101724674|FG000|Overall Study|Other|2|||
33500717|NCT03349060|101724675|FG001|Overall Study|Other|1|||
33500718|NCT03349060|101724676|FG002|Overall Study|Other|0|||
33500719|NCT00628212|101724680|FG000|Overall Study|Adverse Event|2|||
33500720|NCT00628212|101724681|FG001|Overall Study|Adverse Event|0|||
33500721|NCT00628212|101724682|FG002|Overall Study|Adverse Event|1|||
33500722|NCT00628212|101724683|FG003|Overall Study|Adverse Event|2|||
33500723|NCT00628212|101724680|FG000|Overall Study|Physician Decision|1|||
33192130|NCT01109316|100608588|FG003|Study Period 1|Adverse Event|0|||
33192131|NCT01109316|100608589|FG004|Study Period 1|Adverse Event|0|||
33192132|NCT01109316|100608590|FG005|Study Period 1|Adverse Event|0|||
33192133|NCT01109316|100608585|FG000|Study Period 1|Lost to Follow-up|0|||
33192134|NCT01109316|100608586|FG001|Study Period 1|Lost to Follow-up|0|||
33192135|NCT01109316|100608587|FG002|Study Period 1|Lost to Follow-up|1|||
33192136|NCT01109316|100608588|FG003|Study Period 1|Lost to Follow-up|1|||
33394332|NCT03099304|101331736|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
33500724|NCT00628212|101724681|FG001|Overall Study|Physician Decision|1|||
33500725|NCT00628212|101724682|FG002|Overall Study|Physician Decision|2|||
33500726|NCT00628212|101724683|FG003|Overall Study|Physician Decision|3|||
33500727|NCT00703157|101724689|FG000|Overall Study|Lost to Follow-up|0|||
33500728|NCT00703157|101724690|FG001|Overall Study|Lost to Follow-up|1|||
33192137|NCT01109316|100608589|FG004|Study Period 1|Lost to Follow-up|0|||
33192138|NCT01109316|100608590|FG005|Study Period 1|Lost to Follow-up|0|||
33308805|NCT00560066|101026176|FG001|Overall Study|Missing primary reason|2|||
33308806|NCT00194987|101026177|FG000|Overall Study|Withdrawal by Subject|0|||
33308807|NCT00194987|101026178|FG001|Overall Study|Withdrawal by Subject|3|||
33308808|NCT01815138|101026179|FG000|Overall Study|Withdrawal by Subject|0|||
33308809|NCT01815138|101026180|FG001|Overall Study|Withdrawal by Subject|1|||
33308810|NCT01815138|101026179|FG000|Overall Study|Physician Decision|8|||
33308811|NCT01815138|101026180|FG001|Overall Study|Physician Decision|5|||
33308812|NCT02980731|101026181|FG000|Overall Study|Death|63|||
33308813|NCT02980731|101026181|FG000|Overall Study|Withdrawal by Subject|6|||
33308814|NCT02980731|101026181|FG000|Overall Study|Lost to Follow-up|5|||
33308815|NCT02980731|101026181|FG000|Overall Study|Study terminated by Sponsor|4|||
33308816|NCT02980731|101026181|FG000|Overall Study|Completed survival follow-up period|65|||
33308817|NCT02980731|101026181|FG000|Overall Study|COVID-19 infection|1|||
33308818|NCT02980731|101026181|FG000|Overall Study|Other, not specified|66|||
33308819|NCT02689518|101026182|FG000|Overall Study|Withdrawal by Subject|3|||
33308820|NCT01262677|101026192|FG000|Overall Study|Does not meet entrance criteria|0|||
33308821|NCT01262677|101026193|FG001|Overall Study|Does not meet entrance criteria|2|||
33308822|NCT01262677|101026194|FG002|Overall Study|Does not meet entrance criteria|0|||
33308823|NCT01262677|101026192|FG000|Overall Study|Insufficient clinical response|0|||
33308824|NCT01262677|101026193|FG001|Overall Study|Insufficient clinical response|0|||
33308825|NCT01262677|101026194|FG002|Overall Study|Insufficient clinical response|1|||
33308826|NCT01262677|101026192|FG000|Overall Study|Lost to Follow-up|1|||
33308827|NCT01262677|101026193|FG001|Overall Study|Lost to Follow-up|0|||
33308828|NCT01262677|101026194|FG002|Overall Study|Lost to Follow-up|2|||
33308829|NCT01262677|101026192|FG000|Overall Study|No longer willing to participate|3|||
33308830|NCT01262677|101026193|FG001|Overall Study|No longer willing to participate|3|||
33308831|NCT01262677|101026194|FG002|Overall Study|No longer willing to participate|2|||
33308832|NCT01262677|101026192|FG000|Overall Study|Reason not provided|2|||
33308833|NCT01262677|101026193|FG001|Overall Study|Reason not provided|1|||
33308834|NCT01262677|101026194|FG002|Overall Study|Reason not provided|3|||
33308835|NCT01262677|101026192|FG000|Overall Study|Protocol Violation|0|||
33308836|NCT01262677|101026193|FG001|Overall Study|Protocol Violation|1|||
33308837|NCT01262677|101026194|FG002|Overall Study|Protocol Violation|1|||
33308838|NCT01262677|101026192|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
33308839|NCT01262677|101026193|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
33308840|NCT01262677|101026194|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
33308841|NCT00994682|101026195|FG000|Double Bilnd|Withdrawal by Subject|5|||
33308842|NCT00994682|101026196|FG001|Double Bilnd|Withdrawal by Subject|6|||
33308843|NCT00994682|101026195|FG000|Double Bilnd|Lost to Follow-up|3|||
33308844|NCT00994682|101026196|FG001|Double Bilnd|Lost to Follow-up|3|||
33308845|NCT00994682|101026195|FG000|Double Bilnd|Adverse Event|1|||
33308846|NCT00994682|101026196|FG001|Double Bilnd|Adverse Event|0|||
33308847|NCT00994682|101026195|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
33308848|NCT00994682|101026196|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
33308849|NCT00994682|101026195|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
33308850|NCT00994682|101026196|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
33308851|NCT00994682|101026195|FG000|Pioglitazone Open Label|Physician Decision|6|||
33308852|NCT00994682|101026196|FG001|Pioglitazone Open Label|Physician Decision|1|||
33308853|NCT00434213|101026197|FG000|Overall Study|Adverse Event|12|||
33308854|NCT00434213|101026197|FG000|Overall Study|Lack of Efficacy|9|||
33308855|NCT00434213|101026197|FG000|Overall Study|Lost to Follow-up|14|||
33308856|NCT00434213|101026197|FG000|Overall Study|Withdrawal by Subject|7|||
33308857|NCT00434213|101026197|FG000|Overall Study|Protocol Violation|3|||
33308858|NCT00434213|101026197|FG000|Overall Study|Unable to comply with study visit window|2|||
33308859|NCT00434213|101026197|FG000|Overall Study|Application site reaction|1|||
33308860|NCT00434213|101026197|FG000|Overall Study|Non-compliant to study schedule|1|||
33308861|NCT00903682|101026198|FG000|Overall Study|Adverse Event|6|||
33308862|NCT00903682|101026199|FG001|Overall Study|Adverse Event|13|||
33308863|NCT00903682|101026198|FG000|Overall Study|Lost to Follow-up|1|||
33308864|NCT00903682|101026199|FG001|Overall Study|Lost to Follow-up|0|||
33308865|NCT00903682|101026198|FG000|Overall Study|Withdrawal by Subject|5|||
33308866|NCT00903682|101026199|FG001|Overall Study|Withdrawal by Subject|0|||
33308867|NCT00903682|101026198|FG000|Overall Study|Pregnancy|0|||
33308868|NCT00903682|101026199|FG001|Overall Study|Pregnancy|1|||
33308869|NCT00903682|101026198|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
33308870|NCT00903682|101026199|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
33308871|NCT00903682|101026198|FG000|Overall Study|Subject Non-Compliant|1|||
33308872|NCT00903682|101026199|FG001|Overall Study|Subject Non-Compliant|0|||
33308873|NCT00903682|101026198|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
33308874|NCT00903682|101026199|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
33308875|NCT00903682|101026198|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
33308876|NCT00903682|101026199|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
33308877|NCT00825825|101026200|FG000|First Medication Period (14 Days)|Adverse Event|1|||
33308878|NCT00825825|101026201|FG001|First Medication Period (14 Days)|Adverse Event|0|||
33308879|NCT00825825|101026202|FG002|First Medication Period (14 Days)|Adverse Event|0|||
33308880|NCT00825825|101026203|FG003|First Medication Period (14 Days)|Adverse Event|0|||
33308881|NCT00825825|101026204|FG004|First Medication Period (14 Days)|Adverse Event|0|||
33308882|NCT00825825|101026205|FG005|First Medication Period (14 Days)|Adverse Event|1|||
33308883|NCT00825825|101026200|FG000|First Medication Period (14 Days)|Physician Decision|2|||
33308884|NCT00825825|101026201|FG001|First Medication Period (14 Days)|Physician Decision|0|||
33308885|NCT00825825|101026202|FG002|First Medication Period (14 Days)|Physician Decision|1|||
33308886|NCT00825825|101026203|FG003|First Medication Period (14 Days)|Physician Decision|0|||
33308887|NCT00825825|101026204|FG004|First Medication Period (14 Days)|Physician Decision|0|||
33308888|NCT00825825|101026205|FG005|First Medication Period (14 Days)|Physician Decision|1|||
33308889|NCT00825825|101026200|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
33308890|NCT00825825|101026201|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
33308891|NCT00825825|101026202|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
33308892|NCT00825825|101026203|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
33308893|NCT00825825|101026204|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
33308894|NCT00825825|101026205|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
33308895|NCT00825825|101026200|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
33308896|NCT00825825|101026201|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
33308897|NCT00825825|101026202|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
33308898|NCT00825825|101026203|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
33308899|NCT00825825|101026204|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
33308900|NCT00825825|101026205|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
33308901|NCT00825825|101026200|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
33308902|NCT00825825|101026201|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
33308903|NCT00825825|101026202|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
33308904|NCT00825825|101026203|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
33308905|NCT00825825|101026204|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
33308906|NCT00825825|101026205|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
33308907|NCT00825825|101026200|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
33308908|NCT00825825|101026201|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
33308909|NCT00825825|101026202|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
33308910|NCT00825825|101026203|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
33308911|NCT00825825|101026204|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
33308912|NCT00825825|101026205|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
33308913|NCT00825825|101026200|FG000|Third Medication Period (14 Days)|poor data quality|0|||
33308914|NCT00825825|101026201|FG001|Third Medication Period (14 Days)|poor data quality|1|||
33308915|NCT00825825|101026202|FG002|Third Medication Period (14 Days)|poor data quality|0|||
33308916|NCT00825825|101026203|FG003|Third Medication Period (14 Days)|poor data quality|0|||
33308917|NCT00825825|101026204|FG004|Third Medication Period (14 Days)|poor data quality|0|||
33308918|NCT00825825|101026205|FG005|Third Medication Period (14 Days)|poor data quality|0|||
33308919|NCT01119105|101026206|FG000|Overall Study|Withdrawal by Subject|1|||
33308920|NCT01119105|101026207|FG001|Overall Study|Withdrawal by Subject|1|||
33308921|NCT01119105|101026208|FG002|Overall Study|Withdrawal by Subject|1|||
33308922|NCT01119105|101026206|FG000|Overall Study|Lost to Follow-up|0|||
33308923|NCT01119105|101026207|FG001|Overall Study|Lost to Follow-up|2|||
33308924|NCT01119105|101026208|FG002|Overall Study|Lost to Follow-up|5|||
33308925|NCT01119105|101026206|FG000|Overall Study|Adverse Event|1|||
33308926|NCT01119105|101026207|FG001|Overall Study|Adverse Event|0|||
33308927|NCT01119105|101026208|FG002|Overall Study|Adverse Event|1|||
33308928|NCT01119105|101026206|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
33308929|NCT01119105|101026207|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
33308930|NCT01119105|101026208|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
33308931|NCT01119105|101026206|FG000|Overall Study|Other|1|||
33308932|NCT01119105|101026207|FG001|Overall Study|Other|1|||
33308933|NCT01119105|101026208|FG002|Overall Study|Other|0|||
33308934|NCT03694275|101026209|FG000|Overall Study|Adverse Event|0|||
33308935|NCT03694275|101026210|FG001|Overall Study|Adverse Event|1|||
33308936|NCT03694275|101026209|FG000|Overall Study|Reason not Specified|0|||
33308937|NCT03694275|101026210|FG001|Overall Study|Reason not Specified|1|||
33308938|NCT04988867|101026211|FG000|Overall Study|Study terminated by Sponsor|12|||
33308939|NCT04988867|101026211|FG000|Overall Study|Adverse Event|2|||
33308940|NCT04988867|101026211|FG000|Overall Study|Study drug noncompliance|1|||
33308941|NCT01157676|101026212|FG000|Randomization|Death|1|||
33308942|NCT01157676|101026213|FG001|Randomization|Death|1|||
33308943|NCT01157676|101026212|FG000|Randomization|unresectable|2|||
33308944|NCT01157676|101026213|FG001|Randomization|unresectable|3|||
33308945|NCT01157676|101026212|FG000|Randomization|Withdrawal by Subject|17|||
33308946|NCT01157676|101026213|FG001|Randomization|Withdrawal by Subject|13|||
33308947|NCT01157676|101026212|FG000|Randomization|Physician Decision|1|||
33308948|NCT01157676|101026213|FG001|Randomization|Physician Decision|0|||
33308949|NCT01157676|101026212|FG000|Surgery|underwent open cystectomy|0|||
33308950|NCT01157676|101026213|FG001|Surgery|underwent open cystectomy|4|||
33308951|NCT01157676|101026212|FG000|Surgery|converted to open procedure|0|||
33308952|NCT01157676|101026213|FG001|Surgery|converted to open procedure|5|||
33308953|NCT01157676|101026212|FG000|Surgery|underwent robotic cystectomy|1|||
33308954|NCT01157676|101026213|FG001|Surgery|underwent robotic cystectomy|0|||
33308955|NCT01127893|101026214|FG000|Overall Study|Study Termination by the Sponsor|1|||
33308956|NCT01263665|101026216|FG000|Overall Study|Withdrew Consent|1|||
33308957|NCT01263665|101026216|FG000|Overall Study|Lost to Follow-up|3|||
33308958|NCT01263665|101026216|FG000|Overall Study|Death|2|||
33308959|NCT01263665|101026216|FG000|Overall Study|Amputation above the ankle|1|||
33308960|NCT01263665|101026216|FG000|Overall Study|Surgical Bypass|2|||
33308961|NCT02383056|101026228|FG000|Overall Study|Adverse Event|1|||
33308962|NCT02383056|101026229|FG001|Overall Study|Adverse Event|0|||
33308963|NCT02383056|101026228|FG000|Overall Study|Lost to Follow-up|0|||
33308964|NCT02383056|101026229|FG001|Overall Study|Lost to Follow-up|2|||
33308965|NCT02781844|101026230|FG000|Treatment Period 1|Adverse Event|0|||
33308966|NCT02781844|101026231|FG001|Treatment Period 1|Adverse Event|0|||
33308967|NCT02781844|101026232|FG002|Treatment Period 1|Adverse Event|0|||
33308968|NCT02781844|101026233|FG003|Treatment Period 1|Adverse Event|0|||
33308969|NCT02781844|101026234|FG004|Treatment Period 1|Adverse Event|0|||
33500729|NCT00703157|101724689|FG000|Overall Study|source data permanently lost/ other|4|||
33500730|NCT00703157|101724690|FG001|Overall Study|source data permanently lost/ other|1|||
33500731|NCT01532518|101724699|FG000|Overall Study|Withdrawal by Subject|0|||
33500732|NCT01532518|101724700|FG001|Overall Study|Withdrawal by Subject|0|||
33500733|NCT01532518|101724701|FG002|Overall Study|Withdrawal by Subject|1|||
33500734|NCT01611935|101724702|FG000|Overall Study|Family Declined Participation|1|||
33500735|NCT01611935|101724703|FG001|Overall Study|Family Declined Participation|0|||
33500736|NCT03337113|101724708|FG000|Overall Study|Adverse Event|1|||
33500737|NCT03337113|101724709|FG001|Overall Study|Adverse Event|1|||
33308970|NCT02781844|101026235|FG005|Treatment Period 1|Adverse Event|1|||
33308971|NCT02781844|101026236|FG006|Treatment Period 1|Adverse Event|0|||
33308972|NCT02781844|101026237|FG007|Treatment Period 1|Adverse Event|0|||
33500738|NCT03337113|101724710|FG002|Overall Study|Adverse Event|0|||
33500739|NCT03337113|101724711|FG003|Overall Study|Adverse Event|1|||
33500740|NCT03337113|101724708|FG000|Overall Study|Physician Decision|0|||
33500741|NCT03337113|101724709|FG001|Overall Study|Physician Decision|2|||
33500742|NCT03337113|101724710|FG002|Overall Study|Physician Decision|0|||
33500743|NCT03337113|101724711|FG003|Overall Study|Physician Decision|1|||
33500744|NCT03337113|101724708|FG000|Overall Study|Withdrawal by Subject|0|||
33500745|NCT03337113|101724709|FG001|Overall Study|Withdrawal by Subject|0|||
33500746|NCT03337113|101724710|FG002|Overall Study|Withdrawal by Subject|1|||
33500747|NCT03337113|101724711|FG003|Overall Study|Withdrawal by Subject|0|||
33500748|NCT02764762|101724715|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
33500749|NCT02764762|101724715|FG000|Overall Study|Lost to Follow-up|4|||
33500750|NCT02764762|101724715|FG000|Overall Study|Voluntary Withdrawal|8|||
33601622|NCT03899064|102091980|FG000|Overall Study|Protocol Violation|2|||
33601623|NCT03899064|102091980|FG000|Overall Study|Withdrawal by Subject|2|||
33601624|NCT03899064|102091980|FG000|Overall Study|Other|2|||
33308973|NCT00189488|101026238|FG000|Overall Study|Ineligibility determined|1|||
33308974|NCT00189488|101026239|FG001|Overall Study|Ineligibility determined|0|||
33500751|NCT02764762|101724715|FG000|Overall Study|Site Termination|1|||
33500752|NCT02764762|101724715|FG000|Overall Study|Lack of Efficacy|16|||
33500753|NCT02764762|101724715|FG000|Overall Study|Reason not Specified|1|||
33500754|NCT02954601|101724720|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
33308975|NCT00189488|101026238|FG000|Overall Study|Protocol deviation|2|||
33500755|NCT02954601|101724721|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
33500756|NCT02954601|101724722|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
33308976|NCT00189488|101026239|FG001|Overall Study|Protocol deviation|1|||
33308977|NCT00189488|101026238|FG000|Overall Study|Adverse Event|2|||
33308978|NCT00189488|101026239|FG001|Overall Study|Adverse Event|1|||
33308979|NCT00189488|101026238|FG000|Overall Study|Withdrawal by Subject|2|||
33500757|NCT02954601|101724723|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
33500758|NCT01209520|101724724|FG000|Overall Study|Withdrawal by Subject|3|||
33601625|NCT03987932|102091983|FG000|Overall Study|Lost to Follow-up|2|||
33601626|NCT03987932|102091984|FG001|Overall Study|Lost to Follow-up|1|||
33308980|NCT00189488|101026239|FG001|Overall Study|Withdrawal by Subject|6|||
33308981|NCT00189488|101026238|FG000|Overall Study|Disease progression|2|||
33394333|NCT03099304|101331737|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
33308982|NCT00189488|101026239|FG001|Overall Study|Disease progression|4|||
33308983|NCT00189488|101026238|FG000|Overall Study|Administrative Decision|0|||
33308984|NCT00189488|101026239|FG001|Overall Study|Administrative Decision|2|||
33308985|NCT00189488|101026238|FG000|Overall Study|Death|5|||
33308986|NCT00189488|101026239|FG001|Overall Study|Death|8|||
33308987|NCT00189488|101026238|FG000|Overall Study|Other|1|||
33308988|NCT00189488|101026239|FG001|Overall Study|Other|0|||
33308989|NCT00730275|101026240|FG000|Overall Study|Withdrawal by Subject|0|||
33308990|NCT00730275|101026241|FG001|Overall Study|Withdrawal by Subject|0|||
33308991|NCT00730275|101026242|FG002|Overall Study|Withdrawal by Subject|0|||
33308992|NCT00730275|101026243|FG003|Overall Study|Withdrawal by Subject|1|||
33308993|NCT00192647|101026247|FG000|Overall Study|Death|1|||
33308994|NCT00192647|101026248|FG001|Overall Study|Death|1|||
33308995|NCT00192647|101026247|FG000|Overall Study|Adverse Event|35|||
33308996|NCT00192647|101026248|FG001|Overall Study|Adverse Event|29|||
33308997|NCT00192647|101026247|FG000|Overall Study|Laboratory Test Abnormality|4|||
33308998|NCT00192647|101026248|FG001|Overall Study|Laboratory Test Abnormality|2|||
33308999|NCT00192647|101026247|FG000|Overall Study|Insufficient Therapeutic Response|53|||
33309000|NCT00192647|101026248|FG001|Overall Study|Insufficient Therapeutic Response|83|||
33309001|NCT00192647|101026247|FG000|Overall Study|Entry Criteria Violation|6|||
33309002|NCT00192647|101026248|FG001|Overall Study|Entry Criteria Violation|6|||
33309003|NCT00192647|101026247|FG000|Overall Study|Protocol Violation|3|||
33309004|NCT00192647|101026248|FG001|Overall Study|Protocol Violation|1|||
33309005|NCT00192647|101026247|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
33309006|NCT00192647|101026248|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
33309007|NCT00192647|101026247|FG000|Overall Study|Failure to Return|11|||
33309008|NCT00192647|101026248|FG001|Overall Study|Failure to Return|13|||
33309009|NCT00192647|101026247|FG000|Overall Study|Other/Administrative|5|||
33309010|NCT00192647|101026248|FG001|Overall Study|Other/Administrative|3|||
33309011|NCT00819390|101026249|FG000|Overall Study|Lost to Follow-up|1|||
33309012|NCT00819390|101026250|FG001|Overall Study|Lost to Follow-up|1|||
33309013|NCT00819390|101026251|FG002|Overall Study|Lost to Follow-up|0|||
33309014|NCT00819390|101026252|FG003|Overall Study|Lost to Follow-up|0|||
33309015|NCT00819390|101026249|FG000|Overall Study|Withdrawal by Subject|2|||
33309016|NCT00819390|101026250|FG001|Overall Study|Withdrawal by Subject|0|||
33309017|NCT00819390|101026251|FG002|Overall Study|Withdrawal by Subject|0|||
33309018|NCT00819390|101026252|FG003|Overall Study|Withdrawal by Subject|0|||
33309019|NCT00819390|101026249|FG000|Overall Study|Adverse Event|0|||
33309020|NCT00819390|101026250|FG001|Overall Study|Adverse Event|0|||
33309021|NCT00819390|101026251|FG002|Overall Study|Adverse Event|1|||
33309022|NCT00819390|101026252|FG003|Overall Study|Adverse Event|0|||
33309023|NCT00768079|101026253|FG000|Overall Study|Lost to Follow-up|2|||
33309024|NCT00768079|101026254|FG001|Overall Study|Lost to Follow-up|0|||
33309025|NCT00768079|101026255|FG002|Overall Study|Lost to Follow-up|4|||
33309026|NCT00768079|101026253|FG000|Overall Study|Participant incarcerated|0|||
33309027|NCT00768079|101026254|FG001|Overall Study|Participant incarcerated|1|||
33309028|NCT00768079|101026255|FG002|Overall Study|Participant incarcerated|0|||
33309029|NCT02374671|101026256|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
33309030|NCT02374671|101026257|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
33309031|NCT02374671|101026258|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
33309032|NCT02374671|101026256|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
33309033|NCT02374671|101026257|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
33309034|NCT02374671|101026258|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
33309035|NCT02374671|101026256|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
33309036|NCT02374671|101026257|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
33394334|NCT03099304|101331738|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
33394335|NCT03099304|101331739|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
33394336|NCT03099304|101331734|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
33601627|NCT03987932|102091985|FG002|Overall Study|Lost to Follow-up|1|||
33601628|NCT03987932|102091983|FG000|Overall Study|Non-study related elective surgery|0|||
33309037|NCT02374671|101026258|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
33309038|NCT02374671|101026256|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
33309039|NCT02374671|101026257|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
33309040|NCT02374671|101026258|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
33309041|NCT02374671|101026256|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
33309042|NCT02374671|101026257|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
33309043|NCT02374671|101026258|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
33309044|NCT00262951|101026259|FG000|Overall Study|Progressive disease/relapse|3|||
33309045|NCT00262951|101026259|FG000|Overall Study|Adverse Event|7|||
33309046|NCT00262951|101026259|FG000|Overall Study|Death|1|||
33309047|NCT00262951|101026259|FG000|Overall Study|Withdrawal by Subject|1|||
33309048|NCT00262951|101026259|FG000|Overall Study|Alternative treatment|3|||
33309049|NCT00262951|101026259|FG000|Overall Study|Off treatment for other disease|1|||
33309050|NCT00468104|101026266|FG000|First Intervention|Protocol Violation|2|||
33309051|NCT00468104|101026267|FG001|First Intervention|Protocol Violation|1|||
33394337|NCT03099304|101331735|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
33394338|NCT03099304|101331736|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
33394339|NCT03099304|101331737|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
33394340|NCT03099304|101331738|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
33394341|NCT03099304|101331739|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
33394342|NCT03099304|101331734|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
33394343|NCT03099304|101331735|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
33394344|NCT03099304|101331736|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
33394345|NCT03099304|101331737|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
33309052|NCT00468104|101026266|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
33309053|NCT00468104|101026267|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
33309054|NCT00468104|101026266|FG000|First Intervention|died within 3 weeks|1|||
33309055|NCT00468104|101026267|FG001|First Intervention|died within 3 weeks|0|||
33309056|NCT00468104|101026266|FG000|First Intervention|malposition/blocked chest tube tube|2|||
33309057|NCT00468104|101026267|FG001|First Intervention|malposition/blocked chest tube tube|0|||
33309058|NCT00468104|101026266|FG000|First Intervention|large lung mass with minimal effusion|1|||
33309059|NCT00468104|101026267|FG001|First Intervention|large lung mass with minimal effusion|0|||
33309060|NCT00468104|101026266|FG000|First Intervention|associated prolonged pneumothorax|1|||
33309061|NCT00468104|101026267|FG001|First Intervention|associated prolonged pneumothorax|0|||
33309062|NCT00468104|101026266|FG000|First Intervention|trapped lung|1|||
33309063|NCT00468104|101026267|FG001|First Intervention|trapped lung|0|||
33309064|NCT00468104|101026266|FG000|Second Intervention|Withdrawal by Subject|5|||
33309065|NCT00468104|101026267|FG001|Second Intervention|Withdrawal by Subject|2|||
33309066|NCT00468104|101026266|FG000|Second Intervention|discarded for malposition of chest tube|0|||
33309067|NCT00468104|101026267|FG001|Second Intervention|discarded for malposition of chest tube|2|||
33309068|NCT03075410|101026268|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
33309069|NCT03075410|101026269|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
33309070|NCT03075410|101026270|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
33309071|NCT03075410|101026271|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
33309072|NCT03075410|101026272|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
33309073|NCT03075410|101026273|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
33309074|NCT03075410|101026274|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
33309075|NCT03075410|101026275|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
33309076|NCT03075410|101026276|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
33309077|NCT03075410|101026268|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
33309078|NCT03075410|101026269|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33309079|NCT03075410|101026270|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33309080|NCT03075410|101026271|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33309081|NCT03075410|101026272|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33309082|NCT03075410|101026273|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33309083|NCT03075410|101026274|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33309084|NCT03075410|101026275|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33309085|NCT03075410|101026276|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
33309086|NCT01744392|101026277|FG000|Overall Study|Physician Decision|1|||
33309087|NCT03170349|101026278|FG000|At 30 Days Follow-up|Death|1|||
33309088|NCT03170349|101026278|FG000|At 6 Months Follow-up|Exited for Other Reasons|5|||
33309089|NCT03170349|101026278|FG000|At 6 Months Follow-up|Withdrawal by Subject|1|||
33309090|NCT03170349|101026278|FG000|At 6 Months Follow-up|Death|3|||
33309091|NCT03170349|101026278|FG000|At 1 Year Follow-up|Exited for Other Reasons|2|||
33309092|NCT03170349|101026278|FG000|At 1 Year Follow-up|Death|6|||
33309093|NCT03170349|101026278|FG000|At 2 Year Follow-up|Missed Visit|4|||
33309094|NCT03170349|101026278|FG000|At 2 Year Follow-up|Death|13|||
33309095|NCT03170349|101026278|FG000|At 2 Year Follow-up|Withdrawal by Subject|1|||
33309096|NCT03756129|101026279|FG000|Overall Study|Adverse Event|1|||
33309097|NCT03756129|101026280|FG001|Overall Study|Adverse Event|1|||
33309098|NCT03756129|101026281|FG002|Overall Study|Adverse Event|0|||
33309099|NCT03756129|101026282|FG003|Overall Study|Adverse Event|2|||
33309100|NCT03756129|101026283|FG004|Overall Study|Adverse Event|0|||
33309101|NCT03756129|101026284|FG005|Overall Study|Adverse Event|0|||
33309102|NCT03756129|101026279|FG000|Overall Study|Withdrawal by Subject|2|||
33309103|NCT03756129|101026280|FG001|Overall Study|Withdrawal by Subject|1|||
33394346|NCT03099304|101331738|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
33309104|NCT03756129|101026281|FG002|Overall Study|Withdrawal by Subject|3|||
33309105|NCT03756129|101026282|FG003|Overall Study|Withdrawal by Subject|1|||
33309106|NCT03756129|101026283|FG004|Overall Study|Withdrawal by Subject|1|||
33309107|NCT03756129|101026284|FG005|Overall Study|Withdrawal by Subject|3|||
33309108|NCT03756129|101026279|FG000|Overall Study|Lost to Follow-up|0|||
33309109|NCT03756129|101026280|FG001|Overall Study|Lost to Follow-up|0|||
33309110|NCT03756129|101026281|FG002|Overall Study|Lost to Follow-up|0|||
33394347|NCT03099304|101331739|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
33394348|NCT03099304|101331734|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
33309111|NCT03756129|101026282|FG003|Overall Study|Lost to Follow-up|0|||
33309112|NCT03756129|101026283|FG004|Overall Study|Lost to Follow-up|0|||
33309113|NCT03756129|101026284|FG005|Overall Study|Lost to Follow-up|1|||
33309114|NCT03756129|101026279|FG000|Overall Study|Physician Decision|0|||
33309115|NCT03756129|101026280|FG001|Overall Study|Physician Decision|0|||
33309116|NCT03756129|101026281|FG002|Overall Study|Physician Decision|0|||
33309117|NCT03756129|101026282|FG003|Overall Study|Physician Decision|0|||
33309118|NCT03756129|101026283|FG004|Overall Study|Physician Decision|0|||
33500759|NCT04227197|101724725|FG000|Randomization|Protocol Violation|1|||
33500760|NCT04227197|101724726|FG001|Randomization|Protocol Violation|0|||
33500761|NCT04227197|101724725|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
33500762|NCT04227197|101724726|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
33500763|NCT04227197|101724725|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
33500764|NCT04227197|101724726|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
33500765|NCT04227197|101724725|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
33500766|NCT04227197|101724726|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
33500767|NCT04227197|101724725|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
33500768|NCT04227197|101724726|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
33500769|NCT04227197|101724725|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
33500770|NCT04227197|101724726|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
33309119|NCT03756129|101026284|FG005|Overall Study|Physician Decision|1|||
33309120|NCT04971681|101026285|FG000|Followup|Lost to Follow-up|1|||
33309121|NCT04971681|101026286|FG001|Followup|Lost to Follow-up|0|||
33309122|NCT02476279|101026287|FG000|Overall Study|Lost to Follow-up|1|||
33309123|NCT02476279|101026288|FG001|Overall Study|Lost to Follow-up|1|||
33309124|NCT05330312|101026289|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
33309125|NCT05330312|101026290|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
33309126|NCT05330312|101026291|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
33309127|NCT05330312|101026289|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
33500771|NCT04227197|101724725|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
33500772|NCT04227197|101724726|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
33500773|NCT01073605|101724728|FG000|Overall Study|Ongoing at Cutoff Date|1|||
33500774|NCT01073605|101724729|FG001|Overall Study|Ongoing at Cutoff Date|1|||
33500775|NCT01073605|101724730|FG002|Overall Study|Ongoing at Cutoff Date|0|||
33500776|NCT01073605|101724728|FG000|Overall Study|Adverse Event|2|||
33500777|NCT01073605|101724729|FG001|Overall Study|Adverse Event|1|||
33500778|NCT01073605|101724730|FG002|Overall Study|Adverse Event|0|||
33500779|NCT01073605|101724728|FG000|Overall Study|Lost to Follow-up|3|||
33500780|NCT01073605|101724729|FG001|Overall Study|Lost to Follow-up|4|||
33500781|NCT01073605|101724730|FG002|Overall Study|Lost to Follow-up|9|||
33500782|NCT01073605|101724728|FG000|Overall Study|Other|25|||
33500783|NCT01073605|101724729|FG001|Overall Study|Other|21|||
33500784|NCT01073605|101724730|FG002|Overall Study|Other|29|||
33500785|NCT01073605|101724728|FG000|Overall Study|Withdrawal by Subject|31|||
33500786|NCT01073605|101724729|FG001|Overall Study|Withdrawal by Subject|39|||
33500787|NCT01073605|101724730|FG002|Overall Study|Withdrawal by Subject|22|||
33500788|NCT01073605|101724728|FG000|Overall Study|Randomized But Not Treated|0|||
33500789|NCT01073605|101724729|FG001|Overall Study|Randomized But Not Treated|1|||
33500790|NCT01073605|101724730|FG002|Overall Study|Randomized But Not Treated|1|||
33500791|NCT01323387|101724731|FG000|Overall Study|Withdrawal by Subject|41|||
33500792|NCT01323387|101724731|FG000|Overall Study|Radiographic Data Unavailable|1|||
33500793|NCT01323387|101724731|FG000|Overall Study|Revision|14|||
33500794|NCT01323387|101724731|FG000|Overall Study|Protocol Violation|12|||
33500795|NCT01323387|101724731|FG000|Overall Study|Randomized but Never Treated|16|||
33500796|NCT00092118|101724732|FG000|Overall Study|Adverse Event|35|||
33500797|NCT00092118|101724733|FG001|Overall Study|Adverse Event|32|||
33500798|NCT00092118|101724732|FG000|Overall Study|Lack of Efficacy|12|||
33500799|NCT00092118|101724733|FG001|Overall Study|Lack of Efficacy|14|||
33500800|NCT00092118|101724732|FG000|Overall Study|Lost to Follow-up|4|||
33500801|NCT00092118|101724733|FG001|Overall Study|Lost to Follow-up|3|||
33500802|NCT00092118|101724732|FG000|Overall Study|Protocol Violation|23|||
33309128|NCT05330312|101026290|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
33500803|NCT00092118|101724733|FG001|Overall Study|Protocol Violation|25|||
33500804|NCT00092118|101724732|FG000|Overall Study|Withdrawal by Subject|4|||
33309129|NCT05330312|101026291|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
33309130|NCT05330312|101026289|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
33500805|NCT00092118|101724733|FG001|Overall Study|Withdrawal by Subject|10|||
33500806|NCT00092118|101724732|FG000|Overall Study|Other|6|||
33309131|NCT05330312|101026290|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
33500807|NCT00092118|101724733|FG001|Overall Study|Other|5|||
33500808|NCT00683618|101724739|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
33500809|NCT00683618|101724740|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
33500810|NCT00683618|101724741|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
33500811|NCT00683618|101724739|FG000|Randomised Treatment Period|Protocol Violation|0|||
33500812|NCT00683618|101724740|FG001|Randomised Treatment Period|Protocol Violation|1|||
33500813|NCT00683618|101724741|FG002|Randomised Treatment Period|Protocol Violation|0|||
33500814|NCT00683618|101724739|FG000|Randomised Treatment Period|Adverse Event|2|||
33500815|NCT00683618|101724740|FG001|Randomised Treatment Period|Adverse Event|0|||
33500816|NCT00683618|101724741|FG002|Randomised Treatment Period|Adverse Event|2|||
33500817|NCT00683618|101724739|FG000|Randomised Treatment Period|Reason not provided|0|||
33500818|NCT00683618|101724740|FG001|Randomised Treatment Period|Reason not provided|0|||
33500819|NCT00683618|101724741|FG002|Randomised Treatment Period|Reason not provided|2|||
33500820|NCT00683618|101724739|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
33500821|NCT00683618|101724740|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
33500822|NCT00683618|101724741|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
33500823|NCT00683618|101724739|FG000|Extension Treatment Period|Adverse Event|1|||
33500824|NCT00683618|101724740|FG001|Extension Treatment Period|Adverse Event|0|||
33500825|NCT00683618|101724741|FG002|Extension Treatment Period|Adverse Event|0|||
33500826|NCT00683618|101724739|FG000|Extension Treatment Period|Protocol Violation|1|||
33309132|NCT05330312|101026291|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
33309133|NCT05330312|101026289|FG000|Pivotal Investigation - Part 2|Death|1|||
33500827|NCT00683618|101724740|FG001|Extension Treatment Period|Protocol Violation|0|||
33500828|NCT00683618|101724741|FG002|Extension Treatment Period|Protocol Violation|0|||
33500829|NCT00425750|101724742|FG000|Overall Study|Death|1|||
33500830|NCT00425750|101724742|FG000|Overall Study|Withdrawal by Subject|3|||
33500831|NCT00425750|101724742|FG000|Overall Study|Adverse Event|3|||
33500832|NCT00425750|101724742|FG000|Overall Study|Progression of disease|18|||
33309134|NCT05330312|101026290|FG001|Pivotal Investigation - Part 2|Death|4|||
33500833|NCT00961571|101724743|FG000|Overall Study|Physician Decision|39|||
33500834|NCT03225105|101724750|FG000|Overall Study|Withdrawal by Subject|1|||
33500835|NCT03225105|101724751|FG001|Overall Study|Withdrawal by Subject|0|||
33500836|NCT03225105|101724752|FG002|Overall Study|Withdrawal by Subject|0|||
33500837|NCT03225105|101724753|FG003|Overall Study|Withdrawal by Subject|0|||
33500838|NCT03225105|101724750|FG000|Overall Study|Death|0|||
33500839|NCT03225105|101724751|FG001|Overall Study|Death|4|||
33309135|NCT05330312|101026291|FG002|Pivotal Investigation - Part 2|Death|0|||
33309136|NCT01659853|101026293|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
33309137|NCT01659853|101026294|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
33309138|NCT01659853|101026293|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
33309139|NCT01659853|101026294|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
33309140|NCT02679508|101026295|FG000|Healing Phase|Protocol Violation|1|||
33309141|NCT02679508|101026296|FG001|Healing Phase|Protocol Violation|1|||
33309142|NCT02679508|101026295|FG000|Healing Phase|Lost to Follow-up|1|||
33309143|NCT02679508|101026296|FG001|Healing Phase|Lost to Follow-up|0|||
33309144|NCT02679508|101026295|FG000|Maintenance Phase|Adverse Event|12|||
33309145|NCT02679508|101026296|FG001|Maintenance Phase|Adverse Event|2|||
33309146|NCT02679508|101026295|FG000|Maintenance Phase|Lost to Follow-up|0|||
33309147|NCT02679508|101026296|FG001|Maintenance Phase|Lost to Follow-up|1|||
33309148|NCT02679508|101026295|FG000|Maintenance Phase|Withdrawal by Subject|15|||
33309149|NCT02679508|101026296|FG001|Maintenance Phase|Withdrawal by Subject|8|||
33309150|NCT02679508|101026295|FG000|Maintenance Phase|Other|5|||
33309151|NCT02679508|101026296|FG001|Maintenance Phase|Other|4|||
33309152|NCT02947087|101026299|FG000|Overall Study|Withdrawal by Subject|3|||
33309153|NCT02947087|101026300|FG001|Overall Study|Withdrawal by Subject|2|||
33309154|NCT00195091|101026303|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
33309155|NCT00178126|101026304|FG000|Overall Study|Lost to Follow-up|21|||
33309156|NCT00178126|101026305|FG001|Overall Study|Lost to Follow-up|21|||
33309157|NCT00178126|101026304|FG000|Overall Study|did not receive intervention|4|||
33394349|NCT03099304|101331735|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
33394350|NCT03099304|101331736|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
33394351|NCT03099304|101331737|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
33394352|NCT03099304|101331738|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
33394353|NCT03099304|101331739|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
33500840|NCT03225105|101724752|FG002|Overall Study|Death|2|||
33500841|NCT03225105|101724753|FG003|Overall Study|Death|0|||
33500842|NCT03225105|101724750|FG000|Overall Study|Study termination per Sponsor Decision|2|||
33309158|NCT00178126|101026305|FG001|Overall Study|did not receive intervention|6|||
33309159|NCT03254485|101026306|FG000|Overall Study|Adverse Event|3|||
33394354|NCT03099304|101331734|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
33394355|NCT03099304|101331735|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
33394356|NCT03099304|101331736|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
33394357|NCT03099304|101331737|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
33500843|NCT03225105|101724751|FG001|Overall Study|Study termination per Sponsor Decision|0|||
33309160|NCT03254485|101026307|FG001|Overall Study|Adverse Event|0|||
33309161|NCT03254485|101026308|FG002|Overall Study|Adverse Event|0|||
33309162|NCT03254485|101026309|FG003|Overall Study|Adverse Event|6|||
33309163|NCT03254485|101026306|FG000|Overall Study|Protocol Violation|6|||
33309164|NCT03254485|101026307|FG001|Overall Study|Protocol Violation|0|||
33394358|NCT03099304|101331738|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
33394359|NCT03099304|101331739|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
33394360|NCT03099304|101331734|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
33394361|NCT03099304|101331735|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
33394362|NCT03099304|101331736|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
33394363|NCT03099304|101331737|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
33394364|NCT03099304|101331738|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
33394365|NCT03099304|101331739|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
33394366|NCT03099304|101331734|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
33394367|NCT03099304|101331735|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
33394368|NCT03099304|101331736|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
33394369|NCT03099304|101331737|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
33394370|NCT03099304|101331738|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
33394371|NCT03099304|101331739|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
33394372|NCT03099304|101331734|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
33394373|NCT03099304|101331735|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
33394374|NCT03099304|101331736|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
33394375|NCT03099304|101331737|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
33394376|NCT03099304|101331738|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
33394377|NCT03099304|101331739|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
33394378|NCT03099304|101331734|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
33394379|NCT03099304|101331735|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
33394380|NCT03099304|101331736|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
33394381|NCT03099304|101331737|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
33394382|NCT03099304|101331738|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
33394383|NCT03099304|101331739|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
33394384|NCT03099304|101331734|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
33309165|NCT03254485|101026308|FG002|Overall Study|Protocol Violation|0|||
33309166|NCT03254485|101026309|FG003|Overall Study|Protocol Violation|2|||
33309167|NCT03254485|101026306|FG000|Overall Study|Withdrawal by Subject|1|||
33309168|NCT03254485|101026307|FG001|Overall Study|Withdrawal by Subject|0|||
33309169|NCT03254485|101026308|FG002|Overall Study|Withdrawal by Subject|0|||
33309170|NCT03254485|101026309|FG003|Overall Study|Withdrawal by Subject|4|||
33309171|NCT03254485|101026306|FG000|Overall Study|Death|0|||
33309172|NCT03254485|101026307|FG001|Overall Study|Death|0|||
33309173|NCT03254485|101026308|FG002|Overall Study|Death|0|||
33309174|NCT03254485|101026309|FG003|Overall Study|Death|1|||
33309175|NCT03254485|101026306|FG000|Overall Study|Lost to Follow-up|1|||
33309176|NCT03254485|101026307|FG001|Overall Study|Lost to Follow-up|0|||
33309177|NCT03254485|101026308|FG002|Overall Study|Lost to Follow-up|0|||
33309178|NCT03254485|101026309|FG003|Overall Study|Lost to Follow-up|0|||
33309179|NCT03254485|101026306|FG000|Overall Study|Other|1|||
33309180|NCT03254485|101026307|FG001|Overall Study|Other|0|||
33309181|NCT03254485|101026308|FG002|Overall Study|Other|0|||
33309182|NCT03254485|101026309|FG003|Overall Study|Other|2|||
33309183|NCT03695237|101026310|FG000|Overall Study|Withdrawal by Subject|1|||
33309184|NCT03695237|101026311|FG001|Overall Study|Withdrawal by Subject|3|||
33309185|NCT03695237|101026310|FG000|Overall Study|Lost to Follow-up|1|||
33309186|NCT03695237|101026311|FG001|Overall Study|Lost to Follow-up|2|||
33309187|NCT03695237|101026310|FG000|Overall Study|Other, Not Specified|8|||
33309188|NCT03695237|101026311|FG001|Overall Study|Other, Not Specified|2|||
33309189|NCT02004353|101026312|FG000|Overall Study|Voluntary participation|1334|||
33394385|NCT03099304|101331735|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
33394386|NCT03099304|101331736|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
33394387|NCT03099304|101331737|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
33394388|NCT03099304|101331738|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
33394389|NCT03099304|101331739|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
33394390|NCT03099304|101331734|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
33394391|NCT03099304|101331735|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
33394392|NCT03099304|101331736|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
33394393|NCT03099304|101331737|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
33500844|NCT03225105|101724752|FG002|Overall Study|Study termination per Sponsor Decision|3|||
33309190|NCT02414932|101026313|FG000|Overall Study|Withdrawal by Subject|2|||
33309191|NCT02414932|101026314|FG001|Overall Study|Withdrawal by Subject|3|||
33309192|NCT02414932|101026313|FG000|Overall Study|Adverse Event|1|||
33309193|NCT02414932|101026314|FG001|Overall Study|Adverse Event|0|||
33309194|NCT03545503|101026315|FG000|Overall Study|Protocol Violation|14|||
33309195|NCT03545503|101026316|FG001|Overall Study|Protocol Violation|16|||
33309196|NCT02442336|101026323|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
33309197|NCT02442336|101026323|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
33394394|NCT03099304|101331738|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
33394395|NCT03099304|101331739|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
33394396|NCT01131078|101331740|FG000|Overall Study|Adverse Event|22|||
33394397|NCT01131078|101331741|FG001|Overall Study|Adverse Event|12|||
33394398|NCT01131078|101331742|FG002|Overall Study|Adverse Event|17|||
33394399|NCT01131078|101331740|FG000|Overall Study|Progressive Disease|58|||
33394400|NCT01131078|101331741|FG001|Overall Study|Progressive Disease|77|||
33394401|NCT01131078|101331742|FG002|Overall Study|Progressive Disease|71|||
33394402|NCT01131078|101331740|FG000|Overall Study|Protocol Violation|1|||
33394403|NCT01131078|101331741|FG001|Overall Study|Protocol Violation|0|||
33394404|NCT01131078|101331742|FG002|Overall Study|Protocol Violation|0|||
33394405|NCT01131078|101331740|FG000|Overall Study|Lost to Follow-up|1|||
33394406|NCT01131078|101331741|FG001|Overall Study|Lost to Follow-up|1|||
33394407|NCT01131078|101331742|FG002|Overall Study|Lost to Follow-up|1|||
33394408|NCT01131078|101331740|FG000|Overall Study|Withdrawal by Subject|2|||
33394409|NCT01131078|101331741|FG001|Overall Study|Withdrawal by Subject|4|||
33394410|NCT01131078|101331742|FG002|Overall Study|Withdrawal by Subject|3|||
33394411|NCT01131078|101331740|FG000|Overall Study|Non-compliance|3|||
33394412|NCT01131078|101331741|FG001|Overall Study|Non-compliance|0|||
33500845|NCT03225105|101724753|FG003|Overall Study|Study termination per Sponsor Decision|3|||
33500846|NCT01735916|101724754|FG000|Overall Study|Subject not eligible to be randomized|11|||
33309198|NCT02442336|101026323|FG000|Overall Study|Lost to Follow-up|11|||
33309199|NCT03581825|101026324|FG000|Period 1|Lens Discomfort|1|||
33309200|NCT03581825|101026325|FG001|Period 1|Lens Discomfort|0|||
33309201|NCT03581825|101026324|FG000|Period 2|Unsatisfactory Vision to Test|0|||
33309202|NCT03581825|101026325|FG001|Period 2|Unsatisfactory Vision to Test|1|||
33309203|NCT03573583|101026326|FG000|Overall Study|Lost to Follow-up|1|||
33309204|NCT03573583|101026327|FG001|Overall Study|Lost to Follow-up|0|||
33309205|NCT03573583|101026326|FG000|Overall Study|Withdrawal by Subject|1|||
33309206|NCT03573583|101026327|FG001|Overall Study|Withdrawal by Subject|1|||
33309207|NCT02585232|101026328|FG000|Overall Study|Lost to Follow-up|8|||
33309208|NCT02585232|101026329|FG001|Overall Study|Lost to Follow-up|8|||
33309209|NCT02585232|101026328|FG000|Overall Study|Withdrawal by Subject|4|||
33309210|NCT02585232|101026329|FG001|Overall Study|Withdrawal by Subject|8|||
33309211|NCT01474434|101026334|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
33309212|NCT01474434|101026335|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
33309213|NCT01474434|101026336|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
33309214|NCT01474434|101026337|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
33309215|NCT01474434|101026334|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
33309216|NCT01474434|101026335|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
33309217|NCT01474434|101026336|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
33309218|NCT01474434|101026337|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
33309219|NCT01474434|101026334|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
33309220|NCT01474434|101026335|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
33309221|NCT01474434|101026336|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
33309222|NCT01474434|101026337|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
33309223|NCT02891408|101026338|FG000|Overall Study|Lost to Follow-up|0|||
33309224|NCT02891408|101026339|FG001|Overall Study|Lost to Follow-up|0|||
33309225|NCT02891408|101026340|FG002|Overall Study|Lost to Follow-up|1|||
33309226|NCT02891408|101026341|FG003|Overall Study|Lost to Follow-up|0|||
33309227|NCT02891408|101026342|FG004|Overall Study|Lost to Follow-up|0|||
33309228|NCT02891408|101026343|FG005|Overall Study|Lost to Follow-up|0|||
33309229|NCT02891408|101026344|FG006|Overall Study|Lost to Follow-up|0|||
33309230|NCT02859324|101026351|FG000|Overall Study|Death|4|||
33309231|NCT02859324|101026352|FG001|Overall Study|Death|6|||
33394413|NCT01131078|101331742|FG002|Overall Study|Non-compliance|0|||
33309232|NCT02859324|101026353|FG002|Overall Study|Death|5|||
33309233|NCT02859324|101026351|FG000|Overall Study|Other reasons|3|||
33309234|NCT02859324|101026352|FG001|Overall Study|Other reasons|3|||
33309235|NCT02859324|101026353|FG002|Overall Study|Other reasons|0|||
33309236|NCT04002401|101026356|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
33309237|NCT04002401|101026356|FG000|Overall Study|Death|10|||
33309238|NCT04002401|101026356|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
33309239|NCT04002401|101026356|FG000|Overall Study|Enrolled but Never Treated|1|||
33309240|NCT04002401|101026356|FG000|Overall Study|Lost to Follow-up|1|||
33394414|NCT01131078|101331740|FG000|Overall Study|Physician Decision|10|||
33394415|NCT01131078|101331741|FG001|Overall Study|Physician Decision|6|||
33394416|NCT01131078|101331742|FG002|Overall Study|Physician Decision|8|||
33309241|NCT00911937|101026359|FG000|Overall Study|Death|1|||
33309242|NCT00911937|101026360|FG001|Overall Study|Death|0|||
33309243|NCT00911937|101026359|FG000|Overall Study|Lost to Follow-up|8|||
33309244|NCT00911937|101026360|FG001|Overall Study|Lost to Follow-up|5|||
33309245|NCT00911937|101026359|FG000|Overall Study|Withdrawal by Subject|10|||
33309246|NCT00911937|101026360|FG001|Overall Study|Withdrawal by Subject|7|||
33309247|NCT00911937|101026359|FG000|Overall Study|Withdrawn due to pregnancy|1|||
33309248|NCT00911937|101026360|FG001|Overall Study|Withdrawn due to pregnancy|0|||
33309249|NCT00911937|101026359|FG000|Overall Study|Adverse Event|11|||
33309250|NCT00911937|101026360|FG001|Overall Study|Adverse Event|25|||
33309251|NCT00911937|101026359|FG000|Overall Study|Lack of Efficacy|11|||
33309252|NCT00911937|101026360|FG001|Overall Study|Lack of Efficacy|6|||
33309253|NCT00911937|101026359|FG000|Overall Study|Did not meet inclusion criteria|9|||
33309254|NCT00911937|101026360|FG001|Overall Study|Did not meet inclusion criteria|11|||
33309255|NCT00911937|101026359|FG000|Overall Study|Protocol Violation|14|||
33309256|NCT00911937|101026360|FG001|Overall Study|Protocol Violation|23|||
33309257|NCT00911937|101026359|FG000|Overall Study|Randomized but not treated|13|||
33309258|NCT00911937|101026360|FG001|Overall Study|Randomized but not treated|13|||
33309259|NCT00911937|101026359|FG000|Overall Study|Other|9|||
33309260|NCT00911937|101026360|FG001|Overall Study|Other|5|||
33309261|NCT00370682|101026366|FG000|Overall Study|Moved from area|0|||
33309262|NCT00370682|101026367|FG001|Overall Study|Moved from area|2|||
33309263|NCT00370682|101026368|FG002|Overall Study|Moved from area|0|||
33309264|NCT00370682|101026366|FG000|Overall Study|Lost to Follow-up|0|||
33309265|NCT00370682|101026367|FG001|Overall Study|Lost to Follow-up|1|||
33309266|NCT00370682|101026368|FG002|Overall Study|Lost to Follow-up|1|||
33309267|NCT02121301|101026369|FG000|Overall Study|Protocol Violation|1|||
33309268|NCT02121301|101026370|FG001|Overall Study|Protocol Violation|4|||
33309269|NCT02121301|101026371|FG002|Overall Study|Protocol Violation|1|||
33309270|NCT00440999|101026372|FG000|Overall Study|Adverse Event|0|||
33309271|NCT00440999|101026373|FG001|Overall Study|Adverse Event|2|||
33309272|NCT00440999|101026372|FG000|Overall Study|Lack of Efficacy|6|||
33309273|NCT00440999|101026373|FG001|Overall Study|Lack of Efficacy|7|||
33309274|NCT00440999|101026372|FG000|Overall Study|Lost to Follow-up|19|||
33309275|NCT00440999|101026373|FG001|Overall Study|Lost to Follow-up|12|||
33309276|NCT00440999|101026372|FG000|Overall Study|Protocol Violation|1|||
33309277|NCT00440999|101026373|FG001|Overall Study|Protocol Violation|0|||
33309278|NCT00440999|101026372|FG000|Overall Study|Withdrawal by Subject|2|||
33309279|NCT00440999|101026373|FG001|Overall Study|Withdrawal by Subject|5|||
33309280|NCT00440999|101026372|FG000|Overall Study|Subjets missed the visit|1|||
33309281|NCT00440999|101026373|FG001|Overall Study|Subjets missed the visit|0|||
33309282|NCT00440999|101026372|FG000|Overall Study|Mixed infection at entry|1|||
33309283|NCT00440999|101026373|FG001|Overall Study|Mixed infection at entry|0|||
33309284|NCT00440999|101026372|FG000|Overall Study|P. falciparum malaria|5|||
33309285|NCT00440999|101026373|FG001|Overall Study|P. falciparum malaria|14|||
33309286|NCT00440999|101026372|FG000|Overall Study|Subj left hosp without inform staff|0|||
33309287|NCT00440999|101026373|FG001|Overall Study|Subj left hosp without inform staff|1|||
33309288|NCT01028027|101026374|FG000|Overall Study|Lost to Follow-up|4|||
33309289|NCT01028027|101026375|FG001|Overall Study|Lost to Follow-up|1|||
33309290|NCT01028027|101026374|FG000|Overall Study|Withdrawal by Subject|5|||
33309291|NCT01028027|101026375|FG001|Overall Study|Withdrawal by Subject|3|||
33309292|NCT01028027|101026374|FG000|Overall Study|Adverse Event|4|||
33309293|NCT01028027|101026375|FG001|Overall Study|Adverse Event|7|||
33309294|NCT01028027|101026374|FG000|Overall Study|Protocol Violation|3|||
33309295|NCT01028027|101026375|FG001|Overall Study|Protocol Violation|1|||
33309296|NCT01028027|101026374|FG000|Overall Study|Lack of Efficacy|0|||
33309297|NCT01028027|101026375|FG001|Overall Study|Lack of Efficacy|1|||
33192139|NCT01109316|100608585|FG000|Study Period 1|Withdrawal by Subject|0|||
33309298|NCT02319759|101026377|FG000|Week 0 - 16|Lack of Efficacy|1|||
33309299|NCT02319759|101026378|FG001|Week 0 - 16|Lack of Efficacy|0|||
33309300|NCT02319759|101026379|FG002|Week 0 - 16|Lack of Efficacy|0|||
33309301|NCT02319759|101026380|FG003|Week 0 - 16|Lack of Efficacy|0|||
33309302|NCT02319759|101026381|FG004|Week 0 - 16|Lack of Efficacy|0|||
33500847|NCT01735916|101724755|FG001|Overall Study|Subject not eligible to be randomized|0|||
33309303|NCT02319759|101026377|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
33309304|NCT02319759|101026378|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
33309305|NCT02319759|101026379|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
33309306|NCT02319759|101026380|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
33309307|NCT02319759|101026381|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
33309308|NCT02319759|101026377|FG000|Week 16 - 24|Lack of Efficacy|1|||
33309309|NCT02319759|101026378|FG001|Week 16 - 24|Lack of Efficacy|0|||
33309310|NCT02319759|101026379|FG002|Week 16 - 24|Lack of Efficacy|1|||
33394417|NCT01131078|101331740|FG000|Overall Study|Death|4|||
33309311|NCT02319759|101026380|FG003|Week 16 - 24|Lack of Efficacy|0|||
33309312|NCT02319759|101026381|FG004|Week 16 - 24|Lack of Efficacy|0|||
33309313|NCT02319759|101026377|FG000|Week 16 - 24|Lost to Follow-up|1|||
33309314|NCT02319759|101026378|FG001|Week 16 - 24|Lost to Follow-up|0|||
33309315|NCT02319759|101026379|FG002|Week 16 - 24|Lost to Follow-up|0|||
33394418|NCT01131078|101331741|FG001|Overall Study|Death|0|||
33394419|NCT01131078|101331742|FG002|Overall Study|Death|2|||
33394420|NCT01131078|101331740|FG000|Overall Study|Other|0|||
33394421|NCT01131078|101331741|FG001|Overall Study|Other|1|||
33394422|NCT01131078|101331742|FG002|Overall Study|Other|0|||
33394423|NCT02996110|101331745|FG000|Pre-Treatment|Other Reasons|0|||
33394424|NCT02996110|101331746|FG001|Pre-Treatment|Other Reasons|1|||
33394425|NCT02996110|101331747|FG002|Pre-Treatment|Other Reasons|0|||
33309316|NCT02319759|101026380|FG003|Week 16 - 24|Lost to Follow-up|0|||
33309317|NCT02319759|101026381|FG004|Week 16 - 24|Lost to Follow-up|0|||
33309318|NCT02319759|101026377|FG000|Week 16 - 24|Withdrawal by Subject|0|||
33394426|NCT02996110|101331748|FG003|Pre-Treatment|Other Reasons|0|||
33394427|NCT02996110|101331749|FG004|Pre-Treatment|Other Reasons|1|||
33394428|NCT02996110|101331745|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
33500848|NCT01735916|101724756|FG002|Overall Study|Subject not eligible to be randomized|0|||
33500849|NCT01735916|101724754|FG000|Overall Study|Early termination of study by sponsor|4|||
33500850|NCT01735916|101724755|FG001|Overall Study|Early termination of study by sponsor|19|||
33500851|NCT01735916|101724756|FG002|Overall Study|Early termination of study by sponsor|7|||
33500852|NCT01735916|101724754|FG000|Overall Study|Withdrawal by Subject|3|||
33500853|NCT01735916|101724755|FG001|Overall Study|Withdrawal by Subject|0|||
33500854|NCT01735916|101724756|FG002|Overall Study|Withdrawal by Subject|0|||
33500855|NCT00957801|101724757|FG000|Overall Study|Withdrawal by Subject|0|||
33500856|NCT00957801|101724758|FG001|Overall Study|Withdrawal by Subject|0|||
33500857|NCT00957801|101724759|FG002|Overall Study|Withdrawal by Subject|0|||
33500858|NCT00957801|101724760|FG003|Overall Study|Withdrawal by Subject|1|||
33500859|NCT01367886|101724765|FG000|Overall Study|Lost to Follow-up|4|||
33500860|NCT01367886|101724765|FG000|Overall Study|Lack of Efficacy|2|||
33309319|NCT02319759|101026378|FG001|Week 16 - 24|Withdrawal by Subject|0|||
33601629|NCT03987932|102091984|FG001|Overall Study|Non-study related elective surgery|0|||
33601630|NCT03987932|102091985|FG002|Overall Study|Non-study related elective surgery|1|||
33601631|NCT02119156|102091986|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
33601632|NCT02119156|102091987|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
33601633|NCT02119156|102091988|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
33601634|NCT02119156|102091986|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
33309320|NCT02319759|101026379|FG002|Week 16 - 24|Withdrawal by Subject|2|||
33309321|NCT02319759|101026380|FG003|Week 16 - 24|Withdrawal by Subject|0|||
33309322|NCT02319759|101026381|FG004|Week 16 - 24|Withdrawal by Subject|0|||
33309323|NCT02319759|101026377|FG000|Week 24 - 56|Adverse Event|0|||
33309324|NCT02319759|101026378|FG001|Week 24 - 56|Adverse Event|0|||
33309325|NCT02319759|101026379|FG002|Week 24 - 56|Adverse Event|2|||
33309326|NCT02319759|101026380|FG003|Week 24 - 56|Adverse Event|0|||
33309327|NCT02319759|101026381|FG004|Week 24 - 56|Adverse Event|0|||
33309328|NCT02319759|101026377|FG000|Week 24 - 56|Lack of Efficacy|0|||
33309329|NCT02319759|101026378|FG001|Week 24 - 56|Lack of Efficacy|0|||
33309330|NCT02319759|101026379|FG002|Week 24 - 56|Lack of Efficacy|0|||
33309331|NCT02319759|101026380|FG003|Week 24 - 56|Lack of Efficacy|2|||
33309332|NCT02319759|101026381|FG004|Week 24 - 56|Lack of Efficacy|1|||
33309333|NCT02319759|101026377|FG000|Week 24 - 56|Withdrawal by Subject|0|||
33309334|NCT02319759|101026378|FG001|Week 24 - 56|Withdrawal by Subject|1|||
33309335|NCT02319759|101026379|FG002|Week 24 - 56|Withdrawal by Subject|0|||
33309336|NCT02319759|101026380|FG003|Week 24 - 56|Withdrawal by Subject|0|||
33309337|NCT02319759|101026381|FG004|Week 24 - 56|Withdrawal by Subject|0|||
33309338|NCT02319759|101026377|FG000|Week 24 - 56|Lost to Follow-up|0|||
33309339|NCT02319759|101026378|FG001|Week 24 - 56|Lost to Follow-up|0|||
33309340|NCT02319759|101026379|FG002|Week 24 - 56|Lost to Follow-up|0|||
33394429|NCT02996110|101331746|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
33500861|NCT01367886|101724765|FG000|Overall Study|Death|1|||
33500862|NCT04578457|101724776|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
33500863|NCT04578457|101724776|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
33500864|NCT04578457|101724776|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
33500865|NCT04578457|101724776|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
33500866|NCT00777296|101724777|FG000|Overall Study|Adverse Event|0|||
33500867|NCT00777296|101724778|FG001|Overall Study|Adverse Event|1|||
33500868|NCT00777296|101724779|FG002|Overall Study|Adverse Event|0|||
33500869|NCT00777296|101724780|FG003|Overall Study|Adverse Event|1|||
33500870|NCT00777296|101724777|FG000|Overall Study|Withdrawal by Subject|1|||
33500871|NCT00777296|101724778|FG001|Overall Study|Withdrawal by Subject|0|||
33500872|NCT00777296|101724779|FG002|Overall Study|Withdrawal by Subject|0|||
33500873|NCT00777296|101724780|FG003|Overall Study|Withdrawal by Subject|0|||
33500874|NCT00777296|101724777|FG000|Overall Study|CRF form not completed|0|||
33500875|NCT00777296|101724778|FG001|Overall Study|CRF form not completed|0|||
33309341|NCT02319759|101026380|FG003|Week 24 - 56|Lost to Follow-up|0|||
33309342|NCT02319759|101026381|FG004|Week 24 - 56|Lost to Follow-up|1|||
33309343|NCT01183234|101026382|FG000|First Intervention|Adverse Event|1|||
33309344|NCT01183234|101026383|FG001|First Intervention|Adverse Event|0|||
33309345|NCT02891837|101026384|FG000|Overall Study|Lost to Follow-up|2|||
33309346|NCT02891837|101026385|FG001|Overall Study|Lost to Follow-up|0|||
33309347|NCT02891837|101026384|FG000|Overall Study|Withdrawal by Subject|1|||
33309348|NCT02891837|101026385|FG001|Overall Study|Withdrawal by Subject|0|||
33309349|NCT03606668|101026388|FG000|Overall Study|Screen Failure|1|||
33309350|NCT03606668|101026388|FG000|Overall Study|Lost to Follow-up|1|||
33309351|NCT01981473|101026389|FG000|Overall Study|Incorrect diagnosis of RA|0|||
33309352|NCT01981473|101026390|FG001|Overall Study|Incorrect diagnosis of RA|0|||
33309353|NCT01981473|101026391|FG002|Overall Study|Incorrect diagnosis of RA|1|||
33309354|NCT01981473|101026389|FG000|Overall Study|Received treatment for < 6 months|0|||
33309355|NCT01981473|101026390|FG001|Overall Study|Received treatment for < 6 months|0|||
33309356|NCT01981473|101026391|FG002|Overall Study|Received treatment for < 6 months|1|||
33309357|NCT01981473|101026389|FG000|Overall Study|Received treatment for >24 months|2|||
33309358|NCT01981473|101026390|FG001|Overall Study|Received treatment for >24 months|0|||
33309359|NCT01981473|101026391|FG002|Overall Study|Received treatment for >24 months|6|||
33309360|NCT01052103|101026392|FG000|Overall Study|Adverse Event|10|||
33309361|NCT01052103|101026393|FG001|Overall Study|Adverse Event|6|||
33309362|NCT01052103|101026392|FG000|Overall Study|Entry Criteria Not Met|3|||
33309363|NCT01052103|101026393|FG001|Overall Study|Entry Criteria Not Met|1|||
33309364|NCT01052103|101026392|FG000|Overall Study|Lost to Follow-up|3|||
33309365|NCT01052103|101026393|FG001|Overall Study|Lost to Follow-up|5|||
33309366|NCT01052103|101026392|FG000|Overall Study|Protocol Violation|10|||
33309367|NCT01052103|101026393|FG001|Overall Study|Protocol Violation|4|||
33309368|NCT01052103|101026392|FG000|Overall Study|Scheduling conflict|2|||
33309369|NCT01052103|101026393|FG001|Overall Study|Scheduling conflict|1|||
33309370|NCT01052103|101026392|FG000|Overall Study|Sponsor Decision|2|||
33309371|NCT01052103|101026393|FG001|Overall Study|Sponsor Decision|0|||
33309372|NCT01052103|101026392|FG000|Overall Study|Withdrawal by Subject|3|||
33309373|NCT01052103|101026393|FG001|Overall Study|Withdrawal by Subject|6|||
33309374|NCT01052103|101026392|FG000|Overall Study|Perceived Lack of Efficacy|1|||
33309375|NCT01052103|101026393|FG001|Overall Study|Perceived Lack of Efficacy|0|||
33309376|NCT01675479|101026396|FG000|Overall Study|Lost to Follow-up|11|||
33309377|NCT02372136|101026399|FG000|Overall Study|Death|3|||
33309378|NCT02372136|101026400|FG001|Overall Study|Death|1|||
33309379|NCT01079663|101026401|FG000|Overall Study|Adverse Event|0|||
33309380|NCT01079663|101026402|FG001|Overall Study|Adverse Event|2|||
33309381|NCT01079663|101026401|FG000|Overall Study|Protocol Violation|0|||
33309382|NCT01079663|101026402|FG001|Overall Study|Protocol Violation|2|||
33309383|NCT01946438|101026406|FG000|Overall Study|Adverse Event|0|||
33309384|NCT01946438|101026407|FG001|Overall Study|Adverse Event|0|||
33309385|NCT01946438|101026408|FG002|Overall Study|Adverse Event|0|||
33309386|NCT01946438|101026409|FG003|Overall Study|Adverse Event|1|||
33309387|NCT01946438|101026406|FG000|Overall Study|Serious Adverse event|1|||
33500876|NCT00777296|101724779|FG002|Overall Study|CRF form not completed|2|||
33500877|NCT00777296|101724780|FG003|Overall Study|CRF form not completed|0|||
33500878|NCT02091089|101724781|FG000|Overall Study|Lost to Follow-up|2|||
33500879|NCT01757184|101724784|FG000|Double-blind Period|Adverse Event|1|||
33500880|NCT01757184|101724785|FG001|Double-blind Period|Adverse Event|0|||
33500881|NCT01757184|101724786|FG002|Double-blind Period|Adverse Event|0|||
33309388|NCT01946438|101026407|FG001|Overall Study|Serious Adverse event|0|||
33309389|NCT01946438|101026408|FG002|Overall Study|Serious Adverse event|0|||
33309390|NCT01946438|101026409|FG003|Overall Study|Serious Adverse event|0|||
33309391|NCT01946438|101026406|FG000|Overall Study|Protocol Violation|0|||
33309392|NCT01946438|101026407|FG001|Overall Study|Protocol Violation|0|||
33309393|NCT01946438|101026408|FG002|Overall Study|Protocol Violation|1|||
33309394|NCT01946438|101026409|FG003|Overall Study|Protocol Violation|0|||
33309395|NCT01946438|101026406|FG000|Overall Study|Withdrawal by Subject|1|||
33309396|NCT01946438|101026407|FG001|Overall Study|Withdrawal by Subject|0|||
33500882|NCT01757184|101724787|FG003|Double-blind Period|Adverse Event|0|||
33394430|NCT02996110|101331747|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
33394431|NCT02996110|101331748|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
33394432|NCT02996110|101331749|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
33309397|NCT01946438|101026408|FG002|Overall Study|Withdrawal by Subject|0|||
33309398|NCT01946438|101026409|FG003|Overall Study|Withdrawal by Subject|0|||
33309399|NCT03316300|101026413|FG000|Overall Study|Withdrawal by Subject|3|||
33309400|NCT03316300|101026414|FG001|Overall Study|Withdrawal by Subject|2|||
33309401|NCT03316300|101026413|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
33394433|NCT02996110|101331745|FG000|Track 1|Disease Progression|15|||
33394434|NCT02996110|101331746|FG001|Track 1|Disease Progression|17|||
33394435|NCT02996110|101331747|FG002|Track 1|Disease Progression|0|||
33394436|NCT02996110|101331748|FG003|Track 1|Disease Progression|0|||
33394437|NCT02996110|101331749|FG004|Track 1|Disease Progression|0|||
33394438|NCT02996110|101331745|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
33394439|NCT02996110|101331746|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
33394440|NCT02996110|101331747|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
33394441|NCT02996110|101331748|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
33394442|NCT02996110|101331749|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
33394443|NCT02996110|101331745|FG000|Track 1|Study Drug Toxicity|5|||
33394444|NCT02996110|101331746|FG001|Track 1|Study Drug Toxicity|3|||
33394445|NCT02996110|101331747|FG002|Track 1|Study Drug Toxicity|0|||
33394446|NCT02996110|101331748|FG003|Track 1|Study Drug Toxicity|0|||
33394447|NCT02996110|101331749|FG004|Track 1|Study Drug Toxicity|0|||
33394448|NCT02996110|101331745|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
33309402|NCT03316300|101026414|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
33394449|NCT02996110|101331746|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
33394450|NCT02996110|101331747|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
33394451|NCT02996110|101331748|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
33394452|NCT02996110|101331749|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
33394453|NCT02996110|101331745|FG000|Track 1|Administrative Reason by Sponsor|0|||
33394454|NCT02996110|101331746|FG001|Track 1|Administrative Reason by Sponsor|1|||
33394455|NCT02996110|101331747|FG002|Track 1|Administrative Reason by Sponsor|0|||
33394456|NCT02996110|101331748|FG003|Track 1|Administrative Reason by Sponsor|0|||
33394457|NCT02996110|101331749|FG004|Track 1|Administrative Reason by Sponsor|0|||
33394458|NCT02996110|101331745|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
33394459|NCT02996110|101331746|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
33394460|NCT02996110|101331747|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
33309403|NCT03316300|101026413|FG000|Overall Study|Adverse Event|1|||
33309404|NCT03316300|101026414|FG001|Overall Study|Adverse Event|0|||
33309405|NCT03316300|101026413|FG000|Overall Study|COVID-19|0|||
33309406|NCT03316300|101026414|FG001|Overall Study|COVID-19|1|||
33309407|NCT00190749|101029586|FG000|Overall Study|Lost to Follow-up|8|||
33309408|NCT00190749|101029587|FG001|Overall Study|Lost to Follow-up|11|||
33309409|NCT00190749|101029586|FG000|Overall Study|Withdrawal by Subject|10|||
33309410|NCT00190749|101029587|FG001|Overall Study|Withdrawal by Subject|6|||
33309411|NCT00190749|101029586|FG000|Overall Study|Protocol Violation|5|||
33309412|NCT00190749|101029587|FG001|Overall Study|Protocol Violation|4|||
33309413|NCT00190749|101029586|FG000|Overall Study|Adverse Event|0|||
33309414|NCT00190749|101029587|FG001|Overall Study|Adverse Event|5|||
33309415|NCT00190749|101029586|FG000|Overall Study|Lack of Efficacy|2|||
33309416|NCT00190749|101029587|FG001|Overall Study|Lack of Efficacy|3|||
33309417|NCT00190749|101029586|FG000|Overall Study|Reason Not Specified|0|||
33309418|NCT00190749|101029587|FG001|Overall Study|Reason Not Specified|2|||
33309419|NCT00190749|101029586|FG000|Overall Study|Sponsor Decision|1|||
33309420|NCT00190749|101029587|FG001|Overall Study|Sponsor Decision|0|||
33309421|NCT00446992|101029588|FG000|Overall Study|Adverse Event|11|||
33309422|NCT00446992|101029588|FG000|Overall Study|Lost to Follow-up|5|||
33309423|NCT01535560|101029590|FG000|Overall Study|Adverse Event|12|||
33309424|NCT01535560|101029591|FG001|Overall Study|Adverse Event|7|||
33309425|NCT01535560|101029590|FG000|Overall Study|Lost to Follow-up|1|||
33309426|NCT01535560|101029591|FG001|Overall Study|Lost to Follow-up|3|||
33309427|NCT01535560|101029590|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
33309428|NCT01535560|101029591|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
33394461|NCT02996110|101331748|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
33394462|NCT02996110|101331749|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
33309429|NCT01535560|101029590|FG000|Overall Study|Treatment Failure|21|||
33309430|NCT01535560|101029591|FG001|Overall Study|Treatment Failure|83|||
33309431|NCT01535560|101029590|FG000|Overall Study|Other|0|||
33309432|NCT01535560|101029591|FG001|Overall Study|Other|1|||
33394463|NCT02996110|101331745|FG000|Track 2|Disease Progression|33|||
33394464|NCT02996110|101331746|FG001|Track 2|Disease Progression|26|||
33394465|NCT02996110|101331747|FG002|Track 2|Disease Progression|19|||
33309433|NCT01535560|101029590|FG000|Overall Study|Randomized in Error|0|||
33394466|NCT02996110|101331748|FG003|Track 2|Disease Progression|16|||
33394467|NCT02996110|101331749|FG004|Track 2|Disease Progression|15|||
33500883|NCT01757184|101724784|FG000|Open-label Period|Lost to Follow-up|0|||
33500884|NCT01757184|101724785|FG001|Open-label Period|Lost to Follow-up|0|||
33500885|NCT01757184|101724786|FG002|Open-label Period|Lost to Follow-up|2|||
33500886|NCT01757184|101724787|FG003|Open-label Period|Lost to Follow-up|0|||
33500887|NCT01757184|101724784|FG000|Open-label Period|Withdrawal by Subject|0|||
33500888|NCT01757184|101724785|FG001|Open-label Period|Withdrawal by Subject|0|||
33500889|NCT01757184|101724786|FG002|Open-label Period|Withdrawal by Subject|1|||
33500890|NCT01757184|101724787|FG003|Open-label Period|Withdrawal by Subject|1|||
33500891|NCT01757184|101724784|FG000|Open-label Period|Discontinued by Sponsor|0|||
33500892|NCT01757184|101724785|FG001|Open-label Period|Discontinued by Sponsor|0|||
33192140|NCT01109316|100608586|FG001|Study Period 1|Withdrawal by Subject|0|||
33192141|NCT01109316|100608587|FG002|Study Period 1|Withdrawal by Subject|1|||
33192142|NCT01109316|100608588|FG003|Study Period 1|Withdrawal by Subject|0|||
33309434|NCT01535560|101029591|FG001|Overall Study|Randomized in Error|1|||
33309435|NCT00618982|101029592|FG000|Overall Study|Adverse Event|23|||
33309436|NCT00618982|101029592|FG000|Overall Study|Withdrawal by Subject|1|||
33309437|NCT00618982|101029592|FG000|Overall Study|Protocol Violation|1|||
33192143|NCT01109316|100608589|FG004|Study Period 1|Withdrawal by Subject|2|||
33192144|NCT01109316|100608590|FG005|Study Period 1|Withdrawal by Subject|0|||
33192145|NCT01109316|100608585|FG000|Study Period 1|Sponsor Decision|0|||
33192146|NCT01109316|100608586|FG001|Study Period 1|Sponsor Decision|0|||
33192147|NCT01109316|100608587|FG002|Study Period 1|Sponsor Decision|0|||
33192148|NCT01109316|100608588|FG003|Study Period 1|Sponsor Decision|0|||
33192149|NCT01109316|100608589|FG004|Study Period 1|Sponsor Decision|0|||
33192150|NCT01109316|100608590|FG005|Study Period 1|Sponsor Decision|2|||
33192151|NCT01109316|100608585|FG000|Study Period 2|Entry Criteria Not Met|0|||
33192152|NCT01109316|100608586|FG001|Study Period 2|Entry Criteria Not Met|1|||
33192153|NCT01109316|100608587|FG002|Study Period 2|Entry Criteria Not Met|0|||
33192154|NCT01109316|100608588|FG003|Study Period 2|Entry Criteria Not Met|0|||
33192155|NCT01109316|100608589|FG004|Study Period 2|Entry Criteria Not Met|0|||
33192156|NCT01109316|100608590|FG005|Study Period 2|Entry Criteria Not Met|0|||
33309438|NCT00618982|101029592|FG000|Overall Study|ongoing, still treated with study med.|25|||
33309439|NCT03727438|101029593|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
33309440|NCT03727438|101029594|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
33309441|NCT03727438|101029593|FG000|Intervention Period|Excluded (health)|1|||
33309442|NCT03727438|101029594|FG001|Intervention Period|Excluded (health)|0|||
33309443|NCT03727438|101029593|FG000|Intervention Period|Withdrawal by Subject|3|||
33309444|NCT03727438|101029594|FG001|Intervention Period|Withdrawal by Subject|1|||
33309445|NCT03727438|101029593|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
33309446|NCT03727438|101029594|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
33309447|NCT03727438|101029593|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
33309448|NCT03727438|101029594|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
33309449|NCT03727438|101029593|FG000|8 Week Assessment|Withdrawal by Subject|6|||
33500893|NCT01757184|101724786|FG002|Open-label Period|Discontinued by Sponsor|1|||
33500894|NCT01757184|101724787|FG003|Open-label Period|Discontinued by Sponsor|2|||
33500895|NCT04179838|101724790|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
33192157|NCT01109316|100608585|FG000|Study Period 2|Physician Decision|0|||
33192158|NCT01109316|100608586|FG001|Study Period 2|Physician Decision|0|||
33192159|NCT01109316|100608587|FG002|Study Period 2|Physician Decision|0|||
33192160|NCT01109316|100608588|FG003|Study Period 2|Physician Decision|1|||
33192161|NCT01109316|100608589|FG004|Study Period 2|Physician Decision|0|||
33192162|NCT01109316|100608590|FG005|Study Period 2|Physician Decision|0|||
33192163|NCT01109316|100608585|FG000|Study Period 2|Protocol Violation|1|||
33192164|NCT01109316|100608586|FG001|Study Period 2|Protocol Violation|0|||
33192165|NCT01109316|100608587|FG002|Study Period 2|Protocol Violation|0|||
33192166|NCT01109316|100608588|FG003|Study Period 2|Protocol Violation|0|||
33309450|NCT03727438|101029594|FG001|8 Week Assessment|Withdrawal by Subject|1|||
33309451|NCT03727438|101029593|FG000|6 mo Assessment|did not complete assessment|10|||
33309452|NCT03727438|101029594|FG001|6 mo Assessment|did not complete assessment|11|||
33309453|NCT00345293|101029596|FG000|Overall Study|Unable to access line for sample|1|||
33309454|NCT00345293|101029597|FG001|Overall Study|Unable to access line for sample|0|||
33309455|NCT00345293|101029596|FG000|Overall Study|Withdrawal by Subject|1|||
33309456|NCT00345293|101029597|FG001|Overall Study|Withdrawal by Subject|0|||
33500896|NCT04179838|101724791|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
33500897|NCT04179838|101724790|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
33309457|NCT02533531|101029598|FG000|Overall Study|Device did not turn on|1|||
33309458|NCT03035201|101029599|FG000|Overall Study|Death|9|||
33309459|NCT03035201|101029600|FG001|Overall Study|Death|12|||
33309460|NCT03035201|101029601|FG002|Overall Study|Death|9|||
33309461|NCT03035201|101029602|FG003|Overall Study|Death|10|||
33309462|NCT03035201|101029599|FG000|Overall Study|Withdrawal by Subject|51|||
33309463|NCT03035201|101029600|FG001|Overall Study|Withdrawal by Subject|49|||
33309464|NCT03035201|101029601|FG002|Overall Study|Withdrawal by Subject|37|||
33309465|NCT03035201|101029602|FG003|Overall Study|Withdrawal by Subject|46|||
33309466|NCT03035201|101029599|FG000|Overall Study|Lost to Follow-up|67|||
33309467|NCT03035201|101029600|FG001|Overall Study|Lost to Follow-up|51|||
33309468|NCT03035201|101029601|FG002|Overall Study|Lost to Follow-up|64|||
33309469|NCT03035201|101029602|FG003|Overall Study|Lost to Follow-up|69|||
33309470|NCT05087979|101029603|FG000|Overall Study|Converted to general anesthesia|1|||
33309471|NCT05087979|101029604|FG001|Overall Study|Converted to general anesthesia|0|||
33309472|NCT02447172|101029607|FG000|Overall Study|Adverse Event|11|||
33309473|NCT02447172|101029608|FG001|Overall Study|Adverse Event|8|||
33309474|NCT02447172|101029609|FG002|Overall Study|Adverse Event|7|||
33309475|NCT02447172|101029607|FG000|Overall Study|Death|3|||
33309476|NCT02447172|101029608|FG001|Overall Study|Death|1|||
33309477|NCT02447172|101029609|FG002|Overall Study|Death|0|||
33309478|NCT02447172|101029607|FG000|Overall Study|Protocol Violation|2|||
33309479|NCT02447172|101029608|FG001|Overall Study|Protocol Violation|1|||
33309480|NCT02447172|101029609|FG002|Overall Study|Protocol Violation|2|||
33309481|NCT02447172|101029607|FG000|Overall Study|Lost to Follow-up|7|||
33309482|NCT02447172|101029608|FG001|Overall Study|Lost to Follow-up|4|||
33309483|NCT02447172|101029609|FG002|Overall Study|Lost to Follow-up|4|||
33309484|NCT02447172|101029607|FG000|Overall Study|Withdrawal by Subject|5|||
33309485|NCT02447172|101029608|FG001|Overall Study|Withdrawal by Subject|1|||
33309486|NCT02447172|101029609|FG002|Overall Study|Withdrawal by Subject|3|||
33309487|NCT02447172|101029607|FG000|Overall Study|protocol specific treatment unrelated|3|||
33309488|NCT02447172|101029608|FG001|Overall Study|protocol specific treatment unrelated|0|||
33309489|NCT02447172|101029609|FG002|Overall Study|protocol specific treatment unrelated|2|||
33309490|NCT00081497|101029610|FG000|Overall Study|Adverse Event|2|||
33309491|NCT00081497|101029611|FG001|Overall Study|Adverse Event|0|||
33309492|NCT00081497|101029610|FG000|Overall Study|Death|0|||
33309493|NCT00081497|101029611|FG001|Overall Study|Death|1|||
33309494|NCT00081497|101029610|FG000|Overall Study|Withdrawal by Subject|1|||
33309495|NCT00081497|101029611|FG001|Overall Study|Withdrawal by Subject|0|||
33309496|NCT00081497|101029610|FG000|Overall Study|Non-compliance|0|||
33309497|NCT00081497|101029611|FG001|Overall Study|Non-compliance|1|||
33309498|NCT02257567|101029612|FG000|Overall Study|Adverse Event|0|||
33309499|NCT02257567|101029613|FG001|Overall Study|Adverse Event|0|||
33309500|NCT02257567|101029614|FG002|Overall Study|Adverse Event|0|||
33309501|NCT02257567|101029615|FG003|Overall Study|Adverse Event|1|||
33309502|NCT02257567|101029616|FG004|Overall Study|Adverse Event|1|||
33500898|NCT04179838|101724791|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
33309503|NCT02257567|101029617|FG005|Overall Study|Adverse Event|0|||
33309504|NCT02257567|101029618|FG006|Overall Study|Adverse Event|0|||
33309505|NCT02257567|101029619|FG007|Overall Study|Adverse Event|0|||
33309506|NCT02257567|101029620|FG008|Overall Study|Adverse Event|1|||
33309507|NCT02257567|101029621|FG009|Overall Study|Adverse Event|0|||
33309508|NCT02257567|101029622|FG010|Overall Study|Adverse Event|0|||
33309509|NCT02257567|101029612|FG000|Overall Study|Death|2|||
33309510|NCT02257567|101029613|FG001|Overall Study|Death|2|||
33309511|NCT02257567|101029614|FG002|Overall Study|Death|2|||
33309512|NCT02257567|101029615|FG003|Overall Study|Death|4|||
33309513|NCT02257567|101029616|FG004|Overall Study|Death|15|||
33192167|NCT01109316|100608589|FG004|Study Period 2|Protocol Violation|0|||
33192168|NCT01109316|100608590|FG005|Study Period 2|Protocol Violation|0|||
33309514|NCT02257567|101029617|FG005|Overall Study|Death|11|||
33309515|NCT02257567|101029618|FG006|Overall Study|Death|26|||
33309516|NCT02257567|101029619|FG007|Overall Study|Death|30|||
33394468|NCT02996110|101331745|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
33309517|NCT02257567|101029620|FG008|Overall Study|Death|2|||
33309518|NCT02257567|101029621|FG009|Overall Study|Death|18|||
33309519|NCT02257567|101029622|FG010|Overall Study|Death|65|||
33309520|NCT02257567|101029612|FG000|Overall Study|Lost to Follow-up|0|||
33309521|NCT02257567|101029613|FG001|Overall Study|Lost to Follow-up|0|||
33309522|NCT02257567|101029614|FG002|Overall Study|Lost to Follow-up|0|||
33309523|NCT02257567|101029615|FG003|Overall Study|Lost to Follow-up|0|||
33309524|NCT02257567|101029616|FG004|Overall Study|Lost to Follow-up|2|||
33309525|NCT02257567|101029617|FG005|Overall Study|Lost to Follow-up|2|||
33309526|NCT02257567|101029618|FG006|Overall Study|Lost to Follow-up|0|||
33309527|NCT02257567|101029619|FG007|Overall Study|Lost to Follow-up|0|||
33394469|NCT02996110|101331746|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
33394470|NCT02996110|101331747|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
33394471|NCT02996110|101331748|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
33394472|NCT02996110|101331749|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
33394473|NCT02996110|101331745|FG000|Track 2|Death|0|||
33394474|NCT02996110|101331746|FG001|Track 2|Death|0|||
33394475|NCT02996110|101331747|FG002|Track 2|Death|1|||
33394476|NCT02996110|101331748|FG003|Track 2|Death|0|||
33394477|NCT02996110|101331749|FG004|Track 2|Death|1|||
33394478|NCT02996110|101331745|FG000|Track 2|Study Drug Toxicity|4|||
33394479|NCT02996110|101331746|FG001|Track 2|Study Drug Toxicity|1|||
33394480|NCT02996110|101331747|FG002|Track 2|Study Drug Toxicity|4|||
33394481|NCT02996110|101331748|FG003|Track 2|Study Drug Toxicity|1|||
33394482|NCT02996110|101331749|FG004|Track 2|Study Drug Toxicity|0|||
33394483|NCT02996110|101331745|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
33394484|NCT02996110|101331746|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
33394485|NCT02996110|101331747|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
33394486|NCT02996110|101331748|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
33394487|NCT02996110|101331749|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
33394488|NCT02996110|101331745|FG000|Track 2|Participant Withdrew Consent|1|||
33394489|NCT02996110|101331746|FG001|Track 2|Participant Withdrew Consent|2|||
33394490|NCT02996110|101331747|FG002|Track 2|Participant Withdrew Consent|3|||
33394491|NCT02996110|101331748|FG003|Track 2|Participant Withdrew Consent|1|||
33394492|NCT02996110|101331749|FG004|Track 2|Participant Withdrew Consent|1|||
33394493|NCT02996110|101331745|FG000|Track 2|Other Reasons|0|||
33394494|NCT02996110|101331746|FG001|Track 2|Other Reasons|0|||
33394495|NCT02996110|101331747|FG002|Track 2|Other Reasons|1|||
33394496|NCT02996110|101331748|FG003|Track 2|Other Reasons|0|||
33394497|NCT02996110|101331749|FG004|Track 2|Other Reasons|1|||
33394498|NCT00712270|101331750|FG000|Overall Study|Withdrawal by Subject|11|||
33500899|NCT01346696|101724792|FG000|Overall Study|Death|1|||
33309528|NCT02257567|101029620|FG008|Overall Study|Lost to Follow-up|0|||
33309529|NCT02257567|101029621|FG009|Overall Study|Lost to Follow-up|1|||
33309530|NCT02257567|101029622|FG010|Overall Study|Lost to Follow-up|1|||
33309531|NCT02257567|101029612|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33309532|NCT02257567|101029613|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33309533|NCT02257567|101029614|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33309534|NCT02257567|101029615|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33309535|NCT02257567|101029616|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
33309536|NCT02257567|101029617|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33309537|NCT02257567|101029618|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
33309538|NCT02257567|101029619|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33394499|NCT00712270|101331750|FG000|Overall Study|Screen Failure|3|||
33500900|NCT02929589|101724793|FG000|Overall Study|Withdrawal by Subject|1|||
33500901|NCT02929589|101724794|FG001|Overall Study|Withdrawal by Subject|0|||
33500902|NCT02929589|101724795|FG002|Overall Study|Withdrawal by Subject|0|||
33500903|NCT02929589|101724796|FG003|Overall Study|Withdrawal by Subject|0|||
33500904|NCT02929589|101724793|FG000|Overall Study|Physician Decision|2|||
33500905|NCT02929589|101724794|FG001|Overall Study|Physician Decision|0|||
33500906|NCT02929589|101724795|FG002|Overall Study|Physician Decision|0|||
33500907|NCT02929589|101724796|FG003|Overall Study|Physician Decision|0|||
33500908|NCT00427648|101724799|FG000|Overall Study|Protocol Violation|1|||
33394500|NCT00102804|101331758|FG000|Overall Study|Progressive Disease (PD)|307|||
33394501|NCT00102804|101331759|FG001|Overall Study|Progressive Disease (PD)|196|||
33394502|NCT00102804|101331758|FG000|Overall Study|Withdrawal by Subject|46|||
33394503|NCT00102804|101331759|FG001|Overall Study|Withdrawal by Subject|7|||
33394504|NCT00102804|101331758|FG000|Overall Study|Adverse Event|37|||
33394505|NCT00102804|101331759|FG001|Overall Study|Adverse Event|3|||
33394506|NCT00102804|101331758|FG000|Overall Study|Physician Decision|24|||
33500909|NCT00427648|101724800|FG001|Overall Study|Protocol Violation|2|||
33394507|NCT00102804|101331759|FG001|Overall Study|Physician Decision|6|||
33394508|NCT00102804|101331758|FG000|Overall Study|Death|5|||
33394509|NCT00102804|101331759|FG001|Overall Study|Death|6|||
33394510|NCT00102804|101331758|FG000|Overall Study|Enrollment Criteria Not Met|6|||
33500910|NCT00427648|101724799|FG000|Overall Study|Adverse Event|0|||
33500911|NCT00427648|101724800|FG001|Overall Study|Adverse Event|1|||
33500912|NCT01441765|101724808|FG000|Overall Study|Death|1|||
33500913|NCT01441765|101724809|FG001|Overall Study|Death|0|||
33394511|NCT00102804|101331759|FG001|Overall Study|Enrollment Criteria Not Met|0|||
33394512|NCT00102804|101331758|FG000|Overall Study|Lost to Follow-up|4|||
33394513|NCT00102804|101331759|FG001|Overall Study|Lost to Follow-up|1|||
33394514|NCT00102804|101331758|FG000|Overall Study|Protocol Violation|2|||
33394515|NCT00102804|101331759|FG001|Overall Study|Protocol Violation|1|||
33500914|NCT02195869|101724816|FG000|Overall Study|cGVHD Progression|5|||
33500915|NCT02195869|101724816|FG000|Overall Study|Malignancy Progression/relapse|2|||
33500916|NCT02195869|101724816|FG000|Overall Study|Adverse Event|15|||
33500917|NCT02195869|101724816|FG000|Overall Study|Withdrawal by Subject|7|||
33500918|NCT02195869|101724816|FG000|Overall Study|Physician Decision|4|||
33500919|NCT02195869|101724816|FG000|Overall Study|Study Terminated by Sponsor|7|||
33500920|NCT02195869|101724816|FG000|Overall Study|Noncompliance with study drug|2|||
33500921|NCT00586820|101727627|FG000|Overall Study|Unsuccessful PCI|1|||
33500922|NCT00586820|101727628|FG001|Overall Study|Unsuccessful PCI|0|||
33500923|NCT01706939|101727631|FG000|Pre Randomization|Screen Failure|1|||
33500924|NCT01706939|101727632|FG001|Pre Randomization|Screen Failure|0|||
33500925|NCT01706939|101727633|FG002|Pre Randomization|Screen Failure|0|||
33500926|NCT01706939|101727631|FG000|Pre Randomization|Ineligible for Randomization|1|||
33500927|NCT01706939|101727632|FG001|Pre Randomization|Ineligible for Randomization|0|||
33500928|NCT01706939|101727633|FG002|Pre Randomization|Ineligible for Randomization|0|||
33500929|NCT01706939|101727631|FG000|Pre Randomization|Withdrawal by Subject|1|||
33500930|NCT01706939|101727632|FG001|Pre Randomization|Withdrawal by Subject|0|||
33500931|NCT01706939|101727633|FG002|Pre Randomization|Withdrawal by Subject|0|||
33500932|NCT01706939|101727631|FG000|Randomization|Insufficient QoL survey compliance|0|||
33500933|NCT01706939|101727632|FG001|Randomization|Insufficient QoL survey compliance|1|||
33500934|NCT01706939|101727633|FG002|Randomization|Insufficient QoL survey compliance|1|||
33500935|NCT01706939|101727631|FG000|Randomization|Progression of disease|0|||
33500936|NCT01706939|101727632|FG001|Randomization|Progression of disease|2|||
33500937|NCT01706939|101727633|FG002|Randomization|Progression of disease|1|||
33500938|NCT04570670|101727634|FG000|Overall Study|Withdrawal by Subject|1|||
33192169|NCT01109316|100608585|FG000|Study Period 2|Withdrawal by Subject|0|||
33192170|NCT01109316|100608586|FG001|Study Period 2|Withdrawal by Subject|0|||
33192171|NCT01109316|100608587|FG002|Study Period 2|Withdrawal by Subject|1|||
33192172|NCT01109316|100608588|FG003|Study Period 2|Withdrawal by Subject|0|||
33192173|NCT01109316|100608589|FG004|Study Period 2|Withdrawal by Subject|0|||
33192174|NCT01109316|100608590|FG005|Study Period 2|Withdrawal by Subject|1|||
33192175|NCT01109316|100608585|FG000|Study Period 3|Lost to Follow-up|0|||
33394516|NCT00102804|101331758|FG000|Overall Study|Satisfactory Response|2|||
33500939|NCT04570670|101727635|FG001|Overall Study|Withdrawal by Subject|0|||
33500940|NCT02510664|101727636|FG000|Overall Study|Transferred Care|9|||
33500941|NCT02510664|101727637|FG001|Overall Study|Transferred Care|9|||
33500942|NCT02510664|101727638|FG002|Overall Study|Transferred Care|0|||
33500943|NCT02510664|101727636|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
33309539|NCT02257567|101029620|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33309540|NCT02257567|101029621|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33309541|NCT02257567|101029622|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
33309542|NCT02257567|101029612|FG000|Overall Study|Physician Decision|0|||
33309543|NCT02257567|101029613|FG001|Overall Study|Physician Decision|0|||
33309544|NCT02257567|101029614|FG002|Overall Study|Physician Decision|0|||
33309545|NCT02257567|101029615|FG003|Overall Study|Physician Decision|0|||
33309546|NCT02257567|101029616|FG004|Overall Study|Physician Decision|0|||
33309547|NCT02257567|101029617|FG005|Overall Study|Physician Decision|0|||
33309548|NCT02257567|101029618|FG006|Overall Study|Physician Decision|0|||
33309549|NCT02257567|101029619|FG007|Overall Study|Physician Decision|2|||
33309550|NCT02257567|101029620|FG008|Overall Study|Physician Decision|0|||
33309551|NCT02257567|101029621|FG009|Overall Study|Physician Decision|1|||
33309552|NCT02257567|101029622|FG010|Overall Study|Physician Decision|0|||
33309553|NCT02257567|101029612|FG000|Overall Study|Withdrawal by Subject|0|||
33309554|NCT02257567|101029613|FG001|Overall Study|Withdrawal by Subject|0|||
33309555|NCT02257567|101029614|FG002|Overall Study|Withdrawal by Subject|2|||
33309556|NCT02257567|101029615|FG003|Overall Study|Withdrawal by Subject|0|||
33309557|NCT02257567|101029616|FG004|Overall Study|Withdrawal by Subject|0|||
33309558|NCT02257567|101029617|FG005|Overall Study|Withdrawal by Subject|6|||
33309559|NCT02257567|101029618|FG006|Overall Study|Withdrawal by Subject|6|||
33309560|NCT02257567|101029619|FG007|Overall Study|Withdrawal by Subject|6|||
33309561|NCT02257567|101029620|FG008|Overall Study|Withdrawal by Subject|1|||
33309562|NCT02257567|101029621|FG009|Overall Study|Withdrawal by Subject|1|||
33309563|NCT02257567|101029622|FG010|Overall Study|Withdrawal by Subject|10|||
33309564|NCT01880528|101029623|FG000|Overall Study|Other|1|||
33309565|NCT01880528|101029624|FG001|Overall Study|Other|1|||
33309566|NCT00910689|101029625|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
33309567|NCT00910689|101029626|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
33309568|NCT00910689|101029627|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
33309569|NCT00910689|101029628|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
33309570|NCT00910689|101029625|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
33309571|NCT00910689|101029626|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
33309572|NCT00910689|101029627|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
33309573|NCT00910689|101029628|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
33309574|NCT00910689|101029625|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
33309575|NCT00910689|101029626|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
33309576|NCT00910689|101029627|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
33309577|NCT00910689|101029628|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
33309578|NCT00910689|101029625|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
33309579|NCT00910689|101029626|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
33309580|NCT00910689|101029627|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
33309581|NCT00910689|101029628|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
33309582|NCT00910689|101029625|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
33309583|NCT00910689|101029626|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
33309584|NCT00910689|101029627|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
33309585|NCT00910689|101029628|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
33309586|NCT00910689|101029625|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
33309587|NCT00910689|101029626|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
33500944|NCT02510664|101727637|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
33500945|NCT02510664|101727638|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
33500946|NCT02510664|101727636|FG000|Overall Study|Time Constraints|1|||
33500947|NCT02510664|101727637|FG001|Overall Study|Time Constraints|1|||
33500948|NCT02510664|101727638|FG002|Overall Study|Time Constraints|0|||
33500949|NCT04177095|101727639|FG000|Overall Study|Withdrawal by Subject|3|||
33500950|NCT04177095|101727639|FG000|Overall Study|Screen Failure|3|||
33500951|NCT04177095|101727639|FG000|Overall Study|Problems with the Trugraf assay|1|||
33500952|NCT00086684|101727640|FG000|Overall Study|Adverse Event|12|||
33500953|NCT00086684|101727641|FG001|Overall Study|Adverse Event|17|||
33309588|NCT00910689|101029627|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
33309589|NCT00910689|101029628|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
33309590|NCT00910689|101029625|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
33309591|NCT00910689|101029626|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
33309592|NCT00910689|101029627|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
33309593|NCT00910689|101029628|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
33309594|NCT00910689|101029625|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
33309595|NCT00910689|101029626|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
33500954|NCT00086684|101727642|FG002|Overall Study|Adverse Event|14|||
33500955|NCT00086684|101727640|FG000|Overall Study|Lack of Efficacy|6|||
33500956|NCT00086684|101727641|FG001|Overall Study|Lack of Efficacy|6|||
33192176|NCT01109316|100608586|FG001|Study Period 3|Lost to Follow-up|0|||
33192177|NCT01109316|100608587|FG002|Study Period 3|Lost to Follow-up|0|||
33192178|NCT01109316|100608588|FG003|Study Period 3|Lost to Follow-up|0|||
33192179|NCT01109316|100608589|FG004|Study Period 3|Lost to Follow-up|1|||
33192180|NCT01109316|100608590|FG005|Study Period 3|Lost to Follow-up|0|||
33192181|NCT01109316|100608585|FG000|Study Period 3|Withdrawal by Subject|1|||
33192182|NCT01109316|100608586|FG001|Study Period 3|Withdrawal by Subject|0|||
33192183|NCT01109316|100608587|FG002|Study Period 3|Withdrawal by Subject|0|||
33192184|NCT01109316|100608588|FG003|Study Period 3|Withdrawal by Subject|0|||
33192185|NCT01109316|100608589|FG004|Study Period 3|Withdrawal by Subject|1|||
33192186|NCT01109316|100608590|FG005|Study Period 3|Withdrawal by Subject|0|||
33192187|NCT01502644|100608591|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
33192188|NCT01502644|100608592|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
33192189|NCT01502644|100608593|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
33192190|NCT01502644|100608594|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
33192191|NCT01502644|100608591|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
33192192|NCT01502644|100608592|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
33192193|NCT01502644|100608593|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
33192194|NCT01502644|100608594|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
33192195|NCT01502644|100608591|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
33192196|NCT01502644|100608592|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
33192197|NCT01502644|100608593|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
33192198|NCT01502644|100608594|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
33192199|NCT01502644|100608591|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
33192200|NCT01502644|100608592|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
33192201|NCT01502644|100608593|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
33192202|NCT01502644|100608594|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
33192203|NCT01502644|100608591|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
33192204|NCT01502644|100608592|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
33192205|NCT01502644|100608593|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
33192206|NCT01502644|100608594|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
33192207|NCT00080223|100608595|FG000|Overall Study|Adverse Event|23|||
33192208|NCT00080223|100608595|FG000|Overall Study|Death|21|||
33192209|NCT00080223|100608595|FG000|Overall Study|Withdrawal by Subject|13|||
33192210|NCT00080223|100608595|FG000|Overall Study|Lung Transplantation|9|||
33192211|NCT00080223|100608595|FG000|Overall Study|Non-compliance With Study Treatment|7|||
33192212|NCT00080223|100608595|FG000|Overall Study|Participant unwilling to continue|2|||
33192213|NCT00080223|100608595|FG000|Overall Study|Physician Decision|1|||
33192214|NCT04152447|100608599|FG000|Overall Study|Lost to Follow-up|1|||
33192215|NCT04152447|100608600|FG001|Overall Study|Lost to Follow-up|0|||
33192216|NCT04152447|100608599|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
33192217|NCT04152447|100608600|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
33192218|NCT04152447|100608599|FG000|Overall Study|Withdrawal by Subject|0|||
33192219|NCT04152447|100608600|FG001|Overall Study|Withdrawal by Subject|1|||
33192220|NCT04152447|100608599|FG000|Overall Study|Found ineligible after enrolling|1|||
33192221|NCT04152447|100608600|FG001|Overall Study|Found ineligible after enrolling|1|||
33192222|NCT04152447|100608599|FG000|Overall Study|Did not receive VR headset in time.|0|||
33192223|NCT04152447|100608600|FG001|Overall Study|Did not receive VR headset in time.|2|||
33192224|NCT01209624|100608605|FG000|Overall Study|Death|2|||
33192225|NCT01209624|100608605|FG000|Overall Study|Adverse Event|13|||
33192226|NCT01209624|100608605|FG000|Overall Study|Lack of Efficacy|17|||
33192227|NCT01209624|100608605|FG000|Overall Study|Lost to Follow-up|290|||
33192228|NCT01209624|100608605|FG000|Overall Study|Other|4|||
33192229|NCT02177266|100608606|FG000|Overall Study|Adverse Event|0|||
33192230|NCT02177266|100608607|FG001|Overall Study|Adverse Event|1|||
33192231|NCT02177266|100608606|FG000|Overall Study|Withdrawal by Subject|1|||
33192232|NCT02177266|100608607|FG001|Overall Study|Withdrawal by Subject|0|||
33192233|NCT00183872|100608608|FG000|Overall Study|Death|3|||
33192234|NCT00183872|100608608|FG000|Overall Study|Adverse Event|9|||
33192235|NCT00183872|100608608|FG000|Overall Study|Withdrawal by Subject|2|||
33192236|NCT00183872|100608608|FG000|Overall Study|Drug delayed more than 28 days|2|||
33192237|NCT02376166|100608618|FG000|Overall Study|Adverse Event|1|||
33192238|NCT02376166|100608618|FG000|Overall Study|Discontinued metformin early|2|||
33192239|NCT03192150|100608621|FG000|Overall Study|Adverse Event|14|||
33192240|NCT03192150|100608622|FG001|Overall Study|Adverse Event|12|||
33192241|NCT03192150|100608621|FG000|Overall Study|Lack of Efficacy|23|||
33192242|NCT03192150|100608622|FG001|Overall Study|Lack of Efficacy|30|||
33192243|NCT03192150|100608621|FG000|Overall Study|Lost to Follow-up|1|||
33192244|NCT03192150|100608622|FG001|Overall Study|Lost to Follow-up|1|||
33192245|NCT03192150|100608621|FG000|Overall Study|Withdrawal by Subject|4|||
33192246|NCT03192150|100608622|FG001|Overall Study|Withdrawal by Subject|2|||
33309596|NCT00910689|101029627|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
33309597|NCT00910689|101029628|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
33309598|NCT00910689|101029625|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
33500957|NCT00086684|101727642|FG002|Overall Study|Lack of Efficacy|5|||
33500958|NCT00086684|101727640|FG000|Overall Study|Lost to Follow-up|15|||
33309599|NCT00910689|101029626|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
33309600|NCT00910689|101029627|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
33309601|NCT00910689|101029628|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
33309602|NCT00910689|101029625|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
33309603|NCT00910689|101029626|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
33309604|NCT00910689|101029627|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
33309605|NCT00910689|101029628|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
33309606|NCT00910689|101029625|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
33309607|NCT00910689|101029626|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
33309608|NCT00910689|101029627|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
33309609|NCT00910689|101029628|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
33309610|NCT00910689|101029625|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
33309611|NCT00910689|101029626|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
33309612|NCT00910689|101029627|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
33309613|NCT00910689|101029628|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
33309614|NCT00910689|101029625|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
33309615|NCT00910689|101029626|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
33309616|NCT00910689|101029627|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
33309617|NCT00910689|101029628|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
33309618|NCT00910689|101029625|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
33309619|NCT00910689|101029626|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
33309620|NCT00910689|101029627|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
33309621|NCT00910689|101029628|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
33309622|NCT00910689|101029625|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
33309623|NCT00910689|101029626|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
33309624|NCT00910689|101029627|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
33309625|NCT00910689|101029628|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
33309626|NCT00910689|101029625|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
33309627|NCT00910689|101029626|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
33309628|NCT00910689|101029627|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
33309629|NCT00910689|101029628|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
33394517|NCT00102804|101331759|FG001|Overall Study|Satisfactory Response|0|||
33394518|NCT00102804|101331758|FG000|Overall Study|Sponsor Decision|1|||
33394519|NCT00102804|101331759|FG001|Overall Study|Sponsor Decision|0|||
33394520|NCT00102804|101331758|FG000|Overall Study|Alive, Receiving Treatment|7|||
33394521|NCT00102804|101331759|FG001|Overall Study|Alive, Receiving Treatment|2|||
33394522|NCT01432938|101331760|FG000|First Intervention|Protocol Violation|1|||
33394523|NCT01432938|101331761|FG001|First Intervention|Protocol Violation|0|||
33309630|NCT00910689|101029625|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
33309631|NCT00910689|101029626|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
33394524|NCT01432938|101331760|FG000|First Intervention|Physician Decision|1|||
33309632|NCT00910689|101029627|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
33309633|NCT00910689|101029628|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
33309634|NCT00910689|101029625|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
33309635|NCT00910689|101029626|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
33309636|NCT00910689|101029627|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
33309637|NCT00910689|101029628|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
33309638|NCT00910689|101029625|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
33309639|NCT00910689|101029626|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
33309640|NCT00910689|101029627|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
33309641|NCT00910689|101029628|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
33309642|NCT00910689|101029625|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
33309643|NCT00910689|101029626|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
33309644|NCT00910689|101029627|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
33309645|NCT00910689|101029628|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
33394525|NCT01432938|101331761|FG001|First Intervention|Physician Decision|0|||
33500959|NCT00086684|101727641|FG001|Overall Study|Lost to Follow-up|8|||
33500960|NCT00086684|101727642|FG002|Overall Study|Lost to Follow-up|10|||
33500961|NCT00086684|101727640|FG000|Overall Study|Protocol Violation|8|||
33309646|NCT00910689|101029625|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
33394526|NCT01432938|101331760|FG000|Second Intervention|Adverse Event|1|||
33394527|NCT01432938|101331761|FG001|Second Intervention|Adverse Event|0|||
33500962|NCT00086684|101727641|FG001|Overall Study|Protocol Violation|3|||
33500963|NCT00086684|101727642|FG002|Overall Study|Protocol Violation|0|||
33500964|NCT00086684|101727640|FG000|Overall Study|Withdrawal by Subject|0|||
33309647|NCT00910689|101029626|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
33309648|NCT00910689|101029627|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
33309649|NCT00910689|101029628|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
33309650|NCT03212989|101029635|FG000|Overall Study|Physician Decision|8|||
33309651|NCT00618618|101029636|FG000|Overall Study|Patient Request|0|||
33309652|NCT00618618|101029637|FG001|Overall Study|Patient Request|0|||
33309653|NCT00618618|101029638|FG002|Overall Study|Patient Request|2|||
33309654|NCT00618618|101029639|FG003|Overall Study|Patient Request|0|||
33309655|NCT00618618|101029636|FG000|Overall Study|Inability to Complete Study Procedures|0|||
33309656|NCT00618618|101029637|FG001|Overall Study|Inability to Complete Study Procedures|1|||
33309657|NCT00618618|101029638|FG002|Overall Study|Inability to Complete Study Procedures|0|||
33309658|NCT00618618|101029639|FG003|Overall Study|Inability to Complete Study Procedures|0|||
33309659|NCT00618618|101029636|FG000|Overall Study|Lost to Follow-up|3|||
33309660|NCT00618618|101029637|FG001|Overall Study|Lost to Follow-up|0|||
33309661|NCT00618618|101029638|FG002|Overall Study|Lost to Follow-up|0|||
33309662|NCT00618618|101029639|FG003|Overall Study|Lost to Follow-up|1|||
33309663|NCT00618618|101029636|FG000|Overall Study|Non-compliance|1|||
33309664|NCT00618618|101029637|FG001|Overall Study|Non-compliance|1|||
33309665|NCT00618618|101029638|FG002|Overall Study|Non-compliance|0|||
33309666|NCT00618618|101029639|FG003|Overall Study|Non-compliance|0|||
33309667|NCT00618618|101029636|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
33309668|NCT00618618|101029637|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
33309669|NCT00618618|101029638|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
33309670|NCT00618618|101029639|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
33309671|NCT00618618|101029636|FG000|Overall Study|Death|0|||
33309672|NCT00618618|101029637|FG001|Overall Study|Death|1|||
33309673|NCT00618618|101029638|FG002|Overall Study|Death|0|||
33309674|NCT00618618|101029639|FG003|Overall Study|Death|0|||
33309675|NCT00513604|101029640|FG000|Overall Study|Not treated|2|||
33309676|NCT00513604|101029641|FG001|Overall Study|Not treated|0|||
33309677|NCT00513604|101029642|FG002|Overall Study|Not treated|1|||
33309678|NCT00513604|101029643|FG003|Overall Study|Not treated|0|||
33309679|NCT00513604|101029644|FG004|Overall Study|Not treated|0|||
33309680|NCT00513604|101029640|FG000|Overall Study|Death during treatment|0|||
33309681|NCT00513604|101029641|FG001|Overall Study|Death during treatment|3|||
33309682|NCT00513604|101029642|FG002|Overall Study|Death during treatment|2|||
33309683|NCT00513604|101029643|FG003|Overall Study|Death during treatment|0|||
33309684|NCT00513604|101029644|FG004|Overall Study|Death during treatment|0|||
33309685|NCT01575028|101029645|FG000|Overall Study|Physician Decision|0|||
33309686|NCT01575028|101029646|FG001|Overall Study|Physician Decision|1|||
33394528|NCT00732238|101331766|FG000|Overall Study|Bacteremia|4|||
33394529|NCT00732238|101331767|FG001|Overall Study|Bacteremia|1|||
33394530|NCT00732238|101331766|FG000|Overall Study|Asymptomatic bacteriuria|1|||
33309687|NCT00658684|101029648|FG000|Overall Study|Adverse Event|10|||
33309688|NCT00658684|101029649|FG001|Overall Study|Adverse Event|8|||
33309689|NCT00658684|101029650|FG002|Overall Study|Adverse Event|2|||
33394531|NCT00732238|101331767|FG001|Overall Study|Asymptomatic bacteriuria|0|||
33394532|NCT01387594|101331768|FG000|Overall Study|Withdrawal by Subject|0|||
33394533|NCT01387594|101331769|FG001|Overall Study|Withdrawal by Subject|2|||
33394534|NCT01387594|101331768|FG000|Overall Study|Lost to Follow-up|0|||
33394535|NCT01387594|101331769|FG001|Overall Study|Lost to Follow-up|1|||
33394536|NCT02365506|101331772|FG000|Overall Study|Investigator's Discretion|0|||
33394537|NCT02365506|101331773|FG001|Overall Study|Investigator's Discretion|0|||
33394538|NCT02365506|101331774|FG002|Overall Study|Investigator's Discretion|1|||
33394539|NCT01268514|101331775|FG000|Overall Study|Adverse Event|20|||
33394540|NCT01268514|101331775|FG000|Overall Study|Death|8|||
33394541|NCT01268514|101331775|FG000|Overall Study|Lost to Follow-up|5|||
33394542|NCT01268514|101331775|FG000|Overall Study|Withdrawal by Subject|3|||
33394543|NCT01268514|101331775|FG000|Overall Study|Withdrawal by Surgeon|5|||
33394544|NCT03135262|101331776|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
33394545|NCT03135262|101331777|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
33394546|NCT03135262|101331778|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
33394547|NCT03135262|101331779|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
33394548|NCT03135262|101331780|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
33394549|NCT03135262|101331776|FG000|Overall Study|Progression of disease|0|||
33394550|NCT03135262|101331777|FG001|Overall Study|Progression of disease|0|||
33394551|NCT03135262|101331778|FG002|Overall Study|Progression of disease|0|||
33394552|NCT03135262|101331779|FG003|Overall Study|Progression of disease|1|||
33394553|NCT03135262|101331780|FG004|Overall Study|Progression of disease|0|||
33394554|NCT03135262|101331776|FG000|Overall Study|Death|6|||
33394555|NCT03135262|101331777|FG001|Overall Study|Death|2|||
33394556|NCT03135262|101331778|FG002|Overall Study|Death|2|||
33394557|NCT03135262|101331779|FG003|Overall Study|Death|2|||
33394558|NCT03135262|101331780|FG004|Overall Study|Death|0|||
33394559|NCT03135262|101331776|FG000|Overall Study|Withdrawal by Subject|0|||
33309690|NCT00658684|101029651|FG003|Overall Study|Adverse Event|0|||
33309691|NCT00658684|101029648|FG000|Overall Study|Withdrawal by Subject|6|||
33192247|NCT03192150|100608621|FG000|Overall Study|Protocol Violation|5|||
33192248|NCT03192150|100608622|FG001|Overall Study|Protocol Violation|2|||
33192249|NCT03192150|100608621|FG000|Overall Study|Surgery Canceled|6|||
33192250|NCT03192150|100608622|FG001|Overall Study|Surgery Canceled|2|||
33192251|NCT03192150|100608621|FG000|Overall Study|Other-Various Administrative Reasons|2|||
33192252|NCT03192150|100608622|FG001|Overall Study|Other-Various Administrative Reasons|5|||
33192253|NCT01589822|100608623|FG000|Overall Study|Withdrawal by Subject|1|||
33192254|NCT01589822|100608624|FG001|Overall Study|Withdrawal by Subject|2|||
33192255|NCT01589822|100608625|FG002|Overall Study|Withdrawal by Subject|0|||
33192256|NCT01589822|100608623|FG000|Overall Study|Death|1|||
33192257|NCT01589822|100608624|FG001|Overall Study|Death|0|||
33192258|NCT01589822|100608625|FG002|Overall Study|Death|0|||
33192259|NCT01589822|100608623|FG000|Overall Study|Missed 90 day visit|2|||
33192260|NCT01589822|100608624|FG001|Overall Study|Missed 90 day visit|1|||
33192261|NCT01589822|100608625|FG002|Overall Study|Missed 90 day visit|1|||
33192262|NCT02932891|100608626|FG000|Overall Study|Lost to Follow-up|2|||
33192263|NCT02932891|100608626|FG000|Overall Study|HPA Suppress|2|||
33192264|NCT03746522|100608633|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
33309692|NCT00658684|101029649|FG001|Overall Study|Withdrawal by Subject|4|||
33309693|NCT00658684|101029650|FG002|Overall Study|Withdrawal by Subject|1|||
33309694|NCT00658684|101029651|FG003|Overall Study|Withdrawal by Subject|1|||
33309695|NCT00658684|101029648|FG000|Overall Study|Lack of Efficacy|1|||
33309696|NCT00658684|101029649|FG001|Overall Study|Lack of Efficacy|1|||
33309697|NCT00658684|101029650|FG002|Overall Study|Lack of Efficacy|0|||
33309698|NCT00658684|101029651|FG003|Overall Study|Lack of Efficacy|0|||
33309699|NCT00658684|101029648|FG000|Overall Study|Protocol Violation|1|||
33309700|NCT00658684|101029649|FG001|Overall Study|Protocol Violation|1|||
33309701|NCT00658684|101029650|FG002|Overall Study|Protocol Violation|0|||
33309702|NCT00658684|101029651|FG003|Overall Study|Protocol Violation|0|||
33309703|NCT00658684|101029648|FG000|Overall Study|Pregnancy|1|||
33394560|NCT03135262|101331777|FG001|Overall Study|Withdrawal by Subject|0|||
33394561|NCT03135262|101331778|FG002|Overall Study|Withdrawal by Subject|1|||
33394562|NCT03135262|101331779|FG003|Overall Study|Withdrawal by Subject|0|||
33394563|NCT03135262|101331780|FG004|Overall Study|Withdrawal by Subject|1|||
33192265|NCT03746522|100608634|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
33309704|NCT00658684|101029649|FG001|Overall Study|Pregnancy|1|||
33309705|NCT00658684|101029650|FG002|Overall Study|Pregnancy|0|||
33394564|NCT03135262|101331776|FG000|Overall Study|Study terminated by sponsor|2|||
33394565|NCT03135262|101331777|FG001|Overall Study|Study terminated by sponsor|4|||
33394566|NCT03135262|101331778|FG002|Overall Study|Study terminated by sponsor|4|||
33192266|NCT03746522|100608635|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
33309706|NCT00658684|101029651|FG003|Overall Study|Pregnancy|0|||
33309707|NCT03207009|101029652|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
33309708|NCT04447846|101029653|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
33192267|NCT03746522|100608633|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
33192268|NCT03746522|100608634|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
33192269|NCT03746522|100608635|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
33192270|NCT03746522|100608633|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
33192271|NCT03746522|100608634|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
33192272|NCT03746522|100608635|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
33192273|NCT03746522|100608633|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
33192274|NCT03746522|100608634|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
33192275|NCT03746522|100608635|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
33192276|NCT03746522|100608633|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
33192277|NCT03746522|100608634|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
33192278|NCT03746522|100608635|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
33192279|NCT01916304|100608636|FG000|Overall Study|Screening failure|17|||
33192280|NCT00850200|100608637|FG000|Overall Study|Physician Decision|2|||
33192281|NCT00850200|100608637|FG000|Overall Study|Did not recieve treatment|2|||
33192282|NCT00850200|100608637|FG000|Overall Study|Withdrawal by Subject|1|||
33192283|NCT01888497|100608640|FG000|Washout Period 1|Withdrawal by Subject|0|||
33192284|NCT01888497|100608641|FG001|Washout Period 1|Withdrawal by Subject|0|||
33192285|NCT01888497|100608642|FG002|Washout Period 1|Withdrawal by Subject|1|||
33192286|NCT01888497|100608643|FG003|Washout Period 1|Withdrawal by Subject|1|||
33192287|NCT01888497|100608640|FG000|Washout Period 2|Adverse Event|0|||
33192288|NCT01888497|100608641|FG001|Washout Period 2|Adverse Event|0|||
33192289|NCT01888497|100608642|FG002|Washout Period 2|Adverse Event|0|||
33192290|NCT01888497|100608643|FG003|Washout Period 2|Adverse Event|1|||
33192291|NCT01888497|100608640|FG000|Washout Period 2|Withdrawal by Subject|0|||
33192292|NCT01888497|100608641|FG001|Washout Period 2|Withdrawal by Subject|0|||
33192293|NCT01888497|100608642|FG002|Washout Period 2|Withdrawal by Subject|0|||
33192294|NCT01888497|100608643|FG003|Washout Period 2|Withdrawal by Subject|1|||
33192295|NCT00723606|100608647|FG000|Overall Study|Adverse Event|2|||
33192296|NCT00723606|100608648|FG001|Overall Study|Adverse Event|5|||
33192297|NCT00723606|100608647|FG000|Overall Study|Other|2|||
33192298|NCT00723606|100608648|FG001|Overall Study|Other|0|||
33192299|NCT00723606|100608647|FG000|Overall Study|Withdrawal by Subject|0|||
33192300|NCT00723606|100608648|FG001|Overall Study|Withdrawal by Subject|2|||
33192301|NCT03240575|100608649|FG000|Overall Study|Adverse Event|0|||
33309709|NCT00112047|101029655|FG000|Randomized Phase|Lost to Follow-up|26|||
33309710|NCT00112047|101029656|FG001|Randomized Phase|Lost to Follow-up|33|||
33309711|NCT00112047|101029655|FG000|Randomized Phase|Adverse Event|10|||
33309712|NCT00112047|101029656|FG001|Randomized Phase|Adverse Event|10|||
33309713|NCT00112047|101029655|FG000|Randomized Phase|Withrawal of consent|10|||
33309714|NCT00112047|101029656|FG001|Randomized Phase|Withrawal of consent|18|||
33309715|NCT00112047|101029655|FG000|Randomized Phase|Sub-optimal virological response|3|||
33309716|NCT00112047|101029656|FG001|Randomized Phase|Sub-optimal virological response|13|||
33601635|NCT02119156|102091987|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
33601636|NCT02119156|102091988|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
33601637|NCT02119156|102091986|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
33309717|NCT00112047|101029655|FG000|Randomized Phase|Noncompliance|8|||
33309718|NCT00112047|101029656|FG001|Randomized Phase|Noncompliance|4|||
33192302|NCT03240575|100608650|FG001|Overall Study|Adverse Event|2|||
33192303|NCT03240575|100608651|FG002|Overall Study|Adverse Event|0|||
33309719|NCT00112047|101029655|FG000|Randomized Phase|Protocol Violation|2|||
33309720|NCT00112047|101029656|FG001|Randomized Phase|Protocol Violation|0|||
33309721|NCT00112047|101029655|FG000|Randomized Phase|Pregnancy|3|||
33309722|NCT00112047|101029656|FG001|Randomized Phase|Pregnancy|1|||
33309723|NCT00112047|101029655|FG000|Randomized Phase|Death|1|||
33309724|NCT00112047|101029656|FG001|Randomized Phase|Death|3|||
33309725|NCT00112047|101029655|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
33309726|NCT00112047|101029656|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
33309727|NCT00112047|101029655|FG000|Randomized Phase|Inability to swallow pills|0|||
33192304|NCT03240575|100608652|FG003|Overall Study|Adverse Event|1|||
33192305|NCT03240575|100608649|FG000|Overall Study|Withdrawal by Subject|2|||
33192306|NCT03240575|100608650|FG001|Overall Study|Withdrawal by Subject|11|||
33192307|NCT03240575|100608651|FG002|Overall Study|Withdrawal by Subject|0|||
33192308|NCT03240575|100608652|FG003|Overall Study|Withdrawal by Subject|1|||
33192309|NCT03240575|100608649|FG000|Overall Study|Other|0|||
33309728|NCT00112047|101029656|FG001|Randomized Phase|Inability to swallow pills|1|||
33309729|NCT00112047|101029655|FG000|Randomized Phase|Incarceration|3|||
33601638|NCT02119156|102091987|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
33309730|NCT00112047|101029656|FG001|Randomized Phase|Incarceration|2|||
33309731|NCT00112047|101029655|FG000|Randomized Phase|Moved out of State|0|||
33309732|NCT00112047|101029656|FG001|Randomized Phase|Moved out of State|1|||
33192310|NCT03240575|100608650|FG001|Overall Study|Other|1|||
33192311|NCT03240575|100608651|FG002|Overall Study|Other|0|||
33192312|NCT03240575|100608652|FG003|Overall Study|Other|0|||
33192313|NCT02517905|100608653|FG000|Overall Study|Lost to Follow-up|4|||
33309733|NCT00112047|101029655|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
33309734|NCT00112047|101029656|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
33309735|NCT00112047|101029655|FG000|Randomized Phase|High Hepatitis B DNA|0|||
33309736|NCT00112047|101029656|FG001|Randomized Phase|High Hepatitis B DNA|1|||
33309737|NCT00112047|101029655|FG000|Atripla Phase|Adverse Event|2|||
33309738|NCT00112047|101029656|FG001|Atripla Phase|Adverse Event|1|||
33309739|NCT00112047|101029655|FG000|Atripla Phase|Lost to Follow-up|5|||
33309740|NCT00112047|101029656|FG001|Atripla Phase|Lost to Follow-up|7|||
33309741|NCT00112047|101029655|FG000|Atripla Phase|Pregnancy|0|||
33309742|NCT00112047|101029656|FG001|Atripla Phase|Pregnancy|1|||
33309743|NCT00112047|101029655|FG000|Atripla Phase|Death|0|||
33309744|NCT00112047|101029656|FG001|Atripla Phase|Death|2|||
33309745|NCT00112047|101029655|FG000|Atripla Phase|Withdrew consent|7|||
33309746|NCT00112047|101029656|FG001|Atripla Phase|Withdrew consent|7|||
33192314|NCT02517905|100608654|FG001|Overall Study|Lost to Follow-up|0|||
33192315|NCT02517905|100608653|FG000|Overall Study|Withdrawal by Subject|4|||
33192316|NCT02517905|100608654|FG001|Overall Study|Withdrawal by Subject|0|||
33192317|NCT02517905|100608653|FG000|Overall Study|Screen failure|2|||
33192318|NCT02517905|100608654|FG001|Overall Study|Screen failure|2|||
33192319|NCT01856543|100608656|FG000|Overall Study|Treatment discontinued|6|||
33192320|NCT01856543|100608657|FG001|Overall Study|Treatment discontinued|3|||
33192321|NCT01856543|100608656|FG000|Overall Study|Withdrawn before start|7|||
33192322|NCT01856543|100608657|FG001|Overall Study|Withdrawn before start|3|||
33192323|NCT00179647|100608660|FG000|Overall Study|Adverse Event|294|||
33192324|NCT00179647|100608660|FG000|Overall Study|Lack of Efficacy|478|||
33309747|NCT00112047|101029655|FG000|Atripla Phase|Sub-optimal virological response|0|||
33309748|NCT00112047|101029656|FG001|Atripla Phase|Sub-optimal virological response|1|||
33309749|NCT00112047|101029655|FG000|Atripla Phase|Non-compliance|1|||
33309750|NCT00112047|101029656|FG001|Atripla Phase|Non-compliance|0|||
33309751|NCT00112047|101029655|FG000|Atripla Phase|Other|3|||
33309752|NCT00112047|101029656|FG001|Atripla Phase|Other|1|||
33309753|NCT01723254|101029660|FG000|Overall Study|Conflict with work schedule|0|||
33309754|NCT01723254|101029661|FG001|Overall Study|Conflict with work schedule|0|||
33309755|NCT01723254|101029662|FG002|Overall Study|Conflict with work schedule|0|||
33309756|NCT01723254|101029663|FG003|Overall Study|Conflict with work schedule|0|||
33309757|NCT01723254|101029664|FG004|Overall Study|Conflict with work schedule|0|||
33309758|NCT01723254|101029665|FG005|Overall Study|Conflict with work schedule|0|||
33309759|NCT01723254|101029666|FG006|Overall Study|Conflict with work schedule|0|||
33309760|NCT01723254|101029667|FG007|Overall Study|Conflict with work schedule|1|||
33309761|NCT01723254|101029660|FG000|Overall Study|Personal issues|0|||
33309762|NCT01723254|101029661|FG001|Overall Study|Personal issues|0|||
33309763|NCT01723254|101029662|FG002|Overall Study|Personal issues|0|||
33192325|NCT00179647|100608660|FG000|Overall Study|Withdrawal by Subject|83|||
33192326|NCT00179647|100608660|FG000|Overall Study|Lost to Follow-up|4|||
33192327|NCT00179647|100608660|FG000|Overall Study|Death|94|||
33192328|NCT00179647|100608660|FG000|Overall Study|Other|960|||
33192329|NCT04055116|100608661|FG000|First Intervention|Physician Decision|2|||
33309764|NCT01723254|101029663|FG003|Overall Study|Personal issues|0|||
33309765|NCT01723254|101029664|FG004|Overall Study|Personal issues|0|||
33309766|NCT01723254|101029665|FG005|Overall Study|Personal issues|1|||
33192330|NCT04055116|100608662|FG001|First Intervention|Physician Decision|7|||
33309767|NCT01723254|101029666|FG006|Overall Study|Personal issues|0|||
33309768|NCT01723254|101029667|FG007|Overall Study|Personal issues|0|||
33309769|NCT01723254|101029660|FG000|Overall Study|No longer have time to participate|0|||
33309770|NCT01723254|101029661|FG001|Overall Study|No longer have time to participate|0|||
33309771|NCT01723254|101029662|FG002|Overall Study|No longer have time to participate|0|||
33309772|NCT01723254|101029663|FG003|Overall Study|No longer have time to participate|1|||
33309773|NCT01723254|101029664|FG004|Overall Study|No longer have time to participate|0|||
33309774|NCT01723254|101029665|FG005|Overall Study|No longer have time to participate|0|||
33309775|NCT01723254|101029666|FG006|Overall Study|No longer have time to participate|0|||
33309776|NCT01723254|101029667|FG007|Overall Study|No longer have time to participate|0|||
33309777|NCT01723254|101029660|FG000|Overall Study|Move/Left to another country/city|0|||
33309778|NCT01723254|101029661|FG001|Overall Study|Move/Left to another country/city|0|||
33192331|NCT04542070|100608663|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
33309779|NCT01723254|101029662|FG002|Overall Study|Move/Left to another country/city|2|||
33309780|NCT01723254|101029663|FG003|Overall Study|Move/Left to another country/city|1|||
33309781|NCT01723254|101029664|FG004|Overall Study|Move/Left to another country/city|1|||
33309782|NCT01723254|101029665|FG005|Overall Study|Move/Left to another country/city|0|||
33309783|NCT01723254|101029666|FG006|Overall Study|Move/Left to another country/city|0|||
33309784|NCT01723254|101029667|FG007|Overall Study|Move/Left to another country/city|0|||
33309785|NCT01723254|101029660|FG000|Overall Study|Protocol Violation|0|||
33309786|NCT01723254|101029661|FG001|Overall Study|Protocol Violation|1|||
33309787|NCT01723254|101029662|FG002|Overall Study|Protocol Violation|0|||
33192332|NCT04542070|100608664|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
33192333|NCT04542070|100608665|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
33192334|NCT04542070|100608666|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
33192335|NCT04542070|100608663|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
33192336|NCT04542070|100608664|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
33192337|NCT04542070|100608665|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
33192338|NCT04542070|100608666|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
33192339|NCT04542070|100608663|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
33192340|NCT04542070|100608664|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
33192341|NCT04542070|100608665|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
33192342|NCT04542070|100608666|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
33192343|NCT04542070|100608663|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
33309788|NCT01723254|101029663|FG003|Overall Study|Protocol Violation|0|||
33309789|NCT01723254|101029664|FG004|Overall Study|Protocol Violation|0|||
33309790|NCT01723254|101029665|FG005|Overall Study|Protocol Violation|0|||
33309791|NCT01723254|101029666|FG006|Overall Study|Protocol Violation|0|||
33309792|NCT01723254|101029667|FG007|Overall Study|Protocol Violation|0|||
33309793|NCT01723254|101029660|FG000|Overall Study|Withdrawal by Subject|1|||
33309794|NCT01723254|101029661|FG001|Overall Study|Withdrawal by Subject|2|||
33500965|NCT00086684|101727641|FG001|Overall Study|Withdrawal by Subject|4|||
33500966|NCT00086684|101727642|FG002|Overall Study|Withdrawal by Subject|10|||
33500967|NCT00086684|101727640|FG000|Overall Study|NONCOMPLIANCE|5|||
33500968|NCT00086684|101727641|FG001|Overall Study|NONCOMPLIANCE|7|||
33500969|NCT00086684|101727642|FG002|Overall Study|NONCOMPLIANCE|6|||
33500970|NCT00086684|101727640|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
33500971|NCT00086684|101727641|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
33500972|NCT00086684|101727642|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
33500973|NCT00086684|101727640|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
33500974|NCT00086684|101727641|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
33500975|NCT00086684|101727642|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
33500976|NCT00086684|101727640|FG000|Overall Study|Other|4|||
33500977|NCT00086684|101727641|FG001|Overall Study|Other|2|||
33500978|NCT00086684|101727642|FG002|Overall Study|Other|3|||
33500979|NCT01964222|101727651|FG000|Overall Study|Lost to Follow-up|7|||
33500980|NCT01964222|101727652|FG001|Overall Study|Lost to Follow-up|5|||
33500981|NCT01964222|101727651|FG000|Overall Study|Withdrawal by Subject|6|||
33500982|NCT01964222|101727652|FG001|Overall Study|Withdrawal by Subject|6|||
33500983|NCT01964222|101727651|FG000|Overall Study|Screening Failure|2|||
33500984|NCT01964222|101727652|FG001|Overall Study|Screening Failure|0|||
33500985|NCT01704495|101727656|FG000|Subjects Randomized|Other Reason|3|||
33500986|NCT01704495|101727657|FG001|Subjects Randomized|Other Reason|2|||
33500987|NCT01704495|101727658|FG002|Subjects Randomized|Other Reason|3|||
33500988|NCT01704495|101727659|FG003|Subjects Randomized|Other Reason|2|||
33500989|NCT01704495|101727656|FG000|Subjects Randomized|Discontinuation criteria met|4|||
33500990|NCT01704495|101727657|FG001|Subjects Randomized|Discontinuation criteria met|2|||
33500991|NCT01704495|101727658|FG002|Subjects Randomized|Discontinuation criteria met|2|||
33500992|NCT01704495|101727659|FG003|Subjects Randomized|Discontinuation criteria met|0|||
33500993|NCT01704495|101727656|FG000|Subjects Randomized|Adverse Event|8|||
33500994|NCT01704495|101727657|FG001|Subjects Randomized|Adverse Event|2|||
33500995|NCT01704495|101727658|FG002|Subjects Randomized|Adverse Event|0|||
33500996|NCT01704495|101727659|FG003|Subjects Randomized|Adverse Event|7|||
33500997|NCT01704495|101727656|FG000|Subjects Randomized|Withdrawal by Subject|5|||
33500998|NCT01704495|101727657|FG001|Subjects Randomized|Withdrawal by Subject|5|||
33500999|NCT01704495|101727658|FG002|Subjects Randomized|Withdrawal by Subject|5|||
33501000|NCT01704495|101727659|FG003|Subjects Randomized|Withdrawal by Subject|5|||
33501001|NCT01704495|101727656|FG000|Subjects Randomized|Protocol Violation|1|||
33501002|NCT01704495|101727657|FG001|Subjects Randomized|Protocol Violation|1|||
33501003|NCT01704495|101727658|FG002|Subjects Randomized|Protocol Violation|2|||
33501004|NCT01704495|101727659|FG003|Subjects Randomized|Protocol Violation|0|||
33501005|NCT01704495|101727656|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
33501006|NCT01704495|101727657|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
33501007|NCT01704495|101727658|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
33192344|NCT04542070|100608664|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
33192345|NCT04542070|100608665|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
33192346|NCT04542070|100608666|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
33192347|NCT04542070|100608663|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
33309795|NCT01723254|101029662|FG002|Overall Study|Withdrawal by Subject|1|||
33309796|NCT01723254|101029663|FG003|Overall Study|Withdrawal by Subject|0|||
33501008|NCT01704495|101727659|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
33501009|NCT01704495|101727656|FG000|Optional Safety Extension|Adverse Event|0|||
33501010|NCT01704495|101727657|FG001|Optional Safety Extension|Adverse Event|4|||
33501011|NCT01704495|101727658|FG002|Optional Safety Extension|Adverse Event|0|||
33501012|NCT01704495|101727659|FG003|Optional Safety Extension|Adverse Event|1|||
33501013|NCT01704495|101727656|FG000|Optional Safety Extension|Other reason|27|||
33501014|NCT01704495|101727657|FG001|Optional Safety Extension|Other reason|29|||
33501015|NCT01704495|101727658|FG002|Optional Safety Extension|Other reason|30|||
33501016|NCT01704495|101727659|FG003|Optional Safety Extension|Other reason|28|||
33501017|NCT01704495|101727656|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
33501018|NCT01704495|101727657|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
33501019|NCT01704495|101727658|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
33501020|NCT01704495|101727659|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
33501021|NCT00442897|101727660|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
33501022|NCT00442897|101727661|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
33501023|NCT00442897|101727660|FG000|Base Study (12 Week Follow-up)|Death|0|||
33501024|NCT00442897|101727661|FG001|Base Study (12 Week Follow-up)|Death|1|||
33501025|NCT00442897|101727660|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
33501026|NCT00442897|101727661|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
33501027|NCT00442897|101727660|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
33501028|NCT00442897|101727661|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
33501029|NCT00442897|101727660|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
33501030|NCT00442897|101727661|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
33501031|NCT00442897|101727660|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
33501032|NCT00442897|101727661|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
33501033|NCT00442897|101727660|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
33501034|NCT00442897|101727661|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
33501035|NCT00442897|101727660|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
33501036|NCT00442897|101727661|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
33501037|NCT01372995|101727662|FG000|Overall Study|Spouse withdrew participant from study|0|||
33501038|NCT01372995|101727663|FG001|Overall Study|Spouse withdrew participant from study|1|||
33501039|NCT01372995|101727664|FG002|Overall Study|Spouse withdrew participant from study|0|||
33501040|NCT01372995|101727662|FG000|Overall Study|Physician Decision|0|||
33501041|NCT01372995|101727663|FG001|Overall Study|Physician Decision|0|||
33501042|NCT01372995|101727664|FG002|Overall Study|Physician Decision|1|||
33501043|NCT02576847|101727665|FG000|Overall Study|Adverse Event|27|||
33501044|NCT02576847|101727665|FG000|Overall Study|Lost to Follow-up|22|||
33501045|NCT02576847|101727665|FG000|Overall Study|Physician Decision|1|||
33501046|NCT02576847|101727665|FG000|Overall Study|Pregnancy|1|||
33501047|NCT02576847|101727665|FG000|Overall Study|Protocol Violation|3|||
33501048|NCT02576847|101727665|FG000|Overall Study|Withdrawal by Subject|78|||
33501049|NCT02576847|101727665|FG000|Overall Study|Other|5|||
33501050|NCT00651261|101727668|FG000|Overall Study|Adverse Event|32|||
33501051|NCT00651261|101727669|FG001|Overall Study|Adverse Event|22|||
33501052|NCT00651261|101727668|FG000|Overall Study|Death|18|||
33501053|NCT00651261|101727669|FG001|Overall Study|Death|18|||
33501054|NCT00651261|101727668|FG000|Overall Study|Withdrawal by Subject|22|||
33501055|NCT00651261|101727669|FG001|Overall Study|Withdrawal by Subject|40|||
33501056|NCT00651261|101727668|FG000|Overall Study|Induction failure|24|||
33501057|NCT00651261|101727669|FG001|Overall Study|Induction failure|35|||
33501058|NCT00651261|101727668|FG000|Overall Study|Disease progression|58|||
33501059|NCT00651261|101727669|FG001|Overall Study|Disease progression|58|||
33501060|NCT00651261|101727668|FG000|Overall Study|Alternative therapy|109|||
33501061|NCT00651261|101727669|FG001|Overall Study|Alternative therapy|107|||
33501062|NCT00651261|101727668|FG000|Overall Study|Other disease or participant decisions|23|||
33501063|NCT00651261|101727669|FG001|Overall Study|Other disease or participant decisions|23|||
33501064|NCT00651261|101727668|FG000|Overall Study|Never treated|5|||
33501065|NCT00651261|101727669|FG001|Overall Study|Never treated|3|||
33501066|NCT03309943|101727670|FG000|Overall Study|Withdrawal by Subject|0|||
33501067|NCT03309943|101727671|FG001|Overall Study|Withdrawal by Subject|1|||
33501068|NCT03309943|101727670|FG000|Overall Study|Inappropriate behavior towards staff|0|||
33501069|NCT03309943|101727671|FG001|Overall Study|Inappropriate behavior towards staff|1|||
33501070|NCT02159053|101727672|FG000|Overall Study|Death|2|||
33501071|NCT02159053|101727673|FG001|Overall Study|Death|0|||
33501072|NCT02159053|101727674|FG002|Overall Study|Death|1|||
33501073|NCT02159053|101727672|FG000|Overall Study|Physician Decision|0|||
33501074|NCT02159053|101727673|FG001|Overall Study|Physician Decision|1|||
33501075|NCT02159053|101727674|FG002|Overall Study|Physician Decision|1|||
33394567|NCT03135262|101331779|FG003|Overall Study|Study terminated by sponsor|3|||
33501076|NCT02159053|101727672|FG000|Overall Study|Lack of Efficacy|3|||
33394568|NCT03135262|101331780|FG004|Overall Study|Study terminated by sponsor|0|||
33394569|NCT03399786|101331783|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
33394570|NCT03399786|101331784|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
33394571|NCT03399786|101331785|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
33394572|NCT03399786|101331786|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
33394573|NCT03399786|101331783|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
33394574|NCT03399786|101331784|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
33394575|NCT03399786|101331785|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
33501077|NCT02159053|101727673|FG001|Overall Study|Lack of Efficacy|4|||
33501078|NCT02159053|101727674|FG002|Overall Study|Lack of Efficacy|7|||
33501079|NCT02159053|101727672|FG000|Overall Study|Adverse Event|7|||
33501080|NCT02159053|101727673|FG001|Overall Study|Adverse Event|6|||
33501081|NCT02159053|101727674|FG002|Overall Study|Adverse Event|5|||
33501082|NCT02159053|101727672|FG000|Overall Study|Participants/guardian decision|8|||
33501083|NCT02159053|101727673|FG001|Overall Study|Participants/guardian decision|10|||
33192348|NCT04542070|100608664|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
33192349|NCT04542070|100608665|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
33192350|NCT04542070|100608666|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
33192351|NCT04542070|100608663|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
33501084|NCT02159053|101727674|FG002|Overall Study|Participants/guardian decision|6|||
33501085|NCT01401361|101727675|FG000|Overall Study|Withdrawal by Subject|16|||
33601639|NCT02119156|102091988|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
33601640|NCT02119156|102091986|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
33601641|NCT02119156|102091987|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
33601642|NCT02119156|102091988|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
33601643|NCT02119156|102091986|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
33601644|NCT02119156|102091987|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
33601645|NCT02119156|102091988|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
33601646|NCT01565564|102091991|FG000|Overall Study|Lost to Follow-up|5|||
33192352|NCT04542070|100608664|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
33192353|NCT04542070|100608665|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
33192354|NCT04542070|100608666|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
33192355|NCT04542070|100608663|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
33192356|NCT04542070|100608664|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
33501086|NCT01401361|101727675|FG000|Overall Study|Lack of Efficacy|6|||
33501087|NCT01401361|101727675|FG000|Overall Study|Physician Decision|1|||
33501088|NCT01401361|101727675|FG000|Overall Study|Lost to Follow-up|3|||
33501089|NCT01401361|101727675|FG000|Overall Study|Subject/family decision post procedure|2|||
33501090|NCT00566020|101727676|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
33501091|NCT00566020|101727677|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
33501092|NCT00566020|101727676|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
33501093|NCT00566020|101727677|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
33501094|NCT00566020|101727676|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
33601647|NCT01565564|102091992|FG001|Overall Study|Lost to Follow-up|1|||
33601648|NCT02279498|102091993|FG000|Overall Study|Adverse Event|3|||
33601649|NCT02279498|102091994|FG001|Overall Study|Adverse Event|0|||
33192357|NCT04542070|100608665|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
33192358|NCT04542070|100608666|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
33192359|NCT04542070|100608663|FG000|Maintenance + Extension Period|Adverse Event|10|||
33192360|NCT04542070|100608664|FG001|Maintenance + Extension Period|Adverse Event|2|||
33192361|NCT04542070|100608665|FG002|Maintenance + Extension Period|Adverse Event|0|||
33192362|NCT04542070|100608666|FG003|Maintenance + Extension Period|Adverse Event|0|||
33192363|NCT04542070|100608663|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
33192364|NCT04542070|100608664|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
33192365|NCT04542070|100608665|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
33192366|NCT04542070|100608666|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
33192367|NCT04542070|100608663|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
33192368|NCT04542070|100608664|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
33192369|NCT04542070|100608665|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
33192370|NCT04542070|100608666|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
33192371|NCT04542070|100608663|FG000|Maintenance + Extension Period|Physician Decision|1|||
33192372|NCT04542070|100608664|FG001|Maintenance + Extension Period|Physician Decision|1|||
33192373|NCT04542070|100608665|FG002|Maintenance + Extension Period|Physician Decision|0|||
33192374|NCT04542070|100608666|FG003|Maintenance + Extension Period|Physician Decision|0|||
33192375|NCT04542070|100608663|FG000|Maintenance + Extension Period|Protocol Violation|2|||
33192376|NCT04542070|100608664|FG001|Maintenance + Extension Period|Protocol Violation|5|||
33192377|NCT04542070|100608665|FG002|Maintenance + Extension Period|Protocol Violation|0|||
33192378|NCT04542070|100608666|FG003|Maintenance + Extension Period|Protocol Violation|0|||
33192379|NCT04542070|100608663|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
33192380|NCT04542070|100608664|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
33192381|NCT04542070|100608665|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
33192382|NCT04542070|100608666|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
33192383|NCT04542070|100608663|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
33192384|NCT04542070|100608664|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
33192385|NCT04542070|100608665|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
33309797|NCT01723254|101029664|FG004|Overall Study|Withdrawal by Subject|1|||
33501095|NCT00566020|101727677|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
33501096|NCT00566020|101727676|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
33501097|NCT00566020|101727677|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
33501098|NCT00566020|101727676|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
33501099|NCT00566020|101727677|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
33501100|NCT00566020|101727676|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
33501101|NCT00566020|101727677|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
33501102|NCT04938180|101727678|FG000|Overall Study|Adverse Event|1|||
33501103|NCT02075203|101727679|FG000|Overall Study|Withdrawal by Subject|1|||
33309798|NCT01723254|101029665|FG005|Overall Study|Withdrawal by Subject|1|||
33309799|NCT01723254|101029666|FG006|Overall Study|Withdrawal by Subject|1|||
33309800|NCT01723254|101029667|FG007|Overall Study|Withdrawal by Subject|2|||
33309801|NCT00558259|101029670|FG000|Overall Study|Adverse Event|50|||
33309802|NCT00558259|101029671|FG001|Overall Study|Adverse Event|81|||
33309803|NCT00558259|101029670|FG000|Overall Study|Protocol Violation|9|||
33309804|NCT00558259|101029671|FG001|Overall Study|Protocol Violation|5|||
33309805|NCT00558259|101029670|FG000|Overall Study|Withdrawal by Subject|12|||
33309806|NCT00558259|101029671|FG001|Overall Study|Withdrawal by Subject|13|||
33309807|NCT01015560|101029672|FG000|Overall Study|Adverse Event|1|||
33309808|NCT01015560|101029672|FG000|Overall Study|Not protocol specified|1|||
33309809|NCT01015560|101029672|FG000|Overall Study|Withdrawal by Subject|1|||
33309810|NCT02245737|101029680|FG000|Overall Study|Adverse Event|23|||
33309811|NCT02245737|101029681|FG001|Overall Study|Adverse Event|26|||
33309812|NCT02245737|101029682|FG002|Overall Study|Adverse Event|33|||
33309813|NCT02245737|101029680|FG000|Overall Study|Condition Worsened|9|||
33309814|NCT02245737|101029681|FG001|Overall Study|Condition Worsened|10|||
33309815|NCT02245737|101029682|FG002|Overall Study|Condition Worsened|9|||
33309816|NCT02245737|101029680|FG000|Overall Study|Death|2|||
33309817|NCT02245737|101029681|FG001|Overall Study|Death|4|||
33309818|NCT02245737|101029682|FG002|Overall Study|Death|4|||
33309819|NCT02245737|101029680|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
33309820|NCT02245737|101029681|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
33309821|NCT02245737|101029682|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
33309822|NCT02245737|101029680|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
33309823|NCT02245737|101029681|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
33309824|NCT02245737|101029682|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
33309825|NCT02245737|101029680|FG000|Overall Study|Lost to Follow-up|2|||
33309826|NCT02245737|101029681|FG001|Overall Study|Lost to Follow-up|5|||
33309827|NCT02245737|101029682|FG002|Overall Study|Lost to Follow-up|4|||
33309828|NCT02245737|101029680|FG000|Overall Study|Other-determined by Investigator|9|||
33309829|NCT02245737|101029681|FG001|Overall Study|Other-determined by Investigator|10|||
33309830|NCT02245737|101029682|FG002|Overall Study|Other-determined by Investigator|10|||
33309831|NCT02245737|101029680|FG000|Overall Study|Physician Decision|6|||
33309832|NCT02245737|101029681|FG001|Overall Study|Physician Decision|3|||
33309833|NCT02245737|101029682|FG002|Overall Study|Physician Decision|6|||
33309834|NCT02245737|101029680|FG000|Overall Study|Protocol Violation|3|||
33309835|NCT02245737|101029681|FG001|Overall Study|Protocol Violation|2|||
33309836|NCT02245737|101029682|FG002|Overall Study|Protocol Violation|3|||
33309837|NCT02245737|101029680|FG000|Overall Study|Withdrawal by Subject|40|||
33309838|NCT02245737|101029681|FG001|Overall Study|Withdrawal by Subject|41|||
33309839|NCT02245737|101029682|FG002|Overall Study|Withdrawal by Subject|44|||
33309840|NCT02245737|101029680|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
33309841|NCT02245737|101029681|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
33501104|NCT02075203|101727680|FG001|Overall Study|Withdrawal by Subject|0|||
33501105|NCT02075203|101727681|FG002|Overall Study|Withdrawal by Subject|1|||
33501106|NCT02075203|101727679|FG000|Overall Study|Adverse Event|1|||
33501107|NCT02075203|101727680|FG001|Overall Study|Adverse Event|0|||
33501108|NCT02075203|101727681|FG002|Overall Study|Adverse Event|0|||
33501109|NCT02075203|101727679|FG000|Overall Study|participant refused to use contraception|1|||
33501110|NCT02075203|101727680|FG001|Overall Study|participant refused to use contraception|0|||
33501111|NCT02075203|101727681|FG002|Overall Study|participant refused to use contraception|0|||
33601650|NCT02279498|102091993|FG000|Overall Study|Lack of Efficacy|4|||
33309842|NCT02245737|101029682|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
33309843|NCT02245737|101029680|FG000|Overall Study|Sponsor Decision|445|||
33309844|NCT02245737|101029681|FG001|Overall Study|Sponsor Decision|430|||
33309845|NCT02245737|101029682|FG002|Overall Study|Sponsor Decision|432|||
33309846|NCT00324675|101029683|FG000|Overall Study|Adverse Event|1|||
33309847|NCT00324675|101029684|FG001|Overall Study|Adverse Event|0|||
33309848|NCT01226095|101029685|FG000|Overall Study|Poor compliance|1|||
33309849|NCT03110185|101029686|FG000|Overall Study|Death|0|||
33309850|NCT03110185|101029687|FG001|Overall Study|Death|1|||
33309851|NCT03110185|101029686|FG000|Overall Study|Withdrawal by Subject|2|||
33309852|NCT03110185|101029687|FG001|Overall Study|Withdrawal by Subject|7|||
33309853|NCT03110185|101029686|FG000|Overall Study|Time Constraints|0|||
33309854|NCT03110185|101029687|FG001|Overall Study|Time Constraints|6|||
33309855|NCT03110185|101029686|FG000|Overall Study|Conflict with care|5|||
33309856|NCT03110185|101029687|FG001|Overall Study|Conflict with care|12|||
33309857|NCT03110185|101029686|FG000|Overall Study|Protocol Violation|1|||
33309858|NCT03110185|101029687|FG001|Overall Study|Protocol Violation|4|||
33309859|NCT03110185|101029686|FG000|Overall Study|MRI Incompatible|2|||
33601651|NCT02279498|102091994|FG001|Overall Study|Lack of Efficacy|0|||
33309860|NCT03110185|101029687|FG001|Overall Study|MRI Incompatible|0|||
33309861|NCT03110185|101029686|FG000|Overall Study|Patient Refusal|0|||
33309862|NCT03110185|101029687|FG001|Overall Study|Patient Refusal|1|||
33309863|NCT00211185|101029688|FG000|Overall Study|Death|2|||
33309864|NCT00211185|101029688|FG000|Overall Study|Disease progression|7|||
33309865|NCT00211185|101029688|FG000|Overall Study|Withdrawal by Subject|6|||
33309866|NCT00211185|101029688|FG000|Overall Study|Physician Decision|5|||
33309867|NCT02366468|101029691|FG000|Overall Study|Adverse Event|2|||
33309868|NCT02366468|101029692|FG001|Overall Study|Adverse Event|0|||
33394576|NCT03399786|101331786|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
33394577|NCT03399786|101331783|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
33394578|NCT03399786|101331784|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
33394579|NCT03399786|101331785|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
33394580|NCT03399786|101331786|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
33394581|NCT00654368|101331787|FG000|Overall Study|Ineligibility determined|6|||
33394582|NCT00654368|101331788|FG001|Overall Study|Ineligibility determined|0|||
33394583|NCT00654368|101331789|FG002|Overall Study|Ineligibility determined|0|||
33394584|NCT00654368|101331787|FG000|Overall Study|Protocol deviation|3|||
33394585|NCT00654368|101331788|FG001|Overall Study|Protocol deviation|2|||
33394586|NCT00654368|101331789|FG002|Overall Study|Protocol deviation|1|||
33394587|NCT00654368|101331787|FG000|Overall Study|Non-compliance|2|||
33394588|NCT00654368|101331788|FG001|Overall Study|Non-compliance|1|||
33394589|NCT00654368|101331789|FG002|Overall Study|Non-compliance|2|||
33394590|NCT00654368|101331787|FG000|Overall Study|Withdrawal by Subject|5|||
33394591|NCT00654368|101331788|FG001|Overall Study|Withdrawal by Subject|2|||
33394592|NCT00654368|101331789|FG002|Overall Study|Withdrawal by Subject|2|||
33394593|NCT00654368|101331787|FG000|Overall Study|Disease progression|21|||
33394594|NCT00654368|101331788|FG001|Overall Study|Disease progression|31|||
33394595|NCT00654368|101331789|FG002|Overall Study|Disease progression|13|||
33394596|NCT00654368|101331787|FG000|Overall Study|Requirement for alternative therapy|1|||
33394597|NCT00654368|101331788|FG001|Overall Study|Requirement for alternative therapy|1|||
33394598|NCT00654368|101331789|FG002|Overall Study|Requirement for alternative therapy|1|||
33394599|NCT00654368|101331787|FG000|Overall Study|Physician Decision|0|||
33394600|NCT00654368|101331788|FG001|Overall Study|Physician Decision|0|||
33394601|NCT00654368|101331789|FG002|Overall Study|Physician Decision|2|||
33394602|NCT00654368|101331787|FG000|Overall Study|Death|1|||
33394603|NCT00654368|101331788|FG001|Overall Study|Death|0|||
33394604|NCT00654368|101331789|FG002|Overall Study|Death|0|||
33394605|NCT00654368|101331787|FG000|Overall Study|Pregnancy|0|||
33394606|NCT00654368|101331788|FG001|Overall Study|Pregnancy|0|||
33394607|NCT00654368|101331789|FG002|Overall Study|Pregnancy|2|||
33394608|NCT00654368|101331787|FG000|Overall Study|Other|0|||
33394609|NCT00654368|101331788|FG001|Overall Study|Other|2|||
33394610|NCT00654368|101331789|FG002|Overall Study|Other|3|||
33394611|NCT00654368|101331787|FG000|Overall Study|Adverse Event|14|||
33394612|NCT00654368|101331788|FG001|Overall Study|Adverse Event|9|||
33394613|NCT00654368|101331789|FG002|Overall Study|Adverse Event|6|||
33394614|NCT02280096|101331790|FG000|Overall Study|Pregnancy|1|||
33309869|NCT02366468|101029691|FG000|Overall Study|Withdrawal by Subject|1|||
33309870|NCT02366468|101029692|FG001|Overall Study|Withdrawal by Subject|5|||
33309871|NCT02366468|101029691|FG000|Overall Study|Lost to Follow-up|2|||
33309872|NCT02366468|101029692|FG001|Overall Study|Lost to Follow-up|0|||
33394615|NCT02280096|101331791|FG001|Overall Study|Pregnancy|0|||
33394616|NCT02280096|101331790|FG000|Overall Study|Functional neurological disorder|1|||
33394617|NCT02280096|101331791|FG001|Overall Study|Functional neurological disorder|0|||
33394618|NCT02280096|101331790|FG000|Overall Study|Lack of attachment|0|||
33394619|NCT02280096|101331791|FG001|Overall Study|Lack of attachment|1|||
33394620|NCT01756833|101331793|FG000|Overall Study|Withdrawal by Subject|4|||
33601652|NCT02279498|102091993|FG000|Overall Study|Lost to Follow-up|0|||
33601653|NCT02279498|102091994|FG001|Overall Study|Lost to Follow-up|1|||
33601654|NCT02279498|102091993|FG000|Overall Study|Withdrawal by Subject|9|||
33309873|NCT02366468|101029691|FG000|Overall Study|Death|1|||
33394621|NCT01756833|101331794|FG001|Overall Study|Withdrawal by Subject|3|||
33394622|NCT04402385|101331795|FG000|Overall Study|Withdrawal by Subject|4|||
33394623|NCT04402385|101331796|FG001|Overall Study|Withdrawal by Subject|4|||
33394624|NCT04402385|101331795|FG000|Overall Study|Lost to Follow-up|1|||
33309874|NCT02366468|101029692|FG001|Overall Study|Death|2|||
33394625|NCT04402385|101331796|FG001|Overall Study|Lost to Follow-up|1|||
33394626|NCT04402385|101331795|FG000|Overall Study|Physician Decision|0|||
33601655|NCT02279498|102091994|FG001|Overall Study|Withdrawal by Subject|2|||
33309875|NCT02366468|101029691|FG000|Overall Study|Other|0|||
33309876|NCT02366468|101029692|FG001|Overall Study|Other|2|||
33309877|NCT01047293|101029697|FG000|Overall Study|DLT criteria not fulfilled|1|||
33309878|NCT01047293|101029698|FG001|Overall Study|DLT criteria not fulfilled|1|||
33394627|NCT04402385|101331796|FG001|Overall Study|Physician Decision|1|||
33394628|NCT00636155|101331801|FG000|Overall Study|Adverse Event|8|||
33601656|NCT02279498|102091993|FG000|Overall Study|Undefined|2|||
33601657|NCT02279498|102091994|FG001|Overall Study|Undefined|1|||
33601658|NCT02782325|102091995|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
33601659|NCT02782325|102091996|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
33601660|NCT02782325|102091997|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
33601661|NCT02782325|102091995|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
33309879|NCT01047293|101029699|FG002|Overall Study|DLT criteria not fulfilled|0|||
33309880|NCT01047293|101029700|FG003|Overall Study|DLT criteria not fulfilled|0|||
33309881|NCT01959334|101029701|FG000|Second Dose|Adverse Event|1|||
33309882|NCT01959334|101029702|FG001|Second Dose|Adverse Event|0|||
33309883|NCT01959334|101029701|FG000|Third Dose|Adverse Event|0|||
33309884|NCT01959334|101029702|FG001|Third Dose|Adverse Event|1|||
33309885|NCT00432666|101029705|FG000|Main Period|Adverse Event|1|||
33309886|NCT00432666|101029706|FG001|Main Period|Adverse Event|1|||
33309887|NCT00432666|101029705|FG000|Main Period|Consent Withdrawn|1|||
33309888|NCT00432666|101029706|FG001|Main Period|Consent Withdrawn|0|||
33309889|NCT00432666|101029705|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
33309890|NCT00432666|101029706|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
33309891|NCT00432666|101029705|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
33309892|NCT00432666|101029706|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
33601662|NCT02782325|102091996|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
33309893|NCT00432666|101029705|FG000|Open-Label Extension Period|Adverse Event|5|||
33309894|NCT00432666|101029706|FG001|Open-Label Extension Period|Adverse Event|0|||
33309895|NCT00432666|101029705|FG000|Open-Label Extension Period|Consent withdrawn|10|||
33309896|NCT00432666|101029706|FG001|Open-Label Extension Period|Consent withdrawn|0|||
33601663|NCT02782325|102091997|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
33601664|NCT00086502|102091998|FG000|Overall Study|Adverse Event|11|||
33601665|NCT00086502|102091999|FG001|Overall Study|Adverse Event|2|||
33601666|NCT00086502|102091998|FG000|Overall Study|Lack of Efficacy|0|||
33601667|NCT00086502|102091999|FG001|Overall Study|Lack of Efficacy|2|||
33601668|NCT00086502|102091998|FG000|Overall Study|Lost to Follow-up|3|||
33601669|NCT00086502|102091999|FG001|Overall Study|Lost to Follow-up|1|||
33601670|NCT00086502|102091998|FG000|Overall Study|Physician Decision|1|||
33394629|NCT00636155|101331801|FG000|Overall Study|Lack of Efficacy|1|||
33394630|NCT00636155|101331801|FG000|Overall Study|Withdrawal by Subject|3|||
33394631|NCT00636155|101331801|FG000|Overall Study|Stem cell transplant|1|||
33394632|NCT00636155|101331801|FG000|Overall Study|Physician Decision|5|||
33394633|NCT00446641|101331807|FG000|Overall Study|Withdrawal by Subject|8|||
33394634|NCT00446641|101331808|FG001|Overall Study|Withdrawal by Subject|3|||
33394635|NCT00446641|101331807|FG000|Overall Study|poor compliance|8|||
33394636|NCT00446641|101331808|FG001|Overall Study|poor compliance|6|||
33394637|NCT00446641|101331807|FG000|Overall Study|Lost to Follow-up|1|||
33394638|NCT00446641|101331808|FG001|Overall Study|Lost to Follow-up|1|||
33394639|NCT00090766|101331810|FG000|Overall Study|Nephrectomy Planned|0|||
33394640|NCT00090766|101331811|FG001|Overall Study|Nephrectomy Planned|0|||
33394641|NCT00090766|101331812|FG002|Overall Study|Nephrectomy Planned|1|||
33394642|NCT00090766|101331810|FG000|Overall Study|Death|1|||
33394643|NCT00090766|101331811|FG001|Overall Study|Death|0|||
33394644|NCT00090766|101331812|FG002|Overall Study|Death|0|||
33394645|NCT00090766|101331810|FG000|Overall Study|Admin|0|||
33394646|NCT00090766|101331811|FG001|Overall Study|Admin|2|||
33394647|NCT00090766|101331812|FG002|Overall Study|Admin|0|||
33394648|NCT00090766|101331810|FG000|Overall Study|Lost to Follow-up|2|||
33394649|NCT00090766|101331811|FG001|Overall Study|Lost to Follow-up|0|||
33394650|NCT00090766|101331812|FG002|Overall Study|Lost to Follow-up|2|||
33394651|NCT03860844|101331825|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
33394652|NCT03860844|101331826|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
33394653|NCT03860844|101331827|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
33394654|NCT03860844|101331825|FG000|Overall Study|Progressive disease|5|||
33394655|NCT03860844|101331826|FG001|Overall Study|Progressive disease|3|||
33394656|NCT03860844|101331827|FG002|Overall Study|Progressive disease|4|||
33394657|NCT03860844|101331825|FG000|Overall Study|Other, Not related to COVID-19|0|||
33394658|NCT03860844|101331826|FG001|Overall Study|Other, Not related to COVID-19|1|||
33394659|NCT03860844|101331827|FG002|Overall Study|Other, Not related to COVID-19|0|||
33394660|NCT03285490|101331828|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
33394661|NCT03285490|101331829|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
33394662|NCT03285490|101331828|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
33394663|NCT03285490|101331829|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
33601671|NCT00086502|102091999|FG001|Overall Study|Physician Decision|1|||
33601672|NCT00086502|102091998|FG000|Overall Study|Pregnancy|0|||
33601673|NCT00086502|102091999|FG001|Overall Study|Pregnancy|1|||
33309897|NCT00432666|101029705|FG000|Open-Label Extension Period|Physician Decision|3|||
33309898|NCT00432666|101029706|FG001|Open-Label Extension Period|Physician Decision|0|||
33309899|NCT02413333|101029707|FG000|Period 1|Adverse Event|1|||
33309900|NCT02413333|101029708|FG001|Period 1|Adverse Event|0|||
33309901|NCT02413333|101029707|FG000|Period 1|Reason Not Specified|0|||
33309902|NCT02413333|101029708|FG001|Period 1|Reason Not Specified|1|||
33309903|NCT02413333|101029707|FG000|Period 2|Protocol Deviation|1|||
33309904|NCT02413333|101029708|FG001|Period 2|Protocol Deviation|0|||
33309905|NCT00591370|101029717|FG000|Overall Study|Not Treated|2|||
33309906|NCT00423930|101029718|FG000|Overall Study|Withdrawal by Subject|2|||
33309907|NCT00969709|101029719|FG000|Overall Study|Adverse Event|3|||
33309908|NCT00969709|101029720|FG001|Overall Study|Adverse Event|13|||
33309909|NCT00969709|101029721|FG002|Overall Study|Adverse Event|26|||
33394664|NCT02332798|101331834|FG000|Overall Study|Unwilling to Participate in Study|0|||
33501112|NCT03321968|101727682|FG000|Overall Study|Withdrawal by Subject|1|||
33501113|NCT03321968|101727683|FG001|Overall Study|Withdrawal by Subject|2|||
33394665|NCT02332798|101331835|FG001|Overall Study|Unwilling to Participate in Study|1|||
33394666|NCT02332798|101331836|FG002|Overall Study|Unwilling to Participate in Study|1|||
33394667|NCT02332798|101331834|FG000|Overall Study|Positive Urine Drug Test|0|||
33394668|NCT02332798|101331835|FG001|Overall Study|Positive Urine Drug Test|1|||
33394669|NCT02332798|101331836|FG002|Overall Study|Positive Urine Drug Test|0|||
33394670|NCT02332798|101331834|FG000|Overall Study|Abnormal Laboratory Findings|1|||
33394671|NCT02332798|101331835|FG001|Overall Study|Abnormal Laboratory Findings|0|||
33394672|NCT02332798|101331836|FG002|Overall Study|Abnormal Laboratory Findings|0|||
33394673|NCT03277794|101331837|FG000|Overall Study|Lost to Follow-up|2|||
33394674|NCT03277794|101331838|FG001|Overall Study|Lost to Follow-up|4|||
33394675|NCT03277794|101331837|FG000|Overall Study|Withdrew due to high acuity|1|||
33394676|NCT03277794|101331838|FG001|Overall Study|Withdrew due to high acuity|0|||
33394677|NCT02718625|101331839|FG000|Overall Study|Adverse Event|0|||
33394678|NCT02718625|101331840|FG001|Overall Study|Adverse Event|1|||
33394679|NCT02718625|101331839|FG000|Overall Study|Termination of Study by Sponsor|0|||
33394680|NCT02718625|101331840|FG001|Overall Study|Termination of Study by Sponsor|1|||
33394681|NCT04432376|101331841|FG000|Double-blind Treatment Period|Adverse Event|2|||
33394682|NCT04432376|101331842|FG001|Double-blind Treatment Period|Adverse Event|6|||
33394683|NCT04432376|101331843|FG002|Double-blind Treatment Period|Adverse Event|0|||
33394684|NCT04432376|101331841|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
33394685|NCT04432376|101331842|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
33394686|NCT04432376|101331843|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
33394687|NCT04432376|101331841|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
33394688|NCT04432376|101331842|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
33394689|NCT04432376|101331843|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33394690|NCT04432376|101331841|FG000|Double-blind Treatment Period|Protocol Violation|0|||
33394691|NCT04432376|101331842|FG001|Double-blind Treatment Period|Protocol Violation|1|||
33394692|NCT04432376|101331843|FG002|Double-blind Treatment Period|Protocol Violation|0|||
33394693|NCT04432376|101331841|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
33394694|NCT04432376|101331842|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
33394695|NCT04432376|101331843|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
33394696|NCT00002981|101331851|FG000|Overall Study|Inevaluable|6|||
33394697|NCT00729560|101331852|FG000|Overall Study|Withdrawal by Subject|3|||
33394698|NCT01366534|101331853|FG000|Overall Study|Lost to Follow-up|1|||
33394699|NCT01366534|101331854|FG001|Overall Study|Lost to Follow-up|0|||
33394700|NCT01366534|101331855|FG002|Overall Study|Lost to Follow-up|0|||
33394701|NCT01366534|101331853|FG000|Overall Study|Migrated|1|||
33394702|NCT01366534|101331854|FG001|Overall Study|Migrated|1|||
33394703|NCT01366534|101331855|FG002|Overall Study|Migrated|0|||
33394704|NCT01366534|101331853|FG000|Overall Study|Declined challenged|0|||
33394705|NCT01366534|101331854|FG001|Overall Study|Declined challenged|1|||
33394706|NCT01366534|101331855|FG002|Overall Study|Declined challenged|0|||
33394707|NCT03748420|101331856|FG000|Overall Study|No 12 month medication adherence data available|0|||
33394708|NCT03748420|101331857|FG001|Overall Study|No 12 month medication adherence data available|1|||
33394709|NCT03748420|101331856|FG000|Overall Study|Death|24|||
33394710|NCT03748420|101331857|FG001|Overall Study|Death|28|||
33394711|NCT03748420|101331856|FG000|Overall Study|Lost to Follow-up|231|||
33394712|NCT03748420|101331857|FG001|Overall Study|Lost to Follow-up|230|||
33394713|NCT04007367|101331858|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
33501114|NCT03321968|101727684|FG002|Overall Study|Withdrawal by Subject|1|||
33501115|NCT03321968|101727682|FG000|Overall Study|Lost to Follow-up|2|||
33501116|NCT03321968|101727683|FG001|Overall Study|Lost to Follow-up|0|||
33394714|NCT04007367|101331859|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
33394715|NCT04007367|101331860|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
33394716|NCT04007367|101331858|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
33394717|NCT04007367|101331859|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
33394718|NCT04007367|101331860|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
33501117|NCT03321968|101727684|FG002|Overall Study|Lost to Follow-up|1|||
33501118|NCT03321968|101727682|FG000|Overall Study|Other than specified|0|||
33309910|NCT00969709|101029722|FG003|Overall Study|Adverse Event|12|||
33309911|NCT00969709|101029719|FG000|Overall Study|Lack of Efficacy|7|||
33309912|NCT00969709|101029720|FG001|Overall Study|Lack of Efficacy|4|||
33394719|NCT04007367|101331858|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
33309913|NCT00969709|101029721|FG002|Overall Study|Lack of Efficacy|1|||
33309914|NCT00969709|101029722|FG003|Overall Study|Lack of Efficacy|3|||
33309915|NCT00969709|101029719|FG000|Overall Study|Protocol Violation|9|||
33309916|NCT00969709|101029720|FG001|Overall Study|Protocol Violation|5|||
33501119|NCT03321968|101727683|FG001|Overall Study|Other than specified|0|||
33501120|NCT03321968|101727684|FG002|Overall Study|Other than specified|1|||
33501121|NCT02155283|101727685|FG000|Overall Study|Lost to Follow-up|3|||
33501122|NCT02155283|101727685|FG000|Overall Study|Withdrawal by Subject|1|||
33501123|NCT02155283|101727685|FG000|Overall Study|Protocol Violation|3|||
33501124|NCT02283268|101727686|FG000|Overall Study|Withdrawal by Subject|1|||
33501125|NCT01921101|101727689|FG000|Overall Study|Death|16|||
33309917|NCT00969709|101029721|FG002|Overall Study|Protocol Violation|9|||
33309918|NCT00969709|101029722|FG003|Overall Study|Protocol Violation|10|||
33309919|NCT00969709|101029719|FG000|Overall Study|Withdrawal by Subject|9|||
33309920|NCT00969709|101029720|FG001|Overall Study|Withdrawal by Subject|12|||
33309921|NCT00969709|101029721|FG002|Overall Study|Withdrawal by Subject|11|||
33309922|NCT00969709|101029722|FG003|Overall Study|Withdrawal by Subject|23|||
33309923|NCT00969709|101029719|FG000|Overall Study|Lost to Follow-up|10|||
33309924|NCT00969709|101029720|FG001|Overall Study|Lost to Follow-up|14|||
33309925|NCT00969709|101029721|FG002|Overall Study|Lost to Follow-up|8|||
33309926|NCT00969709|101029722|FG003|Overall Study|Lost to Follow-up|15|||
33309927|NCT00969709|101029719|FG000|Overall Study|Other reasons|0|||
33309928|NCT00969709|101029720|FG001|Overall Study|Other reasons|0|||
33309929|NCT00969709|101029721|FG002|Overall Study|Other reasons|3|||
33501126|NCT01921101|101727690|FG001|Overall Study|Death|6|||
33501127|NCT02099110|101727693|FG000|Overall Study|Protocol Violation|2|||
33501128|NCT02099110|101727694|FG001|Overall Study|Protocol Violation|1|||
33501129|NCT02099110|101727695|FG002|Overall Study|Protocol Violation|0|||
33601674|NCT00086502|102091998|FG000|Overall Study|Protocol Violation|3|||
33601675|NCT00086502|102091999|FG001|Overall Study|Protocol Violation|3|||
33309930|NCT00969709|101029722|FG003|Overall Study|Other reasons|0|||
33309931|NCT03801915|101029723|FG000|Overall Study|Screen failure|0|||
33309932|NCT03801915|101029724|FG001|Overall Study|Screen failure|0|||
33309933|NCT03801915|101029725|FG002|Overall Study|Screen failure|1|||
33309934|NCT03801915|101029723|FG000|Overall Study|Ineligible|1|||
33309935|NCT03801915|101029724|FG001|Overall Study|Ineligible|0|||
33309936|NCT03801915|101029725|FG002|Overall Study|Ineligible|0|||
33309937|NCT03801915|101029723|FG000|Overall Study|Physician Decision|2|||
33309938|NCT03801915|101029724|FG001|Overall Study|Physician Decision|1|||
33309939|NCT03801915|101029725|FG002|Overall Study|Physician Decision|0|||
33309940|NCT00986973|101029728|FG000|Overall Study|Withdrawn by study team|1|||
33309941|NCT02673515|101029729|FG000|Overall Study|Lack of motivation|2|||
33309942|NCT02673515|101029730|FG001|Overall Study|Lack of motivation|1|||
33309943|NCT02029846|101029731|FG000|Overall Study|n=1 each arm|1|||
33309944|NCT02029846|101029732|FG001|Overall Study|n=1 each arm|1|||
33309945|NCT03616977|101029733|FG000|Period 1|Physician Decision|0|||
33309946|NCT03616977|101029734|FG001|Period 1|Physician Decision|1|||
33309947|NCT03616977|101029733|FG000|Period 3|Adverse Event|1|||
33309948|NCT03616977|101029734|FG001|Period 3|Adverse Event|1|||
33501130|NCT02099110|101727696|FG003|Overall Study|Protocol Violation|3|||
33501131|NCT02099110|101727697|FG004|Overall Study|Protocol Violation|1|||
33501132|NCT02099110|101727693|FG000|Overall Study|Participant moved|1|||
33501133|NCT02099110|101727694|FG001|Overall Study|Participant moved|1|||
33309949|NCT01201265|101029739|FG000|Overall Study|Death|14|||
33309950|NCT01201265|101029739|FG000|Overall Study|Insufficient Therapeutic Response|3|||
33309951|NCT01201265|101029739|FG000|Overall Study|Lost to Follow-up|10|||
33309952|NCT01201265|101029739|FG000|Overall Study|Withdrawal by Subject|7|||
33309953|NCT01201265|101029739|FG000|Overall Study|Disease Progression|4|||
33309954|NCT01536015|101029743|FG000|Overall Study|Adverse Event|1|||
33309955|NCT01536015|101029744|FG001|Overall Study|Adverse Event|4|||
33501134|NCT02099110|101727695|FG002|Overall Study|Participant moved|1|||
33501135|NCT02099110|101727696|FG003|Overall Study|Participant moved|0|||
33601676|NCT00086502|102091998|FG000|Overall Study|Withdrawal by Subject|5|||
33601677|NCT00086502|102091999|FG001|Overall Study|Withdrawal by Subject|6|||
33601678|NCT00086502|102091998|FG000|Overall Study|Patient Moved|1|||
33601679|NCT00086502|102091999|FG001|Overall Study|Patient Moved|1|||
33601680|NCT00086502|102091998|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
33601681|NCT00086502|102091999|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
33601682|NCT00086502|102091998|FG000|Overall Study|Patient Accidentally Unblinded|1|||
33601683|NCT00086502|102091999|FG001|Overall Study|Patient Accidentally Unblinded|0|||
33601684|NCT00461305|102092000|FG000|Treatment|Adverse Event|26|||
33601685|NCT00461305|102092001|FG001|Treatment|Adverse Event|3|||
33601686|NCT00461305|102092000|FG000|Treatment|Lost to Follow-up|4|||
33601687|NCT00461305|102092001|FG001|Treatment|Lost to Follow-up|2|||
33394720|NCT04007367|101331859|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
33394721|NCT04007367|101331860|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
33394722|NCT04007367|101331858|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
33394723|NCT04007367|101331859|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
33394724|NCT04007367|101331860|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
33394725|NCT04007367|101331858|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
33394726|NCT04007367|101331859|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
33394727|NCT04007367|101331860|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
33394728|NCT01327573|101331861|FG000|Overall Study|Physician Decision|3|||
33394729|NCT01327573|101331862|FG001|Overall Study|Physician Decision|1|||
33394730|NCT00118040|101331863|FG000|Overall Study|Adverse Event|0|||
33394731|NCT00118040|101331864|FG001|Overall Study|Adverse Event|1|||
33501136|NCT02099110|101727697|FG004|Overall Study|Participant moved|2|||
33501137|NCT02099110|101727693|FG000|Overall Study|Withdrawal by Subject|7|||
33501138|NCT02099110|101727694|FG001|Overall Study|Withdrawal by Subject|11|||
33501139|NCT02099110|101727695|FG002|Overall Study|Withdrawal by Subject|13|||
33501140|NCT02099110|101727696|FG003|Overall Study|Withdrawal by Subject|9|||
33501141|NCT02099110|101727697|FG004|Overall Study|Withdrawal by Subject|13|||
33501142|NCT02099110|101727693|FG000|Overall Study|Adverse Event|3|||
33394732|NCT00118040|101331865|FG002|Overall Study|Adverse Event|0|||
33394733|NCT00118040|101331863|FG000|Overall Study|Withdrawal by Subject|0|||
33394734|NCT00118040|101331864|FG001|Overall Study|Withdrawal by Subject|0|||
33394735|NCT00118040|101331865|FG002|Overall Study|Withdrawal by Subject|2|||
33394736|NCT00118040|101331863|FG000|Overall Study|Medical Contraindication|0|||
33394737|NCT00118040|101331864|FG001|Overall Study|Medical Contraindication|0|||
33394738|NCT00118040|101331865|FG002|Overall Study|Medical Contraindication|1|||
33394739|NCT00118040|101331863|FG000|Overall Study|Non-Compliant Participant|1|||
33394740|NCT00118040|101331864|FG001|Overall Study|Non-Compliant Participant|1|||
33394741|NCT00118040|101331865|FG002|Overall Study|Non-Compliant Participant|2|||
33394742|NCT00118040|101331863|FG000|Overall Study|Other|0|||
33394743|NCT00118040|101331864|FG001|Overall Study|Other|0|||
33394744|NCT00118040|101331865|FG002|Overall Study|Other|1|||
33394745|NCT01466062|101331872|FG000|Overall Study|Adverse Event|1|||
33394746|NCT01466062|101331872|FG000|Overall Study|Withdrawal by Subject|1|||
33394747|NCT00086385|101331873|FG000|Overall Study|Death|2|||
33394748|NCT00086385|101331874|FG001|Overall Study|Death|2|||
33394749|NCT00086385|101331875|FG002|Overall Study|Death|1|||
33394750|NCT00086385|101331876|FG003|Overall Study|Death|1|||
33501143|NCT02099110|101727694|FG001|Overall Study|Adverse Event|5|||
33501144|NCT02099110|101727695|FG002|Overall Study|Adverse Event|2|||
33501145|NCT02099110|101727696|FG003|Overall Study|Adverse Event|3|||
33601688|NCT00461305|102092000|FG000|Treatment|Protocol Violation|13|||
33601689|NCT00461305|102092001|FG001|Treatment|Protocol Violation|2|||
33601690|NCT00461305|102092000|FG000|Treatment|Withdrawal by Subject|48|||
33601691|NCT00461305|102092001|FG001|Treatment|Withdrawal by Subject|2|||
33192386|NCT04542070|100608666|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
33192387|NCT04542070|100608663|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
33192388|NCT04542070|100608664|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
33192389|NCT04542070|100608665|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
33192390|NCT04542070|100608666|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
33192391|NCT04542070|100608663|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
33192392|NCT04542070|100608664|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
33192393|NCT04542070|100608665|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
33192394|NCT04542070|100608666|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
33192395|NCT04542070|100608663|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
33192396|NCT04542070|100608664|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
33309956|NCT01536015|101029743|FG000|Overall Study|Lost to Follow-up|0|||
33394751|NCT01894776|101331879|FG000|Overall Study|Withdrawal by Subject|1|||
33394752|NCT01680991|101331882|FG000|Overall Study|Adverse Event|1|||
33394753|NCT01680991|101331883|FG001|Overall Study|Adverse Event|0|||
33394754|NCT01680991|101331884|FG002|Overall Study|Adverse Event|0|||
33501146|NCT02099110|101727697|FG004|Overall Study|Adverse Event|2|||
33601692|NCT00461305|102092000|FG000|Treatment|Never dispensed|5|||
33601693|NCT00461305|102092001|FG001|Treatment|Never dispensed|0|||
33309957|NCT01536015|101029744|FG001|Overall Study|Lost to Follow-up|1|||
33309958|NCT01536015|101029743|FG000|Overall Study|Inclusion Criterion not met|2|||
33309959|NCT01536015|101029744|FG001|Overall Study|Inclusion Criterion not met|0|||
33309960|NCT01536015|101029743|FG000|Overall Study|Study closure|5|||
33309961|NCT01536015|101029744|FG001|Overall Study|Study closure|5|||
33309962|NCT01236534|101029747|FG000|Overall Study|Adverse Event|3|||
33309963|NCT01236534|101029748|FG001|Overall Study|Adverse Event|0|||
33309964|NCT00996476|101029753|FG000|Overall Study|Withdrawal by Subject|1|||
33309965|NCT00996476|101029754|FG001|Overall Study|Withdrawal by Subject|2|||
33309966|NCT00996476|101029755|FG002|Overall Study|Withdrawal by Subject|1|||
33309967|NCT00996476|101029756|FG003|Overall Study|Withdrawal by Subject|0|||
33394755|NCT01680991|101331882|FG000|Overall Study|Death|1|||
33394756|NCT01680991|101331883|FG001|Overall Study|Death|0|||
33394757|NCT01680991|101331884|FG002|Overall Study|Death|1|||
33394758|NCT01680991|101331882|FG000|Overall Study|Protocol Violation|0|||
33394759|NCT01680991|101331883|FG001|Overall Study|Protocol Violation|1|||
33394760|NCT01680991|101331884|FG002|Overall Study|Protocol Violation|0|||
33394761|NCT01680991|101331882|FG000|Overall Study|Withdrawal by Subject|5|||
33394762|NCT01680991|101331883|FG001|Overall Study|Withdrawal by Subject|1|||
33394763|NCT01680991|101331884|FG002|Overall Study|Withdrawal by Subject|0|||
33394764|NCT01680991|101331882|FG000|Overall Study|Progressive disease (PD)|0|||
33394765|NCT01680991|101331883|FG001|Overall Study|Progressive disease (PD)|10|||
33394766|NCT01680991|101331884|FG002|Overall Study|Progressive disease (PD)|0|||
33394767|NCT01680991|101331882|FG000|Overall Study|Physician Decision|0|||
33394768|NCT01680991|101331883|FG001|Overall Study|Physician Decision|7|||
33394769|NCT01680991|101331884|FG002|Overall Study|Physician Decision|2|||
33394770|NCT01680991|101331882|FG000|Overall Study|Bad physical condition|0|||
33394771|NCT01680991|101331883|FG001|Overall Study|Bad physical condition|0|||
33394772|NCT01680991|101331884|FG002|Overall Study|Bad physical condition|1|||
33394773|NCT01680991|101331882|FG000|Overall Study|PD confirmed in other hospital|1|||
33394774|NCT01680991|101331883|FG001|Overall Study|PD confirmed in other hospital|0|||
33394775|NCT01680991|101331884|FG002|Overall Study|PD confirmed in other hospital|0|||
33394776|NCT00859573|101331885|FG000|Overall Study|Withdrawal by Subject|4|||
33394777|NCT00859573|101331886|FG001|Overall Study|Withdrawal by Subject|1|||
33501147|NCT02099110|101727693|FG000|Overall Study|Lost to Follow-up|6|||
33501148|NCT02099110|101727694|FG001|Overall Study|Lost to Follow-up|12|||
33501149|NCT02099110|101727695|FG002|Overall Study|Lost to Follow-up|11|||
33501150|NCT02099110|101727696|FG003|Overall Study|Lost to Follow-up|5|||
33501151|NCT02099110|101727697|FG004|Overall Study|Lost to Follow-up|6|||
33601694|NCT00461305|102092000|FG000|Treatment|Study drug not taken|1|||
33601695|NCT00461305|102092001|FG001|Treatment|Study drug not taken|0|||
33601696|NCT00461305|102092000|FG000|Treatment|Partially missing diary|2|||
33601697|NCT00461305|102092001|FG001|Treatment|Partially missing diary|0|||
33601698|NCT00461305|102092000|FG000|Treatment|Other (missing drug etc)|2|||
33601699|NCT00461305|102092001|FG001|Treatment|Other (missing drug etc)|0|||
33601700|NCT00461305|102092000|FG000|Continued Treatment|Adverse Event|26|||
33601701|NCT00461305|102092001|FG001|Continued Treatment|Adverse Event|0|||
33601702|NCT00461305|102092000|FG000|Continued Treatment|Lost to Follow-up|4|||
33501152|NCT02099110|101727693|FG000|Overall Study|Death|0|||
33501153|NCT02099110|101727694|FG001|Overall Study|Death|1|||
33309968|NCT00996476|101029757|FG004|Overall Study|Withdrawal by Subject|1|||
33309969|NCT00996476|101029753|FG000|Overall Study|Adverse Event|0|||
33309970|NCT00996476|101029754|FG001|Overall Study|Adverse Event|1|||
33309971|NCT00996476|101029755|FG002|Overall Study|Adverse Event|0|||
33309972|NCT00996476|101029756|FG003|Overall Study|Adverse Event|0|||
33309973|NCT00996476|101029757|FG004|Overall Study|Adverse Event|1|||
33309974|NCT02706899|101029758|FG000|Overall Study|Withdrawal by Subject|1|||
33309975|NCT02706899|101029759|FG001|Overall Study|Withdrawal by Subject|0|||
33309976|NCT02706899|101029758|FG000|Overall Study|Death|8|||
33394778|NCT00859573|101331885|FG000|Overall Study|Physician Decision|1|||
33394779|NCT00859573|101331886|FG001|Overall Study|Physician Decision|1|||
33394780|NCT03922711|101331891|FG000|Overall Study|Adverse Event|3|||
33394781|NCT03922711|101331892|FG001|Overall Study|Adverse Event|2|||
33394782|NCT03922711|101331893|FG002|Overall Study|Adverse Event|2|||
33501154|NCT02099110|101727695|FG002|Overall Study|Death|0|||
33601703|NCT00461305|102092001|FG001|Continued Treatment|Lost to Follow-up|0|||
33601704|NCT00461305|102092000|FG000|Continued Treatment|Protocol Violation|13|||
33601705|NCT00461305|102092001|FG001|Continued Treatment|Protocol Violation|0|||
33309977|NCT02706899|101029759|FG001|Overall Study|Death|0|||
33309978|NCT02706899|101029758|FG000|Overall Study|Study Termination by Sponsor|4|||
33309979|NCT02706899|101029759|FG001|Overall Study|Study Termination by Sponsor|6|||
33309980|NCT00918580|101029764|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
33309981|NCT00918580|101029764|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
33309982|NCT00918580|101029764|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
33394783|NCT03922711|101331891|FG000|Overall Study|Protocol Violation|1|||
33394784|NCT03922711|101331892|FG001|Overall Study|Protocol Violation|0|||
33394785|NCT03922711|101331893|FG002|Overall Study|Protocol Violation|0|||
33501155|NCT02099110|101727696|FG003|Overall Study|Death|0|||
33309983|NCT00918580|101029764|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
33309984|NCT00918580|101029764|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
33309985|NCT00918580|101029764|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
33309986|NCT00918580|101029764|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
33309987|NCT00842985|101029765|FG000|Screening|Did not meet entrance requirements|27|||
33309988|NCT00842985|101029765|FG000|First Intervention|Withdrawal by Subject|3|||
33501156|NCT02099110|101727697|FG004|Overall Study|Death|0|||
33501157|NCT02099110|101727693|FG000|Overall Study|Screen failure|0|||
33501158|NCT02099110|101727694|FG001|Overall Study|Screen failure|0|||
33501159|NCT02099110|101727695|FG002|Overall Study|Screen failure|0|||
33501160|NCT02099110|101727696|FG003|Overall Study|Screen failure|0|||
33501161|NCT02099110|101727697|FG004|Overall Study|Screen failure|1|||
33501162|NCT02099110|101727693|FG000|Overall Study|Non-compliance with study drug|2|||
33501163|NCT02099110|101727694|FG001|Overall Study|Non-compliance with study drug|0|||
33501164|NCT02099110|101727695|FG002|Overall Study|Non-compliance with study drug|0|||
33501165|NCT02099110|101727696|FG003|Overall Study|Non-compliance with study drug|0|||
33501166|NCT02099110|101727697|FG004|Overall Study|Non-compliance with study drug|1|||
33501167|NCT02099110|101727693|FG000|Overall Study|Physician Decision|3|||
33501168|NCT02099110|101727694|FG001|Overall Study|Physician Decision|0|||
33501169|NCT02099110|101727695|FG002|Overall Study|Physician Decision|1|||
33501170|NCT02099110|101727696|FG003|Overall Study|Physician Decision|2|||
33501171|NCT02099110|101727697|FG004|Overall Study|Physician Decision|1|||
33501172|NCT03259425|101727698|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
33501173|NCT02343939|101727706|FG000|Overall Study|Death|0|||
33501174|NCT02343939|101727707|FG001|Overall Study|Death|15|||
33501175|NCT02343939|101727708|FG002|Overall Study|Death|4|||
33501176|NCT02343939|101727709|FG003|Overall Study|Death|2|||
33501177|NCT02343939|101727710|FG004|Overall Study|Death|5|||
33501178|NCT02343939|101727711|FG005|Overall Study|Death|11|||
33601706|NCT00461305|102092000|FG000|Continued Treatment|Withdrawal by Subject|48|||
33601707|NCT00461305|102092001|FG001|Continued Treatment|Withdrawal by Subject|0|||
33309989|NCT00842985|101029765|FG000|First Intervention|Protocol Violation|3|||
33309990|NCT00842985|101029765|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
33309991|NCT00842985|101029765|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
33309992|NCT01323647|101029770|FG000|Overall Study|Migrated/moved from study area|2|||
33309993|NCT01323647|101029771|FG001|Overall Study|Migrated/moved from study area|0|||
33309994|NCT01323647|101029770|FG000|Overall Study|Withdrawal by Subject|5|||
33501179|NCT02343939|101727712|FG006|Overall Study|Death|8|||
33501180|NCT02343939|101727713|FG007|Overall Study|Death|22|||
33501181|NCT02343939|101727714|FG008|Overall Study|Death|1|||
33501182|NCT02343939|101727706|FG000|Overall Study|Study terminated by sponsor|0|||
33501183|NCT02343939|101727707|FG001|Overall Study|Study terminated by sponsor|27|||
33501184|NCT02343939|101727708|FG002|Overall Study|Study terminated by sponsor|0|||
33501185|NCT02343939|101727709|FG003|Overall Study|Study terminated by sponsor|1|||
33501186|NCT02343939|101727710|FG004|Overall Study|Study terminated by sponsor|1|||
33501187|NCT02343939|101727711|FG005|Overall Study|Study terminated by sponsor|5|||
33501188|NCT02343939|101727712|FG006|Overall Study|Study terminated by sponsor|3|||
33501189|NCT02343939|101727713|FG007|Overall Study|Study terminated by sponsor|4|||
33501190|NCT02343939|101727714|FG008|Overall Study|Study terminated by sponsor|0|||
33501191|NCT02343939|101727706|FG000|Overall Study|Withdrew consent|3|||
33601708|NCT00461305|102092000|FG000|Continued Treatment|Partially missing diary|2|||
33601709|NCT00461305|102092001|FG001|Continued Treatment|Partially missing diary|0|||
33601710|NCT00461305|102092000|FG000|Continued Treatment|Other (missing drug etc)|2|||
33309995|NCT01323647|101029771|FG001|Overall Study|Withdrawal by Subject|0|||
33309996|NCT01323647|101029770|FG000|Overall Study|Lost to Follow-up|2|||
33309997|NCT01323647|101029771|FG001|Overall Study|Lost to Follow-up|0|||
33309998|NCT02128542|101029773|FG000|Overall Study|Lost to Follow-up|3|||
33309999|NCT02128542|101029774|FG001|Overall Study|Lost to Follow-up|0|||
33310000|NCT02128542|101029773|FG000|Overall Study|Withdrew Consent|1|||
33310001|NCT02128542|101029774|FG001|Overall Study|Withdrew Consent|0|||
33310002|NCT02910739|101029775|FG000|Overall Study|Adverse Event|1|||
33310003|NCT02910739|101029776|FG001|Overall Study|Adverse Event|0|||
33310004|NCT02910739|101029777|FG002|Overall Study|Adverse Event|0|||
33310005|NCT02910739|101029778|FG003|Overall Study|Adverse Event|0|||
33310006|NCT01585987|101029779|FG000|Randomized|Withdrawal by Subject|0|||
33310007|NCT01585987|101029780|FG001|Randomized|Withdrawal by Subject|4|||
33310008|NCT01585987|101029779|FG000|Randomized|No longer met criteria|0|||
33310009|NCT01585987|101029780|FG001|Randomized|No longer met criteria|2|||
33192397|NCT04542070|100608665|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
33192398|NCT04542070|100608666|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
33310010|NCT01585987|101029779|FG000|Treated|Disease Progression|39|||
33310011|NCT01585987|101029780|FG001|Treated|Disease Progression|36|||
33310012|NCT01585987|101029779|FG000|Treated|Study Drug Toxicity|9|||
33310013|NCT01585987|101029780|FG001|Treated|Study Drug Toxicity|5|||
33310014|NCT01585987|101029779|FG000|Treated|Adverse Event|3|||
33601711|NCT00461305|102092001|FG001|Continued Treatment|Other (missing drug etc)|0|||
33601712|NCT01638559|102092008|FG000|Overall Study|Lost to Follow-up|1|||
33601713|NCT01638559|102092008|FG000|Overall Study|Withdrawal by Subject|1|||
33601714|NCT01638559|102092008|FG000|Overall Study|Subject declined to travel for biopsy|1|||
33601715|NCT02920957|102092012|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
33601716|NCT02920957|102092013|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
33601717|NCT02920957|102092012|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
33601718|NCT02920957|102092013|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
33310015|NCT01585987|101029780|FG001|Treated|Adverse Event|0|||
33310016|NCT01585987|101029779|FG000|Treated|Withdrawal by Subject|1|||
33310017|NCT01585987|101029780|FG001|Treated|Withdrawal by Subject|2|||
33192399|NCT04542070|100608663|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
33192400|NCT04542070|100608664|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
33192401|NCT04542070|100608665|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
33192402|NCT04542070|100608666|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
33310018|NCT01585987|101029779|FG000|Treated|Death|1|||
33310019|NCT01585987|101029780|FG001|Treated|Death|0|||
33310020|NCT01585987|101029779|FG000|Treated|Lost to Follow-up|0|||
33310021|NCT01585987|101029780|FG001|Treated|Lost to Follow-up|1|||
33310022|NCT01585987|101029779|FG000|Treated|Maximum Clinical Benefit|0|||
33310023|NCT01585987|101029780|FG001|Treated|Maximum Clinical Benefit|1|||
33310024|NCT01585987|101029779|FG000|Treated|Non-Specified|1|||
33310025|NCT01585987|101029780|FG001|Treated|Non-Specified|2|||
33310026|NCT01585987|101029779|FG000|Treated|Subject Request|0|||
33310027|NCT01585987|101029780|FG001|Treated|Subject Request|1|||
33310028|NCT01585987|101029779|FG000|Treated|Poor/Non-Compliance|0|||
33310029|NCT01585987|101029780|FG001|Treated|Poor/Non-Compliance|1|||
33310030|NCT01065844|101029785|FG000|Overall Study|Adverse Event|5|||
33310031|NCT01183260|101029786|FG000|Overall Study|Intraop screen failure|2|||
33310032|NCT01183260|101029787|FG001|Overall Study|Intraop screen failure|0|||
33310033|NCT01183260|101029786|FG000|Overall Study|Withdrawal by Subject|1|||
33310034|NCT01183260|101029787|FG001|Overall Study|Withdrawal by Subject|1|||
33310035|NCT01183260|101029786|FG000|Overall Study|Revised within 30 days|0|||
33310036|NCT01183260|101029787|FG001|Overall Study|Revised within 30 days|1|||
33310037|NCT01183260|101029786|FG000|Overall Study|Death|1|||
33310038|NCT01183260|101029787|FG001|Overall Study|Death|0|||
33310039|NCT02641496|101029788|FG000|Overall Study|Lost to Follow-up|13|||
33310040|NCT02641496|101029789|FG001|Overall Study|Lost to Follow-up|12|||
33310041|NCT02641496|101029788|FG000|Overall Study|Withdrawal by Subject|1|||
33310042|NCT02641496|101029789|FG001|Overall Study|Withdrawal by Subject|0|||
33310043|NCT01198756|101029790|FG000|Overall Study|Adverse Event|0|||
33310044|NCT01198756|101029791|FG001|Overall Study|Adverse Event|0|||
33310045|NCT01198756|101029792|FG002|Overall Study|Adverse Event|0|||
33310046|NCT01198756|101029793|FG003|Overall Study|Adverse Event|1|||
33310047|NCT01198756|101029790|FG000|Overall Study|Protocol Violation|0|||
33310048|NCT01198756|101029791|FG001|Overall Study|Protocol Violation|0|||
33310049|NCT01198756|101029792|FG002|Overall Study|Protocol Violation|0|||
33310050|NCT01198756|101029793|FG003|Overall Study|Protocol Violation|2|||
33310051|NCT01198756|101029790|FG000|Overall Study|Withdrawal by Subject|9|||
33310052|NCT01198756|101029791|FG001|Overall Study|Withdrawal by Subject|4|||
33310053|NCT01198756|101029792|FG002|Overall Study|Withdrawal by Subject|7|||
33310054|NCT01198756|101029793|FG003|Overall Study|Withdrawal by Subject|5|||
33310055|NCT01198756|101029790|FG000|Overall Study|Lost to Follow-up|29|||
33310056|NCT01198756|101029791|FG001|Overall Study|Lost to Follow-up|36|||
33310057|NCT01198756|101029792|FG002|Overall Study|Lost to Follow-up|23|||
33310058|NCT01198756|101029793|FG003|Overall Study|Lost to Follow-up|18|||
33310059|NCT00196976|101029794|FG000|Primary Study|Migrated from study area|0|||
33310060|NCT00196976|101029795|FG001|Primary Study|Migrated from study area|0|||
33310061|NCT00196976|101029796|FG002|Primary Study|Migrated from study area|0|||
33310062|NCT00196976|101029797|FG003|Primary Study|Migrated from study area|0|||
33310063|NCT00196976|101029798|FG004|Primary Study|Migrated from study area|0|||
33310064|NCT00196976|101029799|FG005|Primary Study|Migrated from study area|0|||
33310065|NCT00196976|101029800|FG006|Primary Study|Migrated from study area|0|||
33310066|NCT00196976|101029801|FG007|Primary Study|Migrated from study area|1|||
33310067|NCT00196976|101029802|FG008|Primary Study|Migrated from study area|0|||
33310068|NCT00196976|101029803|FG009|Primary Study|Migrated from study area|0|||
33310069|NCT00196976|101029804|FG010|Primary Study|Migrated from study area|0|||
33310070|NCT00196976|101029805|FG011|Primary Study|Migrated from study area|0|||
33310071|NCT00196976|101029806|FG012|Primary Study|Migrated from study area|0|||
33310072|NCT00196976|101029807|FG013|Primary Study|Migrated from study area|0|||
33310073|NCT00196976|101029794|FG000|Primary Study|Protocol Violation|0|||
33310074|NCT00196976|101029795|FG001|Primary Study|Protocol Violation|1|||
33310075|NCT00196976|101029796|FG002|Primary Study|Protocol Violation|1|||
33310076|NCT00196976|101029797|FG003|Primary Study|Protocol Violation|0|||
33310077|NCT00196976|101029798|FG004|Primary Study|Protocol Violation|0|||
33310078|NCT00196976|101029799|FG005|Primary Study|Protocol Violation|0|||
33310079|NCT00196976|101029800|FG006|Primary Study|Protocol Violation|0|||
33310080|NCT00196976|101029801|FG007|Primary Study|Protocol Violation|0|||
33192403|NCT04542070|100608663|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
33192404|NCT04542070|100608664|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
33192405|NCT04542070|100608665|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
33192406|NCT04542070|100608666|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
33192407|NCT00773097|100608667|FG000|Overall Study|Withdrawal by Subject|1|||
33192408|NCT00773097|100608667|FG000|Overall Study|Physician Decision|6|||
33192409|NCT02107703|100608668|FG000|Overall Study|Withdrawal by Subject|46|||
33192410|NCT02107703|100608669|FG001|Overall Study|Withdrawal by Subject|21|||
33192411|NCT02107703|100608668|FG000|Overall Study|Lost to Follow-up|20|||
33192412|NCT02107703|100608669|FG001|Overall Study|Lost to Follow-up|9|||
33192413|NCT02107703|100608668|FG000|Overall Study|On study treatment/follow up|48|||
33192414|NCT02107703|100608669|FG001|Overall Study|On study treatment/follow up|5|||
33192415|NCT00179413|100608678|FG000|Overall Study|Adverse Event|38|||
33192416|NCT00179413|100608679|FG001|Overall Study|Adverse Event|20|||
33192417|NCT00179413|100608678|FG000|Overall Study|Withdrawal by Subject|87|||
33192418|NCT00179413|100608679|FG001|Overall Study|Withdrawal by Subject|95|||
33192419|NCT03252522|100608680|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
33192420|NCT03252522|100608681|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
33192421|NCT03252522|100608682|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
33192422|NCT03252522|100608680|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
33192423|NCT03252522|100608681|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
33192424|NCT03252522|100608682|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
33192425|NCT03252522|100608680|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
33192426|NCT03252522|100608681|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
33192427|NCT03252522|100608682|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
33192428|NCT03252522|100608680|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
33192429|NCT03252522|100608681|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
33192430|NCT03252522|100608682|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
33192431|NCT03252522|100608680|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
33192432|NCT03252522|100608681|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
33192433|NCT03252522|100608682|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
33192434|NCT03252522|100608680|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
33192435|NCT03252522|100608681|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
33192436|NCT03252522|100608682|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
33192437|NCT03252522|100608680|FG000|Phase 2: Open Label|Adverse Event|0|||
33192438|NCT03252522|100608681|FG001|Phase 2: Open Label|Adverse Event|0|||
33192439|NCT03252522|100608682|FG002|Phase 2: Open Label|Adverse Event|2|||
33192440|NCT03252522|100608680|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
33192441|NCT03252522|100608681|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
33192442|NCT03252522|100608682|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
33192443|NCT00110812|100608684|FG000|Main Study|Death|0|||
33192444|NCT00110812|100608685|FG001|Main Study|Death|0|||
33192445|NCT00110812|100608686|FG002|Main Study|Death|2|||
33192446|NCT00110812|100608684|FG000|Main Study|Withdrawal by Subject|0|||
33192447|NCT00110812|100608685|FG001|Main Study|Withdrawal by Subject|0|||
33192448|NCT00110812|100608686|FG002|Main Study|Withdrawal by Subject|1|||
33192449|NCT00110812|100608684|FG000|Main Study|Lost to Follow-up|8|||
33192450|NCT00110812|100608685|FG001|Main Study|Lost to Follow-up|11|||
33192451|NCT00110812|100608686|FG002|Main Study|Lost to Follow-up|10|||
33192452|NCT00110812|100608684|FG000|Extended Follow-up|Death|1|||
33192453|NCT00110812|100608685|FG001|Extended Follow-up|Death|0|||
33192454|NCT00110812|100608686|FG002|Extended Follow-up|Death|3|||
33192455|NCT00110812|100608684|FG000|Extended Follow-up|Withdrawal by Subject|0|||
33192456|NCT00110812|100608685|FG001|Extended Follow-up|Withdrawal by Subject|1|||
33192457|NCT00110812|100608686|FG002|Extended Follow-up|Withdrawal by Subject|0|||
33192458|NCT00110812|100608684|FG000|Extended Follow-up|Lost to Follow-up|1|||
33192459|NCT00110812|100608685|FG001|Extended Follow-up|Lost to Follow-up|3|||
33192460|NCT00110812|100608686|FG002|Extended Follow-up|Lost to Follow-up|1|||
33192461|NCT01714310|100608687|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
33192462|NCT01714310|100608688|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
33192463|NCT01714310|100608689|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
33192464|NCT01714310|100608687|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
33192465|NCT01714310|100608688|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
33192466|NCT01714310|100608689|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
33192467|NCT01714310|100608687|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
33192468|NCT01714310|100608688|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
33192469|NCT01714310|100608689|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
33192470|NCT01714310|100608687|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
33192471|NCT01714310|100608688|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
33192472|NCT01714310|100608689|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
33192473|NCT04960228|100608690|FG000|Overall Study|Withdrawal by Subject|216|||
33192474|NCT04960228|100608691|FG001|Overall Study|Withdrawal by Subject|35|||
33310081|NCT00196976|101029802|FG008|Primary Study|Protocol Violation|0|||
33310082|NCT00196976|101029803|FG009|Primary Study|Protocol Violation|0|||
33310083|NCT00196976|101029804|FG010|Primary Study|Protocol Violation|0|||
33310084|NCT00196976|101029805|FG011|Primary Study|Protocol Violation|0|||
33310085|NCT00196976|101029806|FG012|Primary Study|Protocol Violation|0|||
33310086|NCT00196976|101029807|FG013|Primary Study|Protocol Violation|0|||
33310087|NCT00196976|101029794|FG000|Primary Study|Withdrawal by Subject|1|||
33310088|NCT00196976|101029795|FG001|Primary Study|Withdrawal by Subject|0|||
33310089|NCT00196976|101029796|FG002|Primary Study|Withdrawal by Subject|1|||
33310090|NCT00196976|101029797|FG003|Primary Study|Withdrawal by Subject|1|||
33310091|NCT00196976|101029798|FG004|Primary Study|Withdrawal by Subject|2|||
33310092|NCT00196976|101029799|FG005|Primary Study|Withdrawal by Subject|1|||
33310093|NCT00196976|101029800|FG006|Primary Study|Withdrawal by Subject|0|||
33310094|NCT00196976|101029801|FG007|Primary Study|Withdrawal by Subject|0|||
33310095|NCT00196976|101029802|FG008|Primary Study|Withdrawal by Subject|0|||
33310096|NCT00196976|101029803|FG009|Primary Study|Withdrawal by Subject|1|||
33310097|NCT00196976|101029804|FG010|Primary Study|Withdrawal by Subject|0|||
33310098|NCT00196976|101029805|FG011|Primary Study|Withdrawal by Subject|0|||
33310099|NCT00196976|101029806|FG012|Primary Study|Withdrawal by Subject|0|||
33310100|NCT00196976|101029807|FG013|Primary Study|Withdrawal by Subject|0|||
33310101|NCT00196976|101029794|FG000|Primary Study|Lost to Follow-up|0|||
33310102|NCT00196976|101029795|FG001|Primary Study|Lost to Follow-up|0|||
33310103|NCT00196976|101029796|FG002|Primary Study|Lost to Follow-up|0|||
33310104|NCT00196976|101029797|FG003|Primary Study|Lost to Follow-up|0|||
33310105|NCT00196976|101029798|FG004|Primary Study|Lost to Follow-up|1|||
33310106|NCT00196976|101029799|FG005|Primary Study|Lost to Follow-up|1|||
33310107|NCT00196976|101029800|FG006|Primary Study|Lost to Follow-up|0|||
33310108|NCT00196976|101029801|FG007|Primary Study|Lost to Follow-up|2|||
33310109|NCT00196976|101029802|FG008|Primary Study|Lost to Follow-up|0|||
33310110|NCT00196976|101029803|FG009|Primary Study|Lost to Follow-up|0|||
33310111|NCT00196976|101029804|FG010|Primary Study|Lost to Follow-up|0|||
33310112|NCT00196976|101029805|FG011|Primary Study|Lost to Follow-up|0|||
33310113|NCT00196976|101029806|FG012|Primary Study|Lost to Follow-up|0|||
33310114|NCT00196976|101029807|FG013|Primary Study|Lost to Follow-up|0|||
33310115|NCT00196976|101029794|FG000|Primary Study|Other|0|||
33310116|NCT00196976|101029795|FG001|Primary Study|Other|0|||
33310117|NCT00196976|101029796|FG002|Primary Study|Other|2|||
33310118|NCT00196976|101029797|FG003|Primary Study|Other|0|||
33310119|NCT00196976|101029798|FG004|Primary Study|Other|0|||
33310120|NCT00196976|101029799|FG005|Primary Study|Other|0|||
33310121|NCT00196976|101029800|FG006|Primary Study|Other|0|||
33310122|NCT00196976|101029801|FG007|Primary Study|Other|0|||
33310123|NCT00196976|101029802|FG008|Primary Study|Other|0|||
33310124|NCT00196976|101029803|FG009|Primary Study|Other|0|||
33310125|NCT00196976|101029804|FG010|Primary Study|Other|0|||
33310126|NCT00196976|101029805|FG011|Primary Study|Other|0|||
33310127|NCT00196976|101029806|FG012|Primary Study|Other|0|||
33310128|NCT00196976|101029807|FG013|Primary Study|Other|0|||
33310129|NCT00196976|101029794|FG000|Booster Study|Withdrawal by Subject|0|||
33310130|NCT00196976|101029795|FG001|Booster Study|Withdrawal by Subject|0|||
33310131|NCT00196976|101029796|FG002|Booster Study|Withdrawal by Subject|0|||
33310132|NCT00196976|101029797|FG003|Booster Study|Withdrawal by Subject|0|||
33310133|NCT00196976|101029798|FG004|Booster Study|Withdrawal by Subject|0|||
33310134|NCT00196976|101029799|FG005|Booster Study|Withdrawal by Subject|0|||
33310135|NCT00196976|101029800|FG006|Booster Study|Withdrawal by Subject|0|||
33310136|NCT00196976|101029801|FG007|Booster Study|Withdrawal by Subject|0|||
33310137|NCT00196976|101029802|FG008|Booster Study|Withdrawal by Subject|0|||
33310138|NCT00196976|101029803|FG009|Booster Study|Withdrawal by Subject|0|||
33310139|NCT00196976|101029804|FG010|Booster Study|Withdrawal by Subject|1|||
33310140|NCT00196976|101029805|FG011|Booster Study|Withdrawal by Subject|0|||
33310141|NCT00196976|101029806|FG012|Booster Study|Withdrawal by Subject|0|||
33310142|NCT00196976|101029807|FG013|Booster Study|Withdrawal by Subject|0|||
33601719|NCT02920957|102092012|FG000|First Intervention : 1 Month|Adverse Event|1|||
33310143|NCT00196976|101029794|FG000|Booster Study|Lost to Follow-up|0|||
33310144|NCT00196976|101029795|FG001|Booster Study|Lost to Follow-up|0|||
33310145|NCT00196976|101029796|FG002|Booster Study|Lost to Follow-up|0|||
33310146|NCT00196976|101029797|FG003|Booster Study|Lost to Follow-up|0|||
33310147|NCT00196976|101029798|FG004|Booster Study|Lost to Follow-up|0|||
33310148|NCT00196976|101029799|FG005|Booster Study|Lost to Follow-up|0|||
33310149|NCT00196976|101029800|FG006|Booster Study|Lost to Follow-up|0|||
33310150|NCT00196976|101029801|FG007|Booster Study|Lost to Follow-up|0|||
33310151|NCT00196976|101029802|FG008|Booster Study|Lost to Follow-up|0|||
33310152|NCT00196976|101029803|FG009|Booster Study|Lost to Follow-up|0|||
33310153|NCT00196976|101029804|FG010|Booster Study|Lost to Follow-up|1|||
33310154|NCT00196976|101029805|FG011|Booster Study|Lost to Follow-up|2|||
33310155|NCT00196976|101029806|FG012|Booster Study|Lost to Follow-up|0|||
33310156|NCT00196976|101029807|FG013|Booster Study|Lost to Follow-up|0|||
33310157|NCT01074216|101029808|FG000|Overall Study|Physician Decision|1|||
33310158|NCT01074216|101029808|FG000|Overall Study|Not Treated|12|||
33310159|NCT00605215|101029809|FG000|Overall Study|Death|0|||
33310160|NCT00605215|101029810|FG001|Overall Study|Death|0|||
33192475|NCT04960228|100608690|FG000|Overall Study|Failed attention check|69|||
33192476|NCT04960228|100608691|FG001|Overall Study|Failed attention check|148|||
33192477|NCT04960228|100608690|FG000|Overall Study|Flagged for response quality by Dynata|3|||
33192478|NCT04960228|100608691|FG001|Overall Study|Flagged for response quality by Dynata|3|||
33192479|NCT02469610|100608692|FG000|Overall Study|Death|1|||
33192480|NCT02469610|100608693|FG001|Overall Study|Death|0|||
33192481|NCT02469610|100608692|FG000|Overall Study|Lost to Follow-up|1|||
33192482|NCT02469610|100608693|FG001|Overall Study|Lost to Follow-up|0|||
33192483|NCT02469610|100608692|FG000|Overall Study|exclusion criteria|2|||
33192484|NCT02469610|100608693|FG001|Overall Study|exclusion criteria|1|||
33192485|NCT01956110|100608694|FG000|Overall Study|Protocol Violation|25|||
33192486|NCT01956110|100608695|FG001|Overall Study|Protocol Violation|11|||
33192487|NCT01956110|100608694|FG000|Overall Study|Adverse Event|9|||
33192488|NCT01956110|100608695|FG001|Overall Study|Adverse Event|10|||
33192489|NCT01956110|100608694|FG000|Overall Study|Personal reasons|1|||
33192490|NCT01956110|100608695|FG001|Overall Study|Personal reasons|1|||
33192491|NCT01479621|100608696|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
33192492|NCT01479621|100608697|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33192493|NCT01479621|100608698|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33192494|NCT01479621|100608699|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33192495|NCT01479621|100608700|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33192496|NCT01479621|100608701|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33192497|NCT01479621|100608702|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33601720|NCT02920957|102092013|FG001|First Intervention : 1 Month|Adverse Event|0|||
33601721|NCT02920957|102092012|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
33601722|NCT02920957|102092013|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
33601723|NCT01969500|102095074|FG000|Overall Study|Death|0|||
33601724|NCT01969500|102095075|FG001|Overall Study|Death|1|||
33601725|NCT01969500|102095074|FG000|Overall Study|extended hospitalization|1|||
33601726|NCT01969500|102095075|FG001|Overall Study|extended hospitalization|1|||
33601727|NCT00849875|102095076|FG000|Overall Study|Death|28|||
33601728|NCT00849875|102095076|FG000|Overall Study|Ongoing (unknown completion status)|11|||
33601729|NCT00849875|102095076|FG000|Overall Study|Others|6|||
33601730|NCT00849875|102095076|FG000|Overall Study|Lost to Follow-up|2|||
33601731|NCT01617447|102095077|FG000|Overall Study|Adverse Event|0|||
33601732|NCT01617447|102095078|FG001|Overall Study|Adverse Event|1|||
33601733|NCT01617447|102095077|FG000|Overall Study|Physician Decision|0|||
33601734|NCT01617447|102095078|FG001|Overall Study|Physician Decision|2|||
33601735|NCT02421601|102095079|FG000|Overall Study|Adverse Event|4|||
33601736|NCT02421601|102095079|FG000|Overall Study|Lack of Efficacy|5|||
33601737|NCT02421601|102095079|FG000|Overall Study|Physician Decision|1|||
33601738|NCT02421601|102095079|FG000|Overall Study|Withdrawal by Subject|31|||
33601739|NCT02421601|102095079|FG000|Overall Study|Others|41|||
33601740|NCT01711866|102095080|FG000|Overall Study|Noncompliant|3|||
33601741|NCT01711866|102095080|FG000|Overall Study|Withdrawal by Subject|3|||
33601742|NCT01711866|102095080|FG000|Overall Study|Adverse Event|2|||
33601743|NCT00908115|102095083|FG000|Overall Study|Other|14|||
33601744|NCT00343915|102095084|FG000|Primary Study|Withdrawal by Subject|1|||
33601745|NCT00343915|102095085|FG001|Primary Study|Withdrawal by Subject|0|||
33601746|NCT00343915|102095084|FG000|Primary Study|Lost to Follow-up|2|||
33601747|NCT00343915|102095085|FG001|Primary Study|Lost to Follow-up|3|||
33601748|NCT00343915|102095084|FG000|Primary Study|Other|1|||
33601749|NCT00343915|102095085|FG001|Primary Study|Other|0|||
33601750|NCT02677844|102095089|FG000|Period 3|Withdrawal by Subject|0|||
33601751|NCT02677844|102095090|FG001|Period 3|Withdrawal by Subject|0|||
33601752|NCT02677844|102095091|FG002|Period 3|Withdrawal by Subject|0|||
33601753|NCT02677844|102095092|FG003|Period 3|Withdrawal by Subject|1|||
33192498|NCT01479621|100608696|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
33192499|NCT01479621|100608697|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33192500|NCT01479621|100608698|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33192501|NCT01479621|100608699|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33192502|NCT01479621|100608700|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33192503|NCT01479621|100608701|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33192504|NCT01479621|100608702|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33192505|NCT01479621|100608696|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
33192506|NCT01479621|100608697|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33192507|NCT01479621|100608698|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33192508|NCT01479621|100608699|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33601754|NCT02677844|102095093|FG004|Period 3|Withdrawal by Subject|0|||
33601755|NCT02677844|102095094|FG005|Period 3|Withdrawal by Subject|0|||
33601756|NCT02677844|102095095|FG006|Period 3|Withdrawal by Subject|0|||
33601757|NCT03157583|102095096|FG000|Overall Study|Other (did not meet study criteria)|1|||
33601758|NCT02639338|102095097|FG000|Overall Study|Lost to Follow-up|2|||
33601759|NCT02639338|102095098|FG001|Overall Study|Lost to Follow-up|2|||
33601760|NCT02639338|102095097|FG000|Overall Study|Withdrew Consent|1|||
33601761|NCT02639338|102095098|FG001|Overall Study|Withdrew Consent|2|||
33601762|NCT02639338|102095097|FG000|Overall Study|Death|1|||
33601763|NCT02639338|102095098|FG001|Overall Study|Death|0|||
33601764|NCT02639338|102095097|FG000|Overall Study|Randomized but Not Treated|0|||
33601765|NCT02639338|102095098|FG001|Overall Study|Randomized but Not Treated|1|||
33601766|NCT01610596|102095099|FG000|Overall Study|Lost to Follow-up|0|||
33601767|NCT01610596|102095100|FG001|Overall Study|Lost to Follow-up|1|||
33601768|NCT01064687|102095101|FG000|Overall Study|Adverse Event|9|||
33601769|NCT01064687|102095102|FG001|Overall Study|Adverse Event|4|||
33601770|NCT01064687|102095103|FG002|Overall Study|Adverse Event|10|||
33601771|NCT01064687|102095104|FG003|Overall Study|Adverse Event|3|||
33601772|NCT01064687|102095101|FG000|Overall Study|Death|1|||
33601773|NCT01064687|102095102|FG001|Overall Study|Death|1|||
33601774|NCT01064687|102095103|FG002|Overall Study|Death|0|||
33601775|NCT01064687|102095104|FG003|Overall Study|Death|0|||
33601776|NCT01064687|102095101|FG000|Overall Study|Entry Criteria Not Met|3|||
33601777|NCT01064687|102095102|FG001|Overall Study|Entry Criteria Not Met|0|||
33192509|NCT01479621|100608700|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33192510|NCT01479621|100608701|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33192511|NCT01479621|100608702|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33192512|NCT01479621|100608696|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
33192513|NCT01479621|100608697|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33192514|NCT01479621|100608698|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33501192|NCT02343939|101727707|FG001|Overall Study|Withdrew consent|6|||
33501193|NCT02343939|101727708|FG002|Overall Study|Withdrew consent|1|||
33501194|NCT02343939|101727709|FG003|Overall Study|Withdrew consent|2|||
33501195|NCT02343939|101727710|FG004|Overall Study|Withdrew consent|2|||
33501196|NCT02343939|101727711|FG005|Overall Study|Withdrew consent|0|||
33501197|NCT02343939|101727712|FG006|Overall Study|Withdrew consent|0|||
33501198|NCT02343939|101727713|FG007|Overall Study|Withdrew consent|8|||
33501199|NCT02343939|101727714|FG008|Overall Study|Withdrew consent|6|||
33501200|NCT02343939|101727706|FG000|Overall Study|Treatment failure|0|||
33501201|NCT02343939|101727707|FG001|Overall Study|Treatment failure|0|||
33501202|NCT02343939|101727708|FG002|Overall Study|Treatment failure|0|||
33501203|NCT02343939|101727709|FG003|Overall Study|Treatment failure|0|||
33501204|NCT02343939|101727710|FG004|Overall Study|Treatment failure|0|||
33501205|NCT02343939|101727711|FG005|Overall Study|Treatment failure|0|||
33501206|NCT02343939|101727712|FG006|Overall Study|Treatment failure|2|||
33501207|NCT02343939|101727713|FG007|Overall Study|Treatment failure|1|||
33501208|NCT02343939|101727714|FG008|Overall Study|Treatment failure|0|||
33501209|NCT02343939|101727706|FG000|Overall Study|Investigator's discretion|0|||
33501210|NCT02343939|101727707|FG001|Overall Study|Investigator's discretion|0|||
33501211|NCT02343939|101727708|FG002|Overall Study|Investigator's discretion|0|||
33501212|NCT02343939|101727709|FG003|Overall Study|Investigator's discretion|1|||
33501213|NCT02343939|101727710|FG004|Overall Study|Investigator's discretion|0|||
33501214|NCT02343939|101727711|FG005|Overall Study|Investigator's discretion|0|||
33501215|NCT02343939|101727712|FG006|Overall Study|Investigator's discretion|1|||
33501216|NCT02343939|101727713|FG007|Overall Study|Investigator's discretion|0|||
33501217|NCT02343939|101727714|FG008|Overall Study|Investigator's discretion|0|||
33501218|NCT02343939|101727706|FG000|Overall Study|Adverse Event|0|||
33501219|NCT02343939|101727707|FG001|Overall Study|Adverse Event|0|||
33501220|NCT02343939|101727708|FG002|Overall Study|Adverse Event|0|||
33501221|NCT02343939|101727709|FG003|Overall Study|Adverse Event|0|||
33501222|NCT02343939|101727710|FG004|Overall Study|Adverse Event|0|||
33501223|NCT02343939|101727711|FG005|Overall Study|Adverse Event|1|||
33501224|NCT02343939|101727712|FG006|Overall Study|Adverse Event|0|||
33501225|NCT02343939|101727713|FG007|Overall Study|Adverse Event|0|||
33501226|NCT02343939|101727714|FG008|Overall Study|Adverse Event|0|||
33601778|NCT01064687|102095103|FG002|Overall Study|Entry Criteria Not Met|0|||
33601779|NCT01064687|102095104|FG003|Overall Study|Entry Criteria Not Met|0|||
33192515|NCT01479621|100608699|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33601780|NCT01064687|102095101|FG000|Overall Study|Lack of Efficacy|1|||
33601781|NCT01064687|102095102|FG001|Overall Study|Lack of Efficacy|0|||
33601782|NCT01064687|102095103|FG002|Overall Study|Lack of Efficacy|2|||
33192516|NCT01479621|100608700|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33501227|NCT02343939|101727706|FG000|Overall Study|Never Treated With ENTO|0|||
33501228|NCT02343939|101727707|FG001|Overall Study|Never Treated With ENTO|0|||
33501229|NCT02343939|101727708|FG002|Overall Study|Never Treated With ENTO|0|||
33501230|NCT02343939|101727709|FG003|Overall Study|Never Treated With ENTO|0|||
33501231|NCT02343939|101727710|FG004|Overall Study|Never Treated With ENTO|0|||
33501232|NCT02343939|101727711|FG005|Overall Study|Never Treated With ENTO|0|||
33501233|NCT02343939|101727712|FG006|Overall Study|Never Treated With ENTO|1|||
33501234|NCT02343939|101727713|FG007|Overall Study|Never Treated With ENTO|2|||
33601783|NCT01064687|102095104|FG003|Overall Study|Lack of Efficacy|3|||
33601784|NCT01064687|102095101|FG000|Overall Study|Lost to Follow-up|7|||
33192517|NCT01479621|100608701|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33192518|NCT01479621|100608702|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33192519|NCT01479621|100608696|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
33192520|NCT01479621|100608697|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33192521|NCT01479621|100608698|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33192522|NCT01479621|100608699|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33192523|NCT01479621|100608700|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33192524|NCT01479621|100608701|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33192525|NCT01479621|100608702|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33192526|NCT01479621|100608696|FG000|Treatment Period|Adverse Event|0|||
33192527|NCT01479621|100608697|FG001|Treatment Period|Adverse Event|0|||
33192528|NCT01479621|100608698|FG002|Treatment Period|Adverse Event|0|||
33192529|NCT01479621|100608699|FG003|Treatment Period|Adverse Event|0|||
33192530|NCT01479621|100608700|FG004|Treatment Period|Adverse Event|1|||
33192531|NCT01479621|100608701|FG005|Treatment Period|Adverse Event|2|||
33192532|NCT01479621|100608702|FG006|Treatment Period|Adverse Event|2|||
33192533|NCT01479621|100608696|FG000|Treatment Period|Withdrawal by Subject|0|||
33192534|NCT01479621|100608697|FG001|Treatment Period|Withdrawal by Subject|4|||
33192535|NCT01479621|100608698|FG002|Treatment Period|Withdrawal by Subject|2|||
33192536|NCT01479621|100608699|FG003|Treatment Period|Withdrawal by Subject|2|||
33310161|NCT00605215|101029811|FG002|Overall Study|Death|1|||
33310162|NCT00605215|101029809|FG000|Overall Study|Adverse Event|19|||
33310163|NCT00605215|101029810|FG001|Overall Study|Adverse Event|21|||
33310164|NCT00605215|101029811|FG002|Overall Study|Adverse Event|26|||
33310165|NCT00605215|101029809|FG000|Overall Study|Refusal to sign the re-consent form|8|||
33310166|NCT00605215|101029810|FG001|Overall Study|Refusal to sign the re-consent form|3|||
33310167|NCT00605215|101029811|FG002|Overall Study|Refusal to sign the re-consent form|3|||
33310168|NCT00605215|101029809|FG000|Overall Study|Withdrawal by Subject|39|||
33192537|NCT01479621|100608700|FG004|Treatment Period|Withdrawal by Subject|5|||
33192538|NCT01479621|100608701|FG005|Treatment Period|Withdrawal by Subject|5|||
33192539|NCT01479621|100608702|FG006|Treatment Period|Withdrawal by Subject|1|||
33192540|NCT01479621|100608696|FG000|Treatment Period|Physician Decision|0|||
33192541|NCT01479621|100608697|FG001|Treatment Period|Physician Decision|0|||
33310169|NCT00605215|101029810|FG001|Overall Study|Withdrawal by Subject|37|||
33310170|NCT00605215|101029811|FG002|Overall Study|Withdrawal by Subject|27|||
33310171|NCT00605215|101029809|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
33310172|NCT00605215|101029810|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
33310173|NCT00605215|101029811|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
33310174|NCT00605215|101029809|FG000|Overall Study|Protocol Violation|3|||
33310175|NCT00605215|101029810|FG001|Overall Study|Protocol Violation|4|||
33310176|NCT00605215|101029811|FG002|Overall Study|Protocol Violation|1|||
33310177|NCT00605215|101029809|FG000|Overall Study|Pregnancy|8|||
33310178|NCT00605215|101029810|FG001|Overall Study|Pregnancy|5|||
33310179|NCT00605215|101029811|FG002|Overall Study|Pregnancy|4|||
33310180|NCT00605215|101029809|FG000|Overall Study|Lost to Follow-up|8|||
33310181|NCT00605215|101029810|FG001|Overall Study|Lost to Follow-up|5|||
33310182|NCT00605215|101029811|FG002|Overall Study|Lost to Follow-up|2|||
33310183|NCT00605215|101029809|FG000|Overall Study|Other than specified|0|||
33310184|NCT00605215|101029810|FG001|Overall Study|Other than specified|2|||
33310185|NCT00605215|101029811|FG002|Overall Study|Other than specified|1|||
33310186|NCT01383499|101029814|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
33310187|NCT01383499|101029815|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
33310188|NCT01383499|101029816|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
33310189|NCT01383499|101029817|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
33310190|NCT04375761|101029818|FG000|Overall Study|Death|1|||
33310191|NCT04375761|101029819|FG001|Overall Study|Death|2|||
33310192|NCT04375761|101029818|FG000|Overall Study|Lost to Follow-up|203|||
33310193|NCT04375761|101029819|FG001|Overall Study|Lost to Follow-up|380|||
33310194|NCT04375761|101029818|FG000|Overall Study|Withdrawal by Subject|47|||
33310195|NCT04375761|101029819|FG001|Overall Study|Withdrawal by Subject|98|||
33310196|NCT04375761|101029818|FG000|Overall Study|Noncompliance with study procedure|121|||
33310197|NCT04375761|101029819|FG001|Overall Study|Noncompliance with study procedure|251|||
33310198|NCT04375761|101029818|FG000|Overall Study|Reimbursement not enough|1|||
33310199|NCT04375761|101029819|FG001|Overall Study|Reimbursement not enough|2|||
33310200|NCT04375761|101029818|FG000|Overall Study|Unforeseen family circumstances|1|||
33601785|NCT01064687|102095102|FG001|Overall Study|Lost to Follow-up|10|||
33601786|NCT01064687|102095103|FG002|Overall Study|Lost to Follow-up|13|||
33192542|NCT01479621|100608698|FG002|Treatment Period|Physician Decision|0|||
33192543|NCT01479621|100608699|FG003|Treatment Period|Physician Decision|0|||
33192544|NCT01479621|100608700|FG004|Treatment Period|Physician Decision|1|||
33310201|NCT04375761|101029819|FG001|Overall Study|Unforeseen family circumstances|3|||
33310202|NCT04375761|101029818|FG000|Overall Study|Test too painful|1|||
33310203|NCT04375761|101029819|FG001|Overall Study|Test too painful|1|||
33310204|NCT04375761|101029818|FG000|Overall Study|Moved|0|||
33310205|NCT04375761|101029819|FG001|Overall Study|Moved|2|||
33310206|NCT04375761|101029818|FG000|Overall Study|Nonresponsive|0|||
33310207|NCT04375761|101029819|FG001|Overall Study|Nonresponsive|5|||
33310208|NCT03143166|101029820|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
33310209|NCT02146326|101029821|FG000|Overall Study|Lost to Follow-up|3|||
33310210|NCT02146326|101029822|FG001|Overall Study|Lost to Follow-up|3|||
33310211|NCT02146326|101029823|FG002|Overall Study|Lost to Follow-up|11|||
33310212|NCT02146326|101029824|FG003|Overall Study|Lost to Follow-up|19|||
33310213|NCT02146326|101029821|FG000|Overall Study|Withdrawal by Subject|2|||
33394786|NCT03922711|101331891|FG000|Overall Study|Withdrawal by Subject|0|||
33394787|NCT03922711|101331892|FG001|Overall Study|Withdrawal by Subject|3|||
33394788|NCT03922711|101331893|FG002|Overall Study|Withdrawal by Subject|1|||
33394789|NCT03922711|101331891|FG000|Overall Study|Not further specified|0|||
33394790|NCT03922711|101331892|FG001|Overall Study|Not further specified|0|||
33394791|NCT03922711|101331893|FG002|Overall Study|Not further specified|1|||
33394792|NCT02943668|101331895|FG000|Overall Study|Disease Progression|1|||
33394793|NCT03442595|101331897|FG000|Overall Study|Lost to Follow-up|94|||
33394794|NCT03442595|101331898|FG001|Overall Study|Lost to Follow-up|0|||
33394795|NCT00472043|101331901|FG000|Overall Study|Withdrawal by Subject|1|||
33394796|NCT00472043|101331902|FG001|Overall Study|Withdrawal by Subject|0|||
33394797|NCT00472043|101331901|FG000|Overall Study|Death|1|||
33394798|NCT00472043|101331902|FG001|Overall Study|Death|0|||
33394799|NCT02750501|101331904|FG000|Overall Study|Adverse Event|4|||
33394800|NCT02750501|101331904|FG000|Overall Study|Physician Decision|1|||
33394801|NCT02750501|101331904|FG000|Overall Study|Protocol Violation|1|||
33394802|NCT02750501|101331904|FG000|Overall Study|G-tube came out|1|||
33394803|NCT02750501|101331904|FG000|Overall Study|Non-compliant use of PERT|1|||
33394804|NCT00498368|101331905|FG000|Overall Study|Withdrawal by Subject|3|||
33394805|NCT00498368|101331906|FG001|Overall Study|Withdrawal by Subject|2|||
33394806|NCT00509028|101331910|FG000|Overall Study|Adverse Event|2|||
33394807|NCT00509028|101331911|FG001|Overall Study|Adverse Event|0|||
33394808|NCT00509028|101331910|FG000|Overall Study|Withdrawal by Subject|4|||
33394809|NCT00509028|101331911|FG001|Overall Study|Withdrawal by Subject|3|||
33394810|NCT00509028|101331910|FG000|Overall Study|Lost to Follow-up|0|||
33394811|NCT00509028|101331911|FG001|Overall Study|Lost to Follow-up|1|||
33394812|NCT00509028|101331910|FG000|Overall Study|Protocol Violation|4|||
33394813|NCT00509028|101331911|FG001|Overall Study|Protocol Violation|2|||
33394814|NCT00509028|101331910|FG000|Overall Study|Non-compliance|2|||
33394815|NCT00509028|101331911|FG001|Overall Study|Non-compliance|1|||
33394816|NCT00882362|101331912|FG000|Overall Study|Adverse Event|13|||
33394817|NCT00882362|101331913|FG001|Overall Study|Adverse Event|10|||
33394818|NCT00882362|101331912|FG000|Overall Study|Withdrawal by Subject|13|||
33394819|NCT00882362|101331913|FG001|Overall Study|Withdrawal by Subject|10|||
33394820|NCT00882362|101331912|FG000|Overall Study|Lack of Efficacy|3|||
33394821|NCT00882362|101331913|FG001|Overall Study|Lack of Efficacy|0|||
33310214|NCT02146326|101029822|FG001|Overall Study|Withdrawal by Subject|1|||
33310215|NCT02146326|101029823|FG002|Overall Study|Withdrawal by Subject|15|||
33501235|NCT02343939|101727714|FG008|Overall Study|Never Treated With ENTO|0|||
33310216|NCT02146326|101029824|FG003|Overall Study|Withdrawal by Subject|11|||
33310217|NCT02146326|101029821|FG000|Overall Study|Separated from mental health center|23|||
33310218|NCT02146326|101029822|FG001|Overall Study|Separated from mental health center|33|||
33501236|NCT01031680|101727715|FG000|Overall Study|Adverse Event|8|||
33501237|NCT01031680|101727716|FG001|Overall Study|Adverse Event|3|||
33501238|NCT01031680|101727715|FG000|Overall Study|Lost to Follow-up|2|||
33501239|NCT01031680|101727716|FG001|Overall Study|Lost to Follow-up|10|||
33501240|NCT01031680|101727715|FG000|Overall Study|Withdrawal by Subject|12|||
33501241|NCT01031680|101727716|FG001|Overall Study|Withdrawal by Subject|16|||
33310219|NCT02146326|101029823|FG002|Overall Study|Separated from mental health center|0|||
33310220|NCT02146326|101029824|FG003|Overall Study|Separated from mental health center|0|||
33310221|NCT02146326|101029821|FG000|Overall Study|Incarcerated|0|||
33310222|NCT02146326|101029822|FG001|Overall Study|Incarcerated|0|||
33310223|NCT02146326|101029823|FG002|Overall Study|Incarcerated|3|||
33394822|NCT00882362|101331912|FG000|Overall Study|Protocol Violation|7|||
33501242|NCT01031680|101727715|FG000|Overall Study|Death|2|||
33601787|NCT01064687|102095104|FG003|Overall Study|Lost to Follow-up|5|||
33601788|NCT01064687|102095101|FG000|Overall Study|Physician Decision|2|||
33601789|NCT01064687|102095102|FG001|Overall Study|Physician Decision|2|||
33601790|NCT01064687|102095103|FG002|Overall Study|Physician Decision|0|||
33601791|NCT01064687|102095104|FG003|Overall Study|Physician Decision|0|||
33601792|NCT01064687|102095101|FG000|Overall Study|Protocol Violation|1|||
33601793|NCT01064687|102095102|FG001|Overall Study|Protocol Violation|1|||
33394823|NCT00882362|101331913|FG001|Overall Study|Protocol Violation|2|||
33394824|NCT00882362|101331912|FG000|Overall Study|Pregnancy|1|||
33394825|NCT00882362|101331913|FG001|Overall Study|Pregnancy|0|||
33394826|NCT00882362|101331912|FG000|Overall Study|Physician Decision|5|||
33394827|NCT00882362|101331913|FG001|Overall Study|Physician Decision|1|||
33394828|NCT00882362|101331912|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
33394829|NCT00882362|101331913|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
33310224|NCT02146326|101029824|FG003|Overall Study|Incarcerated|8|||
33310225|NCT02146326|101029821|FG000|Overall Study|Death|0|||
33501243|NCT01031680|101727716|FG001|Overall Study|Death|1|||
33601794|NCT01064687|102095103|FG002|Overall Study|Protocol Violation|0|||
33601795|NCT01064687|102095104|FG003|Overall Study|Protocol Violation|1|||
33601796|NCT01064687|102095101|FG000|Overall Study|Sponsor Decision|0|||
33601797|NCT01064687|102095102|FG001|Overall Study|Sponsor Decision|0|||
33601798|NCT01064687|102095103|FG002|Overall Study|Sponsor Decision|3|||
33601799|NCT01064687|102095104|FG003|Overall Study|Sponsor Decision|0|||
33310226|NCT02146326|101029822|FG001|Overall Study|Death|0|||
33310227|NCT02146326|101029823|FG002|Overall Study|Death|4|||
33310228|NCT02146326|101029824|FG003|Overall Study|Death|4|||
33310229|NCT02146326|101029821|FG000|Overall Study|Unable to complete interview|0|||
33310230|NCT02146326|101029822|FG001|Overall Study|Unable to complete interview|0|||
33310231|NCT02146326|101029823|FG002|Overall Study|Unable to complete interview|10|||
33310232|NCT02146326|101029824|FG003|Overall Study|Unable to complete interview|6|||
33310233|NCT01853644|101029825|FG000|Registration and Treatment Start|Did not start treatment|1|||
33310234|NCT01853644|101029825|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
33310235|NCT01853644|101029825|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
33310236|NCT01853644|101029825|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
33310237|NCT01853644|101029825|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
33310238|NCT01853644|101029825|FG000|Continued Treatment After First Response|Adverse Event|2|||
33310239|NCT01853644|101029825|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
33310240|NCT03536143|101029826|FG000|Overall Study|Early termination, Sponsor decision|1|||
33310241|NCT00790751|101029827|FG000|Overall Study|Protocol non-compliance|16|||
33310242|NCT00790751|101029828|FG001|Overall Study|Protocol non-compliance|16|||
33310243|NCT00790751|101029829|FG002|Overall Study|Protocol non-compliance|10|||
33310244|NCT00790751|101029830|FG003|Overall Study|Protocol non-compliance|11|||
33310245|NCT00790751|101029827|FG000|Overall Study|Lost to Follow-up|4|||
33310246|NCT00790751|101029828|FG001|Overall Study|Lost to Follow-up|9|||
33310247|NCT00790751|101029829|FG002|Overall Study|Lost to Follow-up|4|||
33310248|NCT00790751|101029830|FG003|Overall Study|Lost to Follow-up|5|||
33310249|NCT00790751|101029827|FG000|Overall Study|Adverse Event|5|||
33310250|NCT00790751|101029828|FG001|Overall Study|Adverse Event|3|||
33310251|NCT00790751|101029829|FG002|Overall Study|Adverse Event|5|||
33310252|NCT00790751|101029830|FG003|Overall Study|Adverse Event|4|||
33310253|NCT00790751|101029827|FG000|Overall Study|Requirement for restricted medication|0|||
33310254|NCT00790751|101029828|FG001|Overall Study|Requirement for restricted medication|2|||
33310255|NCT00790751|101029829|FG002|Overall Study|Requirement for restricted medication|0|||
33310256|NCT00790751|101029830|FG003|Overall Study|Requirement for restricted medication|0|||
33310257|NCT00790751|101029827|FG000|Overall Study|Death|0|||
33310258|NCT00790751|101029828|FG001|Overall Study|Death|0|||
33310259|NCT00790751|101029829|FG002|Overall Study|Death|1|||
33501244|NCT01031680|101727715|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
33501245|NCT01031680|101727716|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
33501246|NCT01031680|101727715|FG000|Overall Study|Poor/Non-compliance|5|||
33501247|NCT01031680|101727716|FG001|Overall Study|Poor/Non-compliance|6|||
33501248|NCT01031680|101727715|FG000|Overall Study|Safety|1|||
33501249|NCT01031680|101727716|FG001|Overall Study|Safety|0|||
33501250|NCT01031680|101727715|FG000|Overall Study|Incorrect Enrolment|1|||
33501251|NCT01031680|101727716|FG001|Overall Study|Incorrect Enrolment|2|||
33501252|NCT01031680|101727715|FG000|Overall Study|Administrative Reason by Sponsor|0|||
33501253|NCT01031680|101727716|FG001|Overall Study|Administrative Reason by Sponsor|1|||
33601800|NCT01064687|102095101|FG000|Overall Study|Withdrawal by Subject|9|||
33310260|NCT00790751|101029830|FG003|Overall Study|Death|0|||
33310261|NCT00790751|101029827|FG000|Overall Study|Physician Decision|0|||
33501254|NCT01031680|101727715|FG000|Overall Study|Various|0|||
33501255|NCT01031680|101727716|FG001|Overall Study|Various|2|||
33310262|NCT00790751|101029828|FG001|Overall Study|Physician Decision|0|||
33310263|NCT00790751|101029829|FG002|Overall Study|Physician Decision|0|||
33310264|NCT00790751|101029830|FG003|Overall Study|Physician Decision|1|||
33310265|NCT02040584|101029833|FG000|Overall Study|Adverse Event|13|||
33310266|NCT02040584|101029834|FG001|Overall Study|Adverse Event|6|||
33310267|NCT02040584|101029833|FG000|Overall Study|Protocol Violation|9|||
33310268|NCT02040584|101029834|FG001|Overall Study|Protocol Violation|11|||
33310269|NCT02040584|101029833|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33501256|NCT04498182|101727717|FG000|Overall Study|Adverse Event|2|||
33310270|NCT02040584|101029834|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33310271|NCT02040584|101029833|FG000|Overall Study|Death|6|||
33310272|NCT02040584|101029834|FG001|Overall Study|Death|3|||
33310273|NCT02040584|101029833|FG000|Overall Study|Transplant rejection/retransplant|0|||
33601801|NCT01064687|102095102|FG001|Overall Study|Withdrawal by Subject|7|||
33601802|NCT01064687|102095103|FG002|Overall Study|Withdrawal by Subject|12|||
33601803|NCT01064687|102095104|FG003|Overall Study|Withdrawal by Subject|5|||
33601804|NCT01064687|102095101|FG000|Overall Study|Treatment Noncompliance|1|||
33601805|NCT01064687|102095102|FG001|Overall Study|Treatment Noncompliance|1|||
33310274|NCT02040584|101029834|FG001|Overall Study|Transplant rejection/retransplant|1|||
33310275|NCT02040584|101029833|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
33310276|NCT02040584|101029834|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
33310277|NCT01078454|101029839|FG000|Overall Study|Adverse Event|1|||
33310278|NCT01078454|101029840|FG001|Overall Study|Adverse Event|1|||
33310279|NCT01078454|101029839|FG000|Overall Study|Death|0|||
33310280|NCT01078454|101029840|FG001|Overall Study|Death|1|||
33310281|NCT00249002|101029841|FG000|Overall Study|Adverse Event|2|||
33310282|NCT00249002|101029841|FG000|Overall Study|Study cancellation|3|||
33310283|NCT00249002|101029841|FG000|Overall Study|Other|2|||
33310284|NCT04675151|101029842|FG000|Overall Study|Protocol Violation|1|||
33310285|NCT04675151|101029843|FG001|Overall Study|Protocol Violation|0|||
33310286|NCT04675151|101029844|FG002|Overall Study|Protocol Violation|0|||
33310287|NCT04675151|101029845|FG003|Overall Study|Protocol Violation|1|||
33310288|NCT01009580|101029846|FG000|Overall Study|Adverse Event|4|||
33310289|NCT01009580|101029847|FG001|Overall Study|Adverse Event|4|||
33310290|NCT01009580|101029846|FG000|Overall Study|Lack of Efficacy|0|||
33310291|NCT01009580|101029847|FG001|Overall Study|Lack of Efficacy|1|||
33310292|NCT01009580|101029846|FG000|Overall Study|Protocol Violation|2|||
33310293|NCT01009580|101029847|FG001|Overall Study|Protocol Violation|3|||
33310294|NCT01009580|101029846|FG000|Overall Study|Withdrawal Criteria|4|||
33310295|NCT01009580|101029847|FG001|Overall Study|Withdrawal Criteria|6|||
33310296|NCT01009580|101029846|FG000|Overall Study|Unclassified|17|||
33310297|NCT01009580|101029847|FG001|Overall Study|Unclassified|21|||
33310298|NCT04684394|101029851|FG000|Overall Study|Death|1|||
33310299|NCT04684394|101029852|FG001|Overall Study|Death|2|||
33310300|NCT04684394|101029851|FG000|Overall Study|Lost to Follow-up|1|||
33310301|NCT04684394|101029852|FG001|Overall Study|Lost to Follow-up|0|||
33310302|NCT04684394|101029851|FG000|Overall Study|Withdrawal by Subject|2|||
33310303|NCT04684394|101029852|FG001|Overall Study|Withdrawal by Subject|0|||
33310304|NCT04684394|101029851|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
33310305|NCT04684394|101029852|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
33310306|NCT03439254|101029855|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
33310307|NCT03439254|101029856|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
33310308|NCT03439254|101029857|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
33310309|NCT03439254|101029858|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
33310310|NCT03439254|101029859|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
33310311|NCT03439254|101029860|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
33310312|NCT03439254|101029855|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
33310313|NCT03439254|101029856|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
33310314|NCT03439254|101029857|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
33310315|NCT03439254|101029858|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
33310316|NCT03439254|101029859|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
33310317|NCT03439254|101029860|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
33310318|NCT03439254|101029855|FG000|Double-blind Phase (18 Months)|Death|1|||
33310319|NCT03439254|101029856|FG001|Double-blind Phase (18 Months)|Death|2|||
33310320|NCT03439254|101029857|FG002|Double-blind Phase (18 Months)|Death|2|||
33310321|NCT03439254|101029858|FG003|Double-blind Phase (18 Months)|Death|0|||
33310322|NCT03439254|101029859|FG004|Double-blind Phase (18 Months)|Death|0|||
33310323|NCT03439254|101029860|FG005|Double-blind Phase (18 Months)|Death|0|||
33601806|NCT01064687|102095103|FG002|Overall Study|Treatment Noncompliance|1|||
33310324|NCT03439254|101029855|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
33310325|NCT03439254|101029856|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
33310326|NCT03439254|101029857|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
33310327|NCT03439254|101029858|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
33310328|NCT03439254|101029859|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
33310329|NCT03439254|101029860|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
33501257|NCT04498182|101727718|FG001|Overall Study|Adverse Event|3|||
33601807|NCT01064687|102095104|FG003|Overall Study|Treatment Noncompliance|0|||
33601808|NCT01655381|102095105|FG000|Overall Study|Investigator Decision|1|||
33601809|NCT01655381|102095105|FG000|Overall Study|Moved to Another City|1|||
33501258|NCT04498182|101727719|FG002|Overall Study|Adverse Event|2|||
33310330|NCT03439254|101029855|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
33310331|NCT03439254|101029856|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
33310332|NCT03439254|101029857|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
33310333|NCT03439254|101029858|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
33310334|NCT03439254|101029859|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
33310335|NCT03439254|101029860|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
33310336|NCT03439254|101029855|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
33310337|NCT03439254|101029856|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
33310338|NCT03439254|101029857|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
33310339|NCT03439254|101029858|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
33310340|NCT03439254|101029859|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
33310341|NCT03439254|101029860|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
33310342|NCT03439254|101029855|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
33310343|NCT03439254|101029856|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
33310344|NCT03439254|101029857|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
33310345|NCT03439254|101029858|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
33310346|NCT03439254|101029859|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
33310347|NCT03439254|101029860|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
33310348|NCT03439254|101029855|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
33310349|NCT03439254|101029856|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
33310350|NCT03439254|101029857|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
33310351|NCT03439254|101029858|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
33310352|NCT03439254|101029859|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
33310353|NCT03439254|101029860|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
33310354|NCT03439254|101029855|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
33310355|NCT03439254|101029856|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
33310356|NCT03439254|101029857|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
33310357|NCT03439254|101029858|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
33310358|NCT03439254|101029859|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
33310359|NCT03439254|101029860|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
33310360|NCT03439254|101029855|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
33310361|NCT03439254|101029856|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
33310362|NCT03439254|101029857|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
33310363|NCT03439254|101029858|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
33310364|NCT03439254|101029859|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
33310365|NCT03439254|101029860|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
33310366|NCT03439254|101029855|FG000|Double-blind Phase (18 Months)|Site closure|0|||
33310367|NCT03439254|101029856|FG001|Double-blind Phase (18 Months)|Site closure|0|||
33310368|NCT03439254|101029857|FG002|Double-blind Phase (18 Months)|Site closure|1|||
33310369|NCT03439254|101029858|FG003|Double-blind Phase (18 Months)|Site closure|0|||
33310370|NCT03439254|101029859|FG004|Double-blind Phase (18 Months)|Site closure|0|||
33310371|NCT03439254|101029860|FG005|Double-blind Phase (18 Months)|Site closure|0|||
33310372|NCT03439254|101029855|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
33310373|NCT03439254|101029856|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
33310374|NCT03439254|101029857|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
33310375|NCT03439254|101029858|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
33310376|NCT03439254|101029859|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
33310377|NCT03439254|101029860|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
33310378|NCT03439254|101029855|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
33310379|NCT03439254|101029856|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
33310380|NCT03439254|101029857|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
33310381|NCT03439254|101029858|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
33310382|NCT03439254|101029859|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
33310383|NCT03439254|101029860|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
33310384|NCT03439254|101029855|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
33310385|NCT03439254|101029856|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
33310386|NCT03439254|101029857|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
33501259|NCT04498182|101727717|FG000|Overall Study|Withdrawal of Consent|3|||
33501260|NCT04498182|101727718|FG001|Overall Study|Withdrawal of Consent|4|||
33310387|NCT03439254|101029858|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
33310388|NCT03439254|101029859|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
33310389|NCT03439254|101029860|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
33310390|NCT03439254|101029855|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
33310391|NCT03439254|101029856|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
33310392|NCT03439254|101029857|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
33310393|NCT03439254|101029858|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
33501261|NCT04498182|101727719|FG002|Overall Study|Withdrawal of Consent|3|||
33501262|NCT04498182|101727717|FG000|Overall Study|Non-Compliant|1|||
33501263|NCT04498182|101727718|FG001|Overall Study|Non-Compliant|0|||
33501264|NCT04498182|101727719|FG002|Overall Study|Non-Compliant|1|||
33501265|NCT04498182|101727717|FG000|Overall Study|Lost to Follow-up|0|||
33501266|NCT04498182|101727718|FG001|Overall Study|Lost to Follow-up|0|||
33501267|NCT04498182|101727719|FG002|Overall Study|Lost to Follow-up|1|||
33192545|NCT01479621|100608701|FG005|Treatment Period|Physician Decision|1|||
33192546|NCT01479621|100608702|FG006|Treatment Period|Physician Decision|0|||
33192547|NCT01479621|100608696|FG000|Treatment Period|Non-compliance to study drug|0|||
33192548|NCT01479621|100608697|FG001|Treatment Period|Non-compliance to study drug|1|||
33192549|NCT01479621|100608698|FG002|Treatment Period|Non-compliance to study drug|0|||
33310394|NCT03439254|101029859|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
33310395|NCT03439254|101029860|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
33310396|NCT03439254|101029855|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
33310397|NCT03439254|101029856|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
33310398|NCT03439254|101029857|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
33310399|NCT03439254|101029858|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
33310400|NCT03439254|101029859|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
33310401|NCT03439254|101029860|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
33310402|NCT03439254|101029855|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
33310403|NCT03439254|101029856|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
33310404|NCT03439254|101029857|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
33310405|NCT03439254|101029858|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
33310406|NCT03439254|101029859|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
33310407|NCT03439254|101029860|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
33310408|NCT03439254|101029855|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
33310409|NCT03439254|101029856|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
33310410|NCT03439254|101029857|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
33310411|NCT03439254|101029858|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
33310412|NCT03439254|101029859|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
33310413|NCT03439254|101029860|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
33310414|NCT03439254|101029855|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
33310415|NCT03439254|101029856|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
33310416|NCT03439254|101029857|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
33310417|NCT03439254|101029858|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
33310418|NCT03439254|101029859|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
33310419|NCT03439254|101029860|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
33501268|NCT04498182|101727717|FG000|Overall Study|Investigator Decision|0|||
33501269|NCT04498182|101727718|FG001|Overall Study|Investigator Decision|0|||
33501270|NCT04498182|101727719|FG002|Overall Study|Investigator Decision|1|||
33601810|NCT01655381|102095105|FG000|Overall Study|Insufficient Treatment Response|1|||
33601811|NCT00475865|102095106|FG000|Overall Study|Adverse Event|0|||
33601812|NCT00475865|102095107|FG001|Overall Study|Adverse Event|3|||
33601813|NCT00475865|102095108|FG002|Overall Study|Adverse Event|4|||
33310420|NCT03439254|101029855|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
33394830|NCT00882362|101331912|FG000|Overall Study|change of residence or other commitments|5|||
33394831|NCT00882362|101331913|FG001|Overall Study|change of residence or other commitments|0|||
33501271|NCT04498182|101727717|FG000|Overall Study|Protocol Violation|1|||
33501272|NCT04498182|101727718|FG001|Overall Study|Protocol Violation|0|||
33501273|NCT04498182|101727719|FG002|Overall Study|Protocol Violation|2|||
33501274|NCT00891020|101727721|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
33501275|NCT00891020|101727722|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
33501276|NCT00891020|101727723|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
33501277|NCT00891020|101727721|FG000|24 Week Treatment Period|Death|0|||
33501278|NCT00891020|101727722|FG001|24 Week Treatment Period|Death|2|||
33501279|NCT00891020|101727723|FG002|24 Week Treatment Period|Death|0|||
33501280|NCT00891020|101727721|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
33501281|NCT00891020|101727722|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
33501282|NCT00891020|101727723|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
33501283|NCT00891020|101727721|FG000|24 Week Treatment Period|Failure to return|4|||
33501284|NCT00891020|101727722|FG001|24 Week Treatment Period|Failure to return|5|||
33501285|NCT00891020|101727723|FG002|24 Week Treatment Period|Failure to return|5|||
33501286|NCT00891020|101727721|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
33501287|NCT00891020|101727722|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
33501288|NCT00891020|101727723|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
33501289|NCT00891020|101727721|FG000|24 Week Treatment Period|Other protocol violation|1|||
33501290|NCT00891020|101727722|FG001|24 Week Treatment Period|Other protocol violation|1|||
33501291|NCT00891020|101727723|FG002|24 Week Treatment Period|Other protocol violation|2|||
33501292|NCT00891020|101727721|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
33501293|NCT00891020|101727722|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
33501294|NCT00891020|101727723|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
33501295|NCT00891020|101727721|FG000|24 Week Treatment Period|Withdrew consent|6|||
33501296|NCT00891020|101727722|FG001|24 Week Treatment Period|Withdrew consent|3|||
33501297|NCT00891020|101727723|FG002|24 Week Treatment Period|Withdrew consent|15|||
33501298|NCT00891020|101727721|FG000|24 Week Treatment Period|Administrative/Other|5|||
33501299|NCT00891020|101727722|FG001|24 Week Treatment Period|Administrative/Other|6|||
33501300|NCT00891020|101727723|FG002|24 Week Treatment Period|Administrative/Other|1|||
33501301|NCT00891020|101727721|FG000|Long-term Extension Period|Adverse Event|1|||
33501302|NCT00891020|101727722|FG001|Long-term Extension Period|Adverse Event|11|||
33501303|NCT00891020|101727723|FG002|Long-term Extension Period|Adverse Event|10|||
33501304|NCT00891020|101727721|FG000|Long-term Extension Period|Death|0|||
33501305|NCT00891020|101727722|FG001|Long-term Extension Period|Death|0|||
33501306|NCT00891020|101727723|FG002|Long-term Extension Period|Death|1|||
33501307|NCT00891020|101727721|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
33501308|NCT00891020|101727722|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
33501309|NCT00891020|101727723|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
33501310|NCT00891020|101727721|FG000|Long-term Extension Period|Protocol Violation|0|||
33501311|NCT00891020|101727722|FG001|Long-term Extension Period|Protocol Violation|1|||
33501312|NCT00891020|101727723|FG002|Long-term Extension Period|Protocol Violation|1|||
33501313|NCT00891020|101727721|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
33394832|NCT01828567|101331914|FG000|Overall Study|Lost to Follow-up|27|||
33192550|NCT01479621|100608699|FG003|Treatment Period|Non-compliance to study drug|0|||
33192551|NCT01479621|100608700|FG004|Treatment Period|Non-compliance to study drug|0|||
33192552|NCT01479621|100608701|FG005|Treatment Period|Non-compliance to study drug|0|||
33192553|NCT01479621|100608702|FG006|Treatment Period|Non-compliance to study drug|1|||
33192554|NCT01479621|100608696|FG000|Treatment Period|Protocol Violation|0|||
33192555|NCT01479621|100608697|FG001|Treatment Period|Protocol Violation|9|||
33192556|NCT01479621|100608698|FG002|Treatment Period|Protocol Violation|6|||
33192557|NCT01479621|100608699|FG003|Treatment Period|Protocol Violation|5|||
33192558|NCT01479621|100608700|FG004|Treatment Period|Protocol Violation|2|||
33192559|NCT01479621|100608701|FG005|Treatment Period|Protocol Violation|10|||
33192560|NCT01479621|100608702|FG006|Treatment Period|Protocol Violation|6|||
33192561|NCT01479621|100608696|FG000|Treatment Period|Pregnancy|0|||
33192562|NCT01479621|100608697|FG001|Treatment Period|Pregnancy|0|||
33192563|NCT01479621|100608698|FG002|Treatment Period|Pregnancy|2|||
33192564|NCT01479621|100608699|FG003|Treatment Period|Pregnancy|0|||
33192565|NCT01479621|100608700|FG004|Treatment Period|Pregnancy|0|||
33192566|NCT01479621|100608701|FG005|Treatment Period|Pregnancy|0|||
33192567|NCT01479621|100608702|FG006|Treatment Period|Pregnancy|0|||
33192568|NCT01479621|100608696|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
33192569|NCT01479621|100608697|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
33192570|NCT01479621|100608698|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
33192571|NCT01479621|100608699|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
33192572|NCT01479621|100608700|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
33192573|NCT01479621|100608701|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
33192574|NCT01479621|100608702|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
33192575|NCT01479621|100608696|FG000|Treatment Period|Lost to Follow-up|0|||
33192576|NCT01479621|100608697|FG001|Treatment Period|Lost to Follow-up|0|||
33192577|NCT01479621|100608698|FG002|Treatment Period|Lost to Follow-up|1|||
33192578|NCT01479621|100608699|FG003|Treatment Period|Lost to Follow-up|0|||
33192579|NCT01479621|100608700|FG004|Treatment Period|Lost to Follow-up|2|||
33192580|NCT01479621|100608701|FG005|Treatment Period|Lost to Follow-up|2|||
33192581|NCT01479621|100608702|FG006|Treatment Period|Lost to Follow-up|1|||
33192582|NCT01479621|100608696|FG000|Treatment Period|Met stopping criteria|0|||
33192583|NCT01479621|100608697|FG001|Treatment Period|Met stopping criteria|8|||
33192584|NCT01479621|100608698|FG002|Treatment Period|Met stopping criteria|7|||
33192585|NCT01479621|100608699|FG003|Treatment Period|Met stopping criteria|4|||
33192586|NCT01479621|100608700|FG004|Treatment Period|Met stopping criteria|9|||
33192587|NCT01479621|100608701|FG005|Treatment Period|Met stopping criteria|20|||
33192588|NCT01479621|100608702|FG006|Treatment Period|Met stopping criteria|6|||
33192589|NCT00427635|100608703|FG000|Treatment Phase|Withdrawal by Subject|1|||
33192590|NCT00427635|100608704|FG001|Treatment Phase|Withdrawal by Subject|0|||
33192591|NCT00427635|100608703|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
33192592|NCT00427635|100608704|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
33192593|NCT00357370|100608705|FG000|Cohort 2|Lack of Efficacy|0|||
33192594|NCT00357370|100608706|FG001|Cohort 2|Lack of Efficacy|2|||
33501314|NCT00891020|101727722|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
33501315|NCT00891020|101727723|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
33501316|NCT00891020|101727721|FG000|Long-term Extension Period|Failure to return|0|||
33501317|NCT00891020|101727722|FG001|Long-term Extension Period|Failure to return|2|||
33501318|NCT00891020|101727723|FG002|Long-term Extension Period|Failure to return|3|||
33501319|NCT00891020|101727721|FG000|Long-term Extension Period|Administrative|1|||
33501320|NCT00891020|101727722|FG001|Long-term Extension Period|Administrative|2|||
33501321|NCT00891020|101727723|FG002|Long-term Extension Period|Administrative|2|||
33501322|NCT05027451|101727724|FG000|Overall Study|Lost to Follow-up|1|||
33601814|NCT00475865|102095106|FG000|Overall Study|Lack of Efficacy|1|||
33192595|NCT00357370|100608707|FG002|Cohort 2|Lack of Efficacy|1|||
33192596|NCT00357370|100608705|FG000|Cohort 2|Adverse Event|1|||
33192597|NCT00357370|100608706|FG001|Cohort 2|Adverse Event|1|||
33192598|NCT00357370|100608707|FG002|Cohort 2|Adverse Event|1|||
33192599|NCT00357370|100608705|FG000|Cohort 2|Lost to Follow-up|0|||
33192600|NCT00357370|100608706|FG001|Cohort 2|Lost to Follow-up|1|||
33192601|NCT00357370|100608707|FG002|Cohort 2|Lost to Follow-up|0|||
33192602|NCT00357370|100608705|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
33192603|NCT00357370|100608706|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
33192604|NCT00357370|100608707|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
33192605|NCT00357370|100608705|FG000|Cohort 2|Withdrawal by Subject|0|||
33192606|NCT00357370|100608706|FG001|Cohort 2|Withdrawal by Subject|2|||
33192607|NCT00357370|100608707|FG002|Cohort 2|Withdrawal by Subject|0|||
33192608|NCT03228680|100608708|FG000|Overall Study|Adverse Event|13|||
33192609|NCT03228680|100608709|FG001|Overall Study|Adverse Event|18|||
33192610|NCT03228680|100608708|FG000|Overall Study|Randomization failure|0|||
33501323|NCT05027451|101727725|FG001|Overall Study|Lost to Follow-up|1|||
33192611|NCT03228680|100608709|FG001|Overall Study|Randomization failure|1|||
33192612|NCT03228680|100608708|FG000|Overall Study|Withdrawal by Subject|1|||
33192613|NCT03228680|100608709|FG001|Overall Study|Withdrawal by Subject|0|||
33501324|NCT03793842|101727726|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
33501325|NCT03793842|101727727|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
33501326|NCT03793842|101727726|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
33501327|NCT03793842|101727727|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
33501328|NCT02875613|101727728|FG000|Overall Study|Withdrawal by Subject|1|||
33501329|NCT02875613|101727728|FG000|Overall Study|Screen Failure|1|||
33501330|NCT00789373|101727729|FG000|Induction|Adverse Event|64|||
33501331|NCT00789373|101727730|FG001|Induction|Adverse Event|0|||
33501332|NCT00789373|101727731|FG002|Induction|Adverse Event|0|||
33501333|NCT00789373|101727729|FG000|Induction|Death Due to study disease|24|||
33501334|NCT00789373|101727730|FG001|Induction|Death Due to study disease|0|||
33501335|NCT00789373|101727731|FG002|Induction|Death Due to study disease|0|||
33501336|NCT00789373|101727729|FG000|Induction|Death due to adverse event|19|||
33501337|NCT00789373|101727730|FG001|Induction|Death due to adverse event|0|||
33501338|NCT00789373|101727731|FG002|Induction|Death due to adverse event|0|||
33501339|NCT00789373|101727729|FG000|Induction|Death due to toxicity|11|||
33501340|NCT00789373|101727730|FG001|Induction|Death due to toxicity|0|||
33501341|NCT00789373|101727731|FG002|Induction|Death due to toxicity|0|||
33501342|NCT00789373|101727729|FG000|Induction|Death due to procedure|1|||
33501343|NCT00789373|101727730|FG001|Induction|Death due to procedure|0|||
33501344|NCT00789373|101727731|FG002|Induction|Death due to procedure|0|||
33501345|NCT00789373|101727729|FG000|Induction|Investigator decision|7|||
33501346|NCT00789373|101727730|FG001|Induction|Investigator decision|0|||
33501347|NCT00789373|101727731|FG002|Induction|Investigator decision|0|||
33501348|NCT00789373|101727729|FG000|Induction|Protocol entry criteria not met|9|||
33501349|NCT00789373|101727730|FG001|Induction|Protocol entry criteria not met|0|||
33501350|NCT00789373|101727731|FG002|Induction|Protocol entry criteria not met|0|||
33501351|NCT00789373|101727729|FG000|Induction|Lost to Follow-up|6|||
33192614|NCT03228680|100608708|FG000|Overall Study|Other|9|||
33501352|NCT00789373|101727730|FG001|Induction|Lost to Follow-up|0|||
33501353|NCT00789373|101727731|FG002|Induction|Lost to Follow-up|0|||
33501354|NCT00789373|101727729|FG000|Induction|Protocol Violation|1|||
33501355|NCT00789373|101727730|FG001|Induction|Protocol Violation|0|||
33501356|NCT00789373|101727731|FG002|Induction|Protocol Violation|0|||
33601815|NCT00475865|102095107|FG001|Overall Study|Lack of Efficacy|0|||
33601816|NCT00475865|102095108|FG002|Overall Study|Lack of Efficacy|0|||
33601817|NCT00475865|102095106|FG000|Overall Study|Progressive disease|0|||
33601818|NCT00475865|102095107|FG001|Overall Study|Progressive disease|1|||
33601819|NCT00475865|102095108|FG002|Overall Study|Progressive disease|2|||
33192615|NCT03228680|100608709|FG001|Overall Study|Other|16|||
33192616|NCT00770120|100608712|FG000|Overall Study|Progression|31|||
33192617|NCT00770120|100608712|FG000|Overall Study|Adverse Event|11|||
33192618|NCT00770120|100608712|FG000|Overall Study|Not Protocol Specified|11|||
33192619|NCT00770120|100608712|FG000|Overall Study|Death|3|||
33192620|NCT00770120|100608712|FG000|Overall Study|Withdrawal by Subject|2|||
33192621|NCT00770120|100608712|FG000|Overall Study|Ineligible|1|||
33192622|NCT00770120|100608712|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
33310421|NCT03439254|101029856|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
33192623|NCT00770120|100608712|FG000|Overall Study|Reason under Review|1|||
33192624|NCT03144180|100608713|FG000|Overall Study|STAT Delivery|1|||
33310422|NCT03439254|101029857|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
33310423|NCT03439254|101029858|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
33310424|NCT03439254|101029859|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
33310425|NCT03439254|101029860|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
33310426|NCT03439254|101029855|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
33310427|NCT03439254|101029856|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
33310428|NCT03439254|101029857|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
33310429|NCT03439254|101029858|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
33310430|NCT03439254|101029859|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
33501357|NCT00789373|101727729|FG000|Induction|Progressive Disease|220|||
33601820|NCT00475865|102095106|FG000|Overall Study|Participant did not wish to continue|1|||
33601821|NCT00475865|102095107|FG001|Overall Study|Participant did not wish to continue|0|||
33601822|NCT00475865|102095108|FG002|Overall Study|Participant did not wish to continue|0|||
33192625|NCT03144180|100608714|FG001|Overall Study|STAT Delivery|1|||
33192626|NCT03144180|100608713|FG000|Overall Study|Provider forgot to fill out forms|1|||
33192627|NCT03144180|100608714|FG001|Overall Study|Provider forgot to fill out forms|3|||
33501358|NCT00789373|101727730|FG001|Induction|Progressive Disease|0|||
33501359|NCT00789373|101727731|FG002|Induction|Progressive Disease|0|||
33501360|NCT00789373|101727729|FG000|Induction|Withdrawal by Subject|37|||
33501361|NCT00789373|101727730|FG001|Induction|Withdrawal by Subject|0|||
33501362|NCT00789373|101727731|FG002|Induction|Withdrawal by Subject|0|||
33501363|NCT00789373|101727729|FG000|Maintenance|Adverse Event|0|||
33192628|NCT03144180|100608713|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
33192629|NCT03144180|100608714|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
33192630|NCT03144180|100608713|FG000|Overall Study|Scrub tech removed tube cap|0|||
33394833|NCT01828567|101331915|FG001|Overall Study|Lost to Follow-up|9|||
33394834|NCT01828567|101331914|FG000|Overall Study|Excluded - did not meet criteria|4|||
33394835|NCT01828567|101331915|FG001|Overall Study|Excluded - did not meet criteria|1|||
33394836|NCT01678560|101331916|FG000|Overall Study|Physician Decision|4|||
33394837|NCT01678560|101331917|FG001|Overall Study|Physician Decision|4|||
33394838|NCT01678560|101331916|FG000|Overall Study|Death|0|||
33394839|NCT01678560|101331917|FG001|Overall Study|Death|1|||
33394840|NCT01678560|101331916|FG000|Overall Study|Withdrawal by Subject|0|||
33394841|NCT01678560|101331917|FG001|Overall Study|Withdrawal by Subject|1|||
33394842|NCT00122317|101331921|FG000|Overall Study|Death|3|||
33394843|NCT00122317|101331921|FG000|Overall Study|Adverse Event|4|||
33394844|NCT00122317|101331921|FG000|Overall Study|Physician Decision|2|||
33394845|NCT00122317|101331921|FG000|Overall Study|patient non-compliance|1|||
33394846|NCT00122317|101331921|FG000|Overall Study|Withdrawal by Subject|1|||
33394847|NCT02614261|101331924|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
33310431|NCT03439254|101029860|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
33310432|NCT03439254|101029855|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
33310433|NCT03439254|101029856|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
33310434|NCT03439254|101029857|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
33310435|NCT03439254|101029858|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
33310436|NCT03439254|101029859|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
33310437|NCT03439254|101029860|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
33310438|NCT03439254|101029855|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
33310439|NCT03439254|101029856|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
33310440|NCT03439254|101029857|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
33310441|NCT03439254|101029858|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
33310442|NCT03439254|101029859|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
33310443|NCT03439254|101029860|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
33310444|NCT00825916|101033466|FG000|Overall Study|Lost to Follow-up|4|||
33310445|NCT00825916|101033467|FG001|Overall Study|Lost to Follow-up|2|||
33310446|NCT00825916|101033468|FG002|Overall Study|Lost to Follow-up|1|||
33310447|NCT02003573|101033469|FG000|Overall Study|Progressive disease|2|||
33310448|NCT02003573|101033470|FG001|Overall Study|Progressive disease|0|||
33310449|NCT02003573|101033471|FG002|Overall Study|Progressive disease|1|||
33310450|NCT02003573|101033469|FG000|Overall Study|Other Adverse event|0|||
33310451|NCT02003573|101033470|FG001|Overall Study|Other Adverse event|1|||
33310452|NCT02003573|101033471|FG002|Overall Study|Other Adverse event|1|||
33310453|NCT02003573|101033469|FG000|Overall Study|Refuse to take trial medication|0|||
33310454|NCT02003573|101033470|FG001|Overall Study|Refuse to take trial medication|1|||
33310455|NCT02003573|101033471|FG002|Overall Study|Refuse to take trial medication|1|||
33310456|NCT02003573|101033469|FG000|Overall Study|Other than specified|1|||
33310457|NCT02003573|101033470|FG001|Overall Study|Other than specified|2|||
33310458|NCT02003573|101033471|FG002|Overall Study|Other than specified|3|||
33310459|NCT01178385|101033472|FG000|Overall Study|Withdrawal by Subject|2|||
33310460|NCT01178385|101033473|FG001|Overall Study|Withdrawal by Subject|0|||
33310461|NCT03725085|101033474|FG000|Overall Study|Lost to Follow-up|2|||
33310462|NCT00585195|101033480|FG000|Overall Study|Adverse Event|0|||
33310463|NCT00585195|101033481|FG001|Overall Study|Adverse Event|0|||
33310464|NCT00585195|101033482|FG002|Overall Study|Adverse Event|0|||
33310465|NCT00585195|101033483|FG003|Overall Study|Adverse Event|0|||
33310466|NCT00585195|101033484|FG004|Overall Study|Adverse Event|2|||
33310467|NCT00585195|101033485|FG005|Overall Study|Adverse Event|1|||
33310468|NCT00585195|101033486|FG006|Overall Study|Adverse Event|0|||
33310469|NCT00585195|101033487|FG007|Overall Study|Adverse Event|1|||
33310470|NCT00585195|101033488|FG008|Overall Study|Adverse Event|0|||
33310471|NCT00585195|101033489|FG009|Overall Study|Adverse Event|0|||
33310472|NCT00585195|101033490|FG010|Overall Study|Adverse Event|3|||
33310473|NCT00585195|101033491|FG011|Overall Study|Adverse Event|0|||
33310474|NCT00585195|101033492|FG012|Overall Study|Adverse Event|8|||
33310475|NCT00585195|101033493|FG013|Overall Study|Adverse Event|6|||
33310476|NCT00585195|101033494|FG014|Overall Study|Adverse Event|4|||
33310477|NCT00585195|101033495|FG015|Overall Study|Adverse Event|1|||
33394848|NCT02614261|101331925|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
33394849|NCT02614261|101331926|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
33394850|NCT02614261|101331927|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
33310478|NCT00585195|101033496|FG016|Overall Study|Adverse Event|14|||
33310479|NCT00585195|101033497|FG017|Overall Study|Adverse Event|9|||
33310480|NCT00585195|101033498|FG018|Overall Study|Adverse Event|2|||
33310481|NCT00585195|101033499|FG019|Overall Study|Adverse Event|3|||
33310482|NCT00585195|101033500|FG020|Overall Study|Adverse Event|1|||
33394851|NCT02614261|101331924|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
33394852|NCT02614261|101331925|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
33501364|NCT00789373|101727730|FG001|Maintenance|Adverse Event|65|||
33501365|NCT00789373|101727731|FG002|Maintenance|Adverse Event|12|||
33394853|NCT02614261|101331926|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
33394854|NCT02614261|101331927|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
33394855|NCT02614261|101331924|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
33394856|NCT02614261|101331925|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
33394857|NCT02614261|101331926|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
33394858|NCT02614261|101331927|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33394859|NCT02614261|101331924|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
33394860|NCT02614261|101331925|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
33394861|NCT02614261|101331926|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
33394862|NCT02614261|101331927|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
33394863|NCT02614261|101331924|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
33394864|NCT02614261|101331925|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
33394865|NCT02614261|101331926|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
33394866|NCT02614261|101331927|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
33394867|NCT02614261|101331924|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
33394868|NCT02614261|101331925|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
33394869|NCT02614261|101331926|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
33394870|NCT02614261|101331927|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
33394871|NCT02614261|101331924|FG000|Double-Blind Treatment Phase|Screen failure|0|||
33394872|NCT02614261|101331925|FG001|Double-Blind Treatment Phase|Screen failure|1|||
33394873|NCT02614261|101331926|FG002|Double-Blind Treatment Phase|Screen failure|2|||
33394874|NCT02614261|101331927|FG003|Double-Blind Treatment Phase|Screen failure|0|||
33394875|NCT02614261|101331924|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
33394876|NCT02614261|101331925|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
33394877|NCT02614261|101331926|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
33394878|NCT02614261|101331927|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
33394879|NCT02614261|101331924|FG000|Open-Label Extension Phase|Adverse Event|23|||
33394880|NCT02614261|101331925|FG001|Open-Label Extension Phase|Adverse Event|12|||
33394881|NCT02614261|101331926|FG002|Open-Label Extension Phase|Adverse Event|11|||
33394882|NCT02614261|101331927|FG003|Open-Label Extension Phase|Adverse Event|0|||
33394883|NCT02614261|101331924|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
33394884|NCT02614261|101331925|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
33394885|NCT02614261|101331926|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
33394886|NCT02614261|101331927|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
33394887|NCT02614261|101331924|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
33310483|NCT00585195|101033480|FG000|Overall Study|Progressive Disease|2|||
33310484|NCT00585195|101033481|FG001|Overall Study|Progressive Disease|2|||
33310485|NCT00585195|101033482|FG002|Overall Study|Progressive Disease|5|||
33310486|NCT00585195|101033483|FG003|Overall Study|Progressive Disease|4|||
33310487|NCT00585195|101033484|FG004|Overall Study|Progressive Disease|6|||
33310488|NCT00585195|101033485|FG005|Overall Study|Progressive Disease|4|||
33310489|NCT00585195|101033486|FG006|Overall Study|Progressive Disease|6|||
33310490|NCT00585195|101033487|FG007|Overall Study|Progressive Disease|3|||
33310491|NCT00585195|101033488|FG008|Overall Study|Progressive Disease|0|||
33310492|NCT00585195|101033489|FG009|Overall Study|Progressive Disease|5|||
33310493|NCT00585195|101033490|FG010|Overall Study|Progressive Disease|2|||
33310494|NCT00585195|101033491|FG011|Overall Study|Progressive Disease|25|||
33310495|NCT00585195|101033492|FG012|Overall Study|Progressive Disease|29|||
33310496|NCT00585195|101033493|FG013|Overall Study|Progressive Disease|26|||
33310497|NCT00585195|101033494|FG014|Overall Study|Progressive Disease|21|||
33310498|NCT00585195|101033495|FG015|Overall Study|Progressive Disease|12|||
33310499|NCT00585195|101033496|FG016|Overall Study|Progressive Disease|94|||
33310500|NCT00585195|101033497|FG017|Overall Study|Progressive Disease|42|||
33310501|NCT00585195|101033498|FG018|Overall Study|Progressive Disease|4|||
33310502|NCT00585195|101033499|FG019|Overall Study|Progressive Disease|9|||
33310503|NCT00585195|101033500|FG020|Overall Study|Progressive Disease|8|||
33310504|NCT00585195|101033480|FG000|Overall Study|Withdrawal by Subject|1|||
33310505|NCT00585195|101033481|FG001|Overall Study|Withdrawal by Subject|1|||
33310506|NCT00585195|101033482|FG002|Overall Study|Withdrawal by Subject|2|||
33310507|NCT00585195|101033483|FG003|Overall Study|Withdrawal by Subject|2|||
33310508|NCT00585195|101033484|FG004|Overall Study|Withdrawal by Subject|0|||
33310509|NCT00585195|101033485|FG005|Overall Study|Withdrawal by Subject|0|||
33310510|NCT00585195|101033486|FG006|Overall Study|Withdrawal by Subject|0|||
33310511|NCT00585195|101033487|FG007|Overall Study|Withdrawal by Subject|1|||
33310512|NCT00585195|101033488|FG008|Overall Study|Withdrawal by Subject|0|||
33310513|NCT00585195|101033489|FG009|Overall Study|Withdrawal by Subject|0|||
33394888|NCT02614261|101331925|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
33394889|NCT02614261|101331926|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
33310514|NCT00585195|101033490|FG010|Overall Study|Withdrawal by Subject|3|||
33310515|NCT00585195|101033491|FG011|Overall Study|Withdrawal by Subject|8|||
33192631|NCT03144180|100608714|FG001|Overall Study|Scrub tech removed tube cap|1|||
33310516|NCT00585195|101033492|FG012|Overall Study|Withdrawal by Subject|15|||
33310517|NCT00585195|101033493|FG013|Overall Study|Withdrawal by Subject|0|||
33310518|NCT00585195|101033494|FG014|Overall Study|Withdrawal by Subject|3|||
33310519|NCT00585195|101033495|FG015|Overall Study|Withdrawal by Subject|0|||
33310520|NCT00585195|101033496|FG016|Overall Study|Withdrawal by Subject|7|||
33310521|NCT00585195|101033497|FG017|Overall Study|Withdrawal by Subject|1|||
33310522|NCT00585195|101033498|FG018|Overall Study|Withdrawal by Subject|2|||
33310523|NCT00585195|101033499|FG019|Overall Study|Withdrawal by Subject|2|||
33310524|NCT00585195|101033500|FG020|Overall Study|Withdrawal by Subject|0|||
33310525|NCT00585195|101033480|FG000|Overall Study|Other|0|||
33310526|NCT00585195|101033481|FG001|Overall Study|Other|1|||
33310527|NCT00585195|101033482|FG002|Overall Study|Other|1|||
33310528|NCT00585195|101033483|FG003|Overall Study|Other|1|||
33310529|NCT00585195|101033484|FG004|Overall Study|Other|0|||
33310530|NCT00585195|101033485|FG005|Overall Study|Other|1|||
33310531|NCT00585195|101033486|FG006|Overall Study|Other|0|||
33310532|NCT00585195|101033487|FG007|Overall Study|Other|0|||
33310533|NCT00585195|101033488|FG008|Overall Study|Other|2|||
33310534|NCT00585195|101033489|FG009|Overall Study|Other|1|||
33310535|NCT00585195|101033490|FG010|Overall Study|Other|0|||
33310536|NCT00585195|101033491|FG011|Overall Study|Other|19|||
33501366|NCT00789373|101727729|FG000|Maintenance|Death due to study disease|0|||
33501367|NCT00789373|101727730|FG001|Maintenance|Death due to study disease|3|||
33501368|NCT00789373|101727731|FG002|Maintenance|Death due to study disease|1|||
33501369|NCT00789373|101727729|FG000|Maintenance|Death due to adverse event|0|||
33501370|NCT00789373|101727730|FG001|Maintenance|Death due to adverse event|4|||
33501371|NCT00789373|101727731|FG002|Maintenance|Death due to adverse event|1|||
33501372|NCT00789373|101727729|FG000|Maintenance|Death due to toxicity|0|||
33501373|NCT00789373|101727730|FG001|Maintenance|Death due to toxicity|1|||
33501374|NCT00789373|101727731|FG002|Maintenance|Death due to toxicity|2|||
33501375|NCT00789373|101727729|FG000|Maintenance|Investigator Decision|0|||
33501376|NCT00789373|101727730|FG001|Maintenance|Investigator Decision|4|||
33501377|NCT00789373|101727731|FG002|Maintenance|Investigator Decision|2|||
33501378|NCT00789373|101727729|FG000|Maintenance|Protocol entry criteria not met|0|||
33501379|NCT00789373|101727730|FG001|Maintenance|Protocol entry criteria not met|2|||
33501380|NCT00789373|101727731|FG002|Maintenance|Protocol entry criteria not met|0|||
33501381|NCT00789373|101727729|FG000|Maintenance|Lost to Follow-up|0|||
33501382|NCT00789373|101727730|FG001|Maintenance|Lost to Follow-up|2|||
33501383|NCT00789373|101727731|FG002|Maintenance|Lost to Follow-up|0|||
33501384|NCT00789373|101727729|FG000|Maintenance|Progressive Disease|0|||
33501385|NCT00789373|101727730|FG001|Maintenance|Progressive Disease|253|||
33501386|NCT00789373|101727731|FG002|Maintenance|Progressive Disease|152|||
33501387|NCT00789373|101727729|FG000|Maintenance|Withdrawal by Subject|0|||
33501388|NCT00789373|101727730|FG001|Maintenance|Withdrawal by Subject|21|||
33501389|NCT00789373|101727731|FG002|Maintenance|Withdrawal by Subject|8|||
33501390|NCT00789373|101727729|FG000|Maintenance|Sponsor Decision|0|||
33501391|NCT00789373|101727730|FG001|Maintenance|Sponsor Decision|0|||
33501392|NCT00789373|101727731|FG002|Maintenance|Sponsor Decision|2|||
33310537|NCT00585195|101033492|FG012|Overall Study|Other|24|||
33310538|NCT00585195|101033493|FG013|Overall Study|Other|7|||
33501393|NCT00789373|101727729|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
33501394|NCT00789373|101727730|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
33501395|NCT00789373|101727731|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
33601823|NCT00475865|102095106|FG000|Overall Study|Other than above|0|||
33501396|NCT03168711|101727732|FG000|Overall Study|Adverse Event|2|||
33501397|NCT03168711|101727733|FG001|Overall Study|Adverse Event|0|||
33501398|NCT03168711|101727732|FG000|Overall Study|Withdrawal by Subject|0|||
33310539|NCT00585195|101033494|FG014|Overall Study|Other|11|||
33310540|NCT00585195|101033495|FG015|Overall Study|Other|3|||
33310541|NCT00585195|101033496|FG016|Overall Study|Other|28|||
33310542|NCT00585195|101033497|FG017|Overall Study|Other|12|||
33501399|NCT03168711|101727733|FG001|Overall Study|Withdrawal by Subject|1|||
33310543|NCT00585195|101033498|FG018|Overall Study|Other|10|||
33310544|NCT00585195|101033499|FG019|Overall Study|Other|4|||
33310545|NCT00585195|101033500|FG020|Overall Study|Other|2|||
33310546|NCT00585195|101033480|FG000|Overall Study|Randomized not treated|0|||
33310547|NCT00585195|101033481|FG001|Overall Study|Randomized not treated|0|||
33310548|NCT00585195|101033482|FG002|Overall Study|Randomized not treated|1|||
33310549|NCT00585195|101033483|FG003|Overall Study|Randomized not treated|0|||
33310550|NCT00585195|101033484|FG004|Overall Study|Randomized not treated|1|||
33310551|NCT00585195|101033485|FG005|Overall Study|Randomized not treated|0|||
33310552|NCT00585195|101033486|FG006|Overall Study|Randomized not treated|1|||
33310553|NCT00585195|101033487|FG007|Overall Study|Randomized not treated|0|||
33310554|NCT00585195|101033488|FG008|Overall Study|Randomized not treated|0|||
33310555|NCT00585195|101033489|FG009|Overall Study|Randomized not treated|0|||
33310556|NCT00585195|101033490|FG010|Overall Study|Randomized not treated|2|||
33310557|NCT00585195|101033491|FG011|Overall Study|Randomized not treated|0|||
33310558|NCT00585195|101033492|FG012|Overall Study|Randomized not treated|0|||
33310559|NCT00585195|101033493|FG013|Overall Study|Randomized not treated|0|||
33310560|NCT00585195|101033494|FG014|Overall Study|Randomized not treated|0|||
33310561|NCT00585195|101033495|FG015|Overall Study|Randomized not treated|1|||
33310562|NCT00585195|101033496|FG016|Overall Study|Randomized not treated|0|||
33310563|NCT00585195|101033497|FG017|Overall Study|Randomized not treated|1|||
33310564|NCT00585195|101033498|FG018|Overall Study|Randomized not treated|3|||
33310565|NCT00585195|101033499|FG019|Overall Study|Randomized not treated|0|||
33310566|NCT00585195|101033500|FG020|Overall Study|Randomized not treated|2|||
33501400|NCT03168711|101727732|FG000|Overall Study|Death|0|||
33501401|NCT03168711|101727733|FG001|Overall Study|Death|1|||
33601824|NCT00475865|102095107|FG001|Overall Study|Other than above|1|||
33310567|NCT00585195|101033480|FG000|Overall Study|Death|0|||
33310568|NCT00585195|101033481|FG001|Overall Study|Death|0|||
33310569|NCT00585195|101033482|FG002|Overall Study|Death|0|||
33310570|NCT00585195|101033483|FG003|Overall Study|Death|0|||
33501402|NCT00550043|101727734|FG000|Overall Study|Adverse Event|0|||
33501403|NCT00550043|101727735|FG001|Overall Study|Adverse Event|0|||
33601825|NCT00475865|102095108|FG002|Overall Study|Other than above|0|||
33601826|NCT01231321|102095111|FG000|Overall Study|Adverse Event|3|||
33601827|NCT01231321|102095111|FG000|Overall Study|Lack of Efficacy|2|||
33601828|NCT02068118|102095115|FG000|18-month Comparative Study Period|Death|90|||
33601829|NCT02068118|102095116|FG001|18-month Comparative Study Period|Death|97|||
33601830|NCT02068118|102095115|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
33601831|NCT02068118|102095116|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
33601832|NCT02068118|102095115|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
33601833|NCT02068118|102095116|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
33601834|NCT02068118|102095115|FG000|18-month Comparative Study Period|Heart transplant|9|||
33601835|NCT02068118|102095116|FG001|18-month Comparative Study Period|Heart transplant|15|||
33601836|NCT02068118|102095115|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
33601837|NCT02068118|102095116|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
33601838|NCT02068118|102095115|FG000|18-month Comparative Study Period|Hemiplegia|0|||
33601839|NCT02068118|102095116|FG001|18-month Comparative Study Period|Hemiplegia|1|||
33601840|NCT02068118|102095115|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
33601841|NCT02068118|102095116|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
33601842|NCT02068118|102095115|FG000|18-month Comparative Study Period|Move|0|||
33601843|NCT02068118|102095116|FG001|18-month Comparative Study Period|Move|1|||
33601844|NCT02068118|102095115|FG000|18-month Comparative Study Period|Hearing loss|0|||
33601845|NCT02068118|102095116|FG001|18-month Comparative Study Period|Hearing loss|1|||
33601846|NCT02068118|102095115|FG000|Extension Period|Death|0|||
33601847|NCT02068118|102095116|FG001|Extension Period|Death|2|||
33601848|NCT02068118|102095115|FG000|Extension Period|Withdrawal by Subject|1|||
33601849|NCT02068118|102095116|FG001|Extension Period|Withdrawal by Subject|0|||
33601850|NCT02068118|102095115|FG000|Extension Period|Heart transplant|1|||
33601851|NCT02068118|102095116|FG001|Extension Period|Heart transplant|0|||
33601852|NCT02068118|102095115|FG000|Extension Period|Wrong device use|0|||
33601853|NCT02068118|102095116|FG001|Extension Period|Wrong device use|1|||
33601854|NCT02317809|102095117|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
33601855|NCT02317809|102095118|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
33601856|NCT02317809|102095117|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
33601857|NCT02317809|102095118|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
33601858|NCT00871923|102095120|FG000|Overall Study|Death|1|||
33601859|NCT00871923|102095120|FG000|Overall Study|Withdrawal by Subject|1|||
33601860|NCT03242252|102095121|FG000|Overall Study|At the Participant's own Request|18|||
33601861|NCT03242252|102095122|FG001|Overall Study|At the Participant's own Request|10|||
33601862|NCT03242252|102095123|FG002|Overall Study|At the Participant's own Request|15|||
33310571|NCT00585195|101033484|FG004|Overall Study|Death|0|||
33310572|NCT00585195|101033485|FG005|Overall Study|Death|0|||
33310573|NCT00585195|101033486|FG006|Overall Study|Death|0|||
33310574|NCT00585195|101033487|FG007|Overall Study|Death|0|||
33310575|NCT00585195|101033488|FG008|Overall Study|Death|1|||
33310576|NCT00585195|101033489|FG009|Overall Study|Death|0|||
33310577|NCT00585195|101033490|FG010|Overall Study|Death|1|||
33310578|NCT00585195|101033491|FG011|Overall Study|Death|1|||
33394890|NCT02614261|101331927|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
33394891|NCT02614261|101331924|FG000|Open-Label Extension Phase|Physician Decision|2|||
33394892|NCT02614261|101331925|FG001|Open-Label Extension Phase|Physician Decision|0|||
33394893|NCT02614261|101331926|FG002|Open-Label Extension Phase|Physician Decision|0|||
33394894|NCT02614261|101331927|FG003|Open-Label Extension Phase|Physician Decision|0|||
33394895|NCT02614261|101331924|FG000|Open-Label Extension Phase|Pregnancy|1|||
33394896|NCT02614261|101331925|FG001|Open-Label Extension Phase|Pregnancy|2|||
33394897|NCT02614261|101331926|FG002|Open-Label Extension Phase|Pregnancy|1|||
33394898|NCT02614261|101331927|FG003|Open-Label Extension Phase|Pregnancy|0|||
33394899|NCT02614261|101331924|FG000|Open-Label Extension Phase|Protocol Violation|3|||
33394900|NCT02614261|101331925|FG001|Open-Label Extension Phase|Protocol Violation|4|||
33394901|NCT02614261|101331926|FG002|Open-Label Extension Phase|Protocol Violation|1|||
33394902|NCT02614261|101331927|FG003|Open-Label Extension Phase|Protocol Violation|0|||
33394903|NCT02614261|101331924|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
33394904|NCT02614261|101331925|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
33394905|NCT02614261|101331926|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
33394906|NCT02614261|101331927|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
33394907|NCT02614261|101331924|FG000|Follow-up Phase|Adverse Event|2|||
33394908|NCT02614261|101331925|FG001|Follow-up Phase|Adverse Event|0|||
33394909|NCT02614261|101331926|FG002|Follow-up Phase|Adverse Event|1|||
33394910|NCT02614261|101331927|FG003|Follow-up Phase|Adverse Event|0|||
33501404|NCT00550043|101727736|FG002|Overall Study|Adverse Event|0|||
33310579|NCT00585195|101033492|FG012|Overall Study|Death|7|||
33310580|NCT00585195|101033493|FG013|Overall Study|Death|2|||
33310581|NCT00585195|101033494|FG014|Overall Study|Death|8|||
33310582|NCT00585195|101033495|FG015|Overall Study|Death|2|||
33310583|NCT00585195|101033496|FG016|Overall Study|Death|11|||
33310584|NCT00585195|101033497|FG017|Overall Study|Death|0|||
33310585|NCT00585195|101033498|FG018|Overall Study|Death|0|||
33310586|NCT00585195|101033499|FG019|Overall Study|Death|0|||
33310587|NCT00585195|101033500|FG020|Overall Study|Death|1|||
33310588|NCT00585195|101033480|FG000|Overall Study|Lost to Follow-up|0|||
33394911|NCT02614261|101331924|FG000|Follow-up Phase|Lost to Follow-up|12|||
33394912|NCT02614261|101331925|FG001|Follow-up Phase|Lost to Follow-up|5|||
33394913|NCT02614261|101331926|FG002|Follow-up Phase|Lost to Follow-up|2|||
33394914|NCT02614261|101331927|FG003|Follow-up Phase|Lost to Follow-up|0|||
33394915|NCT02614261|101331924|FG000|Follow-up Phase|Physician Decision|5|||
33394916|NCT02614261|101331925|FG001|Follow-up Phase|Physician Decision|1|||
33394917|NCT02614261|101331926|FG002|Follow-up Phase|Physician Decision|0|||
33394918|NCT02614261|101331927|FG003|Follow-up Phase|Physician Decision|0|||
33394919|NCT02614261|101331924|FG000|Follow-up Phase|Pregnancy|0|||
33394920|NCT02614261|101331925|FG001|Follow-up Phase|Pregnancy|1|||
33394921|NCT02614261|101331926|FG002|Follow-up Phase|Pregnancy|0|||
33394922|NCT02614261|101331927|FG003|Follow-up Phase|Pregnancy|0|||
33394923|NCT02614261|101331924|FG000|Follow-up Phase|Protocol Violation|1|||
33394924|NCT02614261|101331925|FG001|Follow-up Phase|Protocol Violation|0|||
33394925|NCT02614261|101331926|FG002|Follow-up Phase|Protocol Violation|0|||
33310589|NCT00585195|101033481|FG001|Overall Study|Lost to Follow-up|0|||
33310590|NCT00585195|101033482|FG002|Overall Study|Lost to Follow-up|0|||
33310591|NCT00585195|101033483|FG003|Overall Study|Lost to Follow-up|0|||
33310592|NCT00585195|101033484|FG004|Overall Study|Lost to Follow-up|0|||
33310593|NCT00585195|101033485|FG005|Overall Study|Lost to Follow-up|0|||
33310594|NCT00585195|101033486|FG006|Overall Study|Lost to Follow-up|0|||
33501405|NCT00550043|101727737|FG003|Overall Study|Adverse Event|1|||
33501406|NCT00550043|101727738|FG004|Overall Study|Adverse Event|1|||
33501407|NCT00550043|101727734|FG000|Overall Study|Subject Withdrew Consent|0|||
33310595|NCT00585195|101033487|FG007|Overall Study|Lost to Follow-up|0|||
33501408|NCT00550043|101727735|FG001|Overall Study|Subject Withdrew Consent|2|||
33310596|NCT00585195|101033488|FG008|Overall Study|Lost to Follow-up|0|||
33310597|NCT00585195|101033489|FG009|Overall Study|Lost to Follow-up|0|||
33310598|NCT00585195|101033490|FG010|Overall Study|Lost to Follow-up|0|||
33394926|NCT02614261|101331927|FG003|Follow-up Phase|Protocol Violation|0|||
33394927|NCT02614261|101331924|FG000|Follow-up Phase|Withdrawal by Subject|12|||
33394928|NCT02614261|101331925|FG001|Follow-up Phase|Withdrawal by Subject|4|||
33394929|NCT02614261|101331926|FG002|Follow-up Phase|Withdrawal by Subject|11|||
33394930|NCT02614261|101331927|FG003|Follow-up Phase|Withdrawal by Subject|0|||
33394931|NCT02614261|101331924|FG000|Israel Addendum|Withdrawal by Subject|0|||
33394932|NCT02614261|101331925|FG001|Israel Addendum|Withdrawal by Subject|0|||
33394933|NCT02614261|101331926|FG002|Israel Addendum|Withdrawal by Subject|0|||
33310599|NCT00585195|101033491|FG011|Overall Study|Lost to Follow-up|0|||
33310600|NCT00585195|101033492|FG012|Overall Study|Lost to Follow-up|1|||
33310601|NCT00585195|101033493|FG013|Overall Study|Lost to Follow-up|0|||
33310602|NCT00585195|101033494|FG014|Overall Study|Lost to Follow-up|0|||
33394934|NCT02614261|101331927|FG003|Israel Addendum|Withdrawal by Subject|4|||
33310603|NCT00585195|101033495|FG015|Overall Study|Lost to Follow-up|0|||
33310604|NCT00585195|101033496|FG016|Overall Study|Lost to Follow-up|0|||
33310605|NCT00585195|101033497|FG017|Overall Study|Lost to Follow-up|2|||
33310606|NCT00585195|101033498|FG018|Overall Study|Lost to Follow-up|0|||
33310607|NCT00585195|101033499|FG019|Overall Study|Lost to Follow-up|0|||
33310608|NCT00585195|101033500|FG020|Overall Study|Lost to Follow-up|0|||
33310609|NCT00585195|101033480|FG000|Overall Study|Site Terminated by Sponsor|0|||
33310610|NCT00585195|101033481|FG001|Overall Study|Site Terminated by Sponsor|0|||
33310611|NCT00585195|101033482|FG002|Overall Study|Site Terminated by Sponsor|0|||
33310612|NCT00585195|101033483|FG003|Overall Study|Site Terminated by Sponsor|0|||
33310613|NCT00585195|101033484|FG004|Overall Study|Site Terminated by Sponsor|0|||
33310614|NCT00585195|101033485|FG005|Overall Study|Site Terminated by Sponsor|0|||
33310615|NCT00585195|101033486|FG006|Overall Study|Site Terminated by Sponsor|0|||
33310616|NCT00585195|101033487|FG007|Overall Study|Site Terminated by Sponsor|0|||
33310617|NCT00585195|101033488|FG008|Overall Study|Site Terminated by Sponsor|0|||
33310618|NCT00585195|101033489|FG009|Overall Study|Site Terminated by Sponsor|0|||
33310619|NCT00585195|101033490|FG010|Overall Study|Site Terminated by Sponsor|0|||
33310620|NCT00585195|101033491|FG011|Overall Study|Site Terminated by Sponsor|0|||
33310621|NCT00585195|101033492|FG012|Overall Study|Site Terminated by Sponsor|1|||
33310622|NCT00585195|101033493|FG013|Overall Study|Site Terminated by Sponsor|0|||
33310623|NCT00585195|101033494|FG014|Overall Study|Site Terminated by Sponsor|0|||
33310624|NCT00585195|101033495|FG015|Overall Study|Site Terminated by Sponsor|0|||
33310625|NCT00585195|101033496|FG016|Overall Study|Site Terminated by Sponsor|0|||
33310626|NCT00585195|101033497|FG017|Overall Study|Site Terminated by Sponsor|0|||
33310627|NCT00585195|101033498|FG018|Overall Study|Site Terminated by Sponsor|0|||
33310628|NCT00585195|101033499|FG019|Overall Study|Site Terminated by Sponsor|0|||
33310629|NCT00585195|101033500|FG020|Overall Study|Site Terminated by Sponsor|0|||
33310630|NCT00585195|101033480|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
33310631|NCT00585195|101033481|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
33310632|NCT00585195|101033482|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
33310633|NCT00585195|101033483|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
33310634|NCT00585195|101033484|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
33310635|NCT00585195|101033485|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
33310636|NCT00585195|101033486|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
33310637|NCT00585195|101033487|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
33310638|NCT00585195|101033488|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
33310639|NCT00585195|101033489|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
33310640|NCT00585195|101033490|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
33310641|NCT00585195|101033491|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
33310642|NCT00585195|101033492|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
33310643|NCT00585195|101033493|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
33310644|NCT00585195|101033494|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
33310645|NCT00585195|101033495|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
33310646|NCT00585195|101033496|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
33310647|NCT00585195|101033497|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
33310648|NCT00585195|101033498|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
33310649|NCT00585195|101033499|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
33310650|NCT00585195|101033500|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
33310651|NCT00816400|101033501|FG000|Overall Study|Death|2|||
33310652|NCT00816400|101033502|FG001|Overall Study|Death|3|||
33310653|NCT00816400|101033503|FG002|Overall Study|Death|3|||
33310654|NCT00816400|101033504|FG003|Overall Study|Death|3|||
33310655|NCT00816400|101033505|FG004|Overall Study|Death|2|||
33310656|NCT00816400|101033506|FG005|Overall Study|Death|3|||
33310657|NCT00816400|101033507|FG006|Overall Study|Death|2|||
33310658|NCT00816400|101033508|FG007|Overall Study|Death|5|||
33310659|NCT00816400|101033509|FG008|Overall Study|Death|6|||
33310660|NCT00816400|101033501|FG000|Overall Study|In hospice care at the end of the study|0|||
33310661|NCT00816400|101033502|FG001|Overall Study|In hospice care at the end of the study|0|||
33310662|NCT00816400|101033503|FG002|Overall Study|In hospice care at the end of the study|2|||
33310663|NCT00816400|101033504|FG003|Overall Study|In hospice care at the end of the study|0|||
33310664|NCT00816400|101033505|FG004|Overall Study|In hospice care at the end of the study|0|||
33310665|NCT00816400|101033506|FG005|Overall Study|In hospice care at the end of the study|0|||
33310666|NCT00816400|101033507|FG006|Overall Study|In hospice care at the end of the study|0|||
33310667|NCT00816400|101033508|FG007|Overall Study|In hospice care at the end of the study|0|||
33310668|NCT00816400|101033509|FG008|Overall Study|In hospice care at the end of the study|0|||
33310669|NCT01489891|101033510|FG000|Overall Study|Endoscopy failure|1|||
33310670|NCT01489891|101033511|FG001|Overall Study|Endoscopy failure|0|||
33310671|NCT01022268|101033512|FG000|Overall Study|Withdrawal by Subject|1|||
33310672|NCT01022268|101033513|FG001|Overall Study|Withdrawal by Subject|0|||
33310673|NCT01022268|101033512|FG000|Overall Study|Withdrawal by Subject|1|||
33310674|NCT01022268|101033513|FG001|Overall Study|Withdrawal by Subject|0|||
33310675|NCT01668667|101033514|FG000|Overall Study|Adverse Event|3|||
33310676|NCT01668667|101033515|FG001|Overall Study|Adverse Event|6|||
33310677|NCT01668667|101033516|FG002|Overall Study|Adverse Event|4|||
33310678|NCT01668667|101033517|FG003|Overall Study|Adverse Event|4|||
33501409|NCT00550043|101727736|FG002|Overall Study|Subject Withdrew Consent|1|||
33501410|NCT00550043|101727737|FG003|Overall Study|Subject Withdrew Consent|0|||
33501411|NCT00550043|101727738|FG004|Overall Study|Subject Withdrew Consent|0|||
33501412|NCT00550043|101727734|FG000|Overall Study|Other Reasons- Unspecified|0|||
33501413|NCT00550043|101727735|FG001|Overall Study|Other Reasons- Unspecified|1|||
33310679|NCT01668667|101033514|FG000|Overall Study|Lack of Efficacy|3|||
33501414|NCT00550043|101727736|FG002|Overall Study|Other Reasons- Unspecified|0|||
33310680|NCT01668667|101033515|FG001|Overall Study|Lack of Efficacy|2|||
33310681|NCT01668667|101033516|FG002|Overall Study|Lack of Efficacy|2|||
33310682|NCT01668667|101033517|FG003|Overall Study|Lack of Efficacy|3|||
33310683|NCT01668667|101033514|FG000|Overall Study|Protocol Violation|6|||
33310684|NCT01668667|101033515|FG001|Overall Study|Protocol Violation|10|||
33310685|NCT01668667|101033516|FG002|Overall Study|Protocol Violation|12|||
33310686|NCT01668667|101033517|FG003|Overall Study|Protocol Violation|5|||
33501415|NCT00550043|101727737|FG003|Overall Study|Other Reasons- Unspecified|1|||
33310687|NCT01668667|101033514|FG000|Overall Study|Lost to Follow-up|9|||
33310688|NCT01668667|101033515|FG001|Overall Study|Lost to Follow-up|4|||
33310689|NCT01668667|101033516|FG002|Overall Study|Lost to Follow-up|7|||
33310690|NCT01668667|101033517|FG003|Overall Study|Lost to Follow-up|6|||
33310691|NCT01668667|101033514|FG000|Overall Study|Physician Decision|3|||
33310692|NCT01668667|101033515|FG001|Overall Study|Physician Decision|0|||
33310693|NCT01668667|101033516|FG002|Overall Study|Physician Decision|1|||
33310694|NCT01668667|101033517|FG003|Overall Study|Physician Decision|0|||
33310695|NCT01668667|101033514|FG000|Overall Study|Withdrawal by Subject|7|||
33310696|NCT01668667|101033515|FG001|Overall Study|Withdrawal by Subject|4|||
33310697|NCT01668667|101033516|FG002|Overall Study|Withdrawal by Subject|5|||
33310698|NCT01668667|101033517|FG003|Overall Study|Withdrawal by Subject|5|||
33310699|NCT03010176|101033518|FG000|Overall Study|Death|21|||
33310700|NCT03010176|101033519|FG001|Overall Study|Death|35|||
33310701|NCT03010176|101033520|FG002|Overall Study|Death|19|||
33310702|NCT03010176|101033521|FG003|Overall Study|Death|19|||
33310703|NCT03010176|101033522|FG004|Overall Study|Death|14|||
33310704|NCT03010176|101033523|FG005|Overall Study|Death|0|||
33310705|NCT03010176|101033518|FG000|Overall Study|Lost to Follow-up|0|||
33310706|NCT03010176|101033519|FG001|Overall Study|Lost to Follow-up|0|||
33310707|NCT03010176|101033520|FG002|Overall Study|Lost to Follow-up|0|||
33310708|NCT03010176|101033521|FG003|Overall Study|Lost to Follow-up|0|||
33310709|NCT03010176|101033522|FG004|Overall Study|Lost to Follow-up|1|||
33310710|NCT03010176|101033523|FG005|Overall Study|Lost to Follow-up|0|||
33310711|NCT03010176|101033518|FG000|Overall Study|Physician Decision|0|||
33310712|NCT03010176|101033519|FG001|Overall Study|Physician Decision|4|||
33310713|NCT03010176|101033520|FG002|Overall Study|Physician Decision|0|||
33310714|NCT03010176|101033521|FG003|Overall Study|Physician Decision|1|||
33310715|NCT03010176|101033522|FG004|Overall Study|Physician Decision|0|||
33310716|NCT03010176|101033523|FG005|Overall Study|Physician Decision|0|||
33310717|NCT03010176|101033518|FG000|Overall Study|Sponsor Decision|0|||
33310718|NCT03010176|101033519|FG001|Overall Study|Sponsor Decision|4|||
33310719|NCT03010176|101033520|FG002|Overall Study|Sponsor Decision|4|||
33310720|NCT03010176|101033521|FG003|Overall Study|Sponsor Decision|1|||
33310721|NCT03010176|101033522|FG004|Overall Study|Sponsor Decision|6|||
33310722|NCT03010176|101033523|FG005|Overall Study|Sponsor Decision|0|||
33310723|NCT03010176|101033518|FG000|Overall Study|Withdrawal by Subject|11|||
33310724|NCT03010176|101033519|FG001|Overall Study|Withdrawal by Subject|9|||
33310725|NCT03010176|101033520|FG002|Overall Study|Withdrawal by Subject|3|||
33310726|NCT03010176|101033521|FG003|Overall Study|Withdrawal by Subject|0|||
33310727|NCT03010176|101033522|FG004|Overall Study|Withdrawal by Subject|4|||
33501416|NCT00550043|101727738|FG004|Overall Study|Other Reasons- Unspecified|0|||
33310728|NCT03010176|101033523|FG005|Overall Study|Withdrawal by Subject|0|||
33310729|NCT02988622|101033526|FG000|Overall Study|Lost to Follow-up|17|||
33310730|NCT01236365|101033527|FG000|Overall Study|Lost to Follow-up|0|||
33310731|NCT01236365|101033528|FG001|Overall Study|Lost to Follow-up|2|||
33501417|NCT01168232|101727739|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
33310732|NCT01236365|101033527|FG000|Overall Study|Moved Out of State|1|||
33310733|NCT01236365|101033528|FG001|Overall Study|Moved Out of State|0|||
33310734|NCT01236365|101033527|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
33501418|NCT01168232|101727739|FG000|Overall Study|Ineligible- Wrong cell type|6|||
33310735|NCT01236365|101033528|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
33310736|NCT00252577|101033529|FG000|Overall Study|Lost to Follow-up|20|||
33310737|NCT03241225|101033530|FG000|Overall Study|Lost to Follow-up|2|||
33310738|NCT03241225|101033531|FG001|Overall Study|Lost to Follow-up|1|||
33501419|NCT01168232|101727739|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
33310739|NCT03241225|101033530|FG000|Overall Study|Protocol Violation|4|||
33310740|NCT03241225|101033531|FG001|Overall Study|Protocol Violation|1|||
33310741|NCT03241225|101033530|FG000|Overall Study|Withdrawal by Subject|1|||
33310742|NCT03241225|101033531|FG001|Overall Study|Withdrawal by Subject|0|||
33310743|NCT01014533|101033535|FG000|Overall Study|Protocol Violation|3|||
33310744|NCT01014533|101033536|FG001|Overall Study|Protocol Violation|2|||
33310745|NCT01014533|101033535|FG000|Overall Study|Withdrawal by Subject|2|||
33310746|NCT01014533|101033536|FG001|Overall Study|Withdrawal by Subject|0|||
33310747|NCT01014533|101033535|FG000|Overall Study|unable to come to appointment|0|||
33310748|NCT01014533|101033536|FG001|Overall Study|unable to come to appointment|3|||
33501420|NCT02556775|101727740|FG000|Overall Study|Withdrawal by Subject|1|||
33501421|NCT02556775|101727741|FG001|Overall Study|Withdrawal by Subject|0|||
33501422|NCT02556775|101727742|FG002|Overall Study|Withdrawal by Subject|1|||
33501423|NCT02556775|101727743|FG003|Overall Study|Withdrawal by Subject|0|||
33501424|NCT02556775|101727740|FG000|Overall Study|Lost to Follow-up|1|||
33501425|NCT02556775|101727741|FG001|Overall Study|Lost to Follow-up|0|||
33501426|NCT02556775|101727742|FG002|Overall Study|Lost to Follow-up|0|||
33501427|NCT02556775|101727743|FG003|Overall Study|Lost to Follow-up|0|||
33501428|NCT00471822|101727744|FG000|Overall Study|Protocol Violation|2|||
33501429|NCT00554515|101727752|FG000|Overall Study|Withdrawal by Subject|3|||
33501430|NCT00554515|101727752|FG000|Overall Study|Disease progression|52|||
33501431|NCT00554515|101727752|FG000|Overall Study|Physician Decision|18|||
33501432|NCT00554515|101727752|FG000|Overall Study|Withdrawal by Subject|11|||
33501433|NCT00554515|101727752|FG000|Overall Study|Adverse Event|9|||
33501434|NCT00554515|101727752|FG000|Overall Study|Death|2|||
33501435|NCT00554515|101727752|FG000|Overall Study|Achieved Stable Disease|7|||
33501436|NCT00554515|101727752|FG000|Overall Study|Other|1|||
33501437|NCT00554515|101727752|FG000|Overall Study|Misc|15|||
33501438|NCT02968173|101727761|FG000|Overall Study|Withdrawal by Subject|1|||
33501439|NCT02490371|101727762|FG000|Overall Study|Lost to Follow-up|1|||
33501440|NCT02490371|101727763|FG001|Overall Study|Lost to Follow-up|1|||
33501441|NCT01562782|101727775|FG000|Overall Study|Withdrawal by Subject|3|||
33501442|NCT01562782|101727776|FG001|Overall Study|Withdrawal by Subject|3|||
33501443|NCT01562782|101727775|FG000|Overall Study|screen failure|1|||
33501444|NCT01562782|101727776|FG001|Overall Study|screen failure|2|||
33501445|NCT03423173|101727777|FG000|Overall Study|Randomized but not vaccinated|1|||
33501446|NCT03423173|101727778|FG001|Overall Study|Randomized but not vaccinated|0|||
33501447|NCT03423173|101727779|FG002|Overall Study|Randomized but not vaccinated|2|||
33501448|NCT03423173|101727780|FG003|Overall Study|Randomized but not vaccinated|1|||
33501449|NCT03423173|101727777|FG000|Overall Study|Adverse Event|1|||
33501450|NCT03423173|101727778|FG001|Overall Study|Adverse Event|1|||
33501451|NCT03423173|101727779|FG002|Overall Study|Adverse Event|1|||
33501452|NCT03423173|101727780|FG003|Overall Study|Adverse Event|1|||
33501453|NCT03423173|101727777|FG000|Overall Study|Lost to Follow-up|10|||
33501454|NCT03423173|101727778|FG001|Overall Study|Lost to Follow-up|19|||
33501455|NCT03423173|101727779|FG002|Overall Study|Lost to Follow-up|17|||
33501456|NCT03423173|101727780|FG003|Overall Study|Lost to Follow-up|22|||
33501457|NCT03423173|101727777|FG000|Overall Study|Withdrawal of consent|4|||
33501458|NCT03423173|101727778|FG001|Overall Study|Withdrawal of consent|10|||
33501459|NCT03423173|101727779|FG002|Overall Study|Withdrawal of consent|4|||
33601863|NCT03242252|102095121|FG000|Overall Study|Adverse Event|8|||
33601864|NCT03242252|102095122|FG001|Overall Study|Adverse Event|6|||
33601865|NCT03242252|102095123|FG002|Overall Study|Adverse Event|9|||
33601866|NCT03242252|102095121|FG000|Overall Study|Poor Compliance to Protocol|0|||
33601867|NCT03242252|102095122|FG001|Overall Study|Poor Compliance to Protocol|2|||
33601868|NCT03242252|102095123|FG002|Overall Study|Poor Compliance to Protocol|3|||
33601869|NCT03242252|102095121|FG000|Overall Study|Study Terminated by Sponsor|1|||
33601870|NCT03242252|102095122|FG001|Overall Study|Study Terminated by Sponsor|0|||
33601871|NCT03242252|102095123|FG002|Overall Study|Study Terminated by Sponsor|0|||
33601872|NCT03242252|102095121|FG000|Overall Study|Reason not Specified|4|||
33601873|NCT03242252|102095122|FG001|Overall Study|Reason not Specified|4|||
33601874|NCT03242252|102095123|FG002|Overall Study|Reason not Specified|1|||
33601875|NCT03242252|102095121|FG000|Overall Study|Lost to Follow-up|5|||
33601876|NCT03242252|102095122|FG001|Overall Study|Lost to Follow-up|1|||
33601877|NCT03242252|102095123|FG002|Overall Study|Lost to Follow-up|4|||
33601878|NCT00276614|102095124|FG000|Overall Study|Progression of disease under study|3|||
33601879|NCT00424190|102095126|FG000|Overall Study|Withdrew consent|3|||
33601880|NCT00424190|102095127|FG001|Overall Study|Withdrew consent|4|||
33601881|NCT00424190|102095126|FG000|Overall Study|Death|3|||
33310749|NCT02924064|101033537|FG000|Overall Study|Adverse Event|2|||
33310750|NCT02924064|101033538|FG001|Overall Study|Adverse Event|2|||
33601882|NCT00424190|102095127|FG001|Overall Study|Death|0|||
33601883|NCT00424190|102095126|FG000|Overall Study|Noncompliance|1|||
33601884|NCT00424190|102095127|FG001|Overall Study|Noncompliance|2|||
33310751|NCT02924064|101033537|FG000|Overall Study|Lost to Follow-up|0|||
33310752|NCT02924064|101033538|FG001|Overall Study|Lost to Follow-up|2|||
33501460|NCT03423173|101727780|FG003|Overall Study|Withdrawal of consent|5|||
33501461|NCT03423173|101727777|FG000|Overall Study|Death|1|||
33501462|NCT03423173|101727778|FG001|Overall Study|Death|0|||
33501463|NCT03423173|101727779|FG002|Overall Study|Death|0|||
33501464|NCT03423173|101727780|FG003|Overall Study|Death|0|||
33501465|NCT03423173|101727777|FG000|Overall Study|Reason not Specified|2|||
33501466|NCT03423173|101727778|FG001|Overall Study|Reason not Specified|5|||
33501467|NCT03423173|101727779|FG002|Overall Study|Reason not Specified|3|||
33501468|NCT03423173|101727780|FG003|Overall Study|Reason not Specified|1|||
33501469|NCT03478644|101727781|FG000|Phase 2|Withdrawal by Subject|2|||
33310753|NCT02924064|101033537|FG000|Overall Study|Physician Decision|0|||
33310754|NCT02924064|101033538|FG001|Overall Study|Physician Decision|2|||
33310755|NCT02924064|101033537|FG000|Overall Study|Protocol Violation|1|||
33310756|NCT02924064|101033538|FG001|Overall Study|Protocol Violation|3|||
33310757|NCT02924064|101033537|FG000|Overall Study|Withdrawal by Subject|4|||
33310758|NCT02924064|101033538|FG001|Overall Study|Withdrawal by Subject|5|||
33310759|NCT02924064|101033537|FG000|Overall Study|Other|17|||
33310760|NCT02924064|101033538|FG001|Overall Study|Other|29|||
33310761|NCT01465347|101033539|FG000|Overall Study|Withdrawal by Subject|1|||
33310762|NCT01465347|101033540|FG001|Overall Study|Withdrawal by Subject|1|||
33310763|NCT01465347|101033539|FG000|Overall Study|Physician Decision|0|||
33310764|NCT01465347|101033540|FG001|Overall Study|Physician Decision|1|||
33310765|NCT01465347|101033539|FG000|Overall Study|Admitted to hospice|0|||
33310766|NCT01465347|101033540|FG001|Overall Study|Admitted to hospice|1|||
33310767|NCT01103362|101033541|FG000|Overall Study|study terminated|596|||
33310768|NCT01642251|101033543|FG000|Overall Study|Progressive disease|0|||
33310769|NCT01642251|101033544|FG001|Overall Study|Progressive disease|0|||
33310770|NCT01642251|101033545|FG002|Overall Study|Progressive disease|3|||
33310771|NCT01642251|101033546|FG003|Overall Study|Progressive disease|3|||
33310772|NCT01642251|101033543|FG000|Overall Study|Adverse Event|0|||
33310773|NCT01642251|101033544|FG001|Overall Study|Adverse Event|0|||
33310774|NCT01642251|101033545|FG002|Overall Study|Adverse Event|5|||
33310775|NCT01642251|101033546|FG003|Overall Study|Adverse Event|4|||
33310776|NCT01642251|101033543|FG000|Overall Study|Death|0|||
33310777|NCT01642251|101033544|FG001|Overall Study|Death|0|||
33310778|NCT01642251|101033545|FG002|Overall Study|Death|1|||
33310779|NCT01642251|101033546|FG003|Overall Study|Death|3|||
33310780|NCT01642251|101033543|FG000|Overall Study|Withdrawal by Subject|0|||
33310781|NCT01642251|101033544|FG001|Overall Study|Withdrawal by Subject|0|||
33310782|NCT01642251|101033545|FG002|Overall Study|Withdrawal by Subject|1|||
33310783|NCT01642251|101033546|FG003|Overall Study|Withdrawal by Subject|3|||
33310784|NCT01642251|101033543|FG000|Overall Study|Alternative therapy|0|||
33310785|NCT01642251|101033544|FG001|Overall Study|Alternative therapy|0|||
33310786|NCT01642251|101033545|FG002|Overall Study|Alternative therapy|0|||
33310787|NCT01642251|101033546|FG003|Overall Study|Alternative therapy|2|||
33310788|NCT01642251|101033543|FG000|Overall Study|Other complicating disease|0|||
33310789|NCT01642251|101033544|FG001|Overall Study|Other complicating disease|0|||
33310790|NCT01642251|101033545|FG002|Overall Study|Other complicating disease|1|||
33310791|NCT01642251|101033546|FG003|Overall Study|Other complicating disease|0|||
33310792|NCT01642251|101033543|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
33310793|NCT01642251|101033544|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
33310794|NCT01642251|101033545|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
33310795|NCT01642251|101033546|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
33310796|NCT01076192|101033547|FG000|Overall Study|Other|197|||
33192632|NCT00259857|100612499|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
33192633|NCT00259857|100612500|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
33192634|NCT00259857|100612499|FG000|24 Months Treatment|Lost to Follow-up|0|||
33192635|NCT00259857|100612500|FG001|24 Months Treatment|Lost to Follow-up|3|||
33192636|NCT01859715|100612501|FG000|Overall Study|No 2nd VAS|16|||
33192637|NCT01859715|100612502|FG001|Overall Study|No 2nd VAS|8|||
33192638|NCT01859715|100612503|FG002|Overall Study|No 2nd VAS|23|||
33310797|NCT00978627|101033548|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
33310798|NCT00978627|101033549|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
33501470|NCT03478644|101727782|FG001|Phase 2|Withdrawal by Subject|1|||
33501471|NCT03478644|101727781|FG000|Phase 2|Lost to Follow-up|1|||
33501472|NCT03478644|101727782|FG001|Phase 2|Lost to Follow-up|0|||
33501473|NCT01741688|101727783|FG000|Overall Study|Lack of insurance coverage|2|||
33310799|NCT00978627|101033548|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
33310800|NCT00978627|101033549|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
33310801|NCT00978627|101033548|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
33310802|NCT00978627|101033549|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
33310803|NCT00978627|101033548|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
33310804|NCT00978627|101033549|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
33394935|NCT01585168|101331928|FG000|Overall Study|Lost to Follow-up|3|||
33501474|NCT01741688|101727783|FG000|Overall Study|Withdrawal by Subject|1|||
33192639|NCT00774995|100612506|FG000|Overall Study|Protocol Violation|0|||
33394936|NCT01585168|101331929|FG001|Overall Study|Lost to Follow-up|1|||
33192640|NCT00774995|100612507|FG001|Overall Study|Protocol Violation|0|||
33310805|NCT00978627|101033548|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
33310806|NCT00978627|101033549|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
33310807|NCT00978627|101033548|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
33310808|NCT00978627|101033549|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
33310809|NCT00978627|101033548|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
33310810|NCT00978627|101033549|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
33501475|NCT02821754|101727784|FG000|Overall Study|Procedure not required prior to amendment change|13|||
33192641|NCT00774995|100612508|FG002|Overall Study|Protocol Violation|1|||
33501476|NCT02821754|101727785|FG001|Overall Study|Procedure not required prior to amendment change|11|||
33501477|NCT02821754|101727786|FG002|Overall Study|Procedure not required prior to amendment change|0|||
33501478|NCT02821754|101727784|FG000|Overall Study|Participant's Clinical status|2|||
33501479|NCT02821754|101727785|FG001|Overall Study|Participant's Clinical status|0|||
33501480|NCT02821754|101727786|FG002|Overall Study|Participant's Clinical status|0|||
33501481|NCT02821754|101727784|FG000|Overall Study|Participant removed for noncompliance|1|||
33501482|NCT02821754|101727785|FG001|Overall Study|Participant removed for noncompliance|0|||
33501483|NCT02821754|101727786|FG002|Overall Study|Participant removed for noncompliance|0|||
33501484|NCT02821754|101727784|FG000|Overall Study|Drug not available.|0|||
33501485|NCT02821754|101727785|FG001|Overall Study|Drug not available.|0|||
33501486|NCT02821754|101727786|FG002|Overall Study|Drug not available.|1|||
33501487|NCT02821754|101727784|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
33501488|NCT02821754|101727785|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
33501489|NCT02821754|101727786|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
33501490|NCT00927862|101727791|FG000|Overall Study|Missing data needed for endpt analyses|27|||
33501491|NCT00927862|101727792|FG001|Overall Study|Missing data needed for endpt analyses|45|||
33501492|NCT00931528|101727793|FG000|Overall Study|Protocol Violation|9|||
33310811|NCT00978627|101033548|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
33394937|NCT01585168|101331930|FG002|Overall Study|Lost to Follow-up|1|||
33501493|NCT00931528|101727794|FG001|Overall Study|Protocol Violation|12|||
33501494|NCT00931528|101727793|FG000|Overall Study|Withdrawal by Subject|4|||
33501495|NCT00931528|101727794|FG001|Overall Study|Withdrawal by Subject|12|||
33501496|NCT00931528|101727793|FG000|Overall Study|Lost to Follow-up|6|||
33501497|NCT00931528|101727794|FG001|Overall Study|Lost to Follow-up|13|||
33501498|NCT00931528|101727793|FG000|Overall Study|Assessment outside of Time Frame|22|||
33501499|NCT00931528|101727794|FG001|Overall Study|Assessment outside of Time Frame|23|||
33501500|NCT00997373|101727795|FG000|Overall Study|Withdrawal by Subject|5|||
33501501|NCT00997373|101727796|FG001|Overall Study|Withdrawal by Subject|0|||
33501502|NCT00997373|101727795|FG000|Overall Study|wrong tumor type|4|||
33501503|NCT00997373|101727796|FG001|Overall Study|wrong tumor type|0|||
33501504|NCT00997373|101727795|FG000|Overall Study|could not have hysterectomy|6|||
33501505|NCT00997373|101727796|FG001|Overall Study|could not have hysterectomy|0|||
33601885|NCT00424190|102095126|FG000|Overall Study|Request of sponsor or investigator|0|||
33601886|NCT00424190|102095127|FG001|Overall Study|Request of sponsor or investigator|2|||
33601887|NCT00424190|102095126|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
33601888|NCT00424190|102095127|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
33601889|NCT00424190|102095126|FG000|Overall Study|Other|15|||
33601890|NCT00424190|102095127|FG001|Overall Study|Other|21|||
33601891|NCT00907296|102095128|FG000|Overall Study|Ineligibility Determined|1|||
33601892|NCT00907296|102095129|FG001|Overall Study|Ineligibility Determined|0|||
33601893|NCT00907296|102095130|FG002|Overall Study|Ineligibility Determined|0|||
33601894|NCT00907296|102095131|FG003|Overall Study|Ineligibility Determined|1|||
33601895|NCT00907296|102095132|FG004|Overall Study|Ineligibility Determined|0|||
33601896|NCT00907296|102095133|FG005|Overall Study|Ineligibility Determined|0|||
33601897|NCT00907296|102095134|FG006|Overall Study|Ineligibility Determined|0|||
33601898|NCT00907296|102095135|FG007|Overall Study|Ineligibility Determined|1|||
33601899|NCT00907296|102095136|FG008|Overall Study|Ineligibility Determined|0|||
33601900|NCT00907296|102095137|FG009|Overall Study|Ineligibility Determined|0|||
33601901|NCT00907296|102095128|FG000|Overall Study|Protocol Deviation|0|||
33601902|NCT00907296|102095129|FG001|Overall Study|Protocol Deviation|1|||
33601903|NCT00907296|102095130|FG002|Overall Study|Protocol Deviation|0|||
33601904|NCT00907296|102095131|FG003|Overall Study|Protocol Deviation|0|||
33601905|NCT00907296|102095132|FG004|Overall Study|Protocol Deviation|0|||
33601906|NCT00907296|102095133|FG005|Overall Study|Protocol Deviation|0|||
33601907|NCT00907296|102095134|FG006|Overall Study|Protocol Deviation|0|||
33601908|NCT00907296|102095135|FG007|Overall Study|Protocol Deviation|0|||
33601909|NCT00907296|102095136|FG008|Overall Study|Protocol Deviation|0|||
33601910|NCT00907296|102095137|FG009|Overall Study|Protocol Deviation|0|||
33601911|NCT00907296|102095128|FG000|Overall Study|Noncompliance|1|||
33601912|NCT00907296|102095129|FG001|Overall Study|Noncompliance|1|||
33601913|NCT00907296|102095130|FG002|Overall Study|Noncompliance|1|||
33601914|NCT00907296|102095131|FG003|Overall Study|Noncompliance|0|||
33601915|NCT00907296|102095132|FG004|Overall Study|Noncompliance|0|||
33501506|NCT04390503|101727798|FG000|Overall Study|Physician Decision|2|||
33501507|NCT04390503|101727799|FG001|Overall Study|Physician Decision|1|||
33501508|NCT04390503|101727798|FG000|Overall Study|Adverse Event|1|||
33601916|NCT00907296|102095133|FG005|Overall Study|Noncompliance|1|||
33601917|NCT00907296|102095134|FG006|Overall Study|Noncompliance|0|||
33501509|NCT04390503|101727799|FG001|Overall Study|Adverse Event|0|||
33501510|NCT01623310|101727800|FG000|Overall Study|Adverse Event|21|||
33501511|NCT01623310|101727800|FG000|Overall Study|Lost to Follow-up|18|||
33601918|NCT00907296|102095135|FG007|Overall Study|Noncompliance|2|||
33601919|NCT00907296|102095136|FG008|Overall Study|Noncompliance|0|||
33601920|NCT00907296|102095137|FG009|Overall Study|Noncompliance|0|||
33601921|NCT00907296|102095128|FG000|Overall Study|Adverse Event|2|||
33310812|NCT00978627|101033549|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
33310813|NCT00978627|101033548|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
33310814|NCT00978627|101033549|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
33310815|NCT01153958|101033554|FG000|Overall Study|Study Terminated|36|||
33310816|NCT01153958|101033555|FG001|Overall Study|Study Terminated|32|||
33310817|NCT03929757|101033556|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
33310818|NCT03929757|101033557|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
33310819|NCT03929757|101033558|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
33310820|NCT03929757|101033556|FG000|Main Study: Up to Day 365|Other|1|||
33310821|NCT03929757|101033557|FG001|Main Study: Up to Day 365|Other|0|||
33310822|NCT03929757|101033558|FG002|Main Study: Up to Day 365|Other|0|||
33310823|NCT03929757|101033556|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
33310824|NCT03929757|101033557|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
33192642|NCT00774995|100612509|FG003|Overall Study|Protocol Violation|0|||
33192643|NCT02047110|100612510|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
33192644|NCT02047110|100612511|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
33192645|NCT02047110|100612512|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
33192646|NCT02047110|100612513|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
33192647|NCT02047110|100612510|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
33192648|NCT02047110|100612511|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
33192649|NCT02047110|100612512|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
33192650|NCT02047110|100612513|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
33192651|NCT02047110|100612510|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
33192652|NCT02047110|100612511|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
33192653|NCT02047110|100612512|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
33192654|NCT02047110|100612513|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
33192655|NCT02047110|100612510|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
33192656|NCT02047110|100612511|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
33192657|NCT02047110|100612512|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
33192658|NCT02047110|100612513|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
33192659|NCT02047110|100612510|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
33192660|NCT02047110|100612511|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
33192661|NCT02047110|100612512|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
33192662|NCT02047110|100612513|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
33192663|NCT02047110|100612510|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
33192664|NCT02047110|100612511|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
33192665|NCT02047110|100612512|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
33192666|NCT02047110|100612513|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
33192667|NCT02047110|100612510|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
33192668|NCT02047110|100612511|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
33192669|NCT02047110|100612512|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
33192670|NCT02047110|100612513|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
33192671|NCT02047110|100612510|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
33192672|NCT02047110|100612511|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
33310825|NCT03929757|101033558|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
33310826|NCT03235284|101033563|FG000|Overall Study|Adverse Event|1|||
33310827|NCT03235284|101033564|FG001|Overall Study|Adverse Event|2|||
33310828|NCT03235284|101033565|FG002|Overall Study|Adverse Event|1|||
33310829|NCT00306670|101033566|FG000|Overall Study|patients recruited; Genentech, the st|0|||
33310830|NCT00306670|101033567|FG001|Overall Study|patients recruited; Genentech, the st|2|||
33310831|NCT04822597|101033568|FG000|Overall Study|Withdrawal by Subject|0|||
33310832|NCT04822597|101033569|FG001|Overall Study|Withdrawal by Subject|1|||
33310833|NCT04822597|101033570|FG002|Overall Study|Withdrawal by Subject|1|||
33310834|NCT04822597|101033571|FG003|Overall Study|Withdrawal by Subject|0|||
33310835|NCT04822597|101033568|FG000|Overall Study|Physician Decision|0|||
33310836|NCT04822597|101033569|FG001|Overall Study|Physician Decision|0|||
33310837|NCT04822597|101033570|FG002|Overall Study|Physician Decision|1|||
33310838|NCT04822597|101033571|FG003|Overall Study|Physician Decision|1|||
33601922|NCT00907296|102095129|FG001|Overall Study|Adverse Event|0|||
33192673|NCT02047110|100612512|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
33192674|NCT02047110|100612513|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
33192675|NCT02047110|100612510|FG000|Escape Treatment Period|Adverse Event|1|||
33192676|NCT02047110|100612511|FG001|Escape Treatment Period|Adverse Event|2|||
33192677|NCT02047110|100612512|FG002|Escape Treatment Period|Adverse Event|2|||
33310839|NCT04822597|101033568|FG000|Overall Study|Subject withdrawn after enrollment|0|||
33310840|NCT04822597|101033569|FG001|Overall Study|Subject withdrawn after enrollment|1|||
33310841|NCT04822597|101033570|FG002|Overall Study|Subject withdrawn after enrollment|0|||
33310842|NCT04822597|101033571|FG003|Overall Study|Subject withdrawn after enrollment|1|||
33310843|NCT04822597|101033568|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
33394938|NCT01585168|101331931|FG003|Overall Study|Lost to Follow-up|1|||
33501512|NCT01623310|101727800|FG000|Overall Study|Lack of Efficacy|6|||
33192678|NCT02047110|100612513|FG003|Escape Treatment Period|Adverse Event|0|||
33192679|NCT02047110|100612510|FG000|Escape Treatment Period|Other than specified|1|||
33192680|NCT02047110|100612511|FG001|Escape Treatment Period|Other than specified|2|||
33192681|NCT02047110|100612512|FG002|Escape Treatment Period|Other than specified|0|||
33192682|NCT02047110|100612513|FG003|Escape Treatment Period|Other than specified|1|||
33192683|NCT02047110|100612510|FG000|OLE Treatment Period|Other than specified|0|||
33310844|NCT04822597|101033569|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
33192684|NCT02047110|100612511|FG001|OLE Treatment Period|Other than specified|0|||
33192685|NCT02047110|100612512|FG002|OLE Treatment Period|Other than specified|1|||
33192686|NCT02047110|100612513|FG003|OLE Treatment Period|Other than specified|0|||
33192687|NCT01800903|100612514|FG000|Second Test Period|unable to catheterise|1|||
33310845|NCT04822597|101033570|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
33310846|NCT04822597|101033571|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
33310847|NCT04275089|101033572|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
33310848|NCT00095498|101033573|FG000|Overall Study|Physician Decision|9|||
33310849|NCT00095498|101033574|FG001|Overall Study|Physician Decision|10|||
33310850|NCT00095498|101033575|FG002|Overall Study|Physician Decision|8|||
33192688|NCT01800903|100612515|FG001|Second Test Period|unable to catheterise|0|||
33192689|NCT01800903|100612516|FG002|Second Test Period|unable to catheterise|0|||
33192690|NCT01800903|100612517|FG003|Second Test Period|unable to catheterise|0|||
33192691|NCT01800903|100612518|FG004|Second Test Period|unable to catheterise|0|||
33192692|NCT01800903|100612519|FG005|Second Test Period|unable to catheterise|0|||
33192693|NCT01898793|100612525|FG000|Overall Study|Death|2|||
33192694|NCT01898793|100612526|FG001|Overall Study|Death|1|||
33192695|NCT01898793|100612527|FG002|Overall Study|Death|4|||
33192696|NCT01898793|100612528|FG003|Overall Study|Death|0|||
33192697|NCT01898793|100612529|FG004|Overall Study|Death|0|||
33192698|NCT01898793|100612530|FG005|Overall Study|Death|0|||
33192699|NCT01898793|100612531|FG006|Overall Study|Death|0|||
33192700|NCT01257204|100612536|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
33192701|NCT01257204|100612537|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
33192702|NCT01257204|100612538|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
33192703|NCT01257204|100612536|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
33192704|NCT01257204|100612537|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
33192705|NCT01257204|100612538|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
33192706|NCT01257204|100612536|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
33192707|NCT01257204|100612537|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
33192708|NCT01257204|100612538|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
33192709|NCT01257204|100612536|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
33192710|NCT01257204|100612537|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
33192711|NCT01257204|100612538|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
33192712|NCT01257204|100612536|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
33192713|NCT01257204|100612537|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
33192714|NCT01257204|100612538|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
33192715|NCT01257204|100612536|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
33192716|NCT01257204|100612537|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
33192717|NCT01257204|100612538|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
33192718|NCT01257204|100612536|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
33192719|NCT01257204|100612537|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
33192720|NCT01257204|100612538|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
33192721|NCT01257204|100612536|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
33192722|NCT01257204|100612537|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
33192723|NCT01257204|100612538|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
33310851|NCT00095498|101033573|FG000|Overall Study|Adverse Event|1|||
33310852|NCT00095498|101033574|FG001|Overall Study|Adverse Event|0|||
33192724|NCT01257204|100612536|FG000|Follow-up Period (up to Week 48)|Other|0|||
33192725|NCT01257204|100612537|FG001|Follow-up Period (up to Week 48)|Other|0|||
33192726|NCT01257204|100612538|FG002|Follow-up Period (up to Week 48)|Other|5|||
33192727|NCT00279708|100612541|FG000|Overall Study|Withdrawal by Subject|2|||
33192728|NCT00279708|100612542|FG001|Overall Study|Withdrawal by Subject|3|||
33310853|NCT00095498|101033575|FG002|Overall Study|Adverse Event|1|||
33310854|NCT00095498|101033573|FG000|Overall Study|Withdrawal by Subject|15|||
33192729|NCT00279708|100612541|FG000|Overall Study|Adverse Event|1|||
33192730|NCT00279708|100612542|FG001|Overall Study|Adverse Event|1|||
33310855|NCT00095498|101033574|FG001|Overall Study|Withdrawal by Subject|16|||
33310856|NCT00095498|101033575|FG002|Overall Study|Withdrawal by Subject|15|||
33192731|NCT03337724|100612547|FG000|Overall Study|Reason not Specified|12|||
33192732|NCT03337724|100612548|FG001|Overall Study|Reason not Specified|21|||
33192733|NCT03337724|100612549|FG002|Overall Study|Reason not Specified|9|||
33192734|NCT03337724|100612550|FG003|Overall Study|Reason not Specified|9|||
33192735|NCT03337724|100612551|FG004|Overall Study|Reason not Specified|29|||
33192736|NCT03337724|100612547|FG000|Overall Study|Withdrawal by Subject|13|||
33310857|NCT00095498|101033573|FG000|Overall Study|Disease progression|0|||
33310858|NCT00095498|101033574|FG001|Overall Study|Disease progression|1|||
33310859|NCT00095498|101033575|FG002|Overall Study|Disease progression|1|||
33310860|NCT00095498|101033573|FG000|Overall Study|Ineligibility determined|3|||
33310861|NCT00095498|101033574|FG001|Overall Study|Ineligibility determined|0|||
33310862|NCT00095498|101033575|FG002|Overall Study|Ineligibility determined|2|||
33310863|NCT00095498|101033573|FG000|Overall Study|Lost to Follow-up|1|||
33192737|NCT03337724|100612548|FG001|Overall Study|Withdrawal by Subject|15|||
33192738|NCT03337724|100612549|FG002|Overall Study|Withdrawal by Subject|4|||
33192739|NCT03337724|100612550|FG003|Overall Study|Withdrawal by Subject|15|||
33192740|NCT03337724|100612551|FG004|Overall Study|Withdrawal by Subject|6|||
33192741|NCT03337724|100612547|FG000|Overall Study|Protocol Deviation|0|||
33192742|NCT03337724|100612548|FG001|Overall Study|Protocol Deviation|1|||
33192743|NCT03337724|100612549|FG002|Overall Study|Protocol Deviation|1|||
33192744|NCT03337724|100612550|FG003|Overall Study|Protocol Deviation|1|||
33192745|NCT03337724|100612551|FG004|Overall Study|Protocol Deviation|0|||
33192746|NCT03337724|100612547|FG000|Overall Study|Adverse Event|1|||
33192747|NCT03337724|100612548|FG001|Overall Study|Adverse Event|1|||
33192748|NCT03337724|100612549|FG002|Overall Study|Adverse Event|0|||
33192749|NCT03337724|100612550|FG003|Overall Study|Adverse Event|1|||
33192750|NCT03337724|100612551|FG004|Overall Study|Adverse Event|0|||
33192751|NCT03337724|100612547|FG000|Overall Study|Death|40|||
33192752|NCT03337724|100612548|FG001|Overall Study|Death|89|||
33192753|NCT03337724|100612549|FG002|Overall Study|Death|43|||
33192754|NCT03337724|100612550|FG003|Overall Study|Death|76|||
33192755|NCT03337724|100612551|FG004|Overall Study|Death|50|||
33192756|NCT03337724|100612547|FG000|Overall Study|Lost to Follow-up|5|||
33192757|NCT03337724|100612548|FG001|Overall Study|Lost to Follow-up|5|||
33192758|NCT03337724|100612549|FG002|Overall Study|Lost to Follow-up|4|||
33192759|NCT03337724|100612550|FG003|Overall Study|Lost to Follow-up|7|||
33192760|NCT03337724|100612551|FG004|Overall Study|Lost to Follow-up|4|||
33192761|NCT03337724|100612547|FG000|Overall Study|Physician Decision|16|||
33192762|NCT03337724|100612548|FG001|Overall Study|Physician Decision|34|||
33192763|NCT03337724|100612549|FG002|Overall Study|Physician Decision|14|||
33192764|NCT03337724|100612550|FG003|Overall Study|Physician Decision|34|||
33192765|NCT03337724|100612551|FG004|Overall Study|Physician Decision|13|||
33192766|NCT03337724|100612547|FG000|Overall Study|Progressive Disease|0|||
33192767|NCT03337724|100612548|FG001|Overall Study|Progressive Disease|2|||
33192768|NCT03337724|100612549|FG002|Overall Study|Progressive Disease|1|||
33192769|NCT03337724|100612550|FG003|Overall Study|Progressive Disease|2|||
33192770|NCT03337724|100612551|FG004|Overall Study|Progressive Disease|0|||
33192771|NCT03337724|100612547|FG000|Overall Study|Symptomatic Deterioration|0|||
33192772|NCT03337724|100612548|FG001|Overall Study|Symptomatic Deterioration|0|||
33310864|NCT00095498|101033574|FG001|Overall Study|Lost to Follow-up|1|||
33192773|NCT03337724|100612549|FG002|Overall Study|Symptomatic Deterioration|0|||
33310865|NCT00095498|101033575|FG002|Overall Study|Lost to Follow-up|2|||
33310866|NCT00095498|101033573|FG000|Overall Study|Noncompliance|1|||
33310867|NCT00095498|101033574|FG001|Overall Study|Noncompliance|0|||
33310868|NCT00095498|101033575|FG002|Overall Study|Noncompliance|1|||
33501513|NCT01623310|101727800|FG000|Overall Study|Protocol Violation|6|||
33501514|NCT01623310|101727800|FG000|Overall Study|Withdrawal by Subject|25|||
33310869|NCT00095498|101033573|FG000|Overall Study|Other|6|||
33310870|NCT00095498|101033574|FG001|Overall Study|Other|7|||
33310871|NCT00095498|101033575|FG002|Overall Study|Other|6|||
33310872|NCT00095498|101033573|FG000|Overall Study|Protocol Violation|0|||
33601923|NCT00907296|102095130|FG002|Overall Study|Adverse Event|0|||
33310873|NCT00095498|101033574|FG001|Overall Study|Protocol Violation|0|||
33310874|NCT00095498|101033575|FG002|Overall Study|Protocol Violation|1|||
33192774|NCT03337724|100612550|FG003|Overall Study|Symptomatic Deterioration|1|||
33192775|NCT03337724|100612551|FG004|Overall Study|Symptomatic Deterioration|0|||
33192776|NCT05009251|100612552|FG000|Overall Study|Protocol Violation|100|||
33192777|NCT05009251|100612553|FG001|Overall Study|Protocol Violation|105|||
33192778|NCT05009251|100612554|FG002|Overall Study|Protocol Violation|119|||
33192779|NCT05009251|100612555|FG003|Overall Study|Protocol Violation|120|||
33192780|NCT05009251|100612556|FG004|Overall Study|Protocol Violation|119|||
33192781|NCT05009251|100612552|FG000|Overall Study|Death|25|||
33192782|NCT05009251|100612553|FG001|Overall Study|Death|22|||
33192783|NCT05009251|100612554|FG002|Overall Study|Death|24|||
33310875|NCT00095498|101033573|FG000|Overall Study|Requirement for alternative therapy|1|||
33310876|NCT00095498|101033574|FG001|Overall Study|Requirement for alternative therapy|0|||
33192784|NCT05009251|100612555|FG003|Overall Study|Death|19|||
33310877|NCT00095498|101033575|FG002|Overall Study|Requirement for alternative therapy|2|||
33601924|NCT00907296|102095131|FG003|Overall Study|Adverse Event|0|||
33310878|NCT02337751|101033576|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
33310879|NCT02337751|101033577|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
33310880|NCT02337751|101033576|FG000|Overall Study|Voluntary Withdrawal|6|||
33310881|NCT02337751|101033577|FG001|Overall Study|Voluntary Withdrawal|8|||
33310882|NCT02337751|101033576|FG000|Overall Study|Lack of Efficacy|2|||
33310883|NCT02337751|101033577|FG001|Overall Study|Lack of Efficacy|5|||
33310884|NCT02337751|101033576|FG000|Overall Study|Investigator's Judgement|1|||
33310885|NCT02337751|101033577|FG001|Overall Study|Investigator's Judgement|0|||
33310886|NCT01315353|101033578|FG000|Overall Study|Death|2|||
33310887|NCT01315353|101033579|FG001|Overall Study|Death|1|||
33310888|NCT01315353|101033580|FG002|Overall Study|Death|0|||
33310889|NCT01315353|101033578|FG000|Overall Study|Withdrawal by Subject|2|||
33310890|NCT01315353|101033579|FG001|Overall Study|Withdrawal by Subject|6|||
33310891|NCT01315353|101033580|FG002|Overall Study|Withdrawal by Subject|1|||
33310892|NCT01315353|101033578|FG000|Overall Study|Lost to Follow-up|13|||
33310893|NCT01315353|101033579|FG001|Overall Study|Lost to Follow-up|6|||
33310894|NCT01315353|101033580|FG002|Overall Study|Lost to Follow-up|6|||
33310895|NCT01315353|101033578|FG000|Overall Study|Unwilling to adhere to requirements|5|||
33394939|NCT03605836|101331932|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
33394940|NCT03605836|101331933|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
33394941|NCT03605836|101331934|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
33394942|NCT03605836|101331935|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
33394943|NCT03605836|101331932|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
33394944|NCT03605836|101331933|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
33394945|NCT03605836|101331934|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
33394946|NCT03605836|101331935|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
33394947|NCT03605836|101331932|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
33394948|NCT03605836|101331933|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
33501515|NCT01623310|101727800|FG000|Overall Study|Became potentially child-bearing|1|||
33501516|NCT01623310|101727800|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
33501517|NCT01623310|101727800|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
33501518|NCT03963232|101727801|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
33501519|NCT03963232|101727802|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
33501520|NCT03963232|101727801|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
33501521|NCT03963232|101727802|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
33501522|NCT03963232|101727801|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
33501523|NCT03963232|101727802|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
33310896|NCT01315353|101033579|FG001|Overall Study|Unwilling to adhere to requirements|5|||
33310897|NCT01315353|101033580|FG002|Overall Study|Unwilling to adhere to requirements|4|||
33310898|NCT01315353|101033578|FG000|Overall Study|Site closing|7|||
33310899|NCT01315353|101033579|FG001|Overall Study|Site closing|4|||
33310900|NCT01315353|101033580|FG002|Overall Study|Site closing|0|||
33310901|NCT01315353|101033578|FG000|Overall Study|Taken off study by site in error|0|||
33310902|NCT01315353|101033579|FG001|Overall Study|Taken off study by site in error|1|||
33310903|NCT01315353|101033580|FG002|Overall Study|Taken off study by site in error|0|||
33310904|NCT01315353|101033578|FG000|Overall Study|Inadvertent randomization/assignment|0|||
33501524|NCT03963232|101727801|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
33501525|NCT03963232|101727802|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
33501526|NCT03963232|101727801|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
33501527|NCT03963232|101727802|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
33501528|NCT03963232|101727801|FG000|Open-Label Treatment Phase|Adverse Event|1|||
33501529|NCT03963232|101727802|FG001|Open-Label Treatment Phase|Adverse Event|2|||
33501530|NCT03963232|101727801|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
33501531|NCT03963232|101727802|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
33501532|NCT03963232|101727801|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
33501533|NCT03963232|101727802|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
33501534|NCT03963232|101727801|FG000|Open-Label Treatment Phase|Pregnancy|1|||
33501535|NCT03963232|101727802|FG001|Open-Label Treatment Phase|Pregnancy|0|||
33501536|NCT03963232|101727801|FG000|Follow-up Phase|Withdrawal by Subject|7|||
33310905|NCT01315353|101033579|FG001|Overall Study|Inadvertent randomization/assignment|0|||
33394949|NCT03605836|101331934|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
33394950|NCT03605836|101331935|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
33501537|NCT03963232|101727802|FG001|Follow-up Phase|Withdrawal by Subject|5|||
33501538|NCT03963232|101727801|FG000|Follow-up Phase|Protocol Violation|0|||
33310906|NCT01315353|101033580|FG002|Overall Study|Inadvertent randomization/assignment|2|||
33310907|NCT01945060|101033585|FG000|Overall Study|Lost to follow up|1|||
33394951|NCT03605836|101331932|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
33394952|NCT03605836|101331933|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
33501539|NCT03963232|101727802|FG001|Follow-up Phase|Protocol Violation|2|||
33501540|NCT03963232|101727801|FG000|Follow-up Phase|Adverse Event|0|||
33501541|NCT03963232|101727802|FG001|Follow-up Phase|Adverse Event|1|||
33501542|NCT03963232|101727801|FG000|Follow-up Phase|Lost to Follow-up|0|||
33501543|NCT03963232|101727802|FG001|Follow-up Phase|Lost to Follow-up|1|||
33501544|NCT01346059|101727806|FG000|Overall Study|Withdrawal by Subject|1|||
33501545|NCT01346059|101727807|FG001|Overall Study|Withdrawal by Subject|0|||
33501546|NCT00083759|101727808|FG000|Overall Study|Adverse Event|5|||
33501547|NCT00083759|101727809|FG001|Overall Study|Adverse Event|3|||
33501548|NCT00083759|101727808|FG000|Overall Study|Lost to Follow-up|1|||
33501549|NCT00083759|101727809|FG001|Overall Study|Lost to Follow-up|0|||
33501550|NCT00083759|101727808|FG000|Overall Study|Death|1|||
33501551|NCT00083759|101727809|FG001|Overall Study|Death|1|||
33601925|NCT00907296|102095132|FG004|Overall Study|Adverse Event|0|||
33601926|NCT00907296|102095133|FG005|Overall Study|Adverse Event|0|||
33601927|NCT00907296|102095134|FG006|Overall Study|Adverse Event|1|||
33601928|NCT00907296|102095135|FG007|Overall Study|Adverse Event|0|||
33601929|NCT00907296|102095136|FG008|Overall Study|Adverse Event|0|||
33601930|NCT00907296|102095137|FG009|Overall Study|Adverse Event|1|||
33310908|NCT01945060|101033586|FG001|Overall Study|Lost to follow up|0|||
33310909|NCT01945060|101033585|FG000|Overall Study|Distress related to IV access|0|||
33310910|NCT01945060|101033586|FG001|Overall Study|Distress related to IV access|1|||
33310911|NCT01435616|101033589|FG000|Overall Study|Adverse Event|39|||
33310912|NCT01435616|101033590|FG001|Overall Study|Adverse Event|21|||
33310913|NCT01435616|101033589|FG000|Overall Study|Death|7|||
33310914|NCT01435616|101033590|FG001|Overall Study|Death|2|||
33310915|NCT01435616|101033589|FG000|Overall Study|Lost to Follow-up|22|||
33310916|NCT01435616|101033590|FG001|Overall Study|Lost to Follow-up|13|||
33310917|NCT01435616|101033589|FG000|Overall Study|Protocol Violation|16|||
33310918|NCT01435616|101033590|FG001|Overall Study|Protocol Violation|13|||
33310919|NCT01435616|101033589|FG000|Overall Study|Withdrawal by Subject|66|||
33310920|NCT01435616|101033590|FG001|Overall Study|Withdrawal by Subject|24|||
33310921|NCT01435616|101033589|FG000|Overall Study|Physician Decision|20|||
33310922|NCT01435616|101033590|FG001|Overall Study|Physician Decision|7|||
33310923|NCT01435616|101033589|FG000|Overall Study|Sponsor Decision|1|||
33310924|NCT01435616|101033590|FG001|Overall Study|Sponsor Decision|0|||
33310925|NCT02831387|101033595|FG000|Overall Study|Withdrawal by Subject|1|||
33310926|NCT02831387|101033596|FG001|Overall Study|Withdrawal by Subject|1|||
33310927|NCT02831387|101033595|FG000|Overall Study|Discontinued due to stock recovery|0|||
33310928|NCT02831387|101033596|FG001|Overall Study|Discontinued due to stock recovery|1|||
33310929|NCT00731120|101033606|FG000|Overall Study|Adverse Event|7|||
33310930|NCT00731120|101033607|FG001|Overall Study|Adverse Event|6|||
33310931|NCT00731120|101033608|FG002|Overall Study|Adverse Event|8|||
33310932|NCT00731120|101033606|FG000|Overall Study|Lack of Efficacy|4|||
33310933|NCT00731120|101033607|FG001|Overall Study|Lack of Efficacy|5|||
33310934|NCT00731120|101033608|FG002|Overall Study|Lack of Efficacy|4|||
33310935|NCT00731120|101033606|FG000|Overall Study|Noncompliance with Study Drug|3|||
33310936|NCT00731120|101033607|FG001|Overall Study|Noncompliance with Study Drug|3|||
33310937|NCT00731120|101033608|FG002|Overall Study|Noncompliance with Study Drug|1|||
33310938|NCT00731120|101033606|FG000|Overall Study|Protocol Deviations|1|||
33310939|NCT00731120|101033607|FG001|Overall Study|Protocol Deviations|6|||
33310940|NCT00731120|101033608|FG002|Overall Study|Protocol Deviations|1|||
33310941|NCT00731120|101033606|FG000|Overall Study|Withdrawal of Consent|13|||
33310942|NCT00731120|101033607|FG001|Overall Study|Withdrawal of Consent|8|||
33310943|NCT00731120|101033608|FG002|Overall Study|Withdrawal of Consent|4|||
33310944|NCT00731120|101033606|FG000|Overall Study|Lost to Follow-up|10|||
33310945|NCT00731120|101033607|FG001|Overall Study|Lost to Follow-up|15|||
33310946|NCT00731120|101033608|FG002|Overall Study|Lost to Follow-up|17|||
33310947|NCT00731120|101033606|FG000|Overall Study|Other|4|||
33310948|NCT00731120|101033607|FG001|Overall Study|Other|0|||
33310949|NCT00731120|101033608|FG002|Overall Study|Other|1|||
33601931|NCT00907296|102095128|FG000|Overall Study|Withdrawal by Subject|7|||
33601932|NCT00907296|102095129|FG001|Overall Study|Withdrawal by Subject|2|||
33601933|NCT00907296|102095130|FG002|Overall Study|Withdrawal by Subject|1|||
33310950|NCT02729753|101033609|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
33310951|NCT02729753|101033610|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
33310952|NCT02730598|101033611|FG000|Overall Study|Withdrawal by Subject|3|||
33310953|NCT02730598|101033612|FG001|Overall Study|Withdrawal by Subject|3|||
33310954|NCT02730598|101033611|FG000|Overall Study|Protocol Violation|0|||
33310955|NCT02730598|101033612|FG001|Overall Study|Protocol Violation|1|||
33310956|NCT02730598|101033611|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
33310957|NCT02730598|101033612|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
33310958|NCT00757588|101033613|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
33310959|NCT00757588|101033614|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
33310960|NCT00757588|101033613|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
33310961|NCT00757588|101033614|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
33310962|NCT00757588|101033613|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
33310963|NCT00757588|101033614|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
33501552|NCT00083759|101727808|FG000|Overall Study|Inadequate Therapeutic Response|32|||
33310964|NCT00757588|101033613|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
33310965|NCT00757588|101033614|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
33310966|NCT00757588|101033613|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
33310967|NCT00757588|101033614|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
33310968|NCT00757588|101033613|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
33310969|NCT00757588|101033614|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
33310970|NCT00757588|101033613|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
33310971|NCT00757588|101033614|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
33310972|NCT00757588|101033613|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
33310973|NCT00757588|101033614|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
33310974|NCT00757588|101033613|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
33310975|NCT00757588|101033614|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
33310976|NCT00757588|101033613|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
33310977|NCT00757588|101033614|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
33310978|NCT00757588|101033613|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
33310979|NCT00757588|101033614|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
33310980|NCT00757588|101033613|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
33310981|NCT00757588|101033614|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
33310982|NCT00757588|101033613|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
33310983|NCT00757588|101033614|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
33310984|NCT00757588|101033613|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
33310985|NCT00757588|101033614|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
33310986|NCT00757588|101033613|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
33310987|NCT00757588|101033614|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
33310988|NCT00757588|101033613|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
33310989|NCT00757588|101033614|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
33310990|NCT02457559|101033615|FG000|Overall Study|Progressive Disease|1|||
33310991|NCT02457559|101033616|FG001|Overall Study|Progressive Disease|2|||
33310992|NCT02457559|101033617|FG002|Overall Study|Progressive Disease|3|||
33310993|NCT02457559|101033618|FG003|Overall Study|Progressive Disease|0|||
33310994|NCT02457559|101033619|FG004|Overall Study|Progressive Disease|0|||
33310995|NCT02457559|101033620|FG005|Overall Study|Progressive Disease|2|||
33310996|NCT02457559|101033621|FG006|Overall Study|Progressive Disease|1|||
33310997|NCT02457559|101033622|FG007|Overall Study|Progressive Disease|0|||
33310998|NCT02457559|101033623|FG008|Overall Study|Progressive Disease|1|||
33310999|NCT02457559|101033624|FG009|Overall Study|Progressive Disease|1|||
33311000|NCT02457559|101033625|FG010|Overall Study|Progressive Disease|1|||
33311001|NCT02457559|101033615|FG000|Overall Study|Investigator's Discretion|0|||
33311002|NCT02457559|101033616|FG001|Overall Study|Investigator's Discretion|0|||
33311003|NCT02457559|101033617|FG002|Overall Study|Investigator's Discretion|2|||
33311004|NCT02457559|101033618|FG003|Overall Study|Investigator's Discretion|0|||
33311005|NCT02457559|101033619|FG004|Overall Study|Investigator's Discretion|1|||
33311006|NCT02457559|101033620|FG005|Overall Study|Investigator's Discretion|0|||
33311007|NCT02457559|101033621|FG006|Overall Study|Investigator's Discretion|1|||
33311008|NCT02457559|101033622|FG007|Overall Study|Investigator's Discretion|0|||
33311009|NCT02457559|101033623|FG008|Overall Study|Investigator's Discretion|1|||
33311010|NCT02457559|101033624|FG009|Overall Study|Investigator's Discretion|0|||
33311011|NCT02457559|101033625|FG010|Overall Study|Investigator's Discretion|1|||
33311012|NCT02457559|101033615|FG000|Overall Study|Adverse Event|0|||
33311013|NCT02457559|101033616|FG001|Overall Study|Adverse Event|1|||
33311014|NCT02457559|101033617|FG002|Overall Study|Adverse Event|2|||
33311015|NCT02457559|101033618|FG003|Overall Study|Adverse Event|0|||
33311016|NCT02457559|101033619|FG004|Overall Study|Adverse Event|0|||
33311017|NCT02457559|101033620|FG005|Overall Study|Adverse Event|0|||
33311018|NCT02457559|101033621|FG006|Overall Study|Adverse Event|0|||
33311019|NCT02457559|101033622|FG007|Overall Study|Adverse Event|0|||
33311020|NCT02457559|101033623|FG008|Overall Study|Adverse Event|0|||
33311021|NCT02457559|101033624|FG009|Overall Study|Adverse Event|0|||
33311022|NCT02457559|101033625|FG010|Overall Study|Adverse Event|0|||
33311023|NCT02457559|101033615|FG000|Overall Study|Reason not Specified|1|||
33311024|NCT02457559|101033616|FG001|Overall Study|Reason not Specified|0|||
33311025|NCT02457559|101033617|FG002|Overall Study|Reason not Specified|0|||
33311026|NCT02457559|101033618|FG003|Overall Study|Reason not Specified|0|||
33311027|NCT02457559|101033619|FG004|Overall Study|Reason not Specified|0|||
33311028|NCT02457559|101033620|FG005|Overall Study|Reason not Specified|0|||
33311029|NCT02457559|101033621|FG006|Overall Study|Reason not Specified|0|||
33311030|NCT02457559|101033622|FG007|Overall Study|Reason not Specified|0|||
33311031|NCT02457559|101033623|FG008|Overall Study|Reason not Specified|0|||
33311032|NCT02457559|101033624|FG009|Overall Study|Reason not Specified|2|||
33311033|NCT02457559|101033625|FG010|Overall Study|Reason not Specified|0|||
33311034|NCT02457559|101033615|FG000|Overall Study|Death|0|||
33311035|NCT02457559|101033616|FG001|Overall Study|Death|0|||
33311036|NCT02457559|101033617|FG002|Overall Study|Death|0|||
33311037|NCT02457559|101033618|FG003|Overall Study|Death|0|||
33501553|NCT00083759|101727809|FG001|Overall Study|Inadequate Therapeutic Response|35|||
33501554|NCT00083759|101727808|FG000|Overall Study|Subject Withdrew Consent|2|||
33501555|NCT00083759|101727809|FG001|Overall Study|Subject Withdrew Consent|2|||
33501556|NCT00083759|101727808|FG000|Overall Study|Non-Compliance|1|||
33311038|NCT02457559|101033619|FG004|Overall Study|Death|0|||
33311039|NCT02457559|101033620|FG005|Overall Study|Death|0|||
33311040|NCT02457559|101033621|FG006|Overall Study|Death|0|||
33311041|NCT02457559|101033622|FG007|Overall Study|Death|0|||
33501557|NCT00083759|101727809|FG001|Overall Study|Non-Compliance|0|||
33501558|NCT00083759|101727808|FG000|Overall Study|Sponsor's Discretion|28|||
33501559|NCT00083759|101727809|FG001|Overall Study|Sponsor's Discretion|29|||
33501560|NCT00083759|101727808|FG000|Overall Study|Other|14|||
33501561|NCT00083759|101727809|FG001|Overall Study|Other|13|||
33501562|NCT00912743|101727810|FG000|Overall Study|Adverse Event|3|||
33501563|NCT00912743|101727811|FG001|Overall Study|Adverse Event|1|||
33501564|NCT00912743|101727810|FG000|Overall Study|Lack of Efficacy|9|||
33501565|NCT00912743|101727811|FG001|Overall Study|Lack of Efficacy|18|||
33501566|NCT00912743|101727810|FG000|Overall Study|Toxicity|0|||
33501567|NCT00912743|101727811|FG001|Overall Study|Toxicity|1|||
33501568|NCT00912743|101727810|FG000|Overall Study|End of treatment form was not collected|1|||
33501569|NCT00912743|101727811|FG001|Overall Study|End of treatment form was not collected|0|||
33501570|NCT01028014|101727813|FG000|Overall Study|Lost to Follow-up|1|||
33501571|NCT01028014|101727814|FG001|Overall Study|Lost to Follow-up|2|||
33501572|NCT01028014|101727815|FG002|Overall Study|Lost to Follow-up|0|||
33501573|NCT01028014|101727816|FG003|Overall Study|Lost to Follow-up|1|||
33501574|NCT01028014|101727817|FG004|Overall Study|Lost to Follow-up|1|||
33501575|NCT01028014|101727818|FG005|Overall Study|Lost to Follow-up|2|||
33501576|NCT02042014|101727820|FG000|Overall Study|Adverse Event|1|||
33501577|NCT02042014|101727820|FG000|Overall Study|Physician Decision|7|||
33501578|NCT02366689|101727821|FG000|Overall Study|Withdrawal by Subject|1|||
33501579|NCT02366689|101727822|FG001|Overall Study|Withdrawal by Subject|0|||
33501580|NCT02366689|101727823|FG002|Overall Study|Withdrawal by Subject|1|||
33501581|NCT02366689|101727821|FG000|Overall Study|Lost to Follow-up|3|||
33501582|NCT02366689|101727822|FG001|Overall Study|Lost to Follow-up|2|||
33501583|NCT02366689|101727823|FG002|Overall Study|Lost to Follow-up|0|||
33501584|NCT02366689|101727821|FG000|Overall Study|Pregnancy|0|||
33501585|NCT02366689|101727822|FG001|Overall Study|Pregnancy|1|||
33501586|NCT02366689|101727823|FG002|Overall Study|Pregnancy|1|||
33501587|NCT00463047|101727824|FG000|Titration Period 1|Adverse Event|10|||
33311042|NCT02457559|101033623|FG008|Overall Study|Death|1|||
33311043|NCT02457559|101033624|FG009|Overall Study|Death|1|||
33311044|NCT02457559|101033625|FG010|Overall Study|Death|0|||
33311045|NCT03737474|101033628|FG000|Overall Study|Adverse Event|18|||
33311046|NCT03737474|101033629|FG001|Overall Study|Adverse Event|48|||
33311047|NCT03737474|101033628|FG000|Overall Study|Lack of Efficacy|1|||
33311048|NCT03737474|101033629|FG001|Overall Study|Lack of Efficacy|3|||
33311049|NCT03737474|101033628|FG000|Overall Study|Protocol Violation|0|||
33311050|NCT03737474|101033629|FG001|Overall Study|Protocol Violation|8|||
33311051|NCT03737474|101033628|FG000|Overall Study|Withdrawal by Subject|5|||
33311052|NCT03737474|101033629|FG001|Overall Study|Withdrawal by Subject|20|||
33311053|NCT03737474|101033628|FG000|Overall Study|Non-compliance With Study Drug|0|||
33311054|NCT03737474|101033629|FG001|Overall Study|Non-compliance With Study Drug|1|||
33311055|NCT03737474|101033628|FG000|Overall Study|Physician Decision|1|||
33311056|NCT03737474|101033629|FG001|Overall Study|Physician Decision|4|||
33311057|NCT02533570|101033632|FG000|Overall Study|Adverse Event|0|||
33501588|NCT00463047|101727825|FG001|Titration Period 1|Adverse Event|8|||
33311058|NCT02533570|101033633|FG001|Overall Study|Adverse Event|1|||
33311059|NCT02533570|101033634|FG002|Overall Study|Adverse Event|1|||
33311060|NCT00158860|101033635|FG000|Overall Study|Adverse Event|3|||
33311061|NCT00158860|101033636|FG001|Overall Study|Adverse Event|6|||
33311062|NCT00158860|101033635|FG000|Overall Study|Lost to Follow-up|11|||
33311063|NCT00158860|101033636|FG001|Overall Study|Lost to Follow-up|17|||
33394953|NCT03605836|101331934|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
33394954|NCT03605836|101331935|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
33501589|NCT00463047|101727824|FG000|Titration Period 1|Lack of Efficacy|10|||
33501590|NCT00463047|101727825|FG001|Titration Period 1|Lack of Efficacy|4|||
33501591|NCT00463047|101727824|FG000|Titration Period 1|Lost to Follow-up|2|||
33501592|NCT00463047|101727825|FG001|Titration Period 1|Lost to Follow-up|0|||
33501593|NCT00463047|101727824|FG000|Titration Period 1|Non-compliance with study medication|3|||
33501594|NCT00463047|101727825|FG001|Titration Period 1|Non-compliance with study medication|5|||
33501595|NCT00463047|101727824|FG000|Titration Period 1|Protocol Violation|5|||
33501596|NCT00463047|101727825|FG001|Titration Period 1|Protocol Violation|5|||
33501597|NCT00463047|101727824|FG000|Titration Period 1|Withdrawal by Subject|3|||
33311064|NCT00158860|101033635|FG000|Overall Study|Protocol Violation|8|||
33311065|NCT00158860|101033636|FG001|Overall Study|Protocol Violation|23|||
33311066|NCT00158860|101033635|FG000|Overall Study|Withdrawal by Subject|7|||
33311067|NCT00158860|101033636|FG001|Overall Study|Withdrawal by Subject|17|||
33311068|NCT00158860|101033635|FG000|Overall Study|MOVING OUT OF STATE|1|||
33501598|NCT00463047|101727825|FG001|Titration Period 1|Withdrawal by Subject|5|||
33501599|NCT00463047|101727824|FG000|Titration Period 1|Non-compliance procedures|4|||
33501600|NCT00463047|101727825|FG001|Titration Period 1|Non-compliance procedures|10|||
33501601|NCT00463047|101727824|FG000|Titration Period 1|Other|0|||
33501602|NCT00463047|101727825|FG001|Titration Period 1|Other|2|||
33501603|NCT00463047|101727824|FG000|Titration Period 2|Adverse Event|9|||
33501604|NCT00463047|101727825|FG001|Titration Period 2|Adverse Event|9|||
33501605|NCT00463047|101727824|FG000|Titration Period 2|Lack of Efficacy|6|||
33311069|NCT00158860|101033636|FG001|Overall Study|MOVING OUT OF STATE|0|||
33311070|NCT00158860|101033635|FG000|Overall Study|Pregnancy|3|||
33311071|NCT00158860|101033636|FG001|Overall Study|Pregnancy|3|||
33311072|NCT00158860|101033635|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
33311073|NCT00158860|101033636|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
33311074|NCT00158860|101033635|FG000|Overall Study|SPONSOR REQUEST|0|||
33311075|NCT00158860|101033636|FG001|Overall Study|SPONSOR REQUEST|1|||
33311076|NCT00158860|101033635|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
33311077|NCT00158860|101033636|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
33311078|NCT00158860|101033635|FG000|Overall Study|Closed per sponsor|0|||
33311079|NCT00158860|101033636|FG001|Overall Study|Closed per sponsor|1|||
33311080|NCT01290315|101033637|FG000|Overall Study|Adverse Event|0|||
33501606|NCT00463047|101727825|FG001|Titration Period 2|Lack of Efficacy|4|||
33501607|NCT00463047|101727824|FG000|Titration Period 2|Withdrawal by Subject|1|||
33311081|NCT01290315|101033638|FG001|Overall Study|Adverse Event|0|||
33501608|NCT00463047|101727825|FG001|Titration Period 2|Withdrawal by Subject|0|||
33501609|NCT00463047|101727824|FG000|Titration Period 2|Protocol Violation|2|||
33501610|NCT00463047|101727825|FG001|Titration Period 2|Protocol Violation|3|||
33501611|NCT00463047|101727824|FG000|Titration Period 2|Lost to Follow-up|1|||
33501612|NCT00463047|101727825|FG001|Titration Period 2|Lost to Follow-up|2|||
33501613|NCT00463047|101727824|FG000|Titration Period 2|Non-compliance study medication|4|||
33501614|NCT00463047|101727825|FG001|Titration Period 2|Non-compliance study medication|2|||
33501615|NCT00463047|101727824|FG000|Titration Period 2|Non-compliance procedures|4|||
33501616|NCT00463047|101727825|FG001|Titration Period 2|Non-compliance procedures|1|||
33501617|NCT00463047|101727824|FG000|Titration Period 2|Other|3|||
33501618|NCT00463047|101727825|FG001|Titration Period 2|Other|2|||
33501619|NCT00463047|101727824|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
33501620|NCT00463047|101727825|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
33501621|NCT00463047|101727824|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
33501622|NCT00463047|101727825|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
33501623|NCT00463047|101727824|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
33501624|NCT00463047|101727825|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
33501625|NCT00463047|101727824|FG000|Double-Blind Treatment Period 1|Other|1|||
33501626|NCT00463047|101727825|FG001|Double-Blind Treatment Period 1|Other|0|||
33501627|NCT00463047|101727824|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
33501628|NCT00463047|101727825|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
33501629|NCT00463047|101727824|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
33501630|NCT00463047|101727825|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
33501631|NCT00463047|101727824|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
33501632|NCT00463047|101727825|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
33501633|NCT03056638|101727826|FG000|Overall Study|Death|1|||
33501634|NCT03056638|101727827|FG001|Overall Study|Death|0|||
33501635|NCT02028767|101727828|FG000|Treatment Period 2|Non compliant with protocol|1|||
33501636|NCT02028767|101727829|FG001|Treatment Period 2|Non compliant with protocol|0|||
33501637|NCT02028767|101727828|FG000|Treatment Period 2|Reason other than those specified above|1|||
33501638|NCT02028767|101727829|FG001|Treatment Period 2|Reason other than those specified above|0|||
33501639|NCT02484456|101727830|FG000|Washout Period|Withdrawal by Subject|0|||
33501640|NCT02484456|101727831|FG001|Washout Period|Withdrawal by Subject|1|||
33501641|NCT02484456|101727830|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
33501642|NCT02484456|101727831|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
33501643|NCT02484456|101727830|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
33501644|NCT02484456|101727831|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
33501645|NCT02484456|101727830|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
33501646|NCT02484456|101727831|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
33501647|NCT00558701|101727834|FG000|Overall Study|Protocol Deviations|1|||
33501648|NCT00558701|101727835|FG001|Overall Study|Protocol Deviations|4|||
33501649|NCT02589626|101727836|FG000|Overall Study|Other than the reason specified|1|||
33192785|NCT05009251|100612556|FG004|Overall Study|Death|15|||
33192786|NCT01800916|100612557|FG000|Test Period 1 (1 Week)|Convex product user|0|||
33192787|NCT01800916|100612558|FG001|Test Period 1 (1 Week)|Convex product user|0|||
33192788|NCT01800916|100612559|FG002|Test Period 1 (1 Week)|Convex product user|0|||
33192789|NCT01800916|100612560|FG003|Test Period 1 (1 Week)|Convex product user|1|||
33501650|NCT02589626|101727837|FG001|Overall Study|Other than the reason specified|0|||
33192790|NCT01800916|100612561|FG004|Test Period 1 (1 Week)|Convex product user|0|||
33311082|NCT01290315|101033639|FG002|Overall Study|Adverse Event|0|||
33311083|NCT01290315|101033640|FG003|Overall Study|Adverse Event|3|||
33501651|NCT02589626|101727836|FG000|Overall Study|Withdrawal by Subject|1|||
33501652|NCT02589626|101727837|FG001|Overall Study|Withdrawal by Subject|1|||
33501653|NCT02589626|101727836|FG000|Overall Study|Adverse Event|1|||
33501654|NCT02589626|101727837|FG001|Overall Study|Adverse Event|1|||
33501655|NCT02068508|101727841|FG000|Overall Study|Case report forms uncollected|27|||
33501656|NCT02068508|101727841|FG000|Overall Study|Patient did not visit the study site|1|||
33501657|NCT02068508|101727841|FG000|Overall Study|Protocol Violation|4|||
33501658|NCT02073929|101727843|FG000|Overall Study|Lost to Follow-up|2|||
33501659|NCT02073929|101727844|FG001|Overall Study|Lost to Follow-up|1|||
33501660|NCT02073929|101727843|FG000|Overall Study|Adverse Event|2|||
33501661|NCT02073929|101727844|FG001|Overall Study|Adverse Event|1|||
33501662|NCT02073929|101727843|FG000|Overall Study|Withdrawal by Subject|0|||
33501663|NCT02073929|101727844|FG001|Overall Study|Withdrawal by Subject|1|||
33501664|NCT02097745|101727845|FG000|Overall Study|Adverse Event|25|||
33501665|NCT02097745|101727845|FG000|Overall Study|Death|16|||
33501666|NCT02097745|101727845|FG000|Overall Study|Failure to Return|14|||
33501667|NCT02097745|101727845|FG000|Overall Study|Administrative/Other|27|||
33501668|NCT02097745|101727845|FG000|Overall Study|Reason Not Specified|96|||
33501669|NCT01435460|101727849|FG000|Overall Study|Adverse Event|2|||
33311084|NCT01290315|101033637|FG000|Overall Study|Selection criteria/compliance|2|||
33311085|NCT01290315|101033638|FG001|Overall Study|Selection criteria/compliance|1|||
33311086|NCT01290315|101033639|FG002|Overall Study|Selection criteria/compliance|0|||
33311087|NCT01290315|101033640|FG003|Overall Study|Selection criteria/compliance|2|||
33311088|NCT01290315|101033637|FG000|Overall Study|Lost to Follow-up|0|||
33311089|NCT01290315|101033638|FG001|Overall Study|Lost to Follow-up|1|||
33311090|NCT01290315|101033639|FG002|Overall Study|Lost to Follow-up|0|||
33311091|NCT01290315|101033640|FG003|Overall Study|Lost to Follow-up|0|||
33311092|NCT01290315|101033637|FG000|Overall Study|Withdrawal by Subject|1|||
33311093|NCT01290315|101033638|FG001|Overall Study|Withdrawal by Subject|1|||
33311094|NCT01290315|101033639|FG002|Overall Study|Withdrawal by Subject|0|||
33311095|NCT01290315|101033640|FG003|Overall Study|Withdrawal by Subject|0|||
33311096|NCT01090427|101033641|FG000|After Controlled Period|Death|0|||
33501670|NCT01435460|101727850|FG001|Overall Study|Adverse Event|1|||
33501671|NCT01435460|101727849|FG000|Overall Study|Lost to Follow-up|6|||
33501672|NCT01435460|101727850|FG001|Overall Study|Lost to Follow-up|1|||
33501673|NCT01435460|101727849|FG000|Overall Study|Withdrawal by Subject|1|||
33501674|NCT01435460|101727850|FG001|Overall Study|Withdrawal by Subject|3|||
33501675|NCT01435460|101727849|FG000|Overall Study|Protocol Violation|0|||
33501676|NCT01435460|101727850|FG001|Overall Study|Protocol Violation|1|||
33501677|NCT01435460|101727849|FG000|Overall Study|Did not meet eligibility criteria|2|||
33501678|NCT01435460|101727850|FG001|Overall Study|Did not meet eligibility criteria|0|||
33501679|NCT01379768|101727851|FG000|Overall Study|Adverse Event|1|||
33501680|NCT01379768|101727852|FG001|Overall Study|Adverse Event|1|||
33501681|NCT01379768|101727853|FG002|Overall Study|Adverse Event|0|||
33501682|NCT01379768|101727851|FG000|Overall Study|Lost to Follow-up|2|||
33501683|NCT01379768|101727852|FG001|Overall Study|Lost to Follow-up|0|||
33501684|NCT01379768|101727853|FG002|Overall Study|Lost to Follow-up|0|||
33501685|NCT02134015|101727856|FG000|Overall Study|Protocol Violation|0|||
33501686|NCT02134015|101727857|FG001|Overall Study|Protocol Violation|1|||
33501687|NCT02134015|101727856|FG000|Overall Study|Death|2|||
33501688|NCT02134015|101727857|FG001|Overall Study|Death|1|||
33501689|NCT02134015|101727856|FG000|Overall Study|Reason not provided|1|||
33501690|NCT02134015|101727857|FG001|Overall Study|Reason not provided|2|||
33501691|NCT02134015|101727856|FG000|Overall Study|Clinical progression|14|||
33501692|NCT02134015|101727857|FG001|Overall Study|Clinical progression|7|||
33501693|NCT02134015|101727856|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
33501694|NCT02134015|101727857|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
33501695|NCT02134015|101727856|FG000|Overall Study|Study terminated by sponsor|2|||
33501696|NCT02134015|101727857|FG001|Overall Study|Study terminated by sponsor|3|||
33501697|NCT02134015|101727856|FG000|Overall Study|Adverse Event|9|||
33601934|NCT00907296|102095131|FG003|Overall Study|Withdrawal by Subject|1|||
33601935|NCT00907296|102095132|FG004|Overall Study|Withdrawal by Subject|1|||
33601936|NCT00907296|102095133|FG005|Overall Study|Withdrawal by Subject|5|||
33601937|NCT00907296|102095134|FG006|Overall Study|Withdrawal by Subject|3|||
33601938|NCT00907296|102095135|FG007|Overall Study|Withdrawal by Subject|2|||
33311097|NCT01090427|101033642|FG001|After Controlled Period|Death|0|||
33501698|NCT02134015|101727857|FG001|Overall Study|Adverse Event|10|||
33501699|NCT02134015|101727856|FG000|Overall Study|Withdrawal by Subject|3|||
33501700|NCT02134015|101727857|FG001|Overall Study|Withdrawal by Subject|7|||
33501701|NCT02589639|101727870|FG000|Overall Study|Lost to Follow-up|1|||
33501702|NCT02589639|101727871|FG001|Overall Study|Lost to Follow-up|0|||
33601939|NCT00907296|102095136|FG008|Overall Study|Withdrawal by Subject|4|||
33311098|NCT01090427|101033643|FG002|After Controlled Period|Death|0|||
33311099|NCT01090427|101033644|FG003|After Controlled Period|Death|0|||
33601940|NCT00907296|102095137|FG009|Overall Study|Withdrawal by Subject|2|||
33501703|NCT02589639|101727872|FG002|Overall Study|Lost to Follow-up|0|||
33311100|NCT01090427|101033645|FG004|After Controlled Period|Death|0|||
33501704|NCT02589639|101727870|FG000|Overall Study|Protocol Violation|1|||
33311101|NCT01090427|101033646|FG005|After Controlled Period|Death|1|||
33311102|NCT01090427|101033647|FG006|After Controlled Period|Death|0|||
33311103|NCT01090427|101033641|FG000|After Controlled Period|Lack of Efficacy|0|||
33311104|NCT01090427|101033642|FG001|After Controlled Period|Lack of Efficacy|0|||
33311105|NCT01090427|101033643|FG002|After Controlled Period|Lack of Efficacy|0|||
33311106|NCT01090427|101033644|FG003|After Controlled Period|Lack of Efficacy|0|||
33311107|NCT01090427|101033645|FG004|After Controlled Period|Lack of Efficacy|0|||
33311108|NCT01090427|101033646|FG005|After Controlled Period|Lack of Efficacy|3|||
33311109|NCT01090427|101033647|FG006|After Controlled Period|Lack of Efficacy|2|||
33311110|NCT01090427|101033641|FG000|After Controlled Period|Adverse Event|0|||
33311111|NCT01090427|101033642|FG001|After Controlled Period|Adverse Event|0|||
33311112|NCT01090427|101033643|FG002|After Controlled Period|Adverse Event|0|||
33311113|NCT01090427|101033644|FG003|After Controlled Period|Adverse Event|2|||
33311114|NCT01090427|101033645|FG004|After Controlled Period|Adverse Event|0|||
33311115|NCT01090427|101033646|FG005|After Controlled Period|Adverse Event|1|||
33311116|NCT01090427|101033647|FG006|After Controlled Period|Adverse Event|0|||
33311117|NCT04161495|101033648|FG000|Overall Study|Withdrawal by Subject|3|||
33311118|NCT04161495|101033649|FG001|Overall Study|Withdrawal by Subject|0|||
33311119|NCT04161495|101033648|FG000|Overall Study|Protocol Violation|1|||
33311120|NCT04161495|101033649|FG001|Overall Study|Protocol Violation|0|||
33311121|NCT04161495|101033648|FG000|Overall Study|Prohibited concomitant medication|3|||
33311122|NCT04161495|101033649|FG001|Overall Study|Prohibited concomitant medication|0|||
33311123|NCT04161495|101033648|FG000|Overall Study|Adverse Event|1|||
33311124|NCT04161495|101033649|FG001|Overall Study|Adverse Event|0|||
33311125|NCT04161495|101033648|FG000|Overall Study|Other - Unspecified|1|||
33311126|NCT04161495|101033649|FG001|Overall Study|Other - Unspecified|0|||
33311127|NCT04161495|101033648|FG000|Overall Study|Death|0|||
33311128|NCT04161495|101033649|FG001|Overall Study|Death|1|||
33311129|NCT00946101|101033651|FG000|Overall Study|Lost to Follow-up|2|||
33311130|NCT00946101|101033652|FG001|Overall Study|Lost to Follow-up|1|||
33311131|NCT00946101|101033651|FG000|Overall Study|Withdrawal of consent|2|||
33311132|NCT00946101|101033652|FG001|Overall Study|Withdrawal of consent|0|||
33311133|NCT00946101|101033651|FG000|Overall Study|Physician Decision|0|||
33311134|NCT00946101|101033652|FG001|Overall Study|Physician Decision|1|||
33311135|NCT02656823|101033657|FG000|Overall Study|Adverse Event|3|||
33311136|NCT02656823|101033657|FG000|Overall Study|Lost to Follow-up|2|||
33311137|NCT01237587|101033658|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
33311138|NCT01237587|101033659|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
33311139|NCT01237587|101033658|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
33311140|NCT01237587|101033659|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
33311141|NCT01237587|101033658|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
33311142|NCT01237587|101033659|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
33311143|NCT01237587|101033658|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
33311144|NCT01237587|101033659|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
33311145|NCT01237587|101033658|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
33311146|NCT01237587|101033659|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
33311147|NCT01237587|101033658|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
33311148|NCT01237587|101033659|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
33311149|NCT01237587|101033658|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
33311150|NCT01237587|101033659|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
33311151|NCT01237587|101033658|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
33311152|NCT01237587|101033659|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
33311153|NCT01237587|101033658|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
33311154|NCT01237587|101033659|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
33311155|NCT01237587|101033658|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
33311156|NCT01237587|101033659|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
33311157|NCT01237587|101033658|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
33311158|NCT01237587|101033659|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
33311159|NCT01237587|101033658|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
33311160|NCT01237587|101033659|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
33311161|NCT01237587|101033658|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
33311162|NCT01237587|101033659|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
33601941|NCT00907296|102095128|FG000|Overall Study|Lost to Follow-up|9|||
33311163|NCT01237587|101033658|FG000|Taper Phase|Adverse Event|0|||
33311164|NCT01237587|101033659|FG001|Taper Phase|Adverse Event|2|||
33311165|NCT01237587|101033658|FG000|Taper Phase|Protocol Violation|2|||
33311166|NCT01237587|101033659|FG001|Taper Phase|Protocol Violation|0|||
33311167|NCT01237587|101033658|FG000|Taper Phase|Lack of Efficacy|2|||
33311168|NCT01237587|101033659|FG001|Taper Phase|Lack of Efficacy|5|||
33311169|NCT01237587|101033658|FG000|Taper Phase|Parent/Guardian Decision|0|||
33311170|NCT01237587|101033659|FG001|Taper Phase|Parent/Guardian Decision|2|||
33311171|NCT01237587|101033658|FG000|Taper Phase|Sponsor Decision|1|||
33601942|NCT00907296|102095129|FG001|Overall Study|Lost to Follow-up|1|||
33501705|NCT02589639|101727871|FG001|Overall Study|Protocol Violation|0|||
33501706|NCT02589639|101727872|FG002|Overall Study|Protocol Violation|0|||
33501707|NCT02589639|101727870|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
33501708|NCT02589639|101727871|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
33501709|NCT02589639|101727872|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
33501710|NCT02589639|101727870|FG000|Overall Study|Adverse Event|4|||
33501711|NCT02589639|101727871|FG001|Overall Study|Adverse Event|5|||
33501712|NCT02589639|101727872|FG002|Overall Study|Adverse Event|3|||
33501713|NCT02589639|101727870|FG000|Overall Study|Other reason than specified above|1|||
33501714|NCT02589639|101727871|FG001|Overall Study|Other reason than specified above|2|||
33501715|NCT02589639|101727872|FG002|Overall Study|Other reason than specified above|1|||
33311172|NCT01237587|101033659|FG001|Taper Phase|Sponsor Decision|0|||
33311173|NCT01237587|101033658|FG000|Taper Phase|Withdrawal by Subject|0|||
33311174|NCT01237587|101033659|FG001|Taper Phase|Withdrawal by Subject|1|||
33311175|NCT00883051|101033660|FG000|Overall Study|Lost to Follow-up|0|||
33311176|NCT00883051|101033661|FG001|Overall Study|Lost to Follow-up|0|||
33311177|NCT00883051|101033662|FG002|Overall Study|Lost to Follow-up|0|||
33311178|NCT00883051|101033663|FG003|Overall Study|Lost to Follow-up|0|||
33311179|NCT00883051|101033664|FG004|Overall Study|Lost to Follow-up|1|||
33311180|NCT00883051|101033660|FG000|Overall Study|Did not use study medication|24|||
33311181|NCT00883051|101033661|FG001|Overall Study|Did not use study medication|22|||
33311182|NCT00883051|101033662|FG002|Overall Study|Did not use study medication|29|||
33311183|NCT00883051|101033663|FG003|Overall Study|Did not use study medication|29|||
33311184|NCT00883051|101033664|FG004|Overall Study|Did not use study medication|17|||
33311185|NCT02962960|101033665|FG000|Overall Study|Withdrawal by Subject|1|||
33311186|NCT02962960|101033666|FG001|Overall Study|Withdrawal by Subject|1|||
33311187|NCT02962960|101033667|FG002|Overall Study|Withdrawal by Subject|0|||
33311188|NCT02962960|101033665|FG000|Overall Study|Adverse Event|1|||
33311189|NCT02962960|101033666|FG001|Overall Study|Adverse Event|1|||
33311190|NCT02962960|101033667|FG002|Overall Study|Adverse Event|0|||
33311191|NCT02962960|101033665|FG000|Overall Study|Protocol Violation|1|||
33311192|NCT02962960|101033666|FG001|Overall Study|Protocol Violation|0|||
33311193|NCT02962960|101033667|FG002|Overall Study|Protocol Violation|0|||
33311194|NCT00545051|101033668|FG000|Overall Study|Adverse Event|7|||
33311195|NCT00545051|101033669|FG001|Overall Study|Adverse Event|3|||
33311196|NCT00545051|101033668|FG000|Overall Study|Death|1|||
33311197|NCT00545051|101033669|FG001|Overall Study|Death|0|||
33311198|NCT00545051|101033668|FG000|Overall Study|Violation of inclusion/exclusion|0|||
33311199|NCT00545051|101033669|FG001|Overall Study|Violation of inclusion/exclusion|2|||
33311200|NCT00545051|101033668|FG000|Overall Study|Protocol Violation|1|||
33311201|NCT00545051|101033669|FG001|Overall Study|Protocol Violation|0|||
33311202|NCT00545051|101033668|FG000|Overall Study|Withdrawal by Subject|0|||
33311203|NCT00545051|101033669|FG001|Overall Study|Withdrawal by Subject|1|||
33311204|NCT00545051|101033668|FG000|Overall Study|Administrative reasons|0|||
33311205|NCT00545051|101033669|FG001|Overall Study|Administrative reasons|1|||
33311206|NCT00424385|101033671|FG000|Cohort 0|Withdrawal by Subject|5|||
33311207|NCT00424385|101033671|FG000|Cohort 0|Physician Decision|1|||
33311208|NCT00424385|101033671|FG000|Cohort 1|Withdrawal by Subject|1|||
33311209|NCT01211288|101033672|FG000|Overall Study|Lost to Follow-up|1|||
33311210|NCT01211288|101033673|FG001|Overall Study|Lost to Follow-up|1|||
33311211|NCT01771107|101033678|FG000|Overall Study|Adverse Event|1|||
33311212|NCT01771107|101033679|FG001|Overall Study|Adverse Event|3|||
33311213|NCT01771107|101033678|FG000|Overall Study|Withdrawal by Subject|0|||
33311214|NCT01771107|101033679|FG001|Overall Study|Withdrawal by Subject|2|||
33311215|NCT01771107|101033678|FG000|Overall Study|Lost to Follow-up|0|||
33311216|NCT01771107|101033679|FG001|Overall Study|Lost to Follow-up|1|||
33311217|NCT01771107|101033678|FG000|Overall Study|participant moved|0|||
33311218|NCT01771107|101033679|FG001|Overall Study|participant moved|1|||
33311219|NCT01771107|101033678|FG000|Overall Study|Other|0|||
33311220|NCT01771107|101033679|FG001|Overall Study|Other|1|||
33311221|NCT00709852|101033682|FG000|Period 1|Adverse Event|2|||
33311222|NCT00709852|101033683|FG001|Period 1|Adverse Event|0|||
33311223|NCT00709852|101033682|FG000|Period 1|Withdrawal by Subject|4|||
33311224|NCT00709852|101033683|FG001|Period 1|Withdrawal by Subject|2|||
33311225|NCT00709852|101033682|FG000|Period 1|Protocol Violation|1|||
33311226|NCT00709852|101033683|FG001|Period 1|Protocol Violation|0|||
33501716|NCT02589639|101727870|FG000|Overall Study|Not Treated|0|||
33501717|NCT02589639|101727871|FG001|Overall Study|Not Treated|3|||
33501718|NCT02589639|101727872|FG002|Overall Study|Not Treated|0|||
33501719|NCT00767455|101727877|FG000|Overall Study|Investigator error|19|||
33311227|NCT00709852|101033682|FG000|Period 1|Defective scanner|0|||
33311228|NCT00709852|101033683|FG001|Period 1|Defective scanner|1|||
33311229|NCT00709852|101033682|FG000|Period 1|Lost to Follow-up|1|||
33311230|NCT00709852|101033683|FG001|Period 1|Lost to Follow-up|0|||
33311231|NCT00709852|101033682|FG000|Period 2|Protocol Violation|4|||
33311232|NCT00709852|101033683|FG001|Period 2|Protocol Violation|1|||
33311233|NCT00709852|101033682|FG000|Period 2|Adverse Event|1|||
33501720|NCT03193853|101727878|FG000|Overall Study|Death|6|||
33311234|NCT00709852|101033683|FG001|Period 2|Adverse Event|1|||
33311235|NCT00709852|101033682|FG000|Period 2|Lost to Follow-up|1|||
33311236|NCT00709852|101033683|FG001|Period 2|Lost to Follow-up|0|||
33311237|NCT00709852|101033682|FG000|Period 2|No 72-hour follow-up|3|||
33311238|NCT00709852|101033683|FG001|Period 2|No 72-hour follow-up|0|||
33311239|NCT00985153|101033684|FG000|Overall Study|Lost to Follow-up|16|||
33311240|NCT00985153|101033685|FG001|Overall Study|Lost to Follow-up|19|||
33311241|NCT00985153|101033686|FG002|Overall Study|Lost to Follow-up|17|||
33311242|NCT00985153|101033687|FG003|Overall Study|Lost to Follow-up|20|||
33311243|NCT00985153|101033684|FG000|Overall Study|Protocol Violation|3|||
33311244|NCT00985153|101033685|FG001|Overall Study|Protocol Violation|2|||
33311245|NCT00985153|101033686|FG002|Overall Study|Protocol Violation|4|||
33311246|NCT00985153|101033687|FG003|Overall Study|Protocol Violation|3|||
33311247|NCT00985153|101033684|FG000|Overall Study|Withdrawal by Subject|6|||
33311248|NCT00985153|101033685|FG001|Overall Study|Withdrawal by Subject|11|||
33311249|NCT00985153|101033686|FG002|Overall Study|Withdrawal by Subject|11|||
33311250|NCT00985153|101033687|FG003|Overall Study|Withdrawal by Subject|10|||
33311251|NCT00985153|101033684|FG000|Overall Study|Missed One or More Bleeds|7|||
33311252|NCT00985153|101033685|FG001|Overall Study|Missed One or More Bleeds|7|||
33311253|NCT00985153|101033686|FG002|Overall Study|Missed One or More Bleeds|8|||
33311254|NCT00985153|101033687|FG003|Overall Study|Missed One or More Bleeds|10|||
33311255|NCT00985153|101033684|FG000|Overall Study|Incomplete Safety Follow-up|3|||
33311256|NCT00985153|101033685|FG001|Overall Study|Incomplete Safety Follow-up|5|||
33311257|NCT00985153|101033686|FG002|Overall Study|Incomplete Safety Follow-up|4|||
33311258|NCT00985153|101033687|FG003|Overall Study|Incomplete Safety Follow-up|4|||
33311259|NCT01209780|101033690|FG000|Overall Study|Adverse Event|0|||
33311260|NCT01209780|101033691|FG001|Overall Study|Adverse Event|1|||
33311261|NCT01209780|101033692|FG002|Overall Study|Adverse Event|0|||
33311262|NCT01209780|101033693|FG003|Overall Study|Adverse Event|0|||
33311263|NCT01209780|101033694|FG004|Overall Study|Adverse Event|0|||
33311264|NCT01209780|101033690|FG000|Overall Study|Withdrawal by Subject|9|||
33311265|NCT01209780|101033691|FG001|Overall Study|Withdrawal by Subject|2|||
33311266|NCT01209780|101033692|FG002|Overall Study|Withdrawal by Subject|1|||
33311267|NCT01209780|101033693|FG003|Overall Study|Withdrawal by Subject|1|||
33311268|NCT01209780|101033694|FG004|Overall Study|Withdrawal by Subject|0|||
33311269|NCT01209780|101033690|FG000|Overall Study|Lost to Follow-up|17|||
33311270|NCT01209780|101033691|FG001|Overall Study|Lost to Follow-up|12|||
33311271|NCT01209780|101033692|FG002|Overall Study|Lost to Follow-up|3|||
33311272|NCT01209780|101033693|FG003|Overall Study|Lost to Follow-up|9|||
33311273|NCT01209780|101033694|FG004|Overall Study|Lost to Follow-up|4|||
33311274|NCT01209780|101033690|FG000|Overall Study|Protocol Violation|0|||
33311275|NCT01209780|101033691|FG001|Overall Study|Protocol Violation|1|||
33311276|NCT01209780|101033692|FG002|Overall Study|Protocol Violation|0|||
33311277|NCT01209780|101033693|FG003|Overall Study|Protocol Violation|0|||
33311278|NCT01209780|101033694|FG004|Overall Study|Protocol Violation|0|||
33311279|NCT01209780|101033690|FG000|Overall Study|Inappropriate enrollment|0|||
33311280|NCT01209780|101033691|FG001|Overall Study|Inappropriate enrollment|2|||
33311281|NCT01209780|101033692|FG002|Overall Study|Inappropriate enrollment|0|||
33311282|NCT01209780|101033693|FG003|Overall Study|Inappropriate enrollment|0|||
33311283|NCT01209780|101033694|FG004|Overall Study|Inappropriate enrollment|1|||
33311284|NCT00055601|101033695|FG000|Overall Study|Protocol Violation|1|||
33311285|NCT00055601|101033696|FG001|Overall Study|Protocol Violation|1|||
33311286|NCT00055601|101033695|FG000|Overall Study|No protocol treatment received|1|||
33311287|NCT00055601|101033696|FG001|Overall Study|No protocol treatment received|1|||
33311288|NCT00848926|101033697|FG000|Treatment Period|Progressive disease|45|||
33311289|NCT00848926|101033697|FG000|Treatment Period|Adverse Event|20|||
33311290|NCT00848926|101033697|FG000|Treatment Period|Physician Decision|12|||
33311291|NCT00848926|101033697|FG000|Treatment Period|Withdrawal by Subject|7|||
33501721|NCT03866512|101727883|FG000|Overall Study|Lost to Follow-up|1|||
33501722|NCT03866512|101727884|FG001|Overall Study|Lost to Follow-up|2|||
33192791|NCT01800916|100612562|FG005|Test Period 1 (1 Week)|Convex product user|0|||
33192792|NCT01800916|100612563|FG006|Test Period 1 (1 Week)|Convex product user|0|||
33311292|NCT00848926|101033697|FG000|Follow-up Period|Lost to Follow-up|7|||
33311293|NCT00848926|101033697|FG000|Follow-up Period|Withdrawal by Subject|3|||
33311294|NCT00848926|101033697|FG000|Follow-up Period|Other|2|||
33311295|NCT03169101|101033698|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
33311296|NCT03169101|101033699|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
33311297|NCT03169101|101033700|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
33311298|NCT03169101|101033701|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
33311299|NCT01773291|101033702|FG000|Overall Study|Protocol Violation|1|||
33311300|NCT01773291|101033703|FG001|Overall Study|Protocol Violation|0|||
33311301|NCT01773291|101033704|FG002|Overall Study|Protocol Violation|0|||
33311302|NCT01773291|101033702|FG000|Overall Study|Withdrawal by Subject|0|||
33311303|NCT01773291|101033703|FG001|Overall Study|Withdrawal by Subject|0|||
33311304|NCT01773291|101033704|FG002|Overall Study|Withdrawal by Subject|1|||
33311305|NCT03562247|101033708|FG000|Overall Study|Lost to Follow-up|3|||
33311306|NCT03562247|101033709|FG001|Overall Study|Lost to Follow-up|1|||
33311307|NCT03562247|101033710|FG002|Overall Study|Lost to Follow-up|1|||
33311308|NCT02217332|101033715|FG000|Overall Study|Adverse Event|3|||
33601943|NCT00907296|102095130|FG002|Overall Study|Lost to Follow-up|0|||
33601944|NCT00907296|102095131|FG003|Overall Study|Lost to Follow-up|2|||
33601945|NCT00907296|102095132|FG004|Overall Study|Lost to Follow-up|0|||
33601946|NCT00907296|102095133|FG005|Overall Study|Lost to Follow-up|3|||
33601947|NCT00907296|102095134|FG006|Overall Study|Lost to Follow-up|2|||
33601948|NCT00907296|102095135|FG007|Overall Study|Lost to Follow-up|2|||
33601949|NCT00907296|102095136|FG008|Overall Study|Lost to Follow-up|0|||
33601950|NCT00907296|102095137|FG009|Overall Study|Lost to Follow-up|4|||
33601951|NCT01672866|102095142|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
33601952|NCT01672866|102095143|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
33601953|NCT01672866|102095144|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
33601954|NCT01672866|102095142|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
33601955|NCT01672866|102095143|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
33601956|NCT01672866|102095144|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
33601957|NCT01672866|102095142|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
33601958|NCT01672866|102095143|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
33601959|NCT01672866|102095144|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
33601960|NCT01672866|102095142|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
33601961|NCT01672866|102095143|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
33601962|NCT01672866|102095144|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
33601963|NCT01672866|102095142|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
33601964|NCT01672866|102095143|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
33601965|NCT01672866|102095144|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
33601966|NCT01672866|102095142|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
33601967|NCT01672866|102095143|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
33601968|NCT01672866|102095144|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
33601969|NCT01672866|102095142|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
33601970|NCT01672866|102095143|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
33601971|NCT01672866|102095144|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
33601972|NCT01672866|102095142|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
33394955|NCT03605836|101331932|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
33394956|NCT03605836|101331933|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
33394957|NCT03605836|101331934|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
33394958|NCT03605836|101331935|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
33394959|NCT03605836|101331932|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
33394960|NCT03605836|101331933|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
33394961|NCT03605836|101331934|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
33394962|NCT03605836|101331935|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
33394963|NCT03605836|101331932|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
33501723|NCT03866512|101727885|FG002|Overall Study|Lost to Follow-up|1|||
33601973|NCT01672866|102095143|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
33601974|NCT01672866|102095144|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
33601975|NCT01672866|102095142|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
33601976|NCT01672866|102095143|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
33601977|NCT01672866|102095144|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
33601978|NCT01672866|102095142|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
33601979|NCT01672866|102095143|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
33601980|NCT01672866|102095144|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
33601981|NCT01672866|102095142|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
33601982|NCT01672866|102095143|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
33601983|NCT01672866|102095144|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
33601984|NCT01672866|102095142|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
33601985|NCT01672866|102095143|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
33601986|NCT01672866|102095144|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
33601987|NCT01672866|102095142|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
33601988|NCT01672866|102095143|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
33601989|NCT01672866|102095144|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
33601990|NCT02634606|102095145|FG000|Overall Study|unable to obtain the drug at start|13|||
33394964|NCT03605836|101331933|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
33501724|NCT03866512|101727883|FG000|Overall Study|Cannulation issues|0|||
33501725|NCT03866512|101727884|FG001|Overall Study|Cannulation issues|1|||
33501726|NCT03866512|101727885|FG002|Overall Study|Cannulation issues|2|||
33501727|NCT01218087|101727890|FG000|Overall Study|Death|2|||
33501728|NCT01218087|101727891|FG001|Overall Study|Death|1|||
33501729|NCT01218087|101727890|FG000|Overall Study|Withdrawal by Subject|5|||
33501730|NCT01218087|101727891|FG001|Overall Study|Withdrawal by Subject|0|||
33501731|NCT01218087|101727890|FG000|Overall Study|Transferred|8|||
33501732|NCT01218087|101727891|FG001|Overall Study|Transferred|5|||
33501733|NCT04537234|101727895|FG000|Overall Study|Withdrawal by Subject|2|||
33501734|NCT04537234|101727896|FG001|Overall Study|Withdrawal by Subject|0|||
33311309|NCT02217332|101033715|FG000|Overall Study|Dose interruption >1 month|1|||
33311310|NCT02217332|101033715|FG000|Overall Study|Protocol Violation (eligibility)|1|||
33311311|NCT02217332|101033715|FG000|Overall Study|Withdrawal by Subject|1|||
33311312|NCT02217332|101033715|FG000|Overall Study|Lost to Follow-up|1|||
33311313|NCT01877837|101033716|FG000|Overall Study|Lost to Follow-up|1|||
33311314|NCT01877837|101033716|FG000|Overall Study|Ineligible|4|||
33311315|NCT01813929|101033717|FG000|Overall Study|Withdrawal by Subject|0|||
33311316|NCT01813929|101033718|FG001|Overall Study|Withdrawal by Subject|1|||
33311317|NCT00705679|101033719|FG000|Overall Study|Adverse Event|1|||
33311318|NCT00705679|101033720|FG001|Overall Study|Adverse Event|1|||
33311319|NCT00705679|101033721|FG002|Overall Study|Adverse Event|0|||
33311320|NCT00705679|101033722|FG003|Overall Study|Adverse Event|0|||
33311321|NCT00705679|101033723|FG004|Overall Study|Adverse Event|0|||
33311322|NCT00705679|101033719|FG000|Overall Study|Death|0|||
33311323|NCT00705679|101033720|FG001|Overall Study|Death|0|||
33311324|NCT00705679|101033721|FG002|Overall Study|Death|3|||
33311325|NCT00705679|101033722|FG003|Overall Study|Death|2|||
33311326|NCT00705679|101033723|FG004|Overall Study|Death|1|||
33311327|NCT00705679|101033719|FG000|Overall Study|Lost to Follow-up|32|||
33311328|NCT00705679|101033720|FG001|Overall Study|Lost to Follow-up|60|||
33311329|NCT00705679|101033721|FG002|Overall Study|Lost to Follow-up|44|||
33311330|NCT00705679|101033722|FG003|Overall Study|Lost to Follow-up|30|||
33311331|NCT00705679|101033723|FG004|Overall Study|Lost to Follow-up|35|||
33311332|NCT00705679|101033719|FG000|Overall Study|Physician Decision|0|||
33311333|NCT00705679|101033720|FG001|Overall Study|Physician Decision|1|||
33311334|NCT00705679|101033721|FG002|Overall Study|Physician Decision|0|||
33311335|NCT00705679|101033722|FG003|Overall Study|Physician Decision|1|||
33311336|NCT00705679|101033723|FG004|Overall Study|Physician Decision|0|||
33311337|NCT00705679|101033719|FG000|Overall Study|Withdrawal by Subject|32|||
33311338|NCT00705679|101033720|FG001|Overall Study|Withdrawal by Subject|77|||
33311339|NCT00705679|101033721|FG002|Overall Study|Withdrawal by Subject|68|||
33311340|NCT00705679|101033722|FG003|Overall Study|Withdrawal by Subject|47|||
33311341|NCT00705679|101033723|FG004|Overall Study|Withdrawal by Subject|33|||
33311342|NCT02407990|101033724|FG000|Overall Study|Death|2|||
33311343|NCT02407990|101033725|FG001|Overall Study|Death|22|||
33311344|NCT02407990|101033726|FG002|Overall Study|Death|23|||
33311345|NCT02407990|101033727|FG003|Overall Study|Death|7|||
33311346|NCT02407990|101033728|FG004|Overall Study|Death|17|||
33311347|NCT02407990|101033729|FG005|Overall Study|Death|16|||
33311348|NCT02407990|101033730|FG006|Overall Study|Death|10|||
33311349|NCT02407990|101033731|FG007|Overall Study|Death|248|||
33311350|NCT02407990|101033724|FG000|Overall Study|Lost to Follow-up|0|||
33311351|NCT02407990|101033725|FG001|Overall Study|Lost to Follow-up|1|||
33311352|NCT02407990|101033726|FG002|Overall Study|Lost to Follow-up|0|||
33311353|NCT02407990|101033727|FG003|Overall Study|Lost to Follow-up|0|||
33311354|NCT02407990|101033728|FG004|Overall Study|Lost to Follow-up|0|||
33311355|NCT02407990|101033729|FG005|Overall Study|Lost to Follow-up|0|||
33311356|NCT02407990|101033730|FG006|Overall Study|Lost to Follow-up|0|||
33311357|NCT02407990|101033731|FG007|Overall Study|Lost to Follow-up|17|||
33311358|NCT02407990|101033724|FG000|Overall Study|Progressive Disease|0|||
33311359|NCT02407990|101033725|FG001|Overall Study|Progressive Disease|0|||
33311360|NCT02407990|101033726|FG002|Overall Study|Progressive Disease|0|||
33311361|NCT02407990|101033727|FG003|Overall Study|Progressive Disease|0|||
33311362|NCT02407990|101033728|FG004|Overall Study|Progressive Disease|0|||
33311363|NCT02407990|101033729|FG005|Overall Study|Progressive Disease|0|||
33311364|NCT02407990|101033730|FG006|Overall Study|Progressive Disease|0|||
33311365|NCT02407990|101033731|FG007|Overall Study|Progressive Disease|1|||
33311366|NCT02407990|101033724|FG000|Overall Study|Withdrawal by Subject|0|||
33311367|NCT02407990|101033725|FG001|Overall Study|Withdrawal by Subject|0|||
33311368|NCT02407990|101033726|FG002|Overall Study|Withdrawal by Subject|0|||
33311369|NCT02407990|101033727|FG003|Overall Study|Withdrawal by Subject|0|||
33311370|NCT02407990|101033728|FG004|Overall Study|Withdrawal by Subject|1|||
33311371|NCT02407990|101033729|FG005|Overall Study|Withdrawal by Subject|0|||
33311372|NCT02407990|101033730|FG006|Overall Study|Withdrawal by Subject|0|||
33311373|NCT02407990|101033731|FG007|Overall Study|Withdrawal by Subject|30|||
33311374|NCT02407990|101033724|FG000|Overall Study|Study Terminated by Sponsor|1|||
33311375|NCT02407990|101033725|FG001|Overall Study|Study Terminated by Sponsor|3|||
33311376|NCT02407990|101033726|FG002|Overall Study|Study Terminated by Sponsor|3|||
33311377|NCT02407990|101033727|FG003|Overall Study|Study Terminated by Sponsor|0|||
33311378|NCT02407990|101033728|FG004|Overall Study|Study Terminated by Sponsor|3|||
33311379|NCT02407990|101033729|FG005|Overall Study|Study Terminated by Sponsor|4|||
33311380|NCT02407990|101033730|FG006|Overall Study|Study Terminated by Sponsor|3|||
33311381|NCT02407990|101033731|FG007|Overall Study|Study Terminated by Sponsor|37|||
33311382|NCT02407990|101033724|FG000|Overall Study|Logistics|0|||
33311383|NCT02407990|101033725|FG001|Overall Study|Logistics|0|||
33311384|NCT02407990|101033726|FG002|Overall Study|Logistics|0|||
33311385|NCT02407990|101033727|FG003|Overall Study|Logistics|0|||
33311386|NCT02407990|101033728|FG004|Overall Study|Logistics|0|||
33311387|NCT02407990|101033729|FG005|Overall Study|Logistics|0|||
33311388|NCT02407990|101033730|FG006|Overall Study|Logistics|0|||
33311389|NCT02407990|101033731|FG007|Overall Study|Logistics|1|||
33311390|NCT02407990|101033724|FG000|Overall Study|Rolled into long-term extension study|0|||
33311391|NCT02407990|101033725|FG001|Overall Study|Rolled into long-term extension study|0|||
33311392|NCT02407990|101033726|FG002|Overall Study|Rolled into long-term extension study|0|||
33311393|NCT02407990|101033727|FG003|Overall Study|Rolled into long-term extension study|0|||
33311394|NCT02407990|101033728|FG004|Overall Study|Rolled into long-term extension study|0|||
33311395|NCT02407990|101033729|FG005|Overall Study|Rolled into long-term extension study|0|||
33311396|NCT02407990|101033730|FG006|Overall Study|Rolled into long-term extension study|0|||
33311397|NCT02407990|101033731|FG007|Overall Study|Rolled into long-term extension study|1|||
33311398|NCT02288247|101033736|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|52|||
33311399|NCT02288247|101033737|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Adverse Event|0|||
33311400|NCT02288247|101033736|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Death|35|||
33311401|NCT02288247|101033737|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Death|0|||
33311402|NCT02288247|101033736|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|1|||
33311403|NCT02288247|101033737|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Lost to Follow-up|0|||
33311404|NCT02288247|101033736|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|392|||
33311405|NCT02288247|101033737|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Progressive Disease|0|||
33311406|NCT02288247|101033736|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|9|||
33311407|NCT02288247|101033737|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Protocol Violation|0|||
33311408|NCT02288247|101033736|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|52|||
33311409|NCT02288247|101033737|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Withdrawal by Subject|0|||
33311410|NCT02288247|101033736|FG000|Period 1: OL Treatment (Max: 315 Weeks)|Other|106|||
33311411|NCT02288247|101033737|FG001|Period 1: OL Treatment (Max: 315 Weeks)|Other|0|||
33311412|NCT02288247|101033736|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
33311413|NCT02288247|101033737|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
33311414|NCT02288247|101033736|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
33311415|NCT02288247|101033737|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
33311416|NCT02288247|101033736|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
33311417|NCT02288247|101033737|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
33311418|NCT02288247|101033736|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
33311419|NCT02288247|101033737|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
33311420|NCT02288247|101033736|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
33311421|NCT02288247|101033737|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
33311422|NCT02288247|101033736|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
33311423|NCT02288247|101033737|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
33311424|NCT02288247|101033736|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|20|||
33311425|NCT02288247|101033737|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
33311426|NCT02288247|101033736|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
33311427|NCT02288247|101033737|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
33311428|NCT03730480|101033738|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
33311429|NCT01296347|101033739|FG000|Allocation|Withdrawal by Subject|1|||
33311430|NCT01296347|101033740|FG001|Allocation|Withdrawal by Subject|2|||
33311431|NCT01296347|101033739|FG000|Allocation|Lack of Efficacy|1|||
33311432|NCT01296347|101033740|FG001|Allocation|Lack of Efficacy|2|||
33311433|NCT01296347|101033739|FG000|Allocation|not received infusion|1|||
33311434|NCT01296347|101033740|FG001|Allocation|not received infusion|0|||
33311435|NCT01296347|101033739|FG000|6 Week Follow up|Death|0|||
33311436|NCT01296347|101033740|FG001|6 Week Follow up|Death|1|||
33311437|NCT01296347|101033739|FG000|3 Month Follow up|Death|1|||
33311438|NCT01296347|101033740|FG001|3 Month Follow up|Death|0|||
33311439|NCT01296347|101033739|FG000|3 Month Follow up|Lost to Follow-up|0|||
33311440|NCT01296347|101033740|FG001|3 Month Follow up|Lost to Follow-up|1|||
33311441|NCT01296347|101033739|FG000|6 Month Follow up|Death|2|||
33311442|NCT01296347|101033740|FG001|6 Month Follow up|Death|1|||
33192793|NCT01800916|100612564|FG007|Test Period 1 (1 Week)|Convex product user|0|||
33192794|NCT01800916|100612565|FG008|Test Period 1 (1 Week)|Convex product user|0|||
33192795|NCT01800916|100612557|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
33311443|NCT01296347|101033739|FG000|6 Month Follow up|Lost to Follow-up|0|||
33311444|NCT01296347|101033740|FG001|6 Month Follow up|Lost to Follow-up|1|||
33311445|NCT01296347|101033739|FG000|12 Month Follow up|Lost to Follow-up|3|||
33311446|NCT01296347|101033740|FG001|12 Month Follow up|Lost to Follow-up|1|||
33311447|NCT01296347|101033739|FG000|12 Month Follow up|Death|1|||
33311448|NCT01296347|101033740|FG001|12 Month Follow up|Death|1|||
33311449|NCT01296347|101033739|FG000|12 Month Follow up|Withdrawal by Subject|0|||
33311450|NCT01296347|101033740|FG001|12 Month Follow up|Withdrawal by Subject|1|||
33311451|NCT03625895|101033741|FG000|Overall Study|Protocol Violation|585|||
33311452|NCT00591721|101033742|FG000|Overall Study|Withdrawal by Subject|10|||
33311453|NCT00591721|101033743|FG001|Overall Study|Withdrawal by Subject|10|||
33311454|NCT00591721|101033742|FG000|Overall Study|Lost to Follow-up|1|||
33311455|NCT00591721|101033743|FG001|Overall Study|Lost to Follow-up|4|||
33311456|NCT00591721|101033742|FG000|Overall Study|Intervention not received|10|||
33311457|NCT00591721|101033743|FG001|Overall Study|Intervention not received|8|||
33311458|NCT00836095|101033744|FG000|Overall Study|Physician Decision|0|||
33311459|NCT00836095|101033745|FG001|Overall Study|Physician Decision|3|||
33311460|NCT03567434|101033747|FG000|Overall Study|Lost to Follow-up|1|||
33311461|NCT03567434|101033748|FG001|Overall Study|Lost to Follow-up|3|||
33311462|NCT00986674|101033752|FG000|Overall Study|Lack of Efficacy|28|||
33311463|NCT00986674|101033753|FG001|Overall Study|Lack of Efficacy|25|||
33311464|NCT00986674|101033754|FG002|Overall Study|Lack of Efficacy|23|||
33501735|NCT03319732|101727897|FG000|Overall Study|Adverse Event|40|||
33501736|NCT03319732|101727897|FG000|Overall Study|Withdrawal by Subject|50|||
33311465|NCT00986674|101033752|FG000|Overall Study|Adverse Event|4|||
33311466|NCT00986674|101033753|FG001|Overall Study|Adverse Event|8|||
33311467|NCT00986674|101033754|FG002|Overall Study|Adverse Event|9|||
33311468|NCT00986674|101033752|FG000|Overall Study|Death|5|||
33311469|NCT00986674|101033753|FG001|Overall Study|Death|0|||
33311470|NCT00986674|101033754|FG002|Overall Study|Death|4|||
33311471|NCT00986674|101033752|FG000|Overall Study|Withdrawal by Subject|6|||
33311472|NCT00986674|101033753|FG001|Overall Study|Withdrawal by Subject|2|||
33311473|NCT00986674|101033754|FG002|Overall Study|Withdrawal by Subject|1|||
33311474|NCT00986674|101033752|FG000|Overall Study|alternative therapy|0|||
33311475|NCT00986674|101033753|FG001|Overall Study|alternative therapy|0|||
33311476|NCT00986674|101033754|FG002|Overall Study|alternative therapy|1|||
33311477|NCT00986674|101033752|FG000|Overall Study|not start protocol therapy|4|||
33311478|NCT00986674|101033753|FG001|Overall Study|not start protocol therapy|3|||
33311479|NCT00986674|101033754|FG002|Overall Study|not start protocol therapy|1|||
33311480|NCT00986674|101033752|FG000|Overall Study|unknown/not specify|0|||
33311481|NCT00986674|101033753|FG001|Overall Study|unknown/not specify|7|||
33311482|NCT00986674|101033754|FG002|Overall Study|unknown/not specify|9|||
33311483|NCT02572882|101037329|FG000|Overall Study|Withdrawal by Subject|1|||
33311484|NCT02572882|101037329|FG000|Overall Study|Participant received kidney transplant|1|||
33601991|NCT05590000|102095146|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
33601992|NCT00748709|102095147|FG000|Overall Study|Progressive disease|15|||
33601993|NCT00748709|102095147|FG000|Overall Study|Drug reducing Toxity|2|||
33601994|NCT00748709|102095147|FG000|Overall Study|Other Adverse Event|1|||
33601995|NCT00748709|102095147|FG000|Overall Study|Withdrawal by Subject|1|||
33601996|NCT00748709|102095147|FG000|Overall Study|Other Reasons|1|||
33601997|NCT00787202|102095148|FG000|Overall Study|Adverse Event|3|||
33601998|NCT00787202|102095149|FG001|Overall Study|Adverse Event|2|||
33601999|NCT00787202|102095150|FG002|Overall Study|Adverse Event|0|||
33602000|NCT00787202|102095151|FG003|Overall Study|Adverse Event|0|||
33602001|NCT00787202|102095152|FG004|Overall Study|Adverse Event|2|||
33602002|NCT00787202|102095148|FG000|Overall Study|Lack of Efficacy|5|||
33602003|NCT00787202|102095149|FG001|Overall Study|Lack of Efficacy|6|||
33602004|NCT00787202|102095150|FG002|Overall Study|Lack of Efficacy|5|||
33602005|NCT00787202|102095151|FG003|Overall Study|Lack of Efficacy|2|||
33602006|NCT00787202|102095152|FG004|Overall Study|Lack of Efficacy|1|||
33602007|NCT00787202|102095148|FG000|Overall Study|Lost to Follow-up|1|||
33602008|NCT00787202|102095149|FG001|Overall Study|Lost to Follow-up|0|||
33602009|NCT00787202|102095150|FG002|Overall Study|Lost to Follow-up|0|||
33602010|NCT00787202|102095151|FG003|Overall Study|Lost to Follow-up|0|||
33602011|NCT00787202|102095152|FG004|Overall Study|Lost to Follow-up|0|||
33602012|NCT00787202|102095148|FG000|Overall Study|Withdrawal by Subject|2|||
33602013|NCT00787202|102095149|FG001|Overall Study|Withdrawal by Subject|2|||
33602014|NCT00787202|102095150|FG002|Overall Study|Withdrawal by Subject|2|||
33602015|NCT00787202|102095151|FG003|Overall Study|Withdrawal by Subject|0|||
33602016|NCT00787202|102095152|FG004|Overall Study|Withdrawal by Subject|0|||
33602017|NCT00787202|102095148|FG000|Overall Study|Protocol Violation|2|||
33602018|NCT00787202|102095149|FG001|Overall Study|Protocol Violation|1|||
33192796|NCT01800916|100612558|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
33192797|NCT01800916|100612559|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
33602019|NCT00787202|102095150|FG002|Overall Study|Protocol Violation|0|||
33602020|NCT00787202|102095151|FG003|Overall Study|Protocol Violation|0|||
33602021|NCT00787202|102095152|FG004|Overall Study|Protocol Violation|1|||
33602022|NCT00787202|102095148|FG000|Overall Study|Randomized, not treated|1|||
33602023|NCT00787202|102095149|FG001|Overall Study|Randomized, not treated|0|||
33602024|NCT00787202|102095150|FG002|Overall Study|Randomized, not treated|0|||
33602025|NCT00787202|102095151|FG003|Overall Study|Randomized, not treated|0|||
33602026|NCT00787202|102095152|FG004|Overall Study|Randomized, not treated|0|||
33602027|NCT00316693|102095153|FG000|Overall Study|Adverse Event|6|||
33192798|NCT01800916|100612560|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
33192799|NCT01800916|100612561|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
33192800|NCT01800916|100612562|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
33192801|NCT01800916|100612563|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
33192802|NCT01800916|100612564|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
33192803|NCT01800916|100612565|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
33602028|NCT00316693|102095154|FG001|Overall Study|Adverse Event|1|||
33602029|NCT00316693|102095153|FG000|Overall Study|Protocol Violation|1|||
33602030|NCT00316693|102095154|FG001|Overall Study|Protocol Violation|0|||
33602031|NCT00316693|102095153|FG000|Overall Study|Withdrawal by Subject|6|||
33192804|NCT02223767|100612566|FG000|Overall Study|Withdrawal by Subject|4|||
33192805|NCT02223767|100612567|FG001|Overall Study|Withdrawal by Subject|4|||
33192806|NCT00678691|100612568|FG000|Overall Study|Adverse Event|6|||
33192807|NCT00678691|100612569|FG001|Overall Study|Adverse Event|4|||
33311485|NCT03541174|101037338|FG000|Part 1 Double-Blind|Adverse Event|6|||
33311486|NCT03541174|101037339|FG001|Part 1 Double-Blind|Adverse Event|5|||
33602032|NCT00316693|102095154|FG001|Overall Study|Withdrawal by Subject|6|||
33602033|NCT00316693|102095153|FG000|Overall Study|Lost to Follow-up|26|||
33602034|NCT00316693|102095154|FG001|Overall Study|Lost to Follow-up|34|||
33311487|NCT03541174|101037340|FG002|Part 1 Double-Blind|Adverse Event|2|||
33311488|NCT03541174|101037341|FG003|Part 1 Double-Blind|Adverse Event|0|||
33311489|NCT03541174|101037342|FG004|Part 1 Double-Blind|Adverse Event|0|||
33311490|NCT03541174|101037343|FG005|Part 1 Double-Blind|Adverse Event|0|||
33192808|NCT00145509|100612570|FG000|Overall Study|Adverse Event|10|||
33192809|NCT00145509|100612571|FG001|Overall Study|Adverse Event|3|||
33192810|NCT00145509|100612570|FG000|Overall Study|Lack of Efficacy|3|||
33192811|NCT00145509|100612571|FG001|Overall Study|Lack of Efficacy|1|||
33192812|NCT00145509|100612570|FG000|Overall Study|Lost to Follow-up|5|||
33192813|NCT00145509|100612571|FG001|Overall Study|Lost to Follow-up|9|||
33192814|NCT00145509|100612570|FG000|Overall Study|Withdrew Consent|2|||
33501737|NCT03319732|101727897|FG000|Overall Study|MS relapse|10|||
33501738|NCT03319732|101727897|FG000|Overall Study|reason not specified|5|||
33501739|NCT02914613|101727898|FG000|Overall Study|Withdrawal by Subject|1|||
33501740|NCT02914613|101727899|FG001|Overall Study|Withdrawal by Subject|2|||
33501741|NCT02914613|101727898|FG000|Overall Study|Adverse Event|1|||
33501742|NCT02914613|101727899|FG001|Overall Study|Adverse Event|0|||
33501743|NCT03382834|101730849|FG000|Step 1|Lost to Follow-up|0|||
33501744|NCT03382834|101730850|FG001|Step 1|Lost to Follow-up|1|||
33501745|NCT03382834|101730849|FG000|Step 2|Death|1|||
33501746|NCT03382834|101730850|FG001|Step 2|Death|0|||
33501747|NCT03382834|101730849|FG000|Step 2|Lost to Follow-up|2|||
33501748|NCT03382834|101730850|FG001|Step 2|Lost to Follow-up|2|||
33501749|NCT03382834|101730849|FG000|Step 2|Site Terminated by Sponsor|1|||
33501750|NCT03382834|101730850|FG001|Step 2|Site Terminated by Sponsor|0|||
33501751|NCT04013672|101730851|FG000|Overall Study|Withdrawal by Subject|3|||
33602035|NCT00316693|102095153|FG000|Overall Study|Other|38|||
33602036|NCT00316693|102095154|FG001|Overall Study|Other|44|||
33192815|NCT00145509|100612571|FG001|Overall Study|Withdrew Consent|7|||
33192816|NCT00145509|100612570|FG000|Overall Study|Reason not provided|2|||
33192817|NCT00145509|100612571|FG001|Overall Study|Reason not provided|1|||
33192818|NCT02052739|100612574|FG000|Overall Study|Withdrew due to Adverse Event|3|||
33192819|NCT02052739|100612575|FG001|Overall Study|Withdrew due to Adverse Event|0|||
33192820|NCT02052739|100612574|FG000|Overall Study|Participant Died|2|||
33192821|NCT02052739|100612575|FG001|Overall Study|Participant Died|1|||
33192822|NCT01866709|100612576|FG000|Overall Study|Adverse Event|1|||
33192823|NCT01866709|100612577|FG001|Overall Study|Adverse Event|0|||
33192824|NCT01976845|100612580|FG000|Overall Study|Physician Decision|8|||
33192825|NCT01976845|100612581|FG001|Overall Study|Physician Decision|8|||
33192826|NCT01976845|100612582|FG002|Overall Study|Physician Decision|3|||
33192827|NCT02118428|100612583|FG000|Overall Study|Physician Decision|0|||
33192828|NCT02118428|100612584|FG001|Overall Study|Physician Decision|1|||
33192829|NCT02118428|100612585|FG002|Overall Study|Physician Decision|0|||
33192830|NCT02118428|100612583|FG000|Overall Study|Withdrawal by Subject|2|||
33192831|NCT02118428|100612584|FG001|Overall Study|Withdrawal by Subject|2|||
33192832|NCT02118428|100612585|FG002|Overall Study|Withdrawal by Subject|0|||
33311491|NCT03541174|101037338|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
33311492|NCT03541174|101037339|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
33311493|NCT03541174|101037340|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
33192833|NCT02118428|100612583|FG000|Overall Study|Death|7|||
33192834|NCT02118428|100612584|FG001|Overall Study|Death|5|||
33192835|NCT02118428|100612585|FG002|Overall Study|Death|0|||
33192836|NCT02118428|100612583|FG000|Overall Study|Lost to Follow-up|3|||
33192837|NCT02118428|100612584|FG001|Overall Study|Lost to Follow-up|1|||
33192838|NCT02118428|100612585|FG002|Overall Study|Lost to Follow-up|0|||
33192839|NCT02118428|100612583|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
33192840|NCT02118428|100612584|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
33192841|NCT02118428|100612585|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
33192842|NCT00779675|100612589|FG000|Treatment Period|Adverse Event|87|||
33192843|NCT00779675|100612589|FG000|Treatment Period|Treatment Failure|80|||
33192844|NCT00779675|100612589|FG000|Treatment Period|Transferred to Another Study|38|||
33192845|NCT00779675|100612589|FG000|Treatment Period|Lost to Follow-up|23|||
33192846|NCT00779675|100612589|FG000|Treatment Period|Withdrawal by Subject|46|||
33192847|NCT00779675|100612589|FG000|Treatment Period|Protocol Violation|54|||
33192848|NCT00779675|100612589|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
33192849|NCT00779675|100612589|FG000|Treatment Period|Administrative|3|||
33192850|NCT00779675|100612589|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
33192851|NCT00779675|100612589|FG000|Extended Treatment Period|Protocol Violation|13|||
33192852|NCT00779675|100612589|FG000|Extended Treatment Period|Adverse Event|6|||
33192853|NCT00779675|100612589|FG000|Extended Treatment Period|Treatment Failure|11|||
33311494|NCT03541174|101037341|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
33192854|NCT00779675|100612589|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
33192855|NCT00779675|100612589|FG000|Extended Treatment Period|Lost to Follow-up|6|||
33311495|NCT03541174|101037342|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
33501752|NCT04013672|101730852|FG001|Overall Study|Withdrawal by Subject|0|||
33501753|NCT04013672|101730851|FG000|Overall Study|Death|1|||
33501754|NCT04013672|101730852|FG001|Overall Study|Death|0|||
33501755|NCT04013672|101730851|FG000|Overall Study|Physician Decision|5|||
33192856|NCT01988571|100612590|FG000|Overall Study|Death|3|||
33192857|NCT01988571|100612591|FG001|Overall Study|Death|1|||
33311496|NCT03541174|101037343|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
33501756|NCT04013672|101730852|FG001|Overall Study|Physician Decision|0|||
33602037|NCT01048866|102095155|FG000|Overall Study|Adverse Event|1|||
33192858|NCT01988571|100612590|FG000|Overall Study|Physician Decision|2|||
33192859|NCT01988571|100612591|FG001|Overall Study|Physician Decision|1|||
33192860|NCT01988571|100612590|FG000|Overall Study|Lost to Follow-up|3|||
33192861|NCT01988571|100612591|FG001|Overall Study|Lost to Follow-up|0|||
33192862|NCT01988571|100612590|FG000|Overall Study|Withdrawal by Subject|31|||
33192863|NCT01988571|100612591|FG001|Overall Study|Withdrawal by Subject|33|||
33192864|NCT03459196|100612592|FG000|Overall Study|Subject didn't receive study catheter|2|||
33192865|NCT01545817|100612593|FG000|Pazopanib|Disease progression|51|||
33192866|NCT01545817|100612594|FG001|Pazopanib|Disease progression|0|||
33192867|NCT01545817|100612593|FG000|Pazopanib|Adverse Event|19|||
33192868|NCT01545817|100612594|FG001|Pazopanib|Adverse Event|0|||
33192869|NCT01545817|100612593|FG000|Pazopanib|Other reason|4|||
33192870|NCT01545817|100612594|FG001|Pazopanib|Other reason|0|||
33192871|NCT01545817|100612593|FG000|Everolimus|Other reason|0|||
33192872|NCT01545817|100612594|FG001|Everolimus|Other reason|7|||
33192873|NCT01545817|100612593|FG000|Everolimus|Disease progression|0|||
33192874|NCT01545817|100612594|FG001|Everolimus|Disease progression|25|||
33192875|NCT01545817|100612593|FG000|Everolimus|Adverse Event|0|||
33192876|NCT01545817|100612594|FG001|Everolimus|Adverse Event|6|||
33192877|NCT01573624|100612595|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
33192878|NCT01573624|100612596|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
33192879|NCT01573624|100612597|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
33192880|NCT01573624|100612598|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
33192881|NCT01573624|100612599|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
33192882|NCT01573624|100612600|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
33192883|NCT01573624|100612601|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
33192884|NCT01573624|100612595|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
33192885|NCT01573624|100612596|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
33192886|NCT01573624|100612597|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
33192887|NCT01573624|100612598|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
33192888|NCT01573624|100612599|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
33192889|NCT01573624|100612600|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
33192890|NCT01573624|100612601|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
33192891|NCT01573624|100612595|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
33192892|NCT01573624|100612596|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
33192893|NCT01573624|100612597|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
33192894|NCT01573624|100612598|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
33192895|NCT01573624|100612599|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
33192896|NCT01573624|100612600|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
33192897|NCT01573624|100612601|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
33192898|NCT01573624|100612595|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33192899|NCT01573624|100612596|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33192900|NCT01573624|100612597|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33192901|NCT01573624|100612598|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33192902|NCT01573624|100612599|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33192903|NCT01573624|100612600|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
33192904|NCT01573624|100612601|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33192905|NCT01573624|100612595|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
33192906|NCT01573624|100612596|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
33192907|NCT01573624|100612597|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
33192908|NCT01573624|100612598|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
33192909|NCT01573624|100612599|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
33192910|NCT01573624|100612600|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
33192911|NCT01573624|100612601|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
33192912|NCT01573624|100612595|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
33192913|NCT01573624|100612596|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
33192914|NCT01573624|100612597|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
33192915|NCT01573624|100612598|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
33192916|NCT01573624|100612599|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
33192917|NCT01573624|100612600|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
33192918|NCT01573624|100612601|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
33192919|NCT01573624|100612595|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
33311497|NCT03541174|101037338|FG000|Part 1 Double-Blind|Other reasons|3|||
33311498|NCT03541174|101037339|FG001|Part 1 Double-Blind|Other reasons|2|||
33311499|NCT03541174|101037340|FG002|Part 1 Double-Blind|Other reasons|3|||
33501757|NCT00410813|101730853|FG000|Overall Study|Adverse Event|6|||
33192920|NCT01573624|100612596|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
33311500|NCT03541174|101037341|FG003|Part 1 Double-Blind|Other reasons|0|||
33192921|NCT01573624|100612597|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
33192922|NCT01573624|100612598|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
33192923|NCT01573624|100612599|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
33192924|NCT01573624|100612600|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
33192925|NCT01573624|100612601|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
33192926|NCT01573624|100612595|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
33192927|NCT01573624|100612596|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33192928|NCT01573624|100612597|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
33192929|NCT01573624|100612598|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
33501758|NCT00410813|101730854|FG001|Overall Study|Adverse Event|11|||
33192930|NCT01573624|100612599|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33192931|NCT01573624|100612600|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33192932|NCT01573624|100612601|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33192933|NCT01573624|100612595|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
33192934|NCT01573624|100612596|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
33192935|NCT01573624|100612597|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
33192936|NCT01573624|100612598|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
33192937|NCT01573624|100612599|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
33192938|NCT01573624|100612600|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
33192939|NCT01573624|100612601|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
33192940|NCT01573624|100612595|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33192941|NCT01573624|100612596|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33192942|NCT01573624|100612597|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33192943|NCT01573624|100612598|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
33192944|NCT01573624|100612599|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33192945|NCT01573624|100612600|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33192946|NCT01573624|100612601|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
33192947|NCT01573624|100612595|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
33192948|NCT01573624|100612596|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
33394965|NCT03605836|101331934|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
33394966|NCT03605836|101331935|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
33501759|NCT00410813|101730853|FG000|Overall Study|Progression|32|||
33501760|NCT00410813|101730854|FG001|Overall Study|Progression|21|||
33501761|NCT00410813|101730853|FG000|Overall Study|Not protocol specified|3|||
33501762|NCT00410813|101730854|FG001|Overall Study|Not protocol specified|4|||
33501763|NCT00410813|101730853|FG000|Overall Study|Ineligible|2|||
33501764|NCT00410813|101730854|FG001|Overall Study|Ineligible|4|||
33501765|NCT00410813|101730853|FG000|Overall Study|Death|0|||
33501766|NCT00410813|101730854|FG001|Overall Study|Death|2|||
33501767|NCT02748213|101730855|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
33501768|NCT02748213|101730856|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
33501769|NCT02748213|101730855|FG000|Overall Study|Abnormal Laboratory Test|1|||
33501770|NCT02748213|101730856|FG001|Overall Study|Abnormal Laboratory Test|0|||
33501771|NCT02748213|101730855|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
33501772|NCT02748213|101730856|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
33501773|NCT02748213|101730855|FG000|Overall Study|Death|5|||
33501774|NCT02748213|101730856|FG001|Overall Study|Death|3|||
33501775|NCT02748213|101730855|FG000|Overall Study|Insufficient Therapeutic Response|56|||
33501776|NCT02748213|101730856|FG001|Overall Study|Insufficient Therapeutic Response|57|||
33501777|NCT02748213|101730855|FG000|Overall Study|Violation of Selection Criteria|2|||
33501778|NCT02748213|101730856|FG001|Overall Study|Violation of Selection Criteria|0|||
33501779|NCT02748213|101730855|FG000|Overall Study|Protocol Violation|6|||
33501780|NCT02748213|101730856|FG001|Overall Study|Protocol Violation|4|||
33501781|NCT02748213|101730855|FG000|Overall Study|Refused Treatment*|6|||
33501782|NCT02748213|101730856|FG001|Overall Study|Refused Treatment*|6|||
33501783|NCT02748213|101730855|FG000|Overall Study|Failure to Return|1|||
33501784|NCT02748213|101730856|FG001|Overall Study|Failure to Return|0|||
33501785|NCT02748213|101730855|FG000|Overall Study|Other|30|||
33501786|NCT02748213|101730856|FG001|Overall Study|Other|29|||
33501787|NCT00326716|101730857|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
33501788|NCT00326716|101730858|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
33501789|NCT00326716|101730859|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
33501790|NCT00326716|101730860|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
33501791|NCT02858583|101730863|FG000|Overall Study|Declined consent|1|||
33501792|NCT02858583|101730864|FG001|Overall Study|Declined consent|1|||
33501793|NCT03476187|101730865|FG000|Overall Study|Protocol Violation|7|||
33501794|NCT03476187|101730865|FG000|Overall Study|Physician Decision|5|||
33602038|NCT01048866|102095156|FG001|Overall Study|Adverse Event|0|||
33192949|NCT01573624|100612597|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
33501795|NCT05047211|101730866|FG000|Overall Study|Lost to Follow-up|8|||
33501796|NCT05047211|101730867|FG001|Overall Study|Lost to Follow-up|5|||
33501797|NCT01288937|101730868|FG000|Overall Study|Adverse Event|1|||
33501798|NCT01288937|101730869|FG001|Overall Study|Adverse Event|0|||
33501799|NCT00454246|101730872|FG000|Overall Study|Adverse Event|2|||
33501800|NCT00454246|101730873|FG001|Overall Study|Adverse Event|2|||
33501801|NCT00454246|101730874|FG002|Overall Study|Adverse Event|0|||
33501802|NCT00454246|101730872|FG000|Overall Study|Violation of selection criteria at entry|6|||
33501803|NCT00454246|101730873|FG001|Overall Study|Violation of selection criteria at entry|0|||
33501804|NCT00454246|101730874|FG002|Overall Study|Violation of selection criteria at entry|0|||
33501805|NCT00454246|101730872|FG000|Overall Study|Protocol Violation|1|||
33501806|NCT00454246|101730873|FG001|Overall Study|Protocol Violation|0|||
33501807|NCT00454246|101730874|FG002|Overall Study|Protocol Violation|0|||
33501808|NCT00454246|101730872|FG000|Overall Study|Refused Treatment|1|||
33501809|NCT00454246|101730873|FG001|Overall Study|Refused Treatment|1|||
33501810|NCT00454246|101730874|FG002|Overall Study|Refused Treatment|0|||
33501811|NCT00454246|101730872|FG000|Overall Study|Failure to return|1|||
33501812|NCT00454246|101730873|FG001|Overall Study|Failure to return|0|||
33501813|NCT00454246|101730874|FG002|Overall Study|Failure to return|0|||
33501814|NCT00454246|101730872|FG000|Overall Study|Early termination of study|62|||
33501815|NCT00454246|101730873|FG001|Overall Study|Early termination of study|26|||
33501816|NCT00454246|101730874|FG002|Overall Study|Early termination of study|9|||
33501817|NCT02473250|101730875|FG000|Overall Study|Lost to Follow-up|10|||
33501818|NCT02473250|101730875|FG000|Overall Study|Physician Decision|5|||
33501819|NCT02473250|101730875|FG000|Overall Study|Did not tolerate medication washout|3|||
33501820|NCT02473250|101730875|FG000|Overall Study|Antidepressant effect of divalproex|2|||
33501821|NCT03482453|101730876|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33501822|NCT03482453|101730877|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33501823|NCT03482453|101730878|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33501824|NCT03482453|101730879|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33501825|NCT03482453|101730880|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33501826|NCT03482453|101730881|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33501827|NCT03482453|101730882|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33501828|NCT03482453|101730883|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33501829|NCT03482453|101730884|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33501830|NCT03482453|101730885|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33501831|NCT03482453|101730886|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
33501832|NCT03482453|101730887|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
33501833|NCT01019694|101730889|FG000|Overall Study|Adverse Event|12|||
33501834|NCT01019694|101730890|FG001|Overall Study|Adverse Event|16|||
33501835|NCT01019694|101730891|FG002|Overall Study|Adverse Event|19|||
33501836|NCT01019694|101730889|FG000|Overall Study|Protocol Violation|2|||
33501837|NCT01019694|101730890|FG001|Overall Study|Protocol Violation|6|||
33602039|NCT01048866|102095155|FG000|Overall Study|Protocol Violation|1|||
33602040|NCT01048866|102095156|FG001|Overall Study|Protocol Violation|0|||
33602041|NCT01048866|102095155|FG000|Overall Study|Physician Decision|1|||
33602042|NCT01048866|102095156|FG001|Overall Study|Physician Decision|0|||
33602043|NCT01048866|102095155|FG000|Overall Study|Withdrawal by Subject|0|||
33602044|NCT01048866|102095156|FG001|Overall Study|Withdrawal by Subject|2|||
33602045|NCT01048866|102095155|FG000|Overall Study|Lost to Follow-up|0|||
33602046|NCT01048866|102095156|FG001|Overall Study|Lost to Follow-up|2|||
33602047|NCT01048866|102095155|FG000|Overall Study|Other|1|||
33602048|NCT01048866|102095156|FG001|Overall Study|Other|1|||
33602049|NCT01541917|102095157|FG000|Overall Study|Lost to Follow-up|2|||
33602050|NCT01541917|102095158|FG001|Overall Study|Lost to Follow-up|2|||
33602051|NCT01541917|102095157|FG000|Overall Study|Withdrawal by Subject|13|||
33311501|NCT03541174|101037342|FG004|Part 1 Double-Blind|Other reasons|0|||
33311502|NCT03541174|101037343|FG005|Part 1 Double-Blind|Other reasons|0|||
33311503|NCT03541174|101037338|FG000|Part 2 Single-Blind|Adverse Event|0|||
33311504|NCT03541174|101037339|FG001|Part 2 Single-Blind|Adverse Event|0|||
33311505|NCT03541174|101037340|FG002|Part 2 Single-Blind|Adverse Event|0|||
33311506|NCT03541174|101037341|FG003|Part 2 Single-Blind|Adverse Event|25|||
33311507|NCT03541174|101037342|FG004|Part 2 Single-Blind|Adverse Event|0|||
33501838|NCT01019694|101730891|FG002|Overall Study|Protocol Violation|4|||
33501839|NCT01019694|101730889|FG000|Overall Study|Lost to Follow-up|5|||
33501840|NCT01019694|101730890|FG001|Overall Study|Lost to Follow-up|3|||
33602052|NCT01541917|102095158|FG001|Overall Study|Withdrawal by Subject|7|||
33602053|NCT01009346|102095161|FG000|Overall Study|Adverse Event|4|||
33311508|NCT03541174|101037343|FG005|Part 2 Single-Blind|Adverse Event|0|||
33394967|NCT03605836|101331932|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
33501841|NCT01019694|101730891|FG002|Overall Study|Lost to Follow-up|3|||
33501842|NCT01019694|101730889|FG000|Overall Study|Withdrawal by Subject|4|||
33602054|NCT00707746|102095179|FG000|Treatment Period|Adverse Event|2|||
33602055|NCT00707746|102095180|FG001|Treatment Period|Adverse Event|4|||
33602056|NCT00707746|102095179|FG000|Treatment Period|Ineligibility|0|||
33311509|NCT03541174|101037338|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
33501843|NCT01019694|101730890|FG001|Overall Study|Withdrawal by Subject|6|||
33501844|NCT01019694|101730891|FG002|Overall Study|Withdrawal by Subject|12|||
33501845|NCT01019694|101730889|FG000|Overall Study|Not treated|0|||
33501846|NCT01019694|101730890|FG001|Overall Study|Not treated|2|||
33501847|NCT01019694|101730891|FG002|Overall Study|Not treated|3|||
33501848|NCT01019694|101730889|FG000|Overall Study|Other reason (not specified)|1|||
33501849|NCT01019694|101730890|FG001|Overall Study|Other reason (not specified)|5|||
33501850|NCT01019694|101730891|FG002|Overall Study|Other reason (not specified)|6|||
33501851|NCT00302328|101730901|FG000|Overall Study|Physician Decision|0|||
33192950|NCT01573624|100612598|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
33501852|NCT00302328|101730902|FG001|Overall Study|Physician Decision|1|||
33501853|NCT00302328|101730903|FG002|Overall Study|Physician Decision|0|||
33501854|NCT02476578|101730907|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
33501855|NCT02476578|101730908|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
33501856|NCT02476578|101730907|FG000|Overall Study|Lost to Follow-up|6|||
33501857|NCT02476578|101730908|FG001|Overall Study|Lost to Follow-up|13|||
33501858|NCT00833105|101730910|FG000|Overall Study|Withdrawal by Subject|1|||
33501859|NCT00833105|101730910|FG000|Overall Study|Adverse Event|2|||
33501860|NCT02920008|101730912|FG000|Overall Study|Death|117|||
33501861|NCT02920008|101730913|FG001|Overall Study|Death|127|||
33501862|NCT02920008|101730912|FG000|Overall Study|Withdrawal by Subject|3|||
33501863|NCT02920008|101730913|FG001|Overall Study|Withdrawal by Subject|6|||
33501864|NCT02920008|101730912|FG000|Overall Study|Lost to Follow-up|0|||
33501865|NCT02920008|101730913|FG001|Overall Study|Lost to Follow-up|1|||
33501866|NCT01470248|101730918|FG000|Overall Study|Withdrawal by Subject|1|||
33501867|NCT02844933|101730924|FG000|Overall Study|Discontinued due to premature termination of study|3|||
33501868|NCT02844933|101730925|FG001|Overall Study|Discontinued due to premature termination of study|2|||
33501869|NCT01209949|101730929|FG000|Overall Study|Lost to Follow-up|3|||
33501870|NCT00658723|101730930|FG000|Overall Study|Lost to Follow-up|0|||
33501871|NCT00658723|101730931|FG001|Overall Study|Lost to Follow-up|2|||
33501872|NCT00658723|101730932|FG002|Overall Study|Lost to Follow-up|2|||
33501873|NCT00658723|101730930|FG000|Overall Study|Death|2|||
33501874|NCT00658723|101730931|FG001|Overall Study|Death|1|||
33501875|NCT00658723|101730932|FG002|Overall Study|Death|4|||
33501876|NCT00658723|101730930|FG000|Overall Study|Scheduling Issue|1|||
33501877|NCT00658723|101730931|FG001|Overall Study|Scheduling Issue|1|||
33501878|NCT00658723|101730932|FG002|Overall Study|Scheduling Issue|0|||
33501879|NCT00658723|101730930|FG000|Overall Study|Withdrawal by Subject|1|||
33501880|NCT00658723|101730931|FG001|Overall Study|Withdrawal by Subject|0|||
33501881|NCT00658723|101730932|FG002|Overall Study|Withdrawal by Subject|1|||
33501882|NCT00356603|101730936|FG000|Overall Study|Other|6|||
33501883|NCT00356603|101730937|FG001|Overall Study|Other|3|||
33501884|NCT00492648|101730938|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
33501885|NCT00492648|101730939|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
33501886|NCT01483027|101730943|FG000|Overall Study|Administrative Reasons|2|||
33501887|NCT01483027|101730944|FG001|Overall Study|Administrative Reasons|1|||
33501888|NCT01483027|101730943|FG000|Overall Study|Withdrawal by Subject|21|||
33501889|NCT01483027|101730944|FG001|Overall Study|Withdrawal by Subject|32|||
33501890|NCT01483027|101730943|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
33501891|NCT01483027|101730944|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
33501892|NCT01483027|101730943|FG000|Overall Study|Lost to Follow-up|1|||
33501893|NCT01483027|101730944|FG001|Overall Study|Lost to Follow-up|1|||
33501894|NCT01483027|101730943|FG000|Overall Study|Adverse Event|0|||
33501895|NCT01483027|101730944|FG001|Overall Study|Adverse Event|1|||
33501896|NCT01483027|101730943|FG000|Overall Study|Withdrawal by Subject|0|||
33501897|NCT01483027|101730944|FG001|Overall Study|Withdrawal by Subject|1|||
33192951|NCT01573624|100612599|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
33192952|NCT01573624|100612600|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
33192953|NCT01573624|100612601|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
33192954|NCT01573624|100612595|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
33192955|NCT01573624|100612596|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
33501898|NCT02406027|101730954|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
33602057|NCT00707746|102095180|FG001|Treatment Period|Ineligibility|1|||
33192956|NCT01573624|100612597|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
33501899|NCT02406027|101730955|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
33501900|NCT02406027|101730956|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
33501901|NCT02406027|101730957|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
33501902|NCT02406027|101730958|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
33602058|NCT00844805|102095181|FG000|Treatment Phase|Adverse Event|5|||
33501903|NCT02406027|101730959|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
33501904|NCT02406027|101730960|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
33192957|NCT01573624|100612598|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
33192958|NCT01573624|100612599|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
33501905|NCT02406027|101730954|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
33501906|NCT02406027|101730955|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
33501907|NCT02406027|101730956|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
33501908|NCT02406027|101730957|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
33501909|NCT02406027|101730958|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
33501910|NCT02406027|101730959|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
33501911|NCT02406027|101730960|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
33501912|NCT02406027|101730954|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
33501913|NCT02406027|101730955|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
33501914|NCT02406027|101730956|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
33501915|NCT02406027|101730957|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
33501916|NCT02406027|101730958|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
33501917|NCT02406027|101730959|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
33501918|NCT02406027|101730960|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
33501919|NCT02406027|101730954|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
33501920|NCT02406027|101730955|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
33501921|NCT02406027|101730956|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
33501922|NCT02406027|101730957|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
33501923|NCT02406027|101730958|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
33501924|NCT02406027|101730959|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
33501925|NCT02406027|101730960|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
33311510|NCT03541174|101037339|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
33311511|NCT03541174|101037340|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
33311512|NCT03541174|101037341|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
33311513|NCT03541174|101037342|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
33311514|NCT03541174|101037343|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
33311515|NCT03541174|101037338|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
33311516|NCT03541174|101037339|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
33311517|NCT03541174|101037340|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
33311518|NCT03541174|101037341|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
33311519|NCT03541174|101037342|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
33311520|NCT03541174|101037343|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
33311521|NCT03541174|101037338|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
33311522|NCT03541174|101037339|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
33311523|NCT03541174|101037340|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
33311524|NCT03541174|101037341|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
33501926|NCT02406027|101730954|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
33501927|NCT02406027|101730955|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
33501928|NCT02406027|101730956|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
33501929|NCT02406027|101730957|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
33501930|NCT02406027|101730958|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
33501931|NCT02406027|101730959|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
33501932|NCT02406027|101730960|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
33501933|NCT02406027|101730954|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
33501934|NCT02406027|101730955|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
33501935|NCT02406027|101730956|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
33501936|NCT02406027|101730957|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
33501937|NCT02406027|101730958|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
33501938|NCT02406027|101730959|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
33501939|NCT02406027|101730960|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
33501940|NCT02406027|101730954|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
33501941|NCT02406027|101730955|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
33501942|NCT02406027|101730956|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
33501943|NCT02406027|101730957|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
33501944|NCT02406027|101730958|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
33192959|NCT01573624|100612600|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
33192960|NCT01573624|100612601|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
33192961|NCT01573624|100612595|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
33192962|NCT01573624|100612596|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
33192963|NCT01573624|100612597|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
33311525|NCT03541174|101037342|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
33311526|NCT03541174|101037343|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
33311527|NCT03541174|101037338|FG000|Part 2 Single-Blind|Death|0|||
33311528|NCT03541174|101037339|FG001|Part 2 Single-Blind|Death|0|||
33311529|NCT03541174|101037340|FG002|Part 2 Single-Blind|Death|0|||
33311530|NCT03541174|101037341|FG003|Part 2 Single-Blind|Death|5|||
33311531|NCT03541174|101037342|FG004|Part 2 Single-Blind|Death|0|||
33192964|NCT01573624|100612598|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
33192965|NCT01573624|100612599|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
33311532|NCT03541174|101037343|FG005|Part 2 Single-Blind|Death|0|||
33311533|NCT03541174|101037338|FG000|Part 2 Single-Blind|Pregnancy|0|||
33311534|NCT03541174|101037339|FG001|Part 2 Single-Blind|Pregnancy|0|||
33311535|NCT03541174|101037340|FG002|Part 2 Single-Blind|Pregnancy|0|||
33311536|NCT03541174|101037341|FG003|Part 2 Single-Blind|Pregnancy|1|||
33311537|NCT03541174|101037342|FG004|Part 2 Single-Blind|Pregnancy|0|||
33311538|NCT03541174|101037343|FG005|Part 2 Single-Blind|Pregnancy|0|||
33311539|NCT03541174|101037338|FG000|Part 2 Single-Blind|Other reasons|0|||
33311540|NCT03541174|101037339|FG001|Part 2 Single-Blind|Other reasons|0|||
33311541|NCT03541174|101037340|FG002|Part 2 Single-Blind|Other reasons|0|||
33311542|NCT03541174|101037341|FG003|Part 2 Single-Blind|Other reasons|32|||
33311543|NCT03541174|101037342|FG004|Part 2 Single-Blind|Other reasons|0|||
33311544|NCT03541174|101037343|FG005|Part 2 Single-Blind|Other reasons|0|||
33311545|NCT03541174|101037338|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
33311546|NCT03541174|101037339|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
33311547|NCT03541174|101037340|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
33311548|NCT03541174|101037341|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
33311549|NCT03541174|101037342|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
33394968|NCT03605836|101331933|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
33501945|NCT02406027|101730959|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
33501946|NCT02406027|101730960|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
33501947|NCT02406027|101730954|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
33501948|NCT02406027|101730955|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
33501949|NCT02406027|101730956|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
33501950|NCT02406027|101730957|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
33501951|NCT02406027|101730958|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
33501952|NCT02406027|101730959|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
33501953|NCT02406027|101730960|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
33501954|NCT02406027|101730954|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
33501955|NCT02406027|101730955|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
33192966|NCT01573624|100612600|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
33192967|NCT01573624|100612601|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
33192968|NCT01573624|100612595|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
33192969|NCT01573624|100612596|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
33192970|NCT01573624|100612597|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
33192971|NCT01573624|100612598|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
33192972|NCT01573624|100612599|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
33192973|NCT01573624|100612600|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
33192974|NCT01573624|100612601|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
33192975|NCT01573624|100612595|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33192976|NCT01573624|100612596|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
33192977|NCT01573624|100612597|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
33192978|NCT01573624|100612598|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33192979|NCT01573624|100612599|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33192980|NCT01573624|100612600|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
33192981|NCT01573624|100612601|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33192982|NCT01573624|100612595|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
33192983|NCT01573624|100612596|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
33192984|NCT01573624|100612597|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
33192985|NCT01573624|100612598|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
33192986|NCT01573624|100612599|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
33192987|NCT01573624|100612600|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
33192988|NCT01573624|100612601|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
33192989|NCT01573624|100612595|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
33192990|NCT01573624|100612596|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
33192991|NCT01573624|100612597|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
33192992|NCT01573624|100612598|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
33192993|NCT01573624|100612599|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
33192994|NCT01573624|100612600|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
33192995|NCT01573624|100612601|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
33192996|NCT01573624|100612595|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
33311550|NCT03541174|101037343|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
33311551|NCT03541174|101037338|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
33394969|NCT03605836|101331934|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
33311552|NCT03541174|101037339|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
33501956|NCT02406027|101730956|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
33501957|NCT02406027|101730957|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
33501958|NCT02406027|101730958|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
33501959|NCT02406027|101730959|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
33501960|NCT02406027|101730960|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
33501961|NCT02406027|101730954|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
33501962|NCT02406027|101730955|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
33501963|NCT02406027|101730956|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
33501964|NCT02406027|101730957|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
33501965|NCT02406027|101730958|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
33501966|NCT02406027|101730959|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
33501967|NCT02406027|101730960|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
33501968|NCT04463251|101730965|FG000|Overall Study|Death|1|||
33501969|NCT04463251|101730966|FG001|Overall Study|Death|0|||
33501970|NCT04463251|101730967|FG002|Overall Study|Death|1|||
33501971|NCT04463251|101730965|FG000|Overall Study|Adverse Event|0|||
33501972|NCT04463251|101730966|FG001|Overall Study|Adverse Event|1|||
33501973|NCT04463251|101730967|FG002|Overall Study|Adverse Event|0|||
33501974|NCT04463251|101730965|FG000|Overall Study|Lost to Follow-up|0|||
33501975|NCT04463251|101730966|FG001|Overall Study|Lost to Follow-up|1|||
33501976|NCT04463251|101730967|FG002|Overall Study|Lost to Follow-up|0|||
33501977|NCT04463251|101730965|FG000|Overall Study|Withdrawal by Subject|0|||
33501978|NCT04463251|101730966|FG001|Overall Study|Withdrawal by Subject|2|||
33501979|NCT04463251|101730967|FG002|Overall Study|Withdrawal by Subject|2|||
33501980|NCT03291431|101730970|FG000|Overall Study|Protocol Violation|2|||
33501981|NCT03291431|101730971|FG001|Overall Study|Protocol Violation|1|||
33501982|NCT03291431|101730970|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
33501983|NCT03291431|101730971|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
33501984|NCT03291431|101730970|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
33501985|NCT03291431|101730971|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
33501986|NCT01068678|101730974|FG000|Overall Study|Lack of Efficacy|3|||
33501987|NCT01068678|101730975|FG001|Overall Study|Lack of Efficacy|2|||
33501988|NCT01068678|101730974|FG000|Overall Study|Protocol Violation|5|||
33501989|NCT01068678|101730975|FG001|Overall Study|Protocol Violation|1|||
33501990|NCT01068678|101730974|FG000|Overall Study|Withdrawal criteria|12|||
33501991|NCT01068678|101730975|FG001|Overall Study|Withdrawal criteria|6|||
33501992|NCT01068678|101730974|FG000|Overall Study|Unclassified|18|||
33501993|NCT01068678|101730975|FG001|Overall Study|Unclassified|15|||
33501994|NCT01754129|101730976|FG000|Overall Study|Death|13|||
33501995|NCT01754129|101730976|FG000|Overall Study|Duodopa discontinuation|9|||
33501996|NCT01754129|101730976|FG000|Overall Study|Lost to Follow-up|7|||
33501997|NCT01754129|101730976|FG000|Overall Study|Withdrew consent|1|||
33501998|NCT01754129|101730976|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
33501999|NCT00347009|101730977|FG000|Overall Study|Death|1|||
33502000|NCT00347009|101730977|FG000|Overall Study|Adverse Event|6|||
33502001|NCT00347009|101730977|FG000|Overall Study|Withdrawal by Subject|3|||
33502002|NCT00347009|101730977|FG000|Overall Study|Physician Decision|5|||
33502003|NCT00347009|101730977|FG000|Overall Study|Lost to Follow-up|4|||
33502004|NCT00347009|101730977|FG000|Overall Study|Protocol Violation|2|||
33502005|NCT00347009|101730977|FG000|Overall Study|Adverse Laboratory Experience|1|||
33502006|NCT00347009|101730977|FG000|Overall Study|Insufficient Viral Suppression|3|||
33502007|NCT00347009|101730977|FG000|Overall Study|Increased ALT/HBV DNA|1|||
33502008|NCT00347009|101730977|FG000|Overall Study|Serious Adverse Event|1|||
33502009|NCT01208974|101730978|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
33502010|NCT01208974|101730979|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
33502011|NCT01208974|101730980|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
33502012|NCT01208974|101730981|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
33502013|NCT01208974|101730978|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
33502014|NCT01208974|101730979|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
33502015|NCT01208974|101730980|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
33502016|NCT01208974|101730981|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
33502017|NCT01208974|101730978|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
33502018|NCT01208974|101730979|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
33192997|NCT01573624|100612596|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
33502019|NCT01208974|101730980|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
33192998|NCT01573624|100612597|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
33502020|NCT01208974|101730981|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
33502021|NCT00282113|101730984|FG000|Overall Study|Removed at parents request|1|||
33502022|NCT00282113|101730985|FG001|Overall Study|Removed at parents request|0|||
33502023|NCT00282113|101730986|FG002|Overall Study|Removed at parents request|0|||
33502024|NCT00406367|101730989|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
33502025|NCT00406367|101730990|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
33502026|NCT00406367|101730989|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
33502027|NCT00406367|101730990|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
33502028|NCT00406367|101730989|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
33502029|NCT00406367|101730990|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
33502030|NCT00406367|101730989|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
33502031|NCT00406367|101730990|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
33502032|NCT00406367|101730989|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
33502033|NCT00406367|101730990|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
33502034|NCT00406367|101730989|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
33502035|NCT00406367|101730990|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
33502036|NCT00406367|101730989|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
33502037|NCT00406367|101730990|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
33502038|NCT00406367|101730989|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
33502039|NCT00406367|101730990|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
33502040|NCT00406367|101730989|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
33502041|NCT00406367|101730990|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
33502042|NCT00406367|101730989|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
33502043|NCT00406367|101730990|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
33502044|NCT00406367|101730989|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
33502045|NCT00406367|101730990|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
33502046|NCT00406367|101730989|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
33502047|NCT00406367|101730990|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
33502048|NCT06110494|101730991|FG000|Overall Study|Protocol Violation|2|||
33502049|NCT06110494|101730992|FG001|Overall Study|Protocol Violation|0|||
33502050|NCT06110494|101730993|FG002|Overall Study|Protocol Violation|1|||
33502051|NCT06110494|101730991|FG000|Overall Study|Dixon's test for outlier analysis|1|||
33502052|NCT06110494|101730992|FG001|Overall Study|Dixon's test for outlier analysis|1|||
33502053|NCT06110494|101730993|FG002|Overall Study|Dixon's test for outlier analysis|0|||
33502054|NCT00740792|101730996|FG000|Overall Study|Adverse Event|3|||
33502055|NCT00740792|101730997|FG001|Overall Study|Adverse Event|1|||
33502056|NCT00740792|101730998|FG002|Overall Study|Adverse Event|1|||
33502057|NCT00740792|101730999|FG003|Overall Study|Adverse Event|3|||
33502058|NCT00740792|101730996|FG000|Overall Study|Lack of Efficacy|1|||
33502059|NCT00740792|101730997|FG001|Overall Study|Lack of Efficacy|1|||
33502060|NCT00740792|101730998|FG002|Overall Study|Lack of Efficacy|0|||
33502061|NCT00740792|101730999|FG003|Overall Study|Lack of Efficacy|3|||
33502062|NCT00740792|101730996|FG000|Overall Study|Lost to Follow-up|2|||
33502063|NCT00740792|101730997|FG001|Overall Study|Lost to Follow-up|1|||
33502064|NCT00740792|101730998|FG002|Overall Study|Lost to Follow-up|0|||
33502065|NCT00740792|101730999|FG003|Overall Study|Lost to Follow-up|0|||
33502066|NCT00740792|101730996|FG000|Overall Study|Protocol Violation|0|||
33502067|NCT00740792|101730997|FG001|Overall Study|Protocol Violation|1|||
33502068|NCT00740792|101730998|FG002|Overall Study|Protocol Violation|0|||
33502069|NCT00740792|101730999|FG003|Overall Study|Protocol Violation|2|||
33502070|NCT00740792|101730996|FG000|Overall Study|Withdrawal by Subject|1|||
33502071|NCT00740792|101730997|FG001|Overall Study|Withdrawal by Subject|1|||
33502072|NCT00740792|101730998|FG002|Overall Study|Withdrawal by Subject|0|||
33502073|NCT00740792|101730999|FG003|Overall Study|Withdrawal by Subject|0|||
33502074|NCT00740792|101730996|FG000|Overall Study|administrative|3|||
33502075|NCT00740792|101730997|FG001|Overall Study|administrative|3|||
33502076|NCT00740792|101730998|FG002|Overall Study|administrative|8|||
33502077|NCT00740792|101730999|FG003|Overall Study|administrative|2|||
33502078|NCT02684097|101731000|FG000|Overall Study|Lack of Efficacy|13|||
33502079|NCT02684097|101731001|FG001|Overall Study|Lack of Efficacy|6|||
33502080|NCT00333983|101731003|FG000|Overall Study|Lost to Follow-up|2|||
33502081|NCT00333983|101731004|FG001|Overall Study|Lost to Follow-up|1|||
33602059|NCT00844805|102095182|FG001|Treatment Phase|Adverse Event|1|||
33602060|NCT00844805|102095183|FG002|Treatment Phase|Adverse Event|0|||
33502082|NCT00333983|101731005|FG002|Overall Study|Lost to Follow-up|0|||
33502083|NCT00333983|101731003|FG000|Overall Study|Adverse Event|1|||
33502084|NCT00333983|101731004|FG001|Overall Study|Adverse Event|1|||
33502085|NCT00333983|101731005|FG002|Overall Study|Adverse Event|1|||
33502086|NCT00333983|101731003|FG000|Overall Study|Withdrawal by Subject|0|||
33502087|NCT00333983|101731004|FG001|Overall Study|Withdrawal by Subject|3|||
33502088|NCT00333983|101731005|FG002|Overall Study|Withdrawal by Subject|1|||
33602061|NCT00844805|102095184|FG003|Treatment Phase|Adverse Event|0|||
33602062|NCT00844805|102095181|FG000|Treatment Phase|Withdrawal by Subject|3|||
33502089|NCT00478777|101731006|FG000|Overall Study|Adverse Event|29|||
33502090|NCT00478777|101731006|FG000|Overall Study|Lack of Efficacy|23|||
33502091|NCT00478777|101731006|FG000|Overall Study|Withdrawal by Subject|4|||
33502092|NCT00478777|101731006|FG000|Overall Study|Death|3|||
33502093|NCT00478777|101731006|FG000|Overall Study|Protocol Violation|3|||
33502094|NCT00478777|101731006|FG000|Overall Study|Lost to Follow-up|3|||
33502095|NCT00478777|101731006|FG000|Overall Study|Physician Decision|1|||
33502096|NCT00478777|101731006|FG000|Overall Study|Intolerance of therapy|1|||
33502097|NCT00478777|101731006|FG000|Overall Study|Lack of compliance|1|||
33502098|NCT00478777|101731006|FG000|Overall Study|Lymphocytes infusion|1|||
33502099|NCT00478777|101731006|FG000|Overall Study|End of therapy|2|||
33502100|NCT00478777|101731006|FG000|Overall Study|Not treated with lenalidomide|6|||
33502101|NCT03668119|101731007|FG000|Pre-treatment|Disease Progression|1|||
33502102|NCT03668119|101731008|FG001|Pre-treatment|Disease Progression|0|||
33502103|NCT03668119|101731007|FG000|Treatment|Disease Progression|76|||
33502104|NCT03668119|101731008|FG001|Treatment|Disease Progression|57|||
33502105|NCT03668119|101731007|FG000|Treatment|Study drug toxicity|19|||
33502106|NCT03668119|101731008|FG001|Treatment|Study drug toxicity|1|||
33502107|NCT03668119|101731007|FG000|Treatment|Death|3|||
33502108|NCT03668119|101731008|FG001|Treatment|Death|0|||
33502109|NCT03668119|101731007|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
33502110|NCT03668119|101731008|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
33502111|NCT03668119|101731007|FG000|Treatment|Withdrawal by Subject|1|||
33502112|NCT03668119|101731008|FG001|Treatment|Withdrawal by Subject|1|||
33502113|NCT03668119|101731007|FG000|Treatment|Participant request to discontinue study treatment|3|||
33502114|NCT03668119|101731008|FG001|Treatment|Participant request to discontinue study treatment|1|||
33502115|NCT03668119|101731007|FG000|Treatment|Maximum Clinical Benefit|0|||
33502116|NCT03668119|101731008|FG001|Treatment|Maximum Clinical Benefit|1|||
33502117|NCT03668119|101731007|FG000|Treatment|Participants completed treatment|27|||
33502118|NCT03668119|101731008|FG001|Treatment|Participants completed treatment|11|||
33502119|NCT03668119|101731007|FG000|Treatment|Other reasons|2|||
33502120|NCT03668119|101731008|FG001|Treatment|Other reasons|1|||
33502121|NCT00839800|101731009|FG000|Overall Study|Adverse Event|8|||
33502122|NCT00839800|101731010|FG001|Overall Study|Adverse Event|12|||
33502123|NCT00839800|101731009|FG000|Overall Study|Lost to Follow-up|31|||
33502124|NCT00839800|101731010|FG001|Overall Study|Lost to Follow-up|26|||
33502125|NCT00839800|101731009|FG000|Overall Study|Withdrawal by Subject|28|||
33502126|NCT00839800|101731010|FG001|Overall Study|Withdrawal by Subject|34|||
33502127|NCT00839800|101731009|FG000|Overall Study|Incorrect Enrolment|3|||
33502128|NCT00839800|101731010|FG001|Overall Study|Incorrect Enrolment|3|||
33502129|NCT00839800|101731009|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
33502130|NCT00839800|101731010|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
33502131|NCT00839800|101731009|FG000|Overall Study|Safety Reasons|2|||
33502132|NCT00839800|101731010|FG001|Overall Study|Safety Reasons|1|||
33502133|NCT00839800|101731009|FG000|Overall Study|Other|8|||
33502134|NCT00839800|101731010|FG001|Overall Study|Other|14|||
33502135|NCT00839800|101731009|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
33502136|NCT00839800|101731010|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
33502137|NCT00644917|101731011|FG000|Overall Study|Withdrawal by Subject|2|||
33311553|NCT03541174|101037340|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
33311554|NCT03541174|101037341|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
33311555|NCT03541174|101037342|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
33311556|NCT03541174|101037343|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
33311557|NCT03541174|101037338|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
33311558|NCT03541174|101037339|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
33311559|NCT03541174|101037340|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
33311560|NCT03541174|101037341|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
33311561|NCT03541174|101037342|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
33311562|NCT03541174|101037343|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
33311563|NCT03541174|101037338|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
33502138|NCT01628198|101731012|FG000|Overall Study|Lost to Follow-up|7|||
33311564|NCT03541174|101037339|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
33311565|NCT03541174|101037340|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
33311566|NCT03541174|101037341|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
33311567|NCT03541174|101037342|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
33502139|NCT01628198|101731012|FG000|Overall Study|Withdrawal by Subject|10|||
33502140|NCT01628198|101731012|FG000|Overall Study|Screen failure|1|||
33502141|NCT02211209|101731016|FG000|Overall Study|Investigator judgment|0|||
33502142|NCT02211209|101731017|FG001|Overall Study|Investigator judgment|1|||
33502143|NCT02211209|101731016|FG000|Overall Study|Voluntary withdrawal|1|||
33311568|NCT03541174|101037343|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
33502144|NCT02211209|101731017|FG001|Overall Study|Voluntary withdrawal|4|||
33502145|NCT02211209|101731016|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
33502146|NCT02211209|101731017|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
33311569|NCT03541174|101037338|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
33311570|NCT03541174|101037339|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
33311571|NCT03541174|101037340|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
33311572|NCT03541174|101037341|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
33311573|NCT03541174|101037342|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
33311574|NCT03541174|101037343|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
33311575|NCT02679573|101037348|FG000|Overall Study|Adverse Event|13|||
33311576|NCT02679573|101037349|FG001|Overall Study|Adverse Event|6|||
33311577|NCT02679573|101037348|FG000|Overall Study|Lack of Efficacy|12|||
33311578|NCT02679573|101037349|FG001|Overall Study|Lack of Efficacy|15|||
33311579|NCT02679573|101037348|FG000|Overall Study|Could not complete required study visits|6|||
33311580|NCT02679573|101037349|FG001|Overall Study|Could not complete required study visits|2|||
33311581|NCT02679573|101037348|FG000|Overall Study|Withdrawal by Subject|2|||
33311582|NCT02679573|101037349|FG001|Overall Study|Withdrawal by Subject|9|||
33311583|NCT02679573|101037348|FG000|Overall Study|Death|2|||
33311584|NCT02679573|101037349|FG001|Overall Study|Death|0|||
33311585|NCT02679573|101037348|FG000|Overall Study|Physician Decision|2|||
33311586|NCT02679573|101037349|FG001|Overall Study|Physician Decision|4|||
33311587|NCT02679573|101037348|FG000|Overall Study|Lost to Follow-up|0|||
33311588|NCT02679573|101037349|FG001|Overall Study|Lost to Follow-up|3|||
33311589|NCT00321373|101037350|FG000|Overall Study|Adverse Event|0|||
33311590|NCT00321373|101037351|FG001|Overall Study|Adverse Event|0|||
33311591|NCT00321373|101037352|FG002|Overall Study|Adverse Event|1|||
33311592|NCT00321373|101037350|FG000|Overall Study|Lost to Follow-up|1|||
33311593|NCT00321373|101037351|FG001|Overall Study|Lost to Follow-up|0|||
33311594|NCT00321373|101037352|FG002|Overall Study|Lost to Follow-up|1|||
33311595|NCT00321373|101037350|FG000|Overall Study|Withdrawal by Subject|1|||
33502147|NCT02211209|101731016|FG000|Overall Study|Reason Not Specified|1|||
33502148|NCT02211209|101731017|FG001|Overall Study|Reason Not Specified|0|||
33502149|NCT02275819|101731018|FG000|Overall Study|Adverse Event|0|||
33502150|NCT02275819|101731019|FG001|Overall Study|Adverse Event|1|||
33502151|NCT00789698|101731021|FG000|Overall Study|Lack of Efficacy|10|||
33502152|NCT00789698|101731022|FG001|Overall Study|Lack of Efficacy|4|||
33502153|NCT00789698|101731023|FG002|Overall Study|Lack of Efficacy|5|||
33502154|NCT00789698|101731024|FG003|Overall Study|Lack of Efficacy|18|||
33502155|NCT00789698|101731021|FG000|Overall Study|Adverse Event|5|||
33502156|NCT00789698|101731022|FG001|Overall Study|Adverse Event|5|||
33502157|NCT00789698|101731023|FG002|Overall Study|Adverse Event|3|||
33502158|NCT00789698|101731024|FG003|Overall Study|Adverse Event|4|||
33502159|NCT00789698|101731021|FG000|Overall Study|Lost to Follow-up|5|||
33502160|NCT00789698|101731022|FG001|Overall Study|Lost to Follow-up|5|||
33502161|NCT00789698|101731023|FG002|Overall Study|Lost to Follow-up|2|||
33502162|NCT00789698|101731024|FG003|Overall Study|Lost to Follow-up|9|||
33502163|NCT00789698|101731021|FG000|Overall Study|Protocol Violation|6|||
33502164|NCT00789698|101731022|FG001|Overall Study|Protocol Violation|1|||
33502165|NCT00789698|101731023|FG002|Overall Study|Protocol Violation|2|||
33502166|NCT00789698|101731024|FG003|Overall Study|Protocol Violation|1|||
33502167|NCT00789698|101731021|FG000|Overall Study|Withdrawal by Subject|14|||
33502168|NCT00789698|101731022|FG001|Overall Study|Withdrawal by Subject|15|||
33502169|NCT00789698|101731023|FG002|Overall Study|Withdrawal by Subject|12|||
33502170|NCT00789698|101731024|FG003|Overall Study|Withdrawal by Subject|19|||
33502171|NCT00789698|101731021|FG000|Overall Study|Administrative|0|||
33502172|NCT00789698|101731022|FG001|Overall Study|Administrative|3|||
33502173|NCT00789698|101731023|FG002|Overall Study|Administrative|3|||
33502174|NCT00789698|101731024|FG003|Overall Study|Administrative|1|||
33502175|NCT00921557|101731025|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
33502176|NCT00921557|101731026|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
33502177|NCT00921557|101731027|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
33502178|NCT00921557|101731025|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
33502179|NCT00921557|101731026|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
33502180|NCT00921557|101731027|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
33502181|NCT00921557|101731025|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
33502182|NCT00921557|101731026|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
33602063|NCT00844805|102095182|FG001|Treatment Phase|Withdrawal by Subject|4|||
33311596|NCT00321373|101037351|FG001|Overall Study|Withdrawal by Subject|0|||
33311597|NCT00321373|101037352|FG002|Overall Study|Withdrawal by Subject|0|||
33311598|NCT00321373|101037350|FG000|Overall Study|Other|0|||
33502183|NCT00921557|101731027|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
33502184|NCT00921557|101731025|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
33502185|NCT00921557|101731026|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
33602064|NCT00844805|102095183|FG002|Treatment Phase|Withdrawal by Subject|0|||
33502186|NCT00921557|101731027|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
33502187|NCT00921557|101731025|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
33502188|NCT00921557|101731026|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
33502189|NCT00921557|101731027|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
33502190|NCT00746564|101731028|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
33502191|NCT02729051|101731029|FG000|Overall Study|Adverse Event|21|||
33502192|NCT02729051|101731030|FG001|Overall Study|Adverse Event|11|||
33502193|NCT02729051|101731029|FG000|Overall Study|Lack of Efficacy|1|||
33502194|NCT02729051|101731030|FG001|Overall Study|Lack of Efficacy|1|||
33502195|NCT02729051|101731029|FG000|Overall Study|Lost to Follow-up|1|||
33502196|NCT02729051|101731030|FG001|Overall Study|Lost to Follow-up|2|||
33502197|NCT02729051|101731029|FG000|Overall Study|Physician Decision|1|||
33502198|NCT02729051|101731030|FG001|Overall Study|Physician Decision|1|||
33502199|NCT02729051|101731029|FG000|Overall Study|Withdrawal by Subject|6|||
33502200|NCT02729051|101731030|FG001|Overall Study|Withdrawal by Subject|17|||
33502201|NCT02027545|101731031|FG000|Overall Study|Failed to sign HIPAA|0|||
33502202|NCT02027545|101731032|FG001|Overall Study|Failed to sign HIPAA|2|||
33502203|NCT02027545|101731031|FG000|Overall Study|Failed to attend study visit|2|||
33502204|NCT02027545|101731032|FG001|Overall Study|Failed to attend study visit|0|||
33502205|NCT02027545|101731031|FG000|Overall Study|Protocol Violation|1|||
33502206|NCT02027545|101731032|FG001|Overall Study|Protocol Violation|0|||
33502207|NCT00708552|101731035|FG000|Overall Study|Adverse Event|10|||
33502208|NCT00708552|101731036|FG001|Overall Study|Adverse Event|3|||
33502209|NCT00708552|101731037|FG002|Overall Study|Adverse Event|4|||
33502210|NCT00708552|101731038|FG003|Overall Study|Adverse Event|6|||
33502211|NCT00708552|101731035|FG000|Overall Study|Lack of Efficacy|0|||
33502212|NCT00708552|101731036|FG001|Overall Study|Lack of Efficacy|4|||
33502213|NCT00708552|101731037|FG002|Overall Study|Lack of Efficacy|1|||
33502214|NCT00708552|101731038|FG003|Overall Study|Lack of Efficacy|0|||
33502215|NCT00708552|101731035|FG000|Overall Study|Protocol Violation|0|||
33502216|NCT00708552|101731036|FG001|Overall Study|Protocol Violation|0|||
33502217|NCT00708552|101731037|FG002|Overall Study|Protocol Violation|2|||
33502218|NCT00708552|101731038|FG003|Overall Study|Protocol Violation|4|||
33502219|NCT00708552|101731035|FG000|Overall Study|Lost to Follow-up|4|||
33502220|NCT00708552|101731036|FG001|Overall Study|Lost to Follow-up|2|||
33502221|NCT00708552|101731037|FG002|Overall Study|Lost to Follow-up|0|||
33502222|NCT00708552|101731038|FG003|Overall Study|Lost to Follow-up|1|||
33502223|NCT00708552|101731035|FG000|Overall Study|Physician Decision|1|||
33502224|NCT00708552|101731036|FG001|Overall Study|Physician Decision|2|||
33502225|NCT00708552|101731037|FG002|Overall Study|Physician Decision|0|||
33502226|NCT00708552|101731038|FG003|Overall Study|Physician Decision|0|||
33502227|NCT00708552|101731035|FG000|Overall Study|Withdrawal by Subject|12|||
33502228|NCT00708552|101731036|FG001|Overall Study|Withdrawal by Subject|7|||
33394970|NCT03605836|101331935|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
33394971|NCT03605836|101331932|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
33394972|NCT03605836|101331933|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
33394973|NCT03605836|101331934|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
33394974|NCT03605836|101331935|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
33502229|NCT00708552|101731037|FG002|Overall Study|Withdrawal by Subject|8|||
33502230|NCT00708552|101731038|FG003|Overall Study|Withdrawal by Subject|10|||
33502231|NCT00955409|101731039|FG000|Overall Study|Lack of Efficacy|1|||
33394975|NCT03605836|101331932|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
33394976|NCT03605836|101331933|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
33394977|NCT03605836|101331934|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
33394978|NCT03605836|101331935|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
33394979|NCT03605836|101331932|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
33502232|NCT00955409|101731040|FG001|Overall Study|Lack of Efficacy|0|||
33502233|NCT00955409|101731041|FG002|Overall Study|Lack of Efficacy|0|||
33502234|NCT00955409|101731042|FG003|Overall Study|Lack of Efficacy|0|||
33502235|NCT00955409|101731043|FG004|Overall Study|Lack of Efficacy|0|||
33394980|NCT03605836|101331933|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
33394981|NCT03605836|101331934|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
33502236|NCT00955409|101731044|FG005|Overall Study|Lack of Efficacy|0|||
33502237|NCT00955409|101731045|FG006|Overall Study|Lack of Efficacy|0|||
33502238|NCT00955409|101731046|FG007|Overall Study|Lack of Efficacy|0|||
33502239|NCT00955409|101731047|FG008|Overall Study|Lack of Efficacy|0|||
33502240|NCT00955409|101731048|FG009|Overall Study|Lack of Efficacy|0|||
33502241|NCT00955409|101731039|FG000|Overall Study|Withdrawal by Subject|1|||
33502242|NCT00955409|101731040|FG001|Overall Study|Withdrawal by Subject|0|||
33502243|NCT00955409|101731041|FG002|Overall Study|Withdrawal by Subject|5|||
33502244|NCT00955409|101731042|FG003|Overall Study|Withdrawal by Subject|2|||
33192999|NCT01573624|100612598|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
33193000|NCT01573624|100612599|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
33193001|NCT01573624|100612600|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
33193002|NCT01573624|100612601|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
33193003|NCT01573624|100612595|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
33193004|NCT01573624|100612596|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
33193005|NCT01573624|100612597|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
33193006|NCT01573624|100612598|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
33193007|NCT01573624|100612599|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
33193008|NCT01573624|100612600|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
33193009|NCT01573624|100612601|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
33193010|NCT01573624|100612595|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
33193011|NCT01573624|100612596|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
33193012|NCT01573624|100612597|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
33193013|NCT01573624|100612598|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
33193014|NCT01573624|100612599|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
33193015|NCT01573624|100612600|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
33502245|NCT00955409|101731043|FG004|Overall Study|Withdrawal by Subject|0|||
33502246|NCT00955409|101731044|FG005|Overall Study|Withdrawal by Subject|0|||
33502247|NCT00955409|101731045|FG006|Overall Study|Withdrawal by Subject|2|||
33602065|NCT00844805|102095184|FG003|Treatment Phase|Withdrawal by Subject|0|||
33602066|NCT00844805|102095181|FG000|Treatment Phase|Noncompliance With Protocol|1|||
33502248|NCT00955409|101731046|FG007|Overall Study|Withdrawal by Subject|0|||
33502249|NCT00955409|101731047|FG008|Overall Study|Withdrawal by Subject|1|||
33502250|NCT00955409|101731048|FG009|Overall Study|Withdrawal by Subject|0|||
33502251|NCT00955409|101731039|FG000|Overall Study|Caregiver Request|2|||
33502252|NCT00955409|101731040|FG001|Overall Study|Caregiver Request|0|||
33502253|NCT00955409|101731041|FG002|Overall Study|Caregiver Request|6|||
33502254|NCT00955409|101731042|FG003|Overall Study|Caregiver Request|5|||
33502255|NCT00955409|101731043|FG004|Overall Study|Caregiver Request|0|||
33502256|NCT00955409|101731044|FG005|Overall Study|Caregiver Request|2|||
33502257|NCT00955409|101731045|FG006|Overall Study|Caregiver Request|3|||
33502258|NCT00955409|101731046|FG007|Overall Study|Caregiver Request|1|||
33502259|NCT00955409|101731047|FG008|Overall Study|Caregiver Request|3|||
33602067|NCT00844805|102095182|FG001|Treatment Phase|Noncompliance With Protocol|0|||
33602068|NCT00844805|102095183|FG002|Treatment Phase|Noncompliance With Protocol|0|||
33602069|NCT00844805|102095184|FG003|Treatment Phase|Noncompliance With Protocol|0|||
33602070|NCT00844805|102095181|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
33602071|NCT00844805|102095182|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
33602072|NCT00844805|102095183|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
33602073|NCT00844805|102095184|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
33602074|NCT00844805|102095181|FG000|Follow-Up Phase|Adverse Event|0|||
33602075|NCT00844805|102095182|FG001|Follow-Up Phase|Adverse Event|0|||
33602076|NCT00844805|102095183|FG002|Follow-Up Phase|Adverse Event|1|||
33602077|NCT00844805|102095184|FG003|Follow-Up Phase|Adverse Event|0|||
33602078|NCT00844805|102095181|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
33602079|NCT00844805|102095182|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
33602080|NCT00844805|102095183|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
33602081|NCT00844805|102095184|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
33602082|NCT00844805|102095181|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
33602083|NCT00844805|102095182|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
33602084|NCT00844805|102095183|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
33602085|NCT00844805|102095184|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
33602086|NCT00844805|102095181|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
33602087|NCT00844805|102095182|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
33502260|NCT00955409|101731048|FG009|Overall Study|Caregiver Request|0|||
33502261|NCT00955409|101731039|FG000|Overall Study|Investigator Request|0|||
33502262|NCT00955409|101731040|FG001|Overall Study|Investigator Request|0|||
33602088|NCT00844805|102095183|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
33311599|NCT00321373|101037351|FG001|Overall Study|Other|0|||
33502263|NCT00955409|101731041|FG002|Overall Study|Investigator Request|1|||
33602089|NCT00844805|102095184|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
33602090|NCT00844805|102095181|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
33502264|NCT00955409|101731042|FG003|Overall Study|Investigator Request|0|||
33502265|NCT00955409|101731043|FG004|Overall Study|Investigator Request|0|||
33602091|NCT00844805|102095182|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
33193016|NCT01573624|100612601|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
33193017|NCT01573624|100612595|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33193018|NCT01573624|100612596|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33193019|NCT01573624|100612597|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33193020|NCT01573624|100612598|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33193021|NCT01573624|100612599|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33193022|NCT01573624|100612600|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
33193023|NCT01573624|100612601|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
33193024|NCT01573624|100612595|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
33193025|NCT01573624|100612596|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
33193026|NCT01573624|100612597|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
33311600|NCT00321373|101037352|FG002|Overall Study|Other|1|||
33502266|NCT00955409|101731044|FG005|Overall Study|Investigator Request|0|||
33502267|NCT00955409|101731045|FG006|Overall Study|Investigator Request|0|||
33502268|NCT00955409|101731046|FG007|Overall Study|Investigator Request|0|||
33502269|NCT00955409|101731047|FG008|Overall Study|Investigator Request|0|||
33502270|NCT00955409|101731048|FG009|Overall Study|Investigator Request|0|||
33502271|NCT00955409|101731039|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
33502272|NCT00955409|101731040|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
33502273|NCT00955409|101731041|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
33502274|NCT00955409|101731042|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
33502275|NCT00955409|101731043|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
33502276|NCT00955409|101731044|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
33502277|NCT00955409|101731045|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
33502278|NCT00955409|101731046|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
33502279|NCT00955409|101731047|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
33502280|NCT00955409|101731048|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
33502281|NCT00955409|101731039|FG000|Overall Study|Lost to Follow-up|0|||
33502282|NCT00955409|101731040|FG001|Overall Study|Lost to Follow-up|0|||
33502283|NCT00955409|101731041|FG002|Overall Study|Lost to Follow-up|1|||
33502284|NCT00955409|101731042|FG003|Overall Study|Lost to Follow-up|0|||
33502285|NCT00955409|101731043|FG004|Overall Study|Lost to Follow-up|0|||
33502286|NCT00955409|101731044|FG005|Overall Study|Lost to Follow-up|0|||
33502287|NCT00955409|101731045|FG006|Overall Study|Lost to Follow-up|1|||
33502288|NCT00955409|101731046|FG007|Overall Study|Lost to Follow-up|0|||
33502289|NCT00955409|101731047|FG008|Overall Study|Lost to Follow-up|0|||
33502290|NCT00955409|101731048|FG009|Overall Study|Lost to Follow-up|0|||
33502291|NCT00955409|101731039|FG000|Overall Study|Failed to Return|2|||
33502292|NCT00955409|101731040|FG001|Overall Study|Failed to Return|0|||
33502293|NCT00955409|101731041|FG002|Overall Study|Failed to Return|0|||
33502294|NCT00955409|101731042|FG003|Overall Study|Failed to Return|0|||
33502295|NCT00955409|101731043|FG004|Overall Study|Failed to Return|0|||
33502296|NCT00955409|101731044|FG005|Overall Study|Failed to Return|0|||
33602092|NCT00844805|102095183|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
33224273|NCT04737109|100721771|FG002|Study Treatment|Disease Progression|0|||
33502297|NCT00955409|101731045|FG006|Overall Study|Failed to Return|0|||
33502298|NCT00955409|101731046|FG007|Overall Study|Failed to Return|2|||
33502299|NCT00955409|101731047|FG008|Overall Study|Failed to Return|0|||
33502300|NCT00955409|101731048|FG009|Overall Study|Failed to Return|0|||
33602093|NCT00844805|102095184|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
33502301|NCT00955409|101731039|FG000|Overall Study|Adverse Event (AE)|2|||
33502302|NCT00955409|101731040|FG001|Overall Study|Adverse Event (AE)|0|||
33502303|NCT00955409|101731041|FG002|Overall Study|Adverse Event (AE)|0|||
33502304|NCT00955409|101731042|FG003|Overall Study|Adverse Event (AE)|0|||
33502305|NCT00955409|101731043|FG004|Overall Study|Adverse Event (AE)|0|||
33502306|NCT00955409|101731044|FG005|Overall Study|Adverse Event (AE)|1|||
33502307|NCT00955409|101731045|FG006|Overall Study|Adverse Event (AE)|2|||
33502308|NCT00955409|101731046|FG007|Overall Study|Adverse Event (AE)|0|||
33602094|NCT02091284|102095187|FG000|Overall Study|Withdrawal by Subject|2|||
33602095|NCT02091284|102095188|FG001|Overall Study|Withdrawal by Subject|1|||
33602096|NCT02091284|102095187|FG000|Overall Study|unreliable data|1|||
33602097|NCT02091284|102095188|FG001|Overall Study|unreliable data|0|||
33193027|NCT01573624|100612598|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
33193028|NCT01573624|100612599|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
33193029|NCT01573624|100612600|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
33193030|NCT01573624|100612601|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
33193031|NCT01573624|100612595|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
33193032|NCT01573624|100612596|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33193033|NCT01573624|100612597|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33193034|NCT01573624|100612598|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33193035|NCT01573624|100612599|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
33193036|NCT01573624|100612600|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
33193037|NCT01573624|100612601|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
33193038|NCT01573624|100612595|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
33602098|NCT01635764|102095192|FG000|Overall Study|Adverse Event|46|||
33602099|NCT01635764|102095192|FG000|Overall Study|Lack of Efficacy|76|||
33193039|NCT01573624|100612596|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
33311601|NCT02729831|101037355|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
33311602|NCT02729831|101037356|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
33311603|NCT02729831|101037357|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
33311604|NCT02729831|101037358|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
33311605|NCT02729831|101037355|FG000|1 Week Post-visit|Lost to Follow-up|43|||
33311606|NCT02729831|101037356|FG001|1 Week Post-visit|Lost to Follow-up|40|||
33311607|NCT02729831|101037357|FG002|1 Week Post-visit|Lost to Follow-up|38|||
33394982|NCT03605836|101331935|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
33394983|NCT03605836|101331932|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
33394984|NCT03605836|101331933|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
33394985|NCT03605836|101331934|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
33394986|NCT03605836|101331935|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
33394987|NCT03605836|101331932|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
33311608|NCT02729831|101037358|FG003|1 Week Post-visit|Lost to Follow-up|36|||
33311609|NCT02729831|101037355|FG000|6 Month Follow-up|Lost to Follow-up|54|||
33311610|NCT02729831|101037356|FG001|6 Month Follow-up|Lost to Follow-up|51|||
33311611|NCT02729831|101037357|FG002|6 Month Follow-up|Lost to Follow-up|48|||
33311612|NCT02729831|101037358|FG003|6 Month Follow-up|Lost to Follow-up|42|||
33311613|NCT02729831|101037355|FG000|6 Month Follow-up|Death|1|||
33311614|NCT02729831|101037356|FG001|6 Month Follow-up|Death|3|||
33311615|NCT02729831|101037357|FG002|6 Month Follow-up|Death|0|||
33311616|NCT02729831|101037358|FG003|6 Month Follow-up|Death|1|||
33311617|NCT00640133|101037359|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
33311618|NCT00640133|101037360|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
33311619|NCT00640133|101037359|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
33311620|NCT00640133|101037360|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
33311621|NCT00640133|101037359|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
33311622|NCT00640133|101037360|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
33311623|NCT01036763|101037362|FG000|Overall Study|Adverse Event|25|||
33311624|NCT01036763|101037362|FG000|Overall Study|Lost to Follow-up|28|||
33311625|NCT01036763|101037362|FG000|Overall Study|Other reason (not specified)|40|||
33394988|NCT03605836|101331933|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
33502309|NCT00955409|101731047|FG008|Overall Study|Adverse Event (AE)|2|||
33502310|NCT00955409|101731048|FG009|Overall Study|Adverse Event (AE)|0|||
33602100|NCT01635764|102095192|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
33602101|NCT01635764|102095192|FG000|Overall Study|Protocol Deviation|1|||
33602102|NCT01635764|102095192|FG000|Overall Study|Withdrew Consent|67|||
33193040|NCT01573624|100612597|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
33602103|NCT01635764|102095192|FG000|Overall Study|Lost to Follow-up|53|||
33602104|NCT01635764|102095192|FG000|Overall Study|Other|28|||
33193041|NCT01573624|100612598|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
33193042|NCT01573624|100612599|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
33193043|NCT01573624|100612600|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
33311626|NCT03607422|101037363|FG000|Overall Study|Adverse Event|7|||
33311627|NCT03607422|101037364|FG001|Overall Study|Adverse Event|3|||
33311628|NCT03607422|101037365|FG002|Overall Study|Adverse Event|2|||
33311629|NCT03607422|101037366|FG003|Overall Study|Adverse Event|0|||
33311630|NCT03607422|101037367|FG004|Overall Study|Adverse Event|2|||
33311631|NCT03607422|101037368|FG005|Overall Study|Adverse Event|0|||
33311632|NCT03607422|101037363|FG000|Overall Study|Withdrawal by Subject|11|||
33311633|NCT03607422|101037364|FG001|Overall Study|Withdrawal by Subject|3|||
33311634|NCT03607422|101037365|FG002|Overall Study|Withdrawal by Subject|6|||
33311635|NCT03607422|101037366|FG003|Overall Study|Withdrawal by Subject|2|||
33311636|NCT03607422|101037367|FG004|Overall Study|Withdrawal by Subject|0|||
33311637|NCT03607422|101037368|FG005|Overall Study|Withdrawal by Subject|0|||
33311638|NCT03607422|101037363|FG000|Overall Study|Lost to Follow-up|0|||
33311639|NCT03607422|101037364|FG001|Overall Study|Lost to Follow-up|0|||
33311640|NCT03607422|101037365|FG002|Overall Study|Lost to Follow-up|1|||
33311641|NCT03607422|101037366|FG003|Overall Study|Lost to Follow-up|0|||
33311642|NCT03607422|101037367|FG004|Overall Study|Lost to Follow-up|0|||
33311643|NCT03607422|101037368|FG005|Overall Study|Lost to Follow-up|0|||
33311644|NCT03607422|101037363|FG000|Overall Study|Other|12|||
33311645|NCT03607422|101037364|FG001|Overall Study|Other|4|||
33311646|NCT03607422|101037365|FG002|Overall Study|Other|1|||
33311647|NCT03607422|101037366|FG003|Overall Study|Other|2|||
33311648|NCT03607422|101037367|FG004|Overall Study|Other|0|||
33311649|NCT03607422|101037368|FG005|Overall Study|Other|2|||
33311650|NCT03607422|101037363|FG000|Overall Study|Ongoing at Time of Analysis|8|||
33311651|NCT03607422|101037364|FG001|Overall Study|Ongoing at Time of Analysis|0|||
33311652|NCT03607422|101037365|FG002|Overall Study|Ongoing at Time of Analysis|2|||
33311653|NCT03607422|101037366|FG003|Overall Study|Ongoing at Time of Analysis|1|||
33311654|NCT03607422|101037367|FG004|Overall Study|Ongoing at Time of Analysis|1|||
33311655|NCT03607422|101037368|FG005|Overall Study|Ongoing at Time of Analysis|1|||
33311656|NCT01598311|101037369|FG000|Overall Study|Physician Decision|4|||
33311657|NCT01598311|101037370|FG001|Overall Study|Physician Decision|5|||
33311658|NCT01598311|101037369|FG000|Overall Study|Adverse Event|9|||
33311659|NCT01598311|101037370|FG001|Overall Study|Adverse Event|13|||
33311660|NCT01598311|101037369|FG000|Overall Study|Lost to Follow-up|7|||
33311661|NCT01598311|101037370|FG001|Overall Study|Lost to Follow-up|12|||
33311662|NCT01598311|101037369|FG000|Overall Study|Withdrawal by Subject|9|||
33311663|NCT01598311|101037370|FG001|Overall Study|Withdrawal by Subject|13|||
33311664|NCT01598311|101037369|FG000|Overall Study|No reason provided.|0|||
33311665|NCT01598311|101037370|FG001|Overall Study|No reason provided.|5|||
33502311|NCT00955409|101731039|FG000|Overall Study|Reason not Specified|2|||
33502312|NCT00955409|101731040|FG001|Overall Study|Reason not Specified|1|||
33311666|NCT01598311|101037369|FG000|Overall Study|Randomized but never treated|8|||
33311667|NCT01598311|101037370|FG001|Overall Study|Randomized but never treated|5|||
33311668|NCT01598311|101037369|FG000|Overall Study|Treated but no confirmed CDAD|9|||
33311669|NCT01598311|101037370|FG001|Overall Study|Treated but no confirmed CDAD|8|||
33311670|NCT01598311|101037369|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
33311671|NCT01598311|101037370|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
33311672|NCT01874431|101037371|FG000|Overall Study|Physician Decision|0|||
33311673|NCT01874431|101037372|FG001|Overall Study|Physician Decision|0|||
33311674|NCT01874431|101037373|FG002|Overall Study|Physician Decision|1|||
33311675|NCT01874431|101037374|FG003|Overall Study|Physician Decision|0|||
33311676|NCT01874431|101037375|FG004|Overall Study|Physician Decision|0|||
33311677|NCT01874431|101037376|FG005|Overall Study|Physician Decision|0|||
33193044|NCT01573624|100612601|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
33311678|NCT01874431|101037377|FG006|Overall Study|Physician Decision|0|||
33311679|NCT01874431|101037378|FG007|Overall Study|Physician Decision|0|||
33311680|NCT01874431|101037371|FG000|Overall Study|Adverse Event|5|||
33311681|NCT01874431|101037372|FG001|Overall Study|Adverse Event|4|||
33602105|NCT02290938|102095193|FG000|Overall Study|Lost to Follow-up|14|||
33311682|NCT01874431|101037373|FG002|Overall Study|Adverse Event|6|||
33311683|NCT01874431|101037374|FG003|Overall Study|Adverse Event|5|||
33502313|NCT00955409|101731041|FG002|Overall Study|Reason not Specified|13|||
33502314|NCT00955409|101731042|FG003|Overall Study|Reason not Specified|1|||
33502315|NCT00955409|101731043|FG004|Overall Study|Reason not Specified|2|||
33502316|NCT00955409|101731044|FG005|Overall Study|Reason not Specified|0|||
33502317|NCT00955409|101731045|FG006|Overall Study|Reason not Specified|16|||
33502318|NCT00955409|101731046|FG007|Overall Study|Reason not Specified|0|||
33502319|NCT00955409|101731047|FG008|Overall Study|Reason not Specified|8|||
33502320|NCT00955409|101731048|FG009|Overall Study|Reason not Specified|1|||
33502321|NCT01326104|101731049|FG000|Overall Study|progressed prior to vaccine|0|||
33502322|NCT01326104|101731050|FG001|Overall Study|progressed prior to vaccine|2|||
33193045|NCT01573624|100612595|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
33502323|NCT01326104|101731049|FG000|Overall Study|unable to make vaccine|0|||
33502324|NCT01326104|101731050|FG001|Overall Study|unable to make vaccine|2|||
33502325|NCT02088905|101731053|FG000|Overall Study|Withdrawal by Subject|5|||
33502326|NCT02088905|101731054|FG001|Overall Study|Withdrawal by Subject|1|||
33502327|NCT00734162|101731059|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
33502328|NCT00734162|101731060|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
33502329|NCT00734162|101731061|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
33502330|NCT00734162|101731062|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
33502331|NCT00734162|101731059|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
33502332|NCT00734162|101731060|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
33502333|NCT00734162|101731061|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
33502334|NCT00734162|101731062|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
33502335|NCT00734162|101731059|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
33502336|NCT00734162|101731060|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
33502337|NCT00734162|101731061|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
33502338|NCT00734162|101731062|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
33502339|NCT00734162|101731059|FG000|Open-Label Phase|Withdrew Consent|1|||
33502340|NCT00734162|101731060|FG001|Open-Label Phase|Withdrew Consent|0|||
33502341|NCT00734162|101731061|FG002|Open-Label Phase|Withdrew Consent|1|||
33502342|NCT00734162|101731062|FG003|Open-Label Phase|Withdrew Consent|1|||
33502343|NCT00734162|101731059|FG000|Open-Label Phase|Lost to Follow-up|1|||
33502344|NCT00734162|101731060|FG001|Open-Label Phase|Lost to Follow-up|2|||
33502345|NCT00734162|101731061|FG002|Open-Label Phase|Lost to Follow-up|0|||
33502346|NCT00734162|101731062|FG003|Open-Label Phase|Lost to Follow-up|1|||
33502347|NCT00734162|101731059|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
33502348|NCT00734162|101731060|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
33502349|NCT00734162|101731061|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
33502350|NCT00734162|101731062|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
33502351|NCT01081769|101731063|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
33502352|NCT01081769|101731064|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
33193046|NCT01573624|100612596|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
33193047|NCT01573624|100612597|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
33193048|NCT01573624|100612598|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
33193049|NCT01573624|100612599|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
33193050|NCT01573624|100612600|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
33193051|NCT01573624|100612601|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
33193052|NCT01573624|100612595|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
33193053|NCT01573624|100612596|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
33193054|NCT01573624|100612597|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
33193055|NCT01573624|100612598|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
33193056|NCT01573624|100612599|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
33193057|NCT01573624|100612600|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
33193058|NCT01573624|100612601|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
33193059|NCT01573624|100612595|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
33193060|NCT01573624|100612596|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
33193061|NCT01573624|100612597|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
33502353|NCT01081769|101731063|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
33502354|NCT01081769|101731064|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
33502355|NCT01081769|101731063|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
33602106|NCT02290938|102095194|FG001|Overall Study|Lost to Follow-up|43|||
33193062|NCT01573624|100612598|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
33193063|NCT01573624|100612599|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
33193064|NCT01573624|100612600|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
33193065|NCT01573624|100612601|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
33602107|NCT00046930|102095201|FG000|Overall Study|Ineligible|12|||
33602108|NCT00046930|102095202|FG001|Overall Study|Ineligible|4|||
33193066|NCT02357576|100612604|FG000|Treatment Period|Withdrawal by Subject|0|||
33193067|NCT02357576|100612605|FG001|Treatment Period|Withdrawal by Subject|1|||
33502356|NCT01081769|101731064|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
33502357|NCT01081769|101731063|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
33502358|NCT01081769|101731064|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
33502359|NCT01081769|101731063|FG000|CORE Intent-To-Treat|Adverse Event|14|||
33502360|NCT01081769|101731064|FG001|CORE Intent-To-Treat|Adverse Event|11|||
33502361|NCT01081769|101731063|FG000|CORE Intent-To-Treat|Death|1|||
33502362|NCT01081769|101731064|FG001|CORE Intent-To-Treat|Death|1|||
33502363|NCT01081769|101731063|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
33502364|NCT01081769|101731064|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
33502365|NCT01081769|101731063|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
33502366|NCT01081769|101731064|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
33502367|NCT01081769|101731063|FG000|CORE Intent-To-Treat|Pregnancy|1|||
33502368|NCT01081769|101731064|FG001|CORE Intent-To-Treat|Pregnancy|0|||
33502369|NCT01081769|101731063|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
33502370|NCT01081769|101731064|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
33602109|NCT04524455|102095203|FG000|Overall Study|Death|3|||
33602110|NCT04524455|102095204|FG001|Overall Study|Death|3|||
33602111|NCT04524455|102095203|FG000|Overall Study|Decision by Sponsor|0|||
33602112|NCT04524455|102095204|FG001|Overall Study|Decision by Sponsor|2|||
33602113|NCT04524455|102095203|FG000|Overall Study|Withdrawal of Consent From Study|1|||
33602114|NCT04524455|102095204|FG001|Overall Study|Withdrawal of Consent From Study|0|||
33602115|NCT04524455|102095203|FG000|Overall Study|Lost to Follow-up|0|||
33602116|NCT04524455|102095204|FG001|Overall Study|Lost to Follow-up|1|||
33602117|NCT02804750|102095205|FG000|Period 1|Adverse Event|0|||
33602118|NCT02804750|102095206|FG001|Period 1|Adverse Event|2|||
33602119|NCT02804750|102095205|FG000|Period 1|Withdrawal by Subject|0|||
33602120|NCT02804750|102095206|FG001|Period 1|Withdrawal by Subject|1|||
33602121|NCT02804750|102095205|FG000|Period 2|Adverse Event|1|||
33602122|NCT02804750|102095206|FG001|Period 2|Adverse Event|0|||
33602123|NCT02804750|102095205|FG000|Period 3|Adverse Event|0|||
33602124|NCT02804750|102095206|FG001|Period 3|Adverse Event|2|||
33602125|NCT02804750|102095205|FG000|Period 4|Adverse Event|0|||
33602126|NCT02804750|102095206|FG001|Period 4|Adverse Event|5|||
33311684|NCT01874431|101037375|FG004|Overall Study|Adverse Event|2|||
33311685|NCT01874431|101037376|FG005|Overall Study|Adverse Event|8|||
33311686|NCT01874431|101037377|FG006|Overall Study|Adverse Event|2|||
33311687|NCT01874431|101037378|FG007|Overall Study|Adverse Event|3|||
33311688|NCT01874431|101037371|FG000|Overall Study|Protocol Violation|1|||
33311689|NCT01874431|101037372|FG001|Overall Study|Protocol Violation|1|||
33311690|NCT01874431|101037373|FG002|Overall Study|Protocol Violation|1|||
33311691|NCT01874431|101037374|FG003|Overall Study|Protocol Violation|0|||
33311692|NCT01874431|101037375|FG004|Overall Study|Protocol Violation|3|||
33311693|NCT01874431|101037376|FG005|Overall Study|Protocol Violation|2|||
33311694|NCT01874431|101037377|FG006|Overall Study|Protocol Violation|1|||
33311695|NCT01874431|101037378|FG007|Overall Study|Protocol Violation|1|||
33311696|NCT01874431|101037371|FG000|Overall Study|Non-compliance|0|||
33311697|NCT01874431|101037372|FG001|Overall Study|Non-compliance|0|||
33311698|NCT01874431|101037373|FG002|Overall Study|Non-compliance|0|||
33311699|NCT01874431|101037374|FG003|Overall Study|Non-compliance|0|||
33311700|NCT01874431|101037375|FG004|Overall Study|Non-compliance|1|||
33311701|NCT01874431|101037376|FG005|Overall Study|Non-compliance|0|||
33311702|NCT01874431|101037377|FG006|Overall Study|Non-compliance|1|||
33311703|NCT01874431|101037378|FG007|Overall Study|Non-compliance|0|||
33394989|NCT03605836|101331934|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
33502371|NCT01081769|101731063|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
33502372|NCT01081769|101731064|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
33502373|NCT01081769|101731063|FG000|CORE Intent-To-Treat|Other|0|||
33502374|NCT01081769|101731064|FG001|CORE Intent-To-Treat|Other|1|||
33502375|NCT01081769|101731063|FG000|CORE Intent-To-Treat|Ineligibility|3|||
33502376|NCT01081769|101731064|FG001|CORE Intent-To-Treat|Ineligibility|4|||
33502377|NCT01081769|101731063|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
33502378|NCT01081769|101731064|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
33602127|NCT00762996|102095209|FG000|Period One|Protocol Violation|0|||
33602128|NCT00762996|102095210|FG001|Period One|Protocol Violation|0|||
33602129|NCT00762996|102095211|FG002|Period One|Protocol Violation|1|||
33602130|NCT00762996|102095212|FG003|Period One|Protocol Violation|0|||
33602131|NCT00762996|102095209|FG000|Period One|ineligible|0|||
33602132|NCT00762996|102095210|FG001|Period One|ineligible|0|||
33602133|NCT00762996|102095211|FG002|Period One|ineligible|1|||
33602134|NCT00762996|102095212|FG003|Period One|ineligible|1|||
33394990|NCT03605836|101331935|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
33394991|NCT03605836|101331932|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
33394992|NCT03605836|101331933|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
33394993|NCT03605836|101331934|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
33394994|NCT03605836|101331935|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
33394995|NCT03605836|101331932|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
33394996|NCT03605836|101331933|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
33394997|NCT03605836|101331934|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
33394998|NCT03605836|101331935|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
33394999|NCT03605836|101331932|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
33395000|NCT03605836|101331933|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
33395001|NCT03605836|101331934|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
33395002|NCT03605836|101331935|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
33395003|NCT03605836|101331932|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
33395004|NCT03605836|101331933|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
33395005|NCT03605836|101331934|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
33395006|NCT03605836|101331935|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
33502379|NCT01081769|101731063|FG000|CORE Intent-To-Treat|Patient Moved|2|||
33502380|NCT01081769|101731064|FG001|CORE Intent-To-Treat|Patient Moved|2|||
33502381|NCT02203721|101731065|FG000|Overall Study|Lost to Follow-up|1|||
33602135|NCT00762996|102095209|FG000|Period One|Adverse Event|0|||
33602136|NCT00762996|102095210|FG001|Period One|Adverse Event|0|||
33602137|NCT00762996|102095211|FG002|Period One|Adverse Event|1|||
33502382|NCT02203721|101731066|FG001|Overall Study|Lost to Follow-up|0|||
33502383|NCT02203721|101731065|FG000|Overall Study|Death|0|||
33502384|NCT02203721|101731066|FG001|Overall Study|Death|2|||
33502385|NCT02203721|101731065|FG000|Overall Study|Illness|0|||
33502386|NCT02203721|101731066|FG001|Overall Study|Illness|1|||
33502387|NCT00072280|101731069|FG000|Treatment|Found ineligible|1|||
33502388|NCT00072280|101731070|FG001|Treatment|Found ineligible|2|||
33502389|NCT00072280|101731069|FG000|Follow-up|Early termination of study|2|||
33502390|NCT00072280|101731070|FG001|Follow-up|Early termination of study|2|||
33502391|NCT01417156|101731071|FG000|Overall Study|Adverse Event|12|||
33502392|NCT01417156|101731071|FG000|Overall Study|Protocol Violation|2|||
33502393|NCT02187198|101731074|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
33502394|NCT02187198|101731075|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
33502395|NCT02187198|101731074|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
33502396|NCT02187198|101731075|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
33502397|NCT01757535|101731076|FG000|Overall Study|Disease Relapse|143|||
33502398|NCT01757535|101731077|FG001|Overall Study|Disease Relapse|180|||
33502399|NCT01757535|101731076|FG000|Overall Study|Adverse Event|29|||
33502400|NCT01757535|101731077|FG001|Overall Study|Adverse Event|11|||
33502401|NCT01757535|101731076|FG000|Overall Study|Withdrawal by Subject|9|||
33502402|NCT01757535|101731077|FG001|Overall Study|Withdrawal by Subject|13|||
33502403|NCT01757535|101731076|FG000|Overall Study|Miscellaneous|5|||
33502404|NCT01757535|101731077|FG001|Overall Study|Miscellaneous|2|||
33502405|NCT01757535|101731076|FG000|Overall Study|Physician Decision|6|||
33502406|NCT01757535|101731077|FG001|Overall Study|Physician Decision|0|||
33502407|NCT01757535|101731076|FG000|Overall Study|Death|1|||
33502408|NCT01757535|101731077|FG001|Overall Study|Death|2|||
33502409|NCT01139125|101731078|FG000|Overall Study|Withdrawal by Subject|1|||
33502410|NCT01732640|101731081|FG000|Overall Study|Adverse Event|0|||
33502411|NCT01732640|101731082|FG001|Overall Study|Adverse Event|1|||
33502412|NCT01732640|101731081|FG000|Overall Study|Death|0|||
33502413|NCT01732640|101731082|FG001|Overall Study|Death|1|||
33502414|NCT00679211|101731083|FG000|Overall Study|Progressive disease|82|||
33502415|NCT00679211|101731083|FG000|Overall Study|Adverse Event|7|||
33311704|NCT01874431|101037371|FG000|Overall Study|Logistical difficulties|0|||
33311705|NCT01874431|101037372|FG001|Overall Study|Logistical difficulties|0|||
33311706|NCT01874431|101037373|FG002|Overall Study|Logistical difficulties|0|||
33311707|NCT01874431|101037374|FG003|Overall Study|Logistical difficulties|0|||
33311708|NCT01874431|101037375|FG004|Overall Study|Logistical difficulties|0|||
33311709|NCT01874431|101037376|FG005|Overall Study|Logistical difficulties|0|||
33311710|NCT01874431|101037377|FG006|Overall Study|Logistical difficulties|1|||
33311711|NCT01874431|101037378|FG007|Overall Study|Logistical difficulties|0|||
33311712|NCT01874431|101037371|FG000|Overall Study|Withdrawal by Subject|0|||
33395007|NCT03605836|101331932|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
33311713|NCT01874431|101037372|FG001|Overall Study|Withdrawal by Subject|0|||
33502416|NCT00679211|101731083|FG000|Overall Study|Withdrawal by Subject|2|||
33502417|NCT00679211|101731083|FG000|Overall Study|Physician Decision|5|||
33502418|NCT00679211|101731083|FG000|Overall Study|Refused to undergo protocol procedures|1|||
33502419|NCT00679211|101731083|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
33602138|NCT00762996|102095212|FG003|Period One|Adverse Event|0|||
33502420|NCT00679211|101731083|FG000|Overall Study|Other|1|||
33502421|NCT02792062|101731084|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
33502422|NCT02792062|101731085|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
33502423|NCT02792062|101731086|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
33502424|NCT02792062|101731087|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
33311714|NCT01874431|101037373|FG002|Overall Study|Withdrawal by Subject|1|||
33311715|NCT01874431|101037374|FG003|Overall Study|Withdrawal by Subject|2|||
33311716|NCT01874431|101037375|FG004|Overall Study|Withdrawal by Subject|1|||
33311717|NCT01874431|101037376|FG005|Overall Study|Withdrawal by Subject|1|||
33311718|NCT01874431|101037377|FG006|Overall Study|Withdrawal by Subject|3|||
33311719|NCT01874431|101037378|FG007|Overall Study|Withdrawal by Subject|0|||
33311720|NCT01874431|101037371|FG000|Overall Study|Sponsor decision|0|||
33311721|NCT01874431|101037372|FG001|Overall Study|Sponsor decision|0|||
33311722|NCT01874431|101037373|FG002|Overall Study|Sponsor decision|0|||
33311723|NCT01874431|101037374|FG003|Overall Study|Sponsor decision|0|||
33311724|NCT01874431|101037375|FG004|Overall Study|Sponsor decision|1|||
33311725|NCT01874431|101037376|FG005|Overall Study|Sponsor decision|0|||
33311726|NCT01874431|101037377|FG006|Overall Study|Sponsor decision|0|||
33311727|NCT01874431|101037378|FG007|Overall Study|Sponsor decision|0|||
33311728|NCT01874431|101037371|FG000|Overall Study|Lost to Follow-up|0|||
33311729|NCT01874431|101037372|FG001|Overall Study|Lost to Follow-up|0|||
33395008|NCT03605836|101331933|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
33395009|NCT03605836|101331934|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
33395010|NCT03605836|101331935|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
33395011|NCT03605836|101331932|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
33395012|NCT03605836|101331933|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
33395013|NCT03605836|101331934|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
33311730|NCT01874431|101037373|FG002|Overall Study|Lost to Follow-up|1|||
33311731|NCT01874431|101037374|FG003|Overall Study|Lost to Follow-up|0|||
33311732|NCT01874431|101037375|FG004|Overall Study|Lost to Follow-up|0|||
33311733|NCT01874431|101037376|FG005|Overall Study|Lost to Follow-up|0|||
33311734|NCT01874431|101037377|FG006|Overall Study|Lost to Follow-up|0|||
33311735|NCT01874431|101037378|FG007|Overall Study|Lost to Follow-up|0|||
33395014|NCT03605836|101331935|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
33395015|NCT03605836|101331932|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
33395016|NCT03605836|101331933|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
33395017|NCT03605836|101331934|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
33395018|NCT03605836|101331935|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
33395019|NCT03605836|101331932|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
33395020|NCT03605836|101331933|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
33395021|NCT03605836|101331934|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
33395022|NCT03605836|101331935|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
33395023|NCT03605836|101331932|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
33395024|NCT03605836|101331933|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
33395025|NCT03605836|101331934|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
33395026|NCT03605836|101331935|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
33395027|NCT01512108|101331938|FG000|Overall Study|Adverse Event|9|||
33395028|NCT01512108|101331939|FG001|Overall Study|Adverse Event|4|||
33395029|NCT01512108|101331938|FG000|Overall Study|Protocol Violation|1|||
33395030|NCT01512108|101331939|FG001|Overall Study|Protocol Violation|2|||
33395031|NCT01512108|101331938|FG000|Overall Study|Withdrawal Criteria|1|||
33395032|NCT01512108|101331939|FG001|Overall Study|Withdrawal Criteria|0|||
33395033|NCT01512108|101331938|FG000|Overall Study|Unclassified|11|||
33395034|NCT01512108|101331939|FG001|Overall Study|Unclassified|3|||
33395035|NCT02967562|101331940|FG000|Overall Study|Consent not obtained|1|||
33395036|NCT02967562|101331941|FG001|Overall Study|Consent not obtained|0|||
33395037|NCT02967562|101331940|FG000|Overall Study|High leak precluding analysis|1|||
33395038|NCT02967562|101331941|FG001|Overall Study|High leak precluding analysis|1|||
33502425|NCT02792062|101731088|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
33502426|NCT02792062|101731089|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
33502427|NCT03656068|101731096|FG000|Overall Study|Withdrawal by Subject|4|||
33502428|NCT03656068|101731096|FG000|Overall Study|Adverse Event|1|||
33502429|NCT02549859|101731097|FG000|Long-term 60 Hz DBS|Study Closed|1|||
33502430|NCT01580670|101731098|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
33502431|NCT01580670|101731098|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
33193068|NCT02357576|100612604|FG000|Treatment Period|Physician Decision|0|||
33193069|NCT02357576|100612605|FG001|Treatment Period|Physician Decision|1|||
33502432|NCT00766636|101731099|FG000|Overall Study|Withdrawal by Subject|1|||
33311736|NCT01970345|101037379|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
33311737|NCT01970345|101037380|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
33193070|NCT02357576|100612604|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
33502433|NCT00766636|101731100|FG001|Overall Study|Withdrawal by Subject|1|||
33502434|NCT00766636|101731099|FG000|Overall Study|Incomplete Treatment|0|||
33502435|NCT00766636|101731100|FG001|Overall Study|Incomplete Treatment|1|||
33502436|NCT00766636|101731099|FG000|Overall Study|Adverse Event|1|||
33502437|NCT00766636|101731100|FG001|Overall Study|Adverse Event|0|||
33502438|NCT00766636|101731099|FG000|Overall Study|Disease Progression|1|||
33502439|NCT00766636|101731100|FG001|Overall Study|Disease Progression|0|||
33502440|NCT03645395|101731109|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
33502441|NCT03645395|101731110|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
33502442|NCT03645395|101731111|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
33502443|NCT03645395|101731112|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
33502444|NCT03645395|101731109|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
33502445|NCT03645395|101731110|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
33502446|NCT03645395|101731111|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
33502447|NCT03645395|101731112|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
33502448|NCT03645395|101731109|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
33502449|NCT03645395|101731110|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
33502450|NCT03645395|101731111|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
33502451|NCT03645395|101731112|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
33502452|NCT03645395|101731109|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
33502453|NCT03645395|101731110|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
33502454|NCT03645395|101731111|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
33502455|NCT03645395|101731112|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
33502456|NCT00546377|101731113|FG000|Overall Study|Deemed ineligible|1|||
33502457|NCT00546377|101731113|FG000|Overall Study|Adverse Event|6|||
33502458|NCT02504827|101731116|FG000|Overall Study|Could not produce sputum|1|||
33502459|NCT03806933|101731117|FG000|Main Period|Physician Decision|0|||
33502460|NCT03806933|101731118|FG001|Main Period|Physician Decision|0|||
33311738|NCT01970345|101037379|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
33311739|NCT01970345|101037380|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
33311740|NCT00372229|101037381|FG000|Study Phase|Graft loss|0|||
33311741|NCT00372229|101037382|FG001|Study Phase|Graft loss|3|||
33311742|NCT00372229|101037381|FG000|Study Phase|Protocol Violation|3|||
33311743|NCT00372229|101037382|FG001|Study Phase|Protocol Violation|4|||
33311744|NCT00372229|101037381|FG000|Study Phase|Consent withdrawn|16|||
33311745|NCT00372229|101037382|FG001|Study Phase|Consent withdrawn|14|||
33311746|NCT00372229|101037381|FG000|Study Phase|Refused treatment/did not cooperate|3|||
33311747|NCT00372229|101037382|FG001|Study Phase|Refused treatment/did not cooperate|1|||
33311748|NCT00372229|101037381|FG000|Study Phase|Death|3|||
33311749|NCT00372229|101037382|FG001|Study Phase|Death|2|||
33311750|NCT00372229|101037381|FG000|Study Phase|Reason not specified|3|||
33311751|NCT00372229|101037382|FG001|Study Phase|Reason not specified|2|||
33311752|NCT00372229|101037381|FG000|Study Phase|Lost to Follow-up|3|||
33311753|NCT00372229|101037382|FG001|Study Phase|Lost to Follow-up|3|||
33311754|NCT00372229|101037381|FG000|Follow-Up Phase|Graft loss|8|||
33311755|NCT00372229|101037382|FG001|Follow-Up Phase|Graft loss|7|||
33311756|NCT00372229|101037381|FG000|Follow-Up Phase|Consent withdrawn|13|||
33311757|NCT00372229|101037382|FG001|Follow-Up Phase|Consent withdrawn|19|||
33311758|NCT00372229|101037381|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
33311759|NCT00372229|101037382|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
33311760|NCT00372229|101037381|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
33311761|NCT00372229|101037382|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
33311762|NCT00372229|101037381|FG000|Follow-Up Phase|Death|9|||
33311763|NCT00372229|101037382|FG001|Follow-Up Phase|Death|12|||
33311764|NCT00372229|101037381|FG000|Follow-Up Phase|Administrative|1|||
33311765|NCT00372229|101037382|FG001|Follow-Up Phase|Administrative|0|||
33311766|NCT00372229|101037381|FG000|Follow-Up Phase|Reason not specified|2|||
33311767|NCT00372229|101037382|FG001|Follow-Up Phase|Reason not specified|3|||
33311768|NCT00372229|101037381|FG000|Follow-Up Phase|Lost to Follow-up|12|||
33311769|NCT00372229|101037382|FG001|Follow-Up Phase|Lost to Follow-up|10|||
33311770|NCT02630693|101037395|FG000|Overall Study|No receive treatment|0|||
33311771|NCT02630693|101037396|FG001|Overall Study|No receive treatment|1|||
33311772|NCT03265938|101037397|FG000|Overall Study|Withdrawal by Subject|1|||
33311773|NCT03265938|101037397|FG000|Overall Study|Physician Decision|1|||
33502461|NCT03806933|101731119|FG002|Main Period|Physician Decision|0|||
33502462|NCT03806933|101731120|FG003|Main Period|Physician Decision|1|||
33502463|NCT03806933|101731117|FG000|Main Period|Pregnancy|0|||
33502464|NCT03806933|101731118|FG001|Main Period|Pregnancy|0|||
33502465|NCT03806933|101731119|FG002|Main Period|Pregnancy|1|||
33502466|NCT03806933|101731120|FG003|Main Period|Pregnancy|0|||
33311774|NCT03265938|101037397|FG000|Overall Study|friable mass|6|||
33311775|NCT01011387|101037399|FG000|Overall Study|Withdrawal by Subject|3|||
33311776|NCT01011387|101037399|FG000|Overall Study|Adverse Event|2|||
33311777|NCT01011387|101037399|FG000|Overall Study|Protocol Violation|1|||
33311778|NCT02667587|101037401|FG000|Pre-Treatment|Not reported|1|||
33502467|NCT03806933|101731117|FG000|Main Period|Withdrawal by Subject|2|||
33502468|NCT03806933|101731118|FG001|Main Period|Withdrawal by Subject|1|||
33502469|NCT03806933|101731119|FG002|Main Period|Withdrawal by Subject|1|||
33502470|NCT03806933|101731120|FG003|Main Period|Withdrawal by Subject|2|||
33502471|NCT03806933|101731117|FG000|Main Period|Lost to Follow-up|2|||
33502472|NCT03806933|101731118|FG001|Main Period|Lost to Follow-up|2|||
33502473|NCT03806933|101731119|FG002|Main Period|Lost to Follow-up|0|||
33502474|NCT03806933|101731120|FG003|Main Period|Lost to Follow-up|0|||
33502475|NCT03806933|101731117|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
33502476|NCT03806933|101731118|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
33502477|NCT03806933|101731119|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
33502478|NCT03806933|101731120|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
33502479|NCT03020992|101731130|FG000|Overall Study|Adverse Event|5|||
33502480|NCT03020992|101731130|FG000|Overall Study|Withdrawal by Subject|1|||
33502481|NCT00179660|101731134|FG000|Overall Study|Adverse Event|7|||
33502482|NCT00179660|101731134|FG000|Overall Study|Lack of therapeutic effect|28|||
33502483|NCT00179660|101731134|FG000|Overall Study|Withdrawal by Subject|2|||
33502484|NCT00179660|101731134|FG000|Overall Study|Lost to Follow-up|1|||
33502485|NCT00179660|101731134|FG000|Overall Study|Death|3|||
33502486|NCT00179660|101731134|FG000|Overall Study|Other - Unspecified|9|||
33567579|NCT02723955|101973177|FG008|Crossover/ Re-treatment Phase|Death|0|||
33567580|NCT02723955|101973178|FG009|Crossover/ Re-treatment Phase|Death|0|||
33567581|NCT02723955|101973179|FG010|Crossover/ Re-treatment Phase|Death|0|||
33567582|NCT02723955|101973180|FG011|Crossover/ Re-treatment Phase|Death|0|||
33567583|NCT02723955|101973181|FG012|Crossover/ Re-treatment Phase|Death|0|||
33567584|NCT02723955|101973182|FG013|Crossover/ Re-treatment Phase|Death|0|||
33567585|NCT02723955|101973183|FG014|Crossover/ Re-treatment Phase|Death|0|||
33567586|NCT02723955|101973184|FG015|Crossover/ Re-treatment Phase|Death|0|||
33567587|NCT02723955|101973185|FG016|Crossover/ Re-treatment Phase|Death|0|||
33567588|NCT02723955|101973186|FG017|Crossover/ Re-treatment Phase|Death|0|||
33311779|NCT02667587|101037402|FG001|Pre-Treatment|Not reported|0|||
33311780|NCT02667587|101037401|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
33567589|NCT02723955|101973187|FG018|Crossover/ Re-treatment Phase|Death|0|||
33311781|NCT02667587|101037402|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
33311782|NCT02667587|101037401|FG000|Pre-Treatment|Participant withdrew consent|0|||
33567590|NCT02723955|101973188|FG019|Crossover/ Re-treatment Phase|Death|0|||
33567591|NCT02723955|101973189|FG020|Crossover/ Re-treatment Phase|Death|0|||
33567592|NCT02723955|101973190|FG021|Crossover/ Re-treatment Phase|Death|0|||
33567593|NCT02723955|101973191|FG022|Crossover/ Re-treatment Phase|Death|0|||
33567594|NCT02723955|101973192|FG023|Crossover/ Re-treatment Phase|Death|0|||
33567595|NCT02723955|101973193|FG024|Crossover/ Re-treatment Phase|Death|0|||
33567596|NCT02723955|101973194|FG025|Crossover/ Re-treatment Phase|Death|0|||
33567597|NCT02723955|101973195|FG026|Crossover/ Re-treatment Phase|Death|0|||
33567598|NCT02723955|101973196|FG027|Crossover/ Re-treatment Phase|Death|0|||
33567599|NCT02723955|101973197|FG028|Crossover/ Re-treatment Phase|Death|0|||
33567600|NCT02723955|101973198|FG029|Crossover/ Re-treatment Phase|Death|0|||
33567601|NCT02723955|101973199|FG030|Crossover/ Re-treatment Phase|Death|0|||
33567602|NCT02723955|101973200|FG031|Crossover/ Re-treatment Phase|Death|0|||
33567603|NCT02723955|101973201|FG032|Crossover/ Re-treatment Phase|Death|0|||
33567604|NCT02723955|101973202|FG033|Crossover/ Re-treatment Phase|Death|0|||
33193071|NCT02357576|100612605|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
33193072|NCT02357576|100612604|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
33311783|NCT02667587|101037402|FG001|Pre-Treatment|Participant withdrew consent|1|||
33311784|NCT02667587|101037401|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
33567605|NCT02723955|101973203|FG034|Crossover/ Re-treatment Phase|Death|0|||
33567606|NCT02723955|101973204|FG035|Crossover/ Re-treatment Phase|Death|0|||
33602139|NCT00762996|102095209|FG000|Period One|Withdrawal by Subject|0|||
33602140|NCT00762996|102095210|FG001|Period One|Withdrawal by Subject|0|||
33602141|NCT00762996|102095211|FG002|Period One|Withdrawal by Subject|1|||
33602142|NCT00762996|102095212|FG003|Period One|Withdrawal by Subject|0|||
33602143|NCT00495755|102095222|FG000|Overall Study|Adverse Event|3|||
33602144|NCT02723175|102095223|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
33602145|NCT02723175|102095224|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
33602146|NCT02723175|102095223|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
33395039|NCT00832091|101331942|FG000|Overall Study|Adverse Event|1|||
33502487|NCT00952068|101734973|FG000|Overall Study|Adverse Event|3|||
33502488|NCT00952068|101734973|FG000|Overall Study|Withdrawal by Subject|4|||
33502489|NCT00975611|101734976|FG000|Overall Study|Screen Fail|16|||
33502490|NCT00975611|101734976|FG000|Overall Study|Physician Decision|1|||
33502491|NCT01894841|101734977|FG000|Overall Study|Withdrawal by Subject|9|||
33502492|NCT01894841|101734978|FG001|Overall Study|Withdrawal by Subject|4|||
33502493|NCT01894841|101734977|FG000|Overall Study|Withdrawn by investigator|2|||
33502494|NCT01894841|101734978|FG001|Overall Study|Withdrawn by investigator|2|||
33502495|NCT01894841|101734977|FG000|Overall Study|Lost to Follow-up|7|||
33502496|NCT01894841|101734978|FG001|Overall Study|Lost to Follow-up|3|||
33502497|NCT00940823|101734979|FG000|Overall Study|Death|8|||
33502498|NCT00940823|101734980|FG001|Overall Study|Death|12|||
33502499|NCT00940823|101734979|FG000|Overall Study|Lost to Follow-up|27|||
33502500|NCT00940823|101734980|FG001|Overall Study|Lost to Follow-up|20|||
33502501|NCT03018080|101734984|FG000|Overall Study|Death|12|||
33502502|NCT03018080|101734985|FG001|Overall Study|Death|19|||
33502503|NCT00454363|101734986|FG000|Overall Study|Adverse Event|1|||
33502504|NCT00454363|101734987|FG001|Overall Study|Adverse Event|2|||
33502505|NCT00454363|101734986|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
33502506|NCT00454363|101734987|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
33502507|NCT02395848|101734989|FG000|Overall Study|Lost to Follow-up|2|||
33502508|NCT04411810|101734992|FG000|Overall Study|Screen failure|1|||
33502509|NCT04411810|101734992|FG000|Overall Study|Withdrawal by Subject|1|||
33502510|NCT03777436|101734993|FG000|Placebo-controlled Phase|Adverse Event|8|||
33502511|NCT03777436|101734994|FG001|Placebo-controlled Phase|Adverse Event|10|||
33502512|NCT03777436|101734995|FG002|Placebo-controlled Phase|Adverse Event|0|||
33502513|NCT03777436|101734993|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
33502514|NCT03777436|101734994|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
33502515|NCT03777436|101734995|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
33502516|NCT03777436|101734993|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
33502517|NCT03777436|101734994|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
33502518|NCT03777436|101734995|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
33502519|NCT03777436|101734993|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
33502520|NCT03777436|101734994|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
33502521|NCT03777436|101734995|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
33502522|NCT03777436|101734993|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
33502523|NCT03777436|101734994|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
33502524|NCT03777436|101734995|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
33502525|NCT03777436|101734993|FG000|Placebo-controlled Phase|Physician Decision|0|||
33602147|NCT02723175|102095224|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
33602148|NCT01995552|102095227|FG000|Overall Study|Protocol Violation|1|||
33602149|NCT01995552|102095227|FG000|Overall Study|Lack of Efficacy|15|||
33602150|NCT01995552|102095227|FG000|Overall Study|Death|1|||
33602151|NCT01167907|102095228|FG000|Overall Study|Protocol Violation|1|||
33602152|NCT01167907|102095229|FG001|Overall Study|Protocol Violation|0|||
33311785|NCT02667587|101037402|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
33311786|NCT02667587|101037401|FG000|End of Treatment|Other reasons|11|||
33311787|NCT02667587|101037402|FG001|End of Treatment|Other reasons|8|||
33311788|NCT02667587|101037401|FG000|End of Treatment|Participant no Longer Meets Study Criteria|1|||
33311789|NCT02667587|101037402|FG001|End of Treatment|Participant no Longer Meets Study Criteria|2|||
33311790|NCT02667587|101037401|FG000|End of Treatment|Poor/Non-Compliance|0|||
33311791|NCT02667587|101037402|FG001|End of Treatment|Poor/Non-Compliance|1|||
33311792|NCT02667587|101037401|FG000|End of Treatment|Maximum Clinical Benefit|3|||
33311793|NCT02667587|101037402|FG001|End of Treatment|Maximum Clinical Benefit|3|||
33311794|NCT02667587|101037401|FG000|End of Treatment|Participant Withdrew Consent|5|||
33311795|NCT02667587|101037402|FG001|End of Treatment|Participant Withdrew Consent|6|||
33311796|NCT02667587|101037401|FG000|End of Treatment|Participants Request to Discontinue Study Treatment|25|||
33311797|NCT02667587|101037402|FG001|End of Treatment|Participants Request to Discontinue Study Treatment|26|||
33311798|NCT02667587|101037401|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
33502526|NCT03777436|101734994|FG001|Placebo-controlled Phase|Physician Decision|1|||
33311799|NCT02667587|101037402|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
33502527|NCT03777436|101734995|FG002|Placebo-controlled Phase|Physician Decision|0|||
33502528|NCT03777436|101734993|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
33502529|NCT03777436|101734994|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
33502530|NCT03777436|101734995|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
33502531|NCT03777436|101734993|FG000|Apremilast Extension Phase|Adverse Event|0|||
33502532|NCT03777436|101734994|FG001|Apremilast Extension Phase|Adverse Event|0|||
33502533|NCT03777436|101734995|FG002|Apremilast Extension Phase|Adverse Event|6|||
33502534|NCT03777436|101734993|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
33502535|NCT03777436|101734994|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
33502536|NCT03777436|101734995|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
33502537|NCT03777436|101734993|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
33502538|NCT03777436|101734994|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
33502539|NCT03777436|101734995|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
33502540|NCT03777436|101734993|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
33502541|NCT03777436|101734994|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
33502542|NCT03777436|101734995|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
33502543|NCT03777436|101734993|FG000|Apremilast Extension Phase|Miscellaneous|0|||
33502544|NCT03777436|101734994|FG001|Apremilast Extension Phase|Miscellaneous|0|||
33502545|NCT03777436|101734995|FG002|Apremilast Extension Phase|Miscellaneous|1|||
33502546|NCT02347774|101734996|FG000|Study Participation|Lost to Follow-up|3|||
33502547|NCT02347774|101734997|FG001|Study Participation|Lost to Follow-up|6|||
33502548|NCT02347774|101734998|FG002|Study Participation|Lost to Follow-up|2|||
33502549|NCT02347774|101734996|FG000|Study Participation|Withdrawal by Subject|8|||
33502550|NCT02347774|101734997|FG001|Study Participation|Withdrawal by Subject|9|||
33502551|NCT02347774|101734998|FG002|Study Participation|Withdrawal by Subject|15|||
33502552|NCT02347774|101734996|FG000|Study Participation|Adverse Event|1|||
33502553|NCT02347774|101734997|FG001|Study Participation|Adverse Event|4|||
33502554|NCT02347774|101734998|FG002|Study Participation|Adverse Event|6|||
33502555|NCT02347774|101734996|FG000|Study Participation|withdrew consent|1|||
33502556|NCT02347774|101734997|FG001|Study Participation|withdrew consent|1|||
33502557|NCT02347774|101734998|FG002|Study Participation|withdrew consent|1|||
33502558|NCT02347774|101734996|FG000|Study Participation|Met Prolonged QT criteria|1|||
33502559|NCT02347774|101734997|FG001|Study Participation|Met Prolonged QT criteria|0|||
33502560|NCT02347774|101734998|FG002|Study Participation|Met Prolonged QT criteria|0|||
33502561|NCT02347774|101734996|FG000|Study Participation|non-compliance with study drug|0|||
33502562|NCT02347774|101734997|FG001|Study Participation|non-compliance with study drug|1|||
33502563|NCT02347774|101734998|FG002|Study Participation|non-compliance with study drug|0|||
33502564|NCT02347774|101734996|FG000|Study Participation|incarceration|1|||
33395040|NCT00832091|101331943|FG001|Overall Study|Adverse Event|1|||
33395041|NCT00832091|101331942|FG000|Overall Study|Protocol Violation|1|||
33395042|NCT00832091|101331943|FG001|Overall Study|Protocol Violation|0|||
33395043|NCT00832091|101331942|FG000|Overall Study|Withdrawal by Subject|2|||
33395044|NCT00832091|101331943|FG001|Overall Study|Withdrawal by Subject|1|||
33395045|NCT00832091|101331942|FG000|Overall Study|Prohibited Medication|1|||
33395046|NCT00832091|101331943|FG001|Overall Study|Prohibited Medication|0|||
33395047|NCT01512693|101331949|FG000|Overall Study|Withdrawal by Subject|0|||
33395048|NCT01512693|101331950|FG001|Overall Study|Withdrawal by Subject|1|||
33502565|NCT02347774|101734997|FG001|Study Participation|incarceration|0|||
33502566|NCT02347774|101734998|FG002|Study Participation|incarceration|0|||
33502567|NCT02347774|101734996|FG000|Study Participation|randomized in error|0|||
33502568|NCT02347774|101734997|FG001|Study Participation|randomized in error|0|||
33502569|NCT02347774|101734998|FG002|Study Participation|randomized in error|1|||
33602153|NCT01167907|102095228|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
33395049|NCT04280081|101331953|FG000|Overall Study|Adverse Event|4|||
33395050|NCT04280081|101331953|FG000|Overall Study|Death|2|||
33395051|NCT04280081|101331953|FG000|Overall Study|Progressive Disease|6|||
33395052|NCT00085644|101331954|FG000|Double-Blind Period|Adverse Event|5|||
33395053|NCT00085644|101331955|FG001|Double-Blind Period|Adverse Event|2|||
33395054|NCT00085644|101331956|FG002|Double-Blind Period|Adverse Event|0|||
33395055|NCT00085644|101331954|FG000|Double-Blind Period|Withdrawal by Subject|3|||
33395056|NCT00085644|101331955|FG001|Double-Blind Period|Withdrawal by Subject|0|||
33395057|NCT00085644|101331956|FG002|Double-Blind Period|Withdrawal by Subject|0|||
33395058|NCT00085644|101331954|FG000|Double-Blind Period|Lost to Follow-up|2|||
33395059|NCT00085644|101331955|FG001|Double-Blind Period|Lost to Follow-up|1|||
33395060|NCT00085644|101331956|FG002|Double-Blind Period|Lost to Follow-up|0|||
33395061|NCT00085644|101331954|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
33395062|NCT00085644|101331955|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
33395063|NCT00085644|101331956|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
33395064|NCT00085644|101331954|FG000|Double-Blind Period|Contemplating pregnancy|1|||
33395065|NCT00085644|101331955|FG001|Double-Blind Period|Contemplating pregnancy|0|||
33395066|NCT00085644|101331956|FG002|Double-Blind Period|Contemplating pregnancy|0|||
33395067|NCT00085644|101331954|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
33395068|NCT00085644|101331955|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
33395069|NCT00085644|101331956|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
33395070|NCT00085644|101331954|FG000|Open-Label Period|Adverse Event|0|||
33395071|NCT00085644|101331955|FG001|Open-Label Period|Adverse Event|0|||
33395072|NCT00085644|101331956|FG002|Open-Label Period|Adverse Event|38|||
33395073|NCT00085644|101331954|FG000|Open-Label Period|Withdrawal by Subject|0|||
33502570|NCT02347774|101734996|FG000|On Study Treatment|Adverse Event|9|||
33502571|NCT02347774|101734997|FG001|On Study Treatment|Adverse Event|15|||
33502572|NCT02347774|101734998|FG002|On Study Treatment|Adverse Event|19|||
33502573|NCT02347774|101734996|FG000|On Study Treatment|Lack of Efficacy|3|||
33502574|NCT02347774|101734997|FG001|On Study Treatment|Lack of Efficacy|0|||
33502575|NCT02347774|101734998|FG002|On Study Treatment|Lack of Efficacy|2|||
33502576|NCT02347774|101734996|FG000|On Study Treatment|non-complicance with study medication|0|||
33502577|NCT02347774|101734997|FG001|On Study Treatment|non-complicance with study medication|2|||
33502578|NCT02347774|101734998|FG002|On Study Treatment|non-complicance with study medication|0|||
33502579|NCT02347774|101734996|FG000|On Study Treatment|Protocol Violation|0|||
33502580|NCT02347774|101734997|FG001|On Study Treatment|Protocol Violation|0|||
33502581|NCT02347774|101734998|FG002|On Study Treatment|Protocol Violation|1|||
33502582|NCT02347774|101734996|FG000|On Study Treatment|withdrew consent|9|||
33502583|NCT02347774|101734997|FG001|On Study Treatment|withdrew consent|8|||
33602154|NCT01167907|102095229|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
33502584|NCT02347774|101734998|FG002|On Study Treatment|withdrew consent|12|||
33502585|NCT02347774|101734996|FG000|On Study Treatment|Lost to Follow-up|2|||
33502586|NCT02347774|101734997|FG001|On Study Treatment|Lost to Follow-up|6|||
33602155|NCT03550404|102095233|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
33602156|NCT03550404|102095234|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
33602157|NCT03550404|102095235|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
33395074|NCT00085644|101331955|FG001|Open-Label Period|Withdrawal by Subject|0|||
33395075|NCT00085644|101331956|FG002|Open-Label Period|Withdrawal by Subject|29|||
33395076|NCT00085644|101331954|FG000|Open-Label Period|Lost to Follow-up|0|||
33395077|NCT00085644|101331955|FG001|Open-Label Period|Lost to Follow-up|0|||
33502587|NCT02347774|101734998|FG002|On Study Treatment|Lost to Follow-up|1|||
33395078|NCT00085644|101331956|FG002|Open-Label Period|Lost to Follow-up|13|||
33395079|NCT00085644|101331954|FG000|Open-Label Period|Lack of Efficacy|0|||
33502588|NCT02347774|101734996|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
33602158|NCT03550404|102095233|FG000|Phase 2|Vacated position|1|||
33602159|NCT03550404|102095234|FG001|Phase 2|Vacated position|0|||
33193073|NCT02357576|100612605|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
33193074|NCT02357576|100612604|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
33193075|NCT02357576|100612605|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
33193076|NCT02357576|100612604|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
33193077|NCT02357576|100612605|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
33193078|NCT02143843|100612606|FG000|Overall Study|Adverse Event|8|||
33193079|NCT02143843|100612606|FG000|Overall Study|Lack of Efficacy|2|||
33193080|NCT02143843|100612606|FG000|Overall Study|Withdrawal by Subject|2|||
33193081|NCT01282216|100612612|FG000|Overall Study|Graft failure|0|||
33193082|NCT01282216|100612613|FG001|Overall Study|Graft failure|0|||
33193083|NCT01282216|100612614|FG002|Overall Study|Graft failure|3|||
33193084|NCT01282216|100612615|FG003|Overall Study|Graft failure|2|||
33193085|NCT01282216|100612612|FG000|Overall Study|Physician Decision|0|||
33193086|NCT01282216|100612613|FG001|Overall Study|Physician Decision|0|||
33193087|NCT01282216|100612614|FG002|Overall Study|Physician Decision|11|||
33193088|NCT01282216|100612615|FG003|Overall Study|Physician Decision|0|||
33193089|NCT01282216|100612612|FG000|Overall Study|Relapse|0|||
33193090|NCT01282216|100612613|FG001|Overall Study|Relapse|0|||
33193091|NCT01282216|100612614|FG002|Overall Study|Relapse|17|||
33193092|NCT01282216|100612615|FG003|Overall Study|Relapse|6|||
33193093|NCT01282216|100612612|FG000|Overall Study|Death|0|||
33193094|NCT01282216|100612613|FG001|Overall Study|Death|0|||
33193095|NCT01282216|100612614|FG002|Overall Study|Death|2|||
33193096|NCT01282216|100612615|FG003|Overall Study|Death|0|||
33193097|NCT03592641|100612616|FG000|Overall Study|Withdrawal by Subject|1|||
33193098|NCT00333229|100612619|FG000|Overall Study|Lack of Efficacy|0|||
33193099|NCT00333229|100612620|FG001|Overall Study|Lack of Efficacy|1|||
33193100|NCT00705575|100612623|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33193101|NCT00705575|100612624|FG001|Overall Study|Abnormal laboratory value(s)|3|||
33193102|NCT00705575|100612623|FG000|Overall Study|Abnormal test procedure result(s)|2|||
33193103|NCT00705575|100612624|FG001|Overall Study|Abnormal test procedure result(s)|12|||
33193104|NCT00705575|100612623|FG000|Overall Study|Adverse Event|11|||
33193105|NCT00705575|100612624|FG001|Overall Study|Adverse Event|15|||
33193106|NCT00705575|100612623|FG000|Overall Study|Lost to Follow-up|3|||
33193107|NCT00705575|100612624|FG001|Overall Study|Lost to Follow-up|4|||
33193108|NCT00705575|100612623|FG000|Overall Study|Protocol Violation|2|||
33193109|NCT00705575|100612624|FG001|Overall Study|Protocol Violation|2|||
33193110|NCT00705575|100612623|FG000|Overall Study|Withdrawal by Subject|5|||
33193111|NCT00705575|100612624|FG001|Overall Study|Withdrawal by Subject|10|||
33193112|NCT00414661|100612625|FG000|Overall Study|Death|2|||
33193113|NCT00414661|100612626|FG001|Overall Study|Death|5|||
33193114|NCT00414661|100612627|FG002|Overall Study|Death|0|||
33193115|NCT00414661|100612628|FG003|Overall Study|Death|0|||
33193116|NCT00414661|100612625|FG000|Overall Study|Lost to Follow-up|1|||
33193117|NCT00414661|100612626|FG001|Overall Study|Lost to Follow-up|4|||
33193118|NCT00414661|100612627|FG002|Overall Study|Lost to Follow-up|0|||
33193119|NCT00414661|100612628|FG003|Overall Study|Lost to Follow-up|1|||
33193120|NCT00414661|100612625|FG000|Overall Study|Withdrawal by Subject|5|||
33193121|NCT00414661|100612626|FG001|Overall Study|Withdrawal by Subject|2|||
33193122|NCT00414661|100612627|FG002|Overall Study|Withdrawal by Subject|2|||
33502589|NCT02347774|101734997|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
33502590|NCT02347774|101734998|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
33193123|NCT00414661|100612628|FG003|Overall Study|Withdrawal by Subject|2|||
33193124|NCT00414661|100612625|FG000|Overall Study|Other|6|||
33193125|NCT00414661|100612626|FG001|Overall Study|Other|3|||
33193126|NCT00414661|100612627|FG002|Overall Study|Other|0|||
33193127|NCT00414661|100612628|FG003|Overall Study|Other|0|||
33193128|NCT02579616|100612634|FG000|Overall Study|Participants did not receive treatment|3|||
33193129|NCT00548808|100612635|FG000|Overall Study|Lost to Follow-up|9|||
33193130|NCT00548808|100612636|FG001|Overall Study|Lost to Follow-up|3|||
33193131|NCT00548808|100612635|FG000|Overall Study|Protocol Violation|8|||
33193132|NCT00548808|100612636|FG001|Overall Study|Protocol Violation|8|||
33193133|NCT00548808|100612635|FG000|Overall Study|Withdrawal by Subject|8|||
33193134|NCT00548808|100612636|FG001|Overall Study|Withdrawal by Subject|4|||
33193135|NCT00548808|100612635|FG000|Overall Study|Physician Decision|6|||
33193136|NCT00548808|100612636|FG001|Overall Study|Physician Decision|3|||
33193137|NCT00548808|100612635|FG000|Overall Study|Adverse Event|4|||
33193138|NCT00548808|100612636|FG001|Overall Study|Adverse Event|5|||
33311800|NCT02667587|101037401|FG000|End of Treatment|Death|2|||
33311801|NCT02667587|101037402|FG001|End of Treatment|Death|1|||
33311802|NCT02667587|101037401|FG000|End of Treatment|Study Drug Toxicity|74|||
33311803|NCT02667587|101037402|FG001|End of Treatment|Study Drug Toxicity|18|||
33311804|NCT02667587|101037401|FG000|End of Treatment|Disease progression|177|||
33311805|NCT02667587|101037402|FG001|End of Treatment|Disease progression|222|||
33311806|NCT02667587|101037401|FG000|End of Treatment|Lost to Follow-up|1|||
33311807|NCT02667587|101037402|FG001|End of Treatment|Lost to Follow-up|3|||
33311808|NCT00153062|101037403|FG000|Overall Study|Death|360|||
33311809|NCT00153062|101037404|FG001|Overall Study|Death|352|||
33311810|NCT00153062|101037405|FG002|Overall Study|Death|369|||
33311811|NCT00153062|101037406|FG003|Overall Study|Death|365|||
33311812|NCT00153062|101037403|FG000|Overall Study|Withdrawal by Subject|14|||
33311813|NCT00153062|101037404|FG001|Overall Study|Withdrawal by Subject|30|||
33311814|NCT00153062|101037405|FG002|Overall Study|Withdrawal by Subject|27|||
33311815|NCT00153062|101037406|FG003|Overall Study|Withdrawal by Subject|28|||
33311816|NCT00153062|101037403|FG000|Overall Study|Lost to Follow-up|12|||
33311817|NCT00153062|101037404|FG001|Overall Study|Lost to Follow-up|20|||
33311818|NCT00153062|101037405|FG002|Overall Study|Lost to Follow-up|15|||
33311819|NCT00153062|101037406|FG003|Overall Study|Lost to Follow-up|16|||
33311820|NCT00153062|101037403|FG000|Overall Study|Adverse Event|0|||
33311821|NCT00153062|101037404|FG001|Overall Study|Adverse Event|1|||
33602160|NCT03550404|102095235|FG002|Phase 2|Vacated position|0|||
33602161|NCT02449018|102095241|FG000|Overall Study|Abnormal laboratory value|0|||
33602162|NCT02449018|102095242|FG001|Overall Study|Abnormal laboratory value|1|||
33602163|NCT02449018|102095241|FG000|Overall Study|Administrative problems|1|||
33602164|NCT02449018|102095242|FG001|Overall Study|Administrative problems|0|||
33311822|NCT00153062|101037405|FG002|Overall Study|Adverse Event|1|||
33311823|NCT00153062|101037406|FG003|Overall Study|Adverse Event|0|||
33311824|NCT00153062|101037403|FG000|Overall Study|Protocol Violation|0|||
33311825|NCT00153062|101037404|FG001|Overall Study|Protocol Violation|2|||
33311826|NCT00153062|101037405|FG002|Overall Study|Protocol Violation|1|||
33311827|NCT00153062|101037406|FG003|Overall Study|Protocol Violation|1|||
33311828|NCT00153062|101037403|FG000|Overall Study|No disposition data available|1|||
33311829|NCT00153062|101037404|FG001|Overall Study|No disposition data available|1|||
33502591|NCT02347774|101734996|FG000|On Study Treatment|ranomized in error|0|||
33502592|NCT02347774|101734997|FG001|On Study Treatment|ranomized in error|0|||
33502593|NCT02347774|101734998|FG002|On Study Treatment|ranomized in error|1|||
33502594|NCT00862823|101734999|FG000|First Intervention|Withdrawal by Subject|1|||
33502595|NCT00862823|101735000|FG001|First Intervention|Withdrawal by Subject|1|||
33502596|NCT01294696|101735001|FG000|Overall Study|Screening failures|7|||
33502597|NCT01294696|101735001|FG000|Overall Study|Protocol Violation|8|||
33502598|NCT01294696|101735001|FG000|Overall Study|Missing BPI Response|7|||
33502599|NCT01294696|101735001|FG000|Overall Study|Site closure|52|||
33602165|NCT02449018|102095241|FG000|Overall Study|Adverse Event|5|||
33602166|NCT02449018|102095242|FG001|Overall Study|Adverse Event|1|||
33602167|NCT02449018|102095241|FG000|Overall Study|Protocol deviation|4|||
33602168|NCT02449018|102095242|FG001|Overall Study|Protocol deviation|0|||
33311830|NCT00153062|101037405|FG002|Overall Study|No disposition data available|1|||
33311831|NCT00153062|101037406|FG003|Overall Study|No disposition data available|1|||
33311832|NCT00153062|101037403|FG000|Overall Study|Other|0|||
33311833|NCT00153062|101037404|FG001|Overall Study|Other|0|||
33311834|NCT00153062|101037405|FG002|Overall Study|Other|1|||
33311835|NCT00153062|101037406|FG003|Overall Study|Other|0|||
33311836|NCT00505284|101037407|FG000|Overall Study|Adverse Event|3|||
33311837|NCT00505284|101037408|FG001|Overall Study|Adverse Event|7|||
33311838|NCT00505284|101037409|FG002|Overall Study|Adverse Event|9|||
33311839|NCT00505284|101037410|FG003|Overall Study|Adverse Event|14|||
33311840|NCT00505284|101037411|FG004|Overall Study|Adverse Event|22|||
33311841|NCT00505284|101037407|FG000|Overall Study|Protocol Violation|0|||
33311842|NCT00505284|101037408|FG001|Overall Study|Protocol Violation|1|||
33395080|NCT00085644|101331955|FG001|Open-Label Period|Lack of Efficacy|0|||
33502600|NCT02780713|101735002|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
33502601|NCT02780713|101735003|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
33602169|NCT02449018|102095241|FG000|Overall Study|Patient decision|2|||
33602170|NCT02449018|102095242|FG001|Overall Study|Patient decision|0|||
33602171|NCT01143896|102095243|FG000|Overall Study|Did not complete Baseline Interview|5|||
33602172|NCT01143896|102095244|FG001|Overall Study|Did not complete Baseline Interview|4|||
33311843|NCT00505284|101037409|FG002|Overall Study|Protocol Violation|1|||
33311844|NCT00505284|101037410|FG003|Overall Study|Protocol Violation|0|||
33311845|NCT00505284|101037411|FG004|Overall Study|Protocol Violation|0|||
33311846|NCT00505284|101037407|FG000|Overall Study|Withdrawal by Subject|2|||
33311847|NCT00505284|101037408|FG001|Overall Study|Withdrawal by Subject|6|||
33502602|NCT02780713|101735004|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
33502603|NCT02780713|101735005|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
33502604|NCT02780713|101735006|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
33502605|NCT02498444|101735009|FG000|Overall Study|Withdrawal by Subject|3|||
33502606|NCT02498444|101735010|FG001|Overall Study|Withdrawal by Subject|0|||
33502607|NCT02498444|101735009|FG000|Overall Study|Physician Decision|1|||
33502608|NCT02498444|101735010|FG001|Overall Study|Physician Decision|0|||
33502609|NCT01684943|101735013|FG000|Overall Study|Inadequate Venous Access|3|||
33502610|NCT01684943|101735014|FG001|Overall Study|Inadequate Venous Access|0|||
33502611|NCT01684943|101735015|FG002|Overall Study|Inadequate Venous Access|0|||
33502612|NCT01684943|101735013|FG000|Overall Study|Principal Investigator Determination|1|||
33502613|NCT01684943|101735014|FG001|Overall Study|Principal Investigator Determination|0|||
33502614|NCT01684943|101735015|FG002|Overall Study|Principal Investigator Determination|0|||
33502615|NCT01684943|101735013|FG000|Overall Study|Excluded from Analysis|1|||
33502616|NCT01684943|101735014|FG001|Overall Study|Excluded from Analysis|1|||
33193139|NCT00548808|100612635|FG000|Overall Study|Death|2|||
33193140|NCT00548808|100612636|FG001|Overall Study|Death|0|||
33193141|NCT00548808|100612635|FG000|Overall Study|Entry Criteria Not Met|2|||
33193142|NCT00548808|100612636|FG001|Overall Study|Entry Criteria Not Met|2|||
33193143|NCT00548808|100612635|FG000|Overall Study|Lack of Efficacy|2|||
33193144|NCT00548808|100612636|FG001|Overall Study|Lack of Efficacy|0|||
33193145|NCT00548808|100612635|FG000|Overall Study|Sponsor Decision|1|||
33193146|NCT00548808|100612636|FG001|Overall Study|Sponsor Decision|1|||
33193147|NCT01434823|100612639|FG000|Overall Study|Incomplete data in medical record|4|||
33311848|NCT00505284|101037409|FG002|Overall Study|Withdrawal by Subject|1|||
33311849|NCT00505284|101037410|FG003|Overall Study|Withdrawal by Subject|0|||
33311850|NCT00505284|101037411|FG004|Overall Study|Withdrawal by Subject|6|||
33311851|NCT00505284|101037407|FG000|Overall Study|Lack of Efficacy|0|||
33311852|NCT00505284|101037408|FG001|Overall Study|Lack of Efficacy|1|||
33311853|NCT00505284|101037409|FG002|Overall Study|Lack of Efficacy|1|||
33311854|NCT00505284|101037410|FG003|Overall Study|Lack of Efficacy|1|||
33311855|NCT00505284|101037411|FG004|Overall Study|Lack of Efficacy|1|||
33311856|NCT00505284|101037407|FG000|Overall Study|Physician Decision|0|||
33311857|NCT00505284|101037408|FG001|Overall Study|Physician Decision|1|||
33311858|NCT00505284|101037409|FG002|Overall Study|Physician Decision|0|||
33311859|NCT00505284|101037410|FG003|Overall Study|Physician Decision|0|||
33311860|NCT00505284|101037411|FG004|Overall Study|Physician Decision|0|||
33311861|NCT00505284|101037407|FG000|Overall Study|Other|5|||
33311862|NCT00505284|101037408|FG001|Overall Study|Other|0|||
33311863|NCT00505284|101037409|FG002|Overall Study|Other|0|||
33311864|NCT00505284|101037410|FG003|Overall Study|Other|4|||
33311865|NCT00505284|101037411|FG004|Overall Study|Other|4|||
33311866|NCT01248780|101037414|FG000|Overall Study|Lack of Efficacy|2|||
33311867|NCT01248780|101037415|FG001|Overall Study|Lack of Efficacy|0|||
33311868|NCT01248780|101037414|FG000|Overall Study|Lost to Follow-up|0|||
33311869|NCT01248780|101037415|FG001|Overall Study|Lost to Follow-up|1|||
33311870|NCT01248780|101037414|FG000|Overall Study|Death|0|||
33311871|NCT01248780|101037415|FG001|Overall Study|Death|1|||
33311872|NCT01248780|101037414|FG000|Overall Study|Adverse Event|2|||
33311873|NCT01248780|101037415|FG001|Overall Study|Adverse Event|7|||
33311874|NCT01248780|101037414|FG000|Overall Study|Protocol Violation|1|||
33311875|NCT01248780|101037415|FG001|Overall Study|Protocol Violation|1|||
33311876|NCT01248780|101037414|FG000|Overall Study|Withdrawal by Subject|4|||
33311877|NCT01248780|101037415|FG001|Overall Study|Withdrawal by Subject|4|||
33311878|NCT01248780|101037414|FG000|Overall Study|Not treated|0|||
33311879|NCT01248780|101037415|FG001|Overall Study|Not treated|1|||
33311880|NCT00901186|101037419|FG000|Overall Study|Lack of Efficacy|0|||
33311881|NCT00901186|101037420|FG001|Overall Study|Lack of Efficacy|1|||
33311882|NCT00901186|101037419|FG000|Overall Study|Abnormal laboratory values|0|||
33311883|NCT00901186|101037420|FG001|Overall Study|Abnormal laboratory values|1|||
33193148|NCT01434823|100612640|FG001|Overall Study|Incomplete data in medical record|7|||
33193149|NCT03837899|100612641|FG000|Overall Study|Death|6|||
33311884|NCT00901186|101037419|FG000|Overall Study|Lost to Follow-up|2|||
33193150|NCT03837899|100612642|FG001|Overall Study|Death|8|||
33193151|NCT03837899|100612643|FG002|Overall Study|Death|3|||
33193152|NCT03837899|100612644|FG003|Overall Study|Death|7|||
33311885|NCT00901186|101037420|FG001|Overall Study|Lost to Follow-up|0|||
33311886|NCT00901186|101037419|FG000|Overall Study|Adverse Event|2|||
33311887|NCT00901186|101037420|FG001|Overall Study|Adverse Event|4|||
33311888|NCT00901186|101037419|FG000|Overall Study|Administration problems|0|||
33193153|NCT03837899|100612645|FG004|Overall Study|Death|8|||
33193154|NCT03837899|100612646|FG005|Overall Study|Death|7|||
33311889|NCT00901186|101037420|FG001|Overall Study|Administration problems|1|||
33311890|NCT00901186|101037419|FG000|Overall Study|Protocol deviations|5|||
33395081|NCT00085644|101331956|FG002|Open-Label Period|Lack of Efficacy|15|||
33395082|NCT00085644|101331954|FG000|Open-Label Period|Pregnancy|0|||
33395083|NCT00085644|101331955|FG001|Open-Label Period|Pregnancy|0|||
33395084|NCT00085644|101331956|FG002|Open-Label Period|Pregnancy|3|||
33395085|NCT00085644|101331954|FG000|Open-Label Period|Contemplating pregnancy|0|||
33395086|NCT00085644|101331955|FG001|Open-Label Period|Contemplating pregnancy|0|||
33395087|NCT00085644|101331956|FG002|Open-Label Period|Contemplating pregnancy|3|||
33395088|NCT00085644|101331954|FG000|Open-Label Period|Protocol Violation|0|||
33395089|NCT00085644|101331955|FG001|Open-Label Period|Protocol Violation|0|||
33395090|NCT00085644|101331956|FG002|Open-Label Period|Protocol Violation|4|||
33395091|NCT00085644|101331954|FG000|Open-Label Period|Personal reason|0|||
33395092|NCT00085644|101331955|FG001|Open-Label Period|Personal reason|0|||
33395093|NCT00085644|101331956|FG002|Open-Label Period|Personal reason|4|||
33395094|NCT00998985|101331957|FG000|Overall Study|Withdrawal by Subject|0|||
33395095|NCT00998985|101331958|FG001|Overall Study|Withdrawal by Subject|0|||
33395096|NCT00998985|101331959|FG002|Overall Study|Withdrawal by Subject|0|||
33395097|NCT00998985|101331960|FG003|Overall Study|Withdrawal by Subject|0|||
33395098|NCT00998985|101331961|FG004|Overall Study|Withdrawal by Subject|0|||
33395099|NCT00998985|101331962|FG005|Overall Study|Withdrawal by Subject|0|||
33395100|NCT00998985|101331963|FG006|Overall Study|Withdrawal by Subject|0|||
33395101|NCT00998985|101331964|FG007|Overall Study|Withdrawal by Subject|0|||
33395102|NCT00998985|101331965|FG008|Overall Study|Withdrawal by Subject|1|||
33395103|NCT00998985|101331966|FG009|Overall Study|Withdrawal by Subject|0|||
33395104|NCT00998985|101331967|FG010|Overall Study|Withdrawal by Subject|0|||
33395105|NCT00998985|101331968|FG011|Overall Study|Withdrawal by Subject|0|||
33395106|NCT00998985|101331969|FG012|Overall Study|Withdrawal by Subject|0|||
33395107|NCT00998985|101331970|FG013|Overall Study|Withdrawal by Subject|0|||
33395108|NCT00998985|101331957|FG000|Overall Study|Protocol Violation|0|||
33395109|NCT00998985|101331958|FG001|Overall Study|Protocol Violation|0|||
33395110|NCT00998985|101331959|FG002|Overall Study|Protocol Violation|0|||
33395111|NCT00998985|101331960|FG003|Overall Study|Protocol Violation|0|||
33395112|NCT00998985|101331961|FG004|Overall Study|Protocol Violation|0|||
33395113|NCT00998985|101331962|FG005|Overall Study|Protocol Violation|1|||
33395114|NCT00998985|101331963|FG006|Overall Study|Protocol Violation|0|||
33395115|NCT00998985|101331964|FG007|Overall Study|Protocol Violation|0|||
33395116|NCT00998985|101331965|FG008|Overall Study|Protocol Violation|0|||
33395117|NCT00998985|101331966|FG009|Overall Study|Protocol Violation|0|||
33395118|NCT00998985|101331967|FG010|Overall Study|Protocol Violation|0|||
33395119|NCT00998985|101331968|FG011|Overall Study|Protocol Violation|0|||
33395120|NCT00998985|101331969|FG012|Overall Study|Protocol Violation|0|||
33395121|NCT00998985|101331970|FG013|Overall Study|Protocol Violation|0|||
33395122|NCT03864627|101331977|FG000|Overall Study|Adverse Event|0|||
33395123|NCT03864627|101331978|FG001|Overall Study|Adverse Event|1|||
33502617|NCT01684943|101735015|FG002|Overall Study|Excluded from Analysis|1|||
33502618|NCT01684943|101735013|FG000|Overall Study|Lost to Follow-up|3|||
33311891|NCT00901186|101037420|FG001|Overall Study|Protocol deviations|4|||
33311892|NCT01506609|101037421|FG000|Overall Study|Adverse Event Related to Progression|0|||
33311893|NCT01506609|101037422|FG001|Overall Study|Adverse Event Related to Progression|0|||
33311894|NCT01506609|101037423|FG002|Overall Study|Adverse Event Related to Progression|0|||
33311895|NCT01506609|101037424|FG003|Overall Study|Adverse Event Related to Progression|3|||
33311896|NCT01506609|101037425|FG004|Overall Study|Adverse Event Related to Progression|7|||
33311897|NCT01506609|101037426|FG005|Overall Study|Adverse Event Related to Progression|3|||
33311898|NCT01506609|101037421|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
33311899|NCT01506609|101037422|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
33311900|NCT01506609|101037423|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
33311901|NCT01506609|101037424|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
33311902|NCT01506609|101037425|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
33311903|NCT01506609|101037426|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
33311904|NCT01506609|101037421|FG000|Overall Study|Withdrawal by Subject|0|||
33311905|NCT01506609|101037422|FG001|Overall Study|Withdrawal by Subject|0|||
33311906|NCT01506609|101037423|FG002|Overall Study|Withdrawal by Subject|0|||
33395124|NCT03864627|101331977|FG000|Overall Study|Lack of Efficacy|0|||
33395125|NCT03864627|101331978|FG001|Overall Study|Lack of Efficacy|1|||
33395126|NCT03864627|101331977|FG000|Overall Study|Lost to Follow-up|0|||
33395127|NCT03864627|101331978|FG001|Overall Study|Lost to Follow-up|1|||
33395128|NCT03864627|101331977|FG000|Overall Study|Withdrawal by Subject|4|||
33395129|NCT03864627|101331978|FG001|Overall Study|Withdrawal by Subject|8|||
33395130|NCT03864627|101331977|FG000|Overall Study|Study terminated by sponsor|0|||
33395131|NCT03864627|101331978|FG001|Overall Study|Study terminated by sponsor|1|||
33311907|NCT01506609|101037424|FG003|Overall Study|Withdrawal by Subject|9|||
33311908|NCT01506609|101037425|FG004|Overall Study|Withdrawal by Subject|7|||
33395132|NCT01080625|101331979|FG000|Overall Study|Physician Decision|0|||
33395133|NCT01080625|101331980|FG001|Overall Study|Physician Decision|2|||
33395134|NCT01080625|101331981|FG002|Overall Study|Physician Decision|1|||
33395135|NCT02096471|101334678|FG000|Overall Study|Adverse Event|1|||
33395136|NCT02096471|101334678|FG000|Overall Study|Lack of Efficacy|7|||
33311909|NCT01506609|101037426|FG005|Overall Study|Withdrawal by Subject|7|||
33311910|NCT01506609|101037421|FG000|Overall Study|Lost to Follow-up|0|||
33311911|NCT01506609|101037422|FG001|Overall Study|Lost to Follow-up|0|||
33311912|NCT01506609|101037423|FG002|Overall Study|Lost to Follow-up|0|||
33311913|NCT01506609|101037424|FG003|Overall Study|Lost to Follow-up|1|||
33311914|NCT01506609|101037425|FG004|Overall Study|Lost to Follow-up|2|||
33311915|NCT01506609|101037426|FG005|Overall Study|Lost to Follow-up|0|||
33311916|NCT01506609|101037421|FG000|Overall Study|Sponsor Discontinued Study|0|||
33311917|NCT01506609|101037422|FG001|Overall Study|Sponsor Discontinued Study|0|||
33311918|NCT01506609|101037423|FG002|Overall Study|Sponsor Discontinued Study|0|||
33311919|NCT01506609|101037424|FG003|Overall Study|Sponsor Discontinued Study|2|||
33311920|NCT01506609|101037425|FG004|Overall Study|Sponsor Discontinued Study|2|||
33311921|NCT01506609|101037426|FG005|Overall Study|Sponsor Discontinued Study|0|||
33311922|NCT01506609|101037421|FG000|Overall Study|Progressive Disease per Protocol|1|||
33311923|NCT01506609|101037422|FG001|Overall Study|Progressive Disease per Protocol|0|||
33311924|NCT01506609|101037423|FG002|Overall Study|Progressive Disease per Protocol|0|||
33311925|NCT01506609|101037424|FG003|Overall Study|Progressive Disease per Protocol|64|||
33311926|NCT01506609|101037425|FG004|Overall Study|Progressive Disease per Protocol|57|||
33311927|NCT01506609|101037426|FG005|Overall Study|Progressive Disease per Protocol|74|||
33311928|NCT01506609|101037421|FG000|Overall Study|Other, Not Specified|0|||
33311929|NCT01506609|101037422|FG001|Overall Study|Other, Not Specified|0|||
33311930|NCT01506609|101037423|FG002|Overall Study|Other, Not Specified|0|||
33311931|NCT01506609|101037424|FG003|Overall Study|Other, Not Specified|10|||
33311932|NCT01506609|101037425|FG004|Overall Study|Other, Not Specified|7|||
33311933|NCT01506609|101037426|FG005|Overall Study|Other, Not Specified|3|||
33311934|NCT01506609|101037421|FG000|Overall Study|Missing / Unknown Reason|1|||
33311935|NCT01506609|101037422|FG001|Overall Study|Missing / Unknown Reason|0|||
33311936|NCT01506609|101037423|FG002|Overall Study|Missing / Unknown Reason|1|||
33311937|NCT01506609|101037424|FG003|Overall Study|Missing / Unknown Reason|4|||
33311938|NCT01506609|101037425|FG004|Overall Study|Missing / Unknown Reason|4|||
33311939|NCT01506609|101037426|FG005|Overall Study|Missing / Unknown Reason|2|||
33311940|NCT00528645|101037430|FG000|Overall Study|Adverse Event|3|||
33311941|NCT02951767|101037438|FG000|Overall Study|Study Terminated By Sponsor|9|||
33311942|NCT02951767|101037438|FG000|Overall Study|Withdrawal by Subject|11|||
33311943|NCT02951767|101037438|FG000|Overall Study|Death|96|||
33311944|NCT02951767|101037438|FG000|Overall Study|Lost to Follow-up|2|||
33311945|NCT02951767|101037438|FG000|Overall Study|Physician Decision|1|||
33311946|NCT02075541|101037439|FG000|Overall Study|Serious Adverse Event|1|||
33311947|NCT02075541|101037440|FG001|Overall Study|Serious Adverse Event|4|||
33311948|NCT02075541|101037439|FG000|Overall Study|Protocol Violation|1|||
33311949|NCT02075541|101037440|FG001|Overall Study|Protocol Violation|0|||
33311950|NCT02075541|101037439|FG000|Overall Study|Withdrawal by Subject|1|||
33311951|NCT02075541|101037440|FG001|Overall Study|Withdrawal by Subject|3|||
33311952|NCT02075541|101037439|FG000|Overall Study|Sponsor study termination|0|||
33311953|NCT02075541|101037440|FG001|Overall Study|Sponsor study termination|1|||
33311954|NCT02075541|101037439|FG000|Overall Study|Other- unable to perform study procedure|1|||
33311955|NCT02075541|101037440|FG001|Overall Study|Other- unable to perform study procedure|0|||
33311956|NCT01650246|101037441|FG000|Overall Study|Adverse Event|23|||
33311957|NCT01650246|101037441|FG000|Overall Study|Protocol Violation|5|||
33311958|NCT01650246|101037441|FG000|Overall Study|Sponsor terminated study|53|||
33311959|NCT01650246|101037441|FG000|Overall Study|Lost to Follow-up|5|||
33311960|NCT01650246|101037441|FG000|Overall Study|Withdrawal by Subject|26|||
33311961|NCT01650246|101037441|FG000|Overall Study|Death|1|||
33311962|NCT01650246|101037441|FG000|Overall Study|Lack of Efficacy|30|||
33311963|NCT01013597|101037444|FG000|Overall Study|Withdrawal by Subject|1|||
33311964|NCT01012713|101037446|FG000|Overall Study|Lack of Efficacy|3|||
33311965|NCT02768870|101037447|FG000|Overall Study|Death|1|||
33311966|NCT02768870|101037447|FG000|Overall Study|Reoperation|6|||
33311967|NCT02768870|101037447|FG000|Overall Study|Lost to Follow-up|1|||
33502619|NCT01684943|101735014|FG001|Overall Study|Lost to Follow-up|0|||
33311968|NCT02768870|101037447|FG000|Overall Study|Exit|4|||
33311969|NCT00903630|101037448|FG000|Phase 2|Adverse Event|0|||
33311970|NCT00903630|101037449|FG001|Phase 2|Adverse Event|0|||
33311971|NCT00903630|101037450|FG002|Phase 2|Adverse Event|1|||
33311972|NCT00784693|101037452|FG000|Overall Study|Lost to Follow-up|0|||
33311973|NCT00784693|101037453|FG001|Overall Study|Lost to Follow-up|1|||
33311974|NCT00784693|101037452|FG000|Overall Study|Lack of Efficacy|1|||
33311975|NCT00784693|101037453|FG001|Overall Study|Lack of Efficacy|1|||
33311976|NCT00784693|101037452|FG000|Overall Study|Withdrawal by Subject|0|||
33311977|NCT00784693|101037453|FG001|Overall Study|Withdrawal by Subject|4|||
33311978|NCT00784693|101037452|FG000|Overall Study|Randomized but not Treated|1|||
33311979|NCT00784693|101037453|FG001|Overall Study|Randomized but not Treated|0|||
33311980|NCT00784693|101037452|FG000|Overall Study|Other|1|||
33311981|NCT00784693|101037453|FG001|Overall Study|Other|0|||
33311982|NCT02502799|101037454|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
33311983|NCT02502799|101037455|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
33311984|NCT02502799|101037456|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
33311985|NCT02502799|101037457|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
33311986|NCT02502799|101037454|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
33311987|NCT02502799|101037455|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
33311988|NCT02502799|101037456|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
33311989|NCT02502799|101037457|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
33311990|NCT02502799|101037454|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
33311991|NCT02502799|101037455|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
33311992|NCT02502799|101037456|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
33311993|NCT02502799|101037457|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
33311994|NCT02502799|101037454|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
33311995|NCT02502799|101037455|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
33311996|NCT02502799|101037456|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
33311997|NCT02502799|101037457|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
33602173|NCT01143896|102095243|FG000|Overall Study|Lost to Follow-up|18|||
33311998|NCT02502799|101037454|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
33311999|NCT02502799|101037455|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
33312000|NCT02502799|101037456|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
33312001|NCT02502799|101037457|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
33312002|NCT01248065|101037462|FG000|Overall Study|Lost to Follow-up|3|||
33312003|NCT01248065|101037463|FG001|Overall Study|Lost to Follow-up|5|||
33312004|NCT01248065|101037462|FG000|Overall Study|Withdrawal by Subject|14|||
33312005|NCT01248065|101037463|FG001|Overall Study|Withdrawal by Subject|11|||
33312006|NCT01248065|101037462|FG000|Overall Study|Adverse Event|3|||
33312007|NCT01248065|101037463|FG001|Overall Study|Adverse Event|0|||
33312008|NCT01248065|101037462|FG000|Overall Study|Third treatment failure event|3|||
33312009|NCT01248065|101037463|FG001|Overall Study|Third treatment failure event|1|||
33312010|NCT01248065|101037462|FG000|Overall Study|Other|3|||
33312011|NCT01248065|101037463|FG001|Overall Study|Other|5|||
33312012|NCT00511901|101037464|FG000|Overall Study|Withdrawal by Subject|1|||
33312013|NCT00511901|101037465|FG001|Overall Study|Withdrawal by Subject|3|||
33312014|NCT01323634|101037466|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
33312015|NCT01323634|101037467|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
33312016|NCT01323634|101037468|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
33312017|NCT01323634|101037466|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
33312018|NCT01323634|101037467|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
33312019|NCT01323634|101037468|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
33312020|NCT01323634|101037466|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
33312021|NCT01323634|101037467|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
33312022|NCT01323634|101037468|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
33312023|NCT01323634|101037466|FG000|2-week Run-in Period|Physician Decision|5|||
33312024|NCT01323634|101037467|FG001|2-week Run-in Period|Physician Decision|0|||
33312025|NCT01323634|101037468|FG002|2-week Run-in Period|Physician Decision|0|||
33312026|NCT01323634|101037466|FG000|2-week Run-in Period|Protocol Violation|1|||
33312027|NCT01323634|101037467|FG001|2-week Run-in Period|Protocol Violation|0|||
33312028|NCT01323634|101037468|FG002|2-week Run-in Period|Protocol Violation|0|||
33312029|NCT01323634|101037466|FG000|2-week Run-in Period|Adverse Event|1|||
33312030|NCT01323634|101037467|FG001|2-week Run-in Period|Adverse Event|0|||
33312031|NCT01323634|101037468|FG002|2-week Run-in Period|Adverse Event|0|||
33312032|NCT01323634|101037466|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33312033|NCT01323634|101037467|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
33312034|NCT01323634|101037468|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
33312035|NCT01323634|101037466|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33312036|NCT01323634|101037467|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33312037|NCT01323634|101037468|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
33312038|NCT01323634|101037466|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33312039|NCT01323634|101037467|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
33312040|NCT01323634|101037468|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
33312041|NCT01323634|101037466|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33312042|NCT01323634|101037467|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
33312043|NCT01323634|101037468|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
33312044|NCT01323634|101037466|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
33312045|NCT01323634|101037467|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
33312046|NCT01323634|101037468|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
33312047|NCT01323634|101037466|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33312048|NCT01323634|101037467|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
33312049|NCT01323634|101037468|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
33602174|NCT01143896|102095244|FG001|Overall Study|Lost to Follow-up|13|||
33502620|NCT01684943|101735015|FG002|Overall Study|Lost to Follow-up|0|||
33602175|NCT01143896|102095243|FG000|Overall Study|Withdrawal by Subject|13|||
33395137|NCT02096471|101334678|FG000|Overall Study|Withdrawal by Subject|3|||
33312050|NCT01323634|101037466|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
33312051|NCT01323634|101037467|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
33312052|NCT01323634|101037468|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
33312053|NCT04788511|101037469|FG000|Overall Study|Withdrawal by Subject|2|||
33312054|NCT04788511|101037470|FG001|Overall Study|Withdrawal by Subject|1|||
33312055|NCT04788511|101037469|FG000|Overall Study|Lost to Follow-up|2|||
33312056|NCT04788511|101037470|FG001|Overall Study|Lost to Follow-up|7|||
33312057|NCT04788511|101037469|FG000|Overall Study|Death|3|||
33312058|NCT04788511|101037470|FG001|Overall Study|Death|4|||
33312059|NCT00346632|101037471|FG000|Overall Study|Progressive Disease|2|||
33312060|NCT00346632|101037472|FG001|Overall Study|Progressive Disease|2|||
33312061|NCT00346632|101037473|FG002|Overall Study|Progressive Disease|4|||
33312062|NCT00346632|101037474|FG003|Overall Study|Progressive Disease|3|||
33312063|NCT00346632|101037475|FG004|Overall Study|Progressive Disease|3|||
33312064|NCT00346632|101037476|FG005|Overall Study|Progressive Disease|1|||
33312065|NCT00346632|101037477|FG006|Overall Study|Progressive Disease|2|||
33312066|NCT00346632|101037478|FG007|Overall Study|Progressive Disease|2|||
33312067|NCT00346632|101037479|FG008|Overall Study|Progressive Disease|2|||
33312068|NCT00346632|101037480|FG009|Overall Study|Progressive Disease|2|||
33312069|NCT00346632|101037471|FG000|Overall Study|Adverse Event|0|||
33312070|NCT00346632|101037472|FG001|Overall Study|Adverse Event|0|||
33312071|NCT00346632|101037473|FG002|Overall Study|Adverse Event|0|||
33312072|NCT00346632|101037474|FG003|Overall Study|Adverse Event|0|||
33312073|NCT00346632|101037475|FG004|Overall Study|Adverse Event|1|||
33312074|NCT00346632|101037476|FG005|Overall Study|Adverse Event|1|||
33312075|NCT00346632|101037477|FG006|Overall Study|Adverse Event|1|||
33312076|NCT00346632|101037478|FG007|Overall Study|Adverse Event|0|||
33312077|NCT00346632|101037479|FG008|Overall Study|Adverse Event|0|||
33312078|NCT00346632|101037480|FG009|Overall Study|Adverse Event|0|||
33312079|NCT00346632|101037471|FG000|Overall Study|Death|0|||
33312080|NCT00346632|101037472|FG001|Overall Study|Death|0|||
33312081|NCT00346632|101037473|FG002|Overall Study|Death|1|||
33312082|NCT00346632|101037474|FG003|Overall Study|Death|0|||
33312083|NCT00346632|101037475|FG004|Overall Study|Death|0|||
33312084|NCT00346632|101037476|FG005|Overall Study|Death|0|||
33312085|NCT00346632|101037477|FG006|Overall Study|Death|0|||
33312086|NCT00346632|101037478|FG007|Overall Study|Death|0|||
33312087|NCT00346632|101037479|FG008|Overall Study|Death|0|||
33312088|NCT00346632|101037480|FG009|Overall Study|Death|0|||
33312089|NCT00346632|101037471|FG000|Overall Study|Protocol Violation|0|||
33312090|NCT00346632|101037472|FG001|Overall Study|Protocol Violation|0|||
33312091|NCT00346632|101037473|FG002|Overall Study|Protocol Violation|0|||
33395138|NCT02096471|101334678|FG000|Overall Study|Non-Compliant|2|||
33395139|NCT03236506|101334679|FG000|Overall Study|Death|1|||
33395140|NCT03236506|101334680|FG001|Overall Study|Death|1|||
33395141|NCT03236506|101334681|FG002|Overall Study|Death|1|||
33395142|NCT03236506|101334679|FG000|Overall Study|Withdrawal by Subject|3|||
33395143|NCT03236506|101334680|FG001|Overall Study|Withdrawal by Subject|3|||
33395144|NCT03236506|101334681|FG002|Overall Study|Withdrawal by Subject|4|||
33395145|NCT03236506|101334679|FG000|Overall Study|Did not initiate treatment|2|||
33395146|NCT03236506|101334680|FG001|Overall Study|Did not initiate treatment|1|||
33395147|NCT03236506|101334681|FG002|Overall Study|Did not initiate treatment|2|||
33395148|NCT00410514|101334682|FG000|Overall Study|Adverse Event|2|||
33395149|NCT00410514|101334683|FG001|Overall Study|Adverse Event|2|||
33395150|NCT00410514|101334684|FG002|Overall Study|Adverse Event|2|||
33395151|NCT00410514|101334682|FG000|Overall Study|Protocol Violation|0|||
33395152|NCT00410514|101334683|FG001|Overall Study|Protocol Violation|1|||
33312092|NCT00346632|101037474|FG003|Overall Study|Protocol Violation|0|||
33395153|NCT00410514|101334684|FG002|Overall Study|Protocol Violation|1|||
33395154|NCT00410514|101334682|FG000|Overall Study|Lost to Follow-up|0|||
33395155|NCT00410514|101334683|FG001|Overall Study|Lost to Follow-up|0|||
33312093|NCT00346632|101037475|FG004|Overall Study|Protocol Violation|0|||
33312094|NCT00346632|101037476|FG005|Overall Study|Protocol Violation|0|||
33312095|NCT00346632|101037477|FG006|Overall Study|Protocol Violation|1|||
33312096|NCT00346632|101037478|FG007|Overall Study|Protocol Violation|0|||
33312097|NCT00346632|101037479|FG008|Overall Study|Protocol Violation|0|||
33312098|NCT00346632|101037480|FG009|Overall Study|Protocol Violation|0|||
33312099|NCT00346632|101037471|FG000|Overall Study|Withdrawal by Subject|0|||
33312100|NCT00346632|101037472|FG001|Overall Study|Withdrawal by Subject|0|||
33312101|NCT00346632|101037473|FG002|Overall Study|Withdrawal by Subject|0|||
33312102|NCT00346632|101037474|FG003|Overall Study|Withdrawal by Subject|0|||
33312103|NCT00346632|101037475|FG004|Overall Study|Withdrawal by Subject|0|||
33395156|NCT00410514|101334684|FG002|Overall Study|Lost to Follow-up|2|||
33312104|NCT00346632|101037476|FG005|Overall Study|Withdrawal by Subject|0|||
33312105|NCT00346632|101037477|FG006|Overall Study|Withdrawal by Subject|1|||
33312106|NCT00346632|101037478|FG007|Overall Study|Withdrawal by Subject|0|||
33312107|NCT00346632|101037479|FG008|Overall Study|Withdrawal by Subject|0|||
33395157|NCT00410514|101334682|FG000|Overall Study|Non-compliant with study procedures|0|||
33502621|NCT01684943|101735013|FG000|Overall Study|Planning Pregnancy|1|||
33502622|NCT01684943|101735014|FG001|Overall Study|Planning Pregnancy|0|||
33502623|NCT01684943|101735015|FG002|Overall Study|Planning Pregnancy|0|||
33193155|NCT03837899|100612641|FG000|Overall Study|Moved to post-trial access program|0|||
33193156|NCT03837899|100612642|FG001|Overall Study|Moved to post-trial access program|1|||
33193157|NCT03837899|100612643|FG002|Overall Study|Moved to post-trial access program|0|||
33312108|NCT00346632|101037480|FG009|Overall Study|Withdrawal by Subject|0|||
33312109|NCT00346632|101037471|FG000|Overall Study|Switched to alternative treatment|0|||
33312110|NCT00346632|101037472|FG001|Overall Study|Switched to alternative treatment|0|||
33312111|NCT00346632|101037473|FG002|Overall Study|Switched to alternative treatment|1|||
33312112|NCT00346632|101037474|FG003|Overall Study|Switched to alternative treatment|0|||
33312113|NCT00346632|101037475|FG004|Overall Study|Switched to alternative treatment|0|||
33312114|NCT00346632|101037476|FG005|Overall Study|Switched to alternative treatment|0|||
33312115|NCT00346632|101037477|FG006|Overall Study|Switched to alternative treatment|0|||
33312116|NCT00346632|101037478|FG007|Overall Study|Switched to alternative treatment|0|||
33312117|NCT00346632|101037479|FG008|Overall Study|Switched to alternative treatment|0|||
33312118|NCT00346632|101037480|FG009|Overall Study|Switched to alternative treatment|0|||
33312119|NCT00346632|101037471|FG000|Overall Study|Not Stated|1|||
33312120|NCT00346632|101037472|FG001|Overall Study|Not Stated|1|||
33312121|NCT00346632|101037473|FG002|Overall Study|Not Stated|0|||
33312122|NCT00346632|101037474|FG003|Overall Study|Not Stated|0|||
33312123|NCT00346632|101037475|FG004|Overall Study|Not Stated|0|||
33312124|NCT00346632|101037476|FG005|Overall Study|Not Stated|0|||
33312125|NCT00346632|101037477|FG006|Overall Study|Not Stated|0|||
33312126|NCT00346632|101037478|FG007|Overall Study|Not Stated|2|||
33193158|NCT03837899|100612644|FG003|Overall Study|Moved to post-trial access program|0|||
33193159|NCT03837899|100612645|FG004|Overall Study|Moved to post-trial access program|0|||
33193160|NCT03837899|100612646|FG005|Overall Study|Moved to post-trial access program|0|||
33193161|NCT03837899|100612641|FG000|Overall Study|Other|0|||
33193162|NCT03837899|100612642|FG001|Overall Study|Other|0|||
33193163|NCT03837899|100612643|FG002|Overall Study|Other|0|||
33193164|NCT03837899|100612644|FG003|Overall Study|Other|0|||
33193165|NCT03837899|100612645|FG004|Overall Study|Other|0|||
33193166|NCT03837899|100612646|FG005|Overall Study|Other|2|||
33193167|NCT03837899|100612641|FG000|Overall Study|Lost to Follow-up|0|||
33193168|NCT03837899|100612642|FG001|Overall Study|Lost to Follow-up|1|||
33193169|NCT03837899|100612643|FG002|Overall Study|Lost to Follow-up|0|||
33193170|NCT03837899|100612644|FG003|Overall Study|Lost to Follow-up|0|||
33312127|NCT00346632|101037479|FG008|Overall Study|Not Stated|2|||
33312128|NCT00346632|101037480|FG009|Overall Study|Not Stated|1|||
33312129|NCT01054170|101037481|FG000|Overall Study|Protocol Violation|1|||
33312130|NCT01054170|101037482|FG001|Overall Study|Protocol Violation|0|||
33312131|NCT01054170|101037481|FG000|Overall Study|Withdrawal by Subject|3|||
33312132|NCT01054170|101037482|FG001|Overall Study|Withdrawal by Subject|2|||
33312133|NCT01054170|101037481|FG000|Overall Study|Adverse Event|0|||
33312134|NCT01054170|101037482|FG001|Overall Study|Adverse Event|4|||
33312135|NCT00757783|101037483|FG000|Overall Study|Adverse Event|0|||
33312136|NCT00757783|101037484|FG001|Overall Study|Adverse Event|2|||
33312137|NCT00757783|101037483|FG000|Overall Study|Lost to Follow-up|1|||
33312138|NCT00757783|101037484|FG001|Overall Study|Lost to Follow-up|1|||
33312139|NCT00757783|101037483|FG000|Overall Study|Protocol Violation|1|||
33312140|NCT00757783|101037484|FG001|Overall Study|Protocol Violation|0|||
33312141|NCT00757783|101037483|FG000|Overall Study|Withdrawal by Subject|2|||
33312142|NCT00757783|101037484|FG001|Overall Study|Withdrawal by Subject|1|||
33312143|NCT00757783|101037483|FG000|Overall Study|Other|1|||
33312144|NCT00757783|101037484|FG001|Overall Study|Other|2|||
33312145|NCT01688830|101037486|FG000|Overall Study|Lost to Follow-up|0|||
33395158|NCT00410514|101334683|FG001|Overall Study|Non-compliant with study procedures|0|||
33395159|NCT00410514|101334684|FG002|Overall Study|Non-compliant with study procedures|2|||
33395160|NCT00364832|101334685|FG000|Core Period|Early Withdrawals|2|||
33395161|NCT00364832|101334686|FG001|Core Period|Early Withdrawals|2|||
33395162|NCT00364832|101334687|FG002|Core Period|Early Withdrawals|1|||
33395163|NCT00364832|101334688|FG003|Core Period|Early Withdrawals|1|||
33193171|NCT03837899|100612645|FG004|Overall Study|Lost to Follow-up|0|||
33193172|NCT03837899|100612646|FG005|Overall Study|Lost to Follow-up|0|||
33312146|NCT01688830|101037487|FG001|Overall Study|Lost to Follow-up|0|||
33312147|NCT01688830|101037488|FG002|Overall Study|Lost to Follow-up|0|||
33312148|NCT01688830|101037489|FG003|Overall Study|Lost to Follow-up|0|||
33312149|NCT01688830|101037490|FG004|Overall Study|Lost to Follow-up|0|||
33312150|NCT01688830|101037491|FG005|Overall Study|Lost to Follow-up|0|||
33312151|NCT01688830|101037492|FG006|Overall Study|Lost to Follow-up|0|||
33312152|NCT01688830|101037493|FG007|Overall Study|Lost to Follow-up|0|||
33312153|NCT01688830|101037494|FG008|Overall Study|Lost to Follow-up|0|||
33312154|NCT01688830|101037495|FG009|Overall Study|Lost to Follow-up|0|||
33395164|NCT00364832|101334689|FG004|Core Period|Early Withdrawals|0|||
33502624|NCT02199795|101735019|FG000|Overall Study|no longer met inclusion criteria|1|||
33193173|NCT03837899|100612641|FG000|Overall Study|Withdrawal by Subject|0|||
33312155|NCT01688830|101037496|FG010|Overall Study|Lost to Follow-up|1|||
33312156|NCT01688830|101037497|FG011|Overall Study|Lost to Follow-up|0|||
33312157|NCT01688830|101037498|FG012|Overall Study|Lost to Follow-up|0|||
33312158|NCT01688830|101037499|FG013|Overall Study|Lost to Follow-up|0|||
33312159|NCT01688830|101037500|FG014|Overall Study|Lost to Follow-up|0|||
33312160|NCT01688830|101037501|FG015|Overall Study|Lost to Follow-up|0|||
33312161|NCT01688830|101037502|FG016|Overall Study|Lost to Follow-up|0|||
33312162|NCT01688830|101037503|FG017|Overall Study|Lost to Follow-up|0|||
33312163|NCT01688830|101037504|FG018|Overall Study|Lost to Follow-up|0|||
33312164|NCT01688830|101037505|FG019|Overall Study|Lost to Follow-up|0|||
33312165|NCT01688830|101037506|FG020|Overall Study|Lost to Follow-up|0|||
33312166|NCT00818649|101037507|FG000|Overall Study|Declining performance status|2|||
33312167|NCT00818649|101037507|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
33312168|NCT00818649|101037507|FG000|Overall Study|Adverse Event|1|||
33312169|NCT01948908|101037508|FG000|Overall Study|Protocol Violation|1|||
33312170|NCT01948908|101037509|FG001|Overall Study|Protocol Violation|0|||
33312171|NCT01948908|101037510|FG002|Overall Study|Protocol Violation|2|||
33312172|NCT02571049|101037525|FG000|Screening|Did not meet entry criteria|2|||
33395165|NCT00364832|101334690|FG005|Core Period|Early Withdrawals|0|||
33395166|NCT00364832|101334691|FG006|Core Period|Early Withdrawals|4|||
33395167|NCT00364832|101334692|FG007|Core Period|Early Withdrawals|1|||
33395168|NCT00364832|101334693|FG008|Core Period|Early Withdrawals|0|||
33395169|NCT00364832|101334694|FG009|Core Period|Early Withdrawals|0|||
33395170|NCT00364832|101334695|FG010|Core Period|Early Withdrawals|0|||
33395171|NCT00364832|101334696|FG011|Core Period|Early Withdrawals|0|||
33395172|NCT00364832|101334685|FG000|Extension Year 1|Early Withdrawals|0|||
33395173|NCT00364832|101334686|FG001|Extension Year 1|Early Withdrawals|0|||
33395174|NCT00364832|101334687|FG002|Extension Year 1|Early Withdrawals|0|||
33395175|NCT00364832|101334688|FG003|Extension Year 1|Early Withdrawals|0|||
33395176|NCT00364832|101334689|FG004|Extension Year 1|Early Withdrawals|0|||
33395177|NCT00364832|101334690|FG005|Extension Year 1|Early Withdrawals|0|||
33395178|NCT00364832|101334691|FG006|Extension Year 1|Early Withdrawals|0|||
33395179|NCT00364832|101334692|FG007|Extension Year 1|Early Withdrawals|0|||
33395180|NCT00364832|101334693|FG008|Extension Year 1|Early Withdrawals|0|||
33395181|NCT00364832|101334694|FG009|Extension Year 1|Early Withdrawals|4|||
33395182|NCT00364832|101334695|FG010|Extension Year 1|Early Withdrawals|2|||
33395183|NCT00364832|101334696|FG011|Extension Year 1|Early Withdrawals|10|||
33395184|NCT00364832|101334685|FG000|Extension Year 2|Early Withdrawals|0|||
33395185|NCT00364832|101334686|FG001|Extension Year 2|Early Withdrawals|0|||
33395186|NCT00364832|101334687|FG002|Extension Year 2|Early Withdrawals|0|||
33395187|NCT00364832|101334688|FG003|Extension Year 2|Early Withdrawals|0|||
33395188|NCT00364832|101334689|FG004|Extension Year 2|Early Withdrawals|0|||
33395189|NCT00364832|101334690|FG005|Extension Year 2|Early Withdrawals|0|||
33395190|NCT00364832|101334691|FG006|Extension Year 2|Early Withdrawals|0|||
33395191|NCT00364832|101334692|FG007|Extension Year 2|Early Withdrawals|0|||
33395192|NCT00364832|101334693|FG008|Extension Year 2|Early Withdrawals|0|||
33395193|NCT00364832|101334694|FG009|Extension Year 2|Early Withdrawals|5|||
33395194|NCT00364832|101334695|FG010|Extension Year 2|Early Withdrawals|5|||
33395195|NCT00364832|101334696|FG011|Extension Year 2|Early Withdrawals|3|||
33395196|NCT00584987|101334697|FG000|Overall Study|Protocol Violation|1|||
33395197|NCT00584987|101334698|FG001|Overall Study|Protocol Violation|1|||
33602176|NCT01143896|102095244|FG001|Overall Study|Withdrawal by Subject|5|||
33312173|NCT02571049|101037526|FG001|Screening|Did not meet entry criteria|2|||
33312174|NCT02571049|101037525|FG000|Randomization|No migraine attack|0|||
33312175|NCT02571049|101037526|FG001|Randomization|No migraine attack|1|||
33395198|NCT00584987|101334699|FG002|Overall Study|Protocol Violation|1|||
33395199|NCT00584987|101334700|FG003|Overall Study|Protocol Violation|0|||
33395200|NCT00584987|101334697|FG000|Overall Study|Adverse Event|0|||
33395201|NCT00584987|101334698|FG001|Overall Study|Adverse Event|0|||
33395202|NCT00584987|101334699|FG002|Overall Study|Adverse Event|0|||
33395203|NCT00584987|101334700|FG003|Overall Study|Adverse Event|1|||
33395204|NCT01188811|101334704|FG000|Overall Study|Withdrawal by Subject|0|||
33395205|NCT01188811|101334705|FG001|Overall Study|Withdrawal by Subject|2|||
33602177|NCT01143896|102095243|FG000|Overall Study|Death|6|||
33502625|NCT02199795|101735020|FG001|Overall Study|no longer met inclusion criteria|0|||
33502626|NCT02199795|101735019|FG000|Overall Study|withdrew due to shoulder pain|1|||
33502627|NCT02199795|101735020|FG001|Overall Study|withdrew due to shoulder pain|0|||
33502628|NCT01732458|101735021|FG000|Overall Study|Lost to Follow-up|0|||
33502629|NCT01732458|101735022|FG001|Overall Study|Lost to Follow-up|2|||
33502630|NCT01732458|101735023|FG002|Overall Study|Lost to Follow-up|0|||
33502631|NCT01732458|101735024|FG003|Overall Study|Lost to Follow-up|0|||
33502632|NCT01732458|101735021|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33502633|NCT01732458|101735022|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33502634|NCT01732458|101735023|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33502635|NCT01732458|101735024|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33502636|NCT01732458|101735021|FG000|Overall Study|Physician Decision|1|||
33502637|NCT01732458|101735022|FG001|Overall Study|Physician Decision|2|||
33502638|NCT01732458|101735023|FG002|Overall Study|Physician Decision|2|||
33502639|NCT01732458|101735024|FG003|Overall Study|Physician Decision|0|||
33502640|NCT01732458|101735021|FG000|Overall Study|Protocol Violation|2|||
33502641|NCT01732458|101735022|FG001|Overall Study|Protocol Violation|0|||
33602178|NCT01143896|102095244|FG001|Overall Study|Death|3|||
33602179|NCT00117793|102095247|FG000|Overall Study|Withdrawal by Subject|12|||
33602180|NCT00416715|102095252|FG000|Overall Study|Not evaluable for joint aches|7|||
33602181|NCT00416715|102095252|FG000|Overall Study|Vitamin D levels not evaluable|8|||
33602182|NCT01319721|102095253|FG000|Overall Study|Lost to Follow-up|1|||
33602183|NCT01319721|102095254|FG001|Overall Study|Lost to Follow-up|6|||
33602184|NCT00509093|102095257|FG000|Overall Study|Adverse Event|10|||
33602185|NCT00509093|102095257|FG000|Overall Study|Disease Progression|9|||
33602186|NCT00509093|102095257|FG000|Overall Study|Transformed into MDS|1|||
33602187|NCT00509093|102095257|FG000|Overall Study|Withdrawal by Subject|3|||
33602188|NCT00509093|102095257|FG000|Overall Study|Physician Decision|1|||
33602189|NCT00583791|102095260|FG000|Overall Study|Other|67|||
33602190|NCT00583791|102095260|FG000|Overall Study|Death|6|||
33602191|NCT00160654|102095268|FG000|Overall Study|Adverse Event|14|||
33602192|NCT00160654|102095268|FG000|Overall Study|Lack of Efficacy|4|||
33602193|NCT00160654|102095268|FG000|Overall Study|Lost to Follow-up|2|||
33602194|NCT00160654|102095268|FG000|Overall Study|Intake of expired drug|7|||
33602195|NCT00160654|102095268|FG000|Overall Study|Psychological trauma|1|||
33602196|NCT00160654|102095268|FG000|Overall Study|Sponsor decision|1|||
33602197|NCT00160654|102095268|FG000|Overall Study|Patient met exclusion criteria|1|||
33602198|NCT00160654|102095268|FG000|Overall Study|Patient decision|1|||
33602199|NCT00160654|102095268|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
33602200|NCT00160654|102095268|FG000|Overall Study|Met exclusion criteria|1|||
33602201|NCT02559414|102095275|FG000|Overall Study|Lost to Follow-up|0|||
33602202|NCT02559414|102095276|FG001|Overall Study|Lost to Follow-up|1|||
33502642|NCT01732458|101735023|FG002|Overall Study|Protocol Violation|0|||
33502643|NCT01732458|101735024|FG003|Overall Study|Protocol Violation|2|||
33502644|NCT01732458|101735021|FG000|Overall Study|Screen Failure|0|||
33602203|NCT02559414|102095277|FG002|Overall Study|Lost to Follow-up|0|||
33602204|NCT02559414|102095275|FG000|Overall Study|Withdrawal by Subject|1|||
33602205|NCT02559414|102095276|FG001|Overall Study|Withdrawal by Subject|0|||
33602206|NCT02559414|102095277|FG002|Overall Study|Withdrawal by Subject|1|||
33602207|NCT02559414|102095275|FG000|Overall Study|Other|0|||
33602208|NCT02559414|102095276|FG001|Overall Study|Other|1|||
33602209|NCT02559414|102095277|FG002|Overall Study|Other|1|||
33602210|NCT00993499|102095278|FG000|Run-in Period (8 Days)|Adverse Event|0|||
33602211|NCT00993499|102095279|FG001|Run-in Period (8 Days)|Adverse Event|1|||
33602212|NCT00993499|102095280|FG002|Run-in Period (8 Days)|Adverse Event|0|||
33602213|NCT00993499|102095281|FG003|Run-in Period (8 Days)|Adverse Event|0|||
33602214|NCT00993499|102095282|FG004|Run-in Period (8 Days)|Adverse Event|0|||
33602215|NCT00993499|102095283|FG005|Run-in Period (8 Days)|Adverse Event|0|||
33602216|NCT00993499|102095278|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
33602217|NCT00993499|102095279|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
33602218|NCT00993499|102095280|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
33602219|NCT00993499|102095281|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
33602220|NCT00993499|102095282|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
33602221|NCT00993499|102095283|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
33602222|NCT00993499|102095278|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
33602223|NCT00993499|102095279|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
33602224|NCT00993499|102095280|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
33602225|NCT00993499|102095281|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
33602226|NCT00993499|102095282|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
33602227|NCT00993499|102095283|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
33602228|NCT00993499|102095278|FG000|Run-in Period (8 Days)|Progressive disease|0|||
33602229|NCT00993499|102095279|FG001|Run-in Period (8 Days)|Progressive disease|1|||
33602230|NCT00993499|102095280|FG002|Run-in Period (8 Days)|Progressive disease|1|||
33602231|NCT00993499|102095281|FG003|Run-in Period (8 Days)|Progressive disease|0|||
33602232|NCT00993499|102095282|FG004|Run-in Period (8 Days)|Progressive disease|0|||
33602233|NCT00993499|102095283|FG005|Run-in Period (8 Days)|Progressive disease|0|||
33602234|NCT00993499|102095278|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
33602235|NCT00993499|102095279|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
33602236|NCT00993499|102095280|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
33602237|NCT00993499|102095281|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
33602238|NCT00993499|102095282|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
33602239|NCT00993499|102095283|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
33602240|NCT00993499|102095278|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
33602241|NCT00993499|102095279|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
33602242|NCT00993499|102095280|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
33602243|NCT00993499|102095281|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
33602244|NCT00993499|102095282|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
33602245|NCT00993499|102095283|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
33602246|NCT00993499|102095278|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
33602247|NCT00993499|102095279|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
33602248|NCT00993499|102095280|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
33602249|NCT00993499|102095281|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
33602250|NCT00993499|102095282|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
33602251|NCT00993499|102095283|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
33602252|NCT00993499|102095278|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
33602253|NCT00993499|102095279|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
33193174|NCT03837899|100612642|FG001|Overall Study|Withdrawal by Subject|0|||
33193175|NCT03837899|100612643|FG002|Overall Study|Withdrawal by Subject|0|||
33193176|NCT03837899|100612644|FG003|Overall Study|Withdrawal by Subject|1|||
33193177|NCT03837899|100612645|FG004|Overall Study|Withdrawal by Subject|0|||
33193178|NCT03837899|100612646|FG005|Overall Study|Withdrawal by Subject|0|||
33193179|NCT03837899|100612641|FG000|Overall Study|Study specific discontinuation criteria|0|||
33193180|NCT03837899|100612642|FG001|Overall Study|Study specific discontinuation criteria|1|||
33193181|NCT03837899|100612643|FG002|Overall Study|Study specific discontinuation criteria|0|||
33193182|NCT03837899|100612644|FG003|Overall Study|Study specific discontinuation criteria|0|||
33193183|NCT03837899|100612645|FG004|Overall Study|Study specific discontinuation criteria|3|||
33193184|NCT03837899|100612646|FG005|Overall Study|Study specific discontinuation criteria|1|||
33193185|NCT01440946|100612647|FG000|Overall Study|Lost to Follow-up|1|||
33193186|NCT01440946|100612648|FG001|Overall Study|Lost to Follow-up|1|||
33193187|NCT01440946|100612647|FG000|Overall Study|Physician Decision|1|||
33193188|NCT01440946|100612648|FG001|Overall Study|Physician Decision|0|||
33312176|NCT02571049|101037525|FG000|Randomization|Adverse Event|0|||
33312177|NCT02571049|101037526|FG001|Randomization|Adverse Event|1|||
33395206|NCT01188811|101334704|FG000|Overall Study|Adverse Event|6|||
33193189|NCT02130765|100612649|FG000|Overall Study|Did not receive treatment|4|||
33193190|NCT02130765|100612650|FG001|Overall Study|Did not receive treatment|0|||
33502645|NCT01732458|101735022|FG001|Overall Study|Screen Failure|1|||
33502646|NCT01732458|101735023|FG002|Overall Study|Screen Failure|0|||
33502647|NCT01732458|101735024|FG003|Overall Study|Screen Failure|0|||
33502648|NCT01866111|101735025|FG000|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|14|||
33502649|NCT01866111|101735026|FG001|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|13|||
33502650|NCT01866111|101735027|FG002|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|20|||
33502651|NCT01866111|101735028|FG003|Double-blind Period of Study YKP3089C017|Not all subjects from double-blind rolled over to open-label|30|||
33502652|NCT01866111|101735025|FG000|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|65|||
33502653|NCT01866111|101735026|FG001|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|67|||
33502654|NCT01866111|101735027|FG002|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|63|||
33502655|NCT01866111|101735028|FG003|Open-label Extension Study YKP3089C017|Not all subjects completed open-label|52|||
33502656|NCT03876743|101735030|FG000|Overall Study|Lost to Follow-up|6|||
33502657|NCT03876743|101735031|FG001|Overall Study|Lost to Follow-up|4|||
33502658|NCT03876743|101735032|FG002|Overall Study|Lost to Follow-up|4|||
33502659|NCT03876743|101735033|FG003|Overall Study|Lost to Follow-up|7|||
33502660|NCT00656292|101735034|FG000|Overall Study|Withdrawal by Subject|2|||
33502661|NCT00656292|101735035|FG001|Overall Study|Withdrawal by Subject|3|||
33502662|NCT00656292|101735034|FG000|Overall Study|Screen failure|1|||
33502663|NCT00656292|101735035|FG001|Overall Study|Screen failure|2|||
33502664|NCT03386994|101735038|FG000|Overall Study|Lung transplant|1|||
33502665|NCT03386994|101735038|FG000|Overall Study|Adverse Event|14|||
33502666|NCT03386994|101735038|FG000|Overall Study|Lost to Follow-up|4|||
33502667|NCT03386994|101735038|FG000|Overall Study|Withdrawal by Subject|3|||
33502668|NCT03386994|101735038|FG000|Overall Study|Death|16|||
33502669|NCT03759587|101735039|FG000|Overall Study|Adverse Event|5|||
33502670|NCT03759587|101735039|FG000|Overall Study|Progressive Disease|10|||
33502671|NCT03759587|101735039|FG000|Overall Study|Site Terminated by Sponsor|3|||
33502672|NCT03759587|101735039|FG000|Overall Study|Withdrawal by Subject|1|||
33502673|NCT03674112|101735040|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
33312178|NCT00370331|101037537|FG000|Overall Study|Adverse Event|4|||
33312179|NCT00370331|101037538|FG001|Overall Study|Adverse Event|13|||
33312180|NCT00370331|101037537|FG000|Overall Study|Withdrawal by Subject|2|||
33312181|NCT00370331|101037538|FG001|Overall Study|Withdrawal by Subject|4|||
33312182|NCT00370331|101037537|FG000|Overall Study|Lost to Follow-up|0|||
33312183|NCT00370331|101037538|FG001|Overall Study|Lost to Follow-up|3|||
33312184|NCT00370331|101037537|FG000|Overall Study|Lack of Efficacy|0|||
33312185|NCT00370331|101037538|FG001|Overall Study|Lack of Efficacy|1|||
33312186|NCT00370331|101037537|FG000|Overall Study|Non-compliance|0|||
33312187|NCT00370331|101037538|FG001|Overall Study|Non-compliance|1|||
33312188|NCT00370331|101037537|FG000|Overall Study|Protocol Violation|1|||
33312189|NCT00370331|101037538|FG001|Overall Study|Protocol Violation|1|||
33312190|NCT02041520|101037539|FG000|Overall Study|Adverse Event|2|||
33312191|NCT02041520|101037540|FG001|Overall Study|Adverse Event|1|||
33312192|NCT02041520|101037539|FG000|Overall Study|Withdrawal by Subject|3|||
33312193|NCT02041520|101037540|FG001|Overall Study|Withdrawal by Subject|4|||
33312194|NCT02041520|101037539|FG000|Overall Study|Protocol Violation|1|||
33312195|NCT02041520|101037540|FG001|Overall Study|Protocol Violation|0|||
33312196|NCT02041520|101037539|FG000|Overall Study|Lost to Follow-up|0|||
33312197|NCT02041520|101037540|FG001|Overall Study|Lost to Follow-up|1|||
33312198|NCT02041520|101037539|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
33312199|NCT02041520|101037540|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
33312200|NCT01639495|101037541|FG000|Overall Study|Lost to Follow-up|6|||
33395207|NCT01188811|101334705|FG001|Overall Study|Adverse Event|0|||
33395208|NCT01518309|101334707|FG000|Overall Study|Adverse Event|6|||
33395209|NCT01518309|101334707|FG000|Overall Study|Death|6|||
33395210|NCT01518309|101334707|FG000|Overall Study|Lack of Efficacy|7|||
33395211|NCT01518309|101334707|FG000|Overall Study|Withdrawal by Subject|6|||
33395212|NCT01518309|101334707|FG000|Overall Study|Physician Decision|3|||
33395213|NCT01518309|101334707|FG000|Overall Study|Sponsor Decision|2|||
33395214|NCT01518309|101334707|FG000|Overall Study|Not in Predefined Categories|9|||
33395215|NCT03458234|101334708|FG000|Overall Study|Withdrawal by Subject|1|||
33395216|NCT00592072|101334709|FG000|Wash Out Period|Lost to Follow-up|1|||
33502674|NCT03674112|101735041|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
33602254|NCT00993499|102095280|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
33312201|NCT01639495|101037541|FG000|Overall Study|Consented but didn't have study catheter|4|||
33395217|NCT00592072|101334710|FG001|Wash Out Period|Lost to Follow-up|1|||
33395218|NCT03887052|101334716|FG000|Overall Study|Adverse Event|2|||
33395219|NCT03887052|101334716|FG000|Overall Study|Physician Decision|2|||
33395220|NCT03887052|101334716|FG000|Overall Study|Withdrawal by Subject|3|||
33395221|NCT03887052|101334716|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
33395222|NCT03887052|101334716|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
33395223|NCT05013385|101334717|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
33395224|NCT01131130|101334723|FG000|Period 1 - Baseline|Pregnancy|1|||
33395225|NCT01131130|101334723|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
33395226|NCT02865928|101334724|FG000|Overall Study|Withdrawal by Subject|1|||
33395227|NCT02865928|101334725|FG001|Overall Study|Withdrawal by Subject|0|||
33395228|NCT02865928|101334724|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
33395229|NCT02865928|101334725|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
33395230|NCT02865928|101334724|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
33395231|NCT02865928|101334725|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
33395232|NCT02579863|101334726|FG000|Overall Study|Final Disposition Unknown|2|||
33395233|NCT02579863|101334727|FG001|Overall Study|Final Disposition Unknown|1|||
33395234|NCT02579863|101334726|FG000|Overall Study|Adverse Event|18|||
33312202|NCT01639495|101037541|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
33312203|NCT01639495|101037541|FG000|Overall Study|No radiofrequency energy applied|2|||
33312204|NCT01664598|101037542|FG000|Overall Study|Sponsor Decision|1|||
33312205|NCT01664598|101037542|FG000|Overall Study|Withdrawal of Informed Consent|4|||
33312206|NCT01664598|101037542|FG000|Overall Study|Adverse Event|1|||
33312207|NCT05323396|101037543|FG000|Overall Study|Lost to Follow-up|1|||
33312208|NCT05323396|101037544|FG001|Overall Study|Lost to Follow-up|31|||
33395235|NCT02579863|101334727|FG001|Overall Study|Adverse Event|11|||
33395236|NCT02579863|101334726|FG000|Overall Study|Death|31|||
33395237|NCT02579863|101334727|FG001|Overall Study|Death|29|||
33395238|NCT02579863|101334726|FG000|Overall Study|Lost to Follow-up|2|||
33395239|NCT02579863|101334727|FG001|Overall Study|Lost to Follow-up|1|||
33395240|NCT02579863|101334726|FG000|Overall Study|Physician Decision|1|||
33395241|NCT02579863|101334727|FG001|Overall Study|Physician Decision|2|||
33502675|NCT03674112|101735040|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
33502676|NCT03674112|101735041|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
33502677|NCT03674112|101735040|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
33502678|NCT03674112|101735041|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
33502679|NCT03674112|101735040|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
33502680|NCT03674112|101735041|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
33502681|NCT03674112|101735040|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
33502682|NCT03674112|101735041|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
33502683|NCT03674112|101735040|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
33502684|NCT03674112|101735041|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
33502685|NCT03674112|101735040|FG000|Follow-Up Period (≥3 Years)|Death|2|||
33502686|NCT03674112|101735041|FG001|Follow-Up Period (≥3 Years)|Death|0|||
33502687|NCT03674112|101735040|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
33502688|NCT03674112|101735041|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
33502689|NCT00570687|101735042|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502690|NCT00570687|101735043|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502691|NCT00570687|101735044|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502692|NCT00570687|101735045|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502693|NCT00570687|101735046|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
33502694|NCT00570687|101735047|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
33502695|NCT00570687|101735048|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
33502696|NCT00570687|101735049|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
33502697|NCT00570687|101735050|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
33502698|NCT00570687|101735051|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
33502699|NCT00570687|101735042|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502700|NCT00570687|101735043|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502701|NCT00570687|101735044|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502702|NCT00570687|101735045|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502703|NCT00570687|101735046|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502704|NCT00570687|101735047|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502705|NCT00570687|101735048|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502706|NCT00570687|101735049|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502707|NCT00570687|101735050|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
33502708|NCT00570687|101735051|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502709|NCT00570687|101735042|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502710|NCT00570687|101735043|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502711|NCT00570687|101735044|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502712|NCT00570687|101735045|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502713|NCT00570687|101735046|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502714|NCT00570687|101735047|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502715|NCT00570687|101735048|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
33502716|NCT00570687|101735049|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502717|NCT00570687|101735050|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502718|NCT00570687|101735051|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
33502719|NCT01609010|101735052|FG000|Overall Study|Stable disease (SD)|22|||
33502720|NCT01609010|101735053|FG001|Overall Study|Stable disease (SD)|16|||
33502721|NCT01609010|101735052|FG000|Overall Study|Progressive disease (PD)|8|||
33502722|NCT01609010|101735053|FG001|Overall Study|Progressive disease (PD)|10|||
33502723|NCT01609010|101735052|FG000|Overall Study|Adverse Event|3|||
33502724|NCT01609010|101735053|FG001|Overall Study|Adverse Event|6|||
33502725|NCT01609010|101735052|FG000|Overall Study|Withdrawal by Subject|2|||
33502726|NCT01609010|101735053|FG001|Overall Study|Withdrawal by Subject|2|||
33502727|NCT01609010|101735052|FG000|Overall Study|Other|2|||
33502728|NCT01609010|101735053|FG001|Overall Study|Other|0|||
33502729|NCT01609010|101735052|FG000|Overall Study|Other malignancy|1|||
33502730|NCT01609010|101735053|FG001|Overall Study|Other malignancy|0|||
33502731|NCT01609010|101735052|FG000|Overall Study|Pathology review|2|||
33502732|NCT01609010|101735053|FG001|Overall Study|Pathology review|1|||
33502733|NCT01609010|101735052|FG000|Overall Study|Protocol Violation|1|||
33502734|NCT01609010|101735053|FG001|Overall Study|Protocol Violation|1|||
33602255|NCT00993499|102095281|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
33602256|NCT00993499|102095282|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
33602257|NCT00993499|102095283|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
33602258|NCT00993499|102095278|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
33602259|NCT00993499|102095279|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
33312209|NCT05323396|101037543|FG000|Overall Study|Pregnancy|1|||
33502735|NCT01609010|101735052|FG000|Overall Study|New cancer|1|||
33193191|NCT02130765|100612651|FG002|Overall Study|Did not receive treatment|0|||
33193192|NCT02130765|100612652|FG003|Overall Study|Did not receive treatment|0|||
33193193|NCT00079274|100612653|FG000|Overall Study|Withdrawal by Subject|111|||
33193194|NCT00079274|100612654|FG001|Overall Study|Withdrawal by Subject|10|||
33193195|NCT00079274|100612655|FG002|Overall Study|Withdrawal by Subject|12|||
33193196|NCT00079274|100612656|FG003|Overall Study|Withdrawal by Subject|163|||
33193197|NCT00079274|100612657|FG004|Overall Study|Withdrawal by Subject|7|||
33193198|NCT00079274|100612658|FG005|Overall Study|Withdrawal by Subject|8|||
33193199|NCT00079274|100612659|FG006|Overall Study|Withdrawal by Subject|0|||
33193200|NCT00079274|100612653|FG000|Overall Study|Adverse Event|130|||
33193201|NCT00079274|100612654|FG001|Overall Study|Adverse Event|8|||
33193202|NCT00079274|100612655|FG002|Overall Study|Adverse Event|8|||
33193203|NCT00079274|100612656|FG003|Overall Study|Adverse Event|184|||
33193204|NCT00079274|100612657|FG004|Overall Study|Adverse Event|7|||
33193205|NCT00079274|100612658|FG005|Overall Study|Adverse Event|8|||
33193206|NCT00079274|100612659|FG006|Overall Study|Adverse Event|0|||
33193207|NCT00079274|100612653|FG000|Overall Study|Recurrence|21|||
33193208|NCT00079274|100612654|FG001|Overall Study|Recurrence|0|||
33193209|NCT00079274|100612655|FG002|Overall Study|Recurrence|1|||
33193210|NCT00079274|100612656|FG003|Overall Study|Recurrence|15|||
33193211|NCT00079274|100612657|FG004|Overall Study|Recurrence|0|||
33193212|NCT00079274|100612658|FG005|Overall Study|Recurrence|2|||
33193213|NCT00079274|100612659|FG006|Overall Study|Recurrence|0|||
33193214|NCT00079274|100612653|FG000|Overall Study|Alternate Treatment|6|||
33193215|NCT00079274|100612654|FG001|Overall Study|Alternate Treatment|1|||
33193216|NCT00079274|100612655|FG002|Overall Study|Alternate Treatment|0|||
33193217|NCT00079274|100612656|FG003|Overall Study|Alternate Treatment|3|||
33193218|NCT00079274|100612657|FG004|Overall Study|Alternate Treatment|0|||
33193219|NCT00079274|100612658|FG005|Overall Study|Alternate Treatment|0|||
33193220|NCT00079274|100612659|FG006|Overall Study|Alternate Treatment|0|||
33193221|NCT00079274|100612653|FG000|Overall Study|Other Medical Problems|6|||
33193222|NCT00079274|100612654|FG001|Overall Study|Other Medical Problems|1|||
33193223|NCT00079274|100612655|FG002|Overall Study|Other Medical Problems|0|||
33193224|NCT00079274|100612656|FG003|Overall Study|Other Medical Problems|7|||
33193225|NCT00079274|100612657|FG004|Overall Study|Other Medical Problems|0|||
33193226|NCT00079274|100612658|FG005|Overall Study|Other Medical Problems|0|||
33193227|NCT00079274|100612659|FG006|Overall Study|Other Medical Problems|0|||
33193228|NCT00079274|100612653|FG000|Overall Study|Death|4|||
33502736|NCT01609010|101735053|FG001|Overall Study|New cancer|0|||
33502737|NCT01609010|101735052|FG000|Overall Study|Lost to Follow-up|1|||
33502738|NCT01609010|101735053|FG001|Overall Study|Lost to Follow-up|1|||
33193229|NCT00079274|100612654|FG001|Overall Study|Death|0|||
33193230|NCT00079274|100612655|FG002|Overall Study|Death|1|||
33193231|NCT00079274|100612656|FG003|Overall Study|Death|15|||
33193232|NCT00079274|100612657|FG004|Overall Study|Death|0|||
33193233|NCT00079274|100612658|FG005|Overall Study|Death|0|||
33193234|NCT00079274|100612659|FG006|Overall Study|Death|0|||
33193235|NCT00079274|100612653|FG000|Overall Study|Cytogenetic resistance|0|||
33193236|NCT00079274|100612654|FG001|Overall Study|Cytogenetic resistance|0|||
33193237|NCT00079274|100612655|FG002|Overall Study|Cytogenetic resistance|0|||
33193238|NCT00079274|100612656|FG003|Overall Study|Cytogenetic resistance|2|||
33193239|NCT00079274|100612657|FG004|Overall Study|Cytogenetic resistance|0|||
33193240|NCT00079274|100612658|FG005|Overall Study|Cytogenetic resistance|0|||
33502739|NCT00686829|101735054|FG000|Overall Study|Adverse Event|5|||
33502740|NCT00686829|101735054|FG000|Overall Study|Lack of Efficacy|6|||
33193241|NCT00079274|100612659|FG006|Overall Study|Cytogenetic resistance|0|||
33193242|NCT00079274|100612653|FG000|Overall Study|Other|43|||
33193243|NCT00079274|100612654|FG001|Overall Study|Other|7|||
33193244|NCT00079274|100612655|FG002|Overall Study|Other|5|||
33193245|NCT00079274|100612656|FG003|Overall Study|Other|55|||
33193246|NCT00079274|100612657|FG004|Overall Study|Other|1|||
33193247|NCT00079274|100612658|FG005|Overall Study|Other|2|||
33312210|NCT05323396|101037544|FG001|Overall Study|Pregnancy|0|||
33193248|NCT00079274|100612659|FG006|Overall Study|Other|0|||
33193249|NCT01743092|100612660|FG000|Overall Study|Lost to Follow-up|14|||
33193250|NCT01743092|100612661|FG001|Overall Study|Lost to Follow-up|15|||
33193251|NCT02316717|100612662|FG000|Overall Study|Adverse Event|2|||
33193252|NCT02316717|100612663|FG001|Overall Study|Adverse Event|2|||
33193253|NCT02316717|100612664|FG002|Overall Study|Adverse Event|0|||
33193254|NCT02316717|100612662|FG000|Overall Study|Lost to Follow-up|1|||
33193255|NCT02316717|100612663|FG001|Overall Study|Lost to Follow-up|2|||
33193256|NCT02316717|100612664|FG002|Overall Study|Lost to Follow-up|1|||
33193257|NCT02316717|100612662|FG000|Overall Study|Non compliance|3|||
33193258|NCT02316717|100612663|FG001|Overall Study|Non compliance|1|||
33193259|NCT02316717|100612664|FG002|Overall Study|Non compliance|0|||
33193260|NCT02316717|100612662|FG000|Overall Study|Protocol Violation|2|||
33193261|NCT02316717|100612663|FG001|Overall Study|Protocol Violation|0|||
33193262|NCT02316717|100612664|FG002|Overall Study|Protocol Violation|0|||
33193263|NCT02316717|100612662|FG000|Overall Study|Withdrawal by Subject|2|||
33193264|NCT02316717|100612663|FG001|Overall Study|Withdrawal by Subject|1|||
33312211|NCT01941719|101037545|FG000|Overall Study|Lost to Follow-up|20|||
33193265|NCT02316717|100612664|FG002|Overall Study|Withdrawal by Subject|1|||
33502741|NCT00686829|101735054|FG000|Overall Study|Lost to Follow-up|4|||
33502742|NCT00686829|101735054|FG000|Overall Study|Withdrawal by Subject|14|||
33502743|NCT00686829|101735054|FG000|Overall Study|Protocol Violation|3|||
33312212|NCT01941719|101037546|FG001|Overall Study|Lost to Follow-up|19|||
33312213|NCT00477334|101037547|FG000|Overall Study|Discontinued prior to taking study drug|106|||
33312214|NCT00477334|101037548|FG001|Overall Study|Discontinued prior to taking study drug|53|||
33312215|NCT00477334|101037547|FG000|Overall Study|Adverse Event|1|||
33193266|NCT02316717|100612662|FG000|Overall Study|Death|0|||
33193267|NCT02316717|100612663|FG001|Overall Study|Death|0|||
33193268|NCT02316717|100612664|FG002|Overall Study|Death|1|||
33502744|NCT00686829|101735054|FG000|Overall Study|Sponsor discontinued VCV|47|||
33502745|NCT02492984|101735057|FG000|Overall Study|Adverse Event|1|||
33502746|NCT02492984|101735058|FG001|Overall Study|Adverse Event|0|||
33193269|NCT02316717|100612662|FG000|Overall Study|Physician Decision|0|||
33193270|NCT02316717|100612663|FG001|Overall Study|Physician Decision|1|||
33312216|NCT00477334|101037548|FG001|Overall Study|Adverse Event|2|||
33312217|NCT00477334|101037547|FG000|Overall Study|Withdrawal by Subject|2|||
33312218|NCT00477334|101037548|FG001|Overall Study|Withdrawal by Subject|1|||
33312219|NCT00477334|101037547|FG000|Overall Study|Lost to Follow-up|15|||
33312220|NCT00477334|101037548|FG001|Overall Study|Lost to Follow-up|4|||
33312221|NCT00477334|101037547|FG000|Overall Study|Administrative Problems|39|||
33312222|NCT00477334|101037548|FG001|Overall Study|Administrative Problems|15|||
33312223|NCT00477334|101037547|FG000|Overall Study|Protocol Violation|7|||
33312224|NCT00477334|101037548|FG001|Overall Study|Protocol Violation|1|||
33312225|NCT00777946|101037551|FG000|Overall Study|Adverse Event|11|||
33312226|NCT00777946|101037552|FG001|Overall Study|Adverse Event|1|||
33312227|NCT00777946|101037553|FG002|Overall Study|Adverse Event|3|||
33312228|NCT00777946|101037551|FG000|Overall Study|Lack of Efficacy|0|||
33395242|NCT02579863|101334726|FG000|Overall Study|Screen Failure|0|||
33395243|NCT02579863|101334727|FG001|Overall Study|Screen Failure|2|||
33502747|NCT02492984|101735057|FG000|Overall Study|Protocol Violation|1|||
33502748|NCT02492984|101735058|FG001|Overall Study|Protocol Violation|0|||
33502749|NCT02492984|101735057|FG000|Overall Study|Withdrawal by Subject|1|||
33502750|NCT02492984|101735058|FG001|Overall Study|Withdrawal by Subject|0|||
33502751|NCT02748356|101735059|FG000|Overall Study|Withdrawal by Subject|1|||
33502752|NCT00101166|101735060|FG000|Overall Study|progressive disease|10|||
33502753|NCT02564900|101735061|FG000|Dose Escalation|Progressive disease per RECIST|2|||
33502754|NCT02564900|101735062|FG001|Dose Escalation|Progressive disease per RECIST|3|||
33502755|NCT02564900|101735063|FG002|Dose Escalation|Progressive disease per RECIST|3|||
33502756|NCT02564900|101735064|FG003|Dose Escalation|Progressive disease per RECIST|3|||
33502757|NCT02564900|101735065|FG004|Dose Escalation|Progressive disease per RECIST|3|||
33502758|NCT02564900|101735066|FG005|Dose Escalation|Progressive disease per RECIST|1|||
33502759|NCT02564900|101735067|FG006|Dose Escalation|Progressive disease per RECIST|0|||
33502760|NCT02564900|101735068|FG007|Dose Escalation|Progressive disease per RECIST|0|||
33502761|NCT02564900|101735069|FG008|Dose Escalation|Progressive disease per RECIST|0|||
33502762|NCT02564900|101735070|FG009|Dose Escalation|Progressive disease per RECIST|0|||
33502763|NCT02564900|101735071|FG010|Dose Escalation|Progressive disease per RECIST|0|||
33502764|NCT02564900|101735072|FG011|Dose Escalation|Progressive disease per RECIST|0|||
33193271|NCT02316717|100612664|FG002|Overall Study|Physician Decision|0|||
33193272|NCT02316717|100612662|FG000|Overall Study|TBC|1|||
33193273|NCT02316717|100612663|FG001|Overall Study|TBC|0|||
33193274|NCT02316717|100612664|FG002|Overall Study|TBC|0|||
33193275|NCT00424372|100612667|FG000|Overall Study|Death|1|||
33193276|NCT00424372|100612667|FG000|Overall Study|Adverse Event|18|||
33193277|NCT00424372|100612667|FG000|Overall Study|Lack of Efficacy|6|||
33193278|NCT00424372|100612667|FG000|Overall Study|Withdrawal by Subject|4|||
33193279|NCT00424372|100612667|FG000|Overall Study|Protocol Violation|1|||
33193280|NCT00424372|100612667|FG000|Overall Study|Health deterioration|1|||
33193281|NCT03912233|100612668|FG000|Overall Study|Adverse Event|1|||
33193282|NCT03912233|100612669|FG001|Overall Study|Adverse Event|0|||
33193283|NCT03912233|100612670|FG002|Overall Study|Adverse Event|0|||
33193284|NCT03912233|100612671|FG003|Overall Study|Adverse Event|0|||
33193285|NCT03912233|100612672|FG004|Overall Study|Adverse Event|0|||
33193286|NCT03912233|100612673|FG005|Overall Study|Adverse Event|0|||
33193287|NCT03912233|100612668|FG000|Overall Study|Physician Decision|1|||
33193288|NCT03912233|100612669|FG001|Overall Study|Physician Decision|0|||
33502765|NCT02564900|101735073|FG012|Dose Escalation|Progressive disease per RECIST|0|||
33193289|NCT03912233|100612670|FG002|Overall Study|Physician Decision|0|||
33312229|NCT00777946|101037552|FG001|Overall Study|Lack of Efficacy|0|||
33312230|NCT00777946|101037553|FG002|Overall Study|Lack of Efficacy|9|||
33312231|NCT00777946|101037551|FG000|Overall Study|Condition no longer required study drug|1|||
33312232|NCT00777946|101037552|FG001|Overall Study|Condition no longer required study drug|0|||
33193290|NCT03912233|100612671|FG003|Overall Study|Physician Decision|0|||
33193291|NCT03912233|100612672|FG004|Overall Study|Physician Decision|0|||
33193292|NCT03912233|100612673|FG005|Overall Study|Physician Decision|0|||
33193293|NCT03912233|100612668|FG000|Overall Study|Other|0|||
33395244|NCT02579863|101334726|FG000|Overall Study|Study Terminated at Selected Sites|82|||
33312233|NCT00777946|101037553|FG002|Overall Study|Condition no longer required study drug|0|||
33312234|NCT00777946|101037551|FG000|Overall Study|Patient withdrew consent|3|||
33312235|NCT00777946|101037552|FG001|Overall Study|Patient withdrew consent|2|||
33312236|NCT00777946|101037553|FG002|Overall Study|Patient withdrew consent|3|||
33312237|NCT00777946|101037551|FG000|Overall Study|Lost to Follow-up|3|||
33312238|NCT00777946|101037552|FG001|Overall Study|Lost to Follow-up|1|||
33312239|NCT00777946|101037553|FG002|Overall Study|Lost to Follow-up|0|||
33312240|NCT00777946|101037551|FG000|Overall Study|Protocol deviation|2|||
33312241|NCT00777946|101037552|FG001|Overall Study|Protocol deviation|1|||
33395245|NCT02579863|101334727|FG001|Overall Study|Study Terminated at Selected Sites|88|||
33395246|NCT02579863|101334726|FG000|Overall Study|Withdrawal by Subject|20|||
33395247|NCT02579863|101334727|FG001|Overall Study|Withdrawal by Subject|20|||
33395248|NCT01440972|101334728|FG000|Overall Study|Withdrawal by Subject|3|||
33395249|NCT01440972|101334729|FG001|Overall Study|Withdrawal by Subject|2|||
33395250|NCT00796549|101334730|FG000|Overall Study|Adverse Event|11|||
33395251|NCT00796549|101334730|FG000|Overall Study|not entered|149|||
33395252|NCT00796549|101334730|FG000|Overall Study|Other|2|||
33395253|NCT00796549|101334730|FG000|Overall Study|Progressive disease|56|||
33395254|NCT00515099|101334731|FG000|Overall Study|Lost to Follow-up|0|||
33395255|NCT00515099|101334732|FG001|Overall Study|Lost to Follow-up|4|||
33395256|NCT00515099|101334731|FG000|Overall Study|Withdrawal by Subject|2|||
33395257|NCT00515099|101334732|FG001|Overall Study|Withdrawal by Subject|0|||
33395258|NCT00515099|101334731|FG000|Overall Study|IRB Recommendation|1|||
33395259|NCT00515099|101334732|FG001|Overall Study|IRB Recommendation|0|||
33395260|NCT01435122|101334733|FG000|Overall Study|Early withdrawal due to toxicity|8|||
33395261|NCT01957215|101334740|FG000|Overall Study|Adverse Event|2|||
33502766|NCT02564900|101735074|FG013|Dose Escalation|Progressive disease per RECIST|0|||
33502767|NCT02564900|101735075|FG014|Dose Escalation|Progressive disease per RECIST|0|||
33502768|NCT02564900|101735061|FG000|Dose Escalation|Ongoing|1|||
33502769|NCT02564900|101735062|FG001|Dose Escalation|Ongoing|0|||
33502770|NCT02564900|101735063|FG002|Dose Escalation|Ongoing|0|||
33502771|NCT02564900|101735064|FG003|Dose Escalation|Ongoing|2|||
33502772|NCT02564900|101735065|FG004|Dose Escalation|Ongoing|2|||
33502773|NCT02564900|101735066|FG005|Dose Escalation|Ongoing|2|||
33502774|NCT02564900|101735067|FG006|Dose Escalation|Ongoing|0|||
33502775|NCT02564900|101735068|FG007|Dose Escalation|Ongoing|0|||
33502776|NCT02564900|101735069|FG008|Dose Escalation|Ongoing|0|||
33502777|NCT02564900|101735070|FG009|Dose Escalation|Ongoing|0|||
33502778|NCT02564900|101735071|FG010|Dose Escalation|Ongoing|0|||
33502779|NCT02564900|101735072|FG011|Dose Escalation|Ongoing|0|||
33502780|NCT02564900|101735073|FG012|Dose Escalation|Ongoing|0|||
33502781|NCT02564900|101735074|FG013|Dose Escalation|Ongoing|0|||
33502782|NCT02564900|101735075|FG014|Dose Escalation|Ongoing|0|||
33502783|NCT02564900|101735061|FG000|Dose Escalation|Adverse Event|0|||
33502784|NCT02564900|101735062|FG001|Dose Escalation|Adverse Event|0|||
33502785|NCT02564900|101735063|FG002|Dose Escalation|Adverse Event|0|||
33502786|NCT02564900|101735064|FG003|Dose Escalation|Adverse Event|1|||
33502787|NCT02564900|101735065|FG004|Dose Escalation|Adverse Event|1|||
33502788|NCT02564900|101735066|FG005|Dose Escalation|Adverse Event|3|||
33502789|NCT02564900|101735067|FG006|Dose Escalation|Adverse Event|0|||
33502790|NCT02564900|101735068|FG007|Dose Escalation|Adverse Event|0|||
33502791|NCT02564900|101735069|FG008|Dose Escalation|Adverse Event|0|||
33502792|NCT02564900|101735070|FG009|Dose Escalation|Adverse Event|0|||
33502793|NCT02564900|101735071|FG010|Dose Escalation|Adverse Event|0|||
33502794|NCT02564900|101735072|FG011|Dose Escalation|Adverse Event|0|||
33502795|NCT02564900|101735073|FG012|Dose Escalation|Adverse Event|0|||
33502796|NCT02564900|101735074|FG013|Dose Escalation|Adverse Event|0|||
33502797|NCT02564900|101735075|FG014|Dose Escalation|Adverse Event|0|||
33502798|NCT02564900|101735061|FG000|Dose Expansion|Progressive disease per RECIST|0|||
33502799|NCT02564900|101735062|FG001|Dose Expansion|Progressive disease per RECIST|0|||
33502800|NCT02564900|101735063|FG002|Dose Expansion|Progressive disease per RECIST|0|||
33502801|NCT02564900|101735064|FG003|Dose Expansion|Progressive disease per RECIST|0|||
33502802|NCT02564900|101735065|FG004|Dose Expansion|Progressive disease per RECIST|0|||
33502803|NCT02564900|101735066|FG005|Dose Expansion|Progressive disease per RECIST|0|||
33312242|NCT00777946|101037553|FG002|Overall Study|Protocol deviation|1|||
33312243|NCT00777946|101037551|FG000|Overall Study|Randomized in error|1|||
33395262|NCT01957215|101334741|FG001|Overall Study|Adverse Event|2|||
33395263|NCT01957215|101334740|FG000|Overall Study|Lost to Follow-up|3|||
33395264|NCT01957215|101334741|FG001|Overall Study|Lost to Follow-up|3|||
33502804|NCT02564900|101735067|FG006|Dose Expansion|Progressive disease per RECIST|19|||
33502805|NCT02564900|101735068|FG007|Dose Expansion|Progressive disease per RECIST|17|||
33312244|NCT00777946|101037552|FG001|Overall Study|Randomized in error|1|||
33312245|NCT00777946|101037553|FG002|Overall Study|Randomized in error|0|||
33312246|NCT00983931|101037557|FG000|14 Day Washout Period|Physician Decision|1|||
33502806|NCT02564900|101735069|FG008|Dose Expansion|Progressive disease per RECIST|8|||
33395265|NCT01957215|101334740|FG000|Overall Study|Protocol Violation|1|||
33395266|NCT01957215|101334741|FG001|Overall Study|Protocol Violation|2|||
33395267|NCT01957215|101334740|FG000|Overall Study|Withdrawal by Subject|7|||
33395268|NCT01957215|101334741|FG001|Overall Study|Withdrawal by Subject|5|||
33395269|NCT03077711|101334743|FG000|Overall Study|Lost to Follow-up|2|||
33395270|NCT03077711|101334744|FG001|Overall Study|Lost to Follow-up|2|||
33395271|NCT03077711|101334743|FG000|Overall Study|noncompliant taking medication|2|||
33395272|NCT03077711|101334744|FG001|Overall Study|noncompliant taking medication|0|||
33395273|NCT00673816|101334745|FG000|Overall Study|Adverse Event|1|||
33395274|NCT00673816|101334745|FG000|Overall Study|Withdrawal by Subject|1|||
33395275|NCT00976963|101334748|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
33395276|NCT00976963|101334749|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
33395277|NCT00976963|101334748|FG000|Overall Study|administrative error|1|||
33395278|NCT00976963|101334749|FG001|Overall Study|administrative error|0|||
33395279|NCT00976963|101334748|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
33395280|NCT00976963|101334749|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
33395281|NCT00623766|101334750|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
33395282|NCT00623766|101334751|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
33395283|NCT00623766|101334750|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
33395284|NCT00623766|101334751|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
33395285|NCT00623766|101334750|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
33602260|NCT00993499|102095280|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
33602261|NCT00993499|102095281|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
33395286|NCT00623766|101334751|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
33395287|NCT00623766|101334750|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
33395288|NCT00623766|101334751|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
33395289|NCT00623766|101334750|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
33395290|NCT00623766|101334751|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
33312247|NCT02518490|101037558|FG000|Overall Study|Withdrawal by Subject|1|||
33312248|NCT02518490|101037559|FG001|Overall Study|Withdrawal by Subject|1|||
33312249|NCT00394082|101037560|FG000|Overall Study|Unacceptable toxicity|15|||
33312250|NCT00394082|101037560|FG000|Overall Study|Adverse Event|4|||
33312251|NCT00394082|101037560|FG000|Overall Study|Physician Decision|4|||
33312252|NCT00394082|101037560|FG000|Overall Study|Withdrawal by Subject|2|||
33312253|NCT00394082|101037560|FG000|Overall Study|Other|1|||
33312254|NCT01411839|101037561|FG000|Overall Study|Lost to Follow-up|4|||
33312255|NCT01411839|101037562|FG001|Overall Study|Lost to Follow-up|3|||
33312256|NCT02783768|101037563|FG000|Overall Study|Lost to Follow-up|1|||
33602262|NCT00993499|102095282|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
33602263|NCT00993499|102095283|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
33602264|NCT00993499|102095278|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
33312257|NCT02783768|101037564|FG001|Overall Study|Lost to Follow-up|0|||
33312258|NCT02009761|101037572|FG000|Overall Study|Adverse Event|4|||
33395291|NCT05283499|101334756|FG000|Overall Study|Did not receive intervention|1|||
33395292|NCT05283499|101334757|FG001|Overall Study|Did not receive intervention|2|||
33395293|NCT02352090|101334762|FG000|Overall Study|general malaise|1|||
33395294|NCT02352090|101334763|FG001|Overall Study|general malaise|0|||
33395295|NCT02352090|101334764|FG002|Overall Study|general malaise|0|||
33395296|NCT02352090|101334762|FG000|Overall Study|non-specified mild side-effects|0|||
33395297|NCT02352090|101334763|FG001|Overall Study|non-specified mild side-effects|0|||
33395298|NCT02352090|101334764|FG002|Overall Study|non-specified mild side-effects|2|||
33395299|NCT04247828|101334767|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
33395300|NCT01685372|101334768|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
33395301|NCT01685372|101334769|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
33395302|NCT00191386|101334771|FG000|Overall Study|Adverse Event|16|||
33395303|NCT00191386|101334771|FG000|Overall Study|Lost to Follow-up|1|||
33502807|NCT02564900|101735070|FG009|Dose Expansion|Progressive disease per RECIST|16|||
33502808|NCT02564900|101735071|FG010|Dose Expansion|Progressive disease per RECIST|13|||
33502809|NCT02564900|101735072|FG011|Dose Expansion|Progressive disease per RECIST|19|||
33502810|NCT02564900|101735073|FG012|Dose Expansion|Progressive disease per RECIST|10|||
33502811|NCT02564900|101735074|FG013|Dose Expansion|Progressive disease per RECIST|13|||
33502812|NCT02564900|101735075|FG014|Dose Expansion|Progressive disease per RECIST|11|||
33502813|NCT02564900|101735061|FG000|Dose Expansion|Clinical progression|0|||
33502814|NCT02564900|101735062|FG001|Dose Expansion|Clinical progression|0|||
33502815|NCT02564900|101735063|FG002|Dose Expansion|Clinical progression|0|||
33395304|NCT00191386|101334771|FG000|Overall Study|Entry Criteria Exclusion|3|||
33312259|NCT01878214|101037573|FG000|Overall Study|Withdrawal by Subject|18|||
33312260|NCT01878214|101037574|FG001|Overall Study|Withdrawal by Subject|7|||
33312261|NCT01878214|101037573|FG000|Overall Study|Death|0|||
33312262|NCT01878214|101037574|FG001|Overall Study|Death|1|||
33395305|NCT00191386|101334771|FG000|Overall Study|Protocol Violation|18|||
33502816|NCT02564900|101735064|FG003|Dose Expansion|Clinical progression|0|||
33502817|NCT02564900|101735065|FG004|Dose Expansion|Clinical progression|0|||
33312263|NCT01878214|101037573|FG000|Overall Study|Lost to Follow-up|35|||
33312264|NCT01878214|101037574|FG001|Overall Study|Lost to Follow-up|36|||
33312265|NCT01340651|101037578|FG000|Overall Study|Adverse Event|3|||
33312266|NCT01340651|101037578|FG000|Overall Study|Consent Withdrawn|2|||
33312267|NCT01340651|101037578|FG000|Overall Study|Commercial Supply per Sponsor|12|||
33312268|NCT01285609|101037581|FG000|Randomized|Progressive Disease|41|||
33312269|NCT01285609|101037582|FG001|Randomized|Progressive Disease|61|||
33312270|NCT01285609|101037581|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
33312271|NCT01285609|101037582|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
33312272|NCT01285609|101037581|FG000|Randomized|Study Drug Toxicity|13|||
33312273|NCT01285609|101037582|FG001|Randomized|Study Drug Toxicity|14|||
33312274|NCT01285609|101037581|FG000|Randomized|Death|5|||
33312275|NCT01285609|101037582|FG001|Randomized|Death|7|||
33312276|NCT01285609|101037581|FG000|Randomized|Withdrawal by Subject|8|||
33312277|NCT01285609|101037582|FG001|Randomized|Withdrawal by Subject|11|||
33312278|NCT01285609|101037581|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
33312279|NCT01285609|101037582|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
33312280|NCT01285609|101037581|FG000|Randomized|Undisclosed Reasons|1|||
33312281|NCT01285609|101037582|FG001|Randomized|Undisclosed Reasons|0|||
33312282|NCT01285609|101037581|FG000|Randomized|Randomized but not Treated|4|||
33312283|NCT01285609|101037582|FG001|Randomized|Randomized but not Treated|4|||
33312284|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
33312285|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
33312286|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
33312287|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
33312288|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
33312289|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
33312290|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
33312291|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
33312292|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Death|11|||
33312293|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Death|3|||
33312294|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
33312295|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
33312296|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Not Reported|0|||
33312297|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Not Reported|2|||
33312298|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
33312299|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
33312300|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
33312301|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
33312302|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
33502818|NCT02564900|101735066|FG005|Dose Expansion|Clinical progression|0|||
33502819|NCT02564900|101735067|FG006|Dose Expansion|Clinical progression|5|||
33502820|NCT02564900|101735068|FG007|Dose Expansion|Clinical progression|12|||
33502821|NCT02564900|101735069|FG008|Dose Expansion|Clinical progression|0|||
33193294|NCT03912233|100612669|FG001|Overall Study|Other|0|||
33193295|NCT03912233|100612670|FG002|Overall Study|Other|0|||
33193296|NCT03912233|100612671|FG003|Overall Study|Other|0|||
33193297|NCT03912233|100612672|FG004|Overall Study|Other|7|||
33312303|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
33312304|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
33312305|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
33312306|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
33312307|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
33312308|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
33312309|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
33312310|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
33312311|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
33395306|NCT00191386|101334771|FG000|Overall Study|Withdrawal by Subject|96|||
33395307|NCT00191386|101334771|FG000|Overall Study|Physician Decision|11|||
33395308|NCT00191386|101334771|FG000|Overall Study|Lack of Efficacy|15|||
33193298|NCT03912233|100612673|FG005|Overall Study|Other|12|||
33502822|NCT02564900|101735070|FG009|Dose Expansion|Clinical progression|3|||
33193299|NCT02908529|100612674|FG000|Overall Study|Lost to Follow-up|0|||
33312312|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
33312313|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
33312314|NCT01285609|101037581|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
33312315|NCT01285609|101037582|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
33312316|NCT01285609|101037581|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
33312317|NCT01285609|101037582|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
33312318|NCT03814187|101037583|FG000|Overall Study|Sponsor's Administrative Decision|0|||
33312319|NCT03814187|101037584|FG001|Overall Study|Sponsor's Administrative Decision|0|||
33312320|NCT03814187|101037585|FG002|Overall Study|Sponsor's Administrative Decision|272|||
33312321|NCT03814187|101037583|FG000|Overall Study|Death|80|||
33312322|NCT03814187|101037584|FG001|Overall Study|Death|81|||
33312323|NCT03814187|101037585|FG002|Overall Study|Death|4|||
33312324|NCT03814187|101037583|FG000|Overall Study|Withdrew Consent|77|||
33312325|NCT03814187|101037584|FG001|Overall Study|Withdrew Consent|78|||
33312326|NCT03814187|101037585|FG002|Overall Study|Withdrew Consent|2|||
33312327|NCT03814187|101037583|FG000|Overall Study|Lost to Follow-up|47|||
33312328|NCT03814187|101037584|FG001|Overall Study|Lost to Follow-up|52|||
33312329|NCT03814187|101037585|FG002|Overall Study|Lost to Follow-up|1|||
33312330|NCT03814187|101037583|FG000|Overall Study|Adverse Event|22|||
33312331|NCT03814187|101037584|FG001|Overall Study|Adverse Event|23|||
33312332|NCT03814187|101037585|FG002|Overall Study|Adverse Event|0|||
33312333|NCT03814187|101037583|FG000|Overall Study|Physician Decision|7|||
33312334|NCT03814187|101037584|FG001|Overall Study|Physician Decision|4|||
33312335|NCT03814187|101037585|FG002|Overall Study|Physician Decision|2|||
33312336|NCT03814187|101037583|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
33312337|NCT03814187|101037584|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
33312338|NCT03814187|101037585|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
33312339|NCT03814187|101037583|FG000|Overall Study|Other reasons|34|||
33312340|NCT03814187|101037584|FG001|Overall Study|Other reasons|40|||
33312341|NCT03814187|101037585|FG002|Overall Study|Other reasons|2|||
33312342|NCT01116882|101037588|FG000|30-day|Lost to Follow-up|50|||
33312343|NCT01116882|101037589|FG001|30-day|Lost to Follow-up|21|||
33312344|NCT01116882|101037588|FG000|30-day|Withdrawal by Subject|2|||
33312345|NCT01116882|101037589|FG001|30-day|Withdrawal by Subject|4|||
33602265|NCT00993499|102095279|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
33602266|NCT00993499|102095280|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
33602267|NCT00993499|102095281|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
33602268|NCT00993499|102095282|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
33602269|NCT00993499|102095283|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
33602270|NCT00993499|102095278|FG000|Discontinued After Starting Course 3|DLT|1|||
33602271|NCT00993499|102095279|FG001|Discontinued After Starting Course 3|DLT|0|||
33602272|NCT00993499|102095280|FG002|Discontinued After Starting Course 3|DLT|2|||
33602273|NCT00993499|102095281|FG003|Discontinued After Starting Course 3|DLT|1|||
33602274|NCT00993499|102095282|FG004|Discontinued After Starting Course 3|DLT|0|||
33602275|NCT00993499|102095283|FG005|Discontinued After Starting Course 3|DLT|0|||
33602276|NCT00993499|102095278|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
33602277|NCT00993499|102095279|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
33602278|NCT00993499|102095280|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
33602279|NCT00993499|102095281|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
33602280|NCT00993499|102095282|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
33602281|NCT00993499|102095283|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
33602282|NCT02046070|102095284|FG000|Overall Study|Progressive Disease|18|||
33312346|NCT01116882|101037588|FG000|30-day|Other Reasons|16|||
33312347|NCT01116882|101037589|FG001|30-day|Other Reasons|6|||
33312348|NCT01116882|101037588|FG000|12-month|Lost to Follow-up|111|||
33312349|NCT01116882|101037589|FG001|12-month|Lost to Follow-up|42|||
33312350|NCT01116882|101037588|FG000|12-month|Other Reasons|151|||
33312351|NCT01116882|101037589|FG001|12-month|Other Reasons|49|||
33312352|NCT01116882|101037588|FG000|12-month|Withdrawal by Subject|5|||
33602283|NCT02046070|102095285|FG001|Overall Study|Progressive Disease|11|||
33602284|NCT02046070|102095286|FG002|Overall Study|Progressive Disease|40|||
33602285|NCT02046070|102095284|FG000|Overall Study|Adverse Event|8|||
33602286|NCT02046070|102095285|FG001|Overall Study|Adverse Event|10|||
33602287|NCT02046070|102095286|FG002|Overall Study|Adverse Event|17|||
33602288|NCT02046070|102095284|FG000|Overall Study|Withdrawal by Subject|1|||
33602289|NCT02046070|102095285|FG001|Overall Study|Withdrawal by Subject|2|||
33602290|NCT02046070|102095286|FG002|Overall Study|Withdrawal by Subject|6|||
33602291|NCT02046070|102095284|FG000|Overall Study|Study Terminated by Sponsor|1|||
33602292|NCT02046070|102095285|FG001|Overall Study|Study Terminated by Sponsor|1|||
33602293|NCT02046070|102095286|FG002|Overall Study|Study Terminated by Sponsor|1|||
33602294|NCT02046070|102095284|FG000|Overall Study|Reason not Specified|4|||
33312353|NCT01116882|101037589|FG001|12-month|Withdrawal by Subject|8|||
33312354|NCT00687973|101037592|FG000|Overall Study|Adverse Event|18|||
33312355|NCT00687973|101037593|FG001|Overall Study|Adverse Event|28|||
33312356|NCT00687973|101037592|FG000|Overall Study|Lack of Efficacy|2|||
33312357|NCT00687973|101037593|FG001|Overall Study|Lack of Efficacy|3|||
33312358|NCT00687973|101037592|FG000|Overall Study|Protocol Violation|1|||
33193300|NCT02908529|100612675|FG001|Overall Study|Lost to Follow-up|2|||
33312359|NCT00687973|101037593|FG001|Overall Study|Protocol Violation|2|||
33602295|NCT02046070|102095285|FG001|Overall Study|Reason not Specified|4|||
33602296|NCT02046070|102095286|FG002|Overall Study|Reason not Specified|6|||
33602297|NCT03684304|102095289|FG000|Overall Study|Lost to Follow-up|19|||
33602298|NCT03684304|102095290|FG001|Overall Study|Lost to Follow-up|17|||
33602299|NCT04208087|102095293|FG000|Overall Study|Adverse Event|1|||
33602300|NCT04208087|102095294|FG001|Overall Study|Adverse Event|0|||
33602301|NCT04208087|102095295|FG002|Overall Study|Adverse Event|0|||
33602302|NCT04208087|102095296|FG003|Overall Study|Adverse Event|0|||
33602303|NCT04208087|102095297|FG004|Overall Study|Adverse Event|0|||
33602304|NCT04208087|102095293|FG000|Overall Study|Withdrawal by Subject|0|||
33602305|NCT04208087|102095294|FG001|Overall Study|Withdrawal by Subject|0|||
33602306|NCT04208087|102095295|FG002|Overall Study|Withdrawal by Subject|1|||
33602307|NCT04208087|102095296|FG003|Overall Study|Withdrawal by Subject|0|||
33602308|NCT04208087|102095297|FG004|Overall Study|Withdrawal by Subject|0|||
33602309|NCT04208087|102095293|FG000|Overall Study|Other|0|||
33602310|NCT04208087|102095294|FG001|Overall Study|Other|0|||
33602311|NCT04208087|102095295|FG002|Overall Study|Other|0|||
33602312|NCT04208087|102095296|FG003|Overall Study|Other|0|||
33602313|NCT04208087|102095297|FG004|Overall Study|Other|1|||
33602314|NCT03283150|102095298|FG000|Overall Study|Withdrawal by Subject|6|||
33602315|NCT03283150|102095299|FG001|Overall Study|Withdrawal by Subject|0|||
33602316|NCT03283150|102095300|FG002|Overall Study|Withdrawal by Subject|0|||
33602317|NCT02535416|102095301|FG000|Overall Study|Family bereavement overseas|1|||
33602318|NCT02535416|102095302|FG001|Overall Study|Family bereavement overseas|0|||
33502823|NCT02564900|101735071|FG010|Dose Expansion|Clinical progression|2|||
33502824|NCT02564900|101735072|FG011|Dose Expansion|Clinical progression|0|||
33502825|NCT02564900|101735073|FG012|Dose Expansion|Clinical progression|1|||
33502826|NCT02564900|101735074|FG013|Dose Expansion|Clinical progression|3|||
33502827|NCT02564900|101735075|FG014|Dose Expansion|Clinical progression|1|||
33502828|NCT02564900|101735061|FG000|Dose Expansion|Adverse Event|0|||
33502829|NCT02564900|101735062|FG001|Dose Expansion|Adverse Event|0|||
33502830|NCT02564900|101735063|FG002|Dose Expansion|Adverse Event|0|||
33502831|NCT02564900|101735064|FG003|Dose Expansion|Adverse Event|0|||
33502832|NCT02564900|101735065|FG004|Dose Expansion|Adverse Event|0|||
33502833|NCT02564900|101735066|FG005|Dose Expansion|Adverse Event|0|||
33602319|NCT02535416|102095303|FG002|Overall Study|Family bereavement overseas|0|||
33602320|NCT02535416|102095304|FG003|Overall Study|Family bereavement overseas|0|||
33602321|NCT02535416|102095305|FG004|Overall Study|Family bereavement overseas|0|||
33602322|NCT02535416|102095306|FG005|Overall Study|Family bereavement overseas|0|||
33602323|NCT02535416|102095307|FG006|Overall Study|Family bereavement overseas|0|||
33602324|NCT02535416|102095308|FG007|Overall Study|Family bereavement overseas|0|||
33602325|NCT02535416|102095309|FG008|Overall Study|Family bereavement overseas|0|||
33602326|NCT02356887|102095311|FG000|Overall Study|poor compliance|2|||
33602327|NCT01754194|102095314|FG000|Overall Study|Lost to Follow-up|39|||
33602328|NCT01754194|102095315|FG001|Overall Study|Lost to Follow-up|14|||
33602329|NCT01754194|102095314|FG000|Overall Study|Withdrawal by Subject|4|||
33602330|NCT01754194|102095315|FG001|Overall Study|Withdrawal by Subject|5|||
33602331|NCT01754194|102095314|FG000|Overall Study|Other|9|||
33193301|NCT00441337|100612678|FG000|Overall Study|Disease Progression|6|||
33312360|NCT00687973|101037592|FG000|Overall Study|Administrative Reasons|0|||
33312361|NCT00687973|101037593|FG001|Overall Study|Administrative Reasons|2|||
33312362|NCT00687973|101037592|FG000|Overall Study|Withdrawal by Subject|3|||
33312363|NCT00687973|101037593|FG001|Overall Study|Withdrawal by Subject|3|||
33312364|NCT04058366|101037596|FG000|Overall Study|Adverse Event|14|||
33312365|NCT04058366|101037596|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
33312366|NCT04058366|101037596|FG000|Overall Study|Commercial drug is available for participants|6|||
33312367|NCT04058366|101037596|FG000|Overall Study|Death|1|||
33312368|NCT04058366|101037596|FG000|Overall Study|Other non-compliance|2|||
33312369|NCT04058366|101037596|FG000|Overall Study|Other|6|||
33312370|NCT01210664|101037599|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
33312371|NCT01210664|101037600|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
33312372|NCT01210664|101037601|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
33502834|NCT02564900|101735067|FG006|Dose Expansion|Adverse Event|9|||
33502835|NCT02564900|101735068|FG007|Dose Expansion|Adverse Event|22|||
33502836|NCT02564900|101735069|FG008|Dose Expansion|Adverse Event|0|||
33502837|NCT02564900|101735070|FG009|Dose Expansion|Adverse Event|11|||
33602332|NCT01754194|102095315|FG001|Overall Study|Other|8|||
33602333|NCT00468845|102095316|FG000|Overall Study|Adverse Event|9|||
33602334|NCT00468845|102095317|FG001|Overall Study|Adverse Event|14|||
33602335|NCT00468845|102095318|FG002|Overall Study|Adverse Event|11|||
33602336|NCT00468845|102095316|FG000|Overall Study|Lost to Follow-up|2|||
33602337|NCT00468845|102095317|FG001|Overall Study|Lost to Follow-up|1|||
33602338|NCT00468845|102095318|FG002|Overall Study|Lost to Follow-up|2|||
33312373|NCT01210664|101037602|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
33502838|NCT02564900|101735071|FG010|Dose Expansion|Adverse Event|0|||
33602339|NCT00468845|102095316|FG000|Overall Study|Other|4|||
33502839|NCT02564900|101735072|FG011|Dose Expansion|Adverse Event|5|||
33602340|NCT00468845|102095317|FG001|Overall Study|Other|9|||
33602341|NCT00468845|102095318|FG002|Overall Study|Other|5|||
33602342|NCT00468845|102095316|FG000|Overall Study|No longer willing to participate|5|||
33602343|NCT00468845|102095317|FG001|Overall Study|No longer willing to participate|6|||
33602344|NCT00468845|102095318|FG002|Overall Study|No longer willing to participate|10|||
33602345|NCT00468845|102095316|FG000|Overall Study|Randomized, not treated|1|||
33602346|NCT00468845|102095317|FG001|Overall Study|Randomized, not treated|4|||
33602347|NCT00468845|102095318|FG002|Overall Study|Randomized, not treated|2|||
33312374|NCT01210664|101037599|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
33312375|NCT01210664|101037600|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
33312376|NCT01210664|101037601|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
33312377|NCT01210664|101037602|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
33312378|NCT01210664|101037599|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
33312379|NCT01210664|101037600|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
33312380|NCT01210664|101037601|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
33312381|NCT01210664|101037602|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
33312382|NCT01227577|101037603|FG000|Overall Study|Protocol deviation|3|||
33312383|NCT01227577|101037603|FG000|Overall Study|Death|3|||
33312384|NCT01227577|101037603|FG000|Overall Study|Administrative problems|2|||
33312385|NCT01227577|101037603|FG000|Overall Study|Lost to Follow-up|1|||
33312386|NCT01227577|101037603|FG000|Overall Study|Withdrawal by Subject|4|||
33312387|NCT01227577|101037603|FG000|Overall Study|Lack of Efficacy|5|||
33312388|NCT01227577|101037603|FG000|Overall Study|Adverse Event|17|||
33312389|NCT03271021|101037604|FG000|Overall Study|Adverse Event|3|||
33312390|NCT03271021|101037605|FG001|Overall Study|Adverse Event|2|||
33312391|NCT03271021|101037604|FG000|Overall Study|Withdrawal by Subject|36|||
33312392|NCT03271021|101037605|FG001|Overall Study|Withdrawal by Subject|53|||
33312393|NCT03271021|101037604|FG000|Overall Study|Lost to Follow-up|34|||
33312394|NCT03271021|101037605|FG001|Overall Study|Lost to Follow-up|39|||
33312395|NCT03271021|101037604|FG000|Overall Study|Protocol Violation|6|||
33312396|NCT03271021|101037605|FG001|Overall Study|Protocol Violation|4|||
33312397|NCT03271021|101037604|FG000|Overall Study|Abnormal Lab Results|1|||
33312398|NCT03271021|101037605|FG001|Overall Study|Abnormal Lab Results|0|||
33312399|NCT03271021|101037604|FG000|Overall Study|Miscellaneous|9|||
33312400|NCT03271021|101037605|FG001|Overall Study|Miscellaneous|8|||
33312401|NCT01952054|101037608|FG000|Overall Study|Physician Decision|1|||
33312402|NCT02649946|101037614|FG000|Overall Study|Withdrawal by Subject|1|||
33312403|NCT02649946|101037615|FG001|Overall Study|Withdrawal by Subject|1|||
33312404|NCT02649946|101037614|FG000|Overall Study|Death|7|||
33312405|NCT02649946|101037615|FG001|Overall Study|Death|9|||
33312406|NCT02649946|101037614|FG000|Overall Study|Physician Decision|1|||
33312407|NCT02649946|101037615|FG001|Overall Study|Physician Decision|0|||
33312408|NCT02649946|101037614|FG000|Overall Study|Lost to Follow-up|2|||
33312409|NCT02649946|101037615|FG001|Overall Study|Lost to Follow-up|1|||
33312410|NCT02649946|101037614|FG000|Overall Study|Erroneously enrolled|1|||
33312411|NCT02649946|101037615|FG001|Overall Study|Erroneously enrolled|0|||
33312412|NCT02649946|101037614|FG000|Overall Study|Missed 6-month follow-up visit|0|||
33312413|NCT02649946|101037615|FG001|Overall Study|Missed 6-month follow-up visit|4|||
33312414|NCT03536754|101037616|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
33312415|NCT03536754|101037617|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
33312416|NCT03536754|101037618|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
33312417|NCT03536754|101037619|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
33312418|NCT03536754|101037620|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
33312419|NCT03536754|101037616|FG000|Open Label Extension|Other|0|||
33312420|NCT03536754|101037617|FG001|Open Label Extension|Other|0|||
33312421|NCT03536754|101037618|FG002|Open Label Extension|Other|0|||
33312422|NCT03536754|101037619|FG003|Open Label Extension|Other|0|||
33312423|NCT03536754|101037620|FG004|Open Label Extension|Other|1|||
33312424|NCT00413972|101037621|FG000|Overall Study|Adverse Event|2|||
33312425|NCT00413972|101037622|FG001|Overall Study|Adverse Event|1|||
33312426|NCT00413972|101037623|FG002|Overall Study|Adverse Event|0|||
33312427|NCT00413972|101037624|FG003|Overall Study|Adverse Event|0|||
33312428|NCT00413972|101037621|FG000|Overall Study|Lost to Follow-up|1|||
33312429|NCT00413972|101037622|FG001|Overall Study|Lost to Follow-up|2|||
33312430|NCT00413972|101037623|FG002|Overall Study|Lost to Follow-up|1|||
33312431|NCT00413972|101037624|FG003|Overall Study|Lost to Follow-up|0|||
33312432|NCT00413972|101037621|FG000|Overall Study|Withdrawal by Subject|4|||
33312433|NCT00413972|101037622|FG001|Overall Study|Withdrawal by Subject|5|||
33312434|NCT00413972|101037623|FG002|Overall Study|Withdrawal by Subject|7|||
33602348|NCT02876328|102095319|FG000|Overall Study|Death|2|||
33312435|NCT00413972|101037624|FG003|Overall Study|Withdrawal by Subject|2|||
33312436|NCT00413972|101037621|FG000|Overall Study|Protocol Violation|0|||
33602349|NCT02876328|102095320|FG001|Overall Study|Death|1|||
33312437|NCT00413972|101037622|FG001|Overall Study|Protocol Violation|0|||
33312438|NCT00413972|101037623|FG002|Overall Study|Protocol Violation|2|||
33312439|NCT00413972|101037624|FG003|Overall Study|Protocol Violation|0|||
33312440|NCT00413972|101037621|FG000|Overall Study|Other|0|||
33193302|NCT00441337|100612679|FG001|Overall Study|Disease Progression|6|||
33312441|NCT00413972|101037622|FG001|Overall Study|Other|0|||
33312442|NCT00413972|101037623|FG002|Overall Study|Other|0|||
33312443|NCT00413972|101037624|FG003|Overall Study|Other|1|||
33312444|NCT00427895|101037631|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
33312445|NCT00427895|101037632|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
33312446|NCT00427895|101037633|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
33312447|NCT00427895|101037634|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
33312448|NCT00427895|101037635|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
33312449|NCT00427895|101037636|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
33312450|NCT00427895|101037637|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
33312451|NCT00427895|101037638|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
33312452|NCT00427895|101037631|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
33312453|NCT00427895|101037632|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
33312454|NCT00427895|101037633|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
33312455|NCT00427895|101037634|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
33312456|NCT00427895|101037635|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
33312457|NCT00427895|101037636|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
33312458|NCT00427895|101037637|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
33312459|NCT00427895|101037638|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
33312460|NCT00427895|101037631|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
33312461|NCT00427895|101037632|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
33312462|NCT00427895|101037633|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
33312463|NCT00427895|101037634|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
33312464|NCT00427895|101037635|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
33312465|NCT00427895|101037636|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
33312466|NCT00427895|101037637|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
33312467|NCT00427895|101037638|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
33312468|NCT00427895|101037631|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
33312469|NCT00427895|101037632|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
33312470|NCT00427895|101037633|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
33312471|NCT00427895|101037634|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
33312472|NCT00427895|101037635|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
33312473|NCT00427895|101037636|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
33312474|NCT00427895|101037637|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
33312475|NCT00427895|101037638|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
33312476|NCT00427895|101037631|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
33312477|NCT00427895|101037632|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
33312478|NCT00427895|101037633|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
33312479|NCT00427895|101037634|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
33312480|NCT00427895|101037635|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
33312481|NCT00427895|101037636|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
33312482|NCT00427895|101037637|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
33312483|NCT00427895|101037638|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
33312484|NCT00427895|101037631|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
33312485|NCT00427895|101037632|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
33312486|NCT00427895|101037633|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
33312487|NCT00427895|101037634|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
33312488|NCT00427895|101037635|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
33312489|NCT00427895|101037636|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
33312490|NCT00427895|101037637|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
33312491|NCT00427895|101037638|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
33312492|NCT00427895|101037631|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
33312493|NCT00427895|101037632|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
33312494|NCT00427895|101037633|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
33312495|NCT00427895|101037634|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
33312496|NCT00427895|101037635|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
33312497|NCT00427895|101037636|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
33312498|NCT00427895|101037637|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
33312499|NCT00427895|101037638|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
33312500|NCT00427895|101037631|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
33312501|NCT00427895|101037632|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
33312502|NCT00427895|101037633|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
33312503|NCT00427895|101037634|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
33312504|NCT00427895|101037635|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
33312505|NCT00427895|101037636|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
33312506|NCT00427895|101037637|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
33312507|NCT00427895|101037638|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
33193303|NCT00441337|100612680|FG002|Overall Study|Disease Progression|4|||
33395309|NCT03898323|101334772|FG000|Overall Study|Physician Decision|1|||
33395310|NCT00464620|101334782|FG000|Overall Study|Physician Decision|1|||
33312508|NCT00427895|101037631|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
33395311|NCT00464620|101334783|FG001|Overall Study|Physician Decision|0|||
33395312|NCT00464620|101334784|FG002|Overall Study|Physician Decision|0|||
33312509|NCT00427895|101037632|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
33395313|NCT00464620|101334782|FG000|Overall Study|Withdrawal by Subject|1|||
33395314|NCT00464620|101334783|FG001|Overall Study|Withdrawal by Subject|0|||
33395315|NCT00464620|101334784|FG002|Overall Study|Withdrawal by Subject|3|||
33395316|NCT00464620|101334782|FG000|Overall Study|Ineligible sarcoma subtype|0|||
33395317|NCT00464620|101334783|FG001|Overall Study|Ineligible sarcoma subtype|2|||
33395318|NCT00464620|101334784|FG002|Overall Study|Ineligible sarcoma subtype|2|||
33395319|NCT00464620|101334782|FG000|Overall Study|Use of prohibited concomitant medication|0|||
33395320|NCT00464620|101334783|FG001|Overall Study|Use of prohibited concomitant medication|0|||
33395321|NCT00464620|101334784|FG002|Overall Study|Use of prohibited concomitant medication|2|||
33395322|NCT00691054|101334787|FG000|Overall Study|Withdrawal by Subject|1|||
33395323|NCT04157751|101334788|FG000|Overall Study|Withdrawal by Subject|12|||
33395324|NCT04157751|101334789|FG001|Overall Study|Withdrawal by Subject|17|||
33395325|NCT04157751|101334788|FG000|Overall Study|Lost to Follow-up|6|||
33395326|NCT04157751|101334789|FG001|Overall Study|Lost to Follow-up|2|||
33395327|NCT04157751|101334788|FG000|Overall Study|Adverse Event|34|||
33395328|NCT04157751|101334789|FG001|Overall Study|Adverse Event|23|||
33395329|NCT04157751|101334788|FG000|Overall Study|Not treated|1|||
33395330|NCT04157751|101334789|FG001|Overall Study|Not treated|5|||
33395331|NCT04157751|101334788|FG000|Overall Study|Other reason not stated above|10|||
33395332|NCT04157751|101334789|FG001|Overall Study|Other reason not stated above|10|||
33395333|NCT05104749|101334790|FG000|Overall Study|Lost to Follow-up|2|||
33395334|NCT05104749|101334791|FG001|Overall Study|Lost to Follow-up|3|||
33395335|NCT00242710|101334797|FG000|Core Study (up to Year 1)|Adverse Event|30|||
33395336|NCT00242710|101334798|FG001|Core Study (up to Year 1)|Adverse Event|25|||
33395337|NCT00242710|101334799|FG002|Core Study (up to Year 1)|Adverse Event|23|||
33312510|NCT00427895|101037633|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
33312511|NCT00427895|101037634|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
33312512|NCT00427895|101037635|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
33312513|NCT00427895|101037636|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
33312514|NCT00427895|101037637|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
33312515|NCT00427895|101037638|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
33312516|NCT00427895|101037631|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
33312517|NCT00427895|101037632|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
33312518|NCT00427895|101037633|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
33312519|NCT00427895|101037634|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
33312520|NCT00427895|101037635|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
33312521|NCT00427895|101037636|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
33312522|NCT00427895|101037637|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
33312523|NCT00427895|101037638|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
33312524|NCT00427895|101037631|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
33312525|NCT00427895|101037632|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
33312526|NCT00427895|101037633|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
33312527|NCT00427895|101037634|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
33395338|NCT00242710|101334800|FG003|Core Study (up to Year 1)|Adverse Event|14|||
33395339|NCT00242710|101334797|FG000|Core Study (up to Year 1)|Death|0|||
33395340|NCT00242710|101334798|FG001|Core Study (up to Year 1)|Death|0|||
33395341|NCT00242710|101334799|FG002|Core Study (up to Year 1)|Death|1|||
33395342|NCT00242710|101334800|FG003|Core Study (up to Year 1)|Death|0|||
33395343|NCT00242710|101334797|FG000|Core Study (up to Year 1)|Physician Decision|0|||
33395344|NCT00242710|101334798|FG001|Core Study (up to Year 1)|Physician Decision|1|||
33395345|NCT00242710|101334799|FG002|Core Study (up to Year 1)|Physician Decision|0|||
33312528|NCT00427895|101037635|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
33395346|NCT00242710|101334800|FG003|Core Study (up to Year 1)|Physician Decision|1|||
33395347|NCT00242710|101334797|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
33395348|NCT00242710|101334798|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
33395349|NCT00242710|101334799|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
33395350|NCT00242710|101334800|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
33395351|NCT00242710|101334797|FG000|Core Study (up to Year 1)|Other|6|||
33193304|NCT00441337|100612681|FG003|Overall Study|Disease Progression|18|||
33193305|NCT00441337|100612678|FG000|Overall Study|Lost to Follow-up|0|||
33395352|NCT00242710|101334798|FG001|Core Study (up to Year 1)|Other|1|||
33395353|NCT00242710|101334799|FG002|Core Study (up to Year 1)|Other|0|||
33395354|NCT00242710|101334800|FG003|Core Study (up to Year 1)|Other|2|||
33395355|NCT00242710|101334797|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
33395356|NCT00242710|101334798|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
33395357|NCT00242710|101334799|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
33395358|NCT00242710|101334800|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
33395359|NCT00242710|101334797|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
33395360|NCT00242710|101334798|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
33395361|NCT00242710|101334799|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
33395362|NCT00242710|101334800|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
33395363|NCT00242710|101334797|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
33395364|NCT00242710|101334798|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
33395365|NCT00242710|101334799|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
33395366|NCT00242710|101334800|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
33395367|NCT00242710|101334797|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
33395368|NCT00242710|101334798|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
33395369|NCT00242710|101334799|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
33602350|NCT02876328|102095321|FG002|Overall Study|Death|3|||
33602351|NCT02876328|102095322|FG003|Overall Study|Death|0|||
33602352|NCT02876328|102095323|FG004|Overall Study|Death|0|||
33602353|NCT02876328|102095324|FG005|Overall Study|Death|0|||
33602354|NCT02876328|102095325|FG006|Overall Study|Death|1|||
33602355|NCT02876328|102095326|FG007|Overall Study|Death|3|||
33602356|NCT02876328|102095327|FG008|Overall Study|Death|0|||
33602357|NCT02876328|102095328|FG009|Overall Study|Death|1|||
33312529|NCT00427895|101037636|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
33312530|NCT00427895|101037637|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
33312531|NCT00427895|101037638|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
33312532|NCT00427895|101037631|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
33602358|NCT02876328|102095329|FG010|Overall Study|Death|1|||
33602359|NCT02876328|102095330|FG011|Overall Study|Death|0|||
33602360|NCT02876328|102095331|FG012|Overall Study|Death|0|||
33312533|NCT00427895|101037632|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
33312534|NCT00427895|101037633|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
33312535|NCT00427895|101037634|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
33312536|NCT00427895|101037635|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
33312537|NCT00427895|101037636|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
33395370|NCT00242710|101334800|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
33395371|NCT00242710|101334797|FG000|Period Between Core Study and Extension|Adverse Event|2|||
33395372|NCT00242710|101334798|FG001|Period Between Core Study and Extension|Adverse Event|3|||
33395373|NCT00242710|101334799|FG002|Period Between Core Study and Extension|Adverse Event|5|||
33395374|NCT00242710|101334800|FG003|Period Between Core Study and Extension|Adverse Event|2|||
33395375|NCT00242710|101334797|FG000|Period Between Core Study and Extension|Physician Decision|1|||
33395376|NCT00242710|101334798|FG001|Period Between Core Study and Extension|Physician Decision|1|||
33395377|NCT00242710|101334799|FG002|Period Between Core Study and Extension|Physician Decision|0|||
33395378|NCT00242710|101334800|FG003|Period Between Core Study and Extension|Physician Decision|0|||
33395379|NCT00242710|101334797|FG000|Period Between Core Study and Extension|Other|24|||
33395380|NCT00242710|101334798|FG001|Period Between Core Study and Extension|Other|24|||
33395381|NCT00242710|101334799|FG002|Period Between Core Study and Extension|Other|9|||
33502840|NCT02564900|101735073|FG012|Dose Expansion|Adverse Event|2|||
33502841|NCT02564900|101735074|FG013|Dose Expansion|Adverse Event|2|||
33312538|NCT00427895|101037637|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
33395382|NCT00242710|101334800|FG003|Period Between Core Study and Extension|Other|11|||
33395383|NCT00242710|101334797|FG000|Period Between Core Study and Extension|Extension not Available|17|||
33502842|NCT02564900|101735075|FG014|Dose Expansion|Adverse Event|1|||
33502843|NCT02564900|101735061|FG000|Dose Expansion|Ongoing|0|||
33502844|NCT02564900|101735062|FG001|Dose Expansion|Ongoing|0|||
33502845|NCT02564900|101735063|FG002|Dose Expansion|Ongoing|0|||
33502846|NCT02564900|101735064|FG003|Dose Expansion|Ongoing|0|||
33502847|NCT02564900|101735065|FG004|Dose Expansion|Ongoing|0|||
33502848|NCT02564900|101735066|FG005|Dose Expansion|Ongoing|0|||
33193306|NCT00441337|100612679|FG001|Overall Study|Lost to Follow-up|0|||
33193307|NCT00441337|100612680|FG002|Overall Study|Lost to Follow-up|0|||
33395384|NCT00242710|101334798|FG001|Period Between Core Study and Extension|Extension not Available|21|||
33502849|NCT02564900|101735067|FG006|Dose Expansion|Ongoing|9|||
33502850|NCT02564900|101735068|FG007|Dose Expansion|Ongoing|10|||
33312539|NCT00427895|101037638|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
33395385|NCT00242710|101334799|FG002|Period Between Core Study and Extension|Extension not Available|8|||
33502851|NCT02564900|101735069|FG008|Dose Expansion|Ongoing|11|||
33502852|NCT02564900|101735070|FG009|Dose Expansion|Ongoing|3|||
33502853|NCT02564900|101735071|FG010|Dose Expansion|Ongoing|0|||
33602361|NCT02876328|102095332|FG013|Overall Study|Death|0|||
33602362|NCT02876328|102095333|FG014|Overall Study|Death|0|||
33312540|NCT00427895|101037631|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
33602363|NCT02876328|102095334|FG015|Overall Study|Death|0|||
33502854|NCT02564900|101735072|FG011|Dose Expansion|Ongoing|0|||
33502855|NCT02564900|101735073|FG012|Dose Expansion|Ongoing|4|||
33502856|NCT02564900|101735074|FG013|Dose Expansion|Ongoing|0|||
33502857|NCT02564900|101735075|FG014|Dose Expansion|Ongoing|6|||
33502858|NCT02564900|101735061|FG000|Dose Expansion|Death|0|||
33502859|NCT02564900|101735062|FG001|Dose Expansion|Death|0|||
33602364|NCT02876328|102095335|FG016|Overall Study|Death|1|||
33602365|NCT02876328|102095336|FG017|Overall Study|Death|1|||
33602366|NCT02876328|102095337|FG018|Overall Study|Death|0|||
33602367|NCT02876328|102095338|FG019|Overall Study|Death|0|||
33193308|NCT00441337|100612681|FG003|Overall Study|Lost to Follow-up|1|||
33193309|NCT00441337|100612678|FG000|Overall Study|Sponsor Decision|0|||
33502860|NCT02564900|101735063|FG002|Dose Expansion|Death|0|||
33502861|NCT02564900|101735064|FG003|Dose Expansion|Death|0|||
33193310|NCT00441337|100612679|FG001|Overall Study|Sponsor Decision|0|||
33193311|NCT00441337|100612680|FG002|Overall Study|Sponsor Decision|1|||
33193312|NCT00441337|100612681|FG003|Overall Study|Sponsor Decision|2|||
33193313|NCT00441337|100612678|FG000|Overall Study|Did not meet inclusion criteria|0|||
33312541|NCT00427895|101037632|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
33312542|NCT00427895|101037633|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
33312543|NCT00427895|101037634|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
33312544|NCT00427895|101037635|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
33312545|NCT00427895|101037636|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
33312546|NCT00427895|101037637|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
33312547|NCT00427895|101037638|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
33312548|NCT00427895|101037631|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
33312549|NCT00427895|101037632|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
33312550|NCT00427895|101037633|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
33312551|NCT00427895|101037634|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
33312552|NCT00427895|101037635|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
33312553|NCT00427895|101037636|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
33312554|NCT00427895|101037637|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
33312555|NCT00427895|101037638|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
33312556|NCT00427895|101037631|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
33312557|NCT00427895|101037632|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
33312558|NCT00427895|101037633|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
33312559|NCT00427895|101037634|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
33312560|NCT00427895|101037635|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
33312561|NCT00427895|101037636|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
33312562|NCT00427895|101037637|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
33312563|NCT00427895|101037638|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
33312564|NCT00427895|101037631|FG000|Vax 1/Year 1 Follow-up|Death|1|||
33312565|NCT00427895|101037632|FG001|Vax 1/Year 1 Follow-up|Death|0|||
33395386|NCT00242710|101334800|FG003|Period Between Core Study and Extension|Extension not Available|7|||
33395387|NCT00242710|101334797|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
33395388|NCT00242710|101334798|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
33395389|NCT00242710|101334799|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
33395390|NCT00242710|101334800|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
33395391|NCT00242710|101334797|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
33312566|NCT00427895|101037633|FG002|Vax 1/Year 1 Follow-up|Death|0|||
33312567|NCT00427895|101037634|FG003|Vax 1/Year 1 Follow-up|Death|0|||
33312568|NCT00427895|101037635|FG004|Vax 1/Year 1 Follow-up|Death|0|||
33312569|NCT00427895|101037636|FG005|Vax 1/Year 1 Follow-up|Death|0|||
33312570|NCT00427895|101037637|FG006|Vax 1/Year 1 Follow-up|Death|0|||
33312571|NCT00427895|101037638|FG007|Vax 1/Year 1 Follow-up|Death|0|||
33312572|NCT00427895|101037631|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
33395392|NCT00242710|101334798|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
33395393|NCT00242710|101334799|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
33395394|NCT00242710|101334800|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
33395395|NCT00242710|101334797|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
33395396|NCT00242710|101334798|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
33502862|NCT02564900|101735065|FG004|Dose Expansion|Death|0|||
33502863|NCT02564900|101735066|FG005|Dose Expansion|Death|0|||
33502864|NCT02564900|101735067|FG006|Dose Expansion|Death|1|||
33502865|NCT02564900|101735068|FG007|Dose Expansion|Death|0|||
33502866|NCT02564900|101735069|FG008|Dose Expansion|Death|0|||
33193314|NCT00441337|100612679|FG001|Overall Study|Did not meet inclusion criteria|0|||
33502867|NCT02564900|101735070|FG009|Dose Expansion|Death|0|||
33502868|NCT02564900|101735071|FG010|Dose Expansion|Death|1|||
33502869|NCT02564900|101735072|FG011|Dose Expansion|Death|0|||
33602368|NCT02876328|102095339|FG020|Overall Study|Death|0|||
33193315|NCT00441337|100612680|FG002|Overall Study|Did not meet inclusion criteria|1|||
33312573|NCT00427895|101037632|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
33312574|NCT00427895|101037633|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
33312575|NCT00427895|101037634|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
33312576|NCT00427895|101037635|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
33193316|NCT00441337|100612681|FG003|Overall Study|Did not meet inclusion criteria|0|||
33395397|NCT00242710|101334799|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
33502870|NCT02564900|101735073|FG012|Dose Expansion|Death|1|||
33502871|NCT02564900|101735074|FG013|Dose Expansion|Death|1|||
33502872|NCT02564900|101735075|FG014|Dose Expansion|Death|0|||
33502873|NCT02564900|101735061|FG000|Dose Expansion|Withdrawal by Subject|0|||
33502874|NCT02564900|101735062|FG001|Dose Expansion|Withdrawal by Subject|0|||
33502875|NCT02564900|101735063|FG002|Dose Expansion|Withdrawal by Subject|0|||
33502876|NCT02564900|101735064|FG003|Dose Expansion|Withdrawal by Subject|0|||
33502877|NCT02564900|101735065|FG004|Dose Expansion|Withdrawal by Subject|0|||
33502878|NCT02564900|101735066|FG005|Dose Expansion|Withdrawal by Subject|0|||
33502879|NCT02564900|101735067|FG006|Dose Expansion|Withdrawal by Subject|4|||
33502880|NCT02564900|101735068|FG007|Dose Expansion|Withdrawal by Subject|0|||
33502881|NCT02564900|101735069|FG008|Dose Expansion|Withdrawal by Subject|0|||
33502882|NCT02564900|101735070|FG009|Dose Expansion|Withdrawal by Subject|0|||
33502883|NCT02564900|101735071|FG010|Dose Expansion|Withdrawal by Subject|1|||
33502884|NCT02564900|101735072|FG011|Dose Expansion|Withdrawal by Subject|0|||
33502885|NCT02564900|101735073|FG012|Dose Expansion|Withdrawal by Subject|0|||
33502886|NCT02564900|101735074|FG013|Dose Expansion|Withdrawal by Subject|1|||
33502887|NCT02564900|101735075|FG014|Dose Expansion|Withdrawal by Subject|1|||
33502888|NCT02564900|101735061|FG000|Dose Expansion|Other|0|||
33502889|NCT02564900|101735062|FG001|Dose Expansion|Other|0|||
33502890|NCT02564900|101735063|FG002|Dose Expansion|Other|0|||
33502891|NCT02564900|101735064|FG003|Dose Expansion|Other|0|||
33502892|NCT02564900|101735065|FG004|Dose Expansion|Other|0|||
33502893|NCT02564900|101735066|FG005|Dose Expansion|Other|0|||
33502894|NCT02564900|101735067|FG006|Dose Expansion|Other|1|||
33502895|NCT02564900|101735068|FG007|Dose Expansion|Other|0|||
33502896|NCT02564900|101735069|FG008|Dose Expansion|Other|1|||
33502897|NCT02564900|101735070|FG009|Dose Expansion|Other|0|||
33502898|NCT02564900|101735071|FG010|Dose Expansion|Other|0|||
33502899|NCT02564900|101735072|FG011|Dose Expansion|Other|0|||
33502900|NCT02564900|101735073|FG012|Dose Expansion|Other|0|||
33502901|NCT02564900|101735074|FG013|Dose Expansion|Other|0|||
33502902|NCT02564900|101735075|FG014|Dose Expansion|Other|1|||
33502903|NCT02564900|101735061|FG000|Dose Expansion|Did not receive treatment|0|||
33502904|NCT02564900|101735062|FG001|Dose Expansion|Did not receive treatment|0|||
33502905|NCT02564900|101735063|FG002|Dose Expansion|Did not receive treatment|0|||
33502906|NCT02564900|101735064|FG003|Dose Expansion|Did not receive treatment|0|||
33502907|NCT02564900|101735065|FG004|Dose Expansion|Did not receive treatment|0|||
33502908|NCT02564900|101735066|FG005|Dose Expansion|Did not receive treatment|0|||
33502909|NCT02564900|101735067|FG006|Dose Expansion|Did not receive treatment|1|||
33395398|NCT00242710|101334800|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
33502910|NCT02564900|101735068|FG007|Dose Expansion|Did not receive treatment|1|||
33502911|NCT02564900|101735069|FG008|Dose Expansion|Did not receive treatment|0|||
33502912|NCT02564900|101735070|FG009|Dose Expansion|Did not receive treatment|0|||
33502913|NCT02564900|101735071|FG010|Dose Expansion|Did not receive treatment|0|||
33502914|NCT02564900|101735072|FG011|Dose Expansion|Did not receive treatment|0|||
33502915|NCT02564900|101735073|FG012|Dose Expansion|Did not receive treatment|0|||
33502916|NCT02564900|101735074|FG013|Dose Expansion|Did not receive treatment|0|||
33502917|NCT02564900|101735075|FG014|Dose Expansion|Did not receive treatment|1|||
33502918|NCT04164732|101735096|FG000|Treatment run-in Period|Adverse Event|4|||
33193317|NCT03306264|100612684|FG000|Overall Study|Death|33|||
33502919|NCT04164732|101735097|FG001|Treatment run-in Period|Adverse Event|0|||
33502920|NCT04164732|101735098|FG002|Treatment run-in Period|Adverse Event|0|||
33502921|NCT04164732|101735096|FG000|Treatment run-in Period|Physician Decision|1|||
33502922|NCT04164732|101735097|FG001|Treatment run-in Period|Physician Decision|0|||
33502923|NCT04164732|101735098|FG002|Treatment run-in Period|Physician Decision|0|||
33502924|NCT04164732|101735096|FG000|Treatment run-in Period|Screen Failure|1|||
33502925|NCT04164732|101735097|FG001|Treatment run-in Period|Screen Failure|0|||
33502926|NCT04164732|101735098|FG002|Treatment run-in Period|Screen Failure|0|||
33502927|NCT04164732|101735096|FG000|Randomized Treatment Period|Adverse Event|0|||
33502928|NCT04164732|101735097|FG001|Randomized Treatment Period|Adverse Event|1|||
33502929|NCT04164732|101735098|FG002|Randomized Treatment Period|Adverse Event|0|||
33502930|NCT04164732|101735096|FG000|Randomized Treatment Period|Protocol Deviation|0|||
33502931|NCT04164732|101735097|FG001|Randomized Treatment Period|Protocol Deviation|1|||
33502932|NCT04164732|101735098|FG002|Randomized Treatment Period|Protocol Deviation|1|||
33502933|NCT04164732|101735096|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
33502934|NCT04164732|101735097|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
33502935|NCT04164732|101735098|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
33502936|NCT03693612|101735099|FG000|Overall Study|Lost to Follow-up|0|||
33502937|NCT03693612|101735100|FG001|Overall Study|Lost to Follow-up|0|||
33502938|NCT03693612|101735101|FG002|Overall Study|Lost to Follow-up|0|||
33502939|NCT03693612|101735102|FG003|Overall Study|Lost to Follow-up|0|||
33502940|NCT03693612|101735103|FG004|Overall Study|Lost to Follow-up|1|||
33502941|NCT03693612|101735104|FG005|Overall Study|Lost to Follow-up|0|||
33502942|NCT03693612|101735105|FG006|Overall Study|Lost to Follow-up|0|||
33502943|NCT03693612|101735099|FG000|Overall Study|Withdrawal by Subject|0|||
33502944|NCT03693612|101735100|FG001|Overall Study|Withdrawal by Subject|0|||
33502945|NCT03693612|101735101|FG002|Overall Study|Withdrawal by Subject|1|||
33502946|NCT03693612|101735102|FG003|Overall Study|Withdrawal by Subject|0|||
33502947|NCT03693612|101735103|FG004|Overall Study|Withdrawal by Subject|2|||
33502948|NCT03693612|101735104|FG005|Overall Study|Withdrawal by Subject|0|||
33502949|NCT03693612|101735105|FG006|Overall Study|Withdrawal by Subject|0|||
33502950|NCT03693612|101735099|FG000|Overall Study|Study Terminated by Sponsor|0|||
33502951|NCT03693612|101735100|FG001|Overall Study|Study Terminated by Sponsor|1|||
33502952|NCT03693612|101735101|FG002|Overall Study|Study Terminated by Sponsor|0|||
33502953|NCT03693612|101735102|FG003|Overall Study|Study Terminated by Sponsor|0|||
33502954|NCT03693612|101735103|FG004|Overall Study|Study Terminated by Sponsor|3|||
33502955|NCT03693612|101735104|FG005|Overall Study|Study Terminated by Sponsor|0|||
33193318|NCT03306264|100612685|FG001|Overall Study|Death|25|||
33502956|NCT03693612|101735105|FG006|Overall Study|Study Terminated by Sponsor|0|||
33602369|NCT02876328|102095340|FG021|Overall Study|Death|1|||
33602370|NCT02876328|102095341|FG022|Overall Study|Death|0|||
33602371|NCT02876328|102095342|FG023|Overall Study|Death|0|||
33602372|NCT02876328|102095319|FG000|Overall Study|Withdrawal by Subject|0|||
33602373|NCT02876328|102095320|FG001|Overall Study|Withdrawal by Subject|2|||
33602374|NCT02876328|102095321|FG002|Overall Study|Withdrawal by Subject|3|||
33602375|NCT02876328|102095322|FG003|Overall Study|Withdrawal by Subject|3|||
33602376|NCT02876328|102095323|FG004|Overall Study|Withdrawal by Subject|0|||
33602377|NCT02876328|102095324|FG005|Overall Study|Withdrawal by Subject|1|||
33602378|NCT02876328|102095325|FG006|Overall Study|Withdrawal by Subject|0|||
33602379|NCT02876328|102095326|FG007|Overall Study|Withdrawal by Subject|1|||
33602380|NCT02876328|102095327|FG008|Overall Study|Withdrawal by Subject|1|||
33193319|NCT03306264|100612686|FG002|Overall Study|Death|34|||
33193320|NCT03306264|100612687|FG003|Overall Study|Death|34|||
33193321|NCT03306264|100612684|FG000|Overall Study|Complete Consent Withdrawal|4|||
33312577|NCT00427895|101037636|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
33312578|NCT00427895|101037637|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
33312579|NCT00427895|101037638|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
33193322|NCT03306264|100612685|FG001|Overall Study|Complete Consent Withdrawal|4|||
33312580|NCT00427895|101037631|FG000|Vax 1/Year 1 Follow-up|Other|0|||
33312581|NCT00427895|101037632|FG001|Vax 1/Year 1 Follow-up|Other|0|||
33312582|NCT00427895|101037633|FG002|Vax 1/Year 1 Follow-up|Other|0|||
33312583|NCT00427895|101037634|FG003|Vax 1/Year 1 Follow-up|Other|2|||
33193323|NCT03306264|100612686|FG002|Overall Study|Complete Consent Withdrawal|1|||
33312584|NCT00427895|101037635|FG004|Vax 1/Year 1 Follow-up|Other|0|||
33312585|NCT00427895|101037636|FG005|Vax 1/Year 1 Follow-up|Other|0|||
33502957|NCT03318861|101735106|FG000|Overall Study|Death|2|||
33502958|NCT03318861|101735107|FG001|Overall Study|Death|3|||
33502959|NCT03318861|101735108|FG002|Overall Study|Death|3|||
33502960|NCT03318861|101735109|FG003|Overall Study|Death|2|||
33602381|NCT02876328|102095328|FG009|Overall Study|Withdrawal by Subject|2|||
33602382|NCT02876328|102095329|FG010|Overall Study|Withdrawal by Subject|0|||
33602383|NCT02876328|102095330|FG011|Overall Study|Withdrawal by Subject|0|||
33602384|NCT02876328|102095331|FG012|Overall Study|Withdrawal by Subject|0|||
33312586|NCT00427895|101037637|FG006|Vax 1/Year 1 Follow-up|Other|0|||
33312587|NCT00427895|101037638|FG007|Vax 1/Year 1 Follow-up|Other|0|||
33312588|NCT00427895|101037631|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
33502961|NCT03318861|101735110|FG004|Overall Study|Death|2|||
33312589|NCT00427895|101037632|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
33312590|NCT00427895|101037633|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
33312591|NCT00427895|101037634|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
33312592|NCT00427895|101037635|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
33312593|NCT00427895|101037636|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
33312594|NCT00427895|101037637|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
33312595|NCT00427895|101037638|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
33312596|NCT04097301|101037639|FG000|Overall Study|Death|1|||
33312597|NCT04097301|101037639|FG000|Overall Study|Withdrawal by Subject|1|||
33502962|NCT03318861|101735106|FG000|Overall Study|Enrolled But Never Treated|0|||
33502963|NCT03318861|101735107|FG001|Overall Study|Enrolled But Never Treated|1|||
33193324|NCT03306264|100612687|FG003|Overall Study|Complete Consent Withdrawal|8|||
33312598|NCT04097301|101037639|FG000|Overall Study|Screening Failure|5|||
33312599|NCT03305731|101037644|FG000|Overall Study|Protocol Violation|1|||
33312600|NCT02084056|101037645|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
33602385|NCT02876328|102095332|FG013|Overall Study|Withdrawal by Subject|0|||
33602386|NCT02876328|102095333|FG014|Overall Study|Withdrawal by Subject|0|||
33602387|NCT02876328|102095334|FG015|Overall Study|Withdrawal by Subject|0|||
33602388|NCT02876328|102095335|FG016|Overall Study|Withdrawal by Subject|1|||
33602389|NCT02876328|102095336|FG017|Overall Study|Withdrawal by Subject|3|||
33602390|NCT02876328|102095337|FG018|Overall Study|Withdrawal by Subject|0|||
33602391|NCT02876328|102095338|FG019|Overall Study|Withdrawal by Subject|0|||
33602392|NCT02876328|102095339|FG020|Overall Study|Withdrawal by Subject|1|||
33602393|NCT02876328|102095340|FG021|Overall Study|Withdrawal by Subject|0|||
33602394|NCT02876328|102095341|FG022|Overall Study|Withdrawal by Subject|0|||
33312601|NCT02084056|101037646|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
33502964|NCT03318861|101735108|FG002|Overall Study|Enrolled But Never Treated|0|||
33502965|NCT03318861|101735109|FG003|Overall Study|Enrolled But Never Treated|1|||
33502966|NCT03318861|101735110|FG004|Overall Study|Enrolled But Never Treated|1|||
33502967|NCT03318861|101735106|FG000|Overall Study|Informed Consent Withdraw|0|||
33502968|NCT03318861|101735107|FG001|Overall Study|Informed Consent Withdraw|0|||
33193325|NCT03306264|100612684|FG000|Overall Study|Lost to Follow-up|1|||
33193326|NCT03306264|100612685|FG001|Overall Study|Lost to Follow-up|0|||
33193327|NCT03306264|100612686|FG002|Overall Study|Lost to Follow-up|1|||
33193328|NCT03306264|100612687|FG003|Overall Study|Lost to Follow-up|0|||
33193329|NCT03306264|100612684|FG000|Overall Study|Rollover to ASTX727-06|10|||
33193330|NCT03306264|100612685|FG001|Overall Study|Rollover to ASTX727-06|18|||
33193331|NCT03306264|100612686|FG002|Overall Study|Rollover to ASTX727-06|4|||
33502969|NCT03318861|101735108|FG002|Overall Study|Informed Consent Withdraw|0|||
33502970|NCT03318861|101735109|FG003|Overall Study|Informed Consent Withdraw|1|||
33193332|NCT03306264|100612687|FG003|Overall Study|Rollover to ASTX727-06|2|||
33193333|NCT03306264|100612684|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
33193334|NCT03306264|100612685|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
33502971|NCT03318861|101735110|FG004|Overall Study|Informed Consent Withdraw|0|||
33193335|NCT03306264|100612686|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
33193336|NCT03306264|100612687|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
33193337|NCT01797536|100612688|FG000|Overall Study|Adverse Event|0|||
33193338|NCT01797536|100612689|FG001|Overall Study|Adverse Event|1|||
33193339|NCT01797536|100612690|FG002|Overall Study|Adverse Event|0|||
33193340|NCT01797536|100612691|FG003|Overall Study|Adverse Event|0|||
33193341|NCT00622635|100612692|FG000|Treatment Period 1|Adverse Event|0|||
33193342|NCT00622635|100612693|FG001|Treatment Period 1|Adverse Event|0|||
33193343|NCT00622635|100612694|FG002|Treatment Period 1|Adverse Event|1|||
33193344|NCT00622635|100612695|FG003|Treatment Period 1|Adverse Event|0|||
33193345|NCT00622635|100612696|FG004|Treatment Period 1|Adverse Event|0|||
33193346|NCT00622635|100612697|FG005|Treatment Period 1|Adverse Event|0|||
33193347|NCT00622635|100612692|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33193348|NCT00622635|100612693|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33193349|NCT00622635|100612694|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33193350|NCT00622635|100612695|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33193351|NCT00622635|100612696|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33312602|NCT02084056|101037647|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
33312603|NCT02084056|101037648|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
33312604|NCT02084056|101037645|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
33312605|NCT02084056|101037646|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
33312606|NCT02084056|101037647|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
33312607|NCT02084056|101037648|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
33312608|NCT02483585|101037649|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
33312609|NCT02483585|101037650|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
33312610|NCT02483585|101037649|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
33312611|NCT02483585|101037650|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
33312612|NCT02483585|101037649|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
33312613|NCT02483585|101037650|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
33312614|NCT02483585|101037649|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
33312615|NCT02483585|101037650|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
33312616|NCT02483585|101037649|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
33312617|NCT02483585|101037650|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
33312618|NCT02483585|101037649|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
33312619|NCT02483585|101037650|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
33312620|NCT02483585|101037649|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
33312621|NCT02483585|101037650|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
33312622|NCT03938545|101037651|FG000|Overall Study|Lost to Follow-up|0|||
33312623|NCT03938545|101037652|FG001|Overall Study|Lost to Follow-up|0|||
33395399|NCT00242710|101334797|FG000|Study Extension (up to Year 2)|Death|0|||
33395400|NCT00242710|101334798|FG001|Study Extension (up to Year 2)|Death|0|||
33395401|NCT00242710|101334799|FG002|Study Extension (up to Year 2)|Death|0|||
33395402|NCT00242710|101334800|FG003|Study Extension (up to Year 2)|Death|1|||
33395403|NCT00242710|101334797|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
33395404|NCT00242710|101334798|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
33312624|NCT03938545|101037653|FG002|Overall Study|Lost to Follow-up|0|||
33312625|NCT03938545|101037654|FG003|Overall Study|Lost to Follow-up|1|||
33312626|NCT03938545|101037651|FG000|Overall Study|Non-compliance with study drug|0|||
33312627|NCT03938545|101037652|FG001|Overall Study|Non-compliance with study drug|0|||
33312628|NCT03938545|101037653|FG002|Overall Study|Non-compliance with study drug|1|||
33312629|NCT03938545|101037654|FG003|Overall Study|Non-compliance with study drug|0|||
33312630|NCT03938545|101037651|FG000|Overall Study|Pregnancy|1|||
33312631|NCT03938545|101037652|FG001|Overall Study|Pregnancy|0|||
33312632|NCT03938545|101037653|FG002|Overall Study|Pregnancy|0|||
33312633|NCT03938545|101037654|FG003|Overall Study|Pregnancy|0|||
33312634|NCT03938545|101037651|FG000|Overall Study|Study terminated by sponsor|6|||
33312635|NCT03938545|101037652|FG001|Overall Study|Study terminated by sponsor|4|||
33312636|NCT03938545|101037653|FG002|Overall Study|Study terminated by sponsor|2|||
33312637|NCT03938545|101037654|FG003|Overall Study|Study terminated by sponsor|4|||
33312638|NCT03938545|101037651|FG000|Overall Study|Withdrawal by Subject|0|||
33312639|NCT03938545|101037652|FG001|Overall Study|Withdrawal by Subject|1|||
33312640|NCT03938545|101037653|FG002|Overall Study|Withdrawal by Subject|0|||
33312641|NCT03938545|101037654|FG003|Overall Study|Withdrawal by Subject|0|||
33395405|NCT00242710|101334799|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
33395406|NCT00242710|101334800|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
33602395|NCT02876328|102095342|FG023|Overall Study|Withdrawal by Subject|0|||
33193352|NCT00622635|100612697|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33193353|NCT00622635|100612692|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
33312642|NCT03938545|101037651|FG000|Overall Study|Adverse Event|1|||
33602396|NCT02876328|102095319|FG000|Overall Study|Missed 12 Month Visit|15|||
33312643|NCT03938545|101037652|FG001|Overall Study|Adverse Event|0|||
33395407|NCT00242710|101334797|FG000|Study Extension (up to Year 2)|Other|3|||
33193354|NCT00622635|100612693|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
33193355|NCT00622635|100612694|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
33312644|NCT03938545|101037653|FG002|Overall Study|Adverse Event|0|||
33312645|NCT03938545|101037654|FG003|Overall Study|Adverse Event|0|||
33312646|NCT02924428|101037655|FG000|Overall Study|Adverse Event|1|||
33312647|NCT02924428|101037656|FG001|Overall Study|Adverse Event|0|||
33312648|NCT02924428|101037655|FG000|Overall Study|Physician Decision|1|||
33312649|NCT02924428|101037656|FG001|Overall Study|Physician Decision|0|||
33312650|NCT02924428|101037655|FG000|Overall Study|Lost to Follow-up|2|||
33312651|NCT02924428|101037656|FG001|Overall Study|Lost to Follow-up|4|||
33312652|NCT02924428|101037655|FG000|Overall Study|Pregnancy|0|||
33312653|NCT02924428|101037656|FG001|Overall Study|Pregnancy|1|||
33312654|NCT01347762|101037657|FG000|Overall Study|Lost to Follow-up|0|||
33312655|NCT01347762|101037658|FG001|Overall Study|Lost to Follow-up|1|||
33312656|NCT01347762|101037659|FG002|Overall Study|Lost to Follow-up|6|||
33312657|NCT01347762|101037660|FG003|Overall Study|Lost to Follow-up|5|||
33312658|NCT01347762|101037657|FG000|Overall Study|Withdrawal by Subject|4|||
33312659|NCT01347762|101037658|FG001|Overall Study|Withdrawal by Subject|1|||
33312660|NCT01347762|101037659|FG002|Overall Study|Withdrawal by Subject|3|||
33312661|NCT01347762|101037660|FG003|Overall Study|Withdrawal by Subject|3|||
33312662|NCT02090959|101037661|FG000|Overall Study|Withdrawal by Subject|10|||
33312663|NCT02090959|101037661|FG000|Overall Study|Adverse Event|1|||
33312664|NCT02090959|101037661|FG000|Overall Study|Investigator decision|2|||
33312665|NCT02090959|101037661|FG000|Overall Study|Study termination|6|||
33312666|NCT02090959|101037661|FG000|Overall Study|Enrolled but not treated|1|||
33312667|NCT02090959|101037661|FG000|Overall Study|Transfer for compassionate use medicine|4|||
33312668|NCT02090959|101037661|FG000|Overall Study|Move to medical need program|3|||
33312669|NCT02090959|101037661|FG000|Overall Study|Entered in to other study|34|||
33312670|NCT02090959|101037661|FG000|Overall Study|Switched to commercial supply|88|||
33312671|NCT02090959|101037661|FG000|Overall Study|Other than specified|2|||
33312672|NCT00950950|101037662|FG000|Overall Study|Adverse Event|1|||
33312673|NCT00950950|101037663|FG001|Overall Study|Adverse Event|0|||
33312674|NCT00950950|101037662|FG000|Overall Study|Withdrawal by Subject|0|||
33312675|NCT00950950|101037663|FG001|Overall Study|Withdrawal by Subject|1|||
33312676|NCT01990560|101037664|FG000|Overall Study|Withdrawal by Subject|1|||
33312677|NCT01154010|101037665|FG000|Overall Study|Lost to Follow-up|0|||
33312678|NCT01154010|101037666|FG001|Overall Study|Lost to Follow-up|1|||
33312679|NCT02292927|101037667|FG000|Overall Study|Protocol Violation|13|||
33312680|NCT02292927|101037668|FG001|Overall Study|Protocol Violation|7|||
33312681|NCT00642772|101037671|FG000|Overall Study|Lost to Follow-up|3|||
33312682|NCT00642772|101037671|FG000|Overall Study|Withdrawal by Subject|7|||
33312683|NCT00928447|101037675|FG000|Overall Study|Withdrawal by Subject|1|||
33312684|NCT00928447|101037675|FG000|Overall Study|Investigator's decision|1|||
33312685|NCT02875977|101037676|FG000|Overall Study|Lost to Follow-up|42|||
33312686|NCT02875977|101037677|FG001|Overall Study|Lost to Follow-up|29|||
33312687|NCT01439360|101037678|FG000|Overall Study|Adverse Event|4|||
33312688|NCT01439360|101037679|FG001|Overall Study|Adverse Event|16|||
33312689|NCT01439360|101037678|FG000|Overall Study|Lost to Follow-up|43|||
33312690|NCT01439360|101037679|FG001|Overall Study|Lost to Follow-up|58|||
33312691|NCT01439360|101037678|FG000|Overall Study|Others|10|||
33312692|NCT01439360|101037679|FG001|Overall Study|Others|5|||
33312693|NCT01439360|101037678|FG000|Overall Study|Protocol Violation|1|||
33312694|NCT01439360|101037679|FG001|Overall Study|Protocol Violation|0|||
33502972|NCT03318861|101735106|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
33502973|NCT03318861|101735107|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
33502974|NCT03318861|101735108|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
33502975|NCT03318861|101735109|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
33502976|NCT03318861|101735110|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
33502977|NCT00931255|101735111|FG000|Overall Study|Follow up biopsy not done|2|||
33502978|NCT00931255|101735112|FG001|Overall Study|Follow up biopsy not done|3|||
33502979|NCT01737710|101735116|FG000|Overall Study|Lost to Follow-up|0|||
33502980|NCT01737710|101735117|FG001|Overall Study|Lost to Follow-up|2|||
33502981|NCT01737710|101735118|FG002|Overall Study|Lost to Follow-up|2|||
33502982|NCT01737710|101735119|FG003|Overall Study|Lost to Follow-up|0|||
33502983|NCT01737710|101735120|FG004|Overall Study|Lost to Follow-up|0|||
33502984|NCT01737710|101735116|FG000|Overall Study|Withdrawal by Subject|1|||
33502985|NCT01737710|101735117|FG001|Overall Study|Withdrawal by Subject|1|||
33312695|NCT01439360|101037678|FG000|Overall Study|Withdrawal by Subject|140|||
33312696|NCT01439360|101037679|FG001|Overall Study|Withdrawal by Subject|129|||
33312697|NCT03343301|101037682|FG000|Overall Study|Withdrawal by Subject|1|||
33312698|NCT03343301|101037683|FG001|Overall Study|Withdrawal by Subject|1|||
33312699|NCT03343301|101037682|FG000|Overall Study|Death|0|||
33312700|NCT03343301|101037683|FG001|Overall Study|Death|2|||
33312701|NCT03343301|101037682|FG000|Overall Study|Other|0|||
33312702|NCT03343301|101037683|FG001|Overall Study|Other|6|||
33312703|NCT03343301|101037682|FG000|Overall Study|Missing|2|||
33312704|NCT03343301|101037683|FG001|Overall Study|Missing|0|||
33312705|NCT00812331|101037684|FG000|Overall Study|Adverse Event|1|||
33502986|NCT01737710|101735118|FG002|Overall Study|Withdrawal by Subject|1|||
33502987|NCT01737710|101735119|FG003|Overall Study|Withdrawal by Subject|0|||
33502988|NCT01737710|101735120|FG004|Overall Study|Withdrawal by Subject|0|||
33502989|NCT01737710|101735116|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
33502990|NCT01737710|101735117|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
33502991|NCT01737710|101735118|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
33502992|NCT01737710|101735119|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
33502993|NCT01737710|101735120|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
33502994|NCT02282813|101735125|FG000|Overall Study|Withdrawal by Subject|4|||
33502995|NCT02282813|101735126|FG001|Overall Study|Withdrawal by Subject|5|||
33502996|NCT02282813|101735127|FG002|Overall Study|Withdrawal by Subject|0|||
33502997|NCT02282813|101735125|FG000|Overall Study|Adverse Event|3|||
33502998|NCT02282813|101735126|FG001|Overall Study|Adverse Event|10|||
33502999|NCT02282813|101735127|FG002|Overall Study|Adverse Event|1|||
33503000|NCT02282813|101735125|FG000|Overall Study|Subject non-compliance|1|||
33503001|NCT02282813|101735126|FG001|Overall Study|Subject non-compliance|4|||
33503002|NCT02282813|101735127|FG002|Overall Study|Subject non-compliance|0|||
33503003|NCT02282813|101735125|FG000|Overall Study|Physician Decision|0|||
33503004|NCT02282813|101735126|FG001|Overall Study|Physician Decision|3|||
33503005|NCT02282813|101735127|FG002|Overall Study|Physician Decision|1|||
33503006|NCT02282813|101735125|FG000|Overall Study|Lost to Follow-up|2|||
33503007|NCT02282813|101735126|FG001|Overall Study|Lost to Follow-up|0|||
33503008|NCT02282813|101735127|FG002|Overall Study|Lost to Follow-up|1|||
33503009|NCT02282813|101735125|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
33503010|NCT02282813|101735126|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
33503011|NCT02282813|101735127|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
33312706|NCT00812331|101037685|FG001|Overall Study|Adverse Event|0|||
33312707|NCT00812331|101037686|FG002|Overall Study|Adverse Event|0|||
33312708|NCT00812331|101037687|FG003|Overall Study|Adverse Event|0|||
33312709|NCT00812331|101037688|FG004|Overall Study|Adverse Event|0|||
33312710|NCT02915302|101040616|FG000|Overall Study|Adverse Event|3|||
33312711|NCT02915302|101040617|FG001|Overall Study|Adverse Event|0|||
33312712|NCT02915302|101040616|FG000|Overall Study|Protocol Violation|20|||
33312713|NCT02915302|101040617|FG001|Overall Study|Protocol Violation|27|||
33312714|NCT02915302|101040616|FG000|Overall Study|Lost to Follow-up|19|||
33312715|NCT02915302|101040617|FG001|Overall Study|Lost to Follow-up|22|||
33312716|NCT02915302|101040616|FG000|Overall Study|Withdrawal by Subject|22|||
33312717|NCT02915302|101040617|FG001|Overall Study|Withdrawal by Subject|29|||
33312718|NCT02915302|101040616|FG000|Overall Study|Other|1|||
33312719|NCT02915302|101040617|FG001|Overall Study|Other|0|||
33312720|NCT02481947|101040618|FG000|Overall Study|Withdrawal by Subject|24|||
33312721|NCT02481947|101040619|FG001|Overall Study|Withdrawal by Subject|10|||
33312722|NCT02481947|101040618|FG000|Overall Study|Lost to Follow-up|11|||
33312723|NCT02481947|101040619|FG001|Overall Study|Lost to Follow-up|5|||
33312724|NCT02481947|101040618|FG000|Overall Study|Adverse Event|6|||
33312725|NCT02481947|101040619|FG001|Overall Study|Adverse Event|11|||
33312726|NCT02481947|101040618|FG000|Overall Study|Physician Decision|4|||
33312727|NCT02481947|101040619|FG001|Overall Study|Physician Decision|5|||
33312728|NCT02481947|101040618|FG000|Overall Study|Protocol Violation|1|||
33312729|NCT02481947|101040619|FG001|Overall Study|Protocol Violation|5|||
33312730|NCT01774487|101040624|FG000|Overall Study|Did not tolerate taste|4|||
33312731|NCT01774487|101040625|FG001|Overall Study|Did not tolerate taste|4|||
33312732|NCT02344004|101040627|FG000|Overall Study|Adverse Event|11|||
33312733|NCT02344004|101040628|FG001|Overall Study|Adverse Event|1|||
33312734|NCT02344004|101040627|FG000|Overall Study|Death|9|||
33312735|NCT02344004|101040628|FG001|Overall Study|Death|7|||
33312736|NCT02344004|101040627|FG000|Overall Study|Physician Decision|4|||
33312737|NCT02344004|101040628|FG001|Overall Study|Physician Decision|1|||
33312738|NCT02344004|101040627|FG000|Overall Study|Withdrawal by Subject|22|||
33503012|NCT02282813|101735125|FG000|Overall Study|Lack of Efficacy|1|||
33503013|NCT02282813|101735126|FG001|Overall Study|Lack of Efficacy|0|||
33503014|NCT02282813|101735127|FG002|Overall Study|Lack of Efficacy|0|||
33503015|NCT02282813|101735125|FG000|Overall Study|Administrative reasons|0|||
33312739|NCT02344004|101040628|FG001|Overall Study|Withdrawal by Subject|5|||
33312740|NCT02344004|101040627|FG000|Overall Study|Rescue Medication|2|||
33312741|NCT02344004|101040628|FG001|Overall Study|Rescue Medication|0|||
33312742|NCT02344004|101040627|FG000|Overall Study|Other Not Specified|12|||
33312743|NCT02344004|101040628|FG001|Overall Study|Other Not Specified|0|||
33312744|NCT02344004|101040627|FG000|Overall Study|Protocol Violation|1|||
33312745|NCT02344004|101040628|FG001|Overall Study|Protocol Violation|0|||
33503016|NCT02282813|101735126|FG001|Overall Study|Administrative reasons|1|||
33503017|NCT02282813|101735127|FG002|Overall Study|Administrative reasons|0|||
33312746|NCT01636960|101040629|FG000|Induction Phase|Adverse Event|2|||
33312747|NCT01636960|101040629|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
33312748|NCT01636960|101040629|FG000|Maintenance Phase|Adverse Event|3|||
33602397|NCT02876328|102095320|FG001|Overall Study|Missed 12 Month Visit|10|||
33312749|NCT01636960|101040629|FG000|Maintenance Phase|Progressive disease|1|||
33503018|NCT01500382|101735128|FG000|Washout Period|Study site went out of business|0|||
33312750|NCT03291587|101040632|FG000|Overall Study|Lost to Follow-up|62|||
33312751|NCT03291587|101040633|FG001|Overall Study|Lost to Follow-up|43|||
33312752|NCT03291587|101040632|FG000|Overall Study|Refused to Answer|5|||
33312753|NCT03291587|101040633|FG001|Overall Study|Refused to Answer|2|||
33312754|NCT03291587|101040632|FG000|Overall Study|Death|2|||
33312755|NCT03291587|101040633|FG001|Overall Study|Death|4|||
33312756|NCT03291587|101040632|FG000|Overall Study|Not interested in participating|8|||
33312757|NCT03291587|101040633|FG001|Overall Study|Not interested in participating|6|||
33312758|NCT03291587|101040632|FG000|Overall Study|Too busy to participate|4|||
33312759|NCT03291587|101040633|FG001|Overall Study|Too busy to participate|2|||
33312760|NCT03038438|101040634|FG000|Overall Study|Death|3|||
33312761|NCT03038438|101040634|FG000|Overall Study|Lost to Follow-up|8|||
33312762|NCT03038438|101040634|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
33503019|NCT01500382|101735129|FG001|Washout Period|Study site went out of business|0|||
33503020|NCT01500382|101735130|FG002|Washout Period|Study site went out of business|1|||
33193356|NCT00622635|100612695|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
33193357|NCT00622635|100612696|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
33193358|NCT00622635|100612697|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
33193359|NCT00622635|100612692|FG000|Treatment Period 2|Adverse Event|1|||
33193360|NCT00622635|100612693|FG001|Treatment Period 2|Adverse Event|0|||
33193361|NCT00622635|100612694|FG002|Treatment Period 2|Adverse Event|0|||
33193362|NCT00622635|100612695|FG003|Treatment Period 2|Adverse Event|0|||
33193363|NCT00622635|100612696|FG004|Treatment Period 2|Adverse Event|0|||
33193364|NCT00622635|100612697|FG005|Treatment Period 2|Adverse Event|0|||
33193365|NCT00622635|100612692|FG000|Treatment Period 3|Adverse Event|0|||
33193366|NCT00622635|100612693|FG001|Treatment Period 3|Adverse Event|0|||
33193367|NCT00622635|100612694|FG002|Treatment Period 3|Adverse Event|0|||
33193368|NCT00622635|100612695|FG003|Treatment Period 3|Adverse Event|2|||
33193369|NCT00622635|100612696|FG004|Treatment Period 3|Adverse Event|0|||
33193370|NCT00622635|100612697|FG005|Treatment Period 3|Adverse Event|0|||
33312763|NCT03038438|101040634|FG000|Overall Study|Withdrawal by Subject|5|||
33503021|NCT01500382|101735131|FG003|Washout Period|Study site went out of business|0|||
33503022|NCT00955955|101735132|FG000|Overall Study|Lost to Follow-up|2|||
33503023|NCT00955955|101735133|FG001|Overall Study|Lost to Follow-up|0|||
33503024|NCT00955955|101735134|FG002|Overall Study|Lost to Follow-up|0|||
33503025|NCT01920958|101735139|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
33503026|NCT01163851|101735140|FG000|Overall Study|Site Closure|0|||
33503027|NCT01163851|101735141|FG001|Overall Study|Site Closure|1|||
33503028|NCT01163851|101735140|FG000|Overall Study|Enrolled but not treated|1|||
33503029|NCT01163851|101735141|FG001|Overall Study|Enrolled but not treated|0|||
33503030|NCT01827267|101735142|FG000|Overall Study|Did not receive study drug|1|||
33503031|NCT01827267|101735143|FG001|Overall Study|Did not receive study drug|1|||
33503032|NCT01827267|101735142|FG000|Overall Study|Physician Decision|1|||
33503033|NCT01827267|101735143|FG001|Overall Study|Physician Decision|0|||
33503034|NCT01827267|101735142|FG000|Overall Study|Disease Progression|1|||
33503035|NCT01827267|101735143|FG001|Overall Study|Disease Progression|1|||
33503036|NCT01827267|101735142|FG000|Overall Study|Sponsor Discontinued Study|2|||
33503037|NCT01827267|101735143|FG001|Overall Study|Sponsor Discontinued Study|8|||
33503038|NCT01827267|101735142|FG000|Overall Study|Still on study|0|||
33503039|NCT01827267|101735143|FG001|Overall Study|Still on study|2|||
33503040|NCT01743560|101735144|FG000|Overall Study|Disease progression|26|||
33503041|NCT01743560|101735144|FG000|Overall Study|Adverse Event|8|||
33503042|NCT01743560|101735144|FG000|Overall Study|Death|3|||
33503043|NCT01743560|101735144|FG000|Overall Study|Withdrawal by Subject|2|||
33503044|NCT01743560|101735144|FG000|Overall Study|Protocol Violation|1|||
33503045|NCT01743560|101735144|FG000|Overall Study|>1 dose of study drug|3|||
33503046|NCT03491462|101735160|FG000|Overall Study|Lost to Follow-up|2|||
33503047|NCT03491462|101735161|FG001|Overall Study|Lost to Follow-up|0|||
33503048|NCT03491462|101735160|FG000|Overall Study|Adverse Event|11|||
33503049|NCT03491462|101735161|FG001|Overall Study|Adverse Event|1|||
33503050|NCT03491462|101735160|FG000|Overall Study|Physician Decision|3|||
33503051|NCT03491462|101735161|FG001|Overall Study|Physician Decision|0|||
33602398|NCT02876328|102095321|FG002|Overall Study|Missed 12 Month Visit|11|||
33602399|NCT02876328|102095322|FG003|Overall Study|Missed 12 Month Visit|6|||
33312764|NCT03038438|101040634|FG000|Overall Study|No 36-Month Follow-Up|18|||
33503052|NCT03491462|101735160|FG000|Overall Study|Withdrawal by Subject|22|||
33602400|NCT02876328|102095323|FG004|Overall Study|Missed 12 Month Visit|10|||
33602401|NCT02876328|102095324|FG005|Overall Study|Missed 12 Month Visit|14|||
33503053|NCT03491462|101735161|FG001|Overall Study|Withdrawal by Subject|15|||
33193371|NCT00622635|100612692|FG000|Treatment Period 3|Withdrawal by Subject|0|||
33193372|NCT00622635|100612693|FG001|Treatment Period 3|Withdrawal by Subject|0|||
33193373|NCT00622635|100612694|FG002|Treatment Period 3|Withdrawal by Subject|0|||
33503054|NCT00552396|101735162|FG000|Overall Study|protocol withdrawal criteria|3|||
33503055|NCT00552396|101735163|FG001|Overall Study|protocol withdrawal criteria|3|||
33503056|NCT00552396|101735164|FG002|Overall Study|protocol withdrawal criteria|3|||
33602402|NCT02876328|102095325|FG006|Overall Study|Missed 12 Month Visit|3|||
33193374|NCT00622635|100612695|FG003|Treatment Period 3|Withdrawal by Subject|1|||
33503057|NCT00552396|101735165|FG003|Overall Study|protocol withdrawal criteria|6|||
33602403|NCT02876328|102095326|FG007|Overall Study|Missed 12 Month Visit|8|||
33503058|NCT00552396|101735166|FG004|Overall Study|protocol withdrawal criteria|3|||
33503059|NCT00552396|101735167|FG005|Overall Study|protocol withdrawal criteria|3|||
33503060|NCT00552396|101735168|FG006|Overall Study|protocol withdrawal criteria|9|||
33503061|NCT01726270|101735176|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
33503062|NCT01726270|101735176|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
33503063|NCT01726270|101735176|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
33503064|NCT01726270|101735176|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
33503065|NCT01726270|101735176|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
33503066|NCT01726270|101735176|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
33503067|NCT00593684|101735182|FG000|Overall Study|Death|2|||
33503068|NCT00593684|101735183|FG001|Overall Study|Death|1|||
33503069|NCT03278613|101735185|FG000|Overall Study|Lost to Follow-up|3|||
33503070|NCT03278613|101735186|FG001|Overall Study|Lost to Follow-up|1|||
33503071|NCT01057810|101735187|FG000|Overall Study|Disease progression|156|||
33503072|NCT01057810|101735188|FG001|Overall Study|Disease progression|197|||
33503073|NCT01057810|101735187|FG000|Overall Study|Study drug toxicity|5|||
33503074|NCT01057810|101735188|FG001|Overall Study|Study drug toxicity|114|||
33503075|NCT01057810|101735187|FG000|Overall Study|Adverse event unrelated to study drug|13|||
33503076|NCT01057810|101735188|FG001|Overall Study|Adverse event unrelated to study drug|29|||
33503077|NCT01057810|101735187|FG000|Overall Study|Withdrawal by Subject|10|||
33503078|NCT01057810|101735188|FG001|Overall Study|Withdrawal by Subject|25|||
33503079|NCT01057810|101735187|FG000|Overall Study|Death|2|||
33503080|NCT01057810|101735188|FG001|Overall Study|Death|12|||
33503081|NCT01057810|101735187|FG000|Overall Study|Maximum clinical benefit|5|||
33503082|NCT01057810|101735188|FG001|Overall Study|Maximum clinical benefit|5|||
33503083|NCT01057810|101735187|FG000|Overall Study|Poor/non-compliance|0|||
33503084|NCT01057810|101735188|FG001|Overall Study|Poor/non-compliance|1|||
33503085|NCT01057810|101735187|FG000|Overall Study|No longer met study criteria|0|||
33503086|NCT01057810|101735188|FG001|Overall Study|No longer met study criteria|1|||
33503087|NCT01057810|101735187|FG000|Overall Study|Other|7|||
33503088|NCT01057810|101735188|FG001|Overall Study|Other|14|||
33503089|NCT01436370|101735189|FG000|Overall Study|Lost to Follow-up|0|||
33503090|NCT01436370|101735190|FG001|Overall Study|Lost to Follow-up|0|||
33503091|NCT01436370|101735191|FG002|Overall Study|Lost to Follow-up|0|||
33503092|NCT01436370|101735192|FG003|Overall Study|Lost to Follow-up|0|||
33503093|NCT01436370|101735193|FG004|Overall Study|Lost to Follow-up|1|||
33503094|NCT01436370|101735194|FG005|Overall Study|Lost to Follow-up|0|||
33503095|NCT01436370|101735195|FG006|Overall Study|Lost to Follow-up|0|||
33503096|NCT01436370|101735196|FG007|Overall Study|Lost to Follow-up|0|||
33503097|NCT02596971|101735197|FG000|Overall Study|Death|5|||
33503098|NCT02596971|101735198|FG001|Overall Study|Death|1|||
33503099|NCT02596971|101735199|FG002|Overall Study|Death|5|||
33503100|NCT02596971|101735197|FG000|Overall Study|Withdrawal by Subject|5|||
33503101|NCT02596971|101735198|FG001|Overall Study|Withdrawal by Subject|1|||
33503102|NCT02596971|101735199|FG002|Overall Study|Withdrawal by Subject|4|||
33503103|NCT01284348|101735212|FG000|Overall Study|Death|1|||
33395408|NCT00242710|101334798|FG001|Study Extension (up to Year 2)|Other|5|||
33395409|NCT00242710|101334799|FG002|Study Extension (up to Year 2)|Other|4|||
33395410|NCT00242710|101334800|FG003|Study Extension (up to Year 2)|Other|3|||
33395411|NCT00242710|101334797|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
33395412|NCT00242710|101334798|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
33395413|NCT00242710|101334799|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
33395414|NCT00242710|101334800|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
33503104|NCT01284348|101735213|FG001|Overall Study|Death|1|||
33503105|NCT01284348|101735212|FG000|Overall Study|Withdrew consent|0|||
33312765|NCT05056987|101040635|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
33312766|NCT05056987|101040636|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
33312767|NCT05056987|101040635|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
33312768|NCT05056987|101040636|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
33312769|NCT01853137|101040637|FG000|Overall Study|Lost to Follow-up|4|||
33312770|NCT01853137|101040638|FG001|Overall Study|Lost to Follow-up|1|||
33312771|NCT00744523|101040639|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
33312772|NCT00744523|101040640|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
33312773|NCT04882995|101040643|FG000|Overall Study|Withdrawal by Subject|1|||
33312774|NCT04882995|101040644|FG001|Overall Study|Withdrawal by Subject|2|||
33312775|NCT04882995|101040643|FG000|Overall Study|Protocol Violation|4|||
33395415|NCT00242710|101334797|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
33503106|NCT01284348|101735213|FG001|Overall Study|Withdrew consent|1|||
33503107|NCT01284348|101735212|FG000|Overall Study|Status not recorded|9|||
33503108|NCT01284348|101735213|FG001|Overall Study|Status not recorded|10|||
33193375|NCT00622635|100612696|FG004|Treatment Period 3|Withdrawal by Subject|0|||
33503109|NCT01430754|101735214|FG000|Run-In Phase|Circadian Period Ineligible|24|||
33503110|NCT01430754|101735215|FG001|Run-In Phase|Circadian Period Ineligible|0|||
33395416|NCT00242710|101334798|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
33503111|NCT01430754|101735214|FG000|Run-In Phase|Protocol Violation|6|||
33503112|NCT01430754|101735215|FG001|Run-In Phase|Protocol Violation|0|||
33503113|NCT01430754|101735214|FG000|Run-In Phase|Adverse Event|2|||
33503114|NCT01430754|101735215|FG001|Run-In Phase|Adverse Event|0|||
33503115|NCT01430754|101735214|FG000|Run-In Phase|Other|2|||
33503116|NCT01430754|101735215|FG001|Run-In Phase|Other|0|||
33503117|NCT01430754|101735214|FG000|Run-In Phase|Withdrawal by Subject|2|||
33503118|NCT01430754|101735215|FG001|Run-In Phase|Withdrawal by Subject|0|||
33503119|NCT01430754|101735214|FG000|Run-In Phase|Lost to Follow-up|1|||
33503120|NCT01430754|101735215|FG001|Run-In Phase|Lost to Follow-up|0|||
33503121|NCT01262287|101735216|FG000|Overall Study|Lost to Follow-up|2|||
33503122|NCT01262287|101735217|FG001|Overall Study|Lost to Follow-up|1|||
33503123|NCT04168112|101735220|FG000|Overall Study|Lost to Follow-up|1|||
33503124|NCT04168112|101735221|FG001|Overall Study|Lost to Follow-up|0|||
33503125|NCT04168112|101735220|FG000|Overall Study|Withdrawal by Subject|1|||
33503126|NCT04168112|101735221|FG001|Overall Study|Withdrawal by Subject|0|||
33503127|NCT02612623|101735222|FG000|Overall Study|Withdrawal by Subject|0|||
33503128|NCT02612623|101735223|FG001|Overall Study|Withdrawal by Subject|1|||
33503129|NCT02612623|101735224|FG002|Overall Study|Withdrawal by Subject|0|||
33503130|NCT02612623|101735225|FG003|Overall Study|Withdrawal by Subject|0|||
33503131|NCT02612623|101735222|FG000|Overall Study|Adverse Event|1|||
33503132|NCT02612623|101735223|FG001|Overall Study|Adverse Event|0|||
33503133|NCT02612623|101735224|FG002|Overall Study|Adverse Event|1|||
33503134|NCT02612623|101735225|FG003|Overall Study|Adverse Event|0|||
33503135|NCT00154284|101735226|FG000|Overall Study|Adverse Event|6|||
33503136|NCT00154284|101735227|FG001|Overall Study|Adverse Event|9|||
33503137|NCT00154284|101735226|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33503138|NCT00154284|101735227|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33503139|NCT00154284|101735226|FG000|Overall Study|Lack of Efficacy|1|||
33503140|NCT00154284|101735227|FG001|Overall Study|Lack of Efficacy|2|||
33503141|NCT00154284|101735226|FG000|Overall Study|Protocol Violation|0|||
33503142|NCT00154284|101735227|FG001|Overall Study|Protocol Violation|1|||
33503143|NCT04520997|101735230|FG000|Overall Study|Lost to Follow-up|1|||
33503144|NCT04520997|101735231|FG001|Overall Study|Lost to Follow-up|1|||
33503145|NCT04520997|101735230|FG000|Overall Study|Withdrawal by Subject|1|||
33503146|NCT04520997|101735231|FG001|Overall Study|Withdrawal by Subject|0|||
33503147|NCT04520997|101735230|FG000|Overall Study|Not Treated|0|||
33503148|NCT04520997|101735231|FG001|Overall Study|Not Treated|1|||
33503149|NCT03515811|101735233|FG000|Overall Study|Lost to Follow-up|2|||
33503150|NCT03515811|101735234|FG001|Overall Study|Lost to Follow-up|1|||
33312776|NCT04882995|101040644|FG001|Overall Study|Protocol Violation|4|||
33312777|NCT04882995|101040643|FG000|Overall Study|Surgery postponed due to COVID|1|||
33312778|NCT04882995|101040644|FG001|Overall Study|Surgery postponed due to COVID|1|||
33503151|NCT03515811|101735233|FG000|Overall Study|Protocol Violation|1|||
33503152|NCT03515811|101735234|FG001|Overall Study|Protocol Violation|1|||
33503153|NCT03515811|101735233|FG000|Overall Study|Death|1|||
33503154|NCT03515811|101735234|FG001|Overall Study|Death|1|||
33503155|NCT03515811|101735233|FG000|Overall Study|Withdrawal by Subject|0|||
33503156|NCT03515811|101735234|FG001|Overall Study|Withdrawal by Subject|2|||
33503157|NCT03515811|101735233|FG000|Overall Study|Technical Problems|1|||
33503158|NCT03515811|101735234|FG001|Overall Study|Technical Problems|0|||
33503159|NCT03515811|101735233|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
33503160|NCT03515811|101735234|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
33503161|NCT03515811|101735233|FG000|Overall Study|COVID-19|0|||
33503162|NCT03515811|101735234|FG001|Overall Study|COVID-19|1|||
33503163|NCT03831113|101735235|FG000|Overall Study|Withdrawal by Subject|0|||
33503164|NCT03831113|101735236|FG001|Overall Study|Withdrawal by Subject|2|||
33503165|NCT03831113|101735235|FG000|Overall Study|Protocol Violation|0|||
33503166|NCT03831113|101735236|FG001|Overall Study|Protocol Violation|9|||
33503167|NCT02230904|101735237|FG000|Overall Study|Safety follow up could not take place|0|||
33503168|NCT02230904|101735238|FG001|Overall Study|Safety follow up could not take place|1|||
33503169|NCT01266291|101735241|FG000|Overall Study|Adverse Event|1|||
33503170|NCT01996254|101735244|FG000|Overall Study|Change in Eligibility|0|||
33503171|NCT01996254|101735245|FG001|Overall Study|Change in Eligibility|2|||
33312779|NCT00759915|101040645|FG000|Overall Study|Withdrawal by Subject|1|||
33503172|NCT01996254|101735246|FG002|Overall Study|Change in Eligibility|0|||
33503173|NCT01996254|101735244|FG000|Overall Study|Withdrawal by Subject|0|||
33503174|NCT01996254|101735245|FG001|Overall Study|Withdrawal by Subject|3|||
33503175|NCT01996254|101735246|FG002|Overall Study|Withdrawal by Subject|4|||
33312780|NCT00759915|101040646|FG001|Overall Study|Withdrawal by Subject|0|||
33503176|NCT01996254|101735244|FG000|Overall Study|Lost to Follow-up|1|||
33503177|NCT01996254|101735245|FG001|Overall Study|Lost to Follow-up|0|||
33503178|NCT01996254|101735246|FG002|Overall Study|Lost to Follow-up|4|||
33503179|NCT02275546|101735250|FG000|Treatment Period 2|Withdrawal by Subject|2|||
33503180|NCT02275546|101735251|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33503181|NCT02275546|101735250|FG000|Treatment Period 2|Protocol Violation|0|||
33503182|NCT02275546|101735251|FG001|Treatment Period 2|Protocol Violation|1|||
33503183|NCT00441129|101735252|FG000|Overall Study|Withdrawal by Subject|6|||
33503184|NCT00441129|101735253|FG001|Overall Study|Withdrawal by Subject|14|||
33503185|NCT04707469|101735254|FG000|Overall Study|Site closure|0|||
33503186|NCT04707469|101735255|FG001|Overall Study|Site closure|2|||
33503187|NCT04707469|101735256|FG002|Overall Study|Site closure|0|||
33503188|NCT04707469|101735254|FG000|Overall Study|Physician Decision|2|||
33503189|NCT04707469|101735255|FG001|Overall Study|Physician Decision|2|||
33503190|NCT04707469|101735256|FG002|Overall Study|Physician Decision|2|||
33503191|NCT04707469|101735254|FG000|Overall Study|Death|1|||
33503192|NCT04707469|101735255|FG001|Overall Study|Death|6|||
33503193|NCT04707469|101735256|FG002|Overall Study|Death|2|||
33503194|NCT04707469|101735254|FG000|Overall Study|Lost to Follow-up|9|||
33503195|NCT04707469|101735255|FG001|Overall Study|Lost to Follow-up|19|||
33503196|NCT04707469|101735256|FG002|Overall Study|Lost to Follow-up|14|||
33503197|NCT04707469|101735254|FG000|Overall Study|Withdrawal by Subject|17|||
33503198|NCT04707469|101735255|FG001|Overall Study|Withdrawal by Subject|16|||
33503199|NCT04707469|101735256|FG002|Overall Study|Withdrawal by Subject|12|||
33503200|NCT01464164|101735257|FG000|Overall Study|Screen failure|0|||
33503201|NCT01464164|101735258|FG001|Overall Study|Screen failure|1|||
33503202|NCT01464164|101735259|FG002|Overall Study|Screen failure|2|||
33503203|NCT01464164|101735260|FG003|Overall Study|Screen failure|0|||
33503204|NCT01464164|101735261|FG004|Overall Study|Screen failure|0|||
33503205|NCT01464164|101735262|FG005|Overall Study|Screen failure|0|||
33503206|NCT01464164|101735263|FG006|Overall Study|Screen failure|0|||
33503207|NCT01464164|101735257|FG000|Overall Study|Physician Decision|0|||
33503208|NCT01464164|101735258|FG001|Overall Study|Physician Decision|1|||
33312781|NCT00759915|101040645|FG000|Overall Study|Adverse Event|0|||
33312782|NCT00759915|101040646|FG001|Overall Study|Adverse Event|1|||
33312783|NCT01257425|101040647|FG000|Overall Study|Lack of Efficacy|3|||
33312784|NCT01257425|101040648|FG001|Overall Study|Lack of Efficacy|3|||
33312785|NCT01257425|101040647|FG000|Overall Study|Adverse Event|1|||
33312786|NCT01257425|101040648|FG001|Overall Study|Adverse Event|1|||
33312787|NCT01257425|101040647|FG000|Overall Study|Protocol Violation|1|||
33312788|NCT01257425|101040648|FG001|Overall Study|Protocol Violation|1|||
33312789|NCT01257425|101040647|FG000|Overall Study|Withdrawal by Subject|0|||
33312790|NCT01257425|101040648|FG001|Overall Study|Withdrawal by Subject|1|||
33312791|NCT01257425|101040647|FG000|Overall Study|Death|1|||
33312792|NCT01257425|101040648|FG001|Overall Study|Death|0|||
33312793|NCT01590017|101040650|FG000|Overall Study|Adverse Event|1|||
33312794|NCT01590017|101040650|FG000|Overall Study|Withdrawal by Subject|1|||
33312795|NCT01590017|101040650|FG000|Overall Study|Lack of Efficacy|1|||
33312796|NCT01590017|101040650|FG000|Overall Study|Physician Decision|1|||
33312797|NCT00932113|101040656|FG000|Overall Study|Lost to Follow-up|1|||
33312798|NCT00932113|101040657|FG001|Overall Study|Lost to Follow-up|0|||
33312799|NCT00390910|101040658|FG000|Overall Study|Adverse Event|1|||
33312800|NCT00390910|101040659|FG001|Overall Study|Adverse Event|0|||
33312801|NCT00390910|101040660|FG002|Overall Study|Adverse Event|0|||
33312802|NCT00390910|101040658|FG000|Overall Study|Lost to Follow-up|0|||
33312803|NCT00390910|101040659|FG001|Overall Study|Lost to Follow-up|1|||
33312804|NCT00390910|101040660|FG002|Overall Study|Lost to Follow-up|5|||
33312805|NCT00390910|101040658|FG000|Overall Study|Withdrawal by Subject|1|||
33312806|NCT00390910|101040659|FG001|Overall Study|Withdrawal by Subject|3|||
33312807|NCT00390910|101040660|FG002|Overall Study|Withdrawal by Subject|2|||
33312808|NCT00390910|101040658|FG000|Overall Study|Migrated/moved from study area|0|||
33312809|NCT00390910|101040659|FG001|Overall Study|Migrated/moved from study area|0|||
33312810|NCT00390910|101040660|FG002|Overall Study|Migrated/moved from study area|3|||
33503209|NCT01464164|101735259|FG002|Overall Study|Physician Decision|0|||
33503210|NCT01464164|101735260|FG003|Overall Study|Physician Decision|0|||
33503211|NCT01464164|101735261|FG004|Overall Study|Physician Decision|0|||
33503212|NCT01464164|101735262|FG005|Overall Study|Physician Decision|0|||
33193376|NCT00622635|100612697|FG005|Treatment Period 3|Withdrawal by Subject|0|||
33193377|NCT02755831|100612702|FG000|Overall Study|Lost to Follow-up|3|||
33193378|NCT02755831|100612703|FG001|Overall Study|Lost to Follow-up|3|||
33312811|NCT01270971|101040661|FG000|Overall Study|Withdrawal by Subject|24|||
33312812|NCT01270971|101040662|FG001|Overall Study|Withdrawal by Subject|11|||
33312813|NCT01270971|101040661|FG000|Overall Study|Lost to Follow-up|18|||
33503213|NCT01464164|101735263|FG006|Overall Study|Physician Decision|2|||
33503214|NCT00300885|101735264|FG000|Treatment|Adverse Event|134|||
33503215|NCT00300885|101735265|FG001|Treatment|Adverse Event|82|||
33503216|NCT00300885|101735264|FG000|Treatment|Death|20|||
33503217|NCT00300885|101735265|FG001|Treatment|Death|7|||
33193379|NCT02472756|100612704|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
33312814|NCT01270971|101040662|FG001|Overall Study|Lost to Follow-up|5|||
33312815|NCT01270971|101040661|FG000|Overall Study|Adverse Event|1|||
33312816|NCT01270971|101040662|FG001|Overall Study|Adverse Event|2|||
33312817|NCT01270971|101040661|FG000|Overall Study|Non compliance|2|||
33312818|NCT01270971|101040662|FG001|Overall Study|Non compliance|2|||
33312819|NCT01270971|101040661|FG000|Overall Study|Non-specific|7|||
33312820|NCT01270971|101040662|FG001|Overall Study|Non-specific|3|||
33312821|NCT01802567|101040663|FG000|Overall Study|Withdrawal by Subject|2|||
33312822|NCT01802567|101040663|FG000|Overall Study|Physician Decision|1|||
33312823|NCT01802567|101040663|FG000|Overall Study|Lack of Efficacy|7|||
33503218|NCT00300885|101735264|FG000|Treatment|Lack of Efficacy|1|||
33503219|NCT00300885|101735265|FG001|Treatment|Lack of Efficacy|1|||
33503220|NCT00300885|101735264|FG000|Treatment|Lost to Follow-up|3|||
33503221|NCT00300885|101735265|FG001|Treatment|Lost to Follow-up|2|||
33503222|NCT00300885|101735264|FG000|Treatment|Physician Decision|4|||
33503223|NCT00300885|101735265|FG001|Treatment|Physician Decision|5|||
33503224|NCT00300885|101735264|FG000|Treatment|Protocol Violation|11|||
33503225|NCT00300885|101735265|FG001|Treatment|Protocol Violation|11|||
33503226|NCT00300885|101735264|FG000|Treatment|Withdrawal by Subject|26|||
33503227|NCT00300885|101735265|FG001|Treatment|Withdrawal by Subject|23|||
33602404|NCT02876328|102095327|FG008|Overall Study|Missed 12 Month Visit|9|||
33602405|NCT02876328|102095328|FG009|Overall Study|Missed 12 Month Visit|5|||
33395417|NCT00242710|101334799|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
33395418|NCT00242710|101334800|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
33395419|NCT00610714|101334801|FG000|Overall Study|Adverse Event|3|||
33395420|NCT00610714|101334802|FG001|Overall Study|Adverse Event|1|||
33602406|NCT02876328|102095329|FG010|Overall Study|Missed 12 Month Visit|4|||
33312824|NCT01802567|101040663|FG000|Overall Study|Consented but did not start therapy|7|||
33312825|NCT01802567|101040663|FG000|Overall Study|Protocol Violation|1|||
33312826|NCT02134977|101040664|FG000|Overall Study|Protocol Deviation|102|||
33312827|NCT00122460|101040665|FG000|Overall Study|investigational study phase ongoing|7|||
33312828|NCT00122460|101040666|FG001|Overall Study|investigational study phase ongoing|1|||
33312829|NCT00156819|101040667|FG000|Overall Study|Lost to Follow-up|1|||
33312830|NCT00156819|101040668|FG001|Overall Study|Lost to Follow-up|1|||
33312831|NCT00156819|101040669|FG002|Overall Study|Lost to Follow-up|3|||
33312832|NCT00723021|101040670|FG000|Intervention Period 4|Adverse Event|0|||
33312833|NCT00723021|101040671|FG001|Intervention Period 4|Adverse Event|0|||
33312834|NCT00723021|101040672|FG002|Intervention Period 4|Adverse Event|0|||
33312835|NCT00723021|101040673|FG003|Intervention Period 4|Adverse Event|0|||
33312836|NCT00723021|101040674|FG004|Intervention Period 4|Adverse Event|1|||
33312837|NCT02963610|101040676|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
33312838|NCT01776541|101040677|FG000|Overall Study|Administrative Reason|6|||
33312839|NCT01776541|101040678|FG001|Overall Study|Administrative Reason|2|||
33312840|NCT01776541|101040677|FG000|Overall Study|Death|4|||
33395421|NCT00610714|101334801|FG000|Overall Study|Death|12|||
33602407|NCT02876328|102095330|FG011|Overall Study|Missed 12 Month Visit|1|||
33602408|NCT02876328|102095331|FG012|Overall Study|Missed 12 Month Visit|5|||
33602409|NCT02876328|102095332|FG013|Overall Study|Missed 12 Month Visit|4|||
33602410|NCT02876328|102095333|FG014|Overall Study|Missed 12 Month Visit|4|||
33602411|NCT02876328|102095334|FG015|Overall Study|Missed 12 Month Visit|4|||
33602412|NCT02876328|102095335|FG016|Overall Study|Missed 12 Month Visit|3|||
33602413|NCT02876328|102095336|FG017|Overall Study|Missed 12 Month Visit|6|||
33602414|NCT02876328|102095337|FG018|Overall Study|Missed 12 Month Visit|2|||
33602415|NCT02876328|102095338|FG019|Overall Study|Missed 12 Month Visit|2|||
33602416|NCT02876328|102095339|FG020|Overall Study|Missed 12 Month Visit|11|||
33602417|NCT02876328|102095340|FG021|Overall Study|Missed 12 Month Visit|7|||
33602418|NCT02876328|102095341|FG022|Overall Study|Missed 12 Month Visit|1|||
33602419|NCT02876328|102095342|FG023|Overall Study|Missed 12 Month Visit|0|||
33602420|NCT02525939|102095343|FG000|Overall Study|Lost to Follow-up|27|||
33602421|NCT02525939|102095344|FG001|Overall Study|Lost to Follow-up|24|||
33602422|NCT02525939|102095343|FG000|Overall Study|Physician Decision|0|||
33602423|NCT02525939|102095344|FG001|Overall Study|Physician Decision|1|||
33602424|NCT02525939|102095343|FG000|Overall Study|Withdrawal by Subject|24|||
33602425|NCT02525939|102095344|FG001|Overall Study|Withdrawal by Subject|39|||
33602426|NCT02525939|102095343|FG000|Overall Study|Death|180|||
33602427|NCT02525939|102095344|FG001|Overall Study|Death|179|||
33602428|NCT01350115|102095345|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
33602429|NCT01350115|102095346|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
33602430|NCT01350115|102095345|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
33312841|NCT01776541|101040678|FG001|Overall Study|Death|0|||
33312842|NCT01776541|101040677|FG000|Overall Study|Lost to Follow-up|27|||
33312843|NCT01776541|101040678|FG001|Overall Study|Lost to Follow-up|48|||
33312844|NCT01776541|101040677|FG000|Overall Study|Unclassified|5|||
33312845|NCT01776541|101040678|FG001|Overall Study|Unclassified|4|||
33312846|NCT01776541|101040677|FG000|Overall Study|Protocol Violation|2|||
33395422|NCT00610714|101334802|FG001|Overall Study|Death|18|||
33395423|NCT00610714|101334801|FG000|Overall Study|Withdrawal by Subject|9|||
33503228|NCT00300885|101735264|FG000|Treatment|Disease progression|171|||
33503229|NCT00300885|101735265|FG001|Treatment|Disease progression|238|||
33602431|NCT01350115|102095346|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
33602432|NCT01350115|102095345|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
33602433|NCT01350115|102095346|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
33602434|NCT03271047|102095347|FG000|Phase 1b: Dose Finding Period|Death|8|||
33602435|NCT03271047|102095348|FG001|Phase 1b: Dose Finding Period|Death|8|||
33602436|NCT03271047|102095349|FG002|Phase 1b: Dose Finding Period|Death|0|||
33602437|NCT03271047|102095350|FG003|Phase 1b: Dose Finding Period|Death|0|||
33602438|NCT03271047|102095347|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
33602439|NCT03271047|102095348|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
33602440|NCT03271047|102095349|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
33602441|NCT03271047|102095350|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
33602442|NCT03271047|102095347|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
33602443|NCT03271047|102095348|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
33602444|NCT03271047|102095349|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
33602445|NCT03271047|102095350|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
33602446|NCT03271047|102095347|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
33395424|NCT00610714|101334802|FG001|Overall Study|Withdrawal by Subject|3|||
33395425|NCT00610714|101334801|FG000|Overall Study|Study completion at 120 PFS events|2|||
33395426|NCT00610714|101334802|FG001|Overall Study|Study completion at 120 PFS events|2|||
33395427|NCT02343952|101334803|FG000|Study Treatment|Disease Progression|23|||
33395428|NCT02343952|101334803|FG000|Study Treatment|Death|3|||
33395429|NCT02343952|101334803|FG000|Study Treatment|Adverse Event|19|||
33395430|NCT02343952|101334803|FG000|Study Treatment|Withdrawal by Subject|7|||
33395431|NCT02343952|101334803|FG000|Study Treatment|other complicating Diseases|1|||
33395432|NCT02343952|101334803|FG000|Follow up|Withdrawal by Subject|3|||
33395433|NCT02343952|101334803|FG000|Follow up|Death|33|||
33395434|NCT02343952|101334803|FG000|Follow up|Patient does not meet eligibility for study.|1|||
33395435|NCT02343952|101334803|FG000|Follow up|Research department closed by the practice.|5|||
33503230|NCT00300885|101735264|FG000|Treatment|Random code broken (subject died)|0|||
33503231|NCT00300885|101735265|FG001|Treatment|Random code broken (subject died)|1|||
33602447|NCT03271047|102095348|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
33602448|NCT03271047|102095349|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
33602449|NCT03271047|102095350|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
33602450|NCT03271047|102095347|FG000|Randomized Phase 2 Period|Other|0|||
33602451|NCT03271047|102095348|FG001|Randomized Phase 2 Period|Other|0|||
33312847|NCT01776541|101040678|FG001|Overall Study|Protocol Violation|1|||
33312848|NCT01776541|101040677|FG000|Overall Study|Withdrawal by Subject|12|||
33312849|NCT01776541|101040678|FG001|Overall Study|Withdrawal by Subject|20|||
33312850|NCT02401867|101040680|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
33312851|NCT02401867|101040680|FG000|Analysis|Cervical assay could not be conducted|9|||
33312852|NCT02684357|101040681|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
33312853|NCT02684357|101040682|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
33312854|NCT02684357|101040683|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
33312855|NCT02684357|101040684|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
33312856|NCT02684357|101040685|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
33312857|NCT02684357|101040686|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
33312858|NCT02684357|101040681|FG000|Part A|Lost to Follow-up|0|||
33312859|NCT02684357|101040682|FG001|Part A|Lost to Follow-up|2|||
33312860|NCT02684357|101040683|FG002|Part A|Lost to Follow-up|2|||
33312861|NCT02684357|101040684|FG003|Part A|Lost to Follow-up|0|||
33312862|NCT02684357|101040685|FG004|Part A|Lost to Follow-up|0|||
33312863|NCT02684357|101040686|FG005|Part A|Lost to Follow-up|0|||
33312864|NCT02684357|101040681|FG000|Part A|Withdrawal by Subject|3|||
33312865|NCT02684357|101040682|FG001|Part A|Withdrawal by Subject|0|||
33395436|NCT02343952|101334803|FG000|Follow up|Patient went home to Russia|1|||
33503232|NCT00300885|101735264|FG000|Treatment|Non-compliant with study medication|3|||
33503233|NCT00300885|101735265|FG001|Treatment|Non-compliant with study medication|4|||
33503234|NCT00300885|101735264|FG000|Follow-up|Death|141|||
33503235|NCT00300885|101735265|FG001|Follow-up|Death|163|||
33503236|NCT00300885|101735264|FG000|Follow-up|Lost to Follow-up|11|||
33503237|NCT00300885|101735265|FG001|Follow-up|Lost to Follow-up|7|||
33503238|NCT00300885|101735264|FG000|Follow-up|Withdrawal by Subject|26|||
33503239|NCT00300885|101735265|FG001|Follow-up|Withdrawal by Subject|25|||
33503240|NCT01868022|101735281|FG000|Overall Study|Withdrawal by Subject|0|||
33503241|NCT01868022|101735282|FG001|Overall Study|Withdrawal by Subject|0|||
33503242|NCT01868022|101735283|FG002|Overall Study|Withdrawal by Subject|1|||
33503243|NCT01868022|101735284|FG003|Overall Study|Withdrawal by Subject|1|||
33503244|NCT01868022|101735285|FG004|Overall Study|Withdrawal by Subject|0|||
33503245|NCT01868022|101735286|FG005|Overall Study|Withdrawal by Subject|0|||
33503246|NCT01868022|101735287|FG006|Overall Study|Withdrawal by Subject|0|||
33503247|NCT01868022|101735288|FG007|Overall Study|Withdrawal by Subject|1|||
33503248|NCT01868022|101735289|FG008|Overall Study|Withdrawal by Subject|0|||
33503249|NCT01868022|101735281|FG000|Overall Study|Adverse Event|0|||
33503250|NCT01868022|101735282|FG001|Overall Study|Adverse Event|0|||
33503251|NCT01868022|101735283|FG002|Overall Study|Adverse Event|0|||
33503252|NCT01868022|101735284|FG003|Overall Study|Adverse Event|0|||
33503253|NCT01868022|101735285|FG004|Overall Study|Adverse Event|2|||
33503254|NCT01868022|101735286|FG005|Overall Study|Adverse Event|0|||
33503255|NCT01868022|101735287|FG006|Overall Study|Adverse Event|0|||
33503256|NCT01868022|101735288|FG007|Overall Study|Adverse Event|2|||
33503257|NCT01868022|101735289|FG008|Overall Study|Adverse Event|2|||
33503258|NCT01868022|101735281|FG000|Overall Study|Physician Decision|0|||
33503259|NCT01868022|101735282|FG001|Overall Study|Physician Decision|0|||
33602452|NCT03271047|102095349|FG002|Randomized Phase 2 Period|Other|0|||
33602453|NCT03271047|102095350|FG003|Randomized Phase 2 Period|Other|1|||
33602454|NCT03271047|102095347|FG000|Randomized Phase 2 Period|Death|0|||
33602455|NCT03271047|102095348|FG001|Randomized Phase 2 Period|Death|0|||
33602456|NCT03271047|102095349|FG002|Randomized Phase 2 Period|Death|20|||
33602457|NCT03271047|102095350|FG003|Randomized Phase 2 Period|Death|21|||
33602458|NCT03271047|102095347|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
33602459|NCT03271047|102095348|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
33602460|NCT03271047|102095349|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
33602461|NCT03271047|102095350|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
33602462|NCT03271047|102095347|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
33602463|NCT03271047|102095348|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
33602464|NCT03271047|102095349|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
33602465|NCT03271047|102095350|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
33602466|NCT03271047|102095347|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
33602467|NCT03271047|102095348|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
33602468|NCT03271047|102095349|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
33602469|NCT03271047|102095350|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
33602470|NCT03689244|102095351|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
33602471|NCT03689244|102095352|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
33602472|NCT03689244|102095353|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
33602473|NCT03689244|102095354|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
33602474|NCT03689244|102095351|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
33602475|NCT03689244|102095352|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
33602476|NCT03689244|102095353|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
33602477|NCT03689244|102095354|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
33602478|NCT03689244|102095351|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
33602479|NCT03689244|102095352|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
33602480|NCT03689244|102095353|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
33395437|NCT02343952|101334803|FG000|Follow up|Disease Progression|1|||
33395438|NCT02343952|101334803|FG000|Follow up|study terminated|1|||
33395439|NCT05333289|101334808|FG000|Overall Study|Other|1|||
33395440|NCT05333289|101334809|FG001|Overall Study|Other|0|||
33395441|NCT05333289|101334810|FG002|Overall Study|Other|0|||
33395442|NCT05333289|101334811|FG003|Overall Study|Other|1|||
33395443|NCT05333289|101334812|FG004|Overall Study|Other|1|||
33395444|NCT05333289|101334813|FG005|Overall Study|Other|2|||
33395445|NCT05333289|101334814|FG006|Overall Study|Other|2|||
33395446|NCT05333289|101334815|FG007|Overall Study|Other|0|||
33395447|NCT05333289|101334808|FG000|Overall Study|Withdrawal by Subject|1|||
33395448|NCT05333289|101334809|FG001|Overall Study|Withdrawal by Subject|2|||
33395449|NCT05333289|101334810|FG002|Overall Study|Withdrawal by Subject|2|||
33395450|NCT05333289|101334811|FG003|Overall Study|Withdrawal by Subject|1|||
33395451|NCT05333289|101334812|FG004|Overall Study|Withdrawal by Subject|1|||
33503260|NCT01868022|101735283|FG002|Overall Study|Physician Decision|0|||
33503261|NCT01868022|101735284|FG003|Overall Study|Physician Decision|0|||
33503262|NCT01868022|101735285|FG004|Overall Study|Physician Decision|0|||
33503263|NCT01868022|101735286|FG005|Overall Study|Physician Decision|1|||
33503264|NCT01868022|101735287|FG006|Overall Study|Physician Decision|0|||
33503265|NCT01868022|101735288|FG007|Overall Study|Physician Decision|2|||
33503266|NCT01868022|101735289|FG008|Overall Study|Physician Decision|0|||
33503267|NCT01868022|101735281|FG000|Overall Study|Study closed/terminated|0|||
33503268|NCT01868022|101735282|FG001|Overall Study|Study closed/terminated|0|||
33503269|NCT01868022|101735283|FG002|Overall Study|Study closed/terminated|0|||
33503270|NCT01868022|101735284|FG003|Overall Study|Study closed/terminated|0|||
33503271|NCT01868022|101735285|FG004|Overall Study|Study closed/terminated|0|||
33503272|NCT01868022|101735286|FG005|Overall Study|Study closed/terminated|0|||
33503273|NCT01868022|101735287|FG006|Overall Study|Study closed/terminated|0|||
33602481|NCT03689244|102095354|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
33602482|NCT03689244|102095351|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
33602483|NCT03689244|102095352|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
33602484|NCT03689244|102095353|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
33602485|NCT03689244|102095354|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
33395452|NCT05333289|101334813|FG005|Overall Study|Withdrawal by Subject|2|||
33602486|NCT03689244|102095351|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
33602487|NCT03689244|102095352|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
33312866|NCT02684357|101040683|FG002|Part A|Withdrawal by Subject|0|||
33395453|NCT05333289|101334814|FG006|Overall Study|Withdrawal by Subject|1|||
33395454|NCT05333289|101334815|FG007|Overall Study|Withdrawal by Subject|3|||
33395455|NCT05333289|101334808|FG000|Overall Study|Protocol Violation|1|||
33503274|NCT01868022|101735288|FG007|Overall Study|Study closed/terminated|1|||
33503275|NCT01868022|101735289|FG008|Overall Study|Study closed/terminated|0|||
33503276|NCT01868022|101735281|FG000|Overall Study|Ongoing|0|||
33395456|NCT05333289|101334809|FG001|Overall Study|Protocol Violation|0|||
33395457|NCT05333289|101334810|FG002|Overall Study|Protocol Violation|0|||
33395458|NCT05333289|101334811|FG003|Overall Study|Protocol Violation|0|||
33395459|NCT05333289|101334812|FG004|Overall Study|Protocol Violation|0|||
33395460|NCT05333289|101334813|FG005|Overall Study|Protocol Violation|0|||
33395461|NCT05333289|101334814|FG006|Overall Study|Protocol Violation|0|||
33395462|NCT05333289|101334815|FG007|Overall Study|Protocol Violation|0|||
33395463|NCT05333289|101334808|FG000|Overall Study|Physician Decision|0|||
33395464|NCT05333289|101334809|FG001|Overall Study|Physician Decision|0|||
33395465|NCT05333289|101334810|FG002|Overall Study|Physician Decision|1|||
33395466|NCT05333289|101334811|FG003|Overall Study|Physician Decision|0|||
33395467|NCT05333289|101334812|FG004|Overall Study|Physician Decision|0|||
33395468|NCT05333289|101334813|FG005|Overall Study|Physician Decision|2|||
33395469|NCT05333289|101334814|FG006|Overall Study|Physician Decision|0|||
33395470|NCT05333289|101334815|FG007|Overall Study|Physician Decision|0|||
33395471|NCT05333289|101334808|FG000|Overall Study|Lost to Follow-up|6|||
33395472|NCT05333289|101334809|FG001|Overall Study|Lost to Follow-up|0|||
33395473|NCT05333289|101334810|FG002|Overall Study|Lost to Follow-up|1|||
33395474|NCT05333289|101334811|FG003|Overall Study|Lost to Follow-up|6|||
33395475|NCT05333289|101334812|FG004|Overall Study|Lost to Follow-up|3|||
33395476|NCT05333289|101334813|FG005|Overall Study|Lost to Follow-up|3|||
33395477|NCT05333289|101334814|FG006|Overall Study|Lost to Follow-up|2|||
33395478|NCT05333289|101334815|FG007|Overall Study|Lost to Follow-up|1|||
33395479|NCT05333289|101334808|FG000|Overall Study|Death|1|||
33395480|NCT05333289|101334809|FG001|Overall Study|Death|0|||
33503277|NCT01868022|101735282|FG001|Overall Study|Ongoing|0|||
33503278|NCT01868022|101735283|FG002|Overall Study|Ongoing|0|||
33503279|NCT01868022|101735284|FG003|Overall Study|Ongoing|0|||
33503280|NCT01868022|101735285|FG004|Overall Study|Ongoing|0|||
33503281|NCT01868022|101735286|FG005|Overall Study|Ongoing|0|||
33503282|NCT01868022|101735287|FG006|Overall Study|Ongoing|0|||
33503283|NCT01868022|101735288|FG007|Overall Study|Ongoing|3|||
33503284|NCT01868022|101735289|FG008|Overall Study|Ongoing|0|||
33503285|NCT02393950|101735290|FG000|Overall Study|Adverse Event|1|||
33503286|NCT02393950|101735291|FG001|Overall Study|Adverse Event|0|||
33503287|NCT02393950|101735290|FG000|Overall Study|Withdrawal by Subject|0|||
33503288|NCT02393950|101735291|FG001|Overall Study|Withdrawal by Subject|1|||
33503289|NCT03850496|101735294|FG000|Overall Study|Withdrawal by Subject|1|||
33503290|NCT03850496|101735295|FG001|Overall Study|Withdrawal by Subject|0|||
33503291|NCT03850496|101735296|FG002|Overall Study|Withdrawal by Subject|0|||
33602488|NCT03689244|102095353|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
33602489|NCT03689244|102095354|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
33602490|NCT03689244|102095351|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
33602491|NCT03689244|102095352|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
33602492|NCT03689244|102095353|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
33602493|NCT03689244|102095354|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
33503292|NCT03850496|101735294|FG000|Overall Study|Lost to Follow-up|0|||
33503293|NCT03850496|101735295|FG001|Overall Study|Lost to Follow-up|1|||
33503294|NCT03850496|101735296|FG002|Overall Study|Lost to Follow-up|4|||
33312867|NCT02684357|101040684|FG003|Part A|Withdrawal by Subject|0|||
33312868|NCT02684357|101040685|FG004|Part A|Withdrawal by Subject|0|||
33312869|NCT02684357|101040686|FG005|Part A|Withdrawal by Subject|0|||
33312870|NCT02684357|101040681|FG000|Part A|Other|0|||
33312871|NCT02684357|101040682|FG001|Part A|Other|1|||
33312872|NCT02684357|101040683|FG002|Part A|Other|0|||
33312873|NCT02684357|101040684|FG003|Part A|Other|0|||
33395481|NCT05333289|101334810|FG002|Overall Study|Death|0|||
33395482|NCT05333289|101334811|FG003|Overall Study|Death|0|||
33503295|NCT02147158|101735298|FG000|Treatment Course 1|Adverse Event|1|||
33503296|NCT02147158|101735299|FG001|Treatment Course 1|Adverse Event|4|||
33503297|NCT02147158|101735300|FG002|Treatment Course 1|Adverse Event|3|||
33503298|NCT02147158|101735301|FG003|Treatment Course 1|Adverse Event|4|||
33503299|NCT02147158|101735302|FG004|Treatment Course 1|Adverse Event|1|||
33503300|NCT02147158|101735303|FG005|Treatment Course 1|Adverse Event|2|||
33312874|NCT02684357|101040685|FG004|Part A|Other|0|||
33312875|NCT02684357|101040686|FG005|Part A|Other|0|||
33395483|NCT05333289|101334812|FG004|Overall Study|Death|0|||
33395484|NCT05333289|101334813|FG005|Overall Study|Death|0|||
33312876|NCT02684357|101040681|FG000|Part B|Adverse Event (Other)|0|||
33395485|NCT05333289|101334814|FG006|Overall Study|Death|0|||
33395486|NCT05333289|101334815|FG007|Overall Study|Death|0|||
33395487|NCT00378534|101334818|FG000|Overall Study|Participants did not receive transplant|3|||
33395488|NCT00378534|101334819|FG001|Overall Study|Participants did not receive transplant|0|||
33395489|NCT02559115|101334823|FG000|Overall Study|Withdrawal by Subject|3|||
33395490|NCT03687827|101334824|FG000|Treatment Period 1|Death|0|||
33503301|NCT02147158|101735298|FG000|Treatment Course 1|Lost to Follow-up|2|||
33503302|NCT02147158|101735299|FG001|Treatment Course 1|Lost to Follow-up|4|||
33503303|NCT02147158|101735300|FG002|Treatment Course 1|Lost to Follow-up|3|||
33503304|NCT02147158|101735301|FG003|Treatment Course 1|Lost to Follow-up|3|||
33503305|NCT02147158|101735302|FG004|Treatment Course 1|Lost to Follow-up|2|||
33503306|NCT02147158|101735303|FG005|Treatment Course 1|Lost to Follow-up|4|||
33503307|NCT02147158|101735298|FG000|Treatment Course 1|Protocol Violation|0|||
33503308|NCT02147158|101735299|FG001|Treatment Course 1|Protocol Violation|0|||
33503309|NCT02147158|101735300|FG002|Treatment Course 1|Protocol Violation|1|||
33503310|NCT02147158|101735301|FG003|Treatment Course 1|Protocol Violation|1|||
33503311|NCT02147158|101735302|FG004|Treatment Course 1|Protocol Violation|0|||
33503312|NCT02147158|101735303|FG005|Treatment Course 1|Protocol Violation|0|||
33503313|NCT02147158|101735298|FG000|Treatment Course 1|Withdrawal of Consent|1|||
33503314|NCT02147158|101735299|FG001|Treatment Course 1|Withdrawal of Consent|1|||
33503315|NCT02147158|101735300|FG002|Treatment Course 1|Withdrawal of Consent|1|||
33503316|NCT02147158|101735301|FG003|Treatment Course 1|Withdrawal of Consent|5|||
33503317|NCT02147158|101735302|FG004|Treatment Course 1|Withdrawal of Consent|3|||
33503318|NCT02147158|101735303|FG005|Treatment Course 1|Withdrawal of Consent|2|||
33503319|NCT02147158|101735298|FG000|Off-Treatment Interval 1|Adverse Event|1|||
33503320|NCT02147158|101735299|FG001|Off-Treatment Interval 1|Adverse Event|0|||
33503321|NCT02147158|101735300|FG002|Off-Treatment Interval 1|Adverse Event|0|||
33503322|NCT02147158|101735301|FG003|Off-Treatment Interval 1|Adverse Event|1|||
33503323|NCT02147158|101735302|FG004|Off-Treatment Interval 1|Adverse Event|0|||
33503324|NCT02147158|101735303|FG005|Off-Treatment Interval 1|Adverse Event|0|||
33503325|NCT02147158|101735298|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
33503326|NCT02147158|101735299|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
33503327|NCT02147158|101735300|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
33503328|NCT02147158|101735301|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
33503329|NCT02147158|101735302|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
33503330|NCT02147158|101735303|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
33503331|NCT02147158|101735298|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
33503332|NCT02147158|101735299|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
33503333|NCT02147158|101735300|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
33503334|NCT02147158|101735301|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
33503335|NCT02147158|101735302|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
33503336|NCT02147158|101735303|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
33503337|NCT02147158|101735298|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
33503338|NCT02147158|101735299|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
33312877|NCT02684357|101040682|FG001|Part B|Adverse Event (Other)|0|||
33312878|NCT02684357|101040683|FG002|Part B|Adverse Event (Other)|0|||
33312879|NCT02684357|101040684|FG003|Part B|Adverse Event (Other)|1|||
33312880|NCT02684357|101040685|FG004|Part B|Adverse Event (Other)|1|||
33312881|NCT02684357|101040686|FG005|Part B|Adverse Event (Other)|1|||
33312882|NCT02684357|101040681|FG000|Part B|Lost to Follow-up|0|||
33312883|NCT02684357|101040682|FG001|Part B|Lost to Follow-up|0|||
33312884|NCT02684357|101040683|FG002|Part B|Lost to Follow-up|0|||
33312885|NCT02684357|101040684|FG003|Part B|Lost to Follow-up|1|||
33312886|NCT02684357|101040685|FG004|Part B|Lost to Follow-up|1|||
33312887|NCT02684357|101040686|FG005|Part B|Lost to Follow-up|7|||
33312888|NCT02684357|101040681|FG000|Part B|Withdrawal by Subject|0|||
33312889|NCT02684357|101040682|FG001|Part B|Withdrawal by Subject|0|||
33312890|NCT02684357|101040683|FG002|Part B|Withdrawal by Subject|0|||
33312891|NCT02684357|101040684|FG003|Part B|Withdrawal by Subject|0|||
33312892|NCT02684357|101040685|FG004|Part B|Withdrawal by Subject|2|||
33312893|NCT02684357|101040686|FG005|Part B|Withdrawal by Subject|4|||
33312894|NCT02684357|101040681|FG000|Part B|Other|0|||
33312895|NCT02684357|101040682|FG001|Part B|Other|0|||
33312896|NCT02684357|101040683|FG002|Part B|Other|0|||
33312897|NCT02684357|101040684|FG003|Part B|Other|1|||
33312898|NCT02684357|101040685|FG004|Part B|Other|0|||
33312899|NCT02684357|101040686|FG005|Part B|Other|1|||
33312900|NCT02354508|101040689|FG000|Period 1: Core Phase|Adverse Event|1|||
33312901|NCT02354508|101040690|FG001|Period 1: Core Phase|Adverse Event|1|||
33312902|NCT02354508|101040691|FG002|Period 1: Core Phase|Adverse Event|2|||
33312903|NCT02354508|101040689|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
33312904|NCT02354508|101040690|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
33312905|NCT02354508|101040691|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
33312906|NCT02354508|101040689|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
33312907|NCT02354508|101040690|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
33312908|NCT02354508|101040691|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
33503339|NCT02147158|101735300|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
33503340|NCT02147158|101735301|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
33312909|NCT02354508|101040689|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
33312910|NCT02354508|101040690|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
33312911|NCT02354508|101040691|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
33503341|NCT02147158|101735302|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
33503342|NCT02147158|101735303|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
33312912|NCT02354508|101040689|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
33312913|NCT02354508|101040690|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
33503343|NCT02147158|101735298|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
33503344|NCT02147158|101735299|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
33503345|NCT02147158|101735300|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
33503346|NCT02147158|101735301|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
33503347|NCT02147158|101735302|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
33503348|NCT02147158|101735303|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
33503349|NCT02147158|101735298|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
33503350|NCT02147158|101735299|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
33503351|NCT02147158|101735300|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
33503352|NCT02147158|101735301|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
33503353|NCT02147158|101735302|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
33503354|NCT02147158|101735303|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
33503355|NCT02147158|101735298|FG000|Treatment Course 2|Adverse Event|0|||
33503356|NCT02147158|101735299|FG001|Treatment Course 2|Adverse Event|4|||
33503357|NCT02147158|101735300|FG002|Treatment Course 2|Adverse Event|2|||
33503358|NCT02147158|101735301|FG003|Treatment Course 2|Adverse Event|1|||
33503359|NCT02147158|101735302|FG004|Treatment Course 2|Adverse Event|0|||
33503360|NCT02147158|101735303|FG005|Treatment Course 2|Adverse Event|1|||
33193380|NCT02472756|100612704|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
33312914|NCT02354508|101040691|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
33312915|NCT02354508|101040689|FG000|Period 2: Extension Phase|Physician Decision|5|||
33312916|NCT02354508|101040690|FG001|Period 2: Extension Phase|Physician Decision|0|||
33312917|NCT02354508|101040691|FG002|Period 2: Extension Phase|Physician Decision|1|||
33312918|NCT02354508|101040689|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
33312919|NCT02354508|101040690|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
33312920|NCT02354508|101040691|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
33312921|NCT02354508|101040689|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
33312922|NCT02354508|101040690|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
33312923|NCT02354508|101040691|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
33312924|NCT02354508|101040689|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
33312925|NCT02354508|101040690|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
33312926|NCT02354508|101040691|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
33312927|NCT01060540|101040694|FG000|Overall Study|Withdrawal by Subject|10|||
33395491|NCT03687827|101334825|FG001|Treatment Period 1|Death|1|||
33503361|NCT02147158|101735298|FG000|Treatment Course 2|Withdrawal of Consent|0|||
33503362|NCT02147158|101735299|FG001|Treatment Course 2|Withdrawal of Consent|1|||
33312928|NCT01060540|101040695|FG001|Overall Study|Withdrawal by Subject|20|||
33312929|NCT01060540|101040694|FG000|Overall Study|Lost to Follow-up|52|||
33312930|NCT01060540|101040695|FG001|Overall Study|Lost to Follow-up|43|||
33312931|NCT01060540|101040694|FG000|Overall Study|Death|2|||
33312932|NCT01060540|101040695|FG001|Overall Study|Death|1|||
33312933|NCT01060540|101040694|FG000|Overall Study|Physician Decision|0|||
33312934|NCT01060540|101040695|FG001|Overall Study|Physician Decision|1|||
33312935|NCT01506453|101040696|FG000|Overall Study|Withdrawal prior to treatment|0|||
33312936|NCT01506453|101040697|FG001|Overall Study|Withdrawal prior to treatment|2|||
33312937|NCT01048671|101040704|FG000|Overall Study|Protocol Violation|0|||
33312938|NCT01048671|101040705|FG001|Overall Study|Protocol Violation|1|||
33312939|NCT01048671|101040706|FG002|Overall Study|Protocol Violation|1|||
33312940|NCT00682890|101040707|FG000|Overall Study|Lost to Follow-up|1|||
33503363|NCT02147158|101735300|FG002|Treatment Course 2|Withdrawal of Consent|2|||
33503364|NCT02147158|101735301|FG003|Treatment Course 2|Withdrawal of Consent|3|||
33503365|NCT02147158|101735302|FG004|Treatment Course 2|Withdrawal of Consent|0|||
33503366|NCT02147158|101735303|FG005|Treatment Course 2|Withdrawal of Consent|0|||
33503367|NCT02147158|101735298|FG000|Treatment Course 2|Lost to Follow-up|1|||
33503368|NCT02147158|101735299|FG001|Treatment Course 2|Lost to Follow-up|0|||
33503369|NCT02147158|101735300|FG002|Treatment Course 2|Lost to Follow-up|1|||
33503370|NCT02147158|101735301|FG003|Treatment Course 2|Lost to Follow-up|1|||
33503371|NCT02147158|101735302|FG004|Treatment Course 2|Lost to Follow-up|0|||
33503372|NCT02147158|101735303|FG005|Treatment Course 2|Lost to Follow-up|1|||
33503373|NCT02147158|101735298|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
33503374|NCT02147158|101735299|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
33503375|NCT02147158|101735300|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
33503376|NCT02147158|101735301|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
33503377|NCT02147158|101735302|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
33312941|NCT00682890|101040708|FG001|Overall Study|Lost to Follow-up|1|||
33395492|NCT03687827|101334824|FG000|Treatment Period 1|Lost to Follow-up|2|||
33503378|NCT02147158|101735303|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
33503379|NCT02147158|101735298|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
33503380|NCT02147158|101735299|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
33193381|NCT02472756|100612704|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
33312942|NCT00682890|101040707|FG000|Overall Study|subject moved away|0|||
33312943|NCT00682890|101040708|FG001|Overall Study|subject moved away|1|||
33312944|NCT00682890|101040707|FG000|Overall Study|heavy menstrual bleeding|1|||
33312945|NCT00682890|101040708|FG001|Overall Study|heavy menstrual bleeding|0|||
33312946|NCT03037931|101040709|FG000|Overall Study|Death|354|||
33312947|NCT03037931|101040710|FG001|Overall Study|Death|367|||
33312948|NCT03037931|101040709|FG000|Overall Study|Lost to Follow-up|7|||
33312949|NCT03037931|101040710|FG001|Overall Study|Lost to Follow-up|4|||
33503381|NCT02147158|101735300|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
33503382|NCT02147158|101735301|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
33503383|NCT02147158|101735302|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
33503384|NCT02147158|101735303|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
33503385|NCT02147158|101735298|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
33503386|NCT02147158|101735299|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
33503387|NCT02147158|101735300|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
33503388|NCT02147158|101735301|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
33503389|NCT02147158|101735302|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
33503390|NCT02147158|101735303|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
33503391|NCT02147158|101735298|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
33503392|NCT02147158|101735299|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
33503393|NCT02147158|101735300|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
33503394|NCT02147158|101735301|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
33503395|NCT02147158|101735302|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
33503396|NCT02147158|101735303|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
33503397|NCT02147158|101735298|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
33503398|NCT02147158|101735299|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
33503399|NCT02147158|101735300|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
33503400|NCT02147158|101735301|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
33503401|NCT02147158|101735302|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
33503402|NCT02147158|101735303|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
33503403|NCT03656692|101735304|FG000|Overall Study|Worsening of disease activity|2|||
33503404|NCT03656692|101735304|FG000|Overall Study|Physician Decision|1|||
33503405|NCT02964208|101735305|FG000|Overall Study|Death|103|||
33503406|NCT02964208|101735305|FG000|Overall Study|Withdrawal by Subject|6|||
33503407|NCT02964208|101735305|FG000|Overall Study|Lost to Follow-up|6|||
33503408|NCT02964208|101735305|FG000|Overall Study|Unsuccessful Procedure|5|||
33503409|NCT02964208|101735305|FG000|Overall Study|Device Explant|1|||
33503410|NCT02964208|101735305|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
33503411|NCT00430573|101735310|FG000|Overall Study|Withdrawal by Subject|5|||
33503412|NCT02861586|101735311|FG000|Overall Study|Withdrawal by Subject|1|||
33503413|NCT02861586|101735312|FG001|Overall Study|Withdrawal by Subject|2|||
33503414|NCT02861586|101735313|FG002|Overall Study|Withdrawal by Subject|0|||
33503415|NCT02861586|101735314|FG003|Overall Study|Withdrawal by Subject|0|||
33503416|NCT02861586|101735315|FG004|Overall Study|Withdrawal by Subject|0|||
33503417|NCT02861586|101735316|FG005|Overall Study|Withdrawal by Subject|1|||
33503418|NCT02861586|101735317|FG006|Overall Study|Withdrawal by Subject|1|||
33503419|NCT02861586|101735318|FG007|Overall Study|Withdrawal by Subject|0|||
33503420|NCT02861586|101735311|FG000|Overall Study|Lost to Follow-up|3|||
33503421|NCT02861586|101735312|FG001|Overall Study|Lost to Follow-up|1|||
33503422|NCT02861586|101735313|FG002|Overall Study|Lost to Follow-up|1|||
33503423|NCT02861586|101735314|FG003|Overall Study|Lost to Follow-up|0|||
33503424|NCT02861586|101735315|FG004|Overall Study|Lost to Follow-up|0|||
33503425|NCT02861586|101735316|FG005|Overall Study|Lost to Follow-up|3|||
33503426|NCT02861586|101735317|FG006|Overall Study|Lost to Follow-up|0|||
33193382|NCT02472756|100612704|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
33193383|NCT02472756|100612704|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
33193384|NCT00192075|100612705|FG000|Overall Study|Disease Progression|23|||
33193385|NCT00192075|100612706|FG001|Overall Study|Disease Progression|6|||
33193386|NCT00192075|100612705|FG000|Overall Study|Adverse Event|1|||
33193387|NCT00192075|100612706|FG001|Overall Study|Adverse Event|3|||
33193388|NCT00192075|100612705|FG000|Overall Study|Death|0|||
33395493|NCT03687827|101334825|FG001|Treatment Period 1|Lost to Follow-up|2|||
33395494|NCT03687827|101334824|FG000|Treatment Period 1|Physician Decision|5|||
33395495|NCT03687827|101334825|FG001|Treatment Period 1|Physician Decision|2|||
33503427|NCT02861586|101735318|FG007|Overall Study|Lost to Follow-up|0|||
33503428|NCT02861586|101735311|FG000|Overall Study|Adverse Event|0|||
33503429|NCT02861586|101735312|FG001|Overall Study|Adverse Event|0|||
33503430|NCT02861586|101735313|FG002|Overall Study|Adverse Event|0|||
33503431|NCT02861586|101735314|FG003|Overall Study|Adverse Event|0|||
33503432|NCT02861586|101735315|FG004|Overall Study|Adverse Event|0|||
33193389|NCT00192075|100612706|FG001|Overall Study|Death|1|||
33193390|NCT00192075|100612705|FG000|Overall Study|Lack of Efficacy|0|||
33312950|NCT03037931|101040709|FG000|Overall Study|Withdrawal by Subject|48|||
33312951|NCT03037931|101040710|FG001|Overall Study|Withdrawal by Subject|41|||
33602494|NCT03689244|102095351|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
33602495|NCT03689244|102095352|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
33602496|NCT03689244|102095353|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
33602497|NCT03689244|102095354|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
33602498|NCT03689244|102095351|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
33602499|NCT03689244|102095352|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
33602500|NCT03689244|102095353|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
33602501|NCT03689244|102095354|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
33602502|NCT01459913|102095355|FG000|Overall Study|Adverse Event|0|||
33602503|NCT01459913|102095356|FG001|Overall Study|Adverse Event|0|||
33602504|NCT01459913|102095357|FG002|Overall Study|Adverse Event|0|||
33602505|NCT01459913|102095358|FG003|Overall Study|Adverse Event|3|||
33602506|NCT01459913|102095355|FG000|Overall Study|Withdrawal by Subject|4|||
33602507|NCT01459913|102095356|FG001|Overall Study|Withdrawal by Subject|0|||
33602508|NCT01459913|102095357|FG002|Overall Study|Withdrawal by Subject|0|||
33602509|NCT01459913|102095358|FG003|Overall Study|Withdrawal by Subject|5|||
33602510|NCT01459913|102095355|FG000|Overall Study|Lost to Follow-up|7|||
33602511|NCT01459913|102095356|FG001|Overall Study|Lost to Follow-up|4|||
33602512|NCT01459913|102095357|FG002|Overall Study|Lost to Follow-up|1|||
33602513|NCT01459913|102095358|FG003|Overall Study|Lost to Follow-up|8|||
33602514|NCT01459913|102095355|FG000|Overall Study|Death|0|||
33602515|NCT01459913|102095356|FG001|Overall Study|Death|0|||
33602516|NCT01459913|102095357|FG002|Overall Study|Death|0|||
33602517|NCT01459913|102095358|FG003|Overall Study|Death|1|||
33503433|NCT02861586|101735316|FG005|Overall Study|Adverse Event|1|||
33503434|NCT02861586|101735317|FG006|Overall Study|Adverse Event|0|||
33503435|NCT02861586|101735318|FG007|Overall Study|Adverse Event|0|||
33503436|NCT02201108|101735319|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
33503437|NCT02201108|101735320|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
33503438|NCT02201108|101735319|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
33503439|NCT02201108|101735320|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
33503440|NCT02201108|101735319|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
33503441|NCT02201108|101735320|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
33503442|NCT02201108|101735319|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
33503443|NCT02201108|101735320|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
33503444|NCT02201108|101735319|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
33503445|NCT02201108|101735320|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
33602518|NCT01459913|102095355|FG000|Overall Study|Non- Compliance|0|||
33602519|NCT01459913|102095356|FG001|Overall Study|Non- Compliance|0|||
33503446|NCT02201108|101735319|FG000|Open Label Period (up to Week 192)|Other reason|4|||
33503447|NCT02201108|101735320|FG001|Open Label Period (up to Week 192)|Other reason|7|||
33503448|NCT02201108|101735319|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
33602520|NCT01459913|102095357|FG002|Overall Study|Non- Compliance|0|||
33602521|NCT01459913|102095358|FG003|Overall Study|Non- Compliance|3|||
33602522|NCT01459913|102095355|FG000|Overall Study|Physician Decision|0|||
33602523|NCT01459913|102095356|FG001|Overall Study|Physician Decision|1|||
33602524|NCT01459913|102095357|FG002|Overall Study|Physician Decision|0|||
33312952|NCT01328717|101040711|FG000|Overall Study|Adverse Event|1|||
33503449|NCT02201108|101735320|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
33503450|NCT00135512|101735321|FG000|Overall Study|Adverse Event|56|||
33503451|NCT00135512|101735321|FG000|Overall Study|Lack of Efficacy|25|||
33503452|NCT00135512|101735321|FG000|Overall Study|Other|42|||
33503453|NCT04478695|101735322|FG000|Overall Study|Death|1|||
33503454|NCT04478695|101735323|FG001|Overall Study|Death|0|||
33503455|NCT00729612|101735325|FG000|Overall Study|Non evaluable for response|10|||
33503456|NCT00078767|101735328|FG000|Overall Study|Withdrawal by Subject|1|||
33503457|NCT00078767|101735329|FG001|Overall Study|Withdrawal by Subject|1|||
33503458|NCT01516008|101735330|FG000|Overall Study|Adverse Event|0|||
33602525|NCT01459913|102095358|FG003|Overall Study|Physician Decision|0|||
33602526|NCT01459913|102095355|FG000|Overall Study|Study Terminated by Sponsor|30|||
33602527|NCT01459913|102095356|FG001|Overall Study|Study Terminated by Sponsor|15|||
33602528|NCT01459913|102095357|FG002|Overall Study|Study Terminated by Sponsor|9|||
33602529|NCT01459913|102095358|FG003|Overall Study|Study Terminated by Sponsor|11|||
33602530|NCT01459913|102095355|FG000|Overall Study|Other|0|||
33602531|NCT01459913|102095356|FG001|Overall Study|Other|0|||
33602532|NCT01459913|102095357|FG002|Overall Study|Other|3|||
33602533|NCT01459913|102095358|FG003|Overall Study|Other|1|||
33602534|NCT01459913|102095355|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
33602535|NCT01459913|102095356|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
33602536|NCT01459913|102095357|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
33602537|NCT01459913|102095358|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
33602538|NCT03458702|102095359|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
33602539|NCT03458702|102095360|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
33602540|NCT03458702|102095359|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
33602541|NCT03458702|102095360|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
33602542|NCT02383433|102095361|FG000|Overall Study|Disease progression|2|||
33602543|NCT02012686|102095362|FG000|Overall Study|muscle contraction|0|||
33602544|NCT02012686|102095363|FG001|Overall Study|muscle contraction|1|||
33602545|NCT02012686|102095362|FG000|Overall Study|electrocardiography monitoring noise|0|||
33602546|NCT02012686|102095363|FG001|Overall Study|electrocardiography monitoring noise|1|||
33602547|NCT00259298|102095364|FG000|Overall Study|Withdrawal by Subject|1|||
33602548|NCT00259298|102095364|FG000|Overall Study|Physician Decision|2|||
33602549|NCT03187834|102095367|FG000|Overall Study|Lost to Follow-up|0|||
33602550|NCT03187834|102095368|FG001|Overall Study|Lost to Follow-up|1|||
33602551|NCT03187834|102095369|FG002|Overall Study|Lost to Follow-up|2|||
33602552|NCT03187834|102095370|FG003|Overall Study|Lost to Follow-up|2|||
33602553|NCT03187834|102095367|FG000|Overall Study|Had invalid anthropometric measurements|5|||
33602554|NCT03187834|102095368|FG001|Overall Study|Had invalid anthropometric measurements|3|||
33602555|NCT03187834|102095369|FG002|Overall Study|Had invalid anthropometric measurements|4|||
33602556|NCT03187834|102095370|FG003|Overall Study|Had invalid anthropometric measurements|2|||
33602557|NCT01498185|102095371|FG000|Overall Study|Adverse Event|0|||
33602558|NCT01498185|102095372|FG001|Overall Study|Adverse Event|0|||
33602559|NCT01498185|102095373|FG002|Overall Study|Adverse Event|0|||
33602560|NCT01498185|102095374|FG003|Overall Study|Adverse Event|1|||
33602561|NCT01498185|102095375|FG004|Overall Study|Adverse Event|0|||
33602562|NCT01498185|102095371|FG000|Overall Study|Withdrawal by Subject|1|||
33602563|NCT01498185|102095372|FG001|Overall Study|Withdrawal by Subject|1|||
33602564|NCT01498185|102095373|FG002|Overall Study|Withdrawal by Subject|0|||
33602565|NCT01498185|102095374|FG003|Overall Study|Withdrawal by Subject|2|||
33602566|NCT01498185|102095375|FG004|Overall Study|Withdrawal by Subject|1|||
33602567|NCT01498185|102095371|FG000|Overall Study|No longer met criteria, etc|0|||
33602568|NCT01498185|102095372|FG001|Overall Study|No longer met criteria, etc|0|||
33602569|NCT01498185|102095373|FG002|Overall Study|No longer met criteria, etc|0|||
33602570|NCT01498185|102095374|FG003|Overall Study|No longer met criteria, etc|0|||
33602571|NCT01498185|102095375|FG004|Overall Study|No longer met criteria, etc|2|||
33602572|NCT00490022|102095376|FG000|Overall Study|Adverse Event|0|||
33602573|NCT00490022|102095377|FG001|Overall Study|Adverse Event|2|||
33602574|NCT00490022|102095376|FG000|Overall Study|Withdrawal by Subject|1|||
33602575|NCT00490022|102095377|FG001|Overall Study|Withdrawal by Subject|0|||
33312953|NCT00906945|101040712|FG000|Overall Study|Found to be not eligible|0|||
33503459|NCT01516008|101735331|FG001|Overall Study|Adverse Event|2|||
33503460|NCT01516008|101735332|FG002|Overall Study|Adverse Event|7|||
33503461|NCT01516008|101735330|FG000|Overall Study|Lack of Efficacy|44|||
33503462|NCT01516008|101735331|FG001|Overall Study|Lack of Efficacy|14|||
33602576|NCT00490022|102095376|FG000|Overall Study|Subject failed to disclose concommitant|0|||
33602577|NCT00490022|102095377|FG001|Overall Study|Subject failed to disclose concommitant|1|||
33602578|NCT02231762|102095378|FG000|Combination Phase|Adverse Event|10|||
33602579|NCT02231762|102095379|FG001|Combination Phase|Adverse Event|0|||
33602580|NCT02231762|102095380|FG002|Combination Phase|Adverse Event|0|||
33602581|NCT02231762|102095381|FG003|Combination Phase|Adverse Event|0|||
33602582|NCT02231762|102095378|FG000|Combination Phase|Withdrawal by Subject|2|||
33602583|NCT02231762|102095379|FG001|Combination Phase|Withdrawal by Subject|0|||
33503463|NCT01516008|101735332|FG002|Overall Study|Lack of Efficacy|10|||
33503464|NCT01516008|101735330|FG000|Overall Study|Protocol Violation|1|||
33503465|NCT01516008|101735331|FG001|Overall Study|Protocol Violation|0|||
33503466|NCT01516008|101735332|FG002|Overall Study|Protocol Violation|0|||
33503467|NCT01516008|101735330|FG000|Overall Study|Reason not specified|0|||
33503468|NCT01516008|101735331|FG001|Overall Study|Reason not specified|0|||
33503469|NCT01516008|101735332|FG002|Overall Study|Reason not specified|1|||
33503470|NCT00485732|101738318|FG000|Overall Study|Protocol Violation|1|||
33503471|NCT00485732|101738319|FG001|Overall Study|Protocol Violation|3|||
33503472|NCT00485732|101738318|FG000|Overall Study|Withdrawal by Subject|5|||
33503473|NCT00485732|101738319|FG001|Overall Study|Withdrawal by Subject|4|||
33503474|NCT00485732|101738318|FG000|Overall Study|Lost to Follow-up|2|||
33503475|NCT00485732|101738319|FG001|Overall Study|Lost to Follow-up|2|||
33503476|NCT00687271|101738320|FG000|Overall Study|Adverse Event|1|||
33503477|NCT00687271|101738321|FG001|Overall Study|Adverse Event|3|||
33503478|NCT00687271|101738322|FG002|Overall Study|Adverse Event|1|||
33503479|NCT00687271|101738323|FG003|Overall Study|Adverse Event|0|||
33503480|NCT00687271|101738320|FG000|Overall Study|Lost to Follow-up|0|||
33503481|NCT00687271|101738321|FG001|Overall Study|Lost to Follow-up|1|||
33503482|NCT00687271|101738322|FG002|Overall Study|Lost to Follow-up|0|||
33503483|NCT00687271|101738323|FG003|Overall Study|Lost to Follow-up|0|||
33503484|NCT00687271|101738320|FG000|Overall Study|Protocol Violation|2|||
33503485|NCT00687271|101738321|FG001|Overall Study|Protocol Violation|1|||
33193391|NCT00192075|100612706|FG001|Overall Study|Lack of Efficacy|0|||
33395496|NCT03687827|101334824|FG000|Treatment Period 1|Withdrawal by Subject|7|||
33503486|NCT00687271|101738322|FG002|Overall Study|Protocol Violation|1|||
33503487|NCT00687271|101738323|FG003|Overall Study|Protocol Violation|0|||
33503488|NCT00687271|101738320|FG000|Overall Study|Withdrawal by Subject|0|||
33395497|NCT03687827|101334825|FG001|Treatment Period 1|Withdrawal by Subject|3|||
33503489|NCT00687271|101738321|FG001|Overall Study|Withdrawal by Subject|1|||
33503490|NCT00687271|101738322|FG002|Overall Study|Withdrawal by Subject|3|||
33503491|NCT00687271|101738323|FG003|Overall Study|Withdrawal by Subject|0|||
33503492|NCT01931475|101738332|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
33503493|NCT01931475|101738333|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
33503494|NCT01931475|101738332|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
33503495|NCT01931475|101738333|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
33503496|NCT01931475|101738332|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
33503497|NCT01931475|101738333|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
33503498|NCT01931475|101738332|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
33503499|NCT01931475|101738333|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
33503500|NCT01931475|101738332|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
33503501|NCT01931475|101738333|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
33503502|NCT01931475|101738332|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
33503503|NCT01931475|101738333|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
33503504|NCT01931475|101738332|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
33503505|NCT01931475|101738333|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
33503506|NCT01931475|101738332|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
33503507|NCT01931475|101738333|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
33503508|NCT01931475|101738332|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
33503509|NCT01931475|101738333|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
33503510|NCT01931475|101738332|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
33503511|NCT01931475|101738333|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
33503512|NCT01931475|101738332|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
33503513|NCT01931475|101738333|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
33503514|NCT01560234|101738336|FG000|Overall Study|Lost to Follow-up|3|||
33503515|NCT01560234|101738337|FG001|Overall Study|Lost to Follow-up|0|||
33602584|NCT02231762|102095380|FG002|Combination Phase|Withdrawal by Subject|0|||
33602585|NCT02231762|102095381|FG003|Combination Phase|Withdrawal by Subject|0|||
33602586|NCT02231762|102095378|FG000|Combination Phase|Disease Progression|6|||
33602587|NCT02231762|102095379|FG001|Combination Phase|Disease Progression|0|||
33602588|NCT02231762|102095380|FG002|Combination Phase|Disease Progression|0|||
33602589|NCT02231762|102095381|FG003|Combination Phase|Disease Progression|0|||
33602590|NCT02231762|102095378|FG000|Combination Phase|Did not meet inclusion criteria|1|||
33602591|NCT02231762|102095379|FG001|Combination Phase|Did not meet inclusion criteria|0|||
33602592|NCT02231762|102095380|FG002|Combination Phase|Did not meet inclusion criteria|0|||
33602593|NCT02231762|102095381|FG003|Combination Phase|Did not meet inclusion criteria|0|||
33602594|NCT02231762|102095378|FG000|Combination Phase|Protocol Violation|1|||
33602595|NCT02231762|102095379|FG001|Combination Phase|Protocol Violation|0|||
33602596|NCT02231762|102095380|FG002|Combination Phase|Protocol Violation|0|||
33602597|NCT02231762|102095381|FG003|Combination Phase|Protocol Violation|0|||
33602598|NCT02231762|102095378|FG000|Maintenance Phase|Disease progression|0|||
33602599|NCT02231762|102095379|FG001|Maintenance Phase|Disease progression|3|||
33602600|NCT02231762|102095380|FG002|Maintenance Phase|Disease progression|4|||
33602601|NCT02231762|102095381|FG003|Maintenance Phase|Disease progression|3|||
33602602|NCT02231762|102095378|FG000|Maintenance Phase|Adverse Event|0|||
33602603|NCT02231762|102095379|FG001|Maintenance Phase|Adverse Event|0|||
33602604|NCT02231762|102095380|FG002|Maintenance Phase|Adverse Event|1|||
33602605|NCT02231762|102095381|FG003|Maintenance Phase|Adverse Event|2|||
33602606|NCT00456599|102095382|FG000|Overall Study|Non-compliance|1|||
33602607|NCT00456599|102095382|FG000|Overall Study|Withdrawal by Subject|2|||
33602608|NCT02636946|102095383|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
33602609|NCT02636946|102095384|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
33602610|NCT02636946|102095383|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
33602611|NCT02636946|102095384|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
33602612|NCT02636946|102095383|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
33602613|NCT02636946|102095384|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
33602614|NCT02636946|102095383|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
33602615|NCT02636946|102095384|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
33602616|NCT02636946|102095383|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
33602617|NCT02636946|102095384|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
33602618|NCT02636946|102095383|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
33602619|NCT02636946|102095384|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
33602620|NCT02250664|102095386|FG000|Overall Study|Lost to Follow-up|18|||
33193392|NCT00192075|100612705|FG000|Overall Study|Physician Decision|3|||
33193393|NCT00192075|100612706|FG001|Overall Study|Physician Decision|0|||
33503516|NCT01560234|101738338|FG002|Overall Study|Lost to Follow-up|1|||
33503517|NCT01560234|101738339|FG003|Overall Study|Lost to Follow-up|0|||
33503518|NCT01560234|101738340|FG004|Overall Study|Lost to Follow-up|0|||
33503519|NCT01560234|101738341|FG005|Overall Study|Lost to Follow-up|2|||
33503520|NCT01560234|101738342|FG006|Overall Study|Lost to Follow-up|0|||
33602621|NCT02250664|102095387|FG001|Overall Study|Lost to Follow-up|28|||
33602622|NCT02250664|102095388|FG002|Overall Study|Lost to Follow-up|33|||
33602623|NCT02250664|102095386|FG000|Overall Study|Personal Reasons|7|||
33602624|NCT02250664|102095387|FG001|Overall Study|Personal Reasons|8|||
33602625|NCT02250664|102095388|FG002|Overall Study|Personal Reasons|14|||
33602626|NCT02250664|102095386|FG000|Overall Study|Adverse Event|6|||
33312954|NCT00906945|101040713|FG001|Overall Study|Found to be not eligible|0|||
33312955|NCT00906945|101040714|FG002|Overall Study|Found to be not eligible|0|||
33602627|NCT02250664|102095387|FG001|Overall Study|Adverse Event|3|||
33602628|NCT02250664|102095388|FG002|Overall Study|Adverse Event|8|||
33602629|NCT02250664|102095386|FG000|Overall Study|Incarcerated|2|||
33602630|NCT02250664|102095387|FG001|Overall Study|Incarcerated|1|||
33312956|NCT00906945|101040715|FG003|Overall Study|Found to be not eligible|1|||
33312957|NCT00906945|101040716|FG004|Overall Study|Found to be not eligible|1|||
33312958|NCT00906945|101040717|FG005|Overall Study|Found to be not eligible|1|||
33312959|NCT00906945|101040712|FG000|Overall Study|Physician Decision|0|||
33503521|NCT01560234|101738343|FG007|Overall Study|Lost to Follow-up|2|||
33503522|NCT04134767|101738344|FG000|Overall Study|Death|0|||
33503523|NCT04134767|101738345|FG001|Overall Study|Death|1|||
33503524|NCT04134767|101738344|FG000|Overall Study|Removed for harassing staff|0|||
33503525|NCT04134767|101738345|FG001|Overall Study|Removed for harassing staff|1|||
33503526|NCT04134767|101738344|FG000|Overall Study|Lost to Follow-up|44|||
33503527|NCT04134767|101738345|FG001|Overall Study|Lost to Follow-up|40|||
33503528|NCT01896128|101738346|FG000|Overall Study|Withdrawal by Subject|3|||
33503529|NCT01896128|101738347|FG001|Overall Study|Withdrawal by Subject|3|||
33503530|NCT00728468|101738348|FG000|Overall Study|Enrolled but not treated|1|||
33503531|NCT00728468|101738348|FG000|Overall Study|Death|1|||
33503532|NCT00728468|101738348|FG000|Overall Study|Protocol Violation|4|||
33503533|NCT00728468|101738348|FG000|Overall Study|Objective progression or relapse|9|||
33503534|NCT00728468|101738348|FG000|Overall Study|Study terminated by sponsor|1|||
33503535|NCT01455597|101738349|FG000|Overall Study|Adverse Event|7|||
33503536|NCT01455597|101738350|FG001|Overall Study|Adverse Event|0|||
33503537|NCT01455597|101738351|FG002|Overall Study|Adverse Event|5|||
33503538|NCT01455597|101738352|FG003|Overall Study|Adverse Event|1|||
33503539|NCT01455597|101738349|FG000|Overall Study|Lack of Efficacy|0|||
33503540|NCT01455597|101738350|FG001|Overall Study|Lack of Efficacy|1|||
33503541|NCT01455597|101738351|FG002|Overall Study|Lack of Efficacy|2|||
33503542|NCT01455597|101738352|FG003|Overall Study|Lack of Efficacy|0|||
33503543|NCT01455597|101738349|FG000|Overall Study|Lost to Follow-up|3|||
33503544|NCT01455597|101738350|FG001|Overall Study|Lost to Follow-up|0|||
33503545|NCT01455597|101738351|FG002|Overall Study|Lost to Follow-up|2|||
33503546|NCT01455597|101738352|FG003|Overall Study|Lost to Follow-up|1|||
33503547|NCT01455597|101738349|FG000|Overall Study|Withdrew Consent|6|||
33602631|NCT02250664|102095388|FG002|Overall Study|Incarcerated|2|||
33602632|NCT02250664|102095386|FG000|Overall Study|Withdrawal by Subject|0|||
33602633|NCT02250664|102095387|FG001|Overall Study|Withdrawal by Subject|1|||
33602634|NCT02250664|102095388|FG002|Overall Study|Withdrawal by Subject|2|||
33602635|NCT02250664|102095386|FG000|Overall Study|Death|0|||
33602636|NCT02250664|102095387|FG001|Overall Study|Death|1|||
33602637|NCT02250664|102095388|FG002|Overall Study|Death|1|||
33602638|NCT02250664|102095386|FG000|Overall Study|Physician Decision|1|||
33602639|NCT02250664|102095387|FG001|Overall Study|Physician Decision|3|||
33602640|NCT02250664|102095388|FG002|Overall Study|Physician Decision|1|||
33602641|NCT02250664|102095386|FG000|Overall Study|Protocol Violation|1|||
33602642|NCT02250664|102095387|FG001|Overall Study|Protocol Violation|0|||
33602643|NCT02250664|102095388|FG002|Overall Study|Protocol Violation|1|||
33602644|NCT02250664|102095386|FG000|Overall Study|Reason unknown|1|||
33602645|NCT02250664|102095387|FG001|Overall Study|Reason unknown|0|||
33602646|NCT02250664|102095388|FG002|Overall Study|Reason unknown|0|||
33503548|NCT01455597|101738350|FG001|Overall Study|Withdrew Consent|5|||
33602647|NCT01703065|102095389|FG000|Overall Study|Lack of Efficacy|1|||
33602648|NCT01703065|102095390|FG001|Overall Study|Lack of Efficacy|0|||
33602649|NCT03773107|102095391|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
33602650|NCT03773107|102095392|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
33602651|NCT03773107|102095393|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
33602652|NCT03773107|102095394|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
33602653|NCT02226549|102095397|FG000|Overall Study|Randomized but Never Treated|1|||
33312960|NCT00906945|101040713|FG001|Overall Study|Physician Decision|0|||
33395498|NCT03687827|101334824|FG000|Treatment Period 2|Physician Decision|4|||
33395499|NCT03687827|101334825|FG001|Treatment Period 2|Physician Decision|1|||
33395500|NCT03687827|101334824|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33312961|NCT00906945|101040714|FG002|Overall Study|Physician Decision|0|||
33503549|NCT01455597|101738351|FG002|Overall Study|Withdrew Consent|8|||
33503550|NCT01455597|101738352|FG003|Overall Study|Withdrew Consent|5|||
33503551|NCT01455597|101738349|FG000|Overall Study|Reason not Specified|1|||
33503552|NCT01455597|101738350|FG001|Overall Study|Reason not Specified|2|||
33503553|NCT01455597|101738351|FG002|Overall Study|Reason not Specified|3|||
33602654|NCT02226549|102095398|FG001|Overall Study|Randomized but Never Treated|0|||
33602655|NCT02226549|102095397|FG000|Overall Study|Lost to Follow-up|0|||
33602656|NCT02226549|102095398|FG001|Overall Study|Lost to Follow-up|1|||
33193394|NCT00192075|100612705|FG000|Overall Study|Withdrawal by Subject|5|||
33193395|NCT00192075|100612706|FG001|Overall Study|Withdrawal by Subject|5|||
33193396|NCT00192075|100612705|FG000|Overall Study|Patient Non-Compliance|0|||
33193397|NCT00192075|100612706|FG001|Overall Study|Patient Non-Compliance|1|||
33193398|NCT00192075|100612705|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
33193399|NCT00192075|100612706|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
33193400|NCT00192075|100612705|FG000|Overall Study|Other|5|||
33193401|NCT00192075|100612706|FG001|Overall Study|Other|2|||
33193402|NCT01777997|100612707|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
33193403|NCT01777997|100612707|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
33193404|NCT01777997|100612707|FG000|Weeks 48 to 72/96 on ART|Death|1|||
33193405|NCT01777997|100612707|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
33193406|NCT04524403|100612708|FG000|Overall Study|Withdrawal by Subject|10|||
33193407|NCT04524403|100612709|FG001|Overall Study|Withdrawal by Subject|3|||
33193408|NCT04524403|100612710|FG002|Overall Study|Withdrawal by Subject|8|||
33312962|NCT00906945|101040715|FG003|Overall Study|Physician Decision|0|||
33312963|NCT00906945|101040716|FG004|Overall Study|Physician Decision|0|||
33312964|NCT00906945|101040717|FG005|Overall Study|Physician Decision|1|||
33312965|NCT00596427|101040720|FG000|Overall Study|Withdrawal by Subject|2|||
33312966|NCT00596427|101040721|FG001|Overall Study|Withdrawal by Subject|2|||
33312967|NCT00596427|101040720|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
33312968|NCT00596427|101040721|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
33312969|NCT00596427|101040720|FG000|Overall Study|Protocol Violation|1|||
33312970|NCT00596427|101040721|FG001|Overall Study|Protocol Violation|0|||
33312971|NCT01696942|101040722|FG000|Overall Study|Withdrawal by Subject|1|||
33312972|NCT01696942|101040723|FG001|Overall Study|Withdrawal by Subject|0|||
33312973|NCT01696942|101040722|FG000|Overall Study|Protocol Violation|1|||
33312974|NCT01696942|101040723|FG001|Overall Study|Protocol Violation|2|||
33312975|NCT01696942|101040722|FG000|Overall Study|screen failure|0|||
33312976|NCT01696942|101040723|FG001|Overall Study|screen failure|1|||
33312977|NCT00966277|101040729|FG000|Overall Study|Withdrawal by Subject|3|||
33312978|NCT00966277|101040730|FG001|Overall Study|Withdrawal by Subject|0|||
33312979|NCT00966277|101040729|FG000|Overall Study|Ineligible|1|||
33312980|NCT00966277|101040730|FG001|Overall Study|Ineligible|3|||
33312981|NCT00966277|101040729|FG000|Overall Study|Treatment Plan Changed|0|||
33312982|NCT00966277|101040730|FG001|Overall Study|Treatment Plan Changed|1|||
33312983|NCT03214094|101040736|FG000|Overall Study|Case Report Forms Uncollected|14|||
33312984|NCT03214094|101040736|FG000|Overall Study|Protocol Deviation|46|||
33312985|NCT01853982|101040741|FG000|Overall Study|Withdrawal by Subject|1|||
33312986|NCT01853982|101040742|FG001|Overall Study|Withdrawal by Subject|0|||
33312987|NCT01853982|101040741|FG000|Overall Study|Death|1|||
33312988|NCT01853982|101040742|FG001|Overall Study|Death|0|||
33312989|NCT01853982|101040741|FG000|Overall Study|Lost to Follow-up|0|||
33312990|NCT01853982|101040742|FG001|Overall Study|Lost to Follow-up|1|||
33312991|NCT00343252|101040743|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
33312992|NCT00343252|101040744|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
33312993|NCT00343252|101040743|FG000|6 Months (All Treated Participants)|Death|0|||
33312994|NCT00343252|101040744|FG001|6 Months (All Treated Participants)|Death|2|||
33312995|NCT00343252|101040743|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
33312996|NCT00343252|101040744|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
33312997|NCT00343252|101040743|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
33312998|NCT00343252|101040744|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
33312999|NCT00343252|101040743|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
33313000|NCT00343252|101040744|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
33313001|NCT00343252|101040743|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
33313002|NCT00343252|101040744|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
33313003|NCT00343252|101040743|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
33313004|NCT00343252|101040744|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
33313005|NCT00343252|101040743|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
33313006|NCT00343252|101040744|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
33313007|NCT00343252|101040743|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
33313008|NCT00343252|101040744|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
33313009|NCT00343252|101040743|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
33503554|NCT01455597|101738352|FG003|Overall Study|Reason not Specified|3|||
33503555|NCT01134107|101738353|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
33193409|NCT04524403|100612708|FG000|Overall Study|Lost to Follow-up|3|||
33193410|NCT04524403|100612709|FG001|Overall Study|Lost to Follow-up|4|||
33313010|NCT00343252|101040744|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
33313011|NCT00343252|101040743|FG000|12 Months (All Treated Participants)|Death|3|||
33313012|NCT00343252|101040744|FG001|12 Months (All Treated Participants)|Death|3|||
33395501|NCT03687827|101334825|FG001|Treatment Period 2|Withdrawal by Subject|2|||
33395502|NCT03858686|101334827|FG000|Period 1|Adverse Event|1|||
33193411|NCT04524403|100612710|FG002|Overall Study|Lost to Follow-up|3|||
33395503|NCT03858686|101334828|FG001|Period 1|Adverse Event|1|||
33395504|NCT03858686|101334827|FG000|Period 1|Lack of compliance|0|||
33395505|NCT03858686|101334828|FG001|Period 1|Lack of compliance|1|||
33395506|NCT03858686|101334827|FG000|Period 1|Adverse Event|0|||
33395507|NCT03858686|101334828|FG001|Period 1|Adverse Event|1|||
33395508|NCT03858686|101334827|FG000|Period 2|Adverse Event|0|||
33395509|NCT03858686|101334828|FG001|Period 2|Adverse Event|1|||
33395510|NCT00528840|101334830|FG000|Overall Study|Lost to Follow-up|10|||
33395511|NCT00528840|101334830|FG000|Overall Study|Adverse Event|1|||
33395512|NCT00528840|101334830|FG000|Overall Study|Withdrawal by Subject|17|||
33395513|NCT00528840|101334830|FG000|Overall Study|Death|2|||
33395514|NCT00528840|101334830|FG000|Overall Study|Administrative Reasons|1|||
33395515|NCT00528840|101334830|FG000|Overall Study|Other|2|||
33395516|NCT03935594|101334831|FG000|Overall Study|Physician Decision|3|||
33395517|NCT02723019|101334832|FG000|Overall Study|Death|17|||
33395518|NCT02723019|101334833|FG001|Overall Study|Death|13|||
33395519|NCT02723019|101334832|FG000|Overall Study|Withdrawal by Subject|11|||
33395520|NCT02723019|101334833|FG001|Overall Study|Withdrawal by Subject|7|||
33395521|NCT02723019|101334832|FG000|Overall Study|Lost to Follow-up|57|||
33395522|NCT02723019|101334833|FG001|Overall Study|Lost to Follow-up|70|||
33395523|NCT02485860|101334836|FG000|Overall Study|Lost to Follow-up|4|||
33395524|NCT02485860|101334837|FG001|Overall Study|Lost to Follow-up|1|||
33395525|NCT02485860|101334836|FG000|Overall Study|Physician Decision|1|||
33395526|NCT02485860|101334837|FG001|Overall Study|Physician Decision|2|||
33395527|NCT02485860|101334836|FG000|Overall Study|Health context (COVID-19)|1|||
33395528|NCT02485860|101334837|FG001|Overall Study|Health context (COVID-19)|0|||
33395529|NCT02092324|101334846|FG000|Overall Study|Adverse Event|1|||
33395530|NCT02092324|101334846|FG000|Overall Study|Lack of Efficacy|6|||
33602657|NCT00624780|102095399|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
33602658|NCT00624780|102095400|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
33602659|NCT00624780|102095401|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
33193412|NCT04524403|100612708|FG000|Overall Study|Adverse Event|3|||
33193413|NCT04524403|100612709|FG001|Overall Study|Adverse Event|1|||
33193414|NCT04524403|100612710|FG002|Overall Study|Adverse Event|4|||
33193415|NCT04524403|100612708|FG000|Overall Study|Non-compliant with study drug|1|||
33193416|NCT04524403|100612709|FG001|Overall Study|Non-compliant with study drug|2|||
33193417|NCT04524403|100612710|FG002|Overall Study|Non-compliant with study drug|3|||
33193418|NCT04524403|100612708|FG000|Overall Study|Moved|0|||
33193419|NCT04524403|100612709|FG001|Overall Study|Moved|1|||
33193420|NCT04524403|100612710|FG002|Overall Study|Moved|0|||
33193421|NCT03795922|100612711|FG000|Overall Study|Adverse Event|2|||
33193422|NCT03795922|100612712|FG001|Overall Study|Adverse Event|1|||
33193423|NCT03795922|100612711|FG000|Overall Study|Withdrawal by Subject|5|||
33193424|NCT03795922|100612712|FG001|Overall Study|Withdrawal by Subject|13|||
33193425|NCT03795922|100612711|FG000|Overall Study|Lost to Follow-up|2|||
33193426|NCT03795922|100612712|FG001|Overall Study|Lost to Follow-up|3|||
33193427|NCT03795922|100612711|FG000|Overall Study|Pregnancy|0|||
33193428|NCT03795922|100612712|FG001|Overall Study|Pregnancy|1|||
33193429|NCT03795922|100612711|FG000|Overall Study|Physician Decision|1|||
33193430|NCT03795922|100612712|FG001|Overall Study|Physician Decision|2|||
33193431|NCT03795922|100612711|FG000|Overall Study|Protocol Violation|0|||
33193432|NCT03795922|100612712|FG001|Overall Study|Protocol Violation|1|||
33193433|NCT03795922|100612711|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
33193434|NCT03795922|100612712|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
33193435|NCT02399085|100612713|FG000|Overall Study|Adverse Event|16|||
33193436|NCT02399085|100612713|FG000|Overall Study|Death|2|||
33193437|NCT02399085|100612713|FG000|Overall Study|Withdrawal by Subject|8|||
33193438|NCT02399085|100612713|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
33193439|NCT02399085|100612713|FG000|Overall Study|Physician Decision|5|||
33193440|NCT02488629|100612714|FG000|Overall Study|Lack of Efficacy|3|||
33193441|NCT02488629|100612715|FG001|Overall Study|Lack of Efficacy|1|||
33193442|NCT02488629|100612716|FG002|Overall Study|Lack of Efficacy|0|||
33193443|NCT02488629|100612717|FG003|Overall Study|Lack of Efficacy|0|||
33193444|NCT02488629|100612714|FG000|Overall Study|Withdrawal by Subject|0|||
33193445|NCT02488629|100612715|FG001|Overall Study|Withdrawal by Subject|1|||
33193446|NCT02488629|100612716|FG002|Overall Study|Withdrawal by Subject|0|||
33193447|NCT02488629|100612717|FG003|Overall Study|Withdrawal by Subject|0|||
33193448|NCT02460224|100612718|FG000|Overall Study|Adverse Event|0|||
33193449|NCT02460224|100612719|FG001|Overall Study|Adverse Event|0|||
33193450|NCT02460224|100612720|FG002|Overall Study|Adverse Event|0|||
33193451|NCT02460224|100612721|FG003|Overall Study|Adverse Event|0|||
33193452|NCT02460224|100612722|FG004|Overall Study|Adverse Event|0|||
33193453|NCT02460224|100612723|FG005|Overall Study|Adverse Event|0|||
33193454|NCT02460224|100612724|FG006|Overall Study|Adverse Event|1|||
33193455|NCT02460224|100612725|FG007|Overall Study|Adverse Event|0|||
33193456|NCT02460224|100612726|FG008|Overall Study|Adverse Event|0|||
33395531|NCT02092324|101334846|FG000|Overall Study|Proceed to Transplant|3|||
33395532|NCT02092324|101334846|FG000|Overall Study|Physician Decision|7|||
33395533|NCT02092324|101334846|FG000|Overall Study|Misdiagnosis|2|||
33313013|NCT00343252|101040743|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
33313014|NCT00343252|101040744|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
33313015|NCT00343252|101040743|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
33313016|NCT00343252|101040744|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
33313017|NCT00343252|101040743|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
33313018|NCT00343252|101040744|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
33313019|NCT00343252|101040743|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
33313020|NCT00343252|101040744|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
33313021|NCT00343252|101040743|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
33313022|NCT00343252|101040744|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
33313023|NCT00343252|101040743|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
33313024|NCT00343252|101040744|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
33313025|NCT00343252|101040743|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
33313026|NCT00343252|101040744|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
33313027|NCT00343252|101040743|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
33313028|NCT00343252|101040744|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
33313029|NCT00343252|101040743|FG000|18 Months (All Treated Participants)|Death|4|||
33313030|NCT00343252|101040744|FG001|18 Months (All Treated Participants)|Death|5|||
33313031|NCT00343252|101040743|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
33313032|NCT00343252|101040744|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
33313033|NCT00343252|101040743|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
33313034|NCT00343252|101040744|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
33313035|NCT00343252|101040743|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
33313036|NCT00343252|101040744|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
33313037|NCT00343252|101040743|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
33313038|NCT00343252|101040744|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
33313039|NCT00343252|101040743|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
33313040|NCT00343252|101040744|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
33313041|NCT00343252|101040743|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
33313042|NCT00343252|101040744|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
33313043|NCT00343252|101040743|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
33313044|NCT00343252|101040744|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
33313045|NCT00601419|101040747|FG000|Overall Study|Lost to Follow-up|3|||
33313046|NCT00601419|101040747|FG000|Overall Study|Missed Visits|1|||
33313047|NCT01580969|101040748|FG000|Overall Study|Physician Decision|3|||
33313048|NCT01580969|101040749|FG001|Overall Study|Physician Decision|0|||
33313049|NCT01580969|101040750|FG002|Overall Study|Physician Decision|0|||
33313050|NCT01635920|101040751|FG000|Overall Study|Adverse Event|1|||
33313051|NCT01635920|101040752|FG001|Overall Study|Adverse Event|0|||
33313052|NCT01635920|101040751|FG000|Overall Study|Lost to Follow-up|0|||
33313053|NCT01635920|101040752|FG001|Overall Study|Lost to Follow-up|1|||
33313054|NCT01635920|101040751|FG000|Overall Study|Subject decision|2|||
33313055|NCT01635920|101040752|FG001|Overall Study|Subject decision|0|||
33313056|NCT01236339|101040756|FG000|Overall Study|Termination of study by sponsor|11|||
33313057|NCT01236339|101040757|FG001|Overall Study|Termination of study by sponsor|13|||
33313058|NCT00336895|101040758|FG000|Overall Study|diarrhea|1|||
33313059|NCT00336895|101040758|FG000|Overall Study|nausea and upset stomach|1|||
33313060|NCT00336895|101040758|FG000|Overall Study|Physician Decision|1|||
33313061|NCT00336895|101040758|FG000|Overall Study|screen failed|1|||
33313062|NCT00753272|101040760|FG000|Overall Study|Adverse Event|878|||
33313063|NCT00753272|101040761|FG001|Overall Study|Adverse Event|869|||
33313064|NCT00753272|101040760|FG000|Overall Study|Protocol Violation|28|||
33313065|NCT00753272|101040761|FG001|Overall Study|Protocol Violation|46|||
33313066|NCT00753272|101040760|FG000|Overall Study|Withdrawal by Subject|2481|||
33313067|NCT00753272|101040761|FG001|Overall Study|Withdrawal by Subject|2407|||
33313068|NCT00753272|101040760|FG000|Overall Study|Lost to Follow-up|491|||
33313069|NCT00753272|101040761|FG001|Overall Study|Lost to Follow-up|497|||
33313070|NCT00753272|101040760|FG000|Overall Study|Other|1104|||
33313071|NCT00753272|101040761|FG001|Overall Study|Other|1088|||
33313072|NCT01411215|101040762|FG000|Overall Study|Adverse Event|1|||
33313073|NCT01411215|101040763|FG001|Overall Study|Adverse Event|2|||
33313074|NCT01411215|101040762|FG000|Overall Study|Lack of Efficacy|2|||
33313075|NCT01411215|101040763|FG001|Overall Study|Lack of Efficacy|4|||
33313076|NCT01411215|101040762|FG000|Overall Study|Lost to Follow-up|12|||
33395534|NCT00777257|101334847|FG000|Overall Study|Adverse Event|3|||
33503556|NCT01134107|101738354|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
33313077|NCT01411215|101040763|FG001|Overall Study|Lost to Follow-up|18|||
33313078|NCT01411215|101040762|FG000|Overall Study|Did not meet entrance criteria|0|||
33313079|NCT01411215|101040763|FG001|Overall Study|Did not meet entrance criteria|1|||
33503557|NCT01134107|101738353|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
33313080|NCT01411215|101040762|FG000|Overall Study|Study terminated by sponsor|2|||
33313081|NCT01411215|101040763|FG001|Overall Study|Study terminated by sponsor|15|||
33313082|NCT01411215|101040762|FG000|Overall Study|Protocol Violation|3|||
33395535|NCT00777257|101334848|FG001|Overall Study|Adverse Event|1|||
33395536|NCT00777257|101334849|FG002|Overall Study|Adverse Event|0|||
33395537|NCT00777257|101334847|FG000|Overall Study|Lost to Follow-up|3|||
33395538|NCT00777257|101334848|FG001|Overall Study|Lost to Follow-up|3|||
33395539|NCT00777257|101334849|FG002|Overall Study|Lost to Follow-up|2|||
33395540|NCT00777257|101334847|FG000|Overall Study|Protocol Violation|2|||
33395541|NCT00777257|101334848|FG001|Overall Study|Protocol Violation|2|||
33395542|NCT00777257|101334849|FG002|Overall Study|Protocol Violation|2|||
33395543|NCT00777257|101334847|FG000|Overall Study|Withdrawal by Subject|3|||
33395544|NCT00777257|101334848|FG001|Overall Study|Withdrawal by Subject|6|||
33395545|NCT00777257|101334849|FG002|Overall Study|Withdrawal by Subject|5|||
33313083|NCT01411215|101040763|FG001|Overall Study|Protocol Violation|5|||
33313084|NCT01411215|101040762|FG000|Overall Study|Withdrawal by Subject|34|||
33313085|NCT01411215|101040763|FG001|Overall Study|Withdrawal by Subject|21|||
33313086|NCT01411215|101040762|FG000|Overall Study|Other|12|||
33313087|NCT01411215|101040763|FG001|Overall Study|Other|17|||
33313088|NCT01411215|101040762|FG000|Overall Study|Screen failure|0|||
33313089|NCT01411215|101040763|FG001|Overall Study|Screen failure|1|||
33313090|NCT00971243|101040764|FG000|Double Blind Period|Adverse Event|2|||
33313091|NCT00971243|101040765|FG001|Double Blind Period|Adverse Event|3|||
33313092|NCT00971243|101040766|FG002|Double Blind Period|Adverse Event|2|||
33313093|NCT00971243|101040767|FG003|Double Blind Period|Adverse Event|2|||
33313094|NCT00971243|101040768|FG004|Double Blind Period|Adverse Event|3|||
33313095|NCT00971243|101040764|FG000|Double Blind Period|Lost to Follow-up|0|||
33313096|NCT00971243|101040765|FG001|Double Blind Period|Lost to Follow-up|1|||
33313097|NCT00971243|101040766|FG002|Double Blind Period|Lost to Follow-up|1|||
33395546|NCT01818765|101334850|FG000|Overall Study|Death|2|||
33395547|NCT01100658|101334861|FG000|Overall Study|Withdrawal by Subject|1|||
33395548|NCT01602744|101334868|FG000|Overall Study|Death|17|||
33395549|NCT01602744|101334869|FG001|Overall Study|Death|15|||
33395550|NCT01602744|101334868|FG000|Overall Study|Lost to Follow-up|13|||
33395551|NCT01602744|101334869|FG001|Overall Study|Lost to Follow-up|8|||
33395552|NCT02436915|101334870|FG000|Overall Study|Withdrawal by Subject|0|||
33395553|NCT02436915|101334871|FG001|Overall Study|Withdrawal by Subject|1|||
33395554|NCT00939055|101334877|FG000|Overall Study|Discontinuation prior to procedure|4|||
33395555|NCT00939055|101334878|FG001|Overall Study|Discontinuation prior to procedure|0|||
33395556|NCT01601873|101334879|FG000|Overall Study|Lost to Follow-up|2|||
33395557|NCT01601873|101334880|FG001|Overall Study|Lost to Follow-up|3|||
33395558|NCT02886338|101334884|FG000|Overall Study|Withdrawal by Subject|1|||
33395559|NCT00444951|101334885|FG000|Overall Study|Lost to Follow-up|1|||
33395560|NCT00444951|101334886|FG001|Overall Study|Lost to Follow-up|1|||
33395561|NCT00444951|101334887|FG002|Overall Study|Lost to Follow-up|0|||
33395562|NCT00444951|101334885|FG000|Overall Study|Withdrawal by Subject|4|||
33395563|NCT00444951|101334886|FG001|Overall Study|Withdrawal by Subject|5|||
33395564|NCT00444951|101334887|FG002|Overall Study|Withdrawal by Subject|3|||
33395565|NCT04009824|101334888|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
33395566|NCT04009824|101334889|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
33395567|NCT04009824|101334890|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
33395568|NCT04009824|101334891|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
33395569|NCT04009824|101334892|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
33395570|NCT01846208|101334893|FG000|Overall Study|Withdrew prior to treatment|1|||
33395571|NCT01846208|101334894|FG001|Overall Study|Withdrew prior to treatment|1|||
33395572|NCT01846208|101334895|FG002|Overall Study|Withdrew prior to treatment|1|||
33395573|NCT01846208|101334893|FG000|Overall Study|Dosing Symptoms|1|||
33395574|NCT01846208|101334894|FG001|Overall Study|Dosing Symptoms|2|||
33395575|NCT01846208|101334895|FG002|Overall Study|Dosing Symptoms|6|||
33395576|NCT01846208|101334893|FG000|Overall Study|Withdrawal by Subject|5|||
33395577|NCT01846208|101334894|FG001|Overall Study|Withdrawal by Subject|0|||
33395578|NCT01846208|101334895|FG002|Overall Study|Withdrawal by Subject|0|||
33395579|NCT01846208|101334893|FG000|Overall Study|Non-compliance|1|||
33313098|NCT00971243|101040767|FG003|Double Blind Period|Lost to Follow-up|0|||
33313099|NCT00971243|101040768|FG004|Double Blind Period|Lost to Follow-up|1|||
33313100|NCT00971243|101040764|FG000|Double Blind Period|Physician Decision|10|||
33313101|NCT00971243|101040765|FG001|Double Blind Period|Physician Decision|6|||
33313102|NCT00971243|101040766|FG002|Double Blind Period|Physician Decision|7|||
33313103|NCT00971243|101040767|FG003|Double Blind Period|Physician Decision|6|||
33313104|NCT00971243|101040768|FG004|Double Blind Period|Physician Decision|7|||
33313105|NCT00971243|101040764|FG000|Double Blind Period|Protocol Violation|2|||
33395580|NCT01846208|101334894|FG001|Overall Study|Non-compliance|1|||
33395581|NCT01846208|101334895|FG002|Overall Study|Non-compliance|0|||
33395582|NCT01846208|101334893|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
33395583|NCT01846208|101334894|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
33395584|NCT01846208|101334895|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
33313106|NCT00971243|101040765|FG001|Double Blind Period|Protocol Violation|0|||
33395585|NCT01846208|101334893|FG000|Overall Study|Refused SU OFC|0|||
33395586|NCT01846208|101334894|FG001|Overall Study|Refused SU OFC|0|||
33395587|NCT01846208|101334895|FG002|Overall Study|Refused SU OFC|1|||
33395588|NCT01878175|101334896|FG000|Overall Study|Developed contraindicated health problem|2|||
33395589|NCT02736474|101334901|FG000|Overall Study|Lost to Follow-up|0|||
33395590|NCT02736474|101334902|FG001|Overall Study|Lost to Follow-up|1|||
33395591|NCT00939094|101334903|FG000|Overall Study|Adverse Event|9|||
33395592|NCT00939094|101334904|FG001|Overall Study|Adverse Event|0|||
33395593|NCT00939094|101334903|FG000|Overall Study|Withdrawal by Subject|1|||
33395594|NCT00939094|101334904|FG001|Overall Study|Withdrawal by Subject|6|||
33395595|NCT00939094|101334903|FG000|Overall Study|Lost to Follow-up|1|||
33395596|NCT00939094|101334904|FG001|Overall Study|Lost to Follow-up|1|||
33395597|NCT00939094|101334903|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33395598|NCT00939094|101334904|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33395599|NCT00939094|101334903|FG000|Overall Study|Severe non-compliance to protocol|0|||
33395600|NCT00939094|101334904|FG001|Overall Study|Severe non-compliance to protocol|1|||
33395601|NCT00939094|101334903|FG000|Overall Study|Study stopped by sponsor|0|||
33395602|NCT00939094|101334904|FG001|Overall Study|Study stopped by sponsor|2|||
33395603|NCT00939094|101334903|FG000|Overall Study|Abnormal ECG findings|1|||
33395604|NCT00939094|101334904|FG001|Overall Study|Abnormal ECG findings|0|||
33395605|NCT00376675|101334907|FG000|Overall Study|Withdrawal by Subject|9|||
33395606|NCT00376675|101334908|FG001|Overall Study|Withdrawal by Subject|2|||
33395607|NCT00376675|101334907|FG000|Overall Study|Adverse Event|10|||
33395608|NCT00376675|101334908|FG001|Overall Study|Adverse Event|5|||
33395609|NCT00376675|101334907|FG000|Overall Study|Other Reason|1|||
33395610|NCT00376675|101334908|FG001|Overall Study|Other Reason|7|||
33395611|NCT01222416|101334911|FG000|Overall Study|ineligible;metastasis|3|||
33395612|NCT01222416|101334912|FG001|Overall Study|ineligible;metastasis|0|||
33395613|NCT01222416|101334911|FG000|Overall Study|Adverse Event|4|||
33395614|NCT01222416|101334912|FG001|Overall Study|Adverse Event|0|||
33395615|NCT01222416|101334911|FG000|Overall Study|Withdrawal by Subject|5|||
33395616|NCT01222416|101334912|FG001|Overall Study|Withdrawal by Subject|0|||
33395617|NCT01222416|101334911|FG000|Overall Study|scheduling|6|||
33395618|NCT01222416|101334912|FG001|Overall Study|scheduling|0|||
33395619|NCT01222416|101334911|FG000|Overall Study|missed view/scan|1|||
33395620|NCT01222416|101334912|FG001|Overall Study|missed view/scan|0|||
33313107|NCT00971243|101040766|FG002|Double Blind Period|Protocol Violation|3|||
33313108|NCT00971243|101040767|FG003|Double Blind Period|Protocol Violation|2|||
33313109|NCT00971243|101040768|FG004|Double Blind Period|Protocol Violation|2|||
33313110|NCT00971243|101040764|FG000|Double Blind Period|Withdrawal by Subject|4|||
33313111|NCT00971243|101040765|FG001|Double Blind Period|Withdrawal by Subject|1|||
33313112|NCT00971243|101040766|FG002|Double Blind Period|Withdrawal by Subject|4|||
33313113|NCT00971243|101040767|FG003|Double Blind Period|Withdrawal by Subject|4|||
33313114|NCT00971243|101040768|FG004|Double Blind Period|Withdrawal by Subject|4|||
33313115|NCT00971243|101040764|FG000|Double Blind Period|Other reasons|1|||
33313116|NCT00971243|101040765|FG001|Double Blind Period|Other reasons|0|||
33313117|NCT00971243|101040766|FG002|Double Blind Period|Other reasons|2|||
33313118|NCT00971243|101040767|FG003|Double Blind Period|Other reasons|0|||
33313119|NCT00971243|101040768|FG004|Double Blind Period|Other reasons|1|||
33313120|NCT00971243|101040764|FG000|Open-label Period|Adverse Event|1|||
33313121|NCT00971243|101040765|FG001|Open-label Period|Adverse Event|0|||
33313122|NCT00971243|101040766|FG002|Open-label Period|Adverse Event|1|||
33313123|NCT00971243|101040767|FG003|Open-label Period|Adverse Event|1|||
33313124|NCT00971243|101040768|FG004|Open-label Period|Adverse Event|0|||
33313125|NCT00971243|101040764|FG000|Open-label Period|Physician Decision|5|||
33313126|NCT00971243|101040765|FG001|Open-label Period|Physician Decision|9|||
33313127|NCT00971243|101040766|FG002|Open-label Period|Physician Decision|3|||
33313128|NCT00971243|101040767|FG003|Open-label Period|Physician Decision|7|||
33313129|NCT00971243|101040768|FG004|Open-label Period|Physician Decision|2|||
33313130|NCT00971243|101040764|FG000|Open-label Period|Protocol Violation|1|||
33313131|NCT00971243|101040765|FG001|Open-label Period|Protocol Violation|1|||
33313132|NCT00971243|101040766|FG002|Open-label Period|Protocol Violation|1|||
33313133|NCT00971243|101040767|FG003|Open-label Period|Protocol Violation|0|||
33313134|NCT00971243|101040768|FG004|Open-label Period|Protocol Violation|1|||
33313135|NCT00971243|101040764|FG000|Open-label Period|Withdrawal by Subject|1|||
33313136|NCT00971243|101040765|FG001|Open-label Period|Withdrawal by Subject|0|||
33313137|NCT00971243|101040766|FG002|Open-label Period|Withdrawal by Subject|0|||
33313138|NCT00971243|101040767|FG003|Open-label Period|Withdrawal by Subject|2|||
33313139|NCT00971243|101040768|FG004|Open-label Period|Withdrawal by Subject|1|||
33313140|NCT00971243|101040764|FG000|Open-label Period|Other reason|0|||
33313141|NCT00971243|101040765|FG001|Open-label Period|Other reason|0|||
33313142|NCT00971243|101040766|FG002|Open-label Period|Other reason|0|||
33313143|NCT00971243|101040767|FG003|Open-label Period|Other reason|0|||
33313144|NCT00971243|101040768|FG004|Open-label Period|Other reason|2|||
33395621|NCT01222416|101334911|FG000|Overall Study|Death|1|||
33395622|NCT01222416|101334912|FG001|Overall Study|Death|0|||
33395623|NCT00606229|101334918|FG000|Overall Study|Adverse Event|11|||
33395624|NCT00606229|101334918|FG000|Overall Study|Lack of Efficacy|1|||
33395625|NCT00606229|101334918|FG000|Overall Study|Withdrawal by Subject|4|||
33395626|NCT00606229|101334918|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
33503558|NCT01134107|101738354|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
33503559|NCT01134107|101738353|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
33503560|NCT01134107|101738354|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
33503561|NCT01134107|101738353|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
33503562|NCT01134107|101738354|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
33503563|NCT01134107|101738353|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
33503564|NCT01134107|101738354|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
33503565|NCT01134107|101738353|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
33503566|NCT01134107|101738354|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
33503567|NCT01134107|101738353|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
33503568|NCT01134107|101738354|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
33503569|NCT00550745|101738355|FG000|Overall Study|Death|20|||
33503570|NCT00550745|101738356|FG001|Overall Study|Death|16|||
33503571|NCT00550745|101738355|FG000|Overall Study|Lost to Follow-up|45|||
33503572|NCT00550745|101738356|FG001|Overall Study|Lost to Follow-up|30|||
33503573|NCT00550745|101738355|FG000|Overall Study|Physician Decision|0|||
33503574|NCT00550745|101738356|FG001|Overall Study|Physician Decision|2|||
33503575|NCT00550745|101738355|FG000|Overall Study|Protocol Violation|4|||
33503576|NCT00550745|101738356|FG001|Overall Study|Protocol Violation|2|||
33503577|NCT00550745|101738355|FG000|Overall Study|Withdrawal by Subject|17|||
33503578|NCT00550745|101738356|FG001|Overall Study|Withdrawal by Subject|10|||
33503579|NCT00550745|101738355|FG000|Overall Study|Screen failure|1|||
33503580|NCT00550745|101738356|FG001|Overall Study|Screen failure|0|||
33503581|NCT01222520|101738357|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
33503582|NCT01222520|101738358|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
33503583|NCT01222520|101738357|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
33503584|NCT01222520|101738358|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
33503585|NCT01222520|101738357|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
33503586|NCT01222520|101738358|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
33503587|NCT01222520|101738357|FG000|Double-blind Period|Adverse Event|0|||
33503588|NCT01222520|101738358|FG001|Double-blind Period|Adverse Event|1|||
33503589|NCT01222520|101738357|FG000|Double-blind Period|Lack of Efficacy|0|||
33193457|NCT02460224|100612727|FG009|Overall Study|Adverse Event|0|||
33503590|NCT01222520|101738358|FG001|Double-blind Period|Lack of Efficacy|1|||
33503591|NCT01222520|101738357|FG000|Double-blind Period|Study medication stolen|1|||
33503592|NCT01222520|101738358|FG001|Double-blind Period|Study medication stolen|0|||
33193458|NCT02460224|100612728|FG010|Overall Study|Adverse Event|0|||
33193459|NCT02460224|100612729|FG011|Overall Study|Adverse Event|0|||
33193460|NCT02460224|100612730|FG012|Overall Study|Adverse Event|1|||
33193461|NCT02460224|100612731|FG013|Overall Study|Adverse Event|0|||
33193462|NCT02460224|100612732|FG014|Overall Study|Adverse Event|0|||
33193463|NCT02460224|100612733|FG015|Overall Study|Adverse Event|0|||
33193464|NCT02460224|100612734|FG016|Overall Study|Adverse Event|1|||
33193465|NCT02460224|100612735|FG017|Overall Study|Adverse Event|0|||
33193466|NCT02460224|100612736|FG018|Overall Study|Adverse Event|1|||
33193467|NCT02460224|100612737|FG019|Overall Study|Adverse Event|0|||
33193468|NCT02460224|100612738|FG020|Overall Study|Adverse Event|1|||
33193469|NCT02460224|100612739|FG021|Overall Study|Adverse Event|1|||
33193470|NCT02460224|100612740|FG022|Overall Study|Adverse Event|1|||
33193471|NCT02460224|100612741|FG023|Overall Study|Adverse Event|0|||
33193472|NCT02460224|100612742|FG024|Overall Study|Adverse Event|0|||
33193473|NCT02460224|100612743|FG025|Overall Study|Adverse Event|0|||
33193474|NCT02460224|100612744|FG026|Overall Study|Adverse Event|11|||
33193475|NCT02460224|100612745|FG027|Overall Study|Adverse Event|1|||
33193476|NCT02460224|100612746|FG028|Overall Study|Adverse Event|6|||
33193477|NCT02460224|100612718|FG000|Overall Study|Death|0|||
33193478|NCT02460224|100612719|FG001|Overall Study|Death|0|||
33193479|NCT02460224|100612720|FG002|Overall Study|Death|0|||
33193480|NCT02460224|100612721|FG003|Overall Study|Death|0|||
33193481|NCT02460224|100612722|FG004|Overall Study|Death|0|||
33193482|NCT02460224|100612723|FG005|Overall Study|Death|2|||
33193483|NCT02460224|100612724|FG006|Overall Study|Death|1|||
33193484|NCT02460224|100612725|FG007|Overall Study|Death|0|||
33193485|NCT02460224|100612726|FG008|Overall Study|Death|0|||
33193486|NCT02460224|100612727|FG009|Overall Study|Death|1|||
33193487|NCT02460224|100612728|FG010|Overall Study|Death|0|||
33193488|NCT02460224|100612729|FG011|Overall Study|Death|0|||
33193489|NCT02460224|100612730|FG012|Overall Study|Death|0|||
33193490|NCT02460224|100612731|FG013|Overall Study|Death|1|||
33193491|NCT02460224|100612732|FG014|Overall Study|Death|0|||
33193492|NCT02460224|100612733|FG015|Overall Study|Death|0|||
33193493|NCT02460224|100612734|FG016|Overall Study|Death|2|||
33193494|NCT02460224|100612735|FG017|Overall Study|Death|1|||
33193495|NCT02460224|100612736|FG018|Overall Study|Death|0|||
33193496|NCT02460224|100612737|FG019|Overall Study|Death|2|||
33193497|NCT02460224|100612738|FG020|Overall Study|Death|0|||
33193498|NCT02460224|100612739|FG021|Overall Study|Death|0|||
33193499|NCT02460224|100612740|FG022|Overall Study|Death|0|||
33193500|NCT02460224|100612741|FG023|Overall Study|Death|0|||
33193501|NCT02460224|100612742|FG024|Overall Study|Death|1|||
33193502|NCT02460224|100612743|FG025|Overall Study|Death|1|||
33193503|NCT02460224|100612744|FG026|Overall Study|Death|5|||
33193504|NCT02460224|100612745|FG027|Overall Study|Death|0|||
33193505|NCT02460224|100612746|FG028|Overall Study|Death|1|||
33193506|NCT02460224|100612718|FG000|Overall Study|Lost to Follow-up|0|||
33193507|NCT02460224|100612719|FG001|Overall Study|Lost to Follow-up|0|||
33193508|NCT02460224|100612720|FG002|Overall Study|Lost to Follow-up|0|||
33193509|NCT02460224|100612721|FG003|Overall Study|Lost to Follow-up|0|||
33193510|NCT02460224|100612722|FG004|Overall Study|Lost to Follow-up|0|||
33193511|NCT02460224|100612723|FG005|Overall Study|Lost to Follow-up|0|||
33193512|NCT02460224|100612724|FG006|Overall Study|Lost to Follow-up|0|||
33193513|NCT02460224|100612725|FG007|Overall Study|Lost to Follow-up|0|||
33193514|NCT02460224|100612726|FG008|Overall Study|Lost to Follow-up|0|||
33193515|NCT02460224|100612727|FG009|Overall Study|Lost to Follow-up|0|||
33193516|NCT02460224|100612728|FG010|Overall Study|Lost to Follow-up|0|||
33193517|NCT02460224|100612729|FG011|Overall Study|Lost to Follow-up|0|||
33193518|NCT02460224|100612730|FG012|Overall Study|Lost to Follow-up|0|||
33193519|NCT02460224|100612731|FG013|Overall Study|Lost to Follow-up|0|||
33193520|NCT02460224|100612732|FG014|Overall Study|Lost to Follow-up|0|||
33193521|NCT02460224|100612733|FG015|Overall Study|Lost to Follow-up|0|||
33313145|NCT02752074|101040769|FG000|Overall Study|Lost to Follow-up|1|||
33503593|NCT02095691|101738364|FG000|Overall Study|Physician Decision|1|||
33503594|NCT00610155|101738367|FG000|Period 1|Withdrawal by Subject|0|||
33503595|NCT00610155|101738368|FG001|Period 1|Withdrawal by Subject|0|||
33193522|NCT02460224|100612734|FG016|Overall Study|Lost to Follow-up|0|||
33193523|NCT02460224|100612735|FG017|Overall Study|Lost to Follow-up|0|||
33193524|NCT02460224|100612736|FG018|Overall Study|Lost to Follow-up|0|||
33193525|NCT02460224|100612737|FG019|Overall Study|Lost to Follow-up|0|||
33193526|NCT02460224|100612738|FG020|Overall Study|Lost to Follow-up|0|||
33193527|NCT02460224|100612739|FG021|Overall Study|Lost to Follow-up|0|||
33193528|NCT02460224|100612740|FG022|Overall Study|Lost to Follow-up|1|||
33193529|NCT02460224|100612741|FG023|Overall Study|Lost to Follow-up|0|||
33193530|NCT02460224|100612742|FG024|Overall Study|Lost to Follow-up|0|||
33193531|NCT02460224|100612743|FG025|Overall Study|Lost to Follow-up|0|||
33193532|NCT02460224|100612744|FG026|Overall Study|Lost to Follow-up|0|||
33193533|NCT02460224|100612745|FG027|Overall Study|Lost to Follow-up|0|||
33193534|NCT02460224|100612746|FG028|Overall Study|Lost to Follow-up|0|||
33193535|NCT02460224|100612718|FG000|Overall Study|Physician Decision|0|||
33193536|NCT02460224|100612719|FG001|Overall Study|Physician Decision|1|||
33503596|NCT00610155|101738369|FG002|Period 1|Withdrawal by Subject|1|||
33193537|NCT02460224|100612720|FG002|Overall Study|Physician Decision|0|||
33193538|NCT02460224|100612721|FG003|Overall Study|Physician Decision|0|||
33193539|NCT02460224|100612722|FG004|Overall Study|Physician Decision|1|||
33193540|NCT02460224|100612723|FG005|Overall Study|Physician Decision|0|||
33193541|NCT02460224|100612724|FG006|Overall Study|Physician Decision|0|||
33193542|NCT02460224|100612725|FG007|Overall Study|Physician Decision|1|||
33193543|NCT02460224|100612726|FG008|Overall Study|Physician Decision|0|||
33193544|NCT02460224|100612727|FG009|Overall Study|Physician Decision|0|||
33313146|NCT02752074|101040770|FG001|Overall Study|Lost to Follow-up|4|||
33313147|NCT02752074|101040769|FG000|Overall Study|Death|146|||
33313148|NCT02752074|101040770|FG001|Overall Study|Death|129|||
33313149|NCT02752074|101040769|FG000|Overall Study|Withdrawal by Subject|9|||
33313150|NCT02752074|101040770|FG001|Overall Study|Withdrawal by Subject|10|||
33313151|NCT00971932|101040771|FG000|Overall Study|Withdrawal by Subject|1|||
33313152|NCT00971932|101040771|FG000|Overall Study|Investigator's decision|2|||
33313153|NCT00971932|101040771|FG000|Overall Study|Ongoing|4|||
33313154|NCT01589237|101040772|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
33313155|NCT01589237|101040773|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
33313156|NCT01589237|101040774|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
33313157|NCT01589237|101040775|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
33313158|NCT01589237|101040772|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
33313159|NCT01589237|101040773|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
33313160|NCT01589237|101040774|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
33313161|NCT01589237|101040775|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
33313162|NCT01589237|101040772|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
33313163|NCT01589237|101040773|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
33313164|NCT01589237|101040774|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
33313165|NCT01589237|101040775|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
33313166|NCT01589237|101040772|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
33193545|NCT02460224|100612728|FG010|Overall Study|Physician Decision|0|||
33193546|NCT02460224|100612729|FG011|Overall Study|Physician Decision|1|||
33193547|NCT02460224|100612730|FG012|Overall Study|Physician Decision|0|||
33193548|NCT02460224|100612731|FG013|Overall Study|Physician Decision|1|||
33193549|NCT02460224|100612732|FG014|Overall Study|Physician Decision|0|||
33193550|NCT02460224|100612733|FG015|Overall Study|Physician Decision|0|||
33193551|NCT02460224|100612734|FG016|Overall Study|Physician Decision|2|||
33193552|NCT02460224|100612735|FG017|Overall Study|Physician Decision|1|||
33193553|NCT02460224|100612736|FG018|Overall Study|Physician Decision|1|||
33193554|NCT02460224|100612737|FG019|Overall Study|Physician Decision|2|||
33193555|NCT02460224|100612738|FG020|Overall Study|Physician Decision|1|||
33313167|NCT01589237|101040773|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
33313168|NCT01589237|101040774|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
33313169|NCT01589237|101040775|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
33193556|NCT02460224|100612739|FG021|Overall Study|Physician Decision|1|||
33193557|NCT02460224|100612740|FG022|Overall Study|Physician Decision|0|||
33193558|NCT02460224|100612741|FG023|Overall Study|Physician Decision|0|||
33193559|NCT02460224|100612742|FG024|Overall Study|Physician Decision|1|||
33193560|NCT02460224|100612743|FG025|Overall Study|Physician Decision|0|||
33193561|NCT02460224|100612744|FG026|Overall Study|Physician Decision|14|||
33193562|NCT02460224|100612745|FG027|Overall Study|Physician Decision|1|||
33193563|NCT02460224|100612746|FG028|Overall Study|Physician Decision|6|||
33193564|NCT02460224|100612718|FG000|Overall Study|Progressive disease|15|||
33193565|NCT02460224|100612719|FG001|Overall Study|Progressive disease|11|||
33193566|NCT02460224|100612720|FG002|Overall Study|Progressive disease|5|||
33193567|NCT02460224|100612721|FG003|Overall Study|Progressive disease|6|||
33193568|NCT02460224|100612722|FG004|Overall Study|Progressive disease|3|||
33193569|NCT02460224|100612723|FG005|Overall Study|Progressive disease|26|||
33193570|NCT02460224|100612724|FG006|Overall Study|Progressive disease|28|||
33193571|NCT02460224|100612725|FG007|Overall Study|Progressive disease|4|||
33193572|NCT02460224|100612726|FG008|Overall Study|Progressive disease|5|||
33193573|NCT02460224|100612727|FG009|Overall Study|Progressive disease|9|||
33193574|NCT02460224|100612728|FG010|Overall Study|Progressive disease|5|||
33193575|NCT02460224|100612729|FG011|Overall Study|Progressive disease|4|||
33193576|NCT02460224|100612730|FG012|Overall Study|Progressive disease|5|||
33193577|NCT02460224|100612731|FG013|Overall Study|Progressive disease|4|||
33193578|NCT02460224|100612732|FG014|Overall Study|Progressive disease|5|||
33193579|NCT02460224|100612733|FG015|Overall Study|Progressive disease|5|||
33193580|NCT02460224|100612734|FG016|Overall Study|Progressive disease|15|||
33193581|NCT02460224|100612735|FG017|Overall Study|Progressive disease|3|||
33193582|NCT02460224|100612736|FG018|Overall Study|Progressive disease|8|||
33193583|NCT02460224|100612737|FG019|Overall Study|Progressive disease|3|||
33193584|NCT02460224|100612738|FG020|Overall Study|Progressive disease|4|||
33193585|NCT02460224|100612739|FG021|Overall Study|Progressive disease|9|||
33193586|NCT02460224|100612740|FG022|Overall Study|Progressive disease|4|||
33193587|NCT02460224|100612741|FG023|Overall Study|Progressive disease|11|||
33193588|NCT02460224|100612742|FG024|Overall Study|Progressive disease|4|||
33193589|NCT02460224|100612743|FG025|Overall Study|Progressive disease|5|||
33193590|NCT02460224|100612744|FG026|Overall Study|Progressive disease|85|||
33193591|NCT02460224|100612745|FG027|Overall Study|Progressive disease|17|||
33193592|NCT02460224|100612746|FG028|Overall Study|Progressive disease|77|||
33193593|NCT02460224|100612718|FG000|Overall Study|Subject/guardian decision|2|||
33193594|NCT02460224|100612719|FG001|Overall Study|Subject/guardian decision|0|||
33193595|NCT02460224|100612720|FG002|Overall Study|Subject/guardian decision|1|||
33193596|NCT02460224|100612721|FG003|Overall Study|Subject/guardian decision|0|||
33193597|NCT02460224|100612722|FG004|Overall Study|Subject/guardian decision|2|||
33193598|NCT02460224|100612723|FG005|Overall Study|Subject/guardian decision|2|||
33193599|NCT02460224|100612724|FG006|Overall Study|Subject/guardian decision|0|||
33193600|NCT02460224|100612725|FG007|Overall Study|Subject/guardian decision|0|||
33193601|NCT02460224|100612726|FG008|Overall Study|Subject/guardian decision|1|||
33193602|NCT02460224|100612727|FG009|Overall Study|Subject/guardian decision|1|||
33193603|NCT02460224|100612728|FG010|Overall Study|Subject/guardian decision|0|||
33193604|NCT02460224|100612729|FG011|Overall Study|Subject/guardian decision|1|||
33193605|NCT02460224|100612730|FG012|Overall Study|Subject/guardian decision|0|||
33193606|NCT02460224|100612731|FG013|Overall Study|Subject/guardian decision|0|||
33193607|NCT02460224|100612732|FG014|Overall Study|Subject/guardian decision|0|||
33193608|NCT02460224|100612733|FG015|Overall Study|Subject/guardian decision|1|||
33193609|NCT02460224|100612734|FG016|Overall Study|Subject/guardian decision|0|||
33193610|NCT02460224|100612735|FG017|Overall Study|Subject/guardian decision|1|||
33193611|NCT02460224|100612736|FG018|Overall Study|Subject/guardian decision|2|||
33193612|NCT02460224|100612737|FG019|Overall Study|Subject/guardian decision|0|||
33193613|NCT02460224|100612738|FG020|Overall Study|Subject/guardian decision|0|||
33193614|NCT02460224|100612739|FG021|Overall Study|Subject/guardian decision|1|||
33193615|NCT02460224|100612740|FG022|Overall Study|Subject/guardian decision|0|||
33193616|NCT02460224|100612741|FG023|Overall Study|Subject/guardian decision|0|||
33193617|NCT02460224|100612742|FG024|Overall Study|Subject/guardian decision|0|||
33193618|NCT02460224|100612743|FG025|Overall Study|Subject/guardian decision|0|||
33193619|NCT02460224|100612744|FG026|Overall Study|Subject/guardian decision|6|||
33193620|NCT02460224|100612745|FG027|Overall Study|Subject/guardian decision|2|||
33193621|NCT02460224|100612746|FG028|Overall Study|Subject/guardian decision|3|||
33193622|NCT02203591|100612751|FG000|Overall Study|Did not meet treatment day baseline|147|||
33193623|NCT02203591|100612752|FG001|Overall Study|Did not meet treatment day baseline|141|||
33193624|NCT02203591|100612753|FG002|Overall Study|Did not meet treatment day baseline|150|||
33193625|NCT02203591|100612754|FG003|Overall Study|Did not meet treatment day baseline|45|||
33193626|NCT02203591|100612755|FG004|Overall Study|Did not meet treatment day baseline|33|||
33503597|NCT00610155|101738370|FG003|Period 1|Withdrawal by Subject|0|||
33193627|NCT02203591|100612756|FG005|Overall Study|Did not meet treatment day baseline|35|||
33193628|NCT02203591|100612757|FG006|Overall Study|Did not meet treatment day baseline|29|||
33503598|NCT00610155|101738371|FG004|Period 1|Withdrawal by Subject|0|||
33193629|NCT02203591|100612758|FG007|Overall Study|Did not meet treatment day baseline|12|||
33193630|NCT02203591|100612751|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
33193631|NCT02203591|100612752|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
33503599|NCT00610155|101738372|FG005|Period 1|Withdrawal by Subject|0|||
33602660|NCT00624780|102095402|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
33193632|NCT02203591|100612753|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
33193633|NCT02203591|100612754|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
33193634|NCT02203591|100612755|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
33193635|NCT02203591|100612756|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
33193636|NCT02203591|100612757|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
33193637|NCT02203591|100612758|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
33193638|NCT00574405|100612760|FG000|Overall Study|Withdrawal by Subject|3|||
33193639|NCT00574405|100612761|FG001|Overall Study|Withdrawal by Subject|2|||
33193640|NCT00937547|100612762|FG000|Overall Study|misdiagnosis|1|||
33193641|NCT00937547|100612763|FG001|Overall Study|misdiagnosis|6|||
33193642|NCT00937547|100612764|FG002|Overall Study|misdiagnosis|7|||
33193643|NCT03100825|100612766|FG000|Overall Study|Participant/Guardian Decision|7|||
33193644|NCT03100825|100612766|FG000|Overall Study|Physician Decision|1|||
33193645|NCT02751983|100612772|FG000|Treatment|Stopped ACT, but Remained in study|2|||
33193646|NCT02751983|100612773|FG001|Treatment|Stopped ACT, but Remained in study|0|||
33193647|NCT02751983|100612772|FG000|Treatment|Discharged prior to beginning ACT|2|||
33193648|NCT02751983|100612773|FG001|Treatment|Discharged prior to beginning ACT|0|||
33193649|NCT02751983|100612772|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
33193650|NCT02751983|100612773|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
33193651|NCT02751983|100612772|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
33193652|NCT02751983|100612773|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
33193653|NCT02751983|100612772|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
33193654|NCT02751983|100612773|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
33193655|NCT01585766|100612774|FG000|Overall Study|Withdrawal by Subject|0|||
33193656|NCT01585766|100612775|FG001|Overall Study|Withdrawal by Subject|1|||
33193657|NCT01585766|100612776|FG002|Overall Study|Withdrawal by Subject|1|||
33193658|NCT01585766|100612777|FG003|Overall Study|Withdrawal by Subject|0|||
33193659|NCT01585766|100612778|FG004|Overall Study|Withdrawal by Subject|0|||
33193660|NCT01585766|100612779|FG005|Overall Study|Withdrawal by Subject|0|||
33193661|NCT01585766|100612774|FG000|Overall Study|Death|0|||
33193662|NCT01585766|100612775|FG001|Overall Study|Death|1|||
33193663|NCT01585766|100612776|FG002|Overall Study|Death|0|||
33193664|NCT01585766|100612777|FG003|Overall Study|Death|0|||
33193665|NCT01585766|100612778|FG004|Overall Study|Death|0|||
33193666|NCT01585766|100612779|FG005|Overall Study|Death|0|||
33193667|NCT01585766|100612774|FG000|Overall Study|Physician Decision|0|||
33193668|NCT01585766|100612775|FG001|Overall Study|Physician Decision|0|||
33193669|NCT01585766|100612776|FG002|Overall Study|Physician Decision|1|||
33193670|NCT01585766|100612777|FG003|Overall Study|Physician Decision|0|||
33193671|NCT01585766|100612778|FG004|Overall Study|Physician Decision|0|||
33193672|NCT01585766|100612779|FG005|Overall Study|Physician Decision|0|||
33193673|NCT00679341|100612782|FG000|Overall Study|Disease progression|42|||
33193674|NCT00679341|100612783|FG001|Overall Study|Disease progression|36|||
33193675|NCT00679341|100612782|FG000|Overall Study|Adverse Event|5|||
33193676|NCT00679341|100612783|FG001|Overall Study|Adverse Event|6|||
33193677|NCT00679341|100612782|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
33193678|NCT00679341|100612783|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
33193679|NCT00679341|100612782|FG000|Overall Study|Death|1|||
33193680|NCT00679341|100612783|FG001|Overall Study|Death|1|||
33193681|NCT00679341|100612782|FG000|Overall Study|Other|1|||
33193682|NCT00679341|100612783|FG001|Overall Study|Other|0|||
33193683|NCT00679341|100612782|FG000|Overall Study|Physician Decision|1|||
33193684|NCT00679341|100612783|FG001|Overall Study|Physician Decision|0|||
33193685|NCT00679341|100612782|FG000|Overall Study|Not treated|0|||
33193686|NCT00679341|100612783|FG001|Overall Study|Not treated|2|||
33193687|NCT00679341|100612782|FG000|Overall Study|Physician/patient decision to withdraw|0|||
33193688|NCT00679341|100612783|FG001|Overall Study|Physician/patient decision to withdraw|6|||
33193689|NCT00767676|100612789|FG000|Overall Study|Investigator error|54|||
33193690|NCT02127307|100612791|FG000|Overall Study|Protocol Violation|36|||
33193691|NCT02127307|100612791|FG000|Overall Study|Lost to Follow-up|2|||
33193692|NCT02127307|100612791|FG000|Overall Study|Death|101|||
33193693|NCT02127307|100612791|FG000|Overall Study|Other than specified above|169|||
33193694|NCT00799617|100612796|FG000|Main Testosterone Trial|Randomized in error|1|||
33193695|NCT00799617|100612797|FG001|Main Testosterone Trial|Randomized in error|1|||
33395627|NCT00606229|101334918|FG000|Overall Study|change of residence or other commitments|2|||
33395628|NCT00398086|101334919|FG000|Overall Study|Unacceptable Toxicity|2|||
33193696|NCT00799617|100612796|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
33193697|NCT00799617|100612797|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
33193698|NCT00799617|100612796|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
33193699|NCT00799617|100612797|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
33193700|NCT00799617|100612796|FG000|Sexual Funtion Trial|No Baseline Data|4|||
33193701|NCT00799617|100612797|FG001|Sexual Funtion Trial|No Baseline Data|7|||
33193702|NCT00799617|100612796|FG000|Physical Function Trial|Lost to Follow-up|6|||
33193703|NCT00799617|100612797|FG001|Physical Function Trial|Lost to Follow-up|11|||
33193704|NCT00799617|100612796|FG000|Vitality Trial|Lost to Follow-up|7|||
33193705|NCT00799617|100612797|FG001|Vitality Trial|Lost to Follow-up|22|||
33193706|NCT00799617|100612796|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
33193707|NCT00799617|100612797|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
33193708|NCT00799617|100612796|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
33193709|NCT00799617|100612797|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
33193710|NCT00799617|100612796|FG000|Bone Trial|Month 12 scan not available|6|||
33193711|NCT00799617|100612797|FG001|Bone Trial|Month 12 scan not available|16|||
33193712|NCT00799617|100612796|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
33193713|NCT00799617|100612797|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
33193714|NCT00799617|100612796|FG000|Anemia Trial|Withdrawal by Subject|3|||
33193715|NCT00799617|100612797|FG001|Anemia Trial|Withdrawal by Subject|3|||
33395629|NCT00398086|101334920|FG001|Overall Study|Unacceptable Toxicity|8|||
33395630|NCT00398086|101334921|FG002|Overall Study|Unacceptable Toxicity|2|||
33602661|NCT00624780|102095403|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
33602662|NCT00624780|102095404|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
33193716|NCT00098839|100612798|FG000|Overall Study|Adverse Event|5|||
33313170|NCT00770341|101040776|FG000|Overall Study|Did not meet eligibility criteria|1|||
33313171|NCT00770341|101040777|FG001|Overall Study|Did not meet eligibility criteria|0|||
33313172|NCT00770341|101040778|FG002|Overall Study|Did not meet eligibility criteria|0|||
33313173|NCT00770341|101040776|FG000|Overall Study|Withdrawal by Subject|0|||
33313174|NCT00770341|101040777|FG001|Overall Study|Withdrawal by Subject|1|||
33313175|NCT00770341|101040778|FG002|Overall Study|Withdrawal by Subject|0|||
33313176|NCT00770341|101040776|FG000|Overall Study|Clinical Adverse Event|3|||
33313177|NCT00770341|101040777|FG001|Overall Study|Clinical Adverse Event|1|||
33313178|NCT00770341|101040778|FG002|Overall Study|Clinical Adverse Event|2|||
33313179|NCT00770341|101040776|FG000|Overall Study|Laboratory adverse event|3|||
33313180|NCT00770341|101040777|FG001|Overall Study|Laboratory adverse event|3|||
33313181|NCT00770341|101040778|FG002|Overall Study|Laboratory adverse event|0|||
33313182|NCT00770341|101040776|FG000|Overall Study|Lack of Efficacy|3|||
33313183|NCT00770341|101040777|FG001|Overall Study|Lack of Efficacy|0|||
33313184|NCT00770341|101040778|FG002|Overall Study|Lack of Efficacy|1|||
33313185|NCT00770341|101040776|FG000|Overall Study|Other|1|||
33313186|NCT00770341|101040777|FG001|Overall Study|Other|0|||
33313187|NCT00770341|101040778|FG002|Overall Study|Other|0|||
33313188|NCT00770341|101040776|FG000|Overall Study|Not treated|1|||
33313189|NCT00770341|101040777|FG001|Overall Study|Not treated|0|||
33313190|NCT00770341|101040778|FG002|Overall Study|Not treated|0|||
33313191|NCT03371381|101040781|FG000|Overall Study|Death|5|||
33313192|NCT03371381|101040781|FG000|Overall Study|Study terminated by sponsor|3|||
33313193|NCT03371381|101040781|FG000|Overall Study|Other|4|||
33313194|NCT01919814|101040782|FG000|Overall Study|Adverse Event|1|||
33313195|NCT01919814|101040783|FG001|Overall Study|Adverse Event|0|||
33313196|NCT01919814|101040782|FG000|Overall Study|Protocol Violation|1|||
33313197|NCT01919814|101040783|FG001|Overall Study|Protocol Violation|0|||
33313198|NCT01919814|101040782|FG000|Overall Study|Withdrawal by Subject|1|||
33313199|NCT01919814|101040783|FG001|Overall Study|Withdrawal by Subject|0|||
33313200|NCT00810394|101040784|FG000|Overall Study|Withdrawal by Subject|3|||
33313201|NCT00552240|101040785|FG000|Overall Study|Adverse Event|9|||
33313202|NCT00552240|101040786|FG001|Overall Study|Adverse Event|9|||
33313203|NCT00552240|101040785|FG000|Overall Study|Protocol Violation|1|||
33313204|NCT00552240|101040786|FG001|Overall Study|Protocol Violation|1|||
33313205|NCT00552240|101040785|FG000|Overall Study|Lost to Follow-up|5|||
33313206|NCT00552240|101040786|FG001|Overall Study|Lost to Follow-up|6|||
33313207|NCT00552240|101040785|FG000|Overall Study|Withdrawal by Subject|2|||
33313208|NCT00552240|101040786|FG001|Overall Study|Withdrawal by Subject|2|||
33313209|NCT00552240|101040785|FG000|Overall Study|Lack of Efficacy|6|||
33313210|NCT00552240|101040786|FG001|Overall Study|Lack of Efficacy|0|||
33313211|NCT00552240|101040785|FG000|Overall Study|Other|1|||
33313212|NCT00552240|101040786|FG001|Overall Study|Other|0|||
33313213|NCT03945825|101040788|FG000|Overall Study|Enrolled but treatment not administered|0|||
33313214|NCT03945825|101040789|FG001|Overall Study|Enrolled but treatment not administered|0|||
33313215|NCT03945825|101040790|FG002|Overall Study|Enrolled but treatment not administered|0|||
33313216|NCT03945825|101040791|FG003|Overall Study|Enrolled but treatment not administered|0|||
33503600|NCT00610155|101738367|FG000|Period 3|Adverse Event|1|||
33503601|NCT00610155|101738368|FG001|Period 3|Adverse Event|0|||
33503602|NCT00610155|101738369|FG002|Period 3|Adverse Event|0|||
33503603|NCT00610155|101738370|FG003|Period 3|Adverse Event|0|||
33503604|NCT00610155|101738371|FG004|Period 3|Adverse Event|0|||
33503605|NCT00610155|101738372|FG005|Period 3|Adverse Event|0|||
33503606|NCT00887315|101738376|FG000|Overall Study|Study termination|7|||
33503607|NCT00887315|101738377|FG001|Overall Study|Study termination|4|||
33503608|NCT03991299|101738378|FG000|Overall Study|Study closed, sponsor decision|3|||
33503609|NCT03991299|101738378|FG000|Overall Study|Withdrawal by Subject|1|||
33503610|NCT01684423|101738382|FG000|Overall Study|Withdrawal by Subject|0|||
33503611|NCT01684423|101738383|FG001|Overall Study|Withdrawal by Subject|0|||
33503612|NCT01684423|101738384|FG002|Overall Study|Withdrawal by Subject|1|||
33395631|NCT00398086|101334919|FG000|Overall Study|Adverse Event|1|||
33395632|NCT00398086|101334920|FG001|Overall Study|Adverse Event|4|||
33503613|NCT01684423|101738385|FG003|Overall Study|Withdrawal by Subject|0|||
33313217|NCT03945825|101040792|FG004|Overall Study|Enrolled but treatment not administered|1|||
33395633|NCT00398086|101334921|FG002|Overall Study|Adverse Event|0|||
33313218|NCT03945825|101040793|FG005|Overall Study|Enrolled but treatment not administered|0|||
33313219|NCT03945825|101040788|FG000|Overall Study|Lost to Follow-up|1|||
33313220|NCT03945825|101040789|FG001|Overall Study|Lost to Follow-up|5|||
33503614|NCT01684423|101738386|FG004|Overall Study|Withdrawal by Subject|0|||
33503615|NCT00267969|101738387|FG000|Controlled Period|Adverse Event|6|||
33503616|NCT00267969|101738388|FG001|Controlled Period|Adverse Event|0|||
33313221|NCT03945825|101040790|FG002|Overall Study|Lost to Follow-up|0|||
33503617|NCT00267969|101738389|FG002|Controlled Period|Adverse Event|2|||
33503618|NCT00267969|101738390|FG003|Controlled Period|Adverse Event|0|||
33313222|NCT03945825|101040791|FG003|Overall Study|Lost to Follow-up|1|||
33313223|NCT03945825|101040792|FG004|Overall Study|Lost to Follow-up|2|||
33313224|NCT03945825|101040793|FG005|Overall Study|Lost to Follow-up|2|||
33313225|NCT03945825|101040788|FG000|Overall Study|Withdrawal by Subject|1|||
33313226|NCT03945825|101040789|FG001|Overall Study|Withdrawal by Subject|0|||
33395634|NCT00398086|101334919|FG000|Overall Study|Physician Decision|1|||
33395635|NCT00398086|101334920|FG001|Overall Study|Physician Decision|4|||
33395636|NCT00398086|101334921|FG002|Overall Study|Physician Decision|0|||
33395637|NCT00398086|101334919|FG000|Overall Study|Withdrawal by Subject|5|||
33395638|NCT00398086|101334920|FG001|Overall Study|Withdrawal by Subject|7|||
33395639|NCT00398086|101334921|FG002|Overall Study|Withdrawal by Subject|0|||
33395640|NCT02870348|101334922|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
33395641|NCT01307046|101334925|FG000|Overall Study|Adverse Event|3|||
33395642|NCT01307046|101334926|FG001|Overall Study|Adverse Event|3|||
33395643|NCT01307046|101334925|FG000|Overall Study|Lack of Efficacy|0|||
33313227|NCT03945825|101040790|FG002|Overall Study|Withdrawal by Subject|1|||
33313228|NCT03945825|101040791|FG003|Overall Study|Withdrawal by Subject|1|||
33313229|NCT03945825|101040792|FG004|Overall Study|Withdrawal by Subject|0|||
33313230|NCT03945825|101040793|FG005|Overall Study|Withdrawal by Subject|1|||
33313231|NCT00775463|101040795|FG000|Overall Study|Withdrawal by Subject|0|||
33313232|NCT00775463|101040796|FG001|Overall Study|Withdrawal by Subject|1|||
33313233|NCT00775463|101040795|FG000|Overall Study|Adverse Event|7|||
33313234|NCT00775463|101040796|FG001|Overall Study|Adverse Event|9|||
33313235|NCT00775463|101040795|FG000|Overall Study|Protocol Violation|2|||
33313236|NCT00775463|101040796|FG001|Overall Study|Protocol Violation|2|||
33313237|NCT00775463|101040795|FG000|Overall Study|Lost to Follow-up|1|||
33313238|NCT00775463|101040796|FG001|Overall Study|Lost to Follow-up|0|||
33313239|NCT00775463|101040795|FG000|Overall Study|Lack of Efficacy|1|||
33313240|NCT00775463|101040796|FG001|Overall Study|Lack of Efficacy|1|||
33313241|NCT01210118|101040798|FG000|Overall Study|Lost to Follow-up|1|||
33313242|NCT01210118|101040799|FG001|Overall Study|Lost to Follow-up|1|||
33313243|NCT01210118|101040798|FG000|Overall Study|Protocol Violation|1|||
33395644|NCT01307046|101334926|FG001|Overall Study|Lack of Efficacy|2|||
33395645|NCT01307046|101334925|FG000|Overall Study|Physician Decision|2|||
33395646|NCT01307046|101334926|FG001|Overall Study|Physician Decision|0|||
33395647|NCT01307046|101334925|FG000|Overall Study|Withdrawal by Subject|1|||
33395648|NCT01307046|101334926|FG001|Overall Study|Withdrawal by Subject|1|||
33395649|NCT01307046|101334925|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
33395650|NCT01307046|101334926|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
33395651|NCT01307046|101334925|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
33395652|NCT01307046|101334926|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
33395653|NCT00686699|101334935|FG000|Treatment Period 1|Adverse Event|0|||
33395654|NCT00686699|101334936|FG001|Treatment Period 1|Adverse Event|2|||
33395655|NCT03462030|101334937|FG000|Overall Study|Withdrawal by Subject|1|||
33395656|NCT03462030|101334938|FG001|Overall Study|Withdrawal by Subject|1|||
33395657|NCT00853112|101334950|FG000|Overall Study|Randomized but not treated|0|||
33395658|NCT00853112|101334951|FG001|Overall Study|Randomized but not treated|1|||
33395659|NCT00853112|101334952|FG002|Overall Study|Randomized but not treated|0|||
33395660|NCT00853112|101334953|FG003|Overall Study|Randomized but not treated|2|||
33395661|NCT00853112|101334954|FG004|Overall Study|Randomized but not treated|0|||
33395662|NCT00853112|101334955|FG005|Overall Study|Randomized but not treated|0|||
33395663|NCT00853112|101334956|FG006|Overall Study|Randomized but not treated|1|||
33395664|NCT00372489|101337635|FG000|Overall Study|Adverse Event|18|||
33395665|NCT00372489|101337635|FG000|Overall Study|Lack of Efficacy|1|||
33395666|NCT00372489|101337635|FG000|Overall Study|Lost to Follow-up|3|||
33395667|NCT00372489|101337635|FG000|Overall Study|Physician Decision|3|||
33395668|NCT00372489|101337635|FG000|Overall Study|Withdrawal by Subject|5|||
33395669|NCT00372489|101337635|FG000|Overall Study|Patient Relocation|2|||
33395670|NCT00372489|101337635|FG000|Overall Study|Renal transplant|6|||
33193717|NCT00098839|100612799|FG001|Overall Study|Adverse Event|2|||
33193718|NCT00098839|100612798|FG000|Overall Study|Death|1|||
33193719|NCT00098839|100612799|FG001|Overall Study|Death|2|||
33193720|NCT00098839|100612798|FG000|Overall Study|Physician Decision|4|||
33193721|NCT00098839|100612799|FG001|Overall Study|Physician Decision|14|||
33193722|NCT00098839|100612798|FG000|Overall Study|Withdrawal by Subject|1|||
33193723|NCT00098839|100612799|FG001|Overall Study|Withdrawal by Subject|0|||
33193724|NCT00098839|100612798|FG000|Overall Study|Refusal of further protocol therapy|3|||
33193725|NCT00098839|100612799|FG001|Overall Study|Refusal of further protocol therapy|1|||
33193726|NCT00098839|100612798|FG000|Overall Study|Relapse|6|||
33193727|NCT00098839|100612799|FG001|Overall Study|Relapse|3|||
33193728|NCT00098839|100612798|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
33193729|NCT00098839|100612799|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
33313244|NCT01210118|101040799|FG001|Overall Study|Protocol Violation|1|||
33313245|NCT01210118|101040798|FG000|Overall Study|Spontaneous abortion|1|||
33313246|NCT01210118|101040799|FG001|Overall Study|Spontaneous abortion|3|||
33313247|NCT00738582|101040800|FG000|Combination Therapy|Completed Combination Therapy|1|||
33395671|NCT00372489|101337635|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
33395672|NCT02142712|101337641|FG000|Overall Study|Lost to Follow-up|1|||
33395673|NCT02142712|101337642|FG001|Overall Study|Lost to Follow-up|1|||
33395674|NCT02142712|101337643|FG002|Overall Study|Lost to Follow-up|1|||
33395675|NCT02142712|101337644|FG003|Overall Study|Lost to Follow-up|0|||
33395676|NCT00038142|101337645|FG000|Overall Study|Ineligible|1|||
33395677|NCT00038142|101337646|FG001|Overall Study|Ineligible|0|||
33395678|NCT00038142|101337645|FG000|Overall Study|Progressive Disease|11|||
33395679|NCT00038142|101337646|FG001|Overall Study|Progressive Disease|7|||
33395680|NCT00038142|101337645|FG000|Overall Study|Death|1|||
33395681|NCT00038142|101337646|FG001|Overall Study|Death|0|||
33395682|NCT00038142|101337645|FG000|Overall Study|Adverse Event|1|||
33395683|NCT00038142|101337646|FG001|Overall Study|Adverse Event|0|||
33395684|NCT00038142|101337645|FG000|Overall Study|Unknown Reason|8|||
33395685|NCT00038142|101337646|FG001|Overall Study|Unknown Reason|0|||
33395686|NCT00420212|101337647|FG000|Overall Study|Adverse Event|22|||
33395687|NCT00420212|101337648|FG001|Overall Study|Adverse Event|40|||
33395688|NCT00420212|101337649|FG002|Overall Study|Adverse Event|36|||
33395689|NCT00420212|101337647|FG000|Overall Study|Lost to Follow-up|9|||
33395690|NCT00420212|101337648|FG001|Overall Study|Lost to Follow-up|11|||
33395691|NCT00420212|101337649|FG002|Overall Study|Lost to Follow-up|11|||
33395692|NCT00420212|101337647|FG000|Overall Study|Withdrawal by Subject|31|||
33395693|NCT00420212|101337648|FG001|Overall Study|Withdrawal by Subject|22|||
33395694|NCT00420212|101337649|FG002|Overall Study|Withdrawal by Subject|19|||
33395695|NCT00420212|101337647|FG000|Overall Study|Physician Decision|4|||
33395696|NCT00420212|101337648|FG001|Overall Study|Physician Decision|4|||
33395697|NCT00420212|101337649|FG002|Overall Study|Physician Decision|3|||
33503619|NCT00267969|101738391|FG004|Controlled Period|Adverse Event|0|||
33503620|NCT00267969|101738392|FG005|Controlled Period|Adverse Event|0|||
33503621|NCT00267969|101738393|FG006|Controlled Period|Adverse Event|0|||
33313248|NCT00738582|101040801|FG001|Combination Therapy|Completed Combination Therapy|0|||
33313249|NCT00738582|101040800|FG000|Combination Therapy|Physician Decision|1|||
33313250|NCT00738582|101040801|FG001|Combination Therapy|Physician Decision|0|||
33313251|NCT00738582|101040800|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
33313252|NCT00738582|101040801|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
33313253|NCT00738582|101040800|FG000|Combination Therapy|Other|5|||
33313254|NCT00738582|101040801|FG001|Combination Therapy|Other|0|||
33313255|NCT00738582|101040800|FG000|Combination Therapy|Adverse Event|16|||
33313256|NCT00738582|101040801|FG001|Combination Therapy|Adverse Event|0|||
33313257|NCT00738582|101040800|FG000|Combination Therapy|Progressive Disease|9|||
33313258|NCT00738582|101040801|FG001|Combination Therapy|Progressive Disease|0|||
33313259|NCT00738582|101040800|FG000|Maintenance Therapy|Other|0|||
33313260|NCT00738582|101040801|FG001|Maintenance Therapy|Other|2|||
33313261|NCT00738582|101040800|FG000|Maintenance Therapy|Adverse Event|0|||
33313262|NCT00738582|101040801|FG001|Maintenance Therapy|Adverse Event|6|||
33313263|NCT00738582|101040800|FG000|Maintenance Therapy|Progressive Disease|0|||
33313264|NCT00738582|101040801|FG001|Maintenance Therapy|Progressive Disease|47|||
33313265|NCT00738582|101040800|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
33313266|NCT00738582|101040801|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
33193730|NCT00098839|100612798|FG000|Overall Study|Ineligible|2|||
33503622|NCT00267969|101738387|FG000|Controlled Period|Lack of Efficacy|3|||
33503623|NCT00267969|101738388|FG001|Controlled Period|Lack of Efficacy|0|||
33503624|NCT00267969|101738389|FG002|Controlled Period|Lack of Efficacy|1|||
33313267|NCT05249829|101040804|FG000|Overall Study|Participant Relocation|0|||
33313268|NCT05249829|101040805|FG001|Overall Study|Participant Relocation|1|||
33313269|NCT05249829|101040806|FG002|Overall Study|Participant Relocation|2|||
33395698|NCT00420212|101337647|FG000|Overall Study|Protocol Violation|4|||
33503625|NCT00267969|101738390|FG003|Controlled Period|Lack of Efficacy|0|||
33503626|NCT00267969|101738391|FG004|Controlled Period|Lack of Efficacy|0|||
33395699|NCT00420212|101337648|FG001|Overall Study|Protocol Violation|4|||
33395700|NCT00420212|101337649|FG002|Overall Study|Protocol Violation|8|||
33395701|NCT00420212|101337647|FG000|Overall Study|Death|0|||
33395702|NCT00420212|101337648|FG001|Overall Study|Death|0|||
33395703|NCT00420212|101337649|FG002|Overall Study|Death|1|||
33503627|NCT00267969|101738392|FG005|Controlled Period|Lack of Efficacy|0|||
33503628|NCT00267969|101738393|FG006|Controlled Period|Lack of Efficacy|0|||
33193731|NCT00098839|100612799|FG001|Overall Study|Ineligible|0|||
33313270|NCT05249829|101040807|FG003|Overall Study|Participant Relocation|2|||
33313271|NCT05249829|101040804|FG000|Overall Study|Withdrawal by Subject|9|||
33395704|NCT00420212|101337647|FG000|Overall Study|Other-Unspecified|21|||
33503629|NCT00267969|101738387|FG000|Controlled Period|Lost to Follow-up|1|||
33503630|NCT00267969|101738388|FG001|Controlled Period|Lost to Follow-up|0|||
33503631|NCT00267969|101738389|FG002|Controlled Period|Lost to Follow-up|1|||
33503632|NCT00267969|101738390|FG003|Controlled Period|Lost to Follow-up|0|||
33602663|NCT00624780|102095399|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
33395705|NCT00420212|101337648|FG001|Overall Study|Other-Unspecified|14|||
33395706|NCT00420212|101337649|FG002|Overall Study|Other-Unspecified|18|||
33395707|NCT00233324|101337650|FG000|Main Study|Death|68|||
33395708|NCT00233324|101337651|FG001|Main Study|Death|60|||
33503633|NCT00267969|101738391|FG004|Controlled Period|Lost to Follow-up|0|||
33503634|NCT00267969|101738392|FG005|Controlled Period|Lost to Follow-up|0|||
33503635|NCT00267969|101738393|FG006|Controlled Period|Lost to Follow-up|0|||
33503636|NCT00267969|101738387|FG000|Controlled Period|Randomized but not treated|0|||
33602664|NCT00624780|102095400|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
33602665|NCT00624780|102095401|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
33503637|NCT00267969|101738388|FG001|Controlled Period|Randomized but not treated|0|||
33503638|NCT00267969|101738389|FG002|Controlled Period|Randomized but not treated|1|||
33503639|NCT00267969|101738390|FG003|Controlled Period|Randomized but not treated|0|||
33503640|NCT00267969|101738391|FG004|Controlled Period|Randomized but not treated|0|||
33503641|NCT00267969|101738392|FG005|Controlled Period|Randomized but not treated|0|||
33503642|NCT00267969|101738393|FG006|Controlled Period|Randomized but not treated|0|||
33503643|NCT00267969|101738387|FG000|Controlled Period|Other|2|||
33503644|NCT00267969|101738388|FG001|Controlled Period|Other|1|||
33503645|NCT00267969|101738389|FG002|Controlled Period|Other|6|||
33503646|NCT00267969|101738390|FG003|Controlled Period|Other|0|||
33503647|NCT00267969|101738391|FG004|Controlled Period|Other|0|||
33503648|NCT00267969|101738392|FG005|Controlled Period|Other|0|||
33503649|NCT00267969|101738393|FG006|Controlled Period|Other|0|||
33503650|NCT00267969|101738387|FG000|After Controlled Period|Adverse Event|0|||
33503651|NCT00267969|101738388|FG001|After Controlled Period|Adverse Event|0|||
33503652|NCT00267969|101738389|FG002|After Controlled Period|Adverse Event|0|||
33503653|NCT00267969|101738390|FG003|After Controlled Period|Adverse Event|7|||
33503654|NCT00267969|101738391|FG004|After Controlled Period|Adverse Event|8|||
33503655|NCT00267969|101738392|FG005|After Controlled Period|Adverse Event|23|||
33503656|NCT00267969|101738393|FG006|After Controlled Period|Adverse Event|21|||
33503657|NCT00267969|101738387|FG000|After Controlled Period|Death|0|||
33503658|NCT00267969|101738388|FG001|After Controlled Period|Death|0|||
33503659|NCT00267969|101738389|FG002|After Controlled Period|Death|0|||
33503660|NCT00267969|101738390|FG003|After Controlled Period|Death|1|||
33395709|NCT00233324|101337652|FG002|Main Study|Death|62|||
33395710|NCT00233324|101337653|FG003|Main Study|Death|47|||
33395711|NCT00233324|101337650|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
33193732|NCT04537806|100612803|FG000|Overall Study|Randomized but not treated|1|||
33503661|NCT00267969|101738391|FG004|After Controlled Period|Death|2|||
33503662|NCT00267969|101738392|FG005|After Controlled Period|Death|0|||
33503663|NCT00267969|101738393|FG006|After Controlled Period|Death|1|||
33503664|NCT00267969|101738387|FG000|After Controlled Period|Lack of Efficacy|0|||
33503665|NCT00267969|101738388|FG001|After Controlled Period|Lack of Efficacy|0|||
33503666|NCT00267969|101738389|FG002|After Controlled Period|Lack of Efficacy|0|||
33503667|NCT00267969|101738390|FG003|After Controlled Period|Lack of Efficacy|10|||
33503668|NCT00267969|101738391|FG004|After Controlled Period|Lack of Efficacy|6|||
33503669|NCT00267969|101738392|FG005|After Controlled Period|Lack of Efficacy|28|||
33503670|NCT00267969|101738393|FG006|After Controlled Period|Lack of Efficacy|15|||
33602666|NCT00624780|102095402|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
33602667|NCT00624780|102095403|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
33602668|NCT00624780|102095404|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
33602669|NCT00624780|102095399|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
33602670|NCT00624780|102095400|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
33602671|NCT00624780|102095401|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
33602672|NCT00624780|102095402|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
33602673|NCT00624780|102095403|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
33602674|NCT00624780|102095404|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
33602675|NCT00624780|102095399|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
33602676|NCT00624780|102095400|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
33602677|NCT00624780|102095401|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
33602678|NCT00624780|102095402|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
33602679|NCT00624780|102095403|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
33193733|NCT04537806|100612804|FG001|Overall Study|Randomized but not treated|0|||
33193734|NCT04537806|100612803|FG000|Overall Study|Adverse Event|1|||
33193735|NCT04537806|100612804|FG001|Overall Study|Adverse Event|1|||
33503671|NCT00267969|101738387|FG000|After Controlled Period|Lost to Follow-up|0|||
33503672|NCT00267969|101738388|FG001|After Controlled Period|Lost to Follow-up|0|||
33503673|NCT00267969|101738389|FG002|After Controlled Period|Lost to Follow-up|0|||
33503674|NCT00267969|101738390|FG003|After Controlled Period|Lost to Follow-up|5|||
33503675|NCT00267969|101738391|FG004|After Controlled Period|Lost to Follow-up|8|||
33503676|NCT00267969|101738392|FG005|After Controlled Period|Lost to Follow-up|9|||
33503677|NCT00267969|101738393|FG006|After Controlled Period|Lost to Follow-up|10|||
33503678|NCT00267969|101738387|FG000|After Controlled Period|Other|0|||
33503679|NCT00267969|101738388|FG001|After Controlled Period|Other|0|||
33503680|NCT00267969|101738389|FG002|After Controlled Period|Other|0|||
33503681|NCT00267969|101738390|FG003|After Controlled Period|Other|13|||
33503682|NCT00267969|101738391|FG004|After Controlled Period|Other|11|||
33503683|NCT00267969|101738392|FG005|After Controlled Period|Other|22|||
33503684|NCT00267969|101738393|FG006|After Controlled Period|Other|25|||
33503685|NCT02035202|101738394|FG000|Overall Study|Lost to Follow-up|8|||
33503686|NCT02035202|101738395|FG001|Overall Study|Lost to Follow-up|16|||
33503687|NCT02035202|101738396|FG002|Overall Study|Lost to Follow-up|2|||
33503688|NCT00713258|101738397|FG000|Overall Study|Adverse Event|2|||
33503689|NCT00713258|101738398|FG001|Overall Study|Adverse Event|4|||
33503690|NCT00713258|101738397|FG000|Overall Study|Non-Compliance|2|||
33503691|NCT00713258|101738398|FG001|Overall Study|Non-Compliance|1|||
33503692|NCT00713258|101738397|FG000|Overall Study|Other|1|||
33503693|NCT00713258|101738398|FG001|Overall Study|Other|1|||
33503694|NCT03887442|101738399|FG000|Overall Study|Adverse Event|1|||
33503695|NCT03887442|101738400|FG001|Overall Study|Adverse Event|0|||
33503696|NCT01091662|101738401|FG000|Overall Study|Adverse Event|1|||
33503697|NCT01091662|101738402|FG001|Overall Study|Adverse Event|9|||
33503698|NCT01091662|101738401|FG000|Overall Study|Physician Decision|1|||
33503699|NCT01091662|101738402|FG001|Overall Study|Physician Decision|1|||
33503700|NCT01091662|101738401|FG000|Overall Study|Withdrawal by Subject|7|||
33503701|NCT01091662|101738402|FG001|Overall Study|Withdrawal by Subject|6|||
33503702|NCT01091662|101738401|FG000|Overall Study|met exit criteria|7|||
33503703|NCT01091662|101738402|FG001|Overall Study|met exit criteria|13|||
33503704|NCT01091662|101738401|FG000|Overall Study|met exclusion criteria|1|||
33503705|NCT01091662|101738402|FG001|Overall Study|met exclusion criteria|0|||
33503706|NCT01091662|101738401|FG000|Overall Study|Lost to Follow-up|0|||
33503707|NCT01091662|101738402|FG001|Overall Study|Lost to Follow-up|1|||
33503708|NCT01091662|101738401|FG000|Overall Study|Pregnancy|0|||
33503709|NCT01091662|101738402|FG001|Overall Study|Pregnancy|1|||
33503710|NCT01091662|101738401|FG000|Overall Study|Protocol Violation|0|||
33503711|NCT01091662|101738402|FG001|Overall Study|Protocol Violation|2|||
33503712|NCT01091662|101738401|FG000|Overall Study|unable to swallow capsule|0|||
33503713|NCT01091662|101738402|FG001|Overall Study|unable to swallow capsule|1|||
33503714|NCT04157296|101738403|FG000|Overall Study|Withdrawal by Subject|0|||
33602680|NCT00624780|102095404|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
33602681|NCT00624780|102095399|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
33602682|NCT00624780|102095400|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
33193736|NCT00775437|100612808|FG000|Overall Study|Loss of efficacy|2|||
33395712|NCT00233324|101337651|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
33395713|NCT00233324|101337652|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
33395714|NCT00233324|101337653|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
33395715|NCT00233324|101337650|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
33395716|NCT00233324|101337651|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
33395717|NCT00233324|101337652|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
33395718|NCT00233324|101337653|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
33395719|NCT00068822|101337656|FG000|First Randomized Intervention|Lost to Follow-up|1|||
33395720|NCT00068822|101337657|FG001|First Randomized Intervention|Lost to Follow-up|2|||
33395721|NCT00290355|101337661|FG000|Overall Study|Serious adverse event|7|||
33395722|NCT00290355|101337662|FG001|Overall Study|Serious adverse event|4|||
33395723|NCT00290355|101337661|FG000|Overall Study|Study product reactogenicity|1|||
33395724|NCT00290355|101337662|FG001|Overall Study|Study product reactogenicity|0|||
33395725|NCT00290355|101337661|FG000|Overall Study|Protocol Violation|1|||
33395726|NCT00290355|101337662|FG001|Overall Study|Protocol Violation|0|||
33395727|NCT00290355|101337661|FG000|Overall Study|Withdrawal by Subject|2|||
33395728|NCT00290355|101337662|FG001|Overall Study|Withdrawal by Subject|0|||
33395729|NCT00290355|101337661|FG000|Overall Study|Migrated / moved from the study area|1|||
33503715|NCT04157296|101738404|FG001|Overall Study|Withdrawal by Subject|1|||
33503716|NCT04157296|101738403|FG000|Overall Study|Did not obtain second fMRI.|0|||
33503717|NCT04157296|101738404|FG001|Overall Study|Did not obtain second fMRI.|1|||
33503718|NCT04157296|101738403|FG000|Overall Study|MRI failed/no second fMRI|0|||
33503719|NCT04157296|101738404|FG001|Overall Study|MRI failed/no second fMRI|1|||
33503720|NCT00665431|101738405|FG000|Overall Study|Adverse Event|16|||
33503721|NCT00665431|101738406|FG001|Overall Study|Adverse Event|22|||
33503722|NCT00665431|101738407|FG002|Overall Study|Adverse Event|6|||
33503723|NCT00665431|101738405|FG000|Overall Study|Withdrawal by Subject|17|||
33503724|NCT00665431|101738406|FG001|Overall Study|Withdrawal by Subject|25|||
33503725|NCT00665431|101738407|FG002|Overall Study|Withdrawal by Subject|15|||
33503726|NCT00665431|101738405|FG000|Overall Study|Lost to Follow-up|3|||
33503727|NCT00665431|101738406|FG001|Overall Study|Lost to Follow-up|3|||
33503728|NCT00665431|101738407|FG002|Overall Study|Lost to Follow-up|1|||
33503729|NCT00665431|101738405|FG000|Overall Study|Other|4|||
33503730|NCT00665431|101738406|FG001|Overall Study|Other|7|||
33503731|NCT00665431|101738407|FG002|Overall Study|Other|2|||
33503732|NCT00379080|101738410|FG000|Overall Study|Withdrawal by Subject|0|||
33503733|NCT00379080|101738411|FG001|Overall Study|Withdrawal by Subject|4|||
33503734|NCT00379080|101738412|FG002|Overall Study|Withdrawal by Subject|0|||
33503735|NCT04747886|101738413|FG000|Overall Study|Withdrawal by Subject|1|||
33503736|NCT04747886|101738414|FG001|Overall Study|Withdrawal by Subject|4|||
33503737|NCT00561392|101738415|FG000|Overall Study|Adverse Event|38|||
33193737|NCT00775437|100612808|FG000|Overall Study|Withdrawal by Subject|3|||
33193738|NCT00775437|100612808|FG000|Overall Study|Lost to Follow-up|1|||
33193739|NCT02797262|100612809|FG000|Overall Study|Withdrawal by Subject|5|||
33193740|NCT02797262|100612810|FG001|Overall Study|Withdrawal by Subject|1|||
33193741|NCT02797262|100612809|FG000|Overall Study|Lost to Follow-up|10|||
33193742|NCT02797262|100612810|FG001|Overall Study|Lost to Follow-up|7|||
33193743|NCT02797262|100612809|FG000|Overall Study|Death|1|||
33193744|NCT02797262|100612810|FG001|Overall Study|Death|2|||
33193745|NCT02797262|100612809|FG000|Overall Study|Adverse Event|1|||
33193746|NCT02797262|100612810|FG001|Overall Study|Adverse Event|0|||
33193747|NCT02797262|100612809|FG000|Overall Study|COVID-19|2|||
33193748|NCT02797262|100612810|FG001|Overall Study|COVID-19|1|||
33193749|NCT02797262|100612809|FG000|Overall Study|Out-of-country|1|||
33193750|NCT02797262|100612810|FG001|Overall Study|Out-of-country|0|||
33193751|NCT02148003|100612818|FG000|Overall Study|Failed inclusion criteria|1|||
33193752|NCT02148003|100612819|FG001|Overall Study|Failed inclusion criteria|0|||
33193753|NCT02148003|100612818|FG000|Overall Study|Met exclusion criteria|0|||
33193754|NCT02148003|100612819|FG001|Overall Study|Met exclusion criteria|1|||
33193755|NCT02148003|100612818|FG000|Overall Study|Withdrawal by Subject|0|||
33193756|NCT02148003|100612819|FG001|Overall Study|Withdrawal by Subject|1|||
33193757|NCT00293384|100612830|FG000|Overall Study|Non-compliance|2|||
33193758|NCT00293384|100612830|FG000|Overall Study|Missed dosage/study drug|1|||
33193759|NCT00293384|100612830|FG000|Overall Study|Ineligible|2|||
33193760|NCT01470469|100612832|FG000|Overall Study|Withdrawal by Subject|4|||
33193761|NCT01470469|100612833|FG001|Overall Study|Withdrawal by Subject|6|||
33193762|NCT01470469|100612832|FG000|Overall Study|Lack of Efficacy|1|||
33193763|NCT01470469|100612833|FG001|Overall Study|Lack of Efficacy|7|||
33193764|NCT01470469|100612832|FG000|Overall Study|Adverse Event|0|||
33193765|NCT01470469|100612833|FG001|Overall Study|Adverse Event|7|||
33193766|NCT01470469|100612832|FG000|Overall Study|Lost to Follow-up|2|||
33193767|NCT01470469|100612833|FG001|Overall Study|Lost to Follow-up|2|||
33193768|NCT01470469|100612832|FG000|Overall Study|Protocol Violation|1|||
33193769|NCT01470469|100612833|FG001|Overall Study|Protocol Violation|1|||
33193770|NCT01470469|100612832|FG000|Overall Study|Other|2|||
33193771|NCT01470469|100612833|FG001|Overall Study|Other|1|||
33193772|NCT00512096|100612836|FG000|Overall Study|Adverse Event|2|||
33193773|NCT00512096|100612836|FG000|Overall Study|Withdrawal by Subject|2|||
33193774|NCT00512096|100612836|FG000|Overall Study|Lack of Efficacy|3|||
33193775|NCT00785486|100612837|FG000|Midazolam Alone|Withdrawal by Subject|1|||
33193776|NCT00596011|100612838|FG000|Overall Study|Withdrawal by Subject|2|||
33193777|NCT00596011|100612839|FG001|Overall Study|Withdrawal by Subject|3|||
33193778|NCT00596011|100612838|FG000|Overall Study|Adverse Event|11|||
33193779|NCT00596011|100612839|FG001|Overall Study|Adverse Event|7|||
33193780|NCT00326911|100612840|FG000|Overall Study|Hospitalization prior to treatment|0|||
33193781|NCT00326911|100612841|FG001|Overall Study|Hospitalization prior to treatment|1|||
33193782|NCT00326911|100612840|FG000|Overall Study|Physician decision prior to treatment|1|||
33193783|NCT00326911|100612841|FG001|Overall Study|Physician decision prior to treatment|0|||
33193784|NCT00326911|100612840|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
33193785|NCT00326911|100612841|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
33193786|NCT01785602|100612843|FG000|Overall Study|Withdrawal by Subject|2|||
33503738|NCT00561392|101738415|FG000|Overall Study|Lack of Efficacy|2|||
33193787|NCT01785602|100612844|FG001|Overall Study|Withdrawal by Subject|0|||
33193788|NCT01785602|100612843|FG000|Overall Study|Lost to Follow-up|1|||
33193789|NCT01785602|100612844|FG001|Overall Study|Lost to Follow-up|1|||
33193790|NCT01785602|100612843|FG000|Overall Study|Adverse Event|3|||
33193791|NCT01785602|100612844|FG001|Overall Study|Adverse Event|5|||
33193792|NCT01785602|100612843|FG000|Overall Study|Administrative problems|7|||
33503739|NCT00561392|101738415|FG000|Overall Study|Protocol Violation|1|||
33503740|NCT00561392|101738415|FG000|Overall Study|Withdrawal by Subject|8|||
33503741|NCT00561392|101738415|FG000|Overall Study|Administrative problems|4|||
33193793|NCT01785602|100612844|FG001|Overall Study|Administrative problems|3|||
33193794|NCT02871375|100612845|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
33193795|NCT02871375|100612846|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
33193796|NCT04879745|100612848|FG000|Overall Study|Lost to Follow-up|4|||
33503742|NCT01575834|101738416|FG000|Overall Study|Withdrawal by Subject|352|||
33503743|NCT01575834|101738417|FG001|Overall Study|Withdrawal by Subject|390|||
33503744|NCT01575834|101738416|FG000|Overall Study|Death|81|||
33503745|NCT01575834|101738417|FG001|Overall Study|Death|74|||
33503746|NCT01575834|101738416|FG000|Overall Study|Other|70|||
33503747|NCT01575834|101738417|FG001|Overall Study|Other|70|||
33503748|NCT01575834|101738416|FG000|Overall Study|Adverse Event|63|||
33503749|NCT01575834|101738417|FG001|Overall Study|Adverse Event|61|||
33602683|NCT00624780|102095401|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
33193797|NCT04879745|100612849|FG001|Overall Study|Lost to Follow-up|1|||
33193798|NCT05044234|100616182|FG000|Overall Study|Lost to Follow-up|2|||
33193799|NCT05044234|100616183|FG001|Overall Study|Lost to Follow-up|1|||
33193800|NCT05044234|100616184|FG002|Overall Study|Lost to Follow-up|1|||
33193801|NCT05044234|100616185|FG003|Overall Study|Lost to Follow-up|2|||
33193802|NCT05044234|100616182|FG000|Overall Study|Withdrawal by Subject|6|||
33193803|NCT05044234|100616183|FG001|Overall Study|Withdrawal by Subject|4|||
33193804|NCT05044234|100616184|FG002|Overall Study|Withdrawal by Subject|5|||
33193805|NCT05044234|100616185|FG003|Overall Study|Withdrawal by Subject|8|||
33193806|NCT05044234|100616182|FG000|Overall Study|Study terminated by Sponsor|21|||
33193807|NCT05044234|100616183|FG001|Overall Study|Study terminated by Sponsor|21|||
33193808|NCT05044234|100616184|FG002|Overall Study|Study terminated by Sponsor|20|||
33193809|NCT05044234|100616185|FG003|Overall Study|Study terminated by Sponsor|14|||
33193810|NCT05044234|100616182|FG000|Overall Study|Other, not specified|0|||
33193811|NCT05044234|100616183|FG001|Overall Study|Other, not specified|0|||
33193812|NCT05044234|100616184|FG002|Overall Study|Other, not specified|1|||
33193813|NCT05044234|100616185|FG003|Overall Study|Other, not specified|2|||
33193814|NCT05044234|100616182|FG000|Overall Study|Delayed data entry|0|||
33193815|NCT05044234|100616183|FG001|Overall Study|Delayed data entry|0|||
33193816|NCT05044234|100616184|FG002|Overall Study|Delayed data entry|0|||
33193817|NCT05044234|100616185|FG003|Overall Study|Delayed data entry|1|||
33193818|NCT01848990|100616188|FG000|Overall Study|Adverse Event|6|||
33193819|NCT01848990|100616189|FG001|Overall Study|Adverse Event|2|||
33193820|NCT01848990|100616190|FG002|Overall Study|Adverse Event|0|||
33193821|NCT01848990|100616188|FG000|Overall Study|Lost to Follow-up|6|||
33193822|NCT01848990|100616189|FG001|Overall Study|Lost to Follow-up|2|||
33395730|NCT00290355|101337662|FG001|Overall Study|Migrated / moved from the study area|0|||
33395731|NCT00290355|101337661|FG000|Overall Study|Lost to Follow-up|3|||
33395732|NCT00290355|101337662|FG001|Overall Study|Lost to Follow-up|1|||
33395733|NCT00290355|101337661|FG000|Overall Study|Other|2|||
33395734|NCT00290355|101337662|FG001|Overall Study|Other|0|||
33395735|NCT01983683|101337665|FG000|Overall Study|Withdrawal by Subject|14|||
33395736|NCT01983683|101337666|FG001|Overall Study|Withdrawal by Subject|18|||
33395737|NCT01983683|101337665|FG000|Overall Study|Death|11|||
33395738|NCT01983683|101337666|FG001|Overall Study|Death|15|||
33395739|NCT01983683|101337665|FG000|Overall Study|Physician Decision|8|||
33395740|NCT01983683|101337666|FG001|Overall Study|Physician Decision|9|||
33395741|NCT01983683|101337665|FG000|Overall Study|Lost to Follow-up|4|||
33395742|NCT01983683|101337666|FG001|Overall Study|Lost to Follow-up|8|||
33395743|NCT01983683|101337665|FG000|Overall Study|Sponsor Decision|1|||
33395744|NCT01983683|101337666|FG001|Overall Study|Sponsor Decision|1|||
33395745|NCT01199198|101337667|FG000|Overall Study|Adverse Event|3|||
33395746|NCT01199198|101337668|FG001|Overall Study|Adverse Event|0|||
33503750|NCT01575834|101738416|FG000|Overall Study|Lost to Follow-up|55|||
33193823|NCT01848990|100616190|FG002|Overall Study|Lost to Follow-up|2|||
33193824|NCT01848990|100616188|FG000|Overall Study|Protocol Violation|1|||
33193825|NCT01848990|100616189|FG001|Overall Study|Protocol Violation|1|||
33503751|NCT01575834|101738417|FG001|Overall Study|Lost to Follow-up|68|||
33503752|NCT01575834|101738416|FG000|Overall Study|Noncompliance|52|||
33503753|NCT01575834|101738417|FG001|Overall Study|Noncompliance|27|||
33503754|NCT01575834|101738416|FG000|Overall Study|Administrative decision|15|||
33503755|NCT01575834|101738417|FG001|Overall Study|Administrative decision|33|||
33503756|NCT01575834|101738416|FG000|Overall Study|Ineligibility Determined|5|||
33503757|NCT01575834|101738417|FG001|Overall Study|Ineligibility Determined|8|||
33503758|NCT01575834|101738416|FG000|Overall Study|Protocol Deviation|4|||
33503759|NCT01575834|101738417|FG001|Overall Study|Protocol Deviation|3|||
33503760|NCT01575834|101738416|FG000|Overall Study|Requirement for Alternative Therapy|2|||
33503761|NCT01575834|101738417|FG001|Overall Study|Requirement for Alternative Therapy|4|||
33503762|NCT00582608|101738420|FG000|Overall Study|Not Treated|7|||
33503763|NCT00582608|101738420|FG000|Overall Study|Patient Ineligible|1|||
33503764|NCT00582608|101738420|FG000|Overall Study|Lack of accrual|4|||
33503765|NCT02844543|101738428|FG000|Overall Study|Withdrawal by Subject|4|||
33503766|NCT02844543|101738428|FG000|Overall Study|Did not meet eligibility criteria|1|||
33503767|NCT00996125|101738431|FG000|Overall Study|Adverse Event|0|||
33503768|NCT00996125|101738432|FG001|Overall Study|Adverse Event|2|||
33503769|NCT00996125|101738431|FG000|Overall Study|Lost to Follow-up|1|||
33193826|NCT01848990|100616190|FG002|Overall Study|Protocol Violation|0|||
33193827|NCT01848990|100616188|FG000|Overall Study|Withdrawal by Subject|29|||
33193828|NCT01848990|100616189|FG001|Overall Study|Withdrawal by Subject|10|||
33193829|NCT01848990|100616190|FG002|Overall Study|Withdrawal by Subject|11|||
33193830|NCT01848990|100616188|FG000|Overall Study|Physician Decision|1|||
33193831|NCT01848990|100616189|FG001|Overall Study|Physician Decision|1|||
33193832|NCT01848990|100616190|FG002|Overall Study|Physician Decision|0|||
33193833|NCT01848990|100616188|FG000|Overall Study|Non Compliance|1|||
33193834|NCT01848990|100616189|FG001|Overall Study|Non Compliance|0|||
33193835|NCT01848990|100616190|FG002|Overall Study|Non Compliance|0|||
33193836|NCT01848990|100616188|FG000|Overall Study|Death|1|||
33193837|NCT01848990|100616189|FG001|Overall Study|Death|0|||
33193838|NCT01848990|100616190|FG002|Overall Study|Death|1|||
33193839|NCT01848990|100616188|FG000|Overall Study|Other|1|||
33193840|NCT01848990|100616189|FG001|Overall Study|Other|4|||
33193841|NCT01848990|100616190|FG002|Overall Study|Other|2|||
33193842|NCT02919670|100616194|FG000|Overall Study|Only 17 participants met compliance|43|||
33193843|NCT02919670|100616195|FG001|Overall Study|Only 17 participants met compliance|39|||
33193844|NCT02433834|100616200|FG000|Overall Study|Protocol-specified criteria|7|||
33193845|NCT02433834|100616200|FG000|Overall Study|Protocol Violation|3|||
33193846|NCT02433834|100616200|FG000|Overall Study|Lost to Follow-up|6|||
33193847|NCT02433834|100616200|FG000|Overall Study|Withdrawal by Subject|14|||
33193848|NCT02433834|100616200|FG000|Overall Study|Adverse Event|6|||
33193849|NCT02433834|100616200|FG000|Overall Study|Physician Decision|1|||
33193850|NCT02948842|100616201|FG000|Overall Study|Withdrawal by Subject|4|||
33193851|NCT00501540|100616207|FG000|Overall Study|Death|5|||
33193852|NCT00827372|100616208|FG000|Overall Study|Adverse Event|5|||
33503770|NCT00996125|101738432|FG001|Overall Study|Lost to Follow-up|6|||
33503771|NCT00996125|101738431|FG000|Overall Study|Withdrawal by Subject|4|||
33503772|NCT00996125|101738432|FG001|Overall Study|Withdrawal by Subject|3|||
33503773|NCT01437995|101738433|FG000|Overall Study|Lost to Follow-up|11|||
33503774|NCT01437995|101738434|FG001|Overall Study|Lost to Follow-up|18|||
33503775|NCT01437995|101738435|FG002|Overall Study|Lost to Follow-up|20|||
33503776|NCT02654977|101738436|FG000|Overall Study|Death|1|||
33503777|NCT02654977|101738436|FG000|Overall Study|Lost to Follow-up|1|||
33503778|NCT02654977|101738436|FG000|Overall Study|Adverse Event|1|||
33503779|NCT02654977|101738436|FG000|Overall Study|Withdrawal by Subject|1|||
33193853|NCT00827372|100616208|FG000|Overall Study|Lack of Efficacy|3|||
33193854|NCT01433263|100616210|FG000|Overall Study|Adverse Event|3|||
33193855|NCT01433263|100616211|FG001|Overall Study|Adverse Event|1|||
33193856|NCT01433263|100616210|FG000|Overall Study|Death|5|||
33193857|NCT01433263|100616211|FG001|Overall Study|Death|3|||
33193858|NCT01433263|100616210|FG000|Overall Study|Lost to Follow-up|0|||
33503780|NCT02654977|101738436|FG000|Overall Study|Lack of Efficacy|3|||
33503781|NCT04075682|101738437|FG000|Overall Study|Lost to Follow-up|5|||
33503782|NCT04075682|101738438|FG001|Overall Study|Lost to Follow-up|5|||
33503783|NCT04075682|101738439|FG002|Overall Study|Lost to Follow-up|2|||
33503784|NCT04075682|101738440|FG003|Overall Study|Lost to Follow-up|2|||
33503785|NCT04075682|101738437|FG000|Overall Study|Withdrawal by Subject|1|||
33503786|NCT04075682|101738438|FG001|Overall Study|Withdrawal by Subject|0|||
33503787|NCT04075682|101738439|FG002|Overall Study|Withdrawal by Subject|1|||
33503788|NCT04075682|101738440|FG003|Overall Study|Withdrawal by Subject|0|||
33503789|NCT04075682|101738437|FG000|Overall Study|Protocol Violation|0|||
33503790|NCT04075682|101738438|FG001|Overall Study|Protocol Violation|1|||
33503791|NCT04075682|101738439|FG002|Overall Study|Protocol Violation|1|||
33503792|NCT04075682|101738440|FG003|Overall Study|Protocol Violation|0|||
33503793|NCT04075682|101738437|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
33503794|NCT04075682|101738438|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
33503795|NCT04075682|101738439|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
33503796|NCT04075682|101738440|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
33503797|NCT04075682|101738437|FG000|Overall Study|Lost study phone the first day of study participation|0|||
33503798|NCT04075682|101738438|FG001|Overall Study|Lost study phone the first day of study participation|1|||
33395747|NCT01199198|101337667|FG000|Overall Study|Lost to Follow-up|1|||
33395748|NCT01199198|101337668|FG001|Overall Study|Lost to Follow-up|5|||
33395749|NCT01199198|101337667|FG000|Overall Study|Withdrawal by Subject|1|||
33395750|NCT01199198|101337668|FG001|Overall Study|Withdrawal by Subject|2|||
33395751|NCT01199198|101337667|FG000|Overall Study|ICU Transfer|1|||
33395752|NCT01199198|101337668|FG001|Overall Study|ICU Transfer|2|||
33395753|NCT01199198|101337667|FG000|Overall Study|Hospice-care transfer|1|||
33395754|NCT01199198|101337668|FG001|Overall Study|Hospice-care transfer|2|||
33395755|NCT02158728|101337669|FG000|Overall Study|no procedure according to CIP done|3|||
33395756|NCT02158728|101337669|FG000|Overall Study|no qualified dataset|24|||
33395757|NCT01347073|101337670|FG000|Overall Study|Adverse Event|1|||
33395758|NCT01347073|101337670|FG000|Overall Study|Liver Transplant|1|||
33395759|NCT01023516|101337674|FG000|Overall Study|Voluntary discontinuation|7|||
33395760|NCT01023516|101337675|FG001|Overall Study|Voluntary discontinuation|5|||
33395761|NCT01023516|101337674|FG000|Overall Study|Adverse Event|9|||
33395762|NCT01023516|101337675|FG001|Overall Study|Adverse Event|6|||
33395763|NCT01023516|101337674|FG000|Overall Study|Safety reason|0|||
33395764|NCT01023516|101337675|FG001|Overall Study|Safety reason|3|||
33395765|NCT01023516|101337674|FG000|Overall Study|Study-specific criteria|4|||
33395766|NCT01023516|101337675|FG001|Overall Study|Study-specific criteria|2|||
33395767|NCT01023516|101337674|FG000|Overall Study|Incorrect enrolment|4|||
33395768|NCT01023516|101337675|FG001|Overall Study|Incorrect enrolment|2|||
33395769|NCT01424306|101337676|FG000|Overall Study|Protocol Violation|0|||
33395770|NCT01424306|101337677|FG001|Overall Study|Protocol Violation|0|||
33395771|NCT01424306|101337678|FG002|Overall Study|Protocol Violation|0|||
33395772|NCT01424306|101337679|FG003|Overall Study|Protocol Violation|0|||
33395773|NCT01424306|101337680|FG004|Overall Study|Protocol Violation|1|||
33395774|NCT01424306|101337681|FG005|Overall Study|Protocol Violation|0|||
33395775|NCT01998906|101337685|FG000|Overall Study|Participants ongoing in follow-up|77|||
33395776|NCT01998906|101337686|FG001|Overall Study|Participants ongoing in follow-up|60|||
33395777|NCT01998906|101337687|FG002|Overall Study|Participants ongoing in follow-up|58|||
33395778|NCT01998906|101337685|FG000|Overall Study|Death|21|||
33395779|NCT01998906|101337686|FG001|Overall Study|Death|30|||
33395780|NCT01998906|101337687|FG002|Overall Study|Death|17|||
33395781|NCT01998906|101337685|FG000|Overall Study|Lack of Efficacy|10|||
33395782|NCT01998906|101337686|FG001|Overall Study|Lack of Efficacy|9|||
33395783|NCT01998906|101337687|FG002|Overall Study|Lack of Efficacy|8|||
33395784|NCT01998906|101337685|FG000|Overall Study|Failure to return|0|||
33395785|NCT01998906|101337686|FG001|Overall Study|Failure to return|2|||
33395786|NCT01998906|101337687|FG002|Overall Study|Failure to return|4|||
33395787|NCT01998906|101337685|FG000|Overall Study|Violation of Selection Criteria|0|||
33395788|NCT01998906|101337686|FG001|Overall Study|Violation of Selection Criteria|0|||
33395789|NCT01998906|101337687|FG002|Overall Study|Violation of Selection Criteria|1|||
33395790|NCT01998906|101337685|FG000|Overall Study|Withdrawal by Subject|1|||
33395791|NCT01998906|101337686|FG001|Overall Study|Withdrawal by Subject|4|||
33395792|NCT01998906|101337687|FG002|Overall Study|Withdrawal by Subject|3|||
33395793|NCT01998906|101337685|FG000|Overall Study|Administrative/Other|2|||
33395794|NCT01998906|101337686|FG001|Overall Study|Administrative/Other|1|||
33395795|NCT01998906|101337687|FG002|Overall Study|Administrative/Other|3|||
33395796|NCT01998906|101337685|FG000|Overall Study|Other|3|||
33395797|NCT01998906|101337686|FG001|Overall Study|Other|8|||
33395798|NCT01998906|101337687|FG002|Overall Study|Other|4|||
33395799|NCT02574520|101337688|FG000|Overall Study|Not dosed|2|||
33395800|NCT02574520|101337689|FG001|Overall Study|Not dosed|0|||
33395801|NCT02574520|101337690|FG002|Overall Study|Not dosed|5|||
33395802|NCT02574520|101337691|FG003|Overall Study|Not dosed|4|||
33567607|NCT02723955|101973205|FG036|Crossover/ Re-treatment Phase|Death|0|||
33395803|NCT02574520|101337688|FG000|Overall Study|Adverse Event|0|||
33395804|NCT02574520|101337689|FG001|Overall Study|Adverse Event|0|||
33503799|NCT04075682|101738439|FG002|Overall Study|Lost study phone the first day of study participation|0|||
33503800|NCT04075682|101738440|FG003|Overall Study|Lost study phone the first day of study participation|0|||
33503801|NCT00556933|101738447|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
33602684|NCT00624780|102095402|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
33602685|NCT00624780|102095403|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
33602686|NCT00624780|102095404|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
33602687|NCT00624780|102095399|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
33602688|NCT00624780|102095400|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
33602689|NCT00624780|102095401|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
33602690|NCT00624780|102095402|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
33602691|NCT00624780|102095403|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
33602692|NCT00624780|102095404|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
33602693|NCT00624780|102095399|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
33602694|NCT00624780|102095400|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
33313272|NCT05249829|101040805|FG001|Overall Study|Withdrawal by Subject|17|||
33313273|NCT05249829|101040806|FG002|Overall Study|Withdrawal by Subject|40|||
33313274|NCT05249829|101040807|FG003|Overall Study|Withdrawal by Subject|35|||
33313275|NCT05249829|101040804|FG000|Overall Study|Physician Decision|1|||
33313276|NCT05249829|101040805|FG001|Overall Study|Physician Decision|0|||
33313277|NCT05249829|101040806|FG002|Overall Study|Physician Decision|0|||
33313278|NCT05249829|101040807|FG003|Overall Study|Physician Decision|0|||
33313279|NCT05249829|101040804|FG000|Overall Study|Lost to Follow-up|16|||
33313280|NCT05249829|101040805|FG001|Overall Study|Lost to Follow-up|16|||
33313281|NCT05249829|101040806|FG002|Overall Study|Lost to Follow-up|57|||
33313282|NCT05249829|101040807|FG003|Overall Study|Lost to Follow-up|60|||
33313283|NCT05249829|101040804|FG000|Overall Study|Adverse Event|2|||
33313284|NCT05249829|101040805|FG001|Overall Study|Adverse Event|2|||
33313285|NCT05249829|101040806|FG002|Overall Study|Adverse Event|2|||
33313286|NCT05249829|101040807|FG003|Overall Study|Adverse Event|2|||
33313287|NCT05249829|101040804|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
33313288|NCT05249829|101040805|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
33313289|NCT05249829|101040806|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
33313290|NCT05249829|101040807|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
33313291|NCT05249829|101040804|FG000|Overall Study|Protocol Violation|2|||
33313292|NCT05249829|101040805|FG001|Overall Study|Protocol Violation|0|||
33313293|NCT05249829|101040806|FG002|Overall Study|Protocol Violation|5|||
33313294|NCT05249829|101040807|FG003|Overall Study|Protocol Violation|3|||
33503802|NCT00556933|101738448|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
33503803|NCT00556933|101738449|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
33503804|NCT00556933|101738450|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
33503805|NCT00556933|101738447|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
33503806|NCT00556933|101738448|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
33503807|NCT00556933|101738449|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
33503808|NCT00556933|101738450|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
33503809|NCT00556933|101738447|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
33503810|NCT00556933|101738448|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
33503811|NCT00556933|101738449|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
33503812|NCT00556933|101738450|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
33503813|NCT00556933|101738447|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
33503814|NCT00556933|101738448|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
33503815|NCT00556933|101738449|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
33503816|NCT00556933|101738450|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
33503817|NCT00556933|101738447|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
33503818|NCT00556933|101738448|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
33503819|NCT00556933|101738449|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
33503820|NCT00556933|101738450|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
33503821|NCT00556933|101738447|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
33503822|NCT00556933|101738448|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
33503823|NCT00556933|101738449|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
33503824|NCT00556933|101738450|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
33602695|NCT00624780|102095401|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
33602696|NCT00624780|102095402|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
33313295|NCT05249829|101040804|FG000|Overall Study|Death|0|||
33313296|NCT05249829|101040805|FG001|Overall Study|Death|1|||
33602697|NCT00624780|102095403|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
33313297|NCT05249829|101040806|FG002|Overall Study|Death|2|||
33313298|NCT05249829|101040807|FG003|Overall Study|Death|4|||
33313299|NCT01768117|101040808|FG000|Overall Study|Lost to Follow-up|1|||
33395805|NCT02574520|101337690|FG002|Overall Study|Adverse Event|0|||
33395806|NCT02574520|101337691|FG003|Overall Study|Adverse Event|1|||
33395807|NCT02574520|101337688|FG000|Overall Study|Withdrawal by Subject|0|||
33313300|NCT01768117|101040808|FG000|Overall Study|Withdrawal by Subject|2|||
33313301|NCT01768117|101040808|FG000|Overall Study|Protocol Violation|3|||
33313302|NCT01007448|101040809|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
33313303|NCT01007448|101040810|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
33313304|NCT01007448|101040809|FG000|Overall Study|Staph Skin Infection Flare|1|||
33313305|NCT01007448|101040810|FG001|Overall Study|Staph Skin Infection Flare|0|||
33313306|NCT01007448|101040809|FG000|Overall Study|Participant Leaving the Country|1|||
33313307|NCT01007448|101040810|FG001|Overall Study|Participant Leaving the Country|0|||
33313308|NCT01007448|101040809|FG000|Overall Study|Participant Given Prohibited Medication|1|||
33313309|NCT01007448|101040810|FG001|Overall Study|Participant Given Prohibited Medication|0|||
33313310|NCT01007448|101040809|FG000|Overall Study|Progressive Disease|1|||
33313311|NCT01007448|101040810|FG001|Overall Study|Progressive Disease|2|||
33313312|NCT01007448|101040809|FG000|Overall Study|Lack of Efficacy|2|||
33313313|NCT01007448|101040810|FG001|Overall Study|Lack of Efficacy|0|||
33313314|NCT01007448|101040809|FG000|Overall Study|Withdrawal by Subject|2|||
33395808|NCT02574520|101337689|FG001|Overall Study|Withdrawal by Subject|0|||
33395809|NCT02574520|101337690|FG002|Overall Study|Withdrawal by Subject|0|||
33395810|NCT02574520|101337691|FG003|Overall Study|Withdrawal by Subject|1|||
33395811|NCT02574520|101337688|FG000|Overall Study|Other|0|||
33395812|NCT02574520|101337689|FG001|Overall Study|Other|0|||
33395813|NCT02574520|101337690|FG002|Overall Study|Other|0|||
33395814|NCT02574520|101337691|FG003|Overall Study|Other|2|||
33395815|NCT03231228|101337697|FG000|Overall Study|Lost to Follow-up|2|||
33395816|NCT03231228|101337698|FG001|Overall Study|Lost to Follow-up|0|||
33395817|NCT03231228|101337697|FG000|Overall Study|Physician Decision|1|||
33395818|NCT03231228|101337698|FG001|Overall Study|Physician Decision|0|||
33395819|NCT00634751|101337703|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
33395820|NCT00634751|101337704|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
33395821|NCT00634751|101337705|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
33395822|NCT00634751|101337706|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
33395823|NCT00634751|101337703|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
33395824|NCT00634751|101337704|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
33395825|NCT00634751|101337705|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
33395826|NCT00634751|101337706|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
33395827|NCT00634751|101337703|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
33395828|NCT00634751|101337704|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
33395829|NCT00634751|101337705|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
33395830|NCT00634751|101337706|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
33395831|NCT00784459|101337707|FG000|Overall Study|Adverse Event|0|||
33395832|NCT00784459|101337708|FG001|Overall Study|Adverse Event|2|||
33395833|NCT04412668|101337715|FG000|Overall Study|Death - multiple comorbidities|2|||
33395834|NCT04412668|101337716|FG001|Overall Study|Death - multiple comorbidities|0|||
33395835|NCT04412668|101337717|FG002|Overall Study|Death - multiple comorbidities|0|||
33503825|NCT00556933|101738447|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
33503826|NCT00556933|101738448|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
33503827|NCT00556933|101738449|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
33503828|NCT00556933|101738450|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
33602698|NCT00624780|102095404|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
33313315|NCT01007448|101040810|FG001|Overall Study|Withdrawal by Subject|3|||
33313316|NCT01007448|101040809|FG000|Overall Study|Adverse Event|1|||
33313317|NCT01007448|101040810|FG001|Overall Study|Adverse Event|4|||
33395836|NCT04412668|101337715|FG000|Overall Study|Withdrawal by Subject|3|||
33395837|NCT04412668|101337716|FG001|Overall Study|Withdrawal by Subject|0|||
33395838|NCT04412668|101337717|FG002|Overall Study|Withdrawal by Subject|0|||
33395839|NCT04412668|101337715|FG000|Overall Study|Other than Specified|2|||
33395840|NCT04412668|101337716|FG001|Overall Study|Other than Specified|0|||
33395841|NCT04412668|101337717|FG002|Overall Study|Other than Specified|0|||
33395842|NCT02332876|101337718|FG000|Overall Study|Lost to Follow-up|1|||
33395843|NCT02332876|101337719|FG001|Overall Study|Lost to Follow-up|1|||
33395844|NCT02015104|101337722|FG000|Overall Study|Withdrew consent after first dose drug|1|||
33395845|NCT02015104|101337723|FG001|Overall Study|Withdrew consent after first dose drug|0|||
33395846|NCT02015104|101337722|FG000|Overall Study|Withdrew consent prior to treatment|0|||
33395847|NCT02015104|101337723|FG001|Overall Study|Withdrew consent prior to treatment|1|||
33395848|NCT00374127|101337726|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
33395849|NCT00374127|101337726|FG000|Overall Study|Blood could not be drawn.|2|||
33395850|NCT00374127|101337726|FG000|Overall Study|Protocol Violation|5|||
33395851|NCT00374127|101337726|FG000|Overall Study|Pregnancy|1|||
33313318|NCT02520284|101040811|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
33395852|NCT00948194|101337729|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
33395853|NCT00948194|101337730|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
33395854|NCT01885104|101337731|FG000|Overall Study|Withdrawal of Consent|1|||
33395855|NCT01885104|101337732|FG001|Overall Study|Withdrawal of Consent|0|||
33395856|NCT01885104|101337731|FG000|Overall Study|Lost to Follow-up|0|||
33395857|NCT01885104|101337732|FG001|Overall Study|Lost to Follow-up|1|||
33395858|NCT01885104|101337731|FG000|Overall Study|Physician Decision|1|||
33395859|NCT01885104|101337732|FG001|Overall Study|Physician Decision|0|||
33313319|NCT02520284|101040812|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
33313320|NCT02520284|101040813|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
33313321|NCT02520284|101040811|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
33313322|NCT02520284|101040812|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
33313323|NCT02520284|101040813|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
33313324|NCT02520284|101040811|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
33313325|NCT02520284|101040812|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
33313326|NCT02520284|101040813|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
33313327|NCT02520284|101040811|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
33313328|NCT02520284|101040812|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
33313329|NCT02520284|101040813|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
33313330|NCT02520284|101040811|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
33313331|NCT02520284|101040812|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
33313332|NCT02520284|101040813|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
33313333|NCT02520284|101040811|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
33313334|NCT02520284|101040812|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
33313335|NCT02520284|101040813|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
33313336|NCT02520284|101040811|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
33313337|NCT02520284|101040812|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
33313338|NCT02520284|101040813|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
33313339|NCT02520284|101040811|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
33313340|NCT02520284|101040812|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
33313341|NCT02520284|101040813|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
33313342|NCT02520284|101040811|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
33313343|NCT02520284|101040812|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
33313344|NCT02520284|101040813|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
33313345|NCT02520284|101040811|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
33313346|NCT02520284|101040812|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
33313347|NCT02520284|101040813|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
33313348|NCT02520284|101040811|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
33313349|NCT02520284|101040812|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
33313350|NCT02520284|101040813|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
33313351|NCT02680002|101040822|FG000|Overall Study|Lost to Follow-up|5|||
33313352|NCT02680002|101040823|FG001|Overall Study|Lost to Follow-up|1|||
33313353|NCT02680002|101040824|FG002|Overall Study|Lost to Follow-up|4|||
33313354|NCT02680002|101040825|FG003|Overall Study|Lost to Follow-up|2|||
33313355|NCT02680002|101040826|FG004|Overall Study|Lost to Follow-up|0|||
33313356|NCT02680002|101040827|FG005|Overall Study|Lost to Follow-up|2|||
33313357|NCT02680002|101040822|FG000|Overall Study|Physician Decision|5|||
33313358|NCT02680002|101040823|FG001|Overall Study|Physician Decision|1|||
33313359|NCT02680002|101040824|FG002|Overall Study|Physician Decision|1|||
33313360|NCT02680002|101040825|FG003|Overall Study|Physician Decision|1|||
33313361|NCT02680002|101040826|FG004|Overall Study|Physician Decision|1|||
33313362|NCT02680002|101040827|FG005|Overall Study|Physician Decision|1|||
33313363|NCT02680002|101040822|FG000|Overall Study|Protocol Violation|1|||
33313364|NCT02680002|101040823|FG001|Overall Study|Protocol Violation|0|||
33313365|NCT02680002|101040824|FG002|Overall Study|Protocol Violation|1|||
33313366|NCT02680002|101040825|FG003|Overall Study|Protocol Violation|0|||
33313367|NCT02680002|101040826|FG004|Overall Study|Protocol Violation|1|||
33313368|NCT02680002|101040827|FG005|Overall Study|Protocol Violation|2|||
33313369|NCT02680002|101040822|FG000|Overall Study|Withdrawal by Subject|0|||
33395860|NCT02100813|101337754|FG000|Overall Study|Adverse Event|0|||
33193859|NCT01433263|100616211|FG001|Overall Study|Lost to Follow-up|1|||
33313370|NCT02680002|101040823|FG001|Overall Study|Withdrawal by Subject|0|||
33313371|NCT02680002|101040824|FG002|Overall Study|Withdrawal by Subject|1|||
33313372|NCT02680002|101040825|FG003|Overall Study|Withdrawal by Subject|0|||
33313373|NCT02680002|101040826|FG004|Overall Study|Withdrawal by Subject|2|||
33313374|NCT02680002|101040827|FG005|Overall Study|Withdrawal by Subject|2|||
33313375|NCT02680002|101040822|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
33313376|NCT02680002|101040823|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
33313377|NCT02680002|101040824|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
33395861|NCT02100813|101337755|FG001|Overall Study|Adverse Event|0|||
33395862|NCT02100813|101337756|FG002|Overall Study|Adverse Event|0|||
33395863|NCT02100813|101337757|FG003|Overall Study|Adverse Event|0|||
33395864|NCT02100813|101337758|FG004|Overall Study|Adverse Event|0|||
33395865|NCT02100813|101337759|FG005|Overall Study|Adverse Event|0|||
33313378|NCT02680002|101040825|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
33313379|NCT02680002|101040826|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
33313380|NCT02680002|101040827|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
33313381|NCT02680002|101040822|FG000|Overall Study|Other|0|||
33503829|NCT00556933|101738447|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
33503830|NCT00556933|101738448|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
33503831|NCT00556933|101738449|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
33503832|NCT00556933|101738450|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
33503833|NCT00556933|101738447|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
33503834|NCT00556933|101738448|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
33503835|NCT00556933|101738449|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
33503836|NCT00556933|101738450|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
33503837|NCT00556933|101738447|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
33503838|NCT00556933|101738448|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
33503839|NCT00556933|101738449|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
33503840|NCT00556933|101738450|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
33503841|NCT00556933|101738447|FG000|CNI Withdrawal vs. Minimization|Death|0|||
33503842|NCT00556933|101738448|FG001|CNI Withdrawal vs. Minimization|Death|0|||
33503843|NCT00556933|101738449|FG002|CNI Withdrawal vs. Minimization|Death|0|||
33503844|NCT00556933|101738450|FG003|CNI Withdrawal vs. Minimization|Death|1|||
33503845|NCT03512210|101738451|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
33503846|NCT03512210|101738451|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
33503847|NCT03512210|101738451|FG000|Step 2:Post-MINMON|Death|2|||
33503848|NCT03512210|101738451|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
33503849|NCT03512210|101738451|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
33503850|NCT03691207|101738453|FG000|Overall Study|Death|41|||
33503851|NCT03691207|101738454|FG001|Overall Study|Death|26|||
33503852|NCT03691207|101738453|FG000|Overall Study|Lost to Follow-up|1|||
33503853|NCT03691207|101738454|FG001|Overall Study|Lost to Follow-up|1|||
33503854|NCT03691207|101738453|FG000|Overall Study|Withdrawal by Subject|2|||
33503855|NCT03691207|101738454|FG001|Overall Study|Withdrawal by Subject|8|||
33503856|NCT03691207|101738453|FG000|Overall Study|Sponsor decision|1|||
33503857|NCT03691207|101738454|FG001|Overall Study|Sponsor decision|7|||
33503858|NCT02760004|101738455|FG000|Overall Study|Lost to Follow-up|13|||
33503859|NCT02760004|101738456|FG001|Overall Study|Lost to Follow-up|22|||
33503860|NCT05140382|101738459|FG000|Overall Study|Death|3|||
33503861|NCT05140382|101738460|FG001|Overall Study|Death|0|||
33503862|NCT05140382|101738461|FG002|Overall Study|Death|0|||
33503863|NCT05140382|101738459|FG000|Overall Study|Investigator decision|1|||
33503864|NCT05140382|101738460|FG001|Overall Study|Investigator decision|0|||
33503865|NCT05140382|101738461|FG002|Overall Study|Investigator decision|0|||
33503866|NCT05140382|101738459|FG000|Overall Study|Other|4|||
33503867|NCT05140382|101738460|FG001|Overall Study|Other|0|||
33503868|NCT05140382|101738461|FG002|Overall Study|Other|1|||
33503869|NCT05140382|101738459|FG000|Overall Study|Progressive disease|20|||
33503870|NCT05140382|101738460|FG001|Overall Study|Progressive disease|1|||
33503871|NCT05140382|101738461|FG002|Overall Study|Progressive disease|12|||
33503872|NCT05140382|101738459|FG000|Overall Study|Subjective disease progression|2|||
33503873|NCT05140382|101738460|FG001|Overall Study|Subjective disease progression|1|||
33193860|NCT01433263|100616210|FG000|Overall Study|Protocol Deviation|1|||
33193861|NCT01433263|100616211|FG001|Overall Study|Protocol Deviation|0|||
33193862|NCT01433263|100616210|FG000|Overall Study|Withdrawal by Subject|10|||
33193863|NCT01433263|100616211|FG001|Overall Study|Withdrawal by Subject|7|||
33193864|NCT00281840|100616212|FG000|Overall Study|Adverse Event|12|||
33193865|NCT00281840|100616212|FG000|Overall Study|Physician Decision|6|||
33193866|NCT00281840|100616212|FG000|Overall Study|Withdrawal by Subject|3|||
33193867|NCT00281840|100616212|FG000|Overall Study|Disease Progression|2|||
33193868|NCT00281840|100616212|FG000|Overall Study|exceed maximum delay in treatment|1|||
33193869|NCT00281840|100616212|FG000|Overall Study|Complicating Disease|1|||
33503874|NCT05140382|101738461|FG002|Overall Study|Subjective disease progression|0|||
33503875|NCT05140382|101738459|FG000|Overall Study|Unknown at data cut-off|0|||
33503876|NCT05140382|101738460|FG001|Overall Study|Unknown at data cut-off|0|||
33503877|NCT05140382|101738461|FG002|Overall Study|Unknown at data cut-off|1|||
33503878|NCT05140382|101738459|FG000|Overall Study|Withdrawal by Subject|1|||
33503879|NCT05140382|101738460|FG001|Overall Study|Withdrawal by Subject|0|||
33503880|NCT05140382|101738461|FG002|Overall Study|Withdrawal by Subject|4|||
33503881|NCT05140382|101738459|FG000|Overall Study|Withdrawal of consent|0|||
33503882|NCT05140382|101738460|FG001|Overall Study|Withdrawal of consent|0|||
33503883|NCT05140382|101738461|FG002|Overall Study|Withdrawal of consent|1|||
33503884|NCT00423332|101738462|FG000|Overall Study|Adverse Event|6|||
33503885|NCT00423332|101738463|FG001|Overall Study|Adverse Event|2|||
33503886|NCT00423332|101738462|FG000|Overall Study|Withdrawal by Subject|1|||
33503887|NCT00423332|101738463|FG001|Overall Study|Withdrawal by Subject|0|||
33503888|NCT00423332|101738462|FG000|Overall Study|Condition under investigation worsened|1|||
33313382|NCT02680002|101040823|FG001|Overall Study|Other|1|||
33313383|NCT02680002|101040824|FG002|Overall Study|Other|0|||
33313384|NCT02680002|101040825|FG003|Overall Study|Other|0|||
33313385|NCT02680002|101040826|FG004|Overall Study|Other|1|||
33313386|NCT02680002|101040827|FG005|Overall Study|Other|0|||
33313387|NCT02680002|101040822|FG000|Overall Study|Adverse Event|0|||
33313388|NCT02680002|101040823|FG001|Overall Study|Adverse Event|0|||
33313389|NCT02680002|101040824|FG002|Overall Study|Adverse Event|0|||
33313390|NCT02680002|101040825|FG003|Overall Study|Adverse Event|0|||
33313391|NCT02680002|101040826|FG004|Overall Study|Adverse Event|1|||
33313392|NCT02680002|101040827|FG005|Overall Study|Adverse Event|2|||
33313393|NCT01275131|101040830|FG000|Period 1|Withdrawal by Subject|1|||
33313394|NCT01275131|101040831|FG001|Period 1|Withdrawal by Subject|0|||
33313395|NCT01275131|101040832|FG002|Period 1|Withdrawal by Subject|3|||
33313396|NCT01275131|101040833|FG003|Period 1|Withdrawal by Subject|2|||
33313397|NCT01275131|101040830|FG000|Period 1|Physician Decision|1|||
33313398|NCT01275131|101040831|FG001|Period 1|Physician Decision|0|||
33313399|NCT01275131|101040832|FG002|Period 1|Physician Decision|0|||
33313400|NCT01275131|101040833|FG003|Period 1|Physician Decision|0|||
33313401|NCT01275131|101040830|FG000|Period 2 (Crossover)|Adverse Event|0|||
33313402|NCT01275131|101040831|FG001|Period 2 (Crossover)|Adverse Event|1|||
33313403|NCT01275131|101040832|FG002|Period 2 (Crossover)|Adverse Event|0|||
33313404|NCT01275131|101040833|FG003|Period 2 (Crossover)|Adverse Event|0|||
33313405|NCT01275131|101040830|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
33395866|NCT02100813|101337760|FG006|Overall Study|Adverse Event|0|||
33395867|NCT02100813|101337761|FG007|Overall Study|Adverse Event|1|||
33395868|NCT01388491|101337762|FG000|Overall Study|Adverse Event|10|||
33395869|NCT01388491|101337763|FG001|Overall Study|Adverse Event|9|||
33503889|NCT00423332|101738463|FG001|Overall Study|Condition under investigation worsened|1|||
33503890|NCT00423332|101738462|FG000|Overall Study|Progressive at Week 6|0|||
33503891|NCT00423332|101738463|FG001|Overall Study|Progressive at Week 6|1|||
33503892|NCT00423332|101738462|FG000|Overall Study|Unblinded before 12 weeks|1|||
33503893|NCT00423332|101738463|FG001|Overall Study|Unblinded before 12 weeks|3|||
33503894|NCT00831311|101738464|FG000|Overall Study|Definitive Contraindication|3|||
33503895|NCT00831311|101738465|FG001|Overall Study|Definitive Contraindication|3|||
33503896|NCT00831311|101738464|FG000|Overall Study|Lost to Follow-up|3|||
33503897|NCT00831311|101738465|FG001|Overall Study|Lost to Follow-up|0|||
33503898|NCT00831311|101738464|FG000|Overall Study|Physician Decision|0|||
33503899|NCT00831311|101738465|FG001|Overall Study|Physician Decision|1|||
33503900|NCT00831311|101738464|FG000|Overall Study|Withdrawal by Subject|6|||
33503901|NCT00831311|101738465|FG001|Overall Study|Withdrawal by Subject|4|||
33503902|NCT02308540|101738466|FG000|Overall Study|Lost to Follow-up|0|||
33503903|NCT02308540|101738467|FG001|Overall Study|Lost to Follow-up|0|||
33503904|NCT02308540|101738468|FG002|Overall Study|Lost to Follow-up|0|||
33503905|NCT02308540|101738469|FG003|Overall Study|Lost to Follow-up|0|||
33503906|NCT02308540|101738470|FG004|Overall Study|Lost to Follow-up|0|||
33503907|NCT02308540|101738471|FG005|Overall Study|Lost to Follow-up|1|||
33503908|NCT00178685|101738472|FG000|Overall Study|Death|3|||
33503909|NCT00178685|101738473|FG001|Overall Study|Death|3|||
33503910|NCT00178685|101738474|FG002|Overall Study|Death|6|||
33602699|NCT00624780|102095399|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
33313406|NCT01275131|101040831|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
33313407|NCT01275131|101040832|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
33313408|NCT01275131|101040833|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
33313409|NCT01596621|101040835|FG000|Overall Study|Death|4|||
33313410|NCT01596621|101040835|FG000|Overall Study|Withdrawal by Subject|9|||
33395870|NCT01388491|101337762|FG000|Overall Study|Sponsor Request|9|||
33503911|NCT00178685|101738472|FG000|Overall Study|Lost to Follow-up|100|||
33503912|NCT00178685|101738473|FG001|Overall Study|Lost to Follow-up|187|||
33503913|NCT00178685|101738474|FG002|Overall Study|Lost to Follow-up|183|||
33503914|NCT00178685|101738472|FG000|Overall Study|Withdrawal by Subject|8|||
33503915|NCT00178685|101738473|FG001|Overall Study|Withdrawal by Subject|14|||
33313411|NCT01596621|101040835|FG000|Overall Study|Disease Progression|49|||
33313412|NCT01596621|101040835|FG000|Overall Study|Lost to Follow-up|3|||
33313413|NCT01596621|101040835|FG000|Overall Study|Other than specified|13|||
33503916|NCT00178685|101738474|FG002|Overall Study|Withdrawal by Subject|7|||
33503917|NCT03058705|101738478|FG000|Overall Study|Withdrawal by Subject|2|||
33503918|NCT03058705|101738478|FG000|Overall Study|Physician Decision|2|||
33313414|NCT00495586|101040836|FG000|Overall Study|Withdrawal by Subject|4|||
33313415|NCT00495586|101040837|FG001|Overall Study|Withdrawal by Subject|4|||
33503919|NCT02411396|101738479|FG000|Overall Study|Lost to Follow-up|31|||
33503920|NCT02411396|101738479|FG000|Overall Study|Death|10|||
33503921|NCT00356122|101738480|FG000|TREATMENT|Lack of Efficacy|26|||
33503922|NCT00356122|101738480|FG000|TREATMENT|Adverse Event|10|||
33503923|NCT00356122|101738480|FG000|TREATMENT|Subject's request|4|||
33503924|NCT00356122|101738480|FG000|TREATMENT|Other|4|||
33503925|NCT00356122|101738480|FG000|TREATMENT|Did not receive study medication|1|||
33602700|NCT00624780|102095400|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
33602701|NCT00624780|102095401|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
33602702|NCT00624780|102095402|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
33313416|NCT04634825|101040838|FG000|Overall Study|Death|10|||
33313417|NCT04634825|101040839|FG001|Overall Study|Death|3|||
33602703|NCT00624780|102095403|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
33602704|NCT00624780|102095404|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
33313418|NCT04634825|101040838|FG000|Overall Study|Lost to Follow-up|1|||
33313419|NCT04634825|101040839|FG001|Overall Study|Lost to Follow-up|0|||
33313420|NCT04634825|101040838|FG000|Overall Study|Study terminated by sponsor|35|||
33313421|NCT04634825|101040839|FG001|Overall Study|Study terminated by sponsor|11|||
33313422|NCT04634825|101040838|FG000|Overall Study|Withdrawal by Subject|2|||
33313423|NCT04634825|101040839|FG001|Overall Study|Withdrawal by Subject|0|||
33602705|NCT00624780|102095399|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
33602706|NCT00624780|102095400|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
33602707|NCT00624780|102095401|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
33602708|NCT00624780|102095402|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
33602709|NCT00624780|102095403|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
33602710|NCT00624780|102095404|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
33602711|NCT00624780|102095399|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
33602712|NCT00624780|102095400|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
33602713|NCT00624780|102095401|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
33602714|NCT00624780|102095402|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
33602715|NCT00624780|102095403|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
33602716|NCT00624780|102095404|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
33602717|NCT00624780|102095399|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
33602718|NCT00624780|102095400|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
33602719|NCT00624780|102095401|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
33602720|NCT00624780|102095402|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
33602721|NCT00624780|102095403|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
33602722|NCT00624780|102095404|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
33602723|NCT00624780|102095399|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
33602724|NCT00624780|102095400|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
33602725|NCT00624780|102095401|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
33602726|NCT00624780|102095402|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
33602727|NCT00624780|102095403|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
33602728|NCT00624780|102095404|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
33602729|NCT00624780|102095399|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
33602730|NCT00624780|102095400|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
33602731|NCT00624780|102095401|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
33602732|NCT00624780|102095402|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
33602733|NCT00624780|102095403|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
33602734|NCT00624780|102095404|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
33602735|NCT00624780|102095399|FG000|Follow-up (Week 26)|Death|0|||
33602736|NCT00624780|102095400|FG001|Follow-up (Week 26)|Death|0|||
33602737|NCT00624780|102095401|FG002|Follow-up (Week 26)|Death|1|||
33313424|NCT03513588|101040841|FG000|Overall Study|Lost to Follow-up|0|||
33313425|NCT03513588|101040842|FG001|Overall Study|Lost to Follow-up|1|||
33313426|NCT03513588|101040843|FG002|Overall Study|Lost to Follow-up|1|||
33313427|NCT03513588|101040841|FG000|Overall Study|Study dosing paused by sponsor|1|||
33313428|NCT03513588|101040842|FG001|Overall Study|Study dosing paused by sponsor|1|||
33313429|NCT03513588|101040843|FG002|Overall Study|Study dosing paused by sponsor|0|||
33313430|NCT03513588|101040841|FG000|Overall Study|Death|0|||
33313431|NCT03513588|101040842|FG001|Overall Study|Death|0|||
33313432|NCT03513588|101040843|FG002|Overall Study|Death|1|||
33395871|NCT01388491|101337763|FG001|Overall Study|Sponsor Request|7|||
33313433|NCT02678247|101040846|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
33313434|NCT02678247|101040847|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
33395872|NCT01388491|101337762|FG000|Overall Study|Withdrawal by Subject|6|||
33313435|NCT02678247|101040846|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
33395873|NCT01388491|101337763|FG001|Overall Study|Withdrawal by Subject|10|||
33503926|NCT00356122|101738480|FG000|FOLLOW-UP|Death|37|||
33503927|NCT00356122|101738480|FG000|FOLLOW-UP|Lost to Follow-up|2|||
33503928|NCT00356122|101738480|FG000|FOLLOW-UP|Other|2|||
33313436|NCT02678247|101040847|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
33313437|NCT02678247|101040846|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
33313438|NCT02678247|101040847|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
33313439|NCT02678247|101040846|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
33313440|NCT02678247|101040847|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
33313441|NCT02678247|101040846|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
33313442|NCT02678247|101040847|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
33313443|NCT02678247|101040846|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
33313444|NCT02678247|101040847|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
33313445|NCT02270515|101040848|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
33313446|NCT02270515|101040848|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
33503929|NCT00820248|101738483|FG000|Overall Study|No treated|4|||
33503930|NCT00820248|101738484|FG001|Overall Study|No treated|1|||
33503931|NCT03086967|101738490|FG000|Overall Study|Screen Failure|2|||
33503932|NCT03086967|101738491|FG001|Overall Study|Screen Failure|2|||
33503933|NCT01029782|101738492|FG000|Overall Study|Lost to Follow-up|2|||
33503934|NCT01029782|101738493|FG001|Overall Study|Lost to Follow-up|2|||
33503935|NCT01029782|101738492|FG000|Overall Study|Diagnosis changed|1|||
33503936|NCT01029782|101738493|FG001|Overall Study|Diagnosis changed|1|||
33313447|NCT02270515|101040848|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
33313448|NCT02270515|101040848|FG000|Intervention Period 1: 0-6 Months|Death|7|||
33313449|NCT02270515|101040848|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
33313450|NCT02270515|101040848|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
33313451|NCT02270515|101040848|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
33313452|NCT02270515|101040848|FG000|Intervention Period 2: 6-12 Months|Death|5|||
33313453|NCT02270515|101040848|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
33313454|NCT02270515|101040848|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
33313455|NCT02270515|101040848|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
33313456|NCT02270515|101040848|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
33313457|NCT02270515|101040848|FG000|Intervention Period 3: 12-18 Months|Death|3|||
33313458|NCT02270515|101040848|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
33313459|NCT01689337|101040849|FG000|Overall Study|Study Discontinuation|1|||
33313460|NCT04256629|101040850|FG000|Overall Study|Adverse Event|0|||
33313461|NCT04256629|101040851|FG001|Overall Study|Adverse Event|0|||
33313462|NCT04256629|101040852|FG002|Overall Study|Adverse Event|0|||
33313463|NCT04256629|101040853|FG003|Overall Study|Adverse Event|0|||
33503937|NCT01029782|101738492|FG000|Overall Study|Adverse Event|0|||
33313464|NCT04256629|101040854|FG004|Overall Study|Adverse Event|0|||
33313465|NCT04256629|101040855|FG005|Overall Study|Adverse Event|1|||
33313466|NCT04256629|101040850|FG000|Overall Study|Protocol Violation|0|||
33313467|NCT04256629|101040851|FG001|Overall Study|Protocol Violation|1|||
33503938|NCT01029782|101738493|FG001|Overall Study|Adverse Event|1|||
33503939|NCT01029782|101738492|FG000|Overall Study|Physician Decision|0|||
33503940|NCT01029782|101738493|FG001|Overall Study|Physician Decision|1|||
33503941|NCT01029782|101738492|FG000|Overall Study|Protocol Violation|0|||
33503942|NCT01029782|101738493|FG001|Overall Study|Protocol Violation|2|||
33503943|NCT01029782|101738492|FG000|Overall Study|Withdrawal by Subject|0|||
33503944|NCT01029782|101738493|FG001|Overall Study|Withdrawal by Subject|1|||
33503945|NCT00754234|101738494|FG000|Overall Study|Withdrawal by Subject|3|||
33503946|NCT02582684|101738495|FG000|Overall Study|Unable to contact subject/parent|4|||
33503947|NCT02582684|101738495|FG000|Overall Study|Subject not able to get to clinic|10|||
33503948|NCT02582684|101738495|FG000|Overall Study|Subject withdrew consent|1|||
33313468|NCT04256629|101040852|FG002|Overall Study|Protocol Violation|0|||
33313469|NCT04256629|101040853|FG003|Overall Study|Protocol Violation|0|||
33313470|NCT04256629|101040854|FG004|Overall Study|Protocol Violation|0|||
33313471|NCT04256629|101040855|FG005|Overall Study|Protocol Violation|0|||
33313472|NCT01614197|101040856|FG000|Overall Study|Withdrawal by Subject|0|||
33313473|NCT01614197|101040857|FG001|Overall Study|Withdrawal by Subject|1|||
33313474|NCT01614197|101040858|FG002|Overall Study|Withdrawal by Subject|0|||
33313475|NCT01614197|101040859|FG003|Overall Study|Withdrawal by Subject|0|||
33313476|NCT02076178|101040863|FG000|Oral Phase|Adverse Event|0|||
33503949|NCT02582684|101738495|FG000|Overall Study|Found to be ineligible after enrollment|2|||
33313477|NCT02076178|101040864|FG001|Oral Phase|Adverse Event|7|||
33313478|NCT02076178|101040863|FG000|Oral Phase|Withdrawal by Subject|0|||
33313479|NCT02076178|101040864|FG001|Oral Phase|Withdrawal by Subject|4|||
33313480|NCT02076178|101040863|FG000|Oral Phase|Physician Decision|0|||
33313481|NCT02076178|101040864|FG001|Oral Phase|Physician Decision|1|||
33313482|NCT02076178|101040863|FG000|Injection Phase|Protocol defined stopping criteria|1|||
33503950|NCT05253573|101738496|FG000|Overall Study|Death|1|||
33503951|NCT05253573|101738497|FG001|Overall Study|Death|0|||
33503952|NCT01986933|101738500|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
33503953|NCT01986933|101738501|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
33503954|NCT01986933|101738502|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
33503955|NCT01986933|101738503|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
33503956|NCT01986933|101738504|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
33503957|NCT01986933|101738500|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
33503958|NCT01986933|101738501|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
33313483|NCT02076178|101040864|FG001|Injection Phase|Protocol defined stopping criteria|0|||
33313484|NCT02076178|101040863|FG000|Injection Phase|Withdrawal by Subject|0|||
33313485|NCT02076178|101040864|FG001|Injection Phase|Withdrawal by Subject|3|||
33313486|NCT02076178|101040863|FG000|Injection Phase|Physician Decision|0|||
33313487|NCT02076178|101040864|FG001|Injection Phase|Physician Decision|3|||
33313488|NCT02076178|101040863|FG000|Injection Phase|Lost to Follow-up|0|||
33503959|NCT01986933|101738502|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
33503960|NCT01986933|101738503|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
33503961|NCT01986933|101738504|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
33503962|NCT01986933|101738500|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
33313489|NCT02076178|101040864|FG001|Injection Phase|Lost to Follow-up|1|||
33313490|NCT01839487|101040865|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
33503963|NCT01986933|101738501|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
33503964|NCT01986933|101738502|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
33503965|NCT01986933|101738503|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
33503966|NCT01986933|101738504|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
33503967|NCT01986933|101738500|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
33503968|NCT01986933|101738501|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
33503969|NCT01986933|101738502|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
33503970|NCT01986933|101738503|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
33503971|NCT01986933|101738504|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
33503972|NCT01986933|101738500|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
33503973|NCT01986933|101738501|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
33503974|NCT01986933|101738502|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
33503975|NCT01986933|101738503|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
33503976|NCT01986933|101738504|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
33503977|NCT01986933|101738500|FG000|Active-to-active (Part B)|Adverse Event|0|||
33503978|NCT01986933|101738501|FG001|Active-to-active (Part B)|Adverse Event|2|||
33503979|NCT01986933|101738502|FG002|Active-to-active (Part B)|Adverse Event|0|||
33503980|NCT01986933|101738503|FG003|Active-to-active (Part B)|Adverse Event|1|||
33503981|NCT01986933|101738504|FG004|Active-to-active (Part B)|Adverse Event|3|||
33503982|NCT01986933|101738500|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
33503983|NCT01986933|101738501|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
33503984|NCT01986933|101738502|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
33503985|NCT01986933|101738503|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
33503986|NCT01986933|101738504|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
33503987|NCT01986933|101738500|FG000|Active-to-active (Part B)|Pregnancy|0|||
33503988|NCT01986933|101738501|FG001|Active-to-active (Part B)|Pregnancy|0|||
33503989|NCT01986933|101738502|FG002|Active-to-active (Part B)|Pregnancy|0|||
33503990|NCT01986933|101738503|FG003|Active-to-active (Part B)|Pregnancy|0|||
33503991|NCT01986933|101738504|FG004|Active-to-active (Part B)|Pregnancy|1|||
33503992|NCT01986933|101738500|FG000|Active-to-active (Part B)|Physician Decision|0|||
33503993|NCT01986933|101738501|FG001|Active-to-active (Part B)|Physician Decision|0|||
33503994|NCT01986933|101738502|FG002|Active-to-active (Part B)|Physician Decision|1|||
33503995|NCT01986933|101738503|FG003|Active-to-active (Part B)|Physician Decision|1|||
33503996|NCT01986933|101738504|FG004|Active-to-active (Part B)|Physician Decision|0|||
33503997|NCT01986933|101738500|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
33503998|NCT01986933|101738501|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
33503999|NCT01986933|101738502|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
33504000|NCT01986933|101738503|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
33313491|NCT01839487|101040866|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
33395874|NCT01388491|101337762|FG000|Overall Study|Lost to Follow-up|4|||
33504001|NCT01986933|101738504|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
33504002|NCT01986933|101738500|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
33504003|NCT01986933|101738501|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
33504004|NCT01986933|101738502|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
33504005|NCT01986933|101738503|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
33504006|NCT01986933|101738504|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
33504007|NCT01986933|101738500|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
33504008|NCT01986933|101738501|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
33504009|NCT01986933|101738502|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
33504010|NCT01986933|101738503|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
33504011|NCT01986933|101738504|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
33504012|NCT01986933|101738500|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
33504013|NCT01986933|101738501|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
33504014|NCT01986933|101738502|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
33504015|NCT01986933|101738503|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
33504016|NCT01986933|101738504|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
33504017|NCT01986933|101738500|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
33504018|NCT01986933|101738501|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
33504019|NCT01986933|101738502|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
33602738|NCT00624780|102095402|FG003|Follow-up (Week 26)|Death|0|||
33602739|NCT00624780|102095403|FG004|Follow-up (Week 26)|Death|0|||
33193870|NCT02652624|100616215|FG000|Randomized Phase|Pregnancy|3|||
33193871|NCT02652624|100616216|FG001|Randomized Phase|Pregnancy|1|||
33193872|NCT02652624|100616215|FG000|Randomized Phase|Investigator's Discretion|0|||
33193873|NCT02652624|100616216|FG001|Randomized Phase|Investigator's Discretion|2|||
33193874|NCT02652624|100616215|FG000|Randomized Phase|Death|0|||
33193875|NCT02652624|100616216|FG001|Randomized Phase|Death|1|||
33193876|NCT02652624|100616215|FG000|Randomized Phase|Lost to Follow-up|0|||
33193877|NCT02652624|100616216|FG001|Randomized Phase|Lost to Follow-up|1|||
33193878|NCT02652624|100616215|FG000|Extension Phase|Lost to Follow-up|3|||
33313492|NCT01839487|101040867|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
33602740|NCT00624780|102095404|FG005|Follow-up (Week 26)|Death|0|||
33602741|NCT00624780|102095399|FG000|Follow-up (Week 26)|Adverse Event|0|||
33602742|NCT00624780|102095400|FG001|Follow-up (Week 26)|Adverse Event|0|||
33602743|NCT00624780|102095401|FG002|Follow-up (Week 26)|Adverse Event|0|||
33602744|NCT00624780|102095402|FG003|Follow-up (Week 26)|Adverse Event|0|||
33602745|NCT00624780|102095403|FG004|Follow-up (Week 26)|Adverse Event|1|||
33602746|NCT00624780|102095404|FG005|Follow-up (Week 26)|Adverse Event|0|||
33602747|NCT00624780|102095399|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
33602748|NCT00624780|102095400|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
33602749|NCT00624780|102095401|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
33602750|NCT00624780|102095402|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
33602751|NCT00624780|102095403|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
33602752|NCT00624780|102095404|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
33602753|NCT00624780|102095399|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
33602754|NCT00624780|102095400|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
33602755|NCT00624780|102095401|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
33602756|NCT00624780|102095402|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
33602757|NCT00624780|102095403|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
33602758|NCT00624780|102095404|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
33602759|NCT00624780|102095399|FG000|Follow-up (Week 26)|Other|1|||
33602760|NCT00624780|102095400|FG001|Follow-up (Week 26)|Other|1|||
33602761|NCT00624780|102095401|FG002|Follow-up (Week 26)|Other|0|||
33602762|NCT00624780|102095402|FG003|Follow-up (Week 26)|Other|0|||
33602763|NCT00624780|102095403|FG004|Follow-up (Week 26)|Other|0|||
33602764|NCT00624780|102095404|FG005|Follow-up (Week 26)|Other|0|||
33602765|NCT05136898|102095405|FG000|Overall Study|Adverse Event|2|||
33602766|NCT02080260|102095406|FG000|Overall Study|Death|18|||
33602767|NCT02080260|102095406|FG000|Overall Study|Withdrawal by Subject|1|||
33602768|NCT01561963|102099112|FG000|Overall Study|Adverse Event|1|||
33602769|NCT03131596|102099113|FG000|Overall Study|Protocol Violation|3|||
33602770|NCT03131596|102099114|FG001|Overall Study|Protocol Violation|3|||
33602771|NCT03131596|102099113|FG000|Overall Study|Lost to Follow-up|3|||
33602772|NCT03131596|102099114|FG001|Overall Study|Lost to Follow-up|0|||
33602773|NCT03559699|102099115|FG000|Overall Study|Withdrawal by Subject|6|||
33602774|NCT03559699|102099115|FG000|Overall Study|Lost to Follow-up|1|||
33602775|NCT02117349|102099118|FG000|Overall Study|Withdrawal by Subject|1|||
33602776|NCT02117349|102099119|FG001|Overall Study|Withdrawal by Subject|0|||
33602777|NCT02117349|102099118|FG000|Overall Study|Lost to Follow-up|1|||
33602778|NCT02117349|102099119|FG001|Overall Study|Lost to Follow-up|1|||
33602779|NCT02117349|102099118|FG000|Overall Study|Death|1|||
33602780|NCT02117349|102099119|FG001|Overall Study|Death|0|||
33602781|NCT02981524|102099120|FG000|Overall Study|Progressive Disease|14|||
33602782|NCT02981524|102099120|FG000|Overall Study|Death (unrelated)|1|||
33602783|NCT02981524|102099120|FG000|Overall Study|Treatment Related Toxicity|1|||
33602784|NCT02981524|102099120|FG000|Overall Study|Withdrawal by Subject|1|||
33602785|NCT05545644|102099121|FG000|Overall Study|Lost to Follow-up|4|||
33602786|NCT05545644|102099122|FG001|Overall Study|Lost to Follow-up|3|||
33193879|NCT02652624|100616216|FG001|Extension Phase|Lost to Follow-up|1|||
33193880|NCT02652624|100616215|FG000|Extension Phase|Pregnancy|1|||
33504020|NCT01986933|101738503|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
33504021|NCT01986933|101738504|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
33504022|NCT01986933|101738500|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
33602787|NCT04063787|102099123|FG000|Overall Study|Inadequate Doppler data|4|||
33602788|NCT04063787|102099123|FG000|Overall Study|Lost to Follow-up|2|||
33602789|NCT04063787|102099123|FG000|Overall Study|Death|3|||
33602790|NCT02683668|102099124|FG000|Period 2|Withdrawal by Subject|0|||
33602791|NCT02683668|102099125|FG001|Period 2|Withdrawal by Subject|1|||
33602792|NCT02683668|102099126|FG002|Period 2|Withdrawal by Subject|0|||
33602793|NCT02715726|102099129|FG000|Overall Study|Adverse Event|2|||
33193881|NCT02652624|100616216|FG001|Extension Phase|Pregnancy|1|||
33193882|NCT02652624|100616215|FG000|Extension Phase|Adverse Event|0|||
33504023|NCT01986933|101738501|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
33504024|NCT01986933|101738502|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
33504025|NCT01986933|101738503|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
33504026|NCT01986933|101738504|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
33193883|NCT02652624|100616216|FG001|Extension Phase|Adverse Event|1|||
33193884|NCT02652624|100616215|FG000|Extension Phase|Withdrew Consent|0|||
33193885|NCT02652624|100616216|FG001|Extension Phase|Withdrew Consent|1|||
33193886|NCT00414050|100616217|FG000|Overall Study|Adverse Event|1|||
33193887|NCT00414050|100616218|FG001|Overall Study|Adverse Event|1|||
33504027|NCT01986933|101738500|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
33504028|NCT01986933|101738501|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
33504029|NCT01986933|101738502|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
33504030|NCT01986933|101738503|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
33504031|NCT01986933|101738504|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
33504032|NCT01986933|101738500|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
33504033|NCT01986933|101738501|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
33504034|NCT01986933|101738502|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
33504035|NCT01986933|101738503|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
33504036|NCT01986933|101738504|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
33504037|NCT02477332|101738505|FG000|Overall Study|Adverse Event|0|||
33504038|NCT02477332|101738506|FG001|Overall Study|Adverse Event|1|||
33504039|NCT02477332|101738507|FG002|Overall Study|Adverse Event|1|||
33504040|NCT02477332|101738508|FG003|Overall Study|Adverse Event|2|||
33504041|NCT02477332|101738509|FG004|Overall Study|Adverse Event|1|||
33504042|NCT02477332|101738510|FG005|Overall Study|Adverse Event|2|||
33504043|NCT02477332|101738505|FG000|Overall Study|Lack of Efficacy|1|||
33504044|NCT02477332|101738506|FG001|Overall Study|Lack of Efficacy|2|||
33504045|NCT02477332|101738507|FG002|Overall Study|Lack of Efficacy|1|||
33504046|NCT02477332|101738508|FG003|Overall Study|Lack of Efficacy|2|||
33504047|NCT02477332|101738509|FG004|Overall Study|Lack of Efficacy|1|||
33504048|NCT02477332|101738510|FG005|Overall Study|Lack of Efficacy|1|||
33504049|NCT02477332|101738505|FG000|Overall Study|Non-compliance with study treatment|0|||
33504050|NCT02477332|101738506|FG001|Overall Study|Non-compliance with study treatment|1|||
33504051|NCT02477332|101738507|FG002|Overall Study|Non-compliance with study treatment|2|||
33504052|NCT02477332|101738508|FG003|Overall Study|Non-compliance with study treatment|0|||
33504053|NCT02477332|101738509|FG004|Overall Study|Non-compliance with study treatment|0|||
33504054|NCT02477332|101738510|FG005|Overall Study|Non-compliance with study treatment|0|||
33504055|NCT02477332|101738505|FG000|Overall Study|Pregnancy|0|||
33504056|NCT02477332|101738506|FG001|Overall Study|Pregnancy|0|||
33504057|NCT02477332|101738507|FG002|Overall Study|Pregnancy|0|||
33504058|NCT02477332|101738508|FG003|Overall Study|Pregnancy|1|||
33504059|NCT02477332|101738509|FG004|Overall Study|Pregnancy|0|||
33504060|NCT02477332|101738510|FG005|Overall Study|Pregnancy|0|||
33504061|NCT02477332|101738505|FG000|Overall Study|Protocol Violation|2|||
33504062|NCT02477332|101738506|FG001|Overall Study|Protocol Violation|0|||
33504063|NCT02477332|101738507|FG002|Overall Study|Protocol Violation|3|||
33504064|NCT02477332|101738508|FG003|Overall Study|Protocol Violation|3|||
33504065|NCT02477332|101738509|FG004|Overall Study|Protocol Violation|1|||
33504066|NCT02477332|101738510|FG005|Overall Study|Protocol Violation|1|||
33504067|NCT02477332|101738505|FG000|Overall Study|Technical problems|0|||
33504068|NCT02477332|101738506|FG001|Overall Study|Technical problems|0|||
33504069|NCT02477332|101738507|FG002|Overall Study|Technical problems|1|||
33504070|NCT02477332|101738508|FG003|Overall Study|Technical problems|0|||
33193888|NCT00414050|100616219|FG002|Overall Study|Adverse Event|1|||
33504071|NCT02477332|101738509|FG004|Overall Study|Technical problems|0|||
33504072|NCT02477332|101738510|FG005|Overall Study|Technical problems|0|||
33504073|NCT02477332|101738505|FG000|Overall Study|Lost to Follow-up|0|||
33504074|NCT02477332|101738506|FG001|Overall Study|Lost to Follow-up|0|||
33504075|NCT02477332|101738507|FG002|Overall Study|Lost to Follow-up|2|||
33504076|NCT02477332|101738508|FG003|Overall Study|Lost to Follow-up|0|||
33504077|NCT02477332|101738509|FG004|Overall Study|Lost to Follow-up|0|||
33504078|NCT02477332|101738510|FG005|Overall Study|Lost to Follow-up|0|||
33504079|NCT02477332|101738505|FG000|Overall Study|Physician Decision|0|||
33504080|NCT02477332|101738506|FG001|Overall Study|Physician Decision|0|||
33504081|NCT02477332|101738507|FG002|Overall Study|Physician Decision|1|||
33504082|NCT02477332|101738508|FG003|Overall Study|Physician Decision|3|||
33504083|NCT02477332|101738509|FG004|Overall Study|Physician Decision|0|||
33504084|NCT02477332|101738510|FG005|Overall Study|Physician Decision|1|||
33504085|NCT02477332|101738505|FG000|Overall Study|Withdrawal by Subject|0|||
33504086|NCT02477332|101738506|FG001|Overall Study|Withdrawal by Subject|3|||
33504087|NCT02477332|101738507|FG002|Overall Study|Withdrawal by Subject|1|||
33504088|NCT02477332|101738508|FG003|Overall Study|Withdrawal by Subject|2|||
33504089|NCT02477332|101738509|FG004|Overall Study|Withdrawal by Subject|1|||
33504090|NCT02477332|101738510|FG005|Overall Study|Withdrawal by Subject|0|||
33504091|NCT00039871|101738516|FG000|Overall Study|Adverse Event|165|||
33504092|NCT00039871|101738516|FG000|Overall Study|Lost to Follow-up|18|||
33504093|NCT00039871|101738516|FG000|Overall Study|Protocol Violation|24|||
33504094|NCT00039871|101738516|FG000|Overall Study|Withdrawal by Subject|97|||
33602794|NCT02715726|102099130|FG001|Overall Study|Adverse Event|6|||
33602795|NCT02715726|102099129|FG000|Overall Study|Protocol Violation|1|||
33602796|NCT02715726|102099130|FG001|Overall Study|Protocol Violation|0|||
33602797|NCT02715726|102099129|FG000|Overall Study|Death|2|||
33602798|NCT02715726|102099130|FG001|Overall Study|Death|1|||
33193889|NCT00414050|100616220|FG003|Overall Study|Adverse Event|1|||
33193890|NCT00414050|100616217|FG000|Overall Study|Lost to Follow-up|2|||
33193891|NCT00414050|100616218|FG001|Overall Study|Lost to Follow-up|2|||
33193892|NCT00414050|100616219|FG002|Overall Study|Lost to Follow-up|1|||
33193893|NCT00414050|100616220|FG003|Overall Study|Lost to Follow-up|1|||
33193894|NCT00414050|100616217|FG000|Overall Study|Withdrawal by Subject|5|||
33193895|NCT00414050|100616218|FG001|Overall Study|Withdrawal by Subject|3|||
33193896|NCT00414050|100616219|FG002|Overall Study|Withdrawal by Subject|2|||
33193897|NCT00414050|100616220|FG003|Overall Study|Withdrawal by Subject|4|||
33193898|NCT00414050|100616217|FG000|Overall Study|Subject discontinued for other reason|1|||
33193899|NCT00414050|100616218|FG001|Overall Study|Subject discontinued for other reason|2|||
33193900|NCT00414050|100616219|FG002|Overall Study|Subject discontinued for other reason|2|||
33193901|NCT00414050|100616220|FG003|Overall Study|Subject discontinued for other reason|1|||
33193902|NCT00414050|100616217|FG000|Overall Study|Subject Moved|0|||
33193903|NCT00414050|100616218|FG001|Overall Study|Subject Moved|0|||
33193904|NCT00414050|100616219|FG002|Overall Study|Subject Moved|0|||
33193905|NCT00414050|100616220|FG003|Overall Study|Subject Moved|1|||
33193906|NCT04251533|100616221|FG000|Overall Study|Progressive disease|33|||
33193907|NCT04251533|100616222|FG001|Overall Study|Progressive disease|29|||
33193908|NCT04251533|100616223|FG002|Overall Study|Progressive disease|22|||
33193909|NCT04251533|100616221|FG000|Overall Study|Death|5|||
33313493|NCT01839487|101040868|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
33313494|NCT01839487|101040869|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
33602799|NCT02715726|102099129|FG000|Overall Study|Participant moved|1|||
33602800|NCT02715726|102099130|FG001|Overall Study|Participant moved|3|||
33602801|NCT02715726|102099129|FG000|Overall Study|Other than specified above|11|||
33602802|NCT02715726|102099130|FG001|Overall Study|Other than specified above|15|||
33504095|NCT00039871|101738516|FG000|Overall Study|Did not meet eligibility criteria|11|||
33193910|NCT04251533|100616222|FG001|Overall Study|Death|1|||
33193911|NCT04251533|100616223|FG002|Overall Study|Death|3|||
33504096|NCT00039871|101738516|FG000|Overall Study|Administrative|1|||
33504097|NCT00039871|101738516|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
33504098|NCT00039871|101738516|FG000|Overall Study|Never entered follow-up|7|||
33602803|NCT02715726|102099129|FG000|Overall Study|Randomized but not treated|1|||
33602804|NCT02715726|102099130|FG001|Overall Study|Randomized but not treated|2|||
33504099|NCT03003494|101738517|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
33504100|NCT00464490|101738519|FG000|Overall Study|Physician Decision|11|||
33504101|NCT00464490|101738520|FG001|Overall Study|Physician Decision|11|||
33504102|NCT02097238|101738521|FG000|Overall Study|Death|1|||
33193912|NCT04251533|100616221|FG000|Overall Study|Physician Decision|3|||
33193913|NCT04251533|100616222|FG001|Overall Study|Physician Decision|2|||
33193914|NCT04251533|100616223|FG002|Overall Study|Physician Decision|4|||
33193915|NCT04251533|100616221|FG000|Overall Study|Participant decision|1|||
33193916|NCT04251533|100616222|FG001|Overall Study|Participant decision|3|||
33193917|NCT04251533|100616223|FG002|Overall Study|Participant decision|1|||
33193918|NCT04251533|100616221|FG000|Overall Study|Adverse Event|2|||
33193919|NCT04251533|100616222|FG001|Overall Study|Adverse Event|1|||
33193920|NCT04251533|100616223|FG002|Overall Study|Adverse Event|1|||
33193921|NCT00983814|100616224|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
33193922|NCT00983814|100616225|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
33193923|NCT00983814|100616226|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
33193924|NCT00983814|100616224|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
33193925|NCT00983814|100616225|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
33193926|NCT00983814|100616226|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
33193927|NCT00983814|100616224|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
33193928|NCT00983814|100616225|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
33193929|NCT00983814|100616226|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
33193930|NCT00983814|100616224|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
33193931|NCT00983814|100616225|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
33193932|NCT00983814|100616226|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
33193933|NCT00983814|100616224|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
33193934|NCT00983814|100616225|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
33193935|NCT00983814|100616226|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
33193936|NCT01632800|100616227|FG000|Overall Study|Subject did not fit in apparatus|1|||
33193937|NCT04115358|100616228|FG000|Overall Study|exfoliation|0|||
33193938|NCT04115358|100616229|FG001|Overall Study|exfoliation|0|||
33193939|NCT04115358|100616230|FG002|Overall Study|exfoliation|1|||
33193940|NCT01461096|100616243|FG000|Overall Study|Death|3|||
33193941|NCT01461096|100616244|FG001|Overall Study|Death|6|||
33193942|NCT01461096|100616243|FG000|Overall Study|Severe debilitation, unable to continue|1|||
33193943|NCT01461096|100616244|FG001|Overall Study|Severe debilitation, unable to continue|1|||
33193944|NCT01461096|100616243|FG000|Overall Study|Subj not able to get to clinic|15|||
33193945|NCT01461096|100616244|FG001|Overall Study|Subj not able to get to clinic|13|||
33193946|NCT01461096|100616243|FG000|Overall Study|Site is closing|27|||
33193947|NCT01461096|100616244|FG001|Overall Study|Site is closing|30|||
33193948|NCT01461096|100616243|FG000|Overall Study|Withdrawal by Subject|5|||
33193949|NCT01461096|100616244|FG001|Overall Study|Withdrawal by Subject|3|||
33193950|NCT01461096|100616243|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
33193951|NCT01461096|100616244|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
33193952|NCT01461096|100616243|FG000|Overall Study|Lost to Follow-up|8|||
33193953|NCT01461096|100616244|FG001|Overall Study|Lost to Follow-up|4|||
33193954|NCT02212730|100616246|FG000|Overall Study|Tumor not of the required cell histology|1|||
33193955|NCT02212730|100616247|FG001|Overall Study|Tumor not of the required cell histology|0|||
33193956|NCT02212730|100616246|FG000|Overall Study|Withdrawal by Subject|1|||
33193957|NCT02212730|100616247|FG001|Overall Study|Withdrawal by Subject|0|||
33193958|NCT02212730|100616246|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
33193959|NCT02212730|100616247|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
33193960|NCT01282424|100616248|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
33193961|NCT01282424|100616248|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
33193962|NCT01282424|100616248|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
33193963|NCT01282424|100616248|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
33193964|NCT01282424|100616248|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
33193965|NCT01282424|100616248|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
33193966|NCT01282424|100616248|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
33193967|NCT01282424|100616248|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
33193968|NCT03235024|100616250|FG000|Overall Study|Adverse Event|2|||
33193969|NCT03235024|100616251|FG001|Overall Study|Adverse Event|2|||
33193970|NCT03235024|100616250|FG000|Overall Study|Death|1|||
33193971|NCT03235024|100616251|FG001|Overall Study|Death|0|||
33193972|NCT03235024|100616250|FG000|Overall Study|Lost to Follow-up|2|||
33193973|NCT03235024|100616251|FG001|Overall Study|Lost to Follow-up|5|||
33193974|NCT03235024|100616250|FG000|Overall Study|Protocol Violation|1|||
33193975|NCT03235024|100616251|FG001|Overall Study|Protocol Violation|0|||
33193976|NCT03235024|100616250|FG000|Overall Study|Withdrawal by Subject|0|||
33193977|NCT03235024|100616251|FG001|Overall Study|Withdrawal by Subject|3|||
33193978|NCT00451282|100616252|FG000|Overall Study|Lost to Follow-up|6|||
33193979|NCT00451282|100616253|FG001|Overall Study|Lost to Follow-up|5|||
33193980|NCT00436280|100616258|FG000|Period 1: Induction|Adverse Event|8|||
33193981|NCT00436280|100616258|FG000|Period 1: Induction|Progressive Disease|12|||
33193982|NCT00436280|100616258|FG000|Period 1: Induction|Stable Disease|6|||
33193983|NCT00436280|100616258|FG000|Period 1: Induction|Withdrawal by Subject|1|||
33313495|NCT01839487|101040870|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
33193984|NCT00436280|100616258|FG000|Period 1: Induction|Death|1|||
33193985|NCT00436280|100616258|FG000|Period 2: Consolidation|Adverse Event|1|||
33193986|NCT00436280|100616258|FG000|Period 2: Consolidation|Progressive Disease|10|||
33313496|NCT01839487|101040865|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
33313497|NCT01839487|101040866|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
33313498|NCT01839487|101040867|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
33313499|NCT01839487|101040868|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
33395875|NCT01388491|101337763|FG001|Overall Study|Lost to Follow-up|3|||
33395876|NCT01388491|101337762|FG000|Overall Study|Protocol Violation|2|||
33313500|NCT01839487|101040869|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
33313501|NCT01839487|101040870|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
33313502|NCT01839487|101040865|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
33313503|NCT01839487|101040866|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
33313504|NCT01839487|101040867|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
33313505|NCT01839487|101040868|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
33313506|NCT01839487|101040869|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
33313507|NCT01839487|101040870|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
33313508|NCT01839487|101040865|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
33313509|NCT01839487|101040866|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
33313510|NCT01839487|101040867|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
33313511|NCT01839487|101040868|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
33313512|NCT01839487|101040869|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
33313513|NCT01839487|101040870|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
33313514|NCT01839487|101040865|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
33313515|NCT01839487|101040866|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
33313516|NCT01839487|101040867|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
33313517|NCT01839487|101040868|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
33313518|NCT01839487|101040869|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
33313519|NCT01839487|101040870|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
33313520|NCT01839487|101040865|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
33313521|NCT01839487|101040866|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
33313522|NCT01839487|101040867|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
33395877|NCT01388491|101337763|FG001|Overall Study|Protocol Violation|0|||
33395878|NCT01388491|101337762|FG000|Overall Study|Noncompliance|2|||
33395879|NCT01388491|101337763|FG001|Overall Study|Noncompliance|0|||
33395880|NCT01388491|101337762|FG000|Overall Study|Pregnancy|1|||
33395881|NCT01388491|101337763|FG001|Overall Study|Pregnancy|0|||
33395882|NCT00683774|101337764|FG000|Overall Study|Withdrawal by Subject|0|||
33395883|NCT00683774|101337765|FG001|Overall Study|Withdrawal by Subject|1|||
33395884|NCT00683774|101337764|FG000|Overall Study|Physician Decision|3|||
33395885|NCT00683774|101337765|FG001|Overall Study|Physician Decision|0|||
33395886|NCT03344562|101337768|FG000|Overall Study|Withdrawal by Subject|2|||
33395887|NCT03344562|101337769|FG001|Overall Study|Withdrawal by Subject|0|||
33395888|NCT02177786|101337772|FG000|Overall Study|Withdrew Consent|2|||
33313523|NCT01839487|101040868|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
33395889|NCT02177786|101337773|FG001|Overall Study|Withdrew Consent|6|||
33395890|NCT02177786|101337774|FG002|Overall Study|Withdrew Consent|9|||
33395891|NCT02177786|101337775|FG003|Overall Study|Withdrew Consent|5|||
33395892|NCT02177786|101337772|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
33395893|NCT02177786|101337773|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
33395894|NCT02177786|101337774|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
33395895|NCT02177786|101337775|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
33395896|NCT02177786|101337772|FG000|Overall Study|Adverse Event|1|||
33395897|NCT02177786|101337773|FG001|Overall Study|Adverse Event|1|||
33395898|NCT02177786|101337774|FG002|Overall Study|Adverse Event|2|||
33395899|NCT02177786|101337775|FG003|Overall Study|Adverse Event|3|||
33395900|NCT02177786|101337772|FG000|Overall Study|Death|1|||
33395901|NCT02177786|101337773|FG001|Overall Study|Death|1|||
33395902|NCT02177786|101337774|FG002|Overall Study|Death|1|||
33395903|NCT02177786|101337775|FG003|Overall Study|Death|1|||
33504103|NCT02097238|101738521|FG000|Overall Study|Physician Decision|1|||
33395904|NCT02177786|101337772|FG000|Overall Study|Lost to Follow-up|0|||
33395905|NCT02177786|101337773|FG001|Overall Study|Lost to Follow-up|0|||
33395906|NCT02177786|101337774|FG002|Overall Study|Lost to Follow-up|2|||
33395907|NCT02177786|101337775|FG003|Overall Study|Lost to Follow-up|2|||
33395908|NCT02177786|101337772|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33504104|NCT02097238|101738521|FG000|Overall Study|Progressive Disease|17|||
33395909|NCT02177786|101337773|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33395910|NCT02177786|101337774|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33395911|NCT02177786|101337775|FG003|Overall Study|Non-Compliance with Study Drug|1|||
33395912|NCT02177786|101337772|FG000|Overall Study|Protocol Violation|0|||
33395913|NCT02177786|101337773|FG001|Overall Study|Protocol Violation|0|||
33395914|NCT02177786|101337774|FG002|Overall Study|Protocol Violation|2|||
33395915|NCT02177786|101337775|FG003|Overall Study|Protocol Violation|0|||
33395916|NCT02177786|101337772|FG000|Overall Study|Progressive Disease|0|||
33395917|NCT02177786|101337773|FG001|Overall Study|Progressive Disease|1|||
33395918|NCT02177786|101337774|FG002|Overall Study|Progressive Disease|0|||
33395919|NCT02177786|101337775|FG003|Overall Study|Progressive Disease|0|||
33395920|NCT02177786|101337772|FG000|Overall Study|Missing study completion status|0|||
33395921|NCT02177786|101337773|FG001|Overall Study|Missing study completion status|1|||
33395922|NCT02177786|101337774|FG002|Overall Study|Missing study completion status|0|||
33395923|NCT02177786|101337775|FG003|Overall Study|Missing study completion status|0|||
33395924|NCT00402285|101337776|FG000|Overall Study|insufficient RNA quality|7|||
33395925|NCT00402285|101337777|FG001|Overall Study|insufficient RNA quality|6|||
33395926|NCT00402285|101337778|FG002|Overall Study|insufficient RNA quality|2|||
33395927|NCT03261037|101337780|FG000|Overall Study|Withdrawal by Subject|2|||
33395928|NCT03261037|101337781|FG001|Overall Study|Withdrawal by Subject|13|||
33395929|NCT03261037|101337782|FG002|Overall Study|Withdrawal by Subject|0|||
33395930|NCT03261037|101337783|FG003|Overall Study|Withdrawal by Subject|18|||
33395931|NCT03261037|101337780|FG000|Overall Study|Non-compliance with study procedures|0|||
33395932|NCT03261037|101337781|FG001|Overall Study|Non-compliance with study procedures|2|||
33395933|NCT03261037|101337782|FG002|Overall Study|Non-compliance with study procedures|0|||
33395934|NCT03261037|101337783|FG003|Overall Study|Non-compliance with study procedures|6|||
33395935|NCT03261037|101337780|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
33395936|NCT03261037|101337781|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
33395937|NCT03261037|101337782|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
33395938|NCT03261037|101337783|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
33395939|NCT03261037|101337780|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
33395940|NCT03261037|101337781|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
33395941|NCT03261037|101337782|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
33395942|NCT03261037|101337783|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
33395943|NCT03261037|101337780|FG000|Overall Study|Diagnosed but protocol deviation|1|||
33395944|NCT03261037|101337781|FG001|Overall Study|Diagnosed but protocol deviation|0|||
33395945|NCT03261037|101337782|FG002|Overall Study|Diagnosed but protocol deviation|0|||
33395946|NCT03261037|101337783|FG003|Overall Study|Diagnosed but protocol deviation|0|||
33395947|NCT03261037|101337780|FG000|Overall Study|Participant did not want to continue the study|0|||
33395948|NCT03261037|101337781|FG001|Overall Study|Participant did not want to continue the study|1|||
33395949|NCT03261037|101337782|FG002|Overall Study|Participant did not want to continue the study|0|||
33395950|NCT03261037|101337783|FG003|Overall Study|Participant did not want to continue the study|0|||
33395951|NCT03261037|101337780|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
33395952|NCT03261037|101337781|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
33395953|NCT03261037|101337782|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
33395954|NCT03261037|101337783|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
33395955|NCT03261037|101337780|FG000|Overall Study|Participant presented clinical improvement|0|||
33395956|NCT03261037|101337781|FG001|Overall Study|Participant presented clinical improvement|2|||
33395957|NCT03261037|101337782|FG002|Overall Study|Participant presented clinical improvement|0|||
33395958|NCT03261037|101337783|FG003|Overall Study|Participant presented clinical improvement|0|||
33395959|NCT03261037|101337780|FG000|Overall Study|Technical difficulties|0|||
33395960|NCT03261037|101337781|FG001|Overall Study|Technical difficulties|0|||
33395961|NCT03261037|101337782|FG002|Overall Study|Technical difficulties|0|||
33395962|NCT03261037|101337783|FG003|Overall Study|Technical difficulties|1|||
33395963|NCT03261037|101337780|FG000|Overall Study|Equipment failed to work|0|||
33395964|NCT03261037|101337781|FG001|Overall Study|Equipment failed to work|0|||
33395965|NCT03261037|101337782|FG002|Overall Study|Equipment failed to work|0|||
33395966|NCT03261037|101337783|FG003|Overall Study|Equipment failed to work|1|||
33395967|NCT03261037|101337780|FG000|Overall Study|End of study for participant and no follow up|0|||
33395968|NCT03261037|101337781|FG001|Overall Study|End of study for participant and no follow up|0|||
33395969|NCT03261037|101337782|FG002|Overall Study|End of study for participant and no follow up|0|||
33395970|NCT03261037|101337783|FG003|Overall Study|End of study for participant and no follow up|1|||
33395971|NCT03261037|101337780|FG000|Overall Study|Participant was too weak to continue in study|1|||
33395972|NCT03261037|101337781|FG001|Overall Study|Participant was too weak to continue in study|0|||
33395973|NCT03261037|101337782|FG002|Overall Study|Participant was too weak to continue in study|0|||
33395974|NCT03261037|101337783|FG003|Overall Study|Participant was too weak to continue in study|0|||
33395975|NCT00621244|101337784|FG000|Overall Study|Withdrawal by Subject|7|||
33395976|NCT00621244|101337785|FG001|Overall Study|Withdrawal by Subject|3|||
33395977|NCT00621244|101337786|FG002|Overall Study|Withdrawal by Subject|3|||
33395978|NCT00621244|101337787|FG003|Overall Study|Withdrawal by Subject|3|||
33395979|NCT00621244|101337784|FG000|Overall Study|Disease progression|44|||
33395980|NCT00621244|101337785|FG001|Overall Study|Disease progression|20|||
33395981|NCT00621244|101337786|FG002|Overall Study|Disease progression|20|||
33395982|NCT00621244|101337787|FG003|Overall Study|Disease progression|15|||
33395983|NCT00621244|101337784|FG000|Overall Study|Death|3|||
33395984|NCT00621244|101337785|FG001|Overall Study|Death|3|||
33395985|NCT00621244|101337786|FG002|Overall Study|Death|1|||
33395986|NCT00621244|101337787|FG003|Overall Study|Death|1|||
33395987|NCT00621244|101337784|FG000|Overall Study|Adverse Event|27|||
33395988|NCT00621244|101337785|FG001|Overall Study|Adverse Event|7|||
33395989|NCT00621244|101337786|FG002|Overall Study|Adverse Event|9|||
33395990|NCT00621244|101337787|FG003|Overall Study|Adverse Event|2|||
33395991|NCT00621244|101337784|FG000|Overall Study|Administrative problems|5|||
33395992|NCT00621244|101337785|FG001|Overall Study|Administrative problems|1|||
33395993|NCT00621244|101337786|FG002|Overall Study|Administrative problems|0|||
33395994|NCT00621244|101337787|FG003|Overall Study|Administrative problems|2|||
33395995|NCT03797144|101337788|FG000|Enrollment|Protocol Violation|4|||
33395996|NCT03797144|101337789|FG001|Enrollment|Protocol Violation|1|||
33395997|NCT03797144|101337788|FG000|Surgery|Protocol Violation|1|||
33395998|NCT03797144|101337789|FG001|Surgery|Protocol Violation|0|||
33395999|NCT03797144|101337788|FG000|3 Month|Early termination cut-off date|2|||
33396000|NCT03797144|101337789|FG001|3 Month|Early termination cut-off date|0|||
33396001|NCT03797144|101337788|FG000|12 Month|Early termination cut-off date|8|||
33396002|NCT03797144|101337789|FG001|12 Month|Early termination cut-off date|9|||
33396003|NCT03797144|101337788|FG000|24 Month|Early termination cut-off date|1|||
33396004|NCT03797144|101337789|FG001|24 Month|Early termination cut-off date|1|||
33396005|NCT00081263|101337790|FG000|Overall Study|clerical error|1|||
33396006|NCT00081263|101337791|FG001|Overall Study|clerical error|0|||
33313524|NCT01839487|101040869|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
33313525|NCT01839487|101040870|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
33313526|NCT01839487|101040865|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
33313527|NCT01839487|101040866|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
33313528|NCT01839487|101040867|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
33313529|NCT01839487|101040868|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
33313530|NCT01839487|101040869|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
33313531|NCT01839487|101040870|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
33313532|NCT01839487|101040865|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
33313533|NCT01839487|101040866|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
33313534|NCT01839487|101040867|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
33313535|NCT01839487|101040868|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
33313536|NCT01839487|101040869|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
33313537|NCT01839487|101040870|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
33313538|NCT01839487|101040865|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
33313539|NCT01839487|101040866|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
33313540|NCT01839487|101040867|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
33313541|NCT01839487|101040868|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
33313542|NCT01839487|101040869|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
33313543|NCT01839487|101040870|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
33313544|NCT02240693|101044222|FG000|Overall Study|Adverse Event|0|||
33313545|NCT02240693|101044223|FG001|Overall Study|Adverse Event|0|||
33313546|NCT02240693|101044224|FG002|Overall Study|Adverse Event|0|||
33313547|NCT02240693|101044225|FG003|Overall Study|Adverse Event|0|||
33313548|NCT02240693|101044226|FG004|Overall Study|Adverse Event|1|||
33313549|NCT02240693|101044222|FG000|Overall Study|Withdrawal by Subject|0|||
33396007|NCT00081263|101337790|FG000|Overall Study|wrong cell type|7|||
33396008|NCT00081263|101337791|FG001|Overall Study|wrong cell type|5|||
33396009|NCT00081263|101337790|FG000|Overall Study|improper pre-protocol therapy|0|||
33396010|NCT00081263|101337791|FG001|Overall Study|improper pre-protocol therapy|1|||
33396011|NCT00081263|101337790|FG000|Overall Study|Inadequate pathology|0|||
33313550|NCT02240693|101044223|FG001|Overall Study|Withdrawal by Subject|0|||
33313551|NCT02240693|101044224|FG002|Overall Study|Withdrawal by Subject|2|||
33396012|NCT00081263|101337791|FG001|Overall Study|Inadequate pathology|1|||
33396013|NCT00081263|101337790|FG000|Overall Study|Never treated|4|||
33504105|NCT02955355|101738524|FG000|Overall Study|Adverse Event|4|||
33313552|NCT02240693|101044225|FG003|Overall Study|Withdrawal by Subject|1|||
33396014|NCT00081263|101337791|FG001|Overall Study|Never treated|5|||
33313553|NCT02240693|101044226|FG004|Overall Study|Withdrawal by Subject|0|||
33313554|NCT02240693|101044222|FG000|Overall Study|Other than specified|0|||
33313555|NCT02240693|101044223|FG001|Overall Study|Other than specified|0|||
33313556|NCT02240693|101044224|FG002|Overall Study|Other than specified|2|||
33313557|NCT02240693|101044225|FG003|Overall Study|Other than specified|0|||
33313558|NCT02240693|101044226|FG004|Overall Study|Other than specified|0|||
33313559|NCT03809429|101044232|FG000|Overall Study|Withdrawal by Subject|7|||
33504106|NCT02955355|101738524|FG000|Overall Study|Death|1|||
33313560|NCT03809429|101044233|FG001|Overall Study|Withdrawal by Subject|3|||
33313561|NCT03809429|101044232|FG000|Overall Study|Adverse Event|6|||
33313562|NCT03809429|101044233|FG001|Overall Study|Adverse Event|9|||
33313563|NCT03809429|101044232|FG000|Overall Study|COVID-19|3|||
33313564|NCT03809429|101044233|FG001|Overall Study|COVID-19|1|||
33313565|NCT03809429|101044232|FG000|Overall Study|Participant was discontinued by investigator|12|||
33313566|NCT03809429|101044233|FG001|Overall Study|Participant was discontinued by investigator|7|||
33313567|NCT02057523|101044245|FG000|Overall Study|Withdrawal by Subject|1|||
33313568|NCT02057523|101044245|FG000|Overall Study|Lack of Efficacy|1|||
33313569|NCT00887432|101044248|FG000|Overall Study|Start Excluded Therapy|3|||
33313570|NCT00887432|101044249|FG001|Overall Study|Start Excluded Therapy|0|||
33313571|NCT00887432|101044248|FG000|Overall Study|Did not complete treatment|6|||
33313572|NCT00887432|101044249|FG001|Overall Study|Did not complete treatment|8|||
33313573|NCT00887432|101044248|FG000|Overall Study|Protocol Violation|2|||
33313574|NCT00887432|101044249|FG001|Overall Study|Protocol Violation|3|||
33313575|NCT00887432|101044248|FG000|Overall Study|Withdrawal by Subject|3|||
33396015|NCT00081263|101337790|FG000|Overall Study|Inadequate data|5|||
33396016|NCT00081263|101337791|FG001|Overall Study|Inadequate data|10|||
33396017|NCT02181504|101337792|FG000|Overall Study|Adverse Event|1|||
33396018|NCT02181504|101337793|FG001|Overall Study|Adverse Event|1|||
33396019|NCT02181504|101337794|FG002|Overall Study|Adverse Event|1|||
33396020|NCT01408732|101337795|FG000|Overall Study|Withdrawal by Subject|2|||
33396021|NCT01408732|101337796|FG001|Overall Study|Withdrawal by Subject|2|||
33396022|NCT01369069|101337797|FG000|Overall Study|Lost to Follow-up|8|||
33396023|NCT01369069|101337798|FG001|Overall Study|Lost to Follow-up|9|||
33396024|NCT01369069|101337797|FG000|Overall Study|Withdrawal by Subject|9|||
33396025|NCT01369069|101337798|FG001|Overall Study|Withdrawal by Subject|7|||
33396026|NCT00736450|101337800|FG000|Overall Study|Not ABC gene eligible|19|||
33396027|NCT00736450|101337800|FG000|Overall Study|Withdrawal by Subject|5|||
33396028|NCT00736450|101337800|FG000|Overall Study|Physician Decision|1|||
33396029|NCT00809614|101337801|FG000|Overall Study|Lack of Efficacy|2|||
33396030|NCT00809614|101337802|FG001|Overall Study|Lack of Efficacy|3|||
33396031|NCT00809614|101337801|FG000|Overall Study|Withdrawal by Subject|1|||
33504107|NCT02955355|101738524|FG000|Overall Study|Physician Decision|21|||
33504108|NCT02955355|101738524|FG000|Overall Study|Site Terminated by Sponsor|35|||
33504109|NCT02955355|101738524|FG000|Overall Study|Withdrawal by Subject|19|||
33504110|NCT02955355|101738524|FG000|Overall Study|Reason Not Specified|5|||
33504111|NCT04740827|101738525|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
33504112|NCT04740827|101738526|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
33504113|NCT04740827|101738525|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
33504114|NCT04740827|101738526|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
33504115|NCT04740827|101738525|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
33504116|NCT04740827|101738526|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
33504117|NCT04740827|101738525|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
33504118|NCT04740827|101738526|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
33504119|NCT04740827|101738525|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
33504120|NCT04740827|101738526|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
33504121|NCT04740827|101738525|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
33504122|NCT04740827|101738526|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
33504123|NCT01948193|101738527|FG000|Overall Study|Serious event|2|||
33504124|NCT01948193|101738527|FG000|Overall Study|Lost to Follow-up|7|||
33504125|NCT05486091|101738528|FG000|Overall Study|Withdrawal by Subject|1|||
33313576|NCT00887432|101044249|FG001|Overall Study|Withdrawal by Subject|2|||
33396032|NCT00809614|101337802|FG001|Overall Study|Withdrawal by Subject|1|||
33396033|NCT02299206|101337810|FG000|Overall Study|Lost to Follow-up|1|||
33396034|NCT02299206|101337810|FG000|Overall Study|Withdrawal by Subject|1|||
33396035|NCT00518336|101337811|FG000|Year 7|Lost to Follow-up|2|||
33504126|NCT05486091|101738528|FG000|Overall Study|Lost to Follow-up|2|||
33504127|NCT01718535|101738529|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
33504128|NCT01718535|101738530|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
33504129|NCT01718535|101738531|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
33313577|NCT00887432|101044248|FG000|Overall Study|Lost to Follow-up|1|||
33313578|NCT00887432|101044249|FG001|Overall Study|Lost to Follow-up|0|||
33313579|NCT00887432|101044248|FG000|Overall Study|No reason provided|0|||
33313580|NCT00887432|101044249|FG001|Overall Study|No reason provided|1|||
33396036|NCT00518336|101337812|FG001|Year 7|Lost to Follow-up|0|||
33396037|NCT00518336|101337811|FG000|Year 7|Could not attend in time|0|||
33396038|NCT00518336|101337812|FG001|Year 7|Could not attend in time|3|||
33313581|NCT01209143|101044250|FG000|Overall Study|Adverse Event|2|||
33602805|NCT01300351|102099131|FG000|Overall Study|Did not receive treatment|2|||
33396039|NCT00518336|101337811|FG000|Year 8|Lost to Follow-up|1|||
33396040|NCT00518336|101337812|FG001|Year 8|Lost to Follow-up|1|||
33396041|NCT00518336|101337811|FG000|Year 8|Could not attend in time|0|||
33396042|NCT00518336|101337812|FG001|Year 8|Could not attend in time|1|||
33396043|NCT00518336|101337811|FG000|Year 9|Migrated/moved from study area|1|||
33396044|NCT00518336|101337812|FG001|Year 9|Migrated/moved from study area|1|||
33396045|NCT00518336|101337811|FG000|Year 9|Lost to Follow-up|3|||
33396046|NCT00518336|101337812|FG001|Year 9|Lost to Follow-up|0|||
33396047|NCT00518336|101337811|FG000|Year 9|Personal reasons|1|||
33396048|NCT00518336|101337812|FG001|Year 9|Personal reasons|0|||
33396049|NCT01700140|101337814|FG000|Overall Study|Use of rescue drugs|3|||
33396050|NCT01700140|101337815|FG001|Overall Study|Use of rescue drugs|3|||
33396051|NCT01700140|101337816|FG002|Overall Study|Use of rescue drugs|1|||
33396052|NCT01700140|101337814|FG000|Overall Study|Discontinuation of radiotherapy|1|||
33396053|NCT01700140|101337815|FG001|Overall Study|Discontinuation of radiotherapy|0|||
33396054|NCT01700140|101337816|FG002|Overall Study|Discontinuation of radiotherapy|0|||
33602806|NCT01300351|102099132|FG001|Overall Study|Did not receive treatment|0|||
33602807|NCT01300351|102099131|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
33602808|NCT01300351|102099132|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
33313582|NCT01209143|101044251|FG001|Overall Study|Adverse Event|1|||
33313583|NCT01209143|101044250|FG000|Overall Study|Death|0|||
33313584|NCT01209143|101044251|FG001|Overall Study|Death|1|||
33313585|NCT01209143|101044250|FG000|Overall Study|Physician Decision|3|||
33313586|NCT01209143|101044251|FG001|Overall Study|Physician Decision|1|||
33313587|NCT01209143|101044250|FG000|Overall Study|Lost to Follow-up|1|||
33313588|NCT01209143|101044251|FG001|Overall Study|Lost to Follow-up|0|||
33313589|NCT01209143|101044250|FG000|Overall Study|Withdrawal by Subject|2|||
33313590|NCT01209143|101044251|FG001|Overall Study|Withdrawal by Subject|1|||
33313591|NCT01209143|101044250|FG000|Overall Study|Disease progression|11|||
33313592|NCT01209143|101044251|FG001|Overall Study|Disease progression|16|||
33313593|NCT01079741|101044252|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
33313594|NCT01079741|101044253|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
33313595|NCT01079741|101044254|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
33313596|NCT01079741|101044255|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
33396055|NCT01700140|101337814|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
33396056|NCT01700140|101337815|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
33396057|NCT01700140|101337816|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
33396058|NCT01700140|101337814|FG000|Overall Study|Aggravation of symptoms|1|||
33396059|NCT01700140|101337815|FG001|Overall Study|Aggravation of symptoms|0|||
33396060|NCT01700140|101337816|FG002|Overall Study|Aggravation of symptoms|0|||
33396061|NCT01700140|101337814|FG000|Overall Study|Adverse Event|0|||
33396062|NCT01700140|101337815|FG001|Overall Study|Adverse Event|1|||
33396063|NCT01700140|101337816|FG002|Overall Study|Adverse Event|0|||
33396064|NCT01700140|101337814|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
33396065|NCT01700140|101337815|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
33396066|NCT01700140|101337816|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
33396067|NCT01166386|101337825|FG000|Overall Study|Withdrawal by Subject|3|||
33396068|NCT01166386|101337826|FG001|Overall Study|Withdrawal by Subject|5|||
33396069|NCT01572480|101337827|FG000|Participants Enrolled|Withdrawal by Subject|1|||
33396070|NCT01572480|101337827|FG000|Drug Administration|Discontinued drug/Off Study|1|||
33396071|NCT01572480|101337827|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
33396072|NCT01572480|101337827|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
33602809|NCT01300351|102099131|FG000|Overall Study|Lost to Follow-up|0|||
33396073|NCT00732472|101337828|FG000|Overall Study|Adverse Event|0|||
33396074|NCT00732472|101337829|FG001|Overall Study|Adverse Event|1|||
33396075|NCT00732472|101337830|FG002|Overall Study|Adverse Event|1|||
33396076|NCT00732472|101337831|FG003|Overall Study|Adverse Event|1|||
33602810|NCT01300351|102099132|FG001|Overall Study|Lost to Follow-up|1|||
33602811|NCT01300351|102099131|FG000|Overall Study|Adverse Event|0|||
33602812|NCT01300351|102099132|FG001|Overall Study|Adverse Event|4|||
33313597|NCT01079741|101044256|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
33313598|NCT01079741|101044252|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
33396077|NCT00732472|101337828|FG000|Overall Study|Protocol Violation|0|||
33396078|NCT00732472|101337829|FG001|Overall Study|Protocol Violation|0|||
33396079|NCT00732472|101337830|FG002|Overall Study|Protocol Violation|0|||
33396080|NCT00732472|101337831|FG003|Overall Study|Protocol Violation|1|||
33396081|NCT00732472|101337828|FG000|Overall Study|Withdrawal by Subject|0|||
33396082|NCT00732472|101337829|FG001|Overall Study|Withdrawal by Subject|2|||
33396083|NCT00732472|101337830|FG002|Overall Study|Withdrawal by Subject|0|||
33313599|NCT01079741|101044253|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
33313600|NCT01079741|101044254|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
33313601|NCT01079741|101044255|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
33396084|NCT00732472|101337831|FG003|Overall Study|Withdrawal by Subject|1|||
33396085|NCT00471276|101337832|FG000|Overall Study|Death|2|||
33396086|NCT00471276|101337832|FG000|Overall Study|Adverse Event|16|||
33396087|NCT00471276|101337832|FG000|Overall Study|Protocol Violation|1|||
33396088|NCT00471276|101337832|FG000|Overall Study|Objective progression or relapse|54|||
33396089|NCT00471276|101337832|FG000|Overall Study|Global deterioration of health status|1|||
33396090|NCT00471276|101337832|FG000|Overall Study|Other|3|||
33396091|NCT00471276|101337832|FG000|Overall Study|Refused treatment|6|||
33396092|NCT02094612|101337833|FG000|Overall Study|Lost to Follow-up|47|||
33396093|NCT02094612|101337834|FG001|Overall Study|Lost to Follow-up|47|||
33396094|NCT02094612|101337833|FG000|Overall Study|Never started ADHD medication|32|||
33396095|NCT02094612|101337834|FG001|Overall Study|Never started ADHD medication|23|||
33396096|NCT00355615|101337835|FG000|Randomized Double Blind Period|Adverse Event|1|||
33396097|NCT00355615|101337836|FG001|Randomized Double Blind Period|Adverse Event|0|||
33396098|NCT00355615|101337837|FG002|Randomized Double Blind Period|Adverse Event|0|||
33396099|NCT00355615|101337838|FG003|Randomized Double Blind Period|Adverse Event|0|||
33396100|NCT00355615|101337839|FG004|Randomized Double Blind Period|Adverse Event|0|||
33396101|NCT00355615|101337835|FG000|Randomized Double Blind Period|Protocol Violation|0|||
33396102|NCT00355615|101337836|FG001|Randomized Double Blind Period|Protocol Violation|0|||
33396103|NCT00355615|101337837|FG002|Randomized Double Blind Period|Protocol Violation|1|||
33396104|NCT00355615|101337838|FG003|Randomized Double Blind Period|Protocol Violation|1|||
33396105|NCT00355615|101337839|FG004|Randomized Double Blind Period|Protocol Violation|0|||
33396106|NCT00355615|101337835|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
33396107|NCT00355615|101337836|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
33396108|NCT00355615|101337837|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
33396109|NCT00355615|101337838|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
33396110|NCT00355615|101337839|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
33396111|NCT00355615|101337835|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
33396112|NCT00355615|101337836|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
33396113|NCT00355615|101337837|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
33396114|NCT00355615|101337838|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
33396115|NCT00355615|101337839|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
33396116|NCT00355615|101337835|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
33396117|NCT00355615|101337836|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
33396118|NCT00355615|101337837|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
33396119|NCT00355615|101337838|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
33396120|NCT00355615|101337839|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
33396121|NCT00355615|101337835|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
33396122|NCT00355615|101337836|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
33396123|NCT00355615|101337837|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
33396124|NCT00355615|101337838|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
33396125|NCT00355615|101337839|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
33396126|NCT01675141|101337840|FG000|Overall Study|Lenalidomide outside NIH|3|||
33313602|NCT01079741|101044256|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
33313603|NCT01676909|101044257|FG000|Overall Study|Withdrawal by Subject|3|||
33313604|NCT01676909|101044258|FG001|Overall Study|Withdrawal by Subject|5|||
33313605|NCT01676909|101044257|FG000|Overall Study|Lost to Follow-up|15|||
33313606|NCT01676909|101044258|FG001|Overall Study|Lost to Follow-up|9|||
33313607|NCT02480153|101044259|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
33602813|NCT01300351|102099131|FG000|Overall Study|Withdrawal by Subject|7|||
33602814|NCT01300351|102099132|FG001|Overall Study|Withdrawal by Subject|10|||
33313608|NCT02480153|101044260|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
33396127|NCT01675141|101337840|FG000|Overall Study|Withdrawal by Subject|3|||
33396128|NCT01675141|101337840|FG000|Overall Study|Physician Decision|4|||
33396129|NCT01675141|101337840|FG000|Overall Study|No treatment, per protocol|1|||
33602815|NCT01646203|102099138|FG000|Overall Study|Adverse Event|2|||
33313609|NCT02480153|101044261|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
33313610|NCT02480153|101044259|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
33396130|NCT05091918|101337843|FG000|Overall Study|Adverse Event|1|||
33396131|NCT05091918|101337843|FG000|Overall Study|Withdrawal by Subject|81|||
33396132|NCT02148952|101337844|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
33396133|NCT02148952|101337845|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
33602816|NCT01646203|102099139|FG001|Overall Study|Adverse Event|0|||
33602817|NCT01646203|102099140|FG002|Overall Study|Adverse Event|1|||
33313611|NCT02480153|101044260|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
33313612|NCT02480153|101044261|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
33313613|NCT02480153|101044259|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
33313614|NCT02480153|101044260|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
33313615|NCT02480153|101044261|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
33313616|NCT02480153|101044259|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
33313617|NCT02480153|101044260|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
33313618|NCT02480153|101044261|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
33313619|NCT02480153|101044259|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
33313620|NCT02480153|101044260|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
33313621|NCT02480153|101044261|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
33313622|NCT02480153|101044259|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
33313623|NCT02480153|101044260|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
33313624|NCT02480153|101044261|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
33313625|NCT02480153|101044259|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
33313626|NCT02480153|101044260|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
33313627|NCT02480153|101044261|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
33313628|NCT02480153|101044259|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
33313629|NCT02480153|101044260|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
33313630|NCT02480153|101044261|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
33313631|NCT02480153|101044259|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
33313632|NCT02480153|101044260|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
33313633|NCT02480153|101044261|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
33313634|NCT02480153|101044259|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
33313635|NCT02480153|101044260|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
33313636|NCT02480153|101044261|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
33313637|NCT02480153|101044259|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
33313638|NCT02480153|101044260|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
33313639|NCT02480153|101044261|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
33313640|NCT02480153|101044259|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
33313641|NCT02480153|101044260|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
33313642|NCT02480153|101044261|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
33313643|NCT02480153|101044259|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
33313644|NCT02480153|101044260|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
33313645|NCT02480153|101044261|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
33313646|NCT02480153|101044259|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
33313647|NCT02480153|101044260|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
33313648|NCT02480153|101044261|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
33313649|NCT02480153|101044259|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
33313650|NCT02480153|101044260|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
33313651|NCT02480153|101044261|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
33313652|NCT02480153|101044259|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
33313653|NCT02480153|101044260|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
33313654|NCT02480153|101044261|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
33313655|NCT02480153|101044259|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
33313656|NCT02480153|101044260|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
33313657|NCT02480153|101044261|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
33313658|NCT02480153|101044259|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
33313659|NCT02480153|101044260|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
33313660|NCT02480153|101044261|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
33313661|NCT00252733|101044262|FG000|Overall Study|Withdrawal by Subject|73|||
33313662|NCT00252733|101044263|FG001|Overall Study|Withdrawal by Subject|67|||
33313663|NCT00252733|101044262|FG000|Overall Study|Death|7|||
33313664|NCT00252733|101044263|FG001|Overall Study|Death|5|||
33313665|NCT00252733|101044262|FG000|Overall Study|Lost to Follow-up|12|||
33313666|NCT00252733|101044263|FG001|Overall Study|Lost to Follow-up|6|||
33313667|NCT00252733|101044262|FG000|Overall Study|Multiple Reasons|14|||
33313668|NCT00252733|101044263|FG001|Overall Study|Multiple Reasons|14|||
33313669|NCT01718353|101044264|FG000|Overall Study|Lost to Follow-up|0|||
33313670|NCT01718353|101044265|FG001|Overall Study|Lost to Follow-up|1|||
33313671|NCT01718353|101044264|FG000|Overall Study|Principal Investigator's Decision|10|||
33313672|NCT01718353|101044265|FG001|Overall Study|Principal Investigator's Decision|4|||
33313673|NCT01718353|101044264|FG000|Overall Study|Randomized but not treated|2|||
33313674|NCT01718353|101044265|FG001|Overall Study|Randomized but not treated|0|||
33313675|NCT02409368|101044266|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
33396134|NCT02148952|101337844|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
33504130|NCT01718535|101738532|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
33504131|NCT01718535|101738533|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
33313676|NCT02409368|101044267|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
33313677|NCT02409368|101044268|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
33313678|NCT02409368|101044269|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
33313679|NCT02409368|101044266|FG000|ECOG Reclassification|Death|1|||
33313680|NCT02409368|101044267|FG001|ECOG Reclassification|Death|5|||
33313681|NCT02409368|101044268|FG002|ECOG Reclassification|Death|0|||
33313682|NCT02409368|101044269|FG003|ECOG Reclassification|Death|0|||
33313683|NCT02409368|101044266|FG000|ECOG Reclassification|Disease Progression|113|||
33313684|NCT02409368|101044267|FG001|ECOG Reclassification|Disease Progression|382|||
33313685|NCT02409368|101044268|FG002|ECOG Reclassification|Disease Progression|70|||
33313686|NCT02409368|101044269|FG003|ECOG Reclassification|Disease Progression|1|||
33313687|NCT02409368|101044266|FG000|ECOG Reclassification|Lost to Follow-up|1|||
33313688|NCT02409368|101044267|FG001|ECOG Reclassification|Lost to Follow-up|5|||
33313689|NCT02409368|101044268|FG002|ECOG Reclassification|Lost to Follow-up|0|||
33313690|NCT02409368|101044269|FG003|ECOG Reclassification|Lost to Follow-up|0|||
33313691|NCT02409368|101044266|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
33313692|NCT02409368|101044267|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
33313693|NCT02409368|101044268|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
33313694|NCT02409368|101044269|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
33313695|NCT02409368|101044266|FG000|ECOG Reclassification|Poor/non-compliance|0|||
33313696|NCT02409368|101044267|FG001|ECOG Reclassification|Poor/non-compliance|3|||
33313697|NCT02409368|101044268|FG002|ECOG Reclassification|Poor/non-compliance|2|||
33313698|NCT02409368|101044269|FG003|ECOG Reclassification|Poor/non-compliance|0|||
33313699|NCT02409368|101044266|FG000|ECOG Reclassification|Study drug toxicity|17|||
33313700|NCT02409368|101044267|FG001|ECOG Reclassification|Study drug toxicity|42|||
33313701|NCT02409368|101044268|FG002|ECOG Reclassification|Study drug toxicity|7|||
33313702|NCT02409368|101044269|FG003|ECOG Reclassification|Study drug toxicity|0|||
33313703|NCT02409368|101044266|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
33313704|NCT02409368|101044267|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
33313705|NCT02409368|101044268|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
33313706|NCT02409368|101044269|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
33313707|NCT02409368|101044266|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
33313708|NCT02409368|101044267|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
33313709|NCT02409368|101044268|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
33313710|NCT02409368|101044269|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
33313711|NCT02409368|101044266|FG000|ECOG Reclassification|Participant withdrew consent|2|||
33313712|NCT02409368|101044267|FG001|ECOG Reclassification|Participant withdrew consent|3|||
33313713|NCT02409368|101044268|FG002|ECOG Reclassification|Participant withdrew consent|4|||
33313714|NCT02409368|101044269|FG003|ECOG Reclassification|Participant withdrew consent|0|||
33313715|NCT02409368|101044266|FG000|ECOG Reclassification|Other Reasons|5|||
33504132|NCT01718535|101738534|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
33504133|NCT01718535|101738535|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
33313716|NCT02409368|101044267|FG001|ECOG Reclassification|Other Reasons|26|||
33313717|NCT02409368|101044268|FG002|ECOG Reclassification|Other Reasons|2|||
33313718|NCT02409368|101044269|FG003|ECOG Reclassification|Other Reasons|0|||
33313719|NCT02409368|101044266|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
33313720|NCT02409368|101044267|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
33313721|NCT02409368|101044268|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
33313722|NCT02409368|101044269|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
33313723|NCT03215810|101044277|FG000|Overall Study|Still responding to nivolumab|1|||
33313724|NCT03215810|101044277|FG000|Overall Study|Insufficient TIL growth|1|||
33504134|NCT01718535|101738536|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
33504135|NCT01718535|101738537|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
33504136|NCT01718535|101738538|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
33504137|NCT00877487|101738541|FG000|Open-label Treatment Phase|Adverse Event|1|||
33504138|NCT00877487|101738542|FG001|Open-label Treatment Phase|Adverse Event|0|||
33504139|NCT00877487|101738541|FG000|Open-label Treatment Phase|Protocol Violation|3|||
33504140|NCT00877487|101738542|FG001|Open-label Treatment Phase|Protocol Violation|0|||
33504141|NCT00877487|101738541|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
33504142|NCT00877487|101738542|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
33504143|NCT00877487|101738541|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
33313725|NCT03215810|101044277|FG000|Overall Study|Decline in performance status|1|||
33417159|NCT00038467|101420220|FG001|Overall Study|Withdrawal by Subject|107|||
33417160|NCT00038467|101420219|FG000|Overall Study|Protocol Violation|19|||
33417161|NCT00038467|101420220|FG001|Overall Study|Protocol Violation|22|||
33417162|NCT00038467|101420219|FG000|Overall Study|Death|22|||
33417163|NCT00038467|101420220|FG001|Overall Study|Death|16|||
33417164|NCT00038467|101420219|FG000|Overall Study|Lost to Follow-up|15|||
33193987|NCT00436280|100616258|FG000|Period 2: Consolidation|Stable Disease|1|||
33193988|NCT00436280|100616258|FG000|Period 2: Consolidation|Physician Decision|2|||
33193989|NCT00436280|100616258|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
33193990|NCT00436280|100616258|FG000|Period 2: Consolidation|Death|1|||
33193991|NCT00436280|100616258|FG000|Period 3: Maintenance|Adverse Event|6|||
33193992|NCT00436280|100616258|FG000|Period 3: Maintenance|Progressive Disease|12|||
33193993|NCT01038778|100616261|FG000|Overall Study|Withdrawal by Subject|0|||
33193994|NCT01038778|100616262|FG001|Overall Study|Withdrawal by Subject|2|||
33193995|NCT01038778|100616263|FG002|Overall Study|Withdrawal by Subject|3|||
33396135|NCT02148952|101337845|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
33396136|NCT02148952|101337844|FG000|Follow-Up|Lost to Follow-up|219|||
33396137|NCT02148952|101337845|FG001|Follow-Up|Lost to Follow-up|231|||
33396138|NCT02148952|101337844|FG000|Follow-Up|Withdrawal by Subject|46|||
33396139|NCT02148952|101337845|FG001|Follow-Up|Withdrawal by Subject|48|||
33396140|NCT01487863|101337846|FG000|Overall Study|Death|19|||
33396141|NCT01487863|101337847|FG001|Overall Study|Death|19|||
33396142|NCT00113555|101337848|FG000|Overall Study|Baseline Failure|59|||
33396143|NCT00113555|101337848|FG000|Overall Study|Permanently Explanted|7|||
33396144|NCT00113555|101337848|FG000|Overall Study|Death|1|||
33396145|NCT00113555|101337848|FG000|Overall Study|Missed Followup|4|||
33396146|NCT00113555|101337848|FG000|Overall Study|Lost to Follow-up|8|||
33396147|NCT00397631|101337850|FG000|Overall Study|Adverse Event|5|||
33396148|NCT00397631|101337851|FG001|Overall Study|Adverse Event|6|||
33396149|NCT00397631|101337850|FG000|Overall Study|Lack of Efficacy|7|||
33396150|NCT00397631|101337851|FG001|Overall Study|Lack of Efficacy|10|||
33396151|NCT00397631|101337850|FG000|Overall Study|Lost to Follow-up|8|||
33396152|NCT00397631|101337851|FG001|Overall Study|Lost to Follow-up|9|||
33396153|NCT00397631|101337850|FG000|Overall Study|Physician Decision|2|||
33396154|NCT00397631|101337851|FG001|Overall Study|Physician Decision|0|||
33396155|NCT00397631|101337850|FG000|Overall Study|Protocol Violation|0|||
33396156|NCT00397631|101337851|FG001|Overall Study|Protocol Violation|1|||
33396157|NCT00397631|101337850|FG000|Overall Study|Withdrawal by Subject|7|||
33396158|NCT00397631|101337851|FG001|Overall Study|Withdrawal by Subject|14|||
33396159|NCT00397631|101337850|FG000|Overall Study|protocol discontinuation criteria|1|||
33396160|NCT00397631|101337851|FG001|Overall Study|protocol discontinuation criteria|4|||
33396161|NCT01594411|101337852|FG000|Overall Study|Lost to Follow-up|2|||
33396162|NCT00901394|101337855|FG000|Overall Study|Physician Decision|1|||
33193996|NCT00727194|100616267|FG000|Screening Period|Low QMG scores|0|||
33193997|NCT00727194|100616268|FG001|Screening Period|Low QMG scores|0|||
33193998|NCT00727194|100616269|FG002|Screening Period|Low QMG scores|6|||
33396163|NCT00901394|101337856|FG001|Overall Study|Physician Decision|1|||
33396164|NCT00901394|101337857|FG002|Overall Study|Physician Decision|2|||
33193999|NCT00727194|100616267|FG000|Screening Period|Lacked AChR antibodies|0|||
33396165|NCT02274766|101337858|FG000|Overall Study|Withdrawal by Subject|3|||
33396166|NCT02274766|101337859|FG001|Overall Study|Withdrawal by Subject|6|||
33396167|NCT02274766|101337858|FG000|Overall Study|Did Not Receive Study Drug|1|||
33396168|NCT02274766|101337859|FG001|Overall Study|Did Not Receive Study Drug|1|||
33396169|NCT02274766|101337858|FG000|Overall Study|Subject Unwilling to Proceed|0|||
33396170|NCT02274766|101337859|FG001|Overall Study|Subject Unwilling to Proceed|1|||
33396171|NCT02274766|101337858|FG000|Overall Study|Adverse Event|0|||
33396172|NCT02274766|101337859|FG001|Overall Study|Adverse Event|1|||
33396173|NCT02447952|101337860|FG000|Overall Study|Adverse Event|2|||
33396174|NCT02447952|101337860|FG000|Overall Study|Physician Decision|1|||
33396175|NCT02447952|101337860|FG000|Overall Study|Withdrawal by Subject|4|||
33396176|NCT00957034|101337862|FG000|Overall Study|Adverse Event|0|||
33396177|NCT00957034|101337863|FG001|Overall Study|Adverse Event|1|||
33396178|NCT00957034|101337864|FG002|Overall Study|Adverse Event|1|||
33504144|NCT00877487|101738542|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
33504145|NCT00877487|101738541|FG000|Open-label Treatment Phase|Out of country for business|1|||
33504146|NCT00877487|101738542|FG001|Open-label Treatment Phase|Out of country for business|0|||
33504147|NCT00877487|101738541|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
33504148|NCT00877487|101738542|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
33504149|NCT00877487|101738541|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
33504150|NCT00877487|101738542|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
33504151|NCT00877487|101738541|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
33504152|NCT00877487|101738542|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
33504153|NCT00877487|101738541|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
33396179|NCT00957034|101337862|FG000|Overall Study|Sponsor Terminated Study|6|||
33504154|NCT00877487|101738542|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
33504155|NCT00402688|101738543|FG000|Overall Study|Adverse Event|12|||
33504156|NCT00402688|101738544|FG001|Overall Study|Adverse Event|9|||
33504157|NCT00402688|101738545|FG002|Overall Study|Adverse Event|3|||
33504158|NCT00402688|101738543|FG000|Overall Study|Withdrawal by Subject|3|||
33194000|NCT00727194|100616268|FG001|Screening Period|Lacked AChR antibodies|0|||
33194001|NCT00727194|100616269|FG002|Screening Period|Lacked AChR antibodies|5|||
33194002|NCT00727194|100616267|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
33194003|NCT00727194|100616268|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
33194004|NCT00727194|100616269|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
33194005|NCT00727194|100616267|FG000|Screening Period|Severe infections|0|||
33194006|NCT00727194|100616268|FG001|Screening Period|Severe infections|0|||
33194007|NCT00727194|100616269|FG002|Screening Period|Severe infections|2|||
33194008|NCT00727194|100616267|FG000|Screening Period|History of thymoma|0|||
33194009|NCT00727194|100616268|FG001|Screening Period|History of thymoma|0|||
33194010|NCT00727194|100616269|FG002|Screening Period|History of thymoma|1|||
33194011|NCT00727194|100616267|FG000|Treatment Period 2|Lack of Efficacy|0|||
33194012|NCT00727194|100616268|FG001|Treatment Period 2|Lack of Efficacy|1|||
33194013|NCT00727194|100616269|FG002|Treatment Period 2|Lack of Efficacy|0|||
33194014|NCT00393939|100616274|FG000|Overall Study|Protocol Violation|1|||
33194015|NCT00393939|100616275|FG001|Overall Study|Protocol Violation|1|||
33194016|NCT00393939|100616274|FG000|Overall Study|Lost to Follow-up|2|||
33194017|NCT00393939|100616275|FG001|Overall Study|Lost to Follow-up|4|||
33194018|NCT00393939|100616274|FG000|Overall Study|Death|10|||
33194019|NCT00393939|100616275|FG001|Overall Study|Death|4|||
33194020|NCT00393939|100616274|FG000|Overall Study|Sponsor|5|||
33194021|NCT00393939|100616275|FG001|Overall Study|Sponsor|13|||
33194022|NCT00393939|100616274|FG000|Overall Study|Objective progression or relapse|239|||
33194023|NCT00393939|100616275|FG001|Overall Study|Objective progression or relapse|223|||
33194024|NCT00393939|100616274|FG000|Overall Study|Withdrawal by Subject|2|||
33194025|NCT00393939|100616275|FG001|Overall Study|Withdrawal by Subject|7|||
33396180|NCT00957034|101337863|FG001|Overall Study|Sponsor Terminated Study|1|||
33396181|NCT00957034|101337864|FG002|Overall Study|Sponsor Terminated Study|5|||
33396182|NCT00957034|101337862|FG000|Overall Study|Withdrawal by Subject|0|||
33396183|NCT00957034|101337863|FG001|Overall Study|Withdrawal by Subject|2|||
33396184|NCT00957034|101337864|FG002|Overall Study|Withdrawal by Subject|0|||
33396185|NCT02449915|101337865|FG000|Overall Study|Exclusion criteria - drug use|1|||
33396186|NCT02449915|101337866|FG001|Overall Study|Exclusion criteria - drug use|0|||
33396187|NCT02449915|101337865|FG000|Overall Study|Withdrawal by Subject|0|||
33396188|NCT02449915|101337866|FG001|Overall Study|Withdrawal by Subject|2|||
33396189|NCT02449915|101337865|FG000|Overall Study|Intraoperative surgical findings|1|||
33396190|NCT02449915|101337866|FG001|Overall Study|Intraoperative surgical findings|1|||
33396191|NCT02449915|101337865|FG000|Overall Study|Abnormal preop lab|0|||
33396192|NCT02449915|101337866|FG001|Overall Study|Abnormal preop lab|1|||
33396193|NCT00958191|101337867|FG000|Overall Study|Death|4|||
33396194|NCT00958191|101337867|FG000|Overall Study|Lost to Follow-up|5|||
33396195|NCT00958191|101337867|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
33396196|NCT00958191|101337867|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
33396197|NCT00958191|101337867|FG000|Overall Study|Revision of study device|4|||
33396198|NCT00958191|101337867|FG000|Overall Study|Site termination|11|||
33396199|NCT00958191|101337867|FG000|Overall Study|No 5 yr x-rays|56|||
33396200|NCT02483611|101337870|FG000|Overall Study|Protocol Violation|0|||
33396201|NCT02483611|101337871|FG001|Overall Study|Protocol Violation|0|||
33396202|NCT02483611|101337872|FG002|Overall Study|Protocol Violation|1|||
33396203|NCT03196973|101337877|FG000|Overall Study|Adverse Event|1|||
33396204|NCT03196973|101337878|FG001|Overall Study|Adverse Event|1|||
33194026|NCT00393939|100616274|FG000|Overall Study|Other|37|||
33396205|NCT03196973|101337879|FG002|Overall Study|Adverse Event|2|||
33396206|NCT03196973|101337877|FG000|Overall Study|Lack of Efficacy|2|||
33194027|NCT00393939|100616275|FG001|Overall Study|Other|45|||
33194028|NCT01101841|100616276|FG000|Overall Study|Adverse Event|15|||
33194029|NCT01101841|100616277|FG001|Overall Study|Adverse Event|15|||
33194030|NCT01101841|100616276|FG000|Overall Study|Lost to Follow-up|9|||
33396207|NCT03196973|101337878|FG001|Overall Study|Lack of Efficacy|6|||
33396208|NCT03196973|101337879|FG002|Overall Study|Lack of Efficacy|1|||
33504159|NCT00402688|101738544|FG001|Overall Study|Withdrawal by Subject|1|||
33194031|NCT01101841|100616277|FG001|Overall Study|Lost to Follow-up|3|||
33194032|NCT01101841|100616276|FG000|Overall Study|Withdrawal by Subject|21|||
33194033|NCT01101841|100616277|FG001|Overall Study|Withdrawal by Subject|40|||
33194034|NCT01101841|100616276|FG000|Overall Study|Protocol Violation|1|||
33194035|NCT01101841|100616277|FG001|Overall Study|Protocol Violation|1|||
33194036|NCT01101841|100616276|FG000|Overall Study|Physician Decision|0|||
33194037|NCT01101841|100616277|FG001|Overall Study|Physician Decision|2|||
33194038|NCT01101841|100616276|FG000|Overall Study|Lack of Efficacy|0|||
33194039|NCT01101841|100616277|FG001|Overall Study|Lack of Efficacy|2|||
33194040|NCT01101841|100616276|FG000|Overall Study|Other|0|||
33194041|NCT01101841|100616277|FG001|Overall Study|Other|1|||
33194042|NCT01101841|100616276|FG000|Overall Study|Suicidality Tracking Scale|3|||
33194043|NCT01101841|100616277|FG001|Overall Study|Suicidality Tracking Scale|1|||
33194044|NCT01101841|100616276|FG000|Overall Study|Eligibility Criteria|1|||
33194045|NCT01101841|100616277|FG001|Overall Study|Eligibility Criteria|2|||
33194046|NCT00853658|100616281|FG000|Overall Study|Death|713|||
33194047|NCT00853658|100616282|FG001|Overall Study|Death|768|||
33194048|NCT00853658|100616283|FG002|Overall Study|Death|753|||
33194049|NCT00853658|100616281|FG000|Overall Study|Lost to Follow-up|11|||
33194050|NCT00853658|100616282|FG001|Overall Study|Lost to Follow-up|6|||
33194051|NCT00853658|100616283|FG002|Overall Study|Lost to Follow-up|11|||
33194052|NCT00853658|100616281|FG000|Overall Study|H.A. Request|26|||
33194053|NCT00853658|100616282|FG001|Overall Study|H.A. Request|23|||
33194054|NCT00853658|100616283|FG002|Overall Study|H.A. Request|19|||
33194055|NCT00853658|100616281|FG000|Overall Study|IRB request|0|||
33194056|NCT00853658|100616282|FG001|Overall Study|IRB request|0|||
33194057|NCT00853658|100616283|FG002|Overall Study|IRB request|2|||
33194058|NCT00853658|100616281|FG000|Overall Study|Vital Status known (alive) at study end|2|||
33194059|NCT00853658|100616282|FG001|Overall Study|Vital Status known (alive) at study end|3|||
33194060|NCT00853658|100616283|FG002|Overall Study|Vital Status known (alive) at study end|3|||
33194061|NCT00853658|100616281|FG000|Overall Study|Vital Status unknown at study end|1|||
33194062|NCT00853658|100616282|FG001|Overall Study|Vital Status unknown at study end|1|||
33194063|NCT00853658|100616283|FG002|Overall Study|Vital Status unknown at study end|0|||
33194064|NCT00853658|100616281|FG000|Overall Study|Vital Status at study end N/A|8|||
33194065|NCT00853658|100616282|FG001|Overall Study|Vital Status at study end N/A|10|||
33194066|NCT00853658|100616283|FG002|Overall Study|Vital Status at study end N/A|10|||
33194067|NCT00853658|100616281|FG000|Overall Study|Patient's request|21|||
33194068|NCT00853658|100616282|FG001|Overall Study|Patient's request|17|||
33194069|NCT00853658|100616283|FG002|Overall Study|Patient's request|11|||
33194070|NCT00853658|100616281|FG000|Overall Study|Missing study completion information|5|||
33194071|NCT00853658|100616282|FG001|Overall Study|Missing study completion information|4|||
33194072|NCT00853658|100616283|FG002|Overall Study|Missing study completion information|6|||
33194073|NCT01400841|100616294|FG000|Initial Study Phase (6 Months)|Death|1|||
33194074|NCT01400841|100616294|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
33194075|NCT02442830|100616295|FG000|Overall Study|Technical Failure|0|||
33194076|NCT02442830|100616296|FG001|Overall Study|Technical Failure|1|||
33194077|NCT03191903|100616302|FG000|Overall Study|Withdrawal by Subject|6|||
33194078|NCT03191903|100616303|FG001|Overall Study|Withdrawal by Subject|5|||
33194079|NCT03191903|100616304|FG002|Overall Study|Withdrawal by Subject|4|||
33194080|NCT03191903|100616302|FG000|Overall Study|Adverse Event|1|||
33194081|NCT03191903|100616303|FG001|Overall Study|Adverse Event|0|||
33194082|NCT03191903|100616304|FG002|Overall Study|Adverse Event|0|||
33194083|NCT00061048|100616305|FG000|Overall Study|Adverse Event|2|||
33194084|NCT00061048|100616305|FG000|Overall Study|disease progression|20|||
33313726|NCT03215810|101044277|FG000|Overall Study|Withdrawal by Subject|1|||
33313727|NCT01313689|101044280|FG000|24-Week Randomization 1|Adverse Event|10|||
33313728|NCT01313689|101044281|FG001|24-Week Randomization 1|Adverse Event|5|||
33313729|NCT01313689|101044282|FG002|24-Week Randomization 1|Adverse Event|0|||
33313730|NCT01313689|101044283|FG003|24-Week Randomization 1|Adverse Event|0|||
33313731|NCT01313689|101044284|FG004|24-Week Randomization 1|Adverse Event|0|||
33313732|NCT01313689|101044280|FG000|24-Week Randomization 1|Physician Decision|4|||
33313733|NCT01313689|101044281|FG001|24-Week Randomization 1|Physician Decision|5|||
33194085|NCT04068181|100616306|FG000|Overall Study|Withdrawal by Subject|2|||
33194086|NCT04068181|100616307|FG001|Overall Study|Withdrawal by Subject|0|||
33194087|NCT04068181|100616308|FG002|Overall Study|Withdrawal by Subject|0|||
33194088|NCT04068181|100616309|FG003|Overall Study|Withdrawal by Subject|0|||
33194089|NCT04068181|100616306|FG000|Overall Study|Lost to Follow-up|1|||
33194090|NCT04068181|100616307|FG001|Overall Study|Lost to Follow-up|0|||
33194091|NCT04068181|100616308|FG002|Overall Study|Lost to Follow-up|0|||
33194092|NCT04068181|100616309|FG003|Overall Study|Lost to Follow-up|0|||
33313734|NCT01313689|101044282|FG002|24-Week Randomization 1|Physician Decision|0|||
33194093|NCT04068181|100616306|FG000|Overall Study|Death|8|||
33194094|NCT04068181|100616307|FG001|Overall Study|Death|8|||
33194095|NCT04068181|100616308|FG002|Overall Study|Death|4|||
33194096|NCT04068181|100616309|FG003|Overall Study|Death|2|||
33194097|NCT04068181|100616306|FG000|Overall Study|Continuing Study|16|||
33194098|NCT04068181|100616307|FG001|Overall Study|Continuing Study|7|||
33396209|NCT03196973|101337877|FG000|Overall Study|Lost to Follow-up|4|||
33396210|NCT03196973|101337878|FG001|Overall Study|Lost to Follow-up|3|||
33396211|NCT03196973|101337879|FG002|Overall Study|Lost to Follow-up|2|||
33396212|NCT03196973|101337877|FG000|Overall Study|Consent withdrawn|2|||
33396213|NCT03196973|101337878|FG001|Overall Study|Consent withdrawn|1|||
33396214|NCT03196973|101337879|FG002|Overall Study|Consent withdrawn|0|||
33396215|NCT03196973|101337877|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
33396216|NCT03196973|101337878|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
33396217|NCT03196973|101337879|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
33396218|NCT02159365|101337885|FG000|Overall Study|Disease Progression|23|||
33396219|NCT02159365|101337885|FG000|Overall Study|Other reasons|11|||
33504160|NCT00402688|101738545|FG002|Overall Study|Withdrawal by Subject|1|||
33504161|NCT00402688|101738543|FG000|Overall Study|Physician Decision|0|||
33504162|NCT00402688|101738544|FG001|Overall Study|Physician Decision|0|||
33504163|NCT00402688|101738545|FG002|Overall Study|Physician Decision|1|||
33504164|NCT00402688|101738543|FG000|Overall Study|Lack of Efficacy|4|||
33504165|NCT00402688|101738544|FG001|Overall Study|Lack of Efficacy|4|||
33504166|NCT00402688|101738545|FG002|Overall Study|Lack of Efficacy|5|||
33504167|NCT00402688|101738543|FG000|Overall Study|Protocol Violation|1|||
33504168|NCT00402688|101738544|FG001|Overall Study|Protocol Violation|1|||
33504169|NCT00402688|101738545|FG002|Overall Study|Protocol Violation|1|||
33504170|NCT00402688|101738543|FG000|Overall Study|Lost to Follow-up|1|||
33504171|NCT00402688|101738544|FG001|Overall Study|Lost to Follow-up|0|||
33504172|NCT00402688|101738545|FG002|Overall Study|Lost to Follow-up|2|||
33504173|NCT00402688|101738543|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
33504174|NCT00402688|101738544|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
33504175|NCT00402688|101738545|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
33504176|NCT00402688|101738543|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
33504177|NCT00402688|101738544|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
33504178|NCT00402688|101738545|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
33504179|NCT00402688|101738543|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
33504180|NCT00402688|101738544|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
33504181|NCT00402688|101738545|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
33504182|NCT04468347|101738546|FG000|Overall Study|Withdrawal by Subject|0|||
33504183|NCT04468347|101738547|FG001|Overall Study|Withdrawal by Subject|1|||
33504184|NCT04468347|101738548|FG002|Overall Study|Withdrawal by Subject|3|||
33504185|NCT04468347|101738549|FG003|Overall Study|Withdrawal by Subject|3|||
33504186|NCT04468347|101738546|FG000|Overall Study|Lost to Follow-up|0|||
33504187|NCT04468347|101738547|FG001|Overall Study|Lost to Follow-up|0|||
33504188|NCT04468347|101738548|FG002|Overall Study|Lost to Follow-up|1|||
33504189|NCT04468347|101738549|FG003|Overall Study|Lost to Follow-up|1|||
33504190|NCT04468347|101738546|FG000|Overall Study|Physician Decision|1|||
33504191|NCT04468347|101738547|FG001|Overall Study|Physician Decision|0|||
33504192|NCT04468347|101738548|FG002|Overall Study|Physician Decision|2|||
33313735|NCT01313689|101044283|FG003|24-Week Randomization 1|Physician Decision|0|||
33313736|NCT01313689|101044284|FG004|24-Week Randomization 1|Physician Decision|0|||
33313737|NCT01313689|101044280|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
33504193|NCT04468347|101738549|FG003|Overall Study|Physician Decision|0|||
33313738|NCT01313689|101044281|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
33313739|NCT01313689|101044282|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
33313740|NCT01313689|101044283|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
33313741|NCT01313689|101044284|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
33313742|NCT01313689|101044280|FG000|24-Week Randomization 2|Adverse Event|0|||
33313743|NCT01313689|101044281|FG001|24-Week Randomization 2|Adverse Event|0|||
33313744|NCT01313689|101044282|FG002|24-Week Randomization 2|Adverse Event|2|||
33313745|NCT01313689|101044283|FG003|24-Week Randomization 2|Adverse Event|0|||
33313746|NCT01313689|101044284|FG004|24-Week Randomization 2|Adverse Event|8|||
33313747|NCT01313689|101044280|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
33313748|NCT01313689|101044281|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
33313749|NCT01313689|101044282|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
33313750|NCT01313689|101044283|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
33313751|NCT01313689|101044284|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
33313752|NCT01313689|101044280|FG000|24-Week Randomization 2|Physician Decision|0|||
33313753|NCT01313689|101044281|FG001|24-Week Randomization 2|Physician Decision|0|||
33313754|NCT01313689|101044282|FG002|24-Week Randomization 2|Physician Decision|0|||
33313755|NCT01313689|101044283|FG003|24-Week Randomization 2|Physician Decision|0|||
33313756|NCT01313689|101044284|FG004|24-Week Randomization 2|Physician Decision|4|||
33313757|NCT00323856|101044285|FG000|Overall Study|Withdrawal by Subject|1|||
33504194|NCT04468347|101738546|FG000|Overall Study|Protocol Violation|1|||
33504195|NCT04468347|101738547|FG001|Overall Study|Protocol Violation|0|||
33504196|NCT04468347|101738548|FG002|Overall Study|Protocol Violation|0|||
33504197|NCT04468347|101738549|FG003|Overall Study|Protocol Violation|0|||
33504198|NCT00356135|101738550|FG000|Overall Study|Protocol Violation|1|||
33504199|NCT00356135|101738551|FG001|Overall Study|Protocol Violation|0|||
33504200|NCT00356135|101738552|FG002|Overall Study|Protocol Violation|0|||
33504201|NCT00356135|101738550|FG000|Overall Study|Adverse Event|1|||
33504202|NCT00356135|101738551|FG001|Overall Study|Adverse Event|0|||
33504203|NCT00356135|101738552|FG002|Overall Study|Adverse Event|0|||
33504204|NCT00356135|101738550|FG000|Overall Study|Lost to Follow-up|0|||
33504205|NCT00356135|101738551|FG001|Overall Study|Lost to Follow-up|0|||
33504206|NCT00356135|101738552|FG002|Overall Study|Lost to Follow-up|1|||
33504207|NCT00356135|101738550|FG000|Overall Study|Physician Decision|1|||
33504208|NCT00356135|101738551|FG001|Overall Study|Physician Decision|1|||
33504209|NCT00356135|101738552|FG002|Overall Study|Physician Decision|1|||
33504210|NCT00356135|101738550|FG000|Overall Study|Subject non-compliance|1|||
33504211|NCT00356135|101738551|FG001|Overall Study|Subject non-compliance|1|||
33504212|NCT00356135|101738552|FG002|Overall Study|Subject non-compliance|3|||
33504213|NCT02257489|101738554|FG000|Overall Study|Withdrawal by Subject|0|||
33504214|NCT02257489|101738555|FG001|Overall Study|Withdrawal by Subject|0|||
33504215|NCT02257489|101738556|FG002|Overall Study|Withdrawal by Subject|0|||
33504216|NCT02257489|101738557|FG003|Overall Study|Withdrawal by Subject|1|||
33504217|NCT02257489|101738558|FG004|Overall Study|Withdrawal by Subject|0|||
33504218|NCT02257489|101738559|FG005|Overall Study|Withdrawal by Subject|0|||
33504219|NCT02257489|101738560|FG006|Overall Study|Withdrawal by Subject|0|||
33504220|NCT02257489|101738561|FG007|Overall Study|Withdrawal by Subject|0|||
33504221|NCT02257489|101738562|FG008|Overall Study|Withdrawal by Subject|0|||
33194099|NCT04068181|100616308|FG002|Overall Study|Continuing Study|11|||
33504222|NCT02126579|101738563|FG000|Overall Study|disease progression|0|||
33504223|NCT02126579|101738564|FG001|Overall Study|disease progression|0|||
33504224|NCT02126579|101738565|FG002|Overall Study|disease progression|0|||
33504225|NCT02126579|101738566|FG003|Overall Study|disease progression|1|||
33504226|NCT02126579|101738567|FG004|Overall Study|disease progression|0|||
33504227|NCT02126579|101738568|FG005|Overall Study|disease progression|0|||
33194100|NCT04068181|100616309|FG003|Overall Study|Continuing Study|13|||
33194101|NCT03779841|100616310|FG000|Randomized Population|Did Not Receive Treatment|3|||
33194102|NCT03779841|100616311|FG001|Randomized Population|Did Not Receive Treatment|1|||
33313758|NCT00323856|101044285|FG000|Overall Study|Was uncooperative and noncompliant|1|||
33313759|NCT00323856|101044285|FG000|Overall Study|Reason not specified|1|||
33313760|NCT00323856|101044285|FG000|Overall Study|Missing|2|||
33313761|NCT00319839|101044286|FG000|Overall Study|Adverse Event|5|||
33313762|NCT00319839|101044286|FG000|Overall Study|Withdrawal by Subject|1|||
33313763|NCT02121834|101044287|FG000|Overall Study|Protocol Violation|0|||
33313764|NCT02121834|101044288|FG001|Overall Study|Protocol Violation|1|||
33313765|NCT02121834|101044289|FG002|Overall Study|Protocol Violation|0|||
33313766|NCT02121834|101044290|FG003|Overall Study|Protocol Violation|0|||
33313767|NCT02121834|101044291|FG004|Overall Study|Protocol Violation|0|||
33313768|NCT02121834|101044292|FG005|Overall Study|Protocol Violation|0|||
33313769|NCT02121834|101044293|FG006|Overall Study|Protocol Violation|0|||
33313770|NCT02121834|101044287|FG000|Overall Study|Withdrawal by Subject|0|||
33313771|NCT02121834|101044288|FG001|Overall Study|Withdrawal by Subject|1|||
33313772|NCT02121834|101044289|FG002|Overall Study|Withdrawal by Subject|1|||
33313773|NCT02121834|101044290|FG003|Overall Study|Withdrawal by Subject|0|||
33313774|NCT02121834|101044291|FG004|Overall Study|Withdrawal by Subject|0|||
33313775|NCT02121834|101044292|FG005|Overall Study|Withdrawal by Subject|0|||
33313776|NCT02121834|101044293|FG006|Overall Study|Withdrawal by Subject|0|||
33313777|NCT02121834|101044287|FG000|Overall Study|Lost to Follow-up|0|||
33313778|NCT02121834|101044288|FG001|Overall Study|Lost to Follow-up|0|||
33396220|NCT02159365|101337885|FG000|Overall Study|Administrative reason by Sponsor|9|||
33396221|NCT02159365|101337885|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
33396222|NCT02159365|101337885|FG000|Overall Study|Study drug toxicity|7|||
33504228|NCT02126579|101738569|FG006|Overall Study|disease progression|1|||
33313779|NCT02121834|101044289|FG002|Overall Study|Lost to Follow-up|1|||
33313780|NCT02121834|101044290|FG003|Overall Study|Lost to Follow-up|0|||
33504229|NCT02737930|101738578|FG000|Overall Study|Withdrawal by Subject|0|||
33504230|NCT02737930|101738579|FG001|Overall Study|Withdrawal by Subject|1|||
33504231|NCT00596817|101738580|FG000|Open-label Period|Adverse Event|0|||
33504232|NCT00596817|101738581|FG001|Open-label Period|Adverse Event|49|||
33504233|NCT00596817|101738580|FG000|Open-label Period|Lack of Efficacy|0|||
33504234|NCT00596817|101738581|FG001|Open-label Period|Lack of Efficacy|33|||
33504235|NCT00596817|101738580|FG000|Open-label Period|Other Reasons|0|||
33504236|NCT00596817|101738581|FG001|Open-label Period|Other Reasons|65|||
33504237|NCT00596817|101738580|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
33194103|NCT03779841|100616312|FG002|Randomized Population|Did Not Receive Treatment|0|||
33313781|NCT02121834|101044291|FG004|Overall Study|Lost to Follow-up|0|||
33504238|NCT00596817|101738581|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
33504239|NCT00596817|101738580|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
33504240|NCT00596817|101738581|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
33504241|NCT00596817|101738580|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
33504242|NCT00596817|101738581|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
33313782|NCT02121834|101044292|FG005|Overall Study|Lost to Follow-up|0|||
33313783|NCT02121834|101044293|FG006|Overall Study|Lost to Follow-up|0|||
33313784|NCT01672723|101044294|FG000|First Intervention|Adverse Event|3|||
33313785|NCT01672723|101044295|FG001|First Intervention|Adverse Event|0|||
33313786|NCT00063154|101044299|FG000|Overall Study|Disease progression|27|||
33504243|NCT00596817|101738580|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
33504244|NCT00596817|101738581|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
33504245|NCT00596817|101738580|FG000|Double-blind Period|Adverse Event|5|||
33504246|NCT00596817|101738581|FG001|Double-blind Period|Adverse Event|16|||
33504247|NCT00596817|101738580|FG000|Double-blind Period|Lack of Efficacy|52|||
33504248|NCT00596817|101738581|FG001|Double-blind Period|Lack of Efficacy|28|||
33504249|NCT00596817|101738580|FG000|Double-blind Period|Non-compliance With Study Product|3|||
33504250|NCT00596817|101738581|FG001|Double-blind Period|Non-compliance With Study Product|4|||
33504251|NCT00596817|101738580|FG000|Double-blind Period|Protocol Violation|11|||
33504252|NCT00596817|101738581|FG001|Double-blind Period|Protocol Violation|8|||
33504253|NCT00596817|101738580|FG000|Double-blind Period|Withdrawal of Consent|7|||
33504254|NCT00596817|101738581|FG001|Double-blind Period|Withdrawal of Consent|3|||
33504255|NCT00596817|101738580|FG000|Double-blind Period|Lost to Follow-up|0|||
33313787|NCT00063154|101044299|FG000|Overall Study|Adverse Event|2|||
33313788|NCT00063154|101044299|FG000|Overall Study|Physician Decision|10|||
33313789|NCT00063154|101044299|FG000|Overall Study|Death|3|||
33313790|NCT00063154|101044299|FG000|Overall Study|Reason unspecified|1|||
33313791|NCT00063154|101044299|FG000|Overall Study|Did not receive treatment|8|||
33313792|NCT01193920|101044300|FG000|Overall Study|Withdrawal by Subject|1|||
33396223|NCT02159365|101337885|FG000|Overall Study|Maximum clinical benefit|3|||
33396224|NCT02159365|101337885|FG000|Overall Study|Subject request to discontinue treatment|3|||
33396225|NCT02159365|101337885|FG000|Overall Study|Subject withdrew consent|3|||
33396226|NCT02159365|101337885|FG000|Overall Study|Death|1|||
33396227|NCT02159365|101337885|FG000|Overall Study|Lost to Follow-up|1|||
33396228|NCT01642004|101337886|FG000|Randomization|Adverse Event unrelated to study drug|1|||
33396229|NCT01642004|101337887|FG001|Randomization|Adverse Event unrelated to study drug|0|||
33396230|NCT01642004|101337886|FG000|Randomization|Participant withdrew consent|1|||
33396231|NCT01642004|101337887|FG001|Randomization|Participant withdrew consent|6|||
33396232|NCT01642004|101337886|FG000|Randomization|No longer meets study criteria|2|||
33396233|NCT01642004|101337887|FG001|Randomization|No longer meets study criteria|2|||
33396234|NCT01642004|101337886|FG000|Treatment|Disease progression|95|||
33396235|NCT01642004|101337887|FG001|Treatment|Disease progression|79|||
33396236|NCT01642004|101337886|FG000|Treatment|Study drug toxicity|10|||
33396237|NCT01642004|101337887|FG001|Treatment|Study drug toxicity|13|||
33396238|NCT01642004|101337886|FG000|Treatment|Death|1|||
33396239|NCT01642004|101337887|FG001|Treatment|Death|1|||
33396240|NCT01642004|101337886|FG000|Treatment|Adverse event unrelated to study drug|9|||
33396241|NCT01642004|101337887|FG001|Treatment|Adverse event unrelated to study drug|13|||
33396242|NCT01642004|101337886|FG000|Treatment|Maximum clinical benefit|1|||
33396243|NCT01642004|101337887|FG001|Treatment|Maximum clinical benefit|9|||
33396244|NCT01642004|101337886|FG000|Treatment|Poor/non-compliance|1|||
33396245|NCT01642004|101337887|FG001|Treatment|Poor/non-compliance|0|||
33396246|NCT01642004|101337886|FG000|Treatment|No longer meets study criteria|1|||
33396247|NCT01642004|101337887|FG001|Treatment|No longer meets study criteria|2|||
33396248|NCT01642004|101337886|FG000|Treatment|Other reasons|2|||
33396249|NCT01642004|101337887|FG001|Treatment|Other reasons|0|||
33396250|NCT01642004|101337886|FG000|Treatment|Not reported|0|||
33396251|NCT01642004|101337887|FG001|Treatment|Not reported|3|||
33396252|NCT01642004|101337886|FG000|Treatment|Participant request to discontinue study treatment|6|||
33504256|NCT00596817|101738581|FG001|Double-blind Period|Lost to Follow-up|2|||
33504257|NCT00596817|101738580|FG000|Double-blind Period|Other Reasons|10|||
33504258|NCT00596817|101738581|FG001|Double-blind Period|Other Reasons|18|||
33504259|NCT00977080|101738584|FG000|Overall Study|Adverse Event|2|||
33313793|NCT01193920|101044301|FG001|Overall Study|Withdrawal by Subject|0|||
33396253|NCT01642004|101337887|FG001|Treatment|Participant request to discontinue study treatment|4|||
33504260|NCT00977080|101738585|FG001|Overall Study|Adverse Event|7|||
33504261|NCT00977080|101738586|FG002|Overall Study|Adverse Event|7|||
33504262|NCT00977080|101738587|FG003|Overall Study|Adverse Event|7|||
33396254|NCT01642004|101337886|FG000|Treatment|Participant withdrew consent|5|||
33396255|NCT01642004|101337887|FG001|Treatment|Participant withdrew consent|5|||
33313794|NCT01193920|101044302|FG002|Overall Study|Withdrawal by Subject|5|||
33313795|NCT01193920|101044303|FG003|Overall Study|Withdrawal by Subject|1|||
33313796|NCT01193920|101044304|FG004|Overall Study|Withdrawal by Subject|3|||
33313797|NCT01193920|101044305|FG005|Overall Study|Withdrawal by Subject|1|||
33313798|NCT01193920|101044306|FG006|Overall Study|Withdrawal by Subject|3|||
33313799|NCT01193920|101044307|FG007|Overall Study|Withdrawal by Subject|0|||
33313800|NCT01193920|101044308|FG008|Overall Study|Withdrawal by Subject|1|||
33313801|NCT01193920|101044309|FG009|Overall Study|Withdrawal by Subject|0|||
33313802|NCT01193920|101044300|FG000|Overall Study|Lost to Follow-up|1|||
33313803|NCT01193920|101044301|FG001|Overall Study|Lost to Follow-up|0|||
33313804|NCT01193920|101044302|FG002|Overall Study|Lost to Follow-up|1|||
33313805|NCT01193920|101044303|FG003|Overall Study|Lost to Follow-up|1|||
33313806|NCT01193920|101044304|FG004|Overall Study|Lost to Follow-up|3|||
33313807|NCT01193920|101044305|FG005|Overall Study|Lost to Follow-up|3|||
33313808|NCT01193920|101044306|FG006|Overall Study|Lost to Follow-up|1|||
33313809|NCT01193920|101044307|FG007|Overall Study|Lost to Follow-up|0|||
33313810|NCT01193920|101044308|FG008|Overall Study|Lost to Follow-up|2|||
33313811|NCT01193920|101044309|FG009|Overall Study|Lost to Follow-up|3|||
33313812|NCT01193920|101044300|FG000|Overall Study|Protocol Violation|1|||
33313813|NCT01193920|101044301|FG001|Overall Study|Protocol Violation|0|||
33313814|NCT01193920|101044302|FG002|Overall Study|Protocol Violation|0|||
33313815|NCT01193920|101044303|FG003|Overall Study|Protocol Violation|0|||
33313816|NCT01193920|101044304|FG004|Overall Study|Protocol Violation|0|||
33313817|NCT01193920|101044305|FG005|Overall Study|Protocol Violation|0|||
33313818|NCT01193920|101044306|FG006|Overall Study|Protocol Violation|0|||
33313819|NCT01193920|101044307|FG007|Overall Study|Protocol Violation|0|||
33313820|NCT01193920|101044308|FG008|Overall Study|Protocol Violation|0|||
33313821|NCT01193920|101044309|FG009|Overall Study|Protocol Violation|0|||
33313822|NCT01193920|101044300|FG000|Overall Study|Death|0|||
33313823|NCT01193920|101044301|FG001|Overall Study|Death|0|||
33504263|NCT00977080|101738584|FG000|Overall Study|Withdrawal by Subject|1|||
33504264|NCT00977080|101738585|FG001|Overall Study|Withdrawal by Subject|5|||
33504265|NCT00977080|101738586|FG002|Overall Study|Withdrawal by Subject|1|||
33504266|NCT00977080|101738587|FG003|Overall Study|Withdrawal by Subject|5|||
33504267|NCT00977080|101738584|FG000|Overall Study|Protocol Violation|7|||
33313824|NCT01193920|101044302|FG002|Overall Study|Death|0|||
33313825|NCT01193920|101044303|FG003|Overall Study|Death|1|||
33313826|NCT01193920|101044304|FG004|Overall Study|Death|0|||
33396256|NCT01266070|101337889|FG000|Overall Study|Adverse Event|3|||
33396257|NCT01266070|101337889|FG000|Overall Study|Protocol Violation|1|||
33396258|NCT01938391|101337892|FG000|6 Month Follow up|Withdrawal by Subject|1|||
33396259|NCT01938391|101337892|FG000|12 Month Follow up|Physician Decision|1|||
33396260|NCT01938391|101337892|FG000|12 Month Follow up|Withdrawal by Subject|1|||
33396261|NCT00893763|101337899|FG000|Overall Study|extubated|110|||
33396262|NCT00893763|101337900|FG001|Overall Study|extubated|110|||
33396263|NCT01326910|101337901|FG000|Overall Study|Withdrawal by Subject|3|||
33396264|NCT01326910|101337902|FG001|Overall Study|Withdrawal by Subject|2|||
33396265|NCT01326910|101337901|FG000|Overall Study|Protocol Violation|1|||
33396266|NCT01326910|101337902|FG001|Overall Study|Protocol Violation|1|||
33396267|NCT02254304|101341765|FG000|Overall Study|Adverse Event|2|||
33396268|NCT02254304|101341766|FG001|Overall Study|Adverse Event|1|||
33396269|NCT02254304|101341765|FG000|Overall Study|Lost to Follow-up|2|||
33396270|NCT02254304|101341766|FG001|Overall Study|Lost to Follow-up|2|||
33396271|NCT02254304|101341765|FG000|Overall Study|Protocol Violation|1|||
33396272|NCT02254304|101341766|FG001|Overall Study|Protocol Violation|0|||
33396273|NCT02254304|101341765|FG000|Overall Study|Withdrawal by Subject|3|||
33396274|NCT02254304|101341766|FG001|Overall Study|Withdrawal by Subject|0|||
33396275|NCT02254304|101341765|FG000|Overall Study|Injection site pain and Injection fear|1|||
33396276|NCT02254304|101341766|FG001|Overall Study|Injection site pain and Injection fear|0|||
33396277|NCT02254304|101341765|FG000|Overall Study|Personal causes|4|||
33396278|NCT02254304|101341766|FG001|Overall Study|Personal causes|1|||
33396279|NCT02254304|101341765|FG000|Overall Study|Personal decision|1|||
33504268|NCT00977080|101738585|FG001|Overall Study|Protocol Violation|3|||
33504269|NCT00977080|101738586|FG002|Overall Study|Protocol Violation|4|||
33313827|NCT01193920|101044305|FG005|Overall Study|Death|0|||
33313828|NCT01193920|101044306|FG006|Overall Study|Death|2|||
33313829|NCT01193920|101044307|FG007|Overall Study|Death|3|||
33313830|NCT01193920|101044308|FG008|Overall Study|Death|2|||
33396280|NCT02254304|101341766|FG001|Overall Study|Personal decision|0|||
33396281|NCT02871791|101341767|FG000|Phase 1b|Death|0|||
33396282|NCT02871791|101341768|FG001|Phase 1b|Death|1|||
33396283|NCT02871791|101341767|FG000|Phase 1b|progressive disease|6|||
33313831|NCT01193920|101044309|FG009|Overall Study|Death|4|||
33313832|NCT01193920|101044300|FG000|Overall Study|Unable to classify|0|||
33504270|NCT00977080|101738587|FG003|Overall Study|Protocol Violation|3|||
33504271|NCT00977080|101738584|FG000|Overall Study|Noncompliance|0|||
33313833|NCT01193920|101044301|FG001|Overall Study|Unable to classify|0|||
33313834|NCT01193920|101044302|FG002|Overall Study|Unable to classify|0|||
33313835|NCT01193920|101044303|FG003|Overall Study|Unable to classify|1|||
33396284|NCT02871791|101341768|FG001|Phase 1b|progressive disease|2|||
33396285|NCT02871791|101341767|FG000|Phase 2|Death|1|||
33313836|NCT01193920|101044304|FG004|Overall Study|Unable to classify|0|||
33313837|NCT01193920|101044305|FG005|Overall Study|Unable to classify|0|||
33313838|NCT01193920|101044306|FG006|Overall Study|Unable to classify|0|||
33313839|NCT01193920|101044307|FG007|Overall Study|Unable to classify|1|||
33313840|NCT01193920|101044308|FG008|Overall Study|Unable to classify|0|||
33313841|NCT01193920|101044309|FG009|Overall Study|Unable to classify|0|||
33313842|NCT02960854|101044310|FG000|Overall Study|Not Disclosed|2|||
33313843|NCT02960854|101044311|FG001|Overall Study|Not Disclosed|2|||
33313844|NCT02960854|101044310|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
33313845|NCT02960854|101044311|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
33313846|NCT02960854|101044310|FG000|Overall Study|Subject Withdrew Consent|0|||
33313847|NCT02960854|101044311|FG001|Overall Study|Subject Withdrew Consent|1|||
33313848|NCT02960854|101044310|FG000|Overall Study|Death|4|||
33313849|NCT02960854|101044311|FG001|Overall Study|Death|6|||
33313850|NCT01588496|101044312|FG000|Overall Study|Withdrawal by Subject|0|||
33313851|NCT01588496|101044313|FG001|Overall Study|Withdrawal by Subject|1|||
33313852|NCT01588496|101044314|FG002|Overall Study|Withdrawal by Subject|0|||
33313853|NCT00645801|101044315|FG000|Overall Study|unclear if patient took all the medication.|1|||
33313854|NCT00645801|101044316|FG001|Overall Study|unclear if patient took all the medication.|0|||
33313855|NCT00645801|101044315|FG000|Overall Study|Lost to Follow-up|19|||
33313856|NCT00645801|101044316|FG001|Overall Study|Lost to Follow-up|15|||
33313857|NCT00852540|101044320|FG000|Overall Study|Adverse Event|10|||
33313858|NCT00852540|101044321|FG001|Overall Study|Adverse Event|3|||
33396286|NCT02871791|101341768|FG001|Phase 2|Death|0|||
33396287|NCT02871791|101341767|FG000|Phase 2|Lost to Follow-up|2|||
33396288|NCT02871791|101341768|FG001|Phase 2|Lost to Follow-up|0|||
33396289|NCT02520141|101341769|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
33396290|NCT02060903|101341770|FG000|Overall Study|Lost to Follow-up|4|||
33396291|NCT02060903|101341771|FG001|Overall Study|Lost to Follow-up|0|||
33396292|NCT02060903|101341770|FG000|Overall Study|Withdrawal by Subject|0|||
33396293|NCT02060903|101341771|FG001|Overall Study|Withdrawal by Subject|7|||
33396294|NCT03733249|101341774|FG000|Overall Study|Death|7|||
33396295|NCT03733249|101341774|FG000|Overall Study|Disease relapse|16|||
33504272|NCT00977080|101738585|FG001|Overall Study|Noncompliance|2|||
33504273|NCT00977080|101738586|FG002|Overall Study|Noncompliance|1|||
33504274|NCT00977080|101738587|FG003|Overall Study|Noncompliance|0|||
33504275|NCT00977080|101738584|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
33504276|NCT00977080|101738585|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
33504277|NCT00977080|101738586|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
33504278|NCT00977080|101738587|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
33504279|NCT00977080|101738584|FG000|Overall Study|Required kidney transplantation|1|||
33504280|NCT00977080|101738585|FG001|Overall Study|Required kidney transplantation|3|||
33504281|NCT00977080|101738586|FG002|Overall Study|Required kidney transplantation|3|||
33504282|NCT00977080|101738587|FG003|Overall Study|Required kidney transplantation|1|||
33504283|NCT00977080|101738584|FG000|Overall Study|Travel for family reasons|1|||
33602818|NCT01646203|102099138|FG000|Overall Study|Withdrawal by Subject|0|||
33602819|NCT01646203|102099139|FG001|Overall Study|Withdrawal by Subject|1|||
33504284|NCT00977080|101738585|FG001|Overall Study|Travel for family reasons|0|||
33194104|NCT03779841|100616310|FG000|Treated (Safety) Population|Adverse Event|1|||
33602820|NCT01646203|102099140|FG002|Overall Study|Withdrawal by Subject|0|||
33602821|NCT01646203|102099138|FG000|Overall Study|Physician's Decision|0|||
33602822|NCT01646203|102099139|FG001|Overall Study|Physician's Decision|1|||
33602823|NCT01646203|102099140|FG002|Overall Study|Physician's Decision|0|||
33602824|NCT02914561|102099141|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
33602825|NCT02914561|102099142|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
33602826|NCT02914561|102099143|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
33602827|NCT02914561|102099144|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
33602828|NCT02914561|102099145|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
33602829|NCT02914561|102099146|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
33602830|NCT02914561|102099147|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
33602831|NCT02914561|102099148|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
33194105|NCT03779841|100616311|FG001|Treated (Safety) Population|Adverse Event|1|||
33313859|NCT00852540|101044320|FG000|Overall Study|Lack of Efficacy|15|||
33313860|NCT00852540|101044321|FG001|Overall Study|Lack of Efficacy|3|||
33313861|NCT00852540|101044320|FG000|Overall Study|Protocol Violation|1|||
33313862|NCT00852540|101044321|FG001|Overall Study|Protocol Violation|2|||
33313863|NCT00852540|101044320|FG000|Overall Study|Lost to Follow-up|2|||
33396296|NCT03733249|101341774|FG000|Overall Study|Lost to Follow-up|4|||
33504285|NCT00977080|101738586|FG002|Overall Study|Travel for family reasons|0|||
33602832|NCT02914561|102099149|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
33313864|NCT00852540|101044321|FG001|Overall Study|Lost to Follow-up|3|||
33396297|NCT03733249|101341774|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
33396298|NCT03733249|101341774|FG000|Overall Study|Withdrawal by Subject|1|||
33504286|NCT00977080|101738587|FG003|Overall Study|Travel for family reasons|0|||
33504287|NCT02530125|101738588|FG000|Completed Treatment|Early termination of study|1|||
33602833|NCT02914561|102099150|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
33504288|NCT02530125|101738588|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
33504289|NCT03474731|101738589|FG000|Overall Study|Withdrawal by Subject|36|||
33504290|NCT03474731|101738590|FG001|Overall Study|Withdrawal by Subject|29|||
33504291|NCT03474731|101738591|FG002|Overall Study|Withdrawal by Subject|11|||
33504292|NCT03474731|101738592|FG003|Overall Study|Withdrawal by Subject|27|||
33504293|NCT03474731|101738589|FG000|Overall Study|COVID|0|||
33504294|NCT03474731|101738590|FG001|Overall Study|COVID|23|||
33504295|NCT03474731|101738591|FG002|Overall Study|COVID|0|||
33504296|NCT03474731|101738592|FG003|Overall Study|COVID|0|||
33504297|NCT03474731|101738589|FG000|Overall Study|Participant moved from area|1|||
33504298|NCT03474731|101738590|FG001|Overall Study|Participant moved from area|0|||
33504299|NCT03474731|101738591|FG002|Overall Study|Participant moved from area|0|||
33504300|NCT03474731|101738592|FG003|Overall Study|Participant moved from area|0|||
33504301|NCT03474731|101738589|FG000|Overall Study|Lost to Follow-up|11|||
33504302|NCT03474731|101738590|FG001|Overall Study|Lost to Follow-up|3|||
33504303|NCT03474731|101738591|FG002|Overall Study|Lost to Follow-up|18|||
33504304|NCT03474731|101738592|FG003|Overall Study|Lost to Follow-up|17|||
33504305|NCT03474731|101738589|FG000|Overall Study|Death|0|||
33504306|NCT03474731|101738590|FG001|Overall Study|Death|1|||
33504307|NCT03474731|101738591|FG002|Overall Study|Death|0|||
33504308|NCT03474731|101738592|FG003|Overall Study|Death|0|||
33504309|NCT03474731|101738589|FG000|Overall Study|Participant Removed|0|||
33504310|NCT03474731|101738590|FG001|Overall Study|Participant Removed|0|||
33396299|NCT01950364|101341777|FG000|Overall Study|Adverse Event|3|||
33504311|NCT03474731|101738591|FG002|Overall Study|Participant Removed|0|||
33504312|NCT03474731|101738592|FG003|Overall Study|Participant Removed|1|||
33504313|NCT00026494|101738595|FG000|Overall Study|Withdrawal by Subject|1|||
33504314|NCT00026494|101738596|FG001|Overall Study|Withdrawal by Subject|0|||
33504315|NCT00026494|101738597|FG002|Overall Study|Withdrawal by Subject|1|||
33504316|NCT00026494|101738598|FG003|Overall Study|Withdrawal by Subject|0|||
33504317|NCT00026494|101738595|FG000|Overall Study|Patient non-compliance|1|||
33504318|NCT00026494|101738596|FG001|Overall Study|Patient non-compliance|0|||
33504319|NCT00026494|101738597|FG002|Overall Study|Patient non-compliance|0|||
33504320|NCT00026494|101738598|FG003|Overall Study|Patient non-compliance|0|||
33504321|NCT00026494|101738595|FG000|Overall Study|Patient not treated|0|||
33504322|NCT00026494|101738596|FG001|Overall Study|Patient not treated|0|||
33504323|NCT00026494|101738597|FG002|Overall Study|Patient not treated|2|||
33504324|NCT00026494|101738598|FG003|Overall Study|Patient not treated|0|||
33504325|NCT00026494|101738595|FG000|Overall Study|Clinical progression|0|||
33504326|NCT00026494|101738596|FG001|Overall Study|Clinical progression|0|||
33504327|NCT00026494|101738597|FG002|Overall Study|Clinical progression|3|||
33504328|NCT00026494|101738598|FG003|Overall Study|Clinical progression|0|||
33504329|NCT02122887|101738604|FG000|Overall Study|Withdrawal by Subject|20|||
33504330|NCT02122887|101738605|FG001|Overall Study|Withdrawal by Subject|2|||
33504331|NCT05326529|101738606|FG000|Overall Study|Lack of Efficacy|0|||
33504332|NCT05326529|101738607|FG001|Overall Study|Lack of Efficacy|1|||
33504333|NCT05326529|101738608|FG002|Overall Study|Lack of Efficacy|0|||
33504334|NCT05326529|101738606|FG000|Overall Study|Physician Decision|0|||
33504335|NCT05326529|101738607|FG001|Overall Study|Physician Decision|0|||
33504336|NCT05326529|101738608|FG002|Overall Study|Physician Decision|2|||
33504337|NCT00022698|101738609|FG000|Overall Study|Adverse Event|5|||
33504338|NCT00022698|101738610|FG001|Overall Study|Adverse Event|9|||
33504339|NCT00022698|101738609|FG000|Overall Study|Death|0|||
33504340|NCT00022698|101738610|FG001|Overall Study|Death|2|||
33504341|NCT00022698|101738609|FG000|Overall Study|Failure to return|0|||
33504342|NCT00022698|101738610|FG001|Overall Study|Failure to return|1|||
33504343|NCT00022698|101738609|FG000|Overall Study|Refused treatment|0|||
33504344|NCT00022698|101738610|FG001|Overall Study|Refused treatment|2|||
33504345|NCT00022698|101738609|FG000|Overall Study|Insufficient therapeutic response|2|||
33504346|NCT00022698|101738610|FG001|Overall Study|Insufficient therapeutic response|14|||
33504347|NCT00022698|101738609|FG000|Overall Study|Administrative /other|1|||
33504348|NCT00022698|101738610|FG001|Overall Study|Administrative /other|7|||
33504349|NCT01340872|101738619|FG000|Double-blind Phase|Adverse Event|6|||
33504350|NCT01340872|101738620|FG001|Double-blind Phase|Adverse Event|4|||
33504351|NCT01340872|101738621|FG002|Double-blind Phase|Adverse Event|0|||
33504352|NCT01340872|101738622|FG003|Double-blind Phase|Adverse Event|0|||
33504353|NCT01340872|101738619|FG000|Double-blind Phase|Withdrawal by Subject|3|||
33504354|NCT01340872|101738620|FG001|Double-blind Phase|Withdrawal by Subject|5|||
33504355|NCT01340872|101738621|FG002|Double-blind Phase|Withdrawal by Subject|0|||
33504356|NCT01340872|101738622|FG003|Double-blind Phase|Withdrawal by Subject|0|||
33504357|NCT01340872|101738619|FG000|Double-blind Phase|Lost to Follow-up|0|||
33504358|NCT01340872|101738620|FG001|Double-blind Phase|Lost to Follow-up|1|||
33396300|NCT01950364|101341778|FG001|Overall Study|Adverse Event|0|||
33396301|NCT01950364|101341777|FG000|Overall Study|Stem Cell Transplant|2|||
33602834|NCT02914561|102099151|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
33602835|NCT02914561|102099141|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
33602836|NCT02914561|102099142|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
33602837|NCT02914561|102099143|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
33602838|NCT02914561|102099144|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
33602839|NCT02914561|102099145|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
33602840|NCT02914561|102099146|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
33602841|NCT02914561|102099147|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
33602842|NCT02914561|102099148|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
33602843|NCT02914561|102099149|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
33602844|NCT02914561|102099150|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
33602845|NCT02914561|102099151|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
33602846|NCT02914561|102099141|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
33602847|NCT02914561|102099142|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
33602848|NCT02914561|102099143|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
33602849|NCT02914561|102099144|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
33602850|NCT02914561|102099145|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
33602851|NCT02914561|102099146|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
33602852|NCT02914561|102099147|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
33602853|NCT02914561|102099148|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
33602854|NCT02914561|102099149|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
33602855|NCT02914561|102099150|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
33602856|NCT02914561|102099151|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
33602857|NCT02914561|102099141|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
33602858|NCT02914561|102099142|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
33602859|NCT02914561|102099143|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
33602860|NCT02914561|102099144|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
33602861|NCT02914561|102099145|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
33602862|NCT02914561|102099146|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
33504359|NCT01340872|101738621|FG002|Double-blind Phase|Lost to Follow-up|0|||
33313865|NCT00852540|101044320|FG000|Overall Study|Investigator Discretion|2|||
33313866|NCT00852540|101044321|FG001|Overall Study|Investigator Discretion|3|||
33313867|NCT00852540|101044320|FG000|Overall Study|Withdrawal by Subject|3|||
33396302|NCT01950364|101341778|FG001|Overall Study|Stem Cell Transplant|6|||
33396303|NCT01950364|101341777|FG000|Overall Study|Disease Progression|5|||
33396304|NCT01950364|101341778|FG001|Overall Study|Disease Progression|2|||
33396305|NCT01950364|101341777|FG000|Overall Study|Withdrawal by Subject|0|||
33396306|NCT01950364|101341778|FG001|Overall Study|Withdrawal by Subject|1|||
33396307|NCT01950364|101341777|FG000|Overall Study|Protocol Violation|0|||
33504360|NCT01340872|101738622|FG003|Double-blind Phase|Lost to Follow-up|0|||
33504361|NCT01340872|101738619|FG000|Double-blind Phase|Protocol Violation|0|||
33504362|NCT01340872|101738620|FG001|Double-blind Phase|Protocol Violation|1|||
33504363|NCT01340872|101738621|FG002|Double-blind Phase|Protocol Violation|0|||
33504364|NCT01340872|101738622|FG003|Double-blind Phase|Protocol Violation|0|||
33504365|NCT01340872|101738619|FG000|Open-label Phase|Physician Decision|0|||
33504366|NCT01340872|101738620|FG001|Open-label Phase|Physician Decision|0|||
33504367|NCT01340872|101738621|FG002|Open-label Phase|Physician Decision|2|||
33504368|NCT01340872|101738622|FG003|Open-label Phase|Physician Decision|1|||
33504369|NCT01340872|101738619|FG000|Open-label Phase|Pregnancy|0|||
33504370|NCT01340872|101738620|FG001|Open-label Phase|Pregnancy|0|||
33504371|NCT01340872|101738621|FG002|Open-label Phase|Pregnancy|1|||
33504372|NCT01340872|101738622|FG003|Open-label Phase|Pregnancy|0|||
33396308|NCT01950364|101341778|FG001|Overall Study|Protocol Violation|1|||
33396309|NCT01183104|101341779|FG000|Overall Study|Adverse Event|8|||
33396310|NCT01183104|101341780|FG001|Overall Study|Adverse Event|6|||
33396311|NCT01183104|101341779|FG000|Overall Study|Death|0|||
33396312|NCT01183104|101341780|FG001|Overall Study|Death|1|||
33396313|NCT01183104|101341779|FG000|Overall Study|Lost to Follow-up|14|||
33396314|NCT01183104|101341780|FG001|Overall Study|Lost to Follow-up|7|||
33504373|NCT01340872|101738619|FG000|Open-label Phase|Adverse Event|0|||
33504374|NCT01340872|101738620|FG001|Open-label Phase|Adverse Event|0|||
33504375|NCT01340872|101738621|FG002|Open-label Phase|Adverse Event|8|||
33602863|NCT02914561|102099147|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
33504376|NCT01340872|101738622|FG003|Open-label Phase|Adverse Event|4|||
33504377|NCT01340872|101738619|FG000|Open-label Phase|Withdrawal by Subject|0|||
33504378|NCT01340872|101738620|FG001|Open-label Phase|Withdrawal by Subject|0|||
33602864|NCT02914561|102099148|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
33504379|NCT01340872|101738621|FG002|Open-label Phase|Withdrawal by Subject|1|||
33504380|NCT01340872|101738622|FG003|Open-label Phase|Withdrawal by Subject|6|||
33504381|NCT01340872|101738619|FG000|Open-label Phase|Worsening of IBD|0|||
33504382|NCT01340872|101738620|FG001|Open-label Phase|Worsening of IBD|0|||
33504383|NCT01340872|101738621|FG002|Open-label Phase|Worsening of IBD|1|||
33504384|NCT01340872|101738622|FG003|Open-label Phase|Worsening of IBD|0|||
33504385|NCT00491556|101738627|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
33504386|NCT00491556|101738628|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
33504387|NCT00491556|101738627|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
33504388|NCT00491556|101738628|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
33504389|NCT00491556|101738627|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
33504390|NCT00491556|101738628|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
33504391|NCT00491556|101738627|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
33504392|NCT00491556|101738628|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
33504393|NCT00491556|101738627|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
33504394|NCT00491556|101738628|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
33504395|NCT00491556|101738627|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
33504396|NCT00491556|101738628|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
33504397|NCT00491556|101738627|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
33504398|NCT00491556|101738628|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
33504399|NCT00491556|101738627|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
33602865|NCT02914561|102099149|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
33602866|NCT02914561|102099150|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
33602867|NCT02914561|102099151|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
33602868|NCT02914561|102099141|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
33194106|NCT03779841|100616312|FG002|Treated (Safety) Population|Adverse Event|0|||
33602869|NCT02914561|102099142|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
33194107|NCT03779841|100616310|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
33194108|NCT03779841|100616311|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
33194109|NCT03779841|100616312|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
33194110|NCT03779841|100616310|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
33194111|NCT03779841|100616311|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
33194112|NCT03779841|100616312|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
33194113|NCT03779841|100616310|FG000|Treated (Safety) Population|Death|1|||
33194114|NCT03779841|100616311|FG001|Treated (Safety) Population|Death|0|||
33194115|NCT03779841|100616312|FG002|Treated (Safety) Population|Death|2|||
33194116|NCT00595582|100616315|FG000|Overall Study|Pilot study that PI terminated|2|||
33194117|NCT00595582|100616315|FG000|Overall Study|Lost to Follow-up|1|||
33194118|NCT00595582|100616315|FG000|Overall Study|Adverse Event|2|||
33194119|NCT00595582|100616315|FG000|Overall Study|Physician Decision|5|||
33194120|NCT01707004|100616316|FG000|Overall Study|Physician Decision|3|||
33194121|NCT01850004|100616317|FG000|Overall Study|Poor/Non-compliance|1|||
33194122|NCT01850004|100616317|FG000|Overall Study|Participant Withdrew Consent|9|||
33194123|NCT01850004|100616317|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
33194124|NCT01850004|100616317|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
33602870|NCT02914561|102099143|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
33602871|NCT02914561|102099144|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
33602872|NCT02914561|102099145|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
33602873|NCT02914561|102099146|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
33602874|NCT02914561|102099147|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
33602875|NCT02914561|102099148|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
33602876|NCT02914561|102099149|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
33602877|NCT02914561|102099150|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
33602878|NCT02914561|102099151|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
33602879|NCT02914561|102099141|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
33602880|NCT02914561|102099142|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
33602881|NCT02914561|102099143|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
33194125|NCT01850004|100616317|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
33504400|NCT00491556|101738628|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
33504401|NCT00491556|101738627|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
33194126|NCT01850004|100616317|FG000|Overall Study|Other Reasons|2|||
33194127|NCT01850004|100616317|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
33194128|NCT01850004|100616317|FG000|Overall Study|Maximum Clinical Benefit|4|||
33194129|NCT01701258|100616318|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
33194130|NCT01701258|100616319|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
33194131|NCT01701258|100616320|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
33504402|NCT00491556|101738628|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
33194132|NCT01701258|100616321|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
33396315|NCT01183104|101341779|FG000|Overall Study|Physician Decision|5|||
33194133|NCT01701258|100616322|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
33194134|NCT01701258|100616323|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
33194135|NCT01701258|100616324|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
33194136|NCT01701258|100616325|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
33194137|NCT01701258|100616326|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
33194138|NCT01701258|100616327|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
33194139|NCT01701258|100616328|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
33194140|NCT01701258|100616329|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
33194141|NCT01701258|100616330|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
33194142|NCT01701258|100616318|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
33194143|NCT01701258|100616319|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
33194144|NCT01701258|100616320|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
33194145|NCT01701258|100616321|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
33194146|NCT01701258|100616322|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
33194147|NCT01701258|100616323|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
33194148|NCT01701258|100616324|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
33194149|NCT01701258|100616325|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
33194150|NCT01701258|100616326|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
33194151|NCT01701258|100616327|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
33194152|NCT01701258|100616328|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
33194153|NCT01701258|100616329|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
33194154|NCT01701258|100616330|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
33194155|NCT01701258|100616318|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
33194156|NCT01701258|100616319|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
33194157|NCT01701258|100616320|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
33313868|NCT00852540|101044321|FG001|Overall Study|Withdrawal by Subject|1|||
33313869|NCT00852540|101044320|FG000|Overall Study|Did Not Receive Study Drug|3|||
33313870|NCT00852540|101044321|FG001|Overall Study|Did Not Receive Study Drug|3|||
33313871|NCT01001832|101044324|FG000|Short-term Period|Adverse Event|2|||
33313872|NCT01001832|101044325|FG001|Short-term Period|Adverse Event|3|||
33313873|NCT01001832|101044324|FG000|Long-term Period|Adverse Event|2|||
33313874|NCT01001832|101044325|FG001|Long-term Period|Adverse Event|1|||
33313875|NCT01001832|101044324|FG000|Long-term Period|Withdrawal by Subject|1|||
33313876|NCT01001832|101044325|FG001|Long-term Period|Withdrawal by Subject|0|||
33313877|NCT01001832|101044324|FG000|Long-term Period|Lack of Efficacy|0|||
33313878|NCT01001832|101044325|FG001|Long-term Period|Lack of Efficacy|2|||
33313879|NCT01001832|101044324|FG000|Long-term Period|Other|1|||
33396316|NCT01183104|101341780|FG001|Overall Study|Physician Decision|8|||
33396317|NCT01183104|101341779|FG000|Overall Study|Withdrawal by Subject|6|||
33396318|NCT01183104|101341780|FG001|Overall Study|Withdrawal by Subject|11|||
33396319|NCT01183104|101341779|FG000|Overall Study|Nonparticipation in Extension Study|39|||
33396320|NCT01183104|101341780|FG001|Overall Study|Nonparticipation in Extension Study|50|||
33396321|NCT01183104|101341779|FG000|Overall Study|Did not receive study drug|5|||
33396322|NCT01183104|101341780|FG001|Overall Study|Did not receive study drug|9|||
33504403|NCT00491556|101738627|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
33504404|NCT00491556|101738628|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
33504405|NCT00491556|101738627|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
33313880|NCT01001832|101044325|FG001|Long-term Period|Other|2|||
33313881|NCT01001832|101044324|FG000|Follow-up Period|Withdrawal by Subject|1|||
33313882|NCT01001832|101044325|FG001|Follow-up Period|Withdrawal by Subject|0|||
33313883|NCT01001832|101044324|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
33313884|NCT01001832|101044325|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
33313885|NCT01001832|101044324|FG000|Follow-up Period|Other|2|||
33313886|NCT01001832|101044325|FG001|Follow-up Period|Other|1|||
33313887|NCT04025580|101044326|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
33313888|NCT04025580|101044327|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
33313889|NCT04025580|101044328|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
33313890|NCT01217957|101044329|FG000|Phase 1|Withdrawal by Patient|1|||
33194158|NCT01701258|100616321|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
33194159|NCT01701258|100616322|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
33194160|NCT01701258|100616323|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
33194161|NCT01701258|100616324|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
33194162|NCT01701258|100616325|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
33194163|NCT01701258|100616326|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
33194164|NCT01701258|100616327|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
33504406|NCT00491556|101738628|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
33504407|NCT00491556|101738627|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
33504408|NCT00491556|101738628|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
33504409|NCT00491556|101738627|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
33504410|NCT00491556|101738628|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
33504411|NCT00491556|101738627|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
33504412|NCT00491556|101738628|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
33504413|NCT00491556|101738627|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
33504414|NCT00491556|101738628|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
33504415|NCT00491556|101738627|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
33504416|NCT00491556|101738628|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
33504417|NCT00491556|101738627|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
33194165|NCT01701258|100616328|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
33504418|NCT00491556|101738628|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
33194166|NCT01701258|100616329|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
33602882|NCT02914561|102099144|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
33602883|NCT02914561|102099145|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
33194167|NCT01701258|100616330|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
33194168|NCT01701258|100616318|FG000|Assessment and Scheduling|Investigator Terminated|2|||
33194169|NCT01701258|100616319|FG001|Assessment and Scheduling|Investigator Terminated|0|||
33194170|NCT01701258|100616320|FG002|Assessment and Scheduling|Investigator Terminated|0|||
33504419|NCT00491556|101738627|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
33504420|NCT00491556|101738628|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
33504421|NCT00491556|101738627|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
33504422|NCT00491556|101738628|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
33504423|NCT00491556|101738627|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
33504424|NCT00491556|101738628|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
33504425|NCT00758485|101738629|FG000|Overall Study|Lost to Follow-up|0|||
33504426|NCT00758485|101738630|FG001|Overall Study|Lost to Follow-up|1|||
33504427|NCT00758485|101738629|FG000|Overall Study|Not Treated|1|||
33602884|NCT02914561|102099146|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
33602885|NCT02914561|102099147|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
33602886|NCT02914561|102099148|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
33194171|NCT01701258|100616321|FG003|Assessment and Scheduling|Investigator Terminated|0|||
33194172|NCT01701258|100616322|FG004|Assessment and Scheduling|Investigator Terminated|0|||
33194173|NCT01701258|100616323|FG005|Assessment and Scheduling|Investigator Terminated|0|||
33194174|NCT01701258|100616324|FG006|Assessment and Scheduling|Investigator Terminated|0|||
33194175|NCT01701258|100616325|FG007|Assessment and Scheduling|Investigator Terminated|0|||
33194176|NCT01701258|100616326|FG008|Assessment and Scheduling|Investigator Terminated|0|||
33194177|NCT01701258|100616327|FG009|Assessment and Scheduling|Investigator Terminated|0|||
33194178|NCT01701258|100616328|FG010|Assessment and Scheduling|Investigator Terminated|0|||
33194179|NCT01701258|100616329|FG011|Assessment and Scheduling|Investigator Terminated|0|||
33194180|NCT01701258|100616330|FG012|Assessment and Scheduling|Investigator Terminated|0|||
33194181|NCT02649972|100616331|FG000|Overall Study|Not treated|1|||
33194182|NCT00813124|100616332|FG000|Overall Study|Death|2|||
33194183|NCT00813124|100616332|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
33194184|NCT00813124|100616332|FG000|Overall Study|Withdrawal by Subject|1|||
33194185|NCT04085523|100616333|FG000|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
33602887|NCT02914561|102099149|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
33602888|NCT02914561|102099150|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
33602889|NCT02914561|102099151|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
33504428|NCT00758485|101738630|FG001|Overall Study|Not Treated|2|||
33602890|NCT02914561|102099141|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
33602891|NCT02914561|102099142|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
33504429|NCT00468481|101738639|FG000|Overall Study|Adverse Event|13|||
33504430|NCT00468481|101738640|FG001|Overall Study|Adverse Event|3|||
33504431|NCT00468481|101738639|FG000|Overall Study|Lost to Follow-up|25|||
33504432|NCT00468481|101738640|FG001|Overall Study|Lost to Follow-up|8|||
33504433|NCT00468481|101738639|FG000|Overall Study|Pregnancy|2|||
33504434|NCT00468481|101738640|FG001|Overall Study|Pregnancy|0|||
33504435|NCT00468481|101738639|FG000|Overall Study|Protocol Violation|18|||
33504436|NCT00468481|101738640|FG001|Overall Study|Protocol Violation|8|||
33504437|NCT00468481|101738639|FG000|Overall Study|Withdrawal by Subject|12|||
33504438|NCT00468481|101738640|FG001|Overall Study|Withdrawal by Subject|3|||
33504439|NCT00468481|101738639|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
33504440|NCT00468481|101738640|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
33504441|NCT00468481|101738639|FG000|Overall Study|Prohibited Medication|1|||
33602892|NCT02914561|102099143|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
33602893|NCT02914561|102099144|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
33602894|NCT02914561|102099145|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
33194186|NCT04085523|100616334|FG001|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
33194187|NCT04085523|100616335|FG002|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
33194188|NCT04085523|100616336|FG003|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
33194189|NCT04085523|100616337|FG004|Open-Label Period (Weeks 52 to 156)|Study Ongoing|0|||
33194190|NCT04085523|100616338|FG005|Open-Label Period (Weeks 52 to 156)|Study Ongoing|57|||
33194191|NCT00428610|100616339|FG000|Overall Study|Death Due to Adverse Event|3|||
33194192|NCT00428610|100616340|FG001|Overall Study|Death Due to Adverse Event|0|||
33194193|NCT00428610|100616341|FG002|Overall Study|Death Due to Adverse Event|5|||
33194194|NCT00428610|100616339|FG000|Overall Study|Death Due to Progressive Disease|0|||
33194195|NCT00428610|100616340|FG001|Overall Study|Death Due to Progressive Disease|0|||
33194196|NCT00428610|100616341|FG002|Overall Study|Death Due to Progressive Disease|2|||
33194197|NCT00428610|100616339|FG000|Overall Study|Adverse Event|2|||
33194198|NCT00428610|100616340|FG001|Overall Study|Adverse Event|3|||
33194199|NCT00428610|100616341|FG002|Overall Study|Adverse Event|2|||
33194200|NCT00428610|100616339|FG000|Overall Study|Investigator Decision|2|||
33194201|NCT00428610|100616340|FG001|Overall Study|Investigator Decision|1|||
33194202|NCT00428610|100616341|FG002|Overall Study|Investigator Decision|1|||
33194203|NCT00428610|100616339|FG000|Overall Study|Progressive Disease|42|||
33602895|NCT02914561|102099146|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
33602896|NCT02914561|102099147|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
33602897|NCT02914561|102099148|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
33602898|NCT02914561|102099149|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
33602899|NCT02914561|102099150|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
33602900|NCT02914561|102099151|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
33602901|NCT02914561|102099141|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
33602902|NCT02914561|102099142|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
33602903|NCT02914561|102099143|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
33602904|NCT02914561|102099144|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
33602905|NCT02914561|102099145|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
33602906|NCT02914561|102099146|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
33602907|NCT02914561|102099147|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
33602908|NCT02914561|102099148|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
33602909|NCT02914561|102099149|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
33602910|NCT02914561|102099150|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
33602911|NCT02914561|102099151|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
33602912|NCT02914561|102099141|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
33602913|NCT02914561|102099142|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
33602914|NCT02914561|102099143|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
33602915|NCT02914561|102099144|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
33602916|NCT02914561|102099145|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
33602917|NCT02914561|102099146|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
33602918|NCT02914561|102099147|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
33313891|NCT01217957|101044330|FG001|Phase 1|Withdrawal by Patient|0|||
33313892|NCT01217957|101044331|FG002|Phase 1|Withdrawal by Patient|1|||
33313893|NCT01217957|101044332|FG003|Phase 1|Withdrawal by Patient|1|||
33313894|NCT01217957|101044333|FG004|Phase 1|Withdrawal by Patient|0|||
33313895|NCT01217957|101044329|FG000|Phase 2|Withdrawal by Patient|0|||
33313896|NCT01217957|101044330|FG001|Phase 2|Withdrawal by Patient|0|||
33194204|NCT00428610|100616340|FG001|Overall Study|Progressive Disease|14|||
33194205|NCT00428610|100616341|FG002|Overall Study|Progressive Disease|22|||
33313897|NCT01217957|101044331|FG002|Phase 2|Withdrawal by Patient|0|||
33194206|NCT00428610|100616339|FG000|Overall Study|Withdrawal by Subject|4|||
33504442|NCT00468481|101738640|FG001|Overall Study|Prohibited Medication|1|||
33504443|NCT00468481|101738639|FG000|Overall Study|Egg Donor|1|||
33313898|NCT01217957|101044332|FG003|Phase 2|Withdrawal by Patient|0|||
33313899|NCT01217957|101044333|FG004|Phase 2|Withdrawal by Patient|1|||
33313900|NCT01111474|101044334|FG000|Overall Study|Lost to Follow-up|12|||
33313901|NCT01801735|101044335|FG000|Overall Study|Adverse Event|79|||
33313902|NCT01801735|101044335|FG000|Overall Study|Lack of Efficacy|28|||
33313903|NCT01801735|101044335|FG000|Overall Study|Withdrawal by Subject|27|||
33313904|NCT01801735|101044335|FG000|Overall Study|Protocol Violation|25|||
33396323|NCT03032523|101341781|FG000|Overall Study|Withdrawal by Subject|2|||
33396324|NCT03032523|101341782|FG001|Overall Study|Withdrawal by Subject|2|||
33396325|NCT03032523|101341781|FG000|Overall Study|Physician Decision|1|||
33396326|NCT03032523|101341782|FG001|Overall Study|Physician Decision|0|||
33396327|NCT03619902|101341783|FG000|Overall Study|Termination of Study by Investigator|1|||
33396328|NCT03619902|101341783|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
33504444|NCT00468481|101738640|FG001|Overall Study|Egg Donor|0|||
33504445|NCT00468481|101738639|FG000|Overall Study|Moved out of area|4|||
33396329|NCT02892734|101341787|FG000|Treatment on Study|Progressive Disease|2|||
33396330|NCT02892734|101341787|FG000|Follow up for 2 Years|Death|2|||
33396331|NCT02892734|101341787|FG000|Follow up for 2 Years|Study closed early|1|||
33504446|NCT00468481|101738640|FG001|Overall Study|Moved out of area|1|||
33504447|NCT00468481|101738639|FG000|Overall Study|Non-Compliance|5|||
33504448|NCT00468481|101738640|FG001|Overall Study|Non-Compliance|0|||
33504449|NCT00468481|101738639|FG000|Overall Study|Other|6|||
33504450|NCT00468481|101738640|FG001|Overall Study|Other|0|||
33504451|NCT01136356|101738643|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
33504452|NCT01136356|101738644|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
33504453|NCT01136356|101738643|FG000|First 18-day Withdrawal|Physician Decision|1|||
33504454|NCT01136356|101738644|FG001|First 18-day Withdrawal|Physician Decision|0|||
33504455|NCT01136356|101738643|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
33504456|NCT01136356|101738644|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
33313905|NCT01801735|101044335|FG000|Overall Study|Lost to Follow-up|15|||
33313906|NCT01801735|101044335|FG000|Overall Study|Non-compliance with Trial Drug|13|||
33313907|NCT01801735|101044335|FG000|Overall Study|Physician Decision|3|||
33313908|NCT01801735|101044335|FG000|Overall Study|Death|1|||
33313909|NCT01801735|101044335|FG000|Overall Study|Other, including site closure|19|||
33313910|NCT01491672|101044337|FG000|Overall Study|Lost to Follow-up|0|||
33313911|NCT01491672|101044338|FG001|Overall Study|Lost to Follow-up|4|||
33313912|NCT01491672|101044339|FG002|Overall Study|Lost to Follow-up|1|||
33313913|NCT01491672|101044337|FG000|Overall Study|Withdrawal by Subject|6|||
33313914|NCT01491672|101044338|FG001|Overall Study|Withdrawal by Subject|7|||
33313915|NCT01491672|101044339|FG002|Overall Study|Withdrawal by Subject|0|||
33313916|NCT01491672|101044337|FG000|Overall Study|Adverse Event|8|||
33313917|NCT01491672|101044338|FG001|Overall Study|Adverse Event|10|||
33313918|NCT01491672|101044339|FG002|Overall Study|Adverse Event|4|||
33313919|NCT01491672|101044337|FG000|Overall Study|Disease progression|42|||
33313920|NCT01491672|101044338|FG001|Overall Study|Disease progression|34|||
33313921|NCT01491672|101044339|FG002|Overall Study|Disease progression|6|||
33313922|NCT01491672|101044337|FG000|Overall Study|Protocol deviation|0|||
33313923|NCT01491672|101044338|FG001|Overall Study|Protocol deviation|1|||
33313924|NCT01491672|101044339|FG002|Overall Study|Protocol deviation|0|||
33313925|NCT01491672|101044337|FG000|Overall Study|Death|0|||
33313926|NCT01491672|101044338|FG001|Overall Study|Death|4|||
33313927|NCT01491672|101044339|FG002|Overall Study|Death|0|||
33396332|NCT02243306|101341788|FG000|Overall Study|Adverse Event|0|||
33504457|NCT00237458|101738646|FG000|Overall Study|Lack of Efficacy|1|||
33504458|NCT00237458|101738646|FG000|Overall Study|Adverse Event|1|||
33504459|NCT00237458|101738646|FG000|Overall Study|Withdrawal by Subject|1|||
33504460|NCT03226769|101741190|FG000|Overall Study|Withdrawal by Subject|0|||
33602919|NCT02914561|102099148|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
33504461|NCT03226769|101741191|FG001|Overall Study|Withdrawal by Subject|1|||
33504462|NCT00356148|101741195|FG000|Overall Study|Reoperation within 30 days|2|||
33504463|NCT00356148|101741196|FG001|Overall Study|Reoperation within 30 days|1|||
33504464|NCT00471081|101741197|FG000|Active Phase|Protocol Violation|1|||
33504465|NCT00471081|101741198|FG001|Active Phase|Protocol Violation|1|||
33313928|NCT00960531|101044340|FG000|Overall Study|Lack of Efficacy|1|||
33313929|NCT00960531|101044341|FG001|Overall Study|Lack of Efficacy|0|||
33396333|NCT02243306|101341789|FG001|Overall Study|Adverse Event|1|||
33313930|NCT00960531|101044342|FG002|Overall Study|Lack of Efficacy|0|||
33313931|NCT00960531|101044343|FG003|Overall Study|Lack of Efficacy|0|||
33313932|NCT00960531|101044344|FG004|Overall Study|Lack of Efficacy|0|||
33313933|NCT00960531|101044345|FG005|Overall Study|Lack of Efficacy|0|||
33313934|NCT00960531|101044346|FG006|Overall Study|Lack of Efficacy|0|||
33313935|NCT00960531|101044347|FG007|Overall Study|Lack of Efficacy|0|||
33313936|NCT00960531|101044348|FG008|Overall Study|Lack of Efficacy|0|||
33313937|NCT00960531|101044349|FG009|Overall Study|Lack of Efficacy|0|||
33396334|NCT02243306|101341788|FG000|Overall Study|Other: Reached stopping criteria|0|||
33396335|NCT02243306|101341789|FG001|Overall Study|Other: Reached stopping criteria|1|||
33396336|NCT02243306|101341788|FG000|Overall Study|Physician Decision|0|||
33396337|NCT02243306|101341789|FG001|Overall Study|Physician Decision|1|||
33396338|NCT04124952|101341796|FG000|Overall Study|Lost to Follow-up|1|||
33396339|NCT00952588|101341798|FG000|Overall Study|Death|28|||
33396340|NCT00952588|101341799|FG001|Overall Study|Death|13|||
33396341|NCT00952588|101341798|FG000|Overall Study|Withdrawal by Subject|2|||
33396342|NCT00952588|101341799|FG001|Overall Study|Withdrawal by Subject|5|||
33396343|NCT00952588|101341798|FG000|Overall Study|Adverse Event|2|||
33396344|NCT00952588|101341799|FG001|Overall Study|Adverse Event|3|||
33396345|NCT00952588|101341798|FG000|Overall Study|Lost to Follow-up|2|||
33396346|NCT00952588|101341799|FG001|Overall Study|Lost to Follow-up|0|||
33396347|NCT00952588|101341798|FG000|Overall Study|Physician Decision|0|||
33396348|NCT00952588|101341799|FG001|Overall Study|Physician Decision|1|||
33396349|NCT00952588|101341798|FG000|Overall Study|Lack of Efficacy|2|||
33396350|NCT00952588|101341799|FG001|Overall Study|Lack of Efficacy|2|||
33396351|NCT00846027|101341804|FG000|Overall Study|Death|3|||
33396352|NCT00846027|101341804|FG000|Overall Study|Disease Progression|30|||
33396353|NCT00846027|101341804|FG000|Overall Study|Toxicity|12|||
33396354|NCT00846027|101341804|FG000|Overall Study|Patient Decision|7|||
33396355|NCT00846027|101341804|FG000|Overall Study|Investigator Discretion|29|||
33313938|NCT00960531|101044340|FG000|Overall Study|Withdrawal by Subject|1|||
33313939|NCT00960531|101044341|FG001|Overall Study|Withdrawal by Subject|0|||
33313940|NCT00960531|101044342|FG002|Overall Study|Withdrawal by Subject|5|||
33313941|NCT00960531|101044343|FG003|Overall Study|Withdrawal by Subject|2|||
33396356|NCT00846027|101341804|FG000|Overall Study|Protocol Violation|2|||
33194207|NCT00428610|100616340|FG001|Overall Study|Withdrawal by Subject|0|||
33313942|NCT00960531|101044344|FG004|Overall Study|Withdrawal by Subject|0|||
33313943|NCT00960531|101044345|FG005|Overall Study|Withdrawal by Subject|0|||
33313944|NCT00960531|101044346|FG006|Overall Study|Withdrawal by Subject|2|||
33313945|NCT00960531|101044347|FG007|Overall Study|Withdrawal by Subject|0|||
33313946|NCT00960531|101044348|FG008|Overall Study|Withdrawal by Subject|1|||
33313947|NCT00960531|101044349|FG009|Overall Study|Withdrawal by Subject|0|||
33396357|NCT00846027|101341804|FG000|Overall Study|Subject Not Treated|7|||
33396358|NCT01875874|101341805|FG000|Overall Study|Death|3|||
33396359|NCT04315298|101341806|FG000|Overall Study|Withdrawal by Subject|0|||
33396360|NCT04315298|101341807|FG001|Overall Study|Withdrawal by Subject|0|||
33396361|NCT04315298|101341808|FG002|Overall Study|Withdrawal by Subject|0|||
33396362|NCT04315298|101341809|FG003|Overall Study|Withdrawal by Subject|2|||
33396363|NCT04315298|101341810|FG004|Overall Study|Withdrawal by Subject|2|||
33396364|NCT04315298|101341811|FG005|Overall Study|Withdrawal by Subject|2|||
33396365|NCT04315298|101341812|FG006|Overall Study|Withdrawal by Subject|0|||
33602920|NCT02914561|102099149|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
33602921|NCT02914561|102099150|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
33602922|NCT02914561|102099151|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
33602923|NCT02914561|102099141|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
33313948|NCT00960531|101044340|FG000|Overall Study|Caregiver Request|2|||
33313949|NCT00960531|101044341|FG001|Overall Study|Caregiver Request|0|||
33313950|NCT00960531|101044342|FG002|Overall Study|Caregiver Request|6|||
33313951|NCT00960531|101044343|FG003|Overall Study|Caregiver Request|5|||
33313952|NCT00960531|101044344|FG004|Overall Study|Caregiver Request|0|||
33313953|NCT00960531|101044345|FG005|Overall Study|Caregiver Request|2|||
33313954|NCT00960531|101044346|FG006|Overall Study|Caregiver Request|3|||
33313955|NCT00960531|101044347|FG007|Overall Study|Caregiver Request|1|||
33313956|NCT00960531|101044348|FG008|Overall Study|Caregiver Request|3|||
33313957|NCT00960531|101044349|FG009|Overall Study|Caregiver Request|0|||
33313958|NCT00960531|101044340|FG000|Overall Study|Investigator Request|0|||
33313959|NCT00960531|101044341|FG001|Overall Study|Investigator Request|0|||
33313960|NCT00960531|101044342|FG002|Overall Study|Investigator Request|1|||
33313961|NCT00960531|101044343|FG003|Overall Study|Investigator Request|0|||
33313962|NCT00960531|101044344|FG004|Overall Study|Investigator Request|0|||
33313963|NCT00960531|101044345|FG005|Overall Study|Investigator Request|0|||
33313964|NCT00960531|101044346|FG006|Overall Study|Investigator Request|0|||
33313965|NCT00960531|101044347|FG007|Overall Study|Investigator Request|0|||
33313966|NCT00960531|101044348|FG008|Overall Study|Investigator Request|0|||
33313967|NCT00960531|101044349|FG009|Overall Study|Investigator Request|0|||
33313968|NCT00960531|101044340|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
33313969|NCT00960531|101044341|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
33313970|NCT00960531|101044342|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
33313971|NCT00960531|101044343|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
33313972|NCT00960531|101044344|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
33313973|NCT00960531|101044345|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
33313974|NCT00960531|101044346|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
33313975|NCT00960531|101044347|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
33313976|NCT00960531|101044348|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
33313977|NCT00960531|101044349|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
33313978|NCT00960531|101044340|FG000|Overall Study|Lost to Follow-up|0|||
33313979|NCT00960531|101044341|FG001|Overall Study|Lost to Follow-up|0|||
33313980|NCT00960531|101044342|FG002|Overall Study|Lost to Follow-up|1|||
33313981|NCT00960531|101044343|FG003|Overall Study|Lost to Follow-up|0|||
33313982|NCT00960531|101044344|FG004|Overall Study|Lost to Follow-up|0|||
33313983|NCT00960531|101044345|FG005|Overall Study|Lost to Follow-up|0|||
33313984|NCT00960531|101044346|FG006|Overall Study|Lost to Follow-up|1|||
33313985|NCT00960531|101044347|FG007|Overall Study|Lost to Follow-up|0|||
33313986|NCT00960531|101044348|FG008|Overall Study|Lost to Follow-up|0|||
33313987|NCT00960531|101044349|FG009|Overall Study|Lost to Follow-up|0|||
33313988|NCT00960531|101044340|FG000|Overall Study|Failed to Return|2|||
33313989|NCT00960531|101044341|FG001|Overall Study|Failed to Return|0|||
33313990|NCT00960531|101044342|FG002|Overall Study|Failed to Return|0|||
33313991|NCT00960531|101044343|FG003|Overall Study|Failed to Return|0|||
33313992|NCT00960531|101044344|FG004|Overall Study|Failed to Return|0|||
33313993|NCT00960531|101044345|FG005|Overall Study|Failed to Return|0|||
33313994|NCT00960531|101044346|FG006|Overall Study|Failed to Return|0|||
33313995|NCT00960531|101044347|FG007|Overall Study|Failed to Return|2|||
33313996|NCT00960531|101044348|FG008|Overall Study|Failed to Return|0|||
33313997|NCT00960531|101044349|FG009|Overall Study|Failed to Return|0|||
33313998|NCT00960531|101044340|FG000|Overall Study|Adverse Event (AE)|2|||
33313999|NCT00960531|101044341|FG001|Overall Study|Adverse Event (AE)|0|||
33314000|NCT00960531|101044342|FG002|Overall Study|Adverse Event (AE)|0|||
33314001|NCT00960531|101044343|FG003|Overall Study|Adverse Event (AE)|0|||
33314002|NCT00960531|101044344|FG004|Overall Study|Adverse Event (AE)|0|||
33314003|NCT00960531|101044345|FG005|Overall Study|Adverse Event (AE)|1|||
33314004|NCT00960531|101044346|FG006|Overall Study|Adverse Event (AE)|2|||
33314005|NCT00960531|101044347|FG007|Overall Study|Adverse Event (AE)|0|||
33314006|NCT00960531|101044348|FG008|Overall Study|Adverse Event (AE)|2|||
33314007|NCT00960531|101044349|FG009|Overall Study|Adverse Event (AE)|0|||
33314008|NCT00960531|101044340|FG000|Overall Study|Reason not Specified|2|||
33314009|NCT00960531|101044341|FG001|Overall Study|Reason not Specified|1|||
33314010|NCT00960531|101044342|FG002|Overall Study|Reason not Specified|13|||
33314011|NCT00960531|101044343|FG003|Overall Study|Reason not Specified|1|||
33314012|NCT00960531|101044344|FG004|Overall Study|Reason not Specified|2|||
33396366|NCT04315298|101341813|FG007|Overall Study|Withdrawal by Subject|1|||
33396367|NCT04315298|101341814|FG008|Overall Study|Withdrawal by Subject|1|||
33396368|NCT04315298|101341815|FG009|Overall Study|Withdrawal by Subject|1|||
33396369|NCT04315298|101341816|FG010|Overall Study|Withdrawal by Subject|0|||
33396370|NCT04315298|101341817|FG011|Overall Study|Withdrawal by Subject|0|||
33396371|NCT04315298|101341818|FG012|Overall Study|Withdrawal by Subject|0|||
33396372|NCT04315298|101341819|FG013|Overall Study|Withdrawal by Subject|0|||
33396373|NCT04315298|101341820|FG014|Overall Study|Withdrawal by Subject|0|||
33396374|NCT04315298|101341821|FG015|Overall Study|Withdrawal by Subject|0|||
33396375|NCT04315298|101341822|FG016|Overall Study|Withdrawal by Subject|0|||
33396376|NCT04315298|101341823|FG017|Overall Study|Withdrawal by Subject|0|||
33396377|NCT04315298|101341824|FG018|Overall Study|Withdrawal by Subject|0|||
33396378|NCT04315298|101341806|FG000|Overall Study|Physician Decision|0|||
33396379|NCT04315298|101341807|FG001|Overall Study|Physician Decision|0|||
33396380|NCT04315298|101341808|FG002|Overall Study|Physician Decision|0|||
33396381|NCT04315298|101341809|FG003|Overall Study|Physician Decision|0|||
33396382|NCT04315298|101341810|FG004|Overall Study|Physician Decision|1|||
33396383|NCT04315298|101341811|FG005|Overall Study|Physician Decision|0|||
33396384|NCT04315298|101341812|FG006|Overall Study|Physician Decision|0|||
33396385|NCT04315298|101341813|FG007|Overall Study|Physician Decision|0|||
33396386|NCT04315298|101341814|FG008|Overall Study|Physician Decision|0|||
33396387|NCT04315298|101341815|FG009|Overall Study|Physician Decision|0|||
33396388|NCT04315298|101341816|FG010|Overall Study|Physician Decision|0|||
33396389|NCT04315298|101341817|FG011|Overall Study|Physician Decision|0|||
33396390|NCT04315298|101341818|FG012|Overall Study|Physician Decision|0|||
33396391|NCT04315298|101341819|FG013|Overall Study|Physician Decision|0|||
33396392|NCT04315298|101341820|FG014|Overall Study|Physician Decision|0|||
33396393|NCT04315298|101341821|FG015|Overall Study|Physician Decision|0|||
33396394|NCT04315298|101341822|FG016|Overall Study|Physician Decision|0|||
33396395|NCT04315298|101341823|FG017|Overall Study|Physician Decision|0|||
33396396|NCT04315298|101341824|FG018|Overall Study|Physician Decision|0|||
33396397|NCT04315298|101341806|FG000|Overall Study|Lost to Follow-up|5|||
33396398|NCT04315298|101341807|FG001|Overall Study|Lost to Follow-up|10|||
33396399|NCT04315298|101341808|FG002|Overall Study|Lost to Follow-up|6|||
33396400|NCT04315298|101341809|FG003|Overall Study|Lost to Follow-up|8|||
33504466|NCT00471081|101741197|FG000|Active Phase|Withdrawal by Subject|0|||
33504467|NCT00471081|101741198|FG001|Active Phase|Withdrawal by Subject|3|||
33314013|NCT00960531|101044345|FG005|Overall Study|Reason not Specified|0|||
33314014|NCT00960531|101044346|FG006|Overall Study|Reason not Specified|16|||
33314015|NCT00960531|101044347|FG007|Overall Study|Reason not Specified|0|||
33314016|NCT00960531|101044348|FG008|Overall Study|Reason not Specified|8|||
33314017|NCT00960531|101044349|FG009|Overall Study|Reason not Specified|1|||
33314018|NCT02054741|101044352|FG000|Overall Study|Protocol Violation|13|||
33314019|NCT02054741|101044353|FG001|Overall Study|Protocol Violation|2|||
33314020|NCT02054741|101044352|FG000|Overall Study|Withdrawal by Subject|10|||
33314021|NCT02054741|101044353|FG001|Overall Study|Withdrawal by Subject|5|||
33314022|NCT02054741|101044352|FG000|Overall Study|Death|94|||
33314023|NCT02054741|101044353|FG001|Overall Study|Death|90|||
33314024|NCT02054741|101044352|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
33314025|NCT02054741|101044353|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
33314026|NCT02966301|101044354|FG000|Overall Study|Death|2|||
33314027|NCT02966301|101044354|FG000|Overall Study|Withdrawal by Subject|1|||
33314028|NCT00346268|101044355|FG000|Overall Study|Adverse Event|1|||
33314029|NCT00346268|101044356|FG001|Overall Study|Adverse Event|0|||
33314030|NCT00346268|101044355|FG000|Overall Study|Protocol Violation|1|||
33314031|NCT00346268|101044356|FG001|Overall Study|Protocol Violation|0|||
33314032|NCT00346268|101044355|FG000|Overall Study|Participant refused|0|||
33314033|NCT00346268|101044356|FG001|Overall Study|Participant refused|3|||
33314034|NCT03527173|101044357|FG000|Overall Study|Lost to Follow-up|4|||
33314035|NCT03527173|101044358|FG001|Overall Study|Lost to Follow-up|2|||
33314036|NCT03527173|101044357|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
33396401|NCT04315298|101341810|FG004|Overall Study|Lost to Follow-up|12|||
33396402|NCT04315298|101341811|FG005|Overall Study|Lost to Follow-up|13|||
33396403|NCT04315298|101341812|FG006|Overall Study|Lost to Follow-up|9|||
33602924|NCT02914561|102099142|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
33602925|NCT02914561|102099143|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
33396404|NCT04315298|101341813|FG007|Overall Study|Lost to Follow-up|16|||
33602926|NCT02914561|102099144|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
33602927|NCT02914561|102099145|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
33314037|NCT03527173|101044358|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
33314038|NCT03527173|101044357|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
33396405|NCT04315298|101341814|FG008|Overall Study|Lost to Follow-up|14|||
33396406|NCT04315298|101341815|FG009|Overall Study|Lost to Follow-up|0|||
33396407|NCT04315298|101341816|FG010|Overall Study|Lost to Follow-up|2|||
33314039|NCT03527173|101044358|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
33396408|NCT04315298|101341817|FG011|Overall Study|Lost to Follow-up|1|||
33314040|NCT03527173|101044357|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
33314041|NCT03527173|101044358|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33314042|NCT02499770|101044359|FG000|Overall Study|Death|17|||
33314043|NCT02499770|101044360|FG001|Overall Study|Death|56|||
33314044|NCT02499770|101044359|FG000|Overall Study|Study completion|1|||
33314045|NCT02499770|101044360|FG001|Overall Study|Study completion|10|||
33314046|NCT02499770|101044359|FG000|Overall Study|Withdrawal by Subject|0|||
33314047|NCT02499770|101044360|FG001|Overall Study|Withdrawal by Subject|7|||
33314048|NCT02499770|101044359|FG000|Overall Study|Lost to Follow-up|0|||
33314049|NCT02499770|101044360|FG001|Overall Study|Lost to Follow-up|2|||
33314050|NCT02499770|101044359|FG000|Overall Study|Subject declined further treatment|1|||
33314051|NCT02499770|101044360|FG001|Overall Study|Subject declined further treatment|0|||
33314052|NCT02499770|101044359|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
33314053|NCT02499770|101044360|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
33314054|NCT02499770|101044359|FG000|Overall Study|Randomized but not enrolled|0|||
33314055|NCT02499770|101044360|FG001|Overall Study|Randomized but not enrolled|1|||
33314056|NCT01122862|101044362|FG000|Period 1|Protocol Violation|0|||
33314057|NCT01122862|101044363|FG001|Period 1|Protocol Violation|1|||
33314058|NCT01122862|101044364|FG002|Period 1|Protocol Violation|0|||
33314059|NCT01122862|101044362|FG000|Period 2|Adverse Event|0|||
33314060|NCT01122862|101044363|FG001|Period 2|Adverse Event|0|||
33314061|NCT01122862|101044364|FG002|Period 2|Adverse Event|1|||
33314062|NCT02434939|101044365|FG000|Overall Study|Lack of Efficacy|34|||
33314063|NCT02434939|101044366|FG001|Overall Study|Lack of Efficacy|48|||
33314064|NCT02434939|101044365|FG000|Overall Study|Withdrawal by Subject|3|||
33314065|NCT02434939|101044366|FG001|Overall Study|Withdrawal by Subject|0|||
33314066|NCT02434939|101044365|FG000|Overall Study|Adverse Event|0|||
33314067|NCT02434939|101044366|FG001|Overall Study|Adverse Event|1|||
33314068|NCT00512317|101044373|FG000|Overall Study|Insufficient clinical response|36|||
33314069|NCT00512317|101044373|FG000|Overall Study|Withdrawal by Subject|23|||
33314070|NCT00512317|101044373|FG000|Overall Study|Sponsor closure of study|21|||
33314071|NCT00512317|101044373|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
33314072|NCT00512317|101044373|FG000|Overall Study|Adverse Event|13|||
33314073|NCT00512317|101044373|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
33314074|NCT00512317|101044373|FG000|Overall Study|Lost to Follow-up|2|||
33314075|NCT00512317|101044373|FG000|Overall Study|Other|2|||
33314076|NCT00655863|101044374|FG000|Overall Study|Lost to Follow-up|0|||
33314077|NCT00655863|101044375|FG001|Overall Study|Lost to Follow-up|0|||
33314078|NCT00655863|101044376|FG002|Overall Study|Lost to Follow-up|1|||
33314079|NCT02937454|101044379|FG000|Overall Study|Adverse Event|0|||
33314080|NCT02937454|101044380|FG001|Overall Study|Adverse Event|1|||
33314081|NCT02937454|101044379|FG000|Overall Study|Death|98|||
33314082|NCT02937454|101044380|FG001|Overall Study|Death|95|||
33314083|NCT02937454|101044379|FG000|Overall Study|Lost to Follow-up|1|||
33314084|NCT02937454|101044380|FG001|Overall Study|Lost to Follow-up|1|||
33314085|NCT02937454|101044379|FG000|Overall Study|Physician Decision|0|||
33314086|NCT02937454|101044380|FG001|Overall Study|Physician Decision|1|||
33314087|NCT02937454|101044379|FG000|Overall Study|Protocol Violation|6|||
33314088|NCT02937454|101044380|FG001|Overall Study|Protocol Violation|10|||
33314089|NCT02937454|101044379|FG000|Overall Study|Withdrawal by Subject|27|||
33314090|NCT02937454|101044380|FG001|Overall Study|Withdrawal by Subject|15|||
33314091|NCT02937454|101044379|FG000|Overall Study|Other|8|||
33314092|NCT02937454|101044380|FG001|Overall Study|Other|5|||
33314093|NCT00577473|101044383|FG000|Overall Study|Protocol Violation|1|||
33314094|NCT00577473|101044384|FG001|Overall Study|Protocol Violation|4|||
33314095|NCT00577473|101044383|FG000|Overall Study|Adverse Event|8|||
33314096|NCT00577473|101044384|FG001|Overall Study|Adverse Event|5|||
33314097|NCT00577473|101044383|FG000|Overall Study|Withdrawal by Subject|2|||
33314098|NCT00577473|101044384|FG001|Overall Study|Withdrawal by Subject|6|||
33314099|NCT00577473|101044383|FG000|Overall Study|Physician Decision|2|||
33314100|NCT00577473|101044384|FG001|Overall Study|Physician Decision|2|||
33314101|NCT00577473|101044383|FG000|Overall Study|Lack of Efficacy|8|||
33314102|NCT00577473|101044384|FG001|Overall Study|Lack of Efficacy|7|||
33314103|NCT03401229|101044391|FG000|Overall Study|Lost to Follow-up|2|||
33314104|NCT03401229|101044392|FG001|Overall Study|Lost to Follow-up|1|||
33396409|NCT04315298|101341818|FG012|Overall Study|Lost to Follow-up|0|||
33194208|NCT00428610|100616341|FG002|Overall Study|Withdrawal by Subject|0|||
33194209|NCT01438541|100616347|FG000|Overall Study|Physician Decision|1|||
33314105|NCT03401229|101044391|FG000|Overall Study|Other|1|||
33314106|NCT03401229|101044392|FG001|Overall Study|Other|3|||
33314107|NCT03401229|101044391|FG000|Overall Study|Adverse Event|8|||
33314108|NCT03401229|101044392|FG001|Overall Study|Adverse Event|6|||
33314109|NCT03401229|101044391|FG000|Overall Study|Withdrawal by Subject|29|||
33314110|NCT03401229|101044392|FG001|Overall Study|Withdrawal by Subject|26|||
33314111|NCT03401229|101044391|FG000|Overall Study|COVID-19|0|||
33314112|NCT03401229|101044392|FG001|Overall Study|COVID-19|1|||
33314113|NCT01313637|101044393|FG000|Overall Study|Adverse Event|17|||
33314114|NCT01313637|101044394|FG001|Overall Study|Adverse Event|24|||
33314115|NCT01313637|101044395|FG002|Overall Study|Adverse Event|25|||
33314116|NCT01313637|101044396|FG003|Overall Study|Adverse Event|18|||
33314117|NCT01313637|101044393|FG000|Overall Study|Lack of Efficacy|44|||
33314118|NCT01313637|101044394|FG001|Overall Study|Lack of Efficacy|38|||
33314119|NCT01313637|101044395|FG002|Overall Study|Lack of Efficacy|37|||
33314120|NCT01313637|101044396|FG003|Overall Study|Lack of Efficacy|24|||
33314121|NCT01313637|101044393|FG000|Overall Study|Protocol Violation|4|||
33314122|NCT01313637|101044394|FG001|Overall Study|Protocol Violation|3|||
33314123|NCT01313637|101044395|FG002|Overall Study|Protocol Violation|11|||
33314124|NCT01313637|101044396|FG003|Overall Study|Protocol Violation|5|||
33314125|NCT01313637|101044393|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
33314126|NCT01313637|101044394|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
33314127|NCT01313637|101044395|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
33314128|NCT01313637|101044396|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
33314129|NCT01313637|101044393|FG000|Overall Study|Lost to Follow-up|0|||
33314130|NCT01313637|101044394|FG001|Overall Study|Lost to Follow-up|2|||
33314131|NCT01313637|101044395|FG002|Overall Study|Lost to Follow-up|1|||
33314132|NCT01313637|101044396|FG003|Overall Study|Lost to Follow-up|3|||
33314133|NCT01313637|101044393|FG000|Overall Study|Withdrawal by Subject|11|||
33314134|NCT01313637|101044394|FG001|Overall Study|Withdrawal by Subject|13|||
33314135|NCT01313637|101044395|FG002|Overall Study|Withdrawal by Subject|18|||
33314136|NCT01313637|101044396|FG003|Overall Study|Withdrawal by Subject|15|||
33314137|NCT01098097|101044397|FG000|Overall Study|Adverse Event|17|||
33314138|NCT01098097|101044397|FG000|Overall Study|Lost to Follow-up|18|||
33314139|NCT01098097|101044397|FG000|Overall Study|Status unknown|16|||
33314140|NCT01098097|101044397|FG000|Overall Study|No reason reported|31|||
33314141|NCT01777269|101044398|FG000|Overall Study|Adverse Event|24|||
33314142|NCT01777269|101044399|FG001|Overall Study|Adverse Event|33|||
33314143|NCT01777269|101044398|FG000|Overall Study|Lack of Efficacy|8|||
33314144|NCT01777269|101044399|FG001|Overall Study|Lack of Efficacy|10|||
33314145|NCT01777269|101044398|FG000|Overall Study|Protocol Violation|4|||
33504468|NCT00471081|101741197|FG000|Active Phase|Lost to Follow-up|0|||
33504469|NCT00471081|101741198|FG001|Active Phase|Lost to Follow-up|1|||
33504470|NCT00471081|101741197|FG000|Active Phase|Lost health plan/insurance|1|||
33504471|NCT00471081|101741198|FG001|Active Phase|Lost health plan/insurance|8|||
33504472|NCT00471081|101741197|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
33504473|NCT00471081|101741198|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
33504474|NCT00471081|101741197|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
33504475|NCT00471081|101741198|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
33504476|NCT00471081|101741197|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
33504477|NCT00471081|101741198|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
33504478|NCT03811093|101741201|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
33504479|NCT03811093|101741202|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
33314146|NCT01777269|101044399|FG001|Overall Study|Protocol Violation|4|||
33314147|NCT01777269|101044398|FG000|Overall Study|Participants reached stopping criteria|1|||
33314148|NCT01777269|101044399|FG001|Overall Study|Participants reached stopping criteria|1|||
33314149|NCT01777269|101044398|FG000|Overall Study|Lost to Follow-up|4|||
33314150|NCT01777269|101044399|FG001|Overall Study|Lost to Follow-up|0|||
33314151|NCT01777269|101044398|FG000|Overall Study|Physician Decision|5|||
33314152|NCT01777269|101044399|FG001|Overall Study|Physician Decision|2|||
33314153|NCT01777269|101044398|FG000|Overall Study|Withdrawal by Subject|9|||
33314154|NCT01777269|101044399|FG001|Overall Study|Withdrawal by Subject|9|||
33314155|NCT01577745|101044402|FG000|Overall Study|Withdrawal by Subject|0|||
33314156|NCT01577745|101044403|FG001|Overall Study|Withdrawal by Subject|1|||
33504480|NCT03811093|101741201|FG000|Overall Study|Unable to measure body fat percentage|2|||
33504481|NCT03811093|101741202|FG001|Overall Study|Unable to measure body fat percentage|0|||
33504482|NCT01127451|101741205|FG000|Overall Study|Other|2|||
33194210|NCT01438541|100616347|FG000|Overall Study|Withdrawal by Subject|1|||
33314157|NCT01577745|101044404|FG002|Overall Study|Withdrawal by Subject|0|||
33314158|NCT01577745|101044405|FG003|Overall Study|Withdrawal by Subject|3|||
33314159|NCT01577745|101044406|FG004|Overall Study|Withdrawal by Subject|2|||
33314160|NCT01577745|101044407|FG005|Overall Study|Withdrawal by Subject|0|||
33314161|NCT01577745|101044402|FG000|Overall Study|Death|3|||
33314162|NCT01577745|101044403|FG001|Overall Study|Death|2|||
33314163|NCT01577745|101044404|FG002|Overall Study|Death|2|||
33314164|NCT01577745|101044405|FG003|Overall Study|Death|1|||
33314165|NCT01577745|101044406|FG004|Overall Study|Death|1|||
33314166|NCT01577745|101044407|FG005|Overall Study|Death|3|||
33314167|NCT01577745|101044402|FG000|Overall Study|Physician Decision|0|||
33504483|NCT01127451|101741206|FG001|Overall Study|Other|1|||
33504484|NCT01127451|101741205|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
33396410|NCT04315298|101341819|FG013|Overall Study|Lost to Follow-up|0|||
33396411|NCT04315298|101341820|FG014|Overall Study|Lost to Follow-up|0|||
33396412|NCT04315298|101341821|FG015|Overall Study|Lost to Follow-up|2|||
33396413|NCT04315298|101341822|FG016|Overall Study|Lost to Follow-up|0|||
33504485|NCT01127451|101741206|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
33504486|NCT01127451|101741205|FG000|Overall Study|Death|22|||
33504487|NCT01127451|101741206|FG001|Overall Study|Death|17|||
33504488|NCT01127451|101741205|FG000|Overall Study|Lost to Follow-up|3|||
33504489|NCT01127451|101741206|FG001|Overall Study|Lost to Follow-up|0|||
33504490|NCT01127451|101741205|FG000|Overall Study|Administrative Reason by Sponsor|2|||
33504491|NCT01127451|101741206|FG001|Overall Study|Administrative Reason by Sponsor|2|||
33504492|NCT03055338|101741211|FG000|Overall Study|Lost to Follow-up|9|||
33504493|NCT03055338|101741212|FG001|Overall Study|Lost to Follow-up|2|||
33504494|NCT03055338|101741213|FG002|Overall Study|Lost to Follow-up|3|||
33504495|NCT03055338|101741211|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
33504496|NCT03055338|101741212|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
33504497|NCT03055338|101741213|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
33504498|NCT03055338|101741211|FG000|Overall Study|Physician Decision|0|||
33504499|NCT03055338|101741212|FG001|Overall Study|Physician Decision|0|||
33504500|NCT03055338|101741213|FG002|Overall Study|Physician Decision|2|||
33504501|NCT03055338|101741211|FG000|Overall Study|Withdrawal by Subject|9|||
33504502|NCT03055338|101741212|FG001|Overall Study|Withdrawal by Subject|8|||
33504503|NCT03055338|101741213|FG002|Overall Study|Withdrawal by Subject|7|||
33504504|NCT04545567|101741214|FG000|Overall Study|tested positive for SARS-co-V2|1|||
33504505|NCT04545567|101741215|FG001|Overall Study|tested positive for SARS-co-V2|1|||
33504506|NCT04545567|101741214|FG000|Overall Study|Withdrawal by Subject|0|||
33504507|NCT04545567|101741215|FG001|Overall Study|Withdrawal by Subject|1|||
33504508|NCT02285166|101741217|FG000|Overall Study|Case Report Forms Uncollected|564|||
33504509|NCT02285166|101741217|FG000|Overall Study|Protocol Deviation|402|||
33504510|NCT01046903|101741220|FG000|Overall Study|Lost to Follow-up|16|||
33504511|NCT01046903|101741220|FG000|Overall Study|Adverse Event|4|||
33504512|NCT01046903|101741220|FG000|Overall Study|Withdrawal by Subject|3|||
33504513|NCT01046903|101741220|FG000|Overall Study|Other|5|||
33504514|NCT00576420|101741226|FG000|Overall Study|Death|0|||
33504515|NCT00576420|101741227|FG001|Overall Study|Death|0|||
33504516|NCT00576420|101741228|FG002|Overall Study|Death|1|||
33504517|NCT04112043|101741235|FG000|Overall Study|Withdrawal by Subject|1|||
33504518|NCT04112043|101741236|FG001|Overall Study|Withdrawal by Subject|1|||
33504519|NCT04112043|101741237|FG002|Overall Study|Withdrawal by Subject|1|||
33504520|NCT04112043|101741235|FG000|Overall Study|Taking NR supplement|1|||
33504521|NCT04112043|101741236|FG001|Overall Study|Taking NR supplement|0|||
33504522|NCT04112043|101741237|FG002|Overall Study|Taking NR supplement|0|||
33504523|NCT04112043|101741235|FG000|Overall Study|Adverse Event|0|||
33504524|NCT04112043|101741236|FG001|Overall Study|Adverse Event|1|||
33504525|NCT04112043|101741237|FG002|Overall Study|Adverse Event|0|||
33504526|NCT00570141|101741238|FG000|Overall Study|Adverse Event|1|||
33504527|NCT00570141|101741238|FG000|Overall Study|Missed visits|1|||
33504528|NCT00570141|101741238|FG000|Overall Study|Lost to Follow-up|1|||
33504529|NCT01680861|101741251|FG000|Early Post-transplant Period|Protocol Violation|1|||
33504530|NCT01680861|101741252|FG001|Early Post-transplant Period|Protocol Violation|1|||
33504531|NCT01295671|101741253|FG000|Overall Study|Lost to Follow-up|4|||
33396414|NCT04315298|101341823|FG017|Overall Study|Lost to Follow-up|0|||
33396415|NCT04315298|101341824|FG018|Overall Study|Lost to Follow-up|0|||
33396416|NCT04315298|101341806|FG000|Overall Study|Death|24|||
33396417|NCT04315298|101341807|FG001|Overall Study|Death|60|||
33396418|NCT04315298|101341808|FG002|Overall Study|Death|49|||
33504532|NCT01295671|101741254|FG001|Overall Study|Lost to Follow-up|6|||
33504533|NCT01295671|101741255|FG002|Overall Study|Lost to Follow-up|3|||
33504534|NCT01295671|101741253|FG000|Overall Study|Withdrawal by Subject|3|||
33504535|NCT01295671|101741254|FG001|Overall Study|Withdrawal by Subject|1|||
33504536|NCT01295671|101741255|FG002|Overall Study|Withdrawal by Subject|0|||
33504537|NCT00782795|101741256|FG000|Overall Study|Withdrawal by Subject|1|||
33504538|NCT00782795|101741257|FG001|Overall Study|Withdrawal by Subject|2|||
33504539|NCT04657198|101741260|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
33504540|NCT04657198|101741261|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
33504541|NCT04657198|101741262|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
33504542|NCT04087720|101741266|FG000|Overall Study|Withdrawal by Subject|2|||
33504543|NCT04087720|101741266|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
33396419|NCT04315298|101341809|FG003|Overall Study|Death|59|||
33504544|NCT02640677|101741269|FG000|Overall Study|Lost to Follow-up|1|||
33504545|NCT02640677|101741269|FG000|Overall Study|Withdrawal by Subject|1|||
33504546|NCT02112045|101741270|FG000|Overall Study|Withdrawal by Subject|1|||
33504547|NCT02112045|101741271|FG001|Overall Study|Withdrawal by Subject|0|||
33504548|NCT01582854|101741272|FG000|Overall Study|Death|8|||
33504549|NCT01582854|101741273|FG001|Overall Study|Death|5|||
33504550|NCT01582854|101741272|FG000|Overall Study|Adverse Event|2|||
33396420|NCT04315298|101341810|FG004|Overall Study|Death|70|||
33504551|NCT01582854|101741273|FG001|Overall Study|Adverse Event|3|||
33504552|NCT01582854|101741272|FG000|Overall Study|Withdrawal by Participant|8|||
33504553|NCT01582854|101741273|FG001|Overall Study|Withdrawal by Participant|11|||
33504554|NCT01582854|101741272|FG000|Overall Study|Lost to Follow-up|1|||
33504555|NCT01582854|101741273|FG001|Overall Study|Lost to Follow-up|2|||
33504556|NCT01582854|101741272|FG000|Overall Study|Physician Decision|0|||
33504557|NCT01582854|101741273|FG001|Overall Study|Physician Decision|1|||
33504558|NCT01582854|101741272|FG000|Overall Study|Recurrent Stroke|13|||
33504559|NCT01582854|101741273|FG001|Overall Study|Recurrent Stroke|8|||
33504560|NCT01582854|101741272|FG000|Overall Study|Disallowed Concomitant Medication|3|||
33504561|NCT01582854|101741273|FG001|Overall Study|Disallowed Concomitant Medication|2|||
33504562|NCT01582854|101741272|FG000|Overall Study|Carotid or Neurosurgery|0|||
33504563|NCT01582854|101741273|FG001|Overall Study|Carotid or Neurosurgery|1|||
33504564|NCT01582854|101741272|FG000|Overall Study|General Anaesthesia|0|||
33504565|NCT01582854|101741273|FG001|Overall Study|General Anaesthesia|1|||
33504566|NCT01582854|101741272|FG000|Overall Study|Other Miscellaneous Reason|1|||
33504567|NCT01582854|101741273|FG001|Overall Study|Other Miscellaneous Reason|0|||
33504568|NCT04109391|101741277|FG000|Overall Study|Adverse Event|2|||
33504569|NCT04109391|101741278|FG001|Overall Study|Adverse Event|2|||
33504570|NCT04109391|101741279|FG002|Overall Study|Adverse Event|0|||
33504571|NCT04109391|101741277|FG000|Overall Study|Withdrawal by Subject|2|||
33504572|NCT04109391|101741278|FG001|Overall Study|Withdrawal by Subject|0|||
33504573|NCT04109391|101741279|FG002|Overall Study|Withdrawal by Subject|0|||
33504574|NCT04109391|101741277|FG000|Overall Study|Pregnancy|1|||
33504575|NCT04109391|101741278|FG001|Overall Study|Pregnancy|0|||
33504576|NCT04109391|101741279|FG002|Overall Study|Pregnancy|0|||
33504577|NCT04109391|101741277|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
33504578|NCT04109391|101741278|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
33504579|NCT04109391|101741279|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
33504580|NCT04109391|101741277|FG000|Overall Study|Lost to Follow-up|0|||
33504581|NCT04109391|101741278|FG001|Overall Study|Lost to Follow-up|0|||
33504582|NCT04109391|101741279|FG002|Overall Study|Lost to Follow-up|1|||
33504583|NCT04109391|101741277|FG000|Overall Study|Lack of Efficacy|2|||
33504584|NCT04109391|101741278|FG001|Overall Study|Lack of Efficacy|2|||
33504585|NCT04109391|101741279|FG002|Overall Study|Lack of Efficacy|3|||
33504586|NCT01186692|101741280|FG000|Overall Study|Not Catheterized|11|||
33504587|NCT01186692|101741280|FG000|Overall Study|Futher testing contraindicated implant|19|||
33504588|NCT01186692|101741280|FG000|Overall Study|Adverse Event|2|||
33504589|NCT05020665|101741281|FG000|Overall Study|Study terminated by Sponsor|5|||
33504590|NCT05020665|101741282|FG001|Overall Study|Study terminated by Sponsor|4|||
33504591|NCT05020665|101741281|FG000|Overall Study|Death|2|||
33504592|NCT05020665|101741282|FG001|Overall Study|Death|1|||
33504593|NCT05020665|101741281|FG000|Overall Study|Physician Decision|0|||
33504594|NCT05020665|101741282|FG001|Overall Study|Physician Decision|1|||
33504595|NCT05020665|101741281|FG000|Overall Study|Withdrawal by Subject|0|||
33504596|NCT05020665|101741282|FG001|Overall Study|Withdrawal by Subject|1|||
33504597|NCT05020665|101741281|FG000|Overall Study|Reason not specified|1|||
33504598|NCT05020665|101741282|FG001|Overall Study|Reason not specified|0|||
33504599|NCT01568034|101741284|FG000|Overall Study|Withdrawal by Subject|1|||
33504600|NCT01568034|101741285|FG001|Overall Study|Withdrawal by Subject|0|||
33504601|NCT01568034|101741286|FG002|Overall Study|Withdrawal by Subject|0|||
33504602|NCT01568034|101741287|FG003|Overall Study|Withdrawal by Subject|0|||
33504603|NCT02418156|101741288|FG000|Overall Study|Lost to Follow-up|12|||
33504604|NCT02418156|101741288|FG000|Overall Study|Death|2|||
33504605|NCT02418156|101741288|FG000|Overall Study|Physician Decision|1|||
33504606|NCT02418156|101741288|FG000|Overall Study|Withdrawal by Subject|1|||
33504607|NCT02418156|101741288|FG000|Overall Study|Subject refused to return|1|||
33504608|NCT01942486|101741291|FG000|Overall Study|Lost to Follow-up|27|||
33504609|NCT04606394|101741292|FG000|Overall Study|Withdrawal by Subject|3|||
33504610|NCT04606394|101741292|FG000|Overall Study|Exclusion criteria screen failure|12|||
33504611|NCT02120833|101741296|FG000|Overall Study|Adverse Event|1|||
33504612|NCT02120833|101741297|FG001|Overall Study|Adverse Event|0|||
33504613|NCT02120833|101741296|FG000|Overall Study|Withdrawal by Subject|2|||
33504614|NCT02120833|101741297|FG001|Overall Study|Withdrawal by Subject|0|||
33504615|NCT02120833|101741296|FG000|Overall Study|Lost to Follow-up|1|||
33504616|NCT02120833|101741297|FG001|Overall Study|Lost to Follow-up|1|||
33504617|NCT03070002|101741298|FG000|Follow up for 2 Years|Death|1|||
33504618|NCT01681212|101741303|FG000|Overall Study|No longer met study criteria|5|||
33504619|NCT01681212|101741303|FG000|Overall Study|Administrative reason by sponsor|1|||
33504620|NCT01106911|101741304|FG000|Overall Study|Physician Decision|2|||
33504621|NCT01106911|101741304|FG000|Overall Study|deemed ineligible after screening|3|||
33504622|NCT02527434|101741311|FG000|Overall Study|Lost to Follow-up|2|||
33504623|NCT02527434|101741312|FG001|Overall Study|Lost to Follow-up|2|||
33504624|NCT02527434|101741313|FG002|Overall Study|Lost to Follow-up|0|||
33504625|NCT02527434|101741311|FG000|Overall Study|Death|19|||
33504626|NCT02527434|101741312|FG001|Overall Study|Death|6|||
33504627|NCT02527434|101741313|FG002|Overall Study|Death|17|||
33504628|NCT02527434|101741311|FG000|Overall Study|Withdrawal by Subject|5|||
33504629|NCT02527434|101741312|FG001|Overall Study|Withdrawal by Subject|3|||
33504630|NCT02527434|101741313|FG002|Overall Study|Withdrawal by Subject|3|||
33504631|NCT02527434|101741311|FG000|Overall Study|Reason Not Specified|1|||
33194211|NCT01438541|100616347|FG000|Overall Study|discharge from the hospital|5|||
33314168|NCT01577745|101044403|FG001|Overall Study|Physician Decision|0|||
33314169|NCT01577745|101044404|FG002|Overall Study|Physician Decision|0|||
33314170|NCT01577745|101044405|FG003|Overall Study|Physician Decision|1|||
33314171|NCT01577745|101044406|FG004|Overall Study|Physician Decision|1|||
33314172|NCT01577745|101044407|FG005|Overall Study|Physician Decision|0|||
33314173|NCT01577745|101044402|FG000|Overall Study|Lost to Follow-up|0|||
33314174|NCT01577745|101044403|FG001|Overall Study|Lost to Follow-up|0|||
33314175|NCT01577745|101044404|FG002|Overall Study|Lost to Follow-up|0|||
33314176|NCT01577745|101044405|FG003|Overall Study|Lost to Follow-up|0|||
33314177|NCT01577745|101044406|FG004|Overall Study|Lost to Follow-up|0|||
33314178|NCT01577745|101044407|FG005|Overall Study|Lost to Follow-up|1|||
33314179|NCT01577745|101044402|FG000|Overall Study|Alternative Therapy|0|||
33314180|NCT01577745|101044403|FG001|Overall Study|Alternative Therapy|0|||
33314181|NCT01577745|101044404|FG002|Overall Study|Alternative Therapy|0|||
33314182|NCT01577745|101044405|FG003|Overall Study|Alternative Therapy|1|||
33314183|NCT01577745|101044406|FG004|Overall Study|Alternative Therapy|1|||
33314184|NCT01577745|101044407|FG005|Overall Study|Alternative Therapy|0|||
33314185|NCT02893930|101044408|FG000|Overall Study|Adverse Event|3|||
33314186|NCT02893930|101044408|FG000|Overall Study|Death|1|||
33314187|NCT02893930|101044408|FG000|Overall Study|Disease progression|5|||
33314188|NCT02893930|101044408|FG000|Overall Study|Withdrawal by Subject|2|||
33314189|NCT02893930|101044408|FG000|Overall Study|Physician Decision|1|||
33314190|NCT02893930|101044408|FG000|Overall Study|Ineligible|1|||
33314191|NCT01759368|101044409|FG000|Overall Study|Lost to Follow-up|1|||
33314192|NCT01759368|101044410|FG001|Overall Study|Lost to Follow-up|0|||
33314193|NCT02175004|101044411|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
33314194|NCT02175004|101044412|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
33314195|NCT02175004|101044411|FG000|Overall Study|Investigator Judgment|1|||
33314196|NCT02175004|101044412|FG001|Overall Study|Investigator Judgment|4|||
33314197|NCT02175004|101044411|FG000|Overall Study|Voluntary Withdrawal|6|||
33314198|NCT02175004|101044412|FG001|Overall Study|Voluntary Withdrawal|19|||
33314199|NCT02175004|101044411|FG000|Overall Study|Liver Transplant|1|||
33314200|NCT02175004|101044412|FG001|Overall Study|Liver Transplant|0|||
33314201|NCT02175004|101044411|FG000|Overall Study|Disease Progression|1|||
33314202|NCT02175004|101044412|FG001|Overall Study|Disease Progression|0|||
33314203|NCT02175004|101044411|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
33314204|NCT02175004|101044412|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
33314205|NCT02973048|101044413|FG000|Overall Study|Epidural catheter insertion failure|1|||
33314206|NCT02973048|101044414|FG001|Overall Study|Epidural catheter insertion failure|0|||
33314207|NCT02973048|101044413|FG000|Overall Study|Withdrawal by Subject|0|||
33314208|NCT02973048|101044414|FG001|Overall Study|Withdrawal by Subject|3|||
33314209|NCT02958267|101044415|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
33314210|NCT02958267|101044416|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
33314211|NCT02958267|101044415|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
33314212|NCT02958267|101044416|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
33314213|NCT02958267|101044415|FG000|Follow-up Visits|Additional treatment pursued|2|||
33314214|NCT02958267|101044416|FG001|Follow-up Visits|Additional treatment pursued|1|||
33314215|NCT01201317|101044419|FG000|Overall Study|Withdrawal by Subject|5|||
33314216|NCT01201317|101044420|FG001|Overall Study|Withdrawal by Subject|0|||
33314217|NCT01201317|101044421|FG002|Overall Study|Withdrawal by Subject|3|||
33314218|NCT01201317|101044419|FG000|Overall Study|Adverse Event|2|||
33314219|NCT01201317|101044420|FG001|Overall Study|Adverse Event|2|||
33314220|NCT01201317|101044421|FG002|Overall Study|Adverse Event|2|||
33314221|NCT01201317|101044419|FG000|Overall Study|Screen failure|1|||
33314222|NCT01201317|101044420|FG001|Overall Study|Screen failure|1|||
33314223|NCT01201317|101044421|FG002|Overall Study|Screen failure|0|||
33314224|NCT01201317|101044419|FG000|Overall Study|Protocol Violation|0|||
33314225|NCT01201317|101044420|FG001|Overall Study|Protocol Violation|1|||
33504632|NCT02527434|101741312|FG001|Overall Study|Reason Not Specified|0|||
33504633|NCT02527434|101741313|FG002|Overall Study|Reason Not Specified|0|||
33504634|NCT02527434|101741311|FG000|Overall Study|Site closure|1|||
33504635|NCT02527434|101741312|FG001|Overall Study|Site closure|0|||
33504636|NCT02527434|101741313|FG002|Overall Study|Site closure|0|||
33504637|NCT01750697|101741314|FG000|Overall Study|Transferred Back to Local Hospital|1|||
33504638|NCT01750697|101741314|FG000|Overall Study|Physician and Family Decision|1|||
33504639|NCT01750697|101741314|FG000|Overall Study|Transferred to Adult Services|5|||
33504640|NCT01750697|101741314|FG000|Overall Study|Physician Decision|1|||
33504641|NCT01750697|101741314|FG000|Overall Study|Withdrawal by Subject|1|||
33504642|NCT01972438|101741319|FG000|Baseline-Month 3 Crossover Period|Death|1|||
33504643|NCT01972438|101741320|FG001|Baseline-Month 3 Crossover Period|Death|0|||
33504644|NCT01972438|101741319|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
33504645|NCT01972438|101741320|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
33504646|NCT01972438|101741319|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
33504647|NCT01972438|101741320|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
33504648|NCT01972438|101741319|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
33504649|NCT01972438|101741320|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
33504650|NCT01972438|101741319|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
33504651|NCT01972438|101741320|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
33504652|NCT01972438|101741319|FG000|Months 6-12 Study Period|Death|1|||
33504653|NCT01972438|101741320|FG001|Months 6-12 Study Period|Death|0|||
33504654|NCT01972438|101741319|FG000|Months 6-12 Study Period|Early Study Closure|2|||
33504655|NCT01972438|101741320|FG001|Months 6-12 Study Period|Early Study Closure|2|||
33504656|NCT01972438|101741319|FG000|Post Month 12 Study Period|Early Study Closure|3|||
33504657|NCT01972438|101741320|FG001|Post Month 12 Study Period|Early Study Closure|4|||
33504658|NCT01682226|101741321|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
33504659|NCT01682226|101741321|FG000|Overall Study|Participants did not receive treatment|2|||
33504660|NCT01682226|101741321|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
33504661|NCT02841280|101741322|FG000|Overall Study|Adverse Event|2|||
33504662|NCT02841280|101741323|FG001|Overall Study|Adverse Event|1|||
33504663|NCT02841280|101741322|FG000|Overall Study|Death|1|||
33504664|NCT02841280|101741323|FG001|Overall Study|Death|0|||
33504665|NCT02841280|101741322|FG000|Overall Study|Lost to Follow-up|2|||
33504666|NCT02841280|101741323|FG001|Overall Study|Lost to Follow-up|2|||
33504667|NCT02841280|101741322|FG000|Overall Study|Withdrawal by Subject|7|||
33504668|NCT02841280|101741323|FG001|Overall Study|Withdrawal by Subject|3|||
33504669|NCT02841280|101741322|FG000|Overall Study|Stop Point: BP above threshold|2|||
33504670|NCT02841280|101741323|FG001|Overall Study|Stop Point: BP above threshold|0|||
33504671|NCT06098339|101741324|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
33504672|NCT06098339|101741325|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
33504673|NCT06098339|101741324|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
33504674|NCT06098339|101741325|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
33504675|NCT03865316|101741326|FG000|Overall Study|Procedure Cancelled|4|||
33504676|NCT03865316|101741326|FG000|Overall Study|Equipment failure|4|||
33504677|NCT01166438|101741327|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
33504678|NCT01166438|101741328|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
33504679|NCT01166438|101741327|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
33504680|NCT01166438|101741328|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
33504681|NCT01166438|101741327|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
33504682|NCT01166438|101741328|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
33504683|NCT01166438|101741327|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
33504684|NCT01166438|101741328|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
33504685|NCT01166438|101741327|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
33504686|NCT01166438|101741328|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
33504687|NCT01166438|101741327|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
33504688|NCT01166438|101741328|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
33504689|NCT02860130|101741331|FG000|Overall Study|Adverse Event|2|||
33504690|NCT02860130|101741332|FG001|Overall Study|Adverse Event|3|||
33504691|NCT02860130|101741331|FG000|Overall Study|Protocol Violation|1|||
33504692|NCT02860130|101741332|FG001|Overall Study|Protocol Violation|1|||
33504693|NCT02860130|101741331|FG000|Overall Study|Withdrawal by Subject|0|||
33504694|NCT02860130|101741332|FG001|Overall Study|Withdrawal by Subject|2|||
33504695|NCT02860130|101741331|FG000|Overall Study|Physician Decision|2|||
33504696|NCT02860130|101741332|FG001|Overall Study|Physician Decision|2|||
33504697|NCT02860130|101741331|FG000|Overall Study|Other|2|||
33504698|NCT02860130|101741332|FG001|Overall Study|Other|1|||
33504699|NCT04105218|101741334|FG000|Overall Study|Withdrawal by Subject|3|||
33504700|NCT04105218|101741335|FG001|Overall Study|Withdrawal by Subject|2|||
33504701|NCT04105218|101741334|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
33504702|NCT04105218|101741335|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
33504703|NCT04105218|101741334|FG000|Overall Study|Failed screening tests|2|||
33504704|NCT04105218|101741335|FG001|Overall Study|Failed screening tests|1|||
33504705|NCT00932373|101741336|FG000|Overall Study|Progressive disease|3|||
33504706|NCT00932373|101741337|FG001|Overall Study|Progressive disease|1|||
33504707|NCT00932373|101741338|FG002|Overall Study|Progressive disease|0|||
33504708|NCT00932373|101741339|FG003|Overall Study|Progressive disease|0|||
33396421|NCT04315298|101341811|FG005|Overall Study|Death|114|||
33504709|NCT00932373|101741340|FG004|Overall Study|Progressive disease|10|||
33504710|NCT00932373|101741341|FG005|Overall Study|Progressive disease|1|||
33504711|NCT00932373|101741342|FG006|Overall Study|Progressive disease|0|||
33504712|NCT00932373|101741343|FG007|Overall Study|Progressive disease|2|||
33504713|NCT00932373|101741344|FG008|Overall Study|Progressive disease|1|||
33504714|NCT00932373|101741345|FG009|Overall Study|Progressive disease|9|||
33504715|NCT00932373|101741346|FG010|Overall Study|Progressive disease|2|||
33504716|NCT00932373|101741336|FG000|Overall Study|Adverse Event|0|||
33504717|NCT00932373|101741337|FG001|Overall Study|Adverse Event|0|||
33504718|NCT00932373|101741338|FG002|Overall Study|Adverse Event|0|||
33504719|NCT00932373|101741339|FG003|Overall Study|Adverse Event|0|||
33504720|NCT00932373|101741340|FG004|Overall Study|Adverse Event|2|||
33504721|NCT00932373|101741341|FG005|Overall Study|Adverse Event|1|||
33504722|NCT00932373|101741342|FG006|Overall Study|Adverse Event|0|||
33504723|NCT00932373|101741343|FG007|Overall Study|Adverse Event|1|||
33504724|NCT00932373|101741344|FG008|Overall Study|Adverse Event|0|||
33504725|NCT00932373|101741345|FG009|Overall Study|Adverse Event|2|||
33602928|NCT02914561|102099146|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
33602929|NCT02914561|102099147|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
33602930|NCT02914561|102099148|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
33602931|NCT02914561|102099149|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
33602932|NCT02914561|102099150|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
33602933|NCT02914561|102099151|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
33602934|NCT02914561|102099141|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
33602935|NCT02914561|102099142|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
33602936|NCT02914561|102099143|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
33396422|NCT04315298|101341812|FG006|Overall Study|Death|9|||
33504726|NCT00932373|101741346|FG010|Overall Study|Adverse Event|1|||
33504727|NCT00932373|101741336|FG000|Overall Study|Physician Decision|0|||
33602937|NCT02914561|102099144|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
33602938|NCT02914561|102099145|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
33602939|NCT02914561|102099146|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
33504728|NCT00932373|101741337|FG001|Overall Study|Physician Decision|0|||
33396423|NCT04315298|101341813|FG007|Overall Study|Death|12|||
33504729|NCT00932373|101741338|FG002|Overall Study|Physician Decision|1|||
33194212|NCT01158924|100616348|FG000|Overall Study|Withdrawal by Subject|1|||
33194213|NCT01158924|100616349|FG001|Overall Study|Withdrawal by Subject|2|||
33194214|NCT01158924|100616348|FG000|Overall Study|Lost to Follow-up|0|||
33194215|NCT01158924|100616349|FG001|Overall Study|Lost to Follow-up|1|||
33194216|NCT02583256|100616352|FG000|Overall Study|Withdrawal by Subject|0|||
33194217|NCT02583256|100616353|FG001|Overall Study|Withdrawal by Subject|1|||
33194218|NCT02583256|100616354|FG002|Overall Study|Withdrawal by Subject|1|||
33194219|NCT02583256|100616355|FG003|Overall Study|Withdrawal by Subject|0|||
33194220|NCT02583256|100616352|FG000|Overall Study|Lost to Follow-up|1|||
33504730|NCT00932373|101741339|FG003|Overall Study|Physician Decision|0|||
33504731|NCT00932373|101741340|FG004|Overall Study|Physician Decision|2|||
33504732|NCT00932373|101741341|FG005|Overall Study|Physician Decision|0|||
33504733|NCT00932373|101741342|FG006|Overall Study|Physician Decision|0|||
33504734|NCT00932373|101741343|FG007|Overall Study|Physician Decision|0|||
33504735|NCT00932373|101741344|FG008|Overall Study|Physician Decision|0|||
33504736|NCT00932373|101741345|FG009|Overall Study|Physician Decision|1|||
33504737|NCT00932373|101741346|FG010|Overall Study|Physician Decision|0|||
33504738|NCT00932373|101741336|FG000|Overall Study|Dose limiting toxicity|0|||
33504739|NCT00932373|101741337|FG001|Overall Study|Dose limiting toxicity|0|||
33504740|NCT00932373|101741338|FG002|Overall Study|Dose limiting toxicity|0|||
33504741|NCT00932373|101741339|FG003|Overall Study|Dose limiting toxicity|0|||
33504742|NCT00932373|101741340|FG004|Overall Study|Dose limiting toxicity|0|||
33504743|NCT00932373|101741341|FG005|Overall Study|Dose limiting toxicity|1|||
33504744|NCT00932373|101741342|FG006|Overall Study|Dose limiting toxicity|0|||
33504745|NCT00932373|101741343|FG007|Overall Study|Dose limiting toxicity|0|||
33504746|NCT00932373|101741344|FG008|Overall Study|Dose limiting toxicity|0|||
33504747|NCT00932373|101741345|FG009|Overall Study|Dose limiting toxicity|0|||
33504748|NCT00932373|101741346|FG010|Overall Study|Dose limiting toxicity|0|||
33504749|NCT00932373|101741336|FG000|Overall Study|Withdrawal by Subject|0|||
33504750|NCT00932373|101741337|FG001|Overall Study|Withdrawal by Subject|0|||
33504751|NCT00932373|101741338|FG002|Overall Study|Withdrawal by Subject|0|||
33504752|NCT00932373|101741339|FG003|Overall Study|Withdrawal by Subject|0|||
33504753|NCT00932373|101741340|FG004|Overall Study|Withdrawal by Subject|0|||
33504754|NCT00932373|101741341|FG005|Overall Study|Withdrawal by Subject|0|||
33504755|NCT00932373|101741342|FG006|Overall Study|Withdrawal by Subject|0|||
33504756|NCT00932373|101741343|FG007|Overall Study|Withdrawal by Subject|0|||
33504757|NCT00932373|101741344|FG008|Overall Study|Withdrawal by Subject|1|||
33504758|NCT00932373|101741345|FG009|Overall Study|Withdrawal by Subject|0|||
33504759|NCT00932373|101741346|FG010|Overall Study|Withdrawal by Subject|0|||
33504760|NCT00932373|101741336|FG000|Overall Study|Clinical progression|0|||
33504761|NCT00932373|101741337|FG001|Overall Study|Clinical progression|0|||
33504762|NCT00932373|101741338|FG002|Overall Study|Clinical progression|0|||
33504763|NCT00932373|101741339|FG003|Overall Study|Clinical progression|0|||
33504764|NCT00932373|101741340|FG004|Overall Study|Clinical progression|0|||
33504765|NCT00932373|101741341|FG005|Overall Study|Clinical progression|0|||
33504766|NCT00932373|101741342|FG006|Overall Study|Clinical progression|1|||
33504767|NCT00932373|101741343|FG007|Overall Study|Clinical progression|0|||
33504768|NCT00932373|101741344|FG008|Overall Study|Clinical progression|0|||
33504769|NCT00932373|101741345|FG009|Overall Study|Clinical progression|0|||
33504770|NCT00932373|101741346|FG010|Overall Study|Clinical progression|0|||
33504771|NCT00932373|101741336|FG000|Overall Study|Lack of Efficacy|0|||
33504772|NCT00932373|101741337|FG001|Overall Study|Lack of Efficacy|0|||
33504773|NCT00932373|101741338|FG002|Overall Study|Lack of Efficacy|0|||
33504774|NCT00932373|101741339|FG003|Overall Study|Lack of Efficacy|0|||
33504775|NCT00932373|101741340|FG004|Overall Study|Lack of Efficacy|0|||
33504776|NCT00932373|101741341|FG005|Overall Study|Lack of Efficacy|0|||
33602940|NCT02914561|102099147|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
33602941|NCT02914561|102099148|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
33602942|NCT02914561|102099149|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
33602943|NCT02914561|102099150|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
33602944|NCT02914561|102099151|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
33602945|NCT02914561|102099141|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
33602946|NCT02914561|102099142|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
33602947|NCT02914561|102099143|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
33602948|NCT02914561|102099144|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
33602949|NCT02914561|102099145|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
33602950|NCT02914561|102099146|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
33602951|NCT02914561|102099147|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
33602952|NCT02914561|102099148|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
33602953|NCT02914561|102099149|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
33602954|NCT02914561|102099150|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
33602955|NCT02914561|102099151|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
33602956|NCT02914561|102099141|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
33602957|NCT02914561|102099142|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
33314226|NCT01201317|101044421|FG002|Overall Study|Protocol Violation|1|||
33504777|NCT00932373|101741342|FG006|Overall Study|Lack of Efficacy|0|||
33504778|NCT00932373|101741343|FG007|Overall Study|Lack of Efficacy|0|||
33504779|NCT00932373|101741344|FG008|Overall Study|Lack of Efficacy|0|||
33504780|NCT00932373|101741345|FG009|Overall Study|Lack of Efficacy|1|||
33504781|NCT00932373|101741346|FG010|Overall Study|Lack of Efficacy|0|||
33504782|NCT00603590|101741347|FG000|Overall Study|Did not attend study clinic|39|||
33504783|NCT00603590|101741348|FG001|Overall Study|Did not attend study clinic|30|||
33504784|NCT00603590|101741347|FG000|Overall Study|Refused blood test|5|||
33504785|NCT00603590|101741348|FG001|Overall Study|Refused blood test|1|||
33504786|NCT00603590|101741347|FG000|Overall Study|Patient discontinued study drug|22|||
33504787|NCT00603590|101741348|FG001|Overall Study|Patient discontinued study drug|15|||
33504788|NCT00603590|101741347|FG000|Overall Study|Adverse Event|2|||
33504789|NCT00603590|101741348|FG001|Overall Study|Adverse Event|0|||
33504790|NCT00603590|101741347|FG000|Overall Study|Lost to Follow-up|8|||
33504791|NCT00603590|101741348|FG001|Overall Study|Lost to Follow-up|4|||
33504792|NCT00603590|101741347|FG000|Overall Study|Cardiovascular event|0|||
33504793|NCT00603590|101741348|FG001|Overall Study|Cardiovascular event|1|||
33504794|NCT00280397|101741351|FG000|Overall Study|Adverse Event|1|||
33504795|NCT03625466|101741352|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
33504796|NCT03625466|101741353|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
33504797|NCT03625466|101741354|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
33504798|NCT03625466|101741352|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
33504799|NCT03625466|101741353|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
33504800|NCT03625466|101741354|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
33504801|NCT03625466|101741352|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
33504802|NCT03625466|101741353|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
33504803|NCT03625466|101741354|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
33504804|NCT01355575|101741359|FG000|Overall Study|Withdrawal by Subject|2|||
33602958|NCT02914561|102099143|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
33602959|NCT02914561|102099144|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
33504805|NCT01387516|101741362|FG000|Overall Study|Lost to Follow-up|4|||
33504806|NCT01387516|101741363|FG001|Overall Study|Lost to Follow-up|4|||
33504807|NCT01387516|101741364|FG002|Overall Study|Lost to Follow-up|2|||
33504808|NCT01387516|101741365|FG003|Overall Study|Lost to Follow-up|3|||
33504809|NCT01387516|101741362|FG000|Overall Study|Withdrawal by Subject|1|||
33504810|NCT01387516|101741363|FG001|Overall Study|Withdrawal by Subject|1|||
33602960|NCT02914561|102099145|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
33602961|NCT02914561|102099146|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
33602962|NCT02914561|102099147|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
33602963|NCT02914561|102099148|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
33602964|NCT02914561|102099149|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
33602965|NCT02914561|102099150|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
33602966|NCT02914561|102099151|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
33602967|NCT02914561|102099141|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
33602968|NCT02914561|102099142|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
33602969|NCT02914561|102099143|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
33602970|NCT02914561|102099144|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
33602971|NCT02914561|102099145|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
33602972|NCT02914561|102099146|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
33602973|NCT02914561|102099147|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
33602974|NCT02914561|102099148|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
33602975|NCT02914561|102099149|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
33602976|NCT02914561|102099150|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
33602977|NCT02914561|102099151|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
33602978|NCT02914561|102099141|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
33602979|NCT02914561|102099142|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
33602980|NCT02914561|102099143|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
33602981|NCT02914561|102099144|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
33602982|NCT02914561|102099145|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
33602983|NCT02914561|102099146|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
33602984|NCT02914561|102099147|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
33602985|NCT02914561|102099148|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
33602986|NCT02914561|102099149|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
33602987|NCT02914561|102099150|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
33602988|NCT02914561|102099151|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
33602989|NCT02914561|102099141|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
33602990|NCT02914561|102099142|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
33602991|NCT02914561|102099143|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
33602992|NCT02914561|102099144|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
33602993|NCT02914561|102099145|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
33504811|NCT01387516|101741364|FG002|Overall Study|Withdrawal by Subject|2|||
33504812|NCT01387516|101741365|FG003|Overall Study|Withdrawal by Subject|0|||
33504813|NCT01387516|101741362|FG000|Overall Study|Death|0|||
33194221|NCT02583256|100616353|FG001|Overall Study|Lost to Follow-up|1|||
33194222|NCT02583256|100616354|FG002|Overall Study|Lost to Follow-up|0|||
33194223|NCT02583256|100616355|FG003|Overall Study|Lost to Follow-up|1|||
33504814|NCT01387516|101741363|FG001|Overall Study|Death|0|||
33504815|NCT01387516|101741364|FG002|Overall Study|Death|0|||
33504816|NCT01387516|101741365|FG003|Overall Study|Death|1|||
33314227|NCT01201317|101044419|FG000|Overall Study|Death|0|||
33314228|NCT01201317|101044420|FG001|Overall Study|Death|1|||
33314229|NCT01201317|101044421|FG002|Overall Study|Death|0|||
33314230|NCT01201317|101044419|FG000|Overall Study|Study-specific withdrawal criteria|0|||
33314231|NCT01201317|101044420|FG001|Overall Study|Study-specific withdrawal criteria|0|||
33314232|NCT01201317|101044421|FG002|Overall Study|Study-specific withdrawal criteria|1|||
33314233|NCT01201317|101044419|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
33314234|NCT01201317|101044420|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
33314235|NCT01201317|101044421|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
33314236|NCT01201317|101044419|FG000|Overall Study|Decrease in renal function|0|||
33194224|NCT02583256|100616352|FG000|Overall Study|Administrative/Other|2|||
33194225|NCT02583256|100616353|FG001|Overall Study|Administrative/Other|0|||
33194226|NCT02583256|100616354|FG002|Overall Study|Administrative/Other|1|||
33194227|NCT02583256|100616355|FG003|Overall Study|Administrative/Other|2|||
33194228|NCT01000051|100616358|FG000|Overall Study|Withdrawal by Subject|1|||
33194229|NCT01000051|100616359|FG001|Overall Study|Withdrawal by Subject|1|||
33194230|NCT01000051|100616358|FG000|Overall Study|Disease Progression|1|||
33194231|NCT01000051|100616359|FG001|Overall Study|Disease Progression|0|||
33194232|NCT01000051|100616358|FG000|Overall Study|Serious noncompliance|1|||
33194233|NCT01000051|100616359|FG001|Overall Study|Serious noncompliance|0|||
33194234|NCT00546715|100616360|FG000|Overall Study|Withdrawal by Subject|0|||
33194235|NCT00546715|100616361|FG001|Overall Study|Withdrawal by Subject|1|||
33194236|NCT00546715|100616362|FG002|Overall Study|Withdrawal by Subject|0|||
33194237|NCT00546715|100616363|FG003|Overall Study|Withdrawal by Subject|0|||
33194238|NCT01687166|100616366|FG000|Overall Study|Attempt subject|2|||
33194239|NCT01687166|100616367|FG001|Overall Study|Attempt subject|3|||
33194240|NCT01687166|100616368|FG002|Overall Study|Attempt subject|2|||
33194241|NCT01687166|100616369|FG003|Overall Study|Attempt subject|0|||
33194242|NCT01687166|100616366|FG000|Overall Study|Did not meet eligibility criteria|4|||
33194243|NCT01687166|100616367|FG001|Overall Study|Did not meet eligibility criteria|6|||
33194244|NCT01687166|100616368|FG002|Overall Study|Did not meet eligibility criteria|1|||
33194245|NCT01687166|100616369|FG003|Overall Study|Did not meet eligibility criteria|1|||
33194246|NCT01687166|100616366|FG000|Overall Study|Adverse Event|2|||
33194247|NCT01687166|100616367|FG001|Overall Study|Adverse Event|1|||
33194248|NCT01687166|100616368|FG002|Overall Study|Adverse Event|0|||
33194249|NCT01687166|100616369|FG003|Overall Study|Adverse Event|0|||
33194250|NCT01687166|100616366|FG000|Overall Study|Physician Decision|3|||
33194251|NCT01687166|100616367|FG001|Overall Study|Physician Decision|2|||
33194252|NCT01687166|100616368|FG002|Overall Study|Physician Decision|1|||
33194253|NCT01687166|100616369|FG003|Overall Study|Physician Decision|0|||
33194254|NCT01687166|100616366|FG000|Overall Study|Withdrawal by Subject|11|||
33194255|NCT01687166|100616367|FG001|Overall Study|Withdrawal by Subject|4|||
33194256|NCT01687166|100616368|FG002|Overall Study|Withdrawal by Subject|3|||
33194257|NCT01687166|100616369|FG003|Overall Study|Withdrawal by Subject|0|||
33194258|NCT01687166|100616366|FG000|Overall Study|Lost to Follow-up|2|||
33194259|NCT01687166|100616367|FG001|Overall Study|Lost to Follow-up|5|||
33314237|NCT01201317|101044420|FG001|Overall Study|Decrease in renal function|1|||
33396424|NCT04315298|101341814|FG008|Overall Study|Death|21|||
33396425|NCT04315298|101341815|FG009|Overall Study|Death|16|||
33396426|NCT04315298|101341816|FG010|Overall Study|Death|40|||
33504817|NCT00667823|101741366|FG000|Overall Study|Lost to Follow-up|5|||
33194260|NCT01687166|100616368|FG002|Overall Study|Lost to Follow-up|1|||
33194261|NCT01687166|100616369|FG003|Overall Study|Lost to Follow-up|0|||
33194262|NCT01687166|100616366|FG000|Overall Study|Equipment/Device Availability|0|||
33194263|NCT01687166|100616367|FG001|Overall Study|Equipment/Device Availability|1|||
33194264|NCT01687166|100616368|FG002|Overall Study|Equipment/Device Availability|0|||
33194265|NCT01687166|100616369|FG003|Overall Study|Equipment/Device Availability|0|||
33194266|NCT01687166|100616366|FG000|Overall Study|Death|1|||
33314238|NCT01201317|101044421|FG002|Overall Study|Decrease in renal function|0|||
33396427|NCT04315298|101341817|FG011|Overall Study|Death|40|||
33194267|NCT01687166|100616367|FG001|Overall Study|Death|1|||
33194268|NCT01687166|100616368|FG002|Overall Study|Death|0|||
33194269|NCT01687166|100616369|FG003|Overall Study|Death|0|||
33194270|NCT01687166|100616366|FG000|Overall Study|Protocol Violation|1|||
33504818|NCT00667823|101741366|FG000|Overall Study|Adverse Event|7|||
33504819|NCT00667823|101741366|FG000|Overall Study|Death|182|||
33504820|NCT00667823|101741366|FG000|Overall Study|Withdrawal by Subject|12|||
33504821|NCT00667823|101741366|FG000|Overall Study|Other|8|||
33504822|NCT00667823|101741366|FG000|Overall Study|Missing (completion page missing)|2|||
33504823|NCT02649439|101741367|FG000|Overall Study|Switched to alternative treatment|6|||
33504824|NCT02649439|101741368|FG001|Overall Study|Switched to alternative treatment|4|||
33194271|NCT01687166|100616367|FG001|Overall Study|Protocol Violation|1|||
33194272|NCT01687166|100616368|FG002|Overall Study|Protocol Violation|1|||
33194273|NCT01687166|100616369|FG003|Overall Study|Protocol Violation|0|||
33194274|NCT01687166|100616366|FG000|Overall Study|Subject moved out of state|0|||
33194275|NCT01687166|100616367|FG001|Overall Study|Subject moved out of state|1|||
33194276|NCT01687166|100616368|FG002|Overall Study|Subject moved out of state|0|||
33194277|NCT01687166|100616369|FG003|Overall Study|Subject moved out of state|0|||
33194278|NCT01687166|100616366|FG000|Overall Study|Patient unable to be compliant|1|||
33194279|NCT01687166|100616367|FG001|Overall Study|Patient unable to be compliant|0|||
33194280|NCT01687166|100616368|FG002|Overall Study|Patient unable to be compliant|0|||
33194281|NCT01687166|100616369|FG003|Overall Study|Patient unable to be compliant|0|||
33194282|NCT01687166|100616366|FG000|Overall Study|Physician choice to use different device|1|||
33194283|NCT01687166|100616367|FG001|Overall Study|Physician choice to use different device|2|||
33194284|NCT01687166|100616368|FG002|Overall Study|Physician choice to use different device|4|||
33194285|NCT01687166|100616369|FG003|Overall Study|Physician choice to use different device|0|||
33194286|NCT01687166|100616366|FG000|Overall Study|Insurance|0|||
33194287|NCT01687166|100616367|FG001|Overall Study|Insurance|0|||
33194288|NCT01687166|100616368|FG002|Overall Study|Insurance|1|||
33194289|NCT01687166|100616369|FG003|Overall Study|Insurance|1|||
33194290|NCT00057746|100616370|FG000|Overall Study|Withdrawal by Subject|0|||
33194291|NCT00057746|100616371|FG001|Overall Study|Withdrawal by Subject|0|||
33194292|NCT00057746|100616372|FG002|Overall Study|Withdrawal by Subject|1|||
33194293|NCT00958880|100616391|FG000|Overall Study|Lost to Follow-up|2|||
33194294|NCT00958880|100616392|FG001|Overall Study|Lost to Follow-up|2|||
33194295|NCT02262728|100616393|FG000|Follow-up Phase (3 Years)|Death|0|||
33194296|NCT02262728|100616394|FG001|Follow-up Phase (3 Years)|Death|1|||
33194297|NCT02262728|100616393|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
33194298|NCT02262728|100616394|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
33194299|NCT02262728|100616393|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
33194300|NCT02262728|100616394|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
33194301|NCT03354429|100616395|FG000|Overall Study|Withdrawal by Subject|8|||
33504825|NCT02649439|101741367|FG000|Overall Study|Patient decision|1|||
33504826|NCT02649439|101741368|FG001|Overall Study|Patient decision|0|||
33504827|NCT02649439|101741367|FG000|Overall Study|Patient going out of country|1|||
33504828|NCT02649439|101741368|FG001|Overall Study|Patient going out of country|0|||
33504829|NCT02649439|101741367|FG000|Overall Study|To start finasteride|1|||
33504830|NCT02649439|101741368|FG001|Overall Study|To start finasteride|0|||
33504831|NCT02649439|101741367|FG000|Overall Study|Physician Decision|1|||
33504832|NCT02649439|101741368|FG001|Overall Study|Physician Decision|0|||
33194302|NCT03354429|100616396|FG001|Overall Study|Withdrawal by Subject|7|||
33194303|NCT03354429|100616395|FG000|Overall Study|Lost to Follow-up|1|||
33194304|NCT03354429|100616396|FG001|Overall Study|Lost to Follow-up|0|||
33194305|NCT03120013|100616397|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33194306|NCT03120013|100616398|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
33194307|NCT00211081|100616401|FG000|Overall Study|Withdrawal by Subject|2|||
33504833|NCT02649439|101741367|FG000|Overall Study|Disease progression on study|12|||
33504834|NCT02649439|101741368|FG001|Overall Study|Disease progression on study|13|||
33504835|NCT02649439|101741367|FG000|Overall Study|Refused further treatment|1|||
33194308|NCT04640311|100616402|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
33194309|NCT04640311|100616403|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194310|NCT04640311|100616404|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194311|NCT04640311|100616405|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194312|NCT04640311|100616406|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33396428|NCT04315298|101341818|FG012|Overall Study|Death|3|||
33396429|NCT04315298|101341819|FG013|Overall Study|Death|4|||
33396430|NCT04315298|101341820|FG014|Overall Study|Death|6|||
33504836|NCT02649439|101741368|FG001|Overall Study|Refused further treatment|0|||
33504837|NCT02649439|101741367|FG000|Overall Study|Refused further follow up|2|||
33504838|NCT02649439|101741368|FG001|Overall Study|Refused further follow up|7|||
33194313|NCT04640311|100616407|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194314|NCT04640311|100616408|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194315|NCT04640311|100616409|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194316|NCT04640311|100616410|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194317|NCT04640311|100616411|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194318|NCT04640311|100616412|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194319|NCT04640311|100616413|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194320|NCT04640311|100616414|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194321|NCT04640311|100616402|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33194322|NCT04640311|100616403|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
33194323|NCT04640311|100616404|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33194324|NCT04640311|100616405|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33194325|NCT04640311|100616406|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33194326|NCT04640311|100616407|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33194327|NCT04640311|100616408|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33194328|NCT04640311|100616409|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33194329|NCT04640311|100616410|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33194330|NCT04640311|100616411|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33194331|NCT04640311|100616412|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33194332|NCT04640311|100616413|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33194333|NCT04640311|100616414|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
33194334|NCT04640311|100616402|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194335|NCT04640311|100616403|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
33504839|NCT02649439|101741367|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
33504840|NCT02649439|101741368|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
33504841|NCT02649439|101741367|FG000|Overall Study|No treatment, per protocol|1|||
33504842|NCT02649439|101741368|FG001|Overall Study|No treatment, per protocol|0|||
33504843|NCT02649439|101741367|FG000|Overall Study|PSA DT makes ineligible|0|||
33504844|NCT02649439|101741368|FG001|Overall Study|PSA DT makes ineligible|1|||
33504845|NCT02649439|101741367|FG000|Overall Study|Rising PSA No Mets|0|||
33504846|NCT02649439|101741368|FG001|Overall Study|Rising PSA No Mets|1|||
33504847|NCT02649439|101741367|FG000|Overall Study|Rising PSA|0|||
33504848|NCT02649439|101741368|FG001|Overall Study|Rising PSA|1|||
33194336|NCT04640311|100616404|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194337|NCT04640311|100616405|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194338|NCT04640311|100616406|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194339|NCT04640311|100616407|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194340|NCT04640311|100616408|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194341|NCT04640311|100616409|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194342|NCT04640311|100616410|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194343|NCT04640311|100616411|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194344|NCT04640311|100616412|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194345|NCT04640311|100616413|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194346|NCT04640311|100616414|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194347|NCT04640311|100616402|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
33194348|NCT04640311|100616403|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
33314239|NCT01201317|101044419|FG000|Overall Study|Lack of Efficacy|1|||
33314240|NCT01201317|101044420|FG001|Overall Study|Lack of Efficacy|0|||
33314241|NCT01201317|101044421|FG002|Overall Study|Lack of Efficacy|0|||
33314242|NCT01201317|101044419|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
33314243|NCT01201317|101044420|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
33314244|NCT01201317|101044421|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
33314245|NCT00959647|101044422|FG000|Overall Study|Adverse Event|2|||
33314246|NCT00959647|101044422|FG000|Overall Study|Progressive disease|6|||
33314247|NCT00959647|101044422|FG000|Overall Study|Study terminated by sponsor|4|||
33314248|NCT00959647|101044422|FG000|Overall Study|Withdrawal by Subject|7|||
33314249|NCT01759407|101044423|FG000|Overall Study|Protocol Violation|0|||
33314250|NCT01759407|101044424|FG001|Overall Study|Protocol Violation|2|||
33314251|NCT02709096|101044425|FG000|Overall Study|non-compliance|1|||
33314252|NCT02709096|101044426|FG001|Overall Study|non-compliance|1|||
33314253|NCT01163916|101044427|FG000|Overall Study|Withdrawal by Subject|2|||
33314254|NCT01163916|101044428|FG001|Overall Study|Withdrawal by Subject|0|||
33504849|NCT02649439|101741367|FG000|Overall Study|Signed follow up protocol|0|||
33504850|NCT02649439|101741368|FG001|Overall Study|Signed follow up protocol|1|||
33504851|NCT00596687|101741369|FG000|Overall Study|< 24 hours of insulin treatment|8|||
33504852|NCT00596687|101741370|FG001|Overall Study|< 24 hours of insulin treatment|6|||
33194349|NCT04640311|100616404|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
33194350|NCT04640311|100616405|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194351|NCT04640311|100616406|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194352|NCT04640311|100616407|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194353|NCT04640311|100616408|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194354|NCT04640311|100616409|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194355|NCT04640311|100616410|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194356|NCT04640311|100616411|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194357|NCT04640311|100616412|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194358|NCT04640311|100616413|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194359|NCT04640311|100616414|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
33194360|NCT04640311|100616402|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33194361|NCT04640311|100616403|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33194362|NCT04640311|100616404|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
33194363|NCT04640311|100616405|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33504853|NCT00596687|101741369|FG000|Overall Study|continuous insulin infusion during TPN|2|||
33504854|NCT00596687|101741370|FG001|Overall Study|continuous insulin infusion during TPN|1|||
33602994|NCT02914561|102099146|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
33194364|NCT04640311|100616406|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33194365|NCT04640311|100616407|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33194366|NCT04640311|100616408|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33194367|NCT04640311|100616409|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33194368|NCT04640311|100616410|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33194369|NCT04640311|100616411|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33194370|NCT04640311|100616412|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33194371|NCT04640311|100616413|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33194372|NCT04640311|100616414|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
33194373|NCT04640311|100616402|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33194374|NCT04640311|100616403|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33194375|NCT04640311|100616404|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33194376|NCT04640311|100616405|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
33194377|NCT04640311|100616406|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33194378|NCT04640311|100616407|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33194379|NCT04640311|100616408|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
33194380|NCT04640311|100616409|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33194381|NCT04640311|100616410|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33194382|NCT04640311|100616411|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33194383|NCT04640311|100616412|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33194384|NCT04640311|100616413|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33194385|NCT04640311|100616414|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
33194386|NCT04640311|100616402|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194387|NCT04640311|100616403|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194388|NCT04640311|100616404|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194389|NCT04640311|100616405|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194390|NCT04640311|100616406|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194391|NCT04640311|100616407|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
33194392|NCT04640311|100616408|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194393|NCT04640311|100616409|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194394|NCT04640311|100616410|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
33194395|NCT04640311|100616411|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194396|NCT04640311|100616412|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194397|NCT04640311|100616413|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194398|NCT04640311|100616414|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
33194399|NCT04640311|100616402|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33194400|NCT04640311|100616403|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33194401|NCT04640311|100616404|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33396431|NCT04315298|101341821|FG015|Overall Study|Death|4|||
33602995|NCT02914561|102099147|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
33602996|NCT02914561|102099148|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
33602997|NCT02914561|102099149|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
33194402|NCT04640311|100616405|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33194403|NCT04640311|100616406|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33194404|NCT04640311|100616407|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33194405|NCT04640311|100616408|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
33194406|NCT04640311|100616409|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33194407|NCT04640311|100616410|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33194408|NCT04640311|100616411|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33194409|NCT04640311|100616412|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
33194410|NCT04640311|100616413|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33194411|NCT04640311|100616414|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
33194412|NCT04640311|100616402|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33602998|NCT02914561|102099150|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
33602999|NCT02914561|102099151|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
33603000|NCT02914561|102099141|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
33603001|NCT02914561|102099142|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
33603002|NCT02914561|102099143|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
33603003|NCT02914561|102099144|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
33603004|NCT02914561|102099145|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
33603005|NCT02914561|102099146|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
33603006|NCT02914561|102099147|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
33603007|NCT02914561|102099148|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
33504855|NCT00596687|101741369|FG000|Overall Study|Withdrawal by Subject|3|||
33504856|NCT00596687|101741370|FG001|Overall Study|Withdrawal by Subject|1|||
33603008|NCT02914561|102099149|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
33603009|NCT02914561|102099150|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
33603010|NCT02914561|102099151|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
33603011|NCT03159104|102099156|FG000|Overall Study|Violation of inclusion criteria|1|||
33603012|NCT03159104|102099157|FG001|Overall Study|Violation of inclusion criteria|2|||
33603013|NCT01490294|102099158|FG000|Overall Study|Prematurely discontinuation|4|||
33603014|NCT01490294|102099159|FG001|Overall Study|Prematurely discontinuation|0|||
33603015|NCT01490294|102099160|FG002|Overall Study|Prematurely discontinuation|1|||
33194413|NCT04640311|100616403|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33194414|NCT04640311|100616404|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33194415|NCT04640311|100616405|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33194416|NCT04640311|100616406|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33194417|NCT04640311|100616407|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33194418|NCT04640311|100616408|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33194419|NCT04640311|100616409|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33194420|NCT04640311|100616410|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33194421|NCT04640311|100616411|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33194422|NCT04640311|100616412|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33314255|NCT01163916|101044429|FG002|Overall Study|Withdrawal by Subject|2|||
33314256|NCT01163916|101044427|FG000|Overall Study|Adverse Event|2|||
33314257|NCT01163916|101044428|FG001|Overall Study|Adverse Event|0|||
33314258|NCT01163916|101044429|FG002|Overall Study|Adverse Event|1|||
33314259|NCT01163916|101044427|FG000|Overall Study|Lack of Efficacy|2|||
33314260|NCT01163916|101044428|FG001|Overall Study|Lack of Efficacy|0|||
33314261|NCT01163916|101044429|FG002|Overall Study|Lack of Efficacy|1|||
33314262|NCT01163916|101044427|FG000|Overall Study|Other|24|||
33314263|NCT01163916|101044428|FG001|Overall Study|Other|4|||
33314264|NCT01163916|101044429|FG002|Overall Study|Other|16|||
33314265|NCT02683876|101044434|FG000|Overall Study|samples damaged during shipping|2|||
33314266|NCT02683876|101044435|FG001|Overall Study|samples damaged during shipping|0|||
33504857|NCT00596687|101741369|FG000|Overall Study|cancelled surgery|1|||
33504858|NCT00596687|101741370|FG001|Overall Study|cancelled surgery|1|||
33504859|NCT03192306|101741371|FG000|Overall Study|Did not treat cold sore during study|149|||
33504860|NCT03192306|101741372|FG001|Overall Study|Did not treat cold sore during study|143|||
33504861|NCT03192306|101741371|FG000|Overall Study|Withdrawal by Subject|1|||
33504862|NCT03192306|101741372|FG001|Overall Study|Withdrawal by Subject|1|||
33504863|NCT03192306|101741371|FG000|Overall Study|Lost to Follow-up|1|||
33504864|NCT03192306|101741372|FG001|Overall Study|Lost to Follow-up|0|||
33504865|NCT03192306|101741371|FG000|Overall Study|Protocol Violation|1|||
33504866|NCT03192306|101741372|FG001|Overall Study|Protocol Violation|1|||
33504867|NCT00984568|101741373|FG000|Overall Study|Withdrawal by Subject|1|||
33603016|NCT01490294|102099161|FG003|Overall Study|Prematurely discontinuation|1|||
33314267|NCT01966471|101044438|FG000|Overall Study|Death|44|||
33504868|NCT00984568|101741374|FG001|Overall Study|Withdrawal by Subject|2|||
33504869|NCT00984568|101741373|FG000|Overall Study|Lack of Efficacy|2|||
33504870|NCT00984568|101741374|FG001|Overall Study|Lack of Efficacy|0|||
33314268|NCT01966471|101044439|FG001|Overall Study|Death|56|||
33504871|NCT00984568|101741373|FG000|Overall Study|Adverse Event|2|||
33504872|NCT00984568|101741374|FG001|Overall Study|Adverse Event|0|||
33504873|NCT00984568|101741373|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
33504874|NCT00984568|101741374|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
33504875|NCT00984568|101741373|FG000|Overall Study|Lost to Follow-up|0|||
33504876|NCT00984568|101741374|FG001|Overall Study|Lost to Follow-up|1|||
33504877|NCT00984568|101741373|FG000|Overall Study|Opportunistic Infection|1|||
33504878|NCT00984568|101741374|FG001|Overall Study|Opportunistic Infection|0|||
33504879|NCT00984568|101741373|FG000|Overall Study|Unknown Reason|1|||
33504880|NCT00984568|101741374|FG001|Overall Study|Unknown Reason|3|||
33504881|NCT01221272|101741386|FG000|Period 1|Adverse Event|2|||
33504882|NCT01221272|101741387|FG001|Period 1|Adverse Event|0|||
33504883|NCT01221272|101741386|FG000|Period 1|Consent Withdrawal|0|||
33504884|NCT01221272|101741387|FG001|Period 1|Consent Withdrawal|1|||
33504885|NCT01221272|101741386|FG000|Period 1|Significant Dosing Noncompliance|0|||
33504886|NCT01221272|101741387|FG001|Period 1|Significant Dosing Noncompliance|1|||
33504887|NCT01221272|101741386|FG000|Period 2|Adverse Event|0|||
33504888|NCT01221272|101741387|FG001|Period 2|Adverse Event|2|||
33504889|NCT01570361|101741388|FG000|Overall Study|Subject discontinued|1|||
33504890|NCT01570361|101741389|FG001|Overall Study|Subject discontinued|2|||
33504891|NCT01570361|101741388|FG000|Overall Study|Sponsor closing the study|51|||
33504892|NCT01570361|101741389|FG001|Overall Study|Sponsor closing the study|50|||
33504893|NCT01570361|101741388|FG000|Overall Study|Subject excluded|5|||
33504894|NCT01570361|101741389|FG001|Overall Study|Subject excluded|3|||
33504895|NCT01570361|101741388|FG000|Overall Study|Subject withdrew consent|14|||
33504896|NCT01570361|101741389|FG001|Overall Study|Subject withdrew consent|9|||
33504897|NCT01570361|101741388|FG000|Overall Study|Adverse Event|2|||
33504898|NCT01570361|101741389|FG001|Overall Study|Adverse Event|1|||
33504899|NCT01570361|101741388|FG000|Overall Study|Lost to Follow-up|4|||
33504900|NCT01570361|101741389|FG001|Overall Study|Lost to Follow-up|4|||
33504901|NCT01570361|101741388|FG000|Overall Study|Death|5|||
33504902|NCT01570361|101741389|FG001|Overall Study|Death|4|||
33504903|NCT01570361|101741388|FG000|Overall Study|Other|0|||
33504904|NCT01570361|101741389|FG001|Overall Study|Other|2|||
33504905|NCT00520533|101741391|FG000|Overall Study|Death|1|||
33504906|NCT00520533|101741391|FG000|Overall Study|Suspension of the study for safety reasons|1|||
33504907|NCT00520533|101741391|FG000|Overall Study|Withdrawal by Subject|1|||
33504908|NCT00520533|101741391|FG000|Overall Study|Physician Decision|1|||
33504909|NCT01876810|101741392|FG000|Overall Study|Physician Decision|0|||
33504910|NCT01876810|101741393|FG001|Overall Study|Physician Decision|1|||
33504911|NCT03425396|101741394|FG000|Overall Study|Lost to Follow-up|2|||
33504912|NCT03425396|101741395|FG001|Overall Study|Lost to Follow-up|5|||
33504913|NCT03425396|101741396|FG002|Overall Study|Lost to Follow-up|2|||
33504914|NCT03425396|101741397|FG003|Overall Study|Lost to Follow-up|0|||
33504915|NCT03425396|101741398|FG004|Overall Study|Lost to Follow-up|0|||
33504916|NCT03425396|101741394|FG000|Overall Study|Withdrawal by Subject|0|||
33504917|NCT03425396|101741395|FG001|Overall Study|Withdrawal by Subject|1|||
33504918|NCT03425396|101741396|FG002|Overall Study|Withdrawal by Subject|0|||
33504919|NCT03425396|101741397|FG003|Overall Study|Withdrawal by Subject|1|||
33504920|NCT03425396|101741398|FG004|Overall Study|Withdrawal by Subject|0|||
33504921|NCT03425396|101741394|FG000|Overall Study|Other|0|||
33504922|NCT03425396|101741395|FG001|Overall Study|Other|1|||
33504923|NCT03425396|101741396|FG002|Overall Study|Other|1|||
33504924|NCT03425396|101741397|FG003|Overall Study|Other|0|||
33504925|NCT03425396|101741398|FG004|Overall Study|Other|1|||
33504926|NCT01540487|101741403|FG000|Overall Study|Protocol Violation|1|||
33504927|NCT01540487|101741404|FG001|Overall Study|Protocol Violation|0|||
33504928|NCT01814696|101741407|FG000|Overall Study|Withdrawal by Subject|1|||
33504929|NCT01814696|101741408|FG001|Overall Study|Withdrawal by Subject|0|||
33504930|NCT01814696|101741407|FG000|Overall Study|Randomized to wrong group|1|||
33504931|NCT01814696|101741408|FG001|Overall Study|Randomized to wrong group|0|||
33504932|NCT02919969|101741411|FG000|Overall Study|Lack of Efficacy|22|||
33504933|NCT02919969|101741411|FG000|Overall Study|Death|4|||
33504934|NCT02919969|101741411|FG000|Overall Study|Physician Decision|3|||
33504935|NCT02919969|101741411|FG000|Overall Study|Withdrawal by Subject|2|||
33504936|NCT02993146|101741412|FG000|Overall Study|Withdrawal by Subject|0|||
33504937|NCT02993146|101741413|FG001|Overall Study|Withdrawal by Subject|0|||
33504938|NCT02993146|101741414|FG002|Overall Study|Withdrawal by Subject|1|||
33504939|NCT02993146|101741415|FG003|Overall Study|Withdrawal by Subject|1|||
33194423|NCT04640311|100616413|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
33504940|NCT02616146|101741418|FG000|Overall Study|Adverse Event|64|||
33504941|NCT02616146|101741419|FG001|Overall Study|Adverse Event|24|||
33504942|NCT02616146|101741418|FG000|Overall Study|Lost to Follow-up|23|||
33504943|NCT02616146|101741419|FG001|Overall Study|Lost to Follow-up|13|||
33504944|NCT02616146|101741418|FG000|Overall Study|Non-compliance with study protocol|2|||
33504945|NCT02616146|101741419|FG001|Overall Study|Non-compliance with study protocol|0|||
33504946|NCT02616146|101741418|FG000|Overall Study|Non-compliance with study drug|4|||
33504947|NCT02616146|101741419|FG001|Overall Study|Non-compliance with study drug|2|||
33504948|NCT02616146|101741418|FG000|Overall Study|Pregnancy|2|||
33504949|NCT02616146|101741419|FG001|Overall Study|Pregnancy|2|||
33504950|NCT02616146|101741418|FG000|Overall Study|Pregnancy wish|3|||
33504951|NCT02616146|101741419|FG001|Overall Study|Pregnancy wish|0|||
33504952|NCT02616146|101741418|FG000|Overall Study|Protocol Violation|6|||
33504953|NCT02616146|101741419|FG001|Overall Study|Protocol Violation|3|||
33504954|NCT02616146|101741418|FG000|Overall Study|Study terminated by sponsor|1372|||
33504955|NCT02616146|101741419|FG001|Overall Study|Study terminated by sponsor|432|||
33504956|NCT02616146|101741418|FG000|Overall Study|Participant moved|4|||
33504957|NCT02616146|101741419|FG001|Overall Study|Participant moved|3|||
33504958|NCT02616146|101741418|FG000|Overall Study|Withdrawal by Subject|30|||
33504959|NCT02616146|101741419|FG001|Overall Study|Withdrawal by Subject|24|||
33504960|NCT02616146|101741418|FG000|Overall Study|Physician Decision|2|||
33504961|NCT02616146|101741419|FG001|Overall Study|Physician Decision|1|||
33504962|NCT03436693|101741420|FG000|Overall Study|Adverse Event|22|||
33504963|NCT03436693|101741421|FG001|Overall Study|Adverse Event|10|||
33504964|NCT03436693|101741420|FG000|Overall Study|Physician Decision|3|||
33504965|NCT03436693|101741421|FG001|Overall Study|Physician Decision|3|||
33504966|NCT03436693|101741420|FG000|Overall Study|Withdrawal by Subject|4|||
33504967|NCT03436693|101741421|FG001|Overall Study|Withdrawal by Subject|13|||
33504968|NCT03436693|101741420|FG000|Overall Study|Progressive Disease|1|||
33504969|NCT03436693|101741421|FG001|Overall Study|Progressive Disease|1|||
33504970|NCT00285207|101741422|FG000|Overall Study|Lost to Follow-up|3|||
33504971|NCT00285207|101741423|FG001|Overall Study|Lost to Follow-up|2|||
33396432|NCT04315298|101341822|FG016|Overall Study|Death|3|||
33396433|NCT04315298|101341823|FG017|Overall Study|Death|1|||
33396434|NCT04315298|101341824|FG018|Overall Study|Death|0|||
33504972|NCT00285207|101741422|FG000|Overall Study|Withdrawal by Subject|5|||
33504973|NCT00285207|101741423|FG001|Overall Study|Withdrawal by Subject|2|||
33504974|NCT00285207|101741422|FG000|Overall Study|Pregnancy|1|||
33504975|NCT00285207|101741423|FG001|Overall Study|Pregnancy|1|||
33504976|NCT00285207|101741422|FG000|Overall Study|non-compliance|0|||
33504977|NCT00285207|101741423|FG001|Overall Study|non-compliance|1|||
33504978|NCT01696929|101741424|FG000|Overall Study|Physician Decision|1|||
33504979|NCT02237196|101741425|FG000|Overall Study|Adverse Event|0|||
33504980|NCT02237196|101741426|FG001|Overall Study|Adverse Event|1|||
33396435|NCT01426009|101341825|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
33396436|NCT01426009|101341825|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
33396437|NCT01426009|101341825|FG000|Washout 1|Withdrawal by Subject|1|||
33396438|NCT01426009|101341825|FG000|Washout 1|Personal Reasons|1|||
33396439|NCT01426009|101341825|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
33396440|NCT01426009|101341825|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
33396441|NCT01426009|101341825|FG000|Washout 2|electrive surgery|1|||
33396442|NCT01426009|101341825|FG000|Washout 3|personal reasons|1|||
33396443|NCT01426009|101341825|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
33396444|NCT01426009|101341825|FG000|Washout 4|Lost to Follow-up|1|||
33396445|NCT04476108|101341826|FG000|Overall Study|Adverse Event|4|||
33396446|NCT04476108|101341827|FG001|Overall Study|Adverse Event|1|||
33396447|NCT04476108|101341826|FG000|Overall Study|Lost to Follow-up|1|||
33396448|NCT04476108|101341827|FG001|Overall Study|Lost to Follow-up|0|||
33396449|NCT04476108|101341826|FG000|Overall Study|Inadvertent Enrollment|1|||
33396450|NCT04476108|101341827|FG001|Overall Study|Inadvertent Enrollment|0|||
33396451|NCT04476108|101341826|FG000|Overall Study|Protocol Violation|1|||
33396452|NCT04476108|101341827|FG001|Overall Study|Protocol Violation|1|||
33396453|NCT04476108|101341826|FG000|Overall Study|Withdrawal by Subject|1|||
33396454|NCT04476108|101341827|FG001|Overall Study|Withdrawal by Subject|1|||
33396455|NCT02139280|101341828|FG000|Overall Study|No longer eligible|2|||
33396456|NCT02139280|101341829|FG001|Overall Study|No longer eligible|0|||
33396457|NCT00636506|101341830|FG000|Overall Study|Lost to Follow-up|8|||
33396458|NCT00636506|101341830|FG000|Overall Study|Explanted|1|||
33396459|NCT00636506|101341830|FG000|Overall Study|Withdrawal by Subject|6|||
33396460|NCT00636506|101341830|FG000|Overall Study|Procedure aborted|1|||
33396461|NCT01836549|101341831|FG000|Overall Study|Did not receive study drug|0|||
33504981|NCT02237196|101741427|FG002|Overall Study|Adverse Event|1|||
33504982|NCT02237196|101741428|FG003|Overall Study|Adverse Event|0|||
33504983|NCT02237196|101741425|FG000|Overall Study|Lost to Follow-up|4|||
33504984|NCT02237196|101741426|FG001|Overall Study|Lost to Follow-up|2|||
33504985|NCT02237196|101741427|FG002|Overall Study|Lost to Follow-up|4|||
33504986|NCT02237196|101741428|FG003|Overall Study|Lost to Follow-up|6|||
33504987|NCT02237196|101741425|FG000|Overall Study|Physician Decision|2|||
33504988|NCT02237196|101741426|FG001|Overall Study|Physician Decision|0|||
33504989|NCT02237196|101741427|FG002|Overall Study|Physician Decision|0|||
33504990|NCT02237196|101741428|FG003|Overall Study|Physician Decision|1|||
33603017|NCT01490294|102099158|FG000|Overall Study|Adverse Event|1|||
33396462|NCT01836549|101341832|FG001|Overall Study|Did not receive study drug|0|||
33396463|NCT01836549|101341833|FG002|Overall Study|Did not receive study drug|1|||
33396464|NCT01836549|101341834|FG003|Overall Study|Did not receive study drug|0|||
33396465|NCT01836549|101341835|FG004|Overall Study|Did not receive study drug|0|||
33504991|NCT02237196|101741425|FG000|Overall Study|Pregnancy|0|||
33504992|NCT02237196|101741426|FG001|Overall Study|Pregnancy|0|||
33504993|NCT02237196|101741427|FG002|Overall Study|Pregnancy|1|||
33504994|NCT02237196|101741428|FG003|Overall Study|Pregnancy|1|||
33504995|NCT02237196|101741425|FG000|Overall Study|Withdrawal by Subject|1|||
33504996|NCT02237196|101741426|FG001|Overall Study|Withdrawal by Subject|1|||
33504997|NCT02237196|101741427|FG002|Overall Study|Withdrawal by Subject|4|||
33504998|NCT02237196|101741428|FG003|Overall Study|Withdrawal by Subject|1|||
33504999|NCT02237196|101741425|FG000|Overall Study|Site Error|1|||
33396466|NCT01836549|101341836|FG005|Overall Study|Did not receive study drug|0|||
33396467|NCT01836549|101341837|FG006|Overall Study|Did not receive study drug|0|||
33396468|NCT01836549|101341831|FG000|Overall Study|Patient declared ineligible|0|||
33396469|NCT01836549|101341832|FG001|Overall Study|Patient declared ineligible|0|||
33603018|NCT01490294|102099159|FG001|Overall Study|Adverse Event|0|||
33603019|NCT01490294|102099160|FG002|Overall Study|Adverse Event|0|||
33603020|NCT01490294|102099161|FG003|Overall Study|Adverse Event|0|||
33194424|NCT04640311|100616414|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
33194425|NCT01302964|100616416|FG000|Overall Study|Adverse Event|1|||
33194426|NCT01302964|100616417|FG001|Overall Study|Adverse Event|0|||
33194427|NCT01649856|100616418|FG000|Overall Study|Withdrawal by Subject|14|||
33194428|NCT01649856|100616419|FG001|Overall Study|Withdrawal by Subject|14|||
33194429|NCT01649856|100616418|FG000|Overall Study|Protocol Violation|4|||
33194430|NCT01649856|100616419|FG001|Overall Study|Protocol Violation|4|||
33194431|NCT01649856|100616418|FG000|Overall Study|Treatment Failure|1|||
33194432|NCT01649856|100616419|FG001|Overall Study|Treatment Failure|1|||
33194433|NCT01649856|100616418|FG000|Overall Study|Death|69|||
33194434|NCT01649856|100616419|FG001|Overall Study|Death|34|||
33194435|NCT01649856|100616418|FG000|Overall Study|Stable or Progressed Disease|5|||
33194436|NCT01649856|100616419|FG001|Overall Study|Stable or Progressed Disease|3|||
33194437|NCT01649856|100616418|FG000|Overall Study|Lost to Follow-up|20|||
33194438|NCT01649856|100616419|FG001|Overall Study|Lost to Follow-up|16|||
33194439|NCT01649856|100616418|FG000|Overall Study|Lack of Compliance|6|||
33194440|NCT01649856|100616419|FG001|Overall Study|Lack of Compliance|1|||
33194441|NCT01649856|100616418|FG000|Overall Study|Other|20|||
33194442|NCT01649856|100616419|FG001|Overall Study|Other|5|||
33396470|NCT01836549|101341833|FG002|Overall Study|Patient declared ineligible|0|||
33396471|NCT01836549|101341834|FG003|Overall Study|Patient declared ineligible|1|||
33396472|NCT01836549|101341835|FG004|Overall Study|Patient declared ineligible|0|||
33396473|NCT01836549|101341836|FG005|Overall Study|Patient declared ineligible|0|||
33396474|NCT01836549|101341837|FG006|Overall Study|Patient declared ineligible|0|||
33505000|NCT02237196|101741426|FG001|Overall Study|Site Error|2|||
33505001|NCT02237196|101741427|FG002|Overall Study|Site Error|0|||
33505002|NCT02237196|101741428|FG003|Overall Study|Site Error|2|||
33505003|NCT02042950|101744545|FG000|Overall Study|Progressive Disease|4|||
33505004|NCT00892151|101744548|FG000|Overall Study|Protocol Violation|1|||
33505005|NCT04382755|101744549|FG000|Overall Study|Withdrawal by Subject|1|||
33505006|NCT04382755|101744550|FG001|Overall Study|Withdrawal by Subject|0|||
33505007|NCT04382755|101744549|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
33505008|NCT04382755|101744550|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
33505009|NCT04382755|101744549|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
33505010|NCT04382755|101744550|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
33505011|NCT00457002|101744551|FG000|Overall Study|Death|40|||
33505012|NCT00457002|101744552|FG001|Overall Study|Death|47|||
33505013|NCT00457002|101744551|FG000|Overall Study|Adverse Event|284|||
33505014|NCT00457002|101744552|FG001|Overall Study|Adverse Event|260|||
33505015|NCT00457002|101744551|FG000|Overall Study|Withdrawal by Subject|299|||
33505016|NCT00457002|101744552|FG001|Overall Study|Withdrawal by Subject|271|||
33505017|NCT00457002|101744551|FG000|Overall Study|Lost to Follow-up|72|||
33505018|NCT00457002|101744552|FG001|Overall Study|Lost to Follow-up|71|||
33505019|NCT00457002|101744551|FG000|Overall Study|Poor/Non-compliance|46|||
33505020|NCT00457002|101744552|FG001|Overall Study|Poor/Non-compliance|33|||
33505021|NCT00457002|101744551|FG000|Overall Study|No longer met criteria|41|||
33505022|NCT00457002|101744552|FG001|Overall Study|No longer met criteria|37|||
33505023|NCT00457002|101744551|FG000|Overall Study|Administrative reason by Sponsor|1|||
33505024|NCT00457002|101744552|FG001|Overall Study|Administrative reason by Sponsor|0|||
33505025|NCT00457002|101744551|FG000|Overall Study|non-specified|29|||
33505026|NCT00457002|101744552|FG001|Overall Study|non-specified|38|||
33396475|NCT01836549|101341831|FG000|Overall Study|Patient inevaluable to start therapy|0|||
33505027|NCT00457002|101744551|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
33505028|NCT00457002|101744552|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
33505029|NCT01289639|101744559|FG000|Overall Study|Lost to Follow-up|1|||
33505030|NCT01289639|101744560|FG001|Overall Study|Lost to Follow-up|0|||
33603021|NCT02976103|102099166|FG000|Overall Study|Withdrawal by Subject|1|||
33194443|NCT00559962|100616421|FG000|Overall Study|Adverse Event|1|||
33194444|NCT00559962|100616422|FG001|Overall Study|Adverse Event|7|||
33194445|NCT00559962|100616423|FG002|Overall Study|Adverse Event|8|||
33194446|NCT00559962|100616424|FG003|Overall Study|Adverse Event|5|||
33396476|NCT01836549|101341832|FG001|Overall Study|Patient inevaluable to start therapy|0|||
33505031|NCT01289639|101744561|FG002|Overall Study|Lost to Follow-up|0|||
33505032|NCT01842633|101744564|FG000|Overall Study|Screen Failure|1|||
33505033|NCT01842633|101744565|FG001|Overall Study|Screen Failure|0|||
33505034|NCT01842633|101744566|FG002|Overall Study|Screen Failure|0|||
33505035|NCT01842633|101744564|FG000|Overall Study|Adverse Event|1|||
33505036|NCT01842633|101744565|FG001|Overall Study|Adverse Event|1|||
33505037|NCT01842633|101744566|FG002|Overall Study|Adverse Event|0|||
33505038|NCT01842633|101744564|FG000|Overall Study|Withdrawal by Subject|0|||
33505039|NCT01842633|101744565|FG001|Overall Study|Withdrawal by Subject|1|||
33505040|NCT01842633|101744566|FG002|Overall Study|Withdrawal by Subject|0|||
33505041|NCT01842633|101744564|FG000|Overall Study|Technical issues|1|||
33505042|NCT01842633|101744565|FG001|Overall Study|Technical issues|0|||
33505043|NCT01842633|101744566|FG002|Overall Study|Technical issues|0|||
33505044|NCT00813813|101744567|FG000|Overall Study|Withdrawal by Subject|1|||
33505045|NCT00813813|101744568|FG001|Overall Study|Withdrawal by Subject|1|||
33505046|NCT00813813|101744567|FG000|Overall Study|Lost to Follow-up|2|||
33505047|NCT00813813|101744568|FG001|Overall Study|Lost to Follow-up|7|||
33505048|NCT00813813|101744567|FG000|Overall Study|Other|0|||
33505049|NCT00813813|101744568|FG001|Overall Study|Other|1|||
33505050|NCT01077154|101744569|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
33505051|NCT01077154|101744570|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
33505052|NCT01077154|101744569|FG000|Overall Study|Withdrawal by Subject|369|||
33505053|NCT01077154|101744570|FG001|Overall Study|Withdrawal by Subject|385|||
33505054|NCT01077154|101744569|FG000|Overall Study|Death|215|||
33505055|NCT01077154|101744570|FG001|Overall Study|Death|214|||
33505056|NCT01077154|101744569|FG000|Overall Study|Lost to Follow-up|43|||
33505057|NCT01077154|101744570|FG001|Overall Study|Lost to Follow-up|35|||
33505058|NCT01077154|101744569|FG000|Overall Study|Noncompliance|22|||
33505059|NCT01077154|101744570|FG001|Overall Study|Noncompliance|20|||
33505060|NCT01077154|101744569|FG000|Overall Study|Disease Progression|18|||
33505061|NCT01077154|101744570|FG001|Overall Study|Disease Progression|20|||
33505062|NCT01077154|101744569|FG000|Overall Study|Ineligibility Determined|10|||
33505063|NCT01077154|101744570|FG001|Overall Study|Ineligibility Determined|14|||
33505064|NCT01077154|101744569|FG000|Overall Study|Other|14|||
33505065|NCT01077154|101744570|FG001|Overall Study|Other|11|||
33505066|NCT01077154|101744569|FG000|Overall Study|Adverse Event|9|||
33505067|NCT01077154|101744570|FG001|Overall Study|Adverse Event|9|||
33505068|NCT01077154|101744569|FG000|Overall Study|Administrative Decision|1|||
33505069|NCT01077154|101744570|FG001|Overall Study|Administrative Decision|6|||
33505070|NCT01077154|101744569|FG000|Overall Study|Protocol Deviation|1|||
33505071|NCT01077154|101744570|FG001|Overall Study|Protocol Deviation|0|||
33505072|NCT00529308|101744573|FG000|Overall Study|Withdrawal by Subject|1|||
33505073|NCT00529308|101744574|FG001|Overall Study|Withdrawal by Subject|1|||
33505074|NCT01263782|101744580|FG000|Overall Study|Death|0|||
33505075|NCT01263782|101744581|FG001|Overall Study|Death|0|||
33194447|NCT00559962|100616425|FG004|Overall Study|Adverse Event|11|||
33194448|NCT00559962|100616426|FG005|Overall Study|Adverse Event|4|||
33194449|NCT00559962|100616427|FG006|Overall Study|Adverse Event|4|||
33194450|NCT00559962|100616428|FG007|Overall Study|Adverse Event|2|||
33194451|NCT00559962|100616421|FG000|Overall Study|Lost to Follow-up|0|||
33314269|NCT01966471|101044438|FG000|Overall Study|Lost to Follow-up|46|||
33314270|NCT01966471|101044439|FG001|Overall Study|Lost to Follow-up|39|||
33314271|NCT01966471|101044438|FG000|Overall Study|Various reasons|4|||
33314272|NCT01966471|101044439|FG001|Overall Study|Various reasons|4|||
33314273|NCT01966471|101044438|FG000|Overall Study|Physician Decision|7|||
33314274|NCT01966471|101044439|FG001|Overall Study|Physician Decision|5|||
33314275|NCT01966471|101044438|FG000|Overall Study|Study Terminated By Sponsor|758|||
33314276|NCT01966471|101044439|FG001|Overall Study|Study Terminated By Sponsor|773|||
33314277|NCT01966471|101044438|FG000|Overall Study|Withdrawal by Subject|59|||
33314278|NCT01966471|101044439|FG001|Overall Study|Withdrawal by Subject|51|||
33314279|NCT01442779|101044440|FG000|Overall Study|Withdrawal by Subject|3|||
33314280|NCT01442779|101044440|FG000|Overall Study|Death|3|||
33314281|NCT01442779|101044440|FG000|Overall Study|Non-compliance|1|||
33314282|NCT01145755|101044443|FG000|Overall Study|Adverse Event|2|||
33314283|NCT01145755|101044444|FG001|Overall Study|Adverse Event|4|||
33314284|NCT01145755|101044445|FG002|Overall Study|Adverse Event|2|||
33603022|NCT02976103|102099167|FG001|Overall Study|Withdrawal by Subject|0|||
33194452|NCT00559962|100616422|FG001|Overall Study|Lost to Follow-up|1|||
33314285|NCT01145755|101044443|FG000|Overall Study|Withdrawal by Subject|2|||
33314286|NCT01145755|101044444|FG001|Overall Study|Withdrawal by Subject|2|||
33314287|NCT01145755|101044445|FG002|Overall Study|Withdrawal by Subject|2|||
33505076|NCT01263782|101744582|FG002|Overall Study|Death|1|||
33505077|NCT01263782|101744583|FG003|Overall Study|Death|0|||
33314288|NCT01145755|101044443|FG000|Overall Study|Lost to Follow-up|2|||
33505078|NCT01263782|101744580|FG000|Overall Study|Progressive disease|0|||
33505079|NCT01263782|101744581|FG001|Overall Study|Progressive disease|0|||
33194453|NCT00559962|100616423|FG002|Overall Study|Lost to Follow-up|0|||
33314289|NCT01145755|101044444|FG001|Overall Study|Lost to Follow-up|3|||
33505080|NCT01263782|101744582|FG002|Overall Study|Progressive disease|0|||
33505081|NCT01263782|101744583|FG003|Overall Study|Progressive disease|1|||
33194454|NCT00559962|100616424|FG003|Overall Study|Lost to Follow-up|0|||
33194455|NCT00559962|100616425|FG004|Overall Study|Lost to Follow-up|0|||
33194456|NCT00559962|100616426|FG005|Overall Study|Lost to Follow-up|0|||
33194457|NCT00559962|100616427|FG006|Overall Study|Lost to Follow-up|0|||
33194458|NCT00559962|100616428|FG007|Overall Study|Lost to Follow-up|0|||
33194459|NCT00559962|100616421|FG000|Overall Study|Withdrawal by Subject|1|||
33194460|NCT00559962|100616422|FG001|Overall Study|Withdrawal by Subject|1|||
33194461|NCT00559962|100616423|FG002|Overall Study|Withdrawal by Subject|2|||
33194462|NCT00559962|100616424|FG003|Overall Study|Withdrawal by Subject|0|||
33194463|NCT00559962|100616425|FG004|Overall Study|Withdrawal by Subject|3|||
33194464|NCT00559962|100616426|FG005|Overall Study|Withdrawal by Subject|1|||
33194465|NCT00559962|100616427|FG006|Overall Study|Withdrawal by Subject|0|||
33194466|NCT00559962|100616428|FG007|Overall Study|Withdrawal by Subject|2|||
33194467|NCT00559962|100616421|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
33194468|NCT00559962|100616422|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
33194469|NCT00559962|100616423|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
33194470|NCT00559962|100616424|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
33194471|NCT00559962|100616425|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
33194472|NCT00559962|100616426|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
33194473|NCT00559962|100616427|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
33194474|NCT00559962|100616428|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
33194475|NCT01110915|100616430|FG000|Overall Study|Death|2|||
33194476|NCT01110915|100616431|FG001|Overall Study|Death|1|||
33194477|NCT01110915|100616430|FG000|Overall Study|Lost to Follow-up|1|||
33194478|NCT01110915|100616431|FG001|Overall Study|Lost to Follow-up|0|||
33194479|NCT01110915|100616430|FG000|Overall Study|Withdrawal by Subject|7|||
33194480|NCT01110915|100616431|FG001|Overall Study|Withdrawal by Subject|1|||
33194481|NCT00667342|100616432|FG000|Overall Study|Protocol Violation|1|||
33194482|NCT00667342|100616433|FG001|Overall Study|Protocol Violation|0|||
33194483|NCT00667342|100616434|FG002|Overall Study|Protocol Violation|0|||
33194484|NCT00667342|100616432|FG000|Overall Study|Withdrawal by Subject|1|||
33194485|NCT00667342|100616433|FG001|Overall Study|Withdrawal by Subject|0|||
33194486|NCT00667342|100616434|FG002|Overall Study|Withdrawal by Subject|0|||
33194487|NCT00667342|100616432|FG000|Overall Study|Physician Decision|3|||
33194488|NCT00667342|100616433|FG001|Overall Study|Physician Decision|0|||
33194489|NCT00667342|100616434|FG002|Overall Study|Physician Decision|0|||
33194490|NCT00667342|100616432|FG000|Overall Study|Relapse or tumor progression|9|||
33194491|NCT00667342|100616433|FG001|Overall Study|Relapse or tumor progression|0|||
33194492|NCT00667342|100616434|FG002|Overall Study|Relapse or tumor progression|7|||
33194493|NCT00667342|100616432|FG000|Overall Study|Adverse Event|0|||
33194494|NCT00667342|100616433|FG001|Overall Study|Adverse Event|0|||
33194495|NCT00667342|100616434|FG002|Overall Study|Adverse Event|1|||
33194496|NCT00667342|100616432|FG000|Overall Study|Ineligible|0|||
33194497|NCT00667342|100616433|FG001|Overall Study|Ineligible|0|||
33194498|NCT00667342|100616434|FG002|Overall Study|Ineligible|1|||
33194499|NCT00796861|100616435|FG000|Overall Study|Withdrawal by Subject|2|||
33194500|NCT00796861|100616435|FG000|Overall Study|Death|2|||
33194501|NCT00691210|100616442|FG000|Overall Study|Progression of Disease|0|||
33194502|NCT00691210|100616443|FG001|Overall Study|Progression of Disease|0|||
33505082|NCT01263782|101744580|FG000|Overall Study|Too early|0|||
33505083|NCT01263782|101744581|FG001|Overall Study|Too early|0|||
33505084|NCT01263782|101744582|FG002|Overall Study|Too early|1|||
33505085|NCT01263782|101744583|FG003|Overall Study|Too early|0|||
33505086|NCT01263782|101744580|FG000|Overall Study|Inevaluable|0|||
33505087|NCT01263782|101744581|FG001|Overall Study|Inevaluable|0|||
33505088|NCT01263782|101744582|FG002|Overall Study|Inevaluable|1|||
33505089|NCT01263782|101744583|FG003|Overall Study|Inevaluable|0|||
33505090|NCT03670836|101744584|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
33505091|NCT03670836|101744585|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
33505092|NCT03670836|101744584|FG000|Per Protocol Population (PP)|Physician Decision|9|||
33505093|NCT03670836|101744585|FG001|Per Protocol Population (PP)|Physician Decision|10|||
33505094|NCT03670836|101744584|FG000|Per Protocol Population (PP)|Physician Decision|4|||
33505095|NCT03670836|101744585|FG001|Per Protocol Population (PP)|Physician Decision|6|||
33505096|NCT03670836|101744584|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
33505097|NCT03670836|101744585|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
33194503|NCT00691210|100616444|FG002|Overall Study|Progression of Disease|0|||
33194504|NCT00691210|100616445|FG003|Overall Study|Progression of Disease|2|||
33194505|NCT00691210|100616446|FG004|Overall Study|Progression of Disease|0|||
33194506|NCT00691210|100616447|FG005|Overall Study|Progression of Disease|0|||
33194507|NCT00691210|100616448|FG006|Overall Study|Progression of Disease|0|||
33194508|NCT00691210|100616449|FG007|Overall Study|Progression of Disease|0|||
33194509|NCT00691210|100616442|FG000|Overall Study|Lack of Efficacy|0|||
33194510|NCT00691210|100616443|FG001|Overall Study|Lack of Efficacy|0|||
33194511|NCT00691210|100616444|FG002|Overall Study|Lack of Efficacy|0|||
33194512|NCT00691210|100616445|FG003|Overall Study|Lack of Efficacy|1|||
33194513|NCT00691210|100616446|FG004|Overall Study|Lack of Efficacy|0|||
33194514|NCT00691210|100616447|FG005|Overall Study|Lack of Efficacy|1|||
33194515|NCT00691210|100616448|FG006|Overall Study|Lack of Efficacy|0|||
33194516|NCT00691210|100616449|FG007|Overall Study|Lack of Efficacy|0|||
33194517|NCT03135522|100616450|FG000|Overall Study|Adverse Event|1|||
33194518|NCT03135522|100616451|FG001|Overall Study|Adverse Event|0|||
33194519|NCT02247349|100616452|FG000|Overall Study|Disease Progression|7|||
33194520|NCT02247349|100616453|FG001|Overall Study|Disease Progression|4|||
33194521|NCT02247349|100616454|FG002|Overall Study|Disease Progression|26|||
33194522|NCT02247349|100616455|FG003|Overall Study|Disease Progression|31|||
33194523|NCT02247349|100616456|FG004|Overall Study|Disease Progression|16|||
33194524|NCT02247349|100616457|FG005|Overall Study|Disease Progression|6|||
33194525|NCT02247349|100616452|FG000|Overall Study|Study drug toxicity|0|||
33505098|NCT01960907|101744586|FG000|Overall Study|Death|4|||
33505099|NCT01960907|101744587|FG001|Overall Study|Death|3|||
33194526|NCT02247349|100616453|FG001|Overall Study|Study drug toxicity|1|||
33194527|NCT02247349|100616454|FG002|Overall Study|Study drug toxicity|1|||
33194528|NCT02247349|100616455|FG003|Overall Study|Study drug toxicity|1|||
33194529|NCT02247349|100616456|FG004|Overall Study|Study drug toxicity|2|||
33194530|NCT02247349|100616457|FG005|Overall Study|Study drug toxicity|2|||
33194531|NCT02247349|100616452|FG000|Overall Study|Death|0|||
33194532|NCT02247349|100616453|FG001|Overall Study|Death|0|||
33194533|NCT02247349|100616454|FG002|Overall Study|Death|0|||
33194534|NCT02247349|100616455|FG003|Overall Study|Death|1|||
33194535|NCT02247349|100616456|FG004|Overall Study|Death|0|||
33194536|NCT02247349|100616457|FG005|Overall Study|Death|0|||
33194537|NCT02247349|100616452|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
33194538|NCT02247349|100616453|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
33194539|NCT02247349|100616454|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
33194540|NCT02247349|100616455|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
33194541|NCT02247349|100616456|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
33194542|NCT02247349|100616457|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
33194543|NCT02247349|100616452|FG000|Overall Study|Participant request to discontinue study treatment|0|||
33194544|NCT02247349|100616453|FG001|Overall Study|Participant request to discontinue study treatment|0|||
33194545|NCT02247349|100616454|FG002|Overall Study|Participant request to discontinue study treatment|1|||
33194546|NCT02247349|100616455|FG003|Overall Study|Participant request to discontinue study treatment|2|||
33194547|NCT02247349|100616456|FG004|Overall Study|Participant request to discontinue study treatment|1|||
33194548|NCT02247349|100616457|FG005|Overall Study|Participant request to discontinue study treatment|0|||
33194549|NCT02247349|100616452|FG000|Overall Study|Withdrawal by Subject|0|||
33194550|NCT02247349|100616453|FG001|Overall Study|Withdrawal by Subject|1|||
33194551|NCT02247349|100616454|FG002|Overall Study|Withdrawal by Subject|0|||
33194552|NCT02247349|100616455|FG003|Overall Study|Withdrawal by Subject|0|||
33194553|NCT02247349|100616456|FG004|Overall Study|Withdrawal by Subject|0|||
33194554|NCT02247349|100616457|FG005|Overall Study|Withdrawal by Subject|0|||
33194555|NCT02247349|100616452|FG000|Overall Study|Administrative reason by sponsor|0|||
33314290|NCT01145755|101044445|FG002|Overall Study|Lost to Follow-up|1|||
33314291|NCT01145755|101044443|FG000|Overall Study|Protocol Violation|0|||
33314292|NCT01145755|101044444|FG001|Overall Study|Protocol Violation|3|||
33314293|NCT01145755|101044445|FG002|Overall Study|Protocol Violation|1|||
33314294|NCT01145755|101044443|FG000|Overall Study|Study Closure|14|||
33314295|NCT01145755|101044444|FG001|Overall Study|Study Closure|14|||
33314296|NCT01145755|101044445|FG002|Overall Study|Study Closure|17|||
33314297|NCT01145755|101044443|FG000|Overall Study|Lack of Efficacy|0|||
33314298|NCT01145755|101044444|FG001|Overall Study|Lack of Efficacy|1|||
33314299|NCT01145755|101044445|FG002|Overall Study|Lack of Efficacy|0|||
33314300|NCT01145755|101044443|FG000|Overall Study|Patient could not swollow medication|0|||
33314301|NCT01145755|101044444|FG001|Overall Study|Patient could not swollow medication|0|||
33505100|NCT01960907|101744586|FG000|Overall Study|Withdrawal by Subject|32|||
33505101|NCT01960907|101744587|FG001|Overall Study|Withdrawal by Subject|42|||
33194556|NCT02247349|100616453|FG001|Overall Study|Administrative reason by sponsor|0|||
33194557|NCT02247349|100616454|FG002|Overall Study|Administrative reason by sponsor|0|||
33194558|NCT02247349|100616455|FG003|Overall Study|Administrative reason by sponsor|0|||
33194559|NCT02247349|100616456|FG004|Overall Study|Administrative reason by sponsor|1|||
33314302|NCT01145755|101044445|FG002|Overall Study|Patient could not swollow medication|1|||
33314303|NCT01145755|101044443|FG000|Overall Study|Withdrawal by Subject|0|||
33314304|NCT01145755|101044444|FG001|Overall Study|Withdrawal by Subject|0|||
33314305|NCT01145755|101044445|FG002|Overall Study|Withdrawal by Subject|1|||
33194560|NCT02247349|100616457|FG005|Overall Study|Administrative reason by sponsor|0|||
33194561|NCT02247349|100616452|FG000|Overall Study|Other reasons|0|||
33194562|NCT02247349|100616453|FG001|Overall Study|Other reasons|0|||
33314306|NCT01145755|101044443|FG000|Overall Study|Positive urine ethanol|0|||
33314307|NCT01145755|101044444|FG001|Overall Study|Positive urine ethanol|1|||
33505102|NCT01515865|101744602|FG000|Part A (Open-label)|Other|3|||
33194563|NCT02247349|100616454|FG002|Overall Study|Other reasons|1|||
33314308|NCT01145755|101044445|FG002|Overall Study|Positive urine ethanol|0|||
33314309|NCT03426267|101044446|FG000|Overall Study|Physician Decision|1|||
33505103|NCT01515865|101744603|FG001|Part A (Open-label)|Other|0|||
33603023|NCT02976103|102099166|FG000|Overall Study|Lost to Follow-up|12|||
33603024|NCT02976103|102099167|FG001|Overall Study|Lost to Follow-up|8|||
33603025|NCT00581360|102099168|FG000|Overall Study|Withdrawal by Subject|1|||
33603026|NCT02066415|102099171|FG000|Overall Study|Decision by Sponsor|5|||
33603027|NCT02066415|102099172|FG001|Overall Study|Decision by Sponsor|4|||
33603028|NCT02066415|102099173|FG002|Overall Study|Decision by Sponsor|2|||
33603029|NCT02066415|102099171|FG000|Overall Study|Withdrawal by Subject|9|||
33603030|NCT02066415|102099172|FG001|Overall Study|Withdrawal by Subject|1|||
33603031|NCT02066415|102099173|FG002|Overall Study|Withdrawal by Subject|4|||
33603032|NCT02066415|102099171|FG000|Overall Study|Lost to Follow-up|7|||
33603033|NCT02066415|102099172|FG001|Overall Study|Lost to Follow-up|2|||
33603034|NCT02066415|102099173|FG002|Overall Study|Lost to Follow-up|2|||
33603035|NCT01685983|102099174|FG000|Overall Study|Adverse Event|7|||
33603036|NCT01685983|102099174|FG000|Overall Study|Death|1|||
33603037|NCT01685983|102099174|FG000|Overall Study|Withdrawal by Subject|19|||
33314310|NCT03426267|101044447|FG001|Overall Study|Physician Decision|4|||
33314311|NCT03426267|101044446|FG000|Overall Study|Lost to Follow-up|1|||
33314312|NCT03426267|101044447|FG001|Overall Study|Lost to Follow-up|0|||
33314313|NCT03426267|101044446|FG000|Overall Study|Withdrawal by Subject|4|||
33314314|NCT03426267|101044447|FG001|Overall Study|Withdrawal by Subject|10|||
33314315|NCT03426267|101044446|FG000|Overall Study|Protocol Violation|1|||
33314316|NCT03426267|101044447|FG001|Overall Study|Protocol Violation|3|||
33314317|NCT03426267|101044446|FG000|Overall Study|Adverse Event|9|||
33505104|NCT01515865|101744604|FG002|Part A (Open-label)|Other|0|||
33505105|NCT01515865|101744602|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
33505106|NCT01515865|101744603|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
33505107|NCT01515865|101744604|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
33505108|NCT01515865|101744602|FG000|Part B (Open-label)|Other|1|||
33505109|NCT01515865|101744603|FG001|Part B (Open-label)|Other|0|||
33505110|NCT01515865|101744604|FG002|Part B (Open-label)|Other|0|||
33505111|NCT01397825|101744605|FG000|Overall Study|Progressive Disease|10|||
33505112|NCT01397825|101744606|FG001|Overall Study|Progressive Disease|3|||
33505113|NCT01397825|101744607|FG002|Overall Study|Progressive Disease|11|||
33505114|NCT01397825|101744608|FG003|Overall Study|Progressive Disease|1|||
33505115|NCT01397825|101744609|FG004|Overall Study|Progressive Disease|0|||
33505116|NCT01397825|101744605|FG000|Overall Study|Symptomatic Deterioration|2|||
33505117|NCT01397825|101744606|FG001|Overall Study|Symptomatic Deterioration|0|||
33505118|NCT01397825|101744607|FG002|Overall Study|Symptomatic Deterioration|4|||
33505119|NCT01397825|101744608|FG003|Overall Study|Symptomatic Deterioration|0|||
33505120|NCT01397825|101744609|FG004|Overall Study|Symptomatic Deterioration|0|||
33505121|NCT01397825|101744605|FG000|Overall Study|Adverse Event|0|||
33505122|NCT01397825|101744606|FG001|Overall Study|Adverse Event|1|||
33505123|NCT01397825|101744607|FG002|Overall Study|Adverse Event|5|||
33505124|NCT01397825|101744608|FG003|Overall Study|Adverse Event|1|||
33505125|NCT01397825|101744609|FG004|Overall Study|Adverse Event|0|||
33505126|NCT01397825|101744605|FG000|Overall Study|Withdrawal by Subject|1|||
33505127|NCT01397825|101744606|FG001|Overall Study|Withdrawal by Subject|0|||
33505128|NCT01397825|101744607|FG002|Overall Study|Withdrawal by Subject|5|||
33505129|NCT01397825|101744608|FG003|Overall Study|Withdrawal by Subject|1|||
33505130|NCT01397825|101744609|FG004|Overall Study|Withdrawal by Subject|0|||
33505131|NCT00125242|101744610|FG000|Overall Study|did not qualify|7|||
33505132|NCT00125242|101744611|FG001|Overall Study|did not qualify|2|||
33505133|NCT02693002|101744613|FG000|Overall Study|Withdrawal by Subject|1|||
33505134|NCT02693002|101744614|FG001|Overall Study|Withdrawal by Subject|0|||
33505135|NCT02016105|101744619|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
33505136|NCT02016105|101744620|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
33505137|NCT02016105|101744621|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
33505138|NCT02016105|101744622|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
33603038|NCT01685983|102099174|FG000|Overall Study|Protocol Violation|2|||
33603039|NCT01685983|102099174|FG000|Overall Study|Physician Decision|13|||
33603040|NCT01685983|102099174|FG000|Overall Study|Other|7|||
33603041|NCT01685983|102099174|FG000|Overall Study|Progressive Disease|32|||
33603042|NCT01685983|102099174|FG000|Overall Study|Noncompliance with Study Drug|1|||
33314318|NCT03426267|101044447|FG001|Overall Study|Adverse Event|27|||
33603043|NCT00459537|102099178|FG000|Overall Study|Adverse Event|1|||
33314319|NCT03426267|101044446|FG000|Overall Study|Prohibited Treatment Intake|2|||
33314320|NCT03426267|101044447|FG001|Overall Study|Prohibited Treatment Intake|3|||
33505139|NCT02016105|101744623|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
33505140|NCT02016105|101744624|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
33505141|NCT02016105|101744619|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
33505142|NCT02016105|101744620|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
33505143|NCT02016105|101744621|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
33505144|NCT02016105|101744622|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
33505145|NCT02016105|101744623|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
33505146|NCT02016105|101744624|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
33603044|NCT00459537|102099179|FG001|Overall Study|Adverse Event|6|||
33603045|NCT00459537|102099178|FG000|Overall Study|Lack of Efficacy|10|||
33603046|NCT00459537|102099179|FG001|Overall Study|Lack of Efficacy|11|||
33603047|NCT00459537|102099178|FG000|Overall Study|Withdrawal by Subject|20|||
33314321|NCT03426267|101044446|FG000|Overall Study|Lack of Efficacy|0|||
33314322|NCT03426267|101044447|FG001|Overall Study|Lack of Efficacy|25|||
33314323|NCT03426267|101044446|FG000|Overall Study|other|3|||
33314324|NCT03426267|101044447|FG001|Overall Study|other|0|||
33603048|NCT00459537|102099179|FG001|Overall Study|Withdrawal by Subject|26|||
33603049|NCT00459537|102099178|FG000|Overall Study|Lost to Follow-up|27|||
33603050|NCT00459537|102099179|FG001|Overall Study|Lost to Follow-up|30|||
33603051|NCT00459537|102099178|FG000|Overall Study|Administrative problems|3|||
33603052|NCT00459537|102099179|FG001|Overall Study|Administrative problems|0|||
33603053|NCT00459537|102099178|FG000|Overall Study|Protocol Violation|4|||
33314325|NCT01249274|101044448|FG000|Overall Study|Lost to Follow-up|3|||
33314326|NCT01249274|101044449|FG001|Overall Study|Lost to Follow-up|4|||
33314327|NCT01249274|101044448|FG000|Overall Study|Received inpatient substance treatment|1|||
33314328|NCT01249274|101044449|FG001|Overall Study|Received inpatient substance treatment|2|||
33314329|NCT01498679|101044450|FG000|Overall Study|Adverse Event|1|||
33314330|NCT01498679|101044451|FG001|Overall Study|Adverse Event|4|||
33314331|NCT01498679|101044450|FG000|Overall Study|Lack of Efficacy|72|||
33314332|NCT01498679|101044451|FG001|Overall Study|Lack of Efficacy|12|||
33314333|NCT01498679|101044450|FG000|Overall Study|Protocol Violation|4|||
33314334|NCT01498679|101044451|FG001|Overall Study|Protocol Violation|0|||
33314335|NCT01498679|101044450|FG000|Overall Study|Physician Decision|0|||
33314336|NCT01498679|101044451|FG001|Overall Study|Physician Decision|2|||
33314337|NCT01498679|101044450|FG000|Overall Study|Withdrawal by Subject|12|||
33314338|NCT01498679|101044451|FG001|Overall Study|Withdrawal by Subject|4|||
33314339|NCT00690443|101044452|FG000|Overall Study|Adverse Event|1|||
33314340|NCT00690443|101044453|FG001|Overall Study|Adverse Event|2|||
33314341|NCT02054520|101044454|FG000|Overall Study|Adverse Event|1|||
33314342|NCT02054520|101044455|FG001|Overall Study|Adverse Event|4|||
33314343|NCT02054520|101044456|FG002|Overall Study|Adverse Event|2|||
33314344|NCT02054520|101044457|FG003|Overall Study|Adverse Event|1|||
33314345|NCT02054520|101044458|FG004|Overall Study|Adverse Event|1|||
33314346|NCT02054520|101044459|FG005|Overall Study|Adverse Event|0|||
33314347|NCT02054520|101044454|FG000|Overall Study|Lack of Efficacy|7|||
33314348|NCT02054520|101044455|FG001|Overall Study|Lack of Efficacy|0|||
33314349|NCT02054520|101044456|FG002|Overall Study|Lack of Efficacy|2|||
33314350|NCT02054520|101044457|FG003|Overall Study|Lack of Efficacy|1|||
33314351|NCT02054520|101044458|FG004|Overall Study|Lack of Efficacy|3|||
33314352|NCT02054520|101044459|FG005|Overall Study|Lack of Efficacy|2|||
33314353|NCT02054520|101044454|FG000|Overall Study|Withdrawal by Subject|1|||
33314354|NCT02054520|101044455|FG001|Overall Study|Withdrawal by Subject|0|||
33314355|NCT02054520|101044456|FG002|Overall Study|Withdrawal by Subject|0|||
33314356|NCT02054520|101044457|FG003|Overall Study|Withdrawal by Subject|2|||
33314357|NCT02054520|101044458|FG004|Overall Study|Withdrawal by Subject|1|||
33314358|NCT02054520|101044459|FG005|Overall Study|Withdrawal by Subject|0|||
33314359|NCT02054520|101044454|FG000|Overall Study|Physician Decision|0|||
33314360|NCT02054520|101044455|FG001|Overall Study|Physician Decision|1|||
33314361|NCT02054520|101044456|FG002|Overall Study|Physician Decision|0|||
33396477|NCT01836549|101341833|FG002|Overall Study|Patient inevaluable to start therapy|0|||
33396478|NCT01836549|101341834|FG003|Overall Study|Patient inevaluable to start therapy|0|||
33396479|NCT01836549|101341835|FG004|Overall Study|Patient inevaluable to start therapy|0|||
33396480|NCT01836549|101341836|FG005|Overall Study|Patient inevaluable to start therapy|0|||
33396481|NCT01836549|101341837|FG006|Overall Study|Patient inevaluable to start therapy|1|||
33396482|NCT02573012|101341838|FG000|Overall Study|Adverse Event|5|||
33396483|NCT02573012|101341839|FG001|Overall Study|Adverse Event|5|||
33396484|NCT02573012|101341838|FG000|Overall Study|Lack of Efficacy|5|||
33396485|NCT02573012|101341839|FG001|Overall Study|Lack of Efficacy|4|||
33396486|NCT02573012|101341838|FG000|Overall Study|Non-compliance|1|||
33396487|NCT02573012|101341839|FG001|Overall Study|Non-compliance|2|||
33396488|NCT02573012|101341838|FG000|Overall Study|Withdrawal by Subject|2|||
33396489|NCT02573012|101341839|FG001|Overall Study|Withdrawal by Subject|2|||
33603054|NCT00459537|102099179|FG001|Overall Study|Protocol Violation|3|||
33603055|NCT00459537|102099178|FG000|Overall Study|Missing|1|||
33603056|NCT00459537|102099179|FG001|Overall Study|Missing|0|||
33603057|NCT03263780|102099180|FG000|Overall Study|Withdrawal by Subject|3|||
33314362|NCT02054520|101044457|FG003|Overall Study|Physician Decision|1|||
33314363|NCT02054520|101044458|FG004|Overall Study|Physician Decision|0|||
33314364|NCT02054520|101044459|FG005|Overall Study|Physician Decision|1|||
33314365|NCT02054520|101044454|FG000|Overall Study|Study terminated by Sponsor|0|||
33314366|NCT02054520|101044455|FG001|Overall Study|Study terminated by Sponsor|0|||
33314367|NCT02054520|101044456|FG002|Overall Study|Study terminated by Sponsor|2|||
33314368|NCT02054520|101044457|FG003|Overall Study|Study terminated by Sponsor|1|||
33314369|NCT02054520|101044458|FG004|Overall Study|Study terminated by Sponsor|0|||
33314370|NCT02054520|101044459|FG005|Overall Study|Study terminated by Sponsor|0|||
33396490|NCT02573012|101341838|FG000|Overall Study|Study Ended per Protocol|1|||
33314371|NCT01313117|101044460|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
33417165|NCT00038467|101420220|FG001|Overall Study|Lost to Follow-up|10|||
33603058|NCT03263780|102099180|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
33396491|NCT02573012|101341839|FG001|Overall Study|Study Ended per Protocol|0|||
33396492|NCT02573012|101341838|FG000|Overall Study|Physician Decision|1|||
33396493|NCT02573012|101341839|FG001|Overall Study|Physician Decision|2|||
33396494|NCT04043416|101341840|FG000|Washout|Change in health condition|0|||
33396495|NCT04043416|101341841|FG001|Washout|Change in health condition|1|||
33396496|NCT01362049|101341842|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
33396497|NCT01362049|101341843|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
33396498|NCT01362049|101341844|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
33505147|NCT02016105|101744619|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
33505148|NCT02016105|101744620|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
33505149|NCT02016105|101744621|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
33505150|NCT02016105|101744622|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
33505151|NCT02016105|101744623|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
33505152|NCT02016105|101744624|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
33505153|NCT02016105|101744619|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
33505154|NCT02016105|101744620|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
33505155|NCT02016105|101744621|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
33603059|NCT02528357|102099182|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603060|NCT02528357|102099183|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
33603061|NCT02528357|102099184|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603062|NCT02528357|102099185|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603063|NCT02528357|102099186|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603064|NCT02528357|102099187|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603065|NCT02528357|102099188|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603066|NCT02528357|102099189|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603067|NCT02528357|102099190|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603068|NCT02528357|102099191|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603069|NCT02528357|102099192|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603070|NCT02528357|102099193|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603071|NCT02528357|102099194|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603072|NCT02528357|102099195|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603073|NCT02528357|102099196|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603074|NCT02528357|102099197|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603075|NCT02528357|102099198|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603076|NCT02528357|102099199|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603077|NCT02528357|102099200|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
33603078|NCT02528357|102099182|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33603079|NCT02528357|102099183|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33603080|NCT02528357|102099184|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33603081|NCT02528357|102099185|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
33603082|NCT02528357|102099186|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33194564|NCT02247349|100616455|FG003|Overall Study|Other reasons|0|||
33314372|NCT01313117|101044460|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
33314373|NCT01190514|101044461|FG000|First Intervention (Period 1)|Adverse Event|1|||
33314374|NCT01190514|101044462|FG001|First Intervention (Period 1)|Adverse Event|0|||
33314375|NCT01190514|101044463|FG002|First Intervention (Period 1)|Adverse Event|0|||
33314376|NCT01190514|101044464|FG003|First Intervention (Period 1)|Adverse Event|0|||
33314377|NCT01190514|101044461|FG000|Third Intervention (Period 3)|Adverse Event|1|||
33314378|NCT01190514|101044462|FG001|Third Intervention (Period 3)|Adverse Event|0|||
33314379|NCT01190514|101044463|FG002|Third Intervention (Period 3)|Adverse Event|0|||
33314380|NCT01190514|101044464|FG003|Third Intervention (Period 3)|Adverse Event|0|||
33314381|NCT00448123|101044465|FG000|Overall Study|Lost to Follow-up|9|||
33314382|NCT00448123|101044466|FG001|Overall Study|Lost to Follow-up|6|||
33314383|NCT00448123|101044465|FG000|Overall Study|Physician Decision|6|||
33314384|NCT00448123|101044466|FG001|Overall Study|Physician Decision|6|||
33314385|NCT00690820|101044467|FG000|Period 1|Withdrawal by Subject|0|||
33314386|NCT00690820|101044468|FG001|Period 1|Withdrawal by Subject|1|||
33314387|NCT01324440|101044471|FG000|Overall Study|Subject moved|0|||
33314388|NCT01324440|101044472|FG001|Overall Study|Subject moved|1|||
33314389|NCT00007345|101044473|FG000|Overall Study|Refused further treatment|0|||
33314390|NCT00007345|101044474|FG001|Overall Study|Refused further treatment|7|||
33314391|NCT00007345|101044473|FG000|Overall Study|Switched to alternative treatment|0|||
33314392|NCT00007345|101044474|FG001|Overall Study|Switched to alternative treatment|3|||
33314393|NCT00007345|101044473|FG000|Overall Study|Intercurrent illness|1|||
33396499|NCT01362049|101341845|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
33194565|NCT02247349|100616456|FG004|Overall Study|Other reasons|0|||
33194566|NCT02247349|100616457|FG005|Overall Study|Other reasons|0|||
33314394|NCT00007345|101044474|FG001|Overall Study|Intercurrent illness|0|||
33314395|NCT00007345|101044473|FG000|Overall Study|Death on study|1|||
33396500|NCT01362049|101341842|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
33505156|NCT02016105|101744622|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
33505157|NCT02016105|101744623|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
33505158|NCT02016105|101744624|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
33505159|NCT02016105|101744619|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
33505160|NCT02016105|101744620|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
33505161|NCT02016105|101744621|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
33505162|NCT02016105|101744622|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
33505163|NCT02016105|101744623|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
33505164|NCT02016105|101744624|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
33505165|NCT02016105|101744619|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
33505166|NCT02016105|101744620|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
33505167|NCT02016105|101744621|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
33505168|NCT02016105|101744622|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
33505169|NCT02016105|101744623|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
33505170|NCT02016105|101744624|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
33603083|NCT02528357|102099187|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
33603084|NCT02528357|102099188|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33396501|NCT01362049|101341843|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
33396502|NCT01362049|101341844|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
33396503|NCT01362049|101341845|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
33396504|NCT01376908|101341848|FG000|Overall Study|Protocol Violation|1|||
33396505|NCT01376908|101341849|FG001|Overall Study|Protocol Violation|1|||
33603085|NCT02528357|102099189|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
33603086|NCT02528357|102099190|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33603087|NCT02528357|102099191|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33603088|NCT02528357|102099192|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33603089|NCT02528357|102099193|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33396506|NCT01376908|101341848|FG000|Overall Study|Withdrawal by Subject|1|||
33396507|NCT01376908|101341849|FG001|Overall Study|Withdrawal by Subject|2|||
33396508|NCT01981096|101341850|FG000|Overall Study|Parent illness|1|||
33396509|NCT01981096|101341851|FG001|Overall Study|Parent illness|0|||
33396510|NCT01981096|101341850|FG000|Overall Study|Withdrawal by Subject|0|||
33396511|NCT01981096|101341851|FG001|Overall Study|Withdrawal by Subject|1|||
33396512|NCT01981096|101341850|FG000|Overall Study|Lost to Follow-up|2|||
33396513|NCT01981096|101341851|FG001|Overall Study|Lost to Follow-up|0|||
33396514|NCT03227692|101341857|FG000|Overall Study|Protocol Violation|1|||
33396515|NCT03227692|101341858|FG001|Overall Study|Protocol Violation|1|||
33396516|NCT03227692|101341857|FG000|Overall Study|Lost to Follow-up|4|||
33396517|NCT03227692|101341858|FG001|Overall Study|Lost to Follow-up|2|||
33396518|NCT03227692|101341857|FG000|Overall Study|Adverse Event|0|||
33396519|NCT03227692|101341858|FG001|Overall Study|Adverse Event|2|||
33396520|NCT02993783|101341859|FG000|Overall Study|Reason not Specified|6|||
33396521|NCT02993783|101341860|FG001|Overall Study|Reason not Specified|9|||
33396522|NCT01017549|101341863|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
33396523|NCT01017549|101341863|FG000|One-year Follow-up|Lost to Follow-up|2|||
33396524|NCT01017549|101341863|FG000|One-year Follow-up|Withdrawal by Subject|5|||
33396525|NCT01017549|101341863|FG000|5 Year Follow-up|Lost to Follow-up|9|||
33396526|NCT01017549|101341863|FG000|5 Year Follow-up|Mastectomy|3|||
33396527|NCT01263470|101341864|FG000|Overall Study|Adverse Event|2|||
33396528|NCT01263470|101341865|FG001|Overall Study|Adverse Event|2|||
33396529|NCT01263470|101341866|FG002|Overall Study|Adverse Event|1|||
33396530|NCT01263470|101341867|FG003|Overall Study|Adverse Event|1|||
33396531|NCT01263470|101341868|FG004|Overall Study|Adverse Event|2|||
33396532|NCT01263470|101341869|FG005|Overall Study|Adverse Event|2|||
33396533|NCT01263470|101341864|FG000|Overall Study|Protocol Violation|0|||
33396534|NCT01263470|101341865|FG001|Overall Study|Protocol Violation|1|||
33396535|NCT01263470|101341866|FG002|Overall Study|Protocol Violation|0|||
33396536|NCT01263470|101341867|FG003|Overall Study|Protocol Violation|0|||
33505171|NCT02016105|101744619|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
33505172|NCT02016105|101744620|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
33396537|NCT01263470|101341868|FG004|Overall Study|Protocol Violation|0|||
33396538|NCT01263470|101341869|FG005|Overall Study|Protocol Violation|1|||
33396539|NCT01263470|101341864|FG000|Overall Study|Withdrawal by Subject|0|||
33396540|NCT01263470|101341865|FG001|Overall Study|Withdrawal by Subject|1|||
33396541|NCT01263470|101341866|FG002|Overall Study|Withdrawal by Subject|1|||
33396542|NCT01263470|101341867|FG003|Overall Study|Withdrawal by Subject|2|||
33505173|NCT02016105|101744621|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
33505174|NCT02016105|101744622|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
33396543|NCT01263470|101341868|FG004|Overall Study|Withdrawal by Subject|0|||
33396544|NCT01263470|101341869|FG005|Overall Study|Withdrawal by Subject|2|||
33396545|NCT01263470|101341864|FG000|Overall Study|Lack of Efficacy|0|||
33396546|NCT01263470|101341865|FG001|Overall Study|Lack of Efficacy|0|||
33396547|NCT01263470|101341866|FG002|Overall Study|Lack of Efficacy|2|||
33396548|NCT01263470|101341867|FG003|Overall Study|Lack of Efficacy|0|||
33505175|NCT02016105|101744623|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
33505176|NCT02016105|101744624|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
33314396|NCT00007345|101044474|FG001|Overall Study|Death on study|1|||
33314397|NCT01959516|101044476|FG000|Epoch 1|Adverse Event|4|||
33314398|NCT01959516|101044477|FG001|Epoch 1|Adverse Event|1|||
33314399|NCT01959516|101044476|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
33603090|NCT02528357|102099194|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33603091|NCT02528357|102099195|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33603092|NCT02528357|102099196|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33603093|NCT02528357|102099197|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33603094|NCT02528357|102099198|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33603095|NCT02528357|102099199|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33603096|NCT02528357|102099200|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
33603097|NCT02528357|102099182|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33194567|NCT00654628|100616458|FG000|6-week Active Treatment Period|Adverse Event|9|||
33194568|NCT00654628|100616458|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
33194569|NCT00654628|100616458|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
33194570|NCT00654628|100616458|FG000|6-week Active Treatment Period|Out of window period|1|||
33194571|NCT00654628|100616458|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
33194572|NCT00654628|100616458|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
33194573|NCT03194646|100616462|FG000|Overall Study|Adverse Event|24|||
33194574|NCT03194646|100616463|FG001|Overall Study|Adverse Event|25|||
33194575|NCT03194646|100616464|FG002|Overall Study|Adverse Event|14|||
33194576|NCT03194646|100616465|FG003|Overall Study|Adverse Event|17|||
33194577|NCT03194646|100616462|FG000|Overall Study|Lack of Efficacy|4|||
33194578|NCT03194646|100616463|FG001|Overall Study|Lack of Efficacy|2|||
33314400|NCT01959516|101044477|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
33314401|NCT01959516|101044476|FG000|Epoch 1|Subject withdrew consent|3|||
33314402|NCT01959516|101044477|FG001|Epoch 1|Subject withdrew consent|2|||
33314403|NCT01959516|101044476|FG000|Epoch 1|Administrative problems|1|||
33314404|NCT01959516|101044477|FG001|Epoch 1|Administrative problems|0|||
33314405|NCT01959516|101044476|FG000|Epoch 1|Use of prohibited treatment|1|||
33314406|NCT01959516|101044477|FG001|Epoch 1|Use of prohibited treatment|0|||
33314407|NCT01959516|101044476|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
33194579|NCT03194646|100616464|FG002|Overall Study|Lack of Efficacy|2|||
33314408|NCT01959516|101044477|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
33314409|NCT01959516|101044476|FG000|Epoch 1|Protocol deviation|0|||
33314410|NCT01959516|101044477|FG001|Epoch 1|Protocol deviation|1|||
33314411|NCT01959516|101044476|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
33314412|NCT01959516|101044477|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
33314413|NCT01959516|101044476|FG000|Epoch 2|Subject withdrew consent|1|||
33314414|NCT01959516|101044477|FG001|Epoch 2|Subject withdrew consent|0|||
33314415|NCT01959516|101044476|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
33314416|NCT01959516|101044477|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
33314417|NCT00406653|101044478|FG000|Induction Period|Adverse Event|1|||
33314418|NCT00406653|101044479|FG001|Induction Period|Adverse Event|10|||
33314419|NCT00406653|101044480|FG002|Induction Period|Adverse Event|4|||
33314420|NCT00406653|101044481|FG003|Induction Period|Adverse Event|11|||
33314421|NCT00406653|101044482|FG004|Induction Period|Adverse Event|0|||
33194580|NCT03194646|100616465|FG003|Overall Study|Lack of Efficacy|12|||
33314422|NCT00406653|101044483|FG005|Induction Period|Adverse Event|0|||
33314423|NCT00406653|101044484|FG006|Induction Period|Adverse Event|0|||
33314424|NCT00406653|101044478|FG000|Induction Period|Lack of Efficacy|11|||
33314425|NCT00406653|101044479|FG001|Induction Period|Lack of Efficacy|14|||
33314426|NCT00406653|101044480|FG002|Induction Period|Lack of Efficacy|8|||
33314427|NCT00406653|101044481|FG003|Induction Period|Lack of Efficacy|10|||
33314428|NCT00406653|101044482|FG004|Induction Period|Lack of Efficacy|0|||
33314429|NCT00406653|101044483|FG005|Induction Period|Lack of Efficacy|0|||
33314430|NCT00406653|101044484|FG006|Induction Period|Lack of Efficacy|0|||
33314431|NCT00406653|101044478|FG000|Induction Period|Lost to Follow-up|0|||
33314432|NCT00406653|101044479|FG001|Induction Period|Lost to Follow-up|2|||
33314433|NCT00406653|101044480|FG002|Induction Period|Lost to Follow-up|0|||
33314434|NCT00406653|101044481|FG003|Induction Period|Lost to Follow-up|0|||
33314435|NCT00406653|101044482|FG004|Induction Period|Lost to Follow-up|0|||
33314436|NCT00406653|101044483|FG005|Induction Period|Lost to Follow-up|0|||
33314437|NCT00406653|101044484|FG006|Induction Period|Lost to Follow-up|0|||
33314438|NCT00406653|101044478|FG000|Induction Period|Withdrawal of Consent|2|||
33314439|NCT00406653|101044479|FG001|Induction Period|Withdrawal of Consent|5|||
33314440|NCT00406653|101044480|FG002|Induction Period|Withdrawal of Consent|1|||
33314441|NCT00406653|101044481|FG003|Induction Period|Withdrawal of Consent|2|||
33314442|NCT00406653|101044482|FG004|Induction Period|Withdrawal of Consent|0|||
33314443|NCT00406653|101044483|FG005|Induction Period|Withdrawal of Consent|0|||
33314444|NCT00406653|101044484|FG006|Induction Period|Withdrawal of Consent|0|||
33314445|NCT00406653|101044478|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
33314446|NCT00406653|101044479|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
33314447|NCT00406653|101044480|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
33194581|NCT03194646|100616462|FG000|Overall Study|Lost to Follow-up|30|||
33194582|NCT03194646|100616463|FG001|Overall Study|Lost to Follow-up|22|||
33194583|NCT03194646|100616464|FG002|Overall Study|Lost to Follow-up|12|||
33194584|NCT03194646|100616465|FG003|Overall Study|Lost to Follow-up|35|||
33194585|NCT03194646|100616462|FG000|Overall Study|Non-compliance with study drug|4|||
33505177|NCT02016105|101744619|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
33505178|NCT02016105|101744620|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
33505179|NCT02016105|101744621|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
33505180|NCT02016105|101744622|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
33505181|NCT02016105|101744623|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
33505182|NCT02016105|101744624|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
33505183|NCT02016105|101744619|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
33505184|NCT02016105|101744620|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
33505185|NCT02016105|101744621|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
33505186|NCT02016105|101744622|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
33505187|NCT02016105|101744623|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
33505188|NCT02016105|101744624|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
33505189|NCT02016105|101744619|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
33505190|NCT02016105|101744620|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
33505191|NCT02016105|101744621|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
33505192|NCT02016105|101744622|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
33505193|NCT02016105|101744623|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
33505194|NCT02016105|101744624|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
33505195|NCT02016105|101744619|FG000|TREATMENT PERIOD 2|Death|0|||
33505196|NCT02016105|101744620|FG001|TREATMENT PERIOD 2|Death|0|||
33505197|NCT02016105|101744621|FG002|TREATMENT PERIOD 2|Death|0|||
33194586|NCT03194646|100616463|FG001|Overall Study|Non-compliance with study drug|0|||
33194587|NCT03194646|100616464|FG002|Overall Study|Non-compliance with study drug|1|||
33194588|NCT03194646|100616465|FG003|Overall Study|Non-compliance with study drug|1|||
33194589|NCT03194646|100616462|FG000|Overall Study|Other|89|||
33194590|NCT03194646|100616463|FG001|Overall Study|Other|68|||
33194591|NCT03194646|100616464|FG002|Overall Study|Other|34|||
33194592|NCT03194646|100616465|FG003|Overall Study|Other|31|||
33194593|NCT03194646|100616462|FG000|Overall Study|Physician Decision|7|||
33194594|NCT03194646|100616463|FG001|Overall Study|Physician Decision|9|||
33194595|NCT03194646|100616464|FG002|Overall Study|Physician Decision|5|||
33194596|NCT03194646|100616465|FG003|Overall Study|Physician Decision|4|||
33194597|NCT03194646|100616462|FG000|Overall Study|Pregnancy|4|||
33194598|NCT03194646|100616463|FG001|Overall Study|Pregnancy|5|||
33194599|NCT03194646|100616464|FG002|Overall Study|Pregnancy|1|||
33194600|NCT03194646|100616465|FG003|Overall Study|Pregnancy|2|||
33194601|NCT03194646|100616462|FG000|Overall Study|Protocol Violation|4|||
33194602|NCT03194646|100616463|FG001|Overall Study|Protocol Violation|2|||
33194603|NCT03194646|100616464|FG002|Overall Study|Protocol Violation|1|||
33194604|NCT03194646|100616465|FG003|Overall Study|Protocol Violation|1|||
33194605|NCT03194646|100616462|FG000|Overall Study|Site terminated by sponsor|0|||
33194606|NCT03194646|100616463|FG001|Overall Study|Site terminated by sponsor|0|||
33194607|NCT03194646|100616464|FG002|Overall Study|Site terminated by sponsor|2|||
33194608|NCT03194646|100616465|FG003|Overall Study|Site terminated by sponsor|0|||
33194609|NCT03194646|100616462|FG000|Overall Study|Study terminated by sponsor|62|||
33194610|NCT03194646|100616463|FG001|Overall Study|Study terminated by sponsor|61|||
33194611|NCT03194646|100616464|FG002|Overall Study|Study terminated by sponsor|30|||
33194612|NCT03194646|100616465|FG003|Overall Study|Study terminated by sponsor|34|||
33194613|NCT03194646|100616462|FG000|Overall Study|Withdrawal by Subject|75|||
33505198|NCT02016105|101744622|FG003|TREATMENT PERIOD 2|Death|0|||
33194614|NCT03194646|100616463|FG001|Overall Study|Withdrawal by Subject|74|||
33194615|NCT03194646|100616464|FG002|Overall Study|Withdrawal by Subject|36|||
33194616|NCT03194646|100616465|FG003|Overall Study|Withdrawal by Subject|131|||
33194617|NCT03194646|100616462|FG000|Overall Study|Missing|1|||
33194618|NCT03194646|100616463|FG001|Overall Study|Missing|0|||
33194619|NCT03194646|100616464|FG002|Overall Study|Missing|1|||
33194620|NCT03194646|100616465|FG003|Overall Study|Missing|12|||
33505199|NCT02016105|101744623|FG004|TREATMENT PERIOD 2|Death|0|||
33194621|NCT03921411|100616466|FG000|Overall Study|Withdrawal by Subject|1|||
33505200|NCT02016105|101744624|FG005|TREATMENT PERIOD 2|Death|1|||
33194622|NCT03921411|100616466|FG000|Overall Study|Protocol Deviation|2|||
33194623|NCT03921411|100616466|FG000|Overall Study|Enrolled, but never treated|2|||
33194624|NCT00807092|100616468|FG000|Overall Study|Adverse Event|0|||
33194625|NCT00807092|100616469|FG001|Overall Study|Adverse Event|1|||
33194626|NCT00807092|100616468|FG000|Overall Study|Protocol Violation|0|||
33194627|NCT00807092|100616469|FG001|Overall Study|Protocol Violation|2|||
33194628|NCT00807092|100616468|FG000|Overall Study|Withdrawal by Subject|1|||
33194629|NCT00807092|100616469|FG001|Overall Study|Withdrawal by Subject|0|||
33194630|NCT00807092|100616468|FG000|Overall Study|CGMS data collection failed|0|||
33194631|NCT00807092|100616469|FG001|Overall Study|CGMS data collection failed|1|||
33194632|NCT00910715|100616470|FG000|Overall Study|Lost to Follow-up|22|||
33194633|NCT00910715|100616471|FG001|Overall Study|Lost to Follow-up|26|||
33314448|NCT00406653|101044481|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
33314449|NCT00406653|101044482|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
33314450|NCT00406653|101044483|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
33314451|NCT00406653|101044484|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
33314452|NCT00406653|101044478|FG000|Induction Period|Pregnancy|1|||
33314453|NCT00406653|101044479|FG001|Induction Period|Pregnancy|0|||
33314454|NCT00406653|101044480|FG002|Induction Period|Pregnancy|0|||
33194634|NCT00910715|100616472|FG002|Overall Study|Lost to Follow-up|0|||
33194635|NCT01440322|100616473|FG000|Overall Study|Discomfort|2|||
33194636|NCT01440322|100616474|FG001|Overall Study|Discomfort|0|||
33194637|NCT01440322|100616473|FG000|Overall Study|Biomicroscopy|1|||
33194638|NCT01440322|100616474|FG001|Overall Study|Biomicroscopy|0|||
33194639|NCT01440322|100616473|FG000|Overall Study|Symptoms and Problems|1|||
33194640|NCT01440322|100616474|FG001|Overall Study|Symptoms and Problems|0|||
33194641|NCT01440322|100616473|FG000|Overall Study|Unacceptable Subjective Vision|1|||
33194642|NCT01440322|100616474|FG001|Overall Study|Unacceptable Subjective Vision|0|||
33194643|NCT01440322|100616473|FG000|Overall Study|Other Product Related|1|||
33194644|NCT01440322|100616474|FG001|Overall Study|Other Product Related|0|||
33194645|NCT01440322|100616473|FG000|Overall Study|Unrelated Medical Problem|0|||
33194646|NCT01440322|100616474|FG001|Overall Study|Unrelated Medical Problem|1|||
33194647|NCT01440322|100616473|FG000|Overall Study|Other Non-Product Related|1|||
33194648|NCT01440322|100616474|FG001|Overall Study|Other Non-Product Related|0|||
33194649|NCT04096560|100616475|FG000|Overall Study|Reason not Specified|1|||
33194650|NCT04096560|100616476|FG001|Overall Study|Reason not Specified|0|||
33194651|NCT04096560|100616477|FG002|Overall Study|Reason not Specified|0|||
33194652|NCT04096560|100616478|FG003|Overall Study|Reason not Specified|0|||
33194653|NCT04096560|100616479|FG004|Overall Study|Reason not Specified|1|||
33194654|NCT04096560|100616480|FG005|Overall Study|Reason not Specified|1|||
33194655|NCT04096560|100616481|FG006|Overall Study|Reason not Specified|1|||
33194656|NCT04096560|100616482|FG007|Overall Study|Reason not Specified|0|||
33194657|NCT04096560|100616475|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
33194658|NCT04096560|100616476|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
33194659|NCT04096560|100616477|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
33194660|NCT04096560|100616478|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
33194661|NCT04096560|100616479|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
33194662|NCT04096560|100616480|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
33194663|NCT04096560|100616481|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
33194664|NCT04096560|100616482|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
33194665|NCT04096560|100616475|FG000|Overall Study|Study Terminated by Sponsor|0|||
33194666|NCT04096560|100616476|FG001|Overall Study|Study Terminated by Sponsor|0|||
33194667|NCT04096560|100616477|FG002|Overall Study|Study Terminated by Sponsor|0|||
33194668|NCT04096560|100616478|FG003|Overall Study|Study Terminated by Sponsor|5|||
33194669|NCT04096560|100616479|FG004|Overall Study|Study Terminated by Sponsor|6|||
33194670|NCT04096560|100616480|FG005|Overall Study|Study Terminated by Sponsor|4|||
33194671|NCT04096560|100616481|FG006|Overall Study|Study Terminated by Sponsor|6|||
33194672|NCT04096560|100616482|FG007|Overall Study|Study Terminated by Sponsor|1|||
33314455|NCT00406653|101044481|FG003|Induction Period|Pregnancy|0|||
33314456|NCT00406653|101044482|FG004|Induction Period|Pregnancy|0|||
33314457|NCT00406653|101044483|FG005|Induction Period|Pregnancy|0|||
33314458|NCT00406653|101044484|FG006|Induction Period|Pregnancy|0|||
33194673|NCT04096560|100616475|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
33194674|NCT04096560|100616476|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
33194675|NCT04096560|100616477|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
33194676|NCT04096560|100616478|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
33194677|NCT04096560|100616479|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
33194678|NCT04096560|100616480|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
33194679|NCT04096560|100616481|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
33314459|NCT00406653|101044478|FG000|Induction Period|Declined participation but followup done|0|||
33314460|NCT00406653|101044479|FG001|Induction Period|Declined participation but followup done|2|||
33314461|NCT00406653|101044480|FG002|Induction Period|Declined participation but followup done|1|||
33194680|NCT04096560|100616482|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
33194681|NCT02566759|100616483|FG000|All Parts|Withdrawal by Subject|0|||
33194682|NCT02566759|100616484|FG001|All Parts|Withdrawal by Subject|1|||
33194683|NCT02566759|100616485|FG002|All Parts|Withdrawal by Subject|0|||
33194684|NCT02566759|100616486|FG003|All Parts|Withdrawal by Subject|0|||
33194685|NCT02566759|100616487|FG004|All Parts|Withdrawal by Subject|0|||
33194686|NCT02566759|100616488|FG005|All Parts|Withdrawal by Subject|0|||
33194687|NCT02566759|100616489|FG006|All Parts|Withdrawal by Subject|0|||
33194688|NCT02566759|100616490|FG007|All Parts|Withdrawal by Subject|0|||
33194689|NCT02566759|100616491|FG008|All Parts|Withdrawal by Subject|0|||
33194690|NCT02566759|100616492|FG009|All Parts|Withdrawal by Subject|0|||
33194691|NCT02566759|100616493|FG010|All Parts|Withdrawal by Subject|0|||
33194692|NCT02566759|100616494|FG011|All Parts|Withdrawal by Subject|0|||
33194693|NCT02566759|100616495|FG012|All Parts|Withdrawal by Subject|0|||
33194694|NCT02566759|100616496|FG013|All Parts|Withdrawal by Subject|0|||
33194695|NCT02566759|100616497|FG014|All Parts|Withdrawal by Subject|0|||
33194696|NCT02566759|100616498|FG015|All Parts|Withdrawal by Subject|0|||
33194697|NCT02566759|100616499|FG016|All Parts|Withdrawal by Subject|0|||
33194698|NCT02566759|100616483|FG000|All Parts|Adverse Event|0|||
33194699|NCT02566759|100616484|FG001|All Parts|Adverse Event|0|||
33194700|NCT02566759|100616485|FG002|All Parts|Adverse Event|0|||
33194701|NCT02566759|100616486|FG003|All Parts|Adverse Event|0|||
33194702|NCT02566759|100616487|FG004|All Parts|Adverse Event|0|||
33194703|NCT02566759|100616488|FG005|All Parts|Adverse Event|0|||
33194704|NCT02566759|100616489|FG006|All Parts|Adverse Event|0|||
33194705|NCT02566759|100616490|FG007|All Parts|Adverse Event|0|||
33194706|NCT02566759|100616491|FG008|All Parts|Adverse Event|0|||
33194707|NCT02566759|100616492|FG009|All Parts|Adverse Event|0|||
33194708|NCT02566759|100616493|FG010|All Parts|Adverse Event|0|||
33194709|NCT02566759|100616494|FG011|All Parts|Adverse Event|0|||
33194710|NCT02566759|100616495|FG012|All Parts|Adverse Event|1|||
33194711|NCT02566759|100616496|FG013|All Parts|Adverse Event|3|||
33194712|NCT02566759|100616497|FG014|All Parts|Adverse Event|0|||
33194713|NCT02566759|100616498|FG015|All Parts|Adverse Event|0|||
33194714|NCT02566759|100616499|FG016|All Parts|Adverse Event|0|||
33194715|NCT02566759|100616483|FG000|All Parts|Other|0|||
33194716|NCT02566759|100616484|FG001|All Parts|Other|0|||
33194717|NCT02566759|100616485|FG002|All Parts|Other|0|||
33194718|NCT02566759|100616486|FG003|All Parts|Other|0|||
33194719|NCT02566759|100616487|FG004|All Parts|Other|0|||
33194720|NCT02566759|100616488|FG005|All Parts|Other|0|||
33194721|NCT02566759|100616489|FG006|All Parts|Other|0|||
33194722|NCT02566759|100616490|FG007|All Parts|Other|0|||
33194723|NCT02566759|100616491|FG008|All Parts|Other|0|||
33194724|NCT02566759|100616492|FG009|All Parts|Other|0|||
33194725|NCT02566759|100616493|FG010|All Parts|Other|0|||
33194726|NCT02566759|100616494|FG011|All Parts|Other|0|||
33194727|NCT02566759|100616495|FG012|All Parts|Other|0|||
33194728|NCT02566759|100616496|FG013|All Parts|Other|2|||
33194729|NCT02566759|100616497|FG014|All Parts|Other|0|||
33194730|NCT02566759|100616498|FG015|All Parts|Other|0|||
33194731|NCT02566759|100616499|FG016|All Parts|Other|0|||
33194732|NCT02566759|100616483|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194733|NCT02566759|100616484|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194734|NCT02566759|100616485|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194735|NCT02566759|100616486|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194736|NCT02566759|100616487|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194737|NCT02566759|100616488|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194738|NCT02566759|100616489|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194739|NCT02566759|100616490|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194740|NCT02566759|100616491|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194741|NCT02566759|100616492|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194742|NCT02566759|100616493|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194743|NCT02566759|100616494|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194744|NCT02566759|100616495|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194745|NCT02566759|100616496|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194746|NCT02566759|100616497|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194747|NCT02566759|100616498|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
33194748|NCT02566759|100616499|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
33194749|NCT00978731|100616500|FG000|Overall Study|Death|4|||
33194750|NCT00978731|100616501|FG001|Overall Study|Death|1|||
33194751|NCT00978731|100616502|FG002|Overall Study|Death|1|||
33194752|NCT00978731|100616503|FG003|Overall Study|Death|0|||
33194753|NCT00978731|100616500|FG000|Overall Study|Lost to Follow-up|0|||
33194754|NCT00978731|100616501|FG001|Overall Study|Lost to Follow-up|0|||
33194755|NCT00978731|100616502|FG002|Overall Study|Lost to Follow-up|0|||
33194756|NCT00978731|100616503|FG003|Overall Study|Lost to Follow-up|1|||
33396549|NCT01263470|101341868|FG004|Overall Study|Lack of Efficacy|0|||
33194757|NCT00978731|100616500|FG000|Overall Study|Adverse Event|5|||
33194758|NCT00978731|100616501|FG001|Overall Study|Adverse Event|2|||
33194759|NCT00978731|100616502|FG002|Overall Study|Adverse Event|0|||
33194760|NCT00978731|100616503|FG003|Overall Study|Adverse Event|0|||
33194761|NCT00978731|100616500|FG000|Overall Study|Participant's request|1|||
33194762|NCT00978731|100616501|FG001|Overall Study|Participant's request|0|||
33194763|NCT00978731|100616502|FG002|Overall Study|Participant's request|0|||
33194764|NCT00978731|100616503|FG003|Overall Study|Participant's request|0|||
33194765|NCT00978731|100616500|FG000|Overall Study|Administrative reason|3|||
33194766|NCT00978731|100616501|FG001|Overall Study|Administrative reason|3|||
33194767|NCT00978731|100616502|FG002|Overall Study|Administrative reason|1|||
33194768|NCT00978731|100616503|FG003|Overall Study|Administrative reason|0|||
33194769|NCT00978731|100616500|FG000|Overall Study|Deterioration without progression|0|||
33194770|NCT00978731|100616501|FG001|Overall Study|Deterioration without progression|1|||
33194771|NCT00978731|100616502|FG002|Overall Study|Deterioration without progression|0|||
33194772|NCT00978731|100616503|FG003|Overall Study|Deterioration without progression|0|||
33194773|NCT00978731|100616500|FG000|Overall Study|Disease progression/relapse|5|||
33194774|NCT00978731|100616501|FG001|Overall Study|Disease progression/relapse|4|||
33194775|NCT00978731|100616502|FG002|Overall Study|Disease progression/relapse|2|||
33194776|NCT00978731|100616503|FG003|Overall Study|Disease progression/relapse|2|||
33194777|NCT00978731|100616500|FG000|Overall Study|Study closure|3|||
33194778|NCT00978731|100616501|FG001|Overall Study|Study closure|4|||
33194779|NCT00978731|100616502|FG002|Overall Study|Study closure|1|||
33194780|NCT00978731|100616503|FG003|Overall Study|Study closure|1|||
33194781|NCT00978731|100616500|FG000|Overall Study|No response|1|||
33194782|NCT00978731|100616501|FG001|Overall Study|No response|0|||
33194783|NCT00978731|100616502|FG002|Overall Study|No response|0|||
33194784|NCT00978731|100616503|FG003|Overall Study|No response|0|||
33194785|NCT00529386|100616510|FG000|Overall Study|Lost to Follow-up|1|||
33194786|NCT03056690|100616518|FG000|Overall Study|Adverse Event|3|||
33194787|NCT03056690|100616519|FG001|Overall Study|Adverse Event|2|||
33194788|NCT03056690|100616518|FG000|Overall Study|Lack of Efficacy|1|||
33194789|NCT03056690|100616519|FG001|Overall Study|Lack of Efficacy|2|||
33194790|NCT03056690|100616518|FG000|Overall Study|Lost to Follow-up|3|||
33194791|NCT03056690|100616519|FG001|Overall Study|Lost to Follow-up|2|||
33194792|NCT03056690|100616518|FG000|Overall Study|Protocol Violation|2|||
33194793|NCT03056690|100616519|FG001|Overall Study|Protocol Violation|2|||
33194794|NCT03056690|100616518|FG000|Overall Study|Withdrawal by Subject|3|||
33194795|NCT03056690|100616519|FG001|Overall Study|Withdrawal by Subject|6|||
33194796|NCT03056690|100616518|FG000|Overall Study|Non-compliance with Study Drug|1|||
33194797|NCT03056690|100616519|FG001|Overall Study|Non-compliance with Study Drug|0|||
33194798|NCT03056690|100616518|FG000|Overall Study|Miscellaneous|1|||
33194799|NCT03056690|100616519|FG001|Overall Study|Miscellaneous|2|||
33194800|NCT04122443|100616525|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
33194801|NCT04122443|100616526|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
33194802|NCT04122443|100616527|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
33194803|NCT04122443|100616525|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
33194804|NCT04122443|100616526|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
33194805|NCT04122443|100616527|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
33194806|NCT01632579|100619498|FG000|Washout Period|Adverse Event|1|||
33194807|NCT01632579|100619499|FG001|Washout Period|Adverse Event|0|||
33194808|NCT01632579|100619500|FG002|Washout Period|Adverse Event|0|||
33194809|NCT01632579|100619501|FG003|Washout Period|Adverse Event|0|||
33194810|NCT01632579|100619502|FG004|Washout Period|Adverse Event|0|||
33194811|NCT01632579|100619503|FG005|Washout Period|Adverse Event|0|||
33194812|NCT01632579|100619504|FG006|Washout Period|Adverse Event|0|||
33194813|NCT01632579|100619505|FG007|Washout Period|Adverse Event|0|||
33194814|NCT01632579|100619506|FG008|Washout Period|Adverse Event|0|||
33194815|NCT01632579|100619498|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
33194816|NCT01632579|100619499|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
33194817|NCT01632579|100619500|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
33194818|NCT01632579|100619501|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
33194819|NCT01632579|100619502|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
33194820|NCT01632579|100619503|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
33505201|NCT02016105|101744619|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
33505202|NCT02016105|101744620|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
33194821|NCT01632579|100619504|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
33194822|NCT01632579|100619505|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
33194823|NCT01632579|100619506|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
33194824|NCT02465528|100619507|FG000|Overall Study|Progressive disease|0|||
33505203|NCT02016105|101744621|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
33505204|NCT02016105|101744622|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
33505205|NCT02016105|101744623|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
33194825|NCT02465528|100619508|FG001|Overall Study|Progressive disease|2|||
33194826|NCT02465528|100619509|FG002|Overall Study|Progressive disease|9|||
33194827|NCT02465528|100619510|FG003|Overall Study|Progressive disease|4|||
33194828|NCT02465528|100619507|FG000|Overall Study|Study terminated by sponsor|1|||
33396550|NCT01263470|101341869|FG005|Overall Study|Lack of Efficacy|0|||
33505206|NCT02016105|101744624|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
33194829|NCT02465528|100619508|FG001|Overall Study|Study terminated by sponsor|2|||
33194830|NCT02465528|100619509|FG002|Overall Study|Study terminated by sponsor|0|||
33194831|NCT02465528|100619510|FG003|Overall Study|Study terminated by sponsor|0|||
33194832|NCT02465528|100619507|FG000|Overall Study|Withdrawal by Subject|0|||
33194833|NCT02465528|100619508|FG001|Overall Study|Withdrawal by Subject|0|||
33194834|NCT02465528|100619509|FG002|Overall Study|Withdrawal by Subject|2|||
33194835|NCT02465528|100619510|FG003|Overall Study|Withdrawal by Subject|0|||
33194836|NCT02465528|100619507|FG000|Overall Study|Adverse Event|0|||
33194837|NCT02465528|100619508|FG001|Overall Study|Adverse Event|0|||
33194838|NCT02465528|100619509|FG002|Overall Study|Adverse Event|0|||
33194839|NCT02465528|100619510|FG003|Overall Study|Adverse Event|1|||
33194840|NCT02465528|100619507|FG000|Overall Study|Physician Decision|0|||
33194841|NCT02465528|100619508|FG001|Overall Study|Physician Decision|0|||
33194842|NCT02465528|100619509|FG002|Overall Study|Physician Decision|1|||
33194843|NCT02465528|100619510|FG003|Overall Study|Physician Decision|0|||
33194844|NCT00797667|100619514|FG000|Overall Study|Lack of Efficacy|0|||
33194845|NCT00797667|100619515|FG001|Overall Study|Lack of Efficacy|1|||
33194846|NCT00797667|100619516|FG002|Overall Study|Lack of Efficacy|0|||
33194847|NCT00797667|100619514|FG000|Overall Study|Lost to Follow-up|8|||
33194848|NCT00797667|100619515|FG001|Overall Study|Lost to Follow-up|12|||
33194849|NCT00797667|100619516|FG002|Overall Study|Lost to Follow-up|2|||
33194850|NCT00797667|100619514|FG000|Overall Study|Physician Decision|3|||
33194851|NCT00797667|100619515|FG001|Overall Study|Physician Decision|1|||
33194852|NCT00797667|100619516|FG002|Overall Study|Physician Decision|0|||
33194853|NCT00797667|100619514|FG000|Overall Study|Pregnancy|2|||
33194854|NCT00797667|100619515|FG001|Overall Study|Pregnancy|0|||
33194855|NCT00797667|100619516|FG002|Overall Study|Pregnancy|0|||
33194856|NCT00797667|100619514|FG000|Overall Study|Protocol Violation|2|||
33194857|NCT00797667|100619515|FG001|Overall Study|Protocol Violation|7|||
33194858|NCT00797667|100619516|FG002|Overall Study|Protocol Violation|0|||
33194859|NCT00797667|100619514|FG000|Overall Study|Study Terminated by Sponsor|217|||
33194860|NCT00797667|100619515|FG001|Overall Study|Study Terminated by Sponsor|216|||
33194861|NCT00797667|100619516|FG002|Overall Study|Study Terminated by Sponsor|115|||
33194862|NCT00797667|100619514|FG000|Overall Study|Withdrawal by Subject|9|||
33194863|NCT00797667|100619515|FG001|Overall Study|Withdrawal by Subject|14|||
33194864|NCT00797667|100619516|FG002|Overall Study|Withdrawal by Subject|2|||
33194865|NCT00797667|100619514|FG000|Overall Study|Adverse Event|19|||
33194866|NCT00797667|100619515|FG001|Overall Study|Adverse Event|8|||
33194867|NCT00797667|100619516|FG002|Overall Study|Adverse Event|8|||
33194868|NCT02880371|100619522|FG000|Phase 1b|Lost to Follow-up|1|||
33194869|NCT02880371|100619523|FG001|Phase 1b|Lost to Follow-up|0|||
33194870|NCT02880371|100619524|FG002|Phase 1b|Lost to Follow-up|0|||
33314462|NCT00406653|101044481|FG003|Induction Period|Declined participation but followup done|1|||
33194871|NCT02880371|100619525|FG003|Phase 1b|Lost to Follow-up|0|||
33194872|NCT02880371|100619526|FG004|Phase 1b|Lost to Follow-up|0|||
33194873|NCT02880371|100619527|FG005|Phase 1b|Lost to Follow-up|0|||
33194874|NCT02880371|100619528|FG006|Phase 1b|Lost to Follow-up|0|||
33194875|NCT02880371|100619529|FG007|Phase 1b|Lost to Follow-up|0|||
33194876|NCT02880371|100619522|FG000|Phase 1b|Participants terminated by Sponsor|1|||
33194877|NCT02880371|100619523|FG001|Phase 1b|Participants terminated by Sponsor|0|||
33194878|NCT02880371|100619524|FG002|Phase 1b|Participants terminated by Sponsor|0|||
33194879|NCT02880371|100619525|FG003|Phase 1b|Participants terminated by Sponsor|0|||
33194880|NCT02880371|100619526|FG004|Phase 1b|Participants terminated by Sponsor|0|||
33194881|NCT02880371|100619527|FG005|Phase 1b|Participants terminated by Sponsor|0|||
33194882|NCT02880371|100619528|FG006|Phase 1b|Participants terminated by Sponsor|0|||
33194883|NCT02880371|100619529|FG007|Phase 1b|Participants terminated by Sponsor|0|||
33194884|NCT02880371|100619522|FG000|Phase 1b|Withdrawal by Subject|0|||
33194885|NCT02880371|100619523|FG001|Phase 1b|Withdrawal by Subject|0|||
33194886|NCT02880371|100619524|FG002|Phase 1b|Withdrawal by Subject|1|||
33194887|NCT02880371|100619525|FG003|Phase 1b|Withdrawal by Subject|0|||
33194888|NCT02880371|100619526|FG004|Phase 1b|Withdrawal by Subject|0|||
33194889|NCT02880371|100619527|FG005|Phase 1b|Withdrawal by Subject|0|||
33194890|NCT02880371|100619528|FG006|Phase 1b|Withdrawal by Subject|0|||
33194891|NCT02880371|100619529|FG007|Phase 1b|Withdrawal by Subject|0|||
33194892|NCT02880371|100619522|FG000|Phase 1b|Death|4|||
33194893|NCT02880371|100619523|FG001|Phase 1b|Death|6|||
33194894|NCT02880371|100619524|FG002|Phase 1b|Death|5|||
33194895|NCT02880371|100619525|FG003|Phase 1b|Death|1|||
33194896|NCT02880371|100619526|FG004|Phase 1b|Death|0|||
33194897|NCT02880371|100619527|FG005|Phase 1b|Death|0|||
33194898|NCT02880371|100619528|FG006|Phase 1b|Death|0|||
33194899|NCT02880371|100619529|FG007|Phase 1b|Death|0|||
33194900|NCT02880371|100619522|FG000|Phase 1b|Enrolled but not Treated|0|||
33194901|NCT02880371|100619523|FG001|Phase 1b|Enrolled but not Treated|1|||
33194902|NCT02880371|100619524|FG002|Phase 1b|Enrolled but not Treated|0|||
33194903|NCT02880371|100619525|FG003|Phase 1b|Enrolled but not Treated|0|||
33194904|NCT02880371|100619526|FG004|Phase 1b|Enrolled but not Treated|0|||
33194905|NCT02880371|100619527|FG005|Phase 1b|Enrolled but not Treated|0|||
33194906|NCT02880371|100619528|FG006|Phase 1b|Enrolled but not Treated|0|||
33194907|NCT02880371|100619529|FG007|Phase 1b|Enrolled but not Treated|0|||
33194908|NCT02880371|100619522|FG000|Phase 2|Enrolled but not Treated|0|||
33194909|NCT02880371|100619523|FG001|Phase 2|Enrolled but not Treated|0|||
33194910|NCT02880371|100619524|FG002|Phase 2|Enrolled but not Treated|0|||
33194911|NCT02880371|100619525|FG003|Phase 2|Enrolled but not Treated|0|||
33194912|NCT02880371|100619526|FG004|Phase 2|Enrolled but not Treated|0|||
33194913|NCT02880371|100619527|FG005|Phase 2|Enrolled but not Treated|1|||
33194914|NCT02880371|100619528|FG006|Phase 2|Enrolled but not Treated|1|||
33194915|NCT02880371|100619529|FG007|Phase 2|Enrolled but not Treated|0|||
33194916|NCT02880371|100619522|FG000|Phase 2|Other|0|||
33194917|NCT02880371|100619523|FG001|Phase 2|Other|0|||
33194918|NCT02880371|100619524|FG002|Phase 2|Other|0|||
33194919|NCT02880371|100619525|FG003|Phase 2|Other|0|||
33194920|NCT02880371|100619526|FG004|Phase 2|Other|0|||
33194921|NCT02880371|100619527|FG005|Phase 2|Other|1|||
33194922|NCT02880371|100619528|FG006|Phase 2|Other|2|||
33194923|NCT02880371|100619529|FG007|Phase 2|Other|1|||
33194924|NCT02880371|100619522|FG000|Phase 2|Participants terminated by Sponsor|0|||
33194925|NCT02880371|100619523|FG001|Phase 2|Participants terminated by Sponsor|0|||
33194926|NCT02880371|100619524|FG002|Phase 2|Participants terminated by Sponsor|0|||
33194927|NCT02880371|100619525|FG003|Phase 2|Participants terminated by Sponsor|0|||
33194928|NCT02880371|100619526|FG004|Phase 2|Participants terminated by Sponsor|1|||
33194929|NCT02880371|100619527|FG005|Phase 2|Participants terminated by Sponsor|6|||
33194930|NCT02880371|100619528|FG006|Phase 2|Participants terminated by Sponsor|1|||
33194931|NCT02880371|100619529|FG007|Phase 2|Participants terminated by Sponsor|5|||
33194932|NCT02880371|100619522|FG000|Phase 2|Death|0|||
33194933|NCT02880371|100619523|FG001|Phase 2|Death|0|||
33194934|NCT02880371|100619524|FG002|Phase 2|Death|0|||
33194935|NCT02880371|100619525|FG003|Phase 2|Death|0|||
33194936|NCT02880371|100619526|FG004|Phase 2|Death|1|||
33194937|NCT02880371|100619527|FG005|Phase 2|Death|10|||
33194938|NCT02880371|100619528|FG006|Phase 2|Death|20|||
33194939|NCT02880371|100619529|FG007|Phase 2|Death|5|||
33194940|NCT02880371|100619522|FG000|Phase 2|Lost to Follow-up|0|||
33194941|NCT02880371|100619523|FG001|Phase 2|Lost to Follow-up|0|||
33194942|NCT02880371|100619524|FG002|Phase 2|Lost to Follow-up|0|||
33194943|NCT02880371|100619525|FG003|Phase 2|Lost to Follow-up|0|||
33194944|NCT02880371|100619526|FG004|Phase 2|Lost to Follow-up|0|||
33194945|NCT02880371|100619527|FG005|Phase 2|Lost to Follow-up|0|||
33194946|NCT02880371|100619528|FG006|Phase 2|Lost to Follow-up|3|||
33194947|NCT02880371|100619529|FG007|Phase 2|Lost to Follow-up|0|||
33194948|NCT02880371|100619522|FG000|Phase 2|Withdrawal by Subject|0|||
33194949|NCT02880371|100619523|FG001|Phase 2|Withdrawal by Subject|0|||
33194950|NCT02880371|100619524|FG002|Phase 2|Withdrawal by Subject|0|||
33194951|NCT02880371|100619525|FG003|Phase 2|Withdrawal by Subject|0|||
33194952|NCT02880371|100619526|FG004|Phase 2|Withdrawal by Subject|0|||
33194953|NCT02880371|100619527|FG005|Phase 2|Withdrawal by Subject|1|||
33194954|NCT02880371|100619528|FG006|Phase 2|Withdrawal by Subject|1|||
33194955|NCT02880371|100619529|FG007|Phase 2|Withdrawal by Subject|0|||
33314463|NCT00406653|101044482|FG004|Induction Period|Declined participation but followup done|0|||
33505207|NCT02016105|101744619|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
33505208|NCT02016105|101744620|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
33505209|NCT02016105|101744621|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
33505210|NCT02016105|101744622|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
33505211|NCT02016105|101744623|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
33505212|NCT02016105|101744624|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
33505213|NCT02016105|101744619|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
33505214|NCT02016105|101744620|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
33505215|NCT02016105|101744621|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
33505216|NCT02016105|101744622|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
33396551|NCT01263470|101341864|FG000|Overall Study|Participant Unavailability|0|||
33396552|NCT01263470|101341865|FG001|Overall Study|Participant Unavailability|1|||
33396553|NCT01263470|101341866|FG002|Overall Study|Participant Unavailability|0|||
33396554|NCT01263470|101341867|FG003|Overall Study|Participant Unavailability|0|||
33396555|NCT01263470|101341868|FG004|Overall Study|Participant Unavailability|0|||
33396556|NCT01263470|101341869|FG005|Overall Study|Participant Unavailability|0|||
33396557|NCT01263470|101341864|FG000|Overall Study|Study Drug Non-compliance|0|||
33396558|NCT01263470|101341865|FG001|Overall Study|Study Drug Non-compliance|0|||
33396559|NCT01263470|101341866|FG002|Overall Study|Study Drug Non-compliance|0|||
33396560|NCT01263470|101341867|FG003|Overall Study|Study Drug Non-compliance|0|||
33505217|NCT02016105|101744623|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
33505218|NCT02016105|101744624|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
33505219|NCT02016105|101744619|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
33505220|NCT02016105|101744620|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
33505221|NCT02016105|101744621|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
33505222|NCT02016105|101744622|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
33505223|NCT02016105|101744623|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
33505224|NCT02016105|101744624|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
33314464|NCT00406653|101044483|FG005|Induction Period|Declined participation but followup done|0|||
33314465|NCT00406653|101044484|FG006|Induction Period|Declined participation but followup done|0|||
33314466|NCT00406653|101044478|FG000|Induction Period|Given prohibited drug|0|||
33314467|NCT00406653|101044479|FG001|Induction Period|Given prohibited drug|1|||
33314468|NCT00406653|101044480|FG002|Induction Period|Given prohibited drug|2|||
33314469|NCT00406653|101044481|FG003|Induction Period|Given prohibited drug|0|||
33314470|NCT00406653|101044482|FG004|Induction Period|Given prohibited drug|0|||
33314471|NCT00406653|101044483|FG005|Induction Period|Given prohibited drug|0|||
33314472|NCT00406653|101044484|FG006|Induction Period|Given prohibited drug|0|||
33314473|NCT00406653|101044478|FG000|Induction Period|Incarcerated|0|||
33314474|NCT00406653|101044479|FG001|Induction Period|Incarcerated|0|||
33314475|NCT00406653|101044480|FG002|Induction Period|Incarcerated|1|||
33314476|NCT00406653|101044481|FG003|Induction Period|Incarcerated|0|||
33314477|NCT00406653|101044482|FG004|Induction Period|Incarcerated|0|||
33314478|NCT00406653|101044483|FG005|Induction Period|Incarcerated|0|||
33314479|NCT00406653|101044484|FG006|Induction Period|Incarcerated|0|||
33314480|NCT00406653|101044478|FG000|Induction Period|Patient relocated|0|||
33314481|NCT00406653|101044479|FG001|Induction Period|Patient relocated|0|||
33314482|NCT00406653|101044480|FG002|Induction Period|Patient relocated|1|||
33314483|NCT00406653|101044481|FG003|Induction Period|Patient relocated|0|||
33314484|NCT00406653|101044482|FG004|Induction Period|Patient relocated|0|||
33314485|NCT00406653|101044483|FG005|Induction Period|Patient relocated|0|||
33314486|NCT00406653|101044484|FG006|Induction Period|Patient relocated|0|||
33314487|NCT00406653|101044478|FG000|Maintenance Period|Adverse Event|0|||
33314488|NCT00406653|101044479|FG001|Maintenance Period|Adverse Event|0|||
33314489|NCT00406653|101044480|FG002|Maintenance Period|Adverse Event|0|||
33314490|NCT00406653|101044481|FG003|Maintenance Period|Adverse Event|0|||
33314491|NCT00406653|101044482|FG004|Maintenance Period|Adverse Event|1|||
33314492|NCT00406653|101044483|FG005|Maintenance Period|Adverse Event|1|||
33314493|NCT00406653|101044484|FG006|Maintenance Period|Adverse Event|0|||
33505225|NCT02016105|101744619|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
33505226|NCT02016105|101744620|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
33194956|NCT02880371|100619522|FG000|Phase 2|End of Study page not completed by error|0|||
33314494|NCT00406653|101044478|FG000|Maintenance Period|Lack of Efficacy|0|||
33314495|NCT00406653|101044479|FG001|Maintenance Period|Lack of Efficacy|0|||
33314496|NCT00406653|101044480|FG002|Maintenance Period|Lack of Efficacy|0|||
33314497|NCT00406653|101044481|FG003|Maintenance Period|Lack of Efficacy|0|||
33314498|NCT00406653|101044482|FG004|Maintenance Period|Lack of Efficacy|20|||
33314499|NCT00406653|101044483|FG005|Maintenance Period|Lack of Efficacy|26|||
33314500|NCT00406653|101044484|FG006|Maintenance Period|Lack of Efficacy|0|||
33314501|NCT00406653|101044478|FG000|Maintenance Period|Lost to Follow-up|0|||
33396561|NCT01263470|101341868|FG004|Overall Study|Study Drug Non-compliance|1|||
33396562|NCT01263470|101341869|FG005|Overall Study|Study Drug Non-compliance|0|||
33396563|NCT04785144|101341871|FG000|Overall Study|Withdrawal by Subject|4|||
33505227|NCT02016105|101744621|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
33505228|NCT02016105|101744622|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
33505229|NCT02016105|101744623|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
33314502|NCT00406653|101044479|FG001|Maintenance Period|Lost to Follow-up|0|||
33314503|NCT00406653|101044480|FG002|Maintenance Period|Lost to Follow-up|0|||
33314504|NCT00406653|101044481|FG003|Maintenance Period|Lost to Follow-up|0|||
33314505|NCT00406653|101044482|FG004|Maintenance Period|Lost to Follow-up|2|||
33314506|NCT00406653|101044483|FG005|Maintenance Period|Lost to Follow-up|1|||
33314507|NCT00406653|101044484|FG006|Maintenance Period|Lost to Follow-up|0|||
33314508|NCT00406653|101044478|FG000|Maintenance Period|Withdrawal of Consent|0|||
33314509|NCT00406653|101044479|FG001|Maintenance Period|Withdrawal of Consent|0|||
33314510|NCT00406653|101044480|FG002|Maintenance Period|Withdrawal of Consent|0|||
33314511|NCT00406653|101044481|FG003|Maintenance Period|Withdrawal of Consent|0|||
33314512|NCT00406653|101044482|FG004|Maintenance Period|Withdrawal of Consent|2|||
33314513|NCT00406653|101044483|FG005|Maintenance Period|Withdrawal of Consent|0|||
33314514|NCT00406653|101044484|FG006|Maintenance Period|Withdrawal of Consent|0|||
33314515|NCT00406653|101044478|FG000|Maintenance Period|Pregnancy|0|||
33314516|NCT00406653|101044479|FG001|Maintenance Period|Pregnancy|0|||
33314517|NCT00406653|101044480|FG002|Maintenance Period|Pregnancy|0|||
33314518|NCT00406653|101044481|FG003|Maintenance Period|Pregnancy|0|||
33314519|NCT00406653|101044482|FG004|Maintenance Period|Pregnancy|0|||
33314520|NCT00406653|101044483|FG005|Maintenance Period|Pregnancy|1|||
33314521|NCT00406653|101044484|FG006|Maintenance Period|Pregnancy|0|||
33314522|NCT00406653|101044478|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
33314523|NCT00406653|101044479|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
33314524|NCT00406653|101044480|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
33314525|NCT00406653|101044481|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
33314526|NCT00406653|101044482|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
33314527|NCT00406653|101044483|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
33314528|NCT00406653|101044484|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
33314529|NCT00406653|101044478|FG000|Maintenance Period|Error in disease score evaluation|0|||
33314530|NCT00406653|101044479|FG001|Maintenance Period|Error in disease score evaluation|0|||
33314531|NCT00406653|101044480|FG002|Maintenance Period|Error in disease score evaluation|0|||
33314532|NCT00406653|101044481|FG003|Maintenance Period|Error in disease score evaluation|0|||
33314533|NCT00406653|101044482|FG004|Maintenance Period|Error in disease score evaluation|1|||
33314534|NCT00406653|101044483|FG005|Maintenance Period|Error in disease score evaluation|0|||
33314535|NCT00406653|101044484|FG006|Maintenance Period|Error in disease score evaluation|0|||
33314536|NCT00406653|101044478|FG000|Open-Label Period|Death|0|||
33314537|NCT00406653|101044479|FG001|Open-Label Period|Death|0|||
33314538|NCT00406653|101044480|FG002|Open-Label Period|Death|0|||
33314539|NCT00406653|101044481|FG003|Open-Label Period|Death|0|||
33314540|NCT00406653|101044482|FG004|Open-Label Period|Death|0|||
33314541|NCT00406653|101044483|FG005|Open-Label Period|Death|0|||
33314542|NCT00406653|101044484|FG006|Open-Label Period|Death|1|||
33314543|NCT00406653|101044478|FG000|Open-Label Period|Adverse Event|0|||
33314544|NCT00406653|101044479|FG001|Open-Label Period|Adverse Event|0|||
33314545|NCT00406653|101044480|FG002|Open-Label Period|Adverse Event|0|||
33314546|NCT00406653|101044481|FG003|Open-Label Period|Adverse Event|0|||
33314547|NCT00406653|101044482|FG004|Open-Label Period|Adverse Event|0|||
33314548|NCT00406653|101044483|FG005|Open-Label Period|Adverse Event|0|||
33314549|NCT00406653|101044484|FG006|Open-Label Period|Adverse Event|18|||
33314550|NCT00406653|101044478|FG000|Open-Label Period|Lack of Efficacy|0|||
33314551|NCT00406653|101044479|FG001|Open-Label Period|Lack of Efficacy|0|||
33314552|NCT00406653|101044480|FG002|Open-Label Period|Lack of Efficacy|0|||
33314553|NCT00406653|101044481|FG003|Open-Label Period|Lack of Efficacy|0|||
33314554|NCT00406653|101044482|FG004|Open-Label Period|Lack of Efficacy|0|||
33314555|NCT00406653|101044483|FG005|Open-Label Period|Lack of Efficacy|0|||
33314556|NCT00406653|101044484|FG006|Open-Label Period|Lack of Efficacy|160|||
33314557|NCT00406653|101044478|FG000|Open-Label Period|Lost to Follow-up|0|||
33314558|NCT00406653|101044479|FG001|Open-Label Period|Lost to Follow-up|0|||
33314559|NCT00406653|101044480|FG002|Open-Label Period|Lost to Follow-up|0|||
33314560|NCT00406653|101044481|FG003|Open-Label Period|Lost to Follow-up|0|||
33314561|NCT00406653|101044482|FG004|Open-Label Period|Lost to Follow-up|0|||
33603098|NCT02528357|102099183|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33603099|NCT02528357|102099184|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
33314562|NCT00406653|101044483|FG005|Open-Label Period|Lost to Follow-up|0|||
33314563|NCT00406653|101044484|FG006|Open-Label Period|Lost to Follow-up|6|||
33314564|NCT00406653|101044478|FG000|Open-Label Period|Withdrawal of Consent|0|||
33314565|NCT00406653|101044479|FG001|Open-Label Period|Withdrawal of Consent|0|||
33314566|NCT00406653|101044480|FG002|Open-Label Period|Withdrawal of Consent|0|||
33314567|NCT00406653|101044481|FG003|Open-Label Period|Withdrawal of Consent|0|||
33314568|NCT00406653|101044482|FG004|Open-Label Period|Withdrawal of Consent|0|||
33314569|NCT00406653|101044483|FG005|Open-Label Period|Withdrawal of Consent|0|||
33314570|NCT00406653|101044484|FG006|Open-Label Period|Withdrawal of Consent|11|||
33314571|NCT00406653|101044478|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
33314572|NCT00406653|101044479|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
33314573|NCT00406653|101044480|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
33314574|NCT00406653|101044481|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
33314575|NCT00406653|101044482|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
33314576|NCT00406653|101044483|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
33314577|NCT00406653|101044484|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
33314578|NCT00406653|101044478|FG000|Open-Label Period|Pregnancy|0|||
33314579|NCT00406653|101044479|FG001|Open-Label Period|Pregnancy|0|||
33314580|NCT00406653|101044480|FG002|Open-Label Period|Pregnancy|0|||
33314581|NCT00406653|101044481|FG003|Open-Label Period|Pregnancy|0|||
33314582|NCT00406653|101044482|FG004|Open-Label Period|Pregnancy|0|||
33314583|NCT00406653|101044483|FG005|Open-Label Period|Pregnancy|0|||
33314584|NCT00406653|101044484|FG006|Open-Label Period|Pregnancy|2|||
33314585|NCT00406653|101044478|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
33314586|NCT00406653|101044479|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
33314587|NCT00406653|101044480|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
33314588|NCT00406653|101044481|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
33314589|NCT00406653|101044482|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
33314590|NCT00406653|101044483|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
33505230|NCT02016105|101744624|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
33505231|NCT02016105|101744619|FG000|EXTENSION PERIOD|Adverse Event|0|||
33505232|NCT02016105|101744620|FG001|EXTENSION PERIOD|Adverse Event|0|||
33505233|NCT02016105|101744621|FG002|EXTENSION PERIOD|Adverse Event|2|||
33314591|NCT00406653|101044484|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
33314592|NCT00406653|101044478|FG000|Open-Label Period|Declined participation but followup done|0|||
33314593|NCT00406653|101044479|FG001|Open-Label Period|Declined participation but followup done|0|||
33314594|NCT00406653|101044480|FG002|Open-Label Period|Declined participation but followup done|0|||
33314595|NCT00406653|101044481|FG003|Open-Label Period|Declined participation but followup done|0|||
33314596|NCT00406653|101044482|FG004|Open-Label Period|Declined participation but followup done|0|||
33314597|NCT00406653|101044483|FG005|Open-Label Period|Declined participation but followup done|0|||
33314598|NCT00406653|101044484|FG006|Open-Label Period|Declined participation but followup done|8|||
33314599|NCT00406653|101044478|FG000|Open-Label Period|Discontinued by Sponsor|0|||
33314600|NCT00406653|101044479|FG001|Open-Label Period|Discontinued by Sponsor|0|||
33314601|NCT00406653|101044480|FG002|Open-Label Period|Discontinued by Sponsor|0|||
33314602|NCT00406653|101044481|FG003|Open-Label Period|Discontinued by Sponsor|0|||
33314603|NCT00406653|101044482|FG004|Open-Label Period|Discontinued by Sponsor|0|||
33314604|NCT00406653|101044483|FG005|Open-Label Period|Discontinued by Sponsor|0|||
33314605|NCT00406653|101044484|FG006|Open-Label Period|Discontinued by Sponsor|1|||
33314606|NCT00406653|101044478|FG000|Open-Label Period|Refused followup|0|||
33314607|NCT00406653|101044479|FG001|Open-Label Period|Refused followup|0|||
33314608|NCT00406653|101044480|FG002|Open-Label Period|Refused followup|0|||
33505234|NCT02016105|101744622|FG003|EXTENSION PERIOD|Adverse Event|0|||
33505235|NCT02016105|101744623|FG004|EXTENSION PERIOD|Adverse Event|1|||
33505236|NCT02016105|101744624|FG005|EXTENSION PERIOD|Adverse Event|0|||
33505237|NCT02016105|101744619|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
33505238|NCT02016105|101744620|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
33505239|NCT02016105|101744621|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
33505240|NCT02016105|101744622|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
33505241|NCT02016105|101744623|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
33505242|NCT02016105|101744624|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
33505243|NCT02016105|101744619|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
33505244|NCT02016105|101744620|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
33314609|NCT00406653|101044481|FG003|Open-Label Period|Refused followup|0|||
33314610|NCT00406653|101044482|FG004|Open-Label Period|Refused followup|0|||
33314611|NCT00406653|101044483|FG005|Open-Label Period|Refused followup|0|||
33314612|NCT00406653|101044484|FG006|Open-Label Period|Refused followup|1|||
33314613|NCT02578862|101044485|FG000|Overall Study|Withdrawal by Subject|0|||
33314614|NCT02578862|101044486|FG001|Overall Study|Withdrawal by Subject|1|||
33314615|NCT02578862|101044485|FG000|Overall Study|Unplanned unilateral procedure|0|||
33314616|NCT02578862|101044486|FG001|Overall Study|Unplanned unilateral procedure|1|||
33314617|NCT00091169|101044487|FG000|Overall Study|Disease progression|3|||
33314618|NCT00091169|101044488|FG001|Overall Study|Disease progression|1|||
33314619|NCT00091169|101044487|FG000|Overall Study|Adverse Event|11|||
33314620|NCT00091169|101044488|FG001|Overall Study|Adverse Event|17|||
33314621|NCT00091169|101044487|FG000|Overall Study|Death|4|||
33314622|NCT00091169|101044488|FG001|Overall Study|Death|1|||
33314623|NCT00091169|101044487|FG000|Overall Study|Withdrawal by Subject|10|||
33314624|NCT00091169|101044488|FG001|Overall Study|Withdrawal by Subject|13|||
33396564|NCT04785144|101341872|FG001|Overall Study|Withdrawal by Subject|1|||
33505245|NCT02016105|101744621|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
33314625|NCT00091169|101044487|FG000|Overall Study|Other|3|||
33314626|NCT00091169|101044488|FG001|Overall Study|Other|4|||
33314627|NCT00091169|101044487|FG000|Overall Study|Not start protocol therapy|26|||
33505246|NCT02016105|101744622|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
33505247|NCT02016105|101744623|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
33396565|NCT04785144|101341873|FG002|Overall Study|Withdrawal by Subject|0|||
33396566|NCT04785144|101341874|FG003|Overall Study|Withdrawal by Subject|0|||
33396567|NCT04785144|101341875|FG004|Overall Study|Withdrawal by Subject|0|||
33396568|NCT04785144|101341876|FG005|Overall Study|Withdrawal by Subject|2|||
33396569|NCT04785144|101341877|FG006|Overall Study|Withdrawal by Subject|2|||
33396570|NCT04785144|101341878|FG007|Overall Study|Withdrawal by Subject|0|||
33396571|NCT04785144|101341879|FG008|Overall Study|Withdrawal by Subject|1|||
33396572|NCT04785144|101341880|FG009|Overall Study|Withdrawal by Subject|0|||
33396573|NCT04785144|101341871|FG000|Overall Study|Lost to Follow-up|1|||
33396574|NCT04785144|101341872|FG001|Overall Study|Lost to Follow-up|0|||
33396575|NCT04785144|101341873|FG002|Overall Study|Lost to Follow-up|0|||
33396576|NCT04785144|101341874|FG003|Overall Study|Lost to Follow-up|0|||
33396577|NCT04785144|101341875|FG004|Overall Study|Lost to Follow-up|1|||
33396578|NCT04785144|101341876|FG005|Overall Study|Lost to Follow-up|2|||
33396579|NCT04785144|101341877|FG006|Overall Study|Lost to Follow-up|1|||
33396580|NCT04785144|101341878|FG007|Overall Study|Lost to Follow-up|2|||
33396581|NCT04785144|101341879|FG008|Overall Study|Lost to Follow-up|4|||
33603100|NCT02528357|102099185|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33603101|NCT02528357|102099186|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
33314628|NCT00091169|101044488|FG001|Overall Study|Not start protocol therapy|17|||
33314629|NCT02070588|101044489|FG000|Overall Study|Withdrawal by Subject|29|||
33314630|NCT02070588|101044490|FG001|Overall Study|Withdrawal by Subject|1|||
33314631|NCT02070588|101044491|FG002|Overall Study|Withdrawal by Subject|0|||
33314632|NCT02070588|101044489|FG000|Overall Study|Writhdrawal due to early termination|9|||
33314633|NCT02070588|101044490|FG001|Overall Study|Writhdrawal due to early termination|0|||
33396582|NCT04785144|101341880|FG009|Overall Study|Lost to Follow-up|1|||
33396583|NCT04785144|101341871|FG000|Overall Study|Protocol Violation|0|||
33396584|NCT04785144|101341872|FG001|Overall Study|Protocol Violation|0|||
33396585|NCT04785144|101341873|FG002|Overall Study|Protocol Violation|0|||
33396586|NCT04785144|101341874|FG003|Overall Study|Protocol Violation|0|||
33396587|NCT04785144|101341875|FG004|Overall Study|Protocol Violation|0|||
33396588|NCT04785144|101341876|FG005|Overall Study|Protocol Violation|0|||
33396589|NCT04785144|101341877|FG006|Overall Study|Protocol Violation|1|||
33396590|NCT04785144|101341878|FG007|Overall Study|Protocol Violation|0|||
33396591|NCT04785144|101341879|FG008|Overall Study|Protocol Violation|0|||
33396592|NCT04785144|101341880|FG009|Overall Study|Protocol Violation|0|||
33396593|NCT04785144|101341871|FG000|Overall Study|Physician Decision|0|||
33396594|NCT04785144|101341872|FG001|Overall Study|Physician Decision|0|||
33396595|NCT04785144|101341873|FG002|Overall Study|Physician Decision|0|||
33396596|NCT04785144|101341874|FG003|Overall Study|Physician Decision|0|||
33396597|NCT04785144|101341875|FG004|Overall Study|Physician Decision|0|||
33396598|NCT04785144|101341876|FG005|Overall Study|Physician Decision|0|||
33396599|NCT04785144|101341877|FG006|Overall Study|Physician Decision|0|||
33396600|NCT04785144|101341878|FG007|Overall Study|Physician Decision|0|||
33396601|NCT04785144|101341879|FG008|Overall Study|Physician Decision|0|||
33396602|NCT04785144|101341880|FG009|Overall Study|Physician Decision|1|||
33396603|NCT04785144|101341871|FG000|Overall Study|Unable to continue due to work schedule|0|||
33396604|NCT04785144|101341872|FG001|Overall Study|Unable to continue due to work schedule|0|||
33396605|NCT04785144|101341873|FG002|Overall Study|Unable to continue due to work schedule|0|||
33396606|NCT04785144|101341874|FG003|Overall Study|Unable to continue due to work schedule|0|||
33396607|NCT04785144|101341875|FG004|Overall Study|Unable to continue due to work schedule|0|||
33396608|NCT04785144|101341876|FG005|Overall Study|Unable to continue due to work schedule|0|||
33396609|NCT04785144|101341877|FG006|Overall Study|Unable to continue due to work schedule|0|||
33396610|NCT04785144|101341878|FG007|Overall Study|Unable to continue due to work schedule|0|||
33396611|NCT04785144|101341879|FG008|Overall Study|Unable to continue due to work schedule|0|||
33396612|NCT04785144|101341880|FG009|Overall Study|Unable to continue due to work schedule|1|||
33505248|NCT02016105|101744624|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
33314634|NCT02070588|101044491|FG002|Overall Study|Writhdrawal due to early termination|0|||
33314635|NCT02070588|101044489|FG000|Overall Study|Adverse Event|1|||
33314636|NCT02070588|101044490|FG001|Overall Study|Adverse Event|0|||
33314637|NCT02070588|101044491|FG002|Overall Study|Adverse Event|0|||
33505249|NCT02016105|101744619|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
33505250|NCT02016105|101744620|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
33505251|NCT02016105|101744621|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
33314638|NCT00332189|101044507|FG000|Overall Study|Adverse Event|3|||
33396613|NCT01012037|101341882|FG000|Overall Study|Adverse Event|0|||
33396614|NCT01012037|101341883|FG001|Overall Study|Adverse Event|8|||
33505252|NCT02016105|101744622|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
33505253|NCT02016105|101744623|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
33505254|NCT02016105|101744624|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
33505255|NCT00002931|101744628|FG000|Overall Study|rapidly progressing disease during|2|||
33505256|NCT02782923|101744629|FG000|Overall Study|Lost to Follow-up|15|||
33396615|NCT01012037|101341884|FG002|Overall Study|Adverse Event|3|||
33396616|NCT01012037|101341882|FG000|Overall Study|Protocol Violation|0|||
33505257|NCT00247611|101744632|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
33314639|NCT00332189|101044507|FG000|Overall Study|Uncooperative/Noncompliant|3|||
33314640|NCT00332189|101044507|FG000|Overall Study|Withdrawal by Subject|9|||
33314641|NCT00332189|101044507|FG000|Overall Study|Lack of Efficacy|4|||
33314642|NCT00332189|101044507|FG000|Overall Study|Moved out of country|2|||
33314643|NCT00938860|101044508|FG000|Overall Study|Adverse Event|2|||
33314644|NCT00938860|101044509|FG001|Overall Study|Adverse Event|1|||
33314645|NCT00938860|101044508|FG000|Overall Study|Abnormal laboratory values|2|||
33314646|NCT00938860|101044509|FG001|Overall Study|Abnormal laboratory values|2|||
33314647|NCT00938860|101044508|FG000|Overall Study|Withdrawal by Subject|11|||
33314648|NCT00938860|101044509|FG001|Overall Study|Withdrawal by Subject|8|||
33314649|NCT00938860|101044508|FG000|Overall Study|Lost to Follow-up|4|||
33314650|NCT00938860|101044509|FG001|Overall Study|Lost to Follow-up|4|||
33314651|NCT00938860|101044508|FG000|Overall Study|Administration problems|2|||
33314652|NCT00938860|101044509|FG001|Overall Study|Administration problems|0|||
33314653|NCT00938860|101044508|FG000|Overall Study|Death|1|||
33314654|NCT00938860|101044509|FG001|Overall Study|Death|1|||
33314655|NCT00938860|101044508|FG000|Overall Study|Protocol Violation|3|||
33314656|NCT00938860|101044509|FG001|Overall Study|Protocol Violation|1|||
33314657|NCT04187989|101044510|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
33314658|NCT04187989|101044511|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
33314659|NCT04187989|101044510|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
33314660|NCT04187989|101044511|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
33314661|NCT00953407|101044514|FG000|Overall Study|Failed inclusion criteria|1|||
33314662|NCT00953407|101044515|FG001|Overall Study|Failed inclusion criteria|1|||
33314663|NCT00953407|101044516|FG002|Overall Study|Failed inclusion criteria|1|||
33314664|NCT00953407|101044517|FG003|Overall Study|Failed inclusion criteria|1|||
33314665|NCT00953407|101044518|FG004|Overall Study|Failed inclusion criteria|1|||
33314666|NCT00953407|101044514|FG000|Overall Study|Lost to Follow-up|0|||
33314667|NCT00953407|101044515|FG001|Overall Study|Lost to Follow-up|0|||
33314668|NCT00953407|101044516|FG002|Overall Study|Lost to Follow-up|0|||
33314669|NCT00953407|101044517|FG003|Overall Study|Lost to Follow-up|1|||
33314670|NCT00953407|101044518|FG004|Overall Study|Lost to Follow-up|0|||
33314671|NCT01403610|101044522|FG000|Overall Study|Withdrawal by Subject|2|||
33314672|NCT01403610|101044523|FG001|Overall Study|Withdrawal by Subject|0|||
33314673|NCT01403610|101044524|FG002|Overall Study|Withdrawal by Subject|0|||
33314674|NCT01403610|101044525|FG003|Overall Study|Withdrawal by Subject|0|||
33314675|NCT01403610|101044522|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
33505258|NCT00247611|101744633|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
33505259|NCT00247611|101744632|FG000|Baselined|Completed baseline only|9|||
33505260|NCT00247611|101744633|FG001|Baselined|Completed baseline only|8|||
33505261|NCT02142959|101744634|FG000|Overall Study|Adverse Event|1|||
33505262|NCT02142959|101744635|FG001|Overall Study|Adverse Event|0|||
33505263|NCT02142959|101744636|FG002|Overall Study|Adverse Event|0|||
33505264|NCT02142959|101744634|FG000|Overall Study|Death|0|||
33505265|NCT02142959|101744635|FG001|Overall Study|Death|1|||
33505266|NCT02142959|101744636|FG002|Overall Study|Death|0|||
33505267|NCT02142959|101744634|FG000|Overall Study|Withdrawal by Subject|3|||
33505268|NCT02142959|101744635|FG001|Overall Study|Withdrawal by Subject|1|||
33505269|NCT02142959|101744636|FG002|Overall Study|Withdrawal by Subject|3|||
33396617|NCT01012037|101341883|FG001|Overall Study|Protocol Violation|3|||
33396618|NCT01012037|101341884|FG002|Overall Study|Protocol Violation|5|||
33396619|NCT01012037|101341882|FG000|Overall Study|Withdrawal by Subject|0|||
33396620|NCT01012037|101341883|FG001|Overall Study|Withdrawal by Subject|4|||
33396621|NCT01012037|101341884|FG002|Overall Study|Withdrawal by Subject|1|||
33194957|NCT02880371|100619523|FG001|Phase 2|End of Study page not completed by error|0|||
33194958|NCT02880371|100619524|FG002|Phase 2|End of Study page not completed by error|0|||
33194959|NCT02880371|100619525|FG003|Phase 2|End of Study page not completed by error|0|||
33314676|NCT01403610|101044523|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
33314677|NCT01403610|101044524|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
33314678|NCT01403610|101044525|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
33314679|NCT03435497|101044526|FG000|Overall Study|Lost to Follow-up|1|||
33314680|NCT03435497|101044527|FG001|Overall Study|Lost to Follow-up|0|||
33314681|NCT03435497|101044526|FG000|Overall Study|Death|1|||
33314682|NCT03435497|101044527|FG001|Overall Study|Death|0|||
33314683|NCT03435497|101044526|FG000|Overall Study|Withdrawal by Subject|0|||
33314684|NCT03435497|101044527|FG001|Overall Study|Withdrawal by Subject|4|||
33314685|NCT03435497|101044526|FG000|Overall Study|Wrong survey administered|0|||
33396622|NCT01012037|101341882|FG000|Overall Study|Other reason (not specified)|1|||
33194960|NCT02880371|100619526|FG004|Phase 2|End of Study page not completed by error|0|||
33314686|NCT03435497|101044527|FG001|Overall Study|Wrong survey administered|2|||
33314687|NCT00547365|101044528|FG000|Overall Study|Physician Decision|1|||
33314688|NCT00547365|101044528|FG000|Overall Study|Lost to Follow-up|1|||
33396623|NCT01012037|101341883|FG001|Overall Study|Other reason (not specified)|1|||
33396624|NCT01012037|101341884|FG002|Overall Study|Other reason (not specified)|1|||
33505270|NCT02142959|101744634|FG000|Overall Study|Administrative Reasons|1|||
33314689|NCT00547365|101044528|FG000|Overall Study|Protocol Violation|2|||
33505271|NCT02142959|101744635|FG001|Overall Study|Administrative Reasons|0|||
33314690|NCT00547365|101044528|FG000|Overall Study|death (not related to study)|4|||
33314691|NCT02668185|101044530|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
33314692|NCT02668185|101044531|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
33314693|NCT02668185|101044530|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
33314694|NCT02668185|101044531|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
33314695|NCT02668185|101044530|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
33314696|NCT02668185|101044531|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
33314697|NCT02668185|101044530|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
33314698|NCT02668185|101044531|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
33314699|NCT02935452|101044532|FG000|Overall Study|work and life commintment|3|||
33314700|NCT02935452|101044533|FG001|Overall Study|work and life commintment|1|||
33314701|NCT01898923|101044534|FG000|Overall Study|Lack of Efficacy|5|||
33314702|NCT01898923|101044535|FG001|Overall Study|Lack of Efficacy|6|||
33314703|NCT01898923|101044534|FG000|Overall Study|Adverse Event|3|||
33505272|NCT02142959|101744636|FG002|Overall Study|Administrative Reasons|1|||
33505273|NCT02142959|101744634|FG000|Overall Study|Missing|0|||
33505274|NCT02142959|101744635|FG001|Overall Study|Missing|1|||
33505275|NCT02142959|101744636|FG002|Overall Study|Missing|0|||
33314704|NCT01898923|101044535|FG001|Overall Study|Adverse Event|1|||
33396625|NCT02045979|101341885|FG000|Overall Study|Informed Consent Withdrawn|2|||
33505276|NCT02142959|101744634|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
33505277|NCT02142959|101744635|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
33505278|NCT02142959|101744636|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
33505279|NCT02142959|101744634|FG000|Overall Study|Patient didn't complete end of study visit|0|||
33505280|NCT02142959|101744635|FG001|Overall Study|Patient didn't complete end of study visit|0|||
33505281|NCT02142959|101744636|FG002|Overall Study|Patient didn't complete end of study visit|1|||
33505282|NCT03508726|101744637|FG000|Overall Study|Withdrawal by Subject|0|||
33603102|NCT02528357|102099187|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33603103|NCT02528357|102099188|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
33603104|NCT02528357|102099189|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
33505283|NCT03508726|101744638|FG001|Overall Study|Withdrawal by Subject|1|||
33505284|NCT01862250|101744639|FG000|Overall Study|Adverse Event|4|||
33505285|NCT00090493|101744640|FG000|Overall Study|Physician Decision|2|||
33505286|NCT01015131|101744650|FG000|Overall Study|Physician Decision|1|||
33505287|NCT01015131|101744650|FG000|Overall Study|Protocol Violation|1|||
33505288|NCT01015131|101744650|FG000|Overall Study|Withdrawal by Subject|2|||
33505289|NCT01015131|101744650|FG000|Overall Study|Other Protocol Specified Criteria|4|||
33505290|NCT02411448|101744651|FG000|Overall Study|Withdrawal by Subject|1|||
33603105|NCT02528357|102099190|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33603106|NCT02528357|102099191|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33603107|NCT02528357|102099192|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33603108|NCT02528357|102099193|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33603109|NCT02528357|102099194|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33603110|NCT02528357|102099195|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33603111|NCT02528357|102099196|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33603112|NCT02528357|102099197|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33603113|NCT02528357|102099198|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33603114|NCT02528357|102099199|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33603115|NCT02528357|102099200|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
33603116|NCT02528357|102099182|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603117|NCT02528357|102099183|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603118|NCT02528357|102099184|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603119|NCT02528357|102099185|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603120|NCT02528357|102099186|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
33603121|NCT02528357|102099187|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603122|NCT02528357|102099188|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603123|NCT02528357|102099189|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603124|NCT02528357|102099190|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33314705|NCT01898923|101044534|FG000|Overall Study|Lost to Follow-up|0|||
33314706|NCT01898923|101044535|FG001|Overall Study|Lost to Follow-up|1|||
33396626|NCT02045979|101341886|FG001|Overall Study|Informed Consent Withdrawn|0|||
33505291|NCT02411448|101744652|FG001|Overall Study|Withdrawal by Subject|14|||
33505292|NCT02411448|101744653|FG002|Overall Study|Withdrawal by Subject|9|||
33505293|NCT02411448|101744651|FG000|Overall Study|Other|0|||
33505294|NCT02411448|101744652|FG001|Overall Study|Other|2|||
33505295|NCT02411448|101744653|FG002|Overall Study|Other|0|||
33505296|NCT02411448|101744651|FG000|Overall Study|Did not receive study treatment|0|||
33505297|NCT02411448|101744652|FG001|Overall Study|Did not receive study treatment|3|||
33505298|NCT02411448|101744653|FG002|Overall Study|Did not receive study treatment|0|||
33505299|NCT02411448|101744651|FG000|Overall Study|Alive on study treatment|3|||
33505300|NCT02411448|101744652|FG001|Overall Study|Alive on study treatment|64|||
33505301|NCT02411448|101744653|FG002|Overall Study|Alive on study treatment|43|||
33505302|NCT02907892|101744654|FG000|Overall Study|Lost to Follow-up|27|||
33603125|NCT02528357|102099191|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603126|NCT02528357|102099192|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603127|NCT02528357|102099193|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603128|NCT02528357|102099194|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603129|NCT02528357|102099195|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603130|NCT02528357|102099196|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603131|NCT02528357|102099197|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603132|NCT02528357|102099198|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603133|NCT02528357|102099199|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603134|NCT02528357|102099200|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603135|NCT02528357|102099182|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603136|NCT02528357|102099183|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603137|NCT02528357|102099184|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603138|NCT02528357|102099185|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603139|NCT02528357|102099186|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603140|NCT02528357|102099187|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603141|NCT02528357|102099188|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603142|NCT02528357|102099189|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603143|NCT02528357|102099190|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603144|NCT02528357|102099191|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603145|NCT02528357|102099192|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603146|NCT02528357|102099193|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603147|NCT02528357|102099194|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603148|NCT02528357|102099195|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
33603149|NCT02528357|102099196|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
33603150|NCT02528357|102099197|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603151|NCT02528357|102099198|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603152|NCT02528357|102099199|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603153|NCT02528357|102099200|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
33603154|NCT02528357|102099182|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603155|NCT02528357|102099183|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33417166|NCT00038467|101420219|FG000|Overall Study|Recurrence|109|||
33417167|NCT00038467|101420220|FG001|Overall Study|Recurrence|179|||
33417168|NCT00038467|101420219|FG000|Overall Study|Randomized, but not treated|31|||
33417169|NCT00038467|101420220|FG001|Overall Study|Randomized, but not treated|35|||
33417170|NCT00038467|101420219|FG000|Overall Study|Other|26|||
33417171|NCT00038467|101420220|FG001|Overall Study|Other|28|||
33417172|NCT01652872|101420224|FG000|Overall Study|Death|36|||
33417173|NCT01652872|101420225|FG001|Overall Study|Death|39|||
33417174|NCT01652872|101420224|FG000|Overall Study|Lost to Follow-up|28|||
33417175|NCT01652872|101420225|FG001|Overall Study|Lost to Follow-up|23|||
33417176|NCT01652872|101420224|FG000|Overall Study|Decision by sponsor|5|||
33417177|NCT01652872|101420225|FG001|Overall Study|Decision by sponsor|7|||
33417178|NCT01652872|101420224|FG000|Overall Study|Withdrawal by Subject|76|||
33417179|NCT01652872|101420225|FG001|Overall Study|Withdrawal by Subject|84|||
33417180|NCT00499252|101420226|FG000|Overall Study|Adverse Event|3|||
33417181|NCT00499252|101420226|FG000|Overall Study|Refused further treatment|2|||
33417182|NCT00499252|101420226|FG000|Overall Study|Ineligible|4|||
33417183|NCT00499252|101420226|FG000|Overall Study|<no further label>|3|||
33417184|NCT00433771|101420227|FG000|Overall Study|screen fail|14|||
33417185|NCT00433771|101420227|FG000|Overall Study|Treated and later found to be ineligible|2|||
33314707|NCT01898923|101044534|FG000|Overall Study|Withdrawal by Subject|4|||
33505303|NCT02907892|101744655|FG001|Overall Study|Lost to Follow-up|40|||
33505304|NCT05985980|101744658|FG000|Overall Study|Withdrawal by Subject|1|||
33505305|NCT05985980|101744658|FG000|Overall Study|Withdrawal by Subject|1|||
33505306|NCT05985980|101744658|FG000|Overall Study|Withdrawal by Subject|1|||
33505307|NCT05985980|101744658|FG000|Overall Study|Withdrawal by Subject|1|||
33505308|NCT02049814|101744661|FG000|Overall Study|Reason not Specified|4|||
33505309|NCT02049814|101744662|FG001|Overall Study|Reason not Specified|3|||
33505310|NCT02049814|101744661|FG000|Overall Study|Pregnancy|1|||
33505311|NCT02049814|101744662|FG001|Overall Study|Pregnancy|0|||
33505312|NCT02049814|101744661|FG000|Overall Study|Lost to Follow-up|2|||
33505313|NCT02049814|101744662|FG001|Overall Study|Lost to Follow-up|3|||
33505314|NCT02049814|101744661|FG000|Overall Study|Serious Protocol Violation|5|||
33505315|NCT02049814|101744662|FG001|Overall Study|Serious Protocol Violation|7|||
33505316|NCT02049814|101744661|FG000|Overall Study|Study Termination|0|||
33505317|NCT02049814|101744662|FG001|Overall Study|Study Termination|1|||
33505318|NCT02049814|101744661|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
33505319|NCT02049814|101744662|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
33314708|NCT01898923|101044535|FG001|Overall Study|Withdrawal by Subject|7|||
33314709|NCT01898923|101044534|FG000|Overall Study|Physician Decision|3|||
33314710|NCT01898923|101044535|FG001|Overall Study|Physician Decision|4|||
33314711|NCT01898923|101044534|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
33314712|NCT01898923|101044535|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
33314713|NCT01012739|101044539|FG000|Treatment Period 1|Adverse Event|0|||
33314714|NCT01012739|101044540|FG001|Treatment Period 1|Adverse Event|0|||
33314715|NCT01012739|101044541|FG002|Treatment Period 1|Adverse Event|0|||
33314716|NCT01012739|101044542|FG003|Treatment Period 1|Adverse Event|1|||
33505320|NCT02049814|101744661|FG000|Overall Study|Voluntary withdrawal|9|||
33505321|NCT02049814|101744662|FG001|Overall Study|Voluntary withdrawal|8|||
33505322|NCT01878149|101744663|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
33505323|NCT01878149|101744664|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
33505324|NCT01014988|101744665|FG000|Overall Study|Adverse Event|20|||
33505325|NCT01014988|101744666|FG001|Overall Study|Adverse Event|0|||
33505326|NCT01014988|101744667|FG002|Overall Study|Adverse Event|1|||
33505327|NCT01014988|101744668|FG003|Overall Study|Adverse Event|0|||
33505328|NCT01014988|101744669|FG004|Overall Study|Adverse Event|1|||
33505329|NCT01014988|101744670|FG005|Overall Study|Adverse Event|3|||
33505330|NCT01014988|101744665|FG000|Overall Study|Lost to Follow-up|1|||
33314717|NCT01012739|101044539|FG000|Treatment Period 2|Abnormal test procedure results|0|||
33505331|NCT01014988|101744666|FG001|Overall Study|Lost to Follow-up|0|||
33603156|NCT02528357|102099184|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603157|NCT02528357|102099185|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33314718|NCT01012739|101044540|FG001|Treatment Period 2|Abnormal test procedure results|0|||
33314719|NCT01012739|101044541|FG002|Treatment Period 2|Abnormal test procedure results|0|||
33314720|NCT01012739|101044542|FG003|Treatment Period 2|Abnormal test procedure results|1|||
33314721|NCT00368992|101044543|FG000|Overall Study|Ineligible|5|||
33314722|NCT00368992|101044543|FG000|Overall Study|Refused treatment|3|||
33314723|NCT00368992|101044543|FG000|Overall Study|Lack of Efficacy|63|||
33314724|NCT00368992|101044543|FG000|Overall Study|Adverse Event|26|||
33314725|NCT00368992|101044543|FG000|Overall Study|Death|4|||
33314726|NCT00368992|101044543|FG000|Overall Study|Other|9|||
33314727|NCT02074553|101044546|FG000|Intervention Period 1|Family Emergency|0|||
33314728|NCT02074553|101044547|FG001|Intervention Period 1|Family Emergency|0|||
33314729|NCT02074553|101044548|FG002|Intervention Period 1|Family Emergency|0|||
33314730|NCT02074553|101044549|FG003|Intervention Period 1|Family Emergency|1|||
33314731|NCT02074553|101044550|FG004|Intervention Period 1|Family Emergency|0|||
33314732|NCT02074553|101044551|FG005|Intervention Period 1|Family Emergency|0|||
33314733|NCT02074553|101044552|FG006|Intervention Period 1|Family Emergency|0|||
33314734|NCT02074553|101044553|FG007|Intervention Period 1|Family Emergency|0|||
33314735|NCT02074553|101044546|FG000|Washout Period 1|Adverse Event|1|||
33314736|NCT02074553|101044547|FG001|Washout Period 1|Adverse Event|0|||
33314737|NCT02074553|101044548|FG002|Washout Period 1|Adverse Event|0|||
33314738|NCT02074553|101044549|FG003|Washout Period 1|Adverse Event|0|||
33314739|NCT02074553|101044550|FG004|Washout Period 1|Adverse Event|0|||
33314740|NCT02074553|101044551|FG005|Washout Period 1|Adverse Event|0|||
33314741|NCT02074553|101044552|FG006|Washout Period 1|Adverse Event|0|||
33314742|NCT02074553|101044553|FG007|Washout Period 1|Adverse Event|0|||
33314743|NCT02074553|101044546|FG000|Washout Period 1|Physician Decision|0|||
33314744|NCT02074553|101044547|FG001|Washout Period 1|Physician Decision|0|||
33314745|NCT02074553|101044548|FG002|Washout Period 1|Physician Decision|0|||
33314746|NCT02074553|101044549|FG003|Washout Period 1|Physician Decision|1|||
33314747|NCT02074553|101044550|FG004|Washout Period 1|Physician Decision|0|||
33505332|NCT01014988|101744667|FG002|Overall Study|Lost to Follow-up|1|||
33505333|NCT01014988|101744668|FG003|Overall Study|Lost to Follow-up|0|||
33505334|NCT01014988|101744669|FG004|Overall Study|Lost to Follow-up|0|||
33505335|NCT01014988|101744670|FG005|Overall Study|Lost to Follow-up|0|||
33314748|NCT02074553|101044551|FG005|Washout Period 1|Physician Decision|0|||
33314749|NCT02074553|101044552|FG006|Washout Period 1|Physician Decision|0|||
33314750|NCT02074553|101044553|FG007|Washout Period 1|Physician Decision|0|||
33314751|NCT02074553|101044546|FG000|Washout Period 1|Other|0|||
33314752|NCT02074553|101044547|FG001|Washout Period 1|Other|0|||
33314753|NCT02074553|101044548|FG002|Washout Period 1|Other|0|||
33314754|NCT02074553|101044549|FG003|Washout Period 1|Other|0|||
33314755|NCT02074553|101044550|FG004|Washout Period 1|Other|0|||
33314756|NCT02074553|101044551|FG005|Washout Period 1|Other|1|||
33314757|NCT02074553|101044552|FG006|Washout Period 1|Other|0|||
33314758|NCT02074553|101044553|FG007|Washout Period 1|Other|0|||
33314759|NCT02074553|101044546|FG000|Washout Period 2|Adverse Event|0|||
33314760|NCT02074553|101044547|FG001|Washout Period 2|Adverse Event|0|||
33314761|NCT02074553|101044548|FG002|Washout Period 2|Adverse Event|0|||
33314762|NCT02074553|101044549|FG003|Washout Period 2|Adverse Event|0|||
33314763|NCT02074553|101044550|FG004|Washout Period 2|Adverse Event|0|||
33314764|NCT02074553|101044551|FG005|Washout Period 2|Adverse Event|0|||
33314765|NCT02074553|101044552|FG006|Washout Period 2|Adverse Event|1|||
33314766|NCT02074553|101044553|FG007|Washout Period 2|Adverse Event|0|||
33314767|NCT02074553|101044546|FG000|Washout Period 2|Physician Decision|0|||
33314768|NCT02074553|101044547|FG001|Washout Period 2|Physician Decision|0|||
33314769|NCT02074553|101044548|FG002|Washout Period 2|Physician Decision|0|||
33314770|NCT02074553|101044549|FG003|Washout Period 2|Physician Decision|0|||
33314771|NCT02074553|101044550|FG004|Washout Period 2|Physician Decision|0|||
33314772|NCT02074553|101044551|FG005|Washout Period 2|Physician Decision|1|||
33314773|NCT02074553|101044552|FG006|Washout Period 2|Physician Decision|0|||
33314774|NCT02074553|101044553|FG007|Washout Period 2|Physician Decision|0|||
33314775|NCT02074553|101044546|FG000|Washout Period 2|Lost to Follow-up|0|||
33314776|NCT02074553|101044547|FG001|Washout Period 2|Lost to Follow-up|0|||
33314777|NCT02074553|101044548|FG002|Washout Period 2|Lost to Follow-up|1|||
33505336|NCT01014988|101744665|FG000|Overall Study|Physician Decision|1|||
33505337|NCT01014988|101744666|FG001|Overall Study|Physician Decision|0|||
33505338|NCT01014988|101744667|FG002|Overall Study|Physician Decision|0|||
33314778|NCT02074553|101044549|FG003|Washout Period 2|Lost to Follow-up|0|||
33314779|NCT02074553|101044550|FG004|Washout Period 2|Lost to Follow-up|0|||
33314780|NCT02074553|101044551|FG005|Washout Period 2|Lost to Follow-up|0|||
33314781|NCT02074553|101044552|FG006|Washout Period 2|Lost to Follow-up|0|||
33314782|NCT02074553|101044553|FG007|Washout Period 2|Lost to Follow-up|0|||
33314783|NCT02074553|101044546|FG000|Washout Period 3|Physician Decision|0|||
33417186|NCT00433771|101420227|FG000|Overall Study|Death|2|||
33314784|NCT02074553|101044547|FG001|Washout Period 3|Physician Decision|0|||
33314785|NCT02074553|101044548|FG002|Washout Period 3|Physician Decision|0|||
33314786|NCT02074553|101044549|FG003|Washout Period 3|Physician Decision|0|||
33417187|NCT00433771|101420227|FG000|Overall Study|Failure to deploy stent|1|||
33417188|NCT01491737|101420228|FG000|Overall Study|Withdrawal by Subject|20|||
33417189|NCT01491737|101420229|FG001|Overall Study|Withdrawal by Subject|17|||
33417190|NCT01491737|101420228|FG000|Overall Study|Lost to Follow-up|2|||
33417191|NCT01491737|101420229|FG001|Overall Study|Lost to Follow-up|10|||
33417192|NCT01491737|101420228|FG000|Overall Study|Death|63|||
33417193|NCT01491737|101420229|FG001|Overall Study|Death|57|||
33417194|NCT01491737|101420228|FG000|Overall Study|Study Termination by Sponsor|36|||
33417195|NCT01491737|101420229|FG001|Overall Study|Study Termination by Sponsor|36|||
33417196|NCT01491737|101420228|FG000|Overall Study|Reason Not Specified|8|||
33417197|NCT01491737|101420229|FG001|Overall Study|Reason Not Specified|9|||
33417198|NCT01473589|101420230|FG000|Overall Study|Adverse Event|1|||
33417199|NCT01473589|101420231|FG001|Overall Study|Adverse Event|1|||
33417200|NCT01473589|101420230|FG000|Overall Study|Death|2|||
33417201|NCT01473589|101420231|FG001|Overall Study|Death|0|||
33417202|NCT01473589|101420230|FG000|Overall Study|Lost to Follow-up|2|||
33417203|NCT01473589|101420231|FG001|Overall Study|Lost to Follow-up|2|||
33417204|NCT01473589|101420230|FG000|Overall Study|Protocol Violation|1|||
33417205|NCT01473589|101420231|FG001|Overall Study|Protocol Violation|0|||
33417206|NCT01473589|101420230|FG000|Overall Study|Withdrawal by Subject|5|||
33417207|NCT01473589|101420231|FG001|Overall Study|Withdrawal by Subject|11|||
33417208|NCT01473589|101420230|FG000|Overall Study|Physician Decision|0|||
33417209|NCT01473589|101420231|FG001|Overall Study|Physician Decision|1|||
33417210|NCT01473589|101420230|FG000|Overall Study|Entry criteria not met|0|||
33417211|NCT01473589|101420231|FG001|Overall Study|Entry criteria not met|1|||
33417212|NCT00960687|101420234|FG000|Washout Period of 7 Days|Adverse Event|3|||
33505339|NCT01014988|101744668|FG003|Overall Study|Physician Decision|0|||
33505340|NCT01014988|101744669|FG004|Overall Study|Physician Decision|0|||
33505341|NCT01014988|101744670|FG005|Overall Study|Physician Decision|0|||
33505342|NCT01014988|101744665|FG000|Overall Study|Withdrawal by Subject|1|||
33505343|NCT01014988|101744666|FG001|Overall Study|Withdrawal by Subject|0|||
33505344|NCT01014988|101744667|FG002|Overall Study|Withdrawal by Subject|0|||
33505345|NCT01014988|101744668|FG003|Overall Study|Withdrawal by Subject|0|||
33505346|NCT01014988|101744669|FG004|Overall Study|Withdrawal by Subject|0|||
33505347|NCT01014988|101744670|FG005|Overall Study|Withdrawal by Subject|0|||
33505348|NCT04292912|101744673|FG000|Overall Study|Physician Decision|1|||
33505349|NCT04292912|101744673|FG000|Overall Study|Protocol Violation|6|||
33505350|NCT04999163|101744681|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
33505351|NCT04999163|101744682|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
33505352|NCT04999163|101744681|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
33505353|NCT04999163|101744682|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
33505354|NCT04999163|101744681|FG000|Overall Study|Withdrawal by Subject|1|||
33505355|NCT04999163|101744682|FG001|Overall Study|Withdrawal by Subject|0|||
33505356|NCT00814333|101744683|FG000|Enrollment|Lost to Follow-up|1|||
33505357|NCT00814333|101744684|FG001|Enrollment|Lost to Follow-up|0|||
33505358|NCT00582816|101744685|FG000|Overall Study|Engraftment Failure|3|||
33505359|NCT01011465|101744686|FG000|Overall Study|Withdrawal by Subject|2|||
33505360|NCT01011465|101744687|FG001|Overall Study|Withdrawal by Subject|1|||
33505361|NCT01011465|101744688|FG002|Overall Study|Withdrawal by Subject|0|||
33505362|NCT01011465|101744689|FG003|Overall Study|Withdrawal by Subject|0|||
33603158|NCT02528357|102099186|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603159|NCT02528357|102099187|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603160|NCT02528357|102099188|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33314787|NCT02074553|101044550|FG004|Washout Period 3|Physician Decision|0|||
33314788|NCT02074553|101044551|FG005|Washout Period 3|Physician Decision|0|||
33314789|NCT02074553|101044552|FG006|Washout Period 3|Physician Decision|0|||
33314790|NCT02074553|101044553|FG007|Washout Period 3|Physician Decision|1|||
33314791|NCT00448279|101044554|FG000|Overall Study|Lost to Follow-up|2|||
33314792|NCT00448279|101044555|FG001|Overall Study|Lost to Follow-up|2|||
33314793|NCT00448279|101044554|FG000|Overall Study|Adverse Event|1|||
33314794|NCT00448279|101044555|FG001|Overall Study|Adverse Event|1|||
33314795|NCT00448279|101044554|FG000|Overall Study|Disease progression|16|||
33314796|NCT00448279|101044555|FG001|Overall Study|Disease progression|18|||
33314797|NCT00448279|101044554|FG000|Overall Study|Withdrawal by Subject|4|||
33314798|NCT00448279|101044555|FG001|Overall Study|Withdrawal by Subject|3|||
33314799|NCT00448279|101044554|FG000|Overall Study|Other|6|||
33314800|NCT00448279|101044555|FG001|Overall Study|Other|4|||
33314801|NCT00448279|101044554|FG000|Overall Study|Protocol Violation|0|||
33314802|NCT00448279|101044555|FG001|Overall Study|Protocol Violation|1|||
33314803|NCT02294227|101044557|FG000|Overall Study|Death|0|||
33314804|NCT02294227|101044558|FG001|Overall Study|Death|0|||
33314805|NCT02294227|101044559|FG002|Overall Study|Death|1|||
33314806|NCT02294227|101044557|FG000|Overall Study|Subject/Guardian Decision|6|||
33314807|NCT02294227|101044558|FG001|Overall Study|Subject/Guardian Decision|3|||
33314808|NCT02294227|101044559|FG002|Overall Study|Subject/Guardian Decision|7|||
33314809|NCT02294227|101044557|FG000|Overall Study|Physician Decision|1|||
33505363|NCT01011465|101744690|FG004|Overall Study|Withdrawal by Subject|1|||
33505364|NCT01011465|101744691|FG005|Overall Study|Withdrawal by Subject|0|||
33505365|NCT01011465|101744692|FG006|Overall Study|Withdrawal by Subject|1|||
33505366|NCT01011465|101744693|FG007|Overall Study|Withdrawal by Subject|0|||
33314810|NCT02294227|101044558|FG001|Overall Study|Physician Decision|2|||
33505367|NCT04553471|101744696|FG000|Overall Study|Did not start treatment on protocol|3|||
33505368|NCT04553471|101744696|FG000|Overall Study|Death|1|||
33505369|NCT03224598|101744698|FG000|Overall Study|Lost to Follow-up|0|||
33505370|NCT03224598|101744699|FG001|Overall Study|Lost to Follow-up|2|||
33505371|NCT03224598|101744700|FG002|Overall Study|Lost to Follow-up|0|||
33505372|NCT03224598|101744698|FG000|Overall Study|Other|0|||
33505373|NCT03224598|101744699|FG001|Overall Study|Other|1|||
33505374|NCT03224598|101744700|FG002|Overall Study|Other|0|||
33505375|NCT00627445|101744703|FG000|Overall Study|Adverse Event|3|||
33505376|NCT00627445|101744704|FG001|Overall Study|Adverse Event|3|||
33505377|NCT00627445|101744703|FG000|Overall Study|Lack of Efficacy|0|||
33505378|NCT00627445|101744704|FG001|Overall Study|Lack of Efficacy|1|||
33505379|NCT00627445|101744703|FG000|Overall Study|Other|6|||
33505380|NCT00627445|101744704|FG001|Overall Study|Other|8|||
33505381|NCT00685399|101744705|FG000|Treatment Period 1|Withdrawal by Subject|2|||
33505382|NCT00685399|101744706|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33505383|NCT00685399|101744707|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33505384|NCT00685399|101744708|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33505385|NCT00685399|101744709|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33505386|NCT00685399|101744710|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33505387|NCT00685399|101744711|FG006|Treatment Period 1|Withdrawal by Subject|0|||
33505388|NCT00685399|101744712|FG007|Treatment Period 1|Withdrawal by Subject|0|||
33505389|NCT00685399|101744705|FG000|Treatment Period 1|Protocol Violation|1|||
33505390|NCT00685399|101744706|FG001|Treatment Period 1|Protocol Violation|0|||
33505391|NCT00685399|101744707|FG002|Treatment Period 1|Protocol Violation|0|||
33505392|NCT00685399|101744708|FG003|Treatment Period 1|Protocol Violation|0|||
33505393|NCT00685399|101744709|FG004|Treatment Period 1|Protocol Violation|0|||
33603161|NCT02528357|102099189|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603162|NCT02528357|102099190|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603163|NCT02528357|102099191|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603164|NCT02528357|102099192|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603165|NCT02528357|102099193|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603166|NCT02528357|102099194|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603167|NCT02528357|102099195|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
33603168|NCT02528357|102099196|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603169|NCT02528357|102099197|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603170|NCT02528357|102099198|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603171|NCT02528357|102099199|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603172|NCT02528357|102099200|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
33603173|NCT02528357|102099182|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33603174|NCT02528357|102099183|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33603175|NCT02528357|102099184|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33603176|NCT02528357|102099185|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33603177|NCT02528357|102099186|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33603178|NCT02528357|102099187|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33603179|NCT02528357|102099188|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33603180|NCT02528357|102099189|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33603181|NCT02528357|102099190|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33603182|NCT02528357|102099191|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33603183|NCT02528357|102099192|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
33603184|NCT02528357|102099193|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33603185|NCT02528357|102099194|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
33603186|NCT02528357|102099195|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
33603187|NCT02528357|102099196|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
33603188|NCT02528357|102099197|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33603189|NCT02528357|102099198|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33603190|NCT02528357|102099199|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33396627|NCT02045979|101341887|FG002|Overall Study|Informed Consent Withdrawn|1|||
33396628|NCT02045979|101341885|FG000|Overall Study|not specified above|0|||
33396629|NCT02045979|101341886|FG001|Overall Study|not specified above|1|||
33396630|NCT02045979|101341887|FG002|Overall Study|not specified above|0|||
33396631|NCT03607994|101341891|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
33505394|NCT00685399|101744710|FG005|Treatment Period 1|Protocol Violation|0|||
33505395|NCT00685399|101744711|FG006|Treatment Period 1|Protocol Violation|0|||
33505396|NCT00685399|101744712|FG007|Treatment Period 1|Protocol Violation|0|||
33505397|NCT00685399|101744705|FG000|Treatment Period 1|Administrative|2|||
33505398|NCT00685399|101744706|FG001|Treatment Period 1|Administrative|0|||
33505399|NCT00685399|101744707|FG002|Treatment Period 1|Administrative|0|||
33505400|NCT00685399|101744708|FG003|Treatment Period 1|Administrative|0|||
33505401|NCT00685399|101744709|FG004|Treatment Period 1|Administrative|0|||
33505402|NCT00685399|101744710|FG005|Treatment Period 1|Administrative|0|||
33505403|NCT00685399|101744711|FG006|Treatment Period 1|Administrative|0|||
33505404|NCT00685399|101744712|FG007|Treatment Period 1|Administrative|0|||
33505405|NCT00685399|101744705|FG000|Treatment Period 1|Lack of Efficacy|1|||
33505406|NCT00685399|101744706|FG001|Treatment Period 1|Lack of Efficacy|0|||
33505407|NCT00685399|101744707|FG002|Treatment Period 1|Lack of Efficacy|0|||
33505408|NCT00685399|101744708|FG003|Treatment Period 1|Lack of Efficacy|0|||
33505409|NCT00685399|101744709|FG004|Treatment Period 1|Lack of Efficacy|0|||
33505410|NCT00685399|101744710|FG005|Treatment Period 1|Lack of Efficacy|0|||
33505411|NCT00685399|101744711|FG006|Treatment Period 1|Lack of Efficacy|0|||
33505412|NCT00685399|101744712|FG007|Treatment Period 1|Lack of Efficacy|0|||
33505413|NCT00685399|101744705|FG000|Treatment Period 2|Administrative Problems|0|||
33505414|NCT00685399|101744706|FG001|Treatment Period 2|Administrative Problems|2|||
33505415|NCT00685399|101744707|FG002|Treatment Period 2|Administrative Problems|1|||
33505416|NCT00685399|101744708|FG003|Treatment Period 2|Administrative Problems|0|||
33505417|NCT00685399|101744709|FG004|Treatment Period 2|Administrative Problems|0|||
33505418|NCT00685399|101744710|FG005|Treatment Period 2|Administrative Problems|0|||
33505419|NCT00685399|101744711|FG006|Treatment Period 2|Administrative Problems|0|||
33505420|NCT00685399|101744712|FG007|Treatment Period 2|Administrative Problems|0|||
33505421|NCT00685399|101744705|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33505422|NCT00685399|101744706|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33505423|NCT00685399|101744707|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33505424|NCT00685399|101744708|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33505425|NCT00685399|101744709|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33505426|NCT00685399|101744710|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33505427|NCT00685399|101744711|FG006|Treatment Period 2|Withdrawal by Subject|0|||
33505428|NCT00685399|101744712|FG007|Treatment Period 2|Withdrawal by Subject|2|||
33505429|NCT00685399|101744705|FG000|Treatment Period 2|Adverse Event|0|||
33505430|NCT00685399|101744706|FG001|Treatment Period 2|Adverse Event|0|||
33505431|NCT00685399|101744707|FG002|Treatment Period 2|Adverse Event|0|||
33505432|NCT00685399|101744708|FG003|Treatment Period 2|Adverse Event|0|||
33505433|NCT00685399|101744709|FG004|Treatment Period 2|Adverse Event|0|||
33505434|NCT00685399|101744710|FG005|Treatment Period 2|Adverse Event|1|||
33505435|NCT00685399|101744711|FG006|Treatment Period 2|Adverse Event|0|||
33505436|NCT00685399|101744712|FG007|Treatment Period 2|Adverse Event|0|||
33505437|NCT00685399|101744705|FG000|Treatment Period 2|Lack of Efficacy|0|||
33505438|NCT00685399|101744706|FG001|Treatment Period 2|Lack of Efficacy|10|||
33505439|NCT00685399|101744707|FG002|Treatment Period 2|Lack of Efficacy|2|||
33505440|NCT00685399|101744708|FG003|Treatment Period 2|Lack of Efficacy|0|||
33505441|NCT00685399|101744709|FG004|Treatment Period 2|Lack of Efficacy|0|||
33505442|NCT00685399|101744710|FG005|Treatment Period 2|Lack of Efficacy|1|||
33505443|NCT00685399|101744711|FG006|Treatment Period 2|Lack of Efficacy|0|||
33505444|NCT00685399|101744712|FG007|Treatment Period 2|Lack of Efficacy|0|||
33505445|NCT00685399|101744705|FG000|Extension|Administrative Issues|0|||
33505446|NCT00685399|101744706|FG001|Extension|Administrative Issues|0|||
33505447|NCT00685399|101744707|FG002|Extension|Administrative Issues|0|||
33505448|NCT00685399|101744708|FG003|Extension|Administrative Issues|1|||
33505449|NCT00685399|101744709|FG004|Extension|Administrative Issues|0|||
33505450|NCT00685399|101744710|FG005|Extension|Administrative Issues|0|||
33505451|NCT00685399|101744711|FG006|Extension|Administrative Issues|0|||
33194961|NCT02880371|100619527|FG005|Phase 2|End of Study page not completed by error|1|||
33194962|NCT02880371|100619528|FG006|Phase 2|End of Study page not completed by error|0|||
33194963|NCT02880371|100619529|FG007|Phase 2|End of Study page not completed by error|0|||
33194964|NCT03698773|100619532|FG000|Overall Study|Lost to Follow-up|2|||
33194965|NCT03698773|100619533|FG001|Overall Study|Lost to Follow-up|1|||
33194966|NCT03146650|100619542|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
33194967|NCT03146650|100619542|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
33194968|NCT03146650|100619542|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
33505452|NCT00685399|101744712|FG007|Extension|Administrative Issues|0|||
33505453|NCT00685399|101744705|FG000|Extension|Withdrawal by Subject|0|||
33505454|NCT00685399|101744706|FG001|Extension|Withdrawal by Subject|0|||
33505455|NCT00685399|101744707|FG002|Extension|Withdrawal by Subject|0|||
33505456|NCT00685399|101744708|FG003|Extension|Withdrawal by Subject|1|||
33505457|NCT00685399|101744709|FG004|Extension|Withdrawal by Subject|0|||
33505458|NCT00685399|101744710|FG005|Extension|Withdrawal by Subject|0|||
33505459|NCT00685399|101744711|FG006|Extension|Withdrawal by Subject|0|||
33603191|NCT02528357|102099200|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
33314811|NCT02294227|101044559|FG002|Overall Study|Physician Decision|1|||
33314812|NCT02294227|101044557|FG000|Overall Study|Lost to Follow-up|1|||
33314813|NCT02294227|101044558|FG001|Overall Study|Lost to Follow-up|0|||
33314814|NCT02294227|101044559|FG002|Overall Study|Lost to Follow-up|0|||
33314815|NCT02294227|101044557|FG000|Overall Study|Lack of Efficacy|11|||
33314816|NCT02294227|101044558|FG001|Overall Study|Lack of Efficacy|12|||
33314817|NCT02294227|101044559|FG002|Overall Study|Lack of Efficacy|8|||
33314818|NCT02294227|101044557|FG000|Overall Study|Adverse Event|6|||
33314819|NCT02294227|101044558|FG001|Overall Study|Adverse Event|8|||
33314820|NCT02294227|101044559|FG002|Overall Study|Adverse Event|2|||
33314821|NCT02325557|101044560|FG000|Overall Study|Progressive disease|1|||
33314822|NCT02325557|101044561|FG001|Overall Study|Progressive disease|0|||
33314823|NCT02325557|101044562|FG002|Overall Study|Progressive disease|0|||
33314824|NCT02325557|101044563|FG003|Overall Study|Progressive disease|0|||
33314825|NCT02325557|101044560|FG000|Overall Study|Withdrawal by Subject|4|||
33396632|NCT03607994|101341892|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
33396633|NCT01142791|101341893|FG000|Overall Study|Alternative Treatment|1|||
33505460|NCT00685399|101744712|FG007|Extension|Withdrawal by Subject|0|||
33505461|NCT00685399|101744705|FG000|Extension|Protocol Violation|0|||
33505462|NCT00685399|101744706|FG001|Extension|Protocol Violation|0|||
33505463|NCT00685399|101744707|FG002|Extension|Protocol Violation|0|||
33505464|NCT00685399|101744708|FG003|Extension|Protocol Violation|1|||
33505465|NCT00685399|101744709|FG004|Extension|Protocol Violation|0|||
33505466|NCT00685399|101744710|FG005|Extension|Protocol Violation|0|||
33603192|NCT02528357|102099182|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33194969|NCT03146650|100619542|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
33194970|NCT03146650|100619542|FG000|2 Year Follow-up|Death|11|||
33505467|NCT00685399|101744711|FG006|Extension|Protocol Violation|0|||
33505468|NCT00685399|101744712|FG007|Extension|Protocol Violation|0|||
33505469|NCT00685399|101744705|FG000|Extension|Lack of Efficacy|0|||
33505470|NCT00685399|101744706|FG001|Extension|Lack of Efficacy|0|||
33505471|NCT00685399|101744707|FG002|Extension|Lack of Efficacy|0|||
33505472|NCT00685399|101744708|FG003|Extension|Lack of Efficacy|2|||
33505473|NCT00685399|101744709|FG004|Extension|Lack of Efficacy|0|||
33505474|NCT00685399|101744710|FG005|Extension|Lack of Efficacy|0|||
33505475|NCT00685399|101744711|FG006|Extension|Lack of Efficacy|0|||
33505476|NCT00685399|101744712|FG007|Extension|Lack of Efficacy|0|||
33505477|NCT00685399|101744705|FG000|Extension|Adverse Event|0|||
33505478|NCT00685399|101744706|FG001|Extension|Adverse Event|0|||
33505479|NCT00685399|101744707|FG002|Extension|Adverse Event|0|||
33505480|NCT00685399|101744708|FG003|Extension|Adverse Event|2|||
33505481|NCT00685399|101744709|FG004|Extension|Adverse Event|0|||
33505482|NCT00685399|101744710|FG005|Extension|Adverse Event|0|||
33505483|NCT00685399|101744711|FG006|Extension|Adverse Event|0|||
33505484|NCT00685399|101744712|FG007|Extension|Adverse Event|0|||
33505485|NCT00427921|101744715|FG000|Overall Study|Adverse Event|26|||
33505486|NCT00427921|101744715|FG000|Overall Study|Withdrawal by Subject|4|||
33505487|NCT00427921|101744715|FG000|Overall Study|Lost to Follow-up|2|||
33505488|NCT00427921|101744715|FG000|Overall Study|Other reason not specified|10|||
33505489|NCT00427921|101744715|FG000|Overall Study|Adverse Event + Hospitalization|1|||
33194971|NCT03146650|100619542|FG000|2 Year Follow-up|Still in follow-up|7|||
33194972|NCT03146650|100619542|FG000|2 Year Follow-up|Lost to Follow-up|1|||
33194973|NCT04439240|100619543|FG000|Overall Study|Ineligible|2|||
33194974|NCT04439240|100619543|FG000|Overall Study|Never started treatment|2|||
33194975|NCT04439240|100619543|FG000|Overall Study|Adverse Event|12|||
33194976|NCT04439240|100619543|FG000|Overall Study|Death|2|||
33194977|NCT04439240|100619543|FG000|Overall Study|Disease progression|25|||
33194978|NCT04439240|100619543|FG000|Overall Study|Other diseases|2|||
33194979|NCT04439240|100619543|FG000|Overall Study|Withdrawal by Subject|3|||
33194980|NCT04439240|100619543|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
33194981|NCT04439240|100619543|FG000|Overall Study|Symptomatic decline|1|||
33194982|NCT04439240|100619543|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
33194983|NCT04439240|100619543|FG000|Overall Study|Clinical progression|1|||
33194984|NCT00724451|100619544|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
33194985|NCT00724451|100619544|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
33194986|NCT00724451|100619544|FG000|Overall Study|Not Eligible for Treatment|431|||
33194987|NCT00724451|100619544|FG000|Overall Study|Participant Refused Treatment|89|||
33194988|NCT00724451|100619544|FG000|Overall Study|Never Started Treatment|89|||
33194989|NCT00724451|100619544|FG000|Overall Study|Unknown; No Data Sources Available|9|||
33194990|NCT00724451|100619544|FG000|Overall Study|Physician Decision|116|||
33194991|NCT00724451|100619544|FG000|Overall Study|Withdrawal by Subject|45|||
33194992|NCT00724451|100619544|FG000|Overall Study|Investigator + Participant Decision|13|||
33194993|NCT00912405|100619548|FG000|Overall Study|Lost to Follow-up|5|||
33194994|NCT02992899|100619549|FG000|Overall Study|Withdrawal by Subject|1|||
33194995|NCT02992899|100619550|FG001|Overall Study|Withdrawal by Subject|0|||
33194996|NCT02992899|100619549|FG000|Overall Study|Lost to Follow-up|1|||
33194997|NCT02992899|100619550|FG001|Overall Study|Lost to Follow-up|3|||
33194998|NCT01824303|100619551|FG000|Randomized Study|Withdrawal by Subject|1|||
33194999|NCT01824303|100619552|FG001|Randomized Study|Withdrawal by Subject|1|||
33195000|NCT01824303|100619551|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
33195001|NCT01824303|100619552|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
33195002|NCT00306592|100619555|FG000|Overall Study|Adverse Event|8|||
33195003|NCT00306592|100619556|FG001|Overall Study|Adverse Event|15|||
33195004|NCT00306592|100619555|FG000|Overall Study|Lost to Follow-up|1|||
33195005|NCT00306592|100619556|FG001|Overall Study|Lost to Follow-up|0|||
33195006|NCT00306592|100619555|FG000|Overall Study|Noncompliance|0|||
33195007|NCT00306592|100619556|FG001|Overall Study|Noncompliance|2|||
33195008|NCT00306592|100619555|FG000|Overall Study|Persistent Antibodies|6|||
33195009|NCT00306592|100619556|FG001|Overall Study|Persistent Antibodies|3|||
33314826|NCT02325557|101044561|FG001|Overall Study|Withdrawal by Subject|0|||
33314827|NCT02325557|101044562|FG002|Overall Study|Withdrawal by Subject|0|||
33314828|NCT02325557|101044563|FG003|Overall Study|Withdrawal by Subject|15|||
33505490|NCT00427921|101744715|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
33505491|NCT00427921|101744715|FG000|Overall Study|Adverse Event + No Response|1|||
33505492|NCT00427921|101744715|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
33195010|NCT00306592|100619555|FG000|Overall Study|Voluntary|10|||
33195011|NCT00306592|100619556|FG001|Overall Study|Voluntary|6|||
33195012|NCT00306592|100619555|FG000|Overall Study|Other|5|||
33505493|NCT00427921|101744715|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
33505494|NCT00427921|101744715|FG000|Overall Study|Adverse Event + Lost Response|1|||
33505495|NCT00427921|101744715|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
33505496|NCT00427921|101744715|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
33195013|NCT00306592|100619556|FG001|Overall Study|Other|10|||
33195014|NCT00306592|100619555|FG000|Overall Study|Other|1|||
33195015|NCT00306592|100619556|FG001|Overall Study|Other|2|||
33195016|NCT00306592|100619555|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
33505497|NCT02058537|101744716|FG000|Overall Study|Withdrawal by Subject|1|||
33505498|NCT01194999|101744717|FG000|Overall Study|Lost to Follow-up|17|||
33505499|NCT00930774|101744720|FG000|Overall Study|Withdrawal by Subject|1|||
33505500|NCT00930774|101744721|FG001|Overall Study|Withdrawal by Subject|9|||
33505501|NCT00930774|101744722|FG002|Overall Study|Withdrawal by Subject|2|||
33505502|NCT00930774|101744723|FG003|Overall Study|Withdrawal by Subject|0|||
33505503|NCT00459290|101744724|FG000|Overall Study|Adverse Event|3|||
33505504|NCT00459290|101744724|FG000|Overall Study|Ineligible|2|||
33505505|NCT02101736|101744733|FG000|Overall Study|Protocol Violation|3|||
33505506|NCT02101736|101744734|FG001|Overall Study|Protocol Violation|0|||
33505507|NCT02101736|101744733|FG000|Overall Study|Withdrawal by Subject|1|||
33505508|NCT02101736|101744734|FG001|Overall Study|Withdrawal by Subject|1|||
33505509|NCT02276560|101744735|FG000|Overall Study|Adverse Event|1|||
33505510|NCT02276560|101744736|FG001|Overall Study|Adverse Event|0|||
33505511|NCT02276560|101744737|FG002|Overall Study|Adverse Event|0|||
33505512|NCT04480424|101744742|FG000|Overall Study|Withdrawal by Subject|0|||
33505513|NCT04480424|101744743|FG001|Overall Study|Withdrawal by Subject|2|||
33314829|NCT02325557|101044560|FG000|Overall Study|Death|5|||
33314830|NCT02325557|101044561|FG001|Overall Study|Death|1|||
33314831|NCT02325557|101044562|FG002|Overall Study|Death|1|||
33314832|NCT02325557|101044563|FG003|Overall Study|Death|16|||
33314833|NCT02325557|101044560|FG000|Overall Study|Lost to Follow-up|0|||
33314834|NCT02325557|101044561|FG001|Overall Study|Lost to Follow-up|0|||
33314835|NCT02325557|101044562|FG002|Overall Study|Lost to Follow-up|1|||
33314836|NCT02325557|101044563|FG003|Overall Study|Lost to Follow-up|1|||
33314837|NCT02325557|101044560|FG000|Overall Study|Other|0|||
33314838|NCT02325557|101044561|FG001|Overall Study|Other|0|||
33314839|NCT02325557|101044562|FG002|Overall Study|Other|0|||
33314840|NCT02325557|101044563|FG003|Overall Study|Other|5|||
33314841|NCT04281004|101044564|FG000|Overall Study|Physician Decision|1|||
33314842|NCT04281004|101044565|FG001|Overall Study|Physician Decision|0|||
33314843|NCT00561951|101047417|FG000|Overall Study|Adverse Event|11|||
33314844|NCT00561951|101047418|FG001|Overall Study|Adverse Event|14|||
33314845|NCT00561951|101047419|FG002|Overall Study|Adverse Event|14|||
33314846|NCT00561951|101047417|FG000|Overall Study|Lack of Efficacy|5|||
33314847|NCT00561951|101047418|FG001|Overall Study|Lack of Efficacy|3|||
33314848|NCT00561951|101047419|FG002|Overall Study|Lack of Efficacy|2|||
33314849|NCT00561951|101047417|FG000|Overall Study|Lost to Follow-up|1|||
33314850|NCT00561951|101047418|FG001|Overall Study|Lost to Follow-up|1|||
33396634|NCT01142791|101341894|FG001|Overall Study|Alternative Treatment|0|||
33314851|NCT00561951|101047419|FG002|Overall Study|Lost to Follow-up|0|||
33314852|NCT00561951|101047417|FG000|Overall Study|Withdrawal by Subject|10|||
33314853|NCT00561951|101047418|FG001|Overall Study|Withdrawal by Subject|9|||
33314854|NCT00561951|101047419|FG002|Overall Study|Withdrawal by Subject|10|||
33314855|NCT00561951|101047417|FG000|Overall Study|Protocol Violation|4|||
33314856|NCT00561951|101047418|FG001|Overall Study|Protocol Violation|3|||
33314857|NCT00561951|101047419|FG002|Overall Study|Protocol Violation|4|||
33314858|NCT00561951|101047417|FG000|Overall Study|Physician Decision|1|||
33396635|NCT01142791|101341893|FG000|Overall Study|Lost to Follow-up|1|||
33396636|NCT01142791|101341894|FG001|Overall Study|Lost to Follow-up|0|||
33396637|NCT01142791|101341893|FG000|Overall Study|Withdrawal by Subject|5|||
33396638|NCT01142791|101341894|FG001|Overall Study|Withdrawal by Subject|0|||
33396639|NCT01142791|101341893|FG000|Overall Study|Received only 1 sonication|0|||
33396640|NCT01142791|101341894|FG001|Overall Study|Received only 1 sonication|6|||
33396641|NCT02590406|101341900|FG000|Overall Study|Adverse Event|1|||
33396642|NCT02590406|101341901|FG001|Overall Study|Adverse Event|0|||
33396643|NCT02590406|101341900|FG000|Overall Study|Saturometer malfunction|0|||
33396644|NCT02590406|101341901|FG001|Overall Study|Saturometer malfunction|1|||
33396645|NCT01646255|101341902|FG000|Overall Study|Adverse Event|7|||
33396646|NCT01646255|101341903|FG001|Overall Study|Adverse Event|8|||
33396647|NCT01646255|101341902|FG000|Overall Study|Lack of Efficacy|2|||
33396648|NCT01646255|101341903|FG001|Overall Study|Lack of Efficacy|0|||
33396649|NCT01646255|101341902|FG000|Overall Study|Withdrawal by Subject|10|||
33396650|NCT01646255|101341903|FG001|Overall Study|Withdrawal by Subject|6|||
33396651|NCT01646255|101341902|FG000|Overall Study|Compliance is not well|1|||
33505514|NCT04480424|101744742|FG000|Overall Study|Lost to Follow-up|3|||
33505515|NCT04480424|101744743|FG001|Overall Study|Lost to Follow-up|3|||
33631264|NCT01231906|102202898|FG001|Overall Study|Withdrawal by Subject|4|||
33314859|NCT00561951|101047418|FG001|Overall Study|Physician Decision|0|||
33314860|NCT00561951|101047419|FG002|Overall Study|Physician Decision|0|||
33314861|NCT00561951|101047417|FG000|Overall Study|Pregnancy|0|||
33314862|NCT00561951|101047418|FG001|Overall Study|Pregnancy|1|||
33314863|NCT00561951|101047419|FG002|Overall Study|Pregnancy|0|||
33314864|NCT00561951|101047417|FG000|Overall Study|Meet Withdrawal Criterion|0|||
33314865|NCT00561951|101047418|FG001|Overall Study|Meet Withdrawal Criterion|1|||
33396652|NCT01646255|101341903|FG001|Overall Study|Compliance is not well|0|||
33396653|NCT01646255|101341902|FG000|Overall Study|Inclusion Criteria Deviation|1|||
33396654|NCT01646255|101341903|FG001|Overall Study|Inclusion Criteria Deviation|0|||
33314866|NCT00561951|101047419|FG002|Overall Study|Meet Withdrawal Criterion|1|||
33505516|NCT04480424|101744742|FG000|Overall Study|Death|14|||
33505517|NCT04480424|101744743|FG001|Overall Study|Death|16|||
33505518|NCT04480424|101744742|FG000|Overall Study|Reason not Specified|5|||
33505519|NCT04480424|101744743|FG001|Overall Study|Reason not Specified|5|||
33505520|NCT03412734|101744744|FG000|Overall Study|Incorrect labeling of samples|2|||
33505521|NCT03412734|101744745|FG001|Overall Study|Incorrect labeling of samples|0|||
33505522|NCT03412734|101744744|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
33505523|NCT03412734|101744745|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
33505524|NCT02714595|101744746|FG000|Overall Study|Lost to Follow-up|1|||
33505525|NCT02714595|101744747|FG001|Overall Study|Lost to Follow-up|0|||
33505526|NCT02714595|101744746|FG000|Overall Study|Withdrawal by Subject|1|||
33505527|NCT02714595|101744747|FG001|Overall Study|Withdrawal by Subject|2|||
33505528|NCT02714595|101744746|FG000|Overall Study|Lack of Efficacy|0|||
33505529|NCT02714595|101744747|FG001|Overall Study|Lack of Efficacy|1|||
33505530|NCT02714595|101744746|FG000|Overall Study|Death|30|||
33505531|NCT02714595|101744747|FG001|Overall Study|Death|9|||
33505532|NCT02714595|101744746|FG000|Overall Study|Other-Miscellaneous|0|||
33505533|NCT02714595|101744747|FG001|Overall Study|Other-Miscellaneous|1|||
33195017|NCT00306592|100619556|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
33195018|NCT00555438|100619557|FG000|10 Days Post-operative|Death|4|||
33195019|NCT00555438|100619557|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
33195020|NCT02097134|100619558|FG000|Overall Study|Physician Decision|4|||
33195021|NCT02097134|100619558|FG000|Overall Study|Non-Protocol Therapy|1|||
33195022|NCT02097134|100619558|FG000|Overall Study|Progressive Disease|3|||
33396655|NCT00589602|101341904|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
33195023|NCT02097134|100619558|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
33195024|NCT02565381|100619559|FG000|Overall Study|Lost to Follow-up|1|||
33195025|NCT02565381|100619560|FG001|Overall Study|Lost to Follow-up|0|||
33314867|NCT00561951|101047417|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
33314868|NCT00561951|101047418|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
33314869|NCT00561951|101047419|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
33314870|NCT01551212|101047421|FG000|Overall Study|Graft loss/Retransplantation|0|||
33314871|NCT01551212|101047422|FG001|Overall Study|Graft loss/Retransplantation|1|||
33314872|NCT01551212|101047421|FG000|Overall Study|Administrative problems|1|||
33314873|NCT01551212|101047422|FG001|Overall Study|Administrative problems|2|||
33314874|NCT01551212|101047421|FG000|Overall Study|Lost to Follow-up|0|||
33314875|NCT01551212|101047422|FG001|Overall Study|Lost to Follow-up|1|||
33314876|NCT01551212|101047421|FG000|Overall Study|Protocol Violation|0|||
33314877|NCT01551212|101047422|FG001|Overall Study|Protocol Violation|1|||
33314878|NCT01551212|101047421|FG000|Overall Study|Withdrawal by Subject|0|||
33314879|NCT01551212|101047422|FG001|Overall Study|Withdrawal by Subject|7|||
33314880|NCT01551212|101047421|FG000|Overall Study|Death|2|||
33314881|NCT01551212|101047422|FG001|Overall Study|Death|4|||
33314882|NCT01551212|101047421|FG000|Overall Study|Never Received Study Treatment|2|||
33314883|NCT01551212|101047422|FG001|Overall Study|Never Received Study Treatment|4|||
33314884|NCT00899548|101047423|FG000|Overall Study|Physician Decision|3|||
33314885|NCT00504881|101047424|FG000|Overall Study|Lack of Efficacy|1|||
33314886|NCT00504881|101047425|FG001|Overall Study|Lack of Efficacy|5|||
33314887|NCT00504881|101047424|FG000|Overall Study|Lost to Follow-up|0|||
33314888|NCT00504881|101047425|FG001|Overall Study|Lost to Follow-up|2|||
33505534|NCT00994461|101744748|FG000|Overall Study|Adverse Event|2|||
33195026|NCT02565381|100619561|FG002|Overall Study|Lost to Follow-up|1|||
33195027|NCT01208233|100619566|FG000|Overall Study|Adverse Event|0|||
33195028|NCT01208233|100619567|FG001|Overall Study|Adverse Event|1|||
33195029|NCT01208233|100619568|FG002|Overall Study|Adverse Event|2|||
33195030|NCT01208233|100619569|FG003|Overall Study|Adverse Event|0|||
33195031|NCT01208233|100619570|FG004|Overall Study|Adverse Event|3|||
33195032|NCT01208233|100619571|FG005|Overall Study|Adverse Event|5|||
33195033|NCT01208233|100619566|FG000|Overall Study|Death|0|||
33195034|NCT01208233|100619567|FG001|Overall Study|Death|0|||
33195035|NCT01208233|100619568|FG002|Overall Study|Death|0|||
33195036|NCT01208233|100619569|FG003|Overall Study|Death|0|||
33195037|NCT01208233|100619570|FG004|Overall Study|Death|3|||
33195038|NCT01208233|100619571|FG005|Overall Study|Death|5|||
33195039|NCT01208233|100619566|FG000|Overall Study|Did not meet entrance criteria|2|||
33314889|NCT00504881|101047424|FG000|Overall Study|Withdrawal by Subject|1|||
33314890|NCT00504881|101047425|FG001|Overall Study|Withdrawal by Subject|4|||
33505535|NCT00994461|101744749|FG001|Overall Study|Adverse Event|1|||
33195040|NCT01208233|100619567|FG001|Overall Study|Did not meet entrance criteria|1|||
33505536|NCT00994461|101744750|FG002|Overall Study|Adverse Event|0|||
33505537|NCT02751931|101744756|FG000|Overall Study|Adverse Event|3|||
33195041|NCT01208233|100619568|FG002|Overall Study|Did not meet entrance criteria|1|||
33195042|NCT01208233|100619569|FG003|Overall Study|Did not meet entrance criteria|0|||
33314891|NCT00504881|101047424|FG000|Overall Study|Non-Compliance|1|||
33314892|NCT00504881|101047425|FG001|Overall Study|Non-Compliance|0|||
33314893|NCT00504881|101047424|FG000|Overall Study|No Birth Control|0|||
33314894|NCT00504881|101047425|FG001|Overall Study|No Birth Control|1|||
33314895|NCT00504881|101047424|FG000|Overall Study|Safety Visit not performed|0|||
33505538|NCT02751931|101744757|FG001|Overall Study|Adverse Event|0|||
33314896|NCT00504881|101047425|FG001|Overall Study|Safety Visit not performed|1|||
33314897|NCT00504881|101047424|FG000|Overall Study|AE, serious fatal|0|||
33396656|NCT02658149|101341905|FG000|Overall Study|Physician Decision|1|||
33396657|NCT02658149|101341906|FG001|Overall Study|Physician Decision|0|||
33396658|NCT03662789|101341907|FG000|Overall Study|Lost to Follow-up|1|||
33396659|NCT03662789|101341908|FG001|Overall Study|Lost to Follow-up|2|||
33396660|NCT03662789|101341907|FG000|Overall Study|Could not perform treadmill test|4|||
33396661|NCT03662789|101341908|FG001|Overall Study|Could not perform treadmill test|4|||
33396662|NCT03662789|101341907|FG000|Overall Study|Death|0|||
33396663|NCT03662789|101341908|FG001|Overall Study|Death|1|||
33396664|NCT00112840|101341911|FG000|Overall Study|Physician Decision|1|||
33396665|NCT00112840|101341912|FG001|Overall Study|Physician Decision|0|||
33396666|NCT00112840|101341913|FG002|Overall Study|Physician Decision|0|||
33396667|NCT00112840|101341911|FG000|Overall Study|Withdrawal by Subject|1|||
33396668|NCT00112840|101341912|FG001|Overall Study|Withdrawal by Subject|0|||
33396669|NCT00112840|101341913|FG002|Overall Study|Withdrawal by Subject|1|||
33396670|NCT00112840|101341911|FG000|Overall Study|Protocol Violation|0|||
33603193|NCT02528357|102099183|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603194|NCT02528357|102099184|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603195|NCT02528357|102099185|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603196|NCT02528357|102099186|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603197|NCT02528357|102099187|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603198|NCT02528357|102099188|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603199|NCT02528357|102099189|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603200|NCT02528357|102099190|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
33603201|NCT02528357|102099191|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
33603202|NCT02528357|102099192|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603203|NCT02528357|102099193|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
33603204|NCT02528357|102099194|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
33603205|NCT02528357|102099195|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
33603206|NCT02528357|102099196|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
33603207|NCT02528357|102099197|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603208|NCT02528357|102099198|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603209|NCT02528357|102099199|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603210|NCT02528357|102099200|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603211|NCT02528357|102099182|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33603212|NCT02528357|102099183|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33603213|NCT02528357|102099184|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33631265|NCT01231906|102202897|FG000|Overall Study|Ineligible|10|||
33314898|NCT00504881|101047425|FG001|Overall Study|AE, serious fatal|1|||
33314899|NCT00504881|101047424|FG000|Overall Study|SAE, non-fatal|2|||
33314900|NCT00504881|101047425|FG001|Overall Study|SAE, non-fatal|6|||
33314901|NCT00504881|101047424|FG000|Overall Study|AE, non-serious non-fatal|4|||
33314902|NCT00504881|101047425|FG001|Overall Study|AE, non-serious non-fatal|14|||
33314903|NCT00504881|101047424|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
33314904|NCT00504881|101047425|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
33314905|NCT00504881|101047424|FG000|Overall Study|AE of unknown type|1|||
33314906|NCT00504881|101047425|FG001|Overall Study|AE of unknown type|0|||
33396671|NCT00112840|101341912|FG001|Overall Study|Protocol Violation|0|||
33396672|NCT00112840|101341913|FG002|Overall Study|Protocol Violation|5|||
33396673|NCT01469637|101341915|FG000|First Intervention|Unacceptable behavior|0|||
33396674|NCT01469637|101341916|FG001|First Intervention|Unacceptable behavior|1|||
33314907|NCT02318797|101047428|FG000|Overall Study|Death|3|||
33314908|NCT02318797|101047429|FG001|Overall Study|Death|6|||
33314909|NCT02318797|101047428|FG000|Overall Study|Lost to Follow-up|85|||
33314910|NCT02318797|101047429|FG001|Overall Study|Lost to Follow-up|96|||
33314911|NCT00494481|101047433|FG000|Overall Study|Condition under investigation worsened|11|||
33314912|NCT00494481|101047434|FG001|Overall Study|Condition under investigation worsened|13|||
33314913|NCT00494481|101047433|FG000|Overall Study|Adverse Event|15|||
33314914|NCT00494481|101047434|FG001|Overall Study|Adverse Event|11|||
33314915|NCT00494481|101047433|FG000|Overall Study|Other|1|||
33314916|NCT00494481|101047434|FG001|Overall Study|Other|0|||
33396675|NCT01469637|101341915|FG000|Second Intervention|Incarcerated|1|||
33396676|NCT01469637|101341916|FG001|Second Intervention|Incarcerated|0|||
33396677|NCT00537810|101341921|FG000|Overall Study|Withdrawal by Subject|4|||
33396678|NCT00537810|101341922|FG001|Overall Study|Withdrawal by Subject|11|||
33396679|NCT00537810|101341923|FG002|Overall Study|Withdrawal by Subject|4|||
33314917|NCT00494481|101047433|FG000|Overall Study|Never received IP|2|||
33314918|NCT00494481|101047434|FG001|Overall Study|Never received IP|0|||
33314919|NCT00824161|101047435|FG000|Overall Study|Withdrawal by Subject|1|||
33314920|NCT00824161|101047435|FG000|Overall Study|Screen Failure|1|||
33314921|NCT01502631|101047436|FG000|Overall Study|Adverse Event|5|||
33314922|NCT01502631|101047437|FG001|Overall Study|Adverse Event|8|||
33314923|NCT01502631|101047436|FG000|Overall Study|Lost to Follow-up|2|||
33314924|NCT01502631|101047437|FG001|Overall Study|Lost to Follow-up|2|||
33314925|NCT01502631|101047436|FG000|Overall Study|Participant withdrew consent|2|||
33314926|NCT01502631|101047437|FG001|Overall Study|Participant withdrew consent|4|||
33314927|NCT01502631|101047436|FG000|Overall Study|Participant non-compliant|1|||
33314928|NCT01502631|101047437|FG001|Overall Study|Participant non-compliant|0|||
33314929|NCT01502631|101047436|FG000|Overall Study|Investigator's decision|0|||
33314930|NCT01502631|101047437|FG001|Overall Study|Investigator's decision|1|||
33314931|NCT01502631|101047436|FG000|Overall Study|Other|10|||
33314932|NCT01502631|101047437|FG001|Overall Study|Other|5|||
33314933|NCT00940108|101047438|FG000|Overall Study|Adverse Event|2|||
33314934|NCT00940108|101047439|FG001|Overall Study|Adverse Event|4|||
33314935|NCT00940108|101047440|FG002|Overall Study|Adverse Event|0|||
33314936|NCT00940108|101047441|FG003|Overall Study|Adverse Event|2|||
33314937|NCT00940108|101047438|FG000|Overall Study|Withdrew Consent|2|||
33314938|NCT00940108|101047439|FG001|Overall Study|Withdrew Consent|1|||
33195043|NCT01208233|100619570|FG004|Overall Study|Did not meet entrance criteria|1|||
33195044|NCT01208233|100619571|FG005|Overall Study|Did not meet entrance criteria|0|||
33195045|NCT01208233|100619566|FG000|Overall Study|Medication error without adverse event|0|||
33195046|NCT01208233|100619567|FG001|Overall Study|Medication error without adverse event|0|||
33195047|NCT01208233|100619568|FG002|Overall Study|Medication error without adverse event|0|||
33195048|NCT01208233|100619569|FG003|Overall Study|Medication error without adverse event|0|||
33195049|NCT01208233|100619570|FG004|Overall Study|Medication error without adverse event|0|||
33195050|NCT01208233|100619571|FG005|Overall Study|Medication error without adverse event|1|||
33195051|NCT01208233|100619566|FG000|Overall Study|Study terminated by sponsor|0|||
33195052|NCT01208233|100619567|FG001|Overall Study|Study terminated by sponsor|0|||
33195053|NCT01208233|100619568|FG002|Overall Study|Study terminated by sponsor|0|||
33195054|NCT01208233|100619569|FG003|Overall Study|Study terminated by sponsor|0|||
33195055|NCT01208233|100619570|FG004|Overall Study|Study terminated by sponsor|10|||
33195056|NCT01208233|100619571|FG005|Overall Study|Study terminated by sponsor|7|||
33195057|NCT01208233|100619566|FG000|Overall Study|Protocol Violation|0|||
33195058|NCT01208233|100619567|FG001|Overall Study|Protocol Violation|0|||
33195059|NCT01208233|100619568|FG002|Overall Study|Protocol Violation|0|||
33195060|NCT01208233|100619569|FG003|Overall Study|Protocol Violation|0|||
33195061|NCT01208233|100619570|FG004|Overall Study|Protocol Violation|3|||
33195062|NCT01208233|100619571|FG005|Overall Study|Protocol Violation|0|||
33195063|NCT01208233|100619566|FG000|Overall Study|Other|2|||
33195064|NCT01208233|100619567|FG001|Overall Study|Other|1|||
33195065|NCT01208233|100619568|FG002|Overall Study|Other|0|||
33195066|NCT01208233|100619569|FG003|Overall Study|Other|0|||
33195067|NCT01208233|100619570|FG004|Overall Study|Other|0|||
33195068|NCT01208233|100619571|FG005|Overall Study|Other|1|||
33195069|NCT01208233|100619566|FG000|Overall Study|Withdrawal by Subject|1|||
33195070|NCT01208233|100619567|FG001|Overall Study|Withdrawal by Subject|0|||
33195071|NCT01208233|100619568|FG002|Overall Study|Withdrawal by Subject|1|||
33195072|NCT01208233|100619569|FG003|Overall Study|Withdrawal by Subject|1|||
33195073|NCT01208233|100619570|FG004|Overall Study|Withdrawal by Subject|4|||
33195074|NCT01208233|100619571|FG005|Overall Study|Withdrawal by Subject|2|||
33195075|NCT04496258|100619572|FG000|Overall Study|Withdrawal by Subject|2|||
33195076|NCT04496258|100619573|FG001|Overall Study|Withdrawal by Subject|1|||
33195077|NCT00550836|100619574|FG000|Overall Study|Withdrawal by Subject|3|||
33195078|NCT00550836|100619575|FG001|Overall Study|Withdrawal by Subject|9|||
33195079|NCT00110266|100619576|FG000|Overall Study|Adverse Event|27|||
33195080|NCT00110266|100619576|FG000|Overall Study|Abnormal laboratory value|15|||
33195081|NCT00110266|100619576|FG000|Overall Study|Withdrawal by Subject|16|||
33195082|NCT00110266|100619576|FG000|Overall Study|Death|17|||
33195083|NCT00110266|100619576|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33195084|NCT00110266|100619576|FG000|Overall Study|Participant condition no longer requires study drug|1|||
33314939|NCT00940108|101047440|FG002|Overall Study|Withdrew Consent|0|||
33505539|NCT02751931|101744756|FG000|Overall Study|Other: Miscelleneous|10|||
33195085|NCT02447991|100619577|FG000|Overall Study|Withdrawn by subject - no data|0|||
33505540|NCT02751931|101744757|FG001|Overall Study|Other: Miscelleneous|8|||
33195086|NCT02447991|100619578|FG001|Overall Study|Withdrawn by subject - no data|2|||
33195087|NCT02447991|100619577|FG000|Overall Study|Withdrawn by Subject - with data|4|||
33195088|NCT02447991|100619578|FG001|Overall Study|Withdrawn by Subject - with data|4|||
33195089|NCT02447991|100619577|FG000|Overall Study|Lost to Follow-up - no data|3|||
33195090|NCT02447991|100619578|FG001|Overall Study|Lost to Follow-up - no data|6|||
33314940|NCT00940108|101047441|FG003|Overall Study|Withdrew Consent|1|||
33314941|NCT00940108|101047438|FG000|Overall Study|Dose 2 contraindicated|1|||
33314942|NCT00940108|101047439|FG001|Overall Study|Dose 2 contraindicated|1|||
33396680|NCT00537810|101341924|FG003|Overall Study|Withdrawal by Subject|3|||
33396681|NCT00537810|101341921|FG000|Overall Study|Medically withdrawn|2|||
33396682|NCT00537810|101341922|FG001|Overall Study|Medically withdrawn|2|||
33396683|NCT00537810|101341923|FG002|Overall Study|Medically withdrawn|0|||
33396684|NCT00537810|101341924|FG003|Overall Study|Medically withdrawn|1|||
33396685|NCT03083470|101341927|FG000|Overall Study|Lost to Follow-up|0|||
33314943|NCT00940108|101047440|FG002|Overall Study|Dose 2 contraindicated|0|||
33314944|NCT00940108|101047441|FG003|Overall Study|Dose 2 contraindicated|1|||
33314945|NCT00940108|101047438|FG000|Overall Study|Declined further vaccination|0|||
33314946|NCT00940108|101047439|FG001|Overall Study|Declined further vaccination|1|||
33314947|NCT00940108|101047440|FG002|Overall Study|Declined further vaccination|3|||
33314948|NCT00940108|101047441|FG003|Overall Study|Declined further vaccination|0|||
33314949|NCT00940108|101047438|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
33314950|NCT00940108|101047439|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
33314951|NCT00940108|101047440|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
33314952|NCT00940108|101047441|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
33314953|NCT00940108|101047438|FG000|Overall Study|Viral illness after Dose 1|0|||
33314954|NCT00940108|101047439|FG001|Overall Study|Viral illness after Dose 1|1|||
33314955|NCT00940108|101047440|FG002|Overall Study|Viral illness after Dose 1|0|||
33314956|NCT00940108|101047441|FG003|Overall Study|Viral illness after Dose 1|0|||
33314957|NCT00940108|101047438|FG000|Overall Study|Diagnosed with H1N1|0|||
33314958|NCT00940108|101047439|FG001|Overall Study|Diagnosed with H1N1|0|||
33314959|NCT00940108|101047440|FG002|Overall Study|Diagnosed with H1N1|0|||
33314960|NCT00940108|101047441|FG003|Overall Study|Diagnosed with H1N1|1|||
33314961|NCT02019927|101047445|FG000|Overall Study|Lost to Follow-up|2|||
33314962|NCT02019927|101047446|FG001|Overall Study|Lost to Follow-up|4|||
33314963|NCT02019927|101047447|FG002|Overall Study|Lost to Follow-up|1|||
33314964|NCT02019927|101047448|FG003|Overall Study|Lost to Follow-up|2|||
33314965|NCT02019927|101047449|FG004|Overall Study|Lost to Follow-up|3|||
33314966|NCT02019927|101047450|FG005|Overall Study|Lost to Follow-up|1|||
33396686|NCT03083470|101341928|FG001|Overall Study|Lost to Follow-up|0|||
33603214|NCT02528357|102099185|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33603215|NCT02528357|102099186|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33603216|NCT02528357|102099187|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33603217|NCT02528357|102099188|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33603218|NCT02528357|102099189|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33314967|NCT03587974|101047451|FG000|Overall Study|caregiver demented, care recipient died|3|||
33314968|NCT03587974|101047452|FG001|Overall Study|caregiver demented, care recipient died|3|||
33314969|NCT03587974|101047451|FG000|Overall Study|Withdrawal by Subject|2|||
33314970|NCT03587974|101047452|FG001|Overall Study|Withdrawal by Subject|1|||
33314971|NCT01745848|101047453|FG000|Overall Study|Adverse Event|6|||
33314972|NCT01030198|101047454|FG000|Overall Study|Could not measure efficacy accurately|0|||
33314973|NCT01030198|101047455|FG001|Overall Study|Could not measure efficacy accurately|7|||
33314974|NCT00799513|101047458|FG000|Overall Study|Physician Decision|1|||
33314975|NCT00799513|101047458|FG000|Overall Study|Adverse Event|1|||
33603219|NCT02528357|102099190|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33603220|NCT02528357|102099191|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33603221|NCT02528357|102099192|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33314976|NCT00421707|101047460|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
33314977|NCT00421707|101047461|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
33396687|NCT03083470|101341929|FG002|Overall Study|Lost to Follow-up|0|||
33396688|NCT03083470|101341930|FG003|Overall Study|Lost to Follow-up|0|||
33396689|NCT03083470|101341931|FG004|Overall Study|Lost to Follow-up|1|||
33603222|NCT02528357|102099193|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33603223|NCT02528357|102099194|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33603224|NCT02528357|102099195|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33603225|NCT02528357|102099196|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33603226|NCT02528357|102099197|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33603227|NCT02528357|102099198|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
33603228|NCT02528357|102099199|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33195091|NCT02447991|100619577|FG000|Overall Study|Lost to follow-up - with data|0|||
33314978|NCT00421707|101047460|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
33314979|NCT00421707|101047461|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
33314980|NCT00421707|101047460|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
33396690|NCT03083470|101341927|FG000|Overall Study|Withdrawal by Subject|0|||
33396691|NCT03083470|101341928|FG001|Overall Study|Withdrawal by Subject|0|||
33396692|NCT03083470|101341929|FG002|Overall Study|Withdrawal by Subject|0|||
33396693|NCT03083470|101341930|FG003|Overall Study|Withdrawal by Subject|0|||
33195092|NCT02447991|100619578|FG001|Overall Study|Lost to follow-up - with data|3|||
33195093|NCT02447991|100619577|FG000|Overall Study|End of study - no treatment results|3|||
33314981|NCT00421707|101047461|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
33603229|NCT02528357|102099200|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
33314982|NCT00421707|101047460|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
33314983|NCT00421707|101047461|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
33314984|NCT00421707|101047460|FG000|Period 2: Washout|Adverse Event|1|||
33314985|NCT00421707|101047461|FG001|Period 2: Washout|Adverse Event|1|||
33314986|NCT00421707|101047460|FG000|Period 2: Washout|Withdrawal by Subject|0|||
33314987|NCT00421707|101047461|FG001|Period 2: Washout|Withdrawal by Subject|1|||
33314988|NCT00421707|101047460|FG000|Period 2: Washout|Lost to Follow-up|0|||
33314989|NCT00421707|101047461|FG001|Period 2: Washout|Lost to Follow-up|1|||
33314990|NCT00421707|101047460|FG000|Period 2: Washout|Other: Pregnancy|0|||
33314991|NCT00421707|101047461|FG001|Period 2: Washout|Other: Pregnancy|1|||
33314992|NCT00421707|101047460|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
33314993|NCT00421707|101047461|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
33314994|NCT00421707|101047460|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
33314995|NCT00421707|101047461|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
33314996|NCT00421707|101047460|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
33314997|NCT00421707|101047461|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
33314998|NCT03718533|101047466|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
33314999|NCT03718533|101047466|FG000|Overall Study|Protocol deviation|1|||
33315000|NCT03718533|101047466|FG000|Overall Study|Disease progression|1|||
33315001|NCT03718533|101047466|FG000|Overall Study|Relapse|1|||
33315002|NCT03718533|101047466|FG000|Overall Study|Physician Decision|2|||
33315003|NCT03718533|101047466|FG000|Overall Study|Physician Decision and Adverse Event|1|||
33315004|NCT02640157|101047470|FG000|Overall Study|Adverse Event|2|||
33315005|NCT02640157|101047471|FG001|Overall Study|Adverse Event|2|||
33315006|NCT02640157|101047472|FG002|Overall Study|Adverse Event|1|||
33315007|NCT02640157|101047470|FG000|Overall Study|Withdrew consent|2|||
33315008|NCT02640157|101047471|FG001|Overall Study|Withdrew consent|0|||
33315009|NCT02640157|101047472|FG002|Overall Study|Withdrew consent|2|||
33315010|NCT02640157|101047470|FG000|Overall Study|Lost to Follow-up|9|||
33315011|NCT02640157|101047471|FG001|Overall Study|Lost to Follow-up|2|||
33315012|NCT02640157|101047472|FG002|Overall Study|Lost to Follow-up|7|||
33315013|NCT02640157|101047470|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
33315014|NCT02640157|101047471|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
33315015|NCT02640157|101047472|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
33315016|NCT01146054|101047473|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
33315017|NCT01146054|101047473|FG000|Overall Study|Rapid tumor progression|2|||
33315018|NCT01146054|101047473|FG000|Overall Study|Other illness precluded treatment|2|||
33315019|NCT01146054|101047473|FG000|Overall Study|Lost to Follow-up|1|||
33315020|NCT03170154|101047474|FG000|Overall Study|Lost to Follow-up|4|||
33315021|NCT03170154|101047474|FG000|Overall Study|Death|2|||
33315022|NCT03170154|101047474|FG000|Overall Study|Withdrawal by Subject|2|||
33315023|NCT02245672|101047475|FG000|Overall Study|Adverse Event|4|||
33396694|NCT03083470|101341931|FG004|Overall Study|Withdrawal by Subject|1|||
33396695|NCT00364611|101341943|FG000|Overall Study|Did not receive study medication|0|||
33396696|NCT00364611|101341944|FG001|Overall Study|Did not receive study medication|1|||
33396697|NCT00364611|101341943|FG000|Overall Study|Adverse Event|7|||
33396698|NCT00364611|101341944|FG001|Overall Study|Adverse Event|4|||
33396699|NCT00364611|101341943|FG000|Overall Study|Participant's Request|3|||
33396700|NCT00364611|101341944|FG001|Overall Study|Participant's Request|4|||
33396701|NCT00364611|101341943|FG000|Overall Study|Disease Progression|38|||
33603230|NCT02528357|102099182|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603231|NCT02528357|102099183|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33396702|NCT00364611|101341944|FG001|Overall Study|Disease Progression|8|||
33396703|NCT00364611|101341943|FG000|Overall Study|Investigator decision|2|||
33396704|NCT00364611|101341944|FG001|Overall Study|Investigator decision|2|||
33396705|NCT00364611|101341943|FG000|Overall Study|Found Ineligible|1|||
33396706|NCT00364611|101341944|FG001|Overall Study|Found Ineligible|0|||
33396707|NCT00364611|101341943|FG000|Overall Study|Presumed CR on Study|0|||
33396708|NCT00364611|101341944|FG001|Overall Study|Presumed CR on Study|1|||
33396709|NCT00364611|101341943|FG000|Overall Study|Receiving Liver Ablation|0|||
33396710|NCT00364611|101341944|FG001|Overall Study|Receiving Liver Ablation|1|||
33396711|NCT00697255|101341945|FG000|Stage 1a|Insufficient ovarian response|1|||
33396712|NCT00697255|101341946|FG001|Stage 1a|Insufficient ovarian response|0|||
33396713|NCT00697255|101341945|FG000|Stage 1a|Multifollicular growth|1|||
33603232|NCT02528357|102099184|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33396714|NCT00697255|101341946|FG001|Stage 1a|Multifollicular growth|0|||
33396715|NCT00697255|101341945|FG000|Stage 1a|Not growing of dominant follicle|1|||
33505541|NCT01344824|101744760|FG000|Overall Study|Adverse Event|15|||
33315024|NCT02245672|101047476|FG001|Overall Study|Adverse Event|4|||
33315025|NCT02245672|101047477|FG002|Overall Study|Adverse Event|4|||
33315026|NCT02245672|101047475|FG000|Overall Study|Lost to Follow-up|3|||
33315027|NCT02245672|101047476|FG001|Overall Study|Lost to Follow-up|5|||
33315028|NCT02245672|101047477|FG002|Overall Study|Lost to Follow-up|1|||
33315029|NCT02245672|101047475|FG000|Overall Study|Withdrawal by Subject|6|||
33315030|NCT02245672|101047476|FG001|Overall Study|Withdrawal by Subject|3|||
33315031|NCT02245672|101047477|FG002|Overall Study|Withdrawal by Subject|0|||
33315032|NCT02245672|101047475|FG000|Overall Study|Randomized in error (not treated)|0|||
33315033|NCT02245672|101047476|FG001|Overall Study|Randomized in error (not treated)|1|||
33315034|NCT02245672|101047477|FG002|Overall Study|Randomized in error (not treated)|0|||
33315035|NCT01386788|101047478|FG000|Overall Study|Lost to Follow-up|2|||
33315036|NCT04875676|101047479|FG000|Overall Study|Lost to Follow-up|1|||
33315037|NCT04875676|101047480|FG001|Overall Study|Lost to Follow-up|0|||
33315038|NCT04875676|101047481|FG002|Overall Study|Lost to Follow-up|0|||
33315039|NCT01079130|101047482|FG000|Overall Study|Adverse Event|1|||
33315040|NCT01079130|101047483|FG001|Overall Study|Adverse Event|1|||
33315041|NCT01079130|101047484|FG002|Overall Study|Adverse Event|0|||
33315042|NCT01079130|101047485|FG003|Overall Study|Adverse Event|1|||
33315043|NCT01079130|101047486|FG004|Overall Study|Adverse Event|5|||
33315044|NCT01079130|101047487|FG005|Overall Study|Adverse Event|1|||
33315045|NCT01079130|101047482|FG000|Overall Study|Administrative problems|1|||
33315046|NCT01079130|101047483|FG001|Overall Study|Administrative problems|3|||
33315047|NCT01079130|101047484|FG002|Overall Study|Administrative problems|0|||
33315048|NCT01079130|101047485|FG003|Overall Study|Administrative problems|0|||
33315049|NCT01079130|101047486|FG004|Overall Study|Administrative problems|0|||
33315050|NCT01079130|101047487|FG005|Overall Study|Administrative problems|1|||
33315051|NCT01079130|101047482|FG000|Overall Study|Withdrawal by Subject|0|||
33315052|NCT01079130|101047483|FG001|Overall Study|Withdrawal by Subject|1|||
33315053|NCT01079130|101047484|FG002|Overall Study|Withdrawal by Subject|0|||
33315054|NCT01079130|101047485|FG003|Overall Study|Withdrawal by Subject|0|||
33315055|NCT01079130|101047486|FG004|Overall Study|Withdrawal by Subject|1|||
33315056|NCT01079130|101047487|FG005|Overall Study|Withdrawal by Subject|3|||
33315057|NCT01079130|101047482|FG000|Overall Study|Protocol deviation|0|||
33315058|NCT01079130|101047483|FG001|Overall Study|Protocol deviation|2|||
33315059|NCT01079130|101047484|FG002|Overall Study|Protocol deviation|1|||
33315060|NCT01079130|101047485|FG003|Overall Study|Protocol deviation|2|||
33315061|NCT01079130|101047486|FG004|Overall Study|Protocol deviation|0|||
33315062|NCT01079130|101047487|FG005|Overall Study|Protocol deviation|0|||
33315063|NCT01079130|101047482|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33315064|NCT01079130|101047483|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33315065|NCT01079130|101047484|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33315066|NCT01079130|101047485|FG003|Overall Study|Abnormal test procedure result(s)|0|||
33315067|NCT01079130|101047486|FG004|Overall Study|Abnormal test procedure result(s)|1|||
33315068|NCT01079130|101047487|FG005|Overall Study|Abnormal test procedure result(s)|0|||
33315069|NCT01079130|101047482|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33315070|NCT01079130|101047483|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33315071|NCT01079130|101047484|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33315072|NCT01079130|101047485|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
33315073|NCT01079130|101047486|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
33315074|NCT01079130|101047487|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
33315075|NCT01079130|101047482|FG000|Overall Study|Lost to Follow-up|0|||
33315076|NCT01079130|101047483|FG001|Overall Study|Lost to Follow-up|0|||
33315077|NCT01079130|101047484|FG002|Overall Study|Lost to Follow-up|0|||
33315078|NCT01079130|101047485|FG003|Overall Study|Lost to Follow-up|0|||
33315079|NCT01079130|101047486|FG004|Overall Study|Lost to Follow-up|1|||
33315080|NCT01079130|101047487|FG005|Overall Study|Lost to Follow-up|0|||
33315081|NCT04751656|101047491|FG000|Overall Study|Lost to Follow-up|1|||
33315082|NCT00609765|101047494|FG000|Overall Study|Study ended prior to 12 months|1|||
33315083|NCT00985946|101047501|FG000|Overall Study|Lost to Follow-up|6|||
33315084|NCT00985946|101047501|FG000|Overall Study|Withdrawal by Subject|1|||
33315085|NCT05220254|101047504|FG000|Overall Study|Withdrawal by Subject|4|||
33603233|NCT02528357|102099185|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603234|NCT02528357|102099186|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33315086|NCT05220254|101047504|FG000|Overall Study|Removed due to ineligibility|1|||
33315087|NCT05220254|101047504|FG000|Overall Study|Lost to Follow-up|7|||
33315088|NCT02208999|101047505|FG000|Overall Study|Lost to Follow-up|1|||
33315089|NCT03240874|101047506|FG000|Overall Study|Lost to Follow-up|0|||
33315090|NCT03240874|101047507|FG001|Overall Study|Lost to Follow-up|2|||
33315091|NCT03240874|101047508|FG002|Overall Study|Lost to Follow-up|4|||
33315092|NCT03240874|101047509|FG003|Overall Study|Lost to Follow-up|1|||
33315093|NCT00896051|101047510|FG000|Overall Study|Adverse Event|2|||
33315094|NCT00896051|101047511|FG001|Overall Study|Adverse Event|1|||
33315095|NCT00896051|101047510|FG000|Overall Study|Lost to Follow-up|3|||
33315096|NCT00896051|101047511|FG001|Overall Study|Lost to Follow-up|2|||
33315097|NCT00896051|101047510|FG000|Overall Study|Withdrawal by Subject|3|||
33315098|NCT00896051|101047511|FG001|Overall Study|Withdrawal by Subject|2|||
33315099|NCT00896051|101047510|FG000|Overall Study|Subject noncompliant|1|||
33315100|NCT00896051|101047511|FG001|Overall Study|Subject noncompliant|3|||
33315101|NCT00896051|101047510|FG000|Overall Study|Other|1|||
33315102|NCT00896051|101047511|FG001|Overall Study|Other|1|||
33315103|NCT02216357|101047512|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
33315104|NCT02216357|101047513|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
33315105|NCT02739360|101047514|FG000|Overall Study|Adverse Event|1|||
33315106|NCT02739360|101047514|FG000|Overall Study|Study terminated by Sponsor|2|||
33315107|NCT02796560|101047515|FG000|Overall Study|Adverse Event|2|||
33315108|NCT02796560|101047516|FG001|Overall Study|Adverse Event|0|||
33315109|NCT02796560|101047515|FG000|Overall Study|Withdrawal by Subject|2|||
33315110|NCT02796560|101047516|FG001|Overall Study|Withdrawal by Subject|2|||
33315111|NCT03153137|101047517|FG000|Overall Study|Lost to Follow-up|1|||
33315112|NCT03153137|101047518|FG001|Overall Study|Lost to Follow-up|0|||
33315113|NCT03153137|101047517|FG000|Overall Study|Withdrawal by Subject|2|||
33315114|NCT03153137|101047518|FG001|Overall Study|Withdrawal by Subject|1|||
33315115|NCT03153137|101047517|FG000|Overall Study|Physician Decision|0|||
33315116|NCT03153137|101047518|FG001|Overall Study|Physician Decision|3|||
33315117|NCT00141726|101047519|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
33315118|NCT00796120|101047520|FG000|Overall Study|Death|3|||
33315119|NCT00796120|101047521|FG001|Overall Study|Death|0|||
33315120|NCT00796120|101047520|FG000|Overall Study|Adverse Event|11|||
33315121|NCT00796120|101047521|FG001|Overall Study|Adverse Event|6|||
33315122|NCT00796120|101047520|FG000|Overall Study|Progressive disease|22|||
33315123|NCT00796120|101047521|FG001|Overall Study|Progressive disease|13|||
33315124|NCT00796120|101047520|FG000|Overall Study|Participant refusal|3|||
33315125|NCT00796120|101047521|FG001|Overall Study|Participant refusal|4|||
33315126|NCT00796120|101047520|FG000|Overall Study|Other|6|||
33315127|NCT00796120|101047521|FG001|Overall Study|Other|17|||
33315128|NCT00796120|101047520|FG000|Overall Study|Physician Decision|16|||
33315129|NCT00796120|101047521|FG001|Overall Study|Physician Decision|17|||
33315130|NCT00796120|101047520|FG000|Overall Study|Randomized but not treated|0|||
33315131|NCT00796120|101047521|FG001|Overall Study|Randomized but not treated|3|||
33315132|NCT02349360|101047522|FG000|Overall Study|Withdrawal by Subject|0|||
33315133|NCT02349360|101047523|FG001|Overall Study|Withdrawal by Subject|1|||
33315134|NCT02471833|101047526|FG000|Overall Study|Lost to Follow-up|1|||
33315135|NCT02471833|101047527|FG001|Overall Study|Lost to Follow-up|0|||
33315136|NCT02471833|101047528|FG002|Overall Study|Lost to Follow-up|0|||
33315137|NCT02471833|101047526|FG000|Overall Study|Withdrawal by Subject|2|||
33315138|NCT02471833|101047527|FG001|Overall Study|Withdrawal by Subject|1|||
33315139|NCT02471833|101047528|FG002|Overall Study|Withdrawal by Subject|5|||
33315140|NCT01828073|101047529|FG000|Overall Study|Lost to Follow-up|1|||
33315141|NCT01828073|101047530|FG001|Overall Study|Lost to Follow-up|2|||
33315142|NCT02795429|101047531|FG000|Overall Study|Adverse Event|1|||
33315143|NCT02795429|101047532|FG001|Overall Study|Adverse Event|2|||
33315144|NCT02795429|101047533|FG002|Overall Study|Adverse Event|1|||
33315145|NCT02795429|101047534|FG003|Overall Study|Adverse Event|2|||
33315146|NCT02795429|101047535|FG004|Overall Study|Adverse Event|1|||
33315147|NCT02795429|101047531|FG000|Overall Study|Death|1|||
33315148|NCT02795429|101047532|FG001|Overall Study|Death|0|||
33315149|NCT02795429|101047533|FG002|Overall Study|Death|1|||
33315150|NCT02795429|101047534|FG003|Overall Study|Death|2|||
33315151|NCT02795429|101047535|FG004|Overall Study|Death|1|||
33315152|NCT02795429|101047531|FG000|Overall Study|Physician Decision|0|||
33315153|NCT02795429|101047532|FG001|Overall Study|Physician Decision|0|||
33315154|NCT02795429|101047533|FG002|Overall Study|Physician Decision|2|||
33315155|NCT02795429|101047534|FG003|Overall Study|Physician Decision|1|||
33315156|NCT02795429|101047535|FG004|Overall Study|Physician Decision|5|||
33315157|NCT02795429|101047531|FG000|Overall Study|Progressive disease|3|||
33315158|NCT02795429|101047532|FG001|Overall Study|Progressive disease|7|||
33315159|NCT02795429|101047533|FG002|Overall Study|Progressive disease|6|||
33315160|NCT02795429|101047534|FG003|Overall Study|Progressive disease|26|||
33315161|NCT02795429|101047535|FG004|Overall Study|Progressive disease|20|||
33315162|NCT02795429|101047531|FG000|Overall Study|Subject/guardian decision|1|||
33315163|NCT02795429|101047532|FG001|Overall Study|Subject/guardian decision|1|||
33315164|NCT02795429|101047533|FG002|Overall Study|Subject/guardian decision|1|||
33315165|NCT02795429|101047534|FG003|Overall Study|Subject/guardian decision|1|||
33315166|NCT02795429|101047535|FG004|Overall Study|Subject/guardian decision|3|||
33315167|NCT02527343|101047536|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
33315168|NCT02527343|101047537|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
33315169|NCT02527343|101047538|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
33315170|NCT02527343|101047539|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
33315171|NCT02527343|101047540|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
33315172|NCT02527343|101047541|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
33315173|NCT02527343|101047536|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
33315174|NCT02527343|101047537|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
33315175|NCT02527343|101047538|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
33315176|NCT02527343|101047539|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
33315177|NCT02527343|101047540|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
33315178|NCT02527343|101047541|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
33315179|NCT02527343|101047536|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
33315180|NCT02527343|101047537|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
33315181|NCT02527343|101047538|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
33315182|NCT02527343|101047539|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
33315183|NCT02527343|101047540|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
33315184|NCT02527343|101047541|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
33315185|NCT02527343|101047536|FG000|RT Period: Weeks 1 to 52|Other|4|||
33315186|NCT02527343|101047537|FG001|RT Period: Weeks 1 to 52|Other|3|||
33315187|NCT02527343|101047538|FG002|RT Period: Weeks 1 to 52|Other|0|||
33315188|NCT02527343|101047539|FG003|RT Period: Weeks 1 to 52|Other|0|||
33315189|NCT02527343|101047540|FG004|RT Period: Weeks 1 to 52|Other|0|||
33315190|NCT02527343|101047541|FG005|RT Period: Weeks 1 to 52|Other|0|||
33315191|NCT02527343|101047536|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
33315192|NCT02527343|101047537|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
33315193|NCT02527343|101047538|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
33315194|NCT02527343|101047539|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
33315195|NCT02527343|101047540|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
33315196|NCT02527343|101047541|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
33315197|NCT02527343|101047536|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
33315198|NCT02527343|101047537|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
33315199|NCT02527343|101047538|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
33315200|NCT02527343|101047539|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
33315201|NCT02527343|101047540|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
33315202|NCT02527343|101047541|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
33315203|NCT02527343|101047536|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
33315204|NCT02527343|101047537|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
33315205|NCT02527343|101047538|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
33315206|NCT02527343|101047539|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
33315207|NCT02527343|101047540|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
33315208|NCT02527343|101047541|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
33315209|NCT02527343|101047536|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
33315210|NCT02527343|101047537|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
33315211|NCT02527343|101047538|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
33315212|NCT02527343|101047539|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
33315213|NCT02527343|101047540|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
33315214|NCT02527343|101047541|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
33315215|NCT02527343|101047536|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
33315216|NCT02527343|101047537|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
33315217|NCT02527343|101047538|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
33315218|NCT02527343|101047539|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
33315219|NCT02527343|101047540|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
33315220|NCT02527343|101047541|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
33315221|NCT02527343|101047536|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
33315222|NCT02527343|101047537|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
33315223|NCT02527343|101047538|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
33315224|NCT02527343|101047539|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
33315225|NCT02527343|101047540|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
33315226|NCT02527343|101047541|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
33315227|NCT02527343|101047536|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
33315228|NCT02527343|101047537|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
33315229|NCT02527343|101047538|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
33315230|NCT02527343|101047539|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
33315231|NCT02527343|101047540|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
33315232|NCT02527343|101047541|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
33315233|NCT02527343|101047536|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
33315234|NCT02527343|101047537|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
33315235|NCT02527343|101047538|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
33315236|NCT02527343|101047539|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
33315237|NCT02527343|101047540|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
33315238|NCT02527343|101047541|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
33315239|NCT02527343|101047536|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
33315240|NCT02527343|101047537|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
33315241|NCT02527343|101047538|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
33603235|NCT02528357|102099187|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603236|NCT02528357|102099188|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603237|NCT02528357|102099189|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33315242|NCT02527343|101047539|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
33315243|NCT02527343|101047540|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
33315244|NCT02527343|101047541|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
33315245|NCT03353350|101047542|FG000|30-week Core Treatment Period|Protocol Violation|1|||
33315246|NCT03353350|101047543|FG001|30-week Core Treatment Period|Protocol Violation|1|||
33315247|NCT03353350|101047544|FG002|30-week Core Treatment Period|Protocol Violation|1|||
33315248|NCT03353350|101047545|FG003|30-week Core Treatment Period|Protocol Violation|0|||
33315249|NCT03353350|101047542|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
33315250|NCT03353350|101047543|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
33315251|NCT03353350|101047544|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
33315252|NCT03353350|101047545|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
33315253|NCT03353350|101047542|FG000|30-week Core Treatment Period|Adverse Event|0|||
33315254|NCT03353350|101047543|FG001|30-week Core Treatment Period|Adverse Event|4|||
33315255|NCT03353350|101047544|FG002|30-week Core Treatment Period|Adverse Event|2|||
33315256|NCT03353350|101047545|FG003|30-week Core Treatment Period|Adverse Event|3|||
33315257|NCT03353350|101047542|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
33315258|NCT03353350|101047543|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
33315259|NCT03353350|101047544|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
33315260|NCT03353350|101047545|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
33315261|NCT03353350|101047542|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
33315262|NCT03353350|101047543|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
33315263|NCT03353350|101047544|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
33315264|NCT03353350|101047545|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
33315265|NCT03353350|101047542|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
33315266|NCT03353350|101047543|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
33315267|NCT03353350|101047544|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
33315268|NCT03353350|101047545|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
33315269|NCT03353350|101047542|FG000|26-week Treatment Extension Period|Adverse Event|1|||
33315270|NCT03353350|101047543|FG001|26-week Treatment Extension Period|Adverse Event|0|||
33315271|NCT03353350|101047544|FG002|26-week Treatment Extension Period|Adverse Event|0|||
33315272|NCT03353350|101047545|FG003|26-week Treatment Extension Period|Adverse Event|1|||
33315273|NCT03353350|101047542|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
33315274|NCT03353350|101047543|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
33315275|NCT03353350|101047544|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
33315276|NCT03353350|101047545|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
33315277|NCT02699983|101047550|FG000|Overall Study|Withdrawal by Subject|1|||
33315278|NCT02699983|101047551|FG001|Overall Study|Withdrawal by Subject|0|||
33315279|NCT01174160|101047552|FG000|Overall Study|Adverse Event|1|||
33315280|NCT01174160|101047553|FG001|Overall Study|Adverse Event|0|||
33315281|NCT01174160|101047552|FG000|Overall Study|Lost to Follow-up|1|||
33315282|NCT01174160|101047553|FG001|Overall Study|Lost to Follow-up|0|||
33315283|NCT01174160|101047552|FG000|Overall Study|Physician Decision|1|||
33315284|NCT01174160|101047553|FG001|Overall Study|Physician Decision|0|||
33315285|NCT01174160|101047552|FG000|Overall Study|Protocol Violation|4|||
33315286|NCT01174160|101047553|FG001|Overall Study|Protocol Violation|6|||
33315287|NCT01174160|101047552|FG000|Overall Study|Withdrawal by Subject|1|||
33315288|NCT01174160|101047553|FG001|Overall Study|Withdrawal by Subject|0|||
33315289|NCT01280812|101047554|FG000|Overall Study|Withdrawal by Subject|2|||
33315290|NCT01280812|101047555|FG001|Overall Study|Withdrawal by Subject|1|||
33315291|NCT01280812|101047556|FG002|Overall Study|Withdrawal by Subject|0|||
33315292|NCT01280812|101047554|FG000|Overall Study|Lost to Follow-up|1|||
33315293|NCT01280812|101047555|FG001|Overall Study|Lost to Follow-up|1|||
33315294|NCT01280812|101047556|FG002|Overall Study|Lost to Follow-up|1|||
33315295|NCT01337115|101047557|FG000|Overall Study|Protocol Violation|2|||
33315296|NCT01337115|101047558|FG001|Overall Study|Protocol Violation|0|||
33315297|NCT02038543|101047560|FG000|Overall Study|Screen Failure|0|||
33315298|NCT02038543|101047561|FG001|Overall Study|Screen Failure|0|||
33603238|NCT02528357|102099190|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603239|NCT02528357|102099191|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603240|NCT02528357|102099192|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33315299|NCT02038543|101047562|FG002|Overall Study|Screen Failure|0|||
33315300|NCT02038543|101047563|FG003|Overall Study|Screen Failure|1|||
33315301|NCT02038543|101047560|FG000|Overall Study|Withdrawal by Subject|0|||
33315302|NCT02038543|101047561|FG001|Overall Study|Withdrawal by Subject|0|||
33315303|NCT02038543|101047562|FG002|Overall Study|Withdrawal by Subject|0|||
33315304|NCT02038543|101047563|FG003|Overall Study|Withdrawal by Subject|1|||
33315305|NCT03019185|101047569|FG000|Overall Study|Lost to Follow-up|3|||
33396716|NCT00697255|101341946|FG001|Stage 1a|Not growing of dominant follicle|0|||
33315306|NCT03019185|101047570|FG001|Overall Study|Lost to Follow-up|0|||
33315307|NCT03019185|101047571|FG002|Overall Study|Lost to Follow-up|2|||
33315308|NCT03019185|101047569|FG000|Overall Study|Withdrawal by Subject|1|||
33315309|NCT03019185|101047570|FG001|Overall Study|Withdrawal by Subject|1|||
33315310|NCT03019185|101047571|FG002|Overall Study|Withdrawal by Subject|0|||
33315311|NCT03019185|101047569|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
33315312|NCT03019185|101047570|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
33315313|NCT03019185|101047571|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
33315314|NCT03019185|101047569|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
33315315|NCT03019185|101047570|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
33315316|NCT03019185|101047571|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
33315317|NCT03021954|101047572|FG000|Overall Study|Lost to Follow-up|10|||
33315318|NCT03021954|101047573|FG001|Overall Study|Lost to Follow-up|43|||
33315319|NCT03021954|101047572|FG000|Overall Study|Subjects had avulsion trauma|4|||
33315320|NCT03021954|101047573|FG001|Overall Study|Subjects had avulsion trauma|1|||
33315321|NCT03628898|101047574|FG000|Overall Study|Device deficiency|1|||
33315322|NCT01620255|101047575|FG000|Overall Study|Withdrawal by Subject|4|||
33315323|NCT01620255|101047576|FG001|Overall Study|Withdrawal by Subject|1|||
33315324|NCT01620255|101047577|FG002|Overall Study|Withdrawal by Subject|1|||
33315325|NCT01620255|101047578|FG003|Overall Study|Withdrawal by Subject|2|||
33315326|NCT01620255|101047579|FG004|Overall Study|Withdrawal by Subject|4|||
33315327|NCT01620255|101047575|FG000|Overall Study|Participant underwent fecal transplant|0|||
33315328|NCT01620255|101047576|FG001|Overall Study|Participant underwent fecal transplant|0|||
33315329|NCT01620255|101047577|FG002|Overall Study|Participant underwent fecal transplant|1|||
33315330|NCT01620255|101047578|FG003|Overall Study|Participant underwent fecal transplant|0|||
33315331|NCT01620255|101047579|FG004|Overall Study|Participant underwent fecal transplant|0|||
33315332|NCT01620255|101047575|FG000|Overall Study|Non-compliance|0|||
33315333|NCT01620255|101047576|FG001|Overall Study|Non-compliance|1|||
33315334|NCT01620255|101047577|FG002|Overall Study|Non-compliance|0|||
33315335|NCT01620255|101047578|FG003|Overall Study|Non-compliance|0|||
33315336|NCT01620255|101047579|FG004|Overall Study|Non-compliance|0|||
33315337|NCT01620255|101047575|FG000|Overall Study|Adverse Event|0|||
33315338|NCT01620255|101047576|FG001|Overall Study|Adverse Event|4|||
33315339|NCT01620255|101047577|FG002|Overall Study|Adverse Event|0|||
33315340|NCT01620255|101047578|FG003|Overall Study|Adverse Event|1|||
33315341|NCT01620255|101047579|FG004|Overall Study|Adverse Event|1|||
33315342|NCT01620255|101047575|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
33315343|NCT01620255|101047576|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
33315344|NCT01620255|101047577|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
33315345|NCT01620255|101047578|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
33315346|NCT01620255|101047579|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
33315347|NCT00250679|101047580|FG000|Overall Study|Adverse Event|12|||
33315348|NCT00250679|101047581|FG001|Overall Study|Adverse Event|15|||
33315349|NCT00250679|101047582|FG002|Overall Study|Adverse Event|16|||
33315350|NCT00250679|101047580|FG000|Overall Study|Protocol Violation|2|||
33315351|NCT00250679|101047581|FG001|Overall Study|Protocol Violation|4|||
33315352|NCT00250679|101047582|FG002|Overall Study|Protocol Violation|3|||
33315353|NCT00250679|101047580|FG000|Overall Study|Withdrawal by Subject|15|||
33315354|NCT00250679|101047581|FG001|Overall Study|Withdrawal by Subject|18|||
33315355|NCT00250679|101047582|FG002|Overall Study|Withdrawal by Subject|15|||
33315356|NCT00250679|101047580|FG000|Overall Study|Lost to Follow-up|3|||
33315357|NCT00250679|101047581|FG001|Overall Study|Lost to Follow-up|4|||
33315358|NCT00250679|101047582|FG002|Overall Study|Lost to Follow-up|2|||
33315359|NCT00250679|101047580|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
33315360|NCT00250679|101047581|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
33315361|NCT00250679|101047582|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
33315362|NCT00250679|101047580|FG000|Overall Study|Lack of Efficacy|0|||
33315363|NCT00250679|101047581|FG001|Overall Study|Lack of Efficacy|1|||
33315364|NCT00250679|101047582|FG002|Overall Study|Lack of Efficacy|3|||
33315365|NCT00250679|101047580|FG000|Overall Study|Technical Holter issues|1|||
33315366|NCT00250679|101047581|FG001|Overall Study|Technical Holter issues|0|||
33315367|NCT00250679|101047582|FG002|Overall Study|Technical Holter issues|2|||
33315368|NCT00250679|101047580|FG000|Overall Study|Moved|1|||
33315369|NCT00250679|101047581|FG001|Overall Study|Moved|1|||
33315370|NCT00250679|101047582|FG002|Overall Study|Moved|0|||
33315371|NCT00250679|101047580|FG000|Overall Study|Non-compliance|1|||
33315372|NCT00250679|101047581|FG001|Overall Study|Non-compliance|1|||
33315373|NCT00250679|101047582|FG002|Overall Study|Non-compliance|0|||
33315374|NCT00250679|101047580|FG000|Overall Study|various single events: hip surgery,diary|3|||
33315375|NCT00250679|101047581|FG001|Overall Study|various single events: hip surgery,diary|1|||
33315376|NCT00250679|101047582|FG002|Overall Study|various single events: hip surgery,diary|1|||
33315377|NCT00717067|101047583|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
33631266|NCT01231906|102202898|FG001|Overall Study|Ineligible|3|||
33396717|NCT00697255|101341945|FG000|Stage 1b|Not growing of dominant follicle|0|||
33396718|NCT00697255|101341946|FG001|Stage 1b|Not growing of dominant follicle|1|||
33396719|NCT00697255|101341945|FG000|Stage 1b|Insufficient ovarian response|0|||
33396720|NCT00697255|101341946|FG001|Stage 1b|Insufficient ovarian response|1|||
33396721|NCT02954952|101341949|FG000|Overall Study|Withdrawal by Subject|1|||
33396722|NCT02954952|101341950|FG001|Overall Study|Withdrawal by Subject|0|||
33396723|NCT02954952|101341951|FG002|Overall Study|Withdrawal by Subject|0|||
33396724|NCT02954952|101341949|FG000|Overall Study|No data collected|0|||
33396725|NCT02954952|101341950|FG001|Overall Study|No data collected|1|||
33396726|NCT02954952|101341951|FG002|Overall Study|No data collected|0|||
33396727|NCT03330106|101341960|FG000|Part A|Withdrawal by Subject|1|||
33396728|NCT03330106|101341961|FG001|Part A|Withdrawal by Subject|1|||
33396729|NCT03330106|101341962|FG002|Part A|Withdrawal by Subject|0|||
33396730|NCT03330106|101341963|FG003|Part A|Withdrawal by Subject|0|||
33396731|NCT03330106|101341960|FG000|Part A|Death|2|||
33396732|NCT03330106|101341961|FG001|Part A|Death|1|||
33396733|NCT03330106|101341962|FG002|Part A|Death|0|||
33396734|NCT03330106|101341963|FG003|Part A|Death|0|||
33396735|NCT03330106|101341960|FG000|Part A|Adverse Event|0|||
33396736|NCT03330106|101341961|FG001|Part A|Adverse Event|1|||
33396737|NCT03330106|101341962|FG002|Part A|Adverse Event|0|||
33396738|NCT03330106|101341963|FG003|Part A|Adverse Event|0|||
33396739|NCT03330106|101341960|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
33396740|NCT03330106|101341961|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
33396741|NCT03330106|101341962|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
33396742|NCT03330106|101341963|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
33396743|NCT03330106|101341960|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
33396744|NCT03330106|101341961|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
33396745|NCT03330106|101341962|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
33396746|NCT03330106|101341963|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
33396747|NCT03330106|101341960|FG000|Part A|Progressive Disease|0|||
33396748|NCT03330106|101341961|FG001|Part A|Progressive Disease|1|||
33396749|NCT03330106|101341962|FG002|Part A|Progressive Disease|0|||
33396750|NCT03330106|101341963|FG003|Part A|Progressive Disease|0|||
33396751|NCT03330106|101341960|FG000|Part B|Lost to Follow-up|0|||
33396752|NCT03330106|101341961|FG001|Part B|Lost to Follow-up|0|||
33396753|NCT03330106|101341962|FG002|Part B|Lost to Follow-up|0|||
33396754|NCT03330106|101341963|FG003|Part B|Lost to Follow-up|1|||
33396755|NCT03330106|101341960|FG000|Part B|Withdrawal by Subject|0|||
33396756|NCT03330106|101341961|FG001|Part B|Withdrawal by Subject|0|||
33396757|NCT03330106|101341962|FG002|Part B|Withdrawal by Subject|4|||
33396758|NCT03330106|101341963|FG003|Part B|Withdrawal by Subject|0|||
33396759|NCT03330106|101341960|FG000|Part B|Death|0|||
33396760|NCT03330106|101341961|FG001|Part B|Death|0|||
33396761|NCT03330106|101341962|FG002|Part B|Death|2|||
33396762|NCT03330106|101341963|FG003|Part B|Death|0|||
33396763|NCT03330106|101341960|FG000|Part B|Clinical Progression|0|||
33396764|NCT03330106|101341961|FG001|Part B|Clinical Progression|0|||
33396765|NCT03330106|101341962|FG002|Part B|Clinical Progression|1|||
33396766|NCT03330106|101341963|FG003|Part B|Clinical Progression|1|||
33396767|NCT03330106|101341960|FG000|Part B|Symptomatic Deterioration|0|||
33396768|NCT03330106|101341961|FG001|Part B|Symptomatic Deterioration|0|||
33396769|NCT03330106|101341962|FG002|Part B|Symptomatic Deterioration|0|||
33396770|NCT03330106|101341963|FG003|Part B|Symptomatic Deterioration|1|||
33396771|NCT03330106|101341960|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
33396772|NCT03330106|101341961|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
33396773|NCT03330106|101341962|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
33396774|NCT03330106|101341963|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
33396775|NCT03330106|101341960|FG000|Part B|Progressive Disease|0|||
33396776|NCT03330106|101341961|FG001|Part B|Progressive Disease|0|||
33396777|NCT03330106|101341962|FG002|Part B|Progressive Disease|11|||
33396778|NCT03330106|101341963|FG003|Part B|Progressive Disease|4|||
33396779|NCT04474366|101341964|FG000|Overall Study|Lost to Follow-up|2|||
33505542|NCT01344824|101744760|FG000|Overall Study|Withdrawal by Subject|6|||
33396780|NCT04474366|101341965|FG001|Overall Study|Lost to Follow-up|5|||
33396781|NCT02178592|101341970|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
33396782|NCT02178592|101341971|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
33396783|NCT02178592|101341970|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
33396784|NCT02178592|101341971|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
33396785|NCT02178592|101341970|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
33396786|NCT02178592|101341971|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
33396787|NCT02178592|101341970|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
33396788|NCT02178592|101341971|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
33396789|NCT02178592|101341970|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
33396790|NCT02178592|101341971|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
33505543|NCT01344824|101744760|FG000|Overall Study|Other complicating disease|1|||
33315378|NCT00717067|101047584|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
33315379|NCT00717067|101047585|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
33315380|NCT00717067|101047586|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
33315381|NCT00717067|101047587|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
33315382|NCT01485354|101047594|FG000|Overall Study|Withdrawal by Subject|5|||
33315383|NCT00666679|101047595|FG000|First Intervention|Lost to Follow-up|1|||
33315384|NCT00666679|101047596|FG001|First Intervention|Lost to Follow-up|0|||
33315385|NCT00666679|101047595|FG000|First Intervention|Protocol Violation|1|||
33315386|NCT00666679|101047596|FG001|First Intervention|Protocol Violation|0|||
33315387|NCT00666679|101047595|FG000|First Intervention|Withdrawal by Subject|1|||
33315388|NCT00666679|101047596|FG001|First Intervention|Withdrawal by Subject|0|||
33315389|NCT00666679|101047595|FG000|First Intervention|Randomized did not start treatment|1|||
33315390|NCT00666679|101047596|FG001|First Intervention|Randomized did not start treatment|1|||
33315391|NCT00666679|101047595|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
33315392|NCT00666679|101047596|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
33315393|NCT00666679|101047595|FG000|Washout Period of 1 Week|Protocol Violation|0|||
33315394|NCT00666679|101047596|FG001|Washout Period of 1 Week|Protocol Violation|1|||
33315395|NCT00666679|101047595|FG000|Second Intervention|Adverse Event|1|||
33315396|NCT00666679|101047596|FG001|Second Intervention|Adverse Event|0|||
33315397|NCT00666679|101047595|FG000|Second Intervention|Death|0|||
33315398|NCT00666679|101047596|FG001|Second Intervention|Death|1|||
33315399|NCT04507126|101047598|FG000|Overall Study|Withdrawal by Subject|1|||
33315400|NCT04507126|101047598|FG000|Overall Study|Protocol Violation|2|||
33315401|NCT04507126|101047598|FG000|Overall Study|Physician Decision|1|||
33315402|NCT02164383|101047601|FG000|Overall Study|Lost to Follow-up|1|||
33315403|NCT02164383|101047602|FG001|Overall Study|Lost to Follow-up|0|||
33315404|NCT02683941|101047610|FG000|Double-blind Phase|Adverse Event|0|||
33315405|NCT02683941|101047611|FG001|Double-blind Phase|Adverse Event|1|||
33315406|NCT02683941|101047610|FG000|Double-blind Phase|Withdrawal by Subject|4|||
33315407|NCT02683941|101047611|FG001|Double-blind Phase|Withdrawal by Subject|2|||
33315408|NCT02683941|101047610|FG000|Double-blind Phase|Lost to Follow-up|1|||
33315409|NCT02683941|101047611|FG001|Double-blind Phase|Lost to Follow-up|0|||
33315410|NCT02683941|101047610|FG000|Double-blind Phase|Disease Progression|5|||
33315411|NCT02683941|101047611|FG001|Double-blind Phase|Disease Progression|2|||
33315412|NCT02683941|101047610|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
33315413|NCT02683941|101047611|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
33315414|NCT02683941|101047610|FG000|Open-label Treatment Phase|Disease Progression|1|||
33315415|NCT02683941|101047611|FG001|Open-label Treatment Phase|Disease Progression|2|||
33315416|NCT02683941|101047610|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
33315417|NCT02683941|101047611|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
33315418|NCT02683941|101047610|FG000|Open-label Treatment Phase|Other|1|||
33315419|NCT02683941|101047611|FG001|Open-label Treatment Phase|Other|0|||
33505544|NCT01344824|101744760|FG000|Overall Study|Progression|15|||
33505545|NCT00443079|101744765|FG000|Overall Study|Lost to Follow-up|0|||
33505546|NCT00443079|101744766|FG001|Overall Study|Lost to Follow-up|1|||
33505547|NCT00869999|101744774|FG000|Overall Study|Withdrawal by Subject|1|||
33505548|NCT00869999|101744774|FG000|Overall Study|removed prior to starting therapy|1|||
33505549|NCT02129777|101744775|FG000|Double-Blind Period|Adverse Event|0|||
33505550|NCT02129777|101744776|FG001|Double-Blind Period|Adverse Event|0|||
33505551|NCT02129777|101744777|FG002|Double-Blind Period|Adverse Event|0|||
33315420|NCT02683941|101047610|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
33315421|NCT02683941|101047611|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
33315422|NCT02683941|101047610|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
33315423|NCT02683941|101047611|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
33315424|NCT02683941|101047610|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
33315425|NCT02683941|101047611|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
33315426|NCT02683941|101047610|FG000|Open-label Follow-up Phase|Other|8|||
33315427|NCT02683941|101047611|FG001|Open-label Follow-up Phase|Other|1|||
33315428|NCT00701779|101047614|FG000|Overall Study|Adverse Event|6|||
33315429|NCT00701779|101047614|FG000|Overall Study|Lost to Follow-up|1|||
33315430|NCT00701779|101047614|FG000|Overall Study|Withdrawal by Subject|2|||
33315431|NCT00275262|101047615|FG000|Overall Study|Adverse Event|2|||
33315432|NCT00275262|101047616|FG001|Overall Study|Adverse Event|0|||
33315433|NCT00275262|101047615|FG000|Overall Study|Disease progression|2|||
33315434|NCT00275262|101047616|FG001|Overall Study|Disease progression|5|||
33505552|NCT02129777|101744778|FG003|Double-Blind Period|Adverse Event|0|||
33505553|NCT02129777|101744779|FG004|Double-Blind Period|Adverse Event|1|||
33505554|NCT02129777|101744780|FG005|Double-Blind Period|Adverse Event|0|||
33505555|NCT02129777|101744781|FG006|Double-Blind Period|Adverse Event|0|||
33505556|NCT02129777|101744775|FG000|Double-Blind Period|Lost to Follow-up|1|||
33505557|NCT02129777|101744776|FG001|Double-Blind Period|Lost to Follow-up|1|||
33315435|NCT00275262|101047615|FG000|Overall Study|Lost to Follow-up|0|||
33315436|NCT00275262|101047616|FG001|Overall Study|Lost to Follow-up|2|||
33315437|NCT00275262|101047615|FG000|Overall Study|Protocol Violation|0|||
33315438|NCT00275262|101047616|FG001|Overall Study|Protocol Violation|2|||
33315439|NCT00275262|101047615|FG000|Overall Study|Death|1|||
33315440|NCT00275262|101047616|FG001|Overall Study|Death|0|||
33315441|NCT00275262|101047615|FG000|Overall Study|Started Chemotherapy|1|||
33315442|NCT00275262|101047616|FG001|Overall Study|Started Chemotherapy|0|||
33315443|NCT00593957|101047617|FG000|Overall Study|Physician Decision|0|||
33315444|NCT00593957|101047618|FG001|Overall Study|Physician Decision|1|||
33315445|NCT00593957|101047619|FG002|Overall Study|Physician Decision|2|||
33315446|NCT04433585|101047621|FG000|Overall Study|Withdrawal by Subject|15|||
33315447|NCT04433585|101047622|FG001|Overall Study|Withdrawal by Subject|3|||
33315448|NCT04433585|101047623|FG002|Overall Study|Withdrawal by Subject|15|||
33315449|NCT04433585|101047624|FG003|Overall Study|Withdrawal by Subject|6|||
33315450|NCT04433585|101047621|FG000|Overall Study|Adverse Event|10|||
33315451|NCT04433585|101047622|FG001|Overall Study|Adverse Event|4|||
33315452|NCT04433585|101047623|FG002|Overall Study|Adverse Event|1|||
33315453|NCT04433585|101047624|FG003|Overall Study|Adverse Event|0|||
33315454|NCT04433585|101047621|FG000|Overall Study|Due to the conflict in Ukraine|2|||
33315455|NCT04433585|101047622|FG001|Overall Study|Due to the conflict in Ukraine|1|||
33315456|NCT04433585|101047623|FG002|Overall Study|Due to the conflict in Ukraine|1|||
33315457|NCT04433585|101047624|FG003|Overall Study|Due to the conflict in Ukraine|2|||
33315458|NCT04433585|101047621|FG000|Overall Study|Physician Decision|1|||
33315459|NCT04433585|101047622|FG001|Overall Study|Physician Decision|2|||
33315460|NCT04433585|101047623|FG002|Overall Study|Physician Decision|0|||
33315461|NCT04433585|101047624|FG003|Overall Study|Physician Decision|0|||
33315462|NCT04433585|101047621|FG000|Overall Study|Lost to Follow-up|1|||
33315463|NCT04433585|101047622|FG001|Overall Study|Lost to Follow-up|1|||
33315464|NCT04433585|101047623|FG002|Overall Study|Lost to Follow-up|1|||
33315465|NCT04433585|101047624|FG003|Overall Study|Lost to Follow-up|0|||
33315466|NCT04433585|101047621|FG000|Overall Study|Lack of Efficacy|0|||
33315467|NCT04433585|101047622|FG001|Overall Study|Lack of Efficacy|1|||
33315468|NCT04433585|101047623|FG002|Overall Study|Lack of Efficacy|1|||
33315469|NCT04433585|101047624|FG003|Overall Study|Lack of Efficacy|1|||
33315470|NCT04433585|101047621|FG000|Overall Study|Death|0|||
33315471|NCT04433585|101047622|FG001|Overall Study|Death|1|||
33315472|NCT04433585|101047623|FG002|Overall Study|Death|0|||
33315473|NCT04433585|101047624|FG003|Overall Study|Death|0|||
33505558|NCT02129777|101744777|FG002|Double-Blind Period|Lost to Follow-up|1|||
33505559|NCT02129777|101744778|FG003|Double-Blind Period|Lost to Follow-up|2|||
33315474|NCT00743275|101047626|FG000|Overall Study|Protocol Violation|0|||
33315475|NCT00743275|101047627|FG001|Overall Study|Protocol Violation|1|||
33315476|NCT01139021|101047628|FG000|Overall Study|Adverse Event|0|||
33315477|NCT01139021|101047629|FG001|Overall Study|Adverse Event|0|||
33315478|NCT01139021|101047630|FG002|Overall Study|Adverse Event|0|||
33315479|NCT01139021|101047631|FG003|Overall Study|Adverse Event|0|||
33315480|NCT01139021|101047632|FG004|Overall Study|Adverse Event|1|||
33315481|NCT01139021|101047633|FG005|Overall Study|Adverse Event|0|||
33315482|NCT01139021|101047628|FG000|Overall Study|Lost to Follow-up|0|||
33315483|NCT01139021|101047629|FG001|Overall Study|Lost to Follow-up|0|||
33315484|NCT01139021|101047630|FG002|Overall Study|Lost to Follow-up|0|||
33315485|NCT01139021|101047631|FG003|Overall Study|Lost to Follow-up|0|||
33315486|NCT01139021|101047632|FG004|Overall Study|Lost to Follow-up|2|||
33315487|NCT01139021|101047633|FG005|Overall Study|Lost to Follow-up|0|||
33315488|NCT01139021|101047628|FG000|Overall Study|Protocol Violation|1|||
33315489|NCT01139021|101047629|FG001|Overall Study|Protocol Violation|0|||
33315490|NCT01139021|101047630|FG002|Overall Study|Protocol Violation|0|||
33315491|NCT01139021|101047631|FG003|Overall Study|Protocol Violation|0|||
33315492|NCT01139021|101047632|FG004|Overall Study|Protocol Violation|2|||
33315493|NCT01139021|101047633|FG005|Overall Study|Protocol Violation|0|||
33315494|NCT01139021|101047628|FG000|Overall Study|Withdrawal by Subject|0|||
33315495|NCT01139021|101047629|FG001|Overall Study|Withdrawal by Subject|0|||
33315496|NCT01139021|101047630|FG002|Overall Study|Withdrawal by Subject|0|||
33505560|NCT02129777|101744779|FG004|Double-Blind Period|Lost to Follow-up|0|||
33315497|NCT01139021|101047631|FG003|Overall Study|Withdrawal by Subject|1|||
33505561|NCT02129777|101744780|FG005|Double-Blind Period|Lost to Follow-up|0|||
33603241|NCT02528357|102099193|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33631267|NCT01231906|102202897|FG000|Overall Study|No treatment|1|||
33315498|NCT01139021|101047632|FG004|Overall Study|Withdrawal by Subject|4|||
33315499|NCT01139021|101047633|FG005|Overall Study|Withdrawal by Subject|0|||
33315500|NCT00838929|101047634|FG000|Overall Study|Protocol Violation|0|||
33315501|NCT00838929|101047635|FG001|Overall Study|Protocol Violation|1|||
33315502|NCT00838929|101047636|FG002|Overall Study|Protocol Violation|0|||
33315503|NCT00838929|101047634|FG000|Overall Study|Disease progression|0|||
33315504|NCT00838929|101047635|FG001|Overall Study|Disease progression|2|||
33315505|NCT00838929|101047636|FG002|Overall Study|Disease progression|1|||
33315506|NCT00372385|101047637|FG000|Overall Study|Adverse Event|6|||
33505562|NCT02129777|101744781|FG006|Double-Blind Period|Lost to Follow-up|0|||
33315507|NCT00372385|101047638|FG001|Overall Study|Adverse Event|11|||
33315508|NCT00372385|101047639|FG002|Overall Study|Adverse Event|9|||
33315509|NCT00372385|101047640|FG003|Overall Study|Adverse Event|7|||
33315510|NCT00372385|101047637|FG000|Overall Study|Noncompliance|0|||
33315511|NCT00372385|101047638|FG001|Overall Study|Noncompliance|1|||
33315512|NCT00372385|101047639|FG002|Overall Study|Noncompliance|1|||
33315513|NCT00372385|101047640|FG003|Overall Study|Noncompliance|1|||
33315514|NCT00372385|101047637|FG000|Overall Study|Physician Decision|1|||
33315515|NCT00372385|101047638|FG001|Overall Study|Physician Decision|0|||
33315516|NCT00372385|101047639|FG002|Overall Study|Physician Decision|0|||
33315517|NCT00372385|101047640|FG003|Overall Study|Physician Decision|0|||
33315518|NCT00372385|101047637|FG000|Overall Study|Lost to Follow-up|2|||
33315519|NCT00372385|101047638|FG001|Overall Study|Lost to Follow-up|0|||
33315520|NCT00372385|101047639|FG002|Overall Study|Lost to Follow-up|0|||
33315521|NCT00372385|101047640|FG003|Overall Study|Lost to Follow-up|0|||
33315522|NCT00372385|101047637|FG000|Overall Study|Withdrawal by Subject|2|||
33315523|NCT00372385|101047638|FG001|Overall Study|Withdrawal by Subject|1|||
33315524|NCT00372385|101047639|FG002|Overall Study|Withdrawal by Subject|0|||
33315525|NCT00372385|101047640|FG003|Overall Study|Withdrawal by Subject|0|||
33315526|NCT00372385|101047637|FG000|Overall Study|Refusal of Treatment|3|||
33315527|NCT00372385|101047638|FG001|Overall Study|Refusal of Treatment|6|||
33396791|NCT02178592|101341970|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
33396792|NCT02178592|101341971|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
33396793|NCT02178592|101341970|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
33396794|NCT02178592|101341971|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
33396795|NCT02178592|101341970|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
33396796|NCT02178592|101341971|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
33396797|NCT02178592|101341970|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
33396798|NCT02178592|101341971|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
33396799|NCT02178592|101341970|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
33396800|NCT02178592|101341971|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
33396801|NCT02178592|101341970|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
33396802|NCT02178592|101341971|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
33396803|NCT02178592|101341970|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
33396804|NCT02178592|101341971|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
33396805|NCT02306148|101341974|FG000|Overall Study|Adverse Event|12|||
33396806|NCT02306148|101341975|FG001|Overall Study|Adverse Event|6|||
33396807|NCT02306148|101341974|FG000|Overall Study|Lost to Follow-up|1|||
33396808|NCT02306148|101341975|FG001|Overall Study|Lost to Follow-up|4|||
33396809|NCT00715949|101341976|FG000|Overall Study|could not finish first test|4|||
33396810|NCT04490499|101341977|FG000|Overall Study|Withdrawal by Subject|2|||
33396811|NCT00362297|101341978|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
33396812|NCT00362297|101341979|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
33396813|NCT01332851|101341980|FG000|Overall Study|Withdrawal by Subject|4|||
33396814|NCT01332851|101341981|FG001|Overall Study|Withdrawal by Subject|2|||
33396815|NCT01332851|101341980|FG000|Overall Study|Lost to Follow-up|7|||
33396816|NCT01332851|101341981|FG001|Overall Study|Lost to Follow-up|11|||
33396817|NCT02010567|101341982|FG000|Overall Study|Adverse Event|0|||
33396818|NCT02010567|101341983|FG001|Overall Study|Adverse Event|0|||
33396819|NCT02010567|101341984|FG002|Overall Study|Adverse Event|1|||
33396820|NCT02010567|101341985|FG003|Overall Study|Adverse Event|0|||
33396821|NCT02010567|101341986|FG004|Overall Study|Adverse Event|1|||
33396822|NCT00381706|101341987|FG000|Overall Study|Never treated|7|||
33396823|NCT00381706|101341988|FG001|Overall Study|Never treated|2|||
33396824|NCT00381706|101341989|FG002|Overall Study|Never treated|1|||
33396825|NCT00088595|101341990|FG000|Overall Study|Adverse Event|11|||
33396826|NCT00088595|101341990|FG000|Overall Study|Withdrawal by Subject|8|||
33396827|NCT00088595|101341990|FG000|Overall Study|Ongoing (After Core)|7|||
33396828|NCT00088595|101341990|FG000|Overall Study|New Cancer Therapy|2|||
33396829|NCT02545049|101341991|FG000|Overall Study|Withdrawal by Subject|1|||
33396830|NCT02545049|101341992|FG001|Overall Study|Withdrawal by Subject|7|||
33396831|NCT02545049|101341991|FG000|Overall Study|Lost to Follow-up|4|||
33396832|NCT02545049|101341992|FG001|Overall Study|Lost to Follow-up|6|||
33396833|NCT02545049|101341991|FG000|Overall Study|GCP violations|37|||
33396834|NCT02545049|101341992|FG001|Overall Study|GCP violations|48|||
33631268|NCT01231906|102202898|FG001|Overall Study|No treatment|2|||
33315528|NCT00372385|101047639|FG002|Overall Study|Refusal of Treatment|0|||
33315529|NCT00372385|101047640|FG003|Overall Study|Refusal of Treatment|0|||
33396835|NCT00424099|101341993|FG000|Overall Study|Adverse Event|0|||
33396836|NCT00424099|101341994|FG001|Overall Study|Adverse Event|1|||
33396837|NCT00424099|101341995|FG002|Overall Study|Adverse Event|1|||
33396838|NCT00424099|101341996|FG003|Overall Study|Adverse Event|0|||
33396839|NCT00424099|101341993|FG000|Overall Study|Death|0|||
33396840|NCT00424099|101341994|FG001|Overall Study|Death|1|||
33396841|NCT00424099|101341995|FG002|Overall Study|Death|0|||
33396842|NCT00424099|101341996|FG003|Overall Study|Death|0|||
33396843|NCT00424099|101341993|FG000|Overall Study|Illness|2|||
33315530|NCT00372385|101047637|FG000|Overall Study|No Response|1|||
33315531|NCT00372385|101047638|FG001|Overall Study|No Response|1|||
33315532|NCT00372385|101047639|FG002|Overall Study|No Response|0|||
33315533|NCT00372385|101047640|FG003|Overall Study|No Response|0|||
33396844|NCT00424099|101341994|FG001|Overall Study|Illness|0|||
33396845|NCT00424099|101341995|FG002|Overall Study|Illness|1|||
33396846|NCT00424099|101341996|FG003|Overall Study|Illness|4|||
33396847|NCT00424099|101341993|FG000|Overall Study|Lost to Follow-up|0|||
33396848|NCT00424099|101341994|FG001|Overall Study|Lost to Follow-up|0|||
33396849|NCT00424099|101341995|FG002|Overall Study|Lost to Follow-up|3|||
33396850|NCT00424099|101341996|FG003|Overall Study|Lost to Follow-up|0|||
33396851|NCT00424099|101341993|FG000|Overall Study|Hospitalized|1|||
33396852|NCT00424099|101341994|FG001|Overall Study|Hospitalized|2|||
33396853|NCT00424099|101341995|FG002|Overall Study|Hospitalized|1|||
33396854|NCT00424099|101341996|FG003|Overall Study|Hospitalized|3|||
33396855|NCT00424099|101341993|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
33396856|NCT00424099|101341994|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
33396857|NCT00424099|101341995|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
33396858|NCT00424099|101341996|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
33396859|NCT00424099|101341993|FG000|Overall Study|Withdrawal by Subject|1|||
33396860|NCT00424099|101341994|FG001|Overall Study|Withdrawal by Subject|9|||
33396861|NCT00424099|101341995|FG002|Overall Study|Withdrawal by Subject|4|||
33505563|NCT02129777|101744775|FG000|Double-Blind Period|Withdrawal by Subject|2|||
33505564|NCT02129777|101744776|FG001|Double-Blind Period|Withdrawal by Subject|4|||
33505565|NCT02129777|101744777|FG002|Double-Blind Period|Withdrawal by Subject|3|||
33505566|NCT02129777|101744778|FG003|Double-Blind Period|Withdrawal by Subject|2|||
33505567|NCT02129777|101744779|FG004|Double-Blind Period|Withdrawal by Subject|3|||
33505568|NCT02129777|101744780|FG005|Double-Blind Period|Withdrawal by Subject|0|||
33505569|NCT02129777|101744781|FG006|Double-Blind Period|Withdrawal by Subject|0|||
33505570|NCT02129777|101744775|FG000|Double-Blind Period|Pregnancy|0|||
33505571|NCT02129777|101744776|FG001|Double-Blind Period|Pregnancy|0|||
33505572|NCT02129777|101744777|FG002|Double-Blind Period|Pregnancy|0|||
33505573|NCT02129777|101744778|FG003|Double-Blind Period|Pregnancy|0|||
33505574|NCT02129777|101744779|FG004|Double-Blind Period|Pregnancy|1|||
33505575|NCT02129777|101744780|FG005|Double-Blind Period|Pregnancy|0|||
33505576|NCT02129777|101744781|FG006|Double-Blind Period|Pregnancy|0|||
33505577|NCT02129777|101744775|FG000|Double-Blind Period|Lack of Efficacy|3|||
33396862|NCT00424099|101341996|FG003|Overall Study|Withdrawal by Subject|6|||
33396863|NCT00424099|101341993|FG000|Overall Study|Physician Decision|0|||
33396864|NCT00424099|101341994|FG001|Overall Study|Physician Decision|0|||
33396865|NCT00424099|101341995|FG002|Overall Study|Physician Decision|1|||
33396866|NCT00424099|101341996|FG003|Overall Study|Physician Decision|0|||
33396867|NCT00424099|101341993|FG000|Overall Study|Missing|0|||
33396868|NCT00424099|101341994|FG001|Overall Study|Missing|0|||
33396869|NCT00424099|101341995|FG002|Overall Study|Missing|1|||
33396870|NCT00424099|101341996|FG003|Overall Study|Missing|0|||
33396871|NCT03685643|101342001|FG000|Overall Study|Lost to Follow-up|14|||
33396872|NCT03685643|101342002|FG001|Overall Study|Lost to Follow-up|22|||
33396873|NCT04921969|101342003|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
33396874|NCT04921969|101342004|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
33396875|NCT04921969|101342005|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
33396876|NCT04921969|101342006|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
33396877|NCT04921969|101342007|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
33396878|NCT04921969|101342008|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
33396879|NCT04921969|101342009|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
33396880|NCT04921969|101342003|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
33396881|NCT04921969|101342004|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33505578|NCT02129777|101744776|FG001|Double-Blind Period|Lack of Efficacy|1|||
33505579|NCT02129777|101744777|FG002|Double-Blind Period|Lack of Efficacy|0|||
33505580|NCT02129777|101744778|FG003|Double-Blind Period|Lack of Efficacy|3|||
33505581|NCT02129777|101744779|FG004|Double-Blind Period|Lack of Efficacy|2|||
33505582|NCT02129777|101744780|FG005|Double-Blind Period|Lack of Efficacy|0|||
33505583|NCT02129777|101744781|FG006|Double-Blind Period|Lack of Efficacy|0|||
33505584|NCT02129777|101744775|FG000|Double-Blind Period|Other|1|||
33505585|NCT02129777|101744776|FG001|Double-Blind Period|Other|2|||
33505586|NCT02129777|101744777|FG002|Double-Blind Period|Other|0|||
33505587|NCT02129777|101744778|FG003|Double-Blind Period|Other|0|||
33505588|NCT02129777|101744779|FG004|Double-Blind Period|Other|0|||
33396882|NCT04921969|101342005|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33396883|NCT04921969|101342006|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33505589|NCT02129777|101744780|FG005|Double-Blind Period|Other|0|||
33505590|NCT02129777|101744781|FG006|Double-Blind Period|Other|0|||
33396884|NCT04921969|101342007|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33396885|NCT04921969|101342008|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33396886|NCT04921969|101342009|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33396887|NCT04921969|101342003|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
33505591|NCT02129777|101744775|FG000|Open-Label Period|Lack of Efficacy|0|||
33505592|NCT02129777|101744776|FG001|Open-Label Period|Lack of Efficacy|0|||
33396888|NCT04921969|101342004|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
33505593|NCT02129777|101744777|FG002|Open-Label Period|Lack of Efficacy|0|||
33505594|NCT02129777|101744778|FG003|Open-Label Period|Lack of Efficacy|0|||
33505595|NCT02129777|101744779|FG004|Open-Label Period|Lack of Efficacy|0|||
33315534|NCT00372385|101047637|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
33505596|NCT02129777|101744780|FG005|Open-Label Period|Lack of Efficacy|0|||
33505597|NCT02129777|101744781|FG006|Open-Label Period|Lack of Efficacy|5|||
33505598|NCT02129777|101744775|FG000|Open-Label Period|Lost to Follow-up|0|||
33505599|NCT02129777|101744776|FG001|Open-Label Period|Lost to Follow-up|0|||
33505600|NCT02129777|101744777|FG002|Open-Label Period|Lost to Follow-up|0|||
33505601|NCT02129777|101744778|FG003|Open-Label Period|Lost to Follow-up|0|||
33505602|NCT02129777|101744779|FG004|Open-Label Period|Lost to Follow-up|0|||
33505603|NCT02129777|101744780|FG005|Open-Label Period|Lost to Follow-up|1|||
33505604|NCT02129777|101744781|FG006|Open-Label Period|Lost to Follow-up|1|||
33505605|NCT02129777|101744775|FG000|Open-Label Period|Withdrawal by Subject|0|||
33505606|NCT02129777|101744776|FG001|Open-Label Period|Withdrawal by Subject|0|||
33505607|NCT02129777|101744777|FG002|Open-Label Period|Withdrawal by Subject|0|||
33505608|NCT02129777|101744778|FG003|Open-Label Period|Withdrawal by Subject|0|||
33505609|NCT02129777|101744779|FG004|Open-Label Period|Withdrawal by Subject|0|||
33505610|NCT02129777|101744780|FG005|Open-Label Period|Withdrawal by Subject|1|||
33505611|NCT02129777|101744781|FG006|Open-Label Period|Withdrawal by Subject|3|||
33505612|NCT02129777|101744775|FG000|Open-Label Period|Study Termination|0|||
33505613|NCT02129777|101744776|FG001|Open-Label Period|Study Termination|0|||
33505614|NCT02129777|101744777|FG002|Open-Label Period|Study Termination|0|||
33505615|NCT02129777|101744778|FG003|Open-Label Period|Study Termination|0|||
33505616|NCT02129777|101744779|FG004|Open-Label Period|Study Termination|0|||
33505617|NCT02129777|101744780|FG005|Open-Label Period|Study Termination|10|||
33505618|NCT02129777|101744781|FG006|Open-Label Period|Study Termination|39|||
33505619|NCT04236141|101744782|FG000|Overall Study|Death|18|||
33505620|NCT04236141|101744783|FG001|Overall Study|Death|10|||
33505621|NCT04236141|101744782|FG000|Overall Study|Withdrawal by Participant|1|||
33505622|NCT04236141|101744783|FG001|Overall Study|Withdrawal by Participant|0|||
33505623|NCT04236141|101744782|FG000|Overall Study|Reason not Specified|1|||
33505624|NCT04236141|101744783|FG001|Overall Study|Reason not Specified|0|||
33505625|NCT04236141|101744782|FG000|Overall Study|Study terminated by Sponsor|8|||
33505626|NCT04236141|101744783|FG001|Overall Study|Study terminated by Sponsor|4|||
33505627|NCT04481789|101744785|FG000|Period 1|Withdrawal by Subject|1|||
33505628|NCT04481789|101744786|FG001|Period 1|Withdrawal by Subject|0|||
33505629|NCT04481789|101744787|FG002|Period 1|Withdrawal by Subject|0|||
33505630|NCT04481789|101744788|FG003|Period 1|Withdrawal by Subject|0|||
33505631|NCT04481789|101744789|FG004|Period 1|Withdrawal by Subject|0|||
33505632|NCT04481789|101744790|FG005|Period 1|Withdrawal by Subject|0|||
33505633|NCT00619892|101744791|FG000|Overall Study|Adverse Event|3|||
33505634|NCT00619892|101744792|FG001|Overall Study|Adverse Event|0|||
33505635|NCT00619892|101744791|FG000|Overall Study|Lost to Follow-up|0|||
33505636|NCT00619892|101744792|FG001|Overall Study|Lost to Follow-up|1|||
33505637|NCT00619892|101744791|FG000|Overall Study|Intercurrent illness|0|||
33505638|NCT00619892|101744792|FG001|Overall Study|Intercurrent illness|1|||
33505639|NCT01508130|101744793|FG000|Overall Study|Adverse Event|81|||
33505640|NCT01508130|101744794|FG001|Overall Study|Adverse Event|28|||
33505641|NCT01508130|101744793|FG000|Overall Study|Death|3|||
33505642|NCT01508130|101744794|FG001|Overall Study|Death|1|||
33505643|NCT01508130|101744793|FG000|Overall Study|Protocol Violation|2|||
33505644|NCT01508130|101744794|FG001|Overall Study|Protocol Violation|0|||
33505645|NCT01508130|101744793|FG000|Overall Study|Lost to Follow-up|25|||
33505646|NCT01508130|101744794|FG001|Overall Study|Lost to Follow-up|2|||
33505647|NCT01508130|101744793|FG000|Overall Study|Withdrawal by Subject|3|||
33505648|NCT01508130|101744794|FG001|Overall Study|Withdrawal by Subject|3|||
33505649|NCT01508130|101744793|FG000|Overall Study|Subject's substantial non-compliance|25|||
33505650|NCT01508130|101744794|FG001|Overall Study|Subject's substantial non-compliance|9|||
33505651|NCT01508130|101744793|FG000|Overall Study|Insufficient therapeutic response|74|||
33505652|NCT01508130|101744794|FG001|Overall Study|Insufficient therapeutic response|23|||
33505653|NCT01508130|101744793|FG000|Overall Study|Administrative|14|||
33505654|NCT01508130|101744794|FG001|Overall Study|Administrative|3|||
33505655|NCT01894100|101744795|FG000|Overall Study|Lost to Follow-up|0|||
33505656|NCT01894100|101744796|FG001|Overall Study|Lost to Follow-up|1|||
33505657|NCT01894100|101744795|FG000|Overall Study|Withdrawal by Subject|3|||
33505658|NCT01894100|101744796|FG001|Overall Study|Withdrawal by Subject|0|||
33505659|NCT03852264|101744798|FG000|Third Research Visit|Lost to Follow-up|1|||
33505660|NCT03852264|101744799|FG001|Third Research Visit|Lost to Follow-up|0|||
33505661|NCT00458536|101744800|FG000|Overall Study|Disease progression prior to treatment|7|||
33505662|NCT00458536|101744800|FG000|Overall Study|Unable to make vaccine|3|||
33505663|NCT00458536|101744800|FG000|Overall Study|No measurable disease after surgery|2|||
33505664|NCT00458536|101744800|FG000|Overall Study|Did not have renal cell carcinoma|2|||
33505665|NCT00458536|101744800|FG000|Overall Study|Patient did not have surgery|1|||
33505666|NCT00458536|101744800|FG000|Overall Study|Ineligible due to toxicity|1|||
33505667|NCT00458536|101744800|FG000|Overall Study|Withdrawal by Subject|1|||
33505668|NCT00458536|101744800|FG000|Overall Study|Progressive disease during treatment|2|||
33505669|NCT00723008|101744801|FG000|Enrollment|Lost to Follow-up|1|||
33505670|NCT00723008|101744802|FG001|Enrollment|Lost to Follow-up|0|||
33505671|NCT00723008|101744801|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
33505672|NCT00723008|101744802|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
33505673|NCT00723008|101744801|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
33505674|NCT00723008|101744802|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
33505675|NCT00723008|101744801|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
33505676|NCT00723008|101744802|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
33505677|NCT00723008|101744801|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
33505678|NCT00723008|101744802|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
33505679|NCT00723008|101744801|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
33505680|NCT00723008|101744802|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
33505681|NCT02366637|101744803|FG000|First Intervention Period|Adverse Event|0|||
33505682|NCT02366637|101744804|FG001|First Intervention Period|Adverse Event|1|||
33505683|NCT02366637|101744803|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
33603242|NCT02528357|102099194|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603243|NCT02528357|102099195|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33505684|NCT02366637|101744804|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
33603244|NCT02528357|102099196|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603245|NCT02528357|102099197|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
33603246|NCT02528357|102099198|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
33603247|NCT02528357|102099199|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
33603248|NCT02528357|102099200|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
33603249|NCT03149003|102099204|FG000|Overall Study|Randomized but not treated|0|||
33603250|NCT03149003|102099205|FG001|Overall Study|Randomized but not treated|1|||
33603251|NCT03149003|102099206|FG002|Overall Study|Randomized but not treated|18|||
33603252|NCT00286221|102099212|FG000|Overall Study|Protocol Violation|2|||
33603253|NCT00286221|102099213|FG001|Overall Study|Protocol Violation|1|||
33603254|NCT00286221|102099214|FG002|Overall Study|Protocol Violation|6|||
33195094|NCT02447991|100619578|FG001|Overall Study|End of study - no treatment results|6|||
33195095|NCT02447991|100619577|FG000|Overall Study|End of study - partial treatment results|0|||
33195096|NCT02447991|100619578|FG001|Overall Study|End of study - partial treatment results|9|||
33195097|NCT01332149|100619581|FG000|Overall Study|Adverse Event|11|||
33195098|NCT01332149|100619582|FG001|Overall Study|Adverse Event|9|||
33195099|NCT01332149|100619581|FG000|Overall Study|Other unspecified|5|||
33195100|NCT01332149|100619582|FG001|Overall Study|Other unspecified|7|||
33195101|NCT01332149|100619581|FG000|Overall Study|Protocol Violation|1|||
33195102|NCT01332149|100619582|FG001|Overall Study|Protocol Violation|3|||
33195103|NCT01332149|100619581|FG000|Overall Study|Withdrawal by Subject|4|||
33195104|NCT01332149|100619582|FG001|Overall Study|Withdrawal by Subject|5|||
33195105|NCT01332149|100619581|FG000|Overall Study|Lost to Follow-up|1|||
33195106|NCT01332149|100619582|FG001|Overall Study|Lost to Follow-up|1|||
33195107|NCT01332149|100619581|FG000|Overall Study|Insufficient clinical response|4|||
33195108|NCT01332149|100619582|FG001|Overall Study|Insufficient clinical response|7|||
33195109|NCT01332149|100619581|FG000|Overall Study|Did not meet entrance criteria|3|||
33195110|NCT01332149|100619582|FG001|Overall Study|Did not meet entrance criteria|4|||
33195111|NCT01332149|100619581|FG000|Overall Study|Randomized but not treated|1|||
33195112|NCT01332149|100619582|FG001|Overall Study|Randomized but not treated|2|||
33195113|NCT03773757|100619585|FG000|Overall Study|Withdrawal by Subject|2|||
33195114|NCT03773757|100619586|FG001|Overall Study|Withdrawal by Subject|4|||
33195115|NCT00087568|100619587|FG000|Overall Study|Adverse Event|4|||
33195116|NCT00087568|100619588|FG001|Overall Study|Adverse Event|0|||
33195117|NCT00087568|100619587|FG000|Overall Study|Withdrawal by Subject|1|||
33195118|NCT00087568|100619588|FG001|Overall Study|Withdrawal by Subject|1|||
33195119|NCT00087568|100619587|FG000|Overall Study|Lost to Follow-up|1|||
33195120|NCT00087568|100619588|FG001|Overall Study|Lost to Follow-up|0|||
33195121|NCT00087568|100619587|FG000|Overall Study|Lack of Efficacy|24|||
33195122|NCT00087568|100619588|FG001|Overall Study|Lack of Efficacy|1|||
33195123|NCT05061446|100619589|FG000|Overall Study|Adverse Event|2|||
33195124|NCT05061446|100619590|FG001|Overall Study|Adverse Event|0|||
33195125|NCT05061446|100619591|FG002|Overall Study|Adverse Event|0|||
33195126|NCT05061446|100619589|FG000|Overall Study|Participant no longer available due to personal reason|0|||
33195127|NCT05061446|100619590|FG001|Overall Study|Participant no longer available due to personal reason|1|||
33195128|NCT05061446|100619591|FG002|Overall Study|Participant no longer available due to personal reason|0|||
33505685|NCT02366637|101744803|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
33505686|NCT02366637|101744804|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
33505687|NCT02977572|101744806|FG000|Overall Study|Exclusion criterion|2|||
33505688|NCT02977572|101744807|FG001|Overall Study|Exclusion criterion|2|||
33195129|NCT01978184|100619592|FG000|Overall Study|Progressive disease|5|||
33195130|NCT01978184|100619593|FG001|Overall Study|Progressive disease|5|||
33195131|NCT01978184|100619592|FG000|Overall Study|Other than PDA|2|||
33195132|NCT01978184|100619593|FG001|Overall Study|Other than PDA|2|||
33505689|NCT01435018|101744815|FG000|Overall Study|Death|37|||
33505690|NCT01435018|101744816|FG001|Overall Study|Death|18|||
33505691|NCT01435018|101744817|FG002|Overall Study|Death|25|||
33505692|NCT01435018|101744815|FG000|Overall Study|Site is closing|4|||
33195133|NCT01978184|100619592|FG000|Overall Study|Physician Decision|0|||
33195134|NCT01978184|100619593|FG001|Overall Study|Physician Decision|3|||
33315535|NCT00372385|101047638|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
33315536|NCT00372385|101047639|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
33315537|NCT00372385|101047640|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
33315538|NCT00372385|101047637|FG000|Overall Study|Virologic Stopping Rule|17|||
33315539|NCT00372385|101047638|FG001|Overall Study|Virologic Stopping Rule|0|||
33315540|NCT00372385|101047639|FG002|Overall Study|Virologic Stopping Rule|0|||
33315541|NCT00372385|101047640|FG003|Overall Study|Virologic Stopping Rule|0|||
33315542|NCT00138671|101047641|FG000|Overall Study|Death|0|||
33315543|NCT00138671|101047642|FG001|Overall Study|Death|3|||
33315544|NCT00138671|101047641|FG000|Overall Study|Adverse Event|6|||
33315545|NCT00138671|101047642|FG001|Overall Study|Adverse Event|3|||
33315546|NCT00138671|101047641|FG000|Overall Study|Lost to Follow-up|1|||
33315547|NCT00138671|101047642|FG001|Overall Study|Lost to Follow-up|2|||
33315548|NCT00138671|101047641|FG000|Overall Study|Withdrawal by Subject|3|||
33315549|NCT00138671|101047642|FG001|Overall Study|Withdrawal by Subject|5|||
33315550|NCT00138671|101047641|FG000|Overall Study|Other|3|||
33315551|NCT00138671|101047642|FG001|Overall Study|Other|3|||
33315552|NCT02513745|101047643|FG000|Overall Study|Criteria at time of surgery not met.|3|||
33315553|NCT02513745|101047644|FG001|Overall Study|Criteria at time of surgery not met.|3|||
33315554|NCT03103763|101047645|FG000|Overall Study|Death|15|||
33315555|NCT03103763|101047646|FG001|Overall Study|Death|5|||
33315556|NCT03103763|101047647|FG002|Overall Study|Death|5|||
33315557|NCT03103763|101047645|FG000|Overall Study|Withdrawal by Subject|0|||
33315558|NCT03103763|101047646|FG001|Overall Study|Withdrawal by Subject|3|||
33315559|NCT03103763|101047647|FG002|Overall Study|Withdrawal by Subject|2|||
33315560|NCT00871780|101047648|FG000|Overall Study|Enrolled But Not Treated|6|||
33315561|NCT00871780|101047648|FG000|Overall Study|Withdrawal by Subject|9|||
33315562|NCT00871780|101047648|FG000|Overall Study|Adverse Event|6|||
33315563|NCT00871780|101047648|FG000|Overall Study|Voluntary Discontinuation|4|||
33315564|NCT00871780|101047648|FG000|Overall Study|Death|1|||
33315565|NCT00871780|101047648|FG000|Overall Study|Physician Decision|1|||
33315566|NCT04335812|101047649|FG000|Overall Study|Withdrawal by Subject|1|||
33315567|NCT04335812|101047650|FG001|Overall Study|Withdrawal by Subject|3|||
33315568|NCT04335812|101047649|FG000|Overall Study|Lost to Follow-up|12|||
33315569|NCT04335812|101047650|FG001|Overall Study|Lost to Follow-up|12|||
33315570|NCT04335812|101047649|FG000|Overall Study|Did not engage in the intervention|22|||
33396889|NCT04921969|101342005|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
33396890|NCT04921969|101342006|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33396891|NCT04921969|101342007|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33396892|NCT04921969|101342008|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33396893|NCT04921969|101342009|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33396894|NCT04921969|101342003|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
33396895|NCT04921969|101342004|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
33396896|NCT04921969|101342005|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
33396897|NCT04921969|101342006|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
33505693|NCT01435018|101744816|FG001|Overall Study|Site is closing|9|||
33505694|NCT01435018|101744817|FG002|Overall Study|Site is closing|7|||
33505695|NCT01435018|101744815|FG000|Overall Study|Withdrew consent|0|||
33195135|NCT01978184|100619592|FG000|Overall Study|Noncompliance|1|||
33315571|NCT04335812|101047650|FG001|Overall Study|Did not engage in the intervention|18|||
33315572|NCT00686725|101047657|FG000|Overall Study|Adverse Event|1|||
33315573|NCT00686725|101047658|FG001|Overall Study|Adverse Event|1|||
33315574|NCT00686725|101047657|FG000|Overall Study|Progressive Disease|17|||
33315575|NCT00686725|101047658|FG001|Overall Study|Progressive Disease|23|||
33315576|NCT00686725|101047657|FG000|Overall Study|Lost to Follow-up|7|||
33315577|NCT00686725|101047658|FG001|Overall Study|Lost to Follow-up|5|||
33315578|NCT00686725|101047657|FG000|Overall Study|Death|6|||
33315579|NCT00686725|101047658|FG001|Overall Study|Death|3|||
33315580|NCT00686725|101047657|FG000|Overall Study|Withdrawal by Subject|13|||
33315581|NCT00686725|101047658|FG001|Overall Study|Withdrawal by Subject|4|||
33315582|NCT00686725|101047657|FG000|Overall Study|Protocol Violation|1|||
33315583|NCT00686725|101047658|FG001|Overall Study|Protocol Violation|3|||
33315584|NCT00686725|101047657|FG000|Overall Study|Other|1|||
33315585|NCT00686725|101047658|FG001|Overall Study|Other|3|||
33315586|NCT02186223|101047661|FG000|Overall Study|Not eligible for device placement|6|||
33315587|NCT02186223|101047661|FG000|Overall Study|Unable to obtain femoral access|3|||
33315588|NCT02186223|101047661|FG000|Overall Study|Death|3|||
33315589|NCT02186223|101047661|FG000|Overall Study|Device in place less than 48 hours|9|||
33315590|NCT01607554|101047662|FG000|Overall Study|Disease progression|2|||
33315591|NCT01295034|101047663|FG000|Overall Study|Lost to Follow-up|5|||
33315592|NCT01295034|101047664|FG001|Overall Study|Lost to Follow-up|5|||
33315593|NCT03486457|101047665|FG000|Up to Month 3|Adverse Event|2|||
33315594|NCT03486457|101047666|FG001|Up to Month 3|Adverse Event|5|||
33315595|NCT03486457|101047665|FG000|Up to Month 3|Lack of Efficacy|1|||
33315596|NCT03486457|101047666|FG001|Up to Month 3|Lack of Efficacy|0|||
33315597|NCT03486457|101047665|FG000|Up to Month 3|Withdrawal by Subject|1|||
33315598|NCT03486457|101047666|FG001|Up to Month 3|Withdrawal by Subject|0|||
33315599|NCT03486457|101047665|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
33315600|NCT03486457|101047666|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
33315601|NCT03486457|101047665|FG000|Up to Month 3|Other|1|||
33315602|NCT03486457|101047666|FG001|Up to Month 3|Other|0|||
33315603|NCT03486457|101047665|FG000|Month 3 to Month 6|Adverse Event|2|||
33315604|NCT03486457|101047666|FG001|Month 3 to Month 6|Adverse Event|0|||
33315605|NCT03486457|101047665|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
33315606|NCT03486457|101047666|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
33315607|NCT03486457|101047665|FG000|Month 3 to Month 6|Pregnancy|0|||
33315608|NCT03486457|101047666|FG001|Month 3 to Month 6|Pregnancy|1|||
33315609|NCT03486457|101047665|FG000|Month 3 to Month 6|Other|1|||
33315610|NCT03486457|101047666|FG001|Month 3 to Month 6|Other|0|||
33315611|NCT00031551|101047667|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
33315612|NCT00031551|101047668|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
33396898|NCT04921969|101342007|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
33396899|NCT04921969|101342008|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
33505696|NCT01435018|101744816|FG001|Overall Study|Withdrew consent|3|||
33505697|NCT01435018|101744817|FG002|Overall Study|Withdrew consent|1|||
33505698|NCT01435018|101744815|FG000|Overall Study|Not willing to adhere to requirements|0|||
33396900|NCT04921969|101342009|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
33396901|NCT04921969|101342003|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
33396902|NCT04921969|101342004|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
33315613|NCT00475033|101047669|FG000|Infant Series|Failed to return|3|||
33396903|NCT04921969|101342005|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
33396904|NCT04921969|101342006|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
33396905|NCT04921969|101342007|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
33396906|NCT04921969|101342008|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
33396907|NCT04921969|101342009|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
33396908|NCT04921969|101342003|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
33396909|NCT04921969|101342004|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
33396910|NCT04921969|101342005|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
33396911|NCT04921969|101342006|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33396912|NCT04921969|101342007|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33396913|NCT04921969|101342008|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33396914|NCT04921969|101342009|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33396915|NCT04921969|101342003|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
33396916|NCT04921969|101342004|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
33396917|NCT04921969|101342005|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
33396918|NCT04921969|101342006|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
33396919|NCT04921969|101342007|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
33505699|NCT01435018|101744816|FG001|Overall Study|Not willing to adhere to requirements|2|||
33505700|NCT01435018|101744817|FG002|Overall Study|Not willing to adhere to requirements|3|||
33396920|NCT04921969|101342008|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
33505701|NCT01435018|101744815|FG000|Overall Study|Not able to get to clinic|2|||
33505702|NCT01435018|101744816|FG001|Overall Study|Not able to get to clinic|0|||
33505703|NCT01435018|101744817|FG002|Overall Study|Not able to get to clinic|2|||
33315614|NCT00475033|101047670|FG001|Infant Series|Failed to return|4|||
33315615|NCT00475033|101047669|FG000|Infant Series|Parent or legal guardian request|1|||
33315616|NCT00475033|101047670|FG001|Infant Series|Parent or legal guardian request|5|||
33315617|NCT00475033|101047669|FG000|Infant Series|Protocol Violation|1|||
33315618|NCT00475033|101047670|FG001|Infant Series|Protocol Violation|2|||
33315619|NCT00475033|101047669|FG000|Infant Series|Lost to Follow-up|2|||
33315620|NCT00475033|101047670|FG001|Infant Series|Lost to Follow-up|0|||
33396921|NCT04921969|101342009|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
33396922|NCT04921969|101342003|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
33396923|NCT04921969|101342004|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
33396924|NCT04921969|101342005|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
33396925|NCT04921969|101342006|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
33396926|NCT04921969|101342007|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
33396927|NCT04921969|101342008|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
33396928|NCT04921969|101342009|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
33396929|NCT04921969|101342003|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33396930|NCT04921969|101342004|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33396931|NCT04921969|101342005|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33396932|NCT04921969|101342006|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
33396933|NCT04921969|101342007|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33396934|NCT04921969|101342008|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
33396935|NCT04921969|101342009|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
33396936|NCT04921969|101342003|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33396937|NCT04921969|101342004|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33396938|NCT04921969|101342005|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33396939|NCT04921969|101342006|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
33396940|NCT04921969|101342007|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|3|||
33396941|NCT04921969|101342008|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|13|||
33396942|NCT04921969|101342009|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
33396943|NCT04921969|101342003|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
33396944|NCT04921969|101342004|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
33396945|NCT04921969|101342005|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
33396946|NCT04921969|101342006|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
33396947|NCT04921969|101342007|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
33396948|NCT04921969|101342008|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
33396949|NCT04921969|101342009|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
33396950|NCT04921969|101342003|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33396951|NCT04921969|101342004|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33396952|NCT04921969|101342005|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33396953|NCT04921969|101342006|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|1|||
33396954|NCT04921969|101342007|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|1|||
33396955|NCT04921969|101342008|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
33396956|NCT04921969|101342009|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|13|||
33396957|NCT04921969|101342003|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
33396958|NCT04921969|101342004|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
33396959|NCT04921969|101342005|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
33396960|NCT04921969|101342006|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
33396961|NCT04921969|101342007|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
33396962|NCT04921969|101342008|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
33396963|NCT04921969|101342009|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
33396964|NCT04921969|101342003|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
33396965|NCT04921969|101342004|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
33396966|NCT04921969|101342005|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
33396967|NCT04921969|101342006|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
33396968|NCT04921969|101342007|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
33396969|NCT04921969|101342008|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
33315621|NCT00475033|101047669|FG000|Infant Series|Adverse Event|0|||
33315622|NCT00475033|101047670|FG001|Infant Series|Adverse Event|2|||
33315623|NCT00475033|101047669|FG000|After the Infant Series|Adverse Event|0|||
33315624|NCT00475033|101047670|FG001|After the Infant Series|Adverse Event|4|||
33315625|NCT00475033|101047669|FG000|After the Infant Series|Parent or legal guardian request|2|||
33315626|NCT00475033|101047670|FG001|After the Infant Series|Parent or legal guardian request|2|||
33315627|NCT00475033|101047669|FG000|After the Infant Series|Failed to return|2|||
33315628|NCT00475033|101047670|FG001|After the Infant Series|Failed to return|1|||
33315629|NCT00475033|101047669|FG000|After the Infant Series|Protocol Violation|1|||
33315630|NCT00475033|101047670|FG001|After the Infant Series|Protocol Violation|0|||
33315631|NCT00475033|101047669|FG000|After the Infant Series|Lost to Follow-up|1|||
33315632|NCT00475033|101047670|FG001|After the Infant Series|Lost to Follow-up|0|||
33315633|NCT00475033|101047669|FG000|After the Infant Series|Other|0|||
33396970|NCT04921969|101342009|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
33396971|NCT04921969|101342003|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
33396972|NCT04921969|101342004|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
33315634|NCT00475033|101047670|FG001|After the Infant Series|Other|1|||
33315635|NCT00475033|101047669|FG000|Toddler Dose|Parent or legal guardian request|2|||
33396973|NCT04921969|101342005|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
33603255|NCT00286221|102099215|FG003|Overall Study|Protocol Violation|4|||
33603256|NCT00286221|102099212|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
33603257|NCT00286221|102099213|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
33603258|NCT00286221|102099214|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
33603259|NCT00286221|102099215|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
33603260|NCT00286221|102099212|FG000|Overall Study|Inability to trigger PCA|2|||
33603261|NCT00286221|102099213|FG001|Overall Study|Inability to trigger PCA|0|||
33603262|NCT00286221|102099214|FG002|Overall Study|Inability to trigger PCA|0|||
33603263|NCT00286221|102099215|FG003|Overall Study|Inability to trigger PCA|0|||
33603264|NCT00286221|102099212|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
33603265|NCT00286221|102099213|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
33603266|NCT00286221|102099214|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
33603267|NCT00286221|102099215|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
33603268|NCT04349033|102099219|FG000|Overall Study|Lost to Follow-up|3|||
33603269|NCT04349033|102099220|FG001|Overall Study|Lost to Follow-up|1|||
33315636|NCT00475033|101047670|FG001|Toddler Dose|Parent or legal guardian request|0|||
33315637|NCT00475033|101047669|FG000|Toddler Dose|Failed to return|1|||
33315638|NCT00475033|101047670|FG001|Toddler Dose|Failed to return|0|||
33315639|NCT00475033|101047669|FG000|Toddler Dose|Lost to Follow-up|1|||
33315640|NCT00475033|101047670|FG001|Toddler Dose|Lost to Follow-up|0|||
33396974|NCT04921969|101342006|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
33396975|NCT04921969|101342007|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
33396976|NCT04921969|101342008|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|1|||
33396977|NCT04921969|101342009|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|2|||
33396978|NCT04921969|101342003|FG000|LTS Period (Weeks 8 to 52)|Ongoing|0|||
33396979|NCT04921969|101342004|FG001|LTS Period (Weeks 8 to 52)|Ongoing|0|||
33396980|NCT04921969|101342005|FG002|LTS Period (Weeks 8 to 52)|Ongoing|0|||
33396981|NCT04921969|101342006|FG003|LTS Period (Weeks 8 to 52)|Ongoing|14|||
33396982|NCT04921969|101342007|FG004|LTS Period (Weeks 8 to 52)|Ongoing|12|||
33396983|NCT04921969|101342008|FG005|LTS Period (Weeks 8 to 52)|Ongoing|55|||
33396984|NCT04921969|101342009|FG006|LTS Period (Weeks 8 to 52)|Ongoing|54|||
33396985|NCT03644173|101342010|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
33396986|NCT03644173|101342010|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
33396987|NCT03644173|101342010|FG000|Participants at the 1-month Follow up|Death|2|||
33396988|NCT03644173|101342010|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
33396989|NCT03483012|101342011|FG000|Overall Study|Lack of Efficacy|6|||
33396990|NCT02875366|101342023|FG000|Overall Study|Adverse Event|0|||
33396991|NCT02875366|101342024|FG001|Overall Study|Adverse Event|2|||
33315641|NCT04214600|101047673|FG000|Overall Study|Lost to Follow-up|9|||
33315642|NCT04214600|101047674|FG001|Overall Study|Lost to Follow-up|14|||
33315643|NCT02043678|101047677|FG000|Overall Study|Never treated|11|||
33315644|NCT02043678|101047678|FG001|Overall Study|Never treated|9|||
33315645|NCT02043678|101047677|FG000|Overall Study|AE with clinical progressive disease(PD)|18|||
33315646|NCT02043678|101047678|FG001|Overall Study|AE with clinical progressive disease(PD)|18|||
33315647|NCT02043678|101047677|FG000|Overall Study|AE without clinical PD|51|||
33315648|NCT02043678|101047678|FG001|Overall Study|AE without clinical PD|34|||
33315649|NCT02043678|101047677|FG000|Overall Study|Lost to Follow-up|1|||
33315650|NCT02043678|101047678|FG001|Overall Study|Lost to Follow-up|1|||
33315651|NCT02043678|101047677|FG000|Overall Study|Other|19|||
33315652|NCT02043678|101047678|FG001|Overall Study|Other|16|||
33315653|NCT02043678|101047677|FG000|Overall Study|Clinical PD|108|||
33315654|NCT02043678|101047678|FG001|Overall Study|Clinical PD|138|||
33315655|NCT02043678|101047677|FG000|Overall Study|Radiological PD|91|||
33315656|NCT02043678|101047678|FG001|Overall Study|Radiological PD|80|||
33315657|NCT02043678|101047677|FG000|Overall Study|Protocol-driven decision point|56|||
33315658|NCT02043678|101047678|FG001|Overall Study|Protocol-driven decision point|56|||
33315659|NCT02043678|101047677|FG000|Overall Study|Withdrawal by Subject|12|||
33315660|NCT02043678|101047678|FG001|Overall Study|Withdrawal by Subject|15|||
33396992|NCT02875366|101342023|FG000|Overall Study|Noncompliance|0|||
33396993|NCT02875366|101342024|FG001|Overall Study|Noncompliance|1|||
33396994|NCT00608894|101342025|FG000|Overall Study|Withdrawal by Subject|0|||
33396995|NCT00608894|101342026|FG001|Overall Study|Withdrawal by Subject|2|||
33396996|NCT02463331|101342027|FG000|Overall Study|Adverse Event|4|||
33396997|NCT02463331|101342028|FG001|Overall Study|Adverse Event|2|||
33396998|NCT02463331|101342027|FG000|Overall Study|Lost to Follow-up|1|||
33396999|NCT02463331|101342028|FG001|Overall Study|Lost to Follow-up|1|||
33397000|NCT02463331|101342027|FG000|Overall Study|Pregnancy|2|||
33397001|NCT02463331|101342028|FG001|Overall Study|Pregnancy|3|||
33397002|NCT02463331|101342027|FG000|Overall Study|Lack of Efficacy|6|||
33603270|NCT04349033|102099221|FG002|Overall Study|Lost to Follow-up|1|||
33603271|NCT02712424|102099222|FG000|Overall Study|Lost to Follow-up|34|||
33315661|NCT02043678|101047677|FG000|Overall Study|Ongoing with treatment|34|||
33315662|NCT02043678|101047678|FG001|Overall Study|Ongoing with treatment|38|||
33315663|NCT03226275|101047680|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
33397003|NCT02463331|101342028|FG001|Overall Study|Lack of Efficacy|0|||
33397004|NCT02463331|101342027|FG000|Overall Study|Physician Decision|3|||
33397005|NCT02463331|101342028|FG001|Overall Study|Physician Decision|0|||
33397006|NCT04021706|101342030|FG000|Overall Study|Adverse Event|2|||
33397007|NCT04021706|101342031|FG001|Overall Study|Adverse Event|0|||
33397008|NCT04021706|101342030|FG000|Overall Study|Withdrawal by Subject|1|||
33397009|NCT04021706|101342031|FG001|Overall Study|Withdrawal by Subject|2|||
33397010|NCT04021706|101342030|FG000|Overall Study|Physician Decision|1|||
33397011|NCT04021706|101342031|FG001|Overall Study|Physician Decision|0|||
33397012|NCT00403390|101342032|FG000|Overall Study|Withdrawal by Subject|1|||
33397013|NCT00403390|101342033|FG001|Overall Study|Withdrawal by Subject|0|||
33397014|NCT00403390|101342032|FG000|Overall Study|samples lost|1|||
33397015|NCT00403390|101342033|FG001|Overall Study|samples lost|0|||
33397016|NCT00403390|101342032|FG000|Overall Study|non-compliant|1|||
33397017|NCT00403390|101342033|FG001|Overall Study|non-compliant|0|||
33397018|NCT02355665|101342034|FG000|Overall Study|Adverse Event|16|||
33397019|NCT02355665|101342035|FG001|Overall Study|Adverse Event|24|||
33397020|NCT02355665|101342034|FG000|Overall Study|Protocol Violation|2|||
33397021|NCT02355665|101342035|FG001|Overall Study|Protocol Violation|0|||
33397022|NCT02355665|101342034|FG000|Overall Study|Withdrawal by Subject|90|||
33397023|NCT02355665|101342035|FG001|Overall Study|Withdrawal by Subject|100|||
33397024|NCT02355665|101342034|FG000|Overall Study|Lost to Follow-up|131|||
33397025|NCT02355665|101342035|FG001|Overall Study|Lost to Follow-up|103|||
33397026|NCT02355665|101342034|FG000|Overall Study|Death|4|||
33397027|NCT02355665|101342035|FG001|Overall Study|Death|2|||
33397028|NCT02355665|101342034|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
33397029|NCT02355665|101342035|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
33397030|NCT01662986|101342036|FG000|Overall Study|Adverse Event|5|||
33397031|NCT01662986|101342037|FG001|Overall Study|Adverse Event|4|||
33397032|NCT01662986|101342036|FG000|Overall Study|Protocol Violation|2|||
33397033|NCT01662986|101342037|FG001|Overall Study|Protocol Violation|3|||
33397034|NCT01662986|101342036|FG000|Overall Study|Lost to Follow-up|5|||
33397035|NCT01662986|101342037|FG001|Overall Study|Lost to Follow-up|4|||
33397036|NCT01662986|101342036|FG000|Overall Study|Withdrawal by Subject|2|||
33397037|NCT01662986|101342037|FG001|Overall Study|Withdrawal by Subject|2|||
33397038|NCT01662986|101342036|FG000|Overall Study|Not Treated|1|||
33397039|NCT01662986|101342037|FG001|Overall Study|Not Treated|0|||
33397040|NCT01662986|101342036|FG000|Overall Study|Other than stated above|3|||
33397041|NCT01662986|101342037|FG001|Overall Study|Other than stated above|0|||
33397042|NCT00394654|101342040|FG000|Overall Study|Lost to Follow-up|1|||
33397043|NCT00394654|101342041|FG001|Overall Study|Lost to Follow-up|0|||
33397044|NCT00394654|101342040|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
33315664|NCT03226275|101047681|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
33315665|NCT03226275|101047682|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
33315666|NCT03226275|101047683|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
33315667|NCT03226275|101047680|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
33315668|NCT03226275|101047681|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
33315669|NCT03226275|101047682|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
33315670|NCT03226275|101047683|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
33315671|NCT00400985|101047684|FG000|Overall Study|Withdrawal by Subject|5|||
33315672|NCT00400985|101047684|FG000|Overall Study|system modification|8|||
33315673|NCT00400985|101047684|FG000|Overall Study|Death|30|||
33315674|NCT00400985|101047684|FG000|Overall Study|Lost to Follow-up|9|||
33315675|NCT01054846|101047688|FG000|Overall Study|Lost to Follow-up|76|||
33315676|NCT01054846|101047689|FG001|Overall Study|Lost to Follow-up|17|||
33315677|NCT00679627|101047690|FG000|Overall Study|Death|41|||
33315678|NCT00679627|101047691|FG001|Overall Study|Death|29|||
33315679|NCT00679627|101047690|FG000|Overall Study|Adverse Event|43|||
33315680|NCT00679627|101047691|FG001|Overall Study|Adverse Event|53|||
33315681|NCT00679627|101047690|FG000|Overall Study|Withdrawal by Subject|168|||
33397045|NCT00394654|101342041|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
33397046|NCT01784211|101342044|FG000|Part A (Days 1-15)|Adverse Event|1|||
33195136|NCT01978184|100619593|FG001|Overall Study|Noncompliance|2|||
33315682|NCT00679627|101047691|FG001|Overall Study|Withdrawal by Subject|172|||
33315683|NCT00679627|101047690|FG000|Overall Study|Lost to Follow-up|22|||
33315684|NCT00679627|101047691|FG001|Overall Study|Lost to Follow-up|26|||
33397047|NCT01784211|101342045|FG001|Part A (Days 1-15)|Adverse Event|1|||
33397048|NCT01784211|101342046|FG002|Part A (Days 1-15)|Adverse Event|0|||
33397049|NCT01784211|101342047|FG003|Part A (Days 1-15)|Adverse Event|0|||
33397050|NCT01784211|101342048|FG004|Part A (Days 1-15)|Adverse Event|0|||
33397051|NCT01784211|101342049|FG005|Part A (Days 1-15)|Adverse Event|0|||
33397052|NCT01784211|101342044|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
33397053|NCT01784211|101342045|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
33397054|NCT01784211|101342046|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
33397055|NCT01784211|101342047|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
33397056|NCT01784211|101342048|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
33397057|NCT01784211|101342049|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
33397058|NCT02087241|101342050|FG000|Overall Study|Death|2|||
33397059|NCT02087241|101342051|FG001|Overall Study|Death|1|||
33397060|NCT02087241|101342052|FG002|Overall Study|Death|1|||
33397061|NCT02087241|101342053|FG003|Overall Study|Death|1|||
33397062|NCT02087241|101342050|FG000|Overall Study|Withdrawal by Subject|1|||
33397063|NCT02087241|101342051|FG001|Overall Study|Withdrawal by Subject|0|||
33397064|NCT02087241|101342052|FG002|Overall Study|Withdrawal by Subject|0|||
33397065|NCT02087241|101342053|FG003|Overall Study|Withdrawal by Subject|1|||
33397066|NCT02087241|101342050|FG000|Overall Study|Progressive Disease|0|||
33397067|NCT02087241|101342051|FG001|Overall Study|Progressive Disease|0|||
33397068|NCT02087241|101342052|FG002|Overall Study|Progressive Disease|0|||
33397069|NCT02087241|101342053|FG003|Overall Study|Progressive Disease|1|||
33397070|NCT02087241|101342050|FG000|Overall Study|Study Terminated by Sponsor|0|||
33397071|NCT02087241|101342051|FG001|Overall Study|Study Terminated by Sponsor|2|||
33397072|NCT02087241|101342052|FG002|Overall Study|Study Terminated by Sponsor|0|||
33397073|NCT02087241|101342053|FG003|Overall Study|Study Terminated by Sponsor|4|||
33397074|NCT02005211|101342054|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
33397075|NCT02005211|101342055|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
33397076|NCT02005211|101342056|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
33397077|NCT02005211|101342057|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
33397078|NCT02005211|101342058|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
33397079|NCT02005211|101342059|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
33397080|NCT02005211|101342060|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
33397081|NCT02274311|101342061|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
33397082|NCT02828644|101342064|FG000|Overall Study|Lost to Follow-up|23|||
33397083|NCT02828644|101342065|FG001|Overall Study|Lost to Follow-up|22|||
33397084|NCT00994890|101342066|FG000|Overall Study|Adverse Event|13|||
33397085|NCT00994890|101342067|FG001|Overall Study|Adverse Event|9|||
33397086|NCT00994890|101342068|FG002|Overall Study|Adverse Event|11|||
33397087|NCT00994890|101342066|FG000|Overall Study|Lack of Efficacy|0|||
33397088|NCT00994890|101342067|FG001|Overall Study|Lack of Efficacy|0|||
33397089|NCT00994890|101342068|FG002|Overall Study|Lack of Efficacy|1|||
33397090|NCT00994890|101342066|FG000|Overall Study|Lost to Follow-up|6|||
33315685|NCT00679627|101047690|FG000|Overall Study|Early Study Closure|425|||
33315686|NCT00679627|101047691|FG001|Overall Study|Early Study Closure|405|||
33315687|NCT04975438|101050722|FG000|Overall Study|Lost to Follow-up|1|||
33315688|NCT04975438|101050723|FG001|Overall Study|Lost to Follow-up|0|||
33315689|NCT04975438|101050724|FG002|Overall Study|Lost to Follow-up|1|||
33315690|NCT04975438|101050725|FG003|Overall Study|Lost to Follow-up|0|||
33397091|NCT00994890|101342067|FG001|Overall Study|Lost to Follow-up|1|||
33315691|NCT04975438|101050722|FG000|Overall Study|Withdrawal by Subject|1|||
33315692|NCT04975438|101050723|FG001|Overall Study|Withdrawal by Subject|0|||
33315693|NCT04975438|101050724|FG002|Overall Study|Withdrawal by Subject|0|||
33315694|NCT04975438|101050725|FG003|Overall Study|Withdrawal by Subject|0|||
33315695|NCT01912456|101050726|FG000|Period 1|Physician Decision|0|||
33397092|NCT00994890|101342068|FG002|Overall Study|Lost to Follow-up|3|||
33505704|NCT01435018|101744815|FG000|Overall Study|Severe debilitation, unable to continue|0|||
33505705|NCT01435018|101744816|FG001|Overall Study|Severe debilitation, unable to continue|0|||
33505706|NCT01435018|101744817|FG002|Overall Study|Severe debilitation, unable to continue|1|||
33505707|NCT01435018|101744815|FG000|Overall Study|Unable to contact participant/parent|1|||
33505708|NCT01435018|101744816|FG001|Overall Study|Unable to contact participant/parent|1|||
33505709|NCT01435018|101744817|FG002|Overall Study|Unable to contact participant/parent|1|||
33505710|NCT01435018|101744815|FG000|Overall Study|Enrollment Violation|0|||
33505711|NCT01435018|101744816|FG001|Overall Study|Enrollment Violation|1|||
33505712|NCT01435018|101744817|FG002|Overall Study|Enrollment Violation|0|||
33505713|NCT01435018|101744815|FG000|Overall Study|Never started chemotherapy|3|||
33505714|NCT01435018|101744816|FG001|Overall Study|Never started chemotherapy|0|||
33505715|NCT01435018|101744817|FG002|Overall Study|Never started chemotherapy|1|||
33315696|NCT01912456|101050727|FG001|Period 1|Physician Decision|0|||
33315697|NCT01912456|101050728|FG002|Period 1|Physician Decision|1|||
33315698|NCT01912456|101050729|FG003|Period 1|Physician Decision|0|||
33397093|NCT00994890|101342066|FG000|Overall Study|No longer willing to participate|8|||
33397094|NCT00994890|101342067|FG001|Overall Study|No longer willing to participate|5|||
33505716|NCT01668173|101744818|FG000|Overall Study|Adverse Event|3|||
33505717|NCT01668173|101744818|FG000|Overall Study|Trial suspension|4|||
33505718|NCT01122394|101744819|FG000|Overall Study|Withdrawal by Subject|1|||
33315699|NCT01912456|101050726|FG000|Period 1|non-compliance|1|||
33315700|NCT01912456|101050727|FG001|Period 1|non-compliance|0|||
33315701|NCT01912456|101050728|FG002|Period 1|non-compliance|0|||
33315702|NCT01912456|101050729|FG003|Period 1|non-compliance|1|||
33315703|NCT01912456|101050726|FG000|Period 1|Adverse Event|1|||
33315704|NCT01912456|101050727|FG001|Period 1|Adverse Event|0|||
33397095|NCT00994890|101342068|FG002|Overall Study|No longer willing to participate|13|||
33397096|NCT00994890|101342066|FG000|Overall Study|Protocol Violation|2|||
33505719|NCT01122394|101744820|FG001|Overall Study|Withdrawal by Subject|1|||
33505720|NCT01122394|101744819|FG000|Overall Study|Lost to Follow-up|2|||
33505721|NCT01122394|101744820|FG001|Overall Study|Lost to Follow-up|2|||
33505722|NCT01122394|101744819|FG000|Overall Study|Adverse Event|0|||
33505723|NCT01122394|101744820|FG001|Overall Study|Adverse Event|1|||
33505724|NCT04300309|101747580|FG000|Overall Study|Lost to Follow-up|1|||
33505725|NCT04300309|101747581|FG001|Overall Study|Lost to Follow-up|0|||
33505726|NCT00794040|101747582|FG000|Overall Study|Withdrawal by Subject|3|||
33505727|NCT00794040|101747583|FG001|Overall Study|Withdrawal by Subject|4|||
33505728|NCT00794040|101747582|FG000|Overall Study|Physician Decision|0|||
33505729|NCT00794040|101747583|FG001|Overall Study|Physician Decision|1|||
33505730|NCT02880865|101747584|FG000|Overall Study|Adverse Event|1|||
33505731|NCT02880865|101747585|FG001|Overall Study|Adverse Event|0|||
33505732|NCT02880865|101747584|FG000|Overall Study|Withdrawal by Subject|0|||
33195137|NCT01978184|100619592|FG000|Overall Study|Death|1|||
33195138|NCT01978184|100619593|FG001|Overall Study|Death|0|||
33195139|NCT01978184|100619592|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
33195140|NCT01978184|100619593|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
33195141|NCT04027686|100619603|FG000|Overall Study|Lost to Follow-up|2|||
33195142|NCT04027686|100619604|FG001|Overall Study|Lost to Follow-up|0|||
33195143|NCT04027686|100619603|FG000|Overall Study|Withdrawal by Subject|0|||
33195144|NCT04027686|100619604|FG001|Overall Study|Withdrawal by Subject|1|||
33315705|NCT01912456|101050728|FG002|Period 1|Adverse Event|0|||
33505733|NCT02880865|101747585|FG001|Overall Study|Withdrawal by Subject|2|||
33505734|NCT02880865|101747584|FG000|Overall Study|Physician Decision|0|||
33505735|NCT02880865|101747585|FG001|Overall Study|Physician Decision|1|||
33505736|NCT02055365|101747586|FG000|Overall Study|Prematurely Withdrawn|1|||
33505737|NCT02429778|101747590|FG000|Overall Study|Lost to Follow-up|2|||
33505738|NCT02429778|101747591|FG001|Overall Study|Lost to Follow-up|0|||
33505739|NCT02429778|101747590|FG000|Overall Study|Withdrawal by Subject|5|||
33505740|NCT02429778|101747591|FG001|Overall Study|Withdrawal by Subject|0|||
33505741|NCT01102257|101747592|FG000|Overall Study|Adverse Event|1|||
33505742|NCT01102257|101747593|FG001|Overall Study|Adverse Event|0|||
33505743|NCT01102257|101747592|FG000|Overall Study|Adverse Event|1|||
33505744|NCT01102257|101747593|FG001|Overall Study|Adverse Event|0|||
33505745|NCT00708214|101747594|FG000|Overall Study|Other Adverse Event|3|||
33505746|NCT00708214|101747595|FG001|Overall Study|Other Adverse Event|6|||
33505747|NCT00708214|101747596|FG002|Overall Study|Other Adverse Event|2|||
33505748|NCT00708214|101747594|FG000|Overall Study|Other|0|||
33505749|NCT00708214|101747595|FG001|Overall Study|Other|1|||
33505750|NCT00708214|101747596|FG002|Overall Study|Other|1|||
33505751|NCT00708214|101747594|FG000|Overall Study|Progressive Disease|4|||
33505752|NCT00708214|101747595|FG001|Overall Study|Progressive Disease|6|||
33505753|NCT00708214|101747596|FG002|Overall Study|Progressive Disease|5|||
33505754|NCT03343704|101747597|FG000|Overall Study|Refused to complete follow up|0|||
33603272|NCT02712424|102099223|FG001|Overall Study|Lost to Follow-up|32|||
33603273|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
33603274|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
33603275|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
33603276|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
33603277|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
33603278|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
33603279|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
33315706|NCT01912456|101050729|FG003|Period 1|Adverse Event|1|||
33505755|NCT03343704|101747598|FG001|Overall Study|Refused to complete follow up|1|||
33505756|NCT03343704|101747597|FG000|Overall Study|Death|0|||
33603280|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
33603281|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
33195145|NCT01049919|100619606|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
33315707|NCT01912456|101050726|FG000|Period 1|Withdrawal by Subject|0|||
33505757|NCT03343704|101747598|FG001|Overall Study|Death|1|||
33505758|NCT03343704|101747597|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
33603282|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
33603283|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
33603284|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
33603285|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
33603286|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
33195146|NCT01049919|100619607|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
33195147|NCT01049919|100619606|FG000|Overall Study|Withdrawal by Subject|5|||
33195148|NCT01049919|100619607|FG001|Overall Study|Withdrawal by Subject|0|||
33195149|NCT01049919|100619606|FG000|Overall Study|Lost to Follow-up|6|||
33195150|NCT01049919|100619607|FG001|Overall Study|Lost to Follow-up|1|||
33195151|NCT01049919|100619606|FG000|Overall Study|Physician Decision|2|||
33195152|NCT01049919|100619607|FG001|Overall Study|Physician Decision|0|||
33195153|NCT01049919|100619606|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
33195154|NCT01049919|100619607|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
33195155|NCT01049919|100619606|FG000|Overall Study|Early study termination by sponsor.|2|||
33195156|NCT01049919|100619607|FG001|Overall Study|Early study termination by sponsor.|0|||
33195157|NCT01276327|100619608|FG000|Overall Study|Adverse Event|1|||
33195158|NCT01276327|100619609|FG001|Overall Study|Adverse Event|3|||
33195159|NCT01276327|100619608|FG000|Overall Study|Withdrawal by Subject|1|||
33195160|NCT01276327|100619609|FG001|Overall Study|Withdrawal by Subject|0|||
33195161|NCT00563797|100619610|FG000|Overall Study|Lost to Follow-up|7|||
33195162|NCT00563797|100619611|FG001|Overall Study|Lost to Follow-up|2|||
33195163|NCT01410110|100619620|FG000|Overall Study|Withdrawal by Subject|4|||
33195164|NCT01410110|100619621|FG001|Overall Study|Withdrawal by Subject|2|||
33315708|NCT01912456|101050727|FG001|Period 1|Withdrawal by Subject|1|||
33315709|NCT01912456|101050728|FG002|Period 1|Withdrawal by Subject|1|||
33315710|NCT01912456|101050729|FG003|Period 1|Withdrawal by Subject|1|||
33315711|NCT01912456|101050726|FG000|Period 2|Lack of Efficacy|0|||
33315712|NCT01912456|101050727|FG001|Period 2|Lack of Efficacy|2|||
33315713|NCT01912456|101050728|FG002|Period 2|Lack of Efficacy|0|||
33315714|NCT01912456|101050729|FG003|Period 2|Lack of Efficacy|0|||
33315715|NCT01912456|101050726|FG000|Period 2|Adverse Event|0|||
33315716|NCT01912456|101050727|FG001|Period 2|Adverse Event|0|||
33315717|NCT01912456|101050728|FG002|Period 2|Adverse Event|0|||
33315718|NCT01912456|101050729|FG003|Period 2|Adverse Event|1|||
33315719|NCT01127139|101050741|FG000|Overall Study|Adverse Event|40|||
33397097|NCT00994890|101342067|FG001|Overall Study|Protocol Violation|4|||
33397098|NCT00994890|101342068|FG002|Overall Study|Protocol Violation|0|||
33397099|NCT00994890|101342066|FG000|Overall Study|Study terminated by sponsor|199|||
33397100|NCT00994890|101342067|FG001|Overall Study|Study terminated by sponsor|201|||
33397101|NCT00994890|101342068|FG002|Overall Study|Study terminated by sponsor|197|||
33397102|NCT00994890|101342066|FG000|Overall Study|Randomized, but not treated|1|||
33397103|NCT00994890|101342067|FG001|Overall Study|Randomized, but not treated|0|||
33397104|NCT00994890|101342068|FG002|Overall Study|Randomized, but not treated|0|||
33397105|NCT00994890|101342066|FG000|Overall Study|Other|2|||
33397106|NCT00994890|101342067|FG001|Overall Study|Other|2|||
33397107|NCT00994890|101342068|FG002|Overall Study|Other|1|||
33397108|NCT01603615|101342069|FG000|Overall Study|Did not Receive Treatment|7|||
33397109|NCT01603615|101342069|FG000|Overall Study|Lost to Follow-up|9|||
33397110|NCT01603615|101342069|FG000|Overall Study|Personal Reasons|17|||
33397111|NCT01603615|101342069|FG000|Overall Study|Other Miscellaneous|1|||
33397112|NCT00312728|101342070|FG000|Overall Study|Progressive disease|53|||
33397113|NCT00312728|101342070|FG000|Overall Study|Adverse Event|32|||
33397114|NCT00312728|101342070|FG000|Overall Study|Withdrawal by Subject|10|||
33195165|NCT03246958|100619624|FG000|Overall Study|Withdrawal by Subject|0|||
33195166|NCT03246958|100619625|FG001|Overall Study|Withdrawal by Subject|1|||
33195167|NCT03246958|100619626|FG002|Overall Study|Withdrawal by Subject|0|||
33195168|NCT03246958|100619627|FG003|Overall Study|Withdrawal by Subject|0|||
33315720|NCT01127139|101050741|FG000|Overall Study|Incompliance|12|||
33315721|NCT01127139|101050741|FG000|Overall Study|Lack of Efficacy|4|||
33315722|NCT01127139|101050741|FG000|Overall Study|Reason not specified|1|||
33315723|NCT00081770|101050742|FG000|Overall Study|Adverse Event|130|||
33315724|NCT00081770|101050743|FG001|Overall Study|Adverse Event|98|||
33315725|NCT00081770|101050744|FG002|Overall Study|Adverse Event|136|||
33315726|NCT00081770|101050742|FG000|Overall Study|Lack of Efficacy|262|||
33315727|NCT00081770|101050743|FG001|Overall Study|Lack of Efficacy|357|||
33195169|NCT03246958|100619628|FG004|Overall Study|Withdrawal by Subject|0|||
33315728|NCT00081770|101050744|FG002|Overall Study|Lack of Efficacy|211|||
33315729|NCT00081770|101050742|FG000|Overall Study|Lost to Follow-up|45|||
33315730|NCT00081770|101050743|FG001|Overall Study|Lost to Follow-up|34|||
33315731|NCT00081770|101050744|FG002|Overall Study|Lost to Follow-up|45|||
33315732|NCT00081770|101050742|FG000|Overall Study|Protocol Violation|15|||
33315733|NCT00081770|101050743|FG001|Overall Study|Protocol Violation|10|||
33397115|NCT00312728|101342070|FG000|Overall Study|Required non-protocol cancer treatment|2|||
33397116|NCT00312728|101342070|FG000|Overall Study|Protocol Violation|2|||
33397117|NCT00312728|101342070|FG000|Overall Study|Other|10|||
33397118|NCT00312728|101342070|FG000|Overall Study|Other|1|||
33505759|NCT03343704|101747598|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
33505760|NCT02582242|101747599|FG000|Overall Study|Adverse Event|4|||
33195170|NCT03246958|100619629|FG005|Overall Study|Withdrawal by Subject|1|||
33315734|NCT00081770|101050744|FG002|Overall Study|Protocol Violation|10|||
33315735|NCT00081770|101050742|FG000|Overall Study|Withdrawal by Subject|45|||
33315736|NCT00081770|101050743|FG001|Overall Study|Withdrawal by Subject|40|||
33315737|NCT00081770|101050744|FG002|Overall Study|Withdrawal by Subject|42|||
33315738|NCT00081770|101050742|FG000|Overall Study|Did not meet protocol eligibility|2|||
33315739|NCT00081770|101050743|FG001|Overall Study|Did not meet protocol eligibility|0|||
33315740|NCT00081770|101050744|FG002|Overall Study|Did not meet protocol eligibility|3|||
33315741|NCT00081770|101050742|FG000|Overall Study|Administrative|1|||
33315742|NCT00081770|101050743|FG001|Overall Study|Administrative|0|||
33315743|NCT00081770|101050744|FG002|Overall Study|Administrative|1|||
33315744|NCT00081770|101050742|FG000|Overall Study|Other|2|||
33315745|NCT00081770|101050743|FG001|Overall Study|Other|7|||
33315746|NCT00081770|101050744|FG002|Overall Study|Other|8|||
33315747|NCT01658826|101050747|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
33315748|NCT01658826|101050748|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
33315749|NCT01658826|101050747|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
33315750|NCT01658826|101050748|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
33315751|NCT01658826|101050747|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
33315752|NCT01658826|101050748|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
33315753|NCT01658826|101050747|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
33315754|NCT01658826|101050748|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
33315755|NCT01658826|101050747|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
33315756|NCT01658826|101050748|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
33315757|NCT01658826|101050747|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
33315758|NCT01658826|101050748|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
33315759|NCT01658826|101050747|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
33315760|NCT01658826|101050748|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
33315761|NCT01658826|101050747|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
33315762|NCT01658826|101050748|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
33315763|NCT01658826|101050747|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
33315764|NCT01658826|101050748|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
33315765|NCT00607022|101050749|FG000|Overall Study|Withdrawal by Subject|1|||
33315766|NCT00607022|101050750|FG001|Overall Study|Withdrawal by Subject|0|||
33315767|NCT00607022|101050751|FG002|Overall Study|Withdrawal by Subject|0|||
33315768|NCT01498653|101050752|FG000|Overall Study|Adverse Event|2|||
33315769|NCT01498653|101050753|FG001|Overall Study|Adverse Event|2|||
33505761|NCT02582242|101747600|FG001|Overall Study|Adverse Event|3|||
33505762|NCT02582242|101747599|FG000|Overall Study|Protocol Violation|3|||
33505763|NCT02582242|101747600|FG001|Overall Study|Protocol Violation|1|||
33505764|NCT02582242|101747599|FG000|Overall Study|Lost to Follow-up|0|||
33505765|NCT02582242|101747600|FG001|Overall Study|Lost to Follow-up|1|||
33505766|NCT02582242|101747599|FG000|Overall Study|Withdrawal by Subject|11|||
33505767|NCT02582242|101747600|FG001|Overall Study|Withdrawal by Subject|11|||
33195171|NCT03246958|100619630|FG006|Overall Study|Withdrawal by Subject|0|||
33195172|NCT03246958|100619624|FG000|Overall Study|Progression|13|||
33195173|NCT03246958|100619625|FG001|Overall Study|Progression|9|||
33195174|NCT03246958|100619626|FG002|Overall Study|Progression|3|||
33195175|NCT03246958|100619627|FG003|Overall Study|Progression|2|||
33195176|NCT03246958|100619628|FG004|Overall Study|Progression|1|||
33195177|NCT03246958|100619629|FG005|Overall Study|Progression|2|||
33195178|NCT03246958|100619630|FG006|Overall Study|Progression|1|||
33195179|NCT03246958|100619624|FG000|Overall Study|Adverse Event|2|||
33195180|NCT03246958|100619625|FG001|Overall Study|Adverse Event|2|||
33195181|NCT03246958|100619626|FG002|Overall Study|Adverse Event|0|||
33195182|NCT03246958|100619627|FG003|Overall Study|Adverse Event|1|||
33195183|NCT03246958|100619628|FG004|Overall Study|Adverse Event|1|||
33505768|NCT02582242|101747599|FG000|Overall Study|Unclassified|2|||
33505769|NCT02582242|101747600|FG001|Overall Study|Unclassified|1|||
33505770|NCT01339923|101747601|FG000|Overall Study|Adverse Event|1|||
33505771|NCT01339923|101747602|FG001|Overall Study|Adverse Event|1|||
33195184|NCT03246958|100619629|FG005|Overall Study|Adverse Event|0|||
33195185|NCT03246958|100619630|FG006|Overall Study|Adverse Event|2|||
33505772|NCT01339923|101747603|FG002|Overall Study|Adverse Event|1|||
33195186|NCT03246958|100619624|FG000|Overall Study|Death|0|||
33195187|NCT03246958|100619625|FG001|Overall Study|Death|1|||
33195188|NCT03246958|100619626|FG002|Overall Study|Death|0|||
33195189|NCT03246958|100619627|FG003|Overall Study|Death|0|||
33195190|NCT03246958|100619628|FG004|Overall Study|Death|0|||
33195191|NCT03246958|100619629|FG005|Overall Study|Death|0|||
33195192|NCT03246958|100619630|FG006|Overall Study|Death|0|||
33505773|NCT01339923|101747604|FG003|Overall Study|Adverse Event|0|||
33195193|NCT03246958|100619624|FG000|Overall Study|Physician Decision|0|||
33195194|NCT03246958|100619625|FG001|Overall Study|Physician Decision|0|||
33195195|NCT03246958|100619626|FG002|Overall Study|Physician Decision|0|||
33195196|NCT03246958|100619627|FG003|Overall Study|Physician Decision|1|||
33505774|NCT01339923|101747605|FG004|Overall Study|Adverse Event|0|||
33505775|NCT01339923|101747606|FG005|Overall Study|Adverse Event|0|||
33195197|NCT03246958|100619628|FG004|Overall Study|Physician Decision|0|||
33195198|NCT03246958|100619629|FG005|Overall Study|Physician Decision|0|||
33195199|NCT03246958|100619630|FG006|Overall Study|Physician Decision|0|||
33195200|NCT03246958|100619624|FG000|Overall Study|Never start treatment|1|||
33195201|NCT03246958|100619625|FG001|Overall Study|Never start treatment|0|||
33195202|NCT03246958|100619626|FG002|Overall Study|Never start treatment|0|||
33195203|NCT03246958|100619627|FG003|Overall Study|Never start treatment|0|||
33195204|NCT03246958|100619628|FG004|Overall Study|Never start treatment|0|||
33195205|NCT03246958|100619629|FG005|Overall Study|Never start treatment|0|||
33195206|NCT03246958|100619630|FG006|Overall Study|Never start treatment|0|||
33195207|NCT03246958|100619624|FG000|Overall Study|Over enrollment|0|||
33195208|NCT03246958|100619625|FG001|Overall Study|Over enrollment|2|||
33195209|NCT03246958|100619626|FG002|Overall Study|Over enrollment|0|||
33195210|NCT03246958|100619627|FG003|Overall Study|Over enrollment|0|||
33195211|NCT03246958|100619628|FG004|Overall Study|Over enrollment|0|||
33195212|NCT03246958|100619629|FG005|Overall Study|Over enrollment|0|||
33195213|NCT03246958|100619630|FG006|Overall Study|Over enrollment|0|||
33195214|NCT04258839|100619635|FG000|Overall Study|Adverse Event|2|||
33195215|NCT04258839|100619636|FG001|Overall Study|Adverse Event|4|||
33195216|NCT04258839|100619635|FG000|Overall Study|Lack of Efficacy|0|||
33195217|NCT04258839|100619636|FG001|Overall Study|Lack of Efficacy|2|||
33195218|NCT04258839|100619635|FG000|Overall Study|Lost to Follow-up|2|||
33195219|NCT04258839|100619636|FG001|Overall Study|Lost to Follow-up|0|||
33195220|NCT04258839|100619635|FG000|Overall Study|Withdrawal by Subject|1|||
33195221|NCT04258839|100619636|FG001|Overall Study|Withdrawal by Subject|2|||
33195222|NCT04258839|100619635|FG000|Overall Study|Withdrawal by Caregiver|5|||
33195223|NCT04258839|100619636|FG001|Overall Study|Withdrawal by Caregiver|6|||
33195224|NCT04258839|100619635|FG000|Overall Study|Reason not Specified|0|||
33195225|NCT04258839|100619636|FG001|Overall Study|Reason not Specified|1|||
33195226|NCT01079234|100619639|FG000|Main: Week 0 to 26|Adverse Event|5|||
33195227|NCT01079234|100619640|FG001|Main: Week 0 to 26|Adverse Event|4|||
33195228|NCT01079234|100619641|FG002|Main: Week 0 to 26|Adverse Event|1|||
33195229|NCT01079234|100619642|FG003|Main: Week 0 to 26|Adverse Event|0|||
33195230|NCT01079234|100619639|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
33195231|NCT01079234|100619640|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
33195232|NCT01079234|100619641|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
33195233|NCT01079234|100619642|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
33195234|NCT01079234|100619639|FG000|Main: Week 0 to 26|Protocol Violation|6|||
33195235|NCT01079234|100619640|FG001|Main: Week 0 to 26|Protocol Violation|2|||
33195236|NCT01079234|100619641|FG002|Main: Week 0 to 26|Protocol Violation|4|||
33195237|NCT01079234|100619642|FG003|Main: Week 0 to 26|Protocol Violation|0|||
33195238|NCT01079234|100619639|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
33195239|NCT01079234|100619640|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
33195240|NCT01079234|100619641|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
33195241|NCT01079234|100619642|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
33195242|NCT01079234|100619639|FG000|Main: Week 0 to 26|Unclassified|7|||
33315770|NCT01498653|101050752|FG000|Overall Study|Lack of Efficacy|12|||
33315771|NCT01498653|101050753|FG001|Overall Study|Lack of Efficacy|26|||
33315772|NCT01498653|101050752|FG000|Overall Study|Protocol Violation|0|||
33315773|NCT01498653|101050753|FG001|Overall Study|Protocol Violation|4|||
33505776|NCT01339923|101747607|FG006|Overall Study|Adverse Event|1|||
33315774|NCT01498653|101050752|FG000|Overall Study|Lost to Follow-up|1|||
33315775|NCT01498653|101050753|FG001|Overall Study|Lost to Follow-up|0|||
33505777|NCT01339923|101747601|FG000|Overall Study|Inappropriate Enrollment|1|||
33505778|NCT01339923|101747602|FG001|Overall Study|Inappropriate Enrollment|0|||
33505779|NCT01339923|101747603|FG002|Overall Study|Inappropriate Enrollment|0|||
33505780|NCT01339923|101747604|FG003|Overall Study|Inappropriate Enrollment|0|||
33505781|NCT01339923|101747605|FG004|Overall Study|Inappropriate Enrollment|0|||
33505782|NCT01339923|101747606|FG005|Overall Study|Inappropriate Enrollment|1|||
33195243|NCT01079234|100619640|FG001|Main: Week 0 to 26|Unclassified|13|||
33195244|NCT01079234|100619641|FG002|Main: Week 0 to 26|Unclassified|4|||
33195245|NCT01079234|100619642|FG003|Main: Week 0 to 26|Unclassified|0|||
33195246|NCT01079234|100619639|FG000|Extension: Week 27 to 52|Adverse Event|0|||
33195247|NCT01079234|100619640|FG001|Extension: Week 27 to 52|Adverse Event|0|||
33195248|NCT01079234|100619641|FG002|Extension: Week 27 to 52|Adverse Event|1|||
33195249|NCT01079234|100619642|FG003|Extension: Week 27 to 52|Adverse Event|0|||
33195250|NCT01079234|100619639|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
33195251|NCT01079234|100619640|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
33195252|NCT01079234|100619641|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
33315776|NCT01498653|101050752|FG000|Overall Study|Physician Decision|2|||
33315777|NCT01498653|101050753|FG001|Overall Study|Physician Decision|0|||
33315778|NCT01498653|101050752|FG000|Overall Study|Withdrawal by Subject|2|||
33315779|NCT01498653|101050753|FG001|Overall Study|Withdrawal by Subject|3|||
33315780|NCT00069238|101050754|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
33315781|NCT00069238|101050755|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
33505783|NCT01339923|101747607|FG006|Overall Study|Inappropriate Enrollment|0|||
33505784|NCT01339923|101747601|FG000|Overall Study|Lost to Follow-up|4|||
33505785|NCT01339923|101747602|FG001|Overall Study|Lost to Follow-up|4|||
33505786|NCT01339923|101747603|FG002|Overall Study|Lost to Follow-up|0|||
33505787|NCT01339923|101747604|FG003|Overall Study|Lost to Follow-up|3|||
33505788|NCT01339923|101747605|FG004|Overall Study|Lost to Follow-up|1|||
33315782|NCT00069238|101050756|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
33315783|NCT00069238|101050754|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
33315784|NCT00069238|101050755|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
33315785|NCT00069238|101050756|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
33505789|NCT01339923|101747606|FG005|Overall Study|Lost to Follow-up|1|||
33505790|NCT01339923|101747607|FG006|Overall Study|Lost to Follow-up|5|||
33505791|NCT01339923|101747601|FG000|Overall Study|Protocol Violation|0|||
33505792|NCT01339923|101747602|FG001|Overall Study|Protocol Violation|0|||
33505793|NCT01339923|101747603|FG002|Overall Study|Protocol Violation|0|||
33505794|NCT01339923|101747604|FG003|Overall Study|Protocol Violation|0|||
33505795|NCT01339923|101747605|FG004|Overall Study|Protocol Violation|0|||
33505796|NCT01339923|101747606|FG005|Overall Study|Protocol Violation|3|||
33505797|NCT01339923|101747607|FG006|Overall Study|Protocol Violation|1|||
33505798|NCT01339923|101747601|FG000|Overall Study|Unable to Classify|1|||
33505799|NCT01339923|101747602|FG001|Overall Study|Unable to Classify|0|||
33505800|NCT01339923|101747603|FG002|Overall Study|Unable to Classify|1|||
33505801|NCT01339923|101747604|FG003|Overall Study|Unable to Classify|0|||
33505802|NCT01339923|101747605|FG004|Overall Study|Unable to Classify|0|||
33505803|NCT01339923|101747606|FG005|Overall Study|Unable to Classify|1|||
33505804|NCT01339923|101747607|FG006|Overall Study|Unable to Classify|5|||
33505805|NCT01339923|101747601|FG000|Overall Study|Withdrawal by Subject|7|||
33505806|NCT01339923|101747602|FG001|Overall Study|Withdrawal by Subject|11|||
33505807|NCT01339923|101747603|FG002|Overall Study|Withdrawal by Subject|6|||
33505808|NCT01339923|101747604|FG003|Overall Study|Withdrawal by Subject|1|||
33505809|NCT01339923|101747605|FG004|Overall Study|Withdrawal by Subject|4|||
33505810|NCT01339923|101747606|FG005|Overall Study|Withdrawal by Subject|3|||
33505811|NCT01339923|101747607|FG006|Overall Study|Withdrawal by Subject|2|||
33505812|NCT03363776|101747608|FG000|Overall Study|Progressive disease|2|||
33505813|NCT03363776|101747609|FG001|Overall Study|Progressive disease|3|||
33505814|NCT03363776|101747610|FG002|Overall Study|Progressive disease|1|||
33505815|NCT03363776|101747608|FG000|Overall Study|Study drug toxicity|0|||
33505816|NCT03363776|101747609|FG001|Overall Study|Study drug toxicity|0|||
33505817|NCT03363776|101747610|FG002|Overall Study|Study drug toxicity|1|||
33505818|NCT03363776|101747608|FG000|Overall Study|Death|1|||
33505819|NCT03363776|101747609|FG001|Overall Study|Death|0|||
33195253|NCT01079234|100619642|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
33195254|NCT01079234|100619639|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
33195255|NCT01079234|100619640|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
33195256|NCT01079234|100619641|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
33195257|NCT01079234|100619642|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
33195258|NCT01079234|100619639|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
33195259|NCT01079234|100619640|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
33195260|NCT01079234|100619641|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
33195261|NCT01079234|100619642|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
33195262|NCT01079234|100619639|FG000|Extension: Week 27 to 52|Unclassified|0|||
33195263|NCT01079234|100619640|FG001|Extension: Week 27 to 52|Unclassified|0|||
33195264|NCT01079234|100619641|FG002|Extension: Week 27 to 52|Unclassified|4|||
33505820|NCT03363776|101747610|FG002|Overall Study|Death|0|||
33505821|NCT05107492|101747611|FG000|Overall Study|Lost to Follow-up|1|||
33505822|NCT05107492|101747612|FG001|Overall Study|Lost to Follow-up|0|||
33505823|NCT03617770|101747614|FG000|Overall Study|Lost to Follow-up|1|||
33505824|NCT03617770|101747615|FG001|Overall Study|Lost to Follow-up|0|||
33505825|NCT02278939|101747616|FG000|Overall Study|lack of time|1|||
33505826|NCT02278939|101747617|FG001|Overall Study|lack of time|0|||
33505827|NCT02278939|101747616|FG000|Overall Study|Lost to Follow-up|1|||
33195265|NCT01079234|100619642|FG003|Extension: Week 27 to 52|Unclassified|7|||
33505828|NCT02278939|101747617|FG001|Overall Study|Lost to Follow-up|1|||
33505829|NCT02278939|101747616|FG000|Overall Study|death in family|1|||
33505830|NCT02278939|101747617|FG001|Overall Study|death in family|0|||
33505831|NCT02278939|101747616|FG000|Overall Study|family emergency unable to commit|2|||
33505832|NCT02278939|101747617|FG001|Overall Study|family emergency unable to commit|0|||
33505833|NCT00507819|101747619|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
33505834|NCT00507819|101747620|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
33195266|NCT02707640|100619644|FG000|Overall Study|Adverse Event|4|||
33505835|NCT03180684|101747627|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
33505836|NCT03180684|101747628|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
33505837|NCT03180684|101747627|FG000|Overall Study|Physician Decision|1|||
33315786|NCT00069238|101050754|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
33315787|NCT00069238|101050755|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
33315788|NCT00069238|101050756|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
33315789|NCT00203476|101050757|FG000|Overall Study|Lost to Follow-up|1|||
33603287|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
33195267|NCT02707640|100619645|FG001|Overall Study|Adverse Event|2|||
33195268|NCT02707640|100619644|FG000|Overall Study|Death|1|||
33195269|NCT02707640|100619645|FG001|Overall Study|Death|2|||
33195270|NCT02707640|100619644|FG000|Overall Study|Physician Decision|2|||
33195271|NCT02707640|100619645|FG001|Overall Study|Physician Decision|0|||
33195272|NCT02707640|100619644|FG000|Overall Study|Withdrawal by Subject|0|||
33195273|NCT02707640|100619645|FG001|Overall Study|Withdrawal by Subject|1|||
33195274|NCT02707640|100619644|FG000|Overall Study|Participant's Personal Decision|1|||
33195275|NCT02707640|100619645|FG001|Overall Study|Participant's Personal Decision|2|||
33195276|NCT02707640|100619644|FG000|Overall Study|Sponsor Discretion|1|||
33195277|NCT02707640|100619645|FG001|Overall Study|Sponsor Discretion|0|||
33195278|NCT01465802|100619649|FG000|Overall Study|Study terminated by sponsor|1|||
33195279|NCT01465802|100619650|FG001|Overall Study|Study terminated by sponsor|0|||
33195280|NCT01465802|100619651|FG002|Overall Study|Study terminated by sponsor|0|||
33195281|NCT01465802|100619652|FG003|Overall Study|Study terminated by sponsor|1|||
33195282|NCT01465802|100619653|FG004|Overall Study|Study terminated by sponsor|7|||
33195283|NCT01465802|100619649|FG000|Overall Study|Withdrawal by Subject|7|||
33195284|NCT01465802|100619650|FG001|Overall Study|Withdrawal by Subject|7|||
33195285|NCT01465802|100619651|FG002|Overall Study|Withdrawal by Subject|0|||
33195286|NCT01465802|100619652|FG003|Overall Study|Withdrawal by Subject|8|||
33195287|NCT01465802|100619653|FG004|Overall Study|Withdrawal by Subject|1|||
33195288|NCT01465802|100619649|FG000|Overall Study|Lost to Follow-up|1|||
33195289|NCT01465802|100619650|FG001|Overall Study|Lost to Follow-up|1|||
33195290|NCT01465802|100619651|FG002|Overall Study|Lost to Follow-up|0|||
33195291|NCT01465802|100619652|FG003|Overall Study|Lost to Follow-up|0|||
33195292|NCT01465802|100619653|FG004|Overall Study|Lost to Follow-up|0|||
33195293|NCT01465802|100619649|FG000|Overall Study|Reason not specified|9|||
33195294|NCT01465802|100619650|FG001|Overall Study|Reason not specified|4|||
33195295|NCT01465802|100619651|FG002|Overall Study|Reason not specified|0|||
33195296|NCT01465802|100619652|FG003|Overall Study|Reason not specified|10|||
33195297|NCT01465802|100619653|FG004|Overall Study|Reason not specified|2|||
33195298|NCT01465802|100619649|FG000|Overall Study|Death|15|||
33195299|NCT01465802|100619650|FG001|Overall Study|Death|12|||
33195300|NCT01465802|100619651|FG002|Overall Study|Death|0|||
33195301|NCT01465802|100619652|FG003|Overall Study|Death|10|||
33195302|NCT01465802|100619653|FG004|Overall Study|Death|2|||
33195303|NCT03149328|100619656|FG000|Overall Study|Withdrawal by Subject|30|||
33195304|NCT03149328|100619657|FG001|Overall Study|Withdrawal by Subject|26|||
33195305|NCT03149328|100619656|FG000|Overall Study|Changed Dialysis Modality|18|||
33195306|NCT03149328|100619657|FG001|Overall Study|Changed Dialysis Modality|1|||
33195307|NCT03149328|100619656|FG000|Overall Study|Transplant|9|||
33195308|NCT03149328|100619657|FG001|Overall Study|Transplant|1|||
33195309|NCT03149328|100619656|FG000|Overall Study|Lost to Follow-up|25|||
33195310|NCT03149328|100619657|FG001|Overall Study|Lost to Follow-up|16|||
33195311|NCT03149328|100619656|FG000|Overall Study|Left Study Site|1|||
33195312|NCT03149328|100619657|FG001|Overall Study|Left Study Site|2|||
33195313|NCT03149328|100619656|FG000|Overall Study|Language Barrier|1|||
33195314|NCT03149328|100619657|FG001|Overall Study|Language Barrier|0|||
33195315|NCT01863446|100619672|FG000|Overall Study|Withdrawal by Subject|1|||
33195316|NCT01863446|100619673|FG001|Overall Study|Withdrawal by Subject|0|||
33195317|NCT01863446|100619674|FG002|Overall Study|Withdrawal by Subject|1|||
33195318|NCT01863446|100619675|FG003|Overall Study|Withdrawal by Subject|2|||
33195319|NCT01863446|100619672|FG000|Overall Study|Physician Decision|0|||
33195320|NCT01863446|100619673|FG001|Overall Study|Physician Decision|0|||
33195321|NCT01863446|100619674|FG002|Overall Study|Physician Decision|1|||
33195322|NCT01863446|100619675|FG003|Overall Study|Physician Decision|0|||
33315790|NCT00203476|101050758|FG001|Overall Study|Lost to Follow-up|0|||
33195323|NCT01175382|100619676|FG000|Overall Study|Lost to Follow-up|4|||
33315791|NCT00203476|101050759|FG002|Overall Study|Lost to Follow-up|0|||
33315792|NCT00203476|101050757|FG000|Overall Study|Withdrawal by Subject|0|||
33195324|NCT01175382|100619677|FG001|Overall Study|Lost to Follow-up|3|||
33195325|NCT01175382|100619678|FG002|Overall Study|Lost to Follow-up|1|||
33195326|NCT01175382|100619676|FG000|Overall Study|Physician Decision|0|||
33195327|NCT01175382|100619677|FG001|Overall Study|Physician Decision|1|||
33195328|NCT01175382|100619678|FG002|Overall Study|Physician Decision|0|||
33195329|NCT01175382|100619676|FG000|Overall Study|Withdrawal by Subject|0|||
33603288|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
33195330|NCT01175382|100619677|FG001|Overall Study|Withdrawal by Subject|0|||
33195331|NCT01175382|100619678|FG002|Overall Study|Withdrawal by Subject|1|||
33195332|NCT01175382|100619676|FG000|Overall Study|No longer having problem|1|||
33195333|NCT01175382|100619677|FG001|Overall Study|No longer having problem|0|||
33195334|NCT01175382|100619678|FG002|Overall Study|No longer having problem|1|||
33195335|NCT01175382|100619676|FG000|Overall Study|Unable/unwilling to attend visits|3|||
33195336|NCT01175382|100619677|FG001|Overall Study|Unable/unwilling to attend visits|1|||
33195337|NCT01175382|100619678|FG002|Overall Study|Unable/unwilling to attend visits|2|||
33195338|NCT01175382|100619676|FG000|Overall Study|Unwilling to follow protocol|0|||
33195339|NCT01175382|100619677|FG001|Overall Study|Unwilling to follow protocol|1|||
33195340|NCT01175382|100619678|FG002|Overall Study|Unwilling to follow protocol|0|||
33195341|NCT01175382|100619676|FG000|Overall Study|Unable to tolerate study meds|0|||
33195342|NCT01175382|100619677|FG001|Overall Study|Unable to tolerate study meds|1|||
33195343|NCT01175382|100619678|FG002|Overall Study|Unable to tolerate study meds|1|||
33195344|NCT02896127|100619679|FG000|COMPLETED WEEK 52|Adverse Event|9|||
33195345|NCT02896127|100619680|FG001|COMPLETED WEEK 52|Adverse Event|2|||
33195346|NCT02896127|100619679|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
33195347|NCT02896127|100619680|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
33195348|NCT02896127|100619679|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
33315793|NCT00203476|101050758|FG001|Overall Study|Withdrawal by Subject|1|||
33315794|NCT00203476|101050759|FG002|Overall Study|Withdrawal by Subject|0|||
33315795|NCT03588728|101050762|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
33315796|NCT03588728|101050763|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
33315797|NCT03588728|101050764|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
33315798|NCT03588728|101050765|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
33315799|NCT03588728|101050762|FG000|Overall Study|Lab shut down due to COVID-19|0|||
33315800|NCT03588728|101050763|FG001|Overall Study|Lab shut down due to COVID-19|0|||
33315801|NCT03588728|101050764|FG002|Overall Study|Lab shut down due to COVID-19|0|||
33315802|NCT03588728|101050765|FG003|Overall Study|Lab shut down due to COVID-19|1|||
33315803|NCT03588728|101050762|FG000|Overall Study|multiple technical issues|1|||
33315804|NCT03588728|101050763|FG001|Overall Study|multiple technical issues|0|||
33505838|NCT03180684|101747628|FG001|Overall Study|Physician Decision|0|||
33505839|NCT03180684|101747627|FG000|Overall Study|Lost to Follow-up|1|||
33505840|NCT03180684|101747628|FG001|Overall Study|Lost to Follow-up|0|||
33505841|NCT03180684|101747627|FG000|Overall Study|Progressive Disease|1|||
33505842|NCT03180684|101747628|FG001|Overall Study|Progressive Disease|0|||
33505843|NCT02235077|101747629|FG000|Overall Study|Death|5|||
33505844|NCT02235077|101747630|FG001|Overall Study|Death|7|||
33505845|NCT02235077|101747629|FG000|Overall Study|Lost to Follow-up|5|||
33505846|NCT02235077|101747630|FG001|Overall Study|Lost to Follow-up|6|||
33505847|NCT02235077|101747629|FG000|Overall Study|Withdrawal by Subject|8|||
33505848|NCT02235077|101747630|FG001|Overall Study|Withdrawal by Subject|5|||
33505849|NCT02235077|101747629|FG000|Overall Study|Physician Decision|0|||
33505850|NCT02235077|101747630|FG001|Overall Study|Physician Decision|1|||
33505851|NCT04484142|101747631|FG000|Overall Study|Adverse Event|13|||
33505852|NCT04484142|101747631|FG000|Overall Study|Progressive Disease|87|||
33505853|NCT04484142|101747631|FG000|Overall Study|Clinical Progression|10|||
33505854|NCT04484142|101747631|FG000|Overall Study|Withdrawal by Subject|6|||
33505855|NCT04484142|101747631|FG000|Overall Study|Physician Decision|1|||
33505856|NCT01944839|101747636|FG000|Overall Study|Physician Decision|2|||
33505857|NCT01944839|101747637|FG001|Overall Study|Physician Decision|2|||
33505858|NCT01944839|101747636|FG000|Overall Study|Protocol Violation|0|||
33505859|NCT01944839|101747637|FG001|Overall Study|Protocol Violation|1|||
33505860|NCT01944839|101747636|FG000|Overall Study|Adverse Event|10|||
33505861|NCT01944839|101747637|FG001|Overall Study|Adverse Event|5|||
33505862|NCT01944839|101747636|FG000|Overall Study|Withdrawal by Subject|9|||
33505863|NCT01944839|101747637|FG001|Overall Study|Withdrawal by Subject|17|||
33505864|NCT01944839|101747636|FG000|Overall Study|Lost to Follow-up|1|||
33505865|NCT01944839|101747637|FG001|Overall Study|Lost to Follow-up|0|||
33505866|NCT01944839|101747636|FG000|Overall Study|Subject non-compliance|0|||
33505867|NCT01944839|101747637|FG001|Overall Study|Subject non-compliance|3|||
33505868|NCT00003830|101747638|FG000|Overall Study|No follow up data|3|||
33505869|NCT00003830|101747639|FG001|Overall Study|No follow up data|0|||
33505870|NCT00003830|101747638|FG000|Overall Study|Sentinel node positive patients|829|||
33505871|NCT00003830|101747639|FG001|Overall Study|Sentinel node positive patients|793|||
33505872|NCT03503370|101747640|FG000|Overall Study|Death|3|||
33505873|NCT03503370|101747641|FG001|Overall Study|Death|1|||
33505874|NCT01163318|101747642|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
33195349|NCT02896127|100619680|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
33195350|NCT02896127|100619679|FG000|COMPLETED WEEK 52|Physician Decision|1|||
33195351|NCT02896127|100619680|FG001|COMPLETED WEEK 52|Physician Decision|1|||
33195352|NCT02896127|100619679|FG000|COMPLETED WEEK 52|Pregnancy|2|||
33195353|NCT02896127|100619680|FG001|COMPLETED WEEK 52|Pregnancy|0|||
33195354|NCT02896127|100619679|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
33315805|NCT03588728|101050764|FG002|Overall Study|multiple technical issues|0|||
33315806|NCT03588728|101050765|FG003|Overall Study|multiple technical issues|0|||
33505875|NCT01163318|101747642|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
33505876|NCT01163318|101747642|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
33505877|NCT01163318|101747642|FG000|Overall Study|Participants Without Case Report Form|7|||
33505878|NCT01163318|101747642|FG000|Overall Study|Multiple Reasons Per Participant|224|||
33505879|NCT03640559|101747643|FG000|Overall Study|Physician Decision|1|||
33505880|NCT03640559|101747644|FG001|Overall Study|Physician Decision|1|||
33505881|NCT03640559|101747643|FG000|Overall Study|Withdrawal by Subject|1|||
33505882|NCT03640559|101747644|FG001|Overall Study|Withdrawal by Subject|0|||
33397119|NCT02516306|101342071|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
33505883|NCT03655470|101747645|FG000|Overall Study|Lost to Follow-up|6|||
33505884|NCT03655470|101747646|FG001|Overall Study|Lost to Follow-up|7|||
33505885|NCT00378508|101747647|FG000|Overall Study|Withdrawal by Subject|1|||
33505886|NCT00378508|101747648|FG001|Overall Study|Withdrawal by Subject|3|||
33505887|NCT00378508|101747647|FG000|Overall Study|Lost to Follow-up|1|||
33505888|NCT00378508|101747648|FG001|Overall Study|Lost to Follow-up|0|||
33505889|NCT02361346|101747650|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
33505890|NCT02361346|101747651|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
33505891|NCT02361346|101747652|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
33505892|NCT02361346|101747653|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
33505893|NCT02361346|101747654|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
33505894|NCT02361346|101747655|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
33505895|NCT02361346|101747656|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
33505896|NCT02361346|101747657|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
33505897|NCT02361346|101747658|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
33505898|NCT02361346|101747650|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33505899|NCT02361346|101747651|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33505900|NCT02361346|101747652|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33505901|NCT02361346|101747653|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33505902|NCT02361346|101747654|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
33505903|NCT02361346|101747655|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33505904|NCT02361346|101747656|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33505905|NCT02361346|101747657|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33505906|NCT02361346|101747658|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
33505907|NCT02361346|101747650|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
33505908|NCT02361346|101747651|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
33505909|NCT02361346|101747652|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
33505910|NCT02361346|101747653|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
33505911|NCT02361346|101747654|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
33505912|NCT02361346|101747655|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
33505913|NCT02361346|101747656|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
33505914|NCT02361346|101747657|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
33505915|NCT02361346|101747658|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
33505916|NCT02361346|101747650|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33505917|NCT02361346|101747651|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33505918|NCT02361346|101747652|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33505919|NCT02361346|101747653|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33505920|NCT02361346|101747654|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33505921|NCT02361346|101747655|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33505922|NCT02361346|101747656|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33505923|NCT02361346|101747657|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
33505924|NCT02361346|101747658|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
33505925|NCT02361346|101747650|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33505926|NCT02361346|101747651|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33505927|NCT02361346|101747652|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33505928|NCT02361346|101747653|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33505929|NCT02361346|101747654|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33505930|NCT02361346|101747655|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33505931|NCT02361346|101747656|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33505932|NCT02361346|101747657|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
33505933|NCT02361346|101747658|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
33505934|NCT02361346|101747650|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33505935|NCT02361346|101747651|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33505936|NCT02361346|101747652|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33505937|NCT02361346|101747653|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33505938|NCT02361346|101747654|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33195355|NCT02896127|100619680|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
33315807|NCT03588728|101050762|FG000|Overall Study|Hospitalized for COVID|1|||
33315808|NCT03588728|101050763|FG001|Overall Study|Hospitalized for COVID|0|||
33315809|NCT03588728|101050764|FG002|Overall Study|Hospitalized for COVID|0|||
33315810|NCT03588728|101050765|FG003|Overall Study|Hospitalized for COVID|0|||
33315811|NCT03588728|101050762|FG000|Overall Study|Schedule change unable to attend sessions|1|||
33315812|NCT03588728|101050763|FG001|Overall Study|Schedule change unable to attend sessions|0|||
33315813|NCT03588728|101050764|FG002|Overall Study|Schedule change unable to attend sessions|0|||
33315814|NCT03588728|101050765|FG003|Overall Study|Schedule change unable to attend sessions|0|||
33315815|NCT02313233|101050766|FG000|Overall Study|Withdrawal by Subject|1|||
33505939|NCT02361346|101747655|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33505940|NCT02361346|101747656|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33505941|NCT02361346|101747657|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
33505942|NCT02361346|101747658|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
33505943|NCT02111577|101747675|FG000|Overall Study|Protocol Violation|2|||
33505944|NCT02111577|101747676|FG001|Overall Study|Protocol Violation|0|||
33505945|NCT02111577|101747675|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
33505946|NCT02111577|101747676|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
33505947|NCT02111577|101747675|FG000|Overall Study|Failure to produce study treatment|6|||
33505948|NCT02111577|101747676|FG001|Overall Study|Failure to produce study treatment|0|||
33505949|NCT02111577|101747675|FG000|Overall Study|Death|518|||
33505950|NCT02111577|101747676|FG001|Overall Study|Death|254|||
33505951|NCT02111577|101747675|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
33505952|NCT02111577|101747676|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
33505953|NCT02111577|101747675|FG000|Overall Study|Adverse Event|1|||
33505954|NCT02111577|101747676|FG001|Overall Study|Adverse Event|1|||
33505955|NCT02111577|101747675|FG000|Overall Study|Withdrawal by Subject|51|||
33397120|NCT02516306|101342072|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
33397121|NCT03523715|101342073|FG000|Overall Study|Lost to Follow-up|11|||
33397122|NCT03523715|101342074|FG001|Overall Study|Lost to Follow-up|14|||
33397123|NCT03523715|101342073|FG000|Overall Study|Did not meet inclusion criteria|1|||
33397124|NCT03523715|101342074|FG001|Overall Study|Did not meet inclusion criteria|0|||
33397125|NCT03523715|101342073|FG000|Overall Study|Internally inconsistent reporting|0|||
33397126|NCT03523715|101342074|FG001|Overall Study|Internally inconsistent reporting|2|||
33397127|NCT00083616|101342075|FG000|Overall Study|Disease Progression|16|||
33397128|NCT00083616|101342075|FG000|Overall Study|Lost to Follow-up|1|||
33397129|NCT00083616|101342075|FG000|Overall Study|Physician Decision|2|||
33397130|NCT00083616|101342075|FG000|Overall Study|Withdrawal by Subject|3|||
33397131|NCT00083616|101342075|FG000|Overall Study|Ineligibility determined|2|||
33397132|NCT00083616|101342075|FG000|Overall Study|Non-compliance|1|||
33397133|NCT00083616|101342075|FG000|Overall Study|Other|6|||
33397134|NCT03323086|101342076|FG000|Overall Study|Lost to Follow-up|3|||
33397135|NCT03323086|101342077|FG001|Overall Study|Lost to Follow-up|2|||
33397136|NCT01051856|101342078|FG000|Overall Study|Withdrawal by Subject|1|||
33397137|NCT01051856|101342079|FG001|Overall Study|Withdrawal by Subject|0|||
33397138|NCT01227252|101342085|FG000|Overall Study|Sponsor Decision|0|||
33397139|NCT01227252|101342086|FG001|Overall Study|Sponsor Decision|1|||
33397140|NCT01227252|101342087|FG002|Overall Study|Sponsor Decision|0|||
33397141|NCT01227252|101342088|FG003|Overall Study|Sponsor Decision|0|||
33397142|NCT01227252|101342085|FG000|Overall Study|Lost to Follow-up|0|||
33397143|NCT01227252|101342086|FG001|Overall Study|Lost to Follow-up|1|||
33397144|NCT01227252|101342087|FG002|Overall Study|Lost to Follow-up|0|||
33397145|NCT01227252|101342088|FG003|Overall Study|Lost to Follow-up|0|||
33397146|NCT01227252|101342085|FG000|Overall Study|Withdrawal by Subject|0|||
33397147|NCT01227252|101342086|FG001|Overall Study|Withdrawal by Subject|1|||
33397148|NCT01227252|101342087|FG002|Overall Study|Withdrawal by Subject|0|||
33397149|NCT01227252|101342088|FG003|Overall Study|Withdrawal by Subject|0|||
33505956|NCT02111577|101747676|FG001|Overall Study|Withdrawal by Subject|23|||
33505957|NCT02111577|101747675|FG000|Overall Study|Disease progression|0|||
33505958|NCT02111577|101747676|FG001|Overall Study|Disease progression|1|||
33505959|NCT02111577|101747675|FG000|Overall Study|Lost to Follow-up|19|||
33315816|NCT02313233|101050767|FG001|Overall Study|Withdrawal by Subject|2|||
33315817|NCT02313233|101050766|FG000|Overall Study|Administrative reason|1|||
33315818|NCT02313233|101050767|FG001|Overall Study|Administrative reason|1|||
33315819|NCT00511472|101050768|FG000|Overall Study|Clinical Adverse Event|1|||
33315820|NCT00511472|101050769|FG001|Overall Study|Clinical Adverse Event|2|||
33315821|NCT00511472|101050768|FG000|Overall Study|Laboratory Adverse Event|0|||
33315822|NCT00511472|101050769|FG001|Overall Study|Laboratory Adverse Event|2|||
33315823|NCT00511472|101050768|FG000|Overall Study|Not reported|2|||
33315824|NCT00511472|101050769|FG001|Overall Study|Not reported|2|||
33315825|NCT02446886|101050770|FG000|Overall Study|Adverse Event|1|||
33315826|NCT02446886|101050771|FG001|Overall Study|Adverse Event|3|||
33397150|NCT01997892|101342089|FG000|Overall Study|Physician Decision|2|||
33397151|NCT01997892|101342089|FG000|Overall Study|Lost to Follow-up|6|||
33505960|NCT02111577|101747676|FG001|Overall Study|Lost to Follow-up|10|||
33505961|NCT01322490|101747678|FG000|Treatment Period|Adverse Event|12|||
33505962|NCT01322490|101747679|FG001|Treatment Period|Adverse Event|18|||
33505963|NCT01322490|101747680|FG002|Treatment Period|Adverse Event|15|||
33505964|NCT01322490|101747678|FG000|Treatment Period|Death|5|||
33505965|NCT01322490|101747679|FG001|Treatment Period|Death|7|||
33315827|NCT02446886|101050770|FG000|Overall Study|Withdrawal by Subject|1|||
33397152|NCT01997892|101342089|FG000|Overall Study|Death|14|||
33397153|NCT01997892|101342089|FG000|Overall Study|Renal transplant|8|||
33397154|NCT01997892|101342089|FG000|Overall Study|Other|3|||
33397155|NCT01997892|101342089|FG000|Overall Study|Study completion data not recorded|35|||
33397156|NCT01610414|101342090|FG000|Study Start - Month 13|Serious Adverse Event|65|||
33397157|NCT01610414|101342091|FG001|Study Start - Month 13|Serious Adverse Event|67|||
33397158|NCT01610414|101342090|FG000|Study Start - Month 13|Adverse Event|14|||
33505966|NCT01322490|101747680|FG002|Treatment Period|Death|3|||
33505967|NCT01322490|101747678|FG000|Treatment Period|Lack of Efficacy|89|||
33505968|NCT01322490|101747679|FG001|Treatment Period|Lack of Efficacy|100|||
33505969|NCT01322490|101747680|FG002|Treatment Period|Lack of Efficacy|112|||
33505970|NCT01322490|101747678|FG000|Treatment Period|Physician Decision|0|||
33505971|NCT01322490|101747679|FG001|Treatment Period|Physician Decision|2|||
33505972|NCT01322490|101747680|FG002|Treatment Period|Physician Decision|1|||
33505973|NCT01322490|101747678|FG000|Treatment Period|Protocol Violation|7|||
33505974|NCT01322490|101747679|FG001|Treatment Period|Protocol Violation|5|||
33505975|NCT01322490|101747680|FG002|Treatment Period|Protocol Violation|4|||
33315828|NCT02446886|101050771|FG001|Overall Study|Withdrawal by Subject|1|||
33315829|NCT04744285|101050772|FG000|Overall Study|Withdrawal by Subject|1|||
33315830|NCT04744285|101050773|FG001|Overall Study|Withdrawal by Subject|1|||
33315831|NCT04744285|101050774|FG002|Overall Study|Withdrawal by Subject|2|||
33315832|NCT04744285|101050775|FG003|Overall Study|Withdrawal by Subject|1|||
33315833|NCT01350336|101050778|FG000|Overall Study|Lost to Follow-up|31|||
33315834|NCT01350336|101050778|FG000|Overall Study|Withdrawal by Subject|14|||
33315835|NCT01350336|101050778|FG000|Overall Study|Physician Decision|8|||
33315836|NCT01350336|101050778|FG000|Overall Study|Death|4|||
33397159|NCT01610414|101342091|FG001|Study Start - Month 13|Adverse Event|14|||
33505976|NCT01322490|101747678|FG000|Treatment Period|Withdrawal by Subject|14|||
33505977|NCT01322490|101747679|FG001|Treatment Period|Withdrawal by Subject|16|||
33505978|NCT01322490|101747680|FG002|Treatment Period|Withdrawal by Subject|11|||
33505979|NCT01322490|101747678|FG000|Treatment Period|Non-compliance with study drug|0|||
33505980|NCT01322490|101747679|FG001|Treatment Period|Non-compliance with study drug|0|||
33505981|NCT01322490|101747680|FG002|Treatment Period|Non-compliance with study drug|1|||
33505982|NCT01322490|101747678|FG000|Treatment Period|Other per report|2|||
33505983|NCT01322490|101747679|FG001|Treatment Period|Other per report|2|||
33505984|NCT01322490|101747680|FG002|Treatment Period|Other per report|1|||
33505985|NCT01322490|101747678|FG000|Treatment Period|Randomized but Not Treated|3|||
33505986|NCT01322490|101747679|FG001|Treatment Period|Randomized but Not Treated|3|||
33505987|NCT01322490|101747680|FG002|Treatment Period|Randomized but Not Treated|5|||
33505988|NCT01322490|101747678|FG000|Long Term Follow-up Period|Death|235|||
33505989|NCT01322490|101747679|FG001|Long Term Follow-up Period|Death|239|||
33505990|NCT01322490|101747680|FG002|Long Term Follow-up Period|Death|236|||
33505991|NCT01322490|101747678|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
33505992|NCT01322490|101747679|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
33505993|NCT01322490|101747680|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
33397160|NCT01610414|101342090|FG000|Study Start - Month 13|Protocol Violation|3|||
33397161|NCT01610414|101342091|FG001|Study Start - Month 13|Protocol Violation|1|||
33397162|NCT01610414|101342090|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
33397163|NCT01610414|101342091|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
33397164|NCT01610414|101342090|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
33397165|NCT01610414|101342091|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
33397166|NCT01610414|101342090|FG000|Study Start - Month 13|Lost to Follow-up|4|||
33397167|NCT01610414|101342091|FG001|Study Start - Month 13|Lost to Follow-up|6|||
33397168|NCT01610414|101342090|FG000|Study Start - Month 13|Suspected HZ episode|1|||
33397169|NCT01610414|101342091|FG001|Study Start - Month 13|Suspected HZ episode|3|||
33397170|NCT01610414|101342090|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
33397171|NCT01610414|101342091|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
33397172|NCT01610414|101342090|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
33397173|NCT01610414|101342091|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
33505994|NCT01322490|101747678|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
33505995|NCT01322490|101747679|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
33505996|NCT01322490|101747680|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
33505997|NCT01322490|101747678|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
33505998|NCT01322490|101747679|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
33505999|NCT01322490|101747680|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
33506000|NCT01322490|101747678|FG000|Long Term Follow-up Period|Other per report|3|||
33506001|NCT01322490|101747679|FG001|Long Term Follow-up Period|Other per report|2|||
33506002|NCT01322490|101747680|FG002|Long Term Follow-up Period|Other per report|2|||
33506003|NCT01322490|101747678|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
33397174|NCT01610414|101342090|FG000|Month 13 - Month 25|Adverse Event|8|||
33397175|NCT01610414|101342091|FG001|Month 13 - Month 25|Adverse Event|4|||
33506004|NCT01322490|101747679|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
33506005|NCT01322490|101747680|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
33506006|NCT00474045|101747683|FG000|Overall Study|Adverse Event|18|||
33506007|NCT00474045|101747684|FG001|Overall Study|Adverse Event|8|||
33506008|NCT00474045|101747683|FG000|Overall Study|Unclassified|1|||
33195356|NCT02896127|100619679|FG000|COMPLETED WEEK 52|Technical problems|1|||
33315837|NCT01444456|101050779|FG000|Overall Study|Withdrawal by Subject|21|||
33315838|NCT01444456|101050779|FG000|Overall Study|Physician Decision|9|||
33397176|NCT01610414|101342090|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
33397177|NCT01610414|101342091|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
33506009|NCT00474045|101747684|FG001|Overall Study|Unclassified|3|||
33506010|NCT00474045|101747683|FG000|Overall Study|Lack of Efficacy|0|||
33506011|NCT00474045|101747684|FG001|Overall Study|Lack of Efficacy|9|||
33506012|NCT00474045|101747683|FG000|Overall Study|Lost to Follow-up|1|||
33506013|NCT00474045|101747684|FG001|Overall Study|Lost to Follow-up|1|||
33506014|NCT00474045|101747683|FG000|Overall Study|Protocol Violation|10|||
33506015|NCT00474045|101747684|FG001|Overall Study|Protocol Violation|12|||
33506016|NCT00474045|101747683|FG000|Overall Study|Withdrawal by Subject|16|||
33506017|NCT00474045|101747684|FG001|Overall Study|Withdrawal by Subject|18|||
33506018|NCT00474045|101747683|FG000|Overall Study|Withdrawal criteria|60|||
33506019|NCT00474045|101747684|FG001|Overall Study|Withdrawal criteria|50|||
33506020|NCT02222545|101747685|FG000|Overall Study|Adverse Event|1|||
33506021|NCT02222545|101747686|FG001|Overall Study|Adverse Event|0|||
33506022|NCT02222545|101747687|FG002|Overall Study|Adverse Event|2|||
33506023|NCT02222545|101747685|FG000|Overall Study|Death|0|||
33506024|NCT02222545|101747686|FG001|Overall Study|Death|0|||
33506025|NCT02222545|101747687|FG002|Overall Study|Death|9|||
33506026|NCT02222545|101747685|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
33506027|NCT02222545|101747686|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
33506028|NCT02222545|101747687|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
33506029|NCT02222545|101747685|FG000|Overall Study|Withdrawal by Subject|0|||
33506030|NCT02222545|101747686|FG001|Overall Study|Withdrawal by Subject|0|||
33397178|NCT01610414|101342090|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
33397179|NCT01610414|101342091|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
33506031|NCT02222545|101747687|FG002|Overall Study|Withdrawal by Subject|3|||
33506032|NCT02222545|101747685|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
33506033|NCT02222545|101747686|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
33603289|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
33603290|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
33603291|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
33603292|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
33603293|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
33603294|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
33603295|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
33603296|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
33603297|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
33603298|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
33603299|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
33603300|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
33506034|NCT02222545|101747687|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
33506035|NCT01637922|101747688|FG000|Overall Study|Adverse Event|0|||
33506036|NCT01637922|101747689|FG001|Overall Study|Adverse Event|1|||
33506037|NCT01637922|101747688|FG000|Overall Study|Protocol Violation|0|||
33506038|NCT01637922|101747689|FG001|Overall Study|Protocol Violation|1|||
33506039|NCT01637922|101747688|FG000|Overall Study|Withdrawal by Subject|0|||
33506040|NCT01637922|101747689|FG001|Overall Study|Withdrawal by Subject|3|||
33506041|NCT01637922|101747688|FG000|Overall Study|Lost to Follow-up|2|||
33506042|NCT01637922|101747689|FG001|Overall Study|Lost to Follow-up|0|||
33506043|NCT00803790|101747690|FG000|Period 1|Adverse Event|0|||
33506044|NCT00803790|101747691|FG001|Period 1|Adverse Event|1|||
33506045|NCT00803790|101747692|FG002|Period 1|Adverse Event|0|||
33506046|NCT00803790|101747693|FG003|Period 1|Adverse Event|0|||
33506047|NCT00803790|101747690|FG000|Period 1|Lost to Follow-up|1|||
33506048|NCT00803790|101747691|FG001|Period 1|Lost to Follow-up|2|||
33506049|NCT00803790|101747692|FG002|Period 1|Lost to Follow-up|0|||
33506050|NCT00803790|101747693|FG003|Period 1|Lost to Follow-up|0|||
33506051|NCT00803790|101747690|FG000|Period 1|Withdrawal by Subject|8|||
33506052|NCT00803790|101747691|FG001|Period 1|Withdrawal by Subject|6|||
33506053|NCT00803790|101747692|FG002|Period 1|Withdrawal by Subject|0|||
33506054|NCT00803790|101747693|FG003|Period 1|Withdrawal by Subject|0|||
33506055|NCT00803790|101747690|FG000|Period 1|positive drug screen or personal reasons|0|||
33506056|NCT00803790|101747691|FG001|Period 1|positive drug screen or personal reasons|3|||
33506057|NCT00803790|101747692|FG002|Period 1|positive drug screen or personal reasons|0|||
33506058|NCT00803790|101747693|FG003|Period 1|positive drug screen or personal reasons|4|||
33506059|NCT00803790|101747690|FG000|Period 1|Protocol Violation|0|||
33506060|NCT00803790|101747691|FG001|Period 1|Protocol Violation|0|||
33506061|NCT00803790|101747692|FG002|Period 1|Protocol Violation|1|||
33506062|NCT00803790|101747693|FG003|Period 1|Protocol Violation|0|||
33506063|NCT00803790|101747690|FG000|Period 2|Adverse Event|0|||
33506064|NCT00803790|101747691|FG001|Period 2|Adverse Event|0|||
33506065|NCT00803790|101747692|FG002|Period 2|Adverse Event|1|||
33506066|NCT00803790|101747693|FG003|Period 2|Adverse Event|1|||
33506067|NCT00803790|101747690|FG000|Period 2|Withdrawal by Subject|1|||
33506068|NCT00803790|101747691|FG001|Period 2|Withdrawal by Subject|0|||
33506069|NCT00803790|101747692|FG002|Period 2|Withdrawal by Subject|0|||
33506070|NCT00803790|101747693|FG003|Period 2|Withdrawal by Subject|0|||
33506071|NCT00803790|101747690|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
33506072|NCT00803790|101747691|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
33506073|NCT00803790|101747692|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
33506074|NCT00803790|101747693|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
33506075|NCT04590586|101747694|FG000|Overall Study|Death|7|||
33506076|NCT04590586|101747695|FG001|Overall Study|Death|1|||
33506077|NCT04590586|101747696|FG002|Overall Study|Death|37|||
33506078|NCT04590586|101747697|FG003|Overall Study|Death|34|||
33506079|NCT04590586|101747698|FG004|Overall Study|Death|19|||
33506080|NCT04590586|101747699|FG005|Overall Study|Death|3|||
33506081|NCT04590586|101747694|FG000|Overall Study|Lost to Follow-up|3|||
33506082|NCT04590586|101747695|FG001|Overall Study|Lost to Follow-up|0|||
33506083|NCT04590586|101747696|FG002|Overall Study|Lost to Follow-up|11|||
33506084|NCT04590586|101747697|FG003|Overall Study|Lost to Follow-up|11|||
33506085|NCT04590586|101747698|FG004|Overall Study|Lost to Follow-up|6|||
33506086|NCT04590586|101747699|FG005|Overall Study|Lost to Follow-up|0|||
33506087|NCT04590586|101747694|FG000|Overall Study|Withdrawal by Subject|0|||
33506088|NCT04590586|101747695|FG001|Overall Study|Withdrawal by Subject|0|||
33506089|NCT04590586|101747696|FG002|Overall Study|Withdrawal by Subject|6|||
33506090|NCT04590586|101747697|FG003|Overall Study|Withdrawal by Subject|0|||
33506091|NCT04590586|101747698|FG004|Overall Study|Withdrawal by Subject|3|||
33506092|NCT04590586|101747699|FG005|Overall Study|Withdrawal by Subject|0|||
33506093|NCT04590586|101747694|FG000|Overall Study|Other|3|||
33506094|NCT04590586|101747695|FG001|Overall Study|Other|0|||
33506095|NCT04590586|101747696|FG002|Overall Study|Other|1|||
33506096|NCT04590586|101747697|FG003|Overall Study|Other|1|||
33506097|NCT04590586|101747698|FG004|Overall Study|Other|2|||
33506098|NCT04590586|101747699|FG005|Overall Study|Other|1|||
33506099|NCT01075256|101747700|FG000|Overall Study|Withdrawal by Subject|1|||
33506100|NCT01075256|101747701|FG001|Overall Study|Withdrawal by Subject|0|||
33506101|NCT01075256|101747702|FG002|Overall Study|Withdrawal by Subject|0|||
33315839|NCT01444456|101050779|FG000|Overall Study|Lost to Follow-up|37|||
33315840|NCT01444456|101050779|FG000|Overall Study|Death|73|||
33315841|NCT01444456|101050779|FG000|Overall Study|Ineligibility determined|23|||
33315842|NCT01444456|101050779|FG000|Overall Study|Other|18|||
33315843|NCT01444456|101050779|FG000|Overall Study|Not treated|104|||
33315844|NCT05208866|101050781|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
33397180|NCT01610414|101342090|FG000|Month 13 - Month 25|Protocol Violation|0|||
33397181|NCT01610414|101342091|FG001|Month 13 - Month 25|Protocol Violation|2|||
33397182|NCT01610414|101342090|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
33397183|NCT01610414|101342091|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
33506102|NCT01089608|101747703|FG000|Overall Study|Adverse Event|0|||
33506103|NCT01089608|101747704|FG001|Overall Study|Adverse Event|4|||
33506104|NCT01089608|101747703|FG000|Overall Study|Lost to Follow-up|0|||
33506105|NCT01089608|101747704|FG001|Overall Study|Lost to Follow-up|2|||
33315845|NCT02260882|101050785|FG000|Overall Study|Protocol Violation|0|||
33315846|NCT02260882|101050786|FG001|Overall Study|Protocol Violation|1|||
33315847|NCT03451162|101050791|FG000|Overall Study|Lost to Follow-up|1|||
33315848|NCT03451162|101050792|FG001|Overall Study|Lost to Follow-up|0|||
33315849|NCT03451162|101050793|FG002|Overall Study|Lost to Follow-up|0|||
33315850|NCT03451162|101050794|FG003|Overall Study|Lost to Follow-up|0|||
33397184|NCT01610414|101342090|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
33397185|NCT01610414|101342091|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
33397186|NCT01610414|101342090|FG000|After Month 25|Study end not reached|48|||
33397187|NCT01610414|101342091|FG001|After Month 25|Study end not reached|53|||
33397188|NCT02735044|101345708|FG000|Overall Study|Adverse Event|3|||
33397189|NCT02735044|101345709|FG001|Overall Study|Adverse Event|3|||
33397190|NCT02735044|101345708|FG000|Overall Study|Lack of Efficacy|1|||
33397191|NCT02735044|101345709|FG001|Overall Study|Lack of Efficacy|0|||
33397192|NCT02735044|101345708|FG000|Overall Study|Poor compliance to protocol|7|||
33397193|NCT02735044|101345709|FG001|Overall Study|Poor compliance to protocol|7|||
33397194|NCT02735044|101345708|FG000|Overall Study|Randomized and not treated|0|||
33397195|NCT02735044|101345709|FG001|Overall Study|Randomized and not treated|2|||
33397196|NCT02735044|101345708|FG000|Overall Study|Other, not specified above|5|||
33506106|NCT02887248|101747705|FG000|Overall Study|Withdrawal by Subject|1|||
33506107|NCT02887248|101747705|FG000|Overall Study|Adverse Event|1|||
33506108|NCT02887248|101747705|FG000|Overall Study|Progressive Disease|1|||
33315851|NCT03451162|101050795|FG004|Overall Study|Lost to Follow-up|0|||
33315852|NCT03451162|101050791|FG000|Overall Study|Physician Decision|0|||
33315853|NCT03451162|101050792|FG001|Overall Study|Physician Decision|1|||
33315854|NCT03451162|101050793|FG002|Overall Study|Physician Decision|0|||
33397197|NCT02735044|101345709|FG001|Overall Study|Other, not specified above|11|||
33397198|NCT00443534|101345710|FG000|Overall Study|Lack of Efficacy|67|||
33397199|NCT00443534|101345710|FG000|Overall Study|Adverse Event|16|||
33397200|NCT00443534|101345710|FG000|Overall Study|Death|9|||
33506109|NCT01264081|101747706|FG000|Participants Screened|Screening failures|30|||
33506110|NCT01264081|101747706|FG000|Started Treatment|Withdrawal by Subject|1|||
33506111|NCT01264081|101747706|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
33506112|NCT00652626|101747707|FG000|Initial Treatment Phase|Adverse Event|0|||
33506113|NCT00652626|101747708|FG001|Initial Treatment Phase|Adverse Event|0|||
33506114|NCT00652626|101747709|FG002|Initial Treatment Phase|Adverse Event|0|||
33506115|NCT00652626|101747710|FG003|Initial Treatment Phase|Adverse Event|0|||
33506116|NCT00652626|101747711|FG004|Initial Treatment Phase|Adverse Event|1|||
33506117|NCT00652626|101747712|FG005|Initial Treatment Phase|Adverse Event|0|||
33506118|NCT00652626|101747713|FG006|Initial Treatment Phase|Adverse Event|0|||
33506119|NCT00652626|101747707|FG000|Initial Treatment Phase|Protocol Violation|0|||
33506120|NCT00652626|101747708|FG001|Initial Treatment Phase|Protocol Violation|0|||
33506121|NCT00652626|101747709|FG002|Initial Treatment Phase|Protocol Violation|0|||
33506122|NCT00652626|101747710|FG003|Initial Treatment Phase|Protocol Violation|1|||
33506123|NCT00652626|101747711|FG004|Initial Treatment Phase|Protocol Violation|0|||
33506124|NCT00652626|101747712|FG005|Initial Treatment Phase|Protocol Violation|0|||
33506125|NCT00652626|101747713|FG006|Initial Treatment Phase|Protocol Violation|0|||
33506126|NCT00652626|101747707|FG000|Initial Treatment Phase|Physician Decision|0|||
33506127|NCT00652626|101747708|FG001|Initial Treatment Phase|Physician Decision|0|||
33506128|NCT00652626|101747709|FG002|Initial Treatment Phase|Physician Decision|0|||
33506129|NCT00652626|101747710|FG003|Initial Treatment Phase|Physician Decision|0|||
33506130|NCT00652626|101747711|FG004|Initial Treatment Phase|Physician Decision|1|||
33603301|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
33603302|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
33603303|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
33603304|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
33603305|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
33603306|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
33603307|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
33603308|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
33603309|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
33603310|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
33603311|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
33603312|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
33603313|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
33603314|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
33603315|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
33603316|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
33603317|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
33603318|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
33603319|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
33603320|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
33603321|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
33603322|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
33603323|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
33603324|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
33603325|NCT02008357|102099224|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
33603326|NCT02008357|102099225|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
33603327|NCT02008357|102099224|FG000|Open-label Extension Period|Adverse Event|8|||
33603328|NCT02008357|102099225|FG001|Open-label Extension Period|Adverse Event|7|||
33603329|NCT02008357|102099224|FG000|Open-label Extension Period|Death|7|||
33603330|NCT02008357|102099225|FG001|Open-label Extension Period|Death|4|||
33603331|NCT02008357|102099224|FG000|Open-label Extension Period|Lack of Efficacy|9|||
33603332|NCT02008357|102099225|FG001|Open-label Extension Period|Lack of Efficacy|5|||
33603333|NCT02008357|102099224|FG000|Open-label Extension Period|Lost to Follow-up|2|||
33603334|NCT02008357|102099225|FG001|Open-label Extension Period|Lost to Follow-up|2|||
33603335|NCT02008357|102099224|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
33603336|NCT02008357|102099225|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
33603337|NCT02008357|102099224|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
33603338|NCT02008357|102099225|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
33603339|NCT02008357|102099224|FG000|Open-label Extension Period|Safety Risk|2|||
33603340|NCT02008357|102099225|FG001|Open-label Extension Period|Safety Risk|1|||
33603341|NCT02008357|102099224|FG000|Open-label Extension Period|Non-Compliance|0|||
33506131|NCT00652626|101747712|FG005|Initial Treatment Phase|Physician Decision|0|||
33506132|NCT00652626|101747713|FG006|Initial Treatment Phase|Physician Decision|0|||
33506133|NCT00652626|101747707|FG000|Initial Treatment Phase|Sponsor Request|0|||
33506134|NCT00652626|101747708|FG001|Initial Treatment Phase|Sponsor Request|0|||
33195357|NCT02896127|100619680|FG001|COMPLETED WEEK 52|Technical problems|0|||
33195358|NCT02896127|100619679|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
33195359|NCT02896127|100619680|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
33195360|NCT02896127|100619679|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
33195361|NCT02896127|100619680|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
33195362|NCT02896127|100619679|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
33195363|NCT02896127|100619680|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
33195364|NCT02896127|100619679|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
33195365|NCT02896127|100619680|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
33195366|NCT02896127|100619679|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
33195367|NCT02896127|100619680|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
33195368|NCT00612313|100619687|FG000|Overall Study|Withdrawal by Subject|6|||
33195369|NCT00612313|100619688|FG001|Overall Study|Withdrawal by Subject|9|||
33195370|NCT00612313|100619687|FG000|Overall Study|Lost to Follow-up|11|||
33195371|NCT00612313|100619688|FG001|Overall Study|Lost to Follow-up|4|||
33195372|NCT03064126|100619689|FG000|Overall Study|Death|40|||
33195373|NCT03064126|100619690|FG001|Overall Study|Death|16|||
33195374|NCT03064126|100619691|FG002|Overall Study|Death|4|||
33195375|NCT03064126|100619692|FG003|Overall Study|Death|2|||
33195376|NCT03064126|100619689|FG000|Overall Study|Withdrawal by Subject|17|||
33195377|NCT03064126|100619690|FG001|Overall Study|Withdrawal by Subject|9|||
33195378|NCT03064126|100619691|FG002|Overall Study|Withdrawal by Subject|0|||
33195379|NCT03064126|100619692|FG003|Overall Study|Withdrawal by Subject|2|||
33195380|NCT03064126|100619689|FG000|Overall Study|Lost to Follow-up|7|||
33195381|NCT03064126|100619690|FG001|Overall Study|Lost to Follow-up|3|||
33195382|NCT03064126|100619691|FG002|Overall Study|Lost to Follow-up|0|||
33195383|NCT03064126|100619692|FG003|Overall Study|Lost to Follow-up|0|||
33195384|NCT03064126|100619689|FG000|Overall Study|Adverse Event|2|||
33195385|NCT03064126|100619690|FG001|Overall Study|Adverse Event|0|||
33195386|NCT03064126|100619691|FG002|Overall Study|Adverse Event|0|||
33195387|NCT03064126|100619692|FG003|Overall Study|Adverse Event|0|||
33195388|NCT03064126|100619689|FG000|Overall Study|Physician Decision|3|||
33195389|NCT03064126|100619690|FG001|Overall Study|Physician Decision|0|||
33195390|NCT03064126|100619691|FG002|Overall Study|Physician Decision|0|||
33195391|NCT03064126|100619692|FG003|Overall Study|Physician Decision|0|||
33195392|NCT03064126|100619689|FG000|Overall Study|Other reason for early termination|3|||
33195393|NCT03064126|100619690|FG001|Overall Study|Other reason for early termination|2|||
33195394|NCT03064126|100619691|FG002|Overall Study|Other reason for early termination|0|||
33195395|NCT03064126|100619692|FG003|Overall Study|Other reason for early termination|0|||
33195396|NCT03064126|100619689|FG000|Overall Study|Missed Visit|3|||
33195397|NCT03064126|100619690|FG001|Overall Study|Missed Visit|1|||
33195398|NCT03064126|100619691|FG002|Overall Study|Missed Visit|0|||
33195399|NCT03064126|100619692|FG003|Overall Study|Missed Visit|0|||
33506135|NCT00652626|101747709|FG002|Initial Treatment Phase|Sponsor Request|1|||
33603342|NCT02008357|102099225|FG001|Open-label Extension Period|Non-Compliance|1|||
33603343|NCT02008357|102099224|FG000|Open-label Extension Period|Investigator Recommendation|0|||
33603344|NCT02008357|102099225|FG001|Open-label Extension Period|Investigator Recommendation|1|||
33603345|NCT02008357|102099224|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
33603346|NCT02008357|102099225|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
33603347|NCT02008357|102099224|FG000|Open-label Extension Period|Coordinating Center Request|2|||
33603348|NCT02008357|102099225|FG001|Open-label Extension Period|Coordinating Center Request|4|||
33603349|NCT02008357|102099224|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
33603350|NCT02008357|102099225|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
33603351|NCT02008357|102099224|FG000|Open-label Extension Period|Study Ended|20|||
33603352|NCT02008357|102099225|FG001|Open-label Extension Period|Study Ended|25|||
33603353|NCT02008357|102099224|FG000|Open-label Extension Period|Personal Reasons|0|||
33603354|NCT02008357|102099225|FG001|Open-label Extension Period|Personal Reasons|1|||
33603355|NCT02008357|102099224|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
33603356|NCT02008357|102099225|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
33603357|NCT02008357|102099224|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
33603358|NCT02008357|102099225|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
33603359|NCT02008357|102099224|FG000|Open-label Extension Period|Other|2|||
33195400|NCT03285477|100619693|FG000|Treatment and Response Assessment Period|Death|1|||
33195401|NCT03285477|100619694|FG001|Treatment and Response Assessment Period|Death|0|||
33195402|NCT03285477|100619693|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
33195403|NCT03285477|100619694|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
33195404|NCT03285477|100619693|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
33195405|NCT03285477|100619694|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
33506136|NCT00652626|101747710|FG003|Initial Treatment Phase|Sponsor Request|0|||
33506137|NCT00652626|101747711|FG004|Initial Treatment Phase|Sponsor Request|0|||
33506138|NCT00652626|101747712|FG005|Initial Treatment Phase|Sponsor Request|0|||
33506139|NCT00652626|101747713|FG006|Initial Treatment Phase|Sponsor Request|0|||
33195406|NCT03285477|100619693|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
33195407|NCT03285477|100619694|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
33195408|NCT03285477|100619693|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
33195409|NCT03285477|100619694|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
33195410|NCT02962895|100619699|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
33195411|NCT02962895|100619700|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
33195412|NCT02962895|100619701|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
33195413|NCT02962895|100619702|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
33195414|NCT02962895|100619703|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
33195415|NCT02962895|100619704|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
33195416|NCT02962895|100619705|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
33195417|NCT02962895|100619699|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
33195418|NCT02962895|100619700|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
33195419|NCT02962895|100619701|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
33195420|NCT02962895|100619702|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
33195421|NCT02962895|100619703|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
33195422|NCT02962895|100619704|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
33195423|NCT02962895|100619705|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
33195424|NCT02962895|100619699|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
33195425|NCT02962895|100619700|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
33195426|NCT02962895|100619701|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
33195427|NCT02962895|100619702|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
33195428|NCT02962895|100619703|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
33195429|NCT02962895|100619704|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
33195430|NCT02962895|100619705|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
33195431|NCT02962895|100619699|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
33195432|NCT02962895|100619700|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
33195433|NCT02962895|100619701|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
33195434|NCT02962895|100619702|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
33195435|NCT02962895|100619703|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
33195436|NCT02962895|100619704|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
33195437|NCT02962895|100619705|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
33195438|NCT02962895|100619699|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
33195439|NCT02962895|100619700|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
33195440|NCT02962895|100619701|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
33195441|NCT02962895|100619702|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
33195442|NCT02962895|100619703|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
33195443|NCT02962895|100619704|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
33195444|NCT02962895|100619705|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
33195445|NCT02962895|100619699|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
33195446|NCT02962895|100619700|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
33195447|NCT02962895|100619701|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
33195448|NCT02962895|100619702|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
33195449|NCT02962895|100619703|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
33195450|NCT02962895|100619704|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
33195451|NCT02962895|100619705|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
33195452|NCT02962895|100619699|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
33195453|NCT02962895|100619700|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
33195454|NCT02962895|100619701|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
33195455|NCT02962895|100619702|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
33195456|NCT02962895|100619703|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
33195457|NCT02962895|100619704|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
33195458|NCT02962895|100619705|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
33195459|NCT02962895|100619699|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
33195460|NCT02962895|100619700|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
33195461|NCT02962895|100619701|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
33315855|NCT03451162|101050794|FG003|Overall Study|Physician Decision|0|||
33315856|NCT03451162|101050795|FG004|Overall Study|Physician Decision|0|||
33315857|NCT03451162|101050791|FG000|Overall Study|Withdrawal by Subject|1|||
33397201|NCT00443534|101345710|FG000|Overall Study|Withdrawal by Subject|8|||
33603360|NCT02008357|102099225|FG001|Open-label Extension Period|Other|0|||
33603361|NCT00637572|102099226|FG000|Overall Study|Adverse Event|1|||
33195462|NCT02962895|100619702|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
33195463|NCT02962895|100619703|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
33195464|NCT02962895|100619704|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
33195465|NCT02962895|100619705|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
33195466|NCT02962895|100619699|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
33195467|NCT02962895|100619700|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
33195468|NCT02962895|100619701|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
33397202|NCT00443534|101345710|FG000|Overall Study|Study Terminated by Sponsor|12|||
33195469|NCT02962895|100619702|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
33195470|NCT02962895|100619703|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
33195471|NCT02962895|100619704|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
33195472|NCT02962895|100619705|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
33195473|NCT02962895|100619699|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
33195474|NCT02962895|100619700|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
33195475|NCT02962895|100619701|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
33195476|NCT02962895|100619702|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
33195477|NCT02962895|100619703|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
33195478|NCT02962895|100619704|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
33195479|NCT02962895|100619705|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
33195480|NCT02962895|100619699|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
33195481|NCT02962895|100619700|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
33195482|NCT02962895|100619701|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
33195483|NCT02962895|100619702|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
33195484|NCT02962895|100619703|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
33195485|NCT02962895|100619704|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
33195486|NCT02962895|100619705|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
33195487|NCT02962895|100619699|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
33397203|NCT00443534|101345710|FG000|Overall Study|Other|10|||
33195488|NCT02962895|100619700|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
33195489|NCT02962895|100619701|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
33195490|NCT02962895|100619702|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
33397204|NCT00443534|101345710|FG000|Overall Study|Enrolled, Not Treated|1|||
33397205|NCT00098865|101345711|FG000|Overall Study|Progressive Disease|6|||
33397206|NCT00098865|101345711|FG000|Overall Study|Adverse Event|2|||
33397207|NCT00098865|101345711|FG000|Overall Study|Alternative Therapy|1|||
33397208|NCT00836953|101345712|FG000|Overall Study|Withdrawal by Subject|1|||
33397209|NCT00836953|101345712|FG000|Overall Study|Lost to Follow-up|1|||
33195491|NCT02962895|100619703|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
33195492|NCT02962895|100619704|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
33195493|NCT02962895|100619705|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
33195494|NCT02962895|100619699|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
33315858|NCT03451162|101050792|FG001|Overall Study|Withdrawal by Subject|1|||
33315859|NCT03451162|101050793|FG002|Overall Study|Withdrawal by Subject|0|||
33315860|NCT03451162|101050794|FG003|Overall Study|Withdrawal by Subject|0|||
33315861|NCT03451162|101050795|FG004|Overall Study|Withdrawal by Subject|0|||
33315862|NCT01640054|101050797|FG000|Overall Study|Study-specific disc criteria|1|||
33315863|NCT01640054|101050797|FG000|Overall Study|Lack of Efficacy|3|||
33315864|NCT01640054|101050797|FG000|Overall Study|Adverse Event|2|||
33315865|NCT01637623|101050800|FG000|Overall Study|Lost to Follow-up|0|||
33315866|NCT01637623|101050801|FG001|Overall Study|Lost to Follow-up|0|||
33315867|NCT01637623|101050802|FG002|Overall Study|Lost to Follow-up|2|||
33315868|NCT01637623|101050800|FG000|Overall Study|Physician Decision|1|||
33315869|NCT01637623|101050801|FG001|Overall Study|Physician Decision|0|||
33315870|NCT01637623|101050802|FG002|Overall Study|Physician Decision|1|||
33315871|NCT01778023|101050806|FG000|Overall Study|Withdrawal by Subject|0|||
33315872|NCT01778023|101050807|FG001|Overall Study|Withdrawal by Subject|3|||
33315873|NCT00706433|101050814|FG000|Overall Study|Lost to Follow-up|3|||
33315874|NCT00706433|101050815|FG001|Overall Study|Lost to Follow-up|1|||
33315875|NCT00706433|101050816|FG002|Overall Study|Lost to Follow-up|6|||
33315876|NCT00706433|101050817|FG003|Overall Study|Lost to Follow-up|0|||
33315877|NCT00706433|101050814|FG000|Overall Study|Withdrawal by Subject|1|||
33315878|NCT00706433|101050815|FG001|Overall Study|Withdrawal by Subject|2|||
33315879|NCT00706433|101050816|FG002|Overall Study|Withdrawal by Subject|3|||
33315880|NCT00706433|101050817|FG003|Overall Study|Withdrawal by Subject|1|||
33315881|NCT00706433|101050814|FG000|Overall Study|Adverse Event|0|||
33315882|NCT00706433|101050815|FG001|Overall Study|Adverse Event|0|||
33315883|NCT00706433|101050816|FG002|Overall Study|Adverse Event|1|||
33315884|NCT00706433|101050817|FG003|Overall Study|Adverse Event|0|||
33315885|NCT00706433|101050814|FG000|Overall Study|Protocol Violation|1|||
33315886|NCT00706433|101050815|FG001|Overall Study|Protocol Violation|0|||
33315887|NCT00706433|101050816|FG002|Overall Study|Protocol Violation|0|||
33397210|NCT02203916|101345716|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
33397211|NCT02203916|101345717|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
33397212|NCT02203916|101345718|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
33397213|NCT02203916|101345716|FG000|Overall Study|Major Protocol Deviation|1|||
33397214|NCT02203916|101345717|FG001|Overall Study|Major Protocol Deviation|1|||
33397215|NCT02203916|101345718|FG002|Overall Study|Major Protocol Deviation|0|||
33397216|NCT02203916|101345716|FG000|Overall Study|Lost to Follow-up|0|||
33397217|NCT02203916|101345717|FG001|Overall Study|Lost to Follow-up|1|||
33195495|NCT02962895|100619700|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
33195496|NCT02962895|100619701|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
33195497|NCT02962895|100619702|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
33195498|NCT02962895|100619703|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
33195499|NCT02962895|100619704|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
33195500|NCT02962895|100619705|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
33195501|NCT02962895|100619699|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
33195502|NCT02962895|100619700|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
33195503|NCT02962895|100619701|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
33195504|NCT02962895|100619702|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
33195505|NCT02962895|100619703|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
33195506|NCT02962895|100619704|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
33195507|NCT02962895|100619705|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
33195508|NCT03049813|100619707|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
33195509|NCT03049813|100619708|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
33195510|NCT03049813|100619709|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
33195511|NCT03049813|100619710|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
33195512|NCT03049813|100619707|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
33195513|NCT03049813|100619708|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
33195514|NCT03049813|100619709|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
33195515|NCT03049813|100619710|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
33195516|NCT03049813|100619707|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
33195517|NCT03049813|100619708|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
33195518|NCT03049813|100619709|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
33195519|NCT03049813|100619710|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
33195520|NCT03049813|100619707|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
33195521|NCT03049813|100619708|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
33195522|NCT03049813|100619709|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
33195523|NCT03049813|100619710|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
33195524|NCT03351049|100619713|FG000|Overall Study|Withdrawal|26|||
33195525|NCT03351049|100619714|FG001|Overall Study|Withdrawal|22|||
33195526|NCT01599650|100619715|FG000|Overall Study|Administrative issue|1|||
33195527|NCT01599650|100619716|FG001|Overall Study|Administrative issue|0|||
33195528|NCT01599650|100619717|FG002|Overall Study|Administrative issue|1|||
33195529|NCT01599650|100619715|FG000|Overall Study|Physician Decision|2|||
33195530|NCT01599650|100619716|FG001|Overall Study|Physician Decision|0|||
33195531|NCT01599650|100619717|FG002|Overall Study|Physician Decision|7|||
33195532|NCT01599650|100619715|FG000|Overall Study|Protocol Violation|0|||
33195533|NCT01599650|100619716|FG001|Overall Study|Protocol Violation|3|||
33195534|NCT01599650|100619717|FG002|Overall Study|Protocol Violation|0|||
33195535|NCT01599650|100619715|FG000|Overall Study|Death|2|||
33195536|NCT01599650|100619716|FG001|Overall Study|Death|1|||
33195537|NCT01599650|100619717|FG002|Overall Study|Death|2|||
33195538|NCT01599650|100619715|FG000|Overall Study|Lost to Follow-up|3|||
33195539|NCT01599650|100619716|FG001|Overall Study|Lost to Follow-up|3|||
33195540|NCT01599650|100619717|FG002|Overall Study|Lost to Follow-up|3|||
33195541|NCT01599650|100619715|FG000|Overall Study|Withdrawal by Subject|11|||
33195542|NCT01599650|100619716|FG001|Overall Study|Withdrawal by Subject|11|||
33195543|NCT01599650|100619717|FG002|Overall Study|Withdrawal by Subject|10|||
33195544|NCT01599650|100619715|FG000|Overall Study|Adverse Event|3|||
33195545|NCT01599650|100619716|FG001|Overall Study|Adverse Event|8|||
33195546|NCT01599650|100619717|FG002|Overall Study|Adverse Event|4|||
33195547|NCT04622254|100619718|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
33195548|NCT04622254|100619719|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
33397218|NCT02203916|101345718|FG002|Overall Study|Lost to Follow-up|0|||
33397219|NCT02203916|101345716|FG000|Overall Study|Voluntary Withdrawal|3|||
33195549|NCT04622254|100619720|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
33195550|NCT04622254|100619721|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
33195551|NCT04622254|100619722|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
33195552|NCT04622254|100619723|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
33195553|NCT04622254|100619718|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
33195554|NCT04622254|100619719|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
33195555|NCT04622254|100619720|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
33315888|NCT00706433|101050817|FG003|Overall Study|Protocol Violation|0|||
33397220|NCT02203916|101345717|FG001|Overall Study|Voluntary Withdrawal|3|||
33195556|NCT04622254|100619721|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
33195557|NCT04622254|100619722|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
33195558|NCT04622254|100619723|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
33195559|NCT04622254|100619718|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
33195560|NCT04622254|100619719|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
33195561|NCT04622254|100619720|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
33195562|NCT04622254|100619721|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
33195563|NCT04622254|100619722|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
33195564|NCT04622254|100619723|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
33195565|NCT04622254|100619718|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
33195566|NCT04622254|100619719|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
33195567|NCT04622254|100619720|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
33195568|NCT04622254|100619721|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
33195569|NCT04622254|100619722|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
33195570|NCT04622254|100619723|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
33195571|NCT04622254|100619718|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
33195572|NCT04622254|100619719|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
33195573|NCT04622254|100619720|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
33195574|NCT04622254|100619721|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
33195575|NCT04622254|100619722|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
33195576|NCT04622254|100619723|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
33195577|NCT04622254|100619718|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
33195578|NCT04622254|100619719|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
33195579|NCT04622254|100619720|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
33195580|NCT04622254|100619721|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
33506140|NCT00652626|101747707|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
33506141|NCT00652626|101747708|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
33506142|NCT00652626|101747709|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
33506143|NCT00652626|101747710|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
33506144|NCT00652626|101747711|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
33506145|NCT00652626|101747712|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
33506146|NCT00652626|101747713|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
33506147|NCT00652626|101747707|FG000|Extension Phase|Withdrawal by Subject|0|||
33506148|NCT00652626|101747708|FG001|Extension Phase|Withdrawal by Subject|0|||
33506149|NCT00652626|101747709|FG002|Extension Phase|Withdrawal by Subject|0|||
33506150|NCT00652626|101747710|FG003|Extension Phase|Withdrawal by Subject|0|||
33506151|NCT00652626|101747711|FG004|Extension Phase|Withdrawal by Subject|0|||
33506152|NCT00652626|101747712|FG005|Extension Phase|Withdrawal by Subject|2|||
33506153|NCT00652626|101747713|FG006|Extension Phase|Withdrawal by Subject|0|||
33506154|NCT00652626|101747707|FG000|Extension Phase|Adverse Event|0|||
33506155|NCT00652626|101747708|FG001|Extension Phase|Adverse Event|0|||
33506156|NCT00652626|101747709|FG002|Extension Phase|Adverse Event|0|||
33506157|NCT00652626|101747710|FG003|Extension Phase|Adverse Event|0|||
33506158|NCT00652626|101747711|FG004|Extension Phase|Adverse Event|0|||
33506159|NCT00652626|101747712|FG005|Extension Phase|Adverse Event|2|||
33506160|NCT00652626|101747713|FG006|Extension Phase|Adverse Event|1|||
33506161|NCT00652626|101747707|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
33506162|NCT00652626|101747708|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
33506163|NCT00652626|101747709|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
33506164|NCT00652626|101747710|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
33506165|NCT00652626|101747711|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
33506166|NCT00652626|101747712|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
33506167|NCT00652626|101747713|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
33506168|NCT00652626|101747707|FG000|Extension Phase|Physician Decision|0|||
33506169|NCT00652626|101747708|FG001|Extension Phase|Physician Decision|0|||
33506170|NCT00652626|101747709|FG002|Extension Phase|Physician Decision|0|||
33506171|NCT00652626|101747710|FG003|Extension Phase|Physician Decision|0|||
33506172|NCT00652626|101747711|FG004|Extension Phase|Physician Decision|0|||
33506173|NCT00652626|101747712|FG005|Extension Phase|Physician Decision|1|||
33506174|NCT00652626|101747713|FG006|Extension Phase|Physician Decision|1|||
33506175|NCT00652626|101747707|FG000|Extension Phase|Death|0|||
33506176|NCT00652626|101747708|FG001|Extension Phase|Death|0|||
33506177|NCT00652626|101747709|FG002|Extension Phase|Death|0|||
33506178|NCT00652626|101747710|FG003|Extension Phase|Death|0|||
33506179|NCT00652626|101747711|FG004|Extension Phase|Death|0|||
33195581|NCT04622254|100619722|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
33195582|NCT04622254|100619723|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
33195583|NCT04622254|100619718|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
33397221|NCT02203916|101345718|FG002|Overall Study|Voluntary Withdrawal|8|||
33397222|NCT02203916|101345716|FG000|Overall Study|Lack of Efficacy|3|||
33506180|NCT00652626|101747712|FG005|Extension Phase|Death|1|||
33506181|NCT00652626|101747713|FG006|Extension Phase|Death|1|||
33506182|NCT01738503|101747715|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
33603362|NCT00637572|102099227|FG001|Overall Study|Adverse Event|2|||
33195584|NCT04622254|100619719|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
33195585|NCT04622254|100619720|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
33195586|NCT04622254|100619721|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
33195587|NCT04622254|100619722|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
33195588|NCT04622254|100619723|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
33195589|NCT04622254|100619718|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
33315889|NCT00706433|101050814|FG000|Overall Study|new job|0|||
33603363|NCT00637572|102099226|FG000|Overall Study|Death|0|||
33603364|NCT00637572|102099227|FG001|Overall Study|Death|1|||
33603365|NCT00637572|102099226|FG000|Overall Study|Lost to Follow-up|0|||
33603366|NCT00637572|102099227|FG001|Overall Study|Lost to Follow-up|1|||
33603367|NCT00637572|102099226|FG000|Overall Study|Physician Decision|1|||
33603368|NCT00637572|102099227|FG001|Overall Study|Physician Decision|1|||
33603369|NCT00637572|102099226|FG000|Overall Study|Withdrawal by Subject|0|||
33315890|NCT00706433|101050815|FG001|Overall Study|new job|0|||
33315891|NCT00706433|101050816|FG002|Overall Study|new job|0|||
33315892|NCT00706433|101050817|FG003|Overall Study|new job|1|||
33603370|NCT00637572|102099227|FG001|Overall Study|Withdrawal by Subject|2|||
33195590|NCT04622254|100619719|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
33195591|NCT04622254|100619720|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
33195592|NCT04622254|100619721|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
33315893|NCT03740997|101050818|FG000|Overall Study|Withdrawal by Subject|1|||
33315894|NCT03740997|101050819|FG001|Overall Study|Withdrawal by Subject|0|||
33315895|NCT03740997|101050818|FG000|Overall Study|Participant was unable to complete study procedures|1|||
33315896|NCT03740997|101050819|FG001|Overall Study|Participant was unable to complete study procedures|0|||
33315897|NCT02502097|101050820|FG000|Period 1|Adverse Event|0|||
33315898|NCT02502097|101050821|FG001|Period 1|Adverse Event|0|||
33315899|NCT02502097|101050822|FG002|Period 1|Adverse Event|1|||
33315900|NCT02502097|101050823|FG003|Period 1|Adverse Event|0|||
33315901|NCT02502097|101050820|FG000|Wash Out Period|Adverse Event|0|||
33315902|NCT02502097|101050821|FG001|Wash Out Period|Adverse Event|1|||
33315903|NCT02502097|101050822|FG002|Wash Out Period|Adverse Event|1|||
33315904|NCT02502097|101050823|FG003|Wash Out Period|Adverse Event|1|||
33315905|NCT02502097|101050820|FG000|Period 2|Adverse Event|0|||
33315906|NCT02502097|101050821|FG001|Period 2|Adverse Event|0|||
33315907|NCT02502097|101050822|FG002|Period 2|Adverse Event|1|||
33315908|NCT02502097|101050823|FG003|Period 2|Adverse Event|0|||
33315909|NCT01029652|101050833|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
33315910|NCT01029652|101050834|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
33315911|NCT01029652|101050833|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
33315912|NCT01029652|101050834|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
33315913|NCT01029652|101050833|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
33315914|NCT01029652|101050834|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
33315915|NCT01029652|101050833|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
33315916|NCT01029652|101050834|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
33315917|NCT01029652|101050833|FG000|Core Study (0-12 Weeks)|Death|0|||
33315918|NCT01029652|101050834|FG001|Core Study (0-12 Weeks)|Death|1|||
33315919|NCT01029652|101050833|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
33315920|NCT01029652|101050834|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
33315921|NCT01029652|101050833|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
33315922|NCT01029652|101050834|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
33315923|NCT01029652|101050833|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
33315924|NCT01029652|101050834|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
33315925|NCT01029652|101050833|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
33315926|NCT01029652|101050834|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
33315927|NCT01029652|101050833|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
33315928|NCT01029652|101050834|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
33315929|NCT01029652|101050833|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
33315930|NCT01029652|101050834|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
33315931|NCT01029652|101050833|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
33315932|NCT01029652|101050834|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
33315933|NCT01211522|101050839|FG000|Overall Study|Withdrawal by Subject|3|||
33315934|NCT01211522|101050840|FG001|Overall Study|Withdrawal by Subject|7|||
33506183|NCT01738503|101747716|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
33506184|NCT01738503|101747717|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
33315935|NCT01211522|101050841|FG002|Overall Study|Withdrawal by Subject|5|||
33315936|NCT03610165|101050842|FG000|Overall Study|Device didn't work|0|||
33315937|NCT03610165|101050843|FG001|Overall Study|Device didn't work|1|||
33506185|NCT01738503|101747718|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
33506186|NCT01738503|101747719|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
33506187|NCT01738503|101747720|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
33506188|NCT01738503|101747721|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
33603371|NCT00637572|102099226|FG000|Overall Study|Illicit Drug Use|1|||
33315938|NCT01016977|101050844|FG000|Overall Study|Lost to Follow-up|1|||
33315939|NCT01016977|101050845|FG001|Overall Study|Lost to Follow-up|0|||
33315940|NCT01016977|101050844|FG000|Overall Study|Withdrawal by Subject|2|||
33315941|NCT01016977|101050845|FG001|Overall Study|Withdrawal by Subject|2|||
33315942|NCT00822172|101050853|FG000|Overall Study|Adverse Event|10|||
33315943|NCT00822172|101050854|FG001|Overall Study|Adverse Event|12|||
33315944|NCT00822172|101050853|FG000|Overall Study|Death|1|||
33315945|NCT00822172|101050854|FG001|Overall Study|Death|0|||
33315946|NCT00822172|101050853|FG000|Overall Study|Lost to Follow-up|3|||
33315947|NCT00822172|101050854|FG001|Overall Study|Lost to Follow-up|1|||
33315948|NCT00822172|101050853|FG000|Overall Study|Withdrawal by Subject|1|||
33315949|NCT00822172|101050854|FG001|Overall Study|Withdrawal by Subject|4|||
33315950|NCT00822172|101050853|FG000|Overall Study|site closed|0|||
33315951|NCT00822172|101050854|FG001|Overall Study|site closed|1|||
33315952|NCT00822172|101050853|FG000|Overall Study|Other|0|||
33315953|NCT00822172|101050854|FG001|Overall Study|Other|1|||
33315954|NCT00402363|101050859|FG000|Overall Study|Adverse Event|9|||
33315955|NCT00402363|101050860|FG001|Overall Study|Adverse Event|14|||
33315956|NCT00402363|101050861|FG002|Overall Study|Adverse Event|2|||
33315957|NCT00402363|101050862|FG003|Overall Study|Adverse Event|2|||
33315958|NCT00402363|101050859|FG000|Overall Study|Withdrew Consent|10|||
33315959|NCT00402363|101050860|FG001|Overall Study|Withdrew Consent|5|||
33315960|NCT00402363|101050861|FG002|Overall Study|Withdrew Consent|2|||
33315961|NCT00402363|101050862|FG003|Overall Study|Withdrew Consent|1|||
33603372|NCT00637572|102099227|FG001|Overall Study|Illicit Drug Use|0|||
33603373|NCT02989805|102099228|FG000|Overall Study|invalid consent|6|||
33603374|NCT02989805|102099229|FG001|Overall Study|invalid consent|4|||
33603375|NCT01475162|102099234|FG000|Overall Study|Physician Decision|1|||
33315962|NCT00402363|101050859|FG000|Overall Study|Protocol Violation|3|||
33315963|NCT00402363|101050860|FG001|Overall Study|Protocol Violation|5|||
33315964|NCT00402363|101050861|FG002|Overall Study|Protocol Violation|0|||
33506189|NCT01738503|101747715|FG000|Treatment Period|Adverse Event|0|||
33506190|NCT01738503|101747716|FG001|Treatment Period|Adverse Event|1|||
33506191|NCT01738503|101747717|FG002|Treatment Period|Adverse Event|0|||
33506192|NCT01738503|101747718|FG003|Treatment Period|Adverse Event|1|||
33506193|NCT01738503|101747719|FG004|Treatment Period|Adverse Event|2|||
33506194|NCT01738503|101747720|FG005|Treatment Period|Adverse Event|2|||
33315965|NCT00402363|101050862|FG003|Overall Study|Protocol Violation|3|||
33315966|NCT00402363|101050859|FG000|Overall Study|Lost to Follow-up|5|||
33315967|NCT00402363|101050860|FG001|Overall Study|Lost to Follow-up|4|||
33315968|NCT00402363|101050861|FG002|Overall Study|Lost to Follow-up|0|||
33315969|NCT00402363|101050862|FG003|Overall Study|Lost to Follow-up|2|||
33315970|NCT00402363|101050859|FG000|Overall Study|"Captured as Other"|6|||
33315971|NCT00402363|101050860|FG001|Overall Study|"Captured as Other"|2|||
33315972|NCT00402363|101050861|FG002|Overall Study|"Captured as Other"|2|||
33315973|NCT00402363|101050862|FG003|Overall Study|"Captured as Other"|2|||
33315974|NCT03064035|101050871|FG000|Overall Study|Did not receive allocated intervention|4|||
33315975|NCT03064035|101050872|FG001|Overall Study|Did not receive allocated intervention|2|||
33315976|NCT03064035|101050871|FG000|Overall Study|Lost to Follow-up|1|||
33315977|NCT03064035|101050872|FG001|Overall Study|Lost to Follow-up|1|||
33315978|NCT00938470|101050877|FG000|Overall Study|Disease Progression|3|||
33315979|NCT00938470|101050878|FG001|Overall Study|Disease Progression|0|||
33315980|NCT00938470|101050877|FG000|Overall Study|Alternate Treatment|1|||
33315981|NCT00938470|101050878|FG001|Overall Study|Alternate Treatment|0|||
33315982|NCT00938470|101050877|FG000|Overall Study|Death|3|||
33315983|NCT00938470|101050878|FG001|Overall Study|Death|2|||
33315984|NCT00938470|101050877|FG000|Overall Study|Other Reason|0|||
33506195|NCT01738503|101747721|FG006|Treatment Period|Adverse Event|2|||
33506196|NCT01738503|101747715|FG000|Treatment Period|Lost to Follow-up|0|||
33315985|NCT00938470|101050878|FG001|Overall Study|Other Reason|1|||
33315986|NCT00381303|101050879|FG000|Overall Study|Lost to Follow-up|25|||
33315987|NCT00381303|101050880|FG001|Overall Study|Lost to Follow-up|9|||
33506197|NCT01738503|101747716|FG001|Treatment Period|Lost to Follow-up|0|||
33315988|NCT00381303|101050879|FG000|Overall Study|AE/HIV-related event|22|||
33315989|NCT00381303|101050880|FG001|Overall Study|AE/HIV-related event|6|||
33315990|NCT00381303|101050879|FG000|Overall Study|Non-Adherence|13|||
33315991|NCT00381303|101050880|FG001|Overall Study|Non-Adherence|6|||
33315992|NCT00381303|101050879|FG000|Overall Study|Withdrawal by Subject|13|||
33315993|NCT00381303|101050880|FG001|Overall Study|Withdrawal by Subject|6|||
33315994|NCT00381303|101050879|FG000|Overall Study|Virologic failure|6|||
33506198|NCT01738503|101747717|FG002|Treatment Period|Lost to Follow-up|3|||
33224274|NCT04737109|100721772|FG003|Study Treatment|Disease Progression|0|||
33315995|NCT00381303|101050880|FG001|Overall Study|Virologic failure|4|||
33315996|NCT00381303|101050879|FG000|Overall Study|Ineligible to continue the trial|2|||
33315997|NCT00381303|101050880|FG001|Overall Study|Ineligible to continue the trial|1|||
33506199|NCT01738503|101747718|FG003|Treatment Period|Lost to Follow-up|4|||
33603376|NCT01475162|102099234|FG000|Overall Study|Death|10|||
33603377|NCT01475162|102099234|FG000|Overall Study|Study closed for safety|3|||
33315998|NCT00381303|101050879|FG000|Overall Study|Pregnancy|2|||
33315999|NCT00381303|101050880|FG001|Overall Study|Pregnancy|0|||
33316000|NCT00381303|101050879|FG000|Overall Study|Physician Decision|1|||
33316001|NCT00381303|101050880|FG001|Overall Study|Physician Decision|0|||
33316002|NCT00381303|101050879|FG000|Overall Study|Physician's decision to close the site|3|||
33316003|NCT00381303|101050880|FG001|Overall Study|Physician's decision to close the site|1|||
33316004|NCT00381303|101050879|FG000|Overall Study|Subject moved out of state|2|||
33316005|NCT00381303|101050880|FG001|Overall Study|Subject moved out of state|0|||
33316006|NCT00381303|101050879|FG000|Overall Study|Subject taking too many different meds|1|||
33316007|NCT00381303|101050880|FG001|Overall Study|Subject taking too many different meds|0|||
33316008|NCT00381303|101050879|FG000|Overall Study|No virologic response by week 12|1|||
33316009|NCT00381303|101050880|FG001|Overall Study|No virologic response by week 12|0|||
33316010|NCT00381303|101050879|FG000|Overall Study|Subject was too busy for appointments|1|||
33316011|NCT00381303|101050880|FG001|Overall Study|Subject was too busy for appointments|0|||
33316012|NCT00381303|101050879|FG000|Overall Study|Subject did not continue visits|1|||
33316013|NCT00381303|101050880|FG001|Overall Study|Subject did not continue visits|0|||
33316014|NCT00381303|101050879|FG000|Overall Study|Subject primary physician's decision|1|||
33316015|NCT00381303|101050880|FG001|Overall Study|Subject primary physician's decision|0|||
33316016|NCT02647866|101050881|FG000|Overall Study|Adverse Event|0|||
33316017|NCT02647866|101050882|FG001|Overall Study|Adverse Event|0|||
33316018|NCT02647866|101050883|FG002|Overall Study|Adverse Event|2|||
33316019|NCT02647866|101050884|FG003|Overall Study|Adverse Event|2|||
33316020|NCT02647866|101050885|FG004|Overall Study|Adverse Event|1|||
33316021|NCT02647866|101050881|FG000|Overall Study|Disease Worsening|3|||
33316022|NCT02647866|101050882|FG001|Overall Study|Disease Worsening|1|||
33316023|NCT02647866|101050883|FG002|Overall Study|Disease Worsening|0|||
33316024|NCT02647866|101050884|FG003|Overall Study|Disease Worsening|0|||
33316025|NCT02647866|101050885|FG004|Overall Study|Disease Worsening|1|||
33316026|NCT02647866|101050881|FG000|Overall Study|Withdrawal by Subject|1|||
33316027|NCT02647866|101050882|FG001|Overall Study|Withdrawal by Subject|1|||
33316028|NCT02647866|101050883|FG002|Overall Study|Withdrawal by Subject|2|||
33316029|NCT02647866|101050884|FG003|Overall Study|Withdrawal by Subject|4|||
33316030|NCT02647866|101050885|FG004|Overall Study|Withdrawal by Subject|4|||
33316031|NCT02647866|101050881|FG000|Overall Study|Physician Decision|0|||
33316032|NCT02647866|101050882|FG001|Overall Study|Physician Decision|1|||
33316033|NCT02647866|101050883|FG002|Overall Study|Physician Decision|1|||
33316034|NCT02647866|101050884|FG003|Overall Study|Physician Decision|0|||
33316035|NCT02647866|101050885|FG004|Overall Study|Physician Decision|2|||
33316036|NCT02647866|101050881|FG000|Overall Study|Death|0|||
33316037|NCT02647866|101050882|FG001|Overall Study|Death|1|||
33316038|NCT02647866|101050883|FG002|Overall Study|Death|0|||
33316039|NCT02647866|101050884|FG003|Overall Study|Death|0|||
33316040|NCT02647866|101050885|FG004|Overall Study|Death|0|||
33316041|NCT02647866|101050881|FG000|Overall Study|Subject moved to different country|1|||
33316042|NCT02647866|101050882|FG001|Overall Study|Subject moved to different country|0|||
33316043|NCT02647866|101050883|FG002|Overall Study|Subject moved to different country|0|||
33316044|NCT02647866|101050884|FG003|Overall Study|Subject moved to different country|0|||
33316045|NCT02647866|101050885|FG004|Overall Study|Subject moved to different country|0|||
33316046|NCT03658668|101050886|FG000|Overall Study|Time Commitment|1|||
33316047|NCT03658668|101050887|FG001|Overall Study|Time Commitment|1|||
33316048|NCT00440700|101050888|FG000|Overall Study|Withdrawal by Subject|8|||
33316049|NCT00440700|101050889|FG001|Overall Study|Withdrawal by Subject|8|||
33316050|NCT00440700|101050890|FG002|Overall Study|Withdrawal by Subject|4|||
33316051|NCT01003990|101050891|FG000|Overall Study|Adverse Event|8|||
33316052|NCT01003990|101050892|FG001|Overall Study|Adverse Event|5|||
33316053|NCT01003990|101050893|FG002|Overall Study|Adverse Event|11|||
33316054|NCT01003990|101050891|FG000|Overall Study|Death|0|||
33316055|NCT01003990|101050892|FG001|Overall Study|Death|8|||
33316056|NCT01003990|101050893|FG002|Overall Study|Death|1|||
33316057|NCT01003990|101050891|FG000|Overall Study|Lack of Efficacy|10|||
33316058|NCT01003990|101050892|FG001|Overall Study|Lack of Efficacy|2|||
33316059|NCT01003990|101050893|FG002|Overall Study|Lack of Efficacy|3|||
33316060|NCT01003990|101050891|FG000|Overall Study|Lost to Follow-up|30|||
33316061|NCT01003990|101050892|FG001|Overall Study|Lost to Follow-up|12|||
33316062|NCT01003990|101050893|FG002|Overall Study|Lost to Follow-up|7|||
33316063|NCT01003990|101050891|FG000|Overall Study|Reasons Not Identified|14|||
33316064|NCT01003990|101050892|FG001|Overall Study|Reasons Not Identified|13|||
33316065|NCT01003990|101050893|FG002|Overall Study|Reasons Not Identified|8|||
33603378|NCT02392403|102099235|FG000|Overall Study|Adverse Event|1|||
33603379|NCT02392403|102099235|FG000|Overall Study|Death|1|||
33603380|NCT02392403|102099235|FG000|Overall Study|Withdrawal by Subject|1|||
33316066|NCT01003990|101050891|FG000|Overall Study|Poor/Non-compliance|4|||
33316067|NCT01003990|101050892|FG001|Overall Study|Poor/Non-compliance|3|||
33316068|NCT01003990|101050893|FG002|Overall Study|Poor/Non-compliance|2|||
33316069|NCT01003990|101050891|FG000|Overall Study|Pregnancy|10|||
33316070|NCT01003990|101050892|FG001|Overall Study|Pregnancy|2|||
33603381|NCT01389323|102099240|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
33397223|NCT02203916|101345717|FG001|Overall Study|Lack of Efficacy|0|||
33397224|NCT02203916|101345718|FG002|Overall Study|Lack of Efficacy|0|||
33397225|NCT02203916|101345716|FG000|Overall Study|Reason Not Specified|0|||
33397226|NCT02203916|101345717|FG001|Overall Study|Reason Not Specified|2|||
33397227|NCT02203916|101345718|FG002|Overall Study|Reason Not Specified|1|||
33397228|NCT01657253|101345720|FG000|Overall Study|Lost to Follow-up|6|||
33397229|NCT01657253|101345721|FG001|Overall Study|Lost to Follow-up|5|||
33397230|NCT01657253|101345720|FG000|Overall Study|Withdrawal by Subject|11|||
33397231|NCT01657253|101345721|FG001|Overall Study|Withdrawal by Subject|12|||
33397232|NCT01657253|101345720|FG000|Overall Study|Adverse Event|0|||
33397233|NCT01657253|101345721|FG001|Overall Study|Adverse Event|1|||
33397234|NCT02390362|101345723|FG000|Overall Study|Withdrawal by Subject|0|||
33397235|NCT02390362|101345724|FG001|Overall Study|Withdrawal by Subject|1|||
33397236|NCT03303625|101345725|FG000|Overall Study|Withdrawal by Subject|2|||
33397237|NCT03303625|101345726|FG001|Overall Study|Withdrawal by Subject|0|||
33397238|NCT03303625|101345727|FG002|Overall Study|Withdrawal by Subject|0|||
33397239|NCT03303625|101345728|FG003|Overall Study|Withdrawal by Subject|0|||
33397240|NCT01034709|101345729|FG000|Overall Study|Protocol Violation|9|||
33397241|NCT01034709|101345730|FG001|Overall Study|Protocol Violation|16|||
33397242|NCT01624974|101345736|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
33397243|NCT01624974|101345737|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
33397244|NCT01624974|101345736|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
33397245|NCT01624974|101345737|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
33397246|NCT01624974|101345736|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
33397247|NCT01624974|101345737|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
33397248|NCT01624974|101345736|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
33397249|NCT01624974|101345737|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
33397250|NCT01624974|101345736|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
33397251|NCT01624974|101345737|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
33397252|NCT01624974|101345736|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
33397253|NCT01624974|101345737|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
33397254|NCT01624974|101345736|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
33397255|NCT01624974|101345737|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
33397256|NCT01624974|101345736|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
33397257|NCT01624974|101345737|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
33397258|NCT01624974|101345736|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
33397259|NCT01624974|101345737|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
33397260|NCT01624974|101345736|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
33397261|NCT01624974|101345737|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
33397262|NCT01624974|101345736|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
33397263|NCT01624974|101345737|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
33397264|NCT01624974|101345736|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
33397265|NCT01624974|101345737|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
33397266|NCT01241318|101345741|FG000|Overall Study|Woman: false pregnancies|27|||
33397267|NCT01241318|101345742|FG001|Overall Study|Woman: false pregnancies|15|||
33397268|NCT01241318|101345741|FG000|Overall Study|Woman: miscarriage/abortion|46|||
33397269|NCT01241318|101345742|FG001|Overall Study|Woman: miscarriage/abortion|38|||
33397270|NCT01241318|101345741|FG000|Overall Study|Withdrawal by Subject|175|||
33397271|NCT01241318|101345742|FG001|Overall Study|Withdrawal by Subject|46|||
33397272|NCT01241318|101345741|FG000|Overall Study|Lost to Follow-up|740|||
33397273|NCT01241318|101345742|FG001|Overall Study|Lost to Follow-up|455|||
33397274|NCT01241318|101345741|FG000|Overall Study|Death|2|||
33397275|NCT01241318|101345742|FG001|Overall Study|Death|4|||
33397276|NCT01241318|101345741|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
33397277|NCT01241318|101345742|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
33397278|NCT01241318|101345741|FG000|Overall Study|Woman: Stillborn infant|129|||
33397279|NCT01241318|101345742|FG001|Overall Study|Woman: Stillborn infant|146|||
33397280|NCT02531633|101345743|FG000|Part A (52 Weeks)|Sponsor request|24|||
33397281|NCT02531633|101345744|FG001|Part A (52 Weeks)|Sponsor request|24|||
33397282|NCT02531633|101345745|FG002|Part A (52 Weeks)|Sponsor request|18|||
33397283|NCT02531633|101345746|FG003|Part A (52 Weeks)|Sponsor request|18|||
33397284|NCT02531633|101345747|FG004|Part A (52 Weeks)|Sponsor request|19|||
33397285|NCT02531633|101345748|FG005|Part A (52 Weeks)|Sponsor request|0|||
33195593|NCT04622254|100619722|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
33397286|NCT02531633|101345749|FG006|Part A (52 Weeks)|Sponsor request|0|||
33397287|NCT02531633|101345750|FG007|Part A (52 Weeks)|Sponsor request|0|||
33397288|NCT02531633|101345751|FG008|Part A (52 Weeks)|Sponsor request|0|||
33195594|NCT04622254|100619723|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
33397289|NCT02531633|101345752|FG009|Part A (52 Weeks)|Sponsor request|0|||
33397290|NCT02531633|101345743|FG000|Part A (52 Weeks)|Protocol Violation|1|||
33397291|NCT02531633|101345744|FG001|Part A (52 Weeks)|Protocol Violation|0|||
33397292|NCT02531633|101345745|FG002|Part A (52 Weeks)|Protocol Violation|0|||
33397293|NCT02531633|101345746|FG003|Part A (52 Weeks)|Protocol Violation|0|||
33603382|NCT01389323|102099240|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
33603383|NCT01389323|102099240|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
33603384|NCT01389323|102099240|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
33603385|NCT01389323|102099240|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
33603386|NCT01389323|102099240|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
33603387|NCT01389323|102099240|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
33603388|NCT01389323|102099240|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
33603389|NCT01389323|102099240|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
33603390|NCT01389323|102099240|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
33603391|NCT01389323|102099240|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
33195595|NCT04622254|100619718|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
33195596|NCT04622254|100619719|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
33195597|NCT04622254|100619720|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
33195598|NCT04622254|100619721|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
33195599|NCT04622254|100619722|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
33195600|NCT04622254|100619723|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
33195601|NCT04622254|100619718|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
33195602|NCT04622254|100619719|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
33195603|NCT04622254|100619720|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
33195604|NCT04622254|100619721|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
33195605|NCT04622254|100619722|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
33195606|NCT04622254|100619723|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
33195607|NCT04622254|100619718|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
33195608|NCT04622254|100619719|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
33195609|NCT04622254|100619720|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
33195610|NCT04622254|100619721|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
33195611|NCT04622254|100619722|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
33195612|NCT04622254|100619723|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
33195613|NCT02984995|100619724|FG000|Overall Study|Required stem cell transplant|13|||
33195614|NCT02984995|100619725|FG001|Overall Study|Required stem cell transplant|2|||
33195615|NCT02984995|100619724|FG000|Overall Study|Progressive disease|11|||
33603392|NCT00635089|102099243|FG000|Overall Study|Adverse Event|7|||
33603393|NCT00635089|102099243|FG000|Overall Study|Lack of Efficacy|28|||
33603394|NCT00635089|102099243|FG000|Overall Study|Protocol Deviation|4|||
33603395|NCT00635089|102099243|FG000|Overall Study|Lost to Follow-up|8|||
33195616|NCT02984995|100619725|FG001|Overall Study|Progressive disease|1|||
33195617|NCT02984995|100619724|FG000|Overall Study|Adverse Event|1|||
33195618|NCT02984995|100619725|FG001|Overall Study|Adverse Event|0|||
33195619|NCT04360824|100619726|FG000|Overall Study|Withdrawal by Subject|2|||
33195620|NCT04360824|100619727|FG001|Overall Study|Withdrawal by Subject|1|||
33195621|NCT04360824|100619726|FG000|Overall Study|Did not receive assigned treatment|1|||
33195622|NCT04360824|100619727|FG001|Overall Study|Did not receive assigned treatment|3|||
33195623|NCT00456092|100619734|FG000|Extension Phase|Grade 2 or Greater AE|2|||
33195624|NCT00456092|100619735|FG001|Extension Phase|Grade 2 or Greater AE|2|||
33195625|NCT00456092|100619736|FG002|Extension Phase|Grade 2 or Greater AE|0|||
33195626|NCT00456092|100619737|FG003|Extension Phase|Grade 2 or Greater AE|0|||
33195627|NCT00456092|100619738|FG004|Extension Phase|Grade 2 or Greater AE|2|||
33195628|NCT00456092|100619734|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
33195629|NCT00456092|100619735|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
33195630|NCT00456092|100619736|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
33195631|NCT00456092|100619737|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
33195632|NCT00456092|100619738|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
33195633|NCT00456092|100619734|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
33195634|NCT00456092|100619735|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
33195635|NCT00456092|100619736|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
33195636|NCT00456092|100619737|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
33195637|NCT00456092|100619738|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
33195638|NCT00456092|100619734|FG000|Extension Phase|Withdrew Consent|2|||
33195639|NCT00456092|100619735|FG001|Extension Phase|Withdrew Consent|0|||
33195640|NCT00456092|100619736|FG002|Extension Phase|Withdrew Consent|0|||
33195641|NCT00456092|100619737|FG003|Extension Phase|Withdrew Consent|0|||
33195642|NCT00456092|100619738|FG004|Extension Phase|Withdrew Consent|0|||
33195643|NCT00456092|100619734|FG000|Extension Phase|Lost to Follow-up|1|||
33195644|NCT00456092|100619735|FG001|Extension Phase|Lost to Follow-up|1|||
33603396|NCT00635089|102099243|FG000|Overall Study|Other|31|||
33195645|NCT00456092|100619736|FG002|Extension Phase|Lost to Follow-up|0|||
33195646|NCT00456092|100619737|FG003|Extension Phase|Lost to Follow-up|0|||
33195647|NCT00456092|100619738|FG004|Extension Phase|Lost to Follow-up|1|||
33195648|NCT00456092|100619734|FG000|Extension Phase|Other|2|||
33195649|NCT00456092|100619735|FG001|Extension Phase|Other|0|||
33195650|NCT00456092|100619736|FG002|Extension Phase|Other|0|||
33195651|NCT00456092|100619737|FG003|Extension Phase|Other|1|||
33195652|NCT00456092|100619738|FG004|Extension Phase|Other|1|||
33195653|NCT00456092|100619734|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
33195654|NCT00456092|100619735|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
33195655|NCT00456092|100619736|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
33195656|NCT00456092|100619737|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
33195657|NCT00456092|100619738|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
33195658|NCT00456092|100619734|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
33195659|NCT00456092|100619735|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
33195660|NCT00456092|100619736|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
33195661|NCT00456092|100619737|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
33195662|NCT00456092|100619738|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
33195663|NCT00456092|100619734|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
33603397|NCT01606787|102099246|FG000|Overall Study|Withdrawal by Subject|4|||
33603398|NCT01606787|102099247|FG001|Overall Study|Withdrawal by Subject|5|||
33603399|NCT01606787|102099246|FG000|Overall Study|Surgery canceled|0|||
33603400|NCT01606787|102099247|FG001|Overall Study|Surgery canceled|2|||
33195664|NCT00456092|100619735|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
33195665|NCT00456092|100619736|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
33195666|NCT00456092|100619737|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
33195667|NCT00456092|100619738|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
33195668|NCT00456092|100619734|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
33195669|NCT00456092|100619735|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
33195670|NCT00456092|100619736|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
33195671|NCT00456092|100619737|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
33195672|NCT00456092|100619738|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
33224275|NCT04737109|100721769|FG000|Study Treatment|Death on study|1|||
33603401|NCT03230292|102099248|FG000|Overall Study|Adverse Event|1|||
33195673|NCT00456092|100619734|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
33195674|NCT00456092|100619735|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
33195675|NCT00456092|100619736|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
33195676|NCT00456092|100619737|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
33195677|NCT00456092|100619738|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
33195678|NCT00456092|100619734|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
33195679|NCT00456092|100619735|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
33195680|NCT00456092|100619736|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
33195681|NCT00456092|100619737|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
33195682|NCT00456092|100619738|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
33195683|NCT00456092|100619734|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
33195684|NCT00456092|100619735|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
33195685|NCT00456092|100619736|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
33195686|NCT00456092|100619737|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
33195687|NCT00456092|100619738|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
33195688|NCT00456092|100619734|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
33195689|NCT00456092|100619735|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
33195690|NCT00456092|100619736|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
33195691|NCT00456092|100619737|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
33195692|NCT00456092|100619738|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
33195693|NCT00456092|100619734|FG000|Treatment Phase (12 Weeks)|Other|1|||
33195694|NCT00456092|100619735|FG001|Treatment Phase (12 Weeks)|Other|0|||
33195695|NCT00456092|100619736|FG002|Treatment Phase (12 Weeks)|Other|1|||
33195696|NCT00456092|100619737|FG003|Treatment Phase (12 Weeks)|Other|0|||
33195697|NCT00456092|100619738|FG004|Treatment Phase (12 Weeks)|Other|0|||
33195698|NCT03511560|100619739|FG000|Overall Study|Death|0|||
33195699|NCT03511560|100619740|FG001|Overall Study|Death|1|||
33195700|NCT03511560|100619739|FG000|Overall Study|Adverse Event|0|||
33195701|NCT03511560|100619740|FG001|Overall Study|Adverse Event|2|||
33195702|NCT03511560|100619739|FG000|Overall Study|Transplant cancelled|0|||
33195703|NCT03511560|100619740|FG001|Overall Study|Transplant cancelled|1|||
33195704|NCT03511560|100619739|FG000|Overall Study|Patient switched to another drug|1|||
33195705|NCT03511560|100619740|FG001|Overall Study|Patient switched to another drug|0|||
33195706|NCT02383758|100619741|FG000|Overall Study|Withdrawal by Subject|0|||
33195707|NCT02383758|100619742|FG001|Overall Study|Withdrawal by Subject|2|||
33195708|NCT03614793|100619743|FG000|Overall Study|Lost to Follow-up|1|||
33195709|NCT03614793|100619744|FG001|Overall Study|Lost to Follow-up|2|||
33195710|NCT03614793|100619743|FG000|Overall Study|Lack of Efficacy|0|||
33195711|NCT03614793|100619744|FG001|Overall Study|Lack of Efficacy|5|||
33195712|NCT03614793|100619743|FG000|Overall Study|Withdrawal by Subject|0|||
33195713|NCT03614793|100619744|FG001|Overall Study|Withdrawal by Subject|1|||
33195714|NCT03614793|100619743|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
33195715|NCT03614793|100619744|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
33195716|NCT04111497|100619759|FG000|Overall Study|relapse of primary disease|1|||
33195717|NCT04111497|100619759|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
33195718|NCT01328002|100619763|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
33195719|NCT01328002|100619764|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
33316071|NCT01003990|101050893|FG002|Overall Study|Pregnancy|4|||
33316072|NCT01003990|101050891|FG000|Overall Study|No Longer Met Study Criteria|4|||
33603402|NCT03230292|102099248|FG000|Overall Study|Protocol Violation|1|||
33603403|NCT03230292|102099248|FG000|Overall Study|Lost to Follow-up|1|||
33603404|NCT03230292|102099248|FG000|Overall Study|Withdrawal by Subject|3|||
33603405|NCT00454649|102099254|FG000|Overall Study|Lack of Efficacy|2|||
33603406|NCT00454649|102099255|FG001|Overall Study|Lack of Efficacy|2|||
33195720|NCT01328002|100619763|FG000|Open-Label Period|Adverse Event|8|||
33195721|NCT01328002|100619764|FG001|Open-Label Period|Adverse Event|0|||
33195722|NCT01328002|100619763|FG000|Open-Label Period|Lack of Efficacy|3|||
33603407|NCT00454649|102099256|FG002|Overall Study|Lack of Efficacy|10|||
33603408|NCT00454649|102099257|FG003|Overall Study|Lack of Efficacy|3|||
33195723|NCT01328002|100619764|FG001|Open-Label Period|Lack of Efficacy|0|||
33195724|NCT01328002|100619763|FG000|Open-Label Period|Protocol Violation|2|||
33195725|NCT01328002|100619764|FG001|Open-Label Period|Protocol Violation|0|||
33195726|NCT01328002|100619763|FG000|Open-Label Period|Withdrawal by Subject|9|||
33195727|NCT01328002|100619764|FG001|Open-Label Period|Withdrawal by Subject|0|||
33603409|NCT00454649|102099258|FG004|Overall Study|Lack of Efficacy|0|||
33195728|NCT01328002|100619763|FG000|Open-Label Period|Lost to Follow-up|6|||
33195729|NCT01328002|100619764|FG001|Open-Label Period|Lost to Follow-up|0|||
33195730|NCT01328002|100619763|FG000|Open-Label Period|Other Reason|2|||
33195731|NCT01328002|100619764|FG001|Open-Label Period|Other Reason|0|||
33195732|NCT01328002|100619763|FG000|Double-Blind Period|Adverse Event|1|||
33195733|NCT01328002|100619764|FG001|Double-Blind Period|Adverse Event|0|||
33195734|NCT01328002|100619763|FG000|Double-Blind Period|Lack of Efficacy|1|||
33195735|NCT01328002|100619764|FG001|Double-Blind Period|Lack of Efficacy|0|||
33195736|NCT02103478|100619765|FG000|Overall Study|Adverse Event|0|||
33195737|NCT02103478|100619766|FG001|Overall Study|Adverse Event|0|||
33195738|NCT02103478|100619767|FG002|Overall Study|Adverse Event|1|||
33195739|NCT02103478|100619768|FG003|Overall Study|Adverse Event|1|||
33195740|NCT02103478|100619769|FG004|Overall Study|Adverse Event|2|||
33195741|NCT02103478|100619770|FG005|Overall Study|Adverse Event|1|||
33195742|NCT02103478|100619771|FG006|Overall Study|Adverse Event|0|||
33195743|NCT02103478|100619772|FG007|Overall Study|Adverse Event|0|||
33195744|NCT02103478|100619773|FG008|Overall Study|Adverse Event|0|||
33195745|NCT02103478|100619765|FG000|Overall Study|Death|2|||
33195746|NCT02103478|100619766|FG001|Overall Study|Death|2|||
33195747|NCT02103478|100619767|FG002|Overall Study|Death|1|||
33195748|NCT02103478|100619768|FG003|Overall Study|Death|1|||
33195749|NCT02103478|100619769|FG004|Overall Study|Death|5|||
33195750|NCT02103478|100619770|FG005|Overall Study|Death|15|||
33195751|NCT02103478|100619771|FG006|Overall Study|Death|14|||
33195752|NCT02103478|100619772|FG007|Overall Study|Death|10|||
33195753|NCT02103478|100619773|FG008|Overall Study|Death|11|||
33195754|NCT02103478|100619765|FG000|Overall Study|Progressive Disease|2|||
33195755|NCT02103478|100619766|FG001|Overall Study|Progressive Disease|1|||
33195756|NCT02103478|100619767|FG002|Overall Study|Progressive Disease|2|||
33195757|NCT02103478|100619768|FG003|Overall Study|Progressive Disease|0|||
33195758|NCT02103478|100619769|FG004|Overall Study|Progressive Disease|9|||
33195759|NCT02103478|100619770|FG005|Overall Study|Progressive Disease|1|||
33195760|NCT02103478|100619771|FG006|Overall Study|Progressive Disease|2|||
33195761|NCT02103478|100619772|FG007|Overall Study|Progressive Disease|0|||
33195762|NCT02103478|100619773|FG008|Overall Study|Progressive Disease|1|||
33195763|NCT02103478|100619765|FG000|Overall Study|Withdrawal by Subject|2|||
33195764|NCT02103478|100619766|FG001|Overall Study|Withdrawal by Subject|0|||
33195765|NCT02103478|100619767|FG002|Overall Study|Withdrawal by Subject|0|||
33195766|NCT02103478|100619768|FG003|Overall Study|Withdrawal by Subject|4|||
33195767|NCT02103478|100619769|FG004|Overall Study|Withdrawal by Subject|0|||
33195768|NCT02103478|100619770|FG005|Overall Study|Withdrawal by Subject|0|||
33195769|NCT02103478|100619771|FG006|Overall Study|Withdrawal by Subject|1|||
33195770|NCT02103478|100619772|FG007|Overall Study|Withdrawal by Subject|1|||
33195771|NCT02103478|100619773|FG008|Overall Study|Withdrawal by Subject|0|||
33195772|NCT02103478|100619765|FG000|Overall Study|Lost to Follow-up|0|||
33195773|NCT02103478|100619766|FG001|Overall Study|Lost to Follow-up|0|||
33195774|NCT02103478|100619767|FG002|Overall Study|Lost to Follow-up|0|||
33195775|NCT02103478|100619768|FG003|Overall Study|Lost to Follow-up|0|||
33195776|NCT02103478|100619769|FG004|Overall Study|Lost to Follow-up|0|||
33195777|NCT02103478|100619770|FG005|Overall Study|Lost to Follow-up|0|||
33195778|NCT02103478|100619771|FG006|Overall Study|Lost to Follow-up|0|||
33195779|NCT02103478|100619772|FG007|Overall Study|Lost to Follow-up|1|||
33195780|NCT02103478|100619773|FG008|Overall Study|Lost to Follow-up|0|||
33195781|NCT02103478|100619765|FG000|Overall Study|Other|1|||
33195782|NCT02103478|100619766|FG001|Overall Study|Other|3|||
33195783|NCT02103478|100619767|FG002|Overall Study|Other|2|||
33195784|NCT02103478|100619768|FG003|Overall Study|Other|0|||
33195785|NCT02103478|100619769|FG004|Overall Study|Other|3|||
33195786|NCT02103478|100619770|FG005|Overall Study|Other|8|||
33195787|NCT02103478|100619771|FG006|Overall Study|Other|8|||
33195788|NCT02103478|100619772|FG007|Overall Study|Other|4|||
33195789|NCT02103478|100619773|FG008|Overall Study|Other|2|||
33195790|NCT02944578|100619774|FG000|Overall Study|Physician Decision|1|||
33195791|NCT02944578|100619775|FG001|Overall Study|Physician Decision|0|||
33195792|NCT02644967|100619778|FG000|Overall Study|Death|26|||
33316073|NCT01003990|101050892|FG001|Overall Study|No Longer Met Study Criteria|1|||
33195793|NCT02644967|100619778|FG000|Overall Study|Physician Decision|1|||
33195794|NCT02644967|100619778|FG000|Overall Study|Withdrawal by Subject|2|||
33195795|NCT02644967|100619778|FG000|Overall Study|Protocol Violation|1|||
33195796|NCT02644967|100619778|FG000|Overall Study|Progressive Disease|1|||
33195797|NCT02644967|100619778|FG000|Overall Study|Study Terminated by Sponsor|4|||
33195798|NCT01565993|100619786|FG000|Overall Study|Physician Decision|0|||
33195799|NCT01565993|100619787|FG001|Overall Study|Physician Decision|3|||
33195800|NCT04327934|100619788|FG000|Overall Study|Did not qualify|7|||
33195801|NCT04327934|100619789|FG001|Overall Study|Did not qualify|4|||
33195802|NCT04327934|100619788|FG000|Overall Study|Physician Decision|0|||
33195803|NCT04327934|100619789|FG001|Overall Study|Physician Decision|1|||
33195804|NCT02970968|100619790|FG000|Overall Study|Withdrawal by Subject|3|||
33195805|NCT02970968|100619791|FG001|Overall Study|Withdrawal by Subject|3|||
33195806|NCT02970968|100619790|FG000|Overall Study|Adverse Event|1|||
33195807|NCT02970968|100619791|FG001|Overall Study|Adverse Event|2|||
33195808|NCT02970968|100619790|FG000|Overall Study|Lost to Follow-up|1|||
33195809|NCT02970968|100619791|FG001|Overall Study|Lost to Follow-up|1|||
33195810|NCT02970968|100619790|FG000|Overall Study|Non-Compliance|0|||
33195811|NCT02970968|100619791|FG001|Overall Study|Non-Compliance|1|||
33195812|NCT01175824|100619792|FG000|Overall Study|Adverse Event|2|||
33195813|NCT01175824|100619793|FG001|Overall Study|Adverse Event|1|||
33195814|NCT01175824|100619792|FG000|Overall Study|Lack of Efficacy|2|||
33195815|NCT01175824|100619793|FG001|Overall Study|Lack of Efficacy|0|||
33195816|NCT01175824|100619792|FG000|Overall Study|Lost to Follow-up|0|||
33195817|NCT01175824|100619793|FG001|Overall Study|Lost to Follow-up|1|||
33195818|NCT01175824|100619792|FG000|Overall Study|Physician Decision|0|||
33195819|NCT01175824|100619793|FG001|Overall Study|Physician Decision|4|||
33195820|NCT01175824|100619792|FG000|Overall Study|Protocol Violation|2|||
33195821|NCT01175824|100619793|FG001|Overall Study|Protocol Violation|5|||
33195822|NCT01175824|100619792|FG000|Overall Study|Withdrawal by Subject|3|||
33506200|NCT01738503|101747719|FG004|Treatment Period|Lost to Follow-up|1|||
33506201|NCT01738503|101747720|FG005|Treatment Period|Lost to Follow-up|1|||
33506202|NCT01738503|101747721|FG006|Treatment Period|Lost to Follow-up|5|||
33506203|NCT01738503|101747715|FG000|Treatment Period|Withdrawal by Subject|0|||
33506204|NCT01738503|101747716|FG001|Treatment Period|Withdrawal by Subject|1|||
33506205|NCT01738503|101747717|FG002|Treatment Period|Withdrawal by Subject|0|||
33195823|NCT01175824|100619793|FG001|Overall Study|Withdrawal by Subject|7|||
33195824|NCT01175824|100619792|FG000|Overall Study|Sponsor Decision|1|||
33195825|NCT01175824|100619793|FG001|Overall Study|Sponsor Decision|0|||
33506206|NCT01738503|101747718|FG003|Treatment Period|Withdrawal by Subject|1|||
33506207|NCT01738503|101747719|FG004|Treatment Period|Withdrawal by Subject|1|||
33506208|NCT01738503|101747720|FG005|Treatment Period|Withdrawal by Subject|1|||
33603410|NCT00454649|102099259|FG005|Overall Study|Lack of Efficacy|4|||
33195826|NCT01175824|100619792|FG000|Overall Study|Entry Criteria Not Met|6|||
33195827|NCT01175824|100619793|FG001|Overall Study|Entry Criteria Not Met|4|||
33316074|NCT01003990|101050893|FG002|Overall Study|No Longer Met Study Criteria|0|||
33316075|NCT01003990|101050891|FG000|Overall Study|Subject Withdrew Consent|12|||
33506209|NCT01738503|101747721|FG006|Treatment Period|Withdrawal by Subject|1|||
33506210|NCT01738503|101747715|FG000|Treatment Period|Protocol Violation|0|||
33506211|NCT01738503|101747716|FG001|Treatment Period|Protocol Violation|3|||
33506212|NCT01738503|101747717|FG002|Treatment Period|Protocol Violation|1|||
33603411|NCT00454649|102099260|FG006|Overall Study|Lack of Efficacy|5|||
33603412|NCT00454649|102099261|FG007|Overall Study|Lack of Efficacy|13|||
33603413|NCT00454649|102099262|FG008|Overall Study|Lack of Efficacy|10|||
33603414|NCT00454649|102099263|FG009|Overall Study|Lack of Efficacy|2|||
33603415|NCT00454649|102099254|FG000|Overall Study|Adverse Event|0|||
33603416|NCT00454649|102099255|FG001|Overall Study|Adverse Event|1|||
33603417|NCT00454649|102099256|FG002|Overall Study|Adverse Event|3|||
33603418|NCT00454649|102099257|FG003|Overall Study|Adverse Event|0|||
33603419|NCT00454649|102099258|FG004|Overall Study|Adverse Event|1|||
33603420|NCT00454649|102099259|FG005|Overall Study|Adverse Event|2|||
33603421|NCT00454649|102099260|FG006|Overall Study|Adverse Event|3|||
33603422|NCT00454649|102099261|FG007|Overall Study|Adverse Event|4|||
33603423|NCT00454649|102099262|FG008|Overall Study|Adverse Event|6|||
33603424|NCT00454649|102099263|FG009|Overall Study|Adverse Event|2|||
33195828|NCT05204134|100619800|FG000|Overall Study|Withdrawal by Subject|3|||
33195829|NCT05204134|100619800|FG000|Overall Study|Physician Decision|1|||
33195830|NCT03586999|100622845|FG000|Overall Study|Lack of Efficacy|2|||
33195831|NCT01581593|100622846|FG000|Overall Study|Withdrawal by Subject|1|||
33195832|NCT02082522|100622847|FG000|Overall Study|Sponsor termination|5|||
33603425|NCT00454649|102099254|FG000|Overall Study|Lost to Follow-up|0|||
33603426|NCT00454649|102099255|FG001|Overall Study|Lost to Follow-up|0|||
33603427|NCT00454649|102099256|FG002|Overall Study|Lost to Follow-up|1|||
33603428|NCT00454649|102099257|FG003|Overall Study|Lost to Follow-up|0|||
33195833|NCT02082522|100622848|FG001|Overall Study|Sponsor termination|3|||
33195834|NCT02082522|100622847|FG000|Overall Study|Withdrawal by Subject|2|||
33195835|NCT02082522|100622848|FG001|Overall Study|Withdrawal by Subject|4|||
33195836|NCT02082522|100622847|FG000|Overall Study|Death|1|||
33195837|NCT02082522|100622848|FG001|Overall Study|Death|0|||
33195838|NCT02082522|100622847|FG000|Overall Study|Lost to Follow-up|1|||
33195839|NCT02082522|100622848|FG001|Overall Study|Lost to Follow-up|0|||
33195840|NCT02082522|100622847|FG000|Overall Study|Physician Decision|3|||
33195841|NCT02082522|100622848|FG001|Overall Study|Physician Decision|1|||
33195842|NCT02082522|100622847|FG000|Overall Study|Disease progression|2|||
33195843|NCT02082522|100622848|FG001|Overall Study|Disease progression|2|||
33195844|NCT02082522|100622847|FG000|Overall Study|Chemotherapy change|1|||
33195845|NCT02082522|100622848|FG001|Overall Study|Chemotherapy change|3|||
33195846|NCT04208412|100622849|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
33195847|NCT04208412|100622850|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
33195848|NCT04208412|100622849|FG000|Overall Study|Withdrawal by Subject|1|||
33195849|NCT04208412|100622850|FG001|Overall Study|Withdrawal by Subject|0|||
33195850|NCT04208412|100622849|FG000|Overall Study|Lost to Follow-up|0|||
33195851|NCT04208412|100622850|FG001|Overall Study|Lost to Follow-up|1|||
33195852|NCT01336738|100622851|FG000|Overall Study|Adverse Event|0|||
33195853|NCT01336738|100622852|FG001|Overall Study|Adverse Event|3|||
33195854|NCT01336738|100622853|FG002|Overall Study|Adverse Event|2|||
33195855|NCT01336738|100622854|FG003|Overall Study|Adverse Event|1|||
33195856|NCT01336738|100622855|FG004|Overall Study|Adverse Event|3|||
33195857|NCT01336738|100622851|FG000|Overall Study|Lost to Follow-up|2|||
33195858|NCT01336738|100622852|FG001|Overall Study|Lost to Follow-up|1|||
33195859|NCT01336738|100622853|FG002|Overall Study|Lost to Follow-up|2|||
33195860|NCT01336738|100622854|FG003|Overall Study|Lost to Follow-up|2|||
33195861|NCT01336738|100622855|FG004|Overall Study|Lost to Follow-up|2|||
33195862|NCT01336738|100622851|FG000|Overall Study|Did not meet entrance criteria|0|||
33195863|NCT01336738|100622852|FG001|Overall Study|Did not meet entrance criteria|1|||
33195864|NCT01336738|100622853|FG002|Overall Study|Did not meet entrance criteria|0|||
33195865|NCT01336738|100622854|FG003|Overall Study|Did not meet entrance criteria|0|||
33195866|NCT01336738|100622855|FG004|Overall Study|Did not meet entrance criteria|0|||
33195867|NCT01336738|100622851|FG000|Overall Study|Protocol Violation|0|||
33195868|NCT01336738|100622852|FG001|Overall Study|Protocol Violation|1|||
33195869|NCT01336738|100622853|FG002|Overall Study|Protocol Violation|0|||
33195870|NCT01336738|100622854|FG003|Overall Study|Protocol Violation|0|||
33195871|NCT01336738|100622855|FG004|Overall Study|Protocol Violation|0|||
33195872|NCT01336738|100622851|FG000|Overall Study|Withdrawal by Subject|2|||
33195873|NCT01336738|100622852|FG001|Overall Study|Withdrawal by Subject|0|||
33195874|NCT01336738|100622853|FG002|Overall Study|Withdrawal by Subject|2|||
33195875|NCT01336738|100622854|FG003|Overall Study|Withdrawal by Subject|1|||
33195876|NCT01336738|100622855|FG004|Overall Study|Withdrawal by Subject|1|||
33195877|NCT01336738|100622851|FG000|Overall Study|Other|3|||
33506213|NCT01738503|101747718|FG003|Treatment Period|Protocol Violation|0|||
33506214|NCT01738503|101747719|FG004|Treatment Period|Protocol Violation|4|||
33195878|NCT01336738|100622852|FG001|Overall Study|Other|3|||
33195879|NCT01336738|100622853|FG002|Overall Study|Other|2|||
33506215|NCT01738503|101747720|FG005|Treatment Period|Protocol Violation|2|||
33506216|NCT01738503|101747721|FG006|Treatment Period|Protocol Violation|0|||
33506217|NCT01738503|101747715|FG000|Treatment Period|Other|0|||
33506218|NCT01738503|101747716|FG001|Treatment Period|Other|0|||
33506219|NCT01738503|101747717|FG002|Treatment Period|Other|1|||
33506220|NCT01738503|101747718|FG003|Treatment Period|Other|0|||
33506221|NCT01738503|101747719|FG004|Treatment Period|Other|0|||
33506222|NCT01738503|101747720|FG005|Treatment Period|Other|0|||
33506223|NCT01738503|101747721|FG006|Treatment Period|Other|0|||
33506224|NCT01738503|101747715|FG000|PET Imaging Sub-study|Adverse Event|0|||
33506225|NCT01738503|101747716|FG001|PET Imaging Sub-study|Adverse Event|0|||
33506226|NCT01738503|101747717|FG002|PET Imaging Sub-study|Adverse Event|0|||
33506227|NCT01738503|101747718|FG003|PET Imaging Sub-study|Adverse Event|0|||
33506228|NCT01738503|101747719|FG004|PET Imaging Sub-study|Adverse Event|0|||
33506229|NCT01738503|101747720|FG005|PET Imaging Sub-study|Adverse Event|1|||
33506230|NCT01738503|101747721|FG006|PET Imaging Sub-study|Adverse Event|0|||
33506231|NCT01738503|101747715|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
33506232|NCT01738503|101747716|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
33506233|NCT01738503|101747717|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
33506234|NCT01738503|101747718|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
33506235|NCT01738503|101747719|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
33506236|NCT01738503|101747720|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
33506237|NCT01738503|101747721|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
33506238|NCT00384839|101747722|FG000|Overall Study|Adverse Event|4|||
33195880|NCT01336738|100622854|FG003|Overall Study|Other|3|||
33506239|NCT00384839|101747722|FG000|Overall Study|Investigator Request|1|||
33195881|NCT01336738|100622855|FG004|Overall Study|Other|4|||
33195882|NCT00941733|100622862|FG000|Overall Study|Death|24|||
33195883|NCT00941733|100622863|FG001|Overall Study|Death|10|||
33195884|NCT00941733|100622862|FG000|Overall Study|Withdrawal by Subject|14|||
33195885|NCT00941733|100622863|FG001|Overall Study|Withdrawal by Subject|6|||
33195886|NCT00941733|100622862|FG000|Overall Study|Adverse Event|20|||
33195887|NCT00941733|100622863|FG001|Overall Study|Adverse Event|4|||
33195888|NCT00941733|100622862|FG000|Overall Study|Lost to Follow-up|1|||
33195889|NCT00941733|100622863|FG001|Overall Study|Lost to Follow-up|2|||
33195890|NCT00941733|100622862|FG000|Overall Study|Protocol Violation|15|||
33195891|NCT00941733|100622863|FG001|Overall Study|Protocol Violation|6|||
33195892|NCT01752933|100622864|FG000|Treatment|Disease Progression|3|||
33195893|NCT01752933|100622865|FG001|Treatment|Disease Progression|29|||
33195894|NCT01752933|100622864|FG000|Treatment|Withdrawal by Subject|0|||
33195895|NCT01752933|100622865|FG001|Treatment|Withdrawal by Subject|5|||
33195896|NCT01752933|100622864|FG000|Treatment|Adverse Event|1|||
33195897|NCT01752933|100622865|FG001|Treatment|Adverse Event|4|||
33195898|NCT01752933|100622864|FG000|Treatment|Physician Decision|0|||
33195899|NCT01752933|100622865|FG001|Treatment|Physician Decision|3|||
33195900|NCT01752933|100622864|FG000|Treatment|Death|0|||
33195901|NCT01752933|100622865|FG001|Treatment|Death|2|||
33195902|NCT01752933|100622864|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
33195903|NCT01752933|100622865|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
33195904|NCT01752933|100622864|FG000|Treatment|Patient noncompliant|0|||
33195905|NCT01752933|100622865|FG001|Treatment|Patient noncompliant|1|||
33195906|NCT01752933|100622864|FG000|Treatment|Patient unable to travel to appointments|0|||
33195907|NCT01752933|100622865|FG001|Treatment|Patient unable to travel to appointments|1|||
33195908|NCT01752933|100622864|FG000|Overall Study and Follow-up|Death|4|||
33195909|NCT01752933|100622865|FG001|Overall Study and Follow-up|Death|34|||
33195910|NCT01752933|100622864|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
33195911|NCT01752933|100622865|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
33195912|NCT01752933|100622864|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
33195913|NCT01752933|100622865|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
33195914|NCT01752933|100622864|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
33195915|NCT01752933|100622865|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
33195916|NCT02550652|100622866|FG000|Overall Study|Death|1|||
33195917|NCT02550652|100622867|FG001|Overall Study|Death|4|||
33195918|NCT02550652|100622866|FG000|Overall Study|Lack of Efficacy|1|||
33195919|NCT02550652|100622867|FG001|Overall Study|Lack of Efficacy|0|||
33195920|NCT02550652|100622866|FG000|Overall Study|Withdrawal by Subject|4|||
33195921|NCT02550652|100622867|FG001|Overall Study|Withdrawal by Subject|7|||
33195922|NCT02550652|100622866|FG000|Overall Study|Post Trial Access|1|||
33195923|NCT02550652|100622867|FG001|Overall Study|Post Trial Access|0|||
33195924|NCT02550652|100622866|FG000|Overall Study|Lost to Follow-up|1|||
33195925|NCT02550652|100622867|FG001|Overall Study|Lost to Follow-up|3|||
33195926|NCT02550652|100622866|FG000|Overall Study|Physician Decision|0|||
33195927|NCT02550652|100622867|FG001|Overall Study|Physician Decision|2|||
33195928|NCT02550652|100622866|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
33195929|NCT02550652|100622867|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
33195930|NCT02496884|100622868|FG000|Overall Study|Counted twice as enrolled|2|||
33195931|NCT02496884|100622869|FG001|Overall Study|Counted twice as enrolled|0|||
33195932|NCT02496884|100622870|FG002|Overall Study|Counted twice as enrolled|0|||
33195933|NCT02496884|100622871|FG003|Overall Study|Counted twice as enrolled|0|||
33195934|NCT02496884|100622868|FG000|Overall Study|Withdrawal by Subject|0|||
33195935|NCT02496884|100622869|FG001|Overall Study|Withdrawal by Subject|3|||
33195936|NCT02496884|100622870|FG002|Overall Study|Withdrawal by Subject|0|||
33195937|NCT02496884|100622871|FG003|Overall Study|Withdrawal by Subject|0|||
33195938|NCT02337829|100622875|FG000|Overall Study|Death|0|||
33195939|NCT02337829|100622876|FG001|Overall Study|Death|1|||
33195940|NCT02337829|100622877|FG002|Overall Study|Death|0|||
33195941|NCT02337829|100622878|FG003|Overall Study|Death|0|||
33195942|NCT02337829|100622875|FG000|Overall Study|Study terminated by sponsor|12|||
33195943|NCT02337829|100622876|FG001|Overall Study|Study terminated by sponsor|10|||
33195944|NCT02337829|100622877|FG002|Overall Study|Study terminated by sponsor|5|||
33195945|NCT02337829|100622878|FG003|Overall Study|Study terminated by sponsor|6|||
33195946|NCT02337829|100622875|FG000|Overall Study|discontinued for other reasons|6|||
33195947|NCT02337829|100622876|FG001|Overall Study|discontinued for other reasons|3|||
33195948|NCT02337829|100622877|FG002|Overall Study|discontinued for other reasons|1|||
33195949|NCT02337829|100622878|FG003|Overall Study|discontinued for other reasons|4|||
33195950|NCT02057757|100622879|FG000|Overall Study|Withdrawal by Subject|3|||
33195951|NCT02057757|100622880|FG001|Overall Study|Withdrawal by Subject|5|||
33195952|NCT02057757|100622879|FG000|Overall Study|Death|2|||
33195953|NCT02057757|100622880|FG001|Overall Study|Death|0|||
33195954|NCT02057757|100622879|FG000|Overall Study|Lost to Follow-up|8|||
33195955|NCT02057757|100622880|FG001|Overall Study|Lost to Follow-up|3|||
33195956|NCT02057757|100622879|FG000|Overall Study|Non-compliance|1|||
33195957|NCT02057757|100622880|FG001|Overall Study|Non-compliance|0|||
33195958|NCT00587587|100622885|FG000|Overall Study|Lost to Follow-up|6|||
33195959|NCT00587587|100622886|FG001|Overall Study|Lost to Follow-up|1|||
33195960|NCT03509948|100622890|FG000|Overall Study|Protocol Violation|0|||
33195961|NCT03509948|100622891|FG001|Overall Study|Protocol Violation|1|||
33195962|NCT02809976|100622892|FG000|Overall Study|Lost to Follow-up|1|||
33195963|NCT02809976|100622892|FG000|Overall Study|Withdrawal by Subject|1|||
33195964|NCT02489981|100622893|FG000|Overall Study|Adverse Event|21|||
33195965|NCT02489981|100622893|FG000|Overall Study|Insufficient effectiveness|16|||
33195966|NCT02489981|100622893|FG000|Overall Study|Improved|31|||
33195967|NCT02489981|100622893|FG000|Overall Study|Lost to Follow-up|31|||
33195968|NCT02489981|100622893|FG000|Overall Study|Other than listed|28|||
33195969|NCT03285646|100622894|FG000|Overall Study|Adverse Event|1|||
33195970|NCT03285646|100622895|FG001|Overall Study|Adverse Event|0|||
33195971|NCT03285646|100622894|FG000|Overall Study|Withdrawal by Subject|10|||
33195972|NCT03285646|100622895|FG001|Overall Study|Withdrawal by Subject|2|||
33195973|NCT03285646|100622894|FG000|Overall Study|Lost to Follow-up|2|||
33195974|NCT03285646|100622895|FG001|Overall Study|Lost to Follow-up|1|||
33195975|NCT03285646|100622894|FG000|Overall Study|Investigator/Sponsor Decision|0|||
33195976|NCT03285646|100622895|FG001|Overall Study|Investigator/Sponsor Decision|1|||
33195977|NCT04709237|100622896|FG000|Overall Study|Lost to Follow-up|1|||
33195978|NCT04709237|100622897|FG001|Overall Study|Lost to Follow-up|0|||
33195979|NCT04709237|100622898|FG002|Overall Study|Lost to Follow-up|0|||
33195980|NCT01940705|100622899|FG000|Overall Study|Lost to Follow-up|1|||
33316076|NCT01003990|101050892|FG001|Overall Study|Subject Withdrew Consent|5|||
33316077|NCT01003990|101050893|FG002|Overall Study|Subject Withdrew Consent|7|||
33316078|NCT00835120|101050894|FG000|Overall Study|Lack of Efficacy|1|||
33316079|NCT00835120|101050894|FG000|Overall Study|Lost to Follow-up|3|||
33316080|NCT00835120|101050894|FG000|Overall Study|Adverse Event|2|||
33316081|NCT00835120|101050894|FG000|Overall Study|Withdrawal by Subject|2|||
33316082|NCT02370043|101050895|FG000|Overall Study|Withdrawal by Subject|0|||
33316083|NCT02370043|101050896|FG001|Overall Study|Withdrawal by Subject|0|||
33316084|NCT02370043|101050897|FG002|Overall Study|Withdrawal by Subject|0|||
33316085|NCT02370043|101050898|FG003|Overall Study|Withdrawal by Subject|0|||
33316086|NCT02370043|101050899|FG004|Overall Study|Withdrawal by Subject|1|||
33316087|NCT02370043|101050900|FG005|Overall Study|Withdrawal by Subject|1|||
33316088|NCT01020448|101050901|FG000|Pre-assignment|Adverse Event|6|||
33316089|NCT01020448|101050901|FG000|Pre-assignment|Withdrawal by Subject|5|||
33316090|NCT01020448|101050901|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
33316091|NCT01020448|101050901|FG000|Treatment|Adverse Event|11|||
33316092|NCT01020448|101050901|FG000|Treatment|Consent Withdrawn|3|||
33316093|NCT01020448|101050901|FG000|Treatment|Disease Progression|2|||
33316094|NCT01020448|101050901|FG000|Treatment|Lack of Efficacy|8|||
33316095|NCT01020448|101050901|FG000|Treatment|Lost to Follow-up|2|||
33316096|NCT01142596|101050902|FG000|Overall Study|Withdrawal by Subject|9|||
33316097|NCT01142596|101050903|FG001|Overall Study|Withdrawal by Subject|35|||
33316098|NCT01142596|101050902|FG000|Overall Study|Adverse Event|8|||
33316099|NCT01142596|101050903|FG001|Overall Study|Adverse Event|35|||
33316100|NCT01142596|101050902|FG000|Overall Study|Lack of Efficacy|5|||
33316101|NCT01142596|101050903|FG001|Overall Study|Lack of Efficacy|9|||
33316102|NCT01142596|101050902|FG000|Overall Study|Lost to Follow-up|2|||
33316103|NCT01142596|101050903|FG001|Overall Study|Lost to Follow-up|3|||
33316104|NCT01142596|101050902|FG000|Overall Study|Other reason (not specified)|5|||
33316105|NCT01142596|101050903|FG001|Overall Study|Other reason (not specified)|4|||
33195981|NCT01940705|100622900|FG001|Overall Study|Lost to Follow-up|3|||
33195982|NCT01940705|100622901|FG002|Overall Study|Lost to Follow-up|2|||
33316106|NCT02319525|101050904|FG000|Overall Study|Withdrawal by Subject|2|||
33603429|NCT00454649|102099258|FG004|Overall Study|Lost to Follow-up|0|||
33603430|NCT00454649|102099259|FG005|Overall Study|Lost to Follow-up|0|||
33603431|NCT00454649|102099260|FG006|Overall Study|Lost to Follow-up|1|||
33603432|NCT00454649|102099261|FG007|Overall Study|Lost to Follow-up|0|||
33603433|NCT00454649|102099262|FG008|Overall Study|Lost to Follow-up|0|||
33316107|NCT02319525|101050905|FG001|Overall Study|Withdrawal by Subject|1|||
33316108|NCT01259726|101050906|FG000|Overall Study|Death|1|||
33316109|NCT01259726|101050907|FG001|Overall Study|Death|0|||
33316110|NCT01259726|101050908|FG002|Overall Study|Death|0|||
33316111|NCT01259726|101050909|FG003|Overall Study|Death|0|||
33316112|NCT01259726|101050906|FG000|Overall Study|Physician Decision|2|||
33316113|NCT01259726|101050907|FG001|Overall Study|Physician Decision|0|||
33316114|NCT01259726|101050908|FG002|Overall Study|Physician Decision|1|||
33316115|NCT01259726|101050909|FG003|Overall Study|Physician Decision|1|||
33316116|NCT01259726|101050906|FG000|Overall Study|Withdrawal by Subject|1|||
33603434|NCT00454649|102099263|FG009|Overall Study|Lost to Follow-up|0|||
33603435|NCT00454649|102099254|FG000|Overall Study|Other|1|||
33316117|NCT01259726|101050907|FG001|Overall Study|Withdrawal by Subject|3|||
33316118|NCT01259726|101050908|FG002|Overall Study|Withdrawal by Subject|2|||
33316119|NCT01259726|101050909|FG003|Overall Study|Withdrawal by Subject|1|||
33316120|NCT01259726|101050906|FG000|Overall Study|Lost to Follow-up|1|||
33316121|NCT01259726|101050907|FG001|Overall Study|Lost to Follow-up|1|||
33316122|NCT01259726|101050908|FG002|Overall Study|Lost to Follow-up|1|||
33603436|NCT00454649|102099255|FG001|Overall Study|Other|1|||
33603437|NCT00454649|102099256|FG002|Overall Study|Other|5|||
33603438|NCT00454649|102099257|FG003|Overall Study|Other|3|||
33603439|NCT00454649|102099258|FG004|Overall Study|Other|0|||
33316123|NCT01259726|101050909|FG003|Overall Study|Lost to Follow-up|3|||
33316124|NCT02170389|101050910|FG000|Overall Study|Study terminated prior to start of treat|1|||
33316125|NCT00866723|101050911|FG000|Overall Study|Withdrawal by Subject|1|||
33316126|NCT00866723|101050911|FG000|Overall Study|Disease Progression|4|||
33316127|NCT01716117|101050915|FG000|Overall Study|Death|5|||
33603440|NCT00454649|102099259|FG005|Overall Study|Other|0|||
33195983|NCT01940705|100622902|FG003|Overall Study|Lost to Follow-up|2|||
33316128|NCT01716117|101050916|FG001|Overall Study|Death|2|||
33316129|NCT01716117|101050915|FG000|Overall Study|Withdrawal by Subject|2|||
33316130|NCT01716117|101050916|FG001|Overall Study|Withdrawal by Subject|0|||
33195984|NCT01940705|100622899|FG000|Overall Study|Withdrawal by Subject|2|||
33195985|NCT01940705|100622900|FG001|Overall Study|Withdrawal by Subject|2|||
33195986|NCT01940705|100622901|FG002|Overall Study|Withdrawal by Subject|3|||
33195987|NCT01940705|100622902|FG003|Overall Study|Withdrawal by Subject|2|||
33195988|NCT01940705|100622899|FG000|Overall Study|Intervention not given|0|||
33195989|NCT01940705|100622900|FG001|Overall Study|Intervention not given|3|||
33195990|NCT01940705|100622901|FG002|Overall Study|Intervention not given|3|||
33195991|NCT01940705|100622902|FG003|Overall Study|Intervention not given|0|||
33195992|NCT01940705|100622899|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
33195993|NCT01940705|100622900|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
33195994|NCT01940705|100622901|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
33195995|NCT01940705|100622902|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
33195996|NCT01181895|100622903|FG000|Overall Study|Adverse Event|3|||
33195997|NCT01181895|100622904|FG001|Overall Study|Adverse Event|1|||
33195998|NCT01181895|100622905|FG002|Overall Study|Adverse Event|1|||
33195999|NCT01181895|100622903|FG000|Overall Study|Lack of Efficacy|8|||
33196000|NCT01181895|100622904|FG001|Overall Study|Lack of Efficacy|9|||
33196001|NCT01181895|100622905|FG002|Overall Study|Lack of Efficacy|9|||
33196002|NCT01181895|100622903|FG000|Overall Study|Protocol Violation|2|||
33196003|NCT01181895|100622904|FG001|Overall Study|Protocol Violation|1|||
33316131|NCT03881553|101050917|FG000|Overall Study|Discharged prior to participation|1|||
33316132|NCT03881553|101050918|FG001|Overall Study|Discharged prior to participation|1|||
33196004|NCT01181895|100622905|FG002|Overall Study|Protocol Violation|0|||
33397294|NCT02531633|101345747|FG004|Part A (52 Weeks)|Protocol Violation|0|||
33196005|NCT01181895|100622903|FG000|Overall Study|Lost to Follow-up|0|||
33316133|NCT03881553|101050919|FG002|Overall Study|Discharged prior to participation|0|||
33316134|NCT03881553|101050917|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
33316135|NCT03881553|101050918|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
33316136|NCT03881553|101050919|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
33316137|NCT00104676|101050920|FG000|Overall Study|Death|3|||
33316138|NCT00104676|101050921|FG001|Overall Study|Death|2|||
33316139|NCT00104676|101050920|FG000|Overall Study|Withdrawal by Subject|0|||
33316140|NCT00104676|101050921|FG001|Overall Study|Withdrawal by Subject|2|||
33316141|NCT00104676|101050920|FG000|Overall Study|treatment interruption|4|||
33316142|NCT00104676|101050921|FG001|Overall Study|treatment interruption|10|||
33316143|NCT02569957|101050922|FG000|Overall Study|Withdrawal by Subject|0|||
33316144|NCT02569957|101050923|FG001|Overall Study|Withdrawal by Subject|1|||
33316145|NCT00762970|101050924|FG000|Overall Study|Withdrawal by Subject|7|||
33316146|NCT00762970|101050925|FG001|Overall Study|Withdrawal by Subject|4|||
33316147|NCT00762970|101050926|FG002|Overall Study|Withdrawal by Subject|0|||
33316148|NCT00762970|101050924|FG000|Overall Study|Protocol Violation|3|||
33316149|NCT00762970|101050925|FG001|Overall Study|Protocol Violation|1|||
33316150|NCT00762970|101050926|FG002|Overall Study|Protocol Violation|1|||
33316151|NCT00762970|101050924|FG000|Overall Study|Lost to Follow-up|1|||
33316152|NCT00762970|101050925|FG001|Overall Study|Lost to Follow-up|2|||
33316153|NCT00762970|101050926|FG002|Overall Study|Lost to Follow-up|0|||
33316154|NCT00762970|101050924|FG000|Overall Study|Difficulty of handling lens|1|||
33316155|NCT00762970|101050925|FG001|Overall Study|Difficulty of handling lens|2|||
33316156|NCT00762970|101050926|FG002|Overall Study|Difficulty of handling lens|0|||
33316157|NCT03118674|101050927|FG000|Overall Study|Lost to Follow-up|2|||
33316158|NCT03118674|101050927|FG000|Overall Study|Screen Faliure|8|||
33316159|NCT03118674|101050927|FG000|Overall Study|Withdrawal by Subject|5|||
33316160|NCT03603028|101050933|FG000|Overall Study|Withdrawal by Subject|1|||
33316161|NCT02095951|101050934|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
33506240|NCT00384839|101747722|FG000|Overall Study|Patient Request|1|||
33506241|NCT00384839|101747722|FG000|Overall Study|Ineligible|2|||
33506242|NCT03287635|101747723|FG000|Overall Study|Lost to Follow-up|5|||
33506243|NCT03287635|101747723|FG000|Overall Study|Withdrawal by Subject|1|||
33506244|NCT03287635|101747723|FG000|Overall Study|Physician Decision|1|||
33506245|NCT01672710|101747724|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
33506246|NCT01672710|101747725|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
33506247|NCT01672710|101747724|FG000|3 Month Follow up|Lost to Follow-up|2|||
33506248|NCT01672710|101747725|FG001|3 Month Follow up|Lost to Follow-up|3|||
33506249|NCT01672710|101747724|FG000|3 Month Follow up|follow up due after termination date|4|||
33506250|NCT01672710|101747725|FG001|3 Month Follow up|follow up due after termination date|1|||
33506251|NCT01068730|101747726|FG000|Period 3|Personal reason|1|||
33506252|NCT01068730|101747727|FG001|Period 3|Personal reason|0|||
33506253|NCT01068730|101747728|FG002|Period 3|Personal reason|0|||
33506254|NCT01068730|101747729|FG003|Period 3|Personal reason|0|||
33506255|NCT01068730|101747726|FG000|Period 4|Family emergency|0|||
33506256|NCT01068730|101747727|FG001|Period 4|Family emergency|1|||
33506257|NCT01068730|101747728|FG002|Period 4|Family emergency|0|||
33506258|NCT01068730|101747729|FG003|Period 4|Family emergency|0|||
33506259|NCT02217410|101747732|FG000|Overall Study|Graft Loss|0|||
33506260|NCT02217410|101747733|FG001|Overall Study|Graft Loss|0|||
33506261|NCT02217410|101747734|FG002|Overall Study|Graft Loss|2|||
33316162|NCT02095951|101050935|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
33316163|NCT01180998|101050936|FG000|Overall Study|Poor Vision|0|||
33316164|NCT01180998|101050937|FG001|Overall Study|Poor Vision|2|||
33316165|NCT01180998|101050938|FG002|Overall Study|Poor Vision|2|||
33316166|NCT01180998|101050936|FG000|Overall Study|Lost to Follow-up|0|||
33397295|NCT02531633|101345748|FG005|Part A (52 Weeks)|Protocol Violation|0|||
33397296|NCT02531633|101345749|FG006|Part A (52 Weeks)|Protocol Violation|0|||
33397297|NCT02531633|101345750|FG007|Part A (52 Weeks)|Protocol Violation|0|||
33397298|NCT02531633|101345751|FG008|Part A (52 Weeks)|Protocol Violation|0|||
33397299|NCT02531633|101345752|FG009|Part A (52 Weeks)|Protocol Violation|0|||
33397300|NCT02531633|101345743|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
33397301|NCT02531633|101345744|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
33397302|NCT02531633|101345745|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
33397303|NCT02531633|101345746|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
33397304|NCT02531633|101345747|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
33397305|NCT02531633|101345748|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
33397306|NCT02531633|101345749|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
33397307|NCT02531633|101345750|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
33397308|NCT02531633|101345751|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
33397309|NCT02531633|101345752|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
33397310|NCT02531633|101345743|FG000|Part A (52 Weeks)|Physician Decision|1|||
33397311|NCT02531633|101345744|FG001|Part A (52 Weeks)|Physician Decision|4|||
33397312|NCT02531633|101345745|FG002|Part A (52 Weeks)|Physician Decision|3|||
33397313|NCT02531633|101345746|FG003|Part A (52 Weeks)|Physician Decision|1|||
33397314|NCT02531633|101345747|FG004|Part A (52 Weeks)|Physician Decision|0|||
33397315|NCT02531633|101345748|FG005|Part A (52 Weeks)|Physician Decision|0|||
33397316|NCT02531633|101345749|FG006|Part A (52 Weeks)|Physician Decision|0|||
33397317|NCT02531633|101345750|FG007|Part A (52 Weeks)|Physician Decision|0|||
33397318|NCT02531633|101345751|FG008|Part A (52 Weeks)|Physician Decision|0|||
33397319|NCT02531633|101345752|FG009|Part A (52 Weeks)|Physician Decision|0|||
33397320|NCT02531633|101345743|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
33397321|NCT02531633|101345744|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
33397322|NCT02531633|101345745|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
33397323|NCT02531633|101345746|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
33397324|NCT02531633|101345747|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
33397325|NCT02531633|101345748|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
33603441|NCT00454649|102099260|FG006|Overall Study|Other|0|||
33397326|NCT02531633|101345749|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
33397327|NCT02531633|101345750|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
33603442|NCT00454649|102099261|FG007|Overall Study|Other|0|||
33603443|NCT00454649|102099262|FG008|Overall Study|Other|3|||
33316167|NCT01180998|101050937|FG001|Overall Study|Lost to Follow-up|0|||
33316168|NCT01180998|101050938|FG002|Overall Study|Lost to Follow-up|1|||
33397328|NCT02531633|101345751|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
33397329|NCT02531633|101345752|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
33397330|NCT02531633|101345743|FG000|Part A (52 Weeks)|Other|2|||
33397331|NCT02531633|101345744|FG001|Part A (52 Weeks)|Other|0|||
33397332|NCT02531633|101345745|FG002|Part A (52 Weeks)|Other|0|||
33397333|NCT02531633|101345746|FG003|Part A (52 Weeks)|Other|0|||
33397334|NCT02531633|101345747|FG004|Part A (52 Weeks)|Other|0|||
33397335|NCT02531633|101345748|FG005|Part A (52 Weeks)|Other|0|||
33397336|NCT02531633|101345749|FG006|Part A (52 Weeks)|Other|0|||
33397337|NCT02531633|101345750|FG007|Part A (52 Weeks)|Other|0|||
33397338|NCT02531633|101345751|FG008|Part A (52 Weeks)|Other|0|||
33397339|NCT02531633|101345752|FG009|Part A (52 Weeks)|Other|0|||
33397340|NCT02531633|101345743|FG000|Part B (104 Weeks)|Sponsor request|0|||
33397341|NCT02531633|101345744|FG001|Part B (104 Weeks)|Sponsor request|0|||
33397342|NCT02531633|101345745|FG002|Part B (104 Weeks)|Sponsor request|0|||
33397343|NCT02531633|101345746|FG003|Part B (104 Weeks)|Sponsor request|0|||
33397344|NCT02531633|101345747|FG004|Part B (104 Weeks)|Sponsor request|0|||
33397345|NCT02531633|101345748|FG005|Part B (104 Weeks)|Sponsor request|8|||
33397346|NCT02531633|101345749|FG006|Part B (104 Weeks)|Sponsor request|5|||
33397347|NCT02531633|101345750|FG007|Part B (104 Weeks)|Sponsor request|3|||
33397348|NCT02531633|101345751|FG008|Part B (104 Weeks)|Sponsor request|5|||
33397349|NCT02531633|101345752|FG009|Part B (104 Weeks)|Sponsor request|4|||
33397350|NCT02531633|101345743|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
33397351|NCT02531633|101345744|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
33397352|NCT02531633|101345745|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
33397353|NCT02531633|101345746|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
33316169|NCT01180998|101050936|FG000|Overall Study|Protocol Violation|1|||
33316170|NCT01180998|101050937|FG001|Overall Study|Protocol Violation|2|||
33316171|NCT01180998|101050938|FG002|Overall Study|Protocol Violation|0|||
33316172|NCT01180998|101050936|FG000|Overall Study|Withdrawal by Subject|0|||
33316173|NCT01180998|101050937|FG001|Overall Study|Withdrawal by Subject|0|||
33316174|NCT01180998|101050938|FG002|Overall Study|Withdrawal by Subject|1|||
33316175|NCT01180998|101050936|FG000|Overall Study|Poor comfort|3|||
33316176|NCT01180998|101050937|FG001|Overall Study|Poor comfort|0|||
33316177|NCT01180998|101050938|FG002|Overall Study|Poor comfort|4|||
33316178|NCT01180998|101050936|FG000|Overall Study|Poor lens handling|0|||
33397354|NCT02531633|101345747|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
33397355|NCT02531633|101345748|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
33397356|NCT02531633|101345749|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
33397357|NCT02531633|101345750|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
33397358|NCT02531633|101345751|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
33397359|NCT02531633|101345752|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
33397360|NCT01948791|101345755|FG000|Overall Study|Adverse Event|12|||
33397361|NCT01948791|101345755|FG000|Overall Study|Lack of Efficacy|3|||
33397362|NCT01948791|101345755|FG000|Overall Study|Protocol Violation|2|||
33397363|NCT01948791|101345755|FG000|Overall Study|Withdrawal by Subject|5|||
33506262|NCT02217410|101747732|FG000|Overall Study|Withdrawal by Subject|0|||
33196006|NCT01181895|100622904|FG001|Overall Study|Lost to Follow-up|1|||
33316179|NCT01180998|101050937|FG001|Overall Study|Poor lens handling|0|||
33397364|NCT01948791|101345755|FG000|Overall Study|Lost to Follow-up|6|||
33397365|NCT01948791|101345755|FG000|Overall Study|Management issues|1|||
33316180|NCT01180998|101050938|FG002|Overall Study|Poor lens handling|2|||
33603444|NCT00454649|102099263|FG009|Overall Study|Other|1|||
33603445|NCT00454649|102099254|FG000|Overall Study|Withdrawal by Subject|0|||
33603446|NCT00454649|102099255|FG001|Overall Study|Withdrawal by Subject|0|||
33603447|NCT00454649|102099256|FG002|Overall Study|Withdrawal by Subject|0|||
33603448|NCT00454649|102099257|FG003|Overall Study|Withdrawal by Subject|0|||
33603449|NCT00454649|102099258|FG004|Overall Study|Withdrawal by Subject|0|||
33603450|NCT00454649|102099259|FG005|Overall Study|Withdrawal by Subject|1|||
33603451|NCT00454649|102099260|FG006|Overall Study|Withdrawal by Subject|0|||
33603452|NCT00454649|102099261|FG007|Overall Study|Withdrawal by Subject|2|||
33603453|NCT00454649|102099262|FG008|Overall Study|Withdrawal by Subject|1|||
33603454|NCT00454649|102099263|FG009|Overall Study|Withdrawal by Subject|0|||
33603455|NCT00693472|102099268|FG000|Part 1|Adverse Event|1|||
33603456|NCT00693472|102099269|FG001|Part 1|Adverse Event|1|||
33603457|NCT00693472|102099270|FG002|Part 1|Adverse Event|0|||
33603458|NCT00693472|102099271|FG003|Part 1|Adverse Event|0|||
33196007|NCT01181895|100622905|FG002|Overall Study|Lost to Follow-up|2|||
33196008|NCT01181895|100622903|FG000|Overall Study|Investigator Discretion|1|||
33196009|NCT01181895|100622904|FG001|Overall Study|Investigator Discretion|2|||
33196010|NCT01181895|100622905|FG002|Overall Study|Investigator Discretion|1|||
33196011|NCT01181895|100622903|FG000|Overall Study|Withdrawal by Subject|3|||
33196012|NCT01181895|100622904|FG001|Overall Study|Withdrawal by Subject|0|||
33196013|NCT01181895|100622905|FG002|Overall Study|Withdrawal by Subject|5|||
33196014|NCT04116229|100622915|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
33196015|NCT04116229|100622916|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
33196016|NCT04116229|100622915|FG000|Overall Study|Scheduling not possible.|0|||
33196017|NCT04116229|100622916|FG001|Overall Study|Scheduling not possible.|1|||
33196018|NCT03003520|100622920|FG000|Overall Study|Adverse Event|9|||
33196019|NCT03003520|100622921|FG001|Overall Study|Adverse Event|0|||
33196020|NCT03003520|100622920|FG000|Overall Study|Death|1|||
33196021|NCT03003520|100622921|FG001|Overall Study|Death|0|||
33196022|NCT03003520|100622920|FG000|Overall Study|Other reasons|4|||
33196023|NCT03003520|100622921|FG001|Overall Study|Other reasons|0|||
33196024|NCT03003520|100622920|FG000|Overall Study|Withdrawal by Subject|6|||
33196025|NCT03003520|100622921|FG001|Overall Study|Withdrawal by Subject|0|||
33196026|NCT03003520|100622920|FG000|Overall Study|Progressive disease|9|||
33196027|NCT03003520|100622921|FG001|Overall Study|Progressive disease|1|||
33196028|NCT02209324|100622922|FG000|Overall Study|Adverse Event|2|||
33196029|NCT02209324|100622922|FG000|Overall Study|Lack of Efficacy|1|||
33196030|NCT02209324|100622922|FG000|Overall Study|Lost to Follow-up|1|||
33196031|NCT02209324|100622922|FG000|Overall Study|Physician Decision|3|||
33196032|NCT02209324|100622922|FG000|Overall Study|Protocol Violation|14|||
33196033|NCT02209324|100622922|FG000|Overall Study|Withdrawal by Subject|8|||
33196034|NCT02209324|100622922|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
33196035|NCT02209324|100622922|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
33196036|NCT02209324|100622922|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
33196037|NCT04776148|100622923|FG000|Overall Study|Death|172|||
33603459|NCT00693472|102099268|FG000|Part 1|Lost to Follow-up|0|||
33603460|NCT00693472|102099269|FG001|Part 1|Lost to Follow-up|1|||
33196038|NCT04776148|100622924|FG001|Overall Study|Death|188|||
33196039|NCT04776148|100622923|FG000|Overall Study|Lost to Follow-up|0|||
33196040|NCT04776148|100622924|FG001|Overall Study|Lost to Follow-up|1|||
33196041|NCT04776148|100622923|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33603461|NCT00693472|102099270|FG002|Part 1|Lost to Follow-up|0|||
33603462|NCT00693472|102099271|FG003|Part 1|Lost to Follow-up|0|||
33196042|NCT04776148|100622924|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33603463|NCT00693472|102099268|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
33603464|NCT00693472|102099269|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
33603465|NCT00693472|102099270|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
33603466|NCT00693472|102099271|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
33603467|NCT00693472|102099268|FG000|Part 2|Adverse Event|0|||
33603468|NCT00693472|102099269|FG001|Part 2|Adverse Event|0|||
33603469|NCT00693472|102099270|FG002|Part 2|Adverse Event|1|||
33603470|NCT00693472|102099271|FG003|Part 2|Adverse Event|0|||
33603471|NCT00693472|102099268|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
33603472|NCT00693472|102099269|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
33603473|NCT00693472|102099270|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
33603474|NCT00693472|102099271|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
33603475|NCT03266172|102099272|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
33603476|NCT03266172|102099273|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
33603477|NCT03266172|102099274|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
33506263|NCT02217410|101747733|FG001|Overall Study|Withdrawal by Subject|0|||
33603478|NCT03266172|102099272|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
33603479|NCT03266172|102099273|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
33603480|NCT03266172|102099274|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
33603481|NCT03266172|102099272|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
33603482|NCT03266172|102099273|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
33603483|NCT03266172|102099274|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
33603484|NCT03266172|102099272|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
33603485|NCT03266172|102099273|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
33603486|NCT03266172|102099274|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
33603487|NCT03266172|102099272|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
33603488|NCT03266172|102099273|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
33603489|NCT03266172|102099274|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
33603490|NCT03266172|102099272|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
33603491|NCT03266172|102099273|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
33603492|NCT03266172|102099274|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
33603493|NCT03374202|102099275|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
33603494|NCT03374202|102099276|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
33603495|NCT03374202|102099277|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
33603496|NCT03374202|102099275|FG000|Five Year Long Term Follow Up|Death|0|||
33603497|NCT03374202|102099276|FG001|Five Year Long Term Follow Up|Death|1|||
33603498|NCT03374202|102099277|FG002|Five Year Long Term Follow Up|Death|0|||
33603499|NCT00840060|102099278|FG000|Overall Study|Withdrawal by Subject|1|||
33196043|NCT04776148|100622923|FG000|Overall Study|Withdrawal by Subject|2|||
33506264|NCT02217410|101747734|FG002|Overall Study|Withdrawal by Subject|2|||
33506265|NCT02217410|101747732|FG000|Overall Study|Lost to Follow-up|0|||
33506266|NCT02217410|101747733|FG001|Overall Study|Lost to Follow-up|0|||
33506267|NCT02217410|101747734|FG002|Overall Study|Lost to Follow-up|1|||
33506268|NCT02217410|101747732|FG000|Overall Study|Lack of Efficacy|0|||
33506269|NCT02217410|101747733|FG001|Overall Study|Lack of Efficacy|1|||
33506270|NCT02217410|101747734|FG002|Overall Study|Lack of Efficacy|0|||
33506271|NCT02217410|101747732|FG000|Overall Study|Physician Decision|1|||
33506272|NCT02217410|101747733|FG001|Overall Study|Physician Decision|3|||
33506273|NCT02217410|101747734|FG002|Overall Study|Physician Decision|0|||
33506274|NCT02609607|101747735|FG000|Overall Study|Lost to Follow-up|0|||
33506275|NCT02609607|101747736|FG001|Overall Study|Lost to Follow-up|1|||
33506276|NCT02424630|101747737|FG000|Overall Study|No rotator cuff tear|1|||
33506277|NCT02424630|101747738|FG001|Overall Study|No rotator cuff tear|2|||
33506278|NCT02424630|101747737|FG000|Overall Study|Open procedure|0|||
33506279|NCT02424630|101747738|FG001|Overall Study|Open procedure|1|||
33506280|NCT01683266|101747741|FG000|Overall Study|Adverse Event|5|||
33506281|NCT01683266|101747742|FG001|Overall Study|Adverse Event|4|||
33506282|NCT01683266|101747741|FG000|Overall Study|Lack of Efficacy|5|||
33506283|NCT01683266|101747742|FG001|Overall Study|Lack of Efficacy|2|||
33506284|NCT01683266|101747741|FG000|Overall Study|Protocol Violation|13|||
33506285|NCT01683266|101747742|FG001|Overall Study|Protocol Violation|6|||
33506286|NCT01683266|101747741|FG000|Overall Study|Personal Reason|17|||
33506287|NCT01683266|101747742|FG001|Overall Study|Personal Reason|25|||
33506288|NCT01683266|101747741|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
33603500|NCT00840060|102099279|FG001|Overall Study|Withdrawal by Subject|0|||
33603501|NCT00840060|102099278|FG000|Overall Study|Change in emotional/behavioral status|0|||
33603502|NCT00840060|102099279|FG001|Overall Study|Change in emotional/behavioral status|1|||
33196044|NCT04776148|100622924|FG001|Overall Study|Withdrawal by Subject|4|||
33196045|NCT04776148|100622923|FG000|Overall Study|Ongoing in Study|67|||
33506289|NCT01683266|101747742|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
33506290|NCT01683266|101747741|FG000|Overall Study|Lost to Follow-up|5|||
33506291|NCT01683266|101747742|FG001|Overall Study|Lost to Follow-up|0|||
33506292|NCT01683266|101747741|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
33506293|NCT01683266|101747742|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
33506294|NCT01683266|101747741|FG000|Overall Study|Nonserious Hypoglycemia|0|||
33603503|NCT01600053|102099280|FG000|Overall Study|Adverse Event|2|||
33603504|NCT01600053|102099280|FG000|Overall Study|trial will not meet the interim endpoint|9|||
33603505|NCT01287195|102099281|FG000|Overall Study|Withdrawal by Subject|2|||
33603506|NCT00330668|102099284|FG000|BID Dosing Period|Adverse Event|1|||
33603507|NCT00330668|102099284|FG000|BID Dosing Period|Lost to Follow-up|7|||
33603508|NCT00330668|102099284|FG000|BID Dosing Period|Non-Compliance|5|||
33603509|NCT00330668|102099284|FG000|BID Dosing Period|Withdrawal by Subject|19|||
33603510|NCT00330668|102099284|FG000|BID Dosing Period|Sponsor's decision|1|||
33603511|NCT00330668|102099284|FG000|BID Dosing Period|Other|3|||
33603512|NCT00330668|102099284|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
33603513|NCT00330668|102099284|FG000|QD Dosing Period|Other|1|||
33603514|NCT00330668|102099284|FG000|QD Dosing Period|Withdrawal by Subject|1|||
33603515|NCT00330668|102099284|FG000|QD Dosing Period|Lost to Follow-up|2|||
33603516|NCT03323736|102099285|FG000|Overall Study|Screen Failure|14|||
33603517|NCT03323736|102099286|FG001|Overall Study|Screen Failure|9|||
33603518|NCT03323736|102099287|FG002|Overall Study|Screen Failure|1|||
33603519|NCT03323736|102099285|FG000|Overall Study|Withdrawal Before Treatment|3|||
33603520|NCT03323736|102099286|FG001|Overall Study|Withdrawal Before Treatment|1|||
33603521|NCT03323736|102099287|FG002|Overall Study|Withdrawal Before Treatment|1|||
33603522|NCT03323736|102099285|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
33603523|NCT03323736|102099286|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
33603524|NCT03323736|102099287|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
33603525|NCT01827332|102099288|FG000|Overall Study|Lost to Follow-up|2|||
33603526|NCT01827332|102099289|FG001|Overall Study|Lost to Follow-up|1|||
33603527|NCT03684694|102099292|FG000|Phase 1|Withdrawal by Subject|1|||
33603528|NCT03684694|102099293|FG001|Phase 1|Withdrawal by Subject|0|||
33603529|NCT03684694|102099294|FG002|Phase 1|Withdrawal by Subject|0|||
33603530|NCT03684694|102099295|FG003|Phase 1|Withdrawal by Subject|0|||
33603531|NCT03684694|102099296|FG004|Phase 1|Withdrawal by Subject|0|||
33603532|NCT03684694|102099297|FG005|Phase 1|Withdrawal by Subject|0|||
33603533|NCT03684694|102099292|FG000|Phase 1|Investigator/Sponsor Decision|12|||
33603534|NCT03684694|102099293|FG001|Phase 1|Investigator/Sponsor Decision|2|||
33603535|NCT03684694|102099294|FG002|Phase 1|Investigator/Sponsor Decision|1|||
33603536|NCT03684694|102099295|FG003|Phase 1|Investigator/Sponsor Decision|0|||
33603537|NCT03684694|102099296|FG004|Phase 1|Investigator/Sponsor Decision|0|||
33603538|NCT03684694|102099297|FG005|Phase 1|Investigator/Sponsor Decision|0|||
33603539|NCT03684694|102099292|FG000|Phase 1|Death|24|||
33603540|NCT03684694|102099293|FG001|Phase 1|Death|0|||
33603541|NCT03684694|102099294|FG002|Phase 1|Death|3|||
33603542|NCT03684694|102099295|FG003|Phase 1|Death|0|||
33603543|NCT03684694|102099296|FG004|Phase 1|Death|0|||
33603544|NCT03684694|102099297|FG005|Phase 1|Death|0|||
33603545|NCT03684694|102099292|FG000|Phase 1|Lost to Follow-up|0|||
33603546|NCT03684694|102099293|FG001|Phase 1|Lost to Follow-up|0|||
33316181|NCT00320541|101050941|FG000|Overall Study|Adverse Event|21|||
33316182|NCT00320541|101050942|FG001|Overall Study|Adverse Event|19|||
33316183|NCT00320541|101050941|FG000|Overall Study|Protocol Violation|0|||
33316184|NCT00320541|101050942|FG001|Overall Study|Protocol Violation|1|||
33316185|NCT00320541|101050941|FG000|Overall Study|Withdrawal by Subject|12|||
33316186|NCT00320541|101050942|FG001|Overall Study|Withdrawal by Subject|16|||
33316187|NCT00320541|101050941|FG000|Overall Study|Physician Decision|9|||
33316188|NCT00320541|101050942|FG001|Overall Study|Physician Decision|13|||
33316189|NCT00320541|101050941|FG000|Overall Study|Other|3|||
33316190|NCT00320541|101050942|FG001|Overall Study|Other|4|||
33316191|NCT00320541|101050941|FG000|Overall Study|Sponsor Decision|2|||
33316192|NCT00320541|101050942|FG001|Overall Study|Sponsor Decision|1|||
33316193|NCT00320541|101050941|FG000|Overall Study|Death due to Study Disease|1|||
33316194|NCT00320541|101050942|FG001|Overall Study|Death due to Study Disease|3|||
33316195|NCT00320541|101050941|FG000|Overall Study|Death due to Adverse Event(s)|1|||
33316196|NCT00320541|101050942|FG001|Overall Study|Death due to Adverse Event(s)|0|||
33397366|NCT01948791|101345755|FG000|Overall Study|Others|7|||
33603547|NCT03684694|102099294|FG002|Phase 1|Lost to Follow-up|1|||
33603548|NCT03684694|102099295|FG003|Phase 1|Lost to Follow-up|0|||
33603549|NCT03684694|102099296|FG004|Phase 1|Lost to Follow-up|0|||
33603550|NCT03684694|102099297|FG005|Phase 1|Lost to Follow-up|0|||
33603551|NCT03684694|102099292|FG000|Phase 1|Miscellaneous|0|||
33603552|NCT03684694|102099293|FG001|Phase 1|Miscellaneous|1|||
33603553|NCT03684694|102099294|FG002|Phase 1|Miscellaneous|0|||
33603554|NCT03684694|102099295|FG003|Phase 1|Miscellaneous|0|||
33603555|NCT03684694|102099296|FG004|Phase 1|Miscellaneous|0|||
33603556|NCT03684694|102099297|FG005|Phase 1|Miscellaneous|0|||
33603557|NCT03684694|102099292|FG000|Phase 2|Withdrawal by Subject|0|||
33603558|NCT03684694|102099293|FG001|Phase 2|Withdrawal by Subject|0|||
33603559|NCT03684694|102099294|FG002|Phase 2|Withdrawal by Subject|0|||
33603560|NCT03684694|102099295|FG003|Phase 2|Withdrawal by Subject|0|||
33603561|NCT03684694|102099296|FG004|Phase 2|Withdrawal by Subject|0|||
33316197|NCT00320541|101050941|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
33316198|NCT00320541|101050942|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
33316199|NCT03278106|101050943|FG000|Overall Study|No protocol treatment|1|||
33397367|NCT01948791|101345755|FG000|Overall Study|Screening failure|35|||
33316200|NCT01340196|101050944|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
33316201|NCT01477333|101050945|FG000|Overall Study|Adverse Event|1|||
33316202|NCT01477333|101050945|FG000|Overall Study|Withdrawal by Subject|1|||
33316203|NCT01477333|101050945|FG000|Overall Study|Clinical Deterioration|1|||
33316204|NCT01498289|101050948|FG000|Overall Study|Adverse Event|16|||
33316205|NCT01498289|101050949|FG001|Overall Study|Adverse Event|18|||
33316206|NCT01498289|101050948|FG000|Overall Study|Death|6|||
33316207|NCT01498289|101050949|FG001|Overall Study|Death|8|||
33316208|NCT01498289|101050948|FG000|Overall Study|Withdrawal unrelated to AE|16|||
33316209|NCT01498289|101050949|FG001|Overall Study|Withdrawal unrelated to AE|16|||
33316210|NCT01498289|101050948|FG000|Overall Study|Progression/relapse|53|||
33316211|NCT01498289|101050949|FG001|Overall Study|Progression/relapse|59|||
33316212|NCT01498289|101050948|FG000|Overall Study|Not protocol specified|7|||
33316213|NCT01498289|101050949|FG001|Overall Study|Not protocol specified|2|||
33316214|NCT01498289|101050948|FG000|Overall Study|Reason under review|0|||
33316215|NCT01498289|101050949|FG001|Overall Study|Reason under review|1|||
33316216|NCT01078675|101050952|FG000|Overall Study|Withdrawal by Subject|7|||
33316217|NCT01078675|101050953|FG001|Overall Study|Withdrawal by Subject|3|||
33316218|NCT01078675|101050952|FG000|Overall Study|Protocol Violation|56|||
33316219|NCT01078675|101050953|FG001|Overall Study|Protocol Violation|0|||
33316220|NCT01078675|101050952|FG000|Overall Study|Provided in CRF for specific reasons|2|||
33316221|NCT01078675|101050953|FG001|Overall Study|Provided in CRF for specific reasons|3|||
33316222|NCT01078675|101050952|FG000|Overall Study|Adverse Event|3|||
33316223|NCT01078675|101050953|FG001|Overall Study|Adverse Event|0|||
33316224|NCT00409773|101050954|FG000|Overall Study|Adverse Event|3|||
33316225|NCT00409773|101050955|FG001|Overall Study|Adverse Event|4|||
33316226|NCT00409773|101050956|FG002|Overall Study|Adverse Event|4|||
33316227|NCT00409773|101050957|FG003|Overall Study|Adverse Event|2|||
33316228|NCT00409773|101050958|FG004|Overall Study|Adverse Event|6|||
33316229|NCT00409773|101050954|FG000|Overall Study|Lost to Follow-up|6|||
33316230|NCT00409773|101050955|FG001|Overall Study|Lost to Follow-up|1|||
33316231|NCT00409773|101050956|FG002|Overall Study|Lost to Follow-up|2|||
33316232|NCT00409773|101050957|FG003|Overall Study|Lost to Follow-up|3|||
33316233|NCT00409773|101050958|FG004|Overall Study|Lost to Follow-up|1|||
33506295|NCT01683266|101747742|FG001|Overall Study|Nonserious Hypoglycemia|3|||
33506296|NCT01683266|101747741|FG000|Overall Study|Perceived Lack of Efficacy|1|||
33506297|NCT01683266|101747742|FG001|Overall Study|Perceived Lack of Efficacy|1|||
33506298|NCT01683266|101747741|FG000|Overall Study|Possibly Hypoglycemia|1|||
33506299|NCT01683266|101747742|FG001|Overall Study|Possibly Hypoglycemia|0|||
33603562|NCT03684694|102099297|FG005|Phase 2|Withdrawal by Subject|1|||
33603563|NCT03684694|102099292|FG000|Phase 2|Investigator/Sponsor Decision|0|||
33603564|NCT03684694|102099293|FG001|Phase 2|Investigator/Sponsor Decision|0|||
33603565|NCT03684694|102099294|FG002|Phase 2|Investigator/Sponsor Decision|0|||
33603566|NCT03684694|102099295|FG003|Phase 2|Investigator/Sponsor Decision|17|||
33603567|NCT03684694|102099296|FG004|Phase 2|Investigator/Sponsor Decision|16|||
33603568|NCT03684694|102099297|FG005|Phase 2|Investigator/Sponsor Decision|6|||
33603569|NCT03684694|102099292|FG000|Phase 2|Death|0|||
33603570|NCT03684694|102099293|FG001|Phase 2|Death|0|||
33603571|NCT03684694|102099294|FG002|Phase 2|Death|0|||
33603572|NCT03684694|102099295|FG003|Phase 2|Death|28|||
33506300|NCT01683266|101747741|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
33506301|NCT01683266|101747742|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
33506302|NCT01857583|101747743|FG000|Overall Study|Adverse Event|0|||
33506303|NCT01857583|101747744|FG001|Overall Study|Adverse Event|0|||
33506304|NCT01857583|101747745|FG002|Overall Study|Adverse Event|1|||
33506305|NCT01857583|101747746|FG003|Overall Study|Adverse Event|1|||
33506306|NCT01857583|101747743|FG000|Overall Study|Death|0|||
33506307|NCT01857583|101747744|FG001|Overall Study|Death|1|||
33506308|NCT01857583|101747745|FG002|Overall Study|Death|1|||
33506309|NCT01857583|101747746|FG003|Overall Study|Death|0|||
33506310|NCT01857583|101747743|FG000|Overall Study|Physician Decision|0|||
33506311|NCT01857583|101747744|FG001|Overall Study|Physician Decision|0|||
33603573|NCT03684694|102099296|FG004|Phase 2|Death|14|||
33316234|NCT00409773|101050954|FG000|Overall Study|Physician Decision|0|||
33316235|NCT00409773|101050955|FG001|Overall Study|Physician Decision|0|||
33316236|NCT00409773|101050956|FG002|Overall Study|Physician Decision|0|||
33316237|NCT00409773|101050957|FG003|Overall Study|Physician Decision|2|||
33316238|NCT00409773|101050958|FG004|Overall Study|Physician Decision|0|||
33316239|NCT00409773|101050954|FG000|Overall Study|Protocol Violation|0|||
33316240|NCT00409773|101050955|FG001|Overall Study|Protocol Violation|2|||
33506312|NCT01857583|101747745|FG002|Overall Study|Physician Decision|0|||
33603574|NCT03684694|102099297|FG005|Phase 2|Death|3|||
33397368|NCT00405275|101345756|FG000|Overall Study|Death|1|||
33397369|NCT00405275|101345757|FG001|Overall Study|Death|0|||
33397370|NCT00405275|101345756|FG000|Overall Study|Lost to Follow-up|5|||
33397371|NCT00405275|101345757|FG001|Overall Study|Lost to Follow-up|1|||
33397372|NCT00405275|101345756|FG000|Overall Study|Withdrawal by Subject|7|||
33397373|NCT00405275|101345757|FG001|Overall Study|Withdrawal by Subject|9|||
33397374|NCT00405275|101345756|FG000|Overall Study|Unwilling to continue|10|||
33397375|NCT00405275|101345757|FG001|Overall Study|Unwilling to continue|9|||
33397376|NCT00366444|101345758|FG000|Overall Study|Withdrawal by Subject|1|||
33397377|NCT00366444|101345759|FG001|Overall Study|Withdrawal by Subject|1|||
33397378|NCT00366444|101345758|FG000|Overall Study|Lack of Efficacy|0|||
33397379|NCT00366444|101345759|FG001|Overall Study|Lack of Efficacy|1|||
33397380|NCT01289028|101345760|FG000|Overall Study|Progressive Disease|49|||
33397381|NCT01289028|101345760|FG000|Overall Study|Adverse Event|14|||
33397382|NCT01289028|101345760|FG000|Overall Study|Withdrawal by Subject|6|||
33397383|NCT01289028|101345760|FG000|Overall Study|Death|4|||
33397384|NCT01289028|101345760|FG000|Overall Study|Lack of Efficacy|2|||
33397385|NCT01289028|101345760|FG000|Overall Study|No longer required|2|||
33506313|NCT01857583|101747746|FG003|Overall Study|Physician Decision|1|||
33506314|NCT01857583|101747743|FG000|Overall Study|Withdrawal by Subject|1|||
33506315|NCT01857583|101747744|FG001|Overall Study|Withdrawal by Subject|0|||
33506316|NCT01857583|101747745|FG002|Overall Study|Withdrawal by Subject|1|||
33603575|NCT03684694|102099292|FG000|Phase 2|Lost to Follow-up|0|||
33603576|NCT03684694|102099293|FG001|Phase 2|Lost to Follow-up|0|||
33603577|NCT03684694|102099294|FG002|Phase 2|Lost to Follow-up|0|||
33603578|NCT03684694|102099295|FG003|Phase 2|Lost to Follow-up|1|||
33603579|NCT03684694|102099296|FG004|Phase 2|Lost to Follow-up|0|||
33603580|NCT03684694|102099297|FG005|Phase 2|Lost to Follow-up|0|||
33603581|NCT03684694|102099292|FG000|Phase 2|Miscellaneous|0|||
33603582|NCT03684694|102099293|FG001|Phase 2|Miscellaneous|0|||
33603583|NCT03684694|102099294|FG002|Phase 2|Miscellaneous|0|||
33603584|NCT03684694|102099295|FG003|Phase 2|Miscellaneous|3|||
33603585|NCT03684694|102099296|FG004|Phase 2|Miscellaneous|0|||
33603586|NCT03684694|102099297|FG005|Phase 2|Miscellaneous|0|||
33603587|NCT00582738|102099298|FG000|Overall Study|Administrative Problems|7|||
33603588|NCT00582738|102099299|FG001|Overall Study|Administrative Problems|8|||
33603589|NCT00582738|102099298|FG000|Overall Study|Adverse Event|0|||
33603590|NCT00582738|102099299|FG001|Overall Study|Adverse Event|5|||
33603591|NCT00582738|102099298|FG000|Overall Study|Graft Lost|0|||
33603592|NCT00582738|102099299|FG001|Overall Study|Graft Lost|1|||
33506317|NCT01857583|101747746|FG003|Overall Study|Withdrawal by Subject|2|||
33506318|NCT01780038|101747747|FG000|Overall Study|Lost to Follow-up|4|||
33506319|NCT01780038|101747748|FG001|Overall Study|Lost to Follow-up|1|||
33506320|NCT00568061|101747754|FG000|Overall Study|Inclusion / exclusion criteria|5|||
33506321|NCT00568061|101747755|FG001|Overall Study|Inclusion / exclusion criteria|1|||
33506322|NCT00568061|101747754|FG000|Overall Study|Adverse Event|0|||
33506323|NCT00568061|101747755|FG001|Overall Study|Adverse Event|1|||
33603593|NCT00582738|102099298|FG000|Overall Study|Other|1|||
33603594|NCT00582738|102099299|FG001|Overall Study|Other|0|||
33603595|NCT00582738|102099298|FG000|Overall Study|Protocol Violation|1|||
33603596|NCT00582738|102099299|FG001|Overall Study|Protocol Violation|1|||
33603597|NCT00582738|102099298|FG000|Overall Study|Withdrawal by Subject|0|||
33603598|NCT00582738|102099299|FG001|Overall Study|Withdrawal by Subject|3|||
33603599|NCT01114360|102099307|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
33603600|NCT01114360|102099308|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
33603601|NCT00262847|102099309|FG000|Overall Study|Disease Progression|309|||
33603602|NCT00262847|102099310|FG001|Overall Study|Disease Progression|274|||
33603603|NCT00262847|102099311|FG002|Overall Study|Disease Progression|195|||
33603604|NCT00262847|102099309|FG000|Overall Study|Patient Refusal|41|||
33603605|NCT00262847|102099310|FG001|Overall Study|Patient Refusal|52|||
33603606|NCT00262847|102099311|FG002|Overall Study|Patient Refusal|47|||
33603607|NCT00262847|102099309|FG000|Overall Study|Adverse Event|74|||
33603608|NCT00262847|102099310|FG001|Overall Study|Adverse Event|88|||
33506324|NCT04470544|101747756|FG000|Overall Study|Withdrawal by Subject|4|||
33603609|NCT00262847|102099311|FG002|Overall Study|Adverse Event|108|||
33603610|NCT00262847|102099309|FG000|Overall Study|Death|8|||
33506325|NCT04470544|101747757|FG001|Overall Study|Withdrawal by Subject|6|||
33603611|NCT00262847|102099310|FG001|Overall Study|Death|8|||
33603612|NCT00262847|102099311|FG002|Overall Study|Death|11|||
33603613|NCT00262847|102099309|FG000|Overall Study|Concomitant disease|3|||
33603614|NCT00262847|102099310|FG001|Overall Study|Concomitant disease|2|||
33603615|NCT00262847|102099311|FG002|Overall Study|Concomitant disease|4|||
33603616|NCT00262847|102099309|FG000|Overall Study|Other Reasons|79|||
33603617|NCT00262847|102099310|FG001|Overall Study|Other Reasons|88|||
33397386|NCT01289028|101345760|FG000|Overall Study|Lost to Follow-up|2|||
33397387|NCT01289028|101345760|FG000|Overall Study|New Cancer Therapy|2|||
33397388|NCT01289028|101345760|FG000|Overall Study|Abnormal Lab Value|1|||
33397389|NCT01289028|101345760|FG000|Overall Study|Missing reason for discon|1|||
33603618|NCT00262847|102099311|FG002|Overall Study|Other Reasons|27|||
33603619|NCT00262847|102099309|FG000|Overall Study|Did not receive study treatment|4|||
33603620|NCT00262847|102099310|FG001|Overall Study|Did not receive study treatment|1|||
33603621|NCT00262847|102099311|FG002|Overall Study|Did not receive study treatment|4|||
33603622|NCT01719003|102099320|FG000|Overall Study|Non compliant with protocol|1|||
33603623|NCT01719003|102099321|FG001|Overall Study|Non compliant with protocol|1|||
33603624|NCT01719003|102099322|FG002|Overall Study|Non compliant with protocol|0|||
33603625|NCT01719003|102099323|FG003|Overall Study|Non compliant with protocol|1|||
33603626|NCT01719003|102099324|FG004|Overall Study|Non compliant with protocol|2|||
33603627|NCT01719003|102099325|FG005|Overall Study|Non compliant with protocol|1|||
33603628|NCT01719003|102099326|FG006|Overall Study|Non compliant with protocol|2|||
33603629|NCT01719003|102099327|FG007|Overall Study|Non compliant with protocol|3|||
33603630|NCT01719003|102099328|FG008|Overall Study|Non compliant with protocol|0|||
33603631|NCT01719003|102099320|FG000|Overall Study|Adverse Event|6|||
33603632|NCT01719003|102099321|FG001|Overall Study|Adverse Event|5|||
33603633|NCT01719003|102099322|FG002|Overall Study|Adverse Event|4|||
33603634|NCT01719003|102099323|FG003|Overall Study|Adverse Event|3|||
33603635|NCT01719003|102099324|FG004|Overall Study|Adverse Event|4|||
33603636|NCT01719003|102099325|FG005|Overall Study|Adverse Event|3|||
33603637|NCT01719003|102099326|FG006|Overall Study|Adverse Event|6|||
33603638|NCT01719003|102099327|FG007|Overall Study|Adverse Event|5|||
33603639|NCT01719003|102099328|FG008|Overall Study|Adverse Event|0|||
33603640|NCT01719003|102099320|FG000|Overall Study|Lost to Follow-up|0|||
33603641|NCT01719003|102099321|FG001|Overall Study|Lost to Follow-up|6|||
33603642|NCT01719003|102099322|FG002|Overall Study|Lost to Follow-up|7|||
33603643|NCT01719003|102099323|FG003|Overall Study|Lost to Follow-up|2|||
33603644|NCT01719003|102099324|FG004|Overall Study|Lost to Follow-up|3|||
33603645|NCT01719003|102099325|FG005|Overall Study|Lost to Follow-up|4|||
33603646|NCT01719003|102099326|FG006|Overall Study|Lost to Follow-up|3|||
33316241|NCT00409773|101050956|FG002|Overall Study|Protocol Violation|3|||
33316242|NCT00409773|101050957|FG003|Overall Study|Protocol Violation|3|||
33603647|NCT01719003|102099327|FG007|Overall Study|Lost to Follow-up|2|||
33603648|NCT01719003|102099328|FG008|Overall Study|Lost to Follow-up|2|||
33603649|NCT01719003|102099320|FG000|Overall Study|Refusal to continue, not due to AE|2|||
33603650|NCT01719003|102099321|FG001|Overall Study|Refusal to continue, not due to AE|5|||
33603651|NCT01719003|102099322|FG002|Overall Study|Refusal to continue, not due to AE|4|||
33603652|NCT01719003|102099323|FG003|Overall Study|Refusal to continue, not due to AE|4|||
33603653|NCT01719003|102099324|FG004|Overall Study|Refusal to continue, not due to AE|4|||
33603654|NCT01719003|102099325|FG005|Overall Study|Refusal to continue, not due to AE|3|||
33603655|NCT01719003|102099326|FG006|Overall Study|Refusal to continue, not due to AE|8|||
33506326|NCT02993250|101747758|FG000|Overall Study|Lost to Follow-up|0|||
33506327|NCT02993250|101747759|FG001|Overall Study|Lost to Follow-up|1|||
33506328|NCT00638404|101747760|FG000|Overall Study|Physician Decision|8|||
33506329|NCT00638404|101747761|FG001|Overall Study|Physician Decision|0|||
33506330|NCT04531462|101747762|FG000|Overall Study|Withdrawal by Subject|3|||
33506331|NCT04531462|101747763|FG001|Overall Study|Withdrawal by Subject|1|||
33506332|NCT04531462|101747762|FG000|Overall Study|Adverse Event|3|||
33506333|NCT04531462|101747763|FG001|Overall Study|Adverse Event|3|||
33506334|NCT01736397|101747764|FG000|Overall Study|Lack of Efficacy|1|||
33506335|NCT01736397|101747765|FG001|Overall Study|Lack of Efficacy|11|||
33506336|NCT01736397|101747764|FG000|Overall Study|Withdrawal by Subject|6|||
33506337|NCT01736397|101747765|FG001|Overall Study|Withdrawal by Subject|5|||
33506338|NCT01736397|101747764|FG000|Overall Study|Lost to Follow-up|0|||
33506339|NCT01736397|101747765|FG001|Overall Study|Lost to Follow-up|1|||
33506340|NCT01736397|101747764|FG000|Overall Study|Adverse Event|6|||
33506341|NCT01736397|101747765|FG001|Overall Study|Adverse Event|3|||
33506342|NCT01736397|101747764|FG000|Overall Study|Not stated|1|||
33506343|NCT01736397|101747765|FG001|Overall Study|Not stated|4|||
33506344|NCT02438826|101747766|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
33506345|NCT02438826|101747767|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
33506346|NCT02438826|101747768|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
33506347|NCT02438826|101747769|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
33506348|NCT02438826|101747766|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
33506349|NCT02438826|101747767|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
33506350|NCT02438826|101747768|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
33506351|NCT02438826|101747769|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
33506352|NCT02438826|101747766|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
33506353|NCT02438826|101747767|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
33506354|NCT02438826|101747768|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
33506355|NCT02438826|101747769|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
33506356|NCT02438826|101747766|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
33506357|NCT02438826|101747767|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
33506358|NCT02438826|101747768|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
33506359|NCT02438826|101747769|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
33506360|NCT02438826|101747766|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
33506361|NCT02438826|101747767|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
33506362|NCT02438826|101747768|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
33506363|NCT02438826|101747769|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
33316243|NCT00409773|101050958|FG004|Overall Study|Protocol Violation|1|||
33506364|NCT02438826|101747766|FG000|Open-Label Treatment Phase|Adverse Event|11|||
33506365|NCT02438826|101747767|FG001|Open-Label Treatment Phase|Adverse Event|6|||
33506366|NCT02438826|101747768|FG002|Open-Label Treatment Phase|Adverse Event|0|||
33506367|NCT02438826|101747769|FG003|Open-Label Treatment Phase|Adverse Event|0|||
33506368|NCT02438826|101747766|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
33506369|NCT02438826|101747767|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
33506370|NCT02438826|101747768|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
33506371|NCT02438826|101747769|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
33316244|NCT00409773|101050954|FG000|Overall Study|Withdrawal by Subject|0|||
33316245|NCT00409773|101050955|FG001|Overall Study|Withdrawal by Subject|0|||
33603656|NCT01719003|102099327|FG007|Overall Study|Refusal to continue, not due to AE|7|||
33603657|NCT01719003|102099328|FG008|Overall Study|Refusal to continue, not due to AE|1|||
33603658|NCT01719003|102099320|FG000|Overall Study|Reason other than those specified|0|||
33603659|NCT01719003|102099321|FG001|Overall Study|Reason other than those specified|0|||
33603660|NCT01719003|102099322|FG002|Overall Study|Reason other than those specified|2|||
33603661|NCT01719003|102099323|FG003|Overall Study|Reason other than those specified|3|||
33603662|NCT01719003|102099324|FG004|Overall Study|Reason other than those specified|4|||
33603663|NCT01719003|102099325|FG005|Overall Study|Reason other than those specified|1|||
33603664|NCT01719003|102099326|FG006|Overall Study|Reason other than those specified|0|||
33603665|NCT01719003|102099327|FG007|Overall Study|Reason other than those specified|3|||
33603666|NCT01719003|102099328|FG008|Overall Study|Reason other than those specified|1|||
33603667|NCT01719003|102099320|FG000|Overall Study|Lack of Efficacy|0|||
33603668|NCT01719003|102099321|FG001|Overall Study|Lack of Efficacy|0|||
33603669|NCT01719003|102099322|FG002|Overall Study|Lack of Efficacy|0|||
33603670|NCT01719003|102099323|FG003|Overall Study|Lack of Efficacy|0|||
33603671|NCT01719003|102099324|FG004|Overall Study|Lack of Efficacy|0|||
33603672|NCT01719003|102099325|FG005|Overall Study|Lack of Efficacy|0|||
33603673|NCT01719003|102099326|FG006|Overall Study|Lack of Efficacy|1|||
33603674|NCT01719003|102099327|FG007|Overall Study|Lack of Efficacy|0|||
33603675|NCT01719003|102099328|FG008|Overall Study|Lack of Efficacy|0|||
33603676|NCT02258529|102099330|FG000|Overall Study|Study Terminated by Sponsor|9|||
33603677|NCT02258529|102099330|FG000|Overall Study|Adverse Event|1|||
33603678|NCT01146288|102099331|FG000|First Intervention(1 Day)|Adverse Event|0|||
33603679|NCT01146288|102099332|FG001|First Intervention(1 Day)|Adverse Event|1|||
33603680|NCT03529110|102099336|FG000|Overall Study|Progressive Disease|66|||
33603681|NCT03529110|102099337|FG001|Overall Study|Progressive Disease|158|||
33603682|NCT03529110|102099336|FG000|Overall Study|Clinical Progression|4|||
33603683|NCT03529110|102099337|FG001|Overall Study|Clinical Progression|12|||
33603684|NCT03529110|102099336|FG000|Overall Study|Adverse Event|35|||
33603685|NCT03529110|102099337|FG001|Overall Study|Adverse Event|17|||
33603686|NCT03529110|102099336|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
33603687|NCT03529110|102099337|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
33603688|NCT03529110|102099336|FG000|Overall Study|Lack of Efficacy|3|||
33603689|NCT03529110|102099337|FG001|Overall Study|Lack of Efficacy|3|||
33603690|NCT03529110|102099336|FG000|Overall Study|Physician Decision|2|||
33603691|NCT03529110|102099337|FG001|Overall Study|Physician Decision|8|||
33603692|NCT03529110|102099336|FG000|Overall Study|Miscellaneous|2|||
33603693|NCT03529110|102099337|FG001|Overall Study|Miscellaneous|5|||
33603694|NCT00870194|102099343|FG000|Overall Study|Adverse Event|10|||
33603695|NCT00870194|102099344|FG001|Overall Study|Adverse Event|5|||
33603696|NCT00870194|102099343|FG000|Overall Study|Lack of Efficacy|0|||
33603697|NCT00870194|102099344|FG001|Overall Study|Lack of Efficacy|1|||
33603698|NCT00870194|102099343|FG000|Overall Study|Lost to Follow-up|2|||
33603699|NCT00870194|102099344|FG001|Overall Study|Lost to Follow-up|0|||
33603700|NCT00870194|102099343|FG000|Overall Study|Physician Decision|3|||
33603701|NCT00870194|102099344|FG001|Overall Study|Physician Decision|1|||
33603702|NCT00870194|102099343|FG000|Overall Study|Protocol Violation|3|||
33603703|NCT00870194|102099344|FG001|Overall Study|Protocol Violation|3|||
33603704|NCT00870194|102099343|FG000|Overall Study|Entry Criteria Not Met|1|||
33603705|NCT00870194|102099344|FG001|Overall Study|Entry Criteria Not Met|2|||
33603706|NCT00870194|102099343|FG000|Overall Study|Subject Decision|7|||
33603707|NCT00870194|102099344|FG001|Overall Study|Subject Decision|2|||
33603708|NCT01443130|102099347|FG000|Overall Study|Lost to Follow-up|44|||
33603709|NCT01443130|102099348|FG001|Overall Study|Lost to Follow-up|42|||
33506372|NCT02438826|101747766|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
33603710|NCT01443130|102099349|FG002|Overall Study|Lost to Follow-up|50|||
33603711|NCT01443130|102099350|FG003|Overall Study|Lost to Follow-up|23|||
33603712|NCT01443130|102099351|FG004|Overall Study|Lost to Follow-up|25|||
33603713|NCT01443130|102099352|FG005|Overall Study|Lost to Follow-up|21|||
33603714|NCT01443130|102099347|FG000|Overall Study|Death|0|||
33603715|NCT01443130|102099348|FG001|Overall Study|Death|1|||
33603716|NCT01443130|102099349|FG002|Overall Study|Death|0|||
33603717|NCT01443130|102099350|FG003|Overall Study|Death|7|||
33603718|NCT01443130|102099351|FG004|Overall Study|Death|10|||
33603719|NCT01443130|102099352|FG005|Overall Study|Death|8|||
33603720|NCT01443130|102099347|FG000|Overall Study|Adverse Event|2|||
33603721|NCT01443130|102099348|FG001|Overall Study|Adverse Event|1|||
33603722|NCT01443130|102099349|FG002|Overall Study|Adverse Event|1|||
33603723|NCT01443130|102099350|FG003|Overall Study|Adverse Event|0|||
33603724|NCT01443130|102099351|FG004|Overall Study|Adverse Event|0|||
33603725|NCT01443130|102099352|FG005|Overall Study|Adverse Event|0|||
33603726|NCT01443130|102099347|FG000|Overall Study|Protocol Violation|2|||
33603727|NCT01443130|102099348|FG001|Overall Study|Protocol Violation|1|||
33603728|NCT01443130|102099349|FG002|Overall Study|Protocol Violation|3|||
33603729|NCT01443130|102099350|FG003|Overall Study|Protocol Violation|2|||
33603730|NCT01443130|102099351|FG004|Overall Study|Protocol Violation|2|||
33603731|NCT01443130|102099352|FG005|Overall Study|Protocol Violation|3|||
33603732|NCT01443130|102099347|FG000|Overall Study|Withdrawal by Subject|15|||
33603733|NCT01443130|102099348|FG001|Overall Study|Withdrawal by Subject|14|||
33603734|NCT01443130|102099349|FG002|Overall Study|Withdrawal by Subject|12|||
33603735|NCT01443130|102099350|FG003|Overall Study|Withdrawal by Subject|7|||
33603736|NCT01443130|102099351|FG004|Overall Study|Withdrawal by Subject|7|||
33603737|NCT01443130|102099352|FG005|Overall Study|Withdrawal by Subject|2|||
33603738|NCT01443130|102099347|FG000|Overall Study|Death of Subject's Infant|5|||
33316246|NCT00409773|101050956|FG002|Overall Study|Withdrawal by Subject|0|||
33603739|NCT01443130|102099348|FG001|Overall Study|Death of Subject's Infant|10|||
33603740|NCT01443130|102099349|FG002|Overall Study|Death of Subject's Infant|11|||
33603741|NCT01443130|102099350|FG003|Overall Study|Death of Subject's Infant|0|||
33603742|NCT01443130|102099351|FG004|Overall Study|Death of Subject's Infant|0|||
33603743|NCT01443130|102099352|FG005|Overall Study|Death of Subject's Infant|0|||
33603744|NCT00499746|102099357|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
33603745|NCT00499746|102099357|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
33196046|NCT04776148|100622924|FG001|Overall Study|Ongoing in Study|45|||
33196047|NCT03251924|100622925|FG000|Overall Study|Disease Progression|6|||
33196048|NCT03251924|100622926|FG001|Overall Study|Disease Progression|6|||
33196049|NCT03251924|100622927|FG002|Overall Study|Disease Progression|7|||
33196050|NCT03251924|100622928|FG003|Overall Study|Disease Progression|8|||
33196051|NCT03251924|100622929|FG004|Overall Study|Disease Progression|8|||
33196052|NCT03251924|100622930|FG005|Overall Study|Disease Progression|7|||
33196053|NCT03251924|100622931|FG006|Overall Study|Disease Progression|6|||
33196054|NCT03251924|100622932|FG007|Overall Study|Disease Progression|10|||
33196055|NCT03251924|100622933|FG008|Overall Study|Disease Progression|6|||
33196056|NCT03251924|100622925|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
33196057|NCT03251924|100622926|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
33196058|NCT03251924|100622927|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
33196059|NCT03251924|100622928|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
33196060|NCT03251924|100622929|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
33196061|NCT03251924|100622930|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
33196062|NCT03251924|100622931|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
33397390|NCT00252499|101345761|FG000|Overall Study|Lost to Follow-up|1|||
33397391|NCT00252499|101345762|FG001|Overall Study|Lost to Follow-up|0|||
33397392|NCT00252499|101345763|FG002|Overall Study|Lost to Follow-up|0|||
33397393|NCT01731600|101345764|FG000|Overall Study|Adverse Event|2|||
33397394|NCT01731600|101345765|FG001|Overall Study|Adverse Event|0|||
33397395|NCT01731600|101345764|FG000|Overall Study|Withdrawal criteria|1|||
33397396|NCT01731600|101345765|FG001|Overall Study|Withdrawal criteria|0|||
33397397|NCT01731600|101345764|FG000|Overall Study|Other reasons|3|||
33397398|NCT01731600|101345765|FG001|Overall Study|Other reasons|0|||
33397399|NCT03742271|101345766|FG000|Overall Study|Unsatisfactory Visual Response|1|||
33397400|NCT03742271|101345766|FG000|Overall Study|Withdrawal by Subject|3|||
33397401|NCT03742271|101345766|FG000|Overall Study|Lost to Follow-up|4|||
33397402|NCT03742271|101345766|FG000|Overall Study|Failed Insertion & removal|3|||
33397403|NCT03742271|101345766|FG000|Overall Study|Protocol Violation|1|||
33397404|NCT00414973|101345767|FG000|Overall Study|Withdrawal by Subject|14|||
33316247|NCT00409773|101050957|FG003|Overall Study|Withdrawal by Subject|2|||
33316248|NCT00409773|101050958|FG004|Overall Study|Withdrawal by Subject|1|||
33316249|NCT00409773|101050954|FG000|Overall Study|Lack of Eligibility|0|||
33316250|NCT00409773|101050955|FG001|Overall Study|Lack of Eligibility|0|||
33316251|NCT00409773|101050956|FG002|Overall Study|Lack of Eligibility|0|||
33316252|NCT00409773|101050957|FG003|Overall Study|Lack of Eligibility|0|||
33316253|NCT00409773|101050958|FG004|Overall Study|Lack of Eligibility|1|||
33316254|NCT01602562|101050959|FG000|Overall Study|Adverse Event|3|||
33316255|NCT01602562|101050960|FG001|Overall Study|Adverse Event|1|||
33316256|NCT01602562|101050959|FG000|Overall Study|Physician Decision|1|||
33316257|NCT01602562|101050960|FG001|Overall Study|Physician Decision|1|||
33316258|NCT01602562|101050959|FG000|Overall Study|Withdrawal by Subject|1|||
33316259|NCT01602562|101050960|FG001|Overall Study|Withdrawal by Subject|1|||
33316260|NCT00395460|101050961|FG000|Overall Study|Withdrawal by Subject|1|||
33316261|NCT00395460|101050962|FG001|Overall Study|Withdrawal by Subject|0|||
33316262|NCT04079803|101050963|FG000|Overall Study|Withdrawal by Subject|0|||
33316263|NCT04079803|101050964|FG001|Overall Study|Withdrawal by Subject|0|||
33316264|NCT04079803|101050965|FG002|Overall Study|Withdrawal by Subject|1|||
33316265|NCT02308020|101050966|FG000|Overall Study|Lost to Follow-up|1|||
33224276|NCT04737109|100721770|FG001|Study Treatment|Death on study|0|||
33316266|NCT02308020|101050967|FG001|Overall Study|Lost to Follow-up|7|||
33316267|NCT02308020|101050968|FG002|Overall Study|Lost to Follow-up|0|||
33316268|NCT02308020|101050969|FG003|Overall Study|Lost to Follow-up|0|||
33397405|NCT00414973|101345768|FG001|Overall Study|Withdrawal by Subject|4|||
33397406|NCT00414973|101345769|FG002|Overall Study|Withdrawal by Subject|1|||
33397407|NCT00414973|101345770|FG003|Overall Study|Withdrawal by Subject|0|||
33397408|NCT00414973|101345767|FG000|Overall Study|Adverse Event|10|||
33397409|NCT00414973|101345768|FG001|Overall Study|Adverse Event|0|||
33397410|NCT00414973|101345769|FG002|Overall Study|Adverse Event|1|||
33397411|NCT00414973|101345770|FG003|Overall Study|Adverse Event|0|||
33397412|NCT00414973|101345767|FG000|Overall Study|Protocol Violation|3|||
33397413|NCT00414973|101345768|FG001|Overall Study|Protocol Violation|4|||
33397414|NCT00414973|101345769|FG002|Overall Study|Protocol Violation|0|||
33397415|NCT00414973|101345770|FG003|Overall Study|Protocol Violation|0|||
33397416|NCT00414973|101345767|FG000|Overall Study|Lost to Follow-up|0|||
33397417|NCT00414973|101345768|FG001|Overall Study|Lost to Follow-up|2|||
33397418|NCT00414973|101345769|FG002|Overall Study|Lost to Follow-up|0|||
33397419|NCT00414973|101345770|FG003|Overall Study|Lost to Follow-up|0|||
33397420|NCT00414973|101345767|FG000|Overall Study|Sponsor Decision|1|||
33397421|NCT00414973|101345768|FG001|Overall Study|Sponsor Decision|0|||
33397422|NCT00414973|101345769|FG002|Overall Study|Sponsor Decision|0|||
33397423|NCT00414973|101345770|FG003|Overall Study|Sponsor Decision|0|||
33397424|NCT00414973|101345767|FG000|Overall Study|Death|0|||
33397425|NCT00414973|101345768|FG001|Overall Study|Death|0|||
33397426|NCT00414973|101345769|FG002|Overall Study|Death|1|||
33397427|NCT00414973|101345770|FG003|Overall Study|Death|0|||
33397428|NCT02471586|101345771|FG000|Overall Study|Lost to Follow-up|3|||
33397429|NCT02471586|101345772|FG001|Overall Study|Lost to Follow-up|8|||
33397430|NCT02471586|101345773|FG002|Overall Study|Lost to Follow-up|4|||
33397431|NCT02471586|101345771|FG000|Overall Study|Death|2|||
33397432|NCT02471586|101345772|FG001|Overall Study|Death|2|||
33397433|NCT02471586|101345773|FG002|Overall Study|Death|0|||
33397434|NCT00631969|101345774|FG000|Overall Study|Adverse Event|3|||
33397435|NCT00631969|101345775|FG001|Overall Study|Adverse Event|1|||
33397436|NCT00631969|101345774|FG000|Overall Study|Lack of Efficacy|2|||
33397437|NCT00631969|101345775|FG001|Overall Study|Lack of Efficacy|8|||
33397438|NCT00631969|101345774|FG000|Overall Study|Lost to Follow-up|2|||
33397439|NCT00631969|101345775|FG001|Overall Study|Lost to Follow-up|1|||
33397440|NCT00631969|101345774|FG000|Overall Study|Protocol Violation|1|||
33397441|NCT00631969|101345775|FG001|Overall Study|Protocol Violation|1|||
33397442|NCT00631969|101345774|FG000|Overall Study|Consent Withdrawn|5|||
33397443|NCT00631969|101345775|FG001|Overall Study|Consent Withdrawn|7|||
33397444|NCT00631969|101345774|FG000|Overall Study|Noncompliant With Study Medication|0|||
33397445|NCT00631969|101345775|FG001|Overall Study|Noncompliant With Study Medication|1|||
33397446|NCT00631969|101345774|FG000|Overall Study|No Drug Exposure|2|||
33397447|NCT00631969|101345775|FG001|Overall Study|No Drug Exposure|2|||
33397448|NCT02202161|101345777|FG000|Overall Study|Adverse Event|1|||
33397449|NCT02202161|101345778|FG001|Overall Study|Adverse Event|1|||
33397450|NCT02202161|101345779|FG002|Overall Study|Adverse Event|0|||
33397451|NCT02202161|101345780|FG003|Overall Study|Adverse Event|0|||
33397452|NCT02202161|101345781|FG004|Overall Study|Adverse Event|0|||
33397453|NCT02202161|101345782|FG005|Overall Study|Adverse Event|1|||
33397454|NCT02202161|101345783|FG006|Overall Study|Adverse Event|0|||
33397455|NCT02202161|101345784|FG007|Overall Study|Adverse Event|0|||
33397456|NCT02202161|101345777|FG000|Overall Study|Did not meet continuation criteria|0|||
33397457|NCT02202161|101345778|FG001|Overall Study|Did not meet continuation criteria|0|||
33397458|NCT02202161|101345779|FG002|Overall Study|Did not meet continuation criteria|0|||
33397459|NCT02202161|101345780|FG003|Overall Study|Did not meet continuation criteria|0|||
33397460|NCT02202161|101345781|FG004|Overall Study|Did not meet continuation criteria|0|||
33397461|NCT02202161|101345782|FG005|Overall Study|Did not meet continuation criteria|0|||
33397462|NCT02202161|101345783|FG006|Overall Study|Did not meet continuation criteria|0|||
33397463|NCT02202161|101345784|FG007|Overall Study|Did not meet continuation criteria|3|||
33397464|NCT02202161|101345777|FG000|Overall Study|Physician Decision|0|||
33397465|NCT02202161|101345778|FG001|Overall Study|Physician Decision|0|||
33397466|NCT02202161|101345779|FG002|Overall Study|Physician Decision|0|||
33397467|NCT02202161|101345780|FG003|Overall Study|Physician Decision|0|||
33603746|NCT00499746|102099357|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
33603747|NCT00499746|102099357|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
33603748|NCT00500760|102099366|FG000|Overall Study|Death|32|||
33603749|NCT00500760|102099367|FG001|Overall Study|Death|15|||
33603750|NCT00500760|102099366|FG000|Overall Study|Withdrawal by Subject|5|||
33603751|NCT00500760|102099367|FG001|Overall Study|Withdrawal by Subject|7|||
33603752|NCT00500760|102099366|FG000|Overall Study|Administrative decision|2|||
33603753|NCT00500760|102099367|FG001|Overall Study|Administrative decision|0|||
33603754|NCT00500760|102099366|FG000|Overall Study|Lost to Follow-up|3|||
33603755|NCT00500760|102099367|FG001|Overall Study|Lost to Follow-up|0|||
33316269|NCT02308020|101050970|FG004|Overall Study|Lost to Follow-up|1|||
33316270|NCT02308020|101050971|FG005|Overall Study|Lost to Follow-up|2|||
33316271|NCT02308020|101050966|FG000|Overall Study|Sponsor Decision|0|||
33316272|NCT02308020|101050967|FG001|Overall Study|Sponsor Decision|8|||
33316273|NCT02308020|101050968|FG002|Overall Study|Sponsor Decision|0|||
33316274|NCT02308020|101050969|FG003|Overall Study|Sponsor Decision|2|||
33316275|NCT02308020|101050970|FG004|Overall Study|Sponsor Decision|2|||
33603756|NCT00500760|102099366|FG000|Overall Study|Other|1|||
33603757|NCT00500760|102099367|FG001|Overall Study|Other|2|||
33603758|NCT01439126|102099371|FG000|Overall Study|Adverse Event|2|||
33397468|NCT02202161|101345781|FG004|Overall Study|Physician Decision|0|||
33603759|NCT01439126|102099372|FG001|Overall Study|Adverse Event|0|||
33316276|NCT02308020|101050971|FG005|Overall Study|Sponsor Decision|1|||
33316277|NCT02308020|101050966|FG000|Overall Study|Withdrawal by Subject|3|||
33603760|NCT01439126|102099371|FG000|Overall Study|Withdrawal by Subject|5|||
33196063|NCT03251924|100622932|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
33316278|NCT02308020|101050967|FG001|Overall Study|Withdrawal by Subject|5|||
33316279|NCT02308020|101050968|FG002|Overall Study|Withdrawal by Subject|3|||
33316280|NCT02308020|101050969|FG003|Overall Study|Withdrawal by Subject|2|||
33316281|NCT02308020|101050970|FG004|Overall Study|Withdrawal by Subject|1|||
33316282|NCT02308020|101050971|FG005|Overall Study|Withdrawal by Subject|2|||
33316283|NCT02647320|101050972|FG000|Overall Study|Adverse Event|0|||
33316284|NCT02647320|101050973|FG001|Overall Study|Adverse Event|1|||
33316285|NCT02647320|101050974|FG002|Overall Study|Adverse Event|3|||
33316286|NCT02647320|101050975|FG003|Overall Study|Adverse Event|2|||
33316287|NCT02647320|101050976|FG004|Overall Study|Adverse Event|1|||
33316288|NCT02647320|101050972|FG000|Overall Study|Protocol Violation|0|||
33316289|NCT02647320|101050973|FG001|Overall Study|Protocol Violation|0|||
33316290|NCT02647320|101050974|FG002|Overall Study|Protocol Violation|3|||
33316291|NCT02647320|101050975|FG003|Overall Study|Protocol Violation|0|||
33316292|NCT02647320|101050976|FG004|Overall Study|Protocol Violation|0|||
33316293|NCT02647320|101050972|FG000|Overall Study|Withdrawal by Subject|7|||
33316294|NCT02647320|101050973|FG001|Overall Study|Withdrawal by Subject|4|||
33316295|NCT02647320|101050974|FG002|Overall Study|Withdrawal by Subject|2|||
33316296|NCT02647320|101050975|FG003|Overall Study|Withdrawal by Subject|2|||
33316297|NCT02647320|101050976|FG004|Overall Study|Withdrawal by Subject|7|||
33316298|NCT02647320|101050972|FG000|Overall Study|Persistent hyperglycemia|0|||
33316299|NCT02647320|101050973|FG001|Overall Study|Persistent hyperglycemia|1|||
33316300|NCT02647320|101050974|FG002|Overall Study|Persistent hyperglycemia|1|||
33316301|NCT02647320|101050975|FG003|Overall Study|Persistent hyperglycemia|1|||
33316302|NCT02647320|101050976|FG004|Overall Study|Persistent hyperglycemia|1|||
33316303|NCT02647320|101050972|FG000|Overall Study|Study terminated by sponsor|1|||
33316304|NCT02647320|101050973|FG001|Overall Study|Study terminated by sponsor|1|||
33316305|NCT02647320|101050974|FG002|Overall Study|Study terminated by sponsor|1|||
33316306|NCT02647320|101050975|FG003|Overall Study|Study terminated by sponsor|1|||
33316307|NCT02647320|101050976|FG004|Overall Study|Study terminated by sponsor|2|||
33316308|NCT02647320|101050972|FG000|Overall Study|Reason not provided|0|||
33316309|NCT02647320|101050973|FG001|Overall Study|Reason not provided|0|||
33316310|NCT02647320|101050974|FG002|Overall Study|Reason not provided|1|||
33316311|NCT02647320|101050975|FG003|Overall Study|Reason not provided|0|||
33316312|NCT02647320|101050976|FG004|Overall Study|Reason not provided|2|||
33316313|NCT02647320|101050972|FG000|Overall Study|Lost to Follow-up|1|||
33316314|NCT02647320|101050973|FG001|Overall Study|Lost to Follow-up|1|||
33316315|NCT02647320|101050974|FG002|Overall Study|Lost to Follow-up|0|||
33316316|NCT02647320|101050975|FG003|Overall Study|Lost to Follow-up|0|||
33316317|NCT02647320|101050976|FG004|Overall Study|Lost to Follow-up|0|||
33316318|NCT02647320|101050972|FG000|Overall Study|Develop anemia|1|||
33316319|NCT02647320|101050973|FG001|Overall Study|Develop anemia|0|||
33316320|NCT02647320|101050974|FG002|Overall Study|Develop anemia|0|||
33316321|NCT02647320|101050975|FG003|Overall Study|Develop anemia|0|||
33316322|NCT02647320|101050976|FG004|Overall Study|Develop anemia|0|||
33316323|NCT02647320|101050972|FG000|Overall Study|Lack of Efficacy|0|||
33316324|NCT02647320|101050973|FG001|Overall Study|Lack of Efficacy|0|||
33316325|NCT02647320|101050974|FG002|Overall Study|Lack of Efficacy|0|||
33316326|NCT02647320|101050975|FG003|Overall Study|Lack of Efficacy|1|||
33316327|NCT02647320|101050976|FG004|Overall Study|Lack of Efficacy|0|||
33196064|NCT03251924|100622933|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
33316328|NCT02647320|101050972|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
33316329|NCT02647320|101050973|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
33316330|NCT02647320|101050974|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
33316331|NCT02647320|101050975|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
33316332|NCT02647320|101050976|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
33316333|NCT00892723|101050983|FG000|Overall Study|Lost to Follow-up|1|||
33316334|NCT00892723|101050984|FG001|Overall Study|Lost to Follow-up|3|||
33316335|NCT00892723|101050985|FG002|Overall Study|Lost to Follow-up|1|||
33397469|NCT02202161|101345782|FG005|Overall Study|Physician Decision|0|||
33397470|NCT02202161|101345783|FG006|Overall Study|Physician Decision|0|||
33397471|NCT02202161|101345784|FG007|Overall Study|Physician Decision|3|||
33397472|NCT02202161|101345777|FG000|Overall Study|Withdrawal by Subject|0|||
33397473|NCT02202161|101345778|FG001|Overall Study|Withdrawal by Subject|0|||
33397474|NCT02202161|101345779|FG002|Overall Study|Withdrawal by Subject|0|||
33397475|NCT02202161|101345780|FG003|Overall Study|Withdrawal by Subject|0|||
33397476|NCT02202161|101345781|FG004|Overall Study|Withdrawal by Subject|1|||
33397477|NCT02202161|101345782|FG005|Overall Study|Withdrawal by Subject|0|||
33397478|NCT02202161|101345783|FG006|Overall Study|Withdrawal by Subject|0|||
33397479|NCT02202161|101345784|FG007|Overall Study|Withdrawal by Subject|0|||
33397480|NCT00764322|101345785|FG000|Overall Study|Withdrawal by Subject|11|||
33397481|NCT00764322|101345785|FG000|Overall Study|No CYP2D6 genotyping|9|||
33397482|NCT01693562|101345787|FG000|Escalation Phase|Withdrawal by Subject|0|||
33397483|NCT01693562|101345788|FG001|Escalation Phase|Withdrawal by Subject|1|||
33397484|NCT01693562|101345789|FG002|Escalation Phase|Withdrawal by Subject|0|||
33397485|NCT01693562|101345790|FG003|Escalation Phase|Withdrawal by Subject|0|||
33397486|NCT01693562|101345791|FG004|Escalation Phase|Withdrawal by Subject|0|||
33397487|NCT01693562|101345792|FG005|Escalation Phase|Withdrawal by Subject|2|||
33397488|NCT01693562|101345793|FG006|Escalation Phase|Withdrawal by Subject|0|||
33397489|NCT01693562|101345794|FG007|Escalation Phase|Withdrawal by Subject|0|||
33603761|NCT01439126|102099372|FG001|Overall Study|Withdrawal by Subject|21|||
33603762|NCT01439126|102099371|FG000|Overall Study|Protocol Violation|6|||
33603763|NCT01439126|102099372|FG001|Overall Study|Protocol Violation|4|||
33316336|NCT00892723|101050983|FG000|Overall Study|Withdrawal by Subject|1|||
33316337|NCT00892723|101050984|FG001|Overall Study|Withdrawal by Subject|1|||
33316338|NCT00892723|101050985|FG002|Overall Study|Withdrawal by Subject|1|||
33316339|NCT02147353|101050986|FG000|Overall Study|Lost to Follow-up|2|||
33316340|NCT02147353|101050987|FG001|Overall Study|Lost to Follow-up|0|||
33316341|NCT02147353|101050986|FG000|Overall Study|unable to make visits|4|||
33316342|NCT02147353|101050987|FG001|Overall Study|unable to make visits|0|||
33316343|NCT02147353|101050986|FG000|Overall Study|medication noncompliance|3|||
33316344|NCT02147353|101050987|FG001|Overall Study|medication noncompliance|0|||
33316345|NCT00718640|101050990|FG000|Overall Study|Adverse Event|4|||
33316346|NCT00718640|101050990|FG000|Overall Study|Death|1|||
33316347|NCT00718640|101050990|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
33316348|NCT03646656|101054134|FG000|Overall Study|Lost to Follow-up|1|||
33316349|NCT03646656|101054135|FG001|Overall Study|Lost to Follow-up|0|||
33316350|NCT03646656|101054134|FG000|Overall Study|Withdrawal by Subject|2|||
33397490|NCT01693562|101345795|FG008|Escalation Phase|Withdrawal by Subject|0|||
33397491|NCT01693562|101345796|FG009|Escalation Phase|Withdrawal by Subject|0|||
33397492|NCT01693562|101345797|FG010|Escalation Phase|Withdrawal by Subject|0|||
33397493|NCT01693562|101345798|FG011|Escalation Phase|Withdrawal by Subject|0|||
33397494|NCT01693562|101345799|FG012|Escalation Phase|Withdrawal by Subject|0|||
33397495|NCT01693562|101345800|FG013|Escalation Phase|Withdrawal by Subject|0|||
33397496|NCT01693562|101345801|FG014|Escalation Phase|Withdrawal by Subject|0|||
33397497|NCT01693562|101345802|FG015|Escalation Phase|Withdrawal by Subject|0|||
33397498|NCT01693562|101345803|FG016|Escalation Phase|Withdrawal by Subject|0|||
33397499|NCT01693562|101345804|FG017|Escalation Phase|Withdrawal by Subject|0|||
33397500|NCT01693562|101345805|FG018|Escalation Phase|Withdrawal by Subject|0|||
33397501|NCT01693562|101345806|FG019|Escalation Phase|Withdrawal by Subject|0|||
33397502|NCT01693562|101345807|FG020|Escalation Phase|Withdrawal by Subject|0|||
33397503|NCT01693562|101345808|FG021|Escalation Phase|Withdrawal by Subject|0|||
33397504|NCT01693562|101345809|FG022|Escalation Phase|Withdrawal by Subject|0|||
33397505|NCT01693562|101345787|FG000|Escalation Phase|Death|4|||
33603764|NCT01439126|102099371|FG000|Overall Study|Lost to Follow-up|6|||
33603765|NCT01439126|102099372|FG001|Overall Study|Lost to Follow-up|3|||
33316351|NCT03646656|101054135|FG001|Overall Study|Withdrawal by Subject|0|||
33316352|NCT01740323|101054142|FG000|Overall Study|Adverse Event|1|||
33397506|NCT01693562|101345788|FG001|Escalation Phase|Death|2|||
33397507|NCT01693562|101345789|FG002|Escalation Phase|Death|0|||
33397508|NCT01693562|101345790|FG003|Escalation Phase|Death|3|||
33397509|NCT01693562|101345791|FG004|Escalation Phase|Death|6|||
33397510|NCT01693562|101345792|FG005|Escalation Phase|Death|4|||
33397511|NCT01693562|101345793|FG006|Escalation Phase|Death|0|||
33397512|NCT01693562|101345794|FG007|Escalation Phase|Death|0|||
33397513|NCT01693562|101345795|FG008|Escalation Phase|Death|0|||
33397514|NCT01693562|101345796|FG009|Escalation Phase|Death|0|||
33397515|NCT01693562|101345797|FG010|Escalation Phase|Death|0|||
33397516|NCT01693562|101345798|FG011|Escalation Phase|Death|0|||
33397517|NCT01693562|101345799|FG012|Escalation Phase|Death|0|||
33397518|NCT01693562|101345800|FG013|Escalation Phase|Death|0|||
33603766|NCT01439126|102099371|FG000|Overall Study|Other-Use of prohibited treatment|0|||
33397519|NCT01693562|101345801|FG014|Escalation Phase|Death|0|||
33603767|NCT01439126|102099372|FG001|Overall Study|Other-Use of prohibited treatment|2|||
33316353|NCT01740323|101054143|FG001|Overall Study|Adverse Event|0|||
33316354|NCT01740323|101054142|FG000|Overall Study|Randomized but did not take study drug|1|||
33397520|NCT01693562|101345802|FG015|Escalation Phase|Death|0|||
33316355|NCT01740323|101054143|FG001|Overall Study|Randomized but did not take study drug|0|||
33316356|NCT02027623|101054144|FG000|Overall Study|Lost to Follow-up|3|||
33316357|NCT02027623|101054145|FG001|Overall Study|Lost to Follow-up|3|||
33316358|NCT02027623|101054144|FG000|Overall Study|Withdrawal by Subject|6|||
33316359|NCT02027623|101054145|FG001|Overall Study|Withdrawal by Subject|9|||
33316360|NCT01222507|101054146|FG000|Overall Study|Physician Decision|1|||
33316361|NCT01222507|101054146|FG000|Overall Study|Withdrawal by Subject|1|||
33316362|NCT02092220|101054147|FG000|Period 1|Unrelated Illness|0|||
33316363|NCT02092220|101054148|FG001|Period 1|Unrelated Illness|2|||
33316364|NCT02092220|101054147|FG000|Period 2|Severe Hypoglycaemia|1|||
33316365|NCT02092220|101054148|FG001|Period 2|Severe Hypoglycaemia|0|||
33316366|NCT02092220|101054147|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
33316367|NCT02092220|101054148|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
33316368|NCT00232141|101054149|FG000|Overall Study|Adverse Event|9|||
33316369|NCT00232141|101054150|FG001|Overall Study|Adverse Event|4|||
33316370|NCT00232141|101054149|FG000|Overall Study|Lack of Efficacy|0|||
33316371|NCT00232141|101054150|FG001|Overall Study|Lack of Efficacy|3|||
33316372|NCT00232141|101054149|FG000|Overall Study|Lost to Follow-up|9|||
33316373|NCT00232141|101054150|FG001|Overall Study|Lost to Follow-up|6|||
33316374|NCT00232141|101054149|FG000|Overall Study|Other|8|||
33316375|NCT00232141|101054150|FG001|Overall Study|Other|10|||
33316376|NCT00232141|101054149|FG000|Overall Study|Withdrawal by Subject|5|||
33316377|NCT00232141|101054150|FG001|Overall Study|Withdrawal by Subject|3|||
33316378|NCT00093808|101054152|FG000|Overall Study|Cancel participation before receiving tx|1|||
33316379|NCT00093808|101054152|FG000|Overall Study|Protocol Violation|1|||
33316380|NCT01100034|101054155|FG000|Overall Study|Lost to Follow-up|11|||
33316381|NCT01100034|101054155|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
33316382|NCT01100034|101054155|FG000|Overall Study|Withdrawal by Subject|4|||
33316383|NCT01100034|101054155|FG000|Overall Study|Sponsor decision|21|||
33316384|NCT01100034|101054155|FG000|Overall Study|Participated in another clinical trial|1|||
33316385|NCT01100034|101054155|FG000|Overall Study|Participants moved to another hospital|4|||
33316386|NCT01100034|101054155|FG000|Overall Study|Site closed due to non-responsiveness|1|||
33316387|NCT00051363|101054156|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
33316388|NCT00051363|101054157|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
33316389|NCT00051363|101054156|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
33316390|NCT00051363|101054157|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
33316391|NCT00051363|101054156|FG000|Overall Study|Death|2|||
33316392|NCT00051363|101054157|FG001|Overall Study|Death|2|||
33316393|NCT00051363|101054156|FG000|Overall Study|Excluded Pre-Randomization|2|||
33316394|NCT00051363|101054157|FG001|Overall Study|Excluded Pre-Randomization|5|||
33316395|NCT01658150|101054158|FG000|Overall Study|Withdrawal by Subject|1|||
33316396|NCT01143038|101054161|FG000|Overall Study|Withdrawal by Subject|4|||
33316397|NCT01143038|101054161|FG000|Overall Study|Requirement for alternative therapy|5|||
33316398|NCT01143038|101054161|FG000|Overall Study|Adverse Event|3|||
33316399|NCT01143038|101054161|FG000|Overall Study|Lost to Follow-up|2|||
33316400|NCT01143038|101054161|FG000|Overall Study|Protocol Deviation|1|||
33316401|NCT01143038|101054161|FG000|Overall Study|Death|1|||
33316402|NCT01272804|101054162|FG000|Overall Study|Adverse Event|1|||
33316403|NCT01272804|101054163|FG001|Overall Study|Adverse Event|0|||
33316404|NCT01272804|101054164|FG002|Overall Study|Adverse Event|0|||
33397521|NCT01693562|101345803|FG016|Escalation Phase|Death|0|||
33316405|NCT01272804|101054165|FG003|Overall Study|Adverse Event|0|||
33316406|NCT01272804|101054166|FG004|Overall Study|Adverse Event|2|||
33316407|NCT01272804|101054167|FG005|Overall Study|Adverse Event|1|||
33316408|NCT01136811|101054172|FG000|Overall Study|Physician Decision|11|||
33316409|NCT01037244|101054173|FG000|Overall Study|Adverse Event|3|||
33316410|NCT01037244|101054174|FG001|Overall Study|Adverse Event|2|||
33316411|NCT01037244|101054175|FG002|Overall Study|Adverse Event|6|||
33316412|NCT01037244|101054176|FG003|Overall Study|Adverse Event|3|||
33316413|NCT01037244|101054173|FG000|Overall Study|Lack of Efficacy|1|||
33316414|NCT01037244|101054174|FG001|Overall Study|Lack of Efficacy|1|||
33316415|NCT01037244|101054175|FG002|Overall Study|Lack of Efficacy|0|||
33316416|NCT01037244|101054176|FG003|Overall Study|Lack of Efficacy|1|||
33397522|NCT01693562|101345804|FG017|Escalation Phase|Death|0|||
33397523|NCT01693562|101345805|FG018|Escalation Phase|Death|0|||
33316417|NCT01037244|101054173|FG000|Overall Study|Lost to Follow-up|3|||
33316418|NCT01037244|101054174|FG001|Overall Study|Lost to Follow-up|3|||
33397524|NCT01693562|101345806|FG019|Escalation Phase|Death|0|||
33316419|NCT01037244|101054175|FG002|Overall Study|Lost to Follow-up|4|||
33316420|NCT01037244|101054176|FG003|Overall Study|Lost to Follow-up|4|||
33316421|NCT01037244|101054173|FG000|Overall Study|Withdrawal by Subject|1|||
33316422|NCT01037244|101054174|FG001|Overall Study|Withdrawal by Subject|5|||
33316423|NCT01037244|101054175|FG002|Overall Study|Withdrawal by Subject|3|||
33316424|NCT01037244|101054176|FG003|Overall Study|Withdrawal by Subject|5|||
33316425|NCT01037244|101054173|FG000|Overall Study|Partner Withdrew Consent|2|||
33316426|NCT01037244|101054174|FG001|Overall Study|Partner Withdrew Consent|1|||
33316427|NCT01037244|101054175|FG002|Overall Study|Partner Withdrew Consent|0|||
33397525|NCT01693562|101345807|FG020|Escalation Phase|Death|0|||
33316428|NCT01037244|101054176|FG003|Overall Study|Partner Withdrew Consent|0|||
33316429|NCT01037244|101054173|FG000|Overall Study|Various|3|||
33316430|NCT01037244|101054174|FG001|Overall Study|Various|2|||
33316431|NCT01037244|101054175|FG002|Overall Study|Various|1|||
33316432|NCT01037244|101054176|FG003|Overall Study|Various|1|||
33316433|NCT00402597|101054177|FG000|Overall Study|Death|15|||
33316434|NCT00402597|101054178|FG001|Overall Study|Death|7|||
33316435|NCT00402597|101054179|FG002|Overall Study|Death|6|||
33316436|NCT00402597|101054180|FG003|Overall Study|Death|4|||
33316437|NCT00402597|101054181|FG004|Overall Study|Death|6|||
33316438|NCT00402597|101054177|FG000|Overall Study|Adverse Event|81|||
33316439|NCT00402597|101054178|FG001|Overall Study|Adverse Event|18|||
33316440|NCT00402597|101054179|FG002|Overall Study|Adverse Event|106|||
33316441|NCT00402597|101054180|FG003|Overall Study|Adverse Event|39|||
33316442|NCT00402597|101054181|FG004|Overall Study|Adverse Event|71|||
33397526|NCT01693562|101345808|FG021|Escalation Phase|Death|0|||
33397527|NCT01693562|101345809|FG022|Escalation Phase|Death|0|||
33397528|NCT01693562|101345787|FG000|Escalation Phase|Lost to Follow-up|0|||
33397529|NCT01693562|101345788|FG001|Escalation Phase|Lost to Follow-up|1|||
33397530|NCT01693562|101345789|FG002|Escalation Phase|Lost to Follow-up|1|||
33397531|NCT01693562|101345790|FG003|Escalation Phase|Lost to Follow-up|0|||
33397532|NCT01693562|101345791|FG004|Escalation Phase|Lost to Follow-up|0|||
33397533|NCT01693562|101345792|FG005|Escalation Phase|Lost to Follow-up|0|||
33397534|NCT01693562|101345793|FG006|Escalation Phase|Lost to Follow-up|0|||
33397535|NCT01693562|101345794|FG007|Escalation Phase|Lost to Follow-up|0|||
33397536|NCT01693562|101345795|FG008|Escalation Phase|Lost to Follow-up|0|||
33397537|NCT01693562|101345796|FG009|Escalation Phase|Lost to Follow-up|0|||
33397538|NCT01693562|101345797|FG010|Escalation Phase|Lost to Follow-up|0|||
33397539|NCT01693562|101345798|FG011|Escalation Phase|Lost to Follow-up|0|||
33397540|NCT01693562|101345799|FG012|Escalation Phase|Lost to Follow-up|0|||
33397541|NCT01693562|101345800|FG013|Escalation Phase|Lost to Follow-up|0|||
33397542|NCT01693562|101345801|FG014|Escalation Phase|Lost to Follow-up|0|||
33397543|NCT01693562|101345802|FG015|Escalation Phase|Lost to Follow-up|0|||
33397544|NCT01693562|101345803|FG016|Escalation Phase|Lost to Follow-up|0|||
33397545|NCT01693562|101345804|FG017|Escalation Phase|Lost to Follow-up|0|||
33397546|NCT01693562|101345805|FG018|Escalation Phase|Lost to Follow-up|0|||
33397547|NCT01693562|101345806|FG019|Escalation Phase|Lost to Follow-up|0|||
33397548|NCT01693562|101345807|FG020|Escalation Phase|Lost to Follow-up|0|||
33397549|NCT01693562|101345808|FG021|Escalation Phase|Lost to Follow-up|0|||
33397550|NCT01693562|101345809|FG022|Escalation Phase|Lost to Follow-up|0|||
33397551|NCT01693562|101345787|FG000|Escalation Phase|Other|0|||
33397552|NCT01693562|101345788|FG001|Escalation Phase|Other|0|||
33397553|NCT01693562|101345789|FG002|Escalation Phase|Other|2|||
33397554|NCT01693562|101345790|FG003|Escalation Phase|Other|0|||
33397555|NCT01693562|101345791|FG004|Escalation Phase|Other|0|||
33316443|NCT00402597|101054177|FG000|Overall Study|Lost to Follow-up|8|||
33397556|NCT01693562|101345792|FG005|Escalation Phase|Other|1|||
33506373|NCT02438826|101747767|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
33316444|NCT00402597|101054178|FG001|Overall Study|Lost to Follow-up|1|||
33316445|NCT00402597|101054179|FG002|Overall Study|Lost to Follow-up|8|||
33316446|NCT00402597|101054180|FG003|Overall Study|Lost to Follow-up|2|||
33316447|NCT00402597|101054181|FG004|Overall Study|Lost to Follow-up|3|||
33316448|NCT00402597|101054177|FG000|Overall Study|Withdrawal by Subject|57|||
33316449|NCT00402597|101054178|FG001|Overall Study|Withdrawal by Subject|16|||
33316450|NCT00402597|101054179|FG002|Overall Study|Withdrawal by Subject|65|||
33316451|NCT00402597|101054180|FG003|Overall Study|Withdrawal by Subject|15|||
33316452|NCT00402597|101054181|FG004|Overall Study|Withdrawal by Subject|24|||
33316453|NCT00402597|101054177|FG000|Overall Study|reason not specified|30|||
33397557|NCT01693562|101345793|FG006|Escalation Phase|Other|0|||
33397558|NCT01693562|101345794|FG007|Escalation Phase|Other|0|||
33397559|NCT01693562|101345795|FG008|Escalation Phase|Other|0|||
33397560|NCT01693562|101345796|FG009|Escalation Phase|Other|0|||
33397561|NCT01693562|101345797|FG010|Escalation Phase|Other|0|||
33506374|NCT02438826|101747768|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
33316454|NCT00402597|101054178|FG001|Overall Study|reason not specified|4|||
33316455|NCT00402597|101054179|FG002|Overall Study|reason not specified|27|||
33316456|NCT00402597|101054180|FG003|Overall Study|reason not specified|14|||
33397562|NCT01693562|101345798|FG011|Escalation Phase|Other|0|||
33397563|NCT01693562|101345799|FG012|Escalation Phase|Other|0|||
33397564|NCT01693562|101345800|FG013|Escalation Phase|Other|0|||
33397565|NCT01693562|101345801|FG014|Escalation Phase|Other|0|||
33397566|NCT01693562|101345802|FG015|Escalation Phase|Other|0|||
33316457|NCT00402597|101054181|FG004|Overall Study|reason not specified|20|||
33316458|NCT01592864|101054184|FG000|Overall Study|Withdrawal by Subject|0|||
33316459|NCT01592864|101054185|FG001|Overall Study|Withdrawal by Subject|1|||
33316460|NCT01440374|101054187|FG000|Part 1: Open-label Phase|Adverse Event|5|||
33316461|NCT01440374|101054188|FG001|Part 1: Open-label Phase|Adverse Event|0|||
33316462|NCT01440374|101054189|FG002|Part 1: Open-label Phase|Adverse Event|0|||
33316463|NCT01440374|101054190|FG003|Part 1: Open-label Phase|Adverse Event|0|||
33316464|NCT01440374|101054187|FG000|Part 1: Open-label Phase|Physician Decision|1|||
33316465|NCT01440374|101054188|FG001|Part 1: Open-label Phase|Physician Decision|0|||
33316466|NCT01440374|101054189|FG002|Part 1: Open-label Phase|Physician Decision|0|||
33316467|NCT01440374|101054190|FG003|Part 1: Open-label Phase|Physician Decision|0|||
33316468|NCT01440374|101054187|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
33397567|NCT01693562|101345803|FG016|Escalation Phase|Other|0|||
33397568|NCT01693562|101345804|FG017|Escalation Phase|Other|0|||
33603768|NCT01439126|102099371|FG000|Overall Study|Other-Miscellaneous|12|||
33603769|NCT01439126|102099372|FG001|Overall Study|Other-Miscellaneous|12|||
33603770|NCT00952614|102099375|FG000|Overall Study|Death|3|||
33603771|NCT00952614|102099375|FG000|Overall Study|Lost to Follow-up|3|||
33603772|NCT00952614|102099375|FG000|Overall Study|other reason|1|||
33603773|NCT02308488|102099376|FG000|Overall Study|Withdrawal by Subject|2|||
33603774|NCT03204890|102099377|FG000|Overall Study|Withdrawal by Subject|1|||
33603775|NCT00096018|102099378|FG000|Overall Study|Became Ineligible (not treated)|0|||
33603776|NCT00096018|102099379|FG001|Overall Study|Became Ineligible (not treated)|3|||
33603777|NCT00096018|102099378|FG000|Overall Study|Miscellaneous (not treated)|0|||
33603778|NCT00096018|102099379|FG001|Overall Study|Miscellaneous (not treated)|2|||
33603779|NCT00096018|102099378|FG000|Overall Study|Adverse Event|0|||
33603780|NCT00096018|102099379|FG001|Overall Study|Adverse Event|5|||
33603781|NCT00096018|102099378|FG000|Overall Study|Death|0|||
33603782|NCT00096018|102099379|FG001|Overall Study|Death|1|||
33603783|NCT00096018|102099378|FG000|Overall Study|Withdrawal by Subject|0|||
33603784|NCT00096018|102099379|FG001|Overall Study|Withdrawal by Subject|2|||
33603785|NCT00096018|102099378|FG000|Overall Study|Miscellaneous|2|||
33603786|NCT00096018|102099379|FG001|Overall Study|Miscellaneous|1|||
33603787|NCT00514020|102099380|FG000|Overall Study|Adverse Event|6|||
33603788|NCT00514020|102099380|FG000|Overall Study|Withdrawal by Subject|3|||
33603789|NCT00514020|102099380|FG000|Overall Study|Physician Decision|1|||
33603790|NCT00514020|102099380|FG000|Overall Study|disease progression|9|||
33603791|NCT00514020|102099380|FG000|Overall Study|other complicating disease|2|||
33603792|NCT00514020|102099380|FG000|Overall Study|patient went to radiation treatment|1|||
33603793|NCT00514020|102099380|FG000|Overall Study|"patients moved to the no tx group"|6|||
33603794|NCT00054691|102099382|FG000|Overall Study|Unmeasurable Disease|2|||
33603795|NCT00054691|102099382|FG000|Overall Study|Noncompliant|1|||
33603796|NCT00413010|102099385|FG000|Overall Study|Adverse Event|8|||
33603797|NCT00413010|102099386|FG001|Overall Study|Adverse Event|4|||
33603798|NCT00413010|102099385|FG000|Overall Study|Laboratory abnormality|0|||
33603799|NCT00413010|102099386|FG001|Overall Study|Laboratory abnormality|2|||
33603800|NCT00413010|102099385|FG000|Overall Study|Lack of Efficacy|0|||
33603801|NCT00413010|102099386|FG001|Overall Study|Lack of Efficacy|3|||
33397569|NCT01693562|101345805|FG018|Escalation Phase|Other|0|||
33603802|NCT00413010|102099385|FG000|Overall Study|Lost to Follow-up|3|||
33603803|NCT00413010|102099386|FG001|Overall Study|Lost to Follow-up|0|||
33316469|NCT01440374|101054188|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
33397570|NCT01693562|101345806|FG019|Escalation Phase|Other|0|||
33397571|NCT01693562|101345807|FG020|Escalation Phase|Other|0|||
33603804|NCT00413010|102099385|FG000|Overall Study|Withdrawal by Subject|7|||
33603805|NCT00413010|102099386|FG001|Overall Study|Withdrawal by Subject|2|||
33603806|NCT00413010|102099385|FG000|Overall Study|Due to termination of the study|54|||
33603807|NCT00413010|102099386|FG001|Overall Study|Due to termination of the study|52|||
33316470|NCT01440374|101054189|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
33397572|NCT01693562|101345808|FG021|Escalation Phase|Other|0|||
33603808|NCT00409344|102099389|FG000|Overall Study|no enrollment|0|||
33506375|NCT02438826|101747769|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
33506376|NCT02438826|101747766|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
33506377|NCT02438826|101747767|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
33506378|NCT02438826|101747768|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
33506379|NCT02438826|101747769|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
33506380|NCT02438826|101747766|FG000|Post-Treatment Phase|Adverse Event|3|||
33506381|NCT02438826|101747767|FG001|Post-Treatment Phase|Adverse Event|0|||
33603809|NCT00409344|102099390|FG001|Overall Study|no enrollment|0|||
33603810|NCT00199888|102099391|FG000|Overall Study|Lost to Follow-up|1|||
33603811|NCT00710385|102099392|FG000|Overall Study|Did not qualify|1|||
33603812|NCT00710385|102099392|FG000|Overall Study|Withdrawal by Subject|1|||
33603813|NCT00710385|102099392|FG000|Overall Study|Undisclosed back pain|1|||
33603814|NCT00710385|102099392|FG000|Overall Study|Physician Decision|1|||
33603815|NCT00710385|102099392|FG000|Overall Study|Undisclosed excessive methadone use|1|||
33603816|NCT01282294|102099393|FG000|Overall Study|Lost to Follow-up|14|||
33603817|NCT01282294|102099393|FG000|Overall Study|Screening failure|1|||
33603818|NCT01282294|102099393|FG000|Overall Study|Adverse Event|1|||
33603819|NCT01282294|102099393|FG000|Overall Study|Patient non-compliance|2|||
33603820|NCT01282294|102099393|FG000|Overall Study|Physician Decision|1|||
33603821|NCT02210091|102099394|FG000|Overall Study|Physician Decision|0|||
33603822|NCT02210091|102099395|FG001|Overall Study|Physician Decision|1|||
33603823|NCT02210091|102099394|FG000|Overall Study|Withdrawal by Sponsor|0|||
33603824|NCT02210091|102099395|FG001|Overall Study|Withdrawal by Sponsor|1|||
33603825|NCT01751776|102099397|FG000|Overall Study|Adverse Event|0|||
33603826|NCT01751776|102099398|FG001|Overall Study|Adverse Event|0|||
33603827|NCT01751776|102099399|FG002|Overall Study|Adverse Event|0|||
33603828|NCT01751776|102099400|FG003|Overall Study|Adverse Event|0|||
33603829|NCT01751776|102099401|FG004|Overall Study|Adverse Event|0|||
33603830|NCT01751776|102099402|FG005|Overall Study|Adverse Event|0|||
33603831|NCT01751776|102099403|FG006|Overall Study|Adverse Event|4|||
33603832|NCT01751776|102099404|FG007|Overall Study|Adverse Event|2|||
33603833|NCT01751776|102099397|FG000|Overall Study|Consent withdrawn|0|||
33603834|NCT01751776|102099398|FG001|Overall Study|Consent withdrawn|0|||
33603835|NCT01751776|102099399|FG002|Overall Study|Consent withdrawn|0|||
33603836|NCT01751776|102099400|FG003|Overall Study|Consent withdrawn|0|||
33603837|NCT01751776|102099401|FG004|Overall Study|Consent withdrawn|0|||
33603838|NCT01751776|102099402|FG005|Overall Study|Consent withdrawn|0|||
33603839|NCT01751776|102099403|FG006|Overall Study|Consent withdrawn|0|||
33603840|NCT01751776|102099404|FG007|Overall Study|Consent withdrawn|1|||
33603841|NCT01751776|102099397|FG000|Overall Study|Other reason not specified above|0|||
33603842|NCT01751776|102099398|FG001|Overall Study|Other reason not specified above|0|||
33603843|NCT01751776|102099399|FG002|Overall Study|Other reason not specified above|0|||
33603844|NCT01751776|102099400|FG003|Overall Study|Other reason not specified above|0|||
33603845|NCT01751776|102099401|FG004|Overall Study|Other reason not specified above|0|||
33603846|NCT01751776|102099402|FG005|Overall Study|Other reason not specified above|0|||
33603847|NCT01751776|102099403|FG006|Overall Study|Other reason not specified above|0|||
33603848|NCT01751776|102099404|FG007|Overall Study|Other reason not specified above|1|||
33603849|NCT01806064|102099405|FG000|Overall Study|Randomized Not Enrolled|0|||
33603850|NCT01806064|102099406|FG001|Overall Study|Randomized Not Enrolled|0|||
33603851|NCT01806064|102099407|FG002|Overall Study|Randomized Not Enrolled|0|||
33603852|NCT01806064|102099408|FG003|Overall Study|Randomized Not Enrolled|1|||
33603853|NCT01806064|102099409|FG004|Overall Study|Randomized Not Enrolled|2|||
33603854|NCT01147900|102099410|FG000|At Year 10|Lost to Follow-up|0|||
33603855|NCT01147900|102099411|FG001|At Year 10|Lost to Follow-up|1|||
33603856|NCT01147900|102099412|FG002|At Year 10|Lost to Follow-up|0|||
33603857|NCT02966015|102099413|FG000|Inclusion Visit|did not answer questionnaire|8|||
33603858|NCT02966015|102099414|FG001|Inclusion Visit|did not answer questionnaire|3|||
33603859|NCT00279812|102099415|FG000|Overall Study|Protocol Violation|1|||
33397573|NCT01693562|101345809|FG022|Escalation Phase|Other|0|||
33506382|NCT02438826|101747768|FG002|Post-Treatment Phase|Adverse Event|0|||
33506383|NCT02438826|101747769|FG003|Post-Treatment Phase|Adverse Event|0|||
33603860|NCT00279812|102099416|FG001|Overall Study|Protocol Violation|1|||
33603861|NCT00279812|102099417|FG002|Overall Study|Protocol Violation|0|||
33506384|NCT02438826|101747766|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
33603862|NCT00279812|102099418|FG003|Overall Study|Protocol Violation|0|||
33603863|NCT00279812|102099419|FG004|Overall Study|Protocol Violation|1|||
33603864|NCT00279812|102099420|FG005|Overall Study|Protocol Violation|0|||
33506385|NCT02438826|101747767|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
33506386|NCT02438826|101747768|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
33506387|NCT02438826|101747769|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
33506388|NCT02438826|101747766|FG000|Post-Treatment Phase|Physician Decision|1|||
33506389|NCT02438826|101747767|FG001|Post-Treatment Phase|Physician Decision|0|||
33506390|NCT02438826|101747768|FG002|Post-Treatment Phase|Physician Decision|0|||
33506391|NCT02438826|101747769|FG003|Post-Treatment Phase|Physician Decision|0|||
33506392|NCT02438826|101747766|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
33506393|NCT02438826|101747767|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
33506394|NCT02438826|101747768|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
33506395|NCT02438826|101747769|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
33506396|NCT00626821|101747776|FG000|Overall Study|Adverse Event|44|||
33506397|NCT00626821|101747776|FG000|Overall Study|Protocol Violation|33|||
33506398|NCT00626821|101747776|FG000|Overall Study|Withdrawal by Subject|10|||
33603865|NCT00279812|102099415|FG000|Overall Study|Withdrawal by Subject|0|||
33603866|NCT00279812|102099416|FG001|Overall Study|Withdrawal by Subject|4|||
33603867|NCT00279812|102099417|FG002|Overall Study|Withdrawal by Subject|2|||
33603868|NCT00279812|102099418|FG003|Overall Study|Withdrawal by Subject|0|||
33603869|NCT00279812|102099419|FG004|Overall Study|Withdrawal by Subject|0|||
33603870|NCT00279812|102099420|FG005|Overall Study|Withdrawal by Subject|0|||
33603871|NCT00279812|102099415|FG000|Overall Study|Adverse Event|0|||
33603872|NCT00279812|102099416|FG001|Overall Study|Adverse Event|1|||
33603873|NCT00279812|102099417|FG002|Overall Study|Adverse Event|1|||
33603874|NCT00279812|102099418|FG003|Overall Study|Adverse Event|0|||
33603875|NCT00279812|102099419|FG004|Overall Study|Adverse Event|2|||
33603876|NCT00279812|102099420|FG005|Overall Study|Adverse Event|1|||
33603877|NCT00025155|102099423|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
33603878|NCT00025155|102099423|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
33603879|NCT02469415|102099427|FG000|Overall Study|Withdrawal by Subject|1|||
33603880|NCT02469415|102099427|FG000|Overall Study|Investigational agent placed on hold|2|||
33603881|NCT00930969|102099431|FG000|Overall Study|Death|5|||
33603882|NCT00930969|102099431|FG000|Overall Study|Lost to Follow-up|1|||
33603883|NCT00930969|102099431|FG000|Overall Study|Physician Decision|13|||
33603884|NCT00930969|102099431|FG000|Overall Study|Withdrawal by Subject|19|||
33603885|NCT03233438|102099432|FG000|Overall Study|Lost to Follow-up|4|||
33603886|NCT03233438|102099433|FG001|Overall Study|Lost to Follow-up|9|||
33603887|NCT03233438|102099432|FG000|Overall Study|Withdrawal by Subject|2|||
33603888|NCT03233438|102099433|FG001|Overall Study|Withdrawal by Subject|1|||
33603889|NCT03233438|102099432|FG000|Overall Study|No recording of dalbavancin|0|||
33603890|NCT03233438|102099433|FG001|Overall Study|No recording of dalbavancin|1|||
33603891|NCT03883113|102102470|FG000|Overall Study|Physician Decision|4|||
33603892|NCT03883113|102102471|FG001|Overall Study|Physician Decision|2|||
33603893|NCT03883113|102102470|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
33603894|NCT03883113|102102471|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
33603895|NCT03883113|102102470|FG000|Overall Study|Pregnancy|1|||
33603896|NCT03883113|102102471|FG001|Overall Study|Pregnancy|0|||
33603897|NCT03883113|102102470|FG000|Overall Study|Adverse Event|0|||
33603898|NCT03883113|102102471|FG001|Overall Study|Adverse Event|1|||
33603899|NCT03883113|102102470|FG000|Overall Study|Withdrawal by Subject|1|||
33603900|NCT03883113|102102471|FG001|Overall Study|Withdrawal by Subject|2|||
33603901|NCT03883113|102102470|FG000|Overall Study|Lost to Follow-up|1|||
33603902|NCT03883113|102102471|FG001|Overall Study|Lost to Follow-up|0|||
33603903|NCT03662659|102102474|FG000|Pre-treatment|Participant no longer met study criteria|1|||
33603904|NCT03662659|102102475|FG001|Pre-treatment|Participant no longer met study criteria|1|||
33603905|NCT03662659|102102474|FG000|Pre-treatment|Other reasons|1|||
33603906|NCT03662659|102102475|FG001|Pre-treatment|Other reasons|0|||
33603907|NCT03662659|102102474|FG000|Treatment|Completed Treatment|0|||
33603908|NCT03662659|102102475|FG001|Treatment|Completed Treatment|3|||
33603909|NCT03662659|102102474|FG000|Treatment|Disease Progression|69|||
33603910|NCT03662659|102102475|FG001|Treatment|Disease Progression|78|||
33603911|NCT03662659|102102474|FG000|Treatment|Study Drug Toxicity|18|||
33603912|NCT03662659|102102475|FG001|Treatment|Study Drug Toxicity|8|||
33603913|NCT03662659|102102474|FG000|Treatment|Death|12|||
33603914|NCT03662659|102102475|FG001|Treatment|Death|7|||
33603915|NCT03662659|102102474|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
33603916|NCT03662659|102102475|FG001|Treatment|Adverse Event unrelated to Study Drug|4|||
33603917|NCT03662659|102102474|FG000|Treatment|Withdrawal by Subject|1|||
33603918|NCT03662659|102102475|FG001|Treatment|Withdrawal by Subject|1|||
33603919|NCT03662659|102102474|FG000|Treatment|Poor/Non-compliance|1|||
33603920|NCT03662659|102102475|FG001|Treatment|Poor/Non-compliance|0|||
33506399|NCT00626821|101747776|FG000|Overall Study|Physician Decision|9|||
33603921|NCT03662659|102102474|FG000|Treatment|Participant no longer meets study criteria|1|||
33603922|NCT03662659|102102475|FG001|Treatment|Participant no longer meets study criteria|0|||
33603923|NCT03662659|102102474|FG000|Treatment|Other reasons|6|||
33506400|NCT00626821|101747776|FG000|Overall Study|Product dysfunction|21|||
33506401|NCT00626821|101747776|FG000|Overall Study|other/unknown reason|104|||
33603924|NCT03662659|102102475|FG001|Treatment|Other reasons|5|||
33196065|NCT03251924|100622925|FG000|Overall Study|Death|0|||
33196066|NCT03251924|100622926|FG001|Overall Study|Death|1|||
33196067|NCT03251924|100622927|FG002|Overall Study|Death|0|||
33196068|NCT03251924|100622928|FG003|Overall Study|Death|1|||
33196069|NCT03251924|100622929|FG004|Overall Study|Death|1|||
33196070|NCT03251924|100622930|FG005|Overall Study|Death|1|||
33196071|NCT03251924|100622931|FG006|Overall Study|Death|0|||
33196072|NCT03251924|100622932|FG007|Overall Study|Death|0|||
33196073|NCT03251924|100622933|FG008|Overall Study|Death|0|||
33196074|NCT03251924|100622925|FG000|Overall Study|Study Drug Toxicity|0|||
33196075|NCT03251924|100622926|FG001|Overall Study|Study Drug Toxicity|0|||
33196076|NCT03251924|100622927|FG002|Overall Study|Study Drug Toxicity|0|||
33196077|NCT03251924|100622928|FG003|Overall Study|Study Drug Toxicity|1|||
33506402|NCT01053663|101747777|FG000|Overall Study|Death|2|||
33506403|NCT01053663|101747777|FG000|Overall Study|Lost to Follow-up|1|||
33506404|NCT01053663|101747777|FG000|Overall Study|Poor IV Access|1|||
33506405|NCT01053663|101747777|FG000|Overall Study|Transferred to Another Hospital|1|||
33506406|NCT01053663|101747777|FG000|Overall Study|Negative Influenza Diagnosis|1|||
33506407|NCT00095238|101747778|FG000|Overall Study|Lack of Efficacy|9|||
33196078|NCT03251924|100622929|FG004|Overall Study|Study Drug Toxicity|0|||
33196079|NCT03251924|100622930|FG005|Overall Study|Study Drug Toxicity|0|||
33196080|NCT03251924|100622931|FG006|Overall Study|Study Drug Toxicity|0|||
33196081|NCT03251924|100622932|FG007|Overall Study|Study Drug Toxicity|0|||
33196082|NCT03251924|100622933|FG008|Overall Study|Study Drug Toxicity|1|||
33196083|NCT03251924|100622925|FG000|Overall Study|Other Reasons|0|||
33196084|NCT03251924|100622926|FG001|Overall Study|Other Reasons|0|||
33196085|NCT03251924|100622927|FG002|Overall Study|Other Reasons|0|||
33196086|NCT03251924|100622928|FG003|Overall Study|Other Reasons|0|||
33196087|NCT03251924|100622929|FG004|Overall Study|Other Reasons|0|||
33196088|NCT03251924|100622930|FG005|Overall Study|Other Reasons|0|||
33196089|NCT03251924|100622931|FG006|Overall Study|Other Reasons|0|||
33196090|NCT03251924|100622932|FG007|Overall Study|Other Reasons|0|||
33196091|NCT03251924|100622933|FG008|Overall Study|Other Reasons|1|||
33196092|NCT03251924|100622925|FG000|Overall Study|Participant request to discontinue study treatment|0|||
33196093|NCT03251924|100622926|FG001|Overall Study|Participant request to discontinue study treatment|0|||
33196094|NCT03251924|100622927|FG002|Overall Study|Participant request to discontinue study treatment|0|||
33196095|NCT03251924|100622928|FG003|Overall Study|Participant request to discontinue study treatment|0|||
33196096|NCT03251924|100622929|FG004|Overall Study|Participant request to discontinue study treatment|0|||
33196097|NCT03251924|100622930|FG005|Overall Study|Participant request to discontinue study treatment|0|||
33196098|NCT03251924|100622931|FG006|Overall Study|Participant request to discontinue study treatment|0|||
33196099|NCT03251924|100622932|FG007|Overall Study|Participant request to discontinue study treatment|1|||
33196100|NCT03251924|100622933|FG008|Overall Study|Participant request to discontinue study treatment|0|||
33196101|NCT04086472|100622935|FG000|Overall Study|Lost to Follow-up|1|||
33196102|NCT04086472|100622936|FG001|Overall Study|Lost to Follow-up|0|||
33506408|NCT00095238|101747779|FG001|Overall Study|Lack of Efficacy|9|||
33196103|NCT04086472|100622937|FG002|Overall Study|Lost to Follow-up|0|||
33196104|NCT04086472|100622938|FG003|Overall Study|Lost to Follow-up|0|||
33196105|NCT04086472|100622939|FG004|Overall Study|Lost to Follow-up|1|||
33196106|NCT04086472|100622935|FG000|Overall Study|Physician Decision|0|||
33397574|NCT01693562|101345787|FG000|Exploration Phase|Withdrawal by Subject|0|||
33397575|NCT01693562|101345788|FG001|Exploration Phase|Withdrawal by Subject|0|||
33196107|NCT04086472|100622936|FG001|Overall Study|Physician Decision|1|||
33196108|NCT04086472|100622937|FG002|Overall Study|Physician Decision|1|||
33196109|NCT04086472|100622938|FG003|Overall Study|Physician Decision|0|||
33196110|NCT04086472|100622939|FG004|Overall Study|Physician Decision|0|||
33196111|NCT04086472|100622935|FG000|Overall Study|Withdrawal by Subject|1|||
33506409|NCT00095238|101747778|FG000|Overall Study|Adverse Event|331|||
33196112|NCT04086472|100622936|FG001|Overall Study|Withdrawal by Subject|1|||
33196113|NCT04086472|100622937|FG002|Overall Study|Withdrawal by Subject|1|||
33196114|NCT04086472|100622938|FG003|Overall Study|Withdrawal by Subject|0|||
33196115|NCT04086472|100622939|FG004|Overall Study|Withdrawal by Subject|0|||
33196116|NCT04086472|100622935|FG000|Overall Study|Various reasons|2|||
33196117|NCT04086472|100622936|FG001|Overall Study|Various reasons|0|||
33196118|NCT04086472|100622937|FG002|Overall Study|Various reasons|0|||
33196119|NCT04086472|100622938|FG003|Overall Study|Various reasons|3|||
33196120|NCT04086472|100622939|FG004|Overall Study|Various reasons|1|||
33196121|NCT02602288|100622940|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
33196122|NCT02602288|100622941|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
33196123|NCT02602288|100622940|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
33196124|NCT02602288|100622941|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
33196125|NCT02602288|100622940|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
33196126|NCT02602288|100622941|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
33196127|NCT02602288|100622940|FG000|12 Month Follow-up|Lost to Follow-up|0|||
33196128|NCT02602288|100622941|FG001|12 Month Follow-up|Lost to Follow-up|4|||
33196129|NCT02602288|100622940|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
33196130|NCT02602288|100622941|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
33196131|NCT03732638|100622948|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
33397576|NCT01693562|101345789|FG002|Exploration Phase|Withdrawal by Subject|0|||
33397577|NCT01693562|101345790|FG003|Exploration Phase|Withdrawal by Subject|0|||
33603925|NCT02455076|102102476|FG000|Inpatient|Withdrawal by Subject|1|||
33603926|NCT02455076|102102477|FG001|Inpatient|Withdrawal by Subject|0|||
33603927|NCT02455076|102102478|FG002|Inpatient|Withdrawal by Subject|0|||
33603928|NCT02455076|102102479|FG003|Inpatient|Withdrawal by Subject|0|||
33603929|NCT02455076|102102480|FG004|Inpatient|Withdrawal by Subject|0|||
33603930|NCT02455076|102102476|FG000|Inpatient|Discharged <24 h after admission|0|||
33603931|NCT02455076|102102477|FG001|Inpatient|Discharged <24 h after admission|1|||
33603932|NCT02455076|102102478|FG002|Inpatient|Discharged <24 h after admission|0|||
33603933|NCT02455076|102102479|FG003|Inpatient|Discharged <24 h after admission|0|||
33196132|NCT03732638|100622949|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
33196133|NCT03732638|100622948|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
33196134|NCT03732638|100622949|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
33196135|NCT03732638|100622948|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
33196136|NCT03732638|100622949|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
33196137|NCT03732638|100622948|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
33196138|NCT03732638|100622949|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
33196139|NCT03732638|100622948|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
33196140|NCT03732638|100622949|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
33196141|NCT03732638|100622948|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
33603934|NCT02455076|102102480|FG004|Inpatient|Discharged <24 h after admission|0|||
33603935|NCT02455076|102102476|FG000|Inpatient|Adverse Event|3|||
33603936|NCT02455076|102102477|FG001|Inpatient|Adverse Event|0|||
33603937|NCT02455076|102102478|FG002|Inpatient|Adverse Event|0|||
33196142|NCT03732638|100622949|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
33196143|NCT03732638|100622948|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
33196144|NCT03732638|100622949|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
33196145|NCT03732638|100622948|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
33196146|NCT03732638|100622949|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
33196147|NCT03732638|100622948|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
33196148|NCT03732638|100622949|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
33196149|NCT03732638|100622948|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
33603938|NCT02455076|102102479|FG003|Inpatient|Adverse Event|0|||
33196150|NCT03732638|100622949|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
33196151|NCT03732638|100622948|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
33196152|NCT03732638|100622949|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
33196153|NCT03732638|100622948|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
33196154|NCT03732638|100622949|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
33196155|NCT03732638|100622948|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
33196156|NCT03732638|100622949|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
33196157|NCT03732638|100622948|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
33196158|NCT03732638|100622949|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
33196159|NCT03732638|100622948|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
33196160|NCT03732638|100622949|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
33196161|NCT03732638|100622948|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
33196162|NCT03732638|100622949|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
33196163|NCT03732638|100622948|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
33196164|NCT03732638|100622949|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
33196165|NCT03732638|100622948|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
33196166|NCT03732638|100622949|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
33196167|NCT03732638|100622948|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
33196168|NCT03732638|100622949|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
33196169|NCT03732638|100622948|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
33196170|NCT03732638|100622949|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
33196171|NCT03732638|100622948|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
33196172|NCT03732638|100622949|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
33196173|NCT03732638|100622948|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
33196174|NCT03732638|100622949|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
33196175|NCT03732638|100622948|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
33196176|NCT03732638|100622949|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
33196177|NCT03732638|100622948|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
33196178|NCT03732638|100622949|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
33196179|NCT00503685|100622952|FG000|Overall Study|Adverse Event|0|||
33196180|NCT00503685|100622953|FG001|Overall Study|Adverse Event|0|||
33196181|NCT00503685|100622954|FG002|Overall Study|Adverse Event|2|||
33196182|NCT00503685|100622952|FG000|Overall Study|Withdrawal by Subject|0|||
33196183|NCT00503685|100622953|FG001|Overall Study|Withdrawal by Subject|1|||
33196184|NCT00503685|100622954|FG002|Overall Study|Withdrawal by Subject|0|||
33196185|NCT00503685|100622952|FG000|Overall Study|Protocol Violation|0|||
33196186|NCT00503685|100622953|FG001|Overall Study|Protocol Violation|1|||
33196187|NCT00503685|100622954|FG002|Overall Study|Protocol Violation|0|||
33196188|NCT00503685|100622952|FG000|Overall Study|Eligibility Criteria Not Met|0|||
33196189|NCT00503685|100622953|FG001|Overall Study|Eligibility Criteria Not Met|1|||
33196190|NCT00503685|100622954|FG002|Overall Study|Eligibility Criteria Not Met|0|||
33196191|NCT04346615|100622955|FG000|Overall Study|Lost to Follow-up|0|||
33603939|NCT02455076|102102480|FG004|Inpatient|Adverse Event|0|||
33603940|NCT02455076|102102476|FG000|Outpatient|Adverse Event|0|||
33603941|NCT02455076|102102477|FG001|Outpatient|Adverse Event|0|||
33603942|NCT02455076|102102478|FG002|Outpatient|Adverse Event|0|||
33603943|NCT02455076|102102479|FG003|Outpatient|Adverse Event|5|||
33603944|NCT02455076|102102480|FG004|Outpatient|Adverse Event|0|||
33603945|NCT02455076|102102476|FG000|Outpatient|Lost to Follow-up|0|||
33603946|NCT02455076|102102477|FG001|Outpatient|Lost to Follow-up|0|||
33603947|NCT02455076|102102478|FG002|Outpatient|Lost to Follow-up|0|||
33196192|NCT04346615|100622956|FG001|Overall Study|Lost to Follow-up|2|||
33316471|NCT01440374|101054190|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
33316472|NCT01440374|101054187|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
33316473|NCT01440374|101054188|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
33316474|NCT01440374|101054189|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
33316475|NCT01440374|101054190|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
33316476|NCT01440374|101054187|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
33316477|NCT01440374|101054188|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
33397578|NCT01693562|101345791|FG004|Exploration Phase|Withdrawal by Subject|0|||
33603948|NCT02455076|102102479|FG003|Outpatient|Lost to Follow-up|1|||
33603949|NCT02455076|102102480|FG004|Outpatient|Lost to Follow-up|12|||
33603950|NCT04375397|102102481|FG000|Overall Study|Death|1|||
33196193|NCT04346615|100622955|FG000|Overall Study|Withdrawal by Subject|1|||
33196194|NCT04346615|100622956|FG001|Overall Study|Withdrawal by Subject|0|||
33196195|NCT04346615|100622955|FG000|Overall Study|Death|5|||
33196196|NCT04346615|100622956|FG001|Overall Study|Death|1|||
33196197|NCT04346615|100622955|FG000|Overall Study|Other|0|||
33196198|NCT04346615|100622956|FG001|Overall Study|Other|2|||
33196199|NCT04346615|100622955|FG000|Overall Study|Randomized not treated|1|||
33196200|NCT04346615|100622956|FG001|Overall Study|Randomized not treated|0|||
33196201|NCT01168999|100622957|FG000|Overall Study|Lost to Follow-up|2|||
33196202|NCT01168999|100622958|FG001|Overall Study|Lost to Follow-up|1|||
33196203|NCT01168999|100622959|FG002|Overall Study|Lost to Follow-up|0|||
33603951|NCT04375397|102102482|FG001|Overall Study|Death|1|||
33196204|NCT01168999|100622960|FG003|Overall Study|Lost to Follow-up|0|||
33196205|NCT04079933|100622965|FG000|Overall Study|Withdrawal by Subject|3|||
33196206|NCT04079933|100622966|FG001|Overall Study|Withdrawal by Subject|4|||
33196207|NCT04079933|100622965|FG000|Overall Study|Lost to Follow-up|0|||
33196208|NCT04079933|100622966|FG001|Overall Study|Lost to Follow-up|1|||
33196209|NCT02047604|100622967|FG000|Overall Study|Withdrawal by Subject|0|||
33196210|NCT02047604|100622968|FG001|Overall Study|Withdrawal by Subject|0|||
33196211|NCT02047604|100622969|FG002|Overall Study|Withdrawal by Subject|0|||
33196212|NCT02047604|100622970|FG003|Overall Study|Withdrawal by Subject|0|||
33196213|NCT02047604|100622971|FG004|Overall Study|Withdrawal by Subject|1|||
33196214|NCT02047604|100622972|FG005|Overall Study|Withdrawal by Subject|1|||
33196215|NCT03296696|100622973|FG000|Overall Study|Started Other Antitumor Therapy|1|||
33196216|NCT03296696|100622974|FG001|Overall Study|Started Other Antitumor Therapy|2|||
33196217|NCT03296696|100622975|FG002|Overall Study|Started Other Antitumor Therapy|1|||
33196218|NCT03296696|100622976|FG003|Overall Study|Started Other Antitumor Therapy|2|||
33196219|NCT03296696|100622977|FG004|Overall Study|Started Other Antitumor Therapy|1|||
33196220|NCT03296696|100622978|FG005|Overall Study|Started Other Antitumor Therapy|1|||
33196221|NCT03296696|100622979|FG006|Overall Study|Started Other Antitumor Therapy|2|||
33196222|NCT03296696|100622980|FG007|Overall Study|Started Other Antitumor Therapy|3|||
33196223|NCT03296696|100622981|FG008|Overall Study|Started Other Antitumor Therapy|1|||
33196224|NCT03296696|100622982|FG009|Overall Study|Started Other Antitumor Therapy|0|||
33196225|NCT03296696|100622973|FG000|Overall Study|Death|0|||
33196226|NCT03296696|100622974|FG001|Overall Study|Death|1|||
33196227|NCT03296696|100622975|FG002|Overall Study|Death|1|||
33196228|NCT03296696|100622976|FG003|Overall Study|Death|2|||
33196229|NCT03296696|100622977|FG004|Overall Study|Death|2|||
33196230|NCT03296696|100622978|FG005|Overall Study|Death|3|||
33196231|NCT03296696|100622979|FG006|Overall Study|Death|1|||
33196232|NCT03296696|100622980|FG007|Overall Study|Death|2|||
33196233|NCT03296696|100622981|FG008|Overall Study|Death|0|||
33196234|NCT03296696|100622982|FG009|Overall Study|Death|0|||
33196235|NCT03296696|100622973|FG000|Overall Study|Withdrawal by Subject|0|||
33196236|NCT03296696|100622974|FG001|Overall Study|Withdrawal by Subject|0|||
33196237|NCT03296696|100622975|FG002|Overall Study|Withdrawal by Subject|1|||
33196238|NCT03296696|100622976|FG003|Overall Study|Withdrawal by Subject|0|||
33196239|NCT03296696|100622977|FG004|Overall Study|Withdrawal by Subject|1|||
33196240|NCT03296696|100622978|FG005|Overall Study|Withdrawal by Subject|0|||
33196241|NCT03296696|100622979|FG006|Overall Study|Withdrawal by Subject|0|||
33196242|NCT03296696|100622980|FG007|Overall Study|Withdrawal by Subject|0|||
33196243|NCT03296696|100622981|FG008|Overall Study|Withdrawal by Subject|0|||
33196244|NCT03296696|100622982|FG009|Overall Study|Withdrawal by Subject|1|||
33196245|NCT00459134|100622983|FG000|Overall Study|Physician Decision|1|||
33196246|NCT00459134|100622984|FG001|Overall Study|Physician Decision|1|||
33196247|NCT00459134|100622983|FG000|Overall Study|Withdrawal by Subject|8|||
33196248|NCT00459134|100622984|FG001|Overall Study|Withdrawal by Subject|7|||
33196249|NCT00459134|100622983|FG000|Overall Study|Lost to Follow-up|6|||
33196250|NCT00459134|100622984|FG001|Overall Study|Lost to Follow-up|7|||
33196251|NCT00459134|100622983|FG000|Overall Study|Surgery|1|||
33196252|NCT00459134|100622984|FG001|Overall Study|Surgery|2|||
33196253|NCT00459134|100622983|FG000|Overall Study|Toxicity|4|||
33196254|NCT00459134|100622984|FG001|Overall Study|Toxicity|5|||
33196255|NCT00459134|100622983|FG000|Overall Study|Progression|1|||
33196256|NCT00459134|100622984|FG001|Overall Study|Progression|0|||
33316478|NCT01440374|101054189|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
33316479|NCT01440374|101054190|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
33603952|NCT04375397|102102481|FG000|Overall Study|Withdrew consent|2|||
33603953|NCT04375397|102102482|FG001|Overall Study|Withdrew consent|0|||
33603954|NCT04375397|102102481|FG000|Overall Study|Lost to Follow-up|6|||
33603955|NCT04375397|102102482|FG001|Overall Study|Lost to Follow-up|4|||
33603956|NCT04375397|102102481|FG000|Overall Study|Other, not specified|0|||
33196257|NCT00459134|100622983|FG000|Overall Study|Multiple Reasons|2|||
33196258|NCT00459134|100622984|FG001|Overall Study|Multiple Reasons|3|||
33196259|NCT00818441|100622987|FG000|Overall Study|Death|69|||
33196260|NCT00818441|100622988|FG001|Overall Study|Death|26|||
33196261|NCT00818441|100622987|FG000|Overall Study|Other|5|||
33196262|NCT00818441|100622988|FG001|Overall Study|Other|0|||
33196263|NCT00818441|100622987|FG000|Overall Study|Lost to Follow-up|2|||
33196264|NCT00818441|100622988|FG001|Overall Study|Lost to Follow-up|1|||
33196265|NCT00818441|100622987|FG000|Overall Study|Withdrawal by Subject|2|||
33196266|NCT00818441|100622988|FG001|Overall Study|Withdrawal by Subject|0|||
33196267|NCT00818441|100622987|FG000|Overall Study|Adverse Event|0|||
33196268|NCT00818441|100622988|FG001|Overall Study|Adverse Event|1|||
33316480|NCT01440374|101054187|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
33196269|NCT00818441|100622987|FG000|Overall Study|Study terminated by sponsor|11|||
33196270|NCT00818441|100622988|FG001|Overall Study|Study terminated by sponsor|2|||
33196271|NCT01600040|100622993|FG000|Overall Study|Withdrawal by Subject|1|||
33196272|NCT01312467|100622994|FG000|Overall Study|Adverse Event|4|||
33196273|NCT01312467|100622994|FG000|Overall Study|Lost to Follow-up|1|||
33603957|NCT04375397|102102482|FG001|Overall Study|Other, not specified|1|||
33397579|NCT01693562|101345792|FG005|Exploration Phase|Withdrawal by Subject|0|||
33397580|NCT01693562|101345793|FG006|Exploration Phase|Withdrawal by Subject|2|||
33397581|NCT01693562|101345794|FG007|Exploration Phase|Withdrawal by Subject|0|||
33196274|NCT01312467|100622994|FG000|Overall Study|Withdrawal by Subject|2|||
33397582|NCT01693562|101345795|FG008|Exploration Phase|Withdrawal by Subject|0|||
33196275|NCT01312467|100622994|FG000|Overall Study|Deported to country of origin|1|||
33397583|NCT01693562|101345796|FG009|Exploration Phase|Withdrawal by Subject|0|||
33397584|NCT01693562|101345797|FG010|Exploration Phase|Withdrawal by Subject|0|||
33397585|NCT01693562|101345798|FG011|Exploration Phase|Withdrawal by Subject|0|||
33397586|NCT01693562|101345799|FG012|Exploration Phase|Withdrawal by Subject|0|||
33397587|NCT01693562|101345800|FG013|Exploration Phase|Withdrawal by Subject|0|||
33397588|NCT01693562|101345801|FG014|Exploration Phase|Withdrawal by Subject|0|||
33397589|NCT01693562|101345802|FG015|Exploration Phase|Withdrawal by Subject|0|||
33397590|NCT01693562|101345803|FG016|Exploration Phase|Withdrawal by Subject|0|||
33397591|NCT01693562|101345804|FG017|Exploration Phase|Withdrawal by Subject|0|||
33397592|NCT01693562|101345805|FG018|Exploration Phase|Withdrawal by Subject|0|||
33397593|NCT01693562|101345806|FG019|Exploration Phase|Withdrawal by Subject|0|||
33397594|NCT01693562|101345807|FG020|Exploration Phase|Withdrawal by Subject|0|||
33397595|NCT01693562|101345808|FG021|Exploration Phase|Withdrawal by Subject|0|||
33397596|NCT01693562|101345809|FG022|Exploration Phase|Withdrawal by Subject|0|||
33196276|NCT01312467|100622994|FG000|Overall Study|Another medical condition|1|||
33196277|NCT01312467|100622994|FG000|Overall Study|Ineligible|4|||
33196278|NCT01532687|100622999|FG000|Overall Study|Death|2|||
33196279|NCT01532687|100623000|FG001|Overall Study|Death|0|||
33196280|NCT01532687|100622999|FG000|Overall Study|Adverse Event|6|||
33397597|NCT01693562|101345787|FG000|Exploration Phase|Death|0|||
33397598|NCT01693562|101345788|FG001|Exploration Phase|Death|0|||
33397599|NCT01693562|101345789|FG002|Exploration Phase|Death|0|||
33397600|NCT01693562|101345790|FG003|Exploration Phase|Death|0|||
33397601|NCT01693562|101345791|FG004|Exploration Phase|Death|0|||
33397602|NCT01693562|101345792|FG005|Exploration Phase|Death|0|||
33397603|NCT01693562|101345793|FG006|Exploration Phase|Death|17|||
33397604|NCT01693562|101345794|FG007|Exploration Phase|Death|0|||
33397605|NCT01693562|101345795|FG008|Exploration Phase|Death|0|||
33397606|NCT01693562|101345796|FG009|Exploration Phase|Death|0|||
33397607|NCT01693562|101345797|FG010|Exploration Phase|Death|0|||
33397608|NCT01693562|101345798|FG011|Exploration Phase|Death|0|||
33397609|NCT01693562|101345799|FG012|Exploration Phase|Death|0|||
33397610|NCT01693562|101345800|FG013|Exploration Phase|Death|0|||
33603958|NCT01369680|102102485|FG000|Overall Study|Lost to Follow-up|0|||
33603959|NCT01369680|102102486|FG001|Overall Study|Lost to Follow-up|0|||
33603960|NCT01369680|102102487|FG002|Overall Study|Lost to Follow-up|1|||
33196281|NCT01532687|100623000|FG001|Overall Study|Adverse Event|1|||
33196282|NCT01532687|100622999|FG000|Overall Study|Withdrawal by Subject|1|||
33196283|NCT01532687|100623000|FG001|Overall Study|Withdrawal by Subject|0|||
33196284|NCT01532687|100622999|FG000|Overall Study|Physician Decision|2|||
33196285|NCT01532687|100623000|FG001|Overall Study|Physician Decision|1|||
33196286|NCT01532687|100622999|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
33196287|NCT01532687|100623000|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
33397611|NCT01693562|101345801|FG014|Exploration Phase|Death|0|||
33397612|NCT01693562|101345802|FG015|Exploration Phase|Death|0|||
33397613|NCT01693562|101345803|FG016|Exploration Phase|Death|0|||
33397614|NCT01693562|101345804|FG017|Exploration Phase|Death|0|||
33397615|NCT01693562|101345805|FG018|Exploration Phase|Death|0|||
33397616|NCT01693562|101345806|FG019|Exploration Phase|Death|0|||
33397617|NCT01693562|101345807|FG020|Exploration Phase|Death|0|||
33397618|NCT01693562|101345808|FG021|Exploration Phase|Death|0|||
33397619|NCT01693562|101345809|FG022|Exploration Phase|Death|0|||
33397620|NCT01693562|101345787|FG000|Exploration Phase|Other|0|||
33397621|NCT01693562|101345788|FG001|Exploration Phase|Other|0|||
33397622|NCT01693562|101345789|FG002|Exploration Phase|Other|0|||
33316481|NCT01440374|101054188|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
33397623|NCT01693562|101345790|FG003|Exploration Phase|Other|0|||
33397624|NCT01693562|101345791|FG004|Exploration Phase|Other|0|||
33397625|NCT01693562|101345792|FG005|Exploration Phase|Other|0|||
33397626|NCT01693562|101345793|FG006|Exploration Phase|Other|2|||
33397627|NCT01693562|101345794|FG007|Exploration Phase|Other|0|||
33397628|NCT01693562|101345795|FG008|Exploration Phase|Other|0|||
33397629|NCT01693562|101345796|FG009|Exploration Phase|Other|0|||
33397630|NCT01693562|101345797|FG010|Exploration Phase|Other|0|||
33397631|NCT01693562|101345798|FG011|Exploration Phase|Other|0|||
33224277|NCT04737109|100721771|FG002|Study Treatment|Death on study|0|||
33224278|NCT04737109|100721772|FG003|Study Treatment|Death on study|0|||
33224279|NCT03351738|100721773|FG000|Overall Study|Withdrawal by Subject|0|||
33224280|NCT03351738|100721774|FG001|Overall Study|Withdrawal by Subject|1|||
33224281|NCT03351738|100721775|FG002|Overall Study|Withdrawal by Subject|0|||
33224282|NCT03351738|100721776|FG003|Overall Study|Withdrawal by Subject|1|||
33224283|NCT03351738|100721777|FG004|Overall Study|Withdrawal by Subject|0|||
33224284|NCT03351738|100721778|FG005|Overall Study|Withdrawal by Subject|0|||
33224285|NCT03386032|100721781|FG000|Overall Study|Lack of Efficacy|6|||
33224286|NCT03386032|100721782|FG001|Overall Study|Lack of Efficacy|2|||
33224287|NCT03386032|100721783|FG002|Overall Study|Lack of Efficacy|0|||
33224288|NCT03386032|100721781|FG000|Overall Study|Adverse Event|2|||
33224289|NCT03386032|100721782|FG001|Overall Study|Adverse Event|2|||
33224290|NCT03386032|100721783|FG002|Overall Study|Adverse Event|0|||
33224291|NCT03386032|100721781|FG000|Overall Study|Withdrawal by Subject|1|||
33224292|NCT03386032|100721782|FG001|Overall Study|Withdrawal by Subject|0|||
33224293|NCT03386032|100721783|FG002|Overall Study|Withdrawal by Subject|0|||
33224294|NCT03386032|100721781|FG000|Overall Study|Lost to Follow-up|9|||
33224295|NCT03386032|100721782|FG001|Overall Study|Lost to Follow-up|3|||
33224296|NCT03386032|100721783|FG002|Overall Study|Lost to Follow-up|0|||
33224297|NCT01255592|100721784|FG000|Overall Study|Adverse Event|5|||
33224298|NCT01255592|100721785|FG001|Overall Study|Adverse Event|0|||
33224299|NCT01255592|100721784|FG000|Overall Study|Withdrawal by Subject|1|||
33224300|NCT01255592|100721785|FG001|Overall Study|Withdrawal by Subject|0|||
33224301|NCT01255592|100721784|FG000|Overall Study|Other|0|||
33224302|NCT01255592|100721785|FG001|Overall Study|Other|1|||
33224303|NCT00785707|100721786|FG000|Overall Study|Lost to Follow-up|7|||
33224304|NCT05076149|100721787|FG000|Overall Study|Adverse Event|3|||
33224305|NCT05076149|100721788|FG001|Overall Study|Adverse Event|9|||
33224306|NCT05076149|100721787|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
33224307|NCT05076149|100721788|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
33224308|NCT05076149|100721787|FG000|Overall Study|Lost to Follow-up|0|||
33224309|NCT05076149|100721788|FG001|Overall Study|Lost to Follow-up|1|||
33224310|NCT05076149|100721787|FG000|Overall Study|Commercial drug is available for participant|0|||
33224311|NCT05076149|100721788|FG001|Overall Study|Commercial drug is available for participant|1|||
33224312|NCT05076149|100721787|FG000|Overall Study|Other non compliance|1|||
33224313|NCT05076149|100721788|FG001|Overall Study|Other non compliance|1|||
33224314|NCT05076149|100721787|FG000|Overall Study|Physician Decision|0|||
33224315|NCT05076149|100721788|FG001|Overall Study|Physician Decision|1|||
33224316|NCT05076149|100721787|FG000|Overall Study|Other|5|||
33224317|NCT05076149|100721788|FG001|Overall Study|Other|4|||
33224318|NCT02202434|100721790|FG000|Overall Study|Death|70|||
33224319|NCT02202434|100721791|FG001|Overall Study|Death|39|||
33224320|NCT02202434|100721792|FG002|Overall Study|Death|13|||
33224321|NCT02202434|100721793|FG003|Overall Study|Death|27|||
33224322|NCT02202434|100721790|FG000|Overall Study|Lost to Follow-up|1|||
33224323|NCT02202434|100721791|FG001|Overall Study|Lost to Follow-up|1|||
33224324|NCT02202434|100721792|FG002|Overall Study|Lost to Follow-up|1|||
33224325|NCT02202434|100721793|FG003|Overall Study|Lost to Follow-up|0|||
33224326|NCT02202434|100721790|FG000|Overall Study|Physician Decision|2|||
33224327|NCT02202434|100721791|FG001|Overall Study|Physician Decision|3|||
33224328|NCT02202434|100721792|FG002|Overall Study|Physician Decision|0|||
33224329|NCT02202434|100721793|FG003|Overall Study|Physician Decision|0|||
33224330|NCT02202434|100721790|FG000|Overall Study|Withdrawal by Subject|13|||
33224331|NCT02202434|100721791|FG001|Overall Study|Withdrawal by Subject|14|||
33224332|NCT02202434|100721792|FG002|Overall Study|Withdrawal by Subject|1|||
33224333|NCT02202434|100721793|FG003|Overall Study|Withdrawal by Subject|4|||
33224334|NCT02202434|100721790|FG000|Overall Study|Completed Study|1|||
33224335|NCT02202434|100721791|FG001|Overall Study|Completed Study|0|||
33224336|NCT02202434|100721792|FG002|Overall Study|Completed Study|0|||
33316482|NCT01440374|101054189|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
33316483|NCT01440374|101054190|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
33316484|NCT01440374|101054187|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
33316485|NCT01440374|101054188|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
33316486|NCT01440374|101054189|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
33316487|NCT01440374|101054190|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
33316488|NCT01440374|101054187|FG000|Part 2; Double-blind Phase|Not treated|0|||
33316489|NCT01440374|101054188|FG001|Part 2; Double-blind Phase|Not treated|0|||
33506410|NCT00095238|101747779|FG001|Overall Study|Adverse Event|287|||
33506411|NCT00095238|101747778|FG000|Overall Study|Subject Withdrew Consent|208|||
33506412|NCT00095238|101747779|FG001|Overall Study|Subject Withdrew Consent|223|||
33506413|NCT00095238|101747778|FG000|Overall Study|Death|154|||
33506414|NCT00095238|101747779|FG001|Overall Study|Death|170|||
33316490|NCT01440374|101054189|FG002|Part 2; Double-blind Phase|Not treated|1|||
33316491|NCT01440374|101054190|FG003|Part 2; Double-blind Phase|Not treated|0|||
33316492|NCT01440374|101054187|FG000|Part 3: Extension|Withdrawal by Subject|0|||
33316493|NCT01440374|101054188|FG001|Part 3: Extension|Withdrawal by Subject|0|||
33316494|NCT01440374|101054189|FG002|Part 3: Extension|Withdrawal by Subject|0|||
33316495|NCT01440374|101054190|FG003|Part 3: Extension|Withdrawal by Subject|5|||
33316496|NCT01440374|101054187|FG000|Part 3: Extension|Adverse Event|0|||
33316497|NCT01440374|101054188|FG001|Part 3: Extension|Adverse Event|0|||
33316498|NCT01440374|101054189|FG002|Part 3: Extension|Adverse Event|0|||
33316499|NCT01440374|101054190|FG003|Part 3: Extension|Adverse Event|13|||
33316500|NCT01440374|101054187|FG000|Part 3: Extension|Physician Decision|0|||
33316501|NCT01440374|101054188|FG001|Part 3: Extension|Physician Decision|0|||
33316502|NCT01440374|101054189|FG002|Part 3: Extension|Physician Decision|0|||
33316503|NCT01440374|101054190|FG003|Part 3: Extension|Physician Decision|14|||
33316504|NCT01313650|101054196|FG000|Overall Study|Adverse Event|9|||
33316505|NCT01313650|101054197|FG001|Overall Study|Adverse Event|34|||
33316506|NCT01313650|101054198|FG002|Overall Study|Adverse Event|24|||
33316507|NCT01313650|101054199|FG003|Overall Study|Adverse Event|23|||
33316508|NCT01313650|101054196|FG000|Overall Study|Lack of Efficacy|37|||
33316509|NCT01313650|101054197|FG001|Overall Study|Lack of Efficacy|20|||
33316510|NCT01313650|101054198|FG002|Overall Study|Lack of Efficacy|32|||
33316511|NCT01313650|101054199|FG003|Overall Study|Lack of Efficacy|20|||
33316512|NCT01313650|101054196|FG000|Overall Study|Lost to Follow-up|1|||
33316513|NCT01313650|101054197|FG001|Overall Study|Lost to Follow-up|0|||
33316514|NCT01313650|101054198|FG002|Overall Study|Lost to Follow-up|3|||
33316515|NCT01313650|101054199|FG003|Overall Study|Lost to Follow-up|2|||
33506415|NCT00095238|101747778|FG000|Overall Study|Lost to Follow-up|19|||
33506416|NCT00095238|101747779|FG001|Overall Study|Lost to Follow-up|24|||
33506417|NCT00095238|101747778|FG000|Overall Study|Noncompliance|44|||
33506418|NCT00095238|101747779|FG001|Overall Study|Noncompliance|45|||
33506419|NCT00095238|101747778|FG000|Overall Study|No longer met study criteria|4|||
33506420|NCT00095238|101747779|FG001|Overall Study|No longer met study criteria|5|||
33506421|NCT00095238|101747778|FG000|Overall Study|Study terminated by sponsor|0|||
33506422|NCT00095238|101747779|FG001|Overall Study|Study terminated by sponsor|1|||
33506423|NCT00095238|101747778|FG000|Overall Study|Missing|1|||
33506424|NCT00095238|101747779|FG001|Overall Study|Missing|0|||
33506425|NCT00095238|101747778|FG000|Overall Study|Other Reasons|87|||
33506426|NCT00095238|101747779|FG001|Overall Study|Other Reasons|88|||
33506427|NCT04672252|101747780|FG000|Overall Study|Protocol Violation|1|||
33506428|NCT04672252|101747781|FG001|Overall Study|Protocol Violation|0|||
33506429|NCT02865499|101747793|FG000|Baseline|Adverse Event|1|||
33506430|NCT02865499|101747793|FG000|Baseline|Withdrawal by Subject|1|||
33506431|NCT00959374|101747794|FG000|Overall Study|Withdrawal by Subject|2|||
33506432|NCT00959374|101747794|FG000|Overall Study|Lost to Follow-up|14|||
33506433|NCT00959374|101747794|FG000|Overall Study|Death|1|||
33506434|NCT00959374|101747794|FG000|Overall Study|Protocol Violation|1|||
33316516|NCT01313650|101054196|FG000|Overall Study|Withdrawal by Subject|16|||
33316517|NCT01313650|101054197|FG001|Overall Study|Withdrawal by Subject|20|||
33316518|NCT01313650|101054198|FG002|Overall Study|Withdrawal by Subject|15|||
33316519|NCT01313650|101054199|FG003|Overall Study|Withdrawal by Subject|15|||
33506435|NCT00959374|101747794|FG000|Overall Study|Implant Removed/Not Replaced|4|||
33506436|NCT00959374|101747794|FG000|Overall Study|Physician Decision|1|||
33506437|NCT02702388|101747796|FG000|Overall Study|Disease Progression|18|||
33506438|NCT02702388|101747797|FG001|Overall Study|Disease Progression|25|||
33506439|NCT02702388|101747796|FG000|Overall Study|Withdrawal by Subject|9|||
33506440|NCT02702388|101747797|FG001|Overall Study|Withdrawal by Subject|7|||
33506441|NCT02702388|101747796|FG000|Overall Study|Adverse Event|11|||
33316520|NCT01313650|101054196|FG000|Overall Study|Protocol Violation|4|||
33316521|NCT01313650|101054197|FG001|Overall Study|Protocol Violation|7|||
33316522|NCT01313650|101054198|FG002|Overall Study|Protocol Violation|5|||
33316523|NCT01313650|101054199|FG003|Overall Study|Protocol Violation|6|||
33316524|NCT01313650|101054196|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
33316525|NCT01313650|101054197|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
33316526|NCT01313650|101054198|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
33316527|NCT01313650|101054199|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
33316528|NCT02168842|101054200|FG000|Overall Study|Withdrawal by Subject|5|||
33316529|NCT02168842|101054201|FG001|Overall Study|Withdrawal by Subject|3|||
33603961|NCT01369680|102102488|FG003|Overall Study|Lost to Follow-up|2|||
33603962|NCT01659255|102102489|FG000|Overall Study|Adverse Event|0|||
33603963|NCT01659255|102102490|FG001|Overall Study|Adverse Event|0|||
33603964|NCT01659255|102102491|FG002|Overall Study|Adverse Event|0|||
33603965|NCT01659255|102102492|FG003|Overall Study|Adverse Event|0|||
33603966|NCT01659255|102102493|FG004|Overall Study|Adverse Event|0|||
33603967|NCT01659255|102102494|FG005|Overall Study|Adverse Event|1|||
33603968|NCT01659255|102102495|FG006|Overall Study|Adverse Event|1|||
33316530|NCT02168842|101054200|FG000|Overall Study|Lost to Follow-up|0|||
33316531|NCT02168842|101054201|FG001|Overall Study|Lost to Follow-up|2|||
33316532|NCT02168842|101054200|FG000|Overall Study|Death|2|||
33316533|NCT02168842|101054201|FG001|Overall Study|Death|1|||
33316534|NCT02168842|101054200|FG000|Overall Study|Physician Decision|1|||
33316535|NCT02168842|101054201|FG001|Overall Study|Physician Decision|2|||
33316536|NCT03681951|101054202|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
33316537|NCT03681951|101054203|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
33316538|NCT03681951|101054204|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
33316539|NCT03681951|101054205|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
33316540|NCT03681951|101054206|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
33316541|NCT03681951|101054207|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
33316542|NCT03681951|101054208|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
33397632|NCT01693562|101345799|FG012|Exploration Phase|Other|0|||
33316543|NCT03681951|101054209|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
33316544|NCT03681951|101054202|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
33397633|NCT01693562|101345800|FG013|Exploration Phase|Other|0|||
33316545|NCT03681951|101054203|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
33316546|NCT03681951|101054204|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
33316547|NCT03681951|101054205|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
33316548|NCT03681951|101054206|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
33316549|NCT03681951|101054207|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
33316550|NCT03681951|101054208|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
33316551|NCT03681951|101054209|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
33316552|NCT03681951|101054202|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
33316553|NCT03681951|101054203|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
33316554|NCT03681951|101054204|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
33316555|NCT03681951|101054205|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
33316556|NCT03681951|101054206|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
33316557|NCT03681951|101054207|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
33316558|NCT03681951|101054208|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
33316559|NCT03681951|101054209|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
33316560|NCT00701220|101054210|FG000|Overall Study|Withdrawal by Subject|0|||
33316561|NCT00701220|101054211|FG001|Overall Study|Withdrawal by Subject|2|||
33316562|NCT00701220|101054210|FG000|Overall Study|Protocol Violation|2|||
33316563|NCT00701220|101054211|FG001|Overall Study|Protocol Violation|0|||
33316564|NCT00705523|101054215|FG000|Overall Study|Lost to Follow-up|2|||
33316565|NCT00705523|101054216|FG001|Overall Study|Lost to Follow-up|3|||
33316566|NCT02080221|101054219|FG000|Overall Study|Withdrawal by Subject|1|||
33316567|NCT02080221|101054219|FG000|Overall Study|Clinical Progression of Disease|1|||
33316568|NCT02374021|101054220|FG000|Overall Study|Adverse Event|1|||
33316569|NCT02374021|101054221|FG001|Overall Study|Adverse Event|0|||
33316570|NCT02374021|101054220|FG000|Overall Study|Lost to Follow-up|3|||
33316571|NCT02374021|101054221|FG001|Overall Study|Lost to Follow-up|2|||
33316572|NCT02374021|101054220|FG000|Overall Study|Physician Decision|0|||
33506442|NCT02702388|101747797|FG001|Overall Study|Adverse Event|15|||
33506443|NCT02702388|101747796|FG000|Overall Study|Other|2|||
33506444|NCT02702388|101747797|FG001|Overall Study|Other|4|||
33506445|NCT01841762|101747798|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
33506446|NCT01841762|101747798|FG000|Treatment Period|Adverse Event|16|||
33316573|NCT02374021|101054221|FG001|Overall Study|Physician Decision|3|||
33316574|NCT02374021|101054220|FG000|Overall Study|Withdrawal by Subject|6|||
33316575|NCT02374021|101054221|FG001|Overall Study|Withdrawal by Subject|5|||
33316576|NCT02374021|101054220|FG000|Overall Study|Poor Adherence|0|||
33506447|NCT01841762|101747798|FG000|Treatment Period|Death|1|||
33397634|NCT01693562|101345801|FG014|Exploration Phase|Other|0|||
33397635|NCT01693562|101345802|FG015|Exploration Phase|Other|0|||
33397636|NCT01693562|101345803|FG016|Exploration Phase|Other|0|||
33397637|NCT01693562|101345804|FG017|Exploration Phase|Other|0|||
33397638|NCT01693562|101345805|FG018|Exploration Phase|Other|0|||
33397639|NCT01693562|101345806|FG019|Exploration Phase|Other|0|||
33316577|NCT02374021|101054221|FG001|Overall Study|Poor Adherence|1|||
33316578|NCT02374021|101054220|FG000|Overall Study|Scan protocol not followed|0|||
33316579|NCT02374021|101054221|FG001|Overall Study|Scan protocol not followed|1|||
33316580|NCT02374021|101054220|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
33316581|NCT02374021|101054221|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
33316582|NCT02720536|101054228|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
33316583|NCT02720536|101054228|FG000|Overall Study|PR - pregnancy|2|||
33316584|NCT02720536|101054228|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
33316585|NCT02720536|101054228|FG000|Overall Study|PR - death|1|||
33316586|NCT02720536|101054228|FG000|Overall Study|PR - adverse event|1|||
33316587|NCT02720536|101054228|FG000|Overall Study|PR - abnormal lab value(s)|1|||
33316588|NCT02720536|101054228|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
33316589|NCT01395316|101054232|FG000|Overall Study|Lost to Follow-up|2|||
33316590|NCT01395316|101054232|FG000|Overall Study|poor MRI quality|1|||
33316591|NCT00995020|101054233|FG000|Overall Study|margin analysis not performed|2|||
33316592|NCT00995020|101054234|FG001|Overall Study|margin analysis not performed|5|||
33316593|NCT00995020|101054233|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
33316594|NCT00995020|101054234|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
33316595|NCT04964414|101054235|FG000|Overall Study|Lost to Follow-up|10|||
33316596|NCT04964414|101054236|FG001|Overall Study|Lost to Follow-up|8|||
33316597|NCT04964414|101054235|FG000|Overall Study|Withdrawal by Subject|1|||
33316598|NCT04964414|101054236|FG001|Overall Study|Withdrawal by Subject|1|||
33316599|NCT04754477|101054237|FG000|Overall Study|Withdrawal by Subject|1|||
33316600|NCT02824263|101054239|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
33316601|NCT02824263|101054240|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
33316602|NCT02824263|101054239|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
33316603|NCT02824263|101054240|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
33316604|NCT05105789|101054241|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
33316605|NCT00537485|101054243|FG000|Overall Study|Adverse Event|10|||
33316606|NCT00537485|101054244|FG001|Overall Study|Adverse Event|5|||
33316607|NCT00537485|101054243|FG000|Overall Study|Withdrawal by Subject|3|||
33316608|NCT00537485|101054244|FG001|Overall Study|Withdrawal by Subject|2|||
33316609|NCT00537485|101054243|FG000|Overall Study|Withdrawal by Subject|1|||
33316610|NCT00537485|101054244|FG001|Overall Study|Withdrawal by Subject|3|||
33316611|NCT00537485|101054243|FG000|Overall Study|Physician Decision|1|||
33316612|NCT00537485|101054244|FG001|Overall Study|Physician Decision|0|||
33316613|NCT00688181|101054249|FG000|Overall Study|Lost to Follow-up|17|||
33316614|NCT00688181|101054249|FG000|Overall Study|Unknown Reason|4|||
33316615|NCT00688181|101054249|FG000|Overall Study|Non-clinical Reason|2|||
33316616|NCT00926211|101054250|FG000|Overall Study|Lost to Follow-up|1|||
33316617|NCT00881608|101054251|FG000|Overall Study|Study prematurely terminated|11|||
33316618|NCT02244996|101054252|FG000|Overall Study|Lack of Efficacy|2|||
33316619|NCT02244996|101054253|FG001|Overall Study|Lack of Efficacy|6|||
33316620|NCT01971203|101054259|FG000|Overall Study|Protocol Violation|3|||
33397640|NCT01693562|101345807|FG020|Exploration Phase|Other|0|||
33397641|NCT01693562|101345808|FG021|Exploration Phase|Other|0|||
33397642|NCT01693562|101345809|FG022|Exploration Phase|Other|0|||
33397643|NCT01693562|101345787|FG000|Expansion Phase|Withdrawal by Subject|0|||
33316621|NCT01971203|101054260|FG001|Overall Study|Protocol Violation|2|||
33316622|NCT01971203|101054259|FG000|Overall Study|Withdrawal by Subject|5|||
33316623|NCT01971203|101054260|FG001|Overall Study|Withdrawal by Subject|6|||
33316624|NCT01971203|101054259|FG000|Overall Study|Adverse Event|1|||
33316625|NCT01971203|101054260|FG001|Overall Study|Adverse Event|0|||
33397644|NCT01693562|101345788|FG001|Expansion Phase|Withdrawal by Subject|0|||
33397645|NCT01693562|101345789|FG002|Expansion Phase|Withdrawal by Subject|0|||
33397646|NCT01693562|101345790|FG003|Expansion Phase|Withdrawal by Subject|0|||
33397647|NCT01693562|101345791|FG004|Expansion Phase|Withdrawal by Subject|0|||
33397648|NCT01693562|101345792|FG005|Expansion Phase|Withdrawal by Subject|0|||
33397649|NCT01693562|101345793|FG006|Expansion Phase|Withdrawal by Subject|0|||
33397650|NCT01693562|101345794|FG007|Expansion Phase|Withdrawal by Subject|16|||
33397651|NCT01693562|101345795|FG008|Expansion Phase|Withdrawal by Subject|2|||
33397652|NCT01693562|101345796|FG009|Expansion Phase|Withdrawal by Subject|54|||
33397653|NCT01693562|101345797|FG010|Expansion Phase|Withdrawal by Subject|2|||
33397654|NCT01693562|101345798|FG011|Expansion Phase|Withdrawal by Subject|2|||
33397655|NCT01693562|101345799|FG012|Expansion Phase|Withdrawal by Subject|3|||
33397656|NCT01693562|101345800|FG013|Expansion Phase|Withdrawal by Subject|5|||
33397657|NCT01693562|101345801|FG014|Expansion Phase|Withdrawal by Subject|16|||
33397658|NCT01693562|101345802|FG015|Expansion Phase|Withdrawal by Subject|7|||
33397659|NCT01693562|101345803|FG016|Expansion Phase|Withdrawal by Subject|40|||
33397660|NCT01693562|101345804|FG017|Expansion Phase|Withdrawal by Subject|4|||
33397661|NCT01693562|101345805|FG018|Expansion Phase|Withdrawal by Subject|8|||
33397662|NCT01693562|101345806|FG019|Expansion Phase|Withdrawal by Subject|3|||
33397663|NCT01693562|101345807|FG020|Expansion Phase|Withdrawal by Subject|1|||
33397664|NCT01693562|101345808|FG021|Expansion Phase|Withdrawal by Subject|8|||
33397665|NCT01693562|101345809|FG022|Expansion Phase|Withdrawal by Subject|1|||
33397666|NCT01693562|101345787|FG000|Expansion Phase|Death|0|||
33397667|NCT01693562|101345788|FG001|Expansion Phase|Death|0|||
33397668|NCT01693562|101345789|FG002|Expansion Phase|Death|0|||
33397669|NCT01693562|101345790|FG003|Expansion Phase|Death|0|||
33397670|NCT01693562|101345791|FG004|Expansion Phase|Death|0|||
33397671|NCT01693562|101345792|FG005|Expansion Phase|Death|0|||
33397672|NCT01693562|101345793|FG006|Expansion Phase|Death|0|||
33397673|NCT01693562|101345794|FG007|Expansion Phase|Death|42|||
33397674|NCT01693562|101345795|FG008|Expansion Phase|Death|17|||
33397675|NCT01693562|101345796|FG009|Expansion Phase|Death|208|||
33397676|NCT01693562|101345797|FG010|Expansion Phase|Death|30|||
33397677|NCT01693562|101345798|FG011|Expansion Phase|Death|8|||
33397678|NCT01693562|101345799|FG012|Expansion Phase|Death|19|||
33397679|NCT01693562|101345800|FG013|Expansion Phase|Death|42|||
33397680|NCT01693562|101345801|FG014|Expansion Phase|Death|23|||
33397681|NCT01693562|101345802|FG015|Expansion Phase|Death|23|||
33397682|NCT01693562|101345803|FG016|Expansion Phase|Death|128|||
33397683|NCT01693562|101345804|FG017|Expansion Phase|Death|16|||
33397684|NCT01693562|101345805|FG018|Expansion Phase|Death|36|||
33397685|NCT01693562|101345806|FG019|Expansion Phase|Death|16|||
33397686|NCT01693562|101345807|FG020|Expansion Phase|Death|17|||
33397687|NCT01693562|101345808|FG021|Expansion Phase|Death|35|||
33397688|NCT01693562|101345809|FG022|Expansion Phase|Death|7|||
33397689|NCT01693562|101345787|FG000|Expansion Phase|Lost to Follow-up|0|||
33397690|NCT01693562|101345788|FG001|Expansion Phase|Lost to Follow-up|0|||
33397691|NCT01693562|101345789|FG002|Expansion Phase|Lost to Follow-up|0|||
33397692|NCT01693562|101345790|FG003|Expansion Phase|Lost to Follow-up|0|||
33397693|NCT01693562|101345791|FG004|Expansion Phase|Lost to Follow-up|0|||
33603969|NCT01659255|102102496|FG007|Overall Study|Adverse Event|0|||
33603970|NCT01659255|102102497|FG008|Overall Study|Adverse Event|0|||
33603971|NCT01659255|102102498|FG009|Overall Study|Adverse Event|1|||
33397694|NCT01693562|101345792|FG005|Expansion Phase|Lost to Follow-up|0|||
33397695|NCT01693562|101345793|FG006|Expansion Phase|Lost to Follow-up|0|||
33397696|NCT01693562|101345794|FG007|Expansion Phase|Lost to Follow-up|1|||
33397697|NCT01693562|101345795|FG008|Expansion Phase|Lost to Follow-up|2|||
33397698|NCT01693562|101345796|FG009|Expansion Phase|Lost to Follow-up|10|||
33397699|NCT01693562|101345797|FG010|Expansion Phase|Lost to Follow-up|4|||
33397700|NCT01693562|101345798|FG011|Expansion Phase|Lost to Follow-up|4|||
33603972|NCT01659255|102102499|FG010|Overall Study|Adverse Event|0|||
33603973|NCT01659255|102102500|FG011|Overall Study|Adverse Event|1|||
33603974|NCT01659255|102102501|FG012|Overall Study|Adverse Event|0|||
33397701|NCT01693562|101345799|FG012|Expansion Phase|Lost to Follow-up|1|||
33397702|NCT01693562|101345800|FG013|Expansion Phase|Lost to Follow-up|3|||
33397703|NCT01693562|101345801|FG014|Expansion Phase|Lost to Follow-up|0|||
33397704|NCT01693562|101345802|FG015|Expansion Phase|Lost to Follow-up|1|||
33397705|NCT01693562|101345803|FG016|Expansion Phase|Lost to Follow-up|1|||
33397706|NCT01693562|101345804|FG017|Expansion Phase|Lost to Follow-up|0|||
33397707|NCT01693562|101345805|FG018|Expansion Phase|Lost to Follow-up|2|||
33397708|NCT01693562|101345806|FG019|Expansion Phase|Lost to Follow-up|1|||
33603975|NCT01659255|102102502|FG013|Overall Study|Adverse Event|2|||
33397709|NCT01693562|101345807|FG020|Expansion Phase|Lost to Follow-up|2|||
33196288|NCT04382612|100623002|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
33196289|NCT03986944|100623005|FG000|Overall Study|Adverse Event|1|||
33196290|NCT03986944|100623006|FG001|Overall Study|Adverse Event|2|||
33196291|NCT03986944|100623007|FG002|Overall Study|Adverse Event|3|||
33196292|NCT03986944|100623005|FG000|Overall Study|Protocol Violation|0|||
33196293|NCT03986944|100623006|FG001|Overall Study|Protocol Violation|1|||
33196294|NCT03986944|100623007|FG002|Overall Study|Protocol Violation|1|||
33196295|NCT03986944|100623005|FG000|Overall Study|Withdrawal by Subject|3|||
33196296|NCT03986944|100623006|FG001|Overall Study|Withdrawal by Subject|5|||
33397710|NCT01693562|101345808|FG021|Expansion Phase|Lost to Follow-up|2|||
33397711|NCT01693562|101345809|FG022|Expansion Phase|Lost to Follow-up|1|||
33397712|NCT01693562|101345787|FG000|Expansion Phase|Other|0|||
33397713|NCT01693562|101345788|FG001|Expansion Phase|Other|0|||
33397714|NCT01693562|101345789|FG002|Expansion Phase|Other|0|||
33397715|NCT01693562|101345790|FG003|Expansion Phase|Other|0|||
33196297|NCT03986944|100623007|FG002|Overall Study|Withdrawal by Subject|5|||
33196298|NCT03986944|100623005|FG000|Overall Study|Study termination|10|||
33316626|NCT02079610|101054261|FG000|Overall Study|Withdrawal by Subject|1|||
33316627|NCT02079610|101054262|FG001|Overall Study|Withdrawal by Subject|1|||
33196299|NCT03986944|100623006|FG001|Overall Study|Study termination|10|||
33196300|NCT03986944|100623007|FG002|Overall Study|Study termination|10|||
33196301|NCT03986944|100623005|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
33316628|NCT01155375|101054264|FG000|Overall Study|Adverse Event|1|||
33196302|NCT03986944|100623006|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
33196303|NCT03986944|100623007|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
33316629|NCT01155375|101054265|FG001|Overall Study|Adverse Event|0|||
33316630|NCT00294554|101054266|FG000|Overall Study|Lack of Efficacy|0|||
33316631|NCT00294554|101054267|FG001|Overall Study|Lack of Efficacy|1|||
33316632|NCT00294554|101054266|FG000|Overall Study|Physician Decision|0|||
33316633|NCT00294554|101054267|FG001|Overall Study|Physician Decision|1|||
33316634|NCT03267940|101054268|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
33316635|NCT03267940|101054269|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
33316636|NCT03267940|101054270|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
33316637|NCT03267940|101054271|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
33316638|NCT03267940|101054272|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
33316639|NCT03267940|101054273|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
33397716|NCT01693562|101345791|FG004|Expansion Phase|Other|0|||
33397717|NCT01693562|101345792|FG005|Expansion Phase|Other|0|||
33397718|NCT01693562|101345793|FG006|Expansion Phase|Other|0|||
33506448|NCT01841762|101747798|FG000|Treatment Period|Withdrawal by Subject|7|||
33506449|NCT01841762|101747798|FG000|Treatment Period|Lost to Follow-up|1|||
33506450|NCT01841762|101747798|FG000|Treatment Period|Physician Decision|2|||
33506451|NCT01841762|101747798|FG000|Treatment Period|Other, including non-compliance|5|||
33506452|NCT01841762|101747798|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
33506453|NCT01841762|101747798|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
33506454|NCT01841762|101747798|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
33506455|NCT01841762|101747798|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
33506456|NCT00886743|101747803|FG000|Overall Study|Adverse Event|3|||
33603976|NCT01659255|102102503|FG014|Overall Study|Adverse Event|0|||
33603977|NCT01659255|102102504|FG015|Overall Study|Adverse Event|1|||
33603978|NCT01659255|102102505|FG016|Overall Study|Adverse Event|0|||
33603979|NCT01659255|102102489|FG000|Overall Study|Death|0|||
33603980|NCT01659255|102102490|FG001|Overall Study|Death|1|||
33603981|NCT01659255|102102491|FG002|Overall Study|Death|0|||
33603982|NCT01659255|102102492|FG003|Overall Study|Death|0|||
33196304|NCT03986944|100623005|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
33196305|NCT03986944|100623006|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
33224337|NCT02202434|100721793|FG003|Overall Study|Completed Study|0|||
33506457|NCT00886743|101747803|FG000|Overall Study|Other|1|||
33506458|NCT04439214|101747805|FG000|Overall Study|Adverse Event|13|||
33506459|NCT04439214|101747805|FG000|Overall Study|Disease progression|16|||
33506460|NCT04439214|101747805|FG000|Overall Study|Death|1|||
33506461|NCT04439214|101747805|FG000|Overall Study|Withdrawal by Subject|2|||
33506462|NCT04439214|101747805|FG000|Overall Study|Declining health|1|||
33506463|NCT04439214|101747805|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
33506464|NCT04439214|101747805|FG000|Overall Study|Ineligible|5|||
33506465|NCT01377922|101747808|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
33196306|NCT03986944|100623007|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
33196307|NCT00132769|100623010|FG000|Overall Study|Withdrawal by Subject|1|||
33196308|NCT00132769|100623011|FG001|Overall Study|Withdrawal by Subject|3|||
33196309|NCT00132769|100623010|FG000|Overall Study|Lack of Efficacy|7|||
33196310|NCT00132769|100623011|FG001|Overall Study|Lack of Efficacy|6|||
33196311|NCT00132769|100623010|FG000|Overall Study|Adverse Event|2|||
33196312|NCT00132769|100623011|FG001|Overall Study|Adverse Event|1|||
33196313|NCT00132769|100623010|FG000|Overall Study|Protocol Violation|1|||
33196314|NCT00132769|100623011|FG001|Overall Study|Protocol Violation|1|||
33196315|NCT02738775|100623012|FG000|Overall Study|Withdrawal by Subject|0|||
33196316|NCT02738775|100623013|FG001|Overall Study|Withdrawal by Subject|1|||
33196317|NCT02738775|100623014|FG002|Overall Study|Withdrawal by Subject|0|||
33196318|NCT02738775|100623015|FG003|Overall Study|Withdrawal by Subject|0|||
33196319|NCT02738775|100623016|FG004|Overall Study|Withdrawal by Subject|0|||
33196320|NCT02738775|100623017|FG005|Overall Study|Withdrawal by Subject|0|||
33196321|NCT02738775|100623012|FG000|Overall Study|Adverse Event|0|||
33196322|NCT02738775|100623013|FG001|Overall Study|Adverse Event|0|||
33196323|NCT02738775|100623014|FG002|Overall Study|Adverse Event|0|||
33196324|NCT02738775|100623015|FG003|Overall Study|Adverse Event|1|||
33196325|NCT02738775|100623016|FG004|Overall Study|Adverse Event|0|||
33196326|NCT02738775|100623017|FG005|Overall Study|Adverse Event|0|||
33196327|NCT02738775|100623012|FG000|Overall Study|Pregnancy|0|||
33196328|NCT02738775|100623013|FG001|Overall Study|Pregnancy|1|||
33316640|NCT03267940|101054268|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
33316641|NCT03267940|101054269|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
33316642|NCT03267940|101054270|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
33316643|NCT03267940|101054271|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
33196329|NCT02738775|100623014|FG002|Overall Study|Pregnancy|0|||
33196330|NCT02738775|100623015|FG003|Overall Study|Pregnancy|0|||
33316644|NCT03267940|101054272|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
33603983|NCT01659255|102102493|FG004|Overall Study|Death|0|||
33603984|NCT01659255|102102494|FG005|Overall Study|Death|0|||
33603985|NCT01659255|102102495|FG006|Overall Study|Death|0|||
33603986|NCT01659255|102102496|FG007|Overall Study|Death|1|||
33603987|NCT01659255|102102497|FG008|Overall Study|Death|1|||
33603988|NCT01659255|102102498|FG009|Overall Study|Death|0|||
33603989|NCT01659255|102102499|FG010|Overall Study|Death|0|||
33603990|NCT01659255|102102500|FG011|Overall Study|Death|0|||
33316645|NCT03267940|101054273|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
33397719|NCT01693562|101345794|FG007|Expansion Phase|Other|3|||
33397720|NCT01693562|101345795|FG008|Expansion Phase|Other|1|||
33397721|NCT01693562|101345796|FG009|Expansion Phase|Other|28|||
33397722|NCT01693562|101345797|FG010|Expansion Phase|Other|4|||
33506466|NCT01377922|101747809|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
33506467|NCT00679029|101747810|FG000|Overall Study|Adverse Event|3|||
33506468|NCT00679029|101747810|FG000|Overall Study|Withdrawal by Subject|1|||
33506469|NCT00679029|101747810|FG000|Overall Study|Lost to Follow-up|1|||
33506470|NCT02964507|101747811|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
33506471|NCT02964507|101747812|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
33506472|NCT02964507|101747813|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
33506473|NCT02964507|101747814|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
33506474|NCT02964507|101747815|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
33506475|NCT02964507|101747816|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
33506476|NCT02964507|101747817|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
33506477|NCT02964507|101747818|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
33603991|NCT01659255|102102501|FG012|Overall Study|Death|1|||
33603992|NCT01659255|102102502|FG013|Overall Study|Death|1|||
33603993|NCT01659255|102102503|FG014|Overall Study|Death|2|||
33603994|NCT01659255|102102504|FG015|Overall Study|Death|1|||
33603995|NCT01659255|102102505|FG016|Overall Study|Death|0|||
33603996|NCT01659255|102102489|FG000|Overall Study|Progressive Disease|2|||
33603997|NCT01659255|102102490|FG001|Overall Study|Progressive Disease|0|||
33603998|NCT01659255|102102491|FG002|Overall Study|Progressive Disease|0|||
33603999|NCT01659255|102102492|FG003|Overall Study|Progressive Disease|0|||
33604000|NCT01659255|102102493|FG004|Overall Study|Progressive Disease|0|||
33604001|NCT01659255|102102494|FG005|Overall Study|Progressive Disease|0|||
33604002|NCT01659255|102102495|FG006|Overall Study|Progressive Disease|0|||
33397723|NCT01693562|101345798|FG011|Expansion Phase|Other|7|||
33397724|NCT01693562|101345799|FG012|Expansion Phase|Other|0|||
33506478|NCT02964507|101747811|FG000|Overall Study|Study terminated by Sponsor|9|||
33604003|NCT01659255|102102496|FG007|Overall Study|Progressive Disease|1|||
33604004|NCT01659255|102102497|FG008|Overall Study|Progressive Disease|0|||
33604005|NCT01659255|102102498|FG009|Overall Study|Progressive Disease|2|||
33196331|NCT02738775|100623016|FG004|Overall Study|Pregnancy|0|||
33196332|NCT02738775|100623017|FG005|Overall Study|Pregnancy|0|||
33196333|NCT02738775|100623012|FG000|Overall Study|Missing|0|||
33196334|NCT02738775|100623013|FG001|Overall Study|Missing|0|||
33196335|NCT02738775|100623014|FG002|Overall Study|Missing|0|||
33196336|NCT02738775|100623015|FG003|Overall Study|Missing|0|||
33196337|NCT02738775|100623016|FG004|Overall Study|Missing|0|||
33196338|NCT02738775|100623017|FG005|Overall Study|Missing|1|||
33196339|NCT02331446|100623018|FG000|Overall Study|Lost to Follow-up|2|||
33196340|NCT02331446|100623019|FG001|Overall Study|Lost to Follow-up|1|||
33196341|NCT02331446|100623020|FG002|Overall Study|Lost to Follow-up|0|||
33196342|NCT02331446|100623021|FG003|Overall Study|Lost to Follow-up|1|||
33196343|NCT02331446|100623018|FG000|Overall Study|Personal Problem|2|||
33196344|NCT02331446|100623019|FG001|Overall Study|Personal Problem|0|||
33196345|NCT02331446|100623020|FG002|Overall Study|Personal Problem|0|||
33196346|NCT02331446|100623021|FG003|Overall Study|Personal Problem|0|||
33196347|NCT02331446|100623018|FG000|Overall Study|Disease|0|||
33196348|NCT02331446|100623019|FG001|Overall Study|Disease|2|||
33196349|NCT02331446|100623020|FG002|Overall Study|Disease|2|||
33196350|NCT02331446|100623021|FG003|Overall Study|Disease|1|||
33196351|NCT02331446|100623018|FG000|Overall Study|Physician Decision|0|||
33196352|NCT02331446|100623019|FG001|Overall Study|Physician Decision|1|||
33196353|NCT02331446|100623020|FG002|Overall Study|Physician Decision|0|||
33196354|NCT02331446|100623021|FG003|Overall Study|Physician Decision|1|||
33196355|NCT02331446|100623018|FG000|Overall Study|Lost before baseline analysis|0|||
33196356|NCT02331446|100623019|FG001|Overall Study|Lost before baseline analysis|1|||
33196357|NCT02331446|100623020|FG002|Overall Study|Lost before baseline analysis|1|||
33196358|NCT02331446|100623021|FG003|Overall Study|Lost before baseline analysis|0|||
33196359|NCT02370888|100623033|FG000|Overall Study|disease progression|2|||
33196360|NCT02370888|100623033|FG000|Overall Study|did not meet chimerism criteria|6|||
33196361|NCT01994395|100623038|FG000|Overall Study|Withdrawal by Subject|1|||
33196362|NCT01994395|100623039|FG001|Overall Study|Withdrawal by Subject|2|||
33196363|NCT04537715|100623040|FG000|Overall Study|Death|3|||
33397725|NCT01693562|101345800|FG013|Expansion Phase|Other|1|||
33397726|NCT01693562|101345801|FG014|Expansion Phase|Other|1|||
33397727|NCT01693562|101345802|FG015|Expansion Phase|Other|0|||
33397728|NCT01693562|101345803|FG016|Expansion Phase|Other|28|||
33397729|NCT01693562|101345804|FG017|Expansion Phase|Other|0|||
33196364|NCT04537715|100623041|FG001|Overall Study|Death|1|||
33196365|NCT04537715|100623040|FG000|Overall Study|Withdrawal by Subject|3|||
33196366|NCT04537715|100623041|FG001|Overall Study|Withdrawal by Subject|1|||
33196367|NCT04537715|100623040|FG000|Overall Study|Other|4|||
33196368|NCT04537715|100623041|FG001|Overall Study|Other|3|||
33196369|NCT04537715|100623040|FG000|Overall Study|Progressive disease|1|||
33196370|NCT04537715|100623041|FG001|Overall Study|Progressive disease|0|||
33196371|NCT04456699|100623042|FG000|Overall Study|Death|48|||
33196372|NCT04456699|100623043|FG001|Overall Study|Death|50|||
33397730|NCT01693562|101345805|FG018|Expansion Phase|Other|1|||
33196373|NCT04456699|100623044|FG002|Overall Study|Death|52|||
33196374|NCT04456699|100623042|FG000|Overall Study|Physician Decision|0|||
33196375|NCT04456699|100623043|FG001|Overall Study|Physician Decision|0|||
33196376|NCT04456699|100623044|FG002|Overall Study|Physician Decision|2|||
33196377|NCT04456699|100623042|FG000|Overall Study|Sponsor Decision|55|||
33196378|NCT04456699|100623043|FG001|Overall Study|Sponsor Decision|61|||
33196379|NCT04456699|100623044|FG002|Overall Study|Sponsor Decision|50|||
33196380|NCT04456699|100623042|FG000|Overall Study|Withdrawal by Subject|8|||
33196381|NCT04456699|100623043|FG001|Overall Study|Withdrawal by Subject|4|||
33196382|NCT04456699|100623044|FG002|Overall Study|Withdrawal by Subject|5|||
33196383|NCT02788175|100623049|FG000|Overall Study|Protocol Violation|3|||
33196384|NCT02788175|100623049|FG000|Overall Study|Withdrawal by Subject|4|||
33196385|NCT02788175|100623049|FG000|Overall Study|Ineligible prior to study agent|6|||
33196386|NCT03433456|100623050|FG000|Overall Study|Death|1|||
33196387|NCT03433456|100623051|FG001|Overall Study|Death|1|||
33196388|NCT03433456|100623050|FG000|Overall Study|Lost to Follow-up|14|||
33506479|NCT02964507|101747812|FG001|Overall Study|Study terminated by Sponsor|1|||
33196389|NCT03433456|100623051|FG001|Overall Study|Lost to Follow-up|11|||
33196390|NCT03433456|100623050|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
33196391|NCT03433456|100623051|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
33196392|NCT04796610|100623052|FG000|Overall Study|Withdrawal by Subject|1|||
33196393|NCT04796610|100623053|FG001|Overall Study|Withdrawal by Subject|0|||
33506480|NCT02964507|101747813|FG002|Overall Study|Study terminated by Sponsor|9|||
33196394|NCT04796610|100623054|FG002|Overall Study|Withdrawal by Subject|0|||
33506481|NCT02964507|101747814|FG003|Overall Study|Study terminated by Sponsor|3|||
33506482|NCT02964507|101747815|FG004|Overall Study|Study terminated by Sponsor|3|||
33506483|NCT02964507|101747816|FG005|Overall Study|Study terminated by Sponsor|2|||
33506484|NCT02964507|101747817|FG006|Overall Study|Study terminated by Sponsor|0|||
33506485|NCT02964507|101747818|FG007|Overall Study|Study terminated by Sponsor|0|||
33506486|NCT02964507|101747811|FG000|Overall Study|Other|3|||
33506487|NCT02964507|101747812|FG001|Overall Study|Other|0|||
33506488|NCT02964507|101747813|FG002|Overall Study|Other|0|||
33506489|NCT02964507|101747814|FG003|Overall Study|Other|0|||
33604006|NCT01659255|102102499|FG010|Overall Study|Progressive Disease|2|||
33604007|NCT01659255|102102500|FG011|Overall Study|Progressive Disease|3|||
33604008|NCT01659255|102102501|FG012|Overall Study|Progressive Disease|5|||
33604009|NCT01659255|102102502|FG013|Overall Study|Progressive Disease|13|||
33604010|NCT01659255|102102503|FG014|Overall Study|Progressive Disease|6|||
33604011|NCT01659255|102102504|FG015|Overall Study|Progressive Disease|2|||
33604012|NCT01659255|102102505|FG016|Overall Study|Progressive Disease|3|||
33604013|NCT01659255|102102489|FG000|Overall Study|Withdrew Consent|0|||
33604014|NCT01659255|102102490|FG001|Overall Study|Withdrew Consent|0|||
33604015|NCT01659255|102102491|FG002|Overall Study|Withdrew Consent|0|||
33604016|NCT01659255|102102492|FG003|Overall Study|Withdrew Consent|0|||
33604017|NCT01659255|102102493|FG004|Overall Study|Withdrew Consent|0|||
33604018|NCT01659255|102102494|FG005|Overall Study|Withdrew Consent|0|||
33604019|NCT01659255|102102495|FG006|Overall Study|Withdrew Consent|0|||
33604020|NCT01659255|102102496|FG007|Overall Study|Withdrew Consent|0|||
33604021|NCT01659255|102102497|FG008|Overall Study|Withdrew Consent|0|||
33604022|NCT01659255|102102498|FG009|Overall Study|Withdrew Consent|0|||
33604023|NCT01659255|102102499|FG010|Overall Study|Withdrew Consent|1|||
33604024|NCT01659255|102102500|FG011|Overall Study|Withdrew Consent|0|||
33604025|NCT01659255|102102501|FG012|Overall Study|Withdrew Consent|0|||
33604026|NCT01659255|102102502|FG013|Overall Study|Withdrew Consent|1|||
33604027|NCT01659255|102102503|FG014|Overall Study|Withdrew Consent|0|||
33604028|NCT01659255|102102504|FG015|Overall Study|Withdrew Consent|0|||
33604029|NCT01659255|102102505|FG016|Overall Study|Withdrew Consent|0|||
33604030|NCT01659255|102102489|FG000|Overall Study|Investigator Decision|0|||
33604031|NCT01659255|102102490|FG001|Overall Study|Investigator Decision|0|||
33604032|NCT01659255|102102491|FG002|Overall Study|Investigator Decision|0|||
33604033|NCT01659255|102102492|FG003|Overall Study|Investigator Decision|0|||
33604034|NCT01659255|102102493|FG004|Overall Study|Investigator Decision|0|||
33604035|NCT01659255|102102494|FG005|Overall Study|Investigator Decision|0|||
33604036|NCT01659255|102102495|FG006|Overall Study|Investigator Decision|0|||
33604037|NCT01659255|102102496|FG007|Overall Study|Investigator Decision|0|||
33604038|NCT01659255|102102497|FG008|Overall Study|Investigator Decision|0|||
33604039|NCT01659255|102102498|FG009|Overall Study|Investigator Decision|0|||
33604040|NCT01659255|102102499|FG010|Overall Study|Investigator Decision|0|||
33604041|NCT01659255|102102500|FG011|Overall Study|Investigator Decision|0|||
33604042|NCT01659255|102102501|FG012|Overall Study|Investigator Decision|1|||
33604043|NCT01659255|102102502|FG013|Overall Study|Investigator Decision|1|||
33604044|NCT01659255|102102503|FG014|Overall Study|Investigator Decision|0|||
33506490|NCT02964507|101747815|FG004|Overall Study|Other|1|||
33506491|NCT02964507|101747816|FG005|Overall Study|Other|0|||
33604045|NCT01659255|102102504|FG015|Overall Study|Investigator Decision|0|||
33196395|NCT04796610|100623055|FG003|Overall Study|Withdrawal by Subject|0|||
33196396|NCT04796610|100623052|FG000|Overall Study|Lost to Follow-up|2|||
33196397|NCT04796610|100623053|FG001|Overall Study|Lost to Follow-up|0|||
33196398|NCT04796610|100623054|FG002|Overall Study|Lost to Follow-up|1|||
33196399|NCT04796610|100623055|FG003|Overall Study|Lost to Follow-up|1|||
33196400|NCT03160703|100623056|FG000|Overall Study|Withdrawal by Subject|0|||
33196401|NCT03160703|100623057|FG001|Overall Study|Withdrawal by Subject|0|||
33196402|NCT03160703|100623058|FG002|Overall Study|Withdrawal by Subject|0|||
33196403|NCT03160703|100623059|FG003|Overall Study|Withdrawal by Subject|1|||
33196404|NCT04713748|100623060|FG000|Overall Study|Not enough kits allocated|35|||
33196405|NCT00733824|100623061|FG000|Phase I|Withdrawal by Subject|1|||
33196406|NCT00733824|100623062|FG001|Phase I|Withdrawal by Subject|0|||
33196407|NCT00733824|100623063|FG002|Phase I|Withdrawal by Subject|0|||
33196408|NCT00733824|100623064|FG003|Phase I|Withdrawal by Subject|0|||
33196409|NCT00733824|100623065|FG004|Phase I|Withdrawal by Subject|0|||
33196410|NCT04101526|100623066|FG000|Overall Study|Did not complete all sleep diary entries|0|||
33196411|NCT04101526|100623067|FG001|Overall Study|Did not complete all sleep diary entries|1|||
33196412|NCT00718718|100623068|FG000|Prior to Week 12|Adverse Event|0|||
33196413|NCT00718718|100623069|FG001|Prior to Week 12|Adverse Event|0|||
33196414|NCT00718718|100623070|FG002|Prior to Week 12|Adverse Event|0|||
33196415|NCT00718718|100623071|FG003|Prior to Week 12|Adverse Event|0|||
33196416|NCT00718718|100623072|FG004|Prior to Week 12|Adverse Event|0|||
33196417|NCT00718718|100623073|FG005|Prior to Week 12|Adverse Event|0|||
33196418|NCT00718718|100623074|FG006|Prior to Week 12|Adverse Event|0|||
33196419|NCT00718718|100623075|FG007|Prior to Week 12|Adverse Event|1|||
33196420|NCT00718718|100623076|FG008|Prior to Week 12|Adverse Event|1|||
33196421|NCT00718718|100623077|FG009|Prior to Week 12|Adverse Event|0|||
33196422|NCT00718718|100623068|FG000|Prior to Week 12|Withdrawal by Subject|0|||
33196423|NCT00718718|100623069|FG001|Prior to Week 12|Withdrawal by Subject|0|||
33196424|NCT00718718|100623070|FG002|Prior to Week 12|Withdrawal by Subject|0|||
33196425|NCT00718718|100623071|FG003|Prior to Week 12|Withdrawal by Subject|0|||
33196426|NCT00718718|100623072|FG004|Prior to Week 12|Withdrawal by Subject|3|||
33196427|NCT00718718|100623073|FG005|Prior to Week 12|Withdrawal by Subject|0|||
33196428|NCT00718718|100623074|FG006|Prior to Week 12|Withdrawal by Subject|1|||
33196429|NCT00718718|100623075|FG007|Prior to Week 12|Withdrawal by Subject|1|||
33196430|NCT00718718|100623076|FG008|Prior to Week 12|Withdrawal by Subject|1|||
33196431|NCT00718718|100623077|FG009|Prior to Week 12|Withdrawal by Subject|0|||
33196432|NCT00718718|100623068|FG000|Prior to Week 12|Other|1|||
33196433|NCT00718718|100623069|FG001|Prior to Week 12|Other|0|||
33196434|NCT00718718|100623070|FG002|Prior to Week 12|Other|1|||
33196435|NCT00718718|100623071|FG003|Prior to Week 12|Other|0|||
33196436|NCT00718718|100623072|FG004|Prior to Week 12|Other|0|||
33196437|NCT00718718|100623073|FG005|Prior to Week 12|Other|0|||
33196438|NCT00718718|100623074|FG006|Prior to Week 12|Other|0|||
33196439|NCT00718718|100623075|FG007|Prior to Week 12|Other|0|||
33196440|NCT00718718|100623076|FG008|Prior to Week 12|Other|0|||
33196441|NCT00718718|100623077|FG009|Prior to Week 12|Other|0|||
33196442|NCT00718718|100623068|FG000|Week 12 to End of Study|Adverse Event|0|||
33196443|NCT00718718|100623069|FG001|Week 12 to End of Study|Adverse Event|0|||
33196444|NCT00718718|100623070|FG002|Week 12 to End of Study|Adverse Event|0|||
33196445|NCT00718718|100623071|FG003|Week 12 to End of Study|Adverse Event|0|||
33604046|NCT01659255|102102505|FG016|Overall Study|Investigator Decision|0|||
33604047|NCT01659255|102102489|FG000|Overall Study|Sponsor's Decision|0|||
33196446|NCT00718718|100623072|FG004|Week 12 to End of Study|Adverse Event|0|||
33196447|NCT00718718|100623073|FG005|Week 12 to End of Study|Adverse Event|0|||
33196448|NCT00718718|100623074|FG006|Week 12 to End of Study|Adverse Event|0|||
33196449|NCT00718718|100623075|FG007|Week 12 to End of Study|Adverse Event|1|||
33196450|NCT00718718|100623076|FG008|Week 12 to End of Study|Adverse Event|0|||
33196451|NCT00718718|100623077|FG009|Week 12 to End of Study|Adverse Event|0|||
33196452|NCT00718718|100623068|FG000|Week 12 to End of Study|Death|0|||
33196453|NCT00718718|100623069|FG001|Week 12 to End of Study|Death|0|||
33196454|NCT00718718|100623070|FG002|Week 12 to End of Study|Death|0|||
33196455|NCT00718718|100623071|FG003|Week 12 to End of Study|Death|0|||
33196456|NCT00718718|100623072|FG004|Week 12 to End of Study|Death|0|||
33196457|NCT00718718|100623073|FG005|Week 12 to End of Study|Death|1|||
33196458|NCT00718718|100623074|FG006|Week 12 to End of Study|Death|0|||
33196459|NCT00718718|100623075|FG007|Week 12 to End of Study|Death|0|||
33196460|NCT00718718|100623076|FG008|Week 12 to End of Study|Death|0|||
33196461|NCT00718718|100623077|FG009|Week 12 to End of Study|Death|0|||
33506492|NCT02964507|101747817|FG006|Overall Study|Other|0|||
33196462|NCT00718718|100623068|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
33196463|NCT00718718|100623069|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
33196464|NCT00718718|100623070|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
33196465|NCT00718718|100623071|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
33196466|NCT00718718|100623072|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
33506493|NCT02964507|101747818|FG007|Overall Study|Other|0|||
33196467|NCT00718718|100623073|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
33196468|NCT00718718|100623074|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
33196469|NCT00718718|100623075|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
33196470|NCT00718718|100623076|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
33196471|NCT00718718|100623077|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
33196472|NCT00718718|100623068|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
33196473|NCT00718718|100623069|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
33196474|NCT00718718|100623070|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
33196475|NCT00718718|100623071|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
33196476|NCT00718718|100623072|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
33196477|NCT00718718|100623073|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
33196478|NCT00718718|100623074|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
33196479|NCT00718718|100623075|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
33506494|NCT02964507|101747811|FG000|Overall Study|Death|11|||
33506495|NCT02964507|101747812|FG001|Overall Study|Death|9|||
33196480|NCT00718718|100623076|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
33196481|NCT00718718|100623077|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
33506496|NCT02964507|101747813|FG002|Overall Study|Death|12|||
33604048|NCT01659255|102102490|FG001|Overall Study|Sponsor's Decision|0|||
33604049|NCT01659255|102102491|FG002|Overall Study|Sponsor's Decision|0|||
33604050|NCT01659255|102102492|FG003|Overall Study|Sponsor's Decision|0|||
33604051|NCT01659255|102102493|FG004|Overall Study|Sponsor's Decision|0|||
33397731|NCT01693562|101345806|FG019|Expansion Phase|Other|0|||
33397732|NCT01693562|101345807|FG020|Expansion Phase|Other|1|||
33397733|NCT01693562|101345808|FG021|Expansion Phase|Other|17|||
33397734|NCT01693562|101345809|FG022|Expansion Phase|Other|1|||
33397735|NCT01308853|101345811|FG000|Overall Study|Adverse Event|1|||
33397736|NCT01308853|101345811|FG000|Overall Study|Lost to Follow-up|2|||
33397737|NCT01308853|101345811|FG000|Overall Study|Insertion of permanent implants|1|||
33397738|NCT00772889|101345822|FG000|Overall Study|Adverse Event|7|||
33397739|NCT00772889|101345823|FG001|Overall Study|Adverse Event|4|||
33397740|NCT00772889|101345824|FG002|Overall Study|Adverse Event|0|||
33397741|NCT00772889|101345822|FG000|Overall Study|Withdrawal by Subject|9|||
33397742|NCT00772889|101345823|FG001|Overall Study|Withdrawal by Subject|8|||
33397743|NCT00772889|101345824|FG002|Overall Study|Withdrawal by Subject|9|||
33397744|NCT00772889|101345822|FG000|Overall Study|Lost to Follow-up|6|||
33397745|NCT00772889|101345823|FG001|Overall Study|Lost to Follow-up|6|||
33397746|NCT00772889|101345824|FG002|Overall Study|Lost to Follow-up|7|||
33397747|NCT03137173|101345825|FG000|Overall Study|Withdrawal by Subject|8|||
33397748|NCT03137173|101345826|FG001|Overall Study|Withdrawal by Subject|13|||
33397749|NCT03137173|101345825|FG000|Overall Study|Death|1|||
33397750|NCT03137173|101345826|FG001|Overall Study|Death|3|||
33506497|NCT02964507|101747814|FG003|Overall Study|Death|2|||
33506498|NCT02964507|101747815|FG004|Overall Study|Death|10|||
33506499|NCT02964507|101747816|FG005|Overall Study|Death|5|||
33506500|NCT02964507|101747817|FG006|Overall Study|Death|0|||
33506501|NCT02964507|101747818|FG007|Overall Study|Death|0|||
33506502|NCT02964507|101747811|FG000|Overall Study|Withdrawal by Subject|1|||
33506503|NCT02964507|101747812|FG001|Overall Study|Withdrawal by Subject|0|||
33506504|NCT02964507|101747813|FG002|Overall Study|Withdrawal by Subject|1|||
33506505|NCT02964507|101747814|FG003|Overall Study|Withdrawal by Subject|1|||
33506506|NCT02964507|101747815|FG004|Overall Study|Withdrawal by Subject|0|||
33506507|NCT02964507|101747816|FG005|Overall Study|Withdrawal by Subject|1|||
33604052|NCT01659255|102102494|FG005|Overall Study|Sponsor's Decision|0|||
33604053|NCT01659255|102102495|FG006|Overall Study|Sponsor's Decision|1|||
33604054|NCT01659255|102102496|FG007|Overall Study|Sponsor's Decision|0|||
33604055|NCT01659255|102102497|FG008|Overall Study|Sponsor's Decision|0|||
33604056|NCT01659255|102102498|FG009|Overall Study|Sponsor's Decision|0|||
33604057|NCT01659255|102102499|FG010|Overall Study|Sponsor's Decision|0|||
33604058|NCT01659255|102102500|FG011|Overall Study|Sponsor's Decision|0|||
33604059|NCT01659255|102102501|FG012|Overall Study|Sponsor's Decision|0|||
33604060|NCT01659255|102102502|FG013|Overall Study|Sponsor's Decision|0|||
33604061|NCT01659255|102102503|FG014|Overall Study|Sponsor's Decision|0|||
33604062|NCT01659255|102102504|FG015|Overall Study|Sponsor's Decision|0|||
33604063|NCT01659255|102102505|FG016|Overall Study|Sponsor's Decision|0|||
33604064|NCT01659255|102102489|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33604065|NCT01659255|102102490|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33397751|NCT03137173|101345825|FG000|Overall Study|Physician Decision|1|||
33397752|NCT03137173|101345826|FG001|Overall Study|Physician Decision|0|||
33506508|NCT02964507|101747817|FG006|Overall Study|Withdrawal by Subject|0|||
33506509|NCT02964507|101747818|FG007|Overall Study|Withdrawal by Subject|0|||
33506510|NCT02964507|101747811|FG000|Overall Study|Physician Decision|2|||
33604066|NCT01659255|102102491|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33604067|NCT01659255|102102492|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33604068|NCT01659255|102102493|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33316646|NCT03267940|101054268|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
33316647|NCT03267940|101054269|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
33316648|NCT03267940|101054270|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
33316649|NCT03267940|101054271|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
33316650|NCT03267940|101054272|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
33316651|NCT03267940|101054273|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
33316652|NCT03267940|101054268|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
33316653|NCT03267940|101054269|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
33316654|NCT03267940|101054270|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
33316655|NCT03267940|101054271|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
33316656|NCT03267940|101054272|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
33316657|NCT03267940|101054273|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
33316658|NCT03267940|101054268|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
33316659|NCT03267940|101054269|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
33316660|NCT03267940|101054270|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
33316661|NCT03267940|101054271|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
33316662|NCT03267940|101054272|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
33316663|NCT03267940|101054273|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
33316664|NCT03267940|101054268|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
33316665|NCT03267940|101054269|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
33316666|NCT03267940|101054270|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
33316667|NCT03267940|101054271|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
33316668|NCT03267940|101054272|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
33316669|NCT03267940|101054273|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
33316670|NCT03267940|101054268|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
33316671|NCT03267940|101054269|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
33316672|NCT03267940|101054270|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
33316673|NCT03267940|101054271|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
33316674|NCT03267940|101054272|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
33316675|NCT03267940|101054273|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
33604069|NCT01659255|102102494|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33604070|NCT01659255|102102495|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33604071|NCT01659255|102102496|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33604072|NCT01659255|102102497|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33604073|NCT01659255|102102498|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33604074|NCT01659255|102102499|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33604075|NCT01659255|102102500|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33604076|NCT01659255|102102501|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33604077|NCT01659255|102102502|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33604078|NCT01659255|102102503|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33604079|NCT01659255|102102504|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
33604080|NCT01659255|102102505|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
33604081|NCT01659255|102102489|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
33604082|NCT01659255|102102490|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
33604083|NCT01659255|102102491|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
33604084|NCT01659255|102102492|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
33604085|NCT01659255|102102493|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
33316676|NCT03267940|101054268|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
33196482|NCT00718718|100623068|FG000|Week 12 to End of Study|Other|0|||
33196483|NCT00718718|100623069|FG001|Week 12 to End of Study|Other|1|||
33196484|NCT00718718|100623070|FG002|Week 12 to End of Study|Other|0|||
33196485|NCT00718718|100623071|FG003|Week 12 to End of Study|Other|1|||
33196486|NCT00718718|100623072|FG004|Week 12 to End of Study|Other|0|||
33196487|NCT00718718|100623073|FG005|Week 12 to End of Study|Other|0|||
33196488|NCT00718718|100623074|FG006|Week 12 to End of Study|Other|1|||
33196489|NCT00718718|100623075|FG007|Week 12 to End of Study|Other|0|||
33196490|NCT00718718|100623076|FG008|Week 12 to End of Study|Other|0|||
33196491|NCT00718718|100623077|FG009|Week 12 to End of Study|Other|0|||
33196492|NCT02985736|100623078|FG000|Overall Study|Lost to Follow-up|3|||
33196493|NCT00298896|100623087|FG000|Overall Study|Death|3|||
33196494|NCT00298896|100623087|FG000|Overall Study|Physician Decision|2|||
33196495|NCT00298896|100623087|FG000|Overall Study|Intercurrent Illness|1|||
33196496|NCT00298896|100623087|FG000|Overall Study|Disease Progression|41|||
33196497|NCT00298896|100623087|FG000|Overall Study|Withdrawal by Subject|2|||
33196498|NCT00298896|100623087|FG000|Overall Study|Assigned to treatment in error|1|||
33196499|NCT00162136|100623092|FG000|Overall Study|Adverse Event|1|||
33196500|NCT00162136|100623092|FG000|Overall Study|Death|1|||
33196501|NCT00162136|100623092|FG000|Overall Study|Disease Progression/Relapse|23|||
33196502|NCT00162136|100623092|FG000|Overall Study|Investigator Request|5|||
33196503|NCT00162136|100623092|FG000|Overall Study|Study Drug Toxicity|4|||
33196504|NCT00162136|100623092|FG000|Overall Study|Withdrawal by Subject|1|||
33196505|NCT04304001|100623093|FG000|Overall Study|Lost to Follow-up|13|||
33196506|NCT04304001|100623094|FG001|Overall Study|Lost to Follow-up|9|||
33196507|NCT00813761|100623098|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
33196508|NCT00813761|100623099|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
33196509|NCT00813761|100623100|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
33196510|NCT00813761|100623101|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
33196511|NCT00813761|100623098|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
33196512|NCT00813761|100623099|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
33196513|NCT00813761|100623100|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
33196514|NCT00813761|100623101|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
33196515|NCT00813761|100623098|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
33196516|NCT00813761|100623099|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
33196517|NCT00813761|100623100|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
33196518|NCT00813761|100623101|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
33196519|NCT00813761|100623098|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
33196520|NCT00813761|100623099|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
33196521|NCT00813761|100623100|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
33196522|NCT00813761|100623101|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
33196523|NCT00813761|100623098|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
33196524|NCT00813761|100623099|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
33196525|NCT00813761|100623100|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
33196526|NCT00813761|100623101|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
33196527|NCT00813761|100623098|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
33196528|NCT00813761|100623099|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
33196529|NCT00813761|100623100|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
33196530|NCT00813761|100623101|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
33196531|NCT00813761|100623098|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
33196532|NCT00813761|100623099|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
33196533|NCT00813761|100623100|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
33196534|NCT00813761|100623101|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
33196535|NCT00813761|100623098|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
33196536|NCT00813761|100623099|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
33196537|NCT00813761|100623100|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
33196538|NCT00813761|100623101|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
33196539|NCT00813761|100623098|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
33196540|NCT00813761|100623099|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
33196541|NCT00813761|100623100|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
33196542|NCT00813761|100623101|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
33196543|NCT00813761|100623098|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
33196544|NCT00813761|100623099|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
33397753|NCT03137173|101345825|FG000|Overall Study|Lost to Follow-up|13|||
33397754|NCT03137173|101345826|FG001|Overall Study|Lost to Follow-up|18|||
33397755|NCT03137173|101345825|FG000|Overall Study|Other reasons|3|||
33397756|NCT03137173|101345826|FG001|Overall Study|Other reasons|2|||
33397757|NCT02607865|101345827|FG000|Overall Study|Lost to Follow-up|9|||
33397758|NCT02607865|101345828|FG001|Overall Study|Lost to Follow-up|7|||
33397759|NCT02607865|101345829|FG002|Overall Study|Lost to Follow-up|7|||
33397760|NCT02607865|101345830|FG003|Overall Study|Lost to Follow-up|5|||
33397761|NCT02607865|101345827|FG000|Overall Study|Withdrawal by Subject|18|||
33397762|NCT02607865|101345828|FG001|Overall Study|Withdrawal by Subject|18|||
33397763|NCT02607865|101345829|FG002|Overall Study|Withdrawal by Subject|17|||
33397764|NCT02607865|101345830|FG003|Overall Study|Withdrawal by Subject|8|||
33506511|NCT02964507|101747812|FG001|Overall Study|Physician Decision|0|||
33506512|NCT02964507|101747813|FG002|Overall Study|Physician Decision|3|||
33506513|NCT02964507|101747814|FG003|Overall Study|Physician Decision|0|||
33506514|NCT02964507|101747815|FG004|Overall Study|Physician Decision|1|||
33506515|NCT02964507|101747816|FG005|Overall Study|Physician Decision|0|||
33506516|NCT02964507|101747817|FG006|Overall Study|Physician Decision|0|||
33506517|NCT02964507|101747818|FG007|Overall Study|Physician Decision|0|||
33506518|NCT04967885|101747819|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
33506519|NCT04967885|101747820|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
33506520|NCT04967885|101747819|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
33506521|NCT04967885|101747820|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
33506522|NCT04967885|101747819|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
33506523|NCT04967885|101747820|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
33506524|NCT04967885|101747819|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
33506525|NCT04967885|101747820|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
33506526|NCT04967885|101747819|FG000|EMI-II Intervention|Lost to Follow-up|14|||
33506527|NCT04967885|101747820|FG001|EMI-II Intervention|Lost to Follow-up|10|||
33506528|NCT01258998|101747826|FG000|Overall Study|Ineligible|1|||
33506529|NCT00900159|101747829|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
33506530|NCT00900159|101747830|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
33506531|NCT00857896|101747833|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
33506532|NCT02632409|101747834|FG000|Randomized|AE unrelated to study Drug|0|||
33506533|NCT02632409|101747835|FG001|Randomized|AE unrelated to study Drug|1|||
33506534|NCT02632409|101747834|FG000|Randomized|Participant withdrew consent|2|||
33506535|NCT02632409|101747835|FG001|Randomized|Participant withdrew consent|1|||
33506536|NCT02632409|101747834|FG000|Randomized|No Longer meets study criteria|5|||
33506537|NCT02632409|101747835|FG001|Randomized|No Longer meets study criteria|0|||
33506538|NCT02632409|101747834|FG000|Randomized|other reasons|1|||
33506539|NCT02632409|101747835|FG001|Randomized|other reasons|0|||
33506540|NCT02632409|101747834|FG000|Treatment Period|Ongoing Treatment|20|||
33506541|NCT02632409|101747835|FG001|Treatment Period|Ongoing Treatment|21|||
33506542|NCT02632409|101747834|FG000|Treatment Period|Disease Recurrence|147|||
33506543|NCT02632409|101747835|FG001|Treatment Period|Disease Recurrence|90|||
33506544|NCT02632409|101747834|FG000|Treatment Period|Study Drug Toxicity|8|||
33506545|NCT02632409|101747835|FG001|Treatment Period|Study Drug Toxicity|49|||
33506546|NCT02632409|101747834|FG000|Treatment Period|Death|1|||
33506547|NCT02632409|101747835|FG001|Treatment Period|Death|0|||
33506548|NCT02632409|101747834|FG000|Treatment Period|AE unrelated to study drug|15|||
33506549|NCT02632409|101747835|FG001|Treatment Period|AE unrelated to study drug|16|||
33397765|NCT02607865|101345827|FG000|Overall Study|Death|5|||
33397766|NCT02607865|101345828|FG001|Overall Study|Death|4|||
33397767|NCT02607865|101345829|FG002|Overall Study|Death|1|||
33506550|NCT02632409|101747834|FG000|Treatment Period|Request to discontinue treatment|4|||
33506551|NCT02632409|101747835|FG001|Treatment Period|Request to discontinue treatment|19|||
33506552|NCT02632409|101747834|FG000|Treatment Period|Participant withdrew consent|7|||
33506553|NCT02632409|101747835|FG001|Treatment Period|Participant withdrew consent|5|||
33506554|NCT02632409|101747834|FG000|Treatment Period|Lost to Follow-up|0|||
33506555|NCT02632409|101747835|FG001|Treatment Period|Lost to Follow-up|1|||
33506556|NCT02632409|101747834|FG000|Treatment Period|Maximum clinical benefit|1|||
33506557|NCT02632409|101747835|FG001|Treatment Period|Maximum clinical benefit|0|||
33506558|NCT02632409|101747834|FG000|Treatment Period|No longer meets study criteria|3|||
33506559|NCT02632409|101747835|FG001|Treatment Period|No longer meets study criteria|0|||
33506560|NCT02632409|101747834|FG000|Treatment Period|Administrative Reason by sponsor|0|||
33506561|NCT02632409|101747835|FG001|Treatment Period|Administrative Reason by sponsor|1|||
33506562|NCT02632409|101747834|FG000|Treatment Period|Other Reasons|10|||
33506563|NCT02632409|101747835|FG001|Treatment Period|Other Reasons|6|||
33397768|NCT02607865|101345830|FG003|Overall Study|Death|3|||
33397769|NCT02607865|101345827|FG000|Overall Study|Unclassified|1|||
33316677|NCT03267940|101054269|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
33316678|NCT03267940|101054270|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
33316679|NCT03267940|101054271|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
33316680|NCT03267940|101054272|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
33316681|NCT03267940|101054273|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
33316682|NCT03267940|101054268|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
33316683|NCT03267940|101054269|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
33316684|NCT03267940|101054270|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
33316685|NCT03267940|101054271|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
33316686|NCT03267940|101054272|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
33397770|NCT02607865|101345828|FG001|Overall Study|Unclassified|1|||
33397771|NCT02607865|101345829|FG002|Overall Study|Unclassified|2|||
33397772|NCT02607865|101345830|FG003|Overall Study|Unclassified|0|||
33397773|NCT02499172|101345831|FG000|Overall Study|Financial reason|0|||
33397774|NCT02499172|101345832|FG001|Overall Study|Financial reason|0|||
33397775|NCT02499172|101345833|FG002|Overall Study|Financial reason|523|||
33397776|NCT02499172|101345834|FG003|Overall Study|Financial reason|436|||
33397777|NCT02499172|101345831|FG000|Overall Study|Lost to Follow-up|65|||
33397778|NCT02499172|101345832|FG001|Overall Study|Lost to Follow-up|64|||
33397779|NCT02499172|101345833|FG002|Overall Study|Lost to Follow-up|0|||
33397780|NCT02499172|101345834|FG003|Overall Study|Lost to Follow-up|0|||
33397781|NCT05375838|101345840|FG000|Overall Study|Other|0|||
33604086|NCT01659255|102102494|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
33397782|NCT05375838|101345841|FG001|Overall Study|Other|0|||
33397783|NCT05375838|101345842|FG002|Overall Study|Other|0|||
33397784|NCT05375838|101345843|FG003|Overall Study|Other|1|||
33397785|NCT05375838|101345844|FG004|Overall Study|Other|1|||
33397786|NCT05375838|101345845|FG005|Overall Study|Other|0|||
33604087|NCT01659255|102102495|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
33604088|NCT01659255|102102496|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
33604089|NCT01659255|102102497|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
33604090|NCT01659255|102102498|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
33604091|NCT01659255|102102499|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
33604092|NCT01659255|102102500|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
33604093|NCT01659255|102102501|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
33604094|NCT01659255|102102502|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
33604095|NCT01659255|102102503|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
33604096|NCT01659255|102102504|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
33604097|NCT01659255|102102505|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
33604098|NCT00975143|102102511|FG000|Overall Study|Adverse Event|19|||
33604099|NCT00975143|102102512|FG001|Overall Study|Adverse Event|15|||
33604100|NCT00975143|102102511|FG000|Overall Study|Withdrawal by Subject|15|||
33604101|NCT00975143|102102512|FG001|Overall Study|Withdrawal by Subject|15|||
33604102|NCT00975143|102102511|FG000|Overall Study|Lost to Follow-up|20|||
33604103|NCT00975143|102102512|FG001|Overall Study|Lost to Follow-up|16|||
33604104|NCT00975143|102102511|FG000|Overall Study|Non-compliance|5|||
33604105|NCT00975143|102102512|FG001|Overall Study|Non-compliance|8|||
33604106|NCT00975143|102102511|FG000|Overall Study|Physician Decision|1|||
33604107|NCT00975143|102102512|FG001|Overall Study|Physician Decision|2|||
33604108|NCT00975143|102102511|FG000|Overall Study|Details not available|10|||
33604109|NCT00975143|102102512|FG001|Overall Study|Details not available|4|||
33604110|NCT01977690|102102513|FG000|Overall Study|Withdrawal by Subject|0|||
33604111|NCT01977690|102102514|FG001|Overall Study|Withdrawal by Subject|4|||
33604112|NCT02544373|102102515|FG000|Overall Study|Lost to Follow-up|5|||
33604113|NCT02544373|102102516|FG001|Overall Study|Lost to Follow-up|3|||
33604114|NCT02544373|102102515|FG000|Overall Study|Withdrawal by Subject|8|||
33604115|NCT02544373|102102516|FG001|Overall Study|Withdrawal by Subject|2|||
33604116|NCT00576576|102102517|FG000|Overall Study|Lost to Follow-up|6|||
33604117|NCT00576576|102102517|FG000|Overall Study|Protocol Violation|1|||
33604118|NCT00758589|102102521|FG000|Overall Study|Adverse Event|3|||
33604119|NCT00758589|102102522|FG001|Overall Study|Adverse Event|2|||
33604120|NCT00758589|102102523|FG002|Overall Study|Adverse Event|5|||
33397787|NCT05375838|101345840|FG000|Overall Study|Withdrawal by Subject|2|||
33397788|NCT05375838|101345841|FG001|Overall Study|Withdrawal by Subject|1|||
33604121|NCT00758589|102102524|FG003|Overall Study|Adverse Event|4|||
33604122|NCT00758589|102102521|FG000|Overall Study|Withdrawal by Subject|0|||
33604123|NCT00758589|102102522|FG001|Overall Study|Withdrawal by Subject|1|||
33316687|NCT03267940|101054273|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
33397789|NCT05375838|101345842|FG002|Overall Study|Withdrawal by Subject|3|||
33397790|NCT05375838|101345843|FG003|Overall Study|Withdrawal by Subject|2|||
33397791|NCT05375838|101345844|FG004|Overall Study|Withdrawal by Subject|2|||
33506564|NCT00977314|101747836|FG000|Overall Study|Withdrawal by Subject|1|||
33506565|NCT00977314|101747837|FG001|Overall Study|Withdrawal by Subject|0|||
33506566|NCT00977314|101747836|FG000|Overall Study|Physician Decision|1|||
33506567|NCT00977314|101747837|FG001|Overall Study|Physician Decision|0|||
33506568|NCT06303167|101747838|FG000|Overall Study|Ineligible|1|||
33506569|NCT06303167|101747838|FG000|Overall Study|Never start protocol therapy|2|||
33506570|NCT06303167|101747838|FG000|Overall Study|Disease progression|16|||
33506571|NCT01250873|101750757|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
33506572|NCT01250873|101750757|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
33506573|NCT02040857|101750758|FG000|Overall Study|Adverse Event|14|||
33506574|NCT02040857|101750758|FG000|Overall Study|Physician Decision|5|||
33506575|NCT02040857|101750758|FG000|Overall Study|Withdrawal by Subject|31|||
33506576|NCT02040857|101750758|FG000|Overall Study|patient non-compliance|3|||
33506577|NCT02040857|101750758|FG000|Overall Study|Lost to Follow-up|2|||
33506578|NCT02040857|101750758|FG000|Overall Study|recurrence|4|||
33506579|NCT02040857|101750758|FG000|Overall Study|ineligible|1|||
33506580|NCT00601172|101750761|FG000|Overall Study|Adverse Event|43|||
33506581|NCT00601172|101750762|FG001|Overall Study|Adverse Event|32|||
33506582|NCT00601172|101750761|FG000|Overall Study|Lack of Efficacy|11|||
33506583|NCT00601172|101750762|FG001|Overall Study|Lack of Efficacy|12|||
33506584|NCT00601172|101750761|FG000|Overall Study|Protocol Violation|2|||
33506585|NCT00601172|101750762|FG001|Overall Study|Protocol Violation|5|||
33506586|NCT00601172|101750761|FG000|Overall Study|Lost to Follow-up|4|||
33506587|NCT00601172|101750762|FG001|Overall Study|Lost to Follow-up|3|||
33506588|NCT00601172|101750761|FG000|Overall Study|Physician Decision|27|||
33506589|NCT00601172|101750762|FG001|Overall Study|Physician Decision|28|||
33506590|NCT00601172|101750761|FG000|Overall Study|Withdrawal by Subject|35|||
33506591|NCT00601172|101750762|FG001|Overall Study|Withdrawal by Subject|27|||
33506592|NCT00601172|101750761|FG000|Overall Study|Did not meet continuation criteria|19|||
33506593|NCT00601172|101750762|FG001|Overall Study|Did not meet continuation criteria|20|||
33506594|NCT03005327|101750765|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
33506595|NCT03005327|101750766|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
33506596|NCT03005327|101750767|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
33506597|NCT03005327|101750768|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
33506598|NCT03005327|101750765|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33506599|NCT03005327|101750766|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
33506600|NCT03005327|101750767|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33506601|NCT03005327|101750768|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33506602|NCT02107859|101750776|FG000|Overall Study|Withdrawal by Subject|14|||
33506603|NCT02107859|101750776|FG000|Overall Study|Adverse Event|3|||
33506604|NCT02107859|101750776|FG000|Overall Study|Study closure|41|||
33506605|NCT02107859|101750776|FG000|Overall Study|Other than specified|3|||
33506606|NCT00325156|101750780|FG000|Overall Study|Protocol Violation|8|||
33506607|NCT00325156|101750780|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
33506608|NCT00325156|101750780|FG000|Overall Study|Migrated/moved from study area|12|||
33506609|NCT00325156|101750780|FG000|Overall Study|Adverse event, non-fatal|3|||
33506610|NCT00325156|101750780|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
33506611|NCT00325156|101750780|FG000|Overall Study|Other|1|||
33506612|NCT00325156|101750780|FG000|Overall Study|Withdrawal by Subject|31|||
33506613|NCT02048826|101750781|FG000|Overall Study|Withdrawal by Subject|1|||
33506614|NCT02048826|101750782|FG001|Overall Study|Withdrawal by Subject|0|||
33506615|NCT01217476|101750783|FG000|Overall Study|Adverse Event|6|||
33506616|NCT01217476|101750784|FG001|Overall Study|Adverse Event|1|||
33506617|NCT01217476|101750783|FG000|Overall Study|Physician Decision|0|||
33506618|NCT01217476|101750784|FG001|Overall Study|Physician Decision|1|||
33506619|NCT01217476|101750783|FG000|Overall Study|Withdrawal by Subject|3|||
33506620|NCT01217476|101750784|FG001|Overall Study|Withdrawal by Subject|3|||
33506621|NCT01217476|101750783|FG000|Overall Study|Surgery on the Target Limb|0|||
33506622|NCT01217476|101750784|FG001|Overall Study|Surgery on the Target Limb|2|||
33506623|NCT01217476|101750783|FG000|Overall Study|Protocol Deviation|1|||
33506624|NCT01217476|101750784|FG001|Overall Study|Protocol Deviation|0|||
33506625|NCT01217476|101750783|FG000|Overall Study|Other|2|||
33506626|NCT01217476|101750784|FG001|Overall Study|Other|0|||
33397792|NCT05375838|101345845|FG005|Overall Study|Withdrawal by Subject|0|||
33506627|NCT00617890|101750787|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
33506628|NCT00617890|101750788|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
33506629|NCT00617890|101750789|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
33506630|NCT00617890|101750790|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
33506631|NCT00617890|101750787|FG000|Overall Study|Lack of Efficacy|23|||
33506632|NCT00617890|101750788|FG001|Overall Study|Lack of Efficacy|26|||
33506633|NCT00617890|101750789|FG002|Overall Study|Lack of Efficacy|30|||
33506634|NCT00617890|101750790|FG003|Overall Study|Lack of Efficacy|97|||
33506635|NCT00617890|101750787|FG000|Overall Study|Lost to Follow-up|0|||
33506636|NCT00617890|101750788|FG001|Overall Study|Lost to Follow-up|0|||
33506637|NCT00617890|101750789|FG002|Overall Study|Lost to Follow-up|1|||
33506638|NCT00617890|101750790|FG003|Overall Study|Lost to Follow-up|2|||
33604124|NCT00758589|102102523|FG002|Overall Study|Withdrawal by Subject|1|||
33604125|NCT00758589|102102524|FG003|Overall Study|Withdrawal by Subject|1|||
33604126|NCT00758589|102102521|FG000|Overall Study|Palm stopped to work|0|||
33604127|NCT00758589|102102522|FG001|Overall Study|Palm stopped to work|0|||
33604128|NCT00758589|102102523|FG002|Overall Study|Palm stopped to work|0|||
33604129|NCT00758589|102102524|FG003|Overall Study|Palm stopped to work|1|||
33604130|NCT05086510|102102525|FG000|Overall Study|Lost to Follow-up|0|||
33604131|NCT05086510|102102526|FG001|Overall Study|Lost to Follow-up|2|||
33604132|NCT05086510|102102525|FG000|Overall Study|Death|0|||
33604133|NCT05086510|102102526|FG001|Overall Study|Death|2|||
33604134|NCT02337725|102102527|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
33604135|NCT02337725|102102528|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
33604136|NCT02337725|102102527|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
33506639|NCT00617890|101750787|FG000|Overall Study|Withdrawal by Subject|4|||
33506640|NCT00617890|101750788|FG001|Overall Study|Withdrawal by Subject|1|||
33506641|NCT00617890|101750789|FG002|Overall Study|Withdrawal by Subject|0|||
33506642|NCT00617890|101750790|FG003|Overall Study|Withdrawal by Subject|2|||
33506643|NCT00617890|101750787|FG000|Overall Study|Protocol Violation|2|||
33506644|NCT00617890|101750788|FG001|Overall Study|Protocol Violation|1|||
33506645|NCT00617890|101750789|FG002|Overall Study|Protocol Violation|0|||
33506646|NCT00617890|101750790|FG003|Overall Study|Protocol Violation|0|||
33506647|NCT00617890|101750787|FG000|Overall Study|Adverse Event|1|||
33506648|NCT00617890|101750788|FG001|Overall Study|Adverse Event|0|||
33506649|NCT00617890|101750789|FG002|Overall Study|Adverse Event|3|||
33506650|NCT00617890|101750790|FG003|Overall Study|Adverse Event|8|||
33506651|NCT00617890|101750787|FG000|Overall Study|Not treated|1|||
33506652|NCT00617890|101750788|FG001|Overall Study|Not treated|0|||
33506653|NCT00617890|101750789|FG002|Overall Study|Not treated|1|||
33506654|NCT00617890|101750790|FG003|Overall Study|Not treated|1|||
33506655|NCT00661609|101750795|FG000|Overall Study|Adverse Event|4|||
33506656|NCT00661609|101750795|FG000|Overall Study|Death|20|||
33506657|NCT00661609|101750795|FG000|Overall Study|Withdrawal by Subject|2|||
33506658|NCT00661609|101750795|FG000|Overall Study|PI Decision|1|||
33506659|NCT00661609|101750795|FG000|Overall Study|Survival follow up stage discontinued|11|||
33506660|NCT00661609|101750795|FG000|Overall Study|Disease progression|3|||
33506661|NCT02727777|101750802|FG000|Overall Study|Screen Failure|2|||
33506662|NCT02727777|101750803|FG001|Overall Study|Screen Failure|0|||
33506663|NCT02727777|101750804|FG002|Overall Study|Screen Failure|0|||
33506664|NCT02727777|101750802|FG000|Overall Study|Progressive disease|2|||
33506665|NCT02727777|101750803|FG001|Overall Study|Progressive disease|0|||
33506666|NCT02727777|101750804|FG002|Overall Study|Progressive disease|0|||
33506667|NCT01609543|101750806|FG000|Overall Study|Disease Progression|28|||
33506668|NCT01609543|101750806|FG000|Overall Study|Adverse Event|5|||
33506669|NCT01609543|101750806|FG000|Overall Study|Withdrawal by Subject|1|||
33506670|NCT01609543|101750806|FG000|Overall Study|Protocol Violation|1|||
33506671|NCT01609543|101750806|FG000|Overall Study|Death|7|||
33506672|NCT00986921|101750809|FG000|Overall Study|Physician Decision|1|||
33506673|NCT00986921|101750810|FG001|Overall Study|Physician Decision|0|||
33506674|NCT03233529|101750813|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
33506675|NCT03233529|101750813|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
33506676|NCT00507728|101750814|FG000|Randomization to Month 3|Lost to Follow-up|15|||
33506677|NCT00507728|101750815|FG001|Randomization to Month 3|Lost to Follow-up|14|||
33506678|NCT00507728|101750816|FG002|Randomization to Month 3|Lost to Follow-up|20|||
33506679|NCT00507728|101750814|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
33506680|NCT00507728|101750815|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
33506681|NCT00507728|101750816|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
33506682|NCT01940887|101750819|FG000|Year 1|Protocol Violation|0|||
33506683|NCT01940887|101750820|FG001|Year 1|Protocol Violation|1|||
33506684|NCT01940887|101750819|FG000|Year 1|Physician Decision|7|||
33506685|NCT01940887|101750820|FG001|Year 1|Physician Decision|3|||
33506686|NCT01940887|101750819|FG000|Year 1|Death|5|||
33506687|NCT01940887|101750820|FG001|Year 1|Death|3|||
33506688|NCT01940887|101750819|FG000|Year 1|Adverse Event|7|||
33506689|NCT01940887|101750820|FG001|Year 1|Adverse Event|6|||
33506690|NCT01940887|101750819|FG000|Year 1|Withdrawal by Subject|18|||
33604137|NCT02337725|102102528|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
33506691|NCT01940887|101750820|FG001|Year 1|Withdrawal by Subject|9|||
33506692|NCT01940887|101750819|FG000|Year 1|Lost to Follow-up|2|||
33506693|NCT01940887|101750820|FG001|Year 1|Lost to Follow-up|1|||
33506694|NCT01940887|101750819|FG000|Year 2|Physician Decision|8|||
33506695|NCT01940887|101750820|FG001|Year 2|Physician Decision|1|||
33506696|NCT01940887|101750819|FG000|Year 2|Death|0|||
33506697|NCT01940887|101750820|FG001|Year 2|Death|2|||
33506698|NCT01940887|101750819|FG000|Year 2|Sponsor Decision, early termination|192|||
33506699|NCT01940887|101750820|FG001|Year 2|Sponsor Decision, early termination|203|||
33604138|NCT02337725|102102527|FG000|Overall Study|Major Protocol Deviation|0|||
33196545|NCT00813761|100623100|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
33196546|NCT00813761|100623101|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
33196547|NCT00813761|100623098|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
33196548|NCT00813761|100623099|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
33196549|NCT00813761|100623100|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
33196550|NCT00813761|100623101|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
33196551|NCT00813761|100623098|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
33196552|NCT00813761|100623099|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
33196553|NCT00813761|100623100|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
33196554|NCT00813761|100623101|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
33196555|NCT00673452|100623102|FG000|Acute Double-Blind Phase|Adverse Event|41|||
33196556|NCT00673452|100623103|FG001|Acute Double-Blind Phase|Adverse Event|24|||
33196557|NCT00673452|100623102|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
33196558|NCT00673452|100623103|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
33196559|NCT00673452|100623102|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
33196560|NCT00673452|100623103|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
33196561|NCT00673452|100623102|FG000|Acute Double-Blind Phase|Physician Decision|0|||
33506700|NCT01940887|101750819|FG000|Year 2|Adverse Event|8|||
33506701|NCT01940887|101750820|FG001|Year 2|Adverse Event|2|||
33506702|NCT01940887|101750819|FG000|Year 2|Withdrawal by Subject|8|||
33506703|NCT01940887|101750820|FG001|Year 2|Withdrawal by Subject|8|||
33196562|NCT00673452|100623103|FG001|Acute Double-Blind Phase|Physician Decision|6|||
33196563|NCT00673452|100623102|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
33196564|NCT00673452|100623103|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
33196565|NCT00673452|100623102|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
33196566|NCT00673452|100623103|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
33196567|NCT00673452|100623102|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
33196568|NCT00673452|100623103|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
33196569|NCT00673452|100623102|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
33196570|NCT00673452|100623103|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
33196571|NCT00673452|100623102|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
33196572|NCT00673452|100623103|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
33196573|NCT00673452|100623102|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
33196574|NCT00673452|100623103|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
33196575|NCT00673452|100623102|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
33196576|NCT00673452|100623103|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
33196577|NCT00673452|100623102|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
33196578|NCT00673452|100623103|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
33196579|NCT00673452|100623102|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
33196580|NCT00673452|100623103|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
33196581|NCT00673452|100623102|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
33196582|NCT00673452|100623103|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
33506704|NCT01940887|101750819|FG000|Year 2|Lost to Follow-up|1|||
33196583|NCT00673452|100623102|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
33196584|NCT00673452|100623103|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
33196585|NCT01040871|100623109|FG000|Overall Study|Adverse Event|6|||
33196586|NCT01040871|100623110|FG001|Overall Study|Adverse Event|2|||
33196587|NCT01040871|100623109|FG000|Overall Study|Withdrawal by Subject|2|||
33196588|NCT01040871|100623110|FG001|Overall Study|Withdrawal by Subject|0|||
33196589|NCT01040871|100623109|FG000|Overall Study|Death|1|||
33196590|NCT01040871|100623110|FG001|Overall Study|Death|3|||
33196591|NCT01040871|100623109|FG000|Overall Study|Lack of Efficacy|1|||
33196592|NCT01040871|100623110|FG001|Overall Study|Lack of Efficacy|1|||
33196593|NCT01040871|100623109|FG000|Overall Study|drug supply issue|1|||
33196594|NCT01040871|100623110|FG001|Overall Study|drug supply issue|0|||
33196595|NCT01040871|100623109|FG000|Overall Study|Randomized and Not Treated|2|||
33196596|NCT01040871|100623110|FG001|Overall Study|Randomized and Not Treated|1|||
33196597|NCT02556710|100623111|FG000|Overall Study|Surgical treatment|3|||
33196598|NCT02556710|100623112|FG001|Overall Study|Surgical treatment|0|||
33196599|NCT02556710|100623111|FG000|Overall Study|Required proscribed pain medication|2|||
33196600|NCT02556710|100623112|FG001|Overall Study|Required proscribed pain medication|1|||
33196601|NCT02556710|100623111|FG000|Overall Study|Lack of Efficacy|1|||
33196602|NCT02556710|100623112|FG001|Overall Study|Lack of Efficacy|0|||
33196603|NCT02556710|100623111|FG000|Overall Study|Worsening osteoarthritis|1|||
33506705|NCT01940887|101750820|FG001|Year 2|Lost to Follow-up|6|||
33506706|NCT02387957|101750824|FG000|Overall Study|The study was discontinued|21|||
33506707|NCT02387957|101750825|FG001|Overall Study|The study was discontinued|21|||
33196604|NCT02556710|100623112|FG001|Overall Study|Worsening osteoarthritis|0|||
33196605|NCT02556710|100623111|FG000|Overall Study|Moved out of state|1|||
33196606|NCT02556710|100623112|FG001|Overall Study|Moved out of state|0|||
33196607|NCT02556710|100623111|FG000|Overall Study|Missing reason|3|||
33196608|NCT02556710|100623112|FG001|Overall Study|Missing reason|1|||
33196609|NCT02556710|100623111|FG000|Overall Study|Pain as lack of efficacy|0|||
33506708|NCT02387957|101750826|FG002|Overall Study|The study was discontinued|20|||
33196610|NCT02556710|100623112|FG001|Overall Study|Pain as lack of efficacy|4|||
33196611|NCT00773175|100623114|FG000|Overall Study|Adverse Event|2|||
33196612|NCT00773175|100623115|FG001|Overall Study|Adverse Event|0|||
33196613|NCT00773175|100623114|FG000|Overall Study|Consent Withdrawn|0|||
33196614|NCT00773175|100623115|FG001|Overall Study|Consent Withdrawn|2|||
33196615|NCT02863354|100623116|FG000|Year 1|Lost to Follow-up|1|||
33196616|NCT02863354|100623117|FG001|Year 1|Lost to Follow-up|1|||
33196617|NCT02863354|100623116|FG000|Year 1|Withdrawal by Subject|3|||
33196618|NCT02863354|100623117|FG001|Year 1|Withdrawal by Subject|0|||
33196619|NCT02863354|100623116|FG000|Year 1|Death|0|||
33506709|NCT05217641|101750827|FG000|Overall Study|Lost to Follow-up|1|||
33506710|NCT05217641|101750828|FG001|Overall Study|Lost to Follow-up|1|||
33506711|NCT05217641|101750829|FG002|Overall Study|Lost to Follow-up|0|||
33506712|NCT05217641|101750830|FG003|Overall Study|Lost to Follow-up|1|||
33506713|NCT05217641|101750831|FG004|Overall Study|Lost to Follow-up|1|||
33506714|NCT05217641|101750832|FG005|Overall Study|Lost to Follow-up|0|||
33506715|NCT05217641|101750827|FG000|Overall Study|Withdrawal by Subject|0|||
33506716|NCT05217641|101750828|FG001|Overall Study|Withdrawal by Subject|0|||
33196620|NCT02863354|100623117|FG001|Year 1|Death|1|||
33196621|NCT02863354|100623116|FG000|Year 2|Lost to Follow-up|2|||
33196622|NCT02863354|100623117|FG001|Year 2|Lost to Follow-up|2|||
33196623|NCT01986829|100623120|FG000|Overall Study|Death|1|||
33196624|NCT01018264|100623122|FG000|Overall Study|Withdrawal by Subject|1|||
33196625|NCT01018264|100623123|FG001|Overall Study|Withdrawal by Subject|0|||
33196626|NCT01018264|100623122|FG000|Overall Study|Lost to Follow-up|0|||
33196627|NCT01018264|100623123|FG001|Overall Study|Lost to Follow-up|1|||
33196628|NCT01827904|100623127|FG000|Main Study|Withdrawal by Subject|1|||
33196629|NCT01827904|100623128|FG001|Main Study|Withdrawal by Subject|0|||
33196630|NCT01827904|100623129|FG002|Main Study|Withdrawal by Subject|0|||
33196631|NCT01827904|100623127|FG000|Main Study|Adverse Event|1|||
33196632|NCT01827904|100623128|FG001|Main Study|Adverse Event|0|||
33196633|NCT01827904|100623129|FG002|Main Study|Adverse Event|0|||
33196634|NCT01827904|100623127|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
33196635|NCT01827904|100623128|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
33196636|NCT01827904|100623129|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
33196637|NCT01827904|100623127|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
33196638|NCT01827904|100623128|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
33506717|NCT05217641|101750829|FG002|Overall Study|Withdrawal by Subject|0|||
33506718|NCT05217641|101750830|FG003|Overall Study|Withdrawal by Subject|3|||
33506719|NCT05217641|101750831|FG004|Overall Study|Withdrawal by Subject|1|||
33506720|NCT05217641|101750832|FG005|Overall Study|Withdrawal by Subject|0|||
33506721|NCT05217641|101750827|FG000|Overall Study|Other: participant did not specify reason|0|||
33506722|NCT05217641|101750828|FG001|Overall Study|Other: participant did not specify reason|0|||
33506723|NCT05217641|101750829|FG002|Overall Study|Other: participant did not specify reason|0|||
33506724|NCT05217641|101750830|FG003|Overall Study|Other: participant did not specify reason|0|||
33506725|NCT05217641|101750831|FG004|Overall Study|Other: participant did not specify reason|1|||
33506726|NCT05217641|101750832|FG005|Overall Study|Other: participant did not specify reason|0|||
33506727|NCT05217641|101750827|FG000|Overall Study|Extended Follow up|1|||
33506728|NCT05217641|101750828|FG001|Overall Study|Extended Follow up|1|||
33506729|NCT05217641|101750829|FG002|Overall Study|Extended Follow up|0|||
33506730|NCT05217641|101750830|FG003|Overall Study|Extended Follow up|0|||
33506731|NCT05217641|101750831|FG004|Overall Study|Extended Follow up|1|||
33506732|NCT05217641|101750832|FG005|Overall Study|Extended Follow up|0|||
33506733|NCT03063086|101750833|FG000|Overall Study|technical problems|1|||
33506734|NCT03063086|101750834|FG001|Overall Study|technical problems|0|||
33506735|NCT03063086|101750835|FG002|Overall Study|technical problems|0|||
33506736|NCT03063086|101750836|FG003|Overall Study|technical problems|0|||
33506737|NCT03063086|101750837|FG004|Overall Study|technical problems|0|||
33506738|NCT03063086|101750838|FG005|Overall Study|technical problems|0|||
33604139|NCT02337725|102102528|FG001|Overall Study|Major Protocol Deviation|1|||
33604140|NCT02337725|102102527|FG000|Overall Study|Voluntary Withdrawal|14|||
33604141|NCT02337725|102102528|FG001|Overall Study|Voluntary Withdrawal|3|||
33604142|NCT02337725|102102527|FG000|Overall Study|Lack of Efficacy|4|||
33196639|NCT01827904|100623129|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
33196640|NCT01827904|100623127|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
33316688|NCT03442985|101054282|FG000|Overall Study|Sponsor Request|55|||
33397793|NCT05375838|101345840|FG000|Overall Study|Protocol Violation|0|||
33506739|NCT03063086|101750833|FG000|Overall Study|Adverse Event|1|||
33506740|NCT03063086|101750834|FG001|Overall Study|Adverse Event|1|||
33604143|NCT02337725|102102528|FG001|Overall Study|Lack of Efficacy|0|||
33604144|NCT00798317|102102529|FG000|Overall Study|Physician Decision|0|||
33604145|NCT00798317|102102530|FG001|Overall Study|Physician Decision|1|||
33506741|NCT03063086|101750835|FG002|Overall Study|Adverse Event|1|||
33604146|NCT00798317|102102529|FG000|Overall Study|Withdrawal by Subject|5|||
33604147|NCT00798317|102102530|FG001|Overall Study|Withdrawal by Subject|4|||
33196641|NCT01827904|100623128|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
33196642|NCT01827904|100623129|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
33506742|NCT03063086|101750836|FG003|Overall Study|Adverse Event|1|||
33506743|NCT03063086|101750837|FG004|Overall Study|Adverse Event|0|||
33196643|NCT01827904|100623127|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
33196644|NCT01827904|100623128|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
33196645|NCT01827904|100623129|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
33196646|NCT01827904|100623127|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
33196647|NCT01827904|100623128|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
33196648|NCT01827904|100623129|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
33196649|NCT01827904|100623127|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
33196650|NCT01827904|100623128|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
33196651|NCT01827904|100623129|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
33196652|NCT01827904|100623127|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
33196653|NCT01827904|100623128|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
33196654|NCT01827904|100623129|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
33196655|NCT01827904|100623127|FG000|Long-term Annual Follow-up|Physician Decision|1|||
33196656|NCT01827904|100623128|FG001|Long-term Annual Follow-up|Physician Decision|0|||
33196657|NCT01827904|100623129|FG002|Long-term Annual Follow-up|Physician Decision|0|||
33196658|NCT01827904|100623127|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
33196659|NCT01827904|100623128|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
33196660|NCT01827904|100623129|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
33196661|NCT01827904|100623127|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
33196662|NCT01827904|100623128|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
33196663|NCT01827904|100623129|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
33196664|NCT03394391|100623130|FG000|Overall Study|Lost to Follow-up|1|||
33196665|NCT03394391|100623131|FG001|Overall Study|Lost to Follow-up|2|||
33196666|NCT02039427|100626300|FG000|Overall Study|Duration of surgery > 3h|1|||
33196667|NCT02039427|100626301|FG001|Overall Study|Duration of surgery > 3h|1|||
33196668|NCT02039427|100626302|FG002|Overall Study|Duration of surgery > 3h|0|||
33196669|NCT02039427|100626303|FG003|Overall Study|Duration of surgery > 3h|0|||
33196670|NCT02039427|100626300|FG000|Overall Study|Withdrawal on concent|0|||
33196671|NCT02039427|100626301|FG001|Overall Study|Withdrawal on concent|0|||
33196672|NCT02039427|100626302|FG002|Overall Study|Withdrawal on concent|0|||
33196673|NCT02039427|100626303|FG003|Overall Study|Withdrawal on concent|1|||
33196674|NCT02039427|100626300|FG000|Overall Study|Cancellation of surgery|0|||
33196675|NCT02039427|100626301|FG001|Overall Study|Cancellation of surgery|0|||
33196676|NCT02039427|100626302|FG002|Overall Study|Cancellation of surgery|1|||
33196677|NCT02039427|100626303|FG003|Overall Study|Cancellation of surgery|0|||
33397794|NCT05375838|101345841|FG001|Overall Study|Protocol Violation|0|||
33397795|NCT05375838|101345842|FG002|Overall Study|Protocol Violation|0|||
33397796|NCT05375838|101345843|FG003|Overall Study|Protocol Violation|0|||
33397797|NCT05375838|101345844|FG004|Overall Study|Protocol Violation|1|||
33397798|NCT05375838|101345845|FG005|Overall Study|Protocol Violation|0|||
33397799|NCT05375838|101345840|FG000|Overall Study|Physician Decision|0|||
33397800|NCT05375838|101345841|FG001|Overall Study|Physician Decision|1|||
33397801|NCT05375838|101345842|FG002|Overall Study|Physician Decision|0|||
33397802|NCT05375838|101345843|FG003|Overall Study|Physician Decision|0|||
33397803|NCT05375838|101345844|FG004|Overall Study|Physician Decision|0|||
33397804|NCT05375838|101345845|FG005|Overall Study|Physician Decision|1|||
33397805|NCT05375838|101345840|FG000|Overall Study|Lost to Follow-up|2|||
33397806|NCT05375838|101345841|FG001|Overall Study|Lost to Follow-up|7|||
33397807|NCT05375838|101345842|FG002|Overall Study|Lost to Follow-up|0|||
33397808|NCT05375838|101345843|FG003|Overall Study|Lost to Follow-up|4|||
33397809|NCT05375838|101345844|FG004|Overall Study|Lost to Follow-up|2|||
33397810|NCT05375838|101345845|FG005|Overall Study|Lost to Follow-up|3|||
33397811|NCT02710422|101345846|FG000|Overall Study|Termination of study|9|||
33397812|NCT02710422|101345847|FG001|Overall Study|Termination of study|9|||
33397813|NCT03228836|101345848|FG000|Overall Study|Adverse Event|3|||
33397814|NCT03228836|101345848|FG000|Overall Study|Withdrawal by Subject|1|||
33397815|NCT03228836|101345848|FG000|Overall Study|Death|1|||
33397816|NCT03228836|101345848|FG000|Overall Study|Physician Decision|1|||
33397817|NCT03228836|101345848|FG000|Overall Study|Disease Progression|7|||
33397818|NCT03228836|101345848|FG000|Overall Study|Other|4|||
33397819|NCT02565576|101345851|FG000|Overall Study|abnormal lab value|2|||
33397820|NCT02565576|101345852|FG001|Overall Study|abnormal lab value|0|||
33397821|NCT02565576|101345851|FG000|Overall Study|subject / guardian decision|1|||
33397822|NCT02565576|101345852|FG001|Overall Study|subject / guardian decision|3|||
33397823|NCT02565576|101345851|FG000|Overall Study|Lost to Follow-up|1|||
33604148|NCT00798317|102102529|FG000|Overall Study|Lost to Follow-up|2|||
33604149|NCT00798317|102102530|FG001|Overall Study|Lost to Follow-up|2|||
33196678|NCT02039427|100626300|FG000|Overall Study|Loss of follow - up|1|||
33196679|NCT02039427|100626301|FG001|Overall Study|Loss of follow - up|0|||
33196680|NCT02039427|100626302|FG002|Overall Study|Loss of follow - up|2|||
33196681|NCT02039427|100626303|FG003|Overall Study|Loss of follow - up|4|||
33397824|NCT02565576|101345852|FG001|Overall Study|Lost to Follow-up|0|||
33397825|NCT02565576|101345851|FG000|Overall Study|Death|0|||
33397826|NCT02565576|101345852|FG001|Overall Study|Death|2|||
33506744|NCT03063086|101750838|FG005|Overall Study|Adverse Event|0|||
33397827|NCT02565576|101345851|FG000|Overall Study|Adverse Event|1|||
33397828|NCT02565576|101345852|FG001|Overall Study|Adverse Event|0|||
33397829|NCT02380703|101345854|FG000|Overall Study|Withdrawal by Subject|12|||
33397830|NCT02380703|101345855|FG001|Overall Study|Withdrawal by Subject|9|||
33397831|NCT02380703|101345854|FG000|Overall Study|Lost to Follow-up|12|||
33397832|NCT02380703|101345855|FG001|Overall Study|Lost to Follow-up|12|||
33397833|NCT02380703|101345854|FG000|Overall Study|Caregiver death|1|||
33397834|NCT02380703|101345855|FG001|Overall Study|Caregiver death|0|||
33397835|NCT02380703|101345854|FG000|Overall Study|Person with dementia (PWD) death|7|||
33397836|NCT02380703|101345855|FG001|Overall Study|Person with dementia (PWD) death|8|||
33397837|NCT02380703|101345854|FG000|Overall Study|Entered Long-term Care|4|||
33397838|NCT02380703|101345855|FG001|Overall Study|Entered Long-term Care|7|||
33397839|NCT01081951|101345856|FG000|Overall Study|Death|54|||
33397840|NCT01081951|101345857|FG001|Overall Study|Death|47|||
33397841|NCT01081951|101345856|FG000|Overall Study|Withdrawal by Subject|2|||
33397842|NCT01081951|101345857|FG001|Overall Study|Withdrawal by Subject|6|||
33397843|NCT01081951|101345856|FG000|Overall Study|Allocated treatment but did not take it|0|||
33316689|NCT03442985|101054283|FG001|Overall Study|Sponsor Request|60|||
33316690|NCT03442985|101054284|FG002|Overall Study|Sponsor Request|54|||
33316691|NCT03442985|101054282|FG000|Overall Study|Lost to Follow-up|5|||
33316692|NCT03442985|101054283|FG001|Overall Study|Lost to Follow-up|2|||
33316693|NCT03442985|101054284|FG002|Overall Study|Lost to Follow-up|7|||
33397844|NCT01081951|101345857|FG001|Overall Study|Allocated treatment but did not take it|1|||
33397845|NCT01081951|101345856|FG000|Overall Study|Lost to Follow-up|0|||
33397846|NCT01081951|101345857|FG001|Overall Study|Lost to Follow-up|1|||
33397847|NCT04652102|101345858|FG000|Overall Study|Adverse Event|14|||
33397848|NCT04652102|101345859|FG001|Overall Study|Adverse Event|13|||
33397849|NCT04652102|101345858|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
33397850|NCT04652102|101345859|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
33397851|NCT04652102|101345858|FG000|Overall Study|Physician Decision|78|||
33397852|NCT04652102|101345859|FG001|Overall Study|Physician Decision|40|||
33397853|NCT04652102|101345858|FG000|Overall Study|Study Ended by Sponsor|64|||
33316694|NCT03442985|101054282|FG000|Overall Study|Withdrawal by Subject|2|||
33397854|NCT04652102|101345859|FG001|Overall Study|Study Ended by Sponsor|17|||
33397855|NCT04652102|101345858|FG000|Overall Study|Withdrawal by Subject|4625|||
33397856|NCT04652102|101345859|FG001|Overall Study|Withdrawal by Subject|5594|||
33397857|NCT04652102|101345858|FG000|Overall Study|Lost to Follow-up|2019|||
33397858|NCT04652102|101345859|FG001|Overall Study|Lost to Follow-up|1082|||
33397859|NCT04652102|101345858|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
33397860|NCT04652102|101345859|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
33397861|NCT04652102|101345858|FG000|Overall Study|Miscellaneous|80|||
33397862|NCT04652102|101345859|FG001|Overall Study|Miscellaneous|64|||
33316695|NCT03442985|101054283|FG001|Overall Study|Withdrawal by Subject|3|||
33316696|NCT03442985|101054284|FG002|Overall Study|Withdrawal by Subject|4|||
33316697|NCT03442985|101054282|FG000|Overall Study|Adverse Event|0|||
33316698|NCT03442985|101054283|FG001|Overall Study|Adverse Event|1|||
33316699|NCT03442985|101054284|FG002|Overall Study|Adverse Event|0|||
33316700|NCT00171704|101054292|FG000|Overall Study|Adverse Event|24|||
33316701|NCT00171704|101054293|FG001|Overall Study|Adverse Event|33|||
33316702|NCT00171704|101054292|FG000|Overall Study|Disease Progression|14|||
33316703|NCT00171704|101054293|FG001|Overall Study|Disease Progression|9|||
33397863|NCT01984294|101345863|FG000|Overall Study|Randomized but Never Treated|0|||
33397864|NCT01984294|101345864|FG001|Overall Study|Randomized but Never Treated|0|||
33397865|NCT01984294|101345865|FG002|Overall Study|Randomized but Never Treated|1|||
33397866|NCT01984294|101345863|FG000|Overall Study|Lack of Efficacy|4|||
33397867|NCT01984294|101345864|FG001|Overall Study|Lack of Efficacy|2|||
33397868|NCT01984294|101345865|FG002|Overall Study|Lack of Efficacy|6|||
33397869|NCT01984294|101345863|FG000|Overall Study|Adverse Event|0|||
33397870|NCT01984294|101345864|FG001|Overall Study|Adverse Event|1|||
33397871|NCT01984294|101345865|FG002|Overall Study|Adverse Event|0|||
33397872|NCT01738594|101345866|FG000|Registration and Treatment Start|Adverse Event|0|||
33397873|NCT01738594|101345867|FG001|Registration and Treatment Start|Adverse Event|1|||
33397874|NCT01738594|101345868|FG002|Registration and Treatment Start|Adverse Event|0|||
33397875|NCT01738594|101345869|FG003|Registration and Treatment Start|Adverse Event|0|||
33397876|NCT01738594|101345870|FG004|Registration and Treatment Start|Adverse Event|0|||
33397877|NCT01738594|101345871|FG005|Registration and Treatment Start|Adverse Event|0|||
33397878|NCT01738594|101345872|FG006|Registration and Treatment Start|Adverse Event|0|||
33397879|NCT01738594|101345873|FG007|Registration and Treatment Start|Adverse Event|0|||
33397880|NCT01738594|101345866|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
33397881|NCT01738594|101345867|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
33397882|NCT01738594|101345868|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
33397883|NCT01738594|101345869|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
33397884|NCT01738594|101345870|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
33397885|NCT01738594|101345871|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
33397886|NCT01738594|101345872|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
33397887|NCT01738594|101345873|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
33397888|NCT01738594|101345866|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
33397889|NCT01738594|101345867|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
33316704|NCT00171704|101054292|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
33316705|NCT00171704|101054293|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
33316706|NCT00171704|101054292|FG000|Overall Study|Administrative Problems|2|||
33397890|NCT01738594|101345868|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
33316707|NCT00171704|101054293|FG001|Overall Study|Administrative Problems|1|||
33397891|NCT01738594|101345869|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
33397892|NCT01738594|101345870|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
33604150|NCT00798317|102102529|FG000|Overall Study|Adverse Event|2|||
33397893|NCT01738594|101345871|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
33397894|NCT01738594|101345872|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
33397895|NCT01738594|101345873|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
33397896|NCT01738594|101345866|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
33397897|NCT01738594|101345867|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
33397898|NCT01738594|101345868|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
33397899|NCT01738594|101345869|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
33397900|NCT01738594|101345870|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
33397901|NCT01738594|101345871|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
33397902|NCT01738594|101345872|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
33397903|NCT01738594|101345873|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
33397904|NCT01738594|101345866|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
33397905|NCT01738594|101345867|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
33397906|NCT01738594|101345868|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
33397907|NCT01738594|101345869|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
33397908|NCT01738594|101345870|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
33397909|NCT01738594|101345871|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
33397910|NCT01738594|101345872|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
33397911|NCT01738594|101345873|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
33397912|NCT01738594|101345866|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
33506745|NCT03063086|101750833|FG000|Overall Study|subject/guardian decision|1|||
33506746|NCT03063086|101750834|FG001|Overall Study|subject/guardian decision|0|||
33604151|NCT00798317|102102530|FG001|Overall Study|Adverse Event|0|||
33196682|NCT02039427|100626300|FG000|Overall Study|Steroid Use|1|||
33196683|NCT02039427|100626301|FG001|Overall Study|Steroid Use|0|||
33196684|NCT02039427|100626302|FG002|Overall Study|Steroid Use|0|||
33316708|NCT00171704|101054292|FG000|Overall Study|Death|2|||
33316709|NCT00171704|101054293|FG001|Overall Study|Death|2|||
33316710|NCT00171704|101054292|FG000|Overall Study|Withdrawal by Subject|1|||
33316711|NCT00171704|101054293|FG001|Overall Study|Withdrawal by Subject|3|||
33604152|NCT00798317|102102529|FG000|Overall Study|Death|1|||
33604153|NCT00798317|102102530|FG001|Overall Study|Death|0|||
33604154|NCT02698371|102102533|FG000|All Participants Flow|Lost to Follow-up|3|||
33316712|NCT00171704|101054292|FG000|Overall Study|Protocol Violation|0|||
33316713|NCT00171704|101054293|FG001|Overall Study|Protocol Violation|1|||
33316714|NCT00551460|101054294|FG000|Overall Study|Adverse Event|1|||
33316715|NCT00551460|101054294|FG000|Overall Study|Withdrawal by Subject|1|||
33316716|NCT00551460|101054294|FG000|Overall Study|Physician Decision|1|||
33316717|NCT00551460|101054294|FG000|Overall Study|Death|7|||
33316718|NCT00551460|101054294|FG000|Overall Study|Ineligible|4|||
33316719|NCT00551460|101054294|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
33316720|NCT01136772|101054295|FG000|Overall Study|Adverse Event|15|||
33316721|NCT01136772|101054296|FG001|Overall Study|Adverse Event|14|||
33316722|NCT01136772|101054295|FG000|Overall Study|Lack of Efficacy|42|||
33316723|NCT01136772|101054296|FG001|Overall Study|Lack of Efficacy|39|||
33316724|NCT01136772|101054295|FG000|Overall Study|Administrative|14|||
33316725|NCT01136772|101054296|FG001|Overall Study|Administrative|12|||
33316726|NCT01136772|101054295|FG000|Overall Study|Withdrawal by Subject|33|||
33316727|NCT01136772|101054296|FG001|Overall Study|Withdrawal by Subject|36|||
33316728|NCT01136772|101054295|FG000|Overall Study|Did not receive injection|10|||
33316729|NCT01136772|101054296|FG001|Overall Study|Did not receive injection|7|||
33196685|NCT02039427|100626303|FG003|Overall Study|Steroid Use|0|||
33196686|NCT00927927|100626304|FG000|Overall Study|Withdrawal by Subject|0|||
33316730|NCT01136772|101054295|FG000|Overall Study|Did not follow up after first injection|2|||
33316731|NCT01136772|101054296|FG001|Overall Study|Did not follow up after first injection|2|||
33316732|NCT04615247|101054297|FG000|Overall Study|Adverse Event|0|||
33316733|NCT04615247|101054298|FG001|Overall Study|Adverse Event|2|||
33316734|NCT04615247|101054297|FG000|Overall Study|Withdrawal by Subject|1|||
33397913|NCT01738594|101345867|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
33196687|NCT00927927|100626305|FG001|Overall Study|Withdrawal by Subject|0|||
33397914|NCT01738594|101345868|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
33397915|NCT01738594|101345869|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
33397916|NCT01738594|101345870|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
33316735|NCT04615247|101054298|FG001|Overall Study|Withdrawal by Subject|1|||
33316736|NCT01177787|101054301|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
33316737|NCT01177787|101054301|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
33316738|NCT01177787|101054301|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
33316739|NCT00807235|101054302|FG000|Overall Study|Adverse Event|1|||
33316740|NCT00807235|101054303|FG001|Overall Study|Adverse Event|0|||
33316741|NCT02225353|101054308|FG000|Overall Study|Lost to Follow-up|0|||
33316742|NCT02225353|101054309|FG001|Overall Study|Lost to Follow-up|1|||
33316743|NCT02225353|101054310|FG002|Overall Study|Lost to Follow-up|3|||
33316744|NCT02225353|101054308|FG000|Overall Study|Protocol Violation|4|||
33316745|NCT02225353|101054309|FG001|Overall Study|Protocol Violation|5|||
33316746|NCT02225353|101054310|FG002|Overall Study|Protocol Violation|12|||
33316747|NCT01326533|101054321|FG000|Overall Study|Lost to Follow-up|2|||
33316748|NCT01326533|101054322|FG001|Overall Study|Lost to Follow-up|0|||
33316749|NCT01326533|101054321|FG000|Overall Study|Withdrawal by Subject|1|||
33316750|NCT01326533|101054322|FG001|Overall Study|Withdrawal by Subject|0|||
33316751|NCT01326533|101054321|FG000|Overall Study|Adverse Event|1|||
33316752|NCT01326533|101054322|FG001|Overall Study|Adverse Event|0|||
33316753|NCT03294109|101054323|FG000|Overall Study|Withdrawal by Subject|6|||
33316754|NCT03294109|101054324|FG001|Overall Study|Withdrawal by Subject|5|||
33316755|NCT01794923|101054325|FG000|Overall Study|Adverse Event|0|||
33316756|NCT01794923|101054326|FG001|Overall Study|Adverse Event|0|||
33316757|NCT01794923|101054327|FG002|Overall Study|Adverse Event|1|||
33316758|NCT02359877|101054328|FG000|Overall Study|Withdrawal by Subject|1|||
33316759|NCT02359877|101054329|FG001|Overall Study|Withdrawal by Subject|0|||
33316760|NCT02359877|101054330|FG002|Overall Study|Withdrawal by Subject|0|||
33316761|NCT02359877|101054331|FG003|Overall Study|Withdrawal by Subject|2|||
33316762|NCT02359877|101054328|FG000|Overall Study|Adverse Event|0|||
33316763|NCT02359877|101054329|FG001|Overall Study|Adverse Event|0|||
33316764|NCT02359877|101054330|FG002|Overall Study|Adverse Event|0|||
33316765|NCT02359877|101054331|FG003|Overall Study|Adverse Event|1|||
33316766|NCT00876928|101054336|FG000|Overall Study|Lost to Follow-up|2|||
33316767|NCT00876928|101054337|FG001|Overall Study|Lost to Follow-up|5|||
33316768|NCT00876928|101054336|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
33316769|NCT00876928|101054337|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
33316770|NCT01271803|101054338|FG000|Overall Study|Progressive disease|0|||
33316771|NCT01271803|101054339|FG001|Overall Study|Progressive disease|0|||
33316772|NCT01271803|101054340|FG002|Overall Study|Progressive disease|2|||
33316773|NCT01271803|101054338|FG000|Overall Study|Death|53|||
33316774|NCT01271803|101054339|FG001|Overall Study|Death|34|||
33316775|NCT01271803|101054340|FG002|Overall Study|Death|0|||
33316776|NCT01271803|101054338|FG000|Overall Study|Withdrawal by Subject|1|||
33316777|NCT01271803|101054339|FG001|Overall Study|Withdrawal by Subject|5|||
33316778|NCT01271803|101054340|FG002|Overall Study|Withdrawal by Subject|0|||
33316779|NCT01271803|101054338|FG000|Overall Study|Lost to Follow-up|1|||
33316780|NCT01271803|101054339|FG001|Overall Study|Lost to Follow-up|0|||
33316781|NCT01271803|101054340|FG002|Overall Study|Lost to Follow-up|0|||
33316782|NCT02038920|101054343|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
33316783|NCT02038920|101054344|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
33316784|NCT02038920|101054345|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
33316785|NCT02038920|101054346|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
33316786|NCT02038920|101054347|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
33316787|NCT02038920|101054348|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
33316788|NCT02038920|101054343|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
33316789|NCT02038920|101054344|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
33224338|NCT02202434|100721790|FG000|Overall Study|Visit Missed|21|||
33316790|NCT02038920|101054345|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
33397917|NCT01738594|101345871|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
33397918|NCT01738594|101345872|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
33397919|NCT01738594|101345873|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
33397920|NCT01738594|101345866|FG000|Follow up for 1 Year|Death|0|||
33397921|NCT01738594|101345867|FG001|Follow up for 1 Year|Death|0|||
33397922|NCT01738594|101345868|FG002|Follow up for 1 Year|Death|0|||
33397923|NCT01738594|101345869|FG003|Follow up for 1 Year|Death|0|||
33397924|NCT01738594|101345870|FG004|Follow up for 1 Year|Death|0|||
33397925|NCT01738594|101345871|FG005|Follow up for 1 Year|Death|1|||
33397926|NCT01738594|101345872|FG006|Follow up for 1 Year|Death|0|||
33397927|NCT01738594|101345873|FG007|Follow up for 1 Year|Death|0|||
33397928|NCT01738594|101345866|FG000|Follow up for 1 Year|Other|0|||
33397929|NCT01738594|101345867|FG001|Follow up for 1 Year|Other|0|||
33397930|NCT01738594|101345868|FG002|Follow up for 1 Year|Other|0|||
33397931|NCT01738594|101345869|FG003|Follow up for 1 Year|Other|0|||
33397932|NCT01738594|101345870|FG004|Follow up for 1 Year|Other|0|||
33397933|NCT01738594|101345871|FG005|Follow up for 1 Year|Other|2|||
33397934|NCT01738594|101345872|FG006|Follow up for 1 Year|Other|0|||
33397935|NCT01738594|101345873|FG007|Follow up for 1 Year|Other|0|||
33397936|NCT03245840|101345874|FG000|Overall Study|Adverse Event|6|||
33397937|NCT03245840|101345875|FG001|Overall Study|Adverse Event|0|||
33397938|NCT03245840|101345874|FG000|Overall Study|Death|2|||
33397939|NCT03245840|101345875|FG001|Overall Study|Death|0|||
33397940|NCT03245840|101345874|FG000|Overall Study|Withdrawal by Subject|31|||
33397941|NCT03245840|101345875|FG001|Overall Study|Withdrawal by Subject|1|||
33397942|NCT03245840|101345874|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
33397943|NCT03245840|101345875|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33397944|NCT03245840|101345874|FG000|Overall Study|Physician Decision|4|||
33397945|NCT03245840|101345875|FG001|Overall Study|Physician Decision|1|||
33397946|NCT03245840|101345874|FG000|Overall Study|Study Terminated by Sponsor|56|||
33397947|NCT03245840|101345875|FG001|Overall Study|Study Terminated by Sponsor|6|||
33397948|NCT03245840|101345874|FG000|Overall Study|Site Terminated by Sponsor|4|||
33397949|NCT03245840|101345875|FG001|Overall Study|Site Terminated by Sponsor|0|||
33397950|NCT03245840|101345874|FG000|Overall Study|Lost to Follow-up|12|||
33397951|NCT03245840|101345875|FG001|Overall Study|Lost to Follow-up|2|||
33397952|NCT03245840|101345874|FG000|Overall Study|Pregnancy|2|||
33397953|NCT03245840|101345875|FG001|Overall Study|Pregnancy|0|||
33397954|NCT03245840|101345874|FG000|Overall Study|Non-Compliance with Study Drug|2|||
33397955|NCT03245840|101345875|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33397956|NCT03245840|101345874|FG000|Overall Study|Not treated|1|||
33397957|NCT03245840|101345875|FG001|Overall Study|Not treated|1|||
33397958|NCT00338806|101345876|FG000|Acute Phase|Withdrawal by Subject|0|||
33397959|NCT00338806|101345877|FG001|Acute Phase|Withdrawal by Subject|1|||
33397960|NCT00338806|101345876|FG000|Follow-up|Lost to Follow-up|1|||
33397961|NCT00338806|101345877|FG001|Follow-up|Lost to Follow-up|3|||
33397962|NCT01234337|101345878|FG000|Overall Study|Adverse Event|58|||
33506747|NCT03063086|101750835|FG002|Overall Study|subject/guardian decision|0|||
33506748|NCT03063086|101750836|FG003|Overall Study|subject/guardian decision|0|||
33506749|NCT03063086|101750837|FG004|Overall Study|subject/guardian decision|0|||
33397963|NCT01234337|101345879|FG001|Overall Study|Adverse Event|21|||
33397964|NCT01234337|101345878|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
33397965|NCT01234337|101345879|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
33397966|NCT01234337|101345878|FG000|Overall Study|Investi. decision not protocol driven|5|||
33397967|NCT01234337|101345879|FG001|Overall Study|Investi. decision not protocol driven|6|||
33397968|NCT01234337|101345878|FG000|Overall Study|Non-compliant with study medication|3|||
33397969|NCT01234337|101345879|FG001|Overall Study|Non-compliant with study medication|2|||
33397970|NCT01234337|101345878|FG000|Overall Study|Randomized but not treated|6|||
33397971|NCT01234337|101345879|FG001|Overall Study|Randomized but not treated|4|||
33397972|NCT01234337|101345878|FG000|Overall Study|Lost to Follow-up|0|||
33397973|NCT01234337|101345879|FG001|Overall Study|Lost to Follow-up|1|||
33397974|NCT01234337|101345878|FG000|Overall Study|Protocol Violation|2|||
33397975|NCT01234337|101345879|FG001|Overall Study|Protocol Violation|3|||
33397976|NCT01234337|101345878|FG000|Overall Study|Withdrawal by Subject|11|||
33604155|NCT02698371|102102533|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
33316791|NCT02038920|101054346|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
33316792|NCT02038920|101054347|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
33316793|NCT02038920|101054348|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
33316794|NCT02038920|101054343|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
33316795|NCT02038920|101054344|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
33316796|NCT02038920|101054345|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
33316797|NCT02038920|101054346|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
33316798|NCT02038920|101054347|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
33316799|NCT02038920|101054348|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
33604156|NCT02698371|102102533|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
33604157|NCT02698371|102102533|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
33604158|NCT02698371|102102533|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
33604159|NCT02698371|102102533|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
33604160|NCT02698371|102102533|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
33604161|NCT00308074|102102534|FG000|Overall Study|Withdrawal by Subject|1|||
33316800|NCT02038920|101054343|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
33316801|NCT02038920|101054344|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
33316802|NCT02038920|101054345|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
33316803|NCT02038920|101054346|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
33316804|NCT02038920|101054347|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
33316805|NCT02038920|101054348|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
33316806|NCT02038920|101054343|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
33316807|NCT02038920|101054344|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
33316808|NCT02038920|101054345|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
33316809|NCT02038920|101054346|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
33316810|NCT02038920|101054347|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
33316811|NCT02038920|101054348|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
33316812|NCT02038920|101054343|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
33316813|NCT02038920|101054344|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
33316814|NCT02038920|101054345|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
33316815|NCT02038920|101054346|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
33316816|NCT02038920|101054347|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
33316817|NCT02038920|101054348|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
33316818|NCT02038920|101054343|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
33316819|NCT02038920|101054344|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
33316820|NCT02038920|101054345|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
33316821|NCT02038920|101054346|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
33316822|NCT02038920|101054347|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
33316823|NCT02038920|101054348|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
33316824|NCT02038920|101054343|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
33316825|NCT02038920|101054344|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
33316826|NCT02038920|101054345|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
33316827|NCT02038920|101054346|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
33316828|NCT02038920|101054347|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
33316829|NCT02038920|101054348|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
33316830|NCT02038920|101054343|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
33316831|NCT02038920|101054344|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
33316832|NCT02038920|101054345|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
33316833|NCT02038920|101054346|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
33316834|NCT02038920|101054347|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
33316835|NCT02038920|101054348|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
33316836|NCT02038920|101054343|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
33316837|NCT02038920|101054344|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
33316838|NCT02038920|101054345|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
33316839|NCT02038920|101054346|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
33604162|NCT03262116|102102540|FG000|Overall Study|Physician Decision|0|||
33604163|NCT03262116|102102541|FG001|Overall Study|Physician Decision|2|||
33604164|NCT03262116|102102542|FG002|Overall Study|Physician Decision|1|||
33604165|NCT03262116|102102543|FG003|Overall Study|Physician Decision|1|||
33604166|NCT03262116|102102544|FG004|Overall Study|Physician Decision|1|||
33604167|NCT03262116|102102545|FG005|Overall Study|Physician Decision|2|||
33604168|NCT01930890|102102548|FG000|Overall Study|Study Termination|14|||
33604169|NCT01930890|102102549|FG001|Overall Study|Study Termination|28|||
33604170|NCT01930890|102102550|FG002|Overall Study|Study Termination|13|||
33506750|NCT03063086|101750838|FG005|Overall Study|subject/guardian decision|0|||
33316840|NCT02038920|101054347|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
33316841|NCT02038920|101054348|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
33316842|NCT02038920|101054343|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
33316843|NCT02038920|101054344|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
33316844|NCT02038920|101054345|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
33316845|NCT02038920|101054346|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
33316846|NCT02038920|101054347|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
33316847|NCT02038920|101054348|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
33316848|NCT02038920|101054343|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
33316849|NCT02038920|101054344|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
33316850|NCT02038920|101054345|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
33316851|NCT02038920|101054346|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
33316852|NCT02038920|101054347|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
33316853|NCT02038920|101054348|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
33316854|NCT03285178|101054349|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
33316855|NCT03285178|101054350|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
33316856|NCT03285178|101054351|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
33316857|NCT03285178|101054352|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
33316858|NCT03285178|101054353|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
33316859|NCT03285178|101054354|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
33316860|NCT03285178|101054355|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
33316861|NCT03285178|101054349|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
33316862|NCT03285178|101054350|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
33316863|NCT03285178|101054351|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
33316864|NCT03285178|101054352|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
33316865|NCT03285178|101054353|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
33316866|NCT03285178|101054354|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
33316867|NCT03285178|101054355|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
33316868|NCT03285178|101054349|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
33316869|NCT03285178|101054350|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
33316870|NCT03285178|101054351|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
33316871|NCT03285178|101054352|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
33316872|NCT03285178|101054353|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
33316873|NCT03285178|101054354|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
33316874|NCT03285178|101054355|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
33316875|NCT03285178|101054349|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
33316876|NCT03285178|101054350|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
33316877|NCT03285178|101054351|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
33316878|NCT03285178|101054352|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
33316879|NCT03285178|101054353|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
33316880|NCT03285178|101054354|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
33316881|NCT03285178|101054355|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
33316882|NCT03285178|101054349|FG000|Single-Blind Run-In Period|Physician Decision|2|||
33316883|NCT03285178|101054350|FG001|Single-Blind Run-In Period|Physician Decision|0|||
33316884|NCT03285178|101054351|FG002|Single-Blind Run-In Period|Physician Decision|0|||
33316885|NCT03285178|101054352|FG003|Single-Blind Run-In Period|Physician Decision|0|||
33316886|NCT03285178|101054353|FG004|Single-Blind Run-In Period|Physician Decision|0|||
33316887|NCT03285178|101054354|FG005|Single-Blind Run-In Period|Physician Decision|0|||
33316888|NCT03285178|101054355|FG006|Single-Blind Run-In Period|Physician Decision|0|||
33316889|NCT03285178|101054349|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
33316890|NCT03285178|101054350|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
33316891|NCT03285178|101054351|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
33316892|NCT03285178|101054352|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
33316893|NCT03285178|101054353|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
33316894|NCT03285178|101054354|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
33316895|NCT03285178|101054355|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
33316896|NCT03285178|101054349|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33316897|NCT03285178|101054350|FG001|Double-Blind Treatment Period|Adverse Event|0|||
33604171|NCT01930890|102102551|FG003|Overall Study|Study Termination|25|||
33604172|NCT01930890|102102548|FG000|Overall Study|Death|0|||
33604173|NCT01930890|102102549|FG001|Overall Study|Death|0|||
33604174|NCT01930890|102102550|FG002|Overall Study|Death|0|||
33604175|NCT01930890|102102551|FG003|Overall Study|Death|1|||
33604176|NCT01930890|102102548|FG000|Overall Study|Investigator Decision|0|||
33604177|NCT01930890|102102549|FG001|Overall Study|Investigator Decision|1|||
33604178|NCT01930890|102102550|FG002|Overall Study|Investigator Decision|0|||
33604179|NCT01930890|102102551|FG003|Overall Study|Investigator Decision|0|||
33604180|NCT01930890|102102548|FG000|Overall Study|Consent Withdrawn|0|||
33604181|NCT01930890|102102549|FG001|Overall Study|Consent Withdrawn|3|||
33604182|NCT01930890|102102550|FG002|Overall Study|Consent Withdrawn|0|||
33604183|NCT01930890|102102551|FG003|Overall Study|Consent Withdrawn|1|||
33604184|NCT01930890|102102548|FG000|Overall Study|Adverse Event|0|||
33604185|NCT01930890|102102549|FG001|Overall Study|Adverse Event|1|||
33604186|NCT01930890|102102550|FG002|Overall Study|Adverse Event|0|||
33604187|NCT01930890|102102551|FG003|Overall Study|Adverse Event|0|||
33604188|NCT02049138|102102552|FG000|Overall Study|Adverse Event|46|||
33604189|NCT02049138|102102553|FG001|Overall Study|Adverse Event|25|||
33604190|NCT02049138|102102554|FG002|Overall Study|Adverse Event|1|||
33604191|NCT02049138|102102552|FG000|Overall Study|Withdrawal by Subject|57|||
33604192|NCT02049138|102102553|FG001|Overall Study|Withdrawal by Subject|21|||
33604193|NCT02049138|102102554|FG002|Overall Study|Withdrawal by Subject|5|||
33604194|NCT02049138|102102552|FG000|Overall Study|Lost to Follow-up|18|||
33604195|NCT02049138|102102553|FG001|Overall Study|Lost to Follow-up|5|||
33604196|NCT02049138|102102554|FG002|Overall Study|Lost to Follow-up|1|||
33604197|NCT02049138|102102552|FG000|Overall Study|Lack of Efficacy|10|||
33604198|NCT02049138|102102553|FG001|Overall Study|Lack of Efficacy|26|||
33604199|NCT02049138|102102554|FG002|Overall Study|Lack of Efficacy|1|||
33604200|NCT02049138|102102552|FG000|Overall Study|Non-Compliance|15|||
33604201|NCT02049138|102102553|FG001|Overall Study|Non-Compliance|6|||
33604202|NCT02049138|102102554|FG002|Overall Study|Non-Compliance|0|||
33604203|NCT02049138|102102552|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
33604204|NCT02049138|102102553|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
33604205|NCT02049138|102102554|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
33604206|NCT02049138|102102552|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
33604207|NCT02049138|102102553|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
33604208|NCT02049138|102102554|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
33604209|NCT02049138|102102552|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
33604210|NCT02049138|102102553|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
33604211|NCT02049138|102102554|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
33604212|NCT02049138|102102552|FG000|Overall Study|Other|15|||
33604213|NCT02049138|102102553|FG001|Overall Study|Other|13|||
33604214|NCT02049138|102102554|FG002|Overall Study|Other|0|||
33604215|NCT02049138|102102552|FG000|Overall Study|Missing|0|||
33604216|NCT02049138|102102553|FG001|Overall Study|Missing|1|||
33316898|NCT03285178|101054351|FG002|Double-Blind Treatment Period|Adverse Event|0|||
33316899|NCT03285178|101054352|FG003|Double-Blind Treatment Period|Adverse Event|0|||
33316900|NCT03285178|101054353|FG004|Double-Blind Treatment Period|Adverse Event|0|||
33316901|NCT03285178|101054354|FG005|Double-Blind Treatment Period|Adverse Event|0|||
33316902|NCT03285178|101054355|FG006|Double-Blind Treatment Period|Adverse Event|2|||
33316903|NCT03285178|101054349|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33316904|NCT03285178|101054350|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
33316905|NCT03285178|101054351|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
33316906|NCT03285178|101054352|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
33316907|NCT03285178|101054353|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
33316908|NCT03285178|101054354|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
33316909|NCT03285178|101054355|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
33316910|NCT03285178|101054349|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33316911|NCT03285178|101054350|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33316912|NCT03285178|101054351|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33316913|NCT03285178|101054352|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33316914|NCT03285178|101054353|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33316915|NCT03285178|101054354|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
33316916|NCT03285178|101054355|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33316917|NCT03285178|101054349|FG000|Double-Blind Treatment Period|COVID-19|0|||
33316918|NCT03285178|101054350|FG001|Double-Blind Treatment Period|COVID-19|0|||
33604217|NCT02049138|102102554|FG002|Overall Study|Missing|0|||
33604218|NCT02017522|102102560|FG000|Overall Study|Withdrawal by Subject|1|||
33316919|NCT03285178|101054351|FG002|Double-Blind Treatment Period|COVID-19|1|||
33316920|NCT03285178|101054352|FG003|Double-Blind Treatment Period|COVID-19|0|||
33316921|NCT03285178|101054353|FG004|Double-Blind Treatment Period|COVID-19|0|||
33604219|NCT00940485|102102561|FG000|Overall Study|HBeAb positive at Baseline|3|||
33604220|NCT00940485|102102562|FG001|Overall Study|HBeAb positive at Baseline|2|||
33604221|NCT00940485|102102561|FG000|Overall Study|Lost to Follow-up|2|||
33604222|NCT00940485|102102562|FG001|Overall Study|Lost to Follow-up|3|||
33604223|NCT00940485|102102561|FG000|Overall Study|Adverse Event|8|||
33196688|NCT00927927|100626306|FG002|Overall Study|Withdrawal by Subject|0|||
33196689|NCT00927927|100626307|FG003|Overall Study|Withdrawal by Subject|0|||
33196690|NCT00927927|100626308|FG004|Overall Study|Withdrawal by Subject|0|||
33196691|NCT00927927|100626309|FG005|Overall Study|Withdrawal by Subject|0|||
33196692|NCT00927927|100626310|FG006|Overall Study|Withdrawal by Subject|0|||
33196693|NCT00927927|100626311|FG007|Overall Study|Withdrawal by Subject|2|||
33196694|NCT00927927|100626312|FG008|Overall Study|Withdrawal by Subject|0|||
33506751|NCT03063086|101750833|FG000|Overall Study|Non-compliance with study treatment|0|||
33316922|NCT03285178|101054354|FG005|Double-Blind Treatment Period|COVID-19|0|||
33316923|NCT03285178|101054355|FG006|Double-Blind Treatment Period|COVID-19|0|||
33316924|NCT01978262|101054360|FG000|Overall Study|Withdrawal by Subject|9|||
33316925|NCT01978262|101054360|FG000|Overall Study|Lost to Follow-up|2|||
33316926|NCT03604523|101054369|FG000|Overall Study|Physician Decision|1|||
33316927|NCT03604523|101054370|FG001|Overall Study|Physician Decision|0|||
33316928|NCT03437278|101054373|FG000|Overall Study|Adverse Event|0|||
33316929|NCT03437278|101054374|FG001|Overall Study|Adverse Event|0|||
33316930|NCT03437278|101054375|FG002|Overall Study|Adverse Event|1|||
33316931|NCT03437278|101054373|FG000|Overall Study|Progressive disease|1|||
33316932|NCT03437278|101054374|FG001|Overall Study|Progressive disease|0|||
33316933|NCT03437278|101054375|FG002|Overall Study|Progressive disease|0|||
33316934|NCT03437278|101054373|FG000|Overall Study|Physician Decision|1|||
33316935|NCT03437278|101054374|FG001|Overall Study|Physician Decision|0|||
33316936|NCT03437278|101054375|FG002|Overall Study|Physician Decision|1|||
33316937|NCT00117845|101054377|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
33316938|NCT01206777|101054378|FG000|Overall Study|Death|1|||
33316939|NCT01206777|101054378|FG000|Overall Study|Adverse Event|1|||
33316940|NCT03384654|101054379|FG000|Overall Study|Withdrawal by Subject|0|||
33316941|NCT03384654|101054380|FG001|Overall Study|Withdrawal by Subject|0|||
33316942|NCT03384654|101054381|FG002|Overall Study|Withdrawal by Subject|1|||
33316943|NCT03384654|101054382|FG003|Overall Study|Withdrawal by Subject|0|||
33316944|NCT01488487|101054384|FG000|Overall Study|Adverse Event|6|||
33316945|NCT01488487|101054384|FG000|Overall Study|Death|1|||
33316946|NCT01488487|101054384|FG000|Overall Study|Withdrawal by Subject|2|||
33316947|NCT02634346|101054386|FG000|Overall Study|Withdrawal by Subject|8|||
33316948|NCT02634346|101054387|FG001|Overall Study|Withdrawal by Subject|9|||
33316949|NCT02634346|101054388|FG002|Overall Study|Withdrawal by Subject|8|||
33316950|NCT02634346|101054386|FG000|Overall Study|Adverse Event|2|||
33316951|NCT02634346|101054387|FG001|Overall Study|Adverse Event|2|||
33316952|NCT02634346|101054388|FG002|Overall Study|Adverse Event|7|||
33316953|NCT02634346|101054386|FG000|Overall Study|Lack of Efficacy|1|||
33316954|NCT02634346|101054387|FG001|Overall Study|Lack of Efficacy|2|||
33316955|NCT02634346|101054388|FG002|Overall Study|Lack of Efficacy|8|||
33506752|NCT03063086|101750834|FG001|Overall Study|Non-compliance with study treatment|0|||
33506753|NCT03063086|101750835|FG002|Overall Study|Non-compliance with study treatment|0|||
33506754|NCT03063086|101750836|FG003|Overall Study|Non-compliance with study treatment|1|||
33506755|NCT03063086|101750837|FG004|Overall Study|Non-compliance with study treatment|0|||
33196695|NCT00927927|100626313|FG009|Overall Study|Withdrawal by Subject|0|||
33196696|NCT00927927|100626314|FG010|Overall Study|Withdrawal by Subject|0|||
33196697|NCT00927927|100626315|FG011|Overall Study|Withdrawal by Subject|2|||
33196698|NCT00927927|100626316|FG012|Overall Study|Withdrawal by Subject|0|||
33196699|NCT00927927|100626317|FG013|Overall Study|Withdrawal by Subject|0|||
33196700|NCT00927927|100626318|FG014|Overall Study|Withdrawal by Subject|0|||
33196701|NCT01529645|100626319|FG000|Overall Study|Lost to Follow-up|0|||
33196702|NCT01529645|100626320|FG001|Overall Study|Lost to Follow-up|1|||
33196703|NCT01529645|100626321|FG002|Overall Study|Lost to Follow-up|1|||
33196704|NCT01529645|100626322|FG003|Overall Study|Lost to Follow-up|1|||
33196705|NCT01529645|100626323|FG004|Overall Study|Lost to Follow-up|1|||
33316956|NCT02634346|101054386|FG000|Overall Study|Lost to Follow-up|1|||
33316957|NCT02634346|101054387|FG001|Overall Study|Lost to Follow-up|0|||
33506756|NCT03063086|101750838|FG005|Overall Study|Non-compliance with study treatment|1|||
33506757|NCT03063086|101750833|FG000|Overall Study|Physician Decision|0|||
33506758|NCT03063086|101750834|FG001|Overall Study|Physician Decision|0|||
33506759|NCT03063086|101750835|FG002|Overall Study|Physician Decision|0|||
33506760|NCT03063086|101750836|FG003|Overall Study|Physician Decision|1|||
33604224|NCT00940485|102102562|FG001|Overall Study|Adverse Event|0|||
33196706|NCT01529645|100626324|FG005|Overall Study|Lost to Follow-up|0|||
33196707|NCT01529645|100626325|FG006|Overall Study|Lost to Follow-up|2|||
33196708|NCT01529645|100626326|FG007|Overall Study|Lost to Follow-up|0|||
33196709|NCT01529645|100626327|FG008|Overall Study|Lost to Follow-up|1|||
33196710|NCT01529645|100626328|FG009|Overall Study|Lost to Follow-up|0|||
33316958|NCT02634346|101054388|FG002|Overall Study|Lost to Follow-up|0|||
33316959|NCT02634346|101054386|FG000|Overall Study|Protocol Violation|0|||
33316960|NCT02634346|101054387|FG001|Overall Study|Protocol Violation|1|||
33316961|NCT02634346|101054388|FG002|Overall Study|Protocol Violation|0|||
33316962|NCT00447382|101054389|FG000|Overall Study|Adverse Event|1|||
33316963|NCT00447382|101054390|FG001|Overall Study|Adverse Event|1|||
33316964|NCT00447382|101054389|FG000|Overall Study|Lack of Efficacy|1|||
33224339|NCT02202434|100721791|FG001|Overall Study|Visit Missed|12|||
33316965|NCT00447382|101054390|FG001|Overall Study|Lack of Efficacy|0|||
33316966|NCT00447382|101054389|FG000|Overall Study|Protocol Violation|2|||
33316967|NCT00447382|101054390|FG001|Overall Study|Protocol Violation|0|||
33316968|NCT00447382|101054389|FG000|Overall Study|Unclassified|2|||
33316969|NCT00447382|101054390|FG001|Overall Study|Unclassified|5|||
33316970|NCT00973362|101054392|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
33316971|NCT00973362|101054393|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
33316972|NCT00973362|101054392|FG000|Baseline Evaluation|No colposcopy visit|62|||
33316973|NCT00973362|101054393|FG001|Baseline Evaluation|No colposcopy visit|0|||
33316974|NCT00973362|101054392|FG000|Baseline Evaluation|Inevaluable|686|||
33316975|NCT00973362|101054393|FG001|Baseline Evaluation|Inevaluable|223|||
33316976|NCT00973362|101054392|FG000|3-Year Follow-up|Lost to Follow-up|17|||
33316977|NCT00973362|101054393|FG001|3-Year Follow-up|Lost to Follow-up|0|||
33316978|NCT04508023|101054394|FG000|Overall Study|Withdrawal by Subject|1|||
33316979|NCT04508023|101054395|FG001|Overall Study|Withdrawal by Subject|2|||
33316980|NCT01139658|101054396|FG000|Overall Study|Adverse Event|10|||
33316981|NCT01139658|101054397|FG001|Overall Study|Adverse Event|27|||
33316982|NCT01139658|101054396|FG000|Overall Study|Lack of Efficacy|15|||
33316983|NCT01139658|101054397|FG001|Overall Study|Lack of Efficacy|7|||
33316984|NCT01139658|101054396|FG000|Overall Study|Withdrawal by Subject|2|||
33316985|NCT01139658|101054397|FG001|Overall Study|Withdrawal by Subject|4|||
33316986|NCT01139658|101054396|FG000|Overall Study|No documentation of treatment|1|||
33316987|NCT01139658|101054397|FG001|Overall Study|No documentation of treatment|0|||
33316988|NCT01139658|101054396|FG000|Overall Study|Other|28|||
33316989|NCT01139658|101054397|FG001|Overall Study|Other|75|||
33316990|NCT00756470|101054400|FG000|Overall Study|Withdrawal by Subject|1|||
33316991|NCT00756470|101054400|FG000|Overall Study|Adverse Event|4|||
33316992|NCT01259284|101054401|FG000|Overall Study|Study Termination|2|||
33316993|NCT01259284|101054402|FG001|Overall Study|Study Termination|0|||
33316994|NCT01259284|101054403|FG002|Overall Study|Study Termination|0|||
33506761|NCT03063086|101750837|FG004|Overall Study|Physician Decision|0|||
33506762|NCT03063086|101750838|FG005|Overall Study|Physician Decision|0|||
33506763|NCT04445714|101750839|FG000|Overall Study|Discontinuation of the study|14|||
33506764|NCT04445714|101750839|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
33506765|NCT04445714|101750839|FG000|Overall Study|Withdrawal of Informed Consent|8|||
33506766|NCT00809471|101750840|FG000|Overall Study|Protocol non-compliance|15|||
33506767|NCT00809471|101750841|FG001|Overall Study|Protocol non-compliance|15|||
33506768|NCT00809471|101750842|FG002|Overall Study|Protocol non-compliance|6|||
33506769|NCT00809471|101750840|FG000|Overall Study|Lost to Follow-up|4|||
33506770|NCT00809471|101750841|FG001|Overall Study|Lost to Follow-up|2|||
33506771|NCT00809471|101750842|FG002|Overall Study|Lost to Follow-up|9|||
33506772|NCT00809471|101750840|FG000|Overall Study|Adverse Event|0|||
33506773|NCT00809471|101750841|FG001|Overall Study|Adverse Event|2|||
33506774|NCT00809471|101750842|FG002|Overall Study|Adverse Event|2|||
33506775|NCT00809471|101750840|FG000|Overall Study|Requirement for restricted medication|1|||
33196711|NCT01529645|100626319|FG000|Overall Study|SAE - Premature contractions|0|||
33316995|NCT01831856|101054404|FG000|Overall Study|Adverse Event|5|||
33316996|NCT01831856|101054405|FG001|Overall Study|Adverse Event|8|||
33316997|NCT01831856|101054404|FG000|Overall Study|Lack of Efficacy|13|||
33316998|NCT01831856|101054405|FG001|Overall Study|Lack of Efficacy|11|||
33506776|NCT00809471|101750841|FG001|Overall Study|Requirement for restricted medication|1|||
33196712|NCT01529645|100626320|FG001|Overall Study|SAE - Premature contractions|0|||
33316999|NCT01831856|101054404|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
33317000|NCT01831856|101054405|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
33317001|NCT00092495|101054412|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
33317002|NCT00092495|101054413|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
33317003|NCT00092495|101054414|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
33317004|NCT00092495|101054415|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
33317005|NCT00092495|101054416|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
33317006|NCT00092495|101054412|FG000|Base Study Vaccination Period|Extended|0|||
33317007|NCT00092495|101054413|FG001|Base Study Vaccination Period|Extended|0|||
33317008|NCT00092495|101054414|FG002|Base Study Vaccination Period|Extended|0|||
33317009|NCT00092495|101054415|FG003|Base Study Vaccination Period|Extended|1|||
33196713|NCT01529645|100626321|FG002|Overall Study|SAE - Premature contractions|1|||
33196714|NCT01529645|100626322|FG003|Overall Study|SAE - Premature contractions|0|||
33604225|NCT00940485|102102561|FG000|Overall Study|Withdrawal by Subject|1|||
33604226|NCT00940485|102102562|FG001|Overall Study|Withdrawal by Subject|1|||
33604227|NCT00940485|102102561|FG000|Overall Study|Others|1|||
33604228|NCT00940485|102102562|FG001|Overall Study|Others|1|||
33604229|NCT02759315|102102563|FG000|Overall Study|Adverse Event|0|||
33604230|NCT02759315|102102564|FG001|Overall Study|Adverse Event|0|||
33604231|NCT02759315|102102565|FG002|Overall Study|Adverse Event|0|||
33604232|NCT02759315|102102566|FG003|Overall Study|Adverse Event|1|||
33196715|NCT01529645|100626323|FG004|Overall Study|SAE - Premature contractions|0|||
33196716|NCT01529645|100626324|FG005|Overall Study|SAE - Premature contractions|0|||
33196717|NCT01529645|100626325|FG006|Overall Study|SAE - Premature contractions|0|||
33196718|NCT01529645|100626326|FG007|Overall Study|SAE - Premature contractions|0|||
33196719|NCT01529645|100626327|FG008|Overall Study|SAE - Premature contractions|0|||
33317010|NCT00092495|101054416|FG004|Base Study Vaccination Period|Extended|0|||
33317011|NCT00092495|101054412|FG000|Base Study Vaccination Period|*Clinical AE|1|||
33317012|NCT00092495|101054413|FG001|Base Study Vaccination Period|*Clinical AE|0|||
33317013|NCT00092495|101054414|FG002|Base Study Vaccination Period|*Clinical AE|1|||
33317014|NCT00092495|101054415|FG003|Base Study Vaccination Period|*Clinical AE|2|||
33317015|NCT00092495|101054416|FG004|Base Study Vaccination Period|*Clinical AE|0|||
33317016|NCT00092495|101054412|FG000|Base Study Vaccination Period|*Other reasons|1|||
33317017|NCT00092495|101054413|FG001|Base Study Vaccination Period|*Other reasons|0|||
33317018|NCT00092495|101054414|FG002|Base Study Vaccination Period|*Other reasons|0|||
33317019|NCT00092495|101054415|FG003|Base Study Vaccination Period|*Other reasons|1|||
33317020|NCT00092495|101054416|FG004|Base Study Vaccination Period|*Other reasons|0|||
33506777|NCT00809471|101750842|FG002|Overall Study|Requirement for restricted medication|0|||
33196720|NCT01529645|100626328|FG009|Overall Study|SAE - Premature contractions|0|||
33196721|NCT01529645|100626319|FG000|Overall Study|Withdrawal by Subject|2|||
33196722|NCT01529645|100626320|FG001|Overall Study|Withdrawal by Subject|0|||
33196723|NCT01529645|100626321|FG002|Overall Study|Withdrawal by Subject|0|||
33196724|NCT01529645|100626322|FG003|Overall Study|Withdrawal by Subject|1|||
33196725|NCT01529645|100626323|FG004|Overall Study|Withdrawal by Subject|1|||
33196726|NCT01529645|100626324|FG005|Overall Study|Withdrawal by Subject|1|||
33196727|NCT01529645|100626325|FG006|Overall Study|Withdrawal by Subject|0|||
33196728|NCT01529645|100626326|FG007|Overall Study|Withdrawal by Subject|0|||
33196729|NCT01529645|100626327|FG008|Overall Study|Withdrawal by Subject|0|||
33506778|NCT03039621|101750843|FG000|Overall Study|Violation of inclusion criteria|3|||
33506779|NCT03039621|101750844|FG001|Overall Study|Violation of inclusion criteria|2|||
33506780|NCT03039621|101750843|FG000|Overall Study|Non-compliance with protocol requirement|4|||
33506781|NCT03039621|101750844|FG001|Overall Study|Non-compliance with protocol requirement|5|||
33506782|NCT03039621|101750843|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
33506783|NCT03039621|101750844|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
33196730|NCT01529645|100626328|FG009|Overall Study|Withdrawal by Subject|0|||
33196731|NCT03120624|100626329|FG000|Overall Study|Withdrawal by Subject|0|||
33196732|NCT03120624|100626330|FG001|Overall Study|Withdrawal by Subject|1|||
33196733|NCT03120624|100626331|FG002|Overall Study|Withdrawal by Subject|0|||
33196734|NCT03120624|100626332|FG003|Overall Study|Withdrawal by Subject|0|||
33196735|NCT03120624|100626333|FG004|Overall Study|Withdrawal by Subject|0|||
33196736|NCT03120624|100626334|FG005|Overall Study|Withdrawal by Subject|0|||
33196737|NCT03120624|100626335|FG006|Overall Study|Withdrawal by Subject|0|||
33196738|NCT03120624|100626336|FG007|Overall Study|Withdrawal by Subject|0|||
33196739|NCT02460198|100626341|FG000|Overall Study|Adverse Event|1|||
33196740|NCT02460198|100626342|FG001|Overall Study|Adverse Event|3|||
33196741|NCT02460198|100626341|FG000|Overall Study|Death|36|||
33196742|NCT02460198|100626342|FG001|Overall Study|Death|28|||
33196743|NCT02460198|100626341|FG000|Overall Study|Lost to Follow-up|1|||
33196744|NCT02460198|100626342|FG001|Overall Study|Lost to Follow-up|1|||
33317021|NCT00092495|101054412|FG000|Base Study Vaccination Period|*Pregnancy|0|||
33317022|NCT00092495|101054413|FG001|Base Study Vaccination Period|*Pregnancy|2|||
33317023|NCT00092495|101054414|FG002|Base Study Vaccination Period|*Pregnancy|5|||
33604233|NCT02759315|102102567|FG004|Overall Study|Adverse Event|0|||
33604234|NCT02759315|102102563|FG000|Overall Study|Death|0|||
33604235|NCT02759315|102102564|FG001|Overall Study|Death|0|||
33196745|NCT02460198|100626341|FG000|Overall Study|Transferred to Extension Study|15|||
33196746|NCT02460198|100626342|FG001|Overall Study|Transferred to Extension Study|15|||
33196747|NCT02460198|100626341|FG000|Overall Study|Withdrawal by Subject|2|||
33196748|NCT02460198|100626342|FG001|Overall Study|Withdrawal by Subject|4|||
33317024|NCT00092495|101054415|FG003|Base Study Vaccination Period|*Pregnancy|7|||
33317025|NCT00092495|101054416|FG004|Base Study Vaccination Period|*Pregnancy|0|||
33317026|NCT00092495|101054412|FG000|Base Study Vaccination Period|Adverse Event|1|||
33317027|NCT00092495|101054413|FG001|Base Study Vaccination Period|Adverse Event|0|||
33604236|NCT02759315|102102565|FG002|Overall Study|Death|1|||
33604237|NCT02759315|102102566|FG003|Overall Study|Death|0|||
33604238|NCT02759315|102102567|FG004|Overall Study|Death|0|||
33196749|NCT02460198|100626341|FG000|Overall Study|Site Terminated By Sponsor|0|||
33196750|NCT02460198|100626342|FG001|Overall Study|Site Terminated By Sponsor|1|||
33196751|NCT02460198|100626341|FG000|Overall Study|Did Not Continue on Extension Study|6|||
33196752|NCT02460198|100626342|FG001|Overall Study|Did Not Continue on Extension Study|11|||
33196753|NCT01344057|100626344|FG000|Overall Study|Premature Withdrawal|1|||
33196754|NCT03952039|100626347|FG000|Overall Study|Adverse Event|22|||
33196755|NCT03952039|100626348|FG001|Overall Study|Adverse Event|8|||
33196756|NCT03952039|100626347|FG000|Overall Study|Withdrawal by Participant|17|||
33196757|NCT03952039|100626348|FG001|Overall Study|Withdrawal by Participant|12|||
33196758|NCT03952039|100626347|FG000|Overall Study|Death|13|||
33196759|NCT03952039|100626348|FG001|Overall Study|Death|6|||
33196760|NCT03952039|100626347|FG000|Overall Study|Lack of Efficacy|12|||
33196761|NCT03952039|100626348|FG001|Overall Study|Lack of Efficacy|2|||
33196762|NCT03952039|100626347|FG000|Overall Study|Physician Decision|9|||
33196763|NCT03952039|100626348|FG001|Overall Study|Physician Decision|3|||
33196764|NCT03952039|100626347|FG000|Overall Study|Progressive Disease|6|||
33196765|NCT03952039|100626348|FG001|Overall Study|Progressive Disease|4|||
33196766|NCT03952039|100626347|FG000|Overall Study|Other Reasons|12|||
33196767|NCT03952039|100626348|FG001|Overall Study|Other Reasons|4|||
33196768|NCT01126541|100626349|FG000|Overall Study|Adverse Event|0|||
33196769|NCT01126541|100626350|FG001|Overall Study|Adverse Event|2|||
33196770|NCT01126541|100626351|FG002|Overall Study|Adverse Event|4|||
33196771|NCT01126541|100626349|FG000|Overall Study|Death|0|||
33196772|NCT01126541|100626350|FG001|Overall Study|Death|1|||
33196773|NCT01126541|100626351|FG002|Overall Study|Death|0|||
33196774|NCT01126541|100626349|FG000|Overall Study|Lack of Efficacy|6|||
33196775|NCT01126541|100626350|FG001|Overall Study|Lack of Efficacy|1|||
33196776|NCT01126541|100626351|FG002|Overall Study|Lack of Efficacy|11|||
33196777|NCT01126541|100626349|FG000|Overall Study|Lost to Follow-up|1|||
33196778|NCT01126541|100626350|FG001|Overall Study|Lost to Follow-up|2|||
33196779|NCT01126541|100626351|FG002|Overall Study|Lost to Follow-up|2|||
33196780|NCT01126541|100626349|FG000|Overall Study|Withdrawal by Subject|2|||
33196781|NCT01126541|100626350|FG001|Overall Study|Withdrawal by Subject|5|||
33196782|NCT01126541|100626351|FG002|Overall Study|Withdrawal by Subject|6|||
33196783|NCT01126541|100626349|FG000|Overall Study|Protocol Violation|0|||
33196784|NCT01126541|100626350|FG001|Overall Study|Protocol Violation|0|||
33196785|NCT01126541|100626351|FG002|Overall Study|Protocol Violation|1|||
33196786|NCT01126541|100626349|FG000|Overall Study|Administrative reason or other|1|||
33196787|NCT01126541|100626350|FG001|Overall Study|Administrative reason or other|1|||
33196788|NCT01126541|100626351|FG002|Overall Study|Administrative reason or other|2|||
33196789|NCT03603964|100626352|FG000|Overall Study|Death|9|||
33196790|NCT03603964|100626352|FG000|Overall Study|Withdrawal by participant|7|||
33196791|NCT03603964|100626352|FG000|Overall Study|Study terminated by Sponsor|19|||
33196792|NCT02334748|100626353|FG000|Overall Study|Adverse Event|1|||
33196793|NCT02334748|100626353|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
33196794|NCT02334748|100626353|FG000|Overall Study|Patient no longer required study drug|2|||
33506784|NCT03039621|101750843|FG000|Overall Study|Violation of non-inclusion criteria|1|||
33506785|NCT03039621|101750844|FG001|Overall Study|Violation of non-inclusion criteria|2|||
33506786|NCT01868438|101750845|FG000|First Intervention|Withdrawal by Subject|5|||
33506787|NCT01868438|101750846|FG001|First Intervention|Withdrawal by Subject|1|||
33506788|NCT01868438|101750845|FG000|First Intervention|Lost to Follow-up|2|||
33506789|NCT01868438|101750846|FG001|First Intervention|Lost to Follow-up|3|||
33506790|NCT01868438|101750845|FG000|First Intervention|Meeting the non-redosing criteria|0|||
33506791|NCT01868438|101750846|FG001|First Intervention|Meeting the non-redosing criteria|1|||
33506792|NCT01868438|101750845|FG000|Second Intervention|Adverse Event|3|||
33506793|NCT01868438|101750846|FG001|Second Intervention|Adverse Event|3|||
33506794|NCT03728426|101750852|FG000|Overall Study|Death|3|||
33506795|NCT03260244|101750859|FG000|Overall Study|Death|19|||
33506796|NCT03260244|101750859|FG000|Overall Study|Lost to Follow-up|60|||
33506797|NCT03260244|101750859|FG000|Overall Study|Withdrawal by Subject|48|||
33506798|NCT03260244|101750859|FG000|Overall Study|Procedure Not Performed|21|||
33506799|NCT03260244|101750859|FG000|Overall Study|Enrollment Criteria Not Met|31|||
33506800|NCT03260244|101750859|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
33196795|NCT02334748|100626353|FG000|Overall Study|Lack of Efficacy|4|||
33196796|NCT02752048|100626354|FG000|Overall Study|Withdrawal by Subject|0|||
33196797|NCT02752048|100626355|FG001|Overall Study|Withdrawal by Subject|0|||
33196798|NCT02752048|100626356|FG002|Overall Study|Withdrawal by Subject|3|||
33196799|NCT00961259|100626357|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
33196800|NCT00961259|100626358|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
33506801|NCT03260244|101750859|FG000|Overall Study|Subject Noncompliance|6|||
33196801|NCT00961259|100626359|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
33196802|NCT00382733|100626362|FG000|Overall Study|Withdrawal by Subject|0|||
33196803|NCT00382733|100626363|FG001|Overall Study|Withdrawal by Subject|1|||
33196804|NCT00382733|100626364|FG002|Overall Study|Withdrawal by Subject|0|||
33196805|NCT00382733|100626365|FG003|Overall Study|Withdrawal by Subject|0|||
33196806|NCT00382733|100626366|FG004|Overall Study|Withdrawal by Subject|0|||
33196807|NCT03003676|100626367|FG000|Overall Study|Lack of Efficacy|5|||
33506802|NCT03260244|101750859|FG000|Overall Study|No inducible Arrhythmia|2|||
33506803|NCT03260244|101750859|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
33506804|NCT03260244|101750859|FG000|Overall Study|Screen Failure|2|||
33506805|NCT03260244|101750859|FG000|Overall Study|Treated Off Label|69|||
33506806|NCT03260244|101750859|FG000|Overall Study|No Radiofrequency Ablation|14|||
33506807|NCT02282631|101750867|FG000|Overall Study|Lost to Follow-up|2|||
33506808|NCT02282631|101750868|FG001|Overall Study|Lost to Follow-up|0|||
33506809|NCT02309411|101750869|FG000|Overall Study|Physician Decision|1|||
33506810|NCT02309411|101750870|FG001|Overall Study|Physician Decision|0|||
33506811|NCT02309411|101750871|FG002|Overall Study|Physician Decision|0|||
33506812|NCT02309411|101750869|FG000|Overall Study|Withdrawal by Subject|1|||
33506813|NCT02309411|101750870|FG001|Overall Study|Withdrawal by Subject|1|||
33506814|NCT02309411|101750871|FG002|Overall Study|Withdrawal by Subject|0|||
33506815|NCT03502070|101750872|FG000|Overall Study|Withdrawal by Subject|1|||
33506816|NCT03502070|101750872|FG000|Overall Study|Screen Failure|1|||
33506817|NCT02782949|101750875|FG000|Overall Study|Protocol Violation|1|||
33506818|NCT02782949|101750876|FG001|Overall Study|Protocol Violation|0|||
33506819|NCT02782949|101750875|FG000|Overall Study|Withdrawal by Subject|0|||
33506820|NCT02782949|101750876|FG001|Overall Study|Withdrawal by Subject|1|||
33506821|NCT05367973|101750877|FG000|Overall Study|Adverse Event|0|||
33506822|NCT05367973|101750878|FG001|Overall Study|Adverse Event|2|||
33196808|NCT03003676|100626368|FG001|Overall Study|Lack of Efficacy|7|||
33196809|NCT03003676|100626367|FG000|Overall Study|Withdrawal by Subject|0|||
33196810|NCT03003676|100626368|FG001|Overall Study|Withdrawal by Subject|1|||
33196811|NCT03003676|100626367|FG000|Overall Study|Hepatitis B infection|1|||
33196812|NCT03003676|100626368|FG001|Overall Study|Hepatitis B infection|0|||
33196813|NCT03096782|100626371|FG000|Overall Study|Death|1|||
33196814|NCT03096782|100626371|FG000|Overall Study|Participant Relapsed|1|||
33196815|NCT02453594|100626373|FG000|Overall Study|Protocol Violation|0|||
33196816|NCT02453594|100626374|FG001|Overall Study|Protocol Violation|0|||
33317028|NCT00092495|101054414|FG002|Base Study Vaccination Period|Adverse Event|0|||
33317029|NCT00092495|101054415|FG003|Base Study Vaccination Period|Adverse Event|3|||
33317030|NCT00092495|101054416|FG004|Base Study Vaccination Period|Adverse Event|0|||
33317031|NCT00092495|101054412|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
33317032|NCT00092495|101054413|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
33317033|NCT00092495|101054414|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
33317034|NCT00092495|101054415|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
33317035|NCT00092495|101054416|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
33317036|NCT00092495|101054412|FG000|Base Study Vaccination Period|Moved|3|||
33317037|NCT00092495|101054413|FG001|Base Study Vaccination Period|Moved|1|||
33317038|NCT00092495|101054414|FG002|Base Study Vaccination Period|Moved|2|||
33317039|NCT00092495|101054415|FG003|Base Study Vaccination Period|Moved|2|||
33317040|NCT00092495|101054416|FG004|Base Study Vaccination Period|Moved|0|||
33317041|NCT00092495|101054412|FG000|Base Study Vaccination Period|Other|1|||
33317042|NCT00092495|101054413|FG001|Base Study Vaccination Period|Other|1|||
33317043|NCT00092495|101054414|FG002|Base Study Vaccination Period|Other|0|||
33317044|NCT00092495|101054415|FG003|Base Study Vaccination Period|Other|2|||
33317045|NCT00092495|101054416|FG004|Base Study Vaccination Period|Other|0|||
33317046|NCT00092495|101054412|FG000|Base Study Vaccination Period|Pregnancy|2|||
33317047|NCT00092495|101054413|FG001|Base Study Vaccination Period|Pregnancy|0|||
33317048|NCT00092495|101054414|FG002|Base Study Vaccination Period|Pregnancy|0|||
33317049|NCT00092495|101054415|FG003|Base Study Vaccination Period|Pregnancy|0|||
33317050|NCT00092495|101054416|FG004|Base Study Vaccination Period|Pregnancy|0|||
33317051|NCT00092495|101054412|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
33317052|NCT00092495|101054413|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
33317053|NCT00092495|101054414|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
33317054|NCT00092495|101054415|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
33317055|NCT00092495|101054416|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
33317056|NCT00092495|101054412|FG000|Base Study Vaccination Period|Protocol Violation|1|||
33506823|NCT02125786|101750884|FG000|Overall Study|Still in Follow-up|3|||
33506824|NCT02125786|101750884|FG000|Overall Study|Screen Failure|2|||
33506825|NCT02125786|101750884|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
33196817|NCT02453594|100626375|FG002|Overall Study|Protocol Violation|1|||
33196818|NCT02453594|100626373|FG000|Overall Study|Cohort Was Closed|17|||
33506826|NCT02125786|101750884|FG000|Overall Study|Progressive Disease|44|||
33604239|NCT02759315|102102563|FG000|Overall Study|Lost to Follow-up|2|||
33317057|NCT00092495|101054413|FG001|Base Study Vaccination Period|Protocol Violation|0|||
33317058|NCT00092495|101054414|FG002|Base Study Vaccination Period|Protocol Violation|0|||
33317059|NCT00092495|101054415|FG003|Base Study Vaccination Period|Protocol Violation|0|||
33317060|NCT00092495|101054416|FG004|Base Study Vaccination Period|Protocol Violation|0|||
33317061|NCT00092495|101054412|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
33317062|NCT00092495|101054413|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
33317063|NCT00092495|101054414|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
33317064|NCT00092495|101054415|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
33317065|NCT00092495|101054416|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
33317066|NCT00092495|101054412|FG000|Base Study Follow-up Period|Extended|0|||
33317067|NCT00092495|101054413|FG001|Base Study Follow-up Period|Extended|0|||
33317068|NCT00092495|101054414|FG002|Base Study Follow-up Period|Extended|1|||
33317069|NCT00092495|101054415|FG003|Base Study Follow-up Period|Extended|2|||
33317070|NCT00092495|101054416|FG004|Base Study Follow-up Period|Extended|0|||
33317071|NCT00092495|101054412|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
33317072|NCT00092495|101054413|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
33317073|NCT00092495|101054414|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
33317074|NCT00092495|101054415|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
33317075|NCT00092495|101054416|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
33317076|NCT00092495|101054412|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
33317077|NCT00092495|101054413|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
33317078|NCT00092495|101054414|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
33317079|NCT00092495|101054415|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
33317080|NCT00092495|101054416|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
33317081|NCT04427501|101054417|FG000|Overall Study|Death|0|||
33317082|NCT04427501|101054418|FG001|Overall Study|Death|0|||
33317083|NCT04427501|101054419|FG002|Overall Study|Death|0|||
33317084|NCT04427501|101054420|FG003|Overall Study|Death|0|||
33317085|NCT04427501|101054421|FG004|Overall Study|Death|0|||
33317086|NCT04427501|101054422|FG005|Overall Study|Death|15|||
33317087|NCT04427501|101054423|FG006|Overall Study|Death|0|||
33317088|NCT04427501|101054424|FG007|Overall Study|Death|0|||
33317089|NCT04427501|101054425|FG008|Overall Study|Death|0|||
33317090|NCT04427501|101054426|FG009|Overall Study|Death|0|||
33317091|NCT04427501|101054427|FG010|Overall Study|Death|0|||
33317092|NCT04427501|101054428|FG011|Overall Study|Death|0|||
33317093|NCT04427501|101054417|FG000|Overall Study|Lost to Follow-up|5|||
33317094|NCT04427501|101054418|FG001|Overall Study|Lost to Follow-up|1|||
33317095|NCT04427501|101054419|FG002|Overall Study|Lost to Follow-up|2|||
33317096|NCT04427501|101054420|FG003|Overall Study|Lost to Follow-up|0|||
33317097|NCT04427501|101054421|FG004|Overall Study|Lost to Follow-up|2|||
33317098|NCT04427501|101054422|FG005|Overall Study|Lost to Follow-up|11|||
33317099|NCT04427501|101054423|FG006|Overall Study|Lost to Follow-up|10|||
33317100|NCT04427501|101054424|FG007|Overall Study|Lost to Follow-up|10|||
33317101|NCT04427501|101054425|FG008|Overall Study|Lost to Follow-up|2|||
33317102|NCT04427501|101054426|FG009|Overall Study|Lost to Follow-up|5|||
33317103|NCT04427501|101054427|FG010|Overall Study|Lost to Follow-up|2|||
33317104|NCT04427501|101054428|FG011|Overall Study|Lost to Follow-up|0|||
33317105|NCT04427501|101054417|FG000|Overall Study|Physician Decision|0|||
33317106|NCT04427501|101054418|FG001|Overall Study|Physician Decision|3|||
33317107|NCT04427501|101054419|FG002|Overall Study|Physician Decision|0|||
33317108|NCT04427501|101054420|FG003|Overall Study|Physician Decision|0|||
33317109|NCT04427501|101054421|FG004|Overall Study|Physician Decision|0|||
33317110|NCT04427501|101054422|FG005|Overall Study|Physician Decision|0|||
33317111|NCT04427501|101054423|FG006|Overall Study|Physician Decision|2|||
33317112|NCT04427501|101054424|FG007|Overall Study|Physician Decision|0|||
33317113|NCT04427501|101054425|FG008|Overall Study|Physician Decision|0|||
33317114|NCT04427501|101054426|FG009|Overall Study|Physician Decision|0|||
33317115|NCT04427501|101054427|FG010|Overall Study|Physician Decision|0|||
33317116|NCT04427501|101054428|FG011|Overall Study|Physician Decision|0|||
33317117|NCT04427501|101054417|FG000|Overall Study|Withdrawal by Subject|9|||
33317118|NCT04427501|101054418|FG001|Overall Study|Withdrawal by Subject|2|||
33317119|NCT04427501|101054419|FG002|Overall Study|Withdrawal by Subject|2|||
33397977|NCT01234337|101345879|FG001|Overall Study|Withdrawal by Subject|9|||
33397978|NCT01234337|101345878|FG000|Overall Study|Death|0|||
33317120|NCT04427501|101054420|FG003|Overall Study|Withdrawal by Subject|3|||
33317121|NCT04427501|101054421|FG004|Overall Study|Withdrawal by Subject|7|||
33317122|NCT04427501|101054422|FG005|Overall Study|Withdrawal by Subject|25|||
33317123|NCT04427501|101054423|FG006|Overall Study|Withdrawal by Subject|15|||
33604240|NCT02759315|102102564|FG001|Overall Study|Lost to Follow-up|0|||
33317124|NCT04427501|101054424|FG007|Overall Study|Withdrawal by Subject|7|||
33317125|NCT04427501|101054425|FG008|Overall Study|Withdrawal by Subject|4|||
33317126|NCT04427501|101054426|FG009|Overall Study|Withdrawal by Subject|1|||
33317127|NCT04427501|101054427|FG010|Overall Study|Withdrawal by Subject|4|||
33397979|NCT01234337|101345879|FG001|Overall Study|Death|1|||
33397980|NCT01234337|101345878|FG000|Overall Study|Switch to commercial drug|0|||
33317128|NCT04427501|101054428|FG011|Overall Study|Withdrawal by Subject|0|||
33397981|NCT01234337|101345879|FG001|Overall Study|Switch to commercial drug|1|||
33397982|NCT03950440|101345880|FG000|Overall Study|Death|8|||
33397983|NCT03950440|101345881|FG001|Overall Study|Death|2|||
33397984|NCT03950440|101345882|FG002|Overall Study|Death|1|||
33397985|NCT00474539|101345891|FG000|Infant Series|Withdrawal by Subject|3|||
33397986|NCT00474539|101345892|FG001|Infant Series|Withdrawal by Subject|4|||
33397987|NCT00474539|101345891|FG000|Infant Series|Randomization error|5|||
33397988|NCT00474539|101345892|FG001|Infant Series|Randomization error|0|||
33397989|NCT00474539|101345891|FG000|Infant Series|Lost to Follow-up|2|||
33397990|NCT00474539|101345892|FG001|Infant Series|Lost to Follow-up|1|||
33397991|NCT00474539|101345891|FG000|Infant Series|Protocol Violation|0|||
33397992|NCT00474539|101345892|FG001|Infant Series|Protocol Violation|1|||
33397993|NCT00474539|101345891|FG000|After Infant Series|Lost to Follow-up|3|||
33397994|NCT00474539|101345892|FG001|After Infant Series|Lost to Follow-up|0|||
33397995|NCT00474539|101345891|FG000|After Infant Series|Withdrawal by Subject|1|||
33397996|NCT00474539|101345892|FG001|After Infant Series|Withdrawal by Subject|0|||
33397997|NCT00474539|101345891|FG000|Toddler Dose|Protocol Violation|1|||
33397998|NCT00474539|101345892|FG001|Toddler Dose|Protocol Violation|0|||
33397999|NCT03377452|101345895|FG000|Overall Study|Refused assessment|0|||
33398000|NCT03377452|101345896|FG001|Overall Study|Refused assessment|2|||
33398001|NCT03377452|101345895|FG000|Overall Study|Lost to Follow-up|5|||
33398002|NCT03377452|101345896|FG001|Overall Study|Lost to Follow-up|4|||
33398003|NCT00850135|101345897|FG000|Overall Study|Physician Decision|1|||
33398004|NCT00806494|101345898|FG000|Overall Study|Adverse Event|29|||
33398005|NCT00806494|101345898|FG000|Overall Study|Lack of Efficacy|6|||
33398006|NCT00806494|101345898|FG000|Overall Study|Lost to Follow-up|10|||
33398007|NCT00806494|101345898|FG000|Overall Study|Other|30|||
33398008|NCT00806494|101345898|FG000|Overall Study|Withdrawal by Subject|5|||
33398009|NCT02712008|101345899|FG000|Baseline (Day 1) up to Week 12|Death|3|||
33398010|NCT02712008|101345900|FG001|Baseline (Day 1) up to Week 12|Death|0|||
33398011|NCT02712008|101345901|FG002|Baseline (Day 1) up to Week 12|Death|0|||
33398012|NCT02712008|101345902|FG003|Baseline (Day 1) up to Week 12|Death|0|||
33398013|NCT02712008|101345903|FG004|Baseline (Day 1) up to Week 12|Death|0|||
33398014|NCT02712008|101345904|FG005|Baseline (Day 1) up to Week 12|Death|0|||
33398015|NCT02712008|101345905|FG006|Baseline (Day 1) up to Week 12|Death|0|||
33398016|NCT02712008|101345906|FG007|Baseline (Day 1) up to Week 12|Death|0|||
33398017|NCT02712008|101345899|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33398018|NCT02712008|101345900|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
33398019|NCT02712008|101345901|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
33398020|NCT02712008|101345902|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33398021|NCT02712008|101345903|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33398022|NCT02712008|101345904|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33398023|NCT02712008|101345905|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33506827|NCT02125786|101750884|FG000|Overall Study|Death|8|||
33398024|NCT02712008|101345906|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33398025|NCT02712008|101345899|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
33506828|NCT00712543|101750885|FG000|Day 8-14|Lost to Follow-up|0|||
33196819|NCT02453594|100626374|FG001|Overall Study|Cohort Was Closed|21|||
33196820|NCT02453594|100626375|FG002|Overall Study|Cohort Was Closed|14|||
33196821|NCT02453594|100626373|FG000|Overall Study|Death|20|||
33196822|NCT02453594|100626374|FG001|Overall Study|Death|24|||
33196823|NCT02453594|100626375|FG002|Overall Study|Death|16|||
33398026|NCT02712008|101345900|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33398027|NCT02712008|101345901|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
33398028|NCT02712008|101345902|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33398029|NCT02712008|101345903|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33398030|NCT02712008|101345904|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33398031|NCT02712008|101345905|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33398032|NCT02712008|101345906|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33506829|NCT00712543|101750886|FG001|Day 8-14|Lost to Follow-up|2|||
33196824|NCT02453594|100626373|FG000|Overall Study|Lost to Follow-up|6|||
33398033|NCT02712008|101345899|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
33398034|NCT02712008|101345900|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
33398035|NCT02712008|101345901|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
33398036|NCT02712008|101345902|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
33398037|NCT02712008|101345903|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
33398038|NCT02712008|101345904|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
33398039|NCT02712008|101345905|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
33398040|NCT02712008|101345906|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
33398041|NCT02712008|101345899|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
33398042|NCT02712008|101345900|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
33398043|NCT02712008|101345901|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
33398044|NCT02712008|101345902|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
33398045|NCT02712008|101345903|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
33196825|NCT02453594|100626374|FG001|Overall Study|Lost to Follow-up|14|||
33196826|NCT02453594|100626375|FG002|Overall Study|Lost to Follow-up|2|||
33196827|NCT02453594|100626373|FG000|Overall Study|Physician Decision|2|||
33398046|NCT02712008|101345904|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
33398047|NCT02712008|101345905|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
33604241|NCT02759315|102102565|FG002|Overall Study|Lost to Follow-up|4|||
33196828|NCT02453594|100626374|FG001|Overall Study|Physician Decision|4|||
33398048|NCT02712008|101345906|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
33196829|NCT02453594|100626375|FG002|Overall Study|Physician Decision|0|||
33317129|NCT04427501|101054417|FG000|Overall Study|Other - as reported by the investigator|1|||
33317130|NCT04427501|101054418|FG001|Overall Study|Other - as reported by the investigator|0|||
33317131|NCT04427501|101054419|FG002|Overall Study|Other - as reported by the investigator|0|||
33317132|NCT04427501|101054420|FG003|Overall Study|Other - as reported by the investigator|0|||
33317133|NCT04427501|101054421|FG004|Overall Study|Other - as reported by the investigator|0|||
33317134|NCT04427501|101054422|FG005|Overall Study|Other - as reported by the investigator|6|||
33317135|NCT04427501|101054423|FG006|Overall Study|Other - as reported by the investigator|6|||
33317136|NCT04427501|101054424|FG007|Overall Study|Other - as reported by the investigator|0|||
33317137|NCT04427501|101054425|FG008|Overall Study|Other - as reported by the investigator|0|||
33398049|NCT02712008|101345899|FG000|From Week 12 up to Week 36|Adverse Event|0|||
33506830|NCT01938430|101750891|FG000|Overall Study|Randomized but Not Treated|0|||
33506831|NCT01938430|101750892|FG001|Overall Study|Randomized but Not Treated|0|||
33506832|NCT01938430|101750893|FG002|Overall Study|Randomized but Not Treated|0|||
33604242|NCT02759315|102102566|FG003|Overall Study|Lost to Follow-up|0|||
33506833|NCT01938430|101750894|FG003|Overall Study|Randomized but Not Treated|0|||
33506834|NCT01938430|101750895|FG004|Overall Study|Randomized but Not Treated|0|||
33506835|NCT01938430|101750896|FG005|Overall Study|Randomized but Not Treated|0|||
33506836|NCT01938430|101750897|FG006|Overall Study|Randomized but Not Treated|0|||
33506837|NCT01938430|101750898|FG007|Overall Study|Randomized but Not Treated|0|||
33506838|NCT01938430|101750899|FG008|Overall Study|Randomized but Not Treated|0|||
33317138|NCT04427501|101054426|FG009|Overall Study|Other - as reported by the investigator|0|||
33317139|NCT04427501|101054427|FG010|Overall Study|Other - as reported by the investigator|0|||
33506839|NCT01938430|101750900|FG009|Overall Study|Randomized but Not Treated|0|||
33506840|NCT01938430|101750901|FG010|Overall Study|Randomized but Not Treated|1|||
33506841|NCT01938430|101750902|FG011|Overall Study|Randomized but Not Treated|0|||
33506842|NCT01938430|101750903|FG012|Overall Study|Randomized but Not Treated|0|||
33506843|NCT01938430|101750904|FG013|Overall Study|Randomized but Not Treated|1|||
33506844|NCT01938430|101750891|FG000|Overall Study|Adverse Event|0|||
33506845|NCT01938430|101750892|FG001|Overall Study|Adverse Event|0|||
33506846|NCT01938430|101750893|FG002|Overall Study|Adverse Event|0|||
33506847|NCT01938430|101750894|FG003|Overall Study|Adverse Event|0|||
33506848|NCT01938430|101750895|FG004|Overall Study|Adverse Event|0|||
33506849|NCT01938430|101750896|FG005|Overall Study|Adverse Event|0|||
33506850|NCT01938430|101750897|FG006|Overall Study|Adverse Event|1|||
33506851|NCT01938430|101750898|FG007|Overall Study|Adverse Event|0|||
33506852|NCT01938430|101750899|FG008|Overall Study|Adverse Event|0|||
33506853|NCT01938430|101750900|FG009|Overall Study|Adverse Event|0|||
33506854|NCT01938430|101750901|FG010|Overall Study|Adverse Event|0|||
33506855|NCT01938430|101750902|FG011|Overall Study|Adverse Event|0|||
33506856|NCT01938430|101750903|FG012|Overall Study|Adverse Event|0|||
33506857|NCT01938430|101750904|FG013|Overall Study|Adverse Event|0|||
33506858|NCT01938430|101750891|FG000|Overall Study|Death|1|||
33506859|NCT01938430|101750892|FG001|Overall Study|Death|2|||
33506860|NCT01938430|101750893|FG002|Overall Study|Death|2|||
33506861|NCT01938430|101750894|FG003|Overall Study|Death|1|||
33506862|NCT01938430|101750895|FG004|Overall Study|Death|0|||
33506863|NCT01938430|101750896|FG005|Overall Study|Death|0|||
33506864|NCT01938430|101750897|FG006|Overall Study|Death|1|||
33506865|NCT01938430|101750898|FG007|Overall Study|Death|1|||
33506866|NCT01938430|101750899|FG008|Overall Study|Death|2|||
33506867|NCT01938430|101750900|FG009|Overall Study|Death|3|||
33506868|NCT01938430|101750901|FG010|Overall Study|Death|0|||
33506869|NCT01938430|101750902|FG011|Overall Study|Death|0|||
33506870|NCT01938430|101750903|FG012|Overall Study|Death|0|||
33506871|NCT01938430|101750904|FG013|Overall Study|Death|0|||
33506872|NCT01938430|101750891|FG000|Overall Study|Investigator's Discretion|0|||
33506873|NCT01938430|101750892|FG001|Overall Study|Investigator's Discretion|0|||
33506874|NCT01938430|101750893|FG002|Overall Study|Investigator's Discretion|1|||
33506875|NCT01938430|101750894|FG003|Overall Study|Investigator's Discretion|0|||
33506876|NCT01938430|101750895|FG004|Overall Study|Investigator's Discretion|0|||
33506877|NCT01938430|101750896|FG005|Overall Study|Investigator's Discretion|0|||
33506878|NCT01938430|101750897|FG006|Overall Study|Investigator's Discretion|0|||
33506879|NCT01938430|101750898|FG007|Overall Study|Investigator's Discretion|0|||
33506880|NCT01938430|101750899|FG008|Overall Study|Investigator's Discretion|0|||
33506881|NCT01938430|101750900|FG009|Overall Study|Investigator's Discretion|0|||
33506882|NCT01938430|101750901|FG010|Overall Study|Investigator's Discretion|0|||
33506883|NCT01938430|101750902|FG011|Overall Study|Investigator's Discretion|0|||
33506884|NCT01938430|101750903|FG012|Overall Study|Investigator's Discretion|0|||
33506885|NCT01938430|101750904|FG013|Overall Study|Investigator's Discretion|0|||
33506886|NCT01938430|101750891|FG000|Overall Study|Lack of Efficacy|3|||
33506887|NCT01938430|101750892|FG001|Overall Study|Lack of Efficacy|1|||
33506888|NCT01938430|101750893|FG002|Overall Study|Lack of Efficacy|1|||
33506889|NCT01938430|101750894|FG003|Overall Study|Lack of Efficacy|1|||
33317140|NCT04427501|101054428|FG011|Overall Study|Other - as reported by the investigator|0|||
33398050|NCT02712008|101345900|FG001|From Week 12 up to Week 36|Adverse Event|0|||
33506890|NCT01938430|101750895|FG004|Overall Study|Lack of Efficacy|0|||
33506891|NCT01938430|101750896|FG005|Overall Study|Lack of Efficacy|0|||
33506892|NCT01938430|101750897|FG006|Overall Study|Lack of Efficacy|0|||
33506893|NCT01938430|101750898|FG007|Overall Study|Lack of Efficacy|0|||
33506894|NCT01938430|101750899|FG008|Overall Study|Lack of Efficacy|1|||
33506895|NCT01938430|101750900|FG009|Overall Study|Lack of Efficacy|0|||
33506896|NCT01938430|101750901|FG010|Overall Study|Lack of Efficacy|2|||
33506897|NCT01938430|101750902|FG011|Overall Study|Lack of Efficacy|1|||
33604243|NCT02759315|102102567|FG004|Overall Study|Lost to Follow-up|0|||
33506898|NCT01938430|101750903|FG012|Overall Study|Lack of Efficacy|0|||
33506899|NCT01938430|101750904|FG013|Overall Study|Lack of Efficacy|0|||
33506900|NCT01938430|101750891|FG000|Overall Study|Lost to Follow-up|0|||
33506901|NCT01938430|101750892|FG001|Overall Study|Lost to Follow-up|0|||
33506902|NCT01938430|101750893|FG002|Overall Study|Lost to Follow-up|1|||
33506903|NCT01938430|101750894|FG003|Overall Study|Lost to Follow-up|0|||
33506904|NCT01938430|101750895|FG004|Overall Study|Lost to Follow-up|0|||
33506905|NCT01938430|101750896|FG005|Overall Study|Lost to Follow-up|1|||
33506906|NCT01938430|101750897|FG006|Overall Study|Lost to Follow-up|0|||
33506907|NCT01938430|101750898|FG007|Overall Study|Lost to Follow-up|0|||
33196830|NCT02453594|100626373|FG000|Overall Study|Site Terminated by Sponsor|1|||
33196831|NCT02453594|100626374|FG001|Overall Study|Site Terminated by Sponsor|0|||
33196832|NCT02453594|100626375|FG002|Overall Study|Site Terminated by Sponsor|1|||
33196833|NCT02453594|100626373|FG000|Overall Study|Transitioned to Extension Study|16|||
33196834|NCT02453594|100626374|FG001|Overall Study|Transitioned to Extension Study|9|||
33196835|NCT02453594|100626375|FG002|Overall Study|Transitioned to Extension Study|16|||
33196836|NCT02453594|100626373|FG000|Overall Study|Withdrawal by Subject|7|||
33196837|NCT02453594|100626374|FG001|Overall Study|Withdrawal by Subject|9|||
33196838|NCT02453594|100626375|FG002|Overall Study|Withdrawal by Subject|11|||
33196839|NCT00530023|100626376|FG000|Overall Study|Withdrawal by Subject|0|||
33196840|NCT00530023|100626377|FG001|Overall Study|Withdrawal by Subject|1|||
33196841|NCT00633984|100626378|FG000|Overall Study|Lost to Follow-up|0|||
33317141|NCT04427501|101054417|FG000|Overall Study|Other|0|||
33317142|NCT04427501|101054418|FG001|Overall Study|Other|0|||
33317143|NCT04427501|101054419|FG002|Overall Study|Other|0|||
33317144|NCT04427501|101054420|FG003|Overall Study|Other|0|||
33317145|NCT04427501|101054421|FG004|Overall Study|Other|0|||
33317146|NCT04427501|101054422|FG005|Overall Study|Other|0|||
33317147|NCT04427501|101054423|FG006|Overall Study|Other|0|||
33317148|NCT04427501|101054424|FG007|Overall Study|Other|0|||
33317149|NCT04427501|101054425|FG008|Overall Study|Other|0|||
33317150|NCT04427501|101054426|FG009|Overall Study|Other|0|||
33506908|NCT01938430|101750899|FG008|Overall Study|Lost to Follow-up|0|||
33506909|NCT01938430|101750900|FG009|Overall Study|Lost to Follow-up|0|||
33506910|NCT01938430|101750901|FG010|Overall Study|Lost to Follow-up|0|||
33506911|NCT01938430|101750902|FG011|Overall Study|Lost to Follow-up|0|||
33506912|NCT01938430|101750903|FG012|Overall Study|Lost to Follow-up|0|||
33604244|NCT02759315|102102563|FG000|Overall Study|Protocol Violation|0|||
33604245|NCT02759315|102102564|FG001|Overall Study|Protocol Violation|1|||
33604246|NCT02759315|102102565|FG002|Overall Study|Protocol Violation|0|||
33604247|NCT02759315|102102566|FG003|Overall Study|Protocol Violation|0|||
33604248|NCT02759315|102102567|FG004|Overall Study|Protocol Violation|0|||
33604249|NCT02759315|102102563|FG000|Overall Study|Study terminated prior to completion|2|||
33604250|NCT02759315|102102564|FG001|Overall Study|Study terminated prior to completion|0|||
33604251|NCT02759315|102102565|FG002|Overall Study|Study terminated prior to completion|5|||
33604252|NCT02759315|102102566|FG003|Overall Study|Study terminated prior to completion|0|||
33604253|NCT02759315|102102567|FG004|Overall Study|Study terminated prior to completion|1|||
33604254|NCT02191605|102102568|FG000|Overall Study|Lost to Follow-up|9|||
33196842|NCT00633984|100626379|FG001|Overall Study|Lost to Follow-up|6|||
33196843|NCT00633984|100626378|FG000|Overall Study|Withdrawal by Subject|8|||
33196844|NCT00633984|100626379|FG001|Overall Study|Withdrawal by Subject|7|||
33506913|NCT01938430|101750904|FG013|Overall Study|Lost to Follow-up|0|||
33506914|NCT01938430|101750891|FG000|Overall Study|Withdrew Consent|0|||
33506915|NCT01938430|101750892|FG001|Overall Study|Withdrew Consent|0|||
33506916|NCT01938430|101750893|FG002|Overall Study|Withdrew Consent|0|||
33506917|NCT01938430|101750894|FG003|Overall Study|Withdrew Consent|0|||
33506918|NCT01938430|101750895|FG004|Overall Study|Withdrew Consent|0|||
33506919|NCT01938430|101750896|FG005|Overall Study|Withdrew Consent|0|||
33506920|NCT01938430|101750897|FG006|Overall Study|Withdrew Consent|0|||
33506921|NCT01938430|101750898|FG007|Overall Study|Withdrew Consent|0|||
33506922|NCT01938430|101750899|FG008|Overall Study|Withdrew Consent|1|||
33506923|NCT01938430|101750900|FG009|Overall Study|Withdrew Consent|0|||
33506924|NCT01938430|101750901|FG010|Overall Study|Withdrew Consent|0|||
33506925|NCT01938430|101750902|FG011|Overall Study|Withdrew Consent|0|||
33506926|NCT01938430|101750903|FG012|Overall Study|Withdrew Consent|0|||
33506927|NCT01938430|101750904|FG013|Overall Study|Withdrew Consent|0|||
33506928|NCT01282372|101750905|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
33506929|NCT01282372|101750905|FG000|Overall Study|Lost to Follow-up|23|||
33506930|NCT01282372|101750905|FG000|Overall Study|Withdrawal by Subject|11|||
33506931|NCT01282372|101750905|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
33604255|NCT02191605|102102569|FG001|Overall Study|Lost to Follow-up|4|||
33196845|NCT00633984|100626378|FG000|Overall Study|Hospitalized|1|||
33196846|NCT00633984|100626379|FG001|Overall Study|Hospitalized|0|||
33196847|NCT01732835|100626380|FG000|6-month Primary Endpoint|Did not receive device|19|||
33317151|NCT04427501|101054427|FG010|Overall Study|Other|0|||
33317152|NCT04427501|101054428|FG011|Overall Study|Other|1|||
33317153|NCT02101034|101054429|FG000|Overall Study|Enrolled but did not start treatment|0|||
33317154|NCT02101034|101054430|FG001|Overall Study|Enrolled but did not start treatment|0|||
33317155|NCT02101034|101054431|FG002|Overall Study|Enrolled but did not start treatment|1|||
33506932|NCT01282372|101750905|FG000|Overall Study|Death|1|||
33317156|NCT02101034|101054432|FG003|Overall Study|Enrolled but did not start treatment|0|||
33506933|NCT01282372|101750905|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
33506934|NCT01282372|101750905|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
33506935|NCT01282372|101750905|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
33506936|NCT01282372|101750905|FG000|Overall Study|Adverse Event|12|||
33506937|NCT01031836|101750908|FG000|Stage I|Adverse Event|1|||
33196848|NCT01732835|100626380|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
33196849|NCT01732835|100626380|FG000|6-month Primary Endpoint|Adverse Event|3|||
33196850|NCT01732835|100626380|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
33196851|NCT01732835|100626380|FG000|2-year Extended Follow-up|Adverse Event|3|||
33196852|NCT01732835|100626380|FG000|2-year Extended Follow-up|Death|1|||
33196853|NCT00142909|100626384|FG000|Randomization|Various Reasons|7|||
33196854|NCT00142909|100626385|FG001|Randomization|Various Reasons|10|||
33196855|NCT00142909|100626384|FG000|Medications Begin|Protocol Violation|2|||
33196856|NCT00142909|100626385|FG001|Medications Begin|Protocol Violation|0|||
33196857|NCT00142909|100626384|FG000|Medications Begin|Withdrawal by Subject|5|||
33196858|NCT00142909|100626385|FG001|Medications Begin|Withdrawal by Subject|3|||
33196859|NCT00142909|100626384|FG000|Medications Begin|Withdrawal by Subject|2|||
33196860|NCT00142909|100626385|FG001|Medications Begin|Withdrawal by Subject|0|||
33196861|NCT02758236|100626386|FG000|Overall Study|Investigator discretion|43|||
33196862|NCT01401530|100626387|FG000|Overall Study|Disease Progression|1|||
33196863|NCT01401530|100626388|FG001|Overall Study|Disease Progression|2|||
33196864|NCT01401530|100626389|FG002|Overall Study|Disease Progression|1|||
33196865|NCT01401530|100626387|FG000|Overall Study|Adverse Event|1|||
33196866|NCT01401530|100626388|FG001|Overall Study|Adverse Event|1|||
33196867|NCT01401530|100626389|FG002|Overall Study|Adverse Event|1|||
33196868|NCT01401530|100626387|FG000|Overall Study|Participant Choice|1|||
33196869|NCT01401530|100626388|FG001|Overall Study|Participant Choice|2|||
33196870|NCT01401530|100626389|FG002|Overall Study|Participant Choice|1|||
33604256|NCT02191605|102102570|FG002|Overall Study|Lost to Follow-up|7|||
33196871|NCT01401530|100626387|FG000|Overall Study|Physician Decision|0|||
33196872|NCT01401530|100626388|FG001|Overall Study|Physician Decision|1|||
33196873|NCT01401530|100626389|FG002|Overall Study|Physician Decision|0|||
33196874|NCT01611259|100626392|FG000|Overall Study|Physician Decision|1|||
33196875|NCT01611259|100626392|FG000|Overall Study|Lack of Efficacy|2|||
33196876|NCT01611259|100626392|FG000|Overall Study|Adverse Event|4|||
33196877|NCT01611259|100626392|FG000|Overall Study|Withdrawal by Subject|7|||
33196878|NCT00991302|100626394|FG000|Overall Study|Death|0|||
33196879|NCT00991302|100626395|FG001|Overall Study|Death|1|||
33196880|NCT00991302|100626394|FG000|Overall Study|Lost to Follow-up|14|||
33196881|NCT00991302|100626395|FG001|Overall Study|Lost to Follow-up|12|||
33196882|NCT02477020|100626400|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
33196883|NCT02477020|100626401|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
33196884|NCT02477020|100626400|FG000|Overall Study|Voluntary Withdrawal|7|||
33196885|NCT02477020|100626401|FG001|Overall Study|Voluntary Withdrawal|16|||
33196886|NCT02477020|100626400|FG000|Overall Study|Reason not Specified|3|||
33196887|NCT02477020|100626401|FG001|Overall Study|Reason not Specified|1|||
33196888|NCT02477020|100626400|FG000|Overall Study|Lack of Efficacy|14|||
33196889|NCT02477020|100626401|FG001|Overall Study|Lack of Efficacy|5|||
33196890|NCT03755765|100626402|FG000|Overall Study|Withdrawal by Subject|2|||
33196891|NCT03755765|100626403|FG001|Overall Study|Withdrawal by Subject|4|||
33196892|NCT03755765|100626404|FG002|Overall Study|Withdrawal by Subject|4|||
33196893|NCT00274716|100626405|FG000|Phase A|Other non-reported reason|4|||
33196894|NCT00274716|100626406|FG001|Phase A|Other non-reported reason|2|||
33196895|NCT00274716|100626407|FG002|Phase A|Other non-reported reason|1|||
33196896|NCT00274716|100626408|FG003|Phase A|Other non-reported reason|2|||
33196897|NCT00274716|100626409|FG004|Phase A|Other non-reported reason|0|||
33196898|NCT00274716|100626410|FG005|Phase A|Other non-reported reason|1|||
33196899|NCT00274716|100626405|FG000|Phase A|Participant moved|0|||
33196900|NCT00274716|100626406|FG001|Phase A|Participant moved|0|||
33196901|NCT00274716|100626407|FG002|Phase A|Participant moved|1|||
33196902|NCT00274716|100626408|FG003|Phase A|Participant moved|0|||
33196903|NCT00274716|100626409|FG004|Phase A|Participant moved|0|||
33196904|NCT00274716|100626410|FG005|Phase A|Participant moved|1|||
33196905|NCT00274716|100626405|FG000|Phase A|Site Terminated|0|||
33196906|NCT00274716|100626406|FG001|Phase A|Site Terminated|0|||
33196907|NCT00274716|100626407|FG002|Phase A|Site Terminated|0|||
33604257|NCT02191605|102102571|FG003|Overall Study|Lost to Follow-up|3|||
33604258|NCT02191605|102102572|FG004|Overall Study|Lost to Follow-up|4|||
33196908|NCT00274716|100626408|FG003|Phase A|Site Terminated|1|||
33196909|NCT00274716|100626409|FG004|Phase A|Site Terminated|0|||
33196910|NCT00274716|100626410|FG005|Phase A|Site Terminated|0|||
33196911|NCT00274716|100626405|FG000|Phase A|Protocol Violation|1|||
33604259|NCT02642965|102102573|FG000|Overall Study|Lack of Efficacy|4|||
33196912|NCT00274716|100626406|FG001|Phase A|Protocol Violation|0|||
33196913|NCT00274716|100626407|FG002|Phase A|Protocol Violation|0|||
33196914|NCT00274716|100626408|FG003|Phase A|Protocol Violation|1|||
33196915|NCT00274716|100626409|FG004|Phase A|Protocol Violation|0|||
33196916|NCT00274716|100626410|FG005|Phase A|Protocol Violation|0|||
33196917|NCT00274716|100626405|FG000|Phase A|Met criteria for discontinuation|1|||
33196918|NCT00274716|100626406|FG001|Phase A|Met criteria for discontinuation|1|||
33196919|NCT00274716|100626407|FG002|Phase A|Met criteria for discontinuation|0|||
33196920|NCT00274716|100626408|FG003|Phase A|Met criteria for discontinuation|0|||
33196921|NCT00274716|100626409|FG004|Phase A|Met criteria for discontinuation|0|||
33196922|NCT00274716|100626410|FG005|Phase A|Met criteria for discontinuation|0|||
33196923|NCT00274716|100626405|FG000|Phase A|Withdrawal by Subject|2|||
33196924|NCT00274716|100626406|FG001|Phase A|Withdrawal by Subject|2|||
33196925|NCT00274716|100626407|FG002|Phase A|Withdrawal by Subject|1|||
33196926|NCT00274716|100626408|FG003|Phase A|Withdrawal by Subject|3|||
33196927|NCT00274716|100626409|FG004|Phase A|Withdrawal by Subject|0|||
33196928|NCT00274716|100626410|FG005|Phase A|Withdrawal by Subject|1|||
33196929|NCT00274716|100626405|FG000|Phase A|Adverse Event|2|||
33196930|NCT00274716|100626406|FG001|Phase A|Adverse Event|3|||
33196931|NCT00274716|100626407|FG002|Phase A|Adverse Event|3|||
33196932|NCT00274716|100626408|FG003|Phase A|Adverse Event|0|||
33196933|NCT00274716|100626409|FG004|Phase A|Adverse Event|2|||
33196934|NCT00274716|100626410|FG005|Phase A|Adverse Event|0|||
33196935|NCT00274716|100626405|FG000|Phase A|Completed but did not enter Phase B|1|||
33196936|NCT00274716|100626406|FG001|Phase A|Completed but did not enter Phase B|2|||
33196937|NCT00274716|100626407|FG002|Phase A|Completed but did not enter Phase B|2|||
33196938|NCT00274716|100626408|FG003|Phase A|Completed but did not enter Phase B|2|||
33196939|NCT00274716|100626409|FG004|Phase A|Completed but did not enter Phase B|1|||
33196940|NCT00274716|100626410|FG005|Phase A|Completed but did not enter Phase B|1|||
33196941|NCT00274716|100626405|FG000|Phase B|Adverse Event|0|||
33196942|NCT00274716|100626406|FG001|Phase B|Adverse Event|0|||
33196943|NCT00274716|100626407|FG002|Phase B|Adverse Event|2|||
33196944|NCT00274716|100626408|FG003|Phase B|Adverse Event|0|||
33196945|NCT00274716|100626409|FG004|Phase B|Adverse Event|0|||
33196946|NCT00274716|100626410|FG005|Phase B|Adverse Event|1|||
33196947|NCT00274716|100626405|FG000|Phase B|Protocol Violation|0|||
33196948|NCT00274716|100626406|FG001|Phase B|Protocol Violation|2|||
33196949|NCT00274716|100626407|FG002|Phase B|Protocol Violation|0|||
33196950|NCT00274716|100626408|FG003|Phase B|Protocol Violation|0|||
33196951|NCT00274716|100626409|FG004|Phase B|Protocol Violation|0|||
33196952|NCT00274716|100626410|FG005|Phase B|Protocol Violation|0|||
33196953|NCT00274716|100626405|FG000|Phase B|Withdrawal by Subject|0|||
33196954|NCT00274716|100626406|FG001|Phase B|Withdrawal by Subject|1|||
33196955|NCT00274716|100626407|FG002|Phase B|Withdrawal by Subject|0|||
33196956|NCT00274716|100626408|FG003|Phase B|Withdrawal by Subject|0|||
33196957|NCT00274716|100626409|FG004|Phase B|Withdrawal by Subject|0|||
33196958|NCT00274716|100626410|FG005|Phase B|Withdrawal by Subject|0|||
33196959|NCT00274716|100626405|FG000|Phase B|Participant moved|1|||
33196960|NCT00274716|100626406|FG001|Phase B|Participant moved|0|||
33196961|NCT00274716|100626407|FG002|Phase B|Participant moved|0|||
33196962|NCT00274716|100626408|FG003|Phase B|Participant moved|0|||
33196963|NCT00274716|100626409|FG004|Phase B|Participant moved|0|||
33196964|NCT00274716|100626410|FG005|Phase B|Participant moved|0|||
33196965|NCT00274716|100626405|FG000|Phase B|Other non-reported reason|0|||
33196966|NCT00274716|100626406|FG001|Phase B|Other non-reported reason|0|||
33196967|NCT00274716|100626407|FG002|Phase B|Other non-reported reason|1|||
33196968|NCT00274716|100626408|FG003|Phase B|Other non-reported reason|1|||
33196969|NCT00274716|100626409|FG004|Phase B|Other non-reported reason|0|||
33196970|NCT00274716|100626410|FG005|Phase B|Other non-reported reason|0|||
33196971|NCT00274716|100626405|FG000|Phase B|Lost to Follow-up|0|||
33196972|NCT00274716|100626406|FG001|Phase B|Lost to Follow-up|1|||
33196973|NCT00274716|100626407|FG002|Phase B|Lost to Follow-up|0|||
33196974|NCT00274716|100626408|FG003|Phase B|Lost to Follow-up|0|||
33196975|NCT00274716|100626409|FG004|Phase B|Lost to Follow-up|0|||
33196976|NCT00274716|100626410|FG005|Phase B|Lost to Follow-up|0|||
33196977|NCT01519518|100626411|FG000|Overall Study|Consent not available|7|||
33196978|NCT01519518|100626412|FG001|Overall Study|Consent not available|10|||
33317157|NCT02101034|101054433|FG004|Overall Study|Enrolled but did not start treatment|0|||
33317158|NCT02986334|101054435|FG000|Overall Study|Withdrawal by Subject|0|||
33317159|NCT02986334|101054436|FG001|Overall Study|Withdrawal by Subject|1|||
33317160|NCT02986334|101054437|FG002|Overall Study|Withdrawal by Subject|2|||
33317161|NCT02986334|101054435|FG000|Overall Study|Lost to Follow-up|1|||
33317162|NCT02986334|101054436|FG001|Overall Study|Lost to Follow-up|2|||
33317163|NCT02986334|101054437|FG002|Overall Study|Lost to Follow-up|1|||
33196979|NCT04452344|100626413|FG000|Overall Study|Withdrawal by Subject|3|||
33317164|NCT02986334|101054435|FG000|Overall Study|Adverse Event|0|||
33196980|NCT04452344|100626414|FG001|Overall Study|Withdrawal by Subject|6|||
33196981|NCT04452344|100626413|FG000|Overall Study|Adverse Event|1|||
33196982|NCT04452344|100626414|FG001|Overall Study|Adverse Event|2|||
33196983|NCT04452344|100626413|FG000|Overall Study|Lost to Follow-up|2|||
33196984|NCT04452344|100626414|FG001|Overall Study|Lost to Follow-up|2|||
33196985|NCT04452344|100626413|FG000|Overall Study|No Post-Op Visit|6|||
33196986|NCT04452344|100626414|FG001|Overall Study|No Post-Op Visit|7|||
33196987|NCT01416805|100626415|FG000|Overall Study|Lost to Follow-up|4|||
33196988|NCT01416805|100626416|FG001|Overall Study|Lost to Follow-up|4|||
33196989|NCT01034397|100626417|FG000|Overall Study|Lack of compliance|0|||
33196990|NCT01034397|100626418|FG001|Overall Study|Lack of compliance|1|||
33196991|NCT01034397|100626417|FG000|Overall Study|Lack of Efficacy|3|||
33196992|NCT01034397|100626418|FG001|Overall Study|Lack of Efficacy|0|||
33196993|NCT01034397|100626417|FG000|Overall Study|Adverse Event|4|||
33196994|NCT01034397|100626418|FG001|Overall Study|Adverse Event|0|||
33196995|NCT01034397|100626417|FG000|Overall Study|Other|0|||
33196996|NCT01034397|100626418|FG001|Overall Study|Other|1|||
33317165|NCT02986334|101054436|FG001|Overall Study|Adverse Event|2|||
33317166|NCT02986334|101054437|FG002|Overall Study|Adverse Event|1|||
33317167|NCT02986334|101054435|FG000|Overall Study|non compliance in phone ratings|2|||
33317168|NCT02986334|101054436|FG001|Overall Study|non compliance in phone ratings|1|||
33317169|NCT02986334|101054437|FG002|Overall Study|non compliance in phone ratings|2|||
33317170|NCT02986334|101054435|FG000|Overall Study|undisclosed comorbidities|0|||
33317171|NCT02986334|101054436|FG001|Overall Study|undisclosed comorbidities|1|||
33317172|NCT02986334|101054437|FG002|Overall Study|undisclosed comorbidities|1|||
33317173|NCT02594163|101054439|FG000|Treatment Period|Progressive disease|2|||
33317174|NCT02594163|101054440|FG001|Treatment Period|Progressive disease|3|||
33317175|NCT02594163|101054439|FG000|Treatment Period|Adverse Event|1|||
33317176|NCT02594163|101054440|FG001|Treatment Period|Adverse Event|5|||
33317177|NCT02594163|101054439|FG000|Treatment Period|Physician Decision|1|||
33317178|NCT02594163|101054440|FG001|Treatment Period|Physician Decision|3|||
33317179|NCT02594163|101054439|FG000|Treatment Period|Study termination by sponsor|2|||
33317180|NCT02594163|101054440|FG001|Treatment Period|Study termination by sponsor|1|||
33317181|NCT02594163|101054439|FG000|Treatment Period|Other, Non-AE|1|||
33317182|NCT02594163|101054440|FG001|Treatment Period|Other, Non-AE|0|||
33317183|NCT02594163|101054439|FG000|Follow-up Period|Withdrawal by Subject|0|||
33317184|NCT02594163|101054440|FG001|Follow-up Period|Withdrawal by Subject|1|||
33317185|NCT02594163|101054439|FG000|Follow-up Period|Study Termination by Sponsor|6|||
33317186|NCT02594163|101054440|FG001|Follow-up Period|Study Termination by Sponsor|4|||
33317187|NCT02594163|101054439|FG000|Follow-up Period|Lost to Follow-up|1|||
33317188|NCT02594163|101054440|FG001|Follow-up Period|Lost to Follow-up|0|||
33317189|NCT02594163|101054439|FG000|Follow-up Period|Death|2|||
33317190|NCT02594163|101054440|FG001|Follow-up Period|Death|5|||
33317191|NCT02594163|101054439|FG000|Follow-up Period|Adverse Event|0|||
33317192|NCT02594163|101054440|FG001|Follow-up Period|Adverse Event|1|||
33317193|NCT02594163|101054439|FG000|Follow-up Period|Progressive Disease|2|||
33317194|NCT02594163|101054440|FG001|Follow-up Period|Progressive Disease|0|||
33317195|NCT02594163|101054439|FG000|Follow-up Period|Physician Decision|0|||
33317196|NCT02594163|101054440|FG001|Follow-up Period|Physician Decision|1|||
33317197|NCT03618823|101054442|FG000|Overall Study|Lost to Follow-up|63|||
33317198|NCT03618823|101054443|FG001|Overall Study|Lost to Follow-up|61|||
33317199|NCT00195507|101054444|FG000|Overall Study|Adverse Event|24|||
33317200|NCT00195507|101054445|FG001|Overall Study|Adverse Event|13|||
33317201|NCT00195507|101054444|FG000|Overall Study|Death|0|||
33317202|NCT00195507|101054445|FG001|Overall Study|Death|1|||
33317203|NCT00195507|101054444|FG000|Overall Study|Failed to Return|4|||
33398051|NCT02712008|101345901|FG002|From Week 12 up to Week 36|Adverse Event|0|||
33398052|NCT02712008|101345902|FG003|From Week 12 up to Week 36|Adverse Event|0|||
33398053|NCT02712008|101345903|FG004|From Week 12 up to Week 36|Adverse Event|1|||
33398054|NCT02712008|101345904|FG005|From Week 12 up to Week 36|Adverse Event|0|||
33398055|NCT02712008|101345905|FG006|From Week 12 up to Week 36|Adverse Event|0|||
33398056|NCT02712008|101345906|FG007|From Week 12 up to Week 36|Adverse Event|2|||
33398057|NCT02712008|101345899|FG000|From Week 12 up to Week 36|Death|1|||
33398058|NCT02712008|101345900|FG001|From Week 12 up to Week 36|Death|0|||
33398059|NCT02712008|101345901|FG002|From Week 12 up to Week 36|Death|0|||
33398060|NCT02712008|101345902|FG003|From Week 12 up to Week 36|Death|0|||
33398061|NCT02712008|101345903|FG004|From Week 12 up to Week 36|Death|0|||
33398062|NCT02712008|101345904|FG005|From Week 12 up to Week 36|Death|0|||
33398063|NCT02712008|101345905|FG006|From Week 12 up to Week 36|Death|1|||
33398064|NCT02712008|101345906|FG007|From Week 12 up to Week 36|Death|0|||
33398065|NCT02712008|101345899|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
33398066|NCT02712008|101345900|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
33398067|NCT02712008|101345901|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
33398068|NCT02712008|101345902|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
33317204|NCT00195507|101054445|FG001|Overall Study|Failed to Return|3|||
33317205|NCT00195507|101054444|FG000|Overall Study|Physician Decision|1|||
33317206|NCT00195507|101054445|FG001|Overall Study|Physician Decision|2|||
33317207|NCT00195507|101054444|FG000|Overall Study|Lost to Follow-up|3|||
33317208|NCT00195507|101054445|FG001|Overall Study|Lost to Follow-up|2|||
33317209|NCT00195507|101054444|FG000|Overall Study|Protocol Violation|5|||
33317210|NCT00195507|101054445|FG001|Overall Study|Protocol Violation|4|||
33317211|NCT00195507|101054444|FG000|Overall Study|Lack of Efficacy|40|||
33317212|NCT00195507|101054445|FG001|Overall Study|Lack of Efficacy|67|||
33398069|NCT02712008|101345903|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
33398070|NCT02712008|101345904|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
33398071|NCT02712008|101345905|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
33398072|NCT02712008|101345906|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
33398073|NCT02712008|101345899|FG000|From Week 12 up to Week 36|Physician Decision|0|||
33398074|NCT02712008|101345900|FG001|From Week 12 up to Week 36|Physician Decision|0|||
33398075|NCT02712008|101345901|FG002|From Week 12 up to Week 36|Physician Decision|0|||
33398076|NCT02712008|101345902|FG003|From Week 12 up to Week 36|Physician Decision|1|||
33398077|NCT02712008|101345903|FG004|From Week 12 up to Week 36|Physician Decision|1|||
33398078|NCT02712008|101345904|FG005|From Week 12 up to Week 36|Physician Decision|0|||
33398079|NCT02712008|101345905|FG006|From Week 12 up to Week 36|Physician Decision|0|||
33398080|NCT02712008|101345906|FG007|From Week 12 up to Week 36|Physician Decision|0|||
33398081|NCT02712008|101345899|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
33604260|NCT02642965|102102573|FG000|Overall Study|Physician Decision|9|||
33196997|NCT00466193|100626421|FG000|Overall Study|Adverse Event|0|||
33398082|NCT02712008|101345900|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
33398083|NCT02712008|101345901|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
33398084|NCT02712008|101345902|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
33398085|NCT02712008|101345903|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
33398086|NCT02712008|101345904|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
33398087|NCT02712008|101345905|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
33398088|NCT02712008|101345906|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
33398089|NCT00423267|101345907|FG000|Period A|Withdrawal by Subject|0|||
33398090|NCT00423267|101345908|FG001|Period A|Withdrawal by Subject|1|||
33398091|NCT00423267|101345907|FG000|Period A|Non-compliance with protocol|1|||
33398092|NCT00423267|101345908|FG001|Period A|Non-compliance with protocol|0|||
33398093|NCT00423267|101345907|FG000|Period A|Administrative|1|||
33398094|NCT00423267|101345908|FG001|Period A|Administrative|0|||
33398095|NCT00684073|101345909|FG000|Selection|Selection/non-selection criteria|3|||
33398096|NCT00684073|101345909|FG000|Selection|Death|1|||
33398097|NCT00684073|101345909|FG000|Selection|noncompliance|1|||
33398098|NCT00684073|101345909|FG000|Selection|Lost to Follow-up|1|||
33398099|NCT00684073|101345909|FG000|Selection|request of the sponsor|1|||
33398100|NCT00684073|101345909|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
33398101|NCT00703781|101345910|FG000|Overall Study|Withdrawal by Subject|1|||
33398102|NCT00703781|101345911|FG001|Overall Study|Withdrawal by Subject|2|||
33398103|NCT00703781|101345910|FG000|Overall Study|Cancelled surgery|1|||
33398104|NCT00703781|101345911|FG001|Overall Study|Cancelled surgery|0|||
33398105|NCT01566981|101345916|FG000|Overall Study|Lost to Follow-up|5|||
33398106|NCT01566981|101345917|FG001|Overall Study|Lost to Follow-up|8|||
33398107|NCT00866606|101345918|FG000|Overall Study|Lost to Follow-up|3|||
33398108|NCT00866606|101345918|FG000|Overall Study|Adverse Event|1|||
33398109|NCT01021293|101345919|FG000|Overall Study|Serious Adverse Event|2|||
33398110|NCT01021293|101345920|FG001|Overall Study|Serious Adverse Event|1|||
33398111|NCT01021293|101345919|FG000|Overall Study|Adverse Event|2|||
33398112|NCT01021293|101345920|FG001|Overall Study|Adverse Event|1|||
33398113|NCT01021293|101345919|FG000|Overall Study|Withdrawal by Subject|1|||
33398114|NCT01021293|101345920|FG001|Overall Study|Withdrawal by Subject|3|||
33398115|NCT01021293|101345919|FG000|Overall Study|Migrated/moved from study area|6|||
33398116|NCT01021293|101345920|FG001|Overall Study|Migrated/moved from study area|18|||
33398117|NCT01021293|101345919|FG000|Overall Study|Lost to Follow-up|1|||
33398118|NCT01021293|101345920|FG001|Overall Study|Lost to Follow-up|1|||
33196998|NCT00466193|100626422|FG001|Overall Study|Adverse Event|1|||
33196999|NCT00466193|100626421|FG000|Overall Study|Lost to Follow-up|2|||
33197000|NCT00466193|100626422|FG001|Overall Study|Lost to Follow-up|4|||
33197001|NCT00466193|100626421|FG000|Overall Study|Physician Decision|1|||
33197002|NCT00466193|100626422|FG001|Overall Study|Physician Decision|0|||
33197003|NCT00466193|100626421|FG000|Overall Study|Protocol Violation|1|||
33197004|NCT00466193|100626422|FG001|Overall Study|Protocol Violation|1|||
33197005|NCT00466193|100626421|FG000|Overall Study|Withdrawal by Subject|7|||
33197006|NCT00466193|100626422|FG001|Overall Study|Withdrawal by Subject|2|||
33197007|NCT00466193|100626421|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
33197008|NCT00466193|100626422|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
33398119|NCT00462488|101345921|FG000|Overall Study|Protocol Violation|1|||
33197009|NCT01609556|100626423|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33197010|NCT01609556|100626424|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33398120|NCT00462488|101345922|FG001|Overall Study|Protocol Violation|0|||
33398121|NCT00462488|101345921|FG000|Overall Study|Lack of Efficacy|19|||
33398122|NCT00462488|101345922|FG001|Overall Study|Lack of Efficacy|17|||
33398123|NCT01057394|101345925|FG000|Overall Study|Not eligible|0|||
33398124|NCT01057394|101345926|FG001|Overall Study|Not eligible|2|||
33398125|NCT01572844|101345927|FG000|Overall Study|Physician Decision|1|||
33398126|NCT01572844|101345928|FG001|Overall Study|Physician Decision|1|||
33197011|NCT01609556|100626425|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33197012|NCT01609556|100626426|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33197013|NCT01609556|100626427|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
33398127|NCT00742391|101345936|FG000|Overall Study|Adverse Event|2|||
33398128|NCT00742391|101345937|FG001|Overall Study|Adverse Event|1|||
33398129|NCT00742391|101345936|FG000|Overall Study|Lost to Follow-up|1|||
33398130|NCT00742391|101345937|FG001|Overall Study|Lost to Follow-up|0|||
33398131|NCT00742391|101345936|FG000|Overall Study|Protocol Violation|1|||
33398132|NCT00742391|101345937|FG001|Overall Study|Protocol Violation|0|||
33197014|NCT01609556|100626428|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33197015|NCT01609556|100626429|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33197016|NCT01609556|100626430|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
33197017|NCT01609556|100626431|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
33197018|NCT01609556|100626432|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33197019|NCT01609556|100626433|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
33197020|NCT01609556|100626434|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
33197021|NCT01609556|100626435|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33197022|NCT01609556|100626436|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33197023|NCT01609556|100626437|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33197024|NCT01609556|100626438|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
33197025|NCT01609556|100626423|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
33197026|NCT01609556|100626424|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
33197027|NCT01609556|100626425|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
33197028|NCT01609556|100626426|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
33317213|NCT00195507|101054444|FG000|Overall Study|Withdrawal by Subject|16|||
33317214|NCT00195507|101054445|FG001|Overall Study|Withdrawal by Subject|23|||
33317215|NCT00195507|101054444|FG000|Overall Study|Protocol Deviation|6|||
33317216|NCT00195507|101054445|FG001|Overall Study|Protocol Deviation|3|||
33317217|NCT02808143|101054446|FG000|Maintenance Phase|Disease recurrence|1|||
33398133|NCT02543801|101345939|FG000|Overall Study|Protocol Violation|1|||
33398134|NCT02543801|101345940|FG001|Overall Study|Protocol Violation|2|||
33398135|NCT02543801|101345941|FG002|Overall Study|Protocol Violation|0|||
33398136|NCT02543801|101345942|FG003|Overall Study|Protocol Violation|0|||
33398137|NCT00440232|101345943|FG000|Overall Study|Lost to Follow-up|1|||
33398138|NCT00440232|101345944|FG001|Overall Study|Lost to Follow-up|1|||
33398139|NCT00440232|101345943|FG000|Overall Study|Unable to treat within allowed time|0|||
33398140|NCT00440232|101345944|FG001|Overall Study|Unable to treat within allowed time|1|||
33398141|NCT00440232|101345943|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
33398142|NCT00440232|101345944|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
33398143|NCT01156012|101345945|FG000|Overall Study|Adverse Event|3|||
33398144|NCT01156012|101345946|FG001|Overall Study|Adverse Event|1|||
33398145|NCT01156012|101345945|FG000|Overall Study|Lost to Follow-up|1|||
33398146|NCT01156012|101345946|FG001|Overall Study|Lost to Follow-up|0|||
33398147|NCT01156012|101345945|FG000|Overall Study|Withdrawal by Subject|1|||
33398148|NCT01156012|101345946|FG001|Overall Study|Withdrawal by Subject|0|||
33398149|NCT01156012|101345945|FG000|Overall Study|use of commercial drug instead of study|0|||
33398150|NCT01156012|101345946|FG001|Overall Study|use of commercial drug instead of study|1|||
33398151|NCT01156012|101345945|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
33398152|NCT01156012|101345946|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
33398153|NCT00550615|101345947|FG000|Overall Study|Withdrawal by Subject|0|||
33398154|NCT00550615|101345948|FG001|Overall Study|Withdrawal by Subject|0|||
33398155|NCT00550615|101345949|FG002|Overall Study|Withdrawal by Subject|2|||
33398156|NCT00550615|101345950|FG003|Overall Study|Withdrawal by Subject|3|||
33317218|NCT02808143|101054447|FG001|Maintenance Phase|Disease recurrence|3|||
33317219|NCT02808143|101054446|FG000|Maintenance Phase|Disease progression|1|||
33317220|NCT02808143|101054447|FG001|Maintenance Phase|Disease progression|2|||
33317221|NCT02808143|101054446|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
33317222|NCT02808143|101054447|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
33317223|NCT02808143|101054446|FG000|Survival Follow-Up|Disease recurrence|0|||
33317224|NCT02808143|101054447|FG001|Survival Follow-Up|Disease recurrence|2|||
33317225|NCT02808143|101054446|FG000|Survival Follow-Up|Adverse Event|0|||
33317226|NCT02808143|101054447|FG001|Survival Follow-Up|Adverse Event|1|||
33317227|NCT02808143|101054446|FG000|Survival Follow-Up|Death|1|||
33317228|NCT02808143|101054447|FG001|Survival Follow-Up|Death|0|||
33317229|NCT01214187|101056895|FG000|Overall Study|Adverse Event|6|||
33317230|NCT01214187|101056896|FG001|Overall Study|Adverse Event|2|||
33506938|NCT01031836|101750909|FG001|Stage I|Adverse Event|1|||
33506939|NCT01031836|101750910|FG002|Stage I|Adverse Event|0|||
33506940|NCT01031836|101750911|FG003|Stage I|Adverse Event|0|||
33197029|NCT01609556|100626427|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
33317231|NCT01214187|101056895|FG000|Overall Study|Death|1|||
33317232|NCT01214187|101056896|FG001|Overall Study|Death|1|||
33317233|NCT01214187|101056895|FG000|Overall Study|Withdrawal by Subject|0|||
33398157|NCT00550615|101345947|FG000|Overall Study|Not evaluable|0|||
33398158|NCT00550615|101345948|FG001|Overall Study|Not evaluable|0|||
33398159|NCT00550615|101345949|FG002|Overall Study|Not evaluable|2|||
33398160|NCT00550615|101345950|FG003|Overall Study|Not evaluable|7|||
33398161|NCT02442765|101345953|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
33506941|NCT01031836|101750912|FG004|Stage I|Adverse Event|0|||
33506942|NCT01031836|101750913|FG005|Stage I|Adverse Event|0|||
33398162|NCT02442765|101345954|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
33398163|NCT02442765|101345955|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
33398164|NCT02442765|101345956|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
33398165|NCT02442765|101345957|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
33398166|NCT02442765|101345958|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
33398167|NCT02442765|101345959|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
33398168|NCT02442765|101345960|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
33398169|NCT02442765|101345953|FG000|Stage 2- (Days 43 to 85)|Death|0|||
33398170|NCT02442765|101345954|FG001|Stage 2- (Days 43 to 85)|Death|0|||
33398171|NCT02442765|101345955|FG002|Stage 2- (Days 43 to 85)|Death|0|||
33398172|NCT02442765|101345956|FG003|Stage 2- (Days 43 to 85)|Death|1|||
33398173|NCT02442765|101345957|FG004|Stage 2- (Days 43 to 85)|Death|1|||
33398174|NCT02442765|101345958|FG005|Stage 2- (Days 43 to 85)|Death|0|||
33398175|NCT02442765|101345959|FG006|Stage 2- (Days 43 to 85)|Death|2|||
33398176|NCT02442765|101345960|FG007|Stage 2- (Days 43 to 85)|Death|0|||
33398177|NCT02442765|101345953|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
33398178|NCT02442765|101345954|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
33398179|NCT02442765|101345955|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
33398180|NCT02442765|101345956|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
33398181|NCT02442765|101345957|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
33398182|NCT02442765|101345958|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
33398183|NCT02442765|101345959|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
33398184|NCT02442765|101345960|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
33398185|NCT02442765|101345953|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
33398186|NCT02442765|101345954|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
33398187|NCT02442765|101345955|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
33398188|NCT02442765|101345956|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
33398189|NCT02442765|101345957|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
33398190|NCT02442765|101345958|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
33398191|NCT02442765|101345959|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
33398192|NCT02442765|101345960|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
33398193|NCT02442765|101345953|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
33398194|NCT02442765|101345954|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
33398195|NCT02442765|101345955|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
33398196|NCT02442765|101345956|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
33398197|NCT02442765|101345957|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
33398198|NCT02442765|101345958|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
33398199|NCT02442765|101345959|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
33398200|NCT02442765|101345960|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
33398201|NCT02442765|101345953|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
33398202|NCT02442765|101345954|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
33398203|NCT02442765|101345955|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
33398204|NCT02442765|101345956|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
33398205|NCT02442765|101345957|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
33398206|NCT02442765|101345958|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
33317234|NCT01214187|101056896|FG001|Overall Study|Withdrawal by Subject|3|||
33317235|NCT02027701|101056897|FG000|Overall Study|Adverse Event|3|||
33317236|NCT02027701|101056897|FG000|Overall Study|Lack of Efficacy|8|||
33317237|NCT02027701|101056897|FG000|Overall Study|Physician Decision|2|||
33317238|NCT02027701|101056897|FG000|Overall Study|Withdrawal by Subject|3|||
33317239|NCT01230788|101056911|FG000|Overall Study|Prescribed exclusion drug|1|||
33317240|NCT03097133|101056914|FG000|Overall Study|Lost to Follow-up|3|||
33317241|NCT03097133|101056915|FG001|Overall Study|Lost to Follow-up|2|||
33317242|NCT03097133|101056914|FG000|Overall Study|Withdrawal by Subject|2|||
33317243|NCT03097133|101056915|FG001|Overall Study|Withdrawal by Subject|5|||
33317244|NCT03097133|101056914|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
33317245|NCT03097133|101056915|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
33317246|NCT03097133|101056914|FG000|Overall Study|Other|3|||
33317247|NCT03097133|101056915|FG001|Overall Study|Other|2|||
33317248|NCT03097133|101056914|FG000|Overall Study|Adverse Event|1|||
33317249|NCT03097133|101056915|FG001|Overall Study|Adverse Event|0|||
33317250|NCT00639223|101056919|FG000|Overall Study|Lost to Follow-up|0|||
33317251|NCT00639223|101056920|FG001|Overall Study|Lost to Follow-up|2|||
33317252|NCT00846391|101056921|FG000|Overall Study|Physician Decision|0|||
33317253|NCT00846391|101056922|FG001|Overall Study|Physician Decision|0|||
33317254|NCT00846391|101056923|FG002|Overall Study|Physician Decision|1|||
33398207|NCT02442765|101345959|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
33398208|NCT02442765|101345960|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
33398209|NCT02442765|101345953|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
33398210|NCT02442765|101345954|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
33398211|NCT02442765|101345955|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
33224340|NCT02202434|100721792|FG002|Overall Study|Visit Missed|0|||
33398212|NCT02442765|101345956|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
33398213|NCT02442765|101345957|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
33398214|NCT02442765|101345958|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
33398215|NCT02442765|101345959|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
33398216|NCT02442765|101345960|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
33398217|NCT02442765|101345953|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
33398218|NCT02442765|101345954|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
33398219|NCT02442765|101345955|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
33398220|NCT02442765|101345956|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
33398221|NCT02442765|101345957|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
33398222|NCT02442765|101345958|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
33398223|NCT02442765|101345959|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
33398224|NCT02442765|101345960|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
33398225|NCT04048876|101345961|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
33398226|NCT04048876|101345962|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
33398227|NCT04048876|101345963|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
33398228|NCT04048876|101345964|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
33398229|NCT04048876|101345961|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
33398230|NCT04048876|101345962|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
33398231|NCT04048876|101345963|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
33398232|NCT04048876|101345964|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
33398233|NCT04048876|101345961|FG000|Placebo Controlled Phase|Adverse Event|0|||
33398234|NCT04048876|101345962|FG001|Placebo Controlled Phase|Adverse Event|1|||
33398235|NCT04048876|101345963|FG002|Placebo Controlled Phase|Adverse Event|0|||
33398236|NCT04048876|101345964|FG003|Placebo Controlled Phase|Adverse Event|0|||
33398237|NCT04048876|101345961|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
33398238|NCT04048876|101345962|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
33506943|NCT01031836|101750908|FG000|Stage I|Other|0|||
33506944|NCT01031836|101750909|FG001|Stage I|Other|1|||
33506945|NCT01031836|101750910|FG002|Stage I|Other|0|||
33506946|NCT01031836|101750911|FG003|Stage I|Other|0|||
33506947|NCT01031836|101750912|FG004|Stage I|Other|0|||
33506948|NCT01031836|101750913|FG005|Stage I|Other|1|||
33506949|NCT01031836|101750908|FG000|Stage II|Adverse Event|0|||
33506950|NCT01031836|101750909|FG001|Stage II|Adverse Event|0|||
33604261|NCT03869333|102102576|FG000|Overall Study|Lost to Follow-up|1|||
33604262|NCT03869333|102102577|FG001|Overall Study|Lost to Follow-up|0|||
33317255|NCT00846391|101056921|FG000|Overall Study|Study Terminated by Sponsor|1|||
33317256|NCT00846391|101056922|FG001|Overall Study|Study Terminated by Sponsor|2|||
33317257|NCT00846391|101056923|FG002|Overall Study|Study Terminated by Sponsor|2|||
33317258|NCT04824521|101056924|FG000|Overall Study|Lost to Follow-up|1|||
33317259|NCT02435966|101056925|FG000|Overall Study|Withdrawal by Subject|0|||
33317260|NCT02435966|101056926|FG001|Overall Study|Withdrawal by Subject|1|||
33317261|NCT02435966|101056927|FG002|Overall Study|Withdrawal by Subject|0|||
33317262|NCT00730171|101056930|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
33317263|NCT00730171|101056930|FG000|Overall Study|Adverse Event|193|||
33317264|NCT00730171|101056930|FG000|Overall Study|Protocol Violation|48|||
33317265|NCT00730171|101056930|FG000|Overall Study|Withdrawal by Subject|202|||
33317266|NCT00730171|101056930|FG000|Overall Study|Lost to Follow-up|121|||
33317267|NCT00730171|101056930|FG000|Overall Study|Insufficient Therapeutic Response|141|||
33317268|NCT00730171|101056930|FG000|Overall Study|Other|61|||
33317269|NCT02604433|101056931|FG000|Overall Study|Withdrawal by Subject|37|||
33317270|NCT02604433|101056932|FG001|Overall Study|Withdrawal by Subject|16|||
33317271|NCT02604433|101056931|FG000|Overall Study|Adverse Event|4|||
33317272|NCT02604433|101056932|FG001|Overall Study|Adverse Event|0|||
33317273|NCT02604433|101056931|FG000|Overall Study|Other reasons|3|||
33317274|NCT02604433|101056932|FG001|Overall Study|Other reasons|5|||
33317275|NCT02604433|101056931|FG000|Overall Study|Death|4|||
33317276|NCT02604433|101056932|FG001|Overall Study|Death|1|||
33317277|NCT02604433|101056931|FG000|Overall Study|Transition to Rollover Protocol|169|||
33317278|NCT02604433|101056932|FG001|Overall Study|Transition to Rollover Protocol|82|||
33317279|NCT02604433|101056931|FG000|Overall Study|Physician Decision|1|||
33317280|NCT02604433|101056932|FG001|Overall Study|Physician Decision|1|||
33398239|NCT04048876|101345963|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
33317281|NCT02604433|101056931|FG000|Overall Study|Lack of Efficacy|0|||
33317282|NCT02604433|101056932|FG001|Overall Study|Lack of Efficacy|1|||
33317283|NCT01376349|101056941|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
33317284|NCT01376349|101056942|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
33398240|NCT04048876|101345964|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
33398241|NCT00819052|101345965|FG000|Overall Study|Adverse Event|0|||
33398242|NCT00819052|101345966|FG001|Overall Study|Adverse Event|5|||
33398243|NCT00819052|101345965|FG000|Overall Study|Protocol Violation|1|||
33506951|NCT01031836|101750910|FG002|Stage II|Adverse Event|2|||
33506952|NCT01031836|101750911|FG003|Stage II|Adverse Event|2|||
33506953|NCT01031836|101750912|FG004|Stage II|Adverse Event|1|||
33506954|NCT01031836|101750913|FG005|Stage II|Adverse Event|1|||
33506955|NCT01031836|101750908|FG000|Stage II|Other|2|||
33506956|NCT01031836|101750909|FG001|Stage II|Other|0|||
33506957|NCT01031836|101750910|FG002|Stage II|Other|0|||
33506958|NCT01031836|101750911|FG003|Stage II|Other|1|||
33506959|NCT01031836|101750912|FG004|Stage II|Other|1|||
33506960|NCT01031836|101750913|FG005|Stage II|Other|0|||
33506961|NCT01981954|101750919|FG000|Titration Period|Protocol Deviation|1|||
33506962|NCT01981954|101750919|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
33604263|NCT03869333|102102578|FG002|Overall Study|Lost to Follow-up|0|||
33604264|NCT03869333|102102579|FG003|Overall Study|Lost to Follow-up|0|||
33604265|NCT03869333|102102576|FG000|Overall Study|Pregnancy|1|||
33604266|NCT03869333|102102577|FG001|Overall Study|Pregnancy|0|||
33604267|NCT03869333|102102578|FG002|Overall Study|Pregnancy|0|||
33398244|NCT00819052|101345966|FG001|Overall Study|Protocol Violation|2|||
33398245|NCT00819052|101345965|FG000|Overall Study|Lost to Follow-up|1|||
33398246|NCT00819052|101345966|FG001|Overall Study|Lost to Follow-up|2|||
33398247|NCT00819052|101345965|FG000|Overall Study|Withdrawal by Subject|1|||
33398248|NCT00819052|101345966|FG001|Overall Study|Withdrawal by Subject|2|||
33398249|NCT00819052|101345965|FG000|Overall Study|Lack of Efficacy|1|||
33398250|NCT00819052|101345966|FG001|Overall Study|Lack of Efficacy|1|||
33398251|NCT00819052|101345965|FG000|Overall Study|Pregnancy|1|||
33398252|NCT00819052|101345966|FG001|Overall Study|Pregnancy|2|||
33398253|NCT00819052|101345965|FG000|Overall Study|Death or events leading to death|1|||
33398254|NCT00819052|101345966|FG001|Overall Study|Death or events leading to death|0|||
33398255|NCT01594749|101345969|FG000|Overall Study|Adverse Event|2|||
33398256|NCT01594749|101345970|FG001|Overall Study|Adverse Event|1|||
33398257|NCT01594749|101345969|FG000|Overall Study|Withdrawal by Subject|2|||
33398258|NCT01594749|101345970|FG001|Overall Study|Withdrawal by Subject|2|||
33398259|NCT01594749|101345969|FG000|Overall Study|Protocol Violation|2|||
33398260|NCT01594749|101345970|FG001|Overall Study|Protocol Violation|0|||
33398261|NCT01594749|101345969|FG000|Overall Study|Physician Decision|1|||
33398262|NCT01594749|101345970|FG001|Overall Study|Physician Decision|1|||
33398263|NCT01594749|101345969|FG000|Overall Study|Non-compliance with Protocol|0|||
33398264|NCT01594749|101345970|FG001|Overall Study|Non-compliance with Protocol|1|||
33604268|NCT03869333|102102579|FG003|Overall Study|Pregnancy|0|||
33604269|NCT03869333|102102576|FG000|Overall Study|Physician Decision|0|||
33604270|NCT03869333|102102577|FG001|Overall Study|Physician Decision|1|||
33604271|NCT03869333|102102578|FG002|Overall Study|Physician Decision|0|||
33317285|NCT01376349|101056943|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
33317286|NCT01376349|101056941|FG000|Raondomized Treatment|Adverse Event|13|||
33317287|NCT01376349|101056942|FG001|Raondomized Treatment|Adverse Event|17|||
33317288|NCT01376349|101056943|FG002|Raondomized Treatment|Adverse Event|14|||
33317289|NCT01376349|101056941|FG000|Raondomized Treatment|Unkown|1|||
33317290|NCT01376349|101056942|FG001|Raondomized Treatment|Unkown|2|||
33604272|NCT03869333|102102579|FG003|Overall Study|Physician Decision|0|||
33604273|NCT02428413|102102580|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
33604274|NCT02428413|102102581|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
33604275|NCT02428413|102102580|FG000|Overall Study|Protocol Violation|1|||
33604276|NCT02428413|102102581|FG001|Overall Study|Protocol Violation|2|||
33604277|NCT02428413|102102580|FG000|Overall Study|Case Cancelled|2|||
33604278|NCT02428413|102102581|FG001|Overall Study|Case Cancelled|0|||
33604279|NCT02428413|102102580|FG000|Overall Study|Missed Cases|1|||
33604280|NCT02428413|102102581|FG001|Overall Study|Missed Cases|2|||
33604281|NCT02428413|102102580|FG000|Overall Study|Nurse Refusal|1|||
33604282|NCT02428413|102102581|FG001|Overall Study|Nurse Refusal|0|||
33317291|NCT01376349|101056943|FG002|Raondomized Treatment|Unkown|1|||
33317292|NCT01376349|101056941|FG000|Raondomized Treatment|Alternative Treatment|0|||
33317293|NCT01376349|101056942|FG001|Raondomized Treatment|Alternative Treatment|0|||
33317294|NCT01376349|101056943|FG002|Raondomized Treatment|Alternative Treatment|1|||
33317295|NCT00985166|101056944|FG000|Overall Study|Lost to Follow-up|3|||
33317296|NCT00985166|101056945|FG001|Overall Study|Lost to Follow-up|2|||
33317297|NCT00985166|101056946|FG002|Overall Study|Lost to Follow-up|2|||
33317298|NCT00985166|101056944|FG000|Overall Study|Withdrawal by Subject|3|||
33317299|NCT00985166|101056945|FG001|Overall Study|Withdrawal by Subject|2|||
33317300|NCT00985166|101056946|FG002|Overall Study|Withdrawal by Subject|0|||
33317301|NCT00985166|101056944|FG000|Overall Study|Test not done|2|||
33317302|NCT00985166|101056945|FG001|Overall Study|Test not done|0|||
33398265|NCT01594749|101345969|FG000|Overall Study|Lost to Follow-up|1|||
33398266|NCT01594749|101345970|FG001|Overall Study|Lost to Follow-up|0|||
33398267|NCT01594749|101345969|FG000|Overall Study|Death|9|||
33317303|NCT00985166|101056946|FG002|Overall Study|Test not done|4|||
33398268|NCT01594749|101345970|FG001|Overall Study|Death|3|||
33398269|NCT01594749|101345969|FG000|Overall Study|Not Treated|4|||
33398270|NCT01594749|101345970|FG001|Overall Study|Not Treated|10|||
33398271|NCT01594749|101345969|FG000|Overall Study|Lost Source Documentation|1|||
33506963|NCT03033602|101750924|FG000|Overall Study|Withdrawal by Subject|11|||
33506964|NCT03033602|101750925|FG001|Overall Study|Withdrawal by Subject|21|||
33506965|NCT03033602|101750924|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
33398272|NCT01594749|101345970|FG001|Overall Study|Lost Source Documentation|0|||
33398273|NCT05466240|101345971|FG000|Overall Study|Adverse Event|1|||
33398274|NCT05466240|101345972|FG001|Overall Study|Adverse Event|0|||
33398275|NCT05466240|101345971|FG000|Overall Study|Withdrawal by Subject|1|||
33398276|NCT05466240|101345972|FG001|Overall Study|Withdrawal by Subject|0|||
33398277|NCT02608892|101345973|FG000|Overall Study|Lost to Follow-up|1|||
33398278|NCT02608892|101345974|FG001|Overall Study|Lost to Follow-up|0|||
33398279|NCT00731666|101345975|FG000|Overall Study|Adverse Event|2|||
33398280|NCT00731666|101345975|FG000|Overall Study|Lost to Follow-up|8|||
33398281|NCT00731666|101345975|FG000|Overall Study|Withdrawal by Subject|2|||
33398282|NCT01425528|101345976|FG000|Overall Study|Withdrawal by Subject|1|||
33398283|NCT01425528|101345977|FG001|Overall Study|Withdrawal by Subject|1|||
33398284|NCT00542425|101345978|FG000|Initial 24 Weeks|Administrative reasons|0|||
33398285|NCT00542425|101345979|FG001|Initial 24 Weeks|Administrative reasons|0|||
33398286|NCT00542425|101345980|FG002|Initial 24 Weeks|Administrative reasons|1|||
33398287|NCT00542425|101345981|FG003|Initial 24 Weeks|Administrative reasons|1|||
33317304|NCT00985166|101056944|FG000|Overall Study|Other|1|||
33317305|NCT00985166|101056945|FG001|Overall Study|Other|0|||
33317306|NCT00985166|101056946|FG002|Overall Study|Other|1|||
33317307|NCT03406260|101056952|FG000|Period 1|Adverse Event|0|||
33317308|NCT03406260|101056953|FG001|Period 1|Adverse Event|0|||
33317309|NCT03406260|101056954|FG002|Period 1|Adverse Event|0|||
33317310|NCT03406260|101056955|FG003|Period 1|Adverse Event|0|||
33317311|NCT03406260|101056956|FG004|Period 1|Adverse Event|1|||
33317312|NCT03406260|101056957|FG005|Period 1|Adverse Event|0|||
33317313|NCT00908232|101056959|FG000|Cycle 1 to 4|Death|5|||
33317314|NCT00908232|101056960|FG001|Cycle 1 to 4|Death|0|||
33317315|NCT00908232|101056961|FG002|Cycle 1 to 4|Death|0|||
33317316|NCT00908232|101056962|FG003|Cycle 1 to 4|Death|0|||
33317317|NCT00908232|101056959|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
33317318|NCT00908232|101056960|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
33317319|NCT00908232|101056961|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
33317320|NCT00908232|101056962|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
33317321|NCT00908232|101056959|FG000|Cycle 1 to 4|Progressive Disease|6|||
33317322|NCT00908232|101056960|FG001|Cycle 1 to 4|Progressive Disease|0|||
33317323|NCT00908232|101056961|FG002|Cycle 1 to 4|Progressive Disease|0|||
33317324|NCT00908232|101056962|FG003|Cycle 1 to 4|Progressive Disease|0|||
33317325|NCT00908232|101056959|FG000|Cycle 1 to 4|Adverse Event|12|||
33317326|NCT00908232|101056960|FG001|Cycle 1 to 4|Adverse Event|0|||
33317327|NCT00908232|101056961|FG002|Cycle 1 to 4|Adverse Event|0|||
33317328|NCT00908232|101056962|FG003|Cycle 1 to 4|Adverse Event|0|||
33317329|NCT00908232|101056959|FG000|Cycle 1 to 4|Other|1|||
33317330|NCT00908232|101056960|FG001|Cycle 1 to 4|Other|0|||
33317331|NCT00908232|101056961|FG002|Cycle 1 to 4|Other|0|||
33317332|NCT00908232|101056962|FG003|Cycle 1 to 4|Other|0|||
33317333|NCT00908232|101056959|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
33317334|NCT00908232|101056960|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
33317335|NCT00908232|101056961|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
33317336|NCT00908232|101056962|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
33317337|NCT00908232|101056959|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
33317338|NCT00908232|101056960|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
33317339|NCT00908232|101056961|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
33317340|NCT00908232|101056962|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
33317341|NCT00908232|101056959|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
33317342|NCT00908232|101056960|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
33317343|NCT00908232|101056961|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
33317344|NCT00908232|101056962|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
33317345|NCT00908232|101056959|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
33317346|NCT00908232|101056960|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
33317347|NCT00908232|101056961|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
33317348|NCT00908232|101056962|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
33317349|NCT00908232|101056959|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
33317350|NCT00908232|101056960|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
33317351|NCT00908232|101056961|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
33317352|NCT00908232|101056962|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
33317353|NCT00908232|101056959|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
33317354|NCT00908232|101056960|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
33317355|NCT00908232|101056961|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
33317356|NCT00908232|101056962|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
33317357|NCT00908232|101056959|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
33317358|NCT00908232|101056960|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
33398288|NCT00542425|101345982|FG004|Initial 24 Weeks|Administrative reasons|0|||
33398289|NCT00542425|101345978|FG000|Initial 24 Weeks|Adverse Event|0|||
33398290|NCT00542425|101345979|FG001|Initial 24 Weeks|Adverse Event|1|||
33317359|NCT00908232|101056961|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
33398291|NCT00542425|101345980|FG002|Initial 24 Weeks|Adverse Event|1|||
33398292|NCT00542425|101345981|FG003|Initial 24 Weeks|Adverse Event|3|||
33398293|NCT00542425|101345982|FG004|Initial 24 Weeks|Adverse Event|2|||
33398294|NCT00542425|101345978|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
33398295|NCT00542425|101345979|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
33398296|NCT00542425|101345980|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
33398297|NCT00542425|101345981|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
33398298|NCT00542425|101345982|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
33398299|NCT00542425|101345978|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
33398300|NCT00542425|101345979|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
33398301|NCT00542425|101345980|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
33398302|NCT00542425|101345981|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
33398303|NCT00542425|101345982|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
33398304|NCT00542425|101345978|FG000|Initial 24 Weeks|Non-compliance|0|||
33398305|NCT00542425|101345979|FG001|Initial 24 Weeks|Non-compliance|0|||
33398306|NCT00542425|101345980|FG002|Initial 24 Weeks|Non-compliance|0|||
33506966|NCT03033602|101750925|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
33506967|NCT02294396|101750926|FG000|Overall Study|Adverse Event|26|||
33604283|NCT00343382|102102587|FG000|Overall Study|Adverse Event|2|||
33604284|NCT00343382|102102588|FG001|Overall Study|Adverse Event|10|||
33604285|NCT00343382|102102589|FG002|Overall Study|Adverse Event|7|||
33604286|NCT00343382|102102587|FG000|Overall Study|Withdrawal by Subject|1|||
33604287|NCT00343382|102102588|FG001|Overall Study|Withdrawal by Subject|2|||
33604288|NCT00343382|102102589|FG002|Overall Study|Withdrawal by Subject|6|||
33604289|NCT00343382|102102587|FG000|Overall Study|Other Reason Not Specified|1|||
33604290|NCT00343382|102102588|FG001|Overall Study|Other Reason Not Specified|2|||
33604291|NCT00343382|102102589|FG002|Overall Study|Other Reason Not Specified|4|||
33317360|NCT00908232|101056962|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
33317361|NCT00908232|101056959|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
33317362|NCT00908232|101056960|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
33317363|NCT00908232|101056961|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
33317364|NCT00908232|101056962|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
33317365|NCT00975507|101056963|FG000|Overall Study|Adverse Event|1|||
33317366|NCT00975507|101056964|FG001|Overall Study|Adverse Event|0|||
33317367|NCT00975507|101056963|FG000|Overall Study|Lost to Follow-up|7|||
33317368|NCT00975507|101056964|FG001|Overall Study|Lost to Follow-up|1|||
33317369|NCT00975507|101056963|FG000|Overall Study|Protocol Violation|2|||
33317370|NCT00975507|101056964|FG001|Overall Study|Protocol Violation|0|||
33317371|NCT00975507|101056963|FG000|Overall Study|Withdrawal by Subject|10|||
33506968|NCT02294396|101750927|FG001|Overall Study|Adverse Event|25|||
33506969|NCT02294396|101750928|FG002|Overall Study|Adverse Event|21|||
33317372|NCT00975507|101056964|FG001|Overall Study|Withdrawal by Subject|3|||
33317373|NCT01862640|101056965|FG000|Overall Study|Adverse Event|4|||
33317374|NCT01862640|101056966|FG001|Overall Study|Adverse Event|10|||
33317375|NCT01862640|101056967|FG002|Overall Study|Adverse Event|6|||
33317376|NCT01862640|101056968|FG003|Overall Study|Adverse Event|8|||
33317377|NCT01862640|101056965|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
33317378|NCT01862640|101056966|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
33317379|NCT01862640|101056967|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
33317380|NCT01862640|101056968|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
33317381|NCT01862640|101056965|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
33317382|NCT01862640|101056966|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
33317383|NCT01862640|101056967|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
33317384|NCT01862640|101056968|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
33317385|NCT01862640|101056965|FG000|Overall Study|Withdrawal by Subject|2|||
33317386|NCT01862640|101056966|FG001|Overall Study|Withdrawal by Subject|4|||
33317387|NCT01862640|101056967|FG002|Overall Study|Withdrawal by Subject|8|||
33317388|NCT01862640|101056968|FG003|Overall Study|Withdrawal by Subject|5|||
33398307|NCT00542425|101345981|FG003|Initial 24 Weeks|Non-compliance|1|||
33398308|NCT00542425|101345982|FG004|Initial 24 Weeks|Non-compliance|1|||
33506970|NCT02294396|101750929|FG003|Overall Study|Adverse Event|24|||
33506971|NCT02294396|101750926|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
33506972|NCT02294396|101750927|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
33604292|NCT00267150|102102590|FG000|Overall Study|Adverse Event|1|||
33604293|NCT02855944|102102591|FG000|Period 1: Treatment|Ongoing|14|||
33317389|NCT01862640|101056965|FG000|Overall Study|Protocol Deviation|0|||
33317390|NCT01862640|101056966|FG001|Overall Study|Protocol Deviation|0|||
33317391|NCT01862640|101056967|FG002|Overall Study|Protocol Deviation|1|||
33317392|NCT01862640|101056968|FG003|Overall Study|Protocol Deviation|0|||
33317393|NCT01906346|101056969|FG000|Overall Study|AEs|1|||
33506973|NCT02294396|101750928|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
33506974|NCT02294396|101750929|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
33604294|NCT02855944|102102592|FG001|Period 1: Treatment|Ongoing|0|||
33604295|NCT02855944|102102591|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
33317394|NCT04484831|101056970|FG000|Overall Study|Withdrawal by Subject|1|||
33398309|NCT00542425|101345978|FG000|Initial 24 Weeks|Protocol Violation|0|||
33398310|NCT00542425|101345979|FG001|Initial 24 Weeks|Protocol Violation|0|||
33398311|NCT00542425|101345980|FG002|Initial 24 Weeks|Protocol Violation|0|||
33398312|NCT00542425|101345981|FG003|Initial 24 Weeks|Protocol Violation|1|||
33398313|NCT00542425|101345982|FG004|Initial 24 Weeks|Protocol Violation|0|||
33398314|NCT00542425|101345978|FG000|Initial 24 Weeks|Refusal of treatment|2|||
33398315|NCT00542425|101345979|FG001|Initial 24 Weeks|Refusal of treatment|2|||
33398316|NCT00542425|101345980|FG002|Initial 24 Weeks|Refusal of treatment|1|||
33317395|NCT04484831|101056971|FG001|Overall Study|Withdrawal by Subject|0|||
33317396|NCT00107120|101056972|FG000|Overall Study|Adverse Event|4|||
33317397|NCT00107120|101056973|FG001|Overall Study|Adverse Event|1|||
33317398|NCT00107120|101056972|FG000|Overall Study|Lack of Efficacy|5|||
33317399|NCT00107120|101056973|FG001|Overall Study|Lack of Efficacy|5|||
33317400|NCT00107120|101056972|FG000|Overall Study|Protocol Violation|3|||
33317401|NCT00107120|101056973|FG001|Overall Study|Protocol Violation|0|||
33398317|NCT00542425|101345981|FG003|Initial 24 Weeks|Refusal of treatment|4|||
33398318|NCT00542425|101345982|FG004|Initial 24 Weeks|Refusal of treatment|1|||
33398319|NCT00542425|101345978|FG000|Initial 24 Weeks|Other|0|||
33398320|NCT00542425|101345979|FG001|Initial 24 Weeks|Other|2|||
33398321|NCT00542425|101345980|FG002|Initial 24 Weeks|Other|1|||
33398322|NCT00542425|101345981|FG003|Initial 24 Weeks|Other|0|||
33398323|NCT00542425|101345982|FG004|Initial 24 Weeks|Other|0|||
33398324|NCT00542425|101345978|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
33398325|NCT00542425|101345979|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
33398326|NCT00542425|101345980|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
33398327|NCT00542425|101345981|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
33398328|NCT00542425|101345982|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
33398329|NCT00542425|101345978|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
33398330|NCT00542425|101345979|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
33398331|NCT00542425|101345980|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
33398332|NCT00542425|101345981|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
33398333|NCT00542425|101345982|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
33398334|NCT00542425|101345978|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
33398335|NCT00542425|101345979|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
33398336|NCT00542425|101345980|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
33398337|NCT00542425|101345981|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
33398338|NCT00542425|101345982|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
33398339|NCT00542425|101345978|FG000|Extended 24 Weeks of Treatment|Other|1|||
33398340|NCT00542425|101345979|FG001|Extended 24 Weeks of Treatment|Other|1|||
33398341|NCT00542425|101345980|FG002|Extended 24 Weeks of Treatment|Other|0|||
33398342|NCT00542425|101345981|FG003|Extended 24 Weeks of Treatment|Other|0|||
33398343|NCT00542425|101345982|FG004|Extended 24 Weeks of Treatment|Other|1|||
33398344|NCT03267576|101345983|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
33398345|NCT03267576|101345984|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
33398346|NCT03267576|101345983|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
33398347|NCT03267576|101345984|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
33398348|NCT04430036|101345985|FG000|Safety Run in Phase|Progression of disease|2|||
33398349|NCT01809327|101345986|FG000|Overall Study|Lost to Follow-up|5|||
33398350|NCT01809327|101345987|FG001|Overall Study|Lost to Follow-up|2|||
33398351|NCT01809327|101345988|FG002|Overall Study|Lost to Follow-up|4|||
33398352|NCT01809327|101345989|FG003|Overall Study|Lost to Follow-up|2|||
33398353|NCT01809327|101345990|FG004|Overall Study|Lost to Follow-up|3|||
33398354|NCT01809327|101345986|FG000|Overall Study|Withdrawal by Subject|6|||
33398355|NCT01809327|101345987|FG001|Overall Study|Withdrawal by Subject|4|||
33398356|NCT01809327|101345988|FG002|Overall Study|Withdrawal by Subject|4|||
33398357|NCT01809327|101345989|FG003|Overall Study|Withdrawal by Subject|2|||
33398358|NCT01809327|101345990|FG004|Overall Study|Withdrawal by Subject|5|||
33398359|NCT01809327|101345986|FG000|Overall Study|Adverse Event|4|||
33398360|NCT01809327|101345987|FG001|Overall Study|Adverse Event|3|||
33398361|NCT01809327|101345988|FG002|Overall Study|Adverse Event|7|||
33398362|NCT01809327|101345989|FG003|Overall Study|Adverse Event|4|||
33398363|NCT01809327|101345990|FG004|Overall Study|Adverse Event|8|||
33398364|NCT01809327|101345986|FG000|Overall Study|Death|1|||
33317402|NCT00107120|101056972|FG000|Overall Study|Withdrawal by Subject|8|||
33398365|NCT01809327|101345987|FG001|Overall Study|Death|0|||
33398366|NCT01809327|101345988|FG002|Overall Study|Death|0|||
33398367|NCT01809327|101345989|FG003|Overall Study|Death|0|||
33398368|NCT01809327|101345990|FG004|Overall Study|Death|0|||
33398369|NCT01809327|101345986|FG000|Overall Study|Protocol Violation|0|||
33398370|NCT01809327|101345987|FG001|Overall Study|Protocol Violation|1|||
33398371|NCT01809327|101345988|FG002|Overall Study|Protocol Violation|0|||
33398372|NCT01809327|101345989|FG003|Overall Study|Protocol Violation|0|||
33398373|NCT01809327|101345990|FG004|Overall Study|Protocol Violation|0|||
33398374|NCT01809327|101345986|FG000|Overall Study|Physician Decision|1|||
33398375|NCT01809327|101345987|FG001|Overall Study|Physician Decision|1|||
33398376|NCT01809327|101345988|FG002|Overall Study|Physician Decision|0|||
33398377|NCT01809327|101345989|FG003|Overall Study|Physician Decision|0|||
33398378|NCT01809327|101345990|FG004|Overall Study|Physician Decision|0|||
33398379|NCT01809327|101345986|FG000|Overall Study|Pregnancy|1|||
33398380|NCT01809327|101345987|FG001|Overall Study|Pregnancy|0|||
33398381|NCT01809327|101345988|FG002|Overall Study|Pregnancy|0|||
33398382|NCT01809327|101345989|FG003|Overall Study|Pregnancy|0|||
33506975|NCT02294396|101750926|FG000|Overall Study|Withdrawal by Subject|8|||
33506976|NCT02294396|101750927|FG001|Overall Study|Withdrawal by Subject|6|||
33506977|NCT02294396|101750928|FG002|Overall Study|Withdrawal by Subject|6|||
33506978|NCT02294396|101750929|FG003|Overall Study|Withdrawal by Subject|8|||
33506979|NCT02294396|101750926|FG000|Overall Study|Lost to Follow-up|0|||
33506980|NCT02294396|101750927|FG001|Overall Study|Lost to Follow-up|0|||
33506981|NCT02294396|101750928|FG002|Overall Study|Lost to Follow-up|1|||
33506982|NCT02294396|101750929|FG003|Overall Study|Lost to Follow-up|1|||
33506983|NCT02294396|101750926|FG000|Overall Study|Protocol Deviation|3|||
33506984|NCT02294396|101750927|FG001|Overall Study|Protocol Deviation|2|||
33506985|NCT02294396|101750928|FG002|Overall Study|Protocol Deviation|2|||
33506986|NCT02294396|101750929|FG003|Overall Study|Protocol Deviation|1|||
33506987|NCT02294396|101750926|FG000|Overall Study|Miscellaneous|2|||
33506988|NCT02294396|101750927|FG001|Overall Study|Miscellaneous|0|||
33506989|NCT02294396|101750928|FG002|Overall Study|Miscellaneous|5|||
33506990|NCT02294396|101750929|FG003|Overall Study|Miscellaneous|2|||
33506991|NCT02208362|101750930|FG000|Overall Study|Participant did not complete treatment|0|||
33506992|NCT02208362|101750931|FG001|Overall Study|Participant did not complete treatment|1|||
33506993|NCT02208362|101750932|FG002|Overall Study|Participant did not complete treatment|0|||
33506994|NCT02208362|101750933|FG003|Overall Study|Participant did not complete treatment|0|||
33506995|NCT02208362|101750934|FG004|Overall Study|Participant did not complete treatment|0|||
33506996|NCT02208362|101750935|FG005|Overall Study|Participant did not complete treatment|0|||
33506997|NCT02208362|101750936|FG006|Overall Study|Participant did not complete treatment|1|||
33506998|NCT02208362|101750937|FG007|Overall Study|Participant did not complete treatment|1|||
33506999|NCT02208362|101750938|FG008|Overall Study|Participant did not complete treatment|2|||
33507000|NCT02208362|101750939|FG009|Overall Study|Participant did not complete treatment|0|||
33507001|NCT02208362|101750940|FG010|Overall Study|Participant did not complete treatment|1|||
33507002|NCT02208362|101750941|FG011|Overall Study|Participant did not complete treatment|0|||
33507003|NCT02208362|101750930|FG000|Overall Study|Participant received disallowed treatment|0|||
33604296|NCT02855944|102102592|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
33317403|NCT00107120|101056973|FG001|Overall Study|Withdrawal by Subject|9|||
33317404|NCT00107120|101056972|FG000|Overall Study|Lost to Follow-up|8|||
33317405|NCT00107120|101056973|FG001|Overall Study|Lost to Follow-up|6|||
33317406|NCT00107120|101056972|FG000|Overall Study|Pregnancy|0|||
33317407|NCT00107120|101056973|FG001|Overall Study|Pregnancy|1|||
33317408|NCT00107120|101056972|FG000|Overall Study|moving away from site|1|||
33317409|NCT00107120|101056973|FG001|Overall Study|moving away from site|1|||
33197030|NCT01609556|100626428|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
33197031|NCT01609556|100626429|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
33197032|NCT01609556|100626430|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
33197033|NCT01609556|100626431|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
33197034|NCT01609556|100626432|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
33197035|NCT01609556|100626433|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
33197036|NCT01609556|100626434|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
33197037|NCT01609556|100626435|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
33197038|NCT01609556|100626436|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
33197039|NCT01609556|100626437|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
33197040|NCT01609556|100626438|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
33197041|NCT01609556|100626423|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33197042|NCT01609556|100626424|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33317410|NCT00107120|101056972|FG000|Overall Study|death of parent|0|||
33317411|NCT00107120|101056973|FG001|Overall Study|death of parent|1|||
33317412|NCT00394953|101056974|FG000|First Treatment Period|Adverse Event|1|||
33317413|NCT00394953|101056975|FG001|First Treatment Period|Adverse Event|2|||
33317414|NCT00394953|101056974|FG000|First Treatment Period|Death|6|||
33317415|NCT00394953|101056975|FG001|First Treatment Period|Death|7|||
33317416|NCT00394953|101056974|FG000|First Treatment Period|Lack of Efficacy|1|||
33317417|NCT00394953|101056975|FG001|First Treatment Period|Lack of Efficacy|1|||
33317418|NCT00394953|101056974|FG000|First Treatment Period|Withdrawal by Subject|6|||
33317419|NCT00394953|101056975|FG001|First Treatment Period|Withdrawal by Subject|3|||
33317420|NCT00394953|101056974|FG000|First Treatment Period|Lost to Follow-up|0|||
33317421|NCT00394953|101056975|FG001|First Treatment Period|Lost to Follow-up|1|||
33317422|NCT00394953|101056974|FG000|First Treatment Period|Renal transplant|11|||
33317423|NCT00394953|101056975|FG001|First Treatment Period|Renal transplant|7|||
33317424|NCT00394953|101056974|FG000|First Treatment Period|Not defined|4|||
33317425|NCT00394953|101056975|FG001|First Treatment Period|Not defined|1|||
33317426|NCT00394953|101056974|FG000|Second Treatment Period|Adverse Event|2|||
33197043|NCT01609556|100626425|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33197044|NCT01609556|100626426|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33197045|NCT01609556|100626427|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33197046|NCT01609556|100626428|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
33197047|NCT01609556|100626429|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
33197048|NCT01609556|100626430|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33197049|NCT01609556|100626431|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33197050|NCT01609556|100626432|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
33197051|NCT01609556|100626433|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
33197052|NCT01609556|100626434|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
33197053|NCT01609556|100626435|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33197054|NCT01609556|100626436|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33197055|NCT01609556|100626437|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33197056|NCT01609556|100626438|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
33197057|NCT01609556|100626423|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33197058|NCT01609556|100626424|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33197059|NCT01609556|100626425|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33197060|NCT01609556|100626426|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33197061|NCT01609556|100626427|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33197062|NCT01609556|100626428|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
33197063|NCT01609556|100626429|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33197064|NCT01609556|100626430|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33197065|NCT01609556|100626431|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33197066|NCT01609556|100626432|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33197067|NCT01609556|100626433|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33197068|NCT01609556|100626434|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
33197069|NCT01609556|100626435|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33197070|NCT01609556|100626436|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33197071|NCT01609556|100626437|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33197072|NCT01609556|100626438|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
33197073|NCT01609556|100626423|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33197074|NCT01609556|100626424|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33197075|NCT01609556|100626425|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33197076|NCT01609556|100626426|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33197077|NCT01609556|100626427|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33197078|NCT01609556|100626428|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
33197079|NCT01609556|100626429|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33197080|NCT01609556|100626430|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33197081|NCT01609556|100626431|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33317427|NCT00394953|101056975|FG001|Second Treatment Period|Adverse Event|5|||
33317428|NCT00394953|101056974|FG000|Second Treatment Period|Death|8|||
33317429|NCT00394953|101056975|FG001|Second Treatment Period|Death|4|||
33317430|NCT00394953|101056974|FG000|Second Treatment Period|Lack of Efficacy|9|||
33317431|NCT00394953|101056975|FG001|Second Treatment Period|Lack of Efficacy|47|||
33317432|NCT00394953|101056974|FG000|Second Treatment Period|Withdrawal by Subject|3|||
33317433|NCT00394953|101056975|FG001|Second Treatment Period|Withdrawal by Subject|3|||
33317434|NCT00394953|101056974|FG000|Second Treatment Period|Lost to Follow-up|0|||
33317435|NCT00394953|101056975|FG001|Second Treatment Period|Lost to Follow-up|1|||
33317436|NCT00394953|101056974|FG000|Second Treatment Period|Renal transplant|4|||
33317437|NCT00394953|101056975|FG001|Second Treatment Period|Renal transplant|6|||
33317438|NCT00394953|101056974|FG000|Second Treatment Period|Not defined|3|||
33317439|NCT00394953|101056975|FG001|Second Treatment Period|Not defined|8|||
33317440|NCT01390181|101056978|FG000|Overall Study|Lost to Follow-up|1|||
33317441|NCT01390181|101056978|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
33317442|NCT01557283|101056979|FG000|Overall Study|Lost to Follow-up|7|||
33317443|NCT01557283|101056979|FG000|Overall Study|Non-responder|19|||
33317444|NCT01557283|101056979|FG000|Overall Study|Adverse Event|7|||
33317445|NCT01557283|101056979|FG000|Overall Study|Lack of Efficacy|1|||
33317446|NCT01557283|101056979|FG000|Overall Study|Non-compliance|1|||
33197082|NCT01609556|100626432|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33197083|NCT01609556|100626433|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33317447|NCT01557283|101056979|FG000|Overall Study|Withdrawal by Subject|1|||
33317448|NCT01557283|101056979|FG000|Overall Study|Participant's weight too high for dose|1|||
33317449|NCT01557283|101056979|FG000|Overall Study|Worsening of psoriasis|1|||
33317450|NCT01557283|101056979|FG000|Overall Study|Other|6|||
33317451|NCT00876694|101056986|FG000|Overall Study|Adverse Event|10|||
33317452|NCT00876694|101056987|FG001|Overall Study|Adverse Event|7|||
33317453|NCT00876694|101056986|FG000|Overall Study|Subject withdrew consent|6|||
33317454|NCT00876694|101056987|FG001|Overall Study|Subject withdrew consent|4|||
33317455|NCT00876694|101056986|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33317456|NCT00876694|101056987|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33317457|NCT00876694|101056986|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33317458|NCT00876694|101056987|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33317459|NCT00876694|101056986|FG000|Overall Study|Administrative problems|1|||
33317460|NCT00876694|101056987|FG001|Overall Study|Administrative problems|1|||
33317461|NCT00876694|101056986|FG000|Overall Study|Death|1|||
33317462|NCT00876694|101056987|FG001|Overall Study|Death|0|||
33317463|NCT00803270|101056991|FG000|Overall Study|Lost to Follow-up|1|||
33317464|NCT00803270|101056992|FG001|Overall Study|Lost to Follow-up|2|||
33317465|NCT03093350|101056993|FG000|Overall Study|Death|1|||
33317466|NCT03093350|101056993|FG000|Overall Study|Signed consent, never began treartment|1|||
33317467|NCT03739437|101056994|FG000|Overall Study|Lost to Follow-up|2|||
33317468|NCT03739437|101056995|FG001|Overall Study|Lost to Follow-up|5|||
33317469|NCT01774110|101056997|FG000|Overall Study|Lost to Follow-up|7|||
33317470|NCT01000636|101056998|FG000|Overall Study|Withdrawal by Subject|1|||
33317471|NCT01000636|101056998|FG000|Overall Study|Adverse Event|1|||
33317472|NCT01387230|101056999|FG000|Overall Study|Adverse Event|0|||
33317473|NCT01387230|101057000|FG001|Overall Study|Adverse Event|1|||
33317474|NCT01387230|101057001|FG002|Overall Study|Adverse Event|3|||
33317475|NCT01387230|101056999|FG000|Overall Study|Lack of Efficacy|8|||
33317476|NCT01387230|101057000|FG001|Overall Study|Lack of Efficacy|5|||
33317477|NCT01387230|101057001|FG002|Overall Study|Lack of Efficacy|4|||
33317478|NCT01387230|101056999|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
33317479|NCT01387230|101057000|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
33507004|NCT02208362|101750931|FG001|Overall Study|Participant received disallowed treatment|0|||
33507005|NCT02208362|101750932|FG002|Overall Study|Participant received disallowed treatment|0|||
33507006|NCT02208362|101750933|FG003|Overall Study|Participant received disallowed treatment|0|||
33507007|NCT02208362|101750934|FG004|Overall Study|Participant received disallowed treatment|0|||
33507008|NCT02208362|101750935|FG005|Overall Study|Participant received disallowed treatment|0|||
33507009|NCT02208362|101750936|FG006|Overall Study|Participant received disallowed treatment|0|||
33507010|NCT02208362|101750937|FG007|Overall Study|Participant received disallowed treatment|0|||
33507011|NCT02208362|101750938|FG008|Overall Study|Participant received disallowed treatment|1|||
33507012|NCT02208362|101750939|FG009|Overall Study|Participant received disallowed treatment|0|||
33507013|NCT02208362|101750940|FG010|Overall Study|Participant received disallowed treatment|0|||
33507014|NCT02208362|101750941|FG011|Overall Study|Participant received disallowed treatment|0|||
33507015|NCT03169881|101750942|FG000|Overall Study|Incomplete Follow-up|10|||
33507016|NCT03169881|101750943|FG001|Overall Study|Incomplete Follow-up|15|||
33507017|NCT03169881|101750942|FG000|Overall Study|Lost to Follow-up|18|||
33507018|NCT03169881|101750943|FG001|Overall Study|Lost to Follow-up|20|||
33507019|NCT03169881|101750942|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
33507020|NCT03169881|101750943|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
33507021|NCT01340027|101750944|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
33317480|NCT01387230|101057001|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
33317481|NCT01387230|101056999|FG000|Overall Study|Lost to Follow-up|0|||
33317482|NCT01387230|101057000|FG001|Overall Study|Lost to Follow-up|0|||
33317483|NCT01387230|101057001|FG002|Overall Study|Lost to Follow-up|1|||
33317484|NCT01387230|101056999|FG000|Overall Study|Withdrawal by Subject|4|||
33317485|NCT01387230|101057000|FG001|Overall Study|Withdrawal by Subject|1|||
33317486|NCT01387230|101057001|FG002|Overall Study|Withdrawal by Subject|0|||
33317487|NCT03333837|101057002|FG000|Overall Study|Adverse Event|2|||
33317488|NCT03333837|101057003|FG001|Overall Study|Adverse Event|1|||
33317489|NCT03333837|101057004|FG002|Overall Study|Adverse Event|1|||
33317490|NCT03333837|101057005|FG003|Overall Study|Adverse Event|1|||
33317491|NCT03333837|101057006|FG004|Overall Study|Adverse Event|0|||
33317492|NCT03333837|101057002|FG000|Overall Study|Caregiver withdrew|0|||
33317493|NCT03333837|101057003|FG001|Overall Study|Caregiver withdrew|2|||
33507022|NCT01340027|101750945|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
33317494|NCT03333837|101057004|FG002|Overall Study|Caregiver withdrew|1|||
33317495|NCT03333837|101057005|FG003|Overall Study|Caregiver withdrew|0|||
33317496|NCT03333837|101057006|FG004|Overall Study|Caregiver withdrew|0|||
33317497|NCT03333837|101057002|FG000|Overall Study|Withdrawal by Subject|0|||
33317498|NCT03333837|101057003|FG001|Overall Study|Withdrawal by Subject|0|||
33317499|NCT03333837|101057004|FG002|Overall Study|Withdrawal by Subject|1|||
33317500|NCT03333837|101057005|FG003|Overall Study|Withdrawal by Subject|1|||
33317501|NCT03333837|101057006|FG004|Overall Study|Withdrawal by Subject|3|||
33317502|NCT03333837|101057002|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
33317503|NCT03333837|101057003|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
33507023|NCT01340027|101750946|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
33398383|NCT01809327|101345990|FG004|Overall Study|Pregnancy|0|||
33398384|NCT01809327|101345986|FG000|Overall Study|Other|14|||
33398385|NCT01809327|101345987|FG001|Overall Study|Other|15|||
33398386|NCT01809327|101345988|FG002|Overall Study|Other|7|||
33398387|NCT01809327|101345989|FG003|Overall Study|Other|4|||
33398388|NCT01809327|101345990|FG004|Overall Study|Other|9|||
33398389|NCT03756285|101345991|FG000|Overall Study|Lost to Follow-up|0|||
33398390|NCT03756285|101345992|FG001|Overall Study|Lost to Follow-up|1|||
33398391|NCT03756285|101345991|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
33398392|NCT03756285|101345992|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
33604297|NCT02855944|102102591|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
33604298|NCT02855944|102102592|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
33317504|NCT03333837|101057004|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
33398393|NCT03756285|101345991|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
33398394|NCT03756285|101345992|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
33398395|NCT00942422|101345993|FG000|Overall Study|Withdrawal by Subject|1|||
33317505|NCT03333837|101057005|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
33317506|NCT03333837|101057006|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
33317507|NCT03040622|101057008|FG000|Overall Study|unable to implant device|3|||
33317508|NCT01272947|101057011|FG000|Overall Study|Abnormal Laboratory Value|2|||
33317509|NCT01272947|101057012|FG001|Overall Study|Abnormal Laboratory Value|2|||
33317510|NCT01840605|101057013|FG000|Overall Study|Adverse Event|0|||
33317511|NCT01840605|101057014|FG001|Overall Study|Adverse Event|1|||
33317512|NCT01840605|101057013|FG000|Overall Study|Physician Decision|2|||
33317513|NCT01840605|101057014|FG001|Overall Study|Physician Decision|1|||
33317514|NCT01016964|101057015|FG000|Overall Study|Lost to Follow-up|3|||
33317515|NCT01016964|101057016|FG001|Overall Study|Lost to Follow-up|3|||
33317516|NCT00769860|101057028|FG000|Overall Study|Withdrawal by Subject|2|||
33317517|NCT00769860|101057029|FG001|Overall Study|Withdrawal by Subject|0|||
33317518|NCT02742766|101057030|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317519|NCT02742766|101057031|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317520|NCT02742766|101057032|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317521|NCT02742766|101057033|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317522|NCT02742766|101057034|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317523|NCT02742766|101057035|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317524|NCT02742766|101057036|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317525|NCT02742766|101057037|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317526|NCT02742766|101057038|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317527|NCT02742766|101057039|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317528|NCT02742766|101057040|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317529|NCT02742766|101057041|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317530|NCT02742766|101057042|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317531|NCT02742766|101057043|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
33317532|NCT02742766|101057044|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317533|NCT02742766|101057045|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317534|NCT02742766|101057046|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317535|NCT02742766|101057047|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317536|NCT02742766|101057048|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
33317537|NCT02742766|101057030|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
33317538|NCT02742766|101057031|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
33317539|NCT02742766|101057032|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
33317540|NCT02742766|101057033|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
33317541|NCT02742766|101057034|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
33317542|NCT02742766|101057035|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
33317543|NCT02742766|101057036|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
33317544|NCT02742766|101057037|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
33317545|NCT02742766|101057038|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
33317546|NCT02742766|101057039|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
33317547|NCT02742766|101057040|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
33398396|NCT00942422|101345993|FG000|Overall Study|Death|1|||
33317548|NCT02742766|101057041|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
33398397|NCT00942422|101345993|FG000|Overall Study|Progressive diease|1|||
33398398|NCT00939341|101345994|FG000|Overall Study|Adverse Event|15|||
33398399|NCT00939341|101345994|FG000|Overall Study|Pregnancy|1|||
33317549|NCT02742766|101057042|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
33317550|NCT02742766|101057043|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
33317551|NCT02742766|101057044|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
33317552|NCT02742766|101057045|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
33317553|NCT02742766|101057046|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
33317554|NCT02742766|101057047|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
33317555|NCT02742766|101057048|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
33317556|NCT02342743|101057049|FG000|Baseline Period|Withdrawal by Subject|3|||
33317557|NCT02342743|101057049|FG000|Baseline Period|Lost to Follow-up|2|||
33317558|NCT02342743|101057049|FG000|Baseline Period|Change in prophylactic medication|3|||
33317559|NCT02342743|101057049|FG000|Baseline Period|Screening failure regarding baseline|7|||
33317560|NCT02342743|101057049|FG000|Treatment Period|Withdrawal by Subject|2|||
33317561|NCT02342743|101057049|FG000|Treatment Period|Lost to Follow-up|8|||
33317562|NCT02342743|101057049|FG000|Treatment Period|Change in prophylactic medication|1|||
33317563|NCT00655486|101057050|FG000|Overall Study|Adverse Event|10|||
33317564|NCT00655486|101057050|FG000|Overall Study|Lack of Efficacy|8|||
33317565|NCT00655486|101057050|FG000|Overall Study|Withdrawal by Subject|4|||
33317566|NCT00655486|101057050|FG000|Overall Study|Protocol Violation|1|||
33317567|NCT00655486|101057050|FG000|Overall Study|Unsatisfactory compliance|2|||
33317568|NCT00655486|101057050|FG000|Overall Study|Other: Pregnancy|1|||
33317569|NCT00655486|101057050|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
33317570|NCT00655486|101057050|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
33317571|NCT01295281|101057051|FG000|First Intervention (7 Days)|Death|0|||
33317572|NCT01295281|101057052|FG001|First Intervention (7 Days)|Death|1|||
33317573|NCT00615836|101057070|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
33317574|NCT00615836|101057071|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
33317575|NCT00615836|101057072|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
33317576|NCT00615836|101057073|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
33317577|NCT00615836|101057074|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
33317578|NCT00615836|101057070|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
33317579|NCT00615836|101057071|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
33317580|NCT00615836|101057072|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
33317581|NCT00615836|101057073|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
33317582|NCT00615836|101057074|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
33317583|NCT00615836|101057070|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
33317584|NCT00615836|101057071|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
33317585|NCT00615836|101057072|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
33317586|NCT00615836|101057073|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
33317587|NCT00615836|101057074|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
33317588|NCT00615836|101057070|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
33317589|NCT00615836|101057071|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
33317590|NCT00615836|101057072|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
33317591|NCT00615836|101057073|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
33317592|NCT00615836|101057074|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
33317593|NCT00615836|101057070|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
33317594|NCT00615836|101057071|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
33317595|NCT00615836|101057072|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
33317596|NCT00615836|101057073|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
33317597|NCT00615836|101057074|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
33317598|NCT00615836|101057070|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
33317599|NCT00615836|101057071|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
33317600|NCT00615836|101057072|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
33317601|NCT00615836|101057073|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
33317602|NCT00615836|101057074|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
33317603|NCT00615836|101057070|FG000|Extension Study (FE992026 CS31)|Other|10|||
33317604|NCT00615836|101057071|FG001|Extension Study (FE992026 CS31)|Other|7|||
33317605|NCT00615836|101057072|FG002|Extension Study (FE992026 CS31)|Other|8|||
33317606|NCT00615836|101057073|FG003|Extension Study (FE992026 CS31)|Other|8|||
33317607|NCT00615836|101057074|FG004|Extension Study (FE992026 CS31)|Other|0|||
33317608|NCT00615836|101057070|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
33317609|NCT00615836|101057071|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
33317610|NCT00615836|101057072|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
33317611|NCT00615836|101057073|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
33317612|NCT00615836|101057074|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
33317613|NCT00615836|101057070|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
33317614|NCT00615836|101057071|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
33317615|NCT00615836|101057072|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
33317616|NCT00615836|101057073|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
33398400|NCT00939341|101345994|FG000|Overall Study|Lost to Follow-up|23|||
33398401|NCT00939341|101345994|FG000|Overall Study|Withdrawal by Subject|13|||
33317617|NCT00615836|101057074|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
33317618|NCT01480674|101057075|FG000|Overall Study|Death|23|||
33317619|NCT01480674|101057075|FG000|Overall Study|Lost to Follow-up|2|||
33317620|NCT01480674|101057075|FG000|Overall Study|visit not done|10|||
33317621|NCT02141984|101057076|FG000|Overall Study|Lack of Efficacy|2|||
33317622|NCT01891721|101057079|FG000|Overall Study|Lost to Follow-up|10|||
33317623|NCT01891721|101057080|FG001|Overall Study|Lost to Follow-up|5|||
33317624|NCT01891721|101057081|FG002|Overall Study|Lost to Follow-up|1|||
33317625|NCT01072877|101057082|FG000|Overall Study|Lost to Follow-up|1|||
33317626|NCT01072877|101057083|FG001|Overall Study|Lost to Follow-up|1|||
33317627|NCT01072877|101057084|FG002|Overall Study|Lost to Follow-up|0|||
33317628|NCT01072877|101057085|FG003|Overall Study|Lost to Follow-up|2|||
33317629|NCT01072877|101057086|FG004|Overall Study|Lost to Follow-up|0|||
33317630|NCT04051827|101057087|FG000|Overall Study|Death|1|||
33317631|NCT04051827|101057087|FG000|Overall Study|Withdrawal by Subject|4|||
33317632|NCT04051827|101057087|FG000|Overall Study|Progressive disease|16|||
33317633|NCT04051827|101057087|FG000|Overall Study|Physician Decision|1|||
33317634|NCT04051827|101057087|FG000|Overall Study|Other|4|||
33317635|NCT01786174|101057098|FG000|Overall Study|Discontinued Study Drug|2|||
33317636|NCT01786174|101057099|FG001|Overall Study|Discontinued Study Drug|0|||
33317637|NCT04209621|101057100|FG000|Overall Study|Death|1|||
33317638|NCT04209621|101057100|FG000|Overall Study|Study Terminated Early|2|||
33317639|NCT01699789|101057101|FG000|Overall Study|Withdrawal by Subject|18|||
33317640|NCT01699789|101057102|FG001|Overall Study|Withdrawal by Subject|23|||
33317641|NCT01699789|101057101|FG000|Overall Study|Death|1|||
33317642|NCT01699789|101057102|FG001|Overall Study|Death|2|||
33317643|NCT01699789|101057101|FG000|Overall Study|Lost to Follow-up|83|||
33317644|NCT01699789|101057102|FG001|Overall Study|Lost to Follow-up|101|||
33317645|NCT03310268|101057103|FG000|Overall Study|(Not specified)|1|||
33317646|NCT03310268|101057104|FG001|Overall Study|(Not specified)|5|||
33317647|NCT03310268|101057105|FG002|Overall Study|(Not specified)|0|||
33317648|NCT03602066|101057109|FG000|Overall Study|Withdrawal by Subject|2|||
33317649|NCT03602066|101057110|FG001|Overall Study|Withdrawal by Subject|0|||
33317650|NCT03602066|101057109|FG000|Overall Study|Physician Decision|1|||
33317651|NCT03602066|101057110|FG001|Overall Study|Physician Decision|0|||
33317652|NCT01019317|101057111|FG000|Overall Study|Not Eligible|4|||
33317653|NCT03566810|101057116|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
33317654|NCT03566810|101057117|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
33317655|NCT03566810|101057118|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
33317656|NCT03566810|101057119|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
33317657|NCT01176773|101057123|FG000|Overall Study|Screen Failure|2|||
33317658|NCT01176773|101057123|FG000|Overall Study|Withdrew consent|1|||
33317659|NCT00059839|101057124|FG000|Overall Study|Death|1|||
33317660|NCT00059839|101057125|FG001|Overall Study|Death|1|||
33317661|NCT00059839|101057124|FG000|Overall Study|Lack of Efficacy|6|||
33317662|NCT00059839|101057125|FG001|Overall Study|Lack of Efficacy|5|||
33317663|NCT00059839|101057124|FG000|Overall Study|Lost to Follow-up|2|||
33317664|NCT00059839|101057125|FG001|Overall Study|Lost to Follow-up|0|||
33317665|NCT00059839|101057124|FG000|Overall Study|Physician Decision|1|||
33317666|NCT00059839|101057125|FG001|Overall Study|Physician Decision|2|||
33317667|NCT00059839|101057124|FG000|Overall Study|Withdrawal by Subject|1|||
33317668|NCT00059839|101057125|FG001|Overall Study|Withdrawal by Subject|6|||
33317669|NCT00059839|101057124|FG000|Overall Study|Ineligible|1|||
33317670|NCT00059839|101057125|FG001|Overall Study|Ineligible|3|||
33317671|NCT01117857|101057126|FG000|Overall Study|Lost to Follow-up|4|||
33317672|NCT01117857|101057126|FG000|Overall Study|Withdrawal by Subject|4|||
33317673|NCT01117857|101057126|FG000|Overall Study|Physician Decision|1|||
33317674|NCT00001962|101057130|FG000|Overall Study|Lack of Efficacy|18|||
33317675|NCT00001962|101057130|FG000|Overall Study|Lack of Accrual|6|||
33317676|NCT00001962|101057130|FG000|Overall Study|Death|1|||
33317677|NCT00001962|101057130|FG000|Overall Study|Lost to Follow-up|2|||
33317678|NCT00001962|101057130|FG000|Overall Study|Adverse Event|1|||
33317679|NCT00634010|101057131|FG000|Overall Study|Adverse Event|2|||
33317680|NCT00634010|101057132|FG001|Overall Study|Adverse Event|5|||
33317681|NCT00634010|101057131|FG000|Overall Study|Withdrawal by Subject|5|||
33317682|NCT00634010|101057132|FG001|Overall Study|Withdrawal by Subject|6|||
33317683|NCT00634010|101057131|FG000|Overall Study|Physician Decision|1|||
33317684|NCT00634010|101057132|FG001|Overall Study|Physician Decision|1|||
33317685|NCT00634010|101057131|FG000|Overall Study|Disease Progression|1|||
33317686|NCT00634010|101057132|FG001|Overall Study|Disease Progression|1|||
33317687|NCT00634010|101057131|FG000|Overall Study|Non-Compliant|1|||
33317688|NCT00634010|101057132|FG001|Overall Study|Non-Compliant|1|||
33604299|NCT00664326|102102595|FG000|Overall Study|Adverse Event|14|||
33317689|NCT00728481|101057133|FG000|Overall Study|Withdrawal by Subject|0|||
33317690|NCT00728481|101057134|FG001|Overall Study|Withdrawal by Subject|1|||
33317691|NCT00728481|101057133|FG000|Overall Study|Adverse Event|0|||
33317692|NCT00728481|101057134|FG001|Overall Study|Adverse Event|1|||
33317693|NCT00728481|101057133|FG000|Overall Study|Study medication non-compliance|0|||
33317694|NCT00728481|101057134|FG001|Overall Study|Study medication non-compliance|2|||
33317695|NCT00728481|101057133|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
33317696|NCT00728481|101057134|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
33317697|NCT00221195|101057138|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
33317698|NCT00221195|101057139|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
33317699|NCT00221195|101057138|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
33317700|NCT00221195|101057139|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
33317701|NCT00221195|101057138|FG000|Washout Period (Months 7-9)|Death|0|||
33317702|NCT00221195|101057139|FG001|Washout Period (Months 7-9)|Death|1|||
33317703|NCT00221195|101057138|FG000|Therapy 2 (Months 10-15)|Death|1|||
33317704|NCT00221195|101057139|FG001|Therapy 2 (Months 10-15)|Death|0|||
33317705|NCT00221195|101057138|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
33317706|NCT00221195|101057139|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
33317707|NCT03057977|101057140|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
33317708|NCT03057977|101057141|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
33317709|NCT03057977|101057140|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
33317710|NCT03057977|101057141|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
33317711|NCT03057977|101057140|FG000|Discontinuation From Treatment|Protocol Violation|6|||
33317712|NCT03057977|101057141|FG001|Discontinuation From Treatment|Protocol Violation|5|||
33317713|NCT03057977|101057140|FG000|Discontinuation From Treatment|Not treated|4|||
33317714|NCT03057977|101057141|FG001|Discontinuation From Treatment|Not treated|0|||
33317715|NCT03057977|101057140|FG000|Discontinuation From Treatment|Adverse Event|343|||
33317716|NCT03057977|101057141|FG001|Discontinuation From Treatment|Adverse Event|337|||
33317717|NCT03057977|101057140|FG000|Discontinuation From Treatment|Reason Unknown|0|||
33317718|NCT03057977|101057141|FG001|Discontinuation From Treatment|Reason Unknown|1|||
33317719|NCT03057977|101057140|FG000|Discontinuation From Treatment|Personal Reasons|1|||
33317720|NCT03057977|101057141|FG001|Discontinuation From Treatment|Personal Reasons|1|||
33317721|NCT03057977|101057140|FG000|Discontinuation From Treatment|Unblinded medication|1|||
33317722|NCT03057977|101057141|FG001|Discontinuation From Treatment|Unblinded medication|0|||
33317723|NCT03057977|101057140|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
33317724|NCT03057977|101057141|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
33317725|NCT03057977|101057140|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
33317726|NCT03057977|101057141|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
33317727|NCT03057977|101057140|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
33317728|NCT03057977|101057141|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
33317729|NCT03057977|101057140|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
33317730|NCT03057977|101057141|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
33317731|NCT03057977|101057140|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
33317732|NCT03057977|101057141|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
33317733|NCT03057977|101057140|FG000|Discontinuation From Treatment|Not attending study visit|3|||
33317734|NCT03057977|101057141|FG001|Discontinuation From Treatment|Not attending study visit|10|||
33317735|NCT03057977|101057140|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
33317736|NCT03057977|101057141|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
33317737|NCT03057977|101057140|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
33317738|NCT03057977|101057141|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
33317739|NCT03057977|101057140|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
33317740|NCT03057977|101057141|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
33317741|NCT03057977|101057140|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
33317742|NCT03057977|101057141|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
33317743|NCT03057977|101057140|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
33317744|NCT03057977|101057141|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
33317745|NCT02901041|101057142|FG000|Overall Study|Withdrawal by PI|4|||
33317746|NCT02901041|101057143|FG001|Overall Study|Withdrawal by PI|8|||
33317747|NCT02901041|101057142|FG000|Overall Study|Withdrawal by Subject|7|||
33317748|NCT02901041|101057143|FG001|Overall Study|Withdrawal by Subject|3|||
33317749|NCT01298518|101057144|FG000|Overall Study|Withdrawal by Subject|0|||
33317750|NCT01298518|101057145|FG001|Overall Study|Withdrawal by Subject|0|||
33317751|NCT01298518|101057146|FG002|Overall Study|Withdrawal by Subject|1|||
33398402|NCT00939341|101345994|FG000|Overall Study|Protocol Violation|6|||
33604300|NCT00664326|102102595|FG000|Overall Study|Noncompliance with study medication|3|||
33317752|NCT01163721|101057147|FG000|Overall Study|Adverse Event|5|||
33317753|NCT01163721|101057148|FG001|Overall Study|Adverse Event|6|||
33317754|NCT01163721|101057147|FG000|Overall Study|Withdrawal by Subject|3|||
33317755|NCT01163721|101057148|FG001|Overall Study|Withdrawal by Subject|4|||
33317756|NCT01163721|101057147|FG000|Overall Study|Lost to Follow-up|0|||
33317757|NCT01163721|101057148|FG001|Overall Study|Lost to Follow-up|1|||
33398403|NCT00939341|101345994|FG000|Overall Study|Incorrect enrolment|8|||
33604301|NCT00664326|102102595|FG000|Overall Study|Withdrawal by Subject|1|||
33604302|NCT00664326|102102595|FG000|Overall Study|Physician Decision|1|||
33604303|NCT00664326|102102595|FG000|Overall Study|Other Reasons|3|||
33604304|NCT00664326|102102595|FG000|Overall Study|Death|2|||
33604305|NCT00664326|102102595|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
33604306|NCT00780273|102102596|FG000|Overall Study|Death|1|||
33317758|NCT01163721|101057147|FG000|Overall Study|Physician Decision|0|||
33317759|NCT01163721|101057148|FG001|Overall Study|Physician Decision|1|||
33398404|NCT02354690|101345995|FG000|Overall Study|Physician Decision|1|||
33604307|NCT00780273|102102596|FG000|Overall Study|Lost to Follow-up|1|||
33507024|NCT01340027|101750947|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
33507025|NCT01340027|101750948|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
33507026|NCT01340027|101750949|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
33197084|NCT01609556|100626434|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33197085|NCT01609556|100626435|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33507027|NCT01340027|101750950|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
33507028|NCT01340027|101750951|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
33507029|NCT01340027|101750952|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
33507030|NCT01340027|101750953|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
33507031|NCT01340027|101750954|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
33507032|NCT01340027|101750955|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
33507033|NCT01340027|101750944|FG000|Overall Study|Adverse Event|0|||
33507034|NCT01340027|101750945|FG001|Overall Study|Adverse Event|1|||
33507035|NCT01340027|101750946|FG002|Overall Study|Adverse Event|2|||
33507036|NCT01340027|101750947|FG003|Overall Study|Adverse Event|0|||
33507037|NCT01340027|101750948|FG004|Overall Study|Adverse Event|1|||
33507038|NCT01340027|101750949|FG005|Overall Study|Adverse Event|2|||
33507039|NCT01340027|101750950|FG006|Overall Study|Adverse Event|2|||
33507040|NCT01340027|101750951|FG007|Overall Study|Adverse Event|1|||
33507041|NCT01340027|101750952|FG008|Overall Study|Adverse Event|4|||
33507042|NCT01340027|101750953|FG009|Overall Study|Adverse Event|1|||
33507043|NCT01340027|101750954|FG010|Overall Study|Adverse Event|1|||
33507044|NCT01340027|101750955|FG011|Overall Study|Adverse Event|3|||
33507045|NCT01340027|101750944|FG000|Overall Study|Lack of Efficacy|0|||
33604308|NCT02621073|102102597|FG000|Overall Study|Lost to Follow-up|0|||
33604309|NCT02621073|102102598|FG001|Overall Study|Lost to Follow-up|1|||
33197086|NCT01609556|100626436|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33197087|NCT01609556|100626437|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33197088|NCT01609556|100626438|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
33197089|NCT01609556|100626423|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33317760|NCT01929980|101057149|FG000|Overall Study|Physician Decision|1|||
33317761|NCT01175356|101057151|FG000|Overall Study|Death|1|||
33317762|NCT01175356|101057151|FG000|Overall Study|Lack of Efficacy|12|||
33317763|NCT01175356|101057151|FG000|Overall Study|Lost to Follow-up|1|||
33317764|NCT01175356|101057151|FG000|Overall Study|Physician Decision|23|||
33317765|NCT01175356|101057151|FG000|Overall Study|Ineligible|1|||
33317766|NCT01175356|101057151|FG000|Overall Study|Treatment Slot Not Available|18|||
33317767|NCT01175356|101057151|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
33317768|NCT01175356|101057151|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
33317769|NCT01175356|101057151|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
33317770|NCT01175356|101057151|FG000|Overall Study|Inadequate stem cell for transplant|1|||
33317771|NCT01175356|101057151|FG000|Overall Study|Initiation other tx prior to completion|9|||
33317772|NCT01067326|101057152|FG000|Overall Study|Adverse Event|0|||
33317773|NCT01067326|101057153|FG001|Overall Study|Adverse Event|2|||
33317774|NCT01067326|101057152|FG000|Overall Study|Withdrawal by Subject|1|||
33317775|NCT01067326|101057153|FG001|Overall Study|Withdrawal by Subject|0|||
33317776|NCT01067326|101057152|FG000|Overall Study|Early Study Termination|1|||
33317777|NCT01067326|101057153|FG001|Overall Study|Early Study Termination|1|||
33317778|NCT01013285|101057154|FG000|Overall Study|Death|48|||
33317779|NCT01013285|101057155|FG001|Overall Study|Death|89|||
33317780|NCT00711529|101057157|FG000|Overall Study|Protocol Violation|2|||
33317781|NCT00711529|101057158|FG001|Overall Study|Protocol Violation|0|||
33317782|NCT00711529|101057157|FG000|Overall Study|Withdrawal by Subject|2|||
33317783|NCT00711529|101057158|FG001|Overall Study|Withdrawal by Subject|6|||
33317784|NCT00292461|101057159|FG000|Overall Study|Adverse Event|4|||
33317785|NCT00292461|101057160|FG001|Overall Study|Adverse Event|2|||
33317786|NCT00292461|101057159|FG000|Overall Study|Lack of Efficacy|1|||
33317787|NCT00292461|101057160|FG001|Overall Study|Lack of Efficacy|0|||
33317788|NCT00292461|101057159|FG000|Overall Study|Withdrawal by Subject|0|||
33317789|NCT00292461|101057160|FG001|Overall Study|Withdrawal by Subject|1|||
33317790|NCT00292461|101057159|FG000|Overall Study|Protocol Violation|4|||
33317791|NCT00292461|101057160|FG001|Overall Study|Protocol Violation|3|||
33398405|NCT03198728|101345997|FG000|Overall Study|Adverse Event|10|||
33197090|NCT01609556|100626424|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33317792|NCT00292461|101057159|FG000|Overall Study|Lost to Follow-up|1|||
33317793|NCT00292461|101057160|FG001|Overall Study|Lost to Follow-up|0|||
33317794|NCT00820027|101057161|FG000|Overall Study|Adverse Event|15|||
33398406|NCT03198728|101345998|FG001|Overall Study|Adverse Event|5|||
33507046|NCT01340027|101750945|FG001|Overall Study|Lack of Efficacy|0|||
33507047|NCT01340027|101750946|FG002|Overall Study|Lack of Efficacy|0|||
33604310|NCT02621073|102102597|FG000|Overall Study|Physician Decision|3|||
33317795|NCT00820027|101057162|FG001|Overall Study|Adverse Event|8|||
33317796|NCT00820027|101057163|FG002|Overall Study|Adverse Event|10|||
33317797|NCT00820027|101057164|FG003|Overall Study|Adverse Event|5|||
33507048|NCT01340027|101750947|FG003|Overall Study|Lack of Efficacy|0|||
33507049|NCT01340027|101750948|FG004|Overall Study|Lack of Efficacy|0|||
33507050|NCT01340027|101750949|FG005|Overall Study|Lack of Efficacy|0|||
33507051|NCT01340027|101750950|FG006|Overall Study|Lack of Efficacy|1|||
33507052|NCT01340027|101750951|FG007|Overall Study|Lack of Efficacy|1|||
33507053|NCT01340027|101750952|FG008|Overall Study|Lack of Efficacy|1|||
33507054|NCT01340027|101750953|FG009|Overall Study|Lack of Efficacy|0|||
33507055|NCT01340027|101750954|FG010|Overall Study|Lack of Efficacy|0|||
33604311|NCT02621073|102102598|FG001|Overall Study|Physician Decision|2|||
33197091|NCT01609556|100626425|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33197092|NCT01609556|100626426|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33197093|NCT01609556|100626427|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33197094|NCT01609556|100626428|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33197095|NCT01609556|100626429|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33197096|NCT01609556|100626430|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33197097|NCT01609556|100626431|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
33197098|NCT01609556|100626432|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33197099|NCT01609556|100626433|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33197100|NCT01609556|100626434|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33197101|NCT01609556|100626435|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33197102|NCT01609556|100626436|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33317798|NCT00820027|101057161|FG000|Overall Study|Lack of Efficacy|2|||
33317799|NCT00820027|101057162|FG001|Overall Study|Lack of Efficacy|1|||
33317800|NCT00820027|101057163|FG002|Overall Study|Lack of Efficacy|2|||
33317801|NCT00820027|101057164|FG003|Overall Study|Lack of Efficacy|2|||
33317802|NCT00820027|101057161|FG000|Overall Study|Physician Decision|0|||
33317803|NCT00820027|101057162|FG001|Overall Study|Physician Decision|1|||
33317804|NCT00820027|101057163|FG002|Overall Study|Physician Decision|1|||
33317805|NCT00820027|101057164|FG003|Overall Study|Physician Decision|0|||
33317806|NCT00820027|101057161|FG000|Overall Study|Protocol Violation|3|||
33398407|NCT03198728|101345997|FG000|Overall Study|Lost to Follow-up|21|||
33398408|NCT03198728|101345998|FG001|Overall Study|Lost to Follow-up|7|||
33604312|NCT03689712|102102599|FG000|Overall Study|Adverse Event|1|||
33197103|NCT01609556|100626437|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33317807|NCT00820027|101057162|FG001|Overall Study|Protocol Violation|0|||
33317808|NCT00820027|101057163|FG002|Overall Study|Protocol Violation|4|||
33317809|NCT00820027|101057164|FG003|Overall Study|Protocol Violation|0|||
33317810|NCT00820027|101057161|FG000|Overall Study|Withdrawal by Subject|6|||
33317811|NCT00820027|101057162|FG001|Overall Study|Withdrawal by Subject|4|||
33317812|NCT00820027|101057163|FG002|Overall Study|Withdrawal by Subject|4|||
33197104|NCT01609556|100626438|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
33197105|NCT01609556|100626423|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
33197106|NCT01609556|100626424|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33197107|NCT01609556|100626425|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33197108|NCT01609556|100626426|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33197109|NCT01609556|100626427|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33197110|NCT01609556|100626428|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
33197111|NCT01609556|100626429|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33197112|NCT01609556|100626430|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33197113|NCT01609556|100626431|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33197114|NCT01609556|100626432|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33197115|NCT01609556|100626433|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
33197116|NCT01609556|100626434|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33197117|NCT01609556|100626435|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33197118|NCT01609556|100626436|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33197119|NCT01609556|100626437|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33197120|NCT01609556|100626438|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
33197121|NCT01609556|100626423|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33197122|NCT01609556|100626424|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33317813|NCT00820027|101057164|FG003|Overall Study|Withdrawal by Subject|6|||
33317814|NCT00026208|101057168|FG000|Overall Study|Complications of auto accident|1|||
33317815|NCT00026208|101057169|FG001|Overall Study|Complications of auto accident|0|||
33317816|NCT04223830|101057170|FG000|Overall Study|Lost to Follow-up|9|||
33317817|NCT04223830|101057170|FG000|Overall Study|Adverse Event|1|||
33317818|NCT04526197|101057171|FG000|Period 1|Adverse Event|0|||
33317819|NCT04526197|101057172|FG001|Period 1|Adverse Event|1|||
33317820|NCT04526197|101057171|FG000|Period 1|Withdrawal by Subject|1|||
33317821|NCT04526197|101057172|FG001|Period 1|Withdrawal by Subject|0|||
33317822|NCT04526197|101057171|FG000|Period 2|Adverse Event|0|||
33317823|NCT04526197|101057172|FG001|Period 2|Adverse Event|1|||
33317824|NCT04526197|101057171|FG000|Period 2|Withdrawal by Subject|0|||
33317825|NCT04526197|101057172|FG001|Period 2|Withdrawal by Subject|1|||
33317826|NCT01026454|101057175|FG000|Second Intervention|Pregnancy|1|||
33317827|NCT01026454|101057176|FG001|Second Intervention|Pregnancy|1|||
33317828|NCT01201343|101059977|FG000|Overall Study|Adverse Event|6|||
33317829|NCT01201343|101059977|FG000|Overall Study|Withdrawal by Subject|5|||
33317830|NCT01201343|101059977|FG000|Overall Study|Lost to Follow-up|2|||
33317831|NCT01201343|101059977|FG000|Overall Study|Lack of Efficacy|2|||
33317832|NCT01201343|101059977|FG000|Overall Study|Participant wrongly included in trial|1|||
33317833|NCT01201343|101059977|FG000|Overall Study|Randomized, not treated|3|||
33317834|NCT02469896|101059978|FG000|Overall Study|Withdrawal by Subject|2|||
33317835|NCT02469896|101059979|FG001|Overall Study|Withdrawal by Subject|0|||
33317836|NCT03678103|101059984|FG000|Overall Study|Withdrawn prior to completion|4|||
33317837|NCT03756350|101059985|FG000|Overall Study|Lost to Follow-up|1|||
33317838|NCT03181451|101059988|FG000|Overall Study|Adverse Event|0|||
33317839|NCT03181451|101059989|FG001|Overall Study|Adverse Event|1|||
33317840|NCT03181451|101059990|FG002|Overall Study|Adverse Event|0|||
33317841|NCT03181451|101059988|FG000|Overall Study|Withdrawal by Subject|0|||
33317842|NCT03181451|101059989|FG001|Overall Study|Withdrawal by Subject|1|||
33317843|NCT03181451|101059990|FG002|Overall Study|Withdrawal by Subject|0|||
33317844|NCT00778622|101059992|FG000|Overall Study|Adverse Event|5|||
33317845|NCT00778622|101059993|FG001|Overall Study|Adverse Event|4|||
33317846|NCT00778622|101059994|FG002|Overall Study|Adverse Event|7|||
33317847|NCT00778622|101059992|FG000|Overall Study|Withdrawal by Subject|4|||
33317848|NCT00778622|101059993|FG001|Overall Study|Withdrawal by Subject|5|||
33317849|NCT00778622|101059994|FG002|Overall Study|Withdrawal by Subject|5|||
33317850|NCT00778622|101059992|FG000|Overall Study|Lost to Follow-up|3|||
33317851|NCT00778622|101059993|FG001|Overall Study|Lost to Follow-up|3|||
33317852|NCT00778622|101059994|FG002|Overall Study|Lost to Follow-up|2|||
33604313|NCT03689712|102102600|FG001|Overall Study|Adverse Event|0|||
33317853|NCT00778622|101059992|FG000|Overall Study|Protocol Violation|0|||
33317854|NCT00778622|101059993|FG001|Overall Study|Protocol Violation|3|||
33317855|NCT00778622|101059994|FG002|Overall Study|Protocol Violation|0|||
33317856|NCT00778622|101059992|FG000|Overall Study|Lack of Efficacy|2|||
33317857|NCT00778622|101059993|FG001|Overall Study|Lack of Efficacy|0|||
33317858|NCT00778622|101059994|FG002|Overall Study|Lack of Efficacy|0|||
33317859|NCT00778622|101059992|FG000|Overall Study|immigration|1|||
33317860|NCT00778622|101059993|FG001|Overall Study|immigration|0|||
33317861|NCT00778622|101059994|FG002|Overall Study|immigration|0|||
33317862|NCT00778622|101059992|FG000|Overall Study|Other|1|||
33317863|NCT00778622|101059993|FG001|Overall Study|Other|0|||
33317864|NCT00778622|101059994|FG002|Overall Study|Other|1|||
33317865|NCT00792805|101059995|FG000|Overall Study|Adverse Event|12|||
33317866|NCT00792805|101059996|FG001|Overall Study|Adverse Event|10|||
33317867|NCT00792805|101059997|FG002|Overall Study|Adverse Event|10|||
33317868|NCT00792805|101059995|FG000|Overall Study|Subject withdrew consent|5|||
33317869|NCT00792805|101059996|FG001|Overall Study|Subject withdrew consent|6|||
33317870|NCT00792805|101059997|FG002|Overall Study|Subject withdrew consent|5|||
33317871|NCT00792805|101059995|FG000|Overall Study|Administrative problems|2|||
33317872|NCT00792805|101059996|FG001|Overall Study|Administrative problems|0|||
33317873|NCT00792805|101059997|FG002|Overall Study|Administrative problems|4|||
33317874|NCT00792805|101059995|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33317875|NCT00792805|101059996|FG001|Overall Study|Abnormal test procedure result(s)|2|||
33507056|NCT01340027|101750955|FG011|Overall Study|Lack of Efficacy|0|||
33507057|NCT01340027|101750944|FG000|Overall Study|Lost to Follow-up|0|||
33317876|NCT00792805|101059997|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33317877|NCT00792805|101059995|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33317878|NCT00792805|101059996|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
33317879|NCT00792805|101059997|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
33317880|NCT00792805|101059995|FG000|Overall Study|Lost to Follow-up|1|||
33317881|NCT00792805|101059996|FG001|Overall Study|Lost to Follow-up|1|||
33317882|NCT00792805|101059997|FG002|Overall Study|Lost to Follow-up|6|||
33317883|NCT00792805|101059995|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33317884|NCT00792805|101059996|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33317885|NCT00792805|101059997|FG002|Overall Study|Abnormal laboratory value(s)|1|||
33317886|NCT00792805|101059995|FG000|Overall Study|Protocol deviation|0|||
33317887|NCT00792805|101059996|FG001|Overall Study|Protocol deviation|1|||
33317888|NCT00792805|101059997|FG002|Overall Study|Protocol deviation|1|||
33317889|NCT03707925|101059998|FG000|Overall Study|Inevaluable|1|||
33317890|NCT01290601|101059999|FG000|Overall Study|Adverse Event|0|||
33317891|NCT01290601|101060000|FG001|Overall Study|Adverse Event|2|||
33317892|NCT01290601|101060001|FG002|Overall Study|Adverse Event|0|||
33317893|NCT01290601|101060002|FG003|Overall Study|Adverse Event|0|||
33398409|NCT03198728|101345997|FG000|Overall Study|Physician Decision|7|||
33398410|NCT03198728|101345998|FG001|Overall Study|Physician Decision|2|||
33398411|NCT03198728|101345997|FG000|Overall Study|Withdrawal by Subject|14|||
33398412|NCT03198728|101345998|FG001|Overall Study|Withdrawal by Subject|10|||
33398413|NCT02994927|101345999|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33398414|NCT02994927|101346000|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33398415|NCT02994927|101345999|FG000|Overall Study|Did not meet eligibility criteria|0|||
33398416|NCT02994927|101346000|FG001|Overall Study|Did not meet eligibility criteria|1|||
33398417|NCT02994927|101345999|FG000|Overall Study|Physician Decision|4|||
33398418|NCT02994927|101346000|FG001|Overall Study|Physician Decision|3|||
33398419|NCT02994927|101345999|FG000|Overall Study|Death|4|||
33398420|NCT02994927|101346000|FG001|Overall Study|Death|2|||
33398421|NCT02994927|101345999|FG000|Overall Study|Adverse Event|2|||
33507058|NCT01340027|101750945|FG001|Overall Study|Lost to Follow-up|1|||
33507059|NCT01340027|101750946|FG002|Overall Study|Lost to Follow-up|0|||
33507060|NCT01340027|101750947|FG003|Overall Study|Lost to Follow-up|0|||
33507061|NCT01340027|101750948|FG004|Overall Study|Lost to Follow-up|0|||
33507062|NCT01340027|101750949|FG005|Overall Study|Lost to Follow-up|0|||
33507063|NCT01340027|101750950|FG006|Overall Study|Lost to Follow-up|1|||
33507064|NCT01340027|101750951|FG007|Overall Study|Lost to Follow-up|0|||
33507065|NCT01340027|101750952|FG008|Overall Study|Lost to Follow-up|0|||
33507066|NCT01340027|101750953|FG009|Overall Study|Lost to Follow-up|1|||
33507067|NCT01340027|101750954|FG010|Overall Study|Lost to Follow-up|0|||
33507068|NCT01340027|101750955|FG011|Overall Study|Lost to Follow-up|0|||
33507069|NCT01340027|101750944|FG000|Overall Study|Protocol Violation|1|||
33507070|NCT01340027|101750945|FG001|Overall Study|Protocol Violation|2|||
33507071|NCT01340027|101750946|FG002|Overall Study|Protocol Violation|0|||
33507072|NCT01340027|101750947|FG003|Overall Study|Protocol Violation|0|||
33317894|NCT01290601|101059999|FG000|Overall Study|Lack of Efficacy|2|||
33317895|NCT01290601|101060000|FG001|Overall Study|Lack of Efficacy|1|||
33317896|NCT01290601|101060001|FG002|Overall Study|Lack of Efficacy|0|||
33317897|NCT01290601|101060002|FG003|Overall Study|Lack of Efficacy|0|||
33317898|NCT01290601|101059999|FG000|Overall Study|Lost to Follow-up|7|||
33507073|NCT01340027|101750948|FG004|Overall Study|Protocol Violation|6|||
33317899|NCT01290601|101060000|FG001|Overall Study|Lost to Follow-up|2|||
33317900|NCT01290601|101060001|FG002|Overall Study|Lost to Follow-up|0|||
33317901|NCT01290601|101060002|FG003|Overall Study|Lost to Follow-up|0|||
33317902|NCT01290601|101059999|FG000|Overall Study|Other|1|||
33507074|NCT01340027|101750949|FG005|Overall Study|Protocol Violation|0|||
33507075|NCT01340027|101750950|FG006|Overall Study|Protocol Violation|0|||
33317903|NCT01290601|101060000|FG001|Overall Study|Other|0|||
33507076|NCT01340027|101750951|FG007|Overall Study|Protocol Violation|1|||
33507077|NCT01340027|101750952|FG008|Overall Study|Protocol Violation|2|||
33507078|NCT01340027|101750953|FG009|Overall Study|Protocol Violation|2|||
33507079|NCT01340027|101750954|FG010|Overall Study|Protocol Violation|0|||
33317904|NCT01290601|101060001|FG002|Overall Study|Other|0|||
33317905|NCT01290601|101060002|FG003|Overall Study|Other|0|||
33317906|NCT01290601|101059999|FG000|Overall Study|Protocol Violation|1|||
33317907|NCT01290601|101060000|FG001|Overall Study|Protocol Violation|0|||
33317908|NCT01290601|101060001|FG002|Overall Study|Protocol Violation|0|||
33317909|NCT01290601|101060002|FG003|Overall Study|Protocol Violation|0|||
33317910|NCT01231516|101060003|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
33317911|NCT01231516|101060004|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
33317912|NCT01231516|101060003|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
33317913|NCT01231516|101060004|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
33317914|NCT01231516|101060003|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
33317915|NCT01231516|101060004|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
33317916|NCT01231516|101060003|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
33317917|NCT01231516|101060004|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
33317918|NCT01231516|101060003|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
33317919|NCT01231516|101060004|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
33317920|NCT01231516|101060003|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
33317921|NCT01231516|101060004|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
33317922|NCT01231516|101060003|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
33317923|NCT01231516|101060004|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
33317924|NCT01231516|101060003|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
33317925|NCT01231516|101060004|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
33317926|NCT01231516|101060003|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
33507080|NCT01340027|101750955|FG011|Overall Study|Protocol Violation|0|||
33507081|NCT01340027|101750944|FG000|Overall Study|Withdrawal by Subject|4|||
33507082|NCT01340027|101750945|FG001|Overall Study|Withdrawal by Subject|3|||
33507083|NCT01340027|101750946|FG002|Overall Study|Withdrawal by Subject|1|||
33507084|NCT01340027|101750947|FG003|Overall Study|Withdrawal by Subject|3|||
33507085|NCT01340027|101750948|FG004|Overall Study|Withdrawal by Subject|3|||
33507086|NCT01340027|101750949|FG005|Overall Study|Withdrawal by Subject|2|||
33507087|NCT01340027|101750950|FG006|Overall Study|Withdrawal by Subject|3|||
33507088|NCT01340027|101750951|FG007|Overall Study|Withdrawal by Subject|4|||
33507089|NCT01340027|101750952|FG008|Overall Study|Withdrawal by Subject|1|||
33507090|NCT01340027|101750953|FG009|Overall Study|Withdrawal by Subject|2|||
33507091|NCT01340027|101750954|FG010|Overall Study|Withdrawal by Subject|0|||
33507092|NCT01340027|101750955|FG011|Overall Study|Withdrawal by Subject|1|||
33507093|NCT01340027|101750944|FG000|Overall Study|Miscellaneous|0|||
33507094|NCT01340027|101750945|FG001|Overall Study|Miscellaneous|0|||
33507095|NCT01340027|101750946|FG002|Overall Study|Miscellaneous|0|||
33507096|NCT01340027|101750947|FG003|Overall Study|Miscellaneous|1|||
33507097|NCT01340027|101750948|FG004|Overall Study|Miscellaneous|0|||
33507098|NCT01340027|101750949|FG005|Overall Study|Miscellaneous|0|||
33507099|NCT01340027|101750950|FG006|Overall Study|Miscellaneous|0|||
33507100|NCT01340027|101750951|FG007|Overall Study|Miscellaneous|0|||
33507101|NCT01340027|101750952|FG008|Overall Study|Miscellaneous|0|||
33507102|NCT01340027|101750953|FG009|Overall Study|Miscellaneous|0|||
33507103|NCT01340027|101750954|FG010|Overall Study|Miscellaneous|1|||
33507104|NCT01340027|101750955|FG011|Overall Study|Miscellaneous|0|||
33507105|NCT02805660|101750956|FG000|Overall Study|Death|5|||
33507106|NCT02805660|101750957|FG001|Overall Study|Death|2|||
33507107|NCT02805660|101750958|FG002|Overall Study|Death|9|||
33507108|NCT02805660|101750959|FG003|Overall Study|Death|5|||
33507109|NCT02805660|101750960|FG004|Overall Study|Death|0|||
33507110|NCT02805660|101750961|FG005|Overall Study|Death|14|||
33507111|NCT02805660|101750962|FG006|Overall Study|Death|12|||
33507112|NCT02805660|101750956|FG000|Overall Study|Lost to Follow-up|0|||
33507113|NCT02805660|101750957|FG001|Overall Study|Lost to Follow-up|1|||
33507114|NCT02805660|101750958|FG002|Overall Study|Lost to Follow-up|1|||
33507115|NCT02805660|101750959|FG003|Overall Study|Lost to Follow-up|2|||
33507116|NCT02805660|101750960|FG004|Overall Study|Lost to Follow-up|0|||
33507117|NCT02805660|101750961|FG005|Overall Study|Lost to Follow-up|0|||
33507118|NCT02805660|101750962|FG006|Overall Study|Lost to Follow-up|0|||
33507119|NCT02805660|101750956|FG000|Overall Study|Withdrawal by Subject|0|||
33364914|NCT01790438|101223682|FG000|Overall Study|Withdrawal by Subject|13|||
33507120|NCT02805660|101750957|FG001|Overall Study|Withdrawal by Subject|0|||
33507121|NCT02805660|101750958|FG002|Overall Study|Withdrawal by Subject|0|||
33507122|NCT02805660|101750959|FG003|Overall Study|Withdrawal by Subject|3|||
33507123|NCT02805660|101750960|FG004|Overall Study|Withdrawal by Subject|1|||
33507124|NCT02805660|101750961|FG005|Overall Study|Withdrawal by Subject|0|||
33507125|NCT02805660|101750962|FG006|Overall Study|Withdrawal by Subject|2|||
33507126|NCT02805660|101750956|FG000|Overall Study|Study terminated by Sponsor|0|||
33317927|NCT01231516|101060004|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
33317928|NCT01231516|101060003|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
33317929|NCT01231516|101060004|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
33317930|NCT01231516|101060003|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
33317931|NCT01231516|101060004|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
33317932|NCT01231516|101060003|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
33317933|NCT01231516|101060004|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
33317934|NCT01231516|101060003|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
33317935|NCT01231516|101060004|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
33317936|NCT01231516|101060003|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
33317937|NCT01231516|101060004|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
33317938|NCT01231516|101060003|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
33317939|NCT01231516|101060004|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
33317940|NCT01231516|101060003|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
33317941|NCT01231516|101060004|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
33317942|NCT00056862|101060005|FG000|Overall Study|Protocol Violation|1|||
33317943|NCT00056862|101060006|FG001|Overall Study|Protocol Violation|0|||
33317944|NCT01211197|101060007|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33317945|NCT01211197|101060008|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33317946|NCT01211197|101060009|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
33317947|NCT01211197|101060010|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33317948|NCT01211197|101060011|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33317949|NCT01211197|101060012|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33317950|NCT01211197|101060007|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
33317951|NCT01211197|101060008|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
33317952|NCT01211197|101060009|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
33317953|NCT01211197|101060010|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
33317954|NCT01211197|101060011|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
33317955|NCT01211197|101060012|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
33317956|NCT00887679|101060013|FG000|Overall Study|Withdrawal by Subject|1|||
33317957|NCT00887679|101060013|FG000|Overall Study|Lost to Follow-up|4|||
33317958|NCT00887679|101060013|FG000|Overall Study|Physician Decision|5|||
33317959|NCT00412971|101060016|FG000|Overall Study|Lost to Follow-up|17|||
33317960|NCT00412971|101060017|FG001|Overall Study|Lost to Follow-up|9|||
33317961|NCT00412971|101060016|FG000|Overall Study|Protocol Violation|13|||
33317962|NCT00412971|101060017|FG001|Overall Study|Protocol Violation|1|||
33317963|NCT02196714|101060020|FG000|Overall Study|Protocol Violation|0|||
33317964|NCT02196714|101060021|FG001|Overall Study|Protocol Violation|0|||
33317965|NCT02196714|101060022|FG002|Overall Study|Protocol Violation|1|||
33317966|NCT02196714|101060023|FG003|Overall Study|Protocol Violation|0|||
33317967|NCT01388790|101060024|FG000|Overall Study|Ongoing at data cut-off date|8|||
33317968|NCT00775450|101060026|FG000|Overall Study|Serious Adverse Event|2|||
33317969|NCT00775450|101060027|FG001|Overall Study|Serious Adverse Event|0|||
33317970|NCT00775450|101060028|FG002|Overall Study|Serious Adverse Event|0|||
33317971|NCT00775450|101060029|FG003|Overall Study|Serious Adverse Event|0|||
33317972|NCT00775450|101060030|FG004|Overall Study|Serious Adverse Event|0|||
33317973|NCT00775450|101060026|FG000|Overall Study|Protocol Violation|0|||
33317974|NCT00775450|101060027|FG001|Overall Study|Protocol Violation|0|||
33317975|NCT00775450|101060028|FG002|Overall Study|Protocol Violation|0|||
33317976|NCT00775450|101060029|FG003|Overall Study|Protocol Violation|0|||
33317977|NCT00775450|101060030|FG004|Overall Study|Protocol Violation|1|||
33317978|NCT00775450|101060026|FG000|Overall Study|Withdrawal by Subject|1|||
33317979|NCT00775450|101060027|FG001|Overall Study|Withdrawal by Subject|0|||
33317980|NCT00775450|101060028|FG002|Overall Study|Withdrawal by Subject|0|||
33317981|NCT00775450|101060029|FG003|Overall Study|Withdrawal by Subject|0|||
33317982|NCT00775450|101060030|FG004|Overall Study|Withdrawal by Subject|1|||
33317983|NCT01791803|101060031|FG000|Overall Study|Withdrawal by Subject|0|||
33317984|NCT01791803|101060032|FG001|Overall Study|Withdrawal by Subject|0|||
33317985|NCT01791803|101060033|FG002|Overall Study|Withdrawal by Subject|0|||
33317986|NCT01791803|101060034|FG003|Overall Study|Withdrawal by Subject|2|||
33317987|NCT01791803|101060031|FG000|Overall Study|Physician Decision|0|||
33317988|NCT01791803|101060032|FG001|Overall Study|Physician Decision|2|||
33317989|NCT01791803|101060033|FG002|Overall Study|Physician Decision|0|||
33317990|NCT01791803|101060034|FG003|Overall Study|Physician Decision|1|||
33317991|NCT01791803|101060031|FG000|Overall Study|Death|0|||
33317992|NCT01791803|101060032|FG001|Overall Study|Death|0|||
33317993|NCT01791803|101060033|FG002|Overall Study|Death|2|||
33317994|NCT01791803|101060034|FG003|Overall Study|Death|2|||
33317995|NCT01137955|101060037|FG000|Overall Study|Withdrawal by Subject|5|||
33317996|NCT01137955|101060038|FG001|Overall Study|Withdrawal by Subject|4|||
33317997|NCT02054325|101060039|FG000|Overall Study|Lost to Follow-up|8|||
33317998|NCT02054325|101060040|FG001|Overall Study|Lost to Follow-up|5|||
33317999|NCT03357952|101060045|FG000|Overall Study|Withdrawal by Subject|0|||
33398422|NCT02994927|101346000|FG001|Overall Study|Adverse Event|1|||
33318000|NCT03357952|101060046|FG001|Overall Study|Withdrawal by Subject|1|||
33318001|NCT03357952|101060045|FG000|Overall Study|Sponsor Decision|9|||
33318002|NCT03357952|101060046|FG001|Overall Study|Sponsor Decision|0|||
33318003|NCT00084266|101060047|FG000|Overall Study|Death|42|||
33318004|NCT00084266|101060048|FG001|Overall Study|Death|39|||
33318005|NCT00084266|101060047|FG000|Overall Study|Adverse Event|8|||
33318006|NCT00084266|101060048|FG001|Overall Study|Adverse Event|5|||
33318007|NCT00084266|101060047|FG000|Overall Study|Lack of Efficacy|2|||
33318008|NCT00084266|101060048|FG001|Overall Study|Lack of Efficacy|4|||
33318009|NCT00084266|101060047|FG000|Overall Study|Lost to Follow-up|5|||
33318010|NCT00084266|101060048|FG001|Overall Study|Lost to Follow-up|3|||
33318011|NCT00084266|101060047|FG000|Overall Study|Participant not willing to participate|3|||
33318012|NCT00084266|101060048|FG001|Overall Study|Participant not willing to participate|8|||
33318013|NCT00084266|101060047|FG000|Overall Study|Other|360|||
33318014|NCT00084266|101060048|FG001|Overall Study|Other|344|||
33318015|NCT00084266|101060047|FG000|Overall Study|Randomized not treated|21|||
33318016|NCT00084266|101060048|FG001|Overall Study|Randomized not treated|20|||
33318017|NCT01101477|101060049|FG000|Overall Study|Protocol Violation|5|||
33318018|NCT01101477|101060050|FG001|Overall Study|Protocol Violation|3|||
33318019|NCT01101477|101060051|FG002|Overall Study|Protocol Violation|1|||
33318020|NCT01933113|101060055|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
33318021|NCT00564018|101060058|FG000|Overall Study|Withdrawal by Subject|2|||
33318022|NCT00564018|101060059|FG001|Overall Study|Withdrawal by Subject|3|||
33318023|NCT00564018|101060060|FG002|Overall Study|Withdrawal by Subject|1|||
33318024|NCT00823901|101060065|FG000|Overall Study|Adverse Event|1|||
33318025|NCT00823901|101060066|FG001|Overall Study|Adverse Event|1|||
33318026|NCT00823901|101060065|FG000|Overall Study|Lack of Efficacy|1|||
33318027|NCT00823901|101060066|FG001|Overall Study|Lack of Efficacy|0|||
33318028|NCT00823901|101060065|FG000|Overall Study|Lost to Follow-up|2|||
33318029|NCT00823901|101060066|FG001|Overall Study|Lost to Follow-up|1|||
33318030|NCT02456662|101060069|FG000|Overall Study|Lost to Follow-up|2|||
33318031|NCT02456662|101060070|FG001|Overall Study|Lost to Follow-up|1|||
33318032|NCT00867113|101060071|FG000|Treatment Period|Adverse Event|15|||
33318033|NCT00867113|101060071|FG000|Treatment Period|Death|2|||
33318034|NCT00867113|101060071|FG000|Treatment Period|Withdrawal by Subject|19|||
33318035|NCT00867113|101060071|FG000|Treatment Period|Lost to Follow-up|3|||
33318036|NCT00867113|101060071|FG000|Treatment Period|Administrative problems|1|||
33318037|NCT00867113|101060071|FG000|Treatment Period|Disease progression/relapse|1|||
33318038|NCT00867113|101060071|FG000|Treatment Period|Protocol Violation|4|||
33318039|NCT00867113|101060071|FG000|Post Treatment After Survival Follow-up|Death|1|||
33318040|NCT00867113|101060071|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
33318041|NCT00867113|101060071|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
33318042|NCT00867113|101060071|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
33318043|NCT00954421|101060074|FG000|Screening|screen failures|3|||
33318044|NCT00954421|101060074|FG000|6 Months of DBS|Withdrawal by Subject|1|||
33318045|NCT00954421|101060074|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
33318046|NCT01968070|101060075|FG000|Period 1|Withdrawal by Subject|0|||
33318047|NCT01968070|101060076|FG001|Period 1|Withdrawal by Subject|1|||
33318048|NCT01968070|101060077|FG002|Period 1|Withdrawal by Subject|0|||
33318049|NCT01968070|101060078|FG003|Period 1|Withdrawal by Subject|0|||
33318050|NCT01968070|101060079|FG004|Period 1|Withdrawal by Subject|0|||
33318051|NCT01968070|101060080|FG005|Period 1|Withdrawal by Subject|0|||
33318052|NCT01968070|101060081|FG006|Period 1|Withdrawal by Subject|1|||
33318053|NCT01968070|101060082|FG007|Period 1|Withdrawal by Subject|0|||
33318054|NCT01968070|101060083|FG008|Period 1|Withdrawal by Subject|0|||
33318055|NCT01968070|101060084|FG009|Period 1|Withdrawal by Subject|0|||
33318056|NCT01968070|101060085|FG010|Period 1|Withdrawal by Subject|0|||
33318057|NCT01968070|101060086|FG011|Period 1|Withdrawal by Subject|0|||
33318058|NCT01968070|101060087|FG012|Period 1|Withdrawal by Subject|0|||
33318059|NCT01968070|101060088|FG013|Period 1|Withdrawal by Subject|0|||
33318060|NCT01968070|101060089|FG014|Period 1|Withdrawal by Subject|0|||
33318061|NCT01968070|101060090|FG015|Period 1|Withdrawal by Subject|1|||
33318062|NCT01968070|101060091|FG016|Period 1|Withdrawal by Subject|0|||
33318063|NCT01968070|101060092|FG017|Period 1|Withdrawal by Subject|0|||
33318064|NCT01968070|101060075|FG000|Period 1|Protocol Violation|0|||
33318065|NCT01968070|101060076|FG001|Period 1|Protocol Violation|0|||
33318066|NCT01968070|101060077|FG002|Period 1|Protocol Violation|0|||
33318067|NCT01968070|101060078|FG003|Period 1|Protocol Violation|1|||
33318068|NCT01968070|101060079|FG004|Period 1|Protocol Violation|1|||
33318069|NCT01968070|101060080|FG005|Period 1|Protocol Violation|0|||
33318070|NCT01968070|101060081|FG006|Period 1|Protocol Violation|0|||
33318071|NCT01968070|101060082|FG007|Period 1|Protocol Violation|0|||
33318072|NCT01968070|101060083|FG008|Period 1|Protocol Violation|0|||
33318073|NCT01968070|101060084|FG009|Period 1|Protocol Violation|0|||
33318074|NCT01968070|101060085|FG010|Period 1|Protocol Violation|0|||
33318075|NCT01968070|101060086|FG011|Period 1|Protocol Violation|0|||
33318076|NCT01968070|101060087|FG012|Period 1|Protocol Violation|0|||
33318077|NCT01968070|101060088|FG013|Period 1|Protocol Violation|0|||
33318078|NCT01968070|101060089|FG014|Period 1|Protocol Violation|0|||
33318079|NCT01968070|101060090|FG015|Period 1|Protocol Violation|0|||
33318080|NCT01968070|101060091|FG016|Period 1|Protocol Violation|0|||
33318081|NCT01968070|101060092|FG017|Period 1|Protocol Violation|0|||
33318082|NCT01968070|101060075|FG000|Period 1|Lost to Follow-up|0|||
33318083|NCT01968070|101060076|FG001|Period 1|Lost to Follow-up|0|||
33604314|NCT03689712|102102599|FG000|Overall Study|Death|20|||
33604315|NCT03689712|102102600|FG001|Overall Study|Death|10|||
33604316|NCT03689712|102102599|FG000|Overall Study|Lost to Follow-up|6|||
33604317|NCT03689712|102102600|FG001|Overall Study|Lost to Follow-up|6|||
33318084|NCT01968070|101060077|FG002|Period 1|Lost to Follow-up|0|||
33318085|NCT01968070|101060078|FG003|Period 1|Lost to Follow-up|1|||
33318086|NCT01968070|101060079|FG004|Period 1|Lost to Follow-up|0|||
33318087|NCT01968070|101060080|FG005|Period 1|Lost to Follow-up|0|||
33318088|NCT01968070|101060081|FG006|Period 1|Lost to Follow-up|0|||
33318089|NCT01968070|101060082|FG007|Period 1|Lost to Follow-up|0|||
33318090|NCT01968070|101060083|FG008|Period 1|Lost to Follow-up|0|||
33318091|NCT01968070|101060084|FG009|Period 1|Lost to Follow-up|0|||
33318092|NCT01968070|101060085|FG010|Period 1|Lost to Follow-up|0|||
33318093|NCT01968070|101060086|FG011|Period 1|Lost to Follow-up|0|||
33318094|NCT01968070|101060087|FG012|Period 1|Lost to Follow-up|0|||
33318095|NCT01968070|101060088|FG013|Period 1|Lost to Follow-up|0|||
33318096|NCT01968070|101060089|FG014|Period 1|Lost to Follow-up|0|||
33318097|NCT01968070|101060090|FG015|Period 1|Lost to Follow-up|0|||
33318098|NCT01968070|101060091|FG016|Period 1|Lost to Follow-up|0|||
33318099|NCT01968070|101060092|FG017|Period 1|Lost to Follow-up|0|||
33318100|NCT01968070|101060075|FG000|Period 1|Adverse Event|0|||
33318101|NCT01968070|101060076|FG001|Period 1|Adverse Event|0|||
33318102|NCT01968070|101060077|FG002|Period 1|Adverse Event|0|||
33318103|NCT01968070|101060078|FG003|Period 1|Adverse Event|0|||
33318104|NCT01968070|101060079|FG004|Period 1|Adverse Event|0|||
33318105|NCT01968070|101060080|FG005|Period 1|Adverse Event|0|||
33318106|NCT01968070|101060081|FG006|Period 1|Adverse Event|1|||
33318107|NCT01968070|101060082|FG007|Period 1|Adverse Event|0|||
33318108|NCT01968070|101060083|FG008|Period 1|Adverse Event|0|||
33318109|NCT01968070|101060084|FG009|Period 1|Adverse Event|0|||
33318110|NCT01968070|101060085|FG010|Period 1|Adverse Event|0|||
33318111|NCT01968070|101060086|FG011|Period 1|Adverse Event|0|||
33318112|NCT01968070|101060087|FG012|Period 1|Adverse Event|0|||
33318113|NCT01968070|101060088|FG013|Period 1|Adverse Event|0|||
33318114|NCT01968070|101060089|FG014|Period 1|Adverse Event|0|||
33318115|NCT01968070|101060090|FG015|Period 1|Adverse Event|0|||
33318116|NCT01968070|101060091|FG016|Period 1|Adverse Event|0|||
33318117|NCT01968070|101060092|FG017|Period 1|Adverse Event|0|||
33318118|NCT01968070|101060075|FG000|Period 1|Physician Decision|0|||
33318119|NCT01968070|101060076|FG001|Period 1|Physician Decision|0|||
33318120|NCT01968070|101060077|FG002|Period 1|Physician Decision|0|||
33318121|NCT01968070|101060078|FG003|Period 1|Physician Decision|0|||
33318122|NCT01968070|101060079|FG004|Period 1|Physician Decision|0|||
33318123|NCT01968070|101060080|FG005|Period 1|Physician Decision|0|||
33318124|NCT01968070|101060081|FG006|Period 1|Physician Decision|0|||
33318125|NCT01968070|101060082|FG007|Period 1|Physician Decision|0|||
33318126|NCT01968070|101060083|FG008|Period 1|Physician Decision|0|||
33318127|NCT01968070|101060084|FG009|Period 1|Physician Decision|0|||
33318128|NCT01968070|101060085|FG010|Period 1|Physician Decision|0|||
33318129|NCT01968070|101060086|FG011|Period 1|Physician Decision|1|||
33318130|NCT01968070|101060087|FG012|Period 1|Physician Decision|0|||
33318131|NCT01968070|101060088|FG013|Period 1|Physician Decision|0|||
33318132|NCT01968070|101060089|FG014|Period 1|Physician Decision|0|||
33318133|NCT01968070|101060090|FG015|Period 1|Physician Decision|0|||
33318134|NCT01968070|101060091|FG016|Period 1|Physician Decision|0|||
33318135|NCT01968070|101060092|FG017|Period 1|Physician Decision|0|||
33318136|NCT01968070|101060075|FG000|Period 2|Withdrawal by Subject|0|||
33318137|NCT01968070|101060076|FG001|Period 2|Withdrawal by Subject|0|||
33507127|NCT02805660|101750957|FG001|Overall Study|Study terminated by Sponsor|0|||
33507128|NCT02805660|101750958|FG002|Overall Study|Study terminated by Sponsor|1|||
33318138|NCT01968070|101060077|FG002|Period 2|Withdrawal by Subject|0|||
33398423|NCT02994927|101345999|FG000|Overall Study|Withdrawal by Subject|3|||
33507129|NCT02805660|101750959|FG003|Overall Study|Study terminated by Sponsor|4|||
33507130|NCT02805660|101750960|FG004|Overall Study|Study terminated by Sponsor|2|||
33604318|NCT03689712|102102599|FG000|Overall Study|Other|1|||
33318139|NCT01968070|101060078|FG003|Period 2|Withdrawal by Subject|0|||
33318140|NCT01968070|101060079|FG004|Period 2|Withdrawal by Subject|1|||
33604319|NCT03689712|102102600|FG001|Overall Study|Other|0|||
33318141|NCT01968070|101060080|FG005|Period 2|Withdrawal by Subject|0|||
33318142|NCT01968070|101060081|FG006|Period 2|Withdrawal by Subject|0|||
33318143|NCT01968070|101060082|FG007|Period 2|Withdrawal by Subject|0|||
33318144|NCT01968070|101060083|FG008|Period 2|Withdrawal by Subject|0|||
33318145|NCT01968070|101060084|FG009|Period 2|Withdrawal by Subject|0|||
33318146|NCT01968070|101060085|FG010|Period 2|Withdrawal by Subject|0|||
33318147|NCT01968070|101060086|FG011|Period 2|Withdrawal by Subject|0|||
33318148|NCT01968070|101060087|FG012|Period 2|Withdrawal by Subject|0|||
33318149|NCT01968070|101060088|FG013|Period 2|Withdrawal by Subject|0|||
33318150|NCT01968070|101060089|FG014|Period 2|Withdrawal by Subject|0|||
33318151|NCT01968070|101060090|FG015|Period 2|Withdrawal by Subject|0|||
33318152|NCT01968070|101060091|FG016|Period 2|Withdrawal by Subject|0|||
33318153|NCT01968070|101060092|FG017|Period 2|Withdrawal by Subject|0|||
33318154|NCT02684279|101060094|FG000|Overall Study|Adverse Event|87|||
33318155|NCT02684279|101060094|FG000|Overall Study|Lack of Efficacy|4|||
33318156|NCT02684279|101060094|FG000|Overall Study|Lost to Follow-up|61|||
33318157|NCT02684279|101060094|FG000|Overall Study|Protocol Violation|6|||
33318158|NCT02684279|101060094|FG000|Overall Study|Pregnancy|8|||
33318159|NCT02684279|101060094|FG000|Overall Study|Withdrawal by Subject|92|||
33318160|NCT02684279|101060094|FG000|Overall Study|non-compliance with study drug|9|||
33318161|NCT02684279|101060094|FG000|Overall Study|non compliance with study visits|2|||
33318162|NCT02684279|101060094|FG000|Overall Study|subject to have surgery|1|||
33318163|NCT02684279|101060094|FG000|Overall Study|family emergency|1|||
33318164|NCT02684279|101060094|FG000|Overall Study|Site closures|7|||
33318165|NCT02684279|101060094|FG000|Overall Study|Physician Decision|1|||
33318166|NCT01372410|101060097|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
33318167|NCT01372410|101060098|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
33318168|NCT01372410|101060099|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
33318169|NCT01372410|101060100|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
33318170|NCT01372410|101060101|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
33318171|NCT01372410|101060102|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
33318172|NCT01372410|101060103|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
33318173|NCT01372410|101060104|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
33318174|NCT01372410|101060097|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
33318175|NCT01372410|101060098|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
33318176|NCT01372410|101060099|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
33318177|NCT01372410|101060100|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
33318178|NCT01372410|101060101|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
33318179|NCT01372410|101060102|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
33318180|NCT01372410|101060103|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
33318181|NCT01372410|101060104|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
33318182|NCT01372410|101060097|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33318183|NCT01372410|101060098|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33318184|NCT01372410|101060099|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33318185|NCT01372410|101060100|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33318186|NCT01372410|101060101|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
33318187|NCT01372410|101060102|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33318188|NCT01372410|101060103|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33318189|NCT01372410|101060104|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33318190|NCT01372410|101060097|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
33318191|NCT01372410|101060098|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
33318192|NCT01372410|101060099|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
33318193|NCT01372410|101060100|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
33318194|NCT01372410|101060101|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
33318195|NCT01372410|101060102|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
33318196|NCT01372410|101060103|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
33318197|NCT01372410|101060104|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
33318198|NCT01372410|101060097|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
33318199|NCT01372410|101060098|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
33318200|NCT01372410|101060099|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
33318201|NCT01372410|101060100|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
33318202|NCT01372410|101060101|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
33318203|NCT01372410|101060102|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
33318204|NCT01372410|101060103|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
33318205|NCT01372410|101060104|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
33318206|NCT01372410|101060097|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
33318207|NCT01372410|101060098|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
33318208|NCT01372410|101060099|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
33318209|NCT01372410|101060100|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
33318210|NCT01372410|101060101|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
33318211|NCT01372410|101060102|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
33318212|NCT01372410|101060103|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
33318213|NCT01372410|101060104|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
33318214|NCT01372410|101060097|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
33318215|NCT01372410|101060098|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
33318216|NCT01372410|101060099|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
33604320|NCT03689712|102102599|FG000|Overall Study|Patient Non-Compliance|0|||
33318217|NCT01372410|101060100|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
33318218|NCT01372410|101060101|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
33318219|NCT01372410|101060102|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
33318220|NCT01372410|101060103|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
33318221|NCT01372410|101060104|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
33318222|NCT01372410|101060097|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
33318223|NCT01372410|101060098|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
33318224|NCT01372410|101060099|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
33318225|NCT01372410|101060100|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
33318226|NCT01372410|101060101|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
33318227|NCT01372410|101060102|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
33318228|NCT01372410|101060103|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
33318229|NCT01372410|101060104|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
33318230|NCT01372410|101060097|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
33318231|NCT01372410|101060098|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
33318232|NCT01372410|101060099|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
33318233|NCT01372410|101060100|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
33318234|NCT01372410|101060101|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
33318235|NCT01372410|101060102|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
33318236|NCT01372410|101060103|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
33318237|NCT01372410|101060104|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
33318238|NCT01372410|101060097|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
33318239|NCT01372410|101060098|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
33318240|NCT01372410|101060099|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
33318241|NCT01372410|101060100|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
33318242|NCT01372410|101060101|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
33318243|NCT01372410|101060102|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
33318244|NCT01372410|101060103|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
33318245|NCT01372410|101060104|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
33318246|NCT00633061|101060105|FG000|Overall Study|Study closed|86|||
33318247|NCT00633061|101060106|FG001|Overall Study|Study closed|0|||
33318248|NCT00323297|101060107|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
33318249|NCT00323297|101060108|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
33318250|NCT00323297|101060107|FG000|Part A (Double Blind Randomized)|Death|0|||
33318251|NCT00323297|101060108|FG001|Part A (Double Blind Randomized)|Death|1|||
33318252|NCT00323297|101060107|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
33318253|NCT00323297|101060108|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
33318254|NCT00323297|101060107|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
33507131|NCT02805660|101750961|FG005|Overall Study|Study terminated by Sponsor|3|||
33507132|NCT02805660|101750962|FG006|Overall Study|Study terminated by Sponsor|1|||
33318255|NCT00323297|101060108|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
33318256|NCT00323297|101060107|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
33318257|NCT00323297|101060108|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
33318258|NCT00323297|101060107|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
33318259|NCT00323297|101060108|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
33318260|NCT00323297|101060107|FG000|Part B (Open-label)|Death|0|||
33318261|NCT00323297|101060108|FG001|Part B (Open-label)|Death|1|||
33318262|NCT00323297|101060107|FG000|Part B (Open-label)|Reason unspecified|0|||
33318263|NCT00323297|101060108|FG001|Part B (Open-label)|Reason unspecified|1|||
33318264|NCT00323297|101060107|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
33318265|NCT00323297|101060108|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
33318266|NCT00323297|101060107|FG000|Part B (Open-label)|Lack of Efficacy|3|||
33318267|NCT00323297|101060108|FG001|Part B (Open-label)|Lack of Efficacy|1|||
33318268|NCT00323297|101060107|FG000|Part B (Open-label)|Adverse Event|5|||
33318269|NCT00323297|101060108|FG001|Part B (Open-label)|Adverse Event|5|||
33318270|NCT00323297|101060107|FG000|Part B (Open-label)|Protocol Violation|0|||
33318271|NCT00323297|101060108|FG001|Part B (Open-label)|Protocol Violation|1|||
33318272|NCT01128894|101060109|FG000|Overall Study|Adverse Event|31|||
33318273|NCT01128894|101060110|FG001|Overall Study|Adverse Event|41|||
33318274|NCT01128894|101060109|FG000|Overall Study|Protocol Violation|2|||
33318275|NCT01128894|101060110|FG001|Overall Study|Protocol Violation|1|||
33318276|NCT01128894|101060109|FG000|Overall Study|Noncompliance|4|||
33318277|NCT01128894|101060110|FG001|Overall Study|Noncompliance|5|||
33507133|NCT02805660|101750956|FG000|Overall Study|Miscellaneous|0|||
33318278|NCT01128894|101060109|FG000|Overall Study|Lost to Follow-up|8|||
33318279|NCT01128894|101060110|FG001|Overall Study|Lost to Follow-up|8|||
33318280|NCT01128894|101060109|FG000|Overall Study|Withdrawal by Subject|10|||
33318281|NCT01128894|101060110|FG001|Overall Study|Withdrawal by Subject|12|||
33507134|NCT02805660|101750957|FG001|Overall Study|Miscellaneous|1|||
33318282|NCT01128894|101060109|FG000|Overall Study|Physician Decision|2|||
33318283|NCT01128894|101060110|FG001|Overall Study|Physician Decision|1|||
33318284|NCT01128894|101060109|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
33507135|NCT02805660|101750958|FG002|Overall Study|Miscellaneous|0|||
33507136|NCT02805660|101750959|FG003|Overall Study|Miscellaneous|4|||
33507137|NCT02805660|101750960|FG004|Overall Study|Miscellaneous|0|||
33507138|NCT02805660|101750961|FG005|Overall Study|Miscellaneous|6|||
33507139|NCT02805660|101750962|FG006|Overall Study|Miscellaneous|4|||
33318285|NCT01128894|101060110|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
33318286|NCT00288509|101060111|FG000|Treatment Cycle 1|Adverse Event|1|||
33318287|NCT00288509|101060111|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
33318288|NCT00288509|101060111|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
33318289|NCT00288509|101060111|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
33318290|NCT00288509|101060111|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
33318291|NCT00288509|101060111|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
33318292|NCT00288509|101060111|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
33318293|NCT00288509|101060111|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
33318294|NCT00288509|101060111|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
33318295|NCT00288509|101060111|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
33318296|NCT00288509|101060111|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
33318297|NCT00288509|101060111|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
33318298|NCT00288509|101060111|FG000|Treatment Cycle 4|Physician Decision|4|||
33318299|NCT00288509|101060111|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
33318300|NCT00147823|101060116|FG000|Overall Study|Lost to Follow-up|6|||
33318301|NCT00147823|101060117|FG001|Overall Study|Lost to Follow-up|12|||
33318302|NCT00147823|101060116|FG000|Overall Study|Physician Decision|1|||
33318303|NCT00147823|101060117|FG001|Overall Study|Physician Decision|0|||
33318304|NCT00147823|101060116|FG000|Overall Study|Withdrawal by Subject|0|||
33318305|NCT00147823|101060117|FG001|Overall Study|Withdrawal by Subject|1|||
33318306|NCT00147823|101060116|FG000|Overall Study|Did not receive vitoss due to infection|6|||
33318307|NCT00147823|101060117|FG001|Overall Study|Did not receive vitoss due to infection|2|||
33318308|NCT00041067|101060118|FG000|Overall Study|Adverse Event|20|||
33318309|NCT00041067|101060118|FG000|Overall Study|Progression|19|||
33318310|NCT00041067|101060118|FG000|Overall Study|Patient refusal|12|||
33318311|NCT00041067|101060118|FG000|Overall Study|Other reasons|23|||
33318312|NCT00041067|101060118|FG000|Overall Study|Ineligible|2|||
33318313|NCT00671554|101060119|FG000|Overall Study|Disease progression|3|||
33318314|NCT01881750|101060121|FG000|Overall Study|Changes in concomitant therapies|2|||
33318315|NCT01881750|101060122|FG001|Overall Study|Changes in concomitant therapies|3|||
33318316|NCT01881750|101060121|FG000|Overall Study|Lost to Follow-up|0|||
33318317|NCT01881750|101060122|FG001|Overall Study|Lost to Follow-up|1|||
33318318|NCT01423253|101060123|FG000|Overall Study|Adverse Event|2|||
33318319|NCT01423253|101060123|FG000|Overall Study|Lack of Efficacy|2|||
33318320|NCT01423253|101060123|FG000|Overall Study|Lost to Follow-up|1|||
33318321|NCT01423253|101060123|FG000|Overall Study|Protocol Violation|2|||
33318322|NCT01423253|101060123|FG000|Overall Study|Withdrawal by Subject|2|||
33318323|NCT03346057|101060124|FG000|Overall Study|Death|1|||
33318324|NCT03346057|101060125|FG001|Overall Study|Death|2|||
33318325|NCT03346057|101060126|FG002|Overall Study|Death|0|||
33318326|NCT03346057|101060127|FG003|Overall Study|Death|0|||
33318327|NCT03346057|101060124|FG000|Overall Study|Lost to Follow-up|0|||
33318328|NCT03346057|101060125|FG001|Overall Study|Lost to Follow-up|2|||
33318329|NCT03346057|101060126|FG002|Overall Study|Lost to Follow-up|1|||
33398424|NCT02994927|101346000|FG001|Overall Study|Withdrawal by Subject|6|||
33398425|NCT02994927|101345999|FG000|Overall Study|Lost to Follow-up|2|||
33398426|NCT02994927|101346000|FG001|Overall Study|Lost to Follow-up|1|||
33398427|NCT00129376|101346001|FG000|Overall Study|Adverse Event|1|||
33398428|NCT00129376|101346001|FG000|Overall Study|Lack of Efficacy|1|||
33398429|NCT01468844|101346002|FG000|Overall Study|Adverse Event|1|||
33398430|NCT01468844|101346003|FG001|Overall Study|Adverse Event|0|||
33398431|NCT01468844|101346002|FG000|Overall Study|Withdrawal by Subject|1|||
33398432|NCT01468844|101346003|FG001|Overall Study|Withdrawal by Subject|0|||
33398433|NCT01970540|101346005|FG000|Overall Study|Non-treatment-related AE|0|||
33398434|NCT01970540|101346006|FG001|Overall Study|Non-treatment-related AE|0|||
33398435|NCT01970540|101346007|FG002|Overall Study|Non-treatment-related AE|1|||
33398436|NCT01970540|101346005|FG000|Overall Study|Progressive disease|55|||
33398437|NCT01970540|101346006|FG001|Overall Study|Progressive disease|23|||
33398438|NCT01970540|101346007|FG002|Overall Study|Progressive disease|10|||
33398439|NCT01970540|101346005|FG000|Overall Study|Treatment delay over protocol|0|||
33507140|NCT04720911|101750963|FG000|Overall Study|Withdrawal by Subject|0|||
33318330|NCT03346057|101060127|FG003|Overall Study|Lost to Follow-up|0|||
33318331|NCT03346057|101060124|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
33318332|NCT03346057|101060125|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
33318333|NCT03346057|101060126|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
33318334|NCT03346057|101060127|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
33318335|NCT03346057|101060124|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
33507141|NCT04720911|101750964|FG001|Overall Study|Withdrawal by Subject|1|||
33318336|NCT03346057|101060125|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
33318337|NCT03346057|101060126|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
33398440|NCT01970540|101346006|FG001|Overall Study|Treatment delay over protocol|0|||
33398441|NCT01970540|101346007|FG002|Overall Study|Treatment delay over protocol|1|||
33398442|NCT01970540|101346005|FG000|Overall Study|Physician Decision|7|||
33507142|NCT04720911|101750965|FG002|Overall Study|Withdrawal by Subject|0|||
33398443|NCT01970540|101346006|FG001|Overall Study|Physician Decision|2|||
33398444|NCT01970540|101346007|FG002|Overall Study|Physician Decision|0|||
33398445|NCT01970540|101346005|FG000|Overall Study|Clinical progression|0|||
33398446|NCT01970540|101346006|FG001|Overall Study|Clinical progression|1|||
33398447|NCT01970540|101346007|FG002|Overall Study|Clinical progression|1|||
33398448|NCT01970540|101346005|FG000|Overall Study|End of study|2|||
33398449|NCT01970540|101346006|FG001|Overall Study|End of study|0|||
33398450|NCT01970540|101346007|FG002|Overall Study|End of study|2|||
33398451|NCT01970540|101346005|FG000|Overall Study|Adverse Event|0|||
33398452|NCT01970540|101346006|FG001|Overall Study|Adverse Event|2|||
33398453|NCT01970540|101346007|FG002|Overall Study|Adverse Event|1|||
33398454|NCT01970540|101346005|FG000|Overall Study|Treatment-related AE|4|||
33398455|NCT01970540|101346006|FG001|Overall Study|Treatment-related AE|0|||
33398456|NCT01970540|101346007|FG002|Overall Study|Treatment-related AE|2|||
33398457|NCT01970540|101346005|FG000|Overall Study|Withdrawal by Subject|4|||
33398458|NCT01970540|101346006|FG001|Overall Study|Withdrawal by Subject|0|||
33398459|NCT01970540|101346007|FG002|Overall Study|Withdrawal by Subject|1|||
33398460|NCT01970540|101346005|FG000|Overall Study|Clinical deterioration|1|||
33398461|NCT01970540|101346006|FG001|Overall Study|Clinical deterioration|0|||
33398462|NCT01970540|101346007|FG002|Overall Study|Clinical deterioration|0|||
33398463|NCT01925014|101346008|FG000|Overall Study|Inappropriate enrollment|4|||
33398464|NCT01925014|101346009|FG001|Overall Study|Inappropriate enrollment|6|||
33398465|NCT01925014|101346008|FG000|Overall Study|Withdrawal by Subject|5|||
33398466|NCT01925014|101346009|FG001|Overall Study|Withdrawal by Subject|13|||
33417213|NCT00960687|101420235|FG001|Washout Period of 7 Days|Adverse Event|2|||
33417214|NCT00960687|101420234|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
33417215|NCT00960687|101420235|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33417216|NCT02803138|101420236|FG000|Overall Study|Failure to return|38|||
33417217|NCT02803138|101420236|FG000|Overall Study|Insufficient virological response|2|||
33417218|NCT02803138|101420236|FG000|Overall Study|Withdrawn consent|1|||
33417219|NCT02803138|101420236|FG000|Overall Study|Death|1|||
33417220|NCT02803138|101420236|FG000|Overall Study|Other, not specified|28|||
33417221|NCT05166512|101420237|FG000|Randomized|Lost to Follow-up|2|||
33417222|NCT05166512|101420238|FG001|Randomized|Lost to Follow-up|0|||
33417223|NCT05166512|101420237|FG000|Randomized|Withdrawal by Subject|1|||
33417224|NCT05166512|101420238|FG001|Randomized|Withdrawal by Subject|0|||
33417225|NCT05166512|101420237|FG000|Baseline Data Collection|Lost to Follow-up|0|||
33417226|NCT05166512|101420238|FG001|Baseline Data Collection|Lost to Follow-up|3|||
33417227|NCT05166512|101420237|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
33417228|NCT05166512|101420238|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
33417229|NCT05166512|101420237|FG000|Baseline Data Collection|Protocol Violation|2|||
33417230|NCT05166512|101420238|FG001|Baseline Data Collection|Protocol Violation|0|||
33417231|NCT05166512|101420237|FG000|4 Month Data Collection|Lost to Follow-up|1|||
33417232|NCT05166512|101420238|FG001|4 Month Data Collection|Lost to Follow-up|0|||
33417233|NCT05166512|101420237|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
33417234|NCT05166512|101420238|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
33417235|NCT05166512|101420237|FG000|12 Month Data Collection|Lost to Follow-up|3|||
33417236|NCT05166512|101420238|FG001|12 Month Data Collection|Lost to Follow-up|1|||
33417237|NCT05166512|101420237|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
33417238|NCT05166512|101420238|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
33417239|NCT04059484|101420239|FG000|Overall Study|Adverse Event|2|||
33417240|NCT04059484|101420240|FG001|Overall Study|Adverse Event|5|||
33417241|NCT04059484|101420239|FG000|Overall Study|Withdrawal by Subject|5|||
33417242|NCT04059484|101420240|FG001|Overall Study|Withdrawal by Subject|3|||
33417243|NCT04059484|101420239|FG000|Overall Study|Progressive disease|112|||
33197123|NCT01609556|100626425|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33417244|NCT04059484|101420240|FG001|Overall Study|Progressive disease|112|||
33417245|NCT04059484|101420239|FG000|Overall Study|Other|8|||
33417246|NCT04059484|101420240|FG001|Overall Study|Other|3|||
33417247|NCT04059484|101420239|FG000|Overall Study|Ongoing|20|||
33417248|NCT04059484|101420240|FG001|Overall Study|Ongoing|20|||
33417249|NCT04856917|101420241|FG000|Overall Study|Withdrawal by Subject|4|||
33417250|NCT04856917|101420242|FG001|Overall Study|Withdrawal by Subject|3|||
33318338|NCT03346057|101060127|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
33318339|NCT03346057|101060124|FG000|Overall Study|Physician Decision|3|||
33318340|NCT03346057|101060125|FG001|Overall Study|Physician Decision|2|||
33318341|NCT03346057|101060126|FG002|Overall Study|Physician Decision|0|||
33398467|NCT01899729|101350038|FG000|Overall Study|Adverse Event|1|||
33398468|NCT01899729|101350039|FG001|Overall Study|Adverse Event|0|||
33398469|NCT01899729|101350040|FG002|Overall Study|Adverse Event|0|||
33398470|NCT01899729|101350041|FG003|Overall Study|Adverse Event|0|||
33398471|NCT01899729|101350042|FG004|Overall Study|Adverse Event|1|||
33398472|NCT01899729|101350038|FG000|Overall Study|Withdrawal by Subject|1|||
33398473|NCT01899729|101350039|FG001|Overall Study|Withdrawal by Subject|2|||
33318342|NCT03346057|101060127|FG003|Overall Study|Physician Decision|2|||
33318343|NCT03346057|101060124|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
33318344|NCT03346057|101060125|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
33318345|NCT03346057|101060126|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
33318346|NCT03346057|101060127|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
33318347|NCT03346057|101060124|FG000|Overall Study|Withdrawal by Subject|1|||
33318348|NCT03346057|101060125|FG001|Overall Study|Withdrawal by Subject|0|||
33318349|NCT03346057|101060126|FG002|Overall Study|Withdrawal by Subject|0|||
33318350|NCT03346057|101060127|FG003|Overall Study|Withdrawal by Subject|0|||
33318351|NCT03471871|101060128|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
33318352|NCT03471871|101060129|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
33318353|NCT03471871|101060130|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
33318354|NCT03471871|101060131|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
33318355|NCT03471871|101060132|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
33318356|NCT03471871|101060128|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
33318357|NCT03471871|101060129|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
33318358|NCT03471871|101060130|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
33318359|NCT03471871|101060131|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
33318360|NCT03471871|101060132|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
33318361|NCT03471871|101060128|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
33318362|NCT03471871|101060129|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
33318363|NCT03471871|101060130|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
33318364|NCT03471871|101060131|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
33318365|NCT03471871|101060132|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
33318366|NCT03471871|101060128|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
33318367|NCT03471871|101060129|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
33318368|NCT03471871|101060130|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
33318369|NCT03471871|101060131|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
33318370|NCT03471871|101060132|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
33318371|NCT03471871|101060128|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
33318372|NCT03471871|101060129|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
33318373|NCT03471871|101060130|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
33318374|NCT03471871|101060131|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
33318375|NCT03471871|101060132|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
33318376|NCT01890148|101060133|FG000|Overall Study|Adverse Event|1|||
33318377|NCT04464265|101060134|FG000|Overall Study|Physician Decision|2|||
33318378|NCT02411578|101060135|FG000|Crossover Trial Phase|Pregnancy|0|||
33398474|NCT01899729|101350040|FG002|Overall Study|Withdrawal by Subject|0|||
33398475|NCT01899729|101350041|FG003|Overall Study|Withdrawal by Subject|0|||
33398476|NCT01899729|101350042|FG004|Overall Study|Withdrawal by Subject|0|||
33398477|NCT01899729|101350038|FG000|Overall Study|Lack of Efficacy|0|||
33398478|NCT01899729|101350039|FG001|Overall Study|Lack of Efficacy|0|||
33398479|NCT01899729|101350040|FG002|Overall Study|Lack of Efficacy|2|||
33398480|NCT01899729|101350041|FG003|Overall Study|Lack of Efficacy|0|||
33398481|NCT01899729|101350042|FG004|Overall Study|Lack of Efficacy|1|||
33398482|NCT03595176|101350050|FG000|Overall Study|Death|0|||
33398483|NCT03595176|101350051|FG001|Overall Study|Death|2|||
33398484|NCT03595176|101350050|FG000|Overall Study|Lost to Follow-up|0|||
33398485|NCT03595176|101350051|FG001|Overall Study|Lost to Follow-up|1|||
33398486|NCT00413777|101350052|FG000|Fixed-dose Period|Lost to Follow-up|1|||
33398487|NCT00413777|101350053|FG001|Fixed-dose Period|Lost to Follow-up|1|||
33398488|NCT00413777|101350052|FG000|Fixed-dose Period|Adverse Event|2|||
33398489|NCT00413777|101350053|FG001|Fixed-dose Period|Adverse Event|1|||
33398490|NCT00413777|101350052|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
33398491|NCT00413777|101350053|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
33398492|NCT00413777|101350052|FG000|Fixed-dose Period|Withdrew Consent|0|||
33398493|NCT00413777|101350053|FG001|Fixed-dose Period|Withdrew Consent|1|||
33398494|NCT04051944|101350054|FG000|Overall Study|Study ending|1|||
33318379|NCT02411578|101060136|FG001|Crossover Trial Phase|Pregnancy|1|||
33318380|NCT01178671|101060137|FG000|Overall Study|Adverse Event|4|||
33318381|NCT01178671|101060138|FG001|Overall Study|Adverse Event|6|||
33318382|NCT01178671|101060137|FG000|Overall Study|Protocol Violation|1|||
33318383|NCT01178671|101060138|FG001|Overall Study|Protocol Violation|1|||
33318384|NCT01178671|101060137|FG000|Overall Study|Lack of Efficacy|0|||
33318385|NCT01178671|101060138|FG001|Overall Study|Lack of Efficacy|1|||
33318386|NCT01178671|101060137|FG000|Overall Study|Lost to Follow-up|3|||
33318387|NCT01178671|101060138|FG001|Overall Study|Lost to Follow-up|1|||
33318388|NCT01178671|101060137|FG000|Overall Study|Physician Decision|4|||
33318389|NCT01178671|101060138|FG001|Overall Study|Physician Decision|6|||
33318390|NCT02745392|101060139|FG000|Overall Study|Lost to Follow-up|0|||
33318391|NCT02745392|101060140|FG001|Overall Study|Lost to Follow-up|1|||
33318392|NCT02745392|101060141|FG002|Overall Study|Lost to Follow-up|0|||
33318393|NCT02745392|101060142|FG003|Overall Study|Lost to Follow-up|0|||
33318394|NCT00150969|101060143|FG000|24 Month Main Study|Adverse Event|3|||
33318395|NCT00150969|101060144|FG001|24 Month Main Study|Adverse Event|4|||
33318396|NCT00150969|101060143|FG000|24 Month Main Study|Death|1|||
33318397|NCT00150969|101060144|FG001|24 Month Main Study|Death|1|||
33318398|NCT00150969|101060143|FG000|24 Month Main Study|Lack of Efficacy|1|||
33318399|NCT00150969|101060144|FG001|24 Month Main Study|Lack of Efficacy|8|||
33318400|NCT00150969|101060143|FG000|24 Month Main Study|Lost to Follow-up|3|||
33318401|NCT00150969|101060144|FG001|24 Month Main Study|Lost to Follow-up|2|||
33318402|NCT00150969|101060143|FG000|24 Month Main Study|Protocol Violation|4|||
33318403|NCT00150969|101060144|FG001|24 Month Main Study|Protocol Violation|2|||
33318404|NCT00150969|101060143|FG000|24 Month Main Study|Withdrawal by Subject|7|||
33318405|NCT00150969|101060144|FG001|24 Month Main Study|Withdrawal by Subject|4|||
33318406|NCT00150969|101060143|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
33398495|NCT04051944|101350055|FG001|Overall Study|Study ending|1|||
33398496|NCT04051944|101350054|FG000|Overall Study|Early study termination by participant|1|||
33398497|NCT04051944|101350055|FG001|Overall Study|Early study termination by participant|0|||
33398498|NCT04051944|101350054|FG000|Overall Study|Withdrawal by Subject|2|||
33398499|NCT04051944|101350055|FG001|Overall Study|Withdrawal by Subject|2|||
33398500|NCT04051944|101350054|FG000|Overall Study|Lack of Efficacy|3|||
33398501|NCT04051944|101350055|FG001|Overall Study|Lack of Efficacy|0|||
33398502|NCT04051944|101350054|FG000|Overall Study|Adverse event, non- fatal|1|||
33398503|NCT04051944|101350055|FG001|Overall Study|Adverse event, non- fatal|1|||
33507143|NCT03485495|101750966|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
33507144|NCT03485495|101750967|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
33507145|NCT02572076|101750968|FG000|Overall Study|Protocol Violation|1|||
33507146|NCT01177293|101750969|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
33507147|NCT01177293|101750970|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
33507148|NCT01475851|101750971|FG000|Overall Study|Protocol defined stopping criteria|1|||
33398504|NCT04815291|101350056|FG000|Overall Study|Lost to Follow-up|1|||
33507149|NCT01475851|101750972|FG001|Overall Study|Protocol defined stopping criteria|0|||
33318407|NCT00150969|101060144|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
33318408|NCT00150969|101060143|FG000|24-48 Month Extension|Lack of Efficacy|0|||
33318409|NCT00150969|101060144|FG001|24-48 Month Extension|Lack of Efficacy|1|||
33318410|NCT00150969|101060143|FG000|24-48 Month Extension|Adverse Event|1|||
33318411|NCT00150969|101060144|FG001|24-48 Month Extension|Adverse Event|3|||
33398505|NCT04815291|101350056|FG000|Overall Study|Physician Decision|4|||
33507150|NCT02693171|101750973|FG000|Overall Study|Adverse Event|1|||
33318412|NCT00150969|101060143|FG000|24-48 Month Extension|Other Reason|81|||
33318413|NCT00150969|101060144|FG001|24-48 Month Extension|Other Reason|91|||
33398506|NCT04815291|101350056|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
33507151|NCT02693171|101750973|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
33398507|NCT01796106|101350059|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
33507152|NCT04666259|101750974|FG000|Overall Study|ongoing at data cut-off|6|||
33507153|NCT04666259|101750975|FG001|Overall Study|ongoing at data cut-off|14|||
33507154|NCT04666259|101750976|FG002|Overall Study|ongoing at data cut-off|0|||
33398508|NCT01796106|101350060|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
33318414|NCT03236246|101060148|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
33318415|NCT03236246|101060149|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
33318416|NCT03236246|101060148|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
33318417|NCT03236246|101060149|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
33318418|NCT03236246|101060148|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
33318419|NCT03236246|101060149|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
33318420|NCT03236246|101060148|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
33318421|NCT03236246|101060149|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
33318422|NCT03236246|101060148|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
33318423|NCT03236246|101060149|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
33318424|NCT03236246|101060148|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
33318425|NCT03236246|101060149|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
33318426|NCT03236246|101060148|FG000|24-Week Dose Titration Period|Death|3|||
33318427|NCT03236246|101060149|FG001|24-Week Dose Titration Period|Death|1|||
33318428|NCT03236246|101060148|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
33318429|NCT03236246|101060149|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
33318430|NCT03236246|101060148|FG000|24-Week Dose Titration Period|Adverse Event|7|||
33318431|NCT03236246|101060149|FG001|24-Week Dose Titration Period|Adverse Event|8|||
33318432|NCT03236246|101060148|FG000|24-Week Dose Titration Period|Captured as Other|1|||
33318433|NCT03236246|101060149|FG001|24-Week Dose Titration Period|Captured as Other|2|||
33318434|NCT03236246|101060148|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
33318435|NCT03236246|101060149|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
33318436|NCT03236246|101060148|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
33318437|NCT03236246|101060149|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
33318438|NCT03236246|101060148|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
33318439|NCT03236246|101060149|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
33318440|NCT03236246|101060148|FG000|24-Week Dose Maintenance Period|Death|0|||
33318441|NCT03236246|101060149|FG001|24-Week Dose Maintenance Period|Death|1|||
33318442|NCT03236246|101060148|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
33318443|NCT03236246|101060149|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
33318444|NCT01369511|101060152|FG000|Overall Study|Adverse Event|1|||
33318445|NCT01369511|101060153|FG001|Overall Study|Adverse Event|1|||
33318446|NCT01369511|101060154|FG002|Overall Study|Adverse Event|5|||
33318447|NCT01369511|101060155|FG003|Overall Study|Adverse Event|0|||
33318448|NCT01369511|101060152|FG000|Overall Study|Entry criteria not met|2|||
33318449|NCT01369511|101060153|FG001|Overall Study|Entry criteria not met|0|||
33318450|NCT01369511|101060154|FG002|Overall Study|Entry criteria not met|0|||
33318451|NCT01369511|101060155|FG003|Overall Study|Entry criteria not met|1|||
33318452|NCT01369511|101060152|FG000|Overall Study|Lost to Follow-up|0|||
33318453|NCT01369511|101060153|FG001|Overall Study|Lost to Follow-up|1|||
33318454|NCT01369511|101060154|FG002|Overall Study|Lost to Follow-up|1|||
33318455|NCT01369511|101060155|FG003|Overall Study|Lost to Follow-up|2|||
33318456|NCT01369511|101060152|FG000|Overall Study|Protocol Violation|0|||
33318457|NCT01369511|101060153|FG001|Overall Study|Protocol Violation|1|||
33318458|NCT01369511|101060154|FG002|Overall Study|Protocol Violation|0|||
33318459|NCT01369511|101060155|FG003|Overall Study|Protocol Violation|2|||
33318460|NCT01369511|101060152|FG000|Overall Study|Physician Decision|3|||
33318461|NCT01369511|101060153|FG001|Overall Study|Physician Decision|4|||
33318462|NCT01369511|101060154|FG002|Overall Study|Physician Decision|0|||
33318463|NCT01369511|101060155|FG003|Overall Study|Physician Decision|0|||
33318464|NCT01369511|101060152|FG000|Overall Study|Sponsor decision|2|||
33318465|NCT01369511|101060153|FG001|Overall Study|Sponsor decision|0|||
33318466|NCT01369511|101060154|FG002|Overall Study|Sponsor decision|1|||
33318467|NCT01369511|101060155|FG003|Overall Study|Sponsor decision|0|||
33318468|NCT01369511|101060152|FG000|Overall Study|Withdrawal by Subject|5|||
33318469|NCT01369511|101060153|FG001|Overall Study|Withdrawal by Subject|6|||
33318470|NCT01369511|101060154|FG002|Overall Study|Withdrawal by Subject|4|||
33398509|NCT00886587|101350064|FG000|Overall Study|Adverse Event|2|||
33398510|NCT00886587|101350065|FG001|Overall Study|Adverse Event|1|||
33398511|NCT00886587|101350064|FG000|Overall Study|Protocol Violation|2|||
33507155|NCT04666259|101750974|FG000|Overall Study|Progressive Disease|0|||
33318471|NCT01369511|101060155|FG003|Overall Study|Withdrawal by Subject|6|||
33318472|NCT00364156|101060159|FG000|Overall Study|Withdrawal by Subject|73|||
33318473|NCT00364156|101060160|FG001|Overall Study|Withdrawal by Subject|80|||
33507156|NCT04666259|101750975|FG001|Overall Study|Progressive Disease|1|||
33507157|NCT04666259|101750976|FG002|Overall Study|Progressive Disease|0|||
33318474|NCT00364156|101060159|FG000|Overall Study|Protocol Violation|6|||
33318475|NCT00364156|101060160|FG001|Overall Study|Protocol Violation|1|||
33398512|NCT00886587|101350065|FG001|Overall Study|Protocol Violation|0|||
33507158|NCT04666259|101750974|FG000|Overall Study|Physician Decision|9|||
33398513|NCT00886587|101350064|FG000|Overall Study|Withdrawal by Subject|0|||
33398514|NCT00886587|101350065|FG001|Overall Study|Withdrawal by Subject|1|||
33398515|NCT04035473|101350066|FG000|Screening/Baseline|Death|0|||
33398516|NCT04035473|101350067|FG001|Screening/Baseline|Death|1|||
33398517|NCT04035473|101350066|FG000|Screening/Baseline|Adverse Event|0|||
33398518|NCT04035473|101350067|FG001|Screening/Baseline|Adverse Event|1|||
33398519|NCT04035473|101350066|FG000|Follow-up Period|Adverse Event|2|||
33398520|NCT04035473|101350067|FG001|Follow-up Period|Adverse Event|0|||
33398521|NCT00827112|101350068|FG000|Overall Study|Adverse Event|2|||
33398522|NCT00827112|101350069|FG001|Overall Study|Adverse Event|0|||
33398523|NCT00827112|101350068|FG000|Overall Study|Lack of Efficacy|2|||
33398524|NCT00827112|101350069|FG001|Overall Study|Lack of Efficacy|0|||
33507159|NCT04666259|101750975|FG001|Overall Study|Physician Decision|3|||
33507160|NCT04666259|101750976|FG002|Overall Study|Physician Decision|3|||
33507161|NCT04666259|101750974|FG000|Overall Study|Adverse Event|3|||
33507162|NCT04666259|101750975|FG001|Overall Study|Adverse Event|1|||
33507163|NCT04666259|101750976|FG002|Overall Study|Adverse Event|0|||
33507164|NCT04666259|101750974|FG000|Overall Study|Withdrawal by Subject|1|||
33507165|NCT04666259|101750975|FG001|Overall Study|Withdrawal by Subject|2|||
33507166|NCT04666259|101750976|FG002|Overall Study|Withdrawal by Subject|0|||
33507167|NCT04666259|101750974|FG000|Overall Study|Enrolled but not treated and discontinued|1|||
33507168|NCT04666259|101750975|FG001|Overall Study|Enrolled but not treated and discontinued|0|||
33507169|NCT04666259|101750976|FG002|Overall Study|Enrolled but not treated and discontinued|0|||
33507170|NCT03575793|101750979|FG000|Overall Study|Withdrawal by Subject|0|||
33507171|NCT03575793|101750980|FG001|Overall Study|Withdrawal by Subject|1|||
33507172|NCT03575793|101750979|FG000|Overall Study|Never Treated|0|||
33507173|NCT03575793|101750980|FG001|Overall Study|Never Treated|2|||
33507174|NCT00957268|101750981|FG000|Overall Study|Voluntary Withdrawal|0|||
33507175|NCT00957268|101750982|FG001|Overall Study|Voluntary Withdrawal|0|||
33507176|NCT00957268|101750983|FG002|Overall Study|Voluntary Withdrawal|1|||
33507177|NCT00957268|101750984|FG003|Overall Study|Voluntary Withdrawal|0|||
33507178|NCT00957268|101750985|FG004|Overall Study|Voluntary Withdrawal|0|||
33507179|NCT00761280|101750989|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
33507180|NCT00761280|101750990|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
33507181|NCT00761280|101750989|FG000|Randomization to First Dose|Sponsor decision|1|||
33507182|NCT00761280|101750990|FG001|Randomization to First Dose|Sponsor decision|0|||
33507183|NCT00761280|101750989|FG000|Randomization to First Dose|Other|1|||
33507184|NCT00761280|101750990|FG001|Randomization to First Dose|Other|0|||
33507185|NCT00761280|101750989|FG000|First Dose to End of Study|End of trial|5|||
33507186|NCT00761280|101750990|FG001|First Dose to End of Study|End of trial|5|||
33507187|NCT00761280|101750989|FG000|First Dose to End of Study|Progressive disease|5|||
33507188|NCT00761280|101750990|FG001|First Dose to End of Study|Progressive disease|3|||
33507189|NCT00761280|101750989|FG000|First Dose to End of Study|Sponsor decision|1|||
33507190|NCT00761280|101750990|FG001|First Dose to End of Study|Sponsor decision|2|||
33507191|NCT00761280|101750989|FG000|First Dose to End of Study|Death|1|||
33507192|NCT00761280|101750990|FG001|First Dose to End of Study|Death|0|||
33507193|NCT00761280|101750989|FG000|First Dose to End of Study|Lost to Follow-up|0|||
33507194|NCT00761280|101750990|FG001|First Dose to End of Study|Lost to Follow-up|1|||
33507195|NCT03557931|101750995|FG000|Overall Study|Adverse Event|4|||
33507196|NCT03557931|101750996|FG001|Overall Study|Adverse Event|6|||
33507197|NCT03557931|101750997|FG002|Overall Study|Adverse Event|1|||
33507198|NCT03557931|101750995|FG000|Overall Study|Lost to Follow-up|4|||
33507199|NCT03557931|101750996|FG001|Overall Study|Lost to Follow-up|4|||
33507200|NCT03557931|101750997|FG002|Overall Study|Lost to Follow-up|1|||
33507201|NCT03557931|101750995|FG000|Overall Study|Protocol Violation|1|||
33507202|NCT03557931|101750996|FG001|Overall Study|Protocol Violation|4|||
33507203|NCT03557931|101750997|FG002|Overall Study|Protocol Violation|1|||
33507204|NCT03557931|101750995|FG000|Overall Study|Withdrawal by Subject|14|||
33507205|NCT03557931|101750996|FG001|Overall Study|Withdrawal by Subject|0|||
33507206|NCT03557931|101750997|FG002|Overall Study|Withdrawal by Subject|7|||
33507207|NCT03557931|101750995|FG000|Overall Study|Miscellaneous|8|||
33507208|NCT03557931|101750996|FG001|Overall Study|Miscellaneous|5|||
33507209|NCT03557931|101750997|FG002|Overall Study|Miscellaneous|3|||
33398525|NCT00827112|101350068|FG000|Overall Study|Lost to Follow-up|3|||
33398526|NCT00827112|101350069|FG001|Overall Study|Lost to Follow-up|2|||
33398527|NCT00827112|101350068|FG000|Overall Study|Pregnancy|0|||
33398528|NCT00827112|101350069|FG001|Overall Study|Pregnancy|1|||
33398529|NCT00827112|101350068|FG000|Overall Study|Protocol Violation|0|||
33507210|NCT05088603|101751004|FG000|Overall Study|Protocol Violation|6|||
33507211|NCT05088603|101751005|FG001|Overall Study|Protocol Violation|1|||
33507212|NCT00812981|101751006|FG000|Overall Study|Other|0|||
33507213|NCT00812981|101751007|FG001|Overall Study|Other|1|||
33507214|NCT02981082|101753106|FG000|Overall Study|Withdrawal by Subject|2|||
33507215|NCT02981082|101753107|FG001|Overall Study|Withdrawal by Subject|0|||
33398530|NCT00827112|101350069|FG001|Overall Study|Protocol Violation|2|||
33398531|NCT00827112|101350068|FG000|Overall Study|Withdrawal by Subject|2|||
33398532|NCT00827112|101350069|FG001|Overall Study|Withdrawal by Subject|1|||
33507216|NCT02981082|101753106|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
33318476|NCT01294683|101060161|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
33318477|NCT01294683|101060162|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
33318478|NCT01294683|101060161|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
33318479|NCT01294683|101060162|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
33507217|NCT02981082|101753107|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
33507218|NCT02981082|101753106|FG000|Overall Study|Adverse Event|0|||
33507219|NCT02981082|101753107|FG001|Overall Study|Adverse Event|1|||
33507220|NCT00915876|101753108|FG000|Overall Study|Adverse Event|0|||
33507221|NCT00915876|101753109|FG001|Overall Study|Adverse Event|1|||
33507222|NCT03261674|101753111|FG000|Overall Study|Lost to Follow-up|6|||
33507223|NCT03261674|101753112|FG001|Overall Study|Lost to Follow-up|7|||
33507224|NCT03261674|101753111|FG000|Overall Study|Protocol Violation|1|||
33507225|NCT03261674|101753112|FG001|Overall Study|Protocol Violation|4|||
33507226|NCT03261674|101753111|FG000|Overall Study|Withdrawal by Subject|1|||
33507227|NCT03261674|101753112|FG001|Overall Study|Withdrawal by Subject|4|||
33507228|NCT03261674|101753111|FG000|Overall Study|Physician Decision|1|||
33507229|NCT03261674|101753112|FG001|Overall Study|Physician Decision|0|||
33507230|NCT00594100|101753113|FG000|Procedure|Technical Failure|9|||
33507231|NCT00594100|101753113|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
33507232|NCT00594100|101753113|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
33507233|NCT00594100|101753113|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
33507234|NCT02291601|101753123|FG000|Abdomen|Did not qualify|333|||
33318480|NCT01294683|101060161|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
33318481|NCT01294683|101060162|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
33318482|NCT01294683|101060161|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
33318483|NCT01294683|101060162|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
33318484|NCT01294683|101060161|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
33318485|NCT01294683|101060162|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
33318486|NCT01294683|101060161|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
33318487|NCT01294683|101060162|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
33318488|NCT01294683|101060161|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
33318489|NCT01294683|101060162|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
33318490|NCT01294683|101060161|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
33318491|NCT01294683|101060162|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
33318492|NCT01294683|101060161|FG000|Post Crossover (Period III)|Adverse Event|6|||
33318493|NCT01294683|101060162|FG001|Post Crossover (Period III)|Adverse Event|6|||
33318494|NCT01294683|101060161|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
33318495|NCT01294683|101060162|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
33318496|NCT01294683|101060161|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
33318497|NCT01294683|101060162|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
33318498|NCT01294683|101060161|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
33318499|NCT01294683|101060162|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
33318500|NCT03645057|101060172|FG000|Randomization to Baseline|Lost to Follow-up|1|||
33318501|NCT03645057|101060173|FG001|Randomization to Baseline|Lost to Follow-up|0|||
33318502|NCT03645057|101060174|FG002|Randomization to Baseline|Lost to Follow-up|1|||
33318503|NCT03645057|101060175|FG003|Randomization to Baseline|Lost to Follow-up|0|||
33318504|NCT03645057|101060172|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
33318505|NCT03645057|101060173|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
33318506|NCT03645057|101060174|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
33318507|NCT03645057|101060175|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
33318508|NCT03645057|101060172|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
33318509|NCT03645057|101060173|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
33318510|NCT03645057|101060174|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
33318511|NCT03645057|101060175|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
33318512|NCT03645057|101060172|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
33318513|NCT03645057|101060173|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
33318514|NCT03645057|101060174|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
33318515|NCT03645057|101060175|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
33318516|NCT01776424|101060179|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
33318517|NCT01776424|101060180|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
33318518|NCT01776424|101060181|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
33318519|NCT01776424|101060179|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
33318520|NCT01776424|101060180|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
33318521|NCT01776424|101060181|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
33197124|NCT01609556|100626426|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33507235|NCT02291601|101753124|FG001|Abdomen|Did not qualify|54|||
33507236|NCT02291601|101753125|FG002|Abdomen|Did not qualify|339|||
33507237|NCT02291601|101753123|FG000|Groin|Did not qualify|183|||
33318522|NCT01776424|101060179|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
33318523|NCT01776424|101060180|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
33507238|NCT02291601|101753124|FG001|Groin|Did not qualify|30|||
33507239|NCT02291601|101753125|FG002|Groin|Did not qualify|177|||
33507240|NCT01953601|101753126|FG000|Part 1 (Base Study)|Adverse Event|24|||
33507241|NCT01953601|101753127|FG001|Part 1 (Base Study)|Adverse Event|37|||
33507242|NCT01953601|101753128|FG002|Part 1 (Base Study)|Adverse Event|15|||
33507243|NCT01953601|101753126|FG000|Part 1 (Base Study)|Death|2|||
33507244|NCT01953601|101753127|FG001|Part 1 (Base Study)|Death|0|||
33507245|NCT01953601|101753128|FG002|Part 1 (Base Study)|Death|3|||
33507246|NCT01953601|101753126|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
33507247|NCT01953601|101753127|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
33507248|NCT01953601|101753128|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
33507249|NCT01953601|101753126|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
33507250|NCT01953601|101753127|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
33507251|NCT01953601|101753128|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
33507252|NCT01953601|101753126|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
33507253|NCT01953601|101753127|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
33507254|NCT01953601|101753128|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
33507255|NCT01953601|101753126|FG000|Part 1 (Base Study)|Physician Decision|3|||
33507256|NCT01953601|101753127|FG001|Part 1 (Base Study)|Physician Decision|7|||
33507257|NCT01953601|101753128|FG002|Part 1 (Base Study)|Physician Decision|4|||
33507258|NCT01953601|101753126|FG000|Part 1 (Base Study)|Screen failure|1|||
33507259|NCT01953601|101753127|FG001|Part 1 (Base Study)|Screen failure|0|||
33507260|NCT01953601|101753128|FG002|Part 1 (Base Study)|Screen failure|1|||
33318524|NCT01776424|101060181|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
33318525|NCT01776424|101060179|FG000|LTOLE Part (Open Label)|Refused|5|||
33318526|NCT01776424|101060180|FG001|LTOLE Part (Open Label)|Refused|2|||
33318527|NCT01776424|101060181|FG002|LTOLE Part (Open Label)|Refused|11|||
33318528|NCT01776424|101060179|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
33318529|NCT01776424|101060180|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
33318530|NCT01776424|101060181|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
33318531|NCT04029961|101060182|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
33318532|NCT04029961|101060183|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
33318533|NCT04029961|101060182|FG000|Overall Study|Change in Treatment Course|0|||
33318534|NCT04029961|101060183|FG001|Overall Study|Change in Treatment Course|1|||
33318535|NCT02593786|101060184|FG000|Overall Study|Disease progression|12|||
33318536|NCT02593786|101060185|FG001|Overall Study|Disease progression|16|||
33318537|NCT02593786|101060186|FG002|Overall Study|Disease progression|10|||
33318538|NCT02593786|101060187|FG003|Overall Study|Disease progression|7|||
33318539|NCT02593786|101060184|FG000|Overall Study|Study drug toxicity|1|||
33318540|NCT02593786|101060185|FG001|Overall Study|Study drug toxicity|0|||
33318541|NCT02593786|101060186|FG002|Overall Study|Study drug toxicity|0|||
33318542|NCT02593786|101060187|FG003|Overall Study|Study drug toxicity|0|||
33318543|NCT02593786|101060184|FG000|Overall Study|Adverse event unrelated to study drug|1|||
33318544|NCT02593786|101060185|FG001|Overall Study|Adverse event unrelated to study drug|1|||
33318545|NCT02593786|101060186|FG002|Overall Study|Adverse event unrelated to study drug|1|||
33318546|NCT02593786|101060187|FG003|Overall Study|Adverse event unrelated to study drug|0|||
33318547|NCT02593786|101060184|FG000|Overall Study|Participant request to discontinue study therapy|0|||
33318548|NCT02593786|101060185|FG001|Overall Study|Participant request to discontinue study therapy|2|||
33318549|NCT02593786|101060186|FG002|Overall Study|Participant request to discontinue study therapy|0|||
33318550|NCT02593786|101060187|FG003|Overall Study|Participant request to discontinue study therapy|0|||
33318551|NCT02593786|101060184|FG000|Overall Study|Other reasons|1|||
33318552|NCT02593786|101060185|FG001|Overall Study|Other reasons|1|||
33318553|NCT02593786|101060186|FG002|Overall Study|Other reasons|0|||
33318554|NCT02593786|101060187|FG003|Overall Study|Other reasons|5|||
33318555|NCT00604279|101060188|FG000|Overall Study|Lack of Efficacy|22|||
33318556|NCT00604279|101060189|FG001|Overall Study|Lack of Efficacy|9|||
33318557|NCT00604279|101060188|FG000|Overall Study|Lost to Follow-up|9|||
33318558|NCT00604279|101060189|FG001|Overall Study|Lost to Follow-up|14|||
33318559|NCT00604279|101060188|FG000|Overall Study|Pregnancy|2|||
33318560|NCT00604279|101060189|FG001|Overall Study|Pregnancy|0|||
33318561|NCT00604279|101060188|FG000|Overall Study|Protocol Violation|3|||
33318562|NCT00604279|101060189|FG001|Overall Study|Protocol Violation|1|||
33318563|NCT00604279|101060188|FG000|Overall Study|Withdrawal by Subject|16|||
33318564|NCT00604279|101060189|FG001|Overall Study|Withdrawal by Subject|5|||
33318565|NCT00604279|101060188|FG000|Overall Study|Adverse Event|4|||
33318566|NCT00604279|101060189|FG001|Overall Study|Adverse Event|5|||
33318567|NCT00604279|101060188|FG000|Overall Study|Other|8|||
33318568|NCT00604279|101060189|FG001|Overall Study|Other|4|||
33318569|NCT01324323|101060193|FG000|Overall Study|Withdrawal by Subject|1|||
33507261|NCT01953601|101753126|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
33507262|NCT01953601|101753127|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
33507263|NCT01953601|101753128|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
33507264|NCT01953601|101753126|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
33507265|NCT01953601|101753127|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
33318570|NCT01289821|101060194|FG000|Treatment Period|Withdrawal by Subject|1|||
33318571|NCT01289821|101060194|FG000|Treatment Period|Physician Decision|3|||
33318572|NCT01289821|101060194|FG000|Treatment Period|Adverse Event|4|||
33318573|NCT01289821|101060194|FG000|Treatment Period|Radiological Progression|43|||
33318574|NCT01289821|101060194|FG000|Treatment Period|Clinical Progression|2|||
33318575|NCT01289821|101060194|FG000|Treatment Period|Therapeutic procedure required|1|||
33318576|NCT01289821|101060194|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
33318577|NCT01289821|101060194|FG000|Safety Follow-up Period|Protocol Violation|3|||
33318578|NCT01289821|101060194|FG000|Safety Follow-up Period|Unspecified reason|1|||
33318579|NCT01289821|101060194|FG000|Survival Follow-up Period|Protocol Violation|1|||
33318580|NCT01289821|101060194|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
33318581|NCT01289821|101060194|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
33318582|NCT01096342|101060196|FG000|Overall Study|Protocol Violation|1|||
33318583|NCT02141074|101060197|FG000|Pre-prophylaxis|Adverse Event|3|||
33318584|NCT02141074|101060198|FG001|Pre-prophylaxis|Adverse Event|0|||
33318585|NCT02141074|101060197|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
33318586|NCT02141074|101060198|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
33318587|NCT02141074|101060197|FG000|Prophylaxis|Adverse Event|0|||
33318588|NCT02141074|101060198|FG001|Prophylaxis|Adverse Event|4|||
33318589|NCT02141074|101060197|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
33318590|NCT02141074|101060198|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
33318591|NCT02141074|101060197|FG000|Prophylaxis|Withdrawal by Subject|0|||
33318592|NCT02141074|101060198|FG001|Prophylaxis|Withdrawal by Subject|1|||
33318593|NCT05266586|101060199|FG000|Overall Study|Adverse Event|2|||
33318594|NCT05266586|101060200|FG001|Overall Study|Adverse Event|2|||
33318595|NCT05266586|101060201|FG002|Overall Study|Adverse Event|1|||
33318596|NCT05266586|101060199|FG000|Overall Study|Withdrawal by Subject|1|||
33318597|NCT05266586|101060200|FG001|Overall Study|Withdrawal by Subject|0|||
33318598|NCT05266586|101060201|FG002|Overall Study|Withdrawal by Subject|1|||
33318599|NCT05266586|101060199|FG000|Overall Study|Non-compliance with study drug|0|||
33318600|NCT05266586|101060200|FG001|Overall Study|Non-compliance with study drug|1|||
33318601|NCT05266586|101060201|FG002|Overall Study|Non-compliance with study drug|0|||
33318602|NCT05266586|101060199|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
33318603|NCT05266586|101060200|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
33318604|NCT05266586|101060201|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
33318605|NCT02804178|101060212|FG000|Overall Study|Adverse Event|1|||
33318606|NCT00651157|101060216|FG000|Overall Study|Death|1|||
33318607|NCT00651157|101060216|FG000|Overall Study|Protocol Violation|1|||
33318608|NCT02465463|101060217|FG000|Overall Study|Lost to Follow-up|2|||
33318609|NCT02465463|101060218|FG001|Overall Study|Lost to Follow-up|1|||
33318610|NCT02465463|101060217|FG000|Overall Study|Death|1|||
33318611|NCT02465463|101060218|FG001|Overall Study|Death|0|||
33318612|NCT02465463|101060217|FG000|Overall Study|Protocol Violation|1|||
33318613|NCT02465463|101060218|FG001|Overall Study|Protocol Violation|0|||
33318614|NCT02336178|101060224|FG000|Overall Study|Lost to Follow-up|1|||
33318615|NCT02336178|101060224|FG000|Overall Study|Protocol Violation|1|||
33318616|NCT02336178|101060224|FG000|Overall Study|Withdrawal by Subject|1|||
33318617|NCT02336178|101060224|FG000|Overall Study|Other|1|||
33318618|NCT00760669|101060225|FG000|Overall Study|Not assessed for overall improvement|18|||
33318619|NCT00760669|101060225|FG000|Overall Study|Participants missing efficacy assessment|6|||
33318620|NCT00760669|101060225|FG000|Overall Study|Participants with overlapping cases|1|||
33318621|NCT00760669|101060225|FG000|Overall Study|Took drug before entering in contract|5|||
33318622|NCT02974088|101060227|FG000|Overall Study|Lost to Follow-up|0|||
33318623|NCT02974088|101060228|FG001|Overall Study|Lost to Follow-up|2|||
33318624|NCT02974088|101060227|FG000|Overall Study|Adverse Event|0|||
33318625|NCT02974088|101060228|FG001|Overall Study|Adverse Event|1|||
33318626|NCT02881957|101060233|FG000|Overall Study|Comfort care|0|||
33318627|NCT02881957|101060234|FG001|Overall Study|Comfort care|1|||
33318628|NCT02881957|101060233|FG000|Overall Study|Concurrent trial enrollment|0|||
33318629|NCT02881957|101060234|FG001|Overall Study|Concurrent trial enrollment|1|||
33318630|NCT02881957|101060233|FG000|Overall Study|Discharged within 48 hours|0|||
33318631|NCT02881957|101060234|FG001|Overall Study|Discharged within 48 hours|1|||
33318632|NCT02881957|101060233|FG000|Overall Study|Withdrawal by Subject|2|||
33318633|NCT02881957|101060234|FG001|Overall Study|Withdrawal by Subject|1|||
33318634|NCT02881957|101060233|FG000|Overall Study|Protocol Violation|1|||
33318635|NCT02881957|101060234|FG001|Overall Study|Protocol Violation|0|||
33318636|NCT01505010|101060244|FG000|Overall Study|Protocol Violation|0|||
33318637|NCT01505010|101060245|FG001|Overall Study|Protocol Violation|1|||
33318638|NCT01505010|101060244|FG000|Overall Study|Lost to Follow-up|0|||
33318639|NCT01505010|101060245|FG001|Overall Study|Lost to Follow-up|1|||
33318640|NCT03575143|101060247|FG000|Overall Study|Lost to Follow-up|0|||
33318641|NCT03575143|101060248|FG001|Overall Study|Lost to Follow-up|0|||
33318642|NCT03575143|101060249|FG002|Overall Study|Lost to Follow-up|4|||
33318643|NCT03575143|101060247|FG000|Overall Study|Withdrawal by Subject|0|||
33318644|NCT03575143|101060248|FG001|Overall Study|Withdrawal by Subject|0|||
33318645|NCT03575143|101060249|FG002|Overall Study|Withdrawal by Subject|5|||
33507266|NCT01953601|101753128|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
33507267|NCT01953601|101753126|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
33507268|NCT01953601|101753127|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
33507269|NCT01953601|101753128|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
33507270|NCT01953601|101753126|FG000|Part 1 (Base Study)|Subject moved|2|||
33507271|NCT01953601|101753127|FG001|Part 1 (Base Study)|Subject moved|2|||
33507272|NCT01953601|101753128|FG002|Part 1 (Base Study)|Subject moved|1|||
33507273|NCT01953601|101753126|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
33507274|NCT01953601|101753127|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
33507275|NCT01953601|101753128|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
33507276|NCT01953601|101753126|FG000|Part 2 (Extension Study)|Adverse Event|1|||
33507277|NCT01953601|101753127|FG001|Part 2 (Extension Study)|Adverse Event|1|||
33507278|NCT01953601|101753128|FG002|Part 2 (Extension Study)|Adverse Event|10|||
33507279|NCT01953601|101753126|FG000|Part 2 (Extension Study)|Death|0|||
33507280|NCT01953601|101753127|FG001|Part 2 (Extension Study)|Death|3|||
33507281|NCT01953601|101753128|FG002|Part 2 (Extension Study)|Death|0|||
33507282|NCT01953601|101753126|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
33507283|NCT01953601|101753127|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
33507284|NCT01953601|101753128|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
33507285|NCT01953601|101753126|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
33507286|NCT01953601|101753127|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
33507287|NCT01953601|101753128|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
33507288|NCT01953601|101753126|FG000|Part 2 (Extension Study)|Physician Decision|2|||
33507289|NCT01953601|101753127|FG001|Part 2 (Extension Study)|Physician Decision|0|||
33507290|NCT01953601|101753128|FG002|Part 2 (Extension Study)|Physician Decision|2|||
33507291|NCT01953601|101753126|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
33507292|NCT01953601|101753127|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
33507293|NCT01953601|101753128|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
33197125|NCT01609556|100626427|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33197126|NCT01609556|100626428|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33318646|NCT03575143|101060247|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
33318647|NCT03575143|101060248|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
33318648|NCT03575143|101060249|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
33318649|NCT03907410|101060252|FG000|Overall Study|Lost to Follow-up|4|||
33318650|NCT03907410|101060253|FG001|Overall Study|Lost to Follow-up|1|||
33318651|NCT03907410|101060254|FG002|Overall Study|Lost to Follow-up|1|||
33318652|NCT03907410|101060252|FG000|Overall Study|Lost to follow-up and research burden|0|||
33318653|NCT03907410|101060253|FG001|Overall Study|Lost to follow-up and research burden|0|||
33318654|NCT03907410|101060254|FG002|Overall Study|Lost to follow-up and research burden|1|||
33318655|NCT01601847|101060255|FG000|Overall Study|Death|1|||
33318656|NCT01601847|101060256|FG001|Overall Study|Death|0|||
33318657|NCT01601847|101060255|FG000|Overall Study|Withdrawal by Subject|11|||
33318658|NCT01601847|101060256|FG001|Overall Study|Withdrawal by Subject|7|||
33318659|NCT01601847|101060255|FG000|Overall Study|Lost to Follow-up|1|||
33318660|NCT01601847|101060256|FG001|Overall Study|Lost to Follow-up|3|||
33318661|NCT02273726|101060257|FG000|Overall Study|Death|70|||
33318662|NCT02273726|101060258|FG001|Overall Study|Death|62|||
33318663|NCT02273726|101060257|FG000|Overall Study|Withdrawal by Subject|41|||
33318664|NCT02273726|101060258|FG001|Overall Study|Withdrawal by Subject|29|||
33318665|NCT02273726|101060257|FG000|Overall Study|Kidney transplant|31|||
33318666|NCT02273726|101060258|FG001|Overall Study|Kidney transplant|39|||
33318667|NCT02273726|101060257|FG000|Overall Study|Physician Decision|30|||
33318668|NCT02273726|101060258|FG001|Overall Study|Physician Decision|15|||
33318669|NCT02273726|101060257|FG000|Overall Study|Adverse Event|27|||
33318670|NCT02273726|101060258|FG001|Overall Study|Adverse Event|9|||
33318671|NCT02273726|101060257|FG000|Overall Study|Lost to Follow-up|6|||
33318672|NCT02273726|101060258|FG001|Overall Study|Lost to Follow-up|3|||
33318673|NCT02273726|101060257|FG000|Overall Study|Lack of Efficacy|6|||
33318674|NCT02273726|101060258|FG001|Overall Study|Lack of Efficacy|1|||
33318675|NCT02273726|101060257|FG000|Overall Study|Protocol Violation|4|||
33318676|NCT02273726|101060258|FG001|Overall Study|Protocol Violation|0|||
33507294|NCT01953601|101753126|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
33507295|NCT01953601|101753127|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
33507296|NCT01953601|101753128|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
33197127|NCT01609556|100626429|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33197128|NCT01609556|100626430|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33318677|NCT02273726|101060257|FG000|Overall Study|Other than specified|28|||
33318678|NCT02273726|101060258|FG001|Overall Study|Other than specified|30|||
33318679|NCT00752622|101060263|FG000|Induction Phase|Adverse Event|3|||
33507297|NCT01953601|101753126|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
33197129|NCT01609556|100626431|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33197130|NCT01609556|100626432|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33197131|NCT01609556|100626433|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33318680|NCT00752622|101060263|FG000|Induction Phase|Other|3|||
33318681|NCT00752622|101060263|FG000|Induction Phase|Non-responder|14|||
33318682|NCT00752622|101060263|FG000|Induction Phase|Withdrawal by Subject|1|||
33318683|NCT00752622|101060263|FG000|Induction Phase|Premature study termination|14|||
33318684|NCT00752622|101060263|FG000|Observational Phase|Premature Study Termination|36|||
33318685|NCT00752622|101060263|FG000|Observational Phase|Non-responder|2|||
33318686|NCT00752622|101060263|FG000|Observational Phase|Withdrawal by Subject|2|||
33507298|NCT01953601|101753127|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
33507299|NCT01953601|101753128|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
33507300|NCT01953601|101753126|FG000|Part 2 (Extension Study)|Subject moved|0|||
33197132|NCT01609556|100626434|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
33197133|NCT01609556|100626435|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
33197134|NCT01609556|100626436|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
33197135|NCT01609556|100626437|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
33197136|NCT01609556|100626438|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
33197137|NCT01609556|100626423|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33197138|NCT01609556|100626424|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33197139|NCT01609556|100626425|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33197140|NCT01609556|100626426|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33197141|NCT01609556|100626427|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33197142|NCT01609556|100626428|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33197143|NCT01609556|100626429|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33197144|NCT01609556|100626430|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33197145|NCT01609556|100626431|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33197146|NCT01609556|100626432|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33197147|NCT01609556|100626433|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33197148|NCT01609556|100626434|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
33197149|NCT01609556|100626435|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
33197150|NCT01609556|100626436|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
33197151|NCT01609556|100626437|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
33197152|NCT01609556|100626438|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
33197153|NCT01609556|100626423|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33197154|NCT01609556|100626424|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33197155|NCT01609556|100626425|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33197156|NCT01609556|100626426|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33197157|NCT01609556|100626427|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33197158|NCT01609556|100626428|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33197159|NCT01609556|100626429|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33197160|NCT01609556|100626430|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33197161|NCT01609556|100626431|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33197162|NCT01609556|100626432|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33197163|NCT01609556|100626433|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33197164|NCT01609556|100626434|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
33197165|NCT01609556|100626435|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
33197166|NCT01609556|100626436|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
33197167|NCT01609556|100626437|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
33224341|NCT02202434|100721793|FG003|Overall Study|Visit Missed|5|||
33224342|NCT02202434|100721790|FG000|Overall Study|Other|1|||
33224343|NCT02202434|100721791|FG001|Overall Study|Other|0|||
33224344|NCT02202434|100721792|FG002|Overall Study|Other|0|||
33224345|NCT02202434|100721793|FG003|Overall Study|Other|1|||
33224346|NCT01953003|100721795|FG000|Overall Study|Not treated|0|||
33224347|NCT01953003|100721796|FG001|Overall Study|Not treated|1|||
33224348|NCT01953003|100721795|FG000|Overall Study|Progressive disease|35|||
33224349|NCT01953003|100721796|FG001|Overall Study|Progressive disease|45|||
33224350|NCT01953003|100721795|FG000|Overall Study|Related Adverse events|7|||
33224351|NCT01953003|100721796|FG001|Overall Study|Related Adverse events|2|||
33224352|NCT01953003|100721795|FG000|Overall Study|Non-related adverse events|0|||
33224353|NCT01953003|100721796|FG001|Overall Study|Non-related adverse events|2|||
33224354|NCT01953003|100721795|FG000|Overall Study|Protocol Violation|0|||
33224355|NCT01953003|100721796|FG001|Overall Study|Protocol Violation|1|||
33224356|NCT01953003|100721795|FG000|Overall Study|Withdrawal by Subject|14|||
33224357|NCT01953003|100721796|FG001|Overall Study|Withdrawal by Subject|4|||
33224358|NCT01282801|100721800|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
33224359|NCT01282801|100721801|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
33224360|NCT05044325|100721811|FG000|Part A:Treatment Period 1|Adverse Event|0|||
33224361|NCT05044325|100721812|FG001|Part A:Treatment Period 1|Adverse Event|0|||
33224362|NCT05044325|100721813|FG002|Part A:Treatment Period 1|Adverse Event|0|||
33224363|NCT05044325|100721814|FG003|Part A:Treatment Period 1|Adverse Event|0|||
33318687|NCT00752622|101060263|FG000|Observational Phase|Adverse Event|1|||
33197168|NCT01609556|100626438|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
33197169|NCT01609556|100626423|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33318688|NCT00752622|101060263|FG000|Observational Phase|Other|2|||
33318689|NCT00752622|101060263|FG000|Interventional Phase|Non-responder|2|||
33318690|NCT00752622|101060263|FG000|Interventional Phase|Physician Decision|1|||
33318691|NCT00752622|101060263|FG000|Interventional Phase|Premature Study Termination|5|||
33318692|NCT02279862|101060264|FG000|Overall Study|Study drug toxicity|3|||
33318693|NCT02279862|101060265|FG001|Overall Study|Study drug toxicity|6|||
33318694|NCT02279862|101060264|FG000|Overall Study|No longer meets criteria|0|||
33318695|NCT02279862|101060265|FG001|Overall Study|No longer meets criteria|1|||
33318696|NCT02279862|101060264|FG000|Overall Study|Administrative reason by sponsor|0|||
33318697|NCT02279862|101060265|FG001|Overall Study|Administrative reason by sponsor|1|||
33318698|NCT02279862|101060264|FG000|Overall Study|Disease progression|5|||
33197170|NCT01609556|100626424|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33197171|NCT01609556|100626425|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33197172|NCT01609556|100626426|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33197173|NCT01609556|100626427|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33197174|NCT01609556|100626428|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33197175|NCT01609556|100626429|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33197176|NCT01609556|100626430|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33197177|NCT01609556|100626431|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33197178|NCT01609556|100626432|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33197179|NCT01609556|100626433|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33197180|NCT01609556|100626434|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33197181|NCT01609556|100626435|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
33197182|NCT01609556|100626436|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33197183|NCT01609556|100626437|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33197184|NCT01609556|100626438|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
33197185|NCT01609556|100626423|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33197186|NCT01609556|100626424|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33197187|NCT01609556|100626425|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33197188|NCT01609556|100626426|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33197189|NCT01609556|100626427|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33197190|NCT01609556|100626428|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33197191|NCT01609556|100626429|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33197192|NCT01609556|100626430|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33197193|NCT01609556|100626431|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33197194|NCT01609556|100626432|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33197195|NCT01609556|100626433|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33197196|NCT01609556|100626434|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
33197197|NCT01609556|100626435|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
33197198|NCT01609556|100626436|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
33197199|NCT01609556|100626437|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
33197200|NCT01609556|100626438|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
33197201|NCT01609556|100626423|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33197202|NCT01609556|100626424|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33197203|NCT01609556|100626425|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33318699|NCT02279862|101060265|FG001|Overall Study|Disease progression|2|||
33318700|NCT02279862|101060264|FG000|Overall Study|Study closed by sponsor|16|||
33318701|NCT02279862|101060265|FG001|Overall Study|Study closed by sponsor|13|||
33197204|NCT01609556|100626426|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33197205|NCT01609556|100626427|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33197206|NCT01609556|100626428|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33197207|NCT01609556|100626429|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33197208|NCT01609556|100626430|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33197209|NCT01609556|100626431|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33197210|NCT01609556|100626432|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33197211|NCT01609556|100626433|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33197212|NCT01609556|100626434|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33197213|NCT01609556|100626435|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33197214|NCT01609556|100626436|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33197215|NCT01609556|100626437|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
33197216|NCT01609556|100626438|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
33197217|NCT01609556|100626423|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
33197218|NCT01609556|100626424|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
33318702|NCT02279862|101060264|FG000|Overall Study|Other|1|||
33197219|NCT01609556|100626425|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
33197220|NCT01609556|100626426|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
33197221|NCT01609556|100626427|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
33197222|NCT01609556|100626428|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
33197223|NCT01609556|100626429|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
33197224|NCT01609556|100626430|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
33197225|NCT01609556|100626431|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
33197226|NCT01609556|100626432|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
33197227|NCT01609556|100626433|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
33197228|NCT01609556|100626434|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
33318703|NCT02279862|101060265|FG001|Overall Study|Other|2|||
33197229|NCT01609556|100626435|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
33197230|NCT01609556|100626436|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
33197231|NCT01609556|100626437|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
33197232|NCT01609556|100626438|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
33197233|NCT01609556|100626423|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197234|NCT01609556|100626424|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197235|NCT01609556|100626425|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197236|NCT01609556|100626426|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197237|NCT01609556|100626427|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197238|NCT01609556|100626428|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197239|NCT01609556|100626429|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197240|NCT01609556|100626430|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197241|NCT01609556|100626431|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197242|NCT01609556|100626432|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197243|NCT01609556|100626433|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197244|NCT01609556|100626434|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197245|NCT01609556|100626435|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
33197246|NCT01609556|100626436|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197247|NCT01609556|100626437|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197248|NCT01609556|100626438|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
33197249|NCT01023659|100626439|FG000|Overall Study|Lost to Follow-up|73|||
33197250|NCT01023659|100626440|FG001|Overall Study|Lost to Follow-up|228|||
33197251|NCT01023659|100626441|FG002|Overall Study|Lost to Follow-up|99|||
33197252|NCT01696032|100626442|FG000|Overall Study|Withdrawal by Subject|0|||
33197253|NCT01696032|100626443|FG001|Overall Study|Withdrawal by Subject|0|||
33197254|NCT01696032|100626444|FG002|Overall Study|Withdrawal by Subject|1|||
33197255|NCT01696032|100626445|FG003|Overall Study|Withdrawal by Subject|2|||
33197256|NCT01696032|100626442|FG000|Overall Study|Death|14|||
33318704|NCT02279862|101060264|FG000|Overall Study|Withdrawal by Subject|1|||
33318705|NCT02279862|101060265|FG001|Overall Study|Withdrawal by Subject|0|||
33318706|NCT01603082|101060266|FG000|Overall Study|Adverse Event|0|||
33318707|NCT01603082|101060267|FG001|Overall Study|Adverse Event|1|||
33318708|NCT01603082|101060266|FG000|Overall Study|Withdrawal by Subject|1|||
33318709|NCT01603082|101060267|FG001|Overall Study|Withdrawal by Subject|0|||
33318710|NCT01603082|101060266|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
33318711|NCT01603082|101060267|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
33318712|NCT00568321|101060270|FG000|Overall Study|Adverse Event|1|||
33318713|NCT00568321|101060271|FG001|Overall Study|Adverse Event|0|||
33318714|NCT00568321|101060272|FG002|Overall Study|Adverse Event|0|||
33318715|NCT00568321|101060270|FG000|Overall Study|Lack of Efficacy|8|||
33318716|NCT00568321|101060271|FG001|Overall Study|Lack of Efficacy|5|||
33318717|NCT00568321|101060272|FG002|Overall Study|Lack of Efficacy|6|||
33318718|NCT00568321|101060270|FG000|Overall Study|Lost to Follow-up|0|||
33318719|NCT00568321|101060271|FG001|Overall Study|Lost to Follow-up|0|||
33318720|NCT00568321|101060272|FG002|Overall Study|Lost to Follow-up|1|||
33318721|NCT00568321|101060270|FG000|Overall Study|Withdrawal by Subject|2|||
33318722|NCT00568321|101060271|FG001|Overall Study|Withdrawal by Subject|0|||
33318723|NCT00568321|101060272|FG002|Overall Study|Withdrawal by Subject|0|||
33318724|NCT00568321|101060270|FG000|Overall Study|Protocol Violation|0|||
33318725|NCT00568321|101060271|FG001|Overall Study|Protocol Violation|0|||
33318726|NCT00568321|101060272|FG002|Overall Study|Protocol Violation|1|||
33318727|NCT00568321|101060270|FG000|Overall Study|Randomized, not treated|2|||
33318728|NCT00568321|101060271|FG001|Overall Study|Randomized, not treated|0|||
33318729|NCT00568321|101060272|FG002|Overall Study|Randomized, not treated|1|||
33318730|NCT02864381|101060273|FG000|Overall Study|Death|58|||
33318731|NCT02864381|101060274|FG001|Overall Study|Death|61|||
33197257|NCT01696032|100626443|FG001|Overall Study|Death|4|||
33197258|NCT01696032|100626444|FG002|Overall Study|Death|43|||
33318732|NCT02864381|101060273|FG000|Overall Study|Withdrew Consent|5|||
33318733|NCT02864381|101060274|FG001|Overall Study|Withdrew Consent|6|||
33197259|NCT01696032|100626445|FG003|Overall Study|Death|18|||
33197260|NCT01696032|100626442|FG000|Overall Study|Lost to Follow-up|0|||
33197261|NCT01696032|100626443|FG001|Overall Study|Lost to Follow-up|1|||
33318734|NCT02864381|101060273|FG000|Overall Study|Reason Unknown|7|||
33318735|NCT02864381|101060274|FG001|Overall Study|Reason Unknown|3|||
33318736|NCT02864381|101060273|FG000|Overall Study|Lost to Follow-up|1|||
33318737|NCT02864381|101060274|FG001|Overall Study|Lost to Follow-up|1|||
33318738|NCT02864381|101060273|FG000|Overall Study|Investigator's Discretion|1|||
33318739|NCT02864381|101060274|FG001|Overall Study|Investigator's Discretion|0|||
33318740|NCT02864381|101060273|FG000|Overall Study|Protocol Violation|0|||
33318741|NCT02864381|101060274|FG001|Overall Study|Protocol Violation|1|||
33318742|NCT01026142|101060275|FG000|Overall Study|Death|136|||
33318743|NCT01026142|101060276|FG001|Overall Study|Death|134|||
33318744|NCT01026142|101060275|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
33318745|NCT01026142|101060276|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
33318746|NCT04178967|101060277|FG000|Induction Period|Adverse Event|4|||
33318747|NCT04178967|101060278|FG001|Induction Period|Adverse Event|6|||
33318748|NCT04178967|101060279|FG002|Induction Period|Adverse Event|0|||
33318749|NCT04178967|101060280|FG003|Induction Period|Adverse Event|0|||
33318750|NCT04178967|101060281|FG004|Induction Period|Adverse Event|0|||
33318751|NCT04178967|101060282|FG005|Induction Period|Adverse Event|0|||
33318752|NCT04178967|101060283|FG006|Induction Period|Adverse Event|0|||
33318753|NCT04178967|101060284|FG007|Induction Period|Adverse Event|0|||
33318754|NCT04178967|101060285|FG008|Induction Period|Adverse Event|0|||
33318755|NCT04178967|101060286|FG009|Induction Period|Adverse Event|0|||
33318756|NCT04178967|101060287|FG010|Induction Period|Adverse Event|0|||
33318757|NCT04178967|101060277|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
33318758|NCT04178967|101060278|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
33318759|NCT04178967|101060279|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
33318760|NCT04178967|101060280|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
33318761|NCT04178967|101060281|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
33318762|NCT04178967|101060282|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
33318763|NCT04178967|101060283|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
33318764|NCT04178967|101060284|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
33318765|NCT04178967|101060285|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
33318766|NCT04178967|101060286|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
33318767|NCT04178967|101060287|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
33318768|NCT04178967|101060277|FG000|Induction Period|Lack of Efficacy|4|||
33318769|NCT04178967|101060278|FG001|Induction Period|Lack of Efficacy|1|||
33318770|NCT04178967|101060279|FG002|Induction Period|Lack of Efficacy|0|||
33318771|NCT04178967|101060280|FG003|Induction Period|Lack of Efficacy|0|||
33318772|NCT04178967|101060281|FG004|Induction Period|Lack of Efficacy|0|||
33318773|NCT04178967|101060282|FG005|Induction Period|Lack of Efficacy|0|||
33318774|NCT04178967|101060283|FG006|Induction Period|Lack of Efficacy|0|||
33318775|NCT04178967|101060284|FG007|Induction Period|Lack of Efficacy|0|||
33318776|NCT04178967|101060285|FG008|Induction Period|Lack of Efficacy|0|||
33318777|NCT04178967|101060286|FG009|Induction Period|Lack of Efficacy|0|||
33318778|NCT04178967|101060287|FG010|Induction Period|Lack of Efficacy|0|||
33318779|NCT04178967|101060277|FG000|Induction Period|Protocol Violation|0|||
33318780|NCT04178967|101060278|FG001|Induction Period|Protocol Violation|6|||
33318781|NCT04178967|101060279|FG002|Induction Period|Protocol Violation|0|||
33318782|NCT04178967|101060280|FG003|Induction Period|Protocol Violation|0|||
33318783|NCT04178967|101060281|FG004|Induction Period|Protocol Violation|0|||
33318784|NCT04178967|101060282|FG005|Induction Period|Protocol Violation|0|||
33318785|NCT04178967|101060283|FG006|Induction Period|Protocol Violation|0|||
33507301|NCT01953601|101753127|FG001|Part 2 (Extension Study)|Subject moved|0|||
33507302|NCT01953601|101753128|FG002|Part 2 (Extension Study)|Subject moved|1|||
33507303|NCT01953601|101753126|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
33507304|NCT01953601|101753127|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
33507305|NCT01953601|101753128|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
33507306|NCT05338502|101753131|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
33507307|NCT05338502|101753132|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
33507308|NCT05338502|101753133|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
33507309|NCT05338502|101753131|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
33507310|NCT05338502|101753132|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
33318786|NCT04178967|101060284|FG007|Induction Period|Protocol Violation|0|||
33318787|NCT04178967|101060285|FG008|Induction Period|Protocol Violation|0|||
33318788|NCT04178967|101060286|FG009|Induction Period|Protocol Violation|0|||
33318789|NCT04178967|101060287|FG010|Induction Period|Protocol Violation|0|||
33507311|NCT05338502|101753133|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
33507312|NCT03681678|101753138|FG000|Overall Study|Lost to Follow-up|20|||
33318790|NCT04178967|101060277|FG000|Induction Period|Withdrawal by Subject|6|||
33318791|NCT04178967|101060278|FG001|Induction Period|Withdrawal by Subject|4|||
33318792|NCT04178967|101060279|FG002|Induction Period|Withdrawal by Subject|0|||
33318793|NCT04178967|101060280|FG003|Induction Period|Withdrawal by Subject|0|||
33318794|NCT04178967|101060281|FG004|Induction Period|Withdrawal by Subject|0|||
33318795|NCT04178967|101060282|FG005|Induction Period|Withdrawal by Subject|0|||
33318796|NCT04178967|101060283|FG006|Induction Period|Withdrawal by Subject|0|||
33318797|NCT04178967|101060284|FG007|Induction Period|Withdrawal by Subject|0|||
33507313|NCT03706430|101753150|FG000|Overall Study|No A-Line placed|5|||
33507314|NCT03706430|101753150|FG000|Overall Study|Subject had gel nail polish|1|||
33507315|NCT03706430|101753150|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
33507316|NCT03706430|101753150|FG000|Overall Study|Cancelled Case|6|||
33507317|NCT03706430|101753150|FG000|Overall Study|Physician Decision|2|||
33507318|NCT02549287|101753158|FG000|Overall Study|Lost to Follow-up|65|||
33507319|NCT02549287|101753159|FG001|Overall Study|Lost to Follow-up|26|||
33507320|NCT02549287|101753158|FG000|Overall Study|Withdrawal by Subject|15|||
33507321|NCT02549287|101753159|FG001|Overall Study|Withdrawal by Subject|6|||
33507322|NCT01252563|101753161|FG000|Overall Study|Contract Deviation|41|||
33507323|NCT01252563|101753161|FG000|Overall Study|Centralized Registration Deviation|30|||
33507324|NCT01252563|101753161|FG000|Overall Study|Lost to Follow-up|161|||
33507325|NCT01252563|101753161|FG000|Overall Study|No visit after first day of treatment|194|||
33507326|NCT01252563|101753161|FG000|Overall Study|No drug administration|6|||
33507327|NCT00090220|101753162|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
33507328|NCT00090220|101753163|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
33507329|NCT00090220|101753164|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
33507330|NCT00090220|101753165|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
33507331|NCT00090220|101753166|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
33507332|NCT00090220|101753167|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
33507333|NCT00090220|101753162|FG000|Base Study Vaccination Period|Adverse Event|6|||
33507334|NCT00090220|101753163|FG001|Base Study Vaccination Period|Adverse Event|1|||
33507335|NCT00090220|101753164|FG002|Base Study Vaccination Period|Adverse Event|0|||
33507336|NCT00090220|101753165|FG003|Base Study Vaccination Period|Adverse Event|0|||
33507337|NCT00090220|101753166|FG004|Base Study Vaccination Period|Adverse Event|0|||
33507338|NCT00090220|101753167|FG005|Base Study Vaccination Period|Adverse Event|0|||
33507339|NCT00090220|101753162|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
33507340|NCT00090220|101753163|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
33507341|NCT00090220|101753164|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
33507342|NCT00090220|101753165|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
33507343|NCT00090220|101753166|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
33507344|NCT00090220|101753167|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
33507345|NCT00090220|101753162|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
33507346|NCT00090220|101753163|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
33507347|NCT00090220|101753164|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
33507348|NCT00090220|101753165|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
33507349|NCT00090220|101753166|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
33507350|NCT00090220|101753167|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
33507351|NCT00090220|101753162|FG000|Base Study Vaccination Period|Patient Moved|6|||
33507352|NCT00090220|101753163|FG001|Base Study Vaccination Period|Patient Moved|2|||
33507353|NCT00090220|101753164|FG002|Base Study Vaccination Period|Patient Moved|0|||
33507354|NCT00090220|101753165|FG003|Base Study Vaccination Period|Patient Moved|0|||
33507355|NCT00090220|101753166|FG004|Base Study Vaccination Period|Patient Moved|0|||
33507356|NCT00090220|101753167|FG005|Base Study Vaccination Period|Patient Moved|0|||
33318798|NCT04178967|101060285|FG008|Induction Period|Withdrawal by Subject|0|||
33318799|NCT04178967|101060286|FG009|Induction Period|Withdrawal by Subject|0|||
33318800|NCT04178967|101060287|FG010|Induction Period|Withdrawal by Subject|0|||
33318801|NCT04178967|101060277|FG000|Induction Period|Lost to Follow-up|2|||
33318802|NCT04178967|101060278|FG001|Induction Period|Lost to Follow-up|0|||
33318803|NCT04178967|101060279|FG002|Induction Period|Lost to Follow-up|0|||
33318804|NCT04178967|101060280|FG003|Induction Period|Lost to Follow-up|0|||
33318805|NCT04178967|101060281|FG004|Induction Period|Lost to Follow-up|0|||
33507357|NCT00090220|101753162|FG000|Base Study Vaccination Period|Other|4|||
33507358|NCT00090220|101753163|FG001|Base Study Vaccination Period|Other|4|||
33507359|NCT00090220|101753164|FG002|Base Study Vaccination Period|Other|0|||
33318806|NCT04178967|101060282|FG005|Induction Period|Lost to Follow-up|0|||
33318807|NCT04178967|101060283|FG006|Induction Period|Lost to Follow-up|0|||
33318808|NCT04178967|101060284|FG007|Induction Period|Lost to Follow-up|0|||
33507360|NCT00090220|101753165|FG003|Base Study Vaccination Period|Other|0|||
33507361|NCT00090220|101753166|FG004|Base Study Vaccination Period|Other|0|||
33507362|NCT00090220|101753167|FG005|Base Study Vaccination Period|Other|0|||
33507363|NCT00090220|101753162|FG000|Base Study Follow-up Period|Adverse Event|6|||
33507364|NCT00090220|101753163|FG001|Base Study Follow-up Period|Adverse Event|1|||
33507365|NCT00090220|101753164|FG002|Base Study Follow-up Period|Adverse Event|0|||
33507366|NCT00090220|101753165|FG003|Base Study Follow-up Period|Adverse Event|0|||
33507367|NCT00090220|101753166|FG004|Base Study Follow-up Period|Adverse Event|0|||
33507368|NCT00090220|101753167|FG005|Base Study Follow-up Period|Adverse Event|0|||
33318809|NCT04178967|101060285|FG008|Induction Period|Lost to Follow-up|0|||
33507369|NCT00090220|101753162|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
33507370|NCT00090220|101753163|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
33318810|NCT04178967|101060286|FG009|Induction Period|Lost to Follow-up|0|||
33318811|NCT04178967|101060287|FG010|Induction Period|Lost to Follow-up|0|||
33197262|NCT01696032|100626444|FG002|Overall Study|Lost to Follow-up|0|||
33318812|NCT04178967|101060277|FG000|Induction Period|Participant Missed Study Visits|0|||
33318813|NCT04178967|101060278|FG001|Induction Period|Participant Missed Study Visits|1|||
33318814|NCT04178967|101060279|FG002|Induction Period|Participant Missed Study Visits|0|||
33318815|NCT04178967|101060280|FG003|Induction Period|Participant Missed Study Visits|0|||
33318816|NCT04178967|101060281|FG004|Induction Period|Participant Missed Study Visits|0|||
33318817|NCT04178967|101060282|FG005|Induction Period|Participant Missed Study Visits|0|||
33318818|NCT04178967|101060283|FG006|Induction Period|Participant Missed Study Visits|0|||
33318819|NCT04178967|101060284|FG007|Induction Period|Participant Missed Study Visits|0|||
33318820|NCT04178967|101060285|FG008|Induction Period|Participant Missed Study Visits|0|||
33318821|NCT04178967|101060286|FG009|Induction Period|Participant Missed Study Visits|0|||
33318822|NCT04178967|101060287|FG010|Induction Period|Participant Missed Study Visits|0|||
33318823|NCT04178967|101060277|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
33318824|NCT04178967|101060278|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
33318825|NCT04178967|101060279|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
33318826|NCT04178967|101060280|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
33318827|NCT04178967|101060281|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
33318828|NCT04178967|101060282|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
33318829|NCT04178967|101060283|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
33318830|NCT04178967|101060284|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
33318831|NCT04178967|101060285|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
33318832|NCT04178967|101060286|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
33318833|NCT04178967|101060287|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
33318834|NCT04178967|101060277|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33318835|NCT04178967|101060278|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33318836|NCT04178967|101060279|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33318837|NCT04178967|101060280|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33318838|NCT04178967|101060281|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33318839|NCT04178967|101060282|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
33318840|NCT04178967|101060283|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33318841|NCT04178967|101060284|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33318842|NCT04178967|101060285|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33318843|NCT04178967|101060286|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33318844|NCT04178967|101060287|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33318845|NCT04178967|101060277|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33318846|NCT04178967|101060278|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33318847|NCT04178967|101060279|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33318848|NCT04178967|101060280|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
33318849|NCT04178967|101060281|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33318850|NCT04178967|101060282|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33318851|NCT04178967|101060283|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33318852|NCT04178967|101060284|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33604321|NCT03689712|102102600|FG001|Overall Study|Patient Non-Compliance|1|||
33604322|NCT03689712|102102599|FG000|Overall Study|Withdrawal by Subject|20|||
33604323|NCT03689712|102102600|FG001|Overall Study|Withdrawal by Subject|4|||
33604324|NCT03689712|102102599|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
33604325|NCT03689712|102102600|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
33318853|NCT04178967|101060285|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33318854|NCT04178967|101060286|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33318855|NCT04178967|101060287|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33318856|NCT04178967|101060277|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
33318857|NCT04178967|101060278|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
33318858|NCT04178967|101060279|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
33318859|NCT04178967|101060280|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
33318860|NCT04178967|101060281|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
33318861|NCT04178967|101060282|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
33318862|NCT04178967|101060283|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
33318863|NCT04178967|101060284|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
33318864|NCT04178967|101060285|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
33318865|NCT04178967|101060286|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
33318866|NCT04178967|101060287|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
33318867|NCT04178967|101060277|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33318868|NCT04178967|101060278|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33318869|NCT04178967|101060279|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33318870|NCT04178967|101060280|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33604326|NCT03689712|102102599|FG000|Overall Study|Randomized but not Treated|13|||
33604327|NCT03689712|102102600|FG001|Overall Study|Randomized but not Treated|7|||
33604328|NCT03689712|102102599|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
33318871|NCT04178967|101060281|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
33318872|NCT04178967|101060282|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
33318873|NCT04178967|101060283|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33318874|NCT04178967|101060284|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
33318875|NCT04178967|101060285|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33318876|NCT04178967|101060286|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33318877|NCT04178967|101060287|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33318878|NCT04178967|101060277|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
33507371|NCT00090220|101753164|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
33507372|NCT00090220|101753165|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
33507373|NCT00090220|101753166|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
33318879|NCT04178967|101060278|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
33318880|NCT04178967|101060279|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
33318881|NCT04178967|101060280|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
33318882|NCT04178967|101060281|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
33318883|NCT04178967|101060282|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
33318884|NCT04178967|101060283|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
33318885|NCT04178967|101060284|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
33318886|NCT04178967|101060285|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
33318887|NCT04178967|101060286|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
33318888|NCT04178967|101060287|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
33507374|NCT00090220|101753167|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
33507375|NCT00090220|101753162|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
33507376|NCT00090220|101753163|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
33507377|NCT00090220|101753164|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
33507378|NCT00090220|101753165|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
33604329|NCT03689712|102102600|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
33604330|NCT01732913|102102601|FG000|Overall Study|Study Terminated by Sponsor|105|||
33604331|NCT01732913|102102602|FG001|Overall Study|Study Terminated by Sponsor|55|||
33604332|NCT01732913|102102601|FG000|Overall Study|Withdrawal by Subject|27|||
33604333|NCT01732913|102102602|FG001|Overall Study|Withdrawal by Subject|4|||
33604334|NCT01732913|102102601|FG000|Overall Study|Physician Decision|14|||
33604335|NCT01732913|102102602|FG001|Overall Study|Physician Decision|7|||
33604336|NCT01732913|102102601|FG000|Overall Study|Other|7|||
33604337|NCT01732913|102102602|FG001|Overall Study|Other|1|||
33507379|NCT00090220|101753166|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
33507380|NCT00090220|101753167|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
33507381|NCT00090220|101753162|FG000|Base Study Follow-up Period|Patient Moved|20|||
33507382|NCT00090220|101753163|FG001|Base Study Follow-up Period|Patient Moved|28|||
33507383|NCT00090220|101753164|FG002|Base Study Follow-up Period|Patient Moved|0|||
33507384|NCT00090220|101753165|FG003|Base Study Follow-up Period|Patient Moved|0|||
33507385|NCT00090220|101753166|FG004|Base Study Follow-up Period|Patient Moved|0|||
33507386|NCT00090220|101753167|FG005|Base Study Follow-up Period|Patient Moved|0|||
33604338|NCT01732913|102102601|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
33604339|NCT01732913|102102602|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
33604340|NCT02704689|102102603|FG000|Overall Study|Physician Decision|1|||
33604341|NCT02704689|102102603|FG000|Overall Study|Study device not implanted|2|||
33604342|NCT03022981|102102609|FG000|Overall Study|Adverse Event|0|||
33604343|NCT03022981|102102610|FG001|Overall Study|Adverse Event|1|||
33604344|NCT03022981|102102611|FG002|Overall Study|Adverse Event|0|||
33604345|NCT03022981|102102609|FG000|Overall Study|Investigator's Discretion|0|||
33604346|NCT03022981|102102610|FG001|Overall Study|Investigator's Discretion|1|||
33604347|NCT03022981|102102611|FG002|Overall Study|Investigator's Discretion|2|||
33604348|NCT03022981|102102609|FG000|Overall Study|Lost to Follow-up|6|||
33604349|NCT03022981|102102610|FG001|Overall Study|Lost to Follow-up|2|||
33604350|NCT03022981|102102611|FG002|Overall Study|Lost to Follow-up|1|||
33604351|NCT03022981|102102609|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33604352|NCT03022981|102102610|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33604353|NCT03022981|102102611|FG002|Overall Study|Non-Compliance With Study Drug|2|||
33604354|NCT03022981|102102609|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
33604355|NCT03022981|102102610|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
33604356|NCT03022981|102102611|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
33604357|NCT02717130|102102612|FG000|Overall Study|Withdrawal by Subject|1|||
33604358|NCT02717130|102102612|FG000|Overall Study|Adverse Event|1|||
33604359|NCT02717130|102102612|FG000|Overall Study|Physician Decision|1|||
33604360|NCT02717130|102102612|FG000|Overall Study|Study Closure|4|||
33604361|NCT00566254|102102615|FG000|Overall Study|Adverse Event|3|||
33604362|NCT00566254|102102616|FG001|Overall Study|Adverse Event|1|||
33604363|NCT00566254|102102615|FG000|Overall Study|Protocol Violation|1|||
33604364|NCT00566254|102102616|FG001|Overall Study|Protocol Violation|3|||
33604365|NCT00566254|102102615|FG000|Overall Study|Withdrawal by Subject|1|||
33604366|NCT00566254|102102616|FG001|Overall Study|Withdrawal by Subject|2|||
33507387|NCT00090220|101753162|FG000|Base Study Follow-up Period|Other|19|||
33507388|NCT00090220|101753163|FG001|Base Study Follow-up Period|Other|21|||
33604367|NCT00566254|102102615|FG000|Overall Study|Lack of Efficacy|5|||
33604368|NCT00566254|102102616|FG001|Overall Study|Lack of Efficacy|6|||
33604369|NCT00566254|102102615|FG000|Overall Study|Other|0|||
33604370|NCT00566254|102102616|FG001|Overall Study|Other|2|||
33604371|NCT00587847|102102617|FG000|Overall Study|Lack of Efficacy|5|||
33604372|NCT00587847|102102617|FG000|Overall Study|Adverse Event|2|||
33604373|NCT01896271|102102618|FG000|Overall Study|Physician Decision|10|||
33604374|NCT01264419|102102619|FG000|Overall Study|Lost to Follow-up|3|||
33604375|NCT00491608|102102620|FG000|Overall Study|Death|2|||
33604376|NCT00491608|102102620|FG000|Overall Study|Withdrawal by Subject|1|||
33604377|NCT02102399|102102623|FG000|Overall Study|Withdrawal by Subject|6|||
33604378|NCT02102399|102102624|FG001|Overall Study|Withdrawal by Subject|4|||
33604379|NCT02713867|102102625|FG000|Randomization|Other Reason|2|||
33604380|NCT02713867|102102626|FG001|Randomization|Other Reason|1|||
33318889|NCT04178967|101060277|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33318890|NCT04178967|101060278|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33318891|NCT04178967|101060279|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33318892|NCT04178967|101060280|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
33318893|NCT04178967|101060281|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33318894|NCT04178967|101060282|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
33318895|NCT04178967|101060283|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
33507389|NCT00090220|101753164|FG002|Base Study Follow-up Period|Other|0|||
33507390|NCT00090220|101753165|FG003|Base Study Follow-up Period|Other|0|||
33507391|NCT00090220|101753166|FG004|Base Study Follow-up Period|Other|0|||
33507392|NCT00090220|101753167|FG005|Base Study Follow-up Period|Other|0|||
33507393|NCT00090220|101753162|FG000|Extension 1 (EXT1)|Adverse Event|0|||
33507394|NCT00090220|101753163|FG001|Extension 1 (EXT1)|Adverse Event|0|||
33507395|NCT00090220|101753164|FG002|Extension 1 (EXT1)|Adverse Event|4|||
33507396|NCT00090220|101753165|FG003|Extension 1 (EXT1)|Adverse Event|0|||
33507397|NCT00090220|101753166|FG004|Extension 1 (EXT1)|Adverse Event|0|||
33507398|NCT00090220|101753167|FG005|Extension 1 (EXT1)|Adverse Event|0|||
33507399|NCT00090220|101753162|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
33507400|NCT00090220|101753163|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
33507401|NCT00090220|101753164|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
33507402|NCT00090220|101753165|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
33507403|NCT00090220|101753166|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
33507404|NCT00090220|101753167|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
33507405|NCT00090220|101753162|FG000|Extension 1 (EXT1)|Moved|0|||
33507406|NCT00090220|101753163|FG001|Extension 1 (EXT1)|Moved|0|||
33507407|NCT00090220|101753164|FG002|Extension 1 (EXT1)|Moved|2|||
33507408|NCT00090220|101753165|FG003|Extension 1 (EXT1)|Moved|1|||
33507409|NCT00090220|101753166|FG004|Extension 1 (EXT1)|Moved|0|||
33507410|NCT00090220|101753167|FG005|Extension 1 (EXT1)|Moved|0|||
33507411|NCT00090220|101753162|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
33507412|NCT00090220|101753163|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
33507413|NCT00090220|101753164|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
33507414|NCT00090220|101753165|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
33507415|NCT00090220|101753166|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
33507416|NCT00090220|101753167|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
33507417|NCT00090220|101753162|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
33507418|NCT00090220|101753163|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
33507419|NCT00090220|101753164|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
33507420|NCT00090220|101753165|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
33507421|NCT00090220|101753166|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
33507422|NCT00090220|101753167|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
33507423|NCT00090220|101753162|FG000|Extension 1 (EXT1)|Other reason|0|||
33604381|NCT02713867|102102625|FG000|Randomization|Participant Withdrew consent|0|||
33604382|NCT02713867|102102626|FG001|Randomization|Participant Withdrew consent|2|||
33604383|NCT02713867|102102625|FG000|Treatment Period|Other Reasons|22|||
33604384|NCT02713867|102102626|FG001|Treatment Period|Other Reasons|28|||
33318896|NCT04178967|101060284|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
33507424|NCT00090220|101753163|FG001|Extension 1 (EXT1)|Other reason|0|||
33507425|NCT00090220|101753164|FG002|Extension 1 (EXT1)|Other reason|2|||
33507426|NCT00090220|101753165|FG003|Extension 1 (EXT1)|Other reason|0|||
33507427|NCT00090220|101753166|FG004|Extension 1 (EXT1)|Other reason|0|||
33507428|NCT00090220|101753167|FG005|Extension 1 (EXT1)|Other reason|0|||
33507429|NCT00090220|101753162|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33507430|NCT00090220|101753163|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33507431|NCT00090220|101753164|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33507432|NCT00090220|101753165|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33507433|NCT00090220|101753166|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
33604385|NCT02713867|102102625|FG000|Treatment Period|Administrative reason by sponsor|21|||
33604386|NCT02713867|102102626|FG001|Treatment Period|Administrative reason by sponsor|16|||
33604387|NCT02713867|102102625|FG000|Treatment Period|No longer meets study criteria|2|||
33604388|NCT02713867|102102626|FG001|Treatment Period|No longer meets study criteria|1|||
33604389|NCT02713867|102102625|FG000|Treatment Period|Poor/Non Compliance|1|||
33604390|NCT02713867|102102626|FG001|Treatment Period|Poor/Non Compliance|0|||
33318897|NCT04178967|101060285|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33318898|NCT04178967|101060286|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33318899|NCT04178967|101060287|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33318900|NCT04178967|101060277|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
33318901|NCT04178967|101060278|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
33318902|NCT04178967|101060279|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
33318903|NCT04178967|101060280|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
33398533|NCT00827112|101350068|FG000|Overall Study|Randomized but not treated|5|||
33398534|NCT00827112|101350069|FG001|Overall Study|Randomized but not treated|3|||
33398535|NCT00827112|101350068|FG000|Overall Study|Other|1|||
33398536|NCT00827112|101350069|FG001|Overall Study|Other|3|||
33398537|NCT00811395|101350070|FG000|Extension Treatment|Adverse Event|1|||
33398538|NCT00811395|101350071|FG001|Extension Treatment|Adverse Event|2|||
33398539|NCT00811395|101350072|FG002|Extension Treatment|Adverse Event|2|||
33398540|NCT00811395|101350073|FG003|Extension Treatment|Adverse Event|2|||
33398541|NCT00811395|101350074|FG004|Extension Treatment|Adverse Event|0|||
33398542|NCT00811395|101350075|FG005|Extension Treatment|Adverse Event|1|||
33398543|NCT00811395|101350070|FG000|Extension Treatment|Progressive disease|1|||
33398544|NCT00811395|101350071|FG001|Extension Treatment|Progressive disease|1|||
33398545|NCT00811395|101350072|FG002|Extension Treatment|Progressive disease|0|||
33398546|NCT00811395|101350073|FG003|Extension Treatment|Progressive disease|0|||
33398547|NCT00811395|101350074|FG004|Extension Treatment|Progressive disease|0|||
33398548|NCT00811395|101350075|FG005|Extension Treatment|Progressive disease|0|||
33398549|NCT00811395|101350070|FG000|Extension Treatment|Participant did not wish to continue|0|||
33398550|NCT00811395|101350071|FG001|Extension Treatment|Participant did not wish to continue|3|||
33398551|NCT00811395|101350072|FG002|Extension Treatment|Participant did not wish to continue|0|||
33398552|NCT00811395|101350073|FG003|Extension Treatment|Participant did not wish to continue|1|||
33398553|NCT00811395|101350074|FG004|Extension Treatment|Participant did not wish to continue|0|||
33398554|NCT00811395|101350075|FG005|Extension Treatment|Participant did not wish to continue|1|||
33398555|NCT00811395|101350070|FG000|Extension Treatment|Other than above|0|||
33398556|NCT00811395|101350071|FG001|Extension Treatment|Other than above|0|||
33398557|NCT00811395|101350072|FG002|Extension Treatment|Other than above|1|||
33398558|NCT00811395|101350073|FG003|Extension Treatment|Other than above|0|||
33398559|NCT00811395|101350074|FG004|Extension Treatment|Other than above|0|||
33398560|NCT00811395|101350075|FG005|Extension Treatment|Other than above|0|||
33398561|NCT02646891|101350080|FG000|Overall Study|Adverse Event|0|||
33398562|NCT02646891|101350081|FG001|Overall Study|Adverse Event|1|||
33398563|NCT02646891|101350082|FG002|Overall Study|Adverse Event|0|||
33398564|NCT02646891|101350083|FG003|Overall Study|Adverse Event|0|||
33604391|NCT02713867|102102625|FG000|Treatment Period|Maximum Clinical Benefit|5|||
33318904|NCT04178967|101060281|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
33398565|NCT02646891|101350084|FG004|Overall Study|Adverse Event|0|||
33398566|NCT02646891|101350085|FG005|Overall Study|Adverse Event|0|||
33398567|NCT02646891|101350086|FG006|Overall Study|Adverse Event|0|||
33318905|NCT04178967|101060282|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
33318906|NCT04178967|101060283|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
33318907|NCT04178967|101060284|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
33318908|NCT04178967|101060285|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
33318909|NCT04178967|101060286|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
33398568|NCT02646891|101350087|FG007|Overall Study|Adverse Event|0|||
33398569|NCT02646891|101350088|FG008|Overall Study|Adverse Event|0|||
33398570|NCT02646891|101350089|FG009|Overall Study|Adverse Event|0|||
33398571|NCT02646891|101350080|FG000|Overall Study|Lost to Follow-up|0|||
33398572|NCT02646891|101350081|FG001|Overall Study|Lost to Follow-up|0|||
33398573|NCT02646891|101350082|FG002|Overall Study|Lost to Follow-up|0|||
33398574|NCT02646891|101350083|FG003|Overall Study|Lost to Follow-up|0|||
33398575|NCT02646891|101350084|FG004|Overall Study|Lost to Follow-up|0|||
33398576|NCT02646891|101350085|FG005|Overall Study|Lost to Follow-up|0|||
33398577|NCT02646891|101350086|FG006|Overall Study|Lost to Follow-up|2|||
33398578|NCT02646891|101350087|FG007|Overall Study|Lost to Follow-up|2|||
33398579|NCT02646891|101350088|FG008|Overall Study|Lost to Follow-up|2|||
33398580|NCT02646891|101350089|FG009|Overall Study|Lost to Follow-up|2|||
33398581|NCT02646891|101350080|FG000|Overall Study|Protocol Violation|0|||
33398582|NCT02646891|101350081|FG001|Overall Study|Protocol Violation|0|||
33398583|NCT02646891|101350082|FG002|Overall Study|Protocol Violation|0|||
33398584|NCT02646891|101350083|FG003|Overall Study|Protocol Violation|0|||
33398585|NCT02646891|101350084|FG004|Overall Study|Protocol Violation|0|||
33398586|NCT02646891|101350085|FG005|Overall Study|Protocol Violation|0|||
33398587|NCT02646891|101350086|FG006|Overall Study|Protocol Violation|1|||
33398588|NCT02646891|101350087|FG007|Overall Study|Protocol Violation|1|||
33604392|NCT02713867|102102626|FG001|Treatment Period|Maximum Clinical Benefit|6|||
33604393|NCT02713867|102102625|FG000|Treatment Period|Withdrew consent|3|||
33318910|NCT04178967|101060287|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
33318911|NCT04178967|101060277|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33318912|NCT04178967|101060278|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33318913|NCT04178967|101060279|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33507434|NCT00090220|101753167|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
33507435|NCT00090220|101753162|FG000|Long-term Follow-up (EXT2)|Death|0|||
33507436|NCT00090220|101753163|FG001|Long-term Follow-up (EXT2)|Death|0|||
33507437|NCT00090220|101753164|FG002|Long-term Follow-up (EXT2)|Death|0|||
33507438|NCT00090220|101753165|FG003|Long-term Follow-up (EXT2)|Death|0|||
33507439|NCT00090220|101753166|FG004|Long-term Follow-up (EXT2)|Death|1|||
33507440|NCT00090220|101753167|FG005|Long-term Follow-up (EXT2)|Death|1|||
33197263|NCT01696032|100626445|FG003|Overall Study|Lost to Follow-up|0|||
33318914|NCT04178967|101060280|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33318915|NCT04178967|101060281|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33318916|NCT04178967|101060282|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33318917|NCT04178967|101060283|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33318918|NCT04178967|101060284|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33318919|NCT04178967|101060285|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
33318920|NCT04178967|101060286|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
33318921|NCT04178967|101060287|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
33318922|NCT04178967|101060277|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33398589|NCT02646891|101350088|FG008|Overall Study|Protocol Violation|0|||
33398590|NCT02646891|101350089|FG009|Overall Study|Protocol Violation|0|||
33507441|NCT00090220|101753162|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33507442|NCT00090220|101753163|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33507443|NCT00090220|101753164|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33507444|NCT00090220|101753165|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33507445|NCT00090220|101753166|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
33507446|NCT00090220|101753167|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
33507447|NCT00090220|101753162|FG000|Long-term Follow-up (EXT2)|Other|0|||
33507448|NCT00090220|101753163|FG001|Long-term Follow-up (EXT2)|Other|0|||
33507449|NCT00090220|101753164|FG002|Long-term Follow-up (EXT2)|Other|0|||
33507450|NCT00090220|101753165|FG003|Long-term Follow-up (EXT2)|Other|0|||
33507451|NCT00090220|101753166|FG004|Long-term Follow-up (EXT2)|Other|1|||
33507452|NCT00090220|101753167|FG005|Long-term Follow-up (EXT2)|Other|0|||
33507453|NCT01940900|101753170|FG000|Overall Study|Physician Decision|4|||
33507454|NCT01940900|101753171|FG001|Overall Study|Physician Decision|0|||
33507455|NCT01940900|101753170|FG000|Overall Study|Adverse Event|10|||
33507456|NCT01940900|101753171|FG001|Overall Study|Adverse Event|15|||
33507457|NCT01940900|101753170|FG000|Overall Study|Withdrawal by Subject|11|||
33507458|NCT01940900|101753171|FG001|Overall Study|Withdrawal by Subject|15|||
33507459|NCT01940900|101753170|FG000|Overall Study|Lost to Follow-up|1|||
33507460|NCT01940900|101753171|FG001|Overall Study|Lost to Follow-up|0|||
33507461|NCT01940900|101753170|FG000|Overall Study|Sponsor Decision|1|||
33507462|NCT01940900|101753171|FG001|Overall Study|Sponsor Decision|0|||
33507463|NCT01940900|101753170|FG000|Overall Study|subject non-compliance|1|||
33507464|NCT01940900|101753171|FG001|Overall Study|subject non-compliance|1|||
33507465|NCT01940900|101753170|FG000|Overall Study|other|1|||
33507466|NCT01940900|101753171|FG001|Overall Study|other|0|||
33507467|NCT02423343|101753172|FG000|Overall Study|Withdrawal by Subject|0|||
33507468|NCT02423343|101753173|FG001|Overall Study|Withdrawal by Subject|1|||
33507469|NCT02423343|101753174|FG002|Overall Study|Withdrawal by Subject|0|||
33507470|NCT02423343|101753175|FG003|Overall Study|Withdrawal by Subject|0|||
33507471|NCT02423343|101753176|FG004|Overall Study|Withdrawal by Subject|0|||
33507472|NCT02423343|101753177|FG005|Overall Study|Withdrawal by Subject|0|||
33507473|NCT02423343|101753172|FG000|Overall Study|Progressive Disease|0|||
33507474|NCT02423343|101753173|FG001|Overall Study|Progressive Disease|0|||
33507475|NCT02423343|101753174|FG002|Overall Study|Progressive Disease|0|||
33398591|NCT02646891|101350080|FG000|Overall Study|Withdrawal by Subject|2|||
33398592|NCT02646891|101350081|FG001|Overall Study|Withdrawal by Subject|0|||
33507476|NCT02423343|101753175|FG003|Overall Study|Progressive Disease|0|||
33507477|NCT02423343|101753176|FG004|Overall Study|Progressive Disease|2|||
33507478|NCT02423343|101753177|FG005|Overall Study|Progressive Disease|0|||
33507479|NCT02423343|101753172|FG000|Overall Study|Adverse Event|0|||
33507480|NCT02423343|101753173|FG001|Overall Study|Adverse Event|0|||
33507481|NCT02423343|101753174|FG002|Overall Study|Adverse Event|0|||
33507482|NCT02423343|101753175|FG003|Overall Study|Adverse Event|0|||
33507483|NCT02423343|101753176|FG004|Overall Study|Adverse Event|2|||
33507484|NCT02423343|101753177|FG005|Overall Study|Adverse Event|0|||
33507485|NCT02423343|101753172|FG000|Overall Study|Death|0|||
33507486|NCT02423343|101753173|FG001|Overall Study|Death|0|||
33507487|NCT02423343|101753174|FG002|Overall Study|Death|0|||
33507488|NCT02423343|101753175|FG003|Overall Study|Death|0|||
33507489|NCT02423343|101753176|FG004|Overall Study|Death|1|||
33507490|NCT02423343|101753177|FG005|Overall Study|Death|0|||
33197264|NCT01696032|100626442|FG000|Overall Study|Database lock|0|||
33507491|NCT01482065|101753183|FG000|Overall Study|Withdrawal by Subject|0|||
33507492|NCT01482065|101753184|FG001|Overall Study|Withdrawal by Subject|1|||
33507493|NCT01062113|101753185|FG000|Overall Study|Adverse Event|1|||
33507494|NCT01062113|101753186|FG001|Overall Study|Adverse Event|0|||
33507495|NCT01062113|101753187|FG002|Overall Study|Adverse Event|0|||
33507496|NCT01062113|101753185|FG000|Overall Study|Lack of Efficacy|38|||
33507497|NCT01062113|101753186|FG001|Overall Study|Lack of Efficacy|22|||
33507498|NCT01062113|101753187|FG002|Overall Study|Lack of Efficacy|31|||
33507499|NCT01062113|101753185|FG000|Overall Study|Withdrawal by Subject|1|||
33507500|NCT01062113|101753186|FG001|Overall Study|Withdrawal by Subject|0|||
33507501|NCT01062113|101753187|FG002|Overall Study|Withdrawal by Subject|0|||
33507502|NCT00355147|101753190|FG000|Overall Study|Lost to Follow-up|10|||
33507503|NCT00355147|101753191|FG001|Overall Study|Lost to Follow-up|8|||
33507504|NCT00355147|101753190|FG000|Overall Study|Withdrawal by Subject|8|||
33507505|NCT00355147|101753191|FG001|Overall Study|Withdrawal by Subject|12|||
33507506|NCT01094301|101753192|FG000|Trial Stage|Withdrawal by Subject|1|||
33507507|NCT01094301|101753192|FG000|Implant Stage|Adverse Event|1|||
33507508|NCT01094301|101753192|FG000|Implant Stage|Protocol Violation|1|||
33507509|NCT01094301|101753192|FG000|Implant Stage|Withdrawal by Subject|2|||
33507510|NCT01094301|101753192|FG000|Implant Stage|No return of pain|4|||
33507511|NCT01925131|101753193|FG000|Overall Study|Death|0|||
33507512|NCT01925131|101753194|FG001|Overall Study|Death|0|||
33507513|NCT01925131|101753195|FG002|Overall Study|Death|1|||
33507514|NCT01925131|101753196|FG003|Overall Study|Death|0|||
33507515|NCT01925131|101753197|FG004|Overall Study|Death|0|||
33507516|NCT01925131|101753198|FG005|Overall Study|Death|0|||
33507517|NCT01925131|101753193|FG000|Overall Study|Progression/Relapse|1|||
33507518|NCT01925131|101753194|FG001|Overall Study|Progression/Relapse|1|||
33507519|NCT01925131|101753195|FG002|Overall Study|Progression/Relapse|4|||
33507520|NCT01925131|101753196|FG003|Overall Study|Progression/Relapse|0|||
33507521|NCT01925131|101753197|FG004|Overall Study|Progression/Relapse|0|||
33507522|NCT01925131|101753198|FG005|Overall Study|Progression/Relapse|1|||
33507523|NCT01925131|101753193|FG000|Overall Study|Patient Refusal|1|||
33507524|NCT01925131|101753194|FG001|Overall Study|Patient Refusal|0|||
33507525|NCT01925131|101753195|FG002|Overall Study|Patient Refusal|0|||
33507526|NCT01925131|101753196|FG003|Overall Study|Patient Refusal|0|||
33507527|NCT01925131|101753197|FG004|Overall Study|Patient Refusal|0|||
33507528|NCT01925131|101753198|FG005|Overall Study|Patient Refusal|0|||
33507529|NCT01925131|101753193|FG000|Overall Study|Adverse Event|0|||
33507530|NCT01925131|101753194|FG001|Overall Study|Adverse Event|0|||
33507531|NCT01925131|101753195|FG002|Overall Study|Adverse Event|2|||
33507532|NCT01925131|101753196|FG003|Overall Study|Adverse Event|0|||
33507533|NCT01925131|101753197|FG004|Overall Study|Adverse Event|1|||
33507534|NCT01925131|101753198|FG005|Overall Study|Adverse Event|3|||
33507535|NCT01925131|101753193|FG000|Overall Study|Other - Not Protocol Specified|3|||
33507536|NCT01925131|101753194|FG001|Overall Study|Other - Not Protocol Specified|1|||
33507537|NCT01925131|101753195|FG002|Overall Study|Other - Not Protocol Specified|2|||
33507538|NCT01925131|101753196|FG003|Overall Study|Other - Not Protocol Specified|5|||
33507539|NCT01925131|101753197|FG004|Overall Study|Other - Not Protocol Specified|10|||
33507540|NCT01925131|101753198|FG005|Overall Study|Other - Not Protocol Specified|6|||
33507541|NCT02448537|101753199|FG000|Overall Study|Withdrawal by Subject|1|||
33507542|NCT02448537|101753200|FG001|Overall Study|Withdrawal by Subject|1|||
33507543|NCT02448537|101753201|FG002|Overall Study|Withdrawal by Subject|1|||
33507544|NCT02453334|101753202|FG000|Overall Study|Death|15|||
33507545|NCT02453334|101753203|FG001|Overall Study|Death|13|||
33507546|NCT02453334|101753202|FG000|Overall Study|Adverse Event|2|||
33507547|NCT02453334|101753203|FG001|Overall Study|Adverse Event|1|||
33507548|NCT02453334|101753202|FG000|Overall Study|Lost to Follow-up|5|||
33507549|NCT02453334|101753203|FG001|Overall Study|Lost to Follow-up|9|||
33507550|NCT02453334|101753202|FG000|Overall Study|Physician Decision|1|||
33507551|NCT02453334|101753203|FG001|Overall Study|Physician Decision|0|||
33507552|NCT02453334|101753202|FG000|Overall Study|Withdrawal by Subject|17|||
33507553|NCT02453334|101753203|FG001|Overall Study|Withdrawal by Subject|13|||
33507554|NCT02453334|101753202|FG000|Overall Study|Other reason|1|||
33507555|NCT02453334|101753203|FG001|Overall Study|Other reason|4|||
33507556|NCT01908829|101753213|FG000|Overall Study|Adverse Event|13|||
33507557|NCT01908829|101753214|FG001|Overall Study|Adverse Event|11|||
33507558|NCT01908829|101753215|FG002|Overall Study|Adverse Event|13|||
33507559|NCT01908829|101753213|FG000|Overall Study|Lost to Follow-up|4|||
33507560|NCT01908829|101753214|FG001|Overall Study|Lost to Follow-up|2|||
33507561|NCT01908829|101753215|FG002|Overall Study|Lost to Follow-up|1|||
33507562|NCT01908829|101753213|FG000|Overall Study|Randomized no double-blind drug received|1|||
33507563|NCT01908829|101753214|FG001|Overall Study|Randomized no double-blind drug received|0|||
33507564|NCT01908829|101753215|FG002|Overall Study|Randomized no double-blind drug received|1|||
33507565|NCT01908829|101753213|FG000|Overall Study|Discontinued (no EoT page)|2|||
33507566|NCT01908829|101753214|FG001|Overall Study|Discontinued (no EoT page)|0|||
33507567|NCT01908829|101753215|FG002|Overall Study|Discontinued (no EoT page)|0|||
33507568|NCT01908829|101753213|FG000|Overall Study|Miscellaneous|0|||
33507569|NCT01908829|101753214|FG001|Overall Study|Miscellaneous|2|||
33197265|NCT01696032|100626443|FG001|Overall Study|Database lock|1|||
33507570|NCT01908829|101753215|FG002|Overall Study|Miscellaneous|0|||
33507571|NCT01908829|101753213|FG000|Overall Study|Protocol Violation|2|||
33197266|NCT01696032|100626444|FG002|Overall Study|Database lock|7|||
33197267|NCT01696032|100626445|FG003|Overall Study|Database lock|2|||
33197268|NCT00844545|100626446|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
33197269|NCT00844545|100626446|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
33197270|NCT00844545|100626446|FG000|Extension Treatment Period|Adverse Event|2|||
33197271|NCT00844545|100626446|FG000|Post Treatment Period|Withdrawal by Subject|1|||
33507572|NCT01908829|101753214|FG001|Overall Study|Protocol Violation|2|||
33507573|NCT01908829|101753215|FG002|Overall Study|Protocol Violation|0|||
33197272|NCT03662750|100626447|FG000|Overall Study|Withdrawal by Subject|1|||
33197273|NCT02610192|100626448|FG000|Overall Study|Received other treatment|8|||
33197274|NCT02610192|100626448|FG000|Overall Study|Physician Decision|1|||
33197275|NCT04808609|100626449|FG000|Overall Study|Lost to Follow-up|0|||
33197276|NCT04808609|100626450|FG001|Overall Study|Lost to Follow-up|2|||
33507574|NCT01908829|101753213|FG000|Overall Study|Lack of Efficacy|1|||
33507575|NCT01908829|101753214|FG001|Overall Study|Lack of Efficacy|3|||
33507576|NCT01908829|101753215|FG002|Overall Study|Lack of Efficacy|2|||
33507577|NCT01908829|101753213|FG000|Overall Study|Withdrawal by Subject|26|||
33604394|NCT02713867|102102626|FG001|Treatment Period|Withdrew consent|6|||
33197277|NCT04808609|100626449|FG000|Overall Study|Administrative Withdrawal|0|||
33197278|NCT04808609|100626450|FG001|Overall Study|Administrative Withdrawal|1|||
33197279|NCT01968434|100626451|FG000|Overall Study|Lost to Follow-up|3|||
33197280|NCT01968434|100626452|FG001|Overall Study|Lost to Follow-up|6|||
33197281|NCT00699699|100626453|FG000|Overall Study|Adverse Event|36|||
33197282|NCT00699699|100626453|FG000|Overall Study|Individual different reasons|21|||
33197283|NCT02664038|100626460|FG000|13 Week|Lost to Follow-up|7|||
33197284|NCT02664038|100626461|FG001|13 Week|Lost to Follow-up|14|||
33197285|NCT02664038|100626460|FG000|13 Week|Withdrawal by Subject|1|||
33197286|NCT02664038|100626461|FG001|13 Week|Withdrawal by Subject|0|||
33197287|NCT02664038|100626460|FG000|26 Week|Lost to Follow-up|5|||
33197288|NCT02664038|100626461|FG001|26 Week|Lost to Follow-up|4|||
33197289|NCT02778204|100626467|FG000|Overall Study|Adverse Event|1|||
33197290|NCT02778204|100626468|FG001|Overall Study|Adverse Event|0|||
33197291|NCT02778204|100626469|FG002|Overall Study|Adverse Event|0|||
33197292|NCT02778204|100626470|FG003|Overall Study|Adverse Event|0|||
33197293|NCT02778204|100626467|FG000|Overall Study|Withdrawal by Subject|0|||
33197294|NCT02778204|100626468|FG001|Overall Study|Withdrawal by Subject|0|||
33197295|NCT02778204|100626469|FG002|Overall Study|Withdrawal by Subject|1|||
33197296|NCT02778204|100626470|FG003|Overall Study|Withdrawal by Subject|2|||
33197297|NCT02778204|100626467|FG000|Overall Study|Lost to Follow-up|1|||
33197298|NCT02778204|100626468|FG001|Overall Study|Lost to Follow-up|0|||
33197299|NCT02778204|100626469|FG002|Overall Study|Lost to Follow-up|2|||
33197300|NCT02778204|100626470|FG003|Overall Study|Lost to Follow-up|1|||
33197301|NCT02778204|100626467|FG000|Overall Study|Protocol Violation|0|||
33197302|NCT02778204|100626468|FG001|Overall Study|Protocol Violation|0|||
33507578|NCT01908829|101753214|FG001|Overall Study|Withdrawal by Subject|29|||
33507579|NCT01908829|101753215|FG002|Overall Study|Withdrawal by Subject|22|||
33507580|NCT02783729|101753226|FG000|Overall Study|Lack of Efficacy|1|||
33507581|NCT02783729|101753227|FG001|Overall Study|Lack of Efficacy|0|||
33507582|NCT02783729|101753228|FG002|Overall Study|Lack of Efficacy|0|||
33507583|NCT02783729|101753229|FG003|Overall Study|Lack of Efficacy|0|||
33604395|NCT02713867|102102625|FG000|Treatment Period|Requested to Discontinue|8|||
33604396|NCT02713867|102102626|FG001|Treatment Period|Requested to Discontinue|8|||
33604397|NCT02713867|102102625|FG000|Treatment Period|AE unrelated to Study Drug|11|||
33604398|NCT02713867|102102626|FG001|Treatment Period|AE unrelated to Study Drug|10|||
33604399|NCT02713867|102102625|FG000|Treatment Period|Death|7|||
33604400|NCT02713867|102102626|FG001|Treatment Period|Death|3|||
33604401|NCT02713867|102102625|FG000|Treatment Period|Study Drug Toxicity|16|||
33604402|NCT02713867|102102626|FG001|Treatment Period|Study Drug Toxicity|19|||
33604403|NCT02713867|102102625|FG000|Treatment Period|Disease Progression|82|||
33604404|NCT02713867|102102626|FG001|Treatment Period|Disease Progression|83|||
33197303|NCT02778204|100626469|FG002|Overall Study|Protocol Violation|1|||
33197304|NCT02778204|100626470|FG003|Overall Study|Protocol Violation|0|||
33197305|NCT02778204|100626467|FG000|Overall Study|Eligibility Violation|0|||
33197306|NCT02778204|100626468|FG001|Overall Study|Eligibility Violation|0|||
33197307|NCT02778204|100626469|FG002|Overall Study|Eligibility Violation|0|||
33197308|NCT02778204|100626470|FG003|Overall Study|Eligibility Violation|1|||
33507584|NCT02783729|101753226|FG000|Overall Study|Adverse Event|2|||
33507585|NCT02783729|101753227|FG001|Overall Study|Adverse Event|6|||
33507586|NCT02783729|101753228|FG002|Overall Study|Adverse Event|2|||
33507587|NCT02783729|101753229|FG003|Overall Study|Adverse Event|3|||
33507588|NCT02783729|101753226|FG000|Overall Study|Other|1|||
33604405|NCT03688555|102102627|FG000|Treatment Period|Adverse Event|0|||
33197309|NCT01310413|100626471|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
33197310|NCT01310413|100626472|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
33197311|NCT01310413|100626473|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
33197312|NCT01310413|100626474|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
33604406|NCT03688555|102102628|FG001|Treatment Period|Adverse Event|0|||
33197313|NCT01310413|100626475|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
33197314|NCT01310413|100626476|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
33197315|NCT01310413|100626477|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
33197316|NCT01310413|100626471|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
33197317|NCT01310413|100626472|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
33604407|NCT03688555|102102629|FG002|Treatment Period|Adverse Event|1|||
33604408|NCT00121641|102102630|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
33604409|NCT00121641|102102631|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
33604410|NCT00121641|102102632|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
33604411|NCT00121641|102102633|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
33604412|NCT00121641|102102634|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
33604413|NCT00121641|102102630|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
33604414|NCT00121641|102102631|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
33604415|NCT00121641|102102632|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
33604416|NCT00121641|102102633|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
33604417|NCT00121641|102102634|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
33197318|NCT01310413|100626473|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
33197319|NCT01310413|100626474|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
33197320|NCT01310413|100626475|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
33197321|NCT01310413|100626476|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
33197322|NCT01310413|100626477|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
33197323|NCT01310413|100626471|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
33197324|NCT01310413|100626472|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
33197325|NCT01310413|100626473|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
33197326|NCT01310413|100626474|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
33197327|NCT01310413|100626475|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
33197328|NCT01310413|100626476|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
33197329|NCT01310413|100626477|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
33197330|NCT01310413|100626471|FG000|Day 0 to Day 385|Other|1|||
33197331|NCT01310413|100626472|FG001|Day 0 to Day 385|Other|0|||
33507589|NCT02783729|101753227|FG001|Overall Study|Other|6|||
33507590|NCT02783729|101753228|FG002|Overall Study|Other|2|||
33507591|NCT02783729|101753229|FG003|Overall Study|Other|3|||
33507592|NCT02783729|101753226|FG000|Overall Study|Withdrawal by Subject|2|||
33507593|NCT02783729|101753227|FG001|Overall Study|Withdrawal by Subject|3|||
33507594|NCT02783729|101753228|FG002|Overall Study|Withdrawal by Subject|1|||
33507595|NCT02783729|101753229|FG003|Overall Study|Withdrawal by Subject|2|||
33197332|NCT01310413|100626473|FG002|Day 0 to Day 385|Other|3|||
33197333|NCT01310413|100626474|FG003|Day 0 to Day 385|Other|0|||
33197334|NCT01310413|100626475|FG004|Day 0 to Day 385|Other|0|||
33197335|NCT01310413|100626476|FG005|Day 0 to Day 385|Other|0|||
33197336|NCT01310413|100626477|FG006|Day 0 to Day 385|Other|0|||
33197337|NCT01310413|100626471|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
33318923|NCT04178967|101060278|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33318924|NCT04178967|101060279|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33197338|NCT01310413|100626472|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
33197339|NCT01310413|100626473|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
33197340|NCT01310413|100626474|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
33197341|NCT01310413|100626475|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
33197342|NCT01310413|100626476|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
33318925|NCT04178967|101060280|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33318926|NCT04178967|101060281|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33318927|NCT04178967|101060282|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33318928|NCT04178967|101060283|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33318929|NCT04178967|101060284|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33507596|NCT02783729|101753226|FG000|Overall Study|Participant's choice|2|||
33507597|NCT02783729|101753227|FG001|Overall Study|Participant's choice|1|||
33507598|NCT02783729|101753228|FG002|Overall Study|Participant's choice|2|||
33507599|NCT02783729|101753229|FG003|Overall Study|Participant's choice|1|||
33507600|NCT02783729|101753226|FG000|Overall Study|Lost to Follow-up|2|||
33507601|NCT02783729|101753227|FG001|Overall Study|Lost to Follow-up|1|||
33507602|NCT02783729|101753228|FG002|Overall Study|Lost to Follow-up|1|||
33507603|NCT02783729|101753229|FG003|Overall Study|Lost to Follow-up|0|||
33507604|NCT01867710|101753233|FG000|Overall Study|Death|25|||
33507605|NCT01867710|101753234|FG001|Overall Study|Death|15|||
33507606|NCT01867710|101753235|FG002|Overall Study|Death|27|||
33507607|NCT01867710|101753236|FG003|Overall Study|Death|20|||
33507608|NCT01867710|101753233|FG000|Overall Study|Lost to Follow-up|3|||
33507609|NCT01867710|101753234|FG001|Overall Study|Lost to Follow-up|4|||
33507610|NCT01867710|101753235|FG002|Overall Study|Lost to Follow-up|3|||
33197343|NCT01310413|100626477|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
33197344|NCT01310413|100626471|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
33507611|NCT01867710|101753236|FG003|Overall Study|Lost to Follow-up|2|||
33507612|NCT01867710|101753233|FG000|Overall Study|Withdrawal of consent|2|||
33318930|NCT04178967|101060285|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33318931|NCT04178967|101060286|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
33318932|NCT04178967|101060287|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33318933|NCT04178967|101060277|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33318934|NCT04178967|101060278|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33318935|NCT04178967|101060279|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33197345|NCT01310413|100626472|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
33197346|NCT01310413|100626473|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
33197347|NCT01310413|100626474|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
33197348|NCT01310413|100626475|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
33197349|NCT01310413|100626476|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
33197350|NCT01310413|100626477|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
33197351|NCT02504866|100626478|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
33197352|NCT02504866|100626479|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
33197353|NCT02504866|100626480|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
33197354|NCT00803023|100626481|FG000|Overall Study|Adverse Event|5|||
33197355|NCT00803023|100626482|FG001|Overall Study|Adverse Event|4|||
33197356|NCT00803023|100626483|FG002|Overall Study|Adverse Event|8|||
33197357|NCT00803023|100626484|FG003|Overall Study|Adverse Event|6|||
33197358|NCT00803023|100626481|FG000|Overall Study|Withdrawal by Subject|0|||
33197359|NCT00803023|100626482|FG001|Overall Study|Withdrawal by Subject|2|||
33197360|NCT00803023|100626483|FG002|Overall Study|Withdrawal by Subject|0|||
33197361|NCT00803023|100626484|FG003|Overall Study|Withdrawal by Subject|0|||
33197362|NCT00803023|100626481|FG000|Overall Study|Lost to Follow-up|0|||
33197363|NCT00803023|100626482|FG001|Overall Study|Lost to Follow-up|1|||
33197364|NCT00803023|100626483|FG002|Overall Study|Lost to Follow-up|2|||
33197365|NCT00803023|100626484|FG003|Overall Study|Lost to Follow-up|1|||
33197366|NCT00803023|100626481|FG000|Overall Study|Lack of Efficacy|0|||
33318936|NCT04178967|101060280|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33318937|NCT04178967|101060281|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33318938|NCT04178967|101060282|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33318939|NCT04178967|101060283|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33318940|NCT04178967|101060284|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33318941|NCT04178967|101060285|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
33318942|NCT04178967|101060286|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
33318943|NCT04178967|101060287|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
33318944|NCT04178967|101060277|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33318945|NCT04178967|101060278|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33318946|NCT04178967|101060279|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33318947|NCT04178967|101060280|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33318948|NCT04178967|101060281|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33318949|NCT04178967|101060282|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33318950|NCT04178967|101060283|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33318951|NCT04178967|101060284|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33318952|NCT04178967|101060285|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33398593|NCT02646891|101350082|FG002|Overall Study|Withdrawal by Subject|1|||
33507613|NCT01867710|101753234|FG001|Overall Study|Withdrawal of consent|5|||
33507614|NCT01867710|101753235|FG002|Overall Study|Withdrawal of consent|1|||
33507615|NCT01867710|101753236|FG003|Overall Study|Withdrawal of consent|2|||
33507616|NCT01867710|101753233|FG000|Overall Study|Study Terminated by Sponsor|9|||
33507617|NCT01867710|101753234|FG001|Overall Study|Study Terminated by Sponsor|13|||
33507618|NCT01867710|101753235|FG002|Overall Study|Study Terminated by Sponsor|8|||
33507619|NCT01867710|101753236|FG003|Overall Study|Study Terminated by Sponsor|16|||
33507620|NCT01867710|101753233|FG000|Overall Study|Biochemical progression|0|||
33507621|NCT01867710|101753234|FG001|Overall Study|Biochemical progression|1|||
33507622|NCT01867710|101753235|FG002|Overall Study|Biochemical progression|0|||
33507623|NCT01867710|101753236|FG003|Overall Study|Biochemical progression|0|||
33197367|NCT00803023|100626482|FG001|Overall Study|Lack of Efficacy|1|||
33197368|NCT00803023|100626483|FG002|Overall Study|Lack of Efficacy|1|||
33197369|NCT00803023|100626484|FG003|Overall Study|Lack of Efficacy|1|||
33197370|NCT00439140|100626485|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
33318953|NCT04178967|101060286|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
33318954|NCT04178967|101060287|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
33318955|NCT04178967|101060277|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33318956|NCT04178967|101060278|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33318957|NCT04178967|101060279|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33318958|NCT04178967|101060280|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33318959|NCT04178967|101060281|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33318960|NCT04178967|101060282|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33318961|NCT04178967|101060283|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33318962|NCT04178967|101060284|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33318963|NCT04178967|101060285|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33318964|NCT04178967|101060286|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
33318965|NCT04178967|101060287|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
33318966|NCT03224325|101060292|FG000|Overall Study|Adverse Event|1|||
33318967|NCT03224325|101060293|FG001|Overall Study|Adverse Event|0|||
33318968|NCT03224325|101060294|FG002|Overall Study|Adverse Event|0|||
33318969|NCT03224325|101060295|FG003|Overall Study|Adverse Event|0|||
33604418|NCT00121641|102102630|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
33604419|NCT00121641|102102631|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
33604420|NCT00121641|102102632|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
33604421|NCT00121641|102102633|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
33604422|NCT00121641|102102634|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
33604423|NCT00121641|102102630|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
33604424|NCT00121641|102102631|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
33604425|NCT00121641|102102632|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
33318970|NCT03224325|101060296|FG004|Overall Study|Adverse Event|0|||
33318971|NCT03224325|101060297|FG005|Overall Study|Adverse Event|0|||
33318972|NCT03224325|101060298|FG006|Overall Study|Adverse Event|1|||
33318973|NCT03224325|101060292|FG000|Overall Study|Withdrawal by Subject|0|||
33318974|NCT03224325|101060293|FG001|Overall Study|Withdrawal by Subject|0|||
33318975|NCT03224325|101060294|FG002|Overall Study|Withdrawal by Subject|0|||
33318976|NCT03224325|101060295|FG003|Overall Study|Withdrawal by Subject|1|||
33318977|NCT03224325|101060296|FG004|Overall Study|Withdrawal by Subject|0|||
33318978|NCT03224325|101060297|FG005|Overall Study|Withdrawal by Subject|0|||
33318979|NCT03224325|101060298|FG006|Overall Study|Withdrawal by Subject|0|||
33318980|NCT01774084|101060301|FG000|Overall Study|Personal reasons|1|||
33318981|NCT01774084|101060302|FG001|Overall Study|Personal reasons|0|||
33318982|NCT04201821|101060303|FG000|Overall Study|Withdrawal by Subject|2|||
33318983|NCT00866697|101063900|FG000|Overall Study|Study closed/terminated|156|||
33318984|NCT00866697|101063901|FG001|Overall Study|Study closed/terminated|138|||
33318985|NCT00866697|101063900|FG000|Overall Study|Lost to Follow-up|22|||
33318986|NCT00866697|101063901|FG001|Overall Study|Lost to Follow-up|28|||
33318987|NCT00866697|101063900|FG000|Overall Study|Physician Decision|3|||
33318988|NCT00866697|101063901|FG001|Overall Study|Physician Decision|5|||
33318989|NCT00866697|101063900|FG000|Overall Study|Withdrawal by Subject|33|||
33318990|NCT00866697|101063901|FG001|Overall Study|Withdrawal by Subject|57|||
33318991|NCT00972777|101063902|FG000|Overall Study|Adverse Event|3|||
33318992|NCT00972777|101063903|FG001|Overall Study|Adverse Event|2|||
33318993|NCT00972777|101063902|FG000|Overall Study|Lost to Follow-up|0|||
33318994|NCT00972777|101063903|FG001|Overall Study|Lost to Follow-up|4|||
33318995|NCT00972777|101063902|FG000|Overall Study|Withdrawal by Subject|4|||
33318996|NCT00972777|101063903|FG001|Overall Study|Withdrawal by Subject|5|||
33318997|NCT00972777|101063902|FG000|Overall Study|Physician Decision|4|||
33318998|NCT00972777|101063903|FG001|Overall Study|Physician Decision|0|||
33318999|NCT00972777|101063902|FG000|Overall Study|Protocol Violation|0|||
33319000|NCT00972777|101063903|FG001|Overall Study|Protocol Violation|2|||
33319001|NCT00972777|101063902|FG000|Overall Study|Screening Failure|2|||
33319002|NCT00972777|101063903|FG001|Overall Study|Screening Failure|1|||
33319003|NCT00972777|101063902|FG000|Overall Study|Missed visit|1|||
33319004|NCT00972777|101063903|FG001|Overall Study|Missed visit|0|||
33319005|NCT00999713|101063906|FG000|Overall Study|Physician Decision|2|||
33319006|NCT00999713|101063907|FG001|Overall Study|Physician Decision|0|||
33319007|NCT03421431|101063908|FG000|Overall Study|Adverse Event|2|||
33319008|NCT03421431|101063909|FG001|Overall Study|Adverse Event|1|||
33319009|NCT03421431|101063910|FG002|Overall Study|Adverse Event|12|||
33319010|NCT03421431|101063908|FG000|Overall Study|Lost to Follow-up|1|||
33319011|NCT03421431|101063909|FG001|Overall Study|Lost to Follow-up|1|||
33319012|NCT03421431|101063910|FG002|Overall Study|Lost to Follow-up|1|||
33319013|NCT03421431|101063908|FG000|Overall Study|Withdrawal by Subject|3|||
33319014|NCT03421431|101063909|FG001|Overall Study|Withdrawal by Subject|2|||
33319015|NCT03421431|101063910|FG002|Overall Study|Withdrawal by Subject|1|||
33319016|NCT03421431|101063908|FG000|Overall Study|Protocol Violation|0|||
33319017|NCT03421431|101063909|FG001|Overall Study|Protocol Violation|1|||
33604426|NCT00121641|102102633|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
33319018|NCT03421431|101063910|FG002|Overall Study|Protocol Violation|0|||
33319019|NCT03421431|101063908|FG000|Overall Study|Participant met Stopping Rules|0|||
33319020|NCT03421431|101063909|FG001|Overall Study|Participant met Stopping Rules|1|||
33319021|NCT03421431|101063910|FG002|Overall Study|Participant met Stopping Rules|0|||
33319022|NCT04014361|101063911|FG000|Period 2|Physician Decision|0|||
33319023|NCT04014361|101063912|FG001|Period 2|Physician Decision|0|||
33319024|NCT04014361|101063913|FG002|Period 2|Physician Decision|0|||
33319025|NCT04014361|101063914|FG003|Period 2|Physician Decision|1|||
33319026|NCT04014361|101063915|FG004|Period 2|Physician Decision|0|||
33319027|NCT04014361|101063916|FG005|Period 2|Physician Decision|0|||
33319028|NCT04014361|101063917|FG006|Period 2|Physician Decision|0|||
33319029|NCT04014361|101063918|FG007|Period 2|Physician Decision|0|||
33319030|NCT02249767|101063920|FG000|Overall Study|Did not use medication|8|||
33319031|NCT02249767|101063921|FG001|Overall Study|Did not use medication|9|||
33319032|NCT02249767|101063922|FG002|Overall Study|Did not use medication|8|||
33319033|NCT03249714|101063923|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
33319034|NCT03249714|101063924|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
33319035|NCT03249714|101063923|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
33319036|NCT03249714|101063924|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
33319037|NCT03249714|101063923|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
33319038|NCT03249714|101063924|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
33319039|NCT03249714|101063923|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
33319040|NCT03249714|101063924|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
33319041|NCT01765192|101063927|FG000|Treatment Period 1|Adverse Event|0|||
33319042|NCT01765192|101063928|FG001|Treatment Period 1|Adverse Event|1|||
33319043|NCT01765192|101063927|FG000|Washout Period|Voluntary Withdrawal|1|||
33319044|NCT01765192|101063928|FG001|Washout Period|Voluntary Withdrawal|1|||
33319045|NCT01765192|101063927|FG000|Washout Period|Reason not specified|1|||
33319046|NCT01765192|101063928|FG001|Washout Period|Reason not specified|0|||
33319047|NCT01765192|101063927|FG000|Treatment Period 2|Reason not specified|0|||
33319048|NCT01765192|101063928|FG001|Treatment Period 2|Reason not specified|2|||
33319049|NCT01765192|101063927|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
33319050|NCT01765192|101063928|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
33319051|NCT01138007|101063929|FG000|Overall Study|Adverse Event|4|||
33319052|NCT01138007|101063930|FG001|Overall Study|Adverse Event|12|||
33319053|NCT01138007|101063931|FG002|Overall Study|Adverse Event|9|||
33319054|NCT01138007|101063929|FG000|Overall Study|Lack of Efficacy|2|||
33319055|NCT01138007|101063930|FG001|Overall Study|Lack of Efficacy|0|||
33319056|NCT01138007|101063931|FG002|Overall Study|Lack of Efficacy|6|||
33319057|NCT01138007|101063929|FG000|Overall Study|Protocol Violation|2|||
33319058|NCT01138007|101063930|FG001|Overall Study|Protocol Violation|3|||
33319059|NCT01138007|101063931|FG002|Overall Study|Protocol Violation|2|||
33319060|NCT01138007|101063929|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
33319061|NCT01138007|101063930|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
33319062|NCT01138007|101063931|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
33319063|NCT01138007|101063929|FG000|Overall Study|Lost to Follow-up|3|||
33319064|NCT01138007|101063930|FG001|Overall Study|Lost to Follow-up|3|||
33319065|NCT01138007|101063931|FG002|Overall Study|Lost to Follow-up|5|||
33319066|NCT01138007|101063929|FG000|Overall Study|Physician Decision|0|||
33319067|NCT01138007|101063930|FG001|Overall Study|Physician Decision|5|||
33319068|NCT01138007|101063931|FG002|Overall Study|Physician Decision|3|||
33319069|NCT01138007|101063929|FG000|Overall Study|Withdrawal by Subject|5|||
33319070|NCT01138007|101063930|FG001|Overall Study|Withdrawal by Subject|6|||
33319071|NCT01138007|101063931|FG002|Overall Study|Withdrawal by Subject|15|||
33319072|NCT04217590|101063932|FG000|Overall Study|Other|1|||
33319073|NCT04217590|101063933|FG001|Overall Study|Other|1|||
33319074|NCT04217590|101063932|FG000|Overall Study|Withdrawal by Subject|3|||
33507624|NCT01867710|101753233|FG000|Overall Study|Clinical progression|0|||
33507625|NCT01867710|101753234|FG001|Overall Study|Clinical progression|0|||
33507626|NCT01867710|101753235|FG002|Overall Study|Clinical progression|1|||
33507627|NCT01867710|101753236|FG003|Overall Study|Clinical progression|0|||
33319075|NCT04217590|101063933|FG001|Overall Study|Withdrawal by Subject|1|||
33319076|NCT04217590|101063932|FG000|Overall Study|Death|0|||
33319077|NCT04217590|101063933|FG001|Overall Study|Death|1|||
33319078|NCT01174238|101063936|FG000|Overall Study|Lost to Follow-up|2|||
33319079|NCT00455325|101063937|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
33319080|NCT00455325|101063938|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
33319081|NCT00455325|101063939|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
33319082|NCT00455325|101063940|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
33319083|NCT00455325|101063937|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
33319084|NCT00455325|101063938|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
33319085|NCT00455325|101063939|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
33319086|NCT00455325|101063940|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
33507628|NCT01867710|101753233|FG000|Overall Study|Disease progression|1|||
33507629|NCT01867710|101753234|FG001|Overall Study|Disease progression|0|||
33319087|NCT00455325|101063937|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
33319088|NCT00455325|101063938|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
33319089|NCT00455325|101063939|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
33319090|NCT00455325|101063940|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
33319091|NCT00455325|101063937|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
33319092|NCT00455325|101063938|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
33319093|NCT00455325|101063939|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
33398594|NCT02646891|101350083|FG003|Overall Study|Withdrawal by Subject|0|||
33507630|NCT01867710|101753235|FG002|Overall Study|Disease progression|0|||
33507631|NCT01867710|101753236|FG003|Overall Study|Disease progression|0|||
33507632|NCT01867710|101753233|FG000|Overall Study|Patient decision|0|||
33507633|NCT01867710|101753234|FG001|Overall Study|Patient decision|0|||
33507634|NCT01867710|101753235|FG002|Overall Study|Patient decision|0|||
33507635|NCT01867710|101753236|FG003|Overall Study|Patient decision|1|||
33507636|NCT01867710|101753233|FG000|Overall Study|Patient to follow subsequent treatment|0|||
33507637|NCT01867710|101753234|FG001|Overall Study|Patient to follow subsequent treatment|1|||
33507638|NCT01867710|101753235|FG002|Overall Study|Patient to follow subsequent treatment|0|||
33507639|NCT01867710|101753236|FG003|Overall Study|Patient to follow subsequent treatment|0|||
33507640|NCT01867710|101753233|FG000|Overall Study|Progressive disease|1|||
33507641|NCT01867710|101753234|FG001|Overall Study|Progressive disease|0|||
33507642|NCT01867710|101753235|FG002|Overall Study|Progressive disease|0|||
33507643|NCT01867710|101753236|FG003|Overall Study|Progressive disease|0|||
33507644|NCT01867710|101753233|FG000|Overall Study|Protocol Violation|0|||
33507645|NCT01867710|101753234|FG001|Overall Study|Protocol Violation|0|||
33507646|NCT01867710|101753235|FG002|Overall Study|Protocol Violation|0|||
33507647|NCT01867710|101753236|FG003|Overall Study|Protocol Violation|1|||
33507648|NCT01867710|101753233|FG000|Overall Study|PSA-progression|0|||
33507649|NCT01867710|101753234|FG001|Overall Study|PSA-progression|1|||
33507650|NCT01867710|101753235|FG002|Overall Study|PSA-progression|0|||
33507651|NCT01867710|101753236|FG003|Overall Study|PSA-progression|0|||
33507652|NCT01867710|101753233|FG000|Overall Study|Study medication no longer effective|0|||
33507653|NCT01867710|101753234|FG001|Overall Study|Study medication no longer effective|1|||
33507654|NCT01867710|101753235|FG002|Overall Study|Study medication no longer effective|0|||
33507655|NCT01867710|101753236|FG003|Overall Study|Study medication no longer effective|0|||
33507656|NCT03589326|101753237|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
33507657|NCT03589326|101753238|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
33507658|NCT03589326|101753237|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
33507659|NCT03589326|101753238|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
33507660|NCT03589326|101753237|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
33507661|NCT03589326|101753238|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
33507662|NCT03589326|101753237|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
33507663|NCT03589326|101753238|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
33507664|NCT03589326|101753237|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
33507665|NCT03589326|101753238|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
33507666|NCT02751450|101753240|FG000|Overall Study|Adverse Event|1|||
33507667|NCT02751450|101753241|FG001|Overall Study|Adverse Event|0|||
33507668|NCT04432831|101753255|FG000|Overall Study|Withdrawal by Subject|24|||
33507669|NCT04432831|101753256|FG001|Overall Study|Withdrawal by Subject|28|||
33507670|NCT04432831|101753257|FG002|Overall Study|Withdrawal by Subject|21|||
33507671|NCT04432831|101753255|FG000|Overall Study|Death|23|||
33507672|NCT04432831|101753256|FG001|Overall Study|Death|23|||
33507673|NCT04432831|101753257|FG002|Overall Study|Death|17|||
33507674|NCT04432831|101753255|FG000|Overall Study|Lost to Follow-up|15|||
33507675|NCT04432831|101753256|FG001|Overall Study|Lost to Follow-up|15|||
33507676|NCT04432831|101753257|FG002|Overall Study|Lost to Follow-up|12|||
33507677|NCT04432831|101753255|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
33507678|NCT04432831|101753256|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
33507679|NCT04432831|101753257|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
33507680|NCT04432831|101753255|FG000|Overall Study|Reason Not Specified|7|||
33507681|NCT04432831|101753256|FG001|Overall Study|Reason Not Specified|11|||
33507682|NCT04432831|101753257|FG002|Overall Study|Reason Not Specified|9|||
33507683|NCT04432831|101753255|FG000|Overall Study|Adverse Event|7|||
33507684|NCT04432831|101753256|FG001|Overall Study|Adverse Event|7|||
33507685|NCT04432831|101753257|FG002|Overall Study|Adverse Event|7|||
33507686|NCT04432831|101753255|FG000|Overall Study|Physician Decision|1|||
33319094|NCT00455325|101063940|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
33319095|NCT00455325|101063937|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
33507687|NCT04432831|101753256|FG001|Overall Study|Physician Decision|3|||
33507688|NCT04432831|101753257|FG002|Overall Study|Physician Decision|6|||
33507689|NCT04432831|101753255|FG000|Overall Study|Protocol Violation|1|||
33507690|NCT04432831|101753256|FG001|Overall Study|Protocol Violation|0|||
33507691|NCT04432831|101753257|FG002|Overall Study|Protocol Violation|2|||
33507692|NCT04432831|101753255|FG000|Overall Study|Pregnancy|0|||
33507693|NCT04432831|101753256|FG001|Overall Study|Pregnancy|1|||
33604427|NCT00121641|102102634|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
33604428|NCT00121641|102102630|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
33604429|NCT00121641|102102631|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
33319096|NCT00455325|101063938|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
33319097|NCT00455325|101063939|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
33604430|NCT00121641|102102632|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
33604431|NCT00121641|102102633|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
33604432|NCT00121641|102102634|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
33319098|NCT00455325|101063940|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
33319099|NCT00455325|101063937|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
33319100|NCT00455325|101063938|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
33319101|NCT00455325|101063939|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
33319102|NCT00455325|101063940|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
33398595|NCT02646891|101350084|FG004|Overall Study|Withdrawal by Subject|0|||
33398596|NCT02646891|101350085|FG005|Overall Study|Withdrawal by Subject|0|||
33398597|NCT02646891|101350086|FG006|Overall Study|Withdrawal by Subject|5|||
33398598|NCT02646891|101350087|FG007|Overall Study|Withdrawal by Subject|9|||
33398599|NCT02646891|101350088|FG008|Overall Study|Withdrawal by Subject|7|||
33398600|NCT02646891|101350089|FG009|Overall Study|Withdrawal by Subject|3|||
33398601|NCT02646891|101350080|FG000|Overall Study|Death|0|||
33398602|NCT02646891|101350081|FG001|Overall Study|Death|0|||
33398603|NCT02646891|101350082|FG002|Overall Study|Death|0|||
33398604|NCT02646891|101350083|FG003|Overall Study|Death|0|||
33398605|NCT02646891|101350084|FG004|Overall Study|Death|0|||
33398606|NCT02646891|101350085|FG005|Overall Study|Death|0|||
33398607|NCT02646891|101350086|FG006|Overall Study|Death|1|||
33398608|NCT02646891|101350087|FG007|Overall Study|Death|1|||
33398609|NCT02646891|101350088|FG008|Overall Study|Death|1|||
33398610|NCT02646891|101350089|FG009|Overall Study|Death|0|||
33398611|NCT03661983|101350090|FG000|Open Label Stabilization Phase|Adverse Event|5|||
33398612|NCT03661983|101350091|FG001|Open Label Stabilization Phase|Adverse Event|0|||
33398613|NCT03661983|101350092|FG002|Open Label Stabilization Phase|Adverse Event|0|||
33398614|NCT03661983|101350093|FG003|Open Label Stabilization Phase|Adverse Event|0|||
33398615|NCT03661983|101350090|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
33398616|NCT03661983|101350091|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
33398617|NCT03661983|101350092|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
33398618|NCT03661983|101350093|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
33398619|NCT03661983|101350090|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
33398620|NCT03661983|101350091|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
33398621|NCT03661983|101350092|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
33398622|NCT03661983|101350093|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
33398623|NCT03661983|101350090|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
33398624|NCT03661983|101350091|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
33398625|NCT03661983|101350092|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
33398626|NCT03661983|101350093|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
33398627|NCT03661983|101350090|FG000|Double-blind Randomized Phase|Adverse Event|0|||
33398628|NCT03661983|101350091|FG001|Double-blind Randomized Phase|Adverse Event|1|||
33398629|NCT03661983|101350092|FG002|Double-blind Randomized Phase|Adverse Event|0|||
33398630|NCT03661983|101350093|FG003|Double-blind Randomized Phase|Adverse Event|0|||
33398631|NCT03661983|101350090|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
33398632|NCT03661983|101350091|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
33398633|NCT03661983|101350092|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
33319103|NCT00455325|101063937|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
33319104|NCT00455325|101063938|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
33398634|NCT03661983|101350093|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
33398635|NCT03661983|101350090|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
33398636|NCT03661983|101350091|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
33398637|NCT03661983|101350092|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
33398638|NCT03661983|101350093|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
33398639|NCT03661983|101350090|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
33398640|NCT03661983|101350091|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
33398641|NCT03661983|101350092|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
33398642|NCT03661983|101350093|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
33398643|NCT00439309|101350094|FG000|Follow-Up|Death|1|||
33398644|NCT00439309|101350095|FG001|Follow-Up|Death|0|||
33398645|NCT00439309|101350094|FG000|Follow-Up|Lost to Follow-up|2|||
33398646|NCT00439309|101350095|FG001|Follow-Up|Lost to Follow-up|0|||
33398647|NCT00439309|101350094|FG000|Follow-Up|Withdrawal by Subject|0|||
33507694|NCT04432831|101753257|FG002|Overall Study|Pregnancy|0|||
33507695|NCT04432831|101753255|FG000|Overall Study|Lack of Efficacy|0|||
33507696|NCT04432831|101753256|FG001|Overall Study|Lack of Efficacy|0|||
33507697|NCT04432831|101753257|FG002|Overall Study|Lack of Efficacy|2|||
33507698|NCT04075266|101753261|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
33507699|NCT04075266|101753262|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
33507700|NCT04075266|101753261|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
33507701|NCT04075266|101753262|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
33507702|NCT05139303|101753263|FG000|Overall Study|Lost to Follow-up|3|||
33507703|NCT05139303|101753264|FG001|Overall Study|Lost to Follow-up|0|||
33507704|NCT05139303|101753263|FG000|Overall Study|Adverse Event|1|||
33507705|NCT05139303|101753264|FG001|Overall Study|Adverse Event|0|||
33507706|NCT02792192|101753265|FG000|Overall Study|Death|1|||
33507707|NCT02792192|101753266|FG001|Overall Study|Death|0|||
33507708|NCT02792192|101753267|FG002|Overall Study|Death|0|||
33507709|NCT02792192|101753268|FG003|Overall Study|Death|0|||
33507710|NCT02792192|101753265|FG000|Overall Study|Informed Consent Withdrawn|4|||
33507711|NCT02792192|101753266|FG001|Overall Study|Informed Consent Withdrawn|0|||
33507712|NCT02792192|101753267|FG002|Overall Study|Informed Consent Withdrawn|0|||
33507713|NCT02792192|101753268|FG003|Overall Study|Informed Consent Withdrawn|0|||
33507714|NCT02792192|101753265|FG000|Overall Study|Physician Decision|1|||
33507715|NCT02792192|101753266|FG001|Overall Study|Physician Decision|0|||
33507716|NCT02792192|101753267|FG002|Overall Study|Physician Decision|0|||
33507717|NCT02792192|101753268|FG003|Overall Study|Physician Decision|0|||
33507718|NCT02792192|101753265|FG000|Overall Study|Progressive Disease|0|||
33507719|NCT02792192|101753266|FG001|Overall Study|Progressive Disease|1|||
33507720|NCT02792192|101753267|FG002|Overall Study|Progressive Disease|0|||
33507721|NCT02792192|101753268|FG003|Overall Study|Progressive Disease|0|||
33507722|NCT02792192|101753265|FG000|Overall Study|Study Terminated By Sponsor|6|||
33507723|NCT02792192|101753266|FG001|Overall Study|Study Terminated By Sponsor|10|||
33507724|NCT02792192|101753267|FG002|Overall Study|Study Terminated By Sponsor|0|||
33507725|NCT02792192|101753268|FG003|Overall Study|Study Terminated By Sponsor|0|||
33507726|NCT03615144|101753269|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
33507727|NCT03615144|101753270|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
33319105|NCT00455325|101063939|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
33319106|NCT00455325|101063940|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
33319107|NCT01215422|101063943|FG000|Overall Study|Relocation|1|||
33319108|NCT01215422|101063944|FG001|Overall Study|Relocation|0|||
33319109|NCT01215422|101063945|FG002|Overall Study|Relocation|0|||
33319110|NCT01215422|101063946|FG003|Overall Study|Relocation|0|||
33319111|NCT01215422|101063943|FG000|Overall Study|Failed intubations|0|||
33319112|NCT01215422|101063944|FG001|Overall Study|Failed intubations|0|||
33319113|NCT01215422|101063945|FG002|Overall Study|Failed intubations|3|||
33507728|NCT01493284|101753271|FG000|Overall Study|Death|29|||
33507729|NCT01493284|101753271|FG000|Overall Study|Withdrawal by Subject|32|||
33507730|NCT03626363|101753272|FG000|Overall Study|Protocol Violation|4|||
33507731|NCT03626363|101753273|FG001|Overall Study|Protocol Violation|0|||
33507732|NCT03626363|101753272|FG000|Overall Study|Lost to Follow-up|5|||
33507733|NCT03626363|101753273|FG001|Overall Study|Lost to Follow-up|7|||
33507734|NCT02693106|101753293|FG000|Overall Study|No time|3|||
33319114|NCT01215422|101063946|FG003|Overall Study|Failed intubations|8|||
33319115|NCT01215422|101063943|FG000|Overall Study|Did not complete all intubations|7|||
33319116|NCT01215422|101063944|FG001|Overall Study|Did not complete all intubations|0|||
33319117|NCT01215422|101063945|FG002|Overall Study|Did not complete all intubations|0|||
33319118|NCT01215422|101063946|FG003|Overall Study|Did not complete all intubations|0|||
33319119|NCT03359590|101063947|FG000|First Intervention|Withdrawal by Subject|1|||
33319120|NCT03359590|101063948|FG001|First Intervention|Withdrawal by Subject|1|||
33319121|NCT03359590|101063947|FG000|First Intervention|Protocol Violation|0|||
33507735|NCT00526669|101753294|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
33507736|NCT00526669|101753295|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
33319122|NCT03359590|101063948|FG001|First Intervention|Protocol Violation|1|||
33319123|NCT00928746|101063952|FG000|Overall Study|Adverse Event|2|||
33319124|NCT00928746|101063952|FG000|Overall Study|Protocol Violation|1|||
33319125|NCT00928746|101063952|FG000|Overall Study|Withdrawal by Subject|1|||
33319126|NCT00928746|101063952|FG000|Overall Study|Other|2|||
33319127|NCT02301936|101063956|FG000|Overall Study|Lost to Follow-up|1|||
33319128|NCT02301936|101063957|FG001|Overall Study|Lost to Follow-up|0|||
33507737|NCT00526669|101753294|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
33507738|NCT00526669|101753295|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
33507739|NCT00526669|101753294|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
33507740|NCT00526669|101753295|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
33507741|NCT00526669|101753294|FG000|Combined Treatment Phase|Death|0|||
33507742|NCT00526669|101753295|FG001|Combined Treatment Phase|Death|2|||
33507743|NCT04871711|101753297|FG000|Overall Study|Withdrawal by Subject|11|||
33507744|NCT04871711|101753298|FG001|Overall Study|Withdrawal by Subject|5|||
33507745|NCT04871711|101753297|FG000|Overall Study|Lack of Efficacy|5|||
33319129|NCT01050205|101063959|FG000|Overall Study|Lost to Follow-up|7|||
33507746|NCT04871711|101753298|FG001|Overall Study|Lack of Efficacy|7|||
33319130|NCT01050205|101063960|FG001|Overall Study|Lost to Follow-up|1|||
33319131|NCT01050205|101063959|FG000|Overall Study|Withdrawal by Subject|1|||
33319132|NCT01050205|101063960|FG001|Overall Study|Withdrawal by Subject|1|||
33319133|NCT01050205|101063959|FG000|Overall Study|Relocated from area|1|||
33319134|NCT01050205|101063960|FG001|Overall Study|Relocated from area|2|||
33319135|NCT01050205|101063959|FG000|Overall Study|Discontinued Intervention|2|||
33319136|NCT01050205|101063960|FG001|Overall Study|Discontinued Intervention|0|||
33319137|NCT02349451|101063963|FG000|Overall Study|Withdrawal by Subject|0|||
33319138|NCT02349451|101063964|FG001|Overall Study|Withdrawal by Subject|1|||
33319139|NCT02349451|101063965|FG002|Overall Study|Withdrawal by Subject|2|||
33319140|NCT02349451|101063966|FG003|Overall Study|Withdrawal by Subject|1|||
33319141|NCT00047320|101063967|FG000|Overall Study|Lack of Efficacy|8|||
33319142|NCT00047320|101063967|FG000|Overall Study|Lost to Follow-up|1|||
33319143|NCT00047320|101063967|FG000|Overall Study|Physician Decision|8|||
33319144|NCT00047320|101063967|FG000|Overall Study|Withdrawal by Subject|9|||
33319145|NCT00047320|101063967|FG000|Overall Study|Ineligible|2|||
33319146|NCT01128738|101063968|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
33319147|NCT01128738|101063969|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
33319148|NCT01128738|101063968|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
33319149|NCT01128738|101063969|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
33319150|NCT01128738|101063968|FG000|Second TP|Lost to Follow-up|0|||
33319151|NCT01128738|101063969|FG001|Second TP|Lost to Follow-up|1|||
33319152|NCT01128738|101063968|FG000|Second TP|Withdrawal by Subject|0|||
33319153|NCT01128738|101063969|FG001|Second TP|Withdrawal by Subject|2|||
33319154|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
33319155|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
33319156|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
33319157|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
33319158|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
33507747|NCT04871711|101753297|FG000|Overall Study|Adverse Event|2|||
33507748|NCT04871711|101753298|FG001|Overall Study|Adverse Event|6|||
33507749|NCT04871711|101753297|FG000|Overall Study|Various reasons|2|||
33507750|NCT04871711|101753298|FG001|Overall Study|Various reasons|1|||
33507751|NCT04871711|101753297|FG000|Overall Study|Lost to Follow-up|0|||
33507752|NCT04871711|101753298|FG001|Overall Study|Lost to Follow-up|2|||
33507753|NCT02211638|101753299|FG000|Overall Study|Case Report Forms Uncollected|291|||
33507754|NCT02211638|101753299|FG000|Overall Study|Protocol Violation|692|||
33507755|NCT01116648|101753302|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
33507756|NCT01116648|101753303|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
33507757|NCT01116648|101753304|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
33507758|NCT01116648|101753305|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
33507759|NCT01116648|101753306|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
33507760|NCT01116648|101753307|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
33507761|NCT01116648|101753308|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
33507762|NCT01116648|101753309|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
33507763|NCT01116648|101753310|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
33507764|NCT01116648|101753311|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
33507765|NCT01116648|101753312|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
33507766|NCT01116648|101753313|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
33507767|NCT01116648|101753314|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
33507768|NCT01116648|101753315|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
33507769|NCT01116648|101753316|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
33507770|NCT02640404|101753317|FG000|Overall Study|Protocol Violation|1|||
33507771|NCT02640404|101753318|FG001|Overall Study|Protocol Violation|0|||
33507772|NCT02640404|101753317|FG000|Overall Study|Withdrawal by Subject|1|||
33507773|NCT02640404|101753318|FG001|Overall Study|Withdrawal by Subject|0|||
33507774|NCT03379753|101753319|FG000|Overall Study|Withdrawal by Subject|2|||
33507775|NCT03379753|101753320|FG001|Overall Study|Withdrawal by Subject|1|||
33507776|NCT03379753|101753319|FG000|Overall Study|not having correct procedure|1|||
33507777|NCT03379753|101753320|FG001|Overall Study|not having correct procedure|2|||
33319159|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
33319160|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
33507778|NCT03379753|101753319|FG000|Overall Study|No primary outcome|12|||
33507779|NCT03379753|101753320|FG001|Overall Study|No primary outcome|22|||
33197371|NCT00439140|100626486|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
33319161|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
33319162|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Death|1|||
33319163|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Death|1|||
33507780|NCT00680901|101753321|FG000|Overall Study|Lost to Follow-up|8|||
33507781|NCT00680901|101753322|FG001|Overall Study|Lost to Follow-up|8|||
33507782|NCT00680901|101753321|FG000|Overall Study|Withdrawal by Subject|4|||
33507783|NCT00680901|101753322|FG001|Overall Study|Withdrawal by Subject|13|||
33507784|NCT00680901|101753321|FG000|Overall Study|Physician Decision|0|||
33507785|NCT00680901|101753322|FG001|Overall Study|Physician Decision|1|||
33507786|NCT00680901|101753321|FG000|Overall Study|Ongoing: On Study Treatment|16|||
33507787|NCT00680901|101753322|FG001|Overall Study|Ongoing: On Study Treatment|13|||
33507788|NCT00680901|101753321|FG000|Overall Study|Ongoing: In Follow Up|45|||
33507789|NCT00680901|101753322|FG001|Overall Study|Ongoing: In Follow Up|41|||
33507790|NCT01082211|101753323|FG000|Overall Study|Protocol Violation|4|||
33507791|NCT01082211|101753323|FG000|Overall Study|No protocol treatment received|3|||
33507792|NCT01704651|101753324|FG000|Overall Study|Pre-op withdrawal by subject|1|||
33507793|NCT01704651|101753325|FG001|Overall Study|Pre-op withdrawal by subject|1|||
33507794|NCT01704651|101753324|FG000|Overall Study|Pre-op change in treatment plan|1|||
33507795|NCT01704651|101753325|FG001|Overall Study|Pre-op change in treatment plan|4|||
33507796|NCT01704651|101753324|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
33507797|NCT01704651|101753325|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
33507798|NCT01704651|101753324|FG000|Overall Study|Post-op did not have laparotomy|2|||
33507799|NCT01704651|101753325|FG001|Overall Study|Post-op did not have laparotomy|1|||
33507800|NCT02640950|101753328|FG000|Overall Study|Adverse Event|1|||
33507801|NCT02640950|101753328|FG000|Overall Study|Withdrawal by Subject|1|||
33507802|NCT01270464|101753331|FG000|Overall Study|Protocol Violation|4|||
33507803|NCT01270464|101753332|FG001|Overall Study|Protocol Violation|3|||
33507804|NCT01270464|101753333|FG002|Overall Study|Protocol Violation|2|||
33507805|NCT01270464|101753331|FG000|Overall Study|Lack of Efficacy|2|||
33507806|NCT01270464|101753332|FG001|Overall Study|Lack of Efficacy|3|||
33507807|NCT01270464|101753333|FG002|Overall Study|Lack of Efficacy|1|||
33507808|NCT01270464|101753331|FG000|Overall Study|Adverse Event|9|||
33197372|NCT00439140|100626487|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
33197373|NCT00439140|100626485|FG000|Treatment Cycle 1|Personal reasons|0|||
33197374|NCT00439140|100626486|FG001|Treatment Cycle 1|Personal reasons|2|||
33197375|NCT00439140|100626487|FG002|Treatment Cycle 1|Personal reasons|0|||
33197376|NCT00439140|100626485|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
33197377|NCT00439140|100626486|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
33197378|NCT00439140|100626487|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
33197379|NCT00439140|100626485|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
33197380|NCT00439140|100626486|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
33197381|NCT00439140|100626487|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
33197382|NCT00439140|100626485|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
33197383|NCT00439140|100626486|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
33197384|NCT00439140|100626487|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
33197385|NCT04532112|100626489|FG000|Overall Study|Adverse Event|3|||
33197386|NCT04532112|100626490|FG001|Overall Study|Adverse Event|0|||
33197387|NCT00048724|100626491|FG000|Overall Study|Adverse Event|53|||
33197388|NCT00048724|100626492|FG001|Overall Study|Adverse Event|12|||
33197389|NCT00048724|100626491|FG000|Overall Study|Withdrawal by Subject|34|||
33197390|NCT00048724|100626492|FG001|Overall Study|Withdrawal by Subject|54|||
33197391|NCT00048724|100626491|FG000|Overall Study|Lost to Follow-up|5|||
33197392|NCT00048724|100626492|FG001|Overall Study|Lost to Follow-up|5|||
33197393|NCT00048724|100626491|FG000|Overall Study|Protocol-defined Clinical Event|17|||
33319164|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
33319165|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
33197394|NCT00048724|100626492|FG001|Overall Study|Protocol-defined Clinical Event|32|||
33197395|NCT00048724|100626491|FG000|Overall Study|Noncompliance With Protocol|4|||
33197396|NCT00048724|100626492|FG001|Overall Study|Noncompliance With Protocol|12|||
33197397|NCT00048724|100626491|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
33197398|NCT00048724|100626492|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
33197399|NCT00048724|100626491|FG000|Overall Study|Administrative|1|||
33197400|NCT00048724|100626492|FG001|Overall Study|Administrative|1|||
33197401|NCT02461589|100626493|FG000|Overall Study|Withdrawal by Subject|5|||
33319166|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
33319167|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
33197402|NCT02461589|100626494|FG001|Overall Study|Withdrawal by Subject|1|||
33197403|NCT02461589|100626495|FG002|Overall Study|Withdrawal by Subject|3|||
33197404|NCT02461589|100626496|FG003|Overall Study|Withdrawal by Subject|2|||
33319168|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
33319169|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
33507809|NCT01270464|101753332|FG001|Overall Study|Adverse Event|1|||
33507810|NCT01270464|101753333|FG002|Overall Study|Adverse Event|7|||
33507811|NCT01270464|101753331|FG000|Overall Study|Withdrawal by Subject|2|||
33197405|NCT02461589|100626497|FG004|Overall Study|Withdrawal by Subject|1|||
33197406|NCT02461589|100626498|FG005|Overall Study|Withdrawal by Subject|2|||
33197407|NCT02461589|100626499|FG006|Overall Study|Withdrawal by Subject|1|||
33197408|NCT02461589|100626500|FG007|Overall Study|Withdrawal by Subject|3|||
33197409|NCT02461589|100626501|FG008|Overall Study|Withdrawal by Subject|3|||
33507812|NCT01270464|101753332|FG001|Overall Study|Withdrawal by Subject|1|||
33507813|NCT01270464|101753333|FG002|Overall Study|Withdrawal by Subject|4|||
33507814|NCT01270464|101753331|FG000|Overall Study|Lost to Follow-up|2|||
33507815|NCT01270464|101753332|FG001|Overall Study|Lost to Follow-up|3|||
33197410|NCT02461589|100626502|FG009|Overall Study|Withdrawal by Subject|1|||
33197411|NCT02461589|100626493|FG000|Overall Study|Lost to Follow-up|0|||
33197412|NCT02461589|100626494|FG001|Overall Study|Lost to Follow-up|0|||
33197413|NCT02461589|100626495|FG002|Overall Study|Lost to Follow-up|2|||
33197414|NCT02461589|100626496|FG003|Overall Study|Lost to Follow-up|3|||
33197415|NCT02461589|100626497|FG004|Overall Study|Lost to Follow-up|1|||
33197416|NCT02461589|100626498|FG005|Overall Study|Lost to Follow-up|1|||
33197417|NCT02461589|100626499|FG006|Overall Study|Lost to Follow-up|3|||
33197418|NCT02461589|100626500|FG007|Overall Study|Lost to Follow-up|1|||
33197419|NCT02461589|100626501|FG008|Overall Study|Lost to Follow-up|3|||
33197420|NCT02461589|100626502|FG009|Overall Study|Lost to Follow-up|1|||
33197421|NCT02461589|100626493|FG000|Overall Study|Death|0|||
33197422|NCT02461589|100626494|FG001|Overall Study|Death|0|||
33197423|NCT02461589|100626495|FG002|Overall Study|Death|0|||
33197424|NCT02461589|100626496|FG003|Overall Study|Death|0|||
33197425|NCT02461589|100626497|FG004|Overall Study|Death|0|||
33197426|NCT02461589|100626498|FG005|Overall Study|Death|0|||
33197427|NCT02461589|100626499|FG006|Overall Study|Death|0|||
33197428|NCT02461589|100626500|FG007|Overall Study|Death|1|||
33197429|NCT02461589|100626501|FG008|Overall Study|Death|0|||
33197430|NCT02461589|100626502|FG009|Overall Study|Death|0|||
33197431|NCT02461589|100626493|FG000|Overall Study|Unclassified|0|||
33197432|NCT02461589|100626494|FG001|Overall Study|Unclassified|0|||
33197433|NCT02461589|100626495|FG002|Overall Study|Unclassified|0|||
33197434|NCT02461589|100626496|FG003|Overall Study|Unclassified|0|||
33197435|NCT02461589|100626497|FG004|Overall Study|Unclassified|0|||
33197436|NCT02461589|100626498|FG005|Overall Study|Unclassified|0|||
33197437|NCT02461589|100626499|FG006|Overall Study|Unclassified|1|||
33197438|NCT02461589|100626500|FG007|Overall Study|Unclassified|0|||
33197439|NCT02461589|100626501|FG008|Overall Study|Unclassified|0|||
33197440|NCT02461589|100626502|FG009|Overall Study|Unclassified|2|||
33197441|NCT02461589|100626493|FG000|Overall Study|Missing follow-up information|1|||
33197442|NCT02461589|100626494|FG001|Overall Study|Missing follow-up information|1|||
33197443|NCT02461589|100626495|FG002|Overall Study|Missing follow-up information|0|||
33197444|NCT02461589|100626496|FG003|Overall Study|Missing follow-up information|0|||
33197445|NCT02461589|100626497|FG004|Overall Study|Missing follow-up information|0|||
33197446|NCT02461589|100626498|FG005|Overall Study|Missing follow-up information|0|||
33197447|NCT02461589|100626499|FG006|Overall Study|Missing follow-up information|1|||
33197448|NCT02461589|100626500|FG007|Overall Study|Missing follow-up information|0|||
33197449|NCT02461589|100626501|FG008|Overall Study|Missing follow-up information|0|||
33197450|NCT02461589|100626502|FG009|Overall Study|Missing follow-up information|0|||
33197451|NCT02461589|100626493|FG000|Overall Study|Withdrawal from trial before exposure|0|||
33197452|NCT02461589|100626494|FG001|Overall Study|Withdrawal from trial before exposure|0|||
33197453|NCT02461589|100626495|FG002|Overall Study|Withdrawal from trial before exposure|0|||
33197454|NCT02461589|100626496|FG003|Overall Study|Withdrawal from trial before exposure|0|||
33197455|NCT02461589|100626497|FG004|Overall Study|Withdrawal from trial before exposure|0|||
33197456|NCT02461589|100626498|FG005|Overall Study|Withdrawal from trial before exposure|0|||
33197457|NCT02461589|100626499|FG006|Overall Study|Withdrawal from trial before exposure|0|||
33319170|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
33319171|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
33319172|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
33319173|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
33319174|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
33319175|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
33319176|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
33319177|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
33319178|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
33319179|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
33319180|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
33319181|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
33319182|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
33319183|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
33319184|NCT00559585|101063970|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
33398648|NCT00439309|101350095|FG001|Follow-Up|Withdrawal by Subject|1|||
33197458|NCT02461589|100626500|FG007|Overall Study|Withdrawal from trial before exposure|0|||
33197459|NCT02461589|100626501|FG008|Overall Study|Withdrawal from trial before exposure|0|||
33197460|NCT02461589|100626502|FG009|Overall Study|Withdrawal from trial before exposure|1|||
33197461|NCT00403455|100626503|FG000|Overall Study|Withdrawal by Subject|1|||
33197462|NCT03042312|100626504|FG000|Overall Study|Administrative Reason|1|||
33197463|NCT03042312|100626505|FG001|Overall Study|Administrative Reason|1|||
33197464|NCT03042312|100626504|FG000|Overall Study|Adverse Event|0|||
33197465|NCT03042312|100626505|FG001|Overall Study|Adverse Event|1|||
33197466|NCT03042312|100626504|FG000|Overall Study|Lost to Follow-up|1|||
33197467|NCT03042312|100626505|FG001|Overall Study|Lost to Follow-up|3|||
33197468|NCT03042312|100626504|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
33197469|NCT03042312|100626505|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
33197470|NCT03042312|100626504|FG000|Overall Study|Withdrawal by Subject|4|||
33197471|NCT03042312|100626505|FG001|Overall Study|Withdrawal by Subject|5|||
33197472|NCT00600821|100626506|FG000|Overall Study|Death|45|||
33197473|NCT00600821|100626507|FG001|Overall Study|Death|46|||
33197474|NCT00600821|100626506|FG000|Overall Study|Lost to Follow-up|2|||
33197475|NCT00600821|100626507|FG001|Overall Study|Lost to Follow-up|2|||
33197476|NCT00600821|100626506|FG000|Overall Study|Withdrawal by Subject|1|||
33197477|NCT00600821|100626507|FG001|Overall Study|Withdrawal by Subject|1|||
33197478|NCT00600821|100626506|FG000|Overall Study|Terminated by sponsor|8|||
33197479|NCT00600821|100626507|FG001|Overall Study|Terminated by sponsor|6|||
33197480|NCT00600821|100626506|FG000|Overall Study|Objective progression or relapse|0|||
33197481|NCT00600821|100626507|FG001|Overall Study|Objective progression or relapse|1|||
33197482|NCT00600821|100626506|FG000|Overall Study|Randomized but not treated|0|||
33197483|NCT00600821|100626507|FG001|Overall Study|Randomized but not treated|1|||
33197484|NCT00600821|100626506|FG000|Overall Study|Other|2|||
33197485|NCT00600821|100626507|FG001|Overall Study|Other|3|||
33197486|NCT04369469|100626510|FG000|Overall Study|Lost to Follow-up|2|||
33197487|NCT04369469|100626511|FG001|Overall Study|Lost to Follow-up|4|||
33197488|NCT04369469|100626510|FG000|Overall Study|Physician Decision|2|||
33197489|NCT04369469|100626511|FG001|Overall Study|Physician Decision|1|||
33197490|NCT04369469|100626510|FG000|Overall Study|Withdrawal by Subject|2|||
33197491|NCT04369469|100626511|FG001|Overall Study|Withdrawal by Subject|3|||
33197492|NCT04369469|100626510|FG000|Overall Study|Adverse Event|1|||
33197493|NCT04369469|100626511|FG001|Overall Study|Adverse Event|0|||
33197494|NCT04369469|100626510|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
33197495|NCT04369469|100626511|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
33197496|NCT04369469|100626510|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
33197497|NCT04369469|100626511|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
33197498|NCT04369469|100626510|FG000|Overall Study|Unable to Provide Consent|0|||
33197499|NCT04369469|100626511|FG001|Overall Study|Unable to Provide Consent|1|||
33197500|NCT00812812|100626514|FG000|Overall Study|Adverse Event|2|||
33197501|NCT00812812|100626515|FG001|Overall Study|Adverse Event|1|||
33197502|NCT00812812|100626514|FG000|Overall Study|Lack of Efficacy|1|||
33197503|NCT00812812|100626515|FG001|Overall Study|Lack of Efficacy|0|||
33197504|NCT00812812|100626514|FG000|Overall Study|Lost to Follow-up|0|||
33197505|NCT00812812|100626515|FG001|Overall Study|Lost to Follow-up|1|||
33197506|NCT00812812|100626514|FG000|Overall Study|Withdrawal by Subject|0|||
33197507|NCT00812812|100626515|FG001|Overall Study|Withdrawal by Subject|2|||
33197508|NCT04028388|100626524|FG000|Overall Study|Evaluations missing|3|||
33197509|NCT04028388|100626525|FG001|Overall Study|Evaluations missing|6|||
33197510|NCT04028388|100626524|FG000|Overall Study|Not started|2|||
33197511|NCT04028388|100626525|FG001|Overall Study|Not started|0|||
33197512|NCT03930745|100626530|FG000|Overall Study|Lost to Follow-up|10|||
33197513|NCT03930745|100626531|FG001|Overall Study|Lost to Follow-up|5|||
33197514|NCT03930745|100626530|FG000|Overall Study|Withdrawal by Subject|1|||
33197515|NCT03930745|100626531|FG001|Overall Study|Withdrawal by Subject|2|||
33197516|NCT03930745|100626530|FG000|Overall Study|Protocol Violation|2|||
33197517|NCT03930745|100626531|FG001|Overall Study|Protocol Violation|2|||
33197518|NCT03930745|100626530|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
33197519|NCT03930745|100626531|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
33197520|NCT03930745|100626530|FG000|Overall Study|Adverse Event|0|||
33197521|NCT03930745|100626531|FG001|Overall Study|Adverse Event|1|||
33197522|NCT03930745|100626530|FG000|Overall Study|Pregnancy|0|||
33197523|NCT03930745|100626531|FG001|Overall Study|Pregnancy|1|||
33197524|NCT00617240|100626534|FG000|Overall Study|Lack of Efficacy|1|||
33197525|NCT00617240|100626535|FG001|Overall Study|Lack of Efficacy|0|||
33197526|NCT04632940|100626536|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
33197527|NCT04632940|100626537|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
33197528|NCT04632940|100626536|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
33197529|NCT04632940|100626537|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
33197530|NCT04632940|100626536|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
33197531|NCT04632940|100626537|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
33197532|NCT04632940|100626536|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
33197533|NCT04632940|100626537|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
33197534|NCT04632940|100626536|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
33197535|NCT04632940|100626537|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
33197536|NCT04632940|100626536|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
33197537|NCT04632940|100626537|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
33197538|NCT04632940|100626536|FG000|OLE Period (52 Weeks)|Other than specified|0|||
33197539|NCT04632940|100626537|FG001|OLE Period (52 Weeks)|Other than specified|1|||
33197540|NCT04632940|100626536|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
33197541|NCT04632940|100626537|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
33197542|NCT02520531|100626542|FG000|Overall Study|Revision of study device components|2|||
33197543|NCT02520531|100626543|FG001|Overall Study|Revision of study device components|2|||
33197544|NCT02520531|100626542|FG000|Overall Study|Death|1|||
33197545|NCT02520531|100626543|FG001|Overall Study|Death|2|||
33197546|NCT02520531|100626542|FG000|Overall Study|Lost to Follow-up|1|||
33197547|NCT02520531|100626543|FG001|Overall Study|Lost to Follow-up|1|||
33197548|NCT02520531|100626542|FG000|Overall Study|Meet exclusion criterion|0|||
33197549|NCT02520531|100626543|FG001|Overall Study|Meet exclusion criterion|1|||
33197550|NCT02520531|100626542|FG000|Overall Study|Withdrawal by Subject|1|||
33197551|NCT02520531|100626543|FG001|Overall Study|Withdrawal by Subject|0|||
33197552|NCT02520531|100626542|FG000|Overall Study|Not study device|1|||
33197553|NCT02520531|100626543|FG001|Overall Study|Not study device|0|||
33197554|NCT01243944|100626547|FG000|Overall Study|Adverse Event|15|||
33197555|NCT01243944|100626548|FG001|Overall Study|Adverse Event|13|||
33197556|NCT01243944|100626547|FG000|Overall Study|Lost to Follow-up|2|||
33197557|NCT01243944|100626548|FG001|Overall Study|Lost to Follow-up|1|||
33197558|NCT01243944|100626547|FG000|Overall Study|Physician Decision|2|||
33197559|NCT01243944|100626548|FG001|Overall Study|Physician Decision|7|||
33197560|NCT01243944|100626547|FG000|Overall Study|Disease progression|12|||
33197561|NCT01243944|100626548|FG001|Overall Study|Disease progression|11|||
33197562|NCT01243944|100626547|FG000|Overall Study|Protocol deviation|1|||
33197563|NCT01243944|100626548|FG001|Overall Study|Protocol deviation|1|||
33197564|NCT01243944|100626547|FG000|Overall Study|Participant decision|10|||
33197565|NCT01243944|100626548|FG001|Overall Study|Participant decision|15|||
33197566|NCT01243944|100626547|FG000|Overall Study|Death|2|||
33197567|NCT01243944|100626548|FG001|Overall Study|Death|3|||
33197568|NCT01243944|100626547|FG000|Overall Study|Non-compliance with study treatment|1|||
33197569|NCT01243944|100626548|FG001|Overall Study|Non-compliance with study treatment|0|||
33197570|NCT04177108|100626552|FG000|Overall Study|Withdrawal by Subject|4|||
33197571|NCT04177108|100626553|FG001|Overall Study|Withdrawal by Subject|8|||
33197572|NCT04177108|100626554|FG002|Overall Study|Withdrawal by Subject|9|||
33197573|NCT04177108|100626555|FG003|Overall Study|Withdrawal by Subject|11|||
33197574|NCT04177108|100626556|FG004|Overall Study|Withdrawal by Subject|13|||
33197575|NCT04177108|100626552|FG000|Overall Study|Physician Decision|23|||
33197576|NCT04177108|100626553|FG001|Overall Study|Physician Decision|15|||
33197577|NCT04177108|100626554|FG002|Overall Study|Physician Decision|18|||
33197578|NCT04177108|100626555|FG003|Overall Study|Physician Decision|29|||
33197579|NCT04177108|100626556|FG004|Overall Study|Physician Decision|23|||
33197580|NCT04177108|100626552|FG000|Overall Study|Reason Not Specified|0|||
33197581|NCT04177108|100626553|FG001|Overall Study|Reason Not Specified|1|||
33197582|NCT04177108|100626554|FG002|Overall Study|Reason Not Specified|0|||
33197583|NCT04177108|100626555|FG003|Overall Study|Reason Not Specified|0|||
33197584|NCT04177108|100626556|FG004|Overall Study|Reason Not Specified|2|||
33197585|NCT04177108|100626552|FG000|Overall Study|Lost to Follow-up|0|||
33197586|NCT04177108|100626553|FG001|Overall Study|Lost to Follow-up|0|||
33197587|NCT04177108|100626554|FG002|Overall Study|Lost to Follow-up|1|||
33197588|NCT04177108|100626555|FG003|Overall Study|Lost to Follow-up|1|||
33197589|NCT04177108|100626556|FG004|Overall Study|Lost to Follow-up|1|||
33197590|NCT04177108|100626552|FG000|Overall Study|Death|16|||
33197591|NCT04177108|100626553|FG001|Overall Study|Death|19|||
33197592|NCT04177108|100626554|FG002|Overall Study|Death|13|||
33197593|NCT04177108|100626555|FG003|Overall Study|Death|17|||
33197594|NCT04177108|100626556|FG004|Overall Study|Death|18|||
33197595|NCT00413413|100626563|FG000|Single-Blind|Adverse Event|0|||
33197596|NCT00413413|100626564|FG001|Single-Blind|Adverse Event|9|||
33197597|NCT00413413|100626565|FG002|Single-Blind|Adverse Event|0|||
33197598|NCT00413413|100626563|FG000|Single-Blind|Lack of Efficacy|0|||
33197599|NCT00413413|100626564|FG001|Single-Blind|Lack of Efficacy|5|||
33197600|NCT00413413|100626565|FG002|Single-Blind|Lack of Efficacy|0|||
33197601|NCT00413413|100626563|FG000|Single-Blind|Subject no longer requires study drug|0|||
33197602|NCT00413413|100626564|FG001|Single-Blind|Subject no longer requires study drug|151|||
33197603|NCT00413413|100626565|FG002|Single-Blind|Subject no longer requires study drug|0|||
33197604|NCT00413413|100626563|FG000|Single-Blind|Protocol Violation|0|||
33197605|NCT00413413|100626564|FG001|Single-Blind|Protocol Violation|16|||
33197606|NCT00413413|100626565|FG002|Single-Blind|Protocol Violation|0|||
33197607|NCT00413413|100626563|FG000|Single-Blind|Withdrawal by Subject|0|||
33197608|NCT00413413|100626564|FG001|Single-Blind|Withdrawal by Subject|27|||
33197609|NCT00413413|100626565|FG002|Single-Blind|Withdrawal by Subject|0|||
33197610|NCT00413413|100626563|FG000|Single-Blind|Lost to Follow-up|0|||
33197611|NCT00413413|100626564|FG001|Single-Blind|Lost to Follow-up|8|||
33197612|NCT00413413|100626565|FG002|Single-Blind|Lost to Follow-up|0|||
33507816|NCT01270464|101753333|FG002|Overall Study|Lost to Follow-up|1|||
33197613|NCT00413413|100626563|FG000|Double-Blind|Adverse Event|6|||
33197614|NCT00413413|100626564|FG001|Double-Blind|Adverse Event|0|||
33197615|NCT00413413|100626565|FG002|Double-Blind|Adverse Event|5|||
33197616|NCT00413413|100626563|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
33197617|NCT00413413|100626564|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
33197618|NCT00413413|100626565|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
33197619|NCT00413413|100626563|FG000|Double-Blind|Protocol deviation|1|||
33197620|NCT00413413|100626564|FG001|Double-Blind|Protocol deviation|2|||
33319185|NCT00559585|101063971|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
33319186|NCT00559585|101063970|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
33319187|NCT00559585|101063971|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
33319188|NCT00559585|101063970|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
33319189|NCT00559585|101063971|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
33319190|NCT00559585|101063970|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
33319191|NCT00559585|101063971|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
33319192|NCT00559585|101063970|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
33507817|NCT01270464|101753331|FG000|Overall Study|Other|1|||
33507818|NCT01270464|101753332|FG001|Overall Study|Other|1|||
33507819|NCT01270464|101753333|FG002|Overall Study|Other|3|||
33507820|NCT01108341|101753334|FG000|Overall Study|Death|2|||
33507821|NCT01108341|101753334|FG000|Overall Study|Withdrawal by Subject|1|||
33507822|NCT01108341|101753334|FG000|Overall Study|Lost to Follow-up|1|||
33507823|NCT01108341|101753334|FG000|Overall Study|Other|1|||
33507824|NCT01399047|101753335|FG000|Overall Study|Withdrawal by Subject|0|||
33507825|NCT01399047|101753336|FG001|Overall Study|Withdrawal by Subject|1|||
33507826|NCT03489707|101753337|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
33507827|NCT03489707|101753338|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
33507828|NCT03489707|101753337|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
33507829|NCT03489707|101753338|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
33507830|NCT04687072|101753342|FG000|Overall Study|Adverse Event|2|||
33507831|NCT04687072|101753343|FG001|Overall Study|Adverse Event|0|||
33507832|NCT04687072|101753342|FG000|Overall Study|Death|1|||
33507833|NCT04687072|101753343|FG001|Overall Study|Death|0|||
33507834|NCT04687072|101753342|FG000|Overall Study|Lack of Efficacy|2|||
33507835|NCT04687072|101753343|FG001|Overall Study|Lack of Efficacy|1|||
33507836|NCT04687072|101753342|FG000|Overall Study|Physician Decision|1|||
33507837|NCT04687072|101753343|FG001|Overall Study|Physician Decision|0|||
33507838|NCT04687072|101753342|FG000|Overall Study|Pregnancy|1|||
33507839|NCT04687072|101753343|FG001|Overall Study|Pregnancy|0|||
33507840|NCT04687072|101753342|FG000|Overall Study|Requires Prohibited Medication|2|||
33507841|NCT04687072|101753343|FG001|Overall Study|Requires Prohibited Medication|0|||
33507842|NCT04687072|101753342|FG000|Overall Study|Withdrawal of Consent|11|||
33507843|NCT04687072|101753343|FG001|Overall Study|Withdrawal of Consent|6|||
33507844|NCT04687072|101753342|FG000|Overall Study|Miscellaneous|4|||
33507845|NCT04687072|101753343|FG001|Overall Study|Miscellaneous|1|||
33507846|NCT01023256|101755883|FG000|Overall Study|Protocol Violation|2|||
33507847|NCT01023256|101755884|FG001|Overall Study|Protocol Violation|3|||
33507848|NCT01023256|101755885|FG002|Overall Study|Protocol Violation|0|||
33507849|NCT01023256|101755886|FG003|Overall Study|Protocol Violation|0|||
33507850|NCT01023256|101755883|FG000|Overall Study|Randomized but not treated|1|||
33507851|NCT01023256|101755884|FG001|Overall Study|Randomized but not treated|0|||
33507852|NCT01023256|101755885|FG002|Overall Study|Randomized but not treated|1|||
33507853|NCT01023256|101755886|FG003|Overall Study|Randomized but not treated|0|||
33507854|NCT01023256|101755883|FG000|Overall Study|Other|1|||
33507855|NCT01023256|101755884|FG001|Overall Study|Other|0|||
33507856|NCT01023256|101755885|FG002|Overall Study|Other|0|||
33507857|NCT01023256|101755886|FG003|Overall Study|Other|2|||
33507858|NCT01023256|101755883|FG000|Overall Study|Adverse Event|0|||
33507859|NCT01023256|101755884|FG001|Overall Study|Adverse Event|0|||
33507860|NCT01023256|101755885|FG002|Overall Study|Adverse Event|0|||
33507861|NCT01023256|101755886|FG003|Overall Study|Adverse Event|1|||
33507862|NCT01023256|101755883|FG000|Overall Study|Withdrawal by Subject|0|||
33507863|NCT01023256|101755884|FG001|Overall Study|Withdrawal by Subject|0|||
33507864|NCT01023256|101755885|FG002|Overall Study|Withdrawal by Subject|0|||
33507865|NCT01023256|101755886|FG003|Overall Study|Withdrawal by Subject|2|||
33507866|NCT00877071|101755887|FG000|Overall Study|disease progression|2|||
33507867|NCT03973918|101755888|FG000|Overall Study|Adverse Event|0|||
33507868|NCT03973918|101755889|FG001|Overall Study|Adverse Event|0|||
33507869|NCT03973918|101755890|FG002|Overall Study|Adverse Event|0|||
33319193|NCT00559585|101063971|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
33319194|NCT00559585|101063970|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
33319195|NCT00559585|101063971|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
33364915|NCT01790438|101223683|FG001|Overall Study|Withdrawal by Subject|2|||
33507870|NCT03973918|101755891|FG003|Overall Study|Adverse Event|1|||
33507871|NCT03973918|101755888|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
33507872|NCT03973918|101755889|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
33507873|NCT03973918|101755890|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
33507874|NCT03973918|101755891|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
33507875|NCT01744184|101755892|FG000|Overall Study|Adverse Event|1|||
33507876|NCT01744184|101755893|FG001|Overall Study|Adverse Event|0|||
33507877|NCT01744184|101755892|FG000|Overall Study|Withdrawal by Subject|0|||
33197621|NCT00413413|100626565|FG002|Double-Blind|Protocol deviation|1|||
33197622|NCT00413413|100626563|FG000|Double-Blind|Subject withdrew consent|4|||
33197623|NCT00413413|100626564|FG001|Double-Blind|Subject withdrew consent|6|||
33197624|NCT00413413|100626565|FG002|Double-Blind|Subject withdrew consent|9|||
33197625|NCT00413413|100626563|FG000|Double-Blind|Lost to Follow-up|3|||
33197626|NCT00413413|100626564|FG001|Double-Blind|Lost to Follow-up|4|||
33197627|NCT00413413|100626565|FG002|Double-Blind|Lost to Follow-up|2|||
33197628|NCT03766009|100626567|FG000|Usual Care|Death|0|||
33604433|NCT00121641|102102630|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
33319196|NCT00559585|101063970|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
33197629|NCT03766009|100626568|FG001|Usual Care|Death|0|||
33197630|NCT03766009|100626569|FG002|Usual Care|Death|0|||
33197631|NCT03766009|100626570|FG003|Usual Care|Death|1|||
33197632|NCT03766009|100626571|FG004|Usual Care|Death|0|||
33197633|NCT03766009|100626572|FG005|Usual Care|Death|0|||
33319197|NCT00559585|101063971|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
33319198|NCT00559585|101063970|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
33319199|NCT00559585|101063971|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
33319200|NCT00559585|101063970|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
33319201|NCT00559585|101063971|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
33604434|NCT00121641|102102631|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
33604435|NCT00121641|102102632|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
33604436|NCT00121641|102102633|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
33604437|NCT00121641|102102634|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
33197634|NCT03766009|100626567|FG000|Usual Care|Lost to Follow-up|0|||
33197635|NCT03766009|100626568|FG001|Usual Care|Lost to Follow-up|0|||
33197636|NCT03766009|100626569|FG002|Usual Care|Lost to Follow-up|0|||
33197637|NCT03766009|100626570|FG003|Usual Care|Lost to Follow-up|1|||
33197638|NCT03766009|100626571|FG004|Usual Care|Lost to Follow-up|0|||
33197639|NCT03766009|100626572|FG005|Usual Care|Lost to Follow-up|0|||
33197640|NCT03766009|100626567|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
33197641|NCT03766009|100626568|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
33197642|NCT03766009|100626569|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
33197643|NCT03766009|100626570|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
33197644|NCT03766009|100626571|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
33197645|NCT03766009|100626572|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
33197646|NCT03766009|100626567|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
33197647|NCT03766009|100626568|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
33197648|NCT03766009|100626569|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
33197649|NCT03766009|100626570|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
33319202|NCT00559585|101063970|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
33319203|NCT00559585|101063971|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
33319204|NCT00559585|101063970|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
33319205|NCT00559585|101063971|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
33319206|NCT00559585|101063970|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
33319207|NCT00559585|101063971|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
33319208|NCT00559585|101063970|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
33319209|NCT00559585|101063971|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
33319210|NCT01119001|101063974|FG000|Overall Study|Withdrawal by Subject|2|||
33507878|NCT01744184|101755893|FG001|Overall Study|Withdrawal by Subject|1|||
33507879|NCT02278120|101755894|FG000|Treatment Period|Progressive disease|234|||
33507880|NCT02278120|101755895|FG001|Treatment Period|Progressive disease|260|||
33507881|NCT02278120|101755894|FG000|Treatment Period|Subject/guardian decision|23|||
33507882|NCT02278120|101755895|FG001|Treatment Period|Subject/guardian decision|20|||
33507883|NCT02278120|101755894|FG000|Treatment Period|Adverse Event|16|||
33507884|NCT02278120|101755895|FG001|Treatment Period|Adverse Event|14|||
33197650|NCT03766009|100626571|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
33197651|NCT03766009|100626572|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
33507885|NCT02278120|101755894|FG000|Treatment Period|Physician Decision|14|||
33604438|NCT00121641|102102630|FG000|24-week Short-term Treatment Period|Other Reason|1|||
33197652|NCT03766009|100626567|FG000|Usual Care|No treatment or declined surgery|0|||
33197653|NCT03766009|100626568|FG001|Usual Care|No treatment or declined surgery|0|||
33319211|NCT01106027|101063977|FG000|Overall Study|Lost graft early, discontinued|1|||
33319212|NCT01717989|101063978|FG000|Overall Study|Ineligibility determined|6|||
33319213|NCT01717989|101063978|FG000|Overall Study|Protocol deviation|6|||
33319214|NCT01717989|101063978|FG000|Overall Study|Withdrawal by Subject|11|||
33319215|NCT01717989|101063978|FG000|Overall Study|Physician Decision|2|||
33319216|NCT01717989|101063978|FG000|Overall Study|Lost to Follow-up|11|||
33319217|NCT01717989|101063978|FG000|Overall Study|Death|439|||
33319218|NCT01717989|101063978|FG000|Overall Study|Protocol-specified criteria|551|||
33319219|NCT01717989|101063978|FG000|Overall Study|Other|40|||
33319220|NCT04142450|101063979|FG000|Overall Study|Screen Failure|1|||
33319221|NCT04142450|101063979|FG000|Overall Study|Lost to Follow-up|1|||
33319222|NCT00628251|101063980|FG000|Randomised Part|Withdrawal by Subject|0|||
33319223|NCT00628251|101063981|FG001|Randomised Part|Withdrawal by Subject|0|||
33319224|NCT00628251|101063982|FG002|Randomised Part|Withdrawal by Subject|1|||
33319225|NCT00628251|101063980|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
33319226|NCT00628251|101063981|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
33319227|NCT00628251|101063982|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
33319228|NCT00628251|101063980|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
33319229|NCT00628251|101063981|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
33319230|NCT00628251|101063982|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
33319231|NCT00628251|101063980|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
33319232|NCT00628251|101063981|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
33319233|NCT00628251|101063982|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
33319234|NCT00628251|101063980|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
33319235|NCT00628251|101063981|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
33319236|NCT00628251|101063982|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
33319237|NCT00628251|101063980|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
33319238|NCT00628251|101063981|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
33319239|NCT00628251|101063982|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
33319240|NCT00874770|101063984|FG000|Overall Study|Lack of Efficacy|2|||
33319241|NCT00874770|101063985|FG001|Overall Study|Lack of Efficacy|0|||
33319242|NCT00874770|101063986|FG002|Overall Study|Lack of Efficacy|0|||
33319243|NCT00874770|101063987|FG003|Overall Study|Lack of Efficacy|2|||
33319244|NCT00874770|101063984|FG000|Overall Study|Adverse Event|1|||
33319245|NCT00874770|101063985|FG001|Overall Study|Adverse Event|1|||
33319246|NCT00874770|101063986|FG002|Overall Study|Adverse Event|4|||
33319247|NCT00874770|101063987|FG003|Overall Study|Adverse Event|2|||
33319248|NCT00874770|101063984|FG000|Overall Study|Lost to Follow-up|1|||
33319249|NCT00874770|101063985|FG001|Overall Study|Lost to Follow-up|0|||
33319250|NCT00874770|101063986|FG002|Overall Study|Lost to Follow-up|0|||
33319251|NCT00874770|101063987|FG003|Overall Study|Lost to Follow-up|1|||
33319252|NCT00874770|101063984|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
33319253|NCT00874770|101063985|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
33507886|NCT02278120|101755895|FG001|Treatment Period|Physician Decision|27|||
33507887|NCT02278120|101755894|FG000|Treatment Period|Death|3|||
33507888|NCT02278120|101755895|FG001|Treatment Period|Death|3|||
33507889|NCT02278120|101755894|FG000|Treatment Period|Lost to Follow-up|2|||
33507890|NCT02278120|101755895|FG001|Treatment Period|Lost to Follow-up|0|||
33507891|NCT02278120|101755894|FG000|Treatment Period|Protocol deviation|0|||
33507892|NCT02278120|101755895|FG001|Treatment Period|Protocol deviation|2|||
33507893|NCT02278120|101755894|FG000|Treatment Period|Study terminated as per protocol|43|||
33507894|NCT02278120|101755895|FG001|Treatment Period|Study terminated as per protocol|11|||
33507895|NCT02278120|101755894|FG000|Post-treatment Efficacy Follow-up|Death|0|||
33507896|NCT02278120|101755895|FG001|Post-treatment Efficacy Follow-up|Death|1|||
33507897|NCT02278120|101755894|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
33507898|NCT02278120|101755895|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
33507899|NCT02278120|101755894|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
33507900|NCT02278120|101755895|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
33507901|NCT02278120|101755894|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
33507902|NCT02278120|101755895|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
33507903|NCT02278120|101755894|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
33197654|NCT03766009|100626569|FG002|Usual Care|No treatment or declined surgery|0|||
33319254|NCT00874770|101063986|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
33319255|NCT00874770|101063987|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
33507904|NCT02278120|101755895|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
33507905|NCT03854370|101755899|FG000|Overall Study|samples not collected|1|||
33319256|NCT02952001|101063994|FG000|Overall Study|Adverse Event|3|||
33319257|NCT02952001|101063995|FG001|Overall Study|Adverse Event|0|||
33319258|NCT02952001|101063994|FG000|Overall Study|Prohibited therapy|10|||
33319259|NCT02952001|101063995|FG001|Overall Study|Prohibited therapy|3|||
33507906|NCT03854370|101755900|FG001|Overall Study|samples not collected|1|||
33507907|NCT03854370|101755901|FG002|Overall Study|samples not collected|1|||
33507908|NCT03854370|101755902|FG003|Overall Study|samples not collected|1|||
33507909|NCT05238025|101755903|FG000|Overall Study|Adverse Event|2|||
33507910|NCT05238025|101755904|FG001|Overall Study|Adverse Event|2|||
33507911|NCT05238025|101755903|FG000|Overall Study|Lost to Follow-up|334|||
33507912|NCT05238025|101755904|FG001|Overall Study|Lost to Follow-up|339|||
33507913|NCT05238025|101755903|FG000|Overall Study|Withdrawal by Subject|203|||
33507914|NCT05238025|101755904|FG001|Overall Study|Withdrawal by Subject|222|||
33507915|NCT05238025|101755903|FG000|Overall Study|Physician Decision|20|||
33507916|NCT05238025|101755904|FG001|Overall Study|Physician Decision|8|||
33507917|NCT05238025|101755903|FG000|Overall Study|Protocol Violation|6|||
33507918|NCT05238025|101755904|FG001|Overall Study|Protocol Violation|2|||
33507919|NCT05238025|101755903|FG000|Overall Study|Death|38|||
33507920|NCT05238025|101755904|FG001|Overall Study|Death|32|||
33507921|NCT05238025|101755903|FG000|Overall Study|Study terminated by Sponsor|6358|||
33319260|NCT02952001|101063994|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
33319261|NCT02952001|101063995|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
33319262|NCT00909792|101063996|FG000|Period 1|Did not meet inclusion criteria|0|||
33319263|NCT00909792|101063997|FG001|Period 1|Did not meet inclusion criteria|1|||
33319264|NCT00909792|101063996|FG000|Period 2|Biomicroscopy|1|||
33507922|NCT05238025|101755904|FG001|Overall Study|Study terminated by Sponsor|6358|||
33507923|NCT05238025|101755903|FG000|Overall Study|Other Reason|669|||
33507924|NCT05238025|101755904|FG001|Overall Study|Other Reason|690|||
33507925|NCT01866657|101755912|FG000|Overall Study|Surgery canceled|2|||
33507926|NCT01866657|101755913|FG001|Overall Study|Surgery canceled|0|||
33507927|NCT00675428|101755914|FG000|Overall Study|Disease Progression|2|||
33507928|NCT00675428|101755915|FG001|Overall Study|Disease Progression|2|||
33507929|NCT00675428|101755914|FG000|Overall Study|No Disease Response After Cycle 6|0|||
33507930|NCT00675428|101755915|FG001|Overall Study|No Disease Response After Cycle 6|1|||
33507931|NCT00675428|101755914|FG000|Overall Study|Physician Decision|1|||
33507932|NCT00675428|101755915|FG001|Overall Study|Physician Decision|0|||
33507933|NCT02778074|101755916|FG000|Overall Study|Lost to Follow-up|7|||
33507934|NCT02778074|101755917|FG001|Overall Study|Lost to Follow-up|10|||
33507935|NCT02137850|101755918|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
33507936|NCT02137850|101755919|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
33507937|NCT02137850|101755920|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
33507938|NCT02137850|101755918|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
33507939|NCT02137850|101755919|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
33507940|NCT02137850|101755920|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
33507941|NCT02137850|101755918|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
33507942|NCT02137850|101755919|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
33507943|NCT02137850|101755920|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
33507944|NCT02137850|101755918|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
33507945|NCT02137850|101755919|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
33507946|NCT02137850|101755920|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
33507947|NCT02137850|101755918|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
33507948|NCT02137850|101755919|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
33507949|NCT02137850|101755920|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
33507950|NCT02137850|101755918|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
33507951|NCT02137850|101755919|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
33507952|NCT02137850|101755920|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
33507953|NCT02137850|101755918|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
33507954|NCT02137850|101755919|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
33507955|NCT02137850|101755920|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
33507956|NCT02137850|101755918|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
33507957|NCT02137850|101755919|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
33507958|NCT02137850|101755920|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
33507959|NCT02137850|101755918|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
33507960|NCT02137850|101755919|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
33507961|NCT02137850|101755920|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
33507962|NCT02137850|101755918|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
33507963|NCT02137850|101755919|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
33507964|NCT02137850|101755920|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
33507965|NCT02137850|101755918|FG000|Main Phase: Prophylaxis|Other|0|||
33507966|NCT02137850|101755919|FG001|Main Phase: Prophylaxis|Other|1|||
33507967|NCT02137850|101755920|FG002|Main Phase: Prophylaxis|Other|0|||
33507968|NCT02137850|101755918|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
33507969|NCT02137850|101755919|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
33507970|NCT02137850|101755920|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
33507971|NCT02137850|101755918|FG000|Main Phase: Prophylaxis|Early site closure|0|||
33507972|NCT02137850|101755919|FG001|Main Phase: Prophylaxis|Early site closure|2|||
33507973|NCT02137850|101755920|FG002|Main Phase: Prophylaxis|Early site closure|0|||
33507974|NCT02137850|101755918|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
33507975|NCT02137850|101755919|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
33507976|NCT02137850|101755920|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
33507977|NCT02137850|101755918|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
33507978|NCT02137850|101755919|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
33507979|NCT02137850|101755920|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
33507980|NCT02137850|101755918|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
33507981|NCT02137850|101755919|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
33507982|NCT02137850|101755920|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
33507983|NCT02137850|101755918|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
33507984|NCT02137850|101755919|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
33507985|NCT02137850|101755920|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
33507986|NCT02137850|101755918|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
33507987|NCT02137850|101755919|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
33507988|NCT02137850|101755920|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
33507989|NCT02137850|101755918|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
33507990|NCT02137850|101755919|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
33507991|NCT02137850|101755920|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
33507992|NCT02137850|101755918|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
33507993|NCT02137850|101755919|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
33507994|NCT02137850|101755920|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
33507995|NCT02137850|101755918|FG000|Extension Phase: Prophylaxis|Other|0|||
33507996|NCT02137850|101755919|FG001|Extension Phase: Prophylaxis|Other|1|||
33507997|NCT02137850|101755920|FG002|Extension Phase: Prophylaxis|Other|0|||
33507998|NCT02137850|101755918|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
33507999|NCT02137850|101755919|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
33508000|NCT02137850|101755920|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
33508001|NCT04964544|101755927|FG000|Overall Study|Screen failure or other uncategorised|10|||
33508002|NCT04964544|101755927|FG000|Overall Study|Physician Decision|4|||
33508003|NCT04964544|101755927|FG000|Overall Study|Lost to Follow-up|9|||
33508004|NCT04964544|101755927|FG000|Overall Study|Withdrawal by Subject|18|||
33508005|NCT04964544|101755927|FG000|Overall Study|Death|1|||
33508006|NCT00833482|101755936|FG000|Days 11-20|Adverse Event|0|||
33508007|NCT00833482|101755937|FG001|Days 11-20|Adverse Event|2|||
33508008|NCT00833482|101755938|FG002|Days 11-20|Adverse Event|0|||
33508009|NCT00833482|101755939|FG003|Days 11-20|Adverse Event|0|||
33508010|NCT00833482|101755940|FG004|Days 11-20|Adverse Event|0|||
33508011|NCT00833482|101755941|FG005|Days 11-20|Adverse Event|0|||
33508012|NCT00833482|101755936|FG000|Days 11-20|Withdrawal by Subject|0|||
33508013|NCT00833482|101755937|FG001|Days 11-20|Withdrawal by Subject|1|||
33508014|NCT00833482|101755938|FG002|Days 11-20|Withdrawal by Subject|0|||
33508015|NCT00833482|101755939|FG003|Days 11-20|Withdrawal by Subject|0|||
33508016|NCT00833482|101755940|FG004|Days 11-20|Withdrawal by Subject|0|||
33508017|NCT00833482|101755941|FG005|Days 11-20|Withdrawal by Subject|0|||
33508018|NCT00833482|101755936|FG000|Days 21-30|Adverse Event|0|||
33508019|NCT00833482|101755937|FG001|Days 21-30|Adverse Event|0|||
33508020|NCT00833482|101755938|FG002|Days 21-30|Adverse Event|1|||
33508021|NCT00833482|101755939|FG003|Days 21-30|Adverse Event|0|||
33508022|NCT00833482|101755940|FG004|Days 21-30|Adverse Event|0|||
33508023|NCT00833482|101755941|FG005|Days 21-30|Adverse Event|0|||
33508024|NCT00833482|101755936|FG000|Days 21-30|Withdrawal by Subject|0|||
33508025|NCT00833482|101755937|FG001|Days 21-30|Withdrawal by Subject|0|||
33508026|NCT00833482|101755938|FG002|Days 21-30|Withdrawal by Subject|0|||
33508027|NCT00833482|101755939|FG003|Days 21-30|Withdrawal by Subject|0|||
33508028|NCT00833482|101755940|FG004|Days 21-30|Withdrawal by Subject|1|||
33508029|NCT00833482|101755941|FG005|Days 21-30|Withdrawal by Subject|0|||
33508030|NCT02537431|101755947|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
33508031|NCT04310397|101755948|FG000|Overall Study|Lack of Efficacy|3|||
33508032|NCT04310397|101755948|FG000|Overall Study|Withdrawal by Subject|1|||
33197655|NCT03766009|100626570|FG003|Usual Care|No treatment or declined surgery|2|||
33197656|NCT03766009|100626571|FG004|Usual Care|No treatment or declined surgery|0|||
33508033|NCT02162719|101755949|FG000|Overall Study|Death|41|||
33604439|NCT00121641|102102631|FG001|24-week Short-term Treatment Period|Other Reason|0|||
33508034|NCT02162719|101755950|FG001|Overall Study|Death|46|||
33508035|NCT02162719|101755949|FG000|Overall Study|Lost to Follow-up|1|||
33508036|NCT02162719|101755950|FG001|Overall Study|Lost to Follow-up|3|||
33508037|NCT02162719|101755949|FG000|Overall Study|Disease Progression|2|||
33508038|NCT02162719|101755950|FG001|Overall Study|Disease Progression|1|||
33508039|NCT02162719|101755949|FG000|Overall Study|Withdrawal by Subject|8|||
33508040|NCT02162719|101755950|FG001|Overall Study|Withdrawal by Subject|2|||
33508041|NCT02162719|101755949|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
33508042|NCT02162719|101755950|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
33508043|NCT03362190|101755951|FG000|Overall Study|Adverse Event|0|||
33508044|NCT03362190|101755952|FG001|Overall Study|Adverse Event|0|||
33508045|NCT03362190|101755953|FG002|Overall Study|Adverse Event|0|||
33508046|NCT03362190|101755954|FG003|Overall Study|Adverse Event|1|||
33508047|NCT03362190|101755951|FG000|Overall Study|Withdrawal by Subject|0|||
33508048|NCT03362190|101755952|FG001|Overall Study|Withdrawal by Subject|0|||
33508049|NCT03362190|101755953|FG002|Overall Study|Withdrawal by Subject|0|||
33508050|NCT03362190|101755954|FG003|Overall Study|Withdrawal by Subject|1|||
33508051|NCT02320058|101755969|FG000|Overall Study|Death|25|||
33508052|NCT02320058|101755970|FG001|Overall Study|Death|10|||
33508053|NCT02320058|101755969|FG000|Overall Study|Lost to Follow-up|4|||
33508054|NCT02320058|101755970|FG001|Overall Study|Lost to Follow-up|0|||
33508055|NCT02320058|101755969|FG000|Overall Study|Other reasons|4|||
33508056|NCT02320058|101755970|FG001|Overall Study|Other reasons|1|||
33508057|NCT02320058|101755969|FG000|Overall Study|Withdrawal by Subject|8|||
33508058|NCT02320058|101755970|FG001|Overall Study|Withdrawal by Subject|2|||
33508059|NCT02320058|101755969|FG000|Overall Study|Not reported|1|||
33508060|NCT02320058|101755970|FG001|Overall Study|Not reported|0|||
33508061|NCT03190915|101755971|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
33508062|NCT03190915|101755971|FG000|Overall Study|Progressive Disease|3|||
33508063|NCT01758731|101755972|FG000|Overall Study|Physician Decision|1|||
33508064|NCT00954512|101755973|FG000|Overall Study|Withdrawal by Subject|0|||
33508065|NCT00954512|101755974|FG001|Overall Study|Withdrawal by Subject|0|||
33508066|NCT00954512|101755975|FG002|Overall Study|Withdrawal by Subject|0|||
33508067|NCT00954512|101755976|FG003|Overall Study|Withdrawal by Subject|0|||
33508068|NCT00954512|101755977|FG004|Overall Study|Withdrawal by Subject|0|||
33508069|NCT00954512|101755978|FG005|Overall Study|Withdrawal by Subject|1|||
33508070|NCT00954512|101755973|FG000|Overall Study|Adverse Event|0|||
33508071|NCT00954512|101755974|FG001|Overall Study|Adverse Event|0|||
33508072|NCT00954512|101755975|FG002|Overall Study|Adverse Event|0|||
33508073|NCT00954512|101755976|FG003|Overall Study|Adverse Event|0|||
33508074|NCT00954512|101755977|FG004|Overall Study|Adverse Event|1|||
33508075|NCT00954512|101755978|FG005|Overall Study|Adverse Event|2|||
33508076|NCT00954512|101755973|FG000|Overall Study|Physician Decision|0|||
33508077|NCT00954512|101755974|FG001|Overall Study|Physician Decision|1|||
33508078|NCT00954512|101755975|FG002|Overall Study|Physician Decision|0|||
33508079|NCT00954512|101755976|FG003|Overall Study|Physician Decision|1|||
33508080|NCT00954512|101755977|FG004|Overall Study|Physician Decision|0|||
33508081|NCT00954512|101755978|FG005|Overall Study|Physician Decision|0|||
33508082|NCT00954512|101755973|FG000|Overall Study|Symptomatic Deterioration|0|||
33508083|NCT00954512|101755974|FG001|Overall Study|Symptomatic Deterioration|1|||
33508084|NCT00954512|101755975|FG002|Overall Study|Symptomatic Deterioration|0|||
33508085|NCT00954512|101755976|FG003|Overall Study|Symptomatic Deterioration|0|||
33508086|NCT00954512|101755977|FG004|Overall Study|Symptomatic Deterioration|2|||
33508087|NCT00954512|101755978|FG005|Overall Study|Symptomatic Deterioration|0|||
33508088|NCT00954512|101755973|FG000|Overall Study|Progression of Disease|2|||
33508089|NCT00954512|101755974|FG001|Overall Study|Progression of Disease|1|||
33508090|NCT00954512|101755975|FG002|Overall Study|Progression of Disease|0|||
33508091|NCT00954512|101755976|FG003|Overall Study|Progression of Disease|1|||
33508092|NCT00954512|101755977|FG004|Overall Study|Progression of Disease|1|||
33508093|NCT00954512|101755978|FG005|Overall Study|Progression of Disease|1|||
33508094|NCT00623935|101755979|FG000|Overall Study|Death|1|||
33508095|NCT00623935|101755979|FG000|Overall Study|Patient Declined Transplant|1|||
33508096|NCT00089778|101755980|FG000|Overall Study|Protocol Violation|0|||
33508097|NCT00089778|101755981|FG001|Overall Study|Protocol Violation|0|||
33508098|NCT00089778|101755982|FG002|Overall Study|Protocol Violation|1|||
33508099|NCT01860040|101755983|FG000|Overall Study|Withdrawal by Subject|1|||
33508100|NCT01860040|101755984|FG001|Overall Study|Withdrawal by Subject|0|||
33508101|NCT05481125|101755985|FG000|Overall Study|Adverse Event|1|||
33508102|NCT05481125|101755986|FG001|Overall Study|Adverse Event|0|||
33508103|NCT05481125|101755985|FG000|Overall Study|Lost to Follow-up|0|||
33508104|NCT05481125|101755986|FG001|Overall Study|Lost to Follow-up|1|||
33508105|NCT05481125|101755985|FG000|Overall Study|Withdrawal by Subject|0|||
33508106|NCT05481125|101755986|FG001|Overall Study|Withdrawal by Subject|1|||
33508107|NCT01769508|101755987|FG000|Overall Study|Death|3|||
33508108|NCT01769508|101755987|FG000|Overall Study|Withdrawal by Subject|1|||
33508109|NCT01769508|101755987|FG000|Overall Study|Adverse Event|1|||
33508110|NCT01769508|101755987|FG000|Overall Study|Lost to Follow-up|1|||
33508111|NCT03689374|101755990|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
33508112|NCT03689374|101755991|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
33508113|NCT03689374|101755992|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
33508114|NCT03689374|101755990|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
33508115|NCT03689374|101755991|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
33508116|NCT03689374|101755992|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
33508117|NCT03689374|101755990|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
33508118|NCT03689374|101755991|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
33508119|NCT03689374|101755992|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
33508120|NCT03689374|101755990|FG000|Treatment Period (Week 0 to 52)|Death|0|||
33508121|NCT03689374|101755991|FG001|Treatment Period (Week 0 to 52)|Death|11|||
33508122|NCT03689374|101755992|FG002|Treatment Period (Week 0 to 52)|Death|1|||
33508123|NCT03613649|101755994|FG000|Second Treatment|Lost to Follow-up|0|||
33508124|NCT03613649|101755995|FG001|Second Treatment|Lost to Follow-up|0|||
33508125|NCT03613649|101755996|FG002|Second Treatment|Lost to Follow-up|1|||
33508126|NCT03613649|101755997|FG003|Second Treatment|Lost to Follow-up|0|||
33508127|NCT03613649|101755998|FG004|Second Treatment|Lost to Follow-up|0|||
33508128|NCT03613649|101755999|FG005|Second Treatment|Lost to Follow-up|0|||
33508129|NCT03613649|101756000|FG006|Second Treatment|Lost to Follow-up|0|||
33508130|NCT03613649|101756001|FG007|Second Treatment|Lost to Follow-up|0|||
33508131|NCT03613649|101756002|FG008|Second Treatment|Lost to Follow-up|0|||
33508132|NCT03613649|101756003|FG009|Second Treatment|Lost to Follow-up|0|||
33508133|NCT03613649|101756004|FG010|Second Treatment|Lost to Follow-up|0|||
33508134|NCT03613649|101756005|FG011|Second Treatment|Lost to Follow-up|0|||
33508135|NCT03613649|101755994|FG000|Second Treatment|Withdrawal by Subject|0|||
33508136|NCT03613649|101755995|FG001|Second Treatment|Withdrawal by Subject|0|||
33508137|NCT03613649|101755996|FG002|Second Treatment|Withdrawal by Subject|0|||
33508138|NCT03613649|101755997|FG003|Second Treatment|Withdrawal by Subject|0|||
33508139|NCT03613649|101755998|FG004|Second Treatment|Withdrawal by Subject|1|||
33508140|NCT03613649|101755999|FG005|Second Treatment|Withdrawal by Subject|0|||
33508141|NCT03613649|101756000|FG006|Second Treatment|Withdrawal by Subject|0|||
33508142|NCT03613649|101756001|FG007|Second Treatment|Withdrawal by Subject|0|||
33508143|NCT03613649|101756002|FG008|Second Treatment|Withdrawal by Subject|0|||
33508144|NCT03613649|101756003|FG009|Second Treatment|Withdrawal by Subject|0|||
33508145|NCT03613649|101756004|FG010|Second Treatment|Withdrawal by Subject|0|||
33508146|NCT03613649|101756005|FG011|Second Treatment|Withdrawal by Subject|0|||
33508147|NCT03613649|101755994|FG000|Third Treatment|Lost to Follow-up|0|||
33508148|NCT03613649|101755995|FG001|Third Treatment|Lost to Follow-up|0|||
33508149|NCT03613649|101755996|FG002|Third Treatment|Lost to Follow-up|0|||
33508150|NCT03613649|101755997|FG003|Third Treatment|Lost to Follow-up|0|||
33508151|NCT03613649|101755998|FG004|Third Treatment|Lost to Follow-up|1|||
33508152|NCT03613649|101755999|FG005|Third Treatment|Lost to Follow-up|0|||
33508153|NCT03613649|101756000|FG006|Third Treatment|Lost to Follow-up|0|||
33508154|NCT03613649|101756001|FG007|Third Treatment|Lost to Follow-up|0|||
33508155|NCT03613649|101756002|FG008|Third Treatment|Lost to Follow-up|0|||
33508156|NCT03613649|101756003|FG009|Third Treatment|Lost to Follow-up|0|||
33508157|NCT03613649|101756004|FG010|Third Treatment|Lost to Follow-up|0|||
33508158|NCT03613649|101756005|FG011|Third Treatment|Lost to Follow-up|1|||
33508159|NCT03613649|101755994|FG000|Third Treatment|Protocol Violation|0|||
33508160|NCT03613649|101755995|FG001|Third Treatment|Protocol Violation|0|||
33508161|NCT03613649|101755996|FG002|Third Treatment|Protocol Violation|0|||
33508162|NCT03613649|101755997|FG003|Third Treatment|Protocol Violation|0|||
33508163|NCT03613649|101755998|FG004|Third Treatment|Protocol Violation|0|||
33508164|NCT03613649|101755999|FG005|Third Treatment|Protocol Violation|0|||
33508165|NCT03613649|101756000|FG006|Third Treatment|Protocol Violation|1|||
33508166|NCT03613649|101756001|FG007|Third Treatment|Protocol Violation|0|||
33508167|NCT03613649|101756002|FG008|Third Treatment|Protocol Violation|0|||
33508168|NCT03613649|101756003|FG009|Third Treatment|Protocol Violation|0|||
33508169|NCT03613649|101756004|FG010|Third Treatment|Protocol Violation|0|||
33508170|NCT03613649|101756005|FG011|Third Treatment|Protocol Violation|1|||
33508171|NCT03613649|101755994|FG000|Fourth Treatment|Protocol Violation|1|||
33508172|NCT03613649|101755995|FG001|Fourth Treatment|Protocol Violation|0|||
33508173|NCT03613649|101755996|FG002|Fourth Treatment|Protocol Violation|0|||
33508174|NCT03613649|101755997|FG003|Fourth Treatment|Protocol Violation|0|||
33508175|NCT03613649|101755998|FG004|Fourth Treatment|Protocol Violation|1|||
33508176|NCT03613649|101755999|FG005|Fourth Treatment|Protocol Violation|0|||
33508177|NCT03613649|101756000|FG006|Fourth Treatment|Protocol Violation|0|||
33508178|NCT03613649|101756001|FG007|Fourth Treatment|Protocol Violation|0|||
33508179|NCT03613649|101756002|FG008|Fourth Treatment|Protocol Violation|0|||
33508180|NCT03613649|101756003|FG009|Fourth Treatment|Protocol Violation|0|||
33508181|NCT03613649|101756004|FG010|Fourth Treatment|Protocol Violation|0|||
33508182|NCT03613649|101756005|FG011|Fourth Treatment|Protocol Violation|0|||
33508183|NCT03613649|101755994|FG000|Fourth Treatment|Physician Decision|0|||
33508184|NCT03613649|101755995|FG001|Fourth Treatment|Physician Decision|0|||
33508185|NCT03613649|101755996|FG002|Fourth Treatment|Physician Decision|0|||
33508186|NCT03613649|101755997|FG003|Fourth Treatment|Physician Decision|0|||
33319265|NCT00909792|101063997|FG001|Period 2|Biomicroscopy|0|||
33508187|NCT03613649|101755998|FG004|Fourth Treatment|Physician Decision|0|||
33508188|NCT03613649|101755999|FG005|Fourth Treatment|Physician Decision|0|||
33508189|NCT03613649|101756000|FG006|Fourth Treatment|Physician Decision|1|||
33508190|NCT03613649|101756001|FG007|Fourth Treatment|Physician Decision|0|||
33508191|NCT03613649|101756002|FG008|Fourth Treatment|Physician Decision|0|||
33508192|NCT03613649|101756003|FG009|Fourth Treatment|Physician Decision|0|||
33508193|NCT03613649|101756004|FG010|Fourth Treatment|Physician Decision|0|||
33508194|NCT03613649|101756005|FG011|Fourth Treatment|Physician Decision|0|||
33508195|NCT02587598|101756006|FG000|Overall Study|Death|4|||
33508196|NCT02587598|101756007|FG001|Overall Study|Death|8|||
33508197|NCT02587598|101756008|FG002|Overall Study|Death|4|||
33508198|NCT02587598|101756009|FG003|Overall Study|Death|16|||
33508199|NCT02587598|101756010|FG004|Overall Study|Death|9|||
33508200|NCT02587598|101756011|FG005|Overall Study|Death|4|||
33508201|NCT02587598|101756012|FG006|Overall Study|Death|6|||
33508202|NCT02587598|101756013|FG007|Overall Study|Death|7|||
33508203|NCT02587598|101756014|FG008|Overall Study|Death|9|||
33508204|NCT02587598|101756015|FG009|Overall Study|Death|1|||
33508205|NCT02587598|101756016|FG010|Overall Study|Death|3|||
33508206|NCT02587598|101756006|FG000|Overall Study|Study Terminated by the Sponsor|0|||
33508207|NCT02587598|101756007|FG001|Overall Study|Study Terminated by the Sponsor|1|||
33508208|NCT02587598|101756008|FG002|Overall Study|Study Terminated by the Sponsor|0|||
33508209|NCT02587598|101756009|FG003|Overall Study|Study Terminated by the Sponsor|3|||
33508210|NCT02587598|101756010|FG004|Overall Study|Study Terminated by the Sponsor|0|||
33508211|NCT02587598|101756011|FG005|Overall Study|Study Terminated by the Sponsor|1|||
33508212|NCT02587598|101756012|FG006|Overall Study|Study Terminated by the Sponsor|0|||
33508213|NCT02587598|101756013|FG007|Overall Study|Study Terminated by the Sponsor|0|||
33508214|NCT02587598|101756014|FG008|Overall Study|Study Terminated by the Sponsor|0|||
33508215|NCT02587598|101756015|FG009|Overall Study|Study Terminated by the Sponsor|1|||
33508216|NCT02587598|101756016|FG010|Overall Study|Study Terminated by the Sponsor|6|||
33508217|NCT02587598|101756006|FG000|Overall Study|Reason for study withdrawal not specified|0|||
33508218|NCT02587598|101756007|FG001|Overall Study|Reason for study withdrawal not specified|1|||
33508219|NCT02587598|101756008|FG002|Overall Study|Reason for study withdrawal not specified|0|||
33508220|NCT02587598|101756009|FG003|Overall Study|Reason for study withdrawal not specified|0|||
33508221|NCT02587598|101756010|FG004|Overall Study|Reason for study withdrawal not specified|0|||
33508222|NCT02587598|101756011|FG005|Overall Study|Reason for study withdrawal not specified|0|||
33508223|NCT02587598|101756012|FG006|Overall Study|Reason for study withdrawal not specified|0|||
33508224|NCT02587598|101756013|FG007|Overall Study|Reason for study withdrawal not specified|0|||
33508225|NCT02587598|101756014|FG008|Overall Study|Reason for study withdrawal not specified|0|||
33508226|NCT02587598|101756015|FG009|Overall Study|Reason for study withdrawal not specified|0|||
33508227|NCT02587598|101756016|FG010|Overall Study|Reason for study withdrawal not specified|0|||
33508228|NCT02587598|101756006|FG000|Overall Study|Withdrawal by Subject|0|||
33508229|NCT02587598|101756007|FG001|Overall Study|Withdrawal by Subject|1|||
33508230|NCT02587598|101756008|FG002|Overall Study|Withdrawal by Subject|0|||
33508231|NCT02587598|101756009|FG003|Overall Study|Withdrawal by Subject|2|||
33508232|NCT02587598|101756010|FG004|Overall Study|Withdrawal by Subject|3|||
33508233|NCT02587598|101756011|FG005|Overall Study|Withdrawal by Subject|1|||
33508234|NCT02587598|101756012|FG006|Overall Study|Withdrawal by Subject|0|||
33508235|NCT02587598|101756013|FG007|Overall Study|Withdrawal by Subject|0|||
33508236|NCT02587598|101756014|FG008|Overall Study|Withdrawal by Subject|0|||
33508237|NCT02587598|101756015|FG009|Overall Study|Withdrawal by Subject|1|||
33508238|NCT02587598|101756016|FG010|Overall Study|Withdrawal by Subject|2|||
33508239|NCT02587598|101756006|FG000|Overall Study|Physician Decision|0|||
33508240|NCT02587598|101756007|FG001|Overall Study|Physician Decision|0|||
33508241|NCT02587598|101756008|FG002|Overall Study|Physician Decision|0|||
33508242|NCT02587598|101756009|FG003|Overall Study|Physician Decision|0|||
33508243|NCT02587598|101756010|FG004|Overall Study|Physician Decision|0|||
33508244|NCT02587598|101756011|FG005|Overall Study|Physician Decision|0|||
33508245|NCT02587598|101756012|FG006|Overall Study|Physician Decision|0|||
33508246|NCT02587598|101756013|FG007|Overall Study|Physician Decision|0|||
33508247|NCT02587598|101756014|FG008|Overall Study|Physician Decision|0|||
33508248|NCT02587598|101756015|FG009|Overall Study|Physician Decision|0|||
33508249|NCT02587598|101756016|FG010|Overall Study|Physician Decision|3|||
33508250|NCT03452488|101756019|FG000|Overall Study|Adverse Event|4|||
33508251|NCT03452488|101756020|FG001|Overall Study|Adverse Event|6|||
33508252|NCT03452488|101756021|FG002|Overall Study|Adverse Event|1|||
33508253|NCT03452488|101756019|FG000|Overall Study|Death|0|||
33508254|NCT03452488|101756020|FG001|Overall Study|Death|0|||
33508255|NCT03452488|101756021|FG002|Overall Study|Death|1|||
33508256|NCT03452488|101756019|FG000|Overall Study|Lost to Follow-up|1|||
33508257|NCT03452488|101756020|FG001|Overall Study|Lost to Follow-up|2|||
33604440|NCT00121641|102102632|FG002|24-week Short-term Treatment Period|Other Reason|0|||
33604441|NCT00121641|102102633|FG003|24-week Short-term Treatment Period|Other Reason|0|||
33508258|NCT03452488|101756021|FG002|Overall Study|Lost to Follow-up|0|||
33508259|NCT03452488|101756019|FG000|Overall Study|PI Decision|1|||
33508260|NCT03452488|101756020|FG001|Overall Study|PI Decision|0|||
33604442|NCT00121641|102102634|FG004|24-week Short-term Treatment Period|Other Reason|0|||
33604443|NCT00121641|102102630|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
33604444|NCT00121641|102102631|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
33604445|NCT00121641|102102632|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
33604446|NCT00121641|102102633|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
33604447|NCT00121641|102102634|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
33604448|NCT00121641|102102630|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
33604449|NCT00121641|102102631|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
33604450|NCT00121641|102102632|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
33604451|NCT00121641|102102633|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
33604452|NCT00121641|102102634|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
33508261|NCT03452488|101756021|FG002|Overall Study|PI Decision|0|||
33604453|NCT00121641|102102630|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
33604454|NCT00121641|102102631|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
33604455|NCT00121641|102102632|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
33604456|NCT00121641|102102633|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
33604457|NCT00121641|102102634|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
33604458|NCT00121641|102102630|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
33604459|NCT00121641|102102631|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
33604460|NCT00121641|102102632|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
33604461|NCT00121641|102102633|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
33604462|NCT00121641|102102634|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
33604463|NCT00121641|102102630|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
33604464|NCT00121641|102102631|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
33604465|NCT00121641|102102632|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
33604466|NCT00121641|102102633|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
33197657|NCT03766009|100626572|FG005|Usual Care|No treatment or declined surgery|0|||
33197658|NCT03766009|100626567|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
33197659|NCT03766009|100626568|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
33319266|NCT00909792|101063996|FG000|Period 2|Lost to Follow-up|0|||
33319267|NCT00909792|101063997|FG001|Period 2|Lost to Follow-up|1|||
33508262|NCT03452488|101756019|FG000|Overall Study|Withdrew consent|4|||
33508263|NCT03452488|101756020|FG001|Overall Study|Withdrew consent|2|||
33508264|NCT03452488|101756021|FG002|Overall Study|Withdrew consent|2|||
33508265|NCT03452488|101756019|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
33508266|NCT03452488|101756020|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
33508267|NCT03452488|101756021|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
33508268|NCT03452488|101756019|FG000|Overall Study|Other|0|||
33508269|NCT03452488|101756020|FG001|Overall Study|Other|2|||
33508270|NCT03452488|101756021|FG002|Overall Study|Other|2|||
33508271|NCT04713592|101756022|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
33398649|NCT00439309|101350094|FG000|Follow-Up|Late response by subject|0|||
33398650|NCT00439309|101350095|FG001|Follow-Up|Late response by subject|1|||
33508272|NCT04713592|101756023|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
33508273|NCT04713592|101756024|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
33508274|NCT04713592|101756025|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
33508275|NCT04713592|101756022|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
33508276|NCT04713592|101756023|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
33508277|NCT04713592|101756024|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
33508278|NCT04713592|101756025|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
33604467|NCT00121641|102102634|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
33319268|NCT00898443|101063998|FG000|Overall Study|Withdrawal by Subject|1|||
33319269|NCT00898443|101063999|FG001|Overall Study|Withdrawal by Subject|0|||
33319270|NCT01055262|101064000|FG000|Overall Study|Adverse Event|5|||
33319271|NCT01055262|101064000|FG000|Overall Study|Protocol Violation|3|||
33319272|NCT01055262|101064000|FG000|Overall Study|Uncooperativeness|1|||
33319273|NCT00826111|101064001|FG000|Overall Study|Lost to Follow-up|0|||
33319274|NCT00826111|101064002|FG001|Overall Study|Lost to Follow-up|1|||
33319275|NCT00826111|101064001|FG000|Overall Study|Protocol Violation|1|||
33398651|NCT00656799|101350099|FG000|Overall Study|Death|2|||
33508279|NCT04713592|101756022|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
33508280|NCT04713592|101756023|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
33508281|NCT04713592|101756024|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
33508282|NCT04713592|101756025|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
33508283|NCT04713592|101756022|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33508284|NCT04713592|101756023|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33508285|NCT04713592|101756024|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
33508286|NCT04713592|101756025|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
33508287|NCT04713592|101756022|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
33508288|NCT04713592|101756023|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
33508289|NCT04713592|101756024|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
33508290|NCT04713592|101756025|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
33508291|NCT04713592|101756022|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33508292|NCT04713592|101756023|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33508293|NCT04713592|101756024|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
33508294|NCT04713592|101756025|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
33508295|NCT04713592|101756022|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
33604468|NCT00121641|102102630|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
33604469|NCT00121641|102102631|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
33604470|NCT00121641|102102632|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
33197660|NCT03766009|100626569|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
33319276|NCT00826111|101064002|FG001|Overall Study|Protocol Violation|0|||
33319277|NCT00826111|101064001|FG000|Overall Study|Withdrawal by Subject|5|||
33319278|NCT00826111|101064002|FG001|Overall Study|Withdrawal by Subject|0|||
33319279|NCT00826111|101064001|FG000|Overall Study|Physician Decision|1|||
33319280|NCT00826111|101064002|FG001|Overall Study|Physician Decision|1|||
33319281|NCT01765179|101064006|FG000|Overall Study|Adverse Event|3|||
33319282|NCT01765179|101064006|FG000|Overall Study|Lost to Follow-up|5|||
33319283|NCT01765179|101064006|FG000|Overall Study|Non-compliance with study drug|2|||
33319284|NCT01765179|101064006|FG000|Overall Study|Protocol Violation|1|||
33319285|NCT01765179|101064006|FG000|Overall Study|Withdrawal by Subject|8|||
33319286|NCT01765179|101064006|FG000|Overall Study|Hematocrit >54%|3|||
33508296|NCT04713592|101756023|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
33508297|NCT04713592|101756024|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
33604471|NCT00121641|102102633|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
33604472|NCT00121641|102102634|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
33604473|NCT00121641|102102630|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
33604474|NCT00121641|102102631|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
33604475|NCT00121641|102102632|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
33604476|NCT00121641|102102633|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
33604477|NCT00121641|102102634|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
33197661|NCT03766009|100626570|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
33197662|NCT03766009|100626571|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
33197663|NCT03766009|100626572|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
33197664|NCT03766009|100626567|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
33197665|NCT03766009|100626568|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
33197666|NCT03766009|100626569|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
33197667|NCT03766009|100626570|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
33197668|NCT03766009|100626571|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
33197669|NCT03766009|100626572|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
33197670|NCT03766009|100626567|FG000|Usual Care|Ineligible|0|||
33197671|NCT03766009|100626568|FG001|Usual Care|Ineligible|1|||
33197672|NCT03766009|100626569|FG002|Usual Care|Ineligible|0|||
33197673|NCT03766009|100626570|FG003|Usual Care|Ineligible|0|||
33197674|NCT03766009|100626571|FG004|Usual Care|Ineligible|0|||
33197675|NCT03766009|100626572|FG005|Usual Care|Ineligible|0|||
33197676|NCT03766009|100626567|FG000|Usual Care|Other: Staff turnover|0|||
33197677|NCT03766009|100626568|FG001|Usual Care|Other: Staff turnover|0|||
33319287|NCT01765179|101064006|FG000|Overall Study|prohibited med|1|||
33319288|NCT01765179|101064006|FG000|Overall Study|Out of country unable to finish study|1|||
33319289|NCT01765179|101064006|FG000|Overall Study|lack of venous access|1|||
33508298|NCT04713592|101756025|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
33319290|NCT01765179|101064006|FG000|Overall Study|work conflict|1|||
33508299|NCT03103321|101756028|FG000|Overall Study|Protocol Violation|1|||
33508300|NCT03103321|101756029|FG001|Overall Study|Protocol Violation|1|||
33508301|NCT03103321|101756030|FG002|Overall Study|Protocol Violation|1|||
33319291|NCT01765179|101064006|FG000|Overall Study|Ca elevated 10.6|1|||
33319292|NCT01431534|101064009|FG000|Treatment Phase|Adverse Event|0|||
33319293|NCT01431534|101064010|FG001|Treatment Phase|Adverse Event|0|||
33319294|NCT01431534|101064011|FG002|Treatment Phase|Adverse Event|1|||
33319295|NCT01431534|101064009|FG000|Treatment Phase|Progressive Disease|4|||
33319296|NCT01431534|101064010|FG001|Treatment Phase|Progressive Disease|3|||
33319297|NCT01431534|101064011|FG002|Treatment Phase|Progressive Disease|10|||
33319298|NCT00719563|101064012|FG000|Overall Study|Adverse Event|16|||
33319299|NCT00719563|101064013|FG001|Overall Study|Adverse Event|13|||
33319300|NCT00719563|101064012|FG000|Overall Study|Medical condition changed|3|||
33319301|NCT00719563|101064013|FG001|Overall Study|Medical condition changed|5|||
33319302|NCT00719563|101064012|FG000|Overall Study|Lack of Efficacy|3|||
33319303|NCT00719563|101064013|FG001|Overall Study|Lack of Efficacy|7|||
33319304|NCT00719563|101064012|FG000|Overall Study|Personal reasons|6|||
33319305|NCT00719563|101064013|FG001|Overall Study|Personal reasons|7|||
33319306|NCT00719563|101064012|FG000|Overall Study|Unknown reasons|4|||
33319307|NCT00719563|101064013|FG001|Overall Study|Unknown reasons|6|||
33319308|NCT00719563|101064012|FG000|Overall Study|Noncompliant|1|||
33319309|NCT00719563|101064013|FG001|Overall Study|Noncompliant|1|||
33319310|NCT00719563|101064012|FG000|Overall Study|Lost to Follow-up|5|||
33319311|NCT00719563|101064013|FG001|Overall Study|Lost to Follow-up|3|||
33319312|NCT00986440|101064018|FG000|Overall Study|Progressive disease|27|||
33319313|NCT00986440|101064019|FG001|Overall Study|Progressive disease|37|||
33319314|NCT00986440|101064018|FG000|Overall Study|Serious adverse event or adverse event|9|||
33319315|NCT00986440|101064019|FG001|Overall Study|Serious adverse event or adverse event|2|||
33319316|NCT00986440|101064018|FG000|Overall Study|Withdrawal by Subject|1|||
33319317|NCT00986440|101064019|FG001|Overall Study|Withdrawal by Subject|2|||
33319318|NCT00986440|101064018|FG000|Overall Study|Screen failure (not dosed)|4|||
33319319|NCT00986440|101064019|FG001|Overall Study|Screen failure (not dosed)|2|||
33319320|NCT05395104|101064020|FG000|Overall Study|Met Liver Stopping Criteria|1|||
33319321|NCT05395104|101064020|FG000|Overall Study|Withdrawal by Subject|1|||
33319322|NCT00892177|101064021|FG000|Phase II|Ineligible|0|||
33319323|NCT00892177|101064022|FG001|Phase II|Ineligible|0|||
33319324|NCT00892177|101064023|FG002|Phase II|Ineligible|0|||
33319325|NCT00892177|101064024|FG003|Phase II|Ineligible|0|||
33319326|NCT00892177|101064025|FG004|Phase II|Ineligible|1|||
33319327|NCT00892177|101064026|FG005|Phase II|Ineligible|1|||
33319328|NCT00892177|101064021|FG000|Phase II|Withdrawal by Subject|0|||
33319329|NCT00892177|101064022|FG001|Phase II|Withdrawal by Subject|0|||
33319330|NCT00892177|101064023|FG002|Phase II|Withdrawal by Subject|0|||
33319331|NCT00892177|101064024|FG003|Phase II|Withdrawal by Subject|0|||
33319332|NCT00892177|101064025|FG004|Phase II|Withdrawal by Subject|4|||
33319333|NCT00892177|101064026|FG005|Phase II|Withdrawal by Subject|1|||
33319334|NCT00975715|101064027|FG000|Titration Period|Adverse Event|6|||
33508302|NCT03103321|101756031|FG003|Overall Study|Protocol Violation|0|||
33508303|NCT01895270|101756036|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
33508304|NCT01895270|101756037|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
33508305|NCT01895270|101756036|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
33508306|NCT01895270|101756037|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
33508307|NCT01895270|101756036|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
33508308|NCT01895270|101756037|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
33508309|NCT01895270|101756036|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
33508310|NCT01895270|101756037|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
33508311|NCT01895270|101756036|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
33604478|NCT00121641|102102630|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
33319335|NCT00975715|101064028|FG001|Titration Period|Adverse Event|0|||
33319336|NCT00975715|101064027|FG000|Titration Period|Protocol Violation|1|||
33319337|NCT00975715|101064028|FG001|Titration Period|Protocol Violation|0|||
33319338|NCT00975715|101064027|FG000|Maintenance Period|Adverse Event|2|||
33508312|NCT01895270|101756037|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
33508313|NCT01895270|101756036|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
33319339|NCT00975715|101064028|FG001|Maintenance Period|Adverse Event|1|||
33319340|NCT01873495|101064029|FG000|Overall Study|Withdrawal by Subject|1|||
33319341|NCT01873495|101064029|FG000|Overall Study|Physician Decision|3|||
33319342|NCT01873495|101064029|FG000|Overall Study|Adverse Event|1|||
33319343|NCT01873495|101064029|FG000|Overall Study|Removed for Transplantation|1|||
33319344|NCT01873495|101064029|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
33319345|NCT02678416|101064030|FG000|Part 1|Withdrawal by Subject|1|||
33319346|NCT02678416|101064030|FG000|Part 2|Adverse Event|2|||
33319347|NCT02678416|101064030|FG000|Part 2|Withdrawal by Subject|1|||
33319348|NCT03431857|101064033|FG000|Overall Study|Death|6|||
33319349|NCT03431857|101064033|FG000|Overall Study|Lost to Follow-up|41|||
33319350|NCT03431857|101064033|FG000|Overall Study|Adverse Event|6|||
33319351|NCT03431857|101064033|FG000|Overall Study|Withdrawal by Subject|1|||
33319352|NCT00174265|101064035|FG000|Overall Study|Adverse Event|7|||
33319353|NCT00174265|101064036|FG001|Overall Study|Adverse Event|4|||
33319354|NCT00174265|101064035|FG000|Overall Study|Lack of Efficacy|2|||
33319355|NCT00174265|101064036|FG001|Overall Study|Lack of Efficacy|2|||
33319356|NCT00174265|101064035|FG000|Overall Study|Withdrawal by Subject|3|||
33319357|NCT00174265|101064036|FG001|Overall Study|Withdrawal by Subject|5|||
33319358|NCT00174265|101064035|FG000|Overall Study|Lost to Follow-up|1|||
33319359|NCT00174265|101064036|FG001|Overall Study|Lost to Follow-up|0|||
33319360|NCT00174265|101064035|FG000|Overall Study|Other (Not specified)|16|||
33319361|NCT00174265|101064036|FG001|Overall Study|Other (Not specified)|10|||
33319362|NCT01480284|101064037|FG000|Overall Study|Withdrawal by Subject|2|||
33319363|NCT01480284|101064038|FG001|Overall Study|Withdrawal by Subject|0|||
33319364|NCT01480284|101064037|FG000|Overall Study|Adverse Event|1|||
33319365|NCT01480284|101064038|FG001|Overall Study|Adverse Event|0|||
33319366|NCT01480284|101064037|FG000|Overall Study|Study closed/terminated|3|||
33319367|NCT01480284|101064038|FG001|Overall Study|Study closed/terminated|0|||
33319368|NCT01480284|101064037|FG000|Overall Study|Lost to Follow-up|1|||
33319369|NCT01480284|101064038|FG001|Overall Study|Lost to Follow-up|0|||
33508314|NCT01895270|101756037|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
33508315|NCT01895270|101756036|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
33508316|NCT01895270|101756037|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
33508317|NCT01489254|101756040|FG000|Double-blind Part|Adverse Event|7|||
33604479|NCT00121641|102102631|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
33604480|NCT00121641|102102632|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
33604481|NCT00121641|102102633|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
33604482|NCT00121641|102102634|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
33197678|NCT03766009|100626569|FG002|Usual Care|Other: Staff turnover|0|||
33197679|NCT03766009|100626570|FG003|Usual Care|Other: Staff turnover|0|||
33508318|NCT01489254|101756041|FG001|Double-blind Part|Adverse Event|2|||
33508319|NCT01489254|101756042|FG002|Double-blind Part|Adverse Event|2|||
33508320|NCT01489254|101756043|FG003|Double-blind Part|Adverse Event|0|||
33508321|NCT01489254|101756040|FG000|Double-blind Part|Pregnancy|1|||
33508322|NCT01489254|101756041|FG001|Double-blind Part|Pregnancy|3|||
33508323|NCT01489254|101756042|FG002|Double-blind Part|Pregnancy|0|||
33508324|NCT01489254|101756043|FG003|Double-blind Part|Pregnancy|0|||
33508325|NCT01489254|101756040|FG000|Double-blind Part|Withdrawal by Subject|12|||
33508326|NCT01489254|101756041|FG001|Double-blind Part|Withdrawal by Subject|20|||
33604483|NCT00121641|102102630|FG000|48-month Short Term + Long Term Period|Death|0|||
33197680|NCT03766009|100626571|FG004|Usual Care|Other: Staff turnover|0|||
33197681|NCT03766009|100626572|FG005|Usual Care|Other: Staff turnover|2|||
33197682|NCT01513291|100626574|FG000|Treatment Period|Adverse Event|8|||
33197683|NCT01513291|100626575|FG001|Treatment Period|Adverse Event|4|||
33197684|NCT01513291|100626576|FG002|Treatment Period|Adverse Event|0|||
33197685|NCT01513291|100626577|FG003|Treatment Period|Adverse Event|0|||
33197686|NCT01513291|100626578|FG004|Treatment Period|Adverse Event|0|||
33197687|NCT01513291|100626574|FG000|Treatment Period|Lack of Efficacy|3|||
33197688|NCT01513291|100626575|FG001|Treatment Period|Lack of Efficacy|0|||
33197689|NCT01513291|100626576|FG002|Treatment Period|Lack of Efficacy|0|||
33197690|NCT01513291|100626577|FG003|Treatment Period|Lack of Efficacy|0|||
33197691|NCT01513291|100626578|FG004|Treatment Period|Lack of Efficacy|0|||
33197692|NCT01513291|100626574|FG000|Treatment Period|Lost to Follow-up|2|||
33197693|NCT01513291|100626575|FG001|Treatment Period|Lost to Follow-up|3|||
33197694|NCT01513291|100626576|FG002|Treatment Period|Lost to Follow-up|0|||
33197695|NCT01513291|100626577|FG003|Treatment Period|Lost to Follow-up|0|||
33197696|NCT01513291|100626578|FG004|Treatment Period|Lost to Follow-up|0|||
33197697|NCT01513291|100626574|FG000|Treatment Period|Physician Decision|1|||
33197698|NCT01513291|100626575|FG001|Treatment Period|Physician Decision|0|||
33319370|NCT01480284|101064037|FG000|Overall Study|Physician Decision|1|||
33319371|NCT01480284|101064038|FG001|Overall Study|Physician Decision|0|||
33319372|NCT00888433|101064039|FG000|Overall Study|Withdrawal by Subject|1|||
33319373|NCT00888433|101064040|FG001|Overall Study|Withdrawal by Subject|2|||
33508327|NCT01489254|101756042|FG002|Double-blind Part|Withdrawal by Subject|1|||
33508328|NCT01489254|101756043|FG003|Double-blind Part|Withdrawal by Subject|0|||
33508329|NCT01489254|101756040|FG000|Double-blind Part|Lost to Follow-up|1|||
33508330|NCT01489254|101756041|FG001|Double-blind Part|Lost to Follow-up|2|||
33197699|NCT01513291|100626576|FG002|Treatment Period|Physician Decision|0|||
33197700|NCT01513291|100626577|FG003|Treatment Period|Physician Decision|0|||
33197701|NCT01513291|100626578|FG004|Treatment Period|Physician Decision|0|||
33197702|NCT01513291|100626574|FG000|Treatment Period|Protocol Violation|1|||
33319374|NCT00888433|101064039|FG000|Overall Study|Missed Visit|2|||
33319375|NCT00888433|101064040|FG001|Overall Study|Missed Visit|1|||
33319376|NCT00375219|101064042|FG000|Overall Study|Failure to achieve a response|16|||
33319377|NCT00375219|101064043|FG001|Overall Study|Failure to achieve a response|2|||
33319378|NCT00375219|101064044|FG002|Overall Study|Failure to achieve a response|0|||
33319379|NCT00375219|101064042|FG000|Overall Study|Adverse Event|8|||
33319380|NCT00375219|101064043|FG001|Overall Study|Adverse Event|2|||
33319381|NCT00375219|101064044|FG002|Overall Study|Adverse Event|1|||
33319382|NCT00375219|101064042|FG000|Overall Study|Protocol Violation|1|||
33319383|NCT00375219|101064043|FG001|Overall Study|Protocol Violation|0|||
33319384|NCT00375219|101064044|FG002|Overall Study|Protocol Violation|1|||
33319385|NCT00375219|101064042|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
33319386|NCT00375219|101064043|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
33319387|NCT00375219|101064044|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
33319388|NCT00375219|101064042|FG000|Overall Study|Lost to Follow-up|1|||
33319389|NCT00375219|101064043|FG001|Overall Study|Lost to Follow-up|1|||
33319390|NCT00375219|101064044|FG002|Overall Study|Lost to Follow-up|0|||
33319391|NCT00375219|101064042|FG000|Overall Study|Disease progression|18|||
33319392|NCT00375219|101064043|FG001|Overall Study|Disease progression|9|||
33319393|NCT00375219|101064044|FG002|Overall Study|Disease progression|12|||
33319394|NCT00375219|101064042|FG000|Overall Study|Death|4|||
33319395|NCT00375219|101064043|FG001|Overall Study|Death|3|||
33319396|NCT00375219|101064044|FG002|Overall Study|Death|7|||
33319397|NCT00375219|101064042|FG000|Overall Study|Hematologic resistance|1|||
33319398|NCT00375219|101064043|FG001|Overall Study|Hematologic resistance|0|||
33319399|NCT00375219|101064044|FG002|Overall Study|Hematologic resistance|0|||
33319400|NCT00375219|101064042|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
33319401|NCT00375219|101064043|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
33319402|NCT00375219|101064044|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
33319403|NCT00375219|101064042|FG000|Overall Study|Allograft|2|||
33319404|NCT00375219|101064043|FG001|Overall Study|Allograft|0|||
33319405|NCT00375219|101064044|FG002|Overall Study|Allograft|0|||
33319406|NCT00375219|101064042|FG000|Overall Study|Cord blood transplantation|1|||
33508331|NCT01489254|101756042|FG002|Double-blind Part|Lost to Follow-up|0|||
33508332|NCT01489254|101756043|FG003|Double-blind Part|Lost to Follow-up|0|||
33508333|NCT01489254|101756040|FG000|Double-blind Part|Other reasons for not completing study|4|||
33508334|NCT01489254|101756041|FG001|Double-blind Part|Other reasons for not completing study|6|||
33319407|NCT00375219|101064043|FG001|Overall Study|Cord blood transplantation|0|||
33319408|NCT00375219|101064044|FG002|Overall Study|Cord blood transplantation|0|||
33319409|NCT00375219|101064042|FG000|Overall Study|Withdrawal by Subject|1|||
33319410|NCT00375219|101064043|FG001|Overall Study|Withdrawal by Subject|0|||
33319411|NCT00375219|101064044|FG002|Overall Study|Withdrawal by Subject|0|||
33319412|NCT00388154|101064056|FG000|Overall Study|Withdrawal by Subject|1|||
33319413|NCT01009203|101064058|FG000|Overall Study|Withdrawal by Subject|1|||
33319414|NCT01009203|101064058|FG000|Overall Study|Adverse Event|5|||
33319415|NCT01009203|101064058|FG000|Overall Study|Treatment-unrelated death|1|||
33319416|NCT05097716|101064061|FG000|Period 1|Adverse Event|1|||
33319417|NCT05097716|101064061|FG000|Period 1|Close contact with highly-transmissible infection|1|||
33319418|NCT00954174|101064064|FG000|Overall Study|Adverse Event|28|||
33319419|NCT00954174|101064065|FG001|Overall Study|Adverse Event|23|||
33319420|NCT00954174|101064066|FG002|Overall Study|Adverse Event|4|||
33319421|NCT00954174|101064067|FG003|Overall Study|Adverse Event|9|||
33319422|NCT00954174|101064064|FG000|Overall Study|Death|4|||
33508335|NCT01489254|101756042|FG002|Double-blind Part|Other reasons for not completing study|0|||
33508336|NCT01489254|101756043|FG003|Double-blind Part|Other reasons for not completing study|0|||
33319423|NCT00954174|101064065|FG001|Overall Study|Death|2|||
33319424|NCT00954174|101064066|FG002|Overall Study|Death|0|||
33319425|NCT00954174|101064067|FG003|Overall Study|Death|0|||
33319426|NCT00954174|101064064|FG000|Overall Study|Lack of Efficacy|32|||
33319427|NCT00954174|101064065|FG001|Overall Study|Lack of Efficacy|22|||
33319428|NCT00954174|101064066|FG002|Overall Study|Lack of Efficacy|8|||
33319429|NCT00954174|101064067|FG003|Overall Study|Lack of Efficacy|6|||
33319430|NCT00954174|101064064|FG000|Overall Study|Withdrawal by Subject|14|||
33319431|NCT00954174|101064065|FG001|Overall Study|Withdrawal by Subject|10|||
33319432|NCT00954174|101064066|FG002|Overall Study|Withdrawal by Subject|4|||
33319433|NCT00954174|101064067|FG003|Overall Study|Withdrawal by Subject|3|||
33508337|NCT01489254|101756040|FG000|Open-label Extension Part|Adverse Event|0|||
33508338|NCT01489254|101756041|FG001|Open-label Extension Part|Adverse Event|0|||
33319434|NCT00954174|101064064|FG000|Overall Study|Medical Reason|4|||
33319435|NCT00954174|101064065|FG001|Overall Study|Medical Reason|2|||
33319436|NCT00954174|101064066|FG002|Overall Study|Medical Reason|1|||
33319437|NCT00954174|101064067|FG003|Overall Study|Medical Reason|0|||
33319438|NCT00954174|101064064|FG000|Overall Study|Ineligible|40|||
33319439|NCT00954174|101064065|FG001|Overall Study|Ineligible|47|||
33319440|NCT00954174|101064066|FG002|Overall Study|Ineligible|7|||
33319441|NCT00954174|101064067|FG003|Overall Study|Ineligible|4|||
33319442|NCT00954174|101064064|FG000|Overall Study|Never Treated|4|||
33319443|NCT00954174|101064065|FG001|Overall Study|Never Treated|17|||
33319444|NCT00954174|101064066|FG002|Overall Study|Never Treated|0|||
33319445|NCT00954174|101064067|FG003|Overall Study|Never Treated|3|||
33319446|NCT05211739|101064072|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
33319447|NCT05211739|101064073|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
33319448|NCT05211739|101064072|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
33319449|NCT05211739|101064073|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
33319450|NCT05211739|101064072|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
33319451|NCT05211739|101064073|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
33319452|NCT05211739|101064072|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
33319453|NCT05211739|101064073|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
33319454|NCT01351623|101064076|FG000|Overall Study|Protocol Violation|2|||
33319455|NCT01351623|101064076|FG000|Overall Study|Adverse Event|4|||
33319456|NCT01351623|101064076|FG000|Overall Study|Withdrawal by Subject|1|||
33319457|NCT01351623|101064076|FG000|Overall Study|Death|2|||
33319458|NCT00293722|101064080|FG000|Overall Study|Other|427|||
33319459|NCT02547233|101064081|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
33319460|NCT02547233|101064082|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
33319461|NCT02547233|101064081|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
33319462|NCT02547233|101064082|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
33319463|NCT02547233|101064081|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
33319464|NCT02547233|101064082|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
33319465|NCT02547233|101064081|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
33319466|NCT02547233|101064082|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
33319467|NCT02547233|101064081|FG000|12-month Follow-up|Withdrawal by Subject|10|||
33319468|NCT02547233|101064082|FG001|12-month Follow-up|Withdrawal by Subject|10|||
33319469|NCT02547233|101064081|FG000|12-month Follow-up|Lost to Follow-up|3|||
33319470|NCT02547233|101064082|FG001|12-month Follow-up|Lost to Follow-up|3|||
33319471|NCT02547233|101064081|FG000|12-month Follow-up|Lack of Efficacy|1|||
33319472|NCT02547233|101064082|FG001|12-month Follow-up|Lack of Efficacy|2|||
33319473|NCT02547233|101064081|FG000|12-month Follow-up|Protocol Violation|0|||
33319474|NCT02547233|101064082|FG001|12-month Follow-up|Protocol Violation|1|||
33319475|NCT02547233|101064081|FG000|12-month Follow-up|Other|0|||
33319476|NCT02547233|101064082|FG001|12-month Follow-up|Other|1|||
33319477|NCT01009034|101064087|FG000|Overall Study|Lost to Follow-up|2|||
33319478|NCT01009034|101064087|FG000|Overall Study|Withdrawal by Subject|2|||
33319479|NCT02460497|101064088|FG000|Overall Study|Participant Requested Withdrawal|4|||
33319480|NCT02460497|101064088|FG000|Overall Study|Non-Compliance|1|||
33319481|NCT02460497|101064088|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
33319482|NCT02460497|101064088|FG000|Overall Study|Lost to Follow-up|2|||
33319483|NCT02460497|101064088|FG000|Overall Study|Investigator Decision|1|||
33319484|NCT04620811|101064089|FG000|Overall Study|Withdrawal by Subject|18|||
33319485|NCT04620811|101064090|FG001|Overall Study|Withdrawal by Subject|15|||
33319486|NCT04620811|101064089|FG000|Overall Study|Adverse Event|6|||
33319487|NCT04620811|101064090|FG001|Overall Study|Adverse Event|11|||
33319488|NCT04620811|101064089|FG000|Overall Study|Lost to Follow-up|4|||
33319489|NCT04620811|101064090|FG001|Overall Study|Lost to Follow-up|8|||
33319490|NCT04620811|101064089|FG000|Overall Study|Physician Decision|1|||
33319491|NCT04620811|101064090|FG001|Overall Study|Physician Decision|4|||
33508339|NCT01489254|101756042|FG002|Open-label Extension Part|Adverse Event|0|||
33508340|NCT01489254|101756043|FG003|Open-label Extension Part|Adverse Event|10|||
33508341|NCT01489254|101756040|FG000|Open-label Extension Part|Pregnancy|0|||
33508342|NCT01489254|101756041|FG001|Open-label Extension Part|Pregnancy|0|||
33508343|NCT01489254|101756042|FG002|Open-label Extension Part|Pregnancy|0|||
33508344|NCT01489254|101756043|FG003|Open-label Extension Part|Pregnancy|3|||
33319492|NCT04620811|101064089|FG000|Overall Study|Sponsor Decision|0|||
33319493|NCT04620811|101064090|FG001|Overall Study|Sponsor Decision|1|||
33319494|NCT04620811|101064089|FG000|Overall Study|Elevation of ALT or AST|1|||
33319495|NCT04620811|101064090|FG001|Overall Study|Elevation of ALT or AST|0|||
33319496|NCT04620811|101064089|FG000|Overall Study|Other|3|||
33319497|NCT04620811|101064090|FG001|Overall Study|Other|5|||
33319498|NCT00528866|101064091|FG000|Overall Study|Protocol Violation|6|||
33319499|NCT01605253|101064092|FG000|Overall Study|Physician Decision|3|||
33508345|NCT01489254|101756040|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
33508346|NCT01489254|101756041|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
33508347|NCT01489254|101756042|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
33319500|NCT01605253|101064093|FG001|Overall Study|Physician Decision|2|||
33319501|NCT01605253|101064092|FG000|Overall Study|Lost to Follow-up|3|||
33319502|NCT01605253|101064093|FG001|Overall Study|Lost to Follow-up|1|||
33319503|NCT01478360|101064094|FG000|Overall Study|Lost to Follow-up|1|||
33319504|NCT01478360|101064095|FG001|Overall Study|Lost to Follow-up|0|||
33319505|NCT01478360|101064094|FG000|Overall Study|Adverse Event|0|||
33319506|NCT01478360|101064095|FG001|Overall Study|Adverse Event|1|||
33319507|NCT01478360|101064094|FG000|Overall Study|Administrative problems|1|||
33319508|NCT01478360|101064095|FG001|Overall Study|Administrative problems|2|||
33508348|NCT01489254|101756043|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
33508349|NCT01489254|101756040|FG000|Open-label Extension Part|Protocol Violation|0|||
33319509|NCT03933397|101064096|FG000|Overall Study|No emergency department visit|65|||
33319510|NCT03933397|101064097|FG001|Overall Study|No emergency department visit|71|||
33319511|NCT03933397|101064096|FG000|Overall Study|Missed emergency department visit|25|||
33319512|NCT03933397|101064097|FG001|Overall Study|Missed emergency department visit|30|||
33319513|NCT03933397|101064096|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
33319514|NCT03933397|101064097|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
33319515|NCT03933397|101064096|FG000|Overall Study|Withdrawal by Subject|1|||
33319516|NCT03933397|101064097|FG001|Overall Study|Withdrawal by Subject|0|||
33319517|NCT03933397|101064096|FG000|Overall Study|Physician Decision|1|||
33319518|NCT03933397|101064097|FG001|Overall Study|Physician Decision|1|||
33319519|NCT03933397|101064096|FG000|Overall Study|missing pain score|1|||
33319520|NCT03933397|101064097|FG001|Overall Study|missing pain score|1|||
33319521|NCT03933397|101064096|FG000|Overall Study|Confirmed COVID-19|1|||
33319522|NCT03933397|101064097|FG001|Overall Study|Confirmed COVID-19|2|||
33319523|NCT02717754|101064100|FG000|Overall Study|Incorrect Infusion Duration|0|||
33319524|NCT02717754|101064101|FG001|Overall Study|Incorrect Infusion Duration|0|||
33319525|NCT02717754|101064102|FG002|Overall Study|Incorrect Infusion Duration|0|||
33319526|NCT02717754|101064103|FG003|Overall Study|Incorrect Infusion Duration|10|||
33319527|NCT02717754|101064104|FG004|Overall Study|Incorrect Infusion Duration|20|||
33319528|NCT02717754|101064105|FG005|Overall Study|Incorrect Infusion Duration|20|||
33319529|NCT00162032|101064107|FG000|Overall Study|Lost to Follow-up|4|||
33319530|NCT00162032|101064108|FG001|Overall Study|Lost to Follow-up|2|||
33319531|NCT00162032|101064107|FG000|Overall Study|Reason not specified|1|||
33319532|NCT00162032|101064108|FG001|Overall Study|Reason not specified|0|||
33319533|NCT00576836|101064112|FG000|Overall Study|Death|0|||
33319534|NCT00576836|101064113|FG001|Overall Study|Death|1|||
33319535|NCT00576836|101064112|FG000|Overall Study|Physician Decision|0|||
33319536|NCT00576836|101064113|FG001|Overall Study|Physician Decision|1|||
33319537|NCT02187809|101064114|FG000|Overall Study|The study was terminated|3|||
33319538|NCT01106404|101064115|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
33319539|NCT01106404|101064116|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
33319540|NCT01106404|101064115|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
33508350|NCT01489254|101756041|FG001|Open-label Extension Part|Protocol Violation|0|||
33508351|NCT01489254|101756042|FG002|Open-label Extension Part|Protocol Violation|0|||
33508352|NCT01489254|101756043|FG003|Open-label Extension Part|Protocol Violation|1|||
33508353|NCT01489254|101756040|FG000|Open-label Extension Part|Lost to Follow-up|0|||
33508354|NCT01489254|101756041|FG001|Open-label Extension Part|Lost to Follow-up|0|||
33508355|NCT01489254|101756042|FG002|Open-label Extension Part|Lost to Follow-up|0|||
33319541|NCT01106404|101064116|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
33319542|NCT01106404|101064115|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
33319543|NCT01106404|101064116|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
33319544|NCT01106404|101064115|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
33319545|NCT01106404|101064116|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
33319546|NCT01975428|101064120|FG000|Overall Study|Lost to Follow-up|17|||
33319547|NCT01975428|101064121|FG001|Overall Study|Lost to Follow-up|4|||
33319548|NCT01975428|101064120|FG000|Overall Study|Withdrawal by Subject|3|||
33319549|NCT01975428|101064121|FG001|Overall Study|Withdrawal by Subject|10|||
33319550|NCT01940354|101064124|FG000|Overall Study|Withdrawal by Subject|4|||
33319551|NCT01940354|101064125|FG001|Overall Study|Withdrawal by Subject|2|||
33319552|NCT01287065|101064131|FG000|Treatment Period 1|Adverse Event|0|||
33319553|NCT01287065|101064132|FG001|Treatment Period 1|Adverse Event|0|||
33319554|NCT01287065|101064133|FG002|Treatment Period 1|Adverse Event|0|||
33319555|NCT01287065|101064134|FG003|Treatment Period 1|Adverse Event|0|||
33319556|NCT01287065|101064135|FG004|Treatment Period 1|Adverse Event|1|||
33319557|NCT01287065|101064136|FG005|Treatment Period 1|Adverse Event|0|||
33319558|NCT01287065|101064131|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33319559|NCT01287065|101064132|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33319560|NCT01287065|101064133|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33319561|NCT01287065|101064134|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33319562|NCT01287065|101064135|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33319563|NCT01287065|101064136|FG005|Treatment Period 1|Withdrawal by Subject|1|||
33319564|NCT03047551|101064140|FG000|Overall Study|Did not receive TAS|1|||
33319565|NCT03047551|101064141|FG001|Overall Study|Did not receive TAS|0|||
33319566|NCT03047551|101064140|FG000|Overall Study|Physician Decision|1|||
33508356|NCT01489254|101756043|FG003|Open-label Extension Part|Lost to Follow-up|9|||
33319567|NCT03047551|101064141|FG001|Overall Study|Physician Decision|0|||
33319568|NCT03047551|101064140|FG000|Overall Study|Withdrawal by Subject|0|||
33319569|NCT03047551|101064141|FG001|Overall Study|Withdrawal by Subject|1|||
33319570|NCT03047551|101064140|FG000|Overall Study|Probe malfunction|0|||
33319571|NCT03047551|101064141|FG001|Overall Study|Probe malfunction|1|||
33319572|NCT03047551|101064140|FG000|Overall Study|Ineligible|0|||
33319573|NCT03047551|101064141|FG001|Overall Study|Ineligible|1|||
33319574|NCT01446016|101064144|FG000|Overall Study|Lost to Follow-up|3|||
33319575|NCT01446016|101064144|FG000|Overall Study|Withdrawal by Subject|1|||
33508357|NCT01489254|101756040|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
33319576|NCT01446016|101064144|FG000|Overall Study|Toxicity|3|||
33319577|NCT00567268|101064146|FG000|Overall Study|Protocol Violation|7|||
33319578|NCT00567268|101064146|FG000|Overall Study|Lost to Follow-up|36|||
33319579|NCT00567268|101064146|FG000|Overall Study|No Visit After First Day of Treatment|2|||
33319580|NCT00567268|101064146|FG000|Overall Study|No Drug Administration|4|||
33319581|NCT00567268|101064146|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
33319582|NCT01215175|101064155|FG000|Overall Study|Lost to Follow-up|0|||
33319583|NCT01215175|101064156|FG001|Overall Study|Lost to Follow-up|1|||
33319584|NCT01215175|101064157|FG002|Overall Study|Lost to Follow-up|0|||
33319585|NCT01215175|101064158|FG003|Overall Study|Lost to Follow-up|1|||
33319586|NCT01215175|101064159|FG004|Overall Study|Lost to Follow-up|0|||
33319587|NCT02020863|101064162|FG000|Overall Study|Discovery of Metastatic disease|4|||
33319588|NCT02020863|101064162|FG000|Overall Study|Team chose not to place an a line|1|||
33319589|NCT00764751|101064166|FG000|Overall Study|Adverse Event|1|||
33319590|NCT00764751|101064167|FG001|Overall Study|Adverse Event|1|||
33319591|NCT00764751|101064166|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
33319592|NCT00764751|101064167|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
33319593|NCT03231943|101064168|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33319594|NCT03231943|101064169|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
33508358|NCT01489254|101756041|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
33508359|NCT01489254|101756042|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
33508360|NCT01489254|101756043|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
33508361|NCT02949843|101756044|FG000|Overall Study|Withdrawal by Subject|0|||
33508362|NCT02949843|101756045|FG001|Overall Study|Withdrawal by Subject|1|||
33508363|NCT02949843|101756046|FG002|Overall Study|Withdrawal by Subject|1|||
33508364|NCT02244463|101756048|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
33508365|NCT02244463|101756049|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
33508366|NCT02244463|101756050|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
33508367|NCT02244463|101756051|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
33508368|NCT02244463|101756052|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
33508369|NCT02244463|101756053|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
33508370|NCT02244463|101756048|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
33508371|NCT02244463|101756049|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
33508372|NCT02244463|101756050|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
33508373|NCT02244463|101756051|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
33508374|NCT02244463|101756052|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
33508375|NCT02244463|101756053|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
33508376|NCT02244463|101756048|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
33508377|NCT02244463|101756049|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
33508378|NCT02244463|101756050|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
33508379|NCT02244463|101756051|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
33508380|NCT02244463|101756052|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
33508381|NCT02244463|101756053|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
33508382|NCT02244463|101756048|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
33508383|NCT02244463|101756049|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
33508384|NCT02244463|101756050|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
33508385|NCT02244463|101756051|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
33508386|NCT02244463|101756052|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
33508387|NCT02244463|101756053|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
33508388|NCT02244463|101756048|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
33508389|NCT02244463|101756049|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
33508390|NCT02244463|101756050|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
33508391|NCT02244463|101756051|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
33508392|NCT02244463|101756052|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
33508393|NCT02244463|101756053|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
33508394|NCT02244463|101756048|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
33508395|NCT02244463|101756049|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
33508396|NCT02244463|101756050|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
33197703|NCT01513291|100626575|FG001|Treatment Period|Protocol Violation|2|||
33197704|NCT01513291|100626576|FG002|Treatment Period|Protocol Violation|0|||
33319595|NCT03231943|101064170|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
33319596|NCT03231943|101064171|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33319597|NCT03231943|101064172|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33319598|NCT03231943|101064173|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33319599|NCT03231943|101064174|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33508397|NCT02244463|101756051|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
33508398|NCT02244463|101756052|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
33508399|NCT02244463|101756053|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
33508400|NCT02244463|101756048|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
33197705|NCT01513291|100626577|FG003|Treatment Period|Protocol Violation|0|||
33508401|NCT02244463|101756049|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
33508402|NCT02244463|101756050|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
33508403|NCT02244463|101756051|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
33508404|NCT02244463|101756052|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
33508405|NCT02244463|101756053|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
33508406|NCT02244463|101756048|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
33508407|NCT02244463|101756049|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
33508408|NCT02244463|101756050|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
33508409|NCT02244463|101756051|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
33508410|NCT02244463|101756052|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
33508411|NCT02244463|101756053|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
33508412|NCT02244463|101756048|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
33508413|NCT02244463|101756049|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
33508414|NCT02244463|101756050|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
33508415|NCT02244463|101756051|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
33508416|NCT02244463|101756052|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
33508417|NCT02244463|101756053|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
33508418|NCT02244463|101756048|FG000|Period 5: Phase II|Disease Progression|0|||
33508419|NCT02244463|101756049|FG001|Period 5: Phase II|Disease Progression|0|||
33508420|NCT02244463|101756050|FG002|Period 5: Phase II|Disease Progression|0|||
33508421|NCT02244463|101756051|FG003|Period 5: Phase II|Disease Progression|0|||
33508422|NCT02244463|101756052|FG004|Period 5: Phase II|Disease Progression|10|||
33508423|NCT02244463|101756053|FG005|Period 5: Phase II|Disease Progression|11|||
33508424|NCT02244463|101756048|FG000|Period 5: Phase II|Physician Decision|0|||
33508425|NCT02244463|101756049|FG001|Period 5: Phase II|Physician Decision|0|||
33508426|NCT02244463|101756050|FG002|Period 5: Phase II|Physician Decision|0|||
33508427|NCT02244463|101756051|FG003|Period 5: Phase II|Physician Decision|0|||
33508428|NCT02244463|101756052|FG004|Period 5: Phase II|Physician Decision|3|||
33508429|NCT02244463|101756053|FG005|Period 5: Phase II|Physician Decision|2|||
33508430|NCT02244463|101756048|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
33508431|NCT02244463|101756049|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
33508432|NCT02244463|101756050|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
33604484|NCT00121641|102102631|FG001|48-month Short Term + Long Term Period|Death|0|||
33604485|NCT00121641|102102632|FG002|48-month Short Term + Long Term Period|Death|0|||
33604486|NCT00121641|102102633|FG003|48-month Short Term + Long Term Period|Death|1|||
33508433|NCT02244463|101756051|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
33604487|NCT00121641|102102634|FG004|48-month Short Term + Long Term Period|Death|0|||
33604488|NCT00121641|102102630|FG000|48-month Short Term + Long Term Period|Missing|0|||
33604489|NCT00121641|102102631|FG001|48-month Short Term + Long Term Period|Missing|0|||
33604490|NCT00121641|102102632|FG002|48-month Short Term + Long Term Period|Missing|1|||
33604491|NCT00121641|102102633|FG003|48-month Short Term + Long Term Period|Missing|0|||
33604492|NCT00121641|102102634|FG004|48-month Short Term + Long Term Period|Missing|0|||
33604493|NCT00121641|102102630|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
33604494|NCT00121641|102102631|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
33604495|NCT00121641|102102632|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
33604496|NCT00121641|102102633|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
33364916|NCT01790438|101223682|FG000|Overall Study|Physician Decision|3|||
33508434|NCT02244463|101756052|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
33508435|NCT02244463|101756053|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
33508436|NCT02244463|101756048|FG000|Period 5: Phase II|Intercurrent Illness|0|||
33508437|NCT02244463|101756049|FG001|Period 5: Phase II|Intercurrent Illness|0|||
33508438|NCT02244463|101756050|FG002|Period 5: Phase II|Intercurrent Illness|0|||
33197706|NCT01513291|100626578|FG004|Treatment Period|Protocol Violation|0|||
33197707|NCT01513291|100626574|FG000|Treatment Period|Withdrawal by Subject|8|||
33197708|NCT01513291|100626575|FG001|Treatment Period|Withdrawal by Subject|5|||
33197709|NCT01513291|100626576|FG002|Treatment Period|Withdrawal by Subject|0|||
33197710|NCT01513291|100626577|FG003|Treatment Period|Withdrawal by Subject|0|||
33197711|NCT01513291|100626578|FG004|Treatment Period|Withdrawal by Subject|0|||
33197712|NCT01513291|100626574|FG000|Treatment Period|Randomized not treated|0|||
33197713|NCT01513291|100626575|FG001|Treatment Period|Randomized not treated|2|||
33197714|NCT01513291|100626576|FG002|Treatment Period|Randomized not treated|0|||
33197715|NCT01513291|100626577|FG003|Treatment Period|Randomized not treated|0|||
33197716|NCT01513291|100626578|FG004|Treatment Period|Randomized not treated|0|||
33197717|NCT01513291|100626574|FG000|Run-out Period|Lost to Follow-up|0|||
33197718|NCT01513291|100626575|FG001|Run-out Period|Lost to Follow-up|0|||
33197719|NCT01513291|100626576|FG002|Run-out Period|Lost to Follow-up|0|||
33197720|NCT01513291|100626577|FG003|Run-out Period|Lost to Follow-up|1|||
33197721|NCT01513291|100626578|FG004|Run-out Period|Lost to Follow-up|0|||
33197722|NCT01513291|100626574|FG000|Run-out Period|Withdrawal by Subject|0|||
33197723|NCT01513291|100626575|FG001|Run-out Period|Withdrawal by Subject|0|||
33197724|NCT01513291|100626576|FG002|Run-out Period|Withdrawal by Subject|0|||
33197725|NCT01513291|100626577|FG003|Run-out Period|Withdrawal by Subject|1|||
33197726|NCT01513291|100626578|FG004|Run-out Period|Withdrawal by Subject|0|||
33197727|NCT02564471|100626579|FG000|Overall Study|Adverse Event|1|||
33197728|NCT02564471|100626580|FG001|Overall Study|Adverse Event|0|||
33197729|NCT02564471|100626581|FG002|Overall Study|Adverse Event|0|||
33197730|NCT02564471|100626582|FG003|Overall Study|Adverse Event|0|||
33319600|NCT03231943|101064175|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33319601|NCT03231943|101064176|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33319602|NCT03231943|101064177|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33319603|NCT03231943|101064178|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33319604|NCT03231943|101064179|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33319605|NCT03231943|101064180|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
33398652|NCT04062240|101350101|FG000|Overall Study|equipment malfunction|1|||
33398653|NCT01320033|101350102|FG000|Overall Study|Lack of Efficacy|0|||
33319606|NCT03231943|101064168|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33398654|NCT01320033|101350103|FG001|Overall Study|Lack of Efficacy|0|||
33398655|NCT01320033|101350104|FG002|Overall Study|Lack of Efficacy|1|||
33398656|NCT01320033|101350102|FG000|Overall Study|Adverse Event|9|||
33398657|NCT01320033|101350103|FG001|Overall Study|Adverse Event|7|||
33398658|NCT01320033|101350104|FG002|Overall Study|Adverse Event|8|||
33398659|NCT01320033|101350102|FG000|Overall Study|Withdrawal by Subject|22|||
33398660|NCT01320033|101350103|FG001|Overall Study|Withdrawal by Subject|23|||
33398661|NCT01320033|101350104|FG002|Overall Study|Withdrawal by Subject|23|||
33398662|NCT01320033|101350102|FG000|Overall Study|Protocol Violation|3|||
33398663|NCT01320033|101350103|FG001|Overall Study|Protocol Violation|5|||
33197731|NCT02564471|100626579|FG000|Overall Study|Withdrawal by Subject|2|||
33197732|NCT02564471|100626580|FG001|Overall Study|Withdrawal by Subject|1|||
33319607|NCT03231943|101064169|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
33319608|NCT03231943|101064170|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33319609|NCT03231943|101064171|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33319610|NCT03231943|101064172|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33319611|NCT03231943|101064173|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33319612|NCT03231943|101064174|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33319613|NCT03231943|101064175|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33319614|NCT03231943|101064176|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33319615|NCT03231943|101064177|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33319616|NCT03231943|101064178|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33319617|NCT03231943|101064179|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33319618|NCT03231943|101064180|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
33319619|NCT03231943|101064168|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
33398664|NCT01320033|101350104|FG002|Overall Study|Protocol Violation|3|||
33398665|NCT01320033|101350102|FG000|Overall Study|Lost to Follow-up|22|||
33398666|NCT01320033|101350103|FG001|Overall Study|Lost to Follow-up|26|||
33197733|NCT02564471|100626581|FG002|Overall Study|Withdrawal by Subject|3|||
33197734|NCT02564471|100626582|FG003|Overall Study|Withdrawal by Subject|0|||
33319620|NCT03231943|101064169|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33319621|NCT03231943|101064170|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33319622|NCT03231943|101064171|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33398667|NCT01320033|101350104|FG002|Overall Study|Lost to Follow-up|17|||
33398668|NCT01320033|101350102|FG000|Overall Study|Other|2|||
33398669|NCT01320033|101350103|FG001|Overall Study|Other|3|||
33398670|NCT01320033|101350104|FG002|Overall Study|Other|1|||
33197735|NCT02564471|100626579|FG000|Overall Study|Lost to Follow-up|0|||
33197736|NCT02564471|100626580|FG001|Overall Study|Lost to Follow-up|2|||
33197737|NCT02564471|100626581|FG002|Overall Study|Lost to Follow-up|0|||
33197738|NCT02564471|100626582|FG003|Overall Study|Lost to Follow-up|0|||
33319623|NCT03231943|101064172|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33319624|NCT03231943|101064173|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33319625|NCT03231943|101064174|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33319626|NCT03231943|101064175|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33319627|NCT03231943|101064176|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33319628|NCT03231943|101064177|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33319629|NCT03231943|101064178|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33319630|NCT03231943|101064179|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33319631|NCT03231943|101064180|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
33319632|NCT03231943|101064168|FG000|Part 2|Adverse Event|0|||
33319633|NCT03231943|101064169|FG001|Part 2|Adverse Event|0|||
33319634|NCT03231943|101064170|FG002|Part 2|Adverse Event|0|||
33319635|NCT03231943|101064171|FG003|Part 2|Adverse Event|0|||
33319636|NCT03231943|101064172|FG004|Part 2|Adverse Event|0|||
33319637|NCT03231943|101064173|FG005|Part 2|Adverse Event|0|||
33319638|NCT03231943|101064174|FG006|Part 2|Adverse Event|0|||
33319639|NCT03231943|101064175|FG007|Part 2|Adverse Event|0|||
33319640|NCT03231943|101064176|FG008|Part 2|Adverse Event|0|||
33319641|NCT03231943|101064177|FG009|Part 2|Adverse Event|0|||
33319642|NCT03231943|101064178|FG010|Part 2|Adverse Event|1|||
33319643|NCT03231943|101064179|FG011|Part 2|Adverse Event|0|||
33319644|NCT03231943|101064180|FG012|Part 2|Adverse Event|0|||
33319645|NCT03231943|101064168|FG000|Part 2|Withdrawal by Subject|0|||
33319646|NCT03231943|101064169|FG001|Part 2|Withdrawal by Subject|0|||
33319647|NCT03231943|101064170|FG002|Part 2|Withdrawal by Subject|0|||
33319648|NCT03231943|101064171|FG003|Part 2|Withdrawal by Subject|0|||
33319649|NCT03231943|101064172|FG004|Part 2|Withdrawal by Subject|0|||
33319650|NCT03231943|101064173|FG005|Part 2|Withdrawal by Subject|0|||
33319651|NCT03231943|101064174|FG006|Part 2|Withdrawal by Subject|0|||
33319652|NCT03231943|101064175|FG007|Part 2|Withdrawal by Subject|0|||
33319653|NCT03231943|101064176|FG008|Part 2|Withdrawal by Subject|0|||
33319654|NCT03231943|101064177|FG009|Part 2|Withdrawal by Subject|0|||
33319655|NCT03231943|101064178|FG010|Part 2|Withdrawal by Subject|0|||
33319656|NCT03231943|101064179|FG011|Part 2|Withdrawal by Subject|1|||
33319657|NCT03231943|101064180|FG012|Part 2|Withdrawal by Subject|0|||
33319658|NCT04936841|101064181|FG000|Overall Study|Death|1|||
33319659|NCT00928564|101064183|FG000|Overall Study|Lost to Follow-up|6|||
33319660|NCT00928564|101064184|FG001|Overall Study|Lost to Follow-up|0|||
33319661|NCT00601250|101064187|FG000|Overall Study|Adverse Event|3|||
33319662|NCT00601250|101064188|FG001|Overall Study|Adverse Event|9|||
33319663|NCT00601250|101064187|FG000|Overall Study|Protocol Violation|3|||
33319664|NCT00601250|101064188|FG001|Overall Study|Protocol Violation|2|||
33319665|NCT00601250|101064187|FG000|Overall Study|Lost to Follow-up|2|||
33319666|NCT00601250|101064188|FG001|Overall Study|Lost to Follow-up|6|||
33319667|NCT00601250|101064187|FG000|Overall Study|Withdrawal by Subject|4|||
33319668|NCT00601250|101064188|FG001|Overall Study|Withdrawal by Subject|13|||
33319669|NCT00601250|101064187|FG000|Overall Study|Other incl. lack of efficacy|2|||
33319670|NCT00601250|101064188|FG001|Overall Study|Other incl. lack of efficacy|9|||
33319671|NCT01979835|101064189|FG000|Primary Outcome SA Measurment|failed insertion|18|||
33319672|NCT01979835|101064189|FG000|Follow-up|Lost to Follow-up|32|||
33319673|NCT00833911|101064190|FG000|Titration|Adverse Event|18|||
33319674|NCT00833911|101064190|FG000|Titration|Withdrawal by Subject|3|||
33319675|NCT00833911|101064190|FG000|Maintenance Phase I|Adverse Event|73|||
33319676|NCT00833911|101064190|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
33319677|NCT00833911|101064190|FG000|Maintenance Phase I|Physician Decision|10|||
33319678|NCT00833911|101064190|FG000|Maintenance Phase I|Lack of Efficacy|4|||
33319679|NCT00833911|101064190|FG000|Maintenance Phase II|Adverse Event|6|||
33319680|NCT00833911|101064190|FG000|Maintenance Phase II|Physician Decision|2|||
33319681|NCT00833911|101064190|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
33319682|NCT00833911|101064190|FG000|Maintenance Phase II|Lack of Efficacy|1|||
33319683|NCT01306890|101064191|FG000|Overall Study|Adverse Event|2|||
33319684|NCT01306890|101064191|FG000|Overall Study|Death|1223|||
33319685|NCT01306890|101064191|FG000|Overall Study|Lost to Follow-up|58|||
33319686|NCT01306890|101064191|FG000|Overall Study|Withdrawal by Subject|88|||
33319687|NCT01306890|101064191|FG000|Overall Study|Unspecified reasons|104|||
33319688|NCT01306890|101064191|FG000|Overall Study|Study Termination|3|||
33319689|NCT01306890|101064191|FG000|Overall Study|No discontinuation documentation|41|||
33319690|NCT02120625|101064192|FG000|Overall Study|Physician Decision|2|||
33398671|NCT00783263|101350105|FG000|Overall Study|Adverse Event|3|||
33604497|NCT00121641|102102634|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
33319691|NCT01009554|101064193|FG000|Overall Study|Adverse Event|1|||
33319692|NCT01009554|101064194|FG001|Overall Study|Adverse Event|1|||
33319693|NCT01009554|101064193|FG000|Overall Study|Withdrawal by Subject|1|||
33319694|NCT01009554|101064194|FG001|Overall Study|Withdrawal by Subject|3|||
33319695|NCT01009554|101064193|FG000|Overall Study|Noncompliant with Study Product|0|||
33319696|NCT01009554|101064194|FG001|Overall Study|Noncompliant with Study Product|3|||
33319697|NCT00462865|101064195|FG000|Overall Study|Adverse Event|1|||
33319698|NCT00821431|101064196|FG000|Overall Study|Adverse Event|6|||
33319699|NCT00821431|101064197|FG001|Overall Study|Adverse Event|3|||
33604498|NCT03779503|102102635|FG000|First Intervention|Adverse Event|0|||
33319700|NCT00821431|101064196|FG000|Overall Study|Withdrawal by Subject|5|||
33604499|NCT03779503|102102636|FG001|First Intervention|Adverse Event|1|||
33604500|NCT03779503|102102635|FG000|First Intervention|Withdrawal by Subject|1|||
33604501|NCT03779503|102102636|FG001|First Intervention|Withdrawal by Subject|0|||
33604502|NCT02262754|102102637|FG000|Overall Study|Adverse Event|3|||
33604503|NCT02262754|102102638|FG001|Overall Study|Adverse Event|4|||
33604504|NCT02262754|102102639|FG002|Overall Study|Adverse Event|0|||
33604505|NCT02262754|102102637|FG000|Overall Study|Lack of Efficacy|2|||
33604506|NCT02262754|102102638|FG001|Overall Study|Lack of Efficacy|0|||
33604507|NCT02262754|102102639|FG002|Overall Study|Lack of Efficacy|1|||
33604508|NCT02262754|102102637|FG000|Overall Study|Lost to Follow-up|0|||
33604509|NCT02262754|102102638|FG001|Overall Study|Lost to Follow-up|0|||
33604510|NCT02262754|102102639|FG002|Overall Study|Lost to Follow-up|1|||
33604511|NCT02262754|102102637|FG000|Overall Study|No longer meets eligibility criteria|0|||
33604512|NCT02262754|102102638|FG001|Overall Study|No longer meets eligibility criteria|1|||
33197739|NCT02838017|100626590|FG000|Overall Study|Lost to Follow-up|14|||
33197740|NCT02838017|100626591|FG001|Overall Study|Lost to Follow-up|11|||
33197741|NCT01375049|100626592|FG000|Overall Study|Adverse Event|2|||
33197742|NCT01375049|100626592|FG000|Overall Study|Lost to Follow-up|1|||
33197743|NCT01375049|100626592|FG000|Overall Study|Withdrawal by Subject|2|||
33197744|NCT01375049|100626592|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
33197745|NCT01709227|100626593|FG000|Overall Study|Physician Decision|1|||
33197746|NCT01709227|100626594|FG001|Overall Study|Physician Decision|0|||
33197747|NCT01709227|100626593|FG000|Overall Study|Pleural Peritoneal communication|0|||
33197748|NCT01709227|100626594|FG001|Overall Study|Pleural Peritoneal communication|9|||
33197749|NCT00852397|100626595|FG000|Overall Study|Adverse Event|4|||
33197750|NCT00852397|100626596|FG001|Overall Study|Adverse Event|6|||
33197751|NCT00852397|100626597|FG002|Overall Study|Adverse Event|4|||
33197752|NCT00852397|100626595|FG000|Overall Study|Death|0|||
33197753|NCT00852397|100626596|FG001|Overall Study|Death|0|||
33197754|NCT00852397|100626597|FG002|Overall Study|Death|1|||
33319701|NCT00821431|101064197|FG001|Overall Study|Withdrawal by Subject|0|||
33319702|NCT00821431|101064196|FG000|Overall Study|Lost to Follow-up|1|||
33319703|NCT00821431|101064197|FG001|Overall Study|Lost to Follow-up|0|||
33398672|NCT00783263|101350106|FG001|Overall Study|Adverse Event|0|||
33398673|NCT00783263|101350107|FG002|Overall Study|Adverse Event|2|||
33398674|NCT00783263|101350108|FG003|Overall Study|Adverse Event|1|||
33319704|NCT00821431|101064196|FG000|Overall Study|Protocol Violation|3|||
33319705|NCT00821431|101064197|FG001|Overall Study|Protocol Violation|1|||
33319706|NCT00821431|101064196|FG000|Overall Study|Physician Decision|0|||
33319707|NCT00821431|101064197|FG001|Overall Study|Physician Decision|1|||
33319708|NCT02608879|101064198|FG000|Overall Study|Lost to Follow-up|1|||
33319709|NCT02608879|101064199|FG001|Overall Study|Lost to Follow-up|0|||
33319710|NCT02608879|101064200|FG002|Overall Study|Lost to Follow-up|0|||
33319711|NCT02608879|101064198|FG000|Overall Study|Did not meet continuation criteria|0|||
33398675|NCT00783263|101350105|FG000|Overall Study|Lost to Follow-up|1|||
33398676|NCT00783263|101350106|FG001|Overall Study|Lost to Follow-up|1|||
33398677|NCT00783263|101350107|FG002|Overall Study|Lost to Follow-up|0|||
33398678|NCT00783263|101350108|FG003|Overall Study|Lost to Follow-up|0|||
33398679|NCT00783263|101350105|FG000|Overall Study|Withdrawal by Subject|0|||
33398680|NCT00783263|101350106|FG001|Overall Study|Withdrawal by Subject|1|||
33398681|NCT00783263|101350107|FG002|Overall Study|Withdrawal by Subject|1|||
33398682|NCT00783263|101350108|FG003|Overall Study|Withdrawal by Subject|2|||
33398683|NCT00957723|101350111|FG000|Overall Study|Death|3|||
33398684|NCT00957723|101350111|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
33398685|NCT00957723|101350111|FG000|Overall Study|Lost to Follow-up|8|||
33398686|NCT00957723|101350111|FG000|Overall Study|Withdrawal by Subject|24|||
33398687|NCT00957723|101350111|FG000|Overall Study|Investigative Site Terminated|61|||
33398688|NCT00957723|101350111|FG000|Overall Study|Intercurrent Illness|2|||
33398689|NCT00957723|101350111|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
33398690|NCT01196091|101350116|FG000|Overall Study|Adverse Event|22|||
33398691|NCT01196091|101350117|FG001|Overall Study|Adverse Event|27|||
33398692|NCT01196091|101350118|FG002|Overall Study|Adverse Event|26|||
33398693|NCT01196091|101350116|FG000|Overall Study|Death|3|||
33398694|NCT01196091|101350117|FG001|Overall Study|Death|2|||
33604513|NCT02262754|102102639|FG002|Overall Study|No longer meets eligibility criteria|0|||
33319712|NCT02608879|101064199|FG001|Overall Study|Did not meet continuation criteria|0|||
33319713|NCT02608879|101064200|FG002|Overall Study|Did not meet continuation criteria|3|||
33319714|NCT03952806|101064205|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
33319715|NCT03952806|101064206|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
33398695|NCT01196091|101350118|FG002|Overall Study|Death|2|||
33604514|NCT02262754|102102637|FG000|Overall Study|Study terminated by sponsor|5|||
33604515|NCT02262754|102102638|FG001|Overall Study|Study terminated by sponsor|4|||
33604516|NCT02262754|102102639|FG002|Overall Study|Study terminated by sponsor|4|||
33398696|NCT01196091|101350116|FG000|Overall Study|Entry Criteria Not Met|11|||
33604517|NCT02262754|102102637|FG000|Overall Study|Protocol Violation|1|||
33364917|NCT01790438|101223683|FG001|Overall Study|Physician Decision|1|||
33197755|NCT00852397|100626595|FG000|Overall Study|Withdrawal by Subject|4|||
33197756|NCT00852397|100626596|FG001|Overall Study|Withdrawal by Subject|1|||
33197757|NCT00852397|100626597|FG002|Overall Study|Withdrawal by Subject|2|||
33197758|NCT00852397|100626595|FG000|Overall Study|Study terminated by sponsor|2|||
33319716|NCT03952806|101064205|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
33319717|NCT03952806|101064206|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
33319718|NCT03952806|101064205|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
33508439|NCT02244463|101756051|FG003|Period 5: Phase II|Intercurrent Illness|0|||
33508440|NCT02244463|101756052|FG004|Period 5: Phase II|Intercurrent Illness|2|||
33508441|NCT02244463|101756053|FG005|Period 5: Phase II|Intercurrent Illness|0|||
33508442|NCT02244463|101756048|FG000|Period 5: Phase II|Adverse Event|0|||
33508443|NCT02244463|101756049|FG001|Period 5: Phase II|Adverse Event|0|||
33508444|NCT02244463|101756050|FG002|Period 5: Phase II|Adverse Event|0|||
33508445|NCT02244463|101756051|FG003|Period 5: Phase II|Adverse Event|0|||
33508446|NCT02244463|101756052|FG004|Period 5: Phase II|Adverse Event|0|||
33508447|NCT02244463|101756053|FG005|Period 5: Phase II|Adverse Event|2|||
33508448|NCT02244463|101756048|FG000|Period 5: Phase II|Still On treatment|0|||
33508449|NCT02244463|101756049|FG001|Period 5: Phase II|Still On treatment|0|||
33508450|NCT02244463|101756050|FG002|Period 5: Phase II|Still On treatment|0|||
33508451|NCT02244463|101756051|FG003|Period 5: Phase II|Still On treatment|0|||
33508452|NCT02244463|101756052|FG004|Period 5: Phase II|Still On treatment|0|||
33508453|NCT02244463|101756053|FG005|Period 5: Phase II|Still On treatment|3|||
33508454|NCT01931956|101756054|FG000|Overall Study|Death|42|||
33508455|NCT01931956|101756055|FG001|Overall Study|Death|7|||
33508456|NCT01931956|101756056|FG002|Overall Study|Death|379|||
33508457|NCT01931956|101756057|FG003|Overall Study|Death|96|||
33508458|NCT01931956|101756054|FG000|Overall Study|Withdrawal by Subject|5|||
33508459|NCT01931956|101756055|FG001|Overall Study|Withdrawal by Subject|0|||
33508460|NCT01931956|101756056|FG002|Overall Study|Withdrawal by Subject|70|||
33508461|NCT01931956|101756057|FG003|Overall Study|Withdrawal by Subject|30|||
33508462|NCT01931956|101756054|FG000|Overall Study|Lost to Follow-up|2|||
33508463|NCT01931956|101756055|FG001|Overall Study|Lost to Follow-up|0|||
33508464|NCT01931956|101756056|FG002|Overall Study|Lost to Follow-up|11|||
33508465|NCT01931956|101756057|FG003|Overall Study|Lost to Follow-up|7|||
33508466|NCT01931956|101756054|FG000|Overall Study|Expected|2|||
33508467|NCT01931956|101756055|FG001|Overall Study|Expected|0|||
33508468|NCT01931956|101756056|FG002|Overall Study|Expected|6|||
33508469|NCT01931956|101756057|FG003|Overall Study|Expected|0|||
33508470|NCT01931956|101756054|FG000|Overall Study|Not due|0|||
33508471|NCT01931956|101756055|FG001|Overall Study|Not due|0|||
33508472|NCT01931956|101756056|FG002|Overall Study|Not due|21|||
33508473|NCT01931956|101756057|FG003|Overall Study|Not due|0|||
33508474|NCT02288091|101756058|FG000|Overall Study|Lost to Follow-up|1|||
33508475|NCT02288091|101756058|FG000|Overall Study|Screen fail|7|||
33508476|NCT00435487|101756060|FG000|Overall Study|Death|3|||
33508477|NCT00435487|101756061|FG001|Overall Study|Death|4|||
33508478|NCT00435487|101756060|FG000|Overall Study|Adverse Event|0|||
33508479|NCT00435487|101756061|FG001|Overall Study|Adverse Event|3|||
33508480|NCT00435487|101756060|FG000|Overall Study|Lost to Follow-up|2|||
33508481|NCT00435487|101756061|FG001|Overall Study|Lost to Follow-up|2|||
33508482|NCT00435487|101756060|FG000|Overall Study|Other|5|||
33508483|NCT00435487|101756061|FG001|Overall Study|Other|2|||
33508484|NCT00435487|101756060|FG000|Overall Study|Withdrawal by Subject|2|||
33508485|NCT00435487|101756061|FG001|Overall Study|Withdrawal by Subject|1|||
33508486|NCT00435487|101756060|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
33508487|NCT00435487|101756061|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
33508488|NCT00435487|101756060|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
33508489|NCT00435487|101756061|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
33508490|NCT02272842|101756062|FG000|Overall Study|Lost to Follow-up|8|||
33508491|NCT02272842|101756063|FG001|Overall Study|Lost to Follow-up|8|||
33508492|NCT02272842|101756062|FG000|Overall Study|Withdrawal by Subject|8|||
33508493|NCT02272842|101756063|FG001|Overall Study|Withdrawal by Subject|2|||
33508494|NCT03301844|101756064|FG000|Overall Study|suspected colon cancer|1|||
33508495|NCT03301844|101756065|FG001|Overall Study|suspected colon cancer|1|||
33508496|NCT00631410|101756068|FG000|Overall Study|Adverse Event|1|||
33319719|NCT03952806|101064206|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
33508497|NCT00631410|101756069|FG001|Overall Study|Adverse Event|3|||
33508498|NCT00631410|101756068|FG000|Overall Study|Objective Progression or Relapse|4|||
33508499|NCT00631410|101756069|FG001|Overall Study|Objective Progression or Relapse|3|||
33508500|NCT00631410|101756068|FG000|Overall Study|Surgery|1|||
33508501|NCT00631410|101756069|FG001|Overall Study|Surgery|0|||
33508502|NCT01085630|101756083|FG000|Overall Study|Insufficient data|1|||
33508503|NCT01085630|101756084|FG001|Overall Study|Insufficient data|0|||
33508504|NCT01085630|101756083|FG000|Overall Study|Ineligible|3|||
33508505|NCT01085630|101756084|FG001|Overall Study|Ineligible|0|||
33508506|NCT04505540|101756085|FG000|Baseline|Protocol Violation|10|||
33508507|NCT04505540|101756085|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
33604518|NCT02262754|102102638|FG001|Overall Study|Protocol Violation|0|||
33319720|NCT03952806|101064205|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
33319721|NCT03952806|101064206|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
33319722|NCT03952806|101064205|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
33319723|NCT03952806|101064206|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
33319724|NCT03952806|101064205|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
33508508|NCT04505540|101756085|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
33508509|NCT04505540|101756085|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
33604519|NCT02262754|102102639|FG002|Overall Study|Protocol Violation|0|||
33604520|NCT02262754|102102637|FG000|Overall Study|Withdrawal by Subject|1|||
33604521|NCT02262754|102102638|FG001|Overall Study|Withdrawal by Subject|0|||
33604522|NCT02262754|102102639|FG002|Overall Study|Withdrawal by Subject|1|||
33604523|NCT02262754|102102637|FG000|Overall Study|Other|4|||
33604524|NCT02262754|102102638|FG001|Overall Study|Other|0|||
33604525|NCT02262754|102102639|FG002|Overall Study|Other|2|||
33604526|NCT02322190|102102640|FG000|Overall Study|Death on study|1|||
33604527|NCT02322190|102102641|FG001|Overall Study|Death on study|0|||
33604528|NCT01554514|102102643|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
33604529|NCT01554514|102102643|FG000|Overall Study|Physician Decision|1|||
33604530|NCT02198794|102102648|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
33604531|NCT02198794|102102649|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
33604532|NCT02198794|102102650|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
33604533|NCT02198794|102102651|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
33508510|NCT04505540|101756085|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
33508511|NCT04505540|101756085|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
33508512|NCT04505540|101756085|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
33508513|NCT04505540|101756085|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
33508514|NCT04505540|101756085|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
33508515|NCT04505540|101756085|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
33508516|NCT04505540|101756085|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
33508517|NCT04505540|101756085|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
33508518|NCT04505540|101756085|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
33508519|NCT03218826|101756098|FG000|Overall Study|Non-compliance with protocol|1|||
33508520|NCT03218826|101756099|FG001|Overall Study|Non-compliance with protocol|0|||
33508521|NCT03218826|101756100|FG002|Overall Study|Non-compliance with protocol|2|||
33604534|NCT02198794|102102648|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
33604535|NCT02198794|102102649|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
33604536|NCT02198794|102102650|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
33604537|NCT02198794|102102651|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
33604538|NCT02198794|102102648|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
33604539|NCT02198794|102102649|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
33604540|NCT02198794|102102650|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
33604541|NCT02198794|102102651|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
33604542|NCT02198794|102102648|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
33604543|NCT02198794|102102649|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
33604544|NCT02198794|102102650|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
33604545|NCT02198794|102102651|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
33604546|NCT02198794|102102648|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
33604547|NCT02198794|102102649|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
33604548|NCT02198794|102102650|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
33604549|NCT02198794|102102651|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
33604550|NCT02198794|102102648|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
33604551|NCT02198794|102102649|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
33604552|NCT02198794|102102650|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
33604553|NCT02198794|102102651|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
33604554|NCT02198794|102102648|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
33604555|NCT02198794|102102649|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
33508522|NCT03218826|101756101|FG003|Overall Study|Non-compliance with protocol|1|||
33508523|NCT03218826|101756102|FG004|Overall Study|Non-compliance with protocol|1|||
33508524|NCT03919695|101756103|FG000|3-month Follow-up|Death|1|||
33508525|NCT03919695|101756104|FG001|3-month Follow-up|Death|1|||
33604556|NCT02198794|102102650|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
33604557|NCT02198794|102102651|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
33508526|NCT03919695|101756103|FG000|3-month Follow-up|unable to contact|0|||
33604558|NCT02198794|102102648|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
33604559|NCT02198794|102102649|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
33604560|NCT02198794|102102650|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
33604561|NCT02198794|102102651|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
33197759|NCT00852397|100626596|FG001|Overall Study|Study terminated by sponsor|1|||
33319725|NCT03952806|101064206|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
33508527|NCT03919695|101756104|FG001|3-month Follow-up|unable to contact|3|||
33508528|NCT03919695|101756103|FG000|3-month Follow-up|in prison|0|||
33508529|NCT03919695|101756104|FG001|3-month Follow-up|in prison|1|||
33508530|NCT03919695|101756103|FG000|6-month Follow-up|Death|0|||
33508531|NCT03919695|101756104|FG001|6-month Follow-up|Death|1|||
33508532|NCT03919695|101756103|FG000|6-month Follow-up|Lost to Follow-up|1|||
33508533|NCT03919695|101756104|FG001|6-month Follow-up|Lost to Follow-up|2|||
33508534|NCT03919695|101756103|FG000|6-month Follow-up|in prison|0|||
33508535|NCT03919695|101756104|FG001|6-month Follow-up|in prison|2|||
33508536|NCT03919695|101756103|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
33508537|NCT03919695|101756104|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
33508538|NCT03919695|101756103|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
33508539|NCT03919695|101756104|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
33508540|NCT03521115|101756108|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
33508541|NCT03521115|101756109|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
33508542|NCT03521115|101756108|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
33508543|NCT03521115|101756109|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
33508544|NCT00941863|101756112|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
33508545|NCT00941863|101756113|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
33508546|NCT00941863|101756114|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
33508547|NCT00941863|101756115|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
33508548|NCT00941863|101756116|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
33508549|NCT00941863|101756112|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
33508550|NCT00941863|101756113|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
33604562|NCT02198794|102102648|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
33604563|NCT02198794|102102649|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
33604564|NCT02198794|102102650|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
33604565|NCT02198794|102102651|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
33604566|NCT02198794|102102648|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
33604567|NCT02198794|102102649|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
33604568|NCT02198794|102102650|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
33604569|NCT02198794|102102651|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
33604570|NCT02198794|102102648|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
33604571|NCT02198794|102102649|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
33604572|NCT02198794|102102650|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
33604573|NCT02198794|102102651|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
33604574|NCT02198794|102102648|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
33604575|NCT02198794|102102649|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
33604576|NCT02198794|102102650|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
33604577|NCT02198794|102102651|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
33604578|NCT02198794|102102648|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
33604579|NCT02198794|102102649|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
33604580|NCT02198794|102102650|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
33604581|NCT02198794|102102651|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
33604582|NCT02198794|102102648|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
33604583|NCT02198794|102102649|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
33319726|NCT03952806|101064205|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
33319727|NCT03952806|101064206|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
33319728|NCT03952806|101064205|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
33319729|NCT03952806|101064206|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
33508551|NCT00941863|101756114|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
33508552|NCT00941863|101756115|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
33508553|NCT00941863|101756116|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
33508554|NCT00941863|101756112|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
33508555|NCT00941863|101756113|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
33508556|NCT00941863|101756114|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
33508557|NCT00941863|101756115|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
33319730|NCT03952806|101064205|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
33508558|NCT00941863|101756116|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
33319731|NCT03952806|101064206|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
33508559|NCT00941863|101756112|FG000|Until Primary Completion Date (PCD)|Death|0|||
33508560|NCT00941863|101756113|FG001|Until Primary Completion Date (PCD)|Death|0|||
33508561|NCT00941863|101756114|FG002|Until Primary Completion Date (PCD)|Death|1|||
33508562|NCT00941863|101756115|FG003|Until Primary Completion Date (PCD)|Death|2|||
33508563|NCT00941863|101756116|FG004|Until Primary Completion Date (PCD)|Death|7|||
33508564|NCT00941863|101756112|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
33508565|NCT00941863|101756113|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
33508566|NCT00941863|101756114|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
33508567|NCT00941863|101756115|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
33508568|NCT00941863|101756116|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
33508569|NCT00941863|101756112|FG000|Continued After PCD|Withdrawal by Subject|0|||
33508570|NCT00941863|101756113|FG001|Continued After PCD|Withdrawal by Subject|0|||
33508571|NCT00941863|101756114|FG002|Continued After PCD|Withdrawal by Subject|0|||
33508572|NCT00941863|101756115|FG003|Continued After PCD|Withdrawal by Subject|0|||
33508573|NCT00941863|101756116|FG004|Continued After PCD|Withdrawal by Subject|1|||
33508574|NCT00941863|101756112|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
33508575|NCT00941863|101756113|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
33508576|NCT00941863|101756114|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
33508577|NCT00941863|101756115|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
33508578|NCT00941863|101756116|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
33508579|NCT04533412|101756117|FG000|Overall Study|Withdrawal by Subject|1|||
33508580|NCT04533412|101756118|FG001|Overall Study|Withdrawal by Subject|1|||
33508581|NCT04533412|101756117|FG000|Overall Study|Lost to Follow-up|1|||
33508582|NCT04533412|101756118|FG001|Overall Study|Lost to Follow-up|4|||
33508583|NCT02496091|101756119|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33508584|NCT01680159|101756126|FG000|Screening Period|Not meet criteria for dose-up period|7|||
33508585|NCT01680159|101756126|FG000|Increased Dose Period|Adverse Event|6|||
33508586|NCT01680159|101756126|FG000|Increased Dose Period|Withdrawal by Subject|2|||
33508587|NCT03875482|101756132|FG000|Overall Study|Adverse Event|0|||
33508588|NCT03875482|101756133|FG001|Overall Study|Adverse Event|1|||
33508589|NCT03875482|101756132|FG000|Overall Study|Withdrew consent|5|||
33508590|NCT03875482|101756133|FG001|Overall Study|Withdrew consent|6|||
33508591|NCT03875482|101756132|FG000|Overall Study|Lost to Follow-up|8|||
33508592|NCT03875482|101756133|FG001|Overall Study|Lost to Follow-up|2|||
33508593|NCT03875482|101756132|FG000|Overall Study|Lack of Efficacy|0|||
33508594|NCT03875482|101756133|FG001|Overall Study|Lack of Efficacy|11|||
33508595|NCT01855243|101756134|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
33508596|NCT01855243|101756135|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
33508597|NCT01855243|101756136|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
33508598|NCT02475265|101756138|FG000|Overall Study|Physician Decision|1|||
33508599|NCT02475265|101756138|FG000|Overall Study|Withdrawal by Subject|2|||
33508600|NCT01421225|101756139|FG000|Overall Study|Withdrawal by Subject|0|||
33508601|NCT01421225|101756140|FG001|Overall Study|Withdrawal by Subject|1|||
33508602|NCT01095978|101756151|FG000|Overall Study|Did not take Klacid SR|2|||
33508603|NCT01095978|101756151|FG000|Overall Study|Adverse Event|1|||
33508604|NCT02045862|101759050|FG000|Overall Study|Death|0|||
33508605|NCT02045862|101759051|FG001|Overall Study|Death|0|||
33508606|NCT02045862|101759052|FG002|Overall Study|Death|1|||
33508607|NCT02045862|101759050|FG000|Overall Study|Miscellaneous|5|||
33508608|NCT02045862|101759051|FG001|Overall Study|Miscellaneous|0|||
33508609|NCT02045862|101759052|FG002|Overall Study|Miscellaneous|8|||
33508610|NCT02045862|101759050|FG000|Overall Study|Withdrawal by Patient|18|||
33508611|NCT02045862|101759051|FG001|Overall Study|Withdrawal by Patient|27|||
33508612|NCT02045862|101759052|FG002|Overall Study|Withdrawal by Patient|57|||
33508613|NCT02045862|101759050|FG000|Overall Study|Protocol Violation|0|||
33508614|NCT02045862|101759051|FG001|Overall Study|Protocol Violation|0|||
33508615|NCT02045862|101759052|FG002|Overall Study|Protocol Violation|6|||
33508616|NCT02045862|101759050|FG000|Overall Study|Lack of Efficacy|8|||
33508617|NCT02045862|101759051|FG001|Overall Study|Lack of Efficacy|4|||
33508618|NCT02045862|101759052|FG002|Overall Study|Lack of Efficacy|13|||
33508619|NCT02045862|101759050|FG000|Overall Study|Randomized but not Received Study Drug|0|||
33508620|NCT02045862|101759051|FG001|Overall Study|Randomized but not Received Study Drug|2|||
33508621|NCT02045862|101759052|FG002|Overall Study|Randomized but not Received Study Drug|8|||
33508622|NCT02045862|101759050|FG000|Overall Study|Adverse Event|7|||
33508623|NCT02045862|101759051|FG001|Overall Study|Adverse Event|5|||
33508624|NCT02045862|101759052|FG002|Overall Study|Adverse Event|27|||
33508625|NCT02045862|101759050|FG000|Overall Study|Lost to Follow-up|1|||
33604584|NCT02198794|102102650|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
33508626|NCT02045862|101759051|FG001|Overall Study|Lost to Follow-up|2|||
33508627|NCT02045862|101759052|FG002|Overall Study|Lost to Follow-up|6|||
33508628|NCT02029989|101759055|FG000|Overall Study|Withdrawal by Subject|1|||
33508629|NCT02029989|101759056|FG001|Overall Study|Withdrawal by Subject|0|||
33508630|NCT02029989|101759055|FG000|Overall Study|Withdrawal: Fear of needles|1|||
33508631|NCT02029989|101759056|FG001|Overall Study|Withdrawal: Fear of needles|0|||
33508632|NCT02029989|101759055|FG000|Overall Study|Change of location|2|||
33508633|NCT02029989|101759056|FG001|Overall Study|Change of location|3|||
33508634|NCT02029989|101759055|FG000|Overall Study|Physician Decision|2|||
33508635|NCT02029989|101759056|FG001|Overall Study|Physician Decision|0|||
33508636|NCT02029989|101759055|FG000|Overall Study|Lost to Follow-up|9|||
33508637|NCT02029989|101759056|FG001|Overall Study|Lost to Follow-up|7|||
33508638|NCT02029989|101759055|FG000|Overall Study|Death|0|||
33508639|NCT02029989|101759056|FG001|Overall Study|Death|1|||
33508640|NCT02029989|101759055|FG000|Overall Study|Protocol Violation|1|||
33508641|NCT02029989|101759056|FG001|Overall Study|Protocol Violation|0|||
33508642|NCT02419612|101759061|FG000|Short-term Treatment Period|Adverse Event|1|||
33508643|NCT02419612|101759062|FG001|Short-term Treatment Period|Adverse Event|1|||
33508644|NCT02419612|101759061|FG000|Short-term Treatment Period|Death|0|||
33508645|NCT02419612|101759062|FG001|Short-term Treatment Period|Death|2|||
33508646|NCT02419612|101759061|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
33508647|NCT02419612|101759062|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
33508648|NCT02419612|101759061|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
33508649|NCT02419612|101759062|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
33508650|NCT02419612|101759061|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
33508651|NCT02419612|101759062|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
33508652|NCT02419612|101759061|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
33508653|NCT02419612|101759062|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
33508654|NCT02419612|101759061|FG000|Short-term Treatment Period|Worsening of liver function|0|||
33508655|NCT02419612|101759062|FG001|Short-term Treatment Period|Worsening of liver function|1|||
33508656|NCT02419612|101759061|FG000|Short-term Treatment Period|Subject moved out of state|0|||
33508657|NCT02419612|101759062|FG001|Short-term Treatment Period|Subject moved out of state|1|||
33508658|NCT02419612|101759061|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
33508659|NCT02419612|101759062|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
33508660|NCT02419612|101759061|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
33508661|NCT02419612|101759062|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
33508662|NCT02419612|101759061|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
33508663|NCT02419612|101759062|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
33508664|NCT02419612|101759061|FG000|Long-term Treatment Period|Death|0|||
33508665|NCT02419612|101759062|FG001|Long-term Treatment Period|Death|1|||
33508666|NCT02419612|101759061|FG000|Long-term Treatment Period|Adverse Event|0|||
33508667|NCT02419612|101759062|FG001|Long-term Treatment Period|Adverse Event|5|||
33508668|NCT02419612|101759061|FG000|Long-term Treatment Period|Other|4|||
33508669|NCT02419612|101759062|FG001|Long-term Treatment Period|Other|4|||
33508670|NCT02419612|101759061|FG000|Long-term Treatment Period|Subject Decision|2|||
33508671|NCT02419612|101759062|FG001|Long-term Treatment Period|Subject Decision|4|||
33508672|NCT02419612|101759061|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
33604585|NCT02198794|102102651|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
33604586|NCT02198794|102102648|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
33508673|NCT02419612|101759062|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
33508674|NCT02730377|101759063|FG000|Overall Study|Other|5|||
33604587|NCT02198794|102102649|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
33604588|NCT02198794|102102650|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
33604589|NCT02198794|102102651|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
33508675|NCT02730377|101759064|FG001|Overall Study|Other|4|||
33508676|NCT02730377|101759063|FG000|Overall Study|Death|1|||
33508677|NCT02730377|101759064|FG001|Overall Study|Death|8|||
33508678|NCT02730377|101759063|FG000|Overall Study|Inadequate glycaemic control|368|||
33508679|NCT02730377|101759064|FG001|Overall Study|Inadequate glycaemic control|473|||
33508680|NCT02730377|101759063|FG000|Overall Study|Adverse Event|79|||
33508681|NCT02730377|101759064|FG001|Overall Study|Adverse Event|41|||
33508682|NCT02730377|101759063|FG000|Overall Study|Protocol Violation|23|||
33508683|NCT02730377|101759064|FG001|Overall Study|Protocol Violation|30|||
33508684|NCT02730377|101759063|FG000|Overall Study|Lack of Efficacy|4|||
33508685|NCT02730377|101759064|FG001|Overall Study|Lack of Efficacy|13|||
33508686|NCT02730377|101759063|FG000|Overall Study|Pregnancy|0|||
33508687|NCT02730377|101759064|FG001|Overall Study|Pregnancy|1|||
33508688|NCT02730377|101759063|FG000|Overall Study|Withdrawal by Subject|45|||
33508689|NCT02730377|101759064|FG001|Overall Study|Withdrawal by Subject|42|||
33508690|NCT02730377|101759063|FG000|Overall Study|Lost to Follow-up|25|||
33508691|NCT02730377|101759064|FG001|Overall Study|Lost to Follow-up|21|||
33508692|NCT00968981|101759069|FG000|Overall Study|Adverse Event|2|||
33508693|NCT00968981|101759070|FG001|Overall Study|Adverse Event|0|||
33508694|NCT00968981|101759071|FG002|Overall Study|Adverse Event|0|||
33508695|NCT00968981|101759069|FG000|Overall Study|Disease Progression|14|||
33604590|NCT00471887|102102655|FG000|Overall Study|Adverse Event|9|||
33508696|NCT00968981|101759070|FG001|Overall Study|Disease Progression|16|||
33508697|NCT00968981|101759071|FG002|Overall Study|Disease Progression|13|||
33508698|NCT00968981|101759069|FG000|Overall Study|Lost to Follow-up|0|||
33508699|NCT00968981|101759070|FG001|Overall Study|Lost to Follow-up|0|||
33508700|NCT00968981|101759071|FG002|Overall Study|Lost to Follow-up|1|||
33508701|NCT00968981|101759069|FG000|Overall Study|Physician Decision|5|||
33508702|NCT00968981|101759070|FG001|Overall Study|Physician Decision|3|||
33508703|NCT00968981|101759071|FG002|Overall Study|Physician Decision|5|||
33508704|NCT00968981|101759069|FG000|Overall Study|Withdrawal by Subject|1|||
33508705|NCT00968981|101759070|FG001|Overall Study|Withdrawal by Subject|3|||
33508706|NCT00968981|101759071|FG002|Overall Study|Withdrawal by Subject|3|||
33508707|NCT00330343|101759074|FG000|Overall Study|Lost to Follow-up|5|||
33508708|NCT05483686|101759075|FG000|Overall Study|Lost to Follow-up|5|||
33508709|NCT05483686|101759076|FG001|Overall Study|Lost to Follow-up|7|||
33508710|NCT00839527|101759079|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
33508711|NCT00839527|101759080|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
33508712|NCT00839527|101759081|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
33508713|NCT00839527|101759079|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
33508714|NCT00839527|101759080|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
33508715|NCT00839527|101759081|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
33508716|NCT00839527|101759079|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
33508717|NCT00839527|101759080|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
33508718|NCT00839527|101759081|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
33508719|NCT00839527|101759079|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
33508720|NCT00839527|101759080|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
33508721|NCT00839527|101759081|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
33508722|NCT00839527|101759079|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
33508723|NCT00839527|101759080|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
33508724|NCT00839527|101759081|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
33508725|NCT00839527|101759079|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
33508726|NCT00839527|101759080|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
33508727|NCT00839527|101759081|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
33508728|NCT00839527|101759079|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
33508729|NCT00839527|101759080|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
33508730|NCT00839527|101759081|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
33508731|NCT00839527|101759079|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
33508732|NCT00839527|101759080|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
33508733|NCT00839527|101759081|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
33508734|NCT00839527|101759079|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
33508735|NCT00839527|101759080|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
33508736|NCT00839527|101759081|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
33508737|NCT00839527|101759079|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
33508738|NCT00839527|101759080|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
33508739|NCT00839527|101759081|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
33508740|NCT00839527|101759079|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
33508741|NCT00839527|101759080|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
33508742|NCT00839527|101759081|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
33508743|NCT00839527|101759079|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
33508744|NCT00839527|101759080|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
33508745|NCT00839527|101759081|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
33508746|NCT00839527|101759079|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
33508747|NCT00839527|101759080|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
33508748|NCT00839527|101759081|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
33508749|NCT00839527|101759079|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
33508750|NCT00839527|101759080|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
33508751|NCT00839527|101759081|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
33508752|NCT00839527|101759079|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
33508753|NCT00839527|101759080|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
33508754|NCT00839527|101759081|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
33508755|NCT00839527|101759079|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
33508756|NCT00839527|101759080|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
33197760|NCT00852397|100626597|FG002|Overall Study|Study terminated by sponsor|6|||
33197761|NCT00852397|100626595|FG000|Overall Study|Difficulty in study site visit|1|||
33508757|NCT00839527|101759081|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
33508758|NCT00839527|101759079|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
33508759|NCT00839527|101759080|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
33508760|NCT00839527|101759081|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
33604591|NCT00869401|102102656|FG000|Overall Study|Withdrawal by Subject|0|||
33319732|NCT03952806|101064205|FG000|OLE Phase (48 Weeks)|Other|16|||
33508761|NCT00839527|101759079|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
33508762|NCT00839527|101759080|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
33508763|NCT00839527|101759081|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
33508764|NCT00839527|101759079|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
33319733|NCT03952806|101064206|FG001|OLE Phase (48 Weeks)|Other|13|||
33319734|NCT03872453|101064207|FG000|Overall Study|Adverse Event|1|||
33319735|NCT03872453|101064208|FG001|Overall Study|Adverse Event|1|||
33319736|NCT03872453|101064209|FG002|Overall Study|Adverse Event|0|||
33319737|NCT03872453|101064210|FG003|Overall Study|Adverse Event|0|||
33319738|NCT03872453|101064207|FG000|Overall Study|Lost to Follow-up|8|||
33508765|NCT00839527|101759080|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
33508766|NCT00839527|101759081|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
33508767|NCT00839527|101759079|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
33508768|NCT00839527|101759080|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
33508769|NCT00839527|101759081|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
33508770|NCT00839527|101759079|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
33319739|NCT03872453|101064208|FG001|Overall Study|Lost to Follow-up|7|||
33319740|NCT03872453|101064209|FG002|Overall Study|Lost to Follow-up|4|||
33319741|NCT03872453|101064210|FG003|Overall Study|Lost to Follow-up|4|||
33319742|NCT03872453|101064207|FG000|Overall Study|Never Treated Migraine|19|||
33508771|NCT00839527|101759080|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
33508772|NCT00839527|101759081|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
33508773|NCT00839527|101759079|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
33508774|NCT00839527|101759080|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
33508775|NCT00839527|101759081|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
33508776|NCT00839527|101759079|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
33508777|NCT00839527|101759080|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
33508778|NCT00839527|101759081|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
33508779|NCT00839527|101759079|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
33508780|NCT00839527|101759080|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
33508781|NCT00839527|101759081|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
33508782|NCT02000622|101759088|FG000|Overall Study|Withdrawal by Subject|5|||
33508783|NCT02000622|101759089|FG001|Overall Study|Withdrawal by Subject|7|||
33508784|NCT02000622|101759088|FG000|Overall Study|Lost to Follow-up|4|||
33508785|NCT02000622|101759089|FG001|Overall Study|Lost to Follow-up|0|||
33508786|NCT02000622|101759088|FG000|Overall Study|Death|159|||
33508787|NCT02000622|101759089|FG001|Overall Study|Death|73|||
33508788|NCT02000622|101759088|FG000|Overall Study|Withdrawn due to site closure|1|||
33508789|NCT02000622|101759089|FG001|Overall Study|Withdrawn due to site closure|0|||
33508790|NCT02682823|101759090|FG000|Overall Study|Withdrawal by Subject|0|||
33508791|NCT02682823|101759091|FG001|Overall Study|Withdrawal by Subject|0|||
33508792|NCT02682823|101759092|FG002|Overall Study|Withdrawal by Subject|1|||
33508793|NCT02682823|101759093|FG003|Overall Study|Withdrawal by Subject|0|||
33508794|NCT02682823|101759094|FG004|Overall Study|Withdrawal by Subject|1|||
33508795|NCT02682823|101759090|FG000|Overall Study|Protocol Deviation|0|||
33508796|NCT02682823|101759091|FG001|Overall Study|Protocol Deviation|1|||
33508797|NCT02682823|101759092|FG002|Overall Study|Protocol Deviation|0|||
33508798|NCT02682823|101759093|FG003|Overall Study|Protocol Deviation|0|||
33508799|NCT02682823|101759094|FG004|Overall Study|Protocol Deviation|0|||
33508800|NCT02682823|101759090|FG000|Overall Study|Adverse Event|0|||
33508801|NCT02682823|101759091|FG001|Overall Study|Adverse Event|0|||
33508802|NCT02682823|101759092|FG002|Overall Study|Adverse Event|0|||
33508803|NCT02682823|101759093|FG003|Overall Study|Adverse Event|1|||
33508804|NCT02682823|101759094|FG004|Overall Study|Adverse Event|0|||
33604592|NCT00869401|102102657|FG001|Overall Study|Withdrawal by Subject|0|||
33604593|NCT00869401|102102658|FG002|Overall Study|Withdrawal by Subject|0|||
33604594|NCT00869401|102102659|FG003|Overall Study|Withdrawal by Subject|5|||
33604595|NCT00869401|102102660|FG004|Overall Study|Withdrawal by Subject|3|||
33604596|NCT00527332|102102662|FG000|Overall Study|Protocol Violation|4|||
33604597|NCT00527332|102102663|FG001|Overall Study|Protocol Violation|8|||
33604598|NCT00527332|102102662|FG000|Overall Study|Withdrew consent|5|||
33604599|NCT00527332|102102663|FG001|Overall Study|Withdrew consent|1|||
33319743|NCT03872453|101064208|FG001|Overall Study|Never Treated Migraine|17|||
33604600|NCT02198235|102102664|FG000|Overall Study|Lost to Follow-up|3|||
33508805|NCT04429555|101759095|FG000|Overall Study|Death|0|||
33508806|NCT04429555|101759096|FG001|Overall Study|Death|2|||
33508807|NCT04429555|101759095|FG000|Overall Study|Other|2|||
33604601|NCT02198235|102102665|FG001|Overall Study|Lost to Follow-up|2|||
33319744|NCT03872453|101064209|FG002|Overall Study|Never Treated Migraine|13|||
33319745|NCT03872453|101064210|FG003|Overall Study|Never Treated Migraine|12|||
33508808|NCT04429555|101759096|FG001|Overall Study|Other|0|||
33508809|NCT00533702|101759097|FG000|Overall Study|Withdrawal by Subject|3|||
33604602|NCT02198235|102102666|FG002|Overall Study|Lost to Follow-up|2|||
33508810|NCT00533702|101759098|FG001|Overall Study|Withdrawal by Subject|1|||
33508811|NCT00533702|101759097|FG000|Overall Study|Found ineligible after randomization|2|||
33508812|NCT00533702|101759098|FG001|Overall Study|Found ineligible after randomization|1|||
33508813|NCT02833844|101759099|FG000|Double-Blind Period|Withdrawal by Subject|2|||
33508814|NCT02833844|101759100|FG001|Double-Blind Period|Withdrawal by Subject|3|||
33508815|NCT02833844|101759099|FG000|Double-Blind Period|Protocol Violation|0|||
33508816|NCT02833844|101759100|FG001|Double-Blind Period|Protocol Violation|4|||
33508817|NCT02833844|101759099|FG000|Open-Label Period|Death|0|||
33508818|NCT02833844|101759100|FG001|Open-Label Period|Death|2|||
33508819|NCT02833844|101759099|FG000|Open-Label Period|Lost to Follow-up|1|||
33197762|NCT00852397|100626596|FG001|Overall Study|Difficulty in study site visit|0|||
33197763|NCT00852397|100626597|FG002|Overall Study|Difficulty in study site visit|0|||
33604603|NCT01943552|102102667|FG000|Overall Study|Adverse Event|3|||
33604604|NCT01943552|102102668|FG001|Overall Study|Adverse Event|2|||
33604605|NCT01943552|102102667|FG000|Overall Study|Withdrawal by Subject|6|||
33604606|NCT01943552|102102668|FG001|Overall Study|Withdrawal by Subject|6|||
33604607|NCT01943552|102102667|FG000|Overall Study|Other Reasons|16|||
33604608|NCT01943552|102102668|FG001|Overall Study|Other Reasons|17|||
33604609|NCT03199391|102102669|FG000|Overall Study|Death|1|||
33604610|NCT03199391|102102669|FG000|Overall Study|Lost to Follow-up|3|||
33604611|NCT03199391|102102669|FG000|Overall Study|Adverse Event|2|||
33604612|NCT03199391|102102669|FG000|Overall Study|Withdrawal by Subject|10|||
33604613|NCT00549770|102102670|FG000|Overall Study|Protocol deviation|1|||
33604614|NCT00549770|102102671|FG001|Overall Study|Protocol deviation|1|||
33604615|NCT00549770|102102672|FG002|Overall Study|Protocol deviation|1|||
33604616|NCT00549770|102102673|FG003|Overall Study|Protocol deviation|2|||
33604617|NCT00549770|102102674|FG004|Overall Study|Protocol deviation|2|||
33604618|NCT00549770|102102675|FG005|Overall Study|Protocol deviation|2|||
33604619|NCT00549770|102102676|FG006|Overall Study|Protocol deviation|1|||
33604620|NCT00549770|102102677|FG007|Overall Study|Protocol deviation|2|||
33604621|NCT00549770|102102670|FG000|Overall Study|Administrative problems|0|||
33604622|NCT00549770|102102671|FG001|Overall Study|Administrative problems|1|||
33604623|NCT00549770|102102672|FG002|Overall Study|Administrative problems|0|||
33604624|NCT00549770|102102673|FG003|Overall Study|Administrative problems|0|||
33604625|NCT00549770|102102674|FG004|Overall Study|Administrative problems|0|||
33604626|NCT00549770|102102675|FG005|Overall Study|Administrative problems|0|||
33604627|NCT00549770|102102676|FG006|Overall Study|Administrative problems|0|||
33604628|NCT00549770|102102677|FG007|Overall Study|Administrative problems|1|||
33604629|NCT00549770|102102670|FG000|Overall Study|Lost to Follow-up|0|||
33604630|NCT00549770|102102671|FG001|Overall Study|Lost to Follow-up|0|||
33604631|NCT00549770|102102672|FG002|Overall Study|Lost to Follow-up|2|||
33604632|NCT00549770|102102673|FG003|Overall Study|Lost to Follow-up|2|||
33604633|NCT00549770|102102674|FG004|Overall Study|Lost to Follow-up|3|||
33604634|NCT00549770|102102675|FG005|Overall Study|Lost to Follow-up|2|||
33604635|NCT00549770|102102676|FG006|Overall Study|Lost to Follow-up|0|||
33604636|NCT00549770|102102677|FG007|Overall Study|Lost to Follow-up|0|||
33604637|NCT00549770|102102670|FG000|Overall Study|Withdrawal by Subject|4|||
33604638|NCT00549770|102102671|FG001|Overall Study|Withdrawal by Subject|6|||
33604639|NCT00549770|102102672|FG002|Overall Study|Withdrawal by Subject|4|||
33604640|NCT00549770|102102673|FG003|Overall Study|Withdrawal by Subject|5|||
33604641|NCT00549770|102102674|FG004|Overall Study|Withdrawal by Subject|6|||
33604642|NCT00549770|102102675|FG005|Overall Study|Withdrawal by Subject|6|||
33604643|NCT00549770|102102676|FG006|Overall Study|Withdrawal by Subject|4|||
33604644|NCT00549770|102102677|FG007|Overall Study|Withdrawal by Subject|9|||
33604645|NCT00549770|102102670|FG000|Overall Study|Lack of Efficacy|1|||
33604646|NCT00549770|102102671|FG001|Overall Study|Lack of Efficacy|0|||
33604647|NCT00549770|102102672|FG002|Overall Study|Lack of Efficacy|2|||
33604648|NCT00549770|102102673|FG003|Overall Study|Lack of Efficacy|3|||
33197764|NCT00852397|100626595|FG000|Overall Study|Protocol Violation|0|||
33508820|NCT02833844|101759100|FG001|Open-Label Period|Lost to Follow-up|0|||
33604649|NCT00549770|102102674|FG004|Overall Study|Lack of Efficacy|5|||
33604650|NCT00549770|102102675|FG005|Overall Study|Lack of Efficacy|1|||
33604651|NCT00549770|102102676|FG006|Overall Study|Lack of Efficacy|3|||
33604652|NCT00549770|102102677|FG007|Overall Study|Lack of Efficacy|8|||
33604653|NCT00549770|102102670|FG000|Overall Study|Abnormal test procedure results|0|||
33197765|NCT00852397|100626596|FG001|Overall Study|Protocol Violation|0|||
33197766|NCT00852397|100626597|FG002|Overall Study|Protocol Violation|1|||
33197767|NCT01816139|100626598|FG000|Overall Study|Adverse Event|6|||
33319746|NCT03872453|101064207|FG000|Overall Study|Pregnancy|1|||
33319747|NCT03872453|101064208|FG001|Overall Study|Pregnancy|0|||
33319748|NCT03872453|101064209|FG002|Overall Study|Pregnancy|0|||
33319749|NCT03872453|101064210|FG003|Overall Study|Pregnancy|0|||
33319750|NCT03872453|101064207|FG000|Overall Study|Protocol Deviation|2|||
33319751|NCT03872453|101064208|FG001|Overall Study|Protocol Deviation|0|||
33319752|NCT03872453|101064209|FG002|Overall Study|Protocol Deviation|0|||
33319753|NCT03872453|101064210|FG003|Overall Study|Protocol Deviation|2|||
33319754|NCT03872453|101064207|FG000|Overall Study|Withdrawal by Subject|0|||
33319755|NCT03872453|101064208|FG001|Overall Study|Withdrawal by Subject|1|||
33319756|NCT03872453|101064209|FG002|Overall Study|Withdrawal by Subject|2|||
33319757|NCT03872453|101064210|FG003|Overall Study|Withdrawal by Subject|0|||
33319758|NCT03872453|101064207|FG000|Overall Study|Other Than Specified|1|||
33319759|NCT03872453|101064208|FG001|Overall Study|Other Than Specified|0|||
33319760|NCT03872453|101064209|FG002|Overall Study|Other Than Specified|0|||
33319761|NCT03872453|101064210|FG003|Overall Study|Other Than Specified|0|||
33319762|NCT02178553|101064215|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
33319763|NCT02178553|101064216|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
33319764|NCT02178553|101064215|FG000|Overall Study|Physician Decision|0|||
33319765|NCT02178553|101064216|FG001|Overall Study|Physician Decision|4|||
33319766|NCT02178553|101064215|FG000|Overall Study|Technical problem with injection|1|||
33319767|NCT02178553|101064216|FG001|Overall Study|Technical problem with injection|3|||
33319768|NCT01422850|101064217|FG000|Overall Study|Physician Decision|3|||
33319769|NCT01251120|101064218|FG000|Overall Study|Lack of Efficacy|0|||
33319770|NCT01251120|101064219|FG001|Overall Study|Lack of Efficacy|1|||
33319771|NCT01296035|101064221|FG000|Overall Study|Withdrawal by Subject|1|||
33319772|NCT00640016|101064222|FG000|Overall Study|Withdrawal by Subject|0|||
33319773|NCT00640016|101064223|FG001|Overall Study|Withdrawal by Subject|1|||
33319774|NCT00640016|101064224|FG002|Overall Study|Withdrawal by Subject|0|||
33319775|NCT00640016|101064225|FG003|Overall Study|Withdrawal by Subject|0|||
33319776|NCT00640016|101064222|FG000|Overall Study|Study termination|2|||
33319777|NCT00640016|101064223|FG001|Overall Study|Study termination|1|||
33319778|NCT00640016|101064224|FG002|Overall Study|Study termination|3|||
33319779|NCT00640016|101064225|FG003|Overall Study|Study termination|2|||
33319780|NCT00640016|101064222|FG000|Overall Study|Adverse Event|0|||
33319781|NCT00640016|101064223|FG001|Overall Study|Adverse Event|0|||
33319782|NCT00640016|101064224|FG002|Overall Study|Adverse Event|0|||
33319783|NCT00640016|101064225|FG003|Overall Study|Adverse Event|1|||
33319784|NCT00300781|101064226|FG000|Overall Study|Disease Progression|55|||
33319785|NCT00300781|101064227|FG001|Overall Study|Disease Progression|52|||
33319786|NCT00300781|101064226|FG000|Overall Study|Adverse Event|5|||
33319787|NCT00300781|101064227|FG001|Overall Study|Adverse Event|6|||
33319788|NCT00300781|101064226|FG000|Overall Study|Withdrawal by Subject|1|||
33319789|NCT00300781|101064227|FG001|Overall Study|Withdrawal by Subject|2|||
33319790|NCT00300781|101064226|FG000|Overall Study|Physician Decision|1|||
33319791|NCT00300781|101064227|FG001|Overall Study|Physician Decision|0|||
33319792|NCT00300781|101064226|FG000|Overall Study|Not Recorded|0|||
33319793|NCT00300781|101064227|FG001|Overall Study|Not Recorded|1|||
33319794|NCT00300781|101064226|FG000|Overall Study|Symptomatic Deterioration|1|||
33319795|NCT00300781|101064227|FG001|Overall Study|Symptomatic Deterioration|0|||
33319796|NCT00300781|101064226|FG000|Overall Study|Lost to Follow-up|0|||
33319797|NCT00300781|101064227|FG001|Overall Study|Lost to Follow-up|1|||
33319798|NCT01256658|101064231|FG000|Period 1|Lost to Follow-up|837|||
33319799|NCT01256658|101064232|FG001|Period 1|Lost to Follow-up|661|||
33319800|NCT01256658|101064231|FG000|Period 1|Withdrawal by Subject|35|||
33319801|NCT01256658|101064232|FG001|Period 1|Withdrawal by Subject|43|||
33319802|NCT01256658|101064231|FG000|Period 1|Death|48|||
33319803|NCT01256658|101064232|FG001|Period 1|Death|44|||
33319804|NCT02982187|101069777|FG000|Overall Study|Withdrawal by Subject|0|||
33319805|NCT02982187|101069778|FG001|Overall Study|Withdrawal by Subject|0|||
33197768|NCT01816139|100626599|FG001|Overall Study|Adverse Event|8|||
33197769|NCT01816139|100626598|FG000|Overall Study|Lack of Efficacy|1|||
33319806|NCT02982187|101069779|FG002|Overall Study|Withdrawal by Subject|0|||
33319807|NCT02982187|101069780|FG003|Overall Study|Withdrawal by Subject|0|||
33319808|NCT02982187|101069781|FG004|Overall Study|Withdrawal by Subject|0|||
33319809|NCT02982187|101069782|FG005|Overall Study|Withdrawal by Subject|0|||
33319810|NCT02982187|101069783|FG006|Overall Study|Withdrawal by Subject|1|||
33319811|NCT02982187|101069784|FG007|Overall Study|Withdrawal by Subject|0|||
33319812|NCT02598557|101069787|FG000|Overall Study|Withdrawal by Subject|1|||
33319813|NCT02598557|101069788|FG001|Overall Study|Withdrawal by Subject|0|||
33319814|NCT02598557|101069789|FG002|Overall Study|Withdrawal by Subject|1|||
33319815|NCT02598557|101069787|FG000|Overall Study|Participant did not start treatment|2|||
33319816|NCT02598557|101069788|FG001|Overall Study|Participant did not start treatment|1|||
33508821|NCT02833844|101759099|FG000|Open-Label Period|Withdrawal by Subject|1|||
33508822|NCT02833844|101759100|FG001|Open-Label Period|Withdrawal by Subject|0|||
33508823|NCT02738879|101759102|FG000|Overall Study|Adverse Event|1|||
33508824|NCT02738879|101759103|FG001|Overall Study|Adverse Event|1|||
33508825|NCT02738879|101759102|FG000|Overall Study|Death|0|||
33508826|NCT02738879|101759103|FG001|Overall Study|Death|2|||
33508827|NCT02738879|101759102|FG000|Overall Study|Lost to Follow-up|1|||
33508828|NCT02738879|101759103|FG001|Overall Study|Lost to Follow-up|5|||
33508829|NCT02738879|101759102|FG000|Overall Study|Protocol Violation|1|||
33508830|NCT02738879|101759103|FG001|Overall Study|Protocol Violation|3|||
33508831|NCT02738879|101759102|FG000|Overall Study|Physician Decision|3|||
33508832|NCT02738879|101759103|FG001|Overall Study|Physician Decision|4|||
33197770|NCT01816139|100626599|FG001|Overall Study|Lack of Efficacy|2|||
33197771|NCT01816139|100626598|FG000|Overall Study|Lost to Follow-up|5|||
33197772|NCT01816139|100626599|FG001|Overall Study|Lost to Follow-up|3|||
33197773|NCT01816139|100626598|FG000|Overall Study|Withdrew Consent|6|||
33197774|NCT01816139|100626599|FG001|Overall Study|Withdrew Consent|4|||
33197775|NCT01816139|100626598|FG000|Overall Study|Protocol Violation|6|||
33197776|NCT01816139|100626599|FG001|Overall Study|Protocol Violation|3|||
33197777|NCT01816139|100626598|FG000|Overall Study|Reason not Specified|4|||
33197778|NCT01816139|100626599|FG001|Overall Study|Reason not Specified|2|||
33197779|NCT03246529|100626600|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
33197780|NCT03246529|100626601|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
33197781|NCT03246529|100626602|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
33197782|NCT03246529|100626600|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
33197783|NCT03246529|100626601|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
33197784|NCT03246529|100626602|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
33197785|NCT03246529|100626600|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
33319817|NCT02598557|101069789|FG002|Overall Study|Participant did not start treatment|1|||
33508833|NCT02738879|101759102|FG000|Overall Study|Pregnancy|0|||
33508834|NCT02738879|101759103|FG001|Overall Study|Pregnancy|1|||
33604654|NCT00549770|102102671|FG001|Overall Study|Abnormal test procedure results|0|||
33604655|NCT00549770|102102672|FG002|Overall Study|Abnormal test procedure results|0|||
33604656|NCT00549770|102102673|FG003|Overall Study|Abnormal test procedure results|2|||
33319818|NCT02598557|101069787|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
33319819|NCT02598557|101069788|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
33319820|NCT02598557|101069789|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
33319821|NCT02598557|101069787|FG000|Overall Study|Adverse Event|1|||
33319822|NCT02598557|101069788|FG001|Overall Study|Adverse Event|1|||
33319823|NCT02598557|101069789|FG002|Overall Study|Adverse Event|0|||
33319824|NCT01008696|101069790|FG000|Overall Study|Participant's evasion of hospital visit|5|||
33319825|NCT01008696|101069791|FG001|Overall Study|Participant's evasion of hospital visit|4|||
33319826|NCT01008696|101069790|FG000|Overall Study|Withdrawal by Subject|2|||
33319827|NCT01008696|101069791|FG001|Overall Study|Withdrawal by Subject|4|||
33319828|NCT01008696|101069790|FG000|Overall Study|Physician Decision|5|||
33319829|NCT01008696|101069791|FG001|Overall Study|Physician Decision|1|||
33319830|NCT01008696|101069790|FG000|Overall Study|Adverse Event|1|||
33319831|NCT01008696|101069791|FG001|Overall Study|Adverse Event|0|||
33319832|NCT01008696|101069790|FG000|Overall Study|Participants' non-cooperation|2|||
33319833|NCT01008696|101069791|FG001|Overall Study|Participants' non-cooperation|3|||
33319834|NCT01008696|101069790|FG000|Overall Study|Other|2|||
33319835|NCT01008696|101069791|FG001|Overall Study|Other|3|||
33319836|NCT01008696|101069790|FG000|Overall Study|Other|0|||
33319837|NCT01008696|101069791|FG001|Overall Study|Other|2|||
33319838|NCT00705432|101069792|FG000|Treatment Period|Adverse Event|45|||
33319839|NCT00705432|101069793|FG001|Treatment Period|Adverse Event|37|||
33319840|NCT00705432|101069794|FG002|Treatment Period|Adverse Event|51|||
33319841|NCT00705432|101069795|FG003|Treatment Period|Adverse Event|12|||
33319842|NCT00705432|101069796|FG004|Treatment Period|Adverse Event|8|||
33319843|NCT00705432|101069797|FG005|Treatment Period|Adverse Event|9|||
33319844|NCT00705432|101069792|FG000|Treatment Period|Treatment failure|92|||
33319845|NCT00705432|101069793|FG001|Treatment Period|Treatment failure|42|||
33319846|NCT00705432|101069794|FG002|Treatment Period|Treatment failure|33|||
33398697|NCT01196091|101350117|FG001|Overall Study|Entry Criteria Not Met|11|||
33319847|NCT00705432|101069795|FG003|Treatment Period|Treatment failure|25|||
33319848|NCT00705432|101069796|FG004|Treatment Period|Treatment failure|13|||
33319849|NCT00705432|101069797|FG005|Treatment Period|Treatment failure|14|||
33319850|NCT00705432|101069792|FG000|Treatment Period|Non medical reason|26|||
33319851|NCT00705432|101069793|FG001|Treatment Period|Non medical reason|32|||
33319852|NCT00705432|101069794|FG002|Treatment Period|Non medical reason|37|||
33319853|NCT00705432|101069795|FG003|Treatment Period|Non medical reason|4|||
33398698|NCT01196091|101350118|FG002|Overall Study|Entry Criteria Not Met|10|||
33398699|NCT01196091|101350116|FG000|Overall Study|Lack of Efficacy|15|||
33398700|NCT01196091|101350117|FG001|Overall Study|Lack of Efficacy|12|||
33398701|NCT01196091|101350118|FG002|Overall Study|Lack of Efficacy|17|||
33398702|NCT01196091|101350116|FG000|Overall Study|Lost to Follow-up|5|||
33398703|NCT01196091|101350117|FG001|Overall Study|Lost to Follow-up|5|||
33398704|NCT01196091|101350118|FG002|Overall Study|Lost to Follow-up|6|||
33398705|NCT01196091|101350116|FG000|Overall Study|Parent/Caregiver Decision|0|||
33398706|NCT01196091|101350117|FG001|Overall Study|Parent/Caregiver Decision|0|||
33398707|NCT01196091|101350118|FG002|Overall Study|Parent/Caregiver Decision|1|||
33398708|NCT01196091|101350116|FG000|Overall Study|Withdrawal by Subject|16|||
33398709|NCT01196091|101350117|FG001|Overall Study|Withdrawal by Subject|19|||
33398710|NCT01196091|101350118|FG002|Overall Study|Withdrawal by Subject|22|||
33398711|NCT01196091|101350116|FG000|Overall Study|Physician Decision|3|||
33398712|NCT01196091|101350117|FG001|Overall Study|Physician Decision|3|||
33398713|NCT01196091|101350118|FG002|Overall Study|Physician Decision|4|||
33398714|NCT01196091|101350116|FG000|Overall Study|Protocol Violation|1|||
33398715|NCT01196091|101350117|FG001|Overall Study|Protocol Violation|3|||
33398716|NCT01196091|101350118|FG002|Overall Study|Protocol Violation|3|||
33398717|NCT01196091|101350116|FG000|Overall Study|Sponsor Decision|6|||
33398718|NCT01196091|101350117|FG001|Overall Study|Sponsor Decision|5|||
33398719|NCT01196091|101350118|FG002|Overall Study|Sponsor Decision|4|||
33398720|NCT01196091|101350116|FG000|Overall Study|Excluded Site|5|||
33398721|NCT01196091|101350117|FG001|Overall Study|Excluded Site|11|||
33398722|NCT01196091|101350118|FG002|Overall Study|Excluded Site|8|||
33398723|NCT01196091|101350116|FG000|Overall Study|Randomized, No Study Drug Received|1|||
33398724|NCT01196091|101350117|FG001|Overall Study|Randomized, No Study Drug Received|0|||
33398725|NCT01196091|101350118|FG002|Overall Study|Randomized, No Study Drug Received|1|||
33398726|NCT03702166|101350119|FG000|Overall Study|Lost to Follow-up|1|||
33604657|NCT00549770|102102674|FG004|Overall Study|Abnormal test procedure results|0|||
33319854|NCT00705432|101069796|FG004|Treatment Period|Non medical reason|7|||
33398727|NCT03702166|101350119|FG000|Overall Study|Withdrawal by Subject|1|||
33398728|NCT00508820|101350120|FG000|Overall Study|Adverse Event|6|||
33398729|NCT00508820|101350121|FG001|Overall Study|Adverse Event|10|||
33398730|NCT00508820|101350120|FG000|Overall Study|Death|6|||
33398731|NCT00508820|101350121|FG001|Overall Study|Death|8|||
33398732|NCT00508820|101350120|FG000|Overall Study|Lost to Follow-up|1|||
33319855|NCT00705432|101069797|FG005|Treatment Period|Non medical reason|7|||
33319856|NCT00705432|101069792|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
33319857|NCT00705432|101069793|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
33319858|NCT00705432|101069794|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
33319859|NCT00705432|101069795|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
33319860|NCT00705432|101069796|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
33319861|NCT00705432|101069797|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
33319862|NCT00705432|101069792|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
33319863|NCT00705432|101069793|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
33319864|NCT00705432|101069794|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
33319865|NCT00705432|101069795|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
33319866|NCT00705432|101069796|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
33319867|NCT00705432|101069797|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
33319868|NCT03037619|101069800|FG000|Overall Study|Lost to Follow-up|0|||
33319869|NCT03037619|101069801|FG001|Overall Study|Lost to Follow-up|1|||
33319870|NCT03503513|101069802|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
33319871|NCT03503513|101069802|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
33319872|NCT03503513|101069802|FG000|Overall Study|Physician Decision|3|||
33319873|NCT03503513|101069802|FG000|Overall Study|Withdrawal by Subject|2|||
33319874|NCT03503513|101069802|FG000|Overall Study|Lost to Follow-up|1|||
33319875|NCT02401412|101069803|FG000|Overall Study|Lost to Follow-up|1|||
33508835|NCT02738879|101759102|FG000|Overall Study|Screen Failure|1|||
33508836|NCT02738879|101759103|FG001|Overall Study|Screen Failure|2|||
33508837|NCT02738879|101759102|FG000|Overall Study|Site Discontinued Study Participation|1|||
33197786|NCT03246529|100626601|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
33197787|NCT03246529|100626602|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
33197788|NCT03246529|100626600|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
33197789|NCT03246529|100626601|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
33197790|NCT03246529|100626602|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
33197791|NCT03246529|100626600|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
33197792|NCT03246529|100626601|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
33197793|NCT03246529|100626602|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
33197794|NCT03246529|100626600|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
33197795|NCT03246529|100626601|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
33197796|NCT03246529|100626602|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
33197797|NCT03246529|100626600|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
33197798|NCT03246529|100626601|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
33197799|NCT03246529|100626602|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
33197800|NCT03246529|100626600|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
33197801|NCT03246529|100626601|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
33197802|NCT03246529|100626602|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
33197803|NCT03246529|100626600|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
33197804|NCT03246529|100626601|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
33197805|NCT03246529|100626602|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
33197806|NCT00774787|100626615|FG000|Overall Study|Lost to Follow-up|1|||
33197807|NCT01513317|100626616|FG000|Overall Study|Withdrawal by Subject|15|||
33197808|NCT01513317|100626617|FG001|Overall Study|Withdrawal by Subject|4|||
33197809|NCT01513317|100626616|FG000|Overall Study|Death|1|||
33197810|NCT01513317|100626617|FG001|Overall Study|Death|1|||
33197811|NCT01513317|100626616|FG000|Overall Study|Study terminated by sponsor|18|||
33197812|NCT01513317|100626617|FG001|Overall Study|Study terminated by sponsor|18|||
33197813|NCT01513317|100626616|FG000|Overall Study|Other|0|||
33197814|NCT01513317|100626617|FG001|Overall Study|Other|1|||
33197815|NCT02091167|100626618|FG000|Overall Study|Lost to Follow-up|0|||
33197816|NCT02091167|100626619|FG001|Overall Study|Lost to Follow-up|2|||
33197817|NCT04354831|100626625|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
33197818|NCT04354831|100626626|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
33197819|NCT04982029|100626627|FG000|Overall Study|Lost to Follow-up|2|||
33319876|NCT02401412|101069804|FG001|Overall Study|Lost to Follow-up|0|||
33319877|NCT02401412|101069803|FG000|Overall Study|Discontinued Intervention|15|||
33319878|NCT02401412|101069804|FG001|Overall Study|Discontinued Intervention|21|||
33319879|NCT02401412|101069803|FG000|Overall Study|Withdrawal by Subject|4|||
33319880|NCT02401412|101069804|FG001|Overall Study|Withdrawal by Subject|4|||
33319881|NCT02401412|101069803|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
33508838|NCT02738879|101759103|FG001|Overall Study|Site Discontinued Study Participation|0|||
33508839|NCT02738879|101759102|FG000|Overall Study|Withdrawal by Subject|5|||
33508840|NCT02738879|101759103|FG001|Overall Study|Withdrawal by Subject|7|||
33197820|NCT04982029|100626628|FG001|Overall Study|Lost to Follow-up|3|||
33197821|NCT02167035|100626629|FG000|Overall Study|Adverse Event|2|||
33319882|NCT02401412|101069804|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
33319883|NCT02401412|101069803|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
33319884|NCT02401412|101069804|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
33319885|NCT01309230|101069805|FG000|Overall Study|Withdrawal by Subject|0|||
33197822|NCT02167035|100626630|FG001|Overall Study|Adverse Event|2|||
33197823|NCT02167035|100626629|FG000|Overall Study|Lost to Follow-up|3|||
33197824|NCT02167035|100626630|FG001|Overall Study|Lost to Follow-up|3|||
33319886|NCT01309230|101069806|FG001|Overall Study|Withdrawal by Subject|2|||
33319887|NCT01309230|101069805|FG000|Overall Study|Observation arm closed|0|||
33319888|NCT01309230|101069806|FG001|Overall Study|Observation arm closed|2|||
33319889|NCT01990534|101069809|FG000|Overall Study|Death|22|||
33319890|NCT01990534|101069809|FG000|Overall Study|Progressive disease|3|||
33319891|NCT01990534|101069809|FG000|Overall Study|Protocol Violation|1|||
33319892|NCT01990534|101069809|FG000|Overall Study|Withdrawal of Informed Consent|2|||
33319893|NCT01990534|101069809|FG000|Overall Study|Symptomatic Deterioration|1|||
33319894|NCT01990534|101069809|FG000|Overall Study|Withdrawal by Subject|3|||
33319895|NCT01990534|101069809|FG000|Overall Study|Reason not Specified|2|||
33319896|NCT01990534|101069809|FG000|Overall Study|Lost to Follow-up|1|||
33319897|NCT01526551|101069810|FG000|Overall Study|Lack of returned parental consent form|424|||
33319898|NCT01810016|101069811|FG000|Overall Study|Progressive disease|1|||
33319899|NCT01810016|101069812|FG001|Overall Study|Progressive disease|1|||
33319900|NCT01810016|101069813|FG002|Overall Study|Progressive disease|0|||
33319901|NCT01810016|101069811|FG000|Overall Study|Death|0|||
33319902|NCT01810016|101069812|FG001|Overall Study|Death|0|||
33319903|NCT01810016|101069813|FG002|Overall Study|Death|1|||
33319904|NCT00907257|101069814|FG000|Overall Study|Adverse Event|0|||
33319905|NCT00907257|101069815|FG001|Overall Study|Adverse Event|4|||
33319906|NCT00907257|101069814|FG000|Overall Study|Protocol Violation|1|||
33319907|NCT00907257|101069815|FG001|Overall Study|Protocol Violation|2|||
33319908|NCT00907257|101069814|FG000|Overall Study|Lost to Follow-up|3|||
33319909|NCT00907257|101069815|FG001|Overall Study|Lost to Follow-up|3|||
33319910|NCT00907257|101069814|FG000|Overall Study|Withdrawal by Subject|1|||
33319911|NCT00907257|101069815|FG001|Overall Study|Withdrawal by Subject|2|||
33319912|NCT00907257|101069814|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
33319913|NCT00907257|101069815|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
33319914|NCT00907257|101069814|FG000|Overall Study|Moved|1|||
33319915|NCT00907257|101069815|FG001|Overall Study|Moved|0|||
33319916|NCT00907257|101069814|FG000|Overall Study|Personal Reasons|6|||
33319917|NCT00907257|101069815|FG001|Overall Study|Personal Reasons|1|||
33319918|NCT00536809|101069816|FG000|Phase II|Adverse Event|1|||
33319919|NCT00536809|101069816|FG000|Phase II|Referred for surgical resection|1|||
33319920|NCT00261846|101069817|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
33319921|NCT00261846|101069818|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
33319922|NCT00261846|101069819|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
33319923|NCT00261846|101069820|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33319924|NCT00261846|101069821|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33319925|NCT00261846|101069822|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33319926|NCT00261846|101069823|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33319927|NCT00261846|101069824|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33319928|NCT00261846|101069825|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33319929|NCT00261846|101069826|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33319930|NCT00261846|101069827|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33319931|NCT00261846|101069828|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
33319932|NCT00261846|101069817|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33319933|NCT00261846|101069818|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33319934|NCT00261846|101069819|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33319935|NCT00261846|101069820|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
33604658|NCT00549770|102102675|FG005|Overall Study|Abnormal test procedure results|1|||
33319936|NCT00261846|101069821|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33319937|NCT00261846|101069822|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33319938|NCT00261846|101069823|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33319939|NCT00261846|101069824|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33319940|NCT00261846|101069825|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
33319941|NCT00261846|101069826|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33319942|NCT00261846|101069827|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33319943|NCT00261846|101069828|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
33319944|NCT00261846|101069817|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
33319945|NCT00261846|101069818|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
33604659|NCT00549770|102102676|FG006|Overall Study|Abnormal test procedure results|1|||
33319946|NCT00261846|101069819|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
33319947|NCT00261846|101069820|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
33319948|NCT00261846|101069821|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
33319949|NCT00261846|101069822|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
33319950|NCT00261846|101069823|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
33319951|NCT00261846|101069824|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
33319952|NCT00261846|101069825|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
33319953|NCT00261846|101069826|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
33319954|NCT00261846|101069827|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
33319955|NCT00261846|101069828|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
33319956|NCT00261846|101069817|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
33508841|NCT03814720|101759104|FG000|Overall Study|Lost to Follow-up|0|||
33508842|NCT03814720|101759105|FG001|Overall Study|Lost to Follow-up|1|||
33508843|NCT03814720|101759106|FG002|Overall Study|Lost to Follow-up|0|||
33508844|NCT03814720|101759107|FG003|Overall Study|Lost to Follow-up|0|||
33508845|NCT03814720|101759108|FG004|Overall Study|Lost to Follow-up|0|||
33508846|NCT03315286|101759111|FG000|Overall Study|Lost to Follow-up|0|||
33508847|NCT03315286|101759112|FG001|Overall Study|Lost to Follow-up|3|||
33508848|NCT03315286|101759111|FG000|Overall Study|Withdrawal by Subject|1|||
33508849|NCT03315286|101759112|FG001|Overall Study|Withdrawal by Subject|0|||
33508850|NCT03315286|101759111|FG000|Overall Study|Protocol Violation|0|||
33508851|NCT03315286|101759112|FG001|Overall Study|Protocol Violation|1|||
33508852|NCT04434469|101759114|FG000|Overall Study|Death|2|||
33508853|NCT04434469|101759115|FG001|Overall Study|Death|3|||
33508854|NCT04434469|101759116|FG002|Overall Study|Death|2|||
33508855|NCT04434469|101759117|FG003|Overall Study|Death|2|||
33508856|NCT04434469|101759118|FG004|Overall Study|Death|2|||
33508857|NCT04434469|101759119|FG005|Overall Study|Death|0|||
33508858|NCT04434469|101759114|FG000|Overall Study|Lost to Follow-up|0|||
33508859|NCT04434469|101759115|FG001|Overall Study|Lost to Follow-up|0|||
33508860|NCT04434469|101759116|FG002|Overall Study|Lost to Follow-up|0|||
33508861|NCT04434469|101759117|FG003|Overall Study|Lost to Follow-up|1|||
33508862|NCT04434469|101759118|FG004|Overall Study|Lost to Follow-up|1|||
33508863|NCT04434469|101759119|FG005|Overall Study|Lost to Follow-up|0|||
33508864|NCT04434469|101759114|FG000|Overall Study|Study terminated by sponsor|1|||
33508865|NCT04434469|101759115|FG001|Overall Study|Study terminated by sponsor|1|||
33508866|NCT04434469|101759116|FG002|Overall Study|Study terminated by sponsor|1|||
33604660|NCT00549770|102102677|FG007|Overall Study|Abnormal test procedure results|1|||
33604661|NCT00549770|102102670|FG000|Overall Study|Abnormal laboratory values|0|||
33604662|NCT00549770|102102671|FG001|Overall Study|Abnormal laboratory values|0|||
33604663|NCT00549770|102102672|FG002|Overall Study|Abnormal laboratory values|0|||
33604664|NCT00549770|102102673|FG003|Overall Study|Abnormal laboratory values|0|||
33604665|NCT00549770|102102674|FG004|Overall Study|Abnormal laboratory values|0|||
33319957|NCT00261846|101069818|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
33319958|NCT00261846|101069819|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
33319959|NCT00261846|101069820|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
33319960|NCT00261846|101069821|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
33319961|NCT00261846|101069822|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
33319962|NCT00261846|101069823|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
33319963|NCT00261846|101069824|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
33319964|NCT00261846|101069825|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
33319965|NCT00261846|101069826|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
33319966|NCT00261846|101069827|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
33319967|NCT00261846|101069828|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
33319968|NCT00261846|101069817|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
33319969|NCT00261846|101069818|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
33319970|NCT00261846|101069819|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
33319971|NCT00261846|101069820|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
33319972|NCT00261846|101069821|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
33319973|NCT00261846|101069822|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
33319974|NCT00261846|101069823|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
33319975|NCT00261846|101069824|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
33319976|NCT00261846|101069825|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
33319977|NCT00261846|101069826|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
33508867|NCT04434469|101759117|FG003|Overall Study|Study terminated by sponsor|2|||
33508868|NCT04434469|101759118|FG004|Overall Study|Study terminated by sponsor|3|||
33508869|NCT04434469|101759119|FG005|Overall Study|Study terminated by sponsor|3|||
33508870|NCT04434469|101759114|FG000|Overall Study|Withdrawal by Subject|0|||
33508871|NCT04434469|101759115|FG001|Overall Study|Withdrawal by Subject|0|||
33508872|NCT04434469|101759116|FG002|Overall Study|Withdrawal by Subject|1|||
33508873|NCT04434469|101759117|FG003|Overall Study|Withdrawal by Subject|0|||
33508874|NCT04434469|101759118|FG004|Overall Study|Withdrawal by Subject|0|||
33604666|NCT00549770|102102675|FG005|Overall Study|Abnormal laboratory values|1|||
33508875|NCT04434469|101759119|FG005|Overall Study|Withdrawal by Subject|0|||
33508876|NCT00076752|101759120|FG000|Overall Study|Death|2|||
33508877|NCT00076752|101759120|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
33508878|NCT03164564|101759121|FG000|Overall Study|Death|3|||
33604667|NCT00549770|102102676|FG006|Overall Study|Abnormal laboratory values|0|||
33508879|NCT03164564|101759122|FG001|Overall Study|Death|0|||
33508880|NCT03164564|101759121|FG000|Overall Study|Withdrawal by Subject|20|||
33508881|NCT03164564|101759122|FG001|Overall Study|Withdrawal by Subject|15|||
33508882|NCT03164564|101759121|FG000|Overall Study|Lost to Follow-up|2|||
33508883|NCT03164564|101759122|FG001|Overall Study|Lost to Follow-up|0|||
33508884|NCT03164564|101759121|FG000|Overall Study|Physician Decision|0|||
33508885|NCT03164564|101759122|FG001|Overall Study|Physician Decision|1|||
33508886|NCT03164564|101759121|FG000|Overall Study|Adverse Event|0|||
33508887|NCT03164564|101759122|FG001|Overall Study|Adverse Event|1|||
33508888|NCT03164564|101759121|FG000|Overall Study|Ongoing|1586|||
33508889|NCT03164564|101759122|FG001|Overall Study|Ongoing|1586|||
33508890|NCT05033262|101759123|FG000|Overall Study|Lost to Follow-up|1|||
33508891|NCT05033262|101759124|FG001|Overall Study|Lost to Follow-up|0|||
33508892|NCT05033262|101759125|FG002|Overall Study|Lost to Follow-up|0|||
33508893|NCT05033262|101759126|FG003|Overall Study|Lost to Follow-up|1|||
33508894|NCT02135107|101759127|FG000|Treatment Period|Withdrawal by Subject|11|||
33508895|NCT02135107|101759128|FG001|Treatment Period|Withdrawal by Subject|0|||
33508896|NCT02135107|101759129|FG002|Treatment Period|Withdrawal by Subject|0|||
33508897|NCT02135107|101759130|FG003|Treatment Period|Withdrawal by Subject|0|||
33508898|NCT02135107|101759127|FG000|Treatment Period|Adverse Event|5|||
33508899|NCT02135107|101759128|FG001|Treatment Period|Adverse Event|2|||
33508900|NCT02135107|101759129|FG002|Treatment Period|Adverse Event|0|||
33508901|NCT02135107|101759130|FG003|Treatment Period|Adverse Event|0|||
33508902|NCT02135107|101759127|FG000|Treatment Period|Pregnancy|1|||
33508903|NCT02135107|101759128|FG001|Treatment Period|Pregnancy|0|||
33508904|NCT02135107|101759129|FG002|Treatment Period|Pregnancy|0|||
33508905|NCT02135107|101759130|FG003|Treatment Period|Pregnancy|0|||
33508906|NCT02135107|101759127|FG000|Treatment Period|Other|115|||
33508907|NCT02135107|101759128|FG001|Treatment Period|Other|24|||
33508908|NCT02135107|101759129|FG002|Treatment Period|Other|0|||
33508909|NCT02135107|101759130|FG003|Treatment Period|Other|0|||
33508910|NCT02135107|101759127|FG000|Maintenance Therapy Period|Adverse Event|0|||
33508911|NCT02135107|101759128|FG001|Maintenance Therapy Period|Adverse Event|0|||
33508912|NCT02135107|101759129|FG002|Maintenance Therapy Period|Adverse Event|3|||
33508913|NCT02135107|101759130|FG003|Maintenance Therapy Period|Adverse Event|7|||
33508914|NCT02135107|101759127|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
33508915|NCT02135107|101759128|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
33508916|NCT02135107|101759129|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
33508917|NCT02135107|101759130|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
33508918|NCT02135107|101759127|FG000|Maintenance Therapy Period|Pregnancy|0|||
33508919|NCT02135107|101759128|FG001|Maintenance Therapy Period|Pregnancy|0|||
33508920|NCT02135107|101759129|FG002|Maintenance Therapy Period|Pregnancy|0|||
33508921|NCT02135107|101759130|FG003|Maintenance Therapy Period|Pregnancy|1|||
33508922|NCT02135107|101759127|FG000|Maintenance Therapy Period|Other|0|||
33508923|NCT02135107|101759128|FG001|Maintenance Therapy Period|Other|0|||
33508924|NCT02135107|101759129|FG002|Maintenance Therapy Period|Other|7|||
33508925|NCT02135107|101759130|FG003|Maintenance Therapy Period|Other|8|||
33508926|NCT00073983|101759136|FG000|Overall Study|not evaluable|1|||
33508927|NCT00688701|101759140|FG000|Overall Study|Adverse Event|1|||
33508928|NCT00688701|101759141|FG001|Overall Study|Adverse Event|0|||
33508929|NCT00688701|101759142|FG002|Overall Study|Adverse Event|5|||
33508930|NCT00688701|101759143|FG003|Overall Study|Adverse Event|3|||
33508931|NCT00688701|101759140|FG000|Overall Study|Lack of Efficacy|0|||
33508932|NCT00688701|101759141|FG001|Overall Study|Lack of Efficacy|1|||
33508933|NCT00688701|101759142|FG002|Overall Study|Lack of Efficacy|0|||
33604668|NCT00549770|102102677|FG007|Overall Study|Abnormal laboratory values|0|||
33604669|NCT00549770|102102670|FG000|Overall Study|Adverse Event|1|||
33508934|NCT00688701|101759143|FG003|Overall Study|Lack of Efficacy|0|||
33508935|NCT00688701|101759140|FG000|Overall Study|Withdrawal by Subject|3|||
33508936|NCT00688701|101759141|FG001|Overall Study|Withdrawal by Subject|3|||
33508937|NCT00688701|101759142|FG002|Overall Study|Withdrawal by Subject|4|||
33508938|NCT00688701|101759143|FG003|Overall Study|Withdrawal by Subject|8|||
33508939|NCT00688701|101759140|FG000|Overall Study|Poor compliance to protocol|0|||
33508940|NCT00688701|101759141|FG001|Overall Study|Poor compliance to protocol|1|||
33508941|NCT00688701|101759142|FG002|Overall Study|Poor compliance to protocol|1|||
33508942|NCT00688701|101759143|FG003|Overall Study|Poor compliance to protocol|0|||
33508943|NCT00679289|101759146|FG000|Overall Study|Progressive disease|4|||
33508944|NCT00679289|101759147|FG001|Overall Study|Progressive disease|5|||
33508945|NCT00679289|101759148|FG002|Overall Study|Progressive disease|18|||
33508946|NCT00679289|101759146|FG000|Overall Study|Withdrawal by Subject|0|||
33508947|NCT00679289|101759147|FG001|Overall Study|Withdrawal by Subject|1|||
33508948|NCT00679289|101759148|FG002|Overall Study|Withdrawal by Subject|1|||
33508949|NCT00679289|101759146|FG000|Overall Study|Adverse Event|0|||
33508950|NCT00679289|101759147|FG001|Overall Study|Adverse Event|0|||
33508951|NCT00679289|101759148|FG002|Overall Study|Adverse Event|3|||
33508952|NCT00679289|101759146|FG000|Overall Study|Physician Decision|1|||
33508953|NCT00679289|101759147|FG001|Overall Study|Physician Decision|0|||
33508954|NCT00679289|101759148|FG002|Overall Study|Physician Decision|1|||
33508955|NCT03981900|101759152|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
33508956|NCT03981900|101759152|FG000|Overall Study|Adverse Event|5|||
33508957|NCT03981900|101759152|FG000|Overall Study|Protocol Violation|1|||
33508958|NCT03981900|101759152|FG000|Overall Study|Withdrawal by Subject|7|||
33508959|NCT03981900|101759152|FG000|Overall Study|Lost to Follow-up|46|||
33508960|NCT03981900|101759152|FG000|Overall Study|Decision of the researcher|3|||
33508961|NCT03981900|101759152|FG000|Overall Study|Death|3|||
33508962|NCT03981900|101759152|FG000|Overall Study|Other|5|||
33508963|NCT00519428|101759153|FG000|Overall Study|Adverse Event|5|||
33508964|NCT00519428|101759154|FG001|Overall Study|Adverse Event|2|||
33508965|NCT00519428|101759155|FG002|Overall Study|Adverse Event|10|||
33508966|NCT00519428|101759153|FG000|Overall Study|Lost to Follow-up|7|||
33508967|NCT00519428|101759154|FG001|Overall Study|Lost to Follow-up|7|||
33508968|NCT00519428|101759155|FG002|Overall Study|Lost to Follow-up|6|||
33508969|NCT00519428|101759153|FG000|Overall Study|Withdrawal by Subject|8|||
33508970|NCT00519428|101759154|FG001|Overall Study|Withdrawal by Subject|3|||
33508971|NCT00519428|101759155|FG002|Overall Study|Withdrawal by Subject|7|||
33604670|NCT00549770|102102671|FG001|Overall Study|Adverse Event|3|||
33604671|NCT00549770|102102672|FG002|Overall Study|Adverse Event|1|||
33604672|NCT00549770|102102673|FG003|Overall Study|Adverse Event|2|||
33604673|NCT00549770|102102674|FG004|Overall Study|Adverse Event|1|||
33604674|NCT00549770|102102675|FG005|Overall Study|Adverse Event|0|||
33604675|NCT00549770|102102676|FG006|Overall Study|Adverse Event|5|||
33604676|NCT00549770|102102677|FG007|Overall Study|Adverse Event|4|||
33319978|NCT00261846|101069827|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
33319979|NCT00261846|101069828|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
33319980|NCT00261846|101069817|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
33319981|NCT00261846|101069818|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
33319982|NCT00261846|101069819|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
33319983|NCT00261846|101069820|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
33319984|NCT00261846|101069821|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
33319985|NCT00261846|101069822|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
33319986|NCT00261846|101069823|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
33319987|NCT00261846|101069824|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
33319988|NCT00261846|101069825|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
33319989|NCT00261846|101069826|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
33319990|NCT00261846|101069827|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
33319991|NCT00261846|101069828|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
33319992|NCT00261846|101069817|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
33319993|NCT00261846|101069818|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
33319994|NCT00261846|101069819|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
33319995|NCT00261846|101069820|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
33319996|NCT00261846|101069821|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
33319997|NCT00261846|101069822|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
33319998|NCT00261846|101069823|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
33319999|NCT00261846|101069824|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
33320000|NCT00261846|101069825|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
33320001|NCT00261846|101069826|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
33320002|NCT00261846|101069827|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
33398733|NCT00508820|101350121|FG001|Overall Study|Lost to Follow-up|1|||
33398734|NCT00508820|101350120|FG000|Overall Study|Physician Decision|8|||
33398735|NCT00508820|101350121|FG001|Overall Study|Physician Decision|2|||
33398736|NCT00508820|101350120|FG000|Overall Study|Pregnancy|0|||
33398737|NCT00508820|101350121|FG001|Overall Study|Pregnancy|2|||
33398738|NCT00508820|101350120|FG000|Overall Study|Protocol Violation|2|||
33398739|NCT00508820|101350121|FG001|Overall Study|Protocol Violation|0|||
33398740|NCT00508820|101350120|FG000|Overall Study|Withdrawal by Subject|10|||
33398741|NCT00508820|101350121|FG001|Overall Study|Withdrawal by Subject|12|||
33398742|NCT00508820|101350120|FG000|Overall Study|Other|11|||
33398743|NCT00508820|101350121|FG001|Overall Study|Other|2|||
33398744|NCT00508820|101350120|FG000|Overall Study|Noncompliance|1|||
33398745|NCT00508820|101350121|FG001|Overall Study|Noncompliance|0|||
33398746|NCT00508820|101350120|FG000|Overall Study|Requirement for alternative therapy|7|||
33398747|NCT00508820|101350121|FG001|Overall Study|Requirement for alternative therapy|15|||
33398748|NCT00508820|101350120|FG000|Overall Study|Protocol-specified Criteria|3|||
33398749|NCT00508820|101350121|FG001|Overall Study|Protocol-specified Criteria|12|||
33398750|NCT02309372|101350122|FG000|Overall Study|Lost to Follow-up|3|||
33398751|NCT02309372|101350123|FG001|Overall Study|Lost to Follow-up|2|||
33508972|NCT00519428|101759153|FG000|Overall Study|unstated|1|||
33508973|NCT00519428|101759154|FG001|Overall Study|unstated|3|||
33508974|NCT00519428|101759155|FG002|Overall Study|unstated|2|||
33604677|NCT02440789|102102678|FG000|Overall Study|Withdrawal by Subject|3|||
33320003|NCT00261846|101069828|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
33398752|NCT02371980|101350124|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
33398753|NCT02371980|101350125|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
33398754|NCT02371980|101350126|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
33508975|NCT00960986|101759156|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
33320004|NCT01032382|101069829|FG000|Overall Study|Disease dissemination|1|||
33320005|NCT01032382|101069830|FG001|Overall Study|Disease dissemination|1|||
33320006|NCT01032382|101069829|FG000|Overall Study|Treatment failure|3|||
33320007|NCT01032382|101069830|FG001|Overall Study|Treatment failure|1|||
33320008|NCT01032382|101069829|FG000|Overall Study|Index lesion relapse|1|||
33320009|NCT01032382|101069830|FG001|Overall Study|Index lesion relapse|3|||
33508976|NCT00960986|101759157|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
33508977|NCT00960986|101759158|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
33508978|NCT00960986|101759159|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
33508979|NCT00960986|101759156|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
33508980|NCT00960986|101759157|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
33320010|NCT01130974|101069835|FG000|Overall Study|Protocol Violation|10|||
33320011|NCT01130974|101069836|FG001|Overall Study|Protocol Violation|10|||
33320012|NCT01130974|101069835|FG000|Overall Study|Withdrawal by Subject|0|||
33320013|NCT01130974|101069836|FG001|Overall Study|Withdrawal by Subject|1|||
33320014|NCT01130974|101069835|FG000|Overall Study|Ineligibility criteria|5|||
33320015|NCT01130974|101069836|FG001|Overall Study|Ineligibility criteria|2|||
33320016|NCT04540133|101069837|FG000|Overall Study|Lost to Follow-up|1|||
33320017|NCT04540133|101069838|FG001|Overall Study|Lost to Follow-up|0|||
33320018|NCT00235326|101069839|FG000|Overall Study|Lost to Follow-up|746|||
33320019|NCT00235326|101069840|FG001|Overall Study|Lost to Follow-up|1400|||
33320020|NCT00887250|101069842|FG000|Overall Study|Adverse Event|3|||
33320021|NCT00887250|101069843|FG001|Overall Study|Adverse Event|0|||
33398755|NCT02371980|101350127|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
33398756|NCT02371980|101350128|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
33398757|NCT02371980|101350124|FG000|Open-label Period|Significant Protocol Deviation|19|||
33398758|NCT02371980|101350125|FG001|Open-label Period|Significant Protocol Deviation|0|||
33398759|NCT02371980|101350126|FG002|Open-label Period|Significant Protocol Deviation|0|||
33398760|NCT02371980|101350127|FG003|Open-label Period|Significant Protocol Deviation|0|||
33398761|NCT02371980|101350128|FG004|Open-label Period|Significant Protocol Deviation|0|||
33398762|NCT02371980|101350124|FG000|Open-label Period|Noncompliance with Study Drug|10|||
33398763|NCT02371980|101350125|FG001|Open-label Period|Noncompliance with Study Drug|0|||
33398764|NCT02371980|101350126|FG002|Open-label Period|Noncompliance with Study Drug|0|||
33508981|NCT00960986|101759158|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
33604678|NCT02440789|102102678|FG000|Overall Study|Not willing to adhere to reqs|1|||
33604679|NCT04109976|102102679|FG000|Overall Study|Withdrawal by Subject|1|||
33604680|NCT04109976|102102680|FG001|Overall Study|Withdrawal by Subject|0|||
33604681|NCT01839656|102102681|FG000|Overall Study|Withdrawal by Subject|1|||
33604682|NCT01839656|102102682|FG001|Overall Study|Withdrawal by Subject|1|||
33398765|NCT02371980|101350127|FG003|Open-label Period|Noncompliance with Study Drug|0|||
33508982|NCT00960986|101759159|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
33508983|NCT00960986|101759156|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
33508984|NCT00960986|101759157|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
33508985|NCT00960986|101759158|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
33508986|NCT00960986|101759159|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
33508987|NCT00960986|101759156|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
33508988|NCT00960986|101759157|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
33508989|NCT00960986|101759158|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
33508990|NCT00960986|101759159|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
33508991|NCT00960986|101759156|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
33508992|NCT00960986|101759157|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
33508993|NCT00960986|101759158|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
33508994|NCT00960986|101759159|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
33508995|NCT00960986|101759156|FG000|Period 3 (7-week Therapy Period)|Death|0|||
33508996|NCT00960986|101759157|FG001|Period 3 (7-week Therapy Period)|Death|0|||
33508997|NCT00960986|101759158|FG002|Period 3 (7-week Therapy Period)|Death|1|||
33508998|NCT00960986|101759159|FG003|Period 3 (7-week Therapy Period)|Death|0|||
33508999|NCT00960986|101759156|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
33509000|NCT00960986|101759157|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
33509001|NCT00960986|101759158|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
33509002|NCT00960986|101759159|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
33509003|NCT00960986|101759156|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
33509004|NCT00960986|101759157|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
33509005|NCT00960986|101759158|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
33509006|NCT00960986|101759159|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
33509007|NCT00960986|101759156|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
33320022|NCT00887250|101069844|FG002|Overall Study|Adverse Event|7|||
33320023|NCT00887250|101069842|FG000|Overall Study|Lack of Efficacy|9|||
33320024|NCT00887250|101069843|FG001|Overall Study|Lack of Efficacy|6|||
33320025|NCT00887250|101069844|FG002|Overall Study|Lack of Efficacy|1|||
33509008|NCT00960986|101759157|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
33509009|NCT00960986|101759158|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
33509010|NCT00960986|101759159|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
33509011|NCT00960986|101759156|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
33509012|NCT00960986|101759157|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
33509013|NCT00960986|101759158|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
33509014|NCT00960986|101759159|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
33604683|NCT01839656|102102681|FG000|Overall Study|Adverse event, serious fatal|1|||
33604684|NCT01839656|102102682|FG001|Overall Study|Adverse event, serious fatal|4|||
33604685|NCT01839656|102102681|FG000|Overall Study|Early study closure|0|||
33604686|NCT01839656|102102682|FG001|Overall Study|Early study closure|11|||
33604687|NCT01839656|102102681|FG000|Overall Study|Adverse Event|1|||
33604688|NCT01839656|102102682|FG001|Overall Study|Adverse Event|0|||
33604689|NCT03480009|102102685|FG000|Overall Study|Lost to Follow-up|4|||
33604690|NCT03480009|102102686|FG001|Overall Study|Lost to Follow-up|5|||
33604691|NCT03480009|102102687|FG002|Overall Study|Lost to Follow-up|4|||
33604692|NCT03480009|102102688|FG003|Overall Study|Lost to Follow-up|0|||
33604693|NCT03412604|102102695|FG000|Overall Study|Withdrawal by Subject|1|||
33604694|NCT02925741|102102698|FG000|Overall Study|Withdrawal by Subject|11|||
33604695|NCT02925741|102102699|FG001|Overall Study|Withdrawal by Subject|0|||
33604696|NCT00387647|102102700|FG000|Overall Study|Death|18|||
33604697|NCT00864851|102102701|FG000|Overall Study|Withdrawal by Subject|0|||
33604698|NCT00864851|102102702|FG001|Overall Study|Withdrawal by Subject|1|||
33604699|NCT00864851|102102703|FG002|Overall Study|Withdrawal by Subject|0|||
33604700|NCT00864851|102102701|FG000|Overall Study|Physician Decision|1|||
33604701|NCT00864851|102102702|FG001|Overall Study|Physician Decision|0|||
33604702|NCT00864851|102102703|FG002|Overall Study|Physician Decision|0|||
33604703|NCT00864851|102102701|FG000|Overall Study|Death|1|||
33604704|NCT00864851|102102702|FG001|Overall Study|Death|0|||
33604705|NCT00864851|102102703|FG002|Overall Study|Death|0|||
33604706|NCT00864851|102102701|FG000|Overall Study|Patient uncooperative|1|||
33604707|NCT00864851|102102702|FG001|Overall Study|Patient uncooperative|0|||
33604708|NCT00864851|102102703|FG002|Overall Study|Patient uncooperative|0|||
33604709|NCT01716104|102102704|FG000|Overall Study|Do not meet inclusion criteria|6|||
33604710|NCT01716104|102102705|FG001|Overall Study|Do not meet inclusion criteria|7|||
33604711|NCT02212678|102102706|FG000|Overall Study|Adverse Event|1|||
33604712|NCT02299076|102102710|FG000|Overall Study|Fraudulent Entries|20|||
33604713|NCT02299076|102102711|FG001|Overall Study|Fraudulent Entries|14|||
33604714|NCT01969721|102102712|FG000|Overall Study|Adverse Event|3|||
33604715|NCT01969721|102102713|FG001|Overall Study|Adverse Event|8|||
33604716|NCT01969721|102102714|FG002|Overall Study|Adverse Event|3|||
33604717|NCT01969721|102102715|FG003|Overall Study|Adverse Event|2|||
33604718|NCT01969721|102102712|FG000|Overall Study|Lack of Efficacy|0|||
33604719|NCT01969721|102102713|FG001|Overall Study|Lack of Efficacy|0|||
33604720|NCT01969721|102102714|FG002|Overall Study|Lack of Efficacy|1|||
33604721|NCT01969721|102102715|FG003|Overall Study|Lack of Efficacy|0|||
33604722|NCT01969721|102102712|FG000|Overall Study|Non compliant with protocol|1|||
33604723|NCT01969721|102102713|FG001|Overall Study|Non compliant with protocol|1|||
33604724|NCT01969721|102102714|FG002|Overall Study|Non compliant with protocol|0|||
33604725|NCT01969721|102102715|FG003|Overall Study|Non compliant with protocol|2|||
33604726|NCT01969721|102102712|FG000|Overall Study|Other not defined above|0|||
33604727|NCT01969721|102102713|FG001|Overall Study|Other not defined above|2|||
33604728|NCT01969721|102102714|FG002|Overall Study|Other not defined above|0|||
33604729|NCT01969721|102102715|FG003|Overall Study|Other not defined above|0|||
33604730|NCT01969721|102102712|FG000|Overall Study|Discontinued during washout periods.|0|||
33604731|NCT01969721|102102713|FG001|Overall Study|Discontinued during washout periods.|1|||
33604732|NCT01969721|102102714|FG002|Overall Study|Discontinued during washout periods.|1|||
33604733|NCT01969721|102102715|FG003|Overall Study|Discontinued during washout periods.|2|||
33604734|NCT03002311|102102716|FG000|Overall Study|Lost to Follow-up|13|||
33604735|NCT03002311|102102717|FG001|Overall Study|Lost to Follow-up|26|||
33604736|NCT03002311|102102716|FG000|Overall Study|Referral provider called to schedule app|3|||
33604737|NCT03002311|102102717|FG001|Overall Study|Referral provider called to schedule app|3|||
33604738|NCT03002311|102102716|FG000|Overall Study|Physician Decision|3|||
33604739|NCT03002311|102102717|FG001|Overall Study|Physician Decision|1|||
33604740|NCT01198509|102102720|FG000|Overall Study|Withdrawal by Subject|1|||
33604741|NCT01198509|102102721|FG001|Overall Study|Withdrawal by Subject|0|||
33604742|NCT01198509|102102722|FG002|Overall Study|Withdrawal by Subject|0|||
33604743|NCT01198509|102102723|FG003|Overall Study|Withdrawal by Subject|0|||
33604744|NCT01198509|102102724|FG004|Overall Study|Withdrawal by Subject|0|||
33604745|NCT01198509|102102725|FG005|Overall Study|Withdrawal by Subject|0|||
33197825|NCT02167035|100626629|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
33509015|NCT02759055|101759160|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
33197826|NCT02167035|100626630|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
33197827|NCT01896895|100626631|FG000|Double-blind MP|Physician Decision|0|||
33197828|NCT01896895|100626632|FG001|Double-blind MP|Physician Decision|0|||
33197829|NCT01896895|100626633|FG002|Double-blind MP|Physician Decision|1|||
33197830|NCT01896895|100626634|FG003|Double-blind MP|Physician Decision|0|||
33197831|NCT01896895|100626631|FG000|Double-blind MP|Withdrawal by Subject|0|||
33197832|NCT01896895|100626632|FG001|Double-blind MP|Withdrawal by Subject|2|||
33197833|NCT01896895|100626633|FG002|Double-blind MP|Withdrawal by Subject|1|||
33197834|NCT01896895|100626634|FG003|Double-blind MP|Withdrawal by Subject|0|||
33197835|NCT01896895|100626631|FG000|Double-blind MP|Lost to Follow-up|1|||
33197836|NCT01896895|100626632|FG001|Double-blind MP|Lost to Follow-up|0|||
33197837|NCT01896895|100626633|FG002|Double-blind MP|Lost to Follow-up|1|||
33197838|NCT01896895|100626634|FG003|Double-blind MP|Lost to Follow-up|0|||
33197839|NCT01110239|100626635|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
33197840|NCT01110239|100626636|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
33197841|NCT01110239|100626637|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
33197842|NCT01110239|100626638|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
33320026|NCT00887250|101069842|FG000|Overall Study|Lost to Follow-up|2|||
33320027|NCT00887250|101069843|FG001|Overall Study|Lost to Follow-up|3|||
33320028|NCT00887250|101069844|FG002|Overall Study|Lost to Follow-up|1|||
33320029|NCT00887250|101069842|FG000|Overall Study|Protocol Violation|2|||
33398766|NCT02371980|101350128|FG004|Open-label Period|Noncompliance with Study Drug|0|||
33398767|NCT02371980|101350124|FG000|Open-label Period|Lost to Follow-up|55|||
33398768|NCT02371980|101350125|FG001|Open-label Period|Lost to Follow-up|0|||
33398769|NCT02371980|101350126|FG002|Open-label Period|Lost to Follow-up|0|||
33197843|NCT01110239|100626635|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
33197844|NCT01110239|100626636|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
33197845|NCT01110239|100626637|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
33197846|NCT01110239|100626638|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
33197847|NCT03085927|100626639|FG000|Overall Study|Withdrawal by Subject|1|||
33197848|NCT03085927|100626640|FG001|Overall Study|Withdrawal by Subject|4|||
33320030|NCT00887250|101069843|FG001|Overall Study|Protocol Violation|2|||
33320031|NCT00887250|101069844|FG002|Overall Study|Protocol Violation|1|||
33320032|NCT00887250|101069842|FG000|Overall Study|Withdrawal by Subject|2|||
33320033|NCT00887250|101069843|FG001|Overall Study|Withdrawal by Subject|1|||
33320034|NCT00887250|101069844|FG002|Overall Study|Withdrawal by Subject|2|||
33320035|NCT00887250|101069842|FG000|Overall Study|Patient uncooperative|0|||
33320036|NCT00887250|101069843|FG001|Overall Study|Patient uncooperative|0|||
33320037|NCT00887250|101069844|FG002|Overall Study|Patient uncooperative|1|||
33320038|NCT03873493|101069845|FG000|Overall Study|Withdrawal by Subject|1|||
33320039|NCT03873493|101069845|FG000|Overall Study|Death|9|||
33320040|NCT03873493|101069845|FG000|Overall Study|Lost to Follow-up|1|||
33320041|NCT03873493|101069845|FG000|Overall Study|Study Terminated by Sponsor|1|||
33320042|NCT03873493|101069845|FG000|Overall Study|Other|2|||
33320043|NCT03785678|101069848|FG000|Overall Study|Death|44|||
33320044|NCT03785678|101069849|FG001|Overall Study|Death|42|||
33320045|NCT03785678|101069848|FG000|Overall Study|Lost to Follow-up|4|||
33320046|NCT03785678|101069849|FG001|Overall Study|Lost to Follow-up|2|||
33320047|NCT03785678|101069848|FG000|Overall Study|Physician Decision|0|||
33320048|NCT03785678|101069849|FG001|Overall Study|Physician Decision|2|||
33509016|NCT02759055|101759161|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
33509017|NCT02353442|101759162|FG000|Overall Study|Withdrawal by Subject|3|||
33509018|NCT02353442|101759163|FG001|Overall Study|Withdrawal by Subject|4|||
33509019|NCT05413369|101759172|FG000|Overall Study|Adverse Event|1|||
33509020|NCT05413369|101759173|FG001|Overall Study|Adverse Event|1|||
33509021|NCT05413369|101759172|FG000|Overall Study|Withdrawal by Subject|13|||
33509022|NCT05413369|101759173|FG001|Overall Study|Withdrawal by Subject|4|||
33509023|NCT05413369|101759172|FG000|Overall Study|Non-compliance with study schedule|2|||
33509024|NCT05413369|101759173|FG001|Overall Study|Non-compliance with study schedule|1|||
33509025|NCT05413369|101759172|FG000|Overall Study|Other|1|||
33509026|NCT05413369|101759173|FG001|Overall Study|Other|1|||
33509027|NCT04016779|101759174|FG000|Overall Study|Adverse Event|9|||
33509028|NCT04016779|101759175|FG001|Overall Study|Adverse Event|17|||
33320049|NCT03785678|101069848|FG000|Overall Study|Withdrawal by Subject|5|||
33320050|NCT03785678|101069849|FG001|Overall Study|Withdrawal by Subject|3|||
33320051|NCT02973425|101069850|FG000|Overall Study|Lost to Follow-up|49|||
33320052|NCT02973425|101069851|FG001|Overall Study|Lost to Follow-up|53|||
33320053|NCT01749540|101069859|FG000|Overall Study|Protocol Violation|0|||
33320054|NCT01749540|101069860|FG001|Overall Study|Protocol Violation|0|||
33509029|NCT04016779|101759174|FG000|Overall Study|Lack of Efficacy|4|||
33509030|NCT04016779|101759175|FG001|Overall Study|Lack of Efficacy|1|||
33509031|NCT04016779|101759174|FG000|Overall Study|Lost to Follow-up|5|||
33320055|NCT01749540|101069861|FG002|Overall Study|Protocol Violation|0|||
33320056|NCT01749540|101069862|FG003|Overall Study|Protocol Violation|0|||
33320057|NCT01749540|101069863|FG004|Overall Study|Protocol Violation|0|||
33320058|NCT01749540|101069864|FG005|Overall Study|Protocol Violation|1|||
33320059|NCT01749540|101069865|FG006|Overall Study|Protocol Violation|1|||
33320060|NCT01749540|101069859|FG000|Overall Study|Withdrawal by Subject|0|||
33320061|NCT01749540|101069860|FG001|Overall Study|Withdrawal by Subject|0|||
33320062|NCT01749540|101069861|FG002|Overall Study|Withdrawal by Subject|0|||
33320063|NCT01749540|101069862|FG003|Overall Study|Withdrawal by Subject|1|||
33320064|NCT01749540|101069863|FG004|Overall Study|Withdrawal by Subject|0|||
33320065|NCT01749540|101069864|FG005|Overall Study|Withdrawal by Subject|0|||
33320066|NCT01749540|101069865|FG006|Overall Study|Withdrawal by Subject|0|||
33320067|NCT01749540|101069859|FG000|Overall Study|Initiated into extension study A536-06|0|||
33320068|NCT01749540|101069860|FG001|Overall Study|Initiated into extension study A536-06|0|||
33320069|NCT01749540|101069861|FG002|Overall Study|Initiated into extension study A536-06|0|||
33320070|NCT01749540|101069862|FG003|Overall Study|Initiated into extension study A536-06|0|||
33320071|NCT01749540|101069863|FG004|Overall Study|Initiated into extension study A536-06|0|||
33320072|NCT01749540|101069864|FG005|Overall Study|Initiated into extension study A536-06|2|||
33320073|NCT01749540|101069865|FG006|Overall Study|Initiated into extension study A536-06|24|||
33320074|NCT00617604|101069868|FG000|Overall Study|Death|2|||
33320075|NCT00617604|101069869|FG001|Overall Study|Death|1|||
33320076|NCT00617604|101069868|FG000|Overall Study|Lost to Follow-up|1|||
33320077|NCT00617604|101069869|FG001|Overall Study|Lost to Follow-up|0|||
33320078|NCT00617604|101069868|FG000|Overall Study|Miscellaneous Reasons|8|||
33320079|NCT00617604|101069869|FG001|Overall Study|Miscellaneous Reasons|10|||
33604746|NCT02900170|102102732|FG000|Overall Study|Lost to Follow-up|8|||
33604747|NCT02096263|102102736|FG000|Overall Study|Adverse Event|1|||
33604748|NCT02096263|102102737|FG001|Overall Study|Adverse Event|0|||
33604749|NCT02096263|102102738|FG002|Overall Study|Adverse Event|1|||
33320080|NCT00617604|101069868|FG000|Overall Study|Withdrawal by Subject|4|||
33320081|NCT00617604|101069869|FG001|Overall Study|Withdrawal by Subject|6|||
33320082|NCT00617604|101069868|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
33320083|NCT00617604|101069869|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
33320084|NCT04448756|101069870|FG000|Overall Study|Adverse Event|0|||
33320085|NCT04448756|101069871|FG001|Overall Study|Adverse Event|1|||
33320086|NCT04448756|101069872|FG002|Overall Study|Adverse Event|0|||
33509032|NCT04016779|101759175|FG001|Overall Study|Lost to Follow-up|14|||
33320087|NCT04448756|101069870|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
33320088|NCT04448756|101069871|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
33509033|NCT04016779|101759174|FG000|Overall Study|Physician Decision|1|||
33509034|NCT04016779|101759175|FG001|Overall Study|Physician Decision|3|||
33509035|NCT04016779|101759174|FG000|Overall Study|Withdrawal by Subject|6|||
33509036|NCT04016779|101759175|FG001|Overall Study|Withdrawal by Subject|8|||
33509037|NCT04016779|101759174|FG000|Overall Study|Non-compliance with Study Drug|2|||
33509038|NCT04016779|101759175|FG001|Overall Study|Non-compliance with Study Drug|3|||
33509039|NCT04016779|101759174|FG000|Overall Study|Other, Multiple categories|17|||
33509040|NCT04016779|101759175|FG001|Overall Study|Other, Multiple categories|17|||
33509041|NCT01343277|101759187|FG000|Overall Study|Other|3|||
33509042|NCT01343277|101759188|FG001|Overall Study|Other|3|||
33509043|NCT01343277|101759187|FG000|Overall Study|Withdrawal by Subject|18|||
33509044|NCT01343277|101759188|FG001|Overall Study|Withdrawal by Subject|13|||
33509045|NCT01343277|101759187|FG000|Overall Study|Physician Decision|1|||
33509046|NCT01343277|101759188|FG001|Overall Study|Physician Decision|2|||
33509047|NCT01343277|101759187|FG000|Overall Study|Death|10|||
33509048|NCT01343277|101759188|FG001|Overall Study|Death|1|||
33509049|NCT01343277|101759187|FG000|Overall Study|Adverse Event|67|||
33509050|NCT01343277|101759188|FG001|Overall Study|Adverse Event|13|||
33509051|NCT01343277|101759187|FG000|Overall Study|Disease progression|270|||
33604750|NCT02096263|102102736|FG000|Overall Study|Lost to Follow-up|14|||
33604751|NCT02096263|102102737|FG001|Overall Study|Lost to Follow-up|18|||
33604752|NCT02096263|102102738|FG002|Overall Study|Lost to Follow-up|15|||
33197849|NCT03085927|100626639|FG000|Overall Study|Lost to Follow-up|3|||
33197850|NCT03085927|100626640|FG001|Overall Study|Lost to Follow-up|1|||
33197851|NCT03085927|100626639|FG000|Overall Study|Death|1|||
33197852|NCT03085927|100626640|FG001|Overall Study|Death|0|||
33197853|NCT03085927|100626639|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
33197854|NCT03085927|100626640|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
33197855|NCT03085927|100626639|FG000|Overall Study|Dyad Became Ineligible|0|||
33197856|NCT03085927|100626640|FG001|Overall Study|Dyad Became Ineligible|1|||
33197857|NCT01692197|100626649|FG000|Overall Study|Failed Screening|3|||
33197858|NCT00938431|100626663|FG000|Overall Study|Adverse Event|5|||
33197859|NCT00938431|100626664|FG001|Overall Study|Adverse Event|8|||
33364918|NCT01790438|101223682|FG000|Overall Study|Sponsor Decision|0|||
33509052|NCT01343277|101759188|FG001|Overall Study|Disease progression|138|||
33509053|NCT01343277|101759187|FG000|Overall Study|Randomized not treated|6|||
33509054|NCT01343277|101759188|FG001|Overall Study|Randomized not treated|21|||
33604753|NCT02096263|102102736|FG000|Overall Study|Other|7|||
33320089|NCT04448756|101069872|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
33320090|NCT04448756|101069870|FG000|Overall Study|Withdrawal by Subject|0|||
33320091|NCT04448756|101069871|FG001|Overall Study|Withdrawal by Subject|3|||
33320092|NCT04448756|101069872|FG002|Overall Study|Withdrawal by Subject|1|||
33320093|NCT04448756|101069870|FG000|Overall Study|Death|2|||
33320094|NCT04448756|101069871|FG001|Overall Study|Death|1|||
33320095|NCT04448756|101069872|FG002|Overall Study|Death|0|||
33320096|NCT01798992|101069873|FG000|Overall Study|Administrative withdrawal|0|||
33320097|NCT01798992|101069874|FG001|Overall Study|Administrative withdrawal|1|||
33320098|NCT01798992|101069875|FG002|Overall Study|Administrative withdrawal|0|||
33320099|NCT01798992|101069876|FG003|Overall Study|Administrative withdrawal|1|||
33320100|NCT01798992|101069873|FG000|Overall Study|Lost to Follow-up|0|||
33320101|NCT01798992|101069874|FG001|Overall Study|Lost to Follow-up|1|||
33320102|NCT01798992|101069875|FG002|Overall Study|Lost to Follow-up|1|||
33320103|NCT01798992|101069876|FG003|Overall Study|Lost to Follow-up|0|||
33320104|NCT01798992|101069873|FG000|Overall Study|Insufficient biopsy tissue|0|||
33604754|NCT02096263|102102737|FG001|Overall Study|Other|9|||
33398770|NCT02371980|101350127|FG003|Open-label Period|Lost to Follow-up|0|||
33398771|NCT02371980|101350128|FG004|Open-label Period|Lost to Follow-up|0|||
33320105|NCT01798992|101069874|FG001|Overall Study|Insufficient biopsy tissue|0|||
33604755|NCT02096263|102102738|FG002|Overall Study|Other|6|||
33604756|NCT02096263|102102736|FG000|Overall Study|Sponsor study termination|0|||
33604757|NCT02096263|102102737|FG001|Overall Study|Sponsor study termination|0|||
33320106|NCT01798992|101069875|FG002|Overall Study|Insufficient biopsy tissue|1|||
33320107|NCT01798992|101069876|FG003|Overall Study|Insufficient biopsy tissue|0|||
33320108|NCT00355056|101069877|FG000|Randomization Period|Early Termination|4|||
33320109|NCT00355056|101069878|FG001|Randomization Period|Early Termination|6|||
33320110|NCT00066742|101069886|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
33320111|NCT00066742|101069886|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
33320112|NCT00066742|101069886|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
33320113|NCT00066742|101069886|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
33320114|NCT00066742|101069886|FG000|Induction Chemoradiotherapy|Ineligible|3|||
33320115|NCT00066742|101069886|FG000|Consolidation Chemotherapy|not protocol specified|1|||
33320116|NCT00066742|101069886|FG000|Consolidation Chemotherapy|Ineligible|2|||
33320117|NCT02072434|101069887|FG000|Overall Study|Protocol Violation|10|||
33320118|NCT02072434|101069888|FG001|Overall Study|Protocol Violation|9|||
33320119|NCT02072434|101069887|FG000|Overall Study|Physician Decision|5|||
33320120|NCT02072434|101069888|FG001|Overall Study|Physician Decision|10|||
33320121|NCT02072434|101069887|FG000|Overall Study|Adverse event, serious fatal|1|||
33320122|NCT02072434|101069888|FG001|Overall Study|Adverse event, serious fatal|6|||
33320123|NCT02072434|101069887|FG000|Overall Study|Adverse Event|7|||
33320124|NCT02072434|101069888|FG001|Overall Study|Adverse Event|6|||
33320125|NCT02072434|101069887|FG000|Overall Study|Withdrawal by Subject|17|||
33398772|NCT02371980|101350124|FG000|Open-label Period|Voluntary Withdrawal|91|||
33398773|NCT02371980|101350125|FG001|Open-label Period|Voluntary Withdrawal|0|||
33398774|NCT02371980|101350126|FG002|Open-label Period|Voluntary Withdrawal|0|||
33398775|NCT02371980|101350127|FG003|Open-label Period|Voluntary Withdrawal|0|||
33398776|NCT02371980|101350128|FG004|Open-label Period|Voluntary Withdrawal|0|||
33398777|NCT02371980|101350124|FG000|Open-label Period|Pregnancy|1|||
33398778|NCT02371980|101350125|FG001|Open-label Period|Pregnancy|0|||
33398779|NCT02371980|101350126|FG002|Open-label Period|Pregnancy|0|||
33398780|NCT02371980|101350127|FG003|Open-label Period|Pregnancy|0|||
33398781|NCT02371980|101350128|FG004|Open-label Period|Pregnancy|0|||
33398782|NCT02371980|101350124|FG000|Open-label Period|Lack of Efficacy|116|||
33398783|NCT02371980|101350125|FG001|Open-label Period|Lack of Efficacy|0|||
33398784|NCT02371980|101350126|FG002|Open-label Period|Lack of Efficacy|0|||
33398785|NCT02371980|101350127|FG003|Open-label Period|Lack of Efficacy|0|||
33398786|NCT02371980|101350128|FG004|Open-label Period|Lack of Efficacy|0|||
33320126|NCT02072434|101069888|FG001|Overall Study|Withdrawal by Subject|29|||
33320127|NCT02072434|101069887|FG000|Overall Study|Other|14|||
33320128|NCT02072434|101069888|FG001|Overall Study|Other|29|||
33320129|NCT02072434|101069887|FG000|Overall Study|Lost to Follow-up|0|||
33398787|NCT02371980|101350124|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
33398788|NCT02371980|101350125|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
33509055|NCT01343277|101759187|FG000|Overall Study|Treatment ongoing|8|||
33320130|NCT02072434|101069888|FG001|Overall Study|Lost to Follow-up|1|||
33398789|NCT02371980|101350126|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
33398790|NCT02371980|101350127|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
33509056|NCT01343277|101759188|FG001|Overall Study|Treatment ongoing|2|||
33509057|NCT01343277|101759187|FG000|Overall Study|Subsequent anticancer therapy|1|||
33509058|NCT01343277|101759188|FG001|Overall Study|Subsequent anticancer therapy|0|||
33509059|NCT02111785|101759191|FG000|Overall Study|Death|0|||
33509060|NCT02111785|101759192|FG001|Overall Study|Death|1|||
33398791|NCT02371980|101350128|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
33509061|NCT02111785|101759193|FG002|Overall Study|Death|0|||
33398792|NCT02371980|101350124|FG000|Open-label Period|Reason not Specified|9|||
33320131|NCT02234323|101069889|FG000|All Enrolled|Not Treated: Completed study in database|2|||
33320132|NCT02234323|101069889|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
33320133|NCT02234323|101069889|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
33320134|NCT02234323|101069889|FG000|All Treated|Death|1|||
33320135|NCT02234323|101069889|FG000|All Treated|Physician Decision|5|||
33320136|NCT02234323|101069889|FG000|All Treated|Lack of Efficacy|3|||
33320137|NCT02234323|101069889|FG000|All Treated|Exceeded lab value limit|2|||
33320138|NCT02234323|101069889|FG000|All Treated|Other|7|||
33320139|NCT02544217|101069890|FG000|Overall Study|Withdrawal by Subject|1|||
33320140|NCT02544217|101069891|FG001|Overall Study|Withdrawal by Subject|1|||
33320141|NCT02544217|101069892|FG002|Overall Study|Withdrawal by Subject|0|||
33320142|NCT02544217|101069893|FG003|Overall Study|Withdrawal by Subject|0|||
33320143|NCT02544217|101069894|FG004|Overall Study|Withdrawal by Subject|0|||
33320144|NCT02544217|101069895|FG005|Overall Study|Withdrawal by Subject|0|||
33320145|NCT03065023|101069896|FG000|Overall Study|Progressive Disease|0|||
33320146|NCT03065023|101069897|FG001|Overall Study|Progressive Disease|1|||
33320147|NCT03065023|101069898|FG002|Overall Study|Progressive Disease|0|||
33320148|NCT03065023|101069899|FG003|Overall Study|Progressive Disease|0|||
33320149|NCT03065023|101069900|FG004|Overall Study|Progressive Disease|0|||
33320150|NCT03065023|101069896|FG000|Overall Study|Death|2|||
33320151|NCT03065023|101069897|FG001|Overall Study|Death|0|||
33320152|NCT03065023|101069898|FG002|Overall Study|Death|1|||
33320153|NCT03065023|101069899|FG003|Overall Study|Death|1|||
33320154|NCT03065023|101069900|FG004|Overall Study|Death|0|||
33320155|NCT03065023|101069896|FG000|Overall Study|Lost to Follow-up|0|||
33320156|NCT03065023|101069897|FG001|Overall Study|Lost to Follow-up|1|||
33320157|NCT03065023|101069898|FG002|Overall Study|Lost to Follow-up|0|||
33320158|NCT03065023|101069899|FG003|Overall Study|Lost to Follow-up|0|||
33320159|NCT03065023|101069900|FG004|Overall Study|Lost to Follow-up|0|||
33320160|NCT03065023|101069896|FG000|Overall Study|Participant Decision|0|||
33320161|NCT03065023|101069897|FG001|Overall Study|Participant Decision|0|||
33320162|NCT03065023|101069898|FG002|Overall Study|Participant Decision|0|||
33320163|NCT03065023|101069899|FG003|Overall Study|Participant Decision|1|||
33320164|NCT03065023|101069900|FG004|Overall Study|Participant Decision|0|||
33320165|NCT03065023|101069896|FG000|Overall Study|Withdrawal by Subject|0|||
33320166|NCT03065023|101069897|FG001|Overall Study|Withdrawal by Subject|0|||
33320167|NCT03065023|101069898|FG002|Overall Study|Withdrawal by Subject|0|||
33320168|NCT03065023|101069899|FG003|Overall Study|Withdrawal by Subject|1|||
33320169|NCT03065023|101069900|FG004|Overall Study|Withdrawal by Subject|0|||
33320170|NCT00702845|101069901|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
33320171|NCT00702845|101069902|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
33320172|NCT00702845|101069901|FG000|Overall Study|Too high ovarian response|5|||
33320173|NCT00702845|101069902|FG001|Overall Study|Too high ovarian response|1|||
33320174|NCT00702845|101069901|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
33320175|NCT00702845|101069902|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
33320176|NCT00702845|101069901|FG000|Overall Study|Insufficient ovarian response|1|||
33320177|NCT00702845|101069902|FG001|Overall Study|Insufficient ovarian response|0|||
33320178|NCT00702845|101069901|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
33320179|NCT00702845|101069902|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
33320180|NCT00702845|101069901|FG000|Overall Study|No or abnormal fertilization|4|||
33320181|NCT00702845|101069902|FG001|Overall Study|No or abnormal fertilization|2|||
33320182|NCT00702845|101069901|FG000|Overall Study|Patient's decision|2|||
33320183|NCT00702845|101069902|FG001|Overall Study|Patient's decision|1|||
33320184|NCT00702845|101069901|FG000|Overall Study|Not randomized|0|||
33320185|NCT00702845|101069902|FG001|Overall Study|Not randomized|1|||
33320186|NCT01479829|101069906|FG000|Overall Study|Withdrawal by Subject|8|||
33320187|NCT01479829|101069907|FG001|Overall Study|Withdrawal by Subject|10|||
33320188|NCT00528567|101069910|FG000|Overall Study|Death|4|||
33320189|NCT00528567|101069911|FG001|Overall Study|Death|5|||
33320190|NCT00528567|101069910|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
33604758|NCT02096263|102102738|FG002|Overall Study|Sponsor study termination|1|||
33197860|NCT00938431|100626665|FG002|Overall Study|Adverse Event|6|||
33197861|NCT00938431|100626663|FG000|Overall Study|Lack of Efficacy|0|||
33197862|NCT00938431|100626664|FG001|Overall Study|Lack of Efficacy|1|||
33320191|NCT00528567|101069911|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
33320192|NCT00528567|101069910|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
33320193|NCT00528567|101069911|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
33320194|NCT00528567|101069910|FG000|Overall Study|Violation Criteria at Entry|3|||
33604759|NCT02096263|102102736|FG000|Overall Study|Protocol Violation|7|||
33604760|NCT02096263|102102737|FG001|Overall Study|Protocol Violation|2|||
33604761|NCT02096263|102102738|FG002|Overall Study|Protocol Violation|8|||
33320195|NCT00528567|101069911|FG001|Overall Study|Violation Criteria at Entry|17|||
33320196|NCT00528567|101069910|FG000|Overall Study|Withdrew Consent|59|||
33320197|NCT00528567|101069911|FG001|Overall Study|Withdrew Consent|55|||
33320198|NCT00528567|101069910|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
33320199|NCT00528567|101069911|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
33320200|NCT00528567|101069910|FG000|Overall Study|Failure to Return|1|||
33320201|NCT00528567|101069911|FG001|Overall Study|Failure to Return|4|||
33320202|NCT00528567|101069910|FG000|Overall Study|Other Protocol Violation|5|||
33320203|NCT00528567|101069911|FG001|Overall Study|Other Protocol Violation|21|||
33320204|NCT00528567|101069910|FG000|Overall Study|Administrative/Other|22|||
33320205|NCT00528567|101069911|FG001|Overall Study|Administrative/Other|75|||
33320206|NCT03250832|101069912|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
33320207|NCT03250832|101069913|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
33320208|NCT03250832|101069914|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
33320209|NCT03250832|101069915|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
33320210|NCT03250832|101069916|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
33320211|NCT03250832|101069917|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
33320212|NCT03250832|101069918|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
33320213|NCT03250832|101069919|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
33320214|NCT03250832|101069920|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
33320215|NCT03250832|101069921|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
33320216|NCT03250832|101069922|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
33320217|NCT03250832|101069923|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
33320218|NCT03250832|101069912|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
33320219|NCT03250832|101069913|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
33320220|NCT03250832|101069914|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
33320221|NCT03250832|101069915|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
33320222|NCT03250832|101069916|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
33320223|NCT03250832|101069917|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
33320224|NCT03250832|101069918|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
33320225|NCT03250832|101069919|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
33320226|NCT03250832|101069920|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
33320227|NCT03250832|101069921|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
33320228|NCT03250832|101069922|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
33320229|NCT03250832|101069923|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
33320230|NCT03250832|101069912|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
33320231|NCT03250832|101069913|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
33320232|NCT03250832|101069914|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
33320233|NCT03250832|101069915|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
33320234|NCT03250832|101069916|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
33320235|NCT03250832|101069917|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
33320236|NCT03250832|101069918|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
33320237|NCT03250832|101069919|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
33320238|NCT03250832|101069920|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
33320239|NCT03250832|101069921|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
33320240|NCT03250832|101069922|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
33320241|NCT03250832|101069923|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
33320242|NCT03250832|101069912|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
33320243|NCT03250832|101069913|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
33320244|NCT03250832|101069914|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
33320245|NCT03250832|101069915|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
33320246|NCT03250832|101069916|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
33320247|NCT03250832|101069917|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
33320248|NCT03250832|101069918|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
33320249|NCT03250832|101069919|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
33320250|NCT03250832|101069920|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
33320251|NCT03250832|101069921|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
33320252|NCT03250832|101069922|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
33320253|NCT03250832|101069923|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
33320254|NCT03250832|101069912|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
33320255|NCT03250832|101069913|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
33320256|NCT03250832|101069914|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
33320257|NCT03250832|101069915|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
33320258|NCT03250832|101069916|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
33320259|NCT03250832|101069917|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
33320260|NCT03250832|101069918|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
33604762|NCT02096263|102102736|FG000|Overall Study|Withdrawal by Subject|5|||
33604763|NCT02096263|102102737|FG001|Overall Study|Withdrawal by Subject|7|||
33320261|NCT03250832|101069919|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
33320262|NCT03250832|101069920|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
33320263|NCT03250832|101069921|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
33604764|NCT02096263|102102738|FG002|Overall Study|Withdrawal by Subject|8|||
33604765|NCT03847909|102102742|FG000|Overall Study|Withdrawal by Subject|1|||
33320264|NCT03250832|101069922|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
33320265|NCT03250832|101069923|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
33320266|NCT03250832|101069912|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
33320267|NCT03250832|101069913|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
33320268|NCT03250832|101069914|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
33320269|NCT03250832|101069915|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
33320270|NCT03250832|101069916|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
33604766|NCT03847909|102102743|FG001|Overall Study|Withdrawal by Subject|1|||
33604767|NCT00530920|102102744|FG000|Overall Study|Randomized but not treated|0|||
33320271|NCT03250832|101069917|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
33320272|NCT03250832|101069918|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
33320273|NCT03250832|101069919|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
33320274|NCT03250832|101069920|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
33398793|NCT02371980|101350125|FG001|Open-label Period|Reason not Specified|0|||
33398794|NCT02371980|101350126|FG002|Open-label Period|Reason not Specified|0|||
33398795|NCT02371980|101350127|FG003|Open-label Period|Reason not Specified|0|||
33509062|NCT02111785|101759194|FG003|Overall Study|Death|0|||
33509063|NCT05318092|101759195|FG000|Overall Study|Lost to Follow-up|3|||
33509064|NCT05318092|101759195|FG000|Overall Study|Withdrawal by Subject|1|||
33509065|NCT01598090|101759196|FG000|Treatment Period|Poor/non-compliance|0|||
33509066|NCT01598090|101759197|FG001|Treatment Period|Poor/non-compliance|2|||
33604768|NCT00530920|102102745|FG001|Overall Study|Randomized but not treated|2|||
33509067|NCT01598090|101759198|FG002|Treatment Period|Poor/non-compliance|0|||
33509068|NCT01598090|101759196|FG000|Treatment Period|No longer meet study criteria|0|||
33509069|NCT01598090|101759197|FG001|Treatment Period|No longer meet study criteria|1|||
33509070|NCT01598090|101759198|FG002|Treatment Period|No longer meet study criteria|0|||
33509071|NCT01598090|101759196|FG000|Treatment Period|Lack of Efficacy|5|||
33509072|NCT01598090|101759197|FG001|Treatment Period|Lack of Efficacy|14|||
33509073|NCT01598090|101759198|FG002|Treatment Period|Lack of Efficacy|6|||
33509074|NCT01598090|101759196|FG000|Treatment Period|Adverse Event|2|||
33509075|NCT01598090|101759197|FG001|Treatment Period|Adverse Event|33|||
33509076|NCT01598090|101759198|FG002|Treatment Period|Adverse Event|17|||
33509077|NCT01598090|101759196|FG000|Treatment Period|Other reasons|0|||
33509078|NCT01598090|101759197|FG001|Treatment Period|Other reasons|4|||
33509079|NCT01598090|101759198|FG002|Treatment Period|Other reasons|1|||
33509080|NCT01598090|101759196|FG000|Treatment Period|Withdrawal by Subject|3|||
33509081|NCT01598090|101759197|FG001|Treatment Period|Withdrawal by Subject|13|||
33509082|NCT01598090|101759198|FG002|Treatment Period|Withdrawal by Subject|10|||
33509083|NCT01598090|101759196|FG000|Treatment Period|Lost to Follow-up|1|||
33509084|NCT01598090|101759197|FG001|Treatment Period|Lost to Follow-up|5|||
33509085|NCT01598090|101759198|FG002|Treatment Period|Lost to Follow-up|1|||
33509086|NCT01598090|101759196|FG000|Follow-up Period|Death|0|||
33509087|NCT01598090|101759197|FG001|Follow-up Period|Death|1|||
33509088|NCT01598090|101759198|FG002|Follow-up Period|Death|0|||
33509089|NCT01598090|101759196|FG000|Follow-up Period|No longer required per protocol|1|||
33509090|NCT01598090|101759197|FG001|Follow-up Period|No longer required per protocol|3|||
33604769|NCT00530920|102102746|FG002|Overall Study|Randomized but not treated|0|||
33604770|NCT00530920|102102744|FG000|Overall Study|Adverse Event|0|||
33604771|NCT00530920|102102745|FG001|Overall Study|Adverse Event|0|||
33604772|NCT00530920|102102746|FG002|Overall Study|Adverse Event|3|||
33604773|NCT00530920|102102744|FG000|Overall Study|Withdrawal by Subject|0|||
33197863|NCT00938431|100626665|FG002|Overall Study|Lack of Efficacy|0|||
33197864|NCT00938431|100626663|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
33364919|NCT01790438|101223683|FG001|Overall Study|Sponsor Decision|3|||
33398796|NCT02371980|101350128|FG004|Open-label Period|Reason not Specified|0|||
33398797|NCT02371980|101350124|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
33398798|NCT02371980|101350125|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
33509091|NCT01598090|101759198|FG002|Follow-up Period|No longer required per protocol|2|||
33509092|NCT01598090|101759196|FG000|Follow-up Period|Not reported|0|||
33509093|NCT01598090|101759197|FG001|Follow-up Period|Not reported|10|||
33509094|NCT01598090|101759198|FG002|Follow-up Period|Not reported|4|||
33509095|NCT01598090|101759196|FG000|Follow-up Period|Withdrawal by Subject|0|||
33509096|NCT01598090|101759197|FG001|Follow-up Period|Withdrawal by Subject|3|||
33509097|NCT01598090|101759198|FG002|Follow-up Period|Withdrawal by Subject|2|||
33509098|NCT01598090|101759196|FG000|Follow-up Period|Other reasons|2|||
33509099|NCT01598090|101759197|FG001|Follow-up Period|Other reasons|8|||
33509100|NCT01598090|101759198|FG002|Follow-up Period|Other reasons|8|||
33509101|NCT01598090|101759196|FG000|Follow-up Period|Lost to Follow-up|2|||
33509102|NCT01598090|101759197|FG001|Follow-up Period|Lost to Follow-up|10|||
33509103|NCT01598090|101759198|FG002|Follow-up Period|Lost to Follow-up|12|||
33509104|NCT01471340|101759203|FG000|Overall Study|Death|5|||
33604774|NCT00530920|102102745|FG001|Overall Study|Withdrawal by Subject|0|||
33509105|NCT01471340|101759204|FG001|Overall Study|Death|4|||
33509106|NCT01471340|101759203|FG000|Overall Study|Lost to Follow-up|0|||
33509107|NCT01471340|101759204|FG001|Overall Study|Lost to Follow-up|1|||
33509108|NCT01471340|101759203|FG000|Overall Study|Investigational site closure|0|||
33509109|NCT01471340|101759204|FG001|Overall Study|Investigational site closure|1|||
33509110|NCT01471340|101759203|FG000|Overall Study|Invalid informed consent|1|||
33509111|NCT01471340|101759204|FG001|Overall Study|Invalid informed consent|0|||
33509112|NCT02256982|101759207|FG000|Overall Study|Disease Progression|0|||
33509113|NCT02256982|101759208|FG001|Overall Study|Disease Progression|1|||
33509114|NCT00965341|101759209|FG000|Overall Study|Withdrew consent|1|||
33509115|NCT00965341|101759210|FG001|Overall Study|Withdrew consent|5|||
33509116|NCT00965341|101759209|FG000|Overall Study|Lost to Follow-up|1|||
33509117|NCT00965341|101759210|FG001|Overall Study|Lost to Follow-up|0|||
33509118|NCT00965341|101759209|FG000|Overall Study|Transportation issues|4|||
33509119|NCT00965341|101759210|FG001|Overall Study|Transportation issues|3|||
33509120|NCT01676896|101759211|FG000|Overall Study|Withdrawal by Subject|12|||
33509121|NCT01676896|101759212|FG001|Overall Study|Withdrawal by Subject|7|||
33509122|NCT01676896|101759213|FG002|Overall Study|Withdrawal by Subject|19|||
33509123|NCT00808639|101759214|FG000|Overall Study|Disease progression before surgery.|1|||
33509124|NCT00723255|101759215|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
33509125|NCT00723255|101759215|FG000|Overall Study|Ineligible: Second primary|1|||
33509126|NCT00723255|101759215|FG000|Overall Study|Ineligible: Wrong Primary|2|||
33509127|NCT00150800|101759218|FG000|Overall Study|Adverse Event|89|||
33509128|NCT00150800|101759218|FG000|Overall Study|Death|18|||
33509129|NCT00150800|101759218|FG000|Overall Study|Lack of Efficacy|166|||
33509130|NCT00150800|101759218|FG000|Overall Study|Lost to Follow-up|58|||
33509131|NCT00150800|101759218|FG000|Overall Study|Subject's choice|90|||
33509132|NCT00150800|101759218|FG000|Overall Study|No compliance|18|||
33509133|NCT00150800|101759218|FG000|Overall Study|IP misshandling|1|||
33509134|NCT00150800|101759218|FG000|Overall Study|Site closure|24|||
33509135|NCT00150800|101759218|FG000|Overall Study|Protocol non-adherence|2|||
33509136|NCT00150800|101759218|FG000|Overall Study|Nobody to accompany patient|1|||
33509137|NCT00150800|101759218|FG000|Overall Study|Distance too long for patient|1|||
33509138|NCT00150800|101759218|FG000|Overall Study|Neurosurgery|2|||
33509139|NCT00150800|101759218|FG000|Overall Study|BRV monotherapy|1|||
33509140|NCT00150800|101759218|FG000|Overall Study|Visit refusal|3|||
33509141|NCT00150800|101759218|FG000|Overall Study|Sponsor's request|2|||
33509142|NCT00150800|101759218|FG000|Overall Study|Generalized Epilepsy|1|||
33509143|NCT00150800|101759218|FG000|Overall Study|Moved from area/country|8|||
33509144|NCT00150800|101759218|FG000|Overall Study|PI retiring|2|||
33509145|NCT00150800|101759218|FG000|Overall Study|PI leaving site|2|||
33509146|NCT00150800|101759218|FG000|Overall Study|Patient insurance|1|||
33509147|NCT00150800|101759218|FG000|Overall Study|Surgical intervention|4|||
33509148|NCT00150800|101759218|FG000|Overall Study|Pregnancy planned|1|||
33509149|NCT00150800|101759218|FG000|Overall Study|PI discontinuation request|1|||
33509150|NCT01290679|101759219|FG000|Overall Study|Adverse Event|2|||
33509151|NCT01290679|101759220|FG001|Overall Study|Adverse Event|0|||
33509152|NCT01290679|101759219|FG000|Overall Study|Lost to Follow-up|8|||
33509153|NCT01290679|101759220|FG001|Overall Study|Lost to Follow-up|10|||
33509154|NCT01290679|101759219|FG000|Overall Study|Protocol Violation|0|||
33509155|NCT01290679|101759220|FG001|Overall Study|Protocol Violation|1|||
33509156|NCT01290679|101759219|FG000|Overall Study|Withdrawal by Subject|6|||
33509157|NCT01290679|101759220|FG001|Overall Study|Withdrawal by Subject|5|||
33509158|NCT01290679|101759219|FG000|Overall Study|Subject Entered Another Trial|0|||
33509159|NCT01290679|101759220|FG001|Overall Study|Subject Entered Another Trial|5|||
33509160|NCT00102531|101759227|FG000|Overall Study|Adverse Event|0|||
33509161|NCT00102531|101759228|FG001|Overall Study|Adverse Event|1|||
33509162|NCT00102531|101759227|FG000|Overall Study|Disease Progression|5|||
33509163|NCT00102531|101759228|FG001|Overall Study|Disease Progression|9|||
33509164|NCT00102531|101759227|FG000|Overall Study|Physician Decision|0|||
33509165|NCT00102531|101759228|FG001|Overall Study|Physician Decision|1|||
33509166|NCT00890084|101759229|FG000|Overall Study|Adverse Event|16|||
33509167|NCT00890084|101759229|FG000|Overall Study|Lost to Follow-up|126|||
33509168|NCT03057054|101759232|FG000|Overall Study|Death|4|||
33509169|NCT03057054|101759233|FG001|Overall Study|Death|4|||
33509170|NCT03057054|101759232|FG000|Overall Study|Withdrawal by Subject|6|||
33509171|NCT03057054|101759233|FG001|Overall Study|Withdrawal by Subject|3|||
33509172|NCT03057054|101759232|FG000|Overall Study|Ineligible|1|||
33509173|NCT03057054|101759233|FG001|Overall Study|Ineligible|1|||
33509174|NCT00537316|101759234|FG000|Part 1|Adverse Event|7|||
33509175|NCT00537316|101759235|FG001|Part 1|Adverse Event|11|||
33509176|NCT00537316|101759236|FG002|Part 1|Adverse Event|8|||
33509177|NCT00537316|101759237|FG003|Part 1|Adverse Event|0|||
33509178|NCT00537316|101759238|FG004|Part 1|Adverse Event|0|||
33509179|NCT00537316|101759239|FG005|Part 1|Adverse Event|0|||
33509180|NCT00537316|101759240|FG006|Part 1|Adverse Event|0|||
33509181|NCT00537316|101759234|FG000|Part 1|Protocol defined clinical event|1|||
33509182|NCT00537316|101759235|FG001|Part 1|Protocol defined clinical event|0|||
33509183|NCT00537316|101759236|FG002|Part 1|Protocol defined clinical event|0|||
33509184|NCT00537316|101759237|FG003|Part 1|Protocol defined clinical event|0|||
33509185|NCT00537316|101759238|FG004|Part 1|Protocol defined clinical event|0|||
33509186|NCT00537316|101759239|FG005|Part 1|Protocol defined clinical event|0|||
33509187|NCT00537316|101759240|FG006|Part 1|Protocol defined clinical event|0|||
33509188|NCT00537316|101759234|FG000|Part 1|Lost to Follow-up|1|||
33509189|NCT00537316|101759235|FG001|Part 1|Lost to Follow-up|0|||
33509190|NCT00537316|101759236|FG002|Part 1|Lost to Follow-up|0|||
33509191|NCT00537316|101759237|FG003|Part 1|Lost to Follow-up|0|||
33509192|NCT00537316|101759238|FG004|Part 1|Lost to Follow-up|0|||
33509193|NCT00537316|101759239|FG005|Part 1|Lost to Follow-up|0|||
33509194|NCT00537316|101759240|FG006|Part 1|Lost to Follow-up|0|||
33509195|NCT00537316|101759234|FG000|Part 1|Withdrawal by Subject|3|||
33509196|NCT00537316|101759235|FG001|Part 1|Withdrawal by Subject|8|||
33509197|NCT00537316|101759236|FG002|Part 1|Withdrawal by Subject|4|||
33509198|NCT00537316|101759237|FG003|Part 1|Withdrawal by Subject|0|||
33509199|NCT00537316|101759238|FG004|Part 1|Withdrawal by Subject|0|||
33509200|NCT00537316|101759239|FG005|Part 1|Withdrawal by Subject|0|||
33509201|NCT00537316|101759240|FG006|Part 1|Withdrawal by Subject|0|||
33509202|NCT00537316|101759234|FG000|Part 1|Protocol Violation|1|||
33509203|NCT00537316|101759235|FG001|Part 1|Protocol Violation|5|||
33509204|NCT00537316|101759236|FG002|Part 1|Protocol Violation|1|||
33509205|NCT00537316|101759237|FG003|Part 1|Protocol Violation|0|||
33509206|NCT00537316|101759238|FG004|Part 1|Protocol Violation|0|||
33509207|NCT00537316|101759239|FG005|Part 1|Protocol Violation|0|||
33509208|NCT00537316|101759240|FG006|Part 1|Protocol Violation|0|||
33509209|NCT00537316|101759234|FG000|Part 1|Did not meet protocol eligibility|1|||
33509210|NCT00537316|101759235|FG001|Part 1|Did not meet protocol eligibility|3|||
33509211|NCT00537316|101759236|FG002|Part 1|Did not meet protocol eligibility|2|||
33509212|NCT00537316|101759237|FG003|Part 1|Did not meet protocol eligibility|0|||
33509213|NCT00537316|101759238|FG004|Part 1|Did not meet protocol eligibility|0|||
33509214|NCT00537316|101759239|FG005|Part 1|Did not meet protocol eligibility|0|||
33509215|NCT00537316|101759240|FG006|Part 1|Did not meet protocol eligibility|0|||
33509216|NCT00537316|101759234|FG000|Part 1|Administrative|0|||
33509217|NCT00537316|101759235|FG001|Part 1|Administrative|0|||
33509218|NCT00537316|101759236|FG002|Part 1|Administrative|2|||
33509219|NCT00537316|101759237|FG003|Part 1|Administrative|0|||
33509220|NCT00537316|101759238|FG004|Part 1|Administrative|0|||
33509221|NCT00537316|101759239|FG005|Part 1|Administrative|0|||
33509222|NCT00537316|101759240|FG006|Part 1|Administrative|0|||
33509223|NCT00537316|101759234|FG000|Part 2|Never entered follow-up|0|||
33604775|NCT00530920|102102746|FG002|Overall Study|Withdrawal by Subject|1|||
33604776|NCT03442296|102102747|FG000|3 Month Follow-up|Death|3|||
33604777|NCT03442296|102102748|FG001|3 Month Follow-up|Death|1|||
33604778|NCT03442296|102102747|FG000|3 Month Follow-up|Lost to Follow-up|1|||
33604779|NCT03442296|102102748|FG001|3 Month Follow-up|Lost to Follow-up|1|||
33320275|NCT03250832|101069921|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
33320276|NCT03250832|101069922|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
33320277|NCT03250832|101069923|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
33320278|NCT03250832|101069912|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
33604780|NCT03442296|102102747|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
33604781|NCT03442296|102102748|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
33604782|NCT03442296|102102747|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
33604783|NCT03442296|102102748|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
33604784|NCT03442296|102102747|FG000|12 Month Follow-up|Incomplete measurement|1|||
33604785|NCT03442296|102102748|FG001|12 Month Follow-up|Incomplete measurement|1|||
33604786|NCT00673881|102102749|FG000|Overall Study|Withdrawal by Subject|1|||
33604787|NCT05059977|102102755|FG000|Overall Study|Withdrawal by Subject|0|||
33604788|NCT05059977|102102756|FG001|Overall Study|Withdrawal by Subject|0|||
33604789|NCT05059977|102102757|FG002|Overall Study|Withdrawal by Subject|1|||
33320279|NCT03250832|101069913|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
33320280|NCT03250832|101069914|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
33320281|NCT03250832|101069915|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
33509224|NCT00537316|101759235|FG001|Part 2|Never entered follow-up|0|||
33509225|NCT00537316|101759236|FG002|Part 2|Never entered follow-up|0|||
33509226|NCT00537316|101759237|FG003|Part 2|Never entered follow-up|0|||
33509227|NCT00537316|101759238|FG004|Part 2|Never entered follow-up|0|||
33509228|NCT00537316|101759239|FG005|Part 2|Never entered follow-up|0|||
33509229|NCT00537316|101759240|FG006|Part 2|Never entered follow-up|1|||
33509230|NCT00537316|101759234|FG000|Part 2|Adverse Event|4|||
33509231|NCT00537316|101759235|FG001|Part 2|Adverse Event|0|||
33604790|NCT02391961|102102758|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
33509232|NCT00537316|101759236|FG002|Part 2|Adverse Event|2|||
33509233|NCT00537316|101759237|FG003|Part 2|Adverse Event|0|||
33509234|NCT00537316|101759238|FG004|Part 2|Adverse Event|0|||
33509235|NCT00537316|101759239|FG005|Part 2|Adverse Event|0|||
33509236|NCT00537316|101759240|FG006|Part 2|Adverse Event|0|||
33509237|NCT00537316|101759234|FG000|Part 2|Lost to Follow-up|1|||
33509238|NCT00537316|101759235|FG001|Part 2|Lost to Follow-up|0|||
33509239|NCT00537316|101759236|FG002|Part 2|Lost to Follow-up|2|||
33509240|NCT00537316|101759237|FG003|Part 2|Lost to Follow-up|0|||
33509241|NCT00537316|101759238|FG004|Part 2|Lost to Follow-up|0|||
33509242|NCT00537316|101759239|FG005|Part 2|Lost to Follow-up|0|||
33509243|NCT00537316|101759240|FG006|Part 2|Lost to Follow-up|0|||
33509244|NCT00537316|101759234|FG000|Part 2|Withdrawal by Subject|5|||
33509245|NCT00537316|101759235|FG001|Part 2|Withdrawal by Subject|1|||
33509246|NCT00537316|101759236|FG002|Part 2|Withdrawal by Subject|4|||
33509247|NCT00537316|101759237|FG003|Part 2|Withdrawal by Subject|0|||
33509248|NCT00537316|101759238|FG004|Part 2|Withdrawal by Subject|0|||
33509249|NCT00537316|101759239|FG005|Part 2|Withdrawal by Subject|0|||
33509250|NCT00537316|101759240|FG006|Part 2|Withdrawal by Subject|0|||
33509251|NCT00537316|101759234|FG000|Part 2|Administrative|16|||
33509252|NCT00537316|101759235|FG001|Part 2|Administrative|8|||
33509253|NCT00537316|101759236|FG002|Part 2|Administrative|24|||
33320282|NCT03250832|101069916|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
33320283|NCT03250832|101069917|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
33320284|NCT03250832|101069918|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
33320285|NCT03250832|101069919|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
33320286|NCT03250832|101069920|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
33320287|NCT03250832|101069921|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
33320288|NCT03250832|101069922|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
33509254|NCT00537316|101759237|FG003|Part 2|Administrative|3|||
33320289|NCT03250832|101069923|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
33320290|NCT03250832|101069912|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
33509255|NCT00537316|101759238|FG004|Part 2|Administrative|1|||
33509256|NCT00537316|101759239|FG005|Part 2|Administrative|4|||
33509257|NCT00537316|101759240|FG006|Part 2|Administrative|1|||
33509258|NCT03429244|101759241|FG000|Overall Study|Withdrawal by Subject|2|||
33509259|NCT03429244|101759242|FG001|Overall Study|Withdrawal by Subject|1|||
33509260|NCT03429244|101759243|FG002|Overall Study|Withdrawal by Subject|1|||
33509261|NCT03528369|101759244|FG000|Overall Study|Withdrawal by Subject|2|||
33509262|NCT03528369|101759245|FG001|Overall Study|Withdrawal by Subject|0|||
33509263|NCT03528369|101759246|FG002|Overall Study|Withdrawal by Subject|0|||
33509264|NCT03528369|101759244|FG000|Overall Study|Lost to Follow-up|1|||
33509265|NCT03528369|101759245|FG001|Overall Study|Lost to Follow-up|0|||
33509266|NCT03528369|101759246|FG002|Overall Study|Lost to Follow-up|0|||
33509267|NCT03528369|101759244|FG000|Overall Study|Adverse Event|0|||
33509268|NCT03528369|101759245|FG001|Overall Study|Adverse Event|1|||
33509269|NCT03528369|101759246|FG002|Overall Study|Adverse Event|0|||
33509270|NCT03514485|101759252|FG000|Overall Study|Lost to Follow-up|5|||
33509271|NCT03514485|101759253|FG001|Overall Study|Lost to Follow-up|3|||
33320291|NCT03250832|101069913|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
33320292|NCT03250832|101069914|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
33320293|NCT03250832|101069915|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
33320294|NCT03250832|101069916|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
33509272|NCT03514485|101759254|FG002|Overall Study|Lost to Follow-up|2|||
33509273|NCT03514485|101759255|FG003|Overall Study|Lost to Follow-up|0|||
33509274|NCT03514485|101759256|FG004|Overall Study|Lost to Follow-up|1|||
33509275|NCT03514485|101759257|FG005|Overall Study|Lost to Follow-up|4|||
33509276|NCT03514485|101759252|FG000|Overall Study|Withdrawal by Subject|0|||
33509277|NCT03514485|101759253|FG001|Overall Study|Withdrawal by Subject|1|||
33509278|NCT03514485|101759254|FG002|Overall Study|Withdrawal by Subject|3|||
33509279|NCT03514485|101759255|FG003|Overall Study|Withdrawal by Subject|1|||
33509280|NCT03514485|101759256|FG004|Overall Study|Withdrawal by Subject|2|||
33509281|NCT03514485|101759257|FG005|Overall Study|Withdrawal by Subject|1|||
33509282|NCT04696354|101759258|FG000|Overall Study|Study termination|6|||
33509283|NCT04696354|101759259|FG001|Overall Study|Study termination|6|||
33509284|NCT00068393|101759262|FG000|Overall Study|Adverse Event|2|||
33509285|NCT00068393|101759262|FG000|Overall Study|Death|3|||
33509286|NCT00068393|101759262|FG000|Overall Study|Withdrawal by Subject|3|||
33509287|NCT00068393|101759262|FG000|Overall Study|Alternative treatment|1|||
33509288|NCT00068393|101759262|FG000|Overall Study|Quality of life worsening|1|||
33509289|NCT03124407|101759263|FG000|Overall Study|Lost to Follow-up|1|||
33509290|NCT03124407|101759264|FG001|Overall Study|Lost to Follow-up|0|||
33509291|NCT03124407|101759265|FG002|Overall Study|Lost to Follow-up|0|||
33509292|NCT03124407|101759266|FG003|Overall Study|Lost to Follow-up|0|||
33509293|NCT03124407|101759263|FG000|Overall Study|Adverse Event|0|||
33509294|NCT03124407|101759264|FG001|Overall Study|Adverse Event|0|||
33509295|NCT03124407|101759265|FG002|Overall Study|Adverse Event|1|||
33509296|NCT03124407|101759266|FG003|Overall Study|Adverse Event|0|||
33509297|NCT03395184|101759267|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
33509298|NCT03395184|101759268|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
33509299|NCT03395184|101759269|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
33509300|NCT03395184|101759270|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
33509301|NCT03395184|101759271|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
33509302|NCT03395184|101759272|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
33509303|NCT03395184|101759273|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
33320295|NCT03250832|101069917|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
33320296|NCT03250832|101069918|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
33320297|NCT03250832|101069919|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
33320298|NCT03250832|101069920|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
33320299|NCT03250832|101069921|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
33320300|NCT03250832|101069922|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
33320301|NCT03250832|101069923|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
33320302|NCT03250832|101069912|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
33320303|NCT03250832|101069913|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
33320304|NCT03250832|101069914|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
33320305|NCT03250832|101069915|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
33320306|NCT03250832|101069916|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
33509304|NCT03395184|101759267|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
33509305|NCT03395184|101759268|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
33509306|NCT03395184|101759269|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
33509307|NCT03395184|101759270|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
33509308|NCT03395184|101759271|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
33509309|NCT03395184|101759272|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
33509310|NCT03395184|101759273|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
33509311|NCT03395184|101759267|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
33509312|NCT03395184|101759268|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
33509313|NCT03395184|101759269|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
33509314|NCT03395184|101759270|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
33509315|NCT03395184|101759271|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
33509316|NCT03395184|101759272|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
33509317|NCT03395184|101759273|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
33509318|NCT03395184|101759267|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
33509319|NCT03395184|101759268|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
33509320|NCT03395184|101759269|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
33509321|NCT03395184|101759270|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
33509322|NCT03395184|101759271|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
33509323|NCT03395184|101759272|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
33509324|NCT03395184|101759273|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
33509325|NCT03395184|101759267|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
33509326|NCT03395184|101759268|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33509327|NCT03395184|101759269|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
33509328|NCT03395184|101759270|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33509329|NCT03395184|101759271|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33509330|NCT03395184|101759272|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33509331|NCT03395184|101759273|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33509332|NCT03395184|101759267|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
33509333|NCT03395184|101759268|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
33509334|NCT03395184|101759269|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
33509335|NCT03395184|101759270|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
33509336|NCT03395184|101759271|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
33509337|NCT03395184|101759272|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
33509338|NCT03395184|101759273|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
33509339|NCT03395184|101759267|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
33509340|NCT03395184|101759268|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
33509341|NCT03395184|101759269|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
33509342|NCT03395184|101759270|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
33509343|NCT03395184|101759271|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
33509344|NCT03395184|101759272|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
33509345|NCT03395184|101759273|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
33509346|NCT03395184|101759267|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
33509347|NCT03395184|101759268|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
33509348|NCT03395184|101759269|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
33509349|NCT03395184|101759270|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
33509350|NCT03395184|101759271|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
33509351|NCT03395184|101759272|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
33509352|NCT03395184|101759273|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
33509353|NCT03395184|101759267|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
33509354|NCT03395184|101759268|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
33509355|NCT03395184|101759269|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
33509356|NCT03395184|101759270|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
33509357|NCT03395184|101759271|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
33509358|NCT03395184|101759272|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
33509359|NCT03395184|101759273|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
33509360|NCT03395184|101759267|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
33509361|NCT03395184|101759268|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
33509362|NCT03395184|101759269|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
33509363|NCT03395184|101759270|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
33509364|NCT03395184|101759271|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
33509365|NCT03395184|101759272|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
33509366|NCT03395184|101759273|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
33509367|NCT03395184|101759267|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
33509368|NCT03395184|101759268|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
33509369|NCT03395184|101759269|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
33509370|NCT03395184|101759270|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
33509371|NCT03395184|101759271|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
33509372|NCT03395184|101759272|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
33509373|NCT03395184|101759273|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
33509374|NCT03395184|101759267|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
33509375|NCT03395184|101759268|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
33509376|NCT03395184|101759269|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
33320307|NCT03250832|101069917|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
33509377|NCT03395184|101759270|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
33509378|NCT03395184|101759271|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
33509379|NCT03395184|101759272|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
33509380|NCT03395184|101759273|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
33509381|NCT03339726|101759274|FG000|Overall Study|Withdrawal by Subject|1|||
33509382|NCT03339726|101759275|FG001|Overall Study|Withdrawal by Subject|0|||
33509383|NCT03339726|101759276|FG002|Overall Study|Withdrawal by Subject|0|||
33509384|NCT03339726|101759274|FG000|Overall Study|Lost to Follow-up|0|||
33509385|NCT03339726|101759275|FG001|Overall Study|Lost to Follow-up|1|||
33509386|NCT03339726|101759276|FG002|Overall Study|Lost to Follow-up|0|||
33509387|NCT00729157|101759277|FG000|Overall Study|Withdrawal by Subject|1|||
33509388|NCT02980341|101759280|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
33509389|NCT02980341|101759281|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
33509390|NCT02980341|101759282|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
33509391|NCT02980341|101759283|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
33509392|NCT02980341|101759284|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
33509393|NCT02980341|101759285|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
33509394|NCT02980341|101759286|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
33509395|NCT02980341|101759287|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
33509396|NCT02980341|101759288|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
33509397|NCT02980341|101759289|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
33509398|NCT02980341|101759290|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
33509399|NCT02980341|101759280|FG000|Dose Escalation|Clinical progression|0|||
33509400|NCT02980341|101759281|FG001|Dose Escalation|Clinical progression|0|||
33509401|NCT02980341|101759282|FG002|Dose Escalation|Clinical progression|2|||
33509402|NCT02980341|101759283|FG003|Dose Escalation|Clinical progression|1|||
33509403|NCT02980341|101759284|FG004|Dose Escalation|Clinical progression|0|||
33509404|NCT02980341|101759285|FG005|Dose Escalation|Clinical progression|0|||
33509405|NCT02980341|101759286|FG006|Dose Escalation|Clinical progression|0|||
33509406|NCT02980341|101759287|FG007|Dose Escalation|Clinical progression|0|||
33509407|NCT02980341|101759288|FG008|Dose Escalation|Clinical progression|0|||
33509408|NCT02980341|101759289|FG009|Dose Escalation|Clinical progression|0|||
33509409|NCT02980341|101759290|FG010|Dose Escalation|Clinical progression|0|||
33509410|NCT02980341|101759280|FG000|Dose Escalation|Adverse Event|0|||
33509411|NCT02980341|101759281|FG001|Dose Escalation|Adverse Event|0|||
33509412|NCT02980341|101759282|FG002|Dose Escalation|Adverse Event|1|||
33509413|NCT02980341|101759283|FG003|Dose Escalation|Adverse Event|2|||
33509414|NCT02980341|101759284|FG004|Dose Escalation|Adverse Event|2|||
33509415|NCT02980341|101759285|FG005|Dose Escalation|Adverse Event|0|||
33509416|NCT02980341|101759286|FG006|Dose Escalation|Adverse Event|0|||
33509417|NCT02980341|101759287|FG007|Dose Escalation|Adverse Event|0|||
33509418|NCT02980341|101759288|FG008|Dose Escalation|Adverse Event|0|||
33509419|NCT02980341|101759289|FG009|Dose Escalation|Adverse Event|0|||
33509420|NCT02980341|101759290|FG010|Dose Escalation|Adverse Event|0|||
33509421|NCT02980341|101759280|FG000|Dose Escalation|Withdrawal by Subject|0|||
33509422|NCT02980341|101759281|FG001|Dose Escalation|Withdrawal by Subject|0|||
33509423|NCT02980341|101759282|FG002|Dose Escalation|Withdrawal by Subject|1|||
33509424|NCT02980341|101759283|FG003|Dose Escalation|Withdrawal by Subject|0|||
33509425|NCT02980341|101759284|FG004|Dose Escalation|Withdrawal by Subject|0|||
33509426|NCT02980341|101759285|FG005|Dose Escalation|Withdrawal by Subject|0|||
33509427|NCT02980341|101759286|FG006|Dose Escalation|Withdrawal by Subject|0|||
33509428|NCT02980341|101759287|FG007|Dose Escalation|Withdrawal by Subject|0|||
33509429|NCT02980341|101759288|FG008|Dose Escalation|Withdrawal by Subject|0|||
33509430|NCT02980341|101759289|FG009|Dose Escalation|Withdrawal by Subject|0|||
33509431|NCT02980341|101759290|FG010|Dose Escalation|Withdrawal by Subject|0|||
33509432|NCT02980341|101759280|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
33509433|NCT02980341|101759281|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
33509434|NCT02980341|101759282|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
33509435|NCT02980341|101759283|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
33509436|NCT02980341|101759284|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
33509437|NCT02980341|101759285|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
33509438|NCT02980341|101759286|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
33509439|NCT02980341|101759287|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
33509440|NCT02980341|101759288|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
33509441|NCT02980341|101759289|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
33509442|NCT02980341|101759290|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
33509443|NCT02980341|101759280|FG000|Dose Escalation|Due to investigator's decision|0|||
33509444|NCT02980341|101759281|FG001|Dose Escalation|Due to investigator's decision|0|||
33509445|NCT02980341|101759282|FG002|Dose Escalation|Due to investigator's decision|0|||
33509446|NCT02980341|101759283|FG003|Dose Escalation|Due to investigator's decision|0|||
33320308|NCT03250832|101069918|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
33509447|NCT02980341|101759284|FG004|Dose Escalation|Due to investigator's decision|1|||
33509448|NCT02980341|101759285|FG005|Dose Escalation|Due to investigator's decision|0|||
33197865|NCT00938431|100626664|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
33197866|NCT00938431|100626665|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
33320309|NCT03250832|101069919|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
33320310|NCT03250832|101069920|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
33320311|NCT03250832|101069921|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
33320312|NCT03250832|101069922|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
33320313|NCT03250832|101069923|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
33320314|NCT03250832|101069912|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
33320315|NCT03250832|101069913|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
33320316|NCT03250832|101069914|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
33320317|NCT03250832|101069915|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
33320318|NCT03250832|101069916|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
33320319|NCT03250832|101069917|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
33320320|NCT03250832|101069918|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
33320321|NCT03250832|101069919|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
33398799|NCT02371980|101350126|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
33509449|NCT02980341|101759286|FG006|Dose Escalation|Due to investigator's decision|0|||
33604791|NCT02391961|102102759|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
33604792|NCT02391961|102102758|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
33604793|NCT02391961|102102759|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
33604794|NCT02391961|102102758|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
33604795|NCT02391961|102102759|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
33604796|NCT02565810|102102760|FG000|Overall Study|Withdrawal by Subject|1|||
33604797|NCT04033068|102102761|FG000|Overall Study|Withdrawal by Subject|0|||
33604798|NCT04033068|102102762|FG001|Overall Study|Withdrawal by Subject|0|||
33604799|NCT04033068|102102763|FG002|Overall Study|Withdrawal by Subject|1|||
33604800|NCT04033068|102102764|FG003|Overall Study|Withdrawal by Subject|0|||
33604801|NCT04033068|102102761|FG000|Overall Study|Lost to Follow-up|0|||
33509450|NCT02980341|101759287|FG007|Dose Escalation|Due to investigator's decision|0|||
33509451|NCT02980341|101759288|FG008|Dose Escalation|Due to investigator's decision|0|||
33509452|NCT02980341|101759289|FG009|Dose Escalation|Due to investigator's decision|0|||
33509453|NCT02980341|101759290|FG010|Dose Escalation|Due to investigator's decision|0|||
33509454|NCT02980341|101759280|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
33509455|NCT02980341|101759281|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
33509456|NCT02980341|101759282|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
33509457|NCT02980341|101759283|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
33509458|NCT02980341|101759284|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
33509459|NCT02980341|101759285|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
33509460|NCT02980341|101759286|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
33509461|NCT02980341|101759287|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
33509462|NCT02980341|101759288|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
33509463|NCT02980341|101759289|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
33509464|NCT02980341|101759290|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
33509465|NCT02980341|101759280|FG000|Dose Finding|Adverse Event|0|||
33509466|NCT02980341|101759281|FG001|Dose Finding|Adverse Event|0|||
33604802|NCT04033068|102102762|FG001|Overall Study|Lost to Follow-up|1|||
33604803|NCT04033068|102102763|FG002|Overall Study|Lost to Follow-up|0|||
33604804|NCT04033068|102102764|FG003|Overall Study|Lost to Follow-up|0|||
33604805|NCT04033068|102102761|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
33604806|NCT04033068|102102762|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
33604807|NCT04033068|102102763|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
33604808|NCT04033068|102102764|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
33604809|NCT01291277|102102765|FG000|Overall Study|Death|2|||
33604810|NCT01291277|102102766|FG001|Overall Study|Death|2|||
33604811|NCT01291277|102102765|FG000|Overall Study|Lost to Follow-up|3|||
33604812|NCT01291277|102102766|FG001|Overall Study|Lost to Follow-up|1|||
33604813|NCT00007020|102102767|FG000|Overall Study|Death|16|||
33604814|NCT00007020|102102767|FG000|Overall Study|Lost to Follow-up|13|||
33604815|NCT00007020|102102767|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
33604816|NCT00007020|102102767|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
33604817|NCT00007020|102102767|FG000|Overall Study|Pt cared for by outside physician|4|||
33604818|NCT00007020|102102767|FG000|Overall Study|No evidence of treatment|6|||
33631269|NCT03279081|102202899|FG000|Overall Study|Withdrawal by Subject|12|||
33631270|NCT03279081|102202900|FG001|Overall Study|Withdrawal by Subject|20|||
33631271|NCT03279081|102202899|FG000|Overall Study|Physician Decision|4|||
33631272|NCT03279081|102202900|FG001|Overall Study|Physician Decision|1|||
33631273|NCT03279081|102202899|FG000|Overall Study|Lost to Follow-up|8|||
33197867|NCT00938431|100626663|FG000|Overall Study|Dosing compliance issue|0|||
33197868|NCT00938431|100626664|FG001|Overall Study|Dosing compliance issue|0|||
33509467|NCT02980341|101759282|FG002|Dose Finding|Adverse Event|0|||
33320322|NCT03250832|101069920|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
33320323|NCT03250832|101069921|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
33320324|NCT03250832|101069922|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
33320325|NCT03250832|101069923|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
33320326|NCT03250832|101069912|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
33320327|NCT03250832|101069913|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
33320328|NCT03250832|101069914|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
33320329|NCT03250832|101069915|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
33320330|NCT03250832|101069916|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
33320331|NCT03250832|101069917|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
33320332|NCT03250832|101069918|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
33320333|NCT03250832|101069919|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
33320334|NCT03250832|101069920|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
33320335|NCT03250832|101069921|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
33320336|NCT03250832|101069922|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
33320337|NCT03250832|101069923|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
33320338|NCT03250832|101069912|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
33320339|NCT03250832|101069913|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
33320340|NCT03250832|101069914|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
33320341|NCT03250832|101069915|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
33320342|NCT03250832|101069916|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
33320343|NCT03250832|101069917|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
33320344|NCT03250832|101069918|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
33320345|NCT03250832|101069919|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
33320346|NCT03250832|101069920|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
33320347|NCT03250832|101069921|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
33320348|NCT03250832|101069922|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
33320349|NCT03250832|101069923|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
33320350|NCT02673619|101069924|FG000|Overall Study|Lost to Follow-up|1|||
33320351|NCT02673619|101069925|FG001|Overall Study|Lost to Follow-up|0|||
33320352|NCT02673619|101069926|FG002|Overall Study|Lost to Follow-up|0|||
33320353|NCT02673619|101069927|FG003|Overall Study|Lost to Follow-up|0|||
33320354|NCT02673619|101069924|FG000|Overall Study|Withdrawal by Subject|1|||
33320355|NCT02673619|101069925|FG001|Overall Study|Withdrawal by Subject|1|||
33320356|NCT02673619|101069926|FG002|Overall Study|Withdrawal by Subject|1|||
33320357|NCT02673619|101069927|FG003|Overall Study|Withdrawal by Subject|0|||
33320358|NCT02673619|101069924|FG000|Overall Study|Adverse Event|0|||
33320359|NCT02673619|101069925|FG001|Overall Study|Adverse Event|0|||
33320360|NCT02673619|101069926|FG002|Overall Study|Adverse Event|1|||
33320361|NCT02673619|101069927|FG003|Overall Study|Adverse Event|0|||
33320362|NCT02673619|101069924|FG000|Overall Study|Lack of Efficacy|0|||
33320363|NCT02673619|101069925|FG001|Overall Study|Lack of Efficacy|0|||
33320364|NCT02673619|101069926|FG002|Overall Study|Lack of Efficacy|1|||
33320365|NCT02673619|101069927|FG003|Overall Study|Lack of Efficacy|0|||
33320366|NCT00352885|101069928|FG000|Overall Study|Withdrawal by Subject|0|||
33320367|NCT00352885|101069929|FG001|Overall Study|Withdrawal by Subject|3|||
33398800|NCT02371980|101350127|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
33509468|NCT02980341|101759283|FG003|Dose Finding|Adverse Event|0|||
33509469|NCT02980341|101759284|FG004|Dose Finding|Adverse Event|0|||
33320368|NCT00352885|101069928|FG000|Overall Study|Development of major depression|0|||
33320369|NCT00352885|101069929|FG001|Overall Study|Development of major depression|1|||
33398801|NCT02371980|101350128|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
33398802|NCT02371980|101350124|FG000|Double-blind Period|Significant Protocol Deviation|0|||
33398803|NCT02371980|101350125|FG001|Double-blind Period|Significant Protocol Deviation|2|||
33398804|NCT02371980|101350126|FG002|Double-blind Period|Significant Protocol Deviation|7|||
33398805|NCT02371980|101350127|FG003|Double-blind Period|Significant Protocol Deviation|3|||
33398806|NCT02371980|101350128|FG004|Double-blind Period|Significant Protocol Deviation|3|||
33398807|NCT02371980|101350124|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
33398808|NCT02371980|101350125|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
33398809|NCT02371980|101350126|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
33398810|NCT02371980|101350127|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
33398811|NCT02371980|101350128|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
33398812|NCT02371980|101350124|FG000|Double-blind Period|Lost to Follow-up|0|||
33398813|NCT02371980|101350125|FG001|Double-blind Period|Lost to Follow-up|8|||
33398814|NCT02371980|101350126|FG002|Double-blind Period|Lost to Follow-up|8|||
33398815|NCT02371980|101350127|FG003|Double-blind Period|Lost to Follow-up|6|||
33398816|NCT02371980|101350128|FG004|Double-blind Period|Lost to Follow-up|5|||
33398817|NCT02371980|101350124|FG000|Double-blind Period|Voluntary Withdrawal|0|||
33509470|NCT02980341|101759285|FG005|Dose Finding|Adverse Event|3|||
33320370|NCT00352885|101069928|FG000|Overall Study|Progression of metastatic melanoma|5|||
33320371|NCT00352885|101069929|FG001|Overall Study|Progression of metastatic melanoma|3|||
33320372|NCT00352885|101069928|FG000|Overall Study|Side effects of IL-2 administration|1|||
33320373|NCT00352885|101069929|FG001|Overall Study|Side effects of IL-2 administration|0|||
33320374|NCT02877927|101069936|FG000|Overall Study|Adverse Event|1|||
33320375|NCT02877927|101069937|FG001|Overall Study|Adverse Event|0|||
33320376|NCT02877927|101069936|FG000|Overall Study|Lost to Follow-up|37|||
33320377|NCT02877927|101069937|FG001|Overall Study|Lost to Follow-up|38|||
33320378|NCT02877927|101069936|FG000|Overall Study|Withdrawal by Subject|11|||
33320379|NCT02877927|101069937|FG001|Overall Study|Withdrawal by Subject|12|||
33320380|NCT02877927|101069936|FG000|Overall Study|Physician Decision|0|||
33320381|NCT02877927|101069937|FG001|Overall Study|Physician Decision|1|||
33320382|NCT02877927|101069936|FG000|Overall Study|Missed EOT/PTE Visit|5|||
33320383|NCT02877927|101069937|FG001|Overall Study|Missed EOT/PTE Visit|6|||
33320384|NCT05116046|101069938|FG000|Overall Study|Withdrawal by parent/guardian|2|||
33320385|NCT05116046|101069939|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33320386|NCT05116046|101069940|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33320387|NCT05116046|101069938|FG000|Overall Study|Study terminated by sponsor|14|||
33320388|NCT05116046|101069939|FG001|Overall Study|Study terminated by sponsor|16|||
33320389|NCT05116046|101069940|FG002|Overall Study|Study terminated by sponsor|1|||
33320390|NCT00795951|101069941|FG000|Overall Study|Lost to Follow-up|1|||
33320391|NCT00795951|101069941|FG000|Overall Study|Withdrawal by Subject|1|||
33320392|NCT01678209|101069947|FG000|Overall Study|could not scan twice|1|||
33320393|NCT01678209|101069948|FG001|Overall Study|could not scan twice|1|||
33320394|NCT01678209|101069949|FG002|Overall Study|could not scan twice|1|||
33320395|NCT01678209|101069947|FG000|Overall Study|scheduling conflicts|0|||
33320396|NCT01678209|101069948|FG001|Overall Study|scheduling conflicts|0|||
33320397|NCT01678209|101069949|FG002|Overall Study|scheduling conflicts|1|||
33320398|NCT01678209|101069947|FG000|Overall Study|screen fail|16|||
33320399|NCT01678209|101069948|FG001|Overall Study|screen fail|17|||
33320400|NCT01678209|101069949|FG002|Overall Study|screen fail|16|||
33320401|NCT03027557|101069950|FG000|Overall Study|Adverse Event|1|||
33320402|NCT03027557|101069951|FG001|Overall Study|Adverse Event|0|||
33320403|NCT03027557|101069952|FG002|Overall Study|Adverse Event|0|||
33320404|NCT00596934|101069953|FG000|Overall Study|Protocol Violation|1|||
33320405|NCT00596934|101069953|FG000|Overall Study|Withdrawal by Subject|1|||
33320406|NCT01920594|101069956|FG000|Overall Study|Adverse Event|4|||
33320407|NCT01920594|101069957|FG001|Overall Study|Adverse Event|2|||
33320408|NCT01920594|101069956|FG000|Overall Study|Lost to Follow-up|1|||
33320409|NCT01920594|101069957|FG001|Overall Study|Lost to Follow-up|0|||
33320410|NCT01920594|101069956|FG000|Overall Study|Recovery|2|||
33320411|NCT01920594|101069957|FG001|Overall Study|Recovery|0|||
33320412|NCT01920594|101069956|FG000|Overall Study|Investigator discretion|0|||
33320413|NCT01920594|101069957|FG001|Overall Study|Investigator discretion|1|||
33320414|NCT01241552|101069958|FG000|Overall Study|Lack of Efficacy|1|||
33320415|NCT01241552|101069959|FG001|Overall Study|Lack of Efficacy|0|||
33320416|NCT01241552|101069960|FG002|Overall Study|Lack of Efficacy|0|||
33320417|NCT01241552|101069961|FG003|Overall Study|Lack of Efficacy|0|||
33320418|NCT01241552|101069958|FG000|Overall Study|Death|26|||
33320419|NCT01241552|101069959|FG001|Overall Study|Death|30|||
33604819|NCT00548717|102105350|FG000|Overall Study|Death|5|||
33604820|NCT00548717|102105351|FG001|Overall Study|Death|2|||
33604821|NCT00548717|102105350|FG000|Overall Study|Relapse|3|||
33604822|NCT00548717|102105351|FG001|Overall Study|Relapse|0|||
33604823|NCT00548717|102105350|FG000|Overall Study|Alternative treatment for GVHD|1|||
33604824|NCT00548717|102105351|FG001|Overall Study|Alternative treatment for GVHD|0|||
33320420|NCT01241552|101069960|FG002|Overall Study|Death|20|||
33320421|NCT01241552|101069961|FG003|Overall Study|Death|25|||
33320422|NCT01241552|101069958|FG000|Overall Study|Adverse Event|1|||
33320423|NCT01241552|101069959|FG001|Overall Study|Adverse Event|1|||
33320424|NCT01241552|101069960|FG002|Overall Study|Adverse Event|0|||
33320425|NCT01241552|101069961|FG003|Overall Study|Adverse Event|0|||
33320426|NCT01241552|101069958|FG000|Overall Study|Technical Problems|2|||
33320427|NCT01241552|101069959|FG001|Overall Study|Technical Problems|0|||
33320428|NCT01241552|101069960|FG002|Overall Study|Technical Problems|2|||
33320429|NCT01241552|101069961|FG003|Overall Study|Technical Problems|2|||
33320430|NCT01241552|101069958|FG000|Overall Study|Progressive Disease|0|||
33320431|NCT01241552|101069959|FG001|Overall Study|Progressive Disease|0|||
33604825|NCT01263015|102105352|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
33320432|NCT01241552|101069960|FG002|Overall Study|Progressive Disease|1|||
33320433|NCT01241552|101069961|FG003|Overall Study|Progressive Disease|2|||
33320434|NCT01241552|101069958|FG000|Overall Study|Protocol Violation|0|||
33320435|NCT01241552|101069959|FG001|Overall Study|Protocol Violation|2|||
33320436|NCT01241552|101069960|FG002|Overall Study|Protocol Violation|6|||
33320437|NCT01241552|101069961|FG003|Overall Study|Protocol Violation|1|||
33320438|NCT01241552|101069958|FG000|Overall Study|Withdrawal by Subject|7|||
33320439|NCT01241552|101069959|FG001|Overall Study|Withdrawal by Subject|15|||
33320440|NCT01241552|101069960|FG002|Overall Study|Withdrawal by Subject|14|||
33320441|NCT01241552|101069961|FG003|Overall Study|Withdrawal by Subject|15|||
33320442|NCT01241552|101069958|FG000|Overall Study|Physician Decision|2|||
33320443|NCT01241552|101069959|FG001|Overall Study|Physician Decision|4|||
33604826|NCT01263015|102105353|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
33604827|NCT01263015|102105352|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
33604828|NCT01263015|102105353|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
33604829|NCT01263015|102105352|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
33604830|NCT01263015|102105353|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
33604831|NCT01263015|102105352|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
33604832|NCT01263015|102105353|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
33604833|NCT01263015|102105352|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
33604834|NCT01263015|102105353|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
33604835|NCT01263015|102105352|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
33320444|NCT01241552|101069960|FG002|Overall Study|Physician Decision|2|||
33320445|NCT01241552|101069961|FG003|Overall Study|Physician Decision|3|||
33320446|NCT01241552|101069958|FG000|Overall Study|Lost to Follow-up|2|||
33320447|NCT01241552|101069959|FG001|Overall Study|Lost to Follow-up|11|||
33320448|NCT01241552|101069960|FG002|Overall Study|Lost to Follow-up|15|||
33320449|NCT01241552|101069961|FG003|Overall Study|Lost to Follow-up|16|||
33320450|NCT01386658|101069962|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
33320451|NCT01386658|101069963|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
33320452|NCT01386658|101069962|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
33320453|NCT01386658|101069963|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
33320454|NCT02119325|101069964|FG000|Washout Period 1|Adverse Event|0|||
33320455|NCT02119325|101069965|FG001|Washout Period 1|Adverse Event|1|||
33509471|NCT02980341|101759286|FG006|Dose Finding|Adverse Event|0|||
33509472|NCT02980341|101759287|FG007|Dose Finding|Adverse Event|0|||
33509473|NCT02980341|101759288|FG008|Dose Finding|Adverse Event|0|||
33509474|NCT02980341|101759289|FG009|Dose Finding|Adverse Event|0|||
33604836|NCT01263015|102105353|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
33604837|NCT01263015|102105352|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
33604838|NCT01263015|102105353|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
33320456|NCT02921269|101069966|FG000|Overall Study|Did not complete DLT period|1|||
33509475|NCT02980341|101759290|FG010|Dose Finding|Adverse Event|0|||
33509476|NCT02980341|101759280|FG000|Dose Finding|Withdrawal by Subject|0|||
33509477|NCT02980341|101759281|FG001|Dose Finding|Withdrawal by Subject|0|||
33509478|NCT02980341|101759282|FG002|Dose Finding|Withdrawal by Subject|0|||
33509479|NCT02980341|101759283|FG003|Dose Finding|Withdrawal by Subject|0|||
33509480|NCT02980341|101759284|FG004|Dose Finding|Withdrawal by Subject|0|||
33509481|NCT02980341|101759285|FG005|Dose Finding|Withdrawal by Subject|1|||
33509482|NCT02980341|101759286|FG006|Dose Finding|Withdrawal by Subject|1|||
33509483|NCT02980341|101759287|FG007|Dose Finding|Withdrawal by Subject|0|||
33509484|NCT02980341|101759288|FG008|Dose Finding|Withdrawal by Subject|0|||
33509485|NCT02980341|101759289|FG009|Dose Finding|Withdrawal by Subject|0|||
33509486|NCT02980341|101759290|FG010|Dose Finding|Withdrawal by Subject|0|||
33509487|NCT02980341|101759280|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
33509488|NCT02980341|101759281|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
33509489|NCT02980341|101759282|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
33509490|NCT02980341|101759283|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
33509491|NCT02980341|101759284|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
33509492|NCT02980341|101759285|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
33509493|NCT02980341|101759286|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
33509494|NCT02980341|101759287|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
33509495|NCT02980341|101759288|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
33509496|NCT02980341|101759289|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
33509497|NCT02980341|101759290|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
33509498|NCT02980341|101759280|FG000|Dose Expansion|Clinical progression|0|||
33604839|NCT01263015|102105352|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
33604840|NCT01263015|102105353|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
33604841|NCT01263015|102105352|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
33320457|NCT03434353|101069967|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
33320458|NCT03434353|101069968|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
33320459|NCT03434353|101069969|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
33320460|NCT03434353|101069970|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
33320461|NCT03434353|101069971|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
33509499|NCT02980341|101759281|FG001|Dose Expansion|Clinical progression|0|||
33509500|NCT02980341|101759282|FG002|Dose Expansion|Clinical progression|0|||
33509501|NCT02980341|101759283|FG003|Dose Expansion|Clinical progression|0|||
33509502|NCT02980341|101759284|FG004|Dose Expansion|Clinical progression|0|||
33509503|NCT02980341|101759285|FG005|Dose Expansion|Clinical progression|0|||
33509504|NCT02980341|101759286|FG006|Dose Expansion|Clinical progression|0|||
33509505|NCT02980341|101759287|FG007|Dose Expansion|Clinical progression|4|||
33509506|NCT02980341|101759288|FG008|Dose Expansion|Clinical progression|3|||
33509507|NCT02980341|101759289|FG009|Dose Expansion|Clinical progression|1|||
33509508|NCT02980341|101759290|FG010|Dose Expansion|Clinical progression|4|||
33509509|NCT02980341|101759280|FG000|Dose Expansion|Adverse Event|0|||
33509510|NCT02980341|101759281|FG001|Dose Expansion|Adverse Event|0|||
33509511|NCT02980341|101759282|FG002|Dose Expansion|Adverse Event|0|||
33509512|NCT02980341|101759283|FG003|Dose Expansion|Adverse Event|0|||
33509513|NCT02980341|101759284|FG004|Dose Expansion|Adverse Event|0|||
33509514|NCT02980341|101759285|FG005|Dose Expansion|Adverse Event|0|||
33509515|NCT02980341|101759286|FG006|Dose Expansion|Adverse Event|0|||
33509516|NCT02980341|101759287|FG007|Dose Expansion|Adverse Event|3|||
33509517|NCT02980341|101759288|FG008|Dose Expansion|Adverse Event|0|||
33509518|NCT02980341|101759289|FG009|Dose Expansion|Adverse Event|1|||
33509519|NCT02980341|101759290|FG010|Dose Expansion|Adverse Event|3|||
33509520|NCT02980341|101759280|FG000|Dose Expansion|Death|0|||
33509521|NCT02980341|101759281|FG001|Dose Expansion|Death|0|||
33509522|NCT02980341|101759282|FG002|Dose Expansion|Death|0|||
33509523|NCT02980341|101759283|FG003|Dose Expansion|Death|0|||
33509524|NCT02980341|101759284|FG004|Dose Expansion|Death|0|||
33509525|NCT02980341|101759285|FG005|Dose Expansion|Death|0|||
33509526|NCT02980341|101759286|FG006|Dose Expansion|Death|0|||
33509527|NCT02980341|101759287|FG007|Dose Expansion|Death|0|||
33509528|NCT02980341|101759288|FG008|Dose Expansion|Death|2|||
33509529|NCT02980341|101759289|FG009|Dose Expansion|Death|1|||
33509530|NCT02980341|101759290|FG010|Dose Expansion|Death|0|||
33509531|NCT02980341|101759280|FG000|Dose Expansion|Withdrawal by Subject|0|||
33509532|NCT02980341|101759281|FG001|Dose Expansion|Withdrawal by Subject|0|||
33509533|NCT02980341|101759282|FG002|Dose Expansion|Withdrawal by Subject|0|||
33509534|NCT02980341|101759283|FG003|Dose Expansion|Withdrawal by Subject|0|||
33509535|NCT02980341|101759284|FG004|Dose Expansion|Withdrawal by Subject|0|||
33509536|NCT02980341|101759285|FG005|Dose Expansion|Withdrawal by Subject|0|||
33509537|NCT02980341|101759286|FG006|Dose Expansion|Withdrawal by Subject|0|||
33509538|NCT02980341|101759287|FG007|Dose Expansion|Withdrawal by Subject|2|||
33509539|NCT02980341|101759288|FG008|Dose Expansion|Withdrawal by Subject|0|||
33509540|NCT02980341|101759289|FG009|Dose Expansion|Withdrawal by Subject|1|||
33509541|NCT02980341|101759290|FG010|Dose Expansion|Withdrawal by Subject|0|||
33509542|NCT02980341|101759280|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
33509543|NCT02980341|101759281|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
33509544|NCT02980341|101759282|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
33509545|NCT02980341|101759283|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
33509546|NCT02980341|101759284|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
33509547|NCT02980341|101759285|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
33509548|NCT02980341|101759286|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
33509549|NCT02980341|101759287|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
33509550|NCT02980341|101759288|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
33509551|NCT02980341|101759289|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
33509552|NCT02980341|101759290|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
33509553|NCT02980341|101759280|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
33509554|NCT02980341|101759281|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
33509555|NCT02980341|101759282|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
33509556|NCT02980341|101759283|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
33509557|NCT02980341|101759284|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
33509558|NCT02980341|101759285|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
33509559|NCT02980341|101759286|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
33509560|NCT02980341|101759287|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
33509561|NCT02980341|101759288|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
33509562|NCT02980341|101759289|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
33509563|NCT02980341|101759290|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
33509564|NCT02980341|101759280|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
33509565|NCT02980341|101759281|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
33320462|NCT03434353|101069967|FG000|Overall Study|Withdrew consent|1|||
33320463|NCT03434353|101069968|FG001|Overall Study|Withdrew consent|0|||
33320464|NCT03434353|101069969|FG002|Overall Study|Withdrew consent|3|||
33320465|NCT03434353|101069970|FG003|Overall Study|Withdrew consent|0|||
33320466|NCT03434353|101069971|FG004|Overall Study|Withdrew consent|0|||
33320467|NCT03434353|101069967|FG000|Overall Study|Adverse Event|1|||
33320468|NCT03434353|101069968|FG001|Overall Study|Adverse Event|0|||
33320469|NCT03434353|101069969|FG002|Overall Study|Adverse Event|0|||
33320470|NCT03434353|101069970|FG003|Overall Study|Adverse Event|0|||
33320471|NCT03434353|101069971|FG004|Overall Study|Adverse Event|1|||
33320472|NCT03434353|101069967|FG000|Overall Study|Lost to Follow-up|2|||
33320473|NCT03434353|101069968|FG001|Overall Study|Lost to Follow-up|0|||
33320474|NCT03434353|101069969|FG002|Overall Study|Lost to Follow-up|0|||
33320475|NCT03434353|101069970|FG003|Overall Study|Lost to Follow-up|0|||
33320476|NCT03434353|101069971|FG004|Overall Study|Lost to Follow-up|0|||
33320477|NCT01118325|101069972|FG000|Overall Study|Adverse Event|1|||
33604842|NCT01263015|102105353|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
33320478|NCT01118325|101069973|FG001|Overall Study|Adverse Event|0|||
33320479|NCT01118325|101069974|FG002|Overall Study|Adverse Event|1|||
33320480|NCT00523718|101069975|FG000|Overall Study|Withdrawal by Subject|1|||
33320481|NCT00523718|101069976|FG001|Overall Study|Withdrawal by Subject|0|||
33320482|NCT00523718|101069975|FG000|Overall Study|Protocol Violation|2|||
33320483|NCT00523718|101069976|FG001|Overall Study|Protocol Violation|0|||
33320484|NCT01770912|101069978|FG000|Overall Study|Lost to Follow-up|2|||
33320485|NCT01770912|101069979|FG001|Overall Study|Lost to Follow-up|0|||
33320486|NCT01630434|101069980|FG000|Overall Study|Donor lungs turned down|1|||
33320487|NCT01630434|101069981|FG001|Overall Study|Donor lungs turned down|0|||
33320488|NCT01630434|101069980|FG000|Overall Study|Protocol Violation|9|||
33320489|NCT01630434|101069981|FG001|Overall Study|Protocol Violation|4|||
33320490|NCT01630434|101069980|FG000|Overall Study|Death|20|||
33320491|NCT01630434|101069981|FG001|Overall Study|Death|26|||
33320492|NCT03370471|101069982|FG000|Overall Study|Withdrawal by Subject|6|||
33320493|NCT03370471|101069983|FG001|Overall Study|Withdrawal by Subject|1|||
33320494|NCT03370471|101069982|FG000|Overall Study|Unable to access veins for blood draw|0|||
33320495|NCT03370471|101069983|FG001|Overall Study|Unable to access veins for blood draw|1|||
33320496|NCT03370471|101069982|FG000|Overall Study|Screen fail|1|||
33320497|NCT03370471|101069983|FG001|Overall Study|Screen fail|0|||
33320498|NCT00445068|101069991|FG000|Overall Study|Disease progression|26|||
33320499|NCT00445068|101069991|FG000|Overall Study|Adverse Event|5|||
33320500|NCT00445068|101069991|FG000|Overall Study|Abnormal laboratory value|2|||
33320501|NCT00445068|101069991|FG000|Overall Study|Withdrawal by Subject|2|||
33320502|NCT00445068|101069991|FG000|Overall Study|Death|1|||
33320503|NCT02366728|101069992|FG000|Overall Study|Death|0|||
33320504|NCT02366728|101069993|FG001|Overall Study|Death|0|||
33320505|NCT02366728|101069994|FG002|Overall Study|Death|1|||
33320506|NCT02366728|101069992|FG000|Overall Study|Adverse Event|1|||
33320507|NCT02366728|101069993|FG001|Overall Study|Adverse Event|0|||
33320508|NCT02366728|101069994|FG002|Overall Study|Adverse Event|0|||
33320509|NCT02366728|101069992|FG000|Overall Study|Screen Failure|2|||
33320510|NCT02366728|101069993|FG001|Overall Study|Screen Failure|1|||
33320511|NCT02366728|101069994|FG002|Overall Study|Screen Failure|0|||
33320512|NCT02366728|101069992|FG000|Overall Study|Only yielded 2 vaccines|1|||
33320513|NCT02366728|101069993|FG001|Overall Study|Only yielded 2 vaccines|0|||
33320514|NCT02366728|101069994|FG002|Overall Study|Only yielded 2 vaccines|0|||
33320515|NCT02545322|101069995|FG000|Overall Study|Withdrawal by Subject|3|||
33604843|NCT01263015|102105352|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
33604844|NCT01263015|102105353|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
33320516|NCT02003014|101069998|FG000|Overall Study|Case report forms uncollected|9|||
33320517|NCT02003014|101069998|FG000|Overall Study|Treatment started after contract period|1|||
33320518|NCT02003014|101069998|FG000|Overall Study|Patient did not visit the study site|5|||
33320519|NCT02003014|101069998|FG000|Overall Study|Investigator's transfer|4|||
33320520|NCT00974090|101070003|FG000|Period 1: Double Blind Period|Adverse Event|2|||
33320521|NCT00974090|101070004|FG001|Period 1: Double Blind Period|Adverse Event|1|||
33320522|NCT00974090|101070003|FG000|Period 1: Double Blind Period|Physician Decision|1|||
33320523|NCT00974090|101070004|FG001|Period 1: Double Blind Period|Physician Decision|0|||
33320524|NCT00974090|101070003|FG000|Period 2: Open-label Period|Adverse Event|4|||
33320525|NCT00974090|101070004|FG001|Period 2: Open-label Period|Adverse Event|6|||
33398818|NCT02371980|101350125|FG001|Double-blind Period|Voluntary Withdrawal|12|||
33320526|NCT00974090|101070003|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
33398819|NCT02371980|101350126|FG002|Double-blind Period|Voluntary Withdrawal|8|||
33604845|NCT01263015|102105352|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
33320527|NCT00974090|101070004|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
33320528|NCT00974090|101070003|FG000|Period 2: Open-label Period|Physician Decision|0|||
33320529|NCT00974090|101070004|FG001|Period 2: Open-label Period|Physician Decision|3|||
33320530|NCT00974090|101070003|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
33320531|NCT00974090|101070004|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
33320532|NCT01399190|101070007|FG000|Overall Study|Not Eligible for Final Analysis|5|||
33509566|NCT02980341|101759282|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
33509567|NCT02980341|101759283|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
33509568|NCT02980341|101759284|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
33509569|NCT02980341|101759285|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
33509570|NCT02980341|101759286|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
33509571|NCT02980341|101759287|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
33509572|NCT02980341|101759288|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
33509573|NCT02980341|101759289|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
33509574|NCT02980341|101759290|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
33509575|NCT02980341|101759280|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
33509576|NCT02980341|101759281|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
33509577|NCT02980341|101759282|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
33509578|NCT02980341|101759283|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
33509579|NCT02980341|101759284|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
33509580|NCT02980341|101759285|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
33509581|NCT02980341|101759286|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
33509582|NCT02980341|101759287|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
33509583|NCT02980341|101759288|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
33509584|NCT02980341|101759289|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
33509585|NCT02980341|101759290|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
33509586|NCT02295020|101759291|FG000|Overall Study|Adverse Event|0|||
33509587|NCT02295020|101759292|FG001|Overall Study|Adverse Event|1|||
33509588|NCT02295020|101759291|FG000|Overall Study|Withdrawal by Subject|3|||
33509589|NCT02295020|101759292|FG001|Overall Study|Withdrawal by Subject|2|||
33509590|NCT01273623|101759301|FG000|Overall Study|did not meet IVUS criteria|29|||
33509591|NCT00160706|101759308|FG000|Overall Study|Adverse Event|53|||
33509592|NCT00160706|101759308|FG000|Overall Study|Adverse Event and Other Reason|105|||
33509593|NCT00160706|101759308|FG000|Overall Study|Protocol Violation|3|||
33509594|NCT00160706|101759308|FG000|Overall Study|Withdrawal by Subject|41|||
33509595|NCT00160706|101759308|FG000|Overall Study|Withdrawal by Subject and Other|12|||
33509596|NCT00160706|101759308|FG000|Overall Study|Physician Decision|10|||
33509597|NCT00160706|101759308|FG000|Overall Study|Physician Decision and Other|3|||
33509598|NCT00160706|101759308|FG000|Overall Study|Lost to Follow-up|4|||
33509599|NCT00160706|101759308|FG000|Overall Study|Lost to Follow-up and Other|1|||
33509600|NCT00160706|101759308|FG000|Overall Study|Lack of Efficacy|42|||
33509601|NCT00160706|101759308|FG000|Overall Study|Lack of Efficacy and Other|1|||
33509602|NCT00160706|101759308|FG000|Overall Study|Other Reason|11|||
33509603|NCT06586788|101759313|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
33509604|NCT01817582|101759314|FG000|Overall Study|Withdrawal by Subject|0|||
33509605|NCT01817582|101759315|FG001|Overall Study|Withdrawal by Subject|1|||
33509606|NCT01817582|101759316|FG002|Overall Study|Withdrawal by Subject|0|||
33509607|NCT01817582|101759314|FG000|Overall Study|Participant revealed masked treatment|1|||
33509608|NCT01817582|101759315|FG001|Overall Study|Participant revealed masked treatment|0|||
33509609|NCT01817582|101759316|FG002|Overall Study|Participant revealed masked treatment|0|||
33509610|NCT01817582|101759314|FG000|Overall Study|Randomized but exclusion criteria met|1|||
33509611|NCT01817582|101759315|FG001|Overall Study|Randomized but exclusion criteria met|0|||
33509612|NCT01817582|101759316|FG002|Overall Study|Randomized but exclusion criteria met|0|||
33509613|NCT02247440|101759317|FG000|Overall Study|Withdrawal by Subject|1|||
33509614|NCT02247440|101759317|FG000|Overall Study|Lack of Efficacy|3|||
33509615|NCT00256854|101759318|FG000|Overall Study|Withdrawal by Subject|2|||
33509616|NCT00256854|101759319|FG001|Overall Study|Withdrawal by Subject|3|||
33509617|NCT00256854|101759320|FG002|Overall Study|Withdrawal by Subject|0|||
33509618|NCT00256854|101759321|FG003|Overall Study|Withdrawal by Subject|0|||
33509619|NCT00256854|101759322|FG004|Overall Study|Withdrawal by Subject|0|||
33509620|NCT00256854|101759323|FG005|Overall Study|Withdrawal by Subject|0|||
33509621|NCT00256854|101759318|FG000|Overall Study|Lack of Efficacy|1|||
33509622|NCT00256854|101759319|FG001|Overall Study|Lack of Efficacy|0|||
33509623|NCT00256854|101759320|FG002|Overall Study|Lack of Efficacy|0|||
33509624|NCT00256854|101759321|FG003|Overall Study|Lack of Efficacy|0|||
33509625|NCT00256854|101759322|FG004|Overall Study|Lack of Efficacy|0|||
33509626|NCT00256854|101759323|FG005|Overall Study|Lack of Efficacy|0|||
33509627|NCT00256854|101759318|FG000|Overall Study|Protocol Violation|0|||
33509628|NCT00256854|101759319|FG001|Overall Study|Protocol Violation|1|||
33509629|NCT00256854|101759320|FG002|Overall Study|Protocol Violation|1|||
33320533|NCT01399190|101070007|FG000|Overall Study|Adverse Event|8|||
33320534|NCT01399190|101070007|FG000|Overall Study|Participant's Request|5|||
33509630|NCT00256854|101759321|FG003|Overall Study|Protocol Violation|1|||
33509631|NCT00256854|101759322|FG004|Overall Study|Protocol Violation|0|||
33509632|NCT00256854|101759323|FG005|Overall Study|Protocol Violation|0|||
33509633|NCT00256854|101759318|FG000|Overall Study|Adverse Event|0|||
33509634|NCT00256854|101759319|FG001|Overall Study|Adverse Event|0|||
33509635|NCT00256854|101759320|FG002|Overall Study|Adverse Event|2|||
33509636|NCT00256854|101759321|FG003|Overall Study|Adverse Event|2|||
33509637|NCT00256854|101759322|FG004|Overall Study|Adverse Event|0|||
33509638|NCT00256854|101759323|FG005|Overall Study|Adverse Event|1|||
33509639|NCT00256854|101759318|FG000|Overall Study|Not compliant with the study drug|0|||
33604846|NCT01263015|102105353|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
33604847|NCT01263015|102105352|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
33604848|NCT01263015|102105353|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
33320535|NCT01399190|101070007|FG000|Overall Study|Physician Decision|2|||
33320536|NCT01102803|101070018|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
33320537|NCT01102803|101070019|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
33320538|NCT01102803|101070018|FG000|Post to Follow-Up|Lost to Follow-up|1|||
33320539|NCT01102803|101070019|FG001|Post to Follow-Up|Lost to Follow-up|3|||
33320540|NCT04880447|101070020|FG000|Overall Study|No vaccination information|1|||
33320541|NCT04880447|101070020|FG000|Overall Study|No adverse event information (missing information)|1|||
33320542|NCT04880447|101070020|FG000|Overall Study|Disease not covered in this study|35|||
33320543|NCT00583024|101070021|FG000|Overall Study|Lost to Follow-up|4|||
33320544|NCT03836807|101070023|FG000|Overall Study|Physician Decision|1|||
33320545|NCT03836807|101070024|FG001|Overall Study|Physician Decision|0|||
33320546|NCT03986866|101070025|FG000|Overall Study|Withdrawal by Subject|0|||
33320547|NCT03986866|101070026|FG001|Overall Study|Withdrawal by Subject|3|||
33320548|NCT03986866|101070025|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
33320549|NCT03986866|101070026|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
33320550|NCT03049735|101070027|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
33509640|NCT00256854|101759319|FG001|Overall Study|Not compliant with the study drug|0|||
33509641|NCT00256854|101759320|FG002|Overall Study|Not compliant with the study drug|0|||
33509642|NCT00256854|101759321|FG003|Overall Study|Not compliant with the study drug|0|||
33509643|NCT00256854|101759322|FG004|Overall Study|Not compliant with the study drug|1|||
33509644|NCT00256854|101759323|FG005|Overall Study|Not compliant with the study drug|0|||
33398820|NCT02371980|101350127|FG003|Double-blind Period|Voluntary Withdrawal|9|||
33398821|NCT02371980|101350128|FG004|Double-blind Period|Voluntary Withdrawal|11|||
33398822|NCT02371980|101350124|FG000|Double-blind Period|Relapse|0|||
33398823|NCT02371980|101350125|FG001|Double-blind Period|Relapse|50|||
33398824|NCT02371980|101350126|FG002|Double-blind Period|Relapse|25|||
33398825|NCT02371980|101350127|FG003|Double-blind Period|Relapse|25|||
33398826|NCT02371980|101350128|FG004|Double-blind Period|Relapse|26|||
33509645|NCT01430403|101759326|FG000|Overall Study|Lost to Follow-up|5|||
33509646|NCT01430403|101759327|FG001|Overall Study|Lost to Follow-up|5|||
33509647|NCT01430403|101759328|FG002|Overall Study|Lost to Follow-up|3|||
33509648|NCT01430403|101759326|FG000|Overall Study|Physician Decision|1|||
33509649|NCT01430403|101759327|FG001|Overall Study|Physician Decision|0|||
33509650|NCT01430403|101759328|FG002|Overall Study|Physician Decision|0|||
33509651|NCT01430403|101759326|FG000|Overall Study|Protocol Violation|2|||
33320551|NCT03049735|101070028|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
33509652|NCT01430403|101759327|FG001|Overall Study|Protocol Violation|3|||
33509653|NCT01430403|101759328|FG002|Overall Study|Protocol Violation|2|||
33509654|NCT01430403|101759326|FG000|Overall Study|Withdrawal by Subject|9|||
33509655|NCT01430403|101759327|FG001|Overall Study|Withdrawal by Subject|1|||
33320552|NCT03049735|101070029|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
33320553|NCT03049735|101070027|FG000|Overall Study|Other|5|||
33320554|NCT03049735|101070028|FG001|Overall Study|Other|3|||
33320555|NCT03049735|101070029|FG002|Overall Study|Other|1|||
33320556|NCT03049735|101070027|FG000|Overall Study|Lack of Efficacy|4|||
33320557|NCT03049735|101070028|FG001|Overall Study|Lack of Efficacy|0|||
33320558|NCT03049735|101070029|FG002|Overall Study|Lack of Efficacy|3|||
33320559|NCT03049735|101070027|FG000|Overall Study|Protocol deviation|1|||
33320560|NCT03049735|101070028|FG001|Overall Study|Protocol deviation|0|||
33320561|NCT03049735|101070029|FG002|Overall Study|Protocol deviation|0|||
33320562|NCT03049735|101070027|FG000|Overall Study|Pregnancy|0|||
33320563|NCT03049735|101070028|FG001|Overall Study|Pregnancy|0|||
33320564|NCT03049735|101070029|FG002|Overall Study|Pregnancy|1|||
33320565|NCT03049735|101070027|FG000|Overall Study|Adverse Event|7|||
33320566|NCT03049735|101070028|FG001|Overall Study|Adverse Event|18|||
33320567|NCT03049735|101070029|FG002|Overall Study|Adverse Event|5|||
33320568|NCT03049735|101070027|FG000|Overall Study|Withdrawal by Subject|10|||
33320569|NCT03049735|101070028|FG001|Overall Study|Withdrawal by Subject|3|||
33320570|NCT03049735|101070029|FG002|Overall Study|Withdrawal by Subject|7|||
33320571|NCT03049735|101070027|FG000|Overall Study|Lost to Follow-up|1|||
33320572|NCT03049735|101070028|FG001|Overall Study|Lost to Follow-up|5|||
33320573|NCT03049735|101070029|FG002|Overall Study|Lost to Follow-up|5|||
33320574|NCT04556136|101070030|FG000|Overall Study|Lost to Follow-up|6|||
33320575|NCT04556136|101070031|FG001|Overall Study|Lost to Follow-up|6|||
33320576|NCT04556136|101070030|FG000|Overall Study|Physician Decision|2|||
33320577|NCT04556136|101070031|FG001|Overall Study|Physician Decision|1|||
33320578|NCT04556136|101070030|FG000|Overall Study|Withdrawal by Subject|2|||
33320579|NCT04556136|101070031|FG001|Overall Study|Withdrawal by Subject|1|||
33320580|NCT00529451|101070032|FG000|Overall Study|Subject withdrew consent|16|||
33320581|NCT00529451|101070033|FG001|Overall Study|Subject withdrew consent|21|||
33320582|NCT00529451|101070034|FG002|Overall Study|Subject withdrew consent|13|||
33320583|NCT00529451|101070035|FG003|Overall Study|Subject withdrew consent|12|||
33320584|NCT00529451|101070032|FG000|Overall Study|Adverse Event|9|||
33320585|NCT00529451|101070033|FG001|Overall Study|Adverse Event|16|||
33320586|NCT00529451|101070034|FG002|Overall Study|Adverse Event|14|||
33320587|NCT00529451|101070035|FG003|Overall Study|Adverse Event|8|||
33320588|NCT00529451|101070032|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
33320589|NCT00529451|101070033|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
33320590|NCT00529451|101070034|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
33320591|NCT00529451|101070035|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
33320592|NCT00529451|101070032|FG000|Overall Study|Lost to Follow-up|4|||
33320593|NCT00529451|101070033|FG001|Overall Study|Lost to Follow-up|7|||
33320594|NCT00529451|101070034|FG002|Overall Study|Lost to Follow-up|4|||
33509656|NCT01430403|101759328|FG002|Overall Study|Withdrawal by Subject|3|||
33398827|NCT02371980|101350124|FG000|Double-blind Period|Reason not Specified|0|||
33398828|NCT02371980|101350125|FG001|Double-blind Period|Reason not Specified|3|||
33398829|NCT02371980|101350126|FG002|Double-blind Period|Reason not Specified|3|||
33320595|NCT00529451|101070035|FG003|Overall Study|Lost to Follow-up|4|||
33320596|NCT00529451|101070032|FG000|Overall Study|Protocol deviation|1|||
33320597|NCT00529451|101070033|FG001|Overall Study|Protocol deviation|1|||
33320598|NCT00529451|101070034|FG002|Overall Study|Protocol deviation|4|||
33320599|NCT00529451|101070035|FG003|Overall Study|Protocol deviation|1|||
33320600|NCT00529451|101070032|FG000|Overall Study|Administrative problems|1|||
33320601|NCT00529451|101070033|FG001|Overall Study|Administrative problems|1|||
33320602|NCT00529451|101070034|FG002|Overall Study|Administrative problems|0|||
33320603|NCT00529451|101070035|FG003|Overall Study|Administrative problems|2|||
33320604|NCT00708175|101070036|FG000|Overall Study|Adverse Event|4|||
33320605|NCT00708175|101070037|FG001|Overall Study|Adverse Event|5|||
33320606|NCT00708175|101070036|FG000|Overall Study|Protocol Violation|2|||
33398830|NCT02371980|101350127|FG003|Double-blind Period|Reason not Specified|2|||
33320607|NCT00708175|101070037|FG001|Overall Study|Protocol Violation|3|||
33320608|NCT00708175|101070036|FG000|Overall Study|Lost to Follow-up|5|||
33320609|NCT00708175|101070037|FG001|Overall Study|Lost to Follow-up|3|||
33320610|NCT00708175|101070036|FG000|Overall Study|Withdrawal by Subject|5|||
33320611|NCT00708175|101070037|FG001|Overall Study|Withdrawal by Subject|7|||
33320612|NCT00708175|101070036|FG000|Overall Study|BMD loss >7%|2|||
33320613|NCT00708175|101070037|FG001|Overall Study|BMD loss >7%|3|||
33320614|NCT01955122|101070038|FG000|Overall Study|Physician Decision|5|||
33320615|NCT01955122|101070039|FG001|Overall Study|Physician Decision|5|||
33320616|NCT01170039|101070040|FG000|Overall Study|Withdrawal by Subject|5|||
33320617|NCT01170039|101070041|FG001|Overall Study|Withdrawal by Subject|3|||
33320618|NCT01170039|101070040|FG000|Overall Study|Lack of funding, drug not available|3|||
33320619|NCT01170039|101070041|FG001|Overall Study|Lack of funding, drug not available|3|||
33320620|NCT01303965|101070044|FG000|Overall Study|Adverse Event|1|||
33320621|NCT01303965|101070045|FG001|Overall Study|Adverse Event|1|||
33320622|NCT01303965|101070044|FG000|Overall Study|Death|0|||
33320623|NCT01303965|101070045|FG001|Overall Study|Death|3|||
33320624|NCT01303965|101070044|FG000|Overall Study|Withdrawal by Subject|1|||
33320625|NCT01303965|101070045|FG001|Overall Study|Withdrawal by Subject|0|||
33320626|NCT01303965|101070044|FG000|Overall Study|Disease Progression|1|||
33320627|NCT01303965|101070045|FG001|Overall Study|Disease Progression|6|||
33320628|NCT01448213|101070046|FG000|Overall Study|Lost to Follow-up|12|||
33320629|NCT01448213|101070047|FG001|Overall Study|Lost to Follow-up|10|||
33320630|NCT01448213|101070046|FG000|Overall Study|Adverse Event|4|||
33320631|NCT01448213|101070047|FG001|Overall Study|Adverse Event|10|||
33320632|NCT01448213|101070046|FG000|Overall Study|Protocol Violation|1|||
33320633|NCT01448213|101070047|FG001|Overall Study|Protocol Violation|2|||
33320634|NCT02805725|101070048|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
33320635|NCT02805725|101070049|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
33320636|NCT02805725|101070050|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
33320637|NCT02805725|101070051|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
33320638|NCT02805725|101070052|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
33320639|NCT02805725|101070048|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
33320640|NCT02805725|101070049|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
33320641|NCT02805725|101070050|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
33320642|NCT02805725|101070051|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
33320643|NCT02805725|101070052|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
33320644|NCT02805725|101070048|FG000|Phase II|Protocol Violation|0|||
33320645|NCT02805725|101070049|FG001|Phase II|Protocol Violation|0|||
33320646|NCT02805725|101070050|FG002|Phase II|Protocol Violation|0|||
33320647|NCT02805725|101070051|FG003|Phase II|Protocol Violation|0|||
33320648|NCT02805725|101070052|FG004|Phase II|Protocol Violation|6|||
33320649|NCT04195581|101070053|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
33320650|NCT04195581|101070053|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
33320651|NCT04195581|101070053|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
33320652|NCT04195581|101070053|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
33320653|NCT04195581|101070053|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
33320654|NCT04195581|101070053|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
33320655|NCT02536755|101070054|FG000|Overall Study|Adverse Event|4|||
33320656|NCT01176968|101070055|FG000|Overall Study|Adverse Event|10|||
33320657|NCT01176968|101070056|FG001|Overall Study|Adverse Event|11|||
33320658|NCT01176968|101070055|FG000|Overall Study|Death|2|||
33320659|NCT01176968|101070056|FG001|Overall Study|Death|3|||
33320660|NCT01176968|101070055|FG000|Overall Study|Lack of Efficacy|0|||
33320661|NCT01176968|101070056|FG001|Overall Study|Lack of Efficacy|1|||
33320662|NCT01176968|101070055|FG000|Overall Study|Lost to Follow-up|16|||
33509657|NCT00750139|101759329|FG000|Overall Study|Adverse Event|1|||
33509658|NCT00750139|101759330|FG001|Overall Study|Adverse Event|2|||
33604849|NCT00924404|102105354|FG000|Overall Study|Lost to Follow-up|6|||
33604850|NCT00924404|102105355|FG001|Overall Study|Lost to Follow-up|4|||
33320663|NCT01176968|101070056|FG001|Overall Study|Lost to Follow-up|14|||
33320664|NCT01176968|101070055|FG000|Overall Study|Withdrawal by Subject|48|||
33320665|NCT01176968|101070056|FG001|Overall Study|Withdrawal by Subject|48|||
33320666|NCT01176968|101070055|FG000|Overall Study|Protocol Violation|2|||
33320667|NCT01176968|101070056|FG001|Overall Study|Protocol Violation|1|||
33320668|NCT01176968|101070055|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
33320669|NCT01176968|101070056|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
33320670|NCT01176968|101070055|FG000|Overall Study|Study terminated by sponsor|0|||
33320671|NCT01176968|101070056|FG001|Overall Study|Study terminated by sponsor|1|||
33320672|NCT01176968|101070055|FG000|Overall Study|Reason not defined|5|||
33320673|NCT01176968|101070056|FG001|Overall Study|Reason not defined|3|||
33320674|NCT01557348|101070059|FG000|Overall Study|Adverse Event|6|||
33320675|NCT01557348|101070060|FG001|Overall Study|Adverse Event|16|||
33320676|NCT01557348|101070059|FG000|Overall Study|Infusion reaction event|5|||
33320677|NCT01557348|101070060|FG001|Overall Study|Infusion reaction event|5|||
33320678|NCT01557348|101070059|FG000|Overall Study|Death|7|||
33320679|NCT01557348|101070060|FG001|Overall Study|Death|4|||
33320680|NCT01557348|101070059|FG000|Overall Study|Insufficient Therapeutic Response|13|||
33320681|NCT01557348|101070060|FG001|Overall Study|Insufficient Therapeutic Response|28|||
33320682|NCT01557348|101070059|FG000|Overall Study|Withdrawal by Subject|5|||
33320683|NCT01557348|101070060|FG001|Overall Study|Withdrawal by Subject|4|||
33320684|NCT01557348|101070059|FG000|Overall Study|Lost to Follow-up|26|||
33320685|NCT01557348|101070060|FG001|Overall Study|Lost to Follow-up|22|||
33320686|NCT01557348|101070059|FG000|Overall Study|Administrative|18|||
33320687|NCT01557348|101070060|FG001|Overall Study|Administrative|11|||
33320688|NCT00325039|101070063|FG000|Overall Study|Lost to Follow-up|18|||
33320689|NCT00325039|101070064|FG001|Overall Study|Lost to Follow-up|14|||
33320690|NCT02525861|101070065|FG000|Overall Study|Adverse Event|1|||
33320691|NCT02525861|101070066|FG001|Overall Study|Adverse Event|0|||
33320692|NCT02525861|101070065|FG000|Overall Study|Withdrawal by Subject|0|||
33320693|NCT02525861|101070066|FG001|Overall Study|Withdrawal by Subject|1|||
33320694|NCT02525861|101070065|FG000|Overall Study|Physician Decision|0|||
33320695|NCT02525861|101070066|FG001|Overall Study|Physician Decision|1|||
33320696|NCT02030405|101070067|FG000|Overall Study|Withdrawal by Subject|1|||
33604851|NCT00689793|102105356|FG000|Overall Study|Lost to Follow-up|4|||
33509659|NCT00750139|101759331|FG002|Overall Study|Adverse Event|0|||
33509660|NCT00750139|101759332|FG003|Overall Study|Adverse Event|1|||
33604852|NCT00689793|102105357|FG001|Overall Study|Lost to Follow-up|5|||
33604853|NCT00612508|102105361|FG000|Overall Study|Withdrawal by Subject|3|||
33604854|NCT00612508|102105362|FG001|Overall Study|Withdrawal by Subject|4|||
33604855|NCT02404649|102105363|FG000|Overall Study|Adverse Event|1|||
33509661|NCT00750139|101759329|FG000|Overall Study|Lost to Follow-up|17|||
33604856|NCT02404649|102105364|FG001|Overall Study|Adverse Event|2|||
33604857|NCT02210832|102105365|FG000|Overall Study|Pregnancy termination .|3|||
33509662|NCT00750139|101759330|FG001|Overall Study|Lost to Follow-up|12|||
33509663|NCT00750139|101759331|FG002|Overall Study|Lost to Follow-up|15|||
33509664|NCT00750139|101759332|FG003|Overall Study|Lost to Follow-up|6|||
33509665|NCT00750139|101759329|FG000|Overall Study|Withdrawal by Subject|3|||
33509666|NCT00750139|101759330|FG001|Overall Study|Withdrawal by Subject|2|||
33509667|NCT00750139|101759331|FG002|Overall Study|Withdrawal by Subject|6|||
33509668|NCT00750139|101759332|FG003|Overall Study|Withdrawal by Subject|2|||
33509669|NCT00750139|101759329|FG000|Overall Study|Physician Decision|1|||
33509670|NCT00750139|101759330|FG001|Overall Study|Physician Decision|1|||
33509671|NCT00750139|101759331|FG002|Overall Study|Physician Decision|0|||
33509672|NCT00750139|101759332|FG003|Overall Study|Physician Decision|0|||
33509673|NCT00750139|101759329|FG000|Overall Study|Non-compliance|1|||
33509674|NCT00750139|101759330|FG001|Overall Study|Non-compliance|0|||
33509675|NCT00750139|101759331|FG002|Overall Study|Non-compliance|1|||
33509676|NCT00750139|101759332|FG003|Overall Study|Non-compliance|3|||
33509677|NCT00750139|101759329|FG000|Overall Study|Termination by sponsor|4|||
33509678|NCT00750139|101759330|FG001|Overall Study|Termination by sponsor|0|||
33509679|NCT00750139|101759331|FG002|Overall Study|Termination by sponsor|0|||
33509680|NCT00750139|101759332|FG003|Overall Study|Termination by sponsor|1|||
33509681|NCT00750139|101759329|FG000|Overall Study|Non-specific|62|||
33509682|NCT00750139|101759330|FG001|Overall Study|Non-specific|42|||
33509683|NCT00750139|101759331|FG002|Overall Study|Non-specific|79|||
33509684|NCT00750139|101759332|FG003|Overall Study|Non-specific|33|||
33509685|NCT01075646|101759335|FG000|Overall Study|Lost to Follow-up|4|||
33509686|NCT01075646|101759336|FG001|Overall Study|Lost to Follow-up|3|||
33509687|NCT01075646|101759337|FG002|Overall Study|Lost to Follow-up|1|||
33509688|NCT01075646|101759338|FG003|Overall Study|Lost to Follow-up|2|||
33509689|NCT00656851|101762045|FG000|Overall Study|Withdrawal by Subject|0|||
33604858|NCT02210832|102105366|FG001|Overall Study|Pregnancy termination .|4|||
33604859|NCT02210832|102105367|FG002|Overall Study|Pregnancy termination .|1|||
33604860|NCT02210832|102105365|FG000|Overall Study|Lost to Follow-up|26|||
33509690|NCT00656851|101762046|FG001|Overall Study|Withdrawal by Subject|4|||
33604861|NCT02210832|102105366|FG001|Overall Study|Lost to Follow-up|32|||
33604862|NCT02210832|102105367|FG002|Overall Study|Lost to Follow-up|17|||
33320697|NCT02030405|101070067|FG000|Overall Study|Lost to Follow-up|1|||
33320698|NCT00937833|101070068|FG000|Overall Study|Protocol Violation|1|||
33509691|NCT03089697|101762049|FG000|Overall Study|Adverse Event|1|||
33509692|NCT03089697|101762050|FG001|Overall Study|Adverse Event|2|||
33509693|NCT03089697|101762049|FG000|Overall Study|Withdrawal by Subject|1|||
33509694|NCT03089697|101762050|FG001|Overall Study|Withdrawal by Subject|0|||
33509695|NCT03881696|101762051|FG000|Overall Study|Adverse Event|2|||
33509696|NCT03881696|101762052|FG001|Overall Study|Adverse Event|0|||
33320699|NCT00937833|101070069|FG001|Overall Study|Protocol Violation|2|||
33320700|NCT00937833|101070068|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
33604863|NCT00897390|102105368|FG000|Overall Study|Adverse Event|2|||
33604864|NCT00897390|102105368|FG000|Overall Study|No Longer Met Study Criteria|1|||
33320701|NCT00937833|101070069|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
33320702|NCT00937833|101070068|FG000|Overall Study|Lost to Follow-up|10|||
33509697|NCT03881696|101762051|FG000|Overall Study|Withdrawal by Subject|2|||
33509698|NCT03881696|101762052|FG001|Overall Study|Withdrawal by Subject|0|||
33509699|NCT03881696|101762051|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
33509700|NCT03881696|101762052|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
33509701|NCT03881696|101762051|FG000|Overall Study|Failure to meet continuation criteria|1|||
33509702|NCT03881696|101762052|FG001|Overall Study|Failure to meet continuation criteria|0|||
33509703|NCT03200704|101762053|FG000|Overall Study|Withdrawal by Subject|1|||
33509704|NCT01106677|101762054|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
33509705|NCT01106677|101762055|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
33509706|NCT01106677|101762056|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
33509707|NCT01106677|101762057|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
33509708|NCT01106677|101762054|FG000|Core Period: Baseline to Week 26|Death|0|||
33509709|NCT01106677|101762055|FG001|Core Period: Baseline to Week 26|Death|0|||
33604865|NCT00897390|102105368|FG000|Overall Study|Personal Reasons|1|||
33604866|NCT00897390|102105368|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
33604867|NCT01378429|102105369|FG000|Overall Study|Noncompliance with study drug|1|||
33604868|NCT01378429|102105370|FG001|Overall Study|Noncompliance with study drug|0|||
33604869|NCT00552760|102105371|FG000|Overall Study|Adverse Event|3|||
33604870|NCT00552760|102105372|FG001|Overall Study|Adverse Event|5|||
33604871|NCT00552760|102105371|FG000|Overall Study|Relapsed- Depressed Event|10|||
33604872|NCT00552760|102105372|FG001|Overall Study|Relapsed- Depressed Event|16|||
33604873|NCT00552760|102105371|FG000|Overall Study|Relapse- Manic Event|3|||
33604874|NCT00552760|102105372|FG001|Overall Study|Relapse- Manic Event|3|||
33604875|NCT00552760|102105371|FG000|Overall Study|Relapsed- Mixed Event|3|||
33604876|NCT00552760|102105372|FG001|Overall Study|Relapsed- Mixed Event|5|||
33604877|NCT00552760|102105371|FG000|Overall Study|Protocol Violation|0|||
33604878|NCT00552760|102105372|FG001|Overall Study|Protocol Violation|1|||
33604879|NCT00552760|102105371|FG000|Overall Study|Lost to Follow-up|1|||
33604880|NCT00552760|102105372|FG001|Overall Study|Lost to Follow-up|1|||
33604881|NCT00552760|102105371|FG000|Overall Study|Non-compliance|1|||
33604882|NCT00552760|102105372|FG001|Overall Study|Non-compliance|1|||
33604883|NCT00552760|102105371|FG000|Overall Study|Medical Condition|1|||
33604884|NCT00552760|102105372|FG001|Overall Study|Medical Condition|1|||
33604885|NCT00552760|102105371|FG000|Overall Study|Withdrawal by Subject|3|||
33604886|NCT00552760|102105372|FG001|Overall Study|Withdrawal by Subject|0|||
33604887|NCT00552760|102105371|FG000|Overall Study|Medication Change|1|||
33604888|NCT00552760|102105372|FG001|Overall Study|Medication Change|0|||
33604889|NCT02266875|102105375|FG000|Overall Study|Withdrawal by Subject|9|||
33604890|NCT02266875|102105376|FG001|Overall Study|Withdrawal by Subject|0|||
33604891|NCT02266875|102105375|FG000|Overall Study|Lost to Follow-up|2|||
33604892|NCT02266875|102105376|FG001|Overall Study|Lost to Follow-up|0|||
33604893|NCT00885482|102105377|FG000|Overall Study|Pregnancy|1|||
33604894|NCT00885482|102105377|FG000|Overall Study|Lack of Efficacy|1|||
33604895|NCT00885482|102105377|FG000|Overall Study|Death|1|||
33509710|NCT01106677|101762056|FG002|Core Period: Baseline to Week 26|Death|1|||
33604896|NCT00885482|102105377|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
33604897|NCT02925728|102105380|FG000|Overall Study|Death|3|||
33509711|NCT01106677|101762057|FG003|Core Period: Baseline to Week 26|Death|0|||
33509712|NCT01106677|101762054|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
33509713|NCT01106677|101762055|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
33604898|NCT02925728|102105381|FG001|Overall Study|Death|5|||
33604899|NCT02925728|102105380|FG000|Overall Study|Physician Decision|1|||
33604900|NCT02925728|102105381|FG001|Overall Study|Physician Decision|0|||
33604901|NCT02925728|102105380|FG000|Overall Study|Withdrawal by Subject|1|||
33604902|NCT02925728|102105381|FG001|Overall Study|Withdrawal by Subject|0|||
33604903|NCT04957758|102105382|FG000|Overall Study|Adverse Event|1|||
33604904|NCT04957758|102105383|FG001|Overall Study|Adverse Event|0|||
33604905|NCT04957758|102105382|FG000|Overall Study|Lost to Follow-up|0|||
33604906|NCT04957758|102105383|FG001|Overall Study|Lost to Follow-up|2|||
33604907|NCT04957758|102105382|FG000|Overall Study|Withdrawal by Subject|4|||
33604908|NCT04957758|102105383|FG001|Overall Study|Withdrawal by Subject|2|||
33604909|NCT04957758|102105382|FG000|Overall Study|Protocol Violation|0|||
33604910|NCT04957758|102105383|FG001|Overall Study|Protocol Violation|1|||
33320703|NCT00937833|101070069|FG001|Overall Study|Lost to Follow-up|8|||
33509714|NCT01106677|101762056|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
33509715|NCT01106677|101762057|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
33509716|NCT01106677|101762054|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
33509717|NCT01106677|101762055|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
33509718|NCT01106677|101762056|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
33509719|NCT01106677|101762057|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
33509720|NCT01106677|101762054|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
33509721|NCT01106677|101762055|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
33320704|NCT00937833|101070068|FG000|Overall Study|Withdrawal by Subject|4|||
33320705|NCT00937833|101070069|FG001|Overall Study|Withdrawal by Subject|6|||
33320706|NCT02092350|101070071|FG000|Overall Study|Adverse Event|0|||
33320707|NCT02092350|101070072|FG001|Overall Study|Adverse Event|3|||
33320708|NCT02092350|101070071|FG000|Overall Study|Death|2|||
33604911|NCT00896649|102105388|FG000|Overall Study|Physician Decision|1|||
33604912|NCT00896649|102105388|FG000|Overall Study|Pregnancy|1|||
33604913|NCT00896649|102105388|FG000|Overall Study|missing documentation|1|||
33604914|NCT00896649|102105388|FG000|Overall Study|technical difficulties|2|||
33320709|NCT02092350|101070072|FG001|Overall Study|Death|5|||
33320710|NCT02092350|101070071|FG000|Overall Study|Lost to Follow-up|3|||
33320711|NCT02092350|101070072|FG001|Overall Study|Lost to Follow-up|1|||
33320712|NCT02092350|101070071|FG000|Overall Study|Protocol Violation|1|||
33320713|NCT02092350|101070072|FG001|Overall Study|Protocol Violation|0|||
33320714|NCT02092350|101070071|FG000|Overall Study|Physician Decision|1|||
33320715|NCT02092350|101070072|FG001|Overall Study|Physician Decision|1|||
33320716|NCT02092350|101070071|FG000|Overall Study|Screen Failure|1|||
33320717|NCT02092350|101070072|FG001|Overall Study|Screen Failure|0|||
33320718|NCT02092350|101070071|FG000|Overall Study|Withdrawal by Subject|2|||
33398831|NCT02371980|101350128|FG004|Double-blind Period|Reason not Specified|1|||
33398832|NCT02371980|101350124|FG000|Double-blind Period|Missing|0|||
33398833|NCT02371980|101350125|FG001|Double-blind Period|Missing|1|||
33509722|NCT01106677|101762056|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
33509723|NCT01106677|101762057|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
33509724|NCT01106677|101762054|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
33509725|NCT01106677|101762055|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
33509726|NCT01106677|101762056|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
33509727|NCT01106677|101762057|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
33509728|NCT01106677|101762054|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
33509729|NCT01106677|101762055|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
33509730|NCT01106677|101762056|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
33509731|NCT01106677|101762057|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
33320719|NCT02092350|101070072|FG001|Overall Study|Withdrawal by Subject|2|||
33509732|NCT01106677|101762054|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
33509733|NCT01106677|101762055|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
33509734|NCT01106677|101762056|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
33604915|NCT00203021|102105389|FG000|Overall Study|Death|4|||
33604916|NCT00203021|102105390|FG001|Overall Study|Death|1|||
33604917|NCT00203021|102105389|FG000|Overall Study|Adverse Event|10|||
33320720|NCT01184053|101070073|FG000|Overall Study|progression while on treatment|3|||
33604918|NCT00203021|102105390|FG001|Overall Study|Adverse Event|5|||
33604919|NCT00203021|102105389|FG000|Overall Study|Withdrawal by Subject|45|||
33604920|NCT00203021|102105390|FG001|Overall Study|Withdrawal by Subject|48|||
33320721|NCT00992511|101070079|FG000|Overall Study|Migrated/moved from study area|1|||
33320722|NCT00992511|101070080|FG001|Overall Study|Migrated/moved from study area|0|||
33320723|NCT00992511|101070081|FG002|Overall Study|Migrated/moved from study area|1|||
33320724|NCT00992511|101070082|FG003|Overall Study|Migrated/moved from study area|2|||
33320725|NCT00992511|101070079|FG000|Overall Study|Lost to Follow-up|1|||
33509735|NCT01106677|101762057|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
33320726|NCT00992511|101070080|FG001|Overall Study|Lost to Follow-up|0|||
33320727|NCT00992511|101070081|FG002|Overall Study|Lost to Follow-up|0|||
33320728|NCT00992511|101070082|FG003|Overall Study|Lost to Follow-up|2|||
33320729|NCT00992511|101070079|FG000|Overall Study|Withdrawal by Subject|0|||
33320730|NCT00992511|101070080|FG001|Overall Study|Withdrawal by Subject|0|||
33320731|NCT00992511|101070081|FG002|Overall Study|Withdrawal by Subject|1|||
33320732|NCT00992511|101070082|FG003|Overall Study|Withdrawal by Subject|1|||
33320733|NCT01672788|101070083|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
33320734|NCT01672788|101070084|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
33320735|NCT01672788|101070085|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
33320736|NCT01672788|101070086|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
33320737|NCT01790126|101070087|FG000|Overall Study|PSA Progression|12|||
33320738|NCT01790126|101070088|FG001|Overall Study|PSA Progression|16|||
33509736|NCT01106677|101762054|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
33509737|NCT01106677|101762055|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
33320739|NCT01790126|101070089|FG002|Overall Study|PSA Progression|16|||
33509738|NCT01106677|101762056|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33509739|NCT01106677|101762057|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33320740|NCT01790126|101070087|FG000|Overall Study|Other|5|||
33320741|NCT01790126|101070088|FG001|Overall Study|Other|4|||
33320742|NCT01790126|101070089|FG002|Overall Study|Other|8|||
33320743|NCT01790126|101070087|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
33320744|NCT01790126|101070088|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
33320745|NCT01790126|101070089|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
33320746|NCT01790126|101070087|FG000|Overall Study|Withdrawal by Physician|1|||
33320747|NCT01790126|101070088|FG001|Overall Study|Withdrawal by Physician|1|||
33320748|NCT01790126|101070089|FG002|Overall Study|Withdrawal by Physician|2|||
33320749|NCT01790126|101070087|FG000|Overall Study|Withdrawal by Subject|3|||
33320750|NCT01790126|101070088|FG001|Overall Study|Withdrawal by Subject|1|||
33320751|NCT01790126|101070089|FG002|Overall Study|Withdrawal by Subject|2|||
33509740|NCT01106677|101762054|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
33509741|NCT01106677|101762055|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
33509742|NCT01106677|101762056|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
33509743|NCT01106677|101762057|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
33509744|NCT01106677|101762054|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
33509745|NCT01106677|101762055|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
33509746|NCT01106677|101762056|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
33509747|NCT01106677|101762057|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
33509748|NCT01106677|101762054|FG000|Core Period: Baseline to Week 26|Other|8|||
33509749|NCT01106677|101762055|FG001|Core Period: Baseline to Week 26|Other|14|||
33509750|NCT01106677|101762056|FG002|Core Period: Baseline to Week 26|Other|8|||
33604921|NCT00203021|102105389|FG000|Overall Study|Lost to Follow-up|9|||
33604922|NCT00203021|102105390|FG001|Overall Study|Lost to Follow-up|7|||
33604923|NCT00203021|102105389|FG000|Overall Study|Other than specified|11|||
33604924|NCT00203021|102105390|FG001|Overall Study|Other than specified|16|||
33604925|NCT04232215|102105391|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
33320752|NCT01790126|101070087|FG000|Overall Study|Lost to Follow-up|1|||
33320753|NCT01790126|101070088|FG001|Overall Study|Lost to Follow-up|0|||
33320754|NCT01790126|101070089|FG002|Overall Study|Lost to Follow-up|1|||
33604926|NCT04232215|102105392|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
33604927|NCT02177838|102105402|FG000|Overall Study|Withdrawal by Subject|1|||
33604928|NCT02177838|102105402|FG000|Overall Study|Physician Decision|1|||
33604929|NCT02177838|102105402|FG000|Overall Study|Death|1|||
33604930|NCT00685373|102105403|FG000|Overall Study|Adverse Event|3|||
33604931|NCT00685373|102105403|FG000|Overall Study|Withdrawal by Subject|5|||
33604932|NCT00685373|102105403|FG000|Overall Study|Lack of Efficacy|3|||
33604933|NCT00685373|102105403|FG000|Overall Study|Condition no longer requires study drug|1|||
33604934|NCT00685373|102105403|FG000|Overall Study|Lost to Follow-up|2|||
33320755|NCT01790126|101070087|FG000|Overall Study|Adverse Event|0|||
33320756|NCT01790126|101070088|FG001|Overall Study|Adverse Event|2|||
33320757|NCT01790126|101070089|FG002|Overall Study|Adverse Event|0|||
33320758|NCT01790126|101070087|FG000|Overall Study|Death|2|||
33320759|NCT01790126|101070088|FG001|Overall Study|Death|0|||
33320760|NCT01790126|101070089|FG002|Overall Study|Death|0|||
33320761|NCT01790126|101070087|FG000|Overall Study|Radiographic Progression|3|||
33320762|NCT01790126|101070088|FG001|Overall Study|Radiographic Progression|1|||
33320763|NCT01790126|101070089|FG002|Overall Study|Radiographic Progression|0|||
33320764|NCT01822522|101070090|FG000|Overall Study|Adverse Event|1|||
33509751|NCT01106677|101762057|FG003|Core Period: Baseline to Week 26|Other|23|||
33320765|NCT01822522|101070091|FG001|Overall Study|Adverse Event|1|||
33320766|NCT01822522|101070092|FG002|Overall Study|Adverse Event|1|||
33320767|NCT01822522|101070093|FG003|Overall Study|Adverse Event|0|||
33320768|NCT01822522|101070094|FG004|Overall Study|Adverse Event|0|||
33320769|NCT01822522|101070095|FG005|Overall Study|Adverse Event|1|||
33320770|NCT01822522|101070090|FG000|Overall Study|Death|3|||
33320771|NCT01822522|101070091|FG001|Overall Study|Death|0|||
33320772|NCT01822522|101070092|FG002|Overall Study|Death|2|||
33320773|NCT01822522|101070093|FG003|Overall Study|Death|0|||
33320774|NCT01822522|101070094|FG004|Overall Study|Death|0|||
33320775|NCT01822522|101070095|FG005|Overall Study|Death|0|||
33509752|NCT01106677|101762054|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
33509753|NCT01106677|101762055|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
33509754|NCT01106677|101762056|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
33509755|NCT01106677|101762057|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
33509756|NCT01106677|101762054|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
33509757|NCT01106677|101762055|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
33509758|NCT01106677|101762056|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
33509759|NCT01106677|101762057|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
33509760|NCT01106677|101762054|FG000|Extension Period: Week 26 to Week 52|Death|0|||
33509761|NCT01106677|101762055|FG001|Extension Period: Week 26 to Week 52|Death|0|||
33509762|NCT01106677|101762056|FG002|Extension Period: Week 26 to Week 52|Death|0|||
33509763|NCT01106677|101762057|FG003|Extension Period: Week 26 to Week 52|Death|1|||
33509764|NCT01106677|101762054|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
33509765|NCT01106677|101762055|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
33509766|NCT01106677|101762056|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
33509767|NCT01106677|101762057|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
33509768|NCT01106677|101762054|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33509769|NCT01106677|101762055|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
33509770|NCT01106677|101762056|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
33509771|NCT01106677|101762057|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
33509772|NCT01106677|101762054|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
33509773|NCT01106677|101762055|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
33509774|NCT01106677|101762056|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
33509775|NCT01106677|101762057|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
33509776|NCT01106677|101762054|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
33509777|NCT01106677|101762055|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33509778|NCT01106677|101762056|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33509779|NCT01106677|101762057|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33509780|NCT01106677|101762054|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33509781|NCT01106677|101762055|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
33509782|NCT01106677|101762056|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
33509783|NCT01106677|101762057|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33509784|NCT01106677|101762054|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
33509785|NCT01106677|101762055|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
33509786|NCT01106677|101762056|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
33509787|NCT01106677|101762057|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
33509788|NCT01106677|101762054|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
33509789|NCT01106677|101762055|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
33509790|NCT01106677|101762056|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
33509791|NCT01106677|101762057|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
33509792|NCT01106677|101762054|FG000|Extension Period: Week 26 to Week 52|Other|6|||
33509793|NCT01106677|101762055|FG001|Extension Period: Week 26 to Week 52|Other|5|||
33509794|NCT01106677|101762056|FG002|Extension Period: Week 26 to Week 52|Other|8|||
33509795|NCT01106677|101762057|FG003|Extension Period: Week 26 to Week 52|Other|5|||
33509796|NCT02004886|101762064|FG000|Overall Study|Adverse Event|0|||
33509797|NCT02004886|101762065|FG001|Overall Study|Adverse Event|1|||
33509798|NCT02004886|101762066|FG002|Overall Study|Adverse Event|0|||
33509799|NCT02004886|101762067|FG003|Overall Study|Adverse Event|0|||
33509800|NCT02004886|101762064|FG000|Overall Study|Unable to attend future visits|1|||
33509801|NCT02004886|101762065|FG001|Overall Study|Unable to attend future visits|0|||
33509802|NCT02004886|101762066|FG002|Overall Study|Unable to attend future visits|0|||
33509803|NCT02004886|101762067|FG003|Overall Study|Unable to attend future visits|0|||
33509804|NCT01880086|101762071|FG000|Overall Study|Lost to Follow-up|1|||
33320776|NCT01822522|101070090|FG000|Overall Study|Lost to Follow-up|0|||
33320777|NCT01822522|101070091|FG001|Overall Study|Lost to Follow-up|0|||
33320778|NCT01822522|101070092|FG002|Overall Study|Lost to Follow-up|1|||
33320779|NCT01822522|101070093|FG003|Overall Study|Lost to Follow-up|1|||
33604935|NCT00685373|102105403|FG000|Overall Study|Protocol Violation|1|||
33604936|NCT05219669|102105404|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
33604937|NCT05219669|102105405|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
33604938|NCT05219669|102105406|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
33604939|NCT05219669|102105407|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
33604940|NCT05219669|102105408|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
33604941|NCT05219669|102105409|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
33604942|NCT00324233|102105410|FG000|First Period|unable to insert catheter|1|||
33604943|NCT00324233|102105411|FG001|First Period|unable to insert catheter|0|||
33604944|NCT00324233|102105410|FG000|Second Period|unable to insert catheter|1|||
33604945|NCT00324233|102105411|FG001|Second Period|unable to insert catheter|1|||
33604946|NCT00324233|102105410|FG000|Second Period|Protocol Violation|4|||
33604947|NCT00324233|102105411|FG001|Second Period|Protocol Violation|6|||
33604948|NCT02434328|102105412|FG000|Overall Study|Adverse Event|9|||
33604949|NCT02434328|102105413|FG001|Overall Study|Adverse Event|4|||
33604950|NCT02434328|102105412|FG000|Overall Study|Lack of Efficacy|0|||
33604951|NCT02434328|102105413|FG001|Overall Study|Lack of Efficacy|2|||
33604952|NCT02434328|102105412|FG000|Overall Study|Physician Decision|0|||
33604953|NCT02434328|102105413|FG001|Overall Study|Physician Decision|1|||
33604954|NCT02434328|102105412|FG000|Overall Study|Withdrawal by Subject|12|||
33604955|NCT02434328|102105413|FG001|Overall Study|Withdrawal by Subject|21|||
33604956|NCT02434328|102105412|FG000|Overall Study|Death|4|||
33604957|NCT02434328|102105413|FG001|Overall Study|Death|7|||
33604958|NCT02434328|102105412|FG000|Overall Study|Lost to Follow-up|1|||
33604959|NCT02434328|102105413|FG001|Overall Study|Lost to Follow-up|6|||
33604960|NCT02434328|102105412|FG000|Overall Study|Other|4|||
33604961|NCT02434328|102105413|FG001|Overall Study|Other|1|||
33604962|NCT02006069|102105414|FG000|Overall Study|MPP other programming|239|||
33604963|NCT02006069|102105415|FG001|Overall Study|MPP other programming|0|||
33604964|NCT02006069|102105414|FG000|Overall Study|RV only pacing|0|||
33604965|NCT02006069|102105415|FG001|Overall Study|RV only pacing|3|||
33604966|NCT01030874|102105418|FG000|Overall Study|Withdrawal by Subject|1|||
33604967|NCT01030874|102105419|FG001|Overall Study|Withdrawal by Subject|0|||
33604968|NCT01030874|102105418|FG000|Overall Study|Discharged in first 2 weeks|17|||
33604969|NCT01030874|102105419|FG001|Overall Study|Discharged in first 2 weeks|16|||
33509805|NCT01880086|101762072|FG001|Overall Study|Lost to Follow-up|1|||
33509806|NCT04934189|101762073|FG000|Overall Study|Lost to Follow-up|4|||
33509807|NCT04934189|101762073|FG000|Overall Study|Withdrawal by Subject|17|||
33509808|NCT00381043|101762088|FG000|Overall Study|Lost to Follow-up|8|||
33509809|NCT00381043|101762089|FG001|Overall Study|Lost to Follow-up|6|||
33509810|NCT00381043|101762088|FG000|Overall Study|Withdrawal by Subject|3|||
33509811|NCT00381043|101762089|FG001|Overall Study|Withdrawal by Subject|1|||
33509812|NCT00381043|101762088|FG000|Overall Study|wanted more care|0|||
33509813|NCT00381043|101762089|FG001|Overall Study|wanted more care|1|||
33509814|NCT00381043|101762088|FG000|Overall Study|incarcerated|1|||
33509815|NCT00381043|101762089|FG001|Overall Study|incarcerated|0|||
33509816|NCT02989649|101762097|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
33509817|NCT02989649|101762097|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
33509818|NCT02989649|101762097|FG000|Overall Study|Lost For Observation During Study|3|||
33509819|NCT02989649|101762097|FG000|Overall Study|Reason Not Specified|13|||
33509820|NCT03214380|101762098|FG000|Lead-in|Adverse Event|3|||
33509821|NCT03214380|101762099|FG001|Lead-in|Adverse Event|0|||
33509822|NCT03214380|101762100|FG002|Lead-in|Adverse Event|0|||
33604970|NCT01927055|102105420|FG000|Open-label|Adverse Event|6|||
33604971|NCT01927055|102105421|FG001|Open-label|Adverse Event|0|||
33604972|NCT01927055|102105422|FG002|Open-label|Adverse Event|0|||
33604973|NCT01927055|102105420|FG000|Open-label|Withdrawal by Subject|1|||
33604974|NCT01927055|102105421|FG001|Open-label|Withdrawal by Subject|0|||
33604975|NCT01927055|102105422|FG002|Open-label|Withdrawal by Subject|0|||
33604976|NCT01927055|102105420|FG000|Open-label|Study Stopped|4|||
33604977|NCT01927055|102105421|FG001|Open-label|Study Stopped|0|||
33604978|NCT01927055|102105422|FG002|Open-label|Study Stopped|0|||
33604979|NCT01927055|102105420|FG000|Open-label|Supine Hypertension|4|||
33604980|NCT01927055|102105421|FG001|Open-label|Supine Hypertension|0|||
33604981|NCT01927055|102105422|FG002|Open-label|Supine Hypertension|0|||
33509823|NCT03214380|101762101|FG003|Lead-in|Adverse Event|1|||
33509824|NCT03214380|101762102|FG004|Lead-in|Adverse Event|0|||
33509825|NCT03214380|101762103|FG005|Lead-in|Adverse Event|0|||
33509826|NCT03214380|101762098|FG000|Lead-in|Lost to Follow-up|4|||
33509827|NCT03214380|101762099|FG001|Lead-in|Lost to Follow-up|0|||
33604982|NCT01927055|102105420|FG000|Open-label|Difficulty attending study visits|1|||
33604983|NCT01927055|102105421|FG001|Open-label|Difficulty attending study visits|0|||
33604984|NCT01927055|102105422|FG002|Open-label|Difficulty attending study visits|0|||
33604985|NCT01927055|102105420|FG000|Double-Blind|Adverse Event|0|||
33604986|NCT01927055|102105421|FG001|Double-Blind|Adverse Event|1|||
33604987|NCT01927055|102105422|FG002|Double-Blind|Adverse Event|1|||
33604988|NCT01927055|102105420|FG000|Double-Blind|Protocol Violation|0|||
33604989|NCT01927055|102105421|FG001|Double-Blind|Protocol Violation|0|||
33604990|NCT01927055|102105422|FG002|Double-Blind|Protocol Violation|1|||
33604991|NCT01927055|102105420|FG000|Double-Blind|Withdrawal by Subject|0|||
33604992|NCT01927055|102105421|FG001|Double-Blind|Withdrawal by Subject|2|||
33604993|NCT01927055|102105422|FG002|Double-Blind|Withdrawal by Subject|3|||
33604994|NCT01927055|102105420|FG000|Double-Blind|Study Stopped|0|||
33604995|NCT01927055|102105421|FG001|Double-Blind|Study Stopped|7|||
33604996|NCT01927055|102105422|FG002|Double-Blind|Study Stopped|7|||
33604997|NCT01927055|102105420|FG000|Double-Blind|Supine Hypertension|0|||
33604998|NCT01927055|102105421|FG001|Double-Blind|Supine Hypertension|0|||
33604999|NCT01927055|102105422|FG002|Double-Blind|Supine Hypertension|1|||
33605000|NCT01927055|102105420|FG000|Double-Blind|Extended Vacation|0|||
33605001|NCT01927055|102105421|FG001|Double-Blind|Extended Vacation|1|||
33605002|NCT01927055|102105422|FG002|Double-Blind|Extended Vacation|0|||
33605003|NCT00440310|102105429|FG000|Overall Study|Lost to Follow-up|4|||
33605004|NCT00440310|102105430|FG001|Overall Study|Lost to Follow-up|5|||
33605005|NCT00440310|102105429|FG000|Overall Study|Protocol Violation|0|||
33605006|NCT00440310|102105430|FG001|Overall Study|Protocol Violation|1|||
33605007|NCT00440310|102105429|FG000|Overall Study|Withdrawal by Subject|15|||
33605008|NCT00440310|102105430|FG001|Overall Study|Withdrawal by Subject|14|||
33605009|NCT00440310|102105429|FG000|Overall Study|No Reply at EOS|7|||
33605010|NCT00440310|102105430|FG001|Overall Study|No Reply at EOS|7|||
33605011|NCT00440310|102105429|FG000|Overall Study|Other|1|||
33605012|NCT00440310|102105430|FG001|Overall Study|Other|0|||
33605013|NCT00440310|102105429|FG000|Overall Study|Status Unknown|1|||
33605014|NCT00440310|102105430|FG001|Overall Study|Status Unknown|3|||
33605015|NCT00619489|102105431|FG000|Overall Study|Adverse Event|0|||
33605016|NCT00619489|102105432|FG001|Overall Study|Adverse Event|7|||
33605017|NCT00619489|102105431|FG000|Overall Study|Withdrawal by Subject|1|||
33605018|NCT00619489|102105432|FG001|Overall Study|Withdrawal by Subject|1|||
33605019|NCT00619489|102105431|FG000|Overall Study|Lack of Efficacy|0|||
33605020|NCT00619489|102105432|FG001|Overall Study|Lack of Efficacy|11|||
33605021|NCT00619489|102105431|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
33605022|NCT00619489|102105432|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
33605023|NCT01300455|102105433|FG000|Washout|Withdrawal by Subject|1|||
33605024|NCT01300455|102105434|FG001|Washout|Withdrawal by Subject|0|||
33509828|NCT03214380|101762100|FG002|Lead-in|Lost to Follow-up|0|||
33509829|NCT03214380|101762101|FG003|Lead-in|Lost to Follow-up|1|||
33509830|NCT03214380|101762102|FG004|Lead-in|Lost to Follow-up|0|||
33509831|NCT03214380|101762103|FG005|Lead-in|Lost to Follow-up|0|||
33509832|NCT03214380|101762098|FG000|Lead-in|Eligibility Criteria|3|||
33509833|NCT03214380|101762099|FG001|Lead-in|Eligibility Criteria|0|||
33509834|NCT03214380|101762100|FG002|Lead-in|Eligibility Criteria|0|||
33509835|NCT03214380|101762101|FG003|Lead-in|Eligibility Criteria|0|||
33509836|NCT03214380|101762102|FG004|Lead-in|Eligibility Criteria|0|||
33509837|NCT03214380|101762103|FG005|Lead-in|Eligibility Criteria|0|||
33509838|NCT03214380|101762098|FG000|Lead-in|Physician Decision|6|||
33509839|NCT03214380|101762099|FG001|Lead-in|Physician Decision|0|||
33509840|NCT03214380|101762100|FG002|Lead-in|Physician Decision|0|||
33509841|NCT03214380|101762101|FG003|Lead-in|Physician Decision|0|||
33509842|NCT03214380|101762102|FG004|Lead-in|Physician Decision|0|||
33509843|NCT03214380|101762103|FG005|Lead-in|Physician Decision|0|||
33509844|NCT03214380|101762098|FG000|Lead-in|Protocol Deviation|7|||
33509845|NCT03214380|101762099|FG001|Lead-in|Protocol Deviation|0|||
33509846|NCT03214380|101762100|FG002|Lead-in|Protocol Deviation|0|||
33509847|NCT03214380|101762101|FG003|Lead-in|Protocol Deviation|3|||
33509848|NCT03214380|101762102|FG004|Lead-in|Protocol Deviation|0|||
33509849|NCT03214380|101762103|FG005|Lead-in|Protocol Deviation|0|||
33509850|NCT03214380|101762098|FG000|Lead-in|Withdrawal by Subject|41|||
33509851|NCT03214380|101762099|FG001|Lead-in|Withdrawal by Subject|0|||
33509852|NCT03214380|101762100|FG002|Lead-in|Withdrawal by Subject|0|||
33605025|NCT00042666|102105435|FG000|Overall Study|Adverse Event|2|||
33605026|NCT00042666|102105435|FG000|Overall Study|Death|4|||
33605027|NCT00042666|102105435|FG000|Overall Study|Protocol Violation|1|||
33605028|NCT00042666|102105435|FG000|Overall Study|Participant/Physician Perception|1|||
33605029|NCT00042666|102105435|FG000|Overall Study|Progressive Disease|41|||
33197869|NCT00938431|100626665|FG002|Overall Study|Dosing compliance issue|1|||
33509853|NCT03214380|101762101|FG003|Lead-in|Withdrawal by Subject|14|||
33509854|NCT03214380|101762102|FG004|Lead-in|Withdrawal by Subject|0|||
33509855|NCT03214380|101762103|FG005|Lead-in|Withdrawal by Subject|0|||
33509856|NCT03214380|101762098|FG000|Lead-in|Family Emergency|1|||
33509857|NCT03214380|101762099|FG001|Lead-in|Family Emergency|0|||
33509858|NCT03214380|101762100|FG002|Lead-in|Family Emergency|0|||
33509859|NCT03214380|101762101|FG003|Lead-in|Family Emergency|0|||
33605030|NCT00042666|102105435|FG000|Overall Study|Other|1|||
33605031|NCT00042666|102105435|FG000|Overall Study|Other|4|||
33605032|NCT01751139|102105441|FG000|Overall Study|Other|135|||
33605033|NCT01751139|102105441|FG000|Overall Study|Sponsor study termination|1609|||
33605034|NCT01751139|102105441|FG000|Overall Study|Lost to Follow-up|240|||
33605035|NCT01751139|102105441|FG000|Overall Study|Withdrawal by Subject|251|||
33605036|NCT01751139|102105441|FG000|Overall Study|Adverse Event|1|||
33605037|NCT01751139|102105441|FG000|Overall Study|Death|31|||
33605038|NCT01424228|102105442|FG000|Overall Study|Withdrawal by Subject|27|||
33605039|NCT01424228|102105443|FG001|Overall Study|Withdrawal by Subject|11|||
33605040|NCT01424228|102105442|FG000|Overall Study|Adverse Event|10|||
33605041|NCT01424228|102105443|FG001|Overall Study|Adverse Event|14|||
33605042|NCT01424228|102105442|FG000|Overall Study|Sponsor's decision|9|||
33605043|NCT01424228|102105443|FG001|Overall Study|Sponsor's decision|12|||
33605044|NCT01424228|102105442|FG000|Overall Study|Lack of Efficacy|5|||
33605045|NCT01424228|102105443|FG001|Overall Study|Lack of Efficacy|7|||
33605046|NCT01424228|102105442|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
33605047|NCT01424228|102105443|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
33605048|NCT01424228|102105442|FG000|Overall Study|Non-compliance|2|||
33605049|NCT01424228|102105443|FG001|Overall Study|Non-compliance|0|||
33605050|NCT01424228|102105442|FG000|Overall Study|Worsening of symptoms|1|||
33605051|NCT01424228|102105443|FG001|Overall Study|Worsening of symptoms|0|||
33605052|NCT01424228|102105442|FG000|Overall Study|Unplanned journey|0|||
33605053|NCT01424228|102105443|FG001|Overall Study|Unplanned journey|1|||
33605054|NCT01062061|102105444|FG000|Overall Study|Enrolled more than once|2|||
33605055|NCT01062061|102105444|FG000|Overall Study|Investigated before study start|13|||
33605056|NCT01062061|102105444|FG000|Overall Study|Outside chief indications|10|||
33605057|NCT01062061|102105444|FG000|Overall Study|Failed to meet inclusion criteria|2|||
33605058|NCT03597061|102105445|FG000|Overall Study|Lost to Follow-up|1|||
33605059|NCT03597061|102105446|FG001|Overall Study|Lost to Follow-up|0|||
33605060|NCT03597061|102105445|FG000|Overall Study|Protocol Violation|0|||
33605061|NCT03597061|102105446|FG001|Overall Study|Protocol Violation|1|||
33605062|NCT00430937|102105447|FG000|Overall Study|Adverse Event|3|||
33605063|NCT00430937|102105448|FG001|Overall Study|Adverse Event|8|||
33320780|NCT01822522|101070094|FG004|Overall Study|Lost to Follow-up|0|||
33320781|NCT01822522|101070095|FG005|Overall Study|Lost to Follow-up|1|||
33320782|NCT01822522|101070090|FG000|Overall Study|Withdrawal by Subject|0|||
33605064|NCT00430937|102105447|FG000|Overall Study|Death|0|||
33605065|NCT00430937|102105448|FG001|Overall Study|Death|1|||
33605066|NCT00430937|102105447|FG000|Overall Study|Lost to Follow-up|6|||
33605067|NCT00430937|102105448|FG001|Overall Study|Lost to Follow-up|6|||
33605068|NCT00430937|102105447|FG000|Overall Study|Withdrawal by Subject|5|||
33605069|NCT00430937|102105448|FG001|Overall Study|Withdrawal by Subject|2|||
33197870|NCT00938431|100626663|FG000|Overall Study|Reached maximum dose early|0|||
33320783|NCT01822522|101070091|FG001|Overall Study|Withdrawal by Subject|0|||
33320784|NCT01822522|101070092|FG002|Overall Study|Withdrawal by Subject|0|||
33320785|NCT01822522|101070093|FG003|Overall Study|Withdrawal by Subject|1|||
33320786|NCT01822522|101070094|FG004|Overall Study|Withdrawal by Subject|0|||
33320787|NCT01822522|101070095|FG005|Overall Study|Withdrawal by Subject|0|||
33509860|NCT03214380|101762102|FG004|Lead-in|Family Emergency|0|||
33509861|NCT03214380|101762103|FG005|Lead-in|Family Emergency|0|||
33509862|NCT03214380|101762098|FG000|Lead-in|Natural Disaster|9|||
33509863|NCT03214380|101762099|FG001|Lead-in|Natural Disaster|0|||
33509864|NCT03214380|101762100|FG002|Lead-in|Natural Disaster|0|||
33509865|NCT03214380|101762101|FG003|Lead-in|Natural Disaster|0|||
33509866|NCT03214380|101762102|FG004|Lead-in|Natural Disaster|0|||
33509867|NCT03214380|101762103|FG005|Lead-in|Natural Disaster|0|||
33509868|NCT03214380|101762098|FG000|Lead-in|Non Compliance|1|||
33509869|NCT03214380|101762099|FG001|Lead-in|Non Compliance|0|||
33509870|NCT03214380|101762100|FG002|Lead-in|Non Compliance|0|||
33605070|NCT00430937|102105447|FG000|Overall Study|Protocol Violation|3|||
33320788|NCT01822522|101070090|FG000|Overall Study|Lack of Efficacy|0|||
33320789|NCT01822522|101070091|FG001|Overall Study|Lack of Efficacy|0|||
33398834|NCT02371980|101350126|FG002|Double-blind Period|Missing|0|||
33398835|NCT02371980|101350127|FG003|Double-blind Period|Missing|0|||
33398836|NCT02371980|101350128|FG004|Double-blind Period|Missing|0|||
33605071|NCT00430937|102105448|FG001|Overall Study|Protocol Violation|2|||
33605072|NCT00430937|102105447|FG000|Overall Study|Lack of Efficacy|6|||
33605073|NCT00430937|102105448|FG001|Overall Study|Lack of Efficacy|5|||
33605074|NCT00430937|102105447|FG000|Overall Study|Inappropriate enrollment|2|||
33605075|NCT00430937|102105448|FG001|Overall Study|Inappropriate enrollment|1|||
33605076|NCT00430937|102105447|FG000|Overall Study|Administrative reasons|1|||
33605077|NCT00430937|102105448|FG001|Overall Study|Administrative reasons|0|||
33605078|NCT00430937|102105447|FG000|Overall Study|Protocol discontinuation criteria met|1|||
33605079|NCT00430937|102105448|FG001|Overall Study|Protocol discontinuation criteria met|2|||
33320790|NCT01822522|101070092|FG002|Overall Study|Lack of Efficacy|0|||
33509871|NCT03214380|101762101|FG003|Lead-in|Non Compliance|0|||
33398837|NCT02177942|101350133|FG000|Overall Study|Adverse Event|1|||
33509872|NCT03214380|101762102|FG004|Lead-in|Non Compliance|0|||
33509873|NCT03214380|101762103|FG005|Lead-in|Non Compliance|0|||
33509874|NCT03214380|101762098|FG000|Lead-in|Participant Schedule|2|||
33509875|NCT03214380|101762099|FG001|Lead-in|Participant Schedule|0|||
33605080|NCT00430937|102105447|FG000|Overall Study|Unable to classify|0|||
33320791|NCT01822522|101070093|FG003|Overall Study|Lack of Efficacy|0|||
33398838|NCT02177942|101350134|FG001|Overall Study|Adverse Event|0|||
33605081|NCT00430937|102105448|FG001|Overall Study|Unable to classify|1|||
33605082|NCT02066129|102105456|FG000|Overall Study|Lost to Follow-up|13|||
33509876|NCT03214380|101762100|FG002|Lead-in|Participant Schedule|0|||
33509877|NCT03214380|101762101|FG003|Lead-in|Participant Schedule|0|||
33509878|NCT03214380|101762102|FG004|Lead-in|Participant Schedule|0|||
33509879|NCT03214380|101762103|FG005|Lead-in|Participant Schedule|0|||
33509880|NCT03214380|101762098|FG000|Treatment Period|Adverse Event|0|||
33509881|NCT03214380|101762099|FG001|Treatment Period|Adverse Event|1|||
33509882|NCT03214380|101762100|FG002|Treatment Period|Adverse Event|1|||
33605083|NCT02066129|102105457|FG001|Overall Study|Lost to Follow-up|12|||
33605084|NCT02066129|102105456|FG000|Overall Study|Withdrawal by Subject|7|||
33605085|NCT02066129|102105457|FG001|Overall Study|Withdrawal by Subject|10|||
33605086|NCT02066129|102105456|FG000|Overall Study|Lack of Efficacy|8|||
33605087|NCT02066129|102105457|FG001|Overall Study|Lack of Efficacy|10|||
33605088|NCT02066129|102105456|FG000|Overall Study|Physician Decision|1|||
33605089|NCT02066129|102105457|FG001|Overall Study|Physician Decision|1|||
33605090|NCT00629798|102105458|FG000|Overall Study|Not Treated|4|||
33605091|NCT01624090|102105464|FG000|Overall Study|DLT, taken off therapy|0|||
33605092|NCT01624090|102105465|FG001|Overall Study|DLT, taken off therapy|1|||
33605093|NCT01624090|102105466|FG002|Overall Study|DLT, taken off therapy|0|||
33605094|NCT01624090|102105467|FG003|Overall Study|DLT, taken off therapy|0|||
33605095|NCT01624090|102105464|FG000|Overall Study|Withdrew prior to treatment|0|||
33605096|NCT01624090|102105465|FG001|Overall Study|Withdrew prior to treatment|1|||
33605097|NCT01624090|102105466|FG002|Overall Study|Withdrew prior to treatment|0|||
33605098|NCT01624090|102105467|FG003|Overall Study|Withdrew prior to treatment|0|||
33605099|NCT01624090|102105464|FG000|Overall Study|Died on study|0|||
33605100|NCT01624090|102105465|FG001|Overall Study|Died on study|0|||
33605101|NCT01624090|102105466|FG002|Overall Study|Died on study|2|||
33605102|NCT01624090|102105467|FG003|Overall Study|Died on study|0|||
33605103|NCT01624090|102105464|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
33605104|NCT01624090|102105465|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
33605105|NCT01624090|102105466|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
33605106|NCT01624090|102105467|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
33605107|NCT01624090|102105464|FG000|Overall Study|Dose escalated|0|||
33605108|NCT01624090|102105465|FG001|Overall Study|Dose escalated|0|||
33605109|NCT01624090|102105466|FG002|Overall Study|Dose escalated|3|||
33605110|NCT01624090|102105467|FG003|Overall Study|Dose escalated|0|||
33605111|NCT01455220|102105468|FG000|Overall Study|screen fail|30|||
33605112|NCT00847015|102105471|FG000|Overall Study|Withdrawal by Subject|1|||
33605113|NCT00847015|102105471|FG000|Overall Study|declined any surgery|1|||
33605114|NCT00847015|102105471|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
33605115|NCT02963701|102105477|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
33605116|NCT02963701|102105478|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
33605117|NCT01422824|102105482|FG000|Overall Study|Case record form not evaluated|1|||
33605118|NCT01422824|102105482|FG000|Overall Study|Lost to Follow-up|37|||
33605119|NCT00483002|102105483|FG000|Overall Study|Adverse Event|68|||
33605120|NCT00483002|102105483|FG000|Overall Study|Lack of Efficacy|555|||
33605121|NCT00483002|102105483|FG000|Overall Study|Lost to Follow-up|962|||
33197871|NCT00938431|100626664|FG001|Overall Study|Reached maximum dose early|0|||
33197872|NCT00938431|100626665|FG002|Overall Study|Reached maximum dose early|1|||
33197873|NCT03099382|100626666|FG000|Overall Study|Protocol Violation|2|||
33197874|NCT03099382|100626667|FG001|Overall Study|Protocol Violation|3|||
33197875|NCT00534352|100630331|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
33509883|NCT03214380|101762101|FG003|Treatment Period|Adverse Event|0|||
33509884|NCT03214380|101762102|FG004|Treatment Period|Adverse Event|1|||
33509885|NCT03214380|101762103|FG005|Treatment Period|Adverse Event|0|||
33509886|NCT03214380|101762098|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
33509887|NCT03214380|101762099|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
33509888|NCT03214380|101762100|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
33509889|NCT03214380|101762101|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
33509890|NCT03214380|101762102|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
33509891|NCT03214380|101762103|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
33509892|NCT03214380|101762098|FG000|Treatment Period|Withdrawal by Subject|0|||
33509893|NCT03214380|101762099|FG001|Treatment Period|Withdrawal by Subject|10|||
33509894|NCT03214380|101762100|FG002|Treatment Period|Withdrawal by Subject|8|||
33509895|NCT03214380|101762101|FG003|Treatment Period|Withdrawal by Subject|0|||
33509896|NCT03214380|101762102|FG004|Treatment Period|Withdrawal by Subject|7|||
33605122|NCT00483002|102105483|FG000|Overall Study|Other|2|||
33605123|NCT00483002|102105483|FG000|Overall Study|Other|967|||
33605124|NCT04969198|102105484|FG000|Overall Study|Withdrawal by Subject|20|||
33605125|NCT04969198|102105484|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
33605126|NCT04969198|102105484|FG000|Overall Study|Lost to Follow-up|20|||
33509897|NCT03214380|101762103|FG005|Treatment Period|Withdrawal by Subject|11|||
33509898|NCT03214380|101762098|FG000|Treatment Period|Death|0|||
33509899|NCT03214380|101762099|FG001|Treatment Period|Death|1|||
33509900|NCT03214380|101762100|FG002|Treatment Period|Death|2|||
33509901|NCT03214380|101762101|FG003|Treatment Period|Death|0|||
33509902|NCT03214380|101762102|FG004|Treatment Period|Death|0|||
33605127|NCT02540291|102105485|FG000|Overall Study|Death|7|||
33320792|NCT01822522|101070094|FG004|Overall Study|Lack of Efficacy|0|||
33320793|NCT01822522|101070095|FG005|Overall Study|Lack of Efficacy|2|||
33320794|NCT01195545|101070096|FG000|Overall Study|Protocol Violation|4|||
33320795|NCT01729156|101070099|FG000|Overall Study|Withdrawal by Subject|1|||
33320796|NCT01729156|101070100|FG001|Overall Study|Withdrawal by Subject|0|||
33320797|NCT01729156|101070101|FG002|Overall Study|Withdrawal by Subject|0|||
33320798|NCT01854645|101070102|FG000|Overall Study|Protocol-Specified Criteria|13|||
33320799|NCT01854645|101070103|FG001|Overall Study|Protocol-Specified Criteria|10|||
33320800|NCT01854645|101070104|FG002|Overall Study|Protocol-Specified Criteria|8|||
33320801|NCT01854645|101070105|FG003|Overall Study|Protocol-Specified Criteria|5|||
33320802|NCT01854645|101070106|FG004|Overall Study|Protocol-Specified Criteria|7|||
33320803|NCT01854645|101070102|FG000|Overall Study|Administrative Reasons / Missing|0|||
33320804|NCT01854645|101070103|FG001|Overall Study|Administrative Reasons / Missing|0|||
33320805|NCT01854645|101070104|FG002|Overall Study|Administrative Reasons / Missing|0|||
33320806|NCT01854645|101070105|FG003|Overall Study|Administrative Reasons / Missing|1|||
33320807|NCT01854645|101070106|FG004|Overall Study|Administrative Reasons / Missing|1|||
33320808|NCT01854645|101070102|FG000|Overall Study|Protocol Violation|3|||
33320809|NCT01854645|101070103|FG001|Overall Study|Protocol Violation|0|||
33320810|NCT01854645|101070104|FG002|Overall Study|Protocol Violation|5|||
33320811|NCT01854645|101070105|FG003|Overall Study|Protocol Violation|4|||
33509903|NCT03214380|101762103|FG005|Treatment Period|Death|0|||
33509904|NCT03214380|101762098|FG000|Treatment Period|Lost to Follow-up|0|||
33509905|NCT03214380|101762099|FG001|Treatment Period|Lost to Follow-up|6|||
33509906|NCT03214380|101762100|FG002|Treatment Period|Lost to Follow-up|3|||
33509907|NCT03214380|101762101|FG003|Treatment Period|Lost to Follow-up|0|||
33509908|NCT03214380|101762102|FG004|Treatment Period|Lost to Follow-up|0|||
33509909|NCT03214380|101762103|FG005|Treatment Period|Lost to Follow-up|0|||
33509910|NCT03214380|101762098|FG000|Treatment Period|Participant schedule|0|||
33509911|NCT03214380|101762099|FG001|Treatment Period|Participant schedule|0|||
33509912|NCT03214380|101762100|FG002|Treatment Period|Participant schedule|1|||
33509913|NCT03214380|101762101|FG003|Treatment Period|Participant schedule|0|||
33509914|NCT03214380|101762102|FG004|Treatment Period|Participant schedule|0|||
33509915|NCT03214380|101762103|FG005|Treatment Period|Participant schedule|0|||
33509916|NCT03214380|101762098|FG000|Treatment Period|Treatment Interruption|0|||
33509917|NCT03214380|101762099|FG001|Treatment Period|Treatment Interruption|0|||
33509918|NCT03214380|101762100|FG002|Treatment Period|Treatment Interruption|1|||
33509919|NCT03214380|101762101|FG003|Treatment Period|Treatment Interruption|0|||
33509920|NCT03214380|101762102|FG004|Treatment Period|Treatment Interruption|0|||
33509921|NCT03214380|101762103|FG005|Treatment Period|Treatment Interruption|0|||
33509922|NCT01646021|101762104|FG000|Overall Study|Death|77|||
33509923|NCT01646021|101762105|FG001|Overall Study|Death|83|||
33509924|NCT01646021|101762104|FG000|Overall Study|Study Terminated by Sponsor|50|||
33509925|NCT01646021|101762105|FG001|Overall Study|Study Terminated by Sponsor|41|||
33509926|NCT01646021|101762104|FG000|Overall Study|Lost to Follow-up|2|||
33509927|NCT01646021|101762105|FG001|Overall Study|Lost to Follow-up|2|||
33509928|NCT01646021|101762104|FG000|Overall Study|Withdrawal by Subject|10|||
33509929|NCT01646021|101762105|FG001|Overall Study|Withdrawal by Subject|15|||
33509930|NCT05500274|101762109|FG000|Overall Study|Not able to complete the session and follow-up visits.|2|||
33509931|NCT05500274|101762110|FG001|Overall Study|Not able to complete the session and follow-up visits.|0|||
33509932|NCT05500274|101762109|FG000|Overall Study|Lost to Follow-up|86|||
33509933|NCT05500274|101762110|FG001|Overall Study|Lost to Follow-up|93|||
33509934|NCT01869699|101762111|FG000|Overall Study|Withdrawal by Subject|1|||
33509935|NCT01869699|101762112|FG001|Overall Study|Withdrawal by Subject|0|||
33509936|NCT01597375|101762113|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
33509937|NCT01597375|101762114|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
33509938|NCT01597375|101762113|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
33509939|NCT01597375|101762114|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
33320812|NCT01854645|101070106|FG004|Overall Study|Protocol Violation|1|||
33320813|NCT01854645|101070102|FG000|Overall Study|Lost to Follow-up|10|||
33320814|NCT01854645|101070103|FG001|Overall Study|Lost to Follow-up|7|||
33320815|NCT01854645|101070104|FG002|Overall Study|Lost to Follow-up|8|||
33320816|NCT01854645|101070105|FG003|Overall Study|Lost to Follow-up|5|||
33320817|NCT01854645|101070106|FG004|Overall Study|Lost to Follow-up|0|||
33320818|NCT01854645|101070102|FG000|Overall Study|Physician Decision|1|||
33320819|NCT01854645|101070103|FG001|Overall Study|Physician Decision|5|||
33320820|NCT01854645|101070104|FG002|Overall Study|Physician Decision|3|||
33320821|NCT01854645|101070105|FG003|Overall Study|Physician Decision|3|||
33320822|NCT01854645|101070106|FG004|Overall Study|Physician Decision|7|||
33320823|NCT01854645|101070102|FG000|Overall Study|Withdrawal by Subject|31|||
33320824|NCT01854645|101070103|FG001|Overall Study|Withdrawal by Subject|41|||
33320825|NCT01854645|101070104|FG002|Overall Study|Withdrawal by Subject|30|||
33509940|NCT01597375|101762113|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
33509941|NCT01597375|101762114|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
33509942|NCT01597375|101762113|FG000|Washout (2 Weeks)|Adverse Event|1|||
33509943|NCT01597375|101762114|FG001|Washout (2 Weeks)|Adverse Event|0|||
33509944|NCT01597375|101762113|FG000|Second Intervention|Failed to react at both Aspirin|1|||
33509945|NCT01597375|101762114|FG001|Second Intervention|Failed to react at both Aspirin|1|||
33509946|NCT00978250|101762117|FG000|Overall Study|Late determination of ineligibility|0|||
33509947|NCT00978250|101762118|FG001|Overall Study|Late determination of ineligibility|1|||
33509948|NCT00978250|101762119|FG002|Overall Study|Late determination of ineligibility|0|||
33509949|NCT00978250|101762120|FG003|Overall Study|Late determination of ineligibility|1|||
33509950|NCT02225366|101762121|FG000|Overall Study|Lack of Efficacy|1|||
33509951|NCT02225366|101762122|FG001|Overall Study|Lack of Efficacy|0|||
33509952|NCT00976820|101762123|FG000|Overall Study|Lost to Follow-up|5|||
33509953|NCT00976820|101762124|FG001|Overall Study|Lost to Follow-up|16|||
33509954|NCT00976820|101762125|FG002|Overall Study|Lost to Follow-up|2|||
33509955|NCT00976820|101762126|FG003|Overall Study|Lost to Follow-up|3|||
33509956|NCT00976820|101762123|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
33509957|NCT00976820|101762124|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
33509958|NCT00976820|101762125|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
33509959|NCT00976820|101762126|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
33509960|NCT00976820|101762123|FG000|Overall Study|Withdrawal by Subject|2|||
33509961|NCT00976820|101762124|FG001|Overall Study|Withdrawal by Subject|4|||
33509962|NCT00976820|101762125|FG002|Overall Study|Withdrawal by Subject|1|||
33509963|NCT00976820|101762126|FG003|Overall Study|Withdrawal by Subject|4|||
33509964|NCT01876784|101762135|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
33509965|NCT01876784|101762136|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
33509966|NCT01876784|101762135|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
33509967|NCT01876784|101762136|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
33509968|NCT01876784|101762135|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
33509969|NCT01876784|101762136|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
33509970|NCT01876784|101762135|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
33509971|NCT01876784|101762136|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
33509972|NCT01876784|101762135|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
33509973|NCT01876784|101762136|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
33509974|NCT01876784|101762135|FG000|Randomized Treatment Period (40 Months)|Death|1|||
33509975|NCT01876784|101762136|FG001|Randomized Treatment Period (40 Months)|Death|0|||
33509976|NCT01876784|101762135|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
33509977|NCT01876784|101762136|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
33509978|NCT01876784|101762135|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
33509979|NCT01876784|101762136|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
33509980|NCT01876784|101762135|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
33509981|NCT01876784|101762136|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
33509982|NCT01876784|101762135|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
33509983|NCT01876784|101762136|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
33509984|NCT01876784|101762135|FG000|Open-label Period (31 Months)|Adverse Event|2|||
33509985|NCT01876784|101762136|FG001|Open-label Period (31 Months)|Adverse Event|6|||
33509986|NCT01876784|101762135|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
33509987|NCT01876784|101762136|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
33509988|NCT01876784|101762135|FG000|Open-label Period (31 Months)|Progressive disease|4|||
33509989|NCT01876784|101762136|FG001|Open-label Period (31 Months)|Progressive disease|35|||
33509990|NCT01876784|101762135|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
33509991|NCT01876784|101762136|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
33509992|NCT01876784|101762135|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
33320826|NCT01854645|101070105|FG003|Overall Study|Withdrawal by Subject|21|||
33320827|NCT01854645|101070106|FG004|Overall Study|Withdrawal by Subject|24|||
33320828|NCT01854645|101070102|FG000|Overall Study|Lack of Efficacy|7|||
33320829|NCT01854645|101070103|FG001|Overall Study|Lack of Efficacy|12|||
33509993|NCT01876784|101762136|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
33509994|NCT01876784|101762135|FG000|Open-label Period (31 Months)|Death|0|||
33509995|NCT01876784|101762136|FG001|Open-label Period (31 Months)|Death|1|||
33509996|NCT01876784|101762135|FG000|Open-label Period (31 Months)|Other than specified above|9|||
33509997|NCT01876784|101762136|FG001|Open-label Period (31 Months)|Other than specified above|18|||
33509998|NCT03533114|101762137|FG000|Overall|Adverse Event|16|||
33320830|NCT01854645|101070104|FG002|Overall Study|Lack of Efficacy|9|||
33320831|NCT01854645|101070105|FG003|Overall Study|Lack of Efficacy|3|||
33320832|NCT01854645|101070106|FG004|Overall Study|Lack of Efficacy|9|||
33320833|NCT01854645|101070102|FG000|Overall Study|Adverse Event|33|||
33320834|NCT01854645|101070103|FG001|Overall Study|Adverse Event|31|||
33320835|NCT01854645|101070104|FG002|Overall Study|Adverse Event|19|||
33320836|NCT01854645|101070105|FG003|Overall Study|Adverse Event|20|||
33320837|NCT01854645|101070106|FG004|Overall Study|Adverse Event|11|||
33320838|NCT01641809|101070133|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
33320839|NCT01641809|101070134|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
33320840|NCT01641809|101070135|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
33320841|NCT01641809|101070136|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
33320842|NCT01641809|101070133|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
33320843|NCT01641809|101070134|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
33320844|NCT01641809|101070135|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
33320845|NCT01641809|101070136|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
33320846|NCT01641809|101070133|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
33320847|NCT01641809|101070134|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
33320848|NCT01641809|101070135|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
33320849|NCT01641809|101070136|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
33320850|NCT01641809|101070133|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
33320851|NCT01641809|101070134|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
33320852|NCT01641809|101070135|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
33320853|NCT01641809|101070136|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
33320854|NCT01641809|101070133|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
33320855|NCT01641809|101070134|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
33320856|NCT01641809|101070135|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
33320857|NCT01641809|101070136|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
33320858|NCT01641809|101070133|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
33320859|NCT01641809|101070134|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
33320860|NCT01641809|101070135|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
33320861|NCT01641809|101070136|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
33320862|NCT01641809|101070133|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
33320863|NCT01641809|101070134|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
33320864|NCT01641809|101070135|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
33320865|NCT01641809|101070136|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
33509999|NCT03533114|101762138|FG001|Overall|Adverse Event|11|||
33510000|NCT03533114|101762137|FG000|Overall|Consent Withdrawal by Participant|7|||
33510001|NCT03533114|101762138|FG001|Overall|Consent Withdrawal by Participant|6|||
33510002|NCT03533114|101762137|FG000|Overall|Lack of Efficacy|5|||
33320866|NCT01641809|101070133|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
33320867|NCT01641809|101070134|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
33320868|NCT01641809|101070135|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
33320869|NCT01641809|101070136|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
33320870|NCT01641809|101070133|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
33320871|NCT01641809|101070134|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
33320872|NCT01641809|101070135|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
33320873|NCT01641809|101070136|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
33320874|NCT01641809|101070133|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
33320875|NCT01641809|101070134|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
33320876|NCT01641809|101070135|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
33320877|NCT01641809|101070136|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
33320878|NCT01641809|101070133|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
33320879|NCT01641809|101070134|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
33320880|NCT01641809|101070135|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
33320881|NCT01641809|101070136|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
33320882|NCT01641809|101070133|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
33510003|NCT03533114|101762138|FG001|Overall|Lack of Efficacy|3|||
33510004|NCT03533114|101762137|FG000|Overall|Lost to Follow-up|1|||
33320883|NCT01641809|101070134|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
33320884|NCT01641809|101070135|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
33320885|NCT01641809|101070136|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
33320886|NCT01641809|101070133|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
33320887|NCT01641809|101070134|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
33320888|NCT01641809|101070135|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
33320889|NCT01641809|101070136|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
33320890|NCT01641809|101070133|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
33320891|NCT01641809|101070134|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
33320892|NCT01641809|101070135|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
33320893|NCT01641809|101070136|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
33320894|NCT01641809|101070133|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
33320895|NCT01641809|101070134|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
33320896|NCT01641809|101070135|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
33320897|NCT01641809|101070136|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
33320898|NCT01641809|101070133|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
33320899|NCT01641809|101070134|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
33320900|NCT01641809|101070135|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
33320901|NCT01641809|101070136|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
33320902|NCT01641809|101070133|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
33320903|NCT01641809|101070134|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
33320904|NCT01641809|101070135|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
33320905|NCT01641809|101070136|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
33320906|NCT01641809|101070133|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
33320907|NCT01641809|101070134|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
33320908|NCT01641809|101070135|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
33320909|NCT01641809|101070136|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
33320910|NCT04399122|101070137|FG000|Overall Study|Lost to Follow-up|2|||
33320911|NCT04399122|101070138|FG001|Overall Study|Lost to Follow-up|0|||
33320912|NCT04399122|101070137|FG000|Overall Study|Withdrawal by Subject|1|||
33320913|NCT04399122|101070138|FG001|Overall Study|Withdrawal by Subject|0|||
33320914|NCT02540538|101070139|FG000|Overall Study|Pregnancy|0|||
33320915|NCT02540538|101070140|FG001|Overall Study|Pregnancy|1|||
33320916|NCT02540538|101070141|FG002|Overall Study|Pregnancy|0|||
33320917|NCT03334409|101070142|FG000|Overall Study|Did not meet inclusion criteria|1|||
33320918|NCT03334409|101070143|FG001|Overall Study|Did not meet inclusion criteria|0|||
33320919|NCT02941926|101070146|FG000|Core Phase|Progressive disease|1109|||
33320920|NCT02941926|101070146|FG000|Core Phase|Adverse Event|504|||
33320921|NCT02941926|101070146|FG000|Core Phase|Subject/guardian decision|127|||
33320922|NCT02941926|101070146|FG000|Core Phase|Physician Decision|112|||
33320923|NCT02941926|101070146|FG000|Core Phase|Death|46|||
33320924|NCT02941926|101070146|FG000|Core Phase|Protocol deviation|34|||
33320925|NCT02941926|101070146|FG000|Core Phase|Lost to Follow-up|8|||
33320926|NCT02941926|101070146|FG000|Core Phase|Technical problems|5|||
33320927|NCT02941926|101070146|FG000|Extension Phase|Physician Decision|155|||
33320928|NCT02941926|101070146|FG000|Extension Phase|Progressive disease|115|||
33320929|NCT02941926|101070146|FG000|Extension Phase|Adverse Event|13|||
33320930|NCT02941926|101070146|FG000|Extension Phase|Subject/Guardian decision|12|||
33320931|NCT02941926|101070146|FG000|Extension Phase|Death|6|||
33320932|NCT01109173|101070147|FG000|Overall Study|Adverse Event|15|||
33320933|NCT01109173|101070148|FG001|Overall Study|Adverse Event|17|||
33320934|NCT01109173|101070149|FG002|Overall Study|Adverse Event|9|||
33320935|NCT01109173|101070150|FG003|Overall Study|Adverse Event|6|||
33320936|NCT01109173|101070147|FG000|Overall Study|Lost to Follow-up|0|||
33320937|NCT01109173|101070148|FG001|Overall Study|Lost to Follow-up|1|||
33320938|NCT01109173|101070149|FG002|Overall Study|Lost to Follow-up|0|||
33320939|NCT01109173|101070150|FG003|Overall Study|Lost to Follow-up|0|||
33320940|NCT01109173|101070147|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
33320941|NCT01109173|101070148|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
33320942|NCT01109173|101070149|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
33320943|NCT01109173|101070150|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
33320944|NCT01109173|101070147|FG000|Overall Study|Noncompliance|0|||
33320945|NCT01109173|101070148|FG001|Overall Study|Noncompliance|1|||
33320946|NCT01109173|101070149|FG002|Overall Study|Noncompliance|0|||
33320947|NCT01109173|101070150|FG003|Overall Study|Noncompliance|0|||
33320948|NCT01109173|101070147|FG000|Overall Study|Treatment Failure|25|||
33320949|NCT01109173|101070148|FG001|Overall Study|Treatment Failure|32|||
33320950|NCT01109173|101070149|FG002|Overall Study|Treatment Failure|69|||
33320951|NCT01109173|101070150|FG003|Overall Study|Treatment Failure|64|||
33320952|NCT01109173|101070147|FG000|Overall Study|Protocol Violation|4|||
33320953|NCT01109173|101070148|FG001|Overall Study|Protocol Violation|5|||
33320954|NCT01109173|101070149|FG002|Overall Study|Protocol Violation|1|||
33320955|NCT01109173|101070150|FG003|Overall Study|Protocol Violation|2|||
33510005|NCT03533114|101762138|FG001|Overall|Lost to Follow-up|1|||
33510006|NCT03533114|101762137|FG000|Overall|Physician Decision|0|||
33320956|NCT01109173|101070147|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
33320957|NCT01109173|101070148|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
33320958|NCT01109173|101070149|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
33320959|NCT01109173|101070150|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
33320960|NCT01109173|101070147|FG000|Overall Study|Not Specifiied|5|||
33320961|NCT01109173|101070148|FG001|Overall Study|Not Specifiied|4|||
33320962|NCT01109173|101070149|FG002|Overall Study|Not Specifiied|9|||
33320963|NCT01109173|101070150|FG003|Overall Study|Not Specifiied|14|||
33320964|NCT00120406|101070151|FG000|Overall Study|Death|9|||
33320965|NCT00120406|101070152|FG001|Overall Study|Death|4|||
33320966|NCT00120406|101070151|FG000|Overall Study|Withdrawal by Subject|5|||
33320967|NCT00120406|101070152|FG001|Overall Study|Withdrawal by Subject|7|||
33320968|NCT00120406|101070151|FG000|Overall Study|Lost to Follow-up|5|||
33320969|NCT00120406|101070152|FG001|Overall Study|Lost to Follow-up|2|||
33320970|NCT00120406|101070151|FG000|Overall Study|received non-study stent|0|||
33320971|NCT00120406|101070152|FG001|Overall Study|received non-study stent|2|||
33320972|NCT00120406|101070151|FG000|Overall Study|patient moved but has not withdrawn|0|||
33320973|NCT00120406|101070152|FG001|Overall Study|patient moved but has not withdrawn|1|||
33364920|NCT01790438|101223682|FG000|Overall Study|Protocol Required Discontinuation|7|||
33364921|NCT01790438|101223683|FG001|Overall Study|Protocol Required Discontinuation|1|||
33364922|NCT00474630|101223684|FG000|Overall Study|Adverse Event|98|||
33364923|NCT00474630|101223685|FG001|Overall Study|Adverse Event|26|||
33364924|NCT00474630|101223684|FG000|Overall Study|Lost to Follow-up|22|||
33364925|NCT00474630|101223685|FG001|Overall Study|Lost to Follow-up|15|||
33364926|NCT00474630|101223684|FG000|Overall Study|Withdrawal by Subject|21|||
33364927|NCT00474630|101223685|FG001|Overall Study|Withdrawal by Subject|15|||
33364928|NCT00474630|101223684|FG000|Overall Study|Protocol Violation|3|||
33364929|NCT00474630|101223685|FG001|Overall Study|Protocol Violation|4|||
33364930|NCT00474630|101223684|FG000|Overall Study|Lack of Efficacy|5|||
33364931|NCT00474630|101223685|FG001|Overall Study|Lack of Efficacy|6|||
33364932|NCT00474630|101223684|FG000|Overall Study|Drug noncompliance, other|11|||
33364933|NCT00474630|101223685|FG001|Overall Study|Drug noncompliance, other|4|||
33364934|NCT04590937|101223686|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
33364935|NCT01000064|101223687|FG000|Overall Study|Withdrawal by Subject|1|||
33364936|NCT01000064|101223688|FG001|Overall Study|Withdrawal by Subject|1|||
33364937|NCT04760314|101223689|FG000|Induction Period|Withdrawal by Subject|0|||
33364938|NCT04760314|101223690|FG001|Induction Period|Withdrawal by Subject|1|||
33364939|NCT04760314|101223691|FG002|Induction Period|Withdrawal by Subject|1|||
33364940|NCT04760314|101223692|FG003|Induction Period|Withdrawal by Subject|0|||
33364941|NCT04760314|101223693|FG004|Induction Period|Withdrawal by Subject|0|||
33364942|NCT04760314|101223694|FG005|Induction Period|Withdrawal by Subject|0|||
33364943|NCT04760314|101223695|FG006|Induction Period|Withdrawal by Subject|0|||
33364944|NCT04760314|101223696|FG007|Induction Period|Withdrawal by Subject|0|||
33364945|NCT04760314|101223697|FG008|Induction Period|Withdrawal by Subject|0|||
33364946|NCT04760314|101223698|FG009|Induction Period|Withdrawal by Subject|0|||
33364947|NCT04760314|101223699|FG010|Induction Period|Withdrawal by Subject|0|||
33364948|NCT04760314|101223689|FG000|Induction Period|Adverse Event|0|||
33364949|NCT04760314|101223690|FG001|Induction Period|Adverse Event|0|||
33364950|NCT04760314|101223691|FG002|Induction Period|Adverse Event|2|||
33364951|NCT04760314|101223692|FG003|Induction Period|Adverse Event|0|||
33364952|NCT04760314|101223693|FG004|Induction Period|Adverse Event|0|||
33364953|NCT04760314|101223694|FG005|Induction Period|Adverse Event|0|||
33510007|NCT03533114|101762138|FG001|Overall|Physician Decision|2|||
33510008|NCT03533114|101762137|FG000|Overall|Protocol deviation|1|||
33510009|NCT03533114|101762138|FG001|Overall|Protocol deviation|1|||
33510010|NCT03533114|101762137|FG000|Overall|Failure to meet randomization criteria|1|||
33510011|NCT03533114|101762138|FG001|Overall|Failure to meet randomization criteria|2|||
33510012|NCT03533114|101762137|FG000|Overall|Non-Compliance with study drug|0|||
33364954|NCT04760314|101223695|FG006|Induction Period|Adverse Event|0|||
33364955|NCT04760314|101223696|FG007|Induction Period|Adverse Event|0|||
33364956|NCT04760314|101223697|FG008|Induction Period|Adverse Event|0|||
33364957|NCT04760314|101223698|FG009|Induction Period|Adverse Event|0|||
33364958|NCT04760314|101223699|FG010|Induction Period|Adverse Event|0|||
33398839|NCT02177942|101350133|FG000|Overall Study|Lost to Follow-up|1|||
33364959|NCT04760314|101223689|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
33364960|NCT04760314|101223690|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
33364961|NCT04760314|101223691|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
33364962|NCT04760314|101223692|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
33364963|NCT04760314|101223693|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
33364964|NCT04760314|101223694|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
33398840|NCT02177942|101350134|FG001|Overall Study|Lost to Follow-up|1|||
33364965|NCT04760314|101223695|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
33398841|NCT02177942|101350133|FG000|Overall Study|Protocol Violation|4|||
33398842|NCT02177942|101350134|FG001|Overall Study|Protocol Violation|6|||
33510013|NCT03533114|101762138|FG001|Overall|Non-Compliance with study drug|1|||
33510014|NCT03533114|101762137|FG000|Overall|Other|0|||
33510015|NCT03533114|101762138|FG001|Overall|Other|1|||
33320974|NCT01326728|101072801|FG000|Overall Study|Death|13|||
33320975|NCT01326728|101072802|FG001|Overall Study|Death|0|||
33320976|NCT01326728|101072801|FG000|Overall Study|Early closure of study|34|||
33320977|NCT01326728|101072802|FG001|Overall Study|Early closure of study|9|||
33320978|NCT01423812|101072806|FG000|Overall Study|Lost to Follow-up|2|||
33320979|NCT01423812|101072807|FG001|Overall Study|Lost to Follow-up|2|||
33320980|NCT01423812|101072806|FG000|Overall Study|Withdrawal by Subject|1|||
33320981|NCT01423812|101072807|FG001|Overall Study|Withdrawal by Subject|2|||
33320982|NCT00597753|101072808|FG000|Overall Study|Adverse Event|6|||
33320983|NCT00597753|101072809|FG001|Overall Study|Adverse Event|2|||
33320984|NCT00597753|101072808|FG000|Overall Study|Death|55|||
33320985|NCT00597753|101072809|FG001|Overall Study|Death|29|||
33320986|NCT00597753|101072808|FG000|Overall Study|Lack of Efficacy|2|||
33320987|NCT00597753|101072809|FG001|Overall Study|Lack of Efficacy|0|||
33320988|NCT00597753|101072808|FG000|Overall Study|Lost to Follow-up|10|||
33320989|NCT00597753|101072809|FG001|Overall Study|Lost to Follow-up|3|||
33320990|NCT00597753|101072808|FG000|Overall Study|Physician Decision|5|||
33510016|NCT03533114|101762137|FG000|Open Label Titration and Optimization|Adverse Event|11|||
33510017|NCT03533114|101762138|FG001|Open Label Titration and Optimization|Adverse Event|8|||
33510018|NCT03533114|101762137|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
33510019|NCT03533114|101762138|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
33510020|NCT03533114|101762137|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
33510021|NCT03533114|101762138|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
33510022|NCT03533114|101762137|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
33510023|NCT03533114|101762138|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
33510024|NCT03533114|101762137|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
33510025|NCT03533114|101762138|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
33510026|NCT03533114|101762137|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
33510027|NCT03533114|101762138|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
33510028|NCT03533114|101762137|FG000|Stable Dose|Adverse Event|0|||
33510029|NCT03533114|101762138|FG001|Stable Dose|Adverse Event|2|||
33510030|NCT03533114|101762137|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
33510031|NCT03533114|101762138|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
33510032|NCT03533114|101762137|FG000|Stable Dose|Lack of Efficacy|1|||
33510033|NCT03533114|101762138|FG001|Stable Dose|Lack of Efficacy|0|||
33510034|NCT03533114|101762137|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
33510035|NCT03533114|101762138|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
33510036|NCT03533114|101762137|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
33510037|NCT03533114|101762138|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
33510038|NCT03533114|101762137|FG000|Open-Label Safety Extension|Adverse Event|3|||
33510039|NCT03533114|101762138|FG001|Open-Label Safety Extension|Adverse Event|0|||
33510040|NCT03533114|101762137|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
33510041|NCT03533114|101762138|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
33510042|NCT03533114|101762137|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
33510043|NCT03533114|101762138|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
33510044|NCT03533114|101762137|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
33510045|NCT03533114|101762138|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
33510046|NCT03533114|101762137|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
33510047|NCT03533114|101762138|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
33510048|NCT01669174|101762139|FG000|Overall Study|Subject withdrew consent|2|||
33510049|NCT01669174|101762140|FG001|Overall Study|Subject withdrew consent|2|||
33510050|NCT01669174|101762139|FG000|Overall Study|Lost to Follow-up|1|||
33510051|NCT01669174|101762140|FG001|Overall Study|Lost to Follow-up|0|||
33510052|NCT01669174|101762139|FG000|Overall Study|Adverse Event|2|||
33510053|NCT01669174|101762140|FG001|Overall Study|Adverse Event|2|||
33510054|NCT01669174|101762139|FG000|Overall Study|Administrative problems|1|||
33510055|NCT01669174|101762140|FG001|Overall Study|Administrative problems|2|||
33510056|NCT00191282|101762141|FG000|Overall Study|Adverse Event|5|||
33510057|NCT00191282|101762142|FG001|Overall Study|Adverse Event|6|||
33510058|NCT00191282|101762141|FG000|Overall Study|Death|51|||
33510059|NCT00191282|101762142|FG001|Overall Study|Death|51|||
33510060|NCT00191282|101762141|FG000|Overall Study|Lack of Efficacy|11|||
33510061|NCT00191282|101762142|FG001|Overall Study|Lack of Efficacy|6|||
33510062|NCT00191282|101762141|FG000|Overall Study|Noncompliance|14|||
33510063|NCT00191282|101762142|FG001|Overall Study|Noncompliance|17|||
33510064|NCT00191282|101762141|FG000|Overall Study|Patient moved|11|||
33510065|NCT00191282|101762142|FG001|Overall Study|Patient moved|14|||
33320991|NCT00597753|101072809|FG001|Overall Study|Physician Decision|1|||
33320992|NCT00597753|101072808|FG000|Overall Study|Pregnancy|1|||
33320993|NCT00597753|101072809|FG001|Overall Study|Pregnancy|0|||
33320994|NCT00597753|101072808|FG000|Overall Study|Withdrawal by Subject|35|||
33320995|NCT00597753|101072809|FG001|Overall Study|Withdrawal by Subject|12|||
33510066|NCT00191282|101762141|FG000|Overall Study|Withdrawal by Subject|59|||
33510067|NCT00191282|101762142|FG001|Overall Study|Withdrawal by Subject|44|||
33510068|NCT00191282|101762141|FG000|Overall Study|Physician Decision|18|||
33398843|NCT02177942|101350133|FG000|Overall Study|Withdrawal by Subject|71|||
33398844|NCT02177942|101350134|FG001|Overall Study|Withdrawal by Subject|81|||
33398845|NCT02773849|101350135|FG000|Overall Study|Lost to Follow-up|11|||
33398846|NCT02773849|101350135|FG000|Overall Study|Death|26|||
33398847|NCT02773849|101350135|FG000|Overall Study|Withdrawal by Subject|5|||
33398848|NCT02773849|101350135|FG000|Overall Study|Withdrawal of Consent|9|||
33398849|NCT02773849|101350135|FG000|Overall Study|Other: not due to lack of tolerability|11|||
33398850|NCT02364999|101350136|FG000|Overall Study|Death|136|||
33398851|NCT02364999|101350137|FG001|Overall Study|Death|138|||
33398852|NCT02364999|101350136|FG000|Overall Study|Lost to Follow-up|10|||
33398853|NCT02364999|101350137|FG001|Overall Study|Lost to Follow-up|15|||
33398854|NCT02364999|101350136|FG000|Overall Study|Protocol Violation|3|||
33398855|NCT02364999|101350137|FG001|Overall Study|Protocol Violation|2|||
33398856|NCT02364999|101350136|FG000|Overall Study|Withdrawal by Subject|14|||
33398857|NCT02364999|101350137|FG001|Overall Study|Withdrawal by Subject|14|||
33398858|NCT02364999|101350136|FG000|Overall Study|Other|0|||
33398859|NCT02364999|101350137|FG001|Overall Study|Other|1|||
33398860|NCT02364999|101350136|FG000|Overall Study|Randomized but did not receive treatment|2|||
33398861|NCT02364999|101350137|FG001|Overall Study|Randomized but did not receive treatment|3|||
33398862|NCT01843933|101350138|FG000|Overall Study|Data lost|6|||
33398863|NCT01843933|101350139|FG001|Overall Study|Data lost|4|||
33398864|NCT00735072|101350140|FG000|Overall Study|interrupted study med during ARV change|1|||
33398865|NCT00735072|101350141|FG001|Overall Study|interrupted study med during ARV change|0|||
33398866|NCT00735072|101350140|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
33398867|NCT00735072|101350141|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
33398868|NCT03345849|101350144|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
33398869|NCT03345849|101350145|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
33398870|NCT03345849|101350146|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
33398871|NCT03345849|101350147|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
33398872|NCT03345849|101350144|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
33398873|NCT03345849|101350145|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
33398874|NCT03345849|101350146|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
33398875|NCT03345849|101350147|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
33398876|NCT03345849|101350144|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
33398877|NCT03345849|101350145|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
33398878|NCT03345849|101350146|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
33398879|NCT03345849|101350147|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
33398880|NCT03345849|101350144|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
33398881|NCT03345849|101350145|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
33398882|NCT03345849|101350146|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
33398883|NCT03345849|101350147|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
33398884|NCT03345849|101350144|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
33398885|NCT03345849|101350145|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
33398886|NCT03345849|101350146|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
33398887|NCT03345849|101350147|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
33398888|NCT03345849|101350144|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
33398889|NCT03345849|101350145|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
33510069|NCT00191282|101762142|FG001|Overall Study|Physician Decision|15|||
33510070|NCT00191282|101762141|FG000|Overall Study|Protocol entry criteria not met|14|||
33510071|NCT00191282|101762142|FG001|Overall Study|Protocol entry criteria not met|9|||
33510072|NCT00191282|101762141|FG000|Overall Study|Protocol Violation|9|||
33510073|NCT00191282|101762142|FG001|Overall Study|Protocol Violation|12|||
33398890|NCT03345849|101350146|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
33398891|NCT03345849|101350147|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
33398892|NCT03345849|101350144|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
33398893|NCT03345849|101350145|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
33398894|NCT03345849|101350146|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
33398895|NCT03345849|101350147|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
33398896|NCT03345849|101350144|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
33398897|NCT03345849|101350145|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
33398898|NCT03345849|101350146|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
33510074|NCT00191282|101762141|FG000|Overall Study|Severity of outcome|2|||
33510075|NCT00191282|101762142|FG001|Overall Study|Severity of outcome|5|||
33398899|NCT03345849|101350147|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
33398900|NCT03345849|101350144|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
33398901|NCT03345849|101350145|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
33398902|NCT03345849|101350146|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
33510076|NCT00191282|101762141|FG000|Overall Study|Sponsor's decision|2|||
33510077|NCT00191282|101762142|FG001|Overall Study|Sponsor's decision|2|||
33398903|NCT03345849|101350147|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
33398904|NCT03345849|101350144|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
33398905|NCT03345849|101350145|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
33398906|NCT03345849|101350146|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
33398907|NCT03345849|101350147|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
33398908|NCT03345849|101350144|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
33398909|NCT03345849|101350145|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
33510078|NCT00191282|101762141|FG000|Overall Study|Lost to Follow-up|24|||
33320996|NCT00597753|101072808|FG000|Overall Study|Discontinued Dialysis|0|||
33320997|NCT00597753|101072809|FG001|Overall Study|Discontinued Dialysis|1|||
33320998|NCT00597753|101072808|FG000|Overall Study|Never dosed|2|||
33320999|NCT00597753|101072809|FG001|Overall Study|Never dosed|0|||
33510079|NCT00191282|101762142|FG001|Overall Study|Lost to Follow-up|31|||
33510080|NCT03782298|101762143|FG000|Overall Study|Protocol Deviation|4|||
33605128|NCT02540291|102105486|FG001|Overall Study|Death|7|||
33605129|NCT02540291|102105487|FG002|Overall Study|Death|5|||
33605130|NCT02540291|102105488|FG003|Overall Study|Death|7|||
33605131|NCT02540291|102105485|FG000|Overall Study|Lost to Follow-up|0|||
33605132|NCT02540291|102105486|FG001|Overall Study|Lost to Follow-up|0|||
33605133|NCT02540291|102105487|FG002|Overall Study|Lost to Follow-up|1|||
33605134|NCT02540291|102105488|FG003|Overall Study|Lost to Follow-up|0|||
33605135|NCT02540291|102105485|FG000|Overall Study|Withdrawal Of Consent|0|||
33605136|NCT02540291|102105486|FG001|Overall Study|Withdrawal Of Consent|1|||
33605137|NCT02540291|102105487|FG002|Overall Study|Withdrawal Of Consent|0|||
33605138|NCT02540291|102105488|FG003|Overall Study|Withdrawal Of Consent|0|||
33605139|NCT02540291|102105485|FG000|Overall Study|Study Terminated By Sponsor|1|||
33605140|NCT02540291|102105486|FG001|Overall Study|Study Terminated By Sponsor|0|||
33605141|NCT02540291|102105487|FG002|Overall Study|Study Terminated By Sponsor|0|||
33605142|NCT02540291|102105488|FG003|Overall Study|Study Terminated By Sponsor|0|||
33605143|NCT02540291|102105485|FG000|Overall Study|Other|0|||
33605144|NCT02540291|102105486|FG001|Overall Study|Other|0|||
33605145|NCT02540291|102105487|FG002|Overall Study|Other|1|||
33605146|NCT02540291|102105488|FG003|Overall Study|Other|0|||
33605147|NCT01985360|102105489|FG000|Overall Study|Withdrawal by Subject|4|||
33321000|NCT00597753|101072808|FG000|Overall Study|Noncompliance|2|||
33321001|NCT00597753|101072809|FG001|Overall Study|Noncompliance|1|||
33510081|NCT01137110|101762146|FG000|Overall Study|Protocol Violation|1|||
33510082|NCT01137110|101762147|FG001|Overall Study|Protocol Violation|0|||
33510083|NCT05113979|101762150|FG000|Overall Study|Death|2|||
33510084|NCT05113979|101762150|FG000|Overall Study|Lost to Follow-up|1|||
33510085|NCT02548351|101762155|FG000|Overall Study|Withdrawal by Subject|149|||
33510086|NCT02548351|101762156|FG001|Overall Study|Withdrawal by Subject|154|||
33510087|NCT02548351|101762157|FG002|Overall Study|Withdrawal by Subject|152|||
33510088|NCT02548351|101762155|FG000|Overall Study|Death|11|||
33510089|NCT02548351|101762156|FG001|Overall Study|Death|15|||
33510090|NCT02548351|101762157|FG002|Overall Study|Death|12|||
33510091|NCT02548351|101762155|FG000|Overall Study|Adverse Event|22|||
33510092|NCT02548351|101762156|FG001|Overall Study|Adverse Event|56|||
33605148|NCT01985360|102105490|FG001|Overall Study|Withdrawal by Subject|0|||
33605149|NCT01985360|102105489|FG000|Overall Study|Lost to Follow-up|5|||
33398910|NCT03345849|101350146|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
33398911|NCT03345849|101350147|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
33398912|NCT00545740|101350152|FG000|Overall Study|Lack of Efficacy|34|||
33398913|NCT00545740|101350153|FG001|Overall Study|Lack of Efficacy|35|||
33605150|NCT01985360|102105490|FG001|Overall Study|Lost to Follow-up|3|||
33605151|NCT00903331|102105491|FG000|Overall Study|Death|4|||
33605152|NCT00903331|102105492|FG001|Overall Study|Death|8|||
33605153|NCT00903331|102105491|FG000|Overall Study|Withdrawal of consent|1|||
33605154|NCT00903331|102105492|FG001|Overall Study|Withdrawal of consent|8|||
33605155|NCT00903331|102105491|FG000|Overall Study|Lung transplant|0|||
33321002|NCT00597753|101072808|FG000|Overall Study|Relocation|17|||
33605156|NCT00903331|102105492|FG001|Overall Study|Lung transplant|2|||
33197876|NCT00534352|100630331|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
33510093|NCT02548351|101762157|FG002|Overall Study|Adverse Event|36|||
33605157|NCT02745535|102105493|FG000|Overall Study|Death|1|||
33605158|NCT02745535|102105493|FG000|Overall Study|Adverse Event|3|||
33321003|NCT00597753|101072809|FG001|Overall Study|Relocation|6|||
33605159|NCT02745535|102105493|FG000|Overall Study|Lost to Follow-up|2|||
33321004|NCT00597753|101072808|FG000|Overall Study|Renal transplant|10|||
33321005|NCT00597753|101072809|FG001|Overall Study|Renal transplant|3|||
33321006|NCT00597753|101072808|FG000|Overall Study|Site closed by sponsor|19|||
33398914|NCT00545740|101350154|FG002|Overall Study|Lack of Efficacy|47|||
33510094|NCT02548351|101762155|FG000|Overall Study|Study Terminated by Sponsor|549|||
33510095|NCT02548351|101762156|FG001|Overall Study|Study Terminated by Sponsor|509|||
33510096|NCT02548351|101762157|FG002|Overall Study|Study Terminated by Sponsor|528|||
33510097|NCT02548351|101762155|FG000|Overall Study|Site Closure|14|||
33605160|NCT01533922|102105494|FG000|Overall Study|Adverse Event|5|||
33605161|NCT01533922|102105495|FG001|Overall Study|Adverse Event|8|||
33321007|NCT00597753|101072809|FG001|Overall Study|Site closed by sponsor|7|||
33321008|NCT00597753|101072808|FG000|Overall Study|Site elected to close|2|||
33321009|NCT00597753|101072809|FG001|Overall Study|Site elected to close|4|||
33321010|NCT01436071|101072810|FG000|Overall Study|Adverse Event|1|||
33321011|NCT01436071|101072811|FG001|Overall Study|Adverse Event|0|||
33321012|NCT01436071|101072810|FG000|Overall Study|Lack of Efficacy|16|||
33321013|NCT01436071|101072811|FG001|Overall Study|Lack of Efficacy|7|||
33321014|NCT01436071|101072810|FG000|Overall Study|Protocol Violation|0|||
33321015|NCT01436071|101072811|FG001|Overall Study|Protocol Violation|1|||
33321016|NCT01436071|101072810|FG000|Overall Study|Lost to Follow-up|3|||
33321017|NCT01436071|101072811|FG001|Overall Study|Lost to Follow-up|1|||
33321018|NCT01436071|101072810|FG000|Overall Study|Physician Decision|1|||
33321019|NCT01436071|101072811|FG001|Overall Study|Physician Decision|0|||
33605162|NCT01533922|102105496|FG002|Overall Study|Adverse Event|6|||
33605163|NCT01533922|102105497|FG003|Overall Study|Adverse Event|3|||
33605164|NCT01533922|102105498|FG004|Overall Study|Adverse Event|4|||
33605165|NCT01533922|102105494|FG000|Overall Study|Lack of Efficacy|0|||
33605166|NCT01533922|102105495|FG001|Overall Study|Lack of Efficacy|0|||
33605167|NCT01533922|102105496|FG002|Overall Study|Lack of Efficacy|1|||
33321020|NCT01436071|101072810|FG000|Overall Study|Withdrawal by Subject|2|||
33321021|NCT01436071|101072811|FG001|Overall Study|Withdrawal by Subject|2|||
33321022|NCT01436071|101072810|FG000|Overall Study|Did Not Receive Trial Medication|3|||
33321023|NCT01436071|101072811|FG001|Overall Study|Did Not Receive Trial Medication|3|||
33321024|NCT02653300|101072812|FG000|Overall Study|Withdrawal by Subject|2|||
33321025|NCT00931944|101072813|FG000|Overall Study|Adverse Event|4|||
33321026|NCT00931944|101072813|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
33321027|NCT00931944|101072813|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
33321028|NCT00931944|101072813|FG000|Overall Study|Death|28|||
33321029|NCT00931944|101072813|FG000|Overall Study|Other|2|||
33321030|NCT00993915|101072816|FG000|Overall Study|Insufficient clinical response|3|||
33321031|NCT00993915|101072816|FG000|Overall Study|Withdrawal by Subject|2|||
33321032|NCT00993915|101072816|FG000|Overall Study|Other|1|||
33321033|NCT00993915|101072816|FG000|Overall Study|Ongoing|3|||
33321034|NCT00667355|101072820|FG000|Overall Study|Adverse Event|5|||
33321035|NCT00667355|101072820|FG000|Overall Study|Lost to Follow-up|1|||
33321036|NCT00667355|101072820|FG000|Overall Study|Other reason was not specified|5|||
33321037|NCT02383589|101072826|FG000|Treatment Period|Adverse Event|1|||
33321038|NCT02383589|101072827|FG001|Treatment Period|Adverse Event|3|||
33605168|NCT01533922|102105497|FG003|Overall Study|Lack of Efficacy|0|||
33605169|NCT01533922|102105498|FG004|Overall Study|Lack of Efficacy|0|||
33605170|NCT01533922|102105494|FG000|Overall Study|Protocol Violation|0|||
33605171|NCT01533922|102105495|FG001|Overall Study|Protocol Violation|3|||
33605172|NCT01533922|102105496|FG002|Overall Study|Protocol Violation|0|||
33605173|NCT01533922|102105497|FG003|Overall Study|Protocol Violation|0|||
33605174|NCT01533922|102105498|FG004|Overall Study|Protocol Violation|1|||
33605175|NCT01533922|102105494|FG000|Overall Study|Withdrawal by Subject|3|||
33605176|NCT01533922|102105495|FG001|Overall Study|Withdrawal by Subject|1|||
33605177|NCT01533922|102105496|FG002|Overall Study|Withdrawal by Subject|2|||
33605178|NCT01533922|102105497|FG003|Overall Study|Withdrawal by Subject|2|||
33605179|NCT01533922|102105498|FG004|Overall Study|Withdrawal by Subject|1|||
33605180|NCT01533922|102105494|FG000|Overall Study|Other reason not defined above|2|||
33605181|NCT01533922|102105495|FG001|Overall Study|Other reason not defined above|0|||
33605182|NCT01533922|102105496|FG002|Overall Study|Other reason not defined above|1|||
33605183|NCT01533922|102105497|FG003|Overall Study|Other reason not defined above|0|||
33605184|NCT01533922|102105498|FG004|Overall Study|Other reason not defined above|0|||
33605185|NCT01455194|102105499|FG000|Overall Study|Screen Failure|20|||
33605186|NCT01455194|102105500|FG001|Overall Study|Screen Failure|0|||
33321039|NCT02383589|101072826|FG000|Treatment Period|Lost to Follow-up|0|||
33321040|NCT02383589|101072827|FG001|Treatment Period|Lost to Follow-up|1|||
33398915|NCT00545740|101350155|FG003|Overall Study|Lack of Efficacy|36|||
33605187|NCT01455194|102105501|FG002|Overall Study|Screen Failure|0|||
33321041|NCT02383589|101072826|FG000|Treatment Period|Withdrawal by Subject|0|||
33321042|NCT02383589|101072827|FG001|Treatment Period|Withdrawal by Subject|5|||
33321043|NCT02383589|101072826|FG000|Treatment Period|Non-compliance with study drug|0|||
33321044|NCT02383589|101072827|FG001|Treatment Period|Non-compliance with study drug|1|||
33605188|NCT01455194|102105502|FG003|Overall Study|Screen Failure|0|||
33605189|NCT01455194|102105499|FG000|Overall Study|Randomisation Failure|90|||
33605190|NCT01455194|102105500|FG001|Overall Study|Randomisation Failure|0|||
33605191|NCT01455194|102105501|FG002|Overall Study|Randomisation Failure|0|||
33605192|NCT01455194|102105502|FG003|Overall Study|Randomisation Failure|0|||
33321045|NCT02383589|101072826|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
33321046|NCT02383589|101072827|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
33321047|NCT02383589|101072826|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
33321048|NCT02383589|101072827|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
33321049|NCT02383589|101072826|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
33605193|NCT01455194|102105499|FG000|Overall Study|Deterioration in asthma|12|||
33605194|NCT01455194|102105500|FG001|Overall Study|Deterioration in asthma|6|||
33605195|NCT01455194|102105501|FG002|Overall Study|Deterioration in asthma|14|||
33605196|NCT01455194|102105502|FG003|Overall Study|Deterioration in asthma|9|||
33605197|NCT01455194|102105499|FG000|Overall Study|Adverse Event|1|||
33605198|NCT01455194|102105500|FG001|Overall Study|Adverse Event|1|||
33605199|NCT01455194|102105501|FG002|Overall Study|Adverse Event|1|||
33605200|NCT01455194|102105502|FG003|Overall Study|Adverse Event|3|||
33605201|NCT01455194|102105499|FG000|Overall Study|Withdrawal by Subject|21|||
33605202|NCT01455194|102105500|FG001|Overall Study|Withdrawal by Subject|16|||
33605203|NCT01455194|102105501|FG002|Overall Study|Withdrawal by Subject|12|||
33605204|NCT01455194|102105502|FG003|Overall Study|Withdrawal by Subject|9|||
33605205|NCT01455194|102105499|FG000|Overall Study|Lost to Follow-up|2|||
33605206|NCT01455194|102105500|FG001|Overall Study|Lost to Follow-up|0|||
33605207|NCT01455194|102105501|FG002|Overall Study|Lost to Follow-up|1|||
33605208|NCT01455194|102105502|FG003|Overall Study|Lost to Follow-up|1|||
33605209|NCT01455194|102105499|FG000|Overall Study|Pregnancy|0|||
33605210|NCT01455194|102105500|FG001|Overall Study|Pregnancy|1|||
33605211|NCT01455194|102105501|FG002|Overall Study|Pregnancy|1|||
33197877|NCT00534352|100630331|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
33321050|NCT02383589|101072827|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
33321051|NCT02202551|101072828|FG000|Overall Study|Adverse Event|8|||
33321052|NCT02202551|101072829|FG001|Overall Study|Adverse Event|19|||
33321053|NCT02202551|101072830|FG002|Overall Study|Adverse Event|5|||
33321054|NCT02202551|101072831|FG003|Overall Study|Adverse Event|9|||
33321055|NCT02202551|101072828|FG000|Overall Study|Death|3|||
33510098|NCT02548351|101762156|FG001|Overall Study|Site Closure|5|||
33510099|NCT02548351|101762157|FG002|Overall Study|Site Closure|7|||
33510100|NCT02548351|101762155|FG000|Overall Study|Non-compliance with Study Drug|4|||
33510101|NCT02548351|101762156|FG001|Overall Study|Non-compliance with Study Drug|2|||
33510102|NCT02548351|101762157|FG002|Overall Study|Non-compliance with Study Drug|0|||
33510103|NCT02548351|101762155|FG000|Overall Study|Protocol Violation|2|||
33510104|NCT02548351|101762156|FG001|Overall Study|Protocol Violation|1|||
33510105|NCT02548351|101762157|FG002|Overall Study|Protocol Violation|2|||
33510106|NCT02548351|101762155|FG000|Overall Study|Physician Decision|11|||
33510107|NCT02548351|101762156|FG001|Overall Study|Physician Decision|18|||
33321056|NCT02202551|101072829|FG001|Overall Study|Death|2|||
33321057|NCT02202551|101072830|FG002|Overall Study|Death|1|||
33321058|NCT02202551|101072831|FG003|Overall Study|Death|1|||
33197878|NCT00534352|100630331|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
33197879|NCT00534352|100630331|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
33197880|NCT00534352|100630331|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
33197881|NCT00608829|100630334|FG000|Overall Study|Death|6|||
33197882|NCT00608829|100630334|FG000|Overall Study|Withdrawal by Subject|4|||
33197883|NCT00608829|100630334|FG000|Overall Study|Subject refuses to follow up or return.|5|||
33197884|NCT00965848|100630335|FG000|Overall Study|Protocol Violation|3|||
33197885|NCT00965848|100630336|FG001|Overall Study|Protocol Violation|0|||
33197886|NCT00965848|100630337|FG002|Overall Study|Protocol Violation|1|||
33197887|NCT00965848|100630335|FG000|Overall Study|Death|11|||
33197888|NCT00965848|100630336|FG001|Overall Study|Death|1|||
33197889|NCT00965848|100630337|FG002|Overall Study|Death|5|||
33197890|NCT00965848|100630335|FG000|Overall Study|Lost to Follow-up|0|||
33197891|NCT00965848|100630336|FG001|Overall Study|Lost to Follow-up|0|||
33197892|NCT00965848|100630337|FG002|Overall Study|Lost to Follow-up|1|||
33197893|NCT00965848|100630335|FG000|Overall Study|Withdrawal by Subject|1|||
33197894|NCT00965848|100630336|FG001|Overall Study|Withdrawal by Subject|0|||
33197895|NCT00965848|100630337|FG002|Overall Study|Withdrawal by Subject|0|||
33197896|NCT00965848|100630335|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
33197897|NCT00965848|100630336|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
33197898|NCT00965848|100630337|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
33197899|NCT00965848|100630335|FG000|Overall Study|Not Clinically Evaluable|7|||
33197900|NCT00965848|100630336|FG001|Overall Study|Not Clinically Evaluable|1|||
33197901|NCT00965848|100630337|FG002|Overall Study|Not Clinically Evaluable|1|||
33321059|NCT02202551|101072828|FG000|Overall Study|Lost to Follow-up|0|||
33197902|NCT00965848|100630335|FG000|Overall Study|Other|5|||
33605212|NCT01455194|102105502|FG003|Overall Study|Pregnancy|0|||
33605213|NCT01455194|102105499|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
33605214|NCT01455194|102105500|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
33605215|NCT01455194|102105501|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
33605216|NCT01455194|102105502|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
33197903|NCT00965848|100630336|FG001|Overall Study|Other|0|||
33197904|NCT00965848|100630337|FG002|Overall Study|Other|1|||
33197905|NCT00440271|100630340|FG000|Overall Study|Protocol Violation|1|||
33197906|NCT00440271|100630341|FG001|Overall Study|Protocol Violation|1|||
33321060|NCT02202551|101072829|FG001|Overall Study|Lost to Follow-up|1|||
33321061|NCT02202551|101072830|FG002|Overall Study|Lost to Follow-up|0|||
33321062|NCT02202551|101072831|FG003|Overall Study|Lost to Follow-up|1|||
33510108|NCT02548351|101762157|FG002|Overall Study|Physician Decision|11|||
33510109|NCT02548351|101762155|FG000|Overall Study|Lost to Follow-up|43|||
33510110|NCT02548351|101762156|FG001|Overall Study|Lost to Follow-up|50|||
33321063|NCT02202551|101072828|FG000|Overall Study|Needed to take excluded medication|0|||
33321064|NCT02202551|101072829|FG001|Overall Study|Needed to take excluded medication|2|||
33321065|NCT02202551|101072830|FG002|Overall Study|Needed to take excluded medication|0|||
33321066|NCT02202551|101072831|FG003|Overall Study|Needed to take excluded medication|1|||
33321067|NCT02202551|101072828|FG000|Overall Study|Subject moved away|0|||
33321068|NCT02202551|101072829|FG001|Overall Study|Subject moved away|1|||
33321069|NCT02202551|101072830|FG002|Overall Study|Subject moved away|0|||
33321070|NCT02202551|101072831|FG003|Overall Study|Subject moved away|0|||
33321071|NCT02202551|101072828|FG000|Overall Study|DBS surgery|3|||
33321072|NCT02202551|101072829|FG001|Overall Study|DBS surgery|0|||
33321073|NCT02202551|101072830|FG002|Overall Study|DBS surgery|0|||
33321074|NCT02202551|101072831|FG003|Overall Study|DBS surgery|0|||
33321075|NCT02202551|101072828|FG000|Overall Study|Dyskinesia upon taper|1|||
33321076|NCT02202551|101072829|FG001|Overall Study|Dyskinesia upon taper|0|||
33321077|NCT02202551|101072830|FG002|Overall Study|Dyskinesia upon taper|0|||
33321078|NCT02202551|101072831|FG003|Overall Study|Dyskinesia upon taper|0|||
33321079|NCT02202551|101072828|FG000|Overall Study|Lack of Efficacy|0|||
33321080|NCT02202551|101072829|FG001|Overall Study|Lack of Efficacy|1|||
33321081|NCT02202551|101072830|FG002|Overall Study|Lack of Efficacy|0|||
33321082|NCT02202551|101072831|FG003|Overall Study|Lack of Efficacy|0|||
33321083|NCT02202551|101072828|FG000|Overall Study|Physician Decision|1|||
33321084|NCT02202551|101072829|FG001|Overall Study|Physician Decision|0|||
33398916|NCT00545740|101350152|FG000|Overall Study|Withdrawal by Subject|17|||
33510111|NCT02548351|101762157|FG002|Overall Study|Lost to Follow-up|57|||
33510112|NCT02548351|101762155|FG000|Overall Study|Other|19|||
33510113|NCT02548351|101762156|FG001|Overall Study|Other|16|||
33510114|NCT02548351|101762157|FG002|Overall Study|Other|20|||
33510115|NCT02548351|101762155|FG000|Overall Study|Missing|1|||
33510116|NCT02548351|101762156|FG001|Overall Study|Missing|1|||
33510117|NCT02548351|101762157|FG002|Overall Study|Missing|0|||
33510118|NCT01083186|101762158|FG000|Overall Study|Lost to Follow-up|48|||
33510119|NCT01083186|101762158|FG000|Overall Study|Consent Withdrawal|7|||
33510120|NCT01083186|101762158|FG000|Overall Study|Death|3|||
33510121|NCT01083186|101762158|FG000|Overall Study|Adverse Event|3|||
33510122|NCT01083186|101762158|FG000|Overall Study|Lack of Efficacy|2|||
33510123|NCT01083186|101762158|FG000|Overall Study|Hemodialysis Initiation|28|||
33510124|NCT01083186|101762158|FG000|Overall Study|Administrative Reasons|2|||
33510125|NCT01083186|101762158|FG000|Overall Study|Non-compliance to Study Treatment|1|||
33510126|NCT02847494|101762159|FG000|Overall Study|Lost to Follow-up|8|||
33510127|NCT02847494|101762160|FG001|Overall Study|Lost to Follow-up|5|||
33510128|NCT05087966|101762167|FG000|Overall Study|Lost to Follow-up|1|||
33510129|NCT05087966|101762167|FG000|Overall Study|Withdrawal by Subject|5|||
33510130|NCT04351373|101762168|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
33510131|NCT04034251|101762169|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
33510132|NCT04034251|101762170|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
33510133|NCT04034251|101762171|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
33510134|NCT03348930|101762177|FG000|Washout (1 Week)|Lost to Follow-up|1|||
33510135|NCT03348930|101762178|FG001|Washout (1 Week)|Lost to Follow-up|1|||
33510136|NCT04064411|101762181|FG000|Overall Study|Adverse Event|29|||
33510137|NCT04064411|101762182|FG001|Overall Study|Adverse Event|19|||
33510138|NCT04064411|101762181|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
33510139|NCT04064411|101762182|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
33510140|NCT04064411|101762181|FG000|Overall Study|Protocol Deviation|0|||
33510141|NCT04064411|101762182|FG001|Overall Study|Protocol Deviation|2|||
33510142|NCT04064411|101762181|FG000|Overall Study|Withdrawal by Subject|25|||
33510143|NCT04064411|101762182|FG001|Overall Study|Withdrawal by Subject|29|||
33510144|NCT04064411|101762181|FG000|Overall Study|Lost to Follow-up|5|||
33510145|NCT04064411|101762182|FG001|Overall Study|Lost to Follow-up|2|||
33510146|NCT04064411|101762181|FG000|Overall Study|Other than Specified|4|||
33510147|NCT04064411|101762182|FG001|Overall Study|Other than Specified|1|||
33510148|NCT04064411|101762181|FG000|Overall Study|Death|1|||
33510149|NCT04064411|101762182|FG001|Overall Study|Death|0|||
33605217|NCT01455194|102105499|FG000|Overall Study|Miscellaneous|4|||
33605218|NCT01455194|102105500|FG001|Overall Study|Miscellaneous|5|||
33605219|NCT01455194|102105501|FG002|Overall Study|Miscellaneous|1|||
33321085|NCT02202551|101072830|FG002|Overall Study|Physician Decision|0|||
33321086|NCT02202551|101072831|FG003|Overall Study|Physician Decision|0|||
33398917|NCT00545740|101350153|FG001|Overall Study|Withdrawal by Subject|15|||
33510150|NCT03990571|101762184|FG000|Overall Study|Withdrawal by Subject|1|||
33321087|NCT02202551|101072828|FG000|Overall Study|Site closure|3|||
33321088|NCT02202551|101072829|FG001|Overall Study|Site closure|0|||
33510151|NCT03990571|101762184|FG000|Overall Study|Insurance Issues|3|||
33510152|NCT03990571|101762184|FG000|Overall Study|Covid Restrictions|2|||
33510153|NCT00231114|101762188|FG000|Randomized|Withdrawal by Subject|6|||
33510154|NCT00231114|101762189|FG001|Randomized|Withdrawal by Subject|3|||
33510155|NCT00231114|101762188|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
33510156|NCT00231114|101762189|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
33510157|NCT00231114|101762188|FG000|Post-Treatment Period|Lost to Follow-up|6|||
33398918|NCT00545740|101350154|FG002|Overall Study|Withdrawal by Subject|16|||
33398919|NCT00545740|101350155|FG003|Overall Study|Withdrawal by Subject|18|||
33510158|NCT00231114|101762189|FG001|Post-Treatment Period|Lost to Follow-up|1|||
33510159|NCT00231114|101762188|FG000|Post-Treatment Period|Physician Decision|1|||
33510160|NCT00231114|101762189|FG001|Post-Treatment Period|Physician Decision|0|||
33510161|NCT00231114|101762188|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
33510162|NCT00231114|101762189|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
33510163|NCT01899742|101762192|FG000|Overall Study|Adverse Event|5|||
33510164|NCT01899742|101762193|FG001|Overall Study|Adverse Event|4|||
33510165|NCT01899742|101762192|FG000|Overall Study|Lack of Efficacy|1|||
33510166|NCT01899742|101762193|FG001|Overall Study|Lack of Efficacy|5|||
33510167|NCT01899742|101762192|FG000|Overall Study|Protocol Violation|2|||
33510168|NCT01899742|101762193|FG001|Overall Study|Protocol Violation|2|||
33510169|NCT01899742|101762192|FG000|Overall Study|Withdrawal by Subject|9|||
33510170|NCT01899742|101762193|FG001|Overall Study|Withdrawal by Subject|5|||
33510171|NCT01966068|101762194|FG000|Overall Study|Withdrawal by Subject|57|||
33510172|NCT01966068|101762194|FG000|Overall Study|Lost to Follow-up|81|||
33510173|NCT04021121|101762197|FG000|Overall Study|Death|3|||
33510174|NCT04021121|101762198|FG001|Overall Study|Death|3|||
33510175|NCT04021121|101762199|FG002|Overall Study|Death|5|||
33510176|NCT04021121|101762200|FG003|Overall Study|Death|4|||
33510177|NCT03702010|101762201|FG000|Follow-up (30days)|Lack of Efficacy|2|||
33510178|NCT03702010|101762202|FG001|Follow-up (30days)|Lack of Efficacy|2|||
33510179|NCT02655016|101762203|FG000|Overall Study|Disease progression|6|||
33510180|NCT02655016|101762204|FG001|Overall Study|Disease progression|4|||
33510181|NCT02655016|101762203|FG000|Overall Study|Site closed|0|||
33510182|NCT02655016|101762204|FG001|Overall Study|Site closed|1|||
33510183|NCT02655016|101762203|FG000|Overall Study|Death|30|||
33510184|NCT02655016|101762204|FG001|Overall Study|Death|48|||
33398920|NCT00545740|101350152|FG000|Overall Study|Adverse Event|10|||
33510185|NCT02655016|101762203|FG000|Overall Study|Lost to Follow-up|1|||
33510186|NCT02655016|101762204|FG001|Overall Study|Lost to Follow-up|1|||
33510187|NCT02655016|101762203|FG000|Overall Study|Withdrawal by Subject|18|||
33510188|NCT02655016|101762204|FG001|Overall Study|Withdrawal by Subject|36|||
33510189|NCT00956592|101762215|FG000|Overall Study|Protocol Violation|1|||
33510190|NCT00956592|101762216|FG001|Overall Study|Protocol Violation|3|||
33510191|NCT01931995|101762217|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
33510192|NCT01931995|101762218|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
33510193|NCT01931995|101762217|FG000|First Intervention (1 Day)|Physician Decision|1|||
33510194|NCT01931995|101762218|FG001|First Intervention (1 Day)|Physician Decision|1|||
33510195|NCT01931995|101762217|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
33510196|NCT01931995|101762218|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
33510197|NCT02651155|101762222|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
33510198|NCT02651155|101762223|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
33510199|NCT02651155|101762222|FG000|Overall Study|Voluntary Withdrawal|5|||
33510200|NCT02651155|101762223|FG001|Overall Study|Voluntary Withdrawal|0|||
33510201|NCT01878084|101762224|FG000|Overall Study|Physician Decision|2|||
33510202|NCT01820572|101762225|FG000|Randomization|Not Treated|2|||
33510203|NCT01820572|101762226|FG001|Randomization|Not Treated|1|||
33510204|NCT01820572|101762225|FG000|Treatment Period|Adverse Event|12|||
33510205|NCT01820572|101762226|FG001|Treatment Period|Adverse Event|7|||
33510206|NCT01820572|101762225|FG000|Treatment Period|Death|3|||
33510207|NCT01820572|101762226|FG001|Treatment Period|Death|3|||
33510208|NCT01820572|101762225|FG000|Treatment Period|Lack of Efficacy|1|||
33510209|NCT01820572|101762226|FG001|Treatment Period|Lack of Efficacy|0|||
33510210|NCT01820572|101762225|FG000|Treatment Period|poor/non compliance|0|||
33510211|NCT01820572|101762226|FG001|Treatment Period|poor/non compliance|3|||
33510212|NCT01820572|101762225|FG000|Treatment Period|request to discontinue|6|||
33510213|NCT01820572|101762226|FG001|Treatment Period|request to discontinue|11|||
33510214|NCT01820572|101762225|FG000|Treatment Period|No longer meets study criteria|3|||
33510215|NCT01820572|101762226|FG001|Treatment Period|No longer meets study criteria|10|||
33510216|NCT01820572|101762225|FG000|Treatment Period|withdrew consent|1|||
33510217|NCT01820572|101762226|FG001|Treatment Period|withdrew consent|2|||
33197907|NCT00440271|100630340|FG000|Overall Study|Adverse Event|0|||
33510218|NCT00562302|101762229|FG000|Overall Study|Lost to Follow-up|3|||
33510219|NCT00562302|101762230|FG001|Overall Study|Lost to Follow-up|3|||
33510220|NCT00562302|101762229|FG000|Overall Study|Adverse Event|0|||
33510221|NCT00562302|101762230|FG001|Overall Study|Adverse Event|6|||
33510222|NCT00562302|101762229|FG000|Overall Study|Non-compliance|1|||
33510223|NCT00562302|101762230|FG001|Overall Study|Non-compliance|2|||
33510224|NCT00562302|101762229|FG000|Overall Study|Withdrawal by Subject|7|||
33510225|NCT00562302|101762230|FG001|Overall Study|Withdrawal by Subject|8|||
33510226|NCT00562302|101762229|FG000|Overall Study|Death|1|||
33510227|NCT00562302|101762230|FG001|Overall Study|Death|2|||
33197908|NCT00440271|100630341|FG001|Overall Study|Adverse Event|1|||
33510228|NCT00562302|101762229|FG000|Overall Study|Lung resection prior to study completion|7|||
33510229|NCT00562302|101762230|FG001|Overall Study|Lung resection prior to study completion|7|||
33510230|NCT00562302|101762229|FG000|Overall Study|Not stated|1|||
33510231|NCT00562302|101762230|FG001|Overall Study|Not stated|4|||
33510232|NCT03483961|101762231|FG000|Overall Study|Lost to Follow-up|7|||
33510233|NCT03483961|101762232|FG001|Overall Study|Lost to Follow-up|6|||
33510234|NCT03483961|101762233|FG002|Overall Study|Lost to Follow-up|6|||
33510235|NCT03483961|101762234|FG003|Overall Study|Lost to Follow-up|6|||
33510236|NCT03483961|101762235|FG004|Overall Study|Lost to Follow-up|6|||
33510237|NCT03483961|101762236|FG005|Overall Study|Lost to Follow-up|4|||
33510238|NCT03483961|101762237|FG006|Overall Study|Lost to Follow-up|4|||
33510239|NCT03483961|101762238|FG007|Overall Study|Lost to Follow-up|11|||
33510240|NCT03483961|101762239|FG008|Overall Study|Lost to Follow-up|1|||
33510241|NCT03483961|101762240|FG009|Overall Study|Lost to Follow-up|0|||
33510242|NCT03483961|101762231|FG000|Overall Study|Withdrawal by Subject|3|||
33510243|NCT03483961|101762232|FG001|Overall Study|Withdrawal by Subject|4|||
33510244|NCT03483961|101762233|FG002|Overall Study|Withdrawal by Subject|5|||
33510245|NCT03483961|101762234|FG003|Overall Study|Withdrawal by Subject|3|||
33510246|NCT03483961|101762235|FG004|Overall Study|Withdrawal by Subject|4|||
33510247|NCT03483961|101762236|FG005|Overall Study|Withdrawal by Subject|2|||
33510248|NCT03483961|101762237|FG006|Overall Study|Withdrawal by Subject|1|||
33510249|NCT03483961|101762238|FG007|Overall Study|Withdrawal by Subject|2|||
33605220|NCT01455194|102105502|FG003|Overall Study|Miscellaneous|4|||
33605221|NCT02014584|102105503|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
33605222|NCT02014584|102105504|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
33605223|NCT02014584|102105505|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
33605224|NCT02014584|102105506|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
33605225|NCT02014584|102105507|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
33605226|NCT02014584|102105508|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
33605227|NCT02014584|102105503|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
33605228|NCT02014584|102105504|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
33605229|NCT02014584|102105505|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
33605230|NCT02014584|102105506|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
33605231|NCT02014584|102105507|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
33605232|NCT02014584|102105508|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
33605233|NCT02014584|102105503|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
33605234|NCT02014584|102105504|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
33605235|NCT02014584|102105505|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
33605236|NCT02014584|102105506|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
33605237|NCT02014584|102105507|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
33605238|NCT02014584|102105508|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
33605239|NCT02014584|102105503|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
33605240|NCT02014584|102105504|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
33605241|NCT02014584|102105505|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
33605242|NCT02014584|102105506|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
33605243|NCT02014584|102105507|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
33605244|NCT02014584|102105508|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
33605245|NCT02014584|102105503|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
33605246|NCT02014584|102105504|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
33605247|NCT02014584|102105505|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
33605248|NCT02014584|102105506|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
33605249|NCT02014584|102105507|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
33631274|NCT03279081|102202900|FG001|Overall Study|Lost to Follow-up|8|||
33510250|NCT03483961|101762239|FG008|Overall Study|Withdrawal by Subject|1|||
33510251|NCT03483961|101762240|FG009|Overall Study|Withdrawal by Subject|0|||
33510252|NCT03483961|101762231|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
33567608|NCT02723955|101973206|FG037|Crossover/ Re-treatment Phase|Death|1|||
33321089|NCT02202551|101072830|FG002|Overall Study|Site closure|0|||
33321090|NCT02202551|101072831|FG003|Overall Study|Site closure|1|||
33321091|NCT02202551|101072828|FG000|Overall Study|Unable to complete visits per protocol|1|||
33321092|NCT02202551|101072829|FG001|Overall Study|Unable to complete visits per protocol|0|||
33321093|NCT02202551|101072830|FG002|Overall Study|Unable to complete visits per protocol|0|||
33321094|NCT02202551|101072831|FG003|Overall Study|Unable to complete visits per protocol|0|||
33321095|NCT02202551|101072828|FG000|Overall Study|Worsening Dyskinesia|0|||
33321096|NCT02202551|101072829|FG001|Overall Study|Worsening Dyskinesia|0|||
33321097|NCT02202551|101072830|FG002|Overall Study|Worsening Dyskinesia|0|||
33605250|NCT02014584|102105508|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
33605251|NCT00031460|102105520|FG000|Overall Study|Lost to Follow-up|0|||
33605252|NCT00031460|102105521|FG001|Overall Study|Lost to Follow-up|1|||
33605253|NCT00031460|102105520|FG000|Overall Study|Withdrawal by Subject|1|||
33605254|NCT00031460|102105521|FG001|Overall Study|Withdrawal by Subject|1|||
33605255|NCT00031460|102105520|FG000|Overall Study|Non-Compliant|1|||
33605256|NCT00031460|102105521|FG001|Overall Study|Non-Compliant|1|||
33605257|NCT00031460|102105520|FG000|Overall Study|Death|0|||
33605258|NCT00031460|102105521|FG001|Overall Study|Death|1|||
33605259|NCT00031460|102105520|FG000|Overall Study|Reactivation of Disease|5|||
33197909|NCT00440271|100630340|FG000|Overall Study|Lost to Follow-up|1|||
33605260|NCT00031460|102105521|FG001|Overall Study|Reactivation of Disease|9|||
33605261|NCT00031460|102105520|FG000|Overall Study|Disruption of blinded drug supply|2|||
33605262|NCT00031460|102105521|FG001|Overall Study|Disruption of blinded drug supply|0|||
33631275|NCT03279081|102202899|FG000|Overall Study|Death|0|||
33197910|NCT00440271|100630341|FG001|Overall Study|Lost to Follow-up|0|||
33197911|NCT00440271|100630340|FG000|Overall Study|Withdrawal by Subject|0|||
33321098|NCT02202551|101072831|FG003|Overall Study|Worsening Dyskinesia|1|||
33321099|NCT02202551|101072828|FG000|Overall Study|Protocol Violation|0|||
33321100|NCT02202551|101072829|FG001|Overall Study|Protocol Violation|1|||
33321101|NCT02202551|101072830|FG002|Overall Study|Protocol Violation|0|||
33321102|NCT02202551|101072831|FG003|Overall Study|Protocol Violation|0|||
33321103|NCT02202551|101072828|FG000|Overall Study|Sponsor's decision|2|||
33321104|NCT02202551|101072829|FG001|Overall Study|Sponsor's decision|0|||
33321105|NCT02202551|101072830|FG002|Overall Study|Sponsor's decision|0|||
33321106|NCT02202551|101072831|FG003|Overall Study|Sponsor's decision|0|||
33398921|NCT00545740|101350153|FG001|Overall Study|Adverse Event|18|||
33398922|NCT00545740|101350154|FG002|Overall Study|Adverse Event|19|||
33398923|NCT00545740|101350155|FG003|Overall Study|Adverse Event|9|||
33321107|NCT02202551|101072828|FG000|Overall Study|Subject unwilling to proceed|1|||
33321108|NCT02202551|101072829|FG001|Overall Study|Subject unwilling to proceed|5|||
33321109|NCT02202551|101072830|FG002|Overall Study|Subject unwilling to proceed|3|||
33321110|NCT02202551|101072831|FG003|Overall Study|Subject unwilling to proceed|5|||
33321111|NCT02202551|101072828|FG000|Overall Study|Subject consent withdrawn|0|||
33321112|NCT02202551|101072829|FG001|Overall Study|Subject consent withdrawn|3|||
33398924|NCT00545740|101350152|FG000|Overall Study|Lost to Follow-up|7|||
33398925|NCT00545740|101350153|FG001|Overall Study|Lost to Follow-up|5|||
33398926|NCT00545740|101350154|FG002|Overall Study|Lost to Follow-up|5|||
33321113|NCT02202551|101072830|FG002|Overall Study|Subject consent withdrawn|1|||
33321114|NCT02202551|101072831|FG003|Overall Study|Subject consent withdrawn|2|||
33321115|NCT02202551|101072828|FG000|Overall Study|eGFR<50mL/min/m2|2|||
33321116|NCT02202551|101072829|FG001|Overall Study|eGFR<50mL/min/m2|2|||
33398927|NCT00545740|101350155|FG003|Overall Study|Lost to Follow-up|6|||
33510253|NCT03483961|101762232|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33510254|NCT03483961|101762233|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33510255|NCT03483961|101762234|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33510256|NCT03483961|101762235|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33510257|NCT03483961|101762236|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33197912|NCT00440271|100630341|FG001|Overall Study|Withdrawal by Subject|2|||
33197913|NCT00440271|100630340|FG000|Overall Study|Lack of Efficacy|0|||
33605263|NCT00031460|102105520|FG000|Overall Study|Confirmed unevaluable|0|||
33605264|NCT00031460|102105521|FG001|Overall Study|Confirmed unevaluable|1|||
33605265|NCT03769311|102105522|FG000|Overall Study|Withdrawal by Subject|1|||
33605266|NCT01038713|102105523|FG000|Overall Study|Patient to hospice|1|||
33605267|NCT01038713|102105524|FG001|Overall Study|Patient to hospice|1|||
33605268|NCT01038713|102105525|FG002|Overall Study|Patient to hospice|1|||
33605269|NCT01038713|102105523|FG000|Overall Study|Lost to Follow-up|3|||
33605270|NCT01038713|102105524|FG001|Overall Study|Lost to Follow-up|0|||
33197914|NCT00440271|100630341|FG001|Overall Study|Lack of Efficacy|1|||
33197915|NCT00440271|100630340|FG000|Overall Study|Due to closure of trial|8|||
33197916|NCT00440271|100630341|FG001|Overall Study|Due to closure of trial|10|||
33197917|NCT00440271|100630340|FG000|Overall Study|Other|2|||
33197918|NCT00440271|100630341|FG001|Overall Study|Other|0|||
33197919|NCT00887341|100630342|FG000|Overall Study|Refused treatment|1|||
33510258|NCT03483961|101762237|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33510259|NCT03483961|101762238|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33510260|NCT03483961|101762239|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33510261|NCT03483961|101762240|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
33510262|NCT03483961|101762231|FG000|Overall Study|Adverse Event|0|||
33510263|NCT03483961|101762232|FG001|Overall Study|Adverse Event|0|||
33510264|NCT03483961|101762233|FG002|Overall Study|Adverse Event|1|||
33510265|NCT03483961|101762234|FG003|Overall Study|Adverse Event|0|||
33510266|NCT03483961|101762235|FG004|Overall Study|Adverse Event|0|||
33605271|NCT01038713|102105525|FG002|Overall Study|Lost to Follow-up|0|||
33605272|NCT01038713|102105523|FG000|Overall Study|Neuroendocrine Tumor|0|||
33605273|NCT01038713|102105524|FG001|Overall Study|Neuroendocrine Tumor|1|||
33605274|NCT01038713|102105525|FG002|Overall Study|Neuroendocrine Tumor|0|||
33605275|NCT01038713|102105523|FG000|Overall Study|died from PEP|0|||
33605276|NCT01038713|102105524|FG001|Overall Study|died from PEP|1|||
33605277|NCT01038713|102105525|FG002|Overall Study|died from PEP|0|||
33605278|NCT01038713|102105523|FG000|Overall Study|Autoimmune Pancreatitis|1|||
33605279|NCT01038713|102105524|FG001|Overall Study|Autoimmune Pancreatitis|0|||
33605280|NCT01038713|102105525|FG002|Overall Study|Autoimmune Pancreatitis|0|||
33605281|NCT03755661|102105526|FG000|Overall Study|Lost to Follow-up|1|||
33197920|NCT00887341|100630343|FG001|Overall Study|Refused treatment|0|||
33605282|NCT03755661|102105527|FG001|Overall Study|Lost to Follow-up|0|||
33197921|NCT00887341|100630342|FG000|Overall Study|Withdrawal by Subject|1|||
33197922|NCT00887341|100630343|FG001|Overall Study|Withdrawal by Subject|1|||
33197923|NCT00887341|100630342|FG000|Overall Study|Adverse Event|0|||
33197924|NCT00887341|100630343|FG001|Overall Study|Adverse Event|1|||
33197925|NCT00887341|100630342|FG000|Overall Study|Lost to Follow-up|0|||
33197926|NCT00887341|100630343|FG001|Overall Study|Lost to Follow-up|1|||
33197927|NCT00718042|100630344|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
33321117|NCT02202551|101072830|FG002|Overall Study|eGFR<50mL/min/m2|0|||
33321118|NCT02202551|101072831|FG003|Overall Study|eGFR<50mL/min/m2|1|||
33321119|NCT03716050|101072832|FG000|Overall Study|Lost to Follow-up|0|||
33321120|NCT03716050|101072833|FG001|Overall Study|Lost to Follow-up|0|||
33321121|NCT03716050|101072834|FG002|Overall Study|Lost to Follow-up|1|||
33321122|NCT03716050|101072835|FG003|Overall Study|Lost to Follow-up|0|||
33321123|NCT03716050|101072836|FG004|Overall Study|Lost to Follow-up|0|||
33605283|NCT00162266|102105528|FG000|Double-Blind Period|Adverse Event|5|||
33605284|NCT00162266|102105529|FG001|Double-Blind Period|Adverse Event|9|||
33605285|NCT00162266|102105530|FG002|Double-Blind Period|Adverse Event|11|||
33605286|NCT00162266|102105531|FG003|Double-Blind Period|Adverse Event|0|||
33605287|NCT00162266|102105528|FG000|Double-Blind Period|Death|0|||
33197928|NCT00718042|100630345|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
33197929|NCT00718042|100630346|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
33197930|NCT00718042|100630347|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
33605288|NCT00162266|102105529|FG001|Double-Blind Period|Death|1|||
33605289|NCT00162266|102105530|FG002|Double-Blind Period|Death|0|||
33197931|NCT00718042|100630348|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
33321124|NCT03716050|101072837|FG005|Overall Study|Lost to Follow-up|0|||
33398928|NCT00545740|101350152|FG000|Overall Study|Protocol Violation|1|||
33398929|NCT00545740|101350153|FG001|Overall Study|Protocol Violation|3|||
33398930|NCT00545740|101350154|FG002|Overall Study|Protocol Violation|1|||
33398931|NCT00545740|101350155|FG003|Overall Study|Protocol Violation|0|||
33398932|NCT00545740|101350152|FG000|Overall Study|Non-compliance|0|||
33398933|NCT00545740|101350153|FG001|Overall Study|Non-compliance|2|||
33398934|NCT00545740|101350154|FG002|Overall Study|Non-compliance|1|||
33398935|NCT00545740|101350155|FG003|Overall Study|Non-compliance|0|||
33398936|NCT00545740|101350152|FG000|Overall Study|Moved|2|||
33398937|NCT00545740|101350153|FG001|Overall Study|Moved|0|||
33398938|NCT00545740|101350154|FG002|Overall Study|Moved|1|||
33398939|NCT00545740|101350155|FG003|Overall Study|Moved|0|||
33398940|NCT00545740|101350152|FG000|Overall Study|Diverticulitis attack|0|||
33398941|NCT00545740|101350153|FG001|Overall Study|Diverticulitis attack|0|||
33398942|NCT00545740|101350154|FG002|Overall Study|Diverticulitis attack|1|||
33398943|NCT00545740|101350155|FG003|Overall Study|Diverticulitis attack|1|||
33398944|NCT00545740|101350152|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
33398945|NCT00545740|101350153|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
33398946|NCT00545740|101350154|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
33398947|NCT00545740|101350155|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
33398948|NCT00545740|101350152|FG000|Overall Study|Site closure|1|||
33398949|NCT00545740|101350153|FG001|Overall Study|Site closure|0|||
33398950|NCT00545740|101350154|FG002|Overall Study|Site closure|0|||
33398951|NCT00545740|101350155|FG003|Overall Study|Site closure|0|||
33398952|NCT00545740|101350152|FG000|Overall Study|Missed visit|1|||
33605290|NCT00162266|102105531|FG003|Double-Blind Period|Death|0|||
33605291|NCT00162266|102105528|FG000|Double-Blind Period|Lost to Follow-up|1|||
33605292|NCT00162266|102105529|FG001|Double-Blind Period|Lost to Follow-up|2|||
33197932|NCT00718042|100630349|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
33197933|NCT00718042|100630344|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
33197934|NCT00718042|100630345|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
33321125|NCT03716050|101072838|FG006|Overall Study|Lost to Follow-up|0|||
33321126|NCT03716050|101072839|FG007|Overall Study|Lost to Follow-up|0|||
33321127|NCT03716050|101072832|FG000|Overall Study|Physician Decision|0|||
33321128|NCT03716050|101072833|FG001|Overall Study|Physician Decision|0|||
33321129|NCT03716050|101072834|FG002|Overall Study|Physician Decision|0|||
33197935|NCT00718042|100630346|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
33197936|NCT00718042|100630347|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
33197937|NCT00718042|100630348|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
33197938|NCT00718042|100630349|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
33197939|NCT00718042|100630344|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
33197940|NCT00718042|100630345|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
33197941|NCT00718042|100630346|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
33197942|NCT00718042|100630347|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
33197943|NCT00718042|100630348|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
33197944|NCT00718042|100630349|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
33197945|NCT00718042|100630344|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
33197946|NCT00718042|100630345|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
33197947|NCT00718042|100630346|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
33197948|NCT00718042|100630347|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
33321130|NCT03716050|101072835|FG003|Overall Study|Physician Decision|1|||
33321131|NCT03716050|101072836|FG004|Overall Study|Physician Decision|0|||
33321132|NCT03716050|101072837|FG005|Overall Study|Physician Decision|0|||
33321133|NCT03716050|101072838|FG006|Overall Study|Physician Decision|0|||
33398953|NCT00545740|101350153|FG001|Overall Study|Missed visit|0|||
33398954|NCT00545740|101350154|FG002|Overall Study|Missed visit|0|||
33510267|NCT03483961|101762236|FG005|Overall Study|Adverse Event|0|||
33510268|NCT03483961|101762237|FG006|Overall Study|Adverse Event|0|||
33605293|NCT00162266|102105530|FG002|Double-Blind Period|Lost to Follow-up|0|||
33605294|NCT00162266|102105531|FG003|Double-Blind Period|Lost to Follow-up|0|||
33605295|NCT00162266|102105528|FG000|Double-Blind Period|Other Reason|1|||
33605296|NCT00162266|102105529|FG001|Double-Blind Period|Other Reason|0|||
33605297|NCT00162266|102105530|FG002|Double-Blind Period|Other Reason|1|||
33605298|NCT00162266|102105531|FG003|Double-Blind Period|Other Reason|0|||
33605299|NCT00162266|102105528|FG000|Double-Blind Period|Lack of Efficacy|13|||
33605300|NCT00162266|102105529|FG001|Double-Blind Period|Lack of Efficacy|17|||
33605301|NCT00162266|102105530|FG002|Double-Blind Period|Lack of Efficacy|30|||
33197949|NCT00718042|100630348|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
33321134|NCT03716050|101072839|FG007|Overall Study|Physician Decision|0|||
33398955|NCT00545740|101350155|FG003|Overall Study|Missed visit|0|||
33398956|NCT00545740|101350152|FG000|Overall Study|Physician Decision|0|||
33398957|NCT00545740|101350153|FG001|Overall Study|Physician Decision|0|||
33398958|NCT00545740|101350154|FG002|Overall Study|Physician Decision|3|||
33398959|NCT00545740|101350155|FG003|Overall Study|Physician Decision|0|||
33398960|NCT00545740|101350152|FG000|Overall Study|Accepted only monthly telephone calls|1|||
33605302|NCT00162266|102105531|FG003|Double-Blind Period|Lack of Efficacy|0|||
33321135|NCT03716050|101072832|FG000|Overall Study|Protocol Violation|0|||
33321136|NCT03716050|101072833|FG001|Overall Study|Protocol Violation|0|||
33321137|NCT03716050|101072834|FG002|Overall Study|Protocol Violation|0|||
33321138|NCT03716050|101072835|FG003|Overall Study|Protocol Violation|1|||
33321139|NCT03716050|101072836|FG004|Overall Study|Protocol Violation|0|||
33321140|NCT03716050|101072837|FG005|Overall Study|Protocol Violation|0|||
33321141|NCT03716050|101072838|FG006|Overall Study|Protocol Violation|0|||
33321142|NCT03716050|101072839|FG007|Overall Study|Protocol Violation|2|||
33321143|NCT01233869|101072840|FG000|Initial Treatment Period (24 Months)|Death|1|||
33321144|NCT01233869|101072841|FG001|Initial Treatment Period (24 Months)|Death|0|||
33321145|NCT01233869|101072842|FG002|Initial Treatment Period (24 Months)|Death|0|||
33321146|NCT01233869|101072843|FG003|Initial Treatment Period (24 Months)|Death|0|||
33321147|NCT01233869|101072840|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
33321148|NCT01233869|101072841|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
33321149|NCT01233869|101072842|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
33321150|NCT01233869|101072843|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
33321151|NCT01233869|101072840|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
33321152|NCT01233869|101072841|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
33321153|NCT01233869|101072842|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
33321154|NCT01233869|101072843|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
33321155|NCT01233869|101072840|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
33321156|NCT01233869|101072841|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
33321157|NCT01233869|101072842|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
33321158|NCT01233869|101072843|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
33321159|NCT01233869|101072840|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
33321160|NCT01233869|101072841|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
33321161|NCT01233869|101072842|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
33321162|NCT01233869|101072843|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
33321163|NCT01233869|101072840|FG000|Extended Treatment Period (46 Months)|Other|3|||
33321164|NCT01233869|101072841|FG001|Extended Treatment Period (46 Months)|Other|0|||
33321165|NCT01233869|101072842|FG002|Extended Treatment Period (46 Months)|Other|0|||
33321166|NCT01233869|101072843|FG003|Extended Treatment Period (46 Months)|Other|3|||
33321167|NCT01233869|101072840|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
33321168|NCT01233869|101072841|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
33321169|NCT01233869|101072842|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
33321170|NCT01233869|101072843|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
33321171|NCT03548987|101072844|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
33321172|NCT03548987|101072845|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
33321173|NCT03548987|101072844|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
33321174|NCT03548987|101072845|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
33321175|NCT03548987|101072844|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
33321176|NCT03548987|101072845|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
33321177|NCT03548987|101072844|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
33321178|NCT03548987|101072845|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
33321179|NCT03548987|101072844|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
33321180|NCT03548987|101072845|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
33321181|NCT03548987|101072844|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
33321182|NCT03548987|101072845|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
33321183|NCT03548987|101072844|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
33321184|NCT03548987|101072845|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
33321185|NCT03548987|101072844|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
33321186|NCT03548987|101072845|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
33321187|NCT03548987|101072844|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
33321188|NCT03548987|101072845|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
33321189|NCT03548987|101072844|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
33321190|NCT03548987|101072845|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
33321191|NCT03548987|101072844|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
33321192|NCT03548987|101072845|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
33321193|NCT03548987|101072844|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
33321194|NCT03548987|101072845|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
33321195|NCT03548987|101072844|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
33605303|NCT00162266|102105528|FG000|Double-Blind Period|Withdrawal by Subject|5|||
33321196|NCT03548987|101072845|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
33321197|NCT03548987|101072844|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
33321198|NCT03548987|101072845|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
33321199|NCT04226833|101072846|FG000|Overall Study|Death|0|||
33321200|NCT04226833|101072847|FG001|Overall Study|Death|0|||
33605304|NCT00162266|102105529|FG001|Double-Blind Period|Withdrawal by Subject|2|||
33321201|NCT04226833|101072848|FG002|Overall Study|Death|1|||
33321202|NCT04226833|101072849|FG003|Overall Study|Death|0|||
33321203|NCT00234494|101072850|FG000|Overall Study|Protocol Violation|2|||
33321204|NCT01284062|101072851|FG000|Overall Study|Adverse Event|4|||
33510269|NCT03483961|101762238|FG007|Overall Study|Adverse Event|0|||
33510270|NCT03483961|101762239|FG008|Overall Study|Adverse Event|0|||
33510271|NCT03483961|101762240|FG009|Overall Study|Adverse Event|0|||
33510272|NCT00637000|101762241|FG000|Overall Study|Withdrawal by Subject|4|||
33510273|NCT00637000|101762242|FG001|Overall Study|Withdrawal by Subject|3|||
33510274|NCT02091986|101762246|FG000|Overall Study|7 rand in error 1 patient decision|2|||
33510275|NCT02091986|101762247|FG001|Overall Study|7 rand in error 1 patient decision|3|||
33510276|NCT02091986|101762248|FG002|Overall Study|7 rand in error 1 patient decision|3|||
33510277|NCT02091986|101762246|FG000|Overall Study|Lost to Follow-up|1|||
33510278|NCT02091986|101762247|FG001|Overall Study|Lost to Follow-up|0|||
33510279|NCT02091986|101762248|FG002|Overall Study|Lost to Follow-up|0|||
33510280|NCT02091986|101762246|FG000|Overall Study|Withdrawal by Subject|4|||
33510281|NCT02091986|101762247|FG001|Overall Study|Withdrawal by Subject|8|||
33510282|NCT02091986|101762248|FG002|Overall Study|Withdrawal by Subject|3|||
33510283|NCT02091986|101762246|FG000|Overall Study|Adverse Event|0|||
33321205|NCT01284062|101072852|FG001|Overall Study|Adverse Event|5|||
33321206|NCT01284062|101072853|FG002|Overall Study|Adverse Event|0|||
33321207|NCT01284062|101072854|FG003|Overall Study|Adverse Event|5|||
33321208|NCT01284062|101072851|FG000|Overall Study|Lack of Efficacy|3|||
33321209|NCT01284062|101072852|FG001|Overall Study|Lack of Efficacy|2|||
33321210|NCT01284062|101072853|FG002|Overall Study|Lack of Efficacy|2|||
33321211|NCT01284062|101072854|FG003|Overall Study|Lack of Efficacy|1|||
33321212|NCT01284062|101072851|FG000|Overall Study|Medication error without adverse event|0|||
33321213|NCT01284062|101072852|FG001|Overall Study|Medication error without adverse event|0|||
33321214|NCT01284062|101072853|FG002|Overall Study|Medication error without adverse event|1|||
33321215|NCT01284062|101072854|FG003|Overall Study|Medication error without adverse event|0|||
33321216|NCT01284062|101072851|FG000|Overall Study|Protocol Violation|1|||
33321217|NCT01284062|101072852|FG001|Overall Study|Protocol Violation|0|||
33321218|NCT01284062|101072853|FG002|Overall Study|Protocol Violation|0|||
33321219|NCT01284062|101072854|FG003|Overall Study|Protocol Violation|2|||
33321220|NCT01284062|101072851|FG000|Overall Study|Withdrawal by Subject|3|||
33321221|NCT01284062|101072852|FG001|Overall Study|Withdrawal by Subject|1|||
33321222|NCT01284062|101072853|FG002|Overall Study|Withdrawal by Subject|2|||
33321223|NCT01284062|101072854|FG003|Overall Study|Withdrawal by Subject|5|||
33321224|NCT01284062|101072851|FG000|Overall Study|Other|0|||
33321225|NCT01284062|101072852|FG001|Overall Study|Other|0|||
33321226|NCT01284062|101072853|FG002|Overall Study|Other|0|||
33321227|NCT01284062|101072854|FG003|Overall Study|Other|1|||
33321228|NCT01284062|101072851|FG000|Overall Study|Site Closed|0|||
33321229|NCT01284062|101072852|FG001|Overall Study|Site Closed|0|||
33321230|NCT01284062|101072853|FG002|Overall Study|Site Closed|1|||
33321231|NCT01284062|101072854|FG003|Overall Study|Site Closed|0|||
33321232|NCT04439071|101072859|FG000|Overall Study|Lost to Follow-up|0|||
33321233|NCT04439071|101072860|FG001|Overall Study|Lost to Follow-up|3|||
33321234|NCT04439071|101072859|FG000|Overall Study|Withdrawal by Subject|3|||
33321235|NCT04439071|101072860|FG001|Overall Study|Withdrawal by Subject|8|||
33321236|NCT04439071|101072859|FG000|Overall Study|Death|6|||
33321237|NCT04439071|101072860|FG001|Overall Study|Death|4|||
33321238|NCT04439071|101072859|FG000|Overall Study|Other than specified|3|||
33321239|NCT04439071|101072860|FG001|Overall Study|Other than specified|3|||
33321240|NCT04439071|101072859|FG000|Overall Study|Randomized but not treated|2|||
33321241|NCT04439071|101072860|FG001|Overall Study|Randomized but not treated|0|||
33321242|NCT01444651|101072864|FG000|Overall Study|Adverse Event|3|||
33321243|NCT01444651|101072865|FG001|Overall Study|Adverse Event|2|||
33321244|NCT01444651|101072864|FG000|Overall Study|Lost to Follow-up|5|||
33321245|NCT01444651|101072865|FG001|Overall Study|Lost to Follow-up|5|||
33321246|NCT01444651|101072864|FG000|Overall Study|Non-fasting|2|||
33321247|NCT01444651|101072865|FG001|Overall Study|Non-fasting|1|||
33321248|NCT01444651|101072864|FG000|Overall Study|Missing data|1|||
33321249|NCT01444651|101072865|FG001|Overall Study|Missing data|1|||
33321250|NCT03942406|101072866|FG000|Overall Study|Lost to Follow-up|4|||
33321251|NCT03942406|101072867|FG001|Overall Study|Lost to Follow-up|5|||
33398961|NCT00545740|101350153|FG001|Overall Study|Accepted only monthly telephone calls|0|||
33510284|NCT02091986|101762247|FG001|Overall Study|Adverse Event|0|||
33510285|NCT02091986|101762248|FG002|Overall Study|Adverse Event|2|||
33510286|NCT02892422|101762252|FG000|Overall Study|Enrolled not treated|4|||
33510287|NCT02892422|101762252|FG000|Overall Study|Adverse Event|38|||
33321252|NCT03942406|101072868|FG002|Overall Study|Lost to Follow-up|3|||
33321253|NCT03942406|101072869|FG003|Overall Study|Lost to Follow-up|7|||
33321254|NCT03942406|101072870|FG004|Overall Study|Lost to Follow-up|1|||
33321255|NCT03942406|101072871|FG005|Overall Study|Lost to Follow-up|0|||
33321256|NCT03942406|101072872|FG006|Overall Study|Lost to Follow-up|0|||
33321257|NCT03942406|101072866|FG000|Overall Study|Withdrawal by Subject|3|||
33321258|NCT03942406|101072867|FG001|Overall Study|Withdrawal by Subject|1|||
33321259|NCT03942406|101072868|FG002|Overall Study|Withdrawal by Subject|1|||
33321260|NCT03942406|101072869|FG003|Overall Study|Withdrawal by Subject|3|||
33321261|NCT03942406|101072870|FG004|Overall Study|Withdrawal by Subject|0|||
33321262|NCT03942406|101072871|FG005|Overall Study|Withdrawal by Subject|0|||
33321263|NCT03942406|101072872|FG006|Overall Study|Withdrawal by Subject|0|||
33321264|NCT03942406|101072866|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
33321265|NCT03942406|101072867|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
33321266|NCT03942406|101072868|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
33321267|NCT03942406|101072869|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
33321268|NCT03942406|101072870|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
33321269|NCT03942406|101072871|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
33321270|NCT03942406|101072872|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
33321271|NCT01717768|101072873|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33321272|NCT01717768|101072874|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
33321273|NCT01717768|101072875|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33321274|NCT01717768|101072876|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33321275|NCT01717768|101072877|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33321276|NCT01717768|101072878|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33321277|NCT01717768|101072879|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33321278|NCT01717768|101072880|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33321279|NCT01717768|101072881|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33321280|NCT01717768|101072882|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33321281|NCT01717768|101072883|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33321282|NCT01717768|101072884|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
33321283|NCT01717768|101072873|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33321284|NCT01717768|101072874|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33321285|NCT01717768|101072875|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33321286|NCT01717768|101072876|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33321287|NCT01717768|101072877|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33321288|NCT01717768|101072878|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33321289|NCT01717768|101072879|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33321290|NCT01717768|101072880|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33321291|NCT01717768|101072881|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33321292|NCT01717768|101072882|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33321293|NCT01717768|101072883|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
33321294|NCT01717768|101072884|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
33321295|NCT01717768|101072873|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33321296|NCT01717768|101072874|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33321297|NCT01717768|101072875|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33321298|NCT01717768|101072876|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33321299|NCT01717768|101072877|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33321300|NCT01717768|101072878|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33321301|NCT01717768|101072879|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33321302|NCT01717768|101072880|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
33321303|NCT01717768|101072881|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33321304|NCT01717768|101072882|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33321305|NCT01717768|101072883|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33321306|NCT01717768|101072884|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
33321307|NCT01717768|101072873|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33321308|NCT01717768|101072874|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33321309|NCT01717768|101072875|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33321310|NCT01717768|101072876|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33321311|NCT01717768|101072877|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33321312|NCT01717768|101072878|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33321313|NCT01717768|101072879|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33398962|NCT00545740|101350154|FG002|Overall Study|Accepted only monthly telephone calls|0|||
33398963|NCT00545740|101350155|FG003|Overall Study|Accepted only monthly telephone calls|0|||
33398964|NCT00545740|101350152|FG000|Overall Study|Sponsor decision|0|||
33398965|NCT00545740|101350153|FG001|Overall Study|Sponsor decision|1|||
33398966|NCT00545740|101350154|FG002|Overall Study|Sponsor decision|0|||
33398967|NCT00545740|101350155|FG003|Overall Study|Sponsor decision|0|||
33398968|NCT00545740|101350152|FG000|Overall Study|Lack of time|0|||
33398969|NCT00545740|101350153|FG001|Overall Study|Lack of time|1|||
33398970|NCT00545740|101350154|FG002|Overall Study|Lack of time|0|||
33398971|NCT00545740|101350155|FG003|Overall Study|Lack of time|0|||
33398972|NCT00545740|101350152|FG000|Overall Study|Non-adherence to visits|0|||
33321314|NCT01717768|101072880|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33321315|NCT01717768|101072881|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33321316|NCT01717768|101072882|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
33321317|NCT01717768|101072883|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33321318|NCT01717768|101072884|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
33321319|NCT01179672|101072885|FG000|Overall Study|Adverse Event|17|||
33321320|NCT01179672|101072886|FG001|Overall Study|Adverse Event|8|||
33321321|NCT01179672|101072885|FG000|Overall Study|Withdrawal by Subject|10|||
33321322|NCT01179672|101072886|FG001|Overall Study|Withdrawal by Subject|12|||
33321323|NCT01179672|101072885|FG000|Overall Study|Entry Criteria Not Met|0|||
33321324|NCT01179672|101072886|FG001|Overall Study|Entry Criteria Not Met|2|||
33321325|NCT01179672|101072885|FG000|Overall Study|Lost to Follow-up|0|||
33321326|NCT01179672|101072886|FG001|Overall Study|Lost to Follow-up|1|||
33321327|NCT01179672|101072885|FG000|Overall Study|Protocol Violation|2|||
33321328|NCT01179672|101072886|FG001|Overall Study|Protocol Violation|2|||
33321329|NCT01179672|101072885|FG000|Overall Study|Physician Decision|1|||
33321330|NCT01179672|101072886|FG001|Overall Study|Physician Decision|1|||
33321331|NCT04752475|101072889|FG000|Overall Study|Withdrawal by Subject|1|||
33321332|NCT04752475|101072890|FG001|Overall Study|Withdrawal by Subject|1|||
33321333|NCT04166383|101072893|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
33321334|NCT04166383|101072893|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
33321335|NCT04166383|101072893|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
33321336|NCT02592018|101072895|FG000|Overall Study|Adverse Event|1|||
33321337|NCT02592018|101072895|FG000|Overall Study|Lost to Follow-up|1|||
33321338|NCT00146328|101072896|FG000|Overall Study|Adverse Event|39|||
33321339|NCT00146328|101072897|FG001|Overall Study|Adverse Event|48|||
33321340|NCT00146328|101072898|FG002|Overall Study|Adverse Event|79|||
33321341|NCT00146328|101072896|FG000|Overall Study|Protocol Violation|11|||
33321342|NCT00146328|101072897|FG001|Overall Study|Protocol Violation|6|||
33321343|NCT00146328|101072898|FG002|Overall Study|Protocol Violation|12|||
33321344|NCT00146328|101072896|FG000|Overall Study|Lost to Follow-up|7|||
33321345|NCT00146328|101072897|FG001|Overall Study|Lost to Follow-up|4|||
33321346|NCT00146328|101072898|FG002|Overall Study|Lost to Follow-up|7|||
33321347|NCT00146328|101072896|FG000|Overall Study|Withdrawal by Subject|16|||
33321348|NCT00146328|101072897|FG001|Overall Study|Withdrawal by Subject|16|||
33321349|NCT00146328|101072898|FG002|Overall Study|Withdrawal by Subject|22|||
33321350|NCT00146328|101072896|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
33321351|NCT00146328|101072897|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
33321352|NCT00146328|101072898|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
33321353|NCT00146328|101072896|FG000|Overall Study|Trial ended/site closed|8|||
33321354|NCT00146328|101072897|FG001|Overall Study|Trial ended/site closed|2|||
33321355|NCT00146328|101072898|FG002|Overall Study|Trial ended/site closed|19|||
33321356|NCT00146328|101072896|FG000|Overall Study|Patient decision to end|0|||
33321357|NCT00146328|101072897|FG001|Overall Study|Patient decision to end|1|||
33321358|NCT00146328|101072898|FG002|Overall Study|Patient decision to end|6|||
33321359|NCT00146328|101072896|FG000|Overall Study|Enroll into other trial|2|||
33321360|NCT00146328|101072897|FG001|Overall Study|Enroll into other trial|4|||
33321361|NCT00146328|101072898|FG002|Overall Study|Enroll into other trial|2|||
33321362|NCT00146328|101072896|FG000|Overall Study|Death|0|||
33321363|NCT00146328|101072897|FG001|Overall Study|Death|1|||
33321364|NCT00146328|101072898|FG002|Overall Study|Death|1|||
33321365|NCT00146328|101072896|FG000|Overall Study|Moved|2|||
33321366|NCT00146328|101072897|FG001|Overall Study|Moved|0|||
33321367|NCT00146328|101072898|FG002|Overall Study|Moved|0|||
33321368|NCT00146328|101072896|FG000|Overall Study|Interaction with other medication|2|||
33321369|NCT00146328|101072897|FG001|Overall Study|Interaction with other medication|0|||
33321370|NCT00146328|101072898|FG002|Overall Study|Interaction with other medication|1|||
33321371|NCT03382652|101072899|FG000|Overall Study|Lost to Follow-up|6|||
33321372|NCT03382652|101072899|FG000|Overall Study|Death|4|||
33321373|NCT03382652|101072899|FG000|Overall Study|Revision|5|||
33321374|NCT03382652|101072899|FG000|Overall Study|Patient withdrew|3|||
33321375|NCT03382652|101072899|FG000|Overall Study|Other reasons|21|||
33321376|NCT02818920|101072900|FG000|Overall Study|Unresectable|4|||
33321377|NCT02818920|101072900|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
33321378|NCT02818920|101072900|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
33321379|NCT02818920|101072900|FG000|Overall Study|Adverse Event|3|||
33321380|NCT02818920|101072900|FG000|Overall Study|Developed Other Disease|1|||
33321381|NCT02818920|101072900|FG000|Overall Study|Refused Further Treatment|1|||
33321382|NCT01159912|101072901|FG000|Overall Study|Adverse Event|2|||
33321383|NCT01159912|101072902|FG001|Overall Study|Adverse Event|2|||
33321384|NCT01159912|101072903|FG002|Overall Study|Adverse Event|3|||
33321385|NCT01159912|101072901|FG000|Overall Study|Lack of Efficacy|23|||
33510288|NCT02892422|101762252|FG000|Overall Study|Lack of Efficacy|32|||
33321386|NCT01159912|101072902|FG001|Overall Study|Lack of Efficacy|15|||
33321387|NCT01159912|101072903|FG002|Overall Study|Lack of Efficacy|14|||
33321388|NCT01159912|101072901|FG000|Overall Study|Protocol Violation|1|||
33321389|NCT01159912|101072902|FG001|Overall Study|Protocol Violation|2|||
33321390|NCT01159912|101072903|FG002|Overall Study|Protocol Violation|3|||
33321391|NCT01159912|101072901|FG000|Overall Study|Lost to Follow-up|4|||
33321392|NCT01159912|101072902|FG001|Overall Study|Lost to Follow-up|0|||
33321393|NCT01159912|101072903|FG002|Overall Study|Lost to Follow-up|0|||
33321394|NCT01159912|101072901|FG000|Overall Study|Physician Decision|0|||
33321395|NCT01159912|101072902|FG001|Overall Study|Physician Decision|0|||
33321396|NCT01159912|101072903|FG002|Overall Study|Physician Decision|3|||
33321397|NCT01159912|101072901|FG000|Overall Study|Withdrawal by Subject|10|||
33321398|NCT01159912|101072902|FG001|Overall Study|Withdrawal by Subject|3|||
33321399|NCT01159912|101072903|FG002|Overall Study|Withdrawal by Subject|3|||
33321400|NCT01829425|101072906|FG000|Overall Study|Withdrawal by Subject|4|||
33321401|NCT01829425|101072907|FG001|Overall Study|Withdrawal by Subject|3|||
33321402|NCT01829425|101072906|FG000|Overall Study|Lost to Follow-up|2|||
33321403|NCT01829425|101072907|FG001|Overall Study|Lost to Follow-up|1|||
33321404|NCT01949155|101072910|FG000|Overall Study|Lost to Follow-up|1|||
33321405|NCT01949155|101072911|FG001|Overall Study|Lost to Follow-up|0|||
33321406|NCT01949155|101072910|FG000|Overall Study|Protocol Violation|1|||
33321407|NCT01949155|101072911|FG001|Overall Study|Protocol Violation|0|||
33321408|NCT04376060|101072912|FG000|Overall Study|Physician Decision|1|||
33321409|NCT01970488|101072913|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
33321410|NCT01970488|101072914|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
33321411|NCT01970488|101072915|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
33321412|NCT01970488|101072916|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
33321413|NCT01970488|101072917|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
33321414|NCT01970488|101072913|FG000|Part 1: Through Week 16|Protocol Violation|1|||
33321415|NCT01970488|101072914|FG001|Part 1: Through Week 16|Protocol Violation|2|||
33321416|NCT01970488|101072915|FG002|Part 1: Through Week 16|Protocol Violation|0|||
33321417|NCT01970488|101072916|FG003|Part 1: Through Week 16|Protocol Violation|0|||
33321418|NCT01970488|101072917|FG004|Part 1: Through Week 16|Protocol Violation|0|||
33321419|NCT01970488|101072913|FG000|Part 1: Through Week 16|Adverse Event|6|||
33321420|NCT01970488|101072914|FG001|Part 1: Through Week 16|Adverse Event|5|||
33321421|NCT01970488|101072915|FG002|Part 1: Through Week 16|Adverse Event|0|||
33321422|NCT01970488|101072916|FG003|Part 1: Through Week 16|Adverse Event|0|||
33321423|NCT01970488|101072917|FG004|Part 1: Through Week 16|Adverse Event|0|||
33398973|NCT00545740|101350153|FG001|Overall Study|Non-adherence to visits|1|||
33605305|NCT00162266|102105530|FG002|Double-Blind Period|Withdrawal by Subject|6|||
33197950|NCT00718042|100630349|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
33197951|NCT00718042|100630344|FG000|Donor Follow-up|Lost to Follow-up|13|||
33197952|NCT00718042|100630345|FG001|Donor Follow-up|Lost to Follow-up|0|||
33197953|NCT00718042|100630346|FG002|Donor Follow-up|Lost to Follow-up|0|||
33197954|NCT00718042|100630347|FG003|Donor Follow-up|Lost to Follow-up|0|||
33197955|NCT00718042|100630348|FG004|Donor Follow-up|Lost to Follow-up|19|||
33197956|NCT00718042|100630349|FG005|Donor Follow-up|Lost to Follow-up|0|||
33197957|NCT04442737|100630350|FG000|Overall Study|Lost to Follow-up|1|||
33197958|NCT04442737|100630351|FG001|Overall Study|Lost to Follow-up|3|||
33197959|NCT04442737|100630350|FG000|Overall Study|Withdrawal by Subject|3|||
33197960|NCT04442737|100630351|FG001|Overall Study|Withdrawal by Subject|2|||
33197961|NCT04442737|100630350|FG000|Overall Study|Adverse Event|3|||
33321424|NCT01970488|101072913|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
33321425|NCT01970488|101072914|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
33321426|NCT01970488|101072915|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
33321427|NCT01970488|101072916|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
33321428|NCT01970488|101072917|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
33321429|NCT01970488|101072913|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
33321430|NCT01970488|101072914|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
33321431|NCT01970488|101072915|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
33321432|NCT01970488|101072916|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
33321433|NCT01970488|101072917|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
33398974|NCT00545740|101350154|FG002|Overall Study|Non-adherence to visits|0|||
33398975|NCT00545740|101350155|FG003|Overall Study|Non-adherence to visits|0|||
33321434|NCT01970488|101072913|FG000|Part 2: Post Week 16|Physician Decision|0|||
33605306|NCT00162266|102105531|FG003|Double-Blind Period|Withdrawal by Subject|0|||
33605307|NCT00162266|102105528|FG000|Open-Label Period|Death|0|||
33197962|NCT04442737|100630351|FG001|Overall Study|Adverse Event|2|||
33197963|NCT04442737|100630350|FG000|Overall Study|Death|0|||
33321435|NCT01970488|101072914|FG001|Part 2: Post Week 16|Physician Decision|0|||
33321436|NCT01970488|101072915|FG002|Part 2: Post Week 16|Physician Decision|0|||
33321437|NCT01970488|101072916|FG003|Part 2: Post Week 16|Physician Decision|0|||
33321438|NCT01970488|101072917|FG004|Part 2: Post Week 16|Physician Decision|1|||
33321439|NCT01970488|101072913|FG000|Part 2: Post Week 16|Non-compliance|0|||
33605308|NCT00162266|102105529|FG001|Open-Label Period|Death|0|||
33197964|NCT04442737|100630351|FG001|Overall Study|Death|1|||
33197965|NCT04442737|100630350|FG000|Overall Study|Protocol Violation|0|||
33197966|NCT04442737|100630351|FG001|Overall Study|Protocol Violation|2|||
33197967|NCT04442737|100630350|FG000|Overall Study|Other|1|||
33197968|NCT04442737|100630351|FG001|Overall Study|Other|1|||
33197969|NCT02720484|100630352|FG000|Treatment on Study|Adverse Event|1|||
33197970|NCT02720484|100630352|FG000|Treatment on Study|Withdrawal by Subject|1|||
33197971|NCT02720484|100630352|FG000|Treatment on Study|Progressive Disease|4|||
33321440|NCT01970488|101072914|FG001|Part 2: Post Week 16|Non-compliance|0|||
33321441|NCT01970488|101072915|FG002|Part 2: Post Week 16|Non-compliance|1|||
33321442|NCT01970488|101072916|FG003|Part 2: Post Week 16|Non-compliance|0|||
33321443|NCT01970488|101072917|FG004|Part 2: Post Week 16|Non-compliance|0|||
33321444|NCT01970488|101072913|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
33321445|NCT01970488|101072914|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
33321446|NCT01970488|101072915|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
33321447|NCT01970488|101072916|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
33321448|NCT01970488|101072917|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
33321449|NCT01970488|101072913|FG000|Part 2: Post Week 16|Adverse Event|0|||
33321450|NCT01970488|101072914|FG001|Part 2: Post Week 16|Adverse Event|0|||
33321451|NCT01970488|101072915|FG002|Part 2: Post Week 16|Adverse Event|5|||
33321452|NCT01970488|101072916|FG003|Part 2: Post Week 16|Adverse Event|1|||
33321453|NCT01970488|101072917|FG004|Part 2: Post Week 16|Adverse Event|1|||
33321454|NCT01970488|101072913|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
33321455|NCT01970488|101072914|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
33321456|NCT01970488|101072915|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
33321457|NCT01970488|101072916|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
33321458|NCT01970488|101072917|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
33321459|NCT01970488|101072913|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
33321460|NCT01970488|101072914|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
33321461|NCT01970488|101072915|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
33321462|NCT01970488|101072916|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
33321463|NCT01970488|101072917|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
33321464|NCT02066051|101072918|FG000|Overall Study|Subject developed active GVHD|1|||
33321465|NCT02606461|101072919|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
33321466|NCT02606461|101072920|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
33321467|NCT02606461|101072921|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
33321468|NCT02606461|101072922|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
33321469|NCT02606461|101072923|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
33321470|NCT02606461|101072924|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
33321471|NCT01494350|101072925|FG000|Overall Study|Worsening of lesion|1|||
33321472|NCT03701763|101072930|FG000|Placebo-controlled Phase|Adverse Event|1|||
33321473|NCT03701763|101072931|FG001|Placebo-controlled Phase|Adverse Event|5|||
33321474|NCT03701763|101072932|FG002|Placebo-controlled Phase|Adverse Event|0|||
33321475|NCT03701763|101072933|FG003|Placebo-controlled Phase|Adverse Event|0|||
33321476|NCT03701763|101072930|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
33321477|NCT03701763|101072931|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
33321478|NCT03701763|101072932|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
33321479|NCT03701763|101072933|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
33321480|NCT03701763|101072930|FG000|Placebo-controlled Phase|Miscellaneous|2|||
33321481|NCT03701763|101072931|FG001|Placebo-controlled Phase|Miscellaneous|0|||
33321482|NCT03701763|101072932|FG002|Placebo-controlled Phase|Miscellaneous|0|||
33321483|NCT03701763|101072933|FG003|Placebo-controlled Phase|Miscellaneous|0|||
33321484|NCT03701763|101072930|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
33321485|NCT03701763|101072931|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
33321486|NCT03701763|101072932|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
33321487|NCT03701763|101072933|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
33398976|NCT00545740|101350152|FG000|Overall Study|Patient difficulties|0|||
33510289|NCT02892422|101762252|FG000|Overall Study|Non-compliance with study drug|11|||
33321488|NCT03701763|101072930|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
33321489|NCT03701763|101072931|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
33321490|NCT03701763|101072932|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
33321491|NCT03701763|101072933|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
33321492|NCT03701763|101072930|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
33321493|NCT03701763|101072931|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
33321494|NCT03701763|101072932|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
33197972|NCT02720484|100630352|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
33197973|NCT02720484|100630352|FG000|Follow Up for 2 Years|Death|3|||
33197974|NCT02720484|100630352|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
33321495|NCT03701763|101072933|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
33321496|NCT03701763|101072930|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
33321497|NCT03701763|101072931|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
33321498|NCT03701763|101072932|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
33321499|NCT03701763|101072933|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
33321500|NCT03701763|101072930|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
33321501|NCT03701763|101072931|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
33510290|NCT02892422|101762252|FG000|Overall Study|Protocol Violation|4|||
33321502|NCT03701763|101072932|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
33321503|NCT03701763|101072933|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
33321504|NCT03701763|101072930|FG000|Apremilast Extension Phase|Adverse Event|0|||
33321505|NCT03701763|101072931|FG001|Apremilast Extension Phase|Adverse Event|0|||
33321506|NCT03701763|101072932|FG002|Apremilast Extension Phase|Adverse Event|3|||
33321507|NCT03701763|101072933|FG003|Apremilast Extension Phase|Adverse Event|1|||
33321508|NCT03701763|101072930|FG000|Apremilast Extension Phase|Miscellaneous|0|||
33321509|NCT03701763|101072931|FG001|Apremilast Extension Phase|Miscellaneous|0|||
33321510|NCT03701763|101072932|FG002|Apremilast Extension Phase|Miscellaneous|2|||
33321511|NCT03701763|101072933|FG003|Apremilast Extension Phase|Miscellaneous|1|||
33321512|NCT03701763|101072930|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
33321513|NCT03701763|101072931|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
33321514|NCT03701763|101072932|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
33321515|NCT03701763|101072933|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
33321516|NCT03701763|101072930|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
33321517|NCT03701763|101072931|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
33321518|NCT03701763|101072932|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
33321519|NCT03701763|101072933|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
33321520|NCT03701763|101072930|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
33321521|NCT03701763|101072931|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
33321522|NCT03701763|101072932|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
33321523|NCT03701763|101072933|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
33321524|NCT03701763|101072930|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
33321525|NCT03701763|101072931|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
33321526|NCT03701763|101072932|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
33321527|NCT03701763|101072933|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
33321528|NCT03701763|101072930|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
33321529|NCT03701763|101072931|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
33321530|NCT03701763|101072932|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
33321531|NCT03701763|101072933|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
33321532|NCT03701763|101072930|FG000|14-Week Observational Follow-up Phase|Other|0|||
33321533|NCT03701763|101072931|FG001|14-Week Observational Follow-up Phase|Other|0|||
33321534|NCT03701763|101072932|FG002|14-Week Observational Follow-up Phase|Other|1|||
33321535|NCT03701763|101072933|FG003|14-Week Observational Follow-up Phase|Other|0|||
33321536|NCT03701763|101072930|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
33321537|NCT03701763|101072931|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
33321538|NCT03701763|101072932|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
33321539|NCT03701763|101072933|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
33321540|NCT03701763|101072930|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
33321541|NCT03701763|101072931|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
33321542|NCT03701763|101072932|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
33321543|NCT03701763|101072933|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
33321544|NCT00818389|101072936|FG000|Overall Study|Death|1|||
33321545|NCT00818389|101072937|FG001|Overall Study|Death|3|||
33321546|NCT00818389|101072936|FG000|Overall Study|ALS Disease Progression|1|||
33321547|NCT00818389|101072937|FG001|Overall Study|ALS Disease Progression|0|||
33321548|NCT00818389|101072936|FG000|Overall Study|Withdrawal by Subject|2|||
33321549|NCT00818389|101072937|FG001|Overall Study|Withdrawal by Subject|2|||
33321550|NCT00818389|101072936|FG000|Overall Study|Adverse Event|0|||
33321551|NCT00818389|101072937|FG001|Overall Study|Adverse Event|1|||
33321552|NCT00685685|101072938|FG000|Washout Period of 7 Days|Adverse Event|2|||
33321553|NCT00685685|101072939|FG001|Washout Period of 7 Days|Adverse Event|0|||
33321554|NCT00685685|101072938|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
33321555|NCT00685685|101072939|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33321556|NCT00307125|101072940|FG000|Screening Phase|Adverse Event|1|||
33321557|NCT00307125|101072941|FG001|Screening Phase|Adverse Event|0|||
33321558|NCT00307125|101072942|FG002|Screening Phase|Adverse Event|0|||
33321559|NCT00307125|101072940|FG000|Screening Phase|Protocol Violation|27|||
33197975|NCT00653224|100630354|FG000|Overall Study|Adverse Event|2|||
33321560|NCT00307125|101072941|FG001|Screening Phase|Protocol Violation|0|||
33321561|NCT00307125|101072942|FG002|Screening Phase|Protocol Violation|0|||
33321562|NCT00307125|101072940|FG000|Screening Phase|Lost to Follow-up|87|||
33321563|NCT00307125|101072941|FG001|Screening Phase|Lost to Follow-up|0|||
33321564|NCT00307125|101072942|FG002|Screening Phase|Lost to Follow-up|0|||
33321565|NCT00307125|101072940|FG000|Screening Phase|Death|10|||
33321566|NCT00307125|101072941|FG001|Screening Phase|Death|0|||
33321567|NCT00307125|101072942|FG002|Screening Phase|Death|0|||
33321568|NCT00307125|101072940|FG000|Screening Phase|Withdrawal by Subject|77|||
33321569|NCT00307125|101072941|FG001|Screening Phase|Withdrawal by Subject|0|||
33321570|NCT00307125|101072942|FG002|Screening Phase|Withdrawal by Subject|0|||
33321571|NCT00307125|101072940|FG000|Screening Phase|Physician Decision|26|||
33321572|NCT00307125|101072941|FG001|Screening Phase|Physician Decision|0|||
33321573|NCT00307125|101072942|FG002|Screening Phase|Physician Decision|0|||
33321574|NCT00307125|101072940|FG000|Screening Phase|Sponsor Decision|4|||
33321575|NCT00307125|101072941|FG001|Screening Phase|Sponsor Decision|0|||
33321576|NCT00307125|101072942|FG002|Screening Phase|Sponsor Decision|0|||
33321577|NCT00307125|101072940|FG000|Screening Phase|Study Terminated|17|||
33321578|NCT00307125|101072941|FG001|Screening Phase|Study Terminated|0|||
33321579|NCT00307125|101072942|FG002|Screening Phase|Study Terminated|0|||
33321580|NCT00307125|101072940|FG000|Screening Phase|Graft Loss|3|||
33321581|NCT00307125|101072941|FG001|Screening Phase|Graft Loss|0|||
33321582|NCT00307125|101072942|FG002|Screening Phase|Graft Loss|0|||
33321583|NCT00307125|101072940|FG000|Screening Phase|Graft Failure|8|||
33321584|NCT00307125|101072941|FG001|Screening Phase|Graft Failure|0|||
33321585|NCT00307125|101072942|FG002|Screening Phase|Graft Failure|0|||
33321586|NCT00307125|101072940|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
33321587|NCT00307125|101072941|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
33321588|NCT00307125|101072942|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
33321589|NCT00307125|101072940|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
33321590|NCT00307125|101072941|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
33321591|NCT00307125|101072942|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
33321592|NCT00307125|101072940|FG000|Screening Phase|Moved or transferred facilities|34|||
33321593|NCT00307125|101072941|FG001|Screening Phase|Moved or transferred facilities|0|||
33321594|NCT00307125|101072942|FG002|Screening Phase|Moved or transferred facilities|0|||
33321595|NCT00307125|101072940|FG000|Screening Phase|Received Pancreas Transplant|8|||
33321596|NCT00307125|101072941|FG001|Screening Phase|Received Pancreas Transplant|0|||
33321597|NCT00307125|101072942|FG002|Screening Phase|Received Pancreas Transplant|0|||
33321598|NCT00307125|101072940|FG000|Screening Phase|Ineligible for pilot|4|||
33321599|NCT00307125|101072941|FG001|Screening Phase|Ineligible for pilot|0|||
33321600|NCT00307125|101072942|FG002|Screening Phase|Ineligible for pilot|0|||
33321601|NCT00307125|101072940|FG000|Screening Phase|Try to get pregnant|1|||
33321602|NCT00307125|101072941|FG001|Screening Phase|Try to get pregnant|0|||
33321603|NCT00307125|101072942|FG002|Screening Phase|Try to get pregnant|0|||
33321604|NCT00307125|101072940|FG000|Screening Phase|Developed acute leukemia|1|||
33321605|NCT00307125|101072941|FG001|Screening Phase|Developed acute leukemia|0|||
33321606|NCT00307125|101072942|FG002|Screening Phase|Developed acute leukemia|0|||
33321607|NCT00307125|101072940|FG000|Screening Phase|Metastatic colon cancer|1|||
33321608|NCT00307125|101072941|FG001|Screening Phase|Metastatic colon cancer|0|||
33321609|NCT00307125|101072942|FG002|Screening Phase|Metastatic colon cancer|0|||
33321610|NCT00307125|101072940|FG000|Screening Phase|Malignancy|1|||
33321611|NCT00307125|101072941|FG001|Screening Phase|Malignancy|0|||
33321612|NCT00307125|101072942|FG002|Screening Phase|Malignancy|0|||
33321613|NCT00307125|101072940|FG000|Screening Phase|PAK|1|||
33321614|NCT00307125|101072941|FG001|Screening Phase|PAK|0|||
33321615|NCT00307125|101072942|FG002|Screening Phase|PAK|0|||
33321616|NCT00307125|101072940|FG000|Screening Phase|Ineligible|1|||
33321617|NCT00307125|101072941|FG001|Screening Phase|Ineligible|0|||
33321618|NCT00307125|101072942|FG002|Screening Phase|Ineligible|0|||
33321619|NCT00307125|101072940|FG000|Screening Phase|Screen Error|1|||
33321620|NCT00307125|101072941|FG001|Screening Phase|Screen Error|0|||
33605309|NCT00162266|102105530|FG002|Open-Label Period|Death|0|||
33321621|NCT00307125|101072942|FG002|Screening Phase|Screen Error|0|||
33510291|NCT02892422|101762252|FG000|Overall Study|Withdrawal by Subject|56|||
33321622|NCT00307125|101072940|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
33321623|NCT00307125|101072941|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
33321624|NCT00307125|101072942|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
33321625|NCT00307125|101072940|FG000|Screening Phase|AMR and treated with rituximab|1|||
33321626|NCT00307125|101072941|FG001|Screening Phase|AMR and treated with rituximab|0|||
33321627|NCT00307125|101072942|FG002|Screening Phase|AMR and treated with rituximab|0|||
33321628|NCT00307125|101072940|FG000|Screening Phase|Coronary artery bypass|1|||
33321629|NCT00307125|101072941|FG001|Screening Phase|Coronary artery bypass|0|||
33510292|NCT02892422|101762252|FG000|Overall Study|Lost to Follow-up|5|||
33510293|NCT02892422|101762252|FG000|Overall Study|sponsor information 16159A results|21|||
33510294|NCT02892422|101762252|FG000|Overall Study|withdrawal of consent|13|||
33510295|NCT02892422|101762252|FG000|Overall Study|exclusion criteria met|3|||
33321630|NCT00307125|101072942|FG002|Screening Phase|Coronary artery bypass|0|||
33510296|NCT02892422|101762252|FG000|Overall Study|moving elsewhere|4|||
33510297|NCT02892422|101762252|FG000|Overall Study|non-compliance|10|||
33605310|NCT00162266|102105531|FG003|Open-Label Period|Death|7|||
33321631|NCT00307125|101072940|FG000|Pilot Phase|Lost to Follow-up|0|||
33321632|NCT00307125|101072941|FG001|Pilot Phase|Lost to Follow-up|1|||
33321633|NCT00307125|101072942|FG002|Pilot Phase|Lost to Follow-up|0|||
33321634|NCT00307125|101072940|FG000|Pilot Phase|Withdrawal by Subject|0|||
33321635|NCT00307125|101072941|FG001|Pilot Phase|Withdrawal by Subject|1|||
33321636|NCT00307125|101072942|FG002|Pilot Phase|Withdrawal by Subject|1|||
33321637|NCT01323621|101072943|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
33321638|NCT01323621|101072944|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
33321639|NCT01323621|101072945|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
33321640|NCT01323621|101072943|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
33321641|NCT01323621|101072944|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
33321642|NCT01323621|101072945|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
33321643|NCT01323621|101072943|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
33321644|NCT01323621|101072944|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
33321645|NCT01323621|101072945|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
33321646|NCT01323621|101072943|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
33321647|NCT01323621|101072944|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
33321648|NCT01323621|101072945|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
33321649|NCT01323621|101072943|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
33321650|NCT01323621|101072944|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
33321651|NCT01323621|101072945|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
33321652|NCT01323621|101072943|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
33321653|NCT01323621|101072944|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
33321654|NCT01323621|101072945|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
33321655|NCT01323621|101072943|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
33321656|NCT01323621|101072944|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
33321657|NCT01323621|101072945|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
33321658|NCT01323621|101072943|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
33321659|NCT01323621|101072944|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
33321660|NCT01323621|101072945|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
33321661|NCT01323621|101072943|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
33321662|NCT01323621|101072944|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
33321663|NCT01323621|101072945|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
33321664|NCT01323621|101072943|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33321665|NCT01323621|101072944|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
33321666|NCT01323621|101072945|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33321667|NCT01323621|101072943|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
33321668|NCT01323621|101072944|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
33321669|NCT01323621|101072945|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
33321670|NCT01323621|101072943|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
33321671|NCT01323621|101072944|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
33321672|NCT01323621|101072945|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
33321673|NCT02743819|101072946|FG000|Overall Study|Lack of Efficacy|5|||
33321674|NCT02743819|101072946|FG000|Overall Study|Death|2|||
33321675|NCT02743819|101072946|FG000|Overall Study|Adverse Event|1|||
33321676|NCT03606980|101072947|FG000|Overall Study|Lost to Follow-up|3|||
33321677|NCT03606980|101072948|FG001|Overall Study|Lost to Follow-up|2|||
33321678|NCT03606980|101072949|FG002|Overall Study|Lost to Follow-up|3|||
33321679|NCT03606980|101072947|FG000|Overall Study|Withdrawal by Subject|1|||
33321680|NCT03606980|101072948|FG001|Overall Study|Withdrawal by Subject|0|||
33321681|NCT03606980|101072949|FG002|Overall Study|Withdrawal by Subject|4|||
33321682|NCT01650285|101072950|FG000|Overall Study|Adverse Event|1|||
33321683|NCT01521897|101072952|FG000|Overall Study|Protocol Violation|18|||
33321684|NCT01521897|101072952|FG000|Overall Study|Lost to Follow-up|5|||
33197976|NCT00653224|100630355|FG001|Overall Study|Adverse Event|1|||
33197977|NCT00653224|100630354|FG000|Overall Study|Lack of Efficacy|1|||
33197978|NCT00653224|100630355|FG001|Overall Study|Lack of Efficacy|2|||
33197979|NCT00653224|100630354|FG000|Overall Study|Loss of efficacy|1|||
33197980|NCT00653224|100630355|FG001|Overall Study|Loss of efficacy|0|||
33197981|NCT00653224|100630354|FG000|Overall Study|Lost to Follow-up|1|||
33197982|NCT00653224|100630355|FG001|Overall Study|Lost to Follow-up|0|||
33197983|NCT00653224|100630354|FG000|Overall Study|Other|2|||
33321685|NCT01667107|101072956|FG000|Overall Study|Adverse Event|4|||
33321686|NCT01667107|101072957|FG001|Overall Study|Adverse Event|3|||
33321687|NCT01667107|101072956|FG000|Overall Study|Tolerability issues|0|||
33321688|NCT01667107|101072957|FG001|Overall Study|Tolerability issues|2|||
33321689|NCT01667107|101072956|FG000|Overall Study|Protocol Violation|0|||
33197984|NCT00653224|100630355|FG001|Overall Study|Other|4|||
33321690|NCT01667107|101072957|FG001|Overall Study|Protocol Violation|1|||
33197985|NCT01229436|100630356|FG000|Overall Study|Withdrawal by Subject|2|||
33197986|NCT01229436|100630356|FG000|Overall Study|Lost to Follow-up|3|||
33321691|NCT01667107|101072956|FG000|Overall Study|Lack of Efficacy|0|||
33321692|NCT01667107|101072957|FG001|Overall Study|Lack of Efficacy|1|||
33321693|NCT01383161|101072963|FG000|Overall Study|Adverse Event|5|||
33321694|NCT01383161|101072964|FG001|Overall Study|Adverse Event|1|||
33321695|NCT01383161|101072963|FG000|Overall Study|Withdrawal by Subject|0|||
33321696|NCT01383161|101072964|FG001|Overall Study|Withdrawal by Subject|2|||
33321697|NCT01383161|101072963|FG000|Overall Study|Lack of Efficacy|0|||
33321698|NCT01383161|101072964|FG001|Overall Study|Lack of Efficacy|1|||
33321699|NCT01186939|101072965|FG000|Overall Study|Death|7|||
33321700|NCT01186939|101072965|FG000|Overall Study|Withdrawal by Subject|2|||
33321701|NCT01186939|101072965|FG000|Overall Study|No longer receiving clinical benefit|17|||
33321702|NCT01186939|101072965|FG000|Overall Study|Program closed|5|||
33321703|NCT01186939|101072965|FG000|Overall Study|Sponsor decision|4|||
33321704|NCT01186939|101072965|FG000|Overall Study|Started additional treatment|1|||
33321705|NCT01186939|101072965|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
33321706|NCT01186939|101072965|FG000|Overall Study|Myocardial infarction|1|||
33321707|NCT01186939|101072965|FG000|Overall Study|Bone marrow transplant|1|||
33321708|NCT01186939|101072965|FG000|Overall Study|Transformation to AML|1|||
33321709|NCT01330914|101072966|FG000|Overall Study|Withdrawal by Subject|4|||
33321710|NCT01330914|101072966|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
33321711|NCT02876835|101072967|FG000|Treatment Period (51.1 Month)|Other|1|||
33321712|NCT02876835|101072968|FG001|Treatment Period (51.1 Month)|Other|0|||
33321713|NCT02876835|101072967|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
33321714|NCT02876835|101072968|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
33321715|NCT02876835|101072967|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
33321716|NCT02876835|101072968|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
33321717|NCT02876835|101072967|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
33321718|NCT02876835|101072968|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
33321719|NCT02511678|101072969|FG000|Overall Study|Withdrawal by Subject|2|||
33321720|NCT02511678|101072969|FG000|Overall Study|Lost to Follow-up|4|||
33321721|NCT02511678|101072969|FG000|Overall Study|Death|19|||
33321722|NCT02511678|101072969|FG000|Overall Study|Adverse Event|1|||
33321723|NCT02511678|101072969|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
33321724|NCT02511678|101072969|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
33321725|NCT02511678|101072969|FG000|Overall Study|Required Radiofrequency Ablation|1|||
33321726|NCT02511678|101072969|FG000|Overall Study|Biopsy was Negative|1|||
33321727|NCT02511678|101072969|FG000|Overall Study|Protocol Violation|1|||
33321728|NCT02511678|101072969|FG000|Overall Study|Received Radiation Treatment|1|||
33321729|NCT01310803|101072970|FG000|Overall Study|Subject terminated by Sponsor|1|||
33321730|NCT01310803|101072971|FG001|Overall Study|Subject terminated by Sponsor|0|||
33321731|NCT00088907|101072972|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
33321732|NCT00088907|101072973|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
33321733|NCT00088907|101072972|FG000|Randomized Study (Step 1)|Adverse Event|14|||
33321734|NCT00088907|101072973|FG001|Randomized Study (Step 1)|Adverse Event|19|||
33321735|NCT00088907|101072972|FG000|Randomized Study (Step 1)|Death|11|||
33321736|NCT00088907|101072973|FG001|Randomized Study (Step 1)|Death|12|||
33321737|NCT00088907|101072972|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
33321738|NCT00088907|101072973|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
33321739|NCT00088907|101072972|FG000|Randomized Study (Step 1)|complicating disease|3|||
33321740|NCT00088907|101072973|FG001|Randomized Study (Step 1)|complicating disease|1|||
33321741|NCT00088907|101072972|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
33321742|NCT00088907|101072973|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
33321743|NCT00088907|101072972|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
33321744|NCT00088907|101072973|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
33321745|NCT00088907|101072972|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
33321746|NCT00088907|101072973|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
33321747|NCT00088907|101072972|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
33321748|NCT00088907|101072973|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
33321749|NCT00088907|101072972|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
33321750|NCT00088907|101072973|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
33321751|NCT00088907|101072972|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
33321752|NCT00088907|101072973|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
33321753|NCT01019980|101072974|FG000|Overall Study|Drug not available.|2|||
33321754|NCT01019980|101072975|FG001|Overall Study|Drug not available.|0|||
33321755|NCT01177722|101072979|FG000|Overall Study|Serious Adverse Event|0|||
33321756|NCT01177722|101072980|FG001|Overall Study|Serious Adverse Event|0|||
33321757|NCT01177722|101072981|FG002|Overall Study|Serious Adverse Event|1|||
33321758|NCT01177722|101072982|FG003|Overall Study|Serious Adverse Event|0|||
33321759|NCT01177722|101072979|FG000|Overall Study|Protocol Violation|0|||
33321760|NCT01177722|101072980|FG001|Overall Study|Protocol Violation|0|||
33321761|NCT01177722|101072981|FG002|Overall Study|Protocol Violation|1|||
33321762|NCT01177722|101072982|FG003|Overall Study|Protocol Violation|0|||
33321763|NCT01177722|101072979|FG000|Overall Study|Lost to Follow-up|3|||
33321764|NCT01177722|101072980|FG001|Overall Study|Lost to Follow-up|4|||
33321765|NCT01177722|101072981|FG002|Overall Study|Lost to Follow-up|3|||
33321766|NCT01177722|101072982|FG003|Overall Study|Lost to Follow-up|1|||
33321767|NCT01177722|101072979|FG000|Overall Study|Withdrawal by Subject|10|||
33321768|NCT01177722|101072980|FG001|Overall Study|Withdrawal by Subject|6|||
33321769|NCT01177722|101072981|FG002|Overall Study|Withdrawal by Subject|4|||
33321770|NCT01177722|101072982|FG003|Overall Study|Withdrawal by Subject|6|||
33321771|NCT01910116|101072983|FG000|Overall Study|Adverse Event|0|||
33321772|NCT01910116|101072984|FG001|Overall Study|Adverse Event|3|||
33321773|NCT01910116|101072983|FG000|Overall Study|Lack of Efficacy|3|||
33510298|NCT02892422|101762252|FG000|Overall Study|patient legally incapable|1|||
33510299|NCT02892422|101762252|FG000|Overall Study|patient decision|7|||
33510300|NCT02892422|101762252|FG000|Overall Study|Investigator decision|1|||
33510301|NCT01893281|101762258|FG000|Overall Study|Adverse Event|1|||
33510302|NCT01893281|101762258|FG000|Overall Study|Protocol Violation|1|||
33510303|NCT01893281|101762258|FG000|Overall Study|Withdrawal by Subject|1|||
33510304|NCT02752165|101762262|FG000|Overall Study|Withdrawal by Subject|6|||
33510305|NCT02752165|101762263|FG001|Overall Study|Withdrawal by Subject|6|||
33510306|NCT02752165|101762262|FG000|Overall Study|Protocol Violation|6|||
33510307|NCT02752165|101762263|FG001|Overall Study|Protocol Violation|5|||
33510308|NCT02752165|101762262|FG000|Overall Study|Lost to Follow-up|33|||
33510309|NCT02752165|101762263|FG001|Overall Study|Lost to Follow-up|38|||
33510310|NCT05036668|101762264|FG000|Overall Study|lost to follow Up|0|||
33197987|NCT00660010|100630357|FG000|Overall Study|Withdrawal by Subject|2|||
33197988|NCT00660010|100630357|FG000|Overall Study|Lost to Follow-up|3|||
33197989|NCT00660010|100630357|FG000|Overall Study|Adverse Event|1|||
33197990|NCT00660010|100630357|FG000|Overall Study|Noncompliance with visit schedule|3|||
33197991|NCT02956629|100630358|FG000|Overall Study|Adverse Event|0|||
33197992|NCT02956629|100630359|FG001|Overall Study|Adverse Event|0|||
33197993|NCT02956629|100630360|FG002|Overall Study|Adverse Event|1|||
33197994|NCT02956629|100630361|FG003|Overall Study|Adverse Event|0|||
33197995|NCT02956629|100630362|FG004|Overall Study|Adverse Event|0|||
33197996|NCT02956629|100630363|FG005|Overall Study|Adverse Event|0|||
33197997|NCT02956629|100630358|FG000|Overall Study|Lost to Follow-up|2|||
33197998|NCT02956629|100630359|FG001|Overall Study|Lost to Follow-up|5|||
33197999|NCT02956629|100630360|FG002|Overall Study|Lost to Follow-up|3|||
33198000|NCT02956629|100630361|FG003|Overall Study|Lost to Follow-up|1|||
33198001|NCT02956629|100630362|FG004|Overall Study|Lost to Follow-up|0|||
33198002|NCT02956629|100630363|FG005|Overall Study|Lost to Follow-up|1|||
33198003|NCT02956629|100630358|FG000|Overall Study|Withdrawal by Subject|3|||
33198004|NCT02956629|100630359|FG001|Overall Study|Withdrawal by Subject|1|||
33321774|NCT01910116|101072984|FG001|Overall Study|Lack of Efficacy|4|||
33321775|NCT01910116|101072983|FG000|Overall Study|Lost to Follow-up|1|||
33321776|NCT01910116|101072984|FG001|Overall Study|Lost to Follow-up|0|||
33321777|NCT01910116|101072983|FG000|Overall Study|Protocol Violation|1|||
33321778|NCT01910116|101072984|FG001|Overall Study|Protocol Violation|2|||
33321779|NCT01910116|101072983|FG000|Overall Study|Withdrawal by Subject|8|||
33321780|NCT01910116|101072984|FG001|Overall Study|Withdrawal by Subject|3|||
33321781|NCT01910116|101072983|FG000|Overall Study|uncertain allocation|1|||
33321782|NCT01910116|101072984|FG001|Overall Study|uncertain allocation|3|||
33321783|NCT01910116|101072983|FG000|Overall Study|incomplete data|0|||
33321784|NCT01910116|101072984|FG001|Overall Study|incomplete data|1|||
33321785|NCT03675776|101072993|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
33321786|NCT03675776|101072994|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
33321787|NCT03675776|101072995|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
33321788|NCT03675776|101072993|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
33321789|NCT03675776|101072994|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
33321790|NCT03675776|101072995|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
33321791|NCT00146757|101072996|FG000|Overall Study|Death|1|||
33321792|NCT00146757|101072997|FG001|Overall Study|Death|0|||
33321793|NCT00146757|101072996|FG000|Overall Study|Adverse Event|1|||
33398977|NCT00545740|101350153|FG001|Overall Study|Patient difficulties|1|||
33398978|NCT00545740|101350154|FG002|Overall Study|Patient difficulties|0|||
33510311|NCT05036668|101762265|FG001|Overall Study|lost to follow Up|0|||
33510312|NCT05036668|101762266|FG002|Overall Study|lost to follow Up|1|||
33198005|NCT02956629|100630360|FG002|Overall Study|Withdrawal by Subject|0|||
33198006|NCT02956629|100630361|FG003|Overall Study|Withdrawal by Subject|0|||
33198007|NCT02956629|100630362|FG004|Overall Study|Withdrawal by Subject|0|||
33321794|NCT00146757|101072997|FG001|Overall Study|Adverse Event|0|||
33510313|NCT01190410|101762270|FG000|Overall Study|Adverse Event|0|||
33510314|NCT01190410|101762271|FG001|Overall Study|Adverse Event|3|||
33510315|NCT01190410|101762270|FG000|Overall Study|Lack of Efficacy|0|||
33198008|NCT02956629|100630363|FG005|Overall Study|Withdrawal by Subject|0|||
33198009|NCT00533949|100630365|FG000|Overall Study|Protocol Violation|12|||
33321795|NCT01674712|101072998|FG000|Overall Study|Adverse Event|5|||
33398979|NCT00545740|101350155|FG003|Overall Study|Patient difficulties|0|||
33510316|NCT01190410|101762271|FG001|Overall Study|Lack of Efficacy|2|||
33198010|NCT00533949|100630366|FG001|Overall Study|Protocol Violation|12|||
33321796|NCT01674712|101072999|FG001|Overall Study|Adverse Event|6|||
33321797|NCT01674712|101073000|FG002|Overall Study|Adverse Event|3|||
33321798|NCT01674712|101073001|FG003|Overall Study|Adverse Event|4|||
33321799|NCT01674712|101073002|FG004|Overall Study|Adverse Event|6|||
33321800|NCT01674712|101072998|FG000|Overall Study|Lost to Follow-up|1|||
33321801|NCT01674712|101072999|FG001|Overall Study|Lost to Follow-up|0|||
33321802|NCT01674712|101073000|FG002|Overall Study|Lost to Follow-up|0|||
33321803|NCT01674712|101073001|FG003|Overall Study|Lost to Follow-up|0|||
33321804|NCT01674712|101073002|FG004|Overall Study|Lost to Follow-up|0|||
33321805|NCT01674712|101072998|FG000|Overall Study|Protocol Violation|2|||
33321806|NCT01674712|101072999|FG001|Overall Study|Protocol Violation|0|||
33321807|NCT01674712|101073000|FG002|Overall Study|Protocol Violation|0|||
33321808|NCT01674712|101073001|FG003|Overall Study|Protocol Violation|0|||
33321809|NCT01674712|101073002|FG004|Overall Study|Protocol Violation|0|||
33321810|NCT01674712|101072998|FG000|Overall Study|Withdrawal by Subject|2|||
33321811|NCT01674712|101072999|FG001|Overall Study|Withdrawal by Subject|2|||
33321812|NCT01674712|101073000|FG002|Overall Study|Withdrawal by Subject|5|||
33321813|NCT01674712|101073001|FG003|Overall Study|Withdrawal by Subject|4|||
33321814|NCT01674712|101073002|FG004|Overall Study|Withdrawal by Subject|3|||
33321815|NCT01674712|101072998|FG000|Overall Study|Administrative|0|||
33321816|NCT01674712|101072999|FG001|Overall Study|Administrative|1|||
33321817|NCT01674712|101073000|FG002|Overall Study|Administrative|0|||
33321818|NCT01674712|101073001|FG003|Overall Study|Administrative|0|||
33321819|NCT01674712|101073002|FG004|Overall Study|Administrative|1|||
33321820|NCT01674712|101072998|FG000|Overall Study|Lack of Efficacy|0|||
33321821|NCT01674712|101072999|FG001|Overall Study|Lack of Efficacy|0|||
33321822|NCT01674712|101073000|FG002|Overall Study|Lack of Efficacy|1|||
33321823|NCT01674712|101073001|FG003|Overall Study|Lack of Efficacy|0|||
33321824|NCT01674712|101073002|FG004|Overall Study|Lack of Efficacy|1|||
33321825|NCT01230554|101073003|FG000|Overall Study|Lost to Follow-up|2|||
33321826|NCT01230554|101073003|FG000|Overall Study|Inability to maintain visit schedule|1|||
33321827|NCT03427125|101073004|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
33321828|NCT03427125|101073005|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
33321829|NCT03427125|101073006|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
33321830|NCT00129623|101073007|FG000|Overall Study|Adverse Event|3|||
33321831|NCT00129623|101073008|FG001|Overall Study|Adverse Event|7|||
33321832|NCT00129623|101073007|FG000|Overall Study|Refused Treatment|5|||
33321833|NCT00129623|101073008|FG001|Overall Study|Refused Treatment|3|||
33321834|NCT00129623|101073007|FG000|Overall Study|Failure to Return|1|||
33321835|NCT00129623|101073008|FG001|Overall Study|Failure to Return|1|||
33321836|NCT00129623|101073007|FG000|Overall Study|Relocated job out of state|1|||
33321837|NCT00129623|101073008|FG001|Overall Study|Relocated job out of state|0|||
33321838|NCT00129623|101073007|FG000|Overall Study|Uncertainty to return|0|||
33321839|NCT00129623|101073008|FG001|Overall Study|Uncertainty to return|1|||
33321840|NCT01428661|101073010|FG000|Double-Masked Phase|Protocol Violation|9|||
33321841|NCT01428661|101073011|FG001|Double-Masked Phase|Protocol Violation|4|||
33321842|NCT01428661|101073012|FG002|Double-Masked Phase|Protocol Violation|0|||
33321843|NCT01428661|101073010|FG000|Double-Masked Phase|Adverse Event|13|||
33321844|NCT01428661|101073011|FG001|Double-Masked Phase|Adverse Event|4|||
33510317|NCT01190410|101762270|FG000|Overall Study|Withdrawal by Subject|0|||
33510318|NCT01190410|101762271|FG001|Overall Study|Withdrawal by Subject|2|||
33510319|NCT01190410|101762270|FG000|Overall Study|Administrative decision|1|||
33510320|NCT01190410|101762271|FG001|Overall Study|Administrative decision|0|||
33510321|NCT01190410|101762270|FG000|Overall Study|PI discretion|0|||
33510322|NCT01190410|101762271|FG001|Overall Study|PI discretion|2|||
33321845|NCT01428661|101073012|FG002|Double-Masked Phase|Adverse Event|0|||
33321846|NCT01428661|101073010|FG000|Double-Masked Phase|Lost to Follow-up|14|||
33321847|NCT01428661|101073011|FG001|Double-Masked Phase|Lost to Follow-up|14|||
33321848|NCT01428661|101073012|FG002|Double-Masked Phase|Lost to Follow-up|0|||
33321849|NCT01428661|101073010|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
33321850|NCT01428661|101073011|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
33321851|NCT01428661|101073012|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
33510323|NCT00319592|101762276|FG000|Overall Study|Protocol Violation|1|||
33510324|NCT00319592|101762277|FG001|Overall Study|Protocol Violation|0|||
33510325|NCT00319592|101762276|FG000|Overall Study|Physician Decision|0|||
33321852|NCT01428661|101073010|FG000|Double-Masked Phase|Lack of Efficacy|2|||
33321853|NCT01428661|101073011|FG001|Double-Masked Phase|Lack of Efficacy|1|||
33321854|NCT01428661|101073012|FG002|Double-Masked Phase|Lack of Efficacy|0|||
33321855|NCT01428661|101073010|FG000|Double-Masked Phase|*Various|1|||
33321856|NCT01428661|101073011|FG001|Double-Masked Phase|*Various|6|||
33321857|NCT01428661|101073012|FG002|Double-Masked Phase|*Various|0|||
33321858|NCT01428661|101073010|FG000|Open Label Extension|Protocol Violation|0|||
33321859|NCT01428661|101073011|FG001|Open Label Extension|Protocol Violation|0|||
33321860|NCT01428661|101073012|FG002|Open Label Extension|Protocol Violation|9|||
33321861|NCT01428661|101073010|FG000|Open Label Extension|Adverse Event|0|||
33321862|NCT01428661|101073011|FG001|Open Label Extension|Adverse Event|0|||
33321863|NCT01428661|101073012|FG002|Open Label Extension|Adverse Event|15|||
33510326|NCT00319592|101762277|FG001|Overall Study|Physician Decision|1|||
33510327|NCT00747474|101762278|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33321864|NCT01428661|101073010|FG000|Open Label Extension|Lost to Follow-up|0|||
33321865|NCT01428661|101073011|FG001|Open Label Extension|Lost to Follow-up|0|||
33510328|NCT00747474|101762279|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33510329|NCT00747474|101762280|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33510330|NCT00747474|101762281|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33510331|NCT00747474|101762282|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33510332|NCT00747474|101762283|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33510333|NCT00747474|101762284|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33510334|NCT00747474|101762285|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
33510335|NCT00747474|101762286|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33510336|NCT00747474|101762287|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33510337|NCT00747474|101762288|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33510338|NCT00747474|101762289|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
33510339|NCT03843541|101762294|FG000|Overall Study|Adverse Event|4|||
33510340|NCT03843541|101762295|FG001|Overall Study|Adverse Event|2|||
33510341|NCT03843541|101762296|FG002|Overall Study|Adverse Event|3|||
33510342|NCT03843541|101762294|FG000|Overall Study|Death|1|||
33510343|NCT03843541|101762295|FG001|Overall Study|Death|0|||
33510344|NCT03843541|101762296|FG002|Overall Study|Death|0|||
33510345|NCT03843541|101762294|FG000|Overall Study|Lack of adherence to study medication|0|||
33510346|NCT03843541|101762295|FG001|Overall Study|Lack of adherence to study medication|0|||
33510347|NCT03843541|101762296|FG002|Overall Study|Lack of adherence to study medication|1|||
33510348|NCT03843541|101762294|FG000|Overall Study|Physician Decision|1|||
33510349|NCT03843541|101762295|FG001|Overall Study|Physician Decision|2|||
33510350|NCT03843541|101762296|FG002|Overall Study|Physician Decision|2|||
33510351|NCT03843541|101762294|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
33510352|NCT03843541|101762295|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
33510353|NCT03843541|101762296|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
33510354|NCT03843541|101762294|FG000|Overall Study|Withdrawal by Subject|6|||
33510355|NCT03843541|101762295|FG001|Overall Study|Withdrawal by Subject|9|||
33510356|NCT03843541|101762296|FG002|Overall Study|Withdrawal by Subject|7|||
33510357|NCT03843541|101762294|FG000|Overall Study|Administration of rescue mucolytic|0|||
33510358|NCT03843541|101762295|FG001|Overall Study|Administration of rescue mucolytic|0|||
33510359|NCT03843541|101762296|FG002|Overall Study|Administration of rescue mucolytic|1|||
33510360|NCT03843541|101762294|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
33510361|NCT03843541|101762295|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
33510362|NCT03843541|101762296|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
33510363|NCT03030989|101762297|FG000|Overall Study|Fever|2|||
33510364|NCT03030989|101762298|FG001|Overall Study|Fever|2|||
33510365|NCT03030989|101762297|FG000|Overall Study|Rash|2|||
33510366|NCT03030989|101762298|FG001|Overall Study|Rash|1|||
33510367|NCT03030989|101762297|FG000|Overall Study|Fatigue/Overwhelmed|1|||
33510368|NCT03030989|101762298|FG001|Overall Study|Fatigue/Overwhelmed|5|||
33510369|NCT03030989|101762297|FG000|Overall Study|Positive Blood Cultures|2|||
33510370|NCT03030989|101762298|FG001|Overall Study|Positive Blood Cultures|1|||
33510371|NCT03030989|101762297|FG000|Overall Study|Line Removed|0|||
33510372|NCT03030989|101762298|FG001|Overall Study|Line Removed|2|||
33510373|NCT03030989|101762297|FG000|Overall Study|No longer interested|5|||
33510374|NCT03030989|101762298|FG001|Overall Study|No longer interested|3|||
33510375|NCT01167881|101762304|FG000|Overall Study|Adverse Event|47|||
33510376|NCT01167881|101762305|FG001|Overall Study|Adverse Event|51|||
33510377|NCT01167881|101762304|FG000|Overall Study|Lack of Efficacy|4|||
33510378|NCT01167881|101762305|FG001|Overall Study|Lack of Efficacy|7|||
33510379|NCT01167881|101762304|FG000|Overall Study|Non compliant with protocol|9|||
33510380|NCT01167881|101762305|FG001|Overall Study|Non compliant with protocol|18|||
33321866|NCT01428661|101073012|FG002|Open Label Extension|Lost to Follow-up|38|||
33321867|NCT01428661|101073010|FG000|Open Label Extension|Withdrawal by Subject|0|||
33321868|NCT01428661|101073011|FG001|Open Label Extension|Withdrawal by Subject|0|||
33321869|NCT01428661|101073012|FG002|Open Label Extension|Withdrawal by Subject|49|||
33321870|NCT01428661|101073010|FG000|Open Label Extension|Lack of Efficacy|0|||
33321871|NCT01428661|101073011|FG001|Open Label Extension|Lack of Efficacy|0|||
33321872|NCT01428661|101073012|FG002|Open Label Extension|Lack of Efficacy|24|||
33321873|NCT01428661|101073010|FG000|Open Label Extension|**Various|0|||
33510381|NCT01167881|101762304|FG000|Overall Study|Lost to Follow-up|19|||
33510382|NCT01167881|101762305|FG001|Overall Study|Lost to Follow-up|20|||
33510383|NCT01167881|101762304|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
33510384|NCT01167881|101762305|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
33321874|NCT01428661|101073011|FG001|Open Label Extension|**Various|0|||
33321875|NCT01428661|101073012|FG002|Open Label Extension|**Various|185|||
33510385|NCT01167881|101762304|FG000|Overall Study|Not treated|4|||
33510386|NCT01167881|101762305|FG001|Overall Study|Not treated|0|||
33510387|NCT01167881|101762304|FG000|Overall Study|Other not defined above|31|||
33510388|NCT01167881|101762305|FG001|Overall Study|Other not defined above|55|||
33510389|NCT00281632|101762306|FG000|Overall Study|Adverse Event|7|||
33510390|NCT00281632|101762306|FG000|Overall Study|Withdrawal by Subject|2|||
33510391|NCT00281632|101762306|FG000|Overall Study|Disease Progression|22|||
33510392|NCT00281632|101762306|FG000|Overall Study|Death|1|||
33510393|NCT00281632|101762306|FG000|Overall Study|Physician Decision|1|||
33510394|NCT00281632|101762306|FG000|Overall Study|Ongoing|3|||
33510395|NCT02005692|101762307|FG000|Overall Study|Protocol Violation|1|||
33510396|NCT02005692|101762307|FG000|Overall Study|Withdrawal by Subject|1|||
33510397|NCT02005692|101762307|FG000|Overall Study|Discharged earlier than anticipated|5|||
33510398|NCT03197324|101762308|FG000|Overall Study|Adverse Event|0|||
33510399|NCT03197324|101762309|FG001|Overall Study|Adverse Event|1|||
33510400|NCT01032239|101762310|FG000|Overall Study|Lost to Follow-up|3|||
33510401|NCT01032239|101762311|FG001|Overall Study|Lost to Follow-up|2|||
33510402|NCT01032239|101762310|FG000|Overall Study|Withdrawal by Subject|2|||
33510403|NCT01032239|101762311|FG001|Overall Study|Withdrawal by Subject|3|||
33510404|NCT01032239|101762310|FG000|Overall Study|Death|1|||
33510405|NCT01032239|101762311|FG001|Overall Study|Death|0|||
33510406|NCT01032239|101762310|FG000|Overall Study|Protocol Violation|1|||
33510407|NCT01032239|101762311|FG001|Overall Study|Protocol Violation|0|||
33510408|NCT02691013|101762312|FG000|Overall Study|Withdrawal by Subject|3|||
33510409|NCT02691013|101762313|FG001|Overall Study|Withdrawal by Subject|0|||
33510410|NCT05835011|101762314|FG000|Overall Study|Study Terminated by the Sponsor|1|||
33510411|NCT05835011|101762314|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
33510412|NCT01608087|101762315|FG000|Overall Study|Lost to Follow-up|0|||
33510413|NCT01608087|101762316|FG001|Overall Study|Lost to Follow-up|1|||
33510414|NCT01608087|101762317|FG002|Overall Study|Lost to Follow-up|0|||
33510415|NCT01608087|101762315|FG000|Overall Study|Other Reason|0|||
33510416|NCT01608087|101762316|FG001|Overall Study|Other Reason|1|||
33510417|NCT01608087|101762317|FG002|Overall Study|Other Reason|0|||
33510418|NCT02009397|101762322|FG000|Overall Study|Protocol Violation|6|||
33510419|NCT02009397|101762322|FG000|Overall Study|Death|8|||
33510420|NCT02009397|101762322|FG000|Overall Study|Lost to Follow-up|6|||
33510421|NCT02396420|101762323|FG000|Overall Study|Death|1|||
33510422|NCT05174949|101764556|FG000|Overall Study|Physician Decision|1|||
33510423|NCT05174949|101764557|FG001|Overall Study|Physician Decision|2|||
33510424|NCT05174949|101764558|FG002|Overall Study|Physician Decision|0|||
33510425|NCT05174949|101764559|FG003|Overall Study|Physician Decision|1|||
33510426|NCT05174949|101764560|FG004|Overall Study|Physician Decision|0|||
33510427|NCT05174949|101764561|FG005|Overall Study|Physician Decision|0|||
33510428|NCT05174949|101764556|FG000|Overall Study|Withdrawal by Subject|0|||
33510429|NCT05174949|101764557|FG001|Overall Study|Withdrawal by Subject|1|||
33510430|NCT05174949|101764558|FG002|Overall Study|Withdrawal by Subject|0|||
33510431|NCT05174949|101764559|FG003|Overall Study|Withdrawal by Subject|0|||
33510432|NCT05174949|101764560|FG004|Overall Study|Withdrawal by Subject|0|||
33510433|NCT05174949|101764561|FG005|Overall Study|Withdrawal by Subject|0|||
33510434|NCT05174949|101764556|FG000|Overall Study|Lost to Follow-up|0|||
33510435|NCT05174949|101764557|FG001|Overall Study|Lost to Follow-up|0|||
33510436|NCT05174949|101764558|FG002|Overall Study|Lost to Follow-up|0|||
33510437|NCT05174949|101764559|FG003|Overall Study|Lost to Follow-up|1|||
33510438|NCT05174949|101764560|FG004|Overall Study|Lost to Follow-up|0|||
33510439|NCT05174949|101764561|FG005|Overall Study|Lost to Follow-up|0|||
33510440|NCT03155178|101764564|FG000|Overall Study|Did not meet treatment day baseline|7|||
33510441|NCT03155178|101764565|FG001|Overall Study|Did not meet treatment day baseline|7|||
33510442|NCT03155178|101764566|FG002|Overall Study|Did not meet treatment day baseline|7|||
33510443|NCT03155178|101764567|FG003|Overall Study|Did not meet treatment day baseline|7|||
33510444|NCT01895608|101764568|FG000|Overall Study|change in health status|0|||
33510445|NCT01895608|101764569|FG001|Overall Study|change in health status|1|||
33510446|NCT01895608|101764570|FG002|Overall Study|change in health status|1|||
33510447|NCT01895608|101764571|FG003|Overall Study|change in health status|0|||
33510448|NCT01895608|101764568|FG000|Overall Study|Withdrawal by Subject|0|||
33510449|NCT01895608|101764569|FG001|Overall Study|Withdrawal by Subject|0|||
33510450|NCT01895608|101764570|FG002|Overall Study|Withdrawal by Subject|2|||
33510451|NCT01895608|101764571|FG003|Overall Study|Withdrawal by Subject|0|||
33510452|NCT01967706|101764572|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
33510453|NCT01967706|101764573|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
33510454|NCT01967706|101764574|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
33510455|NCT01967706|101764575|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
33510456|NCT03499899|101764578|FG000|Overall Study|Adverse Event|2|||
33510457|NCT03499899|101764579|FG001|Overall Study|Adverse Event|3|||
33510458|NCT03499899|101764580|FG002|Overall Study|Adverse Event|3|||
33510459|NCT03499899|101764578|FG000|Overall Study|Death|0|||
33510460|NCT03499899|101764579|FG001|Overall Study|Death|0|||
33510461|NCT03499899|101764580|FG002|Overall Study|Death|1|||
33510462|NCT03499899|101764578|FG000|Overall Study|Physician Decision|3|||
33321876|NCT02322229|101073023|FG000|Overall Study|Physician Decision|2|||
33321877|NCT03211247|101073028|FG000|Overall Study|Adverse Event|8|||
33321878|NCT03211247|101073029|FG001|Overall Study|Adverse Event|0|||
33321879|NCT03211247|101073030|FG002|Overall Study|Adverse Event|1|||
33321880|NCT03211247|101073031|FG003|Overall Study|Adverse Event|0|||
33321881|NCT03211247|101073032|FG004|Overall Study|Adverse Event|0|||
33321882|NCT03211247|101073028|FG000|Overall Study|Lost to Follow-up|2|||
33321883|NCT03211247|101073029|FG001|Overall Study|Lost to Follow-up|1|||
33321884|NCT03211247|101073030|FG002|Overall Study|Lost to Follow-up|0|||
33321885|NCT03211247|101073031|FG003|Overall Study|Lost to Follow-up|0|||
33321886|NCT03211247|101073032|FG004|Overall Study|Lost to Follow-up|0|||
33321887|NCT03211247|101073028|FG000|Overall Study|Physician Decision|1|||
33321888|NCT03211247|101073029|FG001|Overall Study|Physician Decision|2|||
33321889|NCT03211247|101073030|FG002|Overall Study|Physician Decision|0|||
33321890|NCT03211247|101073031|FG003|Overall Study|Physician Decision|0|||
33321891|NCT03211247|101073032|FG004|Overall Study|Physician Decision|0|||
33321892|NCT03211247|101073028|FG000|Overall Study|Non-compliance with study drug|2|||
33321893|NCT03211247|101073029|FG001|Overall Study|Non-compliance with study drug|0|||
33321894|NCT03211247|101073030|FG002|Overall Study|Non-compliance with study drug|0|||
33321895|NCT03211247|101073031|FG003|Overall Study|Non-compliance with study drug|0|||
33321896|NCT03211247|101073032|FG004|Overall Study|Non-compliance with study drug|0|||
33321897|NCT03211247|101073028|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
33321898|NCT03211247|101073029|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
33321899|NCT03211247|101073030|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
33321900|NCT03211247|101073031|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
33321901|NCT03211247|101073032|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
33321902|NCT03211247|101073028|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
33321903|NCT03211247|101073029|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
33321904|NCT03211247|101073030|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
33321905|NCT03211247|101073031|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
33321906|NCT03211247|101073032|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
33321907|NCT03211247|101073028|FG000|Overall Study|Protocol Violation|0|||
33321908|NCT03211247|101073029|FG001|Overall Study|Protocol Violation|1|||
33321909|NCT03211247|101073030|FG002|Overall Study|Protocol Violation|0|||
33321910|NCT03211247|101073031|FG003|Overall Study|Protocol Violation|0|||
33321911|NCT03211247|101073032|FG004|Overall Study|Protocol Violation|0|||
33321912|NCT03374995|101073034|FG000|Overall Study|Withdrawal by Subject|0|||
33321913|NCT03374995|101073035|FG001|Overall Study|Withdrawal by Subject|1|||
33321914|NCT03085758|101073037|FG000|Overall Study|Death|26|||
33321915|NCT03085758|101073038|FG001|Overall Study|Death|24|||
33321916|NCT03085758|101073039|FG002|Overall Study|Death|53|||
33321917|NCT03085758|101073037|FG000|Overall Study|Lost to Follow-up|1|||
33321918|NCT03085758|101073038|FG001|Overall Study|Lost to Follow-up|1|||
33321919|NCT03085758|101073039|FG002|Overall Study|Lost to Follow-up|1|||
33321920|NCT03085758|101073037|FG000|Overall Study|Withdrawal by Subject|2|||
33321921|NCT03085758|101073038|FG001|Overall Study|Withdrawal by Subject|2|||
33321922|NCT03085758|101073039|FG002|Overall Study|Withdrawal by Subject|1|||
33321923|NCT03085758|101073037|FG000|Overall Study|Refusal to recall it up to day 90|0|||
33321924|NCT03085758|101073038|FG001|Overall Study|Refusal to recall it up to day 90|0|||
33321925|NCT03085758|101073039|FG002|Overall Study|Refusal to recall it up to day 90|1|||
33321926|NCT03085758|101073037|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
33321927|NCT03085758|101073038|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
33321928|NCT03085758|101073039|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
33321929|NCT05111041|101073040|FG000|Overall Study|Lost to Follow-up|6|||
33510463|NCT03499899|101764579|FG001|Overall Study|Physician Decision|6|||
33510464|NCT03499899|101764580|FG002|Overall Study|Physician Decision|6|||
33510465|NCT03499899|101764578|FG000|Overall Study|Progressive disease|15|||
33510466|NCT03499899|101764579|FG001|Overall Study|Progressive disease|23|||
33510467|NCT03499899|101764580|FG002|Overall Study|Progressive disease|23|||
33321930|NCT05111041|101073041|FG001|Overall Study|Lost to Follow-up|7|||
33321931|NCT05111041|101073040|FG000|Overall Study|Withdrawal by Subject|1|||
33321932|NCT05111041|101073041|FG001|Overall Study|Withdrawal by Subject|0|||
33321933|NCT03690141|101073042|FG000|Overall Study|Adverse Event|5|||
33510468|NCT03499899|101764578|FG000|Overall Study|Patient decision|0|||
33510469|NCT03499899|101764579|FG001|Overall Study|Patient decision|1|||
33510470|NCT03499899|101764580|FG002|Overall Study|Patient decision|1|||
33510471|NCT03499899|101764578|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
33510472|NCT03499899|101764579|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
33510473|NCT03499899|101764580|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
33510474|NCT01190267|101764581|FG000|Overall Study|Adverse Event|10|||
33510475|NCT01190267|101764582|FG001|Overall Study|Adverse Event|0|||
33510476|NCT01190267|101764581|FG000|Overall Study|Treatment Failure|8|||
33510477|NCT01190267|101764582|FG001|Overall Study|Treatment Failure|2|||
33510478|NCT01190267|101764581|FG000|Overall Study|Lost to Follow-up|2|||
33510479|NCT01190267|101764582|FG001|Overall Study|Lost to Follow-up|0|||
33510480|NCT01190267|101764581|FG000|Overall Study|Withdrawal by Subject|13|||
33510481|NCT01190267|101764582|FG001|Overall Study|Withdrawal by Subject|1|||
33510482|NCT01190267|101764581|FG000|Overall Study|Protocol Violation|8|||
33510483|NCT01190267|101764582|FG001|Overall Study|Protocol Violation|1|||
33510484|NCT01346189|101764586|FG000|Overall Study|Withdrawal by Subject|7|||
33510485|NCT01346189|101764587|FG001|Overall Study|Withdrawal by Subject|5|||
33510486|NCT01346189|101764588|FG002|Overall Study|Withdrawal by Subject|3|||
33510487|NCT01346189|101764589|FG003|Overall Study|Withdrawal by Subject|5|||
33510488|NCT01346189|101764586|FG000|Overall Study|Physician Decision|4|||
33510489|NCT01346189|101764587|FG001|Overall Study|Physician Decision|0|||
33321934|NCT03690141|101073042|FG000|Overall Study|Withdrawal by Subject|3|||
33321935|NCT03690141|101073042|FG000|Overall Study|Physician Decision|4|||
33321936|NCT03690141|101073042|FG000|Overall Study|Disease progression|4|||
33321937|NCT01357577|101073043|FG000|Overall Study|Lost to Follow-up|20|||
33321938|NCT01357577|101073044|FG001|Overall Study|Lost to Follow-up|16|||
33321939|NCT01357577|101073043|FG000|Overall Study|Withdrawal by Subject|16|||
33321940|NCT01357577|101073044|FG001|Overall Study|Withdrawal by Subject|8|||
33321941|NCT01357577|101073043|FG000|Overall Study|look at data in database?|1|||
33321942|NCT01357577|101073044|FG001|Overall Study|look at data in database?|2|||
33321943|NCT03739762|101073045|FG000|Overall Study|Lost to Follow-up|1|||
33321944|NCT03739762|101073046|FG001|Overall Study|Lost to Follow-up|1|||
33321945|NCT03739762|101073045|FG000|Overall Study|Withdrawal by Subject|2|||
33321946|NCT03739762|101073046|FG001|Overall Study|Withdrawal by Subject|6|||
33321947|NCT00216203|101073047|FG000|Overall Study|Withdrawal by Subject|2|||
33321948|NCT00387764|101073049|FG000|Overall Study|Adverse Event|12|||
33321949|NCT00387764|101073049|FG000|Overall Study|Withdrawal by Subject|8|||
33321950|NCT00387764|101073049|FG000|Overall Study|Sponsor Terminated Study|1|||
33321951|NCT00387764|101073049|FG000|Overall Study|Physician Decision|1|||
33398980|NCT00545740|101350152|FG000|Overall Study|Husband against study|0|||
33510490|NCT01346189|101764588|FG002|Overall Study|Physician Decision|0|||
33510491|NCT01346189|101764589|FG003|Overall Study|Physician Decision|0|||
33510492|NCT01346189|101764586|FG000|Overall Study|Moved|3|||
33510493|NCT01346189|101764587|FG001|Overall Study|Moved|0|||
33510494|NCT01346189|101764588|FG002|Overall Study|Moved|4|||
33510495|NCT01346189|101764589|FG003|Overall Study|Moved|0|||
33510496|NCT01346189|101764586|FG000|Overall Study|Other|2|||
33510497|NCT01346189|101764587|FG001|Overall Study|Other|4|||
33510498|NCT01346189|101764588|FG002|Overall Study|Other|7|||
33510499|NCT01346189|101764589|FG003|Overall Study|Other|3|||
33510500|NCT01346189|101764586|FG000|Overall Study|Death|0|||
33510501|NCT01346189|101764587|FG001|Overall Study|Death|3|||
33510502|NCT01346189|101764588|FG002|Overall Study|Death|0|||
33510503|NCT01346189|101764589|FG003|Overall Study|Death|0|||
33510504|NCT01346189|101764586|FG000|Overall Study|Non-health system primary care physician|0|||
33510505|NCT01346189|101764587|FG001|Overall Study|Non-health system primary care physician|5|||
33510506|NCT01346189|101764588|FG002|Overall Study|Non-health system primary care physician|0|||
33510507|NCT01346189|101764589|FG003|Overall Study|Non-health system primary care physician|0|||
33510508|NCT01346189|101764586|FG000|Overall Study|Travel|0|||
33510509|NCT01346189|101764587|FG001|Overall Study|Travel|0|||
33198011|NCT00533949|100630367|FG002|Overall Study|Protocol Violation|9|||
33198012|NCT00533949|100630368|FG003|Overall Study|Protocol Violation|9|||
33198013|NCT00533949|100630365|FG000|Overall Study|Withdrawal by Subject|3|||
33321952|NCT00387764|101073049|FG000|Overall Study|Other|2|||
33321953|NCT00387764|101073049|FG000|Overall Study|Death|7|||
33321954|NCT04004429|101074755|FG000|Overall Study|Protocol Violation|1|||
33510510|NCT01346189|101764588|FG002|Overall Study|Travel|0|||
33510511|NCT01346189|101764589|FG003|Overall Study|Travel|3|||
33510512|NCT01970475|101764593|FG000|Overall Study|Withdrawal by Subject|11|||
33510513|NCT01970475|101764594|FG001|Overall Study|Withdrawal by Subject|6|||
33510514|NCT01970475|101764593|FG000|Overall Study|Adverse Event|7|||
33510515|NCT01970475|101764594|FG001|Overall Study|Adverse Event|3|||
33510516|NCT01970475|101764593|FG000|Overall Study|Lost to Follow-up|2|||
33510517|NCT01970475|101764594|FG001|Overall Study|Lost to Follow-up|2|||
33510518|NCT01970475|101764593|FG000|Overall Study|Protocol Violation|1|||
33510519|NCT01970475|101764594|FG001|Overall Study|Protocol Violation|0|||
33198014|NCT00533949|100630366|FG001|Overall Study|Withdrawal by Subject|2|||
33321955|NCT04004429|101074756|FG001|Overall Study|Protocol Violation|0|||
33510520|NCT00471718|101764597|FG000|Overall Study|Adverse Event|3|||
33510521|NCT00471718|101764597|FG000|Overall Study|other complicating disease|1|||
33510522|NCT00471718|101764597|FG000|Overall Study|disease progression|22|||
33510523|NCT00471718|101764597|FG000|Overall Study|Withdrawal by Subject|1|||
33510524|NCT02659514|101764599|FG000|Overall Study|Adverse Event|3|||
33510525|NCT02659514|101764600|FG001|Overall Study|Adverse Event|12|||
33510526|NCT02659514|101764599|FG000|Overall Study|Disease Progression|23|||
33510527|NCT02659514|101764600|FG001|Overall Study|Disease Progression|13|||
33510528|NCT02659514|101764599|FG000|Overall Study|Withdrawal by Subject|0|||
33510529|NCT02659514|101764600|FG001|Overall Study|Withdrawal by Subject|4|||
33510530|NCT02659514|101764599|FG000|Overall Study|Lost to Follow-up|0|||
33510531|NCT02659514|101764600|FG001|Overall Study|Lost to Follow-up|1|||
33510532|NCT02659514|101764599|FG000|Overall Study|Death|6|||
33510533|NCT02659514|101764600|FG001|Overall Study|Death|1|||
33510534|NCT02659514|101764599|FG000|Overall Study|Reason Unspecified|0|||
33510535|NCT02659514|101764600|FG001|Overall Study|Reason Unspecified|3|||
33510536|NCT00638443|101764603|FG000|First Intervention|Adverse Event|2|||
33510537|NCT00638443|101764604|FG001|First Intervention|Adverse Event|1|||
33510538|NCT03505593|101764605|FG000|Overall Study|Withdrawal by Subject|1|||
33510539|NCT03505593|101764605|FG000|Overall Study|Died before procedure|1|||
33510540|NCT03505593|101764605|FG000|Overall Study|Anatomical abnormality|1|||
33510541|NCT03505593|101764605|FG000|Overall Study|Unable to pass through esophagus|1|||
33510542|NCT03505593|101764605|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
33510543|NCT00749684|101764606|FG000|Overall Study|Death|1|||
33510544|NCT00749684|101764606|FG000|Overall Study|Adverse Event|27|||
33510545|NCT00749684|101764606|FG000|Overall Study|Participant's Wish|10|||
33510546|NCT00749684|101764606|FG000|Overall Study|Not Documented|1|||
33510547|NCT00749684|101764606|FG000|Overall Study|Progressive Desease|31|||
33510548|NCT00749684|101764606|FG000|Overall Study|Therapy according to protocol + AE|2|||
33510549|NCT00749684|101764606|FG000|Overall Study|AE+discontinuation on participants wish|1|||
33510550|NCT00749684|101764606|FG000|Overall Study|Missing|9|||
33510551|NCT02828124|101764607|FG000|Overall Study|Disease Progression|1|||
33510552|NCT02828124|101764608|FG001|Overall Study|Disease Progression|2|||
33510553|NCT02828124|101764609|FG002|Overall Study|Disease Progression|1|||
33510554|NCT02828124|101764610|FG003|Overall Study|Disease Progression|4|||
33510555|NCT02828124|101764607|FG000|Overall Study|AE Unrelated to Study Drug|0|||
33510556|NCT02828124|101764608|FG001|Overall Study|AE Unrelated to Study Drug|0|||
33510557|NCT02828124|101764609|FG002|Overall Study|AE Unrelated to Study Drug|0|||
33510558|NCT02828124|101764610|FG003|Overall Study|AE Unrelated to Study Drug|1|||
33510559|NCT02828124|101764607|FG000|Overall Study|Subject Withdrew Consent|0|||
33510560|NCT02828124|101764608|FG001|Overall Study|Subject Withdrew Consent|0|||
33510561|NCT02828124|101764609|FG002|Overall Study|Subject Withdrew Consent|0|||
33510562|NCT02828124|101764610|FG003|Overall Study|Subject Withdrew Consent|1|||
33510563|NCT04507256|101764613|FG000|Overall Study|Withdrawal by Subject|1|||
33510564|NCT04507256|101764614|FG001|Overall Study|Withdrawal by Subject|0|||
33510565|NCT04507256|101764615|FG002|Overall Study|Withdrawal by Subject|0|||
33510566|NCT04507256|101764616|FG003|Overall Study|Withdrawal by Subject|1|||
33510567|NCT04507256|101764617|FG004|Overall Study|Withdrawal by Subject|0|||
33510568|NCT04507256|101764618|FG005|Overall Study|Withdrawal by Subject|0|||
33510569|NCT02163226|101764619|FG000|Overall Study|Death|2|||
33510570|NCT02163226|101764620|FG001|Overall Study|Death|1|||
33510571|NCT02163226|101764619|FG000|Overall Study|Withdrawal by Subject|5|||
33510572|NCT02163226|101764620|FG001|Overall Study|Withdrawal by Subject|2|||
33510573|NCT02163226|101764619|FG000|Overall Study|Returned home, local radiotherapy|3|||
33510574|NCT02163226|101764620|FG001|Overall Study|Returned home, local radiotherapy|0|||
33510575|NCT02163226|101764619|FG000|Overall Study|Repeat imaging showed no disease|2|||
33510576|NCT02163226|101764620|FG001|Overall Study|Repeat imaging showed no disease|0|||
33510577|NCT02163226|101764619|FG000|Overall Study|Incomplete radiotherapy|3|||
33510578|NCT02163226|101764620|FG001|Overall Study|Incomplete radiotherapy|0|||
33510579|NCT02163226|101764619|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
33510580|NCT02163226|101764620|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
33510581|NCT02163226|101764619|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
33510582|NCT02163226|101764620|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
33510583|NCT02163226|101764619|FG000|Overall Study|ineligible|0|||
33510584|NCT02163226|101764620|FG001|Overall Study|ineligible|3|||
33510585|NCT01194531|101764623|FG000|Overall Study|Withdrawal by Subject|1|||
33510586|NCT01194531|101764624|FG001|Overall Study|Withdrawal by Subject|0|||
33510587|NCT01194531|101764623|FG000|Overall Study|Protocol Violation|4|||
33510588|NCT01194531|101764624|FG001|Overall Study|Protocol Violation|1|||
33510589|NCT01194531|101764623|FG000|Overall Study|Physician Decision|0|||
33321956|NCT04004429|101074757|FG002|Overall Study|Protocol Violation|0|||
33510590|NCT01194531|101764624|FG001|Overall Study|Physician Decision|2|||
33510591|NCT00721279|101764628|FG000|Overall Study|Lack of Efficacy|6|||
33510592|NCT00721279|101764629|FG001|Overall Study|Lack of Efficacy|3|||
33510593|NCT00721279|101764628|FG000|Overall Study|Tolerability insufficient|5|||
33510594|NCT00721279|101764629|FG001|Overall Study|Tolerability insufficient|2|||
33510595|NCT00721279|101764628|FG000|Overall Study|Withdrawal by Subject|13|||
33510596|NCT00721279|101764629|FG001|Overall Study|Withdrawal by Subject|3|||
33510597|NCT00721279|101764628|FG000|Overall Study|Other|12|||
33510598|NCT00721279|101764629|FG001|Overall Study|Other|16|||
33510599|NCT05239494|101764637|FG000|Overall Study|Lost to Follow-up|1|||
33510600|NCT01698879|101764640|FG000|Overall Study|Withdrawal by Subject|1|||
33510601|NCT01698879|101764641|FG001|Overall Study|Withdrawal by Subject|0|||
33510602|NCT01698879|101764642|FG002|Overall Study|Withdrawal by Subject|0|||
33510603|NCT05148234|101764646|FG000|Phase I|Ineligible|0|||
33510604|NCT05148234|101764647|FG001|Phase I|Ineligible|0|||
33510605|NCT05148234|101764648|FG002|Phase I|Ineligible|0|||
33510606|NCT05148234|101764649|FG003|Phase I|Ineligible|0|||
33510607|NCT05148234|101764650|FG004|Phase I|Ineligible|0|||
33510608|NCT05148234|101764651|FG005|Phase I|Ineligible|0|||
33510609|NCT05148234|101764652|FG006|Phase I|Ineligible|0|||
33510610|NCT05148234|101764653|FG007|Phase I|Ineligible|1|||
33510611|NCT05148234|101764646|FG000|Phase I|Company closed the trial.|0|||
33510612|NCT05148234|101764647|FG001|Phase I|Company closed the trial.|1|||
33510613|NCT05148234|101764648|FG002|Phase I|Company closed the trial.|0|||
33510614|NCT05148234|101764649|FG003|Phase I|Company closed the trial.|0|||
33510615|NCT05148234|101764650|FG004|Phase I|Company closed the trial.|0|||
33510616|NCT05148234|101764651|FG005|Phase I|Company closed the trial.|0|||
33510617|NCT05148234|101764652|FG006|Phase I|Company closed the trial.|0|||
33510618|NCT05148234|101764653|FG007|Phase I|Company closed the trial.|0|||
33510619|NCT01901653|101764654|FG000|Overall Study|Death|2|||
33510620|NCT01901653|101764655|FG001|Overall Study|Death|1|||
33510621|NCT01901653|101764656|FG002|Overall Study|Death|8|||
33510622|NCT01901653|101764657|FG003|Overall Study|Death|3|||
33510623|NCT01901653|101764658|FG004|Overall Study|Death|2|||
33510624|NCT01901653|101764659|FG005|Overall Study|Death|2|||
33510625|NCT01901653|101764660|FG006|Overall Study|Death|6|||
33510626|NCT01901653|101764661|FG007|Overall Study|Death|9|||
33510627|NCT01901653|101764662|FG008|Overall Study|Death|1|||
33510628|NCT01901653|101764663|FG009|Overall Study|Death|16|||
33510629|NCT01901653|101764664|FG010|Overall Study|Death|2|||
33510630|NCT01901653|101764665|FG011|Overall Study|Death|15|||
33510631|NCT01901653|101764666|FG012|Overall Study|Death|4|||
33510632|NCT01901653|101764654|FG000|Overall Study|Lost to Follow-up|1|||
33510633|NCT01901653|101764655|FG001|Overall Study|Lost to Follow-up|0|||
33510634|NCT01901653|101764656|FG002|Overall Study|Lost to Follow-up|2|||
33510635|NCT01901653|101764657|FG003|Overall Study|Lost to Follow-up|0|||
33510636|NCT01901653|101764658|FG004|Overall Study|Lost to Follow-up|0|||
33510637|NCT01901653|101764659|FG005|Overall Study|Lost to Follow-up|1|||
33510638|NCT01901653|101764660|FG006|Overall Study|Lost to Follow-up|0|||
33510639|NCT01901653|101764661|FG007|Overall Study|Lost to Follow-up|1|||
33510640|NCT01901653|101764662|FG008|Overall Study|Lost to Follow-up|0|||
33510641|NCT01901653|101764663|FG009|Overall Study|Lost to Follow-up|0|||
33510642|NCT01901653|101764664|FG010|Overall Study|Lost to Follow-up|0|||
33510643|NCT01901653|101764665|FG011|Overall Study|Lost to Follow-up|0|||
33510644|NCT01901653|101764666|FG012|Overall Study|Lost to Follow-up|0|||
33510645|NCT01901653|101764654|FG000|Overall Study|Withdrawal by Subject|0|||
33510646|NCT01901653|101764655|FG001|Overall Study|Withdrawal by Subject|0|||
33510647|NCT01901653|101764656|FG002|Overall Study|Withdrawal by Subject|0|||
33510648|NCT01901653|101764657|FG003|Overall Study|Withdrawal by Subject|0|||
33510649|NCT01901653|101764658|FG004|Overall Study|Withdrawal by Subject|0|||
33510650|NCT01901653|101764659|FG005|Overall Study|Withdrawal by Subject|0|||
33510651|NCT01901653|101764660|FG006|Overall Study|Withdrawal by Subject|1|||
33510652|NCT01901653|101764661|FG007|Overall Study|Withdrawal by Subject|0|||
33510653|NCT01901653|101764662|FG008|Overall Study|Withdrawal by Subject|0|||
33510654|NCT01901653|101764663|FG009|Overall Study|Withdrawal by Subject|0|||
33510655|NCT01901653|101764664|FG010|Overall Study|Withdrawal by Subject|0|||
33510656|NCT01901653|101764665|FG011|Overall Study|Withdrawal by Subject|0|||
33510657|NCT01901653|101764666|FG012|Overall Study|Withdrawal by Subject|0|||
33510658|NCT01901653|101764654|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
33510659|NCT01901653|101764655|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
33321957|NCT04004429|101074755|FG000|Overall Study|Physician Decision|0|||
33510660|NCT01901653|101764656|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
33510661|NCT01901653|101764657|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
33510662|NCT01901653|101764658|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
33510663|NCT01901653|101764659|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
33510664|NCT01901653|101764660|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
33321958|NCT04004429|101074756|FG001|Overall Study|Physician Decision|1|||
33510665|NCT01901653|101764661|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
33510666|NCT01901653|101764662|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
33510667|NCT01901653|101764663|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
33510668|NCT01901653|101764664|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
33510669|NCT01901653|101764665|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
33510670|NCT01901653|101764666|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
33510671|NCT02680834|101764667|FG000|Overall Study|Physician Decision|5|||
33510672|NCT02680834|101764668|FG001|Overall Study|Physician Decision|2|||
33510673|NCT02680834|101764667|FG000|Overall Study|Withdrawal by Subject|6|||
33510674|NCT02680834|101764668|FG001|Overall Study|Withdrawal by Subject|0|||
33510675|NCT02680834|101764667|FG000|Overall Study|Lost to Follow-up|0|||
33510676|NCT02680834|101764668|FG001|Overall Study|Lost to Follow-up|1|||
33510677|NCT02951533|101764669|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
33510678|NCT02951533|101764670|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
33510679|NCT02951533|101764671|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
33510680|NCT02951533|101764669|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
33510681|NCT02951533|101764670|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
33510682|NCT02951533|101764671|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
33510683|NCT02951533|101764669|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
33510684|NCT02951533|101764670|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
33510685|NCT02951533|101764671|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
33510686|NCT02951533|101764669|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
33510687|NCT02951533|101764670|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
33510688|NCT02951533|101764671|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
33510689|NCT02951533|101764669|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
33510690|NCT02951533|101764670|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
33510691|NCT02951533|101764671|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
33510692|NCT02951533|101764669|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
33510693|NCT02951533|101764670|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
33510694|NCT02951533|101764671|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
33510695|NCT02951533|101764669|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
33510696|NCT02951533|101764670|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
33510697|NCT02951533|101764671|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
33510698|NCT02951533|101764669|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
33510699|NCT02951533|101764670|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
33510700|NCT02951533|101764671|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
33510701|NCT02951533|101764669|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
33510702|NCT02951533|101764670|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
33510703|NCT02951533|101764671|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
33510704|NCT02951533|101764669|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
33510705|NCT02951533|101764670|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
33510706|NCT02951533|101764671|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
33510707|NCT02951533|101764669|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
33510708|NCT02951533|101764670|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
33510709|NCT02951533|101764671|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
33510710|NCT04712019|101764672|FG000|Overall Study|Withdrawal by Subject|2|||
33510711|NCT04712019|101764673|FG001|Overall Study|Withdrawal by Subject|2|||
33510712|NCT04712019|101764672|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
33510713|NCT04712019|101764673|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
33510714|NCT01154296|101764675|FG000|Randomization and Intervention|Decided to decline|1|||
33510715|NCT01154296|101764676|FG001|Randomization and Intervention|Decided to decline|1|||
33510716|NCT01154296|101764675|FG000|Randomization and Intervention|Declined by staff|1|||
33510717|NCT01154296|101764676|FG001|Randomization and Intervention|Declined by staff|0|||
33510718|NCT01154296|101764675|FG000|Randomization and Intervention|Did not return|1|||
33510719|NCT01154296|101764676|FG001|Randomization and Intervention|Did not return|0|||
33510720|NCT01154296|101764675|FG000|Randomization and Intervention|Left before test|0|||
33510721|NCT01154296|101764676|FG001|Randomization and Intervention|Left before test|1|||
33510722|NCT01154296|101764675|FG000|Randomization and Intervention|Left clinic early|2|||
33510723|NCT01154296|101764676|FG001|Randomization and Intervention|Left clinic early|0|||
33510724|NCT01154296|101764675|FG000|6-month Follow-up|Lost contact|269|||
33510725|NCT01154296|101764676|FG001|6-month Follow-up|Lost contact|275|||
33321959|NCT04004429|101074757|FG002|Overall Study|Physician Decision|1|||
33321960|NCT04004429|101074755|FG000|Overall Study|Withdrawal by Subject|1|||
33321961|NCT04004429|101074756|FG001|Overall Study|Withdrawal by Subject|1|||
33321962|NCT04004429|101074757|FG002|Overall Study|Withdrawal by Subject|1|||
33321963|NCT00616434|101074758|FG000|Overall Study|Adverse Event|5|||
33398981|NCT00545740|101350153|FG001|Overall Study|Husband against study|0|||
33398982|NCT00545740|101350154|FG002|Overall Study|Husband against study|1|||
33510726|NCT01154296|101764675|FG000|6-month Follow-up|Incarcerated|37|||
33510727|NCT01154296|101764676|FG001|6-month Follow-up|Incarcerated|32|||
33510728|NCT01154296|101764675|FG000|6-month Follow-up|Withdrew consent|14|||
33510729|NCT01154296|101764676|FG001|6-month Follow-up|Withdrew consent|15|||
33605311|NCT00162266|102105528|FG000|Open-Label Period|Adverse Event|0|||
33321964|NCT00616434|101074759|FG001|Overall Study|Adverse Event|2|||
33510730|NCT01154296|101764675|FG000|6-month Follow-up|Death|3|||
33510731|NCT01154296|101764676|FG001|6-month Follow-up|Death|2|||
33510732|NCT01154296|101764675|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
33510733|NCT01154296|101764676|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
33510734|NCT03430895|101764679|FG000|Overall Study|Not Treated|2|||
33510735|NCT00824382|101764682|FG000|Overall Study|Adverse Event|4|||
33510736|NCT00824382|101764683|FG001|Overall Study|Adverse Event|1|||
33510737|NCT00824382|101764684|FG002|Overall Study|Adverse Event|1|||
33510738|NCT00824382|101764685|FG003|Overall Study|Adverse Event|4|||
33510739|NCT00824382|101764682|FG000|Overall Study|Protocol Violation|1|||
33510740|NCT00824382|101764683|FG001|Overall Study|Protocol Violation|0|||
33510741|NCT00824382|101764684|FG002|Overall Study|Protocol Violation|0|||
33510742|NCT00824382|101764685|FG003|Overall Study|Protocol Violation|1|||
33510743|NCT00824382|101764682|FG000|Overall Study|Investigator's decision|0|||
33510744|NCT00824382|101764683|FG001|Overall Study|Investigator's decision|1|||
33510745|NCT00824382|101764684|FG002|Overall Study|Investigator's decision|2|||
33510746|NCT00824382|101764685|FG003|Overall Study|Investigator's decision|0|||
33510747|NCT01905553|101764690|FG000|Period 2|Adverse Event|1|||
33510748|NCT01905553|101764691|FG001|Period 2|Adverse Event|0|||
33510749|NCT00614120|101764692|FG000|Overall Study|Adverse Event|9|||
33510750|NCT00614120|101764693|FG001|Overall Study|Adverse Event|22|||
33510751|NCT00614120|101764694|FG002|Overall Study|Adverse Event|30|||
33510752|NCT00614120|101764695|FG003|Overall Study|Adverse Event|3|||
33510753|NCT00614120|101764692|FG000|Overall Study|Lack of Efficacy|3|||
33510754|NCT00614120|101764693|FG001|Overall Study|Lack of Efficacy|3|||
33510755|NCT00614120|101764694|FG002|Overall Study|Lack of Efficacy|2|||
33510756|NCT00614120|101764695|FG003|Overall Study|Lack of Efficacy|2|||
33510757|NCT00614120|101764692|FG000|Overall Study|Protocol Violation|2|||
33510758|NCT00614120|101764693|FG001|Overall Study|Protocol Violation|5|||
33510759|NCT00614120|101764694|FG002|Overall Study|Protocol Violation|3|||
33510760|NCT00614120|101764695|FG003|Overall Study|Protocol Violation|1|||
33510761|NCT00614120|101764692|FG000|Overall Study|Withdrawal criteria|1|||
33510762|NCT00614120|101764693|FG001|Overall Study|Withdrawal criteria|0|||
33510763|NCT00614120|101764694|FG002|Overall Study|Withdrawal criteria|0|||
33510764|NCT00614120|101764695|FG003|Overall Study|Withdrawal criteria|0|||
33510765|NCT00614120|101764692|FG000|Overall Study|Withdrawal by Subject|9|||
33510766|NCT00614120|101764693|FG001|Overall Study|Withdrawal by Subject|10|||
33510767|NCT00614120|101764694|FG002|Overall Study|Withdrawal by Subject|16|||
33510768|NCT00614120|101764695|FG003|Overall Study|Withdrawal by Subject|3|||
33510769|NCT00614120|101764692|FG000|Overall Study|Did not meet trial criteria|0|||
33510770|NCT00614120|101764693|FG001|Overall Study|Did not meet trial criteria|1|||
33510771|NCT00614120|101764694|FG002|Overall Study|Did not meet trial criteria|1|||
33510772|NCT00614120|101764695|FG003|Overall Study|Did not meet trial criteria|1|||
33510773|NCT00614120|101764692|FG000|Overall Study|hCG positive (not pregnant)|0|||
33510774|NCT00614120|101764693|FG001|Overall Study|hCG positive (not pregnant)|0|||
33510775|NCT00614120|101764694|FG002|Overall Study|hCG positive (not pregnant)|1|||
33510776|NCT00614120|101764695|FG003|Overall Study|hCG positive (not pregnant)|0|||
33510777|NCT00614120|101764692|FG000|Overall Study|Hypoglycaemia|0|||
33510778|NCT00614120|101764693|FG001|Overall Study|Hypoglycaemia|0|||
33510779|NCT00614120|101764694|FG002|Overall Study|Hypoglycaemia|0|||
33510780|NCT00614120|101764695|FG003|Overall Study|Hypoglycaemia|1|||
33510781|NCT00614120|101764692|FG000|Overall Study|Lack of trial product|3|||
33510782|NCT00614120|101764693|FG001|Overall Study|Lack of trial product|3|||
33510783|NCT00614120|101764694|FG002|Overall Study|Lack of trial product|2|||
33510784|NCT00614120|101764695|FG003|Overall Study|Lack of trial product|0|||
33510785|NCT00614120|101764692|FG000|Overall Study|Late syphilis, latent|1|||
33510786|NCT00614120|101764693|FG001|Overall Study|Late syphilis, latent|0|||
33510787|NCT00614120|101764694|FG002|Overall Study|Late syphilis, latent|0|||
33510788|NCT00614120|101764695|FG003|Overall Study|Late syphilis, latent|0|||
33510789|NCT00614120|101764692|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
33321965|NCT00616434|101074758|FG000|Overall Study|Physician Decision|0|||
33321966|NCT00616434|101074759|FG001|Overall Study|Physician Decision|4|||
33510790|NCT00614120|101764693|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
33510791|NCT00614120|101764694|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
33510792|NCT00614120|101764695|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
33510793|NCT00614120|101764692|FG000|Overall Study|Lost to Follow-up|1|||
33510794|NCT00614120|101764693|FG001|Overall Study|Lost to Follow-up|2|||
33510795|NCT00614120|101764694|FG002|Overall Study|Lost to Follow-up|3|||
33510796|NCT00614120|101764695|FG003|Overall Study|Lost to Follow-up|4|||
33510797|NCT03385304|101764701|FG000|Overall Study|Death|19|||
33510798|NCT03385304|101764702|FG001|Overall Study|Death|7|||
33510799|NCT03385304|101764701|FG000|Overall Study|Lost to Follow-up|17|||
33510800|NCT03385304|101764702|FG001|Overall Study|Lost to Follow-up|14|||
33510801|NCT03385304|101764701|FG000|Overall Study|Withdrawal by Subject|3|||
33510802|NCT03385304|101764702|FG001|Overall Study|Withdrawal by Subject|2|||
33321967|NCT00616434|101074758|FG000|Overall Study|Withdrawal by Subject|1|||
33321968|NCT00616434|101074759|FG001|Overall Study|Withdrawal by Subject|1|||
33321969|NCT00616434|101074758|FG000|Overall Study|Protocol deviation|0|||
33321970|NCT00616434|101074759|FG001|Overall Study|Protocol deviation|1|||
33321971|NCT04881461|101074763|FG000|Overall Study|Adverse Event|2|||
33321972|NCT04881461|101074764|FG001|Overall Study|Adverse Event|4|||
33321973|NCT04881461|101074763|FG000|Overall Study|Withdrawal by Subject|19|||
33321974|NCT04881461|101074764|FG001|Overall Study|Withdrawal by Subject|19|||
33321975|NCT04881461|101074763|FG000|Overall Study|Lost to Follow-up|4|||
33321976|NCT04881461|101074764|FG001|Overall Study|Lost to Follow-up|4|||
33321977|NCT04881461|101074763|FG000|Overall Study|Lack of Efficacy|1|||
33321978|NCT04881461|101074764|FG001|Overall Study|Lack of Efficacy|0|||
33321979|NCT04881461|101074763|FG000|Overall Study|"Reason stated as other in CRF"|1|||
33321980|NCT04881461|101074764|FG001|Overall Study|"Reason stated as other in CRF"|2|||
33321981|NCT01133379|101074765|FG000|Overall Study|Withdrawal by Subject|0|||
33398983|NCT00545740|101350155|FG003|Overall Study|Husband against study|0|||
33398984|NCT00590031|101350156|FG000|Overall Study|Adverse Event|3|||
33398985|NCT00590031|101350156|FG000|Overall Study|Withdrawal by Subject|1|||
33398986|NCT00590031|101350156|FG000|Overall Study|Metastatic Disease|1|||
33398987|NCT00590031|101350156|FG000|Overall Study|Admin Hold|1|||
33398988|NCT01888965|101350158|FG000|Overall Study|Adverse Event|5|||
33398989|NCT01888965|101350158|FG000|Overall Study|Lack of Efficacy|4|||
33398990|NCT02140762|101350169|FG000|Overall Study|Adverse Event|1|||
33398991|NCT02140762|101350170|FG001|Overall Study|Adverse Event|1|||
33398992|NCT02140762|101350169|FG000|Overall Study|Lost to Follow-up|9|||
33398993|NCT02140762|101350170|FG001|Overall Study|Lost to Follow-up|5|||
33398994|NCT02140762|101350169|FG000|Overall Study|Protocol Violation|1|||
33398995|NCT02140762|101350170|FG001|Overall Study|Protocol Violation|1|||
33398996|NCT02140762|101350169|FG000|Overall Study|Withdrawal by Subject|6|||
33398997|NCT02140762|101350170|FG001|Overall Study|Withdrawal by Subject|4|||
33398998|NCT02140762|101350169|FG000|Overall Study|Other|0|||
33398999|NCT02140762|101350170|FG001|Overall Study|Other|1|||
33399000|NCT02417935|101350171|FG000|Treatment Period|Adverse Event|12|||
33399001|NCT02417935|101350172|FG001|Treatment Period|Adverse Event|10|||
33399002|NCT02417935|101350171|FG000|Treatment Period|Lost to Follow-up|1|||
33399003|NCT02417935|101350172|FG001|Treatment Period|Lost to Follow-up|0|||
33399004|NCT02417935|101350171|FG000|Treatment Period|Entry Criteria not met|0|||
33399005|NCT02417935|101350172|FG001|Treatment Period|Entry Criteria not met|1|||
33321982|NCT01133379|101074766|FG001|Overall Study|Withdrawal by Subject|1|||
33399006|NCT02417935|101350171|FG000|Treatment Period|Protocol Violation|2|||
33399007|NCT02417935|101350172|FG001|Treatment Period|Protocol Violation|1|||
33399008|NCT02417935|101350171|FG000|Treatment Period|Withdrawal by Subject|3|||
33399009|NCT02417935|101350172|FG001|Treatment Period|Withdrawal by Subject|3|||
33321983|NCT01133379|101074767|FG002|Overall Study|Withdrawal by Subject|1|||
33321984|NCT01133379|101074765|FG000|Overall Study|Lost to Follow-up|1|||
33321985|NCT01133379|101074766|FG001|Overall Study|Lost to Follow-up|1|||
33399010|NCT02417935|101350171|FG000|Treatment Period|Physician Decision|3|||
33399011|NCT02417935|101350172|FG001|Treatment Period|Physician Decision|1|||
33399012|NCT00911144|101350173|FG000|Overall Study|Withdrawal by Subject|16|||
33399013|NCT00911144|101350174|FG001|Overall Study|Withdrawal by Subject|5|||
33399014|NCT02394028|101350175|FG000|Induction Phase|Adverse Event|2|||
33399015|NCT02394028|101350176|FG001|Induction Phase|Adverse Event|4|||
33399016|NCT02394028|101350177|FG002|Induction Phase|Adverse Event|1|||
33399017|NCT02394028|101350178|FG003|Induction Phase|Adverse Event|2|||
33605312|NCT00162266|102105529|FG001|Open-Label Period|Adverse Event|0|||
33605313|NCT00162266|102105530|FG002|Open-Label Period|Adverse Event|0|||
33605314|NCT00162266|102105531|FG003|Open-Label Period|Adverse Event|46|||
33605315|NCT00162266|102105528|FG000|Open-Label Period|Lack of Efficacy|0|||
33605316|NCT00162266|102105529|FG001|Open-Label Period|Lack of Efficacy|0|||
33605317|NCT00162266|102105530|FG002|Open-Label Period|Lack of Efficacy|0|||
33605318|NCT00162266|102105531|FG003|Open-Label Period|Lack of Efficacy|26|||
33605319|NCT00162266|102105528|FG000|Open-Label Period|Lost to Follow-up|0|||
33605320|NCT00162266|102105529|FG001|Open-Label Period|Lost to Follow-up|0|||
33605321|NCT00162266|102105530|FG002|Open-Label Period|Lost to Follow-up|0|||
33605322|NCT00162266|102105531|FG003|Open-Label Period|Lost to Follow-up|3|||
33605323|NCT00162266|102105528|FG000|Open-Label Period|Withdrawal by Subject|0|||
33605324|NCT00162266|102105529|FG001|Open-Label Period|Withdrawal by Subject|0|||
33605325|NCT00162266|102105530|FG002|Open-Label Period|Withdrawal by Subject|0|||
33605326|NCT00162266|102105531|FG003|Open-Label Period|Withdrawal by Subject|31|||
33605327|NCT00162266|102105528|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
33605328|NCT00162266|102105529|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
33605329|NCT00162266|102105530|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
33605330|NCT00162266|102105531|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
33605331|NCT00162266|102105528|FG000|Open-Label Period|Other Reasons|0|||
33605332|NCT00162266|102105529|FG001|Open-Label Period|Other Reasons|0|||
33605333|NCT00162266|102105530|FG002|Open-Label Period|Other Reasons|0|||
33605334|NCT00162266|102105531|FG003|Open-Label Period|Other Reasons|15|||
33605335|NCT02758301|102105537|FG000|Overall Study|Death|12|||
33605336|NCT02758301|102105538|FG001|Overall Study|Death|0|||
33605337|NCT02758301|102105537|FG000|Overall Study|Physician Decision|10|||
33605338|NCT02758301|102105538|FG001|Overall Study|Physician Decision|1|||
33605339|NCT02758301|102105537|FG000|Overall Study|Withdrawal by Subject|5|||
33198015|NCT00533949|100630367|FG002|Overall Study|Withdrawal by Subject|1|||
33198016|NCT00533949|100630368|FG003|Overall Study|Withdrawal by Subject|1|||
33510803|NCT03385304|101764701|FG000|Overall Study|Incarceration|2|||
33510804|NCT03385304|101764702|FG001|Overall Study|Incarceration|3|||
33510805|NCT04739722|101764712|FG000|Overall Study|Lost to Follow-up|5301|||
33510806|NCT04739722|101764712|FG000|Overall Study|Withdrawal by Subject|42|||
33198017|NCT02265705|100630371|FG000|Treatment Period Week 0-24|Adverse Event|3|||
33198018|NCT02265705|100630372|FG001|Treatment Period Week 0-24|Adverse Event|2|||
33198019|NCT02265705|100630373|FG002|Treatment Period Week 0-24|Adverse Event|0|||
33198020|NCT02265705|100630374|FG003|Treatment Period Week 0-24|Adverse Event|0|||
33198021|NCT02265705|100630375|FG004|Treatment Period Week 0-24|Adverse Event|0|||
33198022|NCT02265705|100630376|FG005|Treatment Period Week 0-24|Adverse Event|0|||
33198023|NCT02265705|100630377|FG006|Treatment Period Week 0-24|Adverse Event|0|||
33198024|NCT02265705|100630371|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
33198025|NCT02265705|100630372|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
33198026|NCT02265705|100630373|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
33198027|NCT02265705|100630374|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
33198028|NCT02265705|100630375|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
33198029|NCT02265705|100630376|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
33198030|NCT02265705|100630377|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
33198031|NCT02265705|100630371|FG000|Treatment Period Week 0-24|Physician Decision|1|||
33198032|NCT02265705|100630372|FG001|Treatment Period Week 0-24|Physician Decision|0|||
33198033|NCT02265705|100630373|FG002|Treatment Period Week 0-24|Physician Decision|0|||
33198034|NCT02265705|100630374|FG003|Treatment Period Week 0-24|Physician Decision|0|||
33198035|NCT02265705|100630375|FG004|Treatment Period Week 0-24|Physician Decision|0|||
33198036|NCT02265705|100630376|FG005|Treatment Period Week 0-24|Physician Decision|0|||
33198037|NCT02265705|100630377|FG006|Treatment Period Week 0-24|Physician Decision|0|||
33198038|NCT02265705|100630371|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
33198039|NCT02265705|100630372|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
33198040|NCT02265705|100630373|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
33198041|NCT02265705|100630374|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
33198042|NCT02265705|100630375|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
33198043|NCT02265705|100630376|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
33198044|NCT02265705|100630377|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
33198045|NCT02265705|100630371|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
33321986|NCT01133379|101074767|FG002|Overall Study|Lost to Follow-up|1|||
33321987|NCT02289352|101074768|FG000|Overall Study|Withdrawal by Subject|1|||
33321988|NCT02289352|101074769|FG001|Overall Study|Withdrawal by Subject|1|||
33321989|NCT02289352|101074770|FG002|Overall Study|Withdrawal by Subject|0|||
33321990|NCT03144804|101074771|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
33321991|NCT01807923|101074773|FG000|Overall Study|Adverse Event|2|||
33321992|NCT01807923|101074774|FG001|Overall Study|Adverse Event|1|||
33321993|NCT01807923|101074775|FG002|Overall Study|Adverse Event|2|||
33321994|NCT01807923|101074773|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
33321995|NCT01807923|101074774|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
33321996|NCT01807923|101074775|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
33321997|NCT01807923|101074773|FG000|Overall Study|Physician Decision|0|||
33399018|NCT02394028|101350179|FG004|Induction Phase|Adverse Event|5|||
33399019|NCT02394028|101350180|FG005|Induction Phase|Adverse Event|2|||
33399020|NCT02394028|101350181|FG006|Induction Phase|Adverse Event|0|||
33510807|NCT04739722|101764712|FG000|Overall Study|Non Average-risk|1157|||
33510808|NCT03843632|101764713|FG000|Overall Study|Withdrawal by Subject|1|||
33510809|NCT03843632|101764714|FG001|Overall Study|Withdrawal by Subject|0|||
33198046|NCT02265705|100630372|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
33198047|NCT02265705|100630373|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
33198048|NCT02265705|100630374|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
33198049|NCT02265705|100630375|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
33198050|NCT02265705|100630376|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
33198051|NCT02265705|100630377|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
33321998|NCT01807923|101074774|FG001|Overall Study|Physician Decision|0|||
33321999|NCT01807923|101074775|FG002|Overall Study|Physician Decision|1|||
33322000|NCT01807923|101074773|FG000|Overall Study|Not Eligible (Genotype)|0|||
33399021|NCT02394028|101350182|FG007|Induction Phase|Adverse Event|0|||
33510810|NCT03843632|101764715|FG002|Overall Study|Withdrawal by Subject|0|||
33510811|NCT03843632|101764716|FG003|Overall Study|Withdrawal by Subject|0|||
33510812|NCT01123941|101764717|FG000|Overall Study|Lost to Follow-up|2|||
33399022|NCT02394028|101350183|FG008|Induction Phase|Adverse Event|0|||
33399023|NCT02394028|101350184|FG009|Induction Phase|Adverse Event|0|||
33399024|NCT02394028|101350185|FG010|Induction Phase|Adverse Event|0|||
33399025|NCT02394028|101350175|FG000|Induction Phase|Lack of Efficacy|3|||
33399026|NCT02394028|101350176|FG001|Induction Phase|Lack of Efficacy|6|||
33399027|NCT02394028|101350177|FG002|Induction Phase|Lack of Efficacy|2|||
33399028|NCT02394028|101350178|FG003|Induction Phase|Lack of Efficacy|17|||
33399029|NCT02394028|101350179|FG004|Induction Phase|Lack of Efficacy|14|||
33399030|NCT02394028|101350180|FG005|Induction Phase|Lack of Efficacy|8|||
33399031|NCT02394028|101350181|FG006|Induction Phase|Lack of Efficacy|17|||
33399032|NCT02394028|101350182|FG007|Induction Phase|Lack of Efficacy|23|||
33399033|NCT02394028|101350183|FG008|Induction Phase|Lack of Efficacy|0|||
33399034|NCT02394028|101350184|FG009|Induction Phase|Lack of Efficacy|0|||
33399035|NCT02394028|101350185|FG010|Induction Phase|Lack of Efficacy|0|||
33399036|NCT02394028|101350175|FG000|Induction Phase|Lost to Follow-up|1|||
33399037|NCT02394028|101350176|FG001|Induction Phase|Lost to Follow-up|0|||
33399038|NCT02394028|101350177|FG002|Induction Phase|Lost to Follow-up|0|||
33399039|NCT02394028|101350178|FG003|Induction Phase|Lost to Follow-up|1|||
33399040|NCT02394028|101350179|FG004|Induction Phase|Lost to Follow-up|0|||
33399041|NCT02394028|101350180|FG005|Induction Phase|Lost to Follow-up|0|||
33399042|NCT02394028|101350181|FG006|Induction Phase|Lost to Follow-up|1|||
33399043|NCT02394028|101350182|FG007|Induction Phase|Lost to Follow-up|0|||
33399044|NCT02394028|101350183|FG008|Induction Phase|Lost to Follow-up|0|||
33399045|NCT02394028|101350184|FG009|Induction Phase|Lost to Follow-up|0|||
33399046|NCT02394028|101350185|FG010|Induction Phase|Lost to Follow-up|0|||
33399047|NCT02394028|101350175|FG000|Induction Phase|Non-compliance|0|||
33605340|NCT02758301|102105538|FG001|Overall Study|Withdrawal by Subject|6|||
33605341|NCT02758301|102105537|FG000|Overall Study|Lost to Follow-up|7|||
33605342|NCT02758301|102105538|FG001|Overall Study|Lost to Follow-up|0|||
33605343|NCT02758301|102105537|FG000|Overall Study|Protocol Violation|0|||
33605344|NCT02758301|102105538|FG001|Overall Study|Protocol Violation|1|||
33605345|NCT00249613|102105539|FG000|12 Month Follow-up|Death|1|||
33605346|NCT00249613|102105540|FG001|12 Month Follow-up|Death|1|||
33605347|NCT00249613|102105539|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
33605348|NCT00249613|102105540|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
33605349|NCT00249613|102105539|FG000|12 Month Follow-up|Lost to Follow-up|10|||
33605350|NCT00249613|102105540|FG001|12 Month Follow-up|Lost to Follow-up|8|||
33605351|NCT00453973|102105541|FG000|Overall Study|Adverse Event|4|||
33605352|NCT00453973|102105542|FG001|Overall Study|Adverse Event|9|||
33605353|NCT00453973|102105541|FG000|Overall Study|Withdrawal by Subject|7|||
33605354|NCT00453973|102105542|FG001|Overall Study|Withdrawal by Subject|6|||
33605355|NCT00453973|102105541|FG000|Overall Study|PI Decision|0|||
33605356|NCT00453973|102105542|FG001|Overall Study|PI Decision|2|||
33605357|NCT00453973|102105541|FG000|Overall Study|Relocation|1|||
33399048|NCT02394028|101350176|FG001|Induction Phase|Non-compliance|1|||
33399049|NCT02394028|101350177|FG002|Induction Phase|Non-compliance|3|||
33605358|NCT00453973|102105542|FG001|Overall Study|Relocation|0|||
33399050|NCT02394028|101350178|FG003|Induction Phase|Non-compliance|1|||
33399051|NCT02394028|101350179|FG004|Induction Phase|Non-compliance|3|||
33399052|NCT02394028|101350180|FG005|Induction Phase|Non-compliance|0|||
33399053|NCT02394028|101350181|FG006|Induction Phase|Non-compliance|1|||
33399054|NCT02394028|101350182|FG007|Induction Phase|Non-compliance|1|||
33399055|NCT02394028|101350183|FG008|Induction Phase|Non-compliance|0|||
33399056|NCT02394028|101350184|FG009|Induction Phase|Non-compliance|0|||
33399057|NCT02394028|101350185|FG010|Induction Phase|Non-compliance|0|||
33605359|NCT00453973|102105541|FG000|Overall Study|Renal transplant|1|||
33605360|NCT00453973|102105542|FG001|Overall Study|Renal transplant|1|||
33605361|NCT00453973|102105541|FG000|Overall Study|Site closed by sponsor|3|||
33399058|NCT02394028|101350175|FG000|Induction Phase|Physician Decision|0|||
33605362|NCT00453973|102105542|FG001|Overall Study|Site closed by sponsor|0|||
33605363|NCT00453973|102105541|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
33605364|NCT00453973|102105542|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
33605365|NCT00778895|102105543|FG000|Active Phase|Adverse Event|3|||
33605366|NCT00778895|102105544|FG001|Active Phase|Adverse Event|1|||
33605367|NCT00778895|102105545|FG002|Active Phase|Adverse Event|0|||
33605368|NCT00778895|102105543|FG000|Active Phase|Withdrawal by Subject|1|||
33605369|NCT00778895|102105544|FG001|Active Phase|Withdrawal by Subject|4|||
33605370|NCT00778895|102105545|FG002|Active Phase|Withdrawal by Subject|0|||
33605371|NCT00778895|102105543|FG000|Active Phase|Lost to Follow-up|1|||
33605372|NCT00778895|102105544|FG001|Active Phase|Lost to Follow-up|1|||
33605373|NCT00778895|102105545|FG002|Active Phase|Lost to Follow-up|0|||
33605374|NCT00778895|102105543|FG000|Active Phase|Other|2|||
33605375|NCT00778895|102105544|FG001|Active Phase|Other|0|||
33605376|NCT00778895|102105545|FG002|Active Phase|Other|0|||
33605377|NCT00778895|102105543|FG000|ESFU Phase|Adverse Event|2|||
33605378|NCT00778895|102105544|FG001|ESFU Phase|Adverse Event|1|||
33605379|NCT00778895|102105545|FG002|ESFU Phase|Adverse Event|0|||
33605380|NCT00778895|102105543|FG000|ESFU Phase|Withdrawal by Subject|1|||
33605381|NCT00778895|102105544|FG001|ESFU Phase|Withdrawal by Subject|4|||
33605382|NCT00778895|102105545|FG002|ESFU Phase|Withdrawal by Subject|0|||
33605383|NCT00778895|102105543|FG000|ESFU Phase|Lost to Follow-up|6|||
33605384|NCT00778895|102105544|FG001|ESFU Phase|Lost to Follow-up|7|||
33605385|NCT00778895|102105545|FG002|ESFU Phase|Lost to Follow-up|2|||
33605386|NCT00778895|102105543|FG000|ESFU Phase|Other|2|||
33605387|NCT00778895|102105544|FG001|ESFU Phase|Other|0|||
33605388|NCT00778895|102105545|FG002|ESFU Phase|Other|0|||
33605389|NCT02648217|102105546|FG000|Overall Study|Adverse Event|0|||
33605390|NCT02648217|102105547|FG001|Overall Study|Adverse Event|1|||
33605391|NCT02648217|102105546|FG000|Overall Study|Lost to Follow-up|1|||
33605392|NCT02648217|102105547|FG001|Overall Study|Lost to Follow-up|1|||
33605393|NCT02648217|102105546|FG000|Overall Study|Withdrawal by Subject|4|||
33605394|NCT02648217|102105547|FG001|Overall Study|Withdrawal by Subject|3|||
33605395|NCT02648217|102105546|FG000|Overall Study|Unclassified|5|||
33605396|NCT02648217|102105547|FG001|Overall Study|Unclassified|0|||
33605397|NCT04496453|102105553|FG000|Overall Study|Lost to Follow-up|6|||
33605398|NCT00845065|102105554|FG000|Overall Study|Adverse Event|3|||
33605399|NCT00845065|102105555|FG001|Overall Study|Adverse Event|23|||
33605400|NCT00845065|102105554|FG000|Overall Study|Lack of Efficacy|43|||
33605401|NCT00845065|102105555|FG001|Overall Study|Lack of Efficacy|21|||
33605402|NCT00845065|102105554|FG000|Overall Study|Non-Medical Reasons|1|||
33605403|NCT00845065|102105555|FG001|Overall Study|Non-Medical Reasons|11|||
33605404|NCT01283542|102105556|FG000|Main Phase|Acute or progressive vision loss|1|||
33605405|NCT01283542|102105556|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
33605406|NCT01283542|102105556|FG000|Main Phase|abnormal laboratory values|5|||
33605407|NCT01283542|102105556|FG000|Extension Phase|Physician Decision|1|||
33605408|NCT01283542|102105556|FG000|Extension Phase|Adverse Event|1|||
33605409|NCT01283542|102105556|FG000|Extension Phase|Administrative problems|1|||
33605410|NCT03135210|102105557|FG000|Overall Study|Death|0|||
33605411|NCT03135210|102105558|FG001|Overall Study|Death|1|||
33605412|NCT00290498|102105571|FG000|Overall Study|Death|2|||
33605413|NCT00290498|102105572|FG001|Overall Study|Death|0|||
33605414|NCT00290498|102105571|FG000|Overall Study|Physician Decision|1|||
33605415|NCT00290498|102105572|FG001|Overall Study|Physician Decision|0|||
33605416|NCT00290498|102105571|FG000|Overall Study|Withdrawal by Subject|1|||
33605417|NCT00290498|102105572|FG001|Overall Study|Withdrawal by Subject|0|||
33605418|NCT00290498|102105571|FG000|Overall Study|Ineligible|3|||
33605419|NCT00290498|102105572|FG001|Overall Study|Ineligible|0|||
33605420|NCT00290498|102105571|FG000|Overall Study|Non-Compliance|1|||
33605421|NCT00290498|102105572|FG001|Overall Study|Non-Compliance|0|||
33605422|NCT00084656|102105573|FG000|Overall Study|Other reasons|0|||
33605423|NCT00084656|102105574|FG001|Overall Study|Other reasons|12|||
33605424|NCT00084656|102105575|FG002|Overall Study|Other reasons|11|||
33605425|NCT00084656|102105573|FG000|Overall Study|Withdrawal by Subject|15|||
33605426|NCT00084656|102105574|FG001|Overall Study|Withdrawal by Subject|4|||
33605427|NCT00084656|102105575|FG002|Overall Study|Withdrawal by Subject|4|||
33605428|NCT00084656|102105573|FG000|Overall Study|Disease relapse|0|||
33605429|NCT00084656|102105574|FG001|Overall Study|Disease relapse|9|||
33605430|NCT00084656|102105575|FG002|Overall Study|Disease relapse|10|||
33605431|NCT00084656|102105573|FG000|Overall Study|Disease progression|9|||
33605432|NCT00084656|102105574|FG001|Overall Study|Disease progression|0|||
33605433|NCT00084656|102105575|FG002|Overall Study|Disease progression|0|||
33605434|NCT00084656|102105573|FG000|Overall Study|Lost to Follow-up|1|||
33605435|NCT00084656|102105574|FG001|Overall Study|Lost to Follow-up|0|||
33605436|NCT00084656|102105575|FG002|Overall Study|Lost to Follow-up|1|||
33605437|NCT01264770|102105579|FG000|Overall Study|Not reported|0|||
33605438|NCT01264770|102105580|FG001|Overall Study|Not reported|0|||
33605439|NCT01264770|102105581|FG002|Overall Study|Not reported|1|||
33605440|NCT01264770|102105582|FG003|Overall Study|Not reported|0|||
33605441|NCT01264770|102105583|FG004|Overall Study|Not reported|0|||
33605442|NCT01264770|102105584|FG005|Overall Study|Not reported|0|||
33605443|NCT01264770|102105579|FG000|Overall Study|e.g., change in circumstances|8|||
33605444|NCT01264770|102105580|FG001|Overall Study|e.g., change in circumstances|3|||
33605445|NCT01264770|102105581|FG002|Overall Study|e.g., change in circumstances|3|||
33605446|NCT01264770|102105582|FG003|Overall Study|e.g., change in circumstances|3|||
33605447|NCT01264770|102105583|FG004|Overall Study|e.g., change in circumstances|4|||
33605448|NCT01264770|102105584|FG005|Overall Study|e.g., change in circumstances|4|||
33605449|NCT01264770|102105579|FG000|Overall Study|Severe non-compliance to protocol|0|||
33605450|NCT01264770|102105580|FG001|Overall Study|Severe non-compliance to protocol|0|||
33605451|NCT01264770|102105581|FG002|Overall Study|Severe non-compliance to protocol|1|||
33605452|NCT01264770|102105582|FG003|Overall Study|Severe non-compliance to protocol|1|||
33605453|NCT01264770|102105583|FG004|Overall Study|Severe non-compliance to protocol|0|||
33605454|NCT01264770|102105584|FG005|Overall Study|Severe non-compliance to protocol|0|||
33605455|NCT01264770|102105579|FG000|Overall Study|Lack of therapeutic response|1|||
33605456|NCT01264770|102105580|FG001|Overall Study|Lack of therapeutic response|0|||
33605457|NCT01264770|102105581|FG002|Overall Study|Lack of therapeutic response|2|||
33198052|NCT02265705|100630371|FG000|Rescue Period|Withdrawal by Subject|0|||
33198053|NCT02265705|100630372|FG001|Rescue Period|Withdrawal by Subject|0|||
33198054|NCT02265705|100630373|FG002|Rescue Period|Withdrawal by Subject|1|||
33198055|NCT02265705|100630374|FG003|Rescue Period|Withdrawal by Subject|0|||
33198056|NCT02265705|100630375|FG004|Rescue Period|Withdrawal by Subject|0|||
33198057|NCT02265705|100630376|FG005|Rescue Period|Withdrawal by Subject|0|||
33198058|NCT02265705|100630377|FG006|Rescue Period|Withdrawal by Subject|0|||
33198059|NCT02265705|100630371|FG000|Rescue Period|Death|0|||
33198060|NCT02265705|100630372|FG001|Rescue Period|Death|0|||
33198061|NCT02265705|100630373|FG002|Rescue Period|Death|1|||
33322001|NCT01807923|101074774|FG001|Overall Study|Not Eligible (Genotype)|0|||
33322002|NCT01807923|101074775|FG002|Overall Study|Not Eligible (Genotype)|1|||
33322003|NCT01807923|101074773|FG000|Overall Study|Randomized But Not Treated|3|||
33322004|NCT01807923|101074774|FG001|Overall Study|Randomized But Not Treated|2|||
33198062|NCT02265705|100630374|FG003|Rescue Period|Death|0|||
33198063|NCT02265705|100630375|FG004|Rescue Period|Death|0|||
33198064|NCT02265705|100630376|FG005|Rescue Period|Death|0|||
33198065|NCT02265705|100630377|FG006|Rescue Period|Death|0|||
33198066|NCT02265705|100630371|FG000|Rescue Period|Lack of Efficacy|0|||
33198067|NCT02265705|100630372|FG001|Rescue Period|Lack of Efficacy|0|||
33198068|NCT02265705|100630373|FG002|Rescue Period|Lack of Efficacy|1|||
33198069|NCT02265705|100630374|FG003|Rescue Period|Lack of Efficacy|0|||
33198070|NCT02265705|100630375|FG004|Rescue Period|Lack of Efficacy|0|||
33198071|NCT02265705|100630376|FG005|Rescue Period|Lack of Efficacy|0|||
33198072|NCT02265705|100630377|FG006|Rescue Period|Lack of Efficacy|0|||
33198073|NCT02265705|100630371|FG000|Open Label Period|Adverse Event|0|||
33198074|NCT02265705|100630372|FG001|Open Label Period|Adverse Event|0|||
33198075|NCT02265705|100630373|FG002|Open Label Period|Adverse Event|0|||
33198076|NCT02265705|100630374|FG003|Open Label Period|Adverse Event|2|||
33322005|NCT01807923|101074775|FG002|Overall Study|Randomized But Not Treated|5|||
33322006|NCT01177384|101074780|FG000|Overall Study|Adverse Event|6|||
33322007|NCT01177384|101074781|FG001|Overall Study|Adverse Event|4|||
33322008|NCT01177384|101074780|FG000|Overall Study|Lack of Efficacy|0|||
33322009|NCT01177384|101074781|FG001|Overall Study|Lack of Efficacy|1|||
33322010|NCT01177384|101074780|FG000|Overall Study|Lost to Follow-up|3|||
33322011|NCT01177384|101074781|FG001|Overall Study|Lost to Follow-up|4|||
33605458|NCT01264770|102105582|FG003|Overall Study|Lack of therapeutic response|1|||
33198077|NCT02265705|100630375|FG004|Open Label Period|Adverse Event|2|||
33198078|NCT02265705|100630376|FG005|Open Label Period|Adverse Event|0|||
33198079|NCT02265705|100630377|FG006|Open Label Period|Adverse Event|0|||
33198080|NCT02265705|100630371|FG000|Open Label Period|Physician Decision|0|||
33198081|NCT02265705|100630372|FG001|Open Label Period|Physician Decision|0|||
33198082|NCT02265705|100630373|FG002|Open Label Period|Physician Decision|0|||
33198083|NCT02265705|100630374|FG003|Open Label Period|Physician Decision|0|||
33198084|NCT02265705|100630375|FG004|Open Label Period|Physician Decision|1|||
33198085|NCT02265705|100630376|FG005|Open Label Period|Physician Decision|0|||
33198086|NCT02265705|100630377|FG006|Open Label Period|Physician Decision|0|||
33322012|NCT01177384|101074780|FG000|Overall Study|Physician Decision|0|||
33322013|NCT01177384|101074781|FG001|Overall Study|Physician Decision|3|||
33322014|NCT01177384|101074780|FG000|Overall Study|Protocol Violation|0|||
33605459|NCT01264770|102105583|FG004|Overall Study|Lack of therapeutic response|1|||
33605460|NCT01264770|102105584|FG005|Overall Study|Lack of therapeutic response|0|||
33605461|NCT01264770|102105579|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
33605462|NCT01264770|102105580|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
33198087|NCT02265705|100630371|FG000|Open Label Period|Withdrawal by Subject|0|||
33322015|NCT01177384|101074781|FG001|Overall Study|Protocol Violation|2|||
33322016|NCT01177384|101074780|FG000|Overall Study|Withdrawal by Subject|5|||
33322017|NCT01177384|101074781|FG001|Overall Study|Withdrawal by Subject|12|||
33322018|NCT02019420|101074783|FG000|Overall Study|Did not receive study drug|2|||
33322019|NCT02019420|101074784|FG001|Overall Study|Did not receive study drug|2|||
33322020|NCT02019420|101074783|FG000|Overall Study|Withdrawal by Subject|1|||
33322021|NCT02019420|101074784|FG001|Overall Study|Withdrawal by Subject|3|||
33322022|NCT02019420|101074783|FG000|Overall Study|At request of sponsor or investigator|0|||
33322023|NCT02019420|101074784|FG001|Overall Study|At request of sponsor or investigator|1|||
33322024|NCT02019420|101074783|FG000|Overall Study|Death|104|||
33322025|NCT02019420|101074784|FG001|Overall Study|Death|99|||
33322026|NCT02019420|101074783|FG000|Overall Study|Transferred to other care facility|1|||
33322027|NCT02019420|101074784|FG001|Overall Study|Transferred to other care facility|1|||
33322028|NCT04585646|101074785|FG000|First Intervention|Physician Decision|1|||
33322029|NCT04585646|101074786|FG001|First Intervention|Physician Decision|0|||
33322030|NCT04585646|101074785|FG000|First Intervention|Lost to Follow-up|0|||
33322031|NCT04585646|101074786|FG001|First Intervention|Lost to Follow-up|3|||
33322032|NCT04585646|101074785|FG000|First Intervention|Withdrawal by Subject|0|||
33322033|NCT04585646|101074786|FG001|First Intervention|Withdrawal by Subject|1|||
33322034|NCT00517751|101074787|FG000|Overall Study|Death|3|||
33510813|NCT01123941|101764718|FG001|Overall Study|Lost to Follow-up|1|||
33510814|NCT02231879|101764719|FG000|Overall Study|Adverse Event|2|||
33198088|NCT02265705|100630372|FG001|Open Label Period|Withdrawal by Subject|0|||
33510815|NCT02231879|101764720|FG001|Overall Study|Adverse Event|1|||
33198089|NCT02265705|100630373|FG002|Open Label Period|Withdrawal by Subject|0|||
33198090|NCT02265705|100630374|FG003|Open Label Period|Withdrawal by Subject|0|||
33198091|NCT02265705|100630375|FG004|Open Label Period|Withdrawal by Subject|2|||
33198092|NCT02265705|100630376|FG005|Open Label Period|Withdrawal by Subject|0|||
33510816|NCT02231879|101764719|FG000|Overall Study|Lack of Efficacy|0|||
33510817|NCT02231879|101764720|FG001|Overall Study|Lack of Efficacy|1|||
33510818|NCT00452673|101764721|FG000|Dose Escalation Period|Disease Progression|6|||
33510819|NCT00452673|101764722|FG001|Dose Escalation Period|Disease Progression|6|||
33510820|NCT00452673|101764723|FG002|Dose Escalation Period|Disease Progression|2|||
33510821|NCT00452673|101764724|FG003|Dose Escalation Period|Disease Progression|6|||
33510822|NCT00452673|101764725|FG004|Dose Escalation Period|Disease Progression|0|||
33510823|NCT00452673|101764721|FG000|Dose Escalation Period|study drug toxicity|1|||
33510824|NCT00452673|101764722|FG001|Dose Escalation Period|study drug toxicity|3|||
33510825|NCT00452673|101764723|FG002|Dose Escalation Period|study drug toxicity|3|||
33510826|NCT00452673|101764724|FG003|Dose Escalation Period|study drug toxicity|1|||
33510827|NCT00452673|101764725|FG004|Dose Escalation Period|study drug toxicity|0|||
33510828|NCT00452673|101764721|FG000|Dose Escalation Period|Other|0|||
33510829|NCT00452673|101764722|FG001|Dose Escalation Period|Other|0|||
33510830|NCT00452673|101764723|FG002|Dose Escalation Period|Other|1|||
33510831|NCT00452673|101764724|FG003|Dose Escalation Period|Other|0|||
33510832|NCT00452673|101764725|FG004|Dose Escalation Period|Other|0|||
33510833|NCT00452673|101764721|FG000|Dose Escalation Period|Adverse Event|0|||
33510834|NCT00452673|101764722|FG001|Dose Escalation Period|Adverse Event|0|||
33510835|NCT00452673|101764723|FG002|Dose Escalation Period|Adverse Event|0|||
33510836|NCT00452673|101764724|FG003|Dose Escalation Period|Adverse Event|1|||
33510837|NCT00452673|101764725|FG004|Dose Escalation Period|Adverse Event|0|||
33510838|NCT00452673|101764721|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
33510839|NCT00452673|101764722|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
33510840|NCT00452673|101764723|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
33510841|NCT00452673|101764724|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
33510842|NCT00452673|101764725|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
33510843|NCT00452673|101764721|FG000|Dose Expansion Period|Disease Progression|0|||
33510844|NCT00452673|101764722|FG001|Dose Expansion Period|Disease Progression|0|||
33510845|NCT00452673|101764723|FG002|Dose Expansion Period|Disease Progression|0|||
33510846|NCT00452673|101764724|FG003|Dose Expansion Period|Disease Progression|0|||
33510847|NCT00452673|101764725|FG004|Dose Expansion Period|Disease Progression|19|||
33510848|NCT00452673|101764721|FG000|Dose Expansion Period|Other|0|||
33510849|NCT00452673|101764722|FG001|Dose Expansion Period|Other|0|||
33510850|NCT00452673|101764723|FG002|Dose Expansion Period|Other|0|||
33510851|NCT00452673|101764724|FG003|Dose Expansion Period|Other|0|||
33510852|NCT00452673|101764725|FG004|Dose Expansion Period|Other|2|||
33322035|NCT00517751|101074787|FG000|Overall Study|Withdrawal by Subject|37|||
33322036|NCT00517751|101074787|FG000|Overall Study|Lost to Follow-up|4|||
33510853|NCT03020199|101764726|FG000|Treatment Period|Adverse Event|0|||
33510854|NCT03020199|101764727|FG001|Treatment Period|Adverse Event|2|||
33322037|NCT00517751|101074787|FG000|Overall Study|patient not over due|6|||
33322038|NCT00517751|101074787|FG000|Overall Study|Patient not due for visit|76|||
33322039|NCT00517751|101074787|FG000|Overall Study|Missing|3|||
33322040|NCT04136184|101074793|FG000|Overall Study|Lost to Follow-up|0|||
33510855|NCT03020199|101764726|FG000|Treatment Period|Lack of Efficacy|1|||
33510856|NCT03020199|101764727|FG001|Treatment Period|Lack of Efficacy|6|||
33510857|NCT03020199|101764726|FG000|Treatment Period|Lost to Follow-up|1|||
33510858|NCT03020199|101764727|FG001|Treatment Period|Lost to Follow-up|6|||
33510859|NCT03020199|101764726|FG000|Treatment Period|Physician Decision|0|||
33510860|NCT03020199|101764727|FG001|Treatment Period|Physician Decision|1|||
33510861|NCT03020199|101764726|FG000|Treatment Period|Subject/guardian decision|8|||
33510862|NCT03020199|101764727|FG001|Treatment Period|Subject/guardian decision|15|||
33510863|NCT03020199|101764726|FG000|Treatment Period|Subjects not treated|3|||
33510864|NCT03020199|101764727|FG001|Treatment Period|Subjects not treated|4|||
33510865|NCT03020199|101764726|FG000|Follow-up Period|Disease relapse|32|||
33510866|NCT03020199|101764727|FG001|Follow-up Period|Disease relapse|7|||
33510867|NCT03020199|101764726|FG000|Follow-up Period|Lack of Efficacy|1|||
33510868|NCT03020199|101764727|FG001|Follow-up Period|Lack of Efficacy|2|||
33510869|NCT03020199|101764726|FG000|Follow-up Period|Lost to Follow-up|4|||
33510870|NCT03020199|101764727|FG001|Follow-up Period|Lost to Follow-up|6|||
33510871|NCT03020199|101764726|FG000|Follow-up Period|Physician Decision|2|||
33510872|NCT03020199|101764727|FG001|Follow-up Period|Physician Decision|2|||
33510873|NCT03020199|101764726|FG000|Follow-up Period|Protocol Violation|1|||
33510874|NCT03020199|101764727|FG001|Follow-up Period|Protocol Violation|2|||
33510875|NCT03020199|101764726|FG000|Follow-up Period|Study terminated by Sponsor|6|||
33510876|NCT03020199|101764727|FG001|Follow-up Period|Study terminated by Sponsor|3|||
33510877|NCT03020199|101764726|FG000|Follow-up Period|Subject/guardian decision|14|||
33510878|NCT03020199|101764727|FG001|Follow-up Period|Subject/guardian decision|9|||
33510879|NCT03555565|101764728|FG000|Overall Study|Case Report Forms Uncollected|2|||
33510880|NCT03555565|101764728|FG000|Overall Study|Protocol Deviation|13|||
33510881|NCT01565668|101764732|FG000|Overall Study|Death|2|||
33510882|NCT01565668|101764733|FG001|Overall Study|Death|1|||
33510883|NCT01565668|101764732|FG000|Overall Study|Lack of Efficacy|4|||
33510884|NCT01565668|101764733|FG001|Overall Study|Lack of Efficacy|2|||
33510885|NCT01565668|101764732|FG000|Overall Study|Participant went on Hospice Care|1|||
33510886|NCT01565668|101764733|FG001|Overall Study|Participant went on Hospice Care|0|||
33510887|NCT01565668|101764732|FG000|Overall Study|Adverse Event|6|||
33510888|NCT01565668|101764733|FG001|Overall Study|Adverse Event|1|||
33510889|NCT01565668|101764732|FG000|Overall Study|Randomized, but never received drug|0|||
33510890|NCT01565668|101764733|FG001|Overall Study|Randomized, but never received drug|2|||
33510891|NCT01565668|101764732|FG000|Overall Study|Progressive disease|13|||
33510892|NCT01565668|101764733|FG001|Overall Study|Progressive disease|14|||
33510893|NCT01565668|101764732|FG000|Overall Study|Withdrawal by Subject|1|||
33510894|NCT01565668|101764733|FG001|Overall Study|Withdrawal by Subject|3|||
33510895|NCT01565668|101764732|FG000|Overall Study|HSCT Transplant|11|||
33510896|NCT01565668|101764733|FG001|Overall Study|HSCT Transplant|15|||
33510897|NCT04464720|101764734|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
33510898|NCT03614078|101764739|FG000|Overall Study|Withdrawal by Subject|2|||
33510899|NCT03614078|101764740|FG001|Overall Study|Withdrawal by Subject|2|||
33510900|NCT03614078|101764741|FG002|Overall Study|Withdrawal by Subject|3|||
33510901|NCT03614078|101764739|FG000|Overall Study|Participant Did Not Return for Visit|0|||
33510902|NCT03614078|101764740|FG001|Overall Study|Participant Did Not Return for Visit|1|||
33510903|NCT03614078|101764741|FG002|Overall Study|Participant Did Not Return for Visit|0|||
33510904|NCT03614078|101764739|FG000|Overall Study|High Neutrophils|0|||
33510905|NCT03614078|101764740|FG001|Overall Study|High Neutrophils|0|||
33510906|NCT03614078|101764741|FG002|Overall Study|High Neutrophils|2|||
33510907|NCT03614078|101764739|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
33510908|NCT03614078|101764740|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
33510909|NCT03614078|101764741|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
33510910|NCT03614078|101764739|FG000|Overall Study|Exacerbation of Psoriasis|0|||
33510911|NCT03614078|101764740|FG001|Overall Study|Exacerbation of Psoriasis|1|||
33510912|NCT03614078|101764741|FG002|Overall Study|Exacerbation of Psoriasis|0|||
33510913|NCT03614078|101764739|FG000|Overall Study|Adverse Event|0|||
33510914|NCT03614078|101764740|FG001|Overall Study|Adverse Event|2|||
33510915|NCT03614078|101764741|FG002|Overall Study|Adverse Event|0|||
33510916|NCT03614078|101764739|FG000|Overall Study|Dizziness and Rash|0|||
33510917|NCT03614078|101764740|FG001|Overall Study|Dizziness and Rash|1|||
33510918|NCT03614078|101764741|FG002|Overall Study|Dizziness and Rash|0|||
33510919|NCT03467217|101764742|FG000|Overall Study|Trial stopped early|5|||
33510920|NCT03467217|101764743|FG001|Overall Study|Trial stopped early|2|||
33322041|NCT04136184|101074794|FG001|Overall Study|Lost to Follow-up|3|||
33510921|NCT03467217|101764742|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
33510922|NCT03467217|101764743|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
33322042|NCT04136184|101074793|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
33510923|NCT03467217|101764742|FG000|Overall Study|Lost to Follow-up|0|||
33605463|NCT01264770|102105581|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
33510924|NCT03467217|101764743|FG001|Overall Study|Lost to Follow-up|2|||
33510925|NCT02253316|101764744|FG000|Consolidation|Progression|4|||
33510926|NCT02253316|101764745|FG001|Consolidation|Progression|0|||
33510927|NCT02253316|101764746|FG002|Consolidation|Progression|0|||
33510928|NCT02253316|101764744|FG000|Consolidation|Non-Compliance|1|||
33510929|NCT02253316|101764745|FG001|Consolidation|Non-Compliance|0|||
33510930|NCT02253316|101764746|FG002|Consolidation|Non-Compliance|0|||
33510931|NCT02253316|101764744|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
33510932|NCT02253316|101764745|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
33510933|NCT02253316|101764746|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
33510934|NCT02253316|101764744|FG000|Consolidation|Secondary Malignancy|2|||
33510935|NCT02253316|101764745|FG001|Consolidation|Secondary Malignancy|0|||
33510936|NCT02253316|101764746|FG002|Consolidation|Secondary Malignancy|0|||
33510937|NCT02253316|101764744|FG000|Consolidation|Adverse Event|7|||
33510938|NCT02253316|101764745|FG001|Consolidation|Adverse Event|0|||
33510939|NCT02253316|101764746|FG002|Consolidation|Adverse Event|0|||
33510940|NCT02253316|101764744|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
33510941|NCT02253316|101764745|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
33510942|NCT02253316|101764746|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
33510943|NCT02253316|101764744|FG000|Maintenance|Physician Decision|0|||
33510944|NCT02253316|101764745|FG001|Maintenance|Physician Decision|7|||
33510945|NCT02253316|101764746|FG002|Maintenance|Physician Decision|16|||
33510946|NCT02253316|101764744|FG000|Maintenance|Non-Compliance|0|||
33510947|NCT02253316|101764745|FG001|Maintenance|Non-Compliance|1|||
33510948|NCT02253316|101764746|FG002|Maintenance|Non-Compliance|1|||
33510949|NCT02253316|101764744|FG000|Maintenance|Secondary Malignancy|0|||
33510950|NCT02253316|101764745|FG001|Maintenance|Secondary Malignancy|2|||
33510951|NCT02253316|101764746|FG002|Maintenance|Secondary Malignancy|6|||
33510952|NCT02253316|101764744|FG000|Maintenance|Adverse Event|0|||
33510953|NCT02253316|101764745|FG001|Maintenance|Adverse Event|8|||
33510954|NCT02253316|101764746|FG002|Maintenance|Adverse Event|12|||
33510955|NCT02253316|101764744|FG000|Maintenance|Still receiving active treatment|0|||
33510956|NCT02253316|101764745|FG001|Maintenance|Still receiving active treatment|5|||
33510957|NCT02253316|101764746|FG002|Maintenance|Still receiving active treatment|0|||
33510958|NCT02720744|101764752|FG000|Overall Study|Protocol Violation|0|||
33510959|NCT02720744|101764753|FG001|Overall Study|Protocol Violation|2|||
33510960|NCT02720744|101764752|FG000|Overall Study|Pregnancy|2|||
33510961|NCT02720744|101764753|FG001|Overall Study|Pregnancy|0|||
33510962|NCT02720744|101764752|FG000|Overall Study|Lack of Efficacy|2|||
33510963|NCT02720744|101764753|FG001|Overall Study|Lack of Efficacy|8|||
33510964|NCT02720744|101764752|FG000|Overall Study|Adverse Event|21|||
33510965|NCT02720744|101764753|FG001|Overall Study|Adverse Event|3|||
33510966|NCT02720744|101764752|FG000|Overall Study|Withdrawal by Subject|11|||
33510967|NCT02720744|101764753|FG001|Overall Study|Withdrawal by Subject|11|||
33510968|NCT02720744|101764752|FG000|Overall Study|Lost to follow up|2|||
33510969|NCT02720744|101764753|FG001|Overall Study|Lost to follow up|0|||
33510970|NCT02720744|101764752|FG000|Overall Study|Non Compliance with Investigational Product|0|||
33510971|NCT02720744|101764753|FG001|Overall Study|Non Compliance with Investigational Product|1|||
33510972|NCT02720744|101764752|FG000|Overall Study|Excluded Concomitant Medication|0|||
33510973|NCT02720744|101764753|FG001|Overall Study|Excluded Concomitant Medication|1|||
33510974|NCT03605862|101764755|FG000|Overall Study|Withdrawal by Subject|12|||
33510975|NCT03605862|101764756|FG001|Overall Study|Withdrawal by Subject|9|||
33510976|NCT03605862|101764755|FG000|Overall Study|Adverse Event|2|||
33510977|NCT03605862|101764756|FG001|Overall Study|Adverse Event|1|||
33510978|NCT03605862|101764755|FG000|Overall Study|Physician Decision|3|||
33510979|NCT03605862|101764756|FG001|Overall Study|Physician Decision|1|||
33510980|NCT03605862|101764755|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
33510981|NCT03605862|101764756|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
33510982|NCT03937908|101764759|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
33510983|NCT03937908|101764760|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
33510984|NCT00308087|101764761|FG000|Overall Study|Progressive Disease|19|||
33510985|NCT00308087|101764762|FG001|Overall Study|Progressive Disease|21|||
33510986|NCT00308087|101764761|FG000|Overall Study|Study Closure|11|||
33510987|NCT00308087|101764762|FG001|Overall Study|Study Closure|12|||
33510988|NCT00308087|101764761|FG000|Overall Study|Withdrawal by Subject|2|||
33510989|NCT00308087|101764762|FG001|Overall Study|Withdrawal by Subject|1|||
33510990|NCT00308087|101764761|FG000|Overall Study|Other|4|||
33510991|NCT00308087|101764762|FG001|Overall Study|Other|3|||
33510992|NCT05343364|101764763|FG000|Overall Study|Miscellaneous|0|||
33510993|NCT05343364|101764764|FG001|Overall Study|Miscellaneous|1|||
33510994|NCT03852628|101764765|FG000|Overall Study|Lost to Follow-up|7|||
33510995|NCT03852628|101764766|FG001|Overall Study|Lost to Follow-up|6|||
33510996|NCT03852628|101764765|FG000|Overall Study|Lack of Efficacy|6|||
33510997|NCT03852628|101764766|FG001|Overall Study|Lack of Efficacy|6|||
33510998|NCT01053962|101764767|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
33510999|NCT01053962|101764768|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
33511000|NCT01053962|101764769|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
33511001|NCT01053962|101764770|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
33511002|NCT01053962|101764771|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
33511003|NCT01053962|101764767|FG000|Pretreatment Period|Venipuncture Failure|0|||
33511004|NCT01053962|101764768|FG001|Pretreatment Period|Venipuncture Failure|0|||
33511005|NCT01053962|101764769|FG002|Pretreatment Period|Venipuncture Failure|1|||
33511006|NCT01053962|101764770|FG003|Pretreatment Period|Venipuncture Failure|0|||
33511007|NCT01053962|101764771|FG004|Pretreatment Period|Venipuncture Failure|0|||
33511008|NCT01053962|101764767|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
33511009|NCT01053962|101764768|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
33511010|NCT01053962|101764769|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
33511011|NCT01053962|101764770|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
33511012|NCT01053962|101764771|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
33511013|NCT01053962|101764767|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
33511014|NCT01053962|101764768|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
33511015|NCT01053962|101764769|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
33511016|NCT01053962|101764770|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
33511017|NCT01053962|101764771|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
33511018|NCT01053962|101764767|FG000|Treatment Period|Lack of Efficacy|0|||
33511019|NCT01053962|101764768|FG001|Treatment Period|Lack of Efficacy|0|||
33511020|NCT01053962|101764769|FG002|Treatment Period|Lack of Efficacy|0|||
33511021|NCT01053962|101764770|FG003|Treatment Period|Lack of Efficacy|0|||
33511022|NCT01053962|101764771|FG004|Treatment Period|Lack of Efficacy|1|||
33511023|NCT01053962|101764767|FG000|Treatment Period|Adverse Event|0|||
33511024|NCT01053962|101764768|FG001|Treatment Period|Adverse Event|0|||
33511025|NCT01053962|101764769|FG002|Treatment Period|Adverse Event|0|||
33511026|NCT01053962|101764770|FG003|Treatment Period|Adverse Event|0|||
33511027|NCT01053962|101764771|FG004|Treatment Period|Adverse Event|1|||
33511028|NCT01053962|101764767|FG000|Treatment Period|Withdrawal by Subject|0|||
33511029|NCT01053962|101764768|FG001|Treatment Period|Withdrawal by Subject|0|||
33511030|NCT01053962|101764769|FG002|Treatment Period|Withdrawal by Subject|0|||
33511031|NCT01053962|101764770|FG003|Treatment Period|Withdrawal by Subject|0|||
33511032|NCT01053962|101764771|FG004|Treatment Period|Withdrawal by Subject|1|||
33511033|NCT01053962|101764767|FG000|Treatment Period|Noncompliance with protocol|1|||
33511034|NCT01053962|101764768|FG001|Treatment Period|Noncompliance with protocol|0|||
33511035|NCT01053962|101764769|FG002|Treatment Period|Noncompliance with protocol|0|||
33511036|NCT01053962|101764770|FG003|Treatment Period|Noncompliance with protocol|0|||
33511037|NCT01053962|101764771|FG004|Treatment Period|Noncompliance with protocol|0|||
33511038|NCT03075891|101764773|FG000|Overall Study|Withdrawal by Subject|3|||
33511039|NCT03075891|101764774|FG001|Overall Study|Withdrawal by Subject|6|||
33511040|NCT03075891|101764773|FG000|Overall Study|Lost to Follow-up|1|||
33511041|NCT03075891|101764774|FG001|Overall Study|Lost to Follow-up|0|||
33511042|NCT03075891|101764773|FG000|Overall Study|Pregnancy|3|||
33511043|NCT03075891|101764774|FG001|Overall Study|Pregnancy|1|||
33511044|NCT03075891|101764773|FG000|Overall Study|visits not performed (no time)|1|||
33511045|NCT03075891|101764774|FG001|Overall Study|visits not performed (no time)|0|||
33511046|NCT03075891|101764773|FG000|Overall Study|Drug abuse relapse issue|0|||
33511047|NCT03075891|101764774|FG001|Overall Study|Drug abuse relapse issue|1|||
33511048|NCT03075891|101764773|FG000|Overall Study|Participant requiring study withdrawal|0|||
33511049|NCT03075891|101764774|FG001|Overall Study|Participant requiring study withdrawal|1|||
33511050|NCT03075891|101764773|FG000|Overall Study|Adverse event, non-fatal|1|||
33511051|NCT03075891|101764774|FG001|Overall Study|Adverse event, non-fatal|4|||
33511052|NCT01275755|101764779|FG000|Double-blind Treatment Period|Adverse Event|0|||
33511053|NCT01275755|101764780|FG001|Double-blind Treatment Period|Adverse Event|2|||
33511054|NCT01275755|101764779|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
33511055|NCT01275755|101764780|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
33511056|NCT01275755|101764779|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
33511057|NCT01275755|101764780|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
33511058|NCT01275755|101764779|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
33198093|NCT02265705|100630377|FG006|Open Label Period|Withdrawal by Subject|0|||
33198094|NCT02265705|100630371|FG000|Follow-up Period|Sponsor Decision|0|||
33511059|NCT01275755|101764780|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
33605464|NCT01264770|102105582|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
33198095|NCT02265705|100630372|FG001|Follow-up Period|Sponsor Decision|0|||
33605465|NCT01264770|102105583|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
33605466|NCT01264770|102105584|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
33198096|NCT02265705|100630373|FG002|Follow-up Period|Sponsor Decision|0|||
33198097|NCT02265705|100630374|FG003|Follow-up Period|Sponsor Decision|0|||
33511060|NCT01790828|101764781|FG000|Overall Study|Other|34|||
33511061|NCT02394340|101764782|FG000|Overall Study|Failed drug screen test|1|||
33605467|NCT01264770|102105579|FG000|Overall Study|Lost to Follow-up|0|||
33605468|NCT01264770|102105580|FG001|Overall Study|Lost to Follow-up|0|||
33511062|NCT02394340|101764782|FG000|Overall Study|Adverse Event|1|||
33511063|NCT01936181|101770206|FG000|Randomised, Double-blind|Adverse Event|27|||
33511064|NCT01936181|101770207|FG001|Randomised, Double-blind|Adverse Event|21|||
33511065|NCT01936181|101770208|FG002|Randomised, Double-blind|Adverse Event|0|||
33511066|NCT01936181|101770209|FG003|Randomised, Double-blind|Adverse Event|0|||
33511067|NCT01936181|101770206|FG000|Randomised, Double-blind|Protocol Violation|1|||
33511068|NCT01936181|101770207|FG001|Randomised, Double-blind|Protocol Violation|5|||
33511069|NCT01936181|101770208|FG002|Randomised, Double-blind|Protocol Violation|0|||
33511070|NCT01936181|101770209|FG003|Randomised, Double-blind|Protocol Violation|0|||
33511071|NCT01936181|101770206|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
33511072|NCT01936181|101770207|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
33511073|NCT01936181|101770208|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
33511074|NCT01936181|101770209|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
33511075|NCT01936181|101770206|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
33511076|NCT01936181|101770207|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
33511077|NCT01936181|101770208|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
33511078|NCT01936181|101770209|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
33511079|NCT01936181|101770206|FG000|Randomised, Double-blind|Pregnancy|0|||
33511080|NCT01936181|101770207|FG001|Randomised, Double-blind|Pregnancy|1|||
33511081|NCT01936181|101770208|FG002|Randomised, Double-blind|Pregnancy|0|||
33511082|NCT01936181|101770209|FG003|Randomised, Double-blind|Pregnancy|0|||
33511083|NCT01936181|101770206|FG000|Randomised, Double-blind|Physician Decision|4|||
33511084|NCT01936181|101770207|FG001|Randomised, Double-blind|Physician Decision|4|||
33511085|NCT01936181|101770208|FG002|Randomised, Double-blind|Physician Decision|0|||
33511086|NCT01936181|101770209|FG003|Randomised, Double-blind|Physician Decision|0|||
33511087|NCT01936181|101770206|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
33605469|NCT01264770|102105581|FG002|Overall Study|Lost to Follow-up|1|||
33605470|NCT01264770|102105582|FG003|Overall Study|Lost to Follow-up|1|||
33605471|NCT01264770|102105583|FG004|Overall Study|Lost to Follow-up|0|||
33605472|NCT01264770|102105584|FG005|Overall Study|Lost to Follow-up|0|||
33605473|NCT01264770|102105579|FG000|Overall Study|Adverse Event|7|||
33605474|NCT01264770|102105580|FG001|Overall Study|Adverse Event|7|||
33605475|NCT01264770|102105581|FG002|Overall Study|Adverse Event|8|||
33605476|NCT01264770|102105582|FG003|Overall Study|Adverse Event|0|||
33605477|NCT01264770|102105583|FG004|Overall Study|Adverse Event|2|||
33605478|NCT01264770|102105584|FG005|Overall Study|Adverse Event|1|||
33605479|NCT03238924|102105585|FG000|Overall Study|Withdrawal by Subject|2|||
33605480|NCT03238924|102105586|FG001|Overall Study|Withdrawal by Subject|2|||
33605481|NCT00109577|102105589|FG000|Overall Study|Withdrawal by Subject|3|||
33605482|NCT00109577|102105590|FG001|Overall Study|Withdrawal by Subject|3|||
33605483|NCT02445573|102105591|FG000|Overall Study|Withdrawal by Subject|1|||
33605484|NCT02445573|102105592|FG001|Overall Study|Withdrawal by Subject|1|||
33605485|NCT02445573|102105591|FG000|Overall Study|Lost to Follow-up|0|||
33605486|NCT02445573|102105592|FG001|Overall Study|Lost to Follow-up|1|||
33605487|NCT02905006|102105593|FG000|Overall Study|Adverse Event|1|||
33605488|NCT02905006|102105594|FG001|Overall Study|Adverse Event|1|||
33605489|NCT02905006|102105595|FG002|Overall Study|Adverse Event|1|||
33605490|NCT02905006|102105596|FG003|Overall Study|Adverse Event|1|||
33605491|NCT02905006|102105597|FG004|Overall Study|Adverse Event|0|||
33198098|NCT02265705|100630375|FG004|Follow-up Period|Sponsor Decision|0|||
33511088|NCT01936181|101770207|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
33511089|NCT01936181|101770208|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
33605492|NCT02905006|102105598|FG005|Overall Study|Adverse Event|1|||
33605493|NCT02905006|102105593|FG000|Overall Study|Lack of Efficacy|1|||
33605494|NCT02905006|102105594|FG001|Overall Study|Lack of Efficacy|0|||
33605495|NCT02905006|102105595|FG002|Overall Study|Lack of Efficacy|0|||
33605496|NCT02905006|102105596|FG003|Overall Study|Lack of Efficacy|0|||
33605497|NCT02905006|102105597|FG004|Overall Study|Lack of Efficacy|0|||
33605498|NCT02905006|102105598|FG005|Overall Study|Lack of Efficacy|0|||
33605499|NCT02905006|102105593|FG000|Overall Study|Protocol Violation|2|||
33322043|NCT04136184|101074794|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
33322044|NCT01252810|101074795|FG000|Overall Study|Withdrawal by Subject|4|||
33511090|NCT01936181|101770209|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
33511091|NCT01936181|101770206|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
33511092|NCT01936181|101770207|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
33511093|NCT01936181|101770208|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
33511094|NCT01936181|101770209|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
33511095|NCT01936181|101770206|FG000|Transition-extension|Adverse Event|3|||
33511096|NCT01936181|101770207|FG001|Transition-extension|Adverse Event|0|||
33511097|NCT01936181|101770208|FG002|Transition-extension|Adverse Event|3|||
33511098|NCT01936181|101770209|FG003|Transition-extension|Adverse Event|1|||
33511099|NCT01936181|101770206|FG000|Transition-extension|Lost to Follow-up|3|||
33511100|NCT01936181|101770207|FG001|Transition-extension|Lost to Follow-up|0|||
33511101|NCT01936181|101770208|FG002|Transition-extension|Lost to Follow-up|1|||
33511102|NCT01936181|101770209|FG003|Transition-extension|Lost to Follow-up|2|||
33511103|NCT01936181|101770206|FG000|Transition-extension|Physician Decision|2|||
33511104|NCT01936181|101770207|FG001|Transition-extension|Physician Decision|0|||
33511105|NCT01936181|101770208|FG002|Transition-extension|Physician Decision|0|||
33511106|NCT01936181|101770209|FG003|Transition-extension|Physician Decision|1|||
33511107|NCT01936181|101770206|FG000|Transition-extension|Withdrawal by Subject|7|||
33511108|NCT01936181|101770207|FG001|Transition-extension|Withdrawal by Subject|0|||
33511109|NCT01936181|101770208|FG002|Transition-extension|Withdrawal by Subject|2|||
33511110|NCT01936181|101770209|FG003|Transition-extension|Withdrawal by Subject|1|||
33511111|NCT05129137|101770210|FG000|Second Period|Adverse Event|1|||
33511112|NCT05129137|101770211|FG001|Second Period|Adverse Event|0|||
33511113|NCT05129137|101770212|FG002|Second Period|Adverse Event|0|||
33511114|NCT05129137|101770213|FG003|Second Period|Adverse Event|0|||
33511115|NCT05129137|101770210|FG000|Second Period|Protocol Violation|0|||
33511116|NCT05129137|101770211|FG001|Second Period|Protocol Violation|0|||
33511117|NCT05129137|101770212|FG002|Second Period|Protocol Violation|0|||
33511118|NCT05129137|101770213|FG003|Second Period|Protocol Violation|1|||
33511119|NCT05129137|101770210|FG000|Third Period|Protocol Violation|0|||
33322045|NCT01252810|101074796|FG001|Overall Study|Withdrawal by Subject|1|||
33322046|NCT01252810|101074795|FG000|Overall Study|Lost to Follow-up|0|||
33322047|NCT01252810|101074796|FG001|Overall Study|Lost to Follow-up|1|||
33322048|NCT01252810|101074795|FG000|Overall Study|Physician Decision|2|||
33322049|NCT01252810|101074796|FG001|Overall Study|Physician Decision|1|||
33322050|NCT01252810|101074795|FG000|Overall Study|Various reasons|8|||
33322051|NCT01252810|101074796|FG001|Overall Study|Various reasons|0|||
33322052|NCT05671653|101074797|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
33511120|NCT05129137|101770211|FG001|Third Period|Protocol Violation|0|||
33511121|NCT05129137|101770212|FG002|Third Period|Protocol Violation|0|||
33511122|NCT05129137|101770213|FG003|Third Period|Protocol Violation|1|||
33511123|NCT05129137|101770210|FG000|Forth Period|Protocol Violation|0|||
33511124|NCT05129137|101770211|FG001|Forth Period|Protocol Violation|1|||
33511125|NCT05129137|101770212|FG002|Forth Period|Protocol Violation|0|||
33322053|NCT05671653|101074798|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
33511126|NCT05129137|101770213|FG003|Forth Period|Protocol Violation|0|||
33511127|NCT05129137|101770210|FG000|Forth Period|Withdrawal by Subject|0|||
33511128|NCT05129137|101770211|FG001|Forth Period|Withdrawal by Subject|0|||
33511129|NCT05129137|101770212|FG002|Forth Period|Withdrawal by Subject|1|||
33511130|NCT05129137|101770213|FG003|Forth Period|Withdrawal by Subject|0|||
33511131|NCT01253174|101770214|FG000|Period 1|Randomized but not treated|0|||
33511132|NCT01253174|101770215|FG001|Period 1|Randomized but not treated|1|||
33511133|NCT01253174|101770216|FG002|Period 1|Randomized but not treated|1|||
33511134|NCT01253174|101770217|FG003|Period 1|Randomized but not treated|0|||
33322054|NCT05671653|101074799|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
33511135|NCT01253174|101770218|FG004|Period 1|Randomized but not treated|1|||
33511136|NCT01253174|101770219|FG005|Period 1|Randomized but not treated|0|||
33511137|NCT01253174|101770214|FG000|Period 2|Adverse Event|0|||
33511138|NCT01253174|101770215|FG001|Period 2|Adverse Event|0|||
33511139|NCT01253174|101770216|FG002|Period 2|Adverse Event|1|||
33511140|NCT01253174|101770217|FG003|Period 2|Adverse Event|0|||
33511141|NCT01253174|101770218|FG004|Period 2|Adverse Event|0|||
33511142|NCT01253174|101770219|FG005|Period 2|Adverse Event|0|||
33511143|NCT01253174|101770214|FG000|Period 3|Withdrawal by Subject|0|||
33511144|NCT01253174|101770215|FG001|Period 3|Withdrawal by Subject|1|||
33511145|NCT01253174|101770216|FG002|Period 3|Withdrawal by Subject|0|||
33511146|NCT01253174|101770217|FG003|Period 3|Withdrawal by Subject|0|||
33511147|NCT01253174|101770218|FG004|Period 3|Withdrawal by Subject|1|||
33511148|NCT01253174|101770219|FG005|Period 3|Withdrawal by Subject|0|||
33511149|NCT01253174|101770214|FG000|Period 3|Pregnancy|0|||
33511150|NCT01253174|101770215|FG001|Period 3|Pregnancy|0|||
33511151|NCT01253174|101770216|FG002|Period 3|Pregnancy|1|||
33511152|NCT01253174|101770217|FG003|Period 3|Pregnancy|0|||
33511153|NCT01253174|101770218|FG004|Period 3|Pregnancy|0|||
33511154|NCT01253174|101770219|FG005|Period 3|Pregnancy|0|||
33511155|NCT00425061|101770220|FG000|Overall Study|Adverse Event|1|||
33511156|NCT00425061|101770221|FG001|Overall Study|Adverse Event|0|||
33511157|NCT00425061|101770222|FG002|Overall Study|Adverse Event|0|||
33511158|NCT00425061|101770223|FG003|Overall Study|Adverse Event|2|||
33511159|NCT00425061|101770224|FG004|Overall Study|Adverse Event|2|||
33511160|NCT00425061|101770225|FG005|Overall Study|Adverse Event|0|||
33511161|NCT00425061|101770226|FG006|Overall Study|Adverse Event|0|||
33511162|NCT00425061|101770220|FG000|Overall Study|Lost to Follow-up|0|||
33511163|NCT00425061|101770221|FG001|Overall Study|Lost to Follow-up|1|||
33511164|NCT00425061|101770222|FG002|Overall Study|Lost to Follow-up|0|||
33511165|NCT00425061|101770223|FG003|Overall Study|Lost to Follow-up|0|||
33511166|NCT00425061|101770224|FG004|Overall Study|Lost to Follow-up|0|||
33511167|NCT00425061|101770225|FG005|Overall Study|Lost to Follow-up|0|||
33511168|NCT00425061|101770226|FG006|Overall Study|Lost to Follow-up|0|||
33511169|NCT00425061|101770220|FG000|Overall Study|Protocol Violation|1|||
33511170|NCT00425061|101770221|FG001|Overall Study|Protocol Violation|0|||
33605500|NCT02905006|102105594|FG001|Overall Study|Protocol Violation|0|||
33605501|NCT02905006|102105595|FG002|Overall Study|Protocol Violation|0|||
33605502|NCT02905006|102105596|FG003|Overall Study|Protocol Violation|0|||
33605503|NCT02905006|102105597|FG004|Overall Study|Protocol Violation|0|||
33605504|NCT02905006|102105598|FG005|Overall Study|Protocol Violation|0|||
33605505|NCT02905006|102105593|FG000|Overall Study|Lost to Follow-up|0|||
33605506|NCT02905006|102105594|FG001|Overall Study|Lost to Follow-up|0|||
33605507|NCT02905006|102105595|FG002|Overall Study|Lost to Follow-up|0|||
33605508|NCT02905006|102105596|FG003|Overall Study|Lost to Follow-up|1|||
33198099|NCT02265705|100630376|FG005|Follow-up Period|Sponsor Decision|1|||
33198100|NCT02265705|100630377|FG006|Follow-up Period|Sponsor Decision|6|||
33511171|NCT00425061|101770222|FG002|Overall Study|Protocol Violation|0|||
33511172|NCT00425061|101770223|FG003|Overall Study|Protocol Violation|0|||
33511173|NCT00425061|101770224|FG004|Overall Study|Protocol Violation|0|||
33511174|NCT00425061|101770225|FG005|Overall Study|Protocol Violation|0|||
33511175|NCT00425061|101770226|FG006|Overall Study|Protocol Violation|0|||
33511176|NCT00425061|101770220|FG000|Overall Study|Withdrawal by Subject|0|||
33511177|NCT00425061|101770221|FG001|Overall Study|Withdrawal by Subject|1|||
33511178|NCT00425061|101770222|FG002|Overall Study|Withdrawal by Subject|0|||
33511179|NCT00425061|101770223|FG003|Overall Study|Withdrawal by Subject|0|||
33198101|NCT02265705|100630371|FG000|Follow-up Period|Adverse Event|0|||
33198102|NCT02265705|100630372|FG001|Follow-up Period|Adverse Event|0|||
33198103|NCT02265705|100630373|FG002|Follow-up Period|Adverse Event|0|||
33198104|NCT02265705|100630374|FG003|Follow-up Period|Adverse Event|0|||
33198105|NCT02265705|100630375|FG004|Follow-up Period|Adverse Event|0|||
33198106|NCT02265705|100630376|FG005|Follow-up Period|Adverse Event|0|||
33198107|NCT02265705|100630377|FG006|Follow-up Period|Adverse Event|3|||
33198108|NCT02265705|100630371|FG000|Follow-up Period|Physician Decision|0|||
33198109|NCT02265705|100630372|FG001|Follow-up Period|Physician Decision|0|||
33322055|NCT05671653|101074800|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
33322056|NCT05671653|101074801|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
33322057|NCT05671653|101074802|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
33322058|NCT05671653|101074803|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
33322059|NCT05671653|101074804|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
33322060|NCT05671653|101074805|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
33511180|NCT00425061|101770224|FG004|Overall Study|Withdrawal by Subject|1|||
33511181|NCT00425061|101770225|FG005|Overall Study|Withdrawal by Subject|0|||
33511182|NCT00425061|101770226|FG006|Overall Study|Withdrawal by Subject|3|||
33511183|NCT00425061|101770220|FG000|Overall Study|Sponsor's request|0|||
33511184|NCT00425061|101770221|FG001|Overall Study|Sponsor's request|0|||
33511185|NCT00425061|101770222|FG002|Overall Study|Sponsor's request|0|||
33511186|NCT00425061|101770223|FG003|Overall Study|Sponsor's request|0|||
33511187|NCT00425061|101770224|FG004|Overall Study|Sponsor's request|19|||
33605509|NCT02905006|102105597|FG004|Overall Study|Lost to Follow-up|1|||
33605510|NCT02905006|102105598|FG005|Overall Study|Lost to Follow-up|0|||
33511188|NCT00425061|101770225|FG005|Overall Study|Sponsor's request|4|||
33511189|NCT00425061|101770226|FG006|Overall Study|Sponsor's request|15|||
33511190|NCT00425061|101770220|FG000|Overall Study|Physician Decision|0|||
33511191|NCT00425061|101770221|FG001|Overall Study|Physician Decision|0|||
33511192|NCT00425061|101770222|FG002|Overall Study|Physician Decision|0|||
33511193|NCT00425061|101770223|FG003|Overall Study|Physician Decision|0|||
33511194|NCT00425061|101770224|FG004|Overall Study|Physician Decision|1|||
33511195|NCT00425061|101770225|FG005|Overall Study|Physician Decision|0|||
33511196|NCT00425061|101770226|FG006|Overall Study|Physician Decision|0|||
33511197|NCT00425061|101770220|FG000|Overall Study|Other|0|||
33511198|NCT00425061|101770221|FG001|Overall Study|Other|0|||
33511199|NCT00425061|101770222|FG002|Overall Study|Other|0|||
33511200|NCT00425061|101770223|FG003|Overall Study|Other|0|||
33511201|NCT00425061|101770224|FG004|Overall Study|Other|3|||
33511202|NCT00425061|101770225|FG005|Overall Study|Other|0|||
33511203|NCT00425061|101770226|FG006|Overall Study|Other|1|||
33511204|NCT04776018|101770227|FG000|Overall Study|Death|0|||
33511205|NCT04776018|101770228|FG001|Overall Study|Death|1|||
33511206|NCT04776018|101770229|FG002|Overall Study|Death|4|||
33511207|NCT04776018|101770230|FG003|Overall Study|Death|1|||
33511208|NCT04776018|101770231|FG004|Overall Study|Death|4|||
33511209|NCT04776018|101770232|FG005|Overall Study|Death|0|||
33511210|NCT04776018|101770233|FG006|Overall Study|Death|0|||
33511211|NCT04776018|101770227|FG000|Overall Study|Study terminated by sponsor|2|||
33511212|NCT04776018|101770228|FG001|Overall Study|Study terminated by sponsor|1|||
33511213|NCT04776018|101770229|FG002|Overall Study|Study terminated by sponsor|4|||
33511214|NCT04776018|101770230|FG003|Overall Study|Study terminated by sponsor|0|||
33511215|NCT04776018|101770231|FG004|Overall Study|Study terminated by sponsor|3|||
33511216|NCT04776018|101770232|FG005|Overall Study|Study terminated by sponsor|0|||
33511217|NCT04776018|101770233|FG006|Overall Study|Study terminated by sponsor|0|||
33511218|NCT04776018|101770227|FG000|Overall Study|Withdrawal by Subject|1|||
33511219|NCT04776018|101770228|FG001|Overall Study|Withdrawal by Subject|0|||
33605511|NCT02905006|102105593|FG000|Overall Study|Withdrawal by Subject|0|||
33605512|NCT02905006|102105594|FG001|Overall Study|Withdrawal by Subject|0|||
33605513|NCT02905006|102105595|FG002|Overall Study|Withdrawal by Subject|1|||
33605514|NCT02905006|102105596|FG003|Overall Study|Withdrawal by Subject|1|||
33322061|NCT05671653|101074806|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
33511220|NCT04776018|101770229|FG002|Overall Study|Withdrawal by Subject|0|||
33605515|NCT02905006|102105597|FG004|Overall Study|Withdrawal by Subject|0|||
33322062|NCT05671653|101074807|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
33322063|NCT05671653|101074808|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
33322064|NCT05671653|101074809|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
33322065|NCT05671653|101074797|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
33322066|NCT05671653|101074798|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
33322067|NCT05671653|101074799|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
33322068|NCT05671653|101074800|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
33322069|NCT05671653|101074801|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
33322070|NCT05671653|101074802|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
33322071|NCT05671653|101074803|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
33322072|NCT05671653|101074804|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
33322073|NCT05671653|101074805|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
33322074|NCT05671653|101074806|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
33322075|NCT05671653|101074807|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
33322076|NCT05671653|101074808|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
33322077|NCT05671653|101074809|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
33322078|NCT05671653|101074797|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
33322079|NCT05671653|101074798|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
33322080|NCT05671653|101074799|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
33322081|NCT05671653|101074800|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
33322082|NCT05671653|101074801|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
33322083|NCT05671653|101074802|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
33322084|NCT05671653|101074803|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
33322085|NCT05671653|101074804|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
33322086|NCT05671653|101074805|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
33322087|NCT05671653|101074806|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
33322088|NCT05671653|101074807|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
33322089|NCT05671653|101074808|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
33511221|NCT04776018|101770230|FG003|Overall Study|Withdrawal by Subject|2|||
33511222|NCT04776018|101770231|FG004|Overall Study|Withdrawal by Subject|1|||
33511223|NCT04776018|101770232|FG005|Overall Study|Withdrawal by Subject|0|||
33511224|NCT04776018|101770233|FG006|Overall Study|Withdrawal by Subject|0|||
33511225|NCT04776018|101770227|FG000|Overall Study|Other|0|||
33511226|NCT04776018|101770228|FG001|Overall Study|Other|1|||
33511227|NCT04776018|101770229|FG002|Overall Study|Other|1|||
33605516|NCT02905006|102105598|FG005|Overall Study|Withdrawal by Subject|1|||
33631276|NCT03279081|102202900|FG001|Overall Study|Death|1|||
33511228|NCT04776018|101770230|FG003|Overall Study|Other|0|||
33511229|NCT04776018|101770231|FG004|Overall Study|Other|0|||
33511230|NCT04776018|101770232|FG005|Overall Study|Other|0|||
33511231|NCT04776018|101770233|FG006|Overall Study|Other|0|||
33511232|NCT04776018|101770227|FG000|Overall Study|Lost to Follow-up|0|||
33511233|NCT04776018|101770228|FG001|Overall Study|Lost to Follow-up|0|||
33511234|NCT04776018|101770229|FG002|Overall Study|Lost to Follow-up|1|||
33511235|NCT04776018|101770230|FG003|Overall Study|Lost to Follow-up|0|||
33511236|NCT04776018|101770231|FG004|Overall Study|Lost to Follow-up|0|||
33511237|NCT04776018|101770232|FG005|Overall Study|Lost to Follow-up|0|||
33511238|NCT04776018|101770233|FG006|Overall Study|Lost to Follow-up|0|||
33511239|NCT01084668|101770234|FG000|Overall Study|Lack of Efficacy|5|||
33511240|NCT01084668|101770234|FG000|Overall Study|Withdrawal by Subject|2|||
33511241|NCT01084668|101770234|FG000|Overall Study|Pregnancy|1|||
33511242|NCT01084668|101770234|FG000|Overall Study|Non-compliance|1|||
33511243|NCT04778059|101770236|FG000|Overall Study|Death|2|||
33511244|NCT04778059|101770237|FG001|Overall Study|Death|2|||
33511245|NCT04778059|101770238|FG002|Overall Study|Death|1|||
33511246|NCT04778059|101770239|FG003|Overall Study|Death|1|||
33511247|NCT04778059|101770240|FG004|Overall Study|Death|1|||
33511248|NCT04778059|101770236|FG000|Overall Study|Lost to Follow-up|0|||
33511249|NCT04778059|101770237|FG001|Overall Study|Lost to Follow-up|0|||
33511250|NCT04778059|101770238|FG002|Overall Study|Lost to Follow-up|0|||
33511251|NCT04778059|101770239|FG003|Overall Study|Lost to Follow-up|0|||
33511252|NCT04778059|101770240|FG004|Overall Study|Lost to Follow-up|1|||
33198110|NCT02265705|100630373|FG002|Follow-up Period|Physician Decision|0|||
33198111|NCT02265705|100630374|FG003|Follow-up Period|Physician Decision|0|||
33198112|NCT02265705|100630375|FG004|Follow-up Period|Physician Decision|0|||
33198113|NCT02265705|100630376|FG005|Follow-up Period|Physician Decision|0|||
33198114|NCT02265705|100630377|FG006|Follow-up Period|Physician Decision|1|||
33198115|NCT02265705|100630371|FG000|Follow-up Period|Withdrawal by Subject|0|||
33198116|NCT02265705|100630372|FG001|Follow-up Period|Withdrawal by Subject|0|||
33198117|NCT02265705|100630373|FG002|Follow-up Period|Withdrawal by Subject|0|||
33198118|NCT02265705|100630374|FG003|Follow-up Period|Withdrawal by Subject|0|||
33198119|NCT02265705|100630375|FG004|Follow-up Period|Withdrawal by Subject|0|||
33198120|NCT02265705|100630376|FG005|Follow-up Period|Withdrawal by Subject|0|||
33198121|NCT02265705|100630377|FG006|Follow-up Period|Withdrawal by Subject|1|||
33198122|NCT01677195|100630383|FG000|Overall Study|Lost to Follow-up|14|||
33198123|NCT01677195|100630384|FG001|Overall Study|Lost to Follow-up|22|||
33198124|NCT01677195|100630385|FG002|Overall Study|Lost to Follow-up|22|||
33198125|NCT01677195|100630383|FG000|Overall Study|Withdrawal by Subject|1|||
33198126|NCT01677195|100630384|FG001|Overall Study|Withdrawal by Subject|0|||
33322090|NCT05671653|101074809|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
33511253|NCT04778059|101770236|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
33511254|NCT04778059|101770237|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
33511255|NCT04778059|101770238|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
33511256|NCT04778059|101770239|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
33511257|NCT04778059|101770240|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
33511258|NCT01645891|101770241|FG000|Overall Study|Adverse Event|6|||
33198127|NCT01677195|100630385|FG002|Overall Study|Withdrawal by Subject|1|||
33198128|NCT01677195|100630383|FG000|Overall Study|Adverse Event|6|||
33198129|NCT01677195|100630384|FG001|Overall Study|Adverse Event|4|||
33198130|NCT01677195|100630385|FG002|Overall Study|Adverse Event|1|||
33322091|NCT05671653|101074797|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
33322092|NCT05671653|101074798|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
33511259|NCT01645891|101770242|FG001|Overall Study|Adverse Event|10|||
33511260|NCT01645891|101770241|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
33511261|NCT01645891|101770242|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
33511262|NCT01645891|101770241|FG000|Overall Study|Withdrawal by Subject|3|||
33511263|NCT01645891|101770242|FG001|Overall Study|Withdrawal by Subject|3|||
33322093|NCT05671653|101074799|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
33322094|NCT05671653|101074800|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
33322095|NCT05671653|101074801|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
33322096|NCT05671653|101074802|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
33322097|NCT05671653|101074803|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
33322098|NCT05671653|101074804|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
33322099|NCT05671653|101074805|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
33322100|NCT05671653|101074806|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
33322101|NCT05671653|101074807|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
33322102|NCT05671653|101074808|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
33322103|NCT05671653|101074809|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
33322104|NCT05671653|101074797|FG000|Cohort 2 Period 2|Adverse Event|0|||
33322105|NCT05671653|101074798|FG001|Cohort 2 Period 2|Adverse Event|0|||
33322106|NCT05671653|101074799|FG002|Cohort 2 Period 2|Adverse Event|0|||
33322107|NCT05671653|101074800|FG003|Cohort 2 Period 2|Adverse Event|0|||
33322108|NCT05671653|101074801|FG004|Cohort 2 Period 2|Adverse Event|0|||
33322109|NCT05671653|101074802|FG005|Cohort 2 Period 2|Adverse Event|0|||
33322110|NCT05671653|101074803|FG006|Cohort 2 Period 2|Adverse Event|0|||
33322111|NCT05671653|101074804|FG007|Cohort 2 Period 2|Adverse Event|0|||
33322112|NCT05671653|101074805|FG008|Cohort 2 Period 2|Adverse Event|0|||
33322113|NCT05671653|101074806|FG009|Cohort 2 Period 2|Adverse Event|0|||
33322114|NCT05671653|101074807|FG010|Cohort 2 Period 2|Adverse Event|1|||
33322115|NCT05671653|101074808|FG011|Cohort 2 Period 2|Adverse Event|0|||
33322116|NCT05671653|101074809|FG012|Cohort 2 Period 2|Adverse Event|0|||
33322117|NCT05671653|101074797|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
33322118|NCT05671653|101074798|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
33322119|NCT05671653|101074799|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
33322120|NCT05671653|101074800|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
33322121|NCT05671653|101074801|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
33322122|NCT05671653|101074802|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
33322123|NCT05671653|101074803|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
33322124|NCT05671653|101074804|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
33322125|NCT05671653|101074805|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
33322126|NCT05671653|101074806|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
33605517|NCT02905006|102105593|FG000|Overall Study|Screening exclusion criteria met|1|||
33605518|NCT02905006|102105594|FG001|Overall Study|Screening exclusion criteria met|0|||
33605519|NCT02905006|102105595|FG002|Overall Study|Screening exclusion criteria met|0|||
33605520|NCT02905006|102105596|FG003|Overall Study|Screening exclusion criteria met|0|||
33605521|NCT02905006|102105597|FG004|Overall Study|Screening exclusion criteria met|0|||
33605522|NCT02905006|102105598|FG005|Overall Study|Screening exclusion criteria met|0|||
33605523|NCT02905006|102105593|FG000|Overall Study|Lab withdrawal criterion met|0|||
33605524|NCT02905006|102105594|FG001|Overall Study|Lab withdrawal criterion met|1|||
33605525|NCT02905006|102105595|FG002|Overall Study|Lab withdrawal criterion met|2|||
33605526|NCT02905006|102105596|FG003|Overall Study|Lab withdrawal criterion met|2|||
33605527|NCT02905006|102105597|FG004|Overall Study|Lab withdrawal criterion met|2|||
33322127|NCT05671653|101074807|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
33322128|NCT05671653|101074808|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
33322129|NCT05671653|101074809|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
33322130|NCT05671653|101074797|FG000|Cohort 2 Period 2|Pregnancy|0|||
33322131|NCT05671653|101074798|FG001|Cohort 2 Period 2|Pregnancy|0|||
33322132|NCT05671653|101074799|FG002|Cohort 2 Period 2|Pregnancy|0|||
33322133|NCT05671653|101074800|FG003|Cohort 2 Period 2|Pregnancy|0|||
33322134|NCT05671653|101074801|FG004|Cohort 2 Period 2|Pregnancy|0|||
33322135|NCT05671653|101074802|FG005|Cohort 2 Period 2|Pregnancy|0|||
33322136|NCT05671653|101074803|FG006|Cohort 2 Period 2|Pregnancy|0|||
33322137|NCT05671653|101074804|FG007|Cohort 2 Period 2|Pregnancy|0|||
33322138|NCT05671653|101074805|FG008|Cohort 2 Period 2|Pregnancy|0|||
33322139|NCT05671653|101074806|FG009|Cohort 2 Period 2|Pregnancy|0|||
33322140|NCT05671653|101074807|FG010|Cohort 2 Period 2|Pregnancy|1|||
33322141|NCT05671653|101074808|FG011|Cohort 2 Period 2|Pregnancy|0|||
33399059|NCT02394028|101350176|FG001|Induction Phase|Physician Decision|0|||
33399060|NCT02394028|101350177|FG002|Induction Phase|Physician Decision|1|||
33605528|NCT02905006|102105598|FG005|Overall Study|Lab withdrawal criterion met|1|||
33605529|NCT02905006|102105593|FG000|Overall Study|Positive for Tuberculosis|0|||
33322142|NCT05671653|101074809|FG012|Cohort 2 Period 2|Pregnancy|0|||
33322143|NCT05671653|101074797|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
33322144|NCT05671653|101074798|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
33322145|NCT05671653|101074799|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
33322146|NCT05671653|101074800|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
33322147|NCT05671653|101074801|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
33322148|NCT05671653|101074802|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
33322149|NCT05671653|101074803|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
33322150|NCT05671653|101074804|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
33399061|NCT02394028|101350178|FG003|Induction Phase|Physician Decision|4|||
33605530|NCT02905006|102105594|FG001|Overall Study|Positive for Tuberculosis|1|||
33511264|NCT01645891|101770241|FG000|Overall Study|Protocol Violation|4|||
33511265|NCT01645891|101770242|FG001|Overall Study|Protocol Violation|0|||
33511266|NCT01645891|101770241|FG000|Overall Study|Lost to Follow-up|4|||
33511267|NCT01645891|101770242|FG001|Overall Study|Lost to Follow-up|1|||
33511268|NCT01645891|101770241|FG000|Overall Study|Death|0|||
33511269|NCT01645891|101770242|FG001|Overall Study|Death|2|||
33511270|NCT01613222|101770243|FG000|Overall Study|Physician Decision|1|||
33511271|NCT01613222|101770243|FG000|Overall Study|Unable to place arterial line|1|||
33511272|NCT01613222|101770243|FG000|Overall Study|Reused disposable sensors|10|||
33511273|NCT02832375|101770244|FG000|Overall Study|Lost to Follow-up|1|||
33511274|NCT02832375|101770245|FG001|Overall Study|Lost to Follow-up|0|||
33511275|NCT02832375|101770244|FG000|Overall Study|Withdrawal of Consent|1|||
33511276|NCT02832375|101770245|FG001|Overall Study|Withdrawal of Consent|0|||
33511277|NCT02031640|101770246|FG000|Screening Period|Adverse Event|1|||
33511278|NCT02031640|101770247|FG001|Screening Period|Adverse Event|0|||
33511279|NCT02031640|101770248|FG002|Screening Period|Adverse Event|0|||
33511280|NCT02031640|101770249|FG003|Screening Period|Adverse Event|0|||
33511281|NCT02031640|101770250|FG004|Screening Period|Adverse Event|0|||
33511282|NCT02031640|101770251|FG005|Screening Period|Adverse Event|0|||
33511283|NCT02031640|101770246|FG000|Screening Period|Withdrawal by Subject|29|||
33511284|NCT02031640|101770247|FG001|Screening Period|Withdrawal by Subject|0|||
33511285|NCT02031640|101770248|FG002|Screening Period|Withdrawal by Subject|0|||
33511286|NCT02031640|101770249|FG003|Screening Period|Withdrawal by Subject|0|||
33511287|NCT02031640|101770250|FG004|Screening Period|Withdrawal by Subject|0|||
33511288|NCT02031640|101770251|FG005|Screening Period|Withdrawal by Subject|0|||
33511289|NCT02031640|101770246|FG000|Screening Period|Inclusion criteria not met|312|||
33511290|NCT02031640|101770247|FG001|Screening Period|Inclusion criteria not met|0|||
33511291|NCT02031640|101770248|FG002|Screening Period|Inclusion criteria not met|0|||
33511292|NCT02031640|101770249|FG003|Screening Period|Inclusion criteria not met|0|||
33511293|NCT02031640|101770250|FG004|Screening Period|Inclusion criteria not met|0|||
33511294|NCT02031640|101770251|FG005|Screening Period|Inclusion criteria not met|0|||
33511295|NCT02031640|101770246|FG000|Screening Period|Exclusion criteria met|30|||
33511296|NCT02031640|101770247|FG001|Screening Period|Exclusion criteria met|0|||
33511297|NCT02031640|101770248|FG002|Screening Period|Exclusion criteria met|0|||
33511298|NCT02031640|101770249|FG003|Screening Period|Exclusion criteria met|0|||
33511299|NCT02031640|101770250|FG004|Screening Period|Exclusion criteria met|0|||
33511300|NCT02031640|101770251|FG005|Screening Period|Exclusion criteria met|0|||
33511301|NCT02031640|101770246|FG000|Screening Period|Lost to Follow-up|14|||
33511302|NCT02031640|101770247|FG001|Screening Period|Lost to Follow-up|0|||
33511303|NCT02031640|101770248|FG002|Screening Period|Lost to Follow-up|0|||
33511304|NCT02031640|101770249|FG003|Screening Period|Lost to Follow-up|0|||
33511305|NCT02031640|101770250|FG004|Screening Period|Lost to Follow-up|0|||
33511306|NCT02031640|101770251|FG005|Screening Period|Lost to Follow-up|0|||
33511307|NCT02031640|101770246|FG000|Screening Period|Enrollment closed|26|||
33511308|NCT02031640|101770247|FG001|Screening Period|Enrollment closed|0|||
33511309|NCT02031640|101770248|FG002|Screening Period|Enrollment closed|0|||
33511310|NCT02031640|101770249|FG003|Screening Period|Enrollment closed|0|||
33511311|NCT02031640|101770250|FG004|Screening Period|Enrollment closed|0|||
33511312|NCT02031640|101770251|FG005|Screening Period|Enrollment closed|0|||
33511313|NCT02031640|101770246|FG000|Run-In Period|Adverse Event|4|||
33511314|NCT02031640|101770247|FG001|Run-In Period|Adverse Event|0|||
33511315|NCT02031640|101770248|FG002|Run-In Period|Adverse Event|0|||
33511316|NCT02031640|101770249|FG003|Run-In Period|Adverse Event|0|||
33511317|NCT02031640|101770250|FG004|Run-In Period|Adverse Event|0|||
33511318|NCT02031640|101770251|FG005|Run-In Period|Adverse Event|0|||
33511319|NCT02031640|101770246|FG000|Run-In Period|Withdrawal by Subject|17|||
33511320|NCT02031640|101770247|FG001|Run-In Period|Withdrawal by Subject|0|||
33511321|NCT02031640|101770248|FG002|Run-In Period|Withdrawal by Subject|0|||
33511322|NCT02031640|101770249|FG003|Run-In Period|Withdrawal by Subject|0|||
33511323|NCT02031640|101770250|FG004|Run-In Period|Withdrawal by Subject|0|||
33511324|NCT02031640|101770251|FG005|Run-In Period|Withdrawal by Subject|0|||
33511325|NCT02031640|101770246|FG000|Run-In Period|Inclusion criteria not met|38|||
33511326|NCT02031640|101770247|FG001|Run-In Period|Inclusion criteria not met|0|||
33511327|NCT02031640|101770248|FG002|Run-In Period|Inclusion criteria not met|0|||
33399062|NCT02394028|101350179|FG004|Induction Phase|Physician Decision|0|||
33511328|NCT02031640|101770249|FG003|Run-In Period|Inclusion criteria not met|0|||
33511329|NCT02031640|101770250|FG004|Run-In Period|Inclusion criteria not met|0|||
33511330|NCT02031640|101770251|FG005|Run-In Period|Inclusion criteria not met|0|||
33511331|NCT02031640|101770246|FG000|Run-In Period|Exclusion criteria met|8|||
33511332|NCT02031640|101770247|FG001|Run-In Period|Exclusion criteria met|0|||
33511333|NCT02031640|101770248|FG002|Run-In Period|Exclusion criteria met|0|||
33511334|NCT02031640|101770249|FG003|Run-In Period|Exclusion criteria met|0|||
33511335|NCT02031640|101770250|FG004|Run-In Period|Exclusion criteria met|0|||
33511336|NCT02031640|101770251|FG005|Run-In Period|Exclusion criteria met|0|||
33511337|NCT02031640|101770246|FG000|Run-In Period|Randomization criteria not met|85|||
33511338|NCT02031640|101770247|FG001|Run-In Period|Randomization criteria not met|0|||
33511339|NCT02031640|101770248|FG002|Run-In Period|Randomization criteria not met|0|||
33511340|NCT02031640|101770249|FG003|Run-In Period|Randomization criteria not met|0|||
33511341|NCT02031640|101770250|FG004|Run-In Period|Randomization criteria not met|0|||
33511342|NCT02031640|101770251|FG005|Run-In Period|Randomization criteria not met|0|||
33511343|NCT02031640|101770246|FG000|Run-In Period|Various administrative reasons|17|||
33511344|NCT02031640|101770247|FG001|Run-In Period|Various administrative reasons|0|||
33511345|NCT02031640|101770248|FG002|Run-In Period|Various administrative reasons|0|||
33511346|NCT02031640|101770249|FG003|Run-In Period|Various administrative reasons|0|||
33511347|NCT02031640|101770250|FG004|Run-In Period|Various administrative reasons|0|||
33511348|NCT02031640|101770251|FG005|Run-In Period|Various administrative reasons|0|||
33511349|NCT02031640|101770246|FG000|Double-blind Treatment Period|Protocol deviation|0|||
33511350|NCT02031640|101770247|FG001|Double-blind Treatment Period|Protocol deviation|2|||
33511351|NCT02031640|101770248|FG002|Double-blind Treatment Period|Protocol deviation|0|||
33511352|NCT02031640|101770249|FG003|Double-blind Treatment Period|Protocol deviation|1|||
33511353|NCT02031640|101770250|FG004|Double-blind Treatment Period|Protocol deviation|3|||
33511354|NCT02031640|101770251|FG005|Double-blind Treatment Period|Protocol deviation|1|||
33511355|NCT02031640|101770246|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
33511356|NCT02031640|101770247|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
33511357|NCT02031640|101770248|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
33511358|NCT02031640|101770249|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
33511359|NCT02031640|101770250|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
33511360|NCT02031640|101770251|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
33511361|NCT02031640|101770246|FG000|Double-blind Treatment Period|Non-compliance|0|||
33511362|NCT02031640|101770247|FG001|Double-blind Treatment Period|Non-compliance|1|||
33511363|NCT02031640|101770248|FG002|Double-blind Treatment Period|Non-compliance|0|||
33511364|NCT02031640|101770249|FG003|Double-blind Treatment Period|Non-compliance|1|||
33511365|NCT02031640|101770250|FG004|Double-blind Treatment Period|Non-compliance|1|||
33511366|NCT02031640|101770251|FG005|Double-blind Treatment Period|Non-compliance|0|||
33511367|NCT02031640|101770246|FG000|Double-blind Treatment Period|Adverse Event|0|||
33511368|NCT02031640|101770247|FG001|Double-blind Treatment Period|Adverse Event|0|||
33511369|NCT02031640|101770248|FG002|Double-blind Treatment Period|Adverse Event|0|||
33511370|NCT02031640|101770249|FG003|Double-blind Treatment Period|Adverse Event|2|||
33511371|NCT02031640|101770250|FG004|Double-blind Treatment Period|Adverse Event|0|||
33511372|NCT02031640|101770251|FG005|Double-blind Treatment Period|Adverse Event|0|||
33511373|NCT02031640|101770246|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
33511374|NCT02031640|101770247|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
33511375|NCT02031640|101770248|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
33511376|NCT02031640|101770249|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
33511377|NCT02031640|101770250|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
33511378|NCT02031640|101770251|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
33511379|NCT02031640|101770246|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
33511380|NCT02031640|101770247|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
33511381|NCT02031640|101770248|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
33511382|NCT02031640|101770249|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
33511383|NCT02031640|101770250|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
33511384|NCT02031640|101770251|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
33511385|NCT02487771|101770252|FG000|Overall Study|Lost to Follow-up|2|||
33511386|NCT02487771|101770253|FG001|Overall Study|Lost to Follow-up|3|||
33511387|NCT02487771|101770252|FG000|Overall Study|Moved out of area|5|||
33511388|NCT02487771|101770253|FG001|Overall Study|Moved out of area|6|||
33511389|NCT02487771|101770252|FG000|Overall Study|Withdrawal by Subject|3|||
33511390|NCT02487771|101770253|FG001|Overall Study|Withdrawal by Subject|5|||
33511391|NCT03800836|101770254|FG000|Overall Study|Other|2|||
33511392|NCT03800836|101770255|FG001|Overall Study|Other|1|||
33511393|NCT03800836|101770256|FG002|Overall Study|Other|0|||
33511394|NCT03800836|101770257|FG003|Overall Study|Other|2|||
33605531|NCT02905006|102105595|FG002|Overall Study|Positive for Tuberculosis|0|||
33511395|NCT03800836|101770258|FG004|Overall Study|Other|0|||
33605532|NCT02905006|102105596|FG003|Overall Study|Positive for Tuberculosis|0|||
33605533|NCT02905006|102105597|FG004|Overall Study|Positive for Tuberculosis|0|||
33605534|NCT02905006|102105598|FG005|Overall Study|Positive for Tuberculosis|0|||
33511396|NCT03800836|101770259|FG005|Overall Study|Other|1|||
33511397|NCT03800836|101770254|FG000|Overall Study|Lost to Follow-up|2|||
33511398|NCT03800836|101770255|FG001|Overall Study|Lost to Follow-up|0|||
33511399|NCT03800836|101770256|FG002|Overall Study|Lost to Follow-up|1|||
33511400|NCT03800836|101770257|FG003|Overall Study|Lost to Follow-up|1|||
33605535|NCT02905006|102105593|FG000|Overall Study|Subject positive for Hep B|0|||
33511401|NCT03800836|101770258|FG004|Overall Study|Lost to Follow-up|3|||
33511402|NCT03800836|101770259|FG005|Overall Study|Lost to Follow-up|0|||
33511403|NCT03800836|101770254|FG000|Overall Study|Withdrawal by Subject|1|||
33511404|NCT03800836|101770255|FG001|Overall Study|Withdrawal by Subject|0|||
33511405|NCT03800836|101770256|FG002|Overall Study|Withdrawal by Subject|0|||
33511406|NCT03800836|101770257|FG003|Overall Study|Withdrawal by Subject|0|||
33511407|NCT03800836|101770258|FG004|Overall Study|Withdrawal by Subject|0|||
33511408|NCT03800836|101770259|FG005|Overall Study|Withdrawal by Subject|0|||
33511409|NCT03800836|101770254|FG000|Overall Study|Physician Decision|31|||
33511410|NCT03800836|101770255|FG001|Overall Study|Physician Decision|3|||
33511411|NCT03800836|101770256|FG002|Overall Study|Physician Decision|6|||
33511412|NCT03800836|101770257|FG003|Overall Study|Physician Decision|4|||
33511413|NCT03800836|101770258|FG004|Overall Study|Physician Decision|4|||
33511414|NCT03800836|101770259|FG005|Overall Study|Physician Decision|5|||
33511415|NCT03800836|101770254|FG000|Overall Study|Death|34|||
33511416|NCT03800836|101770255|FG001|Overall Study|Death|16|||
33511417|NCT03800836|101770256|FG002|Overall Study|Death|5|||
33511418|NCT03800836|101770257|FG003|Overall Study|Death|5|||
33511419|NCT03800836|101770258|FG004|Overall Study|Death|10|||
33511420|NCT03800836|101770259|FG005|Overall Study|Death|0|||
33511421|NCT03800836|101770254|FG000|Overall Study|Symptomatic Deterioration|1|||
33511422|NCT03800836|101770255|FG001|Overall Study|Symptomatic Deterioration|0|||
33511423|NCT03800836|101770256|FG002|Overall Study|Symptomatic Deterioration|1|||
33511424|NCT03800836|101770257|FG003|Overall Study|Symptomatic Deterioration|0|||
33511425|NCT03800836|101770258|FG004|Overall Study|Symptomatic Deterioration|0|||
33511426|NCT03800836|101770259|FG005|Overall Study|Symptomatic Deterioration|0|||
33511427|NCT03891862|101770261|FG000|Open-label Period|Adverse Event|2|||
33511428|NCT03891862|101770262|FG001|Open-label Period|Adverse Event|0|||
33511429|NCT03891862|101770263|FG002|Open-label Period|Adverse Event|0|||
33511430|NCT03891862|101770261|FG000|Open-label Period|Protocol Violation|5|||
33511431|NCT03891862|101770262|FG001|Open-label Period|Protocol Violation|0|||
33511432|NCT03891862|101770263|FG002|Open-label Period|Protocol Violation|0|||
33511433|NCT03891862|101770261|FG000|Open-label Period|Withdrawal by Subject|6|||
33511434|NCT03891862|101770262|FG001|Open-label Period|Withdrawal by Subject|0|||
33511435|NCT03891862|101770263|FG002|Open-label Period|Withdrawal by Subject|0|||
33511436|NCT03891862|101770261|FG000|Open-label Period|Death|1|||
33511437|NCT03891862|101770262|FG001|Open-label Period|Death|0|||
33511438|NCT03891862|101770263|FG002|Open-label Period|Death|0|||
33511439|NCT03891862|101770261|FG000|Open-label Period|Lost to Follow-up|2|||
33511440|NCT03891862|101770262|FG001|Open-label Period|Lost to Follow-up|0|||
33511441|NCT03891862|101770263|FG002|Open-label Period|Lost to Follow-up|0|||
33511442|NCT03891862|101770261|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
33511443|NCT03891862|101770262|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
33511444|NCT03891862|101770263|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
33511445|NCT03891862|101770261|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
33511446|NCT03891862|101770262|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
33511447|NCT03891862|101770263|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
33511448|NCT03891862|101770261|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
33511449|NCT03891862|101770262|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
33511450|NCT03891862|101770263|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
33511451|NCT03891862|101770261|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
33511452|NCT03891862|101770262|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
33511453|NCT03891862|101770263|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
33511454|NCT03403751|101770269|FG000|Overall Study|Death|5|||
33511455|NCT03403751|101770270|FG001|Overall Study|Death|6|||
33511456|NCT03403751|101770269|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
33511457|NCT03403751|101770270|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
33511458|NCT01647516|101770272|FG000|Induction Period (IP)|Physician Decision|2|||
33511459|NCT01647516|101770273|FG001|Induction Period (IP)|Physician Decision|0|||
33511460|NCT01647516|101770274|FG002|Induction Period (IP)|Physician Decision|0|||
33511461|NCT01647516|101770275|FG003|Induction Period (IP)|Physician Decision|0|||
33511462|NCT01647516|101770276|FG004|Induction Period (IP)|Physician Decision|0|||
33511463|NCT01647516|101770277|FG005|Induction Period (IP)|Physician Decision|0|||
33511464|NCT01647516|101770272|FG000|Induction Period (IP)|Adverse Event|1|||
33511465|NCT01647516|101770273|FG001|Induction Period (IP)|Adverse Event|2|||
33511466|NCT01647516|101770274|FG002|Induction Period (IP)|Adverse Event|0|||
33511467|NCT01647516|101770275|FG003|Induction Period (IP)|Adverse Event|0|||
33511468|NCT01647516|101770276|FG004|Induction Period (IP)|Adverse Event|0|||
33511469|NCT01647516|101770277|FG005|Induction Period (IP)|Adverse Event|0|||
33511470|NCT01647516|101770272|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
33511471|NCT01647516|101770273|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
33511472|NCT01647516|101770274|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
33511473|NCT01647516|101770275|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
33511474|NCT01647516|101770276|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
33511475|NCT01647516|101770277|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
33511476|NCT01647516|101770272|FG000|Induction Period (IP)|Participant Choice|0|||
33511477|NCT01647516|101770273|FG001|Induction Period (IP)|Participant Choice|0|||
33511478|NCT01647516|101770274|FG002|Induction Period (IP)|Participant Choice|1|||
33511479|NCT01647516|101770275|FG003|Induction Period (IP)|Participant Choice|0|||
33511480|NCT01647516|101770276|FG004|Induction Period (IP)|Participant Choice|0|||
33511481|NCT01647516|101770277|FG005|Induction Period (IP)|Participant Choice|0|||
33511482|NCT01647516|101770272|FG000|Induction Period (IP)|Lack of Efficacy|1|||
33511483|NCT01647516|101770273|FG001|Induction Period (IP)|Lack of Efficacy|0|||
33511484|NCT01647516|101770274|FG002|Induction Period (IP)|Lack of Efficacy|0|||
33511485|NCT01647516|101770275|FG003|Induction Period (IP)|Lack of Efficacy|0|||
33511486|NCT01647516|101770276|FG004|Induction Period (IP)|Lack of Efficacy|0|||
33511487|NCT01647516|101770277|FG005|Induction Period (IP)|Lack of Efficacy|0|||
33511488|NCT01647516|101770272|FG000|Induction Period (IP)|No study drug received|1|||
33511489|NCT01647516|101770273|FG001|Induction Period (IP)|No study drug received|1|||
33511490|NCT01647516|101770274|FG002|Induction Period (IP)|No study drug received|0|||
33511491|NCT01647516|101770275|FG003|Induction Period (IP)|No study drug received|0|||
33511492|NCT01647516|101770276|FG004|Induction Period (IP)|No study drug received|0|||
33605536|NCT02905006|102105594|FG001|Overall Study|Subject positive for Hep B|0|||
33605537|NCT02905006|102105595|FG002|Overall Study|Subject positive for Hep B|1|||
33322151|NCT05671653|101074805|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
33322152|NCT05671653|101074806|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
33322153|NCT05671653|101074807|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
33322154|NCT05671653|101074808|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
33322155|NCT05671653|101074809|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
33322156|NCT05671653|101074797|FG000|Cohort 2 Period 2|Other|0|||
33322157|NCT05671653|101074798|FG001|Cohort 2 Period 2|Other|0|||
33322158|NCT05671653|101074799|FG002|Cohort 2 Period 2|Other|0|||
33322159|NCT05671653|101074800|FG003|Cohort 2 Period 2|Other|0|||
33322160|NCT05671653|101074801|FG004|Cohort 2 Period 2|Other|0|||
33322161|NCT05671653|101074802|FG005|Cohort 2 Period 2|Other|0|||
33322162|NCT05671653|101074803|FG006|Cohort 2 Period 2|Other|0|||
33322163|NCT05671653|101074804|FG007|Cohort 2 Period 2|Other|0|||
33322164|NCT05671653|101074805|FG008|Cohort 2 Period 2|Other|0|||
33322165|NCT05671653|101074806|FG009|Cohort 2 Period 2|Other|0|||
33322166|NCT05671653|101074807|FG010|Cohort 2 Period 2|Other|1|||
33322167|NCT05671653|101074808|FG011|Cohort 2 Period 2|Other|0|||
33322168|NCT05671653|101074809|FG012|Cohort 2 Period 2|Other|0|||
33322169|NCT05671653|101074797|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
33322170|NCT05671653|101074798|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
33322171|NCT05671653|101074799|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
33322172|NCT05671653|101074800|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
33322173|NCT05671653|101074801|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
33605538|NCT02905006|102105596|FG003|Overall Study|Subject positive for Hep B|0|||
33605539|NCT02905006|102105597|FG004|Overall Study|Subject positive for Hep B|0|||
33605540|NCT02905006|102105598|FG005|Overall Study|Subject positive for Hep B|0|||
33605541|NCT02905006|102105593|FG000|Overall Study|Patient moved abroad|0|||
33605542|NCT02905006|102105594|FG001|Overall Study|Patient moved abroad|0|||
33605543|NCT02905006|102105595|FG002|Overall Study|Patient moved abroad|0|||
33605544|NCT02905006|102105596|FG003|Overall Study|Patient moved abroad|1|||
33605545|NCT02905006|102105597|FG004|Overall Study|Patient moved abroad|0|||
33605546|NCT02905006|102105598|FG005|Overall Study|Patient moved abroad|0|||
33322174|NCT05671653|101074802|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
33322175|NCT05671653|101074803|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
33322176|NCT05671653|101074804|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
33322177|NCT05671653|101074805|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
33322178|NCT05671653|101074806|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
33322179|NCT05671653|101074807|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
33322180|NCT05671653|101074808|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
33322181|NCT05671653|101074809|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
33322182|NCT03876171|101074810|FG000|Overall Study|Withdrawal by Subject|3|||
33322183|NCT03876171|101074811|FG001|Overall Study|Withdrawal by Subject|3|||
33605547|NCT02905006|102105593|FG000|Overall Study|Patient randomized by mistake|0|||
33605548|NCT02905006|102105594|FG001|Overall Study|Patient randomized by mistake|0|||
33605549|NCT02905006|102105595|FG002|Overall Study|Patient randomized by mistake|0|||
33322184|NCT03876171|101074810|FG000|Overall Study|Re-arrest|0|||
33322185|NCT03876171|101074811|FG001|Overall Study|Re-arrest|4|||
33322186|NCT01572922|101074814|FG000|Overall Study|Adverse Event|1|||
33322187|NCT01572922|101074814|FG000|Overall Study|Protocol Violation|1|||
33322188|NCT01572922|101074814|FG000|Overall Study|Death|1|||
33511493|NCT01647516|101770277|FG005|Induction Period (IP)|No study drug received|0|||
33511494|NCT01647516|101770272|FG000|Maintenance Period (MP)|Adverse Event|2|||
33511495|NCT01647516|101770273|FG001|Maintenance Period (MP)|Adverse Event|1|||
33605550|NCT02905006|102105596|FG003|Overall Study|Patient randomized by mistake|0|||
33322189|NCT00403754|101074817|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
33322190|NCT00403754|101074818|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
33322191|NCT00403754|101074819|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
33322192|NCT00403754|101074820|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
33322193|NCT00403754|101074817|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
33322194|NCT00403754|101074818|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
33322195|NCT00403754|101074819|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
33322196|NCT00403754|101074820|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
33322197|NCT03953508|101074821|FG000|Baseline|Lost to Follow-up|3|||
33322198|NCT03953508|101074822|FG001|Baseline|Lost to Follow-up|2|||
33322199|NCT03953508|101074821|FG000|6-month Follow-up|Lost to Follow-up|62|||
33322200|NCT03953508|101074822|FG001|6-month Follow-up|Lost to Follow-up|70|||
33322201|NCT03878446|101074823|FG000|Overall Study|Withdrawn by parent or guardian|1|||
33322202|NCT03878446|101074824|FG001|Overall Study|Withdrawn by parent or guardian|0|||
33322203|NCT03878446|101074825|FG002|Overall Study|Withdrawn by parent or guardian|0|||
33322204|NCT03878446|101074826|FG003|Overall Study|Withdrawn by parent or guardian|0|||
33322205|NCT03878446|101074827|FG004|Overall Study|Withdrawn by parent or guardian|0|||
33322206|NCT06065735|101074830|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
33322207|NCT06065735|101074831|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
33322208|NCT06065735|101074832|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
33322209|NCT06065735|101074830|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
33322210|NCT06065735|101074831|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
33322211|NCT06065735|101074832|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
33322212|NCT06065735|101074830|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
33322213|NCT06065735|101074831|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
33322214|NCT06065735|101074832|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
33605551|NCT02905006|102105597|FG004|Overall Study|Patient randomized by mistake|0|||
33605552|NCT02905006|102105598|FG005|Overall Study|Patient randomized by mistake|1|||
33605553|NCT00521222|102105599|FG000|Overall Study|Lost to Follow-up|0|||
33605554|NCT00521222|102105600|FG001|Overall Study|Lost to Follow-up|0|||
33605555|NCT00521222|102105601|FG002|Overall Study|Lost to Follow-up|1|||
33605556|NCT00521222|102105602|FG003|Overall Study|Lost to Follow-up|1|||
33322215|NCT06065735|101074830|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
33322216|NCT06065735|101074831|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
33322217|NCT06065735|101074832|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
33322218|NCT06065735|101074830|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
33322219|NCT06065735|101074831|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
33322220|NCT06065735|101074832|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
33322221|NCT01889238|101074833|FG000|Overall Study|Death|1|||
33322222|NCT01889238|101074833|FG000|Overall Study|Withdrawal by Subject|1|||
33322223|NCT01889238|101074833|FG000|Overall Study|Adverse Event|6|||
33322224|NCT01889238|101074833|FG000|Overall Study|Disease Progression|104|||
33322225|NCT01889238|101074833|FG000|Overall Study|Other|6|||
33322226|NCT03039023|101074834|FG000|Overall Study|Withdrawal by Subject|1|||
33322227|NCT03039023|101074835|FG001|Overall Study|Withdrawal by Subject|0|||
33322228|NCT03039023|101074836|FG002|Overall Study|Withdrawal by Subject|1|||
33322229|NCT03039023|101074837|FG003|Overall Study|Withdrawal by Subject|1|||
33322230|NCT03039023|101074838|FG004|Overall Study|Withdrawal by Subject|0|||
33322231|NCT03039023|101074834|FG000|Overall Study|Physician Decision|0|||
33322232|NCT03039023|101074835|FG001|Overall Study|Physician Decision|0|||
33322233|NCT03039023|101074836|FG002|Overall Study|Physician Decision|0|||
33322234|NCT03039023|101074837|FG003|Overall Study|Physician Decision|1|||
33322235|NCT03039023|101074838|FG004|Overall Study|Physician Decision|0|||
33322236|NCT02243865|101074839|FG000|Overall Study|Protocol Violation|1|||
33322237|NCT02243865|101074840|FG001|Overall Study|Protocol Violation|3|||
33322238|NCT02243865|101074839|FG000|Overall Study|Lost to Follow-up|1|||
33322239|NCT02243865|101074840|FG001|Overall Study|Lost to Follow-up|1|||
33605557|NCT00521222|102105599|FG000|Overall Study|Withdrawal by Subject|0|||
33605558|NCT00521222|102105600|FG001|Overall Study|Withdrawal by Subject|0|||
33605559|NCT00521222|102105601|FG002|Overall Study|Withdrawal by Subject|2|||
33605560|NCT00521222|102105602|FG003|Overall Study|Withdrawal by Subject|0|||
33605561|NCT00521222|102105599|FG000|Overall Study|Physician Decision|0|||
33605562|NCT00521222|102105600|FG001|Overall Study|Physician Decision|1|||
33605563|NCT00521222|102105601|FG002|Overall Study|Physician Decision|0|||
33605564|NCT00521222|102105602|FG003|Overall Study|Physician Decision|1|||
33605565|NCT02726945|102105605|FG000|Overall Study|Withdrawal by Subject|0|||
33605566|NCT02726945|102105606|FG001|Overall Study|Withdrawal by Subject|0|||
33322240|NCT02243865|101074839|FG000|Overall Study|Withdrawal by Subject|1|||
33322241|NCT02243865|101074840|FG001|Overall Study|Withdrawal by Subject|0|||
33322242|NCT02243865|101074839|FG000|Overall Study|Adverse Event|1|||
33322243|NCT02243865|101074840|FG001|Overall Study|Adverse Event|1|||
33322244|NCT01034540|101074845|FG000|Overall Study|Adverse Event|0|||
33322245|NCT01034540|101074846|FG001|Overall Study|Adverse Event|1|||
33322246|NCT05323084|101074858|FG000|Period 2 - Washout|Lost to Follow-up|0|||
33322247|NCT05323084|101074859|FG001|Period 2 - Washout|Lost to Follow-up|1|||
33605567|NCT02726945|102105607|FG002|Overall Study|Withdrawal by Subject|1|||
33605568|NCT02726945|102105605|FG000|Overall Study|Elected to have total knee replacement|0|||
33605569|NCT02726945|102105606|FG001|Overall Study|Elected to have total knee replacement|1|||
33605570|NCT02726945|102105607|FG002|Overall Study|Elected to have total knee replacement|0|||
33605571|NCT01266317|102105608|FG000|Overall Study|Withdrawal by Subject|2|||
33605572|NCT01581619|102105609|FG000|Overall Study|Withdrawal by Subject|1|||
33605573|NCT01581619|102105609|FG000|Overall Study|Lost to Follow-up|1|||
33605574|NCT02456857|102105614|FG000|Overall Study|Disease Progression|4|||
33605575|NCT00129961|102105615|FG000|Overall Study|Adverse Event|1|||
33605576|NCT00129961|102105616|FG001|Overall Study|Adverse Event|0|||
33605577|NCT00129961|102105615|FG000|Overall Study|Death|1|||
33605578|NCT00129961|102105616|FG001|Overall Study|Death|1|||
33605579|NCT00129961|102105615|FG000|Overall Study|Withdrawal by Sponsor|14|||
33605580|NCT00129961|102105616|FG001|Overall Study|Withdrawal by Sponsor|20|||
33605581|NCT00129961|102105615|FG000|Overall Study|Physician Decision|1|||
33605582|NCT00129961|102105616|FG001|Overall Study|Physician Decision|0|||
33605583|NCT00129961|102105615|FG000|Overall Study|Withdrawal by Subject|2|||
33605584|NCT00129961|102105616|FG001|Overall Study|Withdrawal by Subject|1|||
33605585|NCT00129961|102105615|FG000|Overall Study|Missing Record|0|||
33605586|NCT00129961|102105616|FG001|Overall Study|Missing Record|1|||
33605587|NCT00428844|102105617|FG000|Completed Study Drug Treatment|Adverse Event|2|||
33605588|NCT00428844|102105618|FG001|Completed Study Drug Treatment|Adverse Event|4|||
33605589|NCT00428844|102105619|FG002|Completed Study Drug Treatment|Adverse Event|4|||
33605590|NCT00428844|102105617|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
33605591|NCT00428844|102105618|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
33605592|NCT00428844|102105619|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
33605593|NCT00428844|102105617|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
33605594|NCT00428844|102105618|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
33605595|NCT00428844|102105619|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
33605596|NCT00428844|102105617|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
33605597|NCT00428844|102105618|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
33605598|NCT00428844|102105619|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
33605599|NCT00428844|102105617|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
33605600|NCT00428844|102105618|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
33322248|NCT01668719|101074865|FG000|Phase I|On treatment|1|||
33322249|NCT01668719|101074866|FG001|Phase I|On treatment|0|||
33322250|NCT01668719|101074867|FG002|Phase I|On treatment|0|||
33322251|NCT01668719|101074865|FG000|Phase I|Adverse Event|2|||
33322252|NCT01668719|101074866|FG001|Phase I|Adverse Event|0|||
33322253|NCT01668719|101074867|FG002|Phase I|Adverse Event|0|||
33322254|NCT01668719|101074865|FG000|Phase I|Progression/relapse|1|||
33322255|NCT01668719|101074866|FG001|Phase I|Progression/relapse|0|||
33322256|NCT01668719|101074867|FG002|Phase I|Progression/relapse|0|||
33399063|NCT02394028|101350180|FG005|Induction Phase|Physician Decision|2|||
33399064|NCT02394028|101350181|FG006|Induction Phase|Physician Decision|1|||
33399065|NCT02394028|101350182|FG007|Induction Phase|Physician Decision|0|||
33399066|NCT02394028|101350183|FG008|Induction Phase|Physician Decision|0|||
33399067|NCT02394028|101350184|FG009|Induction Phase|Physician Decision|0|||
33399068|NCT02394028|101350185|FG010|Induction Phase|Physician Decision|0|||
33399069|NCT02394028|101350175|FG000|Induction Phase|Protocol Violation|0|||
33511496|NCT01647516|101770274|FG002|Maintenance Period (MP)|Adverse Event|0|||
33511497|NCT01647516|101770275|FG003|Maintenance Period (MP)|Adverse Event|0|||
33511498|NCT01647516|101770276|FG004|Maintenance Period (MP)|Adverse Event|0|||
33511499|NCT01647516|101770277|FG005|Maintenance Period (MP)|Adverse Event|0|||
33511500|NCT01647516|101770272|FG000|Maintenance Period (MP)|Non-compliance|1|||
33511501|NCT01647516|101770273|FG001|Maintenance Period (MP)|Non-compliance|0|||
33511502|NCT01647516|101770274|FG002|Maintenance Period (MP)|Non-compliance|0|||
33511503|NCT01647516|101770275|FG003|Maintenance Period (MP)|Non-compliance|0|||
33511504|NCT01647516|101770276|FG004|Maintenance Period (MP)|Non-compliance|0|||
33511505|NCT01647516|101770277|FG005|Maintenance Period (MP)|Non-compliance|0|||
33511506|NCT01647516|101770272|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
33511507|NCT01647516|101770273|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
33399070|NCT02394028|101350176|FG001|Induction Phase|Protocol Violation|2|||
33605601|NCT00428844|102105619|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
33605602|NCT00428844|102105617|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
33605603|NCT00428844|102105618|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
33605604|NCT00428844|102105619|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
33631277|NCT03279081|102202899|FG000|Overall Study|Adverse Event|1|||
33322257|NCT01668719|101074865|FG000|Phase I|not protocol specified|2|||
33322258|NCT01668719|101074866|FG001|Phase I|not protocol specified|0|||
33322259|NCT01668719|101074867|FG002|Phase I|not protocol specified|0|||
33399071|NCT02394028|101350177|FG002|Induction Phase|Protocol Violation|0|||
33399072|NCT02394028|101350178|FG003|Induction Phase|Protocol Violation|3|||
33511508|NCT01647516|101770274|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
33511509|NCT01647516|101770275|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
33322260|NCT01668719|101074865|FG000|Phase II|On treatment|0|||
33322261|NCT01668719|101074866|FG001|Phase II|On treatment|4|||
33322262|NCT01668719|101074867|FG002|Phase II|On treatment|3|||
33322263|NCT01668719|101074865|FG000|Phase II|Adverse Event|0|||
33322264|NCT01668719|101074866|FG001|Phase II|Adverse Event|18|||
33322265|NCT01668719|101074867|FG002|Phase II|Adverse Event|18|||
33322266|NCT01668719|101074865|FG000|Phase II|Refusal unrelated to adverse event|0|||
33322267|NCT01668719|101074866|FG001|Phase II|Refusal unrelated to adverse event|4|||
33322268|NCT01668719|101074867|FG002|Phase II|Refusal unrelated to adverse event|1|||
33322269|NCT01668719|101074865|FG000|Phase II|Progression/relapse|0|||
33322270|NCT01668719|101074866|FG001|Phase II|Progression/relapse|13|||
33322271|NCT01668719|101074867|FG002|Phase II|Progression/relapse|17|||
33322272|NCT01668719|101074865|FG000|Phase II|Death|0|||
33322273|NCT01668719|101074866|FG001|Phase II|Death|0|||
33322274|NCT01668719|101074867|FG002|Phase II|Death|2|||
33322275|NCT01668719|101074865|FG000|Phase II|not protocol specified|0|||
33322276|NCT01668719|101074866|FG001|Phase II|not protocol specified|13|||
33322277|NCT01668719|101074867|FG002|Phase II|not protocol specified|7|||
33322278|NCT00757003|101074868|FG000|Overall Study|Death|33|||
33322279|NCT00757003|101074868|FG000|Overall Study|Lost to Follow-up|9|||
33322280|NCT00757003|101074868|FG000|Overall Study|Withdrawal by Subject|4|||
33322281|NCT00757003|101074868|FG000|Overall Study|Surgically explanted|2|||
33322282|NCT00757003|101074868|FG000|Overall Study|Not implanted|1|||
33322283|NCT04663737|101074872|FG000|Overall Study|Withdrawal by Subject|2|||
33322284|NCT04663737|101074873|FG001|Overall Study|Withdrawal by Subject|0|||
33322285|NCT04104321|101074874|FG000|Overall Study|didn't take the study drug|3|||
33322286|NCT01207596|101074875|FG000|Overall Study|Physician Decision|4|||
33322287|NCT01207596|101074875|FG000|Overall Study|Lack of Efficacy|1|||
33322288|NCT01207596|101074875|FG000|Overall Study|Adverse Event|3|||
33322289|NCT01207596|101074875|FG000|Overall Study|Withdrawal by Subject|1|||
33322290|NCT00504153|101074876|FG000|Overall Study|Withdrawal by Subject|1|||
33322291|NCT00504153|101074876|FG000|Overall Study|Adverse Event|4|||
33322292|NCT00504153|101074876|FG000|Overall Study|Death|1|||
33322293|NCT01294150|101074884|FG000|Overall Study|Physician Decision|2|||
33322294|NCT01294150|101074885|FG001|Overall Study|Physician Decision|2|||
33322295|NCT05085665|101074888|FG000|Overall Study|Physician Decision|2|||
33322296|NCT00450216|101074889|FG000|Overall Study|Adverse Event|38|||
33322297|NCT00450216|101074890|FG001|Overall Study|Adverse Event|23|||
33322298|NCT00450216|101074889|FG000|Overall Study|Withdrawal by Subject|48|||
33322299|NCT00450216|101074890|FG001|Overall Study|Withdrawal by Subject|26|||
33322300|NCT00450216|101074889|FG000|Overall Study|Lost to Follow-up|16|||
33322301|NCT00450216|101074890|FG001|Overall Study|Lost to Follow-up|9|||
33322302|NCT00450216|101074889|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
33322303|NCT00450216|101074890|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
33322304|NCT00450216|101074889|FG000|Overall Study|misc|21|||
33322305|NCT00450216|101074890|FG001|Overall Study|misc|20|||
33322306|NCT04047797|101074897|FG000|Overall Study|Progressive Disease|1|||
33322307|NCT00450658|101074898|FG000|Overall Study|Adverse Event|24|||
33322308|NCT00450658|101074899|FG001|Overall Study|Adverse Event|15|||
33322309|NCT00450658|101074898|FG000|Overall Study|Withdrawal by Subject|43|||
33322310|NCT00450658|101074899|FG001|Overall Study|Withdrawal by Subject|26|||
33322311|NCT00450658|101074898|FG000|Overall Study|Lost to Follow-up|22|||
33322312|NCT00450658|101074899|FG001|Overall Study|Lost to Follow-up|5|||
33322313|NCT00450658|101074898|FG000|Overall Study|UGI ulcer|33|||
33322314|NCT00450658|101074899|FG001|Overall Study|UGI ulcer|34|||
33322315|NCT00450658|101074898|FG000|Overall Study|misc|21|||
33322316|NCT00450658|101074899|FG001|Overall Study|misc|10|||
33322317|NCT00233363|101074911|FG000|Overall Study|Adverse Event|1|||
33322318|NCT00233363|101074912|FG001|Overall Study|Adverse Event|2|||
33322319|NCT00233363|101074911|FG000|Overall Study|Lack of Efficacy|0|||
33322320|NCT00233363|101074912|FG001|Overall Study|Lack of Efficacy|2|||
33322321|NCT00233363|101074911|FG000|Overall Study|Withdrawal by Subject|1|||
33399073|NCT02394028|101350179|FG004|Induction Phase|Protocol Violation|0|||
33399074|NCT02394028|101350180|FG005|Induction Phase|Protocol Violation|1|||
33511510|NCT01647516|101770276|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
33322322|NCT00233363|101074912|FG001|Overall Study|Withdrawal by Subject|1|||
33322323|NCT00233363|101074911|FG000|Overall Study|Aggravation of complication|1|||
33322324|NCT00233363|101074912|FG001|Overall Study|Aggravation of complication|0|||
33322325|NCT01563185|101074919|FG000|Overall Study|Withdrawal by Subject|1|||
33322326|NCT01563185|101074919|FG000|Overall Study|Non-Compliance with study drug|1|||
33322327|NCT01287364|101074920|FG000|Overall Study|Adverse Event|0|||
33322328|NCT01287364|101074921|FG001|Overall Study|Adverse Event|3|||
33322329|NCT01287364|101074920|FG000|Overall Study|Protocol Violation|5|||
33322330|NCT01287364|101074921|FG001|Overall Study|Protocol Violation|5|||
33322331|NCT01287364|101074920|FG000|Overall Study|Other Reason|4|||
33322332|NCT01287364|101074921|FG001|Overall Study|Other Reason|2|||
33322333|NCT01701674|101074922|FG000|Overall Study|Unable to safely complete treatment|1|||
33322334|NCT01205438|101074923|FG000|Overall Study|Adverse Event|19|||
33322335|NCT01205438|101074924|FG001|Overall Study|Adverse Event|17|||
33322336|NCT01205438|101074925|FG002|Overall Study|Adverse Event|24|||
33322337|NCT01205438|101074923|FG000|Overall Study|Death|1|||
33322338|NCT01205438|101074924|FG001|Overall Study|Death|1|||
33322339|NCT01205438|101074925|FG002|Overall Study|Death|3|||
33322340|NCT01205438|101074923|FG000|Overall Study|Entry Criteria Not Met|16|||
33322341|NCT01205438|101074924|FG001|Overall Study|Entry Criteria Not Met|15|||
33322342|NCT01205438|101074925|FG002|Overall Study|Entry Criteria Not Met|13|||
33322343|NCT01205438|101074923|FG000|Overall Study|Lack of Efficacy|14|||
33322344|NCT01205438|101074924|FG001|Overall Study|Lack of Efficacy|11|||
33322345|NCT01205438|101074925|FG002|Overall Study|Lack of Efficacy|14|||
33322346|NCT01205438|101074923|FG000|Overall Study|Lost to Follow-up|6|||
33322347|NCT01205438|101074924|FG001|Overall Study|Lost to Follow-up|7|||
33322348|NCT01205438|101074925|FG002|Overall Study|Lost to Follow-up|8|||
33322349|NCT01205438|101074923|FG000|Overall Study|Withdrawal by Subject|19|||
33322350|NCT01205438|101074924|FG001|Overall Study|Withdrawal by Subject|25|||
33322351|NCT01205438|101074925|FG002|Overall Study|Withdrawal by Subject|19|||
33322352|NCT01205438|101074923|FG000|Overall Study|Physician Decision|0|||
33322353|NCT01205438|101074924|FG001|Overall Study|Physician Decision|3|||
33322354|NCT01205438|101074925|FG002|Overall Study|Physician Decision|2|||
33322355|NCT01205438|101074923|FG000|Overall Study|Protocol Violation|2|||
33322356|NCT01205438|101074924|FG001|Overall Study|Protocol Violation|7|||
33322357|NCT01205438|101074925|FG002|Overall Study|Protocol Violation|4|||
33322358|NCT01205438|101074923|FG000|Overall Study|Sponsor Decision|0|||
33322359|NCT01205438|101074924|FG001|Overall Study|Sponsor Decision|1|||
33322360|NCT01205438|101074925|FG002|Overall Study|Sponsor Decision|1|||
33322361|NCT03519867|101074928|FG000|Overall Study|Adverse Event|1|||
33322362|NCT03519867|101074929|FG001|Overall Study|Adverse Event|1|||
33322363|NCT03519867|101074930|FG002|Overall Study|Adverse Event|0|||
33322364|NCT03519867|101074931|FG003|Overall Study|Adverse Event|0|||
33322365|NCT03519867|101074932|FG004|Overall Study|Adverse Event|0|||
33322366|NCT03519867|101074933|FG005|Overall Study|Adverse Event|0|||
33322367|NCT03519867|101074934|FG006|Overall Study|Adverse Event|0|||
33322368|NCT03519867|101074935|FG007|Overall Study|Adverse Event|0|||
33322369|NCT03519867|101074936|FG008|Overall Study|Adverse Event|0|||
33322370|NCT03519867|101074937|FG009|Overall Study|Adverse Event|0|||
33322371|NCT03519867|101074928|FG000|Overall Study|Protocol Violation|0|||
33322372|NCT03519867|101074929|FG001|Overall Study|Protocol Violation|0|||
33322373|NCT03519867|101074930|FG002|Overall Study|Protocol Violation|0|||
33322374|NCT03519867|101074931|FG003|Overall Study|Protocol Violation|0|||
33322375|NCT03519867|101074932|FG004|Overall Study|Protocol Violation|0|||
33322376|NCT03519867|101074933|FG005|Overall Study|Protocol Violation|1|||
33322377|NCT03519867|101074934|FG006|Overall Study|Protocol Violation|0|||
33322378|NCT03519867|101074935|FG007|Overall Study|Protocol Violation|0|||
33322379|NCT03519867|101074936|FG008|Overall Study|Protocol Violation|0|||
33322380|NCT03519867|101074937|FG009|Overall Study|Protocol Violation|0|||
33322381|NCT03519867|101074928|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33322382|NCT03519867|101074929|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33322383|NCT03519867|101074930|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33322384|NCT03519867|101074931|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33322385|NCT03519867|101074932|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33322386|NCT03519867|101074933|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33511511|NCT01647516|101770277|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
33511512|NCT01647516|101770272|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
33511513|NCT01647516|101770273|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
33322387|NCT03519867|101074934|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
33322388|NCT03519867|101074935|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33322389|NCT03519867|101074936|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33322390|NCT03519867|101074937|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
33322391|NCT03519867|101074928|FG000|Overall Study|Admin. of other reversal agent|1|||
33322392|NCT03519867|101074929|FG001|Overall Study|Admin. of other reversal agent|1|||
33322393|NCT03519867|101074930|FG002|Overall Study|Admin. of other reversal agent|0|||
33511514|NCT01647516|101770274|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
33322394|NCT03519867|101074931|FG003|Overall Study|Admin. of other reversal agent|0|||
33322395|NCT03519867|101074932|FG004|Overall Study|Admin. of other reversal agent|0|||
33322396|NCT03519867|101074933|FG005|Overall Study|Admin. of other reversal agent|1|||
33322397|NCT03519867|101074934|FG006|Overall Study|Admin. of other reversal agent|0|||
33322398|NCT03519867|101074935|FG007|Overall Study|Admin. of other reversal agent|0|||
33322399|NCT03519867|101074936|FG008|Overall Study|Admin. of other reversal agent|0|||
33322400|NCT03519867|101074937|FG009|Overall Study|Admin. of other reversal agent|0|||
33511515|NCT01647516|101770275|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
33198131|NCT01677195|100630383|FG000|Overall Study|Physician Decision|1|||
33322401|NCT03519867|101074928|FG000|Overall Study|Reason not provided|1|||
33322402|NCT03519867|101074929|FG001|Overall Study|Reason not provided|1|||
33322403|NCT03519867|101074930|FG002|Overall Study|Reason not provided|1|||
33322404|NCT03519867|101074931|FG003|Overall Study|Reason not provided|1|||
33322405|NCT03519867|101074932|FG004|Overall Study|Reason not provided|0|||
33322406|NCT03519867|101074933|FG005|Overall Study|Reason not provided|1|||
33605605|NCT00428844|102105617|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
33605606|NCT00428844|102105618|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
33605607|NCT00428844|102105619|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
33605608|NCT00428844|102105617|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
33605609|NCT00428844|102105618|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
33605610|NCT00428844|102105619|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
33605611|NCT00428844|102105617|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
33605612|NCT00428844|102105618|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
33322407|NCT03519867|101074934|FG006|Overall Study|Reason not provided|0|||
33322408|NCT03519867|101074935|FG007|Overall Study|Reason not provided|1|||
33322409|NCT03519867|101074936|FG008|Overall Study|Reason not provided|1|||
33322410|NCT03519867|101074937|FG009|Overall Study|Reason not provided|0|||
33322411|NCT01028222|101074938|FG000|Overall Study|Protocol deviation|1|||
33322412|NCT01028222|101074939|FG001|Overall Study|Protocol deviation|0|||
33322413|NCT01028222|101074938|FG000|Overall Study|Disease progression|33|||
33322414|NCT01028222|101074939|FG001|Overall Study|Disease progression|9|||
33322415|NCT01028222|101074938|FG000|Overall Study|Administrative problems|1|||
33322416|NCT01028222|101074939|FG001|Overall Study|Administrative problems|1|||
33322417|NCT01028222|101074938|FG000|Overall Study|Lost to Follow-up|0|||
33322418|NCT01028222|101074939|FG001|Overall Study|Lost to Follow-up|1|||
33322419|NCT01028222|101074938|FG000|Overall Study|Withdrawal by Subject|1|||
33322420|NCT01028222|101074939|FG001|Overall Study|Withdrawal by Subject|0|||
33322421|NCT01028222|101074938|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
33322422|NCT01028222|101074939|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
33322423|NCT01028222|101074938|FG000|Overall Study|Adverse Event|2|||
33322424|NCT01028222|101074939|FG001|Overall Study|Adverse Event|0|||
33322425|NCT00607880|101074940|FG000|Overall Study|Unable to place port due to occlusion|1|||
33322426|NCT00607880|101074941|FG001|Overall Study|Unable to place port due to occlusion|0|||
33322427|NCT00239226|101074942|FG000|Overall Study|permAF during stabilization period|0|||
33322428|NCT00239226|101074943|FG001|Overall Study|permAF during stabilization period|0|||
33322429|NCT00239226|101074944|FG002|Overall Study|permAF during stabilization period|0|||
33511516|NCT01647516|101770276|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
33511517|NCT01647516|101770277|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
33511518|NCT01647516|101770272|FG000|Open-Label Period|Adverse Event|0|||
33511519|NCT01647516|101770273|FG001|Open-Label Period|Adverse Event|0|||
33322430|NCT00239226|101074945|FG003|Overall Study|permAF during stabilization period|3|||
33322431|NCT00239226|101074942|FG000|Overall Study|Lost to Follow-up|1|||
33322432|NCT00239226|101074943|FG001|Overall Study|Lost to Follow-up|0|||
33322433|NCT00239226|101074944|FG002|Overall Study|Lost to Follow-up|1|||
33322434|NCT00239226|101074945|FG003|Overall Study|Lost to Follow-up|0|||
33322435|NCT00132496|101074948|FG000|Overall Study|Withdrawal by Subject|1|||
33322436|NCT00132496|101074949|FG001|Overall Study|Withdrawal by Subject|2|||
33322437|NCT00132496|101074948|FG000|Overall Study|Physician Decision|1|||
33322438|NCT00132496|101074949|FG001|Overall Study|Physician Decision|0|||
33322439|NCT00458341|101077411|FG000|Cycle 1|Adverse Event|1|||
33322440|NCT00458341|101077412|FG001|Cycle 1|Adverse Event|0|||
33399075|NCT02394028|101350181|FG006|Induction Phase|Protocol Violation|1|||
33511520|NCT01647516|101770274|FG002|Open-Label Period|Adverse Event|0|||
33511521|NCT01647516|101770275|FG003|Open-Label Period|Adverse Event|5|||
33511522|NCT01647516|101770276|FG004|Open-Label Period|Adverse Event|6|||
33511523|NCT01647516|101770277|FG005|Open-Label Period|Adverse Event|3|||
33511524|NCT01647516|101770272|FG000|Open-Label Period|Pregnancy|0|||
33511525|NCT01647516|101770273|FG001|Open-Label Period|Pregnancy|0|||
33511526|NCT01647516|101770274|FG002|Open-Label Period|Pregnancy|0|||
33511527|NCT01647516|101770275|FG003|Open-Label Period|Pregnancy|0|||
33511528|NCT01647516|101770276|FG004|Open-Label Period|Pregnancy|0|||
33511529|NCT01647516|101770277|FG005|Open-Label Period|Pregnancy|1|||
33511530|NCT01647516|101770272|FG000|Open-Label Period|Non-compliance|0|||
33511531|NCT01647516|101770273|FG001|Open-Label Period|Non-compliance|0|||
33511532|NCT01647516|101770274|FG002|Open-Label Period|Non-compliance|0|||
33511533|NCT01647516|101770275|FG003|Open-Label Period|Non-compliance|1|||
33322441|NCT04683731|101077413|FG000|Overall Study|Withdrawal by Subject|1|||
33399076|NCT02394028|101350182|FG007|Induction Phase|Protocol Violation|0|||
33511534|NCT01647516|101770276|FG004|Open-Label Period|Non-compliance|0|||
33511535|NCT01647516|101770277|FG005|Open-Label Period|Non-compliance|1|||
33605613|NCT00428844|102105619|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
33605614|NCT04030247|102105620|FG000|Overall Study|Withdrawal by Subject|4|||
33322442|NCT04683731|101077414|FG001|Overall Study|Withdrawal by Subject|0|||
33322443|NCT04683731|101077415|FG002|Overall Study|Withdrawal by Subject|3|||
33322444|NCT04683731|101077416|FG003|Overall Study|Withdrawal by Subject|2|||
33322445|NCT04683731|101077413|FG000|Overall Study|Determined patient was not eligible|3|||
33322446|NCT04683731|101077414|FG001|Overall Study|Determined patient was not eligible|3|||
33511536|NCT01647516|101770272|FG000|Open-Label Period|Physician Decision|0|||
33511537|NCT01647516|101770273|FG001|Open-Label Period|Physician Decision|0|||
33511538|NCT01647516|101770274|FG002|Open-Label Period|Physician Decision|0|||
33511539|NCT01647516|101770275|FG003|Open-Label Period|Physician Decision|1|||
33511540|NCT01647516|101770276|FG004|Open-Label Period|Physician Decision|1|||
33511541|NCT01647516|101770277|FG005|Open-Label Period|Physician Decision|0|||
33511542|NCT01647516|101770272|FG000|Open-Label Period|Withdrawal by Subject|0|||
33511543|NCT01647516|101770273|FG001|Open-Label Period|Withdrawal by Subject|0|||
33511544|NCT01647516|101770274|FG002|Open-Label Period|Withdrawal by Subject|0|||
33511545|NCT01647516|101770275|FG003|Open-Label Period|Withdrawal by Subject|9|||
33511546|NCT01647516|101770276|FG004|Open-Label Period|Withdrawal by Subject|11|||
33511547|NCT01647516|101770277|FG005|Open-Label Period|Withdrawal by Subject|6|||
33511548|NCT01647516|101770272|FG000|Open-Label Period|Lost to Follow-up|0|||
33511549|NCT01647516|101770273|FG001|Open-Label Period|Lost to Follow-up|0|||
33511550|NCT01647516|101770274|FG002|Open-Label Period|Lost to Follow-up|0|||
33511551|NCT01647516|101770275|FG003|Open-Label Period|Lost to Follow-up|1|||
33511552|NCT01647516|101770276|FG004|Open-Label Period|Lost to Follow-up|0|||
33511553|NCT01647516|101770277|FG005|Open-Label Period|Lost to Follow-up|1|||
33511554|NCT01647516|101770272|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
33511555|NCT01647516|101770273|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
33511556|NCT01647516|101770274|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
33511557|NCT01647516|101770275|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
33511558|NCT01647516|101770276|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
33511559|NCT01647516|101770277|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
33511560|NCT01647516|101770272|FG000|Open-Label Period|Lack of Efficacy|0|||
33511561|NCT01647516|101770273|FG001|Open-Label Period|Lack of Efficacy|0|||
33511562|NCT01647516|101770274|FG002|Open-Label Period|Lack of Efficacy|0|||
33511563|NCT01647516|101770275|FG003|Open-Label Period|Lack of Efficacy|7|||
33511564|NCT01647516|101770276|FG004|Open-Label Period|Lack of Efficacy|9|||
33511565|NCT01647516|101770277|FG005|Open-Label Period|Lack of Efficacy|10|||
33511566|NCT01647516|101770272|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
33511567|NCT01647516|101770273|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
33511568|NCT01647516|101770274|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
33511569|NCT01647516|101770275|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
33511570|NCT01647516|101770276|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
33511571|NCT01647516|101770277|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
33511572|NCT01647516|101770272|FG000|Open-Label Period|No completion / discontinuation visit|0|||
33511573|NCT01647516|101770273|FG001|Open-Label Period|No completion / discontinuation visit|0|||
33511574|NCT01647516|101770274|FG002|Open-Label Period|No completion / discontinuation visit|0|||
33399077|NCT02394028|101350183|FG008|Induction Phase|Protocol Violation|0|||
33399078|NCT02394028|101350184|FG009|Induction Phase|Protocol Violation|0|||
33511575|NCT01647516|101770275|FG003|Open-Label Period|No completion / discontinuation visit|0|||
33511576|NCT01647516|101770276|FG004|Open-Label Period|No completion / discontinuation visit|2|||
33511577|NCT01647516|101770277|FG005|Open-Label Period|No completion / discontinuation visit|1|||
33322447|NCT04683731|101077415|FG002|Overall Study|Determined patient was not eligible|12|||
33322448|NCT04683731|101077416|FG003|Overall Study|Determined patient was not eligible|3|||
33322449|NCT05505045|101077417|FG000|Overall Study|Withdrawal by Subject|2|||
33322450|NCT05505045|101077418|FG001|Overall Study|Withdrawal by Subject|1|||
33511578|NCT02963558|101770280|FG000|Overall Study|Withdrawn by investigator|1|||
33605615|NCT04030247|102105620|FG000|Overall Study|Lost to Follow-up|13|||
33322451|NCT03952338|101077419|FG000|Overall Study|Lost to Follow-up|11|||
33322452|NCT03952338|101077420|FG001|Overall Study|Lost to Follow-up|17|||
33511579|NCT02963558|101770281|FG001|Overall Study|Withdrawn by investigator|0|||
33511580|NCT02963558|101770280|FG000|Overall Study|Withdrawal by Subject|0|||
33511581|NCT02963558|101770281|FG001|Overall Study|Withdrawal by Subject|1|||
33511582|NCT01968707|101770282|FG000|Overall Study|Did not meet treatment day baseline|49|||
33511583|NCT01968707|101770283|FG001|Overall Study|Did not meet treatment day baseline|12|||
33511584|NCT01968707|101770284|FG002|Overall Study|Did not meet treatment day baseline|41|||
33511585|NCT01968707|101770285|FG003|Overall Study|Did not meet treatment day baseline|44|||
33511586|NCT01968707|101770286|FG004|Overall Study|Did not meet treatment day baseline|36|||
33322453|NCT03952338|101077419|FG000|Overall Study|Withdrawal by Subject|1|||
33322454|NCT03952338|101077420|FG001|Overall Study|Withdrawal by Subject|1|||
33322455|NCT03952338|101077419|FG000|Overall Study|Protocol Violation|1|||
33322456|NCT03952338|101077420|FG001|Overall Study|Protocol Violation|0|||
33322457|NCT04622046|101077421|FG000|Intervention Period|Adverse Event|1|||
33322458|NCT04622046|101077421|FG000|Intervention Period|Withdrawal by Subject|2|||
33322459|NCT04622046|101077421|FG000|Extension Period|Ongoing in the Extension Period|21|||
33322460|NCT02811549|101077422|FG000|Overall Study|Lost to Follow-up|1|||
33511587|NCT01968707|101770287|FG005|Overall Study|Did not meet treatment day baseline|11|||
33511588|NCT01968707|101770288|FG006|Overall Study|Did not meet treatment day baseline|34|||
33511589|NCT01968707|101770289|FG007|Overall Study|Did not meet treatment day baseline|35|||
33511590|NCT02637895|101770290|FG000|Overall Study|Lost to Follow-up|4|||
33511591|NCT02637895|101770291|FG001|Overall Study|Lost to Follow-up|0|||
33605616|NCT02265796|102105622|FG000|Overall Study|Death|1|||
33605617|NCT02265796|102105623|FG001|Overall Study|Death|0|||
33605618|NCT02265796|102105622|FG000|Overall Study|started on excluded medication|1|||
33605619|NCT02265796|102105623|FG001|Overall Study|started on excluded medication|0|||
33605620|NCT02265796|102105622|FG000|Overall Study|Withdrawal by Subject|1|||
33605621|NCT02265796|102105623|FG001|Overall Study|Withdrawal by Subject|1|||
33605622|NCT00626405|102105625|FG000|Overall Study|Deemed Ineligible|1|||
33605623|NCT00626405|102105626|FG001|Overall Study|Deemed Ineligible|0|||
33605624|NCT00626405|102105625|FG000|Overall Study|Withdrawal by Subject|0|||
33605625|NCT00626405|102105626|FG001|Overall Study|Withdrawal by Subject|1|||
33605626|NCT03743064|102105627|FG000|Overall Study|Adverse Event|7|||
33605627|NCT03743064|102105628|FG001|Overall Study|Adverse Event|9|||
33605628|NCT03743064|102105627|FG000|Overall Study|Death|25|||
33605629|NCT03743064|102105628|FG001|Overall Study|Death|28|||
33605630|NCT03743064|102105627|FG000|Overall Study|Lost to Follow-up|3|||
33605631|NCT03743064|102105628|FG001|Overall Study|Lost to Follow-up|6|||
33605632|NCT03743064|102105627|FG000|Overall Study|Withdrawal by Subject|28|||
33605633|NCT03743064|102105628|FG001|Overall Study|Withdrawal by Subject|25|||
33605634|NCT03743064|102105627|FG000|Overall Study|Physician Decision|2|||
33605635|NCT03743064|102105628|FG001|Overall Study|Physician Decision|4|||
33605636|NCT03743064|102105627|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
33605637|NCT03743064|102105628|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
33605638|NCT03848949|102105629|FG000|Overall Study|Lost to Follow-up|5|||
33605639|NCT03848949|102105630|FG001|Overall Study|Lost to Follow-up|7|||
33605640|NCT00444067|102105632|FG000|Overall Study|Lost to Follow-up|0|||
33605641|NCT00444067|102105633|FG001|Overall Study|Lost to Follow-up|1|||
33605642|NCT00462748|102105634|FG000|Overall Study|Adverse Event|7|||
33605643|NCT00462748|102105635|FG001|Overall Study|Adverse Event|5|||
33605644|NCT00462748|102105636|FG002|Overall Study|Adverse Event|9|||
33605645|NCT00462748|102105634|FG000|Overall Study|Protocol Violation|0|||
33605646|NCT00462748|102105635|FG001|Overall Study|Protocol Violation|2|||
33605647|NCT00462748|102105636|FG002|Overall Study|Protocol Violation|1|||
33605648|NCT00462748|102105634|FG000|Overall Study|Withdrew consent|3|||
33605649|NCT00462748|102105635|FG001|Overall Study|Withdrew consent|3|||
33605650|NCT00462748|102105636|FG002|Overall Study|Withdrew consent|0|||
33605651|NCT00462748|102105634|FG000|Overall Study|Lost to Follow-up|1|||
33605652|NCT00462748|102105635|FG001|Overall Study|Lost to Follow-up|1|||
33605653|NCT00462748|102105636|FG002|Overall Study|Lost to Follow-up|1|||
33605654|NCT00462748|102105634|FG000|Overall Study|Discontinued after 41 days Rx|1|||
33322461|NCT02811549|101077422|FG000|Overall Study|Withdrawal by Subject|3|||
33605655|NCT00462748|102105635|FG001|Overall Study|Discontinued after 41 days Rx|0|||
33605656|NCT00462748|102105636|FG002|Overall Study|Discontinued after 41 days Rx|0|||
33605657|NCT00295932|102108151|FG000|Overall Study|Not Treated|0|||
33605658|NCT00295932|102108152|FG001|Overall Study|Not Treated|0|||
33605659|NCT00295932|102108153|FG002|Overall Study|Not Treated|0|||
33605660|NCT00295932|102108154|FG003|Overall Study|Not Treated|0|||
33322462|NCT02811549|101077422|FG000|Overall Study|Subject screen failed|4|||
33511592|NCT02637895|101770290|FG000|Overall Study|Protocol Violation|0|||
33511593|NCT02637895|101770291|FG001|Overall Study|Protocol Violation|1|||
33605661|NCT00295932|102108155|FG004|Overall Study|Not Treated|0|||
33605662|NCT00295932|102108156|FG005|Overall Study|Not Treated|0|||
33605663|NCT00295932|102108157|FG006|Overall Study|Not Treated|0|||
33605664|NCT00295932|102108158|FG007|Overall Study|Not Treated|0|||
33322463|NCT02811549|101077422|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
33322464|NCT04995419|101077423|FG000|Overall Study|Withdrawal by Subject|3|||
33322465|NCT04995419|101077423|FG000|Overall Study|Progressive Disease|19|||
33322466|NCT04995419|101077423|FG000|Overall Study|Adverse Event|2|||
33322467|NCT04995419|101077423|FG000|Overall Study|Ongoing|16|||
33322468|NCT04275297|101077427|FG000|Overall Study|Lost to Follow-up|1|||
33322469|NCT04275297|101077428|FG001|Overall Study|Lost to Follow-up|1|||
33322470|NCT01005745|101077429|FG000|Overall Study|No TIL growth|1|||
33322471|NCT01005745|101077429|FG000|Overall Study|Disease progressed during TIL growth|3|||
33322472|NCT01005745|101077429|FG000|Overall Study|Death prior to treatment|1|||
33322473|NCT01005745|101077429|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
33322474|NCT03781323|101077434|FG000|Overall Study|Withdrawal by Subject|1|||
33322475|NCT00108069|101077437|FG000|Overall Study|Never rec'd study drug|0|||
33322476|NCT00108069|101077438|FG001|Overall Study|Never rec'd study drug|1|||
33322477|NCT00108069|101077437|FG000|Overall Study|Adverse Event|1|||
33322478|NCT00108069|101077438|FG001|Overall Study|Adverse Event|1|||
33322479|NCT00108069|101077437|FG000|Overall Study|Withdrawal by Subject|1|||
33322480|NCT00108069|101077438|FG001|Overall Study|Withdrawal by Subject|0|||
33322481|NCT00108069|101077437|FG000|Overall Study|Death|1|||
33322482|NCT00108069|101077438|FG001|Overall Study|Death|0|||
33322483|NCT00108069|101077437|FG000|Overall Study|Progessive disease|27|||
33399079|NCT02394028|101350185|FG010|Induction Phase|Protocol Violation|0|||
33322484|NCT00108069|101077438|FG001|Overall Study|Progessive disease|11|||
33322485|NCT02708095|101077441|FG000|Overall Study|Adverse Event|4|||
33322486|NCT02708095|101077442|FG001|Overall Study|Adverse Event|10|||
33511594|NCT02637895|101770290|FG000|Overall Study|Lack of Efficacy|1|||
33322487|NCT02708095|101077443|FG002|Overall Study|Adverse Event|11|||
33322488|NCT02708095|101077441|FG000|Overall Study|Lack of Efficacy|9|||
33322489|NCT02708095|101077442|FG001|Overall Study|Lack of Efficacy|3|||
33322490|NCT02708095|101077443|FG002|Overall Study|Lack of Efficacy|0|||
33322491|NCT02708095|101077441|FG000|Overall Study|Lost to Follow-up|2|||
33322492|NCT02708095|101077442|FG001|Overall Study|Lost to Follow-up|0|||
33322493|NCT02708095|101077443|FG002|Overall Study|Lost to Follow-up|0|||
33322494|NCT02708095|101077441|FG000|Overall Study|Physician Decision|2|||
33322495|NCT02708095|101077442|FG001|Overall Study|Physician Decision|3|||
33322496|NCT02708095|101077443|FG002|Overall Study|Physician Decision|2|||
33322497|NCT02708095|101077441|FG000|Overall Study|Protocol Violation|0|||
33322498|NCT02708095|101077442|FG001|Overall Study|Protocol Violation|0|||
33322499|NCT02708095|101077443|FG002|Overall Study|Protocol Violation|1|||
33322500|NCT02708095|101077441|FG000|Overall Study|Withdrawal by Subject|5|||
33322501|NCT02708095|101077442|FG001|Overall Study|Withdrawal by Subject|3|||
33322502|NCT02708095|101077443|FG002|Overall Study|Withdrawal by Subject|4|||
33322503|NCT00935272|101077444|FG000|Overall Study|Lost to Follow-up|10|||
33322504|NCT00935272|101077445|FG001|Overall Study|Lost to Follow-up|3|||
33322505|NCT00935272|101077444|FG000|Overall Study|Withdrawal by Subject|8|||
33322506|NCT00935272|101077445|FG001|Overall Study|Withdrawal by Subject|2|||
33322507|NCT00935272|101077444|FG000|Overall Study|Physician Decision|1|||
33322508|NCT00935272|101077445|FG001|Overall Study|Physician Decision|0|||
33322509|NCT00935272|101077444|FG000|Overall Study|Protocol Violation|0|||
33322510|NCT00935272|101077445|FG001|Overall Study|Protocol Violation|1|||
33322511|NCT00995007|101077446|FG000|Overall Study|Withdrew consent|1|||
33322512|NCT00995007|101077447|FG001|Overall Study|Withdrew consent|0|||
33322513|NCT00995007|101077446|FG000|Overall Study|Refused further treatment|8|||
33322514|NCT00995007|101077447|FG001|Overall Study|Refused further treatment|2|||
33322515|NCT00995007|101077446|FG000|Overall Study|Toxicity|8|||
33322516|NCT00995007|101077447|FG001|Overall Study|Toxicity|0|||
33322517|NCT02060383|101077450|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
33322518|NCT02060383|101077451|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
33322519|NCT02060383|101077452|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
33322520|NCT02060383|101077453|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
33322521|NCT02060383|101077454|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
33322522|NCT02060383|101077450|FG000|Core Phase|Adverse Event|2|||
33322523|NCT02060383|101077451|FG001|Core Phase|Adverse Event|0|||
33322524|NCT02060383|101077452|FG002|Core Phase|Adverse Event|0|||
33322525|NCT02060383|101077453|FG003|Core Phase|Adverse Event|2|||
33322526|NCT02060383|101077454|FG004|Core Phase|Adverse Event|6|||
33322527|NCT02060383|101077450|FG000|Core Phase|Administrative problems|0|||
33322528|NCT02060383|101077451|FG001|Core Phase|Administrative problems|1|||
33322529|NCT02060383|101077452|FG002|Core Phase|Administrative problems|0|||
33322530|NCT02060383|101077453|FG003|Core Phase|Administrative problems|0|||
33322531|NCT02060383|101077454|FG004|Core Phase|Administrative problems|0|||
33322532|NCT02060383|101077450|FG000|Core Phase|Protocol Violation|0|||
33322533|NCT02060383|101077451|FG001|Core Phase|Protocol Violation|0|||
33322534|NCT02060383|101077452|FG002|Core Phase|Protocol Violation|0|||
33322535|NCT02060383|101077453|FG003|Core Phase|Protocol Violation|1|||
33322536|NCT02060383|101077454|FG004|Core Phase|Protocol Violation|0|||
33322537|NCT02060383|101077450|FG000|Core Phase|Withdrawal by Subject|0|||
33605665|NCT00295932|102108159|FG008|Overall Study|Not Treated|0|||
33605666|NCT00295932|102108160|FG009|Overall Study|Not Treated|0|||
33605667|NCT00295932|102108161|FG010|Overall Study|Not Treated|1|||
33605668|NCT01110382|102108176|FG000|Overall Study|Withdrawal by Subject|0|||
33322538|NCT02060383|101077451|FG001|Core Phase|Withdrawal by Subject|0|||
33322539|NCT02060383|101077452|FG002|Core Phase|Withdrawal by Subject|0|||
33322540|NCT02060383|101077453|FG003|Core Phase|Withdrawal by Subject|4|||
33322541|NCT02060383|101077454|FG004|Core Phase|Withdrawal by Subject|2|||
33322542|NCT02060383|101077450|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
33605669|NCT01110382|102108177|FG001|Overall Study|Withdrawal by Subject|1|||
33605670|NCT01110382|102108176|FG000|Overall Study|Protocol Violation|0|||
33322543|NCT02060383|101077451|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
33322544|NCT02060383|101077452|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
33322545|NCT02060383|101077453|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
33322546|NCT02060383|101077454|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
33322547|NCT02060383|101077450|FG000|Extension Phase|Adverse Event|1|||
33322548|NCT02060383|101077451|FG001|Extension Phase|Adverse Event|1|||
33322549|NCT02060383|101077452|FG002|Extension Phase|Adverse Event|2|||
33322550|NCT02060383|101077453|FG003|Extension Phase|Adverse Event|0|||
33605671|NCT01110382|102108177|FG001|Overall Study|Protocol Violation|1|||
33198132|NCT01677195|100630384|FG001|Overall Study|Physician Decision|2|||
33198133|NCT01677195|100630385|FG002|Overall Study|Physician Decision|2|||
33198134|NCT01677195|100630383|FG000|Overall Study|Pregnancy|0|||
33198135|NCT01677195|100630384|FG001|Overall Study|Pregnancy|1|||
33198136|NCT01677195|100630385|FG002|Overall Study|Pregnancy|0|||
33198137|NCT01677195|100630383|FG000|Overall Study|Protocol Violation|7|||
33198138|NCT01677195|100630384|FG001|Overall Study|Protocol Violation|3|||
33198139|NCT01677195|100630385|FG002|Overall Study|Protocol Violation|4|||
33198140|NCT05070897|100630386|FG000|Overall Study|Protocol Violation|123|||
33198141|NCT05070897|100630387|FG001|Overall Study|Protocol Violation|68|||
33198142|NCT04317586|100630388|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
33198143|NCT04317586|100630388|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
33198144|NCT04382326|100630389|FG000|Overall Study|Adverse Event, not serious|1|||
33198145|NCT04382326|100630390|FG001|Overall Study|Adverse Event, not serious|2|||
33198146|NCT04382326|100630389|FG000|Overall Study|Other|1|||
33198147|NCT04382326|100630390|FG001|Overall Study|Other|0|||
33198148|NCT04382326|100630389|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
33198149|NCT04382326|100630390|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
33198150|NCT04382326|100630389|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
33198151|NCT04382326|100630390|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
33198152|NCT04382326|100630389|FG000|Overall Study|Protocol Violation|29|||
33198153|NCT04382326|100630390|FG001|Overall Study|Protocol Violation|23|||
33198154|NCT04382326|100630389|FG000|Overall Study|Physician Decision|0|||
33198155|NCT04382326|100630390|FG001|Overall Study|Physician Decision|1|||
33198156|NCT04382326|100630389|FG000|Overall Study|Lost to Follow-up|48|||
33198157|NCT04382326|100630390|FG001|Overall Study|Lost to Follow-up|63|||
33198158|NCT04382326|100630389|FG000|Overall Study|Adverse Event, non-fatal|1|||
33198159|NCT04382326|100630390|FG001|Overall Study|Adverse Event, non-fatal|1|||
33198160|NCT04798586|100630391|FG000|Overall Study|Death|2|||
33198161|NCT03455855|100630392|FG000|Overall Study|Lost to Follow-up|4|||
33198162|NCT03455855|100630393|FG001|Overall Study|Lost to Follow-up|2|||
33198163|NCT03880578|100630394|FG000|Overall Study|Withdrawal by Subject|0|||
33198164|NCT03880578|100630395|FG001|Overall Study|Withdrawal by Subject|3|||
33198165|NCT03880578|100630396|FG002|Overall Study|Withdrawal by Subject|1|||
33198166|NCT03880578|100630394|FG000|Overall Study|Death|0|||
33198167|NCT03880578|100630395|FG001|Overall Study|Death|1|||
33198168|NCT03880578|100630396|FG002|Overall Study|Death|0|||
33198169|NCT00120042|100630397|FG000|Overall Study|all completed protocl|0|||
33198170|NCT00120042|100630398|FG001|Overall Study|all completed protocl|0|||
33198171|NCT00120042|100630399|FG002|Overall Study|all completed protocl|0|||
33198172|NCT02031276|100630404|FG000|Period 1 Double-blind IV|Adverse Event|6|||
33198173|NCT02031276|100630405|FG001|Period 1 Double-blind IV|Adverse Event|5|||
33198174|NCT02031276|100630406|FG002|Period 1 Double-blind IV|Adverse Event|1|||
33198175|NCT02031276|100630404|FG000|Period 1 Double-blind IV|Other|0|||
33198176|NCT02031276|100630405|FG001|Period 1 Double-blind IV|Other|1|||
33198177|NCT02031276|100630406|FG002|Period 1 Double-blind IV|Other|0|||
33198178|NCT02031276|100630404|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
33198179|NCT02031276|100630405|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
33198180|NCT02031276|100630406|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
33198181|NCT02031276|100630404|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
33198182|NCT02031276|100630405|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
33198183|NCT02031276|100630406|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
33198184|NCT02031276|100630404|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
33198185|NCT02031276|100630405|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
33198186|NCT02031276|100630406|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
33198187|NCT02031276|100630404|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
33198188|NCT02031276|100630405|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
33198189|NCT02031276|100630406|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
33198190|NCT02031276|100630404|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
33198191|NCT02031276|100630405|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
33198192|NCT02031276|100630406|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
33198193|NCT02031276|100630404|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
33198194|NCT02031276|100630405|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
33198195|NCT02031276|100630406|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
33198196|NCT02031276|100630404|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
33322551|NCT02060383|101077454|FG004|Extension Phase|Adverse Event|1|||
33322552|NCT02060383|101077450|FG000|Extension Phase|Withdrawal by Subject|0|||
33322553|NCT02060383|101077451|FG001|Extension Phase|Withdrawal by Subject|1|||
33322554|NCT02060383|101077452|FG002|Extension Phase|Withdrawal by Subject|0|||
33322555|NCT02060383|101077453|FG003|Extension Phase|Withdrawal by Subject|0|||
33322556|NCT02060383|101077454|FG004|Extension Phase|Withdrawal by Subject|2|||
33322557|NCT02060383|101077450|FG000|Extension Phase|Administrative problems|1|||
33322558|NCT02060383|101077451|FG001|Extension Phase|Administrative problems|0|||
33322559|NCT02060383|101077452|FG002|Extension Phase|Administrative problems|0|||
33322560|NCT02060383|101077453|FG003|Extension Phase|Administrative problems|0|||
33322561|NCT02060383|101077454|FG004|Extension Phase|Administrative problems|0|||
33322562|NCT02060383|101077450|FG000|Extension Phase|Death|0|||
33322563|NCT02060383|101077451|FG001|Extension Phase|Death|0|||
33322564|NCT02060383|101077452|FG002|Extension Phase|Death|1|||
33322565|NCT02060383|101077453|FG003|Extension Phase|Death|0|||
33322566|NCT02060383|101077454|FG004|Extension Phase|Death|1|||
33322567|NCT02060383|101077450|FG000|Extension Phase|Protocol Violation|0|||
33322568|NCT02060383|101077451|FG001|Extension Phase|Protocol Violation|0|||
33322569|NCT02060383|101077452|FG002|Extension Phase|Protocol Violation|0|||
33322570|NCT02060383|101077453|FG003|Extension Phase|Protocol Violation|0|||
33605672|NCT01792518|102108182|FG000|Overall Study|Adverse Event|3|||
33198197|NCT02031276|100630405|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
33322571|NCT02060383|101077454|FG004|Extension Phase|Protocol Violation|1|||
33322572|NCT02303704|101077455|FG000|Overall Study|Protocol Violation|5|||
33322573|NCT02303704|101077456|FG001|Overall Study|Protocol Violation|9|||
33322574|NCT01438151|101077457|FG000|Overall Study|study terminated|8|||
33322575|NCT03044886|101077458|FG000|Overall Study|Lost to Follow-up|15|||
33322576|NCT03044886|101077459|FG001|Overall Study|Lost to Follow-up|10|||
33322577|NCT03044886|101077460|FG002|Overall Study|Lost to Follow-up|12|||
33322578|NCT02462928|101077463|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
33322579|NCT02462928|101077464|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
33322580|NCT02462928|101077465|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
33322581|NCT02462928|101077463|FG000|Overall Study|Adverse Event|47|||
33322582|NCT02462928|101077464|FG001|Overall Study|Adverse Event|51|||
33322583|NCT02462928|101077465|FG002|Overall Study|Adverse Event|25|||
33322584|NCT02462928|101077463|FG000|Overall Study|Lack of Efficacy|3|||
33322585|NCT02462928|101077464|FG001|Overall Study|Lack of Efficacy|8|||
33322586|NCT02462928|101077465|FG002|Overall Study|Lack of Efficacy|3|||
33322587|NCT02462928|101077463|FG000|Overall Study|Lost to Follow-up|4|||
33322588|NCT02462928|101077464|FG001|Overall Study|Lost to Follow-up|4|||
33322589|NCT02462928|101077465|FG002|Overall Study|Lost to Follow-up|1|||
33322590|NCT02462928|101077463|FG000|Overall Study|Withdrawal by Patient|31|||
33322591|NCT02462928|101077464|FG001|Overall Study|Withdrawal by Patient|21|||
33322592|NCT02462928|101077465|FG002|Overall Study|Withdrawal by Patient|21|||
33322593|NCT02462928|101077463|FG000|Overall Study|Protocol Violation|0|||
33322594|NCT02462928|101077464|FG001|Overall Study|Protocol Violation|1|||
33322595|NCT02462928|101077465|FG002|Overall Study|Protocol Violation|0|||
33322596|NCT02462928|101077463|FG000|Overall Study|Reason not Specified|4|||
33322597|NCT02462928|101077464|FG001|Overall Study|Reason not Specified|6|||
33322598|NCT02462928|101077465|FG002|Overall Study|Reason not Specified|5|||
33322599|NCT01162239|101077468|FG000|Treatment Phase|Withdrawal by Subject|1|||
33322600|NCT01162239|101077469|FG001|Treatment Phase|Withdrawal by Subject|3|||
33322601|NCT01162239|101077470|FG002|Treatment Phase|Withdrawal by Subject|2|||
33322602|NCT01162239|101077471|FG003|Treatment Phase|Withdrawal by Subject|3|||
33322603|NCT01162239|101077468|FG000|Treatment Phase|Death|0|||
33322604|NCT01162239|101077469|FG001|Treatment Phase|Death|0|||
33322605|NCT01162239|101077470|FG002|Treatment Phase|Death|0|||
33322606|NCT01162239|101077471|FG003|Treatment Phase|Death|1|||
33322607|NCT01162239|101077468|FG000|Treatment Phase|Lost to Follow-up|5|||
33322608|NCT01162239|101077469|FG001|Treatment Phase|Lost to Follow-up|4|||
33322609|NCT01162239|101077470|FG002|Treatment Phase|Lost to Follow-up|2|||
33322610|NCT01162239|101077471|FG003|Treatment Phase|Lost to Follow-up|1|||
33322611|NCT01162239|101077468|FG000|Extended Follow-up|Lost to Follow-up|8|||
33399080|NCT02394028|101350175|FG000|Induction Phase|Withdrawal by Subject|1|||
33605673|NCT01792518|102108183|FG001|Overall Study|Adverse Event|4|||
33605674|NCT01792518|102108182|FG000|Overall Study|Protocol Violation|0|||
33605675|NCT01792518|102108183|FG001|Overall Study|Protocol Violation|1|||
33322612|NCT01162239|101077469|FG001|Extended Follow-up|Lost to Follow-up|13|||
33322613|NCT01162239|101077470|FG002|Extended Follow-up|Lost to Follow-up|8|||
33322614|NCT01162239|101077471|FG003|Extended Follow-up|Lost to Follow-up|6|||
33322615|NCT01211535|101077472|FG000|Overall Study|Adverse Event|0|||
33322616|NCT01211535|101077473|FG001|Overall Study|Adverse Event|1|||
33322617|NCT00908583|101077474|FG000|Phase 1|Withdrawal by Subject|1|||
33322618|NCT00908583|101077474|FG000|Phase 1|Adverse Event|4|||
33322619|NCT00908583|101077474|FG000|Phase 2|Physician Decision|1|||
33322620|NCT00908583|101077474|FG000|Phase 2|Adverse Event|1|||
33322621|NCT00908583|101077474|FG000|Phase 3|Adverse Event|2|||
33322622|NCT00908583|101077474|FG000|Phase 4|Adverse Event|1|||
33605676|NCT01792518|102108182|FG000|Overall Study|Lost to Follow-up|3|||
33322623|NCT00908583|101077474|FG000|Phase 4|Physician Decision|1|||
33322624|NCT00908583|101077474|FG000|Phase 5|Adverse Event|3|||
33322625|NCT01610687|101077477|FG000|Overall Study|Lack of Efficacy|26|||
33322626|NCT01610687|101077477|FG000|Overall Study|Adverse Event|18|||
33322627|NCT01610687|101077477|FG000|Overall Study|Moved out of area|6|||
33322628|NCT01610687|101077477|FG000|Overall Study|Withdrawal by Subject|7|||
33322629|NCT01610687|101077477|FG000|Overall Study|Lost to Follow-up|4|||
33322630|NCT01610687|101077477|FG000|Overall Study|Symptom control without study medication|2|||
33322631|NCT01610687|101077477|FG000|Overall Study|Unable to make journey|1|||
33322632|NCT01610687|101077477|FG000|Overall Study|Death|1|||
33322633|NCT01610687|101077477|FG000|Overall Study|Cannabis affecting job|1|||
33322634|NCT01610687|101077477|FG000|Overall Study|Felt more alter without study medication|1|||
33322635|NCT00024167|101077478|FG000|Overall Study|Death|53|||
33322636|NCT00024167|101077479|FG001|Overall Study|Death|47|||
33322637|NCT01122576|101077496|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
33322638|NCT01122576|101077497|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
33322639|NCT01122576|101077498|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
33322640|NCT01122576|101077496|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
33322641|NCT01122576|101077497|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
33322642|NCT01122576|101077498|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
33322643|NCT01122576|101077496|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
33322644|NCT01122576|101077497|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
33322645|NCT01122576|101077498|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
33322646|NCT05715528|101077501|FG000|Overall Study|Randomized but never treated|11|||
33322647|NCT05715528|101077502|FG001|Overall Study|Randomized but never treated|13|||
33322648|NCT05715528|101077501|FG000|Overall Study|Withdrew consent|7|||
33322649|NCT05715528|101077502|FG001|Overall Study|Withdrew consent|15|||
33322650|NCT05715528|101077501|FG000|Overall Study|Lost to Follow-up|5|||
33322651|NCT05715528|101077502|FG001|Overall Study|Lost to Follow-up|13|||
33322652|NCT05715528|101077501|FG000|Overall Study|Investigator's discretion|3|||
33322653|NCT05715528|101077502|FG001|Overall Study|Investigator's discretion|1|||
33322654|NCT05715528|101077501|FG000|Overall Study|Protocol Violation|2|||
33322655|NCT05715528|101077502|FG001|Overall Study|Protocol Violation|0|||
33322656|NCT05715528|101077501|FG000|Overall Study|Non-compliance with study drug|0|||
33322657|NCT05715528|101077502|FG001|Overall Study|Non-compliance with study drug|1|||
33322658|NCT00659529|101077503|FG000|Overall Study|Withdrawal by Subject|4|||
33322659|NCT00659529|101077503|FG000|Overall Study|Protocol Violation|3|||
33322660|NCT00659529|101077503|FG000|Overall Study|Screen failure|9|||
33322661|NCT00404066|101077504|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
33322662|NCT00404066|101077504|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
33322663|NCT02566577|101077508|FG000|Overall Study|Withdrawal by Subject|1|||
33322664|NCT02566577|101077509|FG001|Overall Study|Withdrawal by Subject|1|||
33322665|NCT02566577|101077508|FG000|Overall Study|Equipment failure|1|||
33322666|NCT02566577|101077509|FG001|Overall Study|Equipment failure|1|||
33322667|NCT02566577|101077508|FG000|Overall Study|Physical limitation|1|||
33322668|NCT02566577|101077509|FG001|Overall Study|Physical limitation|0|||
33322669|NCT01235793|101077510|FG000|Overall Study|Death|6|||
33322670|NCT02378220|101077511|FG000|Overall Study|Death|6|||
33322671|NCT02378220|101077512|FG001|Overall Study|Death|1|||
33322672|NCT00388505|101077513|FG000|Overall Study|Adverse Event or Death|43|||
33322673|NCT00388505|101077514|FG001|Overall Study|Adverse Event or Death|17|||
33322674|NCT00388505|101077513|FG000|Overall Study|Withdrawal by Subject|24|||
33322675|NCT00388505|101077514|FG001|Overall Study|Withdrawal by Subject|9|||
33322676|NCT00388505|101077513|FG000|Overall Study|Lost to Follow-up|5|||
33322677|NCT00388505|101077514|FG001|Overall Study|Lost to Follow-up|3|||
33322678|NCT00388505|101077513|FG000|Overall Study|Inappropriate Enrollment|0|||
33322679|NCT00388505|101077514|FG001|Overall Study|Inappropriate Enrollment|1|||
33322680|NCT00388505|101077513|FG000|Overall Study|Administrative Reason|1|||
33322681|NCT00388505|101077514|FG001|Overall Study|Administrative Reason|0|||
33322682|NCT00388505|101077513|FG000|Overall Study|Protocol Violation|6|||
33322683|NCT00388505|101077514|FG001|Overall Study|Protocol Violation|5|||
33322684|NCT00388505|101077513|FG000|Overall Study|Unable to classify|4|||
33322685|NCT00388505|101077514|FG001|Overall Study|Unable to classify|3|||
33322686|NCT04042740|101077517|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
33322687|NCT04042740|101077517|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
33322688|NCT01708291|101077518|FG000|Overall Study|fighting|2|||
33322689|NCT01708291|101077519|FG001|Overall Study|fighting|1|||
33322690|NCT00448435|101077520|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
33322691|NCT00448435|101077521|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
33322692|NCT01717287|101077522|FG000|Overall Study|Lost to Follow-up|0|||
33322693|NCT01717287|101077523|FG001|Overall Study|Lost to Follow-up|2|||
33322694|NCT01717287|101077522|FG000|Overall Study|Protocol Violation|0|||
33322695|NCT01717287|101077523|FG001|Overall Study|Protocol Violation|1|||
33322696|NCT03794583|101077527|FG000|Overall Study|Death|8|||
33322697|NCT03794583|101077527|FG000|Overall Study|Study Terminated by Sponsor|24|||
33322698|NCT03794583|101077527|FG000|Overall Study|Withdrawal by Subject|9|||
33322699|NCT00763971|101077530|FG000|Overall Study|Adverse Event|5|||
33322700|NCT00763971|101077531|FG001|Overall Study|Adverse Event|2|||
33322701|NCT00763971|101077532|FG002|Overall Study|Adverse Event|4|||
33322702|NCT00763971|101077530|FG000|Overall Study|Protocol Violation|3|||
33322703|NCT00763971|101077531|FG001|Overall Study|Protocol Violation|3|||
33322704|NCT00763971|101077532|FG002|Overall Study|Protocol Violation|2|||
33322705|NCT00763971|101077530|FG000|Overall Study|Withdrawal by Subject|4|||
33322706|NCT00763971|101077531|FG001|Overall Study|Withdrawal by Subject|5|||
33322707|NCT00763971|101077532|FG002|Overall Study|Withdrawal by Subject|5|||
33322708|NCT00763971|101077530|FG000|Overall Study|Lost to Follow-up|0|||
33322709|NCT00763971|101077531|FG001|Overall Study|Lost to Follow-up|1|||
33322710|NCT00763971|101077532|FG002|Overall Study|Lost to Follow-up|0|||
33322711|NCT00763971|101077530|FG000|Overall Study|Lack of Efficacy|11|||
33322712|NCT00763971|101077531|FG001|Overall Study|Lack of Efficacy|22|||
33322713|NCT00763971|101077532|FG002|Overall Study|Lack of Efficacy|54|||
33322714|NCT00763971|101077530|FG000|Overall Study|Unable to swallow capsule|2|||
33322715|NCT00763971|101077531|FG001|Overall Study|Unable to swallow capsule|1|||
33322716|NCT00763971|101077532|FG002|Overall Study|Unable to swallow capsule|1|||
33322717|NCT00763971|101077530|FG000|Overall Study|Personal reason|3|||
33322718|NCT00763971|101077531|FG001|Overall Study|Personal reason|0|||
33322719|NCT00763971|101077532|FG002|Overall Study|Personal reason|0|||
33322720|NCT00763971|101077530|FG000|Overall Study|Exclusion criteria met|1|||
33322721|NCT00763971|101077531|FG001|Overall Study|Exclusion criteria met|0|||
33322722|NCT00763971|101077532|FG002|Overall Study|Exclusion criteria met|0|||
33322723|NCT00763971|101077530|FG000|Overall Study|Sponsor decision|1|||
33322724|NCT00763971|101077531|FG001|Overall Study|Sponsor decision|0|||
33322725|NCT00763971|101077532|FG002|Overall Study|Sponsor decision|0|||
33322726|NCT00763971|101077530|FG000|Overall Study|Due to holiday season|2|||
33322727|NCT00763971|101077531|FG001|Overall Study|Due to holiday season|0|||
33322728|NCT00763971|101077532|FG002|Overall Study|Due to holiday season|1|||
33322729|NCT00763971|101077530|FG000|Overall Study|Randomization error|0|||
33322730|NCT00763971|101077531|FG001|Overall Study|Randomization error|0|||
33322731|NCT00763971|101077532|FG002|Overall Study|Randomization error|1|||
33322732|NCT00763971|101077530|FG000|Overall Study|Medical monitor decision|0|||
33322733|NCT00763971|101077531|FG001|Overall Study|Medical monitor decision|0|||
33322734|NCT00763971|101077532|FG002|Overall Study|Medical monitor decision|1|||
33322735|NCT00763971|101077530|FG000|Overall Study|Moved to another country|0|||
33322736|NCT00763971|101077531|FG001|Overall Study|Moved to another country|1|||
33322737|NCT00763971|101077532|FG002|Overall Study|Moved to another country|0|||
33322738|NCT00763971|101077530|FG000|Overall Study|Subject wanted dose reduction|0|||
33322739|NCT00763971|101077531|FG001|Overall Study|Subject wanted dose reduction|1|||
33322740|NCT00763971|101077532|FG002|Overall Study|Subject wanted dose reduction|0|||
33322741|NCT00763971|101077530|FG000|Overall Study|Lack of availability|0|||
33322742|NCT00763971|101077531|FG001|Overall Study|Lack of availability|1|||
33322743|NCT00763971|101077532|FG002|Overall Study|Lack of availability|0|||
33322744|NCT00763971|101077530|FG000|Overall Study|Performed final visit on phone|0|||
33322745|NCT00763971|101077531|FG001|Overall Study|Performed final visit on phone|1|||
33322746|NCT00763971|101077532|FG002|Overall Study|Performed final visit on phone|0|||
33322747|NCT00763971|101077530|FG000|Overall Study|Participation in 489-326 required|1|||
33322748|NCT00763971|101077531|FG001|Overall Study|Participation in 489-326 required|0|||
33322749|NCT00763971|101077532|FG002|Overall Study|Participation in 489-326 required|0|||
33322750|NCT02459769|101077533|FG000|Overall Study|Withdrawal by Subject|7|||
33322751|NCT02459769|101077534|FG001|Overall Study|Withdrawal by Subject|4|||
33322752|NCT02459769|101077535|FG002|Overall Study|Withdrawal by Subject|8|||
33322753|NCT02459769|101077536|FG003|Overall Study|Withdrawal by Subject|5|||
33322754|NCT02459769|101077533|FG000|Overall Study|Lost to Follow-up|1|||
33322755|NCT02459769|101077534|FG001|Overall Study|Lost to Follow-up|0|||
33322756|NCT02459769|101077535|FG002|Overall Study|Lost to Follow-up|1|||
33322757|NCT02459769|101077536|FG003|Overall Study|Lost to Follow-up|0|||
33322758|NCT02966223|101077544|FG000|Overall Study|Physician Decision|3|||
33322759|NCT02966223|101077544|FG000|Overall Study|Withdrawal by Subject|11|||
33322760|NCT02966223|101077544|FG000|Overall Study|Lost to Follow-up|1|||
33322761|NCT01843972|101077548|FG000|Overall Study|Withdrawal by Subject|0|||
33322762|NCT01843972|101077549|FG001|Overall Study|Withdrawal by Subject|0|||
33322763|NCT01843972|101077550|FG002|Overall Study|Withdrawal by Subject|0|||
33322764|NCT01843972|101077551|FG003|Overall Study|Withdrawal by Subject|0|||
33322765|NCT01843972|101077552|FG004|Overall Study|Withdrawal by Subject|1|||
33322766|NCT01843972|101077553|FG005|Overall Study|Withdrawal by Subject|0|||
33322767|NCT01843972|101077554|FG006|Overall Study|Withdrawal by Subject|0|||
33322768|NCT01843972|101077555|FG007|Overall Study|Withdrawal by Subject|0|||
33511595|NCT02637895|101770291|FG001|Overall Study|Lack of Efficacy|0|||
33322769|NCT01843972|101077556|FG008|Overall Study|Withdrawal by Subject|0|||
33322770|NCT01843972|101077557|FG009|Overall Study|Withdrawal by Subject|0|||
33322771|NCT01130051|101077558|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
33322772|NCT01130051|101077559|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
33322773|NCT01130051|101077558|FG000|Washout Period of 14 Days|Protocol Violation|1|||
33322774|NCT01130051|101077559|FG001|Washout Period of 14 Days|Protocol Violation|1|||
33322775|NCT04906616|101077562|FG000|Overall Study|Divorce|3|||
33322776|NCT04906616|101077563|FG001|Overall Study|Divorce|2|||
33322777|NCT00727649|101077564|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
33322778|NCT00727649|101077565|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
33322779|NCT00727649|101077564|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
33322780|NCT00727649|101077565|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
33322781|NCT00727649|101077564|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
33322782|NCT00727649|101077565|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
33322783|NCT00727649|101077564|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
33322784|NCT00727649|101077565|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
33322785|NCT00727649|101077564|FG000|Second Intervention (4-weeks)|Death|1|||
33322786|NCT00727649|101077565|FG001|Second Intervention (4-weeks)|Death|0|||
33322787|NCT00727649|101077564|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
33322788|NCT00727649|101077565|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
33322789|NCT00727649|101077564|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
33322790|NCT00727649|101077565|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
33322791|NCT01660451|101077574|FG000|Overall Study|Protocol Violation|0|||
33322792|NCT01660451|101077575|FG001|Overall Study|Protocol Violation|1|||
33322793|NCT01660451|101077576|FG002|Overall Study|Protocol Violation|1|||
33322794|NCT01660451|101077574|FG000|Overall Study|AE not associated with clinical disease progression|13|||
33322795|NCT01660451|101077575|FG001|Overall Study|AE not associated with clinical disease progression|10|||
33322796|NCT01660451|101077576|FG002|Overall Study|AE not associated with clinical disease progression|40|||
33322797|NCT01660451|101077574|FG000|Overall Study|AE associated with clinical disease progression|1|||
33322798|NCT01660451|101077575|FG001|Overall Study|AE associated with clinical disease progression|3|||
33322799|NCT01660451|101077576|FG002|Overall Study|AE associated with clinical disease progression|11|||
33322800|NCT01660451|101077574|FG000|Overall Study|Sponsor Decision|0|||
33322801|NCT01660451|101077575|FG001|Overall Study|Sponsor Decision|0|||
33322802|NCT01660451|101077576|FG002|Overall Study|Sponsor Decision|1|||
33322803|NCT01660451|101077574|FG000|Overall Study|Protocol Deviation|0|||
33322804|NCT01660451|101077575|FG001|Overall Study|Protocol Deviation|0|||
33322805|NCT01660451|101077576|FG002|Overall Study|Protocol Deviation|1|||
33322806|NCT01660451|101077574|FG000|Overall Study|Physician Decision|1|||
33322807|NCT01660451|101077575|FG001|Overall Study|Physician Decision|2|||
33322808|NCT01660451|101077576|FG002|Overall Study|Physician Decision|5|||
33322809|NCT01660451|101077574|FG000|Overall Study|Withdrawal by Subject|1|||
33322810|NCT01660451|101077575|FG001|Overall Study|Withdrawal by Subject|1|||
33322811|NCT01660451|101077576|FG002|Overall Study|Withdrawal by Subject|20|||
33322812|NCT01660451|101077574|FG000|Overall Study|Trial closure.|0|||
33322813|NCT01660451|101077575|FG001|Overall Study|Trial closure.|0|||
33322814|NCT01660451|101077576|FG002|Overall Study|Trial closure.|1|||
33322815|NCT01660451|101077574|FG000|Overall Study|Switching to other therapy|0|||
33322816|NCT01660451|101077575|FG001|Overall Study|Switching to other therapy|1|||
33322817|NCT01660451|101077576|FG002|Overall Study|Switching to other therapy|1|||
33322818|NCT01660451|101077574|FG000|Overall Study|Progressive disease - clinical progression|4|||
33322819|NCT01660451|101077575|FG001|Overall Study|Progressive disease - clinical progression|10|||
33322820|NCT01660451|101077576|FG002|Overall Study|Progressive disease - clinical progression|9|||
33322821|NCT01660451|101077574|FG000|Overall Study|Progressive disease - radiological progression|12|||
33322822|NCT01660451|101077575|FG001|Overall Study|Progressive disease - radiological progression|23|||
33322823|NCT01660451|101077576|FG002|Overall Study|Progressive disease - radiological progression|50|||
33322824|NCT01660451|101077574|FG000|Overall Study|Death|1|||
33322825|NCT01660451|101077575|FG001|Overall Study|Death|0|||
33322826|NCT01660451|101077576|FG002|Overall Study|Death|1|||
33322827|NCT01660451|101077574|FG000|Overall Study|Other|0|||
33322828|NCT01660451|101077575|FG001|Overall Study|Other|0|||
33322829|NCT01660451|101077576|FG002|Overall Study|Other|1|||
33322830|NCT03829241|101077577|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
33322831|NCT03829241|101077578|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
33322832|NCT03829241|101077577|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
33322833|NCT03829241|101077578|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
33322834|NCT03829241|101077577|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
33322835|NCT03829241|101077578|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
33322836|NCT03829241|101077577|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
33322837|NCT03829241|101077578|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
33322838|NCT03829241|101077577|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
33322839|NCT03829241|101077578|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
33322840|NCT03829241|101077577|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
33322841|NCT03829241|101077578|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
33322842|NCT03829241|101077577|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
33605677|NCT01792518|102108183|FG001|Overall Study|Lost to Follow-up|1|||
33322843|NCT03829241|101077578|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
33322844|NCT03829241|101077577|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
33322845|NCT03829241|101077578|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
33322846|NCT03829241|101077577|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
33322847|NCT03829241|101077578|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
33322848|NCT03829241|101077577|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
33322849|NCT03829241|101077578|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
33322850|NCT03829241|101077577|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
33322851|NCT03829241|101077578|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
33322852|NCT03829241|101077577|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
33322853|NCT03829241|101077578|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
33322854|NCT03829241|101077577|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
33322855|NCT03829241|101077578|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
33322856|NCT03829241|101077577|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
33322857|NCT03829241|101077578|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
33322858|NCT00631189|101077579|FG000|Initial Phase|Protocol Violation|347|||
33322859|NCT00631189|101077580|FG001|Initial Phase|Protocol Violation|0|||
33322860|NCT00631189|101077581|FG002|Initial Phase|Protocol Violation|0|||
33322861|NCT00631189|101077582|FG003|Initial Phase|Protocol Violation|0|||
33322862|NCT00631189|101077579|FG000|Initial Phase|Withdrawal by Subject|4|||
33322863|NCT00631189|101077580|FG001|Initial Phase|Withdrawal by Subject|0|||
33322864|NCT00631189|101077581|FG002|Initial Phase|Withdrawal by Subject|0|||
33322865|NCT00631189|101077582|FG003|Initial Phase|Withdrawal by Subject|0|||
33322866|NCT00631189|101077579|FG000|Treatment Phase|Withdrawal by Subject|0|||
33322867|NCT00631189|101077580|FG001|Treatment Phase|Withdrawal by Subject|2|||
33322868|NCT00631189|101077581|FG002|Treatment Phase|Withdrawal by Subject|1|||
33322869|NCT00631189|101077582|FG003|Treatment Phase|Withdrawal by Subject|1|||
33322870|NCT00631189|101077579|FG000|Treatment Phase|Protocol Violation|0|||
33322871|NCT00631189|101077580|FG001|Treatment Phase|Protocol Violation|1|||
33322872|NCT00631189|101077581|FG002|Treatment Phase|Protocol Violation|6|||
33322873|NCT00631189|101077582|FG003|Treatment Phase|Protocol Violation|2|||
33322874|NCT00631189|101077579|FG000|Treatment Phase|Adverse Event|0|||
33322875|NCT00631189|101077580|FG001|Treatment Phase|Adverse Event|3|||
33322876|NCT00631189|101077581|FG002|Treatment Phase|Adverse Event|2|||
33322877|NCT00631189|101077582|FG003|Treatment Phase|Adverse Event|4|||
33322878|NCT00631189|101077579|FG000|Treatment Phase|Lost to Follow-up|0|||
33322879|NCT00631189|101077580|FG001|Treatment Phase|Lost to Follow-up|1|||
33322880|NCT00631189|101077581|FG002|Treatment Phase|Lost to Follow-up|0|||
33322881|NCT00631189|101077582|FG003|Treatment Phase|Lost to Follow-up|0|||
33322882|NCT00631189|101077579|FG000|Treatment Phase|Pregnancy|0|||
33322883|NCT00631189|101077580|FG001|Treatment Phase|Pregnancy|0|||
33322884|NCT00631189|101077581|FG002|Treatment Phase|Pregnancy|1|||
33322885|NCT00631189|101077582|FG003|Treatment Phase|Pregnancy|0|||
33322886|NCT00631189|101077579|FG000|Treatment Phase|patient did not take pravastatin|0|||
33322887|NCT00631189|101077580|FG001|Treatment Phase|patient did not take pravastatin|0|||
33322888|NCT00631189|101077581|FG002|Treatment Phase|patient did not take pravastatin|1|||
33322889|NCT00631189|101077582|FG003|Treatment Phase|patient did not take pravastatin|0|||
33322890|NCT00890929|101077583|FG000|Overall Study|Death before treatment|2|||
33322891|NCT00890929|101077583|FG000|Overall Study|Withdrawal by Subject|3|||
33322892|NCT00890929|101077583|FG000|Overall Study|Physician Decision|1|||
33322893|NCT01506960|101077586|FG000|Overall Study|Did not meet angiographic criteria|47|||
33322894|NCT00894686|101077587|FG000|Overall Study|Withdrawal by Subject|50|||
33322895|NCT00894686|101077587|FG000|Overall Study|Physician Decision|1|||
33322896|NCT00894686|101077587|FG000|Overall Study|Other|5|||
33322897|NCT00419120|101077593|FG000|Long Term Follow up Period|study ongoing|10|||
33322898|NCT02308007|101077594|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
33322899|NCT02308007|101077595|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
33322900|NCT02308007|101077596|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
33322901|NCT02308007|101077594|FG000|Overall Study|Positive for STD at Baseline|7|||
33322902|NCT02308007|101077595|FG001|Overall Study|Positive for STD at Baseline|11|||
33322903|NCT02308007|101077596|FG002|Overall Study|Positive for STD at Baseline|7|||
33322904|NCT02308007|101077594|FG000|Overall Study|Lost to Follow-up|3|||
33322905|NCT02308007|101077595|FG001|Overall Study|Lost to Follow-up|0|||
33322906|NCT02308007|101077596|FG002|Overall Study|Lost to Follow-up|1|||
33322907|NCT00369785|101077597|FG000|Overall Study|Physician Decision|3|||
33322908|NCT00369785|101077598|FG001|Overall Study|Physician Decision|2|||
33322909|NCT00369785|101077597|FG000|Overall Study|Death|1|||
33322910|NCT00369785|101077598|FG001|Overall Study|Death|2|||
33322911|NCT00369785|101077597|FG000|Overall Study|Withdrawal by Subject|7|||
33322912|NCT00369785|101077598|FG001|Overall Study|Withdrawal by Subject|6|||
33322913|NCT00369785|101077597|FG000|Overall Study|Toxicity|6|||
33322914|NCT00369785|101077598|FG001|Overall Study|Toxicity|4|||
33322915|NCT00369785|101077597|FG000|Overall Study|Never started|0|||
33322916|NCT00369785|101077598|FG001|Overall Study|Never started|2|||
33322917|NCT00369785|101077597|FG000|Overall Study|Progression|4|||
33322918|NCT00369785|101077598|FG001|Overall Study|Progression|4|||
33322919|NCT00369785|101077597|FG000|Overall Study|Multiple reasons|6|||
33322920|NCT00369785|101077598|FG001|Overall Study|Multiple reasons|5|||
33322921|NCT03684642|101077599|FG000|Overall Study|Adverse Event|6|||
33322922|NCT03684642|101077600|FG001|Overall Study|Adverse Event|15|||
33322923|NCT03684642|101077601|FG002|Overall Study|Adverse Event|11|||
33322924|NCT03684642|101077599|FG000|Overall Study|Withdrawal by Subject|35|||
33322925|NCT03684642|101077600|FG001|Overall Study|Withdrawal by Subject|53|||
33322926|NCT03684642|101077601|FG002|Overall Study|Withdrawal by Subject|23|||
33322927|NCT03684642|101077599|FG000|Overall Study|Lack of Efficacy|0|||
33322928|NCT03684642|101077600|FG001|Overall Study|Lack of Efficacy|0|||
33322929|NCT03684642|101077601|FG002|Overall Study|Lack of Efficacy|1|||
33322930|NCT03684642|101077599|FG000|Overall Study|Poor compliance to protocol|0|||
33322931|NCT03684642|101077600|FG001|Overall Study|Poor compliance to protocol|4|||
33322932|NCT03684642|101077601|FG002|Overall Study|Poor compliance to protocol|1|||
33322933|NCT03684642|101077599|FG000|Overall Study|Other than specified|62|||
33322934|NCT03684642|101077600|FG001|Overall Study|Other than specified|60|||
33322935|NCT03684642|101077601|FG002|Overall Study|Other than specified|67|||
33322936|NCT03684642|101077599|FG000|Overall Study|Randomized and not treated|0|||
33322937|NCT03684642|101077600|FG001|Overall Study|Randomized and not treated|0|||
33322938|NCT03684642|101077601|FG002|Overall Study|Randomized and not treated|1|||
33322939|NCT03684642|101077599|FG000|Overall Study|Missing completion status but alive at last contact|0|||
33322940|NCT03684642|101077600|FG001|Overall Study|Missing completion status but alive at last contact|1|||
33322941|NCT03684642|101077601|FG002|Overall Study|Missing completion status but alive at last contact|2|||
33322942|NCT01383096|101077602|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
33322943|NCT01383096|101077603|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
33322944|NCT01383096|101077604|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
33322945|NCT01383096|101077602|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
33322946|NCT01383096|101077603|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
33322947|NCT01383096|101077604|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
33322948|NCT01383096|101077602|FG000|Third Intervention (8 Days)|Elevated AST|0|||
33322949|NCT01383096|101077603|FG001|Third Intervention (8 Days)|Elevated AST|1|||
33322950|NCT01383096|101077604|FG002|Third Intervention (8 Days)|Elevated AST|0|||
33322951|NCT01383096|101077602|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
33322952|NCT01383096|101077603|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
33322953|NCT01383096|101077604|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
33322954|NCT01383096|101077602|FG000|Third Intervention (8 Days)|Adverse Event|1|||
33322955|NCT01383096|101077603|FG001|Third Intervention (8 Days)|Adverse Event|0|||
33322956|NCT01383096|101077604|FG002|Third Intervention (8 Days)|Adverse Event|0|||
33322957|NCT01383096|101077602|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
33322958|NCT01383096|101077603|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
33322959|NCT01383096|101077604|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
33322960|NCT01383096|101077602|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
33322961|NCT01383096|101077603|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
33322962|NCT01383096|101077604|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
33322963|NCT01383096|101077602|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
33322964|NCT01383096|101077603|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
33322965|NCT01383096|101077604|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
33322966|NCT01383096|101077602|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
33322967|NCT01383096|101077603|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
33322968|NCT01383096|101077604|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
33322969|NCT01383096|101077602|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
33322970|NCT01383096|101077603|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
33322971|NCT01383096|101077604|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
33322972|NCT01383096|101077602|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
33322973|NCT01383096|101077603|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
33322974|NCT01383096|101077604|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
33322975|NCT04695392|101077605|FG000|Overall Study|Withdrawn by parent/guardian|0|||
33322976|NCT04695392|101077606|FG001|Overall Study|Withdrawn by parent/guardian|1|||
33322977|NCT04695392|101077605|FG000|Overall Study|Withdrawn by physician|0|||
33322978|NCT04695392|101077606|FG001|Overall Study|Withdrawn by physician|1|||
33322979|NCT03308942|101077607|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
33322980|NCT03308942|101077608|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
33322981|NCT03308942|101077609|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
33322982|NCT03308942|101077610|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
33322983|NCT03308942|101077611|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
33322984|NCT03308942|101077607|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
33322985|NCT03308942|101077608|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
33322986|NCT03308942|101077609|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
33322987|NCT03308942|101077610|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
33322988|NCT03308942|101077611|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
33322989|NCT03308942|101077607|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
33322990|NCT03308942|101077608|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
33322991|NCT03308942|101077609|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
33322992|NCT03308942|101077610|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
33322993|NCT03308942|101077611|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
33322994|NCT03308942|101077607|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
33322995|NCT03308942|101077608|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
33322996|NCT03308942|101077609|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
33322997|NCT03308942|101077610|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
33322998|NCT03308942|101077611|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
33322999|NCT03308942|101077607|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
33323000|NCT03308942|101077608|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
33323001|NCT03308942|101077609|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
33323002|NCT03308942|101077610|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
33323003|NCT03308942|101077611|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
33323004|NCT03308942|101077607|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
33323005|NCT03308942|101077608|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
33323006|NCT03308942|101077609|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
33323007|NCT03308942|101077610|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
33323008|NCT03308942|101077611|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
33323009|NCT03308942|101077607|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
33323010|NCT03308942|101077608|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
33323011|NCT03308942|101077609|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
33323012|NCT03308942|101077610|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
33323013|NCT03308942|101077611|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
33323014|NCT03627767|101077612|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
33323015|NCT03627767|101077613|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
33323016|NCT03627767|101077614|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
33323017|NCT03627767|101077615|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
33323018|NCT03627767|101077616|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
33323019|NCT03627767|101077612|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
33323020|NCT03627767|101077613|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
33323021|NCT03627767|101077614|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
33323022|NCT03627767|101077615|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
33323023|NCT03627767|101077616|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
33323024|NCT03627767|101077612|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
33323025|NCT03627767|101077613|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
33323026|NCT03627767|101077614|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
33323027|NCT03627767|101077615|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
33323028|NCT03627767|101077616|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
33323029|NCT03627767|101077612|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
33323030|NCT03627767|101077613|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
33323031|NCT03627767|101077614|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
33323032|NCT03627767|101077615|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
33323033|NCT03627767|101077616|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
33323034|NCT03627767|101077612|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
33323035|NCT03627767|101077613|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
33323036|NCT03627767|101077614|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
33323037|NCT03627767|101077615|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
33323038|NCT03627767|101077616|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
33323039|NCT03627767|101077612|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
33323040|NCT03627767|101077613|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
33323041|NCT03627767|101077614|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
33323042|NCT03627767|101077615|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
33323043|NCT03627767|101077616|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
33323044|NCT03627767|101077612|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
33323045|NCT03627767|101077613|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
33323046|NCT03627767|101077614|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
33323047|NCT03627767|101077615|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
33323048|NCT03627767|101077616|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
33323049|NCT03627767|101077612|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
33323050|NCT03627767|101077613|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
33323051|NCT03627767|101077614|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
33198198|NCT02031276|100630406|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
33323052|NCT03627767|101077615|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
33323053|NCT03627767|101077616|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
33323054|NCT03627767|101077612|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
33323055|NCT03627767|101077613|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
33323056|NCT03627767|101077614|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
33323057|NCT03627767|101077615|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
33323058|NCT03627767|101077616|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
33323059|NCT03627767|101077612|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
33323060|NCT03627767|101077613|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
33323061|NCT03627767|101077614|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
33323062|NCT03627767|101077615|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
33323063|NCT03627767|101077616|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
33323064|NCT03627767|101077612|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
33511596|NCT02637895|101770290|FG000|Overall Study|Withdrawal by Subject|1|||
33511597|NCT02637895|101770291|FG001|Overall Study|Withdrawal by Subject|1|||
33511598|NCT02637895|101770290|FG000|Overall Study|Abnormal baseline lab|0|||
33511599|NCT02637895|101770291|FG001|Overall Study|Abnormal baseline lab|1|||
33511600|NCT03589976|101770292|FG000|Overall Study|Death|5|||
33511601|NCT03589976|101770293|FG001|Overall Study|Death|1|||
33323065|NCT03627767|101077613|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
33323066|NCT03627767|101077614|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
33323067|NCT03627767|101077615|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
33511602|NCT03589976|101770292|FG000|Overall Study|Adverse Event|5|||
33511603|NCT03589976|101770293|FG001|Overall Study|Adverse Event|1|||
33511604|NCT03589976|101770292|FG000|Overall Study|Withdrawal by Subject|4|||
33605678|NCT01792518|102108182|FG000|Overall Study|Withdrawal by Subject|2|||
33605679|NCT01792518|102108183|FG001|Overall Study|Withdrawal by Subject|0|||
33605680|NCT01792518|102108182|FG000|Overall Study|Other Reason|0|||
33605681|NCT01792518|102108183|FG001|Overall Study|Other Reason|1|||
33605682|NCT00989781|102108186|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
33605683|NCT00989781|102108187|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
33511605|NCT03589976|101770293|FG001|Overall Study|Withdrawal by Subject|1|||
33511606|NCT03589976|101770292|FG000|Overall Study|Lost to Follow-up|1|||
33511607|NCT03589976|101770293|FG001|Overall Study|Lost to Follow-up|0|||
33511608|NCT03589976|101770292|FG000|Overall Study|Other|4|||
33511609|NCT03589976|101770293|FG001|Overall Study|Other|3|||
33605684|NCT01641822|102108190|FG000|Run-in Phase|Noncompliance with study drug|1|||
33605685|NCT01641822|102108191|FG001|Run-in Phase|Noncompliance with study drug|0|||
33198199|NCT03525834|100630407|FG000|Overall Study|Progressive disease|1|||
33198200|NCT02984020|100630408|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
33198201|NCT02984020|100630408|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
33198202|NCT02984020|100630408|FG000|Overall Study|Other significant protocol violation|2|||
33198203|NCT00844194|100630418|FG000|Overall Study|Adverse Event|17|||
33198204|NCT00844194|100630419|FG001|Overall Study|Adverse Event|5|||
33198205|NCT00844194|100630418|FG000|Overall Study|Protocol Violation|1|||
33198206|NCT00844194|100630419|FG001|Overall Study|Protocol Violation|1|||
33198207|NCT00844194|100630418|FG000|Overall Study|Lost to Follow-up|1|||
33198208|NCT00844194|100630419|FG001|Overall Study|Lost to Follow-up|1|||
33198209|NCT00844194|100630418|FG000|Overall Study|Withdrawal by Subject|2|||
33198210|NCT00844194|100630419|FG001|Overall Study|Withdrawal by Subject|1|||
33198211|NCT00844194|100630418|FG000|Overall Study|Lack of Efficacy|3|||
33198212|NCT00844194|100630419|FG001|Overall Study|Lack of Efficacy|0|||
33198213|NCT00844194|100630418|FG000|Overall Study|Other reason (not specified)|1|||
33198214|NCT00844194|100630419|FG001|Overall Study|Other reason (not specified)|0|||
33198215|NCT02799082|100630420|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
33198216|NCT02799082|100630421|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
33198217|NCT02799082|100630420|FG000|Overall Study|Protocol Violation|0|||
33198218|NCT02799082|100630421|FG001|Overall Study|Protocol Violation|1|||
33198219|NCT01263873|100630422|FG000|Overall Study|One provider unable to complete numbers|1|||
33198220|NCT01263873|100630423|FG001|Overall Study|One provider unable to complete numbers|1|||
33198221|NCT01933334|100630424|FG000|Overall Study|Adverse Event|5|||
33198222|NCT01933334|100630425|FG001|Overall Study|Adverse Event|1|||
33511610|NCT01054300|101770294|FG000|Period 1|Adverse Event|1|||
33511611|NCT01054300|101770295|FG001|Period 1|Adverse Event|0|||
33511612|NCT01054300|101770296|FG002|Period 1|Adverse Event|0|||
33198223|NCT01933334|100630424|FG000|Overall Study|Withdrawal by Subject|0|||
33198224|NCT01933334|100630425|FG001|Overall Study|Withdrawal by Subject|1|||
33511613|NCT01054300|101770297|FG003|Period 1|Adverse Event|0|||
33511614|NCT01054300|101770294|FG000|Period 2|Withdrawal by Subject|0|||
33511615|NCT01054300|101770295|FG001|Period 2|Withdrawal by Subject|0|||
33511616|NCT01054300|101770296|FG002|Period 2|Withdrawal by Subject|1|||
33511617|NCT01054300|101770297|FG003|Period 2|Withdrawal by Subject|0|||
33511618|NCT00380081|101770300|FG000|Overall Study|Withdrawal by Subject|0|||
33511619|NCT00380081|101770301|FG001|Overall Study|Withdrawal by Subject|0|||
33198225|NCT04067141|100630429|FG000|First Intervention|Withdrawal by Subject|0|||
33198226|NCT04067141|100630430|FG001|First Intervention|Withdrawal by Subject|1|||
33198227|NCT04067141|100630429|FG000|Second Intervention|Adverse Event|0|||
33198228|NCT04067141|100630430|FG001|Second Intervention|Adverse Event|2|||
33198229|NCT00634647|100630431|FG000|Overall Study|death on study|3|||
33198230|NCT00634647|100630431|FG000|Overall Study|refused further treatment|3|||
33198231|NCT00634647|100630431|FG000|Overall Study|declined to participate before treatment|1|||
33198232|NCT05789875|100630432|FG000|Overall Study|Lost to Follow-up|6|||
33198233|NCT00194012|100630433|FG000|Randomized Phase|Lack of Efficacy|8|||
33198234|NCT00194012|100630434|FG001|Randomized Phase|Lack of Efficacy|18|||
33198235|NCT00194012|100630433|FG000|Randomized Phase|Study nonadherence|2|||
33198236|NCT00194012|100630434|FG001|Randomized Phase|Study nonadherence|1|||
33198237|NCT00194012|100630433|FG000|Randomized Phase|Withdrawal by Subject|3|||
33198238|NCT00194012|100630434|FG001|Randomized Phase|Withdrawal by Subject|3|||
33198239|NCT00194012|100630433|FG000|Randomized Phase|Adverse Event|2|||
33323068|NCT03627767|101077616|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
33323069|NCT03627767|101077612|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
33323070|NCT03627767|101077613|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
33511620|NCT00380081|101770302|FG002|Overall Study|Withdrawal by Subject|0|||
33198240|NCT00194012|100630434|FG001|Randomized Phase|Adverse Event|1|||
33198241|NCT00194012|100630433|FG000|Randomized Phase|Participant reported having a rash|1|||
33198242|NCT00194012|100630434|FG001|Randomized Phase|Participant reported having a rash|0|||
33198243|NCT00194012|100630433|FG000|Randomized Phase|Emesis and enuresis|0|||
33198244|NCT00194012|100630434|FG001|Randomized Phase|Emesis and enuresis|1|||
33198245|NCT00194012|100630433|FG000|Randomized Phase|Oral/nasal twitching|0|||
33198246|NCT00194012|100630434|FG001|Randomized Phase|Oral/nasal twitching|1|||
33511621|NCT00380081|101770303|FG003|Overall Study|Withdrawal by Subject|0|||
33511622|NCT00380081|101770304|FG004|Overall Study|Withdrawal by Subject|1|||
33511623|NCT00380081|101770305|FG005|Overall Study|Withdrawal by Subject|0|||
33511624|NCT00380081|101770300|FG000|Overall Study|Family Emergency|0|||
33198247|NCT00194012|100630433|FG000|Open Label Extension (OLE)|Weight Gain|1|||
33198248|NCT00194012|100630434|FG001|Open Label Extension (OLE)|Weight Gain|0|||
33323071|NCT03627767|101077614|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
33323072|NCT03627767|101077615|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
33323073|NCT03627767|101077616|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
33323074|NCT03627767|101077612|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
33323075|NCT03627767|101077613|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
33323076|NCT03627767|101077614|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
33323077|NCT03627767|101077615|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
33323078|NCT03627767|101077616|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
33323079|NCT03627767|101077612|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
33323080|NCT03627767|101077613|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
33323081|NCT03627767|101077614|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
33323082|NCT03627767|101077615|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
33323083|NCT03627767|101077616|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
33323084|NCT03627767|101077612|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
33323085|NCT03627767|101077613|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
33323086|NCT03627767|101077614|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
33323087|NCT03627767|101077615|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
33323088|NCT03627767|101077616|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
33323089|NCT03627767|101077612|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
33323090|NCT03627767|101077613|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
33323091|NCT03627767|101077614|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
33323092|NCT03627767|101077615|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
33323093|NCT03627767|101077616|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
33323094|NCT03627767|101077612|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
33323095|NCT03627767|101077613|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
33323096|NCT03627767|101077614|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
33323097|NCT03627767|101077615|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
33323098|NCT03627767|101077616|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
33323099|NCT03627767|101077612|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
33323100|NCT03627767|101077613|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
33323101|NCT03627767|101077614|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
33511625|NCT00380081|101770301|FG001|Overall Study|Family Emergency|0|||
33511626|NCT00380081|101770302|FG002|Overall Study|Family Emergency|0|||
33511627|NCT00380081|101770303|FG003|Overall Study|Family Emergency|0|||
33198249|NCT00194012|100630433|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
33198250|NCT00194012|100630434|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
33198251|NCT00194012|100630433|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
33198252|NCT00194012|100630434|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
33198253|NCT00194012|100630433|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
33198254|NCT00194012|100630434|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
33198255|NCT02293005|100630435|FG000|Overall Study|Adverse Event|2|||
33198256|NCT02293005|100630435|FG000|Overall Study|Death|4|||
33198257|NCT02293005|100630435|FG000|Overall Study|Lost to Follow-up|1|||
33198258|NCT02293005|100630435|FG000|Overall Study|Withdrawal by Subject|2|||
33198259|NCT02293005|100630435|FG000|Overall Study|Progression|17|||
33198260|NCT03143829|100630440|FG000|Overall Study|Withdrawal by Subject|2|||
33198261|NCT03143829|100630441|FG001|Overall Study|Withdrawal by Subject|5|||
33198262|NCT03143829|100630440|FG000|Overall Study|Lost to Follow-up|0|||
33323102|NCT03627767|101077615|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
33323103|NCT03627767|101077616|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
33323104|NCT03627767|101077612|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
33323105|NCT03627767|101077613|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
33511628|NCT00380081|101770304|FG004|Overall Study|Family Emergency|0|||
33198263|NCT03143829|100630441|FG001|Overall Study|Lost to Follow-up|2|||
33198264|NCT03143829|100630440|FG000|Overall Study|Death|1|||
33198265|NCT03143829|100630441|FG001|Overall Study|Death|1|||
33198266|NCT03143829|100630440|FG000|Overall Study|changed treatment, no longer eligible|2|||
33198267|NCT03143829|100630441|FG001|Overall Study|changed treatment, no longer eligible|2|||
33198268|NCT03169153|100630442|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
33198269|NCT03169153|100630443|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
33198270|NCT03169153|100630442|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
33198271|NCT03169153|100630443|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
33198272|NCT03169153|100630442|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
33198273|NCT03169153|100630443|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
33198274|NCT03169153|100630442|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
33198275|NCT03169153|100630443|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
33198276|NCT00575588|100630444|FG000|Overall Study|Adverse Event|11|||
33198277|NCT00575588|100630445|FG001|Overall Study|Adverse Event|13|||
33198278|NCT00575588|100630444|FG000|Overall Study|Withdrawal by Subject|27|||
33198279|NCT00575588|100630445|FG001|Overall Study|Withdrawal by Subject|31|||
33198280|NCT00575588|100630444|FG000|Overall Study|Lost to Follow-up|1|||
33198281|NCT00575588|100630445|FG001|Overall Study|Lost to Follow-up|3|||
33198282|NCT00575588|100630444|FG000|Overall Study|Death|4|||
33198283|NCT00575588|100630445|FG001|Overall Study|Death|2|||
33198284|NCT00575588|100630444|FG000|Overall Study|Incorrect enrollment|8|||
33198285|NCT00575588|100630445|FG001|Overall Study|Incorrect enrollment|4|||
33198286|NCT00575588|100630444|FG000|Overall Study|Study specific discontinuation criteria|203|||
33198287|NCT00575588|100630445|FG001|Overall Study|Study specific discontinuation criteria|218|||
33198288|NCT00575588|100630444|FG000|Overall Study|Severe non-compliance to protocol|5|||
33198289|NCT00575588|100630445|FG001|Overall Study|Severe non-compliance to protocol|7|||
33198290|NCT00575588|100630444|FG000|Overall Study|Safety reasons|2|||
33198291|NCT00575588|100630445|FG001|Overall Study|Safety reasons|1|||
33198292|NCT00575588|100630444|FG000|Overall Study|Elevated triglyceride|1|||
33198293|NCT00575588|100630445|FG001|Overall Study|Elevated triglyceride|0|||
33198294|NCT00575588|100630444|FG000|Overall Study|Patient moved|1|||
33198295|NCT00575588|100630445|FG001|Overall Study|Patient moved|3|||
33198296|NCT00575588|100630444|FG000|Overall Study|Impossible to determine HbA1c|0|||
33198297|NCT00575588|100630445|FG001|Overall Study|Impossible to determine HbA1c|1|||
33198298|NCT01312961|100630446|FG000|Overall Study|Adverse Event|3|||
33198299|NCT01312961|100630447|FG001|Overall Study|Adverse Event|3|||
33198300|NCT01312961|100630446|FG000|Overall Study|Lack of Efficacy|11|||
33198301|NCT01312961|100630447|FG001|Overall Study|Lack of Efficacy|1|||
33198302|NCT01312961|100630446|FG000|Overall Study|Poor compliance to protocol|1|||
33198303|NCT01312961|100630447|FG001|Overall Study|Poor compliance to protocol|0|||
33198304|NCT01312961|100630446|FG000|Overall Study|Other than specified above|2|||
33198305|NCT01312961|100630447|FG001|Overall Study|Other than specified above|3|||
33198306|NCT01858194|100630452|FG000|Overall Study|Total Artificial Heart Implant|0|||
33198307|NCT01858194|100630453|FG001|Overall Study|Total Artificial Heart Implant|1|||
33198308|NCT01858194|100630452|FG000|Overall Study|Lost to Follow-up|0|||
33198309|NCT01858194|100630453|FG001|Overall Study|Lost to Follow-up|1|||
33198310|NCT02443298|100630459|FG000|Overall Study|Adverse Event|3|||
33198311|NCT02443298|100630460|FG001|Overall Study|Adverse Event|3|||
33198312|NCT02443298|100630459|FG000|Overall Study|Withdrawal by Subject|1|||
33198313|NCT02443298|100630460|FG001|Overall Study|Withdrawal by Subject|2|||
33198314|NCT01959581|100630464|FG000|Overall Study|Lost to Follow-up|5|||
33198315|NCT02732847|100630467|FG000|Overall Study|some filled early|42|||
33198316|NCT02732847|100630468|FG001|Overall Study|some filled early|42|||
33198317|NCT00023673|100630469|FG000|Overall Study|Ineligible / no protocol treatment|0|||
33198318|NCT00023673|100630470|FG001|Overall Study|Ineligible / no protocol treatment|0|||
33198319|NCT00023673|100630471|FG002|Overall Study|Ineligible / no protocol treatment|0|||
33198320|NCT00023673|100630472|FG003|Overall Study|Ineligible / no protocol treatment|1|||
33198321|NCT00023673|100630469|FG000|Overall Study|Patient withdrew consent|0|||
33198322|NCT00023673|100630470|FG001|Overall Study|Patient withdrew consent|0|||
33198323|NCT00023673|100630471|FG002|Overall Study|Patient withdrew consent|0|||
33198324|NCT00023673|100630472|FG003|Overall Study|Patient withdrew consent|1|||
33198325|NCT03732248|100630473|FG000|Overall Study|Withdrawal by Subject|1|||
33198326|NCT03732248|100630474|FG001|Overall Study|Withdrawal by Subject|0|||
33198327|NCT02770391|100630475|FG000|Overall Study|Lost to Follow-up|2|||
33198328|NCT02770391|100630475|FG000|Overall Study|Withdrawal by Subject|1|||
33198329|NCT02770391|100630475|FG000|Overall Study|Surgery delayed unevaluable|2|||
33198330|NCT02770391|100630475|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
33323106|NCT03627767|101077614|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
33198331|NCT03832192|100630477|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
33198332|NCT03832192|100630478|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
33198333|NCT01274637|100630479|FG000|Overall Study|Withdrawal by Subject|0|||
33198334|NCT01274637|100630480|FG001|Overall Study|Withdrawal by Subject|1|||
33198335|NCT01274637|100630479|FG000|Overall Study|Lost to Follow-up|0|||
33198336|NCT01274637|100630480|FG001|Overall Study|Lost to Follow-up|1|||
33198337|NCT02610140|100630481|FG000|Randomization and Treatment Period|Radiological progression|23|||
33323107|NCT03627767|101077615|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
33323108|NCT03627767|101077616|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
33323109|NCT03627767|101077612|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
33323110|NCT03627767|101077613|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
33323111|NCT03627767|101077614|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
33323112|NCT03627767|101077615|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
33323113|NCT03627767|101077616|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
33323114|NCT01472380|101077617|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
33323115|NCT01472380|101077617|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
33323116|NCT01754857|101077618|FG000|Overall Study|Adverse Event|7|||
33323117|NCT01754857|101077618|FG000|Overall Study|Disease progression|3|||
33323118|NCT01754857|101077618|FG000|Overall Study|Physician Decision|2|||
33323119|NCT01754857|101077618|FG000|Overall Study|Withdrawal by Subject|3|||
33323120|NCT01754857|101077618|FG000|Overall Study|other complicating disease|1|||
33323121|NCT01754857|101077618|FG000|Overall Study|ineligible to continue onto maintenance|1|||
33323122|NCT01754857|101077618|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
33323123|NCT01754857|101077618|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
33323124|NCT00800683|101077622|FG000|Overall Study|Adverse Event|11|||
33323125|NCT00800683|101077623|FG001|Overall Study|Adverse Event|8|||
33323126|NCT00800683|101077622|FG000|Overall Study|Lost to Follow-up|3|||
33323127|NCT00800683|101077623|FG001|Overall Study|Lost to Follow-up|1|||
33323128|NCT00800683|101077622|FG000|Overall Study|Withdrawal by Subject|1|||
33323129|NCT00800683|101077623|FG001|Overall Study|Withdrawal by Subject|7|||
33323130|NCT00800683|101077622|FG000|Overall Study|Lack of Efficacy|1|||
33323131|NCT00800683|101077623|FG001|Overall Study|Lack of Efficacy|1|||
33323132|NCT00800683|101077622|FG000|Overall Study|Other|1|||
33323133|NCT00800683|101077623|FG001|Overall Study|Other|2|||
33323134|NCT00521053|101077624|FG000|Observation Phase|Disease Progression|55|||
33323135|NCT00521053|101077624|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
33323136|NCT00521053|101077624|FG000|Observation Phase|Death|2|||
33323137|NCT00521053|101077624|FG000|Observation Phase|Adverse Event|1|||
33323138|NCT00521053|101077624|FG000|Observation Phase|Other non-study melanoma treatment|1|||
33323139|NCT00521053|101077624|FG000|Observation Phase|Physician Decision|1|||
33323140|NCT00916149|101077627|FG000|Overall Study|Lost to Follow-up|3|||
33323141|NCT00916149|101077628|FG001|Overall Study|Lost to Follow-up|2|||
33323142|NCT00916149|101077629|FG002|Overall Study|Lost to Follow-up|0|||
33323143|NCT00916149|101077627|FG000|Overall Study|Unable to place scalp EEG leads|1|||
33323144|NCT00916149|101077628|FG001|Overall Study|Unable to place scalp EEG leads|0|||
33323145|NCT00916149|101077629|FG002|Overall Study|Unable to place scalp EEG leads|0|||
33323146|NCT01098812|101077630|FG000|Overall Study|Death|2|||
33323147|NCT01098812|101077631|FG001|Overall Study|Death|0|||
33323148|NCT01098812|101077632|FG002|Overall Study|Death|1|||
33323149|NCT01098812|101077630|FG000|Overall Study|Lost to Follow-up|0|||
33323150|NCT01098812|101077631|FG001|Overall Study|Lost to Follow-up|1|||
33323151|NCT01098812|101077632|FG002|Overall Study|Lost to Follow-up|0|||
33323152|NCT01103245|101077633|FG000|Overall Study|Withdrawal by Subject|1|||
33323153|NCT01103245|101077634|FG001|Overall Study|Withdrawal by Subject|0|||
33323154|NCT01103245|101077635|FG002|Overall Study|Withdrawal by Subject|3|||
33323155|NCT01103245|101077636|FG003|Overall Study|Withdrawal by Subject|0|||
33323156|NCT01103245|101077633|FG000|Overall Study|Inadequate IV access|1|||
33323157|NCT01103245|101077634|FG001|Overall Study|Inadequate IV access|0|||
33323158|NCT01103245|101077635|FG002|Overall Study|Inadequate IV access|0|||
33511629|NCT00380081|101770305|FG005|Overall Study|Family Emergency|1|||
33511630|NCT00658775|101770306|FG000|Overall Study|Adverse Event|4|||
33511631|NCT00658775|101770307|FG001|Overall Study|Adverse Event|6|||
33511632|NCT00658775|101770306|FG000|Overall Study|Lost to Follow-up|17|||
33511633|NCT00658775|101770307|FG001|Overall Study|Lost to Follow-up|18|||
33511634|NCT00658775|101770306|FG000|Overall Study|Withdrawal by Subject|6|||
33511635|NCT00658775|101770307|FG001|Overall Study|Withdrawal by Subject|4|||
33323159|NCT01103245|101077636|FG003|Overall Study|Inadequate IV access|0|||
33323160|NCT01103245|101077633|FG000|Overall Study|Adverse Event|0|||
33323161|NCT01103245|101077634|FG001|Overall Study|Adverse Event|2|||
33323162|NCT01103245|101077635|FG002|Overall Study|Adverse Event|1|||
33323163|NCT01103245|101077636|FG003|Overall Study|Adverse Event|0|||
33323164|NCT01103245|101077633|FG000|Overall Study|Physician Decision|1|||
33323165|NCT01103245|101077634|FG001|Overall Study|Physician Decision|0|||
33323166|NCT01103245|101077635|FG002|Overall Study|Physician Decision|0|||
33323167|NCT01103245|101077636|FG003|Overall Study|Physician Decision|0|||
33323168|NCT01210690|101077637|FG000|Overall Study|Adverse Event|7|||
33323169|NCT01210690|101077637|FG000|Overall Study|Lack of Efficacy|12|||
33323170|NCT01210690|101077637|FG000|Overall Study|Lost to Follow-up|3|||
33323171|NCT01210690|101077637|FG000|Overall Study|Disease Remission|1|||
33323172|NCT01210690|101077637|FG000|Overall Study|Withdrawal by Subject|1|||
33323173|NCT01210690|101077637|FG000|Overall Study|Patient refused to swallow|1|||
33323174|NCT01210690|101077637|FG000|Overall Study|Patient could not take glucose|1|||
33511636|NCT00658775|101770306|FG000|Overall Study|Withdrawal of consent|8|||
33511637|NCT00658775|101770307|FG001|Overall Study|Withdrawal of consent|7|||
33323175|NCT00493220|101077646|FG000|Third Intervention|Withdrawal by Subject|1|||
33323176|NCT00493220|101077647|FG001|Third Intervention|Withdrawal by Subject|0|||
33323177|NCT00493220|101077648|FG002|Third Intervention|Withdrawal by Subject|0|||
33323178|NCT00493220|101077649|FG003|Third Intervention|Withdrawal by Subject|0|||
33323179|NCT00493220|101077650|FG004|Third Intervention|Withdrawal by Subject|0|||
33323180|NCT00493220|101077651|FG005|Third Intervention|Withdrawal by Subject|0|||
33323181|NCT03239483|101077652|FG000|Overall Study|Lost to Follow-up|1|||
33323182|NCT03239483|101077653|FG001|Overall Study|Lost to Follow-up|0|||
33323183|NCT03239483|101077652|FG000|Overall Study|Withdrawal by Subject|1|||
33323184|NCT03239483|101077653|FG001|Overall Study|Withdrawal by Subject|0|||
33323185|NCT01514136|101077654|FG000|Test Period 1; Test A|Protocol Violation|1|||
33323186|NCT01514136|101077655|FG001|Test Period 1; Test A|Protocol Violation|0|||
33323187|NCT01514136|101077656|FG002|Test Period 1; Test A|Protocol Violation|0|||
33323188|NCT01514136|101077657|FG003|Test Period 1; Test A|Protocol Violation|0|||
33323189|NCT01514136|101077658|FG004|Test Period 1; Test A|Protocol Violation|0|||
33323190|NCT01514136|101077659|FG005|Test Period 1; Test A|Protocol Violation|0|||
33323191|NCT01514136|101077660|FG006|Test Period 1; Test A|Protocol Violation|0|||
33323192|NCT01514136|101077661|FG007|Test Period 1; Test A|Protocol Violation|0|||
33323193|NCT01514136|101077654|FG000|Test Period 1; Test A|Break from study holiday|2|||
33323194|NCT01514136|101077655|FG001|Test Period 1; Test A|Break from study holiday|0|||
33323195|NCT01514136|101077656|FG002|Test Period 1; Test A|Break from study holiday|0|||
33323196|NCT01514136|101077657|FG003|Test Period 1; Test A|Break from study holiday|0|||
33323197|NCT01514136|101077658|FG004|Test Period 1; Test A|Break from study holiday|0|||
33323198|NCT01514136|101077659|FG005|Test Period 1; Test A|Break from study holiday|0|||
33323199|NCT01514136|101077660|FG006|Test Period 1; Test A|Break from study holiday|0|||
33323200|NCT01514136|101077661|FG007|Test Period 1; Test A|Break from study holiday|0|||
33323201|NCT01514136|101077654|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
33323202|NCT01514136|101077655|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
33323203|NCT01514136|101077656|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
33323204|NCT01514136|101077657|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
33323205|NCT01514136|101077658|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
33323206|NCT01514136|101077659|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
33323207|NCT01514136|101077660|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
33323208|NCT01514136|101077661|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
33323209|NCT01514136|101077654|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
33323210|NCT01514136|101077655|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
33323211|NCT01514136|101077656|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
33323212|NCT01514136|101077657|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
33323213|NCT01514136|101077658|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
33323214|NCT01514136|101077659|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
33323215|NCT01514136|101077660|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
33323216|NCT01514136|101077661|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
33323217|NCT01514136|101077654|FG000|Test Period 2; Test A*|Adverse Event|0|||
33323218|NCT01514136|101077655|FG001|Test Period 2; Test A*|Adverse Event|0|||
33323219|NCT01514136|101077656|FG002|Test Period 2; Test A*|Adverse Event|0|||
33323220|NCT01514136|101077657|FG003|Test Period 2; Test A*|Adverse Event|0|||
33323221|NCT01514136|101077658|FG004|Test Period 2; Test A*|Adverse Event|1|||
33323222|NCT01514136|101077659|FG005|Test Period 2; Test A*|Adverse Event|0|||
33323223|NCT01514136|101077660|FG006|Test Period 2; Test A*|Adverse Event|0|||
33323224|NCT01514136|101077661|FG007|Test Period 2; Test A*|Adverse Event|0|||
33323225|NCT01514136|101077654|FG000|Test Period 2; Test A*|Holiday|0|||
33323226|NCT01514136|101077655|FG001|Test Period 2; Test A*|Holiday|0|||
33323227|NCT01514136|101077656|FG002|Test Period 2; Test A*|Holiday|0|||
33323228|NCT01514136|101077657|FG003|Test Period 2; Test A*|Holiday|0|||
33323229|NCT01514136|101077658|FG004|Test Period 2; Test A*|Holiday|1|||
33323230|NCT01514136|101077659|FG005|Test Period 2; Test A*|Holiday|0|||
33323231|NCT01514136|101077660|FG006|Test Period 2; Test A*|Holiday|0|||
33323232|NCT01514136|101077661|FG007|Test Period 2; Test A*|Holiday|0|||
33323233|NCT01514136|101077654|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
33323234|NCT01514136|101077655|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
33323235|NCT01514136|101077656|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
33323236|NCT01514136|101077657|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
33323237|NCT01514136|101077658|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
33323238|NCT01514136|101077659|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
33323239|NCT01514136|101077660|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
33323240|NCT01514136|101077661|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
33323241|NCT01514136|101077654|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
33323242|NCT01514136|101077655|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
33323243|NCT01514136|101077656|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
33323244|NCT01514136|101077657|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
33323245|NCT01514136|101077658|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
33323246|NCT01514136|101077659|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
33511638|NCT00658775|101770306|FG000|Overall Study|Other|7|||
33323247|NCT01514136|101077660|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
33323248|NCT01514136|101077661|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
33323249|NCT01514136|101077654|FG000|Test Period 2; Test C*|holiday|0|||
33323250|NCT01514136|101077655|FG001|Test Period 2; Test C*|holiday|0|||
33323251|NCT01514136|101077656|FG002|Test Period 2; Test C*|holiday|0|||
33323252|NCT01514136|101077657|FG003|Test Period 2; Test C*|holiday|0|||
33323253|NCT01514136|101077658|FG004|Test Period 2; Test C*|holiday|0|||
33323254|NCT01514136|101077659|FG005|Test Period 2; Test C*|holiday|0|||
33323255|NCT01514136|101077660|FG006|Test Period 2; Test C*|holiday|1|||
33323256|NCT01514136|101077661|FG007|Test Period 2; Test C*|holiday|0|||
33198338|NCT02610140|100630482|FG001|Randomization and Treatment Period|Radiological progression|15|||
33198339|NCT02610140|100630481|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
33198340|NCT02610140|100630482|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
33198341|NCT02610140|100630481|FG000|Randomization and Treatment Period|Protocol Violation|1|||
33198342|NCT02610140|100630482|FG001|Randomization and Treatment Period|Protocol Violation|0|||
33198343|NCT02610140|100630481|FG000|Randomization and Treatment Period|Physician Decision|0|||
33198344|NCT02610140|100630482|FG001|Randomization and Treatment Period|Physician Decision|1|||
33198345|NCT02610140|100630481|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
33198346|NCT02610140|100630482|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
33198347|NCT02610140|100630481|FG000|Randomization and Treatment Period|Death|7|||
33198348|NCT02610140|100630482|FG001|Randomization and Treatment Period|Death|1|||
33198349|NCT02610140|100630481|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
33198350|NCT02610140|100630482|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
33198351|NCT02610140|100630481|FG000|Randomization and Treatment Period|Adverse Event|44|||
33198352|NCT02610140|100630482|FG001|Randomization and Treatment Period|Adverse Event|13|||
33198353|NCT02610140|100630481|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
33198354|NCT02610140|100630482|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
33198355|NCT02610140|100630481|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
33198356|NCT02610140|100630482|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
33198357|NCT02610140|100630481|FG000|Randomization and Treatment Period|Not treated|3|||
33198358|NCT02610140|100630482|FG001|Randomization and Treatment Period|Not treated|10|||
33198359|NCT02610140|100630481|FG000|Safety Follow-up|Other|0|||
33198360|NCT02610140|100630482|FG001|Safety Follow-up|Other|2|||
33198361|NCT02610140|100630481|FG000|Safety Follow-up|Lost to Follow-up|1|||
33198362|NCT02610140|100630482|FG001|Safety Follow-up|Lost to Follow-up|0|||
33198363|NCT02610140|100630481|FG000|Safety Follow-up|No follow-up|5|||
33198364|NCT02610140|100630482|FG001|Safety Follow-up|No follow-up|3|||
33198365|NCT02610140|100630481|FG000|Safety Follow-up|Death|12|||
33198366|NCT02610140|100630482|FG001|Safety Follow-up|Death|2|||
33198367|NCT02610140|100630481|FG000|Safety Follow-up|Deterioration of general conditions|15|||
33198368|NCT02610140|100630482|FG001|Safety Follow-up|Deterioration of general conditions|5|||
33198369|NCT02610140|100630481|FG000|Safety Follow-up|Withdrawal by Subject|12|||
33198370|NCT02610140|100630482|FG001|Safety Follow-up|Withdrawal by Subject|12|||
33198371|NCT02610140|100630481|FG000|Active Follow-up|Progressive disease - radiological|30|||
33198372|NCT02610140|100630482|FG001|Active Follow-up|Progressive disease - radiological|22|||
33198373|NCT02610140|100630481|FG000|Active Follow-up|Death|8|||
33198374|NCT02610140|100630482|FG001|Active Follow-up|Death|1|||
33198375|NCT02610140|100630481|FG000|Active Follow-up|Withdrawal by Subject|4|||
33198376|NCT02610140|100630482|FG001|Active Follow-up|Withdrawal by Subject|0|||
33198377|NCT02610140|100630481|FG000|Active Follow-up|Progressive disease - clinical|1|||
33198378|NCT02610140|100630482|FG001|Active Follow-up|Progressive disease - clinical|2|||
33198379|NCT02610140|100630481|FG000|Active Follow-up|Deterioration of general conditions|1|||
33198380|NCT02610140|100630482|FG001|Active Follow-up|Deterioration of general conditions|0|||
33198381|NCT02610140|100630481|FG000|Active Follow-up|Ongoing but not completed|4|||
33198382|NCT02610140|100630482|FG001|Active Follow-up|Ongoing but not completed|1|||
33198383|NCT02610140|100630481|FG000|Long-term Follow-up|Death|86|||
33198384|NCT02610140|100630482|FG001|Long-term Follow-up|Death|44|||
33198385|NCT02610140|100630481|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
33198386|NCT02610140|100630482|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
33198387|NCT02610140|100630481|FG000|Long-term Follow-up|Lost to Follow-up|1|||
33323257|NCT01514136|101077654|FG000|Test Period 2; Test C*|Protocol Violation|0|||
33323258|NCT01514136|101077655|FG001|Test Period 2; Test C*|Protocol Violation|0|||
33323259|NCT01514136|101077656|FG002|Test Period 2; Test C*|Protocol Violation|0|||
33631278|NCT03279081|102202900|FG001|Overall Study|Adverse Event|0|||
33198388|NCT02610140|100630482|FG001|Long-term Follow-up|Lost to Follow-up|2|||
33198389|NCT02610140|100630481|FG000|Long-term Follow-up|Ongoing but not completed|30|||
33198390|NCT02610140|100630482|FG001|Long-term Follow-up|Ongoing but not completed|17|||
33323260|NCT01514136|101077657|FG003|Test Period 2; Test C*|Protocol Violation|0|||
33323261|NCT01514136|101077658|FG004|Test Period 2; Test C*|Protocol Violation|0|||
33198391|NCT02663128|100630483|FG000|Period 2|Physician Decision|0|||
33198392|NCT02663128|100630484|FG001|Period 2|Physician Decision|0|||
33323262|NCT01514136|101077659|FG005|Test Period 2; Test C*|Protocol Violation|0|||
33323263|NCT01514136|101077660|FG006|Test Period 2; Test C*|Protocol Violation|1|||
33323264|NCT01514136|101077661|FG007|Test Period 2; Test C*|Protocol Violation|0|||
33323265|NCT01237340|101077662|FG000|Overall Study|Adverse Event|3|||
33323266|NCT01237340|101077662|FG000|Overall Study|Withdrawal by Subject|1|||
33323267|NCT01237340|101077662|FG000|Overall Study|Early termination of the trial|36|||
33323268|NCT03715153|101077664|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
33323269|NCT03715153|101077665|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
33323270|NCT03715153|101077664|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
33323271|NCT03715153|101077665|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
33605686|NCT01641822|102108192|FG002|Run-in Phase|Noncompliance with study drug|0|||
33605687|NCT01641822|102108190|FG000|Run-in Phase|Adverse Event|3|||
33605688|NCT01641822|102108191|FG001|Run-in Phase|Adverse Event|0|||
33605689|NCT01641822|102108192|FG002|Run-in Phase|Adverse Event|0|||
33605690|NCT01641822|102108190|FG000|Run-in Phase|Withdrew consent|1|||
33605691|NCT01641822|102108191|FG001|Run-in Phase|Withdrew consent|0|||
33605692|NCT01641822|102108192|FG002|Run-in Phase|Withdrew consent|0|||
33605693|NCT01641822|102108190|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
33605694|NCT01641822|102108191|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
33605695|NCT01641822|102108192|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
33323272|NCT03715153|101077664|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
33323273|NCT03715153|101077665|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
33323274|NCT03715153|101077664|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
33323275|NCT03715153|101077665|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
33323276|NCT03715153|101077664|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
33323277|NCT03715153|101077665|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
33323278|NCT03715153|101077664|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
33323279|NCT03715153|101077665|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
33323280|NCT00909181|101077666|FG000|Overall Study|Lost to Follow-up|39|||
33323281|NCT00909181|101077667|FG001|Overall Study|Lost to Follow-up|18|||
33323282|NCT00909181|101077668|FG002|Overall Study|Lost to Follow-up|33|||
33511639|NCT00658775|101770307|FG001|Overall Study|Other|8|||
33511640|NCT02836236|101770308|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
33511641|NCT02836236|101770309|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
33511642|NCT02836236|101770310|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
33511643|NCT02836236|101770311|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
33511644|NCT02836236|101770308|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
33511645|NCT02836236|101770309|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
33511646|NCT02836236|101770310|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
33511647|NCT02836236|101770311|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
33511648|NCT02836236|101770308|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
33511649|NCT02836236|101770309|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
33511650|NCT02836236|101770310|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
33511651|NCT02836236|101770311|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
33511652|NCT02836236|101770308|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
33511653|NCT02836236|101770309|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
33511654|NCT02836236|101770310|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
33511655|NCT02836236|101770311|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
33511656|NCT02836236|101770308|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
33511657|NCT02836236|101770309|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
33511658|NCT02836236|101770310|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
33511659|NCT02836236|101770311|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
33511660|NCT02836236|101770308|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
33511661|NCT02836236|101770309|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
33511662|NCT02836236|101770310|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
33511663|NCT02836236|101770311|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
33323283|NCT00932425|101077669|FG000|Overall Study|Lost to Follow-up|0|||
33323284|NCT00932425|101077670|FG001|Overall Study|Lost to Follow-up|1|||
33323285|NCT00932425|101077669|FG000|Overall Study|Withdrawal by Subject|0|||
33323286|NCT00932425|101077670|FG001|Overall Study|Withdrawal by Subject|1|||
33323287|NCT00832117|101077673|FG000|Overall Study|Death|1|||
33323288|NCT00832117|101077673|FG000|Overall Study|Disease Progression|11|||
33511664|NCT02836236|101770308|FG000|Open-Label TAF Treatment Phase|Death|0|||
33605696|NCT01641822|102108190|FG000|Comparative Phase|Noncompliance with study drug|0|||
33605697|NCT01641822|102108191|FG001|Comparative Phase|Noncompliance with study drug|1|||
33605698|NCT01641822|102108192|FG002|Comparative Phase|Noncompliance with study drug|0|||
33605699|NCT01641822|102108190|FG000|Comparative Phase|Investigator's discretion|0|||
33605700|NCT01641822|102108191|FG001|Comparative Phase|Investigator's discretion|0|||
33605701|NCT01641822|102108192|FG002|Comparative Phase|Investigator's discretion|1|||
33605702|NCT01641822|102108190|FG000|Comparative Phase|Pregnancy|0|||
33605703|NCT01641822|102108191|FG001|Comparative Phase|Pregnancy|0|||
33605704|NCT01641822|102108192|FG002|Comparative Phase|Pregnancy|1|||
33511665|NCT02836236|101770309|FG001|Open-Label TAF Treatment Phase|Death|0|||
33511666|NCT02836236|101770310|FG002|Open-Label TAF Treatment Phase|Death|1|||
33323289|NCT00578786|101077682|FG000|Overall Study|Adverse Event|27|||
33323290|NCT00578786|101077683|FG001|Overall Study|Adverse Event|37|||
33323291|NCT00578786|101077684|FG002|Overall Study|Adverse Event|17|||
33323292|NCT00578786|101077682|FG000|Overall Study|Lack of Efficacy|2|||
33323293|NCT00578786|101077683|FG001|Overall Study|Lack of Efficacy|5|||
33323294|NCT00578786|101077684|FG002|Overall Study|Lack of Efficacy|2|||
33323295|NCT00578786|101077682|FG000|Overall Study|Early Escape from Prior Study|2|||
33323296|NCT00578786|101077683|FG001|Overall Study|Early Escape from Prior Study|1|||
33323297|NCT00578786|101077684|FG002|Overall Study|Early Escape from Prior Study|2|||
33323298|NCT00578786|101077682|FG000|Overall Study|Withdrawal by Subject|7|||
33323299|NCT00578786|101077683|FG001|Overall Study|Withdrawal by Subject|8|||
33323300|NCT00578786|101077684|FG002|Overall Study|Withdrawal by Subject|5|||
33323301|NCT00578786|101077682|FG000|Overall Study|Protocol Violation|0|||
33323302|NCT00578786|101077683|FG001|Overall Study|Protocol Violation|3|||
33323303|NCT00578786|101077684|FG002|Overall Study|Protocol Violation|1|||
33323304|NCT00578786|101077682|FG000|Overall Study|Physician Decision|1|||
33323305|NCT00578786|101077683|FG001|Overall Study|Physician Decision|0|||
33323306|NCT00578786|101077684|FG002|Overall Study|Physician Decision|1|||
33323307|NCT00578786|101077682|FG000|Overall Study|Sponsor Decision|0|||
33323308|NCT00578786|101077683|FG001|Overall Study|Sponsor Decision|0|||
33323309|NCT00578786|101077684|FG002|Overall Study|Sponsor Decision|1|||
33323310|NCT00578786|101077682|FG000|Overall Study|Lost to Follow-up|0|||
33323311|NCT00578786|101077683|FG001|Overall Study|Lost to Follow-up|4|||
33323312|NCT00578786|101077684|FG002|Overall Study|Lost to Follow-up|0|||
33323313|NCT00578786|101077682|FG000|Overall Study|Pregnancy|0|||
33323314|NCT00578786|101077683|FG001|Overall Study|Pregnancy|1|||
33323315|NCT00578786|101077684|FG002|Overall Study|Pregnancy|0|||
33323316|NCT00578786|101077682|FG000|Overall Study|Not Otherwise Specified|0|||
33323317|NCT00578786|101077683|FG001|Overall Study|Not Otherwise Specified|4|||
33323318|NCT00578786|101077684|FG002|Overall Study|Not Otherwise Specified|1|||
33323319|NCT00578786|101077682|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
33323320|NCT00578786|101077683|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
33323321|NCT00578786|101077684|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
33323322|NCT03583450|101080807|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
33323323|NCT03583450|101080808|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
33323324|NCT01681628|101080814|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
33323325|NCT01681628|101080815|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
33323326|NCT01681628|101080814|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
33323327|NCT01681628|101080815|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
33323328|NCT01681628|101080814|FG000|19 Months Follow-up|Death|1|||
33323329|NCT01681628|101080815|FG001|19 Months Follow-up|Death|0|||
33323330|NCT01681628|101080814|FG000|19 Months Follow-up|Lost to Follow-up|61|||
33323331|NCT01681628|101080815|FG001|19 Months Follow-up|Lost to Follow-up|43|||
33323332|NCT01829360|101080816|FG000|Overall Study|Protocol Violation|0|||
33323333|NCT01829360|101080817|FG001|Overall Study|Protocol Violation|0|||
33323334|NCT01829360|101080818|FG002|Overall Study|Protocol Violation|1|||
33323335|NCT01829360|101080819|FG003|Overall Study|Protocol Violation|0|||
33323336|NCT04343248|101080837|FG000|Overall Study|Withdrawal by Subject|5|||
33323337|NCT04343248|101080838|FG001|Overall Study|Withdrawal by Subject|6|||
33323338|NCT04343248|101080837|FG000|Overall Study|Death|1|||
33323339|NCT04343248|101080838|FG001|Overall Study|Death|2|||
33323340|NCT04343248|101080837|FG000|Overall Study|Lost to Follow-up|9|||
33323341|NCT04343248|101080838|FG001|Overall Study|Lost to Follow-up|6|||
33323342|NCT04343248|101080837|FG000|Overall Study|Physician Decision|0|||
33323343|NCT04343248|101080838|FG001|Overall Study|Physician Decision|1|||
33323344|NCT04343248|101080837|FG000|Overall Study|Adverse Event|1|||
33323345|NCT04343248|101080838|FG001|Overall Study|Adverse Event|0|||
33323346|NCT02445755|101080839|FG000|Overall Study|Withdrawal by Subject|2|||
33323347|NCT02445755|101080839|FG000|Overall Study|Protocol Violation|6|||
33323348|NCT02445755|101080839|FG000|Overall Study|Screen Failure|5|||
33511667|NCT02836236|101770311|FG003|Open-Label TAF Treatment Phase|Death|1|||
33511668|NCT02836236|101770308|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
33323349|NCT00911625|101080845|FG000|Overall Study|Lost to Follow-up|7|||
33511669|NCT02836236|101770309|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
33605705|NCT01641822|102108190|FG000|Comparative Phase|Adverse event, serious fatal|0|||
33323350|NCT00911625|101080846|FG001|Overall Study|Lost to Follow-up|0|||
33323351|NCT02615470|101080847|FG000|Overall Study|Lost to Follow-up|21|||
33323352|NCT02615470|101080848|FG001|Overall Study|Lost to Follow-up|32|||
33323353|NCT00860951|101080850|FG000|Overall Study|Withdrawal by Subject|2|||
33323354|NCT00860951|101080850|FG000|Overall Study|Lost to Follow-up|5|||
33323355|NCT00430482|101080851|FG000|Completed Treatment|Insufficient Treatment|7|||
33323356|NCT00430482|101080852|FG001|Completed Treatment|Insufficient Treatment|11|||
33323357|NCT01431274|101080853|FG000|Overall Study|Adverse Event|51|||
33323358|NCT01431274|101080854|FG001|Overall Study|Adverse Event|37|||
33323359|NCT01431274|101080855|FG002|Overall Study|Adverse Event|43|||
33323360|NCT01431274|101080856|FG003|Overall Study|Adverse Event|30|||
33323361|NCT01431274|101080857|FG004|Overall Study|Adverse Event|37|||
33323362|NCT01431274|101080853|FG000|Overall Study|Consent withdrawn not due to AE|29|||
33323363|NCT01431274|101080854|FG001|Overall Study|Consent withdrawn not due to AE|20|||
33323364|NCT01431274|101080855|FG002|Overall Study|Consent withdrawn not due to AE|17|||
33323365|NCT01431274|101080856|FG003|Overall Study|Consent withdrawn not due to AE|20|||
33198393|NCT02663128|100630485|FG002|Period 2|Physician Decision|0|||
33198394|NCT02663128|100630486|FG003|Period 2|Physician Decision|0|||
33198395|NCT02663128|100630487|FG004|Period 2|Physician Decision|1|||
33323366|NCT01431274|101080857|FG004|Overall Study|Consent withdrawn not due to AE|11|||
33323367|NCT01431274|101080853|FG000|Overall Study|Non compliant with protocol|5|||
33511670|NCT02836236|101770310|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
33511671|NCT02836236|101770311|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
33511672|NCT00725608|101770316|FG000|Overall Study|Lost to Follow-up|60|||
33511673|NCT00725608|101770316|FG000|Overall Study|Adverse Event|14|||
33511674|NCT00725608|101770316|FG000|Overall Study|Individual reasons|86|||
33511675|NCT00725608|101770316|FG000|Overall Study|Other|7|||
33511676|NCT02541669|101770317|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
33511677|NCT02541669|101770318|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
33511678|NCT02541669|101770319|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
33511679|NCT02541669|101770320|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
33511680|NCT02541669|101770321|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
33511681|NCT03361865|101770324|FG000|Overall Study|Death|17|||
33511682|NCT03361865|101770325|FG001|Overall Study|Death|18|||
33511683|NCT03361865|101770324|FG000|Overall Study|Physician Decision|1|||
33511684|NCT03361865|101770325|FG001|Overall Study|Physician Decision|9|||
33511685|NCT03361865|101770324|FG000|Overall Study|Withdrawal by Subject|1|||
33511686|NCT03361865|101770325|FG001|Overall Study|Withdrawal by Subject|0|||
33511687|NCT03045276|101770326|FG000|Intervention Phase|Withdrawal by Subject|7|||
33511688|NCT03045276|101770327|FG001|Intervention Phase|Withdrawal by Subject|2|||
33198396|NCT02663128|100630488|FG005|Period 2|Physician Decision|0|||
33323368|NCT01431274|101080854|FG001|Overall Study|Non compliant with protocol|8|||
33511689|NCT03045276|101770328|FG002|Intervention Phase|Withdrawal by Subject|3|||
33511690|NCT03045276|101770329|FG003|Intervention Phase|Withdrawal by Subject|7|||
33511691|NCT03045276|101770326|FG000|Intervention Phase|Developed exclusionary criteria|3|||
33323369|NCT01431274|101080855|FG002|Overall Study|Non compliant with protocol|4|||
33323370|NCT01431274|101080856|FG003|Overall Study|Non compliant with protocol|4|||
33323371|NCT01431274|101080857|FG004|Overall Study|Non compliant with protocol|4|||
33323372|NCT01431274|101080853|FG000|Overall Study|Lost to Follow-up|6|||
33323373|NCT01431274|101080854|FG001|Overall Study|Lost to Follow-up|7|||
33323374|NCT01431274|101080855|FG002|Overall Study|Lost to Follow-up|1|||
33323375|NCT01431274|101080856|FG003|Overall Study|Lost to Follow-up|4|||
33323376|NCT01431274|101080857|FG004|Overall Study|Lost to Follow-up|0|||
33323377|NCT01431274|101080853|FG000|Overall Study|Other reason not stated above|6|||
33323378|NCT01431274|101080854|FG001|Overall Study|Other reason not stated above|5|||
33323379|NCT01431274|101080855|FG002|Overall Study|Other reason not stated above|7|||
33323380|NCT01431274|101080856|FG003|Overall Study|Other reason not stated above|2|||
33323381|NCT01431274|101080857|FG004|Overall Study|Other reason not stated above|4|||
33323382|NCT02113579|101080858|FG000|Overall Study|Adverse Event|1|||
33323383|NCT02113579|101080859|FG001|Overall Study|Adverse Event|0|||
33198397|NCT02052466|100630489|FG000|Overall Study|Withdrawal by Subject|1|||
33198398|NCT02052466|100630489|FG000|Overall Study|Acromial fracture|1|||
33323384|NCT02113579|101080858|FG000|Overall Study|Withdrawal by Subject|3|||
33323385|NCT02113579|101080859|FG001|Overall Study|Withdrawal by Subject|2|||
33323386|NCT02113579|101080858|FG000|Overall Study|Lost to Follow-up|6|||
33323387|NCT02113579|101080859|FG001|Overall Study|Lost to Follow-up|2|||
33323388|NCT00962390|101080860|FG000|Overall Study|Adverse Event|0|||
33323389|NCT00962390|101080861|FG001|Overall Study|Adverse Event|0|||
33323390|NCT00962390|101080862|FG002|Overall Study|Adverse Event|3|||
33323391|NCT00962390|101080863|FG003|Overall Study|Adverse Event|1|||
33323392|NCT00962390|101080860|FG000|Overall Study|Lost to Follow-up|2|||
33323393|NCT00962390|101080861|FG001|Overall Study|Lost to Follow-up|2|||
33323394|NCT00962390|101080862|FG002|Overall Study|Lost to Follow-up|0|||
33323395|NCT00962390|101080863|FG003|Overall Study|Lost to Follow-up|0|||
33323396|NCT00962390|101080860|FG000|Overall Study|Protocol Violation|1|||
33323397|NCT00962390|101080861|FG001|Overall Study|Protocol Violation|0|||
33323398|NCT00962390|101080862|FG002|Overall Study|Protocol Violation|0|||
33323399|NCT00962390|101080863|FG003|Overall Study|Protocol Violation|0|||
33323400|NCT00962390|101080860|FG000|Overall Study|Withdrawal by Subject|1|||
33323401|NCT00962390|101080861|FG001|Overall Study|Withdrawal by Subject|1|||
33323402|NCT00962390|101080862|FG002|Overall Study|Withdrawal by Subject|1|||
33323403|NCT00962390|101080863|FG003|Overall Study|Withdrawal by Subject|0|||
33323404|NCT01221727|101080867|FG000|Overall Study|Physician Decision|2|||
33323405|NCT01221727|101080868|FG001|Overall Study|Physician Decision|0|||
33323406|NCT01221727|101080867|FG000|Overall Study|Withdrawal by Subject|1|||
33323407|NCT01221727|101080868|FG001|Overall Study|Withdrawal by Subject|1|||
33323408|NCT00041080|101080869|FG000|Overall Study|Adverse Event|21|||
33323409|NCT00041080|101080870|FG001|Overall Study|Adverse Event|1|||
33323410|NCT00041080|101080869|FG000|Overall Study|Withdrawal by Subject|6|||
33323411|NCT00041080|101080870|FG001|Overall Study|Withdrawal by Subject|6|||
33323412|NCT00041080|101080869|FG000|Overall Study|Concommitant Illness/Other|1|||
33323413|NCT00041080|101080870|FG001|Overall Study|Concommitant Illness/Other|2|||
33511692|NCT03045276|101770327|FG001|Intervention Phase|Developed exclusionary criteria|3|||
33511693|NCT03045276|101770328|FG002|Intervention Phase|Developed exclusionary criteria|0|||
33511694|NCT03045276|101770329|FG003|Intervention Phase|Developed exclusionary criteria|0|||
33511695|NCT03045276|101770326|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
33511696|NCT03045276|101770327|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
33511697|NCT03045276|101770328|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
33511698|NCT03045276|101770329|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
33511699|NCT03045276|101770326|FG000|Follow-Up Phase|Lost to Follow-up|0|||
33511700|NCT03045276|101770327|FG001|Follow-Up Phase|Lost to Follow-up|1|||
33511701|NCT03045276|101770328|FG002|Follow-Up Phase|Lost to Follow-up|0|||
33511702|NCT03045276|101770329|FG003|Follow-Up Phase|Lost to Follow-up|1|||
33511703|NCT03045276|101770326|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
33511704|NCT03045276|101770327|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
33323414|NCT00041080|101080869|FG000|Overall Study|Did not start therapy|1|||
33323415|NCT00041080|101080870|FG001|Overall Study|Did not start therapy|1|||
33323416|NCT00041080|101080869|FG000|Overall Study|Ineligible|1|||
33323417|NCT00041080|101080870|FG001|Overall Study|Ineligible|0|||
33511705|NCT03045276|101770328|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
33511706|NCT03045276|101770329|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
33511707|NCT04323306|101770330|FG000|Overall Study|Physician Decision|1|||
33323418|NCT03155373|101080872|FG000|Overall Study|No longer required surgery|1|||
33323419|NCT03155373|101080872|FG000|Overall Study|Protocol Violation|1|||
33323420|NCT03155373|101080872|FG000|Overall Study|Death|2|||
33323421|NCT03155373|101080872|FG000|Overall Study|Withdrawal by Subject|3|||
33511708|NCT04323306|101770331|FG001|Overall Study|Physician Decision|0|||
33511709|NCT04323306|101770332|FG002|Overall Study|Physician Decision|0|||
33511710|NCT04323306|101770333|FG003|Overall Study|Physician Decision|0|||
33198399|NCT01430130|100630497|FG000|Overall Study|Lost to Follow-up|1|||
33323422|NCT00929656|101080875|FG000|Overall Study|Lost to Follow-up|0|||
33323423|NCT00929656|101080876|FG001|Overall Study|Lost to Follow-up|1|||
33323424|NCT01379573|101080879|FG000|Overall Study|Lost to Follow-up|1|||
33323425|NCT01379573|101080879|FG000|Overall Study|Screen Failure|10|||
33323426|NCT02361944|101080880|FG000|Overall Study|surgery cancellation|0|||
33323427|NCT02361944|101080881|FG001|Overall Study|surgery cancellation|1|||
33323428|NCT00385203|101080884|FG000|Overall Study|Adverse Event|5|||
33323429|NCT00385203|101080885|FG001|Overall Study|Adverse Event|4|||
33323430|NCT00385203|101080884|FG000|Overall Study|Death|1|||
33323431|NCT00385203|101080885|FG001|Overall Study|Death|0|||
33323432|NCT00385203|101080884|FG000|Overall Study|Condition under investigation worsened|18|||
33323433|NCT00385203|101080885|FG001|Overall Study|Condition under investigation worsened|3|||
33323434|NCT00385203|101080884|FG000|Overall Study|Incorrect enrollment|2|||
33323435|NCT00385203|101080885|FG001|Overall Study|Incorrect enrollment|0|||
33323436|NCT00702325|101080886|FG000|Overall Study|Adverse Event|1|||
33323437|NCT00702325|101080887|FG001|Overall Study|Adverse Event|0|||
33323438|NCT00702325|101080886|FG000|Overall Study|Withdrawal by Subject|7|||
33323439|NCT00702325|101080887|FG001|Overall Study|Withdrawal by Subject|7|||
33323440|NCT00702325|101080886|FG000|Overall Study|Lost to Follow-up|3|||
33323441|NCT00702325|101080887|FG001|Overall Study|Lost to Follow-up|4|||
33323442|NCT00702325|101080886|FG000|Overall Study|Incorrect enrollment|5|||
33323443|NCT00702325|101080887|FG001|Overall Study|Incorrect enrollment|7|||
33323444|NCT00702325|101080886|FG000|Overall Study|Developed study discontinuation criteria|18|||
33323445|NCT00702325|101080887|FG001|Overall Study|Developed study discontinuation criteria|28|||
33323446|NCT00702325|101080886|FG000|Overall Study|Severe noncompliance to protocol|3|||
33323447|NCT00702325|101080887|FG001|Overall Study|Severe noncompliance to protocol|3|||
33323448|NCT00702325|101080886|FG000|Overall Study|Termination due to lab results|1|||
33323449|NCT00702325|101080887|FG001|Overall Study|Termination due to lab results|0|||
33323450|NCT00702325|101080886|FG000|Overall Study|Didn't follow study medication dosage|0|||
33323451|NCT00702325|101080887|FG001|Overall Study|Didn't follow study medication dosage|2|||
33323452|NCT00702325|101080886|FG000|Overall Study|Withdrew consent|0|||
33323453|NCT00702325|101080887|FG001|Overall Study|Withdrew consent|1|||
33323454|NCT00702325|101080886|FG000|Overall Study|Incorrectly Discontinued|0|||
33323455|NCT00702325|101080887|FG001|Overall Study|Incorrectly Discontinued|1|||
33323456|NCT05093322|101080891|FG000|Overall Study|Death|6|||
33323457|NCT05093322|101080892|FG001|Overall Study|Death|2|||
33323458|NCT05093322|101080891|FG000|Overall Study|Other|4|||
33323459|NCT05093322|101080892|FG001|Overall Study|Other|1|||
33323460|NCT01886313|101080895|FG000|Overall Study|Adverse Event|1|||
33323461|NCT01886313|101080896|FG001|Overall Study|Adverse Event|1|||
33323462|NCT00314249|101080897|FG000|Overall Study|Adverse Event|73|||
33323463|NCT00314249|101080898|FG001|Overall Study|Adverse Event|94|||
33323464|NCT00314249|101080897|FG000|Overall Study|Lack of Efficacy|33|||
33323465|NCT00314249|101080898|FG001|Overall Study|Lack of Efficacy|24|||
33323466|NCT00314249|101080897|FG000|Overall Study|Withdrawal by Subject|21|||
33198400|NCT01430130|100630497|FG000|Overall Study|Infection on Control Side of Incision|1|||
33198401|NCT00345579|100630501|FG000|Overall Study|Adverse Event|9|||
33198402|NCT00345579|100630502|FG001|Overall Study|Adverse Event|6|||
33198403|NCT00345579|100630501|FG000|Overall Study|Protocol Violation|14|||
33198404|NCT00345579|100630502|FG001|Overall Study|Protocol Violation|5|||
33198405|NCT00345579|100630501|FG000|Overall Study|Withdrawal by Subject|50|||
33198406|NCT00345579|100630502|FG001|Overall Study|Withdrawal by Subject|17|||
33323467|NCT00314249|101080898|FG001|Overall Study|Withdrawal by Subject|28|||
33323468|NCT00314249|101080897|FG000|Overall Study|Lost to Follow-up|15|||
33323469|NCT00314249|101080898|FG001|Overall Study|Lost to Follow-up|9|||
33323470|NCT00314249|101080897|FG000|Overall Study|Physician Decision|1|||
33323471|NCT00314249|101080898|FG001|Overall Study|Physician Decision|1|||
33605706|NCT01641822|102108191|FG001|Comparative Phase|Adverse event, serious fatal|1|||
33323472|NCT00314249|101080897|FG000|Overall Study|Withdrawn for other reasons|4|||
33323473|NCT00314249|101080898|FG001|Overall Study|Withdrawn for other reasons|1|||
33323474|NCT00314249|101080897|FG000|Overall Study|Non-Compliant|5|||
33323475|NCT00314249|101080898|FG001|Overall Study|Non-Compliant|6|||
33323476|NCT01519934|101080905|FG000|Overall Study|Lost to Follow-up|3|||
33323477|NCT00882310|101080906|FG000|Overall Study|Screen Failure|10|||
33323478|NCT00882310|101080906|FG000|Overall Study|Never received treatment|1|||
33323479|NCT00882310|101080906|FG000|Overall Study|Death|6|||
33323480|NCT00882310|101080906|FG000|Overall Study|Progression of disease|4|||
33323481|NCT00882310|101080906|FG000|Overall Study|Adverse Event|1|||
33198407|NCT00345579|100630501|FG000|Overall Study|Lost to Follow-up|82|||
33323482|NCT02129205|101080911|FG000|Overall Study|Withdrawal by Subject|0|||
33323483|NCT02129205|101080912|FG001|Overall Study|Withdrawal by Subject|0|||
33323484|NCT02129205|101080913|FG002|Overall Study|Withdrawal by Subject|0|||
33323485|NCT02129205|101080914|FG003|Overall Study|Withdrawal by Subject|0|||
33323486|NCT02129205|101080915|FG004|Overall Study|Withdrawal by Subject|1|||
33323487|NCT02129205|101080916|FG005|Overall Study|Withdrawal by Subject|1|||
33323488|NCT02129205|101080917|FG006|Overall Study|Withdrawal by Subject|1|||
33323489|NCT02129205|101080918|FG007|Overall Study|Withdrawal by Subject|0|||
33323490|NCT02129205|101080919|FG008|Overall Study|Withdrawal by Subject|1|||
33323491|NCT02129205|101080920|FG009|Overall Study|Withdrawal by Subject|0|||
33323492|NCT02129205|101080911|FG000|Overall Study|Other|1|||
33323493|NCT02129205|101080912|FG001|Overall Study|Other|0|||
33323494|NCT02129205|101080913|FG002|Overall Study|Other|0|||
33323495|NCT02129205|101080914|FG003|Overall Study|Other|0|||
33323496|NCT02129205|101080915|FG004|Overall Study|Other|2|||
33323497|NCT02129205|101080916|FG005|Overall Study|Other|3|||
33323498|NCT02129205|101080917|FG006|Overall Study|Other|3|||
33323499|NCT02129205|101080918|FG007|Overall Study|Other|2|||
33323500|NCT02129205|101080919|FG008|Overall Study|Other|1|||
33323501|NCT02129205|101080920|FG009|Overall Study|Other|0|||
33323502|NCT04784897|101080924|FG000|Overall Study|Death|4|||
33323503|NCT04784897|101080925|FG001|Overall Study|Death|2|||
33198408|NCT00345579|100630502|FG001|Overall Study|Lost to Follow-up|36|||
33198409|NCT00345579|100630501|FG000|Overall Study|Other|9|||
33323504|NCT04784897|101080926|FG002|Overall Study|Death|1|||
33323505|NCT04784897|101080924|FG000|Overall Study|Withdrawal by Subject|0|||
33323506|NCT04784897|101080925|FG001|Overall Study|Withdrawal by Subject|0|||
33323507|NCT04784897|101080926|FG002|Overall Study|Withdrawal by Subject|1|||
33198410|NCT00345579|100630502|FG001|Overall Study|Other|1|||
33198411|NCT00690755|100630505|FG000|Overall Study|Physician Decision|2|||
33198412|NCT00690755|100630506|FG001|Overall Study|Physician Decision|0|||
33198413|NCT00690755|100630507|FG002|Overall Study|Physician Decision|46|||
33198414|NCT00690755|100630508|FG003|Overall Study|Physician Decision|5|||
33198415|NCT00690755|100630509|FG004|Overall Study|Physician Decision|0|||
33198416|NCT00690755|100630510|FG005|Overall Study|Physician Decision|4|||
33198417|NCT00690755|100630511|FG006|Overall Study|Physician Decision|0|||
33198418|NCT00298038|100630512|FG000|Overall Study|Lost to Follow-up|0|||
33198419|NCT00298038|100630513|FG001|Overall Study|Lost to Follow-up|1|||
33323508|NCT03838198|101080927|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
33323509|NCT03838198|101080928|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
33323510|NCT03838198|101080929|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
33323511|NCT03838198|101080930|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
33323512|NCT03838198|101080927|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
33323513|NCT03838198|101080928|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
33323514|NCT03838198|101080929|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
33323515|NCT03838198|101080930|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
33323516|NCT01849497|101080933|FG000|Overall Study|Withdrawal by Subject|1|||
33323517|NCT01849497|101080934|FG001|Overall Study|Withdrawal by Subject|2|||
33323518|NCT01849497|101080933|FG000|Overall Study|Sponsor Decision|0|||
33198420|NCT00298038|100630512|FG000|Overall Study|Liver Transplant|0|||
33198421|NCT00298038|100630513|FG001|Overall Study|Liver Transplant|1|||
33198422|NCT00298038|100630512|FG000|Overall Study|Protocol Violation|1|||
33198423|NCT00298038|100630513|FG001|Overall Study|Protocol Violation|3|||
33198424|NCT00298038|100630512|FG000|Overall Study|Death|6|||
33198425|NCT00298038|100630513|FG001|Overall Study|Death|3|||
33198426|NCT00298038|100630512|FG000|Overall Study|Withdrawal by Subject|6|||
33198427|NCT00298038|100630513|FG001|Overall Study|Withdrawal by Subject|9|||
33198428|NCT00298038|100630512|FG000|Overall Study|Adverse Event|8|||
33198429|NCT00298038|100630513|FG001|Overall Study|Adverse Event|7|||
33198430|NCT00298038|100630512|FG000|Overall Study|Breakthrough overt HE episode|28|||
33198431|NCT00298038|100630513|FG001|Overall Study|Breakthrough overt HE episode|69|||
33198432|NCT00298038|100630512|FG000|Overall Study|Noncompliance|1|||
33198433|NCT00298038|100630513|FG001|Overall Study|Noncompliance|0|||
33198434|NCT00298038|100630512|FG000|Overall Study|Cocaine Abuse|1|||
33198435|NCT00298038|100630513|FG001|Overall Study|Cocaine Abuse|0|||
33198436|NCT00298038|100630512|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
33323519|NCT01849497|101080934|FG001|Overall Study|Sponsor Decision|1|||
33323520|NCT01849497|101080933|FG000|Overall Study|Lost to Follow-up|0|||
33399081|NCT02394028|101350176|FG001|Induction Phase|Withdrawal by Subject|2|||
33198437|NCT00298038|100630513|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
33323521|NCT01849497|101080934|FG001|Overall Study|Lost to Follow-up|1|||
33323522|NCT04490395|101080935|FG000|Overall Study|Lost to Follow-up|0|||
33198438|NCT01575561|100630514|FG000|Overall Study|Adverse Event|9|||
33198439|NCT01575561|100630514|FG000|Overall Study|Lack of Efficacy|8|||
33323523|NCT04490395|101080936|FG001|Overall Study|Lost to Follow-up|1|||
33323524|NCT01641237|101080937|FG000|Period II|Withdrawal by Subject|1|||
33198440|NCT01575561|100630514|FG000|Overall Study|Lost to Follow-up|6|||
33198441|NCT01575561|100630514|FG000|Overall Study|Protocol Violation|4|||
33511711|NCT04323306|101770334|FG004|Overall Study|Physician Decision|0|||
33511712|NCT04323306|101770335|FG005|Overall Study|Physician Decision|0|||
33323525|NCT01641237|101080938|FG001|Period II|Withdrawal by Subject|0|||
33323526|NCT01641237|101080939|FG002|Period II|Withdrawal by Subject|0|||
33323527|NCT01641237|101080940|FG003|Period II|Withdrawal by Subject|0|||
33323528|NCT01641237|101080937|FG000|Period III|Lost to Follow-up|1|||
33323529|NCT01641237|101080938|FG001|Period III|Lost to Follow-up|0|||
33323530|NCT01641237|101080939|FG002|Period III|Lost to Follow-up|0|||
33323531|NCT01641237|101080940|FG003|Period III|Lost to Follow-up|0|||
33323532|NCT00736034|101080941|FG000|Overall Study|Adverse Event|2|||
33323533|NCT01335009|101080942|FG000|Overall Study|Too ill to travel to study sites|1|||
33323534|NCT01335009|101080943|FG001|Overall Study|Too ill to travel to study sites|0|||
33323535|NCT01335009|101080942|FG000|Overall Study|Death|28|||
33323536|NCT01335009|101080943|FG001|Overall Study|Death|32|||
33323537|NCT01335009|101080942|FG000|Overall Study|Withdrawal by Subject|1|||
33323538|NCT01335009|101080943|FG001|Overall Study|Withdrawal by Subject|1|||
33323539|NCT01335009|101080942|FG000|Overall Study|Lost to Follow-up|1|||
33323540|NCT01335009|101080943|FG001|Overall Study|Lost to Follow-up|0|||
33323541|NCT00455013|101080944|FG000|Short Term Period|Adverse Event|2|||
33323542|NCT00455013|101080945|FG001|Short Term Period|Adverse Event|5|||
33323543|NCT00455013|101080946|FG002|Short Term Period|Adverse Event|0|||
33323544|NCT00455013|101080944|FG000|Short Term Period|Withdrawal by Subject|0|||
33323545|NCT00455013|101080945|FG001|Short Term Period|Withdrawal by Subject|0|||
33323546|NCT00455013|101080946|FG002|Short Term Period|Withdrawal by Subject|1|||
33323547|NCT00455013|101080944|FG000|Short Term Period|Lack of Efficacy|4|||
33323548|NCT00455013|101080945|FG001|Short Term Period|Lack of Efficacy|0|||
33323549|NCT00455013|101080946|FG002|Short Term Period|Lack of Efficacy|0|||
33323550|NCT00455013|101080944|FG000|Short Term Period|Other|0|||
33323551|NCT00455013|101080945|FG001|Short Term Period|Other|0|||
33511713|NCT04323306|101770336|FG006|Overall Study|Physician Decision|0|||
33511714|NCT04323306|101770337|FG007|Overall Study|Physician Decision|0|||
33323552|NCT00455013|101080946|FG002|Short Term Period|Other|1|||
33323553|NCT00455013|101080944|FG000|Long Term Extension (LTE)|Adverse Event|0|||
33323554|NCT00455013|101080945|FG001|Long Term Extension (LTE)|Adverse Event|1|||
33323555|NCT00455013|101080946|FG002|Long Term Extension (LTE)|Adverse Event|1|||
33323556|NCT00455013|101080944|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
33323557|NCT00455013|101080945|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
33323558|NCT00455013|101080946|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
33323559|NCT00455013|101080944|FG000|Long Term Extension (LTE)|Death|1|||
33323560|NCT00455013|101080945|FG001|Long Term Extension (LTE)|Death|1|||
33511715|NCT04323306|101770338|FG008|Overall Study|Physician Decision|0|||
33511716|NCT04323306|101770330|FG000|Overall Study|Withdrawal by Subject|0|||
33511717|NCT04323306|101770331|FG001|Overall Study|Withdrawal by Subject|0|||
33511718|NCT04323306|101770332|FG002|Overall Study|Withdrawal by Subject|0|||
33511719|NCT04323306|101770333|FG003|Overall Study|Withdrawal by Subject|0|||
33511720|NCT04323306|101770334|FG004|Overall Study|Withdrawal by Subject|0|||
33511721|NCT04323306|101770335|FG005|Overall Study|Withdrawal by Subject|1|||
33511722|NCT04323306|101770336|FG006|Overall Study|Withdrawal by Subject|3|||
33511723|NCT04323306|101770337|FG007|Overall Study|Withdrawal by Subject|0|||
33511724|NCT04323306|101770338|FG008|Overall Study|Withdrawal by Subject|1|||
33511725|NCT03917472|101770339|FG000|Overall Study|Physician Decision|4|||
33511726|NCT03917472|101770340|FG001|Overall Study|Physician Decision|0|||
33511727|NCT03917472|101770339|FG000|Overall Study|Adverse Event|3|||
33511728|NCT03917472|101770340|FG001|Overall Study|Adverse Event|1|||
33323561|NCT00455013|101080946|FG002|Long Term Extension (LTE)|Death|0|||
33323562|NCT00455013|101080944|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
33323563|NCT00455013|101080945|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
33323564|NCT00455013|101080946|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
33323565|NCT00455013|101080944|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
33323566|NCT00455013|101080945|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
33323567|NCT00455013|101080946|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
33323568|NCT00455013|101080944|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
33323569|NCT00455013|101080945|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
33511729|NCT03917472|101770339|FG000|Overall Study|Death|7|||
33511730|NCT03917472|101770340|FG001|Overall Study|Death|5|||
33511731|NCT03917472|101770339|FG000|Overall Study|Withdrawal by Subject|11|||
33511732|NCT03917472|101770340|FG001|Overall Study|Withdrawal by Subject|4|||
33511733|NCT03917472|101770339|FG000|Overall Study|Lost to Follow-up|10|||
33323570|NCT00455013|101080946|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
33323571|NCT00455013|101080944|FG000|Long Term Extension (LTE)|non-specified|0|||
33323572|NCT00455013|101080945|FG001|Long Term Extension (LTE)|non-specified|0|||
33323573|NCT00455013|101080946|FG002|Long Term Extension (LTE)|non-specified|1|||
33323574|NCT00590044|101080947|FG000|Overall Study|Withdrawal by Subject|2|||
33323575|NCT00590044|101080948|FG001|Overall Study|Withdrawal by Subject|2|||
33323576|NCT00590044|101080947|FG000|Overall Study|wrong insulin arm assigned|1|||
33511734|NCT03917472|101770340|FG001|Overall Study|Lost to Follow-up|5|||
33511735|NCT04050124|101770341|FG000|Overall Study|Death|1|||
33323577|NCT00590044|101080948|FG001|Overall Study|wrong insulin arm assigned|0|||
33323578|NCT00590044|101080947|FG000|Overall Study|Protocol Violation|1|||
33323579|NCT00590044|101080948|FG001|Overall Study|Protocol Violation|0|||
33323580|NCT04411628|101080952|FG000|Overall Study|Withdrawal by Subject|1|||
33323581|NCT04411628|101080953|FG001|Overall Study|Withdrawal by Subject|1|||
33323582|NCT04411628|101080954|FG002|Overall Study|Withdrawal by Subject|2|||
33323583|NCT04411628|101080955|FG003|Overall Study|Withdrawal by Subject|0|||
33323584|NCT04411628|101080952|FG000|Overall Study|Lost to Follow-up|0|||
33511736|NCT04050124|101770342|FG001|Overall Study|Death|0|||
33511737|NCT00791661|101770343|FG000|7 Day Wash-out|Adverse Event|0|||
33511738|NCT00791661|101770344|FG001|7 Day Wash-out|Adverse Event|0|||
33511739|NCT00791661|101770345|FG002|7 Day Wash-out|Adverse Event|1|||
33511740|NCT00791661|101770343|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
33511741|NCT00791661|101770344|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
33511742|NCT00791661|101770345|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
33511743|NCT04725812|101770346|FG000|Overall Study|Withdrawal by Subject|1|||
33511744|NCT00567489|101770347|FG000|Overall Study|Adverse Event|6|||
33511745|NCT00567489|101770348|FG001|Overall Study|Adverse Event|14|||
33511746|NCT00567489|101770347|FG000|Overall Study|Physician Decision|0|||
33511747|NCT00567489|101770348|FG001|Overall Study|Physician Decision|4|||
33511748|NCT00567489|101770347|FG000|Overall Study|Withdrawal by Subject|0|||
33511749|NCT00567489|101770348|FG001|Overall Study|Withdrawal by Subject|2|||
33511750|NCT00567489|101770347|FG000|Overall Study|Renal Transplantation|0|||
33511751|NCT00567489|101770348|FG001|Overall Study|Renal Transplantation|3|||
33511752|NCT00567489|101770347|FG000|Overall Study|Other|1|||
33511753|NCT00567489|101770348|FG001|Overall Study|Other|0|||
33511754|NCT03696108|101770349|FG000|Overall Study|Physician Decision|1|||
33511755|NCT03696108|101770350|FG001|Overall Study|Physician Decision|0|||
33511756|NCT03696108|101770349|FG000|Overall Study|Withdrawal by Subject|3|||
33511757|NCT03696108|101770350|FG001|Overall Study|Withdrawal by Subject|6|||
33511758|NCT04017832|101770351|FG000|Overall Study|Withdrawal by Subject|13|||
33511759|NCT04017832|101770352|FG001|Overall Study|Withdrawal by Subject|12|||
33511760|NCT04017832|101770353|FG002|Overall Study|Withdrawal by Subject|21|||
33511761|NCT04017832|101770354|FG003|Overall Study|Withdrawal by Subject|7|||
33511762|NCT04017832|101770351|FG000|Overall Study|Lost to Follow-up|0|||
33511763|NCT04017832|101770352|FG001|Overall Study|Lost to Follow-up|3|||
33323585|NCT04411628|101080953|FG001|Overall Study|Lost to Follow-up|1|||
33323586|NCT04411628|101080954|FG002|Overall Study|Lost to Follow-up|0|||
33323587|NCT04411628|101080955|FG003|Overall Study|Lost to Follow-up|0|||
33323588|NCT03768505|101080957|FG000|Overall Study|sponsor decision|76|||
33323589|NCT03768505|101080957|FG000|Overall Study|Death|35|||
33511764|NCT04017832|101770353|FG002|Overall Study|Lost to Follow-up|3|||
33511765|NCT04017832|101770354|FG003|Overall Study|Lost to Follow-up|1|||
33511766|NCT04017832|101770351|FG000|Overall Study|Physician Decision|1|||
33511767|NCT04017832|101770352|FG001|Overall Study|Physician Decision|1|||
33511768|NCT04017832|101770353|FG002|Overall Study|Physician Decision|1|||
33511769|NCT04017832|101770354|FG003|Overall Study|Physician Decision|1|||
33511770|NCT04017832|101770351|FG000|Overall Study|Death|2|||
33511771|NCT04017832|101770352|FG001|Overall Study|Death|2|||
33323590|NCT03768505|101080957|FG000|Overall Study|Other -Various|30|||
33323591|NCT03768505|101080957|FG000|Overall Study|Withdrawal by Subject|22|||
33323592|NCT03768505|101080957|FG000|Overall Study|Lost to Follow-up|6|||
33511772|NCT04017832|101770353|FG002|Overall Study|Death|1|||
33511773|NCT04017832|101770354|FG003|Overall Study|Death|0|||
33511774|NCT02234596|101770355|FG000|Overall Study|Participant not treated|2|||
33511775|NCT03409107|101770356|FG000|Overall Study|Withdrawal by Subject|4|||
33605707|NCT01641822|102108192|FG002|Comparative Phase|Adverse event, serious fatal|0|||
33605708|NCT01641822|102108190|FG000|Comparative Phase|Withdrew consent|0|||
33511776|NCT03409107|101770357|FG001|Overall Study|Withdrawal by Subject|2|||
33511777|NCT03409107|101770356|FG000|Overall Study|Physician Decision|1|||
33511778|NCT03409107|101770357|FG001|Overall Study|Physician Decision|0|||
33511779|NCT03409107|101770356|FG000|Overall Study|Lost to Follow-up|7|||
33511780|NCT03409107|101770357|FG001|Overall Study|Lost to Follow-up|2|||
33511781|NCT03409107|101770356|FG000|Overall Study|Adverse Event|5|||
33511782|NCT03409107|101770357|FG001|Overall Study|Adverse Event|3|||
33511783|NCT01701193|101770358|FG000|Overall Study|Withdrawal by Subject|2|||
33323593|NCT00210184|101080960|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
33323594|NCT01200238|101080965|FG000|Overall Study|Adverse Event|2|||
33511784|NCT01701193|101770359|FG001|Overall Study|Withdrawal by Subject|2|||
33511785|NCT01701193|101770360|FG002|Overall Study|Withdrawal by Subject|1|||
33511786|NCT01701193|101770361|FG003|Overall Study|Withdrawal by Subject|2|||
33511787|NCT01701193|101770358|FG000|Overall Study|Adverse Event|1|||
33511788|NCT01701193|101770359|FG001|Overall Study|Adverse Event|0|||
33511789|NCT01701193|101770360|FG002|Overall Study|Adverse Event|0|||
33511790|NCT01701193|101770361|FG003|Overall Study|Adverse Event|0|||
33511791|NCT02100670|101770362|FG000|Overall Study|Adverse Event|10|||
33511792|NCT02100670|101770363|FG001|Overall Study|Adverse Event|3|||
33511793|NCT02100670|101770364|FG002|Overall Study|Adverse Event|3|||
33323595|NCT01200238|101080966|FG001|Overall Study|Adverse Event|1|||
33323596|NCT01200238|101080965|FG000|Overall Study|Progressive Disease|5|||
33511794|NCT02100670|101770365|FG003|Overall Study|Adverse Event|0|||
33511795|NCT02100670|101770362|FG000|Overall Study|Lost to Follow-up|1|||
33511796|NCT02100670|101770363|FG001|Overall Study|Lost to Follow-up|0|||
33511797|NCT02100670|101770364|FG002|Overall Study|Lost to Follow-up|0|||
33511798|NCT02100670|101770365|FG003|Overall Study|Lost to Follow-up|0|||
33511799|NCT02100670|101770362|FG000|Overall Study|Protocol Violation|0|||
33511800|NCT02100670|101770363|FG001|Overall Study|Protocol Violation|1|||
33511801|NCT02100670|101770364|FG002|Overall Study|Protocol Violation|0|||
33323597|NCT01200238|101080966|FG001|Overall Study|Progressive Disease|8|||
33323598|NCT01200238|101080965|FG000|Overall Study|Withdrawal by Subject|0|||
33323599|NCT01200238|101080966|FG001|Overall Study|Withdrawal by Subject|1|||
33323600|NCT02294682|101080967|FG000|Overall Study|Could not swallow pills|1|||
33323601|NCT02294682|101080968|FG001|Overall Study|Could not swallow pills|0|||
33323602|NCT00993954|101080969|FG000|Overall Study|Protocol Violation|21|||
33323603|NCT00993954|101080970|FG001|Overall Study|Protocol Violation|2|||
33323604|NCT00732251|101080971|FG000|Overall Study|Lost to Follow-up|3|||
33323605|NCT00732251|101080971|FG000|Overall Study|Withdrawal by Subject|3|||
33323606|NCT00732251|101080971|FG000|Overall Study|Early Term due to Site Closure|1|||
33323607|NCT01105091|101080972|FG000|Overall Study|Death|2|||
33323608|NCT01105091|101080973|FG001|Overall Study|Death|0|||
33323609|NCT01493557|101080974|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
33323610|NCT01493557|101080975|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
33323611|NCT01493557|101080976|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
33323612|NCT01493557|101080974|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
33323613|NCT01493557|101080975|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
33323614|NCT01493557|101080976|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
33323615|NCT01493557|101080974|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
33323616|NCT01493557|101080975|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
33511802|NCT02100670|101770365|FG003|Overall Study|Protocol Violation|1|||
33511803|NCT02100670|101770362|FG000|Overall Study|Withdrawal of Consent|0|||
33511804|NCT02100670|101770363|FG001|Overall Study|Withdrawal of Consent|1|||
33511805|NCT02100670|101770364|FG002|Overall Study|Withdrawal of Consent|1|||
33511806|NCT02100670|101770365|FG003|Overall Study|Withdrawal of Consent|0|||
33323617|NCT01493557|101080976|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
33323618|NCT01493557|101080974|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
33323619|NCT01493557|101080975|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
33323620|NCT01493557|101080976|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
33323621|NCT01493557|101080974|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
33323622|NCT01493557|101080975|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
33323623|NCT01493557|101080976|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
33323624|NCT01493557|101080974|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
33323625|NCT01493557|101080975|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
33323626|NCT01493557|101080976|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
33323627|NCT01493557|101080974|FG000|Not Randomized to Management Strategies|Early termination|0|||
33323628|NCT01493557|101080975|FG001|Not Randomized to Management Strategies|Early termination|0|||
33323629|NCT01493557|101080976|FG002|Not Randomized to Management Strategies|Early termination|34|||
33323630|NCT01493557|101080974|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
33323631|NCT01493557|101080975|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
33323632|NCT01493557|101080976|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
33323633|NCT01493557|101080974|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
33323634|NCT01493557|101080975|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
33323635|NCT01493557|101080976|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
33323636|NCT01493557|101080974|FG000|Randomized to Management Strategies|Other adverse event|8|||
33323637|NCT01493557|101080975|FG001|Randomized to Management Strategies|Other adverse event|5|||
33323638|NCT01493557|101080976|FG002|Randomized to Management Strategies|Other adverse event|0|||
33323639|NCT01493557|101080974|FG000|Randomized to Management Strategies|Protocol Violation|3|||
33323640|NCT01493557|101080975|FG001|Randomized to Management Strategies|Protocol Violation|0|||
33323641|NCT01493557|101080976|FG002|Randomized to Management Strategies|Protocol Violation|0|||
33323642|NCT01493557|101080974|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
33323643|NCT01493557|101080975|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
33323644|NCT01493557|101080976|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
33323645|NCT01493557|101080974|FG000|Randomized to Management Strategies|Other than stated above|1|||
33323646|NCT01493557|101080975|FG001|Randomized to Management Strategies|Other than stated above|3|||
33323647|NCT01493557|101080976|FG002|Randomized to Management Strategies|Other than stated above|0|||
33323648|NCT01493557|101080974|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
33323649|NCT01493557|101080975|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
33323650|NCT01493557|101080976|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
33323651|NCT01493557|101080974|FG000|Adding the Second Strategy|Other adverse event|1|||
33323652|NCT01493557|101080975|FG001|Adding the Second Strategy|Other adverse event|2|||
33323653|NCT01493557|101080976|FG002|Adding the Second Strategy|Other adverse event|0|||
33323654|NCT01493557|101080974|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
33323655|NCT01493557|101080975|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
33323656|NCT01493557|101080976|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
33323657|NCT00851682|101080978|FG000|Overall Study|screen failure|5|||
33323658|NCT00851682|101080979|FG001|Overall Study|screen failure|0|||
33323659|NCT00068588|101080980|FG000|Overall Study|Adverse Event|0|||
33323660|NCT00068588|101080981|FG001|Overall Study|Adverse Event|0|||
33323661|NCT00068588|101080982|FG002|Overall Study|Adverse Event|2|||
33323662|NCT00068588|101080980|FG000|Overall Study|Withdrawal by Subject|0|||
33323663|NCT00068588|101080981|FG001|Overall Study|Withdrawal by Subject|0|||
33323664|NCT00068588|101080982|FG002|Overall Study|Withdrawal by Subject|1|||
33323665|NCT00068588|101080980|FG000|Overall Study|Poor KPS|0|||
33323666|NCT00068588|101080981|FG001|Overall Study|Poor KPS|0|||
33323667|NCT00068588|101080982|FG002|Overall Study|Poor KPS|1|||
33323668|NCT00726622|101080984|FG000|Overall Study|Withdrawal by Subject|16|||
33323669|NCT00726622|101080985|FG001|Overall Study|Withdrawal by Subject|2|||
33323670|NCT00726622|101080984|FG000|Overall Study|Physician Decision|0|||
33323671|NCT00726622|101080985|FG001|Overall Study|Physician Decision|1|||
33323672|NCT00726622|101080984|FG000|Overall Study|Metastasis|2|||
33605709|NCT01641822|102108191|FG001|Comparative Phase|Withdrew consent|3|||
33323673|NCT00726622|101080985|FG001|Overall Study|Metastasis|0|||
33323674|NCT03808688|101080986|FG000|Overall Study|Adverse Event|13|||
33323675|NCT03808688|101080987|FG001|Overall Study|Adverse Event|17|||
33323676|NCT03808688|101080986|FG000|Overall Study|Lack of Efficacy|2|||
33511807|NCT02100670|101770362|FG000|Overall Study|No swelling no pain|1|||
33511808|NCT02100670|101770363|FG001|Overall Study|No swelling no pain|0|||
33511809|NCT02100670|101770364|FG002|Overall Study|No swelling no pain|0|||
33511810|NCT02100670|101770365|FG003|Overall Study|No swelling no pain|0|||
33511811|NCT02100670|101770362|FG000|Overall Study|Poor Efficacy|0|||
33511812|NCT02100670|101770363|FG001|Overall Study|Poor Efficacy|1|||
33511813|NCT02100670|101770364|FG002|Overall Study|Poor Efficacy|0|||
33511814|NCT02100670|101770365|FG003|Overall Study|Poor Efficacy|0|||
33511815|NCT02100670|101770362|FG000|Overall Study|Physician Decision|0|||
33511816|NCT02100670|101770363|FG001|Overall Study|Physician Decision|1|||
33511817|NCT02100670|101770364|FG002|Overall Study|Physician Decision|0|||
33511818|NCT02100670|101770365|FG003|Overall Study|Physician Decision|0|||
33511819|NCT02100670|101770362|FG000|Overall Study|Withdrawal by Subject|1|||
33511820|NCT02100670|101770363|FG001|Overall Study|Withdrawal by Subject|0|||
33511821|NCT02100670|101770364|FG002|Overall Study|Withdrawal by Subject|0|||
33511822|NCT02100670|101770365|FG003|Overall Study|Withdrawal by Subject|0|||
33511823|NCT03671564|101770369|FG000|Overall Study|Progressive Disease|3|||
33511824|NCT03671564|101770370|FG001|Overall Study|Progressive Disease|5|||
33511825|NCT03671564|101770371|FG002|Overall Study|Progressive Disease|3|||
33511826|NCT03671564|101770369|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
33511827|NCT03671564|101770370|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
33511828|NCT03671564|101770371|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
33511829|NCT03671564|101770369|FG000|Overall Study|Withdrawal by Subject|1|||
33511830|NCT03671564|101770370|FG001|Overall Study|Withdrawal by Subject|1|||
33511831|NCT03671564|101770371|FG002|Overall Study|Withdrawal by Subject|0|||
33511832|NCT02279745|101770372|FG000|Overall Study|Adverse Event|7|||
33511833|NCT02279745|101770372|FG000|Overall Study|Death|6|||
33511834|NCT02279745|101770372|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
33511835|NCT02279745|101770372|FG000|Overall Study|Withdrawal by Subject|2|||
33511836|NCT02279745|101770372|FG000|Overall Study|Pregnancy|1|||
33511837|NCT02279745|101770372|FG000|Overall Study|Study Non-compliance|1|||
33511838|NCT02279745|101770372|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
33511839|NCT02677038|101770375|FG000|Overall Study|Physician Decision|1|||
33511840|NCT02677038|101770375|FG000|Overall Study|Withdrawal by Subject|1|||
33511841|NCT02822573|101770379|FG000|Overall Study|Lost to Follow-up|5|||
33511842|NCT02822573|101770380|FG001|Overall Study|Lost to Follow-up|3|||
33511843|NCT02822573|101770379|FG000|Overall Study|Physician Decision|1|||
33511844|NCT02822573|101770380|FG001|Overall Study|Physician Decision|1|||
33511845|NCT02822573|101770379|FG000|Overall Study|Withdrawal by Subject|9|||
33511846|NCT02822573|101770380|FG001|Overall Study|Withdrawal by Subject|5|||
33511847|NCT02822573|101770379|FG000|Overall Study|Protocol Violation|6|||
33511848|NCT02822573|101770380|FG001|Overall Study|Protocol Violation|4|||
33511849|NCT02822573|101770379|FG000|Overall Study|Too sick or ill|2|||
33511850|NCT02822573|101770380|FG001|Overall Study|Too sick or ill|1|||
33511851|NCT02822573|101770379|FG000|Overall Study|Disease Progression|1|||
33511852|NCT02822573|101770380|FG001|Overall Study|Disease Progression|1|||
33511853|NCT02822573|101770379|FG000|Overall Study|No reason given|6|||
33511854|NCT02822573|101770380|FG001|Overall Study|No reason given|4|||
33511855|NCT00614523|101770381|FG000|Overall Study|Adverse Event|4|||
33511856|NCT00614523|101770382|FG001|Overall Study|Adverse Event|20|||
33511857|NCT00614523|101770381|FG000|Overall Study|Death|5|||
33511858|NCT00614523|101770382|FG001|Overall Study|Death|8|||
33511859|NCT00614523|101770381|FG000|Overall Study|Lack of Efficacy|9|||
33511860|NCT00614523|101770382|FG001|Overall Study|Lack of Efficacy|11|||
33511861|NCT00614523|101770381|FG000|Overall Study|Lost to Follow-up|0|||
33511862|NCT00614523|101770382|FG001|Overall Study|Lost to Follow-up|1|||
33511863|NCT00614523|101770381|FG000|Overall Study|Protocol Violation|3|||
33511864|NCT00614523|101770382|FG001|Overall Study|Protocol Violation|2|||
33511865|NCT00614523|101770381|FG000|Overall Study|Withdrawal by Subject|12|||
33511866|NCT00614523|101770382|FG001|Overall Study|Withdrawal by Subject|22|||
33511867|NCT00614523|101770381|FG000|Overall Study|Other|6|||
33511868|NCT00614523|101770382|FG001|Overall Study|Other|11|||
33511869|NCT00614523|101770381|FG000|Overall Study|Ineligibility Determined|1|||
33511870|NCT00614523|101770382|FG001|Overall Study|Ineligibility Determined|2|||
33511871|NCT00614523|101770381|FG000|Overall Study|Disease Progression|0|||
33511872|NCT00614523|101770382|FG001|Overall Study|Disease Progression|8|||
33511873|NCT00614523|101770381|FG000|Overall Study|Administrative Decision|23|||
33511874|NCT00614523|101770382|FG001|Overall Study|Administrative Decision|46|||
33511875|NCT05723328|101770383|FG000|Overall Study|Investigator's Decision|5|||
33511876|NCT05723328|101770384|FG001|Overall Study|Investigator's Decision|2|||
33511877|NCT00348790|101770385|FG000|Completed Treatment|Withdrawal by Subject|4|||
33511878|NCT00348790|101770385|FG000|Completed Treatment|Disease progression|14|||
33511879|NCT00348790|101770385|FG000|Completed Treatment|Adverse Event|4|||
33511880|NCT00348790|101770385|FG000|Completed Treatment|Required surgery|2|||
33511881|NCT00348790|101770385|FG000|Completed Treatment|Unable to travel to study site|1|||
33511882|NCT02656290|101770386|FG000|Overall Study|Lost to Follow-up|1|||
33511883|NCT02656290|101770386|FG000|Overall Study|Reintervention|3|||
33511884|NCT00782184|101770387|FG000|Overall Study|Adverse Event|1|||
33323677|NCT03808688|101080987|FG001|Overall Study|Lack of Efficacy|0|||
33323678|NCT03808688|101080986|FG000|Overall Study|Lost to Follow-up|0|||
33323679|NCT03808688|101080987|FG001|Overall Study|Lost to Follow-up|2|||
33323680|NCT03808688|101080986|FG000|Overall Study|Withdrawal by Subject|1|||
33323681|NCT03808688|101080987|FG001|Overall Study|Withdrawal by Subject|0|||
33198442|NCT01575561|100630514|FG000|Overall Study|Withdrawal by Subject|11|||
33198443|NCT01575561|100630514|FG000|Overall Study|administration|1|||
33198444|NCT01046110|100630519|FG000|Overall Study|Adverse Event|9|||
33198445|NCT01046110|100630520|FG001|Overall Study|Adverse Event|2|||
33198446|NCT01046110|100630519|FG000|Overall Study|Lack of Efficacy|0|||
33198447|NCT01046110|100630520|FG001|Overall Study|Lack of Efficacy|1|||
33198448|NCT01046110|100630519|FG000|Overall Study|Protocol Violation|7|||
33198449|NCT01046110|100630520|FG001|Overall Study|Protocol Violation|12|||
33198450|NCT01046110|100630519|FG000|Overall Study|Withdrawal Criteria|3|||
33198451|NCT01046110|100630520|FG001|Overall Study|Withdrawal Criteria|5|||
33198452|NCT01046110|100630519|FG000|Overall Study|Unclassified|36|||
33198453|NCT01046110|100630520|FG001|Overall Study|Unclassified|35|||
33198454|NCT02673697|100630521|FG000|Overall Study|Adverse Event|2|||
33198455|NCT02673697|100630522|FG001|Overall Study|Adverse Event|0|||
33198456|NCT02673697|100630521|FG000|Overall Study|Death|32|||
33198457|NCT02673697|100630522|FG001|Overall Study|Death|24|||
33198458|NCT02673697|100630521|FG000|Overall Study|Lost to Follow-up|5|||
33198459|NCT02673697|100630522|FG001|Overall Study|Lost to Follow-up|2|||
33198460|NCT02673697|100630521|FG000|Overall Study|Physician Decision|2|||
33198461|NCT02673697|100630522|FG001|Overall Study|Physician Decision|1|||
33198462|NCT02673697|100630521|FG000|Overall Study|Withdrawal by Subject|10|||
33323682|NCT03808688|101080986|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
33323683|NCT03808688|101080987|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
33323684|NCT03808688|101080986|FG000|Overall Study|IOP Too High|1|||
33323685|NCT03808688|101080987|FG001|Overall Study|IOP Too High|1|||
33323686|NCT03808688|101080986|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
33323687|NCT03808688|101080987|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
33323688|NCT03808688|101080986|FG000|Overall Study|Visit Out of Window|0|||
33511885|NCT00782184|101770388|FG001|Overall Study|Adverse Event|2|||
33323689|NCT03808688|101080987|FG001|Overall Study|Visit Out of Window|1|||
33323690|NCT03808688|101080986|FG000|Overall Study|Medication Non-Compliance|0|||
33323691|NCT03808688|101080987|FG001|Overall Study|Medication Non-Compliance|1|||
33323692|NCT02973087|101080989|FG000|Overall Study|Withdrawal by Subject|2|||
33323693|NCT02973087|101080990|FG001|Overall Study|Withdrawal by Subject|1|||
33511886|NCT00782184|101770387|FG000|Overall Study|Protocol Violation|0|||
33511887|NCT00782184|101770388|FG001|Overall Study|Protocol Violation|1|||
33511888|NCT00782184|101770387|FG000|Overall Study|Withdrawal by Subject|3|||
33323694|NCT02973087|101080989|FG000|Overall Study|Adverse Event|1|||
33323695|NCT02973087|101080990|FG001|Overall Study|Adverse Event|0|||
33511889|NCT00782184|101770388|FG001|Overall Study|Withdrawal by Subject|2|||
33511890|NCT05845567|101770389|FG000|Overall Study|Withdrawal by Subject|1|||
33198463|NCT02673697|100630522|FG001|Overall Study|Withdrawal by Subject|7|||
33198464|NCT02673697|100630521|FG000|Overall Study|Change subj medical status|1|||
33198465|NCT02673697|100630522|FG001|Overall Study|Change subj medical status|2|||
33198466|NCT02673697|100630521|FG000|Overall Study|Explant|10|||
33198467|NCT02673697|100630522|FG001|Overall Study|Explant|5|||
33323696|NCT02973087|101080989|FG000|Overall Study|other|1|||
33323697|NCT02973087|101080990|FG001|Overall Study|other|1|||
33323698|NCT04029116|101080994|FG000|Overall Study|Adverse Event|0|||
33323699|NCT04029116|101080995|FG001|Overall Study|Adverse Event|2|||
33323700|NCT04029116|101080994|FG000|Overall Study|Lost to Follow-up|3|||
33323701|NCT04029116|101080995|FG001|Overall Study|Lost to Follow-up|5|||
33323702|NCT04029116|101080994|FG000|Overall Study|Physician Decision|2|||
33323703|NCT04029116|101080995|FG001|Overall Study|Physician Decision|0|||
33323704|NCT04029116|101080994|FG000|Overall Study|Pregnancy|1|||
33323705|NCT04029116|101080995|FG001|Overall Study|Pregnancy|2|||
33198468|NCT02673697|100630521|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
33198469|NCT02673697|100630522|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
33198470|NCT01193556|100630532|FG000|Overall Study|Study termination|26|||
33198471|NCT01193556|100630533|FG001|Overall Study|Study termination|25|||
33198472|NCT04121962|100630536|FG000|Overall Study|Lost to Follow-up|42|||
33198473|NCT04121962|100630537|FG001|Overall Study|Lost to Follow-up|39|||
33198474|NCT03403634|100630544|FG000|Overall Study|Disease progression|3|||
33198475|NCT03403634|100630544|FG000|Overall Study|Did not meet eligibility criteria|4|||
33198476|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
33198477|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
33198478|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
33198479|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
33198480|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
33198481|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
33198482|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
33198483|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
33323706|NCT04029116|101080994|FG000|Overall Study|Withdrawal by Subject|4|||
33323707|NCT04029116|101080995|FG001|Overall Study|Withdrawal by Subject|6|||
33198484|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
33198485|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
33198486|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
33198487|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
33198488|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
33198489|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
33198490|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
33323708|NCT04029116|101080994|FG000|Overall Study|Other|2|||
33323709|NCT04029116|101080995|FG001|Overall Study|Other|1|||
33323710|NCT00798135|101081000|FG000|Overall Study|Disease progression, relapse|11|||
33323711|NCT00798135|101081000|FG000|Overall Study|Disease progression, refractory|1|||
33323712|NCT00798135|101081000|FG000|Overall Study|Physician Decision|1|||
33323713|NCT03422172|101081004|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
33511891|NCT01500187|101770396|FG000|Overall Study|Lost to Follow-up|6|||
33511892|NCT01500187|101770397|FG001|Overall Study|Lost to Follow-up|0|||
33323714|NCT03422172|101081004|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
33323715|NCT03422172|101081004|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
33323716|NCT00074581|101081005|FG000|Overall Study|Death|15|||
33323717|NCT00074581|101081006|FG001|Overall Study|Death|16|||
33323718|NCT00074581|101081005|FG000|Overall Study|Withdrawal by Subject|50|||
33323719|NCT00074581|101081006|FG001|Overall Study|Withdrawal by Subject|49|||
33323720|NCT00074581|101081005|FG000|Overall Study|Unable to adhere to visit schedule|13|||
33323721|NCT00074581|101081006|FG001|Overall Study|Unable to adhere to visit schedule|14|||
33323722|NCT00074581|101081005|FG000|Overall Study|Relocated|14|||
33323723|NCT00074581|101081006|FG001|Overall Study|Relocated|9|||
33323724|NCT00074581|101081005|FG000|Overall Study|Were withdrawn by investigator|5|||
33323725|NCT00074581|101081006|FG001|Overall Study|Were withdrawn by investigator|2|||
33323726|NCT00074581|101081005|FG000|Overall Study|Lost to Follow-up|16|||
33511893|NCT04216589|101770402|FG000|Overall Study|Withdrawal by Subject|2|||
33511894|NCT04216589|101770402|FG000|Overall Study|Protocol Violation|1|||
33511895|NCT04216589|101770402|FG000|Overall Study|Incarceration|1|||
33511896|NCT02968433|101770415|FG000|Overall Study|Withdrawal by Subject|1|||
33323727|NCT00074581|101081006|FG001|Overall Study|Lost to Follow-up|11|||
33511897|NCT02218736|101770421|FG000|Overall Study|Withdrawal by Subject|10|||
33511898|NCT02218736|101770422|FG001|Overall Study|Withdrawal by Subject|9|||
33511899|NCT02218736|101770421|FG000|Overall Study|Protocol Violation|2|||
33511900|NCT02218736|101770422|FG001|Overall Study|Protocol Violation|0|||
33511901|NCT01254318|101770423|FG000|Overall Study|Lost to Follow-up|5|||
33511902|NCT01254318|101770423|FG000|Overall Study|Death|47|||
33511903|NCT02347891|101770424|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
33198491|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
33198492|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
33224364|NCT05044325|100721815|FG004|Part A:Treatment Period 1|Adverse Event|0|||
33323728|NCT00074581|101081005|FG000|Overall Study|Ended relationship w. index participant|117|||
33323729|NCT00074581|101081006|FG001|Overall Study|Ended relationship w. index participant|106|||
33323730|NCT00074581|101081005|FG000|Overall Study|Other|14|||
33323731|NCT00074581|101081006|FG001|Overall Study|Other|19|||
33323732|NCT01145495|101081015|FG000|Overall Study|Adverse Event|6|||
33323733|NCT01145495|101081015|FG000|Overall Study|Withdrawal by Subject|6|||
33323734|NCT01145495|101081015|FG000|Overall Study|Disease progression after respone|2|||
33323735|NCT00478933|101081016|FG000|Overall Study|Protocol Violation|22|||
33323736|NCT00478933|101081016|FG000|Overall Study|Informed consent not verified|3|||
33323737|NCT00478933|101081016|FG000|Overall Study|Inadequate data available|53|||
33323738|NCT01942148|101081019|FG000|Overall Study|Adverse Event|4|||
33323739|NCT01942148|101081019|FG000|Overall Study|Lack of Efficacy|2|||
33323740|NCT01942148|101081019|FG000|Overall Study|Physician Decision|11|||
33323741|NCT01942148|101081019|FG000|Overall Study|Protocol Violation|1|||
33323742|NCT01942148|101081019|FG000|Overall Study|Withdrawal by Subject|8|||
33323743|NCT01942148|101081019|FG000|Overall Study|Use of the prohibition medicine|1|||
33323744|NCT03123250|101081022|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
33198493|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
33198494|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
33198495|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
33198496|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
33198497|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
33198498|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
33323745|NCT00228566|101081025|FG000|Overall Study|Adverse Event|31|||
33323746|NCT00228566|101081025|FG000|Overall Study|Lack of Efficacy|14|||
33323747|NCT00228566|101081025|FG000|Overall Study|Lost to Follow-up|16|||
33323748|NCT00228566|101081025|FG000|Overall Study|Physician Decision|5|||
33323749|NCT00228566|101081025|FG000|Overall Study|Withdrawal by Subject|4|||
33323750|NCT00228566|101081025|FG000|Overall Study|Miscellaneous|1|||
33323751|NCT03805750|101081026|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
33323752|NCT03805750|101081027|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
33323753|NCT00356889|101081030|FG000|Overall Study|Protocol Violation|2|||
33323754|NCT00356889|101081030|FG000|Overall Study|Adverse Event|1|||
33323755|NCT03426787|101081031|FG000|Overall Study|Withdrawal by Subject|6|||
33323756|NCT03426787|101081031|FG000|Overall Study|Lost to Follow-up|7|||
33323757|NCT03426787|101081031|FG000|Overall Study|Unrelated to intervention death|1|||
33323758|NCT00525044|101081033|FG000|Overall Study|Lost to Follow-up|0|||
33323759|NCT00525044|101081034|FG001|Overall Study|Lost to Follow-up|1|||
33323760|NCT04422990|101081035|FG000|Overall Study|Withdrawal by Subject|0|||
33323761|NCT04422990|101081036|FG001|Overall Study|Withdrawal by Subject|1|||
33323762|NCT04422990|101081035|FG000|Overall Study|Travel|3|||
33323763|NCT04422990|101081036|FG001|Overall Study|Travel|0|||
33323764|NCT01555151|101081037|FG000|Overall Study|Withdrawal by Subject|6|||
33323765|NCT01555151|101081038|FG001|Overall Study|Withdrawal by Subject|2|||
33323766|NCT01555151|101081039|FG002|Overall Study|Withdrawal by Subject|0|||
33323767|NCT01555151|101081040|FG003|Overall Study|Withdrawal by Subject|2|||
33323768|NCT01555151|101081037|FG000|Overall Study|Administrative|3|||
33323769|NCT01555151|101081038|FG001|Overall Study|Administrative|1|||
33323770|NCT01555151|101081039|FG002|Overall Study|Administrative|2|||
33323771|NCT01555151|101081040|FG003|Overall Study|Administrative|0|||
33198499|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
33323772|NCT01555151|101081037|FG000|Overall Study|Protocol Violation|3|||
33323773|NCT01555151|101081038|FG001|Overall Study|Protocol Violation|3|||
33323774|NCT01555151|101081039|FG002|Overall Study|Protocol Violation|3|||
33323775|NCT01555151|101081040|FG003|Overall Study|Protocol Violation|5|||
33323776|NCT01555151|101081037|FG000|Overall Study|Adverse Event|1|||
33323777|NCT01555151|101081038|FG001|Overall Study|Adverse Event|2|||
33323778|NCT01555151|101081039|FG002|Overall Study|Adverse Event|1|||
33323779|NCT01555151|101081040|FG003|Overall Study|Adverse Event|2|||
33323780|NCT01555151|101081037|FG000|Overall Study|Lost to Follow-up|0|||
33323781|NCT01555151|101081038|FG001|Overall Study|Lost to Follow-up|0|||
33323782|NCT01555151|101081039|FG002|Overall Study|Lost to Follow-up|0|||
33323783|NCT01555151|101081040|FG003|Overall Study|Lost to Follow-up|1|||
33323784|NCT01378104|101081041|FG000|Overall Study|Adverse Event|8|||
33323785|NCT01378104|101081042|FG001|Overall Study|Adverse Event|8|||
33323786|NCT01378104|101081041|FG000|Overall Study|Lack of Efficacy|7|||
33323787|NCT01378104|101081042|FG001|Overall Study|Lack of Efficacy|5|||
33323788|NCT01378104|101081041|FG000|Overall Study|Withdrawal by Subject|12|||
33198500|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
33198501|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
33323789|NCT01378104|101081042|FG001|Overall Study|Withdrawal by Subject|13|||
33323790|NCT00865904|101081045|FG000|Overall Study|Randomized but not Treated|2|||
33323791|NCT00865904|101081046|FG001|Overall Study|Randomized but not Treated|0|||
33323792|NCT00865904|101081047|FG002|Overall Study|Randomized but not Treated|0|||
33323793|NCT00865904|101081048|FG003|Overall Study|Randomized but not Treated|1|||
33323794|NCT00865904|101081049|FG004|Overall Study|Randomized but not Treated|1|||
33323795|NCT03842163|101081052|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
33323796|NCT03842163|101081052|FG000|Overall Study|Scintigraphy was not performed|44|||
33323797|NCT00773136|101081053|FG000|Overall Study|Physician Decision|2|||
33323798|NCT01509079|101081054|FG000|Overall Study|Lack of Efficacy|0|||
33323799|NCT01509079|101081055|FG001|Overall Study|Lack of Efficacy|2|||
33323800|NCT01509079|101081054|FG000|Overall Study|started an excluded medication|0|||
33323801|NCT01509079|101081055|FG001|Overall Study|started an excluded medication|1|||
33323802|NCT00930722|101081057|FG000|Overall Study|Lost to Follow-up|16|||
33323803|NCT00930722|101081057|FG000|Overall Study|No longer willing to participate|9|||
33323804|NCT00930722|101081057|FG000|Overall Study|Study terminated by sponsor|2|||
33323805|NCT01846624|101081062|FG000|Overall Study|Died during induction, no midostaurin|1|||
33323806|NCT03492554|101081063|FG000|Overall Study|Protocol Violation|0|||
33323807|NCT03492554|101081064|FG001|Overall Study|Protocol Violation|14|||
33323808|NCT00888381|101081069|FG000|Overall Study|Lost to Follow-up|0|||
33323809|NCT00888381|101081070|FG001|Overall Study|Lost to Follow-up|1|||
33323810|NCT02982239|101081071|FG000|Overall Study|Lost to Follow-up|3|||
33323811|NCT02982239|101081072|FG001|Overall Study|Lost to Follow-up|2|||
33323812|NCT03472924|101081076|FG000|Overall Study|Adverse Event|1|||
33323813|NCT03472924|101081077|FG001|Overall Study|Adverse Event|0|||
33323814|NCT01576172|101081078|FG000|Overall Study|Ineligible|2|||
33323815|NCT01576172|101081079|FG001|Overall Study|Ineligible|1|||
33323816|NCT01576172|101081078|FG000|Overall Study|Withdrawal by Subject|2|||
33323817|NCT01576172|101081079|FG001|Overall Study|Withdrawal by Subject|0|||
33323818|NCT01576172|101081078|FG000|Overall Study|Insurance issue|1|||
33323819|NCT01576172|101081079|FG001|Overall Study|Insurance issue|0|||
33323820|NCT02710136|101084487|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
33323821|NCT02710136|101084488|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
33323822|NCT02464228|101084489|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
33323823|NCT02464228|101084490|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
33323824|NCT02464228|101084491|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
33323825|NCT02464228|101084492|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
33323826|NCT02464228|101084489|FG000|Overall Study|Physician Decision|2|||
33323827|NCT02464228|101084490|FG001|Overall Study|Physician Decision|0|||
33323828|NCT02464228|101084491|FG002|Overall Study|Physician Decision|1|||
33323829|NCT02464228|101084492|FG003|Overall Study|Physician Decision|0|||
33323830|NCT02464228|101084489|FG000|Overall Study|Miscellaneous|1|||
33323831|NCT02464228|101084490|FG001|Overall Study|Miscellaneous|0|||
33323832|NCT02464228|101084491|FG002|Overall Study|Miscellaneous|1|||
33323833|NCT02464228|101084492|FG003|Overall Study|Miscellaneous|0|||
33323834|NCT02464228|101084489|FG000|Overall Study|Adverse Event|9|||
33323835|NCT02464228|101084490|FG001|Overall Study|Adverse Event|0|||
33323836|NCT02464228|101084491|FG002|Overall Study|Adverse Event|3|||
33323837|NCT02464228|101084492|FG003|Overall Study|Adverse Event|0|||
33323838|NCT02464228|101084489|FG000|Overall Study|Withdrawal by Subject|1|||
33323839|NCT02464228|101084490|FG001|Overall Study|Withdrawal by Subject|1|||
33323840|NCT02464228|101084491|FG002|Overall Study|Withdrawal by Subject|1|||
33198502|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
33198503|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
33323841|NCT02464228|101084492|FG003|Overall Study|Withdrawal by Subject|0|||
33323842|NCT02464228|101084489|FG000|Overall Study|Disease Progression|22|||
33323843|NCT02464228|101084490|FG001|Overall Study|Disease Progression|12|||
33323844|NCT02464228|101084491|FG002|Overall Study|Disease Progression|5|||
33323845|NCT02464228|101084492|FG003|Overall Study|Disease Progression|2|||
33198504|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
33323846|NCT00418665|101084495|FG000|Treatment Period|Ineligibility determined|1|||
33323847|NCT00418665|101084496|FG001|Treatment Period|Ineligibility determined|1|||
33323848|NCT00418665|101084497|FG002|Treatment Period|Ineligibility determined|0|||
33323849|NCT00418665|101084495|FG000|Treatment Period|Adverse Event|2|||
33323850|NCT00418665|101084496|FG001|Treatment Period|Adverse Event|2|||
33323851|NCT00418665|101084497|FG002|Treatment Period|Adverse Event|0|||
33323852|NCT00418665|101084495|FG000|Treatment Period|Withdrawal by Subject|0|||
33323853|NCT00418665|101084496|FG001|Treatment Period|Withdrawal by Subject|3|||
33511904|NCT02347891|101770425|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
33511905|NCT02347891|101770424|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
33511906|NCT02347891|101770425|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
33511907|NCT02276053|101770426|FG000|Overall Study|Death|2|||
33511908|NCT02276053|101770426|FG000|Overall Study|Adverse Event|5|||
33511909|NCT02276053|101770426|FG000|Overall Study|Lack of Efficacy|2|||
33511910|NCT02276053|101770426|FG000|Overall Study|Withdrawal by Subject|1|||
33511911|NCT02276053|101770426|FG000|Overall Study|Patient does not meet selection criteria|3|||
33511912|NCT02276053|101770426|FG000|Overall Study|Patient needs to increase baseline AED|1|||
33511913|NCT00174967|101770427|FG000|Overall Study|Adverse Event|1|||
33511914|NCT00174967|101770428|FG001|Overall Study|Adverse Event|2|||
33511915|NCT00174967|101770429|FG002|Overall Study|Adverse Event|2|||
33511916|NCT00174967|101770430|FG003|Overall Study|Adverse Event|1|||
33511917|NCT00174967|101770427|FG000|Overall Study|Gout Flare|0|||
33511918|NCT00174967|101770428|FG001|Overall Study|Gout Flare|0|||
33511919|NCT00174967|101770429|FG002|Overall Study|Gout Flare|0|||
33511920|NCT00174967|101770430|FG003|Overall Study|Gout Flare|1|||
33323854|NCT00418665|101084497|FG002|Treatment Period|Withdrawal by Subject|1|||
33323855|NCT00418665|101084495|FG000|Treatment Period|Requirement for alternative therapy|1|||
33323856|NCT00418665|101084496|FG001|Treatment Period|Requirement for alternative therapy|0|||
33323857|NCT00418665|101084497|FG002|Treatment Period|Requirement for alternative therapy|0|||
33323858|NCT00418665|101084495|FG000|Treatment Period|Physician Decision|1|||
33323859|NCT00418665|101084496|FG001|Treatment Period|Physician Decision|0|||
33323860|NCT00418665|101084497|FG002|Treatment Period|Physician Decision|3|||
33323861|NCT00418665|101084495|FG000|Treatment Extension|Adverse Event|1|||
33323862|NCT00418665|101084496|FG001|Treatment Extension|Adverse Event|0|||
33323863|NCT00418665|101084497|FG002|Treatment Extension|Adverse Event|0|||
33323864|NCT00418665|101084495|FG000|Treatment Extension|Withdrawal by Subject|1|||
33323865|NCT00418665|101084496|FG001|Treatment Extension|Withdrawal by Subject|0|||
33323866|NCT00418665|101084497|FG002|Treatment Extension|Withdrawal by Subject|0|||
33323867|NCT00418665|101084495|FG000|Treatment Extension|Requirement for alternative therapy|2|||
33323868|NCT00418665|101084496|FG001|Treatment Extension|Requirement for alternative therapy|2|||
33323869|NCT00418665|101084497|FG002|Treatment Extension|Requirement for alternative therapy|0|||
33323870|NCT00418665|101084495|FG000|Treatment Extension|Physician Decision|2|||
33323871|NCT00418665|101084496|FG001|Treatment Extension|Physician Decision|2|||
33323872|NCT00418665|101084497|FG002|Treatment Extension|Physician Decision|1|||
33323873|NCT00418665|101084495|FG000|Treatment Extension|Death|0|||
33323874|NCT00418665|101084496|FG001|Treatment Extension|Death|0|||
33323875|NCT00418665|101084497|FG002|Treatment Extension|Death|1|||
33323876|NCT02012296|101084498|FG000|Overall Study|Lack of Efficacy|0|||
33323877|NCT02012296|101084499|FG001|Overall Study|Lack of Efficacy|0|||
33323878|NCT02012296|101084500|FG002|Overall Study|Lack of Efficacy|15|||
33323879|NCT02012296|101084498|FG000|Overall Study|Adverse Event|0|||
33323880|NCT02012296|101084499|FG001|Overall Study|Adverse Event|0|||
33323881|NCT02012296|101084500|FG002|Overall Study|Adverse Event|2|||
33323882|NCT02012296|101084498|FG000|Overall Study|Early study closure|0|||
33323883|NCT02012296|101084499|FG001|Overall Study|Early study closure|0|||
33323884|NCT02012296|101084500|FG002|Overall Study|Early study closure|5|||
33323885|NCT02012296|101084498|FG000|Overall Study|Protocol Violation|0|||
33511921|NCT00174967|101770427|FG000|Overall Study|Other|0|||
33511922|NCT00174967|101770428|FG001|Overall Study|Other|1|||
33511923|NCT00174967|101770429|FG002|Overall Study|Other|0|||
33511924|NCT00174967|101770430|FG003|Overall Study|Other|0|||
33511925|NCT04852679|101770434|FG000|Main Intervention Period|Withdrawal by Subject|3|||
33323886|NCT02012296|101084499|FG001|Overall Study|Protocol Violation|1|||
33323887|NCT02012296|101084500|FG002|Overall Study|Protocol Violation|0|||
33323888|NCT00509067|101084501|FG000|Overall Study|Lost to Follow-up|1|||
33511926|NCT04852679|101770434|FG000|Main Intervention Period|Adverse Event|1|||
33511927|NCT04852679|101770434|FG000|Main Intervention Period|Progressive Disease|16|||
33323889|NCT00509067|101084502|FG001|Overall Study|Lost to Follow-up|1|||
33323890|NCT00509067|101084501|FG000|Overall Study|Adverse Event|3|||
33323891|NCT00509067|101084502|FG001|Overall Study|Adverse Event|1|||
33323892|NCT00509067|101084501|FG000|Overall Study|Protocol Violation|0|||
33511928|NCT04852679|101770434|FG000|Main Intervention Period|Refused study visit|1|||
33511929|NCT04852679|101770434|FG000|Independent Injection Period|Missed study visit|1|||
33511930|NCT02855359|101770435|FG000|Overall Study|Death|2|||
33323893|NCT00509067|101084502|FG001|Overall Study|Protocol Violation|3|||
33323894|NCT00915772|101084503|FG000|Overall Study|Adverse Event|12|||
33323895|NCT00915772|101084504|FG001|Overall Study|Adverse Event|13|||
33323896|NCT00915772|101084505|FG002|Overall Study|Adverse Event|11|||
33323897|NCT00915772|101084503|FG000|Overall Study|Protocol Violation|4|||
33323898|NCT00915772|101084504|FG001|Overall Study|Protocol Violation|1|||
33323899|NCT00915772|101084505|FG002|Overall Study|Protocol Violation|2|||
33323900|NCT00915772|101084503|FG000|Overall Study|Lost to Follow-up|1|||
33323901|NCT00915772|101084504|FG001|Overall Study|Lost to Follow-up|2|||
33323902|NCT00915772|101084505|FG002|Overall Study|Lost to Follow-up|2|||
33323903|NCT00915772|101084503|FG000|Overall Study|Lack of Efficacy|9|||
33323904|NCT00915772|101084504|FG001|Overall Study|Lack of Efficacy|15|||
33323905|NCT00915772|101084505|FG002|Overall Study|Lack of Efficacy|3|||
33323906|NCT00915772|101084503|FG000|Overall Study|Refused to continue trial medication|6|||
33323907|NCT00915772|101084504|FG001|Overall Study|Refused to continue trial medication|8|||
33605710|NCT01641822|102108192|FG002|Comparative Phase|Withdrew consent|7|||
33605711|NCT01641822|102108190|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
33605712|NCT01641822|102108191|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
33511931|NCT02855359|101770436|FG001|Overall Study|Death|2|||
33511932|NCT02855359|101770437|FG002|Overall Study|Death|0|||
33511933|NCT02855359|101770438|FG003|Overall Study|Death|0|||
33511934|NCT02855359|101770435|FG000|Overall Study|Study Termination by Sponsor|9|||
33511935|NCT02855359|101770436|FG001|Overall Study|Study Termination by Sponsor|11|||
33511936|NCT02855359|101770437|FG002|Overall Study|Study Termination by Sponsor|0|||
33511937|NCT02855359|101770438|FG003|Overall Study|Study Termination by Sponsor|0|||
33511938|NCT01943851|101770442|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33511939|NCT01943851|101770443|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33511940|NCT01943851|101770444|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33511941|NCT01943851|101770445|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
33511942|NCT01943851|101770446|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33511943|NCT01943851|101770447|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33511944|NCT01943851|101770448|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
33511945|NCT01943851|101770449|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
33511946|NCT01943851|101770450|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
33511947|NCT01943851|101770451|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33511948|NCT01943851|101770452|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33511949|NCT01943851|101770453|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33511950|NCT01943851|101770454|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33511951|NCT01943851|101770455|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33605713|NCT01641822|102108192|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
33605714|NCT01818492|102108193|FG000|Overall Study|Adverse Event|2|||
33605715|NCT01818492|102108193|FG000|Overall Study|Death|3|||
33323908|NCT00915772|101084505|FG002|Overall Study|Refused to continue trial medication|4|||
33323909|NCT00915772|101084503|FG000|Overall Study|Any other reason|4|||
33323910|NCT00915772|101084504|FG001|Overall Study|Any other reason|7|||
33323911|NCT00915772|101084505|FG002|Overall Study|Any other reason|7|||
33323912|NCT00733304|101084506|FG000|Overall Study|Adverse Event|3|||
33511952|NCT01943851|101770456|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33605716|NCT01818492|102108193|FG000|Overall Study|Withdrawal by Subject|1|||
33323913|NCT00733304|101084507|FG001|Overall Study|Adverse Event|0|||
33323914|NCT00733304|101084508|FG002|Overall Study|Adverse Event|0|||
33323915|NCT00733304|101084506|FG000|Overall Study|Lack of Efficacy|0|||
33323916|NCT00733304|101084507|FG001|Overall Study|Lack of Efficacy|0|||
33323917|NCT00733304|101084508|FG002|Overall Study|Lack of Efficacy|2|||
33323918|NCT00733304|101084506|FG000|Overall Study|Lost to Follow-up|0|||
33323919|NCT00733304|101084507|FG001|Overall Study|Lost to Follow-up|1|||
33323920|NCT00733304|101084508|FG002|Overall Study|Lost to Follow-up|0|||
33323921|NCT00733304|101084506|FG000|Overall Study|Physician Decision|3|||
33323922|NCT00733304|101084507|FG001|Overall Study|Physician Decision|1|||
33323923|NCT00733304|101084508|FG002|Overall Study|Physician Decision|3|||
33323924|NCT00733304|101084506|FG000|Overall Study|Withdrawal by Subject|1|||
33323925|NCT00733304|101084507|FG001|Overall Study|Withdrawal by Subject|1|||
33323926|NCT00733304|101084508|FG002|Overall Study|Withdrawal by Subject|0|||
33605717|NCT01818492|102108193|FG000|Overall Study|Additional therapy when not allowed PP|4|||
33323927|NCT01301456|101084509|FG000|Stage 1|Withdrawal by Subject|0|||
33323928|NCT01301456|101084510|FG001|Stage 1|Withdrawal by Subject|0|||
33605718|NCT02613169|102108194|FG000|Overall Study|Withdrawal by Subject|4|||
33323929|NCT01301456|101084511|FG002|Stage 1|Withdrawal by Subject|1|||
33323930|NCT01301456|101084512|FG003|Stage 1|Withdrawal by Subject|0|||
33323931|NCT01301456|101084513|FG004|Stage 1|Withdrawal by Subject|1|||
33511953|NCT01943851|101770457|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33511954|NCT01943851|101770458|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33605719|NCT02613169|102108195|FG001|Overall Study|Withdrawal by Subject|1|||
33323932|NCT01301456|101084514|FG005|Stage 1|Withdrawal by Subject|0|||
33323933|NCT01301456|101084515|FG006|Stage 1|Withdrawal by Subject|0|||
33323934|NCT01301456|101084516|FG007|Stage 1|Withdrawal by Subject|0|||
33323935|NCT01301456|101084517|FG008|Stage 1|Withdrawal by Subject|0|||
33323936|NCT01301456|101084518|FG009|Stage 1|Withdrawal by Subject|0|||
33323937|NCT01301456|101084519|FG010|Stage 1|Withdrawal by Subject|0|||
33323938|NCT01301456|101084520|FG011|Stage 1|Withdrawal by Subject|0|||
33323939|NCT01301456|101084509|FG000|Stage 1|Randomized but not treated|0|||
33323940|NCT01301456|101084510|FG001|Stage 1|Randomized but not treated|0|||
33323941|NCT01301456|101084511|FG002|Stage 1|Randomized but not treated|0|||
33323942|NCT01301456|101084512|FG003|Stage 1|Randomized but not treated|0|||
33323943|NCT01301456|101084513|FG004|Stage 1|Randomized but not treated|0|||
33323944|NCT01301456|101084514|FG005|Stage 1|Randomized but not treated|0|||
33323945|NCT01301456|101084515|FG006|Stage 1|Randomized but not treated|1|||
33323946|NCT01301456|101084516|FG007|Stage 1|Randomized but not treated|0|||
33323947|NCT01301456|101084517|FG008|Stage 1|Randomized but not treated|0|||
33511955|NCT01943851|101770459|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
33511956|NCT01943851|101770442|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511957|NCT01943851|101770443|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511958|NCT01943851|101770444|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511959|NCT01943851|101770445|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511960|NCT01943851|101770446|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
33511961|NCT01943851|101770447|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511962|NCT01943851|101770448|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511963|NCT01943851|101770449|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
33511964|NCT01943851|101770450|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511965|NCT01943851|101770451|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511966|NCT01943851|101770452|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511967|NCT01943851|101770453|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511968|NCT01943851|101770454|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511969|NCT01943851|101770455|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511970|NCT01943851|101770456|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511971|NCT01943851|101770457|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511972|NCT01943851|101770458|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511973|NCT01943851|101770459|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
33511974|NCT01943851|101770442|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511975|NCT01943851|101770443|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511976|NCT01943851|101770444|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511977|NCT01943851|101770445|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511978|NCT01943851|101770446|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511979|NCT01943851|101770447|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511980|NCT01943851|101770448|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511981|NCT01943851|101770449|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511982|NCT01943851|101770450|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511983|NCT01943851|101770451|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511984|NCT01943851|101770452|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511985|NCT01943851|101770453|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511986|NCT01943851|101770454|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511987|NCT01943851|101770455|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
33511988|NCT01943851|101770456|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511989|NCT01943851|101770457|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511990|NCT01943851|101770458|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511991|NCT01943851|101770459|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
33511992|NCT01943851|101770442|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33511993|NCT01943851|101770443|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33605720|NCT02613169|102108194|FG000|Overall Study|Lost to Follow-up|0|||
33605721|NCT02613169|102108195|FG001|Overall Study|Lost to Follow-up|5|||
33605722|NCT02613169|102108194|FG000|Overall Study|HIV|0|||
33605723|NCT02613169|102108195|FG001|Overall Study|HIV|2|||
33605724|NCT02613169|102108194|FG000|Overall Study|No TB infection endpoint|14|||
33323948|NCT01301456|101084518|FG009|Stage 1|Randomized but not treated|0|||
33323949|NCT01301456|101084519|FG010|Stage 1|Randomized but not treated|0|||
33323950|NCT01301456|101084520|FG011|Stage 1|Randomized but not treated|0|||
33323951|NCT01301456|101084509|FG000|Stage 2|Adverse Event|0|||
33511994|NCT01943851|101770444|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33511995|NCT01943851|101770445|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33511996|NCT01943851|101770446|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33511997|NCT01943851|101770447|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33605725|NCT02613169|102108195|FG001|Overall Study|No TB infection endpoint|9|||
33605726|NCT01176565|102108196|FG000|Overall Study|Lost to Follow-up|12|||
33605727|NCT01176565|102108197|FG001|Overall Study|Lost to Follow-up|16|||
33323952|NCT01301456|101084510|FG001|Stage 2|Adverse Event|0|||
33323953|NCT01301456|101084511|FG002|Stage 2|Adverse Event|0|||
33605728|NCT01176565|102108196|FG000|Overall Study|Withdrawal by Subject|7|||
33323954|NCT01301456|101084512|FG003|Stage 2|Adverse Event|0|||
33323955|NCT01301456|101084513|FG004|Stage 2|Adverse Event|0|||
33323956|NCT01301456|101084514|FG005|Stage 2|Adverse Event|0|||
33323957|NCT01301456|101084515|FG006|Stage 2|Adverse Event|0|||
33323958|NCT01301456|101084516|FG007|Stage 2|Adverse Event|0|||
33323959|NCT01301456|101084517|FG008|Stage 2|Adverse Event|0|||
33323960|NCT01301456|101084518|FG009|Stage 2|Adverse Event|0|||
33323961|NCT01301456|101084519|FG010|Stage 2|Adverse Event|1|||
33323962|NCT01301456|101084520|FG011|Stage 2|Adverse Event|0|||
33323963|NCT00709111|101084521|FG000|Overall Study|Withdrawal by Subject|1|||
33323964|NCT00709111|101084521|FG000|Overall Study|Unable to attend clinic visits|1|||
33323965|NCT00880555|101084522|FG000|Overall Study|Physician Decision|0|||
33323966|NCT00880555|101084523|FG001|Overall Study|Physician Decision|8|||
33323967|NCT00880555|101084524|FG002|Overall Study|Physician Decision|0|||
33323968|NCT00880555|101084525|FG003|Overall Study|Physician Decision|2|||
33323969|NCT00880555|101084526|FG004|Overall Study|Physician Decision|1|||
33323970|NCT00880555|101084527|FG005|Overall Study|Physician Decision|0|||
33323971|NCT00880555|101084522|FG000|Overall Study|Withdrawal by Subject|1|||
33323972|NCT00880555|101084523|FG001|Overall Study|Withdrawal by Subject|1|||
33323973|NCT00880555|101084524|FG002|Overall Study|Withdrawal by Subject|0|||
33511998|NCT01943851|101770448|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33511999|NCT01943851|101770449|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33323974|NCT00880555|101084525|FG003|Overall Study|Withdrawal by Subject|0|||
33323975|NCT00880555|101084526|FG004|Overall Study|Withdrawal by Subject|0|||
33323976|NCT00880555|101084527|FG005|Overall Study|Withdrawal by Subject|0|||
33323977|NCT00880555|101084522|FG000|Overall Study|Lack of resources (hired rater)|9|||
33323978|NCT00880555|101084523|FG001|Overall Study|Lack of resources (hired rater)|7|||
33323979|NCT00880555|101084524|FG002|Overall Study|Lack of resources (hired rater)|5|||
33323980|NCT00880555|101084525|FG003|Overall Study|Lack of resources (hired rater)|0|||
33323981|NCT00880555|101084526|FG004|Overall Study|Lack of resources (hired rater)|0|||
33323982|NCT00880555|101084527|FG005|Overall Study|Lack of resources (hired rater)|0|||
33323983|NCT00880555|101084522|FG000|Overall Study|Death|0|||
33323984|NCT00880555|101084523|FG001|Overall Study|Death|0|||
33323985|NCT00880555|101084524|FG002|Overall Study|Death|0|||
33323986|NCT00880555|101084525|FG003|Overall Study|Death|0|||
33323987|NCT00880555|101084526|FG004|Overall Study|Death|0|||
33323988|NCT00880555|101084527|FG005|Overall Study|Death|1|||
33323989|NCT00880555|101084522|FG000|Overall Study|Lost to Follow-up|0|||
33605729|NCT01176565|102108197|FG001|Overall Study|Withdrawal by Subject|1|||
33605730|NCT01176565|102108196|FG000|Overall Study|Not Analyzed (any other reason)|1|||
33605731|NCT01176565|102108197|FG001|Overall Study|Not Analyzed (any other reason)|2|||
33323990|NCT00880555|101084523|FG001|Overall Study|Lost to Follow-up|1|||
33323991|NCT00880555|101084524|FG002|Overall Study|Lost to Follow-up|0|||
33323992|NCT00880555|101084525|FG003|Overall Study|Lost to Follow-up|0|||
33323993|NCT00880555|101084526|FG004|Overall Study|Lost to Follow-up|0|||
33323994|NCT00880555|101084527|FG005|Overall Study|Lost to Follow-up|0|||
33323995|NCT02014740|101084538|FG000|Overall Study|Lost to Follow-up|4|||
33323996|NCT02014740|101084539|FG001|Overall Study|Lost to Follow-up|4|||
33323997|NCT02014740|101084538|FG000|Overall Study|Withdrawal by Subject|2|||
33323998|NCT02014740|101084539|FG001|Overall Study|Withdrawal by Subject|1|||
33323999|NCT02281357|101084544|FG000|Overall Study|Adverse Event|2|||
33512000|NCT01943851|101770450|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33512001|NCT01943851|101770451|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33512002|NCT01943851|101770452|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33512003|NCT01943851|101770453|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33324000|NCT02281357|101084545|FG001|Overall Study|Adverse Event|1|||
33324001|NCT02281357|101084544|FG000|Overall Study|Lost to Follow-up|1|||
33324002|NCT02281357|101084545|FG001|Overall Study|Lost to Follow-up|0|||
33324003|NCT02281357|101084544|FG000|Overall Study|Withdrawal by Subject|4|||
33324004|NCT02281357|101084545|FG001|Overall Study|Withdrawal by Subject|3|||
33324005|NCT02906787|101084546|FG000|Overall Study|Withdrawal by Subject|12|||
33324006|NCT02906787|101084547|FG001|Overall Study|Withdrawal by Subject|10|||
33512004|NCT01943851|101770454|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33512005|NCT01943851|101770455|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33512006|NCT01943851|101770456|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33512007|NCT01943851|101770457|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
33512008|NCT01943851|101770458|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33512009|NCT01943851|101770459|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
33512010|NCT01943851|101770442|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33512011|NCT01943851|101770443|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33512012|NCT01943851|101770444|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33512013|NCT01943851|101770445|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33512014|NCT01943851|101770446|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33512015|NCT01943851|101770447|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33512016|NCT01943851|101770448|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33512017|NCT01943851|101770449|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33324007|NCT02906787|101084546|FG000|Overall Study|Missed|24|||
33324008|NCT02906787|101084547|FG001|Overall Study|Missed|22|||
33324009|NCT04060563|101084550|FG000|Overall Study|Lost to Follow-up|1|||
33324010|NCT04060563|101084551|FG001|Overall Study|Lost to Follow-up|1|||
33324011|NCT04060563|101084550|FG000|Overall Study|Physician Decision|0|||
33324012|NCT04060563|101084551|FG001|Overall Study|Physician Decision|1|||
33324013|NCT03329196|101084556|FG000|Overall Study|Adverse Event|10|||
33324014|NCT03329196|101084557|FG001|Overall Study|Adverse Event|5|||
33324015|NCT03329196|101084556|FG000|Overall Study|Physician Decision|2|||
33324016|NCT03329196|101084557|FG001|Overall Study|Physician Decision|2|||
33324017|NCT03329196|101084556|FG000|Overall Study|Withdrawal by Subject|11|||
33324018|NCT03329196|101084557|FG001|Overall Study|Withdrawal by Subject|3|||
33324019|NCT03329196|101084556|FG000|Overall Study|Hepatic function abnormalities|0|||
33324020|NCT03329196|101084557|FG001|Overall Study|Hepatic function abnormalities|1|||
33324021|NCT03329196|101084556|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
33324022|NCT03329196|101084557|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
33324023|NCT03329196|101084556|FG000|Overall Study|Difficult to control Hb|2|||
33324024|NCT03329196|101084557|FG001|Overall Study|Difficult to control Hb|3|||
33512018|NCT01943851|101770450|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33512019|NCT01943851|101770451|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33512020|NCT01943851|101770452|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33512021|NCT01943851|101770453|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33512022|NCT01943851|101770454|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33512023|NCT01943851|101770455|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33512024|NCT01943851|101770456|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
33512025|NCT01943851|101770457|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
33512026|NCT01943851|101770458|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
33512027|NCT01943851|101770459|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
33512028|NCT02662764|101770460|FG000|Overall Study|Adverse Event|6|||
33512029|NCT02662764|101770460|FG000|Overall Study|Lack of Efficacy|8|||
33512030|NCT02662764|101770460|FG000|Overall Study|Protocol Violation|1|||
33512031|NCT02662764|101770460|FG000|Overall Study|Withdrawal by Subject|5|||
33512032|NCT02662764|101770460|FG000|Overall Study|Device failure|4|||
33512033|NCT02662764|101770460|FG000|Overall Study|Patient changed treatment|1|||
33512034|NCT02662764|101770460|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
33512035|NCT04756154|101770461|FG000|Overall Study|Did not meet treatment day baseline|30|||
33512036|NCT04756154|101770462|FG001|Overall Study|Did not meet treatment day baseline|28|||
33512037|NCT04756154|101770463|FG002|Overall Study|Did not meet treatment day baseline|7|||
33512038|NCT04756154|101770461|FG000|Overall Study|Did not return for final sample collection|1|||
33512039|NCT04756154|101770462|FG001|Overall Study|Did not return for final sample collection|1|||
33512040|NCT04756154|101770463|FG002|Overall Study|Did not return for final sample collection|0|||
33512041|NCT02829723|101770468|FG000|Overall Study|Adverse Event|0|||
33512042|NCT02829723|101770469|FG001|Overall Study|Adverse Event|0|||
33512043|NCT02829723|101770470|FG002|Overall Study|Adverse Event|1|||
33512044|NCT02829723|101770471|FG003|Overall Study|Adverse Event|1|||
33512045|NCT02829723|101770472|FG004|Overall Study|Adverse Event|0|||
33512046|NCT02829723|101770473|FG005|Overall Study|Adverse Event|0|||
33512047|NCT02829723|101770474|FG006|Overall Study|Adverse Event|0|||
33512048|NCT02829723|101770475|FG007|Overall Study|Adverse Event|1|||
33512049|NCT02829723|101770476|FG008|Overall Study|Adverse Event|0|||
33512050|NCT02829723|101770477|FG009|Overall Study|Adverse Event|0|||
33512051|NCT02829723|101770478|FG010|Overall Study|Adverse Event|0|||
33512052|NCT02829723|101770479|FG011|Overall Study|Adverse Event|0|||
33512053|NCT02829723|101770480|FG012|Overall Study|Adverse Event|0|||
33512054|NCT02829723|101770481|FG013|Overall Study|Adverse Event|0|||
33512055|NCT02829723|101770482|FG014|Overall Study|Adverse Event|1|||
33512056|NCT02829723|101770483|FG015|Overall Study|Adverse Event|1|||
33512057|NCT02829723|101770484|FG016|Overall Study|Adverse Event|1|||
33512058|NCT02829723|101770485|FG017|Overall Study|Adverse Event|2|||
33512059|NCT02829723|101770486|FG018|Overall Study|Adverse Event|1|||
33512060|NCT02829723|101770487|FG019|Overall Study|Adverse Event|1|||
33512061|NCT02829723|101770488|FG020|Overall Study|Adverse Event|3|||
33512062|NCT02829723|101770489|FG021|Overall Study|Adverse Event|0|||
33512063|NCT02829723|101770490|FG022|Overall Study|Adverse Event|0|||
33324025|NCT03329196|101084556|FG000|Overall Study|Dialysis or renal transplant|13|||
33512064|NCT02829723|101770491|FG023|Overall Study|Adverse Event|1|||
33512065|NCT02829723|101770492|FG024|Overall Study|Adverse Event|1|||
33605732|NCT02228096|102108198|FG000|Overall Study|Study terminated by Sponsor|24|||
33324026|NCT03329196|101084557|FG001|Overall Study|Dialysis or renal transplant|15|||
33324027|NCT00698204|101084558|FG000|Overall Study|Withdrawal by Subject|1|||
33324028|NCT00698204|101084559|FG001|Overall Study|Withdrawal by Subject|0|||
33512066|NCT02829723|101770493|FG025|Overall Study|Adverse Event|3|||
33512067|NCT02829723|101770494|FG026|Overall Study|Adverse Event|5|||
33512068|NCT02829723|101770468|FG000|Overall Study|Death|1|||
33512069|NCT02829723|101770469|FG001|Overall Study|Death|0|||
33512070|NCT02829723|101770470|FG002|Overall Study|Death|1|||
33512071|NCT02829723|101770471|FG003|Overall Study|Death|1|||
33512072|NCT02829723|101770472|FG004|Overall Study|Death|0|||
33512073|NCT02829723|101770473|FG005|Overall Study|Death|0|||
33605733|NCT02228096|102108198|FG000|Overall Study|Lack of Efficacy|18|||
33605734|NCT02228096|102108198|FG000|Overall Study|Death|12|||
33605735|NCT02228096|102108198|FG000|Overall Study|Physician Decision|3|||
33605736|NCT02228096|102108198|FG000|Overall Study|Subject/guardian decision|2|||
33605737|NCT02228096|102108198|FG000|Overall Study|New therapy for study indication|1|||
33605738|NCT02228096|102108198|FG000|Overall Study|Enrolled, not infused|11|||
33605739|NCT03629912|102108201|FG000|Overall Study|Lost to Follow-up|19|||
33605740|NCT03629912|102108202|FG001|Overall Study|Lost to Follow-up|7|||
33605741|NCT03629912|102108203|FG002|Overall Study|Lost to Follow-up|5|||
33605742|NCT03629912|102108204|FG003|Overall Study|Lost to Follow-up|1|||
33605743|NCT03629912|102108201|FG000|Overall Study|Withdrawal by Subject|6|||
33605744|NCT03629912|102108202|FG001|Overall Study|Withdrawal by Subject|0|||
33324029|NCT03189862|101084562|FG000|Overall Study|Withdrawal by Subject|1|||
33324030|NCT03189862|101084563|FG001|Overall Study|Withdrawal by Subject|0|||
33324031|NCT03189862|101084562|FG000|Overall Study|Lost to Follow-up|54|||
33324032|NCT03189862|101084563|FG001|Overall Study|Lost to Follow-up|62|||
33324033|NCT00789880|101084574|FG000|Overall Study|Adverse Event|0|||
33324034|NCT00789880|101084575|FG001|Overall Study|Adverse Event|0|||
33324035|NCT00789880|101084576|FG002|Overall Study|Adverse Event|0|||
33324036|NCT00789880|101084577|FG003|Overall Study|Adverse Event|0|||
33512074|NCT02829723|101770474|FG006|Overall Study|Death|2|||
33512075|NCT02829723|101770475|FG007|Overall Study|Death|0|||
33512076|NCT02829723|101770476|FG008|Overall Study|Death|1|||
33512077|NCT02829723|101770477|FG009|Overall Study|Death|0|||
33512078|NCT02829723|101770478|FG010|Overall Study|Death|0|||
33512079|NCT02829723|101770479|FG011|Overall Study|Death|0|||
33512080|NCT02829723|101770480|FG012|Overall Study|Death|2|||
33512081|NCT02829723|101770481|FG013|Overall Study|Death|1|||
33512082|NCT02829723|101770482|FG014|Overall Study|Death|0|||
33512083|NCT02829723|101770483|FG015|Overall Study|Death|0|||
33512084|NCT02829723|101770484|FG016|Overall Study|Death|0|||
33512085|NCT02829723|101770485|FG017|Overall Study|Death|0|||
33512086|NCT02829723|101770486|FG018|Overall Study|Death|0|||
33512087|NCT02829723|101770487|FG019|Overall Study|Death|0|||
33512088|NCT02829723|101770488|FG020|Overall Study|Death|0|||
33512089|NCT02829723|101770489|FG021|Overall Study|Death|2|||
33512090|NCT02829723|101770490|FG022|Overall Study|Death|0|||
33512091|NCT02829723|101770491|FG023|Overall Study|Death|0|||
33512092|NCT02829723|101770492|FG024|Overall Study|Death|0|||
33324037|NCT00789880|101084578|FG004|Overall Study|Adverse Event|1|||
33324038|NCT00789880|101084579|FG005|Overall Study|Adverse Event|0|||
33324039|NCT00789880|101084574|FG000|Overall Study|Protocol Violation|0|||
33324040|NCT00789880|101084575|FG001|Overall Study|Protocol Violation|1|||
33324041|NCT00789880|101084576|FG002|Overall Study|Protocol Violation|0|||
33324042|NCT00789880|101084577|FG003|Overall Study|Protocol Violation|1|||
33324043|NCT00789880|101084578|FG004|Overall Study|Protocol Violation|0|||
33324044|NCT00789880|101084579|FG005|Overall Study|Protocol Violation|0|||
33324045|NCT00789880|101084574|FG000|Overall Study|Withdrawal by Subject|1|||
33324046|NCT00789880|101084575|FG001|Overall Study|Withdrawal by Subject|0|||
33324047|NCT00789880|101084576|FG002|Overall Study|Withdrawal by Subject|0|||
33324048|NCT00789880|101084577|FG003|Overall Study|Withdrawal by Subject|0|||
33324049|NCT00789880|101084578|FG004|Overall Study|Withdrawal by Subject|2|||
33324050|NCT00789880|101084579|FG005|Overall Study|Withdrawal by Subject|0|||
33324051|NCT00791258|101084580|FG000|Overall Study|Adverse Event|87|||
33324052|NCT00791258|101084580|FG000|Overall Study|Lost to Follow-up|18|||
33324053|NCT00791258|101084580|FG000|Overall Study|Protocol Violation|109|||
33324054|NCT00791258|101084580|FG000|Overall Study|Withdrawal by Subject|40|||
33324055|NCT00791258|101084580|FG000|Overall Study|Did not take medication for >3 days|1|||
33324056|NCT00791258|101084580|FG000|Overall Study|subject left area|2|||
33324057|NCT00791258|101084580|FG000|Overall Study|non-compliance|3|||
33324058|NCT00791258|101084580|FG000|Overall Study|Subject incarcerated|1|||
33324059|NCT00791258|101084580|FG000|Overall Study|Subject required restricted medication|1|||
33512093|NCT02829723|101770493|FG025|Overall Study|Death|1|||
33512094|NCT02829723|101770494|FG026|Overall Study|Death|2|||
33512095|NCT02829723|101770468|FG000|Overall Study|Physician Decision|0|||
33512096|NCT02829723|101770469|FG001|Overall Study|Physician Decision|0|||
33605745|NCT03629912|102108203|FG002|Overall Study|Withdrawal by Subject|1|||
33605746|NCT03629912|102108204|FG003|Overall Study|Withdrawal by Subject|2|||
33605747|NCT03629912|102108201|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
33605748|NCT03629912|102108202|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
33605749|NCT03629912|102108203|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
33324060|NCT00791258|101084580|FG000|Overall Study|Lack of Efficacy|1|||
33324061|NCT01132612|101084583|FG000|Overall Study|Death|0|||
33324062|NCT01132612|101084584|FG001|Overall Study|Death|0|||
33324063|NCT01132612|101084585|FG002|Overall Study|Death|1|||
33512097|NCT02829723|101770470|FG002|Overall Study|Physician Decision|0|||
33512098|NCT02829723|101770471|FG003|Overall Study|Physician Decision|0|||
33512099|NCT02829723|101770472|FG004|Overall Study|Physician Decision|0|||
33512100|NCT02829723|101770473|FG005|Overall Study|Physician Decision|0|||
33512101|NCT02829723|101770474|FG006|Overall Study|Physician Decision|0|||
33512102|NCT02829723|101770475|FG007|Overall Study|Physician Decision|0|||
33512103|NCT02829723|101770476|FG008|Overall Study|Physician Decision|0|||
33512104|NCT02829723|101770477|FG009|Overall Study|Physician Decision|1|||
33512105|NCT02829723|101770478|FG010|Overall Study|Physician Decision|1|||
33324064|NCT01132612|101084583|FG000|Overall Study|Protocol deviation|0|||
33324065|NCT01132612|101084584|FG001|Overall Study|Protocol deviation|0|||
33324066|NCT01132612|101084585|FG002|Overall Study|Protocol deviation|3|||
33324067|NCT01132612|101084583|FG000|Overall Study|Lost to Follow-up|2|||
33324068|NCT01132612|101084584|FG001|Overall Study|Lost to Follow-up|2|||
33324069|NCT01132612|101084585|FG002|Overall Study|Lost to Follow-up|7|||
33324070|NCT01132612|101084583|FG000|Overall Study|Adverse Event|5|||
33324071|NCT01132612|101084584|FG001|Overall Study|Adverse Event|2|||
33324072|NCT01132612|101084585|FG002|Overall Study|Adverse Event|15|||
33324073|NCT01132612|101084583|FG000|Overall Study|Withdrawal by Subject|5|||
33324074|NCT01132612|101084584|FG001|Overall Study|Withdrawal by Subject|8|||
33324075|NCT01132612|101084585|FG002|Overall Study|Withdrawal by Subject|19|||
33324076|NCT01132612|101084583|FG000|Overall Study|Administrative problems|5|||
33324077|NCT01132612|101084584|FG001|Overall Study|Administrative problems|1|||
33324078|NCT01132612|101084585|FG002|Overall Study|Administrative problems|52|||
33324079|NCT01132612|101084583|FG000|Overall Study|Lack of Efficacy|23|||
33324080|NCT01132612|101084584|FG001|Overall Study|Lack of Efficacy|22|||
33324081|NCT01132612|101084585|FG002|Overall Study|Lack of Efficacy|73|||
33324082|NCT00544648|101084590|FG000|Overall Study|Withdrawal by Subject|1|||
33324083|NCT00544648|101084591|FG001|Overall Study|Withdrawal by Subject|0|||
33324084|NCT00544648|101084590|FG000|Overall Study|Adverse Event|1|||
33324085|NCT00544648|101084591|FG001|Overall Study|Adverse Event|1|||
33324086|NCT00544648|101084590|FG000|Overall Study|progression of disease|1|||
33324087|NCT00544648|101084591|FG001|Overall Study|progression of disease|0|||
33324088|NCT01007032|101084592|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
33324089|NCT01007032|101084593|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
33324090|NCT01007032|101084594|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
33324091|NCT01007032|101084595|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
33512106|NCT02829723|101770479|FG011|Overall Study|Physician Decision|0|||
33512107|NCT02829723|101770480|FG012|Overall Study|Physician Decision|0|||
33512108|NCT02829723|101770481|FG013|Overall Study|Physician Decision|1|||
33512109|NCT02829723|101770482|FG014|Overall Study|Physician Decision|0|||
33512110|NCT02829723|101770483|FG015|Overall Study|Physician Decision|0|||
33512111|NCT02829723|101770484|FG016|Overall Study|Physician Decision|2|||
33512112|NCT02829723|101770485|FG017|Overall Study|Physician Decision|0|||
33512113|NCT02829723|101770486|FG018|Overall Study|Physician Decision|0|||
33512114|NCT02829723|101770487|FG019|Overall Study|Physician Decision|0|||
33512115|NCT02829723|101770488|FG020|Overall Study|Physician Decision|0|||
33512116|NCT02829723|101770489|FG021|Overall Study|Physician Decision|0|||
33512117|NCT02829723|101770490|FG022|Overall Study|Physician Decision|1|||
33512118|NCT02829723|101770491|FG023|Overall Study|Physician Decision|1|||
33512119|NCT02829723|101770492|FG024|Overall Study|Physician Decision|1|||
33512120|NCT02829723|101770493|FG025|Overall Study|Physician Decision|1|||
33512121|NCT02829723|101770494|FG026|Overall Study|Physician Decision|3|||
33512122|NCT02829723|101770468|FG000|Overall Study|Progressive disease|4|||
33512123|NCT02829723|101770469|FG001|Overall Study|Progressive disease|6|||
33512124|NCT02829723|101770470|FG002|Overall Study|Progressive disease|3|||
33512125|NCT02829723|101770471|FG003|Overall Study|Progressive disease|3|||
33512126|NCT02829723|101770472|FG004|Overall Study|Progressive disease|3|||
33512127|NCT02829723|101770473|FG005|Overall Study|Progressive disease|5|||
33512128|NCT02829723|101770474|FG006|Overall Study|Progressive disease|4|||
33512129|NCT02829723|101770475|FG007|Overall Study|Progressive disease|6|||
33324092|NCT01007032|101084592|FG000|Overall Study|Withdrawal by Subject|0|||
33324093|NCT01007032|101084593|FG001|Overall Study|Withdrawal by Subject|0|||
33324094|NCT01007032|101084594|FG002|Overall Study|Withdrawal by Subject|0|||
33324095|NCT01007032|101084595|FG003|Overall Study|Withdrawal by Subject|1|||
33324096|NCT02163187|101084598|FG000|Overall Study|Device removed|1|||
33512130|NCT02829723|101770476|FG008|Overall Study|Progressive disease|8|||
33605750|NCT03629912|102108204|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
33605751|NCT03629912|102108201|FG000|Overall Study|Death|1|||
33512131|NCT02829723|101770477|FG009|Overall Study|Progressive disease|4|||
33512132|NCT02829723|101770478|FG010|Overall Study|Progressive disease|9|||
33324097|NCT02163187|101084599|FG001|Overall Study|Device removed|0|||
33324098|NCT02163187|101084598|FG000|Overall Study|Progressive disease|1|||
33324099|NCT02163187|101084599|FG001|Overall Study|Progressive disease|0|||
33512133|NCT02829723|101770479|FG011|Overall Study|Progressive disease|0|||
33512134|NCT02829723|101770480|FG012|Overall Study|Progressive disease|3|||
33512135|NCT02829723|101770481|FG013|Overall Study|Progressive disease|4|||
33512136|NCT02829723|101770482|FG014|Overall Study|Progressive disease|2|||
33512137|NCT02829723|101770483|FG015|Overall Study|Progressive disease|4|||
33512138|NCT02829723|101770484|FG016|Overall Study|Progressive disease|5|||
33512139|NCT02829723|101770485|FG017|Overall Study|Progressive disease|3|||
33512140|NCT02829723|101770486|FG018|Overall Study|Progressive disease|4|||
33512141|NCT02829723|101770487|FG019|Overall Study|Progressive disease|4|||
33512142|NCT02829723|101770488|FG020|Overall Study|Progressive disease|7|||
33512143|NCT02829723|101770489|FG021|Overall Study|Progressive disease|6|||
33512144|NCT02829723|101770490|FG022|Overall Study|Progressive disease|3|||
33512145|NCT02829723|101770491|FG023|Overall Study|Progressive disease|3|||
33512146|NCT02829723|101770492|FG024|Overall Study|Progressive disease|3|||
33512147|NCT02829723|101770493|FG025|Overall Study|Progressive disease|16|||
33512148|NCT02829723|101770494|FG026|Overall Study|Progressive disease|10|||
33512149|NCT02829723|101770468|FG000|Overall Study|Subject/guardian decision|0|||
33605752|NCT03629912|102108202|FG001|Overall Study|Death|0|||
33324100|NCT02170779|101084611|FG000|Overall Study|Withdrawal by Subject|1|||
33324101|NCT02170779|101084612|FG001|Overall Study|Withdrawal by Subject|0|||
33324102|NCT02170779|101084611|FG000|Overall Study|Lost to Follow-up|0|||
33324103|NCT02170779|101084612|FG001|Overall Study|Lost to Follow-up|1|||
33324104|NCT04823611|101084613|FG000|Overall Study|Adverse Event|2|||
33324105|NCT04823611|101084614|FG001|Overall Study|Adverse Event|0|||
33324106|NCT04823611|101084615|FG002|Overall Study|Adverse Event|1|||
33324107|NCT04823611|101084616|FG003|Overall Study|Adverse Event|0|||
33324108|NCT04823611|101084617|FG004|Overall Study|Adverse Event|0|||
33324109|NCT04823611|101084618|FG005|Overall Study|Adverse Event|0|||
33324110|NCT04823611|101084619|FG006|Overall Study|Adverse Event|0|||
33324111|NCT04340557|101084621|FG000|Overall Study|Transferred to ICU and/or death|1|||
33324112|NCT04340557|101084622|FG001|Overall Study|Transferred to ICU and/or death|2|||
33324113|NCT01293968|101084623|FG000|Overall Study|non-cooperation|3|||
33324114|NCT01293968|101084624|FG001|Overall Study|non-cooperation|3|||
33324115|NCT00805025|101084627|FG000|Overall Study|Screened but not enrolled/treated|42|||
33324116|NCT00805025|101084627|FG000|Overall Study|Adverse Event|4|||
33324117|NCT00805025|101084627|FG000|Overall Study|Withdrawal by Subject|2|||
33324118|NCT00805025|101084627|FG000|Overall Study|Physician Decision|1|||
33324119|NCT02790138|101084628|FG000|Overall Study|Adverse Event|5|||
33324120|NCT02790138|101084629|FG001|Overall Study|Adverse Event|2|||
33324121|NCT02790138|101084628|FG000|Overall Study|Significant Protocol Deviation|0|||
33324122|NCT02790138|101084629|FG001|Overall Study|Significant Protocol Deviation|1|||
33324123|NCT02790138|101084628|FG000|Overall Study|Lost to Follow-up|1|||
33324124|NCT02790138|101084629|FG001|Overall Study|Lost to Follow-up|0|||
33324125|NCT02790138|101084628|FG000|Overall Study|Voluntary Withdrawal|8|||
33324126|NCT02790138|101084629|FG001|Overall Study|Voluntary Withdrawal|9|||
33324127|NCT02790138|101084628|FG000|Overall Study|Lack of Efficacy|6|||
33324128|NCT02790138|101084629|FG001|Overall Study|Lack of Efficacy|7|||
33324129|NCT02790138|101084628|FG000|Overall Study|Reason not Specified|1|||
33324130|NCT02790138|101084629|FG001|Overall Study|Reason not Specified|0|||
33324131|NCT00718549|101084630|FG000|Induction Phase|Disease Progression|1|||
33324132|NCT00718549|101084631|FG001|Induction Phase|Disease Progression|0|||
33324133|NCT00718549|101084632|FG002|Induction Phase|Disease Progression|0|||
33324134|NCT00718549|101084630|FG000|Induction Phase|Eligibility Criteria Violation|2|||
33324135|NCT00718549|101084631|FG001|Induction Phase|Eligibility Criteria Violation|0|||
33324136|NCT00718549|101084632|FG002|Induction Phase|Eligibility Criteria Violation|0|||
33324137|NCT00718549|101084630|FG000|Induction Phase|Early Termination - No Additional Info|59|||
33512150|NCT02829723|101770469|FG001|Overall Study|Subject/guardian decision|1|||
33605753|NCT03629912|102108203|FG002|Overall Study|Death|0|||
33605754|NCT03629912|102108204|FG003|Overall Study|Death|0|||
33605755|NCT03443427|102108205|FG000|Overall Study|Adverse Event|2|||
33605756|NCT03443427|102108206|FG001|Overall Study|Adverse Event|3|||
33605757|NCT03443427|102108205|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
33605758|NCT03443427|102108206|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
33324138|NCT00718549|101084631|FG001|Induction Phase|Early Termination - No Additional Info|0|||
33605759|NCT03443427|102108205|FG000|Overall Study|Other|4|||
33605760|NCT03443427|102108206|FG001|Overall Study|Other|6|||
33324139|NCT00718549|101084632|FG002|Induction Phase|Early Termination - No Additional Info|0|||
33324140|NCT00718549|101084630|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
33324141|NCT00718549|101084631|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
33324142|NCT00718549|101084632|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
33512151|NCT02829723|101770470|FG002|Overall Study|Subject/guardian decision|0|||
33605761|NCT01272869|102108207|FG000|Period 2 (14 Days)|Adverse Event|1|||
33324143|NCT00718549|101084630|FG000|Maintenance/ Observation Phase|Death|0|||
33512152|NCT02829723|101770471|FG003|Overall Study|Subject/guardian decision|1|||
33605762|NCT01272869|102108208|FG001|Period 2 (14 Days)|Adverse Event|0|||
33324144|NCT00718549|101084631|FG001|Maintenance/ Observation Phase|Death|1|||
33324145|NCT00718549|101084632|FG002|Maintenance/ Observation Phase|Death|2|||
33324146|NCT00718549|101084630|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
33324147|NCT00718549|101084631|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
33324148|NCT00718549|101084632|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
33324149|NCT00718549|101084630|FG000|Maintenance/ Observation Phase|Progression|0|||
33324150|NCT00718549|101084631|FG001|Maintenance/ Observation Phase|Progression|5|||
33324151|NCT00718549|101084632|FG002|Maintenance/ Observation Phase|Progression|14|||
33324152|NCT00718549|101084630|FG000|Maintenance/ Observation Phase|Relapse|0|||
33324153|NCT00718549|101084631|FG001|Maintenance/ Observation Phase|Relapse|3|||
33324154|NCT00718549|101084632|FG002|Maintenance/ Observation Phase|Relapse|2|||
33324155|NCT02248259|101084633|FG000|Treatment Period 1|Adverse Event|0|||
33324156|NCT02248259|101084634|FG001|Treatment Period 1|Adverse Event|0|||
33324157|NCT02248259|101084635|FG002|Treatment Period 1|Adverse Event|1|||
33324158|NCT02248259|101084636|FG003|Treatment Period 1|Adverse Event|0|||
33324159|NCT00687440|101084637|FG000|Overall Study|Adverse Event|3|||
33324160|NCT00687440|101084637|FG000|Overall Study|Lost to Follow-up|3|||
33324161|NCT00687440|101084637|FG000|Overall Study|Lack of Efficacy|2|||
33512153|NCT02829723|101770472|FG004|Overall Study|Subject/guardian decision|0|||
33512154|NCT02829723|101770473|FG005|Overall Study|Subject/guardian decision|0|||
33512155|NCT02829723|101770474|FG006|Overall Study|Subject/guardian decision|0|||
33512156|NCT02829723|101770475|FG007|Overall Study|Subject/guardian decision|1|||
33512157|NCT02829723|101770476|FG008|Overall Study|Subject/guardian decision|0|||
33512158|NCT02829723|101770477|FG009|Overall Study|Subject/guardian decision|0|||
33512159|NCT02829723|101770478|FG010|Overall Study|Subject/guardian decision|0|||
33512160|NCT02829723|101770479|FG011|Overall Study|Subject/guardian decision|0|||
33512161|NCT02829723|101770480|FG012|Overall Study|Subject/guardian decision|0|||
33512162|NCT02829723|101770481|FG013|Overall Study|Subject/guardian decision|0|||
33512163|NCT02829723|101770482|FG014|Overall Study|Subject/guardian decision|1|||
33512164|NCT02829723|101770483|FG015|Overall Study|Subject/guardian decision|0|||
33512165|NCT02829723|101770484|FG016|Overall Study|Subject/guardian decision|1|||
33512166|NCT02829723|101770485|FG017|Overall Study|Subject/guardian decision|0|||
33512167|NCT02829723|101770486|FG018|Overall Study|Subject/guardian decision|1|||
33512168|NCT02829723|101770487|FG019|Overall Study|Subject/guardian decision|0|||
33512169|NCT02829723|101770488|FG020|Overall Study|Subject/guardian decision|1|||
33512170|NCT02829723|101770489|FG021|Overall Study|Subject/guardian decision|0|||
33512171|NCT02829723|101770490|FG022|Overall Study|Subject/guardian decision|0|||
33512172|NCT02829723|101770491|FG023|Overall Study|Subject/guardian decision|1|||
33512173|NCT02829723|101770492|FG024|Overall Study|Subject/guardian decision|0|||
33512174|NCT02829723|101770493|FG025|Overall Study|Subject/guardian decision|1|||
33512175|NCT02829723|101770494|FG026|Overall Study|Subject/guardian decision|1|||
33512176|NCT02829723|101770468|FG000|Overall Study|Study terminated by sponsor|0|||
33324162|NCT00687440|101084637|FG000|Overall Study|Death|2|||
33324163|NCT00687440|101084637|FG000|Overall Study|Other|1|||
33512177|NCT02829723|101770469|FG001|Overall Study|Study terminated by sponsor|0|||
33512178|NCT02829723|101770470|FG002|Overall Study|Study terminated by sponsor|0|||
33512179|NCT02829723|101770471|FG003|Overall Study|Study terminated by sponsor|0|||
33512180|NCT02829723|101770472|FG004|Overall Study|Study terminated by sponsor|0|||
33512181|NCT02829723|101770473|FG005|Overall Study|Study terminated by sponsor|0|||
33512182|NCT02829723|101770474|FG006|Overall Study|Study terminated by sponsor|0|||
33512183|NCT02829723|101770475|FG007|Overall Study|Study terminated by sponsor|0|||
33512184|NCT02829723|101770476|FG008|Overall Study|Study terminated by sponsor|0|||
33512185|NCT02829723|101770477|FG009|Overall Study|Study terminated by sponsor|0|||
33512186|NCT02829723|101770478|FG010|Overall Study|Study terminated by sponsor|0|||
33512187|NCT02829723|101770479|FG011|Overall Study|Study terminated by sponsor|0|||
33512188|NCT02829723|101770480|FG012|Overall Study|Study terminated by sponsor|0|||
33512189|NCT02829723|101770481|FG013|Overall Study|Study terminated by sponsor|0|||
33512190|NCT02829723|101770482|FG014|Overall Study|Study terminated by sponsor|0|||
33512191|NCT02829723|101770483|FG015|Overall Study|Study terminated by sponsor|0|||
33605763|NCT03908970|102108211|FG000|Overall Study|Adverse Event|7|||
33605764|NCT03908970|102108212|FG001|Overall Study|Adverse Event|21|||
33605765|NCT03908970|102108211|FG000|Overall Study|Physician Decision|1|||
33605766|NCT03908970|102108212|FG001|Overall Study|Physician Decision|4|||
33605767|NCT03908970|102108211|FG000|Overall Study|Withdrawal by Subject|9|||
33605768|NCT03908970|102108212|FG001|Overall Study|Withdrawal by Subject|22|||
33605769|NCT04356040|102108214|FG000|Overall Study|Death|2|||
33512192|NCT02829723|101770484|FG016|Overall Study|Study terminated by sponsor|0|||
33512193|NCT02829723|101770485|FG017|Overall Study|Study terminated by sponsor|0|||
33512194|NCT02829723|101770486|FG018|Overall Study|Study terminated by sponsor|0|||
33605770|NCT04356040|102108215|FG001|Overall Study|Death|0|||
33605771|NCT04356040|102108214|FG000|Overall Study|Lost to Follow-up|1|||
33605772|NCT04356040|102108215|FG001|Overall Study|Lost to Follow-up|0|||
33605773|NCT04356040|102108214|FG000|Overall Study|Physician Decision|0|||
33605774|NCT04356040|102108215|FG001|Overall Study|Physician Decision|1|||
33605775|NCT04356040|102108214|FG000|Overall Study|Withdrawal by Subject|13|||
33605776|NCT04356040|102108215|FG001|Overall Study|Withdrawal by Subject|1|||
33605777|NCT04356040|102108214|FG000|Overall Study|Enrollment Pause|10|||
33324164|NCT00687440|101084637|FG000|Overall Study|Missing|1|||
33512195|NCT02829723|101770487|FG019|Overall Study|Study terminated by sponsor|0|||
33512196|NCT02829723|101770488|FG020|Overall Study|Study terminated by sponsor|0|||
33324165|NCT01131351|101084639|FG000|Overall Study|Adverse Event|0|||
33512197|NCT02829723|101770489|FG021|Overall Study|Study terminated by sponsor|1|||
33512198|NCT02829723|101770490|FG022|Overall Study|Study terminated by sponsor|0|||
33605778|NCT04356040|102108215|FG001|Overall Study|Enrollment Pause|0|||
33512199|NCT02829723|101770491|FG023|Overall Study|Study terminated by sponsor|0|||
33605779|NCT04356040|102108214|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
33605780|NCT04356040|102108215|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
33605781|NCT04356040|102108214|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
33605782|NCT04356040|102108215|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
33605783|NCT04356040|102108214|FG000|Overall Study|PI left institution|3|||
33605784|NCT04356040|102108215|FG001|Overall Study|PI left institution|0|||
33605785|NCT01972789|102108216|FG000|Overall Study|Adverse Event|11|||
33605786|NCT01972789|102108217|FG001|Overall Study|Adverse Event|4|||
33605787|NCT01972789|102108216|FG000|Overall Study|Subject withdrew consent|14|||
33605788|NCT01972789|102108217|FG001|Overall Study|Subject withdrew consent|12|||
33605789|NCT01972789|102108216|FG000|Overall Study|Lost to Follow-up|4|||
33605790|NCT01972789|102108217|FG001|Overall Study|Lost to Follow-up|7|||
33605791|NCT01972789|102108216|FG000|Overall Study|Death|7|||
33512200|NCT02829723|101770492|FG024|Overall Study|Study terminated by sponsor|0|||
33512201|NCT02829723|101770493|FG025|Overall Study|Study terminated by sponsor|0|||
33512202|NCT02829723|101770494|FG026|Overall Study|Study terminated by sponsor|0|||
33512203|NCT02062944|101770495|FG000|Overall Study|Lost to Follow-up|1|||
33512204|NCT02062944|101770495|FG000|Overall Study|New hemotological disorder identified|1|||
33512205|NCT02062944|101770495|FG000|Overall Study|Uncontrolled Hypertension|1|||
33512206|NCT02062944|101770495|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
33512207|NCT03053063|101770496|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
33512208|NCT03053063|101770497|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
33512209|NCT03053063|101770498|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
33512210|NCT03053063|101770499|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
33512211|NCT03053063|101770496|FG000|Randomized Phase|Withdrew consent|8|||
33512212|NCT03053063|101770497|FG001|Randomized Phase|Withdrew consent|11|||
33512213|NCT03053063|101770498|FG002|Randomized Phase|Withdrew consent|5|||
33512214|NCT03053063|101770499|FG003|Randomized Phase|Withdrew consent|0|||
33512215|NCT03053063|101770496|FG000|Randomized Phase|Investigator's Discretion|8|||
33512216|NCT03053063|101770497|FG001|Randomized Phase|Investigator's Discretion|6|||
33512217|NCT03053063|101770498|FG002|Randomized Phase|Investigator's Discretion|2|||
33512218|NCT03053063|101770499|FG003|Randomized Phase|Investigator's Discretion|0|||
33512219|NCT03053063|101770496|FG000|Randomized Phase|Lost to Follow-up|3|||
33512220|NCT03053063|101770497|FG001|Randomized Phase|Lost to Follow-up|5|||
33512221|NCT03053063|101770498|FG002|Randomized Phase|Lost to Follow-up|1|||
33512222|NCT03053063|101770499|FG003|Randomized Phase|Lost to Follow-up|0|||
33512223|NCT03053063|101770496|FG000|Randomized Phase|Adverse Event|0|||
33512224|NCT03053063|101770497|FG001|Randomized Phase|Adverse Event|1|||
33512225|NCT03053063|101770498|FG002|Randomized Phase|Adverse Event|0|||
33512226|NCT03053063|101770499|FG003|Randomized Phase|Adverse Event|0|||
33512227|NCT03053063|101770496|FG000|Randomized Phase|Randomized but Never Treated|1|||
33512228|NCT03053063|101770497|FG001|Randomized Phase|Randomized but Never Treated|3|||
33512229|NCT03053063|101770498|FG002|Randomized Phase|Randomized but Never Treated|2|||
33512230|NCT03053063|101770499|FG003|Randomized Phase|Randomized but Never Treated|0|||
33512231|NCT03053063|101770496|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
33512232|NCT03053063|101770497|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
33512233|NCT03053063|101770498|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
33512234|NCT03053063|101770499|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
33512235|NCT03053063|101770496|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
33512236|NCT03053063|101770497|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
33512237|NCT03053063|101770498|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
33512238|NCT03053063|101770499|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
33512239|NCT03053063|101770496|FG000|Open-Label Phase|Death|0|||
33512240|NCT03053063|101770497|FG001|Open-Label Phase|Death|0|||
33512241|NCT03053063|101770498|FG002|Open-Label Phase|Death|0|||
33512242|NCT03053063|101770499|FG003|Open-Label Phase|Death|2|||
33512243|NCT03053063|101770496|FG000|Open-Label Phase|Investigator's discretion|0|||
33512244|NCT03053063|101770497|FG001|Open-Label Phase|Investigator's discretion|0|||
33512245|NCT03053063|101770498|FG002|Open-Label Phase|Investigator's discretion|0|||
33512246|NCT03053063|101770499|FG003|Open-Label Phase|Investigator's discretion|2|||
33512247|NCT03962790|101770500|FG000|Period 1|Adverse Event|0|||
33512248|NCT03962790|101770501|FG001|Period 1|Adverse Event|1|||
33512249|NCT03962790|101770500|FG000|Period 1|Failed to meet all eligibility criteria|1|||
33512250|NCT03962790|101770501|FG001|Period 1|Failed to meet all eligibility criteria|1|||
33512251|NCT03962790|101770500|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
33512252|NCT03962790|101770501|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
33605792|NCT01972789|102108217|FG001|Overall Study|Death|5|||
33512253|NCT03962790|101770500|FG000|Period 1|Withdrawal by Subject|1|||
33512254|NCT03962790|101770501|FG001|Period 1|Withdrawal by Subject|0|||
33324166|NCT01131351|101084640|FG001|Overall Study|Adverse Event|2|||
33324167|NCT01131351|101084639|FG000|Overall Study|Protocol Deviation|0|||
33324168|NCT01131351|101084640|FG001|Overall Study|Protocol Deviation|1|||
33324169|NCT02000427|101084642|FG000|Overall Study|Death|22|||
33324170|NCT01069172|101084643|FG000|Overall Study|Withdrawal by Subject|1|||
33324171|NCT01069172|101084644|FG001|Overall Study|Withdrawal by Subject|0|||
33324172|NCT01794520|101084645|FG000|Overall Study|Adverse events- related to progression|0|||
33324173|NCT01794520|101084646|FG001|Overall Study|Adverse events- related to progression|0|||
33324174|NCT01794520|101084647|FG002|Overall Study|Adverse events- related to progression|1|||
33324175|NCT01794520|101084648|FG003|Overall Study|Adverse events- related to progression|2|||
33324176|NCT01794520|101084649|FG004|Overall Study|Adverse events- related to progression|0|||
33324177|NCT01794520|101084650|FG005|Overall Study|Adverse events- related to progression|1|||
33324178|NCT01794520|101084651|FG006|Overall Study|Adverse events- related to progression|0|||
33324179|NCT01794520|101084645|FG000|Overall Study|Adverse event- not related to progression|1|||
33324180|NCT01794520|101084646|FG001|Overall Study|Adverse event- not related to progression|1|||
33324181|NCT01794520|101084647|FG002|Overall Study|Adverse event- not related to progression|0|||
33324182|NCT01794520|101084648|FG003|Overall Study|Adverse event- not related to progression|0|||
33324183|NCT01794520|101084649|FG004|Overall Study|Adverse event- not related to progression|2|||
33324184|NCT01794520|101084650|FG005|Overall Study|Adverse event- not related to progression|0|||
33324185|NCT01794520|101084651|FG006|Overall Study|Adverse event- not related to progression|0|||
33324186|NCT01794520|101084645|FG000|Overall Study|Progressive disease|5|||
33324187|NCT01794520|101084646|FG001|Overall Study|Progressive disease|6|||
33324188|NCT01794520|101084647|FG002|Overall Study|Progressive disease|2|||
33324189|NCT01794520|101084648|FG003|Overall Study|Progressive disease|5|||
33324190|NCT01794520|101084649|FG004|Overall Study|Progressive disease|27|||
33324191|NCT01794520|101084650|FG005|Overall Study|Progressive disease|18|||
33324192|NCT01794520|101084651|FG006|Overall Study|Progressive disease|0|||
33324193|NCT01794520|101084645|FG000|Overall Study|Withdrew consent|0|||
33324194|NCT01794520|101084646|FG001|Overall Study|Withdrew consent|0|||
33324195|NCT01794520|101084647|FG002|Overall Study|Withdrew consent|1|||
33324196|NCT01794520|101084648|FG003|Overall Study|Withdrew consent|1|||
33324197|NCT01794520|101084649|FG004|Overall Study|Withdrew consent|0|||
33324198|NCT01794520|101084650|FG005|Overall Study|Withdrew consent|0|||
33324199|NCT01794520|101084651|FG006|Overall Study|Withdrew consent|0|||
33324200|NCT01794520|101084645|FG000|Overall Study|Lost to Follow-up|0|||
33324201|NCT01794520|101084646|FG001|Overall Study|Lost to Follow-up|0|||
33324202|NCT01794520|101084647|FG002|Overall Study|Lost to Follow-up|0|||
33324203|NCT01794520|101084648|FG003|Overall Study|Lost to Follow-up|0|||
33324204|NCT01794520|101084649|FG004|Overall Study|Lost to Follow-up|1|||
33324205|NCT01794520|101084650|FG005|Overall Study|Lost to Follow-up|0|||
33324206|NCT01794520|101084651|FG006|Overall Study|Lost to Follow-up|0|||
33324207|NCT01794520|101084645|FG000|Overall Study|Toxicity|0|||
33324208|NCT01794520|101084646|FG001|Overall Study|Toxicity|2|||
33324209|NCT01794520|101084647|FG002|Overall Study|Toxicity|0|||
33324210|NCT01794520|101084648|FG003|Overall Study|Toxicity|0|||
33324211|NCT01794520|101084649|FG004|Overall Study|Toxicity|0|||
33324212|NCT01794520|101084650|FG005|Overall Study|Toxicity|0|||
33324213|NCT01794520|101084651|FG006|Overall Study|Toxicity|0|||
33324214|NCT01794520|101084645|FG000|Overall Study|Study terminated by sponsor|0|||
33324215|NCT01794520|101084646|FG001|Overall Study|Study terminated by sponsor|0|||
33324216|NCT01794520|101084647|FG002|Overall Study|Study terminated by sponsor|1|||
33324217|NCT01794520|101084648|FG003|Overall Study|Study terminated by sponsor|0|||
33512255|NCT01992653|101770502|FG000|Overall Study|Death|0|||
33512256|NCT01992653|101770503|FG001|Overall Study|Death|0|||
33512257|NCT01992653|101770504|FG002|Overall Study|Death|1|||
33512258|NCT01992653|101770505|FG003|Overall Study|Death|0|||
33512259|NCT01992653|101770506|FG004|Overall Study|Death|1|||
33512260|NCT01992653|101770507|FG005|Overall Study|Death|0|||
33512261|NCT01992653|101770508|FG006|Overall Study|Death|4|||
33512262|NCT01992653|101770509|FG007|Overall Study|Death|2|||
33512263|NCT01992653|101770502|FG000|Overall Study|Lost to Follow-up|0|||
33512264|NCT01992653|101770503|FG001|Overall Study|Lost to Follow-up|0|||
33512265|NCT01992653|101770504|FG002|Overall Study|Lost to Follow-up|0|||
33324218|NCT01794520|101084649|FG004|Overall Study|Study terminated by sponsor|1|||
33324219|NCT01794520|101084650|FG005|Overall Study|Study terminated by sponsor|0|||
33324220|NCT01794520|101084651|FG006|Overall Study|Study terminated by sponsor|7|||
33324221|NCT01794520|101084645|FG000|Overall Study|Death|0|||
33198505|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
33324222|NCT01794520|101084646|FG001|Overall Study|Death|0|||
33324223|NCT01794520|101084647|FG002|Overall Study|Death|0|||
33324224|NCT01794520|101084648|FG003|Overall Study|Death|0|||
33324225|NCT01794520|101084649|FG004|Overall Study|Death|1|||
33324226|NCT01794520|101084650|FG005|Overall Study|Death|0|||
33324227|NCT01794520|101084651|FG006|Overall Study|Death|22|||
33512266|NCT01992653|101770505|FG003|Overall Study|Lost to Follow-up|0|||
33324228|NCT01794520|101084645|FG000|Overall Study|Other, not specified|0|||
33324229|NCT01794520|101084646|FG001|Overall Study|Other, not specified|0|||
33512267|NCT01992653|101770506|FG004|Overall Study|Lost to Follow-up|0|||
33324230|NCT01794520|101084647|FG002|Overall Study|Other, not specified|1|||
33324231|NCT01794520|101084648|FG003|Overall Study|Other, not specified|1|||
33324232|NCT01794520|101084649|FG004|Overall Study|Other, not specified|4|||
33324233|NCT01794520|101084650|FG005|Overall Study|Other, not specified|1|||
33324234|NCT01794520|101084651|FG006|Overall Study|Other, not specified|2|||
33324235|NCT00495820|101084652|FG000|Overall Study|Adverse Event|1|||
33324236|NCT00495820|101084653|FG001|Overall Study|Adverse Event|1|||
33324237|NCT00601705|101084656|FG000|Overall Study|Withdrawal by Subject|1|||
33324238|NCT01458366|101084658|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
33324239|NCT01458366|101084659|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
33324240|NCT01458366|101084660|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
33324241|NCT01458366|101084661|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
33324242|NCT01458366|101084662|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
33324243|NCT01458366|101084658|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
33324244|NCT01458366|101084659|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
33324245|NCT01458366|101084660|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
33324246|NCT01458366|101084661|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
33324247|NCT01458366|101084662|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
33324248|NCT02224599|101084665|FG000|Overall Study|Physician Decision|1|||
33324249|NCT02224599|101084665|FG000|Overall Study|Progression of Disease|1|||
33324250|NCT01721057|101084666|FG000|Treatment Period|Withdrawal by Subject|11|||
33324251|NCT01721057|101084667|FG001|Treatment Period|Withdrawal by Subject|5|||
33324252|NCT01721057|101084668|FG002|Treatment Period|Withdrawal by Subject|8|||
33324253|NCT01721057|101084669|FG003|Treatment Period|Withdrawal by Subject|0|||
33324254|NCT01721057|101084670|FG004|Treatment Period|Withdrawal by Subject|0|||
33324255|NCT01721057|101084671|FG005|Treatment Period|Withdrawal by Subject|0|||
33324256|NCT01721057|101084672|FG006|Treatment Period|Withdrawal by Subject|0|||
33324257|NCT01721057|101084666|FG000|Treatment Period|Adverse Event|7|||
33324258|NCT01721057|101084667|FG001|Treatment Period|Adverse Event|10|||
33324259|NCT01721057|101084668|FG002|Treatment Period|Adverse Event|12|||
33324260|NCT01721057|101084669|FG003|Treatment Period|Adverse Event|0|||
33324261|NCT01721057|101084670|FG004|Treatment Period|Adverse Event|0|||
33324262|NCT01721057|101084671|FG005|Treatment Period|Adverse Event|0|||
33324263|NCT01721057|101084672|FG006|Treatment Period|Adverse Event|0|||
33324264|NCT01721057|101084666|FG000|Treatment Period|Lack of Efficacy|7|||
33324265|NCT01721057|101084667|FG001|Treatment Period|Lack of Efficacy|3|||
33324266|NCT01721057|101084668|FG002|Treatment Period|Lack of Efficacy|0|||
33605793|NCT01972789|102108216|FG000|Overall Study|Protocol deviation|1|||
33605794|NCT01972789|102108217|FG001|Overall Study|Protocol deviation|0|||
33605795|NCT01972789|102108216|FG000|Overall Study|Physician Decision|3|||
33605796|NCT01972789|102108217|FG001|Overall Study|Physician Decision|2|||
33605797|NCT01600092|102108218|FG000|Overall Study|Adverse Event|2|||
33605798|NCT01600092|102108219|FG001|Overall Study|Adverse Event|0|||
33605799|NCT01600092|102108218|FG000|Overall Study|Lost to Follow-up|4|||
33605800|NCT01600092|102108219|FG001|Overall Study|Lost to Follow-up|6|||
33605801|NCT01600092|102108218|FG000|Overall Study|Withdrawal by parent/guardian|8|||
33605802|NCT01600092|102108219|FG001|Overall Study|Withdrawal by parent/guardian|6|||
33605803|NCT01600092|102108218|FG000|Overall Study|Physician Decision|1|||
33605804|NCT01600092|102108219|FG001|Overall Study|Physician Decision|1|||
33605805|NCT01600092|102108218|FG000|Overall Study|Randomized but not vaccinated|3|||
33605806|NCT01600092|102108219|FG001|Overall Study|Randomized but not vaccinated|3|||
33605807|NCT04023682|102108220|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
33605808|NCT01831817|102108221|FG000|Overall Study|Lost to Follow-up|1|||
33605809|NCT01831817|102108222|FG001|Overall Study|Lost to Follow-up|0|||
33605810|NCT01831817|102108223|FG002|Overall Study|Lost to Follow-up|0|||
33605811|NCT01831817|102108224|FG003|Overall Study|Lost to Follow-up|0|||
33605812|NCT01831817|102108221|FG000|Overall Study|Withdrawl of Consent|3|||
33605813|NCT01831817|102108222|FG001|Overall Study|Withdrawl of Consent|0|||
33324267|NCT01721057|101084669|FG003|Treatment Period|Lack of Efficacy|0|||
33605814|NCT01831817|102108223|FG002|Overall Study|Withdrawl of Consent|0|||
33324268|NCT01721057|101084670|FG004|Treatment Period|Lack of Efficacy|0|||
33324269|NCT01721057|101084671|FG005|Treatment Period|Lack of Efficacy|0|||
33324270|NCT01721057|101084672|FG006|Treatment Period|Lack of Efficacy|0|||
33324271|NCT01721057|101084666|FG000|Treatment Period|Lost to Follow-up|1|||
33512268|NCT01992653|101770507|FG005|Overall Study|Lost to Follow-up|0|||
33512269|NCT01992653|101770508|FG006|Overall Study|Lost to Follow-up|0|||
33605815|NCT01831817|102108224|FG003|Overall Study|Withdrawl of Consent|0|||
33605816|NCT00734071|102108225|FG000|Overall Study|Adverse Event|4|||
33605817|NCT00734071|102108226|FG001|Overall Study|Adverse Event|3|||
33512270|NCT01992653|101770509|FG007|Overall Study|Lost to Follow-up|1|||
33512271|NCT01992653|101770502|FG000|Overall Study|Study Completed|0|||
33512272|NCT01992653|101770503|FG001|Overall Study|Study Completed|0|||
33512273|NCT01992653|101770504|FG002|Overall Study|Study Completed|0|||
33512274|NCT01992653|101770505|FG003|Overall Study|Study Completed|0|||
33512275|NCT01992653|101770506|FG004|Overall Study|Study Completed|0|||
33512276|NCT01992653|101770507|FG005|Overall Study|Study Completed|0|||
33512277|NCT01992653|101770508|FG006|Overall Study|Study Completed|0|||
33198506|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
33198507|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
33324272|NCT01721057|101084667|FG001|Treatment Period|Lost to Follow-up|0|||
33324273|NCT01721057|101084668|FG002|Treatment Period|Lost to Follow-up|0|||
33324274|NCT01721057|101084669|FG003|Treatment Period|Lost to Follow-up|0|||
33324275|NCT01721057|101084670|FG004|Treatment Period|Lost to Follow-up|0|||
33324276|NCT01721057|101084671|FG005|Treatment Period|Lost to Follow-up|0|||
33324277|NCT01721057|101084672|FG006|Treatment Period|Lost to Follow-up|0|||
33324278|NCT01721057|101084666|FG000|Treatment Period|Physician Decision|0|||
33512278|NCT01992653|101770509|FG007|Overall Study|Study Completed|1|||
33512279|NCT01992653|101770502|FG000|Overall Study|Disease Progression|0|||
33512280|NCT01992653|101770503|FG001|Overall Study|Disease Progression|0|||
33324279|NCT01721057|101084667|FG001|Treatment Period|Physician Decision|1|||
33324280|NCT01721057|101084668|FG002|Treatment Period|Physician Decision|3|||
33324281|NCT01721057|101084669|FG003|Treatment Period|Physician Decision|0|||
33324282|NCT01721057|101084670|FG004|Treatment Period|Physician Decision|0|||
33324283|NCT01721057|101084671|FG005|Treatment Period|Physician Decision|0|||
33324284|NCT01721057|101084672|FG006|Treatment Period|Physician Decision|0|||
33324285|NCT01721057|101084666|FG000|Treatment Period|Death|2|||
33324286|NCT01721057|101084667|FG001|Treatment Period|Death|0|||
33324287|NCT01721057|101084668|FG002|Treatment Period|Death|0|||
33512281|NCT01992653|101770504|FG002|Overall Study|Disease Progression|0|||
33198508|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
33198509|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
33324288|NCT01721057|101084669|FG003|Treatment Period|Death|0|||
33324289|NCT01721057|101084670|FG004|Treatment Period|Death|0|||
33512282|NCT01992653|101770505|FG003|Overall Study|Disease Progression|0|||
33512283|NCT01992653|101770506|FG004|Overall Study|Disease Progression|0|||
33512284|NCT01992653|101770507|FG005|Overall Study|Disease Progression|0|||
33512285|NCT01992653|101770508|FG006|Overall Study|Disease Progression|4|||
33512286|NCT01992653|101770509|FG007|Overall Study|Disease Progression|0|||
33512287|NCT04413552|101770510|FG000|Overall Study|Adverse Event|0|||
33198510|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
33198511|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
33324290|NCT01721057|101084671|FG005|Treatment Period|Death|0|||
33324291|NCT01721057|101084672|FG006|Treatment Period|Death|0|||
33324292|NCT01721057|101084666|FG000|Rescue Period|Adverse Event|0|||
33324293|NCT01721057|101084667|FG001|Rescue Period|Adverse Event|0|||
33324294|NCT01721057|101084668|FG002|Rescue Period|Adverse Event|0|||
33324295|NCT01721057|101084669|FG003|Rescue Period|Adverse Event|1|||
33324296|NCT01721057|101084670|FG004|Rescue Period|Adverse Event|0|||
33324297|NCT01721057|101084671|FG005|Rescue Period|Adverse Event|0|||
33324298|NCT01721057|101084672|FG006|Rescue Period|Adverse Event|0|||
33324299|NCT01721057|101084666|FG000|Rescue Period|Lack of Efficacy|0|||
33324300|NCT01721057|101084667|FG001|Rescue Period|Lack of Efficacy|0|||
33324301|NCT01721057|101084668|FG002|Rescue Period|Lack of Efficacy|0|||
33324302|NCT01721057|101084669|FG003|Rescue Period|Lack of Efficacy|2|||
33324303|NCT01721057|101084670|FG004|Rescue Period|Lack of Efficacy|0|||
33324304|NCT01721057|101084671|FG005|Rescue Period|Lack of Efficacy|0|||
33324305|NCT01721057|101084672|FG006|Rescue Period|Lack of Efficacy|0|||
33324306|NCT00786565|101084673|FG000|Enrollment Prior to Surgery|Site Closed|3|||
33324307|NCT00786565|101084673|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
33324308|NCT00786565|101084673|FG000|Post Surgery|Abnormal macular pucker|1|||
33324309|NCT00786565|101084673|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
33324310|NCT00591214|101084674|FG000|Overall Study|Physician Decision|7|||
33324311|NCT00591214|101084674|FG000|Overall Study|Withdrawal by Subject|1|||
33324312|NCT00290186|101084677|FG000|Overall Study|Adverse Event|1|||
33324313|NCT00290186|101084678|FG001|Overall Study|Adverse Event|1|||
33324314|NCT00290186|101084677|FG000|Overall Study|Lost to Follow-up|3|||
33324315|NCT00290186|101084678|FG001|Overall Study|Lost to Follow-up|2|||
33324316|NCT00290186|101084677|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
33324317|NCT00290186|101084678|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
33324318|NCT00290186|101084677|FG000|Overall Study|Withdrawal by Subject|0|||
33324319|NCT00290186|101084678|FG001|Overall Study|Withdrawal by Subject|1|||
33324320|NCT00701090|101084679|FG000|Overall Study|Adverse Event|11|||
33324321|NCT00701090|101084680|FG001|Overall Study|Adverse Event|2|||
33324322|NCT00701090|101084679|FG000|Overall Study|Death|0|||
33324323|NCT00701090|101084680|FG001|Overall Study|Death|1|||
33324324|NCT00701090|101084679|FG000|Overall Study|Lack of Efficacy|5|||
33324325|NCT00701090|101084680|FG001|Overall Study|Lack of Efficacy|4|||
33324326|NCT00701090|101084679|FG000|Overall Study|Lost to Follow-up|9|||
33324327|NCT00701090|101084680|FG001|Overall Study|Lost to Follow-up|9|||
33324328|NCT00701090|101084679|FG000|Overall Study|Physician Decision|3|||
33324329|NCT00701090|101084680|FG001|Overall Study|Physician Decision|4|||
33324330|NCT00701090|101084679|FG000|Overall Study|Protocol Violation|2|||
33324331|NCT00701090|101084680|FG001|Overall Study|Protocol Violation|3|||
33324332|NCT00701090|101084679|FG000|Overall Study|Withdrawal by Subject|11|||
33324333|NCT00701090|101084680|FG001|Overall Study|Withdrawal by Subject|16|||
33324334|NCT00701090|101084679|FG000|Overall Study|Other|7|||
33324335|NCT00701090|101084680|FG001|Overall Study|Other|12|||
33324336|NCT01022502|101084681|FG000|Overall Study|Adverse Event|1|||
33324337|NCT01022502|101084681|FG000|Overall Study|employment related reasons|1|||
33324338|NCT01022502|101084681|FG000|Overall Study|Withdrawal by Subject|1|||
33324339|NCT02716675|101084682|FG000|Overall Study|Death|2|||
33324340|NCT02716675|101084683|FG001|Overall Study|Death|3|||
33324341|NCT02716675|101084684|FG002|Overall Study|Death|0|||
33324342|NCT02716675|101084682|FG000|Overall Study|Physician Decision|2|||
33324343|NCT02716675|101084683|FG001|Overall Study|Physician Decision|1|||
33324344|NCT02716675|101084684|FG002|Overall Study|Physician Decision|1|||
33324345|NCT02716675|101084682|FG000|Overall Study|Lost to Follow-up|100|||
33324346|NCT02716675|101084683|FG001|Overall Study|Lost to Follow-up|87|||
33324347|NCT02716675|101084684|FG002|Overall Study|Lost to Follow-up|99|||
33324348|NCT02716675|101084682|FG000|Overall Study|Withdrawal by Subject|22|||
33512288|NCT04413552|101770511|FG001|Overall Study|Adverse Event|0|||
33512289|NCT04413552|101770512|FG002|Overall Study|Adverse Event|0|||
33324349|NCT02716675|101084683|FG001|Overall Study|Withdrawal by Subject|25|||
33324350|NCT02716675|101084684|FG002|Overall Study|Withdrawal by Subject|20|||
33324351|NCT02716675|101084682|FG000|Overall Study|Protocol Violation|0|||
33324352|NCT02716675|101084683|FG001|Overall Study|Protocol Violation|3|||
33324353|NCT02716675|101084684|FG002|Overall Study|Protocol Violation|1|||
33324354|NCT02716675|101084682|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
33324355|NCT02716675|101084683|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
33324356|NCT02716675|101084684|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
33324357|NCT02716675|101084682|FG000|Overall Study|Other|38|||
33512290|NCT04413552|101770513|FG003|Overall Study|Adverse Event|0|||
33512291|NCT04413552|101770514|FG004|Overall Study|Adverse Event|0|||
33512292|NCT04413552|101770515|FG005|Overall Study|Adverse Event|0|||
33512293|NCT04413552|101770516|FG006|Overall Study|Adverse Event|1|||
33512294|NCT04413552|101770517|FG007|Overall Study|Adverse Event|0|||
33512295|NCT04413552|101770518|FG008|Overall Study|Adverse Event|0|||
33512296|NCT04413552|101770519|FG009|Overall Study|Adverse Event|0|||
33512297|NCT02777970|101770521|FG000|Overall Study|Lost to Follow-up|0|||
33512298|NCT02777970|101770522|FG001|Overall Study|Lost to Follow-up|1|||
33512299|NCT02777970|101770523|FG002|Overall Study|Lost to Follow-up|0|||
33512300|NCT02777970|101770521|FG000|Overall Study|Protocol Violation|1|||
33512301|NCT02777970|101770522|FG001|Overall Study|Protocol Violation|0|||
33512302|NCT02777970|101770523|FG002|Overall Study|Protocol Violation|0|||
33512303|NCT00793624|101770524|FG000|Overall Study|Adverse Event|18|||
33512304|NCT00793624|101770525|FG001|Overall Study|Adverse Event|16|||
33512305|NCT00793624|101770526|FG002|Overall Study|Adverse Event|15|||
33512306|NCT00793624|101770527|FG003|Overall Study|Adverse Event|20|||
33512307|NCT00793624|101770524|FG000|Overall Study|Lost to Follow-up|2|||
33512308|NCT00793624|101770525|FG001|Overall Study|Lost to Follow-up|2|||
33512309|NCT00793624|101770526|FG002|Overall Study|Lost to Follow-up|4|||
33512310|NCT00793624|101770527|FG003|Overall Study|Lost to Follow-up|0|||
33512311|NCT00793624|101770524|FG000|Overall Study|Withdrawal by Subject|20|||
33512312|NCT00793624|101770525|FG001|Overall Study|Withdrawal by Subject|9|||
33512313|NCT00793624|101770526|FG002|Overall Study|Withdrawal by Subject|11|||
33512314|NCT00793624|101770527|FG003|Overall Study|Withdrawal by Subject|14|||
33512315|NCT00793624|101770524|FG000|Overall Study|Lack of Efficacy|9|||
33512316|NCT00793624|101770525|FG001|Overall Study|Lack of Efficacy|2|||
33512317|NCT00793624|101770526|FG002|Overall Study|Lack of Efficacy|1|||
33512318|NCT00793624|101770527|FG003|Overall Study|Lack of Efficacy|3|||
33512319|NCT00793624|101770524|FG000|Overall Study|Non compliance with protocol|2|||
33512320|NCT00793624|101770525|FG001|Overall Study|Non compliance with protocol|3|||
33512321|NCT00793624|101770526|FG002|Overall Study|Non compliance with protocol|2|||
33512322|NCT00793624|101770527|FG003|Overall Study|Non compliance with protocol|3|||
33512323|NCT00793624|101770524|FG000|Overall Study|Other reason not described above|6|||
33512324|NCT00793624|101770525|FG001|Overall Study|Other reason not described above|4|||
33512325|NCT00793624|101770526|FG002|Overall Study|Other reason not described above|6|||
33512326|NCT00793624|101770527|FG003|Overall Study|Other reason not described above|3|||
33512327|NCT01077739|101770528|FG000|Overall Study|Premature withdrawal|1|||
33512328|NCT01077739|101770529|FG001|Overall Study|Premature withdrawal|3|||
33512329|NCT01077739|101770528|FG000|Overall Study|Withdrawal by Subject|1|||
33512330|NCT01077739|101770529|FG001|Overall Study|Withdrawal by Subject|0|||
33512331|NCT01077739|101770528|FG000|Overall Study|Death|0|||
33605818|NCT00734071|102108225|FG000|Overall Study|Lack of Efficacy|3|||
33605819|NCT00734071|102108226|FG001|Overall Study|Lack of Efficacy|1|||
33605820|NCT00734071|102108225|FG000|Overall Study|Noncompliance|2|||
33605821|NCT00734071|102108226|FG001|Overall Study|Noncompliance|2|||
33605822|NCT00734071|102108225|FG000|Overall Study|Protocol Deviations|3|||
33324358|NCT02716675|101084683|FG001|Overall Study|Other|47|||
33324359|NCT02716675|101084684|FG002|Overall Study|Other|48|||
33324360|NCT01358760|101084687|FG000|Overall Study|Adverse Event|3|||
33324361|NCT01358760|101084688|FG001|Overall Study|Adverse Event|4|||
33512332|NCT01077739|101770529|FG001|Overall Study|Death|3|||
33512333|NCT01077739|101770528|FG000|Overall Study|Unacceptable toxicity|1|||
33512334|NCT01077739|101770529|FG001|Overall Study|Unacceptable toxicity|2|||
33512335|NCT01077739|101770528|FG000|Overall Study|Other|2|||
33512336|NCT01077739|101770529|FG001|Overall Study|Other|2|||
33512337|NCT04791319|101770538|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
33512338|NCT04791319|101770539|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
33512339|NCT04791319|101770540|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
33512340|NCT04791319|101770541|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
33512341|NCT04791319|101770542|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
33512342|NCT04791319|101770543|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
33512343|NCT04791319|101770544|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
33512344|NCT04791319|101770545|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
33512345|NCT04791319|101770546|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
33512346|NCT04791319|101770547|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
33512347|NCT04791319|101770548|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
33512348|NCT04791319|101770538|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
33512349|NCT04791319|101770539|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33512350|NCT04791319|101770540|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
33512351|NCT04791319|101770541|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
33512352|NCT04791319|101770542|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33512353|NCT04791319|101770543|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33512354|NCT04791319|101770544|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33512355|NCT04791319|101770545|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33512356|NCT04791319|101770546|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33512357|NCT04791319|101770547|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33512358|NCT04791319|101770548|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
33512359|NCT04791319|101770538|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
33512360|NCT04791319|101770539|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
33512361|NCT04791319|101770540|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
33512362|NCT04791319|101770541|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
33512363|NCT04791319|101770542|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
33512364|NCT04791319|101770543|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
33512365|NCT04791319|101770544|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
33512366|NCT04791319|101770545|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
33512367|NCT04791319|101770546|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
33512368|NCT04791319|101770547|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
33512369|NCT04791319|101770548|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
33512370|NCT04791319|101770538|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
33512371|NCT04791319|101770539|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
33512372|NCT04791319|101770540|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
33512373|NCT04791319|101770541|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
33512374|NCT04791319|101770542|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
33512375|NCT04791319|101770543|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
33512376|NCT04791319|101770544|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
33512377|NCT04791319|101770545|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
33512378|NCT04791319|101770546|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
33512379|NCT04791319|101770547|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
33605823|NCT00734071|102108226|FG001|Overall Study|Protocol Deviations|4|||
33324362|NCT01358760|101084689|FG002|Overall Study|Adverse Event|3|||
33324363|NCT01358760|101084687|FG000|Overall Study|Lost to Follow-up|1|||
33324364|NCT01358760|101084688|FG001|Overall Study|Lost to Follow-up|1|||
33324365|NCT01358760|101084689|FG002|Overall Study|Lost to Follow-up|3|||
33324366|NCT01358760|101084687|FG000|Overall Study|Withdrawal by Subject|5|||
33324367|NCT01358760|101084688|FG001|Overall Study|Withdrawal by Subject|3|||
33324368|NCT01358760|101084689|FG002|Overall Study|Withdrawal by Subject|2|||
33324369|NCT01358760|101084687|FG000|Overall Study|Physician Decision|1|||
33324370|NCT01358760|101084688|FG001|Overall Study|Physician Decision|0|||
33324371|NCT01358760|101084689|FG002|Overall Study|Physician Decision|1|||
33324372|NCT01358760|101084687|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
33399082|NCT02394028|101350177|FG002|Induction Phase|Withdrawal by Subject|4|||
33399083|NCT02394028|101350178|FG003|Induction Phase|Withdrawal by Subject|6|||
33399084|NCT02394028|101350179|FG004|Induction Phase|Withdrawal by Subject|7|||
33399085|NCT02394028|101350180|FG005|Induction Phase|Withdrawal by Subject|4|||
33399086|NCT02394028|101350181|FG006|Induction Phase|Withdrawal by Subject|3|||
33399087|NCT02394028|101350182|FG007|Induction Phase|Withdrawal by Subject|6|||
33324373|NCT01358760|101084688|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
33324374|NCT01358760|101084689|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
33324375|NCT00594516|101084690|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
33324376|NCT00594516|101084691|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
33324377|NCT00594516|101084692|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
33324378|NCT00594516|101084690|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
33324379|NCT00594516|101084691|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
33324380|NCT00594516|101084692|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
33324381|NCT00594516|101084690|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
33324382|NCT00594516|101084691|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
33324383|NCT00594516|101084692|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
33324384|NCT00594516|101084690|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
33324385|NCT00594516|101084691|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
33324386|NCT00594516|101084692|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
33324387|NCT00594516|101084690|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
33198512|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
33198513|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
33198514|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
33198515|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
33324388|NCT00594516|101084691|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
33324389|NCT00594516|101084692|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
33324390|NCT00594516|101084690|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
33324391|NCT00594516|101084691|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
33324392|NCT00594516|101084692|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
33324393|NCT00594516|101084690|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
33324394|NCT00594516|101084691|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
33324395|NCT00594516|101084692|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
33324396|NCT00594516|101084690|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
33324397|NCT00594516|101084691|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
33324398|NCT00594516|101084692|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
33324399|NCT00594516|101084690|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
33324400|NCT00594516|101084691|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
33324401|NCT00594516|101084692|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
33324402|NCT01524133|101084693|FG000|Treatment Phase|Withdrawal by Subject|13|||
33324403|NCT01524133|101084694|FG001|Treatment Phase|Withdrawal by Subject|28|||
33324404|NCT01524133|101084695|FG002|Treatment Phase|Withdrawal by Subject|31|||
33605824|NCT00734071|102108225|FG000|Overall Study|Voluntary Withdrawal|9|||
33605825|NCT00734071|102108226|FG001|Overall Study|Voluntary Withdrawal|7|||
33605826|NCT00734071|102108225|FG000|Overall Study|Lost to Follow-up|16|||
33605827|NCT00734071|102108226|FG001|Overall Study|Lost to Follow-up|8|||
33605828|NCT00734071|102108225|FG000|Overall Study|Other|1|||
33605829|NCT00734071|102108226|FG001|Overall Study|Other|2|||
33605830|NCT01375608|102108227|FG000|Overall Study|Withdrawal by Subject|2|||
33605831|NCT00895661|102108228|FG000|Overall Study|Death|1|||
33605832|NCT00895661|102108228|FG000|Overall Study|reason unknown|2|||
33605833|NCT00958217|102108229|FG000|Overall Study|Death|2|||
33605834|NCT00958217|102108230|FG001|Overall Study|Death|1|||
33605835|NCT00958217|102108229|FG000|Overall Study|Withdrawal by Subject|4|||
33605836|NCT00958217|102108230|FG001|Overall Study|Withdrawal by Subject|3|||
33605837|NCT00958217|102108229|FG000|Overall Study|Lost to Follow-up|17|||
33605838|NCT00958217|102108230|FG001|Overall Study|Lost to Follow-up|19|||
33605839|NCT00958217|102108229|FG000|Overall Study|Moved out of area|1|||
33605840|NCT00958217|102108230|FG001|Overall Study|Moved out of area|1|||
33399088|NCT02394028|101350183|FG008|Induction Phase|Withdrawal by Subject|0|||
33399089|NCT02394028|101350184|FG009|Induction Phase|Withdrawal by Subject|0|||
33605841|NCT00958217|102108229|FG000|Overall Study|Inpatient hospitalization|0|||
33605842|NCT00958217|102108230|FG001|Overall Study|Inpatient hospitalization|1|||
33605843|NCT00576472|102108231|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
33198516|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
33512380|NCT04791319|101770548|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
33512381|NCT04791319|101770538|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33512382|NCT04791319|101770539|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33512383|NCT04791319|101770540|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33512384|NCT04791319|101770541|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
33512385|NCT04791319|101770542|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33512386|NCT04791319|101770543|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33512387|NCT04791319|101770544|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33512388|NCT04791319|101770545|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33512389|NCT04791319|101770546|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33512390|NCT04791319|101770547|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33512391|NCT04791319|101770548|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
33512392|NCT04791319|101770538|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
33512393|NCT04791319|101770539|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
33512394|NCT04791319|101770540|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
33512395|NCT04791319|101770541|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
33512396|NCT04791319|101770542|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
33512397|NCT04791319|101770543|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
33512398|NCT04791319|101770544|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
33512399|NCT04791319|101770545|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
33512400|NCT04791319|101770546|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
33512401|NCT04791319|101770547|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
33512402|NCT04791319|101770548|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
33512403|NCT04791319|101770538|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33512404|NCT04791319|101770539|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33512405|NCT04791319|101770540|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33512406|NCT04791319|101770541|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33512407|NCT04791319|101770542|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33512408|NCT04791319|101770543|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33512409|NCT04791319|101770544|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33512410|NCT04791319|101770545|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33512411|NCT04791319|101770546|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33512412|NCT04791319|101770547|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
33512413|NCT04791319|101770548|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
33512414|NCT04791319|101770538|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
33512415|NCT04791319|101770539|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
33512416|NCT04791319|101770540|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
33512417|NCT04791319|101770541|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
33512418|NCT04791319|101770542|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
33512419|NCT04791319|101770543|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
33324405|NCT01524133|101084693|FG000|Treatment Phase|Physician Decision|6|||
33512420|NCT04791319|101770544|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
33605844|NCT00576472|102108232|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
33324406|NCT01524133|101084694|FG001|Treatment Phase|Physician Decision|3|||
33324407|NCT01524133|101084695|FG002|Treatment Phase|Physician Decision|3|||
33324408|NCT01524133|101084693|FG000|Treatment Phase|Lost to Follow-up|0|||
33324409|NCT01524133|101084694|FG001|Treatment Phase|Lost to Follow-up|1|||
33324410|NCT01524133|101084695|FG002|Treatment Phase|Lost to Follow-up|2|||
33605845|NCT00576472|102108233|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
33605846|NCT00576472|102108234|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
33605847|NCT00576472|102108235|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
33605848|NCT00576472|102108236|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
33605849|NCT00576472|102108237|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
33605850|NCT00576472|102108238|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
33605851|NCT00576472|102108239|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
33605852|NCT00576472|102108240|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
33605853|NCT00576472|102108241|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
33605854|NCT00576472|102108242|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
33605855|NCT00576472|102108243|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
33605856|NCT00576472|102108244|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
33605857|NCT00576472|102108245|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
33324411|NCT01524133|101084693|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
33324412|NCT01524133|101084694|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
33605858|NCT00576472|102108231|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
33605859|NCT00576472|102108232|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
33605860|NCT00576472|102108233|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
33605861|NCT00576472|102108234|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
33605862|NCT00576472|102108235|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
33605863|NCT00576472|102108236|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
33605864|NCT00576472|102108237|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
33605865|NCT00576472|102108238|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
33605866|NCT00576472|102108239|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
33605867|NCT00576472|102108240|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
33605868|NCT00576472|102108241|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
33605869|NCT00576472|102108242|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
33605870|NCT00576472|102108243|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
33605871|NCT00576472|102108244|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
33605872|NCT00576472|102108245|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
33605873|NCT00576472|102108231|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33605874|NCT00576472|102108232|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33605875|NCT00576472|102108233|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33605876|NCT00576472|102108234|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
33605877|NCT00576472|102108235|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33605878|NCT00576472|102108236|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33324413|NCT01524133|101084695|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
33324414|NCT01524133|101084693|FG000|Overall Study 52 Weeks|Physician Decision|1|||
33324415|NCT01524133|101084694|FG001|Overall Study 52 Weeks|Physician Decision|0|||
33324416|NCT01524133|101084695|FG002|Overall Study 52 Weeks|Physician Decision|2|||
33324417|NCT01524133|101084693|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
33324418|NCT01524133|101084694|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
33324419|NCT01524133|101084695|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
33324420|NCT02194062|101084696|FG000|Overall Study|Lost to Follow-up|2|||
33324421|NCT02194062|101084697|FG001|Overall Study|Lost to Follow-up|2|||
33324422|NCT02194062|101084698|FG002|Overall Study|Lost to Follow-up|5|||
33399090|NCT02394028|101350185|FG010|Induction Phase|Withdrawal by Subject|0|||
33605879|NCT00576472|102108237|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33605880|NCT00576472|102108238|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33605881|NCT00576472|102108239|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33605882|NCT00576472|102108240|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33605883|NCT00576472|102108241|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33605884|NCT00576472|102108242|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33605885|NCT00576472|102108243|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33605886|NCT00576472|102108244|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33324423|NCT01817751|101084699|FG000|Overall Study|Physician Decision|1|||
33324424|NCT01279850|101084700|FG000|Overall Study|Protocol Violation|50|||
33324425|NCT01279850|101084700|FG000|Overall Study|No Drug Administration Information|7|||
33324426|NCT01279850|101084700|FG000|Overall Study|No Visit After Treatment|34|||
33512421|NCT04791319|101770545|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
33512422|NCT04791319|101770546|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
33512423|NCT04791319|101770547|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
33512424|NCT04791319|101770548|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
33512425|NCT04791319|101770538|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
33512426|NCT04791319|101770539|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
33512427|NCT04791319|101770540|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
33605887|NCT00576472|102108245|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
33605888|NCT00576472|102108231|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
33605889|NCT00576472|102108232|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
33605890|NCT00576472|102108233|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
33605891|NCT00576472|102108234|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
33605892|NCT00576472|102108235|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
33605893|NCT00576472|102108236|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
33605894|NCT00576472|102108237|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
33605895|NCT00576472|102108238|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
33605896|NCT00576472|102108239|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
33605897|NCT00576472|102108240|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
33605898|NCT00576472|102108241|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
33605899|NCT00576472|102108242|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
33605900|NCT00576472|102108243|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
33605901|NCT00576472|102108244|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
33605902|NCT00576472|102108245|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
33605903|NCT00576472|102108231|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
33605904|NCT00576472|102108232|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
33605905|NCT00576472|102108233|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
33605906|NCT00576472|102108234|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
33605907|NCT00576472|102108235|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
33605908|NCT00576472|102108236|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
33605909|NCT00576472|102108237|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
33605910|NCT00576472|102108238|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
33605911|NCT00576472|102108239|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
33605912|NCT00576472|102108240|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
33605913|NCT00576472|102108241|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
33605914|NCT00576472|102108242|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
33605915|NCT00576472|102108243|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
33605916|NCT00576472|102108244|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
33605917|NCT00576472|102108245|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
33605918|NCT00576472|102108231|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
33605919|NCT00576472|102108232|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
33605920|NCT00576472|102108233|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
33605921|NCT00576472|102108234|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
33605922|NCT00576472|102108235|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
33605923|NCT00576472|102108236|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
33605924|NCT00576472|102108237|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
33605925|NCT00576472|102108238|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
33605926|NCT00576472|102108239|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
33605927|NCT00576472|102108240|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
33605928|NCT00576472|102108241|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
33605929|NCT00576472|102108242|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
33605930|NCT00576472|102108243|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
33605931|NCT00576472|102108244|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
33605932|NCT00576472|102108245|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
33605933|NCT00576472|102108231|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
33605934|NCT00576472|102108232|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
33605935|NCT00576472|102108233|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
33605936|NCT00576472|102108234|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
33605937|NCT00576472|102108235|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
33605938|NCT00576472|102108236|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
33605939|NCT00576472|102108237|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
33605940|NCT00576472|102108238|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
33324427|NCT00381563|101084701|FG000|Overall Study|Withdrawal by Subject|5|||
33605941|NCT00576472|102108239|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
33605942|NCT00576472|102108240|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
33605943|NCT00576472|102108241|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
33605944|NCT00576472|102108242|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
33324428|NCT00381563|101084702|FG001|Overall Study|Withdrawal by Subject|5|||
33512428|NCT04791319|101770541|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
33512429|NCT04791319|101770542|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
33512430|NCT04791319|101770543|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
33512431|NCT04791319|101770544|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
33512432|NCT04791319|101770545|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
33512433|NCT04791319|101770546|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
33512434|NCT04791319|101770547|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
33512435|NCT04791319|101770548|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
33512436|NCT04143594|101770549|FG000|Overall Study|Withdrew consent|3|||
33512437|NCT04143594|101770550|FG001|Overall Study|Withdrew consent|10|||
33512438|NCT04143594|101770551|FG002|Overall Study|Withdrew consent|3|||
33512439|NCT04143594|101770552|FG003|Overall Study|Withdrew consent|1|||
33512440|NCT04143594|101770549|FG000|Overall Study|Lost to Follow-up|3|||
33512441|NCT04143594|101770550|FG001|Overall Study|Lost to Follow-up|5|||
33512442|NCT04143594|101770551|FG002|Overall Study|Lost to Follow-up|11|||
33512443|NCT04143594|101770552|FG003|Overall Study|Lost to Follow-up|0|||
33512444|NCT04143594|101770549|FG000|Overall Study|Investigator's discretion|2|||
33605945|NCT00576472|102108243|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
33605946|NCT00576472|102108244|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
33605947|NCT00576472|102108245|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
33605948|NCT00576472|102108231|FG000|MPH Cross Over Phase|Physician Decision|0|||
33605949|NCT00576472|102108232|FG001|MPH Cross Over Phase|Physician Decision|0|||
33605950|NCT00576472|102108233|FG002|MPH Cross Over Phase|Physician Decision|0|||
33605951|NCT00576472|102108234|FG003|MPH Cross Over Phase|Physician Decision|0|||
33605952|NCT00576472|102108235|FG004|MPH Cross Over Phase|Physician Decision|0|||
33605953|NCT00576472|102108236|FG005|MPH Cross Over Phase|Physician Decision|0|||
33605954|NCT00576472|102108237|FG006|MPH Cross Over Phase|Physician Decision|4|||
33605955|NCT00576472|102108238|FG007|MPH Cross Over Phase|Physician Decision|0|||
33605956|NCT00576472|102108239|FG008|MPH Cross Over Phase|Physician Decision|0|||
33605957|NCT00576472|102108240|FG009|MPH Cross Over Phase|Physician Decision|0|||
33605958|NCT00576472|102108241|FG010|MPH Cross Over Phase|Physician Decision|0|||
33605959|NCT00576472|102108242|FG011|MPH Cross Over Phase|Physician Decision|0|||
33605960|NCT00576472|102108243|FG012|MPH Cross Over Phase|Physician Decision|0|||
33605961|NCT00576472|102108244|FG013|MPH Cross Over Phase|Physician Decision|0|||
33605962|NCT00576472|102108245|FG014|MPH Cross Over Phase|Physician Decision|0|||
33605963|NCT00576472|102108231|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
33605964|NCT00576472|102108232|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
33605965|NCT00576472|102108233|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
33605966|NCT00576472|102108234|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
33605967|NCT00576472|102108235|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
33605968|NCT00576472|102108236|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
33605969|NCT00576472|102108237|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
33605970|NCT00576472|102108238|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
33605971|NCT00576472|102108239|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
33605972|NCT00576472|102108240|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
33605973|NCT00576472|102108241|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
33605974|NCT00576472|102108242|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
33605975|NCT00576472|102108243|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
33605976|NCT00576472|102108244|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
33605977|NCT00576472|102108245|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
33605978|NCT00576472|102108231|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33605979|NCT00576472|102108232|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33605980|NCT00576472|102108233|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33605981|NCT00576472|102108234|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33605982|NCT00576472|102108235|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33605983|NCT00576472|102108236|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33399091|NCT02394028|101350175|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
33512445|NCT04143594|101770550|FG001|Overall Study|Investigator's discretion|2|||
33512446|NCT04143594|101770551|FG002|Overall Study|Investigator's discretion|0|||
33512447|NCT04143594|101770552|FG003|Overall Study|Investigator's discretion|0|||
33512448|NCT04143594|101770549|FG000|Overall Study|Randomized but never treated|0|||
33512449|NCT04143594|101770550|FG001|Overall Study|Randomized but never treated|0|||
33512450|NCT04143594|101770551|FG002|Overall Study|Randomized but never treated|0|||
33399092|NCT02394028|101350176|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
33605984|NCT00576472|102108237|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33605985|NCT00576472|102108238|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33605986|NCT00576472|102108239|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33605987|NCT00576472|102108240|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33512451|NCT04143594|101770552|FG003|Overall Study|Randomized but never treated|1|||
33512452|NCT04143594|101770549|FG000|Overall Study|Death|1|||
33512453|NCT04143594|101770550|FG001|Overall Study|Death|0|||
33512454|NCT04143594|101770551|FG002|Overall Study|Death|1|||
33512455|NCT04143594|101770552|FG003|Overall Study|Death|0|||
33512456|NCT04143594|101770549|FG000|Overall Study|Adverse Event|1|||
33512457|NCT04143594|101770550|FG001|Overall Study|Adverse Event|0|||
33512458|NCT04143594|101770551|FG002|Overall Study|Adverse Event|0|||
33512459|NCT04143594|101770552|FG003|Overall Study|Adverse Event|0|||
33512460|NCT04143594|101770549|FG000|Overall Study|Pregnancy|0|||
33512461|NCT04143594|101770550|FG001|Overall Study|Pregnancy|0|||
33512462|NCT04143594|101770551|FG002|Overall Study|Pregnancy|1|||
33512463|NCT04143594|101770552|FG003|Overall Study|Pregnancy|0|||
33512464|NCT04143594|101770549|FG000|Overall Study|Lack of Efficacy|1|||
33512465|NCT04143594|101770550|FG001|Overall Study|Lack of Efficacy|1|||
33512466|NCT04143594|101770551|FG002|Overall Study|Lack of Efficacy|0|||
33512467|NCT04143594|101770552|FG003|Overall Study|Lack of Efficacy|0|||
33512468|NCT02520427|101770554|FG000|Overall Study|Decision by sponsor|0|||
33512469|NCT02520427|101770555|FG001|Overall Study|Decision by sponsor|0|||
33512470|NCT02520427|101770556|FG002|Overall Study|Decision by sponsor|0|||
33512471|NCT02520427|101770557|FG003|Overall Study|Decision by sponsor|0|||
33512472|NCT02520427|101770558|FG004|Overall Study|Decision by sponsor|0|||
33512473|NCT02520427|101770559|FG005|Overall Study|Decision by sponsor|0|||
33512474|NCT02520427|101770560|FG006|Overall Study|Decision by sponsor|0|||
33512475|NCT02520427|101770561|FG007|Overall Study|Decision by sponsor|0|||
33512476|NCT02520427|101770562|FG008|Overall Study|Decision by sponsor|1|||
33512477|NCT02520427|101770563|FG009|Overall Study|Decision by sponsor|1|||
33512478|NCT02520427|101770564|FG010|Overall Study|Decision by sponsor|0|||
33512479|NCT02520427|101770565|FG011|Overall Study|Decision by sponsor|0|||
33512480|NCT02520427|101770566|FG012|Overall Study|Decision by sponsor|0|||
33512481|NCT02520427|101770567|FG013|Overall Study|Decision by sponsor|0|||
33512482|NCT02520427|101770568|FG014|Overall Study|Decision by sponsor|0|||
33512483|NCT02520427|101770569|FG015|Overall Study|Decision by sponsor|0|||
33512484|NCT02520427|101770570|FG016|Overall Study|Decision by sponsor|0|||
33512485|NCT02520427|101770571|FG017|Overall Study|Decision by sponsor|0|||
33512486|NCT02520427|101770572|FG018|Overall Study|Decision by sponsor|0|||
33512487|NCT02520427|101770573|FG019|Overall Study|Decision by sponsor|0|||
33512488|NCT02520427|101770574|FG020|Overall Study|Decision by sponsor|0|||
33512489|NCT02520427|101770575|FG021|Overall Study|Decision by sponsor|0|||
33512490|NCT02520427|101770576|FG022|Overall Study|Decision by sponsor|0|||
33512491|NCT02520427|101770577|FG023|Overall Study|Decision by sponsor|0|||
33512492|NCT02520427|101770578|FG024|Overall Study|Decision by sponsor|0|||
33512493|NCT02520427|101770579|FG025|Overall Study|Decision by sponsor|0|||
33512494|NCT02520427|101770554|FG000|Overall Study|Withdrawal by Subject|0|||
33512495|NCT02520427|101770555|FG001|Overall Study|Withdrawal by Subject|0|||
33512496|NCT02520427|101770556|FG002|Overall Study|Withdrawal by Subject|1|||
33512497|NCT02520427|101770557|FG003|Overall Study|Withdrawal by Subject|0|||
33512498|NCT02520427|101770558|FG004|Overall Study|Withdrawal by Subject|0|||
33512499|NCT02520427|101770559|FG005|Overall Study|Withdrawal by Subject|0|||
33512500|NCT02520427|101770560|FG006|Overall Study|Withdrawal by Subject|0|||
33512501|NCT02520427|101770561|FG007|Overall Study|Withdrawal by Subject|0|||
33512502|NCT02520427|101770562|FG008|Overall Study|Withdrawal by Subject|0|||
33512503|NCT02520427|101770563|FG009|Overall Study|Withdrawal by Subject|0|||
33512504|NCT02520427|101770564|FG010|Overall Study|Withdrawal by Subject|0|||
33512505|NCT02520427|101770565|FG011|Overall Study|Withdrawal by Subject|0|||
33512506|NCT02520427|101770566|FG012|Overall Study|Withdrawal by Subject|1|||
33512507|NCT02520427|101770567|FG013|Overall Study|Withdrawal by Subject|1|||
33324429|NCT00381563|101084701|FG000|Overall Study|Lost to Follow-up|2|||
33512508|NCT02520427|101770568|FG014|Overall Study|Withdrawal by Subject|1|||
33512509|NCT02520427|101770569|FG015|Overall Study|Withdrawal by Subject|0|||
33512510|NCT02520427|101770570|FG016|Overall Study|Withdrawal by Subject|1|||
33605988|NCT00576472|102108241|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33324430|NCT00381563|101084702|FG001|Overall Study|Lost to Follow-up|0|||
33512511|NCT02520427|101770571|FG017|Overall Study|Withdrawal by Subject|0|||
33512512|NCT02520427|101770572|FG018|Overall Study|Withdrawal by Subject|0|||
33512513|NCT02520427|101770573|FG019|Overall Study|Withdrawal by Subject|3|||
33512514|NCT02520427|101770574|FG020|Overall Study|Withdrawal by Subject|2|||
33512515|NCT02520427|101770575|FG021|Overall Study|Withdrawal by Subject|0|||
33512516|NCT02520427|101770576|FG022|Overall Study|Withdrawal by Subject|0|||
33512517|NCT02520427|101770577|FG023|Overall Study|Withdrawal by Subject|0|||
33512518|NCT02520427|101770578|FG024|Overall Study|Withdrawal by Subject|0|||
33512519|NCT02520427|101770579|FG025|Overall Study|Withdrawal by Subject|0|||
33512520|NCT02520427|101770554|FG000|Overall Study|Death|1|||
33512521|NCT02520427|101770555|FG001|Overall Study|Death|0|||
33324431|NCT00381563|101084701|FG000|Overall Study|Protocol Violation|0|||
33512522|NCT02520427|101770556|FG002|Overall Study|Death|0|||
33512523|NCT02520427|101770557|FG003|Overall Study|Death|0|||
33512524|NCT02520427|101770558|FG004|Overall Study|Death|0|||
33512525|NCT02520427|101770559|FG005|Overall Study|Death|0|||
33512526|NCT02520427|101770560|FG006|Overall Study|Death|0|||
33512527|NCT02520427|101770561|FG007|Overall Study|Death|0|||
33512528|NCT02520427|101770562|FG008|Overall Study|Death|0|||
33512529|NCT02520427|101770563|FG009|Overall Study|Death|0|||
33512530|NCT02520427|101770564|FG010|Overall Study|Death|0|||
33512531|NCT02520427|101770565|FG011|Overall Study|Death|0|||
33512532|NCT02520427|101770566|FG012|Overall Study|Death|0|||
33512533|NCT02520427|101770567|FG013|Overall Study|Death|0|||
33512534|NCT02520427|101770568|FG014|Overall Study|Death|0|||
33512535|NCT02520427|101770569|FG015|Overall Study|Death|0|||
33512536|NCT02520427|101770570|FG016|Overall Study|Death|2|||
33512537|NCT02520427|101770571|FG017|Overall Study|Death|1|||
33512538|NCT02520427|101770572|FG018|Overall Study|Death|3|||
33512539|NCT02520427|101770573|FG019|Overall Study|Death|2|||
33512540|NCT02520427|101770574|FG020|Overall Study|Death|0|||
33512541|NCT02520427|101770575|FG021|Overall Study|Death|0|||
33512542|NCT02520427|101770576|FG022|Overall Study|Death|1|||
33512543|NCT02520427|101770577|FG023|Overall Study|Death|0|||
33512544|NCT02520427|101770578|FG024|Overall Study|Death|1|||
33512545|NCT02520427|101770579|FG025|Overall Study|Death|0|||
33512546|NCT00727844|101773439|FG000|Initial Randomization|Physician Decision|2|||
33512547|NCT00727844|101773440|FG001|Initial Randomization|Physician Decision|0|||
33512548|NCT00727844|101773441|FG002|Initial Randomization|Physician Decision|0|||
33512549|NCT00727844|101773442|FG003|Initial Randomization|Physician Decision|0|||
33512550|NCT04521621|101773444|FG000|Overall Study|Death|17|||
33512551|NCT04521621|101773445|FG001|Overall Study|Death|8|||
33512552|NCT04521621|101773446|FG002|Overall Study|Death|8|||
33324432|NCT00381563|101084702|FG001|Overall Study|Protocol Violation|1|||
33324433|NCT02568475|101084703|FG000|Overall Study|Lost to Follow-up|40|||
33324434|NCT02568475|101084704|FG001|Overall Study|Lost to Follow-up|39|||
33512553|NCT04521621|101773447|FG003|Overall Study|Death|5|||
33605989|NCT00576472|102108242|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33605990|NCT00576472|102108243|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33605991|NCT00576472|102108244|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
33605992|NCT00576472|102108245|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
33605993|NCT00576472|102108231|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
33605994|NCT00576472|102108232|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
33605995|NCT00576472|102108233|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
33605996|NCT00576472|102108234|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
33605997|NCT00576472|102108235|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
33605998|NCT00576472|102108236|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
33605999|NCT00576472|102108237|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
33606000|NCT00576472|102108238|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
33606001|NCT00576472|102108239|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
33606002|NCT00576472|102108240|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
33606003|NCT00576472|102108241|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
33606004|NCT00576472|102108242|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
33606005|NCT00576472|102108243|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
33606006|NCT00576472|102108244|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
33606007|NCT00576472|102108245|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
33606008|NCT00576472|102108231|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
33606009|NCT00576472|102108232|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
33606010|NCT00576472|102108233|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
33606011|NCT00576472|102108234|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
33606012|NCT00576472|102108235|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
33606013|NCT00576472|102108236|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
33606014|NCT00576472|102108237|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
33606015|NCT00576472|102108238|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
33606016|NCT00576472|102108239|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
33606017|NCT00576472|102108240|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
33606018|NCT00576472|102108241|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
33606019|NCT00576472|102108242|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
33606020|NCT00576472|102108243|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
33606021|NCT00576472|102108244|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
33606022|NCT00576472|102108245|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
33606023|NCT00576472|102108231|FG000|MPH Home Maintenance Phase|Side effects|0|||
33606024|NCT00576472|102108232|FG001|MPH Home Maintenance Phase|Side effects|0|||
33606025|NCT00576472|102108233|FG002|MPH Home Maintenance Phase|Side effects|0|||
33606026|NCT00576472|102108234|FG003|MPH Home Maintenance Phase|Side effects|0|||
33606027|NCT00576472|102108235|FG004|MPH Home Maintenance Phase|Side effects|0|||
33606028|NCT00576472|102108236|FG005|MPH Home Maintenance Phase|Side effects|0|||
33606029|NCT00576472|102108237|FG006|MPH Home Maintenance Phase|Side effects|0|||
33606030|NCT00576472|102108238|FG007|MPH Home Maintenance Phase|Side effects|0|||
33512554|NCT04521621|101773448|FG004|Overall Study|Death|2|||
33512555|NCT04521621|101773449|FG005|Overall Study|Death|7|||
33512556|NCT04521621|101773450|FG006|Overall Study|Death|0|||
33512557|NCT04521621|101773451|FG007|Overall Study|Death|0|||
33512558|NCT04521621|101773444|FG000|Overall Study|Study Terminated by Sponsor|4|||
33512559|NCT04521621|101773445|FG001|Overall Study|Study Terminated by Sponsor|6|||
33512560|NCT04521621|101773446|FG002|Overall Study|Study Terminated by Sponsor|8|||
33512561|NCT04521621|101773447|FG003|Overall Study|Study Terminated by Sponsor|0|||
33512562|NCT04521621|101773448|FG004|Overall Study|Study Terminated by Sponsor|1|||
33512563|NCT04521621|101773449|FG005|Overall Study|Study Terminated by Sponsor|7|||
33512564|NCT04521621|101773450|FG006|Overall Study|Study Terminated by Sponsor|0|||
33512565|NCT04521621|101773451|FG007|Overall Study|Study Terminated by Sponsor|0|||
33512566|NCT04521621|101773444|FG000|Overall Study|Withdrawal by Subject|0|||
33512567|NCT04521621|101773445|FG001|Overall Study|Withdrawal by Subject|0|||
33512568|NCT04521621|101773446|FG002|Overall Study|Withdrawal by Subject|1|||
33512569|NCT04521621|101773447|FG003|Overall Study|Withdrawal by Subject|1|||
33512570|NCT04521621|101773448|FG004|Overall Study|Withdrawal by Subject|0|||
33512571|NCT04521621|101773449|FG005|Overall Study|Withdrawal by Subject|0|||
33512572|NCT04521621|101773450|FG006|Overall Study|Withdrawal by Subject|0|||
33512573|NCT04521621|101773451|FG007|Overall Study|Withdrawal by Subject|0|||
33512574|NCT04521621|101773444|FG000|Overall Study|Allocated in error without study intervention|1|||
33512575|NCT04521621|101773445|FG001|Overall Study|Allocated in error without study intervention|0|||
33512576|NCT04521621|101773446|FG002|Overall Study|Allocated in error without study intervention|0|||
33512577|NCT04521621|101773447|FG003|Overall Study|Allocated in error without study intervention|0|||
33606031|NCT00576472|102108239|FG008|MPH Home Maintenance Phase|Side effects|0|||
33606032|NCT00576472|102108240|FG009|MPH Home Maintenance Phase|Side effects|0|||
33606033|NCT00576472|102108241|FG010|MPH Home Maintenance Phase|Side effects|0|||
33606034|NCT00576472|102108242|FG011|MPH Home Maintenance Phase|Side effects|0|||
33606035|NCT00576472|102108243|FG012|MPH Home Maintenance Phase|Side effects|0|||
33324435|NCT02568475|101084703|FG000|Overall Study|Withdrawal by Subject|2|||
33324436|NCT02568475|101084704|FG001|Overall Study|Withdrawal by Subject|0|||
33512578|NCT04521621|101773448|FG004|Overall Study|Allocated in error without study intervention|0|||
33512579|NCT04521621|101773449|FG005|Overall Study|Allocated in error without study intervention|0|||
33324437|NCT02568475|101084703|FG000|Overall Study|Discharged home|4|||
33324438|NCT02568475|101084704|FG001|Overall Study|Discharged home|4|||
33324439|NCT02568475|101084703|FG000|Overall Study|Short-term: Discharge location unknown|4|||
33324440|NCT02568475|101084704|FG001|Overall Study|Short-term: Discharge location unknown|0|||
33512580|NCT04521621|101773450|FG006|Overall Study|Allocated in error without study intervention|0|||
33512581|NCT04521621|101773451|FG007|Overall Study|Allocated in error without study intervention|0|||
33512582|NCT05178641|101773452|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
33512583|NCT05178641|101773453|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
33512584|NCT05178641|101773452|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
33512585|NCT05178641|101773453|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
33512586|NCT03201874|101773454|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
33512587|NCT03201874|101773455|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
33606036|NCT00576472|102108244|FG013|MPH Home Maintenance Phase|Side effects|0|||
33606037|NCT00576472|102108245|FG014|MPH Home Maintenance Phase|Side effects|8|||
33606038|NCT00576472|102108231|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33606039|NCT00576472|102108232|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33606040|NCT00576472|102108233|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33606041|NCT00576472|102108234|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33606042|NCT00576472|102108235|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33606043|NCT00576472|102108236|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33606044|NCT00576472|102108237|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33606045|NCT00576472|102108238|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33606046|NCT00576472|102108239|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33606047|NCT00576472|102108240|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33606048|NCT00576472|102108241|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33606049|NCT00576472|102108242|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33606050|NCT00576472|102108243|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33606051|NCT00576472|102108244|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
33606052|NCT00576472|102108245|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
33606053|NCT00576472|102108231|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
33606054|NCT00576472|102108232|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
33606055|NCT00576472|102108233|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
33606056|NCT00576472|102108234|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
33324441|NCT02568475|101084703|FG000|Overall Study|Transferred to another facility|1|||
33606057|NCT00576472|102108235|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
33606058|NCT00576472|102108236|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
33606059|NCT00576472|102108237|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
33606060|NCT00576472|102108238|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
33606061|NCT00576472|102108239|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
33324442|NCT02568475|101084704|FG001|Overall Study|Transferred to another facility|0|||
33324443|NCT02109562|101084705|FG000|Overall Study|Insufficient clinical response|2|||
33512588|NCT03201874|101773454|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
33512589|NCT03201874|101773455|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
33606062|NCT00576472|102108240|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
33606063|NCT00576472|102108241|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
33606064|NCT00576472|102108242|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
33606065|NCT00576472|102108243|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
33606066|NCT00576472|102108244|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
33606067|NCT00576472|102108245|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
33606068|NCT00576472|102108231|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33512590|NCT01582178|101773456|FG000|Overall Study|Physician Decision|6|||
33512591|NCT01582178|101773457|FG001|Overall Study|Physician Decision|5|||
33512592|NCT02733185|101773464|FG000|Overall Study|Withdrawal by Subject|12|||
33512593|NCT02733185|101773465|FG001|Overall Study|Withdrawal by Subject|10|||
33512594|NCT02733185|101773466|FG002|Overall Study|Withdrawal by Subject|17|||
33512595|NCT02733185|101773467|FG003|Overall Study|Withdrawal by Subject|21|||
33512596|NCT02733185|101773464|FG000|Overall Study|Death|46|||
33512597|NCT02733185|101773465|FG001|Overall Study|Death|34|||
33512598|NCT02733185|101773466|FG002|Overall Study|Death|35|||
33512599|NCT02733185|101773467|FG003|Overall Study|Death|43|||
33512600|NCT02733185|101773464|FG000|Overall Study|Lost to Follow-up|17|||
33512601|NCT02733185|101773465|FG001|Overall Study|Lost to Follow-up|18|||
33512602|NCT02733185|101773466|FG002|Overall Study|Lost to Follow-up|16|||
33512603|NCT02733185|101773467|FG003|Overall Study|Lost to Follow-up|11|||
33512604|NCT00748189|101773468|FG000|Overall Study|Death|99|||
33512605|NCT00748189|101773469|FG001|Overall Study|Death|84|||
33512606|NCT00748189|101773468|FG000|Overall Study|Withdrawal by Subject|23|||
33512607|NCT00748189|101773469|FG001|Overall Study|Withdrawal by Subject|29|||
33512608|NCT00748189|101773468|FG000|Overall Study|Physician Decision|16|||
33512609|NCT00748189|101773469|FG001|Overall Study|Physician Decision|5|||
33512610|NCT00748189|101773468|FG000|Overall Study|Lost to Follow-up|8|||
33512611|NCT00748189|101773469|FG001|Overall Study|Lost to Follow-up|15|||
33512612|NCT00748189|101773468|FG000|Overall Study|Study terminated by Sponsor|70|||
33512613|NCT00748189|101773469|FG001|Overall Study|Study terminated by Sponsor|79|||
33512614|NCT00394836|101773474|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
33512615|NCT00394836|101773475|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
33512616|NCT00394836|101773474|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
33512617|NCT00394836|101773475|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
33512618|NCT00394836|101773474|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
33606069|NCT00576472|102108232|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33512619|NCT00394836|101773475|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
33512620|NCT00394836|101773474|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
33512621|NCT00394836|101773475|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
33512622|NCT00394836|101773474|FG000|Teatment or Follow-up Phase|Death|0|||
33512623|NCT00394836|101773475|FG001|Teatment or Follow-up Phase|Death|1|||
33512624|NCT00394836|101773474|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
33606070|NCT00576472|102108233|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33606071|NCT00576472|102108234|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33606072|NCT00576472|102108235|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33606073|NCT00576472|102108236|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33606074|NCT00576472|102108237|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33606075|NCT00576472|102108238|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33606076|NCT00576472|102108239|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33606077|NCT00576472|102108240|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33606078|NCT00576472|102108241|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33606079|NCT00576472|102108242|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33606080|NCT00576472|102108243|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33606081|NCT00576472|102108244|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
33606082|NCT00576472|102108245|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
33606083|NCT01075984|102108247|FG000|Treatment Phase|Adverse Event|0|||
33606084|NCT01075984|102108248|FG001|Treatment Phase|Adverse Event|1|||
33606085|NCT01075984|102108249|FG002|Treatment Phase|Adverse Event|3|||
33606086|NCT01075984|102108250|FG003|Treatment Phase|Adverse Event|7|||
33606087|NCT01075984|102108251|FG004|Treatment Phase|Adverse Event|35|||
33606088|NCT01075984|102108247|FG000|Treatment Phase|Protocol Violation|0|||
33606089|NCT01075984|102108248|FG001|Treatment Phase|Protocol Violation|0|||
33606090|NCT01075984|102108249|FG002|Treatment Phase|Protocol Violation|1|||
33606091|NCT01075984|102108250|FG003|Treatment Phase|Protocol Violation|0|||
33606092|NCT01075984|102108251|FG004|Treatment Phase|Protocol Violation|3|||
33606093|NCT01075984|102108247|FG000|Treatment Phase|Withdrawal by Subject|0|||
33606094|NCT01075984|102108248|FG001|Treatment Phase|Withdrawal by Subject|0|||
33606095|NCT01075984|102108249|FG002|Treatment Phase|Withdrawal by Subject|2|||
33606096|NCT01075984|102108250|FG003|Treatment Phase|Withdrawal by Subject|0|||
33606097|NCT01075984|102108251|FG004|Treatment Phase|Withdrawal by Subject|15|||
33606098|NCT01075984|102108247|FG000|Treatment Phase|Treatment Failure|0|||
33606099|NCT01075984|102108248|FG001|Treatment Phase|Treatment Failure|0|||
33606100|NCT01075984|102108249|FG002|Treatment Phase|Treatment Failure|1|||
33606101|NCT01075984|102108250|FG003|Treatment Phase|Treatment Failure|0|||
33606102|NCT01075984|102108251|FG004|Treatment Phase|Treatment Failure|5|||
33606103|NCT01075984|102108247|FG000|Treatment Phase|Progression of disease|0|||
33606104|NCT01075984|102108248|FG001|Treatment Phase|Progression of disease|0|||
33606105|NCT01075984|102108249|FG002|Treatment Phase|Progression of disease|0|||
33606106|NCT01075984|102108250|FG003|Treatment Phase|Progression of disease|0|||
33606107|NCT01075984|102108251|FG004|Treatment Phase|Progression of disease|2|||
33606108|NCT01075984|102108247|FG000|Follow-up Phase|Protocol Violation|0|||
33606109|NCT01075984|102108248|FG001|Follow-up Phase|Protocol Violation|0|||
33606110|NCT01075984|102108249|FG002|Follow-up Phase|Protocol Violation|1|||
33606111|NCT01075984|102108250|FG003|Follow-up Phase|Protocol Violation|0|||
33606112|NCT01075984|102108251|FG004|Follow-up Phase|Protocol Violation|3|||
33606113|NCT01075984|102108247|FG000|Follow-up Phase|Adverse Event|0|||
33606114|NCT01075984|102108248|FG001|Follow-up Phase|Adverse Event|0|||
33606115|NCT01075984|102108249|FG002|Follow-up Phase|Adverse Event|0|||
33606116|NCT01075984|102108250|FG003|Follow-up Phase|Adverse Event|2|||
33606117|NCT01075984|102108251|FG004|Follow-up Phase|Adverse Event|27|||
33606118|NCT01075984|102108247|FG000|Follow-up Phase|Administrative|0|||
33606119|NCT01075984|102108248|FG001|Follow-up Phase|Administrative|0|||
33606120|NCT01075984|102108249|FG002|Follow-up Phase|Administrative|0|||
33606121|NCT01075984|102108250|FG003|Follow-up Phase|Administrative|0|||
33606122|NCT01075984|102108251|FG004|Follow-up Phase|Administrative|1|||
33606123|NCT01075984|102108247|FG000|Follow-up Phase|Withdrawal by Subject|0|||
33606124|NCT01075984|102108248|FG001|Follow-up Phase|Withdrawal by Subject|0|||
33606125|NCT01075984|102108249|FG002|Follow-up Phase|Withdrawal by Subject|0|||
33606126|NCT01075984|102108250|FG003|Follow-up Phase|Withdrawal by Subject|0|||
33606127|NCT01075984|102108251|FG004|Follow-up Phase|Withdrawal by Subject|10|||
33606128|NCT01075984|102108247|FG000|Follow-up Phase|Progression of disease|0|||
33606129|NCT01075984|102108248|FG001|Follow-up Phase|Progression of disease|0|||
33606130|NCT01075984|102108249|FG002|Follow-up Phase|Progression of disease|0|||
33606131|NCT01075984|102108250|FG003|Follow-up Phase|Progression of disease|0|||
33606132|NCT01075984|102108251|FG004|Follow-up Phase|Progression of disease|2|||
33606133|NCT01075984|102108247|FG000|Follow-up Phase|Treatment failure|0|||
33606134|NCT01075984|102108248|FG001|Follow-up Phase|Treatment failure|0|||
33606135|NCT01075984|102108249|FG002|Follow-up Phase|Treatment failure|0|||
33606136|NCT01075984|102108250|FG003|Follow-up Phase|Treatment failure|0|||
33606137|NCT01075984|102108251|FG004|Follow-up Phase|Treatment failure|4|||
33606138|NCT00760838|102108252|FG000|Overall Study|Adverse Event|1|||
33606139|NCT00760838|102108253|FG001|Overall Study|Adverse Event|1|||
33606140|NCT00760838|102108252|FG000|Overall Study|Lack of Efficacy|1|||
33606141|NCT00760838|102108253|FG001|Overall Study|Lack of Efficacy|0|||
33606142|NCT00760838|102108252|FG000|Overall Study|Lost to Follow-up|2|||
33606143|NCT00760838|102108253|FG001|Overall Study|Lost to Follow-up|0|||
33606144|NCT00760838|102108252|FG000|Overall Study|Withdrawal by Subject|1|||
33606145|NCT00760838|102108253|FG001|Overall Study|Withdrawal by Subject|1|||
33606146|NCT00086411|102108254|FG000|Overall Study|Lost to Follow-up|11|||
33606147|NCT00086411|102108255|FG001|Overall Study|Lost to Follow-up|11|||
33606148|NCT00086411|102108256|FG002|Overall Study|Lost to Follow-up|13|||
33606149|NCT00086411|102108257|FG003|Overall Study|Lost to Follow-up|12|||
33606150|NCT00454584|102108258|FG000|Controlled Period|Adverse Event|5|||
33606151|NCT00454584|102108259|FG001|Controlled Period|Adverse Event|2|||
33606152|NCT00454584|102108260|FG002|Controlled Period|Adverse Event|1|||
33606153|NCT00454584|102108261|FG003|Controlled Period|Adverse Event|0|||
33606154|NCT00454584|102108262|FG004|Controlled Period|Adverse Event|0|||
33198517|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
33198518|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
33324444|NCT02109562|101084706|FG001|Overall Study|Insufficient clinical response|0|||
33324445|NCT02109562|101084707|FG002|Overall Study|Insufficient clinical response|4|||
33324446|NCT02109562|101084705|FG000|Overall Study|Adverse Event|0|||
33324447|NCT02109562|101084706|FG001|Overall Study|Adverse Event|2|||
33324448|NCT02109562|101084707|FG002|Overall Study|Adverse Event|3|||
33324449|NCT02109562|101084705|FG000|Overall Study|Lost to Follow-up|1|||
33324450|NCT02109562|101084706|FG001|Overall Study|Lost to Follow-up|0|||
33324451|NCT02109562|101084707|FG002|Overall Study|Lost to Follow-up|1|||
33324452|NCT02109562|101084705|FG000|Overall Study|Protocol Violation|0|||
33324453|NCT02109562|101084706|FG001|Overall Study|Protocol Violation|3|||
33324454|NCT02109562|101084707|FG002|Overall Study|Protocol Violation|1|||
33324455|NCT02109562|101084705|FG000|Overall Study|Withdrawal by Subject|20|||
33324456|NCT02109562|101084706|FG001|Overall Study|Withdrawal by Subject|25|||
33324457|NCT02109562|101084707|FG002|Overall Study|Withdrawal by Subject|21|||
33324458|NCT02109562|101084705|FG000|Overall Study|Physician Decision|3|||
33324459|NCT02109562|101084706|FG001|Overall Study|Physician Decision|4|||
33324460|NCT02109562|101084707|FG002|Overall Study|Physician Decision|5|||
33324461|NCT00545402|101084713|FG000|Overall Study|Discontinuation of treatment|17|||
33324462|NCT00545402|101084714|FG001|Overall Study|Discontinuation of treatment|9|||
33324463|NCT00545402|101084713|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
33324464|NCT00545402|101084714|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
33324465|NCT00545402|101084713|FG000|Overall Study|Death|5|||
33324466|NCT00545402|101084714|FG001|Overall Study|Death|7|||
33324467|NCT00545402|101084713|FG000|Overall Study|Graft loss|2|||
33324468|NCT00545402|101084714|FG001|Overall Study|Graft loss|4|||
33198519|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
33198520|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
33198521|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
33198522|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
33198523|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
33198524|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
33198525|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
33198526|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
33198527|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
33198528|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
33198529|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
33198530|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
33198531|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
33198532|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
33198533|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
33198534|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
33198535|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
33198536|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
33198537|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
33198538|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
33198539|NCT01884350|100630545|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
33198540|NCT01884350|100630546|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
33324469|NCT00545402|101084713|FG000|Overall Study|Withdrawal by Subject|0|||
33324470|NCT00545402|101084714|FG001|Overall Study|Withdrawal by Subject|1|||
33324471|NCT00545402|101084713|FG000|Overall Study|Protocol Violation|1|||
33324472|NCT00545402|101084714|FG001|Overall Study|Protocol Violation|0|||
33606155|NCT00454584|102108263|FG005|Controlled Period|Adverse Event|0|||
33606156|NCT00454584|102108258|FG000|Controlled Period|Lost to Follow-up|1|||
33198541|NCT01884350|100630547|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
33198542|NCT00982319|100630548|FG000|Overall Study|Surgery date change|1|||
33198543|NCT00982319|100630549|FG001|Overall Study|Surgery date change|0|||
33324473|NCT00545402|101084713|FG000|Overall Study|Reason not specified|1|||
33324474|NCT00545402|101084714|FG001|Overall Study|Reason not specified|1|||
33324475|NCT02046096|101084716|FG000|Overall Study|Death|28|||
33324476|NCT02046096|101084717|FG001|Overall Study|Death|45|||
33324477|NCT02046096|101084716|FG000|Overall Study|Lost to Follow-up|9|||
33606157|NCT00454584|102108259|FG001|Controlled Period|Lost to Follow-up|2|||
33606158|NCT00454584|102108260|FG002|Controlled Period|Lost to Follow-up|2|||
33606159|NCT00454584|102108261|FG003|Controlled Period|Lost to Follow-up|0|||
33606160|NCT00454584|102108262|FG004|Controlled Period|Lost to Follow-up|0|||
33606161|NCT00454584|102108263|FG005|Controlled Period|Lost to Follow-up|0|||
33606162|NCT00454584|102108258|FG000|Controlled Period|Other|5|||
33606163|NCT00454584|102108259|FG001|Controlled Period|Other|4|||
33606164|NCT00454584|102108260|FG002|Controlled Period|Other|2|||
33606165|NCT00454584|102108261|FG003|Controlled Period|Other|0|||
33606166|NCT00454584|102108262|FG004|Controlled Period|Other|0|||
33606167|NCT00454584|102108263|FG005|Controlled Period|Other|0|||
33606168|NCT00454584|102108258|FG000|After Controlled Period|Adverse Event|0|||
33606169|NCT00454584|102108259|FG001|After Controlled Period|Adverse Event|0|||
33606170|NCT00454584|102108260|FG002|After Controlled Period|Adverse Event|0|||
33606171|NCT00454584|102108261|FG003|After Controlled Period|Adverse Event|9|||
33606172|NCT00454584|102108262|FG004|After Controlled Period|Adverse Event|3|||
33606173|NCT00454584|102108263|FG005|After Controlled Period|Adverse Event|9|||
33606174|NCT00454584|102108258|FG000|After Controlled Period|Lack of Efficacy|0|||
33606175|NCT00454584|102108259|FG001|After Controlled Period|Lack of Efficacy|0|||
33606176|NCT00454584|102108260|FG002|After Controlled Period|Lack of Efficacy|0|||
33606177|NCT00454584|102108261|FG003|After Controlled Period|Lack of Efficacy|1|||
33606178|NCT00454584|102108262|FG004|After Controlled Period|Lack of Efficacy|0|||
33606179|NCT00454584|102108263|FG005|After Controlled Period|Lack of Efficacy|0|||
33606180|NCT00454584|102108258|FG000|After Controlled Period|Lost to Follow-up|0|||
33606181|NCT00454584|102108259|FG001|After Controlled Period|Lost to Follow-up|0|||
33606182|NCT00454584|102108260|FG002|After Controlled Period|Lost to Follow-up|0|||
33606183|NCT00454584|102108261|FG003|After Controlled Period|Lost to Follow-up|2|||
33606184|NCT00454584|102108262|FG004|After Controlled Period|Lost to Follow-up|4|||
33606185|NCT00454584|102108263|FG005|After Controlled Period|Lost to Follow-up|6|||
33606186|NCT00454584|102108258|FG000|After Controlled Period|Other|0|||
33606187|NCT00454584|102108259|FG001|After Controlled Period|Other|0|||
33606188|NCT00454584|102108260|FG002|After Controlled Period|Other|0|||
33606189|NCT00454584|102108261|FG003|After Controlled Period|Other|1|||
33606190|NCT00454584|102108262|FG004|After Controlled Period|Other|0|||
33606191|NCT00454584|102108263|FG005|After Controlled Period|Other|0|||
33606192|NCT00454584|102108258|FG000|After Controlled Period|Other|0|||
33606193|NCT00454584|102108259|FG001|After Controlled Period|Other|0|||
33606194|NCT00454584|102108260|FG002|After Controlled Period|Other|0|||
33606195|NCT00454584|102108261|FG003|After Controlled Period|Other|13|||
33606196|NCT00454584|102108262|FG004|After Controlled Period|Other|5|||
33606197|NCT00454584|102108263|FG005|After Controlled Period|Other|17|||
33606198|NCT00351273|102108264|FG000|Overall Study|Lost to Follow-up|1|||
33606199|NCT00351273|102108265|FG001|Overall Study|Lost to Follow-up|2|||
33606200|NCT00351273|102108266|FG002|Overall Study|Lost to Follow-up|5|||
33606201|NCT03959982|102108267|FG000|Overall Study|Withdrawal by Subject|1|||
33606202|NCT03959982|102108268|FG001|Overall Study|Withdrawal by Subject|0|||
33606203|NCT03959982|102108267|FG000|Overall Study|Physician Decision|2|||
33324478|NCT02046096|101084717|FG001|Overall Study|Lost to Follow-up|20|||
33324479|NCT02046096|101084716|FG000|Overall Study|Withdrawal by Subject|5|||
33324480|NCT02046096|101084717|FG001|Overall Study|Withdrawal by Subject|17|||
33324481|NCT02046096|101084716|FG000|Overall Study|Other endpoint|2|||
33324482|NCT02046096|101084717|FG001|Overall Study|Other endpoint|19|||
33324483|NCT03710486|101084722|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
33324484|NCT03710486|101084723|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
33324485|NCT03710486|101084722|FG000|Overall Study|Missing|0|||
33324486|NCT03710486|101084723|FG001|Overall Study|Missing|2|||
33324487|NCT03974334|101084724|FG000|Overall Study|Lost to Follow-up|1|||
33324488|NCT02409290|101084733|FG000|Overall Study|Protocol Violation|3|||
33324489|NCT02409290|101084734|FG001|Overall Study|Protocol Violation|6|||
33324490|NCT02409290|101084735|FG002|Overall Study|Protocol Violation|9|||
33324491|NCT02409290|101084736|FG003|Overall Study|Protocol Violation|4|||
33324492|NCT02409290|101084733|FG000|Overall Study|No positive culture/no baseline sample|3|||
33606204|NCT03959982|102108268|FG001|Overall Study|Physician Decision|0|||
33606205|NCT03959982|102108267|FG000|Overall Study|Lost to Follow-up|1|||
33606206|NCT03959982|102108268|FG001|Overall Study|Lost to Follow-up|0|||
33606207|NCT01274429|102108269|FG000|Overall Study|Study closed do to lack of funding|5|||
33606208|NCT01267175|102108270|FG000|Overall Study|Withdrawal by Subject|1|||
33606209|NCT01267175|102108270|FG000|Overall Study|Lost to Follow-up|1|||
33606210|NCT00443781|102108273|FG000|Overall Study|Lost to Follow-up|10|||
33606211|NCT00443781|102108273|FG000|Overall Study|Physician Decision|2|||
33606212|NCT00443781|102108273|FG000|Overall Study|Protocol Violation|1|||
33606213|NCT00443781|102108273|FG000|Overall Study|Withdrawal by Subject|6|||
33324493|NCT02409290|101084734|FG001|Overall Study|No positive culture/no baseline sample|9|||
33606214|NCT00443781|102108273|FG000|Overall Study|Unable to comply with study follow up|2|||
33606215|NCT00443781|102108273|FG000|Overall Study|Investigator terminated participation|1|||
33606216|NCT00443781|102108273|FG000|Overall Study|Insurance not covered|2|||
33606217|NCT00443781|102108273|FG000|Overall Study|PD/FAD not done|1|||
33606218|NCT04881747|102108277|FG000|Period 2 Washout|Adverse Event|1|||
33606219|NCT04881747|102108278|FG001|Period 2 Washout|Adverse Event|0|||
33324494|NCT02409290|101084735|FG002|Overall Study|No positive culture/no baseline sample|6|||
33324495|NCT02409290|101084736|FG003|Overall Study|No positive culture/no baseline sample|5|||
33324496|NCT02409290|101084733|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
33324497|NCT02409290|101084734|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
33324498|NCT02409290|101084735|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
33324499|NCT02409290|101084736|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
33324500|NCT01704287|101084739|FG000|Initial Treatment Period|Death|139|||
33324501|NCT01704287|101084740|FG001|Initial Treatment Period|Death|129|||
33324502|NCT01704287|101084741|FG002|Initial Treatment Period|Death|71|||
33324503|NCT01704287|101084742|FG003|Initial Treatment Period|Death|0|||
33324504|NCT01704287|101084743|FG004|Initial Treatment Period|Death|0|||
33324505|NCT01704287|101084739|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
33324506|NCT01704287|101084740|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
33324507|NCT01704287|101084741|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
33324508|NCT01704287|101084742|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
33324509|NCT01704287|101084743|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
33324510|NCT01704287|101084739|FG000|Initial Treatment Period|Lost to Follow-up|5|||
33324511|NCT01704287|101084740|FG001|Initial Treatment Period|Lost to Follow-up|3|||
33324512|NCT01704287|101084741|FG002|Initial Treatment Period|Lost to Follow-up|0|||
33324513|NCT01704287|101084742|FG003|Initial Treatment Period|Lost to Follow-up|0|||
33324514|NCT01704287|101084743|FG004|Initial Treatment Period|Lost to Follow-up|0|||
33324515|NCT01704287|101084739|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
33324516|NCT01704287|101084740|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
33324517|NCT01704287|101084741|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
33324518|NCT01704287|101084742|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
33324519|NCT01704287|101084743|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
33324520|NCT01704287|101084739|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
33324521|NCT01704287|101084740|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
33324522|NCT01704287|101084741|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
33324523|NCT01704287|101084742|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
33512625|NCT00394836|101773475|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
33512626|NCT00394836|101773474|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
33512627|NCT00394836|101773475|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
33512628|NCT00394836|101773474|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
33512629|NCT00394836|101773475|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
33512630|NCT00394836|101773474|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
33512631|NCT00394836|101773475|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
33512632|NCT00394836|101773474|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
33512633|NCT00394836|101773475|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
33512634|NCT00394836|101773474|FG000|Teatment or Follow-up Phase|Non compliance|0|||
33512635|NCT00394836|101773475|FG001|Teatment or Follow-up Phase|Non compliance|1|||
33512636|NCT00394836|101773474|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
33512637|NCT00394836|101773475|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
33512638|NCT00394836|101773474|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
33512639|NCT00394836|101773475|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
33512640|NCT00394836|101773474|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
33512641|NCT00394836|101773475|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
33512642|NCT00394836|101773474|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
33512643|NCT00394836|101773475|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
33512644|NCT04161079|101773476|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
33512645|NCT02600845|101773477|FG000|Overall Study|Reason Not Specified|3|||
33512646|NCT02600845|101773477|FG000|Overall Study|Non-compliance with Study Procedures|10|||
33324524|NCT01704287|101084743|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
33324525|NCT01704287|101084739|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
33324526|NCT01704287|101084740|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
33324527|NCT01704287|101084741|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
33324528|NCT01704287|101084742|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
33324529|NCT01704287|101084743|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
33324530|NCT01704287|101084739|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
33324531|NCT01704287|101084740|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
33512647|NCT02600845|101773477|FG000|Overall Study|Consent Withdrawal|5|||
33512648|NCT00432276|101773486|FG000|Overall Study|Hyperglycemic Rescue|44|||
33512649|NCT00432276|101773487|FG001|Overall Study|Hyperglycemic Rescue|87|||
33512650|NCT00432276|101773486|FG000|Overall Study|Adverse Event|13|||
33512651|NCT00432276|101773487|FG001|Overall Study|Adverse Event|16|||
33324532|NCT01704287|101084741|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
33324533|NCT01704287|101084742|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
33198544|NCT00982319|100630548|FG000|Overall Study|Preop values out of acceptable range|1|||
33198545|NCT00982319|100630549|FG001|Overall Study|Preop values out of acceptable range|1|||
33198546|NCT00982319|100630548|FG000|Overall Study|Pregnancy|0|||
33198547|NCT00982319|100630549|FG001|Overall Study|Pregnancy|1|||
33198548|NCT00499369|100630550|FG000|Overall Study|Adverse Event|2|||
33198549|NCT00499369|100630551|FG001|Overall Study|Adverse Event|2|||
33198550|NCT00499369|100630552|FG002|Overall Study|Adverse Event|3|||
33198551|NCT00499369|100630553|FG003|Overall Study|Adverse Event|1|||
33198552|NCT00499369|100630554|FG004|Overall Study|Adverse Event|2|||
33198553|NCT00499369|100630550|FG000|Overall Study|Withdrawal by Subject|0|||
33512652|NCT00432276|101773486|FG000|Overall Study|Protocol Violation|25|||
33512653|NCT00432276|101773487|FG001|Overall Study|Protocol Violation|20|||
33198554|NCT00499369|100630551|FG001|Overall Study|Withdrawal by Subject|1|||
33198555|NCT00499369|100630552|FG002|Overall Study|Withdrawal by Subject|1|||
33198556|NCT00499369|100630553|FG003|Overall Study|Withdrawal by Subject|0|||
33198557|NCT00499369|100630554|FG004|Overall Study|Withdrawal by Subject|0|||
33324534|NCT01704287|101084743|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
33324535|NCT00804570|101084744|FG000|Overall Study|Adverse Event|14|||
33324536|NCT00804570|101084745|FG001|Overall Study|Adverse Event|7|||
33324537|NCT00804570|101084744|FG000|Overall Study|Lack of Efficacy|0|||
33324538|NCT00804570|101084745|FG001|Overall Study|Lack of Efficacy|1|||
33324539|NCT00804570|101084744|FG000|Overall Study|Lost to Follow-up|18|||
33324540|NCT00804570|101084745|FG001|Overall Study|Lost to Follow-up|21|||
33324541|NCT00804570|101084744|FG000|Overall Study|Entry criteria not met|5|||
33198558|NCT00499369|100630550|FG000|Overall Study|Progression|10|||
33198559|NCT00499369|100630551|FG001|Overall Study|Progression|12|||
33198560|NCT00499369|100630552|FG002|Overall Study|Progression|9|||
33198561|NCT00499369|100630553|FG003|Overall Study|Progression|6|||
33198562|NCT00499369|100630554|FG004|Overall Study|Progression|10|||
33198563|NCT00499369|100630550|FG000|Overall Study|Death|0|||
33198564|NCT00499369|100630551|FG001|Overall Study|Death|1|||
33198565|NCT00499369|100630552|FG002|Overall Study|Death|0|||
33198566|NCT00499369|100630553|FG003|Overall Study|Death|0|||
33198567|NCT00499369|100630554|FG004|Overall Study|Death|0|||
33198568|NCT00499369|100630550|FG000|Overall Study|Not protocol specified|2|||
33198569|NCT00499369|100630551|FG001|Overall Study|Not protocol specified|0|||
33198570|NCT00499369|100630552|FG002|Overall Study|Not protocol specified|3|||
33198571|NCT00499369|100630553|FG003|Overall Study|Not protocol specified|1|||
33198572|NCT00499369|100630554|FG004|Overall Study|Not protocol specified|0|||
33198573|NCT00499369|100630550|FG000|Overall Study|Ineligible|2|||
33198574|NCT00499369|100630551|FG001|Overall Study|Ineligible|2|||
33198575|NCT00499369|100630552|FG002|Overall Study|Ineligible|1|||
33198576|NCT00499369|100630553|FG003|Overall Study|Ineligible|1|||
33198577|NCT00499369|100630554|FG004|Overall Study|Ineligible|0|||
33198578|NCT03728582|100630555|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
33198579|NCT03728582|100630556|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
33198580|NCT03728582|100630555|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
33198581|NCT03728582|100630556|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
33198582|NCT03653429|100630561|FG000|Overall Study|Physician Decision|4|||
33198583|NCT03653429|100630562|FG001|Overall Study|Physician Decision|10|||
33198584|NCT00765245|100630563|FG000|Overall Study|disease progression|3|||
33198585|NCT00765245|100630564|FG001|Overall Study|disease progression|2|||
33198586|NCT00765245|100630563|FG000|Overall Study|Withdrawal by Subject|3|||
33198587|NCT00765245|100630564|FG001|Overall Study|Withdrawal by Subject|0|||
33198588|NCT00765245|100630563|FG000|Overall Study|Adverse Event|5|||
33324542|NCT00804570|101084745|FG001|Overall Study|Entry criteria not met|5|||
33324543|NCT00804570|101084744|FG000|Overall Study|Protocol Violation|12|||
33324544|NCT00804570|101084745|FG001|Overall Study|Protocol Violation|16|||
33324545|NCT00804570|101084744|FG000|Overall Study|Physician Decision|1|||
33324546|NCT00804570|101084745|FG001|Overall Study|Physician Decision|2|||
33198589|NCT00765245|100630564|FG001|Overall Study|Adverse Event|0|||
33198590|NCT00765245|100630563|FG000|Overall Study|Physician Decision|1|||
33198591|NCT00765245|100630564|FG001|Overall Study|Physician Decision|0|||
33198592|NCT00765245|100630563|FG000|Overall Study|Death|1|||
33198593|NCT00765245|100630564|FG001|Overall Study|Death|0|||
33198594|NCT01643473|100630565|FG000|Overall Study|Lost to Follow-up|1|||
33324547|NCT00804570|101084744|FG000|Overall Study|Sponsor decision|1|||
33324548|NCT00804570|101084745|FG001|Overall Study|Sponsor decision|4|||
33512654|NCT00432276|101773486|FG000|Overall Study|Lost to Follow-up|6|||
33198595|NCT01643473|100630566|FG001|Overall Study|Lost to Follow-up|0|||
33198596|NCT00377676|100630567|FG000|Overall Study|Adverse Event|498|||
33198597|NCT00377676|100630568|FG001|Overall Study|Adverse Event|107|||
33198598|NCT00377676|100630567|FG000|Overall Study|Protocol Violation|33|||
33198599|NCT00377676|100630568|FG001|Overall Study|Protocol Violation|27|||
33198600|NCT00377676|100630567|FG000|Overall Study|Death|5|||
33198601|NCT00377676|100630568|FG001|Overall Study|Death|2|||
33198602|NCT00377676|100630567|FG000|Overall Study|Withdrawal by Subject|187|||
33198603|NCT00377676|100630568|FG001|Overall Study|Withdrawal by Subject|72|||
33198604|NCT00377676|100630567|FG000|Overall Study|Lost to Follow-up|120|||
33198605|NCT00377676|100630568|FG001|Overall Study|Lost to Follow-up|56|||
33198606|NCT00377676|100630567|FG000|Overall Study|Other|118|||
33198607|NCT00377676|100630568|FG001|Overall Study|Other|58|||
33198608|NCT02838420|100630571|FG000|Overall Study|Ongoing in Study|113|||
33198609|NCT02838420|100630572|FG001|Overall Study|Ongoing in Study|45|||
33198610|NCT02838420|100630571|FG000|Overall Study|Lost to Follow-up|1|||
33198611|NCT02838420|100630572|FG001|Overall Study|Lost to Follow-up|0|||
33198612|NCT02838420|100630571|FG000|Overall Study|Withdrawal by Subject|3|||
33198613|NCT02838420|100630572|FG001|Overall Study|Withdrawal by Subject|4|||
33198614|NCT02838420|100630571|FG000|Overall Study|Death|8|||
33198615|NCT02838420|100630572|FG001|Overall Study|Death|13|||
33198616|NCT01813019|100630573|FG000|Overall Study|Adverse Event|0|||
33198617|NCT01813019|100630574|FG001|Overall Study|Adverse Event|3|||
33198618|NCT01813019|100630573|FG000|Overall Study|Withdrawal by Subject|3|||
33198619|NCT01813019|100630574|FG001|Overall Study|Withdrawal by Subject|2|||
33198620|NCT01813019|100630573|FG000|Overall Study|administrative problems|2|||
33198621|NCT01813019|100630574|FG001|Overall Study|administrative problems|0|||
33198622|NCT01813019|100630573|FG000|Overall Study|Protocol Deviation|2|||
33198623|NCT01813019|100630574|FG001|Overall Study|Protocol Deviation|1|||
33198624|NCT02199691|100630579|FG000|Overall Study|Protocol Violation|3|||
33198625|NCT02199691|100630580|FG001|Overall Study|Protocol Violation|3|||
33198626|NCT02199691|100630581|FG002|Overall Study|Protocol Violation|6|||
33198627|NCT02199691|100630582|FG003|Overall Study|Protocol Violation|7|||
33198628|NCT02199691|100630579|FG000|Overall Study|Withdrawal by Subject|5|||
33198629|NCT02199691|100630580|FG001|Overall Study|Withdrawal by Subject|3|||
33198630|NCT02199691|100630581|FG002|Overall Study|Withdrawal by Subject|12|||
33198631|NCT02199691|100630582|FG003|Overall Study|Withdrawal by Subject|13|||
33198632|NCT02199691|100630579|FG000|Overall Study|Lost to Follow-up|2|||
33198633|NCT02199691|100630580|FG001|Overall Study|Lost to Follow-up|1|||
33198634|NCT02199691|100630581|FG002|Overall Study|Lost to Follow-up|9|||
33198635|NCT02199691|100630582|FG003|Overall Study|Lost to Follow-up|10|||
33198636|NCT01818336|100630583|FG000|Overall Study|Declined retest visit|0|||
33198637|NCT01818336|100630584|FG001|Overall Study|Declined retest visit|11|||
33198638|NCT01818336|100630583|FG000|Overall Study|Lost to Follow-up|0|||
33198639|NCT01818336|100630584|FG001|Overall Study|Lost to Follow-up|1|||
33198640|NCT02604589|100630585|FG000|Overall Study|catheter dislodgement|0|||
33198641|NCT02604589|100630586|FG001|Overall Study|catheter dislodgement|0|||
33198642|NCT02604589|100630587|FG002|Overall Study|catheter dislodgement|1|||
33198643|NCT02266381|100630588|FG000|Overall Study|Physician Decision|3|||
33198644|NCT02266381|100630589|FG001|Overall Study|Physician Decision|5|||
33198645|NCT02266381|100630590|FG002|Overall Study|Physician Decision|4|||
33198646|NCT00096941|100630591|FG000|Overall Study|disease progression|3|||
33198647|NCT04394351|100630592|FG000|Part A (16 Weeks)|Adverse Event|1|||
33198648|NCT04394351|100630593|FG001|Part A (16 Weeks)|Adverse Event|0|||
33198649|NCT04394351|100630594|FG002|Part A (16 Weeks)|Adverse Event|0|||
33198650|NCT04394351|100630595|FG003|Part A (16 Weeks)|Adverse Event|0|||
33198651|NCT04394351|100630596|FG004|Part A (16 Weeks)|Adverse Event|0|||
33198652|NCT04394351|100630597|FG005|Part A (16 Weeks)|Adverse Event|0|||
33198653|NCT04394351|100630598|FG006|Part A (16 Weeks)|Adverse Event|0|||
33198654|NCT04394351|100630599|FG007|Part A (16 Weeks)|Adverse Event|0|||
33198655|NCT04394351|100630592|FG000|Part A (16 Weeks)|Physician Decision|0|||
33198656|NCT04394351|100630593|FG001|Part A (16 Weeks)|Physician Decision|1|||
33198657|NCT04394351|100630594|FG002|Part A (16 Weeks)|Physician Decision|0|||
33324549|NCT00804570|101084744|FG000|Overall Study|Withdrawal by Subject|21|||
33324550|NCT00804570|101084745|FG001|Overall Study|Withdrawal by Subject|38|||
33198658|NCT04394351|100630595|FG003|Part A (16 Weeks)|Physician Decision|0|||
33198659|NCT04394351|100630596|FG004|Part A (16 Weeks)|Physician Decision|0|||
33198660|NCT04394351|100630597|FG005|Part A (16 Weeks)|Physician Decision|0|||
33198661|NCT04394351|100630598|FG006|Part A (16 Weeks)|Physician Decision|0|||
33198662|NCT04394351|100630599|FG007|Part A (16 Weeks)|Physician Decision|0|||
33198663|NCT04394351|100630592|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
33198664|NCT04394351|100630593|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
33198665|NCT04394351|100630594|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
33198666|NCT04394351|100630595|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
33198667|NCT04394351|100630596|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
33198668|NCT04394351|100630597|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
33198669|NCT04394351|100630598|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
33198670|NCT04394351|100630599|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
33198671|NCT04394351|100630592|FG000|Part B (36 Weeks)|Adverse Event|0|||
33198672|NCT04394351|100630593|FG001|Part B (36 Weeks)|Adverse Event|0|||
33198673|NCT04394351|100630594|FG002|Part B (36 Weeks)|Adverse Event|0|||
33198674|NCT04394351|100630595|FG003|Part B (36 Weeks)|Adverse Event|0|||
33198675|NCT04394351|100630596|FG004|Part B (36 Weeks)|Adverse Event|0|||
33198676|NCT04394351|100630597|FG005|Part B (36 Weeks)|Adverse Event|0|||
33198677|NCT04394351|100630598|FG006|Part B (36 Weeks)|Adverse Event|1|||
33198678|NCT04394351|100630599|FG007|Part B (36 Weeks)|Adverse Event|0|||
33198679|NCT01802411|100630600|FG000|Overall Study|Death|2|||
33324551|NCT01117454|101084746|FG000|Overall Study|Pregnancy|0|||
33324552|NCT01117454|101084747|FG001|Overall Study|Pregnancy|1|||
33324553|NCT02576444|101084748|FG000|Overall Study|Death|1|||
33324554|NCT02576444|101084749|FG001|Overall Study|Death|1|||
33324555|NCT02576444|101084750|FG002|Overall Study|Death|0|||
33324556|NCT02576444|101084751|FG003|Overall Study|Death|0|||
33324557|NCT02576444|101084748|FG000|Overall Study|Withdrawal by Subject|0|||
33324558|NCT02576444|101084749|FG001|Overall Study|Withdrawal by Subject|0|||
33324559|NCT02576444|101084750|FG002|Overall Study|Withdrawal by Subject|2|||
33324560|NCT02576444|101084751|FG003|Overall Study|Withdrawal by Subject|0|||
33324561|NCT02576444|101084748|FG000|Overall Study|Adverse Event|0|||
33324562|NCT02576444|101084749|FG001|Overall Study|Adverse Event|0|||
33324563|NCT02576444|101084750|FG002|Overall Study|Adverse Event|1|||
33324564|NCT02576444|101084751|FG003|Overall Study|Adverse Event|0|||
33512655|NCT00432276|101773487|FG001|Overall Study|Lost to Follow-up|2|||
33512656|NCT00432276|101773486|FG000|Overall Study|Withdrawal by Subject|25|||
33512657|NCT00432276|101773487|FG001|Overall Study|Withdrawal by Subject|20|||
33512658|NCT00432276|101773486|FG000|Overall Study|Physician Decision|6|||
33324565|NCT02576444|101084748|FG000|Overall Study|Physician Decision|0|||
33324566|NCT02576444|101084749|FG001|Overall Study|Physician Decision|0|||
33512659|NCT00432276|101773487|FG001|Overall Study|Physician Decision|8|||
33512660|NCT00432276|101773486|FG000|Overall Study|Other|2|||
33512661|NCT00432276|101773487|FG001|Overall Study|Other|3|||
33512662|NCT02484651|101773488|FG000|Overall Study|Patients' data files were corrupted.|1|||
33512663|NCT02484651|101773489|FG001|Overall Study|Patients' data files were corrupted.|1|||
33512664|NCT02484651|101773488|FG000|Overall Study|BIS monitoring failed.|1|||
33512665|NCT02484651|101773489|FG001|Overall Study|BIS monitoring failed.|1|||
33198680|NCT01802411|100630601|FG001|Overall Study|Death|1|||
33198681|NCT01802411|100630600|FG000|Overall Study|Adverse Event|2|||
33198682|NCT01802411|100630601|FG001|Overall Study|Adverse Event|7|||
33198683|NCT01802411|100630600|FG000|Overall Study|Lack of Efficacy|8|||
33198684|NCT01802411|100630601|FG001|Overall Study|Lack of Efficacy|10|||
33198685|NCT01802411|100630600|FG000|Overall Study|Withdrawal by Subject|0|||
33198686|NCT01802411|100630601|FG001|Overall Study|Withdrawal by Subject|2|||
33198687|NCT01802411|100630600|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
33198688|NCT01802411|100630601|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
33198689|NCT01802411|100630600|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
33198690|NCT01802411|100630601|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
33198691|NCT01802411|100630600|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
33198692|NCT01802411|100630601|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
33198693|NCT02822794|100630604|FG000|Overall Study|Withdrew Consent|1|||
33198694|NCT02822794|100630605|FG001|Overall Study|Withdrew Consent|0|||
33198695|NCT01975389|100630610|FG000|Overall Study|Adverse Event|10|||
33198696|NCT01975389|100630611|FG001|Overall Study|Adverse Event|6|||
33198697|NCT01975389|100630610|FG000|Overall Study|Death|61|||
33198698|NCT01975389|100630611|FG001|Overall Study|Death|54|||
33198699|NCT01975389|100630610|FG000|Overall Study|Lost to Follow-up|81|||
33198700|NCT01975389|100630611|FG001|Overall Study|Lost to Follow-up|86|||
33198701|NCT01975389|100630610|FG000|Overall Study|Withdrawal by Subject|90|||
33198702|NCT01975389|100630611|FG001|Overall Study|Withdrawal by Subject|76|||
33198703|NCT01975389|100630610|FG000|Overall Study|Other|6|||
33198704|NCT01975389|100630611|FG001|Overall Study|Other|9|||
33198705|NCT01975389|100630610|FG000|Overall Study|Randomized, not treated|4|||
33198706|NCT01975389|100630611|FG001|Overall Study|Randomized, not treated|5|||
33324567|NCT02576444|101084750|FG002|Overall Study|Physician Decision|1|||
33324568|NCT02576444|101084751|FG003|Overall Study|Physician Decision|0|||
33512666|NCT02484651|101773488|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
33512667|NCT02484651|101773489|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
33512668|NCT00970632|101773491|FG000|Overall Study|Adverse Event|2|||
33512669|NCT00970632|101773492|FG001|Overall Study|Adverse Event|2|||
33198707|NCT01958918|100630612|FG000|Overall Study|Death|1|||
33198708|NCT01958918|100630613|FG001|Overall Study|Death|3|||
33198709|NCT01958918|100630612|FG000|Overall Study|Lost to Follow-up|4|||
33198710|NCT01958918|100630613|FG001|Overall Study|Lost to Follow-up|7|||
33324569|NCT02357134|101084752|FG000|Overall Study|Lost to Follow-up|1|||
33324570|NCT02357134|101084753|FG001|Overall Study|Lost to Follow-up|0|||
33324571|NCT02357134|101084754|FG002|Overall Study|Lost to Follow-up|0|||
33198711|NCT01958918|100630612|FG000|Overall Study|Withdrawal by Subject|13|||
33198712|NCT01958918|100630613|FG001|Overall Study|Withdrawal by Subject|8|||
33512670|NCT00970632|101773493|FG002|Overall Study|Adverse Event|1|||
33512671|NCT00970632|101773491|FG000|Overall Study|Lack of Efficacy|3|||
33512672|NCT00970632|101773492|FG001|Overall Study|Lack of Efficacy|0|||
33512673|NCT00970632|101773493|FG002|Overall Study|Lack of Efficacy|0|||
33198713|NCT01958918|100630612|FG000|Overall Study|Lack of Efficacy|13|||
33198714|NCT01958918|100630613|FG001|Overall Study|Lack of Efficacy|10|||
33198715|NCT01958918|100630612|FG000|Overall Study|Adverse Event|12|||
33198716|NCT01958918|100630613|FG001|Overall Study|Adverse Event|12|||
33324572|NCT02357134|101084755|FG003|Overall Study|Lost to Follow-up|0|||
33324573|NCT00058552|101084756|FG000|Overall Study|Died prior to receiving treatment|4|||
33606220|NCT04881747|102108279|FG002|Period 2 Washout|Adverse Event|0|||
33606221|NCT04881747|102108280|FG003|Period 2 Washout|Adverse Event|0|||
33606222|NCT04881747|102108281|FG004|Period 2 Washout|Adverse Event|1|||
33606223|NCT04881747|102108282|FG005|Period 2 Washout|Adverse Event|0|||
33512674|NCT00970632|101773491|FG000|Overall Study|Lost to Follow-up|3|||
33512675|NCT00970632|101773492|FG001|Overall Study|Lost to Follow-up|0|||
33512676|NCT00970632|101773493|FG002|Overall Study|Lost to Follow-up|2|||
33512677|NCT00970632|101773491|FG000|Overall Study|Protocol Violation|8|||
33512678|NCT00970632|101773492|FG001|Overall Study|Protocol Violation|5|||
33512679|NCT00970632|101773493|FG002|Overall Study|Protocol Violation|8|||
33512680|NCT00970632|101773491|FG000|Overall Study|Withdrawal by Subject|7|||
33512681|NCT00970632|101773492|FG001|Overall Study|Withdrawal by Subject|6|||
33512682|NCT00970632|101773493|FG002|Overall Study|Withdrawal by Subject|4|||
33512683|NCT00970632|101773491|FG000|Overall Study|Entry criteria not met|0|||
33512684|NCT00970632|101773492|FG001|Overall Study|Entry criteria not met|2|||
33512685|NCT00970632|101773493|FG002|Overall Study|Entry criteria not met|2|||
33512686|NCT00970632|101773491|FG000|Overall Study|Sponsor decision|1|||
33512687|NCT00970632|101773492|FG001|Overall Study|Sponsor decision|0|||
33512688|NCT00970632|101773493|FG002|Overall Study|Sponsor decision|1|||
33512689|NCT02275780|101773494|FG000|Base Study: 96 Weeks|Adverse Event|6|||
33512690|NCT02275780|101773495|FG001|Base Study: 96 Weeks|Adverse Event|14|||
33512691|NCT02275780|101773494|FG000|Base Study: 96 Weeks|Death|3|||
33512692|NCT02275780|101773495|FG001|Base Study: 96 Weeks|Death|1|||
33512693|NCT02275780|101773494|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
33512694|NCT02275780|101773495|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
33512695|NCT02275780|101773494|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
33512696|NCT02275780|101773495|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
33512697|NCT02275780|101773494|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
33512698|NCT02275780|101773495|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
33606224|NCT04881747|102108277|FG000|Period 2 Washout|Withdrawal by Subject|1|||
33606225|NCT04881747|102108278|FG001|Period 2 Washout|Withdrawal by Subject|0|||
33606226|NCT04881747|102108279|FG002|Period 2 Washout|Withdrawal by Subject|0|||
33606227|NCT04881747|102108280|FG003|Period 2 Washout|Withdrawal by Subject|1|||
33606228|NCT04881747|102108281|FG004|Period 2 Washout|Withdrawal by Subject|0|||
33606229|NCT04881747|102108282|FG005|Period 2 Washout|Withdrawal by Subject|0|||
33606230|NCT01746173|102108283|FG000|Overall Study|Disease Progression|2|||
33606231|NCT00849108|102108284|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
33606232|NCT00849108|102108285|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
33606233|NCT00849108|102108284|FG000|Cohort 2 Efficacy|Adverse Event|0|||
33606234|NCT00849108|102108285|FG001|Cohort 2 Efficacy|Adverse Event|1|||
33606235|NCT00849108|102108284|FG000|Cohort 2 Efficacy|Other|0|||
33606236|NCT00849108|102108285|FG001|Cohort 2 Efficacy|Other|9|||
33606237|NCT01457846|102108286|FG000|Overall Study|Death before treatment|1|||
33606238|NCT01457846|102108287|FG001|Overall Study|Death before treatment|2|||
33606239|NCT01457846|102108286|FG000|Overall Study|Did not receive treatment|0|||
33606240|NCT01457846|102108287|FG001|Overall Study|Did not receive treatment|1|||
33606241|NCT01457846|102108286|FG000|Overall Study|Death|27|||
33606242|NCT01457846|102108287|FG001|Overall Study|Death|16|||
33606243|NCT01457846|102108286|FG000|Overall Study|Unclassified reason for not completed|11|||
33606244|NCT01457846|102108287|FG001|Overall Study|Unclassified reason for not completed|10|||
33606245|NCT01457846|102108286|FG000|Overall Study|Withdrawal by Subject|1|||
33606246|NCT01457846|102108287|FG001|Overall Study|Withdrawal by Subject|1|||
33606247|NCT01457846|102108286|FG000|Overall Study|Lost to Follow-up|1|||
33606248|NCT01457846|102108287|FG001|Overall Study|Lost to Follow-up|0|||
33606249|NCT02273960|102108289|FG000|Short Term Period|Lost to Follow-up|1|||
33606250|NCT02273960|102108290|FG001|Short Term Period|Lost to Follow-up|0|||
33606251|NCT02273960|102108291|FG002|Short Term Period|Lost to Follow-up|0|||
33606252|NCT02273960|102108292|FG003|Short Term Period|Lost to Follow-up|0|||
33198717|NCT01958918|100630612|FG000|Overall Study|administrative problems|0|||
33606253|NCT02273960|102108289|FG000|Short Term Period|Lack of Efficacy|0|||
33606254|NCT02273960|102108290|FG001|Short Term Period|Lack of Efficacy|0|||
33606255|NCT02273960|102108291|FG002|Short Term Period|Lack of Efficacy|0|||
33606256|NCT02273960|102108292|FG003|Short Term Period|Lack of Efficacy|1|||
33606257|NCT02273960|102108289|FG000|Short Term Period|ST complete, not entering LTE|4|||
33606258|NCT02273960|102108290|FG001|Short Term Period|ST complete, not entering LTE|6|||
33606259|NCT02273960|102108291|FG002|Short Term Period|ST complete, not entering LTE|4|||
33606260|NCT02273960|102108292|FG003|Short Term Period|ST complete, not entering LTE|5|||
33606261|NCT02273960|102108289|FG000|Long Term Extension|Death|0|||
33512699|NCT02275780|101773494|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
33512700|NCT02275780|101773495|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
33512701|NCT02275780|101773494|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
33512702|NCT02275780|101773495|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
33606262|NCT02273960|102108290|FG001|Long Term Extension|Death|0|||
33606263|NCT02273960|102108291|FG002|Long Term Extension|Death|0|||
33512703|NCT02275780|101773494|FG000|Base Study: 96 Weeks|Physician Decision|2|||
33512704|NCT02275780|101773495|FG001|Base Study: 96 Weeks|Physician Decision|4|||
33512705|NCT02275780|101773494|FG000|Base Study: 96 Weeks|Pregnancy|2|||
33512706|NCT02275780|101773495|FG001|Base Study: 96 Weeks|Pregnancy|1|||
33512707|NCT02275780|101773494|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
33512708|NCT02275780|101773495|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
33512709|NCT02275780|101773494|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
33512710|NCT02275780|101773495|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
33512711|NCT02275780|101773494|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
33512712|NCT02275780|101773495|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
33512713|NCT02275780|101773494|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
33512714|NCT02275780|101773495|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
33512715|NCT02275780|101773494|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
33512716|NCT02275780|101773495|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
33512717|NCT02275780|101773494|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
33512718|NCT02275780|101773495|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
33512719|NCT02275780|101773494|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
33512720|NCT02275780|101773495|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
33512721|NCT02275780|101773494|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
33512722|NCT02275780|101773495|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
33512723|NCT02275780|101773494|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
33512724|NCT02275780|101773495|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
33512725|NCT02275780|101773494|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
33512726|NCT02275780|101773495|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
33512727|NCT02275780|101773494|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
33512728|NCT02275780|101773495|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
33512729|NCT02275780|101773494|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
33512730|NCT02275780|101773495|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
33606264|NCT02273960|102108292|FG003|Long Term Extension|Death|1|||
33606265|NCT02708355|102108293|FG000|Overall Study|Adverse Event|1|||
33606266|NCT02708355|102108294|FG001|Overall Study|Adverse Event|0|||
33606267|NCT02708355|102108295|FG002|Overall Study|Adverse Event|0|||
33606268|NCT04094584|102108296|FG000|Overall Study|No interest in study|88|||
33606269|NCT04094584|102108296|FG000|Overall Study|Unwilling to undergo screening tests|36|||
33606270|NCT04094584|102108296|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
33606271|NCT04094584|102108296|FG000|Overall Study|Opioid use|7|||
33606272|NCT04094584|102108296|FG000|Overall Study|Need for major surgery in study period|4|||
33606273|NCT04094584|102108296|FG000|Overall Study|eligible but declined enrollment|4|||
33606274|NCT04094584|102108296|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
33606275|NCT04094584|102108296|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
33606276|NCT04094584|102108296|FG000|Overall Study|Lost to Follow-up|3|||
33606277|NCT04094584|102108296|FG000|Overall Study|Withdrawal by Subject|2|||
33606278|NCT04598269|102108297|FG000|Overall Study|Adverse Event|0|||
33606279|NCT04598269|102108298|FG001|Overall Study|Adverse Event|3|||
33512731|NCT02275780|101773494|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
33512732|NCT02275780|101773495|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
33512733|NCT02275780|101773494|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
33512734|NCT02275780|101773495|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
33512735|NCT02275780|101773494|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
33512736|NCT02275780|101773495|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
33512737|NCT02275780|101773494|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
33512738|NCT02275780|101773495|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
33512739|NCT02275780|101773494|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
33512740|NCT02275780|101773495|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
33512741|NCT02275780|101773494|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
33512742|NCT02275780|101773495|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
33512743|NCT02275780|101773494|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
33512744|NCT02275780|101773495|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
33512745|NCT02275780|101773494|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
33512746|NCT02275780|101773495|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
33512747|NCT02275780|101773494|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
33512748|NCT02275780|101773495|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
33512749|NCT02275780|101773494|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
33512750|NCT02275780|101773495|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
33512751|NCT00157248|101773496|FG000|Overall Study|Adverse Event|36|||
33512752|NCT00157248|101773497|FG001|Overall Study|Adverse Event|25|||
33512753|NCT00157248|101773498|FG002|Overall Study|Adverse Event|13|||
33512754|NCT00157248|101773499|FG003|Overall Study|Adverse Event|33|||
33512755|NCT00157248|101773496|FG000|Overall Study|Protocol Violation|4|||
33512756|NCT00157248|101773497|FG001|Overall Study|Protocol Violation|0|||
33512757|NCT00157248|101773498|FG002|Overall Study|Protocol Violation|2|||
33512758|NCT00157248|101773499|FG003|Overall Study|Protocol Violation|2|||
33512759|NCT00157248|101773496|FG000|Overall Study|Lost to Follow-up|0|||
33512760|NCT00157248|101773497|FG001|Overall Study|Lost to Follow-up|1|||
33512761|NCT00157248|101773498|FG002|Overall Study|Lost to Follow-up|0|||
33512762|NCT00157248|101773499|FG003|Overall Study|Lost to Follow-up|0|||
33512763|NCT00157248|101773496|FG000|Overall Study|Withdrawal by Subject|1|||
33512764|NCT00157248|101773497|FG001|Overall Study|Withdrawal by Subject|4|||
33512765|NCT00157248|101773498|FG002|Overall Study|Withdrawal by Subject|3|||
33512766|NCT00157248|101773499|FG003|Overall Study|Withdrawal by Subject|3|||
33512767|NCT00157248|101773496|FG000|Overall Study|site closures, subject moving|7|||
33512768|NCT00157248|101773497|FG001|Overall Study|site closures, subject moving|7|||
33512769|NCT00157248|101773498|FG002|Overall Study|site closures, subject moving|3|||
33512770|NCT00157248|101773499|FG003|Overall Study|site closures, subject moving|9|||
33512771|NCT00759785|101773500|FG000|Overall Study|Participant sample not evaluable|11|||
33512772|NCT00759785|101773501|FG001|Overall Study|Participant sample not evaluable|2|||
33512773|NCT00759785|101773500|FG000|Overall Study|Participant sample lost|0|||
33512774|NCT00759785|101773501|FG001|Overall Study|Participant sample lost|1|||
33512775|NCT00759785|101773500|FG000|Overall Study|Protocol Violation|1|||
33512776|NCT00759785|101773501|FG001|Overall Study|Protocol Violation|0|||
33512777|NCT00759785|101773500|FG000|Overall Study|Physician Decision|0|||
33512778|NCT00759785|101773501|FG001|Overall Study|Physician Decision|1|||
33512779|NCT00759785|101773500|FG000|Overall Study|Withdrawal by Subject|0|||
33512780|NCT00759785|101773501|FG001|Overall Study|Withdrawal by Subject|1|||
33512781|NCT04258254|101773502|FG000|Overall Study|Withdrawal by Subject|0|||
33512782|NCT04258254|101773503|FG001|Overall Study|Withdrawal by Subject|1|||
33512783|NCT04258254|101773504|FG002|Overall Study|Withdrawal by Subject|0|||
33512784|NCT02908672|101773507|FG000|Overall Study|Death|112|||
33512785|NCT02908672|101773508|FG001|Overall Study|Death|93|||
33512786|NCT02908672|101773507|FG000|Overall Study|Lost to Follow-up|3|||
33512787|NCT02908672|101773508|FG001|Overall Study|Lost to Follow-up|3|||
33512788|NCT02908672|101773507|FG000|Overall Study|Other|2|||
33512789|NCT02908672|101773508|FG001|Overall Study|Other|0|||
33512790|NCT02908672|101773507|FG000|Overall Study|Protocol Violation|1|||
33512791|NCT02908672|101773508|FG001|Overall Study|Protocol Violation|1|||
33512792|NCT02908672|101773507|FG000|Overall Study|Withdrawal by Subject|13|||
33512793|NCT02908672|101773508|FG001|Overall Study|Withdrawal by Subject|18|||
33512794|NCT02908672|101773507|FG000|Overall Study|Study is ongoing|124|||
33512795|NCT02908672|101773508|FG001|Overall Study|Study is ongoing|141|||
33512796|NCT02908672|101773507|FG000|Overall Study|Discontinued the study during run-in|3|||
33512797|NCT02908672|101773508|FG001|Overall Study|Discontinued the study during run-in|0|||
33399093|NCT02394028|101350177|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
33399094|NCT02394028|101350178|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
33512798|NCT00712881|101773509|FG000|Overall Study|Adverse Event|3|||
33512799|NCT00712881|101773510|FG001|Overall Study|Adverse Event|3|||
33512800|NCT00712881|101773509|FG000|Overall Study|Withdrawal by Subject|1|||
33399095|NCT02394028|101350179|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
33399096|NCT02394028|101350180|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
33399097|NCT02394028|101350181|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
33399098|NCT02394028|101350182|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
33399099|NCT02394028|101350183|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
33512801|NCT00712881|101773510|FG001|Overall Study|Withdrawal by Subject|1|||
33512802|NCT00712881|101773509|FG000|Overall Study|Disease Progression|2|||
33512803|NCT00712881|101773510|FG001|Overall Study|Disease Progression|1|||
33512804|NCT00712881|101773509|FG000|Overall Study|Lost to Follow-up|1|||
33512805|NCT00712881|101773510|FG001|Overall Study|Lost to Follow-up|1|||
33512806|NCT00712881|101773509|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
33512807|NCT00712881|101773510|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
33512808|NCT00712881|101773509|FG000|Overall Study|Protocol Violation|1|||
33512809|NCT00712881|101773510|FG001|Overall Study|Protocol Violation|1|||
33512810|NCT00712881|101773509|FG000|Overall Study|Randomized but not treated|1|||
33512811|NCT00712881|101773510|FG001|Overall Study|Randomized but not treated|0|||
33512812|NCT05177354|101773512|FG000|Implant to 30-day Visit|Physician Decision|1|||
33512813|NCT05177354|101773512|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
33512814|NCT05177354|101773512|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
33198718|NCT01958918|100630613|FG001|Overall Study|administrative problems|2|||
33198719|NCT01709318|100630614|FG000|Overall Study|Adverse Event|3|||
33198720|NCT01709318|100630615|FG001|Overall Study|Adverse Event|4|||
33198721|NCT01709318|100630616|FG002|Overall Study|Adverse Event|2|||
33198722|NCT01709318|100630617|FG003|Overall Study|Adverse Event|2|||
33198723|NCT01709318|100630618|FG004|Overall Study|Adverse Event|0|||
33198724|NCT01709318|100630619|FG005|Overall Study|Adverse Event|1|||
33198725|NCT01709318|100630620|FG006|Overall Study|Adverse Event|2|||
33198726|NCT01709318|100630614|FG000|Overall Study|Lost to Follow-up|2|||
33324574|NCT00058552|101084757|FG001|Overall Study|Died prior to receiving treatment|2|||
33324575|NCT00058552|101084756|FG000|Overall Study|Disease progression|52|||
33324576|NCT00058552|101084757|FG001|Overall Study|Disease progression|44|||
33324577|NCT00058552|101084756|FG000|Overall Study|Adverse Event|4|||
33324578|NCT00058552|101084757|FG001|Overall Study|Adverse Event|2|||
33324579|NCT00058552|101084756|FG000|Overall Study|Withdrawal by Subject|3|||
33324580|NCT00058552|101084757|FG001|Overall Study|Withdrawal by Subject|5|||
33324581|NCT00058552|101084756|FG000|Overall Study|Physician Decision|2|||
33324582|NCT00058552|101084757|FG001|Overall Study|Physician Decision|5|||
33399100|NCT02394028|101350184|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
33512815|NCT05177354|101773512|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
33512816|NCT01806961|101773516|FG000|Overall Study|sponsor decision|16|||
33512817|NCT05249127|101773523|FG000|Overall Study|Protocol Violation|13|||
33512818|NCT05249127|101773523|FG000|Overall Study|Physician Decision|4|||
33512819|NCT05249127|101773523|FG000|Overall Study|Withdrawal by Subject|2|||
33512820|NCT05249127|101773523|FG000|Overall Study|Participant Non-compliance|1|||
33512821|NCT00477750|101773524|FG000|Overall Study|Currently Receiving Treatment|11|||
33512822|NCT01447446|101773525|FG000|Overall Study|Death|6|||
33512823|NCT01447446|101773526|FG001|Overall Study|Death|3|||
33198727|NCT01709318|100630615|FG001|Overall Study|Lost to Follow-up|0|||
33198728|NCT01709318|100630616|FG002|Overall Study|Lost to Follow-up|0|||
33324583|NCT00058552|101084756|FG000|Overall Study|Clinical disease progression|0|||
33512824|NCT01447446|101773527|FG002|Overall Study|Death|2|||
33512825|NCT01447446|101773528|FG003|Overall Study|Death|1|||
33512826|NCT01447446|101773529|FG004|Overall Study|Death|7|||
33512827|NCT01447446|101773530|FG005|Overall Study|Death|0|||
33512828|NCT01447446|101773525|FG000|Overall Study|Adverse Event|3|||
33512829|NCT01447446|101773526|FG001|Overall Study|Adverse Event|0|||
33512830|NCT01447446|101773527|FG002|Overall Study|Adverse Event|1|||
33512831|NCT01447446|101773528|FG003|Overall Study|Adverse Event|0|||
33606280|NCT04598269|102108297|FG000|Overall Study|Withdrawal by Subject|1|||
33606281|NCT04598269|102108298|FG001|Overall Study|Withdrawal by Subject|4|||
33606282|NCT04598269|102108297|FG000|Overall Study|Lost to Follow-up|1|||
33606283|NCT04598269|102108298|FG001|Overall Study|Lost to Follow-up|0|||
33606284|NCT04598269|102108297|FG000|Overall Study|Not Treated|2|||
33606285|NCT04598269|102108298|FG001|Overall Study|Not Treated|0|||
33606286|NCT03281304|102108301|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
33606287|NCT03281304|102108302|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
33512832|NCT01447446|101773529|FG004|Overall Study|Adverse Event|2|||
33512833|NCT01447446|101773530|FG005|Overall Study|Adverse Event|0|||
33512834|NCT01447446|101773525|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
33512835|NCT01447446|101773526|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
33512836|NCT01447446|101773527|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
33512837|NCT01447446|101773528|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
33512838|NCT01447446|101773529|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
33512839|NCT01447446|101773530|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
33512840|NCT01447446|101773525|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
33512841|NCT01447446|101773526|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
33512842|NCT01447446|101773527|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
33512843|NCT01447446|101773528|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
33512844|NCT01447446|101773529|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
33512845|NCT01447446|101773530|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
33512846|NCT01447446|101773525|FG000|Overall Study|Administrative/Other|34|||
33512847|NCT01447446|101773526|FG001|Overall Study|Administrative/Other|9|||
33512848|NCT01447446|101773527|FG002|Overall Study|Administrative/Other|10|||
33512849|NCT01447446|101773528|FG003|Overall Study|Administrative/Other|2|||
33512850|NCT01447446|101773529|FG004|Overall Study|Administrative/Other|33|||
33512851|NCT01447446|101773530|FG005|Overall Study|Administrative/Other|4|||
33512852|NCT01447446|101773525|FG000|Overall Study|SVR12 Assessment|13|||
33512853|NCT01447446|101773526|FG001|Overall Study|SVR12 Assessment|1|||
33512854|NCT01447446|101773527|FG002|Overall Study|SVR12 Assessment|2|||
33512855|NCT01447446|101773528|FG003|Overall Study|SVR12 Assessment|1|||
33512856|NCT01447446|101773529|FG004|Overall Study|SVR12 Assessment|5|||
33512857|NCT01447446|101773530|FG005|Overall Study|SVR12 Assessment|5|||
33512858|NCT01447446|101773525|FG000|Overall Study|New Treatment Started|8|||
33512859|NCT01447446|101773526|FG001|Overall Study|New Treatment Started|2|||
33512860|NCT01447446|101773527|FG002|Overall Study|New Treatment Started|1|||
33512861|NCT01447446|101773528|FG003|Overall Study|New Treatment Started|0|||
33512862|NCT01447446|101773529|FG004|Overall Study|New Treatment Started|2|||
33512863|NCT01447446|101773530|FG005|Overall Study|New Treatment Started|0|||
33512864|NCT01447446|101773525|FG000|Overall Study|Reason not Specified|1|||
33512865|NCT01447446|101773526|FG001|Overall Study|Reason not Specified|1|||
33512866|NCT01447446|101773527|FG002|Overall Study|Reason not Specified|1|||
33512867|NCT01447446|101773528|FG003|Overall Study|Reason not Specified|1|||
33512868|NCT01447446|101773529|FG004|Overall Study|Reason not Specified|1|||
33512869|NCT01447446|101773530|FG005|Overall Study|Reason not Specified|0|||
33512870|NCT04325698|101773531|FG000|Overall Study|Study Terminated By Sponsor|1|||
33512871|NCT04325698|101773532|FG001|Overall Study|Study Terminated By Sponsor|1|||
33512872|NCT04325698|101773531|FG000|Overall Study|Withdrawal by Subject|0|||
33512873|NCT04325698|101773532|FG001|Overall Study|Withdrawal by Subject|2|||
33512874|NCT01154088|101773533|FG000|Overall Study|Lost to Follow-up|4|||
33198729|NCT01709318|100630617|FG003|Overall Study|Lost to Follow-up|0|||
33198730|NCT01709318|100630618|FG004|Overall Study|Lost to Follow-up|1|||
33512875|NCT01154088|101773534|FG001|Overall Study|Lost to Follow-up|6|||
33512876|NCT01154088|101773535|FG002|Overall Study|Lost to Follow-up|7|||
33512877|NCT03535740|101773536|FG000|Overall Study|Ongoing at Data Cut-off Date: 30 September 2020|55|||
33512878|NCT03535740|101773536|FG000|Overall Study|Death|34|||
33512879|NCT03535740|101773536|FG000|Overall Study|Lost to Follow-up|1|||
33606288|NCT03281304|102108301|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
33512880|NCT03535740|101773536|FG000|Overall Study|Withdrawal by Subject|13|||
33512881|NCT04506905|101773537|FG000|Overall Study|Lost to Follow-up|1|||
33512882|NCT04506905|101773538|FG001|Overall Study|Lost to Follow-up|0|||
33512883|NCT04506905|101773539|FG002|Overall Study|Lost to Follow-up|0|||
33512884|NCT04506905|101773540|FG003|Overall Study|Lost to Follow-up|1|||
33606289|NCT03281304|102108302|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
33198731|NCT01709318|100630619|FG005|Overall Study|Lost to Follow-up|1|||
33324584|NCT00058552|101084757|FG001|Overall Study|Clinical disease progression|4|||
33512885|NCT04506905|101773541|FG004|Overall Study|Lost to Follow-up|0|||
33512886|NCT04506905|101773542|FG005|Overall Study|Lost to Follow-up|0|||
33512887|NCT04506905|101773543|FG006|Overall Study|Lost to Follow-up|0|||
33512888|NCT04506905|101773544|FG007|Overall Study|Lost to Follow-up|0|||
33512889|NCT04506905|101773545|FG008|Overall Study|Lost to Follow-up|0|||
33512890|NCT04506905|101773537|FG000|Overall Study|Withdrawal by Subject|0|||
33512891|NCT04506905|101773538|FG001|Overall Study|Withdrawal by Subject|0|||
33512892|NCT04506905|101773539|FG002|Overall Study|Withdrawal by Subject|0|||
33512893|NCT04506905|101773540|FG003|Overall Study|Withdrawal by Subject|2|||
33512894|NCT04506905|101773541|FG004|Overall Study|Withdrawal by Subject|0|||
33512895|NCT04506905|101773542|FG005|Overall Study|Withdrawal by Subject|0|||
33606290|NCT03281304|102108301|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
33606291|NCT03281304|102108302|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
33606292|NCT03281304|102108301|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
33324585|NCT01553188|101084758|FG000|Overall Study|Patient choice|1|||
33324586|NCT01553188|101084759|FG001|Overall Study|Patient choice|0|||
33324587|NCT01553188|101084760|FG002|Overall Study|Patient choice|0|||
33606293|NCT03281304|102108302|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
33606294|NCT03281304|102108301|FG000|Treatment Phase (up to 42 Months)|Death|0|||
33606295|NCT03281304|102108302|FG001|Treatment Phase (up to 42 Months)|Death|1|||
33606296|NCT03281304|102108301|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
33606297|NCT03281304|102108302|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
33606298|NCT03281304|102108301|FG000|Treatment Phase (up to 42 Months)|Other|0|||
33606299|NCT03281304|102108302|FG001|Treatment Phase (up to 42 Months)|Other|2|||
33606300|NCT03281304|102108301|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
33606301|NCT03281304|102108302|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
33198732|NCT01709318|100630620|FG006|Overall Study|Lost to Follow-up|1|||
33324588|NCT01553188|101084761|FG003|Overall Study|Patient choice|0|||
33324589|NCT01553188|101084758|FG000|Overall Study|Intercurrent illness and adverse event|0|||
33324590|NCT01553188|101084759|FG001|Overall Study|Intercurrent illness and adverse event|1|||
33324591|NCT01553188|101084760|FG002|Overall Study|Intercurrent illness and adverse event|2|||
33324592|NCT01553188|101084761|FG003|Overall Study|Intercurrent illness and adverse event|0|||
33324593|NCT02448225|101084762|FG000|Overall Study|Withdrawal by Subject|1|||
33324594|NCT02448225|101084762|FG000|Overall Study|Did not get FSPG scan|18|||
33324595|NCT02448225|101084762|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
33324596|NCT01086410|101084763|FG000|Overall Study|Adverse Event|1|||
33324597|NCT01086410|101084764|FG001|Overall Study|Adverse Event|0|||
33324598|NCT01086410|101084765|FG002|Overall Study|Adverse Event|0|||
33324599|NCT01086410|101084766|FG003|Overall Study|Adverse Event|2|||
33324600|NCT01086410|101084763|FG000|Overall Study|Lack of Efficacy|1|||
33324601|NCT01086410|101084764|FG001|Overall Study|Lack of Efficacy|1|||
33324602|NCT01086410|101084765|FG002|Overall Study|Lack of Efficacy|0|||
33324603|NCT01086410|101084766|FG003|Overall Study|Lack of Efficacy|0|||
33324604|NCT01086410|101084763|FG000|Overall Study|Protocol Violation|1|||
33324605|NCT01086410|101084764|FG001|Overall Study|Protocol Violation|1|||
33324606|NCT01086410|101084765|FG002|Overall Study|Protocol Violation|0|||
33324607|NCT01086410|101084766|FG003|Overall Study|Protocol Violation|0|||
33324608|NCT01086410|101084763|FG000|Overall Study|Lost to Follow-up|0|||
33324609|NCT01086410|101084764|FG001|Overall Study|Lost to Follow-up|0|||
33324610|NCT01086410|101084765|FG002|Overall Study|Lost to Follow-up|1|||
33324611|NCT01086410|101084766|FG003|Overall Study|Lost to Follow-up|0|||
33324612|NCT02739620|101084773|FG000|Overall Study|Lost to Follow-up|3|||
33324613|NCT02739620|101084774|FG001|Overall Study|Lost to Follow-up|1|||
33324614|NCT02739620|101084773|FG000|Overall Study|Adverse Event|0|||
33324615|NCT02739620|101084774|FG001|Overall Study|Adverse Event|1|||
33324616|NCT04353596|101084780|FG000|Overall Study|Protocol Violation|4|||
33512896|NCT04506905|101773543|FG006|Overall Study|Withdrawal by Subject|0|||
33512897|NCT04506905|101773544|FG007|Overall Study|Withdrawal by Subject|0|||
33512898|NCT04506905|101773545|FG008|Overall Study|Withdrawal by Subject|0|||
33606302|NCT00558272|102108303|FG000|Overall Study|Adverse Event|10|||
33606303|NCT00558272|102108304|FG001|Overall Study|Adverse Event|0|||
33606304|NCT00558272|102108303|FG000|Overall Study|Death|1|||
33606305|NCT00558272|102108304|FG001|Overall Study|Death|0|||
33324617|NCT04353596|101084781|FG001|Overall Study|Protocol Violation|4|||
33512899|NCT02658734|101773547|FG000|Overall Study|Adverse Event|2|||
33606306|NCT00558272|102108303|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
33606307|NCT00558272|102108304|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
33606308|NCT00558272|102108303|FG000|Overall Study|AZ study team decision|0|||
33606309|NCT00558272|102108304|FG001|Overall Study|AZ study team decision|1|||
33198733|NCT01709318|100630614|FG000|Overall Study|Non-compliance with Study Drug|0|||
33198734|NCT01709318|100630615|FG001|Overall Study|Non-compliance with Study Drug|2|||
33198735|NCT01709318|100630616|FG002|Overall Study|Non-compliance with Study Drug|1|||
33324618|NCT04353596|101084780|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
33324619|NCT04353596|101084781|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
33324620|NCT02217436|101084782|FG000|Overall Study|Protocol Violation|1|||
33606310|NCT00558272|102108303|FG000|Overall Study|Incorrectly enrolled|1|||
33606311|NCT00558272|102108304|FG001|Overall Study|Incorrectly enrolled|0|||
33606312|NCT00558272|102108303|FG000|Overall Study|Withdrawal by Subject|0|||
33606313|NCT00558272|102108304|FG001|Overall Study|Withdrawal by Subject|1|||
33606314|NCT03101085|102108305|FG000|Overall Study|Lost to Follow-up|0|||
33606315|NCT03101085|102108306|FG001|Overall Study|Lost to Follow-up|1|||
33606316|NCT00257660|102108307|FG000|Overall Study|Lack of Efficacy|5|||
33606317|NCT00257660|102108308|FG001|Overall Study|Lack of Efficacy|23|||
33324621|NCT02217436|101084783|FG001|Overall Study|Protocol Violation|1|||
33324622|NCT02217436|101084782|FG000|Overall Study|Incomplete data|0|||
33324623|NCT02217436|101084783|FG001|Overall Study|Incomplete data|1|||
33324624|NCT01519765|101084785|FG000|Overall Study|Adverse Event|0|||
33324625|NCT01519765|101084786|FG001|Overall Study|Adverse Event|1|||
33324626|NCT01519765|101084785|FG000|Overall Study|Lack of Efficacy|2|||
33324627|NCT01519765|101084786|FG001|Overall Study|Lack of Efficacy|0|||
33399101|NCT02394028|101350185|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
33399102|NCT02394028|101350175|FG000|Induction Phase|Sponsor decision|0|||
33399103|NCT02394028|101350176|FG001|Induction Phase|Sponsor decision|1|||
33399104|NCT02394028|101350177|FG002|Induction Phase|Sponsor decision|2|||
33399105|NCT02394028|101350178|FG003|Induction Phase|Sponsor decision|0|||
33606318|NCT00257660|102108307|FG000|Overall Study|Withdrawal by Subject|2|||
33606319|NCT00257660|102108308|FG001|Overall Study|Withdrawal by Subject|0|||
33606320|NCT00257660|102108307|FG000|Overall Study|Lost to Follow-up|1|||
33324628|NCT01519765|101084785|FG000|Overall Study|Protocol Violation|1|||
33324629|NCT01519765|101084786|FG001|Overall Study|Protocol Violation|0|||
33324630|NCT01519765|101084785|FG000|Overall Study|Withdrawal by Subject|0|||
33606321|NCT00257660|102108308|FG001|Overall Study|Lost to Follow-up|0|||
33606322|NCT00257660|102108307|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
33606323|NCT00257660|102108308|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
33606324|NCT00257660|102108307|FG000|Overall Study|No longer wanted to do blood draws|1|||
33606325|NCT00257660|102108308|FG001|Overall Study|No longer wanted to do blood draws|0|||
33606326|NCT00590577|102108309|FG000|Overall Study|Lack of Efficacy|31|||
33606327|NCT00590577|102108310|FG001|Overall Study|Lack of Efficacy|28|||
33606328|NCT00590577|102108311|FG002|Overall Study|Lack of Efficacy|23|||
33606329|NCT00590577|102108312|FG003|Overall Study|Lack of Efficacy|45|||
33606330|NCT00590577|102108309|FG000|Overall Study|Withdrawal by Subject|23|||
33606331|NCT00590577|102108310|FG001|Overall Study|Withdrawal by Subject|28|||
33324631|NCT01519765|101084786|FG001|Overall Study|Withdrawal by Subject|1|||
33324632|NCT00283049|101084792|FG000|Overall Study|Adverse Event|6|||
33324633|NCT00283049|101084793|FG001|Overall Study|Adverse Event|1|||
33324634|NCT00283049|101084794|FG002|Overall Study|Adverse Event|4|||
33324635|NCT00283049|101084792|FG000|Overall Study|Protocol Violation|3|||
33399106|NCT02394028|101350179|FG004|Induction Phase|Sponsor decision|0|||
33399107|NCT02394028|101350180|FG005|Induction Phase|Sponsor decision|0|||
33606332|NCT00590577|102108311|FG002|Overall Study|Withdrawal by Subject|30|||
33606333|NCT00590577|102108312|FG003|Overall Study|Withdrawal by Subject|26|||
33606334|NCT00590577|102108309|FG000|Overall Study|Adverse Event|10|||
33606335|NCT00590577|102108310|FG001|Overall Study|Adverse Event|10|||
33512900|NCT02658734|101773547|FG000|Overall Study|Death|4|||
33512901|NCT02658734|101773547|FG000|Overall Study|Lost to Follow-up|7|||
33512902|NCT02658734|101773547|FG000|Overall Study|Withdrawal of Consent|16|||
33512903|NCT02658734|101773547|FG000|Overall Study|Disease Progression|28|||
33512904|NCT01867294|101773548|FG000|Overall Study|Withdrawal by Subject|1|||
33512905|NCT01867294|101773549|FG001|Overall Study|Withdrawal by Subject|1|||
33512906|NCT01867294|101773550|FG002|Overall Study|Withdrawal by Subject|0|||
33512907|NCT01867294|101773551|FG003|Overall Study|Withdrawal by Subject|0|||
33512908|NCT00654875|101773552|FG000|Overall Study|Adverse Event|5|||
33512909|NCT00654875|101773553|FG001|Overall Study|Adverse Event|5|||
33512910|NCT00654875|101773552|FG000|Overall Study|Withdrawal by Subject|4|||
33512911|NCT00654875|101773553|FG001|Overall Study|Withdrawal by Subject|4|||
33512912|NCT00654875|101773552|FG000|Overall Study|Protocol Violation|3|||
33512913|NCT00654875|101773553|FG001|Overall Study|Protocol Violation|3|||
33512914|NCT00654875|101773552|FG000|Overall Study|Lack of Efficacy|2|||
33512915|NCT00654875|101773553|FG001|Overall Study|Lack of Efficacy|2|||
33512916|NCT00654875|101773552|FG000|Overall Study|Lost to Follow-up|1|||
33512917|NCT00654875|101773553|FG001|Overall Study|Lost to Follow-up|3|||
33512918|NCT00654875|101773552|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
33512919|NCT00654875|101773553|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
33512920|NCT00654875|101773552|FG000|Overall Study|Administrative Problems|1|||
33512921|NCT00654875|101773553|FG001|Overall Study|Administrative Problems|0|||
33512922|NCT03692325|101773554|FG000|Overall Study|Adverse Event|2|||
33512923|NCT03692325|101773554|FG000|Overall Study|Progression/Recurrence|2|||
33512924|NCT03721835|101773555|FG000|Overall Study|Participant not able to return|1|||
33512925|NCT03721835|101773555|FG000|Overall Study|Lost to Follow-up|1|||
33512926|NCT03721835|101773555|FG000|Overall Study|Revision of the components of the study device|2|||
33512927|NCT03721835|101773555|FG000|Overall Study|Sponsor terminated study|6|||
33512928|NCT03721835|101773555|FG000|Overall Study|Death|1|||
33512929|NCT03721835|101773555|FG000|Overall Study|Sponsor decision|1|||
33512930|NCT01438294|101773556|FG000|Overall Study|Lost to Follow-up|3|||
33512931|NCT01438294|101773557|FG001|Overall Study|Lost to Follow-up|7|||
33512932|NCT00546117|101773558|FG000|Overall Study|Withdrawal by Subject|3|||
33512933|NCT00546117|101773559|FG001|Overall Study|Withdrawal by Subject|0|||
33512934|NCT00546117|101773558|FG000|Overall Study|Inability to schedule follow-up visit|1|||
33512935|NCT00546117|101773559|FG001|Overall Study|Inability to schedule follow-up visit|0|||
33512936|NCT00474786|101773560|FG000|Overall Study|Not Meeting Study Criteria|0|||
33512937|NCT00474786|101773561|FG001|Overall Study|Not Meeting Study Criteria|1|||
33512938|NCT00474786|101773560|FG000|Overall Study|Investigator Request|2|||
33512939|NCT00474786|101773561|FG001|Overall Study|Investigator Request|1|||
33512940|NCT00474786|101773560|FG000|Overall Study|Death|189|||
33512941|NCT00474786|101773561|FG001|Overall Study|Death|170|||
33512942|NCT00474786|101773560|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
33512943|NCT00474786|101773561|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
33512944|NCT00474786|101773560|FG000|Overall Study|Lost to Follow-up|4|||
33512945|NCT00474786|101773561|FG001|Overall Study|Lost to Follow-up|7|||
33512946|NCT00474786|101773560|FG000|Overall Study|Protocol Violation|2|||
33512947|NCT00474786|101773561|FG001|Overall Study|Protocol Violation|0|||
33512948|NCT00474786|101773560|FG000|Overall Study|Withdrawal by Subject|15|||
33512949|NCT00474786|101773561|FG001|Overall Study|Withdrawal by Subject|15|||
33512950|NCT00474786|101773560|FG000|Overall Study|Other|5|||
33512951|NCT00474786|101773561|FG001|Overall Study|Other|0|||
33512952|NCT04114357|101773566|FG000|Baseline-Randomization|Adverse Event|2|||
33512953|NCT04114357|101773567|FG001|Baseline-Randomization|Adverse Event|1|||
33399108|NCT02394028|101350181|FG006|Induction Phase|Sponsor decision|0|||
33512954|NCT04114357|101773566|FG000|Baseline-Randomization|Lost to Follow-up|1|||
33606336|NCT00590577|102108311|FG002|Overall Study|Adverse Event|13|||
33399109|NCT02394028|101350182|FG007|Induction Phase|Sponsor decision|0|||
33606337|NCT00590577|102108312|FG003|Overall Study|Adverse Event|11|||
33606338|NCT00590577|102108309|FG000|Overall Study|Lost to Follow-up|12|||
33606339|NCT00590577|102108310|FG001|Overall Study|Lost to Follow-up|6|||
33606340|NCT00590577|102108311|FG002|Overall Study|Lost to Follow-up|6|||
33606341|NCT00590577|102108312|FG003|Overall Study|Lost to Follow-up|9|||
33606342|NCT00590577|102108309|FG000|Overall Study|Pregnancy|0|||
33606343|NCT00590577|102108310|FG001|Overall Study|Pregnancy|1|||
33606344|NCT00590577|102108311|FG002|Overall Study|Pregnancy|0|||
33606345|NCT00590577|102108312|FG003|Overall Study|Pregnancy|0|||
33606346|NCT00590577|102108309|FG000|Overall Study|Various reasons|1|||
33606347|NCT00590577|102108310|FG001|Overall Study|Various reasons|3|||
33606348|NCT00590577|102108311|FG002|Overall Study|Various reasons|1|||
33606349|NCT00590577|102108312|FG003|Overall Study|Various reasons|2|||
33606350|NCT00118430|102108313|FG000|Overall Study|Withdrawal by Subject|6|||
33606351|NCT00118430|102108314|FG001|Overall Study|Withdrawal by Subject|2|||
33606352|NCT00118430|102108315|FG002|Overall Study|Withdrawal by Subject|0|||
33606353|NCT00118430|102108313|FG000|Overall Study|Lost to Follow-up|15|||
33606354|NCT00118430|102108314|FG001|Overall Study|Lost to Follow-up|22|||
33606355|NCT00118430|102108315|FG002|Overall Study|Lost to Follow-up|28|||
33606356|NCT01966445|102108317|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
33606357|NCT01966445|102108318|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
33606358|NCT01966445|102108319|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
33606359|NCT01966445|102108320|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
33606360|NCT01966445|102108321|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
33606361|NCT01966445|102108322|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
33606362|NCT01966445|102108323|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
33606363|NCT01966445|102108317|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
33606364|NCT01966445|102108318|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
33606365|NCT01966445|102108319|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
33606366|NCT01966445|102108320|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
33606367|NCT01966445|102108321|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
33606368|NCT01966445|102108322|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
33399110|NCT02394028|101350183|FG008|Induction Phase|Sponsor decision|0|||
33606369|NCT01966445|102108323|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
33606370|NCT01966445|102108317|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
33606371|NCT01966445|102108318|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
33512955|NCT04114357|101773567|FG001|Baseline-Randomization|Lost to Follow-up|1|||
33512956|NCT04114357|101773566|FG000|Cross-over|Adverse Event|0|||
33512957|NCT04114357|101773567|FG001|Cross-over|Adverse Event|1|||
33512958|NCT04972968|101773568|FG000|Overall Study|Adverse Event|3|||
33512959|NCT04972968|101773569|FG001|Overall Study|Adverse Event|1|||
33512960|NCT04972968|101773570|FG002|Overall Study|Adverse Event|1|||
33606372|NCT01966445|102108319|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
33198736|NCT01709318|100630617|FG003|Overall Study|Non-compliance with Study Drug|1|||
33198737|NCT01709318|100630618|FG004|Overall Study|Non-compliance with Study Drug|0|||
33512961|NCT04972968|101773571|FG003|Overall Study|Adverse Event|7|||
33512962|NCT04972968|101773568|FG000|Overall Study|Lack of Efficacy|2|||
33512963|NCT04972968|101773569|FG001|Overall Study|Lack of Efficacy|1|||
33512964|NCT04972968|101773570|FG002|Overall Study|Lack of Efficacy|0|||
33512965|NCT04972968|101773571|FG003|Overall Study|Lack of Efficacy|0|||
33512966|NCT04972968|101773568|FG000|Overall Study|Withdrawal by Subject|7|||
33512967|NCT04972968|101773569|FG001|Overall Study|Withdrawal by Subject|4|||
33512968|NCT04972968|101773570|FG002|Overall Study|Withdrawal by Subject|3|||
33512969|NCT04972968|101773571|FG003|Overall Study|Withdrawal by Subject|2|||
33512970|NCT04972968|101773568|FG000|Overall Study|Study Terminated by Sponsor|25|||
33512971|NCT04972968|101773569|FG001|Overall Study|Study Terminated by Sponsor|28|||
33512972|NCT04972968|101773570|FG002|Overall Study|Study Terminated by Sponsor|32|||
33512973|NCT04972968|101773571|FG003|Overall Study|Study Terminated by Sponsor|27|||
33512974|NCT04972968|101773568|FG000|Overall Study|Other|1|||
33512975|NCT04972968|101773569|FG001|Overall Study|Other|0|||
33512976|NCT04972968|101773570|FG002|Overall Study|Other|1|||
33512977|NCT04972968|101773571|FG003|Overall Study|Other|1|||
33512978|NCT02589522|101773572|FG000|Overall Study|Physician Decision|1|||
33512979|NCT02589522|101773573|FG001|Overall Study|Physician Decision|2|||
33512980|NCT02589522|101773574|FG002|Overall Study|Physician Decision|0|||
33512981|NCT02589522|101773572|FG000|Overall Study|Did not start treatment|1|||
33512982|NCT02589522|101773573|FG001|Overall Study|Did not start treatment|0|||
33512983|NCT02589522|101773574|FG002|Overall Study|Did not start treatment|0|||
33512984|NCT03602391|101773575|FG000|Overall Study|COVID-19|7|||
33512985|NCT03602391|101773576|FG001|Overall Study|COVID-19|6|||
33512986|NCT01730534|101773577|FG000|Overall Study|Withdrawal by Subject|97|||
33512987|NCT01730534|101773578|FG001|Overall Study|Withdrawal by Subject|127|||
33512988|NCT01730534|101773577|FG000|Overall Study|Lost to Follow-up|12|||
33512989|NCT01730534|101773578|FG001|Overall Study|Lost to Follow-up|18|||
33512990|NCT01104246|101773583|FG000|Overall Study|Withdrawal by Subject|1|||
33512991|NCT01104246|101773583|FG000|Overall Study|did not meet inclusion criteria|4|||
33512992|NCT05397171|101773585|FG000|Overall Study|Death|2|||
33512993|NCT05397171|101773586|FG001|Overall Study|Death|3|||
33512994|NCT05397171|101773587|FG002|Overall Study|Death|3|||
33512995|NCT05397171|101773585|FG000|Overall Study|Study Terminated By Sponsor|1|||
33512996|NCT05397171|101773586|FG001|Overall Study|Study Terminated By Sponsor|2|||
33512997|NCT05397171|101773587|FG002|Overall Study|Study Terminated By Sponsor|3|||
33512998|NCT05397171|101773585|FG000|Overall Study|Withdrawal by Subject|0|||
33512999|NCT05397171|101773586|FG001|Overall Study|Withdrawal by Subject|1|||
33513000|NCT05397171|101773587|FG002|Overall Study|Withdrawal by Subject|1|||
33513001|NCT02499146|101773588|FG000|Overall Study|Lost to Follow-up|1|||
33513002|NCT02499146|101773588|FG000|Overall Study|Withdrawal by Subject|1|||
33513003|NCT02499146|101773588|FG000|Overall Study|Other|2|||
33513004|NCT02499146|101773588|FG000|Overall Study|Ongoing at date of cut-off|9|||
33513005|NCT02499146|101773588|FG000|Overall Study|Began other treatment/therapy|13|||
33513006|NCT02375555|101773589|FG000|Induction Period|Adverse Event|7|||
33513007|NCT02375555|101773589|FG000|Induction Period|Withdrawal by Subject|2|||
33513008|NCT02375555|101773589|FG000|Induction Period|Other|1|||
33513009|NCT02375555|101773589|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
33513010|NCT02375555|101773589|FG000|Maintenance Period|Adverse Event|2|||
33513011|NCT02375555|101773589|FG000|Maintenance Period|Withdrawal by Subject|4|||
33606373|NCT01966445|102108320|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
33513012|NCT02375555|101773589|FG000|Maintenance Period|Death|1|||
33513013|NCT02375555|101773589|FG000|Maintenance Period|Disease Progression|5|||
33198738|NCT01709318|100630619|FG005|Overall Study|Non-compliance with Study Drug|0|||
33513014|NCT02375555|101773589|FG000|Maintenance Period|Patient Non-compliance|1|||
33513015|NCT02375555|101773589|FG000|Maintenance Period|Still on maintenance|16|||
33513016|NCT02407457|101773590|FG000|1 Month|Death|3|||
33513017|NCT02407457|101773591|FG001|1 Month|Death|0|||
33513018|NCT02407457|101773590|FG000|1 Month|Lost to Follow-up|1|||
33513019|NCT02407457|101773591|FG001|1 Month|Lost to Follow-up|1|||
33513020|NCT02407457|101773590|FG000|1 Month|missed visit|2|||
33513021|NCT02407457|101773591|FG001|1 Month|missed visit|5|||
33513022|NCT02407457|101773590|FG000|6-Month|Death|2|||
33513023|NCT02407457|101773591|FG001|6-Month|Death|8|||
33513024|NCT02407457|101773590|FG000|6-Month|Lost to Follow-up|2|||
33513025|NCT02407457|101773591|FG001|6-Month|Lost to Follow-up|2|||
33513026|NCT02407457|101773590|FG000|6-Month|missed visit|16|||
33513027|NCT02407457|101773591|FG001|6-Month|missed visit|14|||
33513028|NCT02407457|101773590|FG000|6-Month|Open Repair|0|||
33513029|NCT02407457|101773591|FG001|6-Month|Open Repair|1|||
33513030|NCT02407457|101773590|FG000|1 Year|Death|6|||
33513031|NCT02407457|101773591|FG001|1 Year|Death|11|||
33513032|NCT02407457|101773590|FG000|1 Year|Lost to Follow-up|3|||
33513033|NCT02407457|101773591|FG001|1 Year|Lost to Follow-up|2|||
33513034|NCT02407457|101773590|FG000|1 Year|Missed Visit|24|||
33513035|NCT02407457|101773591|FG001|1 Year|Missed Visit|14|||
33513036|NCT02407457|101773590|FG000|1 Year|Open Repair|0|||
33513037|NCT02407457|101773591|FG001|1 Year|Open Repair|1|||
33513038|NCT02407457|101773590|FG000|2-year|Death|14|||
33513039|NCT02407457|101773591|FG001|2-year|Death|8|||
33513040|NCT02407457|101773590|FG000|2-year|Lost to Follow-up|7|||
33513041|NCT02407457|101773591|FG001|2-year|Lost to Follow-up|10|||
33513042|NCT02407457|101773590|FG000|2-year|Missed Visit|13|||
33513043|NCT02407457|101773591|FG001|2-year|Missed Visit|15|||
33513044|NCT02407457|101773590|FG000|2-year|Open Repair|0|||
33513045|NCT02407457|101773591|FG001|2-year|Open Repair|2|||
33513046|NCT02407457|101773590|FG000|3-year|Death|11|||
33513047|NCT02407457|101773591|FG001|3-year|Death|10|||
33513048|NCT02407457|101773590|FG000|3-year|Lost to Follow-up|9|||
33513049|NCT02407457|101773591|FG001|3-year|Lost to Follow-up|10|||
33513050|NCT02407457|101773590|FG000|3-year|Missed Visit|19|||
33513051|NCT02407457|101773591|FG001|3-year|Missed Visit|16|||
33513052|NCT02407457|101773590|FG000|4-year|Death|18|||
33606374|NCT01966445|102108321|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
33606375|NCT01966445|102108322|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
33606376|NCT01966445|102108323|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
33606377|NCT01966445|102108317|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
33606378|NCT01966445|102108318|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
33606379|NCT01966445|102108319|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
33606380|NCT01966445|102108320|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
33606381|NCT01966445|102108321|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
33606382|NCT01966445|102108322|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
33606383|NCT01966445|102108323|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
33606384|NCT01966445|102108317|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
33606385|NCT01966445|102108318|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
33606386|NCT01966445|102108319|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
33606387|NCT01966445|102108320|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
33606388|NCT01966445|102108321|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
33606389|NCT01966445|102108322|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
33606390|NCT01966445|102108323|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
33606391|NCT03834220|102108327|FG000|Overall Study|Adverse Event|1|||
33606392|NCT03834220|102108328|FG001|Overall Study|Adverse Event|0|||
33606393|NCT03834220|102108329|FG002|Overall Study|Adverse Event|0|||
33606394|NCT03834220|102108327|FG000|Overall Study|Death|8|||
33606395|NCT03834220|102108328|FG001|Overall Study|Death|1|||
33606396|NCT03834220|102108329|FG002|Overall Study|Death|17|||
33606397|NCT03834220|102108327|FG000|Overall Study|Reason not Specified|9|||
33513053|NCT02407457|101773591|FG001|4-year|Death|10|||
33513054|NCT02407457|101773590|FG000|4-year|Lost to Follow-up|10|||
33513055|NCT02407457|101773591|FG001|4-year|Lost to Follow-up|12|||
33513056|NCT02407457|101773590|FG000|4-year|Missed Visit|18|||
33513057|NCT02407457|101773591|FG001|4-year|Missed Visit|16|||
33513058|NCT02407457|101773590|FG000|5-year|Death|10|||
33513059|NCT02407457|101773591|FG001|5-year|Death|3|||
33513060|NCT02407457|101773590|FG000|5-year|Lost to Follow-up|22|||
33513061|NCT02407457|101773591|FG001|5-year|Lost to Follow-up|13|||
33513062|NCT02407457|101773590|FG000|5-year|Missed Visit|9|||
33513063|NCT02407457|101773591|FG001|5-year|Missed Visit|1|||
33606398|NCT03834220|102108328|FG001|Overall Study|Reason not Specified|0|||
33513064|NCT04598451|101773592|FG000|Overall Study|Adverse Event|3|||
33513065|NCT04598451|101773593|FG001|Overall Study|Adverse Event|2|||
33513066|NCT04598451|101773592|FG000|Overall Study|Withdrawal by Subject|3|||
33606399|NCT03834220|102108329|FG002|Overall Study|Reason not Specified|6|||
33513067|NCT04598451|101773593|FG001|Overall Study|Withdrawal by Subject|7|||
33513068|NCT04598451|101773592|FG000|Overall Study|Lost to Follow-up|2|||
33513069|NCT04598451|101773593|FG001|Overall Study|Lost to Follow-up|0|||
33513070|NCT04598451|101773592|FG000|Overall Study|Physician Decision|4|||
33513071|NCT04598451|101773593|FG001|Overall Study|Physician Decision|1|||
33513072|NCT04598451|101773592|FG000|Overall Study|Requires Prohibited Medication|1|||
33513073|NCT04598451|101773593|FG001|Overall Study|Requires Prohibited Medication|0|||
33513074|NCT04598451|101773592|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
33513075|NCT04598451|101773593|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
33513076|NCT00514904|101773598|FG000|Overall Study|Withdrawal by Subject|3|||
33513077|NCT00514904|101773599|FG001|Overall Study|Withdrawal by Subject|2|||
33513078|NCT00514904|101773598|FG000|Overall Study|Lost to Follow-up|21|||
33513079|NCT00514904|101773599|FG001|Overall Study|Lost to Follow-up|3|||
33513080|NCT02703272|101773603|FG000|Overall Study|Death|4|||
33513081|NCT02703272|101773604|FG001|Overall Study|Death|9|||
33513082|NCT02703272|101773605|FG002|Overall Study|Death|19|||
33513083|NCT02703272|101773606|FG003|Overall Study|Death|10|||
33513084|NCT02703272|101773603|FG000|Overall Study|Withdrawal by Subject|0|||
33513085|NCT02703272|101773604|FG001|Overall Study|Withdrawal by Subject|0|||
33513086|NCT02703272|101773605|FG002|Overall Study|Withdrawal by Subject|4|||
33513087|NCT02703272|101773606|FG003|Overall Study|Withdrawal by Subject|2|||
33513088|NCT02703272|101773603|FG000|Overall Study|Study Terminated by Sponsor|6|||
33606400|NCT03834220|102108327|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
33606401|NCT03834220|102108328|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
33606402|NCT03834220|102108329|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
33606403|NCT03834220|102108327|FG000|Overall Study|Withdrawal of Consent|2|||
33606404|NCT03834220|102108328|FG001|Overall Study|Withdrawal of Consent|2|||
33606405|NCT03834220|102108329|FG002|Overall Study|Withdrawal of Consent|2|||
33606406|NCT02437084|102108330|FG000|Overall Study|Withdrawal by Subject|2|||
33606407|NCT02437084|102108330|FG000|Overall Study|Physician Decision|1|||
33606408|NCT00881504|102108333|FG000|Overall Study|Withdrawal by Subject|1|||
33606409|NCT01895309|102108334|FG000|Overall Study|Adverse Event|13|||
33606410|NCT01895309|102108335|FG001|Overall Study|Adverse Event|17|||
33606411|NCT01895309|102108334|FG000|Overall Study|Protocol Violation|1|||
33606412|NCT01895309|102108335|FG001|Overall Study|Protocol Violation|0|||
33606413|NCT01895309|102108334|FG000|Overall Study|Lack of Efficacy|1|||
33606414|NCT01895309|102108335|FG001|Overall Study|Lack of Efficacy|3|||
33606415|NCT01895309|102108334|FG000|Overall Study|Lost to Follow-up|1|||
33606416|NCT01895309|102108335|FG001|Overall Study|Lost to Follow-up|3|||
33606417|NCT01895309|102108334|FG000|Overall Study|Physician Decision|15|||
33606418|NCT01895309|102108335|FG001|Overall Study|Physician Decision|10|||
33606419|NCT01895309|102108334|FG000|Overall Study|Withdrawal by Subject|9|||
33606420|NCT01895309|102108335|FG001|Overall Study|Withdrawal by Subject|18|||
33606421|NCT00490776|102108338|FG000|Overall Study|Withdrawal by Subject|1|||
33606422|NCT00490776|102108338|FG000|Overall Study|Administrative Problems|1|||
33606423|NCT00490776|102108338|FG000|Overall Study|Death|1|||
33606424|NCT00490776|102108338|FG000|Overall Study|New Cancer Therapy|1|||
33606425|NCT00490776|102108338|FG000|Overall Study|Disease Progression|5|||
33606426|NCT00727558|102108339|FG000|Overall Study|Lens issue|0|||
33606427|NCT00727558|102108340|FG001|Overall Study|Lens issue|1|||
33606428|NCT00727558|102108339|FG000|Overall Study|Adverse Event|0|||
33606429|NCT00727558|102108340|FG001|Overall Study|Adverse Event|1|||
33606430|NCT00727558|102108339|FG000|Overall Study|Subject unable to return for follow-up|1|||
33606431|NCT00727558|102108340|FG001|Overall Study|Subject unable to return for follow-up|1|||
33606432|NCT00727558|102108339|FG000|Overall Study|Lost to Follow-up|1|||
33606433|NCT00727558|102108340|FG001|Overall Study|Lost to Follow-up|0|||
33606434|NCT03664765|102108341|FG000|Overall Study|Withdrawal by Subject|4|||
33606435|NCT03664765|102108342|FG001|Overall Study|Withdrawal by Subject|1|||
33606436|NCT03664765|102108341|FG000|Overall Study|Lost to Follow-up|0|||
33606437|NCT03664765|102108342|FG001|Overall Study|Lost to Follow-up|1|||
33606438|NCT00708734|102108346|FG000|Overall Study|scheduling conflict|2|||
33606439|NCT00708734|102108346|FG000|Overall Study|moved|1|||
33513089|NCT02703272|101773604|FG001|Overall Study|Study Terminated by Sponsor|1|||
33513090|NCT02703272|101773605|FG002|Overall Study|Study Terminated by Sponsor|12|||
33513091|NCT02703272|101773606|FG003|Overall Study|Study Terminated by Sponsor|4|||
33513092|NCT02703272|101773603|FG000|Overall Study|Other|1|||
33606440|NCT00708734|102108346|FG000|Overall Study|leg injury|1|||
33606441|NCT00708734|102108346|FG000|Overall Study|knee replacement|1|||
33606442|NCT00708734|102108346|FG000|Overall Study|vertigo|1|||
33606443|NCT00708734|102108346|FG000|Overall Study|leg fracture|1|||
33606444|NCT01220180|102108347|FG000|Overall Study|Lost to Follow-up|76|||
33606445|NCT01220180|102108347|FG000|Overall Study|Other|72|||
33606446|NCT01220180|102108347|FG000|Overall Study|Adverse Event|35|||
33606447|NCT01220180|102108347|FG000|Overall Study|Lack of Efficacy|22|||
33606448|NCT01220180|102108347|FG000|Overall Study|Death|1|||
33606449|NCT01220180|102108347|FG000|Overall Study|Randomized but not treated|1|||
33606450|NCT02760810|102108348|FG000|Overall Study|Protocol Violation|1|||
33606451|NCT02478255|102108349|FG000|Overall Study|Physician Decision|6|||
33606452|NCT02478255|102108350|FG001|Overall Study|Physician Decision|0|||
33513093|NCT02703272|101773604|FG001|Overall Study|Other|0|||
33513094|NCT02703272|101773605|FG002|Overall Study|Other|0|||
33513095|NCT02703272|101773606|FG003|Overall Study|Other|0|||
33513096|NCT00199797|101773607|FG000|Overall Study|Progressive Disease|1|||
33513097|NCT00199797|101773607|FG000|Overall Study|Adverse Event|1|||
33513098|NCT00199797|101773607|FG000|Overall Study|Physician Decision|1|||
33606453|NCT02478255|102108349|FG000|Overall Study|Withdrawal by Subject|2|||
33606454|NCT02478255|102108350|FG001|Overall Study|Withdrawal by Subject|0|||
33606455|NCT03332160|102108351|FG000|Overall Study|Withdrawal by Subject|1|||
33606456|NCT03332160|102108352|FG001|Overall Study|Withdrawal by Subject|1|||
33606457|NCT03332160|102108351|FG000|Overall Study|Adverse Event|0|||
33606458|NCT03332160|102108352|FG001|Overall Study|Adverse Event|1|||
33606459|NCT03332160|102108351|FG000|Overall Study|Developed Exclusion Criteria|0|||
33513099|NCT04505722|101773610|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
33606460|NCT03332160|102108352|FG001|Overall Study|Developed Exclusion Criteria|1|||
33606461|NCT03332160|102108351|FG000|Overall Study|Non-adherence to treatment|0|||
33606462|NCT03332160|102108352|FG001|Overall Study|Non-adherence to treatment|2|||
33606463|NCT05026853|102108358|FG000|Overall Study|Cancelled appointment|1|||
33606464|NCT05026853|102108359|FG001|Overall Study|Cancelled appointment|0|||
33606465|NCT05026853|102108358|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
33606466|NCT05026853|102108359|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
33606467|NCT05026853|102108358|FG000|Overall Study|Did not complete 12-week survey|16|||
33606468|NCT05026853|102108359|FG001|Overall Study|Did not complete 12-week survey|16|||
33606469|NCT00694304|102108360|FG000|Overall Study|Adverse Event|42|||
33606470|NCT00694304|102108360|FG000|Overall Study|Lack of Efficacy|35|||
33606471|NCT00694304|102108360|FG000|Overall Study|Non-compliance With Study Product|16|||
33606472|NCT00694304|102108360|FG000|Overall Study|Protocol Violation|6|||
33513100|NCT04505722|101773611|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
33513101|NCT04505722|101773612|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
33513102|NCT04505722|101773610|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
33513103|NCT04505722|101773611|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
33513104|NCT04505722|101773612|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
33513105|NCT04505722|101773610|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
33513106|NCT04505722|101773611|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
33513107|NCT04505722|101773612|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
33513108|NCT04505722|101773610|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
33513109|NCT04505722|101773611|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
33513110|NCT04505722|101773612|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
33513111|NCT04505722|101773610|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
33513112|NCT04505722|101773611|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
33513113|NCT04505722|101773612|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
33513114|NCT04505722|101773610|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
33513115|NCT04505722|101773611|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
33513116|NCT04505722|101773612|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
33513117|NCT04505722|101773610|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
33513118|NCT04505722|101773611|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
33513119|NCT04505722|101773612|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
33513120|NCT04505722|101773610|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
33513121|NCT04505722|101773611|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
33513122|NCT04505722|101773612|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
33513123|NCT04505722|101773610|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
33513124|NCT04505722|101773611|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
33513125|NCT04505722|101773612|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
33513126|NCT04505722|101773610|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
33513127|NCT04505722|101773611|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
33513128|NCT04505722|101773612|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
33513129|NCT04505722|101773610|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
33513130|NCT04505722|101773611|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
33513131|NCT04505722|101773612|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
33513132|NCT04505722|101773610|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
33606473|NCT00694304|102108360|FG000|Overall Study|Withdrawal of Consent|61|||
33606474|NCT00694304|102108360|FG000|Overall Study|Lost to Follow-up|15|||
33606475|NCT00694304|102108360|FG000|Overall Study|Administrative or Other Reasons|32|||
33606476|NCT03890367|102108361|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33513133|NCT04505722|101773611|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
33513134|NCT04505722|101773612|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
33324636|NCT00283049|101084793|FG001|Overall Study|Protocol Violation|0|||
33513135|NCT04505722|101773610|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
33513136|NCT04505722|101773611|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
33513137|NCT04505722|101773612|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
33513138|NCT04505722|101773610|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
33513139|NCT04505722|101773611|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
33513140|NCT04505722|101773612|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
33513141|NCT04505722|101773610|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
33513142|NCT04505722|101773611|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
33606477|NCT03890367|102108362|FG001|Overall Study|Withdrawal by parent/guardian|3|||
33606478|NCT03890367|102108363|FG002|Overall Study|Withdrawal by parent/guardian|0|||
33606479|NCT03890367|102108361|FG000|Overall Study|Protocol deviation|2|||
33606480|NCT03890367|102108362|FG001|Overall Study|Protocol deviation|2|||
33606481|NCT03890367|102108363|FG002|Overall Study|Protocol deviation|1|||
33198739|NCT01709318|100630620|FG006|Overall Study|Non-compliance with Study Drug|2|||
33198740|NCT01709318|100630614|FG000|Overall Study|Physician Decision|0|||
33198741|NCT01709318|100630615|FG001|Overall Study|Physician Decision|0|||
33198742|NCT01709318|100630616|FG002|Overall Study|Physician Decision|0|||
33198743|NCT01709318|100630617|FG003|Overall Study|Physician Decision|0|||
33198744|NCT01709318|100630618|FG004|Overall Study|Physician Decision|0|||
33324637|NCT00283049|101084794|FG002|Overall Study|Protocol Violation|3|||
33324638|NCT00283049|101084792|FG000|Overall Study|Death|1|||
33324639|NCT00283049|101084793|FG001|Overall Study|Death|1|||
33324640|NCT00283049|101084794|FG002|Overall Study|Death|1|||
33324641|NCT00283049|101084792|FG000|Overall Study|Lack of Efficacy|0|||
33324642|NCT00283049|101084793|FG001|Overall Study|Lack of Efficacy|1|||
33324643|NCT00283049|101084794|FG002|Overall Study|Lack of Efficacy|1|||
33324644|NCT00283049|101084792|FG000|Overall Study|Lost to Follow-up|4|||
33513143|NCT04505722|101773612|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
33513144|NCT01362244|101773614|FG000|Overall Study|Adverse Event|3|||
33513145|NCT01362244|101773615|FG001|Overall Study|Adverse Event|5|||
33198745|NCT01709318|100630619|FG005|Overall Study|Physician Decision|0|||
33198746|NCT01709318|100630620|FG006|Overall Study|Physician Decision|1|||
33513146|NCT01362244|101773614|FG000|Overall Study|Lack of Efficacy|5|||
33513147|NCT01362244|101773615|FG001|Overall Study|Lack of Efficacy|11|||
33513148|NCT01362244|101773614|FG000|Overall Study|Lost to Follow-up|0|||
33513149|NCT01362244|101773615|FG001|Overall Study|Lost to Follow-up|2|||
33513150|NCT01362244|101773614|FG000|Overall Study|Protocol Violation|5|||
33513151|NCT01362244|101773615|FG001|Overall Study|Protocol Violation|1|||
33513152|NCT01362244|101773614|FG000|Overall Study|Withdrawal by Subject|2|||
33513153|NCT01362244|101773615|FG001|Overall Study|Withdrawal by Subject|1|||
33513154|NCT01362244|101773614|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
33513155|NCT01362244|101773615|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
33513156|NCT01362244|101773614|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
33513157|NCT01362244|101773615|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
33513158|NCT00336024|101773616|FG000|Overall Study|Death|2|||
33513159|NCT00336024|101773617|FG001|Overall Study|Death|1|||
33513160|NCT00336024|101773616|FG000|Overall Study|Physician Decision|4|||
33513161|NCT00336024|101773617|FG001|Overall Study|Physician Decision|1|||
33513162|NCT00336024|101773616|FG000|Overall Study|Protocol Violation|1|||
33513163|NCT00336024|101773617|FG001|Overall Study|Protocol Violation|0|||
33513164|NCT00336024|101773616|FG000|Overall Study|Withdrawal by Subject|1|||
33513165|NCT00336024|101773617|FG001|Overall Study|Withdrawal by Subject|2|||
33513166|NCT00336024|101773616|FG000|Overall Study|Failure to fulfill consolidation|1|||
33513167|NCT00336024|101773617|FG001|Overall Study|Failure to fulfill consolidation|1|||
33513168|NCT00336024|101773616|FG000|Overall Study|Progressive Disease|4|||
33513169|NCT00336024|101773617|FG001|Overall Study|Progressive Disease|7|||
33513170|NCT00336024|101773616|FG000|Overall Study|Ineligible|7|||
33513171|NCT00336024|101773617|FG001|Overall Study|Ineligible|7|||
33513172|NCT04852276|101773618|FG000|Overall Study|Death|2|||
33513173|NCT04852276|101773619|FG001|Overall Study|Death|0|||
33513174|NCT04852276|101773618|FG000|Overall Study|Lost to Follow-up|15|||
33513175|NCT04852276|101773619|FG001|Overall Study|Lost to Follow-up|9|||
33513176|NCT04852276|101773618|FG000|Overall Study|Withdrawal by Subject|26|||
33513177|NCT04852276|101773619|FG001|Overall Study|Withdrawal by Subject|6|||
33513178|NCT03091192|101773620|FG000|Overall Study|Study terminated by sponsor|21|||
33513179|NCT03091192|101773621|FG001|Overall Study|Study terminated by sponsor|14|||
33513180|NCT03091192|101773620|FG000|Overall Study|Death|9|||
33513181|NCT03091192|101773621|FG001|Overall Study|Death|13|||
33513182|NCT03091192|101773620|FG000|Overall Study|Withdrawal by Subject|2|||
33513183|NCT03091192|101773621|FG001|Overall Study|Withdrawal by Subject|0|||
33513184|NCT03091192|101773620|FG000|Overall Study|Lost to Follow-up|1|||
33513185|NCT03091192|101773621|FG001|Overall Study|Lost to Follow-up|0|||
33513186|NCT02553499|101773622|FG000|Overall Study|Adverse Event|0|||
33513187|NCT02553499|101773623|FG001|Overall Study|Adverse Event|0|||
33513188|NCT02553499|101773624|FG002|Overall Study|Adverse Event|0|||
33513189|NCT02553499|101773625|FG003|Overall Study|Adverse Event|0|||
33513190|NCT02553499|101773626|FG004|Overall Study|Adverse Event|0|||
33513191|NCT02553499|101773627|FG005|Overall Study|Adverse Event|0|||
33513192|NCT02553499|101773628|FG006|Overall Study|Adverse Event|1|||
33513193|NCT02553499|101773629|FG007|Overall Study|Adverse Event|1|||
33513194|NCT02553499|101773630|FG008|Overall Study|Adverse Event|0|||
33513195|NCT02553499|101773631|FG009|Overall Study|Adverse Event|0|||
33513196|NCT02553499|101773632|FG010|Overall Study|Adverse Event|0|||
33513197|NCT02553499|101773633|FG011|Overall Study|Adverse Event|0|||
33513198|NCT02553499|101773634|FG012|Overall Study|Adverse Event|0|||
33513199|NCT02553499|101773635|FG013|Overall Study|Adverse Event|1|||
33513200|NCT02553499|101773622|FG000|Overall Study|Death|0|||
33513201|NCT02553499|101773623|FG001|Overall Study|Death|1|||
33606482|NCT03890367|102108361|FG000|Overall Study|Lost to Follow-up|1|||
33198747|NCT01709318|100630614|FG000|Overall Study|Pregnancy|0|||
33324645|NCT00283049|101084793|FG001|Overall Study|Lost to Follow-up|2|||
33324646|NCT00283049|101084794|FG002|Overall Study|Lost to Follow-up|5|||
33513202|NCT02553499|101773624|FG002|Overall Study|Death|1|||
33513203|NCT02553499|101773625|FG003|Overall Study|Death|0|||
33513204|NCT02553499|101773626|FG004|Overall Study|Death|1|||
33513205|NCT02553499|101773627|FG005|Overall Study|Death|2|||
33513206|NCT02553499|101773628|FG006|Overall Study|Death|0|||
33513207|NCT02553499|101773629|FG007|Overall Study|Death|0|||
33513208|NCT02553499|101773630|FG008|Overall Study|Death|0|||
33513209|NCT02553499|101773631|FG009|Overall Study|Death|0|||
33198748|NCT01709318|100630615|FG001|Overall Study|Pregnancy|0|||
33198749|NCT01709318|100630616|FG002|Overall Study|Pregnancy|0|||
33513210|NCT02553499|101773632|FG010|Overall Study|Death|1|||
33513211|NCT02553499|101773633|FG011|Overall Study|Death|0|||
33513212|NCT02553499|101773634|FG012|Overall Study|Death|0|||
33198750|NCT01709318|100630617|FG003|Overall Study|Pregnancy|0|||
33513213|NCT02553499|101773635|FG013|Overall Study|Death|0|||
33513214|NCT02553499|101773622|FG000|Overall Study|Lost to Follow-up|0|||
33513215|NCT02553499|101773623|FG001|Overall Study|Lost to Follow-up|0|||
33513216|NCT02553499|101773624|FG002|Overall Study|Lost to Follow-up|0|||
33513217|NCT02553499|101773625|FG003|Overall Study|Lost to Follow-up|0|||
33513218|NCT02553499|101773626|FG004|Overall Study|Lost to Follow-up|0|||
33513219|NCT02553499|101773627|FG005|Overall Study|Lost to Follow-up|0|||
33606483|NCT03890367|102108362|FG001|Overall Study|Lost to Follow-up|1|||
33513220|NCT02553499|101773628|FG006|Overall Study|Lost to Follow-up|1|||
33513221|NCT02553499|101773629|FG007|Overall Study|Lost to Follow-up|0|||
33513222|NCT02553499|101773630|FG008|Overall Study|Lost to Follow-up|0|||
33513223|NCT02553499|101773631|FG009|Overall Study|Lost to Follow-up|0|||
33513224|NCT02553499|101773632|FG010|Overall Study|Lost to Follow-up|0|||
33513225|NCT02553499|101773633|FG011|Overall Study|Lost to Follow-up|0|||
33513226|NCT02553499|101773634|FG012|Overall Study|Lost to Follow-up|0|||
33513227|NCT02553499|101773635|FG013|Overall Study|Lost to Follow-up|0|||
33513228|NCT02553499|101773622|FG000|Overall Study|Physician Decision|0|||
33513229|NCT02553499|101773623|FG001|Overall Study|Physician Decision|1|||
33399111|NCT02394028|101350184|FG009|Induction Phase|Sponsor decision|0|||
33399112|NCT02394028|101350185|FG010|Induction Phase|Sponsor decision|0|||
33513230|NCT02553499|101773624|FG002|Overall Study|Physician Decision|1|||
33513231|NCT02553499|101773625|FG003|Overall Study|Physician Decision|0|||
33606484|NCT03890367|102108363|FG002|Overall Study|Lost to Follow-up|0|||
33606485|NCT00671437|102108386|FG000|Overall Study|Progressive disease before C1 week 8|8|||
33606486|NCT00671437|102108386|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
33606487|NCT00671437|102108386|FG000|Overall Study|Adverse Event|3|||
33606488|NCT00671437|102108386|FG000|Overall Study|Ineligible post-hoc|1|||
33198751|NCT01709318|100630618|FG004|Overall Study|Pregnancy|1|||
33198752|NCT01709318|100630619|FG005|Overall Study|Pregnancy|0|||
33198753|NCT01709318|100630620|FG006|Overall Study|Pregnancy|0|||
33198754|NCT01709318|100630614|FG000|Overall Study|Protocol Violation|0|||
33198755|NCT01709318|100630615|FG001|Overall Study|Protocol Violation|0|||
33198756|NCT01709318|100630616|FG002|Overall Study|Protocol Violation|0|||
33198757|NCT01709318|100630617|FG003|Overall Study|Protocol Violation|0|||
33198758|NCT01709318|100630618|FG004|Overall Study|Protocol Violation|2|||
33198759|NCT01709318|100630619|FG005|Overall Study|Protocol Violation|0|||
33198760|NCT01709318|100630620|FG006|Overall Study|Protocol Violation|1|||
33198761|NCT01709318|100630614|FG000|Overall Study|Technical Problems|1|||
33198762|NCT01709318|100630615|FG001|Overall Study|Technical Problems|0|||
33198763|NCT01709318|100630616|FG002|Overall Study|Technical Problems|0|||
33198764|NCT01709318|100630617|FG003|Overall Study|Technical Problems|0|||
33198765|NCT01709318|100630618|FG004|Overall Study|Technical Problems|0|||
33198766|NCT01709318|100630619|FG005|Overall Study|Technical Problems|0|||
33198767|NCT01709318|100630620|FG006|Overall Study|Technical Problems|0|||
33324647|NCT00283049|101084792|FG000|Overall Study|Withdrawal by Subject|26|||
33324648|NCT00283049|101084793|FG001|Overall Study|Withdrawal by Subject|24|||
33324649|NCT00283049|101084794|FG002|Overall Study|Withdrawal by Subject|19|||
33324650|NCT00283049|101084792|FG000|Overall Study|Discontinuation of Study|18|||
33324651|NCT00283049|101084793|FG001|Overall Study|Discontinuation of Study|16|||
33324652|NCT00283049|101084794|FG002|Overall Study|Discontinuation of Study|20|||
33324653|NCT00283049|101084792|FG000|Overall Study|No longer requires study treatment|0|||
33324654|NCT00283049|101084793|FG001|Overall Study|No longer requires study treatment|0|||
33324655|NCT00283049|101084794|FG002|Overall Study|No longer requires study treatment|1|||
33513232|NCT02553499|101773626|FG004|Overall Study|Physician Decision|1|||
33513233|NCT02553499|101773627|FG005|Overall Study|Physician Decision|0|||
33513234|NCT02553499|101773628|FG006|Overall Study|Physician Decision|0|||
33606489|NCT01177969|102108390|FG000|Overall Study|Protocol Violation|2|||
33606490|NCT01177969|102108391|FG001|Overall Study|Protocol Violation|1|||
33606491|NCT01177969|102108390|FG000|Overall Study|Withdrawal by Subject|1|||
33606492|NCT01177969|102108391|FG001|Overall Study|Withdrawal by Subject|2|||
33606493|NCT00541346|102108394|FG000|Follow-up|Adverse Event|1|||
33606494|NCT04046250|102108396|FG000|Overall Study|Death|0|||
33606495|NCT04046250|102108397|FG001|Overall Study|Death|1|||
33606496|NCT04046250|102108396|FG000|Overall Study|Withdrawal by Subject|3|||
33606497|NCT04046250|102108397|FG001|Overall Study|Withdrawal by Subject|3|||
33606498|NCT01549873|102108398|FG000|Overall Study|Physician Decision|0|||
33606499|NCT01549873|102108399|FG001|Overall Study|Physician Decision|1|||
33324656|NCT00698451|101084795|FG000|Overall Study|Adverse Event|22|||
33324657|NCT00698451|101084795|FG000|Overall Study|Physician Decision|2|||
33513235|NCT02553499|101773629|FG007|Overall Study|Physician Decision|1|||
33513236|NCT02553499|101773630|FG008|Overall Study|Physician Decision|1|||
33513237|NCT02553499|101773631|FG009|Overall Study|Physician Decision|2|||
33513238|NCT02553499|101773632|FG010|Overall Study|Physician Decision|1|||
33606500|NCT01302054|102108400|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
33606501|NCT01302054|102108401|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
33606502|NCT01302054|102108402|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
33198768|NCT01709318|100630614|FG000|Overall Study|Withdrawal by Subject|3|||
33198769|NCT01709318|100630615|FG001|Overall Study|Withdrawal by Subject|0|||
33198770|NCT01709318|100630616|FG002|Overall Study|Withdrawal by Subject|3|||
33324658|NCT00698451|101084795|FG000|Overall Study|Protocol Violation|6|||
33324659|NCT00698451|101084795|FG000|Overall Study|Withdrawal by Subject|6|||
33399113|NCT02394028|101350175|FG000|Induction Phase|Technical reason|0|||
33513239|NCT02553499|101773633|FG011|Overall Study|Physician Decision|3|||
33606503|NCT01302054|102108400|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
33198771|NCT01709318|100630617|FG003|Overall Study|Withdrawal by Subject|3|||
33198772|NCT01709318|100630618|FG004|Overall Study|Withdrawal by Subject|0|||
33606504|NCT01302054|102108401|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
33513240|NCT02553499|101773634|FG012|Overall Study|Physician Decision|1|||
33606505|NCT01302054|102108402|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
33606506|NCT01302054|102108400|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
33513241|NCT02553499|101773635|FG013|Overall Study|Physician Decision|0|||
33513242|NCT02553499|101773622|FG000|Overall Study|Progressive Disease|0|||
33513243|NCT02553499|101773623|FG001|Overall Study|Progressive Disease|0|||
33513244|NCT02553499|101773624|FG002|Overall Study|Progressive Disease|0|||
33513245|NCT02553499|101773625|FG003|Overall Study|Progressive Disease|2|||
33513246|NCT02553499|101773626|FG004|Overall Study|Progressive Disease|1|||
33513247|NCT02553499|101773627|FG005|Overall Study|Progressive Disease|1|||
33513248|NCT02553499|101773628|FG006|Overall Study|Progressive Disease|1|||
33399114|NCT02394028|101350176|FG001|Induction Phase|Technical reason|0|||
33399115|NCT02394028|101350177|FG002|Induction Phase|Technical reason|0|||
33399116|NCT02394028|101350178|FG003|Induction Phase|Technical reason|1|||
33399117|NCT02394028|101350179|FG004|Induction Phase|Technical reason|0|||
33399118|NCT02394028|101350180|FG005|Induction Phase|Technical reason|0|||
33399119|NCT02394028|101350181|FG006|Induction Phase|Technical reason|0|||
33399120|NCT02394028|101350182|FG007|Induction Phase|Technical reason|0|||
33399121|NCT02394028|101350183|FG008|Induction Phase|Technical reason|0|||
33399122|NCT02394028|101350184|FG009|Induction Phase|Technical reason|0|||
33513249|NCT02553499|101773629|FG007|Overall Study|Progressive Disease|0|||
33606507|NCT01302054|102108401|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
33606508|NCT01302054|102108402|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
33606509|NCT01302054|102108400|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
33606510|NCT01302054|102108401|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
33606511|NCT01302054|102108402|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
33606512|NCT01302054|102108400|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
33606513|NCT01302054|102108401|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
33606514|NCT01302054|102108402|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
33606515|NCT01302054|102108400|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
33513250|NCT02553499|101773630|FG008|Overall Study|Progressive Disease|0|||
33513251|NCT02553499|101773631|FG009|Overall Study|Progressive Disease|1|||
33513252|NCT02553499|101773632|FG010|Overall Study|Progressive Disease|0|||
33513253|NCT02553499|101773633|FG011|Overall Study|Progressive Disease|0|||
33513254|NCT02553499|101773634|FG012|Overall Study|Progressive Disease|2|||
33513255|NCT02553499|101773635|FG013|Overall Study|Progressive Disease|1|||
33513256|NCT02553499|101773622|FG000|Overall Study|Study Terminated by Sponsor|0|||
33513257|NCT02553499|101773623|FG001|Overall Study|Study Terminated by Sponsor|0|||
33513258|NCT02553499|101773624|FG002|Overall Study|Study Terminated by Sponsor|0|||
33513259|NCT02553499|101773625|FG003|Overall Study|Study Terminated by Sponsor|0|||
33513260|NCT02553499|101773626|FG004|Overall Study|Study Terminated by Sponsor|0|||
33513261|NCT02553499|101773627|FG005|Overall Study|Study Terminated by Sponsor|0|||
33513262|NCT02553499|101773628|FG006|Overall Study|Study Terminated by Sponsor|0|||
33513263|NCT02553499|101773629|FG007|Overall Study|Study Terminated by Sponsor|0|||
33513264|NCT02553499|101773630|FG008|Overall Study|Study Terminated by Sponsor|1|||
33513265|NCT02553499|101773631|FG009|Overall Study|Study Terminated by Sponsor|0|||
33513266|NCT02553499|101773632|FG010|Overall Study|Study Terminated by Sponsor|0|||
33513267|NCT02553499|101773633|FG011|Overall Study|Study Terminated by Sponsor|0|||
33513268|NCT02553499|101773634|FG012|Overall Study|Study Terminated by Sponsor|0|||
33513269|NCT02553499|101773635|FG013|Overall Study|Study Terminated by Sponsor|0|||
33513270|NCT02553499|101773622|FG000|Overall Study|Withdrawal by Subject|2|||
33513271|NCT02553499|101773623|FG001|Overall Study|Withdrawal by Subject|0|||
33513272|NCT02553499|101773624|FG002|Overall Study|Withdrawal by Subject|0|||
33513273|NCT02553499|101773625|FG003|Overall Study|Withdrawal by Subject|0|||
33513274|NCT02553499|101773626|FG004|Overall Study|Withdrawal by Subject|0|||
33513275|NCT02553499|101773627|FG005|Overall Study|Withdrawal by Subject|0|||
33513276|NCT02553499|101773628|FG006|Overall Study|Withdrawal by Subject|0|||
33513277|NCT02553499|101773629|FG007|Overall Study|Withdrawal by Subject|1|||
33513278|NCT02553499|101773630|FG008|Overall Study|Withdrawal by Subject|1|||
33513279|NCT02553499|101773631|FG009|Overall Study|Withdrawal by Subject|0|||
33513280|NCT02553499|101773632|FG010|Overall Study|Withdrawal by Subject|1|||
33513281|NCT02553499|101773633|FG011|Overall Study|Withdrawal by Subject|0|||
33399123|NCT02394028|101350185|FG010|Induction Phase|Technical reason|0|||
33399124|NCT02394028|101350175|FG000|Induction Phase|:ack of calculation|0|||
33399125|NCT02394028|101350176|FG001|Induction Phase|:ack of calculation|0|||
33399126|NCT02394028|101350177|FG002|Induction Phase|:ack of calculation|0|||
33513282|NCT02553499|101773634|FG012|Overall Study|Withdrawal by Subject|0|||
33513283|NCT02553499|101773635|FG013|Overall Study|Withdrawal by Subject|0|||
33513284|NCT04696861|101773641|FG000|Overall Study|Death|1|||
33513285|NCT04696861|101773642|FG001|Overall Study|Death|0|||
33513286|NCT04696861|101773641|FG000|Overall Study|Lost to Follow-up|3|||
33513287|NCT04696861|101773642|FG001|Overall Study|Lost to Follow-up|0|||
33513288|NCT03627416|101773645|FG000|Overall Study|Adverse Event|0|||
33513289|NCT03627416|101773646|FG001|Overall Study|Adverse Event|1|||
33513290|NCT01044290|101773651|FG000|Follow-up 1|Death|3|||
33513291|NCT01044290|101773652|FG001|Follow-up 1|Death|3|||
33513292|NCT01044290|101773653|FG002|Follow-up 1|Death|1|||
33513293|NCT01044290|101773651|FG000|Follow-up 1|Withdrawal by Subject|2|||
33513294|NCT01044290|101773652|FG001|Follow-up 1|Withdrawal by Subject|2|||
33513295|NCT01044290|101773653|FG002|Follow-up 1|Withdrawal by Subject|0|||
33513296|NCT01044290|101773651|FG000|Follow-Up 2|Death|0|||
33513297|NCT01044290|101773652|FG001|Follow-Up 2|Death|1|||
33513298|NCT01044290|101773653|FG002|Follow-Up 2|Death|1|||
33513299|NCT01044290|101773651|FG000|Follow-Up 2|Withdrawal by Subject|0|||
33513300|NCT01044290|101773652|FG001|Follow-Up 2|Withdrawal by Subject|1|||
33513301|NCT01044290|101773653|FG002|Follow-Up 2|Withdrawal by Subject|1|||
33513302|NCT02345889|101773654|FG000|Overall Study|Inadequate Bowel Prep|17|||
33513303|NCT02345889|101773655|FG001|Overall Study|Inadequate Bowel Prep|16|||
33513304|NCT02345889|101773656|FG002|Overall Study|Inadequate Bowel Prep|18|||
33513305|NCT02345889|101773657|FG003|Overall Study|Inadequate Bowel Prep|14|||
33513306|NCT02345889|101773654|FG000|Overall Study|Polyposis identified during procedure|1|||
33513307|NCT02345889|101773655|FG001|Overall Study|Polyposis identified during procedure|1|||
33513308|NCT02345889|101773656|FG002|Overall Study|Polyposis identified during procedure|0|||
33513309|NCT02345889|101773657|FG003|Overall Study|Polyposis identified during procedure|1|||
33513310|NCT02345889|101773654|FG000|Overall Study|Recognized ineligible post-randomization|1|||
33513311|NCT02345889|101773655|FG001|Overall Study|Recognized ineligible post-randomization|0|||
33513312|NCT02345889|101773656|FG002|Overall Study|Recognized ineligible post-randomization|2|||
33513313|NCT02345889|101773657|FG003|Overall Study|Recognized ineligible post-randomization|1|||
33513314|NCT02345889|101773654|FG000|Overall Study|Ulcerative Colitis identified|1|||
33513315|NCT02345889|101773655|FG001|Overall Study|Ulcerative Colitis identified|0|||
33513316|NCT02345889|101773656|FG002|Overall Study|Ulcerative Colitis identified|0|||
33513317|NCT02345889|101773657|FG003|Overall Study|Ulcerative Colitis identified|0|||
33513318|NCT02345889|101773654|FG000|Overall Study|Cecum not intubated|1|||
33513319|NCT02345889|101773655|FG001|Overall Study|Cecum not intubated|0|||
33513320|NCT02345889|101773656|FG002|Overall Study|Cecum not intubated|0|||
33513321|NCT02345889|101773657|FG003|Overall Study|Cecum not intubated|0|||
33513322|NCT01217385|101773658|FG000|Overall Study|Withdrawal by Subject|3|||
33513323|NCT01217385|101773658|FG000|Overall Study|DOSI not performed/not eval|12|||
33513324|NCT01217385|101773658|FG000|Overall Study|Central Path not Available|1|||
33513325|NCT01217385|101773658|FG000|Overall Study|Normal Breast TOI not available|10|||
33513326|NCT03729570|101773663|FG000|Overall Study|Lost to Follow-up|16|||
33513327|NCT03729570|101773664|FG001|Overall Study|Lost to Follow-up|20|||
33513328|NCT03729570|101773663|FG000|Overall Study|Seroconversion|5|||
33513329|NCT03729570|101773664|FG001|Overall Study|Seroconversion|0|||
33513330|NCT03729570|101773663|FG000|Overall Study|Moved out of the city|1|||
33513331|NCT03729570|101773664|FG001|Overall Study|Moved out of the city|0|||
33513332|NCT03729570|101773663|FG000|Overall Study|Time Conflict|1|||
33198773|NCT01709318|100630619|FG005|Overall Study|Withdrawal by Subject|2|||
33198774|NCT01709318|100630620|FG006|Overall Study|Withdrawal by Subject|4|||
33198775|NCT01709318|100630614|FG000|Overall Study|Other Protocol Specified Criteria|0|||
33399127|NCT02394028|101350178|FG003|Induction Phase|:ack of calculation|0|||
33513333|NCT03729570|101773664|FG001|Overall Study|Time Conflict|0|||
33513334|NCT03729570|101773663|FG000|Overall Study|Time Commitment|2|||
33513335|NCT03729570|101773664|FG001|Overall Study|Time Commitment|0|||
33513336|NCT03729570|101773663|FG000|Overall Study|Bad Experience|0|||
33513337|NCT03729570|101773664|FG001|Overall Study|Bad Experience|1|||
33198776|NCT01709318|100630615|FG001|Overall Study|Other Protocol Specified Criteria|1|||
33513338|NCT03729570|101773663|FG000|Overall Study|No reason provided|2|||
33513339|NCT03729570|101773664|FG001|Overall Study|No reason provided|1|||
33513340|NCT03729570|101773663|FG000|Overall Study|Family Conflict|0|||
33513341|NCT03729570|101773664|FG001|Overall Study|Family Conflict|1|||
33513342|NCT03729570|101773663|FG000|Overall Study|Did not want to continue taking medications|0|||
33513343|NCT03729570|101773664|FG001|Overall Study|Did not want to continue taking medications|1|||
33513344|NCT03729570|101773663|FG000|Overall Study|Found another PrEP provider|1|||
33513345|NCT03729570|101773664|FG001|Overall Study|Found another PrEP provider|0|||
33513346|NCT03729570|101773663|FG000|Overall Study|Did not enjoy being in the control group|0|||
33513347|NCT03729570|101773664|FG001|Overall Study|Did not enjoy being in the control group|1|||
33513348|NCT03205761|101773668|FG000|Overall Study|Withdrawal by Subject|1|||
33513349|NCT03205761|101773668|FG000|Overall Study|Progressive Disease|10|||
33513350|NCT01424514|101776534|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
33513351|NCT01424514|101776535|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
33513352|NCT01424514|101776534|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
33513353|NCT01424514|101776535|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
33513354|NCT02889835|101776536|FG000|Overall Study|Lost to Follow-up|13|||
33513355|NCT02889835|101776537|FG001|Overall Study|Lost to Follow-up|13|||
33513356|NCT02889835|101776538|FG002|Overall Study|Lost to Follow-up|13|||
33513357|NCT02889835|101776536|FG000|Overall Study|Withdrawal by Subject|2|||
33513358|NCT02889835|101776537|FG001|Overall Study|Withdrawal by Subject|2|||
33513359|NCT02889835|101776538|FG002|Overall Study|Withdrawal by Subject|2|||
33513360|NCT02889835|101776536|FG000|Overall Study|Protocol Violation|1|||
33513361|NCT02889835|101776537|FG001|Overall Study|Protocol Violation|1|||
33513362|NCT02889835|101776538|FG002|Overall Study|Protocol Violation|1|||
33513363|NCT02889835|101776536|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
33513364|NCT02889835|101776537|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
33513365|NCT02889835|101776538|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
33606516|NCT01302054|102108401|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
33324660|NCT00698451|101084795|FG000|Overall Study|Disease progression|3|||
33324661|NCT00698997|101084796|FG000|Overall Study|Lost to Follow-up|3|||
33324662|NCT00698997|101084797|FG001|Overall Study|Lost to Follow-up|0|||
33324663|NCT00698997|101084796|FG000|Overall Study|Withdrawal by Subject|7|||
33324664|NCT00698997|101084797|FG001|Overall Study|Withdrawal by Subject|27|||
33324665|NCT01087957|101084800|FG000|Overall Study|Death|2|||
33513366|NCT02889835|101776536|FG000|Overall Study|Death|1|||
33513367|NCT02889835|101776537|FG001|Overall Study|Death|1|||
33606517|NCT01302054|102108402|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
33606518|NCT01302054|102108400|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
33606519|NCT01302054|102108401|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
33606520|NCT01302054|102108402|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
33606521|NCT01302054|102108400|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
33606522|NCT01302054|102108401|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
33606523|NCT01302054|102108402|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
33606524|NCT01302054|102108400|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
33606525|NCT01302054|102108401|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
33606526|NCT01302054|102108402|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
33606527|NCT01302054|102108400|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33198777|NCT01709318|100630616|FG002|Overall Study|Other Protocol Specified Criteria|0|||
33324666|NCT01087957|101084801|FG001|Overall Study|Death|2|||
33324667|NCT01087957|101084800|FG000|Overall Study|Lost to Follow-up|3|||
33513368|NCT02889835|101776538|FG002|Overall Study|Death|1|||
33513369|NCT01984892|101776539|FG000|Overall Study|Progressive disease|7|||
33606528|NCT01302054|102108401|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
33324668|NCT01087957|101084801|FG001|Overall Study|Lost to Follow-up|4|||
33324669|NCT01087957|101084800|FG000|Overall Study|Protocol Violation|13|||
33513370|NCT00664859|101776541|FG000|Overall Study|Adverse Event|2|||
33513371|NCT00664859|101776542|FG001|Overall Study|Adverse Event|1|||
33513372|NCT00664859|101776543|FG002|Overall Study|Adverse Event|3|||
33513373|NCT00664859|101776541|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
33513374|NCT00664859|101776542|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
33513375|NCT00664859|101776543|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
33399128|NCT02394028|101350179|FG004|Induction Phase|:ack of calculation|0|||
33399129|NCT02394028|101350180|FG005|Induction Phase|:ack of calculation|0|||
33513376|NCT00664859|101776541|FG000|Overall Study|Noncompliance with protocol|1|||
33513377|NCT00664859|101776542|FG001|Overall Study|Noncompliance with protocol|0|||
33513378|NCT00664859|101776543|FG002|Overall Study|Noncompliance with protocol|4|||
33513379|NCT00664859|101776541|FG000|Overall Study|Laboratory abnormality|2|||
33513380|NCT00664859|101776542|FG001|Overall Study|Laboratory abnormality|1|||
33513381|NCT00664859|101776543|FG002|Overall Study|Laboratory abnormality|4|||
33513382|NCT00664859|101776541|FG000|Overall Study|Withdrawal by Subject|4|||
33513383|NCT00664859|101776542|FG001|Overall Study|Withdrawal by Subject|1|||
33513384|NCT00664859|101776543|FG002|Overall Study|Withdrawal by Subject|3|||
33513385|NCT00664859|101776541|FG000|Overall Study|Lost to Follow-up|2|||
33513386|NCT00664859|101776542|FG001|Overall Study|Lost to Follow-up|2|||
33513387|NCT00664859|101776543|FG002|Overall Study|Lost to Follow-up|1|||
33513388|NCT00664859|101776541|FG000|Overall Study|Other|0|||
33513389|NCT00664859|101776542|FG001|Overall Study|Other|1|||
33513390|NCT00664859|101776543|FG002|Overall Study|Other|2|||
33513391|NCT03687372|101776544|FG000|Overall Study|Lost to Follow-up|12|||
33513392|NCT03687372|101776545|FG001|Overall Study|Lost to Follow-up|21|||
33513393|NCT03687372|101776544|FG000|Overall Study|Withdrawal by Subject|4|||
33513394|NCT03687372|101776545|FG001|Overall Study|Withdrawal by Subject|17|||
33513395|NCT03687372|101776544|FG000|Overall Study|Investigator Decision|1|||
33513396|NCT03687372|101776545|FG001|Overall Study|Investigator Decision|1|||
33513397|NCT02620384|101776555|FG000|Overall Study|Adverse Event|2|||
33513398|NCT02620384|101776556|FG001|Overall Study|Adverse Event|1|||
33513399|NCT02620384|101776555|FG000|Overall Study|Discharged prior to 2nd dose|2|||
33513400|NCT02620384|101776556|FG001|Overall Study|Discharged prior to 2nd dose|5|||
33513401|NCT02620384|101776555|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
33513402|NCT02620384|101776556|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
33513403|NCT03813147|101776558|FG000|Overall Study|Lack of Efficacy|4|||
33513404|NCT03813147|101776559|FG001|Overall Study|Lack of Efficacy|4|||
33513405|NCT03813147|101776558|FG000|Overall Study|Physician Decision|2|||
33513406|NCT03813147|101776559|FG001|Overall Study|Physician Decision|1|||
33513407|NCT00138073|101776560|FG000|Overall Study|lack of resources|55|||
33513408|NCT03698994|101776563|FG000|Overall Study|Adverse Event|2|||
33513409|NCT03698994|101776563|FG000|Overall Study|Death|1|||
33513410|NCT03698994|101776563|FG000|Overall Study|Physician Decision|1|||
33513411|NCT03698994|101776563|FG000|Overall Study|Withdrawal by Subject|3|||
33513412|NCT03698994|101776563|FG000|Overall Study|Progressive Disease|12|||
33513413|NCT01740128|101776565|FG000|Overall Study|Pregnancy|0|||
33513414|NCT01740128|101776566|FG001|Overall Study|Pregnancy|1|||
33513415|NCT01740128|101776565|FG000|Overall Study|Protocol Violation|1|||
33513416|NCT01740128|101776566|FG001|Overall Study|Protocol Violation|2|||
33513417|NCT01740128|101776565|FG000|Overall Study|Lost to Follow-up|2|||
33513418|NCT01740128|101776566|FG001|Overall Study|Lost to Follow-up|2|||
33513419|NCT01740128|101776565|FG000|Overall Study|Withdrawal by Subject|1|||
33513420|NCT01740128|101776566|FG001|Overall Study|Withdrawal by Subject|0|||
33324670|NCT01087957|101084801|FG001|Overall Study|Protocol Violation|25|||
33324671|NCT01087957|101084800|FG000|Overall Study|Withdrawal by Subject|18|||
33324672|NCT01087957|101084801|FG001|Overall Study|Withdrawal by Subject|15|||
33513421|NCT01740128|101776565|FG000|Overall Study|Insufficient protocol compliance|2|||
33324673|NCT01087957|101084800|FG000|Overall Study|Physician Decision|5|||
33324674|NCT01087957|101084801|FG001|Overall Study|Physician Decision|9|||
33198778|NCT01709318|100630617|FG003|Overall Study|Other Protocol Specified Criteria|0|||
33324675|NCT01069120|101084807|FG000|Overall Study|Study prematurely terminated|27|||
33324676|NCT00117507|101084808|FG000|Overall Study|Adverse Event|4|||
33513422|NCT01740128|101776566|FG001|Overall Study|Insufficient protocol compliance|2|||
33513423|NCT02344290|101776570|FG000|Overall Study|Withdrawal by Subject|315|||
33513424|NCT02344290|101776571|FG001|Overall Study|Withdrawal by Subject|324|||
33513425|NCT02344290|101776570|FG000|Overall Study|Lost to Follow-up|258|||
33513426|NCT02344290|101776571|FG001|Overall Study|Lost to Follow-up|249|||
33513427|NCT02344290|101776570|FG000|Overall Study|Unable to get to clinic|69|||
33324677|NCT00117507|101084808|FG000|Overall Study|Abnormal laboratory values|3|||
33324678|NCT00117507|101084808|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33513428|NCT02344290|101776571|FG001|Overall Study|Unable to get to clinic|60|||
33513429|NCT02344290|101776570|FG000|Overall Study|Physician Decision|25|||
33513430|NCT02344290|101776571|FG001|Overall Study|Physician Decision|25|||
33198779|NCT01709318|100630618|FG004|Overall Study|Other Protocol Specified Criteria|0|||
33198780|NCT01709318|100630619|FG005|Overall Study|Other Protocol Specified Criteria|0|||
33198781|NCT01709318|100630620|FG006|Overall Study|Other Protocol Specified Criteria|0|||
33198782|NCT01700946|100630621|FG000|Overall Study|Lost to Follow-up|1|||
33198783|NCT01700946|100630622|FG001|Overall Study|Lost to Follow-up|0|||
33198784|NCT01700946|100630621|FG000|Overall Study|Physician Decision|7|||
33198785|NCT01700946|100630622|FG001|Overall Study|Physician Decision|12|||
33198786|NCT01700946|100630621|FG000|Overall Study|Withdrawal by Subject|0|||
33198787|NCT01700946|100630622|FG001|Overall Study|Withdrawal by Subject|2|||
33198788|NCT01700946|100630621|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
33198789|NCT01700946|100630622|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
33198790|NCT01700946|100630621|FG000|Overall Study|Relapse|2|||
33198791|NCT01700946|100630622|FG001|Overall Study|Relapse|1|||
33198792|NCT01700946|100630621|FG000|Overall Study|Unacceptable toxicity|1|||
33198793|NCT01700946|100630622|FG001|Overall Study|Unacceptable toxicity|0|||
33198794|NCT01163682|100630623|FG000|Overall Study|Lost to Follow-up|6|||
33198795|NCT01163682|100630624|FG001|Overall Study|Lost to Follow-up|9|||
33198796|NCT01431508|100630625|FG000|Overall Study|Lack of Efficacy|1|||
33198797|NCT01431508|100630625|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
33198798|NCT03286140|100630628|FG000|Overall Study|Withdrawal by Subject|10|||
33198799|NCT03286140|100630629|FG001|Overall Study|Withdrawal by Subject|5|||
33198800|NCT03286140|100630628|FG000|Overall Study|Lost to Follow-up|5|||
33198801|NCT03286140|100630629|FG001|Overall Study|Lost to Follow-up|10|||
33198802|NCT03286140|100630628|FG000|Overall Study|Failure to comply|0|||
33198803|NCT03286140|100630629|FG001|Overall Study|Failure to comply|1|||
33198804|NCT00346034|100630632|FG000|Overall Study|Adverse Event|34|||
33198805|NCT00346034|100630632|FG000|Overall Study|Lack of Efficacy|8|||
33198806|NCT00346034|100630632|FG000|Overall Study|Withdrawal by Subject|13|||
33198807|NCT00346034|100630632|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
33198808|NCT00346034|100630632|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
33198809|NCT01578551|100630633|FG000|Overall Study|Adverse Event|1|||
33198810|NCT01578551|100630634|FG001|Overall Study|Adverse Event|0|||
33198811|NCT03323099|100630635|FG000|Overall Study|Withdrawal by Subject|6|||
33198812|NCT03323099|100630636|FG001|Overall Study|Withdrawal by Subject|12|||
33198813|NCT03323099|100630635|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
33198814|NCT03323099|100630636|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
33198815|NCT01313559|100630637|FG000|Overall Study|Withdrawal by Subject|1|||
33198816|NCT01313559|100630638|FG001|Overall Study|Withdrawal by Subject|2|||
33198817|NCT01313559|100630637|FG000|Overall Study|Disease progression|1|||
33198818|NCT01313559|100630638|FG001|Overall Study|Disease progression|0|||
33198819|NCT01313559|100630637|FG000|Overall Study|Rising PSA|2|||
33198820|NCT01313559|100630638|FG001|Overall Study|Rising PSA|0|||
33198821|NCT01060384|100630648|FG000|Overall Study|Withdrawal by Subject|0|||
33198822|NCT01060384|100630649|FG001|Overall Study|Withdrawal by Subject|1|||
33198823|NCT01060384|100630650|FG002|Overall Study|Withdrawal by Subject|0|||
33198824|NCT01060384|100630651|FG003|Overall Study|Withdrawal by Subject|0|||
33198825|NCT01060384|100630652|FG004|Overall Study|Withdrawal by Subject|0|||
33198826|NCT01060384|100630648|FG000|Overall Study|Death|0|||
33198827|NCT01060384|100630649|FG001|Overall Study|Death|0|||
33198828|NCT01060384|100630650|FG002|Overall Study|Death|0|||
33198829|NCT01060384|100630651|FG003|Overall Study|Death|0|||
33198830|NCT01060384|100630652|FG004|Overall Study|Death|1|||
33198831|NCT01060384|100630648|FG000|Overall Study|Intercurrent illness|0|||
33198832|NCT01060384|100630649|FG001|Overall Study|Intercurrent illness|0|||
33198833|NCT01060384|100630650|FG002|Overall Study|Intercurrent illness|0|||
33198834|NCT01060384|100630651|FG003|Overall Study|Intercurrent illness|0|||
33198835|NCT01060384|100630652|FG004|Overall Study|Intercurrent illness|1|||
33198836|NCT01412424|100630653|FG000|Core Treatment Period|Treatment Failure|24|||
33198837|NCT01412424|100630653|FG000|Core Treatment Period|Adverse Event|21|||
33198838|NCT01412424|100630653|FG000|Core Treatment Period|Patient Request|5|||
33198839|NCT01412424|100630653|FG000|Core Treatment Period|Lost to Follow-up|2|||
33198840|NCT01412424|100630653|FG000|Core Treatment Period|Sponsor Request|1|||
33198841|NCT01412424|100630653|FG000|Extension Treatment Period|Adverse Event|2|||
33198842|NCT01412424|100630653|FG000|Extension Treatment Period|Treatment Failure|2|||
33198843|NCT01412424|100630653|FG000|Extension Treatment Period|Patient Request|2|||
33324679|NCT00117507|101084808|FG000|Overall Study|Patient withdrew consent|4|||
33198844|NCT02104557|100630654|FG000|Overall Study|Adverse Event|24|||
33198845|NCT02104557|100630654|FG000|Overall Study|Lost to Follow-up|34|||
33198846|NCT02104557|100630654|FG000|Overall Study|Violated the usage and dosage|14|||
33198847|NCT02104557|100630654|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
33198848|NCT02104557|100630654|FG000|Overall Study|Administered Sayana prior to the contract|1|||
33198849|NCT02104557|100630654|FG000|Overall Study|Other|17|||
33198850|NCT02104557|100630654|FG000|Overall Study|Change to other contraception methods|5|||
33198851|NCT02104557|100630654|FG000|Overall Study|Discontinuation due to no pain|1|||
33198852|NCT02104557|100630654|FG000|Overall Study|Withdrawal consent|2|||
33324680|NCT00117507|101084808|FG000|Overall Study|Death|3|||
33198853|NCT02104557|100630654|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
33198854|NCT02104557|100630654|FG000|Overall Study|Discontinuation of contraception|9|||
33198855|NCT00829621|100630658|FG000|Overall Study|Death|1|||
33198856|NCT00829621|100630659|FG001|Overall Study|Death|0|||
33198857|NCT00829621|100630658|FG000|Overall Study|Lost to Follow-up|3|||
33198858|NCT00829621|100630659|FG001|Overall Study|Lost to Follow-up|4|||
33198859|NCT03495908|100630660|FG000|Overall Study|Withdrawal by Subject|3|||
33198860|NCT03495908|100630661|FG001|Overall Study|Withdrawal by Subject|1|||
33324681|NCT01473563|101084809|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
33324682|NCT01401842|101084810|FG000|Overall Study|Withdrawal by Subject|3|||
33513431|NCT02344290|101776570|FG000|Overall Study|Site Closure|15|||
33513432|NCT02344290|101776571|FG001|Overall Study|Site Closure|19|||
33513433|NCT02344290|101776570|FG000|Overall Study|Other|5|||
33513434|NCT02344290|101776571|FG001|Overall Study|Other|3|||
33513435|NCT00834639|101776572|FG000|Second Intervention|Physician Decision|0|||
33513436|NCT00834639|101776573|FG001|Second Intervention|Physician Decision|2|||
33513437|NCT01093326|101776574|FG000|Overall Study|Death|0|||
33513438|NCT01093326|101776575|FG001|Overall Study|Death|1|||
33513439|NCT01093326|101776576|FG002|Overall Study|Death|0|||
33513440|NCT01093326|101776574|FG000|Overall Study|Lack of Efficacy|7|||
33513441|NCT01093326|101776575|FG001|Overall Study|Lack of Efficacy|6|||
33513442|NCT01093326|101776576|FG002|Overall Study|Lack of Efficacy|3|||
33513443|NCT01093326|101776574|FG000|Overall Study|Lost to Follow-up|2|||
33606529|NCT01302054|102108402|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
33606530|NCT01302054|102108400|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
33606531|NCT01302054|102108401|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
33606532|NCT01302054|102108402|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
33606533|NCT01302054|102108400|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
33606534|NCT01302054|102108401|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
33606535|NCT01302054|102108402|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
33606536|NCT01302054|102108400|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
33606537|NCT01302054|102108401|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
33606538|NCT01302054|102108402|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
33606539|NCT01302054|102108400|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
33606540|NCT01302054|102108401|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
33324683|NCT01401842|101084811|FG001|Overall Study|Withdrawal by Subject|2|||
33324684|NCT01401842|101084810|FG000|Overall Study|academic reason|4|||
33324685|NCT01401842|101084811|FG001|Overall Study|academic reason|1|||
33324686|NCT01401842|101084810|FG000|Overall Study|changed companies|20|||
33324687|NCT01401842|101084811|FG001|Overall Study|changed companies|34|||
33324688|NCT01401842|101084810|FG000|Overall Study|discharged from US Army|3|||
33324689|NCT01401842|101084811|FG001|Overall Study|discharged from US Army|4|||
33324690|NCT01401842|101084810|FG000|Overall Study|invalid follow-up strength data|1|||
33324691|NCT01401842|101084811|FG001|Overall Study|invalid follow-up strength data|4|||
33324692|NCT01401842|101084810|FG000|Overall Study|on profile|9|||
33324693|NCT01401842|101084811|FG001|Overall Study|on profile|5|||
33324694|NCT01401842|101084810|FG000|Overall Study|other/unknown|28|||
33324695|NCT01401842|101084811|FG001|Overall Study|other/unknown|17|||
33324696|NCT01101438|101084812|FG000|Overall Study|Withdrawal by Subject|8|||
33324697|NCT01101438|101084813|FG001|Overall Study|Withdrawal by Subject|9|||
33324698|NCT01848353|101084815|FG000|Phase 1|Withdrawal by Subject|3|||
33324699|NCT01848353|101084816|FG001|Phase 1|Withdrawal by Subject|1|||
33324700|NCT01848353|101084817|FG002|Phase 1|Withdrawal by Subject|0|||
33513444|NCT01093326|101776575|FG001|Overall Study|Lost to Follow-up|5|||
33513445|NCT01093326|101776576|FG002|Overall Study|Lost to Follow-up|4|||
33606541|NCT01302054|102108402|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
33606542|NCT01302054|102108400|FG000|Double-Blind Treatment Phase|Other|0|||
33606543|NCT01302054|102108401|FG001|Double-Blind Treatment Phase|Other|4|||
33606544|NCT01302054|102108402|FG002|Double-Blind Treatment Phase|Other|9|||
33606545|NCT00483041|102108403|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
33606546|NCT00483041|102108404|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
33606547|NCT01278407|102108405|FG000|Confirmatory Phase|Adverse Event|5|||
33606548|NCT01278407|102108406|FG001|Confirmatory Phase|Adverse Event|10|||
33606549|NCT01278407|102108407|FG002|Confirmatory Phase|Adverse Event|1|||
33606550|NCT01278407|102108408|FG003|Confirmatory Phase|Adverse Event|0|||
33606551|NCT01278407|102108409|FG004|Confirmatory Phase|Adverse Event|0|||
33198861|NCT03495908|100630660|FG000|Overall Study|Lost to Follow-up|1|||
33198862|NCT03495908|100630661|FG001|Overall Study|Lost to Follow-up|4|||
33198863|NCT03495908|100630660|FG000|Overall Study|Adverse Event|0|||
33324701|NCT01848353|101084818|FG003|Phase 1|Withdrawal by Subject|0|||
33324702|NCT01848353|101084815|FG000|Phase 2|Withdrawal by Subject|3|||
33513446|NCT01093326|101776574|FG000|Overall Study|Physician Decision|3|||
33513447|NCT01093326|101776575|FG001|Overall Study|Physician Decision|1|||
33513448|NCT01093326|101776576|FG002|Overall Study|Physician Decision|3|||
33513449|NCT01093326|101776574|FG000|Overall Study|Withdrawal by Subject|30|||
33513450|NCT01093326|101776575|FG001|Overall Study|Withdrawal by Subject|27|||
33606552|NCT01278407|102108405|FG000|Confirmatory Phase|Participant's Choice|3|||
33606553|NCT01278407|102108406|FG001|Confirmatory Phase|Participant's Choice|5|||
33606554|NCT01278407|102108407|FG002|Confirmatory Phase|Participant's Choice|3|||
33606555|NCT01278407|102108408|FG003|Confirmatory Phase|Participant's Choice|0|||
33606556|NCT01278407|102108409|FG004|Confirmatory Phase|Participant's Choice|0|||
33606557|NCT01278407|102108405|FG000|Confirmatory Phase|Other|1|||
33606558|NCT01278407|102108406|FG001|Confirmatory Phase|Other|1|||
33606559|NCT01278407|102108407|FG002|Confirmatory Phase|Other|2|||
33606560|NCT01278407|102108408|FG003|Confirmatory Phase|Other|0|||
33606561|NCT01278407|102108409|FG004|Confirmatory Phase|Other|0|||
33606562|NCT01278407|102108405|FG000|Extension Phase|Adverse Event|0|||
33606563|NCT01278407|102108406|FG001|Extension Phase|Adverse Event|0|||
33606564|NCT01278407|102108407|FG002|Extension Phase|Adverse Event|0|||
33606565|NCT01278407|102108408|FG003|Extension Phase|Adverse Event|7|||
33606566|NCT01278407|102108409|FG004|Extension Phase|Adverse Event|16|||
33606567|NCT01278407|102108405|FG000|Extension Phase|Participant's Choice|0|||
33606568|NCT01278407|102108406|FG001|Extension Phase|Participant's Choice|0|||
33606569|NCT01278407|102108407|FG002|Extension Phase|Participant's Choice|0|||
33606570|NCT01278407|102108408|FG003|Extension Phase|Participant's Choice|4|||
33606571|NCT01278407|102108409|FG004|Extension Phase|Participant's Choice|11|||
33606572|NCT01278407|102108405|FG000|Extension Phase|Other|0|||
33606573|NCT01278407|102108406|FG001|Extension Phase|Other|0|||
33606574|NCT01278407|102108407|FG002|Extension Phase|Other|0|||
33606575|NCT01278407|102108408|FG003|Extension Phase|Other|1|||
33606576|NCT01278407|102108409|FG004|Extension Phase|Other|3|||
33513451|NCT01093326|101776576|FG002|Overall Study|Withdrawal by Subject|26|||
33513452|NCT01093326|101776574|FG000|Overall Study|Adverse Event|2|||
33513453|NCT01093326|101776575|FG001|Overall Study|Adverse Event|1|||
33513454|NCT01093326|101776576|FG002|Overall Study|Adverse Event|4|||
33513455|NCT01093326|101776574|FG000|Overall Study|Other|0|||
33513456|NCT01093326|101776575|FG001|Overall Study|Other|0|||
33606577|NCT00619099|102108410|FG000|Overall Study|Progressive Disease|7|||
33606578|NCT00619099|102108411|FG001|Overall Study|Progressive Disease|5|||
33606579|NCT00619099|102108410|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
33606580|NCT00619099|102108411|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
33606581|NCT00619099|102108410|FG000|Overall Study|Adverse Event|4|||
33606582|NCT00619099|102108411|FG001|Overall Study|Adverse Event|3|||
33606583|NCT00619099|102108410|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
33606584|NCT00619099|102108411|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
33606585|NCT00619099|102108410|FG000|Overall Study|Withdrawal by Subject|10|||
33606586|NCT00619099|102108411|FG001|Overall Study|Withdrawal by Subject|2|||
33606587|NCT00619099|102108410|FG000|Overall Study|Physician Decision|9|||
33606588|NCT00619099|102108411|FG001|Overall Study|Physician Decision|6|||
33198864|NCT03495908|100630661|FG001|Overall Study|Adverse Event|2|||
33198865|NCT03495908|100630660|FG000|Overall Study|Death|1|||
33198866|NCT03495908|100630661|FG001|Overall Study|Death|0|||
33513457|NCT01093326|101776576|FG002|Overall Study|Other|1|||
33513458|NCT01037127|101776577|FG000|Overall Study|Lost to Follow-up|2|||
33606589|NCT01879072|102108412|FG000|Overall Study|Withdrawal by Subject|121|||
33606590|NCT01879072|102108412|FG000|Overall Study|Not Transplanted|30|||
33606591|NCT01424566|102108419|FG000|Single-blind Treatment|Adverse Event|71|||
33606592|NCT01424566|102108420|FG001|Single-blind Treatment|Adverse Event|0|||
33606593|NCT01424566|102108421|FG002|Single-blind Treatment|Adverse Event|0|||
33606594|NCT01424566|102108419|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
33606595|NCT01424566|102108420|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
33606596|NCT01424566|102108421|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
33606597|NCT01424566|102108419|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
33606598|NCT01424566|102108420|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
33606599|NCT01424566|102108421|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
33606600|NCT01424566|102108419|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
33606601|NCT01424566|102108420|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
33606602|NCT01424566|102108421|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
33513459|NCT01037127|101776578|FG001|Overall Study|Lost to Follow-up|4|||
33513460|NCT01037127|101776577|FG000|Overall Study|Physician Decision|1|||
33513461|NCT01037127|101776578|FG001|Overall Study|Physician Decision|0|||
33606603|NCT01424566|102108419|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
33513462|NCT01037127|101776577|FG000|Overall Study|Study Closed Terminated|2|||
33606604|NCT01424566|102108420|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
33606605|NCT01424566|102108421|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
33606606|NCT01424566|102108419|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
33606607|NCT01424566|102108420|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
33399130|NCT02394028|101350181|FG006|Induction Phase|:ack of calculation|0|||
33399131|NCT02394028|101350182|FG007|Induction Phase|:ack of calculation|1|||
33399132|NCT02394028|101350183|FG008|Induction Phase|:ack of calculation|0|||
33399133|NCT02394028|101350184|FG009|Induction Phase|:ack of calculation|0|||
33399134|NCT02394028|101350185|FG010|Induction Phase|:ack of calculation|0|||
33399135|NCT02394028|101350175|FG000|Maintenance Phase|Protocol Violation|0|||
33399136|NCT02394028|101350176|FG001|Maintenance Phase|Protocol Violation|0|||
33399137|NCT02394028|101350177|FG002|Maintenance Phase|Protocol Violation|0|||
33399138|NCT02394028|101350178|FG003|Maintenance Phase|Protocol Violation|0|||
33399139|NCT02394028|101350179|FG004|Maintenance Phase|Protocol Violation|0|||
33399140|NCT02394028|101350180|FG005|Maintenance Phase|Protocol Violation|0|||
33399141|NCT02394028|101350181|FG006|Maintenance Phase|Protocol Violation|0|||
33399142|NCT02394028|101350182|FG007|Maintenance Phase|Protocol Violation|0|||
33399143|NCT02394028|101350183|FG008|Maintenance Phase|Protocol Violation|0|||
33399144|NCT02394028|101350184|FG009|Maintenance Phase|Protocol Violation|0|||
33399145|NCT02394028|101350185|FG010|Maintenance Phase|Protocol Violation|1|||
33399146|NCT02394028|101350175|FG000|Maintenance Phase|Physician Decision|0|||
33399147|NCT02394028|101350176|FG001|Maintenance Phase|Physician Decision|0|||
33399148|NCT02394028|101350177|FG002|Maintenance Phase|Physician Decision|0|||
33399149|NCT02394028|101350178|FG003|Maintenance Phase|Physician Decision|0|||
33399150|NCT02394028|101350179|FG004|Maintenance Phase|Physician Decision|0|||
33399151|NCT02394028|101350180|FG005|Maintenance Phase|Physician Decision|0|||
33399152|NCT02394028|101350181|FG006|Maintenance Phase|Physician Decision|0|||
33399153|NCT02394028|101350182|FG007|Maintenance Phase|Physician Decision|0|||
33399154|NCT02394028|101350183|FG008|Maintenance Phase|Physician Decision|1|||
33399155|NCT02394028|101350184|FG009|Maintenance Phase|Physician Decision|3|||
33399156|NCT02394028|101350185|FG010|Maintenance Phase|Physician Decision|2|||
33399157|NCT02394028|101350175|FG000|Maintenance Phase|Lack of Efficacy|0|||
33399158|NCT02394028|101350176|FG001|Maintenance Phase|Lack of Efficacy|0|||
33399159|NCT02394028|101350177|FG002|Maintenance Phase|Lack of Efficacy|0|||
33399160|NCT02394028|101350178|FG003|Maintenance Phase|Lack of Efficacy|0|||
33399161|NCT02394028|101350179|FG004|Maintenance Phase|Lack of Efficacy|0|||
33399162|NCT02394028|101350180|FG005|Maintenance Phase|Lack of Efficacy|0|||
33399163|NCT02394028|101350181|FG006|Maintenance Phase|Lack of Efficacy|0|||
33399164|NCT02394028|101350182|FG007|Maintenance Phase|Lack of Efficacy|0|||
33399165|NCT02394028|101350183|FG008|Maintenance Phase|Lack of Efficacy|7|||
33399166|NCT02394028|101350184|FG009|Maintenance Phase|Lack of Efficacy|25|||
33399167|NCT02394028|101350185|FG010|Maintenance Phase|Lack of Efficacy|33|||
33399168|NCT02394028|101350175|FG000|Maintenance Phase|Death|0|||
33399169|NCT02394028|101350176|FG001|Maintenance Phase|Death|0|||
33399170|NCT02394028|101350177|FG002|Maintenance Phase|Death|0|||
33399171|NCT02394028|101350178|FG003|Maintenance Phase|Death|0|||
33399172|NCT02394028|101350179|FG004|Maintenance Phase|Death|0|||
33399173|NCT02394028|101350180|FG005|Maintenance Phase|Death|0|||
33399174|NCT02394028|101350181|FG006|Maintenance Phase|Death|0|||
33399175|NCT02394028|101350182|FG007|Maintenance Phase|Death|0|||
33399176|NCT02394028|101350183|FG008|Maintenance Phase|Death|0|||
33399177|NCT02394028|101350184|FG009|Maintenance Phase|Death|0|||
33399178|NCT02394028|101350185|FG010|Maintenance Phase|Death|1|||
33399179|NCT02394028|101350175|FG000|Maintenance Phase|Adverse Event|0|||
33399180|NCT02394028|101350176|FG001|Maintenance Phase|Adverse Event|0|||
33606608|NCT01424566|102108421|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
33606609|NCT01424566|102108419|FG000|Double-blind Treatment|Adverse Event|0|||
33606610|NCT01424566|102108420|FG001|Double-blind Treatment|Adverse Event|21|||
33606611|NCT01424566|102108421|FG002|Double-blind Treatment|Adverse Event|13|||
33606612|NCT01424566|102108419|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
33399181|NCT02394028|101350177|FG002|Maintenance Phase|Adverse Event|0|||
33399182|NCT02394028|101350178|FG003|Maintenance Phase|Adverse Event|0|||
33399183|NCT02394028|101350179|FG004|Maintenance Phase|Adverse Event|0|||
33399184|NCT02394028|101350180|FG005|Maintenance Phase|Adverse Event|0|||
33399185|NCT02394028|101350181|FG006|Maintenance Phase|Adverse Event|0|||
33399186|NCT02394028|101350182|FG007|Maintenance Phase|Adverse Event|0|||
33399187|NCT02394028|101350183|FG008|Maintenance Phase|Adverse Event|1|||
33399188|NCT02394028|101350184|FG009|Maintenance Phase|Adverse Event|1|||
33399189|NCT02394028|101350185|FG010|Maintenance Phase|Adverse Event|3|||
33399190|NCT02394028|101350175|FG000|Maintenance Phase|Site closure|0|||
33399191|NCT02394028|101350176|FG001|Maintenance Phase|Site closure|0|||
33399192|NCT02394028|101350177|FG002|Maintenance Phase|Site closure|0|||
33399193|NCT02394028|101350178|FG003|Maintenance Phase|Site closure|0|||
33399194|NCT02394028|101350179|FG004|Maintenance Phase|Site closure|0|||
33399195|NCT02394028|101350180|FG005|Maintenance Phase|Site closure|0|||
33399196|NCT02394028|101350181|FG006|Maintenance Phase|Site closure|0|||
33399197|NCT02394028|101350182|FG007|Maintenance Phase|Site closure|0|||
33399198|NCT02394028|101350183|FG008|Maintenance Phase|Site closure|0|||
33399199|NCT02394028|101350184|FG009|Maintenance Phase|Site closure|1|||
33399200|NCT02394028|101350185|FG010|Maintenance Phase|Site closure|0|||
33399201|NCT02394028|101350175|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33399202|NCT02394028|101350176|FG001|Maintenance Phase|Withdrawal by Subject|0|||
33399203|NCT02394028|101350177|FG002|Maintenance Phase|Withdrawal by Subject|0|||
33399204|NCT02394028|101350178|FG003|Maintenance Phase|Withdrawal by Subject|0|||
33399205|NCT02394028|101350179|FG004|Maintenance Phase|Withdrawal by Subject|0|||
33399206|NCT02394028|101350180|FG005|Maintenance Phase|Withdrawal by Subject|0|||
33399207|NCT02394028|101350181|FG006|Maintenance Phase|Withdrawal by Subject|0|||
33399208|NCT02394028|101350182|FG007|Maintenance Phase|Withdrawal by Subject|0|||
33399209|NCT02394028|101350183|FG008|Maintenance Phase|Withdrawal by Subject|3|||
33399210|NCT02394028|101350184|FG009|Maintenance Phase|Withdrawal by Subject|12|||
33399211|NCT02394028|101350185|FG010|Maintenance Phase|Withdrawal by Subject|12|||
33399212|NCT00517634|101350186|FG000|Second Treatment Period|Withdrawal by Subject|0|||
33399213|NCT00517634|101350187|FG001|Second Treatment Period|Withdrawal by Subject|0|||
33399214|NCT00517634|101350188|FG002|Second Treatment Period|Withdrawal by Subject|0|||
33399215|NCT00517634|101350189|FG003|Second Treatment Period|Withdrawal by Subject|0|||
33399216|NCT00517634|101350190|FG004|Second Treatment Period|Withdrawal by Subject|1|||
33399217|NCT00517634|101350191|FG005|Second Treatment Period|Withdrawal by Subject|0|||
33399218|NCT02407236|101350192|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
33399219|NCT02407236|101350193|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
33399220|NCT02407236|101350194|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
33399221|NCT02407236|101350195|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
33399222|NCT02407236|101350196|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
33399223|NCT02407236|101350197|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
33399224|NCT02407236|101350198|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
33399225|NCT02407236|101350199|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
33399226|NCT02407236|101350200|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
33399227|NCT02407236|101350201|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
33399228|NCT02407236|101350202|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
33399229|NCT02407236|101350203|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
33399230|NCT02407236|101350204|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
33399231|NCT02407236|101350192|FG000|Induction Study (8 Weeks)|Death|0|||
33399232|NCT02407236|101350193|FG001|Induction Study (8 Weeks)|Death|0|||
33399233|NCT02407236|101350194|FG002|Induction Study (8 Weeks)|Death|1|||
33399234|NCT02407236|101350195|FG003|Induction Study (8 Weeks)|Death|0|||
33399235|NCT02407236|101350196|FG004|Induction Study (8 Weeks)|Death|0|||
33399236|NCT02407236|101350197|FG005|Induction Study (8 Weeks)|Death|0|||
33399237|NCT02407236|101350198|FG006|Induction Study (8 Weeks)|Death|0|||
33399238|NCT02407236|101350199|FG007|Induction Study (8 Weeks)|Death|0|||
33399239|NCT02407236|101350200|FG008|Induction Study (8 Weeks)|Death|0|||
33399240|NCT02407236|101350201|FG009|Induction Study (8 Weeks)|Death|0|||
33399241|NCT02407236|101350202|FG010|Induction Study (8 Weeks)|Death|0|||
33399242|NCT02407236|101350203|FG011|Induction Study (8 Weeks)|Death|0|||
33399243|NCT02407236|101350204|FG012|Induction Study (8 Weeks)|Death|0|||
33399244|NCT02407236|101350192|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
33399245|NCT02407236|101350193|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
33399246|NCT02407236|101350194|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
33399247|NCT02407236|101350195|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33399248|NCT02407236|101350196|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33399249|NCT02407236|101350197|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33399250|NCT02407236|101350198|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33399251|NCT02407236|101350199|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33399252|NCT02407236|101350200|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33399253|NCT02407236|101350201|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33399254|NCT02407236|101350202|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33606613|NCT01424566|102108420|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
33606614|NCT01424566|102108421|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
33606615|NCT01424566|102108419|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
33399255|NCT02407236|101350203|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33399256|NCT02407236|101350204|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
33399257|NCT02407236|101350192|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33399258|NCT02407236|101350193|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33399259|NCT02407236|101350194|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
33399260|NCT02407236|101350195|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33399261|NCT02407236|101350196|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33399262|NCT02407236|101350197|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33399263|NCT02407236|101350198|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33399264|NCT02407236|101350199|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33399265|NCT02407236|101350200|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33399266|NCT02407236|101350201|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33399267|NCT02407236|101350202|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33399268|NCT02407236|101350203|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33399269|NCT02407236|101350204|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
33399270|NCT02407236|101350192|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
33399271|NCT02407236|101350193|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
33399272|NCT02407236|101350194|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
33399273|NCT02407236|101350195|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
33399274|NCT02407236|101350196|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
33399275|NCT02407236|101350197|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
33399276|NCT02407236|101350198|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
33399277|NCT02407236|101350199|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
33399278|NCT02407236|101350200|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
33399279|NCT02407236|101350201|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
33399280|NCT02407236|101350202|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
33399281|NCT02407236|101350203|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
33399282|NCT02407236|101350204|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
33399283|NCT02407236|101350192|FG000|Induction Study (8 Weeks)|Other|2|||
33513463|NCT01037127|101776578|FG001|Overall Study|Study Closed Terminated|17|||
33513464|NCT02691936|101776579|FG000|Overall Study|Withdrawal by Subject|2|||
33513465|NCT02691936|101776580|FG001|Overall Study|Withdrawal by Subject|5|||
33513466|NCT02447497|101776581|FG000|Overall Study|Did not meet treatment day baseline.|6|||
33513467|NCT02447497|101776582|FG001|Overall Study|Did not meet treatment day baseline.|5|||
33606616|NCT01424566|102108420|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
33606617|NCT01424566|102108421|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
33606618|NCT01424566|102108419|FG000|Double-blind Treatment|Lack of Efficacy|0|||
33606619|NCT01424566|102108420|FG001|Double-blind Treatment|Lack of Efficacy|1|||
33606620|NCT01424566|102108421|FG002|Double-blind Treatment|Lack of Efficacy|1|||
33606621|NCT00772109|102108422|FG000|Overall Study|Serious adverse event|1|||
33606622|NCT00772109|102108423|FG001|Overall Study|Serious adverse event|0|||
33606623|NCT00772109|102108424|FG002|Overall Study|Serious adverse event|1|||
33606624|NCT00772109|102108425|FG003|Overall Study|Serious adverse event|0|||
33606625|NCT00772109|102108422|FG000|Overall Study|Protocol Violation|5|||
33606626|NCT00772109|102108423|FG001|Overall Study|Protocol Violation|8|||
33606627|NCT00772109|102108424|FG002|Overall Study|Protocol Violation|7|||
33606628|NCT00772109|102108425|FG003|Overall Study|Protocol Violation|6|||
33198867|NCT03495908|100630660|FG000|Overall Study|Physician Decision|5|||
33198868|NCT03495908|100630661|FG001|Overall Study|Physician Decision|4|||
33198869|NCT03495908|100630660|FG000|Overall Study|No documented reason|0|||
33324703|NCT01848353|101084816|FG001|Phase 2|Withdrawal by Subject|2|||
33324704|NCT01848353|101084817|FG002|Phase 2|Withdrawal by Subject|0|||
33324705|NCT01848353|101084818|FG003|Phase 2|Withdrawal by Subject|0|||
33324706|NCT01848353|101084815|FG000|Phase 3|Withdrawal by Subject|1|||
33324707|NCT01848353|101084816|FG001|Phase 3|Withdrawal by Subject|1|||
33324708|NCT01848353|101084817|FG002|Phase 3|Withdrawal by Subject|0|||
33324709|NCT01848353|101084818|FG003|Phase 3|Withdrawal by Subject|0|||
33513468|NCT02447497|101776583|FG002|Overall Study|Did not meet treatment day baseline.|2|||
33513469|NCT02447497|101776584|FG003|Overall Study|Did not meet treatment day baseline.|2|||
33513470|NCT02447497|101776581|FG000|Overall Study|Dressing was compromised|0|||
33513471|NCT02447497|101776582|FG001|Overall Study|Dressing was compromised|1|||
33513472|NCT02447497|101776583|FG002|Overall Study|Dressing was compromised|0|||
33606629|NCT00772109|102108422|FG000|Overall Study|Lost to Follow-up|7|||
33606630|NCT00772109|102108423|FG001|Overall Study|Lost to Follow-up|3|||
33606631|NCT00772109|102108424|FG002|Overall Study|Lost to Follow-up|5|||
33198870|NCT03495908|100630661|FG001|Overall Study|No documented reason|2|||
33198871|NCT00129259|100630662|FG000|Overall Study|Lost to Follow-up|1|||
33198872|NCT00129259|100630663|FG001|Overall Study|Lost to Follow-up|1|||
33324710|NCT03654976|101084820|FG000|Overall Study|Withdrawal by Subject|12|||
33324711|NCT03654976|101084821|FG001|Overall Study|Withdrawal by Subject|11|||
33324712|NCT03654976|101084820|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
33324713|NCT03654976|101084821|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
33198873|NCT00129259|100630662|FG000|Overall Study|Withdrawal by Subject|2|||
33324714|NCT03654976|101084820|FG000|Overall Study|Adverse Event|5|||
33324715|NCT03654976|101084821|FG001|Overall Study|Adverse Event|0|||
33324716|NCT03654976|101084820|FG000|Overall Study|Lost to Follow-up|2|||
33324717|NCT03654976|101084821|FG001|Overall Study|Lost to Follow-up|0|||
33606632|NCT00772109|102108425|FG003|Overall Study|Lost to Follow-up|9|||
33606633|NCT00772109|102108422|FG000|Overall Study|Withdrawal by Subject|8|||
33606634|NCT00772109|102108423|FG001|Overall Study|Withdrawal by Subject|8|||
33198874|NCT00129259|100630663|FG001|Overall Study|Withdrawal by Subject|1|||
33198875|NCT00129259|100630662|FG000|Overall Study|Only available minimal phone assessments|0|||
33324718|NCT03654976|101084820|FG000|Overall Study|Lack of Efficacy|0|||
33324719|NCT03654976|101084821|FG001|Overall Study|Lack of Efficacy|1|||
33399284|NCT02407236|101350193|FG001|Induction Study (8 Weeks)|Other|1|||
33399285|NCT02407236|101350194|FG002|Induction Study (8 Weeks)|Other|5|||
33399286|NCT02407236|101350195|FG003|Induction Study (8 Weeks)|Other|0|||
33513473|NCT02447497|101776584|FG003|Overall Study|Dressing was compromised|0|||
33513474|NCT03673345|101776590|FG000|Overall Study|Lost to Follow-up|1|||
33513475|NCT03673345|101776591|FG001|Overall Study|Lost to Follow-up|0|||
33513476|NCT03673345|101776592|FG002|Overall Study|Lost to Follow-up|3|||
33513477|NCT03673345|101776593|FG003|Overall Study|Lost to Follow-up|3|||
33513478|NCT03673345|101776594|FG004|Overall Study|Lost to Follow-up|2|||
33513479|NCT03673345|101776595|FG005|Overall Study|Lost to Follow-up|1|||
33513480|NCT03673345|101776596|FG006|Overall Study|Lost to Follow-up|0|||
33513481|NCT03673345|101776597|FG007|Overall Study|Lost to Follow-up|0|||
33513482|NCT03673345|101776590|FG000|Overall Study|Withdrawal by Subject|1|||
33513483|NCT03673345|101776591|FG001|Overall Study|Withdrawal by Subject|0|||
33513484|NCT03673345|101776592|FG002|Overall Study|Withdrawal by Subject|4|||
33513485|NCT03673345|101776593|FG003|Overall Study|Withdrawal by Subject|2|||
33513486|NCT03673345|101776594|FG004|Overall Study|Withdrawal by Subject|0|||
33513487|NCT03673345|101776595|FG005|Overall Study|Withdrawal by Subject|0|||
33513488|NCT03673345|101776596|FG006|Overall Study|Withdrawal by Subject|0|||
33513489|NCT03673345|101776597|FG007|Overall Study|Withdrawal by Subject|0|||
33513490|NCT03673345|101776590|FG000|Overall Study|Physician Decision|0|||
33513491|NCT03673345|101776591|FG001|Overall Study|Physician Decision|0|||
33513492|NCT03673345|101776592|FG002|Overall Study|Physician Decision|2|||
33513493|NCT03673345|101776593|FG003|Overall Study|Physician Decision|0|||
33513494|NCT03673345|101776594|FG004|Overall Study|Physician Decision|0|||
33513495|NCT03673345|101776595|FG005|Overall Study|Physician Decision|0|||
33513496|NCT03673345|101776596|FG006|Overall Study|Physician Decision|0|||
33513497|NCT03673345|101776597|FG007|Overall Study|Physician Decision|0|||
33513498|NCT00636194|101776598|FG000|Overall Study|Study related symptoms and complaints|1|||
33513499|NCT00636194|101776599|FG001|Overall Study|Study related symptoms and complaints|0|||
33513500|NCT00636194|101776598|FG000|Overall Study|Protocol Violation|2|||
33513501|NCT00636194|101776599|FG001|Overall Study|Protocol Violation|0|||
33513502|NCT01088243|101776600|FG000|Overall Study|Adverse Event|1|||
33513503|NCT01088243|101776601|FG001|Overall Study|Adverse Event|0|||
33513504|NCT03126019|101776624|FG000|Overall Study|Participants Still Ongoing in the Study|17|||
33513505|NCT03126019|101776625|FG001|Overall Study|Participants Still Ongoing in the Study|87|||
33513506|NCT03126019|101776624|FG000|Overall Study|Death|2|||
33513507|NCT03126019|101776625|FG001|Overall Study|Death|7|||
33513508|NCT03126019|101776624|FG000|Overall Study|Lost to Follow-up|2|||
33513509|NCT03126019|101776625|FG001|Overall Study|Lost to Follow-up|3|||
33513510|NCT03126019|101776624|FG000|Overall Study|Withdrawal by Participant|1|||
33513511|NCT03126019|101776625|FG001|Overall Study|Withdrawal by Participant|3|||
33513512|NCT03126019|101776624|FG000|Overall Study|Reason not Specified|1|||
33513513|NCT03126019|101776625|FG001|Overall Study|Reason not Specified|3|||
33513514|NCT00520481|101776628|FG000|Overall Study|Adverse Event|4|||
33513515|NCT00520481|101776629|FG001|Overall Study|Adverse Event|1|||
33513516|NCT00520481|101776628|FG000|Overall Study|Withdrawal by Subject|3|||
33606635|NCT00772109|102108424|FG002|Overall Study|Withdrawal by Subject|6|||
33606636|NCT00772109|102108425|FG003|Overall Study|Withdrawal by Subject|16|||
33606637|NCT02438813|102108426|FG000|Overall Study|Patient Decision|59|||
33606638|NCT02438813|102108426|FG000|Overall Study|Patient Lost to Follow-Up|137|||
33606639|NCT02438813|102108426|FG000|Overall Study|Study Ended by Sponsor|80|||
33606640|NCT02438813|102108426|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
33606641|NCT04006392|102108429|FG000|Overall Study|Lost to Follow-up|0|||
33606642|NCT04006392|102108430|FG001|Overall Study|Lost to Follow-up|1|||
33606643|NCT02160145|102108431|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
33606644|NCT02160145|102108432|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
33606645|NCT02160145|102108433|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
33606646|NCT02160145|102108431|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
33513517|NCT00520481|101776629|FG001|Overall Study|Withdrawal by Subject|0|||
33513518|NCT02017912|101776641|FG000|Overall Study|Withdrawal by Subject|2|||
33513519|NCT02017912|101776642|FG001|Overall Study|Withdrawal by Subject|1|||
33513520|NCT02017912|101776641|FG000|Overall Study|miscellaneous|1|||
33513521|NCT02017912|101776642|FG001|Overall Study|miscellaneous|1|||
33513522|NCT01317797|101776643|FG000|Overall Study|Other|0|||
33513523|NCT01317797|101776644|FG001|Overall Study|Other|1|||
33513524|NCT01317797|101776645|FG002|Overall Study|Other|0|||
33513525|NCT01317797|101776643|FG000|Overall Study|Withdrawal of Patient|0|||
33513526|NCT01317797|101776644|FG001|Overall Study|Withdrawal of Patient|0|||
33513527|NCT01317797|101776645|FG002|Overall Study|Withdrawal of Patient|1|||
33513528|NCT00595517|101776655|FG000|Overall Study|Adverse Event|6|||
33513529|NCT00595517|101776655|FG000|Overall Study|Withdrawal by Subject|4|||
33324720|NCT00295633|101084822|FG000|Overall Study|Lack of Efficacy|19|||
33324721|NCT00295633|101084823|FG001|Overall Study|Lack of Efficacy|7|||
33324722|NCT00295633|101084824|FG002|Overall Study|Lack of Efficacy|16|||
33198876|NCT00129259|100630663|FG001|Overall Study|Only available minimal phone assessments|1|||
33198877|NCT02200042|100630664|FG000|Overall Study|Withdrawal by Subject|0|||
33324723|NCT00295633|101084822|FG000|Overall Study|Withdrawal of consent by subject|16|||
33324724|NCT00295633|101084823|FG001|Overall Study|Withdrawal of consent by subject|16|||
33324725|NCT00295633|101084824|FG002|Overall Study|Withdrawal of consent by subject|26|||
33324726|NCT00295633|101084822|FG000|Overall Study|Adverse Event|9|||
33324727|NCT00295633|101084823|FG001|Overall Study|Adverse Event|17|||
33399287|NCT02407236|101350196|FG004|Induction Study (8 Weeks)|Other|0|||
33399288|NCT02407236|101350197|FG005|Induction Study (8 Weeks)|Other|0|||
33399289|NCT02407236|101350198|FG006|Induction Study (8 Weeks)|Other|0|||
33324728|NCT00295633|101084824|FG002|Overall Study|Adverse Event|9|||
33324729|NCT00295633|101084822|FG000|Overall Study|Lost to Follow-up|6|||
33324730|NCT00295633|101084823|FG001|Overall Study|Lost to Follow-up|11|||
33324731|NCT00295633|101084824|FG002|Overall Study|Lost to Follow-up|7|||
33324732|NCT00295633|101084822|FG000|Overall Study|Physician Decision|9|||
33324733|NCT00295633|101084823|FG001|Overall Study|Physician Decision|10|||
33324734|NCT00295633|101084824|FG002|Overall Study|Physician Decision|8|||
33324735|NCT00295633|101084822|FG000|Overall Study|Poor/Noncompliance|2|||
33324736|NCT00295633|101084823|FG001|Overall Study|Poor/Noncompliance|2|||
33324737|NCT00295633|101084824|FG002|Overall Study|Poor/Noncompliance|6|||
33324738|NCT00295633|101084822|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
33324739|NCT00295633|101084823|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
33324740|NCT00295633|101084824|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
33324741|NCT00295633|101084822|FG000|Overall Study|Death|1|||
33606647|NCT02160145|102108432|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
33606648|NCT02160145|102108433|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
33606649|NCT02160145|102108431|FG000|Randomized Double-blind Period|Subject decision|0|||
33606650|NCT02160145|102108432|FG001|Randomized Double-blind Period|Subject decision|21|||
33606651|NCT02160145|102108433|FG002|Randomized Double-blind Period|Subject decision|20|||
33606652|NCT02160145|102108431|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
33606653|NCT02160145|102108432|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
33606654|NCT02160145|102108433|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
33606655|NCT02160145|102108431|FG000|Randomized Double-blind Period|Physician Decision|0|||
33606656|NCT02160145|102108432|FG001|Randomized Double-blind Period|Physician Decision|7|||
33606657|NCT02160145|102108433|FG002|Randomized Double-blind Period|Physician Decision|5|||
33606658|NCT03565237|102108434|FG000|Overall Study|Non-compliance of Investigational Product|1|||
33606659|NCT03565237|102108434|FG000|Overall Study|Physician Decision|1|||
33606660|NCT01814670|102108435|FG000|Overall Study|Protocol Violation|12|||
33606661|NCT01825941|102108436|FG000|Overall Study|Lost to Follow-up|4|||
33606662|NCT01825941|102108437|FG001|Overall Study|Lost to Follow-up|1|||
33606663|NCT03316950|102108440|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
33606664|NCT03316950|102108441|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
33606665|NCT03316950|102108442|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
33606666|NCT03316950|102108443|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
33606667|NCT03316950|102108440|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
33606668|NCT03316950|102108441|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
33606669|NCT03316950|102108442|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
33606670|NCT03316950|102108443|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
33606671|NCT03316950|102108440|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
33606672|NCT03316950|102108441|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
33606673|NCT03316950|102108442|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
33606674|NCT03316950|102108443|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
33606675|NCT01009086|102111493|FG000|Overall Study|Lack of Efficacy|16|||
33606676|NCT01009086|102111494|FG001|Overall Study|Lack of Efficacy|15|||
33606677|NCT01009086|102111495|FG002|Overall Study|Lack of Efficacy|9|||
33606678|NCT01009086|102111493|FG000|Overall Study|Lost to Follow-up|4|||
33606679|NCT01009086|102111494|FG001|Overall Study|Lost to Follow-up|5|||
33606680|NCT01009086|102111495|FG002|Overall Study|Lost to Follow-up|3|||
33606681|NCT01009086|102111493|FG000|Overall Study|Adverse Event|12|||
33606682|NCT01009086|102111494|FG001|Overall Study|Adverse Event|11|||
33606683|NCT01009086|102111495|FG002|Overall Study|Adverse Event|8|||
33606684|NCT01009086|102111493|FG000|Overall Study|Withdrawal by Subject|9|||
33606685|NCT01009086|102111494|FG001|Overall Study|Withdrawal by Subject|11|||
33606686|NCT01009086|102111495|FG002|Overall Study|Withdrawal by Subject|13|||
33606687|NCT01009086|102111493|FG000|Overall Study|Other|3|||
33606688|NCT01009086|102111494|FG001|Overall Study|Other|5|||
33606689|NCT01009086|102111495|FG002|Overall Study|Other|1|||
33606690|NCT00771615|102111497|FG000|Overall Study|Withdrawal by Subject|0|||
33606691|NCT00771615|102111498|FG001|Overall Study|Withdrawal by Subject|1|||
33606692|NCT00771615|102111499|FG002|Overall Study|Withdrawal by Subject|0|||
33606693|NCT00771615|102111500|FG003|Overall Study|Withdrawal by Subject|0|||
33606694|NCT00771615|102111501|FG004|Overall Study|Withdrawal by Subject|0|||
33606695|NCT00771615|102111502|FG005|Overall Study|Withdrawal by Subject|0|||
33606696|NCT00771615|102111503|FG006|Overall Study|Withdrawal by Subject|0|||
33606697|NCT00771615|102111504|FG007|Overall Study|Withdrawal by Subject|1|||
33606698|NCT00771615|102111505|FG008|Overall Study|Withdrawal by Subject|0|||
33606699|NCT00771615|102111497|FG000|Overall Study|Lost to Follow-up|1|||
33606700|NCT00771615|102111498|FG001|Overall Study|Lost to Follow-up|1|||
33324742|NCT00295633|101084823|FG001|Overall Study|Death|1|||
33324743|NCT00295633|101084824|FG002|Overall Study|Death|0|||
33324744|NCT00295633|101084822|FG000|Overall Study|Administrative reason by sponsor|0|||
33324745|NCT00295633|101084823|FG001|Overall Study|Administrative reason by sponsor|0|||
33324746|NCT00295633|101084824|FG002|Overall Study|Administrative reason by sponsor|1|||
33324747|NCT02146599|101084825|FG000|Overall Study|Failed to meet inclusion criteria|5|||
33324748|NCT01010633|101084826|FG000|Overall Study|Adverse Event|1|||
33324749|NCT01010633|101084827|FG001|Overall Study|Adverse Event|1|||
33324750|NCT01010633|101084826|FG000|Overall Study|Protocol Violation|1|||
33324751|NCT01010633|101084827|FG001|Overall Study|Protocol Violation|2|||
33324752|NCT01010633|101084826|FG000|Overall Study|Withdrawal by Subject|2|||
33324753|NCT01010633|101084827|FG001|Overall Study|Withdrawal by Subject|1|||
33324754|NCT01010633|101084826|FG000|Overall Study|Investigator decision|0|||
33324755|NCT01010633|101084827|FG001|Overall Study|Investigator decision|1|||
33324756|NCT00578136|101084828|FG000|Overall Study|Not given intervention|1|||
33324757|NCT00578136|101084829|FG001|Overall Study|Not given intervention|1|||
33324758|NCT00938717|101084830|FG000|Overall Study|Adverse Event|10|||
33324759|NCT00938717|101084831|FG001|Overall Study|Adverse Event|41|||
33324760|NCT00938717|101084830|FG000|Overall Study|Protocol Violation|11|||
33324761|NCT00938717|101084831|FG001|Overall Study|Protocol Violation|8|||
33324762|NCT00938717|101084830|FG000|Overall Study|Withdrawal by Subject|26|||
33324763|NCT00938717|101084831|FG001|Overall Study|Withdrawal by Subject|24|||
33324764|NCT00938717|101084830|FG000|Overall Study|Lost to Follow-up|13|||
33513530|NCT00595517|101776655|FG000|Overall Study|Protocol Violation|2|||
33324765|NCT00938717|101084831|FG001|Overall Study|Lost to Follow-up|18|||
33513531|NCT00595517|101776655|FG000|Overall Study|Recurrence of ulcer|5|||
33606701|NCT00771615|102111499|FG002|Overall Study|Lost to Follow-up|1|||
33324766|NCT00938717|101084830|FG000|Overall Study|Lack of Efficacy|33|||
33324767|NCT00938717|101084831|FG001|Overall Study|Lack of Efficacy|15|||
33324768|NCT00938717|101084830|FG000|Overall Study|Other reason|5|||
33324769|NCT00938717|101084831|FG001|Overall Study|Other reason|2|||
33606702|NCT00771615|102111500|FG003|Overall Study|Lost to Follow-up|1|||
33198878|NCT02200042|100630665|FG001|Overall Study|Withdrawal by Subject|1|||
33198879|NCT03156023|100633661|FG000|Overall Study|Withdrawal by Subject|1|||
33198880|NCT03156023|100633662|FG001|Overall Study|Withdrawal by Subject|0|||
33198881|NCT03156023|100633663|FG002|Overall Study|Withdrawal by Subject|2|||
33198882|NCT03156023|100633664|FG003|Overall Study|Withdrawal by Subject|1|||
33198883|NCT03156023|100633665|FG004|Overall Study|Withdrawal by Subject|1|||
33198884|NCT03156023|100633661|FG000|Overall Study|Lost to Follow-up|0|||
33198885|NCT03156023|100633662|FG001|Overall Study|Lost to Follow-up|0|||
33198886|NCT03156023|100633663|FG002|Overall Study|Lost to Follow-up|0|||
33198887|NCT03156023|100633664|FG003|Overall Study|Lost to Follow-up|0|||
33198888|NCT03156023|100633665|FG004|Overall Study|Lost to Follow-up|1|||
33198889|NCT00646958|100633666|FG000|Overall Study|Lack of Efficacy|1|||
33198890|NCT00646958|100633667|FG001|Overall Study|Lack of Efficacy|0|||
33198891|NCT00646958|100633668|FG002|Overall Study|Lack of Efficacy|0|||
33198892|NCT00646958|100633666|FG000|Overall Study|Adverse Event|4|||
33198893|NCT00646958|100633667|FG001|Overall Study|Adverse Event|0|||
33198894|NCT00646958|100633668|FG002|Overall Study|Adverse Event|0|||
33198895|NCT00646958|100633666|FG000|Overall Study|Lost to Follow-up|1|||
33198896|NCT00646958|100633667|FG001|Overall Study|Lost to Follow-up|5|||
33198897|NCT00646958|100633668|FG002|Overall Study|Lost to Follow-up|7|||
33198898|NCT00646958|100633666|FG000|Overall Study|Protocol Violation|1|||
33198899|NCT00646958|100633667|FG001|Overall Study|Protocol Violation|1|||
33198900|NCT00646958|100633668|FG002|Overall Study|Protocol Violation|0|||
33198901|NCT00646958|100633666|FG000|Overall Study|Abnormal screening lab tests|1|||
33198902|NCT00646958|100633667|FG001|Overall Study|Abnormal screening lab tests|1|||
33198903|NCT00646958|100633668|FG002|Overall Study|Abnormal screening lab tests|0|||
33198904|NCT00646958|100633666|FG000|Overall Study|Withdrawal by Subject|1|||
33198905|NCT00646958|100633667|FG001|Overall Study|Withdrawal by Subject|2|||
33198906|NCT00646958|100633668|FG002|Overall Study|Withdrawal by Subject|0|||
33198907|NCT00646958|100633666|FG000|Overall Study|Did not receive study drug|2|||
33198908|NCT00646958|100633667|FG001|Overall Study|Did not receive study drug|0|||
33198909|NCT00646958|100633668|FG002|Overall Study|Did not receive study drug|2|||
33198910|NCT03823651|100633671|FG000|Overall Study|Death|5|||
33198911|NCT03823651|100633672|FG001|Overall Study|Death|0|||
33198912|NCT03823651|100633671|FG000|Overall Study|Physician Decision|1|||
33198913|NCT03823651|100633672|FG001|Overall Study|Physician Decision|0|||
33198914|NCT03823651|100633671|FG000|Overall Study|Caregiver to patient who died|0|||
33198915|NCT03823651|100633672|FG001|Overall Study|Caregiver to patient who died|5|||
33198916|NCT03823651|100633671|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
33198917|NCT03823651|100633672|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
33198918|NCT04666441|100633673|FG000|Overall Study|Lost to Follow-up|1|||
33198919|NCT04666441|100633674|FG001|Overall Study|Lost to Follow-up|4|||
33198920|NCT04666441|100633675|FG002|Overall Study|Lost to Follow-up|1|||
33198921|NCT04666441|100633676|FG003|Overall Study|Lost to Follow-up|3|||
33198922|NCT04666441|100633677|FG004|Overall Study|Lost to Follow-up|0|||
33198923|NCT04666441|100633678|FG005|Overall Study|Lost to Follow-up|2|||
33198924|NCT04666441|100633679|FG006|Overall Study|Lost to Follow-up|2|||
33198925|NCT04666441|100633680|FG007|Overall Study|Lost to Follow-up|2|||
33513532|NCT00595517|101776655|FG000|Overall Study|usage of prohibited treatment|1|||
33513533|NCT00595517|101776655|FG000|Overall Study|No intention to attend regularly|1|||
33513534|NCT02892513|101776656|FG000|Overall Study|Withdrawal by Subject|0|||
33198926|NCT04666441|100633673|FG000|Overall Study|Subject Decision|1|||
33198927|NCT04666441|100633674|FG001|Overall Study|Subject Decision|1|||
33198928|NCT04666441|100633675|FG002|Overall Study|Subject Decision|3|||
33198929|NCT04666441|100633676|FG003|Overall Study|Subject Decision|1|||
33198930|NCT04666441|100633677|FG004|Overall Study|Subject Decision|0|||
33198931|NCT04666441|100633678|FG005|Overall Study|Subject Decision|1|||
33513535|NCT02892513|101776657|FG001|Overall Study|Withdrawal by Subject|1|||
33513536|NCT02609724|101776667|FG000|Overall Study|Death|2|||
33513537|NCT02609724|101776668|FG001|Overall Study|Death|0|||
33513538|NCT02609724|101776669|FG002|Overall Study|Death|1|||
33513539|NCT02609724|101776667|FG000|Overall Study|Withdrawal by Subject|1|||
33606703|NCT00771615|102111501|FG004|Overall Study|Lost to Follow-up|0|||
33198932|NCT04666441|100633679|FG006|Overall Study|Subject Decision|3|||
33198933|NCT04666441|100633680|FG007|Overall Study|Subject Decision|2|||
33513540|NCT02609724|101776668|FG001|Overall Study|Withdrawal by Subject|2|||
33513541|NCT02609724|101776669|FG002|Overall Study|Withdrawal by Subject|3|||
33513542|NCT02609724|101776667|FG000|Overall Study|Illness|2|||
33513543|NCT02609724|101776668|FG001|Overall Study|Illness|1|||
33513544|NCT02609724|101776669|FG002|Overall Study|Illness|0|||
33513545|NCT02543892|101776670|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
33513546|NCT02543892|101776671|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
33513547|NCT02543892|101776672|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
33513548|NCT02543892|101776673|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
33513549|NCT02543892|101776674|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
33513550|NCT02543892|101776675|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
33513551|NCT02543892|101776676|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
33513552|NCT02543892|101776677|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
33513553|NCT02543892|101776670|FG000|Received Vaccination 2|Physician Decision|0|||
33513554|NCT02543892|101776671|FG001|Received Vaccination 2|Physician Decision|0|||
33513555|NCT02543892|101776672|FG002|Received Vaccination 2|Physician Decision|0|||
33513556|NCT02543892|101776673|FG003|Received Vaccination 2|Physician Decision|0|||
33513557|NCT02543892|101776674|FG004|Received Vaccination 2|Physician Decision|0|||
33513558|NCT02543892|101776675|FG005|Received Vaccination 2|Physician Decision|1|||
33513559|NCT02543892|101776676|FG006|Received Vaccination 2|Physician Decision|0|||
33513560|NCT02543892|101776677|FG007|Received Vaccination 2|Physician Decision|0|||
33513561|NCT02543892|101776670|FG000|Received Vaccination 2|Adverse Event|0|||
33513562|NCT02543892|101776671|FG001|Received Vaccination 2|Adverse Event|1|||
33513563|NCT02543892|101776672|FG002|Received Vaccination 2|Adverse Event|0|||
33513564|NCT02543892|101776673|FG003|Received Vaccination 2|Adverse Event|0|||
33513565|NCT02543892|101776674|FG004|Received Vaccination 2|Adverse Event|0|||
33513566|NCT02543892|101776675|FG005|Received Vaccination 2|Adverse Event|0|||
33513567|NCT02543892|101776676|FG006|Received Vaccination 2|Adverse Event|0|||
33513568|NCT02543892|101776677|FG007|Received Vaccination 2|Adverse Event|0|||
33513569|NCT02543892|101776670|FG000|Had Immunology Data|Withdrawal by Subject|0|||
33513570|NCT02543892|101776671|FG001|Had Immunology Data|Withdrawal by Subject|0|||
33513571|NCT02543892|101776672|FG002|Had Immunology Data|Withdrawal by Subject|0|||
33513572|NCT02543892|101776673|FG003|Had Immunology Data|Withdrawal by Subject|0|||
33513573|NCT02543892|101776674|FG004|Had Immunology Data|Withdrawal by Subject|0|||
33513574|NCT02543892|101776675|FG005|Had Immunology Data|Withdrawal by Subject|0|||
33513575|NCT02543892|101776676|FG006|Had Immunology Data|Withdrawal by Subject|1|||
33513576|NCT02543892|101776677|FG007|Had Immunology Data|Withdrawal by Subject|0|||
33513577|NCT00937040|101776678|FG000|Overall Study|Adverse Event|5|||
33513578|NCT00937040|101776679|FG001|Overall Study|Adverse Event|8|||
33513579|NCT00937040|101776678|FG000|Overall Study|Lost to Follow-up|12|||
33513580|NCT00937040|101776679|FG001|Overall Study|Lost to Follow-up|12|||
33513581|NCT00937040|101776678|FG000|Overall Study|Protocol Violation|3|||
33513582|NCT00937040|101776679|FG001|Overall Study|Protocol Violation|0|||
33513583|NCT00937040|101776678|FG000|Overall Study|Withdrawal by Subject|13|||
33513584|NCT00937040|101776679|FG001|Overall Study|Withdrawal by Subject|7|||
33513585|NCT00937040|101776678|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
33513586|NCT00937040|101776679|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
33513587|NCT00937040|101776678|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
33513588|NCT00937040|101776679|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
33513589|NCT04450407|101776680|FG000|Overall Study|Withdrawal by Subject|10|||
33513590|NCT04450407|101776681|FG001|Overall Study|Withdrawal by Subject|1|||
33513591|NCT04450407|101776682|FG002|Overall Study|Withdrawal by Subject|4|||
33513592|NCT04450407|101776680|FG000|Overall Study|Adverse Event|0|||
33198934|NCT01723904|100633681|FG000|Overall Study|Noncompliant|3|||
33324770|NCT02596620|101084832|FG000|Overall Study|Lost to Follow-up|1|||
33324771|NCT02596620|101084833|FG001|Overall Study|Lost to Follow-up|1|||
33513593|NCT04450407|101776681|FG001|Overall Study|Adverse Event|0|||
33513594|NCT04450407|101776682|FG002|Overall Study|Adverse Event|1|||
33513595|NCT04450407|101776680|FG000|Overall Study|Lost to Follow-up|1|||
33513596|NCT04450407|101776681|FG001|Overall Study|Lost to Follow-up|0|||
33513597|NCT04450407|101776682|FG002|Overall Study|Lost to Follow-up|0|||
33513598|NCT04450407|101776680|FG000|Overall Study|Physician Decision|0|||
33513599|NCT04450407|101776681|FG001|Overall Study|Physician Decision|0|||
33513600|NCT04450407|101776682|FG002|Overall Study|Physician Decision|1|||
33513601|NCT04450407|101776680|FG000|Overall Study|Pregnancy|1|||
33513602|NCT04450407|101776681|FG001|Overall Study|Pregnancy|0|||
33324772|NCT02463071|101084834|FG000|Overall Study|Adverse Event|3|||
33513603|NCT04450407|101776682|FG002|Overall Study|Pregnancy|0|||
33513604|NCT04450407|101776680|FG000|Overall Study|Protocol Violation|2|||
33513605|NCT04450407|101776681|FG001|Overall Study|Protocol Violation|0|||
33198935|NCT01723904|100633681|FG000|Overall Study|Adverse Event|5|||
33513606|NCT04450407|101776682|FG002|Overall Study|Protocol Violation|0|||
33513607|NCT04450407|101776680|FG000|Overall Study|Investigational site terminated by sponsor|3|||
33513608|NCT04450407|101776681|FG001|Overall Study|Investigational site terminated by sponsor|0|||
33606704|NCT00771615|102111502|FG005|Overall Study|Lost to Follow-up|1|||
33198936|NCT01723904|100633681|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
33198937|NCT00304070|100633682|FG000|Overall Study|Death|0|||
33198938|NCT00304070|100633683|FG001|Overall Study|Death|0|||
33198939|NCT00304070|100633684|FG002|Overall Study|Death|3|||
33198940|NCT00304070|100633682|FG000|Overall Study|Lost to Follow-up|0|||
33198941|NCT00304070|100633683|FG001|Overall Study|Lost to Follow-up|0|||
33198942|NCT00304070|100633684|FG002|Overall Study|Lost to Follow-up|1|||
33513609|NCT04450407|101776682|FG002|Overall Study|Investigational site terminated by sponsor|2|||
33513610|NCT04743804|101776686|FG000|Overall Study|Other|1|||
33513611|NCT04743804|101776687|FG001|Overall Study|Other|0|||
33513612|NCT04743804|101776686|FG000|Overall Study|Withdrawal by Subject|0|||
33513613|NCT04743804|101776687|FG001|Overall Study|Withdrawal by Subject|1|||
33513614|NCT04743804|101776686|FG000|Overall Study|Study Terminated by Sponsor|1|||
33513615|NCT04743804|101776687|FG001|Overall Study|Study Terminated by Sponsor|4|||
33513616|NCT04743804|101776686|FG000|Overall Study|Physician Decision|0|||
33513617|NCT04743804|101776687|FG001|Overall Study|Physician Decision|1|||
33513618|NCT04743804|101776686|FG000|Overall Study|Death|3|||
33198943|NCT00304070|100633682|FG000|Overall Study|Physician Decision|0|||
33198944|NCT00304070|100633683|FG001|Overall Study|Physician Decision|0|||
33198945|NCT00304070|100633684|FG002|Overall Study|Physician Decision|3|||
33198946|NCT00304070|100633682|FG000|Overall Study|Withdrawal by Subject|0|||
33198947|NCT00304070|100633683|FG001|Overall Study|Withdrawal by Subject|0|||
33198948|NCT00304070|100633684|FG002|Overall Study|Withdrawal by Subject|1|||
33198949|NCT00304070|100633682|FG000|Overall Study|Progressive Disease|3|||
33198950|NCT00304070|100633683|FG001|Overall Study|Progressive Disease|7|||
33198951|NCT00304070|100633684|FG002|Overall Study|Progressive Disease|4|||
33198952|NCT02486406|100633687|FG000|Overall Study|Withdrew consent|1|||
33198953|NCT02486406|100633688|FG001|Overall Study|Withdrew consent|0|||
33198954|NCT02486406|100633689|FG002|Overall Study|Withdrew consent|0|||
33198955|NCT02486406|100633690|FG003|Overall Study|Withdrew consent|1|||
33198956|NCT02486406|100633687|FG000|Overall Study|Lost to Follow-up|1|||
33198957|NCT02486406|100633688|FG001|Overall Study|Lost to Follow-up|3|||
33198958|NCT02486406|100633689|FG002|Overall Study|Lost to Follow-up|1|||
33198959|NCT02486406|100633690|FG003|Overall Study|Lost to Follow-up|3|||
33198960|NCT02486406|100633687|FG000|Overall Study|Other, not specified|0|||
33198961|NCT02486406|100633688|FG001|Overall Study|Other, not specified|0|||
33198962|NCT02486406|100633689|FG002|Overall Study|Other, not specified|1|||
33198963|NCT02486406|100633690|FG003|Overall Study|Other, not specified|0|||
33198964|NCT02617589|100633691|FG000|Randomization|Request to Discontinue Study Treatment|1|||
33198965|NCT02617589|100633692|FG001|Randomization|Request to Discontinue Study Treatment|3|||
33198966|NCT02617589|100633691|FG000|Randomization|Participant Withdrew Consent|1|||
33198967|NCT02617589|100633692|FG001|Randomization|Participant Withdrew Consent|2|||
33198968|NCT02617589|100633691|FG000|Treatment|Other Reasons|3|||
33198969|NCT02617589|100633692|FG001|Treatment|Other Reasons|3|||
33198970|NCT02617589|100633691|FG000|Treatment|Poor/Non Compliance|1|||
33198971|NCT02617589|100633692|FG001|Treatment|Poor/Non Compliance|1|||
33198972|NCT02617589|100633691|FG000|Treatment|Maximum Clinical Benefit|0|||
33198973|NCT02617589|100633692|FG001|Treatment|Maximum Clinical Benefit|2|||
33198974|NCT02617589|100633691|FG000|Treatment|Participant Withdrew Consent|2|||
33198975|NCT02617589|100633692|FG001|Treatment|Participant Withdrew Consent|6|||
33198976|NCT02617589|100633691|FG000|Treatment|Participant Request to Discontinue|12|||
33198977|NCT02617589|100633692|FG001|Treatment|Participant Request to Discontinue|21|||
33399290|NCT02407236|101350199|FG007|Induction Study (8 Weeks)|Other|0|||
33399291|NCT02407236|101350200|FG008|Induction Study (8 Weeks)|Other|0|||
33399292|NCT02407236|101350201|FG009|Induction Study (8 Weeks)|Other|0|||
33198978|NCT02617589|100633691|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
33198979|NCT02617589|100633692|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
33198980|NCT02617589|100633691|FG000|Treatment|Death|1|||
33198981|NCT02617589|100633692|FG001|Treatment|Death|1|||
33198982|NCT02617589|100633691|FG000|Treatment|Study Drug Toxicity|27|||
33198983|NCT02617589|100633692|FG001|Treatment|Study Drug Toxicity|20|||
33198984|NCT02617589|100633691|FG000|Treatment|Disease Progression|216|||
33198985|NCT02617589|100633692|FG001|Treatment|Disease Progression|136|||
33198986|NCT01993719|100633696|FG000|First Drug Administration|Not treated|1|||
33198987|NCT01993719|100633697|FG001|First Drug Administration|Not treated|0|||
33198988|NCT01993719|100633698|FG002|First Drug Administration|Not treated|0|||
33399293|NCT02407236|101350202|FG010|Induction Study (8 Weeks)|Other|0|||
33399294|NCT02407236|101350203|FG011|Induction Study (8 Weeks)|Other|0|||
33513619|NCT04743804|101776687|FG001|Overall Study|Death|0|||
33513620|NCT01854879|101776688|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
33513621|NCT01854879|101776688|FG000|Overall Study|screen fail|3|||
33198989|NCT01993719|100633699|FG003|First Drug Administration|Not treated|0|||
33198990|NCT01993719|100633700|FG004|First Drug Administration|Not treated|0|||
33198991|NCT02348489|100633701|FG000|Overall Study|Death|336|||
33198992|NCT02348489|100633702|FG001|Overall Study|Death|335|||
33198993|NCT02348489|100633701|FG000|Overall Study|Withdrawal by Subject|14|||
33324773|NCT02463071|101084835|FG001|Overall Study|Adverse Event|5|||
33399295|NCT02407236|101350204|FG012|Induction Study (8 Weeks)|Other|0|||
33324774|NCT02463071|101084836|FG002|Overall Study|Adverse Event|1|||
33324775|NCT02463071|101084834|FG000|Overall Study|Death|1|||
33324776|NCT02463071|101084835|FG001|Overall Study|Death|0|||
33324777|NCT02463071|101084836|FG002|Overall Study|Death|0|||
33324778|NCT02463071|101084834|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
33324779|NCT02463071|101084835|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33324780|NCT02463071|101084836|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
33324781|NCT02463071|101084834|FG000|Overall Study|Reason not specified|7|||
33324782|NCT02463071|101084835|FG001|Overall Study|Reason not specified|9|||
33324783|NCT02463071|101084836|FG002|Overall Study|Reason not specified|4|||
33324784|NCT02463071|101084834|FG000|Overall Study|Protocol Violation|0|||
33324785|NCT02463071|101084835|FG001|Overall Study|Protocol Violation|2|||
33324786|NCT02463071|101084836|FG002|Overall Study|Protocol Violation|0|||
33324787|NCT02463071|101084834|FG000|Overall Study|Lost to Follow-up|0|||
33324788|NCT02463071|101084835|FG001|Overall Study|Lost to Follow-up|0|||
33324789|NCT02463071|101084836|FG002|Overall Study|Lost to Follow-up|1|||
33324790|NCT00332839|101084837|FG000|Core (Months 0 - 12)|Administrative problems|1|||
33324791|NCT00332839|101084838|FG001|Core (Months 0 - 12)|Administrative problems|1|||
33324792|NCT00332839|101084837|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
33324793|NCT00332839|101084838|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
33324794|NCT00332839|101084837|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
33324795|NCT00332839|101084838|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
33324796|NCT00332839|101084837|FG000|Core (Months 0 - 12)|Adverse Event|5|||
33324797|NCT00332839|101084838|FG001|Core (Months 0 - 12)|Adverse Event|15|||
33324798|NCT00332839|101084837|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
33324799|NCT00332839|101084838|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
33324800|NCT00332839|101084837|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
33324801|NCT00332839|101084838|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
33324802|NCT00332839|101084837|FG000|Follow-up (Months 12 - 60)|Death|1|||
33324803|NCT00332839|101084838|FG001|Follow-up (Months 12 - 60)|Death|1|||
33324804|NCT00449670|101084839|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
33324805|NCT00449670|101084840|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
33324806|NCT00449670|101084839|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
33324807|NCT00449670|101084840|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
33324808|NCT00449670|101084839|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
33324809|NCT00449670|101084840|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
33324810|NCT00449670|101084839|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
33399296|NCT02407236|101350192|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
33399297|NCT02407236|101350193|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
33399298|NCT02407236|101350194|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
33324811|NCT00449670|101084840|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
33324812|NCT00449670|101084839|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
33324813|NCT00449670|101084840|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
33324814|NCT00449670|101084839|FG000|Booster Phase (Study no.109873)|Other|0|||
33324815|NCT00449670|101084840|FG001|Booster Phase (Study no.109873)|Other|2|||
33324816|NCT00382018|101084841|FG000|Overall Study|Progression|0|||
33324817|NCT00382018|101084842|FG001|Overall Study|Progression|136|||
33324818|NCT00382018|101084843|FG002|Overall Study|Progression|51|||
33399299|NCT02407236|101350195|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
33399300|NCT02407236|101350196|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
33399301|NCT02407236|101350197|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
33399302|NCT02407236|101350198|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
33399303|NCT02407236|101350199|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
33399304|NCT02407236|101350200|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
33399305|NCT02407236|101350201|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
33513622|NCT01854879|101776688|FG000|Overall Study|incomplete data set|1|||
33513623|NCT03652636|101776689|FG000|Overall Study|Withdrawal by Subject|7|||
33513624|NCT04569968|101776695|FG000|Overall Study|Lost to Follow-up|2|||
33324819|NCT00382018|101084844|FG003|Overall Study|Progression|43|||
33513625|NCT04569968|101776696|FG001|Overall Study|Lost to Follow-up|5|||
33513626|NCT04569968|101776695|FG000|Overall Study|Story of head and/or neck surgery|2|||
33513627|NCT04569968|101776696|FG001|Overall Study|Story of head and/or neck surgery|2|||
33513628|NCT04569968|101776695|FG000|Overall Study|Time of stroke onset|8|||
33198994|NCT02348489|100633702|FG001|Overall Study|Withdrawal by Subject|27|||
33198995|NCT02348489|100633701|FG000|Overall Study|Lost to Follow-up|3|||
33324820|NCT00382018|101084841|FG000|Overall Study|Death|0|||
33324821|NCT00382018|101084842|FG001|Overall Study|Death|9|||
33324822|NCT00382018|101084843|FG002|Overall Study|Death|7|||
33324823|NCT00382018|101084844|FG003|Overall Study|Death|11|||
33324824|NCT00382018|101084841|FG000|Overall Study|Withdrawal by Subject|0|||
33513629|NCT04569968|101776696|FG001|Overall Study|Time of stroke onset|7|||
33198996|NCT02348489|100633702|FG001|Overall Study|Lost to Follow-up|5|||
33198997|NCT01083433|100633705|FG000|Overall Study|Lost to Follow-up|2|||
33198998|NCT01083433|100633706|FG001|Overall Study|Lost to Follow-up|1|||
33198999|NCT01083433|100633707|FG002|Overall Study|Lost to Follow-up|1|||
33199000|NCT01083433|100633705|FG000|Overall Study|Withdrawal by Subject|0|||
33199001|NCT01083433|100633706|FG001|Overall Study|Withdrawal by Subject|5|||
33324825|NCT00382018|101084842|FG001|Overall Study|Withdrawal by Subject|4|||
33324826|NCT00382018|101084843|FG002|Overall Study|Withdrawal by Subject|3|||
33324827|NCT00382018|101084844|FG003|Overall Study|Withdrawal by Subject|4|||
33324828|NCT00382018|101084841|FG000|Overall Study|Other, not protocol specified|0|||
33513630|NCT04569968|101776695|FG000|Overall Study|Type of strokr|12|||
33513631|NCT04569968|101776696|FG001|Overall Study|Type of strokr|8|||
33513632|NCT04569968|101776695|FG000|Overall Study|Cooperation|8|||
33513633|NCT04569968|101776696|FG001|Overall Study|Cooperation|8|||
33513634|NCT04569968|101776695|FG000|Overall Study|Age interval|17|||
33513635|NCT04569968|101776696|FG001|Overall Study|Age interval|6|||
33513636|NCT04569968|101776695|FG000|Overall Study|Denial of participation to the study|0|||
33513637|NCT04569968|101776696|FG001|Overall Study|Denial of participation to the study|3|||
33513638|NCT04569968|101776695|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
33513639|NCT04569968|101776696|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
33513640|NCT04569968|101776695|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
33513641|NCT04569968|101776696|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
33513642|NCT04569968|101776695|FG000|Overall Study|Quarantine|1|||
33513643|NCT04569968|101776696|FG001|Overall Study|Quarantine|0|||
33513644|NCT04569968|101776695|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
33513645|NCT04569968|101776696|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
33513646|NCT04569968|101776695|FG000|Overall Study|Repetitive stroke|8|||
33513647|NCT04569968|101776696|FG001|Overall Study|Repetitive stroke|0|||
33513648|NCT04569968|101776695|FG000|Overall Study|Insufficient mastication|1|||
33513649|NCT04569968|101776696|FG001|Overall Study|Insufficient mastication|0|||
33513650|NCT04569968|101776695|FG000|Overall Study|Infection|1|||
33513651|NCT04569968|101776696|FG001|Overall Study|Infection|0|||
33513652|NCT02071706|101776701|FG000|Overall Study|Adverse Event|1|||
33513653|NCT02071706|101776701|FG000|Overall Study|Withdrawal by Subject|2|||
33199002|NCT01083433|100633707|FG002|Overall Study|Withdrawal by Subject|3|||
33324829|NCT00382018|101084842|FG001|Overall Study|Other, not protocol specified|16|||
33324830|NCT00382018|101084843|FG002|Overall Study|Other, not protocol specified|3|||
33324831|NCT00382018|101084844|FG003|Overall Study|Other, not protocol specified|1|||
33324832|NCT02767323|101087857|FG000|Overall Study|Withdrawal by Subject|17|||
33324833|NCT02767323|101087858|FG001|Overall Study|Withdrawal by Subject|5|||
33324834|NCT02767323|101087859|FG002|Overall Study|Withdrawal by Subject|13|||
33324835|NCT02767323|101087860|FG003|Overall Study|Withdrawal by Subject|0|||
33324836|NCT02767323|101087857|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
33324837|NCT02767323|101087858|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
33399306|NCT02407236|101350202|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
33399307|NCT02407236|101350203|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
33513654|NCT00738881|101776702|FG000|Overall Study|Withdrawal by Subject|0|||
33513655|NCT00738881|101776703|FG001|Overall Study|Withdrawal by Subject|2|||
33513656|NCT00916344|101776704|FG000|Overall Study|Death|2|||
33513657|NCT00916344|101776704|FG000|Overall Study|ICD upgrade|1|||
33199003|NCT01083433|100633705|FG000|Overall Study|Pregnancy|0|||
33199004|NCT01083433|100633706|FG001|Overall Study|Pregnancy|0|||
33199005|NCT01083433|100633707|FG002|Overall Study|Pregnancy|1|||
33199006|NCT00889421|100633708|FG000|Overall Study|Lack of Efficacy|3|||
33199007|NCT04788147|100633709|FG000|Overall Study|Screen Failure|3|||
33199008|NCT04788147|100633710|FG001|Overall Study|Screen Failure|10|||
33199009|NCT04788147|100633709|FG000|Overall Study|Incomplete RMRS image session|2|||
33199010|NCT04788147|100633710|FG001|Overall Study|Incomplete RMRS image session|0|||
33199011|NCT03586869|100633711|FG000|Overall Study|Progressive Disease|3|||
33199012|NCT01663636|100633712|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
33199013|NCT01663636|100633713|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
33199014|NCT03238001|100633714|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
33199015|NCT03238001|100633714|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
33199016|NCT03238001|100633714|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
33199017|NCT03238001|100633714|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
33199018|NCT03238001|100633714|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
33199019|NCT03238001|100633714|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
33199020|NCT03238001|100633714|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
33199021|NCT03238001|100633714|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
33199022|NCT01003249|100633717|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
33199023|NCT01003249|100633718|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
33199024|NCT01003249|100633717|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
33199025|NCT01003249|100633718|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
33606705|NCT00771615|102111503|FG006|Overall Study|Lost to Follow-up|1|||
33606706|NCT00771615|102111504|FG007|Overall Study|Lost to Follow-up|0|||
33606707|NCT00771615|102111505|FG008|Overall Study|Lost to Follow-up|0|||
33606708|NCT00884832|102111506|FG000|Overall Study|Withdrawal by Subject|0|||
33606709|NCT00884832|102111507|FG001|Overall Study|Withdrawal by Subject|1|||
33606710|NCT03908476|102111510|FG000|Overall Study|Death|3|||
33606711|NCT03908476|102111511|FG001|Overall Study|Death|0|||
33606712|NCT03908476|102111510|FG000|Overall Study|Lost to Follow-up|3|||
33606713|NCT03908476|102111511|FG001|Overall Study|Lost to Follow-up|1|||
33606714|NCT03908476|102111510|FG000|Overall Study|Withdrawal by Subject|7|||
33606715|NCT03908476|102111511|FG001|Overall Study|Withdrawal by Subject|1|||
33606716|NCT03908476|102111510|FG000|Overall Study|Physician Decision|2|||
33606717|NCT03908476|102111511|FG001|Overall Study|Physician Decision|0|||
33606718|NCT03908476|102111510|FG000|Overall Study|System Explanted and not Replaced|4|||
33606719|NCT03908476|102111511|FG001|Overall Study|System Explanted and not Replaced|0|||
33606720|NCT03908476|102111510|FG000|Overall Study|Intrathecal Pump|1|||
33324838|NCT02767323|101087859|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
33324839|NCT02767323|101087860|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
33324840|NCT04233164|101087866|FG000|Overall Study|Unable to obtain specimen|0|||
33399308|NCT02407236|101350204|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
33399309|NCT02407236|101350192|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33399310|NCT02407236|101350193|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33399311|NCT02407236|101350194|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33399312|NCT02407236|101350195|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
33399313|NCT02407236|101350196|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
33399314|NCT02407236|101350197|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
33399315|NCT02407236|101350198|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
33399316|NCT02407236|101350199|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
33399317|NCT02407236|101350200|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33399318|NCT02407236|101350201|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33399319|NCT02407236|101350202|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33399320|NCT02407236|101350203|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33399321|NCT02407236|101350204|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
33399322|NCT02407236|101350192|FG000|Maintenance Study (44 Weeks)|Other|0|||
33399323|NCT02407236|101350193|FG001|Maintenance Study (44 Weeks)|Other|0|||
33513658|NCT00916344|101776704|FG000|Overall Study|Drop-out|5|||
33513659|NCT03193801|101776707|FG000|Overall Study|Physician Decision|2|||
33513660|NCT03193801|101776707|FG000|Overall Study|Withdrawal by Subject|1|||
33324841|NCT04233164|101087867|FG001|Overall Study|Unable to obtain specimen|1|||
33324842|NCT01092143|101087868|FG000|Overall Study|Adverse Event|10|||
33324843|NCT01092143|101087869|FG001|Overall Study|Adverse Event|5|||
33324844|NCT01092143|101087870|FG002|Overall Study|Adverse Event|1|||
33324845|NCT01092143|101087871|FG003|Overall Study|Adverse Event|4|||
33324846|NCT01092143|101087872|FG004|Overall Study|Adverse Event|3|||
33324847|NCT01092143|101087868|FG000|Overall Study|Lost to Follow-up|1|||
33324848|NCT01092143|101087869|FG001|Overall Study|Lost to Follow-up|0|||
33399324|NCT02407236|101350194|FG002|Maintenance Study (44 Weeks)|Other|0|||
33513661|NCT00705718|101776708|FG000|Overall Study|Death|6|||
33513662|NCT00705718|101776709|FG001|Overall Study|Death|6|||
33513663|NCT00705718|101776708|FG000|Overall Study|Not due for Visit|0|||
33513664|NCT00705718|101776709|FG001|Overall Study|Not due for Visit|12|||
33513665|NCT00705718|101776708|FG000|Overall Study|Follow up not done|1|||
33513666|NCT00705718|101776709|FG001|Overall Study|Follow up not done|4|||
33513667|NCT00381238|101776717|FG000|Overall Study|Adverse Event|3|||
33513668|NCT00381238|101776717|FG000|Overall Study|Protocol Violation|1|||
33513669|NCT00381238|101776717|FG000|Overall Study|Withdrawal by Subject|4|||
33513670|NCT00381238|101776717|FG000|Overall Study|Lack of Efficacy|2|||
33513671|NCT00381238|101776717|FG000|Overall Study|Withdrew by physician|1|||
33513672|NCT00381238|101776717|FG000|Overall Study|Disease progression|1|||
33513673|NCT01173055|101776720|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
33513674|NCT01173055|101776721|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
33513675|NCT01173055|101776720|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
33513676|NCT01173055|101776721|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
33513677|NCT00710684|101776722|FG000|Overall Study|Adverse Event|11|||
33606721|NCT03908476|102111511|FG001|Overall Study|Intrathecal Pump|0|||
33513678|NCT00710684|101776723|FG001|Overall Study|Adverse Event|19|||
33513679|NCT00710684|101776724|FG002|Overall Study|Adverse Event|16|||
33513680|NCT00710684|101776722|FG000|Overall Study|Lack of Efficacy|4|||
33513681|NCT00710684|101776723|FG001|Overall Study|Lack of Efficacy|3|||
33513682|NCT00710684|101776724|FG002|Overall Study|Lack of Efficacy|5|||
33606722|NCT03908476|102111510|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
33606723|NCT03908476|102111511|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
33606724|NCT00300365|102111512|FG000|Overall Study|Lost to Follow-up|1|||
33324849|NCT01092143|101087870|FG002|Overall Study|Lost to Follow-up|1|||
33324850|NCT01092143|101087871|FG003|Overall Study|Lost to Follow-up|0|||
33513683|NCT00710684|101776722|FG000|Overall Study|Protocol Violation|5|||
33513684|NCT00710684|101776723|FG001|Overall Study|Protocol Violation|5|||
33513685|NCT00710684|101776724|FG002|Overall Study|Protocol Violation|5|||
33513686|NCT00710684|101776722|FG000|Overall Study|Lost to Follow-up|4|||
33513687|NCT00710684|101776723|FG001|Overall Study|Lost to Follow-up|6|||
33513688|NCT00710684|101776724|FG002|Overall Study|Lost to Follow-up|7|||
33513689|NCT00710684|101776722|FG000|Overall Study|Physician Decision|0|||
33513690|NCT00710684|101776723|FG001|Overall Study|Physician Decision|2|||
33513691|NCT00710684|101776724|FG002|Overall Study|Physician Decision|4|||
33513692|NCT00710684|101776722|FG000|Overall Study|Withdrawal by Subject|24|||
33513693|NCT00710684|101776723|FG001|Overall Study|Withdrawal by Subject|18|||
33513694|NCT00710684|101776724|FG002|Overall Study|Withdrawal by Subject|11|||
33513695|NCT00710684|101776722|FG000|Overall Study|Missing|1|||
33513696|NCT00710684|101776723|FG001|Overall Study|Missing|0|||
33513697|NCT00710684|101776724|FG002|Overall Study|Missing|0|||
33513698|NCT00710684|101776722|FG000|Overall Study|Did not continue after week 24|25|||
33513699|NCT00710684|101776723|FG001|Overall Study|Did not continue after week 24|21|||
33513700|NCT00710684|101776724|FG002|Overall Study|Did not continue after week 24|16|||
33513701|NCT00278148|101776725|FG000|Phase II - Expansion Phase|Disease progression|0|||
33513702|NCT00278148|101776726|FG001|Phase II - Expansion Phase|Disease progression|0|||
33513703|NCT00278148|101776727|FG002|Phase II - Expansion Phase|Disease progression|4|||
33513704|NCT00278148|101776725|FG000|Phase II - Expansion Phase|Adverse Event|0|||
33513705|NCT00278148|101776726|FG001|Phase II - Expansion Phase|Adverse Event|0|||
33513706|NCT00278148|101776727|FG002|Phase II - Expansion Phase|Adverse Event|2|||
33513707|NCT03634033|101776728|FG000|Overall Study|Did not have a post-assessment|384|||
33324851|NCT01092143|101087872|FG004|Overall Study|Lost to Follow-up|0|||
33324852|NCT01092143|101087868|FG000|Overall Study|Consent withdrawn|2|||
33324853|NCT01092143|101087869|FG001|Overall Study|Consent withdrawn|1|||
33324854|NCT01092143|101087870|FG002|Overall Study|Consent withdrawn|0|||
33324855|NCT01092143|101087871|FG003|Overall Study|Consent withdrawn|1|||
33324856|NCT01092143|101087872|FG004|Overall Study|Consent withdrawn|3|||
33513708|NCT03634033|101776729|FG001|Overall Study|Did not have a post-assessment|291|||
33513709|NCT03634033|101776730|FG002|Overall Study|Did not have a post-assessment|114|||
33513710|NCT03634033|101776731|FG003|Overall Study|Did not have a post-assessment|161|||
33513711|NCT03634033|101776732|FG004|Overall Study|Did not have a post-assessment|5|||
33513712|NCT03634033|101776733|FG005|Overall Study|Did not have a post-assessment|0|||
33513713|NCT03634033|101776734|FG006|Overall Study|Did not have a post-assessment|0|||
33513714|NCT03634033|101776728|FG000|Overall Study|Death|0|||
33513715|NCT03634033|101776729|FG001|Overall Study|Death|0|||
33513716|NCT03634033|101776730|FG002|Overall Study|Death|0|||
33513717|NCT03634033|101776731|FG003|Overall Study|Death|0|||
33513718|NCT03634033|101776732|FG004|Overall Study|Death|0|||
33513719|NCT03634033|101776733|FG005|Overall Study|Death|7|||
33513720|NCT03634033|101776734|FG006|Overall Study|Death|7|||
33513721|NCT03634033|101776728|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
33513722|NCT03634033|101776729|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
33513723|NCT03634033|101776730|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
33513724|NCT03634033|101776731|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
33513725|NCT03634033|101776732|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
33513726|NCT03634033|101776733|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
33513727|NCT03634033|101776734|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
33513728|NCT03634033|101776728|FG000|Overall Study|Lost to Follow-up|0|||
33513729|NCT03634033|101776729|FG001|Overall Study|Lost to Follow-up|0|||
33513730|NCT03634033|101776730|FG002|Overall Study|Lost to Follow-up|0|||
33513731|NCT03634033|101776731|FG003|Overall Study|Lost to Follow-up|0|||
33513732|NCT03634033|101776732|FG004|Overall Study|Lost to Follow-up|0|||
33513733|NCT03634033|101776733|FG005|Overall Study|Lost to Follow-up|1|||
33513734|NCT03634033|101776734|FG006|Overall Study|Lost to Follow-up|2|||
33513735|NCT03634033|101776728|FG000|Overall Study|Withdrawal by Subject|0|||
33513736|NCT03634033|101776729|FG001|Overall Study|Withdrawal by Subject|0|||
33513737|NCT03634033|101776730|FG002|Overall Study|Withdrawal by Subject|0|||
33513738|NCT03634033|101776731|FG003|Overall Study|Withdrawal by Subject|0|||
33513739|NCT03634033|101776732|FG004|Overall Study|Withdrawal by Subject|0|||
33199026|NCT01003249|100633717|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
33513740|NCT03634033|101776733|FG005|Overall Study|Withdrawal by Subject|0|||
33513741|NCT03634033|101776734|FG006|Overall Study|Withdrawal by Subject|1|||
33513742|NCT00972816|101776735|FG000|Overall Study|Adverse Event|0|||
33513743|NCT00972816|101776736|FG001|Overall Study|Adverse Event|0|||
33513744|NCT00972816|101776737|FG002|Overall Study|Adverse Event|1|||
33513745|NCT00972816|101776738|FG003|Overall Study|Adverse Event|0|||
33513746|NCT00972816|101776739|FG004|Overall Study|Adverse Event|0|||
33513747|NCT00972816|101776740|FG005|Overall Study|Adverse Event|0|||
33199027|NCT01003249|100633718|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
33324857|NCT01092143|101087868|FG000|Overall Study|Not treated|0|||
33513748|NCT00972816|101776741|FG006|Overall Study|Adverse Event|0|||
33513749|NCT00972816|101776742|FG007|Overall Study|Adverse Event|0|||
33513750|NCT00972816|101776735|FG000|Overall Study|Withdrawal by Subject|4|||
33513751|NCT00972816|101776736|FG001|Overall Study|Withdrawal by Subject|2|||
33324858|NCT01092143|101087869|FG001|Overall Study|Not treated|0|||
33324859|NCT01092143|101087870|FG002|Overall Study|Not treated|1|||
33324860|NCT01092143|101087871|FG003|Overall Study|Not treated|0|||
33324861|NCT01092143|101087872|FG004|Overall Study|Not treated|0|||
33324862|NCT01092143|101087868|FG000|Overall Study|did not reversibility criteria|0|||
33324863|NCT01092143|101087869|FG001|Overall Study|did not reversibility criteria|0|||
33324864|NCT01092143|101087870|FG002|Overall Study|did not reversibility criteria|1|||
33324865|NCT01092143|101087871|FG003|Overall Study|did not reversibility criteria|0|||
33324866|NCT01092143|101087872|FG004|Overall Study|did not reversibility criteria|0|||
33324867|NCT01092143|101087868|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
33324868|NCT01092143|101087869|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
33324869|NCT01092143|101087870|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
33324870|NCT01092143|101087871|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
33324871|NCT01092143|101087872|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
33324872|NCT01092143|101087868|FG000|Overall Study|Ineligible patient|1|||
33324873|NCT01092143|101087869|FG001|Overall Study|Ineligible patient|0|||
33324874|NCT01092143|101087870|FG002|Overall Study|Ineligible patient|0|||
33324875|NCT01092143|101087871|FG003|Overall Study|Ineligible patient|0|||
33324876|NCT01092143|101087872|FG004|Overall Study|Ineligible patient|0|||
33324877|NCT01092143|101087868|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
33324878|NCT01092143|101087869|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
33324879|NCT01092143|101087870|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
33324880|NCT01092143|101087871|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
33324881|NCT01092143|101087872|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
33513752|NCT00972816|101776737|FG002|Overall Study|Withdrawal by Subject|1|||
33513753|NCT00972816|101776738|FG003|Overall Study|Withdrawal by Subject|3|||
33513754|NCT00972816|101776739|FG004|Overall Study|Withdrawal by Subject|0|||
33513755|NCT00972816|101776740|FG005|Overall Study|Withdrawal by Subject|1|||
33513756|NCT00972816|101776741|FG006|Overall Study|Withdrawal by Subject|1|||
33513757|NCT00972816|101776742|FG007|Overall Study|Withdrawal by Subject|2|||
33513758|NCT00972816|101776735|FG000|Overall Study|Lost to Follow-up|11|||
33513759|NCT00972816|101776736|FG001|Overall Study|Lost to Follow-up|9|||
33513760|NCT00972816|101776737|FG002|Overall Study|Lost to Follow-up|7|||
33513761|NCT00972816|101776738|FG003|Overall Study|Lost to Follow-up|5|||
33513762|NCT00972816|101776739|FG004|Overall Study|Lost to Follow-up|11|||
33513763|NCT00972816|101776740|FG005|Overall Study|Lost to Follow-up|10|||
33513764|NCT00972816|101776741|FG006|Overall Study|Lost to Follow-up|7|||
33513765|NCT00972816|101776742|FG007|Overall Study|Lost to Follow-up|7|||
33513766|NCT00972816|101776735|FG000|Overall Study|Inappropriate enrolment|0|||
33513767|NCT00972816|101776736|FG001|Overall Study|Inappropriate enrolment|0|||
33513768|NCT00972816|101776737|FG002|Overall Study|Inappropriate enrolment|0|||
33513769|NCT00972816|101776738|FG003|Overall Study|Inappropriate enrolment|0|||
33513770|NCT00972816|101776739|FG004|Overall Study|Inappropriate enrolment|0|||
33513771|NCT00972816|101776740|FG005|Overall Study|Inappropriate enrolment|0|||
33513772|NCT00972816|101776741|FG006|Overall Study|Inappropriate enrolment|2|||
33513773|NCT00972816|101776742|FG007|Overall Study|Inappropriate enrolment|0|||
33513774|NCT00972816|101776735|FG000|Overall Study|Unable to classify|2|||
33513775|NCT00972816|101776736|FG001|Overall Study|Unable to classify|0|||
33513776|NCT00972816|101776737|FG002|Overall Study|Unable to classify|0|||
33513777|NCT00972816|101776738|FG003|Overall Study|Unable to classify|0|||
33513778|NCT00972816|101776739|FG004|Overall Study|Unable to classify|1|||
33513779|NCT00972816|101776740|FG005|Overall Study|Unable to classify|0|||
33513780|NCT00972816|101776741|FG006|Overall Study|Unable to classify|0|||
33513781|NCT00972816|101776742|FG007|Overall Study|Unable to classify|0|||
33513782|NCT03320850|101776743|FG000|Overall Study|Lost to Follow-up|0|||
33513783|NCT03320850|101776744|FG001|Overall Study|Lost to Follow-up|0|||
33513784|NCT03320850|101776745|FG002|Overall Study|Lost to Follow-up|0|||
33513785|NCT03320850|101776746|FG003|Overall Study|Lost to Follow-up|0|||
33513786|NCT03320850|101776747|FG004|Overall Study|Lost to Follow-up|1|||
33513787|NCT03320850|101776748|FG005|Overall Study|Lost to Follow-up|2|||
33199028|NCT01003249|100633717|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
33199029|NCT01003249|100633718|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
33199030|NCT01458171|100633719|FG000|Overall Study|Adverse Event|1|||
33199031|NCT04934670|100633722|FG000|Overall Study|Death|4|||
33199032|NCT04934670|100633723|FG001|Overall Study|Death|0|||
33324882|NCT01092143|101087868|FG000|Overall Study|Patient travel|0|||
33513788|NCT03320850|101776749|FG006|Overall Study|Lost to Follow-up|2|||
33513789|NCT03320850|101776750|FG007|Overall Study|Lost to Follow-up|0|||
33199033|NCT04934670|100633722|FG000|Overall Study|Lost to Follow-up|1|||
33324883|NCT01092143|101087869|FG001|Overall Study|Patient travel|0|||
33399325|NCT02407236|101350195|FG003|Maintenance Study (44 Weeks)|Other|5|||
33513790|NCT03320850|101776751|FG008|Overall Study|Lost to Follow-up|6|||
33324884|NCT01092143|101087870|FG002|Overall Study|Patient travel|0|||
33513791|NCT03320850|101776752|FG009|Overall Study|Lost to Follow-up|4|||
33513792|NCT03320850|101776743|FG000|Overall Study|Withdrawal by Subject|0|||
33513793|NCT03320850|101776744|FG001|Overall Study|Withdrawal by Subject|0|||
33513794|NCT03320850|101776745|FG002|Overall Study|Withdrawal by Subject|0|||
33513795|NCT03320850|101776746|FG003|Overall Study|Withdrawal by Subject|0|||
33399326|NCT02407236|101350196|FG004|Maintenance Study (44 Weeks)|Other|7|||
33399327|NCT02407236|101350197|FG005|Maintenance Study (44 Weeks)|Other|8|||
33399328|NCT02407236|101350198|FG006|Maintenance Study (44 Weeks)|Other|4|||
33399329|NCT02407236|101350199|FG007|Maintenance Study (44 Weeks)|Other|6|||
33399330|NCT02407236|101350200|FG008|Maintenance Study (44 Weeks)|Other|0|||
33399331|NCT02407236|101350201|FG009|Maintenance Study (44 Weeks)|Other|0|||
33399332|NCT02407236|101350202|FG010|Maintenance Study (44 Weeks)|Other|0|||
33399333|NCT02407236|101350203|FG011|Maintenance Study (44 Weeks)|Other|0|||
33399334|NCT02407236|101350204|FG012|Maintenance Study (44 Weeks)|Other|0|||
33399335|NCT02407236|101350192|FG000|Maintenance Study (44 Weeks)|Death|0|||
33399336|NCT02407236|101350193|FG001|Maintenance Study (44 Weeks)|Death|0|||
33399337|NCT02407236|101350194|FG002|Maintenance Study (44 Weeks)|Death|0|||
33399338|NCT02407236|101350195|FG003|Maintenance Study (44 Weeks)|Death|0|||
33399339|NCT02407236|101350196|FG004|Maintenance Study (44 Weeks)|Death|0|||
33399340|NCT02407236|101350197|FG005|Maintenance Study (44 Weeks)|Death|0|||
33399341|NCT02407236|101350198|FG006|Maintenance Study (44 Weeks)|Death|0|||
33399342|NCT02407236|101350199|FG007|Maintenance Study (44 Weeks)|Death|1|||
33399343|NCT02407236|101350200|FG008|Maintenance Study (44 Weeks)|Death|0|||
33399344|NCT02407236|101350201|FG009|Maintenance Study (44 Weeks)|Death|0|||
33399345|NCT02407236|101350202|FG010|Maintenance Study (44 Weeks)|Death|0|||
33399346|NCT02407236|101350203|FG011|Maintenance Study (44 Weeks)|Death|0|||
33399347|NCT02407236|101350204|FG012|Maintenance Study (44 Weeks)|Death|0|||
33399348|NCT02407236|101350192|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33399349|NCT02407236|101350193|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33399350|NCT02407236|101350194|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33399351|NCT02407236|101350195|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33399352|NCT02407236|101350196|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33399353|NCT02407236|101350197|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33399354|NCT02407236|101350198|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33399355|NCT02407236|101350199|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
33399356|NCT02407236|101350200|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
33399357|NCT02407236|101350201|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
33399358|NCT02407236|101350202|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
33399359|NCT02407236|101350203|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
33399360|NCT02407236|101350204|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
33399361|NCT02407236|101350192|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33399362|NCT02407236|101350193|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33399363|NCT02407236|101350194|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33399364|NCT02407236|101350195|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33399365|NCT02407236|101350196|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33399366|NCT02407236|101350197|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33399367|NCT02407236|101350198|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33399368|NCT02407236|101350199|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33399369|NCT02407236|101350200|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33399370|NCT02407236|101350201|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33399371|NCT02407236|101350202|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
33399372|NCT02407236|101350203|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33399373|NCT02407236|101350204|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
33399374|NCT02407236|101350192|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33399375|NCT02407236|101350193|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33399376|NCT02407236|101350194|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33399377|NCT02407236|101350195|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33399378|NCT02407236|101350196|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33399379|NCT02407236|101350197|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33399380|NCT02407236|101350198|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33399381|NCT02407236|101350199|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
33606725|NCT00300365|102111513|FG001|Overall Study|Lost to Follow-up|0|||
33199034|NCT04934670|100633723|FG001|Overall Study|Lost to Follow-up|4|||
33199035|NCT00503841|100633724|FG000|Overall Study|All screen failures|44|||
33399382|NCT02407236|101350200|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
33399383|NCT02407236|101350201|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
33399384|NCT02407236|101350202|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
33399385|NCT02407236|101350203|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
33324885|NCT01092143|101087871|FG003|Overall Study|Patient travel|0|||
33324886|NCT01092143|101087872|FG004|Overall Study|Patient travel|1|||
33324887|NCT01092143|101087868|FG000|Overall Study|Non compliance with study medication|0|||
33324888|NCT01092143|101087869|FG001|Overall Study|Non compliance with study medication|0|||
33324889|NCT01092143|101087870|FG002|Overall Study|Non compliance with study medication|0|||
33324890|NCT01092143|101087871|FG003|Overall Study|Non compliance with study medication|0|||
33324891|NCT01092143|101087872|FG004|Overall Study|Non compliance with study medication|1|||
33324892|NCT01092143|101087868|FG000|Overall Study|Randomized by mistake|0|||
33399386|NCT02407236|101350204|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
33399387|NCT02407236|101350192|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
33399388|NCT02407236|101350193|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
33399389|NCT02407236|101350194|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
33399390|NCT02407236|101350195|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
33399391|NCT02407236|101350196|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
33399392|NCT02407236|101350197|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
33399393|NCT02407236|101350198|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
33399394|NCT02407236|101350199|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
33606726|NCT00300365|102111512|FG000|Overall Study|Physician Decision|2|||
33606727|NCT00300365|102111513|FG001|Overall Study|Physician Decision|0|||
33606728|NCT00300365|102111512|FG000|Overall Study|Withdrawal by Subject|1|||
33606729|NCT00300365|102111513|FG001|Overall Study|Withdrawal by Subject|0|||
33606730|NCT00300365|102111512|FG000|Overall Study|Adverse Event|0|||
33606731|NCT00300365|102111513|FG001|Overall Study|Adverse Event|2|||
33606732|NCT01423916|102111514|FG000|Overall Study|Adverse Event|5|||
33606733|NCT01423916|102111515|FG001|Overall Study|Adverse Event|9|||
33606734|NCT01423916|102111516|FG002|Overall Study|Adverse Event|2|||
33606735|NCT01423916|102111514|FG000|Overall Study|Met Withdrawal Criteria|1|||
33606736|NCT01423916|102111515|FG001|Overall Study|Met Withdrawal Criteria|1|||
33606737|NCT01423916|102111516|FG002|Overall Study|Met Withdrawal Criteria|1|||
33606738|NCT01423916|102111514|FG000|Overall Study|Physician Decision|1|||
33606739|NCT01423916|102111515|FG001|Overall Study|Physician Decision|0|||
33606740|NCT01423916|102111516|FG002|Overall Study|Physician Decision|1|||
33606741|NCT01423916|102111514|FG000|Overall Study|Withdrawal by Subject|3|||
33606742|NCT01423916|102111515|FG001|Overall Study|Withdrawal by Subject|10|||
33606743|NCT01423916|102111516|FG002|Overall Study|Withdrawal by Subject|3|||
33606744|NCT01423916|102111514|FG000|Overall Study|Protocol Deviation|1|||
33606745|NCT01423916|102111515|FG001|Overall Study|Protocol Deviation|0|||
33606746|NCT01423916|102111516|FG002|Overall Study|Protocol Deviation|0|||
33606747|NCT00701805|102111517|FG000|Overall Study|Withdrawal by Subject|3|||
33606748|NCT00701805|102111518|FG001|Overall Study|Withdrawal by Subject|1|||
33606749|NCT00701805|102111519|FG002|Overall Study|Withdrawal by Subject|4|||
33606750|NCT00701805|102111520|FG003|Overall Study|Withdrawal by Subject|3|||
33606751|NCT00701805|102111517|FG000|Overall Study|Adverse Event|0|||
33606752|NCT00701805|102111518|FG001|Overall Study|Adverse Event|1|||
33606753|NCT00701805|102111519|FG002|Overall Study|Adverse Event|1|||
33606754|NCT00701805|102111520|FG003|Overall Study|Adverse Event|0|||
33606755|NCT00701805|102111517|FG000|Overall Study|Missed 7 consecutive doses|0|||
33606756|NCT00701805|102111518|FG001|Overall Study|Missed 7 consecutive doses|1|||
33606757|NCT00701805|102111519|FG002|Overall Study|Missed 7 consecutive doses|0|||
33606758|NCT00701805|102111520|FG003|Overall Study|Missed 7 consecutive doses|0|||
33606759|NCT00701805|102111517|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
33606760|NCT00701805|102111518|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
33324893|NCT01092143|101087869|FG001|Overall Study|Randomized by mistake|0|||
33324894|NCT01092143|101087870|FG002|Overall Study|Randomized by mistake|0|||
33324895|NCT01092143|101087871|FG003|Overall Study|Randomized by mistake|1|||
33399395|NCT02407236|101350200|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
33606761|NCT00701805|102111519|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
33399396|NCT02407236|101350201|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
33606762|NCT00701805|102111520|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
33399397|NCT02407236|101350202|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
33606763|NCT00701805|102111517|FG000|Overall Study|Physician decision, change of therapy|0|||
33606764|NCT00701805|102111518|FG001|Overall Study|Physician decision, change of therapy|0|||
33606765|NCT00701805|102111519|FG002|Overall Study|Physician decision, change of therapy|0|||
33606766|NCT00701805|102111520|FG003|Overall Study|Physician decision, change of therapy|1|||
33324896|NCT01092143|101087872|FG004|Overall Study|Randomized by mistake|0|||
33324897|NCT01092143|101087868|FG000|Overall Study|Pregnancy|0|||
33324898|NCT01092143|101087869|FG001|Overall Study|Pregnancy|0|||
33324899|NCT01092143|101087870|FG002|Overall Study|Pregnancy|0|||
33324900|NCT01092143|101087871|FG003|Overall Study|Pregnancy|1|||
33324901|NCT01092143|101087872|FG004|Overall Study|Pregnancy|0|||
33324902|NCT00078325|101087873|FG000|Overall Study|Adverse Event|15|||
33324903|NCT00078325|101087874|FG001|Overall Study|Adverse Event|10|||
33324904|NCT00078325|101087875|FG002|Overall Study|Adverse Event|5|||
33324905|NCT00078325|101087873|FG000|Overall Study|Protocol Violation|2|||
33324906|NCT00078325|101087874|FG001|Overall Study|Protocol Violation|2|||
33324907|NCT00078325|101087875|FG002|Overall Study|Protocol Violation|0|||
33324908|NCT00078325|101087873|FG000|Overall Study|Withdrawal by Subject|1|||
33324909|NCT00078325|101087874|FG001|Overall Study|Withdrawal by Subject|5|||
33324910|NCT00078325|101087875|FG002|Overall Study|Withdrawal by Subject|3|||
33324911|NCT00078325|101087873|FG000|Overall Study|Lost to Follow-up|0|||
33324912|NCT00078325|101087874|FG001|Overall Study|Lost to Follow-up|1|||
33324913|NCT00078325|101087875|FG002|Overall Study|Lost to Follow-up|1|||
33324914|NCT00078325|101087873|FG000|Overall Study|Physician Decision|2|||
33324915|NCT00078325|101087874|FG001|Overall Study|Physician Decision|0|||
33324916|NCT00078325|101087875|FG002|Overall Study|Physician Decision|1|||
33324917|NCT00078325|101087873|FG000|Overall Study|Miscellaneous|1|||
33324918|NCT00078325|101087874|FG001|Overall Study|Miscellaneous|1|||
33324919|NCT00078325|101087875|FG002|Overall Study|Miscellaneous|1|||
33324920|NCT00711425|101087876|FG000|Overall Study|Protocol Violation|1|||
33324921|NCT00711425|101087876|FG000|Overall Study|Death|2|||
33324922|NCT00711425|101087876|FG000|Overall Study|Lost to Follow-up|1|||
33324923|NCT02689284|101087877|FG000|Overall Study|Adverse Event|1|||
33324924|NCT02689284|101087878|FG001|Overall Study|Adverse Event|8|||
33324925|NCT02689284|101087877|FG000|Overall Study|Death|0|||
33324926|NCT02689284|101087878|FG001|Overall Study|Death|1|||
33324927|NCT02689284|101087877|FG000|Overall Study|Physician Decision|1|||
33324928|NCT02689284|101087878|FG001|Overall Study|Physician Decision|2|||
33324929|NCT02689284|101087877|FG000|Overall Study|Withdrawal by Subject|0|||
33324930|NCT02689284|101087878|FG001|Overall Study|Withdrawal by Subject|1|||
33324931|NCT02689284|101087877|FG000|Overall Study|progression of cancer|1|||
33324932|NCT02689284|101087878|FG001|Overall Study|progression of cancer|72|||
33324933|NCT02689284|101087877|FG000|Overall Study|decreased heart function|0|||
33324934|NCT02689284|101087878|FG001|Overall Study|decreased heart function|1|||
33324935|NCT02689284|101087877|FG000|Overall Study|concern for anemia|0|||
33324936|NCT02689284|101087878|FG001|Overall Study|concern for anemia|1|||
33324937|NCT02689284|101087877|FG000|Overall Study|no measurable cancer for evaluation|0|||
33324938|NCT02689284|101087878|FG001|Overall Study|no measurable cancer for evaluation|1|||
33324939|NCT04196803|101087879|FG000|Overall Study|Withdrawal by Subject|1|||
33324940|NCT04196803|101087880|FG001|Overall Study|Withdrawal by Subject|3|||
33324941|NCT04196803|101087879|FG000|Overall Study|Adverse Event|4|||
33324942|NCT04196803|101087880|FG001|Overall Study|Adverse Event|2|||
33324943|NCT04196803|101087879|FG000|Overall Study|Lost to Follow-up|0|||
33324944|NCT04196803|101087880|FG001|Overall Study|Lost to Follow-up|1|||
33324945|NCT05513625|101087881|FG000|Overall Study|Withdrawal by Subject|1|||
33324946|NCT01045798|101087882|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
33324947|NCT01045798|101087883|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
33324948|NCT01045798|101087882|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
33324949|NCT01045798|101087883|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
33324950|NCT01045798|101087882|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
33324951|NCT01045798|101087883|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
33324952|NCT01045798|101087882|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
33324953|NCT01045798|101087883|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
33324954|NCT01202279|101087886|FG000|Overall Study|Adverse Event|8|||
33324955|NCT01202279|101087887|FG001|Overall Study|Adverse Event|6|||
33324956|NCT01202279|101087886|FG000|Overall Study|Withdrawal by Subject|13|||
33324957|NCT01202279|101087887|FG001|Overall Study|Withdrawal by Subject|10|||
33399398|NCT02407236|101350203|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
33513796|NCT03320850|101776747|FG004|Overall Study|Withdrawal by Subject|1|||
33513797|NCT03320850|101776748|FG005|Overall Study|Withdrawal by Subject|2|||
33324958|NCT01202279|101087886|FG000|Overall Study|Physician Decision|0|||
33324959|NCT01202279|101087887|FG001|Overall Study|Physician Decision|1|||
33324960|NCT01202279|101087886|FG000|Overall Study|Lost to Follow-up|10|||
33324961|NCT01202279|101087887|FG001|Overall Study|Lost to Follow-up|7|||
33324962|NCT01202279|101087886|FG000|Overall Study|Protocol Violation|1|||
33324963|NCT01202279|101087887|FG001|Overall Study|Protocol Violation|1|||
33324964|NCT01202279|101087886|FG000|Overall Study|study compliance|5|||
33324965|NCT01202279|101087887|FG001|Overall Study|study compliance|2|||
33324966|NCT01536951|101087888|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33324967|NCT01536951|101087889|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33324968|NCT01536951|101087890|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
33324969|NCT01536951|101087891|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33199036|NCT03136068|100633726|FG000|Overall Study|Lost to Follow-up|1|||
33324970|NCT01536951|101087892|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33324971|NCT01536951|101087893|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33324972|NCT01536951|101087894|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33324973|NCT01536951|101087895|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33324974|NCT01536951|101087896|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
33324975|NCT01536951|101087888|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
33324976|NCT01536951|101087889|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
33324977|NCT01536951|101087890|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
33324978|NCT01536951|101087891|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
33324979|NCT01536951|101087892|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
33324980|NCT01536951|101087893|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
33324981|NCT01536951|101087894|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
33324982|NCT01536951|101087895|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
33324983|NCT01536951|101087896|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
33324984|NCT00873366|101087897|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
33324985|NCT00873366|101087897|FG000|Overall Study|Off tamoxifen due to side effects|2|||
33324986|NCT00873366|101087897|FG000|Overall Study|Refused to continue DM-BT testing|3|||
33324987|NCT00307333|101087898|FG000|Overall Study|Lost to Follow-up|11|||
33324988|NCT00307333|101087899|FG001|Overall Study|Lost to Follow-up|3|||
33324989|NCT00454857|101087900|FG000|Overall Study|Withdrawal by Subject|15|||
33324990|NCT00454857|101087900|FG000|Overall Study|Lost to Follow-up|16|||
33324991|NCT00454857|101087900|FG000|Overall Study|Noncompliance|6|||
33324992|NCT00454857|101087900|FG000|Overall Study|Death|5|||
33324993|NCT00454857|101087900|FG000|Overall Study|Other|11|||
33324994|NCT00454857|101087900|FG000|Overall Study|Reason unknown|1|||
33324995|NCT03496012|101087901|FG000|Overall Study|Withdrawal by Subject|2|||
33324996|NCT03496012|101087902|FG001|Overall Study|Withdrawal by Subject|0|||
33324997|NCT03496012|101087903|FG002|Overall Study|Withdrawal by Subject|2|||
33324998|NCT03496012|101087901|FG000|Overall Study|Adverse Event|0|||
33324999|NCT03496012|101087902|FG001|Overall Study|Adverse Event|0|||
33325000|NCT03496012|101087903|FG002|Overall Study|Adverse Event|1|||
33325001|NCT03496012|101087901|FG000|Overall Study|Reason Not Specified|2|||
33325002|NCT03496012|101087902|FG001|Overall Study|Reason Not Specified|0|||
33325003|NCT03496012|101087903|FG002|Overall Study|Reason Not Specified|1|||
33325004|NCT03086057|101087904|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
33325005|NCT03086057|101087905|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
33325006|NCT03086057|101087906|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
33325007|NCT03086057|101087907|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
33325008|NCT03086057|101087904|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
33325009|NCT03086057|101087905|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
33325010|NCT03086057|101087906|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
33325011|NCT03086057|101087907|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
33325012|NCT03086057|101087904|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
33325013|NCT03086057|101087905|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
33325014|NCT03086057|101087906|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
33325015|NCT03086057|101087907|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
33325016|NCT03086057|101087904|FG000|Stage 1: PrEP Uptake|Death|1|||
33325017|NCT03086057|101087905|FG001|Stage 1: PrEP Uptake|Death|0|||
33325018|NCT03086057|101087906|FG002|Stage 1: PrEP Uptake|Death|0|||
33325019|NCT03086057|101087907|FG003|Stage 1: PrEP Uptake|Death|0|||
33325020|NCT03086057|101087904|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
33513798|NCT03320850|101776749|FG006|Overall Study|Withdrawal by Subject|4|||
33513799|NCT03320850|101776750|FG007|Overall Study|Withdrawal by Subject|5|||
33513800|NCT03320850|101776751|FG008|Overall Study|Withdrawal by Subject|2|||
33513801|NCT03320850|101776752|FG009|Overall Study|Withdrawal by Subject|1|||
33513802|NCT03320850|101776743|FG000|Overall Study|Lack of Efficacy|0|||
33513803|NCT03320850|101776744|FG001|Overall Study|Lack of Efficacy|0|||
33513804|NCT03320850|101776745|FG002|Overall Study|Lack of Efficacy|0|||
33513805|NCT03320850|101776746|FG003|Overall Study|Lack of Efficacy|1|||
33513806|NCT03320850|101776747|FG004|Overall Study|Lack of Efficacy|0|||
33199037|NCT03136068|100633727|FG001|Overall Study|Lost to Follow-up|1|||
33325021|NCT03086057|101087905|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
33325022|NCT03086057|101087906|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
33325023|NCT03086057|101087907|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
33325024|NCT03086057|101087904|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
33325025|NCT03086057|101087905|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
33325026|NCT03086057|101087906|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
33513807|NCT03320850|101776748|FG005|Overall Study|Lack of Efficacy|1|||
33325027|NCT03086057|101087907|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
33325028|NCT03086057|101087904|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
33513808|NCT03320850|101776749|FG006|Overall Study|Lack of Efficacy|0|||
33513809|NCT03320850|101776750|FG007|Overall Study|Lack of Efficacy|2|||
33325029|NCT03086057|101087905|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
33325030|NCT03086057|101087906|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
33325031|NCT03086057|101087907|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
33325032|NCT00102960|101087908|FG000|Overall Study|Death|23|||
33325033|NCT00102960|101087909|FG001|Overall Study|Death|11|||
33513810|NCT03320850|101776751|FG008|Overall Study|Lack of Efficacy|0|||
33513811|NCT03320850|101776752|FG009|Overall Study|Lack of Efficacy|3|||
33513812|NCT03320850|101776743|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
33513813|NCT03320850|101776744|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
33513814|NCT03320850|101776745|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
33513815|NCT03320850|101776746|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
33513816|NCT03320850|101776747|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
33513817|NCT03320850|101776748|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
33513818|NCT03320850|101776749|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
33513819|NCT03320850|101776750|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
33513820|NCT03320850|101776751|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
33513821|NCT03320850|101776752|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
33513822|NCT03320850|101776743|FG000|Overall Study|Adverse Event|0|||
33513823|NCT03320850|101776744|FG001|Overall Study|Adverse Event|0|||
33513824|NCT03320850|101776745|FG002|Overall Study|Adverse Event|0|||
33513825|NCT03320850|101776746|FG003|Overall Study|Adverse Event|0|||
33513826|NCT03320850|101776747|FG004|Overall Study|Adverse Event|0|||
33513827|NCT03320850|101776748|FG005|Overall Study|Adverse Event|2|||
33513828|NCT03320850|101776749|FG006|Overall Study|Adverse Event|1|||
33513829|NCT03320850|101776750|FG007|Overall Study|Adverse Event|0|||
33513830|NCT03320850|101776751|FG008|Overall Study|Adverse Event|2|||
33513831|NCT03320850|101776752|FG009|Overall Study|Adverse Event|0|||
33513832|NCT03320850|101776743|FG000|Overall Study|Reason Not Specified|0|||
33513833|NCT03320850|101776744|FG001|Overall Study|Reason Not Specified|0|||
33513834|NCT03320850|101776745|FG002|Overall Study|Reason Not Specified|0|||
33513835|NCT03320850|101776746|FG003|Overall Study|Reason Not Specified|0|||
33513836|NCT03320850|101776747|FG004|Overall Study|Reason Not Specified|0|||
33513837|NCT03320850|101776748|FG005|Overall Study|Reason Not Specified|1|||
33513838|NCT03320850|101776749|FG006|Overall Study|Reason Not Specified|0|||
33513839|NCT03320850|101776750|FG007|Overall Study|Reason Not Specified|0|||
33513840|NCT03320850|101776751|FG008|Overall Study|Reason Not Specified|0|||
33513841|NCT03320850|101776752|FG009|Overall Study|Reason Not Specified|1|||
33513842|NCT06137703|101776753|FG000|Overall Study|Other|0|||
33513843|NCT06137703|101776754|FG001|Overall Study|Other|1|||
33513844|NCT06137703|101776755|FG002|Overall Study|Other|0|||
33513845|NCT06137703|101776756|FG003|Overall Study|Other|0|||
33513846|NCT06137703|101776753|FG000|Overall Study|Adverse Event|0|||
33513847|NCT06137703|101776754|FG001|Overall Study|Adverse Event|0|||
33513848|NCT06137703|101776755|FG002|Overall Study|Adverse Event|1|||
33513849|NCT06137703|101776756|FG003|Overall Study|Adverse Event|0|||
33513850|NCT01552915|101776757|FG000|Overall Study|Adverse Event|3|||
33513851|NCT01552915|101776758|FG001|Overall Study|Adverse Event|14|||
33513852|NCT01552915|101776759|FG002|Overall Study|Adverse Event|3|||
33513853|NCT01552915|101776757|FG000|Overall Study|Lost to Follow-up|4|||
33325034|NCT00102960|101087910|FG002|Overall Study|Death|11|||
33325035|NCT00102960|101087908|FG000|Overall Study|Lost to Follow-up|6|||
33513854|NCT01552915|101776758|FG001|Overall Study|Lost to Follow-up|6|||
33513855|NCT01552915|101776759|FG002|Overall Study|Lost to Follow-up|5|||
33513856|NCT01552915|101776757|FG000|Overall Study|Withdrawal by Subject|6|||
33513857|NCT01552915|101776758|FG001|Overall Study|Withdrawal by Subject|4|||
33513858|NCT01552915|101776759|FG002|Overall Study|Withdrawal by Subject|5|||
33513859|NCT01552915|101776757|FG000|Overall Study|Protocol Violation|0|||
33513860|NCT01552915|101776758|FG001|Overall Study|Protocol Violation|4|||
33513861|NCT01552915|101776759|FG002|Overall Study|Protocol Violation|4|||
33513862|NCT01552915|101776757|FG000|Overall Study|Lack of Efficacy|8|||
33199038|NCT03136068|100633726|FG000|Overall Study|Protocol Violation|1|||
33325036|NCT00102960|101087909|FG001|Overall Study|Lost to Follow-up|12|||
33325037|NCT00102960|101087910|FG002|Overall Study|Lost to Follow-up|16|||
33513863|NCT01552915|101776758|FG001|Overall Study|Lack of Efficacy|1|||
33513864|NCT01552915|101776759|FG002|Overall Study|Lack of Efficacy|4|||
33513865|NCT01552915|101776757|FG000|Overall Study|Other|2|||
33513866|NCT01552915|101776758|FG001|Overall Study|Other|0|||
33513867|NCT01552915|101776759|FG002|Overall Study|Other|6|||
33513868|NCT03875092|101776760|FG000|Overall Study|Adverse Event|2|||
33513869|NCT03875092|101776761|FG001|Overall Study|Adverse Event|5|||
33325038|NCT00102960|101087908|FG000|Overall Study|Withdrawal by Subject|1|||
33325039|NCT00102960|101087909|FG001|Overall Study|Withdrawal by Subject|0|||
33513870|NCT03875092|101776760|FG000|Overall Study|Death|44|||
33513871|NCT03875092|101776761|FG001|Overall Study|Death|51|||
33513872|NCT03875092|101776760|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
33513873|NCT03875092|101776761|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
33513874|NCT01892085|101776766|FG000|Overall Study|Death|4|||
33513875|NCT01892085|101776767|FG001|Overall Study|Death|1|||
33325040|NCT00102960|101087910|FG002|Overall Study|Withdrawal by Subject|1|||
33325041|NCT01809132|101087913|FG000|Overall Study|Withdrawal by Subject|0|||
33325042|NCT01809132|101087914|FG001|Overall Study|Withdrawal by Subject|0|||
33325043|NCT01809132|101087915|FG002|Overall Study|Withdrawal by Subject|1|||
33325044|NCT01161043|101087916|FG000|Overall Study|Withdrawal by Subject|3|||
33325045|NCT01732796|101087918|FG000|Overall Study|Adverse Event|16|||
33325046|NCT01732796|101087919|FG001|Overall Study|Adverse Event|16|||
33325047|NCT01732796|101087920|FG002|Overall Study|Adverse Event|4|||
33325048|NCT01732796|101087918|FG000|Overall Study|Lack of Efficacy|21|||
33325049|NCT01732796|101087919|FG001|Overall Study|Lack of Efficacy|18|||
33325050|NCT01732796|101087920|FG002|Overall Study|Lack of Efficacy|5|||
33325051|NCT01732796|101087918|FG000|Overall Study|Lost to Follow-up|2|||
33325052|NCT01732796|101087919|FG001|Overall Study|Lost to Follow-up|0|||
33325053|NCT01732796|101087920|FG002|Overall Study|Lost to Follow-up|0|||
33513876|NCT01892085|101776768|FG002|Overall Study|Death|3|||
33513877|NCT01892085|101776766|FG000|Overall Study|Withdrawal by Subject|2|||
33513878|NCT01892085|101776767|FG001|Overall Study|Withdrawal by Subject|0|||
33513879|NCT01892085|101776768|FG002|Overall Study|Withdrawal by Subject|2|||
33513880|NCT00875433|101776769|FG000|Overall Study|Progressive disease|41|||
33513881|NCT00875433|101776769|FG000|Overall Study|Other Adverse Event|14|||
33513882|NCT00875433|101776769|FG000|Overall Study|Withdrawal by Subject|2|||
33513883|NCT00875433|101776769|FG000|Overall Study|Other|3|||
33513884|NCT00504725|101776776|FG000|Overall Study|Protocol Violation|1|||
33513885|NCT00504725|101776777|FG001|Overall Study|Protocol Violation|0|||
33513886|NCT02052596|101776778|FG000|Active Phase|Adverse Event|3|||
33513887|NCT02052596|101776779|FG001|Active Phase|Adverse Event|2|||
33513888|NCT02052596|101776778|FG000|Active Phase|Lost to Follow-up|8|||
33513889|NCT02052596|101776779|FG001|Active Phase|Lost to Follow-up|11|||
33513890|NCT02052596|101776778|FG000|Active Phase|Protocol Violation|1|||
33513891|NCT02052596|101776779|FG001|Active Phase|Protocol Violation|2|||
33513892|NCT02052596|101776778|FG000|Active Phase|Withdrawal by Subject|3|||
33513893|NCT02052596|101776779|FG001|Active Phase|Withdrawal by Subject|4|||
33606767|NCT00701805|102111517|FG000|Overall Study|Difficult to travel to dialysis site|0|||
33606768|NCT00701805|102111518|FG001|Overall Study|Difficult to travel to dialysis site|0|||
33606769|NCT00701805|102111519|FG002|Overall Study|Difficult to travel to dialysis site|1|||
33606770|NCT00701805|102111520|FG003|Overall Study|Difficult to travel to dialysis site|0|||
33606771|NCT00701805|102111517|FG000|Overall Study|Resumption criteria were not met|0|||
33606772|NCT00701805|102111518|FG001|Overall Study|Resumption criteria were not met|1|||
33606773|NCT00701805|102111519|FG002|Overall Study|Resumption criteria were not met|0|||
33606774|NCT00701805|102111520|FG003|Overall Study|Resumption criteria were not met|0|||
33606775|NCT00931801|102111521|FG000|Overall Study|Adverse Event|0|||
33606776|NCT00931801|102111522|FG001|Overall Study|Adverse Event|0|||
33606777|NCT00931801|102111523|FG002|Overall Study|Adverse Event|1|||
33606778|NCT00931801|102111521|FG000|Overall Study|Lost to Follow-up|0|||
33606779|NCT00931801|102111522|FG001|Overall Study|Lost to Follow-up|1|||
33606780|NCT00931801|102111523|FG002|Overall Study|Lost to Follow-up|0|||
33606781|NCT00931801|102111521|FG000|Overall Study|Withdrawal by Subject|1|||
33606782|NCT00931801|102111522|FG001|Overall Study|Withdrawal by Subject|0|||
33606783|NCT00931801|102111523|FG002|Overall Study|Withdrawal by Subject|0|||
33606784|NCT00931801|102111521|FG000|Overall Study|Confirmed Virologic Failure|0|||
33606785|NCT00931801|102111522|FG001|Overall Study|Confirmed Virologic Failure|0|||
33606786|NCT00931801|102111523|FG002|Overall Study|Confirmed Virologic Failure|3|||
33606787|NCT01657760|102111528|FG000|Overall Study|Withdrawal by Subject|0|||
33606788|NCT01657760|102111529|FG001|Overall Study|Withdrawal by Subject|0|||
33606789|NCT01657760|102111530|FG002|Overall Study|Withdrawal by Subject|0|||
33606790|NCT01657760|102111531|FG003|Overall Study|Withdrawal by Subject|1|||
33606791|NCT01657760|102111528|FG000|Overall Study|Physician Decision|1|||
33606792|NCT01657760|102111529|FG001|Overall Study|Physician Decision|1|||
33606793|NCT01657760|102111530|FG002|Overall Study|Physician Decision|1|||
33513894|NCT02052596|101776778|FG000|Active Phase|Enrolled in error|1|||
33513895|NCT02052596|101776779|FG001|Active Phase|Enrolled in error|0|||
33513896|NCT02052596|101776778|FG000|Active Phase|Lost due to Crohn's disease|0|||
33513897|NCT02052596|101776779|FG001|Active Phase|Lost due to Crohn's disease|1|||
33513898|NCT02052596|101776778|FG000|Safety Phase|Adverse Event|6|||
33606794|NCT01657760|102111531|FG003|Overall Study|Physician Decision|2|||
33606795|NCT01543776|102111537|FG000|Overall Study|Withdrawal by Subject|2|||
33606796|NCT01543776|102111538|FG001|Overall Study|Withdrawal by Subject|2|||
33325054|NCT01732796|101087918|FG000|Overall Study|Withdrawal by Subject|6|||
33325055|NCT01732796|101087919|FG001|Overall Study|Withdrawal by Subject|8|||
33325056|NCT01732796|101087920|FG002|Overall Study|Withdrawal by Subject|2|||
33199039|NCT03136068|100633727|FG001|Overall Study|Protocol Violation|0|||
33399399|NCT02407236|101350204|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
33399400|NCT00750867|101350206|FG000|Overall Study|Adverse Event|2|||
33513899|NCT02052596|101776779|FG001|Safety Phase|Adverse Event|3|||
33513900|NCT02052596|101776778|FG000|Safety Phase|Lost to Follow-up|11|||
33513901|NCT02052596|101776779|FG001|Safety Phase|Lost to Follow-up|18|||
33199040|NCT00642304|100633728|FG000|Overall Study|Adverse Event|1|||
33513902|NCT02052596|101776778|FG000|Safety Phase|Protocol Violation|1|||
33513903|NCT02052596|101776779|FG001|Safety Phase|Protocol Violation|2|||
33513904|NCT02052596|101776778|FG000|Safety Phase|Withdrawal by Subject|8|||
33513905|NCT02052596|101776779|FG001|Safety Phase|Withdrawal by Subject|11|||
33199041|NCT00642304|100633728|FG000|Overall Study|Death|1|||
33513906|NCT02052596|101776778|FG000|Safety Phase|Enrolled in error|1|||
33199042|NCT00642304|100633728|FG000|Overall Study|Blood transfusion|2|||
33199043|NCT00642304|100633728|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
33199044|NCT00642304|100633728|FG000|Overall Study|Transplantation|1|||
33199045|NCT03348904|100633729|FG000|Overall Study|Administrative reason by the sponsor|0|||
33199046|NCT03348904|100633730|FG001|Overall Study|Administrative reason by the sponsor|1|||
33199047|NCT03348904|100633731|FG002|Overall Study|Administrative reason by the sponsor|0|||
33199048|NCT01785524|100633743|FG000|Overall Study|Withdrawal by Subject|2|||
33199049|NCT01785524|100633744|FG001|Overall Study|Withdrawal by Subject|2|||
33199050|NCT00320216|100633745|FG000|Overall Study|Adverse Event|0|||
33199051|NCT00320216|100633746|FG001|Overall Study|Adverse Event|6|||
33199052|NCT00320216|100633747|FG002|Overall Study|Adverse Event|0|||
33199053|NCT00320216|100633748|FG003|Overall Study|Adverse Event|2|||
33199054|NCT00320216|100633749|FG004|Overall Study|Adverse Event|2|||
33199055|NCT00320216|100633745|FG000|Overall Study|Lack of Efficacy|6|||
33199056|NCT00320216|100633746|FG001|Overall Study|Lack of Efficacy|2|||
33199057|NCT00320216|100633747|FG002|Overall Study|Lack of Efficacy|1|||
33199058|NCT00320216|100633748|FG003|Overall Study|Lack of Efficacy|0|||
33199059|NCT00320216|100633749|FG004|Overall Study|Lack of Efficacy|1|||
33199060|NCT00320216|100633745|FG000|Overall Study|Lost to Follow-up|3|||
33199061|NCT00320216|100633746|FG001|Overall Study|Lost to Follow-up|0|||
33199062|NCT00320216|100633747|FG002|Overall Study|Lost to Follow-up|0|||
33199063|NCT00320216|100633748|FG003|Overall Study|Lost to Follow-up|0|||
33199064|NCT00320216|100633749|FG004|Overall Study|Lost to Follow-up|0|||
33513907|NCT02052596|101776779|FG001|Safety Phase|Enrolled in error|0|||
33513908|NCT02052596|101776778|FG000|Safety Phase|Lost due to Crohn's disease|0|||
33199065|NCT00320216|100633745|FG000|Overall Study|Other|7|||
33199066|NCT00320216|100633746|FG001|Overall Study|Other|2|||
33199067|NCT00320216|100633747|FG002|Overall Study|Other|5|||
33199068|NCT00320216|100633748|FG003|Overall Study|Other|1|||
33199069|NCT00320216|100633749|FG004|Overall Study|Other|3|||
33199070|NCT02252081|100633750|FG000|Overall Study|Withdrawal by Subject|2|||
33513909|NCT02052596|101776779|FG001|Safety Phase|Lost due to Crohn's disease|1|||
33513910|NCT01797081|101776780|FG000|Overall Study|Adverse Event|1|||
33513911|NCT01797081|101776781|FG001|Overall Study|Adverse Event|0|||
33513912|NCT01797081|101776782|FG002|Overall Study|Adverse Event|1|||
33606797|NCT00991406|102111539|FG000|Overall Study|One participant did not respond to FES.|1|||
33606798|NCT01704456|102111540|FG000|Overall Study|Lost to Follow-up|8|||
33606799|NCT01704456|102111541|FG001|Overall Study|Lost to Follow-up|14|||
33606800|NCT03688100|102111546|FG000|Overall Study|Lost to Follow-up|21|||
33325057|NCT01732796|101087918|FG000|Overall Study|Other reason not defined above|1|||
33325058|NCT01732796|101087919|FG001|Overall Study|Other reason not defined above|0|||
33325059|NCT01732796|101087920|FG002|Overall Study|Other reason not defined above|2|||
33325060|NCT01721876|101087923|FG000|Overall Study|Not treated|1|||
33325061|NCT01721876|101087924|FG001|Overall Study|Not treated|4|||
33325062|NCT01721876|101087923|FG000|Overall Study|Disease progression / relapse|123|||
33325063|NCT01721876|101087924|FG001|Overall Study|Disease progression / relapse|156|||
33325064|NCT01721876|101087923|FG000|Overall Study|Death|6|||
33513913|NCT01797081|101776783|FG003|Overall Study|Adverse Event|0|||
33513914|NCT01797081|101776780|FG000|Overall Study|Pregnancy|1|||
33606801|NCT03688100|102111547|FG001|Overall Study|Lost to Follow-up|15|||
33606802|NCT03688100|102111548|FG002|Overall Study|Lost to Follow-up|15|||
33606803|NCT03688100|102111549|FG003|Overall Study|Lost to Follow-up|18|||
33606804|NCT03688100|102111546|FG000|Overall Study|Withdrawal by Subject|19|||
33606805|NCT03688100|102111547|FG001|Overall Study|Withdrawal by Subject|16|||
33199071|NCT02252081|100633751|FG001|Overall Study|Withdrawal by Subject|1|||
33325065|NCT01721876|101087924|FG001|Overall Study|Death|13|||
33513915|NCT01797081|101776781|FG001|Overall Study|Pregnancy|0|||
33513916|NCT01797081|101776782|FG002|Overall Study|Pregnancy|0|||
33513917|NCT01797081|101776783|FG003|Overall Study|Pregnancy|0|||
33606806|NCT03688100|102111548|FG002|Overall Study|Withdrawal by Subject|0|||
33606807|NCT03688100|102111549|FG003|Overall Study|Withdrawal by Subject|0|||
33199072|NCT02252081|100633750|FG000|Overall Study|Adverse Event|4|||
33199073|NCT02252081|100633751|FG001|Overall Study|Adverse Event|1|||
33325066|NCT01721876|101087923|FG000|Overall Study|Adverse Event|41|||
33513918|NCT01797081|101776780|FG000|Overall Study|Personal Reasons|12|||
33606808|NCT03688100|102111546|FG000|Overall Study|Death|36|||
33606809|NCT03688100|102111547|FG001|Overall Study|Death|27|||
33325067|NCT01721876|101087924|FG001|Overall Study|Adverse Event|165|||
33325068|NCT01721876|101087923|FG000|Overall Study|Protocol Violation|2|||
33325069|NCT01721876|101087924|FG001|Overall Study|Protocol Violation|1|||
33513919|NCT01797081|101776781|FG001|Overall Study|Personal Reasons|4|||
33606810|NCT03688100|102111548|FG002|Overall Study|Death|0|||
33606811|NCT03688100|102111549|FG003|Overall Study|Death|0|||
33606812|NCT01067469|102111550|FG000|Overall Study|Withdrawal by Subject|0|||
33606813|NCT01067469|102111551|FG001|Overall Study|Withdrawal by Subject|1|||
33199074|NCT02252081|100633750|FG000|Overall Study|non compliance & others|0|||
33199075|NCT02252081|100633751|FG001|Overall Study|non compliance & others|2|||
33199076|NCT02530619|100633752|FG000|Registered for Study|Withdrawal by Subject|2|||
33325070|NCT01721876|101087923|FG000|Overall Study|Withdrawal by Subject|15|||
33199077|NCT02530619|100633752|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
33199078|NCT02530619|100633752|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
33199079|NCT02530619|100633752|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
33199080|NCT02530619|100633752|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
33199081|NCT02530619|100633752|FG000|Follow-up Period (6 Months)|Death|4|||
33199082|NCT02530619|100633752|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
33199083|NCT02530619|100633752|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
33199084|NCT01969838|100633754|FG000|Double-blind Phase|Adverse Event|10|||
33199085|NCT01969838|100633755|FG001|Double-blind Phase|Adverse Event|4|||
33325071|NCT01721876|101087924|FG001|Overall Study|Withdrawal by Subject|38|||
33325072|NCT01721876|101087923|FG000|Overall Study|Reason not listed|34|||
33325073|NCT01721876|101087924|FG001|Overall Study|Reason not listed|63|||
33513920|NCT01797081|101776782|FG002|Overall Study|Personal Reasons|4|||
33513921|NCT01797081|101776783|FG003|Overall Study|Personal Reasons|8|||
33513922|NCT01797081|101776780|FG000|Overall Study|Protocol Violation|0|||
33513923|NCT01797081|101776781|FG001|Overall Study|Protocol Violation|0|||
33513924|NCT01797081|101776782|FG002|Overall Study|Protocol Violation|0|||
33513925|NCT01797081|101776783|FG003|Overall Study|Protocol Violation|1|||
33513926|NCT01796197|101776785|FG000|Overall Study|Lost to Follow-up|1|||
33513927|NCT01796197|101776785|FG000|Overall Study|Lack of Efficacy|1|||
33513928|NCT00348595|101776787|FG000|Overall Study|Adverse Event|5|||
33513929|NCT00348595|101776788|FG001|Overall Study|Adverse Event|8|||
33513930|NCT00189306|101776789|FG000|Treatment Period|Withdrawal by Subject|2|||
33513931|NCT00189306|101776789|FG000|Treatment Period|Adverse Event|2|||
33513932|NCT00189306|101776789|FG000|Treatment Period|Protocol Violation|1|||
33513933|NCT00189306|101776789|FG000|Posttreatment Period|Death|1|||
33513934|NCT00189306|101776789|FG000|Posttreatment Period|Withdrawal by Subject|2|||
33513935|NCT00189306|101776789|FG000|Posttreatment Period|Noncompliance|1|||
33513936|NCT00189306|101776789|FG000|Posttreatment Period|Target lesion excised|1|||
33513937|NCT00189306|101776789|FG000|Posttreatment Period|Protocol Violation|1|||
33513938|NCT00189306|101776789|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
33606814|NCT01067469|102111550|FG000|Overall Study|Disease Progression|0|||
33606815|NCT01067469|102111551|FG001|Overall Study|Disease Progression|1|||
33606816|NCT02477553|102111552|FG000|Overall Study|Screening up-to-date|12|||
33606817|NCT02477553|102111553|FG001|Overall Study|Screening up-to-date|13|||
33606818|NCT02477553|102111552|FG000|Overall Study|No MD visit|1|||
33606819|NCT02477553|102111553|FG001|Overall Study|No MD visit|1|||
33606820|NCT02477553|102111552|FG000|Overall Study|Workup consistent w/CRC|1|||
33606821|NCT02477553|102111553|FG001|Overall Study|Workup consistent w/CRC|1|||
33513939|NCT00189306|101776789|FG000|Posttreatment Period|Local skin reaction/sign|1|||
33606822|NCT02477553|102111552|FG000|Overall Study|Technical issues with intervention|2|||
33513940|NCT00189306|101776789|FG000|Long-Term Follow-up|Adverse Event|2|||
33513941|NCT00189306|101776789|FG000|Long-Term Follow-up|Death|4|||
33513942|NCT00189306|101776789|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
33513943|NCT00189306|101776789|FG000|Long-Term Follow-up|Intercurrent disease|2|||
33513944|NCT00189306|101776789|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
33513945|NCT00189306|101776789|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
33513946|NCT01300338|101776793|FG000|Overall Study|Lost to Follow-up|5|||
33513947|NCT01300338|101776794|FG001|Overall Study|Lost to Follow-up|0|||
33513948|NCT01282164|101776795|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
33513949|NCT01282164|101776796|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
33513950|NCT04186806|101776800|FG000|Period 1: 7 Days|Adverse Event|1|||
33513951|NCT04186806|101776801|FG001|Period 1: 7 Days|Adverse Event|0|||
33513952|NCT00090987|101776802|FG000|Overall Study|Adverse Event|5|||
33513953|NCT00090987|101776802|FG000|Overall Study|Lack of Efficacy|7|||
33513954|NCT00090987|101776802|FG000|Overall Study|Withdrawal by Subject|3|||
33513955|NCT00090987|101776802|FG000|Overall Study|alternative therapy|1|||
33513956|NCT00090987|101776802|FG000|Overall Study|Non-compliance|4|||
33513957|NCT00090987|101776802|FG000|Overall Study|Incarcerated|1|||
33513958|NCT00176644|101776803|FG000|Overall Study|Withdrawal by Subject|1|||
33513959|NCT03558152|101776804|FG000|Overall Study|Adverse Event|0|||
33513960|NCT03558152|101776805|FG001|Overall Study|Adverse Event|0|||
33606823|NCT02477553|102111553|FG001|Overall Study|Technical issues with intervention|0|||
33606824|NCT02477553|102111552|FG000|Overall Study|Elevated risk for CRC|2|||
33199086|NCT01969838|100633756|FG002|Double-blind Phase|Adverse Event|0|||
33199087|NCT01969838|100633757|FG003|Double-blind Phase|Adverse Event|0|||
33199088|NCT01969838|100633754|FG000|Double-blind Phase|Death|5|||
33199089|NCT01969838|100633755|FG001|Double-blind Phase|Death|2|||
33199090|NCT01969838|100633756|FG002|Double-blind Phase|Death|0|||
33325074|NCT01721876|101087923|FG000|Overall Study|Sponsor terminated trial|0|||
33325075|NCT01721876|101087924|FG001|Overall Study|Sponsor terminated trial|4|||
33325076|NCT04246801|101087925|FG000|Overall Study|Adverse Event|1|||
33325077|NCT04246801|101087926|FG001|Overall Study|Adverse Event|1|||
33325078|NCT04246801|101087925|FG000|Overall Study|Protocol Violation|1|||
33325079|NCT04246801|101087926|FG001|Overall Study|Protocol Violation|1|||
33325080|NCT04246801|101087925|FG000|Overall Study|Lack of Efficacy|0|||
33325081|NCT04246801|101087926|FG001|Overall Study|Lack of Efficacy|2|||
33325082|NCT04246801|101087925|FG000|Overall Study|Lost to Follow-up|1|||
33325083|NCT04246801|101087926|FG001|Overall Study|Lost to Follow-up|1|||
33325084|NCT04246801|101087925|FG000|Overall Study|Withdrawal by Subject|2|||
33325085|NCT04246801|101087926|FG001|Overall Study|Withdrawal by Subject|1|||
33325086|NCT01735279|101087929|FG000|Overall Study|Lost to Follow-up|11|||
33325087|NCT01735279|101087930|FG001|Overall Study|Lost to Follow-up|8|||
33325088|NCT03083847|101087931|FG000|Main|Physician Decision|0|||
33606825|NCT02477553|102111553|FG001|Overall Study|Elevated risk for CRC|2|||
33606826|NCT02477553|102111552|FG000|Overall Study|MD advised against screening|1|||
33606827|NCT02477553|102111553|FG001|Overall Study|MD advised against screening|3|||
33606828|NCT02477553|102111552|FG000|Overall Study|patient deceased|1|||
33606829|NCT02477553|102111553|FG001|Overall Study|patient deceased|0|||
33606830|NCT01639755|102111554|FG000|Overall Study|Study Ongoing|15|||
33606831|NCT01639755|102111554|FG000|Overall Study|Patient had device explantation|4|||
33606832|NCT05098509|102111555|FG000|Overall Study|Withdrawal by Subject|0|||
33199091|NCT01969838|100633757|FG003|Double-blind Phase|Death|0|||
33199092|NCT01969838|100633754|FG000|Double-blind Phase|Physician Decision|5|||
33325089|NCT03083847|101087932|FG001|Main|Physician Decision|0|||
33325090|NCT03083847|101087933|FG002|Main|Physician Decision|0|||
33325091|NCT03083847|101087934|FG003|Main|Physician Decision|0|||
33325092|NCT03083847|101087935|FG004|Main|Physician Decision|0|||
33325093|NCT03083847|101087936|FG005|Main|Physician Decision|1|||
33325094|NCT03083847|101087937|FG006|Main|Physician Decision|0|||
33325095|NCT03083847|101087938|FG007|Main|Physician Decision|0|||
33325096|NCT03083847|101087939|FG008|Main|Physician Decision|0|||
33325097|NCT03083847|101087940|FG009|Main|Physician Decision|0|||
33325098|NCT03083847|101087931|FG000|Main|Pregnancy|0|||
33325099|NCT03083847|101087932|FG001|Main|Pregnancy|0|||
33325100|NCT03083847|101087933|FG002|Main|Pregnancy|0|||
33513961|NCT03558152|101776806|FG002|Overall Study|Adverse Event|1|||
33513962|NCT03558152|101776807|FG003|Overall Study|Adverse Event|1|||
33513963|NCT03558152|101776808|FG004|Overall Study|Adverse Event|2|||
33513964|NCT03558152|101776809|FG005|Overall Study|Adverse Event|1|||
33513965|NCT03558152|101776810|FG006|Overall Study|Adverse Event|1|||
33199093|NCT01969838|100633755|FG001|Double-blind Phase|Physician Decision|1|||
33325101|NCT03083847|101087934|FG003|Main|Pregnancy|0|||
33325102|NCT03083847|101087935|FG004|Main|Pregnancy|0|||
33513966|NCT03558152|101776811|FG007|Overall Study|Adverse Event|0|||
33513967|NCT03558152|101776804|FG000|Overall Study|Death|0|||
33325103|NCT03083847|101087936|FG005|Main|Pregnancy|0|||
33325104|NCT03083847|101087937|FG006|Main|Pregnancy|0|||
33513968|NCT03558152|101776805|FG001|Overall Study|Death|0|||
33513969|NCT03558152|101776806|FG002|Overall Study|Death|0|||
33513970|NCT03558152|101776807|FG003|Overall Study|Death|0|||
33513971|NCT03558152|101776808|FG004|Overall Study|Death|1|||
33325105|NCT03083847|101087938|FG007|Main|Pregnancy|1|||
33325106|NCT03083847|101087939|FG008|Main|Pregnancy|0|||
33325107|NCT03083847|101087940|FG009|Main|Pregnancy|0|||
33325108|NCT03083847|101087931|FG000|Main|Adverse Event|0|||
33325109|NCT03083847|101087932|FG001|Main|Adverse Event|0|||
33325110|NCT03083847|101087933|FG002|Main|Adverse Event|0|||
33399401|NCT00887913|101350207|FG000|Overall Study|Withdrawal by Subject|6|||
33399402|NCT04554394|101350208|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
33399403|NCT04554394|101350209|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
33399404|NCT04554394|101350208|FG000|Overall Study|Withdrawal by Subject|2|||
33399405|NCT04554394|101350209|FG001|Overall Study|Withdrawal by Subject|2|||
33399406|NCT04554394|101350208|FG000|Overall Study|Lost to Follow-up|2|||
33399407|NCT04554394|101350209|FG001|Overall Study|Lost to Follow-up|2|||
33399408|NCT04554394|101350208|FG000|Overall Study|Physician Decision|1|||
33399409|NCT04554394|101350209|FG001|Overall Study|Physician Decision|1|||
33399410|NCT03481634|101350212|FG000|Overall Study|Withdrawal by Subject|16|||
33399411|NCT03481634|101350213|FG001|Overall Study|Withdrawal by Subject|19|||
33399412|NCT03481634|101350214|FG002|Overall Study|Withdrawal by Subject|14|||
33399413|NCT03481634|101350212|FG000|Overall Study|Protocol Violation|1|||
33399414|NCT03481634|101350213|FG001|Overall Study|Protocol Violation|0|||
33399415|NCT03481634|101350214|FG002|Overall Study|Protocol Violation|1|||
33399416|NCT03481634|101350212|FG000|Overall Study|Progressive disease|0|||
33399417|NCT03481634|101350213|FG001|Overall Study|Progressive disease|1|||
33399418|NCT03481634|101350214|FG002|Overall Study|Progressive disease|0|||
33399419|NCT03481634|101350212|FG000|Overall Study|Physician Decision|3|||
33399420|NCT03481634|101350213|FG001|Overall Study|Physician Decision|0|||
33325111|NCT03083847|101087934|FG003|Main|Adverse Event|0|||
33325112|NCT03083847|101087935|FG004|Main|Adverse Event|0|||
33399421|NCT03481634|101350214|FG002|Overall Study|Physician Decision|1|||
33399422|NCT03481634|101350212|FG000|Overall Study|Lost to Follow-up|3|||
33399423|NCT03481634|101350213|FG001|Overall Study|Lost to Follow-up|4|||
33399424|NCT03481634|101350214|FG002|Overall Study|Lost to Follow-up|4|||
33399425|NCT03481634|101350212|FG000|Overall Study|Death|4|||
33399426|NCT03481634|101350213|FG001|Overall Study|Death|8|||
33399427|NCT03481634|101350214|FG002|Overall Study|Death|7|||
33399428|NCT03481634|101350212|FG000|Overall Study|Adverse Event|6|||
33399429|NCT03481634|101350213|FG001|Overall Study|Adverse Event|3|||
33399430|NCT03481634|101350214|FG002|Overall Study|Adverse Event|7|||
33399431|NCT00908895|101350217|FG000|Overall Study|Lost to Follow-up|1|||
33399432|NCT00908895|101350218|FG001|Overall Study|Lost to Follow-up|3|||
33399433|NCT00908895|101350217|FG000|Overall Study|algodystrophy|2|||
33399434|NCT00908895|101350218|FG001|Overall Study|algodystrophy|2|||
33399435|NCT00908895|101350217|FG000|Overall Study|Adverse Event|1|||
33513972|NCT03558152|101776809|FG005|Overall Study|Death|0|||
33513973|NCT03558152|101776810|FG006|Overall Study|Death|0|||
33513974|NCT03558152|101776811|FG007|Overall Study|Death|0|||
33513975|NCT03558152|101776804|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
33513976|NCT03558152|101776805|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
33513977|NCT03558152|101776806|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
33513978|NCT03558152|101776807|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
33325113|NCT03083847|101087936|FG005|Main|Adverse Event|0|||
33325114|NCT03083847|101087937|FG006|Main|Adverse Event|0|||
33513979|NCT03558152|101776808|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
33513980|NCT03558152|101776809|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
33513981|NCT03558152|101776810|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
33513982|NCT03558152|101776811|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
33513983|NCT03558152|101776804|FG000|Overall Study|Miscalculation in mmcs|0|||
33513984|NCT03558152|101776805|FG001|Overall Study|Miscalculation in mmcs|0|||
33325115|NCT03083847|101087938|FG007|Main|Adverse Event|2|||
33325116|NCT03083847|101087939|FG008|Main|Adverse Event|0|||
33325117|NCT03083847|101087940|FG009|Main|Adverse Event|0|||
33325118|NCT03083847|101087931|FG000|Main|Withdrawal by Subject|0|||
33325119|NCT03083847|101087932|FG001|Main|Withdrawal by Subject|0|||
33325120|NCT03083847|101087933|FG002|Main|Withdrawal by Subject|0|||
33325121|NCT03083847|101087934|FG003|Main|Withdrawal by Subject|0|||
33325122|NCT03083847|101087935|FG004|Main|Withdrawal by Subject|0|||
33399436|NCT00908895|101350218|FG001|Overall Study|Adverse Event|1|||
33399437|NCT01225211|101350219|FG000|Overall Study|Adverse Event|0|||
33399438|NCT01225211|101350220|FG001|Overall Study|Adverse Event|0|||
33399439|NCT01225211|101350221|FG002|Overall Study|Adverse Event|1|||
33399440|NCT01225211|101350222|FG003|Overall Study|Adverse Event|0|||
33399441|NCT01225211|101350223|FG004|Overall Study|Adverse Event|0|||
33399442|NCT01225211|101350224|FG005|Overall Study|Adverse Event|0|||
33399443|NCT01225211|101350225|FG006|Overall Study|Adverse Event|0|||
33325123|NCT03083847|101087936|FG005|Main|Withdrawal by Subject|0|||
33325124|NCT03083847|101087937|FG006|Main|Withdrawal by Subject|1|||
33399444|NCT01225211|101350226|FG007|Overall Study|Adverse Event|0|||
33399445|NCT01225211|101350227|FG008|Overall Study|Adverse Event|0|||
33399446|NCT01225211|101350228|FG009|Overall Study|Adverse Event|1|||
33399447|NCT01225211|101350219|FG000|Overall Study|Withdrawal by Subject|0|||
33399448|NCT01225211|101350220|FG001|Overall Study|Withdrawal by Subject|0|||
33606833|NCT05098509|102111556|FG001|Overall Study|Withdrawal by Subject|0|||
33606834|NCT05098509|102111557|FG002|Overall Study|Withdrawal by Subject|1|||
33606835|NCT05098509|102111558|FG003|Overall Study|Withdrawal by Subject|0|||
33606836|NCT05098509|102111555|FG000|Overall Study|Early study termination|1|||
33606837|NCT05098509|102111556|FG001|Overall Study|Early study termination|1|||
33606838|NCT05098509|102111557|FG002|Overall Study|Early study termination|1|||
33606839|NCT05098509|102111558|FG003|Overall Study|Early study termination|0|||
33606840|NCT04268745|102111560|FG000|Overall Study|Lost to Follow-up|2|||
33606841|NCT04268745|102111561|FG001|Overall Study|Lost to Follow-up|3|||
33606842|NCT04268745|102111560|FG000|Overall Study|Withdrawal by Subject|4|||
33325125|NCT03083847|101087938|FG007|Main|Withdrawal by Subject|1|||
33325126|NCT03083847|101087939|FG008|Main|Withdrawal by Subject|0|||
33325127|NCT03083847|101087940|FG009|Main|Withdrawal by Subject|0|||
33325128|NCT02269787|101087941|FG000|Overall Study|Lost to Follow-up|20|||
33513985|NCT03558152|101776806|FG002|Overall Study|Miscalculation in mmcs|0|||
33513986|NCT03558152|101776807|FG003|Overall Study|Miscalculation in mmcs|0|||
33513987|NCT03558152|101776808|FG004|Overall Study|Miscalculation in mmcs|0|||
33513988|NCT03558152|101776809|FG005|Overall Study|Miscalculation in mmcs|0|||
33513989|NCT03558152|101776810|FG006|Overall Study|Miscalculation in mmcs|1|||
33513990|NCT03558152|101776811|FG007|Overall Study|Miscalculation in mmcs|0|||
33513991|NCT03558152|101776804|FG000|Overall Study|Mistake in calculation|0|||
33513992|NCT03558152|101776805|FG001|Overall Study|Mistake in calculation|0|||
33513993|NCT03558152|101776806|FG002|Overall Study|Mistake in calculation|0|||
33513994|NCT03558152|101776807|FG003|Overall Study|Mistake in calculation|1|||
33513995|NCT03558152|101776808|FG004|Overall Study|Mistake in calculation|0|||
33513996|NCT03558152|101776809|FG005|Overall Study|Mistake in calculation|0|||
33606843|NCT04268745|102111561|FG001|Overall Study|Withdrawal by Subject|2|||
33325129|NCT02269787|101087942|FG001|Overall Study|Lost to Follow-up|6|||
33325130|NCT02269787|101087941|FG000|Overall Study|Death|2|||
33325131|NCT02269787|101087942|FG001|Overall Study|Death|3|||
33325132|NCT02269787|101087941|FG000|Overall Study|Incapacitated|0|||
33325133|NCT02269787|101087942|FG001|Overall Study|Incapacitated|1|||
33325134|NCT02321930|101087948|FG000|Overall Study|Lost to Follow-up|1|||
33325135|NCT03520959|101087952|FG000|Overall Study|Study terminated by Sponsor|0|||
33325136|NCT03520959|101087953|FG001|Overall Study|Study terminated by Sponsor|1|||
33325137|NCT00006392|101087959|FG000|Overall Study|Ineligible|11|||
33325138|NCT00006392|101087960|FG001|Overall Study|Ineligible|3|||
33325139|NCT00006392|101087961|FG002|Overall Study|Ineligible|5|||
33325140|NCT00006392|101087962|FG003|Overall Study|Ineligible|5|||
33325141|NCT00006392|101087959|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
33325142|NCT00006392|101087960|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
33325143|NCT00006392|101087961|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
33325144|NCT00006392|101087962|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
33325145|NCT01621542|101087963|FG000|Overall Study|Adverse Event|0|||
33325146|NCT01621542|101087964|FG001|Overall Study|Adverse Event|0|||
33325147|NCT01621542|101087965|FG002|Overall Study|Adverse Event|1|||
33325148|NCT01621542|101087966|FG003|Overall Study|Adverse Event|3|||
33325149|NCT01621542|101087967|FG004|Overall Study|Adverse Event|0|||
33325150|NCT01621542|101087968|FG005|Overall Study|Adverse Event|0|||
33325151|NCT01621542|101087963|FG000|Overall Study|Death|0|||
33325152|NCT01621542|101087964|FG001|Overall Study|Death|1|||
33325153|NCT01621542|101087965|FG002|Overall Study|Death|0|||
33325154|NCT01621542|101087966|FG003|Overall Study|Death|0|||
33325155|NCT01621542|101087967|FG004|Overall Study|Death|0|||
33325156|NCT01621542|101087968|FG005|Overall Study|Death|0|||
33399449|NCT01225211|101350221|FG002|Overall Study|Withdrawal by Subject|0|||
33399450|NCT01225211|101350222|FG003|Overall Study|Withdrawal by Subject|0|||
33606844|NCT04268745|102111560|FG000|Overall Study|Death in the family|1|||
33606845|NCT04268745|102111561|FG001|Overall Study|Death in the family|0|||
33606846|NCT00172042|102111562|FG000|Overall Study|Adverse Event|27|||
33606847|NCT00172042|102111563|FG001|Overall Study|Adverse Event|13|||
33325157|NCT01621542|101087963|FG000|Overall Study|Physician Decision|1|||
33606848|NCT00172042|102111562|FG000|Overall Study|Abnormal laboratory value(s)|5|||
33325158|NCT01621542|101087964|FG001|Overall Study|Physician Decision|0|||
33325159|NCT01621542|101087965|FG002|Overall Study|Physician Decision|1|||
33325160|NCT01621542|101087966|FG003|Overall Study|Physician Decision|13|||
33325161|NCT01621542|101087967|FG004|Overall Study|Physician Decision|3|||
33325162|NCT01621542|101087968|FG005|Overall Study|Physician Decision|1|||
33399451|NCT01225211|101350223|FG004|Overall Study|Withdrawal by Subject|0|||
33399452|NCT01225211|101350224|FG005|Overall Study|Withdrawal by Subject|0|||
33513997|NCT03558152|101776810|FG006|Overall Study|Mistake in calculation|0|||
33513998|NCT03558152|101776811|FG007|Overall Study|Mistake in calculation|0|||
33325163|NCT01621542|101087963|FG000|Overall Study|Withdrawal by Subject|2|||
33325164|NCT01621542|101087964|FG001|Overall Study|Withdrawal by Subject|0|||
33325165|NCT01621542|101087965|FG002|Overall Study|Withdrawal by Subject|1|||
33325166|NCT01621542|101087966|FG003|Overall Study|Withdrawal by Subject|3|||
33325167|NCT01621542|101087967|FG004|Overall Study|Withdrawal by Subject|3|||
33325168|NCT01621542|101087968|FG005|Overall Study|Withdrawal by Subject|3|||
33325169|NCT01621542|101087963|FG000|Overall Study|progression/treatment failure|2|||
33325170|NCT01621542|101087964|FG001|Overall Study|progression/treatment failure|4|||
33325171|NCT01621542|101087965|FG002|Overall Study|progression/treatment failure|3|||
33399453|NCT01225211|101350225|FG006|Overall Study|Withdrawal by Subject|1|||
33399454|NCT01225211|101350226|FG007|Overall Study|Withdrawal by Subject|0|||
33399455|NCT01225211|101350227|FG008|Overall Study|Withdrawal by Subject|1|||
33325172|NCT01621542|101087966|FG003|Overall Study|progression/treatment failure|7|||
33325173|NCT01621542|101087967|FG004|Overall Study|progression/treatment failure|3|||
33325174|NCT01621542|101087968|FG005|Overall Study|progression/treatment failure|5|||
33325175|NCT01621542|101087963|FG000|Overall Study|Protocol Violation|0|||
33325176|NCT01621542|101087964|FG001|Overall Study|Protocol Violation|0|||
33325177|NCT01621542|101087965|FG002|Overall Study|Protocol Violation|0|||
33325178|NCT01621542|101087966|FG003|Overall Study|Protocol Violation|1|||
33325179|NCT01621542|101087967|FG004|Overall Study|Protocol Violation|0|||
33325180|NCT01621542|101087968|FG005|Overall Study|Protocol Violation|0|||
33325181|NCT01621542|101087963|FG000|Overall Study|study stopped by sponsor|0|||
33325182|NCT01621542|101087964|FG001|Overall Study|study stopped by sponsor|0|||
33325183|NCT01621542|101087965|FG002|Overall Study|study stopped by sponsor|0|||
33325184|NCT01621542|101087966|FG003|Overall Study|study stopped by sponsor|1|||
33325185|NCT01621542|101087967|FG004|Overall Study|study stopped by sponsor|0|||
33325186|NCT01621542|101087968|FG005|Overall Study|study stopped by sponsor|0|||
33325187|NCT00853749|101087969|FG000|Overall Study|Lost to Follow-up|0|||
33325188|NCT00853749|101087970|FG001|Overall Study|Lost to Follow-up|1|||
33325189|NCT05082376|101087973|FG000|Overall Study|Lost to Follow-up|2|||
33325190|NCT00073528|101087974|FG000|Overall Study|Death|488|||
33325191|NCT00073528|101087975|FG001|Overall Study|Death|473|||
33325192|NCT00073528|101087974|FG000|Overall Study|Lost to Follow-up|52|||
33325193|NCT00073528|101087975|FG001|Overall Study|Lost to Follow-up|45|||
33325194|NCT00073528|101087974|FG000|Overall Study|Withdrawal by Subject|50|||
33325195|NCT00073528|101087975|FG001|Overall Study|Withdrawal by Subject|45|||
33325196|NCT00073528|101087974|FG000|Overall Study|Study terminated by Sponsor|10|||
33325197|NCT00073528|101087975|FG001|Overall Study|Study terminated by Sponsor|29|||
33325198|NCT00073528|101087974|FG000|Overall Study|Other|18|||
33325199|NCT00073528|101087975|FG001|Overall Study|Other|19|||
33325200|NCT00073528|101087974|FG000|Overall Study|Other|9|||
33325201|NCT00073528|101087975|FG001|Overall Study|Other|12|||
33325202|NCT00073528|101087974|FG000|Overall Study|Protocol Violation|3|||
33325203|NCT00073528|101087975|FG001|Overall Study|Protocol Violation|5|||
33325204|NCT02064920|101087977|FG000|Overall Study|Adverse Event|0|||
33325205|NCT02064920|101087978|FG001|Overall Study|Adverse Event|4|||
33325206|NCT02064920|101087977|FG000|Overall Study|Physician Decision|0|||
33325207|NCT02064920|101087978|FG001|Overall Study|Physician Decision|1|||
33325208|NCT02064920|101087977|FG000|Overall Study|Technical Problems|0|||
33325209|NCT02064920|101087978|FG001|Overall Study|Technical Problems|1|||
33325210|NCT02064920|101087977|FG000|Overall Study|Withdrawal by Subject|1|||
33325211|NCT02064920|101087978|FG001|Overall Study|Withdrawal by Subject|3|||
33325212|NCT02375724|101087981|FG000|Overall Study|Lack of Efficacy|1|||
33399456|NCT01225211|101350228|FG009|Overall Study|Withdrawal by Subject|3|||
33399457|NCT01225211|101350219|FG000|Overall Study|Other|0|||
33399458|NCT01225211|101350220|FG001|Overall Study|Other|0|||
33399459|NCT01225211|101350221|FG002|Overall Study|Other|0|||
33399460|NCT01225211|101350222|FG003|Overall Study|Other|0|||
33399461|NCT01225211|101350223|FG004|Overall Study|Other|0|||
33399462|NCT01225211|101350224|FG005|Overall Study|Other|0|||
33399463|NCT01225211|101350225|FG006|Overall Study|Other|0|||
33399464|NCT01225211|101350226|FG007|Overall Study|Other|0|||
33399465|NCT01225211|101350227|FG008|Overall Study|Other|0|||
33399466|NCT01225211|101350228|FG009|Overall Study|Other|1|||
33399467|NCT01590810|101350231|FG000|Overall Study|Physician Decision|0|||
33399468|NCT01590810|101350232|FG001|Overall Study|Physician Decision|1|||
33325213|NCT02375724|101087982|FG001|Overall Study|Lack of Efficacy|1|||
33325214|NCT02375724|101087981|FG000|Overall Study|Withdrawal by Subject|1|||
33325215|NCT02375724|101087982|FG001|Overall Study|Withdrawal by Subject|1|||
33325216|NCT02375724|101087981|FG000|Overall Study|Lost to Follow-up|1|||
33325217|NCT02375724|101087982|FG001|Overall Study|Lost to Follow-up|0|||
33325218|NCT02375724|101087981|FG000|Overall Study|Protocol Violation|1|||
33399469|NCT01590810|101350233|FG002|Overall Study|Physician Decision|1|||
33399470|NCT01590810|101350234|FG003|Overall Study|Physician Decision|0|||
33399471|NCT01590810|101350235|FG004|Overall Study|Physician Decision|0|||
33325219|NCT02375724|101087982|FG001|Overall Study|Protocol Violation|0|||
33325220|NCT02375724|101087981|FG000|Overall Study|Adverse Event|2|||
33399472|NCT01815099|101350236|FG000|Overall Study|Lack of Efficacy|1|||
33399473|NCT01815099|101350236|FG000|Overall Study|unable to attend study visits|1|||
33513999|NCT03558152|101776804|FG000|Overall Study|Mistake in evaluation of disease status|0|||
33514000|NCT03558152|101776805|FG001|Overall Study|Mistake in evaluation of disease status|0|||
33514001|NCT03558152|101776806|FG002|Overall Study|Mistake in evaluation of disease status|0|||
33514002|NCT03558152|101776807|FG003|Overall Study|Mistake in evaluation of disease status|0|||
33514003|NCT03558152|101776808|FG004|Overall Study|Mistake in evaluation of disease status|0|||
33514004|NCT03558152|101776809|FG005|Overall Study|Mistake in evaluation of disease status|0|||
33514005|NCT03558152|101776810|FG006|Overall Study|Mistake in evaluation of disease status|0|||
33514006|NCT03558152|101776811|FG007|Overall Study|Mistake in evaluation of disease status|1|||
33514007|NCT03558152|101776804|FG000|Overall Study|Physician Decision|0|||
33514008|NCT03558152|101776805|FG001|Overall Study|Physician Decision|0|||
33514009|NCT03558152|101776806|FG002|Overall Study|Physician Decision|0|||
33514010|NCT03558152|101776807|FG003|Overall Study|Physician Decision|0|||
33514011|NCT03558152|101776808|FG004|Overall Study|Physician Decision|0|||
33514012|NCT03558152|101776809|FG005|Overall Study|Physician Decision|0|||
33514013|NCT03558152|101776810|FG006|Overall Study|Physician Decision|1|||
33514014|NCT03558152|101776811|FG007|Overall Study|Physician Decision|0|||
33514015|NCT03558152|101776804|FG000|Overall Study|Withdrawal by Subject|2|||
33514016|NCT03558152|101776805|FG001|Overall Study|Withdrawal by Subject|3|||
33514017|NCT03558152|101776806|FG002|Overall Study|Withdrawal by Subject|2|||
33514018|NCT03558152|101776807|FG003|Overall Study|Withdrawal by Subject|1|||
33514019|NCT03558152|101776808|FG004|Overall Study|Withdrawal by Subject|1|||
33514020|NCT03558152|101776809|FG005|Overall Study|Withdrawal by Subject|1|||
33514021|NCT03558152|101776810|FG006|Overall Study|Withdrawal by Subject|3|||
33514022|NCT03558152|101776811|FG007|Overall Study|Withdrawal by Subject|2|||
33514023|NCT03558152|101776804|FG000|Overall Study|Lack of Efficacy|11|||
33514024|NCT03558152|101776805|FG001|Overall Study|Lack of Efficacy|11|||
33514025|NCT03558152|101776806|FG002|Overall Study|Lack of Efficacy|10|||
33514026|NCT03558152|101776807|FG003|Overall Study|Lack of Efficacy|11|||
33514027|NCT03558152|101776808|FG004|Overall Study|Lack of Efficacy|14|||
33514028|NCT03558152|101776809|FG005|Overall Study|Lack of Efficacy|12|||
33514029|NCT03558152|101776810|FG006|Overall Study|Lack of Efficacy|14|||
33514030|NCT03558152|101776811|FG007|Overall Study|Lack of Efficacy|13|||
33514031|NCT03558152|101776804|FG000|Overall Study|Protocol Violation|1|||
33514032|NCT03558152|101776805|FG001|Overall Study|Protocol Violation|1|||
33514033|NCT03558152|101776806|FG002|Overall Study|Protocol Violation|0|||
33514034|NCT03558152|101776807|FG003|Overall Study|Protocol Violation|1|||
33514035|NCT03558152|101776808|FG004|Overall Study|Protocol Violation|1|||
33514036|NCT03558152|101776809|FG005|Overall Study|Protocol Violation|0|||
33514037|NCT03558152|101776810|FG006|Overall Study|Protocol Violation|2|||
33514038|NCT03558152|101776811|FG007|Overall Study|Protocol Violation|0|||
33514039|NCT00784238|101776812|FG000|Overall Study|Adverse Event|14|||
33514040|NCT00784238|101776812|FG000|Overall Study|Death|2|||
33514041|NCT00784238|101776812|FG000|Overall Study|Lack of Efficacy|33|||
33514042|NCT00784238|101776812|FG000|Overall Study|Lost to Follow-up|29|||
33514043|NCT00784238|101776812|FG000|Overall Study|Pregnancy|1|||
33514044|NCT00784238|101776812|FG000|Overall Study|Withdrawal by Subject|26|||
33514045|NCT00784238|101776812|FG000|Overall Study|Other|14|||
33514046|NCT01668966|101776818|FG000|Overall Study|Withdrawal by Subject|1|||
33514047|NCT01668966|101776818|FG000|Overall Study|Death|1|||
33514048|NCT01668966|101776818|FG000|Overall Study|Not treated|2|||
33514049|NCT05153148|101776821|FG000|Overall Study|Adverse Event|1|||
33514050|NCT05153148|101776822|FG001|Overall Study|Adverse Event|0|||
33514051|NCT05153148|101776823|FG002|Overall Study|Adverse Event|3|||
33514052|NCT05153148|101776824|FG003|Overall Study|Adverse Event|5|||
33514053|NCT05153148|101776821|FG000|Overall Study|Lost to Follow-up|1|||
33514054|NCT05153148|101776822|FG001|Overall Study|Lost to Follow-up|1|||
33514055|NCT05153148|101776823|FG002|Overall Study|Lost to Follow-up|2|||
33514056|NCT05153148|101776824|FG003|Overall Study|Lost to Follow-up|0|||
33514057|NCT05153148|101776821|FG000|Overall Study|Withdrawal by Subject|6|||
33514058|NCT05153148|101776822|FG001|Overall Study|Withdrawal by Subject|8|||
33514059|NCT05153148|101776823|FG002|Overall Study|Withdrawal by Subject|6|||
33514060|NCT05153148|101776824|FG003|Overall Study|Withdrawal by Subject|8|||
33514061|NCT05153148|101776821|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
33514062|NCT05153148|101776822|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
33514063|NCT05153148|101776823|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
33606849|NCT00172042|102111563|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33514064|NCT05153148|101776824|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
33514065|NCT05153148|101776821|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
33514066|NCT05153148|101776822|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
33514067|NCT05153148|101776823|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
33514068|NCT05153148|101776824|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
33606850|NCT00172042|102111562|FG000|Overall Study|Abnormal test procedure(s)|0|||
33514069|NCT05153148|101776821|FG000|Overall Study|Reason not Specified|1|||
33514070|NCT05153148|101776822|FG001|Overall Study|Reason not Specified|1|||
33514071|NCT05153148|101776823|FG002|Overall Study|Reason not Specified|1|||
33606851|NCT00172042|102111563|FG001|Overall Study|Abnormal test procedure(s)|3|||
33514072|NCT05153148|101776824|FG003|Overall Study|Reason not Specified|1|||
33514073|NCT00459706|101776825|FG000|Overall Study|Adverse Event|19|||
33514074|NCT00459706|101776826|FG001|Overall Study|Adverse Event|13|||
33514075|NCT00459706|101776825|FG000|Overall Study|Withdrawal by Subject|1|||
33514076|NCT00459706|101776826|FG001|Overall Study|Withdrawal by Subject|6|||
33514077|NCT00459706|101776825|FG000|Overall Study|Physician Decision|2|||
33514078|NCT00459706|101776826|FG001|Overall Study|Physician Decision|0|||
33606852|NCT00172042|102111562|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
33606853|NCT00172042|102111563|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
33606854|NCT00172042|102111562|FG000|Overall Study|Patient no longer requires study drug|10|||
33325221|NCT02375724|101087982|FG001|Overall Study|Adverse Event|4|||
33514079|NCT00459706|101776825|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
33514080|NCT00459706|101776826|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
33514081|NCT00459706|101776825|FG000|Overall Study|Protocol Violation|2|||
33514082|NCT00459706|101776826|FG001|Overall Study|Protocol Violation|1|||
33514083|NCT00459706|101776825|FG000|Overall Study|Failed to Return|1|||
33514084|NCT00459706|101776826|FG001|Overall Study|Failed to Return|0|||
33514085|NCT00459706|101776825|FG000|Overall Study|Other|0|||
33514086|NCT00459706|101776826|FG001|Overall Study|Other|1|||
33514087|NCT00732758|101776827|FG000|Overall Study|Lost to Follow-up|8|||
33514088|NCT00732758|101776828|FG001|Overall Study|Lost to Follow-up|16|||
33514089|NCT01995175|101776829|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
33514090|NCT01995175|101776829|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
33514091|NCT01995175|101776829|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
33514092|NCT01995175|101776829|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
33514093|NCT01995175|101776829|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
33325222|NCT04498169|101087983|FG000|Study Completion|Adverse Event|1|||
33325223|NCT04498169|101087984|FG001|Study Completion|Adverse Event|1|||
33325224|NCT01877915|101087988|FG000|Overall Study|Lost to Follow-up|10|||
33325225|NCT01877915|101087989|FG001|Overall Study|Lost to Follow-up|9|||
33325226|NCT01877915|101087988|FG000|Overall Study|Withdrawal by Subject|42|||
33325227|NCT01877915|101087989|FG001|Overall Study|Withdrawal by Subject|55|||
33325228|NCT01877915|101087988|FG000|Overall Study|Other|2|||
33325229|NCT01877915|101087989|FG001|Overall Study|Other|4|||
33399474|NCT02141854|101350237|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
33399475|NCT02141854|101350238|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33399476|NCT02141854|101350239|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33399477|NCT02141854|101350240|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33399478|NCT02141854|101350241|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33399479|NCT02141854|101350242|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33399480|NCT02141854|101350237|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
33399481|NCT02141854|101350238|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33325230|NCT02729740|101087991|FG000|Overall Study|Early Termination|130|||
33325231|NCT02729740|101087991|FG000|Overall Study|Other|1|||
33325232|NCT02873936|101087992|FG000|Overall Study|Withdrew Consent|4|||
33325233|NCT02873936|101087993|FG001|Overall Study|Withdrew Consent|11|||
33325234|NCT02873936|101087994|FG002|Overall Study|Withdrew Consent|20|||
33325235|NCT02873936|101087992|FG000|Overall Study|Investigator's Discretion|3|||
33325236|NCT02873936|101087993|FG001|Overall Study|Investigator's Discretion|5|||
33325237|NCT02873936|101087994|FG002|Overall Study|Investigator's Discretion|4|||
33325238|NCT02873936|101087992|FG000|Overall Study|Adverse Event|3|||
33325239|NCT02873936|101087993|FG001|Overall Study|Adverse Event|5|||
33325240|NCT02873936|101087994|FG002|Overall Study|Adverse Event|3|||
33325241|NCT02873936|101087992|FG000|Overall Study|Protocol Violation|0|||
33325242|NCT02873936|101087993|FG001|Overall Study|Protocol Violation|1|||
33325243|NCT02873936|101087994|FG002|Overall Study|Protocol Violation|3|||
33325244|NCT02873936|101087992|FG000|Overall Study|Lost to Follow-up|1|||
33399482|NCT02141854|101350239|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33514094|NCT01995175|101776829|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
33514095|NCT01995175|101776829|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
33514096|NCT01995175|101776829|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
33325245|NCT02873936|101087993|FG001|Overall Study|Lost to Follow-up|1|||
33325246|NCT02873936|101087994|FG002|Overall Study|Lost to Follow-up|1|||
33325247|NCT02873936|101087992|FG000|Overall Study|Non-compliance With Study Drug|1|||
33325248|NCT02873936|101087993|FG001|Overall Study|Non-compliance With Study Drug|0|||
33514097|NCT01995175|101776829|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
33514098|NCT02461524|101779655|FG000|Overall Study|Death|16|||
33514099|NCT02461524|101779655|FG000|Overall Study|Withdrawal by Subject|4|||
33606855|NCT00172042|102111563|FG001|Overall Study|Patient no longer requires study drug|8|||
33325249|NCT02873936|101087994|FG002|Overall Study|Non-compliance With Study Drug|1|||
33325250|NCT02873936|101087992|FG000|Overall Study|Randomized but not Dosed|1|||
33399483|NCT02141854|101350240|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33399484|NCT02141854|101350241|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33514100|NCT02461524|101779655|FG000|Overall Study|Device Explanted|5|||
33514101|NCT02461524|101779655|FG000|Overall Study|Missed Visit|6|||
33514102|NCT03047720|101779656|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
33514103|NCT03047720|101779657|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
33514104|NCT02089334|101779660|FG000|Overall Study|Withdrawal by Subject|0|||
33514105|NCT02089334|101779661|FG001|Overall Study|Withdrawal by Subject|0|||
33514106|NCT02089334|101779662|FG002|Overall Study|Withdrawal by Subject|0|||
33514107|NCT02089334|101779663|FG003|Overall Study|Withdrawal by Subject|2|||
33514108|NCT02089334|101779660|FG000|Overall Study|Adverse Event|0|||
33514109|NCT02089334|101779661|FG001|Overall Study|Adverse Event|0|||
33514110|NCT02089334|101779662|FG002|Overall Study|Adverse Event|0|||
33514111|NCT02089334|101779663|FG003|Overall Study|Adverse Event|2|||
33514112|NCT02089334|101779660|FG000|Overall Study|Progressive disease|0|||
33514113|NCT02089334|101779661|FG001|Overall Study|Progressive disease|0|||
33514114|NCT02089334|101779662|FG002|Overall Study|Progressive disease|0|||
33399485|NCT02141854|101350242|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33399486|NCT02141854|101350237|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
33399487|NCT02141854|101350238|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33399488|NCT02141854|101350239|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33399489|NCT02141854|101350240|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33399490|NCT02141854|101350241|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33399491|NCT02141854|101350242|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33399492|NCT02141854|101350237|FG000|Run-In Period (Pre-assignment)|Other|14|||
33399493|NCT02141854|101350238|FG001|Run-In Period (Pre-assignment)|Other|0|||
33399494|NCT02141854|101350239|FG002|Run-In Period (Pre-assignment)|Other|0|||
33399495|NCT02141854|101350240|FG003|Run-In Period (Pre-assignment)|Other|0|||
33399496|NCT02141854|101350241|FG004|Run-In Period (Pre-assignment)|Other|0|||
33399497|NCT02141854|101350242|FG005|Run-In Period (Pre-assignment)|Other|0|||
33399498|NCT02141854|101350237|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
33399499|NCT02141854|101350238|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
33399500|NCT02141854|101350239|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
33399501|NCT02141854|101350240|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
33399502|NCT02141854|101350241|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
33399503|NCT02141854|101350242|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
33399504|NCT02141854|101350237|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
33399505|NCT02141854|101350238|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33399506|NCT02141854|101350239|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33399507|NCT02141854|101350240|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33514115|NCT02089334|101779663|FG003|Overall Study|Progressive disease|2|||
33514116|NCT02089334|101779660|FG000|Overall Study|Physician Decision|0|||
33514117|NCT02089334|101779661|FG001|Overall Study|Physician Decision|0|||
33325251|NCT02873936|101087993|FG001|Overall Study|Randomized but not Dosed|0|||
33325252|NCT02873936|101087994|FG002|Overall Study|Randomized but not Dosed|0|||
33325253|NCT03104075|101087995|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
33325254|NCT03104075|101087996|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
33325255|NCT01628107|101087999|FG000|Overall Study|Withdrawal by Subject|17|||
33325256|NCT01628107|101087999|FG000|Overall Study|Lost to Follow-up|4|||
33325257|NCT01628107|101087999|FG000|Overall Study|Adverse Event|33|||
33325258|NCT01628107|101087999|FG000|Overall Study|Physician Decision|2|||
33325259|NCT01628107|101087999|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
33325260|NCT01628107|101087999|FG000|Overall Study|Non-compliant with Study Procedures|10|||
33325261|NCT01628107|101087999|FG000|Overall Study|Not Treated|8|||
33325262|NCT01628107|101087999|FG000|Overall Study|Sponsor Decision|11|||
33325263|NCT01628107|101087999|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
33325264|NCT01628107|101087999|FG000|Overall Study|Relocated|8|||
33325265|NCT01628107|101087999|FG000|Overall Study|Kidney Transplant|9|||
33325266|NCT01628107|101087999|FG000|Overall Study|Use of Standard of Care|9|||
33325267|NCT02114268|101088003|FG000|Overall Study|Lost to Follow-up|4|||
33325268|NCT02114268|101088004|FG001|Overall Study|Lost to Follow-up|1|||
33325269|NCT02114268|101088005|FG002|Overall Study|Lost to Follow-up|1|||
33325270|NCT02114268|101088006|FG003|Overall Study|Lost to Follow-up|0|||
33325271|NCT02114268|101088007|FG004|Overall Study|Lost to Follow-up|0|||
33325272|NCT02114268|101088008|FG005|Overall Study|Lost to Follow-up|2|||
33325273|NCT02114268|101088003|FG000|Overall Study|Withdrawal by Subject|1|||
33325274|NCT02114268|101088004|FG001|Overall Study|Withdrawal by Subject|0|||
33325275|NCT02114268|101088005|FG002|Overall Study|Withdrawal by Subject|0|||
33399508|NCT02141854|101350241|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33399509|NCT02141854|101350242|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33514118|NCT02089334|101779662|FG002|Overall Study|Physician Decision|1|||
33514119|NCT02089334|101779663|FG003|Overall Study|Physician Decision|1|||
33325276|NCT02114268|101088006|FG003|Overall Study|Withdrawal by Subject|0|||
33325277|NCT02114268|101088007|FG004|Overall Study|Withdrawal by Subject|0|||
33325278|NCT02114268|101088008|FG005|Overall Study|Withdrawal by Subject|1|||
33325279|NCT02114268|101088003|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
33325280|NCT02114268|101088004|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
33325281|NCT02114268|101088005|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
33325282|NCT02114268|101088006|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
33325283|NCT02114268|101088007|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
33325284|NCT02114268|101088008|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
33325285|NCT01873417|101088009|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
33325286|NCT01873417|101088009|FG000|Overall Study|Adverse Event|24|||
33325287|NCT01873417|101088009|FG000|Overall Study|Lost to Follow-up|2|||
33325288|NCT01873417|101088009|FG000|Overall Study|Withdrawal by Subject|2|||
33325289|NCT01873417|101088009|FG000|Overall Study|Physician Decision|3|||
33325290|NCT00729378|101088012|FG000|Baseline|Did not complete study measurements|72|||
33325291|NCT00729378|101088013|FG001|Baseline|Did not complete study measurements|33|||
33325292|NCT00729378|101088012|FG000|Baseline|Withdrawal by Subject|66|||
33325293|NCT00729378|101088013|FG001|Baseline|Withdrawal by Subject|59|||
33325294|NCT00729378|101088012|FG000|12-months|Lost to Follow-up|100|||
33325295|NCT00729378|101088013|FG001|12-months|Lost to Follow-up|65|||
33325296|NCT00729378|101088012|FG000|24-months|Lost to Follow-up|72|||
33325297|NCT00729378|101088013|FG001|24-months|Lost to Follow-up|51|||
33325298|NCT00729378|101088012|FG000|36-months|Lost to Follow-up|15|||
33325299|NCT00729378|101088013|FG001|36-months|Lost to Follow-up|6|||
33325300|NCT02546765|101088021|FG000|Overall Study|Withdrawal by Subject|0|||
33325301|NCT02546765|101088022|FG001|Overall Study|Withdrawal by Subject|1|||
33325302|NCT02546765|101088023|FG002|Overall Study|Withdrawal by Subject|0|||
33325303|NCT02546765|101088024|FG003|Overall Study|Withdrawal by Subject|0|||
33325304|NCT01984164|101088025|FG000|Overall Study|Withdrawal by Subject|4|||
33325305|NCT01984164|101088026|FG001|Overall Study|Withdrawal by Subject|3|||
33325306|NCT01984164|101088025|FG000|Overall Study|Adverse Event|5|||
33325307|NCT01984164|101088026|FG001|Overall Study|Adverse Event|19|||
33325308|NCT01984164|101088025|FG000|Overall Study|Lost to Follow-up|1|||
33325309|NCT01984164|101088026|FG001|Overall Study|Lost to Follow-up|3|||
33325310|NCT01368536|101088027|FG000|Overall Study|Adverse Event|5|||
33325311|NCT01368536|101088028|FG001|Overall Study|Adverse Event|6|||
33325312|NCT01368536|101088029|FG002|Overall Study|Adverse Event|8|||
33325313|NCT01368536|101088027|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33325314|NCT01368536|101088028|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33325315|NCT01368536|101088029|FG002|Overall Study|Abnormal laboratory value(s)|2|||
33325316|NCT01368536|101088027|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33325317|NCT01368536|101088028|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33325318|NCT01368536|101088029|FG002|Overall Study|Abnormal test procedure result(s)|1|||
33325319|NCT01368536|101088027|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
33325320|NCT01368536|101088028|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33514120|NCT02817516|101779664|FG000|Overall Study|Other|0|||
33199094|NCT01969838|100633756|FG002|Double-blind Phase|Physician Decision|0|||
33199095|NCT01969838|100633757|FG003|Double-blind Phase|Physician Decision|0|||
33199096|NCT01969838|100633754|FG000|Double-blind Phase|Subject Decision|4|||
33199097|NCT01969838|100633755|FG001|Double-blind Phase|Subject Decision|2|||
33199098|NCT01969838|100633756|FG002|Double-blind Phase|Subject Decision|0|||
33199099|NCT01969838|100633757|FG003|Double-blind Phase|Subject Decision|0|||
33199100|NCT01969838|100633754|FG000|Double-blind Phase|Disease Progression|2|||
33199101|NCT01969838|100633755|FG001|Double-blind Phase|Disease Progression|0|||
33199102|NCT01969838|100633756|FG002|Double-blind Phase|Disease Progression|0|||
33199103|NCT01969838|100633757|FG003|Double-blind Phase|Disease Progression|0|||
33199104|NCT01969838|100633754|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
33199105|NCT01969838|100633755|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
33199106|NCT01969838|100633756|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
33199107|NCT01969838|100633757|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
33199108|NCT01969838|100633754|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
33199109|NCT01969838|100633755|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
33199110|NCT01969838|100633756|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
33199111|NCT01969838|100633757|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
33199112|NCT01969838|100633754|FG000|Open-label Phase|Adverse Event|0|||
33325321|NCT01368536|101088029|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
33325322|NCT01368536|101088027|FG000|Overall Study|No longer required study medication|0|||
33325323|NCT01368536|101088028|FG001|Overall Study|No longer required study medication|0|||
33514121|NCT02817516|101779665|FG001|Overall Study|Other|0|||
33325324|NCT01368536|101088029|FG002|Overall Study|No longer required study medication|1|||
33325325|NCT01368536|101088027|FG000|Overall Study|Withdrawal by Subject|2|||
33325326|NCT01368536|101088028|FG001|Overall Study|Withdrawal by Subject|5|||
33514122|NCT02817516|101779666|FG002|Overall Study|Other|1|||
33514123|NCT02817516|101779667|FG003|Overall Study|Other|0|||
33514124|NCT05072964|101779668|FG000|Overall Study|Withdrawal by Subject|4|||
33514125|NCT05072964|101779668|FG000|Overall Study|Death|1|||
33514126|NCT02987972|101779669|FG000|Overall Study|Adverse Event|1|||
33514127|NCT02987972|101779670|FG001|Overall Study|Adverse Event|1|||
33514128|NCT02987972|101779671|FG002|Overall Study|Adverse Event|0|||
33514129|NCT02987972|101779669|FG000|Overall Study|Death|1|||
33514130|NCT02987972|101779670|FG001|Overall Study|Death|0|||
33514131|NCT02987972|101779671|FG002|Overall Study|Death|0|||
33514132|NCT02987972|101779669|FG000|Overall Study|Lack of Efficacy|9|||
33514133|NCT02987972|101779670|FG001|Overall Study|Lack of Efficacy|12|||
33514134|NCT02987972|101779671|FG002|Overall Study|Lack of Efficacy|12|||
33514135|NCT02987972|101779669|FG000|Overall Study|Lost to Follow-up|7|||
33514136|NCT02987972|101779670|FG001|Overall Study|Lost to Follow-up|8|||
33514137|NCT02987972|101779671|FG002|Overall Study|Lost to Follow-up|4|||
33514138|NCT02987972|101779669|FG000|Overall Study|Physician Decision|1|||
33514139|NCT02987972|101779670|FG001|Overall Study|Physician Decision|6|||
33514140|NCT02987972|101779671|FG002|Overall Study|Physician Decision|0|||
33514141|NCT02987972|101779669|FG000|Overall Study|Protocol Violation|2|||
33514142|NCT02987972|101779670|FG001|Overall Study|Protocol Violation|1|||
33514143|NCT02987972|101779671|FG002|Overall Study|Protocol Violation|5|||
33514144|NCT02987972|101779669|FG000|Overall Study|Withdrawal by Subject|22|||
33514145|NCT02987972|101779670|FG001|Overall Study|Withdrawal by Subject|17|||
33514146|NCT02987972|101779671|FG002|Overall Study|Withdrawal by Subject|21|||
33514147|NCT02706886|101779672|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
33514148|NCT02706886|101779673|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
33514149|NCT02706886|101779674|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
33514150|NCT02706886|101779675|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
33514151|NCT02706886|101779676|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
33514152|NCT02706886|101779677|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
33514153|NCT02706886|101779678|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
33514154|NCT02706886|101779679|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
33514155|NCT02706886|101779680|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
33514156|NCT01328548|101779682|FG000|Overall Study|Death|3|||
33514157|NCT01328548|101779683|FG001|Overall Study|Death|0|||
33514158|NCT01328548|101779682|FG000|Overall Study|Protocol Violation|1|||
33514159|NCT01328548|101779683|FG001|Overall Study|Protocol Violation|0|||
33514160|NCT03104400|101779686|FG000|Overall Study|Adverse Event|5|||
33514161|NCT03104400|101779687|FG001|Overall Study|Adverse Event|7|||
33514162|NCT03104400|101779688|FG002|Overall Study|Adverse Event|11|||
33514163|NCT03104400|101779689|FG003|Overall Study|Adverse Event|9|||
33514164|NCT03104400|101779690|FG004|Overall Study|Adverse Event|21|||
33514165|NCT03104400|101779686|FG000|Overall Study|Withdrawal by Subject|17|||
33514166|NCT03104400|101779687|FG001|Overall Study|Withdrawal by Subject|19|||
33514167|NCT03104400|101779688|FG002|Overall Study|Withdrawal by Subject|29|||
33514168|NCT03104400|101779689|FG003|Overall Study|Withdrawal by Subject|25|||
33514169|NCT03104400|101779690|FG004|Overall Study|Withdrawal by Subject|24|||
33514170|NCT03104400|101779686|FG000|Overall Study|Lost to Follow-up|4|||
33514171|NCT03104400|101779687|FG001|Overall Study|Lost to Follow-up|1|||
33514172|NCT03104400|101779688|FG002|Overall Study|Lost to Follow-up|4|||
33514173|NCT03104400|101779689|FG003|Overall Study|Lost to Follow-up|8|||
33514174|NCT03104400|101779690|FG004|Overall Study|Lost to Follow-up|7|||
33514175|NCT03104400|101779686|FG000|Overall Study|Lack of Efficacy|6|||
33514176|NCT03104400|101779687|FG001|Overall Study|Lack of Efficacy|3|||
33199113|NCT01969838|100633755|FG001|Open-label Phase|Adverse Event|0|||
33325327|NCT01368536|101088029|FG002|Overall Study|Withdrawal by Subject|4|||
33325328|NCT01368536|101088027|FG000|Overall Study|Lost to Follow-up|3|||
33325329|NCT01368536|101088028|FG001|Overall Study|Lost to Follow-up|3|||
33325330|NCT01368536|101088029|FG002|Overall Study|Lost to Follow-up|5|||
33325331|NCT01368536|101088027|FG000|Overall Study|Administrative problems|34|||
33325332|NCT01368536|101088028|FG001|Overall Study|Administrative problems|39|||
33399510|NCT02141854|101350237|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
33514177|NCT03104400|101779688|FG002|Overall Study|Lack of Efficacy|8|||
33514178|NCT03104400|101779689|FG003|Overall Study|Lack of Efficacy|2|||
33514179|NCT03104400|101779690|FG004|Overall Study|Lack of Efficacy|1|||
33514180|NCT03104400|101779686|FG000|Overall Study|COVID Logistical Restrictions|0|||
33199114|NCT01969838|100633756|FG002|Open-label Phase|Adverse Event|37|||
33199115|NCT01969838|100633757|FG003|Open-label Phase|Adverse Event|49|||
33199116|NCT01969838|100633754|FG000|Open-label Phase|Disease Progression|0|||
33199117|NCT01969838|100633755|FG001|Open-label Phase|Disease Progression|0|||
33199118|NCT01969838|100633756|FG002|Open-label Phase|Disease Progression|26|||
33514181|NCT03104400|101779687|FG001|Overall Study|COVID Logistical Restrictions|0|||
33514182|NCT03104400|101779688|FG002|Overall Study|COVID Logistical Restrictions|0|||
33325333|NCT01368536|101088029|FG002|Overall Study|Administrative problems|35|||
33514183|NCT03104400|101779689|FG003|Overall Study|COVID Logistical Restrictions|1|||
33325334|NCT01368536|101088027|FG000|Overall Study|Protocol deviation|0|||
33514184|NCT03104400|101779690|FG004|Overall Study|COVID Logistical Restrictions|0|||
33514185|NCT03104400|101779686|FG000|Overall Study|Other|2|||
33514186|NCT03104400|101779687|FG001|Overall Study|Other|3|||
33514187|NCT03104400|101779688|FG002|Overall Study|Other|7|||
33514188|NCT03104400|101779689|FG003|Overall Study|Other|6|||
33514189|NCT03104400|101779690|FG004|Overall Study|Other|4|||
33514190|NCT03104400|101779686|FG000|Overall Study|Other|0|||
33514191|NCT03104400|101779687|FG001|Overall Study|Other|1|||
33514192|NCT03104400|101779688|FG002|Overall Study|Other|0|||
33514193|NCT03104400|101779689|FG003|Overall Study|Other|0|||
33514194|NCT03104400|101779690|FG004|Overall Study|Other|0|||
33514195|NCT06011161|101779692|FG000|Overall Study|Withdrawal by Subject|2|||
33514196|NCT06011161|101779692|FG000|Overall Study|Lost to Follow-up|5|||
33514197|NCT00793546|101779693|FG000|Overall Study|Death|3|||
33514198|NCT00793546|101779694|FG001|Overall Study|Death|0|||
33514199|NCT00793546|101779693|FG000|Overall Study|Lost to Follow-up|1|||
33514200|NCT00793546|101779694|FG001|Overall Study|Lost to Follow-up|0|||
33514201|NCT00793546|101779693|FG000|Overall Study|Withdrawal by Subject|1|||
33514202|NCT00793546|101779694|FG001|Overall Study|Withdrawal by Subject|1|||
33514203|NCT00793546|101779693|FG000|Overall Study|Study Terminated by Sponsor|8|||
33514204|NCT00793546|101779694|FG001|Overall Study|Study Terminated by Sponsor|27|||
33514205|NCT00793546|101779693|FG000|Overall Study|Other|1|||
33514206|NCT00793546|101779694|FG001|Overall Study|Other|0|||
33514207|NCT02474589|101779695|FG000|Overall Study|Adverse Event|6|||
33514208|NCT02474589|101779696|FG001|Overall Study|Adverse Event|2|||
33514209|NCT02474589|101779695|FG000|Overall Study|Lost to Follow-up|6|||
33514210|NCT02474589|101779696|FG001|Overall Study|Lost to Follow-up|1|||
33514211|NCT02474589|101779695|FG000|Overall Study|Protocol Violation|4|||
33514212|NCT02474589|101779696|FG001|Overall Study|Protocol Violation|1|||
33514213|NCT02474589|101779695|FG000|Overall Study|Withdrawal by Subject|4|||
33514214|NCT02474589|101779696|FG001|Overall Study|Withdrawal by Subject|0|||
33514215|NCT02474589|101779695|FG000|Overall Study|Inability to complete study procedures|5|||
33399511|NCT02141854|101350238|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33399512|NCT02141854|101350239|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33399513|NCT02141854|101350240|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33399514|NCT02141854|101350241|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33399515|NCT02141854|101350242|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33399516|NCT02141854|101350237|FG000|Treatment Period|Protocol Violation|0|||
33399517|NCT02141854|101350238|FG001|Treatment Period|Protocol Violation|1|||
33325335|NCT01368536|101088028|FG001|Overall Study|Protocol deviation|3|||
33325336|NCT01368536|101088029|FG002|Overall Study|Protocol deviation|1|||
33325337|NCT01876251|101088033|FG000|Overall Study|Clinical progression|1|||
33325338|NCT01876251|101088034|FG001|Overall Study|Clinical progression|0|||
33325339|NCT01876251|101088035|FG002|Overall Study|Clinical progression|0|||
33325340|NCT01876251|101088033|FG000|Overall Study|Death|2|||
33325341|NCT01876251|101088034|FG001|Overall Study|Death|0|||
33325342|NCT01876251|101088035|FG002|Overall Study|Death|1|||
33325343|NCT01876251|101088033|FG000|Overall Study|Participant started new treatment|1|||
33514216|NCT02474589|101779696|FG001|Overall Study|Inability to complete study procedures|1|||
33514217|NCT04299048|101779697|FG000|Overall Study|Death|1|||
33514218|NCT04299048|101779697|FG000|Overall Study|Global deterioration of health status|2|||
33199119|NCT01969838|100633757|FG003|Open-label Phase|Disease Progression|27|||
33199120|NCT01969838|100633754|FG000|Open-label Phase|Lack of Efficacy|0|||
33514219|NCT04299048|101779697|FG000|Overall Study|Enrolled and not treated|1|||
33514220|NCT04683939|101779698|FG000|Overall Study|Study termination by the sponsor|0|||
33514221|NCT04683939|101779699|FG001|Overall Study|Study termination by the sponsor|1|||
33514222|NCT04683939|101779700|FG002|Overall Study|Study termination by the sponsor|2|||
33514223|NCT04683939|101779701|FG003|Overall Study|Study termination by the sponsor|2|||
33514224|NCT04683939|101779698|FG000|Overall Study|Death|1|||
33514225|NCT04683939|101779699|FG001|Overall Study|Death|1|||
33514226|NCT04683939|101779700|FG002|Overall Study|Death|2|||
33514227|NCT04683939|101779701|FG003|Overall Study|Death|1|||
33514228|NCT04683939|101779698|FG000|Overall Study|Withdrawal by Subject|1|||
33514229|NCT04683939|101779699|FG001|Overall Study|Withdrawal by Subject|0|||
33514230|NCT04683939|101779700|FG002|Overall Study|Withdrawal by Subject|0|||
33199121|NCT01969838|100633755|FG001|Open-label Phase|Lack of Efficacy|0|||
33199122|NCT01969838|100633756|FG002|Open-label Phase|Lack of Efficacy|17|||
33199123|NCT01969838|100633757|FG003|Open-label Phase|Lack of Efficacy|19|||
33399518|NCT02141854|101350239|FG002|Treatment Period|Protocol Violation|0|||
33399519|NCT02141854|101350240|FG003|Treatment Period|Protocol Violation|2|||
33399520|NCT02141854|101350241|FG004|Treatment Period|Protocol Violation|2|||
33514231|NCT04683939|101779701|FG003|Overall Study|Withdrawal by Subject|0|||
33514232|NCT04683939|101779698|FG000|Overall Study|Physician Decision|1|||
33514233|NCT04683939|101779699|FG001|Overall Study|Physician Decision|0|||
33514234|NCT04683939|101779700|FG002|Overall Study|Physician Decision|0|||
33514235|NCT04683939|101779701|FG003|Overall Study|Physician Decision|0|||
33514236|NCT04683939|101779698|FG000|Overall Study|Lost to Follow-up|0|||
33514237|NCT04683939|101779699|FG001|Overall Study|Lost to Follow-up|1|||
33199124|NCT01969838|100633754|FG000|Open-label Phase|Subject Decision|0|||
33325344|NCT01876251|101088034|FG001|Overall Study|Participant started new treatment|0|||
33325345|NCT01876251|101088035|FG002|Overall Study|Participant started new treatment|1|||
33399521|NCT02141854|101350242|FG005|Treatment Period|Protocol Violation|1|||
33399522|NCT02141854|101350237|FG000|Treatment Period|Noncompliance|0|||
33399523|NCT02141854|101350238|FG001|Treatment Period|Noncompliance|0|||
33399524|NCT02141854|101350239|FG002|Treatment Period|Noncompliance|0|||
33399525|NCT02141854|101350240|FG003|Treatment Period|Noncompliance|1|||
33399526|NCT02141854|101350241|FG004|Treatment Period|Noncompliance|0|||
33399527|NCT02141854|101350242|FG005|Treatment Period|Noncompliance|0|||
33399528|NCT02141854|101350237|FG000|Treatment Period|Lack of Efficacy|0|||
33325346|NCT01876251|101088033|FG000|Overall Study|Participant refused further follow-up|0|||
33325347|NCT01876251|101088034|FG001|Overall Study|Participant refused further follow-up|0|||
33325348|NCT01876251|101088035|FG002|Overall Study|Participant refused further follow-up|1|||
33325349|NCT01876251|101088033|FG000|Overall Study|Study terminated|1|||
33399529|NCT02141854|101350238|FG001|Treatment Period|Lack of Efficacy|0|||
33399530|NCT02141854|101350239|FG002|Treatment Period|Lack of Efficacy|0|||
33399531|NCT02141854|101350240|FG003|Treatment Period|Lack of Efficacy|1|||
33514238|NCT04683939|101779700|FG002|Overall Study|Lost to Follow-up|0|||
33325350|NCT01876251|101088034|FG001|Overall Study|Study terminated|0|||
33325351|NCT01876251|101088035|FG002|Overall Study|Study terminated|0|||
33325352|NCT01876251|101088033|FG000|Overall Study|Objective progression or relapse|10|||
33325353|NCT01876251|101088034|FG001|Overall Study|Objective progression or relapse|3|||
33514239|NCT04683939|101779701|FG003|Overall Study|Lost to Follow-up|0|||
33514240|NCT01097421|101779702|FG000|Overall Study|Adverse Event|8|||
33325354|NCT01876251|101088035|FG002|Overall Study|Objective progression or relapse|8|||
33325355|NCT04607148|101088036|FG000|Overall Study|Withdrawal by Subject|0|||
33199125|NCT01969838|100633755|FG001|Open-label Phase|Subject Decision|0|||
33199126|NCT01969838|100633756|FG002|Open-label Phase|Subject Decision|14|||
33325356|NCT04607148|101088037|FG001|Overall Study|Withdrawal by Subject|4|||
33325357|NCT04607148|101088038|FG002|Overall Study|Withdrawal by Subject|2|||
33325358|NCT04607148|101088039|FG003|Overall Study|Withdrawal by Subject|8|||
33325359|NCT04607148|101088036|FG000|Overall Study|Study Terminated by Sponsor|14|||
33399532|NCT02141854|101350241|FG004|Treatment Period|Lack of Efficacy|1|||
33399533|NCT02141854|101350242|FG005|Treatment Period|Lack of Efficacy|7|||
33399534|NCT02141854|101350237|FG000|Treatment Period|Pregnancy|0|||
33514241|NCT01097421|101779702|FG000|Overall Study|Protocol Violation|2|||
33325360|NCT04607148|101088037|FG001|Overall Study|Study Terminated by Sponsor|59|||
33325361|NCT04607148|101088038|FG002|Overall Study|Study Terminated by Sponsor|9|||
33325362|NCT04607148|101088039|FG003|Overall Study|Study Terminated by Sponsor|39|||
33325363|NCT04607148|101088036|FG000|Overall Study|Sponsor Decision|0|||
33514242|NCT01097421|101779702|FG000|Overall Study|Lost to Follow-up|1|||
33325364|NCT04607148|101088037|FG001|Overall Study|Sponsor Decision|0|||
33399535|NCT02141854|101350238|FG001|Treatment Period|Pregnancy|1|||
33514243|NCT01097421|101779702|FG000|Overall Study|Withdrawal by Subject|3|||
33514244|NCT01446237|101779706|FG000|Overall Study|Adverse Event|1|||
33514245|NCT01446237|101779706|FG000|Overall Study|Lost to Follow-up|2|||
33399536|NCT02141854|101350239|FG002|Treatment Period|Pregnancy|0|||
33399537|NCT02141854|101350240|FG003|Treatment Period|Pregnancy|0|||
33399538|NCT02141854|101350241|FG004|Treatment Period|Pregnancy|0|||
33399539|NCT02141854|101350242|FG005|Treatment Period|Pregnancy|0|||
33399540|NCT02141854|101350237|FG000|Treatment Period|Other|0|||
33399541|NCT02141854|101350238|FG001|Treatment Period|Other|1|||
33514246|NCT01446237|101779706|FG000|Overall Study|Withdrawal by Subject|7|||
33514247|NCT01661933|101779707|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
33514248|NCT01661933|101779707|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
33514249|NCT01632904|101779708|FG000|Overall Study|Adverse Event|4|||
33514250|NCT01632904|101779709|FG001|Overall Study|Adverse Event|1|||
33514251|NCT01632904|101779708|FG000|Overall Study|Physician Decision|0|||
33514252|NCT01632904|101779709|FG001|Overall Study|Physician Decision|1|||
33514253|NCT01632904|101779708|FG000|Overall Study|Subject decision|3|||
33514254|NCT01632904|101779709|FG001|Overall Study|Subject decision|2|||
33514255|NCT01632904|101779708|FG000|Overall Study|Disease Progression|0|||
33514256|NCT01632904|101779709|FG001|Overall Study|Disease Progression|1|||
33514257|NCT01632904|101779708|FG000|Overall Study|Reason for discontinuation not available|0|||
33514258|NCT01632904|101779709|FG001|Overall Study|Reason for discontinuation not available|1|||
33514259|NCT00412217|101779710|FG000|Overall Study|Insufficient Data Available|8|||
33514260|NCT00412217|101779711|FG001|Overall Study|Insufficient Data Available|3|||
33514261|NCT00412217|101779710|FG000|Overall Study|Death|5|||
33514262|NCT00412217|101779711|FG001|Overall Study|Death|4|||
33514263|NCT00412217|101779710|FG000|Overall Study|Disease Progression|2|||
33514264|NCT00412217|101779711|FG001|Overall Study|Disease Progression|3|||
33514265|NCT00412217|101779710|FG000|Overall Study|Investigator Decision|1|||
33514266|NCT00412217|101779711|FG001|Overall Study|Investigator Decision|0|||
33514267|NCT00412217|101779710|FG000|Overall Study|Withdrawal by Subject|2|||
33514268|NCT00412217|101779711|FG001|Overall Study|Withdrawal by Subject|0|||
33514269|NCT00412217|101779710|FG000|Overall Study|Lost to Follow-up|1|||
33514270|NCT00412217|101779711|FG001|Overall Study|Lost to Follow-up|4|||
33514271|NCT00412217|101779710|FG000|Overall Study|Study Terminated by Sponsor|26|||
33514272|NCT00412217|101779711|FG001|Overall Study|Study Terminated by Sponsor|33|||
33514273|NCT00412217|101779710|FG000|Overall Study|Other|1|||
33514274|NCT00412217|101779711|FG001|Overall Study|Other|1|||
33514275|NCT05619536|101779714|FG000|Overall Study|Withdrawal by Subject|0|||
33514276|NCT05619536|101779715|FG001|Overall Study|Withdrawal by Subject|1|||
33514277|NCT05619536|101779716|FG002|Overall Study|Withdrawal by Subject|0|||
33514278|NCT05619536|101779717|FG003|Overall Study|Withdrawal by Subject|1|||
33514279|NCT05619536|101779714|FG000|Overall Study|Lost to Follow-up|0|||
33514280|NCT05619536|101779715|FG001|Overall Study|Lost to Follow-up|1|||
33514281|NCT05619536|101779716|FG002|Overall Study|Lost to Follow-up|1|||
33514282|NCT05619536|101779717|FG003|Overall Study|Lost to Follow-up|0|||
33514283|NCT03467763|101779718|FG000|Overall Study|Lost to Follow-up|1|||
33514284|NCT03467763|101779718|FG000|Overall Study|Protocol Violation|2|||
33514285|NCT00878969|101779726|FG000|Overall Study|Physician Decision|5|||
33514286|NCT00878969|101779727|FG001|Overall Study|Physician Decision|3|||
33199127|NCT01969838|100633757|FG003|Open-label Phase|Subject Decision|15|||
33199128|NCT01969838|100633754|FG000|Open-label Phase|Death|0|||
33199129|NCT01969838|100633755|FG001|Open-label Phase|Death|0|||
33514287|NCT00878969|101779728|FG002|Overall Study|Physician Decision|2|||
33514288|NCT00878969|101779726|FG000|Overall Study|Withdrawal by Subject|1|||
33514289|NCT00878969|101779727|FG001|Overall Study|Withdrawal by Subject|6|||
33514290|NCT00878969|101779728|FG002|Overall Study|Withdrawal by Subject|3|||
33514291|NCT00878969|101779726|FG000|Overall Study|kidney transplant|2|||
33514292|NCT00878969|101779727|FG001|Overall Study|kidney transplant|3|||
33514293|NCT00878969|101779728|FG002|Overall Study|kidney transplant|2|||
33325365|NCT04607148|101088038|FG002|Overall Study|Sponsor Decision|1|||
33325366|NCT04607148|101088039|FG003|Overall Study|Sponsor Decision|0|||
33325367|NCT04607148|101088036|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33325368|NCT04607148|101088037|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33325369|NCT04607148|101088038|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33325370|NCT04607148|101088039|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33325371|NCT04607148|101088036|FG000|Overall Study|Lost to Follow-up|0|||
33514294|NCT00878969|101779726|FG000|Overall Study|Adverse Event|3|||
33399542|NCT02141854|101350239|FG002|Treatment Period|Other|2|||
33514295|NCT00878969|101779727|FG001|Overall Study|Adverse Event|1|||
33514296|NCT00878969|101779728|FG002|Overall Study|Adverse Event|2|||
33514297|NCT00878969|101779726|FG000|Overall Study|Lost to Follow-up|2|||
33514298|NCT00878969|101779727|FG001|Overall Study|Lost to Follow-up|1|||
33514299|NCT00878969|101779728|FG002|Overall Study|Lost to Follow-up|0|||
33514300|NCT00878969|101779726|FG000|Overall Study|Protocol Violation|2|||
33514301|NCT00878969|101779727|FG001|Overall Study|Protocol Violation|0|||
33514302|NCT00878969|101779728|FG002|Overall Study|Protocol Violation|0|||
33514303|NCT00878969|101779726|FG000|Overall Study|Death|0|||
33514304|NCT00878969|101779727|FG001|Overall Study|Death|0|||
33514305|NCT00878969|101779728|FG002|Overall Study|Death|2|||
33514306|NCT00878969|101779726|FG000|Overall Study|Pregnancy|0|||
33514307|NCT00878969|101779727|FG001|Overall Study|Pregnancy|1|||
33514308|NCT00878969|101779728|FG002|Overall Study|Pregnancy|0|||
33514309|NCT00177307|101779729|FG000|Overall Study|Withdrawal by Subject|1|||
33514310|NCT00655733|101779732|FG000|Overall Study|Lost to Follow-up|2|||
33514311|NCT00655733|101779733|FG001|Overall Study|Lost to Follow-up|2|||
33514312|NCT00655733|101779732|FG000|Overall Study|Adverse Event|2|||
33514313|NCT00655733|101779733|FG001|Overall Study|Adverse Event|2|||
33514314|NCT00655733|101779732|FG000|Overall Study|Withdrawal by Subject|3|||
33514315|NCT00655733|101779733|FG001|Overall Study|Withdrawal by Subject|3|||
33514316|NCT00655733|101779732|FG000|Overall Study|Physician Decision|0|||
33514317|NCT00655733|101779733|FG001|Overall Study|Physician Decision|1|||
33514318|NCT01741792|101779734|FG000|Overall Study|Death|6|||
33514319|NCT01741792|101779735|FG001|Overall Study|Death|1|||
33514320|NCT01741792|101779736|FG002|Overall Study|Death|12|||
33514321|NCT00723190|101779737|FG000|Overall Study|Withdrawal by Subject|45|||
33514322|NCT00723190|101779737|FG000|Overall Study|Lost to Follow-up|37|||
33514323|NCT00723190|101779737|FG000|Overall Study|Adverse Event|18|||
33514324|NCT00723190|101779737|FG000|Overall Study|Lack of Efficacy|16|||
33514325|NCT00723190|101779737|FG000|Overall Study|Protocol Violation|15|||
33514326|NCT00723190|101779737|FG000|Overall Study|Other-Premature Discontinuation|9|||
33514327|NCT00723190|101779737|FG000|Overall Study|Other-Not included in safety population|2|||
33514328|NCT02083185|101779738|FG000|Overall Study|Lost to Follow-up|0|||
33514329|NCT02083185|101779739|FG001|Overall Study|Lost to Follow-up|3|||
33514330|NCT02083185|101779740|FG002|Overall Study|Lost to Follow-up|0|||
33514331|NCT02083185|101779738|FG000|Overall Study|Withdrawal by Subject|9|||
33514332|NCT02083185|101779739|FG001|Overall Study|Withdrawal by Subject|15|||
33514333|NCT02083185|101779740|FG002|Overall Study|Withdrawal by Subject|1|||
33514334|NCT02083185|101779738|FG000|Overall Study|Death|2|||
33514335|NCT02083185|101779739|FG001|Overall Study|Death|2|||
33514336|NCT02083185|101779740|FG002|Overall Study|Death|1|||
33514337|NCT02083185|101779738|FG000|Overall Study|Reason not Specified|9|||
33514338|NCT02083185|101779739|FG001|Overall Study|Reason not Specified|6|||
33514339|NCT02083185|101779740|FG002|Overall Study|Reason not Specified|5|||
33514340|NCT02083185|101779738|FG000|Overall Study|Study Terminated by Sponsor|0|||
33514341|NCT02083185|101779739|FG001|Overall Study|Study Terminated by Sponsor|1|||
33606856|NCT00172042|102111562|FG000|Overall Study|Protocol Violation|8|||
33606857|NCT00172042|102111563|FG001|Overall Study|Protocol Violation|7|||
33606858|NCT00172042|102111562|FG000|Overall Study|Withdrawal by Subject|37|||
33606859|NCT00172042|102111563|FG001|Overall Study|Withdrawal by Subject|25|||
33606860|NCT00172042|102111562|FG000|Overall Study|Lost to Follow-up|3|||
33606861|NCT00172042|102111563|FG001|Overall Study|Lost to Follow-up|5|||
33606862|NCT00172042|102111562|FG000|Overall Study|Administrative problems|13|||
33399543|NCT02141854|101350240|FG003|Treatment Period|Other|0|||
33514342|NCT02083185|101779740|FG002|Overall Study|Study Terminated by Sponsor|0|||
33514343|NCT02083185|101779738|FG000|Overall Study|Did not Receive Study Drug|0|||
33514344|NCT02083185|101779739|FG001|Overall Study|Did not Receive Study Drug|2|||
33514345|NCT02083185|101779740|FG002|Overall Study|Did not Receive Study Drug|0|||
33514346|NCT00131365|101779752|FG000|Overall Study|Withdrawal by Subject|1|||
33514347|NCT00131365|101779752|FG000|Overall Study|Alternative treatment|3|||
33514348|NCT00347919|101779753|FG000|Overall Study|Lost to Follow-up|11|||
33514349|NCT00347919|101779754|FG001|Overall Study|Lost to Follow-up|13|||
33514350|NCT00347919|101779755|FG002|Overall Study|Lost to Follow-up|0|||
33514351|NCT00347919|101779753|FG000|Overall Study|Withdrawal by Subject|6|||
33514352|NCT00347919|101779754|FG001|Overall Study|Withdrawal by Subject|8|||
33514353|NCT00347919|101779755|FG002|Overall Study|Withdrawal by Subject|0|||
33514354|NCT00347919|101779753|FG000|Overall Study|Physician Decision|1|||
33514355|NCT00347919|101779754|FG001|Overall Study|Physician Decision|1|||
33514356|NCT00347919|101779755|FG002|Overall Study|Physician Decision|0|||
33606863|NCT00172042|102111563|FG001|Overall Study|Administrative problems|10|||
33399544|NCT02141854|101350241|FG004|Treatment Period|Other|1|||
33514357|NCT00347919|101779753|FG000|Overall Study|Sponsor terminated study|15|||
33514358|NCT00347919|101779754|FG001|Overall Study|Sponsor terminated study|10|||
33514359|NCT00347919|101779755|FG002|Overall Study|Sponsor terminated study|16|||
33514360|NCT00347919|101779753|FG000|Overall Study|Death|35|||
33514361|NCT00347919|101779754|FG001|Overall Study|Death|42|||
33514362|NCT00347919|101779755|FG002|Overall Study|Death|19|||
33606864|NCT00172042|102111562|FG000|Overall Study|Death|42|||
33606865|NCT00172042|102111563|FG001|Overall Study|Death|42|||
33514363|NCT00347919|101779753|FG000|Overall Study|Par. Started Other Treatment|1|||
33514364|NCT00347919|101779754|FG001|Overall Study|Par. Started Other Treatment|1|||
33514365|NCT00347919|101779755|FG002|Overall Study|Par. Started Other Treatment|1|||
33514366|NCT00347919|101779753|FG000|Overall Study|Missing|2|||
33514367|NCT00347919|101779754|FG001|Overall Study|Missing|1|||
33514368|NCT00347919|101779755|FG002|Overall Study|Missing|2|||
33514369|NCT00819780|101779758|FG000|Overall Study|Did not receive study drug|3|||
33514370|NCT00819780|101779759|FG001|Overall Study|Did not receive study drug|4|||
33514371|NCT00819780|101779758|FG000|Overall Study|Still in treatment|25|||
33514372|NCT00819780|101779759|FG001|Overall Study|Still in treatment|17|||
33514373|NCT01447927|101779760|FG000|Overall Study|Adverse Event|4|||
33514374|NCT01447927|101779761|FG001|Overall Study|Adverse Event|3|||
33325372|NCT04607148|101088037|FG001|Overall Study|Lost to Follow-up|2|||
33325373|NCT04607148|101088038|FG002|Overall Study|Lost to Follow-up|0|||
33325374|NCT04607148|101088039|FG003|Overall Study|Lost to Follow-up|0|||
33514375|NCT01447927|101779760|FG000|Overall Study|Withdrawal by Subject|1|||
33514376|NCT01447927|101779761|FG001|Overall Study|Withdrawal by Subject|0|||
33514377|NCT01459718|101779762|FG000|Overall Study|Physician Decision|1|||
33514378|NCT01459718|101779762|FG000|Overall Study|Lost to Follow-up|1|||
33514379|NCT01459718|101779762|FG000|Overall Study|Adverse Event|1|||
33199130|NCT01969838|100633756|FG002|Open-label Phase|Death|13|||
33325375|NCT04607148|101088036|FG000|Overall Study|Death|0|||
33325376|NCT04607148|101088037|FG001|Overall Study|Death|3|||
33325377|NCT04607148|101088038|FG002|Overall Study|Death|0|||
33325378|NCT04607148|101088039|FG003|Overall Study|Death|1|||
33325379|NCT04607148|101088036|FG000|Overall Study|Adverse Event|0|||
33325380|NCT04607148|101088037|FG001|Overall Study|Adverse Event|1|||
33325381|NCT04607148|101088038|FG002|Overall Study|Adverse Event|0|||
33325382|NCT04607148|101088039|FG003|Overall Study|Adverse Event|0|||
33325383|NCT00290290|101088042|FG000|Overall Study|Death|3|||
33325384|NCT00290290|101088043|FG001|Overall Study|Death|4|||
33325385|NCT00290290|101088042|FG000|Overall Study|Withdrawal by Subject|2|||
33325386|NCT00290290|101088043|FG001|Overall Study|Withdrawal by Subject|2|||
33325387|NCT00290290|101088042|FG000|Overall Study|Underwent clean surgical procedure|13|||
33325388|NCT00290290|101088043|FG001|Overall Study|Underwent clean surgical procedure|12|||
33325389|NCT00467779|101088049|FG000|Stage 1|Adverse Event|1|||
33325390|NCT00467779|101088050|FG001|Stage 1|Adverse Event|0|||
33325391|NCT00467779|101088051|FG002|Stage 1|Adverse Event|0|||
33399545|NCT02141854|101350242|FG005|Treatment Period|Other|2|||
33399546|NCT02141854|101350237|FG000|Treatment Period|Adverse Event|0|||
33399547|NCT02141854|101350238|FG001|Treatment Period|Adverse Event|2|||
33399548|NCT02141854|101350239|FG002|Treatment Period|Adverse Event|2|||
33399549|NCT02141854|101350240|FG003|Treatment Period|Adverse Event|0|||
33399550|NCT02141854|101350241|FG004|Treatment Period|Adverse Event|2|||
33399551|NCT02141854|101350242|FG005|Treatment Period|Adverse Event|2|||
33399552|NCT02141854|101350237|FG000|Treatment Period|Withdrawal by Subject|0|||
33399553|NCT02141854|101350238|FG001|Treatment Period|Withdrawal by Subject|2|||
33399554|NCT02141854|101350239|FG002|Treatment Period|Withdrawal by Subject|3|||
33399555|NCT02141854|101350240|FG003|Treatment Period|Withdrawal by Subject|3|||
33399556|NCT02141854|101350241|FG004|Treatment Period|Withdrawal by Subject|4|||
33399557|NCT02141854|101350242|FG005|Treatment Period|Withdrawal by Subject|7|||
33399558|NCT02141854|101350237|FG000|Treatment Period|Disease progression|0|||
33399559|NCT02141854|101350238|FG001|Treatment Period|Disease progression|2|||
33399560|NCT02141854|101350239|FG002|Treatment Period|Disease progression|1|||
33399561|NCT02141854|101350240|FG003|Treatment Period|Disease progression|3|||
33399562|NCT02141854|101350241|FG004|Treatment Period|Disease progression|0|||
33399563|NCT02141854|101350242|FG005|Treatment Period|Disease progression|18|||
33399564|NCT02141854|101350237|FG000|Treatment Period|Lost to Follow-up|0|||
33399565|NCT02141854|101350238|FG001|Treatment Period|Lost to Follow-up|1|||
33399566|NCT02141854|101350239|FG002|Treatment Period|Lost to Follow-up|1|||
33399567|NCT02141854|101350240|FG003|Treatment Period|Lost to Follow-up|1|||
33399568|NCT02141854|101350241|FG004|Treatment Period|Lost to Follow-up|0|||
33514380|NCT04007107|101779765|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
33514381|NCT04007107|101779766|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
33199131|NCT01969838|100633757|FG003|Open-label Phase|Death|11|||
33325392|NCT00467779|101088052|FG003|Stage 1|Adverse Event|0|||
33325393|NCT00467779|101088053|FG004|Stage 1|Adverse Event|0|||
33325394|NCT00467779|101088054|FG005|Stage 1|Adverse Event|1|||
33399569|NCT02141854|101350242|FG005|Treatment Period|Lost to Follow-up|1|||
33399570|NCT03018340|101350253|FG000|Overall Study|Adverse Event|1|||
33399571|NCT03018340|101350254|FG001|Overall Study|Adverse Event|2|||
33399572|NCT03018340|101350253|FG000|Overall Study|Withdrawal by Subject|0|||
33325395|NCT00467779|101088055|FG006|Stage 1|Adverse Event|2|||
33325396|NCT00467779|101088056|FG007|Stage 1|Adverse Event|1|||
33325397|NCT00467779|101088057|FG008|Stage 1|Adverse Event|0|||
33399573|NCT03018340|101350254|FG001|Overall Study|Withdrawal by Subject|8|||
33325398|NCT00467779|101088058|FG009|Stage 1|Adverse Event|0|||
33325399|NCT00467779|101088059|FG010|Stage 1|Adverse Event|0|||
33514382|NCT04007107|101779767|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
33514383|NCT04007107|101779768|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
33514384|NCT00769067|101779771|FG000|Overall Study|Death|89|||
33514385|NCT00769067|101779772|FG001|Overall Study|Death|86|||
33514386|NCT00769067|101779771|FG000|Overall Study|Lost to Follow-up|3|||
33514387|NCT00769067|101779772|FG001|Overall Study|Lost to Follow-up|1|||
33514388|NCT00769067|101779771|FG000|Overall Study|Study terminated by sponsor|1|||
33514389|NCT00769067|101779772|FG001|Overall Study|Study terminated by sponsor|3|||
33514390|NCT00769067|101779771|FG000|Overall Study|Other|1|||
33514391|NCT00769067|101779772|FG001|Overall Study|Other|3|||
33514392|NCT00769067|101779771|FG000|Overall Study|Withdrawal by Subject|0|||
33514393|NCT00769067|101779772|FG001|Overall Study|Withdrawal by Subject|1|||
33514394|NCT00108485|101779773|FG000|Overall Study|Withdrawal by Subject|3|||
33514395|NCT00108485|101779774|FG001|Overall Study|Withdrawal by Subject|0|||
33514396|NCT00108485|101779773|FG000|Overall Study|Lost to Follow-up|0|||
33514397|NCT00108485|101779774|FG001|Overall Study|Lost to Follow-up|2|||
33514398|NCT02879994|101779775|FG000|Overall Study|off treatment early|7|||
33514399|NCT02879994|101779775|FG000|Overall Study|Adverse Event|2|||
33514400|NCT02879994|101779775|FG000|Overall Study|Death|2|||
33514401|NCT01283334|101779776|FG000|Overall Study|Withdrawal by Subject|1|||
33514402|NCT01283334|101779776|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
33514403|NCT01283334|101779776|FG000|Overall Study|Adverse Event|4|||
33514404|NCT01283334|101779776|FG000|Overall Study|Physician Decision|1|||
33199132|NCT01969838|100633754|FG000|Open-label Phase|Physician Decision|0|||
33199133|NCT01969838|100633755|FG001|Open-label Phase|Physician Decision|0|||
33199134|NCT01969838|100633756|FG002|Open-label Phase|Physician Decision|9|||
33199135|NCT01969838|100633757|FG003|Open-label Phase|Physician Decision|14|||
33199136|NCT01969838|100633754|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
33199137|NCT01969838|100633755|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
33199138|NCT01969838|100633756|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
33199139|NCT01969838|100633757|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
33199140|NCT02139644|100633760|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
33199141|NCT02139644|100633761|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33199142|NCT02139644|100633762|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33199143|NCT02139644|100633763|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33199144|NCT02139644|100633764|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33199145|NCT02139644|100633765|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33199146|NCT02139644|100633760|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
33199147|NCT02139644|100633761|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33199148|NCT02139644|100633762|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33199149|NCT02139644|100633763|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33199150|NCT02139644|100633764|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33199151|NCT02139644|100633765|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33199152|NCT02139644|100633760|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
33199153|NCT02139644|100633761|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33199154|NCT02139644|100633762|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33199155|NCT02139644|100633763|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33199156|NCT02139644|100633764|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33199157|NCT02139644|100633765|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33199158|NCT02139644|100633760|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
33514405|NCT02407054|101779777|FG000|Overall Study|Adverse Event|1|||
33514406|NCT02407054|101779778|FG001|Overall Study|Adverse Event|4|||
33514407|NCT02407054|101779779|FG002|Overall Study|Adverse Event|1|||
33514408|NCT02407054|101779777|FG000|Overall Study|Non-compliance with Study|0|||
33514409|NCT02407054|101779778|FG001|Overall Study|Non-compliance with Study|2|||
33514410|NCT02407054|101779779|FG002|Overall Study|Non-compliance with Study|1|||
33514411|NCT02407054|101779777|FG000|Overall Study|Physician Decision|1|||
33514412|NCT02407054|101779778|FG001|Overall Study|Physician Decision|3|||
33325400|NCT00467779|101088060|FG011|Stage 1|Adverse Event|0|||
33325401|NCT00467779|101088061|FG012|Stage 1|Adverse Event|0|||
33399574|NCT03018340|101350253|FG000|Overall Study|Lack of Efficacy|0|||
33514413|NCT02407054|101779779|FG002|Overall Study|Physician Decision|3|||
33514414|NCT02407054|101779777|FG000|Overall Study|Withdrawal by Subject|5|||
33514415|NCT02407054|101779778|FG001|Overall Study|Withdrawal by Subject|9|||
33514416|NCT02407054|101779779|FG002|Overall Study|Withdrawal by Subject|2|||
33514417|NCT01004406|101779780|FG000|Overall Study|Withdrawal by Subject|2|||
33514418|NCT01004406|101779781|FG001|Overall Study|Withdrawal by Subject|0|||
33514419|NCT01004406|101779780|FG000|Overall Study|Lost to Follow-up|1|||
33514420|NCT01004406|101779781|FG001|Overall Study|Lost to Follow-up|0|||
33514421|NCT03435224|101779793|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
33514422|NCT01279070|101779796|FG000|Overall Study|Withdrawal by Subject|2|||
33325402|NCT00467779|101088062|FG013|Stage 1|Adverse Event|0|||
33514423|NCT01279070|101779797|FG001|Overall Study|Withdrawal by Subject|3|||
33514424|NCT01279070|101779796|FG000|Overall Study|Acute exacerbation|3|||
33514425|NCT01279070|101779797|FG001|Overall Study|Acute exacerbation|1|||
33514426|NCT04250350|101779800|FG000|Overall Study|Withdrawal by Subject|13|||
33514427|NCT04250350|101779800|FG000|Overall Study|Lost to Follow-up|8|||
33514428|NCT04250350|101779800|FG000|Overall Study|Adverse Event|5|||
33514429|NCT04250350|101779800|FG000|Overall Study|Lack of Efficacy|4|||
33514430|NCT04250350|101779800|FG000|Overall Study|Physician Decision|1|||
33514431|NCT04250350|101779800|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
33514432|NCT00373958|101779801|FG000|Infant Series|Withdrawal by Subject|13|||
33514433|NCT00373958|101779802|FG001|Infant Series|Withdrawal by Subject|15|||
33514434|NCT00373958|101779801|FG000|Infant Series|Failed to return|8|||
33514435|NCT00373958|101779802|FG001|Infant Series|Failed to return|13|||
33514436|NCT00373958|101779801|FG000|Infant Series|Lost to Follow-up|6|||
33514437|NCT00373958|101779802|FG001|Infant Series|Lost to Follow-up|5|||
33514438|NCT00373958|101779801|FG000|Infant Series|Protocol Violation|3|||
33514439|NCT00373958|101779802|FG001|Infant Series|Protocol Violation|7|||
33514440|NCT00373958|101779801|FG000|Infant Series|Lost Kaiser coverage|4|||
33514441|NCT00373958|101779802|FG001|Infant Series|Lost Kaiser coverage|0|||
33514442|NCT00373958|101779801|FG000|Infant Series|Child relocated|1|||
33514443|NCT00373958|101779802|FG001|Infant Series|Child relocated|0|||
33514444|NCT00373958|101779801|FG000|Infant Series|Consent was not received|1|||
33514445|NCT00373958|101779802|FG001|Infant Series|Consent was not received|0|||
33514446|NCT00373958|101779801|FG000|Infant Series|Adverse Event|3|||
33514447|NCT00373958|101779802|FG001|Infant Series|Adverse Event|1|||
33514448|NCT00373958|101779801|FG000|Infant Series|Physician Decision|1|||
33514449|NCT00373958|101779802|FG001|Infant Series|Physician Decision|1|||
33606866|NCT00447122|102111568|FG000|Overall Study|worsening medical condition -came off|0|||
33606867|NCT00447122|102111569|FG001|Overall Study|worsening medical condition -came off|1|||
33399575|NCT03018340|101350254|FG001|Overall Study|Lack of Efficacy|1|||
33399576|NCT03018340|101350253|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
33399577|NCT03018340|101350254|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
33399578|NCT03018340|101350253|FG000|Overall Study|Lost to Follow-up|1|||
33399579|NCT03018340|101350254|FG001|Overall Study|Lost to Follow-up|7|||
33399580|NCT03018340|101350253|FG000|Overall Study|Protocol Violation|3|||
33399581|NCT03018340|101350254|FG001|Overall Study|Protocol Violation|7|||
33399582|NCT03018340|101350253|FG000|Overall Study|Not further specified|0|||
33399583|NCT03018340|101350254|FG001|Overall Study|Not further specified|1|||
33399584|NCT01685060|101350256|FG000|Overall Study|Rollover patients|16|||
33399585|NCT01685060|101350256|FG000|Overall Study|Adverse Event|12|||
33399586|NCT01685060|101350256|FG000|Overall Study|Progressive disease|69|||
33399587|NCT01685060|101350256|FG000|Overall Study|Physician Decision|14|||
33399588|NCT01685060|101350256|FG000|Overall Study|Subject/guardian decision|20|||
33399589|NCT01685060|101350256|FG000|Overall Study|Lost to Follow-up|1|||
33399590|NCT01685060|101350256|FG000|Overall Study|Death|8|||
33399591|NCT00216086|101350266|FG000|Overall Study|Protocol Violation|1|||
33399592|NCT00216086|101350266|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
33399593|NCT00216086|101350266|FG000|Overall Study|Social Reasons|2|||
33399594|NCT00256204|101350267|FG000|Overall Study|Adverse Event|10|||
33399595|NCT00256204|101350268|FG001|Overall Study|Adverse Event|14|||
33199159|NCT02139644|100633761|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33199160|NCT02139644|100633762|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33199161|NCT02139644|100633763|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33199162|NCT02139644|100633764|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33199163|NCT02139644|100633765|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33199164|NCT02139644|100633760|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
33199165|NCT02139644|100633761|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33399596|NCT00256204|101350269|FG002|Overall Study|Adverse Event|16|||
33514450|NCT00373958|101779801|FG000|Toddler Dose|Lost to Follow-up|5|||
33399597|NCT00256204|101350270|FG003|Overall Study|Adverse Event|14|||
33514451|NCT00373958|101779802|FG001|Toddler Dose|Lost to Follow-up|8|||
33514452|NCT00373958|101779801|FG000|Toddler Dose|Withdrawal by Subject|2|||
33199166|NCT02139644|100633762|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33514453|NCT00373958|101779802|FG001|Toddler Dose|Withdrawal by Subject|2|||
33514454|NCT00373958|101779801|FG000|Toddler Dose|Failed to return|1|||
33399598|NCT00256204|101350267|FG000|Overall Study|Death|0|||
33514455|NCT00373958|101779802|FG001|Toddler Dose|Failed to return|2|||
33399599|NCT00256204|101350268|FG001|Overall Study|Death|1|||
33399600|NCT00256204|101350269|FG002|Overall Study|Death|0|||
33399601|NCT00256204|101350270|FG003|Overall Study|Death|0|||
33199167|NCT02139644|100633763|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33199168|NCT02139644|100633764|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33199169|NCT02139644|100633765|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33199170|NCT02139644|100633760|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
33199171|NCT02139644|100633761|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
33199172|NCT02139644|100633762|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
33199173|NCT02139644|100633763|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
33199174|NCT02139644|100633764|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
33199175|NCT02139644|100633765|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
33199176|NCT02139644|100633760|FG000|Run-In Period (Pre-assignment)|Other|6|||
33199177|NCT02139644|100633761|FG001|Run-In Period (Pre-assignment)|Other|0|||
33514456|NCT00373958|101779801|FG000|Toddler Dose|Protocol Violation|0|||
33514457|NCT00373958|101779802|FG001|Toddler Dose|Protocol Violation|1|||
33514458|NCT00373958|101779801|FG000|Toddler Dose|Withdrawn after infant series|22|||
33514459|NCT00373958|101779802|FG001|Toddler Dose|Withdrawn after infant series|25|||
33514460|NCT01871402|101779805|FG000|Overall Study|Lost to Follow-up|1|||
33514461|NCT01871402|101779806|FG001|Overall Study|Lost to Follow-up|0|||
33514462|NCT01871402|101779805|FG000|Overall Study|Withdrawal by Subject|0|||
33514463|NCT01871402|101779806|FG001|Overall Study|Withdrawal by Subject|2|||
33514464|NCT01871402|101779805|FG000|Overall Study|Non-compliance|0|||
33514465|NCT01871402|101779806|FG001|Overall Study|Non-compliance|1|||
33514466|NCT01482962|101779807|FG000|Overall Study|Progressive Disease|65|||
33199178|NCT02139644|100633762|FG002|Run-In Period (Pre-assignment)|Other|0|||
33199179|NCT02139644|100633763|FG003|Run-In Period (Pre-assignment)|Other|0|||
33199180|NCT02139644|100633764|FG004|Run-In Period (Pre-assignment)|Other|0|||
33199181|NCT02139644|100633765|FG005|Run-In Period (Pre-assignment)|Other|0|||
33199182|NCT02139644|100633760|FG000|Treatment Period|Adverse Event|0|||
33199183|NCT02139644|100633761|FG001|Treatment Period|Adverse Event|0|||
33199184|NCT02139644|100633762|FG002|Treatment Period|Adverse Event|3|||
33199185|NCT02139644|100633763|FG003|Treatment Period|Adverse Event|2|||
33199186|NCT02139644|100633764|FG004|Treatment Period|Adverse Event|1|||
33199187|NCT02139644|100633765|FG005|Treatment Period|Adverse Event|6|||
33199188|NCT02139644|100633760|FG000|Treatment Period|Withdrawal by Subject|0|||
33199189|NCT02139644|100633761|FG001|Treatment Period|Withdrawal by Subject|0|||
33199190|NCT02139644|100633762|FG002|Treatment Period|Withdrawal by Subject|2|||
33199191|NCT02139644|100633763|FG003|Treatment Period|Withdrawal by Subject|2|||
33199192|NCT02139644|100633764|FG004|Treatment Period|Withdrawal by Subject|3|||
33199193|NCT02139644|100633765|FG005|Treatment Period|Withdrawal by Subject|2|||
33199194|NCT02139644|100633760|FG000|Treatment Period|Non-compliance|0|||
33199195|NCT02139644|100633761|FG001|Treatment Period|Non-compliance|0|||
33199196|NCT02139644|100633762|FG002|Treatment Period|Non-compliance|0|||
33199197|NCT02139644|100633763|FG003|Treatment Period|Non-compliance|1|||
33199198|NCT02139644|100633764|FG004|Treatment Period|Non-compliance|0|||
33199199|NCT02139644|100633765|FG005|Treatment Period|Non-compliance|0|||
33199200|NCT02139644|100633760|FG000|Treatment Period|Protocol Violation|0|||
33199201|NCT02139644|100633761|FG001|Treatment Period|Protocol Violation|0|||
33199202|NCT02139644|100633762|FG002|Treatment Period|Protocol Violation|0|||
33199203|NCT02139644|100633763|FG003|Treatment Period|Protocol Violation|1|||
33199204|NCT02139644|100633764|FG004|Treatment Period|Protocol Violation|1|||
33514467|NCT01482962|101779808|FG001|Overall Study|Progressive Disease|53|||
33514468|NCT01482962|101779807|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
33606868|NCT00447122|102111570|FG002|Overall Study|worsening medical condition -came off|0|||
33606869|NCT00447122|102111571|FG003|Overall Study|worsening medical condition -came off|0|||
33199205|NCT02139644|100633765|FG005|Treatment Period|Protocol Violation|1|||
33199206|NCT02139644|100633760|FG000|Treatment Period|Disease progression|0|||
33199207|NCT02139644|100633761|FG001|Treatment Period|Disease progression|0|||
33199208|NCT02139644|100633762|FG002|Treatment Period|Disease progression|0|||
33199209|NCT02139644|100633763|FG003|Treatment Period|Disease progression|1|||
33199210|NCT02139644|100633764|FG004|Treatment Period|Disease progression|1|||
33199211|NCT02139644|100633765|FG005|Treatment Period|Disease progression|2|||
33199212|NCT02139644|100633760|FG000|Treatment Period|Lost to Follow-up|0|||
33199213|NCT02139644|100633761|FG001|Treatment Period|Lost to Follow-up|0|||
33199214|NCT02139644|100633762|FG002|Treatment Period|Lost to Follow-up|1|||
33199215|NCT02139644|100633763|FG003|Treatment Period|Lost to Follow-up|1|||
33199216|NCT02139644|100633764|FG004|Treatment Period|Lost to Follow-up|1|||
33514469|NCT01482962|101779808|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
33514470|NCT01482962|101779807|FG000|Overall Study|Adverse Event|18|||
33199217|NCT02139644|100633765|FG005|Treatment Period|Lost to Follow-up|1|||
33199218|NCT02139644|100633760|FG000|Treatment Period|Lack of Efficacy|0|||
33325403|NCT00467779|101088063|FG014|Stage 1|Adverse Event|0|||
33199219|NCT02139644|100633761|FG001|Treatment Period|Lack of Efficacy|0|||
33199220|NCT02139644|100633762|FG002|Treatment Period|Lack of Efficacy|1|||
33399602|NCT00256204|101350267|FG000|Overall Study|Lost to Follow-up|1|||
33399603|NCT00256204|101350268|FG001|Overall Study|Lost to Follow-up|1|||
33514471|NCT01482962|101779808|FG001|Overall Study|Adverse Event|22|||
33514472|NCT01482962|101779807|FG000|Overall Study|Withdrawal by Participant|8|||
33514473|NCT01482962|101779808|FG001|Overall Study|Withdrawal by Participant|13|||
33514474|NCT01482962|101779807|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
33514475|NCT01482962|101779808|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
33514476|NCT01482962|101779807|FG000|Overall Study|Other Reason|1|||
33514477|NCT01482962|101779808|FG001|Overall Study|Other Reason|5|||
33514478|NCT01482962|101779807|FG000|Overall Study|Study Terminated by Sponsor|5|||
33514479|NCT01482962|101779808|FG001|Overall Study|Study Terminated by Sponsor|2|||
33606870|NCT02345330|102111572|FG000|Overall Study|Death|1|||
33606871|NCT02345330|102111572|FG000|Overall Study|Progressive Disease|2|||
33606872|NCT03836677|102111573|FG000|Period 1|Adverse Event|0|||
33199221|NCT02139644|100633763|FG003|Treatment Period|Lack of Efficacy|0|||
33199222|NCT02139644|100633764|FG004|Treatment Period|Lack of Efficacy|1|||
33199223|NCT02139644|100633765|FG005|Treatment Period|Lack of Efficacy|4|||
33199224|NCT02139644|100633760|FG000|Treatment Period|Other|0|||
33199225|NCT02139644|100633761|FG001|Treatment Period|Other|3|||
33199226|NCT02139644|100633762|FG002|Treatment Period|Other|1|||
33199227|NCT02139644|100633763|FG003|Treatment Period|Other|1|||
33199228|NCT02139644|100633764|FG004|Treatment Period|Other|0|||
33199229|NCT02139644|100633765|FG005|Treatment Period|Other|1|||
33199230|NCT00047463|100633766|FG000|Overall Study|Withdrawal by Subject|0|||
33199231|NCT00047463|100633767|FG001|Overall Study|Withdrawal by Subject|3|||
33199232|NCT02554773|100633771|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
33199233|NCT02554773|100633772|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
33199234|NCT02554773|100633771|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
33199235|NCT02554773|100633772|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
33199236|NCT02554773|100633771|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
33199237|NCT02554773|100633772|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
33199238|NCT02554773|100633771|FG000|Original Dose Regimen (SAS 1)|Death|1|||
33199239|NCT02554773|100633772|FG001|Original Dose Regimen (SAS 1)|Death|0|||
33199240|NCT02554773|100633771|FG000|Original Dose Regimen (SAS 1)|Other|4|||
33199241|NCT02554773|100633772|FG001|Original Dose Regimen (SAS 1)|Other|0|||
33199242|NCT02554773|100633771|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
33199243|NCT02554773|100633772|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
33199244|NCT02554773|100633771|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
33199245|NCT02554773|100633772|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
33199246|NCT02554773|100633771|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
33199247|NCT02554773|100633772|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
33199248|NCT02554773|100633771|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
33199249|NCT02554773|100633772|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
33199250|NCT00359762|100633773|FG000|Period II|Adverse Event|17|||
33199251|NCT00359762|100633774|FG001|Period II|Adverse Event|0|||
33199252|NCT00359762|100633775|FG002|Period II|Adverse Event|0|||
33199253|NCT00359762|100633776|FG003|Period II|Adverse Event|0|||
33199254|NCT00359762|100633777|FG004|Period II|Adverse Event|49|||
33199255|NCT00359762|100633773|FG000|Period II|Protocol Violation|18|||
33199256|NCT00359762|100633774|FG001|Period II|Protocol Violation|0|||
33199257|NCT00359762|100633775|FG002|Period II|Protocol Violation|0|||
33199258|NCT00359762|100633776|FG003|Period II|Protocol Violation|0|||
33199259|NCT00359762|100633777|FG004|Period II|Protocol Violation|11|||
33199260|NCT00359762|100633773|FG000|Period II|Physician Decision|17|||
33199261|NCT00359762|100633774|FG001|Period II|Physician Decision|0|||
33199262|NCT00359762|100633775|FG002|Period II|Physician Decision|0|||
33199263|NCT00359762|100633776|FG003|Period II|Physician Decision|0|||
33199264|NCT00359762|100633777|FG004|Period II|Physician Decision|23|||
33199265|NCT00359762|100633773|FG000|Period II|Death|2|||
33199266|NCT00359762|100633774|FG001|Period II|Death|0|||
33514480|NCT01482962|101779807|FG000|Overall Study|Did not Receive Study Drug|1|||
33514481|NCT01482962|101779808|FG001|Overall Study|Did not Receive Study Drug|6|||
33514482|NCT03419598|101779813|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
33514483|NCT01573767|101779814|FG000|Overall Study|Adverse Event|0|||
33514484|NCT01573767|101779815|FG001|Overall Study|Adverse Event|1|||
33606873|NCT03836677|102111574|FG001|Period 1|Adverse Event|1|||
33514485|NCT01573767|101779816|FG002|Overall Study|Adverse Event|0|||
33514486|NCT01573767|101779817|FG003|Overall Study|Adverse Event|1|||
33514487|NCT01573767|101779814|FG000|Overall Study|Lack of Efficacy|18|||
33514488|NCT01573767|101779815|FG001|Overall Study|Lack of Efficacy|15|||
33514489|NCT01573767|101779816|FG002|Overall Study|Lack of Efficacy|12|||
33199267|NCT00359762|100633775|FG002|Period II|Death|0|||
33199268|NCT00359762|100633776|FG003|Period II|Death|0|||
33199269|NCT00359762|100633777|FG004|Period II|Death|4|||
33199270|NCT00359762|100633773|FG000|Period II|Lack of Efficacy|11|||
33514490|NCT01573767|101779817|FG003|Overall Study|Lack of Efficacy|17|||
33514491|NCT01573767|101779814|FG000|Overall Study|Protocol Violation|3|||
33514492|NCT01573767|101779815|FG001|Overall Study|Protocol Violation|1|||
33199271|NCT00359762|100633774|FG001|Period II|Lack of Efficacy|0|||
33199272|NCT00359762|100633775|FG002|Period II|Lack of Efficacy|0|||
33199273|NCT00359762|100633776|FG003|Period II|Lack of Efficacy|0|||
33199274|NCT00359762|100633777|FG004|Period II|Lack of Efficacy|8|||
33514493|NCT01573767|101779816|FG002|Overall Study|Protocol Violation|1|||
33514494|NCT01573767|101779817|FG003|Overall Study|Protocol Violation|3|||
33514495|NCT01573767|101779814|FG000|Overall Study|Lost to Follow-up|0|||
33514496|NCT01573767|101779815|FG001|Overall Study|Lost to Follow-up|1|||
33514497|NCT01573767|101779816|FG002|Overall Study|Lost to Follow-up|1|||
33514498|NCT01573767|101779817|FG003|Overall Study|Lost to Follow-up|1|||
33606874|NCT03836677|102111573|FG000|Period 2|Severe non-compliance to protocol|1|||
33606875|NCT03836677|102111574|FG001|Period 2|Severe non-compliance to protocol|0|||
33606876|NCT00129467|102111576|FG000|Received Intervention|Death|1|||
33606877|NCT00129467|102111577|FG001|Received Intervention|Death|1|||
33606878|NCT00129467|102111576|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
33606879|NCT00129467|102111577|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
33606880|NCT00129467|102111576|FG000|Received Intervention|Delirium|2|||
33606881|NCT00129467|102111577|FG001|Received Intervention|Delirium|0|||
33199275|NCT00359762|100633773|FG000|Period II|Lost to follow up|5|||
33199276|NCT00359762|100633774|FG001|Period II|Lost to follow up|0|||
33199277|NCT00359762|100633775|FG002|Period II|Lost to follow up|0|||
33199278|NCT00359762|100633776|FG003|Period II|Lost to follow up|0|||
33199279|NCT00359762|100633777|FG004|Period II|Lost to follow up|5|||
33199280|NCT00359762|100633773|FG000|Period II|Entry Criteria Not Met|8|||
33199281|NCT00359762|100633774|FG001|Period II|Entry Criteria Not Met|0|||
33199282|NCT00359762|100633775|FG002|Period II|Entry Criteria Not Met|0|||
33199283|NCT00359762|100633776|FG003|Period II|Entry Criteria Not Met|0|||
33199284|NCT00359762|100633777|FG004|Period II|Entry Criteria Not Met|4|||
33199285|NCT00359762|100633773|FG000|Period II|Subject Decision|50|||
33199286|NCT00359762|100633774|FG001|Period II|Subject Decision|0|||
33199287|NCT00359762|100633775|FG002|Period II|Subject Decision|0|||
33199288|NCT00359762|100633776|FG003|Period II|Subject Decision|0|||
33199289|NCT00359762|100633777|FG004|Period II|Subject Decision|70|||
33199290|NCT00359762|100633773|FG000|Period III|Protocol Violation|0|||
33199291|NCT00359762|100633774|FG001|Period III|Protocol Violation|5|||
33199292|NCT00359762|100633775|FG002|Period III|Protocol Violation|3|||
33199293|NCT00359762|100633776|FG003|Period III|Protocol Violation|8|||
33199294|NCT00359762|100633777|FG004|Period III|Protocol Violation|0|||
33199295|NCT00359762|100633773|FG000|Period III|Adverse Event|0|||
33199296|NCT00359762|100633774|FG001|Period III|Adverse Event|3|||
33199297|NCT00359762|100633775|FG002|Period III|Adverse Event|4|||
33199298|NCT00359762|100633776|FG003|Period III|Adverse Event|10|||
33199299|NCT00359762|100633777|FG004|Period III|Adverse Event|0|||
33199300|NCT00359762|100633773|FG000|Period III|Physician Decision|0|||
33199301|NCT00359762|100633774|FG001|Period III|Physician Decision|5|||
33199302|NCT00359762|100633775|FG002|Period III|Physician Decision|9|||
33199303|NCT00359762|100633776|FG003|Period III|Physician Decision|15|||
33199304|NCT00359762|100633777|FG004|Period III|Physician Decision|0|||
33199305|NCT00359762|100633773|FG000|Period III|Lack of Efficacy|0|||
33199306|NCT00359762|100633774|FG001|Period III|Lack of Efficacy|7|||
33199307|NCT00359762|100633775|FG002|Period III|Lack of Efficacy|5|||
33199308|NCT00359762|100633776|FG003|Period III|Lack of Efficacy|9|||
33199309|NCT00359762|100633777|FG004|Period III|Lack of Efficacy|0|||
33199310|NCT00359762|100633773|FG000|Period III|Lost to follow up|0|||
33199311|NCT00359762|100633774|FG001|Period III|Lost to follow up|1|||
33199312|NCT00359762|100633775|FG002|Period III|Lost to follow up|1|||
33199313|NCT00359762|100633776|FG003|Period III|Lost to follow up|2|||
33199314|NCT00359762|100633777|FG004|Period III|Lost to follow up|0|||
33199315|NCT00359762|100633773|FG000|Period III|Entry Criteria Not Met|0|||
33199316|NCT00359762|100633774|FG001|Period III|Entry Criteria Not Met|1|||
33199317|NCT00359762|100633775|FG002|Period III|Entry Criteria Not Met|0|||
33199318|NCT00359762|100633776|FG003|Period III|Entry Criteria Not Met|1|||
33199319|NCT00359762|100633777|FG004|Period III|Entry Criteria Not Met|0|||
33199320|NCT00359762|100633773|FG000|Period III|Subject Decision|0|||
33199321|NCT00359762|100633774|FG001|Period III|Subject Decision|7|||
33199322|NCT00359762|100633775|FG002|Period III|Subject Decision|8|||
33199323|NCT00359762|100633776|FG003|Period III|Subject Decision|20|||
33199324|NCT00359762|100633777|FG004|Period III|Subject Decision|0|||
33199325|NCT03864614|100633778|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
33199326|NCT03864614|100633779|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
33199327|NCT03864614|100633780|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
33199328|NCT03864614|100633781|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
33325404|NCT00467779|101088049|FG000|Stage 1|Disease Progression|2|||
33325405|NCT00467779|101088050|FG001|Stage 1|Disease Progression|2|||
33606882|NCT00129467|102111576|FG000|Received Intervention|Withdrawal by Subject|1|||
33606883|NCT00129467|102111577|FG001|Received Intervention|Withdrawal by Subject|0|||
33325406|NCT00467779|101088051|FG002|Stage 1|Disease Progression|2|||
33325407|NCT00467779|101088052|FG003|Stage 1|Disease Progression|3|||
33199329|NCT03864614|100633778|FG000|Overall Study|Withdrawal by Subject|72|||
33199330|NCT03864614|100633779|FG001|Overall Study|Withdrawal by Subject|100|||
33199331|NCT03864614|100633780|FG002|Overall Study|Withdrawal by Subject|1|||
33199332|NCT03864614|100633781|FG003|Overall Study|Withdrawal by Subject|21|||
33199333|NCT03864614|100633778|FG000|Overall Study|Lost to Follow-up|45|||
33199334|NCT03864614|100633779|FG001|Overall Study|Lost to Follow-up|54|||
33199335|NCT03864614|100633780|FG002|Overall Study|Lost to Follow-up|0|||
33199336|NCT03864614|100633781|FG003|Overall Study|Lost to Follow-up|9|||
33199337|NCT03864614|100633778|FG000|Overall Study|Adverse Event|42|||
33199338|NCT03864614|100633779|FG001|Overall Study|Adverse Event|30|||
33199339|NCT03864614|100633780|FG002|Overall Study|Adverse Event|1|||
33199340|NCT03864614|100633781|FG003|Overall Study|Adverse Event|9|||
33199341|NCT03864614|100633778|FG000|Overall Study|Protocol Deviation|6|||
33199342|NCT03864614|100633779|FG001|Overall Study|Protocol Deviation|26|||
33199343|NCT03864614|100633780|FG002|Overall Study|Protocol Deviation|0|||
33199344|NCT03864614|100633781|FG003|Overall Study|Protocol Deviation|1|||
33199345|NCT03864614|100633778|FG000|Overall Study|Physician Decision|7|||
33199346|NCT03864614|100633779|FG001|Overall Study|Physician Decision|10|||
33199347|NCT03864614|100633780|FG002|Overall Study|Physician Decision|1|||
33199348|NCT03864614|100633781|FG003|Overall Study|Physician Decision|5|||
33199349|NCT03864614|100633778|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
33199350|NCT03864614|100633779|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
33199351|NCT03864614|100633780|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
33199352|NCT03864614|100633781|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
33199353|NCT03864614|100633778|FG000|Overall Study|Sponsor Decision|1|||
33199354|NCT03864614|100633779|FG001|Overall Study|Sponsor Decision|2|||
33199355|NCT03864614|100633780|FG002|Overall Study|Sponsor Decision|0|||
33199356|NCT03864614|100633781|FG003|Overall Study|Sponsor Decision|0|||
33199357|NCT03864614|100633778|FG000|Overall Study|Pregnancy|0|||
33199358|NCT03864614|100633779|FG001|Overall Study|Pregnancy|1|||
33199359|NCT03864614|100633780|FG002|Overall Study|Pregnancy|0|||
33199360|NCT03864614|100633781|FG003|Overall Study|Pregnancy|0|||
33199361|NCT03864614|100633778|FG000|Overall Study|Other|7|||
33199362|NCT03864614|100633779|FG001|Overall Study|Other|9|||
33199363|NCT03864614|100633780|FG002|Overall Study|Other|1|||
33199364|NCT03864614|100633781|FG003|Overall Study|Other|4|||
33199365|NCT03864614|100633778|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
33199366|NCT03864614|100633779|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
33199367|NCT03864614|100633780|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
33199368|NCT03864614|100633781|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
33199369|NCT02742103|100633782|FG000|Overall Study|Protocol Violation|1|||
33199370|NCT02742103|100633783|FG001|Overall Study|Protocol Violation|0|||
33199371|NCT02742103|100633782|FG000|Overall Study|Death|2|||
33199372|NCT02742103|100633783|FG001|Overall Study|Death|2|||
33199373|NCT02742103|100633782|FG000|Overall Study|Adverse Event|1|||
33199374|NCT02742103|100633783|FG001|Overall Study|Adverse Event|0|||
33199375|NCT02742103|100633782|FG000|Overall Study|Moved to another town|0|||
33199376|NCT02742103|100633783|FG001|Overall Study|Moved to another town|1|||
33199377|NCT02742103|100633782|FG000|Overall Study|Withdrawal by Subject|5|||
33199378|NCT02742103|100633783|FG001|Overall Study|Withdrawal by Subject|2|||
33199379|NCT01459796|100633786|FG000|Overall Study|Non compliance with protocol|2|||
33199380|NCT01459796|100633787|FG001|Overall Study|Non compliance with protocol|4|||
33199381|NCT01459796|100633786|FG000|Overall Study|Adverse Event|5|||
33199382|NCT01459796|100633787|FG001|Overall Study|Adverse Event|5|||
33199383|NCT01459796|100633786|FG000|Overall Study|Withdrawal by Subject|6|||
33199384|NCT01459796|100633787|FG001|Overall Study|Withdrawal by Subject|3|||
33199385|NCT01459796|100633786|FG000|Overall Study|Lost to Follow-up|5|||
33199386|NCT01459796|100633787|FG001|Overall Study|Lost to Follow-up|4|||
33199387|NCT01459796|100633786|FG000|Overall Study|Reason unspecified|1|||
33199388|NCT01459796|100633787|FG001|Overall Study|Reason unspecified|2|||
33199389|NCT01459796|100633786|FG000|Overall Study|Decision by the sponsor|75|||
33199390|NCT01459796|100633787|FG001|Overall Study|Decision by the sponsor|108|||
33199391|NCT00612066|100633788|FG000|Overall Study|Adverse Event|1|||
33199392|NCT01639001|100633789|FG000|Overall Study|Refused further follow-up|9|||
33199393|NCT01639001|100633790|FG001|Overall Study|Refused further follow-up|12|||
33199394|NCT01639001|100633789|FG000|Overall Study|Lost to Follow-up|3|||
33199395|NCT01639001|100633790|FG001|Overall Study|Lost to Follow-up|0|||
33199396|NCT01639001|100633789|FG000|Overall Study|Death|62|||
33199397|NCT01639001|100633790|FG001|Overall Study|Death|61|||
33199398|NCT01639001|100633789|FG000|Overall Study|Randomized but not treated|0|||
33199399|NCT01639001|100633790|FG001|Overall Study|Randomized but not treated|2|||
33199400|NCT01639001|100633789|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
33199401|NCT01639001|100633790|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
33199402|NCT01075321|100633792|FG000|Overall Study|Withdrawal by Subject|0|||
33325408|NCT00467779|101088053|FG004|Stage 1|Disease Progression|2|||
33325409|NCT00467779|101088054|FG005|Stage 1|Disease Progression|2|||
33325410|NCT00467779|101088055|FG006|Stage 1|Disease Progression|4|||
33325411|NCT00467779|101088056|FG007|Stage 1|Disease Progression|5|||
33199403|NCT01075321|100633793|FG001|Overall Study|Withdrawal by Subject|0|||
33199404|NCT01075321|100633794|FG002|Overall Study|Withdrawal by Subject|1|||
33199405|NCT01075321|100633795|FG003|Overall Study|Withdrawal by Subject|1|||
33199406|NCT01075321|100633792|FG000|Overall Study|Protocol Violation|0|||
33325412|NCT00467779|101088057|FG008|Stage 1|Disease Progression|0|||
33199407|NCT01075321|100633793|FG001|Overall Study|Protocol Violation|0|||
33199408|NCT01075321|100633794|FG002|Overall Study|Protocol Violation|1|||
33199409|NCT01075321|100633795|FG003|Overall Study|Protocol Violation|0|||
33199410|NCT01075321|100633792|FG000|Overall Study|Treatment Incomplete due to progression|1|||
33199411|NCT01075321|100633793|FG001|Overall Study|Treatment Incomplete due to progression|0|||
33325413|NCT00467779|101088058|FG009|Stage 1|Disease Progression|0|||
33199412|NCT01075321|100633794|FG002|Overall Study|Treatment Incomplete due to progression|0|||
33399604|NCT00256204|101350269|FG002|Overall Study|Lost to Follow-up|1|||
33399605|NCT00256204|101350270|FG003|Overall Study|Lost to Follow-up|2|||
33399606|NCT00256204|101350267|FG000|Overall Study|Protocol Violation|1|||
33399607|NCT00256204|101350268|FG001|Overall Study|Protocol Violation|0|||
33399608|NCT00256204|101350269|FG002|Overall Study|Protocol Violation|2|||
33399609|NCT00256204|101350270|FG003|Overall Study|Protocol Violation|1|||
33514499|NCT01573767|101779814|FG000|Overall Study|Physician Decision|1|||
33514500|NCT01573767|101779815|FG001|Overall Study|Physician Decision|2|||
33514501|NCT01573767|101779816|FG002|Overall Study|Physician Decision|0|||
33514502|NCT01573767|101779817|FG003|Overall Study|Physician Decision|2|||
33514503|NCT01573767|101779814|FG000|Overall Study|Withdrawal by Subject|0|||
33514504|NCT01573767|101779815|FG001|Overall Study|Withdrawal by Subject|1|||
33514505|NCT01573767|101779816|FG002|Overall Study|Withdrawal by Subject|0|||
33514506|NCT01573767|101779817|FG003|Overall Study|Withdrawal by Subject|0|||
33514507|NCT02044874|101779827|FG000|Overall Study|Adverse Event|5|||
33514508|NCT02044874|101779828|FG001|Overall Study|Adverse Event|6|||
33514509|NCT02044874|101779829|FG002|Overall Study|Adverse Event|6|||
33514510|NCT02044874|101779827|FG000|Overall Study|Withdrawal by Subject|8|||
33514511|NCT02044874|101779828|FG001|Overall Study|Withdrawal by Subject|16|||
33514512|NCT02044874|101779829|FG002|Overall Study|Withdrawal by Subject|23|||
33514513|NCT02044874|101779827|FG000|Overall Study|Physician Decision|0|||
33514514|NCT02044874|101779828|FG001|Overall Study|Physician Decision|2|||
33514515|NCT02044874|101779829|FG002|Overall Study|Physician Decision|1|||
33514516|NCT02044874|101779827|FG000|Overall Study|Lost to Follow-up|10|||
33514517|NCT02044874|101779828|FG001|Overall Study|Lost to Follow-up|27|||
33514518|NCT02044874|101779829|FG002|Overall Study|Lost to Follow-up|21|||
33514519|NCT02044874|101779827|FG000|Overall Study|Sponsor Decision|0|||
33514520|NCT02044874|101779828|FG001|Overall Study|Sponsor Decision|1|||
33514521|NCT02044874|101779829|FG002|Overall Study|Sponsor Decision|1|||
33514522|NCT02044874|101779827|FG000|Overall Study|Other|7|||
33514523|NCT02044874|101779828|FG001|Overall Study|Other|3|||
33514524|NCT02044874|101779829|FG002|Overall Study|Other|8|||
33514525|NCT02267135|101779830|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
33514526|NCT02267135|101779831|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
33514527|NCT02267135|101779830|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
33514528|NCT02267135|101779831|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
33514529|NCT02267135|101779830|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
33514530|NCT02267135|101779831|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
33514531|NCT02267135|101779830|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
33514532|NCT02267135|101779831|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
33606884|NCT00129467|102111576|FG000|Received Intervention|Nausea|1|||
33514533|NCT02267135|101779830|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
33199413|NCT01075321|100633795|FG003|Overall Study|Treatment Incomplete due to progression|0|||
33399610|NCT00256204|101350267|FG000|Overall Study|Physician Decision|0|||
33514534|NCT02267135|101779831|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
33514535|NCT00084318|101779833|FG000|Overall Study|Withdrawal by Subject|5|||
33514536|NCT00084318|101779834|FG001|Overall Study|Withdrawal by Subject|2|||
33514537|NCT00084318|101779833|FG000|Overall Study|Protocol Violation|15|||
33514538|NCT00084318|101779834|FG001|Overall Study|Protocol Violation|11|||
33514539|NCT00084318|101779833|FG000|Overall Study|No protocol treatment|2|||
33514540|NCT00084318|101779834|FG001|Overall Study|No protocol treatment|0|||
33514541|NCT04416737|101779839|FG000|Week 1 (First Injection)|Physician Decision|0|||
33514542|NCT04416737|101779840|FG001|Week 1 (First Injection)|Physician Decision|1|||
33514543|NCT01322035|101779841|FG000|Overall Study|Lost to Follow-up|8|||
33514544|NCT01322035|101779842|FG001|Overall Study|Lost to Follow-up|3|||
33514545|NCT03191864|101779844|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
33514546|NCT03191864|101779845|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
33514547|NCT03191864|101779846|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
33514548|NCT03191864|101779847|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
33514549|NCT03191864|101779848|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
33514550|NCT03191864|101779849|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
33514551|NCT03191864|101779844|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
33514552|NCT03191864|101779845|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
33514553|NCT03191864|101779846|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
33514554|NCT03191864|101779847|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
33514555|NCT03191864|101779848|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
33514556|NCT03191864|101779849|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
33514557|NCT03191864|101779844|FG000|Baseline Symptom Assessment|Adverse Event|0|||
33514558|NCT03191864|101779845|FG001|Baseline Symptom Assessment|Adverse Event|0|||
33514559|NCT03191864|101779846|FG002|Baseline Symptom Assessment|Adverse Event|0|||
33514560|NCT03191864|101779847|FG003|Baseline Symptom Assessment|Adverse Event|0|||
33514561|NCT03191864|101779848|FG004|Baseline Symptom Assessment|Adverse Event|0|||
33514562|NCT03191864|101779849|FG005|Baseline Symptom Assessment|Adverse Event|2|||
33514563|NCT03191864|101779844|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
33514564|NCT03191864|101779845|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
33514565|NCT03191864|101779846|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
33514566|NCT03191864|101779847|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
33514567|NCT03191864|101779848|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
33514568|NCT03191864|101779849|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
33514569|NCT03191864|101779844|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
33514570|NCT03191864|101779845|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
33514571|NCT03191864|101779846|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
33514572|NCT03191864|101779847|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
33514573|NCT03191864|101779848|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
33514574|NCT03191864|101779849|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
33514575|NCT03191864|101779844|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
33514576|NCT03191864|101779845|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
33514577|NCT03191864|101779846|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
33514578|NCT03191864|101779847|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
33514579|NCT03191864|101779848|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
33514580|NCT03191864|101779849|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
33514581|NCT03191864|101779844|FG000|Part 1 - Induction|Adverse Event|0|||
33514582|NCT03191864|101779845|FG001|Part 1 - Induction|Adverse Event|2|||
33199414|NCT01075321|100633792|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
33199415|NCT01075321|100633793|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
33199416|NCT01075321|100633794|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
33199417|NCT01075321|100633795|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
33199418|NCT03219333|100633796|FG000|Overall Study|Withdrawal by Subject|9|||
33199419|NCT03219333|100633797|FG001|Overall Study|Withdrawal by Subject|4|||
33199420|NCT03219333|100633796|FG000|Overall Study|Lost to Follow-up|1|||
33514583|NCT03191864|101779846|FG002|Part 1 - Induction|Adverse Event|0|||
33514584|NCT03191864|101779847|FG003|Part 1 - Induction|Adverse Event|1|||
33514585|NCT03191864|101779848|FG004|Part 1 - Induction|Adverse Event|0|||
33514586|NCT03191864|101779849|FG005|Part 1 - Induction|Adverse Event|2|||
33514587|NCT03191864|101779844|FG000|Part 1 - Induction|Randomized but never dosed|0|||
33514588|NCT03191864|101779845|FG001|Part 1 - Induction|Randomized but never dosed|0|||
33514589|NCT03191864|101779846|FG002|Part 1 - Induction|Randomized but never dosed|1|||
33514590|NCT03191864|101779847|FG003|Part 1 - Induction|Randomized but never dosed|0|||
33514591|NCT03191864|101779848|FG004|Part 1 - Induction|Randomized but never dosed|0|||
33514592|NCT03191864|101779849|FG005|Part 1 - Induction|Randomized but never dosed|0|||
33514593|NCT03191864|101779844|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
33514594|NCT03191864|101779845|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
33514595|NCT03191864|101779846|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
33514596|NCT03191864|101779847|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
33514597|NCT03191864|101779848|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
33514598|NCT03191864|101779849|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
33514599|NCT03191864|101779844|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
33514600|NCT03191864|101779845|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
33514601|NCT03191864|101779846|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
33606885|NCT00129467|102111577|FG001|Received Intervention|Nausea|0|||
33606886|NCT00129467|102111576|FG000|Received Intervention|Intolerance to citalopram|0|||
33606887|NCT00129467|102111577|FG001|Received Intervention|Intolerance to citalopram|1|||
33606888|NCT00129467|102111576|FG000|Received Intervention|Dizzyness, fatigue|0|||
33606889|NCT00129467|102111577|FG001|Received Intervention|Dizzyness, fatigue|1|||
33606890|NCT00129467|102111576|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
33606891|NCT00129467|102111577|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
33606892|NCT00129467|102111576|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
33606893|NCT00129467|102111577|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
33606894|NCT02895945|102111580|FG000|Overall Study|Physician Decision|2|||
33606895|NCT02895945|102111581|FG001|Overall Study|Physician Decision|1|||
33606896|NCT01147848|102111582|FG000|Run-in Period|Screen Failure|623|||
33606897|NCT01147848|102111583|FG001|Run-in Period|Screen Failure|0|||
33606898|NCT01147848|102111584|FG002|Run-in Period|Screen Failure|0|||
33606899|NCT01147848|102111582|FG000|Run-in Period|Run-in Failure|135|||
33325414|NCT00467779|101088059|FG010|Stage 1|Disease Progression|0|||
33325415|NCT00467779|101088060|FG011|Stage 1|Disease Progression|0|||
33325416|NCT00467779|101088061|FG012|Stage 1|Disease Progression|0|||
33514602|NCT03191864|101779847|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
33514603|NCT03191864|101779848|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
33514604|NCT03191864|101779849|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
33514605|NCT03191864|101779844|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
33514606|NCT03191864|101779845|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
33514607|NCT03191864|101779846|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
33514608|NCT03191864|101779847|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
33514609|NCT03191864|101779848|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
33514610|NCT03191864|101779849|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
33514611|NCT03191864|101779844|FG000|Part 2 - Maintenance|Physician Decision|1|||
33514612|NCT03191864|101779845|FG001|Part 2 - Maintenance|Physician Decision|0|||
33514613|NCT03191864|101779846|FG002|Part 2 - Maintenance|Physician Decision|0|||
33514614|NCT03191864|101779847|FG003|Part 2 - Maintenance|Physician Decision|0|||
33514615|NCT03191864|101779848|FG004|Part 2 - Maintenance|Physician Decision|0|||
33514616|NCT03191864|101779849|FG005|Part 2 - Maintenance|Physician Decision|0|||
33514617|NCT03191864|101779844|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
33514618|NCT03191864|101779845|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
33514619|NCT03191864|101779846|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
33514620|NCT03191864|101779847|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
33514621|NCT03191864|101779848|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
33514622|NCT03191864|101779849|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
33514623|NCT03191864|101779844|FG000|Part 2 - Maintenance|Adverse Event|0|||
33514624|NCT03191864|101779845|FG001|Part 2 - Maintenance|Adverse Event|0|||
33514625|NCT03191864|101779846|FG002|Part 2 - Maintenance|Adverse Event|0|||
33514626|NCT03191864|101779847|FG003|Part 2 - Maintenance|Adverse Event|0|||
33514627|NCT03191864|101779848|FG004|Part 2 - Maintenance|Adverse Event|1|||
33514628|NCT03191864|101779849|FG005|Part 2 - Maintenance|Adverse Event|0|||
33514629|NCT03191864|101779844|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
33399611|NCT00256204|101350268|FG001|Overall Study|Physician Decision|0|||
33514630|NCT03191864|101779845|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
33514631|NCT03191864|101779846|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
33514632|NCT03191864|101779847|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
33514633|NCT03191864|101779848|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
33514634|NCT03191864|101779849|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
33325417|NCT00467779|101088062|FG013|Stage 1|Disease Progression|0|||
33514635|NCT03191864|101779844|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
33514636|NCT03191864|101779845|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
33514637|NCT03191864|101779846|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
33514638|NCT03191864|101779847|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
33514639|NCT03191864|101779848|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
33514640|NCT03191864|101779849|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
33514641|NCT00894790|101779853|FG000|Overall Study|Protocol Violation|0|||
33514642|NCT00894790|101779854|FG001|Overall Study|Protocol Violation|1|||
33514643|NCT00894790|101779853|FG000|Overall Study|Lost to Follow-up|0|||
33514644|NCT00894790|101779854|FG001|Overall Study|Lost to Follow-up|1|||
33514645|NCT00894790|101779853|FG000|Overall Study|Did not meet entrance criteria|1|||
33514646|NCT00894790|101779854|FG001|Overall Study|Did not meet entrance criteria|0|||
33514647|NCT01793688|101779855|FG000|Overall Study|Protocol Violation|2|||
33514648|NCT01306045|101779856|FG000|Met General Eligibility Criteria|Screen failures|193|||
33514649|NCT01306045|101779857|FG001|Met General Eligibility Criteria|Screen failures|11|||
33514650|NCT01306045|101779858|FG002|Met General Eligibility Criteria|Screen failures|8|||
33514651|NCT00094536|101779860|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
33514652|NCT00094536|101779860|FG000|Treatment and Follow-up|Adverse Event|4|||
33514653|NCT00094536|101779860|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
33514654|NCT00094536|101779860|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
33514655|NCT00094536|101779860|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
33514656|NCT00094536|101779860|FG000|Treatment and Follow-up|Subject non-compliance|9|||
33199421|NCT03219333|100633797|FG001|Overall Study|Lost to Follow-up|1|||
33199422|NCT03219333|100633796|FG000|Overall Study|Death|104|||
33199423|NCT03219333|100633797|FG001|Overall Study|Death|72|||
33399612|NCT00256204|101350269|FG002|Overall Study|Physician Decision|1|||
33399613|NCT00256204|101350270|FG003|Overall Study|Physician Decision|2|||
33399614|NCT00256204|101350267|FG000|Overall Study|Withdrawal by Subject|17|||
33399615|NCT00256204|101350268|FG001|Overall Study|Withdrawal by Subject|6|||
33399616|NCT00256204|101350269|FG002|Overall Study|Withdrawal by Subject|7|||
33399617|NCT00256204|101350270|FG003|Overall Study|Withdrawal by Subject|5|||
33399618|NCT00256204|101350267|FG000|Overall Study|Need for additional prohibited treatment|38|||
33399619|NCT00256204|101350268|FG001|Overall Study|Need for additional prohibited treatment|28|||
33399620|NCT00256204|101350269|FG002|Overall Study|Need for additional prohibited treatment|27|||
33399621|NCT00256204|101350270|FG003|Overall Study|Need for additional prohibited treatment|25|||
33399622|NCT03323385|101350271|FG000|Overall Study|Withdrawal by Subject|1|||
33399623|NCT03323385|101350272|FG001|Overall Study|Withdrawal by Subject|2|||
33399624|NCT03323385|101350271|FG000|Overall Study|Noncompliance|0|||
33399625|NCT03323385|101350272|FG001|Overall Study|Noncompliance|1|||
33399626|NCT04397757|101350275|FG000|Overall Study|Death|3|||
33399627|NCT04397757|101350276|FG001|Overall Study|Death|11|||
33399628|NCT04397757|101350275|FG000|Overall Study|Withdrawal by Subject|2|||
33399629|NCT04397757|101350276|FG001|Overall Study|Withdrawal by Subject|0|||
33399630|NCT04397757|101350275|FG000|Overall Study|Lost to Follow-up|4|||
33399631|NCT04397757|101350276|FG001|Overall Study|Lost to Follow-up|3|||
33399632|NCT03512028|101350277|FG000|Overall Study|Withdrawal by Subject|2|||
33399633|NCT03512028|101350278|FG001|Overall Study|Withdrawal by Subject|0|||
33399634|NCT03512028|101350277|FG000|Overall Study|Protocol Violation|2|||
33399635|NCT03512028|101350278|FG001|Overall Study|Protocol Violation|0|||
33399636|NCT01882439|101350288|FG000|Overall Study|Adverse event related to study drug|3|||
33399637|NCT01882439|101350289|FG001|Overall Study|Adverse event related to study drug|8|||
33399638|NCT01882439|101350290|FG002|Overall Study|Adverse event related to study drug|1|||
33399639|NCT01882439|101350291|FG003|Overall Study|Adverse event related to study drug|2|||
33399640|NCT01882439|101350288|FG000|Overall Study|Pregnancy|0|||
33399641|NCT01882439|101350289|FG001|Overall Study|Pregnancy|1|||
33399642|NCT01882439|101350290|FG002|Overall Study|Pregnancy|0|||
33399643|NCT01882439|101350291|FG003|Overall Study|Pregnancy|0|||
33399644|NCT01882439|101350288|FG000|Overall Study|Protocol Violation|2|||
33399645|NCT01882439|101350289|FG001|Overall Study|Protocol Violation|2|||
33399646|NCT01882439|101350290|FG002|Overall Study|Protocol Violation|0|||
33399647|NCT01882439|101350291|FG003|Overall Study|Protocol Violation|1|||
33399648|NCT01882439|101350288|FG000|Overall Study|No longer willing to participate|1|||
33399649|NCT01882439|101350289|FG001|Overall Study|No longer willing to participate|4|||
33399650|NCT01882439|101350290|FG002|Overall Study|No longer willing to participate|2|||
33399651|NCT01882439|101350291|FG003|Overall Study|No longer willing to participate|3|||
33399652|NCT01882439|101350288|FG000|Overall Study|Medication error with no associated AE|0|||
33399653|NCT01882439|101350289|FG001|Overall Study|Medication error with no associated AE|0|||
33514657|NCT00094536|101779860|FG000|Treatment and Follow-up|Unable to attend visits|1|||
33514658|NCT05323994|101779861|FG000|Overall Study|Protocol Violation|1|||
33514659|NCT01286168|101779866|FG000|Overall Study|Withdrawal by Subject|1|||
33224365|NCT05044325|100721816|FG005|Part A:Treatment Period 1|Adverse Event|1|||
33399654|NCT01882439|101350290|FG002|Overall Study|Medication error with no associated AE|2|||
33399655|NCT01882439|101350291|FG003|Overall Study|Medication error with no associated AE|0|||
33199424|NCT03219333|100633796|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
33199425|NCT03219333|100633797|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
33199426|NCT03219333|100633796|FG000|Overall Study|Other|2|||
33199427|NCT03219333|100633797|FG001|Overall Study|Other|2|||
33199428|NCT04535037|100633798|FG000|Overall Study|Protocol Violation|1|||
33199429|NCT04535037|100633799|FG001|Overall Study|Protocol Violation|0|||
33199430|NCT04535037|100633798|FG000|Overall Study|Withdrawal by Subject|8|||
33199431|NCT04535037|100633799|FG001|Overall Study|Withdrawal by Subject|9|||
33199432|NCT04535037|100633798|FG000|Overall Study|Migrated / moved from the study area|1|||
33199433|NCT04535037|100633799|FG001|Overall Study|Migrated / moved from the study area|4|||
33199434|NCT04535037|100633798|FG000|Overall Study|Other|2|||
33199435|NCT04535037|100633799|FG001|Overall Study|Other|5|||
33199436|NCT00861341|100633800|FG000|Overall Study|Withdrawal by Subject|2|||
33199437|NCT03588572|100633801|FG000|Visitation 1|Lack of Efficacy|1|||
33199438|NCT03588572|100633802|FG001|Visitation 1|Lack of Efficacy|1|||
33199439|NCT03588572|100633801|FG000|Visitation 2|Lost to Follow-up|1|||
33199440|NCT03588572|100633802|FG001|Visitation 2|Lost to Follow-up|1|||
33199441|NCT03588572|100633801|FG000|Visitation 2|Lack of Efficacy|0|||
33199442|NCT03588572|100633802|FG001|Visitation 2|Lack of Efficacy|1|||
33199443|NCT03588572|100633801|FG000|Visitation 2|Withdrawal by Subject|1|||
33199444|NCT03588572|100633802|FG001|Visitation 2|Withdrawal by Subject|0|||
33199445|NCT03588572|100633801|FG000|Visitation 3|Lost to Follow-up|1|||
33199446|NCT03588572|100633802|FG001|Visitation 3|Lost to Follow-up|1|||
33199447|NCT03588572|100633801|FG000|Visitation 3|Physician Decision|1|||
33399656|NCT01882439|101350288|FG000|Overall Study|Insufficient clinical response|1|||
33399657|NCT01882439|101350289|FG001|Overall Study|Insufficient clinical response|4|||
33399658|NCT01882439|101350290|FG002|Overall Study|Insufficient clinical response|4|||
33399659|NCT01882439|101350291|FG003|Overall Study|Insufficient clinical response|2|||
33399660|NCT01882439|101350288|FG000|Overall Study|Adverse event unrelated to study drug|2|||
33399661|NCT01882439|101350289|FG001|Overall Study|Adverse event unrelated to study drug|2|||
33399662|NCT01882439|101350290|FG002|Overall Study|Adverse event unrelated to study drug|1|||
33399663|NCT01882439|101350291|FG003|Overall Study|Adverse event unrelated to study drug|1|||
33399664|NCT05643170|101350292|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
33399665|NCT05643170|101350292|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
33399666|NCT02061540|101350295|FG000|Overall Study|Adverse Event|2|||
33606900|NCT01147848|102111583|FG001|Run-in Period|Run-in Failure|0|||
33606901|NCT01147848|102111584|FG002|Run-in Period|Run-in Failure|0|||
33606902|NCT01147848|102111582|FG000|Randomized Phase|Adverse Event|0|||
33606903|NCT01147848|102111583|FG001|Randomized Phase|Adverse Event|6|||
33606904|NCT01147848|102111584|FG002|Randomized Phase|Adverse Event|8|||
33606905|NCT01147848|102111582|FG000|Randomized Phase|Lack of Efficacy|0|||
33606906|NCT01147848|102111583|FG001|Randomized Phase|Lack of Efficacy|20|||
33199448|NCT03588572|100633802|FG001|Visitation 3|Physician Decision|1|||
33199449|NCT03588572|100633801|FG000|Visitation 3|Withdrawal by Subject|1|||
33514660|NCT01286168|101779866|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
33514661|NCT00232596|101779872|FG000|6-Week Titration Phase|Adverse Event|6|||
33514662|NCT00232596|101779873|FG001|6-Week Titration Phase|Adverse Event|19|||
33514663|NCT00232596|101779872|FG000|6-Week Titration Phase|Failed to Return|2|||
33514664|NCT00232596|101779873|FG001|6-Week Titration Phase|Failed to Return|1|||
33514665|NCT00232596|101779872|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
33514666|NCT00232596|101779873|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
33514667|NCT00232596|101779872|FG000|6-Week Titration Phase|Protocol Violation|1|||
33199450|NCT03588572|100633802|FG001|Visitation 3|Withdrawal by Subject|0|||
33199451|NCT01358981|100633806|FG000|Period 1|Withdrawal by Subject|0|||
33199452|NCT01358981|100633807|FG001|Period 1|Withdrawal by Subject|0|||
33199453|NCT01358981|100633808|FG002|Period 1|Withdrawal by Subject|0|||
33199454|NCT01358981|100633809|FG003|Period 1|Withdrawal by Subject|1|||
33199455|NCT01358981|100633810|FG004|Period 1|Withdrawal by Subject|0|||
33199456|NCT01358981|100633811|FG005|Period 1|Withdrawal by Subject|0|||
33199457|NCT01358981|100633812|FG006|Period 1|Withdrawal by Subject|0|||
33199458|NCT02715765|100633819|FG000|Overall Study|Study Termination|3|||
33199459|NCT02715765|100633820|FG001|Overall Study|Study Termination|0|||
33514668|NCT00232596|101779873|FG001|6-Week Titration Phase|Protocol Violation|3|||
33514669|NCT00232596|101779872|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
33514670|NCT00232596|101779873|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
33514671|NCT00232596|101779872|FG000|6-Week Titration Phase|Other|3|||
33514672|NCT00232596|101779873|FG001|6-Week Titration Phase|Other|3|||
33514673|NCT00232596|101779872|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
33514674|NCT00232596|101779873|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
33514675|NCT00232596|101779872|FG000|12-Week Maintenance Phase|Adverse Event|7|||
33514676|NCT00232596|101779873|FG001|12-Week Maintenance Phase|Adverse Event|22|||
33514677|NCT00232596|101779872|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
33514678|NCT00232596|101779873|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
33514679|NCT00232596|101779872|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
33514680|NCT00232596|101779873|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
33514681|NCT00232596|101779872|FG000|12-Week Maintenance Phase|Other|1|||
33514682|NCT00232596|101779873|FG001|12-Week Maintenance Phase|Other|3|||
33514683|NCT04420585|101779874|FG000|Overall Study|Adverse Event|1|||
33514684|NCT04420585|101779874|FG000|Overall Study|Never initiated medication|2|||
33514685|NCT02035748|101779877|FG000|Overall Study|Adverse Event|5|||
33514686|NCT02035748|101779877|FG000|Overall Study|Death|3|||
33514687|NCT02035748|101779877|FG000|Overall Study|Lost to Follow-up|2|||
33514688|NCT02035748|101779877|FG000|Overall Study|Physician Decision|3|||
33514689|NCT02035748|101779877|FG000|Overall Study|Withdrawal by Subject|6|||
33514690|NCT02035748|101779877|FG000|Overall Study|Progressive Disease|1|||
33514691|NCT02079636|101779880|FG000|Overall Study|Death|2|||
33514692|NCT02079636|101779881|FG001|Overall Study|Death|1|||
33514693|NCT02079636|101779882|FG002|Overall Study|Death|0|||
33514694|NCT02079636|101779883|FG003|Overall Study|Death|5|||
33514695|NCT02079636|101779884|FG004|Overall Study|Death|1|||
33514696|NCT02079636|101779885|FG005|Overall Study|Death|2|||
33514697|NCT02079636|101779886|FG006|Overall Study|Death|1|||
33514698|NCT02079636|101779887|FG007|Overall Study|Death|0|||
33514699|NCT02079636|101779888|FG008|Overall Study|Death|0|||
33514700|NCT02079636|101779889|FG009|Overall Study|Death|0|||
33514701|NCT02079636|101779890|FG010|Overall Study|Death|0|||
33514702|NCT02079636|101779891|FG011|Overall Study|Death|1|||
33514703|NCT02079636|101779892|FG012|Overall Study|Death|1|||
33514704|NCT02079636|101779893|FG013|Overall Study|Death|0|||
33514705|NCT02079636|101779894|FG014|Overall Study|Death|2|||
33514706|NCT02079636|101779880|FG000|Overall Study|Adverse Event|1|||
33514707|NCT02079636|101779881|FG001|Overall Study|Adverse Event|1|||
33514708|NCT02079636|101779882|FG002|Overall Study|Adverse Event|0|||
33514709|NCT02079636|101779883|FG003|Overall Study|Adverse Event|1|||
33514710|NCT02079636|101779884|FG004|Overall Study|Adverse Event|1|||
33514711|NCT02079636|101779885|FG005|Overall Study|Adverse Event|2|||
33514712|NCT02079636|101779886|FG006|Overall Study|Adverse Event|0|||
33514713|NCT02079636|101779887|FG007|Overall Study|Adverse Event|0|||
33514714|NCT02079636|101779888|FG008|Overall Study|Adverse Event|0|||
33514715|NCT02079636|101779889|FG009|Overall Study|Adverse Event|0|||
33606907|NCT01147848|102111584|FG002|Randomized Phase|Lack of Efficacy|11|||
33199460|NCT02715765|100633821|FG002|Overall Study|Study Termination|0|||
33199461|NCT01826825|100633824|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
33325418|NCT00467779|101088063|FG014|Stage 1|Disease Progression|0|||
33514716|NCT02079636|101779890|FG010|Overall Study|Adverse Event|0|||
33514717|NCT02079636|101779891|FG011|Overall Study|Adverse Event|0|||
33514718|NCT02079636|101779892|FG012|Overall Study|Adverse Event|0|||
33224366|NCT05044325|100721817|FG006|Part A:Treatment Period 1|Adverse Event|0|||
33514719|NCT02079636|101779893|FG013|Overall Study|Adverse Event|0|||
33514720|NCT02079636|101779894|FG014|Overall Study|Adverse Event|0|||
33514721|NCT02079636|101779880|FG000|Overall Study|Progressive disease|0|||
33606908|NCT01147848|102111582|FG000|Randomized Phase|Protocol Violation|0|||
33606909|NCT01147848|102111583|FG001|Randomized Phase|Protocol Violation|7|||
33199462|NCT01826825|100633825|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
33199463|NCT04260191|100633826|FG000|Overall Study|Decision by Sponsor|0|||
33199464|NCT04260191|100633827|FG001|Overall Study|Decision by Sponsor|1|||
33514722|NCT02079636|101779881|FG001|Overall Study|Progressive disease|0|||
33399667|NCT02061540|101350295|FG000|Overall Study|Withdrawal by Subject|2|||
33399668|NCT02850276|101350298|FG000|Overall Study|screen failure|43|||
33399669|NCT02850276|101350298|FG000|Overall Study|Withdrawal by Subject|14|||
33514723|NCT02079636|101779882|FG002|Overall Study|Progressive disease|0|||
33399670|NCT02850276|101350298|FG000|Overall Study|Physician Decision|2|||
33399671|NCT02850276|101350298|FG000|Overall Study|Lost to Follow-up|2|||
33514724|NCT02079636|101779883|FG003|Overall Study|Progressive disease|2|||
33514725|NCT02079636|101779884|FG004|Overall Study|Progressive disease|0|||
33514726|NCT02079636|101779885|FG005|Overall Study|Progressive disease|0|||
33514727|NCT02079636|101779886|FG006|Overall Study|Progressive disease|0|||
33325419|NCT00467779|101088049|FG000|Stage 1|Unspecified Reason|1|||
33325420|NCT00467779|101088050|FG001|Stage 1|Unspecified Reason|0|||
33325421|NCT00467779|101088051|FG002|Stage 1|Unspecified Reason|1|||
33325422|NCT00467779|101088052|FG003|Stage 1|Unspecified Reason|0|||
33325423|NCT00467779|101088053|FG004|Stage 1|Unspecified Reason|1|||
33325424|NCT00467779|101088054|FG005|Stage 1|Unspecified Reason|2|||
33325425|NCT00467779|101088055|FG006|Stage 1|Unspecified Reason|0|||
33325426|NCT00467779|101088056|FG007|Stage 1|Unspecified Reason|0|||
33325427|NCT00467779|101088057|FG008|Stage 1|Unspecified Reason|0|||
33399672|NCT03598140|101350299|FG000|Overall Study|enrolled but didn't start|1|||
33399673|NCT03598140|101350300|FG001|Overall Study|enrolled but didn't start|0|||
33514728|NCT02079636|101779887|FG007|Overall Study|Progressive disease|0|||
33514729|NCT02079636|101779888|FG008|Overall Study|Progressive disease|0|||
33514730|NCT02079636|101779889|FG009|Overall Study|Progressive disease|0|||
33514731|NCT02079636|101779890|FG010|Overall Study|Progressive disease|0|||
33514732|NCT02079636|101779891|FG011|Overall Study|Progressive disease|0|||
33514733|NCT02079636|101779892|FG012|Overall Study|Progressive disease|1|||
33514734|NCT02079636|101779893|FG013|Overall Study|Progressive disease|0|||
33514735|NCT02079636|101779894|FG014|Overall Study|Progressive disease|0|||
33514736|NCT02079636|101779880|FG000|Overall Study|Withdrawal by Subject|0|||
33514737|NCT02079636|101779881|FG001|Overall Study|Withdrawal by Subject|0|||
33514738|NCT02079636|101779882|FG002|Overall Study|Withdrawal by Subject|0|||
33514739|NCT02079636|101779883|FG003|Overall Study|Withdrawal by Subject|4|||
33514740|NCT02079636|101779884|FG004|Overall Study|Withdrawal by Subject|0|||
33514741|NCT02079636|101779885|FG005|Overall Study|Withdrawal by Subject|1|||
33514742|NCT02079636|101779886|FG006|Overall Study|Withdrawal by Subject|0|||
33514743|NCT02079636|101779887|FG007|Overall Study|Withdrawal by Subject|0|||
33514744|NCT02079636|101779888|FG008|Overall Study|Withdrawal by Subject|0|||
33514745|NCT02079636|101779889|FG009|Overall Study|Withdrawal by Subject|2|||
33514746|NCT02079636|101779890|FG010|Overall Study|Withdrawal by Subject|1|||
33399674|NCT00033293|101350301|FG000|Overall Study|Death|0|||
33514747|NCT02079636|101779891|FG011|Overall Study|Withdrawal by Subject|1|||
33514748|NCT02079636|101779892|FG012|Overall Study|Withdrawal by Subject|1|||
33514749|NCT02079636|101779893|FG013|Overall Study|Withdrawal by Subject|0|||
33514750|NCT02079636|101779894|FG014|Overall Study|Withdrawal by Subject|2|||
33199465|NCT04260191|100633828|FG002|Overall Study|Decision by Sponsor|0|||
33199466|NCT04260191|100633826|FG000|Overall Study|Withdrawal by Subject|1|||
33199467|NCT04260191|100633827|FG001|Overall Study|Withdrawal by Subject|0|||
33199468|NCT04260191|100633828|FG002|Overall Study|Withdrawal by Subject|3|||
33199469|NCT04260191|100633826|FG000|Overall Study|Death|4|||
33199470|NCT04260191|100633827|FG001|Overall Study|Death|3|||
33199471|NCT04260191|100633828|FG002|Overall Study|Death|2|||
33199472|NCT03370341|100633832|FG000|Overall Study|Lost to Follow-up|0|||
33514751|NCT02079636|101779880|FG000|Overall Study|Physician Decision|0|||
33514752|NCT02079636|101779881|FG001|Overall Study|Physician Decision|0|||
33514753|NCT02079636|101779882|FG002|Overall Study|Physician Decision|0|||
33514754|NCT02079636|101779883|FG003|Overall Study|Physician Decision|0|||
33325428|NCT00467779|101088058|FG009|Stage 1|Unspecified Reason|0|||
33399675|NCT00033293|101350302|FG001|Overall Study|Death|1|||
33514755|NCT02079636|101779884|FG004|Overall Study|Physician Decision|0|||
33514756|NCT02079636|101779885|FG005|Overall Study|Physician Decision|1|||
33514757|NCT02079636|101779886|FG006|Overall Study|Physician Decision|0|||
33514758|NCT02079636|101779887|FG007|Overall Study|Physician Decision|0|||
33514759|NCT02079636|101779888|FG008|Overall Study|Physician Decision|0|||
33606910|NCT01147848|102111584|FG002|Randomized Phase|Protocol Violation|10|||
33325429|NCT00467779|101088059|FG010|Stage 1|Unspecified Reason|0|||
33399676|NCT00033293|101350301|FG000|Overall Study|Lack of Efficacy|5|||
33399677|NCT00033293|101350302|FG001|Overall Study|Lack of Efficacy|8|||
33514760|NCT02079636|101779889|FG009|Overall Study|Physician Decision|1|||
33514761|NCT02079636|101779890|FG010|Overall Study|Physician Decision|1|||
33514762|NCT02079636|101779891|FG011|Overall Study|Physician Decision|0|||
33514763|NCT02079636|101779892|FG012|Overall Study|Physician Decision|0|||
33514764|NCT02079636|101779893|FG013|Overall Study|Physician Decision|0|||
33514765|NCT02079636|101779894|FG014|Overall Study|Physician Decision|1|||
33514766|NCT02079636|101779880|FG000|Overall Study|Lost to Follow-up|0|||
33514767|NCT02079636|101779881|FG001|Overall Study|Lost to Follow-up|0|||
33514768|NCT02079636|101779882|FG002|Overall Study|Lost to Follow-up|0|||
33514769|NCT02079636|101779883|FG003|Overall Study|Lost to Follow-up|0|||
33514770|NCT02079636|101779884|FG004|Overall Study|Lost to Follow-up|0|||
33514771|NCT02079636|101779885|FG005|Overall Study|Lost to Follow-up|0|||
33514772|NCT02079636|101779886|FG006|Overall Study|Lost to Follow-up|0|||
33514773|NCT02079636|101779887|FG007|Overall Study|Lost to Follow-up|1|||
33514774|NCT02079636|101779888|FG008|Overall Study|Lost to Follow-up|0|||
33514775|NCT02079636|101779889|FG009|Overall Study|Lost to Follow-up|0|||
33514776|NCT02079636|101779890|FG010|Overall Study|Lost to Follow-up|0|||
33514777|NCT02079636|101779891|FG011|Overall Study|Lost to Follow-up|0|||
33514778|NCT02079636|101779892|FG012|Overall Study|Lost to Follow-up|0|||
33514779|NCT02079636|101779893|FG013|Overall Study|Lost to Follow-up|0|||
33514780|NCT02079636|101779894|FG014|Overall Study|Lost to Follow-up|0|||
33325430|NCT00467779|101088060|FG011|Stage 1|Unspecified Reason|0|||
33325431|NCT00467779|101088061|FG012|Stage 1|Unspecified Reason|0|||
33325432|NCT00467779|101088062|FG013|Stage 1|Unspecified Reason|0|||
33325433|NCT00467779|101088063|FG014|Stage 1|Unspecified Reason|0|||
33325434|NCT00467779|101088049|FG000|Stage 1|Physician Decision|0|||
33514781|NCT04329091|101779901|FG000|Overall Study|Physician Decision|5|||
33514782|NCT02850016|101779909|FG000|Overall Study|Withdrawal by Subject|1|||
33514783|NCT02850016|101779910|FG001|Overall Study|Withdrawal by Subject|2|||
33514784|NCT00467961|101779911|FG000|Overall Study|Technical Failures|5|||
33514785|NCT00467961|101779911|FG000|Overall Study|Disease Progression|2|||
33514786|NCT00955968|101779912|FG000|Overall Study|Death|2|||
33514787|NCT00955968|101779913|FG001|Overall Study|Death|4|||
33514788|NCT00955968|101779912|FG000|Overall Study|Withdrawal by Subject|35|||
33514789|NCT00955968|101779913|FG001|Overall Study|Withdrawal by Subject|31|||
33514790|NCT00955968|101779912|FG000|Overall Study|Lost to Follow-up|45|||
33514791|NCT00955968|101779913|FG001|Overall Study|Lost to Follow-up|39|||
33514792|NCT00955968|101779912|FG000|Overall Study|Site closed|55|||
33514793|NCT00955968|101779913|FG001|Overall Study|Site closed|52|||
33514794|NCT00900757|101779914|FG000|Overall Study|screen failure|19|||
33514795|NCT02284568|101779915|FG000|Overall Study|Adverse Event|2|||
33514796|NCT02284568|101779916|FG001|Overall Study|Adverse Event|9|||
33514797|NCT02284568|101779917|FG002|Overall Study|Adverse Event|4|||
33514798|NCT02284568|101779915|FG000|Overall Study|Withdrawal by Subject|22|||
33514799|NCT02284568|101779916|FG001|Overall Study|Withdrawal by Subject|21|||
33514800|NCT02284568|101779917|FG002|Overall Study|Withdrawal by Subject|1|||
33514801|NCT02284568|101779915|FG000|Overall Study|Noncompliance with study drug admin|1|||
33514802|NCT02284568|101779916|FG001|Overall Study|Noncompliance with study drug admin|2|||
33514803|NCT02284568|101779917|FG002|Overall Study|Noncompliance with study drug admin|0|||
33514804|NCT02284568|101779915|FG000|Overall Study|Noncompliance|1|||
33514805|NCT02284568|101779916|FG001|Overall Study|Noncompliance|0|||
33514806|NCT02284568|101779917|FG002|Overall Study|Noncompliance|0|||
33514807|NCT02284568|101779915|FG000|Overall Study|Protocol Violation|0|||
33514808|NCT02284568|101779916|FG001|Overall Study|Protocol Violation|1|||
33514809|NCT02284568|101779917|FG002|Overall Study|Protocol Violation|0|||
33514810|NCT02284568|101779915|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
33514811|NCT02284568|101779916|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
33514812|NCT02284568|101779917|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
33514813|NCT02284568|101779915|FG000|Overall Study|Lost to Follow-up|0|||
33514814|NCT02284568|101779916|FG001|Overall Study|Lost to Follow-up|3|||
33514815|NCT02284568|101779917|FG002|Overall Study|Lost to Follow-up|0|||
33514816|NCT02284568|101779915|FG000|Overall Study|Lack of Efficacy|4|||
33514817|NCT02284568|101779916|FG001|Overall Study|Lack of Efficacy|7|||
33514818|NCT02284568|101779917|FG002|Overall Study|Lack of Efficacy|0|||
33199473|NCT03370341|100633833|FG001|Overall Study|Lost to Follow-up|1|||
33199474|NCT01767116|100633834|FG000|Overall Study|Lost to Follow-up|2|||
33199475|NCT01767116|100633835|FG001|Overall Study|Lost to Follow-up|2|||
33514819|NCT02284568|101779915|FG000|Overall Study|Other|1|||
33514820|NCT02284568|101779916|FG001|Overall Study|Other|2|||
33514821|NCT02284568|101779917|FG002|Overall Study|Other|0|||
33199476|NCT02096835|100633836|FG000|Overall Study|Withdrawal by Subject|1|||
33514822|NCT02284568|101779915|FG000|Overall Study|Withdrew before taking study drug|0|||
33514823|NCT02284568|101779916|FG001|Overall Study|Withdrew before taking study drug|1|||
33514824|NCT02284568|101779917|FG002|Overall Study|Withdrew before taking study drug|0|||
33514825|NCT04253782|101779918|FG000|Overall Study|Death|2|||
33514826|NCT04253782|101779919|FG001|Overall Study|Death|0|||
33325435|NCT00467779|101088050|FG001|Stage 1|Physician Decision|1|||
33514827|NCT00197002|101779920|FG000|Overall Study|Adverse Event|0|||
33514828|NCT00197002|101779921|FG001|Overall Study|Adverse Event|1|||
33514829|NCT00197002|101779922|FG002|Overall Study|Adverse Event|0|||
33514830|NCT00197002|101779920|FG000|Overall Study|Protocol Violation|1|||
33514831|NCT00197002|101779921|FG001|Overall Study|Protocol Violation|0|||
33514832|NCT00197002|101779922|FG002|Overall Study|Protocol Violation|2|||
33514833|NCT00197002|101779920|FG000|Overall Study|Withdrawal by Subject|9|||
33514834|NCT00197002|101779921|FG001|Overall Study|Withdrawal by Subject|5|||
33514835|NCT00197002|101779922|FG002|Overall Study|Withdrawal by Subject|7|||
33514836|NCT00197002|101779920|FG000|Overall Study|Migrated/moved from study area|3|||
33514837|NCT00197002|101779921|FG001|Overall Study|Migrated/moved from study area|5|||
33514838|NCT00197002|101779922|FG002|Overall Study|Migrated/moved from study area|1|||
33514839|NCT00197002|101779920|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
33514840|NCT00197002|101779921|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
33514841|NCT00197002|101779922|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
33514842|NCT00197002|101779920|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
33514843|NCT00197002|101779921|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
33514844|NCT00197002|101779922|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
33514845|NCT00197002|101779920|FG000|Overall Study|Others|3|||
33514846|NCT00197002|101779921|FG001|Overall Study|Others|1|||
33514847|NCT00197002|101779922|FG002|Overall Study|Others|1|||
33514848|NCT02054910|101779925|FG000|Overall Study|Lost to Follow-up|4|||
33514849|NCT02054910|101779926|FG001|Overall Study|Lost to Follow-up|1|||
33514850|NCT00932698|101779927|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
33514851|NCT00932698|101779928|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
33514852|NCT00932698|101779929|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
33514853|NCT00932698|101779930|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
33514854|NCT00932698|101779931|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
33514855|NCT00932698|101779932|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
33514856|NCT00932698|101779933|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
33514857|NCT00932698|101779934|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
33514858|NCT00932698|101779935|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
33514859|NCT00932698|101779936|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
33514860|NCT00932698|101779937|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
33514861|NCT00932698|101779927|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
33514862|NCT00932698|101779928|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
33514863|NCT00932698|101779929|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
33514864|NCT00932698|101779930|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
33514865|NCT00932698|101779931|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
33514866|NCT00932698|101779932|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
33514867|NCT00932698|101779933|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
33514868|NCT00932698|101779934|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
33514869|NCT00932698|101779935|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
33514870|NCT00932698|101779936|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
33514871|NCT00932698|101779937|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
33514872|NCT00932698|101779927|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
33514873|NCT00932698|101779928|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
33514874|NCT00932698|101779929|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
33514875|NCT00932698|101779930|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
33514876|NCT00932698|101779931|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
33514877|NCT00932698|101779932|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
33514878|NCT00932698|101779933|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
33514879|NCT00932698|101779934|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
33514880|NCT00932698|101779935|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
33514881|NCT00932698|101779936|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
33514882|NCT00932698|101779937|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
33514883|NCT00932698|101779927|FG000|Part 1 (Dose Escalation)|Other|0|||
33514884|NCT00932698|101779928|FG001|Part 1 (Dose Escalation)|Other|0|||
33514885|NCT00932698|101779929|FG002|Part 1 (Dose Escalation)|Other|1|||
33514886|NCT00932698|101779930|FG003|Part 1 (Dose Escalation)|Other|0|||
33514887|NCT00932698|101779931|FG004|Part 1 (Dose Escalation)|Other|0|||
33514888|NCT00932698|101779932|FG005|Part 1 (Dose Escalation)|Other|0|||
33514889|NCT00932698|101779933|FG006|Part 1 (Dose Escalation)|Other|1|||
33514890|NCT00932698|101779934|FG007|Part 1 (Dose Escalation)|Other|0|||
33325436|NCT00467779|101088051|FG002|Stage 1|Physician Decision|0|||
33514891|NCT00932698|101779935|FG008|Part 1 (Dose Escalation)|Other|0|||
33514892|NCT00932698|101779936|FG009|Part 1 (Dose Escalation)|Other|0|||
33514893|NCT00932698|101779937|FG010|Part 1 (Dose Escalation)|Other|0|||
33514894|NCT00932698|101779927|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
33514895|NCT00932698|101779928|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
33514896|NCT00932698|101779929|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
33606911|NCT01147848|102111582|FG000|Randomized Phase|Lost to Follow-up|0|||
33325437|NCT00467779|101088052|FG003|Stage 1|Physician Decision|0|||
33606912|NCT01147848|102111583|FG001|Randomized Phase|Lost to Follow-up|5|||
33514897|NCT00932698|101779930|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
33325438|NCT00467779|101088053|FG004|Stage 1|Physician Decision|0|||
33325439|NCT00467779|101088054|FG005|Stage 1|Physician Decision|0|||
33325440|NCT00467779|101088055|FG006|Stage 1|Physician Decision|0|||
33325441|NCT00467779|101088056|FG007|Stage 1|Physician Decision|0|||
33514898|NCT00932698|101779931|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
33514899|NCT00932698|101779932|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
33514900|NCT00932698|101779933|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
33514901|NCT00932698|101779934|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
33514902|NCT00932698|101779935|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
33514903|NCT00932698|101779936|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
33514904|NCT00932698|101779937|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
33514905|NCT00932698|101779927|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33514906|NCT00932698|101779928|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33514907|NCT00932698|101779929|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33514908|NCT00932698|101779930|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33514909|NCT00932698|101779931|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33514910|NCT00932698|101779932|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33514911|NCT00932698|101779933|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33514912|NCT00932698|101779934|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
33514913|NCT00932698|101779935|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
33514914|NCT00932698|101779936|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
33514915|NCT00932698|101779937|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
33514916|NCT00932698|101779927|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
33514917|NCT00932698|101779928|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
33514918|NCT00932698|101779929|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
33325442|NCT00467779|101088057|FG008|Stage 1|Physician Decision|0|||
33325443|NCT00467779|101088058|FG009|Stage 1|Physician Decision|0|||
33325444|NCT00467779|101088059|FG010|Stage 1|Physician Decision|0|||
33325445|NCT00467779|101088060|FG011|Stage 1|Physician Decision|0|||
33325446|NCT00467779|101088061|FG012|Stage 1|Physician Decision|0|||
33325447|NCT00467779|101088062|FG013|Stage 1|Physician Decision|0|||
33325448|NCT00467779|101088063|FG014|Stage 1|Physician Decision|0|||
33399678|NCT00033293|101350301|FG000|Overall Study|Lost to Follow-up|0|||
33514919|NCT00932698|101779930|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
33514920|NCT00932698|101779931|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
33514921|NCT00932698|101779932|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
33514922|NCT00932698|101779933|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
33514923|NCT00932698|101779934|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
33514924|NCT00932698|101779935|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
33514925|NCT00932698|101779936|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
33514926|NCT00932698|101779937|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
33514927|NCT01096589|101779938|FG000|Overall Study|Adverse Event|2|||
33514928|NCT01096589|101779939|FG001|Overall Study|Adverse Event|1|||
33514929|NCT01096589|101779940|FG002|Overall Study|Adverse Event|2|||
33514930|NCT01096589|101779941|FG003|Overall Study|Adverse Event|1|||
33514931|NCT01096589|101779938|FG000|Overall Study|Withdrawal by Subject|2|||
33514932|NCT01096589|101779939|FG001|Overall Study|Withdrawal by Subject|1|||
33514933|NCT01096589|101779940|FG002|Overall Study|Withdrawal by Subject|1|||
33514934|NCT01096589|101779941|FG003|Overall Study|Withdrawal by Subject|1|||
33514935|NCT01096589|101779938|FG000|Overall Study|Compliance with protocol|0|||
33514936|NCT01096589|101779939|FG001|Overall Study|Compliance with protocol|0|||
33514937|NCT01096589|101779940|FG002|Overall Study|Compliance with protocol|1|||
33514938|NCT01096589|101779941|FG003|Overall Study|Compliance with protocol|0|||
33514939|NCT01096589|101779938|FG000|Overall Study|found treatment exhausting|0|||
33514940|NCT01096589|101779939|FG001|Overall Study|found treatment exhausting|0|||
33514941|NCT01096589|101779940|FG002|Overall Study|found treatment exhausting|0|||
33514942|NCT01096589|101779941|FG003|Overall Study|found treatment exhausting|1|||
33514943|NCT00460265|101779942|FG000|Overall Study|Lost to Follow-up|14|||
33514944|NCT00460265|101779943|FG001|Overall Study|Lost to Follow-up|15|||
33514945|NCT00460265|101779942|FG000|Overall Study|Physician Decision|1|||
33514946|NCT00460265|101779943|FG001|Overall Study|Physician Decision|2|||
33514947|NCT00460265|101779942|FG000|Overall Study|Withdrawal by Subject|10|||
33514948|NCT00460265|101779943|FG001|Overall Study|Withdrawal by Subject|25|||
33399679|NCT00033293|101350302|FG001|Overall Study|Lost to Follow-up|1|||
33514949|NCT00460265|101779942|FG000|Overall Study|Ongoing|60|||
33514950|NCT00460265|101779943|FG001|Overall Study|Ongoing|47|||
33514951|NCT00535847|101779944|FG000|Overall Study|Adverse Event|5|||
33514952|NCT00535847|101779945|FG001|Overall Study|Adverse Event|3|||
33514953|NCT00535847|101779946|FG002|Overall Study|Adverse Event|2|||
33514954|NCT00535847|101779944|FG000|Overall Study|Non compliance|1|||
33325449|NCT00467779|101088049|FG000|Stage 1|Withdrawal by Subject|0|||
33514955|NCT00535847|101779945|FG001|Overall Study|Non compliance|1|||
33514956|NCT00535847|101779946|FG002|Overall Study|Non compliance|0|||
33514957|NCT00535847|101779944|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
33606913|NCT01147848|102111584|FG002|Randomized Phase|Lost to Follow-up|7|||
33325450|NCT00467779|101088050|FG001|Stage 1|Withdrawal by Subject|0|||
33514958|NCT00535847|101779945|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
33514959|NCT00535847|101779946|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
33514960|NCT00358956|101779949|FG000|Overall Study|Adverse Event|3|||
33514961|NCT00358956|101779949|FG000|Overall Study|condition under investigation worsened|4|||
33514962|NCT00358956|101779949|FG000|Overall Study|Withdrawal by Subject|1|||
33514963|NCT03181503|101779952|FG000|Overall Study|Adverse Event|2|||
33514964|NCT03181503|101779953|FG001|Overall Study|Adverse Event|2|||
33514965|NCT03181503|101779952|FG000|Overall Study|Protocol Violation|1|||
33514966|NCT03181503|101779953|FG001|Overall Study|Protocol Violation|0|||
33514967|NCT03181503|101779952|FG000|Overall Study|Withdrawal by Subject|3|||
33514968|NCT03181503|101779953|FG001|Overall Study|Withdrawal by Subject|0|||
33514969|NCT03181503|101779952|FG000|Overall Study|Lost to Follow-up|1|||
33514970|NCT03181503|101779953|FG001|Overall Study|Lost to Follow-up|1|||
33514971|NCT01179737|101782891|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
33514972|NCT01179737|101782892|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
33199477|NCT02096835|100633837|FG001|Overall Study|Withdrawal by Subject|0|||
33199478|NCT02096835|100633838|FG002|Overall Study|Withdrawal by Subject|0|||
33325451|NCT00467779|101088051|FG002|Stage 1|Withdrawal by Subject|0|||
33325452|NCT00467779|101088052|FG003|Stage 1|Withdrawal by Subject|0|||
33325453|NCT00467779|101088053|FG004|Stage 1|Withdrawal by Subject|0|||
33325454|NCT00467779|101088054|FG005|Stage 1|Withdrawal by Subject|0|||
33325455|NCT00467779|101088055|FG006|Stage 1|Withdrawal by Subject|1|||
33325456|NCT00467779|101088056|FG007|Stage 1|Withdrawal by Subject|1|||
33325457|NCT00467779|101088057|FG008|Stage 1|Withdrawal by Subject|0|||
33325458|NCT00467779|101088058|FG009|Stage 1|Withdrawal by Subject|0|||
33325459|NCT00467779|101088059|FG010|Stage 1|Withdrawal by Subject|0|||
33325460|NCT00467779|101088060|FG011|Stage 1|Withdrawal by Subject|0|||
33325461|NCT00467779|101088061|FG012|Stage 1|Withdrawal by Subject|0|||
33514973|NCT01179737|101782893|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
33325462|NCT00467779|101088062|FG013|Stage 1|Withdrawal by Subject|0|||
33325463|NCT00467779|101088063|FG014|Stage 1|Withdrawal by Subject|0|||
33325464|NCT00467779|101088049|FG000|Stage 1A|Adverse Event|0|||
33325465|NCT00467779|101088050|FG001|Stage 1A|Adverse Event|0|||
33325466|NCT00467779|101088051|FG002|Stage 1A|Adverse Event|0|||
33325467|NCT00467779|101088052|FG003|Stage 1A|Adverse Event|0|||
33325468|NCT00467779|101088053|FG004|Stage 1A|Adverse Event|0|||
33325469|NCT00467779|101088054|FG005|Stage 1A|Adverse Event|0|||
33325470|NCT00467779|101088055|FG006|Stage 1A|Adverse Event|0|||
33325471|NCT00467779|101088056|FG007|Stage 1A|Adverse Event|0|||
33325472|NCT00467779|101088057|FG008|Stage 1A|Adverse Event|0|||
33325473|NCT00467779|101088058|FG009|Stage 1A|Adverse Event|0|||
33325474|NCT00467779|101088059|FG010|Stage 1A|Adverse Event|0|||
33325475|NCT00467779|101088060|FG011|Stage 1A|Adverse Event|0|||
33325476|NCT00467779|101088061|FG012|Stage 1A|Adverse Event|1|||
33325477|NCT00467779|101088062|FG013|Stage 1A|Adverse Event|0|||
33325478|NCT00467779|101088063|FG014|Stage 1A|Adverse Event|0|||
33325479|NCT00467779|101088049|FG000|Stage 1A|Death|0|||
33325480|NCT00467779|101088050|FG001|Stage 1A|Death|0|||
33325481|NCT00467779|101088051|FG002|Stage 1A|Death|0|||
33325482|NCT00467779|101088052|FG003|Stage 1A|Death|0|||
33325483|NCT00467779|101088053|FG004|Stage 1A|Death|0|||
33325484|NCT00467779|101088054|FG005|Stage 1A|Death|0|||
33325485|NCT00467779|101088055|FG006|Stage 1A|Death|0|||
33325486|NCT00467779|101088056|FG007|Stage 1A|Death|0|||
33325487|NCT00467779|101088057|FG008|Stage 1A|Death|0|||
33325488|NCT00467779|101088058|FG009|Stage 1A|Death|0|||
33325489|NCT00467779|101088059|FG010|Stage 1A|Death|0|||
33325490|NCT00467779|101088060|FG011|Stage 1A|Death|1|||
33325491|NCT00467779|101088061|FG012|Stage 1A|Death|1|||
33325492|NCT00467779|101088062|FG013|Stage 1A|Death|0|||
33325493|NCT00467779|101088063|FG014|Stage 1A|Death|0|||
33325494|NCT00467779|101088049|FG000|Stage 1A|Disease Progression|0|||
33325495|NCT00467779|101088050|FG001|Stage 1A|Disease Progression|0|||
33325496|NCT00467779|101088051|FG002|Stage 1A|Disease Progression|0|||
33325497|NCT00467779|101088052|FG003|Stage 1A|Disease Progression|0|||
33325498|NCT00467779|101088053|FG004|Stage 1A|Disease Progression|0|||
33514974|NCT01179737|101782894|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
33514975|NCT01179737|101782891|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
33199479|NCT02096835|100633836|FG000|Overall Study|converted to open procedures|1|||
33325499|NCT00467779|101088054|FG005|Stage 1A|Disease Progression|0|||
33325500|NCT00467779|101088055|FG006|Stage 1A|Disease Progression|0|||
33514976|NCT01179737|101782892|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
33514977|NCT01179737|101782893|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
33514978|NCT01179737|101782894|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
33325501|NCT00467779|101088056|FG007|Stage 1A|Disease Progression|0|||
33514979|NCT01179737|101782891|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
33325502|NCT00467779|101088057|FG008|Stage 1A|Disease Progression|0|||
33325503|NCT00467779|101088058|FG009|Stage 1A|Disease Progression|2|||
33325504|NCT00467779|101088059|FG010|Stage 1A|Disease Progression|2|||
33325505|NCT00467779|101088060|FG011|Stage 1A|Disease Progression|5|||
33325506|NCT00467779|101088061|FG012|Stage 1A|Disease Progression|2|||
33325507|NCT00467779|101088062|FG013|Stage 1A|Disease Progression|0|||
33325508|NCT00467779|101088063|FG014|Stage 1A|Disease Progression|0|||
33514980|NCT01179737|101782892|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
33514981|NCT01179737|101782893|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
33514982|NCT01179737|101782894|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
33199480|NCT02096835|100633837|FG001|Overall Study|converted to open procedures|0|||
33199481|NCT02096835|100633838|FG002|Overall Study|converted to open procedures|0|||
33514983|NCT01179737|101782891|FG000|Cohort 1 & Cohort 2|Death|0|||
33514984|NCT01179737|101782892|FG001|Cohort 1 & Cohort 2|Death|0|||
33514985|NCT01179737|101782893|FG002|Cohort 1 & Cohort 2|Death|1|||
33514986|NCT01179737|101782894|FG003|Cohort 1 & Cohort 2|Death|0|||
33514987|NCT01179737|101782891|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
33514988|NCT01179737|101782892|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
33514989|NCT01179737|101782893|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
33514990|NCT01179737|101782894|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
33514991|NCT01179737|101782891|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
33514992|NCT01179737|101782892|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
33514993|NCT01179737|101782893|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
33514994|NCT01179737|101782894|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
33514995|NCT01179737|101782891|FG000|Extension|The study was terminated|3|||
33514996|NCT01179737|101782892|FG001|Extension|The study was terminated|0|||
33514997|NCT01179737|101782893|FG002|Extension|The study was terminated|0|||
33514998|NCT01179737|101782894|FG003|Extension|The study was terminated|0|||
33514999|NCT01794793|101782895|FG000|Treatment Period|Withdrawal by Subject|24|||
33515000|NCT01794793|101782895|FG000|Treatment Period|Lack of Efficacy|22|||
33515001|NCT01794793|101782895|FG000|Treatment Period|Adverse Event|17|||
33515002|NCT01794793|101782895|FG000|Treatment Period|Physician Decision|14|||
33515003|NCT01794793|101782895|FG000|Treatment Period|Lost to Follow-up|7|||
33515004|NCT01794793|101782895|FG000|Treatment Period|Death|6|||
33515005|NCT01794793|101782895|FG000|Treatment Period|Protocol Violation|5|||
33515006|NCT01794793|101782895|FG000|Treatment Period|administrative problem|3|||
33515007|NCT01794793|101782895|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
33515008|NCT01794793|101782895|FG000|Post-treatment Follow-up|Adverse Event|8|||
33515009|NCT01794793|101782895|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
33515010|NCT01794793|101782895|FG000|Post-treatment Follow-up|administrative problem|5|||
33515011|NCT01794793|101782895|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
33515012|NCT01794793|101782895|FG000|Post-treatment Follow-up|Protocol Violation|3|||
33515013|NCT01917344|101782896|FG000|Overall Study|Withdrawal by Subject|1|||
33515014|NCT02954653|101782897|FG000|Overall Study|Death|3|||
33515015|NCT02954653|101782898|FG001|Overall Study|Death|1|||
33515016|NCT02954653|101782899|FG002|Overall Study|Death|0|||
33515017|NCT02954653|101782900|FG003|Overall Study|Death|0|||
33515018|NCT02954653|101782901|FG004|Overall Study|Death|0|||
33515019|NCT02954653|101782902|FG005|Overall Study|Death|0|||
33515020|NCT02954653|101782903|FG006|Overall Study|Death|0|||
33606914|NCT01147848|102111582|FG000|Randomized Phase|Physician Decision|0|||
33606915|NCT01147848|102111583|FG001|Randomized Phase|Physician Decision|0|||
33606916|NCT01147848|102111584|FG002|Randomized Phase|Physician Decision|1|||
33606917|NCT01147848|102111582|FG000|Randomized Phase|Withdrawal by Subject|0|||
33606918|NCT01147848|102111583|FG001|Randomized Phase|Withdrawal by Subject|7|||
33606919|NCT01147848|102111584|FG002|Randomized Phase|Withdrawal by Subject|9|||
33606920|NCT00895453|102111585|FG000|Overall Study|Lost to Follow-up|25|||
33606921|NCT00895453|102111586|FG001|Overall Study|Lost to Follow-up|25|||
33606922|NCT00895453|102111587|FG002|Overall Study|Lost to Follow-up|23|||
33606923|NCT00812565|102111588|FG000|Overall Study|Did Not Receive Study Medication|1|||
33606924|NCT00812565|102111589|FG001|Overall Study|Did Not Receive Study Medication|1|||
33606925|NCT00812565|102111590|FG002|Overall Study|Did Not Receive Study Medication|0|||
33606926|NCT00812565|102111591|FG003|Overall Study|Did Not Receive Study Medication|0|||
33606927|NCT00812565|102111592|FG004|Overall Study|Did Not Receive Study Medication|0|||
33606928|NCT00812565|102111593|FG005|Overall Study|Did Not Receive Study Medication|0|||
33606929|NCT00812565|102111594|FG006|Overall Study|Did Not Receive Study Medication|0|||
33606930|NCT00812565|102111595|FG007|Overall Study|Did Not Receive Study Medication|0|||
33606931|NCT00812565|102111588|FG000|Overall Study|Adverse Event|0|||
33606932|NCT00812565|102111589|FG001|Overall Study|Adverse Event|0|||
33606933|NCT00812565|102111590|FG002|Overall Study|Adverse Event|0|||
33606934|NCT00812565|102111591|FG003|Overall Study|Adverse Event|2|||
33515021|NCT02954653|101782904|FG007|Overall Study|Death|0|||
33515022|NCT02954653|101782905|FG008|Overall Study|Death|0|||
33515023|NCT02954653|101782897|FG000|Overall Study|Randomized but did not receive treatment|1|||
33515024|NCT02954653|101782898|FG001|Overall Study|Randomized but did not receive treatment|0|||
33515025|NCT02954653|101782899|FG002|Overall Study|Randomized but did not receive treatment|0|||
33606935|NCT00812565|102111592|FG004|Overall Study|Adverse Event|0|||
33606936|NCT00812565|102111593|FG005|Overall Study|Adverse Event|0|||
33606937|NCT00812565|102111594|FG006|Overall Study|Adverse Event|0|||
33515026|NCT02954653|101782900|FG003|Overall Study|Randomized but did not receive treatment|0|||
33515027|NCT02954653|101782901|FG004|Overall Study|Randomized but did not receive treatment|0|||
33515028|NCT02954653|101782902|FG005|Overall Study|Randomized but did not receive treatment|0|||
33606938|NCT00812565|102111595|FG007|Overall Study|Adverse Event|1|||
33606939|NCT00812565|102111588|FG000|Overall Study|Did Not Come to Study Visit|1|||
33606940|NCT00812565|102111589|FG001|Overall Study|Did Not Come to Study Visit|0|||
33606941|NCT00812565|102111590|FG002|Overall Study|Did Not Come to Study Visit|0|||
33606942|NCT00812565|102111591|FG003|Overall Study|Did Not Come to Study Visit|0|||
33606943|NCT00812565|102111592|FG004|Overall Study|Did Not Come to Study Visit|0|||
33606944|NCT00812565|102111593|FG005|Overall Study|Did Not Come to Study Visit|0|||
33606945|NCT00812565|102111594|FG006|Overall Study|Did Not Come to Study Visit|0|||
33606946|NCT00812565|102111595|FG007|Overall Study|Did Not Come to Study Visit|0|||
33606947|NCT00812565|102111588|FG000|Overall Study|Withdrawal of Consent|1|||
33606948|NCT00812565|102111589|FG001|Overall Study|Withdrawal of Consent|0|||
33606949|NCT00812565|102111590|FG002|Overall Study|Withdrawal of Consent|0|||
33606950|NCT00812565|102111591|FG003|Overall Study|Withdrawal of Consent|0|||
33606951|NCT00812565|102111592|FG004|Overall Study|Withdrawal of Consent|1|||
33515029|NCT02954653|101782903|FG006|Overall Study|Randomized but did not receive treatment|0|||
33515030|NCT02954653|101782904|FG007|Overall Study|Randomized but did not receive treatment|0|||
33515031|NCT02954653|101782905|FG008|Overall Study|Randomized but did not receive treatment|0|||
33515032|NCT02954653|101782897|FG000|Overall Study|Started another anti-cancer therapy|0|||
33515033|NCT02954653|101782898|FG001|Overall Study|Started another anti-cancer therapy|1|||
33515034|NCT02954653|101782899|FG002|Overall Study|Started another anti-cancer therapy|0|||
33515035|NCT02954653|101782900|FG003|Overall Study|Started another anti-cancer therapy|0|||
33515036|NCT02954653|101782901|FG004|Overall Study|Started another anti-cancer therapy|0|||
33515037|NCT02954653|101782902|FG005|Overall Study|Started another anti-cancer therapy|0|||
33515038|NCT02954653|101782903|FG006|Overall Study|Started another anti-cancer therapy|0|||
33515039|NCT02954653|101782904|FG007|Overall Study|Started another anti-cancer therapy|0|||
33515040|NCT02954653|101782905|FG008|Overall Study|Started another anti-cancer therapy|0|||
33515041|NCT02954653|101782897|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
33515042|NCT02954653|101782898|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
33515043|NCT02954653|101782899|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
33515044|NCT02954653|101782900|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
33515045|NCT02954653|101782901|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
33515046|NCT02954653|101782902|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
33515047|NCT02954653|101782903|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
33515048|NCT02954653|101782904|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
33515049|NCT02954653|101782905|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
33325509|NCT00467779|101088049|FG000|Stage 1A|Physician Decision|0|||
33325510|NCT00467779|101088050|FG001|Stage 1A|Physician Decision|0|||
33325511|NCT00467779|101088051|FG002|Stage 1A|Physician Decision|0|||
33325512|NCT00467779|101088052|FG003|Stage 1A|Physician Decision|0|||
33325513|NCT00467779|101088053|FG004|Stage 1A|Physician Decision|0|||
33325514|NCT00467779|101088054|FG005|Stage 1A|Physician Decision|0|||
33325515|NCT00467779|101088055|FG006|Stage 1A|Physician Decision|0|||
33325516|NCT00467779|101088056|FG007|Stage 1A|Physician Decision|0|||
33325517|NCT00467779|101088057|FG008|Stage 1A|Physician Decision|0|||
33325518|NCT00467779|101088058|FG009|Stage 1A|Physician Decision|1|||
33325519|NCT00467779|101088059|FG010|Stage 1A|Physician Decision|0|||
33325520|NCT00467779|101088060|FG011|Stage 1A|Physician Decision|0|||
33325521|NCT00467779|101088061|FG012|Stage 1A|Physician Decision|0|||
33325522|NCT00467779|101088062|FG013|Stage 1A|Physician Decision|0|||
33325523|NCT00467779|101088063|FG014|Stage 1A|Physician Decision|0|||
33325524|NCT00467779|101088049|FG000|Stage 1A|Withdrawal by Subject|0|||
33325525|NCT00467779|101088050|FG001|Stage 1A|Withdrawal by Subject|0|||
33325526|NCT00467779|101088051|FG002|Stage 1A|Withdrawal by Subject|0|||
33325527|NCT00467779|101088052|FG003|Stage 1A|Withdrawal by Subject|0|||
33325528|NCT00467779|101088053|FG004|Stage 1A|Withdrawal by Subject|0|||
33325529|NCT00467779|101088054|FG005|Stage 1A|Withdrawal by Subject|0|||
33325530|NCT00467779|101088055|FG006|Stage 1A|Withdrawal by Subject|0|||
33325531|NCT00467779|101088056|FG007|Stage 1A|Withdrawal by Subject|0|||
33515050|NCT00984061|101782909|FG000|Clarithromycin Alone|Protocol Violation|1|||
33515051|NCT00387010|101782914|FG000|Dose Titration Period|Adverse Event|12|||
33606952|NCT00812565|102111593|FG005|Overall Study|Withdrawal of Consent|0|||
33606953|NCT00812565|102111594|FG006|Overall Study|Withdrawal of Consent|0|||
33606954|NCT00812565|102111595|FG007|Overall Study|Withdrawal of Consent|0|||
33606955|NCT00812565|102111588|FG000|Overall Study|Reason Not Specified|0|||
33325532|NCT00467779|101088057|FG008|Stage 1A|Withdrawal by Subject|0|||
33325533|NCT00467779|101088058|FG009|Stage 1A|Withdrawal by Subject|0|||
33325534|NCT00467779|101088059|FG010|Stage 1A|Withdrawal by Subject|1|||
33325535|NCT00467779|101088060|FG011|Stage 1A|Withdrawal by Subject|1|||
33199482|NCT02096835|100633836|FG000|Overall Study|Lost to Follow-up|1|||
33199483|NCT02096835|100633837|FG001|Overall Study|Lost to Follow-up|0|||
33325536|NCT00467779|101088061|FG012|Stage 1A|Withdrawal by Subject|1|||
33325537|NCT00467779|101088062|FG013|Stage 1A|Withdrawal by Subject|0|||
33325538|NCT00467779|101088063|FG014|Stage 1A|Withdrawal by Subject|0|||
33325539|NCT00467779|101088049|FG000|Stage 1A|Unspecified Reason|0|||
33325540|NCT00467779|101088050|FG001|Stage 1A|Unspecified Reason|0|||
33325541|NCT00467779|101088051|FG002|Stage 1A|Unspecified Reason|0|||
33515052|NCT00387010|101782914|FG000|Dose Titration Period|Lack of Efficacy|5|||
33515053|NCT00387010|101782914|FG000|Dose Titration Period|Withdrawal by Subject|3|||
33515054|NCT00387010|101782914|FG000|Dose Titration Period|Protocol Violation|1|||
33515055|NCT00387010|101782914|FG000|Dose Titration Period|Lost to Follow-up|2|||
33515056|NCT00387010|101782914|FG000|Dose Titration Period|Noncompliance with study medication|8|||
33515057|NCT00387010|101782914|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
33515058|NCT00387010|101782914|FG000|Treatment Period|Adverse Event|4|||
33515059|NCT00387010|101782914|FG000|Treatment Period|Withdrawal by Subject|1|||
33515060|NCT00387010|101782914|FG000|Treatment Period|Noncompliance with study medication|2|||
33515061|NCT00387010|101782914|FG000|Treatment Period|Noncompliance with study procedures|3|||
33515062|NCT00387010|101782914|FG000|Treatment Period|Participant reported study drug stolen|1|||
33515063|NCT02928770|101782915|FG000|Overall Study|Withdrawal by Subject|2|||
33515064|NCT02122770|101782916|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
33515065|NCT02122770|101782917|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
33515066|NCT02122770|101782918|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
33515067|NCT02122770|101782919|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
33515068|NCT02122770|101782920|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
33515069|NCT02122770|101782921|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
33515070|NCT02122770|101782916|FG000|Part A: Drug-drug Interaction 2|Other|0|||
33515071|NCT02122770|101782917|FG001|Part A: Drug-drug Interaction 2|Other|0|||
33515072|NCT02122770|101782918|FG002|Part A: Drug-drug Interaction 2|Other|1|||
33515073|NCT02122770|101782919|FG003|Part A: Drug-drug Interaction 2|Other|0|||
33515074|NCT02122770|101782920|FG004|Part A: Drug-drug Interaction 2|Other|0|||
33515075|NCT02122770|101782921|FG005|Part A: Drug-drug Interaction 2|Other|0|||
33515076|NCT02122770|101782916|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
33199484|NCT02096835|100633838|FG002|Overall Study|Lost to Follow-up|1|||
33199485|NCT03029208|100633843|FG000|Overall Study|Withdrawal by Subject|2|||
33199486|NCT03029208|100633844|FG001|Overall Study|Withdrawal by Subject|3|||
33199487|NCT03029208|100633843|FG000|Overall Study|Lost to Follow-up|0|||
33199488|NCT03029208|100633844|FG001|Overall Study|Lost to Follow-up|1|||
33199489|NCT01260922|100633850|FG000|First Intervention|Withdrawal by Subject|0|||
33199490|NCT01260922|100633851|FG001|First Intervention|Withdrawal by Subject|1|||
33199491|NCT01260922|100633850|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
33199492|NCT01260922|100633851|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
33199493|NCT01260922|100633850|FG000|Second Intervention|Emesis|0|||
33199494|NCT01260922|100633851|FG001|Second Intervention|Emesis|2|||
33199495|NCT04223856|100633854|FG000|Overall Study|Progressive disease|153|||
33199496|NCT04223856|100633855|FG001|Overall Study|Progressive disease|73|||
33199497|NCT04223856|100633854|FG000|Overall Study|Adverse Event|97|||
33199498|NCT04223856|100633855|FG001|Overall Study|Adverse Event|62|||
33199499|NCT04223856|100633854|FG000|Overall Study|Physician Decision|9|||
33199500|NCT04223856|100633855|FG001|Overall Study|Physician Decision|28|||
33199501|NCT04223856|100633854|FG000|Overall Study|Withdrawal by Subject|22|||
33199502|NCT04223856|100633855|FG001|Overall Study|Withdrawal by Subject|24|||
33199503|NCT04223856|100633854|FG000|Overall Study|Other|7|||
33199504|NCT04223856|100633855|FG001|Overall Study|Other|2|||
33199505|NCT04223856|100633854|FG000|Overall Study|Randomized but not treated|2|||
33199506|NCT04223856|100633855|FG001|Overall Study|Randomized but not treated|11|||
33199507|NCT04223856|100633854|FG000|Overall Study|On-treatment|144|||
33199508|NCT04223856|100633855|FG001|Overall Study|On-treatment|0|||
33325542|NCT00467779|101088052|FG003|Stage 1A|Unspecified Reason|0|||
33325543|NCT00467779|101088053|FG004|Stage 1A|Unspecified Reason|0|||
33325544|NCT00467779|101088054|FG005|Stage 1A|Unspecified Reason|0|||
33325545|NCT00467779|101088055|FG006|Stage 1A|Unspecified Reason|0|||
33515077|NCT02122770|101782917|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
33199509|NCT02766608|100633856|FG000|Overall Study|Adverse Event|27|||
33199510|NCT02766608|100633857|FG001|Overall Study|Adverse Event|22|||
33199511|NCT02766608|100633858|FG002|Overall Study|Adverse Event|17|||
33199512|NCT02766608|100633859|FG003|Overall Study|Adverse Event|13|||
33199513|NCT02766608|100633860|FG004|Overall Study|Adverse Event|12|||
33199514|NCT02766608|100633856|FG000|Overall Study|Withdrawal by Subject|21|||
33325546|NCT00467779|101088056|FG007|Stage 1A|Unspecified Reason|0|||
33325547|NCT00467779|101088057|FG008|Stage 1A|Unspecified Reason|0|||
33515078|NCT02122770|101782918|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
33515079|NCT02122770|101782919|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
33515080|NCT02122770|101782920|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
33399680|NCT00033293|101350301|FG000|Overall Study|Physician Decision|3|||
33399681|NCT00033293|101350302|FG001|Overall Study|Physician Decision|1|||
33399682|NCT00033293|101350301|FG000|Overall Study|Withdrawal by Subject|1|||
33399683|NCT00033293|101350302|FG001|Overall Study|Withdrawal by Subject|0|||
33399684|NCT00033293|101350301|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
33515081|NCT02122770|101782921|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
33515082|NCT02122770|101782916|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
33515083|NCT02122770|101782917|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
33399685|NCT00033293|101350302|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
33515084|NCT02122770|101782918|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
33515085|NCT02122770|101782919|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
33325548|NCT00467779|101088058|FG009|Stage 1A|Unspecified Reason|0|||
33325549|NCT00467779|101088059|FG010|Stage 1A|Unspecified Reason|0|||
33325550|NCT00467779|101088060|FG011|Stage 1A|Unspecified Reason|1|||
33325551|NCT00467779|101088061|FG012|Stage 1A|Unspecified Reason|1|||
33325552|NCT00467779|101088062|FG013|Stage 1A|Unspecified Reason|0|||
33325553|NCT00467779|101088063|FG014|Stage 1A|Unspecified Reason|0|||
33199515|NCT02766608|100633857|FG001|Overall Study|Withdrawal by Subject|20|||
33325554|NCT00467779|101088049|FG000|Stage 2|Adverse Event|0|||
33325555|NCT00467779|101088050|FG001|Stage 2|Adverse Event|0|||
33325556|NCT00467779|101088051|FG002|Stage 2|Adverse Event|0|||
33325557|NCT00467779|101088052|FG003|Stage 2|Adverse Event|0|||
33325558|NCT00467779|101088053|FG004|Stage 2|Adverse Event|0|||
33325559|NCT00467779|101088054|FG005|Stage 2|Adverse Event|0|||
33325560|NCT00467779|101088055|FG006|Stage 2|Adverse Event|0|||
33325561|NCT00467779|101088056|FG007|Stage 2|Adverse Event|0|||
33325562|NCT00467779|101088057|FG008|Stage 2|Adverse Event|1|||
33325563|NCT00467779|101088058|FG009|Stage 2|Adverse Event|0|||
33325564|NCT00467779|101088059|FG010|Stage 2|Adverse Event|0|||
33325565|NCT00467779|101088060|FG011|Stage 2|Adverse Event|0|||
33325566|NCT00467779|101088061|FG012|Stage 2|Adverse Event|0|||
33325567|NCT00467779|101088062|FG013|Stage 2|Adverse Event|0|||
33325568|NCT00467779|101088063|FG014|Stage 2|Adverse Event|0|||
33325569|NCT00467779|101088049|FG000|Stage 2|Death|0|||
33325570|NCT00467779|101088050|FG001|Stage 2|Death|0|||
33325571|NCT00467779|101088051|FG002|Stage 2|Death|0|||
33325572|NCT00467779|101088052|FG003|Stage 2|Death|0|||
33199516|NCT02766608|100633858|FG002|Overall Study|Withdrawal by Subject|24|||
33199517|NCT02766608|100633859|FG003|Overall Study|Withdrawal by Subject|13|||
33199518|NCT02766608|100633860|FG004|Overall Study|Withdrawal by Subject|10|||
33199519|NCT02766608|100633856|FG000|Overall Study|Lack of Efficacy|16|||
33199520|NCT02766608|100633857|FG001|Overall Study|Lack of Efficacy|15|||
33199521|NCT02766608|100633858|FG002|Overall Study|Lack of Efficacy|32|||
33515086|NCT02122770|101782920|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
33515087|NCT02122770|101782921|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
33515088|NCT02122770|101782916|FG000|Part B: Standard of Care|Adverse Event|0|||
33515089|NCT02122770|101782917|FG001|Part B: Standard of Care|Adverse Event|0|||
33515090|NCT02122770|101782918|FG002|Part B: Standard of Care|Adverse Event|0|||
33515091|NCT02122770|101782919|FG003|Part B: Standard of Care|Adverse Event|0|||
33515092|NCT02122770|101782920|FG004|Part B: Standard of Care|Adverse Event|4|||
33606956|NCT00812565|102111589|FG001|Overall Study|Reason Not Specified|0|||
33606957|NCT00812565|102111590|FG002|Overall Study|Reason Not Specified|0|||
33606958|NCT00812565|102111591|FG003|Overall Study|Reason Not Specified|0|||
33606959|NCT00812565|102111592|FG004|Overall Study|Reason Not Specified|0|||
33606960|NCT00812565|102111593|FG005|Overall Study|Reason Not Specified|1|||
33606961|NCT00812565|102111594|FG006|Overall Study|Reason Not Specified|0|||
33606962|NCT00812565|102111595|FG007|Overall Study|Reason Not Specified|0|||
33606963|NCT03134183|102111596|FG000|Overall Study|Withdrawal by Subject|1|||
33606964|NCT03134183|102111597|FG001|Overall Study|Withdrawal by Subject|1|||
33606965|NCT04311463|102111598|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
33606966|NCT04311463|102111599|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
33606967|NCT04311463|102111598|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
33606968|NCT04311463|102111599|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
33606969|NCT04311463|102111598|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
33606970|NCT04311463|102111599|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
33606971|NCT02553538|102111605|FG000|Overall Study|Could Not Reach by Telephone|133|||
33606972|NCT02553538|102111606|FG001|Overall Study|Could Not Reach by Telephone|0|||
33606973|NCT02553538|102111605|FG000|Overall Study|Died or Left Network|54|||
33606974|NCT02553538|102111606|FG001|Overall Study|Died or Left Network|56|||
33606975|NCT01789606|102111607|FG000|Overall Study|Participant not Purchased the Product|0|||
33606976|NCT01789606|102111608|FG001|Overall Study|Participant not Purchased the Product|20|||
33606977|NCT01789606|102111607|FG000|Overall Study|Withdrawal by Subject|0|||
33606978|NCT01789606|102111608|FG001|Overall Study|Withdrawal by Subject|1|||
33606979|NCT01789606|102111607|FG000|Overall Study|Ineligible|6|||
33606980|NCT01789606|102111608|FG001|Overall Study|Ineligible|2|||
33606981|NCT01789606|102111607|FG000|Overall Study|Administrative Reasons|17|||
33606982|NCT01789606|102111608|FG001|Overall Study|Administrative Reasons|6|||
33606983|NCT01789606|102111607|FG000|Overall Study|No Study Medication Taken|0|||
33606984|NCT01789606|102111608|FG001|Overall Study|No Study Medication Taken|1|||
33606985|NCT01789606|102111607|FG000|Overall Study|Protocol Violation|0|||
33606986|NCT01789606|102111608|FG001|Overall Study|Protocol Violation|55|||
33606987|NCT01789606|102111607|FG000|Overall Study|Adverse Event|0|||
33606988|NCT01789606|102111608|FG001|Overall Study|Adverse Event|3|||
33606989|NCT01789606|102111607|FG000|Overall Study|Lost to Follow-up|0|||
33606990|NCT01789606|102111608|FG001|Overall Study|Lost to Follow-up|14|||
33606991|NCT01789606|102111607|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
33606992|NCT01789606|102111608|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
33606993|NCT00547521|102111610|FG000|Short Term Study (4 Months)|Adverse Event|1|||
33606994|NCT00547521|102111611|FG001|Short Term Study (4 Months)|Adverse Event|0|||
33606995|NCT00547521|102111610|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
33606996|NCT00547521|102111611|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
33606997|NCT00547521|102111610|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
33606998|NCT00547521|102111611|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
33606999|NCT00547521|102111610|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
33607000|NCT00547521|102111611|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
33607001|NCT00547521|102111610|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
33607002|NCT00547521|102111611|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
33607003|NCT00547521|102111610|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
33607004|NCT00547521|102111611|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
33607005|NCT00547521|102111610|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
33607006|NCT00547521|102111611|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
33607007|NCT00547521|102111610|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
33607008|NCT00547521|102111611|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
33607009|NCT00547521|102111610|FG000|Long Term Extension (LTE) Study|Other|0|||
33607010|NCT00547521|102111611|FG001|Long Term Extension (LTE) Study|Other|2|||
33199522|NCT02766608|100633859|FG003|Overall Study|Lack of Efficacy|8|||
33515093|NCT02122770|101782921|FG005|Part B: Standard of Care|Adverse Event|1|||
33515094|NCT02122770|101782916|FG000|Part B: Standard of Care|Other|0|||
33515095|NCT02122770|101782917|FG001|Part B: Standard of Care|Other|0|||
33515096|NCT02122770|101782918|FG002|Part B: Standard of Care|Other|0|||
33515097|NCT02122770|101782919|FG003|Part B: Standard of Care|Other|0|||
33515098|NCT02122770|101782920|FG004|Part B: Standard of Care|Other|0|||
33199523|NCT02766608|100633860|FG004|Overall Study|Lack of Efficacy|2|||
33199524|NCT02766608|100633856|FG000|Overall Study|Lost to Follow-up|6|||
33515099|NCT02122770|101782921|FG005|Part B: Standard of Care|Other|2|||
33515100|NCT02122770|101782916|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
33515101|NCT02122770|101782917|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
33515102|NCT02122770|101782918|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
33515103|NCT02122770|101782919|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
33515104|NCT02122770|101782920|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
33515105|NCT02122770|101782921|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
33515106|NCT02122770|101782916|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
33515107|NCT02122770|101782917|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
33515108|NCT02122770|101782918|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
33515109|NCT02122770|101782919|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
33515110|NCT02122770|101782920|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
33515111|NCT02122770|101782921|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
33515112|NCT02122770|101782916|FG000|Part B: Standard of Care|Progressive Disease|0|||
33325573|NCT00467779|101088053|FG004|Stage 2|Death|0|||
33325574|NCT00467779|101088054|FG005|Stage 2|Death|0|||
33325575|NCT00467779|101088055|FG006|Stage 2|Death|0|||
33325576|NCT00467779|101088056|FG007|Stage 2|Death|0|||
33325577|NCT00467779|101088057|FG008|Stage 2|Death|1|||
33325578|NCT00467779|101088058|FG009|Stage 2|Death|0|||
33325579|NCT00467779|101088059|FG010|Stage 2|Death|0|||
33325580|NCT00467779|101088060|FG011|Stage 2|Death|0|||
33325581|NCT00467779|101088061|FG012|Stage 2|Death|0|||
33325582|NCT00467779|101088062|FG013|Stage 2|Death|0|||
33325583|NCT00467779|101088063|FG014|Stage 2|Death|0|||
33515113|NCT02122770|101782917|FG001|Part B: Standard of Care|Progressive Disease|0|||
33515114|NCT02122770|101782918|FG002|Part B: Standard of Care|Progressive Disease|0|||
33515115|NCT02122770|101782919|FG003|Part B: Standard of Care|Progressive Disease|0|||
33515116|NCT02122770|101782920|FG004|Part B: Standard of Care|Progressive Disease|10|||
33515117|NCT02122770|101782921|FG005|Part B: Standard of Care|Progressive Disease|8|||
33515118|NCT01382225|101782922|FG000|Overall Study|Adverse Event|3|||
33515119|NCT01382225|101782923|FG001|Overall Study|Adverse Event|2|||
33515120|NCT01382225|101782922|FG000|Overall Study|Protocol Violation|2|||
33515121|NCT01382225|101782923|FG001|Overall Study|Protocol Violation|1|||
33515122|NCT01382225|101782922|FG000|Overall Study|Subject Withdrew Consent|5|||
33199525|NCT02766608|100633857|FG001|Overall Study|Lost to Follow-up|3|||
33199526|NCT02766608|100633858|FG002|Overall Study|Lost to Follow-up|5|||
33325584|NCT00467779|101088049|FG000|Stage 2|Disease Progression|0|||
33325585|NCT00467779|101088050|FG001|Stage 2|Disease Progression|0|||
33325586|NCT00467779|101088051|FG002|Stage 2|Disease Progression|0|||
33325587|NCT00467779|101088052|FG003|Stage 2|Disease Progression|0|||
33325588|NCT00467779|101088053|FG004|Stage 2|Disease Progression|0|||
33325589|NCT00467779|101088054|FG005|Stage 2|Disease Progression|0|||
33325590|NCT00467779|101088055|FG006|Stage 2|Disease Progression|0|||
33325591|NCT00467779|101088056|FG007|Stage 2|Disease Progression|0|||
33325592|NCT00467779|101088057|FG008|Stage 2|Disease Progression|16|||
33325593|NCT00467779|101088058|FG009|Stage 2|Disease Progression|0|||
33325594|NCT00467779|101088059|FG010|Stage 2|Disease Progression|0|||
33325595|NCT00467779|101088060|FG011|Stage 2|Disease Progression|0|||
33325596|NCT00467779|101088061|FG012|Stage 2|Disease Progression|0|||
33325597|NCT00467779|101088062|FG013|Stage 2|Disease Progression|0|||
33325598|NCT00467779|101088063|FG014|Stage 2|Disease Progression|0|||
33325599|NCT00467779|101088049|FG000|Stage 2|Unspecified Reason|0|||
33325600|NCT00467779|101088050|FG001|Stage 2|Unspecified Reason|0|||
33325601|NCT00467779|101088051|FG002|Stage 2|Unspecified Reason|0|||
33325602|NCT00467779|101088052|FG003|Stage 2|Unspecified Reason|0|||
33325603|NCT00467779|101088053|FG004|Stage 2|Unspecified Reason|0|||
33515123|NCT01382225|101782923|FG001|Overall Study|Subject Withdrew Consent|2|||
33325604|NCT00467779|101088054|FG005|Stage 2|Unspecified Reason|0|||
33325605|NCT00467779|101088055|FG006|Stage 2|Unspecified Reason|0|||
33325606|NCT00467779|101088056|FG007|Stage 2|Unspecified Reason|0|||
33325607|NCT00467779|101088057|FG008|Stage 2|Unspecified Reason|3|||
33325608|NCT00467779|101088058|FG009|Stage 2|Unspecified Reason|0|||
33325609|NCT00467779|101088059|FG010|Stage 2|Unspecified Reason|0|||
33515124|NCT01382225|101782922|FG000|Overall Study|Other|4|||
33515125|NCT01382225|101782923|FG001|Overall Study|Other|2|||
33199527|NCT02766608|100633859|FG003|Overall Study|Lost to Follow-up|2|||
33199528|NCT02766608|100633860|FG004|Overall Study|Lost to Follow-up|2|||
33325610|NCT00467779|101088060|FG011|Stage 2|Unspecified Reason|0|||
33325611|NCT00467779|101088061|FG012|Stage 2|Unspecified Reason|0|||
33325612|NCT00467779|101088062|FG013|Stage 2|Unspecified Reason|0|||
33325613|NCT00467779|101088063|FG014|Stage 2|Unspecified Reason|0|||
33515126|NCT00386425|101782924|FG000|Overall Study|Physician Decision|3|||
33515127|NCT00386425|101782925|FG001|Overall Study|Physician Decision|0|||
33325614|NCT00467779|101088049|FG000|Stage 2A|Adverse Event|0|||
33325615|NCT00467779|101088050|FG001|Stage 2A|Adverse Event|0|||
33325616|NCT00467779|101088051|FG002|Stage 2A|Adverse Event|0|||
33325617|NCT00467779|101088052|FG003|Stage 2A|Adverse Event|0|||
33325618|NCT00467779|101088053|FG004|Stage 2A|Adverse Event|0|||
33325619|NCT00467779|101088054|FG005|Stage 2A|Adverse Event|0|||
33325620|NCT00467779|101088055|FG006|Stage 2A|Adverse Event|0|||
33325621|NCT00467779|101088056|FG007|Stage 2A|Adverse Event|0|||
33325622|NCT00467779|101088057|FG008|Stage 2A|Adverse Event|0|||
33325623|NCT00467779|101088058|FG009|Stage 2A|Adverse Event|0|||
33325624|NCT00467779|101088059|FG010|Stage 2A|Adverse Event|0|||
33325625|NCT00467779|101088060|FG011|Stage 2A|Adverse Event|0|||
33325626|NCT00467779|101088061|FG012|Stage 2A|Adverse Event|0|||
33325627|NCT00467779|101088062|FG013|Stage 2A|Adverse Event|2|||
33325628|NCT00467779|101088063|FG014|Stage 2A|Adverse Event|0|||
33325629|NCT00467779|101088049|FG000|Stage 2A|Death|0|||
33325630|NCT00467779|101088050|FG001|Stage 2A|Death|0|||
33325631|NCT00467779|101088051|FG002|Stage 2A|Death|0|||
33325632|NCT00467779|101088052|FG003|Stage 2A|Death|0|||
33325633|NCT00467779|101088053|FG004|Stage 2A|Death|0|||
33325634|NCT00467779|101088054|FG005|Stage 2A|Death|0|||
33325635|NCT00467779|101088055|FG006|Stage 2A|Death|0|||
33325636|NCT00467779|101088056|FG007|Stage 2A|Death|0|||
33515128|NCT00386425|101782926|FG002|Overall Study|Physician Decision|0|||
33515129|NCT00386425|101782924|FG000|Overall Study|Withdrawal by Subject|0|||
33515130|NCT00386425|101782925|FG001|Overall Study|Withdrawal by Subject|1|||
33515131|NCT00386425|101782926|FG002|Overall Study|Withdrawal by Subject|0|||
33515132|NCT00900731|101782927|FG000|Overall Study|Adverse Event|31|||
33515133|NCT00900731|101782928|FG001|Overall Study|Adverse Event|27|||
33515134|NCT00900731|101782927|FG000|Overall Study|Withdrawal by Subject|8|||
33515135|NCT00900731|101782928|FG001|Overall Study|Withdrawal by Subject|7|||
33515136|NCT00900731|101782927|FG000|Overall Study|Protocol Deviation|8|||
33515137|NCT00900731|101782928|FG001|Overall Study|Protocol Deviation|11|||
33515138|NCT00900731|101782927|FG000|Overall Study|Administrative Problems|5|||
33515139|NCT00900731|101782928|FG001|Overall Study|Administrative Problems|4|||
33515140|NCT00900731|101782927|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
33515141|NCT00900731|101782928|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
33515142|NCT00900731|101782927|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
33515143|NCT00900731|101782928|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
33515144|NCT00900731|101782927|FG000|Overall Study|Lost to Follow-up|2|||
33515145|NCT00900731|101782928|FG001|Overall Study|Lost to Follow-up|3|||
33515146|NCT00900731|101782927|FG000|Overall Study|Lack of Efficacy|1|||
33515147|NCT00900731|101782928|FG001|Overall Study|Lack of Efficacy|3|||
33515148|NCT00900731|101782927|FG000|Overall Study|Death|0|||
33325637|NCT00467779|101088057|FG008|Stage 2A|Death|0|||
33325638|NCT00467779|101088058|FG009|Stage 2A|Death|0|||
33325639|NCT00467779|101088059|FG010|Stage 2A|Death|0|||
33325640|NCT00467779|101088060|FG011|Stage 2A|Death|0|||
33399686|NCT00033293|101350301|FG000|Overall Study|Treatment refused|0|||
33399687|NCT00033293|101350302|FG001|Overall Study|Treatment refused|6|||
33399688|NCT00826540|101350305|FG000|Overall Study|ineligible|3|||
33399689|NCT00826540|101350305|FG000|Overall Study|Withdrawal by Subject|1|||
33399690|NCT01279954|101350306|FG000|Overall Study|Lack of Efficacy|3|||
33399691|NCT01279954|101350307|FG001|Overall Study|Lack of Efficacy|4|||
33399692|NCT00808028|101350308|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
33515149|NCT00900731|101782928|FG001|Overall Study|Death|2|||
33515150|NCT00976209|101782937|FG000|Treatment Period 1|Protocol Violation|1|||
33325641|NCT00467779|101088061|FG012|Stage 2A|Death|0|||
33399693|NCT00808028|101350309|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
33515151|NCT00976209|101782938|FG001|Treatment Period 1|Protocol Violation|0|||
33515152|NCT00976209|101782937|FG000|Treatment Period 1|Lost to Follow-up|2|||
33515153|NCT00976209|101782938|FG001|Treatment Period 1|Lost to Follow-up|0|||
33515154|NCT00976209|101782937|FG000|Treatment Period 1|Other|0|||
33515155|NCT00976209|101782938|FG001|Treatment Period 1|Other|1|||
33515156|NCT00976209|101782937|FG000|Wash-out Period|Adverse Event|1|||
33325642|NCT00467779|101088062|FG013|Stage 2A|Death|1|||
33325643|NCT00467779|101088063|FG014|Stage 2A|Death|0|||
33325644|NCT00467779|101088049|FG000|Stage 2A|Disease Progression|0|||
33325645|NCT00467779|101088050|FG001|Stage 2A|Disease Progression|0|||
33325646|NCT00467779|101088051|FG002|Stage 2A|Disease Progression|0|||
33325647|NCT00467779|101088052|FG003|Stage 2A|Disease Progression|0|||
33325648|NCT00467779|101088053|FG004|Stage 2A|Disease Progression|0|||
33325649|NCT00467779|101088054|FG005|Stage 2A|Disease Progression|0|||
33399694|NCT00808028|101350310|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
33399695|NCT00808028|101350311|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
33607011|NCT00547521|102111610|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
33607012|NCT00547521|102111611|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
33607013|NCT05079477|102111613|FG000|Overall Study|Lost to Follow-up|2|||
33607014|NCT05079477|102111614|FG001|Overall Study|Lost to Follow-up|0|||
33515157|NCT00976209|101782938|FG001|Wash-out Period|Adverse Event|2|||
33515158|NCT00976209|101782937|FG000|Wash-out Period|Lost to Follow-up|1|||
33515159|NCT00976209|101782938|FG001|Wash-out Period|Lost to Follow-up|0|||
33515160|NCT00976209|101782937|FG000|Wash-out Period|Protocol Violation|1|||
33607015|NCT05079477|102111613|FG000|Overall Study|Withdrawal by Subject|1|||
33607016|NCT05079477|102111614|FG001|Overall Study|Withdrawal by Subject|0|||
33607017|NCT05079477|102111613|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
33607018|NCT05079477|102111614|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
33607019|NCT05079477|102111613|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
33607020|NCT05079477|102111614|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
33607021|NCT01438177|102111616|FG000|Overall Study|Withdrawal by Subject|1|||
33607022|NCT01438177|102111616|FG000|Overall Study|Initiation of new therapy|1|||
33607023|NCT02607228|102111617|FG000|Overall Study|Progressive Disease|4|||
33607024|NCT02607228|102111618|FG001|Overall Study|Progressive Disease|3|||
33515161|NCT00976209|101782938|FG001|Wash-out Period|Protocol Violation|0|||
33515162|NCT00976209|101782937|FG000|Wash-out Period|Other|1|||
33515163|NCT00976209|101782938|FG001|Wash-out Period|Other|0|||
33515164|NCT00976209|101782937|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33515165|NCT00976209|101782938|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33515166|NCT00976209|101782937|FG000|Treatment Period 2|Lost to Follow-up|0|||
33515167|NCT00976209|101782938|FG001|Treatment Period 2|Lost to Follow-up|1|||
33515168|NCT00270231|101782939|FG000|First Intervention|Lost to Follow-up|1|||
33515169|NCT00270231|101782940|FG001|First Intervention|Lost to Follow-up|1|||
33515170|NCT00270231|101782939|FG000|Washout Period|Lost to Follow-up|1|||
33515171|NCT00270231|101782940|FG001|Washout Period|Lost to Follow-up|0|||
33515172|NCT00270231|101782939|FG000|Second Intervention|Lost to Follow-up|0|||
33515173|NCT00270231|101782940|FG001|Second Intervention|Lost to Follow-up|1|||
33515174|NCT02998476|101782942|FG000|Overall Study|Lost to Follow-up|1|||
33515175|NCT02998476|101782943|FG001|Overall Study|Lost to Follow-up|0|||
33515176|NCT02998476|101782942|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
33515177|NCT02998476|101782943|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
33515178|NCT02998476|101782942|FG000|Overall Study|Withdrawal by Subject|1|||
33515179|NCT02998476|101782943|FG001|Overall Study|Withdrawal by Subject|2|||
33515180|NCT02998476|101782942|FG000|Overall Study|Death|45|||
33515181|NCT02998476|101782943|FG001|Overall Study|Death|2|||
33515182|NCT02998476|101782942|FG000|Overall Study|Other|6|||
33515183|NCT02998476|101782943|FG001|Overall Study|Other|1|||
33515184|NCT02002533|101782944|FG000|Overall Study|Withdrawal by Subject|6|||
33515185|NCT02002533|101782945|FG001|Overall Study|Withdrawal by Subject|13|||
33515186|NCT02002533|101782944|FG000|Overall Study|Protocol Violation|0|||
33515187|NCT02002533|101782945|FG001|Overall Study|Protocol Violation|1|||
33515188|NCT02002533|101782944|FG000|Overall Study|Adverse Event|0|||
33515189|NCT02002533|101782945|FG001|Overall Study|Adverse Event|3|||
33515190|NCT02002533|101782944|FG000|Overall Study|Lost to Follow-up|0|||
33515191|NCT02002533|101782945|FG001|Overall Study|Lost to Follow-up|1|||
33515192|NCT04045132|101782946|FG000|Overall Study|Lost to Follow-up|3|||
33515193|NCT04045132|101782947|FG001|Overall Study|Lost to Follow-up|6|||
33607025|NCT02607228|102111619|FG002|Overall Study|Progressive Disease|1|||
33515194|NCT03085238|101782948|FG000|Overall Study|Adverse Event|2|||
33515195|NCT03085238|101782948|FG000|Overall Study|Death|2|||
33515196|NCT01378975|101782949|FG000|Overall Study|Death|77|||
33515197|NCT01378975|101782950|FG001|Overall Study|Death|46|||
33515198|NCT01378975|101782949|FG000|Overall Study|Investigator Request|1|||
33515199|NCT01378975|101782950|FG001|Overall Study|Investigator Request|0|||
33515200|NCT01378975|101782949|FG000|Overall Study|Lost to Follow-up|4|||
33607026|NCT02607228|102111620|FG003|Overall Study|Progressive Disease|5|||
33607027|NCT02607228|102111621|FG004|Overall Study|Progressive Disease|4|||
33607028|NCT02607228|102111622|FG005|Overall Study|Progressive Disease|3|||
33607029|NCT02607228|102111623|FG006|Overall Study|Progressive Disease|1|||
33607030|NCT02607228|102111617|FG000|Overall Study|Adverse Event|1|||
33607031|NCT02607228|102111618|FG001|Overall Study|Adverse Event|0|||
33607032|NCT02607228|102111619|FG002|Overall Study|Adverse Event|1|||
33607033|NCT02607228|102111620|FG003|Overall Study|Adverse Event|0|||
33325650|NCT00467779|101088055|FG006|Stage 2A|Disease Progression|0|||
33325651|NCT00467779|101088056|FG007|Stage 2A|Disease Progression|0|||
33325652|NCT00467779|101088057|FG008|Stage 2A|Disease Progression|0|||
33325653|NCT00467779|101088058|FG009|Stage 2A|Disease Progression|0|||
33325654|NCT00467779|101088059|FG010|Stage 2A|Disease Progression|0|||
33325655|NCT00467779|101088060|FG011|Stage 2A|Disease Progression|0|||
33325656|NCT00467779|101088061|FG012|Stage 2A|Disease Progression|0|||
33325657|NCT00467779|101088062|FG013|Stage 2A|Disease Progression|10|||
33325658|NCT00467779|101088063|FG014|Stage 2A|Disease Progression|0|||
33325659|NCT00467779|101088049|FG000|Stage 2A|Unspecified Reason|0|||
33325660|NCT00467779|101088050|FG001|Stage 2A|Unspecified Reason|0|||
33325661|NCT00467779|101088051|FG002|Stage 2A|Unspecified Reason|0|||
33325662|NCT00467779|101088052|FG003|Stage 2A|Unspecified Reason|0|||
33325663|NCT00467779|101088053|FG004|Stage 2A|Unspecified Reason|0|||
33325664|NCT00467779|101088054|FG005|Stage 2A|Unspecified Reason|0|||
33325665|NCT00467779|101088055|FG006|Stage 2A|Unspecified Reason|0|||
33607034|NCT02607228|102111621|FG004|Overall Study|Adverse Event|1|||
33607035|NCT02607228|102111622|FG005|Overall Study|Adverse Event|1|||
33607036|NCT02607228|102111623|FG006|Overall Study|Adverse Event|1|||
33607037|NCT02607228|102111617|FG000|Overall Study|Investigator's Discretion|0|||
33607038|NCT02607228|102111618|FG001|Overall Study|Investigator's Discretion|0|||
33607039|NCT02607228|102111619|FG002|Overall Study|Investigator's Discretion|1|||
33607040|NCT02607228|102111620|FG003|Overall Study|Investigator's Discretion|0|||
33607041|NCT02607228|102111621|FG004|Overall Study|Investigator's Discretion|0|||
33607042|NCT02607228|102111622|FG005|Overall Study|Investigator's Discretion|1|||
33607043|NCT02607228|102111623|FG006|Overall Study|Investigator's Discretion|0|||
33607044|NCT02607228|102111617|FG000|Overall Study|Withdrew Consent|0|||
33607045|NCT02607228|102111618|FG001|Overall Study|Withdrew Consent|1|||
33607046|NCT02607228|102111619|FG002|Overall Study|Withdrew Consent|0|||
33607047|NCT02607228|102111620|FG003|Overall Study|Withdrew Consent|0|||
33607048|NCT02607228|102111621|FG004|Overall Study|Withdrew Consent|0|||
33607049|NCT02607228|102111622|FG005|Overall Study|Withdrew Consent|1|||
33607050|NCT02607228|102111623|FG006|Overall Study|Withdrew Consent|0|||
33607051|NCT02607228|102111617|FG000|Overall Study|Study Terminated by Sponsor|0|||
33607052|NCT02607228|102111618|FG001|Overall Study|Study Terminated by Sponsor|0|||
33607053|NCT02607228|102111619|FG002|Overall Study|Study Terminated by Sponsor|0|||
33607054|NCT02607228|102111620|FG003|Overall Study|Study Terminated by Sponsor|1|||
33607055|NCT02607228|102111621|FG004|Overall Study|Study Terminated by Sponsor|0|||
33607056|NCT02607228|102111622|FG005|Overall Study|Study Terminated by Sponsor|0|||
33607057|NCT02607228|102111623|FG006|Overall Study|Study Terminated by Sponsor|0|||
33607058|NCT00098306|102111624|FG000|Double Blind|Randomized, not treated|9|||
33325666|NCT00467779|101088056|FG007|Stage 2A|Unspecified Reason|0|||
33325667|NCT00467779|101088057|FG008|Stage 2A|Unspecified Reason|0|||
33325668|NCT00467779|101088058|FG009|Stage 2A|Unspecified Reason|0|||
33325669|NCT00467779|101088059|FG010|Stage 2A|Unspecified Reason|0|||
33325670|NCT00467779|101088060|FG011|Stage 2A|Unspecified Reason|0|||
33325671|NCT00467779|101088061|FG012|Stage 2A|Unspecified Reason|0|||
33607059|NCT00098306|102111625|FG001|Double Blind|Randomized, not treated|5|||
33607060|NCT00098306|102111626|FG002|Double Blind|Randomized, not treated|2|||
33607061|NCT00098306|102111627|FG003|Double Blind|Randomized, not treated|0|||
33607062|NCT00098306|102111628|FG004|Double Blind|Randomized, not treated|0|||
33607063|NCT00098306|102111629|FG005|Double Blind|Randomized, not treated|0|||
33607064|NCT00098306|102111630|FG006|Double Blind|Randomized, not treated|0|||
33325672|NCT00467779|101088062|FG013|Stage 2A|Unspecified Reason|7|||
33325673|NCT00467779|101088063|FG014|Stage 2A|Unspecified Reason|0|||
33325674|NCT00467779|101088049|FG000|Stage 2A|Withdrawal by Subject|0|||
33325675|NCT00467779|101088050|FG001|Stage 2A|Withdrawal by Subject|0|||
33607065|NCT00098306|102111624|FG000|Double Blind|Ongoing at cut-off date|151|||
33607066|NCT00098306|102111625|FG001|Double Blind|Ongoing at cut-off date|166|||
33607067|NCT00098306|102111626|FG002|Double Blind|Ongoing at cut-off date|72|||
33607068|NCT00098306|102111627|FG003|Double Blind|Ongoing at cut-off date|0|||
33607069|NCT00098306|102111628|FG004|Double Blind|Ongoing at cut-off date|0|||
33607070|NCT00098306|102111629|FG005|Double Blind|Ongoing at cut-off date|0|||
33607071|NCT00098306|102111630|FG006|Double Blind|Ongoing at cut-off date|0|||
33325676|NCT00467779|101088051|FG002|Stage 2A|Withdrawal by Subject|0|||
33325677|NCT00467779|101088052|FG003|Stage 2A|Withdrawal by Subject|0|||
33325678|NCT00467779|101088053|FG004|Stage 2A|Withdrawal by Subject|0|||
33607072|NCT00098306|102111624|FG000|Double Blind|Adverse Event|11|||
33607073|NCT00098306|102111625|FG001|Double Blind|Adverse Event|10|||
33325679|NCT00467779|101088054|FG005|Stage 2A|Withdrawal by Subject|0|||
33325680|NCT00467779|101088055|FG006|Stage 2A|Withdrawal by Subject|0|||
33325681|NCT00467779|101088056|FG007|Stage 2A|Withdrawal by Subject|0|||
33607074|NCT00098306|102111626|FG002|Double Blind|Adverse Event|6|||
33607075|NCT00098306|102111627|FG003|Double Blind|Adverse Event|0|||
33607076|NCT00098306|102111628|FG004|Double Blind|Adverse Event|0|||
33607077|NCT00098306|102111629|FG005|Double Blind|Adverse Event|0|||
33607078|NCT00098306|102111630|FG006|Double Blind|Adverse Event|0|||
33607079|NCT00098306|102111624|FG000|Double Blind|Lack of Efficacy|43|||
33607080|NCT00098306|102111625|FG001|Double Blind|Lack of Efficacy|34|||
33607081|NCT00098306|102111626|FG002|Double Blind|Lack of Efficacy|17|||
33607082|NCT00098306|102111627|FG003|Double Blind|Lack of Efficacy|0|||
33607083|NCT00098306|102111628|FG004|Double Blind|Lack of Efficacy|0|||
33607084|NCT00098306|102111629|FG005|Double Blind|Lack of Efficacy|0|||
33607085|NCT00098306|102111630|FG006|Double Blind|Lack of Efficacy|0|||
33607086|NCT00098306|102111624|FG000|Double Blind|Death|1|||
33515201|NCT01378975|101782950|FG001|Overall Study|Lost to Follow-up|1|||
33515202|NCT01378975|101782949|FG000|Overall Study|Withdrew Consent|4|||
33515203|NCT01378975|101782950|FG001|Overall Study|Withdrew Consent|3|||
33515204|NCT03521817|101782951|FG000|Overall Study|Protocol Violation|0|||
33515205|NCT03521817|101782952|FG001|Overall Study|Protocol Violation|1|||
33515206|NCT00962091|101782956|FG000|Overall Study|Withdrawal by Subject|1|||
33515207|NCT00962091|101782957|FG001|Overall Study|Withdrawal by Subject|2|||
33515208|NCT00962091|101782958|FG002|Overall Study|Withdrawal by Subject|1|||
33515209|NCT00962091|101782959|FG003|Overall Study|Withdrawal by Subject|1|||
33515210|NCT00962091|101782960|FG004|Overall Study|Withdrawal by Subject|0|||
33515211|NCT00962091|101782961|FG005|Overall Study|Withdrawal by Subject|1|||
33515212|NCT00962091|101782962|FG006|Overall Study|Withdrawal by Subject|0|||
33515213|NCT00962091|101782956|FG000|Overall Study|Adverse Event|0|||
33515214|NCT00962091|101782957|FG001|Overall Study|Adverse Event|0|||
33515215|NCT00962091|101782958|FG002|Overall Study|Adverse Event|0|||
33515216|NCT00962091|101782959|FG003|Overall Study|Adverse Event|0|||
33515217|NCT00962091|101782960|FG004|Overall Study|Adverse Event|0|||
33515218|NCT00962091|101782961|FG005|Overall Study|Adverse Event|0|||
33515219|NCT00962091|101782962|FG006|Overall Study|Adverse Event|1|||
33515220|NCT02332239|101782966|FG000|Overall Study|Lost to Follow-up|4|||
33515221|NCT02332239|101782967|FG001|Overall Study|Lost to Follow-up|6|||
33515222|NCT01534208|101782969|FG000|Overall Study|Lost to Follow-up|19|||
33515223|NCT01534208|101782970|FG001|Overall Study|Lost to Follow-up|14|||
33515224|NCT01534208|101782969|FG000|Overall Study|Withdrawal by Subject|6|||
33515225|NCT01534208|101782970|FG001|Overall Study|Withdrawal by Subject|20|||
33515226|NCT01534208|101782969|FG000|Overall Study|Adverse Event|15|||
33515227|NCT01534208|101782970|FG001|Overall Study|Adverse Event|8|||
33515228|NCT01534208|101782969|FG000|Overall Study|Physician Decision|2|||
33515229|NCT01534208|101782970|FG001|Overall Study|Physician Decision|0|||
33515230|NCT01534208|101782969|FG000|Overall Study|Lack of Efficacy|0|||
33515231|NCT01534208|101782970|FG001|Overall Study|Lack of Efficacy|3|||
33515232|NCT01534208|101782969|FG000|Overall Study|Protocol Violation|2|||
33515233|NCT01534208|101782970|FG001|Overall Study|Protocol Violation|2|||
33607087|NCT00098306|102111625|FG001|Double Blind|Death|4|||
33607088|NCT00098306|102111626|FG002|Double Blind|Death|1|||
33199529|NCT02766608|100633856|FG000|Overall Study|Physician Decision|3|||
33199530|NCT02766608|100633857|FG001|Overall Study|Physician Decision|2|||
33515234|NCT01534208|101782969|FG000|Overall Study|Sponsor decision|4|||
33515235|NCT01534208|101782970|FG001|Overall Study|Sponsor decision|1|||
33515236|NCT01534208|101782969|FG000|Overall Study|Subject relocation|2|||
33515237|NCT01534208|101782970|FG001|Overall Study|Subject relocation|0|||
33515238|NCT01534208|101782969|FG000|Overall Study|Lab assessment|2|||
33515239|NCT01534208|101782970|FG001|Overall Study|Lab assessment|1|||
33515240|NCT01534208|101782969|FG000|Overall Study|Eligibility error|3|||
33515241|NCT01534208|101782970|FG001|Overall Study|Eligibility error|0|||
33607089|NCT00098306|102111627|FG003|Double Blind|Death|0|||
33607090|NCT00098306|102111628|FG004|Double Blind|Death|0|||
33199531|NCT02766608|100633858|FG002|Overall Study|Physician Decision|3|||
33515242|NCT01534208|101782969|FG000|Overall Study|PCP decision|1|||
33515243|NCT01534208|101782970|FG001|Overall Study|PCP decision|0|||
33515244|NCT01534208|101782969|FG000|Overall Study|Needed prohibited meds|1|||
33607091|NCT00098306|102111629|FG005|Double Blind|Death|0|||
33515245|NCT01534208|101782970|FG001|Overall Study|Needed prohibited meds|0|||
33515246|NCT01149421|101782971|FG000|Overall Study|Adverse Event|22|||
33515247|NCT01149421|101782972|FG001|Overall Study|Adverse Event|6|||
33515248|NCT01149421|101782973|FG002|Overall Study|Adverse Event|11|||
33515249|NCT01149421|101782971|FG000|Overall Study|Withdrawal by Subject|20|||
33325682|NCT00467779|101088057|FG008|Stage 2A|Withdrawal by Subject|0|||
33325683|NCT00467779|101088058|FG009|Stage 2A|Withdrawal by Subject|0|||
33325684|NCT00467779|101088059|FG010|Stage 2A|Withdrawal by Subject|0|||
33325685|NCT00467779|101088060|FG011|Stage 2A|Withdrawal by Subject|0|||
33325686|NCT00467779|101088061|FG012|Stage 2A|Withdrawal by Subject|0|||
33325687|NCT00467779|101088062|FG013|Stage 2A|Withdrawal by Subject|1|||
33325688|NCT00467779|101088063|FG014|Stage 2A|Withdrawal by Subject|0|||
33325689|NCT00467779|101088049|FG000|Stage 3|Adverse Event|0|||
33325690|NCT00467779|101088050|FG001|Stage 3|Adverse Event|0|||
33325691|NCT00467779|101088051|FG002|Stage 3|Adverse Event|0|||
33325692|NCT00467779|101088052|FG003|Stage 3|Adverse Event|0|||
33515250|NCT01149421|101782972|FG001|Overall Study|Withdrawal by Subject|12|||
33515251|NCT01149421|101782973|FG002|Overall Study|Withdrawal by Subject|13|||
33515252|NCT01149421|101782971|FG000|Overall Study|Sponsor Decision|0|||
33515253|NCT01149421|101782972|FG001|Overall Study|Sponsor Decision|1|||
33515254|NCT01149421|101782973|FG002|Overall Study|Sponsor Decision|1|||
33515255|NCT01149421|101782971|FG000|Overall Study|Lost to Follow-up|2|||
33607092|NCT00098306|102111630|FG006|Double Blind|Death|0|||
33607093|NCT00098306|102111624|FG000|Double Blind|Participant defaulted|19|||
33607094|NCT00098306|102111625|FG001|Double Blind|Participant defaulted|18|||
33607095|NCT00098306|102111626|FG002|Double Blind|Participant defaulted|11|||
33607096|NCT00098306|102111627|FG003|Double Blind|Participant defaulted|0|||
33607097|NCT00098306|102111628|FG004|Double Blind|Participant defaulted|0|||
33607098|NCT00098306|102111629|FG005|Double Blind|Participant defaulted|0|||
33607099|NCT00098306|102111630|FG006|Double Blind|Participant defaulted|0|||
33607100|NCT00098306|102111624|FG000|Double Blind|Un-specified|7|||
33607101|NCT00098306|102111625|FG001|Double Blind|Un-specified|3|||
33607102|NCT00098306|102111626|FG002|Double Blind|Un-specified|11|||
33607103|NCT00098306|102111627|FG003|Double Blind|Un-specified|0|||
33607104|NCT00098306|102111628|FG004|Double Blind|Un-specified|0|||
33607105|NCT00098306|102111629|FG005|Double Blind|Un-specified|0|||
33607106|NCT00098306|102111630|FG006|Double Blind|Un-specified|0|||
33607107|NCT00098306|102111624|FG000|Open Label|Lack of Efficacy|0|||
33607108|NCT00098306|102111625|FG001|Open Label|Lack of Efficacy|0|||
33607109|NCT00098306|102111626|FG002|Open Label|Lack of Efficacy|0|||
33607110|NCT00098306|102111627|FG003|Open Label|Lack of Efficacy|13|||
33607111|NCT00098306|102111628|FG004|Open Label|Lack of Efficacy|0|||
33607112|NCT00098306|102111629|FG005|Open Label|Lack of Efficacy|0|||
33607113|NCT00098306|102111630|FG006|Open Label|Lack of Efficacy|0|||
33607114|NCT00098306|102111624|FG000|Open Label|Adverse Event|0|||
33607115|NCT00098306|102111625|FG001|Open Label|Adverse Event|0|||
33607116|NCT00098306|102111626|FG002|Open Label|Adverse Event|0|||
33607117|NCT00098306|102111627|FG003|Open Label|Adverse Event|2|||
33607118|NCT00098306|102111628|FG004|Open Label|Adverse Event|0|||
33607119|NCT00098306|102111629|FG005|Open Label|Adverse Event|0|||
33607120|NCT00098306|102111630|FG006|Open Label|Adverse Event|0|||
33607121|NCT00098306|102111624|FG000|Open Label|Death|0|||
33607122|NCT00098306|102111625|FG001|Open Label|Death|0|||
33607123|NCT00098306|102111626|FG002|Open Label|Death|0|||
33607124|NCT00098306|102111627|FG003|Open Label|Death|4|||
33607125|NCT00098306|102111628|FG004|Open Label|Death|0|||
33607126|NCT00098306|102111629|FG005|Open Label|Death|0|||
33607127|NCT00098306|102111630|FG006|Open Label|Death|0|||
33607128|NCT00098306|102111624|FG000|Open Label|Participant defaulted|0|||
33607129|NCT00098306|102111625|FG001|Open Label|Participant defaulted|0|||
33607130|NCT00098306|102111626|FG002|Open Label|Participant defaulted|0|||
33607131|NCT00098306|102111627|FG003|Open Label|Participant defaulted|24|||
33607132|NCT00098306|102111628|FG004|Open Label|Participant defaulted|0|||
33607133|NCT00098306|102111629|FG005|Open Label|Participant defaulted|0|||
33607134|NCT00098306|102111630|FG006|Open Label|Participant defaulted|0|||
33607135|NCT00098306|102111624|FG000|Open Label|Un-specified|0|||
33607136|NCT00098306|102111625|FG001|Open Label|Un-specified|0|||
33607137|NCT00098306|102111626|FG002|Open Label|Un-specified|0|||
33607138|NCT00098306|102111627|FG003|Open Label|Un-specified|15|||
33607139|NCT00098306|102111628|FG004|Open Label|Un-specified|0|||
33607140|NCT00098306|102111629|FG005|Open Label|Un-specified|0|||
33325693|NCT00467779|101088053|FG004|Stage 3|Adverse Event|0|||
33325694|NCT00467779|101088054|FG005|Stage 3|Adverse Event|0|||
33607141|NCT00098306|102111630|FG006|Open Label|Un-specified|0|||
33607142|NCT00098306|102111624|FG000|Open Label|Ongoing at cut-off date|0|||
33325695|NCT00467779|101088055|FG006|Stage 3|Adverse Event|0|||
33515256|NCT01149421|101782972|FG001|Overall Study|Lost to Follow-up|4|||
33607143|NCT00098306|102111625|FG001|Open Label|Ongoing at cut-off date|0|||
33607144|NCT00098306|102111626|FG002|Open Label|Ongoing at cut-off date|0|||
33607145|NCT00098306|102111627|FG003|Open Label|Ongoing at cut-off date|269|||
33607146|NCT00098306|102111628|FG004|Open Label|Ongoing at cut-off date|62|||
33607147|NCT00098306|102111629|FG005|Open Label|Ongoing at cut-off date|0|||
33607148|NCT00098306|102111630|FG006|Open Label|Ongoing at cut-off date|0|||
33515257|NCT01149421|101782973|FG002|Overall Study|Lost to Follow-up|5|||
33515258|NCT01149421|101782971|FG000|Overall Study|Physician Decision|5|||
33515259|NCT01149421|101782972|FG001|Overall Study|Physician Decision|3|||
33515260|NCT01149421|101782973|FG002|Overall Study|Physician Decision|6|||
33515261|NCT01149421|101782971|FG000|Overall Study|Entry Criteria Not Met|1|||
33515262|NCT01149421|101782972|FG001|Overall Study|Entry Criteria Not Met|1|||
33515263|NCT01149421|101782973|FG002|Overall Study|Entry Criteria Not Met|2|||
33515264|NCT01149421|101782971|FG000|Overall Study|Protocol Violation|2|||
33515265|NCT01149421|101782972|FG001|Overall Study|Protocol Violation|2|||
33515266|NCT01149421|101782973|FG002|Overall Study|Protocol Violation|6|||
33515267|NCT00070018|101782976|FG000|Overall Study|Adverse Event|2|||
33515268|NCT00070018|101782976|FG000|Overall Study|Lack of Efficacy|1|||
33515269|NCT00070018|101782976|FG000|Overall Study|Withdrawal by Subject|1|||
33515270|NCT00784550|101782982|FG000|Overall Study|Adverse Event|12|||
33325696|NCT00467779|101088056|FG007|Stage 3|Adverse Event|0|||
33325697|NCT00467779|101088057|FG008|Stage 3|Adverse Event|0|||
33325698|NCT00467779|101088058|FG009|Stage 3|Adverse Event|0|||
33325699|NCT00467779|101088059|FG010|Stage 3|Adverse Event|0|||
33325700|NCT00467779|101088060|FG011|Stage 3|Adverse Event|0|||
33325701|NCT00467779|101088061|FG012|Stage 3|Adverse Event|0|||
33325702|NCT00467779|101088062|FG013|Stage 3|Adverse Event|0|||
33199532|NCT02766608|100633859|FG003|Overall Study|Physician Decision|1|||
33515271|NCT00784550|101782983|FG001|Overall Study|Adverse Event|10|||
33515272|NCT00784550|101782982|FG000|Overall Study|Lack of Efficacy|0|||
33515273|NCT00784550|101782983|FG001|Overall Study|Lack of Efficacy|1|||
33607149|NCT00098306|102111624|FG000|Observational Phase|Death|0|||
33607150|NCT00098306|102111625|FG001|Observational Phase|Death|0|||
33199533|NCT02766608|100633860|FG004|Overall Study|Physician Decision|2|||
33325703|NCT00467779|101088063|FG014|Stage 3|Adverse Event|2|||
33325704|NCT00467779|101088049|FG000|Stage 3|Death|0|||
33325705|NCT00467779|101088050|FG001|Stage 3|Death|0|||
33325706|NCT00467779|101088051|FG002|Stage 3|Death|0|||
33199534|NCT02766608|100633856|FG000|Overall Study|Protocol disc criteria|3|||
33325707|NCT00467779|101088052|FG003|Stage 3|Death|0|||
33515274|NCT00784550|101782982|FG000|Overall Study|Protocol Violation|10|||
33325708|NCT00467779|101088053|FG004|Stage 3|Death|0|||
33325709|NCT00467779|101088054|FG005|Stage 3|Death|0|||
33325710|NCT00467779|101088055|FG006|Stage 3|Death|0|||
33325711|NCT00467779|101088056|FG007|Stage 3|Death|0|||
33325712|NCT00467779|101088057|FG008|Stage 3|Death|0|||
33325713|NCT00467779|101088058|FG009|Stage 3|Death|0|||
33325714|NCT00467779|101088059|FG010|Stage 3|Death|0|||
33325715|NCT00467779|101088060|FG011|Stage 3|Death|0|||
33515275|NCT00784550|101782983|FG001|Overall Study|Protocol Violation|10|||
33515276|NCT00784550|101782982|FG000|Overall Study|Lost to Follow-up|8|||
33607151|NCT00098306|102111626|FG002|Observational Phase|Death|0|||
33607152|NCT00098306|102111627|FG003|Observational Phase|Death|0|||
33515277|NCT00784550|101782983|FG001|Overall Study|Lost to Follow-up|5|||
33515278|NCT00784550|101782982|FG000|Overall Study|Physician Decision|2|||
33515279|NCT00784550|101782983|FG001|Overall Study|Physician Decision|3|||
33515280|NCT00784550|101782982|FG000|Overall Study|Withdrawal by Subject|4|||
33515281|NCT00784550|101782983|FG001|Overall Study|Withdrawal by Subject|13|||
33515282|NCT02719353|101782984|FG000|First Intervention|Physician Decision|0|||
33515283|NCT02719353|101782985|FG001|First Intervention|Physician Decision|1|||
33515284|NCT01527487|101782986|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
33607153|NCT00098306|102111628|FG004|Observational Phase|Death|0|||
33607154|NCT00098306|102111629|FG005|Observational Phase|Death|5|||
33607155|NCT00098306|102111630|FG006|Observational Phase|Death|4|||
33607156|NCT00098306|102111624|FG000|Observational Phase|Participant defaulted|0|||
33607157|NCT00098306|102111625|FG001|Observational Phase|Participant defaulted|0|||
33607158|NCT00098306|102111626|FG002|Observational Phase|Participant defaulted|0|||
33607159|NCT00098306|102111627|FG003|Observational Phase|Participant defaulted|0|||
33607160|NCT00098306|102111628|FG004|Observational Phase|Participant defaulted|0|||
33607161|NCT00098306|102111629|FG005|Observational Phase|Participant defaulted|34|||
33607162|NCT00098306|102111630|FG006|Observational Phase|Participant defaulted|18|||
33607163|NCT00098306|102111624|FG000|Observational Phase|Un-specified|0|||
33607164|NCT00098306|102111625|FG001|Observational Phase|Un-specified|0|||
33607165|NCT00098306|102111626|FG002|Observational Phase|Un-specified|0|||
33607166|NCT00098306|102111627|FG003|Observational Phase|Un-specified|0|||
33607167|NCT00098306|102111628|FG004|Observational Phase|Un-specified|0|||
33607168|NCT00098306|102111629|FG005|Observational Phase|Un-specified|7|||
33607169|NCT00098306|102111630|FG006|Observational Phase|Un-specified|4|||
33607170|NCT01270256|102111631|FG000|Overall Study|Withdrawal by Subject|1|||
33607171|NCT01270256|102111632|FG001|Overall Study|Withdrawal by Subject|0|||
33607172|NCT01141478|102111633|FG000|Overall Study|Withdrawal by Subject|1|||
33607173|NCT01141478|102111634|FG001|Overall Study|Withdrawal by Subject|1|||
33607174|NCT03824587|102111635|FG000|Run-in Period|Screen Failure|0|||
33607175|NCT03824587|102111636|FG001|Run-in Period|Screen Failure|275|||
33325716|NCT00467779|101088061|FG012|Stage 3|Death|0|||
33325717|NCT00467779|101088062|FG013|Stage 3|Death|0|||
33515285|NCT01527487|101782987|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
33325718|NCT00467779|101088063|FG014|Stage 3|Death|1|||
33515286|NCT01527487|101782986|FG000|Overall Study|Disease Progression|4|||
33607176|NCT03824587|102111635|FG000|Treatment Period|Adverse Event|4|||
33607177|NCT03824587|102111636|FG001|Treatment Period|Adverse Event|1|||
33325719|NCT00467779|101088049|FG000|Stage 3|Disease Progression|0|||
33199535|NCT02766608|100633857|FG001|Overall Study|Protocol disc criteria|3|||
33199536|NCT02766608|100633858|FG002|Overall Study|Protocol disc criteria|4|||
33199537|NCT02766608|100633859|FG003|Overall Study|Protocol disc criteria|0|||
33199538|NCT02766608|100633860|FG004|Overall Study|Protocol disc criteria|0|||
33515287|NCT01527487|101782987|FG001|Overall Study|Disease Progression|1|||
33515288|NCT01527487|101782986|FG000|Overall Study|Adverse Event|1|||
33515289|NCT01527487|101782987|FG001|Overall Study|Adverse Event|1|||
33515290|NCT01527487|101782986|FG000|Overall Study|Death|0|||
33515291|NCT01527487|101782987|FG001|Overall Study|Death|1|||
33515292|NCT04495816|101782988|FG000|Overall Study|Lost to Follow-up|10|||
33515293|NCT04495816|101782989|FG001|Overall Study|Lost to Follow-up|4|||
33515294|NCT04495816|101782988|FG000|Overall Study|Withdrawal by Subject|3|||
33515295|NCT04495816|101782989|FG001|Overall Study|Withdrawal by Subject|5|||
33199539|NCT02766608|100633856|FG000|Overall Study|Protocol Violation|0|||
33199540|NCT02766608|100633857|FG001|Overall Study|Protocol Violation|4|||
33199541|NCT02766608|100633858|FG002|Overall Study|Protocol Violation|4|||
33515296|NCT01664949|101782990|FG000|Overall Study|Adverse Event|11|||
33515297|NCT01664949|101782991|FG001|Overall Study|Adverse Event|12|||
33515298|NCT01664949|101782990|FG000|Overall Study|Lack of Efficacy|1|||
33515299|NCT01664949|101782991|FG001|Overall Study|Lack of Efficacy|1|||
33515300|NCT01664949|101782990|FG000|Overall Study|Lost to Follow-up|1|||
33515301|NCT01664949|101782991|FG001|Overall Study|Lost to Follow-up|2|||
33515302|NCT01664949|101782990|FG000|Overall Study|Personal Reasons|3|||
33515303|NCT01664949|101782991|FG001|Overall Study|Personal Reasons|4|||
33515304|NCT01664949|101782990|FG000|Overall Study|Protocol Violation|5|||
33515305|NCT01664949|101782991|FG001|Overall Study|Protocol Violation|5|||
33515306|NCT01664949|101782990|FG000|Overall Study|Other Miscellaneous Reasons|3|||
33515307|NCT01664949|101782991|FG001|Overall Study|Other Miscellaneous Reasons|1|||
33515308|NCT02091375|101782993|FG000|Overall Study|Adverse Event|8|||
33515309|NCT02091375|101782994|FG001|Overall Study|Adverse Event|1|||
33515310|NCT02091375|101782993|FG000|Overall Study|Lost to Follow-up|0|||
33515311|NCT02091375|101782994|FG001|Overall Study|Lost to Follow-up|1|||
33515312|NCT02091375|101782993|FG000|Overall Study|Withdrawal by Subject|0|||
33515313|NCT02091375|101782994|FG001|Overall Study|Withdrawal by Subject|1|||
33515314|NCT02091375|101782993|FG000|Overall Study|Withdrawn by the investigator|1|||
33199542|NCT02766608|100633859|FG003|Overall Study|Protocol Violation|0|||
33199543|NCT02766608|100633860|FG004|Overall Study|Protocol Violation|1|||
33199544|NCT02766608|100633856|FG000|Overall Study|Administrative Reasons|3|||
33199545|NCT02766608|100633857|FG001|Overall Study|Administrative Reasons|1|||
33199546|NCT02766608|100633858|FG002|Overall Study|Administrative Reasons|1|||
33199547|NCT02766608|100633859|FG003|Overall Study|Administrative Reasons|0|||
33199548|NCT02766608|100633860|FG004|Overall Study|Administrative Reasons|0|||
33199549|NCT02349711|100633863|FG000|Overall Study|Withdrawal by Subject|2|||
33199550|NCT02349711|100633864|FG001|Overall Study|Withdrawal by Subject|1|||
33199551|NCT02349711|100633863|FG000|Overall Study|Lost to Follow-up|1|||
33199552|NCT02349711|100633864|FG001|Overall Study|Lost to Follow-up|1|||
33199553|NCT01775137|100633865|FG000|Overall Study|Death|1|||
33199554|NCT01775137|100633865|FG000|Overall Study|Protocol deviation|2|||
33199555|NCT01775137|100633865|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33199556|NCT01775137|100633865|FG000|Overall Study|Adverse Event|1|||
33199557|NCT01775137|100633865|FG000|Overall Study|Withdrawal by participants|5|||
33325720|NCT00467779|101088050|FG001|Stage 3|Disease Progression|0|||
33325721|NCT00467779|101088051|FG002|Stage 3|Disease Progression|0|||
33325722|NCT00467779|101088052|FG003|Stage 3|Disease Progression|0|||
33325723|NCT00467779|101088053|FG004|Stage 3|Disease Progression|0|||
33515315|NCT02091375|101782994|FG001|Overall Study|Withdrawn by the investigator|0|||
33515316|NCT01001598|101783006|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
33199558|NCT00812929|100633866|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
33199559|NCT00812929|100633867|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
33199560|NCT00812929|100633868|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
33199561|NCT00812929|100633869|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
33325724|NCT00467779|101088054|FG005|Stage 3|Disease Progression|0|||
33325725|NCT00467779|101088055|FG006|Stage 3|Disease Progression|0|||
33325726|NCT00467779|101088056|FG007|Stage 3|Disease Progression|0|||
33515317|NCT01001598|101783006|FG000|Overall Study|Adverse Event|1|||
33515318|NCT02255552|101783007|FG000|Overall Study|Participants enrolled into another study|0|||
33515319|NCT02255552|101783008|FG001|Overall Study|Participants enrolled into another study|11|||
33515320|NCT02255552|101783007|FG000|Overall Study|Withdrawal by Subject|1|||
33515321|NCT02255552|101783008|FG001|Overall Study|Withdrawal by Subject|4|||
33515322|NCT01783821|101783011|FG000|Overall Study|Screen Failure|1|||
33515323|NCT01783821|101783012|FG001|Overall Study|Screen Failure|1|||
33515324|NCT02918552|101783013|FG000|Overall Study|Failed Pharmacokinetics|1|||
33515325|NCT02918552|101783014|FG001|Overall Study|Failed Pharmacokinetics|0|||
33515326|NCT02918552|101783013|FG000|Overall Study|Withdrawal by Subject|0|||
33515327|NCT02918552|101783014|FG001|Overall Study|Withdrawal by Subject|1|||
33515328|NCT02918552|101783013|FG000|Overall Study|Lost to Follow-up|0|||
33515329|NCT02918552|101783014|FG001|Overall Study|Lost to Follow-up|1|||
33515330|NCT03495154|101783015|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
33515331|NCT03495154|101783015|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
33515332|NCT03495154|101783015|FG000|Overall Study|Screen Failures During Surgery|6|||
33515333|NCT03495154|101783015|FG000|Overall Study|Death|2|||
33515334|NCT03495154|101783015|FG000|Overall Study|Lost to Follow-up|16|||
33515335|NCT03495154|101783015|FG000|Overall Study|Withdrawal by Subject|2|||
33515336|NCT03495154|101783015|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
33515337|NCT00477607|101783016|FG000|Overall Study|Lost to Follow-up|7|||
33515338|NCT00477607|101783017|FG001|Overall Study|Lost to Follow-up|7|||
33515339|NCT04608344|101783020|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
33515340|NCT04608344|101783021|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
33515341|NCT04608344|101783020|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
33515342|NCT04608344|101783021|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
33515343|NCT01732471|101783022|FG000|Overall Study|Withdrawal by Subject|1|||
33515344|NCT01404208|101783023|FG000|Overall Study|Discontinued|3|||
33515345|NCT01404208|101783024|FG001|Overall Study|Discontinued|0|||
33515346|NCT01537068|101783025|FG000|Overall Study|Lost to Follow-up|2|||
33515347|NCT01537068|101783026|FG001|Overall Study|Lost to Follow-up|1|||
33515348|NCT01537068|101783025|FG000|Overall Study|Adverse Event|0|||
33515349|NCT01537068|101783026|FG001|Overall Study|Adverse Event|1|||
33515350|NCT01537068|101783025|FG000|Overall Study|Withdrawal by Subject|1|||
33515351|NCT01537068|101783026|FG001|Overall Study|Withdrawal by Subject|1|||
33515352|NCT01537068|101783025|FG000|Overall Study|Lack of Efficacy|1|||
33515353|NCT01537068|101783026|FG001|Overall Study|Lack of Efficacy|0|||
33515354|NCT03026530|101783027|FG000|Overall Study|Lost to Follow-up|19|||
33515355|NCT03026530|101783028|FG001|Overall Study|Lost to Follow-up|24|||
33515356|NCT03026530|101783027|FG000|Overall Study|Protocol Violation|2|||
33515357|NCT03026530|101783028|FG001|Overall Study|Protocol Violation|5|||
33515358|NCT01472965|101783030|FG000|Overall Study|Withdrawal by Subject|1|||
33515359|NCT01472965|101783031|FG001|Overall Study|Withdrawal by Subject|0|||
33515360|NCT04829331|101783032|FG000|Overall Study|Lost to Follow-up|1|||
33515361|NCT04829331|101783033|FG001|Overall Study|Lost to Follow-up|0|||
33515362|NCT03301740|101783035|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
33515363|NCT03301740|101783036|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
33515364|NCT03301740|101783035|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
33515365|NCT03301740|101783036|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
33515366|NCT01185509|101783037|FG000|Overall Study|Progression/Relapse|9|||
33515367|NCT01185509|101783038|FG001|Overall Study|Progression/Relapse|15|||
33515368|NCT01185509|101783037|FG000|Overall Study|Physician Decision|2|||
33515369|NCT01185509|101783038|FG001|Overall Study|Physician Decision|2|||
33515370|NCT01185509|101783037|FG000|Overall Study|Withdrawal by Subject|0|||
33325727|NCT00467779|101088057|FG008|Stage 3|Disease Progression|0|||
33325728|NCT00467779|101088058|FG009|Stage 3|Disease Progression|0|||
33325729|NCT00467779|101088059|FG010|Stage 3|Disease Progression|0|||
33325730|NCT00467779|101088060|FG011|Stage 3|Disease Progression|0|||
33325731|NCT00467779|101088061|FG012|Stage 3|Disease Progression|0|||
33325732|NCT00467779|101088062|FG013|Stage 3|Disease Progression|0|||
33325733|NCT00467779|101088063|FG014|Stage 3|Disease Progression|9|||
33325734|NCT00467779|101088049|FG000|Stage 3|Unspecified Reason|0|||
33325735|NCT00467779|101088050|FG001|Stage 3|Unspecified Reason|0|||
33325736|NCT00467779|101088051|FG002|Stage 3|Unspecified Reason|0|||
33325737|NCT00467779|101088052|FG003|Stage 3|Unspecified Reason|0|||
33325738|NCT00467779|101088053|FG004|Stage 3|Unspecified Reason|0|||
33325739|NCT00467779|101088054|FG005|Stage 3|Unspecified Reason|0|||
33325740|NCT00467779|101088055|FG006|Stage 3|Unspecified Reason|0|||
33325741|NCT00467779|101088056|FG007|Stage 3|Unspecified Reason|0|||
33325742|NCT00467779|101088057|FG008|Stage 3|Unspecified Reason|0|||
33325743|NCT00467779|101088058|FG009|Stage 3|Unspecified Reason|0|||
33325744|NCT00467779|101088059|FG010|Stage 3|Unspecified Reason|0|||
33515371|NCT01185509|101783038|FG001|Overall Study|Withdrawal by Subject|1|||
33325745|NCT00467779|101088060|FG011|Stage 3|Unspecified Reason|0|||
33325746|NCT00467779|101088061|FG012|Stage 3|Unspecified Reason|0|||
33325747|NCT00467779|101088062|FG013|Stage 3|Unspecified Reason|0|||
33325748|NCT00467779|101088063|FG014|Stage 3|Unspecified Reason|5|||
33325749|NCT01353508|101088064|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
33515372|NCT01185509|101783037|FG000|Overall Study|Death|0|||
33515373|NCT01185509|101783038|FG001|Overall Study|Death|1|||
33515374|NCT01185509|101783037|FG000|Overall Study|Intercurrent Illness|0|||
33515375|NCT01185509|101783038|FG001|Overall Study|Intercurrent Illness|1|||
33515376|NCT03426436|101783039|FG000|Overall Study|Incorrect lead placement|12|||
33199562|NCT00812929|100633870|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
33199563|NCT00812929|100633871|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
33199564|NCT00812929|100633872|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
33199565|NCT00812929|100633873|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
33199566|NCT00812929|100633874|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
33199567|NCT00812929|100633875|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
33199568|NCT00812929|100633866|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
33199569|NCT00812929|100633867|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
33199570|NCT00812929|100633868|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
33199571|NCT00812929|100633869|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
33199572|NCT00812929|100633870|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
33199573|NCT00812929|100633871|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
33199574|NCT00812929|100633872|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
33199575|NCT00812929|100633873|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
33199576|NCT00812929|100633874|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
33199577|NCT00812929|100633875|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
33199578|NCT00812929|100633866|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
33199579|NCT00812929|100633867|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
33325750|NCT01353508|101088065|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
33515377|NCT03426436|101783039|FG000|Overall Study|Withdrawal by Subject|2|||
33515378|NCT03426436|101783039|FG000|Overall Study|Consent issue|1|||
33515379|NCT03426436|101783039|FG000|Overall Study|ECGs not saved|4|||
33515380|NCT01841567|101783042|FG000|Overall Study|Adverse Event|3|||
33325751|NCT01353508|101088066|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
33515381|NCT02429310|101783043|FG000|Overall Study|Lost to Follow-up|1|||
33515382|NCT02429310|101783044|FG001|Overall Study|Lost to Follow-up|2|||
33515383|NCT02429310|101783043|FG000|Overall Study|Protocol Violation|1|||
33515384|NCT02429310|101783044|FG001|Overall Study|Protocol Violation|1|||
33515385|NCT00157820|101783045|FG000|Randomized|Physician Decision|4|||
33515386|NCT00157820|101783046|FG001|Randomized|Physician Decision|2|||
33515387|NCT00157820|101783047|FG002|Randomized|Physician Decision|3|||
33515388|NCT00157820|101783045|FG000|Randomized|Withdrawal by Subject|1|||
33515389|NCT00157820|101783046|FG001|Randomized|Withdrawal by Subject|2|||
33515390|NCT00157820|101783047|FG002|Randomized|Withdrawal by Subject|3|||
33515391|NCT00157820|101783045|FG000|Randomized|Protocol Violation|2|||
33515392|NCT00157820|101783046|FG001|Randomized|Protocol Violation|1|||
33515393|NCT00157820|101783047|FG002|Randomized|Protocol Violation|2|||
33515394|NCT00157820|101783045|FG000|1st 8 Month|Death|7|||
33515395|NCT00157820|101783046|FG001|1st 8 Month|Death|8|||
33515396|NCT00157820|101783047|FG002|1st 8 Month|Death|3|||
33515397|NCT00157820|101783045|FG000|1st 8 Month|Lost to Follow-up|1|||
33515398|NCT00157820|101783046|FG001|1st 8 Month|Lost to Follow-up|2|||
33515399|NCT00157820|101783047|FG002|1st 8 Month|Lost to Follow-up|1|||
33515400|NCT00157820|101783045|FG000|1st 8 Month|Premature cross-over|0|||
33515401|NCT00157820|101783046|FG001|1st 8 Month|Premature cross-over|2|||
33515402|NCT00157820|101783047|FG002|1st 8 Month|Premature cross-over|2|||
33515403|NCT00157820|101783045|FG000|2nd 8 Months|Death|3|||
33515404|NCT00157820|101783046|FG001|2nd 8 Months|Death|1|||
33515405|NCT00157820|101783047|FG002|2nd 8 Months|Death|3|||
33515406|NCT00157820|101783045|FG000|2nd 8 Months|Lost to Follow-up|1|||
33515407|NCT00157820|101783046|FG001|2nd 8 Months|Lost to Follow-up|5|||
33607178|NCT03824587|102111635|FG000|Treatment Period|Withdrawal by Subject|0|||
33607179|NCT03824587|102111636|FG001|Treatment Period|Withdrawal by Subject|1|||
33607180|NCT03824587|102111635|FG000|Treatment Period|Kidney Transplant|1|||
33607181|NCT03824587|102111636|FG001|Treatment Period|Kidney Transplant|1|||
33325752|NCT01353508|101088067|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
33399696|NCT00808028|101350308|FG000|Stage 1 (6 Months)|Other|1|||
33515408|NCT00157820|101783047|FG002|2nd 8 Months|Lost to Follow-up|2|||
33515409|NCT00157820|101783045|FG000|2nd 8 Months|Premature cross-over|1|||
33515410|NCT00157820|101783046|FG001|2nd 8 Months|Premature cross-over|7|||
33515411|NCT00157820|101783047|FG002|2nd 8 Months|Premature cross-over|9|||
33515412|NCT03332628|101783048|FG000|Overall Study|Physician Decision|2|||
33515413|NCT00860249|101783052|FG000|Overall Study|trial was terminated prior to completion|21|||
33515414|NCT00860249|101783053|FG001|Overall Study|trial was terminated prior to completion|18|||
33515415|NCT00860249|101783054|FG002|Overall Study|trial was terminated prior to completion|21|||
33515416|NCT01041976|101783055|FG000|Overall Study|Withdrawal by Subject|3|||
33515417|NCT01041976|101783056|FG001|Overall Study|Withdrawal by Subject|0|||
33515418|NCT01041976|101783055|FG000|Overall Study|Incarceration|2|||
33607182|NCT00619307|102111642|FG000|Overall Study|Adverse Event|0|||
33199580|NCT00812929|100633868|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
33199581|NCT00812929|100633869|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
33199582|NCT00812929|100633870|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
33199583|NCT00812929|100633871|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
33607183|NCT00619307|102111643|FG001|Overall Study|Adverse Event|1|||
33607184|NCT00619307|102111642|FG000|Overall Study|Lost to Follow-up|0|||
33607185|NCT00619307|102111643|FG001|Overall Study|Lost to Follow-up|1|||
33607186|NCT00619307|102111642|FG000|Overall Study|Protocol Violation|3|||
33607187|NCT00619307|102111643|FG001|Overall Study|Protocol Violation|0|||
33607188|NCT00619307|102111642|FG000|Overall Study|Withdrew consent|1|||
33199584|NCT00812929|100633872|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
33607189|NCT00619307|102111643|FG001|Overall Study|Withdrew consent|0|||
33607190|NCT00619307|102111642|FG000|Overall Study|Severe migraine|0|||
33607191|NCT00619307|102111643|FG001|Overall Study|Severe migraine|1|||
33607192|NCT00619307|102111642|FG000|Overall Study|MS attack plus steroids|0|||
33325753|NCT01353508|101088064|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
33325754|NCT01353508|101088065|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
33325755|NCT01353508|101088066|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
33607193|NCT00619307|102111643|FG001|Overall Study|MS attack plus steroids|1|||
33607194|NCT04732949|102111644|FG000|Overall Study|Withdrawal by Subject|23|||
33607195|NCT04732949|102111645|FG001|Overall Study|Withdrawal by Subject|27|||
33607196|NCT04732949|102111644|FG000|Overall Study|Protocol Violation|0|||
33607197|NCT04732949|102111645|FG001|Overall Study|Protocol Violation|1|||
33607198|NCT04732949|102111644|FG000|Overall Study|Non-compliance|0|||
33607199|NCT04732949|102111645|FG001|Overall Study|Non-compliance|2|||
33607200|NCT04732949|102111644|FG000|Overall Study|Physician Decision|2|||
33607201|NCT04732949|102111645|FG001|Overall Study|Physician Decision|1|||
33607202|NCT04732949|102111644|FG000|Overall Study|Serious adverse event (Fatal)|16|||
33607203|NCT04732949|102111645|FG001|Overall Study|Serious adverse event (Fatal)|18|||
33607204|NCT04732949|102111644|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
33607205|NCT04732949|102111645|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
33607206|NCT04732949|102111644|FG000|Overall Study|Non-serious adverse event|1|||
33607207|NCT04732949|102111645|FG001|Overall Study|Non-serious adverse event|3|||
33607208|NCT04732949|102111644|FG000|Overall Study|Lost to Follow-up|26|||
33607209|NCT04732949|102111645|FG001|Overall Study|Lost to Follow-up|27|||
33607210|NCT04732949|102111644|FG000|Overall Study|Other|6|||
33607211|NCT04732949|102111645|FG001|Overall Study|Other|3|||
33607212|NCT00528996|102111646|FG000|Overall Study|Other reasons than listing|6|||
33607213|NCT00528996|102111647|FG001|Overall Study|Other reasons than listing|7|||
33325756|NCT01353508|101088067|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
33325757|NCT02616614|101088068|FG000|Overall Study|Withdrawal by Subject|10|||
33325758|NCT02616614|101088069|FG001|Overall Study|Withdrawal by Subject|5|||
33325759|NCT02616614|101088070|FG002|Overall Study|Withdrawal by Subject|6|||
33325760|NCT02616614|101088068|FG000|Overall Study|Physician Decision|2|||
33325761|NCT02616614|101088069|FG001|Overall Study|Physician Decision|1|||
33325762|NCT02616614|101088070|FG002|Overall Study|Physician Decision|0|||
33325763|NCT02616614|101088068|FG000|Overall Study|Adverse Event|1|||
33325764|NCT02616614|101088069|FG001|Overall Study|Adverse Event|4|||
33325765|NCT02616614|101088070|FG002|Overall Study|Adverse Event|1|||
33199585|NCT00812929|100633873|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
33607214|NCT00528996|102111648|FG002|Overall Study|Other reasons than listing|14|||
33607215|NCT00528996|102111649|FG003|Overall Study|Other reasons than listing|11|||
33607216|NCT00528996|102111650|FG004|Overall Study|Other reasons than listing|5|||
33607217|NCT00528996|102111646|FG000|Overall Study|Refused continue medication|16|||
33607218|NCT00528996|102111647|FG001|Overall Study|Refused continue medication|0|||
33607219|NCT00528996|102111648|FG002|Overall Study|Refused continue medication|3|||
33607220|NCT00528996|102111649|FG003|Overall Study|Refused continue medication|3|||
33607221|NCT00528996|102111650|FG004|Overall Study|Refused continue medication|6|||
33607222|NCT00528996|102111646|FG000|Overall Study|Lost to Follow-up|2|||
33607223|NCT00528996|102111647|FG001|Overall Study|Lost to Follow-up|0|||
33607224|NCT00528996|102111648|FG002|Overall Study|Lost to Follow-up|4|||
33607225|NCT00528996|102111649|FG003|Overall Study|Lost to Follow-up|1|||
33607226|NCT00528996|102111650|FG004|Overall Study|Lost to Follow-up|3|||
33325766|NCT02616614|101088068|FG000|Overall Study|Protocol Violation|0|||
33325767|NCT02616614|101088069|FG001|Overall Study|Protocol Violation|3|||
33607227|NCT00528996|102111646|FG000|Overall Study|Protocol Violation|1|||
33325768|NCT02616614|101088070|FG002|Overall Study|Protocol Violation|1|||
33607228|NCT00528996|102111647|FG001|Overall Study|Protocol Violation|2|||
33607229|NCT00528996|102111648|FG002|Overall Study|Protocol Violation|3|||
33607230|NCT00528996|102111649|FG003|Overall Study|Protocol Violation|3|||
33325769|NCT02616614|101088068|FG000|Overall Study|Prohibited Medication|12|||
33325770|NCT02616614|101088069|FG001|Overall Study|Prohibited Medication|9|||
33325771|NCT02616614|101088070|FG002|Overall Study|Prohibited Medication|5|||
33325772|NCT02616614|101088068|FG000|Overall Study|More than 3 applications missed|6|||
33325773|NCT02616614|101088069|FG001|Overall Study|More than 3 applications missed|8|||
33325774|NCT02616614|101088070|FG002|Overall Study|More than 3 applications missed|1|||
33325775|NCT02616614|101088068|FG000|Overall Study|Lost to Follow-up|31|||
33325776|NCT02616614|101088069|FG001|Overall Study|Lost to Follow-up|28|||
33325777|NCT02616614|101088070|FG002|Overall Study|Lost to Follow-up|13|||
33325778|NCT02616614|101088068|FG000|Overall Study|Pregnancy|2|||
33325779|NCT02616614|101088069|FG001|Overall Study|Pregnancy|0|||
33325780|NCT02616614|101088070|FG002|Overall Study|Pregnancy|1|||
33325781|NCT02616614|101088068|FG000|Overall Study|Other|1|||
33325782|NCT02616614|101088069|FG001|Overall Study|Other|2|||
33515419|NCT01041976|101783056|FG001|Overall Study|Incarceration|0|||
33515420|NCT01041976|101783055|FG000|Overall Study|Death|0|||
33515421|NCT01041976|101783056|FG001|Overall Study|Death|4|||
33515422|NCT00379808|101783058|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
33515423|NCT00379808|101783059|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
33515424|NCT03840148|101783070|FG000|Study Drug Disposition|Adverse Event|13|||
33515425|NCT03840148|101783071|FG001|Study Drug Disposition|Adverse Event|2|||
33515426|NCT03840148|101783070|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
33515427|NCT03840148|101783071|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
33515428|NCT03840148|101783070|FG000|Study Drug Disposition|Lack of Efficacy|3|||
33607231|NCT00528996|102111650|FG004|Overall Study|Protocol Violation|2|||
33607232|NCT00528996|102111646|FG000|Overall Study|Lack of Efficacy|7|||
33199586|NCT00812929|100633874|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
33199587|NCT00812929|100633875|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
33199588|NCT01438411|100633878|FG000|Overall Study|Adverse Event|8|||
33199589|NCT01438411|100633878|FG000|Overall Study|Lost to Follow-up|1|||
33199590|NCT01438411|100633878|FG000|Overall Study|Lack of Efficacy|1|||
33199591|NCT01438411|100633878|FG000|Overall Study|Withdrawal by Subject|3|||
33199592|NCT02086591|100633879|FG000|Overall Study|Adverse Event|1|||
33325783|NCT02616614|101088070|FG002|Overall Study|Other|1|||
33325784|NCT01538628|101088071|FG000|Overall Study|Withdrawal by Subject|1|||
33607233|NCT00528996|102111647|FG001|Overall Study|Lack of Efficacy|2|||
33607234|NCT00528996|102111648|FG002|Overall Study|Lack of Efficacy|1|||
33607235|NCT00528996|102111649|FG003|Overall Study|Lack of Efficacy|3|||
33607236|NCT00528996|102111650|FG004|Overall Study|Lack of Efficacy|3|||
33607237|NCT00528996|102111646|FG000|Overall Study|Adverse Event|32|||
33607238|NCT00528996|102111647|FG001|Overall Study|Adverse Event|13|||
33607239|NCT00528996|102111648|FG002|Overall Study|Adverse Event|18|||
33607240|NCT00528996|102111649|FG003|Overall Study|Adverse Event|29|||
33607241|NCT00528996|102111650|FG004|Overall Study|Adverse Event|18|||
33325785|NCT01538628|101088072|FG001|Overall Study|Withdrawal by Subject|1|||
33515429|NCT03840148|101783071|FG001|Study Drug Disposition|Lack of Efficacy|0|||
33325786|NCT01538628|101088071|FG000|Overall Study|Lost to Follow-up|0|||
33325787|NCT01538628|101088072|FG001|Overall Study|Lost to Follow-up|1|||
33515430|NCT03840148|101783070|FG000|Study Drug Disposition|Physician Decision|2|||
33607242|NCT03596450|102111653|FG000|Overall Study|Death|9|||
33607243|NCT03596450|102111654|FG001|Overall Study|Death|9|||
33325788|NCT02252536|101088077|FG000|Overall Study|Lost to Follow-up|5|||
33325789|NCT02252536|101088078|FG001|Overall Study|Lost to Follow-up|3|||
33325790|NCT04344301|101088079|FG000|Overall Study|Withdrawal by Subject|1|||
33325791|NCT04344301|101088080|FG001|Overall Study|Withdrawal by Subject|0|||
33325792|NCT04344301|101088079|FG000|Overall Study|Death|0|||
33325793|NCT04344301|101088080|FG001|Overall Study|Death|1|||
33325794|NCT00404820|101088081|FG000|Overall Study|Adverse Event|4|||
33325795|NCT00404820|101088082|FG001|Overall Study|Adverse Event|16|||
33325796|NCT00404820|101088081|FG000|Overall Study|Withdrawal by Subject|5|||
33325797|NCT00404820|101088082|FG001|Overall Study|Withdrawal by Subject|3|||
33325798|NCT00404820|101088081|FG000|Overall Study|Lost to Follow-up|7|||
33325799|NCT00404820|101088082|FG001|Overall Study|Lost to Follow-up|3|||
33325800|NCT00404820|101088081|FG000|Overall Study|Administrative problems|2|||
33325801|NCT00404820|101088082|FG001|Overall Study|Administrative problems|0|||
33325802|NCT00404820|101088081|FG000|Overall Study|Death|1|||
33325803|NCT00404820|101088082|FG001|Overall Study|Death|0|||
33325804|NCT00404820|101088081|FG000|Overall Study|Other|0|||
33325805|NCT00404820|101088082|FG001|Overall Study|Other|2|||
33325806|NCT00646906|101088089|FG000|Crossover Period 1|Withdrawal by Subject|1|||
33325807|NCT00646906|101088090|FG001|Crossover Period 1|Withdrawal by Subject|0|||
33325808|NCT00646906|101088091|FG002|Crossover Period 1|Withdrawal by Subject|0|||
33325809|NCT00646906|101088092|FG003|Crossover Period 1|Withdrawal by Subject|0|||
33325810|NCT00646906|101088093|FG004|Crossover Period 1|Withdrawal by Subject|0|||
33325811|NCT00646906|101088094|FG005|Crossover Period 1|Withdrawal by Subject|1|||
33325812|NCT00646906|101088095|FG006|Crossover Period 1|Withdrawal by Subject|0|||
33325813|NCT00646906|101088089|FG000|Crossover Period 2|Withdrawal by Subject|0|||
33325814|NCT00646906|101088090|FG001|Crossover Period 2|Withdrawal by Subject|1|||
33325815|NCT00646906|101088091|FG002|Crossover Period 2|Withdrawal by Subject|2|||
33325816|NCT00646906|101088092|FG003|Crossover Period 2|Withdrawal by Subject|1|||
33325817|NCT00646906|101088093|FG004|Crossover Period 2|Withdrawal by Subject|0|||
33607244|NCT03596450|102111653|FG000|Overall Study|Protocol Violation|18|||
33607245|NCT03596450|102111654|FG001|Overall Study|Protocol Violation|26|||
33607246|NCT03596450|102111653|FG000|Overall Study|Lost to Follow-up|50|||
33607247|NCT03596450|102111654|FG001|Overall Study|Lost to Follow-up|56|||
33607248|NCT03596450|102111653|FG000|Overall Study|Adverse Event|14|||
33607249|NCT03596450|102111654|FG001|Overall Study|Adverse Event|7|||
33607250|NCT03596450|102111653|FG000|Overall Study|Withdrawal by Subject|38|||
33607251|NCT03596450|102111654|FG001|Overall Study|Withdrawal by Subject|36|||
33607252|NCT03596450|102111653|FG000|Overall Study|Accidentally Randomized|2|||
33607253|NCT03596450|102111654|FG001|Overall Study|Accidentally Randomized|0|||
33607254|NCT03596450|102111653|FG000|Overall Study|Other reasons|48|||
33607255|NCT03596450|102111654|FG001|Overall Study|Other reasons|53|||
33607256|NCT03596450|102111653|FG000|Overall Study|Pregnancy|2|||
33607257|NCT03596450|102111654|FG001|Overall Study|Pregnancy|0|||
33607258|NCT02666105|102111655|FG000|Overall Study|Death|1|||
33607259|NCT02554981|102111657|FG000|Overall Study|Adverse Event|1|||
33607260|NCT02554981|102111657|FG000|Overall Study|Administrative Reasons|1|||
33607261|NCT02554981|102111657|FG000|Overall Study|Other Miscellaneous Reasons|3|||
33607262|NCT03320330|102111658|FG000|Overall Study|Lack of Efficacy|5|||
33607263|NCT03320330|102111659|FG001|Overall Study|Lack of Efficacy|5|||
33607264|NCT03320330|102111660|FG002|Overall Study|Lack of Efficacy|14|||
33607265|NCT03320330|102111658|FG000|Overall Study|Physician Decision|1|||
33607266|NCT03320330|102111659|FG001|Overall Study|Physician Decision|0|||
33607267|NCT03320330|102111660|FG002|Overall Study|Physician Decision|0|||
33325818|NCT00646906|101088094|FG005|Crossover Period 2|Withdrawal by Subject|0|||
33607268|NCT01403116|102111661|FG000|Overall Study|Adverse Event|7|||
33607269|NCT01403116|102111662|FG001|Overall Study|Adverse Event|4|||
33607270|NCT01403116|102111661|FG000|Overall Study|Lost to Follow-up|7|||
33607271|NCT01403116|102111662|FG001|Overall Study|Lost to Follow-up|5|||
33607272|NCT01403116|102111661|FG000|Overall Study|Withdrawal by Subject|12|||
33607273|NCT01403116|102111662|FG001|Overall Study|Withdrawal by Subject|15|||
33607274|NCT01403116|102111661|FG000|Overall Study|Non-compliance of study drug|3|||
33607275|NCT01403116|102111662|FG001|Overall Study|Non-compliance of study drug|0|||
33607276|NCT01403116|102111661|FG000|Overall Study|Protocol Violation|0|||
33607277|NCT01403116|102111662|FG001|Overall Study|Protocol Violation|1|||
33325819|NCT00646906|101088095|FG006|Crossover Period 2|Withdrawal by Subject|0|||
33325820|NCT00646906|101088089|FG000|Crossover Period 2|Physician Decision|0|||
33325821|NCT00646906|101088090|FG001|Crossover Period 2|Physician Decision|0|||
33325822|NCT00646906|101088091|FG002|Crossover Period 2|Physician Decision|0|||
33399697|NCT00808028|101350309|FG001|Stage 1 (6 Months)|Other|0|||
33399698|NCT00808028|101350310|FG002|Stage 1 (6 Months)|Other|2|||
33399699|NCT00808028|101350311|FG003|Stage 1 (6 Months)|Other|4|||
33399700|NCT00808028|101350308|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
33399701|NCT00808028|101350309|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
33399702|NCT00808028|101350310|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
33399703|NCT00808028|101350311|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
33399704|NCT00808028|101350308|FG000|Stage 1 (6 Months)|Adverse Event|0|||
33399705|NCT00808028|101350309|FG001|Stage 1 (6 Months)|Adverse Event|0|||
33399706|NCT00808028|101350310|FG002|Stage 1 (6 Months)|Adverse Event|1|||
33399707|NCT00808028|101350311|FG003|Stage 1 (6 Months)|Adverse Event|2|||
33399708|NCT00808028|101350308|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
33399709|NCT00808028|101350309|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
33399710|NCT00808028|101350310|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
33399711|NCT00808028|101350311|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
33399712|NCT00808028|101350308|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
33399713|NCT00808028|101350309|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
33399714|NCT00808028|101350310|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
33399715|NCT00808028|101350311|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
33399716|NCT00808028|101350308|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
33399717|NCT00808028|101350309|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
33399718|NCT00808028|101350310|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
33399719|NCT00808028|101350311|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
33399720|NCT00808028|101350308|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
33399721|NCT00808028|101350309|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
33399722|NCT00808028|101350310|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
33399723|NCT00808028|101350311|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
33399724|NCT00808028|101350308|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
33399725|NCT00808028|101350309|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
33399726|NCT00808028|101350310|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
33399727|NCT00808028|101350311|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
33399728|NCT00808028|101350308|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
33399729|NCT00808028|101350309|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
33399730|NCT00808028|101350310|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
33399731|NCT00808028|101350311|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
33399732|NCT00808028|101350308|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
33399733|NCT00808028|101350309|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
33399734|NCT00808028|101350310|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
33399735|NCT00808028|101350311|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
33399736|NCT00808028|101350308|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
33399737|NCT00808028|101350309|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
33399738|NCT00808028|101350310|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
33399739|NCT00808028|101350311|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
33399740|NCT00808028|101350308|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
33399741|NCT00808028|101350309|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
33399742|NCT00808028|101350310|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
33399743|NCT00808028|101350311|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
33399744|NCT00808028|101350308|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
33399745|NCT00808028|101350309|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
33399746|NCT00808028|101350310|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
33399747|NCT00808028|101350311|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
33399748|NCT00808028|101350308|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
33399749|NCT00808028|101350309|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
33515431|NCT03840148|101783071|FG001|Study Drug Disposition|Physician Decision|0|||
33515432|NCT03840148|101783070|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
33515433|NCT03840148|101783071|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
33515434|NCT03840148|101783070|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
33515435|NCT03840148|101783071|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
33515436|NCT03840148|101783070|FG000|Study Completion Disposition|Physician Decision|2|||
33515437|NCT03840148|101783071|FG001|Study Completion Disposition|Physician Decision|0|||
33515438|NCT03840148|101783070|FG000|Study Completion Disposition|Covid-19 related|2|||
33515439|NCT03840148|101783071|FG001|Study Completion Disposition|Covid-19 related|0|||
33515440|NCT03840148|101783070|FG000|Study Completion Disposition|Lost to Follow-up|1|||
33515441|NCT03840148|101783071|FG001|Study Completion Disposition|Lost to Follow-up|1|||
33399750|NCT00808028|101350310|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
33399751|NCT00808028|101350311|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
33399752|NCT00303329|101350312|FG000|Overall Study|Adverse Event|7|||
33399753|NCT00303329|101350313|FG001|Overall Study|Adverse Event|14|||
33515442|NCT03840148|101783070|FG000|Study Completion Disposition|Death|1|||
33515443|NCT03840148|101783071|FG001|Study Completion Disposition|Death|0|||
33515444|NCT03840148|101783070|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
33515445|NCT03840148|101783071|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
33515446|NCT00980174|101783072|FG000|Overall Study|Withdrawal by Subject|1|||
33515447|NCT00980174|101783073|FG001|Overall Study|Withdrawal by Subject|4|||
33515448|NCT00980174|101783072|FG000|Overall Study|Adverse Event|0|||
33515449|NCT00980174|101783073|FG001|Overall Study|Adverse Event|3|||
33515450|NCT00980174|101783072|FG000|Overall Study|Ineligibility determined|2|||
33515451|NCT00980174|101783073|FG001|Overall Study|Ineligibility determined|1|||
33515452|NCT00980174|101783072|FG000|Overall Study|Death|1|||
33515453|NCT00980174|101783073|FG001|Overall Study|Death|1|||
33515454|NCT00980174|101783072|FG000|Overall Study|Other|0|||
33515455|NCT00980174|101783073|FG001|Overall Study|Other|1|||
33515456|NCT00454818|101783084|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
33515457|NCT00454818|101783085|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
33515458|NCT00454818|101783086|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
33515459|NCT00454818|101783087|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
33515460|NCT00454818|101783088|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
33515461|NCT00454818|101783084|FG000|Phase I: Open-label Dose-escalation|Death|0|||
33515462|NCT00454818|101783085|FG001|Phase I: Open-label Dose-escalation|Death|1|||
33607278|NCT01403116|102111661|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
33607279|NCT01403116|102111662|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
33607280|NCT01403116|102111661|FG000|Overall Study|Hct >54%|2|||
33607281|NCT01403116|102111662|FG001|Overall Study|Hct >54%|0|||
33607282|NCT01403116|102111661|FG000|Overall Study|unable to keep appointments|0|||
33607283|NCT01403116|102111662|FG001|Overall Study|unable to keep appointments|2|||
33607284|NCT05327361|102111665|FG000|Overall Study|Lost to Follow-up|4|||
33607285|NCT01753401|102111667|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
33607286|NCT01753401|102111668|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
33607287|NCT01753401|102111669|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
33607288|NCT01753401|102111670|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
33399754|NCT00303329|101350312|FG000|Overall Study|Abnormal Laboratory Values|0|||
33399755|NCT00303329|101350313|FG001|Overall Study|Abnormal Laboratory Values|1|||
33515463|NCT00454818|101783086|FG002|Phase I: Open-label Dose-escalation|Death|0|||
33325823|NCT00646906|101088092|FG003|Crossover Period 2|Physician Decision|0|||
33325824|NCT00646906|101088093|FG004|Crossover Period 2|Physician Decision|0|||
33325825|NCT00646906|101088094|FG005|Crossover Period 2|Physician Decision|0|||
33325826|NCT00646906|101088095|FG006|Crossover Period 2|Physician Decision|1|||
33325827|NCT00436618|101088096|FG000|Overall Study|Withdrawal by Subject|5|||
33515464|NCT00454818|101783087|FG003|Phase I: Open-label Dose-escalation|Death|0|||
33515465|NCT00454818|101783088|FG004|Phase I: Open-label Dose-escalation|Death|0|||
33515466|NCT00454818|101783084|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
33607289|NCT01753401|102111667|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
33607290|NCT01753401|102111668|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
33607291|NCT01753401|102111669|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
33607292|NCT01753401|102111670|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
33607293|NCT01753401|102111667|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
33607294|NCT01753401|102111668|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
33325828|NCT00436618|101088097|FG001|Overall Study|Withdrawal by Subject|8|||
33325829|NCT00436618|101088098|FG002|Overall Study|Withdrawal by Subject|11|||
33325830|NCT00436618|101088096|FG000|Overall Study|Adverse Event|8|||
33325831|NCT00436618|101088097|FG001|Overall Study|Adverse Event|8|||
33325832|NCT00436618|101088098|FG002|Overall Study|Adverse Event|9|||
33325833|NCT00436618|101088096|FG000|Overall Study|Alternate Treatment|3|||
33325834|NCT00436618|101088097|FG001|Overall Study|Alternate Treatment|4|||
33325835|NCT00436618|101088098|FG002|Overall Study|Alternate Treatment|12|||
33325836|NCT00436618|101088096|FG000|Overall Study|Other Medical Problems|3|||
33325837|NCT00436618|101088097|FG001|Overall Study|Other Medical Problems|1|||
33325838|NCT00436618|101088098|FG002|Overall Study|Other Medical Problems|7|||
33325839|NCT00436618|101088096|FG000|Overall Study|Death|4|||
33325840|NCT00436618|101088097|FG001|Overall Study|Death|2|||
33325841|NCT00436618|101088098|FG002|Overall Study|Death|3|||
33325842|NCT00436618|101088096|FG000|Overall Study|New Primary or Other Reasons|6|||
33325843|NCT00436618|101088097|FG001|Overall Study|New Primary or Other Reasons|2|||
33325844|NCT00436618|101088098|FG002|Overall Study|New Primary or Other Reasons|12|||
33325845|NCT00436618|101088096|FG000|Overall Study|Still on treatment|1|||
33515467|NCT00454818|101783085|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
33607295|NCT01753401|102111669|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
33325846|NCT00436618|101088097|FG001|Overall Study|Still on treatment|2|||
33325847|NCT00436618|101088098|FG002|Overall Study|Still on treatment|7|||
33399756|NCT00303329|101350312|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
33399757|NCT00303329|101350313|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33325848|NCT02247960|101088099|FG000|Patient Consent and Randomization|Physician Decision|2|||
33325849|NCT02247960|101088100|FG001|Patient Consent and Randomization|Physician Decision|2|||
33325850|NCT02247960|101088099|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
33325851|NCT02247960|101088100|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
33325852|NCT02247960|101088099|FG000|Catheter Removed|Lost to Follow-up|7|||
33325853|NCT02247960|101088100|FG001|Catheter Removed|Lost to Follow-up|10|||
33325854|NCT00621751|101088103|FG000|Overall Study|Adverse Event|0|||
33325855|NCT00621751|101088104|FG001|Overall Study|Adverse Event|1|||
33325856|NCT01624259|101088109|FG000|Overall Study|Adverse Event|18|||
33325857|NCT01624259|101088110|FG001|Overall Study|Adverse Event|18|||
33325858|NCT01624259|101088109|FG000|Overall Study|Protocol Violation|1|||
33325859|NCT01624259|101088110|FG001|Overall Study|Protocol Violation|2|||
33325860|NCT01624259|101088109|FG000|Overall Study|Withdrawal by Subject|5|||
33325861|NCT01624259|101088110|FG001|Overall Study|Withdrawal by Subject|7|||
33399758|NCT00303329|101350312|FG000|Overall Study|Condition no longer requires study drug|0|||
33399759|NCT00303329|101350313|FG001|Overall Study|Condition no longer requires study drug|8|||
33399760|NCT00303329|101350312|FG000|Overall Study|Protocol Violation|3|||
33399761|NCT00303329|101350313|FG001|Overall Study|Protocol Violation|0|||
33399762|NCT00303329|101350312|FG000|Overall Study|Withdrawal by Subject|9|||
33399763|NCT00303329|101350313|FG001|Overall Study|Withdrawal by Subject|15|||
33399764|NCT00303329|101350312|FG000|Overall Study|Lost to Follow-up|0|||
33399765|NCT00303329|101350313|FG001|Overall Study|Lost to Follow-up|1|||
33399766|NCT00303329|101350312|FG000|Overall Study|Administrative problems|1|||
33399767|NCT00303329|101350313|FG001|Overall Study|Administrative problems|0|||
33399768|NCT00303329|101350312|FG000|Overall Study|Death|2|||
33399769|NCT00303329|101350313|FG001|Overall Study|Death|12|||
33399770|NCT00303329|101350312|FG000|Overall Study|Stopped at end of core|3|||
33399771|NCT00303329|101350313|FG001|Overall Study|Stopped at end of core|9|||
33399772|NCT00303329|101350312|FG000|Overall Study|Stopped at end of extension 1|1|||
33399773|NCT00303329|101350313|FG001|Overall Study|Stopped at end of extension 1|0|||
33399774|NCT00829010|101350317|FG000|Overall Study|Adverse Event|1|||
33325862|NCT01624259|101088109|FG000|Overall Study|Physician Decision|1|||
33399775|NCT00829010|101350318|FG001|Overall Study|Adverse Event|0|||
33399776|NCT00829010|101350319|FG002|Overall Study|Adverse Event|0|||
33399777|NCT00829010|101350320|FG003|Overall Study|Adverse Event|0|||
33399778|NCT00829010|101350321|FG004|Overall Study|Adverse Event|0|||
33399779|NCT00829010|101350317|FG000|Overall Study|Withdrawal by Subject|0|||
33399780|NCT00829010|101350318|FG001|Overall Study|Withdrawal by Subject|1|||
33399781|NCT00829010|101350319|FG002|Overall Study|Withdrawal by Subject|1|||
33399782|NCT00829010|101350320|FG003|Overall Study|Withdrawal by Subject|0|||
33399783|NCT00829010|101350321|FG004|Overall Study|Withdrawal by Subject|2|||
33399784|NCT00829010|101350317|FG000|Overall Study|Lost to Follow-up|1|||
33399785|NCT00829010|101350318|FG001|Overall Study|Lost to Follow-up|0|||
33607296|NCT01753401|102111670|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
33607297|NCT01753401|102111667|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
33607298|NCT01753401|102111668|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
33607299|NCT01753401|102111669|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
33607300|NCT01753401|102111670|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
33607301|NCT01753401|102111667|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
33607302|NCT01753401|102111668|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
33607303|NCT01753401|102111669|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
33607304|NCT01753401|102111670|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
33607305|NCT01753401|102111667|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
33325863|NCT01624259|101088110|FG001|Overall Study|Physician Decision|1|||
33325864|NCT01624259|101088109|FG000|Overall Study|Lost to Follow-up|2|||
33325865|NCT01624259|101088110|FG001|Overall Study|Lost to Follow-up|3|||
33325866|NCT01624259|101088109|FG000|Overall Study|Abnormal laboratory measure|3|||
33325867|NCT01624259|101088110|FG001|Overall Study|Abnormal laboratory measure|0|||
33325868|NCT00943579|101088114|FG000|Overall Study|Adverse Event|4|||
33325869|NCT00943579|101088115|FG001|Overall Study|Adverse Event|3|||
33399786|NCT00829010|101350319|FG002|Overall Study|Lost to Follow-up|2|||
33399787|NCT00829010|101350320|FG003|Overall Study|Lost to Follow-up|0|||
33399788|NCT00829010|101350321|FG004|Overall Study|Lost to Follow-up|0|||
33399789|NCT00829010|101350317|FG000|Overall Study|Fatality|5|||
33399790|NCT00829010|101350318|FG001|Overall Study|Fatality|4|||
33399791|NCT00829010|101350319|FG002|Overall Study|Fatality|0|||
33399792|NCT00829010|101350320|FG003|Overall Study|Fatality|3|||
33399793|NCT00829010|101350321|FG004|Overall Study|Fatality|0|||
33399794|NCT00829010|101350317|FG000|Overall Study|Migrated/Moved from study area|3|||
33399795|NCT00829010|101350318|FG001|Overall Study|Migrated/Moved from study area|4|||
33325870|NCT00943579|101088114|FG000|Overall Study|Lack of Efficacy|2|||
33399796|NCT00829010|101350319|FG002|Overall Study|Migrated/Moved from study area|0|||
33399797|NCT00829010|101350320|FG003|Overall Study|Migrated/Moved from study area|5|||
33607306|NCT01753401|102111668|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
33607307|NCT01753401|102111669|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
33607308|NCT01753401|102111670|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
33607309|NCT01753401|102111667|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
33607310|NCT01753401|102111668|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
33607311|NCT01753401|102111669|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
33399798|NCT00829010|101350321|FG004|Overall Study|Migrated/Moved from study area|0|||
33399799|NCT00935701|101350322|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
33399800|NCT02933489|101350325|FG000|Overall Study|Ineligible|3|||
33399801|NCT02933489|101350326|FG001|Overall Study|Ineligible|3|||
33399802|NCT02933489|101350325|FG000|Overall Study|Withdrawal by Subject|27|||
33399803|NCT02933489|101350326|FG001|Overall Study|Withdrawal by Subject|18|||
33399804|NCT02933489|101350325|FG000|Overall Study|Unable to complete exams (other)|14|||
33399805|NCT02933489|101350326|FG001|Overall Study|Unable to complete exams (other)|7|||
33399806|NCT03147495|101350327|FG000|Overall Study|Physician Decision|0|||
33399807|NCT03147495|101350328|FG001|Overall Study|Physician Decision|6|||
33399808|NCT01947127|101350329|FG000|Overall Study|Protocol Violation|18|||
33399809|NCT01947127|101350330|FG001|Overall Study|Protocol Violation|38|||
33515468|NCT00454818|101783086|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
33515469|NCT00454818|101783087|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
33515470|NCT00454818|101783088|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
33515471|NCT00454818|101783084|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
33515472|NCT00454818|101783085|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
33515473|NCT00454818|101783086|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
33515474|NCT00454818|101783087|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
33515475|NCT00454818|101783088|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
33515476|NCT00454818|101783084|FG000|Phase 2: Randomized Double-blind|Death|0|||
33515477|NCT00454818|101783085|FG001|Phase 2: Randomized Double-blind|Death|1|||
33515478|NCT00454818|101783086|FG002|Phase 2: Randomized Double-blind|Death|0|||
33515479|NCT00454818|101783087|FG003|Phase 2: Randomized Double-blind|Death|0|||
33515480|NCT00454818|101783088|FG004|Phase 2: Randomized Double-blind|Death|1|||
33515481|NCT00454818|101783084|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
33515482|NCT00454818|101783085|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
33515483|NCT00454818|101783086|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
33515484|NCT00454818|101783087|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
33515485|NCT00454818|101783088|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
33515486|NCT00454818|101783084|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
33607312|NCT01753401|102111670|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
33325871|NCT00943579|101088115|FG001|Overall Study|Lack of Efficacy|2|||
33325872|NCT03337542|101088118|FG000|Overall Study|Withdrew Consent|17|||
33325873|NCT03337542|101088118|FG000|Overall Study|Allergic Adverse Event|1|||
33325874|NCT03337542|101088118|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
33325875|NCT03337542|101088118|FG000|Overall Study|Lost to Follow-up|1|||
33325876|NCT03337542|101088118|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
33325877|NCT04163900|101088119|FG000|Overall Study|Radiological disease progression|112|||
33325878|NCT04163900|101088120|FG001|Overall Study|Radiological disease progression|127|||
33325879|NCT04163900|101088119|FG000|Overall Study|Study closure|98|||
33325880|NCT04163900|101088120|FG001|Overall Study|Study closure|133|||
33325881|NCT04163900|101088119|FG000|Overall Study|Adverse Event|78|||
33325882|NCT04163900|101088120|FG001|Overall Study|Adverse Event|32|||
33325883|NCT04163900|101088119|FG000|Overall Study|Withdrawal by Subject|37|||
33325884|NCT04163900|101088120|FG001|Overall Study|Withdrawal by Subject|34|||
33325885|NCT04163900|101088119|FG000|Overall Study|Death|29|||
33325886|NCT04163900|101088120|FG001|Overall Study|Death|16|||
33325887|NCT04163900|101088119|FG000|Overall Study|Physician Decision|17|||
33325888|NCT04163900|101088120|FG001|Overall Study|Physician Decision|25|||
33325889|NCT04163900|101088119|FG000|Overall Study|Clinical disease progression|14|||
33325890|NCT04163900|101088120|FG001|Overall Study|Clinical disease progression|13|||
33325891|NCT04163900|101088119|FG000|Overall Study|Protocol Violation|3|||
33325892|NCT04163900|101088120|FG001|Overall Study|Protocol Violation|4|||
33325893|NCT04163900|101088119|FG000|Overall Study|Lost to Follow-up|0|||
33325894|NCT04163900|101088120|FG001|Overall Study|Lost to Follow-up|1|||
33325895|NCT01011439|101088121|FG000|Overall Study|Death|37|||
33325896|NCT01011439|101088121|FG000|Overall Study|Lost to Follow-up|4|||
33325897|NCT01011439|101088121|FG000|Overall Study|Withdrawal by Subject|1|||
33325898|NCT01011439|101088121|FG000|Overall Study|Sponsor's decision|15|||
33325899|NCT02486653|101088122|FG000|Overall Study|Withdrawal by Subject|1|||
33325900|NCT02486653|101088123|FG001|Overall Study|Withdrawal by Subject|3|||
33325901|NCT02486653|101088122|FG000|Overall Study|Protocol Violation|1|||
33325902|NCT02486653|101088123|FG001|Overall Study|Protocol Violation|0|||
33325903|NCT02486653|101088122|FG000|Overall Study|surgery cancelled|4|||
33325904|NCT02486653|101088123|FG001|Overall Study|surgery cancelled|1|||
33399810|NCT01947127|101350329|FG000|Overall Study|Withdrawal by Subject|1|||
33399811|NCT01947127|101350330|FG001|Overall Study|Withdrawal by Subject|1|||
33399812|NCT01947127|101350329|FG000|Overall Study|Data loss|4|||
33399813|NCT01947127|101350330|FG001|Overall Study|Data loss|4|||
33399814|NCT00989664|101350331|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
33399815|NCT00989664|101350331|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
33399816|NCT00989664|101350331|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
33399817|NCT00989664|101350331|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
33399818|NCT00989664|101350331|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
33399819|NCT00989664|101350331|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
33399820|NCT00989664|101350331|FG000|Long-Term Follow-Up|Death|3|||
33399821|NCT00890201|101350333|FG000|Overall Study|Protocol Violation|5|||
33399822|NCT00890201|101350334|FG001|Overall Study|Protocol Violation|56|||
33399823|NCT02881151|101350335|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
33607313|NCT02305238|102111671|FG000|Overall Study|Death|2|||
33607314|NCT02305238|102111672|FG001|Overall Study|Death|1|||
33607315|NCT02305238|102111673|FG002|Overall Study|Death|0|||
33607316|NCT02305238|102111671|FG000|Overall Study|Progressive disease|4|||
33607317|NCT02305238|102111672|FG001|Overall Study|Progressive disease|4|||
33399824|NCT02477800|101350336|FG000|Placebo-Controlled Period|Adverse Event|16|||
33399825|NCT02477800|101350337|FG001|Placebo-Controlled Period|Adverse Event|25|||
33399826|NCT02477800|101350338|FG002|Placebo-Controlled Period|Adverse Event|28|||
33399827|NCT02477800|101350339|FG003|Placebo-Controlled Period|Adverse Event|0|||
33399828|NCT02477800|101350340|FG004|Placebo-Controlled Period|Adverse Event|0|||
33399829|NCT02477800|101350341|FG005|Placebo-Controlled Period|Adverse Event|0|||
33399830|NCT02477800|101350342|FG006|Placebo-Controlled Period|Adverse Event|0|||
33399831|NCT02477800|101350336|FG000|Placebo-Controlled Period|Change of Treatment|1|||
33399832|NCT02477800|101350337|FG001|Placebo-Controlled Period|Change of Treatment|2|||
33399833|NCT02477800|101350338|FG002|Placebo-Controlled Period|Change of Treatment|1|||
33399834|NCT02477800|101350339|FG003|Placebo-Controlled Period|Change of Treatment|0|||
33399835|NCT02477800|101350340|FG004|Placebo-Controlled Period|Change of Treatment|0|||
33399836|NCT02477800|101350341|FG005|Placebo-Controlled Period|Change of Treatment|0|||
33399837|NCT02477800|101350342|FG006|Placebo-Controlled Period|Change of Treatment|0|||
33399838|NCT02477800|101350336|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
33399839|NCT02477800|101350337|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
33515487|NCT00454818|101783085|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
33515488|NCT00454818|101783086|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
33515489|NCT00454818|101783087|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
33515490|NCT00454818|101783088|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
33515491|NCT03738800|101783089|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
33515492|NCT03738800|101783090|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
33515493|NCT03738800|101783091|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33515494|NCT03738800|101783089|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
33515495|NCT03738800|101783090|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
33515496|NCT03738800|101783091|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
33515497|NCT03738800|101783089|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
33515498|NCT03738800|101783090|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
33515499|NCT03738800|101783091|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
33515500|NCT02669082|101783092|FG000|Overall Study|Adverse Event|1|||
33515501|NCT00622336|101783093|FG000|Treatment Phase|Progression of Disease|181|||
33515502|NCT00622336|101783093|FG000|Treatment Phase|Adverse Event|46|||
33515503|NCT00622336|101783093|FG000|Treatment Phase|Other|40|||
33515504|NCT00622336|101783093|FG000|Treatment Phase|Death|14|||
33515505|NCT00622336|101783093|FG000|Treatment Phase|Lack of therapeutic effect|13|||
33515506|NCT00622336|101783093|FG000|Treatment Phase|Withdrawal by Subject|13|||
33515507|NCT00622336|101783093|FG000|Treatment Phase|Lost to Follow-up|2|||
33515508|NCT00622336|101783093|FG000|Extension Phase|Adverse Event|2|||
33515509|NCT00622336|101783093|FG000|Extension Phase|Progressive Disease|6|||
33515510|NCT00622336|101783093|FG000|Extension Phase|Lack of therapeutic effect|2|||
33515511|NCT00622336|101783093|FG000|Extension Phase|Withdrawal by Subject|1|||
33515512|NCT00622336|101783093|FG000|Extension Phase|Lost to Follow-up|1|||
33515513|NCT00622336|101783093|FG000|Extension Phase|Other|9|||
33515514|NCT01801358|101783094|FG000|Overall Study|Adverse Event|0|||
33515515|NCT01801358|101783095|FG001|Overall Study|Adverse Event|2|||
33515516|NCT01801358|101783096|FG002|Overall Study|Adverse Event|1|||
33515517|NCT01801358|101783097|FG003|Overall Study|Adverse Event|0|||
33399840|NCT02477800|101350338|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
33399841|NCT02477800|101350339|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
33515518|NCT01801358|101783098|FG004|Overall Study|Adverse Event|0|||
33515519|NCT01801358|101783099|FG005|Overall Study|Adverse Event|1|||
33515520|NCT01801358|101783094|FG000|Overall Study|Physician Decision|0|||
33607318|NCT02305238|102111673|FG002|Overall Study|Progressive disease|0|||
33607319|NCT02305238|102111671|FG000|Overall Study|Logistical difficulties|1|||
33399842|NCT02477800|101350340|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
33399843|NCT02477800|101350341|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
33399844|NCT02477800|101350342|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
33399845|NCT02477800|101350336|FG000|Placebo-Controlled Period|Death|0|||
33399846|NCT02477800|101350337|FG001|Placebo-Controlled Period|Death|3|||
33399847|NCT02477800|101350338|FG002|Placebo-Controlled Period|Death|2|||
33399848|NCT02477800|101350339|FG003|Placebo-Controlled Period|Death|0|||
33515521|NCT01801358|101783095|FG001|Overall Study|Physician Decision|0|||
33515522|NCT01801358|101783096|FG002|Overall Study|Physician Decision|1|||
33515523|NCT01801358|101783097|FG003|Overall Study|Physician Decision|0|||
33515524|NCT01801358|101783098|FG004|Overall Study|Physician Decision|0|||
33515525|NCT01801358|101783099|FG005|Overall Study|Physician Decision|0|||
33515526|NCT01801358|101783094|FG000|Overall Study|Progressive Disease|6|||
33607320|NCT02305238|102111672|FG001|Overall Study|Logistical difficulties|3|||
33607321|NCT02305238|102111673|FG002|Overall Study|Logistical difficulties|0|||
33515527|NCT01801358|101783095|FG001|Overall Study|Progressive Disease|4|||
33515528|NCT01801358|101783096|FG002|Overall Study|Progressive Disease|4|||
33515529|NCT01801358|101783097|FG003|Overall Study|Progressive Disease|5|||
33515530|NCT01801358|101783098|FG004|Overall Study|Progressive Disease|6|||
33515531|NCT01801358|101783099|FG005|Overall Study|Progressive Disease|5|||
33515532|NCT01801358|101783094|FG000|Overall Study|Withdrawal by Subject|0|||
33515533|NCT01801358|101783095|FG001|Overall Study|Withdrawal by Subject|0|||
33515534|NCT01801358|101783096|FG002|Overall Study|Withdrawal by Subject|0|||
33515535|NCT01801358|101783097|FG003|Overall Study|Withdrawal by Subject|1|||
33515536|NCT01801358|101783098|FG004|Overall Study|Withdrawal by Subject|0|||
33515537|NCT01801358|101783099|FG005|Overall Study|Withdrawal by Subject|2|||
33515538|NCT02638259|101783100|FG000|Treatment Period 1|Adverse Event|1|||
33515539|NCT02638259|101783101|FG001|Treatment Period 1|Adverse Event|5|||
33515540|NCT02638259|101783100|FG000|Treatment Period 1|Death|0|||
33515541|NCT02638259|101783101|FG001|Treatment Period 1|Death|1|||
33515542|NCT02638259|101783100|FG000|Treatment Period 1|Lack of Efficacy|0|||
33515543|NCT02638259|101783101|FG001|Treatment Period 1|Lack of Efficacy|1|||
33515544|NCT02638259|101783100|FG000|Treatment Period 1|Protocol Violation|0|||
33515545|NCT02638259|101783101|FG001|Treatment Period 1|Protocol Violation|3|||
33515546|NCT02638259|101783100|FG000|Treatment Period 1|Withdrawal by Subject|4|||
33515547|NCT02638259|101783101|FG001|Treatment Period 1|Withdrawal by Subject|6|||
33515548|NCT02638259|101783100|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
33515549|NCT02638259|101783101|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
33515550|NCT02638259|101783100|FG000|Treatment Period 2|Adverse Event|5|||
33515551|NCT02638259|101783101|FG001|Treatment Period 2|Adverse Event|4|||
33515552|NCT02638259|101783100|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33515553|NCT02638259|101783101|FG001|Treatment Period 2|Withdrawal by Subject|7|||
33515554|NCT02203851|101783102|FG000|Overall Study|Lost to Follow-up|4|||
33515555|NCT02203851|101783102|FG000|Overall Study|Withdrawal by Subject|6|||
33515556|NCT02203851|101783102|FG000|Overall Study|Other|1|||
33515557|NCT01846221|101783113|FG000|Overall Study|Catheter Failure|2|||
33515558|NCT01846221|101783114|FG001|Overall Study|Catheter Failure|0|||
33515559|NCT01846221|101783113|FG000|Overall Study|Age Exclusion|1|||
33515560|NCT01846221|101783114|FG001|Overall Study|Age Exclusion|0|||
33515561|NCT02342548|101783117|FG000|Overall Study|Adverse Event|12|||
33515562|NCT02342548|101783118|FG001|Overall Study|Adverse Event|17|||
33515563|NCT02342548|101783119|FG002|Overall Study|Adverse Event|13|||
33515564|NCT02342548|101783117|FG000|Overall Study|Lost to Follow-up|0|||
33515565|NCT02342548|101783118|FG001|Overall Study|Lost to Follow-up|1|||
33515566|NCT02342548|101783119|FG002|Overall Study|Lost to Follow-up|0|||
33515567|NCT02342548|101783117|FG000|Overall Study|Study terminated by sponsor|20|||
33515568|NCT02342548|101783118|FG001|Overall Study|Study terminated by sponsor|39|||
33515569|NCT02342548|101783119|FG002|Overall Study|Study terminated by sponsor|25|||
33515570|NCT02342548|101783117|FG000|Overall Study|Protocol Violation|0|||
33607322|NCT02305238|102111671|FG000|Overall Study|Protocol Violation|0|||
33607323|NCT02305238|102111672|FG001|Overall Study|Protocol Violation|3|||
33325905|NCT03007979|101088126|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
33325906|NCT01444742|101088127|FG000|Overall Study|Death|1|||
33325907|NCT03227471|101088128|FG000|Overall Study|Withdrawal by Subject|0|||
33325908|NCT03227471|101088129|FG001|Overall Study|Withdrawal by Subject|0|||
33325909|NCT03227471|101088130|FG002|Overall Study|Withdrawal by Subject|0|||
33325910|NCT03227471|101088131|FG003|Overall Study|Withdrawal by Subject|0|||
33325911|NCT03227471|101088132|FG004|Overall Study|Withdrawal by Subject|1|||
33325912|NCT03227471|101088133|FG005|Overall Study|Withdrawal by Subject|0|||
33515571|NCT02342548|101783118|FG001|Overall Study|Protocol Violation|1|||
33515572|NCT02342548|101783119|FG002|Overall Study|Protocol Violation|0|||
33515573|NCT02342548|101783117|FG000|Overall Study|Withdrawal by Subject|1|||
33515574|NCT02342548|101783118|FG001|Overall Study|Withdrawal by Subject|3|||
33515575|NCT02342548|101783119|FG002|Overall Study|Withdrawal by Subject|4|||
33515576|NCT02342548|101783117|FG000|Overall Study|Other|1|||
33515577|NCT02342548|101783118|FG001|Overall Study|Other|1|||
33607324|NCT02305238|102111673|FG002|Overall Study|Protocol Violation|0|||
33515578|NCT02342548|101783119|FG002|Overall Study|Other|1|||
33515579|NCT01632150|101783120|FG000|Overall Study|Disease progression|27|||
33515580|NCT01632150|101783120|FG000|Overall Study|Study drug toxicity|1|||
33515581|NCT01632150|101783120|FG000|Overall Study|Unrelated adverse event|7|||
33515582|NCT01632150|101783120|FG000|Overall Study|Withdrawal by Subject|2|||
33515583|NCT01632150|101783120|FG000|Overall Study|Patient underwent autologous transplant|1|||
33515584|NCT01632150|101783120|FG000|Overall Study|Moved to compassionate program|2|||
33515585|NCT02603562|101783121|FG000|Overall Study|Lost to Follow-up|1|||
33515586|NCT00558896|101783122|FG000|Overall Study|Adverse Event|1|||
33515587|NCT00558896|101783123|FG001|Overall Study|Adverse Event|1|||
33515588|NCT00558896|101783124|FG002|Overall Study|Adverse Event|1|||
33515589|NCT00558896|101783125|FG003|Overall Study|Adverse Event|3|||
33515590|NCT00558896|101783126|FG004|Overall Study|Adverse Event|4|||
33515591|NCT00558896|101783127|FG005|Overall Study|Adverse Event|10|||
33515592|NCT00558896|101783128|FG006|Overall Study|Adverse Event|3|||
33515593|NCT00558896|101783122|FG000|Overall Study|Death|3|||
33515594|NCT00558896|101783123|FG001|Overall Study|Death|0|||
33515595|NCT00558896|101783124|FG002|Overall Study|Death|2|||
33515596|NCT00558896|101783125|FG003|Overall Study|Death|3|||
33515597|NCT00558896|101783126|FG004|Overall Study|Death|2|||
33515598|NCT00558896|101783127|FG005|Overall Study|Death|2|||
33515599|NCT00558896|101783128|FG006|Overall Study|Death|6|||
33515600|NCT00558896|101783122|FG000|Overall Study|Withdrawal by Subject|2|||
33515601|NCT00558896|101783123|FG001|Overall Study|Withdrawal by Subject|1|||
33515602|NCT00558896|101783124|FG002|Overall Study|Withdrawal by Subject|1|||
33515603|NCT00558896|101783125|FG003|Overall Study|Withdrawal by Subject|1|||
33515604|NCT00558896|101783126|FG004|Overall Study|Withdrawal by Subject|1|||
33515605|NCT00558896|101783127|FG005|Overall Study|Withdrawal by Subject|5|||
33515606|NCT00558896|101783128|FG006|Overall Study|Withdrawal by Subject|5|||
33515607|NCT00558896|101783122|FG000|Overall Study|Alternative Treatment|2|||
33515608|NCT00558896|101783123|FG001|Overall Study|Alternative Treatment|2|||
33515609|NCT00558896|101783124|FG002|Overall Study|Alternative Treatment|0|||
33515610|NCT00558896|101783125|FG003|Overall Study|Alternative Treatment|2|||
33515611|NCT00558896|101783126|FG004|Overall Study|Alternative Treatment|6|||
33515612|NCT00558896|101783127|FG005|Overall Study|Alternative Treatment|7|||
33515613|NCT00558896|101783128|FG006|Overall Study|Alternative Treatment|1|||
33515614|NCT00558896|101783122|FG000|Overall Study|Physician discretion|3|||
33515615|NCT00558896|101783123|FG001|Overall Study|Physician discretion|2|||
33515616|NCT00558896|101783124|FG002|Overall Study|Physician discretion|1|||
33515617|NCT00558896|101783125|FG003|Overall Study|Physician discretion|2|||
33515618|NCT00558896|101783126|FG004|Overall Study|Physician discretion|1|||
33515619|NCT00558896|101783127|FG005|Overall Study|Physician discretion|3|||
33515620|NCT00558896|101783128|FG006|Overall Study|Physician discretion|3|||
33515621|NCT00558896|101783122|FG000|Overall Study|Continues on treatment|10|||
33515622|NCT00558896|101783123|FG001|Overall Study|Continues on treatment|1|||
33515623|NCT00558896|101783124|FG002|Overall Study|Continues on treatment|0|||
33515624|NCT00558896|101783125|FG003|Overall Study|Continues on treatment|1|||
33515625|NCT00558896|101783126|FG004|Overall Study|Continues on treatment|9|||
33515626|NCT00558896|101783127|FG005|Overall Study|Continues on treatment|25|||
33515627|NCT00558896|101783128|FG006|Overall Study|Continues on treatment|6|||
33515628|NCT00985959|101783129|FG000|Overall Study|Adverse Event|0|||
33199593|NCT02086591|100633879|FG000|Overall Study|Withdrawal by Subject|1|||
33199594|NCT02086591|100633879|FG000|Overall Study|protocol terminated|3|||
33515629|NCT00985959|101783130|FG001|Overall Study|Adverse Event|0|||
33515630|NCT00985959|101783131|FG002|Overall Study|Adverse Event|19|||
33515631|NCT00985959|101783129|FG000|Overall Study|Withdrawal by Subject|0|||
33515632|NCT00985959|101783130|FG001|Overall Study|Withdrawal by Subject|0|||
33515633|NCT00985959|101783131|FG002|Overall Study|Withdrawal by Subject|8|||
33515634|NCT00985959|101783129|FG000|Overall Study|Progressive disease|1|||
33515635|NCT00985959|101783130|FG001|Overall Study|Progressive disease|2|||
33515636|NCT00985959|101783131|FG002|Overall Study|Progressive disease|8|||
33515637|NCT00985959|101783129|FG000|Overall Study|Unrecovered toxicity|0|||
33515638|NCT00985959|101783130|FG001|Overall Study|Unrecovered toxicity|0|||
33515639|NCT00985959|101783131|FG002|Overall Study|Unrecovered toxicity|7|||
33199595|NCT00113516|100633880|FG000|Part 1|Adverse Event|6|||
33199596|NCT00113516|100633881|FG001|Part 1|Adverse Event|0|||
33515640|NCT00985959|101783129|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
33515641|NCT00985959|101783130|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
33515642|NCT00985959|101783131|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
33515643|NCT00985959|101783129|FG000|Overall Study|Complete response observed over 2 cycles|0|||
33515644|NCT00985959|101783130|FG001|Overall Study|Complete response observed over 2 cycles|1|||
33515645|NCT00985959|101783131|FG002|Overall Study|Complete response observed over 2 cycles|4|||
33515646|NCT00985959|101783129|FG000|Overall Study|Other|0|||
33515647|NCT00985959|101783130|FG001|Overall Study|Other|0|||
33515648|NCT00985959|101783131|FG002|Overall Study|Other|11|||
33515649|NCT00655681|101783136|FG000|Overall Study|Lost to Follow-up|1|||
33515650|NCT00655681|101783137|FG001|Overall Study|Lost to Follow-up|1|||
33515651|NCT04481191|101783138|FG000|Overall Study|Withdrawn by parent/guardian|15|||
33399849|NCT02477800|101350340|FG004|Placebo-Controlled Period|Death|0|||
33399850|NCT02477800|101350341|FG005|Placebo-Controlled Period|Death|0|||
33399851|NCT02477800|101350342|FG006|Placebo-Controlled Period|Death|0|||
33399852|NCT02477800|101350336|FG000|Placebo-Controlled Period|Disease Progression|1|||
33399853|NCT02477800|101350337|FG001|Placebo-Controlled Period|Disease Progression|0|||
33399854|NCT02477800|101350338|FG002|Placebo-Controlled Period|Disease Progression|1|||
33399855|NCT02477800|101350339|FG003|Placebo-Controlled Period|Disease Progression|0|||
33399856|NCT02477800|101350340|FG004|Placebo-Controlled Period|Disease Progression|0|||
33399857|NCT02477800|101350341|FG005|Placebo-Controlled Period|Disease Progression|0|||
33399858|NCT02477800|101350342|FG006|Placebo-Controlled Period|Disease Progression|0|||
33399859|NCT02477800|101350336|FG000|Placebo-Controlled Period|Investigator Decision|3|||
33399860|NCT02477800|101350337|FG001|Placebo-Controlled Period|Investigator Decision|2|||
33399861|NCT02477800|101350338|FG002|Placebo-Controlled Period|Investigator Decision|1|||
33515652|NCT04481191|101783139|FG001|Overall Study|Withdrawn by parent/guardian|10|||
33515653|NCT03769675|101783140|FG000|Overall Study|Lost to Follow-up|1|||
33515654|NCT00250458|101783141|FG000|Overall Study|Lost to Follow-up|4|||
33515655|NCT00250458|101783142|FG001|Overall Study|Lost to Follow-up|2|||
33515656|NCT00250458|101783141|FG000|Overall Study|Protocol Violation|0|||
33515657|NCT00250458|101783142|FG001|Overall Study|Protocol Violation|1|||
33515658|NCT00250458|101783141|FG000|Overall Study|Withdrawal by Subject|4|||
33515659|NCT00250458|101783142|FG001|Overall Study|Withdrawal by Subject|2|||
33399862|NCT02477800|101350339|FG003|Placebo-Controlled Period|Investigator Decision|0|||
33399863|NCT02477800|101350340|FG004|Placebo-Controlled Period|Investigator Decision|0|||
33399864|NCT02477800|101350341|FG005|Placebo-Controlled Period|Investigator Decision|0|||
33399865|NCT02477800|101350342|FG006|Placebo-Controlled Period|Investigator Decision|0|||
33399866|NCT02477800|101350336|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
33399867|NCT02477800|101350337|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
33399868|NCT02477800|101350338|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
33399869|NCT02477800|101350339|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
33399870|NCT02477800|101350340|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
33399871|NCT02477800|101350341|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
33399872|NCT02477800|101350342|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
33399873|NCT02477800|101350336|FG000|Placebo-Controlled Period|Relocation|2|||
33399874|NCT02477800|101350337|FG001|Placebo-Controlled Period|Relocation|0|||
33399875|NCT02477800|101350338|FG002|Placebo-Controlled Period|Relocation|0|||
33607325|NCT02305238|102111671|FG000|Overall Study|Physician Decision|2|||
33607326|NCT02305238|102111672|FG001|Overall Study|Physician Decision|1|||
33607327|NCT02305238|102111673|FG002|Overall Study|Physician Decision|0|||
33607328|NCT02305238|102111671|FG000|Overall Study|Adverse Event|4|||
33607329|NCT02305238|102111672|FG001|Overall Study|Adverse Event|2|||
33607330|NCT02305238|102111673|FG002|Overall Study|Adverse Event|0|||
33607331|NCT02305238|102111671|FG000|Overall Study|Withdrawal by Subject|3|||
33607332|NCT02305238|102111672|FG001|Overall Study|Withdrawal by Subject|4|||
33607333|NCT02305238|102111673|FG002|Overall Study|Withdrawal by Subject|0|||
33607334|NCT02305238|102111671|FG000|Overall Study|Randomized failure|0|||
33325913|NCT03227471|101088134|FG006|Overall Study|Withdrawal by Subject|0|||
33325914|NCT03227471|101088135|FG007|Overall Study|Withdrawal by Subject|0|||
33325915|NCT03227471|101088136|FG008|Overall Study|Withdrawal by Subject|0|||
33325916|NCT03227471|101088137|FG009|Overall Study|Withdrawal by Subject|0|||
33325917|NCT03227471|101088138|FG010|Overall Study|Withdrawal by Subject|0|||
33325918|NCT03227471|101088139|FG011|Overall Study|Withdrawal by Subject|0|||
33325919|NCT03227471|101088140|FG012|Overall Study|Withdrawal by Subject|1|||
33325920|NCT03227471|101088141|FG013|Overall Study|Withdrawal by Subject|0|||
33325921|NCT03227471|101088142|FG014|Overall Study|Withdrawal by Subject|0|||
33325922|NCT03227471|101088128|FG000|Overall Study|Randomized, Never Dosed|0|||
33325923|NCT03227471|101088129|FG001|Overall Study|Randomized, Never Dosed|0|||
33325924|NCT03227471|101088130|FG002|Overall Study|Randomized, Never Dosed|0|||
33325925|NCT03227471|101088131|FG003|Overall Study|Randomized, Never Dosed|0|||
33325926|NCT03227471|101088132|FG004|Overall Study|Randomized, Never Dosed|0|||
33325927|NCT03227471|101088133|FG005|Overall Study|Randomized, Never Dosed|0|||
33325928|NCT03227471|101088134|FG006|Overall Study|Randomized, Never Dosed|0|||
33325929|NCT03227471|101088135|FG007|Overall Study|Randomized, Never Dosed|0|||
33325930|NCT03227471|101088136|FG008|Overall Study|Randomized, Never Dosed|0|||
33325931|NCT03227471|101088137|FG009|Overall Study|Randomized, Never Dosed|0|||
33325932|NCT03227471|101088138|FG010|Overall Study|Randomized, Never Dosed|0|||
33325933|NCT03227471|101088139|FG011|Overall Study|Randomized, Never Dosed|0|||
33325934|NCT03227471|101088140|FG012|Overall Study|Randomized, Never Dosed|0|||
33399876|NCT02477800|101350339|FG003|Placebo-Controlled Period|Relocation|0|||
33399877|NCT02477800|101350340|FG004|Placebo-Controlled Period|Relocation|0|||
33399878|NCT02477800|101350341|FG005|Placebo-Controlled Period|Relocation|0|||
33399879|NCT02477800|101350342|FG006|Placebo-Controlled Period|Relocation|0|||
33515660|NCT00250458|101783141|FG000|Overall Study|Lack of Migraine Attack|20|||
33515661|NCT00250458|101783142|FG001|Overall Study|Lack of Migraine Attack|9|||
33607335|NCT02305238|102111672|FG001|Overall Study|Randomized failure|0|||
33515662|NCT00250458|101783141|FG000|Overall Study|Qualifying migraine but did not treat|3|||
33515663|NCT00250458|101783142|FG001|Overall Study|Qualifying migraine but did not treat|3|||
33515664|NCT00250458|101783141|FG000|Overall Study|Other|1|||
33515665|NCT00250458|101783142|FG001|Overall Study|Other|0|||
33515666|NCT01346540|101783143|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
33515667|NCT01346540|101783144|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
33515668|NCT01346540|101783143|FG000|Overall Study|Adverse Event|0|||
33515669|NCT01346540|101783144|FG001|Overall Study|Adverse Event|4|||
33515670|NCT00843037|101783147|FG000|Overall Study|Lost to Follow-up|1|||
33515671|NCT01546168|101783148|FG000|Overall Study|Lost to Follow-up|1|||
33515672|NCT01546168|101783149|FG001|Overall Study|Lost to Follow-up|0|||
33515673|NCT01546168|101783148|FG000|Overall Study|Withdrawal by Subject|1|||
33515674|NCT01546168|101783149|FG001|Overall Study|Withdrawal by Subject|0|||
33515675|NCT01546168|101783148|FG000|Overall Study|ineligible after signing consent|2|||
33515676|NCT01546168|101783149|FG001|Overall Study|ineligible after signing consent|0|||
33515677|NCT01877382|101783150|FG000|Dose Escalation|Progressive disease|2|||
33515678|NCT01877382|101783151|FG001|Dose Escalation|Progressive disease|0|||
33515679|NCT01877382|101783152|FG002|Dose Escalation|Progressive disease|1|||
33515680|NCT01877382|101783153|FG003|Dose Escalation|Progressive disease|6|||
33515681|NCT01877382|101783154|FG004|Dose Escalation|Progressive disease|1|||
33515682|NCT01877382|101783155|FG005|Dose Escalation|Progressive disease|0|||
33515683|NCT01877382|101783156|FG006|Dose Escalation|Progressive disease|3|||
33515684|NCT01877382|101783157|FG007|Dose Escalation|Progressive disease|10|||
33515685|NCT01877382|101783158|FG008|Dose Escalation|Progressive disease|4|||
33515686|NCT01877382|101783159|FG009|Dose Escalation|Progressive disease|2|||
33515687|NCT01877382|101783160|FG010|Dose Escalation|Progressive disease|3|||
33515688|NCT01877382|101783161|FG011|Dose Escalation|Progressive disease|3|||
33515689|NCT01877382|101783162|FG012|Dose Escalation|Progressive disease|13|||
33515690|NCT01877382|101783163|FG013|Dose Escalation|Progressive disease|1|||
33515691|NCT01877382|101783164|FG014|Dose Escalation|Progressive disease|0|||
33515692|NCT01877382|101783150|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
33515693|NCT01877382|101783151|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515694|NCT01877382|101783152|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515695|NCT01877382|101783153|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
33515696|NCT01877382|101783154|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515697|NCT01877382|101783155|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515698|NCT01877382|101783156|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
33515699|NCT01877382|101783157|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515700|NCT01877382|101783158|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515701|NCT01877382|101783159|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515702|NCT01877382|101783160|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515703|NCT01877382|101783161|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515704|NCT01877382|101783162|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515705|NCT01877382|101783163|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515706|NCT01877382|101783164|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515707|NCT01877382|101783150|FG000|Dose Escalation|Clinical progression|0|||
33515708|NCT01877382|101783151|FG001|Dose Escalation|Clinical progression|1|||
33515709|NCT01877382|101783152|FG002|Dose Escalation|Clinical progression|0|||
33515710|NCT01877382|101783153|FG003|Dose Escalation|Clinical progression|2|||
33515711|NCT01877382|101783154|FG004|Dose Escalation|Clinical progression|0|||
33515712|NCT01877382|101783155|FG005|Dose Escalation|Clinical progression|0|||
33515713|NCT01877382|101783156|FG006|Dose Escalation|Clinical progression|1|||
33515714|NCT01877382|101783157|FG007|Dose Escalation|Clinical progression|0|||
33515715|NCT01877382|101783158|FG008|Dose Escalation|Clinical progression|0|||
33515716|NCT01877382|101783159|FG009|Dose Escalation|Clinical progression|1|||
33515717|NCT01877382|101783160|FG010|Dose Escalation|Clinical progression|0|||
33515718|NCT01877382|101783161|FG011|Dose Escalation|Clinical progression|0|||
33515719|NCT01877382|101783162|FG012|Dose Escalation|Clinical progression|2|||
33515720|NCT01877382|101783163|FG013|Dose Escalation|Clinical progression|1|||
33515721|NCT01877382|101783164|FG014|Dose Escalation|Clinical progression|0|||
33515722|NCT01877382|101783150|FG000|Dose Escalation|Adverse Event|0|||
33515723|NCT01877382|101783151|FG001|Dose Escalation|Adverse Event|0|||
33515724|NCT01877382|101783152|FG002|Dose Escalation|Adverse Event|0|||
33607336|NCT02305238|102111673|FG002|Overall Study|Randomized failure|8|||
33515725|NCT01877382|101783153|FG003|Dose Escalation|Adverse Event|4|||
33515726|NCT01877382|101783154|FG004|Dose Escalation|Adverse Event|1|||
33515727|NCT01877382|101783155|FG005|Dose Escalation|Adverse Event|2|||
33515728|NCT01877382|101783156|FG006|Dose Escalation|Adverse Event|1|||
33515729|NCT01877382|101783157|FG007|Dose Escalation|Adverse Event|2|||
33399880|NCT02477800|101350336|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
33399881|NCT02477800|101350337|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
33399882|NCT02477800|101350338|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
33399883|NCT02477800|101350339|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
33399884|NCT02477800|101350340|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
33399885|NCT02477800|101350341|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
33399886|NCT02477800|101350342|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
33399887|NCT02477800|101350336|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
33399888|NCT02477800|101350337|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
33399889|NCT02477800|101350338|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
33399890|NCT02477800|101350339|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
33399891|NCT02477800|101350340|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
33399892|NCT02477800|101350341|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
33399893|NCT02477800|101350342|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
33399894|NCT02477800|101350336|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
33399895|NCT02477800|101350337|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
33399896|NCT02477800|101350338|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
33399897|NCT02477800|101350339|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
33399898|NCT02477800|101350340|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
33399899|NCT02477800|101350341|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
33399900|NCT02477800|101350342|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
33399901|NCT02477800|101350336|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
33399902|NCT02477800|101350337|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
33399903|NCT02477800|101350338|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
33399904|NCT02477800|101350339|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33399905|NCT02477800|101350340|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33399906|NCT02477800|101350341|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33399907|NCT02477800|101350342|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33399908|NCT02477800|101350336|FG000|Placebo-Controlled Period|Reason not Specified|161|||
33399909|NCT02477800|101350337|FG001|Placebo-Controlled Period|Reason not Specified|161|||
33399910|NCT02477800|101350338|FG002|Placebo-Controlled Period|Reason not Specified|189|||
33399911|NCT02477800|101350339|FG003|Placebo-Controlled Period|Reason not Specified|0|||
33399912|NCT02477800|101350340|FG004|Placebo-Controlled Period|Reason not Specified|0|||
33399913|NCT02477800|101350341|FG005|Placebo-Controlled Period|Reason not Specified|0|||
33399914|NCT02477800|101350342|FG006|Placebo-Controlled Period|Reason not Specified|0|||
33399915|NCT02477800|101350336|FG000|Long Term Extension Period|Adverse Event|0|||
33399916|NCT02477800|101350337|FG001|Long Term Extension Period|Adverse Event|0|||
33399917|NCT02477800|101350338|FG002|Long Term Extension Period|Adverse Event|0|||
33399918|NCT02477800|101350339|FG003|Long Term Extension Period|Adverse Event|6|||
33399919|NCT02477800|101350340|FG004|Long Term Extension Period|Adverse Event|2|||
33399920|NCT02477800|101350341|FG005|Long Term Extension Period|Adverse Event|4|||
33399921|NCT02477800|101350342|FG006|Long Term Extension Period|Adverse Event|3|||
33399922|NCT02477800|101350336|FG000|Long Term Extension Period|Death|0|||
33399923|NCT02477800|101350337|FG001|Long Term Extension Period|Death|0|||
33399924|NCT02477800|101350338|FG002|Long Term Extension Period|Death|0|||
33399925|NCT02477800|101350339|FG003|Long Term Extension Period|Death|1|||
33399926|NCT02477800|101350340|FG004|Long Term Extension Period|Death|1|||
33399927|NCT02477800|101350341|FG005|Long Term Extension Period|Death|1|||
33399928|NCT02477800|101350342|FG006|Long Term Extension Period|Death|2|||
33399929|NCT02477800|101350336|FG000|Long Term Extension Period|Consent Withdrawn|0|||
33399930|NCT02477800|101350337|FG001|Long Term Extension Period|Consent Withdrawn|0|||
33399931|NCT02477800|101350338|FG002|Long Term Extension Period|Consent Withdrawn|0|||
33399932|NCT02477800|101350339|FG003|Long Term Extension Period|Consent Withdrawn|10|||
33399933|NCT02477800|101350340|FG004|Long Term Extension Period|Consent Withdrawn|4|||
33399934|NCT02477800|101350341|FG005|Long Term Extension Period|Consent Withdrawn|13|||
33399935|NCT02477800|101350342|FG006|Long Term Extension Period|Consent Withdrawn|16|||
33399936|NCT02477800|101350336|FG000|Long Term Extension Period|Disease Progression|0|||
33399937|NCT02477800|101350337|FG001|Long Term Extension Period|Disease Progression|0|||
33399938|NCT02477800|101350338|FG002|Long Term Extension Period|Disease Progression|0|||
33399939|NCT02477800|101350339|FG003|Long Term Extension Period|Disease Progression|3|||
33399940|NCT02477800|101350340|FG004|Long Term Extension Period|Disease Progression|1|||
33399941|NCT02477800|101350341|FG005|Long Term Extension Period|Disease Progression|1|||
33515730|NCT01877382|101783158|FG008|Dose Escalation|Adverse Event|0|||
33515731|NCT01877382|101783159|FG009|Dose Escalation|Adverse Event|0|||
33515732|NCT01877382|101783160|FG010|Dose Escalation|Adverse Event|0|||
33515733|NCT01877382|101783161|FG011|Dose Escalation|Adverse Event|0|||
33515734|NCT01877382|101783162|FG012|Dose Escalation|Adverse Event|1|||
33515735|NCT01877382|101783163|FG013|Dose Escalation|Adverse Event|0|||
33399942|NCT02477800|101350342|FG006|Long Term Extension Period|Disease Progression|0|||
33515736|NCT01877382|101783164|FG014|Dose Escalation|Adverse Event|0|||
33515737|NCT01877382|101783150|FG000|Dose Escalation|Withdrawal by Subject|0|||
33199597|NCT00113516|100633880|FG000|Part 1|Death|3|||
33515738|NCT01877382|101783151|FG001|Dose Escalation|Withdrawal by Subject|0|||
33515739|NCT01877382|101783152|FG002|Dose Escalation|Withdrawal by Subject|0|||
33515740|NCT01877382|101783153|FG003|Dose Escalation|Withdrawal by Subject|0|||
33515741|NCT01877382|101783154|FG004|Dose Escalation|Withdrawal by Subject|0|||
33515742|NCT01877382|101783155|FG005|Dose Escalation|Withdrawal by Subject|3|||
33515743|NCT01877382|101783156|FG006|Dose Escalation|Withdrawal by Subject|2|||
33515744|NCT01877382|101783157|FG007|Dose Escalation|Withdrawal by Subject|1|||
33515745|NCT01877382|101783158|FG008|Dose Escalation|Withdrawal by Subject|1|||
33515746|NCT01877382|101783159|FG009|Dose Escalation|Withdrawal by Subject|0|||
33515747|NCT01877382|101783160|FG010|Dose Escalation|Withdrawal by Subject|0|||
33515748|NCT01877382|101783161|FG011|Dose Escalation|Withdrawal by Subject|0|||
33515749|NCT01877382|101783162|FG012|Dose Escalation|Withdrawal by Subject|0|||
33515750|NCT01877382|101783163|FG013|Dose Escalation|Withdrawal by Subject|0|||
33515751|NCT01877382|101783164|FG014|Dose Escalation|Withdrawal by Subject|0|||
33515752|NCT01877382|101783150|FG000|Dose Escalation|Protocol Violation|0|||
33515753|NCT01877382|101783151|FG001|Dose Escalation|Protocol Violation|0|||
33515754|NCT01877382|101783152|FG002|Dose Escalation|Protocol Violation|0|||
33515755|NCT01877382|101783153|FG003|Dose Escalation|Protocol Violation|0|||
33515756|NCT01877382|101783154|FG004|Dose Escalation|Protocol Violation|0|||
33515757|NCT01877382|101783155|FG005|Dose Escalation|Protocol Violation|0|||
33515758|NCT01877382|101783156|FG006|Dose Escalation|Protocol Violation|1|||
33515759|NCT01877382|101783157|FG007|Dose Escalation|Protocol Violation|0|||
33515760|NCT01877382|101783158|FG008|Dose Escalation|Protocol Violation|0|||
33515761|NCT01877382|101783159|FG009|Dose Escalation|Protocol Violation|0|||
33515762|NCT01877382|101783160|FG010|Dose Escalation|Protocol Violation|0|||
33515763|NCT01877382|101783161|FG011|Dose Escalation|Protocol Violation|0|||
33515764|NCT01877382|101783162|FG012|Dose Escalation|Protocol Violation|0|||
33515765|NCT01877382|101783163|FG013|Dose Escalation|Protocol Violation|0|||
33515766|NCT01877382|101783164|FG014|Dose Escalation|Protocol Violation|0|||
33515767|NCT01877382|101783150|FG000|Dose Escalation|Study terminated by sponsor|0|||
33515768|NCT01877382|101783151|FG001|Dose Escalation|Study terminated by sponsor|0|||
33515769|NCT01877382|101783152|FG002|Dose Escalation|Study terminated by sponsor|0|||
33515770|NCT01877382|101783153|FG003|Dose Escalation|Study terminated by sponsor|0|||
33515771|NCT01877382|101783154|FG004|Dose Escalation|Study terminated by sponsor|0|||
33515772|NCT01877382|101783155|FG005|Dose Escalation|Study terminated by sponsor|0|||
33515773|NCT01877382|101783156|FG006|Dose Escalation|Study terminated by sponsor|0|||
33515774|NCT01877382|101783157|FG007|Dose Escalation|Study terminated by sponsor|1|||
33515775|NCT01877382|101783158|FG008|Dose Escalation|Study terminated by sponsor|1|||
33515776|NCT01877382|101783159|FG009|Dose Escalation|Study terminated by sponsor|0|||
33515777|NCT01877382|101783160|FG010|Dose Escalation|Study terminated by sponsor|0|||
33515778|NCT01877382|101783161|FG011|Dose Escalation|Study terminated by sponsor|0|||
33515779|NCT01877382|101783162|FG012|Dose Escalation|Study terminated by sponsor|3|||
33515780|NCT01877382|101783163|FG013|Dose Escalation|Study terminated by sponsor|0|||
33515781|NCT01877382|101783164|FG014|Dose Escalation|Study terminated by sponsor|0|||
33515782|NCT01877382|101783150|FG000|Dose Escalation|Death|0|||
33515783|NCT01877382|101783151|FG001|Dose Escalation|Death|0|||
33515784|NCT01877382|101783152|FG002|Dose Escalation|Death|0|||
33515785|NCT01877382|101783153|FG003|Dose Escalation|Death|0|||
33515786|NCT01877382|101783154|FG004|Dose Escalation|Death|0|||
33515787|NCT01877382|101783155|FG005|Dose Escalation|Death|0|||
33515788|NCT01877382|101783156|FG006|Dose Escalation|Death|0|||
33515789|NCT01877382|101783157|FG007|Dose Escalation|Death|1|||
33515790|NCT01877382|101783158|FG008|Dose Escalation|Death|0|||
33515791|NCT01877382|101783159|FG009|Dose Escalation|Death|0|||
33515792|NCT01877382|101783160|FG010|Dose Escalation|Death|0|||
33515793|NCT01877382|101783161|FG011|Dose Escalation|Death|0|||
33515794|NCT01877382|101783162|FG012|Dose Escalation|Death|1|||
33515795|NCT01877382|101783163|FG013|Dose Escalation|Death|1|||
33515796|NCT01877382|101783164|FG014|Dose Escalation|Death|0|||
33515797|NCT01877382|101783150|FG000|Dose Expansion|Progressive disease|0|||
33199598|NCT00113516|100633881|FG001|Part 1|Death|0|||
33399943|NCT02477800|101350336|FG000|Long Term Extension Period|Investigator Decision|0|||
33515798|NCT01877382|101783151|FG001|Dose Expansion|Progressive disease|0|||
33515799|NCT01877382|101783152|FG002|Dose Expansion|Progressive disease|0|||
33515800|NCT01877382|101783153|FG003|Dose Expansion|Progressive disease|0|||
33515801|NCT01877382|101783154|FG004|Dose Expansion|Progressive disease|0|||
33515802|NCT01877382|101783155|FG005|Dose Expansion|Progressive disease|0|||
33515803|NCT01877382|101783156|FG006|Dose Expansion|Progressive disease|0|||
33515804|NCT01877382|101783157|FG007|Dose Expansion|Progressive disease|0|||
33515805|NCT01877382|101783158|FG008|Dose Expansion|Progressive disease|0|||
33515806|NCT01877382|101783159|FG009|Dose Expansion|Progressive disease|0|||
33515807|NCT01877382|101783160|FG010|Dose Expansion|Progressive disease|0|||
33515808|NCT01877382|101783161|FG011|Dose Expansion|Progressive disease|0|||
33515809|NCT01877382|101783162|FG012|Dose Expansion|Progressive disease|0|||
33515810|NCT01877382|101783163|FG013|Dose Expansion|Progressive disease|0|||
33325935|NCT03227471|101088141|FG013|Overall Study|Randomized, Never Dosed|0|||
33325936|NCT03227471|101088142|FG014|Overall Study|Randomized, Never Dosed|1|||
33325937|NCT01265615|101088143|FG000|Overall Study|Protocol Violation|2|||
33515811|NCT01877382|101783164|FG014|Dose Expansion|Progressive disease|11|||
33515812|NCT01877382|101783150|FG000|Dose Expansion|Clinical progression|0|||
33515813|NCT01877382|101783151|FG001|Dose Expansion|Clinical progression|0|||
33515814|NCT01877382|101783152|FG002|Dose Expansion|Clinical progression|0|||
33515815|NCT01877382|101783153|FG003|Dose Expansion|Clinical progression|0|||
33515816|NCT01877382|101783154|FG004|Dose Expansion|Clinical progression|0|||
33515817|NCT01877382|101783155|FG005|Dose Expansion|Clinical progression|0|||
33515818|NCT01877382|101783156|FG006|Dose Expansion|Clinical progression|0|||
33515819|NCT01877382|101783157|FG007|Dose Expansion|Clinical progression|0|||
33515820|NCT01877382|101783158|FG008|Dose Expansion|Clinical progression|0|||
33325938|NCT01265615|101088144|FG001|Overall Study|Protocol Violation|2|||
33325939|NCT01265615|101088145|FG002|Overall Study|Protocol Violation|4|||
33325940|NCT01265615|101088146|FG003|Overall Study|Protocol Violation|3|||
33325941|NCT01187550|101088147|FG000|Overall Study|Protocol Violation|3|||
33515821|NCT01877382|101783159|FG009|Dose Expansion|Clinical progression|0|||
33515822|NCT01877382|101783160|FG010|Dose Expansion|Clinical progression|0|||
33325942|NCT01187550|101088148|FG001|Overall Study|Protocol Violation|1|||
33325943|NCT01187550|101088147|FG000|Overall Study|Other|3|||
33515823|NCT01877382|101783161|FG011|Dose Expansion|Clinical progression|0|||
33515824|NCT01877382|101783162|FG012|Dose Expansion|Clinical progression|0|||
33199599|NCT00113516|100633880|FG000|Part 1|Other|3|||
33325944|NCT01187550|101088148|FG001|Overall Study|Other|0|||
33199600|NCT00113516|100633881|FG001|Part 1|Other|0|||
33515825|NCT01877382|101783163|FG013|Dose Expansion|Clinical progression|0|||
33607337|NCT02305238|102111671|FG000|Overall Study|Required procedure failed|0|||
33607338|NCT02305238|102111672|FG001|Overall Study|Required procedure failed|1|||
33607339|NCT02305238|102111673|FG002|Overall Study|Required procedure failed|0|||
33607340|NCT03624127|102111680|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
33607341|NCT03624127|102111681|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
33199601|NCT00113516|100633880|FG000|Part 1|Withdrawal by Subject|2|||
33399944|NCT02477800|101350337|FG001|Long Term Extension Period|Investigator Decision|0|||
33399945|NCT02477800|101350338|FG002|Long Term Extension Period|Investigator Decision|0|||
33399946|NCT02477800|101350339|FG003|Long Term Extension Period|Investigator Decision|0|||
33399947|NCT02477800|101350340|FG004|Long Term Extension Period|Investigator Decision|0|||
33399948|NCT02477800|101350341|FG005|Long Term Extension Period|Investigator Decision|0|||
33325945|NCT01187550|101088147|FG000|Overall Study|Randomized but not treated|8|||
33325946|NCT01187550|101088148|FG001|Overall Study|Randomized but not treated|0|||
33325947|NCT00932360|101088149|FG000|Washout (One Week)|Withdrawal by Subject|0|||
33325948|NCT00932360|101088150|FG001|Washout (One Week)|Withdrawal by Subject|0|||
33325949|NCT00932360|101088151|FG002|Washout (One Week)|Withdrawal by Subject|0|||
33515826|NCT01877382|101783164|FG014|Dose Expansion|Clinical progression|6|||
33515827|NCT01877382|101783150|FG000|Dose Expansion|Adverse Event|0|||
33515828|NCT01877382|101783151|FG001|Dose Expansion|Adverse Event|0|||
33515829|NCT01877382|101783152|FG002|Dose Expansion|Adverse Event|0|||
33515830|NCT01877382|101783153|FG003|Dose Expansion|Adverse Event|0|||
33515831|NCT01877382|101783154|FG004|Dose Expansion|Adverse Event|0|||
33515832|NCT01877382|101783155|FG005|Dose Expansion|Adverse Event|0|||
33515833|NCT01877382|101783156|FG006|Dose Expansion|Adverse Event|0|||
33515834|NCT01877382|101783157|FG007|Dose Expansion|Adverse Event|0|||
33515835|NCT01877382|101783158|FG008|Dose Expansion|Adverse Event|0|||
33515836|NCT01877382|101783159|FG009|Dose Expansion|Adverse Event|0|||
33515837|NCT01877382|101783160|FG010|Dose Expansion|Adverse Event|0|||
33515838|NCT01877382|101783161|FG011|Dose Expansion|Adverse Event|0|||
33515839|NCT01877382|101783162|FG012|Dose Expansion|Adverse Event|0|||
33515840|NCT01877382|101783163|FG013|Dose Expansion|Adverse Event|0|||
33515841|NCT01877382|101783164|FG014|Dose Expansion|Adverse Event|1|||
33515842|NCT01877382|101783150|FG000|Dose Expansion|Death|0|||
33515843|NCT01877382|101783151|FG001|Dose Expansion|Death|0|||
33515844|NCT01877382|101783152|FG002|Dose Expansion|Death|0|||
33607342|NCT03624127|102111682|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
33607343|NCT03624127|102111680|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
33607344|NCT03624127|102111681|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
33607345|NCT03624127|102111682|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
33607346|NCT03624127|102111680|FG000|Treatment Week 0 - Week 16|Death|0|||
33607347|NCT03624127|102111681|FG001|Treatment Week 0 - Week 16|Death|1|||
33607348|NCT03624127|102111682|FG002|Treatment Week 0 - Week 16|Death|0|||
33607349|NCT03624127|102111680|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
33607350|NCT03624127|102111681|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
33607351|NCT03624127|102111682|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
33607352|NCT03624127|102111680|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
33607353|NCT03624127|102111681|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
33515845|NCT01877382|101783153|FG003|Dose Expansion|Death|0|||
33515846|NCT01877382|101783154|FG004|Dose Expansion|Death|0|||
33515847|NCT01877382|101783155|FG005|Dose Expansion|Death|0|||
33325950|NCT00932360|101088152|FG003|Washout (One Week)|Withdrawal by Subject|0|||
33515848|NCT01877382|101783156|FG006|Dose Expansion|Death|0|||
33515849|NCT01877382|101783157|FG007|Dose Expansion|Death|0|||
33515850|NCT01877382|101783158|FG008|Dose Expansion|Death|0|||
33515851|NCT01877382|101783159|FG009|Dose Expansion|Death|0|||
33515852|NCT01877382|101783160|FG010|Dose Expansion|Death|0|||
33515853|NCT01877382|101783161|FG011|Dose Expansion|Death|0|||
33515854|NCT01877382|101783162|FG012|Dose Expansion|Death|0|||
33515855|NCT01877382|101783163|FG013|Dose Expansion|Death|0|||
33515856|NCT01877382|101783164|FG014|Dose Expansion|Death|1|||
33515857|NCT01877382|101783150|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515858|NCT01877382|101783151|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515859|NCT01877382|101783152|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515860|NCT01877382|101783153|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515861|NCT01877382|101783154|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515862|NCT01877382|101783155|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515863|NCT01877382|101783156|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515864|NCT01877382|101783157|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515865|NCT01877382|101783158|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515866|NCT01877382|101783159|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515867|NCT01877382|101783160|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515868|NCT01877382|101783161|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515869|NCT01877382|101783162|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515870|NCT01877382|101783163|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
33515871|NCT01877382|101783164|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
33515872|NCT02143791|101783167|FG000|Enrolled|Withdrawal by Subject|4|||
33515873|NCT02143791|101783167|FG000|Trial Stimulation|Lack of Efficacy|21|||
33515874|NCT02143791|101783167|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
33515875|NCT02143791|101783167|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
33515876|NCT02143791|101783167|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
33515877|NCT02143791|101783167|FG000|Any Programming (3-6 Months)|Missing Data|1|||
33515878|NCT02143791|101783167|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
33515879|NCT02678000|101783168|FG000|PART 2|Adverse Event|0|||
33515880|NCT02678000|101783169|FG001|PART 2|Adverse Event|0|||
33515881|NCT02678000|101783170|FG002|PART 2|Adverse Event|2|||
33515882|NCT02678000|101783171|FG003|PART 2|Adverse Event|1|||
33515883|NCT02678000|101783172|FG004|PART 2|Adverse Event|0|||
33515884|NCT02678000|101783168|FG000|PART 2|Withdrawal by Subject|0|||
33515885|NCT02678000|101783169|FG001|PART 2|Withdrawal by Subject|0|||
33515886|NCT02678000|101783170|FG002|PART 2|Withdrawal by Subject|1|||
33515887|NCT02678000|101783171|FG003|PART 2|Withdrawal by Subject|0|||
33515888|NCT02678000|101783172|FG004|PART 2|Withdrawal by Subject|0|||
33515889|NCT04489381|101783173|FG000|Overall Study|Lost to Follow-up|2|||
33515890|NCT04489381|101783174|FG001|Overall Study|Lost to Follow-up|3|||
33515891|NCT04489381|101783173|FG000|Overall Study|Withdrawal by Subject|1|||
33515892|NCT04489381|101783174|FG001|Overall Study|Withdrawal by Subject|0|||
33515893|NCT01777295|101783178|FG000|Overall Study|Withdrawal by Subject|2|||
33515894|NCT01777295|101783179|FG001|Overall Study|Withdrawal by Subject|2|||
33515895|NCT01777295|101783178|FG000|Overall Study|Pregnancy|0|||
33515896|NCT01777295|101783179|FG001|Overall Study|Pregnancy|1|||
33515897|NCT01777295|101783178|FG000|Overall Study|Personal problem|1|||
33515898|NCT01777295|101783179|FG001|Overall Study|Personal problem|0|||
33325951|NCT00932360|101088153|FG004|Washout (One Week)|Withdrawal by Subject|2|||
33325952|NCT00932360|101088154|FG005|Washout (One Week)|Withdrawal by Subject|0|||
33515899|NCT01777295|101783178|FG000|Overall Study|Investigator call for AEs check|1|||
33515900|NCT01777295|101783179|FG001|Overall Study|Investigator call for AEs check|0|||
33515901|NCT02847182|101783180|FG000|Overall Study|Withdrawal by Subject|0|||
33515902|NCT02847182|101783181|FG001|Overall Study|Withdrawal by Subject|1|||
33515903|NCT01764997|101783182|FG000|Run-in Period|Adverse Event|15|||
33515904|NCT01764997|101783183|FG001|Run-in Period|Adverse Event|0|||
33515905|NCT01764997|101783184|FG002|Run-in Period|Adverse Event|0|||
33515906|NCT01764997|101783185|FG003|Run-in Period|Adverse Event|0|||
33515907|NCT01764997|101783186|FG004|Run-in Period|Adverse Event|0|||
33515908|NCT01764997|101783182|FG000|Run-in Period|Lack of Efficacy|5|||
33515909|NCT01764997|101783183|FG001|Run-in Period|Lack of Efficacy|0|||
33515910|NCT01764997|101783184|FG002|Run-in Period|Lack of Efficacy|0|||
33607354|NCT03624127|102111682|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
33607355|NCT03624127|102111680|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
33515911|NCT01764997|101783185|FG003|Run-in Period|Lack of Efficacy|0|||
33515912|NCT01764997|101783186|FG004|Run-in Period|Lack of Efficacy|0|||
33515913|NCT01764997|101783182|FG000|Run-in Period|Poor compliance to protocol|1|||
33515914|NCT01764997|101783183|FG001|Run-in Period|Poor compliance to protocol|0|||
33515915|NCT01764997|101783184|FG002|Run-in Period|Poor compliance to protocol|0|||
33515916|NCT01764997|101783185|FG003|Run-in Period|Poor compliance to protocol|0|||
33515917|NCT01764997|101783186|FG004|Run-in Period|Poor compliance to protocol|0|||
33515918|NCT01764997|101783182|FG000|Run-in Period|Other than specified above|17|||
33515919|NCT01764997|101783183|FG001|Run-in Period|Other than specified above|0|||
33515920|NCT01764997|101783184|FG002|Run-in Period|Other than specified above|0|||
33515921|NCT01764997|101783185|FG003|Run-in Period|Other than specified above|0|||
33515922|NCT01764997|101783186|FG004|Run-in Period|Other than specified above|0|||
33515923|NCT01764997|101783182|FG000|Study Drug Treatment Period|Adverse Event|0|||
33515924|NCT01764997|101783183|FG001|Study Drug Treatment Period|Adverse Event|1|||
33515925|NCT01764997|101783184|FG002|Study Drug Treatment Period|Adverse Event|0|||
33515926|NCT01764997|101783185|FG003|Study Drug Treatment Period|Adverse Event|0|||
33607356|NCT03624127|102111681|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
33607357|NCT03624127|102111682|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
33607358|NCT03624127|102111680|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
33607359|NCT03624127|102111681|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
33607360|NCT03624127|102111682|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
33607361|NCT03624127|102111680|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
33607362|NCT03624127|102111681|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
33607363|NCT03624127|102111682|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
33607364|NCT03624127|102111680|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
33607365|NCT03624127|102111681|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
33607366|NCT03624127|102111682|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
33607367|NCT03624127|102111680|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
33607368|NCT03624127|102111681|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
33607369|NCT03624127|102111682|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
33607370|NCT03624127|102111680|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
33607371|NCT03624127|102111681|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
33607372|NCT03624127|102111682|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
33607373|NCT03624127|102111680|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
33607374|NCT03624127|102111681|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
33607375|NCT03624127|102111682|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
33607376|NCT03624127|102111680|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
33607377|NCT03624127|102111681|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
33607378|NCT03624127|102111682|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
33607379|NCT03624127|102111680|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
33607380|NCT03624127|102111681|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
33607381|NCT03624127|102111682|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
33607382|NCT03624127|102111680|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
33607383|NCT03624127|102111681|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
33607384|NCT03624127|102111682|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
33607385|NCT03624127|102111680|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
33607386|NCT03624127|102111681|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
33607387|NCT03624127|102111682|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
33515927|NCT01764997|101783186|FG004|Study Drug Treatment Period|Adverse Event|24|||
33515928|NCT01764997|101783182|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
33515929|NCT01764997|101783183|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
33515930|NCT01764997|101783184|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
33607388|NCT03624127|102111680|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
33607389|NCT03624127|102111681|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
33607390|NCT03624127|102111682|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
33607391|NCT03624127|102111680|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
33607392|NCT03624127|102111681|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
33607393|NCT03624127|102111682|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
33199602|NCT00113516|100633881|FG001|Part 1|Withdrawal by Subject|0|||
33607394|NCT03624127|102111680|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
33607395|NCT03624127|102111681|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
33607396|NCT03624127|102111682|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
33607397|NCT03624127|102111680|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
33607398|NCT03624127|102111681|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
33607399|NCT03624127|102111682|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
33607400|NCT03624127|102111680|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
33607401|NCT03624127|102111681|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
33607402|NCT03624127|102111682|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
33607403|NCT04405245|102111683|FG000|Overall Study|Adverse Event|0|||
33607404|NCT04405245|102111684|FG001|Overall Study|Adverse Event|1|||
33607405|NCT04405245|102111685|FG002|Overall Study|Adverse Event|0|||
33607406|NCT00902174|102111686|FG000|Overall Study|Adverse Event|27|||
33607407|NCT00902174|102111687|FG001|Overall Study|Adverse Event|7|||
33607408|NCT00902174|102111686|FG000|Overall Study|Lack of Efficacy|1|||
33607409|NCT00902174|102111687|FG001|Overall Study|Lack of Efficacy|5|||
33607410|NCT00902174|102111686|FG000|Overall Study|Death|2|||
33607411|NCT00902174|102111687|FG001|Overall Study|Death|2|||
33607412|NCT00902174|102111686|FG000|Overall Study|Withdrawal by Subject|2|||
33607413|NCT00902174|102111687|FG001|Overall Study|Withdrawal by Subject|1|||
33607414|NCT00902174|102111686|FG000|Overall Study|Abnormal labs|1|||
33607415|NCT00902174|102111687|FG001|Overall Study|Abnormal labs|1|||
33607416|NCT00902174|102111686|FG000|Overall Study|Protocol Violation|1|||
33607417|NCT00902174|102111687|FG001|Overall Study|Protocol Violation|1|||
33607418|NCT00902174|102111686|FG000|Overall Study|Administration problem|0|||
33607419|NCT00902174|102111687|FG001|Overall Study|Administration problem|1|||
33607420|NCT01309269|102111690|FG000|Overall Study|Adverse Event|56|||
33607421|NCT01309269|102111690|FG000|Overall Study|Withdrawal by Subject|25|||
33607422|NCT01309269|102111690|FG000|Overall Study|Lack of Acceptance|15|||
33607423|NCT01309269|102111690|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
33607424|NCT01309269|102111690|FG000|Overall Study|Kidney Transplant|25|||
33607425|NCT01309269|102111690|FG000|Overall Study|Administrative Problems|141|||
33607426|NCT01309269|102111690|FG000|Overall Study|Other|256|||
33607427|NCT01309269|102111690|FG000|Overall Study|Other|1|||
33607428|NCT01309269|102111690|FG000|Overall Study|Study Completion Data Not Recorded|95|||
33607429|NCT01309269|102111690|FG000|Overall Study|Enrolled but not Treated|107|||
33607430|NCT01026220|102111691|FG000|Induction|Death|1|||
33607431|NCT01026220|102111692|FG001|Induction|Death|0|||
33607432|NCT01026220|102111693|FG002|Induction|Death|0|||
33607433|NCT01026220|102111691|FG000|Induction|Lack of Efficacy|2|||
33607434|NCT01026220|102111692|FG001|Induction|Lack of Efficacy|0|||
33607435|NCT01026220|102111693|FG002|Induction|Lack of Efficacy|0|||
33607436|NCT01026220|102111691|FG000|Induction|Physician Decision|12|||
33607437|NCT01026220|102111692|FG001|Induction|Physician Decision|0|||
33607438|NCT01026220|102111693|FG002|Induction|Physician Decision|0|||
33607439|NCT01026220|102111691|FG000|Induction|Withdrawal by Subject|9|||
33607440|NCT01026220|102111692|FG001|Induction|Withdrawal by Subject|0|||
33607441|NCT01026220|102111693|FG002|Induction|Withdrawal by Subject|0|||
33607442|NCT01026220|102111691|FG000|Induction|Ineligible|1|||
33607443|NCT01026220|102111692|FG001|Induction|Ineligible|0|||
33607444|NCT01026220|102111693|FG002|Induction|Ineligible|0|||
33607445|NCT01026220|102111691|FG000|Consolidation Maintenance|Death|0|||
33607446|NCT01026220|102111692|FG001|Consolidation Maintenance|Death|1|||
33607447|NCT01026220|102111693|FG002|Consolidation Maintenance|Death|0|||
33607448|NCT01026220|102111691|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
33607449|NCT01026220|102111692|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
33607450|NCT01026220|102111693|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
33607451|NCT01026220|102111691|FG000|Consolidation Maintenance|Physician Decision|0|||
33607452|NCT01026220|102111692|FG001|Consolidation Maintenance|Physician Decision|2|||
33607453|NCT01026220|102111693|FG002|Consolidation Maintenance|Physician Decision|7|||
33607454|NCT01026220|102111691|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
33607455|NCT01026220|102111692|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
33607456|NCT01026220|102111693|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
33607457|NCT00915551|102111694|FG000|Overall Study|Withdrawal by Subject|0|||
33607458|NCT00915551|102111695|FG001|Overall Study|Withdrawal by Subject|1|||
33607459|NCT01983774|102111696|FG000|Overall Study|Lung Transplant|0|||
33607460|NCT01983774|102111697|FG001|Overall Study|Lung Transplant|1|||
33607461|NCT01983774|102111696|FG000|Overall Study|Lost to Follow-up|1|||
33607462|NCT01983774|102111697|FG001|Overall Study|Lost to Follow-up|0|||
33607463|NCT01078168|102111699|FG000|Overall Study|Physician Decision|0|||
33607464|NCT01078168|102111700|FG001|Overall Study|Physician Decision|1|||
33607465|NCT03180307|102111701|FG000|Overall Study|Lost to Follow-up|2|||
33607466|NCT03180307|102111702|FG001|Overall Study|Lost to Follow-up|0|||
33607467|NCT03180307|102111701|FG000|Overall Study|Death|1|||
33607468|NCT03180307|102111702|FG001|Overall Study|Death|0|||
33607469|NCT03180307|102111701|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
33607470|NCT03180307|102111702|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
33607471|NCT01431963|102111703|FG000|Overall Study|Adverse Event|18|||
33607472|NCT01431963|102111703|FG000|Overall Study|Lack of Efficacy|7|||
33607473|NCT01431963|102111703|FG000|Overall Study|Protocol Violation|1|||
33607474|NCT01431963|102111703|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
33607475|NCT01431963|102111703|FG000|Overall Study|Physician Decision|4|||
33607476|NCT01431963|102111703|FG000|Overall Study|Withdrawal by Subject|3|||
33607477|NCT00559988|102111708|FG000|Overall Study|Death|147|||
33607478|NCT00559988|102111709|FG001|Overall Study|Death|140|||
33607479|NCT00559988|102111708|FG000|Overall Study|Withdrawal by Subject|152|||
33607480|NCT00559988|102111709|FG001|Overall Study|Withdrawal by Subject|139|||
33607481|NCT00559988|102111708|FG000|Overall Study|Lost to Follow-up|42|||
33607482|NCT00559988|102111709|FG001|Overall Study|Lost to Follow-up|56|||
33607483|NCT00559988|102111708|FG000|Overall Study|ICD device explanted|10|||
33607484|NCT00559988|102111709|FG001|Overall Study|ICD device explanted|17|||
33607485|NCT00551291|102111710|FG000|Overall Study|Physician Decision|1|||
33607486|NCT03006887|102111711|FG000|Overall Study|Adverse Event|1|||
33607487|NCT00932165|102111712|FG000|Overall Study|Lost to Follow-up|1|||
33607488|NCT02461745|102111713|FG000|Overall Study|Lack of Efficacy|9|||
33607489|NCT02461745|102111714|FG001|Overall Study|Lack of Efficacy|1|||
33607490|NCT02461745|102111713|FG000|Overall Study|Lost to Follow-up|2|||
33607491|NCT02461745|102111714|FG001|Overall Study|Lost to Follow-up|2|||
33607492|NCT02461745|102111713|FG000|Overall Study|Withdrawal by Subject|3|||
33607493|NCT02461745|102111714|FG001|Overall Study|Withdrawal by Subject|1|||
33607494|NCT04566692|102111715|FG000|Overall Study|Adverse Event|2|||
33607495|NCT04566692|102111716|FG001|Overall Study|Adverse Event|0|||
33607496|NCT04566692|102111715|FG000|Overall Study|Withdrawal by Subject|1|||
33607497|NCT04566692|102111716|FG001|Overall Study|Withdrawal by Subject|1|||
33607498|NCT02271945|102111717|FG000|Overall Study|Death|3|||
33607499|NCT02271945|102111718|FG001|Overall Study|Death|3|||
33607500|NCT02271945|102111717|FG000|Overall Study|Withdrawal by Subject|1|||
33607501|NCT02271945|102111718|FG001|Overall Study|Withdrawal by Subject|1|||
33607502|NCT02271945|102111717|FG000|Overall Study|Other|1|||
33607503|NCT02271945|102111718|FG001|Overall Study|Other|1|||
33607504|NCT02408523|102111723|FG000|Overall Study|Adverse Event|4|||
33607505|NCT02408523|102111724|FG001|Overall Study|Adverse Event|10|||
33607506|NCT02408523|102111723|FG000|Overall Study|Lack of Efficacy|0|||
33607507|NCT02408523|102111724|FG001|Overall Study|Lack of Efficacy|1|||
33607508|NCT02408523|102111723|FG000|Overall Study|Protocol Violation|1|||
33607509|NCT02408523|102111724|FG001|Overall Study|Protocol Violation|2|||
33607510|NCT02408523|102111723|FG000|Overall Study|Lost to Follow-up|2|||
33607511|NCT02408523|102111724|FG001|Overall Study|Lost to Follow-up|3|||
33607512|NCT02408523|102111723|FG000|Overall Study|Withdrawal by Subject|3|||
33607513|NCT02408523|102111724|FG001|Overall Study|Withdrawal by Subject|1|||
33607514|NCT02408523|102111723|FG000|Overall Study|Sponsor request|1|||
33607515|NCT02408523|102111724|FG001|Overall Study|Sponsor request|0|||
33607516|NCT02408523|102111723|FG000|Overall Study|Did not satisfy extension conditions|0|||
33607517|NCT02408523|102111724|FG001|Overall Study|Did not satisfy extension conditions|1|||
33607518|NCT00820222|102111725|FG000|Overall Study|Lost to Follow-up|10|||
33607519|NCT00820222|102111726|FG001|Overall Study|Lost to Follow-up|9|||
33607520|NCT00820222|102111725|FG000|Overall Study|Withdrawal by Subject|19|||
33607521|NCT00820222|102111726|FG001|Overall Study|Withdrawal by Subject|21|||
33607522|NCT00820222|102111725|FG000|Overall Study|Physician Decision|93|||
33607523|NCT00820222|102111726|FG001|Overall Study|Physician Decision|88|||
33607524|NCT00820222|102111725|FG000|Overall Study|Sponsor Terminated Study|43|||
33607525|NCT00820222|102111726|FG001|Overall Study|Sponsor Terminated Study|65|||
33607526|NCT00820222|102111725|FG000|Overall Study|Unkown|11|||
33325953|NCT02101021|101088155|FG000|Overall Study|Death|4|||
33325954|NCT02101021|101088156|FG001|Overall Study|Death|3|||
33325955|NCT02101021|101088157|FG002|Overall Study|Death|6|||
33325956|NCT02101021|101088158|FG003|Overall Study|Death|0|||
33325957|NCT02101021|101088159|FG004|Overall Study|Death|3|||
33607527|NCT00820222|102111726|FG001|Overall Study|Unkown|7|||
33325958|NCT02101021|101088155|FG000|Overall Study|Withdrew Consent from study|1|||
33607528|NCT00837759|102111727|FG000|Overall Study|Protocol Violation|3|||
33199603|NCT00113516|100633880|FG000|Part 1|Lack of Efficacy|2|||
33325959|NCT02101021|101088156|FG001|Overall Study|Withdrew Consent from study|1|||
33607529|NCT00837759|102111727|FG000|Overall Study|Lost to Follow-up|1|||
33399949|NCT02477800|101350342|FG006|Long Term Extension Period|Investigator Decision|2|||
33607530|NCT01736618|102111731|FG000|Overall Study|Death|294|||
33607531|NCT01736618|102111731|FG000|Overall Study|Lost to Follow-up|193|||
33607532|NCT01736618|102111731|FG000|Overall Study|Withdrawal by Subject|54|||
33607533|NCT01736618|102111731|FG000|Overall Study|Subject unable to be followed at study location|223|||
33607534|NCT01736618|102111731|FG000|Overall Study|Physician Decision|33|||
33607535|NCT01736618|102111731|FG000|Overall Study|Transplant or removal of target organ|19|||
33607536|NCT01736618|102111731|FG000|Overall Study|Change in indication or condition|78|||
33325960|NCT02101021|101088157|FG002|Overall Study|Withdrew Consent from study|0|||
33325961|NCT02101021|101088158|FG003|Overall Study|Withdrew Consent from study|2|||
33325962|NCT02101021|101088159|FG004|Overall Study|Withdrew Consent from study|0|||
33325963|NCT02101021|101088155|FG000|Overall Study|Lost to Follow-up|1|||
33325964|NCT02101021|101088156|FG001|Overall Study|Lost to Follow-up|0|||
33325965|NCT02101021|101088157|FG002|Overall Study|Lost to Follow-up|0|||
33325966|NCT02101021|101088158|FG003|Overall Study|Lost to Follow-up|0|||
33325967|NCT02101021|101088159|FG004|Overall Study|Lost to Follow-up|0|||
33325968|NCT02101021|101088155|FG000|Overall Study|Study Terminated by Sponsor|1|||
33325969|NCT02101021|101088156|FG001|Overall Study|Study Terminated by Sponsor|0|||
33325970|NCT02101021|101088157|FG002|Overall Study|Study Terminated by Sponsor|1|||
33607537|NCT01736618|102111731|FG000|Overall Study|Study device explant|103|||
33607538|NCT01736618|102111731|FG000|Overall Study|Unable to complete implant|2|||
33399950|NCT02477800|101350336|FG000|Long Term Extension Period|Lost to Follow-up|0|||
33399951|NCT02477800|101350337|FG001|Long Term Extension Period|Lost to Follow-up|0|||
33399952|NCT02477800|101350338|FG002|Long Term Extension Period|Lost to Follow-up|0|||
33515931|NCT01764997|101783185|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
33515932|NCT01764997|101783186|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
33325971|NCT02101021|101088158|FG003|Overall Study|Study Terminated by Sponsor|1|||
33325972|NCT02101021|101088159|FG004|Overall Study|Study Terminated by Sponsor|1|||
33325973|NCT01128361|101088161|FG000|Overall Study|Lost to Follow-up|0|||
33325974|NCT01128361|101088162|FG001|Overall Study|Lost to Follow-up|1|||
33325975|NCT01128361|101088161|FG000|Overall Study|Withdrawal by Subject|5|||
33325976|NCT01128361|101088162|FG001|Overall Study|Withdrawal by Subject|2|||
33325977|NCT00955279|101088168|FG000|Overall Study|Other|0|||
33325978|NCT00955279|101088169|FG001|Overall Study|Other|0|||
33399953|NCT02477800|101350339|FG003|Long Term Extension Period|Lost to Follow-up|0|||
33399954|NCT02477800|101350340|FG004|Long Term Extension Period|Lost to Follow-up|1|||
33325979|NCT00955279|101088170|FG002|Overall Study|Other|3|||
33399955|NCT02477800|101350341|FG005|Long Term Extension Period|Lost to Follow-up|3|||
33515933|NCT01764997|101783182|FG000|Study Drug Treatment Period|Other than specified above|0|||
33515934|NCT01764997|101783183|FG001|Study Drug Treatment Period|Other than specified above|0|||
33515935|NCT01764997|101783184|FG002|Study Drug Treatment Period|Other than specified above|0|||
33515936|NCT01764997|101783185|FG003|Study Drug Treatment Period|Other than specified above|0|||
33515937|NCT01764997|101783186|FG004|Study Drug Treatment Period|Other than specified above|10|||
33515938|NCT00767039|101783187|FG000|Overall Study|Death|5|||
33199604|NCT00113516|100633881|FG001|Part 1|Lack of Efficacy|0|||
33199605|NCT00113516|100633880|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
33199606|NCT00113516|100633881|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
33199607|NCT00113516|100633880|FG000|Part 1|Laboratory Abnormality|1|||
33199608|NCT00113516|100633881|FG001|Part 1|Laboratory Abnormality|0|||
33199609|NCT00113516|100633880|FG000|Part 1|Ongoing|1|||
33399956|NCT02477800|101350342|FG006|Long Term Extension Period|Lost to Follow-up|0|||
33399957|NCT02477800|101350336|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
33399958|NCT02477800|101350337|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
33515939|NCT00767039|101783188|FG001|Overall Study|Death|2|||
33515940|NCT02059434|101786325|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
33515941|NCT02059434|101786326|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
33199610|NCT00113516|100633881|FG001|Part 1|Ongoing|0|||
33199611|NCT00113516|100633880|FG000|Part 1|Missing|65|||
33199612|NCT00113516|100633881|FG001|Part 1|Missing|0|||
33325980|NCT00955279|101088168|FG000|Overall Study|Death|1|||
33325981|NCT00955279|101088169|FG001|Overall Study|Death|1|||
33325982|NCT00955279|101088170|FG002|Overall Study|Death|1|||
33325983|NCT00955279|101088168|FG000|Overall Study|Lost to Follow-up|0|||
33399959|NCT02477800|101350338|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
33399960|NCT02477800|101350339|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
33399961|NCT02477800|101350340|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
33399962|NCT02477800|101350341|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
33399963|NCT02477800|101350342|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
33399964|NCT02477800|101350336|FG000|Long Term Extension Period|Study Visit Burden|0|||
33515942|NCT02059434|101786327|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
33515943|NCT02059434|101786328|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
33515944|NCT02059434|101786329|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
33515945|NCT02059434|101786330|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
33607539|NCT02039856|102111732|FG000|Overall Study|Death|5|||
33607540|NCT02039856|102111733|FG001|Overall Study|Death|3|||
33199613|NCT00113516|100633880|FG000|Part 2|Adverse Event|0|||
33325984|NCT00955279|101088169|FG001|Overall Study|Lost to Follow-up|3|||
33325985|NCT00955279|101088170|FG002|Overall Study|Lost to Follow-up|1|||
33325986|NCT00955279|101088168|FG000|Overall Study|Withdrawal by Subject|2|||
33325987|NCT00955279|101088169|FG001|Overall Study|Withdrawal by Subject|0|||
33325988|NCT00955279|101088170|FG002|Overall Study|Withdrawal by Subject|3|||
33325989|NCT02319668|101088172|FG000|Overall Study|Other (Not specified)|0|||
33325990|NCT02319668|101088173|FG001|Overall Study|Other (Not specified)|2|||
33399965|NCT02477800|101350337|FG001|Long Term Extension Period|Study Visit Burden|0|||
33399966|NCT02477800|101350338|FG002|Long Term Extension Period|Study Visit Burden|0|||
33399967|NCT02477800|101350339|FG003|Long Term Extension Period|Study Visit Burden|3|||
33399968|NCT02477800|101350340|FG004|Long Term Extension Period|Study Visit Burden|0|||
33399969|NCT02477800|101350341|FG005|Long Term Extension Period|Study Visit Burden|2|||
33399970|NCT02477800|101350342|FG006|Long Term Extension Period|Study Visit Burden|2|||
33399971|NCT02477800|101350336|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
33399972|NCT02477800|101350337|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
33399973|NCT02477800|101350338|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
33399974|NCT02477800|101350339|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
33399975|NCT02477800|101350340|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
33399976|NCT02477800|101350341|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
33399977|NCT02477800|101350342|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
33399978|NCT02477800|101350336|FG000|Long Term Extension Period|Reason not Specified|0|||
33199614|NCT00113516|100633881|FG001|Part 2|Adverse Event|16|||
33199615|NCT00113516|100633880|FG000|Part 2|Death|0|||
33199616|NCT00113516|100633881|FG001|Part 2|Death|5|||
33199617|NCT00113516|100633880|FG000|Part 2|Lack of Efficacy|0|||
33199618|NCT00113516|100633881|FG001|Part 2|Lack of Efficacy|37|||
33199619|NCT00113516|100633880|FG000|Part 2|Withdrawal by Subject|0|||
33199620|NCT00113516|100633881|FG001|Part 2|Withdrawal by Subject|3|||
33199621|NCT00113516|100633880|FG000|Part 2|Other|0|||
33199622|NCT00113516|100633881|FG001|Part 2|Other|3|||
33515946|NCT02059434|101786331|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
33515947|NCT02059434|101786332|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
33515948|NCT02059434|101786333|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
33515949|NCT02059434|101786325|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
33515950|NCT02059434|101786326|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
33515951|NCT02059434|101786327|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
33515952|NCT02059434|101786328|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
33515953|NCT02059434|101786329|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
33515954|NCT02059434|101786330|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
33199623|NCT00113516|100633880|FG000|Part 2|Laboratory Abnormality|0|||
33199624|NCT00113516|100633881|FG001|Part 2|Laboratory Abnormality|1|||
33199625|NCT00113516|100633880|FG000|Part 2|Ongoing|0|||
33199626|NCT00113516|100633881|FG001|Part 2|Ongoing|1|||
33199627|NCT01962974|100633882|FG000|Overall Study|Study termination|7|||
33199628|NCT02120924|100633883|FG000|Overall Study|Lack of Efficacy|1|||
33199629|NCT02120924|100633884|FG001|Overall Study|Lack of Efficacy|2|||
33199630|NCT02120924|100633885|FG002|Overall Study|Lack of Efficacy|3|||
33325991|NCT01368042|101088174|FG000|Overall Study|Death|14|||
33325992|NCT01368042|101088174|FG000|Overall Study|Protocol Violation|11|||
33325993|NCT01368042|101088174|FG000|Overall Study|Lost to Follow-up|4|||
33325994|NCT01368042|101088174|FG000|Overall Study|Transplanted|1|||
33325995|NCT00122681|101090991|FG000|Overall Study|Adverse Event|20|||
33325996|NCT00122681|101090992|FG001|Overall Study|Adverse Event|16|||
33325997|NCT00122681|101090991|FG000|Overall Study|Lost to Follow-up|1080|||
33325998|NCT00122681|101090992|FG001|Overall Study|Lost to Follow-up|1097|||
33325999|NCT00122681|101090991|FG000|Overall Study|Protocol Violation|7|||
33326000|NCT00122681|101090992|FG001|Overall Study|Protocol Violation|10|||
33326001|NCT00122681|101090991|FG000|Overall Study|Withdrawal by Subject|257|||
33326002|NCT00122681|101090992|FG001|Overall Study|Withdrawal by Subject|251|||
33326003|NCT00122681|101090991|FG000|Overall Study|Personal reasons|150|||
33326004|NCT00122681|101090992|FG001|Overall Study|Personal reasons|147|||
33326005|NCT02043548|101090993|FG000|Overall Study|Lack of Efficacy|1|||
33326006|NCT02043548|101090994|FG001|Overall Study|Lack of Efficacy|0|||
33326007|NCT02043548|101090993|FG000|Overall Study|Adverse Event|0|||
33326008|NCT02043548|101090994|FG001|Overall Study|Adverse Event|1|||
33326009|NCT02161575|101090995|FG000|Overall Study|Protocol Violation|8|||
33399979|NCT02477800|101350337|FG001|Long Term Extension Period|Reason not Specified|0|||
33399980|NCT02477800|101350338|FG002|Long Term Extension Period|Reason not Specified|0|||
33515955|NCT02059434|101786331|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
33515956|NCT02059434|101786332|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
33515957|NCT02059434|101786333|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
33515958|NCT02059434|101786325|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
33199631|NCT02120924|100633883|FG000|Overall Study|Adverse Event|0|||
33199632|NCT02120924|100633884|FG001|Overall Study|Adverse Event|1|||
33326010|NCT02161575|101090995|FG000|Overall Study|Lack of Efficacy|1|||
33199633|NCT02120924|100633885|FG002|Overall Study|Adverse Event|3|||
33326011|NCT02161575|101090995|FG000|Overall Study|Adverse Event|2|||
33199634|NCT02120924|100633883|FG000|Overall Study|Withdrawal by Subject|16|||
33199635|NCT02120924|100633884|FG001|Overall Study|Withdrawal by Subject|20|||
33326012|NCT03150862|101091000|FG000|Overall Study|Death|2|||
33326013|NCT03150862|101091001|FG001|Overall Study|Death|7|||
33326014|NCT03150862|101091002|FG002|Overall Study|Death|8|||
33326015|NCT03150862|101091003|FG003|Overall Study|Death|27|||
33326016|NCT03150862|101091004|FG004|Overall Study|Death|4|||
33326017|NCT03150862|101091005|FG005|Overall Study|Death|8|||
33326018|NCT03150862|101091006|FG006|Overall Study|Death|6|||
33326019|NCT03150862|101091007|FG007|Overall Study|Death|21|||
33326020|NCT03150862|101091000|FG000|Overall Study|Withdrawal by Subject|1|||
33326021|NCT03150862|101091001|FG001|Overall Study|Withdrawal by Subject|1|||
33326022|NCT03150862|101091002|FG002|Overall Study|Withdrawal by Subject|0|||
33326023|NCT03150862|101091003|FG003|Overall Study|Withdrawal by Subject|3|||
33326024|NCT03150862|101091004|FG004|Overall Study|Withdrawal by Subject|1|||
33326025|NCT03150862|101091005|FG005|Overall Study|Withdrawal by Subject|1|||
33326026|NCT03150862|101091006|FG006|Overall Study|Withdrawal by Subject|1|||
33326027|NCT03150862|101091007|FG007|Overall Study|Withdrawal by Subject|3|||
33326028|NCT03150862|101091000|FG000|Overall Study|Lost to Follow-up|0|||
33326029|NCT03150862|101091001|FG001|Overall Study|Lost to Follow-up|0|||
33326030|NCT03150862|101091002|FG002|Overall Study|Lost to Follow-up|1|||
33326031|NCT03150862|101091003|FG003|Overall Study|Lost to Follow-up|0|||
33326032|NCT03150862|101091004|FG004|Overall Study|Lost to Follow-up|0|||
33326033|NCT03150862|101091005|FG005|Overall Study|Lost to Follow-up|0|||
33326034|NCT03150862|101091006|FG006|Overall Study|Lost to Follow-up|0|||
33326035|NCT03150862|101091007|FG007|Overall Study|Lost to Follow-up|2|||
33326036|NCT03150862|101091000|FG000|Overall Study|Sponsor's decision|0|||
33326037|NCT03150862|101091001|FG001|Overall Study|Sponsor's decision|0|||
33326038|NCT03150862|101091002|FG002|Overall Study|Sponsor's decision|0|||
33326039|NCT03150862|101091003|FG003|Overall Study|Sponsor's decision|10|||
33326040|NCT03150862|101091004|FG004|Overall Study|Sponsor's decision|3|||
33326041|NCT03150862|101091005|FG005|Overall Study|Sponsor's decision|0|||
33326042|NCT03150862|101091006|FG006|Overall Study|Sponsor's decision|1|||
33326043|NCT03150862|101091007|FG007|Overall Study|Sponsor's decision|1|||
33326044|NCT03150862|101091000|FG000|Overall Study|Change in Methylation status|0|||
33326045|NCT03150862|101091001|FG001|Overall Study|Change in Methylation status|0|||
33326046|NCT03150862|101091002|FG002|Overall Study|Change in Methylation status|0|||
33326047|NCT03150862|101091003|FG003|Overall Study|Change in Methylation status|0|||
33326048|NCT03150862|101091004|FG004|Overall Study|Change in Methylation status|1|||
33326049|NCT03150862|101091005|FG005|Overall Study|Change in Methylation status|0|||
33326050|NCT03150862|101091006|FG006|Overall Study|Change in Methylation status|0|||
33326051|NCT03150862|101091007|FG007|Overall Study|Change in Methylation status|0|||
33326052|NCT03150862|101091000|FG000|Overall Study|Roll over in to Long Term Extension|0|||
33326053|NCT03150862|101091001|FG001|Overall Study|Roll over in to Long Term Extension|0|||
33326054|NCT03150862|101091002|FG002|Overall Study|Roll over in to Long Term Extension|0|||
33326055|NCT03150862|101091003|FG003|Overall Study|Roll over in to Long Term Extension|0|||
33326056|NCT03150862|101091004|FG004|Overall Study|Roll over in to Long Term Extension|0|||
33326057|NCT03150862|101091005|FG005|Overall Study|Roll over in to Long Term Extension|0|||
33326058|NCT03150862|101091006|FG006|Overall Study|Roll over in to Long Term Extension|0|||
33326059|NCT03150862|101091007|FG007|Overall Study|Roll over in to Long Term Extension|1|||
33326060|NCT03150862|101091000|FG000|Overall Study|Progressive Disease|0|||
33326061|NCT03150862|101091001|FG001|Overall Study|Progressive Disease|0|||
33326062|NCT03150862|101091002|FG002|Overall Study|Progressive Disease|0|||
33326063|NCT03150862|101091003|FG003|Overall Study|Progressive Disease|0|||
33326064|NCT03150862|101091004|FG004|Overall Study|Progressive Disease|0|||
33326065|NCT03150862|101091005|FG005|Overall Study|Progressive Disease|0|||
33399981|NCT02477800|101350339|FG003|Long Term Extension Period|Reason not Specified|126|||
33399982|NCT02477800|101350340|FG004|Long Term Extension Period|Reason not Specified|140|||
33399983|NCT02477800|101350341|FG005|Long Term Extension Period|Reason not Specified|270|||
33399984|NCT02477800|101350342|FG006|Long Term Extension Period|Reason not Specified|224|||
33399985|NCT00877890|101350343|FG000|Overall Study|Adverse Event|6|||
33515959|NCT02059434|101786326|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
33515960|NCT02059434|101786327|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
33515961|NCT02059434|101786328|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
33515962|NCT02059434|101786329|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
33515963|NCT02059434|101786330|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
33326066|NCT03150862|101091006|FG006|Overall Study|Progressive Disease|0|||
33326067|NCT03150862|101091007|FG007|Overall Study|Progressive Disease|2|||
33326068|NCT00187096|101091012|FG000|Overall Study|unacceptable toxicity|0|||
33326069|NCT00187096|101091013|FG001|Overall Study|unacceptable toxicity|0|||
33326070|NCT00187096|101091014|FG002|Overall Study|unacceptable toxicity|1|||
33326071|NCT02495844|101091017|FG000|Overall Study|Lack of Efficacy|1|||
33399986|NCT00877890|101350344|FG001|Overall Study|Adverse Event|6|||
33326072|NCT02495844|101091018|FG001|Overall Study|Lack of Efficacy|2|||
33326073|NCT02495844|101091017|FG000|Overall Study|AE, non-fatal|0|||
33326074|NCT02495844|101091018|FG001|Overall Study|AE, non-fatal|1|||
33326075|NCT02495844|101091017|FG000|Overall Study|Hepatitis Positivity|0|||
33326076|NCT02495844|101091018|FG001|Overall Study|Hepatitis Positivity|1|||
33326077|NCT01168973|101091032|FG000|Overall Study|Progressive Disease|341|||
33326078|NCT01168973|101091033|FG001|Overall Study|Progressive Disease|429|||
33326079|NCT01168973|101091032|FG000|Overall Study|Adverse Event|94|||
33326080|NCT01168973|101091033|FG001|Overall Study|Adverse Event|55|||
33326081|NCT01168973|101091032|FG000|Overall Study|Withdrawal by Subject|90|||
33326082|NCT01168973|101091033|FG001|Overall Study|Withdrawal by Subject|53|||
33326083|NCT01168973|101091032|FG000|Overall Study|Death|42|||
33326084|NCT01168973|101091033|FG001|Overall Study|Death|45|||
33326085|NCT01168973|101091032|FG000|Overall Study|Physician Decision|37|||
33326086|NCT01168973|101091033|FG001|Overall Study|Physician Decision|19|||
33326087|NCT01168973|101091032|FG000|Overall Study|Sponsor Decision|2|||
33326088|NCT01168973|101091033|FG001|Overall Study|Sponsor Decision|1|||
33326089|NCT01168973|101091032|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
33326090|NCT01168973|101091033|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
33326091|NCT03713034|101091034|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
33326092|NCT03713034|101091035|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
33326093|NCT00516048|101091036|FG000|Overall Study|Death|0|||
33326094|NCT00516048|101091037|FG001|Overall Study|Death|0|||
33326095|NCT00516048|101091038|FG002|Overall Study|Death|1|||
33326096|NCT00516048|101091036|FG000|Overall Study|Subject Decision|0|||
33326097|NCT00516048|101091037|FG001|Overall Study|Subject Decision|2|||
33326098|NCT00516048|101091038|FG002|Overall Study|Subject Decision|0|||
33326099|NCT03677596|101091039|FG000|Overall Study|Adverse Event|0|||
33326100|NCT03677596|101091040|FG001|Overall Study|Adverse Event|1|||
33326101|NCT03677596|101091039|FG000|Overall Study|Death|10|||
33326102|NCT03677596|101091040|FG001|Overall Study|Death|6|||
33326103|NCT03677596|101091039|FG000|Overall Study|Lost to Follow-up|0|||
33326104|NCT03677596|101091040|FG001|Overall Study|Lost to Follow-up|1|||
33326105|NCT03677596|101091039|FG000|Overall Study|Progressive Disease|8|||
33326106|NCT03677596|101091040|FG001|Overall Study|Progressive Disease|8|||
33326107|NCT03677596|101091039|FG000|Overall Study|Withdrawal by Subject|3|||
33326108|NCT03677596|101091040|FG001|Overall Study|Withdrawal by Subject|0|||
33326109|NCT03677596|101091039|FG000|Overall Study|Disease Relapse|2|||
33326110|NCT03677596|101091040|FG001|Overall Study|Disease Relapse|2|||
33326111|NCT03677596|101091039|FG000|Overall Study|Other|0|||
33326112|NCT03677596|101091040|FG001|Overall Study|Other|1|||
33326113|NCT00574145|101091042|FG000|Overall Study|Withdrawal by Subject|2|||
33326114|NCT00574145|101091043|FG001|Overall Study|Withdrawal by Subject|1|||
33326115|NCT03975920|101091047|FG000|Overall Study|Lost to Follow-up|1|||
33326116|NCT03975920|101091048|FG001|Overall Study|Lost to Follow-up|2|||
33515964|NCT02059434|101786331|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
33515965|NCT02059434|101786332|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
33515966|NCT02059434|101786333|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
33515967|NCT02059434|101786325|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
33515968|NCT02059434|101786326|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
33515969|NCT02059434|101786327|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
33515970|NCT02059434|101786328|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
33515971|NCT02059434|101786329|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
33515972|NCT02059434|101786330|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
33515973|NCT02059434|101786331|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
33515974|NCT02059434|101786332|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
33515975|NCT02059434|101786333|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
33515976|NCT02059434|101786325|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33515977|NCT02059434|101786326|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33515978|NCT02059434|101786327|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33515979|NCT02059434|101786328|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33326117|NCT03975920|101091047|FG000|Overall Study|Protocol Violation|1|||
33326118|NCT03975920|101091048|FG001|Overall Study|Protocol Violation|1|||
33326119|NCT03975920|101091047|FG000|Overall Study|Did not complete survey|2|||
33326120|NCT03975920|101091048|FG001|Overall Study|Did not complete survey|1|||
33326121|NCT02663271|101091049|FG000|Overall Study|Withdrawal by Subject|5|||
33326122|NCT02663271|101091049|FG000|Overall Study|Lack of Efficacy|1|||
33326123|NCT04126083|101091050|FG000|Overall Study|Withdrawal by Subject|1|||
33326124|NCT00698932|101091051|FG000|Overall Study|Adverse Event|0|||
33326125|NCT00698932|101091052|FG001|Overall Study|Adverse Event|2|||
33326126|NCT00698932|101091051|FG000|Overall Study|Incorrect enrollment|0|||
33326127|NCT00698932|101091052|FG001|Overall Study|Incorrect enrollment|2|||
33326128|NCT00698932|101091051|FG000|Overall Study|Study specific discontinuation criteria|3|||
33326129|NCT00698932|101091052|FG001|Overall Study|Study specific discontinuation criteria|4|||
33326130|NCT00698932|101091051|FG000|Overall Study|Withdrawal by Subject|11|||
33515980|NCT02059434|101786329|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33515981|NCT02059434|101786330|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33515982|NCT02059434|101786331|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33515983|NCT02059434|101786332|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
33515984|NCT02059434|101786333|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
33515985|NCT03168919|101786334|FG000|Overall Study|Withdrawal by Subject|2|||
33515986|NCT00081731|101786337|FG000|Overall Study|scientific integrity issue|8|||
33515987|NCT00081731|101786338|FG001|Overall Study|scientific integrity issue|8|||
33515988|NCT02631746|101786339|FG000|Overall Study|Lack of Efficacy|3|||
33515989|NCT01952080|101786342|FG000|Overall Study|Withdrawal by Subject|0|||
33515990|NCT01952080|101786343|FG001|Overall Study|Withdrawal by Subject|0|||
33515991|NCT01952080|101786344|FG002|Overall Study|Withdrawal by Subject|0|||
33399987|NCT00877890|101350343|FG000|Overall Study|Lost to Follow-up|5|||
33515992|NCT01952080|101786345|FG003|Overall Study|Withdrawal by Subject|1|||
33515993|NCT01952080|101786342|FG000|Overall Study|Protocol Non-compliance|0|||
33515994|NCT01952080|101786343|FG001|Overall Study|Protocol Non-compliance|1|||
33515995|NCT01952080|101786344|FG002|Overall Study|Protocol Non-compliance|0|||
33399988|NCT00877890|101350344|FG001|Overall Study|Lost to Follow-up|5|||
33199636|NCT02120924|100633885|FG002|Overall Study|Withdrawal by Subject|8|||
33199637|NCT02120924|100633883|FG000|Overall Study|Lost to Follow-up|14|||
33199638|NCT02120924|100633884|FG001|Overall Study|Lost to Follow-up|14|||
33199639|NCT02120924|100633885|FG002|Overall Study|Lost to Follow-up|11|||
33199640|NCT02120924|100633883|FG000|Overall Study|Pregnancy|2|||
33199641|NCT02120924|100633884|FG001|Overall Study|Pregnancy|0|||
33199642|NCT02120924|100633885|FG002|Overall Study|Pregnancy|0|||
33199643|NCT02120924|100633883|FG000|Overall Study|Protocol Violation|3|||
33199644|NCT02120924|100633884|FG001|Overall Study|Protocol Violation|7|||
33199645|NCT02120924|100633885|FG002|Overall Study|Protocol Violation|2|||
33199646|NCT02120924|100633883|FG000|Overall Study|Physician Decision|0|||
33199647|NCT02120924|100633884|FG001|Overall Study|Physician Decision|1|||
33199648|NCT02120924|100633885|FG002|Overall Study|Physician Decision|1|||
33199649|NCT02120924|100633883|FG000|Overall Study|Death|1|||
33199650|NCT02120924|100633884|FG001|Overall Study|Death|0|||
33607541|NCT02039856|102111732|FG000|Overall Study|Partial survey completion|61|||
33607542|NCT02039856|102111733|FG001|Overall Study|Partial survey completion|26|||
33607543|NCT02039856|102111732|FG000|Overall Study|Lost to Follow-up|388|||
33607544|NCT02039856|102111733|FG001|Overall Study|Lost to Follow-up|206|||
33607545|NCT02039856|102111732|FG000|Overall Study|Withdrawal by Subject|1573|||
33607546|NCT02039856|102111733|FG001|Overall Study|Withdrawal by Subject|618|||
33607547|NCT03652675|102111734|FG000|Overall Study|Lost to Follow-up|4|||
33607548|NCT03652675|102111735|FG001|Overall Study|Lost to Follow-up|4|||
33607549|NCT04699461|102111738|FG000|Overall Study|Withdrawal by Subject|1|||
33199651|NCT02120924|100633885|FG002|Overall Study|Death|0|||
33199652|NCT02120924|100633883|FG000|Overall Study|Compliance with IP|5|||
33607550|NCT04699461|102111739|FG001|Overall Study|Withdrawal by Subject|0|||
33607551|NCT04699461|102111738|FG000|Overall Study|Study termination by sponsor|2|||
33607552|NCT04699461|102111739|FG001|Overall Study|Study termination by sponsor|1|||
33326131|NCT00698932|101091052|FG001|Overall Study|Withdrawal by Subject|23|||
33326132|NCT00698932|101091051|FG000|Overall Study|Lost to Follow-up|6|||
33326133|NCT00698932|101091052|FG001|Overall Study|Lost to Follow-up|1|||
33326134|NCT00698932|101091051|FG000|Overall Study|Severe non-compliance to protocol|1|||
33326135|NCT00698932|101091052|FG001|Overall Study|Severe non-compliance to protocol|2|||
33326136|NCT00698932|101091051|FG000|Overall Study|Safety reasons|0|||
33515996|NCT01952080|101786345|FG003|Overall Study|Protocol Non-compliance|0|||
33515997|NCT02124759|101786346|FG000|Overall Study|Withdrawal by Subject|3|||
33515998|NCT02124759|101786347|FG001|Overall Study|Withdrawal by Subject|1|||
33515999|NCT02124759|101786348|FG002|Overall Study|Withdrawal by Subject|1|||
33516000|NCT02124759|101786346|FG000|Overall Study|Screen Fail|2|||
33516001|NCT02124759|101786347|FG001|Overall Study|Screen Fail|2|||
33516002|NCT02124759|101786348|FG002|Overall Study|Screen Fail|3|||
33516003|NCT02278367|101786349|FG000|Overall Study|Physician Decision|5|||
33516004|NCT02278367|101786350|FG001|Overall Study|Physician Decision|0|||
33516005|NCT02278367|101786349|FG000|Overall Study|Withdrawal by Subject|5|||
33516006|NCT02278367|101786350|FG001|Overall Study|Withdrawal by Subject|0|||
33516007|NCT01472757|101786356|FG000|Overall Study|Withdrawal by Subject|1|||
33516008|NCT01472757|101786357|FG001|Overall Study|Withdrawal by Subject|2|||
33516009|NCT01472757|101786358|FG002|Overall Study|Withdrawal by Subject|2|||
33516010|NCT01472757|101786359|FG003|Overall Study|Withdrawal by Subject|0|||
33516011|NCT01472757|101786356|FG000|Overall Study|Asthma exacerbation|4|||
33516012|NCT01472757|101786357|FG001|Overall Study|Asthma exacerbation|1|||
33516013|NCT01472757|101786358|FG002|Overall Study|Asthma exacerbation|2|||
33516014|NCT01472757|101786359|FG003|Overall Study|Asthma exacerbation|1|||
33516015|NCT01472757|101786356|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
33516016|NCT01472757|101786357|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
33516017|NCT01472757|101786358|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
33516018|NCT01472757|101786359|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
33516019|NCT01472757|101786356|FG000|Overall Study|Protocol Violation|3|||
33516020|NCT01472757|101786357|FG001|Overall Study|Protocol Violation|2|||
33516021|NCT01472757|101786358|FG002|Overall Study|Protocol Violation|4|||
33516022|NCT01472757|101786359|FG003|Overall Study|Protocol Violation|4|||
33607553|NCT04699461|102111738|FG000|Overall Study|Death|1|||
33516023|NCT01472757|101786356|FG000|Overall Study|Other reasons|1|||
33516024|NCT01472757|101786357|FG001|Overall Study|Other reasons|0|||
33607554|NCT04699461|102111739|FG001|Overall Study|Death|0|||
33607555|NCT04699461|102111738|FG000|Overall Study|Radiographic progression|0|||
33607556|NCT04699461|102111739|FG001|Overall Study|Radiographic progression|1|||
33199653|NCT02120924|100633884|FG001|Overall Study|Compliance with IP|1|||
33516025|NCT01472757|101786358|FG002|Overall Study|Other reasons|2|||
33516026|NCT01472757|101786359|FG003|Overall Study|Other reasons|2|||
33516027|NCT03417024|101786360|FG000|Overall Study|Study Termination prior to follow-up|11|||
33516028|NCT03417024|101786360|FG000|Overall Study|Physician Decision|2|||
33516029|NCT00329641|101786361|FG000|Overall Study|Did not start treatment|1|||
33516030|NCT00329641|101786361|FG000|Overall Study|Not eligible|1|||
33516031|NCT00329641|101786361|FG000|Overall Study|Adverse Event|3|||
33516032|NCT00329641|101786361|FG000|Overall Study|Other reason, not protocol specified|1|||
33516033|NCT00115037|101786366|FG000|Phase1|Lost to Follow-up|16|||
33516034|NCT00115037|101786367|FG001|Phase1|Lost to Follow-up|23|||
33516035|NCT00115037|101786368|FG002|Phase1|Lost to Follow-up|0|||
33516036|NCT00115037|101786369|FG003|Phase1|Lost to Follow-up|0|||
33516037|NCT00115037|101786370|FG004|Phase1|Lost to Follow-up|0|||
33516038|NCT00115037|101786371|FG005|Phase1|Lost to Follow-up|0|||
33516039|NCT00115037|101786366|FG000|Phase1|Withdrawal by Subject|9|||
33516040|NCT00115037|101786367|FG001|Phase1|Withdrawal by Subject|4|||
33516041|NCT00115037|101786368|FG002|Phase1|Withdrawal by Subject|0|||
33516042|NCT00115037|101786369|FG003|Phase1|Withdrawal by Subject|0|||
33516043|NCT00115037|101786370|FG004|Phase1|Withdrawal by Subject|0|||
33516044|NCT00115037|101786371|FG005|Phase1|Withdrawal by Subject|0|||
33516045|NCT00115037|101786366|FG000|Phase2|Death|0|||
33516046|NCT00115037|101786367|FG001|Phase2|Death|0|||
33516047|NCT00115037|101786368|FG002|Phase2|Death|1|||
33516048|NCT00115037|101786369|FG003|Phase2|Death|0|||
33516049|NCT00115037|101786370|FG004|Phase2|Death|0|||
33516050|NCT00115037|101786371|FG005|Phase2|Death|1|||
33516051|NCT00115037|101786366|FG000|Phase2|Withdrawal by Subject|0|||
33516052|NCT00115037|101786367|FG001|Phase2|Withdrawal by Subject|0|||
33516053|NCT00115037|101786368|FG002|Phase2|Withdrawal by Subject|2|||
33516054|NCT00115037|101786369|FG003|Phase2|Withdrawal by Subject|1|||
33516055|NCT00115037|101786370|FG004|Phase2|Withdrawal by Subject|2|||
33516056|NCT00115037|101786371|FG005|Phase2|Withdrawal by Subject|1|||
33516057|NCT00115037|101786366|FG000|Phase2|Lost to Follow-up|0|||
33516058|NCT00115037|101786367|FG001|Phase2|Lost to Follow-up|0|||
33516059|NCT00115037|101786368|FG002|Phase2|Lost to Follow-up|12|||
33516060|NCT00115037|101786369|FG003|Phase2|Lost to Follow-up|14|||
33516061|NCT00115037|101786370|FG004|Phase2|Lost to Follow-up|4|||
33516062|NCT00115037|101786371|FG005|Phase2|Lost to Follow-up|10|||
33516063|NCT00334802|101786372|FG000|Overall Study|Progressive Disease|2|||
33516064|NCT00334802|101786373|FG001|Overall Study|Progressive Disease|24|||
33516065|NCT00334802|101786372|FG000|Overall Study|Toxicity|1|||
33516066|NCT00334802|101786373|FG001|Overall Study|Toxicity|5|||
33516067|NCT00334802|101786372|FG000|Overall Study|Lack of Efficacy|1|||
33516068|NCT00334802|101786373|FG001|Overall Study|Lack of Efficacy|3|||
33516069|NCT00334802|101786372|FG000|Overall Study|Patient Condition Aggrevated|1|||
33516070|NCT00334802|101786373|FG001|Overall Study|Patient Condition Aggrevated|0|||
33516071|NCT00334802|101786372|FG000|Overall Study|Physician Decision|1|||
33516072|NCT00334802|101786373|FG001|Overall Study|Physician Decision|0|||
33516073|NCT00334802|101786372|FG000|Overall Study|Withdrawal by Subject|0|||
33516074|NCT00334802|101786373|FG001|Overall Study|Withdrawal by Subject|4|||
33516075|NCT00334802|101786372|FG000|Overall Study|Adverse Event|0|||
33516076|NCT00334802|101786373|FG001|Overall Study|Adverse Event|3|||
33516077|NCT00334802|101786372|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
33516078|NCT00334802|101786373|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
33516079|NCT03244618|101786377|FG000|Overall Study|Lost to Follow-up|3|||
33516080|NCT03244618|101786378|FG001|Overall Study|Lost to Follow-up|4|||
33516081|NCT03244618|101786377|FG000|Overall Study|Protocol Violation|4|||
33516082|NCT03244618|101786378|FG001|Overall Study|Protocol Violation|3|||
33516083|NCT03244618|101786377|FG000|Overall Study|Withdrawal by Subject|0|||
33607557|NCT01306656|102111740|FG000|Overall Study|Lost to Follow-up|1|||
33199654|NCT02120924|100633885|FG002|Overall Study|Compliance with IP|1|||
33199655|NCT02464969|100633886|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
33199656|NCT02464969|100633887|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
33399989|NCT00877890|101350343|FG000|Overall Study|Protocol Violation|0|||
33516084|NCT03244618|101786378|FG001|Overall Study|Withdrawal by Subject|2|||
33516085|NCT04331067|101786379|FG000|Overall Study|Adverse Event|1|||
33516086|NCT04331067|101786380|FG001|Overall Study|Adverse Event|3|||
33516087|NCT04331067|101786381|FG002|Overall Study|Adverse Event|1|||
33516088|NCT04331067|101786379|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
33516089|NCT04331067|101786380|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
33516090|NCT04331067|101786381|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
33516091|NCT00415597|101786382|FG000|Enrollment|Withdrawal by Subject|1|||
33516092|NCT00415597|101786382|FG000|Enrollment|Protocol Violation|1|||
33516093|NCT00415597|101786382|FG000|Treatment|Adverse Event|110|||
33516094|NCT00415597|101786382|FG000|Treatment|Lack of Efficacy|39|||
33516095|NCT00415597|101786382|FG000|Treatment|Protocol Violation|67|||
33516096|NCT00415597|101786382|FG000|Treatment|Physician Decision|3|||
33516097|NCT00415597|101786382|FG000|Treatment|Withdrawal by Subject|51|||
33199657|NCT02464969|100633886|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
33199658|NCT02464969|100633887|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
33199659|NCT02464969|100633886|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
33199660|NCT02464969|100633887|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
33199661|NCT02464969|100633886|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
33199662|NCT02464969|100633887|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
33199663|NCT02464969|100633886|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
33199664|NCT02464969|100633887|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
33199665|NCT02464969|100633886|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
33199666|NCT02464969|100633887|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
33199667|NCT02464969|100633886|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
33199668|NCT02464969|100633887|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
33199669|NCT02464969|100633886|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
33199670|NCT02464969|100633887|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
33199671|NCT02464969|100633886|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
33199672|NCT02464969|100633887|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
33199673|NCT02464969|100633886|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
33199674|NCT02464969|100633887|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
33199675|NCT02464969|100633886|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
33199676|NCT02464969|100633887|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
33199677|NCT00614939|100633888|FG000|Overall Study|Withdrawal by Subject|10|||
33199678|NCT00614939|100633889|FG001|Overall Study|Withdrawal by Subject|17|||
33199679|NCT00614939|100633888|FG000|Overall Study|Study specific discontinuation criteris|13|||
33199680|NCT00614939|100633889|FG001|Overall Study|Study specific discontinuation criteris|16|||
33199681|NCT00614939|100633888|FG000|Overall Study|Adverse Event|2|||
33199682|NCT00614939|100633889|FG001|Overall Study|Adverse Event|5|||
33326137|NCT00698932|101091052|FG001|Overall Study|Safety reasons|2|||
33326138|NCT00698932|101091051|FG000|Overall Study|Death|1|||
33516098|NCT00415597|101786382|FG000|Treatment|Lost to Follow-up|28|||
33516099|NCT00415597|101786382|FG000|Treatment|Drug Screen|2|||
33516100|NCT00415597|101786382|FG000|Treatment|Administrative|3|||
33516101|NCT00415597|101786382|FG000|Treatment|Sponsor Decision|1|||
33516102|NCT00415597|101786382|FG000|Treatment|Multiple Reasons|1|||
33516103|NCT00783224|101786386|FG000|Overall Study|Adverse Event|0|||
33516104|NCT00783224|101786387|FG001|Overall Study|Adverse Event|0|||
33516105|NCT00783224|101786388|FG002|Overall Study|Adverse Event|1|||
33516106|NCT00783224|101786389|FG003|Overall Study|Adverse Event|0|||
33516107|NCT00783224|101786386|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
33516108|NCT00783224|101786387|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
33516109|NCT00783224|101786388|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
33516110|NCT00783224|101786389|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
33516111|NCT00783224|101786386|FG000|Overall Study|Inappropriate as a study subject|0|||
33516112|NCT00783224|101786387|FG001|Overall Study|Inappropriate as a study subject|0|||
33516113|NCT00783224|101786388|FG002|Overall Study|Inappropriate as a study subject|0|||
33516114|NCT00783224|101786389|FG003|Overall Study|Inappropriate as a study subject|1|||
33516115|NCT01524783|101786391|FG000|Blinded Period|Adverse Event|64|||
33516116|NCT01524783|101786392|FG001|Blinded Period|Adverse Event|7|||
33516117|NCT01524783|101786393|FG002|Blinded Period|Adverse Event|0|||
33516118|NCT01524783|101786391|FG000|Blinded Period|Disease Progression|89|||
33516119|NCT01524783|101786392|FG001|Blinded Period|Disease Progression|75|||
33516120|NCT01524783|101786393|FG002|Blinded Period|Disease Progression|0|||
33516121|NCT01524783|101786391|FG000|Blinded Period|Withdrawal by Subject|19|||
33516122|NCT01524783|101786392|FG001|Blinded Period|Withdrawal by Subject|6|||
33516123|NCT01524783|101786393|FG002|Blinded Period|Withdrawal by Subject|0|||
33516124|NCT01524783|101786391|FG000|Blinded Period|Protocol deviation|2|||
33516125|NCT01524783|101786392|FG001|Blinded Period|Protocol deviation|1|||
33516126|NCT01524783|101786393|FG002|Blinded Period|Protocol deviation|0|||
33516127|NCT01524783|101786391|FG000|Blinded Period|Death|5|||
33516128|NCT01524783|101786392|FG001|Blinded Period|Death|2|||
33516129|NCT01524783|101786393|FG002|Blinded Period|Death|0|||
33516130|NCT01524783|101786391|FG000|Open-label Period|Disease progression|13|||
33516131|NCT01524783|101786392|FG001|Open-label Period|Disease progression|0|||
33516132|NCT01524783|101786393|FG002|Open-label Period|Disease progression|2|||
33326139|NCT00698932|101091052|FG001|Overall Study|Death|0|||
33326140|NCT00884325|101091053|FG000|Overall Study|Lost to Follow-up|1|||
33607558|NCT01306656|102111741|FG001|Overall Study|Lost to Follow-up|0|||
33607559|NCT03657095|102111744|FG000|Overall Study|Withdrawal by Subject|1|||
33326141|NCT00884325|101091054|FG001|Overall Study|Lost to Follow-up|2|||
33607560|NCT03657095|102111745|FG001|Overall Study|Withdrawal by Subject|1|||
33607561|NCT03657095|102111744|FG000|Overall Study|Adverse Event|0|||
33516133|NCT01524783|101786391|FG000|Open-label Period|Administrative problems|5|||
33516134|NCT01524783|101786392|FG001|Open-label Period|Administrative problems|0|||
33516135|NCT01524783|101786393|FG002|Open-label Period|Administrative problems|2|||
33516136|NCT01524783|101786391|FG000|Open-label Period|Adverse Event|5|||
33326142|NCT00884325|101091053|FG000|Overall Study|Lack of Efficacy|0|||
33516137|NCT01524783|101786392|FG001|Open-label Period|Adverse Event|0|||
33516138|NCT01524783|101786393|FG002|Open-label Period|Adverse Event|1|||
33516139|NCT01524783|101786391|FG000|Open-label Period|Withdrawal by Subject|2|||
33516140|NCT01524783|101786392|FG001|Open-label Period|Withdrawal by Subject|0|||
33516141|NCT01524783|101786393|FG002|Open-label Period|Withdrawal by Subject|1|||
33516142|NCT01524783|101786391|FG000|Open-label Period|Protocol deviation|1|||
33516143|NCT01524783|101786392|FG001|Open-label Period|Protocol deviation|0|||
33516144|NCT01524783|101786393|FG002|Open-label Period|Protocol deviation|0|||
33516145|NCT01294371|101786412|FG000|Overall Study|Adverse Event|1|||
33516146|NCT01294371|101786412|FG000|Overall Study|Withdrawal by Subject|12|||
33326143|NCT00884325|101091054|FG001|Overall Study|Lack of Efficacy|1|||
33326144|NCT00884325|101091053|FG000|Overall Study|Withdrawal by Subject|1|||
33516147|NCT01294371|101786412|FG000|Overall Study|Lost to Follow-up|6|||
33516148|NCT01294371|101786412|FG000|Overall Study|Administrative Reason|1|||
33516149|NCT01294371|101786412|FG000|Overall Study|Other|14|||
33516150|NCT00526331|101786413|FG000|Overall Study|Sponsor Termination|55|||
33516151|NCT02360475|101786414|FG000|Overall Study|Lost to Follow-up|4|||
33516152|NCT02360475|101786415|FG001|Overall Study|Lost to Follow-up|12|||
33516153|NCT02360475|101786416|FG002|Overall Study|Lost to Follow-up|6|||
33516154|NCT02360475|101786417|FG003|Overall Study|Lost to Follow-up|4|||
33516155|NCT02360475|101786414|FG000|Overall Study|Withdrawal by Subject|0|||
33516156|NCT02360475|101786415|FG001|Overall Study|Withdrawal by Subject|1|||
33516157|NCT02360475|101786416|FG002|Overall Study|Withdrawal by Subject|2|||
33607562|NCT03657095|102111745|FG001|Overall Study|Adverse Event|3|||
33607563|NCT03657095|102111744|FG000|Overall Study|Study Terminated by Sponsor|58|||
33326145|NCT00884325|101091054|FG001|Overall Study|Withdrawal by Subject|1|||
33326146|NCT00884325|101091053|FG000|Overall Study|Not provided|1|||
33326147|NCT00884325|101091054|FG001|Overall Study|Not provided|0|||
33326148|NCT05092919|101091068|FG000|Overall Study|Lost to Follow-up|7|||
33326149|NCT05092919|101091068|FG000|Overall Study|Withdrawal by Subject|2|||
33326150|NCT00474708|101091069|FG000|Overall Study|Lack of Efficacy|11|||
33326151|NCT00474708|101091070|FG001|Overall Study|Lack of Efficacy|5|||
33326152|NCT00474708|101091069|FG000|Overall Study|Suicide ideation/behavior|0|||
33326153|NCT00474708|101091070|FG001|Overall Study|Suicide ideation/behavior|1|||
33326154|NCT00474708|101091069|FG000|Overall Study|Withdrawal by Subject|7|||
33326155|NCT00474708|101091070|FG001|Overall Study|Withdrawal by Subject|0|||
33326156|NCT00474708|101091069|FG000|Overall Study|Lack of compliance|12|||
33326157|NCT00474708|101091070|FG001|Overall Study|Lack of compliance|4|||
33326158|NCT00474708|101091069|FG000|Overall Study|Lost to Follow-up|18|||
33326159|NCT00474708|101091070|FG001|Overall Study|Lost to Follow-up|9|||
33326160|NCT00474708|101091069|FG000|Overall Study|Physician Decision|9|||
33326161|NCT00474708|101091070|FG001|Overall Study|Physician Decision|6|||
33326162|NCT02844920|101091080|FG000|Overall Study|Lost to Follow-up|2|||
33326163|NCT04641299|101091083|FG000|Overall Study|Adverse Event|0|||
33326164|NCT04641299|101091084|FG001|Overall Study|Adverse Event|0|||
33326165|NCT04641299|101091085|FG002|Overall Study|Adverse Event|2|||
33326166|NCT04641299|101091086|FG003|Overall Study|Adverse Event|0|||
33326167|NCT04641299|101091083|FG000|Overall Study|Lost to Follow-up|0|||
33326168|NCT04641299|101091084|FG001|Overall Study|Lost to Follow-up|1|||
33326169|NCT04641299|101091085|FG002|Overall Study|Lost to Follow-up|0|||
33326170|NCT04641299|101091086|FG003|Overall Study|Lost to Follow-up|0|||
33326171|NCT04641299|101091083|FG000|Overall Study|Withdrawal by Subject|1|||
33326172|NCT04641299|101091084|FG001|Overall Study|Withdrawal by Subject|0|||
33326173|NCT04641299|101091085|FG002|Overall Study|Withdrawal by Subject|0|||
33326174|NCT04641299|101091086|FG003|Overall Study|Withdrawal by Subject|0|||
33326175|NCT04641299|101091083|FG000|Overall Study|Reason not given|1|||
33326176|NCT04641299|101091084|FG001|Overall Study|Reason not given|0|||
33399990|NCT00877890|101350344|FG001|Overall Study|Protocol Violation|1|||
33399991|NCT00877890|101350343|FG000|Overall Study|Withdrawal of Consent|6|||
33326177|NCT04641299|101091085|FG002|Overall Study|Reason not given|0|||
33326178|NCT04641299|101091086|FG003|Overall Study|Reason not given|0|||
33326179|NCT01003210|101091087|FG000|Overall Study|Lost to Follow-up|1|||
33326180|NCT01003210|101091088|FG001|Overall Study|Lost to Follow-up|3|||
33326181|NCT04857996|101091089|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
33326182|NCT04857996|101091090|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
33326183|NCT04857996|101091089|FG000|Overall Study|Lost to Follow-up|1|||
33326184|NCT04857996|101091090|FG001|Overall Study|Lost to Follow-up|3|||
33326185|NCT04857996|101091089|FG000|Overall Study|Site Closure|1|||
33326186|NCT04857996|101091090|FG001|Overall Study|Site Closure|0|||
33326187|NCT04857996|101091089|FG000|Overall Study|Withdrawal by Subject|1|||
33516158|NCT02360475|101786417|FG003|Overall Study|Withdrawal by Subject|0|||
33516159|NCT02360475|101786414|FG000|Overall Study|Migrated/moved from study area|0|||
33516160|NCT02360475|101786415|FG001|Overall Study|Migrated/moved from study area|0|||
33516161|NCT02360475|101786416|FG002|Overall Study|Migrated/moved from study area|0|||
33516162|NCT02360475|101786417|FG003|Overall Study|Migrated/moved from study area|1|||
33326188|NCT04857996|101091090|FG001|Overall Study|Withdrawal by Subject|0|||
33326189|NCT00470054|101091091|FG000|Overall Study|Ineligible|1|||
33326190|NCT00310804|101091103|FG000|Overall Study|Lost to Follow-up|2|||
33326191|NCT00310804|101091104|FG001|Overall Study|Lost to Follow-up|0|||
33326192|NCT00310804|101091103|FG000|Overall Study|Withdrawal by Subject|3|||
33326193|NCT00310804|101091104|FG001|Overall Study|Withdrawal by Subject|0|||
33326194|NCT01977820|101091108|FG000|Overall Study|Sponsor terminated the study|1|||
33326195|NCT01977820|101091109|FG001|Overall Study|Sponsor terminated the study|1|||
33326196|NCT01484977|101091118|FG000|Overall Study|Adverse Event|8|||
33326197|NCT01484977|101091118|FG000|Overall Study|Lack of Efficacy|4|||
33326198|NCT01484977|101091118|FG000|Overall Study|Protocol Violation|6|||
33326199|NCT01484977|101091118|FG000|Overall Study|Lost to Follow-up|1|||
33326200|NCT01484977|101091118|FG000|Overall Study|Withdrawal by Subject|4|||
33326201|NCT01484977|101091118|FG000|Overall Study|Subject Protocol Non-compliant|1|||
33326202|NCT01484977|101091118|FG000|Overall Study|Moving Overseas|1|||
33516163|NCT00574795|101786420|FG000|Infant Series|Withdrawal by Subject|2|||
33516164|NCT00574795|101786420|FG000|Infant Series|Protocol Violation|2|||
33516165|NCT00574795|101786420|FG000|Infant Series|Adverse Event|1|||
33516166|NCT00574795|101786420|FG000|After Infant Series|Withdrawal by Subject|1|||
33516167|NCT00574795|101786420|FG000|After Infant Series|Adverse Event|2|||
33516168|NCT00574795|101786420|FG000|Toddler Dose|Withdrawal by Subject|1|||
33516169|NCT00943670|101786421|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
33516170|NCT00943670|101786421|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
33516171|NCT00943670|101786421|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
33516172|NCT00943670|101786421|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
33516173|NCT00943670|101786421|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
33516174|NCT00943670|101786421|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
33516175|NCT00943670|101786421|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
33516176|NCT00943670|101786421|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
33516177|NCT00943670|101786421|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
33516178|NCT00943670|101786421|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
33516179|NCT00335959|101786424|FG000|Overall Study|Adverse Event|2|||
33516180|NCT00335959|101786424|FG000|Overall Study|Ineligible|1|||
33516181|NCT02515994|101786426|FG000|Overall Study|Protocol Violation|3|||
33516182|NCT02515994|101786427|FG001|Overall Study|Protocol Violation|5|||
33516183|NCT02515994|101786426|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
33516184|NCT02515994|101786427|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
33516185|NCT02515994|101786426|FG000|Overall Study|Adverse Event|3|||
33516186|NCT02515994|101786427|FG001|Overall Study|Adverse Event|1|||
33516187|NCT02515994|101786426|FG000|Overall Study|Withdrawal by Subject|2|||
33516188|NCT02515994|101786427|FG001|Overall Study|Withdrawal by Subject|0|||
33516189|NCT01549041|101786428|FG000|Overall Study|Lack of Efficacy|2|||
33516190|NCT01549041|101786429|FG001|Overall Study|Lack of Efficacy|4|||
33516191|NCT01549041|101786428|FG000|Overall Study|Adverse Event|0|||
33326203|NCT01484977|101091118|FG000|Overall Study|Low White Blood Cell Count|1|||
33516192|NCT01549041|101786429|FG001|Overall Study|Adverse Event|4|||
33326204|NCT01484977|101091118|FG000|Overall Study|Lack of Compliance|1|||
33326205|NCT00243386|101091121|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
33326206|NCT00243386|101091122|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
33326207|NCT00243386|101091123|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
33326208|NCT00243386|101091121|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
33326209|NCT00243386|101091122|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
33326210|NCT00243386|101091123|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
33326211|NCT00243386|101091121|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
33326212|NCT00243386|101091122|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
33326213|NCT00243386|101091123|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
33516193|NCT01384019|101786430|FG000|Overall Study|Withdrawal by Subject|3|||
33516194|NCT01384019|101786431|FG001|Overall Study|Withdrawal by Subject|0|||
33516195|NCT01384019|101786430|FG000|Overall Study|Death|1|||
33516196|NCT01384019|101786431|FG001|Overall Study|Death|0|||
33516197|NCT01384019|101786430|FG000|Overall Study|MRI refusal|6|||
33516198|NCT01384019|101786431|FG001|Overall Study|MRI refusal|6|||
33516199|NCT01280682|101786432|FG000|Overall Study|Lost to Follow-up|0|||
33326214|NCT00243386|101091121|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
33516200|NCT01280682|101786433|FG001|Overall Study|Lost to Follow-up|6|||
33516201|NCT01280682|101786432|FG000|Overall Study|Withdrawal by Subject|0|||
33516202|NCT01280682|101786433|FG001|Overall Study|Withdrawal by Subject|7|||
33516203|NCT01801280|101786434|FG000|Period 1|Withdrawal by Subject|0|||
33516204|NCT01801280|101786435|FG001|Period 1|Withdrawal by Subject|1|||
33326215|NCT00243386|101091122|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
33326216|NCT00243386|101091123|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
33326217|NCT00243386|101091121|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
33516205|NCT01801280|101786436|FG002|Period 1|Withdrawal by Subject|0|||
33326218|NCT00243386|101091122|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
33326219|NCT00243386|101091123|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
33326220|NCT00243386|101091121|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
33326221|NCT00243386|101091122|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
33326222|NCT00243386|101091123|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
33326223|NCT00243386|101091121|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
33326224|NCT00243386|101091122|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
33326225|NCT00243386|101091123|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
33326226|NCT00243386|101091121|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
33326227|NCT00243386|101091122|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
33326228|NCT00243386|101091123|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
33326229|NCT01177683|101091124|FG000|Study Treatment|Disease Progressions during treatment|2|||
33326230|NCT01177683|101091125|FG001|Study Treatment|Disease Progressions during treatment|0|||
33326231|NCT01177683|101091126|FG002|Study Treatment|Disease Progressions during treatment|3|||
33326232|NCT01177683|101091124|FG000|Study Treatment|Adverse Event|0|||
33326233|NCT01177683|101091125|FG001|Study Treatment|Adverse Event|1|||
33326234|NCT01177683|101091126|FG002|Study Treatment|Adverse Event|12|||
33326235|NCT01177683|101091124|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
33326236|NCT01177683|101091125|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
33326237|NCT01177683|101091126|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
33326238|NCT01177683|101091124|FG000|Study Treatment|Alternative therapy|0|||
33326239|NCT01177683|101091125|FG001|Study Treatment|Alternative therapy|0|||
33326240|NCT01177683|101091126|FG002|Study Treatment|Alternative therapy|4|||
33326241|NCT01177683|101091124|FG000|Study Treatment|Physician Decision|1|||
33326242|NCT01177683|101091125|FG001|Study Treatment|Physician Decision|0|||
33326243|NCT01177683|101091126|FG002|Study Treatment|Physician Decision|1|||
33516206|NCT01801280|101786437|FG003|Period 1|Withdrawal by Subject|0|||
33516207|NCT01801280|101786434|FG000|Period 2|Withdrawal by Subject|1|||
33607564|NCT03657095|102111745|FG001|Overall Study|Study Terminated by Sponsor|49|||
33607565|NCT00079677|102111748|FG000|Overall Study|Adverse Event|5|||
33607566|NCT00079677|102111749|FG001|Overall Study|Adverse Event|6|||
33607567|NCT00079677|102111748|FG000|Overall Study|Lack of Efficacy|1|||
33607568|NCT00079677|102111749|FG001|Overall Study|Lack of Efficacy|0|||
33607569|NCT00079677|102111748|FG000|Overall Study|Lost to Follow-up|2|||
33326244|NCT01177683|101091124|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
33326245|NCT01177683|101091125|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
33326246|NCT01177683|101091126|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
33326247|NCT01177683|101091124|FG000|Study Treatment|Symptomatic Deterioration|0|||
33516208|NCT01801280|101786435|FG001|Period 2|Withdrawal by Subject|0|||
33326248|NCT01177683|101091125|FG001|Study Treatment|Symptomatic Deterioration|0|||
33326249|NCT01177683|101091126|FG002|Study Treatment|Symptomatic Deterioration|1|||
33326250|NCT01177683|101091124|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
33326251|NCT01177683|101091125|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
33326252|NCT01177683|101091126|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
33326253|NCT01177683|101091124|FG000|Follow up|Patient lost to follow up|0|||
33326254|NCT01177683|101091125|FG001|Follow up|Patient lost to follow up|0|||
33326255|NCT01177683|101091126|FG002|Follow up|Patient lost to follow up|2|||
33326256|NCT01177683|101091124|FG000|Follow up|Death|2|||
33326257|NCT01177683|101091125|FG001|Follow up|Death|1|||
33326258|NCT01177683|101091126|FG002|Follow up|Death|7|||
33326259|NCT01177683|101091124|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
33326260|NCT01177683|101091125|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
33326261|NCT01177683|101091126|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
33516209|NCT01801280|101786436|FG002|Period 2|Withdrawal by Subject|0|||
33516210|NCT01801280|101786437|FG003|Period 2|Withdrawal by Subject|0|||
33516211|NCT01801280|101786434|FG000|Period 4|Protocol Violation|0|||
33516212|NCT01801280|101786435|FG001|Period 4|Protocol Violation|0|||
33516213|NCT01801280|101786436|FG002|Period 4|Protocol Violation|1|||
33516214|NCT01801280|101786437|FG003|Period 4|Protocol Violation|0|||
33516215|NCT01314105|101786438|FG000|Overall Study|Progressive Disease|6|||
33607570|NCT00079677|102111749|FG001|Overall Study|Lost to Follow-up|2|||
33607571|NCT00079677|102111748|FG000|Overall Study|Physician Decision|3|||
33607572|NCT00079677|102111749|FG001|Overall Study|Physician Decision|0|||
33607573|NCT00079677|102111748|FG000|Overall Study|Protocol Violation|2|||
33516216|NCT01314105|101786439|FG001|Overall Study|Progressive Disease|10|||
33516217|NCT01314105|101786438|FG000|Overall Study|Refused to continue taking medication|0|||
33607574|NCT00079677|102111749|FG001|Overall Study|Protocol Violation|3|||
33326262|NCT00922480|101091127|FG000|Main Study|Protocol Violation|3|||
33326263|NCT00922480|101091128|FG001|Main Study|Protocol Violation|6|||
33326264|NCT00922480|101091127|FG000|Main Study|Adverse Event|6|||
33326265|NCT00922480|101091128|FG001|Main Study|Adverse Event|7|||
33516218|NCT01314105|101786439|FG001|Overall Study|Refused to continue taking medication|1|||
33607575|NCT00079677|102111748|FG000|Overall Study|Withdrawal by Subject|5|||
33607576|NCT00079677|102111749|FG001|Overall Study|Withdrawal by Subject|3|||
33516219|NCT01314105|101786438|FG000|Overall Study|Other Adverse Event|1|||
33516220|NCT01314105|101786439|FG001|Overall Study|Other Adverse Event|1|||
33516221|NCT02195427|101786440|FG000|Overall Study|Did not consent to study extension|13|||
33516222|NCT02195427|101786441|FG001|Overall Study|Did not consent to study extension|9|||
33516223|NCT02195427|101786440|FG000|Overall Study|Withdrawal by Subject|4|||
33516224|NCT02195427|101786441|FG001|Overall Study|Withdrawal by Subject|2|||
33516225|NCT02195427|101786440|FG000|Overall Study|Lost to Follow-up|0|||
33516226|NCT02195427|101786441|FG001|Overall Study|Lost to Follow-up|1|||
33326266|NCT00922480|101091127|FG000|Main Study|Lack of Efficacy|3|||
33326267|NCT00922480|101091128|FG001|Main Study|Lack of Efficacy|0|||
33326268|NCT00922480|101091127|FG000|Main Study|Withdrawal by Subject|20|||
33326269|NCT00922480|101091128|FG001|Main Study|Withdrawal by Subject|15|||
33326270|NCT00922480|101091127|FG000|Main Study|Lost to Follow-up|5|||
33326271|NCT00922480|101091128|FG001|Main Study|Lost to Follow-up|0|||
33326272|NCT00922480|101091127|FG000|Main Study|Physician Decision|0|||
33326273|NCT00922480|101091128|FG001|Main Study|Physician Decision|1|||
33326274|NCT00922480|101091127|FG000|Extension Study|Protocol Violation|3|||
33326275|NCT00922480|101091128|FG001|Extension Study|Protocol Violation|0|||
33326276|NCT00922480|101091127|FG000|Extension Study|Adverse Event|1|||
33516227|NCT02195427|101786440|FG000|Overall Study|Protocol Violation|7|||
33516228|NCT02195427|101786441|FG001|Overall Study|Protocol Violation|14|||
33516229|NCT02195427|101786440|FG000|Overall Study|Conditional re-treatment at W52|2|||
33607577|NCT00079677|102111748|FG000|Overall Study|Miscellaneous|2|||
33326277|NCT00922480|101091128|FG001|Extension Study|Adverse Event|1|||
33326278|NCT00922480|101091127|FG000|Extension Study|Withdrawal by Subject|1|||
33326279|NCT00922480|101091128|FG001|Extension Study|Withdrawal by Subject|1|||
33326280|NCT00922480|101091127|FG000|Extension Study|Others|0|||
33607578|NCT00079677|102111749|FG001|Overall Study|Miscellaneous|0|||
33326281|NCT00922480|101091128|FG001|Extension Study|Others|1|||
33326282|NCT00282295|101091129|FG000|Overall Study|Adverse Event|0|||
33326283|NCT00282295|101091130|FG001|Overall Study|Adverse Event|1|||
33516230|NCT02195427|101786441|FG001|Overall Study|Conditional re-treatment at W52|1|||
33516231|NCT00672841|101786442|FG000|Overall Study|Comfort care|1|||
33516232|NCT00672841|101786443|FG001|Overall Study|Comfort care|4|||
33516233|NCT00672841|101786442|FG000|Overall Study|icteric specimens|0|||
33516234|NCT00672841|101786443|FG001|Overall Study|icteric specimens|3|||
33516235|NCT00672841|101786442|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
33516236|NCT00672841|101786443|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
33516237|NCT00672841|101786442|FG000|Overall Study|Adverse Event|0|||
33516238|NCT00672841|101786443|FG001|Overall Study|Adverse Event|3|||
33516239|NCT00672841|101786442|FG000|Overall Study|Pregnancy|0|||
33516240|NCT00672841|101786443|FG001|Overall Study|Pregnancy|1|||
33516241|NCT02333383|101786444|FG000|Overall Study|Adalimumab discontinuation|21|||
33516242|NCT02333383|101786444|FG000|Overall Study|Lost to Follow-up|15|||
33516243|NCT02333383|101786444|FG000|Overall Study|Withdrawal by Subject|3|||
33516244|NCT02333383|101786444|FG000|Overall Study|Transfer to another hospital|2|||
33516245|NCT01959698|101786445|FG000|Overall Study|Adverse Event|0|||
33516246|NCT01959698|101786446|FG001|Overall Study|Adverse Event|0|||
33516247|NCT01959698|101786447|FG002|Overall Study|Adverse Event|0|||
33516248|NCT01959698|101786448|FG003|Overall Study|Adverse Event|0|||
33516249|NCT01959698|101786449|FG004|Overall Study|Adverse Event|0|||
33516250|NCT01959698|101786450|FG005|Overall Study|Adverse Event|0|||
33516251|NCT01959698|101786451|FG006|Overall Study|Adverse Event|1|||
33326284|NCT00282295|101091131|FG002|Overall Study|Adverse Event|0|||
33326285|NCT00282295|101091129|FG000|Overall Study|Serious Adverse Events|0|||
33326286|NCT00282295|101091130|FG001|Overall Study|Serious Adverse Events|0|||
33326287|NCT00282295|101091131|FG002|Overall Study|Serious Adverse Events|1|||
33516252|NCT01959698|101786445|FG000|Overall Study|Physician Decision|1|||
33326288|NCT00282295|101091129|FG000|Overall Study|Protocol Violation|0|||
33326289|NCT00282295|101091130|FG001|Overall Study|Protocol Violation|2|||
33326290|NCT00282295|101091131|FG002|Overall Study|Protocol Violation|1|||
33326291|NCT00282295|101091129|FG000|Overall Study|Withdrawal by Subject|2|||
33326292|NCT00282295|101091130|FG001|Overall Study|Withdrawal by Subject|6|||
33326293|NCT00282295|101091131|FG002|Overall Study|Withdrawal by Subject|4|||
33326294|NCT00282295|101091129|FG000|Overall Study|Lost to Follow-up|1|||
33516253|NCT01959698|101786446|FG001|Overall Study|Physician Decision|0|||
33516254|NCT01959698|101786447|FG002|Overall Study|Physician Decision|1|||
33516255|NCT01959698|101786448|FG003|Overall Study|Physician Decision|2|||
33516256|NCT01959698|101786449|FG004|Overall Study|Physician Decision|0|||
33516257|NCT01959698|101786450|FG005|Overall Study|Physician Decision|3|||
33516258|NCT01959698|101786451|FG006|Overall Study|Physician Decision|3|||
33516259|NCT01944670|101786452|FG000|Overall Study|Lost to Follow-up|2|||
33516260|NCT00803205|101786453|FG000|Overall Study|Adverse Event|7|||
33516261|NCT00803205|101786454|FG001|Overall Study|Adverse Event|2|||
33516262|NCT00803205|101786453|FG000|Overall Study|Lost to Follow-up|1|||
33516263|NCT00803205|101786454|FG001|Overall Study|Lost to Follow-up|0|||
33516264|NCT00803205|101786453|FG000|Overall Study|Withdrawal by Subject|9|||
33516265|NCT00803205|101786454|FG001|Overall Study|Withdrawal by Subject|9|||
33326295|NCT00282295|101091130|FG001|Overall Study|Lost to Follow-up|7|||
33516266|NCT00803205|101786453|FG000|Overall Study|Physician Decision|1|||
33516267|NCT00803205|101786454|FG001|Overall Study|Physician Decision|0|||
33516268|NCT00803205|101786453|FG000|Overall Study|Protocol Violation|1|||
33516269|NCT00803205|101786454|FG001|Overall Study|Protocol Violation|1|||
33516270|NCT00803205|101786453|FG000|Overall Study|Medical Monitor Decision|1|||
33516271|NCT00803205|101786454|FG001|Overall Study|Medical Monitor Decision|0|||
33516272|NCT00803205|101786453|FG000|Overall Study|Acquired a Lung Infection|0|||
33516273|NCT00803205|101786454|FG001|Overall Study|Acquired a Lung Infection|1|||
33516274|NCT00803205|101786453|FG000|Overall Study|Sponsor Decision|0|||
33607579|NCT03966885|102111754|FG000|Overall Study|Death|1|||
33607580|NCT03966885|102111755|FG001|Overall Study|Death|0|||
33326296|NCT00282295|101091131|FG002|Overall Study|Lost to Follow-up|2|||
33326297|NCT00282295|101091129|FG000|Overall Study|Other|0|||
33326298|NCT00282295|101091130|FG001|Overall Study|Other|1|||
33516275|NCT00803205|101786454|FG001|Overall Study|Sponsor Decision|1|||
33516276|NCT00623597|101786455|FG000|Overall Study|Failed to return|1|||
33516277|NCT00623597|101786456|FG001|Overall Study|Failed to return|0|||
33516278|NCT00550862|101786457|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
33516279|NCT00550862|101786458|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
33516280|NCT00550862|101786459|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
33607581|NCT03966885|102111754|FG000|Overall Study|Lost to Follow-up|1|||
33516281|NCT00550862|101786460|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
33516282|NCT00550862|101786461|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
33516283|NCT00550862|101786457|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
33516284|NCT00550862|101786458|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
33326299|NCT00282295|101091131|FG002|Overall Study|Other|0|||
33326300|NCT03593850|101091134|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
33326301|NCT03593850|101091135|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
33326302|NCT00555477|101091137|FG000|Overall Study|Adverse Event|0|||
33326303|NCT00555477|101091138|FG001|Overall Study|Adverse Event|9|||
33326304|NCT00555477|101091137|FG000|Overall Study|Withdrawal by Subject|1|||
33516285|NCT00550862|101786459|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
33516286|NCT00550862|101786460|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
33516287|NCT00550862|101786461|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
33516288|NCT00550862|101786457|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
33516289|NCT00550862|101786458|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
33516290|NCT00550862|101786459|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
33516291|NCT00550862|101786460|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
33516292|NCT00550862|101786461|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
33516293|NCT00550862|101786457|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
33516294|NCT00550862|101786458|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
33516295|NCT00550862|101786459|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
33516296|NCT00550862|101786460|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
33516297|NCT00550862|101786461|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
33516298|NCT00550862|101786457|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
33516299|NCT00550862|101786458|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
33516300|NCT00550862|101786459|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
33516301|NCT00550862|101786460|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
33516302|NCT00550862|101786461|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
33516303|NCT00550862|101786457|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
33516304|NCT00550862|101786458|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
33326305|NCT00555477|101091138|FG001|Overall Study|Withdrawal by Subject|2|||
33326306|NCT00555477|101091137|FG000|Overall Study|Physician Decision|1|||
33326307|NCT00555477|101091138|FG001|Overall Study|Physician Decision|2|||
33326308|NCT00916279|101091140|FG000|Overall Study|Death|2|||
33326309|NCT00916279|101091140|FG000|Overall Study|Lost to Follow-up|2|||
33326310|NCT03511053|101091141|FG000|Overall Study|Withdrawal by Subject|1|||
33326311|NCT03945591|101091144|FG000|Overall Study|Participant not transplanted|1|||
33326312|NCT03945591|101091144|FG000|Overall Study|Change in treatment plan|3|||
33326313|NCT03945591|101091144|FG000|Overall Study|Adverse Event|1|||
33326314|NCT03302975|101091147|FG000|Overall Study|Lost to Follow-up|4|||
33516305|NCT00550862|101786459|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
33516306|NCT00550862|101786460|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
33516307|NCT00550862|101786461|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
33516308|NCT00550862|101786457|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
33516309|NCT00550862|101786458|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
33516310|NCT00550862|101786459|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
33516311|NCT00550862|101786460|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
33516312|NCT00550862|101786461|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
33516313|NCT00550862|101786457|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
33516314|NCT00550862|101786458|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
33516315|NCT00550862|101786459|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
33516316|NCT00550862|101786460|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
33516317|NCT00550862|101786461|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
33516318|NCT00550862|101786457|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
33516319|NCT00550862|101786458|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
33516320|NCT00550862|101786459|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
33516321|NCT00550862|101786460|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
33516322|NCT00550862|101786461|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
33516323|NCT00550862|101786457|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
33607582|NCT03966885|102111755|FG001|Overall Study|Lost to Follow-up|2|||
33326315|NCT00993265|101091149|FG000|Overall Study|Adverse Event|1|||
33326316|NCT00993265|101091150|FG001|Overall Study|Adverse Event|0|||
33326317|NCT00993265|101091149|FG000|Overall Study|Changed dose of concomitant drug|2|||
33326318|NCT00993265|101091150|FG001|Overall Study|Changed dose of concomitant drug|0|||
33326319|NCT00993265|101091149|FG000|Overall Study|Non-compliant with study medication|1|||
33516324|NCT00550862|101786458|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
33516325|NCT00550862|101786459|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
33516326|NCT00550862|101786460|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
33516327|NCT00550862|101786461|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
33516328|NCT02382796|101786463|FG000|Overall Study|Global deterioration of health status|1|||
33516329|NCT02382796|101786463|FG000|Overall Study|Objective progression or relapse|3|||
33516330|NCT02382796|101786463|FG000|Overall Study|Commercial dacomitinib became available|3|||
33516331|NCT00401544|101786464|FG000|Overall Study|Adverse Event|5|||
33516332|NCT00401544|101786465|FG001|Overall Study|Adverse Event|1|||
33516333|NCT00401544|101786466|FG002|Overall Study|Adverse Event|1|||
33516334|NCT00401544|101786467|FG003|Overall Study|Adverse Event|1|||
33516335|NCT00401544|101786464|FG000|Overall Study|Death|3|||
33516336|NCT00401544|101786465|FG001|Overall Study|Death|6|||
33516337|NCT00401544|101786466|FG002|Overall Study|Death|2|||
33516338|NCT00401544|101786467|FG003|Overall Study|Death|5|||
33516339|NCT00401544|101786464|FG000|Overall Study|Lost to Follow-up|2|||
33516340|NCT00401544|101786465|FG001|Overall Study|Lost to Follow-up|0|||
33516341|NCT00401544|101786466|FG002|Overall Study|Lost to Follow-up|1|||
33516342|NCT00401544|101786467|FG003|Overall Study|Lost to Follow-up|1|||
33516343|NCT00401544|101786464|FG000|Overall Study|Withdrawal by Subject|7|||
33516344|NCT00401544|101786465|FG001|Overall Study|Withdrawal by Subject|6|||
33516345|NCT00401544|101786466|FG002|Overall Study|Withdrawal by Subject|6|||
33516346|NCT00401544|101786467|FG003|Overall Study|Withdrawal by Subject|5|||
33516347|NCT00401544|101786464|FG000|Overall Study|Physician Decision|1|||
33516348|NCT00401544|101786465|FG001|Overall Study|Physician Decision|3|||
33516349|NCT00401544|101786466|FG002|Overall Study|Physician Decision|0|||
33516350|NCT00401544|101786467|FG003|Overall Study|Physician Decision|0|||
33516351|NCT00401544|101786464|FG000|Overall Study|Ineligibility determined|0|||
33516352|NCT00401544|101786465|FG001|Overall Study|Ineligibility determined|1|||
33516353|NCT00401544|101786466|FG002|Overall Study|Ineligibility determined|0|||
33516354|NCT00401544|101786467|FG003|Overall Study|Ineligibility determined|2|||
33516355|NCT00401544|101786464|FG000|Overall Study|Disease progression|0|||
33516356|NCT00401544|101786465|FG001|Overall Study|Disease progression|1|||
33516357|NCT00401544|101786466|FG002|Overall Study|Disease progression|0|||
33516358|NCT00401544|101786467|FG003|Overall Study|Disease progression|0|||
33516359|NCT00401544|101786464|FG000|Overall Study|Other|0|||
33516360|NCT00401544|101786465|FG001|Overall Study|Other|0|||
33516361|NCT00401544|101786466|FG002|Overall Study|Other|2|||
33516362|NCT00401544|101786467|FG003|Overall Study|Other|2|||
33516363|NCT02637713|101786472|FG000|Overall Study|Screen Failure|2|||
33516364|NCT03787303|101786473|FG000|Overall Study|Death|1|||
33516365|NCT03787303|101786473|FG000|Overall Study|Premature Termination of Study|1|||
33199683|NCT00614939|100633888|FG000|Overall Study|Incorrect enrollment|1|||
33199684|NCT00614939|100633889|FG001|Overall Study|Incorrect enrollment|2|||
33199685|NCT00614939|100633888|FG000|Overall Study|Death|4|||
33199686|NCT00614939|100633889|FG001|Overall Study|Death|3|||
33516366|NCT02653170|101786482|FG000|Overall Study|Withdrawal by Subject|3|||
33516367|NCT02653170|101786483|FG001|Overall Study|Withdrawal by Subject|8|||
33516368|NCT02653170|101786484|FG002|Overall Study|Withdrawal by Subject|3|||
33516369|NCT02653170|101786482|FG000|Overall Study|withdrawn by study team|2|||
33516370|NCT02653170|101786483|FG001|Overall Study|withdrawn by study team|4|||
33516371|NCT02653170|101786484|FG002|Overall Study|withdrawn by study team|5|||
33516372|NCT02653170|101786482|FG000|Overall Study|Lost to Follow-up|12|||
33516373|NCT02653170|101786483|FG001|Overall Study|Lost to Follow-up|4|||
33199687|NCT00614939|100633888|FG000|Overall Study|Poor/non-compliance|4|||
33516374|NCT02653170|101786484|FG002|Overall Study|Lost to Follow-up|10|||
33607583|NCT03966885|102111754|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
33516375|NCT02101359|101786486|FG000|Overall Study|Not included|23|||
33516376|NCT02101359|101786487|FG001|Overall Study|Not included|13|||
33516377|NCT02101359|101786486|FG000|Overall Study|Withdrawal by Subject|5|||
33516378|NCT02101359|101786487|FG001|Overall Study|Withdrawal by Subject|4|||
33516379|NCT02101359|101786486|FG000|Overall Study|Lost to Follow-up|1|||
33516380|NCT02101359|101786487|FG001|Overall Study|Lost to Follow-up|0|||
33516381|NCT02101359|101786486|FG000|Overall Study|Protocol Violation|0|||
33516382|NCT02101359|101786487|FG001|Overall Study|Protocol Violation|2|||
33516383|NCT00435019|101786490|FG000|Overall Study|Adverse Event|1|||
33516384|NCT00435019|101786491|FG001|Overall Study|Adverse Event|0|||
33199688|NCT00614939|100633889|FG001|Overall Study|Poor/non-compliance|0|||
33516385|NCT00435019|101786490|FG000|Overall Study|Lack of Efficacy|1|||
33516386|NCT00435019|101786491|FG001|Overall Study|Lack of Efficacy|2|||
33516387|NCT00435019|101786490|FG000|Overall Study|Protocol Violation|3|||
33516388|NCT00435019|101786491|FG001|Overall Study|Protocol Violation|1|||
33516389|NCT00435019|101786490|FG000|Overall Study|Personal reasons for withdrawal|8|||
33326320|NCT00993265|101091150|FG001|Overall Study|Non-compliant with study medication|0|||
33326321|NCT00688155|101091151|FG000|Overall Study|Withdrawal by Subject|2|||
33326322|NCT00688155|101091152|FG001|Overall Study|Withdrawal by Subject|2|||
33516390|NCT00435019|101786491|FG001|Overall Study|Personal reasons for withdrawal|7|||
33516391|NCT00835679|101786492|FG000|Overall Study|Withdrawal by Subject|1|||
33516392|NCT00835679|101786493|FG001|Overall Study|Withdrawal by Subject|0|||
33516393|NCT00835679|101786494|FG002|Overall Study|Withdrawal by Subject|0|||
33516394|NCT00835679|101786495|FG003|Overall Study|Withdrawal by Subject|0|||
33516395|NCT01258075|101786501|FG000|Overall Study|Adverse Event|8|||
33516396|NCT01258075|101786502|FG001|Overall Study|Adverse Event|3|||
33516397|NCT01258075|101786501|FG000|Overall Study|Lost to Follow-up|11|||
33516398|NCT01258075|101786502|FG001|Overall Study|Lost to Follow-up|6|||
33516399|NCT01258075|101786501|FG000|Overall Study|Withdrawal by Subject|10|||
33516400|NCT01258075|101786502|FG001|Overall Study|Withdrawal by Subject|7|||
33516401|NCT01258075|101786501|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
33516402|NCT01258075|101786502|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
33516403|NCT01258075|101786501|FG000|Overall Study|Other|12|||
33516404|NCT01258075|101786502|FG001|Overall Study|Other|5|||
33516405|NCT02604550|101786503|FG000|Overall Study|Lost to Follow-up|7|||
33516406|NCT02604550|101786504|FG001|Overall Study|Lost to Follow-up|6|||
33516407|NCT02604550|101786503|FG000|Overall Study|Withdrawal by Subject|0|||
33326323|NCT00688155|101091153|FG002|Overall Study|Withdrawal by Subject|1|||
33326324|NCT00688155|101091154|FG003|Overall Study|Withdrawal by Subject|1|||
33516408|NCT02604550|101786504|FG001|Overall Study|Withdrawal by Subject|1|||
33516409|NCT02604550|101786503|FG000|Overall Study|Incomplete data using paper journal|18|||
33516410|NCT02604550|101786504|FG001|Overall Study|Incomplete data using paper journal|19|||
33516411|NCT03956615|101786505|FG000|Overall Study|No multiple myeloma confirmed|2|||
33516412|NCT03956615|101786505|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
33516413|NCT03956615|101786505|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
33516414|NCT03956615|101786505|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
33516415|NCT04907227|101786507|FG000|Overall Study|Death|12|||
33516416|NCT04907227|101786508|FG001|Overall Study|Death|8|||
33516417|NCT04907227|101786507|FG000|Overall Study|Withdrawal by Subject|2|||
33516418|NCT04907227|101786508|FG001|Overall Study|Withdrawal by Subject|2|||
33516419|NCT04907227|101786507|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
33516420|NCT04907227|101786508|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
33516421|NCT04907227|101786507|FG000|Overall Study|Sponsor Decision|25|||
33516422|NCT04907227|101786508|FG001|Overall Study|Sponsor Decision|30|||
33516423|NCT04907227|101786507|FG000|Overall Study|Physician Decision|1|||
33516424|NCT04907227|101786508|FG001|Overall Study|Physician Decision|0|||
33516425|NCT02370667|101786515|FG000|Overall Study|Lost to Follow-up|0|||
33516426|NCT02370667|101786516|FG001|Overall Study|Lost to Follow-up|1|||
33516427|NCT02370667|101786517|FG002|Overall Study|Lost to Follow-up|0|||
33516428|NCT02186847|101786522|FG000|Overall Study|Protocol Violation|3|||
33516429|NCT02186847|101786523|FG001|Overall Study|Protocol Violation|0|||
33516430|NCT01907217|101786527|FG000|Overall Study|Withdrawal by Subject|0|||
33516431|NCT01907217|101786528|FG001|Overall Study|Withdrawal by Subject|2|||
33516432|NCT00597506|101786533|FG000|Overall Study|Subject is being followed for survival|1|||
33516433|NCT00742508|101786534|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
33516434|NCT00742508|101786535|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
33516435|NCT00742508|101786534|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
33516436|NCT00742508|101786535|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
33516437|NCT00742508|101786534|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
33516438|NCT00742508|101786535|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
33516439|NCT00742508|101786534|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
33516440|NCT00742508|101786535|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
33516441|NCT00742508|101786534|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
33516442|NCT00742508|101786535|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
33516443|NCT02071082|101786536|FG000|Overall Study|Enrolled and Never Treated|1|||
33516444|NCT02071082|101786537|FG001|Overall Study|Enrolled and Never Treated|1|||
33516445|NCT02071082|101786536|FG000|Overall Study|Adverse Event|0|||
33516446|NCT02071082|101786537|FG001|Overall Study|Adverse Event|1|||
33516447|NCT02071082|101786536|FG000|Overall Study|Withdrew Consent|0|||
33516448|NCT02071082|101786537|FG001|Overall Study|Withdrew Consent|4|||
33516449|NCT02071082|101786536|FG000|Overall Study|Lost to Follow-up|1|||
33516450|NCT02071082|101786537|FG001|Overall Study|Lost to Follow-up|1|||
33516451|NCT00990665|101786538|FG000|Overall Study|Unsuccessful Implant|8|||
33516452|NCT00990665|101786538|FG000|Overall Study|Death|29|||
33516453|NCT00990665|101786538|FG000|Overall Study|Heart Transplant|1|||
33516454|NCT00990665|101786538|FG000|Overall Study|Withdrawal by Subject|6|||
33516455|NCT00990665|101786538|FG000|Overall Study|Lost to Follow-up|1|||
33516456|NCT00990665|101786538|FG000|Overall Study|System Explant|3|||
33516457|NCT02554318|101786539|FG000|Overall Study|Withdrawal by Subject|10|||
33516458|NCT02554318|101786540|FG001|Overall Study|Withdrawal by Subject|8|||
33516459|NCT02607306|101786548|FG000|Overall Study|Adverse Event|8|||
33516460|NCT02607306|101786549|FG001|Overall Study|Adverse Event|6|||
33516461|NCT02607306|101786550|FG002|Overall Study|Adverse Event|6|||
33516462|NCT02607306|101786548|FG000|Overall Study|Unclassified|1|||
33516463|NCT02607306|101786549|FG001|Overall Study|Unclassified|4|||
33516464|NCT02607306|101786550|FG002|Overall Study|Unclassified|0|||
33516465|NCT02607306|101786548|FG000|Overall Study|Withdrawal by Subject|8|||
33516466|NCT02607306|101786549|FG001|Overall Study|Withdrawal by Subject|10|||
33516467|NCT02607306|101786550|FG002|Overall Study|Withdrawal by Subject|2|||
33516468|NCT02607306|101786548|FG000|Overall Study|Lack of Efficacy|0|||
33199689|NCT00614939|100633888|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
33516469|NCT02607306|101786549|FG001|Overall Study|Lack of Efficacy|1|||
33516470|NCT02607306|101786550|FG002|Overall Study|Lack of Efficacy|1|||
33199690|NCT00614939|100633889|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
33199691|NCT03394924|100633890|FG000|Overall Study|Adverse Event|0|||
33399992|NCT00877890|101350344|FG001|Overall Study|Withdrawal of Consent|12|||
33516471|NCT02607306|101786548|FG000|Overall Study|Protocol Violation|4|||
33516472|NCT02607306|101786549|FG001|Overall Study|Protocol Violation|2|||
33516473|NCT02607306|101786550|FG002|Overall Study|Protocol Violation|1|||
33516474|NCT03054064|101786553|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
33516475|NCT03054064|101786553|FG000|Overall Study|Investigator Decision|2|||
33516476|NCT03054064|101786553|FG000|Overall Study|Bladder Issue|1|||
33516477|NCT03054064|101786553|FG000|Overall Study|High Blood Pressure|1|||
33516478|NCT03054064|101786553|FG000|Overall Study|Change in Status|1|||
33516479|NCT00480493|101786554|FG000|Overall Study|moved|2|||
33516480|NCT00480493|101786555|FG001|Overall Study|moved|7|||
33516481|NCT00501059|101786557|FG000|Overall Study|Protocol Violation|80|||
33516482|NCT00501059|101786558|FG001|Overall Study|Protocol Violation|69|||
33516483|NCT00501059|101786557|FG000|Overall Study|Death|140|||
33516484|NCT00501059|101786558|FG001|Overall Study|Death|137|||
33516485|NCT00501059|101786557|FG000|Overall Study|Other|236|||
33516486|NCT00501059|101786558|FG001|Overall Study|Other|239|||
33516487|NCT00501059|101786557|FG000|Overall Study|Missing end-of-study page|91|||
33516488|NCT00501059|101786558|FG001|Overall Study|Missing end-of-study page|92|||
33516489|NCT00501059|101786557|FG000|Overall Study|Clinical endpoint reached|110|||
33516490|NCT00501059|101786558|FG001|Overall Study|Clinical endpoint reached|123|||
33516491|NCT00501059|101786557|FG000|Overall Study|Insufficient therapeutic effect|4|||
33516492|NCT00501059|101786558|FG001|Overall Study|Insufficient therapeutic effect|5|||
33516493|NCT00501059|101786557|FG000|Overall Study|Consent withdrawn by subject|817|||
33516494|NCT00501059|101786558|FG001|Overall Study|Consent withdrawn by subject|873|||
33516495|NCT00501059|101786557|FG000|Overall Study|Non-compliant with study treatment|23|||
33516496|NCT00501059|101786558|FG001|Overall Study|Non-compliant with study treatment|16|||
33516497|NCT00501059|101786557|FG000|Overall Study|Reason not given|3|||
33516498|NCT00501059|101786558|FG001|Overall Study|Reason not given|1|||
33516499|NCT00501059|101786557|FG000|Overall Study|Adverse Event|129|||
33516500|NCT00501059|101786558|FG001|Overall Study|Adverse Event|122|||
33516501|NCT00501059|101786557|FG000|Overall Study|Lost to Follow-up|210|||
33516502|NCT00501059|101786558|FG001|Overall Study|Lost to Follow-up|198|||
33516503|NCT00501059|101786557|FG000|Overall Study|Not treated|25|||
33516504|NCT00501059|101786558|FG001|Overall Study|Not treated|17|||
33516505|NCT00785213|101786559|FG000|Quinine Sulfate Alone|Adverse Event|4|||
33516506|NCT00785213|101786559|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
33516507|NCT02134353|101786560|FG000|Overall Study|Adverse Event|10|||
33516508|NCT02134353|101786561|FG001|Overall Study|Adverse Event|6|||
33516509|NCT02134353|101786560|FG000|Overall Study|Lost to Follow-up|1|||
33326325|NCT02632721|101091157|FG000|Overall Study|Adverse Event|0|||
33516510|NCT02134353|101786561|FG001|Overall Study|Lost to Follow-up|1|||
33516511|NCT02134353|101786560|FG000|Overall Study|Lack of Efficacy|2|||
33516512|NCT02134353|101786561|FG001|Overall Study|Lack of Efficacy|1|||
33516513|NCT02134353|101786560|FG000|Overall Study|Withdrawal by Subject|12|||
33199692|NCT03394924|100633891|FG001|Overall Study|Adverse Event|5|||
33516514|NCT02134353|101786561|FG001|Overall Study|Withdrawal by Subject|13|||
33516515|NCT02134353|101786560|FG000|Overall Study|Death|0|||
33516516|NCT02134353|101786561|FG001|Overall Study|Death|1|||
33516517|NCT02134353|101786560|FG000|Overall Study|Pregnancy|0|||
33516518|NCT02134353|101786561|FG001|Overall Study|Pregnancy|1|||
33516519|NCT02134353|101786560|FG000|Overall Study|Relocation|1|||
33516520|NCT02134353|101786561|FG001|Overall Study|Relocation|0|||
33516521|NCT02134353|101786560|FG000|Overall Study|Other - Patient's Choice|0|||
33199693|NCT03394924|100633892|FG002|Overall Study|Adverse Event|0|||
33199694|NCT03394924|100633890|FG000|Overall Study|Withdrawal by Subject|2|||
33326326|NCT02632721|101091158|FG001|Overall Study|Adverse Event|0|||
33516522|NCT02134353|101786561|FG001|Overall Study|Other - Patient's Choice|1|||
33516523|NCT01397786|101786562|FG000|Phase A|Lost to Follow-up|0|||
33516524|NCT01397786|101786563|FG001|Phase A|Lost to Follow-up|0|||
33516525|NCT01397786|101786564|FG002|Phase A|Lost to Follow-up|6|||
33516526|NCT01397786|101786562|FG000|Phase A|Adverse Event|0|||
33516527|NCT01397786|101786563|FG001|Phase A|Adverse Event|0|||
33516528|NCT01397786|101786564|FG002|Phase A|Adverse Event|8|||
33199695|NCT03394924|100633891|FG001|Overall Study|Withdrawal by Subject|0|||
33516529|NCT01397786|101786562|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
33516530|NCT01397786|101786563|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
33516531|NCT01397786|101786564|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
33326327|NCT02632721|101091159|FG002|Overall Study|Adverse Event|2|||
33326328|NCT02632721|101091160|FG003|Overall Study|Adverse Event|5|||
33326329|NCT02632721|101091161|FG004|Overall Study|Adverse Event|3|||
33199696|NCT03394924|100633892|FG002|Overall Study|Withdrawal by Subject|0|||
33199697|NCT03394924|100633890|FG000|Overall Study|Lost to Follow-up|0|||
33326330|NCT02632721|101091157|FG000|Overall Study|Dose limiting toxicity|0|||
33326331|NCT02632721|101091158|FG001|Overall Study|Dose limiting toxicity|0|||
33516532|NCT01397786|101786562|FG000|Phase A|Physician Decision|0|||
33516533|NCT01397786|101786563|FG001|Phase A|Physician Decision|0|||
33516534|NCT01397786|101786564|FG002|Phase A|Physician Decision|1|||
33516535|NCT01397786|101786562|FG000|Phase A|Withdrawal by Subject|0|||
33516536|NCT01397786|101786563|FG001|Phase A|Withdrawal by Subject|0|||
33516537|NCT01397786|101786564|FG002|Phase A|Withdrawal by Subject|5|||
33516538|NCT01397786|101786562|FG000|Phase A|Lack of Efficacy|0|||
33516539|NCT01397786|101786563|FG001|Phase A|Lack of Efficacy|0|||
33516540|NCT01397786|101786564|FG002|Phase A|Lack of Efficacy|1|||
33516541|NCT01397786|101786562|FG000|Phase B|Lost to Follow-up|22|||
33516542|NCT01397786|101786563|FG001|Phase B|Lost to Follow-up|12|||
33516543|NCT01397786|101786564|FG002|Phase B|Lost to Follow-up|22|||
33516544|NCT01397786|101786562|FG000|Phase B|Adverse Event|109|||
33516545|NCT01397786|101786563|FG001|Phase B|Adverse Event|23|||
33516546|NCT01397786|101786564|FG002|Phase B|Adverse Event|27|||
33516547|NCT01397786|101786562|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
33516548|NCT01397786|101786563|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
33516549|NCT01397786|101786564|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
33516550|NCT01397786|101786562|FG000|Phase B|Physician Decision|9|||
33516551|NCT01397786|101786563|FG001|Phase B|Physician Decision|1|||
33516552|NCT01397786|101786564|FG002|Phase B|Physician Decision|3|||
33199698|NCT03394924|100633891|FG001|Overall Study|Lost to Follow-up|1|||
33326332|NCT02632721|101091159|FG002|Overall Study|Dose limiting toxicity|0|||
33326333|NCT02632721|101091160|FG003|Overall Study|Dose limiting toxicity|1|||
33326334|NCT02632721|101091161|FG004|Overall Study|Dose limiting toxicity|0|||
33326335|NCT02632721|101091157|FG000|Overall Study|Progressive disease|3|||
33326336|NCT02632721|101091158|FG001|Overall Study|Progressive disease|0|||
33326337|NCT02632721|101091159|FG002|Overall Study|Progressive disease|4|||
33326338|NCT02632721|101091160|FG003|Overall Study|Progressive disease|6|||
33326339|NCT02632721|101091161|FG004|Overall Study|Progressive disease|5|||
33399993|NCT00877890|101350343|FG000|Overall Study|Investigator Decision|0|||
33399994|NCT00877890|101350344|FG001|Overall Study|Investigator Decision|2|||
33399995|NCT00877890|101350343|FG000|Overall Study|Loss of Glucose Control|3|||
33199699|NCT03394924|100633892|FG002|Overall Study|Lost to Follow-up|0|||
33326340|NCT02632721|101091157|FG000|Overall Study|Refused to continue taking trial medication|0|||
33399996|NCT00877890|101350344|FG001|Overall Study|Loss of Glucose Control|4|||
33607584|NCT03966885|102111755|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
33607585|NCT03966885|102111754|FG000|Overall Study|Moved from study area.|0|||
33607586|NCT03966885|102111755|FG001|Overall Study|Moved from study area.|2|||
33607587|NCT03344172|102111759|FG000|Overall Study|Received <1 dose of treatment|1|||
33607588|NCT03344172|102111760|FG001|Overall Study|Received <1 dose of treatment|0|||
33607589|NCT04439318|102111766|FG000|Overall Study|Ineligible|1|||
33607590|NCT04439318|102111766|FG000|Overall Study|Never Started Treatment|3|||
33199700|NCT03394924|100633890|FG000|Overall Study|Did not meet all inclusion criteria|1|||
33199701|NCT03394924|100633891|FG001|Overall Study|Did not meet all inclusion criteria|0|||
33199702|NCT03394924|100633892|FG002|Overall Study|Did not meet all inclusion criteria|0|||
33326341|NCT02632721|101091158|FG001|Overall Study|Refused to continue taking trial medication|1|||
33326342|NCT02632721|101091159|FG002|Overall Study|Refused to continue taking trial medication|1|||
33326343|NCT02632721|101091160|FG003|Overall Study|Refused to continue taking trial medication|1|||
33326344|NCT02632721|101091161|FG004|Overall Study|Refused to continue taking trial medication|2|||
33326345|NCT02632721|101091157|FG000|Overall Study|Inadequate clinical condition|0|||
33326346|NCT02632721|101091158|FG001|Overall Study|Inadequate clinical condition|0|||
33326347|NCT02632721|101091159|FG002|Overall Study|Inadequate clinical condition|0|||
33516553|NCT01397786|101786562|FG000|Phase B|Withdrawal by Subject|102|||
33516554|NCT01397786|101786563|FG001|Phase B|Withdrawal by Subject|45|||
33516555|NCT01397786|101786564|FG002|Phase B|Withdrawal by Subject|30|||
33516556|NCT01397786|101786562|FG000|Phase B|Protocol Deviation|1|||
33516557|NCT01397786|101786563|FG001|Phase B|Protocol Deviation|2|||
33516558|NCT01397786|101786564|FG002|Phase B|Protocol Deviation|4|||
33516559|NCT01397786|101786562|FG000|Phase B|Lack of Efficacy|22|||
33516560|NCT01397786|101786563|FG001|Phase B|Lack of Efficacy|7|||
33516561|NCT01397786|101786564|FG002|Phase B|Lack of Efficacy|14|||
33516562|NCT03806231|101786565|FG000|Overall Study|Physician Decision|1|||
33516563|NCT03806231|101786566|FG001|Overall Study|Physician Decision|0|||
33516564|NCT03806231|101786565|FG000|Overall Study|Withdrawal by Subject|1|||
33516565|NCT03806231|101786566|FG001|Overall Study|Withdrawal by Subject|0|||
33516566|NCT01629823|101786567|FG000|Trial Period|Missed visit|11|||
33516567|NCT01629823|101786568|FG001|Trial Period|Missed visit|9|||
33516568|NCT01629823|101786569|FG002|Trial Period|Missed visit|8|||
33199703|NCT00779246|100633893|FG000|Overall Study|Missing sufficient data for analysis|33|||
33199704|NCT00779246|100633894|FG001|Overall Study|Missing sufficient data for analysis|53|||
33199705|NCT01038921|100633895|FG000|Overall Study|Withdrawal by Subject|1|||
33199706|NCT01038921|100633896|FG001|Overall Study|Withdrawal by Subject|0|||
33199707|NCT01038921|100633895|FG000|Overall Study|Physician Decision|1|||
33199708|NCT01038921|100633896|FG001|Overall Study|Physician Decision|0|||
33199709|NCT03221257|100633898|FG000|Overall Study|Lost to Follow-up|0|||
33199710|NCT03221257|100633899|FG001|Overall Study|Lost to Follow-up|1|||
33199711|NCT03221257|100633898|FG000|Overall Study|Withdrawal by Subject|1|||
33199712|NCT03221257|100633899|FG001|Overall Study|Withdrawal by Subject|1|||
33199713|NCT01923181|100633900|FG000|Overall Study|Protocol Violation|2|||
33199714|NCT01923181|100633901|FG001|Overall Study|Protocol Violation|2|||
33199715|NCT01923181|100633902|FG002|Overall Study|Protocol Violation|0|||
33199716|NCT01923181|100633903|FG003|Overall Study|Protocol Violation|2|||
33199717|NCT01923181|100633904|FG004|Overall Study|Protocol Violation|2|||
33199718|NCT01923181|100633905|FG005|Overall Study|Protocol Violation|1|||
33199719|NCT01923181|100633906|FG006|Overall Study|Protocol Violation|1|||
33199720|NCT01923181|100633907|FG007|Overall Study|Protocol Violation|2|||
33199721|NCT01923181|100633908|FG008|Overall Study|Protocol Violation|1|||
33199722|NCT01923181|100633900|FG000|Overall Study|Withdrawal by Subject|0|||
33199723|NCT01923181|100633901|FG001|Overall Study|Withdrawal by Subject|1|||
33326348|NCT02632721|101091160|FG003|Overall Study|Inadequate clinical condition|0|||
33607591|NCT04439318|102111766|FG000|Overall Study|Adverse Event|10|||
33199724|NCT01923181|100633902|FG002|Overall Study|Withdrawal by Subject|0|||
33326349|NCT02632721|101091161|FG004|Overall Study|Inadequate clinical condition|1|||
33326350|NCT02632721|101091157|FG000|Overall Study|No meet eligibility|0|||
33516569|NCT01629823|101786567|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
33516570|NCT01629823|101786568|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
33607592|NCT04439318|102111766|FG000|Overall Study|Death|2|||
33516571|NCT01629823|101786569|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
33516572|NCT01629823|101786567|FG000|Trial Period|Pregnancy|1|||
33607593|NCT04439318|102111766|FG000|Overall Study|Disease Progression|25|||
33607594|NCT04439318|102111766|FG000|Overall Study|Other Complicating Disease|2|||
33607595|NCT04439318|102111766|FG000|Overall Study|Withdrawal by Subject|4|||
33607596|NCT04439318|102111766|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
33607597|NCT04439318|102111766|FG000|Overall Study|Non-Compliance|1|||
33607598|NCT04439318|102111766|FG000|Overall Study|Still on Treatment|1|||
33607599|NCT01012323|102111768|FG000|Overall Study|Investigator Judgment|1|||
33607600|NCT02453555|102111772|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
33516573|NCT01629823|101786568|FG001|Trial Period|Pregnancy|0|||
33516574|NCT01629823|101786569|FG002|Trial Period|Pregnancy|0|||
33516575|NCT01629823|101786567|FG000|Trial Period|Adverse Event|0|||
33516576|NCT01629823|101786568|FG001|Trial Period|Adverse Event|1|||
33516577|NCT01629823|101786569|FG002|Trial Period|Adverse Event|0|||
33516578|NCT01629823|101786567|FG000|Trial Period|Out-of-window visit|0|||
33516579|NCT01629823|101786568|FG001|Trial Period|Out-of-window visit|2|||
33516580|NCT01629823|101786569|FG002|Trial Period|Out-of-window visit|0|||
33516581|NCT01629823|101786567|FG000|Trial Period|Failed to hold medication|0|||
33607601|NCT02453555|102111773|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
33199725|NCT01923181|100633903|FG003|Overall Study|Withdrawal by Subject|1|||
33326351|NCT02632721|101091158|FG001|Overall Study|No meet eligibility|0|||
33326352|NCT02632721|101091159|FG002|Overall Study|No meet eligibility|0|||
33326353|NCT02632721|101091160|FG003|Overall Study|No meet eligibility|0|||
33326354|NCT02632721|101091161|FG004|Overall Study|No meet eligibility|1|||
33399997|NCT00967343|101350347|FG000|Overall Study|Study termination by sponsor|12|||
33399998|NCT00967343|101350347|FG000|Overall Study|Death|24|||
33399999|NCT00967343|101350347|FG000|Overall Study|Relapse|1|||
33400000|NCT00967343|101350347|FG000|Overall Study|Lost to Follow-up|1|||
33400001|NCT05049122|101350351|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
33400002|NCT05049122|101350351|FG000|Overall Study|Participant moved|1|||
33400003|NCT05049122|101350351|FG000|Overall Study|At the direction of the doctor|1|||
33400004|NCT01351415|101350354|FG000|Overall Study|Withdrawal by Subject|15|||
33400005|NCT01351415|101350355|FG001|Overall Study|Withdrawal by Subject|17|||
33400006|NCT01351415|101350354|FG000|Overall Study|Trial termination by the Sponsor|28|||
33400007|NCT01351415|101350355|FG001|Overall Study|Trial termination by the Sponsor|19|||
33516582|NCT01629823|101786568|FG001|Trial Period|Failed to hold medication|0|||
33326355|NCT02632721|101091157|FG000|Overall Study|Allergic reaction|0|||
33326356|NCT02632721|101091158|FG001|Overall Study|Allergic reaction|0|||
33326357|NCT02632721|101091159|FG002|Overall Study|Allergic reaction|0|||
33326358|NCT02632721|101091160|FG003|Overall Study|Allergic reaction|1|||
33326359|NCT02632721|101091161|FG004|Overall Study|Allergic reaction|0|||
33326360|NCT02632721|101091157|FG000|Overall Study|Receiving Decitabine locally|0|||
33326361|NCT02632721|101091158|FG001|Overall Study|Receiving Decitabine locally|0|||
33326362|NCT02632721|101091159|FG002|Overall Study|Receiving Decitabine locally|1|||
33326363|NCT02632721|101091160|FG003|Overall Study|Receiving Decitabine locally|0|||
33326364|NCT02632721|101091161|FG004|Overall Study|Receiving Decitabine locally|0|||
33326365|NCT02632721|101091157|FG000|Overall Study|No benefit from study treatment|1|||
33326366|NCT02632721|101091158|FG001|Overall Study|No benefit from study treatment|1|||
33326367|NCT02632721|101091159|FG002|Overall Study|No benefit from study treatment|0|||
33326368|NCT02632721|101091160|FG003|Overall Study|No benefit from study treatment|0|||
33326369|NCT02632721|101091161|FG004|Overall Study|No benefit from study treatment|1|||
33326370|NCT02632721|101091157|FG000|Overall Study|Patient wish for other treatment|0|||
33326371|NCT02632721|101091158|FG001|Overall Study|Patient wish for other treatment|1|||
33326372|NCT02632721|101091159|FG002|Overall Study|Patient wish for other treatment|0|||
33326373|NCT02632721|101091160|FG003|Overall Study|Patient wish for other treatment|0|||
33326374|NCT02632721|101091161|FG004|Overall Study|Patient wish for other treatment|0|||
33326375|NCT02632721|101091157|FG000|Overall Study|Relapsed Pneumonia|0|||
33326376|NCT02632721|101091158|FG001|Overall Study|Relapsed Pneumonia|0|||
33326377|NCT02632721|101091159|FG002|Overall Study|Relapsed Pneumonia|0|||
33326378|NCT02632721|101091160|FG003|Overall Study|Relapsed Pneumonia|0|||
33326379|NCT02632721|101091161|FG004|Overall Study|Relapsed Pneumonia|1|||
33326380|NCT02632721|101091157|FG000|Overall Study|Therapy refractory AML|0|||
33400008|NCT01351415|101350354|FG000|Overall Study|Lost to Follow-up|5|||
33607602|NCT02453555|102111774|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
33199726|NCT01923181|100633904|FG004|Overall Study|Withdrawal by Subject|4|||
33326381|NCT02632721|101091158|FG001|Overall Study|Therapy refractory AML|0|||
33400009|NCT01351415|101350355|FG001|Overall Study|Lost to Follow-up|7|||
33326382|NCT02632721|101091159|FG002|Overall Study|Therapy refractory AML|0|||
33326383|NCT02632721|101091160|FG003|Overall Study|Therapy refractory AML|0|||
33400010|NCT01351415|101350354|FG000|Overall Study|Death|190|||
33516583|NCT01629823|101786569|FG002|Trial Period|Failed to hold medication|1|||
33516584|NCT01629823|101786567|FG000|Washout Period|Safety|2|||
33326384|NCT02632721|101091161|FG004|Overall Study|Therapy refractory AML|1|||
33326385|NCT02632721|101091157|FG000|Overall Study|Increase of white blood cell count|0|||
33400011|NCT01351415|101350355|FG001|Overall Study|Death|187|||
33516585|NCT01629823|101786568|FG001|Washout Period|Safety|5|||
33607603|NCT02453555|102111775|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
33516586|NCT01629823|101786569|FG002|Washout Period|Safety|0|||
33516587|NCT01629823|101786567|FG000|Washout Period|Pregnancy|1|||
33516588|NCT01629823|101786568|FG001|Washout Period|Pregnancy|0|||
33516589|NCT01629823|101786569|FG002|Washout Period|Pregnancy|0|||
33516590|NCT01629823|101786567|FG000|Washout Period|Protocol Violation|0|||
33516591|NCT01629823|101786568|FG001|Washout Period|Protocol Violation|1|||
33516592|NCT01629823|101786569|FG002|Washout Period|Protocol Violation|0|||
33516593|NCT03640481|101786572|FG000|Overall Study|Death|14|||
33516594|NCT03640481|101786573|FG001|Overall Study|Death|14|||
33516595|NCT03640481|101786574|FG002|Overall Study|Death|0|||
33516596|NCT03640481|101786575|FG003|Overall Study|Death|0|||
33516597|NCT03640481|101786572|FG000|Overall Study|Lost to Follow-up|2|||
33516598|NCT03640481|101786573|FG001|Overall Study|Lost to Follow-up|0|||
33326386|NCT02632721|101091158|FG001|Overall Study|Increase of white blood cell count|0|||
33326387|NCT02632721|101091159|FG002|Overall Study|Increase of white blood cell count|0|||
33326388|NCT02632721|101091160|FG003|Overall Study|Increase of white blood cell count|0|||
33326389|NCT02632721|101091161|FG004|Overall Study|Increase of white blood cell count|1|||
33326390|NCT02632721|101091157|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
33326391|NCT02632721|101091158|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
33326392|NCT02632721|101091159|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
33326393|NCT02632721|101091160|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
33326394|NCT02632721|101091161|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
33326395|NCT00253643|101091162|FG000|Overall Study|Withdrawal by Subject|0|||
33326396|NCT00253643|101091163|FG001|Overall Study|Withdrawal by Subject|0|||
33326397|NCT00253643|101091164|FG002|Overall Study|Withdrawal by Subject|1|||
33326398|NCT00253643|101091165|FG003|Overall Study|Withdrawal by Subject|1|||
33326399|NCT00253643|101091162|FG000|Overall Study|Non-Compliance|0|||
33326400|NCT00253643|101091163|FG001|Overall Study|Non-Compliance|0|||
33326401|NCT00253643|101091164|FG002|Overall Study|Non-Compliance|0|||
33516599|NCT03640481|101786574|FG002|Overall Study|Lost to Follow-up|0|||
33516600|NCT03640481|101786575|FG003|Overall Study|Lost to Follow-up|0|||
33516601|NCT03640481|101786572|FG000|Overall Study|Site terminated by sponsor|1|||
33516602|NCT03640481|101786573|FG001|Overall Study|Site terminated by sponsor|3|||
33516603|NCT03640481|101786574|FG002|Overall Study|Site terminated by sponsor|0|||
33516604|NCT03640481|101786575|FG003|Overall Study|Site terminated by sponsor|0|||
33516605|NCT03640481|101786572|FG000|Overall Study|Study terminated by sponsor|29|||
33516606|NCT03640481|101786573|FG001|Overall Study|Study terminated by sponsor|42|||
33607604|NCT02453555|102111776|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
33326402|NCT00253643|101091165|FG003|Overall Study|Non-Compliance|2|||
33326403|NCT01195090|101091166|FG000|Overall Study|Adverse Event|1|||
33326404|NCT01195090|101091167|FG001|Overall Study|Adverse Event|2|||
33326405|NCT01195090|101091166|FG000|Overall Study|Lost to Follow-up|2|||
33326406|NCT01195090|101091167|FG001|Overall Study|Lost to Follow-up|2|||
33326407|NCT01195090|101091166|FG000|Overall Study|Protocol Violation|3|||
33326408|NCT01195090|101091167|FG001|Overall Study|Protocol Violation|4|||
33326409|NCT03034460|101091168|FG000|Overall Study|Adverse Event|0|||
33326410|NCT03034460|101091169|FG001|Overall Study|Adverse Event|1|||
33326411|NCT03034460|101091168|FG000|Overall Study|Withdrawal by Subject|2|||
33326412|NCT03034460|101091169|FG001|Overall Study|Withdrawal by Subject|2|||
33326413|NCT03034460|101091168|FG000|Overall Study|Personal Reasons|1|||
33326414|NCT03034460|101091169|FG001|Overall Study|Personal Reasons|0|||
33326415|NCT03451084|101091172|FG000|Overall Study|Withdrawal by Subject|2|||
33326416|NCT03451084|101091173|FG001|Overall Study|Withdrawal by Subject|1|||
33326417|NCT03451084|101091174|FG002|Overall Study|Withdrawal by Subject|2|||
33326418|NCT03451084|101091175|FG003|Overall Study|Withdrawal by Subject|1|||
33326419|NCT03451084|101091172|FG000|Overall Study|Disease recurrence|0|||
33326420|NCT03451084|101091173|FG001|Overall Study|Disease recurrence|2|||
33326421|NCT03451084|101091174|FG002|Overall Study|Disease recurrence|0|||
33326422|NCT03451084|101091175|FG003|Overall Study|Disease recurrence|0|||
33326423|NCT03451084|101091172|FG000|Overall Study|Lack of Efficacy|0|||
33326424|NCT03451084|101091173|FG001|Overall Study|Lack of Efficacy|3|||
33326425|NCT03451084|101091174|FG002|Overall Study|Lack of Efficacy|0|||
33326426|NCT03451084|101091175|FG003|Overall Study|Lack of Efficacy|1|||
33400012|NCT01351415|101350354|FG000|Overall Study|Physician Decision|2|||
33607605|NCT02453555|102111777|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
33326427|NCT03451084|101091172|FG000|Overall Study|Death|1|||
33326428|NCT03451084|101091173|FG001|Overall Study|Death|0|||
33326429|NCT03451084|101091174|FG002|Overall Study|Death|2|||
33326430|NCT03451084|101091175|FG003|Overall Study|Death|0|||
33326431|NCT03451084|101091172|FG000|Overall Study|Physician Decision|0|||
33326432|NCT03451084|101091173|FG001|Overall Study|Physician Decision|0|||
33400013|NCT01351415|101350355|FG001|Overall Study|Physician Decision|3|||
33400014|NCT01351415|101350354|FG000|Overall Study|Reason unknown|0|||
33516607|NCT03640481|101786574|FG002|Overall Study|Study terminated by sponsor|1|||
33516608|NCT03640481|101786575|FG003|Overall Study|Study terminated by sponsor|0|||
33516609|NCT03640481|101786572|FG000|Overall Study|Withdrawal by Subject|5|||
33516610|NCT03640481|101786573|FG001|Overall Study|Withdrawal by Subject|4|||
33400015|NCT01351415|101350355|FG001|Overall Study|Reason unknown|2|||
33400016|NCT01351415|101350354|FG000|Overall Study|Never Started|5|||
33400017|NCT01351415|101350355|FG001|Overall Study|Never Started|5|||
33400018|NCT01495689|101350363|FG000|Overall Study|Death|0|||
33400019|NCT01495689|101350364|FG001|Overall Study|Death|1|||
33516611|NCT03640481|101786574|FG002|Overall Study|Withdrawal by Subject|0|||
33516612|NCT03640481|101786575|FG003|Overall Study|Withdrawal by Subject|1|||
33516613|NCT03640481|101786572|FG000|Overall Study|Other|26|||
33516614|NCT03640481|101786573|FG001|Overall Study|Other|12|||
33516615|NCT03640481|101786574|FG002|Overall Study|Other|1|||
33516616|NCT03640481|101786575|FG003|Overall Study|Other|0|||
33516617|NCT03640481|101786572|FG000|Overall Study|Randomized, but not treated|1|||
33516618|NCT03640481|101786573|FG001|Overall Study|Randomized, but not treated|3|||
33516619|NCT03640481|101786574|FG002|Overall Study|Randomized, but not treated|0|||
33516620|NCT03640481|101786575|FG003|Overall Study|Randomized, but not treated|0|||
33516621|NCT00628095|101786576|FG000|Overall Study|Adverse Event|5|||
33516622|NCT00628095|101786577|FG001|Overall Study|Adverse Event|3|||
33516623|NCT00628095|101786576|FG000|Overall Study|Lack of Efficacy|0|||
33516624|NCT00628095|101786577|FG001|Overall Study|Lack of Efficacy|3|||
33516625|NCT00628095|101786576|FG000|Overall Study|Withdrawal by Subject|2|||
33516626|NCT00628095|101786577|FG001|Overall Study|Withdrawal by Subject|0|||
33516627|NCT00628095|101786576|FG000|Overall Study|Other|0|||
33516628|NCT00628095|101786577|FG001|Overall Study|Other|1|||
33516629|NCT01210495|101786578|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
33516630|NCT01210495|101786579|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
33516631|NCT01210495|101786580|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
33516632|NCT01210495|101786581|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
33516633|NCT01210495|101786578|FG000|Overall Study|Death|14|||
33516634|NCT01210495|101786579|FG001|Overall Study|Death|7|||
33516635|NCT01210495|101786580|FG002|Overall Study|Death|112|||
33516636|NCT01210495|101786581|FG003|Overall Study|Death|54|||
33516637|NCT01210495|101786578|FG000|Overall Study|Study Terminated by Sponsor|0|||
33516638|NCT01210495|101786579|FG001|Overall Study|Study Terminated by Sponsor|0|||
33516639|NCT01210495|101786580|FG002|Overall Study|Study Terminated by Sponsor|4|||
33516640|NCT01210495|101786581|FG003|Overall Study|Study Terminated by Sponsor|11|||
33516641|NCT01210495|101786578|FG000|Overall Study|Lost to Follow-up|0|||
33516642|NCT01210495|101786579|FG001|Overall Study|Lost to Follow-up|0|||
33516643|NCT01210495|101786580|FG002|Overall Study|Lost to Follow-up|1|||
33516644|NCT01210495|101786581|FG003|Overall Study|Lost to Follow-up|1|||
33516645|NCT01210495|101786578|FG000|Overall Study|Other unspecified|0|||
33516646|NCT01210495|101786579|FG001|Overall Study|Other unspecified|0|||
33516647|NCT01210495|101786580|FG002|Overall Study|Other unspecified|6|||
33516648|NCT01210495|101786581|FG003|Overall Study|Other unspecified|0|||
33516649|NCT03199612|101786582|FG000|Overall Study|Adverse Event|1|||
33516650|NCT03199612|101786583|FG001|Overall Study|Adverse Event|0|||
33516651|NCT00581542|101786584|FG000|Overall Study|they met an exclusion criteria|2|||
33516652|NCT00581542|101786585|FG001|Overall Study|they met an exclusion criteria|2|||
33516653|NCT00581542|101786584|FG000|Overall Study|Lost to Follow-up|9|||
33516654|NCT00581542|101786585|FG001|Overall Study|Lost to Follow-up|21|||
33516655|NCT02326298|101786586|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33516656|NCT02326298|101786587|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33516657|NCT02326298|101786588|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
33516658|NCT02326298|101786589|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33516659|NCT02326298|101786590|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33516660|NCT02326298|101786591|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33516661|NCT02326298|101786592|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33516662|NCT02326298|101786593|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33516663|NCT02326298|101786594|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33516664|NCT02326298|101786595|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33516665|NCT02326298|101786596|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33516666|NCT02326298|101786597|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33516667|NCT02326298|101786598|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33516668|NCT02326298|101786599|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33516669|NCT02326298|101786586|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
33516670|NCT02326298|101786587|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33516671|NCT02326298|101786588|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33516672|NCT02326298|101786589|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33516673|NCT02326298|101786590|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33516674|NCT02326298|101786591|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33400020|NCT01495689|101350363|FG000|Overall Study|Withdrawal by Subject|3|||
33516675|NCT02326298|101786592|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33516676|NCT02326298|101786593|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33516677|NCT02326298|101786594|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33516678|NCT02326298|101786595|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33516679|NCT02326298|101786596|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33400021|NCT01495689|101350364|FG001|Overall Study|Withdrawal by Subject|0|||
33400022|NCT01495689|101350363|FG000|Overall Study|Lost to Follow-up|7|||
33400023|NCT01495689|101350364|FG001|Overall Study|Lost to Follow-up|6|||
33516680|NCT02326298|101786597|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33516681|NCT02326298|101786598|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33326433|NCT03451084|101091174|FG002|Overall Study|Physician Decision|2|||
33326434|NCT03451084|101091175|FG003|Overall Study|Physician Decision|2|||
33326435|NCT03451084|101091172|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
33326436|NCT03451084|101091173|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
33326437|NCT03451084|101091174|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
33326438|NCT03451084|101091175|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
33326439|NCT01093625|101091176|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
33326440|NCT01093625|101091177|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
33326441|NCT01093625|101091176|FG000|2-Week Visit|Withdrawal by Subject|1|||
33326442|NCT01093625|101091177|FG001|2-Week Visit|Withdrawal by Subject|0|||
33326443|NCT01093625|101091176|FG000|1-Month Visit|Lost to Follow-up|2|||
33326444|NCT01093625|101091177|FG001|1-Month Visit|Lost to Follow-up|0|||
33326445|NCT01093625|101091176|FG000|3-Month Visit|Lost to Follow-up|2|||
33326446|NCT01093625|101091177|FG001|3-Month Visit|Lost to Follow-up|0|||
33326447|NCT01093625|101091176|FG000|6-Month Visit|Withdrawal by Subject|6|||
33326448|NCT01093625|101091177|FG001|6-Month Visit|Withdrawal by Subject|7|||
33326449|NCT01093625|101091176|FG000|6-Month Visit|Lost to Follow-up|2|||
33326450|NCT01093625|101091177|FG001|6-Month Visit|Lost to Follow-up|2|||
33326451|NCT01093625|101091176|FG000|1-Year Visit|Lost to Follow-up|5|||
33326452|NCT01093625|101091177|FG001|1-Year Visit|Lost to Follow-up|3|||
33326453|NCT02090413|101091178|FG000|Overall Study|Adverse Event|11|||
33326454|NCT02090413|101091179|FG001|Overall Study|Adverse Event|15|||
33326455|NCT02090413|101091180|FG002|Overall Study|Adverse Event|20|||
33326456|NCT02090413|101091178|FG000|Overall Study|Flushing event|2|||
33326457|NCT02090413|101091179|FG001|Overall Study|Flushing event|0|||
33326458|NCT02090413|101091180|FG002|Overall Study|Flushing event|1|||
33326459|NCT02090413|101091178|FG000|Overall Study|Withdrawal by Subject|2|||
33326460|NCT02090413|101091179|FG001|Overall Study|Withdrawal by Subject|2|||
33326461|NCT02090413|101091180|FG002|Overall Study|Withdrawal by Subject|2|||
33326462|NCT02090413|101091178|FG000|Overall Study|Investigator Decision|1|||
33326463|NCT02090413|101091179|FG001|Overall Study|Investigator Decision|1|||
33326464|NCT02090413|101091180|FG002|Overall Study|Investigator Decision|0|||
33326465|NCT02090413|101091178|FG000|Overall Study|Other|2|||
33326466|NCT02090413|101091179|FG001|Overall Study|Other|1|||
33326467|NCT02090413|101091180|FG002|Overall Study|Other|0|||
33326468|NCT02090413|101091178|FG000|Overall Study|Lost to Follow-up|1|||
33326469|NCT02090413|101091179|FG001|Overall Study|Lost to Follow-up|1|||
33326470|NCT02090413|101091180|FG002|Overall Study|Lost to Follow-up|0|||
33326471|NCT01073267|101091182|FG000|Overall Study|Disease Progression|3|||
33326472|NCT03349099|101091185|FG000|Overall Study|Physician Decision|3|||
33326473|NCT03349099|101091186|FG001|Overall Study|Physician Decision|4|||
33400024|NCT01060150|101350365|FG000|Overall Study|Adverse Event|6|||
33516682|NCT02326298|101786599|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
33516683|NCT02326298|101786586|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
33516684|NCT02326298|101786587|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
33516685|NCT02326298|101786588|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33516686|NCT02326298|101786589|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33516687|NCT02326298|101786590|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33516688|NCT02326298|101786591|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33516689|NCT02326298|101786592|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33516690|NCT02326298|101786593|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33516691|NCT02326298|101786594|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33516692|NCT02326298|101786595|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33516693|NCT02326298|101786596|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33516694|NCT02326298|101786597|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33516695|NCT02326298|101786598|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33400025|NCT01060150|101350365|FG000|Overall Study|Lost to Follow-up|1|||
33400026|NCT01060150|101350365|FG000|Overall Study|Protocol Violation|6|||
33516696|NCT02326298|101786599|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33516697|NCT02326298|101786586|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
33516698|NCT02326298|101786587|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
33516699|NCT02326298|101786588|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33516700|NCT02326298|101786589|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33326474|NCT03349099|101091185|FG000|Overall Study|Stone migrated from the kidney|1|||
33326475|NCT03349099|101091186|FG001|Overall Study|Stone migrated from the kidney|0|||
33400027|NCT01060150|101350365|FG000|Overall Study|Withdrawal by Subject|8|||
33326476|NCT02228720|101091187|FG000|Open Label - Day 30|Lost to Follow-up|1|||
33326477|NCT04534491|101091188|FG000|Overall Study|Not completed end-of-study interview|24|||
33326478|NCT04534491|101091188|FG000|Overall Study|Non-users|70|||
33326479|NCT04534491|101091188|FG000|Overall Study|Non-verifiable users|58|||
33516701|NCT02326298|101786590|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33516702|NCT02326298|101786591|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33516703|NCT02326298|101786592|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33516704|NCT02326298|101786593|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33326480|NCT03179891|101091189|FG000|First Intervention|Withdrawal by Subject|1|||
33326481|NCT03179891|101091190|FG001|First Intervention|Withdrawal by Subject|1|||
33326482|NCT03179891|101091189|FG000|First Intervention|Unspecified reason|1|||
33326483|NCT03179891|101091190|FG001|First Intervention|Unspecified reason|0|||
33516705|NCT02326298|101786594|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33516706|NCT02326298|101786595|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33516707|NCT02326298|101786596|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33516708|NCT02326298|101786597|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33516709|NCT02326298|101786598|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33516710|NCT02326298|101786599|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33326484|NCT03179891|101091189|FG000|First Intervention|Protocol Violation|0|||
33326485|NCT03179891|101091190|FG001|First Intervention|Protocol Violation|1|||
33326486|NCT00766090|101091192|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33326487|NCT00766090|101091193|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33326488|NCT00766090|101091194|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33326489|NCT00766090|101091195|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33326490|NCT00766090|101091196|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33400028|NCT01060150|101350365|FG000|Overall Study|Enrolled, but not treated|2|||
33400029|NCT01775995|101350366|FG000|Overall Study|Lost to Follow-up|1|||
33400030|NCT01775995|101350367|FG001|Overall Study|Lost to Follow-up|1|||
33400031|NCT01108263|101350370|FG000|Overall Study|Adverse Event|0|||
33516711|NCT02326298|101786586|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33516712|NCT02326298|101786587|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33516713|NCT02326298|101786588|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
33516714|NCT02326298|101786589|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33516715|NCT02326298|101786590|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33516716|NCT02326298|101786591|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33516717|NCT02326298|101786592|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33516718|NCT02326298|101786593|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33516719|NCT02326298|101786594|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33516720|NCT02326298|101786595|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33516721|NCT02326298|101786596|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33516722|NCT02326298|101786597|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33516723|NCT02326298|101786598|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33516724|NCT02326298|101786599|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
33516725|NCT02326298|101786586|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33516726|NCT02326298|101786587|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33516727|NCT02326298|101786588|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33516728|NCT02326298|101786589|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33516729|NCT02326298|101786590|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33516730|NCT02326298|101786591|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33516731|NCT02326298|101786592|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
33516732|NCT02326298|101786593|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33516733|NCT02326298|101786594|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33516734|NCT02326298|101786595|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33516735|NCT02326298|101786596|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33516736|NCT02326298|101786597|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33516737|NCT02326298|101786598|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33516738|NCT02326298|101786599|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33516739|NCT02326298|101786586|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33516740|NCT02326298|101786587|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33516741|NCT02326298|101786588|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33516742|NCT02326298|101786589|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33199727|NCT01923181|100633905|FG005|Overall Study|Withdrawal by Subject|2|||
33326491|NCT00766090|101091197|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33326492|NCT00766090|101091198|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33326493|NCT00766090|101091199|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33326494|NCT00766090|101091200|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
33326495|NCT00766090|101091201|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33326496|NCT00766090|101091202|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33326497|NCT00766090|101091203|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33516743|NCT02326298|101786590|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33516744|NCT02326298|101786591|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
33516745|NCT02326298|101786592|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
33516746|NCT02326298|101786593|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33516747|NCT02326298|101786594|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
33516748|NCT02326298|101786595|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33516749|NCT02326298|101786596|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33516750|NCT02326298|101786597|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33516751|NCT02326298|101786598|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33516752|NCT02326298|101786599|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
33516753|NCT02326298|101786586|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33516754|NCT02326298|101786587|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33516755|NCT02326298|101786588|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33516756|NCT02326298|101786589|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33516757|NCT02326298|101786590|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33516758|NCT02326298|101786591|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
33516759|NCT02326298|101786592|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33516760|NCT02326298|101786593|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33516761|NCT02326298|101786594|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33516762|NCT02326298|101786595|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33516763|NCT02326298|101786596|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33516764|NCT02326298|101786597|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33516765|NCT02326298|101786598|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33516766|NCT02326298|101786599|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
33516767|NCT02326298|101786586|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33516768|NCT02326298|101786587|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33516769|NCT02326298|101786588|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33516770|NCT02326298|101786589|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33516771|NCT02326298|101786590|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33516772|NCT02326298|101786591|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33516773|NCT02326298|101786592|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
33516774|NCT02326298|101786593|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33516775|NCT02326298|101786594|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33516776|NCT02326298|101786595|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33516777|NCT02326298|101786596|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33516778|NCT02326298|101786597|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33516779|NCT02326298|101786598|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33516780|NCT02326298|101786599|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33516781|NCT02326298|101786586|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33326498|NCT00766090|101091192|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
33326499|NCT00766090|101091193|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33326500|NCT00766090|101091194|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33326501|NCT00766090|101091195|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33326502|NCT00766090|101091196|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33326503|NCT00766090|101091197|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33326504|NCT00766090|101091198|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33326505|NCT00766090|101091199|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33516782|NCT02326298|101786587|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33516783|NCT02326298|101786588|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33516784|NCT02326298|101786589|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33326506|NCT00766090|101091200|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33326507|NCT00766090|101091201|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33326508|NCT00766090|101091202|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33326509|NCT00766090|101091203|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
33516785|NCT02326298|101786590|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33516786|NCT02326298|101786591|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33516787|NCT02326298|101786592|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33516788|NCT02326298|101786593|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
33516789|NCT02326298|101786594|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33516790|NCT02326298|101786595|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33516791|NCT02326298|101786596|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33516792|NCT02326298|101786597|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33516793|NCT02326298|101786598|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33516794|NCT02326298|101786599|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
33516795|NCT02326298|101786586|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33516796|NCT02326298|101786587|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33516797|NCT02326298|101786588|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33516798|NCT02326298|101786589|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33516799|NCT02326298|101786590|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33516800|NCT02326298|101786591|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33516801|NCT02326298|101786592|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
33516802|NCT02326298|101786593|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
33516803|NCT02326298|101786594|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33516804|NCT02326298|101786595|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33516805|NCT02326298|101786596|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33516806|NCT02326298|101786597|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33516807|NCT02326298|101786598|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33199728|NCT01923181|100633906|FG006|Overall Study|Withdrawal by Subject|4|||
33199729|NCT01923181|100633907|FG007|Overall Study|Withdrawal by Subject|3|||
33199730|NCT01923181|100633908|FG008|Overall Study|Withdrawal by Subject|1|||
33199731|NCT01923181|100633900|FG000|Overall Study|Other|1|||
33199732|NCT01923181|100633901|FG001|Overall Study|Other|0|||
33199733|NCT01923181|100633902|FG002|Overall Study|Other|0|||
33199734|NCT01923181|100633903|FG003|Overall Study|Other|1|||
33199735|NCT01923181|100633904|FG004|Overall Study|Other|0|||
33199736|NCT01923181|100633905|FG005|Overall Study|Other|0|||
33199737|NCT01923181|100633906|FG006|Overall Study|Other|0|||
33199738|NCT01923181|100633907|FG007|Overall Study|Other|0|||
33199739|NCT01923181|100633908|FG008|Overall Study|Other|0|||
33199740|NCT01923181|100633900|FG000|Overall Study|Lost to Follow-up|0|||
33199741|NCT01923181|100633901|FG001|Overall Study|Lost to Follow-up|3|||
33199742|NCT01923181|100633902|FG002|Overall Study|Lost to Follow-up|2|||
33199743|NCT01923181|100633903|FG003|Overall Study|Lost to Follow-up|1|||
33199744|NCT01923181|100633904|FG004|Overall Study|Lost to Follow-up|2|||
33199745|NCT01923181|100633905|FG005|Overall Study|Lost to Follow-up|1|||
33199746|NCT01923181|100633906|FG006|Overall Study|Lost to Follow-up|3|||
33199747|NCT01923181|100633907|FG007|Overall Study|Lost to Follow-up|3|||
33199748|NCT01923181|100633908|FG008|Overall Study|Lost to Follow-up|1|||
33199749|NCT01324024|100633909|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
33199750|NCT01324024|100633910|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
33199751|NCT00672477|100633911|FG000|Overall Study|Adverse Event|10|||
33199752|NCT00672477|100633912|FG001|Overall Study|Adverse Event|7|||
33199753|NCT00672477|100633911|FG000|Overall Study|Death|7|||
33199754|NCT00672477|100633912|FG001|Overall Study|Death|11|||
33199755|NCT00672477|100633911|FG000|Overall Study|Physician Decision|2|||
33199756|NCT00672477|100633912|FG001|Overall Study|Physician Decision|0|||
33199757|NCT00672477|100633911|FG000|Overall Study|Protocol Violation|1|||
33199758|NCT00672477|100633912|FG001|Overall Study|Protocol Violation|1|||
33199759|NCT00672477|100633911|FG000|Overall Study|Withdrawal by Subject|5|||
33199760|NCT00672477|100633912|FG001|Overall Study|Withdrawal by Subject|3|||
33199761|NCT00672477|100633911|FG000|Overall Study|Lack of Efficacy|1|||
33516808|NCT02326298|101786599|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33199762|NCT00672477|100633912|FG001|Overall Study|Lack of Efficacy|1|||
33199763|NCT00672477|100633911|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
33516809|NCT02326298|101786586|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33516810|NCT02326298|101786587|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33516811|NCT02326298|101786588|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33516812|NCT02326298|101786589|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33199764|NCT00672477|100633912|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
33199765|NCT00403546|100633913|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
33199766|NCT00403546|100633914|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
33199767|NCT00403546|100633915|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
33199768|NCT00403546|100633913|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
33199769|NCT00403546|100633914|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
33199770|NCT00403546|100633915|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
33199771|NCT00403546|100633913|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
33199772|NCT00403546|100633914|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
33199773|NCT00403546|100633915|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
33326510|NCT00766090|101091192|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
33326511|NCT00766090|101091193|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33326512|NCT00766090|101091194|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33326513|NCT00766090|101091195|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
33326514|NCT00766090|101091196|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33326515|NCT00766090|101091197|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33326516|NCT00766090|101091198|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33516813|NCT02326298|101786590|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33516814|NCT02326298|101786591|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33516815|NCT02326298|101786592|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33607606|NCT02453555|102111772|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
33607607|NCT02453555|102111773|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
33607608|NCT02453555|102111774|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
33607609|NCT02453555|102111775|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
33607610|NCT02453555|102111776|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
33607611|NCT02453555|102111777|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
33400032|NCT01108263|101350371|FG001|Overall Study|Adverse Event|1|||
33400033|NCT00281528|101350373|FG000|Overall Study|Progressive Disease|28|||
33400034|NCT00281528|101350374|FG001|Overall Study|Progressive Disease|18|||
33400035|NCT00281528|101350375|FG002|Overall Study|Progressive Disease|27|||
33400036|NCT00281528|101350373|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
33400037|NCT00281528|101350374|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
33400038|NCT00281528|101350375|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
33400039|NCT00281528|101350373|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
33400040|NCT00281528|101350374|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
33400041|NCT00281528|101350375|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
33400042|NCT00281528|101350373|FG000|Overall Study|Physician Decision|11|||
33326517|NCT00766090|101091199|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33400043|NCT00281528|101350374|FG001|Overall Study|Physician Decision|4|||
33400044|NCT00281528|101350375|FG002|Overall Study|Physician Decision|5|||
33400045|NCT00281528|101350373|FG000|Overall Study|Protocol Violation|1|||
33516816|NCT02326298|101786593|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
33516817|NCT02326298|101786594|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33400046|NCT00281528|101350374|FG001|Overall Study|Protocol Violation|0|||
33400047|NCT00281528|101350375|FG002|Overall Study|Protocol Violation|1|||
33400048|NCT00281528|101350373|FG000|Overall Study|Withdrawal by Subject|5|||
33400049|NCT00281528|101350374|FG001|Overall Study|Withdrawal by Subject|5|||
33516818|NCT02326298|101786595|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33516819|NCT02326298|101786596|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33516820|NCT02326298|101786597|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33516821|NCT02326298|101786598|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33516822|NCT02326298|101786599|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33607612|NCT02453555|102111772|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
33400050|NCT00281528|101350375|FG002|Overall Study|Withdrawal by Subject|7|||
33400051|NCT00281528|101350373|FG000|Overall Study|Other|6|||
33400052|NCT00281528|101350374|FG001|Overall Study|Other|3|||
33400053|NCT00281528|101350375|FG002|Overall Study|Other|5|||
33400054|NCT00523744|101350378|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
33400055|NCT00523744|101350378|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
33400056|NCT00523744|101350378|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
33400057|NCT00523744|101350378|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
33607613|NCT02453555|102111773|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
33607614|NCT02453555|102111774|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33607615|NCT02453555|102111775|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33607616|NCT02453555|102111776|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33607617|NCT02453555|102111777|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33607618|NCT02453555|102111772|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
33607619|NCT02453555|102111773|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
33607620|NCT02453555|102111774|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
33607621|NCT02453555|102111775|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
33607622|NCT02453555|102111776|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
33400058|NCT00523744|101350378|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
33400059|NCT00523744|101350378|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
33400060|NCT01277666|101350383|FG000|Overall Study|Adverse Event|26|||
33400061|NCT01277666|101350384|FG001|Overall Study|Adverse Event|25|||
33516823|NCT02326298|101786586|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33516824|NCT02326298|101786587|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33516825|NCT02326298|101786588|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33516826|NCT02326298|101786589|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33516827|NCT02326298|101786590|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33516828|NCT02326298|101786591|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
33516829|NCT02326298|101786592|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33516830|NCT02326298|101786593|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33516831|NCT02326298|101786594|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33516832|NCT02326298|101786595|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33516833|NCT02326298|101786596|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33516834|NCT02326298|101786597|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33516835|NCT02326298|101786598|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33516836|NCT02326298|101786599|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
33516837|NCT02326298|101786586|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
33516838|NCT02326298|101786587|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
33516839|NCT02326298|101786588|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
33516840|NCT02326298|101786589|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
33516841|NCT02326298|101786590|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
33516842|NCT02326298|101786591|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
33516843|NCT02326298|101786592|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
33516844|NCT02326298|101786593|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
33516845|NCT02326298|101786594|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
33516846|NCT02326298|101786595|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
33516847|NCT02326298|101786596|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
33516848|NCT02326298|101786597|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
33326518|NCT00766090|101091200|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33516849|NCT02326298|101786598|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
33516850|NCT02326298|101786599|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
33516851|NCT02326298|101786586|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33516852|NCT02326298|101786587|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33516853|NCT02326298|101786588|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33516854|NCT02326298|101786589|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33516855|NCT02326298|101786590|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33516856|NCT02326298|101786591|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33516857|NCT02326298|101786592|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33516858|NCT02326298|101786593|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33516859|NCT02326298|101786594|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33516860|NCT02326298|101786595|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33516861|NCT02326298|101786596|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33516862|NCT02326298|101786597|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
33516863|NCT02326298|101786598|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
33516864|NCT02326298|101786599|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33516865|NCT02326298|101786586|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33516866|NCT02326298|101786587|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33516867|NCT02326298|101786588|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33516868|NCT02326298|101786589|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33516869|NCT02326298|101786590|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33516870|NCT02326298|101786591|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33516871|NCT02326298|101786592|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33516872|NCT02326298|101786593|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33516873|NCT02326298|101786594|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33516874|NCT02326298|101786595|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33516875|NCT02326298|101786596|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33516876|NCT02326298|101786597|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
33516877|NCT02326298|101786598|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
33607623|NCT02453555|102111777|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
33516878|NCT02326298|101786599|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33516879|NCT02326298|101786586|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33516880|NCT02326298|101786587|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33516881|NCT02326298|101786588|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33516882|NCT02326298|101786589|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33516883|NCT02326298|101786590|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33516884|NCT02326298|101786591|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33516885|NCT02326298|101786592|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33516886|NCT02326298|101786593|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33516887|NCT02326298|101786594|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33516888|NCT02326298|101786595|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33516889|NCT02326298|101786596|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33516890|NCT02326298|101786597|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33516891|NCT02326298|101786598|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33516892|NCT02326298|101786599|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
33516893|NCT02326298|101786586|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33516894|NCT02326298|101786587|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33516895|NCT02326298|101786588|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33516896|NCT02326298|101786589|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33516897|NCT02326298|101786590|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33516898|NCT02326298|101786591|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33516899|NCT02326298|101786592|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33516900|NCT02326298|101786593|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33516901|NCT02326298|101786594|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33607624|NCT02453555|102111772|FG000|Extension Period|Adverse Event|0|||
33607625|NCT02453555|102111773|FG001|Extension Period|Adverse Event|0|||
33607626|NCT02453555|102111774|FG002|Extension Period|Adverse Event|1|||
33607627|NCT02453555|102111775|FG003|Extension Period|Adverse Event|2|||
33607628|NCT02453555|102111776|FG004|Extension Period|Adverse Event|1|||
33607629|NCT02453555|102111777|FG005|Extension Period|Adverse Event|1|||
33607630|NCT02453555|102111772|FG000|Extension Period|Protocol Violation|0|||
33607631|NCT02453555|102111773|FG001|Extension Period|Protocol Violation|0|||
33607632|NCT02453555|102111774|FG002|Extension Period|Protocol Violation|1|||
33607633|NCT02453555|102111775|FG003|Extension Period|Protocol Violation|0|||
33607634|NCT02453555|102111776|FG004|Extension Period|Protocol Violation|0|||
33607635|NCT02453555|102111777|FG005|Extension Period|Protocol Violation|0|||
33607636|NCT02453555|102111772|FG000|Extension Period|Withdrawal by Subject|0|||
33607637|NCT02453555|102111773|FG001|Extension Period|Withdrawal by Subject|0|||
33607638|NCT02453555|102111774|FG002|Extension Period|Withdrawal by Subject|1|||
33607639|NCT02453555|102111775|FG003|Extension Period|Withdrawal by Subject|0|||
33607640|NCT02453555|102111776|FG004|Extension Period|Withdrawal by Subject|0|||
33607641|NCT02453555|102111777|FG005|Extension Period|Withdrawal by Subject|0|||
33607642|NCT03626545|102111778|FG000|Overall Study|Progressive disease|3|||
33607643|NCT03626545|102111779|FG001|Overall Study|Progressive disease|82|||
33607644|NCT03626545|102111780|FG002|Overall Study|Progressive disease|85|||
33607645|NCT03626545|102111778|FG000|Overall Study|Adverse Event|3|||
33607646|NCT03626545|102111779|FG001|Overall Study|Adverse Event|13|||
33607647|NCT03626545|102111780|FG002|Overall Study|Adverse Event|10|||
33607648|NCT03626545|102111778|FG000|Overall Study|Physician Decision|1|||
33607649|NCT03626545|102111779|FG001|Overall Study|Physician Decision|18|||
33607650|NCT03626545|102111780|FG002|Overall Study|Physician Decision|14|||
33607651|NCT03626545|102111778|FG000|Overall Study|Subject Decision|0|||
33199774|NCT00403546|100633913|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
33199775|NCT00403546|100633914|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
33199776|NCT00403546|100633915|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
33199777|NCT00403546|100633913|FG000|Screening Phase|Screening Failure|22|||
33199778|NCT00403546|100633914|FG001|Screening Phase|Screening Failure|0|||
33199779|NCT00403546|100633915|FG002|Screening Phase|Screening Failure|0|||
33199780|NCT00403546|100633913|FG000|Screening Phase|Adverse Event|1|||
33199781|NCT00403546|100633914|FG001|Screening Phase|Adverse Event|0|||
33199782|NCT00403546|100633915|FG002|Screening Phase|Adverse Event|0|||
33199783|NCT00403546|100633913|FG000|Screening Phase|Terminated Prior to Randomization|5|||
33199784|NCT00403546|100633914|FG001|Screening Phase|Terminated Prior to Randomization|0|||
33199785|NCT00403546|100633915|FG002|Screening Phase|Terminated Prior to Randomization|0|||
33199786|NCT00403546|100633913|FG000|Randomized Trial|Early Terminations|0|||
33199787|NCT00403546|100633914|FG001|Randomized Trial|Early Terminations|17|||
33199788|NCT00403546|100633915|FG002|Randomized Trial|Early Terminations|16|||
33516902|NCT02326298|101786595|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33516903|NCT02326298|101786596|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33516904|NCT02326298|101786597|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
33516905|NCT02326298|101786598|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
33199789|NCT00097591|100633916|FG000|Overall Study|Withdrawal of consent|342|||
33199790|NCT00097591|100633917|FG001|Overall Study|Withdrawal of consent|323|||
33199791|NCT00097591|100633916|FG000|Overall Study|Less than 6 months on study drug|9|||
33199792|NCT00097591|100633917|FG001|Overall Study|Less than 6 months on study drug|7|||
33199793|NCT00097591|100633916|FG000|Overall Study|Unable to attend termination visit|53|||
33199794|NCT00097591|100633917|FG001|Overall Study|Unable to attend termination visit|51|||
33199795|NCT00097591|100633916|FG000|Overall Study|Lost to follow up|6|||
33199796|NCT00097591|100633917|FG001|Overall Study|Lost to follow up|10|||
33199797|NCT00097591|100633916|FG000|Overall Study|Other|0|||
33199798|NCT00097591|100633917|FG001|Overall Study|Other|3|||
33199799|NCT02170727|100633919|FG000|Overall Study|Lost to Follow-up|1|||
33199800|NCT02170727|100633920|FG001|Overall Study|Lost to Follow-up|0|||
33199801|NCT02170727|100633919|FG000|Overall Study|Withdrawal by Subject|2|||
33199802|NCT02170727|100633920|FG001|Overall Study|Withdrawal by Subject|0|||
33199803|NCT01591681|100633926|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
33199804|NCT01591681|100633926|FG000|Overall Study|Failed to use system during run-in|1|||
33199805|NCT02207829|100633929|FG000|Overall Study|Adverse Event|10|||
33199806|NCT02207829|100633930|FG001|Overall Study|Adverse Event|9|||
33199807|NCT02207829|100633929|FG000|Overall Study|Lack of Efficacy|7|||
33199808|NCT02207829|100633930|FG001|Overall Study|Lack of Efficacy|5|||
33199809|NCT02207829|100633929|FG000|Overall Study|Lost to Follow-up|2|||
33516906|NCT02326298|101786599|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
33516907|NCT02326298|101786586|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33199810|NCT02207829|100633930|FG001|Overall Study|Lost to Follow-up|2|||
33199811|NCT02207829|100633929|FG000|Overall Study|Protocol deviation|5|||
33199812|NCT02207829|100633930|FG001|Overall Study|Protocol deviation|4|||
33199813|NCT02207829|100633929|FG000|Overall Study|Withdrew consent|18|||
33199814|NCT02207829|100633930|FG001|Overall Study|Withdrew consent|14|||
33199815|NCT03231371|100633938|FG000|Overall Study|Withdrawal by Subject|1|||
33199816|NCT03231371|100633938|FG000|Overall Study|chose or were ineligible to have MRI|12|||
33199817|NCT01794949|100633939|FG000|Overall Study|Lost to Follow-up|1|||
33199818|NCT01794949|100633940|FG001|Overall Study|Lost to Follow-up|0|||
33199819|NCT02647359|100633941|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
33199820|NCT02647359|100633942|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
33199821|NCT02647359|100633941|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
33199822|NCT02647359|100633942|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
33199823|NCT02647359|100633941|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
33199824|NCT02647359|100633942|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
33199825|NCT02647359|100633941|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
33199826|NCT02647359|100633942|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
33199827|NCT02647359|100633941|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
33199828|NCT02647359|100633942|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
33199829|NCT02647359|100633941|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
33199830|NCT02647359|100633942|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
33199831|NCT01602315|100633943|FG000|Overall Study|Protocol Violation|0|||
33199832|NCT01602315|100633944|FG001|Overall Study|Protocol Violation|0|||
33516908|NCT02326298|101786587|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33516909|NCT02326298|101786588|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33516910|NCT02326298|101786589|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33199833|NCT01602315|100633945|FG002|Overall Study|Protocol Violation|0|||
33607652|NCT03626545|102111779|FG001|Overall Study|Subject Decision|5|||
33199834|NCT01602315|100633946|FG003|Overall Study|Protocol Violation|0|||
33326519|NCT00766090|101091201|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33199835|NCT01602315|100633947|FG004|Overall Study|Protocol Violation|0|||
33199836|NCT01602315|100633948|FG005|Overall Study|Protocol Violation|1|||
33199837|NCT01602315|100633949|FG006|Overall Study|Protocol Violation|0|||
33199838|NCT01602315|100633943|FG000|Overall Study|Physician Decision|2|||
33199839|NCT01602315|100633944|FG001|Overall Study|Physician Decision|0|||
33516911|NCT02326298|101786590|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33607653|NCT03626545|102111780|FG002|Overall Study|Subject Decision|5|||
33607654|NCT03626545|102111778|FG000|Overall Study|Death|1|||
33607655|NCT03626545|102111779|FG001|Overall Study|Death|1|||
33607656|NCT03626545|102111780|FG002|Overall Study|Death|1|||
33607657|NCT03626545|102111778|FG000|Overall Study|Protocol Deviation|0|||
33607658|NCT03626545|102111779|FG001|Overall Study|Protocol Deviation|1|||
33607659|NCT03626545|102111780|FG002|Overall Study|Protocol Deviation|1|||
33607660|NCT03626545|102111778|FG000|Overall Study|Guardian Decision|0|||
33607661|NCT03626545|102111779|FG001|Overall Study|Guardian Decision|0|||
33607662|NCT03626545|102111780|FG002|Overall Study|Guardian Decision|1|||
33607663|NCT03927404|102111781|FG000|Overall Study|Withdrawal by Subject|1|||
33607664|NCT02516228|102111782|FG000|Overall Study|Lost to Follow-up|1|||
33607665|NCT02516228|102111782|FG000|Overall Study|Withdrawal by Subject|1|||
33607666|NCT02516228|102111782|FG000|Overall Study|Physician Decision|1|||
33607667|NCT02032407|102114849|FG000|Overall Study|Lost to Follow-up|2|||
33607668|NCT02032407|102114849|FG000|Overall Study|Pregnancy|1|||
33607669|NCT02032407|102114849|FG000|Overall Study|Other Miscellaneous Reasons|2|||
33607670|NCT00752726|102114850|FG000|Overall Study|Lost to Follow-up|2|||
33199840|NCT01602315|100633945|FG002|Overall Study|Physician Decision|0|||
33326520|NCT00766090|101091202|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33516912|NCT02326298|101786591|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33516913|NCT02326298|101786592|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33516914|NCT02326298|101786593|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33516915|NCT02326298|101786594|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33516916|NCT02326298|101786595|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33516917|NCT02326298|101786596|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33516918|NCT02326298|101786597|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
33516919|NCT02326298|101786598|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
33516920|NCT02326298|101786599|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
33516921|NCT02326298|101786586|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33516922|NCT02326298|101786587|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33516923|NCT02326298|101786588|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33516924|NCT02326298|101786589|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33516925|NCT02326298|101786590|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33516926|NCT02326298|101786591|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33516927|NCT02326298|101786592|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33516928|NCT02326298|101786593|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33516929|NCT02326298|101786594|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33516930|NCT02326298|101786595|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33516931|NCT02326298|101786596|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33516932|NCT02326298|101786597|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
33516933|NCT02326298|101786598|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
33516934|NCT02326298|101786599|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
33516935|NCT04601103|101786601|FG000|Overall Study|Needed crown & cleaning|0|||
33516936|NCT04601103|101786602|FG001|Overall Study|Needed crown & cleaning|0|||
33516937|NCT04601103|101786603|FG002|Overall Study|Needed crown & cleaning|1|||
33516938|NCT04601103|101786601|FG000|Overall Study|study was terminated|18|||
33516939|NCT04601103|101786602|FG001|Overall Study|study was terminated|18|||
33516940|NCT04601103|101786603|FG002|Overall Study|study was terminated|16|||
33516941|NCT01211483|101786608|FG000|Phase 1b|Death|6|||
33516942|NCT01211483|101786609|FG001|Phase 1b|Death|0|||
33516943|NCT01211483|101786610|FG002|Phase 1b|Death|0|||
33516944|NCT01211483|101786611|FG003|Phase 1b|Death|0|||
33516945|NCT01211483|101786608|FG000|Phase 1b|Withdrawal by Subject|1|||
33516946|NCT01211483|101786609|FG001|Phase 1b|Withdrawal by Subject|0|||
33516947|NCT01211483|101786610|FG002|Phase 1b|Withdrawal by Subject|0|||
33516948|NCT01211483|101786611|FG003|Phase 1b|Withdrawal by Subject|0|||
33516949|NCT01211483|101786608|FG000|Phase 2|Lost to Follow-up|0|||
33516950|NCT01211483|101786609|FG001|Phase 2|Lost to Follow-up|1|||
33607671|NCT00752726|102114851|FG001|Overall Study|Lost to Follow-up|1|||
33607672|NCT00752726|102114850|FG000|Overall Study|Adverse Event|3|||
33607673|NCT00752726|102114851|FG001|Overall Study|Adverse Event|0|||
33199841|NCT01602315|100633946|FG003|Overall Study|Physician Decision|0|||
33516951|NCT01211483|101786610|FG002|Phase 2|Lost to Follow-up|1|||
33516952|NCT01211483|101786611|FG003|Phase 2|Lost to Follow-up|2|||
33516953|NCT01211483|101786608|FG000|Phase 2|Death|0|||
33516954|NCT01211483|101786609|FG001|Phase 2|Death|64|||
33516955|NCT01211483|101786610|FG002|Phase 2|Death|53|||
33607674|NCT00752726|102114850|FG000|Overall Study|Withdrawal by Subject|5|||
33607675|NCT00752726|102114851|FG001|Overall Study|Withdrawal by Subject|10|||
33607676|NCT00752726|102114850|FG000|Overall Study|Other Reason|1|||
33607677|NCT00752726|102114851|FG001|Overall Study|Other Reason|2|||
33607678|NCT01229449|102114854|FG000|Overall Study|Withdrawal by Subject|0|||
33607679|NCT01229449|102114855|FG001|Overall Study|Withdrawal by Subject|3|||
33607680|NCT01229449|102114856|FG002|Overall Study|Withdrawal by Subject|0|||
33607681|NCT01229449|102114857|FG003|Overall Study|Withdrawal by Subject|1|||
33607682|NCT01229449|102114858|FG004|Overall Study|Withdrawal by Subject|1|||
33607683|NCT01229449|102114854|FG000|Overall Study|Lost to Follow-up|1|||
33607684|NCT01229449|102114855|FG001|Overall Study|Lost to Follow-up|1|||
33607685|NCT01229449|102114856|FG002|Overall Study|Lost to Follow-up|1|||
33607686|NCT01229449|102114857|FG003|Overall Study|Lost to Follow-up|0|||
33607687|NCT01229449|102114858|FG004|Overall Study|Lost to Follow-up|0|||
33607688|NCT01229449|102114854|FG000|Overall Study|Physician Decision|0|||
33607689|NCT01229449|102114855|FG001|Overall Study|Physician Decision|0|||
33607690|NCT01229449|102114856|FG002|Overall Study|Physician Decision|1|||
33607691|NCT01229449|102114857|FG003|Overall Study|Physician Decision|0|||
33607692|NCT01229449|102114858|FG004|Overall Study|Physician Decision|0|||
33607693|NCT01620528|102114860|FG000|Treatment Period|Did Not Receive Study Drug|0|||
33199842|NCT01602315|100633947|FG004|Overall Study|Physician Decision|2|||
33199843|NCT01602315|100633948|FG005|Overall Study|Physician Decision|1|||
33199844|NCT01602315|100633949|FG006|Overall Study|Physician Decision|1|||
33516956|NCT01211483|101786611|FG003|Phase 2|Death|53|||
33516957|NCT01211483|101786608|FG000|Phase 2|Withdrawal by Subject|0|||
33516958|NCT01211483|101786609|FG001|Phase 2|Withdrawal by Subject|1|||
33516959|NCT01211483|101786610|FG002|Phase 2|Withdrawal by Subject|10|||
33516960|NCT01211483|101786611|FG003|Phase 2|Withdrawal by Subject|5|||
33516961|NCT01211483|101786608|FG000|Phase 2|Study terminated by Sponsor|0|||
33516962|NCT01211483|101786609|FG001|Phase 2|Study terminated by Sponsor|6|||
33516963|NCT01211483|101786610|FG002|Phase 2|Study terminated by Sponsor|8|||
33199845|NCT01602315|100633943|FG000|Overall Study|Disease progression|6|||
33199846|NCT01602315|100633944|FG001|Overall Study|Disease progression|3|||
33199847|NCT01602315|100633945|FG002|Overall Study|Disease progression|10|||
33199848|NCT01602315|100633946|FG003|Overall Study|Disease progression|1|||
33199849|NCT01602315|100633947|FG004|Overall Study|Disease progression|41|||
33199850|NCT01602315|100633948|FG005|Overall Study|Disease progression|12|||
33199851|NCT01602315|100633949|FG006|Overall Study|Disease progression|15|||
33199852|NCT01602315|100633943|FG000|Overall Study|Death|1|||
33199853|NCT01602315|100633944|FG001|Overall Study|Death|1|||
33199854|NCT01602315|100633945|FG002|Overall Study|Death|1|||
33199855|NCT01602315|100633946|FG003|Overall Study|Death|1|||
33199856|NCT01602315|100633947|FG004|Overall Study|Death|7|||
33199857|NCT01602315|100633948|FG005|Overall Study|Death|2|||
33516964|NCT01211483|101786611|FG003|Phase 2|Study terminated by Sponsor|11|||
33516965|NCT00948506|101786612|FG000|Overall Study|Withdrawal by Subject|3|||
33516966|NCT00948506|101786613|FG001|Overall Study|Withdrawal by Subject|1|||
33516967|NCT02306694|101786614|FG000|Overall Study|Withdrawal by Subject|3|||
33607694|NCT01620528|102114861|FG001|Treatment Period|Did Not Receive Study Drug|0|||
33607695|NCT01620528|102114862|FG002|Treatment Period|Did Not Receive Study Drug|1|||
33607696|NCT01620528|102114860|FG000|Treatment Period|Withdrawal by Subject|35|||
33607697|NCT01620528|102114861|FG001|Treatment Period|Withdrawal by Subject|21|||
33607698|NCT01620528|102114862|FG002|Treatment Period|Withdrawal by Subject|16|||
33199858|NCT01602315|100633949|FG006|Overall Study|Death|2|||
33516968|NCT02306694|101786614|FG000|Overall Study|Lost to Follow-up|1|||
33199859|NCT01602315|100633943|FG000|Overall Study|Withdrawal by Subject|2|||
33199860|NCT01602315|100633944|FG001|Overall Study|Withdrawal by Subject|0|||
33607699|NCT01620528|102114860|FG000|Treatment Period|Adverse Event|17|||
33607700|NCT01620528|102114861|FG001|Treatment Period|Adverse Event|13|||
33607701|NCT01620528|102114862|FG002|Treatment Period|Adverse Event|21|||
33607702|NCT01620528|102114860|FG000|Treatment Period|Lost to Follow-up|16|||
33199861|NCT01602315|100633945|FG002|Overall Study|Withdrawal by Subject|2|||
33199862|NCT01602315|100633946|FG003|Overall Study|Withdrawal by Subject|0|||
33199863|NCT01602315|100633947|FG004|Overall Study|Withdrawal by Subject|6|||
33199864|NCT01602315|100633948|FG005|Overall Study|Withdrawal by Subject|0|||
33199865|NCT01602315|100633949|FG006|Overall Study|Withdrawal by Subject|1|||
33199866|NCT01602315|100633943|FG000|Overall Study|Adverse Event|5|||
33199867|NCT01602315|100633944|FG001|Overall Study|Adverse Event|1|||
33199868|NCT01602315|100633945|FG002|Overall Study|Adverse Event|5|||
33199869|NCT01602315|100633946|FG003|Overall Study|Adverse Event|4|||
33199870|NCT01602315|100633947|FG004|Overall Study|Adverse Event|15|||
33199871|NCT01602315|100633948|FG005|Overall Study|Adverse Event|3|||
33199872|NCT01602315|100633949|FG006|Overall Study|Adverse Event|9|||
33199873|NCT01602315|100633943|FG000|Overall Study|Subject/guardian decision|0|||
33199874|NCT01602315|100633944|FG001|Overall Study|Subject/guardian decision|0|||
33199875|NCT01602315|100633945|FG002|Overall Study|Subject/guardian decision|0|||
33199876|NCT01602315|100633946|FG003|Overall Study|Subject/guardian decision|0|||
33199877|NCT01602315|100633947|FG004|Overall Study|Subject/guardian decision|0|||
33199878|NCT01602315|100633948|FG005|Overall Study|Subject/guardian decision|0|||
33199879|NCT01602315|100633949|FG006|Overall Study|Subject/guardian decision|1|||
33199880|NCT01602315|100633943|FG000|Overall Study|Cross-over patients to combo treatment|0|||
33199881|NCT01602315|100633944|FG001|Overall Study|Cross-over patients to combo treatment|0|||
33199882|NCT01602315|100633945|FG002|Overall Study|Cross-over patients to combo treatment|0|||
33199883|NCT01602315|100633946|FG003|Overall Study|Cross-over patients to combo treatment|0|||
33199884|NCT01602315|100633947|FG004|Overall Study|Cross-over patients to combo treatment|0|||
33199885|NCT01602315|100633948|FG005|Overall Study|Cross-over patients to combo treatment|16|||
33326521|NCT00766090|101091203|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33326522|NCT00766090|101091192|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
33326523|NCT00766090|101091193|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
33516969|NCT04984681|101786615|FG000|Overall Study|Lost to Follow-up|3|||
33516970|NCT04984681|101786616|FG001|Overall Study|Lost to Follow-up|1|||
33326524|NCT00766090|101091194|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
33326525|NCT00766090|101091195|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
33326526|NCT00766090|101091196|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
33516971|NCT02258334|101786617|FG000|Overall Study|Adverse Event|1|||
33516972|NCT02258334|101786618|FG001|Overall Study|Adverse Event|0|||
33516973|NCT02258334|101786619|FG002|Overall Study|Adverse Event|0|||
33516974|NCT02258334|101786620|FG003|Overall Study|Adverse Event|0|||
33516975|NCT00503997|101786622|FG000|Overall Study|disease progression|1|||
33516976|NCT00503997|101786622|FG000|Overall Study|Adverse Event|5|||
33516977|NCT00503997|101786622|FG000|Overall Study|Death|1|||
33516978|NCT00503997|101786622|FG000|Overall Study|Withdrawal by Subject|1|||
33516979|NCT02906033|101786623|FG000|Baseline|Protocol Violation|37|||
33516980|NCT02906033|101786624|FG001|Baseline|Protocol Violation|33|||
33516981|NCT02906033|101786623|FG000|Follow-up|Lost to Follow-up|46|||
33516982|NCT02906033|101786624|FG001|Follow-up|Lost to Follow-up|62|||
33516983|NCT02505334|101786627|FG000|Main Treatment Period|Adverse Event|3|||
33326527|NCT00766090|101091197|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
33326528|NCT00766090|101091198|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
33326529|NCT00766090|101091199|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
33326530|NCT00766090|101091200|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
33326531|NCT00766090|101091201|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
33326532|NCT00766090|101091202|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
33326533|NCT00766090|101091203|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
33326534|NCT00766090|101091192|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33326535|NCT00766090|101091193|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33326536|NCT00766090|101091194|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33516984|NCT02505334|101786628|FG001|Main Treatment Period|Adverse Event|3|||
33516985|NCT02505334|101786627|FG000|Main Treatment Period|Lack of Efficacy|7|||
33516986|NCT02505334|101786628|FG001|Main Treatment Period|Lack of Efficacy|17|||
33516987|NCT02505334|101786627|FG000|Main Treatment Period|Protocol Violation|0|||
33199886|NCT01602315|100633949|FG006|Overall Study|Cross-over patients to combo treatment|0|||
33199887|NCT00767000|100638141|FG000|54-week Study|Adverse Event|4|||
33199888|NCT00767000|100638142|FG001|54-week Study|Adverse Event|6|||
33326537|NCT00766090|101091195|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33516988|NCT02505334|101786628|FG001|Main Treatment Period|Protocol Violation|1|||
33516989|NCT02505334|101786627|FG000|Main Treatment Period|Withdrawal by Subject|1|||
33516990|NCT02505334|101786628|FG001|Main Treatment Period|Withdrawal by Subject|8|||
33516991|NCT02505334|101786627|FG000|Main Treatment Period|Unclassified|4|||
33516992|NCT02505334|101786628|FG001|Main Treatment Period|Unclassified|10|||
33516993|NCT02505334|101786627|FG000|Extension Treatment Period|Adverse Event|5|||
33516994|NCT02505334|101786628|FG001|Extension Treatment Period|Adverse Event|0|||
33516995|NCT02505334|101786627|FG000|Extension Treatment Period|Lack of Efficacy|4|||
33516996|NCT02505334|101786628|FG001|Extension Treatment Period|Lack of Efficacy|0|||
33516997|NCT02505334|101786627|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
33516998|NCT02505334|101786628|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
33516999|NCT02505334|101786627|FG000|Extension Treatment Period|Unclassified|3|||
33517000|NCT02505334|101786628|FG001|Extension Treatment Period|Unclassified|0|||
33517001|NCT04599933|101786629|FG000|Overall Study|Adverse Event|4|||
33517002|NCT04599933|101786630|FG001|Overall Study|Adverse Event|1|||
33517003|NCT04599933|101786629|FG000|Overall Study|Withdrawal by Subject|4|||
33517004|NCT04599933|101786630|FG001|Overall Study|Withdrawal by Subject|2|||
33517005|NCT04599933|101786629|FG000|Overall Study|Lost to Follow-up|0|||
33517006|NCT04599933|101786630|FG001|Overall Study|Lost to Follow-up|1|||
33517007|NCT04599933|101786629|FG000|Overall Study|Physician Decision|0|||
33517008|NCT04599933|101786630|FG001|Overall Study|Physician Decision|1|||
33517009|NCT04599933|101786629|FG000|Overall Study|Screen Failure|1|||
33517010|NCT04599933|101786630|FG001|Overall Study|Screen Failure|2|||
33517011|NCT01844505|101789433|FG000|Overall Study|Disease progression|170|||
33517012|NCT01844505|101789434|FG001|Overall Study|Disease progression|88|||
33517013|NCT01844505|101789435|FG002|Overall Study|Disease progression|224|||
33517014|NCT01844505|101789433|FG000|Overall Study|Study drug toxicity|40|||
33517015|NCT01844505|101789434|FG001|Overall Study|Study drug toxicity|131|||
33517016|NCT01844505|101789435|FG002|Overall Study|Study drug toxicity|50|||
33517017|NCT01844505|101789433|FG000|Overall Study|Death|1|||
33517018|NCT01844505|101789434|FG001|Overall Study|Death|3|||
33517019|NCT01844505|101789435|FG002|Overall Study|Death|1|||
33517020|NCT01844505|101789433|FG000|Overall Study|Adverse event unrelated to study drug|7|||
33517021|NCT01844505|101789434|FG001|Overall Study|Adverse event unrelated to study drug|15|||
33517022|NCT01844505|101789435|FG002|Overall Study|Adverse event unrelated to study drug|6|||
33517023|NCT01844505|101789433|FG000|Overall Study|Subject request discontinue treatment|17|||
33517024|NCT01844505|101789434|FG001|Overall Study|Subject request discontinue treatment|14|||
33517025|NCT01844505|101789435|FG002|Overall Study|Subject request discontinue treatment|8|||
33517026|NCT01844505|101789433|FG000|Overall Study|Withdrawal by Subject|0|||
33517027|NCT01844505|101789434|FG001|Overall Study|Withdrawal by Subject|3|||
33517028|NCT01844505|101789435|FG002|Overall Study|Withdrawal by Subject|0|||
33517029|NCT01844505|101789433|FG000|Overall Study|Lost to Follow-up|1|||
33517030|NCT01844505|101789434|FG001|Overall Study|Lost to Follow-up|0|||
33517031|NCT01844505|101789435|FG002|Overall Study|Lost to Follow-up|0|||
33517032|NCT01844505|101789433|FG000|Overall Study|Maximum clinical benefit|8|||
33517033|NCT01844505|101789434|FG001|Overall Study|Maximum clinical benefit|11|||
33517034|NCT01844505|101789435|FG002|Overall Study|Maximum clinical benefit|2|||
33517035|NCT01844505|101789433|FG000|Overall Study|Poor/non-compliance|1|||
33517036|NCT01844505|101789434|FG001|Overall Study|Poor/non-compliance|1|||
33517037|NCT01844505|101789435|FG002|Overall Study|Poor/non-compliance|1|||
33517038|NCT01844505|101789433|FG000|Overall Study|Subject no longer meets criteria|0|||
33517039|NCT01844505|101789434|FG001|Overall Study|Subject no longer meets criteria|1|||
33517040|NCT01844505|101789435|FG002|Overall Study|Subject no longer meets criteria|0|||
33517041|NCT01844505|101789433|FG000|Overall Study|Other Reasons|4|||
33517042|NCT01844505|101789434|FG001|Overall Study|Other Reasons|2|||
33517043|NCT01844505|101789435|FG002|Overall Study|Other Reasons|2|||
33517044|NCT01844505|101789433|FG000|Overall Study|Not Reported|0|||
33517045|NCT01844505|101789434|FG001|Overall Study|Not Reported|0|||
33517046|NCT01844505|101789435|FG002|Overall Study|Not Reported|1|||
33517047|NCT00866333|101789436|FG000|Overall Study|Withdrawal of consent|0|||
33517048|NCT00866333|101789437|FG001|Overall Study|Withdrawal of consent|1|||
33517049|NCT00866333|101789438|FG002|Overall Study|Withdrawal of consent|2|||
33517050|NCT00866333|101789436|FG000|Overall Study|Reason not Specified|3|||
33517051|NCT00866333|101789437|FG001|Overall Study|Reason not Specified|1|||
33199889|NCT00767000|100638143|FG002|54-week Study|Adverse Event|6|||
33517052|NCT00866333|101789438|FG002|Overall Study|Reason not Specified|1|||
33517053|NCT00866333|101789436|FG000|Overall Study|Study Terminated by Sponsor|2|||
33517054|NCT00866333|101789437|FG001|Overall Study|Study Terminated by Sponsor|5|||
33517055|NCT00866333|101789438|FG002|Overall Study|Study Terminated by Sponsor|9|||
33517056|NCT01143064|101789447|FG000|Overall Study|Death|109|||
33517057|NCT01143064|101789448|FG001|Overall Study|Death|91|||
33199890|NCT00767000|100638144|FG003|54-week Study|Adverse Event|8|||
33517058|NCT01143064|101789447|FG000|Overall Study|Adverse Event|0|||
33517059|NCT01143064|101789448|FG001|Overall Study|Adverse Event|1|||
33199891|NCT00767000|100638145|FG004|54-week Study|Adverse Event|4|||
33517060|NCT01143064|101789447|FG000|Overall Study|Withdrawal by Subject|7|||
33517061|NCT01143064|101789448|FG001|Overall Study|Withdrawal by Subject|5|||
33607703|NCT01620528|102114861|FG001|Treatment Period|Lost to Follow-up|8|||
33607704|NCT01620528|102114862|FG002|Treatment Period|Lost to Follow-up|14|||
33607705|NCT01620528|102114860|FG000|Treatment Period|Other|9|||
33607706|NCT01620528|102114861|FG001|Treatment Period|Other|5|||
33607707|NCT01620528|102114862|FG002|Treatment Period|Other|7|||
33607708|NCT01620528|102114860|FG000|Treatment Period|Subject Noncompliant|11|||
33607709|NCT01620528|102114861|FG001|Treatment Period|Subject Noncompliant|2|||
33607710|NCT01620528|102114862|FG002|Treatment Period|Subject Noncompliant|2|||
33607711|NCT01620528|102114860|FG000|Treatment Period|Pregnancy|7|||
33607712|NCT01620528|102114861|FG001|Treatment Period|Pregnancy|2|||
33607713|NCT01620528|102114862|FG002|Treatment Period|Pregnancy|2|||
33607714|NCT01620528|102114860|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
33607715|NCT01620528|102114861|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
33607716|NCT01620528|102114862|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
33400062|NCT01277666|101350385|FG002|Overall Study|Adverse Event|20|||
33400063|NCT01277666|101350383|FG000|Overall Study|Lack of Efficacy|8|||
33400064|NCT01277666|101350384|FG001|Overall Study|Lack of Efficacy|20|||
33400065|NCT01277666|101350385|FG002|Overall Study|Lack of Efficacy|12|||
33400066|NCT01277666|101350383|FG000|Overall Study|Protocol Violation|2|||
33400067|NCT01277666|101350384|FG001|Overall Study|Protocol Violation|3|||
33400068|NCT01277666|101350385|FG002|Overall Study|Protocol Violation|2|||
33400069|NCT01277666|101350383|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
33400070|NCT01277666|101350384|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
33400071|NCT01277666|101350385|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
33400072|NCT01277666|101350383|FG000|Overall Study|Lost to Follow-up|1|||
33400073|NCT01277666|101350384|FG001|Overall Study|Lost to Follow-up|1|||
33607717|NCT01620528|102114860|FG000|Treatment Period|Exclusionary Medication Received|0|||
33607718|NCT01620528|102114861|FG001|Treatment Period|Exclusionary Medication Received|1|||
33326538|NCT00766090|101091196|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
33326539|NCT00766090|101091197|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33326540|NCT00766090|101091198|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33326541|NCT00766090|101091199|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33326542|NCT00766090|101091200|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33326543|NCT00766090|101091201|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33326544|NCT00766090|101091202|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33326545|NCT00766090|101091203|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33326546|NCT00766090|101091192|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33326547|NCT00766090|101091193|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33326548|NCT00766090|101091194|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
33326549|NCT00766090|101091195|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33326550|NCT00766090|101091196|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33326551|NCT00766090|101091197|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33326552|NCT00766090|101091198|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33326553|NCT00766090|101091199|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33400074|NCT01277666|101350385|FG002|Overall Study|Lost to Follow-up|2|||
33400075|NCT01277666|101350383|FG000|Overall Study|Withdrawal by Subject|7|||
33400076|NCT01277666|101350384|FG001|Overall Study|Withdrawal by Subject|8|||
33400077|NCT01277666|101350385|FG002|Overall Study|Withdrawal by Subject|6|||
33400078|NCT01277666|101350383|FG000|Overall Study|Death|0|||
33400079|NCT01277666|101350384|FG001|Overall Study|Death|0|||
33400080|NCT01277666|101350385|FG002|Overall Study|Death|1|||
33400081|NCT01542632|101350392|FG000|Overall Study|Withdrawal of Consent|0|||
33607719|NCT01620528|102114862|FG002|Treatment Period|Exclusionary Medication Received|0|||
33607720|NCT01620528|102114860|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
33607721|NCT01620528|102114861|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
33607722|NCT01620528|102114862|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
33607723|NCT01620528|102114860|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
33400082|NCT01542632|101350393|FG001|Overall Study|Withdrawal of Consent|0|||
33607724|NCT01620528|102114861|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
33607725|NCT01620528|102114862|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
33607726|NCT01620528|102114860|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
33607727|NCT01620528|102114861|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
33607728|NCT01620528|102114862|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
33607729|NCT01620528|102114860|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
33607730|NCT01620528|102114861|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
33607731|NCT01620528|102114862|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
33400083|NCT01542632|101350394|FG002|Overall Study|Withdrawal of Consent|0|||
33400084|NCT01542632|101350395|FG003|Overall Study|Withdrawal of Consent|2|||
33400085|NCT01542632|101350396|FG004|Overall Study|Withdrawal of Consent|3|||
33400086|NCT01542632|101350397|FG005|Overall Study|Withdrawal of Consent|0|||
33326554|NCT00766090|101091200|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33326555|NCT00766090|101091201|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33607732|NCT01620528|102114860|FG000|Post-Treatment Follow-Up Period|Other|6|||
33400087|NCT01542632|101350392|FG000|Overall Study|Adverse Event|0|||
33400088|NCT01542632|101350393|FG001|Overall Study|Adverse Event|0|||
33400089|NCT01542632|101350394|FG002|Overall Study|Adverse Event|1|||
33400090|NCT01542632|101350395|FG003|Overall Study|Adverse Event|0|||
33400091|NCT01542632|101350396|FG004|Overall Study|Adverse Event|0|||
33400092|NCT01542632|101350397|FG005|Overall Study|Adverse Event|0|||
33400093|NCT01542632|101350392|FG000|Overall Study|Lost to Follow-up|0|||
33400094|NCT01542632|101350393|FG001|Overall Study|Lost to Follow-up|1|||
33400095|NCT01542632|101350394|FG002|Overall Study|Lost to Follow-up|0|||
33400096|NCT01542632|101350395|FG003|Overall Study|Lost to Follow-up|0|||
33400097|NCT01542632|101350396|FG004|Overall Study|Lost to Follow-up|0|||
33400098|NCT01542632|101350397|FG005|Overall Study|Lost to Follow-up|0|||
33400099|NCT01542632|101350392|FG000|Overall Study|Sponsor/Investigator Decision|0|||
33400100|NCT01542632|101350393|FG001|Overall Study|Sponsor/Investigator Decision|0|||
33400101|NCT01542632|101350394|FG002|Overall Study|Sponsor/Investigator Decision|0|||
33400102|NCT01542632|101350395|FG003|Overall Study|Sponsor/Investigator Decision|0|||
33400103|NCT01542632|101350396|FG004|Overall Study|Sponsor/Investigator Decision|1|||
33400104|NCT01542632|101350397|FG005|Overall Study|Sponsor/Investigator Decision|0|||
33400105|NCT01526928|101350403|FG000|Overall Study|Progressive Disease|35|||
33400106|NCT01526928|101350404|FG001|Overall Study|Progressive Disease|17|||
33517062|NCT01143064|101789447|FG000|Overall Study|Lost to Follow-up|17|||
33517063|NCT01143064|101789448|FG001|Overall Study|Lost to Follow-up|14|||
33517064|NCT01143064|101789447|FG000|Overall Study|Physician Decision|0|||
33517065|NCT01143064|101789448|FG001|Overall Study|Physician Decision|4|||
33517066|NCT01904903|101789449|FG000|Overall Study|Withdrawal by Subject|1|||
33517067|NCT01195844|101789450|FG000|Overall Study|Fecal sample not collected|40|||
33517068|NCT02243046|101789453|FG000|Overall Study|Lost to Follow-up|1|||
33517069|NCT02243046|101789454|FG001|Overall Study|Lost to Follow-up|1|||
33517070|NCT02243046|101789455|FG002|Overall Study|Lost to Follow-up|4|||
33517071|NCT01876979|101789457|FG000|Overall Study|Physician Decision|2|||
33517072|NCT01876979|101789458|FG001|Overall Study|Physician Decision|3|||
33517073|NCT03515629|101789460|FG000|Overall Study|Death|0|||
33517074|NCT03515629|101789461|FG001|Overall Study|Death|1|||
33517075|NCT03515629|101789462|FG002|Overall Study|Death|1|||
33517076|NCT03515629|101789460|FG000|Overall Study|Progressive disease|0|||
33517077|NCT03515629|101789461|FG001|Overall Study|Progressive disease|1|||
33517078|NCT03515629|101789462|FG002|Overall Study|Progressive disease|0|||
33517079|NCT02294175|101789464|FG000|Overall Study|Withdrawal by Subject|1|||
33517080|NCT02294175|101789465|FG001|Overall Study|Withdrawal by Subject|2|||
33517081|NCT02294175|101789464|FG000|Overall Study|pt taking excluded medication|3|||
33517082|NCT02294175|101789465|FG001|Overall Study|pt taking excluded medication|1|||
33517083|NCT02294175|101789464|FG000|Overall Study|Protocol Violation|1|||
33517084|NCT02294175|101789465|FG001|Overall Study|Protocol Violation|0|||
33517085|NCT02294175|101789464|FG000|Overall Study|Lost to Follow-up|0|||
33517086|NCT02294175|101789465|FG001|Overall Study|Lost to Follow-up|1|||
33517087|NCT02294175|101789464|FG000|Overall Study|wound healed|0|||
33517088|NCT02294175|101789465|FG001|Overall Study|wound healed|2|||
33517089|NCT02939716|101789466|FG000|Overall Study|scanner failure|0|||
33517090|NCT02939716|101789467|FG001|Overall Study|scanner failure|0|||
33517091|NCT02939716|101789468|FG002|Overall Study|scanner failure|0|||
33517092|NCT02939716|101789469|FG003|Overall Study|scanner failure|1|||
33517093|NCT02939716|101789470|FG004|Overall Study|scanner failure|1|||
33517094|NCT02939716|101789471|FG005|Overall Study|scanner failure|1|||
33517095|NCT02073565|101789474|FG000|Cohort A|Withdrawal by Subject|1|||
33517096|NCT02073565|101789475|FG001|Cohort A|Withdrawal by Subject|0|||
33517097|NCT02073565|101789474|FG000|Cohort B|Withdrawal by Subject|1|||
33517098|NCT02073565|101789475|FG001|Cohort B|Withdrawal by Subject|2|||
33517099|NCT02073565|101789474|FG000|Cohort C|Withdrawal by Subject|0|||
33400107|NCT01526928|101350405|FG002|Overall Study|Progressive Disease|150|||
33400108|NCT01526928|101350406|FG003|Overall Study|Progressive Disease|182|||
33400109|NCT01526928|101350407|FG004|Overall Study|Progressive Disease|76|||
33400110|NCT01526928|101350408|FG005|Overall Study|Progressive Disease|4|||
33400111|NCT01526928|101350403|FG000|Overall Study|Adverse Event|2|||
33400112|NCT01526928|101350404|FG001|Overall Study|Adverse Event|1|||
33400113|NCT01526928|101350405|FG002|Overall Study|Adverse Event|29|||
33400114|NCT01526928|101350406|FG003|Overall Study|Adverse Event|40|||
33400115|NCT01526928|101350407|FG004|Overall Study|Adverse Event|13|||
33517100|NCT02073565|101789475|FG001|Cohort C|Withdrawal by Subject|2|||
33517101|NCT02073565|101789474|FG000|Cohort C|Lost to Follow-up|0|||
33517102|NCT02073565|101789475|FG001|Cohort C|Lost to Follow-up|2|||
33517103|NCT00367484|101789476|FG000|Overall Study|Adverse Event|7|||
33517104|NCT00367484|101789476|FG000|Overall Study|Withdrew informed consent|5|||
33517105|NCT00367484|101789476|FG000|Overall Study|Travel to USA|1|||
33400116|NCT01526928|101350408|FG005|Overall Study|Adverse Event|2|||
33400117|NCT01526928|101350403|FG000|Overall Study|Death|0|||
33400118|NCT01526928|101350404|FG001|Overall Study|Death|0|||
33400119|NCT01526928|101350405|FG002|Overall Study|Death|3|||
33400120|NCT01526928|101350406|FG003|Overall Study|Death|0|||
33400121|NCT01526928|101350407|FG004|Overall Study|Death|0|||
33400122|NCT01526928|101350408|FG005|Overall Study|Death|0|||
33400123|NCT01526928|101350403|FG000|Overall Study|Withdrawal by Subject|1|||
33400124|NCT01526928|101350404|FG001|Overall Study|Withdrawal by Subject|0|||
33400125|NCT01526928|101350405|FG002|Overall Study|Withdrawal by Subject|13|||
33400126|NCT01526928|101350406|FG003|Overall Study|Withdrawal by Subject|11|||
33400127|NCT01526928|101350407|FG004|Overall Study|Withdrawal by Subject|3|||
33400128|NCT01526928|101350408|FG005|Overall Study|Withdrawal by Subject|0|||
33400129|NCT01526928|101350403|FG000|Overall Study|Physician Decision|0|||
33400130|NCT01526928|101350404|FG001|Overall Study|Physician Decision|0|||
33400131|NCT01526928|101350405|FG002|Overall Study|Physician Decision|2|||
33400132|NCT01526928|101350406|FG003|Overall Study|Physician Decision|5|||
33400133|NCT01526928|101350407|FG004|Overall Study|Physician Decision|0|||
33400134|NCT01526928|101350408|FG005|Overall Study|Physician Decision|0|||
33400135|NCT01526928|101350403|FG000|Overall Study|Other Reason|0|||
33400136|NCT01526928|101350404|FG001|Overall Study|Other Reason|1|||
33400137|NCT01526928|101350405|FG002|Overall Study|Other Reason|11|||
33400138|NCT01526928|101350406|FG003|Overall Study|Other Reason|4|||
33400139|NCT01526928|101350407|FG004|Overall Study|Other Reason|1|||
33400140|NCT01526928|101350408|FG005|Overall Study|Other Reason|0|||
33400141|NCT01526928|101350403|FG000|Overall Study|Lost to Follow-up|0|||
33400142|NCT01526928|101350404|FG001|Overall Study|Lost to Follow-up|0|||
33400143|NCT01526928|101350405|FG002|Overall Study|Lost to Follow-up|0|||
33400144|NCT01526928|101350406|FG003|Overall Study|Lost to Follow-up|1|||
33400145|NCT01526928|101350407|FG004|Overall Study|Lost to Follow-up|0|||
33400146|NCT01526928|101350408|FG005|Overall Study|Lost to Follow-up|0|||
33400147|NCT01526928|101350403|FG000|Overall Study|Protocol Deviation|0|||
33400148|NCT01526928|101350404|FG001|Overall Study|Protocol Deviation|0|||
33400149|NCT01526928|101350405|FG002|Overall Study|Protocol Deviation|0|||
33400150|NCT01526928|101350406|FG003|Overall Study|Protocol Deviation|2|||
33400151|NCT01526928|101350407|FG004|Overall Study|Protocol Deviation|0|||
33400152|NCT01526928|101350408|FG005|Overall Study|Protocol Deviation|0|||
33400153|NCT01526928|101350403|FG000|Overall Study|Missing|0|||
33400154|NCT01526928|101350404|FG001|Overall Study|Missing|0|||
33400155|NCT01526928|101350405|FG002|Overall Study|Missing|1|||
33400156|NCT01526928|101350406|FG003|Overall Study|Missing|0|||
33400157|NCT01526928|101350407|FG004|Overall Study|Missing|2|||
33400158|NCT01526928|101350408|FG005|Overall Study|Missing|0|||
33400159|NCT02975206|101350409|FG000|Overall Study|Withdrawal by Subject|14|||
33400160|NCT02975206|101350410|FG001|Overall Study|Withdrawal by Subject|11|||
33400161|NCT02975206|101350411|FG002|Overall Study|Withdrawal by Subject|11|||
33400162|NCT02975206|101350409|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
33400163|NCT02975206|101350410|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
33400164|NCT02975206|101350411|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
33400165|NCT01987609|101353287|FG000|Overall Study|Adverse Event|1|||
33400166|NCT03267511|101353288|FG000|Overall Study|Lost to Follow-up|0|||
33400167|NCT03267511|101353289|FG001|Overall Study|Lost to Follow-up|0|||
33400168|NCT03267511|101353290|FG002|Overall Study|Lost to Follow-up|0|||
33400169|NCT03267511|101353291|FG003|Overall Study|Lost to Follow-up|1|||
33400170|NCT00626795|101353295|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
33400171|NCT00626795|101353296|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
33400172|NCT00626795|101353297|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
33400173|NCT00626795|101353295|FG000|Blinded Treatment|Lack of Efficacy|2|||
33400174|NCT00626795|101353296|FG001|Blinded Treatment|Lack of Efficacy|0|||
33400175|NCT00626795|101353297|FG002|Blinded Treatment|Lack of Efficacy|0|||
33400176|NCT00626795|101353295|FG000|Blinded Treatment|Unacceptable adverse event|0|||
33400177|NCT00626795|101353296|FG001|Blinded Treatment|Unacceptable adverse event|0|||
33400178|NCT00626795|101353297|FG002|Blinded Treatment|Unacceptable adverse event|1|||
33400179|NCT00626795|101353295|FG000|Blinded Treatment|Protocol Violation|0|||
33400180|NCT00626795|101353296|FG001|Blinded Treatment|Protocol Violation|1|||
33400181|NCT00626795|101353297|FG002|Blinded Treatment|Protocol Violation|1|||
33400182|NCT00626795|101353295|FG000|Blinded Treatment|Withdrawal by Subject|1|||
33400183|NCT00626795|101353296|FG001|Blinded Treatment|Withdrawal by Subject|1|||
33400184|NCT00626795|101353297|FG002|Blinded Treatment|Withdrawal by Subject|0|||
33400185|NCT00626795|101353295|FG000|Blinded Treatment|Other reasons|2|||
33400186|NCT00626795|101353296|FG001|Blinded Treatment|Other reasons|0|||
33400187|NCT00626795|101353297|FG002|Blinded Treatment|Other reasons|2|||
33400188|NCT00626795|101353295|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
33400189|NCT00626795|101353296|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
33400190|NCT00626795|101353297|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
33400191|NCT01599585|101353298|FG000|Overall Study|Withdrawal by Subject|16|||
33400192|NCT01599585|101353299|FG001|Overall Study|Withdrawal by Subject|9|||
33400193|NCT01599585|101353298|FG000|Overall Study|Lost to Follow-up|3|||
33400194|NCT01599585|101353299|FG001|Overall Study|Lost to Follow-up|5|||
33400195|NCT01599585|101353298|FG000|Overall Study|randomized did not start treatment|3|||
33400196|NCT01599585|101353299|FG001|Overall Study|randomized did not start treatment|3|||
33517106|NCT00367484|101789476|FG000|Overall Study|Lost to Follow-up|1|||
33517107|NCT00367484|101789476|FG000|Overall Study|Protocol Violation|1|||
33517108|NCT00367484|101789476|FG000|Overall Study|The choice of the patient|1|||
33517109|NCT00367484|101789476|FG000|Overall Study|Lack of Efficacy|1|||
33517110|NCT00766467|101789477|FG000|Overall Study|Withdrawal by Subject|7|||
33517111|NCT00766467|101789478|FG001|Overall Study|Withdrawal by Subject|2|||
33517112|NCT00766467|101789477|FG000|Overall Study|Adverse Event|1|||
33517113|NCT00766467|101789478|FG001|Overall Study|Adverse Event|1|||
33517114|NCT00766467|101789477|FG000|Overall Study|Protocol Violation|2|||
33607733|NCT01620528|102114861|FG001|Post-Treatment Follow-Up Period|Other|4|||
33607734|NCT01620528|102114862|FG002|Post-Treatment Follow-Up Period|Other|2|||
33400197|NCT02802735|101353300|FG000|Overall Study|Withdrawal by Subject|0|||
33400198|NCT02802735|101353301|FG001|Overall Study|Withdrawal by Subject|1|||
33400199|NCT02802735|101353302|FG002|Overall Study|Withdrawal by Subject|0|||
33400200|NCT02802735|101353303|FG003|Overall Study|Withdrawal by Subject|0|||
33400201|NCT02802735|101353304|FG004|Overall Study|Withdrawal by Subject|0|||
33400202|NCT02709889|101353305|FG000|Overall Study|Withdrawal by Subject|11|||
33400203|NCT02709889|101353306|FG001|Overall Study|Withdrawal by Subject|10|||
33400204|NCT02709889|101353307|FG002|Overall Study|Withdrawal by Subject|2|||
33400205|NCT02709889|101353308|FG003|Overall Study|Withdrawal by Subject|12|||
33400206|NCT02709889|101353305|FG000|Overall Study|Death|25|||
33400207|NCT02709889|101353306|FG001|Overall Study|Death|38|||
33400208|NCT02709889|101353307|FG002|Overall Study|Death|4|||
33400209|NCT02709889|101353308|FG003|Overall Study|Death|44|||
33400210|NCT02709889|101353305|FG000|Overall Study|Physician Decision|1|||
33400211|NCT02709889|101353306|FG001|Overall Study|Physician Decision|2|||
33400212|NCT02709889|101353307|FG002|Overall Study|Physician Decision|3|||
33400213|NCT02709889|101353308|FG003|Overall Study|Physician Decision|5|||
33400214|NCT02709889|101353305|FG000|Overall Study|Lost to Follow-up|2|||
33400215|NCT02709889|101353306|FG001|Overall Study|Lost to Follow-up|0|||
33400216|NCT02709889|101353307|FG002|Overall Study|Lost to Follow-up|0|||
33400217|NCT02709889|101353308|FG003|Overall Study|Lost to Follow-up|4|||
33400218|NCT02709889|101353305|FG000|Overall Study|Study Terminated by Sponsor|4|||
33400219|NCT02709889|101353306|FG001|Overall Study|Study Terminated by Sponsor|6|||
33400220|NCT02709889|101353307|FG002|Overall Study|Study Terminated by Sponsor|2|||
33400221|NCT02709889|101353308|FG003|Overall Study|Study Terminated by Sponsor|17|||
33400222|NCT02709889|101353305|FG000|Overall Study|Other, Not Specified|0|||
33400223|NCT02709889|101353306|FG001|Overall Study|Other, Not Specified|1|||
33400224|NCT02709889|101353307|FG002|Overall Study|Other, Not Specified|1|||
33400225|NCT02709889|101353308|FG003|Overall Study|Other, Not Specified|6|||
33400226|NCT00125268|101353309|FG000|Overall Study|Withdrawal by Subject|1|||
33400227|NCT00125268|101353310|FG001|Overall Study|Withdrawal by Subject|1|||
33400228|NCT04735432|101353316|FG000|Overall Study|Other - due to personal reason|1|||
33400229|NCT04735432|101353317|FG001|Overall Study|Other - due to personal reason|0|||
33400230|NCT04735432|101353316|FG000|Overall Study|Adverse Event|2|||
33400231|NCT04735432|101353317|FG001|Overall Study|Adverse Event|0|||
33400232|NCT01195636|101353319|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
33400233|NCT01195636|101353320|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
33400234|NCT01195636|101353319|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
33400235|NCT01195636|101353320|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
33400236|NCT01195636|101353319|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33400237|NCT01195636|101353320|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
33400238|NCT01195636|101353319|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
33400239|NCT01195636|101353320|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
33400240|NCT01195636|101353319|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
33400241|NCT01195636|101353320|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
33400242|NCT01195636|101353319|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
33400243|NCT01195636|101353320|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
33400244|NCT01195636|101353319|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
33517115|NCT00766467|101789478|FG001|Overall Study|Protocol Violation|4|||
33517116|NCT00766467|101789477|FG000|Overall Study|Tumor Progression on Study|0|||
33199892|NCT00767000|100638141|FG000|54-week Study|Creaninine/creatinine clearance|2|||
33400245|NCT01195636|101353320|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
33400246|NCT01195636|101353319|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
33400247|NCT01195636|101353320|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
33400248|NCT00606931|101353326|FG000|Overall Study|Withdrawal by Subject|3|||
33400249|NCT00089505|101353331|FG000|Overall Study|Death|4|||
33400250|NCT00089505|101353332|FG001|Overall Study|Death|1|||
33400251|NCT00089505|101353333|FG002|Overall Study|Death|5|||
33400252|NCT00089505|101353334|FG003|Overall Study|Death|8|||
33517117|NCT00766467|101789478|FG001|Overall Study|Tumor Progression on Study|1|||
33517118|NCT00766467|101789477|FG000|Overall Study|Physician Decision|1|||
33400253|NCT00089505|101353331|FG000|Overall Study|Withdrawal by Subject|3|||
33400254|NCT00089505|101353332|FG001|Overall Study|Withdrawal by Subject|0|||
33400255|NCT00089505|101353333|FG002|Overall Study|Withdrawal by Subject|6|||
33400256|NCT00089505|101353334|FG003|Overall Study|Withdrawal by Subject|6|||
33400257|NCT00089505|101353331|FG000|Overall Study|Lost to Follow-up|1|||
33400258|NCT00089505|101353332|FG001|Overall Study|Lost to Follow-up|1|||
33400259|NCT00089505|101353333|FG002|Overall Study|Lost to Follow-up|9|||
33400260|NCT00089505|101353334|FG003|Overall Study|Lost to Follow-up|7|||
33400261|NCT00089505|101353331|FG000|Overall Study|Physician Decision|1|||
33400262|NCT00089505|101353332|FG001|Overall Study|Physician Decision|0|||
33400263|NCT00089505|101353333|FG002|Overall Study|Physician Decision|0|||
33400264|NCT00089505|101353334|FG003|Overall Study|Physician Decision|0|||
33400265|NCT00089505|101353331|FG000|Overall Study|Protocol Violation|0|||
33400266|NCT00089505|101353332|FG001|Overall Study|Protocol Violation|0|||
33400267|NCT00089505|101353333|FG002|Overall Study|Protocol Violation|1|||
33517119|NCT00766467|101789478|FG001|Overall Study|Physician Decision|0|||
33517120|NCT03646305|101789480|FG000|Overall Study|Lost to Follow-up|4|||
33517121|NCT03646305|101789481|FG001|Overall Study|Lost to Follow-up|2|||
33517122|NCT03646305|101789482|FG002|Overall Study|Lost to Follow-up|2|||
33517123|NCT03646305|101789483|FG003|Overall Study|Lost to Follow-up|1|||
33517124|NCT03646305|101789480|FG000|Overall Study|Withdrawal by Subject|1|||
33326556|NCT00766090|101091202|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33326557|NCT00766090|101091203|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
33517125|NCT03646305|101789481|FG001|Overall Study|Withdrawal by Subject|0|||
33517126|NCT03646305|101789482|FG002|Overall Study|Withdrawal by Subject|0|||
33517127|NCT03646305|101789483|FG003|Overall Study|Withdrawal by Subject|1|||
33517128|NCT03672461|101789484|FG000|Overall Study|COVID Related|4|||
33517129|NCT03672461|101789485|FG001|Overall Study|COVID Related|2|||
33517130|NCT03672461|101789484|FG000|Overall Study|Adverse Event|2|||
33517131|NCT03672461|101789485|FG001|Overall Study|Adverse Event|0|||
33517132|NCT03672461|101789484|FG000|Overall Study|Serious Adverse Event|0|||
33517133|NCT03672461|101789485|FG001|Overall Study|Serious Adverse Event|1|||
33517134|NCT03672461|101789484|FG000|Overall Study|Too Busy|3|||
33517135|NCT03672461|101789485|FG001|Overall Study|Too Busy|1|||
33517136|NCT03672461|101789484|FG000|Overall Study|Lost to Follow-up|1|||
33517137|NCT03672461|101789485|FG001|Overall Study|Lost to Follow-up|2|||
33517138|NCT03672461|101789484|FG000|Overall Study|Family|2|||
33517139|NCT03672461|101789485|FG001|Overall Study|Family|2|||
33326558|NCT00766090|101091192|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
33326559|NCT00766090|101091193|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
33326560|NCT00766090|101091194|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
33326561|NCT00766090|101091195|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
33326562|NCT00766090|101091196|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
33326563|NCT00766090|101091197|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
33326564|NCT00766090|101091198|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
33326565|NCT00766090|101091199|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
33326566|NCT00766090|101091200|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
33326567|NCT00766090|101091201|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
33326568|NCT00766090|101091202|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
33326569|NCT00766090|101091203|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
33326570|NCT00766090|101091192|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33326571|NCT00766090|101091193|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33326572|NCT00766090|101091194|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33326573|NCT00766090|101091195|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33326574|NCT00766090|101091196|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33326575|NCT00766090|101091197|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
33326576|NCT00766090|101091198|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33326577|NCT00766090|101091199|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33326578|NCT00766090|101091200|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33326579|NCT00766090|101091201|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33326580|NCT00766090|101091202|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33326581|NCT00766090|101091203|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
33326582|NCT00766090|101091192|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33326583|NCT00766090|101091193|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
33326584|NCT00766090|101091194|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33326585|NCT00766090|101091195|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
33400268|NCT00089505|101353334|FG003|Overall Study|Protocol Violation|0|||
33400269|NCT00392210|101353335|FG000|First Voiding Trial|Physician Decision|2|||
33400270|NCT00392210|101353336|FG001|First Voiding Trial|Physician Decision|2|||
33400271|NCT00934791|101353340|FG000|Overall Study|Withdrawal by Subject|1|||
33517140|NCT03672461|101789484|FG000|Overall Study|No remote technology access|0|||
33517141|NCT03672461|101789485|FG001|Overall Study|No remote technology access|1|||
33517142|NCT03672461|101789484|FG000|Overall Study|Withdrawal by Subject|1|||
33517143|NCT03672461|101789485|FG001|Overall Study|Withdrawal by Subject|0|||
33517144|NCT03672461|101789484|FG000|Overall Study|Cannot tolerate intervention|1|||
33607735|NCT03149029|102114867|FG000|Overall Study|Adverse Event|2|||
33607736|NCT03149029|102114868|FG001|Overall Study|Adverse Event|0|||
33607737|NCT00718770|102114870|FG000|Overall Study|Adverse Event|1|||
33607738|NCT00718770|102114870|FG000|Overall Study|Lack of Efficacy|1|||
33400272|NCT00934791|101353341|FG001|Overall Study|Withdrawal by Subject|0|||
33400273|NCT04411472|101353342|FG000|Overall Study|Adverse Event|5|||
33400274|NCT04411472|101353343|FG001|Overall Study|Adverse Event|10|||
33400275|NCT04411472|101353344|FG002|Overall Study|Adverse Event|1|||
33400276|NCT04411472|101353345|FG003|Overall Study|Adverse Event|0|||
33400277|NCT04411472|101353346|FG004|Overall Study|Adverse Event|0|||
33400278|NCT04411472|101353347|FG005|Overall Study|Adverse Event|0|||
33400279|NCT04411472|101353342|FG000|Overall Study|Protocol Violation|1|||
33400280|NCT04411472|101353343|FG001|Overall Study|Protocol Violation|0|||
33400281|NCT04411472|101353344|FG002|Overall Study|Protocol Violation|0|||
33400282|NCT04411472|101353345|FG003|Overall Study|Protocol Violation|0|||
33400283|NCT04411472|101353346|FG004|Overall Study|Protocol Violation|0|||
33400284|NCT04411472|101353347|FG005|Overall Study|Protocol Violation|0|||
33400285|NCT04411472|101353342|FG000|Overall Study|Withdrawal by Subject|0|||
33400286|NCT04411472|101353343|FG001|Overall Study|Withdrawal by Subject|1|||
33400287|NCT04411472|101353344|FG002|Overall Study|Withdrawal by Subject|0|||
33400288|NCT04411472|101353345|FG003|Overall Study|Withdrawal by Subject|1|||
33400289|NCT04411472|101353346|FG004|Overall Study|Withdrawal by Subject|0|||
33400290|NCT04411472|101353347|FG005|Overall Study|Withdrawal by Subject|0|||
33400291|NCT04411472|101353342|FG000|Overall Study|Physician Decision|1|||
33400292|NCT04411472|101353343|FG001|Overall Study|Physician Decision|0|||
33400293|NCT04411472|101353344|FG002|Overall Study|Physician Decision|0|||
33400294|NCT04411472|101353345|FG003|Overall Study|Physician Decision|0|||
33400295|NCT04411472|101353346|FG004|Overall Study|Physician Decision|0|||
33400296|NCT04411472|101353347|FG005|Overall Study|Physician Decision|0|||
33400297|NCT04411472|101353342|FG000|Overall Study|Study terminated by sponsor|17|||
33400298|NCT04411472|101353343|FG001|Overall Study|Study terminated by sponsor|20|||
33400299|NCT04411472|101353344|FG002|Overall Study|Study terminated by sponsor|3|||
33400300|NCT04411472|101353345|FG003|Overall Study|Study terminated by sponsor|0|||
33400301|NCT04411472|101353346|FG004|Overall Study|Study terminated by sponsor|0|||
33400302|NCT04411472|101353347|FG005|Overall Study|Study terminated by sponsor|0|||
33400303|NCT01021553|101353348|FG000|Overall Study|Adverse Event|1|||
33400304|NCT01021553|101353349|FG001|Overall Study|Adverse Event|0|||
33400305|NCT01021553|101353350|FG002|Overall Study|Adverse Event|0|||
33400306|NCT01021553|101353348|FG000|Overall Study|Lack of Efficacy|2|||
33400307|NCT01021553|101353349|FG001|Overall Study|Lack of Efficacy|2|||
33400308|NCT01021553|101353350|FG002|Overall Study|Lack of Efficacy|0|||
33400309|NCT01021553|101353348|FG000|Overall Study|Protocol Violation|0|||
33400310|NCT01021553|101353349|FG001|Overall Study|Protocol Violation|2|||
33400311|NCT01021553|101353350|FG002|Overall Study|Protocol Violation|2|||
33400312|NCT01021553|101353348|FG000|Overall Study|Lost to Follow-up|0|||
33400313|NCT01021553|101353349|FG001|Overall Study|Lost to Follow-up|0|||
33400314|NCT01021553|101353350|FG002|Overall Study|Lost to Follow-up|1|||
33400315|NCT01021553|101353348|FG000|Overall Study|Withdrawal by Subject|1|||
33400316|NCT01021553|101353349|FG001|Overall Study|Withdrawal by Subject|1|||
33400317|NCT01021553|101353350|FG002|Overall Study|Withdrawal by Subject|0|||
33400318|NCT00984009|101353353|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
33400319|NCT04905563|101353354|FG000|Overall Study|Withdrawal by Subject|1|||
33400320|NCT04905563|101353355|FG001|Overall Study|Withdrawal by Subject|0|||
33400321|NCT04905563|101353354|FG000|Overall Study|Standard of care orders entered by resident|1|||
33400322|NCT04905563|101353355|FG001|Overall Study|Standard of care orders entered by resident|0|||
33400323|NCT04905563|101353354|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
33400324|NCT04905563|101353355|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
33400325|NCT04905563|101353354|FG000|Overall Study|Withdrawal by Subject|0|||
33400326|NCT04905563|101353355|FG001|Overall Study|Withdrawal by Subject|1|||
33400327|NCT03500419|101353367|FG000|Overall Study|Withdrawal by Subject|2|||
33400328|NCT03500419|101353368|FG001|Overall Study|Withdrawal by Subject|25|||
33400329|NCT02324049|101353381|FG000|Part C|Study terminated|11|||
33326586|NCT00766090|101091196|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33400330|NCT02176226|101353389|FG000|Overall Study|Lost to Follow-up|3|||
33517145|NCT03672461|101789485|FG001|Overall Study|Cannot tolerate intervention|0|||
33517146|NCT03672461|101789484|FG000|Overall Study|Incomplete outcome data|6|||
33517147|NCT03672461|101789485|FG001|Overall Study|Incomplete outcome data|1|||
33400331|NCT02176226|101353389|FG000|Overall Study|Withdrew prior to treatment|6|||
33400332|NCT00397891|101353390|FG000|Overall Study|Withdrawal by Subject|1|||
33400333|NCT00397891|101353391|FG001|Overall Study|Withdrawal by Subject|0|||
33517148|NCT00844480|101789488|FG000|Overall Study|Withdrawal by Subject|2|||
33517149|NCT00844480|101789489|FG001|Overall Study|Withdrawal by Subject|3|||
33517150|NCT00725101|101789490|FG000|Overall Study|Death|3|||
33400334|NCT00397891|101353392|FG002|Overall Study|Withdrawal by Subject|0|||
33400335|NCT00397891|101353393|FG003|Overall Study|Withdrawal by Subject|0|||
33400336|NCT00397891|101353394|FG004|Overall Study|Withdrawal by Subject|1|||
33400337|NCT03696576|101353396|FG000|Overall Study|Soreness of throat after therapy|1|||
33517151|NCT00725101|101789490|FG000|Overall Study|Lost to Follow-up|353|||
33517152|NCT00725101|101789490|FG000|Overall Study|Protocol Violation|1|||
33517153|NCT00725101|101789490|FG000|Overall Study|Withdrawal by Subject|127|||
33517154|NCT00725101|101789490|FG000|Overall Study|not specified/no reason given|11|||
33517155|NCT03325894|101789491|FG000|Overall Study|Adverse Event|2|||
33517156|NCT03325894|101789492|FG001|Overall Study|Adverse Event|3|||
33517157|NCT03325894|101789491|FG000|Overall Study|Protocol Violation|1|||
33517158|NCT03325894|101789492|FG001|Overall Study|Protocol Violation|2|||
33517159|NCT03325894|101789491|FG000|Overall Study|Withdrawal by Subject|10|||
33517160|NCT03325894|101789492|FG001|Overall Study|Withdrawal by Subject|6|||
33517161|NCT03325894|101789491|FG000|Overall Study|Lost to Follow-up|4|||
33517162|NCT03325894|101789492|FG001|Overall Study|Lost to Follow-up|9|||
33517163|NCT03325894|101789491|FG000|Overall Study|Lack of Efficacy|8|||
33517164|NCT03325894|101789492|FG001|Overall Study|Lack of Efficacy|14|||
33517165|NCT03325894|101789491|FG000|Overall Study|Study Terminated by Sponsor|38|||
33517166|NCT03325894|101789492|FG001|Overall Study|Study Terminated by Sponsor|43|||
33517167|NCT03325894|101789491|FG000|Overall Study|Other (Not received Treatment)|1|||
33517168|NCT03325894|101789492|FG001|Overall Study|Other (Not received Treatment)|0|||
33517169|NCT02984267|101789493|FG000|Overall Study|Protocol Violation|1|||
33517170|NCT02984267|101789494|FG001|Overall Study|Protocol Violation|0|||
33517171|NCT02984267|101789493|FG000|Overall Study|Withdrawal by Subject|0|||
33517172|NCT02984267|101789494|FG001|Overall Study|Withdrawal by Subject|1|||
33517173|NCT01371877|101789499|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
33517174|NCT01371877|101789500|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
33517175|NCT03673501|101789503|FG000|Overall Study|Participants ongoing.|36|||
33517176|NCT03673501|101789504|FG001|Overall Study|Participants ongoing.|24|||
33517177|NCT03408444|101789505|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
33517178|NCT03408444|101789506|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
33517179|NCT03408444|101789507|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
33517180|NCT03408444|101789508|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
33517181|NCT03408444|101789505|FG000|Overall Study|Lens Discomfort|0|||
33517182|NCT03408444|101789506|FG001|Overall Study|Lens Discomfort|1|||
33517183|NCT03408444|101789507|FG002|Overall Study|Lens Discomfort|0|||
33517184|NCT03408444|101789508|FG003|Overall Study|Lens Discomfort|0|||
33517185|NCT03408444|101789505|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
33517186|NCT03408444|101789506|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
33517187|NCT03408444|101789507|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
33517188|NCT03408444|101789508|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
33517189|NCT03408444|101789505|FG000|Overall Study|Withdrawal by Subject|0|||
33517190|NCT03408444|101789506|FG001|Overall Study|Withdrawal by Subject|2|||
33517191|NCT03408444|101789507|FG002|Overall Study|Withdrawal by Subject|3|||
33517192|NCT03408444|101789508|FG003|Overall Study|Withdrawal by Subject|0|||
33517193|NCT03408444|101789505|FG000|Overall Study|Lost to Follow-up|0|||
33517194|NCT03408444|101789506|FG001|Overall Study|Lost to Follow-up|0|||
33607739|NCT00718770|102114870|FG000|Overall Study|Lack of Efficacy|1|||
33607740|NCT00718770|102114870|FG000|Overall Study|Adverse Event|1|||
33517195|NCT03408444|101789507|FG002|Overall Study|Lost to Follow-up|1|||
33517196|NCT03408444|101789508|FG003|Overall Study|Lost to Follow-up|0|||
33517197|NCT03408444|101789505|FG000|Overall Study|Adverse Event|0|||
33517198|NCT03408444|101789506|FG001|Overall Study|Adverse Event|0|||
33517199|NCT03408444|101789507|FG002|Overall Study|Adverse Event|0|||
33517200|NCT03408444|101789508|FG003|Overall Study|Adverse Event|1|||
33517201|NCT03408444|101789505|FG000|Overall Study|Lens Handling Difficulties|0|||
33517202|NCT03408444|101789506|FG001|Overall Study|Lens Handling Difficulties|0|||
33517203|NCT03408444|101789507|FG002|Overall Study|Lens Handling Difficulties|1|||
33517204|NCT03408444|101789508|FG003|Overall Study|Lens Handling Difficulties|0|||
33517205|NCT03408444|101789505|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
33517206|NCT03408444|101789506|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
33517207|NCT03408444|101789507|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
33517208|NCT03408444|101789508|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
33517209|NCT05007041|101789509|FG000|Overall Study|Missing Diary Entries|0|||
33517210|NCT05007041|101789510|FG001|Overall Study|Missing Diary Entries|1|||
33517211|NCT04102865|101789511|FG000|Overall Study|Adverse Event|4|||
33607741|NCT00718770|102114870|FG000|Overall Study|Lack of Efficacy|1|||
33607742|NCT00718770|102114870|FG000|Overall Study|Adverse Event|1|||
33199893|NCT00767000|100638142|FG001|54-week Study|Creaninine/creatinine clearance|1|||
33517212|NCT04102865|101789512|FG001|Overall Study|Adverse Event|0|||
33607743|NCT00718770|102114870|FG000|Overall Study|Lack of Efficacy|1|||
33199894|NCT00767000|100638143|FG002|54-week Study|Creaninine/creatinine clearance|2|||
33607744|NCT00718770|102114870|FG000|Overall Study|Adverse Event|1|||
33517213|NCT04102865|101789511|FG000|Overall Study|Lost to Follow-up|1|||
33517214|NCT04102865|101789512|FG001|Overall Study|Lost to Follow-up|0|||
33517215|NCT04102865|101789511|FG000|Overall Study|Withdrawal by Subject|2|||
33607745|NCT03459365|102114875|FG000|Overall Study|Withdrawal by Subject|6|||
33607746|NCT03459365|102114875|FG000|Overall Study|Protocol Violation|8|||
33517216|NCT04102865|101789512|FG001|Overall Study|Withdrawal by Subject|0|||
33517217|NCT01592292|101789513|FG000|Overall Study|Follow-up loss|3|||
33517218|NCT01592292|101789514|FG001|Overall Study|Follow-up loss|3|||
33517219|NCT01592292|101789515|FG002|Overall Study|Follow-up loss|1|||
33517220|NCT01592292|101789516|FG003|Overall Study|Follow-up loss|0|||
33517221|NCT01592292|101789513|FG000|Overall Study|Withdrew consent|2|||
33517222|NCT01592292|101789514|FG001|Overall Study|Withdrew consent|1|||
33517223|NCT01592292|101789515|FG002|Overall Study|Withdrew consent|0|||
33517224|NCT01592292|101789516|FG003|Overall Study|Withdrew consent|0|||
33517225|NCT01592292|101789513|FG000|Overall Study|Other|1|||
33517226|NCT01592292|101789514|FG001|Overall Study|Other|1|||
33517227|NCT01592292|101789515|FG002|Overall Study|Other|2|||
33517228|NCT01592292|101789516|FG003|Overall Study|Other|1|||
33517229|NCT00248833|101789518|FG000|Overall Study|Adverse Event|2|||
33517230|NCT00248833|101789519|FG001|Overall Study|Adverse Event|0|||
33517231|NCT00248833|101789520|FG002|Overall Study|Adverse Event|0|||
33517232|NCT00248833|101789518|FG000|Overall Study|Withdrawal by Subject|0|||
33517233|NCT00248833|101789519|FG001|Overall Study|Withdrawal by Subject|1|||
33517234|NCT00248833|101789520|FG002|Overall Study|Withdrawal by Subject|1|||
33517235|NCT00248833|101789518|FG000|Overall Study|Lost to Follow-up|1|||
33517236|NCT00248833|101789519|FG001|Overall Study|Lost to Follow-up|1|||
33517237|NCT00248833|101789520|FG002|Overall Study|Lost to Follow-up|1|||
33517238|NCT00248833|101789518|FG000|Overall Study|Other|0|||
33517239|NCT00248833|101789519|FG001|Overall Study|Other|1|||
33517240|NCT00248833|101789520|FG002|Overall Study|Other|0|||
33517241|NCT00505661|101789522|FG000|Overall Study|Not Eligible|4|||
33517242|NCT01298141|101789527|FG000|Overall Study|Adverse Event|3|||
33517243|NCT01298141|101789527|FG000|Overall Study|Refusal of Required Study Procedures|1|||
33517244|NCT01298141|101789527|FG000|Overall Study|Withdrawal by Subject|6|||
33517245|NCT01298141|101789527|FG000|Overall Study|Termination of Study by the Investigator|5|||
33517246|NCT01298141|101789527|FG000|Overall Study|Other|5|||
33517247|NCT01298141|101789527|FG000|Overall Study|Lost to Follow-up|1|||
33517248|NCT01298141|101789527|FG000|Overall Study|Death|6|||
33517249|NCT01298141|101789527|FG000|Overall Study|Not treated|4|||
33517250|NCT02386345|101789530|FG000|Overall Study|Not treated|14|||
33517251|NCT02386345|101789530|FG000|Overall Study|Lost to Follow-up|1|||
33517252|NCT02386345|101789530|FG000|Overall Study|Adverse Event|5|||
33517253|NCT02386345|101789530|FG000|Overall Study|Repeat Procedure|10|||
33517254|NCT02386345|101789530|FG000|Overall Study|Did not complete 12-month follow-up|72|||
33517255|NCT00481767|101789531|FG000|Overall Study|Withdrawal by Subject|16|||
33517256|NCT00481767|101789532|FG001|Overall Study|Withdrawal by Subject|11|||
33517257|NCT00481767|101789531|FG000|Overall Study|Lost to Follow-up|16|||
33517258|NCT00481767|101789532|FG001|Overall Study|Lost to Follow-up|10|||
33517259|NCT04438499|101789533|FG000|Overall Study|Lack of Efficacy|3|||
33517260|NCT01432275|101789535|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
33517261|NCT01432275|101789536|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
33517262|NCT01432275|101789535|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
33517263|NCT01432275|101789536|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
33517264|NCT01432275|101789535|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
33517265|NCT01432275|101789536|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
33517266|NCT01432275|101789535|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
33517267|NCT01432275|101789536|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
33517268|NCT01432275|101789535|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
33517269|NCT01432275|101789536|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
33517270|NCT01432275|101789535|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
33517271|NCT01432275|101789536|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
33517272|NCT01432275|101789535|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
33517273|NCT01432275|101789536|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
33517274|NCT01432275|101789535|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
33517275|NCT01432275|101789536|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
33517276|NCT01432275|101789535|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
33517277|NCT01432275|101789536|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
33199895|NCT00767000|100638144|FG003|54-week Study|Creaninine/creatinine clearance|2|||
33517278|NCT00561470|101789537|FG000|Overall Study|Adverse Event|74|||
33517279|NCT00561470|101789538|FG001|Overall Study|Adverse Event|163|||
33517280|NCT00561470|101789537|FG000|Overall Study|Disease progression|437|||
33517281|NCT00561470|101789538|FG001|Overall Study|Disease progression|305|||
33517282|NCT00561470|101789537|FG000|Overall Study|poor compliance to protocol|4|||
33517283|NCT00561470|101789538|FG001|Overall Study|poor compliance to protocol|4|||
33517284|NCT00561470|101789537|FG000|Overall Study|Lost to Follow-up|2|||
33517285|NCT00561470|101789538|FG001|Overall Study|Lost to Follow-up|0|||
33517286|NCT00561470|101789537|FG000|Overall Study|Physician Decision|21|||
33517287|NCT00561470|101789538|FG001|Overall Study|Physician Decision|20|||
33517288|NCT00561470|101789537|FG000|Overall Study|Consent Withdrawn|2|||
33517289|NCT00561470|101789538|FG001|Overall Study|Consent Withdrawn|6|||
33517290|NCT00561470|101789537|FG000|Overall Study|Subject request|43|||
33517291|NCT00561470|101789538|FG001|Overall Study|Subject request|77|||
33517292|NCT00561470|101789537|FG000|Overall Study|Metastatic surgery|10|||
33517293|NCT00561470|101789538|FG001|Overall Study|Metastatic surgery|12|||
33517294|NCT00561470|101789537|FG000|Overall Study|Unauthorized procedure|3|||
33517295|NCT00561470|101789538|FG001|Overall Study|Unauthorized procedure|1|||
33517296|NCT00561470|101789537|FG000|Overall Study|Randomized but not treated|5|||
33517297|NCT00561470|101789538|FG001|Overall Study|Randomized but not treated|5|||
33517298|NCT00561470|101789537|FG000|Overall Study|Missed visit window|1|||
33517299|NCT00561470|101789538|FG001|Overall Study|Missed visit window|4|||
33517300|NCT00561470|101789537|FG000|Overall Study|Planning surgery|1|||
33517301|NCT00561470|101789538|FG001|Overall Study|Planning surgery|1|||
33517302|NCT00561470|101789537|FG000|Overall Study|Ongoing Treatment|11|||
33517303|NCT00561470|101789538|FG001|Overall Study|Ongoing Treatment|14|||
33517304|NCT01473394|101789541|FG000|Overall Study|Adverse Event|13|||
33517305|NCT01473394|101789542|FG001|Overall Study|Adverse Event|16|||
33517306|NCT01473394|101789541|FG000|Overall Study|Insufficient Therapeutic Response|4|||
33517307|NCT01473394|101789542|FG001|Overall Study|Insufficient Therapeutic Response|1|||
33517308|NCT01473394|101789541|FG000|Overall Study|Protocol Violation|7|||
33517309|NCT01473394|101789542|FG001|Overall Study|Protocol Violation|5|||
33199896|NCT00767000|100638145|FG004|54-week Study|Creaninine/creatinine clearance|4|||
33199897|NCT00767000|100638141|FG000|54-week Study|Hyperglycemia|0|||
33199898|NCT00767000|100638142|FG001|54-week Study|Hyperglycemia|0|||
33326587|NCT00766090|101091197|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33326588|NCT00766090|101091198|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33326589|NCT00766090|101091199|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33326590|NCT00766090|101091200|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33517310|NCT01473394|101789541|FG000|Overall Study|Withdrew Consent|12|||
33517311|NCT01473394|101789542|FG001|Overall Study|Withdrew Consent|10|||
33517312|NCT01473394|101789541|FG000|Overall Study|Lost to Follow-up|9|||
33517313|NCT01473394|101789542|FG001|Overall Study|Lost to Follow-up|11|||
33517314|NCT00787917|101789543|FG000|Blinded Treatment|Adverse Event|1|||
33517315|NCT00787917|101789544|FG001|Blinded Treatment|Adverse Event|0|||
33517316|NCT00787917|101789543|FG000|Blinded Treatment|Lack of Efficacy|1|||
33517317|NCT00787917|101789544|FG001|Blinded Treatment|Lack of Efficacy|0|||
33517318|NCT00787917|101789543|FG000|Blinded Treatment|Administrative problems|3|||
33517319|NCT00787917|101789544|FG001|Blinded Treatment|Administrative problems|2|||
33517320|NCT00787917|101789543|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
33517321|NCT00787917|101789544|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
33517322|NCT00787917|101789543|FG000|Open Label|Administrative problems|3|||
33517323|NCT00787917|101789544|FG001|Open Label|Administrative problems|0|||
33517324|NCT04472026|101789547|FG000|Overall Study|Lost to Follow-up|5|||
33517325|NCT04326439|101789548|FG000|Overall Study|Withdrawal by Subject|1|||
33517326|NCT04326439|101789549|FG001|Overall Study|Withdrawal by Subject|0|||
33517327|NCT04326439|101789548|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
33517328|NCT04326439|101789549|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
33517329|NCT04326439|101789548|FG000|Overall Study|Relapse after Induction 2|0|||
33517330|NCT04326439|101789549|FG001|Overall Study|Relapse after Induction 2|1|||
33517331|NCT04326439|101789548|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
33517332|NCT04326439|101789549|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
33517333|NCT00987402|101789550|FG000|Overall Study|Insufficient data entry|86|||
33517334|NCT00987402|101789551|FG001|Overall Study|Insufficient data entry|98|||
33517335|NCT01085136|101789556|FG000|Part A|Other Adverse event|223|||
33517336|NCT01085136|101789557|FG001|Part A|Other Adverse event|0|||
33517337|NCT01085136|101789558|FG002|Part A|Other Adverse event|0|||
33199899|NCT00767000|100638143|FG002|54-week Study|Hyperglycemia|1|||
33517338|NCT01085136|101789556|FG000|Part A|Protocol Violation|3|||
33517339|NCT01085136|101789557|FG001|Part A|Protocol Violation|0|||
33199900|NCT00767000|100638144|FG003|54-week Study|Hyperglycemia|0|||
33199901|NCT00767000|100638145|FG004|54-week Study|Hyperglycemia|1|||
33199902|NCT00767000|100638141|FG000|54-week Study|Hypoglycemia|0|||
33199903|NCT00767000|100638142|FG001|54-week Study|Hypoglycemia|1|||
33199904|NCT00767000|100638143|FG002|54-week Study|Hypoglycemia|0|||
33517340|NCT01085136|101789558|FG002|Part A|Protocol Violation|0|||
33517341|NCT01085136|101789556|FG000|Part A|Lost to Follow-up|3|||
33517342|NCT01085136|101789557|FG001|Part A|Lost to Follow-up|0|||
33199905|NCT00767000|100638144|FG003|54-week Study|Hypoglycemia|0|||
33199906|NCT00767000|100638145|FG004|54-week Study|Hypoglycemia|0|||
33199907|NCT00767000|100638141|FG000|54-week Study|Interruption of study medication|0|||
33199908|NCT00767000|100638142|FG001|54-week Study|Interruption of study medication|0|||
33199909|NCT00767000|100638143|FG002|54-week Study|Interruption of study medication|1|||
33199910|NCT00767000|100638144|FG003|54-week Study|Interruption of study medication|0|||
33199911|NCT00767000|100638145|FG004|54-week Study|Interruption of study medication|0|||
33199912|NCT00767000|100638141|FG000|54-week Study|Lack of Efficacy|2|||
33199913|NCT00767000|100638142|FG001|54-week Study|Lack of Efficacy|0|||
33199914|NCT00767000|100638143|FG002|54-week Study|Lack of Efficacy|1|||
33199915|NCT00767000|100638144|FG003|54-week Study|Lack of Efficacy|0|||
33199916|NCT00767000|100638145|FG004|54-week Study|Lack of Efficacy|5|||
33199917|NCT00767000|100638141|FG000|54-week Study|Lost to Follow-up|4|||
33326591|NCT00766090|101091201|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33326592|NCT00766090|101091202|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
33326593|NCT00766090|101091203|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
33517343|NCT01085136|101789558|FG002|Part A|Lost to Follow-up|0|||
33517344|NCT01085136|101789556|FG000|Part A|Refusal to continue trial medication|64|||
33517345|NCT01085136|101789557|FG001|Part A|Refusal to continue trial medication|0|||
33517346|NCT01085136|101789558|FG002|Part A|Refusal to continue trial medication|0|||
33517347|NCT01085136|101789556|FG000|Part A|Other reason not defined above|30|||
33517348|NCT01085136|101789557|FG001|Part A|Other reason not defined above|0|||
33517349|NCT01085136|101789558|FG002|Part A|Other reason not defined above|0|||
33517350|NCT01085136|101789556|FG000|Part B|Other AE|0|||
33517351|NCT01085136|101789557|FG001|Part B|Other AE|29|||
33517352|NCT01085136|101789558|FG002|Part B|Other AE|8|||
33517353|NCT01085136|101789556|FG000|Part B|Refusal to continue trial medication|0|||
33517354|NCT01085136|101789557|FG001|Part B|Refusal to continue trial medication|12|||
33517355|NCT01085136|101789558|FG002|Part B|Refusal to continue trial medication|7|||
33517356|NCT01085136|101789556|FG000|Part B|Not treated|0|||
33326594|NCT00766090|101091192|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33517357|NCT01085136|101789557|FG001|Part B|Not treated|4|||
33517358|NCT01085136|101789558|FG002|Part B|Not treated|8|||
33517359|NCT01085136|101789556|FG000|Part B|Other reason not defined above|0|||
33517360|NCT01085136|101789557|FG001|Part B|Other reason not defined above|6|||
33517361|NCT01085136|101789558|FG002|Part B|Other reason not defined above|3|||
33517362|NCT00328094|101789559|FG000|Overall Study|Physician Decision|3|||
33517363|NCT00328094|101789560|FG001|Overall Study|Physician Decision|3|||
33517364|NCT02921750|101789561|FG000|Overall Study|Adverse Event|1|||
33517365|NCT02921750|101789562|FG001|Overall Study|Adverse Event|2|||
33517366|NCT02921750|101789561|FG000|Overall Study|Withdrawal by Subject|1|||
33517367|NCT02921750|101789562|FG001|Overall Study|Withdrawal by Subject|1|||
33517368|NCT02921750|101789561|FG000|Overall Study|Lost to Follow-up|3|||
33517369|NCT02921750|101789562|FG001|Overall Study|Lost to Follow-up|3|||
33517370|NCT02921750|101789561|FG000|Overall Study|Wound healed|3|||
33517371|NCT02921750|101789562|FG001|Overall Study|Wound healed|3|||
33517372|NCT02921750|101789561|FG000|Overall Study|Serious Adverse Event|1|||
33517373|NCT02921750|101789562|FG001|Overall Study|Serious Adverse Event|2|||
33517374|NCT03578146|101789563|FG000|Overall Study|Did Not Receive Treatment|1|||
33199918|NCT00767000|100638142|FG001|54-week Study|Lost to Follow-up|0|||
33199919|NCT00767000|100638143|FG002|54-week Study|Lost to Follow-up|1|||
33517375|NCT03578146|101789564|FG001|Overall Study|Did Not Receive Treatment|0|||
33517376|NCT03578146|101789565|FG002|Overall Study|Did Not Receive Treatment|0|||
33517377|NCT03578146|101789566|FG003|Overall Study|Did Not Receive Treatment|0|||
33517378|NCT03578146|101789567|FG004|Overall Study|Did Not Receive Treatment|0|||
33517379|NCT03578146|101789568|FG005|Overall Study|Did Not Receive Treatment|2|||
33517380|NCT03578146|101789563|FG000|Overall Study|Lost to Follow-up|0|||
33517381|NCT03578146|101789564|FG001|Overall Study|Lost to Follow-up|1|||
33517382|NCT03578146|101789565|FG002|Overall Study|Lost to Follow-up|1|||
33517383|NCT03578146|101789566|FG003|Overall Study|Lost to Follow-up|0|||
33517384|NCT03578146|101789567|FG004|Overall Study|Lost to Follow-up|0|||
33607747|NCT04891107|102114876|FG000|Overall Study|Physician Decision|1|||
33607748|NCT04891107|102114876|FG000|Overall Study|Withdrawal by Subject|1|||
33607749|NCT04891107|102114876|FG000|Overall Study|Screen failure after consent|1|||
33607750|NCT02951429|102114877|FG000|Overall Study|Adverse Event|3|||
33607751|NCT02951429|102114878|FG001|Overall Study|Adverse Event|7|||
33607752|NCT02951429|102114877|FG000|Overall Study|Death|28|||
33607753|NCT02951429|102114878|FG001|Overall Study|Death|36|||
33607754|NCT02951429|102114877|FG000|Overall Study|Lack of Efficacy|0|||
33607755|NCT02951429|102114878|FG001|Overall Study|Lack of Efficacy|1|||
33607756|NCT02951429|102114877|FG000|Overall Study|Lost to Follow-up|0|||
33607757|NCT02951429|102114878|FG001|Overall Study|Lost to Follow-up|1|||
33607758|NCT02951429|102114877|FG000|Overall Study|Lung Transplantation|9|||
33607759|NCT02951429|102114878|FG001|Overall Study|Lung Transplantation|6|||
33607760|NCT02951429|102114877|FG000|Overall Study|Other|1|||
33607761|NCT02951429|102114878|FG001|Overall Study|Other|3|||
33607762|NCT02951429|102114877|FG000|Overall Study|Progressive Disease|1|||
33607763|NCT02951429|102114878|FG001|Overall Study|Progressive Disease|1|||
33607764|NCT02951429|102114877|FG000|Overall Study|Withdrawal by Subject|7|||
33326595|NCT00766090|101091193|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33400338|NCT03696576|101353397|FG001|Overall Study|Soreness of throat after therapy|1|||
33400339|NCT03696576|101353396|FG000|Overall Study|Lost to Follow-up|2|||
33400340|NCT03696576|101353397|FG001|Overall Study|Lost to Follow-up|4|||
33400341|NCT01058395|101353398|FG000|Overall Study|Death|2|||
33400342|NCT01058395|101353399|FG001|Overall Study|Death|1|||
33400343|NCT01058395|101353398|FG000|Overall Study|Lost to Follow-up|1|||
33400344|NCT01058395|101353399|FG001|Overall Study|Lost to Follow-up|0|||
33400345|NCT02504424|101353401|FG000|Overall Study|Withdrawal by Subject|2|||
33400346|NCT00775138|101353402|FG000|Overall Study|Withdrawal by Subject|0|||
33400347|NCT00775138|101353403|FG001|Overall Study|Withdrawal by Subject|0|||
33400348|NCT00775138|101353404|FG002|Overall Study|Withdrawal by Subject|2|||
33400349|NCT00775138|101353405|FG003|Overall Study|Withdrawal by Subject|2|||
33400350|NCT00775138|101353402|FG000|Overall Study|Adverse Event|0|||
33400351|NCT00775138|101353403|FG001|Overall Study|Adverse Event|0|||
33400352|NCT00775138|101353404|FG002|Overall Study|Adverse Event|1|||
33400353|NCT00775138|101353405|FG003|Overall Study|Adverse Event|0|||
33400354|NCT00951912|101353406|FG000|Overall Study|Lack of Efficacy|1|||
33400355|NCT00951912|101353407|FG001|Overall Study|Lack of Efficacy|0|||
33400356|NCT00951912|101353408|FG002|Overall Study|Lack of Efficacy|0|||
33400357|NCT00951912|101353406|FG000|Overall Study|Adverse Event|0|||
33400358|NCT00951912|101353407|FG001|Overall Study|Adverse Event|1|||
33400359|NCT00951912|101353408|FG002|Overall Study|Adverse Event|1|||
33400360|NCT00951912|101353406|FG000|Overall Study|Lost to Follow-up|2|||
33400361|NCT00951912|101353407|FG001|Overall Study|Lost to Follow-up|2|||
33400362|NCT00951912|101353408|FG002|Overall Study|Lost to Follow-up|0|||
33400363|NCT00951912|101353406|FG000|Overall Study|Physician Decision|1|||
33400364|NCT00951912|101353407|FG001|Overall Study|Physician Decision|0|||
33400365|NCT00951912|101353408|FG002|Overall Study|Physician Decision|1|||
33400366|NCT00951912|101353406|FG000|Overall Study|Withdrawal by Subject|1|||
33400367|NCT00951912|101353407|FG001|Overall Study|Withdrawal by Subject|1|||
33400368|NCT00951912|101353408|FG002|Overall Study|Withdrawal by Subject|0|||
33400369|NCT00951912|101353406|FG000|Overall Study|Other:Depression|1|||
33400370|NCT00951912|101353407|FG001|Overall Study|Other:Depression|0|||
33400371|NCT00951912|101353408|FG002|Overall Study|Other:Depression|0|||
33400372|NCT00951912|101353406|FG000|Overall Study|Other: Colon cancer|1|||
33400373|NCT00951912|101353407|FG001|Overall Study|Other: Colon cancer|0|||
33400374|NCT00951912|101353408|FG002|Overall Study|Other: Colon cancer|0|||
33400375|NCT00951912|101353406|FG000|Overall Study|Other: Stroke|0|||
33400376|NCT00951912|101353407|FG001|Overall Study|Other: Stroke|1|||
33400377|NCT00951912|101353408|FG002|Overall Study|Other: Stroke|0|||
33400378|NCT02382276|101353409|FG000|Overall Study|Withdrawal by Subject|4|||
33517385|NCT03578146|101789568|FG005|Overall Study|Lost to Follow-up|1|||
33517386|NCT00394771|101789569|FG000|Overall Study|Did not meet protocol requirements|1|||
33517387|NCT00394771|101789570|FG001|Overall Study|Did not meet protocol requirements|0|||
33517388|NCT00394771|101789571|FG002|Overall Study|Did not meet protocol requirements|2|||
33607765|NCT02951429|102114878|FG001|Overall Study|Withdrawal by Subject|11|||
33400379|NCT02382276|101353410|FG001|Overall Study|Withdrawal by Subject|8|||
33400380|NCT02382276|101353411|FG002|Overall Study|Withdrawal by Subject|5|||
33607766|NCT02951429|102114877|FG000|Overall Study|Participant ongoing in the study|23|||
33517389|NCT00394771|101789572|FG003|Overall Study|Did not meet protocol requirements|0|||
33517390|NCT00394771|101789569|FG000|Overall Study|Protocol Violation|2|||
33517391|NCT00394771|101789570|FG001|Overall Study|Protocol Violation|4|||
33517392|NCT00394771|101789571|FG002|Overall Study|Protocol Violation|9|||
33517393|NCT00394771|101789572|FG003|Overall Study|Protocol Violation|7|||
33517394|NCT00394771|101789569|FG000|Overall Study|Withdrawal by Subject|10|||
33517395|NCT00394771|101789570|FG001|Overall Study|Withdrawal by Subject|6|||
33517396|NCT00394771|101789571|FG002|Overall Study|Withdrawal by Subject|8|||
33517397|NCT00394771|101789572|FG003|Overall Study|Withdrawal by Subject|12|||
33517398|NCT00394771|101789569|FG000|Overall Study|Adverse Event|10|||
33517399|NCT00394771|101789570|FG001|Overall Study|Adverse Event|5|||
33517400|NCT00394771|101789571|FG002|Overall Study|Adverse Event|12|||
33517401|NCT00394771|101789572|FG003|Overall Study|Adverse Event|8|||
33517402|NCT00394771|101789569|FG000|Overall Study|Participant pregnant|0|||
33517403|NCT00394771|101789570|FG001|Overall Study|Participant pregnant|1|||
33517404|NCT00394771|101789571|FG002|Overall Study|Participant pregnant|2|||
33517405|NCT00394771|101789572|FG003|Overall Study|Participant pregnant|2|||
33517406|NCT00394771|101789569|FG000|Overall Study|Lost to Follow-up|15|||
33517407|NCT00394771|101789570|FG001|Overall Study|Lost to Follow-up|15|||
33517408|NCT00394771|101789571|FG002|Overall Study|Lost to Follow-up|13|||
33517409|NCT00394771|101789572|FG003|Overall Study|Lost to Follow-up|10|||
33517410|NCT00394771|101789569|FG000|Overall Study|Other|3|||
33517411|NCT00394771|101789570|FG001|Overall Study|Other|3|||
33517412|NCT00394771|101789571|FG002|Overall Study|Other|1|||
33199920|NCT00767000|100638144|FG003|54-week Study|Lost to Follow-up|4|||
33400381|NCT02382276|101353409|FG000|Overall Study|Adverse Event|7|||
33400382|NCT02382276|101353410|FG001|Overall Study|Adverse Event|2|||
33400383|NCT02382276|101353411|FG002|Overall Study|Adverse Event|32|||
33400384|NCT02382276|101353409|FG000|Overall Study|Physician Decision|0|||
33400385|NCT02382276|101353410|FG001|Overall Study|Physician Decision|0|||
33400386|NCT02382276|101353411|FG002|Overall Study|Physician Decision|2|||
33400387|NCT03480841|101353412|FG000|Overall Study|Lost to Follow-up|2|||
33400388|NCT03961529|101353413|FG000|Overall Study|Adverse Event|13|||
33400389|NCT03961529|101353414|FG001|Overall Study|Adverse Event|5|||
33400390|NCT03961529|101353415|FG002|Overall Study|Adverse Event|2|||
33400391|NCT03961529|101353413|FG000|Overall Study|Withdrawal by Subject|17|||
33400392|NCT03961529|101353414|FG001|Overall Study|Withdrawal by Subject|2|||
33400393|NCT03961529|101353415|FG002|Overall Study|Withdrawal by Subject|1|||
33400394|NCT03961529|101353413|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33400395|NCT03961529|101353414|FG001|Overall Study|Withdrawal by parent/guardian|7|||
33400396|NCT03961529|101353415|FG002|Overall Study|Withdrawal by parent/guardian|0|||
33400397|NCT03961529|101353413|FG000|Overall Study|Physician Decision|2|||
33400398|NCT03961529|101353414|FG001|Overall Study|Physician Decision|1|||
33400399|NCT03961529|101353415|FG002|Overall Study|Physician Decision|1|||
33400400|NCT03961529|101353413|FG000|Overall Study|Lost to Follow-up|2|||
33400401|NCT03961529|101353414|FG001|Overall Study|Lost to Follow-up|1|||
33400402|NCT03961529|101353415|FG002|Overall Study|Lost to Follow-up|0|||
33400403|NCT03961529|101353413|FG000|Overall Study|Lack of Efficacy|2|||
33400404|NCT03961529|101353414|FG001|Overall Study|Lack of Efficacy|0|||
33400405|NCT03961529|101353415|FG002|Overall Study|Lack of Efficacy|1|||
33400406|NCT03961529|101353413|FG000|Overall Study|Other|6|||
33400407|NCT03961529|101353414|FG001|Overall Study|Other|1|||
33400408|NCT03961529|101353415|FG002|Overall Study|Other|0|||
33400409|NCT01078974|101353416|FG000|Overall Study|Adverse Event|3|||
33400410|NCT02260791|101353417|FG000|Overall Study|Lost to Follow-up|4|||
33400411|NCT02260791|101353418|FG001|Overall Study|Lost to Follow-up|4|||
33400412|NCT02260791|101353417|FG000|Overall Study|Lack of Efficacy|2|||
33400413|NCT02260791|101353418|FG001|Overall Study|Lack of Efficacy|1|||
33400414|NCT02260791|101353417|FG000|Overall Study|Adverse Event|13|||
33400415|NCT02260791|101353418|FG001|Overall Study|Adverse Event|9|||
33400416|NCT02260791|101353417|FG000|Overall Study|Death|1|||
33400417|NCT02260791|101353418|FG001|Overall Study|Death|0|||
33400418|NCT02260791|101353417|FG000|Overall Study|Withdrawal by Subject|11|||
33400419|NCT02260791|101353418|FG001|Overall Study|Withdrawal by Subject|16|||
33400420|NCT02260791|101353417|FG000|Overall Study|Screen failure|0|||
33517413|NCT00394771|101789572|FG003|Overall Study|Other|0|||
33517414|NCT00637806|101789574|FG000|Double-blind Phase|Study Discontinued|2|||
33517415|NCT00637806|101789575|FG001|Double-blind Phase|Study Discontinued|0|||
33517416|NCT00637806|101789576|FG002|Double-blind Phase|Study Discontinued|1|||
33400421|NCT02260791|101353418|FG001|Overall Study|Screen failure|1|||
33400422|NCT02260791|101353417|FG000|Overall Study|Protocol deviation|2|||
33400423|NCT02260791|101353418|FG001|Overall Study|Protocol deviation|3|||
33400424|NCT03258762|101353421|FG000|Overall Study|Lost to Follow-up|0|||
33400425|NCT03258762|101353422|FG001|Overall Study|Lost to Follow-up|1|||
33400426|NCT02811640|101353423|FG000|Overall Study|Technology malfunction|2|||
33400427|NCT03590613|101353424|FG000|Period 2, 4 Days|Physician Decision|0|||
33400428|NCT03590613|101353425|FG001|Period 2, 4 Days|Physician Decision|0|||
33400429|NCT03590613|101353426|FG002|Period 2, 4 Days|Physician Decision|0|||
33517417|NCT00637806|101789577|FG003|Double-blind Phase|Study Discontinued|0|||
33517418|NCT00637806|101789574|FG000|Extension Phase|Study Discontinued|0|||
33517419|NCT00637806|101789575|FG001|Extension Phase|Study Discontinued|0|||
33517420|NCT00637806|101789576|FG002|Extension Phase|Study Discontinued|0|||
33517421|NCT00637806|101789577|FG003|Extension Phase|Study Discontinued|1|||
33517422|NCT01416155|101789578|FG000|Overall Study|Adverse Event|8|||
33517423|NCT01416155|101789578|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
33517424|NCT01416155|101789578|FG000|Overall Study|Withdrawal by Subject|33|||
33517425|NCT01416155|101789578|FG000|Overall Study|Investigator decision|8|||
33517426|NCT01416155|101789578|FG000|Overall Study|Other|7|||
33517427|NCT02670382|101789581|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
33517428|NCT02670382|101789582|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
33517429|NCT01625689|101789584|FG000|Overall Study|Migration|2|||
33517430|NCT01625689|101789585|FG001|Overall Study|Migration|1|||
33517431|NCT02908074|101789586|FG000|Overall Study|sponsor/ICON decision|0|||
33517432|NCT02908074|101789587|FG001|Overall Study|sponsor/ICON decision|0|||
33517433|NCT02908074|101789588|FG002|Overall Study|sponsor/ICON decision|1|||
33517434|NCT02908074|101789589|FG003|Overall Study|sponsor/ICON decision|0|||
33517435|NCT02908074|101789590|FG004|Overall Study|sponsor/ICON decision|0|||
33517436|NCT02908074|101789591|FG005|Overall Study|sponsor/ICON decision|0|||
33517437|NCT02908074|101789586|FG000|Overall Study|Protocol Violation|0|||
33517438|NCT02908074|101789587|FG001|Overall Study|Protocol Violation|1|||
33517439|NCT02908074|101789588|FG002|Overall Study|Protocol Violation|0|||
33517440|NCT02908074|101789589|FG003|Overall Study|Protocol Violation|0|||
33517441|NCT02908074|101789590|FG004|Overall Study|Protocol Violation|0|||
33517442|NCT02908074|101789591|FG005|Overall Study|Protocol Violation|0|||
33517443|NCT02908074|101789586|FG000|Overall Study|Adverse Event|5|||
33517444|NCT02908074|101789587|FG001|Overall Study|Adverse Event|2|||
33517445|NCT02908074|101789588|FG002|Overall Study|Adverse Event|0|||
33517446|NCT02908074|101789589|FG003|Overall Study|Adverse Event|0|||
33517447|NCT02908074|101789590|FG004|Overall Study|Adverse Event|1|||
33517448|NCT02908074|101789591|FG005|Overall Study|Adverse Event|0|||
33517449|NCT02908074|101789586|FG000|Overall Study|AESI|1|||
33517450|NCT02908074|101789587|FG001|Overall Study|AESI|0|||
33517451|NCT02908074|101789588|FG002|Overall Study|AESI|1|||
33517452|NCT02908074|101789589|FG003|Overall Study|AESI|0|||
33517453|NCT02908074|101789590|FG004|Overall Study|AESI|1|||
33517454|NCT02908074|101789591|FG005|Overall Study|AESI|0|||
33517455|NCT02908074|101789586|FG000|Overall Study|Discontinuation criteria per protocol|0|||
33517456|NCT02908074|101789587|FG001|Overall Study|Discontinuation criteria per protocol|0|||
33607767|NCT02951429|102114878|FG001|Overall Study|Participant ongoing in the study|17|||
33607768|NCT01345682|102114880|FG000|Overall Study|Progressive disease per RECIST|226|||
33607769|NCT01345682|102114881|FG001|Overall Study|Progressive disease per RECIST|93|||
33607770|NCT01345682|102114880|FG000|Overall Study|Worsening of underlying cancer disease|23|||
33607771|NCT01345682|102114881|FG001|Overall Study|Worsening of underlying cancer disease|12|||
33607772|NCT01345682|102114880|FG000|Overall Study|Adverse Event|51|||
33607773|NCT01345682|102114881|FG001|Overall Study|Adverse Event|41|||
33607774|NCT01345682|102114880|FG000|Overall Study|Non-compliance with protocol|0|||
33607775|NCT01345682|102114881|FG001|Overall Study|Non-compliance with protocol|1|||
33607776|NCT01345682|102114880|FG000|Overall Study|Lost to Follow-up|0|||
33607777|NCT01345682|102114881|FG001|Overall Study|Lost to Follow-up|1|||
33607778|NCT01345682|102114880|FG000|Overall Study|Refused to continue trial medication|16|||
33607779|NCT01345682|102114881|FG001|Overall Study|Refused to continue trial medication|9|||
33607780|NCT01345682|102114880|FG000|Overall Study|Not treated|2|||
33607781|NCT01345682|102114881|FG001|Overall Study|Not treated|1|||
33607782|NCT01345682|102114880|FG000|Overall Study|Reason other than those specified above|4|||
33607783|NCT01345682|102114881|FG001|Overall Study|Reason other than those specified above|3|||
33607784|NCT03429543|102114882|FG000|Overall Study|Adverse Event|1|||
33607785|NCT03429543|102114883|FG001|Overall Study|Adverse Event|1|||
33607786|NCT03429543|102114884|FG002|Overall Study|Adverse Event|0|||
33607787|NCT03429543|102114885|FG003|Overall Study|Adverse Event|0|||
33607788|NCT03429543|102114886|FG004|Overall Study|Adverse Event|0|||
33517457|NCT02908074|101789588|FG002|Overall Study|Discontinuation criteria per protocol|1|||
33517458|NCT02908074|101789589|FG003|Overall Study|Discontinuation criteria per protocol|0|||
33517459|NCT02908074|101789590|FG004|Overall Study|Discontinuation criteria per protocol|0|||
33517460|NCT02908074|101789591|FG005|Overall Study|Discontinuation criteria per protocol|1|||
33326596|NCT00766090|101091194|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33517461|NCT02908074|101789586|FG000|Overall Study|Withdrawal by Subject|3|||
33517462|NCT02908074|101789587|FG001|Overall Study|Withdrawal by Subject|2|||
33517463|NCT02908074|101789588|FG002|Overall Study|Withdrawal by Subject|2|||
33517464|NCT02908074|101789589|FG003|Overall Study|Withdrawal by Subject|2|||
33517465|NCT02908074|101789590|FG004|Overall Study|Withdrawal by Subject|2|||
33607789|NCT03429543|102114887|FG005|Overall Study|Adverse Event|2|||
33607790|NCT03429543|102114888|FG006|Overall Study|Adverse Event|0|||
33607791|NCT03429543|102114882|FG000|Overall Study|Lost to Follow-up|1|||
33517466|NCT02908074|101789591|FG005|Overall Study|Withdrawal by Subject|2|||
33517467|NCT02908074|101789586|FG000|Overall Study|Lost to Follow-up|0|||
33517468|NCT02908074|101789587|FG001|Overall Study|Lost to Follow-up|1|||
33199921|NCT00767000|100638145|FG004|54-week Study|Lost to Follow-up|2|||
33199922|NCT00767000|100638141|FG000|54-week Study|Physician Decision|4|||
33199923|NCT00767000|100638142|FG001|54-week Study|Physician Decision|0|||
33517469|NCT02908074|101789588|FG002|Overall Study|Lost to Follow-up|1|||
33517470|NCT02908074|101789589|FG003|Overall Study|Lost to Follow-up|1|||
33517471|NCT02908074|101789590|FG004|Overall Study|Lost to Follow-up|0|||
33517472|NCT02908074|101789591|FG005|Overall Study|Lost to Follow-up|1|||
33517473|NCT00741091|101789595|FG000|Overall Study|Death|13|||
33517474|NCT00741091|101789595|FG000|Overall Study|Lost to Follow-up|16|||
33517475|NCT00741091|101789595|FG000|Overall Study|Withdrawal by Subject|6|||
33517476|NCT00741091|101789595|FG000|Overall Study|Missed Visit|22|||
33517477|NCT01069419|101789596|FG000|Overall Study|Adverse Event|233|||
33517478|NCT01069419|101789596|FG000|Overall Study|Lack of Efficacy|332|||
33517479|NCT01069419|101789596|FG000|Overall Study|Lost to Follow-up|49|||
33517480|NCT01069419|101789596|FG000|Overall Study|Remission of disease|11|||
33517481|NCT01069419|101789596|FG000|Overall Study|Withdrawal by Subject|34|||
33517482|NCT01069419|101789596|FG000|Overall Study|Other Reason|43|||
33517483|NCT01069419|101789596|FG000|Overall Study|Missing termination information|13|||
33517484|NCT00207727|101789599|FG000|Overall Study|Withdrawal by Subject|0|||
33517485|NCT00207727|101789600|FG001|Overall Study|Withdrawal by Subject|0|||
33517486|NCT00207727|101789601|FG002|Overall Study|Withdrawal by Subject|0|||
33517487|NCT00207727|101789602|FG003|Overall Study|Withdrawal by Subject|0|||
33517488|NCT00207727|101789603|FG004|Overall Study|Withdrawal by Subject|1|||
33517489|NCT00207727|101789599|FG000|Overall Study|Lost to Follow-up|0|||
33517490|NCT00207727|101789600|FG001|Overall Study|Lost to Follow-up|1|||
33517491|NCT00207727|101789601|FG002|Overall Study|Lost to Follow-up|0|||
33517492|NCT00207727|101789602|FG003|Overall Study|Lost to Follow-up|0|||
33517493|NCT00207727|101789603|FG004|Overall Study|Lost to Follow-up|0|||
33199924|NCT00767000|100638143|FG002|54-week Study|Physician Decision|1|||
33199925|NCT00767000|100638144|FG003|54-week Study|Physician Decision|1|||
33199926|NCT00767000|100638145|FG004|54-week Study|Physician Decision|1|||
33199927|NCT00767000|100638141|FG000|54-week Study|Progressive disease|0|||
33517494|NCT00207727|101789599|FG000|Overall Study|Other|38|||
33517495|NCT00207727|101789600|FG001|Overall Study|Other|41|||
33199928|NCT00767000|100638142|FG001|54-week Study|Progressive disease|0|||
33199929|NCT00767000|100638143|FG002|54-week Study|Progressive disease|1|||
33199930|NCT00767000|100638144|FG003|54-week Study|Progressive disease|0|||
33199931|NCT00767000|100638145|FG004|54-week Study|Progressive disease|0|||
33199932|NCT00767000|100638141|FG000|54-week Study|Protocol Violation|0|||
33199933|NCT00767000|100638142|FG001|54-week Study|Protocol Violation|0|||
33199934|NCT00767000|100638143|FG002|54-week Study|Protocol Violation|1|||
33199935|NCT00767000|100638144|FG003|54-week Study|Protocol Violation|2|||
33199936|NCT00767000|100638145|FG004|54-week Study|Protocol Violation|0|||
33199937|NCT00767000|100638141|FG000|54-week Study|Withdrawal by Subject|2|||
33199938|NCT00767000|100638142|FG001|54-week Study|Withdrawal by Subject|3|||
33199939|NCT00767000|100638143|FG002|54-week Study|Withdrawal by Subject|5|||
33199940|NCT00767000|100638144|FG003|54-week Study|Withdrawal by Subject|11|||
33199941|NCT00767000|100638145|FG004|54-week Study|Withdrawal by Subject|13|||
33326597|NCT00766090|101091195|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33326598|NCT00766090|101091196|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
33517496|NCT00207727|101789601|FG002|Overall Study|Other|41|||
33517497|NCT00207727|101789602|FG003|Overall Study|Other|37|||
33517498|NCT00207727|101789603|FG004|Overall Study|Other|33|||
33517499|NCT00430352|101789604|FG000|Overall Study|Disease progression|58|||
33517500|NCT00430352|101789604|FG000|Overall Study|Withdrawal by Subject|11|||
33517501|NCT00430352|101789604|FG000|Overall Study|Adverse Event|16|||
33517502|NCT00430352|101789604|FG000|Overall Study|Death|5|||
33517503|NCT00430352|101789604|FG000|Overall Study|Other|48|||
33199942|NCT00767000|100638141|FG000|54-week Study|Study terminated by sponsor|90|||
33199943|NCT00767000|100638142|FG001|54-week Study|Study terminated by sponsor|102|||
33199944|NCT00767000|100638143|FG002|54-week Study|Study terminated by sponsor|89|||
33199945|NCT00767000|100638144|FG003|54-week Study|Study terminated by sponsor|196|||
33199946|NCT00767000|100638145|FG004|54-week Study|Study terminated by sponsor|194|||
33199947|NCT00767000|100638141|FG000|54-week Study|Reason not reported|0|||
33326599|NCT00766090|101091197|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33517504|NCT01124292|101789605|FG000|Overall Study|Lost to Follow-up|2|||
33199948|NCT00767000|100638142|FG001|54-week Study|Reason not reported|0|||
33517505|NCT01124292|101789606|FG001|Overall Study|Lost to Follow-up|4|||
33199949|NCT00767000|100638143|FG002|54-week Study|Reason not reported|0|||
33326600|NCT00766090|101091198|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33517506|NCT01124292|101789607|FG002|Overall Study|Lost to Follow-up|3|||
33517507|NCT01124292|101789605|FG000|Overall Study|Physician Decision|0|||
33517508|NCT01124292|101789606|FG001|Overall Study|Physician Decision|3|||
33517509|NCT01124292|101789607|FG002|Overall Study|Physician Decision|2|||
33517510|NCT01124292|101789605|FG000|Overall Study|Withdrawal by Subject|0|||
33517511|NCT01124292|101789606|FG001|Overall Study|Withdrawal by Subject|6|||
33199950|NCT00767000|100638144|FG003|54-week Study|Reason not reported|1|||
33199951|NCT00767000|100638145|FG004|54-week Study|Reason not reported|0|||
33326601|NCT00766090|101091199|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33517512|NCT01124292|101789607|FG002|Overall Study|Withdrawal by Subject|2|||
33517513|NCT01124292|101789605|FG000|Overall Study|medical issue unrelated to the study|0|||
33517514|NCT01124292|101789606|FG001|Overall Study|medical issue unrelated to the study|0|||
33517515|NCT01124292|101789607|FG002|Overall Study|medical issue unrelated to the study|2|||
33517516|NCT01124292|101789605|FG000|Overall Study|piercing track closed|0|||
33517517|NCT01124292|101789606|FG001|Overall Study|piercing track closed|2|||
33517518|NCT01124292|101789607|FG002|Overall Study|piercing track closed|1|||
33517519|NCT01935700|101789608|FG000|Overall Study|Withdrawal by Subject|1|||
33517520|NCT01935700|101789609|FG001|Overall Study|Withdrawal by Subject|0|||
33517521|NCT01935700|101789608|FG000|Overall Study|Physician Decision|4|||
33517522|NCT01935700|101789609|FG001|Overall Study|Physician Decision|0|||
33517523|NCT02457832|101789612|FG000|Training|Lost to Follow-up|10|||
33517524|NCT02457832|101789613|FG001|Training|Lost to Follow-up|6|||
33517525|NCT02457832|101789614|FG002|Training|Lost to Follow-up|3|||
33517526|NCT02457832|101789612|FG000|One Month Washout|Lost to Follow-up|0|||
33517527|NCT02457832|101789613|FG001|One Month Washout|Lost to Follow-up|1|||
33517528|NCT02457832|101789614|FG002|One Month Washout|Lost to Follow-up|1|||
33517529|NCT03570554|101789615|FG000|Overall Study|Non-compliance with study drug|0|||
33326602|NCT00766090|101091200|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33326603|NCT00766090|101091201|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33326604|NCT00766090|101091202|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33326605|NCT00766090|101091203|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
33517530|NCT03570554|101789616|FG001|Overall Study|Non-compliance with study drug|0|||
33517531|NCT03570554|101789617|FG002|Overall Study|Non-compliance with study drug|1|||
33517532|NCT03570554|101789618|FG003|Overall Study|Non-compliance with study drug|0|||
33517533|NCT03570554|101789615|FG000|Overall Study|Adverse Event|0|||
33517534|NCT03570554|101789616|FG001|Overall Study|Adverse Event|0|||
33400430|NCT03590613|101353427|FG003|Period 2, 4 Days|Physician Decision|1|||
33400431|NCT03049852|101353428|FG000|Overall Study|Lost to Follow-up|0|||
33400432|NCT03049852|101353429|FG001|Overall Study|Lost to Follow-up|1|||
33400433|NCT03049852|101353430|FG002|Overall Study|Lost to Follow-up|0|||
33400434|NCT00286156|101353435|FG000|Overall Study|Missed 12 month visit|0|||
33400435|NCT00286156|101353436|FG001|Overall Study|Missed 12 month visit|0|||
33517535|NCT03570554|101789617|FG002|Overall Study|Adverse Event|0|||
33607792|NCT03429543|102114883|FG001|Overall Study|Lost to Follow-up|0|||
33607793|NCT03429543|102114884|FG002|Overall Study|Lost to Follow-up|0|||
33607794|NCT03429543|102114885|FG003|Overall Study|Lost to Follow-up|0|||
33607795|NCT03429543|102114886|FG004|Overall Study|Lost to Follow-up|1|||
33607796|NCT03429543|102114887|FG005|Overall Study|Lost to Follow-up|0|||
33607797|NCT03429543|102114888|FG006|Overall Study|Lost to Follow-up|0|||
33607798|NCT03429543|102114882|FG000|Overall Study|Withdrawal by Subject|5|||
33607799|NCT03429543|102114883|FG001|Overall Study|Withdrawal by Subject|0|||
33607800|NCT03429543|102114884|FG002|Overall Study|Withdrawal by Subject|1|||
33326606|NCT02023242|101091206|FG000|Overall Study|Lost to Follow-up|3|||
33326607|NCT02023242|101091207|FG001|Overall Study|Lost to Follow-up|1|||
33326608|NCT02023242|101091206|FG000|Overall Study|Death|0|||
33326609|NCT02023242|101091207|FG001|Overall Study|Death|1|||
33326610|NCT01299376|101091208|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
33326611|NCT01299376|101091209|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
33326612|NCT01299376|101091208|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
33326613|NCT01299376|101091209|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
33326614|NCT01299376|101091208|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
33326615|NCT01299376|101091209|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
33400436|NCT00286156|101353437|FG002|Overall Study|Missed 12 month visit|1|||
33517536|NCT03570554|101789618|FG003|Overall Study|Adverse Event|1|||
33517537|NCT00525902|101789619|FG000|Overall Study|Lack of Efficacy|1|||
33607801|NCT03429543|102114885|FG003|Overall Study|Withdrawal by Subject|2|||
33607802|NCT03429543|102114886|FG004|Overall Study|Withdrawal by Subject|6|||
33607803|NCT03429543|102114887|FG005|Overall Study|Withdrawal by Subject|3|||
33607804|NCT03429543|102114888|FG006|Overall Study|Withdrawal by Subject|1|||
33607805|NCT03429543|102114882|FG000|Overall Study|Other reason than listed|0|||
33326616|NCT01299376|101091208|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
33326617|NCT01299376|101091209|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
33400437|NCT00286156|101353435|FG000|Overall Study|AE: pulmonary embolus|0|||
33400438|NCT00286156|101353436|FG001|Overall Study|AE: pulmonary embolus|1|||
33400439|NCT00286156|101353437|FG002|Overall Study|AE: pulmonary embolus|0|||
33517538|NCT01214252|101789620|FG000|Overall Study|Not eligible per protocol|82|||
33517539|NCT03782974|101789621|FG000|Overall Study|Withdrawal by Subject|7|||
33517540|NCT03782974|101789622|FG001|Overall Study|Withdrawal by Subject|7|||
33517541|NCT03782974|101789621|FG000|Overall Study|Pregnancy|1|||
33517542|NCT03782974|101789622|FG001|Overall Study|Pregnancy|0|||
33607806|NCT03429543|102114883|FG001|Overall Study|Other reason than listed|1|||
33326618|NCT01299376|101091208|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
33607807|NCT03429543|102114884|FG002|Overall Study|Other reason than listed|0|||
33607808|NCT03429543|102114885|FG003|Overall Study|Other reason than listed|0|||
33607809|NCT03429543|102114886|FG004|Overall Study|Other reason than listed|4|||
33607810|NCT03429543|102114887|FG005|Overall Study|Other reason than listed|4|||
33607811|NCT03429543|102114888|FG006|Overall Study|Other reason than listed|0|||
33607812|NCT03429543|102114882|FG000|Overall Study|Not treated|0|||
33607813|NCT03429543|102114883|FG001|Overall Study|Not treated|0|||
33607814|NCT03429543|102114884|FG002|Overall Study|Not treated|0|||
33607815|NCT03429543|102114885|FG003|Overall Study|Not treated|0|||
33607816|NCT03429543|102114886|FG004|Overall Study|Not treated|1|||
33607817|NCT03429543|102114887|FG005|Overall Study|Not treated|0|||
33607818|NCT03429543|102114888|FG006|Overall Study|Not treated|0|||
33607819|NCT01959243|102114889|FG000|Overall Study|Investigator Decision|3|||
33607820|NCT01959243|102114890|FG001|Overall Study|Investigator Decision|0|||
33607821|NCT01959243|102114889|FG000|Overall Study|Adverse Event|5|||
33607822|NCT01959243|102114890|FG001|Overall Study|Adverse Event|2|||
33607823|NCT01959243|102114889|FG000|Overall Study|Administrative reasons|2|||
33607824|NCT01959243|102114890|FG001|Overall Study|Administrative reasons|1|||
33607825|NCT01959243|102114889|FG000|Overall Study|Lost to Follow-up|3|||
33607826|NCT01959243|102114890|FG001|Overall Study|Lost to Follow-up|1|||
33607827|NCT00504894|102114898|FG000|Overall Study|fMRI technical problems|1|||
33607828|NCT00504894|102114899|FG001|Overall Study|fMRI technical problems|1|||
33607829|NCT00504894|102114900|FG002|Overall Study|fMRI technical problems|0|||
33607830|NCT00504894|102114898|FG000|Overall Study|Withdrawal by Subject|0|||
33607831|NCT00504894|102114899|FG001|Overall Study|Withdrawal by Subject|1|||
33607832|NCT00504894|102114900|FG002|Overall Study|Withdrawal by Subject|0|||
33607833|NCT00504894|102114898|FG000|Overall Study|Infusion technical problems|0|||
33607834|NCT00504894|102114899|FG001|Overall Study|Infusion technical problems|1|||
33607835|NCT00504894|102114900|FG002|Overall Study|Infusion technical problems|0|||
33607836|NCT00504894|102114898|FG000|Overall Study|poor subject data|2|||
33326619|NCT01299376|101091209|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
33326620|NCT01299376|101091208|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
33326621|NCT01299376|101091209|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
33326622|NCT01299376|101091208|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
33326623|NCT01299376|101091209|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
33326624|NCT01299376|101091208|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
33326625|NCT01299376|101091209|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
33326626|NCT01299376|101091208|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
33326627|NCT01299376|101091209|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
33607837|NCT00504894|102114899|FG001|Overall Study|poor subject data|0|||
33607838|NCT00504894|102114900|FG002|Overall Study|poor subject data|0|||
33607839|NCT01939366|102114901|FG000|Overall Study|Adverse Event|8|||
33607840|NCT01939366|102114902|FG001|Overall Study|Adverse Event|17|||
33607841|NCT01939366|102114903|FG002|Overall Study|Adverse Event|30|||
33607842|NCT01939366|102114904|FG003|Overall Study|Adverse Event|8|||
33607843|NCT01939366|102114905|FG004|Overall Study|Adverse Event|5|||
33607844|NCT01939366|102114901|FG000|Overall Study|Lack of Efficacy|2|||
33607845|NCT01939366|102114902|FG001|Overall Study|Lack of Efficacy|1|||
33607846|NCT01939366|102114903|FG002|Overall Study|Lack of Efficacy|1|||
33607847|NCT01939366|102114904|FG003|Overall Study|Lack of Efficacy|1|||
33607848|NCT01939366|102114905|FG004|Overall Study|Lack of Efficacy|3|||
33607849|NCT01939366|102114901|FG000|Overall Study|Lost to Follow-up|1|||
33607850|NCT01939366|102114902|FG001|Overall Study|Lost to Follow-up|1|||
33607851|NCT01939366|102114903|FG002|Overall Study|Lost to Follow-up|0|||
33607852|NCT01939366|102114904|FG003|Overall Study|Lost to Follow-up|0|||
33607853|NCT01939366|102114905|FG004|Overall Study|Lost to Follow-up|0|||
33607854|NCT01939366|102114901|FG000|Overall Study|Withdrawal by Subject|1|||
33607855|NCT01939366|102114902|FG001|Overall Study|Withdrawal by Subject|0|||
33607856|NCT01939366|102114903|FG002|Overall Study|Withdrawal by Subject|2|||
33607857|NCT01939366|102114904|FG003|Overall Study|Withdrawal by Subject|2|||
33607858|NCT01939366|102114905|FG004|Overall Study|Withdrawal by Subject|3|||
33326628|NCT01299376|101091208|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
33326629|NCT01299376|101091209|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
33326630|NCT01299376|101091208|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
33326631|NCT01299376|101091209|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
33326632|NCT00482703|101091210|FG000|Overall Study|Poor compliance|1|||
33326633|NCT00482703|101091211|FG001|Overall Study|Poor compliance|0|||
33326634|NCT00312221|101091212|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
33607859|NCT01939366|102114901|FG000|Overall Study|Inclusion criteria not met|0|||
33607860|NCT01939366|102114902|FG001|Overall Study|Inclusion criteria not met|1|||
33607861|NCT01939366|102114903|FG002|Overall Study|Inclusion criteria not met|1|||
33607862|NCT01939366|102114904|FG003|Overall Study|Inclusion criteria not met|0|||
33607863|NCT01939366|102114905|FG004|Overall Study|Inclusion criteria not met|1|||
33607864|NCT01939366|102114901|FG000|Overall Study|Other|0|||
33607865|NCT01939366|102114902|FG001|Overall Study|Other|0|||
33607866|NCT01939366|102114903|FG002|Overall Study|Other|2|||
33607867|NCT01939366|102114904|FG003|Overall Study|Other|2|||
33607868|NCT01939366|102114905|FG004|Overall Study|Other|1|||
33607869|NCT01939366|102114901|FG000|Overall Study|Protocol Violation|0|||
33517543|NCT02470403|101789623|FG000|Overall Study|Adverse Event|1|||
33517544|NCT02470403|101789624|FG001|Overall Study|Adverse Event|0|||
33517545|NCT02470403|101789625|FG002|Overall Study|Adverse Event|0|||
33517546|NCT02470403|101789626|FG003|Overall Study|Adverse Event|0|||
33517547|NCT02470403|101789627|FG004|Overall Study|Adverse Event|0|||
33517548|NCT02470403|101789623|FG000|Overall Study|Lost to Follow-up|0|||
33517549|NCT02470403|101789624|FG001|Overall Study|Lost to Follow-up|1|||
33517550|NCT02470403|101789625|FG002|Overall Study|Lost to Follow-up|0|||
33517551|NCT02470403|101789626|FG003|Overall Study|Lost to Follow-up|0|||
33517552|NCT02470403|101789627|FG004|Overall Study|Lost to Follow-up|0|||
33517553|NCT02470403|101789623|FG000|Overall Study|Subject/guardian decision|1|||
33607870|NCT01939366|102114902|FG001|Overall Study|Protocol Violation|0|||
33607871|NCT01939366|102114903|FG002|Overall Study|Protocol Violation|0|||
33517554|NCT02470403|101789624|FG001|Overall Study|Subject/guardian decision|0|||
33517555|NCT02470403|101789625|FG002|Overall Study|Subject/guardian decision|0|||
33517556|NCT02470403|101789626|FG003|Overall Study|Subject/guardian decision|4|||
33607872|NCT01939366|102114904|FG003|Overall Study|Protocol Violation|1|||
33607873|NCT01939366|102114905|FG004|Overall Study|Protocol Violation|0|||
33607874|NCT01939366|102114901|FG000|Overall Study|Sponsor decision|0|||
33607875|NCT01939366|102114902|FG001|Overall Study|Sponsor decision|0|||
33607876|NCT01939366|102114903|FG002|Overall Study|Sponsor decision|0|||
33607877|NCT01939366|102114904|FG003|Overall Study|Sponsor decision|0|||
33607878|NCT01939366|102114905|FG004|Overall Study|Sponsor decision|2|||
33607879|NCT01939366|102114901|FG000|Overall Study|GCP non-compliance at site|2|||
33607880|NCT01939366|102114902|FG001|Overall Study|GCP non-compliance at site|3|||
33607881|NCT01939366|102114903|FG002|Overall Study|GCP non-compliance at site|2|||
33607882|NCT01939366|102114904|FG003|Overall Study|GCP non-compliance at site|3|||
33607883|NCT01939366|102114905|FG004|Overall Study|GCP non-compliance at site|3|||
33607884|NCT02277119|102114910|FG000|Overall Study|Lack of Efficacy|1|||
33607885|NCT02277119|102114911|FG001|Overall Study|Lack of Efficacy|1|||
33607886|NCT02277119|102114912|FG002|Overall Study|Lack of Efficacy|1|||
33607887|NCT02277119|102114910|FG000|Overall Study|Protocol Violation|2|||
33607888|NCT02277119|102114911|FG001|Overall Study|Protocol Violation|3|||
33607889|NCT02277119|102114912|FG002|Overall Study|Protocol Violation|7|||
33607890|NCT01174173|102114915|FG000|Overall Study|drug-drug interaction|1|||
33517557|NCT02470403|101789627|FG004|Overall Study|Subject/guardian decision|0|||
33517558|NCT01706575|101789630|FG000|Overall Study|Participant Withdrew Consent|4|||
33517559|NCT01706575|101789630|FG000|Overall Study|Lost to Follow-up|2|||
33517560|NCT01706575|101789630|FG000|Overall Study|Started but not Treated|6|||
33517561|NCT01712334|101789631|FG000|Treatment Period 1|Randomized in Error|0|||
33517562|NCT01712334|101789632|FG001|Treatment Period 1|Randomized in Error|2|||
33517563|NCT01886781|101789633|FG000|Overall Study|Protocol Violation|5|||
33607891|NCT00383162|102114923|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
33607892|NCT00383162|102114924|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
33607893|NCT00383162|102114923|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
33607894|NCT00383162|102114924|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
33607895|NCT00383162|102114923|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
33607896|NCT00383162|102114924|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
33607897|NCT00383162|102114923|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
33607898|NCT00383162|102114924|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
33607899|NCT00383162|102114923|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
33607900|NCT00383162|102114924|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
33607901|NCT00383162|102114923|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
33607902|NCT00383162|102114924|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
33607903|NCT00383162|102114923|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
33607904|NCT00383162|102114924|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
33607905|NCT00383162|102114923|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
33607906|NCT00383162|102114924|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
33607907|NCT00383162|102114923|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
33607908|NCT00383162|102114924|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
33607909|NCT01092663|102114933|FG000|Overall Study|Withdrawal by Subject|3|||
33326635|NCT00312221|101091213|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
33326636|NCT00312221|101091214|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
33607910|NCT01092663|102114934|FG001|Overall Study|Withdrawal by Subject|2|||
33517564|NCT01886781|101789634|FG001|Overall Study|Protocol Violation|0|||
33517565|NCT01886781|101789633|FG000|Overall Study|Adverse Event|1|||
33517566|NCT01886781|101789634|FG001|Overall Study|Adverse Event|0|||
33517567|NCT01886781|101789633|FG000|Overall Study|Lost to Follow-up|5|||
33517568|NCT01886781|101789634|FG001|Overall Study|Lost to Follow-up|0|||
33607911|NCT01092663|102114933|FG000|Overall Study|Glucose >300mg/dL|1|||
33607912|NCT01092663|102114934|FG001|Overall Study|Glucose >300mg/dL|0|||
33607913|NCT01092663|102114933|FG000|Overall Study|High fasting triglyceride|2|||
33517569|NCT01886781|101789633|FG000|Overall Study|Withdrawal by Subject|2|||
33517570|NCT01886781|101789634|FG001|Overall Study|Withdrawal by Subject|1|||
33517571|NCT01886781|101789633|FG000|Overall Study|Worsening of symptoms|1|||
33517572|NCT01886781|101789634|FG001|Overall Study|Worsening of symptoms|1|||
33517573|NCT02223819|101789635|FG000|Overall Study|Lost to Follow-up|2|||
33517574|NCT00033657|101789642|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
33517575|NCT00033657|101789643|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
33517576|NCT00033657|101789642|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
33517577|NCT00033657|101789643|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
33517578|NCT00033657|101789642|FG000|Neoadjuvant Chemotherapy|Death|1|||
33517579|NCT00033657|101789643|FG001|Neoadjuvant Chemotherapy|Death|1|||
33517580|NCT00033657|101789642|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
33517581|NCT00033657|101789643|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
33517582|NCT00033657|101789642|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
33517583|NCT00033657|101789643|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
33517584|NCT00033657|101789642|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
33517585|NCT00033657|101789643|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
33517586|NCT00033657|101789642|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
33607914|NCT01092663|102114934|FG001|Overall Study|High fasting triglyceride|0|||
33607915|NCT01092663|102114933|FG000|Overall Study|Adverse Event|1|||
33607916|NCT01092663|102114934|FG001|Overall Study|Adverse Event|1|||
33607917|NCT01092663|102114933|FG000|Overall Study|Protocol Violation|0|||
33607918|NCT01092663|102114934|FG001|Overall Study|Protocol Violation|1|||
33607919|NCT01331291|102114935|FG000|Overall Study|Lack of Efficacy|2|||
33607920|NCT01331291|102114936|FG001|Overall Study|Lack of Efficacy|8|||
33607921|NCT01331291|102114935|FG000|Overall Study|Death|0|||
33199952|NCT00767000|100638141|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
33199953|NCT00767000|100638142|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
33199954|NCT00767000|100638143|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
33199955|NCT00767000|100638144|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
33199956|NCT00767000|100638145|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
33199957|NCT03738150|100638146|FG000|Base Study|Withdrawal by Subject|1|||
33199958|NCT03738150|100638146|FG000|Extension Study|Withdrawal by Subject|1|||
33199959|NCT01307501|100638147|FG000|Overall Study|Treatment Failure|1|||
33199960|NCT01307501|100638147|FG000|Overall Study|Death|20|||
33199961|NCT01307501|100638147|FG000|Overall Study|Lost to Follow-up|1|||
33199962|NCT01307501|100638147|FG000|Overall Study|Starting Hospice|1|||
33326637|NCT00312221|101091215|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
33326638|NCT00312221|101091212|FG000|Open-label Run-in Period|Adverse Event|74|||
33326639|NCT00312221|101091213|FG001|Open-label Run-in Period|Adverse Event|0|||
33199963|NCT00968617|100638148|FG000|Overall Study|Study terminated by sponsor|6|||
33326640|NCT00312221|101091214|FG002|Open-label Run-in Period|Adverse Event|0|||
33326641|NCT00312221|101091215|FG003|Open-label Run-in Period|Adverse Event|0|||
33326642|NCT00312221|101091212|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
33326643|NCT00312221|101091213|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
33326644|NCT00312221|101091214|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
33326645|NCT00312221|101091215|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
33326646|NCT00312221|101091212|FG000|Open-label Run-in Period|Administrative|42|||
33400440|NCT00286156|101353435|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
33400441|NCT00286156|101353436|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
33400442|NCT00286156|101353437|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
33400443|NCT00286156|101353435|FG000|Overall Study|AE: pneumonia|1|||
33400444|NCT00286156|101353436|FG001|Overall Study|AE: pneumonia|0|||
33400445|NCT00286156|101353437|FG002|Overall Study|AE: pneumonia|0|||
33400446|NCT01682759|101353441|FG000|Overall Study|Death|2|||
33400447|NCT01682759|101353442|FG001|Overall Study|Death|1|||
33400448|NCT01682759|101353441|FG000|Overall Study|Lost to Follow-up|10|||
33400449|NCT01682759|101353442|FG001|Overall Study|Lost to Follow-up|13|||
33400450|NCT01682759|101353441|FG000|Overall Study|Physician Decision|1|||
33199964|NCT01047683|100638149|FG000|Overall Study|Adverse Event|3|||
33199965|NCT01047683|100638150|FG001|Overall Study|Adverse Event|1|||
33326647|NCT00312221|101091213|FG001|Open-label Run-in Period|Administrative|0|||
33400451|NCT01682759|101353442|FG001|Overall Study|Physician Decision|1|||
33400452|NCT01682759|101353441|FG000|Overall Study|Withdrawal by Subject|56|||
33400453|NCT01682759|101353442|FG001|Overall Study|Withdrawal by Subject|55|||
33517587|NCT00033657|101789643|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
33607922|NCT01331291|102114936|FG001|Overall Study|Death|1|||
33607923|NCT01571232|102114940|FG000|Overall Study|Lost to Follow-up|0|||
33607924|NCT01571232|102114941|FG001|Overall Study|Lost to Follow-up|1|||
33199966|NCT01047683|100638151|FG002|Overall Study|Adverse Event|0|||
33199967|NCT01047683|100638149|FG000|Overall Study|Withdrew Consent|1|||
33607925|NCT01571232|102114940|FG000|Overall Study|Withdrawal by Subject|1|||
33326648|NCT00312221|101091214|FG002|Open-label Run-in Period|Administrative|0|||
33326649|NCT00312221|101091215|FG003|Open-label Run-in Period|Administrative|0|||
33326650|NCT00312221|101091212|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
33326651|NCT00312221|101091213|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
33326652|NCT00312221|101091214|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
33326653|NCT00312221|101091215|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
33326654|NCT00312221|101091212|FG000|Open-label Run-in Period|Did not qualify|5|||
33326655|NCT00312221|101091213|FG001|Open-label Run-in Period|Did not qualify|0|||
33326656|NCT00312221|101091214|FG002|Open-label Run-in Period|Did not qualify|0|||
33326657|NCT00312221|101091215|FG003|Open-label Run-in Period|Did not qualify|0|||
33326658|NCT00312221|101091212|FG000|Double-blind Phase|Withdrawal by Subject|0|||
33326659|NCT00312221|101091213|FG001|Double-blind Phase|Withdrawal by Subject|6|||
33326660|NCT00312221|101091214|FG002|Double-blind Phase|Withdrawal by Subject|8|||
33326661|NCT00312221|101091215|FG003|Double-blind Phase|Withdrawal by Subject|7|||
33326662|NCT00312221|101091212|FG000|Double-blind Phase|Adverse Event|0|||
33326663|NCT00312221|101091213|FG001|Double-blind Phase|Adverse Event|10|||
33326664|NCT00312221|101091214|FG002|Double-blind Phase|Adverse Event|19|||
33326665|NCT00312221|101091215|FG003|Double-blind Phase|Adverse Event|18|||
33326666|NCT00312221|101091212|FG000|Double-blind Phase|Lost to Follow-up|0|||
33326667|NCT00312221|101091213|FG001|Double-blind Phase|Lost to Follow-up|0|||
33326668|NCT00312221|101091214|FG002|Double-blind Phase|Lost to Follow-up|2|||
33326669|NCT00312221|101091215|FG003|Double-blind Phase|Lost to Follow-up|2|||
33326670|NCT00312221|101091212|FG000|Double-blind Phase|Administrative|0|||
33326671|NCT00312221|101091213|FG001|Double-blind Phase|Administrative|26|||
33326672|NCT00312221|101091214|FG002|Double-blind Phase|Administrative|37|||
33326673|NCT00312221|101091215|FG003|Double-blind Phase|Administrative|33|||
33326674|NCT00312221|101091212|FG000|Double-blind Phase|Lack of Efficacy|0|||
33326675|NCT00312221|101091213|FG001|Double-blind Phase|Lack of Efficacy|17|||
33326676|NCT00312221|101091214|FG002|Double-blind Phase|Lack of Efficacy|6|||
33326677|NCT00312221|101091215|FG003|Double-blind Phase|Lack of Efficacy|10|||
33326678|NCT01129921|101091216|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
33326679|NCT01129921|101091217|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
33326680|NCT01129921|101091216|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
33326681|NCT01129921|101091217|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
33326682|NCT01129921|101091216|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
33326683|NCT01129921|101091217|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
33326684|NCT01129921|101091216|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
33326685|NCT01129921|101091217|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
33326686|NCT03441334|101091221|FG000|Overall Study|Withdrawal by Subject|1|||
33326687|NCT03441334|101091222|FG001|Overall Study|Withdrawal by Subject|0|||
33326688|NCT01342484|101091227|FG000|Overall Study|Other Reasons|1|||
33326689|NCT01342484|101091228|FG001|Overall Study|Other Reasons|0|||
33326690|NCT01342484|101091229|FG002|Overall Study|Other Reasons|0|||
33326691|NCT01342484|101091227|FG000|Overall Study|Protocol Violation|0|||
33326692|NCT01342484|101091228|FG001|Overall Study|Protocol Violation|0|||
33326693|NCT01342484|101091229|FG002|Overall Study|Protocol Violation|1|||
33326694|NCT01342484|101091227|FG000|Overall Study|Withdrawal by Subject|1|||
33326695|NCT01342484|101091228|FG001|Overall Study|Withdrawal by Subject|0|||
33326696|NCT01342484|101091229|FG002|Overall Study|Withdrawal by Subject|0|||
33326697|NCT01022996|101091230|FG000|Overall Study|Adverse Event|14|||
33326698|NCT01022996|101091230|FG000|Overall Study|Withdrawal by Subject|3|||
33326699|NCT01022996|101091230|FG000|Overall Study|Lost to Follow-up|1|||
33326700|NCT01022996|101091230|FG000|Overall Study|Administrative problems|6|||
33326701|NCT01022996|101091230|FG000|Overall Study|Disease Progression|32|||
33326702|NCT01022996|101091230|FG000|Overall Study|Protocol Violation|1|||
33326703|NCT00121108|101091231|FG000|Overall Study|Lost to Follow-up|10|||
33326704|NCT00121108|101091232|FG001|Overall Study|Lost to Follow-up|22|||
33326705|NCT00121108|101091231|FG000|Overall Study|Withdrawal by Subject|106|||
33326706|NCT00121108|101091232|FG001|Overall Study|Withdrawal by Subject|195|||
33326707|NCT00121108|101091231|FG000|Overall Study|Death|5|||
33326708|NCT00121108|101091232|FG001|Overall Study|Death|8|||
33326709|NCT03574753|101091233|FG000|Overall Study|Adverse Event|3|||
33326710|NCT03574753|101091233|FG000|Overall Study|Progression/relapse|19|||
33326711|NCT03574753|101091233|FG000|Overall Study|Death|1|||
33517588|NCT00033657|101789642|FG000|Surgical Resection|not complete resection|0|||
33326712|NCT03000179|101091240|FG000|Overall Study|Lost to Follow-up|2|||
33326713|NCT01054144|101091245|FG000|Overall Study|Death|2|||
33326714|NCT00362414|101091246|FG000|Overall Study|Death|2|||
33326715|NCT00362414|101091246|FG000|Overall Study|Adverse Event|1|||
33326716|NCT01131520|101091249|FG000|Overall Study|Computer problem|1|||
33326717|NCT01131520|101091250|FG001|Overall Study|Computer problem|0|||
33326718|NCT01131520|101091249|FG000|Overall Study|Counselor not available|0|||
33326719|NCT01131520|101091250|FG001|Overall Study|Counselor not available|3|||
33326720|NCT01131520|101091249|FG000|Overall Study|Subject changed history after enrollment|0|||
33326721|NCT01131520|101091250|FG001|Overall Study|Subject changed history after enrollment|1|||
33326722|NCT03184077|101091251|FG000|Overall Study|Lost to Follow-up|21|||
33517589|NCT00033657|101789643|FG001|Surgical Resection|not complete resection|3|||
33607926|NCT01571232|102114941|FG001|Overall Study|Withdrawal by Subject|0|||
33607927|NCT00588094|102114944|FG000|Overall Study|Adverse Event|3|||
33607928|NCT00588094|102114944|FG000|Overall Study|Progression of Disease|2|||
33607929|NCT00737633|102114953|FG000|Overall Study|Study terminated by sponsor|44|||
33607930|NCT00737633|102114954|FG001|Overall Study|Study terminated by sponsor|55|||
33607931|NCT00737633|102114953|FG000|Overall Study|Lost to Follow-up|0|||
33607932|NCT00737633|102114954|FG001|Overall Study|Lost to Follow-up|1|||
33607933|NCT00737633|102114953|FG000|Overall Study|protocol non-compliance|0|||
33607934|NCT00737633|102114954|FG001|Overall Study|protocol non-compliance|1|||
33607935|NCT00094107|102114959|FG000|Overall Study|Lack of Efficacy|23|||
33607936|NCT00094107|102114959|FG000|Overall Study|Death|5|||
33607937|NCT00094107|102114959|FG000|Overall Study|Adverse Event|3|||
33607938|NCT00094107|102114959|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
33607939|NCT04896593|102114966|FG000|Overall Study|Withdrawal by Subject|2|||
33607940|NCT04896593|102114966|FG000|Overall Study|Lost to Follow-up|1|||
33607941|NCT04896593|102114966|FG000|Overall Study|Did not complete onboarding|2|||
33607942|NCT01353911|102114973|FG000|Overall Study|Lost to Follow-up|2|||
33607943|NCT01353911|102114974|FG001|Overall Study|Lost to Follow-up|6|||
33607944|NCT01353911|102114975|FG002|Overall Study|Lost to Follow-up|4|||
33607945|NCT01353911|102114976|FG003|Overall Study|Lost to Follow-up|0|||
33607946|NCT01353911|102114977|FG004|Overall Study|Lost to Follow-up|4|||
33607947|NCT01353911|102114978|FG005|Overall Study|Lost to Follow-up|4|||
33607948|NCT01353911|102114979|FG006|Overall Study|Lost to Follow-up|3|||
33607949|NCT01353911|102114980|FG007|Overall Study|Lost to Follow-up|6|||
33607950|NCT01353911|102114973|FG000|Overall Study|Withdrawal by Subject|2|||
33607951|NCT01353911|102114974|FG001|Overall Study|Withdrawal by Subject|3|||
33607952|NCT01353911|102114975|FG002|Overall Study|Withdrawal by Subject|4|||
33517590|NCT00033657|101789642|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
33517591|NCT00033657|101789643|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
33517592|NCT00033657|101789642|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
33517593|NCT00033657|101789643|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
33517594|NCT00033657|101789642|FG000|Adjuvant Chemotherapy|Death|2|||
33517595|NCT00033657|101789643|FG001|Adjuvant Chemotherapy|Death|1|||
33517596|NCT00033657|101789642|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
33517597|NCT00033657|101789643|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
33517598|NCT00033657|101789642|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
33517599|NCT00033657|101789643|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
33517600|NCT00033657|101789642|FG000|Adjuvant Chemotherapy|Other|0|||
33517601|NCT00033657|101789643|FG001|Adjuvant Chemotherapy|Other|2|||
33517602|NCT02418585|101789644|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
33517603|NCT02418585|101789645|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
33517604|NCT02418585|101789644|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
33517605|NCT02418585|101789645|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
33517606|NCT02418585|101789644|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
33517607|NCT02418585|101789645|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
33517608|NCT02418585|101789644|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
33517609|NCT02418585|101789645|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
33517610|NCT02418585|101789644|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
33517611|NCT02418585|101789645|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
33517612|NCT02418585|101789644|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
33517613|NCT02418585|101789645|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
33517614|NCT02418585|101789644|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
33517615|NCT02418585|101789645|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
33517616|NCT02418585|101789644|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
33517617|NCT02418585|101789645|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
33517618|NCT02418585|101789644|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
33517619|NCT02418585|101789645|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
33517620|NCT02418585|101789644|FG000|Follow-up Phase (24 Weeks)|Other|3|||
33517621|NCT02418585|101789645|FG001|Follow-up Phase (24 Weeks)|Other|2|||
33517622|NCT00616603|101789646|FG000|Overall Study|Physician Decision|2|||
33517623|NCT00616603|101789647|FG001|Overall Study|Physician Decision|0|||
33517624|NCT00616603|101789648|FG002|Overall Study|Physician Decision|2|||
33517625|NCT01420679|101789651|FG000|Overall Study|Disease Progression|3|||
33517626|NCT01420679|101789652|FG001|Overall Study|Disease Progression|2|||
33326723|NCT03184077|101091252|FG001|Overall Study|Lost to Follow-up|21|||
33517627|NCT01420679|101789651|FG000|Overall Study|Adverse Event|4|||
33517628|NCT01420679|101789652|FG001|Overall Study|Adverse Event|0|||
33517629|NCT01420679|101789651|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
33607953|NCT01353911|102114976|FG003|Overall Study|Withdrawal by Subject|2|||
33607954|NCT01353911|102114977|FG004|Overall Study|Withdrawal by Subject|2|||
33607955|NCT01353911|102114978|FG005|Overall Study|Withdrawal by Subject|3|||
33607956|NCT01353911|102114979|FG006|Overall Study|Withdrawal by Subject|3|||
33607957|NCT01353911|102114980|FG007|Overall Study|Withdrawal by Subject|9|||
33199968|NCT01047683|100638150|FG001|Overall Study|Withdrew Consent|4|||
33326724|NCT02246582|101091260|FG000|Overall Study|Withdrawal by Subject|3|||
33517630|NCT01420679|101789652|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
33517631|NCT01420679|101789651|FG000|Overall Study|Patient Decision|1|||
33517632|NCT01420679|101789652|FG001|Overall Study|Patient Decision|0|||
33517633|NCT01420679|101789651|FG000|Overall Study|Investigator Decision|1|||
33517634|NCT01420679|101789652|FG001|Overall Study|Investigator Decision|2|||
33517635|NCT01420679|101789651|FG000|Overall Study|Sponsor Decision|3|||
33517636|NCT01420679|101789652|FG001|Overall Study|Sponsor Decision|3|||
33517637|NCT01420679|101789651|FG000|Overall Study|Other|1|||
33517638|NCT01420679|101789652|FG001|Overall Study|Other|0|||
33517639|NCT04392167|101789656|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
33517640|NCT00908076|101789657|FG000|Overall Study|Lack of Efficacy|1|||
33517641|NCT00908076|101789658|FG001|Overall Study|Lack of Efficacy|1|||
33199969|NCT01047683|100638151|FG002|Overall Study|Withdrew Consent|2|||
33199970|NCT01047683|100638149|FG000|Overall Study|Lost to Follow-up|0|||
33199971|NCT01047683|100638150|FG001|Overall Study|Lost to Follow-up|1|||
33199972|NCT01047683|100638151|FG002|Overall Study|Lost to Follow-up|0|||
33199973|NCT01047683|100638149|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
33326725|NCT02246582|101091261|FG001|Overall Study|Withdrawal by Subject|4|||
33326726|NCT01667081|101091262|FG000|Overall Study|Death|43|||
33326727|NCT01667081|101091263|FG001|Overall Study|Death|3|||
33326728|NCT01667081|101091262|FG000|Overall Study|Lost to Follow-up|99|||
33326729|NCT01667081|101091263|FG001|Overall Study|Lost to Follow-up|48|||
33326730|NCT01667081|101091262|FG000|Overall Study|Physician Decision|16|||
33326731|NCT01667081|101091263|FG001|Overall Study|Physician Decision|2|||
33326732|NCT01667081|101091262|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
33326733|NCT01667081|101091263|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
33326734|NCT01667081|101091262|FG000|Overall Study|Withdrawal by Subject|90|||
33326735|NCT01667081|101091263|FG001|Overall Study|Withdrawal by Subject|35|||
33326736|NCT00618410|101091264|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
33326737|NCT00618410|101091265|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
33326738|NCT00445224|101091266|FG000|Specific Exercises|Withdrawal by Subject|3|||
33326739|NCT00445224|101091267|FG001|Specific Exercises|Withdrawal by Subject|3|||
33326740|NCT00445224|101091266|FG000|Specific Exercises|Withdrawal by Subject|1|||
33326741|NCT00445224|101091267|FG001|Specific Exercises|Withdrawal by Subject|0|||
33326742|NCT04353284|101091268|FG000|Overall Study|Adverse Event|1|||
33326743|NCT04353284|101091269|FG001|Overall Study|Adverse Event|1|||
33326744|NCT04353284|101091268|FG000|Overall Study|Lost to Follow-up|1|||
33326745|NCT04353284|101091269|FG001|Overall Study|Lost to Follow-up|0|||
33326746|NCT03625687|101091270|FG000|Overall Study|Death|1|||
33326747|NCT03823404|101091271|FG000|Overall Study|Lost to Follow-up|1|||
33326748|NCT03823404|101091272|FG001|Overall Study|Lost to Follow-up|2|||
33326749|NCT03823404|101091273|FG002|Overall Study|Lost to Follow-up|3|||
33326750|NCT03823404|101091271|FG000|Overall Study|Protocol Violation|2|||
33326751|NCT03823404|101091272|FG001|Overall Study|Protocol Violation|0|||
33326752|NCT03823404|101091273|FG002|Overall Study|Protocol Violation|2|||
33326753|NCT03823404|101091271|FG000|Overall Study|Adverse Event|35|||
33326754|NCT03823404|101091272|FG001|Overall Study|Adverse Event|38|||
33326755|NCT03823404|101091273|FG002|Overall Study|Adverse Event|8|||
33326756|NCT03823404|101091271|FG000|Overall Study|Withdrawal by Subject|38|||
33326757|NCT03823404|101091272|FG001|Overall Study|Withdrawal by Subject|40|||
33607958|NCT01353911|102114973|FG000|Overall Study|Status Not Recorded|4|||
33607959|NCT01353911|102114974|FG001|Overall Study|Status Not Recorded|0|||
33607960|NCT01353911|102114975|FG002|Overall Study|Status Not Recorded|1|||
33607961|NCT01353911|102114976|FG003|Overall Study|Status Not Recorded|0|||
33607962|NCT01353911|102114977|FG004|Overall Study|Status Not Recorded|0|||
33607963|NCT01353911|102114978|FG005|Overall Study|Status Not Recorded|0|||
33607964|NCT01353911|102114979|FG006|Overall Study|Status Not Recorded|0|||
33607965|NCT01353911|102114980|FG007|Overall Study|Status Not Recorded|0|||
33607966|NCT02175368|102114981|FG000|Overall Study|Lost to Follow-up|1|||
33607967|NCT03422536|102114984|FG000|Randomized|Physician Decision|1|||
33607968|NCT03422536|102114985|FG001|Randomized|Physician Decision|1|||
33607969|NCT03422536|102114984|FG000|Allocation - Received Intervention|Disease progression|19|||
33607970|NCT03422536|102114985|FG001|Allocation - Received Intervention|Disease progression|25|||
33607971|NCT03422536|102114984|FG000|Allocation - Received Intervention|Death|1|||
33607972|NCT03422536|102114985|FG001|Allocation - Received Intervention|Death|3|||
33517642|NCT03536949|101789660|FG000|Overall Study|Adverse Event|4|||
33517643|NCT03536949|101789661|FG001|Overall Study|Adverse Event|0|||
33517644|NCT03536949|101789660|FG000|Overall Study|Lost to Follow-up|2|||
33199974|NCT01047683|100638150|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
33199975|NCT01047683|100638151|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
33607973|NCT03422536|102114984|FG000|Allocation - Received Intervention|Adverse Event|1|||
33607974|NCT03422536|102114985|FG001|Allocation - Received Intervention|Adverse Event|0|||
33326758|NCT03823404|101091273|FG002|Overall Study|Withdrawal by Subject|35|||
33326759|NCT03823404|101091271|FG000|Overall Study|Death|4|||
33326760|NCT03823404|101091272|FG001|Overall Study|Death|0|||
33326761|NCT03823404|101091273|FG002|Overall Study|Death|0|||
33326762|NCT03823404|101091271|FG000|Overall Study|Other: Various reasons provided|5|||
33326763|NCT03823404|101091272|FG001|Overall Study|Other: Various reasons provided|5|||
33326764|NCT03823404|101091273|FG002|Overall Study|Other: Various reasons provided|6|||
33326765|NCT00475722|101091274|FG000|Overall Study|Withdrawal by Subject|12|||
33326766|NCT00475722|101091275|FG001|Overall Study|Withdrawal by Subject|12|||
33326767|NCT00475722|101091274|FG000|Overall Study|Protocol Violation|3|||
33326768|NCT00475722|101091275|FG001|Overall Study|Protocol Violation|0|||
33326769|NCT00733954|101091276|FG000|Overall Study|Lost to Follow-up|5|||
33326770|NCT00733954|101091277|FG001|Overall Study|Lost to Follow-up|2|||
33326771|NCT00733954|101091276|FG000|Overall Study|Protocol Violation|1|||
33326772|NCT00733954|101091277|FG001|Overall Study|Protocol Violation|0|||
33326773|NCT00733954|101091276|FG000|Overall Study|Withdrawal by Subject|2|||
33326774|NCT00733954|101091277|FG001|Overall Study|Withdrawal by Subject|0|||
33326775|NCT02613884|101091278|FG000|Overall Study|Death|1|||
33326776|NCT02613884|101091278|FG000|Overall Study|Lost to Follow-up|1|||
33326777|NCT02016820|101091285|FG000|Overall Study|Lost to Follow-up|2|||
33326778|NCT02016820|101091286|FG001|Overall Study|Lost to Follow-up|4|||
33326779|NCT01671111|101091287|FG000|Overall Study|Adverse Event|2|||
33326780|NCT01671111|101091287|FG000|Overall Study|Lack of Efficacy|1|||
33326781|NCT01671111|101091287|FG000|Overall Study|Withdrawal by Subject|2|||
33326782|NCT01671111|101091287|FG000|Overall Study|Physician Decision|1|||
33326783|NCT01671111|101091287|FG000|Overall Study|Other|24|||
33326784|NCT01423851|101091288|FG000|Whole Study|Disease progression|2|||
33517645|NCT03536949|101789661|FG001|Overall Study|Lost to Follow-up|1|||
33517646|NCT03536949|101789660|FG000|Overall Study|Withdrawal by Subject|6|||
33517647|NCT03536949|101789661|FG001|Overall Study|Withdrawal by Subject|0|||
33517648|NCT03536949|101789660|FG000|Overall Study|Non-compliance|2|||
33517649|NCT03536949|101789661|FG001|Overall Study|Non-compliance|1|||
33517650|NCT04679051|101789662|FG000|Overall Study|felt tired after restricted time in bed|3|||
33517651|NCT04679051|101789663|FG001|Overall Study|felt tired after restricted time in bed|0|||
33517652|NCT04679051|101789662|FG000|Overall Study|discomfort with blood pressure cuff|2|||
33517653|NCT04679051|101789663|FG001|Overall Study|discomfort with blood pressure cuff|0|||
33517654|NCT04679051|101789662|FG000|Overall Study|scheduling conflict|1|||
33517655|NCT04679051|101789663|FG001|Overall Study|scheduling conflict|1|||
33517656|NCT04679051|101789662|FG000|Overall Study|Protocol Violation|0|||
33517657|NCT04679051|101789663|FG001|Overall Study|Protocol Violation|4|||
33517658|NCT04327661|101789666|FG000|Overall Study|Withdrawal by Subject|1|||
33517659|NCT04327661|101789667|FG001|Overall Study|Withdrawal by Subject|0|||
33326785|NCT01423851|101091289|FG001|Whole Study|Disease progression|1|||
33326786|NCT01423851|101091290|FG002|Whole Study|Disease progression|1|||
33326787|NCT01423851|101091291|FG003|Whole Study|Disease progression|4|||
33326788|NCT01423851|101091292|FG004|Whole Study|Disease progression|1|||
33326789|NCT01423851|101091293|FG005|Whole Study|Disease progression|3|||
33326790|NCT01423851|101091294|FG006|Whole Study|Disease progression|1|||
33517660|NCT04327661|101789668|FG002|Overall Study|Withdrawal by Subject|0|||
33517661|NCT02614131|101789670|FG000|Overall Study|Withdrawal by Subject|1|||
33517662|NCT02614131|101789671|FG001|Overall Study|Withdrawal by Subject|0|||
33517663|NCT02614131|101789672|FG002|Overall Study|Withdrawal by Subject|0|||
33517664|NCT02614131|101789673|FG003|Overall Study|Withdrawal by Subject|0|||
33326791|NCT01423851|101091295|FG007|Whole Study|Disease progression|4|||
33326792|NCT01423851|101091296|FG008|Whole Study|Disease progression|0|||
33326793|NCT01423851|101091297|FG009|Whole Study|Disease progression|2|||
33326794|NCT01423851|101091298|FG010|Whole Study|Disease progression|10|||
33326795|NCT01423851|101091288|FG000|Whole Study|Physician Decision|0|||
33326796|NCT01423851|101091289|FG001|Whole Study|Physician Decision|1|||
33326797|NCT01423851|101091290|FG002|Whole Study|Physician Decision|2|||
33326798|NCT01423851|101091291|FG003|Whole Study|Physician Decision|0|||
33326799|NCT01423851|101091292|FG004|Whole Study|Physician Decision|2|||
33326800|NCT01423851|101091293|FG005|Whole Study|Physician Decision|0|||
33326801|NCT01423851|101091294|FG006|Whole Study|Physician Decision|2|||
33326802|NCT01423851|101091295|FG007|Whole Study|Physician Decision|1|||
33517665|NCT02614131|101789674|FG004|Overall Study|Withdrawal by Subject|0|||
33517666|NCT02614131|101789675|FG005|Overall Study|Withdrawal by Subject|0|||
33517667|NCT02614131|101789676|FG006|Overall Study|Withdrawal by Subject|0|||
33517668|NCT02614131|101789670|FG000|Overall Study|Adverse Event|0|||
33517669|NCT02614131|101789671|FG001|Overall Study|Adverse Event|0|||
33326803|NCT01423851|101091296|FG008|Whole Study|Physician Decision|3|||
33326804|NCT01423851|101091297|FG009|Whole Study|Physician Decision|4|||
33326805|NCT01423851|101091298|FG010|Whole Study|Physician Decision|12|||
33326806|NCT01423851|101091288|FG000|Whole Study|Withdrawal by Subject|1|||
33326807|NCT01423851|101091289|FG001|Whole Study|Withdrawal by Subject|1|||
33326808|NCT01423851|101091290|FG002|Whole Study|Withdrawal by Subject|0|||
33326809|NCT01423851|101091291|FG003|Whole Study|Withdrawal by Subject|0|||
33326810|NCT01423851|101091292|FG004|Whole Study|Withdrawal by Subject|0|||
33326811|NCT01423851|101091293|FG005|Whole Study|Withdrawal by Subject|0|||
33517670|NCT02614131|101789672|FG002|Overall Study|Adverse Event|0|||
33517671|NCT02614131|101789673|FG003|Overall Study|Adverse Event|0|||
33517672|NCT02614131|101789674|FG004|Overall Study|Adverse Event|0|||
33517673|NCT02614131|101789675|FG005|Overall Study|Adverse Event|0|||
33517674|NCT02614131|101789676|FG006|Overall Study|Adverse Event|1|||
33517675|NCT02258542|101789683|FG000|Overall Study|eg. not made to the visit|7|||
33517676|NCT02258542|101789684|FG001|Overall Study|eg. not made to the visit|4|||
33517677|NCT02258542|101789685|FG002|Overall Study|eg. not made to the visit|0|||
33517678|NCT02258542|101789686|FG003|Overall Study|eg. not made to the visit|1|||
33607975|NCT03422536|102114984|FG000|Allocation - Received Intervention|Physician Decision|1|||
33607976|NCT03422536|102114985|FG001|Allocation - Received Intervention|Physician Decision|1|||
33607977|NCT03422536|102114984|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
33607978|NCT03422536|102114985|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
33607979|NCT03422536|102114984|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
33517679|NCT02258542|101789683|FG000|Overall Study|study specific discount. criteria|1|||
33517680|NCT02258542|101789684|FG001|Overall Study|study specific discount. criteria|1|||
33607980|NCT03422536|102114985|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
33607981|NCT01041287|102114991|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
33607982|NCT01041287|102114992|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
33607983|NCT01041287|102114991|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
33607984|NCT01041287|102114992|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
33607985|NCT02726022|102114993|FG000|Overall Study|Adverse Event|14|||
33607986|NCT02726022|102114993|FG000|Overall Study|Treatment Failure|8|||
33607987|NCT02726022|102114993|FG000|Overall Study|Poor Compliance|13|||
33607988|NCT02726022|102114993|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
33607989|NCT04576897|102114994|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
33326812|NCT01423851|101091294|FG006|Whole Study|Withdrawal by Subject|0|||
33517681|NCT02258542|101789685|FG002|Overall Study|study specific discount. criteria|0|||
33607990|NCT05320393|102114995|FG000|Overall Study|Withdrawal by Subject|1|||
33517682|NCT02258542|101789686|FG003|Overall Study|study specific discount. criteria|0|||
33517683|NCT02258542|101789683|FG000|Overall Study|Withdrawal by Subject|20|||
33517684|NCT02258542|101789684|FG001|Overall Study|Withdrawal by Subject|20|||
33517685|NCT02258542|101789685|FG002|Overall Study|Withdrawal by Subject|7|||
33517686|NCT02258542|101789686|FG003|Overall Study|Withdrawal by Subject|1|||
33517687|NCT02258542|101789683|FG000|Overall Study|Lost to Follow-up|5|||
33517688|NCT02258542|101789684|FG001|Overall Study|Lost to Follow-up|12|||
33517689|NCT02258542|101789685|FG002|Overall Study|Lost to Follow-up|1|||
33517690|NCT02258542|101789686|FG003|Overall Study|Lost to Follow-up|2|||
33517691|NCT02258542|101789683|FG000|Overall Study|Death|5|||
33517692|NCT02258542|101789684|FG001|Overall Study|Death|4|||
33199976|NCT00975975|100638152|FG000|Overall Study|Death|6|||
33199977|NCT02731131|100638153|FG000|Overall Study|Psychiatric Disorder|0|||
33199978|NCT02731131|100638154|FG001|Overall Study|Psychiatric Disorder|1|||
33199979|NCT02731131|100638153|FG000|Overall Study|Refused Therapy|0|||
33199980|NCT02731131|100638154|FG001|Overall Study|Refused Therapy|1|||
33199981|NCT01033747|100638156|FG000|Overall Study|Adverse Event|9|||
33199982|NCT01033747|100638157|FG001|Overall Study|Adverse Event|4|||
33199983|NCT01033747|100638156|FG000|Overall Study|Abnormal Laboratory Value|1|||
33199984|NCT01033747|100638157|FG001|Overall Study|Abnormal Laboratory Value|0|||
33199985|NCT01033747|100638156|FG000|Overall Study|Abnormal test procedure|0|||
33199986|NCT01033747|100638157|FG001|Overall Study|Abnormal test procedure|1|||
33199987|NCT01033747|100638156|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
33199988|NCT01033747|100638157|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
33199989|NCT01033747|100638156|FG000|Overall Study|Protocol Violation|1|||
33199990|NCT01033747|100638157|FG001|Overall Study|Protocol Violation|0|||
33199991|NCT01033747|100638156|FG000|Overall Study|Withdrawal by Subject|9|||
33199992|NCT01033747|100638157|FG001|Overall Study|Withdrawal by Subject|6|||
33326813|NCT01423851|101091295|FG007|Whole Study|Withdrawal by Subject|0|||
33326814|NCT01423851|101091296|FG008|Whole Study|Withdrawal by Subject|2|||
33326815|NCT01423851|101091297|FG009|Whole Study|Withdrawal by Subject|0|||
33326816|NCT01423851|101091298|FG010|Whole Study|Withdrawal by Subject|4|||
33326817|NCT01423851|101091288|FG000|Whole Study|Adverse Event|0|||
33326818|NCT01423851|101091289|FG001|Whole Study|Adverse Event|0|||
33326819|NCT01423851|101091290|FG002|Whole Study|Adverse Event|0|||
33400454|NCT04109066|101353443|FG000|Pre-treatment|Participant withdrew consent|2|||
33517693|NCT02258542|101789685|FG002|Overall Study|Death|0|||
33517694|NCT02258542|101789686|FG003|Overall Study|Death|1|||
33517695|NCT02258542|101789683|FG000|Overall Study|Adverse Event|3|||
33517696|NCT02258542|101789684|FG001|Overall Study|Adverse Event|4|||
33517697|NCT02258542|101789685|FG002|Overall Study|Adverse Event|0|||
33517698|NCT02258542|101789686|FG003|Overall Study|Adverse Event|0|||
33607991|NCT05320393|102114996|FG001|Overall Study|Withdrawal by Subject|0|||
33607992|NCT05320393|102114997|FG002|Overall Study|Withdrawal by Subject|2|||
33199993|NCT01033747|100638156|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
33326820|NCT01423851|101091291|FG003|Whole Study|Adverse Event|2|||
33326821|NCT01423851|101091292|FG004|Whole Study|Adverse Event|0|||
33326822|NCT01423851|101091293|FG005|Whole Study|Adverse Event|0|||
33326823|NCT01423851|101091294|FG006|Whole Study|Adverse Event|0|||
33326824|NCT01423851|101091295|FG007|Whole Study|Adverse Event|3|||
33326825|NCT01423851|101091296|FG008|Whole Study|Adverse Event|3|||
33326826|NCT01423851|101091297|FG009|Whole Study|Adverse Event|2|||
33326827|NCT01423851|101091298|FG010|Whole Study|Adverse Event|3|||
33326828|NCT00682448|101091299|FG000|Overall Study|Adverse Event|1|||
33326829|NCT00682448|101091300|FG001|Overall Study|Adverse Event|2|||
33326830|NCT00682448|101091299|FG000|Overall Study|Lack of Efficacy|1|||
33326831|NCT00682448|101091300|FG001|Overall Study|Lack of Efficacy|0|||
33326832|NCT00682448|101091299|FG000|Overall Study|Lost to Follow-up|1|||
33326833|NCT00682448|101091300|FG001|Overall Study|Lost to Follow-up|3|||
33326834|NCT00682448|101091299|FG000|Overall Study|Pregnancy|0|||
33326835|NCT00682448|101091300|FG001|Overall Study|Pregnancy|1|||
33326836|NCT00682448|101091299|FG000|Overall Study|Withdrawal by Subject|2|||
33326837|NCT00682448|101091300|FG001|Overall Study|Withdrawal by Subject|0|||
33326838|NCT01572675|101091301|FG000|Overall Study|End of prescribed treatment|140|||
33326839|NCT01572675|101091302|FG001|Overall Study|End of prescribed treatment|118|||
33199994|NCT01033747|100638157|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
33326840|NCT01572675|101091301|FG000|Overall Study|Recovery|16|||
33326841|NCT01572675|101091302|FG001|Overall Study|Recovery|23|||
33326842|NCT01572675|101091301|FG000|Overall Study|Lack of Efficacy|31|||
33326843|NCT01572675|101091302|FG001|Overall Study|Lack of Efficacy|31|||
33326844|NCT01572675|101091301|FG000|Overall Study|Intolerance|6|||
33326845|NCT01572675|101091302|FG001|Overall Study|Intolerance|5|||
33326846|NCT01572675|101091301|FG000|Overall Study|Improved symptoms|8|||
33326847|NCT01572675|101091302|FG001|Overall Study|Improved symptoms|2|||
33326848|NCT01572675|101091301|FG000|Overall Study|Surgical intervention|3|||
33326849|NCT01572675|101091302|FG001|Overall Study|Surgical intervention|6|||
33326850|NCT01572675|101091301|FG000|Overall Study|Withdrawal by Subject|5|||
33326851|NCT01572675|101091302|FG001|Overall Study|Withdrawal by Subject|1|||
33326852|NCT01572675|101091301|FG000|Overall Study|Physician Decision|2|||
33326853|NCT01572675|101091302|FG001|Overall Study|Physician Decision|2|||
33326854|NCT01572675|101091301|FG000|Overall Study|Death unrelated to coxibs|1|||
33326855|NCT01572675|101091302|FG001|Overall Study|Death unrelated to coxibs|1|||
33326856|NCT01572675|101091301|FG000|Overall Study|Other disease detected|1|||
33326857|NCT01572675|101091302|FG001|Overall Study|Other disease detected|1|||
33326858|NCT01572675|101091301|FG000|Overall Study|Unknown reason|1|||
33326859|NCT01572675|101091302|FG001|Overall Study|Unknown reason|1|||
33326860|NCT01572675|101091301|FG000|Overall Study|Rheumatologist new evaluation|0|||
33326861|NCT01572675|101091302|FG001|Overall Study|Rheumatologist new evaluation|1|||
33326862|NCT01572675|101091301|FG000|Overall Study|Missing data|1|||
33326863|NCT01572675|101091302|FG001|Overall Study|Missing data|4|||
33326864|NCT01572675|101091301|FG000|Overall Study|Lost to Follow-up|22|||
33326865|NCT01572675|101091302|FG001|Overall Study|Lost to Follow-up|27|||
33199995|NCT01033747|100638156|FG000|Overall Study|Stopped at end of Extension 1|2|||
33326866|NCT00397033|101091303|FG000|Overall Study|Adverse Event|7|||
33326867|NCT00397033|101091304|FG001|Overall Study|Adverse Event|10|||
33326868|NCT00397033|101091305|FG002|Overall Study|Adverse Event|4|||
33326869|NCT00397033|101091303|FG000|Overall Study|Lack of Efficacy|22|||
33326870|NCT00397033|101091304|FG001|Overall Study|Lack of Efficacy|12|||
33326871|NCT00397033|101091305|FG002|Overall Study|Lack of Efficacy|9|||
33326872|NCT00397033|101091303|FG000|Overall Study|Lost to Follow-up|3|||
33326873|NCT00397033|101091304|FG001|Overall Study|Lost to Follow-up|3|||
33326874|NCT00397033|101091305|FG002|Overall Study|Lost to Follow-up|3|||
33326875|NCT00397033|101091303|FG000|Overall Study|Withdrawal by Subject|12|||
33326876|NCT00397033|101091304|FG001|Overall Study|Withdrawal by Subject|7|||
33326877|NCT00397033|101091305|FG002|Overall Study|Withdrawal by Subject|5|||
33326878|NCT00397033|101091303|FG000|Overall Study|Other|0|||
33326879|NCT00397033|101091304|FG001|Overall Study|Other|5|||
33326880|NCT00397033|101091305|FG002|Overall Study|Other|2|||
33326881|NCT02535715|101091308|FG000|Overall Study|Withdrawal by Subject|0|||
33326882|NCT02535715|101091309|FG001|Overall Study|Withdrawal by Subject|0|||
33326883|NCT02535715|101091310|FG002|Overall Study|Withdrawal by Subject|1|||
33400455|NCT04109066|101353444|FG001|Pre-treatment|Participant withdrew consent|0|||
33326884|NCT01372150|101091312|FG000|Overall Study|Lack of Efficacy|3|||
33400456|NCT04109066|101353443|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
33326885|NCT01372150|101091313|FG001|Overall Study|Lack of Efficacy|0|||
33326886|NCT01372150|101091314|FG002|Overall Study|Lack of Efficacy|1|||
33326887|NCT01372150|101091312|FG000|Overall Study|Lost to Follow-up|4|||
33326888|NCT01372150|101091313|FG001|Overall Study|Lost to Follow-up|5|||
33326889|NCT01372150|101091314|FG002|Overall Study|Lost to Follow-up|6|||
33326890|NCT01372150|101091312|FG000|Overall Study|Protocol Violation|1|||
33517699|NCT02258542|101789683|FG000|Overall Study|Protocol Violation|1|||
33517700|NCT02258542|101789684|FG001|Overall Study|Protocol Violation|2|||
33517701|NCT02258542|101789685|FG002|Overall Study|Protocol Violation|0|||
33517702|NCT02258542|101789686|FG003|Overall Study|Protocol Violation|0|||
33517703|NCT02258542|101789683|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33517704|NCT02258542|101789684|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
33517705|NCT02258542|101789685|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
33517706|NCT02258542|101789686|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
33199996|NCT01033747|100638157|FG001|Overall Study|Stopped at end of Extension 1|0|||
33199997|NCT02080091|100638158|FG000|Overall Study|Study Terminated|22|||
33199998|NCT02080091|100638158|FG000|Overall Study|Death|1|||
33199999|NCT02080091|100638158|FG000|Overall Study|Withdrawal by Subject|1|||
33200000|NCT02080091|100638158|FG000|Overall Study|Other|1|||
33200001|NCT01427712|100638159|FG000|Overall Study|Transfer to a different hospital|2|||
33517707|NCT01047332|101789687|FG000|Overall Study|SEMS Obstruction|11|||
33517708|NCT01047332|101789688|FG001|Overall Study|SEMS Obstruction|20|||
33517709|NCT01047332|101789687|FG000|Overall Study|Died Unobstructed|38|||
33517710|NCT01047332|101789688|FG001|Overall Study|Died Unobstructed|41|||
33517711|NCT01047332|101789687|FG000|Overall Study|Lost to Follow-up|8|||
33517712|NCT01047332|101789688|FG001|Overall Study|Lost to Follow-up|3|||
33517713|NCT03309696|101789689|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
33517714|NCT03309696|101789690|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
33517715|NCT03309696|101789691|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
33517716|NCT03309696|101789692|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
33517717|NCT02919267|101789695|FG000|Overall Study|Protocol Violation|0|||
33517718|NCT02919267|101789696|FG001|Overall Study|Protocol Violation|3|||
33517719|NCT02919267|101789697|FG002|Overall Study|Protocol Violation|3|||
33517720|NCT02919267|101789698|FG003|Overall Study|Protocol Violation|4|||
33517721|NCT00979420|101789699|FG000|Overall Study|Adverse Event|1|||
33517722|NCT00979420|101789700|FG001|Overall Study|Adverse Event|0|||
33517723|NCT00979420|101789701|FG002|Overall Study|Adverse Event|0|||
33517724|NCT00979420|101789702|FG003|Overall Study|Adverse Event|0|||
33517725|NCT00979420|101789699|FG000|Overall Study|Lack of Efficacy|3|||
33517726|NCT00979420|101789700|FG001|Overall Study|Lack of Efficacy|0|||
33517727|NCT00979420|101789701|FG002|Overall Study|Lack of Efficacy|1|||
33517728|NCT00979420|101789702|FG003|Overall Study|Lack of Efficacy|1|||
33517729|NCT00979420|101789699|FG000|Overall Study|Other reasons not related to Viramune|3|||
33517730|NCT00979420|101789700|FG001|Overall Study|Other reasons not related to Viramune|0|||
33517731|NCT00979420|101789701|FG002|Overall Study|Other reasons not related to Viramune|0|||
33517732|NCT00979420|101789702|FG003|Overall Study|Other reasons not related to Viramune|1|||
33517733|NCT01267201|101789703|FG000|First Intervention Period|Withdrawal by Subject|1|||
33517734|NCT01267201|101789704|FG001|First Intervention Period|Withdrawal by Subject|0|||
33517735|NCT01267201|101789705|FG002|First Intervention Period|Withdrawal by Subject|0|||
33517736|NCT01267201|101789706|FG003|First Intervention Period|Withdrawal by Subject|0|||
33517737|NCT01267201|101789707|FG004|First Intervention Period|Withdrawal by Subject|0|||
33517738|NCT01267201|101789708|FG005|First Intervention Period|Withdrawal by Subject|0|||
33607993|NCT05320393|102114995|FG000|Overall Study|Lost to Follow-up|1|||
33607994|NCT05320393|102114996|FG001|Overall Study|Lost to Follow-up|2|||
33607995|NCT05320393|102114997|FG002|Overall Study|Lost to Follow-up|1|||
33607996|NCT05320393|102114995|FG000|Overall Study|Moved; too much driving|0|||
33607997|NCT05320393|102114996|FG001|Overall Study|Moved; too much driving|0|||
33607998|NCT05320393|102114997|FG002|Overall Study|Moved; too much driving|2|||
33607999|NCT05320393|102114995|FG000|Overall Study|Did not receive treatment|0|||
33608000|NCT05320393|102114996|FG001|Overall Study|Did not receive treatment|0|||
33608001|NCT05320393|102114997|FG002|Overall Study|Did not receive treatment|1|||
33200002|NCT01427712|100638159|FG000|Overall Study|Lost to Follow-up|1|||
33200003|NCT01427712|100638159|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
33200004|NCT01427712|100638159|FG000|Overall Study|Failure to visit|1|||
33200005|NCT03766646|100638173|FG000|Overall Study|Withdrawal by Subject|1|||
33200006|NCT03766646|100638174|FG001|Overall Study|Withdrawal by Subject|0|||
33200007|NCT03766646|100638173|FG000|Overall Study|Protocol Violation|0|||
33200008|NCT03766646|100638174|FG001|Overall Study|Protocol Violation|3|||
33200009|NCT02041429|100638175|FG000|Overall Study|Progressive Disease|2|||
33200010|NCT02041429|100638176|FG001|Overall Study|Progressive Disease|2|||
33200011|NCT02041429|100638177|FG002|Overall Study|Progressive Disease|3|||
33200012|NCT02041429|100638178|FG003|Overall Study|Progressive Disease|2|||
33200013|NCT02041429|100638175|FG000|Overall Study|Toxicity|0|||
33200014|NCT02041429|100638176|FG001|Overall Study|Toxicity|1|||
33200015|NCT02041429|100638177|FG002|Overall Study|Toxicity|4|||
33517739|NCT01267201|101789703|FG000|Second Intervention Period|Withdrawal by Subject|0|||
33517740|NCT01267201|101789704|FG001|Second Intervention Period|Withdrawal by Subject|1|||
33517741|NCT01267201|101789705|FG002|Second Intervention Period|Withdrawal by Subject|0|||
33517742|NCT01267201|101789706|FG003|Second Intervention Period|Withdrawal by Subject|0|||
33608002|NCT04268173|102114999|FG000|Overall Study|Lost to Follow-up|75|||
33608003|NCT04268173|102115000|FG001|Overall Study|Lost to Follow-up|108|||
33200016|NCT02041429|100638178|FG003|Overall Study|Toxicity|2|||
33608004|NCT03052816|102115001|FG000|Overall Study|Withdrawal by Subject|1|||
33608005|NCT03052816|102115002|FG001|Overall Study|Withdrawal by Subject|0|||
33608006|NCT03052816|102115001|FG000|Overall Study|Desired opioids|2|||
33608007|NCT03052816|102115002|FG001|Overall Study|Desired opioids|0|||
33608008|NCT00844558|102115004|FG000|Overall Study|Withdrawal by Subject|9|||
33608009|NCT00844558|102115005|FG001|Overall Study|Withdrawal by Subject|2|||
33608010|NCT00844558|102115004|FG000|Overall Study|Death|1|||
33608011|NCT00844558|102115005|FG001|Overall Study|Death|0|||
33608012|NCT00844558|102115004|FG000|Overall Study|Protocol Violation|1|||
33608013|NCT00844558|102115005|FG001|Overall Study|Protocol Violation|1|||
33608014|NCT00844558|102115004|FG000|Overall Study|Lost to Follow-up|0|||
33608015|NCT00844558|102115005|FG001|Overall Study|Lost to Follow-up|1|||
33608016|NCT00844558|102115004|FG000|Overall Study|Physician Decision|1|||
33608017|NCT00844558|102115005|FG001|Overall Study|Physician Decision|0|||
33608018|NCT00454181|102115006|FG000|Overall Study|Adverse Event|1|||
33608019|NCT00454181|102115007|FG001|Overall Study|Adverse Event|1|||
33608020|NCT00454181|102115006|FG000|Overall Study|Lost to Follow-up|11|||
33608021|NCT00454181|102115007|FG001|Overall Study|Lost to Follow-up|1|||
33608022|NCT00454181|102115006|FG000|Overall Study|Protocol Violation|1|||
33608023|NCT00454181|102115007|FG001|Overall Study|Protocol Violation|1|||
33608024|NCT00454181|102115006|FG000|Overall Study|Withdrawal by Subject|2|||
33608025|NCT00454181|102115007|FG001|Overall Study|Withdrawal by Subject|0|||
33608026|NCT00788710|102115011|FG000|Overall Study|Adverse Event|1|||
33608027|NCT00788710|102115012|FG001|Overall Study|Adverse Event|3|||
33608028|NCT00788710|102115013|FG002|Overall Study|Adverse Event|4|||
33608029|NCT00788710|102115011|FG000|Overall Study|Lack of Efficacy|0|||
33517743|NCT01267201|101789707|FG004|Second Intervention Period|Withdrawal by Subject|0|||
33517744|NCT01267201|101789708|FG005|Second Intervention Period|Withdrawal by Subject|0|||
33517745|NCT00334295|101789709|FG000|Overall Study|Patients received fewer than 3 injection|5|||
33517746|NCT02240069|101789710|FG000|Overall Study|Withdrawal by Subject|5|||
33517747|NCT02240069|101789711|FG001|Overall Study|Withdrawal by Subject|5|||
33517748|NCT02240069|101789712|FG002|Overall Study|Withdrawal by Subject|2|||
33517749|NCT00778102|101789717|FG000|Overall Study|Adverse Event|8|||
33517750|NCT00778102|101789718|FG001|Overall Study|Adverse Event|5|||
33517751|NCT00778102|101789717|FG000|Overall Study|Death|1|||
33517752|NCT00778102|101789718|FG001|Overall Study|Death|1|||
33517753|NCT00778102|101789717|FG000|Overall Study|Lost to Follow-up|1|||
33517754|NCT00778102|101789718|FG001|Overall Study|Lost to Follow-up|0|||
33517755|NCT00778102|101789717|FG000|Overall Study|Violation of Selection Criteria|1|||
33517756|NCT00778102|101789718|FG001|Overall Study|Violation of Selection Criteria|1|||
33517757|NCT00778102|101789717|FG000|Overall Study|Protocol Violation|0|||
33517758|NCT00778102|101789718|FG001|Overall Study|Protocol Violation|1|||
33517759|NCT00778102|101789717|FG000|Overall Study|Refused Treatment|2|||
33517760|NCT00778102|101789718|FG001|Overall Study|Refused Treatment|3|||
33517761|NCT00778102|101789717|FG000|Overall Study|Withdrawal by Subject|1|||
33517762|NCT00778102|101789718|FG001|Overall Study|Withdrawal by Subject|1|||
33517763|NCT00778102|101789717|FG000|Overall Study|Administrative Reason|7|||
33517764|NCT00778102|101789718|FG001|Overall Study|Administrative Reason|10|||
33517765|NCT00551161|101789719|FG000|Overall Study|Withdrawal by Subject|1|||
33517766|NCT03197870|101789722|FG000|Overall Study|Adverse Event|9|||
33517767|NCT03197870|101789723|FG001|Overall Study|Adverse Event|4|||
33517768|NCT03197870|101789724|FG002|Overall Study|Adverse Event|6|||
33517769|NCT03197870|101789722|FG000|Overall Study|Withdrawal by Subject|2|||
33517770|NCT03197870|101789723|FG001|Overall Study|Withdrawal by Subject|3|||
33517771|NCT03197870|101789724|FG002|Overall Study|Withdrawal by Subject|0|||
33517772|NCT03197870|101789722|FG000|Overall Study|Lost to Follow-up|2|||
33517773|NCT03197870|101789723|FG001|Overall Study|Lost to Follow-up|2|||
33517774|NCT03197870|101789724|FG002|Overall Study|Lost to Follow-up|0|||
33517775|NCT03197870|101789722|FG000|Overall Study|data not available|1|||
33517776|NCT03197870|101789723|FG001|Overall Study|data not available|1|||
33608030|NCT00788710|102115012|FG001|Overall Study|Lack of Efficacy|0|||
33608031|NCT00788710|102115013|FG002|Overall Study|Lack of Efficacy|1|||
33608032|NCT00788710|102115011|FG000|Overall Study|Lost to Follow-up|0|||
33517777|NCT03197870|101789724|FG002|Overall Study|data not available|0|||
33517778|NCT01043705|101789730|FG000|Overall Study|Death|28|||
33517779|NCT01043705|101789731|FG001|Overall Study|Death|60|||
33517780|NCT01043705|101789732|FG002|Overall Study|Death|26|||
33517781|NCT01043705|101789730|FG000|Overall Study|Lost to Follow-up|27|||
33517782|NCT01043705|101789731|FG001|Overall Study|Lost to Follow-up|12|||
33517783|NCT01043705|101789732|FG002|Overall Study|Lost to Follow-up|0|||
33517784|NCT01043705|101789730|FG000|Overall Study|Multiple Reasons|4|||
33608033|NCT00788710|102115012|FG001|Overall Study|Lost to Follow-up|1|||
33608034|NCT00788710|102115013|FG002|Overall Study|Lost to Follow-up|0|||
33608035|NCT00788710|102115011|FG000|Overall Study|Physician Decision|2|||
33608036|NCT00788710|102115012|FG001|Overall Study|Physician Decision|1|||
33517785|NCT01043705|101789731|FG001|Overall Study|Multiple Reasons|7|||
33608037|NCT00788710|102115013|FG002|Overall Study|Physician Decision|0|||
33608038|NCT00788710|102115011|FG000|Overall Study|Protocol Violation|0|||
33517786|NCT01043705|101789732|FG002|Overall Study|Multiple Reasons|0|||
33517787|NCT01043705|101789730|FG000|Overall Study|Protocol Violation|2|||
33517788|NCT01043705|101789731|FG001|Overall Study|Protocol Violation|1|||
33517789|NCT01043705|101789732|FG002|Overall Study|Protocol Violation|0|||
33517790|NCT01043705|101789730|FG000|Overall Study|Withdrawal by Subject|8|||
33517791|NCT01043705|101789731|FG001|Overall Study|Withdrawal by Subject|6|||
33517792|NCT01043705|101789732|FG002|Overall Study|Withdrawal by Subject|0|||
33517793|NCT01043705|101789730|FG000|Overall Study|Site Closure|8|||
33517794|NCT01043705|101789731|FG001|Overall Study|Site Closure|0|||
33517795|NCT01043705|101789732|FG002|Overall Study|Site Closure|0|||
33517796|NCT01043705|101789730|FG000|Overall Study|Subsequent Procedure|9|||
33517797|NCT01043705|101789731|FG001|Overall Study|Subsequent Procedure|24|||
33517798|NCT01043705|101789732|FG002|Overall Study|Subsequent Procedure|29|||
33517799|NCT01043705|101789730|FG000|Overall Study|Adverse Event|0|||
33517800|NCT01043705|101789731|FG001|Overall Study|Adverse Event|2|||
33517801|NCT01043705|101789732|FG002|Overall Study|Adverse Event|0|||
33517802|NCT01043705|101789730|FG000|Overall Study|Screen Fail|21|||
33517803|NCT01043705|101789731|FG001|Overall Study|Screen Fail|0|||
33517804|NCT01043705|101789732|FG002|Overall Study|Screen Fail|0|||
33517805|NCT01043705|101789730|FG000|Overall Study|Other|0|||
33517806|NCT01043705|101789731|FG001|Overall Study|Other|19|||
33517807|NCT01043705|101789732|FG002|Overall Study|Other|25|||
33517808|NCT02956057|101789735|FG000|Overall Study|Discontinued intervention|14|||
33326891|NCT01372150|101091313|FG001|Overall Study|Protocol Violation|0|||
33517809|NCT02956057|101789736|FG001|Overall Study|Discontinued intervention|10|||
33517810|NCT02956057|101789737|FG002|Overall Study|Discontinued intervention|7|||
33517811|NCT02956057|101789738|FG003|Overall Study|Discontinued intervention|14|||
33517812|NCT02956057|101789739|FG004|Overall Study|Discontinued intervention|4|||
33517813|NCT02956057|101789740|FG005|Overall Study|Discontinued intervention|17|||
33517814|NCT02956057|101789735|FG000|Overall Study|Lost to Follow-up|0|||
33517815|NCT02956057|101789736|FG001|Overall Study|Lost to Follow-up|2|||
33517816|NCT02956057|101789737|FG002|Overall Study|Lost to Follow-up|1|||
33517817|NCT02956057|101789738|FG003|Overall Study|Lost to Follow-up|1|||
33517818|NCT02956057|101789739|FG004|Overall Study|Lost to Follow-up|1|||
33517819|NCT02956057|101789740|FG005|Overall Study|Lost to Follow-up|0|||
33517820|NCT01542034|101792748|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
33517821|NCT01542034|101792749|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
33517822|NCT01542034|101792748|FG000|Overall Study|Administrative decision|0|||
33517823|NCT01542034|101792749|FG001|Overall Study|Administrative decision|3|||
33517824|NCT01542034|101792748|FG000|Overall Study|Subject Noncompliance|1|||
33517825|NCT01542034|101792749|FG001|Overall Study|Subject Noncompliance|0|||
33517826|NCT01542034|101792748|FG000|Overall Study|Adverse Event|2|||
33517827|NCT01542034|101792749|FG001|Overall Study|Adverse Event|2|||
33517828|NCT01542034|101792748|FG000|Overall Study|Lost to Follow-up|7|||
33517829|NCT01542034|101792749|FG001|Overall Study|Lost to Follow-up|6|||
33517830|NCT00574249|101792750|FG000|Overall Study|Adverse Event|6|||
33517831|NCT00574249|101792751|FG001|Overall Study|Adverse Event|18|||
33517832|NCT00574249|101792750|FG000|Overall Study|Lack of Efficacy|5|||
33517833|NCT00574249|101792751|FG001|Overall Study|Lack of Efficacy|3|||
33517834|NCT00574249|101792750|FG000|Overall Study|Lost to Follow-up|4|||
33517835|NCT00574249|101792751|FG001|Overall Study|Lost to Follow-up|3|||
33517836|NCT00574249|101792750|FG000|Overall Study|Protocol Violation|5|||
33517837|NCT00574249|101792751|FG001|Overall Study|Protocol Violation|2|||
33517838|NCT00574249|101792750|FG000|Overall Study|History of carcinoma|1|||
33517839|NCT00574249|101792751|FG001|Overall Study|History of carcinoma|0|||
33517840|NCT00574249|101792750|FG000|Overall Study|Withdrawal by Subject|3|||
33517841|NCT00574249|101792751|FG001|Overall Study|Withdrawal by Subject|0|||
33517842|NCT00574249|101792750|FG000|Overall Study|Physician Decision|1|||
33517843|NCT00574249|101792751|FG001|Overall Study|Physician Decision|0|||
33517844|NCT00574249|101792750|FG000|Overall Study|Pregnancy|1|||
33517845|NCT00574249|101792751|FG001|Overall Study|Pregnancy|0|||
33517846|NCT00574249|101792750|FG000|Overall Study|Excluded by company|0|||
33517847|NCT00574249|101792751|FG001|Overall Study|Excluded by company|1|||
33517848|NCT00574249|101792750|FG000|Overall Study|PPD test taken twice|0|||
33517849|NCT00574249|101792751|FG001|Overall Study|PPD test taken twice|1|||
33517850|NCT03077659|101792752|FG000|Overall Study|Withdrawal by Subject|0|||
33517851|NCT03077659|101792753|FG001|Overall Study|Withdrawal by Subject|0|||
33517852|NCT03077659|101792754|FG002|Overall Study|Withdrawal by Subject|1|||
33517853|NCT03677934|101792755|FG000|Overall Study|Adverse Event|1|||
33517854|NCT03677934|101792756|FG001|Overall Study|Adverse Event|1|||
33517855|NCT03677934|101792755|FG000|Overall Study|Death|8|||
33517856|NCT03677934|101792756|FG001|Overall Study|Death|4|||
33517857|NCT03677934|101792755|FG000|Overall Study|Lost to Follow-up|3|||
33517858|NCT03677934|101792756|FG001|Overall Study|Lost to Follow-up|0|||
33517859|NCT03677934|101792755|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33517860|NCT03677934|101792756|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33517861|NCT03677934|101792755|FG000|Overall Study|Physician Decision|0|||
33517862|NCT03677934|101792756|FG001|Overall Study|Physician Decision|1|||
33517863|NCT03677934|101792755|FG000|Overall Study|Withdrawal by Subject|1|||
33517864|NCT03677934|101792756|FG001|Overall Study|Withdrawal by Subject|7|||
33517865|NCT04459598|101792757|FG000|Overall Study|Adverse Event|1|||
33517866|NCT04459598|101792758|FG001|Overall Study|Adverse Event|1|||
33517867|NCT01987232|101792759|FG000|Overall Study|Ongoing in Study|0|||
33517868|NCT01987232|101792760|FG001|Overall Study|Ongoing in Study|0|||
33517869|NCT01987232|101792761|FG002|Overall Study|Ongoing in Study|0|||
33517870|NCT01987232|101792762|FG003|Overall Study|Ongoing in Study|1|||
33517871|NCT01987232|101792763|FG004|Overall Study|Ongoing in Study|0|||
33517872|NCT03422159|101792764|FG000|Overall Study|Exclusion due to terminal disease|2|||
33517873|NCT03422159|101792765|FG001|Overall Study|Exclusion due to terminal disease|1|||
33517874|NCT03003000|101792766|FG000|Overall Study|Adverse Event|1|||
33517875|NCT03003000|101792767|FG001|Overall Study|Adverse Event|2|||
33517876|NCT03003000|101792768|FG002|Overall Study|Adverse Event|3|||
33517877|NCT03003000|101792766|FG000|Overall Study|Lack of Efficacy|1|||
33517878|NCT03003000|101792767|FG001|Overall Study|Lack of Efficacy|0|||
33517879|NCT03003000|101792768|FG002|Overall Study|Lack of Efficacy|0|||
33517880|NCT03003000|101792766|FG000|Overall Study|Non-compliant with protocol|0|||
33517881|NCT03003000|101792767|FG001|Overall Study|Non-compliant with protocol|1|||
33517882|NCT03003000|101792768|FG002|Overall Study|Non-compliant with protocol|1|||
33517883|NCT03003000|101792766|FG000|Overall Study|Refused to continue medication|2|||
33517884|NCT03003000|101792767|FG001|Overall Study|Refused to continue medication|0|||
33517885|NCT03003000|101792768|FG002|Overall Study|Refused to continue medication|0|||
33517886|NCT03003000|101792766|FG000|Overall Study|Other than listed|1|||
33517887|NCT03003000|101792767|FG001|Overall Study|Other than listed|1|||
33517888|NCT03003000|101792768|FG002|Overall Study|Other than listed|1|||
33608039|NCT00788710|102115012|FG001|Overall Study|Protocol Violation|1|||
33517889|NCT00980018|101792772|FG000|Overall Study|Adverse Event|8|||
33517890|NCT00980018|101792772|FG000|Overall Study|Patient withdrew consent|3|||
33517891|NCT00980018|101792772|FG000|Overall Study|Lost to Follow-up|1|||
33517892|NCT03235115|101792776|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
33517893|NCT03235115|101792777|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
33517894|NCT03235115|101792778|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
33517895|NCT03235115|101792779|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
33608040|NCT00788710|102115013|FG002|Overall Study|Protocol Violation|1|||
33608041|NCT00788710|102115011|FG000|Overall Study|Withdrawal by Subject|2|||
33608042|NCT00788710|102115012|FG001|Overall Study|Withdrawal by Subject|2|||
33608043|NCT00788710|102115013|FG002|Overall Study|Withdrawal by Subject|0|||
33608044|NCT01276223|102115014|FG000|Overall Study|Adverse Event|7|||
33608045|NCT01276223|102115015|FG001|Overall Study|Adverse Event|4|||
33608046|NCT01276223|102115016|FG002|Overall Study|Adverse Event|1|||
33608047|NCT01276223|102115014|FG000|Overall Study|Lost to Follow-up|0|||
33608048|NCT01276223|102115015|FG001|Overall Study|Lost to Follow-up|0|||
33608049|NCT01276223|102115016|FG002|Overall Study|Lost to Follow-up|1|||
33608050|NCT01276223|102115014|FG000|Overall Study|Other|0|||
33608051|NCT01276223|102115015|FG001|Overall Study|Other|0|||
33608052|NCT01276223|102115016|FG002|Overall Study|Other|1|||
33608053|NCT01276223|102115014|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
33326892|NCT01372150|101091314|FG002|Overall Study|Protocol Violation|3|||
33326893|NCT01372150|101091312|FG000|Overall Study|Withdrawal by Subject|2|||
33608054|NCT01276223|102115015|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
33608055|NCT01276223|102115016|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
33608056|NCT01276223|102115014|FG000|Overall Study|Protocol Violation|1|||
33608057|NCT01276223|102115015|FG001|Overall Study|Protocol Violation|0|||
33608058|NCT01276223|102115016|FG002|Overall Study|Protocol Violation|0|||
33608059|NCT02999633|102115017|FG000|Overall Study|Adverse Event|2|||
33326894|NCT01372150|101091313|FG001|Overall Study|Withdrawal by Subject|7|||
33517896|NCT03235115|101792780|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
33517897|NCT03235115|101792781|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
33517898|NCT04068688|101792782|FG000|Overall Study|Lost to Follow-up|1|||
33517899|NCT04068688|101792783|FG001|Overall Study|Lost to Follow-up|1|||
33517900|NCT04068688|101792784|FG002|Overall Study|Lost to Follow-up|0|||
33517901|NCT04068688|101792785|FG003|Overall Study|Lost to Follow-up|0|||
33517902|NCT04068688|101792786|FG004|Overall Study|Lost to Follow-up|5|||
33517903|NCT04068688|101792787|FG005|Overall Study|Lost to Follow-up|5|||
33517904|NCT04068688|101792788|FG006|Overall Study|Lost to Follow-up|0|||
33517905|NCT04068688|101792789|FG007|Overall Study|Lost to Follow-up|0|||
33517906|NCT04068688|101792790|FG008|Overall Study|Lost to Follow-up|1|||
33517907|NCT04068688|101792791|FG009|Overall Study|Lost to Follow-up|0|||
33517908|NCT04068688|101792782|FG000|Overall Study|Withdrawal by Subject|1|||
33517909|NCT04068688|101792783|FG001|Overall Study|Withdrawal by Subject|1|||
33517910|NCT04068688|101792784|FG002|Overall Study|Withdrawal by Subject|0|||
33517911|NCT04068688|101792785|FG003|Overall Study|Withdrawal by Subject|0|||
33517912|NCT04068688|101792786|FG004|Overall Study|Withdrawal by Subject|0|||
33517913|NCT04068688|101792787|FG005|Overall Study|Withdrawal by Subject|0|||
33517914|NCT04068688|101792788|FG006|Overall Study|Withdrawal by Subject|0|||
33517915|NCT04068688|101792789|FG007|Overall Study|Withdrawal by Subject|0|||
33517916|NCT04068688|101792790|FG008|Overall Study|Withdrawal by Subject|0|||
33517917|NCT04068688|101792791|FG009|Overall Study|Withdrawal by Subject|0|||
33517918|NCT04068688|101792782|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
33517919|NCT04068688|101792783|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
33517920|NCT04068688|101792784|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33326895|NCT01372150|101091314|FG002|Overall Study|Withdrawal by Subject|2|||
33326896|NCT01372150|101091312|FG000|Overall Study|Other|1|||
33326897|NCT01372150|101091313|FG001|Overall Study|Other|0|||
33326898|NCT01372150|101091314|FG002|Overall Study|Other|2|||
33326899|NCT01372150|101091312|FG000|Overall Study|Adverse Event|2|||
33326900|NCT01372150|101091313|FG001|Overall Study|Adverse Event|1|||
33326901|NCT01372150|101091314|FG002|Overall Study|Adverse Event|2|||
33326902|NCT01372150|101091312|FG000|Overall Study|Randomized but not treated|0|||
33326903|NCT01372150|101091313|FG001|Overall Study|Randomized but not treated|1|||
33326904|NCT01372150|101091314|FG002|Overall Study|Randomized but not treated|0|||
33326905|NCT01245387|101094061|FG000|Overall Study|Lost to Follow-up|106|||
33326906|NCT01245387|101094061|FG000|Overall Study|Lack of Efficacy|195|||
33326907|NCT01245387|101094061|FG000|Overall Study|Adverse Event|9|||
33326908|NCT01245387|101094061|FG000|Overall Study|Death|3|||
33326909|NCT01245387|101094061|FG000|Overall Study|Other|131|||
33326910|NCT01245387|101094061|FG000|Overall Study|Missing discontinuation status|369|||
33326911|NCT00747643|101094067|FG000|Overall Study|Withdrawal by Subject|36|||
33326912|NCT00747643|101094068|FG001|Overall Study|Withdrawal by Subject|27|||
33326913|NCT01987960|101094072|FG000|Period 1|Adverse Event|24|||
33326914|NCT01987960|101094073|FG001|Period 1|Adverse Event|0|||
33326915|NCT01987960|101094074|FG002|Period 1|Adverse Event|0|||
33326916|NCT01987960|101094075|FG003|Period 1|Adverse Event|0|||
33326917|NCT01987960|101094072|FG000|Period 1|Lack of Efficacy|4|||
33326918|NCT01987960|101094073|FG001|Period 1|Lack of Efficacy|0|||
33326919|NCT01987960|101094074|FG002|Period 1|Lack of Efficacy|0|||
33326920|NCT01987960|101094075|FG003|Period 1|Lack of Efficacy|0|||
33326921|NCT01987960|101094072|FG000|Period 1|Non-compliance with IMP|6|||
33326922|NCT01987960|101094073|FG001|Period 1|Non-compliance with IMP|0|||
33326923|NCT01987960|101094074|FG002|Period 1|Non-compliance with IMP|0|||
33517921|NCT04068688|101792785|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33517922|NCT04068688|101792786|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33608060|NCT02999633|102115017|FG000|Overall Study|Progressive disease|12|||
33326924|NCT01987960|101094075|FG003|Period 1|Non-compliance with IMP|0|||
33608061|NCT00852241|102115020|FG000|Overall Study|Physician Decision|18|||
33326925|NCT01987960|101094072|FG000|Period 1|Protocol Violation|12|||
33326926|NCT01987960|101094073|FG001|Period 1|Protocol Violation|0|||
33326927|NCT01987960|101094074|FG002|Period 1|Protocol Violation|0|||
33326928|NCT01987960|101094075|FG003|Period 1|Protocol Violation|0|||
33326929|NCT01987960|101094072|FG000|Period 1|Withdrawal by Subject|21|||
33517923|NCT04068688|101792787|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33326930|NCT01987960|101094073|FG001|Period 1|Withdrawal by Subject|0|||
33608062|NCT00908037|102115022|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33608063|NCT00908037|102115023|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33608064|NCT00908037|102115024|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33608065|NCT00908037|102115025|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33608066|NCT00908037|102115026|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
33608067|NCT00908037|102115027|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33608068|NCT00908037|102115028|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
33608069|NCT00908037|102115029|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33608070|NCT00908037|102115030|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
33608071|NCT00908037|102115031|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33608072|NCT00908037|102115032|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33608073|NCT00908037|102115033|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
33608074|NCT00908037|102115022|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33608075|NCT00908037|102115023|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33608076|NCT00908037|102115024|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33608077|NCT00908037|102115025|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33608078|NCT00908037|102115026|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
33608079|NCT00908037|102115027|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33608080|NCT00908037|102115028|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33608081|NCT00908037|102115029|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33608082|NCT00908037|102115030|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
33608083|NCT00908037|102115031|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33608084|NCT00908037|102115032|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33608085|NCT00908037|102115033|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
33608086|NCT00908037|102115022|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33608087|NCT00908037|102115023|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33608088|NCT00908037|102115024|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33608089|NCT00908037|102115025|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
33608090|NCT00908037|102115026|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33608091|NCT00908037|102115027|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33608092|NCT00908037|102115028|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
33608093|NCT00908037|102115029|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33608094|NCT00908037|102115030|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33608095|NCT00908037|102115031|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33608096|NCT00908037|102115032|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33608097|NCT00908037|102115033|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
33608098|NCT00908037|102115022|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33608099|NCT00908037|102115023|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33608100|NCT00908037|102115024|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33608101|NCT00908037|102115025|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33608102|NCT00908037|102115026|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33608103|NCT00908037|102115027|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33608104|NCT00908037|102115028|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33608105|NCT00908037|102115029|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33608106|NCT00908037|102115030|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33608107|NCT00908037|102115031|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33608108|NCT00908037|102115032|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
33608109|NCT00908037|102115033|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
33608110|NCT00908037|102115022|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33608111|NCT00908037|102115023|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33608112|NCT00908037|102115024|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33608113|NCT00908037|102115025|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33608114|NCT00908037|102115026|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33608115|NCT00908037|102115027|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33608116|NCT00908037|102115028|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33608117|NCT00908037|102115029|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33608118|NCT00908037|102115030|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33608119|NCT00908037|102115031|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
33608120|NCT00908037|102115032|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
33608121|NCT00908037|102115033|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
33608122|NCT00908037|102115022|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33608123|NCT00908037|102115023|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33608124|NCT00908037|102115024|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33326931|NCT01987960|101094074|FG002|Period 1|Withdrawal by Subject|0|||
33608125|NCT00908037|102115025|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33608126|NCT00908037|102115026|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33608127|NCT00908037|102115027|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33608128|NCT00908037|102115028|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33608129|NCT00908037|102115029|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33608130|NCT00908037|102115030|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33608131|NCT00908037|102115031|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
33608132|NCT00908037|102115032|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33608133|NCT00908037|102115033|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
33608134|NCT00908037|102115022|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33608135|NCT00908037|102115023|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33608136|NCT00908037|102115024|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33608137|NCT00908037|102115025|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33608138|NCT00908037|102115026|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33608139|NCT00908037|102115027|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33608140|NCT00908037|102115028|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33608141|NCT00908037|102115029|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33608142|NCT00908037|102115030|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33608143|NCT00908037|102115031|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33608144|NCT00908037|102115032|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
33608145|NCT00908037|102115033|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
33608146|NCT00908037|102115022|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33608147|NCT00908037|102115023|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33608148|NCT00908037|102115024|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33608149|NCT00908037|102115025|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33608150|NCT00908037|102115026|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33608151|NCT00908037|102115027|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33608152|NCT00908037|102115028|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33608153|NCT00908037|102115029|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33608154|NCT00908037|102115030|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33608155|NCT00908037|102115031|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
33608156|NCT00908037|102115032|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33608157|NCT00908037|102115033|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
33608158|NCT00908037|102115022|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33608159|NCT00908037|102115023|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33608160|NCT00908037|102115024|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33608161|NCT00908037|102115025|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33608162|NCT00908037|102115026|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33608163|NCT00908037|102115027|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33608164|NCT00908037|102115028|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33608165|NCT00908037|102115029|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33608166|NCT00908037|102115030|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33608167|NCT00908037|102115031|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33608168|NCT00908037|102115032|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
33608169|NCT00908037|102115033|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
33608170|NCT02328027|102115036|FG000|Overall Study|Withdrawal by Subject|0|||
33608171|NCT02328027|102115037|FG001|Overall Study|Withdrawal by Subject|1|||
33608172|NCT02335424|102115041|FG000|Overall Study|Withdrawal by Subject|19|||
33608173|NCT02335424|102115041|FG000|Overall Study|Adverse Event|25|||
33608174|NCT02335424|102115041|FG000|Overall Study|Death|273|||
33608175|NCT02335424|102115041|FG000|Overall Study|Lost to Follow-up|3|||
33608176|NCT02335424|102115041|FG000|Overall Study|Physician Decision|13|||
33608177|NCT02335424|102115041|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
33608178|NCT02335424|102115041|FG000|Overall Study|Protocol Violation|1|||
33608179|NCT02335424|102115041|FG000|Overall Study|Screen failure|1|||
33608180|NCT00545103|102115042|FG000|Overall Study|Lack of Efficacy|48|||
33608181|NCT00545103|102115043|FG001|Overall Study|Lack of Efficacy|45|||
33608182|NCT00545103|102115044|FG002|Overall Study|Lack of Efficacy|31|||
33608183|NCT00545103|102115045|FG003|Overall Study|Lack of Efficacy|27|||
33608184|NCT00545103|102115042|FG000|Overall Study|Withdrawal by Subject|6|||
33608185|NCT00545103|102115043|FG001|Overall Study|Withdrawal by Subject|10|||
33326932|NCT01987960|101094075|FG003|Period 1|Withdrawal by Subject|0|||
33400457|NCT04109066|101353444|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
33400458|NCT04109066|101353443|FG000|Treatment|Lack of Efficacy|2|||
33400459|NCT04109066|101353444|FG001|Treatment|Lack of Efficacy|3|||
33400460|NCT04109066|101353443|FG000|Treatment|Adverse Event|19|||
33400461|NCT04109066|101353444|FG001|Treatment|Adverse Event|6|||
33400462|NCT04109066|101353443|FG000|Treatment|Participant request to discontinue Study treatment|12|||
33517924|NCT04068688|101792788|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33400463|NCT04109066|101353444|FG001|Treatment|Participant request to discontinue Study treatment|14|||
33400464|NCT04109066|101353443|FG000|Treatment|Withdrawal by Subject|7|||
33517925|NCT04068688|101792789|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33517926|NCT04068688|101792790|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33517927|NCT04068688|101792791|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
33517928|NCT04063657|101792792|FG000|Overall Study|Lost to Follow-up|1|||
33517929|NCT04063657|101792793|FG001|Overall Study|Lost to Follow-up|0|||
33517930|NCT03802565|101792794|FG000|Overall Study|Adverse Event|0|||
33517931|NCT03802565|101792795|FG001|Overall Study|Adverse Event|1|||
33517932|NCT03802565|101792796|FG002|Overall Study|Adverse Event|2|||
33517933|NCT03802565|101792797|FG003|Overall Study|Adverse Event|1|||
33517934|NCT03802565|101792798|FG004|Overall Study|Adverse Event|1|||
33517935|NCT03802565|101792794|FG000|Overall Study|Withdrawal by Subject|2|||
33517936|NCT03802565|101792795|FG001|Overall Study|Withdrawal by Subject|2|||
33517937|NCT03802565|101792796|FG002|Overall Study|Withdrawal by Subject|2|||
33517938|NCT03802565|101792797|FG003|Overall Study|Withdrawal by Subject|0|||
33517939|NCT03802565|101792798|FG004|Overall Study|Withdrawal by Subject|1|||
33517940|NCT03802565|101792794|FG000|Overall Study|Protocol Violation|2|||
33517941|NCT03802565|101792795|FG001|Overall Study|Protocol Violation|1|||
33517942|NCT03802565|101792796|FG002|Overall Study|Protocol Violation|4|||
33400465|NCT04109066|101353444|FG001|Treatment|Withdrawal by Subject|8|||
33517943|NCT03802565|101792797|FG003|Overall Study|Protocol Violation|5|||
33517944|NCT03802565|101792798|FG004|Overall Study|Protocol Violation|1|||
33326933|NCT01987960|101094072|FG000|Period 1|Lost to Follow-up|40|||
33517945|NCT03802565|101792794|FG000|Overall Study|Lost to Follow-up|0|||
33517946|NCT03802565|101792795|FG001|Overall Study|Lost to Follow-up|0|||
33517947|NCT03802565|101792796|FG002|Overall Study|Lost to Follow-up|1|||
33517948|NCT03802565|101792797|FG003|Overall Study|Lost to Follow-up|0|||
33517949|NCT03802565|101792798|FG004|Overall Study|Lost to Follow-up|0|||
33200017|NCT02041429|100638175|FG000|Overall Study|Withdrawal by Subject|0|||
33200018|NCT02041429|100638176|FG001|Overall Study|Withdrawal by Subject|1|||
33517950|NCT03802565|101792794|FG000|Overall Study|Subjects Related to Each Other|1|||
33200019|NCT02041429|100638177|FG002|Overall Study|Withdrawal by Subject|0|||
33200020|NCT02041429|100638178|FG003|Overall Study|Withdrawal by Subject|0|||
33200021|NCT02041429|100638175|FG000|Overall Study|On Maintenance Therapy|1|||
33200022|NCT02041429|100638176|FG001|Overall Study|On Maintenance Therapy|0|||
33200023|NCT02041429|100638177|FG002|Overall Study|On Maintenance Therapy|0|||
33200024|NCT02041429|100638178|FG003|Overall Study|On Maintenance Therapy|2|||
33200025|NCT02056301|100638188|FG000|Overall Study|Protocol Violation|1|||
33200026|NCT02056301|100638189|FG001|Overall Study|Protocol Violation|2|||
33200027|NCT02056301|100638188|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
33200028|NCT02056301|100638189|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
33200029|NCT02056301|100638188|FG000|Overall Study|Withdrawal by Subject|0|||
33200030|NCT02056301|100638189|FG001|Overall Study|Withdrawal by Subject|1|||
33200031|NCT02056301|100638188|FG000|Overall Study|Issues with epidural|0|||
33200032|NCT02056301|100638189|FG001|Overall Study|Issues with epidural|3|||
33200033|NCT01462344|100638190|FG000|Overall Study|Withdrawal by Subject|245|||
33200034|NCT01462344|100638191|FG001|Overall Study|Withdrawal by Subject|226|||
33200035|NCT01462344|100638190|FG000|Overall Study|Adverse Event|24|||
33200036|NCT01462344|100638191|FG001|Overall Study|Adverse Event|23|||
33200037|NCT01462344|100638190|FG000|Overall Study|Asthma Exacerbation|34|||
33200038|NCT01462344|100638191|FG001|Overall Study|Asthma Exacerbation|35|||
33200039|NCT01462344|100638190|FG000|Overall Study|Lack of Efficacy|5|||
33200040|NCT01462344|100638191|FG001|Overall Study|Lack of Efficacy|6|||
33200041|NCT01462344|100638190|FG000|Overall Study|Protocol Violation|68|||
33200042|NCT01462344|100638191|FG001|Overall Study|Protocol Violation|53|||
33200043|NCT01462344|100638190|FG000|Overall Study|Lost to Follow-up|7|||
33200044|NCT01462344|100638191|FG001|Overall Study|Lost to Follow-up|7|||
33200045|NCT03634579|100638192|FG000|Overall Study|study termination|9|||
33200046|NCT01898195|100638193|FG000|Smoking Abstinence|Did not have good measurements|35|||
33200047|NCT01898195|100638194|FG001|Smoking Abstinence|Did not have good measurements|38|||
33200048|NCT01898195|100638195|FG002|Smoking Abstinence|Did not have good measurements|36|||
33200049|NCT02317575|100638197|FG000|Period 1|Difficulty with venous cannulation|0|||
33200050|NCT02317575|100638198|FG001|Period 1|Difficulty with venous cannulation|1|||
33200051|NCT02317575|100638199|FG002|Period 1|Difficulty with venous cannulation|0|||
33200052|NCT02317575|100638200|FG003|Period 1|Difficulty with venous cannulation|0|||
33200053|NCT02317575|100638201|FG004|Period 1|Difficulty with venous cannulation|0|||
33200054|NCT02317575|100638197|FG000|Period 1|Withdrawal by Subject|1|||
33200055|NCT02317575|100638198|FG001|Period 1|Withdrawal by Subject|0|||
33200056|NCT02317575|100638199|FG002|Period 1|Withdrawal by Subject|0|||
33200057|NCT02317575|100638200|FG003|Period 1|Withdrawal by Subject|0|||
33200058|NCT02317575|100638201|FG004|Period 1|Withdrawal by Subject|0|||
33200059|NCT03062891|100638203|FG000|Overall Study|Withdrawal by Subject|2|||
33200060|NCT03062891|100638204|FG001|Overall Study|Withdrawal by Subject|0|||
33200061|NCT03062891|100638203|FG000|Overall Study|Lost to Follow-up|50|||
33200062|NCT03062891|100638204|FG001|Overall Study|Lost to Follow-up|38|||
33200063|NCT04321460|100638208|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
33200064|NCT04321460|100638209|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
33200065|NCT02391948|100638210|FG000|6-month Assessment|Death|0|||
33200066|NCT02391948|100638211|FG001|6-month Assessment|Death|0|||
33200067|NCT02391948|100638212|FG002|6-month Assessment|Death|0|||
33200068|NCT02391948|100638213|FG003|6-month Assessment|Death|0|||
33200069|NCT02391948|100638214|FG004|6-month Assessment|Death|1|||
33400466|NCT04109066|101353443|FG000|Treatment|Death|3|||
33400467|NCT04109066|101353444|FG001|Treatment|Death|0|||
33400468|NCT04109066|101353443|FG000|Treatment|Participant no longer meets study criteria|3|||
33400469|NCT04109066|101353444|FG001|Treatment|Participant no longer meets study criteria|1|||
33400470|NCT04109066|101353443|FG000|Treatment|Administrative reasons by sponsor|2|||
33400471|NCT04109066|101353444|FG001|Treatment|Administrative reasons by sponsor|3|||
33400472|NCT04109066|101353443|FG000|Treatment|Other reasons|17|||
33400473|NCT04109066|101353444|FG001|Treatment|Other reasons|23|||
33400474|NCT04109066|101353443|FG000|Treatment|Disease Progression|4|||
33400475|NCT04109066|101353444|FG001|Treatment|Disease Progression|7|||
33400476|NCT04109066|101353443|FG000|Treatment|Study drug toxicity|13|||
33400477|NCT04109066|101353444|FG001|Treatment|Study drug toxicity|5|||
33400478|NCT04109066|101353443|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
33400479|NCT04109066|101353444|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
33400480|NCT04109066|101353443|FG000|Treatment|Disease Recurrence|0|||
33400481|NCT04109066|101353444|FG001|Treatment|Disease Recurrence|2|||
33400482|NCT04109066|101353443|FG000|Treatment|Not reported|6|||
33400483|NCT04109066|101353444|FG001|Treatment|Not reported|8|||
33400484|NCT04109066|101353443|FG000|Treatment|On-going treatment|48|||
33400485|NCT04109066|101353444|FG001|Treatment|On-going treatment|52|||
33400486|NCT03287830|101353445|FG000|Overall Study|Withdrawal by Subject|1|||
33400487|NCT03287830|101353446|FG001|Overall Study|Withdrawal by Subject|1|||
33400488|NCT03287830|101353445|FG000|Overall Study|not meeting inclusion criteria|5|||
33400489|NCT03287830|101353446|FG001|Overall Study|not meeting inclusion criteria|12|||
33400490|NCT01266876|101353447|FG000|Overall Study|Adverse Event|0|||
33400491|NCT01266876|101353448|FG001|Overall Study|Adverse Event|0|||
33400492|NCT01266876|101353449|FG002|Overall Study|Adverse Event|0|||
33400493|NCT01266876|101353450|FG003|Overall Study|Adverse Event|1|||
33400494|NCT01266876|101353451|FG004|Overall Study|Adverse Event|0|||
33400495|NCT02059174|101353452|FG000|Period 1|Withdrawal by Subject|0|||
33400496|NCT02059174|101353453|FG001|Period 1|Withdrawal by Subject|2|||
33400497|NCT02059174|101353452|FG000|Period 2|Withdrawal by Subject|0|||
33400498|NCT02059174|101353453|FG001|Period 2|Withdrawal by Subject|2|||
33400499|NCT02059174|101353452|FG000|Period 2|Protocol Violation|1|||
33400500|NCT02059174|101353453|FG001|Period 2|Protocol Violation|0|||
33400501|NCT02059174|101353452|FG000|Period 3|Physician Decision|1|||
33400502|NCT02059174|101353453|FG001|Period 3|Physician Decision|0|||
33400503|NCT02129192|101353457|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
33400504|NCT02129192|101353458|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
33400505|NCT01038635|101353459|FG000|Overall Study|Disease Progression|2|||
33400506|NCT01038635|101353460|FG001|Overall Study|Disease Progression|0|||
33400507|NCT01038635|101353461|FG002|Overall Study|Disease Progression|0|||
33400508|NCT01038635|101353462|FG003|Overall Study|Disease Progression|0|||
33400509|NCT01038635|101353463|FG004|Overall Study|Disease Progression|0|||
33400510|NCT01038635|101353464|FG005|Overall Study|Disease Progression|0|||
33400511|NCT01038635|101353465|FG006|Overall Study|Disease Progression|1|||
33400512|NCT01038635|101353466|FG007|Overall Study|Disease Progression|4|||
33400513|NCT01038635|101353467|FG008|Overall Study|Disease Progression|0|||
33400514|NCT01038635|101353459|FG000|Overall Study|Death|0|||
33400515|NCT01038635|101353460|FG001|Overall Study|Death|0|||
33400516|NCT01038635|101353461|FG002|Overall Study|Death|0|||
33400517|NCT01038635|101353462|FG003|Overall Study|Death|0|||
33400518|NCT01038635|101353463|FG004|Overall Study|Death|1|||
33400519|NCT01038635|101353464|FG005|Overall Study|Death|0|||
33400520|NCT01038635|101353465|FG006|Overall Study|Death|1|||
33400521|NCT01038635|101353466|FG007|Overall Study|Death|1|||
33400522|NCT01038635|101353467|FG008|Overall Study|Death|2|||
33400523|NCT00643851|101353468|FG000|Overall Study|Death|0|||
33400524|NCT00643851|101353469|FG001|Overall Study|Death|1|||
33400525|NCT00643851|101353470|FG002|Overall Study|Death|0|||
33400526|NCT00643851|101353468|FG000|Overall Study|Lack of Efficacy|0|||
33400527|NCT00643851|101353469|FG001|Overall Study|Lack of Efficacy|1|||
33400528|NCT00643851|101353470|FG002|Overall Study|Lack of Efficacy|0|||
33400529|NCT00643851|101353468|FG000|Overall Study|Adverse Event|2|||
33400530|NCT00643851|101353469|FG001|Overall Study|Adverse Event|6|||
33400531|NCT00643851|101353470|FG002|Overall Study|Adverse Event|6|||
33400532|NCT00643851|101353468|FG000|Overall Study|Lost to Follow-up|4|||
33400533|NCT00643851|101353469|FG001|Overall Study|Lost to Follow-up|6|||
33400534|NCT00643851|101353470|FG002|Overall Study|Lost to Follow-up|9|||
33200070|NCT02391948|100638210|FG000|6-month Assessment|Withdrawal by Subject|0|||
33200071|NCT02391948|100638211|FG001|6-month Assessment|Withdrawal by Subject|0|||
33517951|NCT03802565|101792795|FG001|Overall Study|Subjects Related to Each Other|0|||
33517952|NCT03802565|101792796|FG002|Overall Study|Subjects Related to Each Other|0|||
33517953|NCT03802565|101792797|FG003|Overall Study|Subjects Related to Each Other|2|||
33517954|NCT03802565|101792798|FG004|Overall Study|Subjects Related to Each Other|1|||
33517955|NCT03802565|101792794|FG000|Overall Study|Elevated Enzymes|0|||
33517956|NCT03802565|101792795|FG001|Overall Study|Elevated Enzymes|0|||
33517957|NCT03802565|101792796|FG002|Overall Study|Elevated Enzymes|0|||
33517958|NCT03802565|101792797|FG003|Overall Study|Elevated Enzymes|0|||
33517959|NCT03802565|101792798|FG004|Overall Study|Elevated Enzymes|2|||
33517960|NCT02686658|101792801|FG000|Overall Study|Adverse Event|0|||
33517961|NCT02686658|101792802|FG001|Overall Study|Adverse Event|0|||
33517962|NCT02686658|101792803|FG002|Overall Study|Adverse Event|1|||
33517963|NCT02686658|101792804|FG003|Overall Study|Adverse Event|1|||
33517964|NCT02686658|101792805|FG004|Overall Study|Adverse Event|2|||
33517965|NCT02686658|101792806|FG005|Overall Study|Adverse Event|1|||
33517966|NCT02686658|101792801|FG000|Overall Study|Investigator decision|0|||
33517967|NCT02686658|101792802|FG001|Overall Study|Investigator decision|0|||
33517968|NCT02686658|101792803|FG002|Overall Study|Investigator decision|0|||
33517969|NCT02686658|101792804|FG003|Overall Study|Investigator decision|1|||
33517970|NCT02686658|101792805|FG004|Overall Study|Investigator decision|2|||
33517971|NCT02686658|101792806|FG005|Overall Study|Investigator decision|1|||
33517972|NCT02686658|101792801|FG000|Overall Study|Sponsor decision|1|||
33517973|NCT02686658|101792802|FG001|Overall Study|Sponsor decision|2|||
33517974|NCT02686658|101792803|FG002|Overall Study|Sponsor decision|1|||
33517975|NCT02686658|101792804|FG003|Overall Study|Sponsor decision|5|||
33517976|NCT02686658|101792805|FG004|Overall Study|Sponsor decision|13|||
33517977|NCT02686658|101792806|FG005|Overall Study|Sponsor decision|2|||
33517978|NCT02686658|101792801|FG000|Overall Study|Lost to Follow-up|0|||
33517979|NCT02686658|101792802|FG001|Overall Study|Lost to Follow-up|0|||
33517980|NCT02686658|101792803|FG002|Overall Study|Lost to Follow-up|2|||
33517981|NCT02686658|101792804|FG003|Overall Study|Lost to Follow-up|0|||
33517982|NCT02686658|101792805|FG004|Overall Study|Lost to Follow-up|0|||
33517983|NCT02686658|101792806|FG005|Overall Study|Lost to Follow-up|1|||
33517984|NCT02686658|101792801|FG000|Overall Study|Death|1|||
33517985|NCT02686658|101792802|FG001|Overall Study|Death|0|||
33517986|NCT02686658|101792803|FG002|Overall Study|Death|0|||
33517987|NCT02686658|101792804|FG003|Overall Study|Death|1|||
33517988|NCT02686658|101792805|FG004|Overall Study|Death|1|||
33517989|NCT02686658|101792806|FG005|Overall Study|Death|1|||
33517990|NCT02686658|101792801|FG000|Overall Study|Withdrawal by Subject|2|||
33517991|NCT02686658|101792802|FG001|Overall Study|Withdrawal by Subject|5|||
33517992|NCT02686658|101792803|FG002|Overall Study|Withdrawal by Subject|4|||
33517993|NCT02686658|101792804|FG003|Overall Study|Withdrawal by Subject|4|||
33517994|NCT02686658|101792805|FG004|Overall Study|Withdrawal by Subject|17|||
33517995|NCT02686658|101792806|FG005|Overall Study|Withdrawal by Subject|8|||
33517996|NCT02686658|101792801|FG000|Overall Study|Placed in hospice care|0|||
33517997|NCT02686658|101792802|FG001|Overall Study|Placed in hospice care|0|||
33517998|NCT02686658|101792803|FG002|Overall Study|Placed in hospice care|1|||
33517999|NCT02686658|101792804|FG003|Overall Study|Placed in hospice care|0|||
33518000|NCT02686658|101792805|FG004|Overall Study|Placed in hospice care|0|||
33518001|NCT02686658|101792806|FG005|Overall Study|Placed in hospice care|0|||
33518002|NCT02686658|101792801|FG000|Overall Study|Participant non-compliance|0|||
33518003|NCT02686658|101792802|FG001|Overall Study|Participant non-compliance|0|||
33518004|NCT02686658|101792803|FG002|Overall Study|Participant non-compliance|0|||
33518005|NCT02686658|101792804|FG003|Overall Study|Participant non-compliance|0|||
33518006|NCT02686658|101792805|FG004|Overall Study|Participant non-compliance|0|||
33518007|NCT02686658|101792806|FG005|Overall Study|Participant non-compliance|1|||
33518008|NCT02686658|101792801|FG000|Overall Study|Concern over coronavirus disease care|0|||
33518009|NCT02686658|101792802|FG001|Overall Study|Concern over coronavirus disease care|0|||
33518010|NCT02686658|101792803|FG002|Overall Study|Concern over coronavirus disease care|0|||
33518011|NCT02686658|101792804|FG003|Overall Study|Concern over coronavirus disease care|0|||
33518012|NCT02686658|101792805|FG004|Overall Study|Concern over coronavirus disease care|2|||
33518013|NCT02686658|101792806|FG005|Overall Study|Concern over coronavirus disease care|1|||
33518014|NCT00114738|101792820|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
33518015|NCT00114738|101792821|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
33200072|NCT02391948|100638212|FG002|6-month Assessment|Withdrawal by Subject|1|||
33518016|NCT00114738|101792822|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
33518017|NCT00114738|101792820|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
33518018|NCT00114738|101792821|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
33518019|NCT00114738|101792822|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
33518020|NCT00114738|101792820|FG000|Screening for Randomization|Neuropathy|17|||
33518021|NCT00114738|101792821|FG001|Screening for Randomization|Neuropathy|0|||
33518022|NCT00114738|101792822|FG002|Screening for Randomization|Neuropathy|0|||
33518023|NCT00114738|101792820|FG000|Screening for Randomization|Progressive disease|2|||
33518024|NCT00114738|101792821|FG001|Screening for Randomization|Progressive disease|0|||
33518025|NCT00114738|101792822|FG002|Screening for Randomization|Progressive disease|0|||
33518026|NCT00114738|101792820|FG000|Screening for Randomization|CNS Hemorrhage|1|||
33518027|NCT00114738|101792821|FG001|Screening for Randomization|CNS Hemorrhage|0|||
33608186|NCT00545103|102115044|FG002|Overall Study|Withdrawal by Subject|18|||
33608187|NCT00545103|102115045|FG003|Overall Study|Withdrawal by Subject|22|||
33608188|NCT00545103|102115042|FG000|Overall Study|Adverse Event|11|||
33200073|NCT02391948|100638213|FG003|6-month Assessment|Withdrawal by Subject|2|||
33200074|NCT02391948|100638214|FG004|6-month Assessment|Withdrawal by Subject|0|||
33400535|NCT00643851|101353468|FG000|Overall Study|Withdrawal by Subject|8|||
33400536|NCT00643851|101353469|FG001|Overall Study|Withdrawal by Subject|15|||
33400537|NCT00643851|101353470|FG002|Overall Study|Withdrawal by Subject|9|||
33518028|NCT00114738|101792822|FG002|Screening for Randomization|CNS Hemorrhage|0|||
33518029|NCT00114738|101792820|FG000|Screening for Randomization|Other|1|||
33518030|NCT00114738|101792821|FG001|Screening for Randomization|Other|0|||
33518031|NCT00114738|101792822|FG002|Screening for Randomization|Other|0|||
33518032|NCT02086448|101792823|FG000|Overall Study|Withdrawal by Subject|1|||
33518033|NCT02086448|101792824|FG001|Overall Study|Withdrawal by Subject|0|||
33518034|NCT02086448|101792825|FG002|Overall Study|Withdrawal by Subject|0|||
33518035|NCT02086448|101792826|FG003|Overall Study|Withdrawal by Subject|2|||
33518036|NCT00424021|101792827|FG000|NCT00046319 Study Period|Adverse Event|1|||
33518037|NCT00424021|101792828|FG001|NCT00046319 Study Period|Adverse Event|0|||
33518038|NCT00424021|101792829|FG002|NCT00046319 Study Period|Adverse Event|1|||
33518039|NCT00424021|101792830|FG003|NCT00046319 Study Period|Adverse Event|1|||
33200075|NCT02391948|100638210|FG000|6-month Assessment|Lost to Follow-up|4|||
33400538|NCT00643851|101353468|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
33518040|NCT00424021|101792827|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
33518041|NCT00424021|101792828|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
33518042|NCT00424021|101792829|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
33518043|NCT00424021|101792830|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
33518044|NCT00424021|101792827|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
33518045|NCT00424021|101792828|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
33518046|NCT00424021|101792829|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
33518047|NCT00424021|101792830|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
33518048|NCT00424021|101792827|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
33518049|NCT00424021|101792828|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
33518050|NCT00424021|101792829|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
33518051|NCT00424021|101792830|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
33518052|NCT00424021|101792827|FG000|AMB-220-E Study Period|Adverse Event|1|||
33518053|NCT00424021|101792828|FG001|AMB-220-E Study Period|Adverse Event|1|||
33518054|NCT00424021|101792829|FG002|AMB-220-E Study Period|Adverse Event|3|||
33518055|NCT00424021|101792830|FG003|AMB-220-E Study Period|Adverse Event|7|||
33518056|NCT00424021|101792827|FG000|AMB-220-E Study Period|Death|0|||
33518057|NCT00424021|101792828|FG001|AMB-220-E Study Period|Death|0|||
33518058|NCT00424021|101792829|FG002|AMB-220-E Study Period|Death|1|||
33400539|NCT00643851|101353469|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
33400540|NCT00643851|101353470|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
33400541|NCT00305773|101353473|FG000|Overall Study|Death|3|||
33400542|NCT00305773|101353474|FG001|Overall Study|Death|2|||
33400543|NCT00305773|101353473|FG000|Overall Study|Adverse Event|1|||
33400544|NCT00305773|101353474|FG001|Overall Study|Adverse Event|2|||
33400545|NCT00305773|101353473|FG000|Overall Study|Alternative Treatment|4|||
33400546|NCT00305773|101353474|FG001|Overall Study|Alternative Treatment|4|||
33400547|NCT00305773|101353473|FG000|Overall Study|Physician Decision|1|||
33518059|NCT00424021|101792830|FG003|AMB-220-E Study Period|Death|1|||
33518060|NCT00424021|101792827|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
33518061|NCT00424021|101792828|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
33518062|NCT00424021|101792829|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
33518063|NCT00424021|101792830|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
33518064|NCT00424021|101792827|FG000|AMB-220-E Study Period|Physician Decision|0|||
33518065|NCT00424021|101792828|FG001|AMB-220-E Study Period|Physician Decision|0|||
33518066|NCT00424021|101792829|FG002|AMB-220-E Study Period|Physician Decision|0|||
33518067|NCT00424021|101792830|FG003|AMB-220-E Study Period|Physician Decision|1|||
33400548|NCT00305773|101353474|FG001|Overall Study|Physician Decision|1|||
33400549|NCT00305773|101353473|FG000|Overall Study|Withdrawal by Subject|1|||
33400550|NCT00305773|101353474|FG001|Overall Study|Withdrawal by Subject|4|||
33608189|NCT00545103|102115043|FG001|Overall Study|Adverse Event|12|||
33200076|NCT02391948|100638211|FG001|6-month Assessment|Lost to Follow-up|5|||
33400551|NCT00305773|101353473|FG000|Overall Study|Disease Progression|1|||
33400552|NCT00305773|101353474|FG001|Overall Study|Disease Progression|3|||
33400553|NCT00305773|101353473|FG000|Overall Study|All other reasons|3|||
33400554|NCT00305773|101353474|FG001|Overall Study|All other reasons|2|||
33400555|NCT01997333|101353475|FG000|Randomization and Treatment|Disease Progression|70|||
33400556|NCT01997333|101353476|FG001|Randomization and Treatment|Disease Progression|159|||
33400557|NCT01997333|101353475|FG000|Randomization and Treatment|Adverse Event|10|||
33400558|NCT01997333|101353476|FG001|Randomization and Treatment|Adverse Event|32|||
33400559|NCT01997333|101353475|FG000|Randomization and Treatment|Physician Decision|0|||
33400560|NCT01997333|101353476|FG001|Randomization and Treatment|Physician Decision|4|||
33400561|NCT01997333|101353475|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
33400562|NCT01997333|101353476|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
33400563|NCT01997333|101353475|FG000|Randomization and Treatment|Did not receive treatment|17|||
33400564|NCT01997333|101353476|FG001|Randomization and Treatment|Did not receive treatment|5|||
33400565|NCT01997333|101353475|FG000|Survival Follow up|Withdrawal by Subject|15|||
33400566|NCT01997333|101353476|FG001|Survival Follow up|Withdrawal by Subject|6|||
33400567|NCT01997333|101353475|FG000|Survival Follow up|Lost to Follow-up|0|||
33400568|NCT01997333|101353476|FG001|Survival Follow up|Lost to Follow-up|6|||
33400569|NCT01997333|101353475|FG000|Survival Follow up|Various|1|||
33400570|NCT01997333|101353476|FG001|Survival Follow up|Various|2|||
33400571|NCT00170846|101353477|FG000|Overall Study|Subject withdrew Informed Consent|5|||
33400572|NCT00170846|101353478|FG001|Overall Study|Subject withdrew Informed Consent|12|||
33400573|NCT00170846|101353479|FG002|Overall Study|Subject withdrew Informed Consent|8|||
33518068|NCT02093390|101792831|FG000|Overall Study|Withdrawal by Subject|0|||
33518069|NCT02093390|101792832|FG001|Overall Study|Withdrawal by Subject|1|||
33518070|NCT02923245|101792833|FG000|Overall Study|ultrasound order was cancelled|2|||
33518071|NCT02923245|101792834|FG001|Overall Study|ultrasound order was cancelled|1|||
33518072|NCT01472939|101792835|FG000|Overall Study|Adverse Event|3|||
33518073|NCT01472939|101792836|FG001|Overall Study|Adverse Event|7|||
33518074|NCT01472939|101792837|FG002|Overall Study|Adverse Event|7|||
33518075|NCT01472939|101792838|FG003|Overall Study|Adverse Event|14|||
33518076|NCT01472939|101792835|FG000|Overall Study|Lack of Efficacy|1|||
33518077|NCT01472939|101792836|FG001|Overall Study|Lack of Efficacy|0|||
33518078|NCT01472939|101792837|FG002|Overall Study|Lack of Efficacy|0|||
33518079|NCT01472939|101792838|FG003|Overall Study|Lack of Efficacy|1|||
33518080|NCT01472939|101792835|FG000|Overall Study|Lost to Follow-up|3|||
33518081|NCT01472939|101792836|FG001|Overall Study|Lost to Follow-up|0|||
33518082|NCT01472939|101792837|FG002|Overall Study|Lost to Follow-up|2|||
33518083|NCT01472939|101792838|FG003|Overall Study|Lost to Follow-up|0|||
33200077|NCT02391948|100638212|FG002|6-month Assessment|Lost to Follow-up|2|||
33200078|NCT02391948|100638213|FG003|6-month Assessment|Lost to Follow-up|3|||
33200079|NCT02391948|100638214|FG004|6-month Assessment|Lost to Follow-up|1|||
33200080|NCT02391948|100638210|FG000|6-month Assessment|Medical issue/illness|1|||
33200081|NCT02391948|100638211|FG001|6-month Assessment|Medical issue/illness|1|||
33200082|NCT02391948|100638212|FG002|6-month Assessment|Medical issue/illness|0|||
33200083|NCT02391948|100638213|FG003|6-month Assessment|Medical issue/illness|0|||
33200084|NCT02391948|100638214|FG004|6-month Assessment|Medical issue/illness|0|||
33200085|NCT02391948|100638210|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
33200086|NCT02391948|100638211|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
33200087|NCT02391948|100638212|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
33200088|NCT02391948|100638213|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
33200089|NCT02391948|100638214|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
33200090|NCT02391948|100638210|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
33200091|NCT02391948|100638211|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
33200092|NCT02391948|100638212|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
33200093|NCT02391948|100638213|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
33200094|NCT02391948|100638214|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
33200095|NCT02391948|100638210|FG000|12-month Assessment|Death|0|||
33200096|NCT02391948|100638211|FG001|12-month Assessment|Death|0|||
33200097|NCT02391948|100638212|FG002|12-month Assessment|Death|0|||
33200098|NCT02391948|100638213|FG003|12-month Assessment|Death|1|||
33200099|NCT02391948|100638214|FG004|12-month Assessment|Death|0|||
33326934|NCT01987960|101094073|FG001|Period 1|Lost to Follow-up|0|||
33326935|NCT01987960|101094074|FG002|Period 1|Lost to Follow-up|0|||
33326936|NCT01987960|101094075|FG003|Period 1|Lost to Follow-up|0|||
33326937|NCT01987960|101094072|FG000|Period 1|administrative or other reason|75|||
33326938|NCT01987960|101094073|FG001|Period 1|administrative or other reason|0|||
33326939|NCT01987960|101094074|FG002|Period 1|administrative or other reason|0|||
33326940|NCT01987960|101094075|FG003|Period 1|administrative or other reason|0|||
33326941|NCT01987960|101094072|FG000|Period 1|Withdrawal of consent before treatment|4|||
33326942|NCT01987960|101094073|FG001|Period 1|Withdrawal of consent before treatment|0|||
33326943|NCT01987960|101094074|FG002|Period 1|Withdrawal of consent before treatment|0|||
33400574|NCT00170846|101353477|FG000|Overall Study|Lost to Follow-up|6|||
33518084|NCT01472939|101792835|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
33518085|NCT01472939|101792836|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
33518086|NCT01472939|101792837|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
33518087|NCT01472939|101792838|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
33518088|NCT01472939|101792835|FG000|Overall Study|Prohibited Medication|0|||
33518089|NCT01472939|101792836|FG001|Overall Study|Prohibited Medication|1|||
33518090|NCT01472939|101792837|FG002|Overall Study|Prohibited Medication|0|||
33518091|NCT01472939|101792838|FG003|Overall Study|Prohibited Medication|0|||
33518092|NCT01472939|101792835|FG000|Overall Study|Withdrawal By PI|1|||
33518093|NCT01472939|101792836|FG001|Overall Study|Withdrawal By PI|0|||
33518094|NCT01472939|101792837|FG002|Overall Study|Withdrawal By PI|0|||
33518095|NCT01472939|101792838|FG003|Overall Study|Withdrawal By PI|0|||
33518096|NCT01472939|101792835|FG000|Overall Study|Protocol Violation|3|||
33518097|NCT01472939|101792836|FG001|Overall Study|Protocol Violation|3|||
33518098|NCT01472939|101792837|FG002|Overall Study|Protocol Violation|0|||
33518099|NCT01472939|101792838|FG003|Overall Study|Protocol Violation|1|||
33518100|NCT01472939|101792835|FG000|Overall Study|Withdrawal by Subject|9|||
33518101|NCT01472939|101792836|FG001|Overall Study|Withdrawal by Subject|3|||
33518102|NCT01472939|101792837|FG002|Overall Study|Withdrawal by Subject|1|||
33518103|NCT01472939|101792838|FG003|Overall Study|Withdrawal by Subject|4|||
33518104|NCT00603382|101792839|FG000|Overall Study|Adverse Event|0|||
33518105|NCT00603382|101792840|FG001|Overall Study|Adverse Event|1|||
33518106|NCT00603382|101792841|FG002|Overall Study|Adverse Event|1|||
33518107|NCT00603382|101792842|FG003|Overall Study|Adverse Event|2|||
33518108|NCT00603382|101792843|FG004|Overall Study|Adverse Event|1|||
33518109|NCT00603382|101792844|FG005|Overall Study|Adverse Event|2|||
33518110|NCT00603382|101792839|FG000|Overall Study|Lack of Efficacy|14|||
33608190|NCT00545103|102115044|FG002|Overall Study|Adverse Event|17|||
33608191|NCT00545103|102115045|FG003|Overall Study|Adverse Event|10|||
33608192|NCT00545103|102115042|FG000|Overall Study|Lost to Follow-up|4|||
33608193|NCT00545103|102115043|FG001|Overall Study|Lost to Follow-up|6|||
33608194|NCT00545103|102115044|FG002|Overall Study|Lost to Follow-up|3|||
33608195|NCT00545103|102115045|FG003|Overall Study|Lost to Follow-up|4|||
33608196|NCT00545103|102115042|FG000|Overall Study|Protocol Violation|1|||
33608197|NCT00545103|102115043|FG001|Overall Study|Protocol Violation|2|||
33608198|NCT00545103|102115044|FG002|Overall Study|Protocol Violation|3|||
33608199|NCT00545103|102115045|FG003|Overall Study|Protocol Violation|0|||
33608200|NCT00545103|102115042|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
33608201|NCT00545103|102115043|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
33608202|NCT00545103|102115044|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
33608203|NCT00545103|102115045|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
33608204|NCT00545103|102115042|FG000|Overall Study|Difficult to open package|0|||
33608205|NCT00545103|102115043|FG001|Overall Study|Difficult to open package|0|||
33608206|NCT00545103|102115044|FG002|Overall Study|Difficult to open package|0|||
33608207|NCT00545103|102115045|FG003|Overall Study|Difficult to open package|1|||
33608208|NCT00545103|102115042|FG000|Overall Study|Investigational product not taken|1|||
33608209|NCT00545103|102115043|FG001|Overall Study|Investigational product not taken|0|||
33608210|NCT00545103|102115044|FG002|Overall Study|Investigational product not taken|0|||
33608211|NCT00545103|102115045|FG003|Overall Study|Investigational product not taken|1|||
33608212|NCT00545103|102115042|FG000|Overall Study|Wish to start a family|0|||
33608213|NCT00545103|102115043|FG001|Overall Study|Wish to start a family|0|||
33608214|NCT00545103|102115044|FG002|Overall Study|Wish to start a family|0|||
33608215|NCT00545103|102115045|FG003|Overall Study|Wish to start a family|1|||
33608216|NCT00545103|102115042|FG000|Overall Study|Diverticulitis crisis|0|||
33608217|NCT00545103|102115043|FG001|Overall Study|Diverticulitis crisis|0|||
33608218|NCT00545103|102115044|FG002|Overall Study|Diverticulitis crisis|0|||
33608219|NCT00545103|102115045|FG003|Overall Study|Diverticulitis crisis|1|||
33608220|NCT00545103|102115042|FG000|Overall Study|Personal reasons|1|||
33608221|NCT00545103|102115043|FG001|Overall Study|Personal reasons|0|||
33608222|NCT00545103|102115044|FG002|Overall Study|Personal reasons|0|||
33608223|NCT00545103|102115045|FG003|Overall Study|Personal reasons|0|||
33608224|NCT00545103|102115042|FG000|Overall Study|Subject's decision|1|||
33608225|NCT00545103|102115043|FG001|Overall Study|Subject's decision|0|||
33608226|NCT00545103|102115044|FG002|Overall Study|Subject's decision|0|||
33608227|NCT00545103|102115045|FG003|Overall Study|Subject's decision|0|||
33518111|NCT00603382|101792840|FG001|Overall Study|Lack of Efficacy|9|||
33518112|NCT00603382|101792841|FG002|Overall Study|Lack of Efficacy|3|||
33518113|NCT00603382|101792842|FG003|Overall Study|Lack of Efficacy|6|||
33518114|NCT00603382|101792843|FG004|Overall Study|Lack of Efficacy|6|||
33518115|NCT00603382|101792844|FG005|Overall Study|Lack of Efficacy|11|||
33518116|NCT00603382|101792839|FG000|Overall Study|Protocol Violation|1|||
33518117|NCT00603382|101792840|FG001|Overall Study|Protocol Violation|0|||
33518118|NCT00603382|101792841|FG002|Overall Study|Protocol Violation|1|||
33608228|NCT00545103|102115042|FG000|Overall Study|Noncompliance|0|||
33608229|NCT00545103|102115043|FG001|Overall Study|Noncompliance|1|||
33608230|NCT00545103|102115044|FG002|Overall Study|Noncompliance|0|||
33608231|NCT00545103|102115045|FG003|Overall Study|Noncompliance|0|||
33608232|NCT00545103|102115042|FG000|Overall Study|Investigator decision|0|||
33608233|NCT00545103|102115043|FG001|Overall Study|Investigator decision|0|||
33518119|NCT00603382|101792842|FG003|Overall Study|Protocol Violation|2|||
33518120|NCT00603382|101792843|FG004|Overall Study|Protocol Violation|1|||
33518121|NCT00603382|101792844|FG005|Overall Study|Protocol Violation|0|||
33518122|NCT00603382|101792839|FG000|Overall Study|Lost to Follow-up|0|||
33518123|NCT00603382|101792840|FG001|Overall Study|Lost to Follow-up|1|||
33518124|NCT00603382|101792841|FG002|Overall Study|Lost to Follow-up|1|||
33518125|NCT00603382|101792842|FG003|Overall Study|Lost to Follow-up|1|||
33518126|NCT00603382|101792843|FG004|Overall Study|Lost to Follow-up|0|||
33518127|NCT00603382|101792844|FG005|Overall Study|Lost to Follow-up|1|||
33518128|NCT00603382|101792839|FG000|Overall Study|Physician Decision|0|||
33518129|NCT00603382|101792840|FG001|Overall Study|Physician Decision|0|||
33518130|NCT00603382|101792841|FG002|Overall Study|Physician Decision|2|||
33518131|NCT00603382|101792842|FG003|Overall Study|Physician Decision|0|||
33518132|NCT00603382|101792843|FG004|Overall Study|Physician Decision|1|||
33518133|NCT00603382|101792844|FG005|Overall Study|Physician Decision|3|||
33518134|NCT00603382|101792839|FG000|Overall Study|Withdrawal by Subject|3|||
33518135|NCT00603382|101792840|FG001|Overall Study|Withdrawal by Subject|3|||
33518136|NCT00603382|101792841|FG002|Overall Study|Withdrawal by Subject|1|||
33518137|NCT00603382|101792842|FG003|Overall Study|Withdrawal by Subject|1|||
33518138|NCT00603382|101792843|FG004|Overall Study|Withdrawal by Subject|0|||
33518139|NCT00603382|101792844|FG005|Overall Study|Withdrawal by Subject|1|||
33518140|NCT00314132|101792846|FG000|Overall Study|Lost to Follow-up|3|||
33518141|NCT00314132|101792847|FG001|Overall Study|Lost to Follow-up|13|||
33518142|NCT00314132|101792846|FG000|Overall Study|Withdrawal by Subject|3|||
33518143|NCT00314132|101792847|FG001|Overall Study|Withdrawal by Subject|5|||
33518144|NCT00314132|101792846|FG000|Overall Study|Adverse Event|1|||
33518145|NCT00314132|101792847|FG001|Overall Study|Adverse Event|0|||
33518146|NCT00314132|101792846|FG000|Overall Study|Physician Decision|1|||
33518147|NCT00314132|101792847|FG001|Overall Study|Physician Decision|0|||
33518148|NCT02631070|101792848|FG000|Overall Study|Withdrawal by Subject|35|||
33518149|NCT02631070|101792849|FG001|Overall Study|Withdrawal by Subject|13|||
33518150|NCT02631070|101792848|FG000|Overall Study|Death|45|||
33518151|NCT02631070|101792849|FG001|Overall Study|Death|24|||
33608234|NCT00545103|102115044|FG002|Overall Study|Investigator decision|1|||
33608235|NCT00545103|102115045|FG003|Overall Study|Investigator decision|0|||
33608236|NCT00545103|102115042|FG000|Overall Study|Subject moved|0|||
33608237|NCT00545103|102115043|FG001|Overall Study|Subject moved|1|||
33608238|NCT00545103|102115044|FG002|Overall Study|Subject moved|0|||
33608239|NCT00545103|102115045|FG003|Overall Study|Subject moved|0|||
33608240|NCT00545103|102115042|FG000|Overall Study|Use of prohibited medication|0|||
33326944|NCT01987960|101094075|FG003|Period 1|Withdrawal of consent before treatment|0|||
33400575|NCT00170846|101353478|FG001|Overall Study|Lost to Follow-up|3|||
33400576|NCT00170846|101353479|FG002|Overall Study|Lost to Follow-up|2|||
33400577|NCT00170846|101353477|FG000|Overall Study|Death|0|||
33400578|NCT00170846|101353478|FG001|Overall Study|Death|3|||
33400579|NCT00170846|101353479|FG002|Overall Study|Death|3|||
33400580|NCT00170846|101353477|FG000|Overall Study|Reason Missing|0|||
33400581|NCT00170846|101353478|FG001|Overall Study|Reason Missing|1|||
33400582|NCT00170846|101353479|FG002|Overall Study|Reason Missing|0|||
33400583|NCT00529152|101353480|FG000|Overall Study|Adverse Event|2|||
33400584|NCT00529152|101353480|FG000|Overall Study|Withdrawal by Subject|2|||
33400585|NCT00529152|101353480|FG000|Overall Study|Lost to Follow-up|1|||
33400586|NCT02853318|101353481|FG000|Overall Study|Withdrawal by Subject|1|||
33400587|NCT03018028|101353488|FG000|Overall Study|Withdrawal by Subject|3|||
33400588|NCT03018028|101353489|FG001|Overall Study|Withdrawal by Subject|0|||
33400589|NCT03018028|101353490|FG002|Overall Study|Withdrawal by Subject|1|||
33400590|NCT03018028|101353491|FG003|Overall Study|Withdrawal by Subject|2|||
33400591|NCT03018028|101353492|FG004|Overall Study|Withdrawal by Subject|0|||
33400592|NCT01977040|101353493|FG000|Overall Study|Vasa previa not confirmed|2|||
33400593|NCT01842334|101353496|FG000|Overall Study|Withdrawal by Subject|3|||
33400594|NCT01842334|101353497|FG001|Overall Study|Withdrawal by Subject|3|||
33400595|NCT01842334|101353496|FG000|Overall Study|Moved away mid-study|0|||
33400596|NCT01842334|101353497|FG001|Overall Study|Moved away mid-study|1|||
33518152|NCT02631070|101792848|FG000|Overall Study|Lost to Follow-up|5|||
33518153|NCT02631070|101792849|FG001|Overall Study|Lost to Follow-up|1|||
33518154|NCT02631070|101792848|FG000|Overall Study|Transition to rollover protocol|52|||
33518155|NCT02631070|101792849|FG001|Overall Study|Transition to rollover protocol|21|||
33518156|NCT02631070|101792848|FG000|Overall Study|Other reasons|12|||
33518157|NCT02631070|101792849|FG001|Overall Study|Other reasons|5|||
33518158|NCT00423189|101792852|FG000|Overall Study|Death|0|||
33518159|NCT00423189|101792853|FG001|Overall Study|Death|1|||
33518160|NCT00423189|101792854|FG002|Overall Study|Death|0|||
33518161|NCT01430624|101792855|FG000|Overall Study|Lost to Follow-up|23|||
33518162|NCT01430624|101792856|FG001|Overall Study|Lost to Follow-up|29|||
33518163|NCT01430624|101792857|FG002|Overall Study|Lost to Follow-up|27|||
33608241|NCT00545103|102115043|FG001|Overall Study|Use of prohibited medication|0|||
33608242|NCT00545103|102115044|FG002|Overall Study|Use of prohibited medication|1|||
33400597|NCT02036476|101353500|FG000|Overall Study|Withdrawal by Subject|2|||
33400598|NCT02036476|101353500|FG000|Overall Study|Progressive Disease|4|||
33518164|NCT01430624|101792855|FG000|Overall Study|technical or eligibility|5|||
33518165|NCT01430624|101792856|FG001|Overall Study|technical or eligibility|5|||
33518166|NCT01430624|101792857|FG002|Overall Study|technical or eligibility|2|||
33518167|NCT04240457|101792858|FG000|Overall Study|Lost to Follow-up|5|||
33518168|NCT04240457|101792859|FG001|Overall Study|Lost to Follow-up|1|||
33400599|NCT02036476|101353500|FG000|Overall Study|Unacceptable Toxicity|2|||
33400600|NCT00323479|101353505|FG000|Overall Study|Adverse Event|2|||
33518169|NCT00388297|101792864|FG000|Overall Study|Lost to Follow-up|16|||
33518170|NCT00388297|101792865|FG001|Overall Study|Lost to Follow-up|12|||
33518171|NCT00388297|101792866|FG002|Overall Study|Lost to Follow-up|11|||
33518172|NCT00388297|101792867|FG003|Overall Study|Lost to Follow-up|8|||
33518173|NCT00401960|101792873|FG000|Overall Study|Lost to Follow-up|3|||
33518174|NCT00401960|101792874|FG001|Overall Study|Lost to Follow-up|0|||
33518175|NCT00401960|101792873|FG000|Overall Study|Death|2|||
33518176|NCT00401960|101792874|FG001|Overall Study|Death|0|||
33518177|NCT01606748|101792882|FG000|Overall Study|Adverse Event|1|||
33518178|NCT01606748|101792883|FG001|Overall Study|Adverse Event|0|||
33518179|NCT01606748|101792882|FG000|Overall Study|Progressive Disease|1|||
33518180|NCT01606748|101792883|FG001|Overall Study|Progressive Disease|0|||
33400601|NCT00323479|101353505|FG000|Overall Study|Withdrawal by Subject|2|||
33400602|NCT00323479|101353505|FG000|Overall Study|Protocol Violation|3|||
33518181|NCT01606748|101792882|FG000|Overall Study|Withdrawal by Subject|1|||
33518182|NCT01606748|101792883|FG001|Overall Study|Withdrawal by Subject|0|||
33518183|NCT02117713|101792884|FG000|Week 48|Adverse Event|4|||
33518184|NCT02117713|101792884|FG000|Week 48|Withdrawal by caregiver|2|||
33518185|NCT02117713|101792884|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
33518186|NCT02117713|101792884|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
33518187|NCT02117713|101792884|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
33518188|NCT02117713|101792884|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
33518189|NCT02949908|101792888|FG000|Overall Study|Study termination|2|||
33518190|NCT03759366|101792890|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
33518191|NCT03759366|101792890|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
33518192|NCT03759366|101792890|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
33518193|NCT03759366|101792890|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
33400603|NCT00323479|101353505|FG000|Overall Study|house moving|1|||
33400604|NCT00434876|101353510|FG000|Overall Study|Lost to Follow-up|1|||
33400605|NCT00434876|101353511|FG001|Overall Study|Lost to Follow-up|1|||
33400606|NCT01696396|101353514|FG000|Overall Study|Withdrawal by Subject|19|||
33400607|NCT01696396|101353515|FG001|Overall Study|Withdrawal by Subject|5|||
33400608|NCT01696396|101353516|FG002|Overall Study|Withdrawal by Subject|19|||
33400609|NCT01696396|101353517|FG003|Overall Study|Withdrawal by Subject|11|||
33400610|NCT01696396|101353514|FG000|Overall Study|Decision by Sponsor|3|||
33400611|NCT01696396|101353515|FG001|Overall Study|Decision by Sponsor|1|||
33400612|NCT01696396|101353516|FG002|Overall Study|Decision by Sponsor|2|||
33400613|NCT01696396|101353517|FG003|Overall Study|Decision by Sponsor|2|||
33400614|NCT01696396|101353514|FG000|Overall Study|Lost to Follow-up|9|||
33400615|NCT01696396|101353515|FG001|Overall Study|Lost to Follow-up|1|||
33400616|NCT01696396|101353516|FG002|Overall Study|Lost to Follow-up|4|||
33400617|NCT01696396|101353517|FG003|Overall Study|Lost to Follow-up|1|||
33400618|NCT01696396|101353514|FG000|Overall Study|Death|0|||
33400619|NCT01696396|101353515|FG001|Overall Study|Death|0|||
33400620|NCT01696396|101353516|FG002|Overall Study|Death|1|||
33400621|NCT01696396|101353517|FG003|Overall Study|Death|0|||
33400622|NCT04129242|101353518|FG000|Overall Study|Physician Decision|1|||
33400623|NCT04129242|101353519|FG001|Overall Study|Physician Decision|1|||
33400624|NCT04129242|101353518|FG000|Overall Study|Protocol Violation|0|||
33400625|NCT04129242|101353519|FG001|Overall Study|Protocol Violation|1|||
33400626|NCT02405091|101353520|FG000|Overall Study|Adverse Event|16|||
33400627|NCT02405091|101353521|FG001|Overall Study|Adverse Event|10|||
33400628|NCT02405091|101353522|FG002|Overall Study|Adverse Event|0|||
33400629|NCT02405091|101353520|FG000|Overall Study|Protocol Violation|1|||
33518194|NCT03759366|101792890|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
33518195|NCT03759366|101792890|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
33518196|NCT03759366|101792890|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
33518197|NCT04027075|101792895|FG000|Overall Study|Lost to Follow-up|41|||
33518198|NCT04027075|101792896|FG001|Overall Study|Lost to Follow-up|22|||
33518199|NCT00552032|101792897|FG000|Overall Study|Withdrawal by Subject|2|||
33518200|NCT00552032|101792898|FG001|Overall Study|Withdrawal by Subject|2|||
33518201|NCT00552032|101792897|FG000|Overall Study|Protocol Violation|7|||
33518202|NCT00552032|101792898|FG001|Overall Study|Protocol Violation|12|||
33400630|NCT02405091|101353521|FG001|Overall Study|Protocol Violation|0|||
33400631|NCT02405091|101353522|FG002|Overall Study|Protocol Violation|0|||
33400632|NCT02405091|101353520|FG000|Overall Study|Noncompliance|1|||
33400633|NCT02405091|101353521|FG001|Overall Study|Noncompliance|6|||
33518203|NCT00552032|101792897|FG000|Overall Study|Lost to Follow-up|8|||
33518204|NCT00552032|101792898|FG001|Overall Study|Lost to Follow-up|5|||
33518205|NCT04272606|101792899|FG000|Overall Study|Protocol Violation|1|||
33400634|NCT02405091|101353522|FG002|Overall Study|Noncompliance|2|||
33518206|NCT04272606|101792900|FG001|Overall Study|Protocol Violation|1|||
33518207|NCT04272606|101792899|FG000|Overall Study|Physician Decision|0|||
33518208|NCT04272606|101792900|FG001|Overall Study|Physician Decision|1|||
33518209|NCT00345878|101792901|FG000|Overall Study|Adverse Event|1|||
33518210|NCT00345878|101792902|FG001|Overall Study|Adverse Event|0|||
33518211|NCT00345878|101792901|FG000|Overall Study|Lost to Follow-up|2|||
33518212|NCT00345878|101792902|FG001|Overall Study|Lost to Follow-up|1|||
33518213|NCT00345878|101792901|FG000|Overall Study|Other|1|||
33518214|NCT00345878|101792902|FG001|Overall Study|Other|0|||
33518215|NCT03755518|101792903|FG000|Overall Study|Lack of Efficacy|10|||
33518216|NCT03755518|101792903|FG000|Overall Study|Adverse Event|7|||
33518217|NCT03755518|101792903|FG000|Overall Study|Study Terminated by Sponsor|5|||
33518218|NCT03755518|101792903|FG000|Overall Study|Death|1|||
33518219|NCT03755518|101792903|FG000|Overall Study|Withdrawal by Subject|3|||
33518220|NCT03755518|101792903|FG000|Overall Study|Progressive Disease|4|||
33518221|NCT03755518|101792903|FG000|Overall Study|Bone Marrow Transplant|4|||
33200100|NCT02391948|100638210|FG000|12-month Assessment|Withdrawal by Subject|1|||
33200101|NCT02391948|100638211|FG001|12-month Assessment|Withdrawal by Subject|0|||
33200102|NCT02391948|100638212|FG002|12-month Assessment|Withdrawal by Subject|0|||
33200103|NCT02391948|100638213|FG003|12-month Assessment|Withdrawal by Subject|1|||
33200104|NCT02391948|100638214|FG004|12-month Assessment|Withdrawal by Subject|0|||
33200105|NCT02391948|100638210|FG000|12-month Assessment|Lost to Follow-up|5|||
33200106|NCT02391948|100638211|FG001|12-month Assessment|Lost to Follow-up|4|||
33200107|NCT02391948|100638212|FG002|12-month Assessment|Lost to Follow-up|4|||
33200108|NCT02391948|100638213|FG003|12-month Assessment|Lost to Follow-up|4|||
33200109|NCT02391948|100638214|FG004|12-month Assessment|Lost to Follow-up|5|||
33200110|NCT02391948|100638210|FG000|12-month Assessment|Medical issue/illness|0|||
33200111|NCT02391948|100638211|FG001|12-month Assessment|Medical issue/illness|1|||
33200112|NCT02391948|100638212|FG002|12-month Assessment|Medical issue/illness|0|||
33200113|NCT02391948|100638213|FG003|12-month Assessment|Medical issue/illness|1|||
33200114|NCT02391948|100638214|FG004|12-month Assessment|Medical issue/illness|0|||
33518222|NCT03755518|101792903|FG000|Overall Study|Physicians Decision|1|||
33518223|NCT03755518|101792903|FG000|Overall Study|Relapse|1|||
33518224|NCT03755518|101792903|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
33518225|NCT03755518|101792903|FG000|Overall Study|Withdrawal by PI|1|||
33518226|NCT02844907|101792909|FG000|With Dexamethasone|No IV access|1|||
33518227|NCT01167634|101792910|FG000|Overall Study|Lost to Follow-up|1|||
33518228|NCT01167634|101792911|FG001|Overall Study|Lost to Follow-up|3|||
33518229|NCT01167634|101792912|FG002|Overall Study|Lost to Follow-up|3|||
33518230|NCT01167634|101792913|FG003|Overall Study|Lost to Follow-up|4|||
33518231|NCT01167634|101792910|FG000|Overall Study|Withdrawal by Subject|1|||
33518232|NCT01167634|101792911|FG001|Overall Study|Withdrawal by Subject|1|||
33518233|NCT01167634|101792912|FG002|Overall Study|Withdrawal by Subject|0|||
33518234|NCT01167634|101792913|FG003|Overall Study|Withdrawal by Subject|0|||
33608243|NCT00545103|102115045|FG003|Overall Study|Use of prohibited medication|0|||
33200115|NCT02391948|100638210|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
33326945|NCT01987960|101094072|FG000|Period 2|Adverse Event|0|||
33326946|NCT01987960|101094073|FG001|Period 2|Adverse Event|0|||
33326947|NCT01987960|101094074|FG002|Period 2|Adverse Event|1|||
33326948|NCT01987960|101094075|FG003|Period 2|Adverse Event|0|||
33326949|NCT01987960|101094072|FG000|Period 2|Withdrawal by Subject|0|||
33326950|NCT01987960|101094073|FG001|Period 2|Withdrawal by Subject|0|||
33326951|NCT01987960|101094074|FG002|Period 2|Withdrawal by Subject|1|||
33326952|NCT01987960|101094075|FG003|Period 2|Withdrawal by Subject|0|||
33326953|NCT01987960|101094072|FG000|Period 2|Administrative or other reason|0|||
33326954|NCT01987960|101094073|FG001|Period 2|Administrative or other reason|5|||
33326955|NCT01987960|101094074|FG002|Period 2|Administrative or other reason|7|||
33326956|NCT01987960|101094075|FG003|Period 2|Administrative or other reason|0|||
33326957|NCT01987960|101094072|FG000|Period 3|Adverse Event|0|||
33326958|NCT01987960|101094073|FG001|Period 3|Adverse Event|0|||
33326959|NCT01987960|101094074|FG002|Period 3|Adverse Event|0|||
33326960|NCT01987960|101094075|FG003|Period 3|Adverse Event|7|||
33326961|NCT01987960|101094072|FG000|Period 3|Non-compliance with IMP|0|||
33400635|NCT02405091|101353520|FG000|Overall Study|Withdrawal by Subject|4|||
33518235|NCT02655419|101792914|FG000|Overall Study|Enrolled but not treated|1|||
33518236|NCT02655419|101792915|FG001|Overall Study|Enrolled but not treated|5|||
33326962|NCT01987960|101094073|FG001|Period 3|Non-compliance with IMP|0|||
33518237|NCT02655419|101792914|FG000|Overall Study|Withdrawal by Subject|4|||
33518238|NCT02655419|101792915|FG001|Overall Study|Withdrawal by Subject|1|||
33518239|NCT02655419|101792914|FG000|Overall Study|Other|0|||
33518240|NCT02655419|101792915|FG001|Overall Study|Other|1|||
33200116|NCT02391948|100638211|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
33326963|NCT01987960|101094074|FG002|Period 3|Non-compliance with IMP|0|||
33326964|NCT01987960|101094075|FG003|Period 3|Non-compliance with IMP|1|||
33326965|NCT01987960|101094072|FG000|Period 3|Protocol Violation|0|||
33326966|NCT01987960|101094073|FG001|Period 3|Protocol Violation|0|||
33518241|NCT00394433|101792916|FG000|Overall Study|Adverse Event|2|||
33518242|NCT00394433|101792916|FG000|Overall Study|Alternative Therapy|1|||
33518243|NCT01428115|101792917|FG000|Overall Study|Lack of Efficacy|3|||
33518244|NCT01428115|101792917|FG000|Overall Study|Lost to Follow-up|10|||
33518245|NCT01428115|101792917|FG000|Overall Study|Pregnancy|1|||
33518246|NCT01428115|101792917|FG000|Overall Study|Protocol Violation|3|||
33518247|NCT01428115|101792917|FG000|Overall Study|Withdrawal by Subject|4|||
33518248|NCT03597022|101792918|FG000|Overall Study|Premature termination of the study|7|||
33518249|NCT03597022|101792919|FG001|Overall Study|Premature termination of the study|7|||
33518250|NCT03597022|101792920|FG002|Overall Study|Premature termination of the study|8|||
33400636|NCT02405091|101353521|FG001|Overall Study|Withdrawal by Subject|8|||
33400637|NCT02405091|101353522|FG002|Overall Study|Withdrawal by Subject|0|||
33200117|NCT02391948|100638212|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
33200118|NCT02391948|100638213|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
33200119|NCT02391948|100638214|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
33200120|NCT02391948|100638210|FG000|18-month Assessment|Death|0|||
33200121|NCT02391948|100638211|FG001|18-month Assessment|Death|0|||
33200122|NCT02391948|100638212|FG002|18-month Assessment|Death|0|||
33200123|NCT02391948|100638213|FG003|18-month Assessment|Death|1|||
33200124|NCT02391948|100638214|FG004|18-month Assessment|Death|1|||
33200125|NCT02391948|100638210|FG000|18-month Assessment|Withdrawal by Subject|1|||
33200126|NCT02391948|100638211|FG001|18-month Assessment|Withdrawal by Subject|0|||
33326967|NCT01987960|101094074|FG002|Period 3|Protocol Violation|0|||
33326968|NCT01987960|101094075|FG003|Period 3|Protocol Violation|6|||
33200127|NCT02391948|100638212|FG002|18-month Assessment|Withdrawal by Subject|0|||
33400638|NCT02405091|101353520|FG000|Overall Study|Death|0|||
33326969|NCT01987960|101094072|FG000|Period 3|Withdrawal by Subject|0|||
33326970|NCT01987960|101094073|FG001|Period 3|Withdrawal by Subject|0|||
33326971|NCT01987960|101094074|FG002|Period 3|Withdrawal by Subject|0|||
33400639|NCT02405091|101353521|FG001|Overall Study|Death|1|||
33400640|NCT02405091|101353522|FG002|Overall Study|Death|0|||
33400641|NCT02405091|101353520|FG000|Overall Study|Lost to Follow-up|5|||
33400642|NCT02405091|101353521|FG001|Overall Study|Lost to Follow-up|6|||
33400643|NCT02405091|101353522|FG002|Overall Study|Lost to Follow-up|0|||
33400644|NCT02405091|101353520|FG000|Overall Study|Physician Decision|2|||
33400645|NCT02405091|101353521|FG001|Overall Study|Physician Decision|2|||
33400646|NCT02405091|101353522|FG002|Overall Study|Physician Decision|0|||
33400647|NCT05158244|101353523|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
33400648|NCT05158244|101353524|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
33400649|NCT05158244|101353525|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
33400650|NCT05158244|101353526|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
33400651|NCT05158244|101353527|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
33400652|NCT05158244|101353523|FG000|Overall Study|Withdrawal by Subject|0|||
33400653|NCT05158244|101353524|FG001|Overall Study|Withdrawal by Subject|0|||
33400654|NCT05158244|101353525|FG002|Overall Study|Withdrawal by Subject|1|||
33400655|NCT05158244|101353526|FG003|Overall Study|Withdrawal by Subject|0|||
33400656|NCT05158244|101353527|FG004|Overall Study|Withdrawal by Subject|0|||
33400657|NCT03225833|101353528|FG000|Overall Study|Adverse Event|0|||
33518251|NCT03597022|101792918|FG000|Overall Study|Serious adverse event|1|||
33326972|NCT01987960|101094075|FG003|Period 3|Withdrawal by Subject|9|||
33326973|NCT01987960|101094072|FG000|Period 3|Lost to Follow-up|0|||
33326974|NCT01987960|101094073|FG001|Period 3|Lost to Follow-up|0|||
33326975|NCT01987960|101094074|FG002|Period 3|Lost to Follow-up|0|||
33326976|NCT01987960|101094075|FG003|Period 3|Lost to Follow-up|5|||
33326977|NCT01987960|101094072|FG000|Period 3|Administrative or other reason|0|||
33326978|NCT01987960|101094073|FG001|Period 3|Administrative or other reason|0|||
33326979|NCT01987960|101094074|FG002|Period 3|Administrative or other reason|0|||
33326980|NCT01987960|101094075|FG003|Period 3|Administrative or other reason|43|||
33326981|NCT00054704|101094076|FG000|Overall Study|Lack of Efficacy|2|||
33326982|NCT00054704|101094077|FG001|Overall Study|Lack of Efficacy|3|||
33326983|NCT00054704|101094076|FG000|Overall Study|Adverse Event|3|||
33326984|NCT00054704|101094077|FG001|Overall Study|Adverse Event|1|||
33326985|NCT00054704|101094076|FG000|Overall Study|Lost to Follow-up|0|||
33326986|NCT00054704|101094077|FG001|Overall Study|Lost to Follow-up|1|||
33326987|NCT00785044|101094078|FG000|Overall Study|Dosed at non-participating sites|152|||
33400658|NCT03225833|101353529|FG001|Overall Study|Adverse Event|1|||
33518252|NCT03597022|101792919|FG001|Overall Study|Serious adverse event|1|||
33326988|NCT00785044|101094078|FG000|Overall Study|Death|77|||
33326989|NCT00785044|101094078|FG000|Overall Study|Lost to Follow-up|266|||
33326990|NCT00785044|101094078|FG000|Overall Study|Withdrawal by Subject|1|||
33326991|NCT02700997|101094081|FG000|Overall Study|Did not undergo CT imaging|1|||
33400659|NCT03225833|101353530|FG002|Overall Study|Adverse Event|2|||
33400660|NCT03225833|101353531|FG003|Overall Study|Adverse Event|0|||
33326992|NCT02700997|101094081|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
33326993|NCT01378858|101094082|FG000|Overall Study|Withdrawal by Subject|4|||
33326994|NCT01378858|101094083|FG001|Overall Study|Withdrawal by Subject|4|||
33200128|NCT02391948|100638213|FG003|18-month Assessment|Withdrawal by Subject|1|||
33200129|NCT02391948|100638214|FG004|18-month Assessment|Withdrawal by Subject|0|||
33200130|NCT02391948|100638210|FG000|18-month Assessment|Lost to Follow-up|2|||
33200131|NCT02391948|100638211|FG001|18-month Assessment|Lost to Follow-up|6|||
33326995|NCT02181816|101094084|FG000|Overall Study|Case Report Forms Uncollected|38|||
33326996|NCT02181816|101094084|FG000|Overall Study|Protocol Deviation|21|||
33326997|NCT00395863|101094085|FG000|Overall Study|Patients did not complete both exams|2|||
33326998|NCT00395863|101094086|FG001|Overall Study|Patients did not complete both exams|3|||
33326999|NCT01147744|101094087|FG000|Overall Study|Protocol Violation|1|||
33327000|NCT01147744|101094088|FG001|Overall Study|Protocol Violation|0|||
33327001|NCT01147744|101094089|FG002|Overall Study|Protocol Violation|1|||
33327002|NCT01147744|101094090|FG003|Overall Study|Protocol Violation|0|||
33327003|NCT01147744|101094091|FG004|Overall Study|Protocol Violation|1|||
33327004|NCT01147744|101094092|FG005|Overall Study|Protocol Violation|3|||
33327005|NCT01147744|101094093|FG006|Overall Study|Protocol Violation|1|||
33327006|NCT01147744|101094087|FG000|Overall Study|Physician Decision|0|||
33400661|NCT03225833|101353532|FG004|Overall Study|Adverse Event|0|||
33400662|NCT03225833|101353533|FG005|Overall Study|Adverse Event|2|||
33327007|NCT01147744|101094088|FG001|Overall Study|Physician Decision|1|||
33327008|NCT01147744|101094089|FG002|Overall Study|Physician Decision|1|||
33327009|NCT01147744|101094090|FG003|Overall Study|Physician Decision|0|||
33327010|NCT01147744|101094091|FG004|Overall Study|Physician Decision|0|||
33327011|NCT01147744|101094092|FG005|Overall Study|Physician Decision|0|||
33327012|NCT01147744|101094093|FG006|Overall Study|Physician Decision|1|||
33327013|NCT01147744|101094087|FG000|Overall Study|Lack of Efficacy|11|||
33327014|NCT01147744|101094088|FG001|Overall Study|Lack of Efficacy|11|||
33327015|NCT01147744|101094089|FG002|Overall Study|Lack of Efficacy|9|||
33327016|NCT01147744|101094090|FG003|Overall Study|Lack of Efficacy|11|||
33518253|NCT03597022|101792920|FG002|Overall Study|Serious adverse event|0|||
33518254|NCT03781583|101792924|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
33518255|NCT03781583|101792925|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
33518256|NCT03781583|101792926|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
33327017|NCT01147744|101094091|FG004|Overall Study|Lack of Efficacy|13|||
33400663|NCT03225833|101353528|FG000|Overall Study|Withdrawal by Subject|1|||
33400664|NCT03225833|101353529|FG001|Overall Study|Withdrawal by Subject|0|||
33400665|NCT03225833|101353530|FG002|Overall Study|Withdrawal by Subject|0|||
33400666|NCT03225833|101353531|FG003|Overall Study|Withdrawal by Subject|0|||
33400667|NCT03225833|101353532|FG004|Overall Study|Withdrawal by Subject|1|||
33400668|NCT03225833|101353533|FG005|Overall Study|Withdrawal by Subject|0|||
33400669|NCT03225833|101353528|FG000|Overall Study|Termination of Study by Sponsor|4|||
33400670|NCT03225833|101353529|FG001|Overall Study|Termination of Study by Sponsor|0|||
33400671|NCT03225833|101353530|FG002|Overall Study|Termination of Study by Sponsor|0|||
33400672|NCT03225833|101353531|FG003|Overall Study|Termination of Study by Sponsor|0|||
33400673|NCT03225833|101353532|FG004|Overall Study|Termination of Study by Sponsor|0|||
33518257|NCT03781583|101792927|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
33518258|NCT03781583|101792924|FG000|Overall Study|Technology did not work for that person in that environment|1|||
33518259|NCT03781583|101792925|FG001|Overall Study|Technology did not work for that person in that environment|0|||
33518260|NCT03781583|101792926|FG002|Overall Study|Technology did not work for that person in that environment|0|||
33518261|NCT03781583|101792927|FG003|Overall Study|Technology did not work for that person in that environment|0|||
33518262|NCT03781583|101792924|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
33518263|NCT03781583|101792925|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
33518264|NCT03781583|101792926|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
33518265|NCT03781583|101792927|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
33567609|NCT02723955|101973207|FG038|Crossover/ Re-treatment Phase|Death|14|||
33327018|NCT01147744|101094092|FG005|Overall Study|Lack of Efficacy|8|||
33200132|NCT02391948|100638212|FG002|18-month Assessment|Lost to Follow-up|2|||
33200133|NCT02391948|100638213|FG003|18-month Assessment|Lost to Follow-up|2|||
33200134|NCT02391948|100638214|FG004|18-month Assessment|Lost to Follow-up|3|||
33200135|NCT02391948|100638210|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
33200136|NCT02391948|100638211|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
33200137|NCT02391948|100638212|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
33200138|NCT02391948|100638213|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
33200139|NCT02391948|100638214|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
33200140|NCT02391948|100638210|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
33200141|NCT02391948|100638211|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
33200142|NCT02391948|100638212|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
33200143|NCT02391948|100638213|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
33200144|NCT02391948|100638214|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
33200145|NCT02391948|100638210|FG000|24-month Assessment|Death|0|||
33200146|NCT02391948|100638211|FG001|24-month Assessment|Death|0|||
33200147|NCT02391948|100638212|FG002|24-month Assessment|Death|0|||
33200148|NCT02391948|100638213|FG003|24-month Assessment|Death|0|||
33200149|NCT02391948|100638214|FG004|24-month Assessment|Death|1|||
33200150|NCT02391948|100638210|FG000|24-month Assessment|Withdrawal by Subject|1|||
33200151|NCT02391948|100638211|FG001|24-month Assessment|Withdrawal by Subject|1|||
33200152|NCT02391948|100638212|FG002|24-month Assessment|Withdrawal by Subject|0|||
33200153|NCT02391948|100638213|FG003|24-month Assessment|Withdrawal by Subject|0|||
33200154|NCT02391948|100638214|FG004|24-month Assessment|Withdrawal by Subject|1|||
33200155|NCT02391948|100638210|FG000|24-month Assessment|Lost to Follow-up|5|||
33200156|NCT02391948|100638211|FG001|24-month Assessment|Lost to Follow-up|4|||
33200157|NCT02391948|100638212|FG002|24-month Assessment|Lost to Follow-up|0|||
33200158|NCT02391948|100638213|FG003|24-month Assessment|Lost to Follow-up|0|||
33518266|NCT03781583|101792924|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
33200159|NCT02391948|100638214|FG004|24-month Assessment|Lost to Follow-up|0|||
33200160|NCT02391948|100638210|FG000|24-month Assessment|Medical issue/illness|0|||
33200161|NCT02391948|100638211|FG001|24-month Assessment|Medical issue/illness|0|||
33200162|NCT02391948|100638212|FG002|24-month Assessment|Medical issue/illness|1|||
33200163|NCT02391948|100638213|FG003|24-month Assessment|Medical issue/illness|0|||
33200164|NCT02391948|100638214|FG004|24-month Assessment|Medical issue/illness|0|||
33200165|NCT02391948|100638210|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
33200166|NCT02391948|100638211|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
33200167|NCT02391948|100638212|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
33200168|NCT02391948|100638213|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
33200169|NCT02391948|100638214|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
33200170|NCT00009737|100638215|FG000|Overall Study|Adverse Event|112|||
33200171|NCT00009737|100638216|FG001|Overall Study|Adverse Event|75|||
33200172|NCT00009737|100638215|FG000|Overall Study|Death|4|||
33327019|NCT01147744|101094093|FG006|Overall Study|Lack of Efficacy|7|||
33327020|NCT01147744|101094087|FG000|Overall Study|Adverse Event|1|||
33327021|NCT01147744|101094088|FG001|Overall Study|Adverse Event|2|||
33327022|NCT01147744|101094089|FG002|Overall Study|Adverse Event|3|||
33327023|NCT01147744|101094090|FG003|Overall Study|Adverse Event|0|||
33327024|NCT01147744|101094091|FG004|Overall Study|Adverse Event|2|||
33327025|NCT01147744|101094092|FG005|Overall Study|Adverse Event|1|||
33327026|NCT01147744|101094093|FG006|Overall Study|Adverse Event|2|||
33327027|NCT01147744|101094087|FG000|Overall Study|Withdrawal by Subject|8|||
33327028|NCT01147744|101094088|FG001|Overall Study|Withdrawal by Subject|4|||
33327029|NCT01147744|101094089|FG002|Overall Study|Withdrawal by Subject|2|||
33327030|NCT01147744|101094090|FG003|Overall Study|Withdrawal by Subject|2|||
33327031|NCT01147744|101094091|FG004|Overall Study|Withdrawal by Subject|2|||
33518267|NCT03781583|101792925|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
33518268|NCT03781583|101792926|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
33518269|NCT03781583|101792927|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
33518270|NCT03114657|101792931|FG000|Overall Study|Adverse Event|9|||
33608244|NCT00545103|102115042|FG000|Overall Study|Does not want to take study drug anymore|1|||
33200173|NCT00009737|100638216|FG001|Overall Study|Death|6|||
33327032|NCT01147744|101094092|FG005|Overall Study|Withdrawal by Subject|5|||
33327033|NCT01147744|101094093|FG006|Overall Study|Withdrawal by Subject|2|||
33327034|NCT01147744|101094087|FG000|Overall Study|Lost to Follow-up|0|||
33327035|NCT01147744|101094088|FG001|Overall Study|Lost to Follow-up|1|||
33327036|NCT01147744|101094089|FG002|Overall Study|Lost to Follow-up|0|||
33327037|NCT01147744|101094090|FG003|Overall Study|Lost to Follow-up|0|||
33327038|NCT01147744|101094091|FG004|Overall Study|Lost to Follow-up|0|||
33200174|NCT00009737|100638215|FG000|Overall Study|Lack of Efficacy|17|||
33200175|NCT00009737|100638216|FG001|Overall Study|Lack of Efficacy|15|||
33200176|NCT00009737|100638215|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
33400674|NCT03225833|101353533|FG005|Overall Study|Termination of Study by Sponsor|7|||
33400675|NCT03225833|101353528|FG000|Overall Study|Sponsor Decision|0|||
33400676|NCT03225833|101353529|FG001|Overall Study|Sponsor Decision|0|||
33518271|NCT03114657|101792932|FG001|Overall Study|Adverse Event|6|||
33518272|NCT03114657|101792931|FG000|Overall Study|Death|4|||
33518273|NCT03114657|101792932|FG001|Overall Study|Death|0|||
33518274|NCT03114657|101792931|FG000|Overall Study|Multiple Reasons|1|||
33518275|NCT03114657|101792932|FG001|Overall Study|Multiple Reasons|2|||
33518276|NCT03114657|101792931|FG000|Overall Study|Physician Decision|2|||
33518277|NCT03114657|101792932|FG001|Overall Study|Physician Decision|2|||
33518278|NCT03114657|101792931|FG000|Overall Study|Study Terminated By Sponsor|355|||
33400677|NCT03225833|101353530|FG002|Overall Study|Sponsor Decision|0|||
33400678|NCT03225833|101353531|FG003|Overall Study|Sponsor Decision|0|||
33518279|NCT03114657|101792932|FG001|Overall Study|Study Terminated By Sponsor|374|||
33518280|NCT03114657|101792931|FG000|Overall Study|Symptomatic Deterioration|0|||
33518281|NCT03114657|101792932|FG001|Overall Study|Symptomatic Deterioration|1|||
33518282|NCT03114657|101792931|FG000|Overall Study|Withdrawal by Subject|28|||
33518283|NCT03114657|101792932|FG001|Overall Study|Withdrawal by Subject|22|||
33518284|NCT00630747|101792933|FG000|Overall Study|Death|1|||
33518285|NCT00630747|101792933|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
33518286|NCT00630747|101792933|FG000|Overall Study|Returned to country of origin|1|||
33518287|NCT00662558|101792934|FG000|Overall Study|Adverse Event|21|||
33518288|NCT00662558|101792935|FG001|Overall Study|Adverse Event|59|||
33518289|NCT00662558|101792934|FG000|Overall Study|Lack of Efficacy|4|||
33518290|NCT00662558|101792935|FG001|Overall Study|Lack of Efficacy|7|||
33518291|NCT00662558|101792934|FG000|Overall Study|Lost to Follow-up|13|||
33518292|NCT00662558|101792935|FG001|Overall Study|Lost to Follow-up|10|||
33518293|NCT00662558|101792934|FG000|Overall Study|Other|9|||
33518294|NCT00662558|101792935|FG001|Overall Study|Other|14|||
33400679|NCT03225833|101353532|FG004|Overall Study|Sponsor Decision|0|||
33400680|NCT03225833|101353533|FG005|Overall Study|Sponsor Decision|1|||
33400681|NCT00413231|101353534|FG000|0 to 30-day Post Treatment|Death|5|||
33400682|NCT00413231|101353534|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
33400683|NCT00413231|101353534|FG000|30-day to 365-day Post Treatment|Death|13|||
33400684|NCT00413231|101353534|FG000|365-day to 60-month Post Treatment|Death|36|||
33400685|NCT00413231|101353534|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
33518295|NCT00662558|101792934|FG000|Overall Study|Withdrawal by Subject|7|||
33518296|NCT00662558|101792935|FG001|Overall Study|Withdrawal by Subject|12|||
33518297|NCT00662558|101792934|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
33518298|NCT00662558|101792935|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
33518299|NCT01259375|101792937|FG000|Overall Study|Adverse Event|1|||
33518300|NCT01969084|101792938|FG000|Overall Study|Adverse Event|0|||
33518301|NCT01969084|101792939|FG001|Overall Study|Adverse Event|1|||
33518302|NCT02732327|101792944|FG000|Overall Study|Protocol Violation|0|||
33518303|NCT02732327|101792945|FG001|Overall Study|Protocol Violation|1|||
33608245|NCT00545103|102115043|FG001|Overall Study|Does not want to take study drug anymore|0|||
33327039|NCT01147744|101094092|FG005|Overall Study|Lost to Follow-up|0|||
33327040|NCT01147744|101094093|FG006|Overall Study|Lost to Follow-up|0|||
33327041|NCT01147744|101094087|FG000|Overall Study|Sponsor decision to amend protocol|7|||
33327042|NCT01147744|101094088|FG001|Overall Study|Sponsor decision to amend protocol|4|||
33327043|NCT01147744|101094089|FG002|Overall Study|Sponsor decision to amend protocol|2|||
33327044|NCT01147744|101094090|FG003|Overall Study|Sponsor decision to amend protocol|5|||
33327045|NCT01147744|101094091|FG004|Overall Study|Sponsor decision to amend protocol|7|||
33327046|NCT01147744|101094092|FG005|Overall Study|Sponsor decision to amend protocol|2|||
33327047|NCT01147744|101094093|FG006|Overall Study|Sponsor decision to amend protocol|6|||
33327048|NCT01147744|101094087|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33327049|NCT01147744|101094088|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
33327050|NCT01147744|101094089|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
33327051|NCT01147744|101094090|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
33327052|NCT01147744|101094091|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
33327053|NCT01147744|101094092|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33327054|NCT01147744|101094093|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
33327055|NCT03021499|101094094|FG000|Overall Study|Adverse Event|1|||
33327056|NCT03021499|101094095|FG001|Overall Study|Adverse Event|0|||
33327057|NCT03021499|101094094|FG000|Overall Study|Death|1|||
33327058|NCT03021499|101094095|FG001|Overall Study|Death|5|||
33327059|NCT03021499|101094094|FG000|Overall Study|Lack of Efficacy|0|||
33327060|NCT03021499|101094095|FG001|Overall Study|Lack of Efficacy|1|||
33327061|NCT03021499|101094094|FG000|Overall Study|Lost to Follow-up|1|||
33327062|NCT03021499|101094095|FG001|Overall Study|Lost to Follow-up|3|||
33327063|NCT03021499|101094094|FG000|Overall Study|Physician Decision|2|||
33327064|NCT03021499|101094095|FG001|Overall Study|Physician Decision|3|||
33400686|NCT00413231|101353534|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
33400687|NCT00413231|101353534|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
33400688|NCT01058356|101353535|FG000|Overall Study|Adverse Event|5|||
33400689|NCT01058356|101353535|FG000|Overall Study|Administration of contraindicated drugs|12|||
33400690|NCT01058356|101353535|FG000|Overall Study|Withdrawal by Subject|21|||
33518304|NCT03434249|101792959|FG000|Overall Study|Adverse Event|1|||
33518305|NCT03434249|101792960|FG001|Overall Study|Adverse Event|0|||
33518306|NCT03434249|101792959|FG000|Overall Study|Lost to Follow-up|0|||
33518307|NCT03434249|101792960|FG001|Overall Study|Lost to Follow-up|1|||
33518308|NCT03434249|101792959|FG000|Overall Study|Non-compliance of family|2|||
33518309|NCT03434249|101792960|FG001|Overall Study|Non-compliance of family|1|||
33518310|NCT03434249|101792959|FG000|Overall Study|Difficulties in completing daily diary|2|||
33518311|NCT03434249|101792960|FG001|Overall Study|Difficulties in completing daily diary|1|||
33518312|NCT03053427|101792961|FG000|Overall Study|Adverse Event|4|||
33518313|NCT03053427|101792962|FG001|Overall Study|Adverse Event|4|||
33518314|NCT03053427|101792961|FG000|Overall Study|Lack of Efficacy|1|||
33518315|NCT03053427|101792962|FG001|Overall Study|Lack of Efficacy|3|||
33518316|NCT03053427|101792961|FG000|Overall Study|Lost to Follow-up|2|||
33518317|NCT03053427|101792962|FG001|Overall Study|Lost to Follow-up|2|||
33518318|NCT03053427|101792961|FG000|Overall Study|Worsening of the target disease|0|||
33518319|NCT03053427|101792962|FG001|Overall Study|Worsening of the target disease|1|||
33518320|NCT03053427|101792961|FG000|Overall Study|Protocol Deviation|3|||
33518321|NCT03053427|101792962|FG001|Overall Study|Protocol Deviation|3|||
33518322|NCT03053427|101792961|FG000|Overall Study|Withdrawal by Subject|3|||
33518323|NCT03053427|101792962|FG001|Overall Study|Withdrawal by Subject|2|||
33518324|NCT03053427|101792961|FG000|Overall Study|Miscellaneous|0|||
33518325|NCT03053427|101792962|FG001|Overall Study|Miscellaneous|1|||
33518326|NCT02073656|101792963|FG000|Primary Study|Lost to Follow-up|6|||
33518327|NCT02073656|101792963|FG000|Primary Study|Death|1|||
33518328|NCT02073656|101792963|FG000|Primary Study|Withdrew Consent|1|||
33518329|NCT01554176|101792964|FG000|Treatment Phase|Protocol Violation|1|||
33518330|NCT01554176|101792965|FG001|Treatment Phase|Protocol Violation|2|||
33518331|NCT01554176|101792966|FG002|Treatment Phase|Protocol Violation|0|||
33518332|NCT01554176|101792967|FG003|Treatment Phase|Protocol Violation|0|||
33518333|NCT01554176|101792968|FG004|Treatment Phase|Protocol Violation|0|||
33518334|NCT01554176|101792964|FG000|Treatment Phase|Physician Decision|1|||
33518335|NCT01554176|101792965|FG001|Treatment Phase|Physician Decision|1|||
33518336|NCT01554176|101792966|FG002|Treatment Phase|Physician Decision|0|||
33518337|NCT01554176|101792967|FG003|Treatment Phase|Physician Decision|0|||
33518338|NCT01554176|101792968|FG004|Treatment Phase|Physician Decision|0|||
33327065|NCT03021499|101094094|FG000|Overall Study|Pregnancy|1|||
33327066|NCT03021499|101094095|FG001|Overall Study|Pregnancy|0|||
33327067|NCT03021499|101094094|FG000|Overall Study|Withdrawal by Subject|7|||
33327068|NCT03021499|101094095|FG001|Overall Study|Withdrawal by Subject|14|||
33327069|NCT03021499|101094094|FG000|Overall Study|Prohibited medication required|1|||
33327070|NCT03021499|101094095|FG001|Overall Study|Prohibited medication required|0|||
33327071|NCT03021499|101094094|FG000|Overall Study|Protocol non-compliance|1|||
33327072|NCT03021499|101094095|FG001|Overall Study|Protocol non-compliance|1|||
33327073|NCT03021499|101094094|FG000|Overall Study|None of the above|0|||
33327074|NCT03021499|101094095|FG001|Overall Study|None of the above|4|||
33327075|NCT03021499|101094094|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
33327076|NCT03021499|101094095|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
33327077|NCT00097773|101094102|FG000|Overall Study|Lost to Follow-up|2|||
33327078|NCT00097773|101094103|FG001|Overall Study|Lost to Follow-up|2|||
33327079|NCT00097773|101094104|FG002|Overall Study|Lost to Follow-up|0|||
33327080|NCT00097773|101094105|FG003|Overall Study|Lost to Follow-up|1|||
33327081|NCT00097773|101094102|FG000|Overall Study|Physician Decision|2|||
33327082|NCT00097773|101094103|FG001|Overall Study|Physician Decision|2|||
33327083|NCT00097773|101094104|FG002|Overall Study|Physician Decision|3|||
33327084|NCT00097773|101094105|FG003|Overall Study|Physician Decision|1|||
33327085|NCT00097773|101094102|FG000|Overall Study|Withdrawal by Subject|3|||
33327086|NCT00097773|101094103|FG001|Overall Study|Withdrawal by Subject|3|||
33327087|NCT00097773|101094104|FG002|Overall Study|Withdrawal by Subject|3|||
33327088|NCT00097773|101094105|FG003|Overall Study|Withdrawal by Subject|1|||
33400691|NCT01058356|101353535|FG000|Overall Study|Lost to Follow-up|4|||
33400692|NCT02067104|101353536|FG000|Overall Study|Study termination due to low accrual|4|||
33400693|NCT02067104|101353537|FG001|Overall Study|Study termination due to low accrual|5|||
33518339|NCT01554176|101792964|FG000|Treatment Phase|Lack of Efficacy|0|||
33327089|NCT00097773|101094102|FG000|Overall Study|Adverse Event|0|||
33327090|NCT00097773|101094103|FG001|Overall Study|Adverse Event|1|||
33327091|NCT00097773|101094104|FG002|Overall Study|Adverse Event|0|||
33518340|NCT01554176|101792965|FG001|Treatment Phase|Lack of Efficacy|1|||
33327092|NCT00097773|101094105|FG003|Overall Study|Adverse Event|0|||
33518341|NCT01554176|101792966|FG002|Treatment Phase|Lack of Efficacy|0|||
33518342|NCT01554176|101792967|FG003|Treatment Phase|Lack of Efficacy|0|||
33518343|NCT01554176|101792968|FG004|Treatment Phase|Lack of Efficacy|0|||
33327093|NCT00097773|101094102|FG000|Overall Study|Other|1|||
33327094|NCT00097773|101094103|FG001|Overall Study|Other|0|||
33327095|NCT00097773|101094104|FG002|Overall Study|Other|2|||
33327096|NCT00097773|101094105|FG003|Overall Study|Other|0|||
33327097|NCT03668600|101094106|FG000|Overall Study|Study Terminated by the Sponsor|157|||
33327098|NCT03668600|101094106|FG000|Overall Study|Protocol Violation|1|||
33327099|NCT03668600|101094106|FG000|Overall Study|Pregnancy|1|||
33327100|NCT03668600|101094106|FG000|Overall Study|Lost to Follow-up|7|||
33327101|NCT03668600|101094106|FG000|Overall Study|Withdrawal by Subject|56|||
33327102|NCT03668600|101094106|FG000|Overall Study|Lack of Efficacy|7|||
33327103|NCT03668600|101094106|FG000|Overall Study|Adverse Event|1|||
33327104|NCT02230254|101094107|FG000|Overall Study|Lost to Follow-up|3|||
33327105|NCT00596947|101094110|FG000|Overall Study|study halted due to low enrollment|5|||
33327106|NCT00596947|101094111|FG001|Overall Study|study halted due to low enrollment|3|||
33327107|NCT00596947|101094110|FG000|Overall Study|Lost to Follow-up|1|||
33327108|NCT00596947|101094111|FG001|Overall Study|Lost to Follow-up|0|||
33327109|NCT00290342|101094114|FG000|Overall Study|Other|0|||
33327110|NCT00290342|101094115|FG001|Overall Study|Other|1|||
33327111|NCT00290342|101094114|FG000|Overall Study|Withdrawal by Subject|6|||
33327112|NCT00290342|101094115|FG001|Overall Study|Withdrawal by Subject|4|||
33327113|NCT00290342|101094114|FG000|Overall Study|Lost to Follow-up|1|||
33327114|NCT00290342|101094115|FG001|Overall Study|Lost to Follow-up|0|||
33327115|NCT00268437|101094124|FG000|Overall Study|Ineligible|1|||
33327116|NCT02066311|101094127|FG000|Overall Study|Adverse Event|4|||
33327117|NCT02066311|101094127|FG000|Overall Study|Withdrawal by Subject|1|||
33327118|NCT00942175|101094128|FG000|Overall Study|Adverse Event|2|||
33327119|NCT00942175|101094129|FG001|Overall Study|Adverse Event|1|||
33327120|NCT00942175|101094130|FG002|Overall Study|Adverse Event|0|||
33327121|NCT00942175|101094131|FG003|Overall Study|Adverse Event|0|||
33327122|NCT00942175|101094128|FG000|Overall Study|Protocol Violation|0|||
33327123|NCT00942175|101094129|FG001|Overall Study|Protocol Violation|1|||
33327124|NCT00942175|101094130|FG002|Overall Study|Protocol Violation|2|||
33327125|NCT00942175|101094131|FG003|Overall Study|Protocol Violation|0|||
33327126|NCT00942175|101094128|FG000|Overall Study|Pregnancy|0|||
33327127|NCT00942175|101094129|FG001|Overall Study|Pregnancy|0|||
33327128|NCT00942175|101094130|FG002|Overall Study|Pregnancy|0|||
33327129|NCT00942175|101094131|FG003|Overall Study|Pregnancy|1|||
33327130|NCT00942175|101094128|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
33327131|NCT00942175|101094129|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
33327132|NCT00942175|101094130|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
33327133|NCT00942175|101094131|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
33327134|NCT00942175|101094128|FG000|Overall Study|Low Platelet Count|0|||
33327135|NCT00942175|101094129|FG001|Overall Study|Low Platelet Count|2|||
33327136|NCT00942175|101094130|FG002|Overall Study|Low Platelet Count|0|||
33327137|NCT00942175|101094131|FG003|Overall Study|Low Platelet Count|0|||
33327138|NCT01830855|101094133|FG000|Overall Study|Other|7|||
33327139|NCT01830855|101094134|FG001|Overall Study|Other|1|||
33327140|NCT01830855|101094135|FG002|Overall Study|Other|4|||
33327141|NCT01830855|101094136|FG003|Overall Study|Other|4|||
33327142|NCT01830855|101094133|FG000|Overall Study|Medication error without associated AE|1|||
33327143|NCT01830855|101094134|FG001|Overall Study|Medication error without associated AE|0|||
33518344|NCT01554176|101792964|FG000|Treatment Phase|Adverse event, non-fatal|1|||
33400694|NCT01077193|101353538|FG000|Overall Study|Lost to Follow-up|1|||
33518345|NCT01554176|101792965|FG001|Treatment Phase|Adverse event, non-fatal|1|||
33518346|NCT01554176|101792966|FG002|Treatment Phase|Adverse event, non-fatal|0|||
33400695|NCT01077193|101353538|FG000|Overall Study|Withdrawal by Subject|2|||
33518347|NCT01554176|101792967|FG003|Treatment Phase|Adverse event, non-fatal|0|||
33518348|NCT01554176|101792968|FG004|Treatment Phase|Adverse event, non-fatal|0|||
33518349|NCT01554176|101792964|FG000|Treatment Phase|Non-compliance with study drug|1|||
33518350|NCT01554176|101792965|FG001|Treatment Phase|Non-compliance with study drug|0|||
33327144|NCT01830855|101094135|FG002|Overall Study|Medication error without associated AE|0|||
33200177|NCT00009737|100638216|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
33200178|NCT00009737|100638215|FG000|Overall Study|Other Protocol Violation|1|||
33608246|NCT00545103|102115044|FG002|Overall Study|Does not want to take study drug anymore|1|||
33327145|NCT01830855|101094136|FG003|Overall Study|Medication error without associated AE|1|||
33327146|NCT01830855|101094133|FG000|Overall Study|Pregnancy|3|||
33327147|NCT01830855|101094134|FG001|Overall Study|Pregnancy|1|||
33327148|NCT01830855|101094135|FG002|Overall Study|Pregnancy|2|||
33327149|NCT01830855|101094136|FG003|Overall Study|Pregnancy|1|||
33327150|NCT01830855|101094133|FG000|Overall Study|No longer meets eligibility criteria|11|||
33327151|NCT01830855|101094134|FG001|Overall Study|No longer meets eligibility criteria|2|||
33327152|NCT01830855|101094135|FG002|Overall Study|No longer meets eligibility criteria|3|||
33327153|NCT01830855|101094136|FG003|Overall Study|No longer meets eligibility criteria|5|||
33327154|NCT01830855|101094133|FG000|Overall Study|Adverse Event|11|||
33400696|NCT01077193|101353538|FG000|Overall Study|Lack of Efficacy|1|||
33400697|NCT01077193|101353538|FG000|Overall Study|Study Terminated by Sponsor|40|||
33400698|NCT02646332|101353539|FG000|Overall Study|Lost to Follow-up|0|||
33400699|NCT02646332|101353540|FG001|Overall Study|Lost to Follow-up|3|||
33400700|NCT04610827|101353541|FG000|Overall Study|Withdrawal by Subject|1|||
33400701|NCT04610827|101353542|FG001|Overall Study|Withdrawal by Subject|1|||
33400702|NCT04610827|101353543|FG002|Overall Study|Withdrawal by Subject|0|||
33400703|NCT01852591|101353544|FG000|Overall Study|Withdrawal by Subject|2|||
33400704|NCT01852591|101353544|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
33400705|NCT02630459|101353545|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
33400706|NCT02630459|101353546|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
33327155|NCT01830855|101094134|FG001|Overall Study|Adverse Event|5|||
33327156|NCT01830855|101094135|FG002|Overall Study|Adverse Event|6|||
33400707|NCT02630459|101353547|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
33400708|NCT02630459|101353548|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
33400709|NCT02630459|101353549|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
33400710|NCT02630459|101353550|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
33400711|NCT02630459|101353551|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
33400712|NCT02630459|101353552|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
33400713|NCT02630459|101353545|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
33400714|NCT02630459|101353546|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
33400715|NCT02630459|101353547|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
33400716|NCT02630459|101353548|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
33400717|NCT02630459|101353549|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
33400718|NCT02630459|101353550|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
33400719|NCT02630459|101353551|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
33400720|NCT02630459|101353552|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
33400721|NCT02630459|101353545|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
33400722|NCT02630459|101353546|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
33400723|NCT02630459|101353547|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
33400724|NCT02630459|101353548|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
33400725|NCT02630459|101353549|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
33400726|NCT02630459|101353550|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
33400727|NCT02630459|101353551|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
33400728|NCT02630459|101353552|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
33400729|NCT02630459|101353545|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
33400730|NCT02630459|101353546|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
33400731|NCT02630459|101353547|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
33400732|NCT02630459|101353548|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
33400733|NCT02630459|101353549|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
33400734|NCT02630459|101353550|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
33400735|NCT02630459|101353551|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
33400736|NCT02630459|101353552|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
33400737|NCT02630459|101353545|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
33400738|NCT02630459|101353546|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
33400739|NCT02630459|101353547|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
33400740|NCT02630459|101353548|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
33400741|NCT02630459|101353549|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
33400742|NCT02630459|101353550|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
33400743|NCT02630459|101353551|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
33400744|NCT02630459|101353552|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
33400745|NCT02630459|101353545|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
33327157|NCT01830855|101094136|FG003|Overall Study|Adverse Event|3|||
33327158|NCT01830855|101094133|FG000|Overall Study|Protocol deviation|10|||
33327159|NCT01830855|101094134|FG001|Overall Study|Protocol deviation|5|||
33327160|NCT01830855|101094135|FG002|Overall Study|Protocol deviation|6|||
33327161|NCT01830855|101094136|FG003|Overall Study|Protocol deviation|6|||
33327162|NCT01830855|101094133|FG000|Overall Study|Withdrawal by Subject|33|||
33327163|NCT01830855|101094134|FG001|Overall Study|Withdrawal by Subject|14|||
33327164|NCT01830855|101094135|FG002|Overall Study|Withdrawal by Subject|10|||
33327165|NCT01830855|101094136|FG003|Overall Study|Withdrawal by Subject|12|||
33327166|NCT01830855|101094133|FG000|Overall Study|No longer willing to participate|32|||
33400746|NCT02630459|101353546|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
33400747|NCT02630459|101353547|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
33400748|NCT02630459|101353548|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
33400749|NCT02630459|101353549|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
33400750|NCT02630459|101353550|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
33518351|NCT01554176|101792966|FG002|Treatment Phase|Non-compliance with study drug|0|||
33518352|NCT01554176|101792967|FG003|Treatment Phase|Non-compliance with study drug|0|||
33327167|NCT01830855|101094134|FG001|Overall Study|No longer willing to participate|13|||
33327168|NCT01830855|101094135|FG002|Overall Study|No longer willing to participate|12|||
33327169|NCT01830855|101094136|FG003|Overall Study|No longer willing to participate|17|||
33327170|NCT01830855|101094133|FG000|Overall Study|Lost to Follow-up|47|||
33327171|NCT01830855|101094134|FG001|Overall Study|Lost to Follow-up|20|||
33327172|NCT01830855|101094135|FG002|Overall Study|Lost to Follow-up|23|||
33327173|NCT01830855|101094136|FG003|Overall Study|Lost to Follow-up|33|||
33327174|NCT01040351|101094145|FG000|Overall Study|poor ovarian response|1|||
33327175|NCT01040351|101094146|FG001|Overall Study|poor ovarian response|2|||
33327176|NCT01015768|101094147|FG000|Overall Study|Some subject data unuseable|4|||
33327177|NCT01015768|101094148|FG001|Overall Study|Some subject data unuseable|4|||
33327178|NCT00829179|101094153|FG000|Overall Study|Withdrawal by Subject|1|||
33327179|NCT01524198|101094156|FG000|Overall Study|Protocol Violation|8|||
33327180|NCT01524198|101094157|FG001|Overall Study|Protocol Violation|6|||
33518353|NCT01554176|101792968|FG004|Treatment Phase|Non-compliance with study drug|0|||
33518354|NCT01554176|101792964|FG000|Treatment Phase|Withdrawal by Subject|1|||
33518355|NCT01554176|101792965|FG001|Treatment Phase|Withdrawal by Subject|0|||
33518356|NCT01554176|101792966|FG002|Treatment Phase|Withdrawal by Subject|0|||
33518357|NCT01554176|101792967|FG003|Treatment Phase|Withdrawal by Subject|0|||
33518358|NCT01554176|101792968|FG004|Treatment Phase|Withdrawal by Subject|0|||
33518359|NCT01554176|101792964|FG000|Treatment Phase|Lost to Follow-up|3|||
33518360|NCT01554176|101792965|FG001|Treatment Phase|Lost to Follow-up|0|||
33518361|NCT01554176|101792966|FG002|Treatment Phase|Lost to Follow-up|0|||
33518362|NCT01554176|101792967|FG003|Treatment Phase|Lost to Follow-up|0|||
33518363|NCT01554176|101792968|FG004|Treatment Phase|Lost to Follow-up|0|||
33518364|NCT01554176|101792964|FG000|Run-out Phase|Protocol Violation|0|||
33518365|NCT01554176|101792965|FG001|Run-out Phase|Protocol Violation|0|||
33518366|NCT01554176|101792966|FG002|Run-out Phase|Protocol Violation|0|||
33518367|NCT01554176|101792967|FG003|Run-out Phase|Protocol Violation|1|||
33518368|NCT01554176|101792968|FG004|Run-out Phase|Protocol Violation|0|||
33518369|NCT05385224|101792969|FG000|Overall Study|Unable to swallow capsule|2|||
33518370|NCT05385224|101792969|FG000|Overall Study|Withdrawal by Subject|2|||
33518371|NCT05385224|101792969|FG000|Overall Study|Did not meet study criteria|1|||
33518372|NCT00087126|101792970|FG000|Overall Study|Ineligible - second primary|1|||
33518373|NCT00087126|101792970|FG000|Overall Study|Never treated|1|||
33518374|NCT01546038|101792976|FG000|Overall Study|Death|15|||
33518375|NCT01546038|101792977|FG001|Overall Study|Death|6|||
33518376|NCT01546038|101792978|FG002|Overall Study|Death|4|||
33518377|NCT01546038|101792979|FG003|Overall Study|Death|2|||
33518378|NCT01546038|101792980|FG004|Overall Study|Death|9|||
33518379|NCT01546038|101792981|FG005|Overall Study|Death|3|||
33518380|NCT01546038|101792982|FG006|Overall Study|Death|46|||
33518381|NCT01546038|101792983|FG007|Overall Study|Death|76|||
33518382|NCT01546038|101792984|FG008|Overall Study|Death|39|||
33518383|NCT01546038|101792976|FG000|Overall Study|Lost to Follow-up|0|||
33518384|NCT01546038|101792977|FG001|Overall Study|Lost to Follow-up|0|||
33327181|NCT01524198|101094156|FG000|Overall Study|Withdrawal by Subject|15|||
33327182|NCT01524198|101094157|FG001|Overall Study|Withdrawal by Subject|10|||
33518385|NCT01546038|101792978|FG002|Overall Study|Lost to Follow-up|0|||
33518386|NCT01546038|101792979|FG003|Overall Study|Lost to Follow-up|0|||
33518387|NCT01546038|101792980|FG004|Overall Study|Lost to Follow-up|1|||
33518388|NCT01546038|101792981|FG005|Overall Study|Lost to Follow-up|0|||
33327183|NCT03962738|101094159|FG000|Overall Study|Protocol Deviation|3|||
33327184|NCT03962738|101094160|FG001|Overall Study|Protocol Deviation|0|||
33518389|NCT01546038|101792982|FG006|Overall Study|Lost to Follow-up|2|||
33327185|NCT03962738|101094161|FG002|Overall Study|Protocol Deviation|1|||
33327186|NCT03962738|101094162|FG003|Overall Study|Protocol Deviation|1|||
33518390|NCT01546038|101792983|FG007|Overall Study|Lost to Follow-up|1|||
33518391|NCT01546038|101792984|FG008|Overall Study|Lost to Follow-up|0|||
33518392|NCT01546038|101792976|FG000|Overall Study|Withdrawal by Subject|1|||
33518393|NCT01546038|101792977|FG001|Overall Study|Withdrawal by Subject|0|||
33327187|NCT03962738|101094159|FG000|Overall Study|Withdrawal by Subject|4|||
33327188|NCT03962738|101094160|FG001|Overall Study|Withdrawal by Subject|0|||
33327189|NCT03962738|101094161|FG002|Overall Study|Withdrawal by Subject|0|||
33327190|NCT03962738|101094162|FG003|Overall Study|Withdrawal by Subject|0|||
33327191|NCT03962738|101094159|FG000|Overall Study|Lost to Follow-up|0|||
33327192|NCT03962738|101094160|FG001|Overall Study|Lost to Follow-up|0|||
33327193|NCT03962738|101094161|FG002|Overall Study|Lost to Follow-up|1|||
33327194|NCT03962738|101094162|FG003|Overall Study|Lost to Follow-up|0|||
33327195|NCT04425720|101094168|FG000|Overall Study|Withdrawal by Subject|0|||
33327196|NCT04425720|101094169|FG001|Overall Study|Withdrawal by Subject|20|||
33327197|NCT01543828|101094175|FG000|Treatment 2|Lost to Follow-up|1|||
33327198|NCT01543828|101094176|FG001|Treatment 2|Lost to Follow-up|0|||
33327199|NCT02554903|101094177|FG000|Overall Study|Death|1|||
33327200|NCT02554903|101094178|FG001|Overall Study|Death|1|||
33327201|NCT02554903|101094177|FG000|Overall Study|Physician Decision|2|||
33327202|NCT02554903|101094178|FG001|Overall Study|Physician Decision|2|||
33327203|NCT02554903|101094177|FG000|Overall Study|Heart Transplant|1|||
33327204|NCT02554903|101094178|FG001|Overall Study|Heart Transplant|2|||
33327205|NCT01380379|101094181|FG000|Overall Study|Pregnancy|1|||
33327206|NCT00750698|101094199|FG000|Overall Study|Withdrawal by Subject|1|||
33327207|NCT00750698|101094200|FG001|Overall Study|Withdrawal by Subject|0|||
33327208|NCT00750698|101094199|FG000|Overall Study|Progressive disease|5|||
33327209|NCT00750698|101094200|FG001|Overall Study|Progressive disease|2|||
33327210|NCT01056510|101094201|FG000|Overall Study|Dropout Before Start of Treatment|1|||
33327211|NCT01056510|101094202|FG001|Overall Study|Dropout Before Start of Treatment|1|||
33327212|NCT01056510|101094201|FG000|Overall Study|Withdrawal by Subject|4|||
33327213|NCT01056510|101094202|FG001|Overall Study|Withdrawal by Subject|2|||
33327214|NCT01056510|101094201|FG000|Overall Study|Death|29|||
33327215|NCT01056510|101094202|FG001|Overall Study|Death|34|||
33327216|NCT01056510|101094201|FG000|Overall Study|Noncompliance|1|||
33327217|NCT01056510|101094202|FG001|Overall Study|Noncompliance|3|||
33327218|NCT01056510|101094201|FG000|Overall Study|Physician Decision|4|||
33327219|NCT01056510|101094202|FG001|Overall Study|Physician Decision|5|||
33327220|NCT01056510|101094201|FG000|Overall Study|Lost to Follow-up|5|||
33327221|NCT01056510|101094202|FG001|Overall Study|Lost to Follow-up|6|||
33327222|NCT01056510|101094201|FG000|Overall Study|Other|10|||
33327223|NCT01056510|101094202|FG001|Overall Study|Other|12|||
33327224|NCT01056510|101094201|FG000|Overall Study|Missing|0|||
33327225|NCT01056510|101094202|FG001|Overall Study|Missing|1|||
33327226|NCT04416555|101094203|FG000|Overall Study|Withdrawal by Subject|0|||
33327227|NCT04416555|101094204|FG001|Overall Study|Withdrawal by Subject|3|||
33327228|NCT00928889|101094205|FG000|Overall Study|Lost to Follow-up|3|||
33327229|NCT00928889|101094206|FG001|Overall Study|Lost to Follow-up|1|||
33327230|NCT00928889|101094205|FG000|Overall Study|Protocol Violation|0|||
33327231|NCT00928889|101094206|FG001|Overall Study|Protocol Violation|1|||
33327232|NCT00928889|101094205|FG000|Overall Study|Adverse Event|1|||
33327233|NCT00928889|101094206|FG001|Overall Study|Adverse Event|0|||
33327234|NCT00928889|101094205|FG000|Overall Study|Other|1|||
33327235|NCT00928889|101094206|FG001|Overall Study|Other|0|||
33327236|NCT01553136|101094207|FG000|Overall Study|Adverse Event|3|||
33327237|NCT01553136|101094208|FG001|Overall Study|Adverse Event|2|||
33327238|NCT01553136|101094207|FG000|Overall Study|Withdrawal by Subject|2|||
33327239|NCT01553136|101094208|FG001|Overall Study|Withdrawal by Subject|3|||
33327240|NCT01553136|101094207|FG000|Overall Study|Lost to Follow-up|4|||
33327241|NCT01553136|101094208|FG001|Overall Study|Lost to Follow-up|10|||
33327242|NCT01553136|101094207|FG000|Overall Study|Physician Decision|2|||
33327243|NCT01553136|101094208|FG001|Overall Study|Physician Decision|3|||
33327244|NCT01553136|101094207|FG000|Overall Study|Scheduling Difficulties|5|||
33327245|NCT01553136|101094208|FG001|Overall Study|Scheduling Difficulties|4|||
33327246|NCT02490475|101094209|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
33327247|NCT02490475|101094210|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
33327248|NCT02490475|101094211|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
33327249|NCT02490475|101094212|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
33327250|NCT02490475|101094209|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
33327251|NCT02490475|101094210|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
33327252|NCT02490475|101094211|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
33327253|NCT02490475|101094212|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
33327254|NCT02490475|101094209|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
33327255|NCT02490475|101094210|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
33327256|NCT02490475|101094211|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
33327257|NCT02490475|101094212|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
33327258|NCT02490475|101094209|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
33327259|NCT02490475|101094210|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
33327260|NCT02490475|101094211|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
33327261|NCT02490475|101094212|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
33327262|NCT02490475|101094209|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
33327263|NCT02490475|101094210|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
33327264|NCT02490475|101094211|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
33327265|NCT02490475|101094212|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
33327266|NCT02490475|101094209|FG000|Period 2: Extension Phase|Refused Treatment|0|||
33327267|NCT02490475|101094210|FG001|Period 2: Extension Phase|Refused Treatment|0|||
33327268|NCT02490475|101094211|FG002|Period 2: Extension Phase|Refused Treatment|0|||
33327269|NCT02490475|101094212|FG003|Period 2: Extension Phase|Refused Treatment|1|||
33327270|NCT02490475|101094209|FG000|Period 2: Extension Phase|Adverse Event|0|||
33327271|NCT02490475|101094210|FG001|Period 2: Extension Phase|Adverse Event|0|||
33327272|NCT02490475|101094211|FG002|Period 2: Extension Phase|Adverse Event|1|||
33327273|NCT02490475|101094212|FG003|Period 2: Extension Phase|Adverse Event|0|||
33327274|NCT00770770|101094215|FG000|Overall Study|Lost to Follow-up|1|||
33327275|NCT00770770|101094216|FG001|Overall Study|Lost to Follow-up|0|||
33327276|NCT00770770|101094215|FG000|Overall Study|Withdrawal by Subject|1|||
33327277|NCT00770770|101094216|FG001|Overall Study|Withdrawal by Subject|0|||
33327278|NCT00770770|101094215|FG000|Overall Study|Death|0|||
33327279|NCT00770770|101094216|FG001|Overall Study|Death|1|||
33327280|NCT00770770|101094215|FG000|Overall Study|Study Terminated|8|||
33327281|NCT00770770|101094216|FG001|Overall Study|Study Terminated|0|||
33327282|NCT01429584|101094217|FG000|Overall Study|Withdrawal by Subject|1|||
33327283|NCT01429584|101094218|FG001|Overall Study|Withdrawal by Subject|0|||
33327284|NCT01429584|101094217|FG000|Overall Study|Protocol Violation|0|||
33327285|NCT01429584|101094218|FG001|Overall Study|Protocol Violation|1|||
33327286|NCT03281668|101094221|FG000|Overall Study|Physician Decision|1|||
33327287|NCT03281668|101094221|FG000|Overall Study|scheduling conflict, family circumstance|2|||
33518394|NCT01546038|101792978|FG002|Overall Study|Withdrawal by Subject|0|||
33518395|NCT01546038|101792979|FG003|Overall Study|Withdrawal by Subject|1|||
33518396|NCT01546038|101792980|FG004|Overall Study|Withdrawal by Subject|0|||
33518397|NCT01546038|101792981|FG005|Overall Study|Withdrawal by Subject|1|||
33518398|NCT01546038|101792982|FG006|Overall Study|Withdrawal by Subject|3|||
33608247|NCT00545103|102115045|FG003|Overall Study|Does not want to take study drug anymore|0|||
33608248|NCT00545103|102115042|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
33608249|NCT00545103|102115043|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
33327288|NCT03281668|101094221|FG000|Overall Study|Withdrawal by Subject|4|||
33327289|NCT03281668|101094221|FG000|Overall Study|Lost to Follow-up|1|||
33327290|NCT01274715|101094222|FG000|Overall Study|Lost to Follow-up|1|||
33327291|NCT01274715|101094222|FG000|Overall Study|After consent, met exclusion criteria.|1|||
33327292|NCT01274715|101094222|FG000|Overall Study|After consent, met exclusion criteria.|1|||
33327293|NCT01274715|101094222|FG000|Overall Study|After consent, met exclusion criteria.|1|||
33327294|NCT00113074|101094225|FG000|Overall Study|Lost to Follow-up|10|||
33327295|NCT00113074|101094226|FG001|Overall Study|Lost to Follow-up|10|||
33327296|NCT00113074|101094227|FG002|Overall Study|Lost to Follow-up|14|||
33518399|NCT01546038|101792983|FG007|Overall Study|Withdrawal by Subject|3|||
33518400|NCT01546038|101792984|FG008|Overall Study|Withdrawal by Subject|1|||
33518401|NCT01546038|101792976|FG000|Overall Study|: Randomized, not treated|0|||
33518402|NCT01546038|101792977|FG001|Overall Study|: Randomized, not treated|0|||
33518403|NCT01546038|101792978|FG002|Overall Study|: Randomized, not treated|0|||
33518404|NCT01546038|101792979|FG003|Overall Study|: Randomized, not treated|0|||
33518405|NCT01546038|101792980|FG004|Overall Study|: Randomized, not treated|0|||
33518406|NCT01546038|101792981|FG005|Overall Study|: Randomized, not treated|0|||
33518407|NCT01546038|101792982|FG006|Overall Study|: Randomized, not treated|2|||
33518408|NCT01546038|101792983|FG007|Overall Study|: Randomized, not treated|4|||
33518409|NCT01546038|101792984|FG008|Overall Study|: Randomized, not treated|3|||
33518410|NCT01362517|101792987|FG000|Overall Study|Protocol Violation|1|||
33608250|NCT00545103|102115044|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
33608251|NCT00545103|102115045|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
33608252|NCT00545103|102115042|FG000|Overall Study|Death|0|||
33608253|NCT00545103|102115043|FG001|Overall Study|Death|1|||
33608254|NCT00545103|102115044|FG002|Overall Study|Death|0|||
33608255|NCT00545103|102115045|FG003|Overall Study|Death|0|||
33608256|NCT00861471|102115046|FG000|Overall Study|Withdrawal by Subject|1|||
33608257|NCT00861471|102115046|FG000|Overall Study|Adverse Event|2|||
33608258|NCT00861471|102115046|FG000|Overall Study|Lack of Efficacy|3|||
33608259|NCT00861471|102115046|FG000|Overall Study|treatment for lumbar laminectomy|1|||
33608260|NCT00861471|102115046|FG000|Overall Study|Physician Decision|2|||
33608261|NCT00498355|102115047|FG000|Overall Study|Lost to Follow-up|1|||
33327297|NCT00262522|101094228|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
33327298|NCT00262522|101094229|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
33327299|NCT00262522|101094230|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
33327300|NCT00262522|101094231|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
33327301|NCT00262522|101094228|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
33327302|NCT00262522|101094229|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
33327303|NCT00262522|101094230|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
33327304|NCT00262522|101094231|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
33327305|NCT00262522|101094228|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
33327306|NCT00262522|101094229|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
33327307|NCT00262522|101094230|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
33518411|NCT01362517|101792987|FG000|Overall Study|Lost to Follow-up|1|||
33518412|NCT03391232|101792988|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
33518413|NCT03391232|101792989|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
33518414|NCT03391232|101792988|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
33518415|NCT03391232|101792989|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
33518416|NCT04686266|101792991|FG000|Overall Study|Withdrawal by Subject|0|||
33518417|NCT04686266|101792992|FG001|Overall Study|Withdrawal by Subject|1|||
33518418|NCT03233204|101792993|FG000|Overall Study|Adverse Event|1|||
33518419|NCT03233204|101792993|FG000|Overall Study|Death|1|||
33518420|NCT03233204|101792993|FG000|Overall Study|Withdrawal by Subject|1|||
33518421|NCT03233204|101792993|FG000|Overall Study|Progressive Disease|3|||
33518422|NCT01826370|101792994|FG000|Overall Study|Protocol Violation|6|||
33518423|NCT01826370|101792994|FG000|Overall Study|Lost to Follow-up|12|||
33518424|NCT01826370|101792994|FG000|Overall Study|Other reason not defined above|2|||
33518425|NCT01398410|101792995|FG000|Overall Study|Adverse Event|12|||
33518426|NCT01398410|101792996|FG001|Overall Study|Adverse Event|16|||
33518427|NCT01398410|101792995|FG000|Overall Study|Participants Choice|8|||
33518428|NCT01398410|101792996|FG001|Overall Study|Participants Choice|11|||
33518429|NCT01398410|101792995|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
33518430|NCT01398410|101792996|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
33518431|NCT01398410|101792995|FG000|Overall Study|Other|36|||
33518432|NCT01398410|101792996|FG001|Overall Study|Other|29|||
33518433|NCT01500213|101792999|FG000|Overall Study|Adverse Event|35|||
33518434|NCT01500213|101793000|FG001|Overall Study|Adverse Event|35|||
33518435|NCT01500213|101792999|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
33518436|NCT01500213|101793000|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
33518437|NCT01500213|101792999|FG000|Overall Study|Withdrawal by Subject|28|||
33518438|NCT01500213|101793000|FG001|Overall Study|Withdrawal by Subject|37|||
33518439|NCT01500213|101792999|FG000|Overall Study|Death|7|||
33518440|NCT01500213|101793000|FG001|Overall Study|Death|3|||
33518441|NCT01500213|101792999|FG000|Overall Study|Disease Progression|13|||
33518442|NCT01500213|101793000|FG001|Overall Study|Disease Progression|21|||
33518443|NCT01500213|101792999|FG000|Overall Study|Protocol Violation|19|||
33518444|NCT01500213|101793000|FG001|Overall Study|Protocol Violation|19|||
33608262|NCT01452919|102115048|FG000|Open-Label Treatment|Adverse Event|5|||
33608263|NCT01452919|102115049|FG001|Open-Label Treatment|Adverse Event|0|||
33608264|NCT01452919|102115050|FG002|Open-Label Treatment|Adverse Event|0|||
33608265|NCT01452919|102115048|FG000|Open-Label Treatment|Lost to Follow-up|4|||
33608266|NCT01452919|102115049|FG001|Open-Label Treatment|Lost to Follow-up|0|||
33608267|NCT01452919|102115050|FG002|Open-Label Treatment|Lost to Follow-up|0|||
33400751|NCT02630459|101353551|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
33400752|NCT02630459|101353552|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
33400753|NCT02630459|101353545|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
33400754|NCT02630459|101353546|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
33400755|NCT02630459|101353547|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
33400756|NCT02630459|101353548|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
33400757|NCT02630459|101353549|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
33400758|NCT02630459|101353550|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
33400759|NCT02630459|101353551|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
33400760|NCT02630459|101353552|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
33400761|NCT01657903|101353553|FG000|Overall Study|Lost to Follow-up|1|||
33400762|NCT01657903|101353553|FG000|Overall Study|Withdrawal by Subject|1|||
33400763|NCT03419741|101353554|FG000|Overall Study|Adverse Event|1|||
33400764|NCT03419741|101353555|FG001|Overall Study|Adverse Event|0|||
33400765|NCT03419741|101353554|FG000|Overall Study|Withdrawal by Subject|1|||
33400766|NCT03419741|101353555|FG001|Overall Study|Withdrawal by Subject|2|||
33400767|NCT01072500|101353558|FG000|Overall Study|Death|2|||
33400768|NCT01072500|101353559|FG001|Overall Study|Death|2|||
33400769|NCT01072500|101353558|FG000|Overall Study|Lost to Follow-up|5|||
33400770|NCT01072500|101353559|FG001|Overall Study|Lost to Follow-up|2|||
33518445|NCT01500213|101792999|FG000|Overall Study|Physician Decision|12|||
33518446|NCT01500213|101793000|FG001|Overall Study|Physician Decision|10|||
33518447|NCT01500213|101792999|FG000|Overall Study|Lack of Efficacy|9|||
33518448|NCT01500213|101793000|FG001|Overall Study|Lack of Efficacy|7|||
33518449|NCT01500213|101792999|FG000|Overall Study|Lost to Follow-up|3|||
33518450|NCT01500213|101793000|FG001|Overall Study|Lost to Follow-up|6|||
33518451|NCT01500213|101792999|FG000|Overall Study|Other Reasons|7|||
33518452|NCT01500213|101793000|FG001|Overall Study|Other Reasons|5|||
33518453|NCT04015518|101793001|FG000|Overall Study|Adverse Event|6|||
33518454|NCT04015518|101793002|FG001|Overall Study|Adverse Event|1|||
33518455|NCT04015518|101793003|FG002|Overall Study|Adverse Event|1|||
33518456|NCT04015518|101793004|FG003|Overall Study|Adverse Event|3|||
33608268|NCT01452919|102115048|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
33608269|NCT01452919|102115049|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
33608270|NCT01452919|102115050|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
33608271|NCT01452919|102115048|FG000|Open-Label Treatment|Protocol Violation|4|||
33400771|NCT01072500|101353558|FG000|Overall Study|Withdrawal by Subject|17|||
33400772|NCT01072500|101353559|FG001|Overall Study|Withdrawal by Subject|10|||
33400773|NCT02168816|101353560|FG000|Overall Study|Lost to Follow-up|2|||
33400774|NCT02168816|101353561|FG001|Overall Study|Lost to Follow-up|2|||
33400775|NCT01728454|101353562|FG000|Stage 1 and 2|Pregnancy|1|||
33400776|NCT01728454|101353563|FG001|Stage 1 and 2|Pregnancy|0|||
33400777|NCT01728454|101353564|FG002|Stage 1 and 2|Pregnancy|0|||
33400778|NCT01728454|101353562|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
33400779|NCT01728454|101353563|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
33400780|NCT01728454|101353564|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
33400781|NCT01728454|101353562|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
33400782|NCT01728454|101353563|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
33400783|NCT01728454|101353564|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
33400784|NCT01728454|101353562|FG000|Stage 1 and 2|Lost to Follow-up|1|||
33400785|NCT01728454|101353563|FG001|Stage 1 and 2|Lost to Follow-up|1|||
33400786|NCT01728454|101353564|FG002|Stage 1 and 2|Lost to Follow-up|0|||
33400787|NCT01728454|101353562|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
33400788|NCT01728454|101353563|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
33400789|NCT01728454|101353564|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
33400790|NCT01728454|101353562|FG000|Stage 3|Reason Missing|0|||
33400791|NCT01728454|101353563|FG001|Stage 3|Reason Missing|0|||
33400792|NCT01728454|101353564|FG002|Stage 3|Reason Missing|1|||
33400793|NCT01728454|101353562|FG000|Stage 3|Subject Required Other Treatment|0|||
33400794|NCT01728454|101353563|FG001|Stage 3|Subject Required Other Treatment|1|||
33400795|NCT01728454|101353564|FG002|Stage 3|Subject Required Other Treatment|0|||
33518457|NCT04015518|101793005|FG004|Overall Study|Adverse Event|3|||
33518458|NCT04015518|101793001|FG000|Overall Study|Lack of Efficacy|1|||
33518459|NCT04015518|101793002|FG001|Overall Study|Lack of Efficacy|0|||
33518460|NCT04015518|101793003|FG002|Overall Study|Lack of Efficacy|1|||
33327308|NCT00262522|101094231|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
33327309|NCT00262522|101094228|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
33327310|NCT00262522|101094229|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
33327311|NCT00262522|101094230|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
33327312|NCT00262522|101094231|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
33518461|NCT04015518|101793004|FG003|Overall Study|Lack of Efficacy|0|||
33327313|NCT00262522|101094228|FG000|Study Start Through 8 Weeks|Death|1|||
33327314|NCT00262522|101094229|FG001|Study Start Through 8 Weeks|Death|0|||
33327315|NCT00262522|101094230|FG002|Study Start Through 8 Weeks|Death|0|||
33327316|NCT00262522|101094231|FG003|Study Start Through 8 Weeks|Death|0|||
33327317|NCT00262522|101094228|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
33518462|NCT04015518|101793005|FG004|Overall Study|Lack of Efficacy|4|||
33518463|NCT04015518|101793001|FG000|Overall Study|Lost to Follow-up|0|||
33327318|NCT00262522|101094229|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
33327319|NCT00262522|101094230|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
33327320|NCT00262522|101094231|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
33327321|NCT00262522|101094228|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
33327322|NCT00262522|101094229|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
33327323|NCT00262522|101094230|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
33327324|NCT00262522|101094231|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
33327325|NCT00262522|101094228|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
33400796|NCT01728454|101353562|FG000|Stage 3|Pregnancy|1|||
33518464|NCT04015518|101793002|FG001|Overall Study|Lost to Follow-up|0|||
33518465|NCT04015518|101793003|FG002|Overall Study|Lost to Follow-up|0|||
33518466|NCT04015518|101793004|FG003|Overall Study|Lost to Follow-up|0|||
33518467|NCT04015518|101793005|FG004|Overall Study|Lost to Follow-up|1|||
33518468|NCT04015518|101793001|FG000|Overall Study|Withdrawal by Subject|0|||
33518469|NCT04015518|101793002|FG001|Overall Study|Withdrawal by Subject|1|||
33518470|NCT04015518|101793003|FG002|Overall Study|Withdrawal by Subject|0|||
33518471|NCT04015518|101793004|FG003|Overall Study|Withdrawal by Subject|1|||
33518472|NCT04015518|101793005|FG004|Overall Study|Withdrawal by Subject|1|||
33518473|NCT04015518|101793001|FG000|Overall Study|Patient did not come for consecutive visits|0|||
33518474|NCT04015518|101793002|FG001|Overall Study|Patient did not come for consecutive visits|1|||
33518475|NCT04015518|101793003|FG002|Overall Study|Patient did not come for consecutive visits|0|||
33608272|NCT01452919|102115049|FG001|Open-Label Treatment|Protocol Violation|0|||
33327326|NCT00262522|101094229|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
33327327|NCT00262522|101094230|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
33327328|NCT00262522|101094231|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
33400797|NCT01728454|101353563|FG001|Stage 3|Pregnancy|0|||
33400798|NCT01728454|101353564|FG002|Stage 3|Pregnancy|0|||
33327329|NCT00262522|101094228|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
33400799|NCT01728454|101353562|FG000|Stage 3|Withdrew Consent|1|||
33518476|NCT04015518|101793004|FG003|Overall Study|Patient did not come for consecutive visits|0|||
33518477|NCT04015518|101793005|FG004|Overall Study|Patient did not come for consecutive visits|0|||
33518478|NCT04015518|101793001|FG000|Overall Study|not willing to travel due to Covid-19|0|||
33608273|NCT01452919|102115050|FG002|Open-Label Treatment|Protocol Violation|0|||
33327330|NCT00262522|101094229|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
33400800|NCT01728454|101353563|FG001|Stage 3|Withdrew Consent|0|||
33400801|NCT01728454|101353564|FG002|Stage 3|Withdrew Consent|1|||
33400802|NCT01728454|101353562|FG000|Stage 3|Non-compliance with Protocol|0|||
33400803|NCT01728454|101353563|FG001|Stage 3|Non-compliance with Protocol|0|||
33400804|NCT01728454|101353564|FG002|Stage 3|Non-compliance with Protocol|1|||
33400805|NCT01728454|101353562|FG000|Stage 3|Lost to Follow-up|0|||
33400806|NCT01728454|101353563|FG001|Stage 3|Lost to Follow-up|3|||
33400807|NCT01728454|101353564|FG002|Stage 3|Lost to Follow-up|1|||
33400808|NCT01728454|101353562|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
33400809|NCT01728454|101353563|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
33400810|NCT01728454|101353564|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
33400811|NCT01603628|101353565|FG000|Overall Study|Personal Reasons|1|||
33400812|NCT01603628|101353566|FG001|Overall Study|Personal Reasons|1|||
33400813|NCT01603628|101353567|FG002|Overall Study|Personal Reasons|2|||
33400814|NCT01603628|101353565|FG000|Overall Study|Protocol Violation|1|||
33400815|NCT01603628|101353566|FG001|Overall Study|Protocol Violation|1|||
33400816|NCT01603628|101353567|FG002|Overall Study|Protocol Violation|0|||
33400817|NCT01603628|101353565|FG000|Overall Study|Lost to Follow-up|0|||
33400818|NCT01603628|101353566|FG001|Overall Study|Lost to Follow-up|1|||
33327331|NCT00262522|101094230|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
33327332|NCT00262522|101094231|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
33327333|NCT00262522|101094228|FG000|Study Start Through 48 Weeks|Death|2|||
33327334|NCT00262522|101094229|FG001|Study Start Through 48 Weeks|Death|0|||
33327335|NCT00262522|101094230|FG002|Study Start Through 48 Weeks|Death|1|||
33327336|NCT00262522|101094231|FG003|Study Start Through 48 Weeks|Death|0|||
33327337|NCT00262522|101094228|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
33327338|NCT00262522|101094229|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
33327339|NCT00262522|101094230|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
33327340|NCT00262522|101094231|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
33327341|NCT00262522|101094228|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
33327342|NCT00262522|101094229|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
33327343|NCT00262522|101094230|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
33327344|NCT00262522|101094231|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
33327345|NCT00262522|101094228|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
33327346|NCT00262522|101094229|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
33327347|NCT00262522|101094230|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
33327348|NCT00262522|101094231|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
33327349|NCT00262522|101094228|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
33327350|NCT00262522|101094229|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
33327351|NCT00262522|101094230|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
33327352|NCT00262522|101094231|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
33327353|NCT00262522|101094228|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
33327354|NCT00262522|101094229|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
33327355|NCT00262522|101094230|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
33327356|NCT00262522|101094231|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
33327357|NCT00262522|101094228|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
33327358|NCT00262522|101094229|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
33327359|NCT00262522|101094230|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
33327360|NCT00262522|101094231|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
33327361|NCT00262522|101094228|FG000|Study Start Through 96 Weeks|Death|2|||
33327362|NCT00262522|101094229|FG001|Study Start Through 96 Weeks|Death|0|||
33327363|NCT00262522|101094230|FG002|Study Start Through 96 Weeks|Death|2|||
33327364|NCT00262522|101094231|FG003|Study Start Through 96 Weeks|Death|0|||
33327365|NCT00262522|101094228|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
33327366|NCT00262522|101094229|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
33327367|NCT00262522|101094230|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
33327368|NCT00262522|101094231|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
33400819|NCT01603628|101353567|FG002|Overall Study|Lost to Follow-up|0|||
33400820|NCT01603628|101353565|FG000|Overall Study|Other Miscellaneous Reason|1|||
33400821|NCT01603628|101353566|FG001|Overall Study|Other Miscellaneous Reason|0|||
33327369|NCT00262522|101094228|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
33327370|NCT00262522|101094229|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
33327371|NCT00262522|101094230|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
33327372|NCT00262522|101094231|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
33327373|NCT02687542|101094232|FG000|Overall Study|Medication error without associated AEs|0|||
33400822|NCT01603628|101353567|FG002|Overall Study|Other Miscellaneous Reason|0|||
33400823|NCT01888367|101356816|FG000|Overall Study|Physician Decision|3|||
33518479|NCT04015518|101793002|FG001|Overall Study|not willing to travel due to Covid-19|0|||
33518480|NCT04015518|101793003|FG002|Overall Study|not willing to travel due to Covid-19|1|||
33518481|NCT04015518|101793004|FG003|Overall Study|not willing to travel due to Covid-19|0|||
33518482|NCT04015518|101793005|FG004|Overall Study|not willing to travel due to Covid-19|0|||
33518483|NCT04015518|101793001|FG000|Overall Study|Patient wants to discontinue treatment|0|||
33518484|NCT04015518|101793002|FG001|Overall Study|Patient wants to discontinue treatment|0|||
33518485|NCT04015518|101793003|FG002|Overall Study|Patient wants to discontinue treatment|0|||
33518486|NCT04015518|101793004|FG003|Overall Study|Patient wants to discontinue treatment|1|||
33518487|NCT04015518|101793005|FG004|Overall Study|Patient wants to discontinue treatment|0|||
33518488|NCT04015518|101793001|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
33518489|NCT04015518|101793002|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
33518490|NCT04015518|101793003|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
33518491|NCT04015518|101793004|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
33518492|NCT04015518|101793005|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
33518493|NCT04015518|101793001|FG000|Overall Study|Pregnancy|0|||
33518494|NCT04015518|101793002|FG001|Overall Study|Pregnancy|0|||
33518495|NCT04015518|101793003|FG002|Overall Study|Pregnancy|0|||
33518496|NCT04015518|101793004|FG003|Overall Study|Pregnancy|0|||
33518497|NCT04015518|101793005|FG004|Overall Study|Pregnancy|1|||
33518498|NCT04015518|101793001|FG000|Overall Study|Personal reasons|1|||
33518499|NCT04015518|101793002|FG001|Overall Study|Personal reasons|0|||
33518500|NCT04015518|101793003|FG002|Overall Study|Personal reasons|0|||
33518501|NCT04015518|101793004|FG003|Overall Study|Personal reasons|0|||
33518502|NCT04015518|101793005|FG004|Overall Study|Personal reasons|1|||
33518503|NCT04015518|101793001|FG000|Overall Study|Withdrew consent|1|||
33518504|NCT04015518|101793002|FG001|Overall Study|Withdrew consent|0|||
33518505|NCT04015518|101793003|FG002|Overall Study|Withdrew consent|0|||
33518506|NCT04015518|101793004|FG003|Overall Study|Withdrew consent|0|||
33518507|NCT04015518|101793005|FG004|Overall Study|Withdrew consent|0|||
33518508|NCT04015518|101793001|FG000|Overall Study|Prostate carcinoma|1|||
33518509|NCT04015518|101793002|FG001|Overall Study|Prostate carcinoma|0|||
33518510|NCT04015518|101793003|FG002|Overall Study|Prostate carcinoma|0|||
33518511|NCT04015518|101793004|FG003|Overall Study|Prostate carcinoma|0|||
33518512|NCT04015518|101793005|FG004|Overall Study|Prostate carcinoma|0|||
33518513|NCT04015518|101793001|FG000|Overall Study|Could not keep appointments due to work|1|||
33518514|NCT04015518|101793002|FG001|Overall Study|Could not keep appointments due to work|0|||
33518515|NCT04015518|101793003|FG002|Overall Study|Could not keep appointments due to work|0|||
33518516|NCT04015518|101793004|FG003|Overall Study|Could not keep appointments due to work|0|||
33518517|NCT04015518|101793005|FG004|Overall Study|Could not keep appointments due to work|0|||
33518518|NCT03448939|101793006|FG000|Overall Study|Adverse Event|5|||
33518519|NCT03448939|101793007|FG001|Overall Study|Adverse Event|1|||
33327374|NCT02687542|101094233|FG001|Overall Study|Medication error without associated AEs|0|||
33327375|NCT02687542|101094234|FG002|Overall Study|Medication error without associated AEs|0|||
33518520|NCT03448939|101793006|FG000|Overall Study|Lost to Follow-up|6|||
33518521|NCT03448939|101793007|FG001|Overall Study|Lost to Follow-up|6|||
33518522|NCT03448939|101793006|FG000|Overall Study|Pregnancy|1|||
33518523|NCT03448939|101793007|FG001|Overall Study|Pregnancy|1|||
33518524|NCT03448939|101793006|FG000|Overall Study|Withdrawal by Subject|9|||
33518525|NCT03448939|101793007|FG001|Overall Study|Withdrawal by Subject|3|||
33518526|NCT01440569|101793013|FG000|Main Study|Enrolled but not treated|1|||
33518527|NCT01440569|101793014|FG001|Main Study|Enrolled but not treated|0|||
33518528|NCT01440569|101793013|FG000|Main Study|Adverse Event|9|||
33518529|NCT01440569|101793014|FG001|Main Study|Adverse Event|0|||
33518530|NCT01440569|101793013|FG000|Main Study|Pregnancy|1|||
33518531|NCT01440569|101793014|FG001|Main Study|Pregnancy|0|||
33518532|NCT01440569|101793013|FG000|Main Study|Investigator's Discretion|1|||
33518533|NCT01440569|101793014|FG001|Main Study|Investigator's Discretion|1|||
33518534|NCT01440569|101793013|FG000|Main Study|Withdrew Consent|7|||
33518535|NCT01440569|101793014|FG001|Main Study|Withdrew Consent|1|||
33518536|NCT01440569|101793013|FG000|Main Study|Lost to Follow-up|13|||
33518537|NCT01440569|101793014|FG001|Main Study|Lost to Follow-up|2|||
33518538|NCT01440569|101793013|FG000|Main Study|Subject Non-Compliance|3|||
33518539|NCT01440569|101793014|FG001|Main Study|Subject Non-Compliance|0|||
33518540|NCT01440569|101793013|FG000|Main Study|Protocol Violation|1|||
33518541|NCT01440569|101793014|FG001|Main Study|Protocol Violation|0|||
33518542|NCT01440569|101793013|FG000|Open-Label Rollover Phase|Adverse Event|3|||
33518543|NCT01440569|101793014|FG001|Open-Label Rollover Phase|Adverse Event|0|||
33518544|NCT01440569|101793013|FG000|Open-Label Rollover Phase|Pregnancy|1|||
33518545|NCT01440569|101793014|FG001|Open-Label Rollover Phase|Pregnancy|0|||
33518546|NCT01440569|101793013|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
33518547|NCT01440569|101793014|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
33518548|NCT01440569|101793013|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
33518549|NCT01440569|101793014|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
33518550|NCT01440569|101793013|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
33518551|NCT01440569|101793014|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
33518552|NCT01440569|101793013|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
33518553|NCT01440569|101793014|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
33518554|NCT01440569|101793013|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
33518555|NCT01440569|101793014|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
33518556|NCT02248974|101793019|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
33518557|NCT02248974|101793020|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
33518558|NCT02248974|101793019|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
33518559|NCT02248974|101793020|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
33518560|NCT02248974|101793019|FG000|1-Day Follow-Up|Enrolled in another study|1|||
33518561|NCT02248974|101793020|FG001|1-Day Follow-Up|Enrolled in another study|0|||
33518562|NCT02248974|101793019|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
33518563|NCT02248974|101793020|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
33518564|NCT02248974|101793019|FG000|1-Week Follow-Up|Enrolled in another study|1|||
33518565|NCT02248974|101793020|FG001|1-Week Follow-Up|Enrolled in another study|1|||
33518566|NCT02248974|101793019|FG000|1-Week Follow-Up|Transferred to another facility|1|||
33518567|NCT02248974|101793020|FG001|1-Week Follow-Up|Transferred to another facility|0|||
33518568|NCT02248974|101793019|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
33518569|NCT02248974|101793020|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
33518570|NCT02248974|101793019|FG000|1-Week Follow-Up|Death|1|||
33518571|NCT02248974|101793020|FG001|1-Week Follow-Up|Death|1|||
33518572|NCT02248974|101793019|FG000|1-Week Follow-Up|Excluded because of age|0|||
33518573|NCT02248974|101793020|FG001|1-Week Follow-Up|Excluded because of age|1|||
33518574|NCT02248974|101793019|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
33518575|NCT02248974|101793020|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
33518576|NCT02248974|101793019|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
33518577|NCT02248974|101793020|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
33518578|NCT02248974|101793019|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
33518579|NCT02248974|101793020|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
33518580|NCT02248974|101793019|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
33518581|NCT02248974|101793020|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
33518582|NCT02248974|101793019|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
33518583|NCT02248974|101793020|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
33518584|NCT02791438|101793021|FG000|Treatment Period|Adverse Event|1|||
33518585|NCT02791438|101793022|FG001|Treatment Period|Adverse Event|0|||
33518586|NCT02791438|101793021|FG000|Treatment Period|Withdrawal by Subject|0|||
33518587|NCT02791438|101793022|FG001|Treatment Period|Withdrawal by Subject|1|||
33518588|NCT02791438|101793021|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
33518589|NCT02791438|101793022|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
33518590|NCT03488225|101793023|FG000|Overall Study|Off Protocol Therapy|2|||
33518591|NCT03488225|101793023|FG000|Overall Study|Stem Cell Transplant|2|||
33518592|NCT00717275|101793029|FG000|Overall Study|Premature study termination.|3|||
33518593|NCT04395274|101793030|FG000|Overall Study|Lost to Follow-up|20|||
33518594|NCT04395274|101793031|FG001|Overall Study|Lost to Follow-up|11|||
33518595|NCT04395274|101793030|FG000|Overall Study|Withdrawal by Subject|13|||
33518596|NCT04395274|101793031|FG001|Overall Study|Withdrawal by Subject|10|||
33518597|NCT04395274|101793030|FG000|Overall Study|Moved Abroad|0|||
33518598|NCT04395274|101793031|FG001|Overall Study|Moved Abroad|1|||
33518599|NCT01606202|101793032|FG000|Overall Study|Adverse Event|5|||
33518600|NCT01606202|101793033|FG001|Overall Study|Adverse Event|0|||
33518601|NCT01606202|101793032|FG000|Overall Study|Withdrawal by Subject|2|||
33518602|NCT01606202|101793033|FG001|Overall Study|Withdrawal by Subject|1|||
33518603|NCT01606202|101793032|FG000|Overall Study|Personal problems|0|||
33518604|NCT01606202|101793033|FG001|Overall Study|Personal problems|1|||
33518605|NCT01606202|101793032|FG000|Overall Study|Problems with administration|0|||
33518606|NCT01606202|101793033|FG001|Overall Study|Problems with administration|1|||
33518607|NCT02858180|101793036|FG000|Overall Study|Lost to Follow-up|0|||
33518608|NCT02858180|101793037|FG001|Overall Study|Lost to Follow-up|2|||
33518609|NCT02920177|101796547|FG000|Overall Study|Withdrawal by Subject|1|||
33518610|NCT02920177|101796548|FG001|Overall Study|Withdrawal by Subject|1|||
33518611|NCT02920177|101796547|FG000|Overall Study|Physician Decision|1|||
33518612|NCT02920177|101796548|FG001|Overall Study|Physician Decision|0|||
33518613|NCT02920177|101796547|FG000|Overall Study|Lost to Follow-up|0|||
33518614|NCT02920177|101796548|FG001|Overall Study|Lost to Follow-up|1|||
33518615|NCT01785849|101796549|FG000|Overall Study|Death|7|||
33518616|NCT01785849|101796550|FG001|Overall Study|Death|9|||
33518617|NCT01785849|101796549|FG000|Overall Study|Protocol Specified Criteria|29|||
33518618|NCT01785849|101796550|FG001|Overall Study|Protocol Specified Criteria|1|||
33518619|NCT01785849|101796549|FG000|Overall Study|Withdrawal by Subject|15|||
33518620|NCT01785849|101796550|FG001|Overall Study|Withdrawal by Subject|12|||
33518621|NCT01785849|101796549|FG000|Overall Study|Sponsor Decision|0|||
33518622|NCT01785849|101796550|FG001|Overall Study|Sponsor Decision|1|||
33518623|NCT01785849|101796549|FG000|Overall Study|Lost to Follow-up|10|||
33518624|NCT01785849|101796550|FG001|Overall Study|Lost to Follow-up|11|||
33518625|NCT03172364|101796552|FG000|Overall Study|Adverse Event|1|||
33518626|NCT03172364|101796553|FG001|Overall Study|Adverse Event|1|||
33518627|NCT03172364|101796552|FG000|Overall Study|Protocol Violation|1|||
33518628|NCT03172364|101796553|FG001|Overall Study|Protocol Violation|0|||
33518629|NCT00772005|101796554|FG000|Overall Study|Adverse Event|9|||
33518630|NCT00772005|101796555|FG001|Overall Study|Adverse Event|14|||
33518631|NCT00772005|101796556|FG002|Overall Study|Adverse Event|10|||
33608274|NCT01452919|102115048|FG000|Open-Label Treatment|Sponsor Decision|1|||
33608275|NCT01452919|102115049|FG001|Open-Label Treatment|Sponsor Decision|0|||
33608276|NCT01452919|102115050|FG002|Open-Label Treatment|Sponsor Decision|0|||
33608277|NCT01452919|102115048|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
33518632|NCT00772005|101796557|FG003|Overall Study|Adverse Event|13|||
33518633|NCT00772005|101796554|FG000|Overall Study|Lack of Efficacy|0|||
33518634|NCT00772005|101796555|FG001|Overall Study|Lack of Efficacy|1|||
33518635|NCT00772005|101796556|FG002|Overall Study|Lack of Efficacy|0|||
33518636|NCT00772005|101796557|FG003|Overall Study|Lack of Efficacy|0|||
33518637|NCT00772005|101796554|FG000|Overall Study|Withdrawal by Subject|3|||
33518638|NCT00772005|101796555|FG001|Overall Study|Withdrawal by Subject|7|||
33608278|NCT01452919|102115049|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
33327376|NCT02687542|101094235|FG003|Overall Study|Medication error without associated AEs|0|||
33327377|NCT02687542|101094236|FG004|Overall Study|Medication error without associated AEs|1|||
33400824|NCT01888367|101356817|FG001|Overall Study|Physician Decision|4|||
33400825|NCT01888367|101356818|FG002|Overall Study|Physician Decision|2|||
33400826|NCT01888367|101356816|FG000|Overall Study|Death|2|||
33518639|NCT00772005|101796556|FG002|Overall Study|Withdrawal by Subject|10|||
33518640|NCT00772005|101796557|FG003|Overall Study|Withdrawal by Subject|2|||
33518641|NCT00772005|101796554|FG000|Overall Study|Protocol Violation|2|||
33518642|NCT00772005|101796555|FG001|Overall Study|Protocol Violation|4|||
33518643|NCT00772005|101796556|FG002|Overall Study|Protocol Violation|1|||
33518644|NCT00772005|101796557|FG003|Overall Study|Protocol Violation|6|||
33518645|NCT00772005|101796554|FG000|Overall Study|Lost to Follow-up|7|||
33608279|NCT01452919|102115050|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
33608280|NCT01452919|102115048|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
33327378|NCT02687542|101094232|FG000|Overall Study|Lost to Follow-up|0|||
33327379|NCT02687542|101094233|FG001|Overall Study|Lost to Follow-up|0|||
33327380|NCT02687542|101094234|FG002|Overall Study|Lost to Follow-up|0|||
33327381|NCT02687542|101094235|FG003|Overall Study|Lost to Follow-up|0|||
33327382|NCT02687542|101094236|FG004|Overall Study|Lost to Follow-up|1|||
33327383|NCT02687542|101094232|FG000|Overall Study|Protocol Violation|0|||
33327384|NCT02687542|101094233|FG001|Overall Study|Protocol Violation|1|||
33327385|NCT02687542|101094234|FG002|Overall Study|Protocol Violation|0|||
33400827|NCT01888367|101356817|FG001|Overall Study|Death|0|||
33400828|NCT01888367|101356818|FG002|Overall Study|Death|1|||
33518646|NCT00772005|101796555|FG001|Overall Study|Lost to Follow-up|3|||
33518647|NCT00772005|101796556|FG002|Overall Study|Lost to Follow-up|6|||
33518648|NCT00772005|101796557|FG003|Overall Study|Lost to Follow-up|3|||
33518649|NCT00772005|101796554|FG000|Overall Study|Non-compliance with study procedures|1|||
33518650|NCT00772005|101796555|FG001|Overall Study|Non-compliance with study procedures|1|||
33518651|NCT00772005|101796556|FG002|Overall Study|Non-compliance with study procedures|0|||
33518652|NCT00772005|101796557|FG003|Overall Study|Non-compliance with study procedures|1|||
33518653|NCT00772005|101796554|FG000|Overall Study|Non-compliance with drug administration|3|||
33518654|NCT00772005|101796555|FG001|Overall Study|Non-compliance with drug administration|0|||
33518655|NCT00772005|101796556|FG002|Overall Study|Non-compliance with drug administration|1|||
33518656|NCT00772005|101796557|FG003|Overall Study|Non-compliance with drug administration|1|||
33518657|NCT01675154|101796558|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
33518658|NCT01675154|101796559|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
33518659|NCT01675154|101796560|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
33518660|NCT01675154|101796561|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
33518661|NCT02667626|101796562|FG000|Overall Study|Withdrawal by Subject|0|||
33518662|NCT02667626|101796563|FG001|Overall Study|Withdrawal by Subject|1|||
33518663|NCT03383692|101796564|FG000|Overall Study|Progressive disease as per RECIST|3|||
33518664|NCT03383692|101796565|FG001|Overall Study|Progressive disease as per RECIST|3|||
33518665|NCT03383692|101796564|FG000|Overall Study|Clinical progression|0|||
33518666|NCT03383692|101796565|FG001|Overall Study|Clinical progression|1|||
33518667|NCT03383692|101796564|FG000|Overall Study|Adverse Event|3|||
33518668|NCT03383692|101796565|FG001|Overall Study|Adverse Event|0|||
33518669|NCT03605849|101796566|FG000|Overall Study|Adverse Event|20|||
33518670|NCT03605849|101796567|FG001|Overall Study|Adverse Event|21|||
33518671|NCT03605849|101796568|FG002|Overall Study|Adverse Event|29|||
33518672|NCT03605849|101796569|FG003|Overall Study|Adverse Event|11|||
33518673|NCT03605849|101796566|FG000|Overall Study|Lack of Efficacy|4|||
33518674|NCT03605849|101796567|FG001|Overall Study|Lack of Efficacy|7|||
33518675|NCT03605849|101796568|FG002|Overall Study|Lack of Efficacy|9|||
33518676|NCT03605849|101796569|FG003|Overall Study|Lack of Efficacy|2|||
33518677|NCT03605849|101796566|FG000|Overall Study|Lost to Follow-up|8|||
33518678|NCT03605849|101796567|FG001|Overall Study|Lost to Follow-up|8|||
33518679|NCT03605849|101796568|FG002|Overall Study|Lost to Follow-up|14|||
33518680|NCT03605849|101796569|FG003|Overall Study|Lost to Follow-up|11|||
33518681|NCT03605849|101796566|FG000|Overall Study|Non-compliance With IMP|6|||
33518682|NCT03605849|101796567|FG001|Overall Study|Non-compliance With IMP|5|||
33518683|NCT03605849|101796568|FG002|Overall Study|Non-compliance With IMP|2|||
33518684|NCT03605849|101796569|FG003|Overall Study|Non-compliance With IMP|1|||
33518685|NCT03605849|101796566|FG000|Overall Study|Protocol Deviation|1|||
33518686|NCT03605849|101796567|FG001|Overall Study|Protocol Deviation|2|||
33518687|NCT03605849|101796568|FG002|Overall Study|Protocol Deviation|1|||
33518688|NCT03605849|101796569|FG003|Overall Study|Protocol Deviation|3|||
33518689|NCT03605849|101796566|FG000|Overall Study|Withdrawal by Subject|33|||
33518690|NCT03605849|101796567|FG001|Overall Study|Withdrawal by Subject|28|||
33518691|NCT03605849|101796568|FG002|Overall Study|Withdrawal by Subject|30|||
33518692|NCT03605849|101796569|FG003|Overall Study|Withdrawal by Subject|28|||
33518693|NCT03605849|101796566|FG000|Overall Study|Site Terminated by Sponsor|0|||
33518694|NCT03605849|101796567|FG001|Overall Study|Site Terminated by Sponsor|0|||
33518695|NCT03605849|101796568|FG002|Overall Study|Site Terminated by Sponsor|0|||
33518696|NCT03605849|101796569|FG003|Overall Study|Site Terminated by Sponsor|1|||
33518697|NCT03605849|101796566|FG000|Overall Study|Physician Decision|2|||
33518698|NCT03605849|101796567|FG001|Overall Study|Physician Decision|1|||
33518699|NCT03605849|101796568|FG002|Overall Study|Physician Decision|2|||
33518700|NCT03605849|101796569|FG003|Overall Study|Physician Decision|1|||
33518701|NCT03605849|101796566|FG000|Overall Study|Enrolled, but not Treated|2|||
33518702|NCT03605849|101796567|FG001|Overall Study|Enrolled, but not Treated|2|||
33518703|NCT03605849|101796568|FG002|Overall Study|Enrolled, but not Treated|3|||
33518704|NCT03605849|101796569|FG003|Overall Study|Enrolled, but not Treated|2|||
33518705|NCT03605849|101796566|FG000|Overall Study|Other (COVID-19 Related)|0|||
33518706|NCT03605849|101796567|FG001|Overall Study|Other (COVID-19 Related)|1|||
33518707|NCT03605849|101796568|FG002|Overall Study|Other (COVID-19 Related)|1|||
33518708|NCT03605849|101796569|FG003|Overall Study|Other (COVID-19 Related)|0|||
33518709|NCT03605849|101796566|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
33518710|NCT03605849|101796567|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
33200179|NCT00009737|100638216|FG001|Overall Study|Other Protocol Violation|0|||
33518711|NCT03605849|101796568|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
33518712|NCT03605849|101796569|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
33518713|NCT00078949|101796574|FG000|Overall Study|No treated|4|||
33518714|NCT00078949|101796575|FG001|Overall Study|No treated|5|||
33518715|NCT00078949|101796576|FG002|Overall Study|No treated|3|||
33518716|NCT00078949|101796577|FG003|Overall Study|No treated|3|||
33518717|NCT01078298|101796578|FG000|Overall Study|Lost to Follow-up|12|||
33518718|NCT01078298|101796579|FG001|Overall Study|Lost to Follow-up|13|||
33518719|NCT01078298|101796578|FG000|Overall Study|Withdrawal by Subject|31|||
33518720|NCT01078298|101796579|FG001|Overall Study|Withdrawal by Subject|33|||
33608281|NCT01452919|102115049|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
33608282|NCT01452919|102115050|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
33608283|NCT01452919|102115048|FG000|Randomization Treatment|Adverse Event|0|||
33327386|NCT02687542|101094235|FG003|Overall Study|Protocol Violation|0|||
33327387|NCT02687542|101094236|FG004|Overall Study|Protocol Violation|0|||
33518721|NCT01078298|101796578|FG000|Overall Study|Protocol Violation|6|||
33518722|NCT01078298|101796579|FG001|Overall Study|Protocol Violation|6|||
33518723|NCT01078298|101796578|FG000|Overall Study|Adverse Event|6|||
33518724|NCT01078298|101796579|FG001|Overall Study|Adverse Event|5|||
33518725|NCT01078298|101796578|FG000|Overall Study|Death|2|||
33518726|NCT01078298|101796579|FG001|Overall Study|Death|0|||
33518727|NCT01078298|101796578|FG000|Overall Study|Did not meet entrance criteria|0|||
33518728|NCT01078298|101796579|FG001|Overall Study|Did not meet entrance criteria|1|||
33518729|NCT01078298|101796578|FG000|Overall Study|Other|24|||
33608284|NCT01452919|102115049|FG001|Randomization Treatment|Adverse Event|0|||
33608285|NCT01452919|102115050|FG002|Randomization Treatment|Adverse Event|2|||
33608286|NCT01452919|102115048|FG000|Randomization Treatment|Sponsor Decision|0|||
33608287|NCT01452919|102115049|FG001|Randomization Treatment|Sponsor Decision|1|||
33608288|NCT01452919|102115050|FG002|Randomization Treatment|Sponsor Decision|0|||
33608289|NCT01452919|102115048|FG000|Randomization Treatment|Withdrawal by Subject|0|||
33608290|NCT01452919|102115049|FG001|Randomization Treatment|Withdrawal by Subject|1|||
33608291|NCT01452919|102115050|FG002|Randomization Treatment|Withdrawal by Subject|0|||
33608292|NCT01452919|102115048|FG000|Randomization Treatment|Subject is moving or has moved|0|||
33608293|NCT01452919|102115049|FG001|Randomization Treatment|Subject is moving or has moved|1|||
33608294|NCT01452919|102115050|FG002|Randomization Treatment|Subject is moving or has moved|0|||
33608295|NCT00828750|102115051|FG000|Overall Study|Lack of Efficacy|3|||
33608296|NCT00828750|102115051|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
33608297|NCT02891382|102115052|FG000|Overall Study|Lost to Follow-up|3|||
33608298|NCT02891382|102115053|FG001|Overall Study|Lost to Follow-up|4|||
33608299|NCT02891382|102115054|FG002|Overall Study|Lost to Follow-up|5|||
33608300|NCT02891382|102115055|FG003|Overall Study|Lost to Follow-up|3|||
33608301|NCT02891382|102115056|FG004|Overall Study|Lost to Follow-up|4|||
33608302|NCT00666965|102115057|FG000|Overall Study|Adverse Event|0|||
33608303|NCT00666965|102115058|FG001|Overall Study|Adverse Event|2|||
33608304|NCT00666965|102115059|FG002|Overall Study|Adverse Event|1|||
33608305|NCT00666965|102115060|FG003|Overall Study|Adverse Event|9|||
33608306|NCT00666965|102115057|FG000|Overall Study|Lack of Efficacy|1|||
33608307|NCT00666965|102115058|FG001|Overall Study|Lack of Efficacy|1|||
33608308|NCT00666965|102115059|FG002|Overall Study|Lack of Efficacy|0|||
33608309|NCT00666965|102115060|FG003|Overall Study|Lack of Efficacy|0|||
33608310|NCT00666965|102115057|FG000|Overall Study|Protocol Violation|0|||
33608311|NCT00666965|102115058|FG001|Overall Study|Protocol Violation|0|||
33608312|NCT00666965|102115059|FG002|Overall Study|Protocol Violation|0|||
33608313|NCT00666965|102115060|FG003|Overall Study|Protocol Violation|2|||
33608314|NCT00666965|102115057|FG000|Overall Study|Discontinuation criteria|2|||
33608315|NCT00666965|102115058|FG001|Overall Study|Discontinuation criteria|1|||
33327388|NCT02687542|101094232|FG000|Overall Study|Other|5|||
33608316|NCT00666965|102115059|FG002|Overall Study|Discontinuation criteria|1|||
33608317|NCT00666965|102115060|FG003|Overall Study|Discontinuation criteria|2|||
33518730|NCT01078298|101796579|FG001|Overall Study|Other|32|||
33608318|NCT00666965|102115057|FG000|Overall Study|Withdrawal by Subject|0|||
33608319|NCT00666965|102115058|FG001|Overall Study|Withdrawal by Subject|0|||
33608320|NCT00666965|102115059|FG002|Overall Study|Withdrawal by Subject|0|||
33608321|NCT00666965|102115060|FG003|Overall Study|Withdrawal by Subject|2|||
33518731|NCT00597012|101796580|FG000|Overall Study|Death|1|||
33400829|NCT01888367|101356816|FG000|Overall Study|Withdrawal by Subject|1|||
33400830|NCT01888367|101356817|FG001|Overall Study|Withdrawal by Subject|0|||
33400831|NCT01888367|101356818|FG002|Overall Study|Withdrawal by Subject|1|||
33400832|NCT01888367|101356816|FG000|Overall Study|Lost to Follow-up|1|||
33518732|NCT00597012|101796581|FG001|Overall Study|Death|1|||
33518733|NCT00597012|101796580|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
33518734|NCT00597012|101796581|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
33518735|NCT00597012|101796580|FG000|Overall Study|Withdrawal by Subject|7|||
33518736|NCT00597012|101796581|FG001|Overall Study|Withdrawal by Subject|4|||
33518737|NCT00597012|101796580|FG000|Overall Study|Ineligible|2|||
33200180|NCT00009737|100638215|FG000|Overall Study|Refused Treatment|15|||
33200181|NCT00009737|100638216|FG001|Overall Study|Refused Treatment|16|||
33200182|NCT00009737|100638215|FG000|Overall Study|Lost to Follow-up|1|||
33200183|NCT00009737|100638216|FG001|Overall Study|Lost to Follow-up|1|||
33327389|NCT02687542|101094233|FG001|Overall Study|Other|9|||
33518738|NCT00597012|101796581|FG001|Overall Study|Ineligible|0|||
33518739|NCT00597012|101796580|FG000|Overall Study|Lost to Follow-up|0|||
33518740|NCT00597012|101796581|FG001|Overall Study|Lost to Follow-up|2|||
33518741|NCT02450552|101796582|FG000|Overall Study|Withdrawal by Subject|4|||
33518742|NCT02450552|101796583|FG001|Overall Study|Withdrawal by Subject|0|||
33518743|NCT02450552|101796584|FG002|Overall Study|Withdrawal by Subject|4|||
33518744|NCT02450552|101796582|FG000|Overall Study|Physician Decision|1|||
33327390|NCT02687542|101094234|FG002|Overall Study|Other|10|||
33327391|NCT02687542|101094235|FG003|Overall Study|Other|6|||
33327392|NCT02687542|101094236|FG004|Overall Study|Other|5|||
33327393|NCT02687542|101094232|FG000|Overall Study|Adverse Event|3|||
33327394|NCT02687542|101094233|FG001|Overall Study|Adverse Event|1|||
33327395|NCT02687542|101094234|FG002|Overall Study|Adverse Event|3|||
33327396|NCT02687542|101094235|FG003|Overall Study|Adverse Event|2|||
33327397|NCT02687542|101094236|FG004|Overall Study|Adverse Event|9|||
33327398|NCT02687542|101094232|FG000|Overall Study|Withdrawal by Subject|0|||
33400833|NCT01888367|101356817|FG001|Overall Study|Lost to Follow-up|1|||
33200184|NCT00009737|100638215|FG000|Overall Study|Administrative/Other Reasons|7|||
33200185|NCT00009737|100638216|FG001|Overall Study|Administrative/Other Reasons|1|||
33518745|NCT02450552|101796583|FG001|Overall Study|Physician Decision|0|||
33518746|NCT02450552|101796584|FG002|Overall Study|Physician Decision|1|||
33518747|NCT01634659|101796585|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
33200186|NCT03021187|100638217|FG000|Overall Study|Death|0|||
33200187|NCT03021187|100638218|FG001|Overall Study|Death|0|||
33200188|NCT03021187|100638219|FG002|Overall Study|Death|3|||
33200189|NCT03021187|100638220|FG003|Overall Study|Death|0|||
33200190|NCT03021187|100638217|FG000|Overall Study|Withdrawal by Subject|0|||
33200191|NCT03021187|100638218|FG001|Overall Study|Withdrawal by Subject|6|||
33200192|NCT03021187|100638219|FG002|Overall Study|Withdrawal by Subject|2|||
33200193|NCT03021187|100638220|FG003|Overall Study|Withdrawal by Subject|5|||
33200194|NCT03021187|100638217|FG000|Overall Study|Lost to Follow-up|10|||
33518748|NCT01634659|101796586|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
33518749|NCT01634659|101796585|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
33518750|NCT01634659|101796586|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
33518751|NCT04594941|101796587|FG000|Overall Study|Other|0|||
33518752|NCT04594941|101796588|FG001|Overall Study|Other|3|||
33518753|NCT04594941|101796589|FG002|Overall Study|Other|1|||
33518754|NCT04594941|101796590|FG003|Overall Study|Other|0|||
33518755|NCT03117881|101796593|FG000|Baseline|Withdrawal by Subject|21|||
33518756|NCT03117881|101796594|FG001|Baseline|Withdrawal by Subject|10|||
33518757|NCT03117881|101796595|FG002|Baseline|Withdrawal by Subject|0|||
33518758|NCT03117881|101796593|FG000|Baseline|Lost to Follow-up|22|||
33200195|NCT03021187|100638218|FG001|Overall Study|Lost to Follow-up|3|||
33518759|NCT03117881|101796594|FG001|Baseline|Lost to Follow-up|25|||
33518760|NCT03117881|101796595|FG002|Baseline|Lost to Follow-up|0|||
33518761|NCT03117881|101796593|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
33518762|NCT03117881|101796594|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
33518763|NCT03117881|101796595|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
33518764|NCT03117881|101796593|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
33518765|NCT03117881|101796594|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
33518766|NCT03117881|101796595|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
33518767|NCT03117881|101796593|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
33200196|NCT03021187|100638219|FG002|Overall Study|Lost to Follow-up|1|||
33200197|NCT03021187|100638220|FG003|Overall Study|Lost to Follow-up|4|||
33200198|NCT02606136|100638221|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
33200199|NCT02606136|100638221|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
33200200|NCT02606136|100638221|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
33327399|NCT02687542|101094233|FG001|Overall Study|Withdrawal by Subject|1|||
33327400|NCT02687542|101094234|FG002|Overall Study|Withdrawal by Subject|1|||
33327401|NCT02687542|101094235|FG003|Overall Study|Withdrawal by Subject|2|||
33518768|NCT03117881|101796594|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
33518769|NCT03117881|101796595|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
33518770|NCT03117881|101796593|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
33518771|NCT03117881|101796594|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
33518772|NCT03117881|101796595|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
33518773|NCT03117881|101796593|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
33518774|NCT03117881|101796594|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
33518775|NCT03117881|101796595|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
33518776|NCT03117881|101796593|FG000|6-Month Follow-Up|Did not complete test|53|||
33518777|NCT03117881|101796594|FG001|6-Month Follow-Up|Did not complete test|25|||
33518778|NCT03117881|101796595|FG002|6-Month Follow-Up|Did not complete test|7|||
33518779|NCT03117881|101796593|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
33518780|NCT03117881|101796594|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
33518781|NCT03117881|101796595|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
33518782|NCT03117881|101796593|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
33518783|NCT03117881|101796594|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
33518784|NCT03117881|101796595|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
33518785|NCT03117881|101796593|FG000|12-Month Follow-Up|Did not complete test|40|||
33518786|NCT03117881|101796594|FG001|12-Month Follow-Up|Did not complete test|0|||
33518787|NCT03117881|101796595|FG002|12-Month Follow-Up|Did not complete test|0|||
33518788|NCT04529850|101796596|FG000|Overall Study|Death|2|||
33327402|NCT02687542|101094236|FG004|Overall Study|Withdrawal by Subject|4|||
33400834|NCT01888367|101356818|FG002|Overall Study|Lost to Follow-up|0|||
33518789|NCT04529850|101796596|FG000|Overall Study|Physician Decision|1|||
33518790|NCT04529850|101796596|FG000|Overall Study|Withdrawal by Subject|2|||
33518791|NCT04643964|101796597|FG000|Overall Study|Lost to Follow-up|55|||
33518792|NCT04643964|101796598|FG001|Overall Study|Lost to Follow-up|59|||
33518793|NCT04643964|101796599|FG002|Overall Study|Lost to Follow-up|54|||
33518794|NCT04643964|101796600|FG003|Overall Study|Lost to Follow-up|129|||
33518795|NCT04643964|101796601|FG004|Overall Study|Lost to Follow-up|48|||
33518796|NCT04643964|101796597|FG000|Overall Study|Failed attention check|1|||
33200201|NCT02606136|100638221|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
33200202|NCT02667912|100638222|FG000|Overall Study|Death|3|||
33200203|NCT02667912|100638223|FG001|Overall Study|Death|1|||
33518797|NCT04643964|101796598|FG001|Overall Study|Failed attention check|8|||
33518798|NCT04643964|101796599|FG002|Overall Study|Failed attention check|2|||
33518799|NCT04643964|101796600|FG003|Overall Study|Failed attention check|14|||
33400835|NCT01888367|101356816|FG000|Overall Study|Protocol Violation|0|||
33400836|NCT01888367|101356817|FG001|Overall Study|Protocol Violation|0|||
33400837|NCT01888367|101356818|FG002|Overall Study|Protocol Violation|1|||
33400838|NCT01888367|101356816|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
33400839|NCT01888367|101356817|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
33400840|NCT01888367|101356818|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
33518800|NCT04643964|101796601|FG004|Overall Study|Failed attention check|11|||
33518801|NCT03304184|101796602|FG000|Overall Study|Withdrawal by Subject|1|||
33518802|NCT03304184|101796603|FG001|Overall Study|Withdrawal by Subject|2|||
33518803|NCT00904839|101796604|FG000|Overall Study|Adverse Event|0|||
33518804|NCT00904839|101796605|FG001|Overall Study|Adverse Event|5|||
33518805|NCT00904839|101796606|FG002|Overall Study|Adverse Event|4|||
33518806|NCT00904839|101796604|FG000|Overall Study|Protocol Violation|0|||
33518807|NCT00904839|101796605|FG001|Overall Study|Protocol Violation|1|||
33518808|NCT00904839|101796606|FG002|Overall Study|Protocol Violation|1|||
33518809|NCT00904839|101796604|FG000|Overall Study|Lost to Follow-up|0|||
33518810|NCT00904839|101796605|FG001|Overall Study|Lost to Follow-up|1|||
33518811|NCT00904839|101796606|FG002|Overall Study|Lost to Follow-up|2|||
33518812|NCT00904839|101796604|FG000|Overall Study|Withdrawal by Subject|0|||
33518813|NCT00904839|101796605|FG001|Overall Study|Withdrawal by Subject|2|||
33327403|NCT02285920|101094244|FG000|Overall Study|Kidney transplantation|2|||
33327404|NCT02285920|101094245|FG001|Overall Study|Kidney transplantation|2|||
33327405|NCT02285920|101094246|FG002|Overall Study|Kidney transplantation|2|||
33327406|NCT02285920|101094247|FG003|Overall Study|Kidney transplantation|0|||
33327407|NCT02285920|101094244|FG000|Overall Study|Change to peritoneal dialysis|0|||
33327408|NCT02285920|101094245|FG001|Overall Study|Change to peritoneal dialysis|0|||
33327409|NCT02285920|101094246|FG002|Overall Study|Change to peritoneal dialysis|1|||
33327410|NCT02285920|101094247|FG003|Overall Study|Change to peritoneal dialysis|0|||
33327411|NCT02285920|101094244|FG000|Overall Study|Transfer to non-participating unit|0|||
33327412|NCT02285920|101094245|FG001|Overall Study|Transfer to non-participating unit|1|||
33400841|NCT00266695|101356819|FG000|Overall Study|Adverse Event|1|||
33400842|NCT00266695|101356819|FG000|Overall Study|Death|9|||
33518814|NCT00904839|101796606|FG002|Overall Study|Withdrawal by Subject|0|||
33518815|NCT00904839|101796604|FG000|Overall Study|Not treated|1|||
33518816|NCT00904839|101796605|FG001|Overall Study|Not treated|0|||
33518817|NCT00904839|101796606|FG002|Overall Study|Not treated|1|||
33518818|NCT00904839|101796604|FG000|Overall Study|Other than above|0|||
33518819|NCT00904839|101796605|FG001|Overall Study|Other than above|9|||
33518820|NCT00904839|101796606|FG002|Overall Study|Other than above|7|||
33518821|NCT04226495|101796607|FG000|Overall Study|Withdrawal by Subject|3|||
33518822|NCT04226495|101796608|FG001|Overall Study|Withdrawal by Subject|3|||
33518823|NCT04226495|101796607|FG000|Overall Study|PI discretion|3|||
33518824|NCT04226495|101796608|FG001|Overall Study|PI discretion|4|||
33518825|NCT03329248|101796609|FG000|Overall Study|Progressive Disease|6|||
33518826|NCT01032070|101796610|FG000|Overall Study|Disease progression|13|||
33518827|NCT01032070|101796611|FG001|Overall Study|Disease progression|8|||
33518828|NCT01032070|101796610|FG000|Overall Study|Medical or ethical reasons|0|||
33518829|NCT01032070|101796611|FG001|Overall Study|Medical or ethical reasons|2|||
33518830|NCT01032070|101796610|FG000|Overall Study|Withdrawal by Subject|0|||
33518831|NCT01032070|101796611|FG001|Overall Study|Withdrawal by Subject|2|||
33518832|NCT02339155|101796612|FG000|Overall Study|Adverse Event|0|||
33518833|NCT02339155|101796613|FG001|Overall Study|Adverse Event|6|||
33518834|NCT02339155|101796612|FG000|Overall Study|Death|1|||
33518835|NCT02339155|101796613|FG001|Overall Study|Death|1|||
33518836|NCT02339155|101796612|FG000|Overall Study|Lost to Follow-up|8|||
33518837|NCT02339155|101796613|FG001|Overall Study|Lost to Follow-up|9|||
33518838|NCT02339155|101796612|FG000|Overall Study|Physician Decision|2|||
33608322|NCT00620113|102115061|FG000|Overall Study|Adverse Event|3|||
33608323|NCT00620113|102115062|FG001|Overall Study|Adverse Event|2|||
33327413|NCT02285920|101094246|FG002|Overall Study|Transfer to non-participating unit|0|||
33327414|NCT02285920|101094247|FG003|Overall Study|Transfer to non-participating unit|0|||
33327415|NCT02285920|101094244|FG000|Overall Study|Dialysis discontinuation|0|||
33327416|NCT02285920|101094245|FG001|Overall Study|Dialysis discontinuation|1|||
33327417|NCT02285920|101094246|FG002|Overall Study|Dialysis discontinuation|0|||
33608324|NCT00620113|102115063|FG002|Overall Study|Adverse Event|2|||
33608325|NCT00620113|102115064|FG003|Overall Study|Adverse Event|1|||
33327418|NCT02285920|101094247|FG003|Overall Study|Dialysis discontinuation|0|||
33518839|NCT02339155|101796613|FG001|Overall Study|Physician Decision|1|||
33608326|NCT00620113|102115061|FG000|Overall Study|Lack of Efficacy|2|||
33327419|NCT02285920|101094244|FG000|Overall Study|Death|2|||
33400843|NCT00266695|101356819|FG000|Overall Study|Physician Decision|1|||
33400844|NCT00266695|101356819|FG000|Overall Study|Lost to Follow-up|3|||
33608327|NCT00620113|102115062|FG001|Overall Study|Lack of Efficacy|3|||
33518840|NCT02339155|101796612|FG000|Overall Study|Withdrawal by Subject|4|||
33518841|NCT02339155|101796613|FG001|Overall Study|Withdrawal by Subject|4|||
33400845|NCT00266695|101356819|FG000|Overall Study|Withdrawal by Subject|15|||
33400846|NCT01957111|101356820|FG000|Overall Study|Withdrawal by Subject|1|||
33400847|NCT01957111|101356821|FG001|Overall Study|Withdrawal by Subject|1|||
33400848|NCT03818399|101356823|FG000|Overall Study|Lost to Follow-up|11|||
33400849|NCT03818399|101356823|FG000|Overall Study|Withdrawal by Subject|1|||
33518842|NCT01249833|101796614|FG000|Overall Study|Lost to Follow-up|0|||
33518843|NCT01249833|101796615|FG001|Overall Study|Lost to Follow-up|1|||
33518844|NCT01451554|101796618|FG000|Overall Study|Withdrawal by Subject|14|||
33518845|NCT01451554|101796619|FG001|Overall Study|Withdrawal by Subject|9|||
33518846|NCT03226678|101796620|FG000|Part A (Core Study Phase)|Adverse Event|0|||
33518847|NCT03226678|101796621|FG001|Part A (Core Study Phase)|Adverse Event|1|||
33518848|NCT03226678|101796622|FG002|Part A (Core Study Phase)|Adverse Event|0|||
33518849|NCT03226678|101796623|FG003|Part A (Core Study Phase)|Adverse Event|0|||
33518850|NCT03226678|101796624|FG004|Part A (Core Study Phase)|Adverse Event|0|||
33518851|NCT03226678|101796625|FG005|Part A (Core Study Phase)|Adverse Event|0|||
33518852|NCT03226678|101796620|FG000|Part A (Core Study Phase)|Death|0|||
33518853|NCT03226678|101796621|FG001|Part A (Core Study Phase)|Death|0|||
33400850|NCT03818399|101356823|FG000|Overall Study|Protocol Violation|2|||
33400851|NCT02576652|101356825|FG000|Overall Study|Withdrawal by Subject|2|||
33400852|NCT01849289|101356828|FG000|Overall Study|Adverse Event|3|||
33400853|NCT01849289|101356829|FG001|Overall Study|Adverse Event|3|||
33400854|NCT01849289|101356828|FG000|Overall Study|Protocol Violation|3|||
33400855|NCT01849289|101356829|FG001|Overall Study|Protocol Violation|3|||
33400856|NCT01849289|101356828|FG000|Overall Study|Withdrawal criteria|1|||
33400857|NCT01849289|101356829|FG001|Overall Study|Withdrawal criteria|0|||
33400858|NCT01849289|101356828|FG000|Overall Study|Unclassified|25|||
33400859|NCT01849289|101356829|FG001|Overall Study|Unclassified|18|||
33518854|NCT03226678|101796622|FG002|Part A (Core Study Phase)|Death|1|||
33518855|NCT03226678|101796623|FG003|Part A (Core Study Phase)|Death|0|||
33518856|NCT03226678|101796624|FG004|Part A (Core Study Phase)|Death|0|||
33518857|NCT03226678|101796625|FG005|Part A (Core Study Phase)|Death|0|||
33518858|NCT03226678|101796620|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
33518859|NCT03226678|101796621|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
33400860|NCT00732199|101356830|FG000|Overall Study|Withdrawal by Subject|25|||
33400861|NCT00732199|101356831|FG001|Overall Study|Withdrawal by Subject|18|||
33400862|NCT00732199|101356830|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
33400863|NCT00732199|101356831|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
33400864|NCT04107935|101356835|FG000|Overall Study|Death|1|||
33400865|NCT04107935|101356836|FG001|Overall Study|Death|0|||
33400866|NCT01314261|101356844|FG000|Overall Study|Adverse Event|1|||
33400867|NCT01314261|101356845|FG001|Overall Study|Adverse Event|0|||
33400868|NCT01314261|101356846|FG002|Overall Study|Adverse Event|0|||
33400869|NCT01314261|101356847|FG003|Overall Study|Adverse Event|0|||
33400870|NCT01314261|101356844|FG000|Overall Study|Withdrawal by Subject|0|||
33400871|NCT01314261|101356845|FG001|Overall Study|Withdrawal by Subject|3|||
33400872|NCT01314261|101356846|FG002|Overall Study|Withdrawal by Subject|1|||
33400873|NCT01314261|101356847|FG003|Overall Study|Withdrawal by Subject|0|||
33400874|NCT01314261|101356844|FG000|Overall Study|Lost to Follow-up|1|||
33400875|NCT01314261|101356845|FG001|Overall Study|Lost to Follow-up|0|||
33400876|NCT01314261|101356846|FG002|Overall Study|Lost to Follow-up|2|||
33400877|NCT01314261|101356847|FG003|Overall Study|Lost to Follow-up|2|||
33400878|NCT01314261|101356844|FG000|Overall Study|Virologic Failure|0|||
33400879|NCT01314261|101356845|FG001|Overall Study|Virologic Failure|1|||
33400880|NCT01314261|101356846|FG002|Overall Study|Virologic Failure|0|||
33400881|NCT01314261|101356847|FG003|Overall Study|Virologic Failure|1|||
33400882|NCT02155712|101356852|FG000|Overall Study|Death|12|||
33400883|NCT02155712|101356853|FG001|Overall Study|Death|0|||
33400884|NCT02155712|101356852|FG000|Overall Study|Lost to Follow-up|37|||
33400885|NCT02155712|101356853|FG001|Overall Study|Lost to Follow-up|22|||
33518860|NCT03226678|101796622|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
33518861|NCT03226678|101796623|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
33400886|NCT02155712|101356852|FG000|Overall Study|Revision of device|4|||
33400887|NCT02155712|101356853|FG001|Overall Study|Revision of device|3|||
33518862|NCT03226678|101796624|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
33518863|NCT03226678|101796625|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
33518864|NCT03226678|101796620|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
33518865|NCT03226678|101796621|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
33327420|NCT02285920|101094245|FG001|Overall Study|Death|0|||
33400888|NCT02155712|101356852|FG000|Overall Study|Withdrawal by Subject|39|||
33400889|NCT02155712|101356853|FG001|Overall Study|Withdrawal by Subject|21|||
33400890|NCT02155712|101356852|FG000|Overall Study|Site termination|77|||
33400891|NCT02155712|101356853|FG001|Overall Study|Site termination|19|||
33400892|NCT02155712|101356852|FG000|Overall Study|Sponsor terminated study early|150|||
33400893|NCT02155712|101356853|FG001|Overall Study|Sponsor terminated study early|0|||
33400894|NCT02155712|101356852|FG000|Overall Study|Missed final 5-year protocol visit|0|||
33400895|NCT02155712|101356853|FG001|Overall Study|Missed final 5-year protocol visit|32|||
33400896|NCT02155712|101356852|FG000|Overall Study|Censored because surgery cancelled|6|||
33400897|NCT02155712|101356853|FG001|Overall Study|Censored because surgery cancelled|10|||
33400898|NCT02155712|101356852|FG000|Overall Study|Censored because study device was not implanted|61|||
33400899|NCT02155712|101356853|FG001|Overall Study|Censored because study device was not implanted|66|||
33400900|NCT02155712|101356852|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
33400901|NCT02155712|101356853|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
33400902|NCT00554229|101356864|FG000|Overall Study|Lost to Follow-up|3|||
33400903|NCT00554229|101356865|FG001|Overall Study|Lost to Follow-up|6|||
33400904|NCT00554229|101356864|FG000|Overall Study|Withdrawal by Subject|29|||
33518866|NCT03226678|101796622|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
33518867|NCT03226678|101796623|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
33518868|NCT03226678|101796624|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
33518869|NCT03226678|101796625|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
33518870|NCT03226678|101796620|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
33518871|NCT03226678|101796621|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
33518872|NCT03226678|101796622|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
33518873|NCT03226678|101796623|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
33518874|NCT03226678|101796624|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
33518875|NCT03226678|101796625|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
33518876|NCT03226678|101796620|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
33518877|NCT03226678|101796621|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
33518878|NCT03226678|101796622|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
33518879|NCT03226678|101796623|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
33518880|NCT03226678|101796624|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
33518881|NCT03226678|101796625|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
33518882|NCT03226678|101796620|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
33518883|NCT03226678|101796621|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
33518884|NCT03226678|101796622|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
33518885|NCT03226678|101796623|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
33518886|NCT03226678|101796624|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
33518887|NCT03226678|101796625|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
33518888|NCT03226678|101796620|FG000|Part B (Long-Term Extension Phase)|Death|0|||
33518889|NCT03226678|101796621|FG001|Part B (Long-Term Extension Phase)|Death|0|||
33518890|NCT03226678|101796622|FG002|Part B (Long-Term Extension Phase)|Death|0|||
33518891|NCT03226678|101796623|FG003|Part B (Long-Term Extension Phase)|Death|0|||
33518892|NCT03226678|101796624|FG004|Part B (Long-Term Extension Phase)|Death|0|||
33518893|NCT03226678|101796625|FG005|Part B (Long-Term Extension Phase)|Death|1|||
33518894|NCT03226678|101796620|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
33518895|NCT03226678|101796621|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
33518896|NCT03226678|101796622|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
33518897|NCT03226678|101796623|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
33518898|NCT03226678|101796624|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
33518899|NCT03226678|101796625|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
33518900|NCT03226678|101796620|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
33518901|NCT03226678|101796621|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
33518902|NCT03226678|101796622|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
33518903|NCT03226678|101796623|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
33518904|NCT03226678|101796624|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
33518905|NCT03226678|101796625|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
33518906|NCT03226678|101796620|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
33518907|NCT03226678|101796621|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
33518908|NCT03226678|101796622|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
33518909|NCT03226678|101796623|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
33518910|NCT03226678|101796624|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
33518911|NCT03226678|101796625|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
33518912|NCT02539134|101796626|FG000|Overall Study|Lost to Follow-up|1|||
33518913|NCT02539134|101796627|FG001|Overall Study|Lost to Follow-up|0|||
33518914|NCT02539134|101796628|FG002|Overall Study|Lost to Follow-up|0|||
33518915|NCT02539134|101796629|FG003|Overall Study|Lost to Follow-up|0|||
33200204|NCT02667912|100638222|FG000|Overall Study|Withdrawal by Subject|1|||
33200205|NCT02667912|100638223|FG001|Overall Study|Withdrawal by Subject|2|||
33400905|NCT00554229|101356865|FG001|Overall Study|Withdrawal by Subject|37|||
33400906|NCT00554229|101356864|FG000|Overall Study|Adverse Event|71|||
33518916|NCT02539134|101796630|FG004|Overall Study|Lost to Follow-up|0|||
33518917|NCT02539134|101796631|FG005|Overall Study|Lost to Follow-up|0|||
33518918|NCT01643798|101796632|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
33608328|NCT00620113|102115063|FG002|Overall Study|Lack of Efficacy|0|||
33400907|NCT00554229|101356865|FG001|Overall Study|Adverse Event|39|||
33608329|NCT00620113|102115064|FG003|Overall Study|Lack of Efficacy|2|||
33608330|NCT00620113|102115061|FG000|Overall Study|Physician Decision|1|||
33608331|NCT00620113|102115062|FG001|Overall Study|Physician Decision|0|||
33608332|NCT00620113|102115063|FG002|Overall Study|Physician Decision|0|||
33608333|NCT00620113|102115064|FG003|Overall Study|Physician Decision|2|||
33608334|NCT00620113|102115061|FG000|Overall Study|Protocol Violation|2|||
33608335|NCT00620113|102115062|FG001|Overall Study|Protocol Violation|1|||
33608336|NCT00620113|102115063|FG002|Overall Study|Protocol Violation|0|||
33608337|NCT00620113|102115064|FG003|Overall Study|Protocol Violation|0|||
33608338|NCT00620113|102115061|FG000|Overall Study|Withdrawal by Subject|5|||
33608339|NCT00620113|102115062|FG001|Overall Study|Withdrawal by Subject|1|||
33608340|NCT00620113|102115063|FG002|Overall Study|Withdrawal by Subject|3|||
33608341|NCT00620113|102115064|FG003|Overall Study|Withdrawal by Subject|5|||
33608342|NCT01571453|102115067|FG000|Overall Study|Adverse Event|14|||
33608343|NCT01571453|102115068|FG001|Overall Study|Adverse Event|32|||
33608344|NCT01571453|102115067|FG000|Overall Study|Lack of Efficacy|8|||
33608345|NCT01571453|102115068|FG001|Overall Study|Lack of Efficacy|3|||
33608346|NCT01571453|102115067|FG000|Overall Study|Non-compliance|2|||
33608347|NCT01571453|102115068|FG001|Overall Study|Non-compliance|4|||
33608348|NCT01571453|102115067|FG000|Overall Study|Protocol Violation|1|||
33608349|NCT01571453|102115068|FG001|Overall Study|Protocol Violation|5|||
33518919|NCT01643798|101796633|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
33518920|NCT02607280|101796634|FG000|Overall Study|Adverse Event|4|||
33518921|NCT02607280|101796635|FG001|Overall Study|Adverse Event|0|||
33518922|NCT02607280|101796634|FG000|Overall Study|Decrease in CrCl <15|0|||
33518923|NCT02607280|101796635|FG001|Overall Study|Decrease in CrCl <15|1|||
33518924|NCT00829829|101796638|FG000|Overall Study|Protocol Violation|0|||
33518925|NCT00829829|101796639|FG001|Overall Study|Protocol Violation|3|||
33518926|NCT00829829|101796640|FG002|Overall Study|Protocol Violation|0|||
33518927|NCT00829829|101796638|FG000|Overall Study|Adverse Event|4|||
33518928|NCT00829829|101796639|FG001|Overall Study|Adverse Event|4|||
33518929|NCT00829829|101796640|FG002|Overall Study|Adverse Event|3|||
33518930|NCT00829829|101796638|FG000|Overall Study|Withdrawal by Subject|8|||
33518931|NCT00829829|101796639|FG001|Overall Study|Withdrawal by Subject|4|||
33518932|NCT00829829|101796640|FG002|Overall Study|Withdrawal by Subject|2|||
33518933|NCT00829829|101796638|FG000|Overall Study|Decision by the Sponsor|1|||
33518934|NCT00829829|101796639|FG001|Overall Study|Decision by the Sponsor|0|||
33518935|NCT00829829|101796640|FG002|Overall Study|Decision by the Sponsor|2|||
33518936|NCT00829829|101796638|FG000|Overall Study|Lost to Follow-up|7|||
33518937|NCT00829829|101796639|FG001|Overall Study|Lost to Follow-up|3|||
33518938|NCT00829829|101796640|FG002|Overall Study|Lost to Follow-up|3|||
33518939|NCT00829829|101796638|FG000|Overall Study|Other than specified above|2|||
33518940|NCT00829829|101796639|FG001|Overall Study|Other than specified above|2|||
33518941|NCT00829829|101796640|FG002|Overall Study|Other than specified above|1|||
33518942|NCT00792116|101796642|FG000|Overall Study|Lost to Follow-up|0|||
33518943|NCT00792116|101796643|FG001|Overall Study|Lost to Follow-up|1|||
33518944|NCT00792116|101796642|FG000|Overall Study|Discontnued intervention|1|||
33518945|NCT00792116|101796643|FG001|Overall Study|Discontnued intervention|0|||
33518946|NCT02634710|101796644|FG000|Overall Study|Death|4|||
33518947|NCT00524173|101796645|FG000|Overall Study|Lost to Follow-up|0|||
33518948|NCT00524173|101796646|FG001|Overall Study|Lost to Follow-up|1|||
33518949|NCT00524173|101796645|FG000|Overall Study|Death|1|||
33518950|NCT00524173|101796646|FG001|Overall Study|Death|0|||
33518951|NCT00524173|101796645|FG000|Overall Study|Had not reached endpoint at study close|4|||
33518952|NCT00524173|101796646|FG001|Overall Study|Had not reached endpoint at study close|1|||
33518953|NCT04652700|101796652|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
33518954|NCT04652700|101796653|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
33518955|NCT04652700|101796652|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
33608350|NCT01571453|102115067|FG000|Overall Study|Withdrawal of consent|5|||
33518956|NCT04652700|101796653|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
33518957|NCT04652700|101796652|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
33518958|NCT04652700|101796653|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
33518959|NCT04652700|101796652|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
33518960|NCT04652700|101796653|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
33608351|NCT01571453|102115068|FG001|Overall Study|Withdrawal of consent|13|||
33608352|NCT01571453|102115067|FG000|Overall Study|Lost to Follow-up|4|||
33608353|NCT01571453|102115068|FG001|Overall Study|Lost to Follow-up|2|||
33608354|NCT01571453|102115067|FG000|Overall Study|Administrative or other reason(s)|4|||
33608355|NCT01571453|102115068|FG001|Overall Study|Administrative or other reason(s)|3|||
33518961|NCT04652700|101796652|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
33518962|NCT04652700|101796653|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
33518963|NCT04652700|101796652|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
33518964|NCT04652700|101796653|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
33518965|NCT04652700|101796652|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
33518966|NCT04652700|101796653|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
33518967|NCT04652700|101796652|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
33518968|NCT04652700|101796653|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
33518969|NCT04652700|101796652|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
33518970|NCT04652700|101796653|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
33518971|NCT00738062|101796656|FG000|Open Label Treatment|Lack of Efficacy|5|||
33518972|NCT00738062|101796657|FG001|Open Label Treatment|Lack of Efficacy|0|||
33518973|NCT00738062|101796658|FG002|Open Label Treatment|Lack of Efficacy|0|||
33518974|NCT00738062|101796656|FG000|Open Label Treatment|Adverse Event|11|||
33518975|NCT00738062|101796657|FG001|Open Label Treatment|Adverse Event|0|||
33518976|NCT00738062|101796658|FG002|Open Label Treatment|Adverse Event|0|||
33518977|NCT00738062|101796656|FG000|Open Label Treatment|Protocol Violation|2|||
33518978|NCT00738062|101796657|FG001|Open Label Treatment|Protocol Violation|0|||
33518979|NCT00738062|101796658|FG002|Open Label Treatment|Protocol Violation|0|||
33518980|NCT00738062|101796656|FG000|Open Label Treatment|Withdrawal by Subject|9|||
33518981|NCT00738062|101796657|FG001|Open Label Treatment|Withdrawal by Subject|0|||
33518982|NCT00738062|101796658|FG002|Open Label Treatment|Withdrawal by Subject|0|||
33518983|NCT00738062|101796656|FG000|Open Label Treatment|Investigator Decision|1|||
33518984|NCT00738062|101796657|FG001|Open Label Treatment|Investigator Decision|0|||
33518985|NCT00738062|101796658|FG002|Open Label Treatment|Investigator Decision|0|||
33518986|NCT00738062|101796656|FG000|Open-Label Extension|Adverse Event|5|||
33518987|NCT00738062|101796657|FG001|Open-Label Extension|Adverse Event|0|||
33518988|NCT00738062|101796658|FG002|Open-Label Extension|Adverse Event|0|||
33518989|NCT00738062|101796656|FG000|Open-Label Extension|Physician Decision|1|||
33518990|NCT00738062|101796657|FG001|Open-Label Extension|Physician Decision|0|||
33518991|NCT00738062|101796658|FG002|Open-Label Extension|Physician Decision|0|||
33518992|NCT00738062|101796656|FG000|Open-Label Extension|Lack of Efficacy|2|||
33518993|NCT00738062|101796657|FG001|Open-Label Extension|Lack of Efficacy|0|||
33518994|NCT00738062|101796658|FG002|Open-Label Extension|Lack of Efficacy|0|||
33608356|NCT01090063|102115069|FG000|Screen|Screen Failed|4|||
33608357|NCT01090063|102115069|FG000|Treatment|Withdrawal by Subject|4|||
33608358|NCT01772576|102115070|FG000|Overall Study|Death|15|||
33608359|NCT01772576|102115070|FG000|Overall Study|Protocol Violation|1|||
33608360|NCT01772576|102115070|FG000|Overall Study|Lost to Follow-up|3|||
33608361|NCT01772576|102115070|FG000|Overall Study|Study device not used|3|||
33608362|NCT01772576|102115070|FG000|Overall Study|Adverse Event|6|||
33608363|NCT01772576|102115070|FG000|Overall Study|Withdrawal by Subject|6|||
33608364|NCT00395850|102115071|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
33608365|NCT00395850|102115072|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
33608366|NCT00395850|102115073|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
33608367|NCT00395850|102115074|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
33608368|NCT00395850|102115071|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
33608369|NCT00395850|102115072|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
33608370|NCT00395850|102115073|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
33608371|NCT00395850|102115074|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
33608372|NCT00395850|102115071|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
33608373|NCT00395850|102115072|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
33608374|NCT00395850|102115073|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
33608375|NCT00395850|102115074|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
33608376|NCT00395850|102115071|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
33608377|NCT00395850|102115072|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
33327421|NCT02285920|101094246|FG002|Overall Study|Death|2|||
33518995|NCT00738062|101796656|FG000|Open-Label Extension|Withdrawal by Subject|6|||
33608378|NCT00395850|102115073|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
33608379|NCT00395850|102115074|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
33608380|NCT00395850|102115071|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
33608381|NCT00395850|102115072|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
33608382|NCT00395850|102115073|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
33327422|NCT02285920|101094247|FG003|Overall Study|Death|1|||
33327423|NCT02665052|101094248|FG000|Overall Study|Lost to Follow-up|1|||
33518996|NCT00738062|101796657|FG001|Open-Label Extension|Withdrawal by Subject|0|||
33518997|NCT00738062|101796658|FG002|Open-Label Extension|Withdrawal by Subject|0|||
33518998|NCT00738062|101796656|FG000|Open-Label Extension|Protocol Violation|1|||
33518999|NCT00738062|101796657|FG001|Open-Label Extension|Protocol Violation|0|||
33519000|NCT00738062|101796658|FG002|Open-Label Extension|Protocol Violation|0|||
33519001|NCT00738062|101796656|FG000|Open-Label Extension|Study Terminated|2|||
33519002|NCT00738062|101796657|FG001|Open-Label Extension|Study Terminated|0|||
33519003|NCT00738062|101796658|FG002|Open-Label Extension|Study Terminated|0|||
33519004|NCT01380691|101796660|FG000|Washout (7 Days)|Protocol Violation|0|||
33519005|NCT01380691|101796661|FG001|Washout (7 Days)|Protocol Violation|0|||
33519006|NCT01380691|101796662|FG002|Washout (7 Days)|Protocol Violation|0|||
33519007|NCT01380691|101796663|FG003|Washout (7 Days)|Protocol Violation|1|||
33519008|NCT01380691|101796660|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
33519009|NCT01380691|101796661|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
33519010|NCT01380691|101796662|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
33519011|NCT01380691|101796663|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
33519012|NCT04245202|101796664|FG000|Overall Study|Lack of Efficacy|10|||
33519013|NCT04245202|101796665|FG001|Overall Study|Lack of Efficacy|1|||
33519014|NCT00986986|101796667|FG000|Overall Study|Lost to Follow-up|0|||
33519015|NCT00986986|101796668|FG001|Overall Study|Lost to Follow-up|1|||
33519016|NCT01199822|101796671|FG000|Overall Study|Investigator discontinued therapy|0|||
33519017|NCT01199822|101796672|FG001|Overall Study|Investigator discontinued therapy|1|||
33519018|NCT01199822|101796673|FG002|Overall Study|Investigator discontinued therapy|0|||
33519019|NCT01324570|101796675|FG000|Overall Study|Adverse Event|4|||
33519020|NCT01324570|101796676|FG001|Overall Study|Adverse Event|7|||
33519021|NCT01324570|101796675|FG000|Overall Study|Withdrawal by Subject|0|||
33519022|NCT01324570|101796676|FG001|Overall Study|Withdrawal by Subject|3|||
33519023|NCT01324570|101796675|FG000|Overall Study|Lack of Efficacy|0|||
33519024|NCT01324570|101796676|FG001|Overall Study|Lack of Efficacy|1|||
33519025|NCT01324570|101796675|FG000|Overall Study|Confirmed or suspected diversion|0|||
33519026|NCT01324570|101796676|FG001|Overall Study|Confirmed or suspected diversion|1|||
33519027|NCT01324570|101796675|FG000|Overall Study|Administrative|0|||
33519028|NCT01324570|101796676|FG001|Overall Study|Administrative|2|||
33519029|NCT01573754|101796677|FG000|Overall Study|Noncompliance or remission not achieved|3|||
33519030|NCT01573754|101796678|FG001|Overall Study|Noncompliance or remission not achieved|15|||
33519031|NCT00634049|101796681|FG000|Overall Study|Never received study drug|1|||
33519032|NCT00634049|101796681|FG000|Overall Study|Died prior to receiving study drug|1|||
33519033|NCT00634049|101796681|FG000|Overall Study|Screening failure|1|||
33519034|NCT02562235|101796687|FG000|Overall Study|Adverse Event|3|||
33519035|NCT00090584|101796690|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
33519036|NCT00090584|101796691|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
33519037|NCT00090584|101796690|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
33519038|NCT00090584|101796691|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
33519039|NCT03379792|101796692|FG000|Overall Study|Physician Decision|0|||
33519040|NCT03379792|101796693|FG001|Overall Study|Physician Decision|0|||
33519041|NCT03379792|101796694|FG002|Overall Study|Physician Decision|0|||
33519042|NCT03379792|101796695|FG003|Overall Study|Physician Decision|1|||
33519043|NCT03379792|101796696|FG004|Overall Study|Physician Decision|0|||
33519044|NCT03379792|101796697|FG005|Overall Study|Physician Decision|0|||
33519045|NCT03379792|101796692|FG000|Overall Study|Withdrawal by Subject|0|||
33519046|NCT03379792|101796693|FG001|Overall Study|Withdrawal by Subject|0|||
33519047|NCT03379792|101796694|FG002|Overall Study|Withdrawal by Subject|0|||
33519048|NCT03379792|101796695|FG003|Overall Study|Withdrawal by Subject|0|||
33519049|NCT03379792|101796696|FG004|Overall Study|Withdrawal by Subject|1|||
33519050|NCT03379792|101796697|FG005|Overall Study|Withdrawal by Subject|1|||
33519051|NCT02368210|101796701|FG000|Overall Study|Withdrawal by Subject|1|||
33519052|NCT02368210|101796702|FG001|Overall Study|Withdrawal by Subject|0|||
33519053|NCT02368210|101796701|FG000|Overall Study|Adverse Event|0|||
33519054|NCT02368210|101796702|FG001|Overall Study|Adverse Event|1|||
33519055|NCT02774005|101796704|FG000|Overall Study|Adverse Event|8|||
33519056|NCT02774005|101796704|FG000|Overall Study|Withdrawal by Subject|23|||
33519057|NCT02774005|101796704|FG000|Overall Study|Lost to Follow-up|7|||
33519058|NCT02774005|101796704|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
33519059|NCT02774005|101796704|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
33519060|NCT02774005|101796704|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
33519061|NCT02774005|101796704|FG000|Overall Study|Death|1|||
33519062|NCT02774005|101796704|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
33519063|NCT02774005|101796704|FG000|Overall Study|Lack of compliance with study medication|4|||
33519064|NCT02774005|101796704|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
33519065|NCT02774005|101796704|FG000|Overall Study|another study|1|||
33519066|NCT02774005|101796704|FG000|Overall Study|cardiologist imposed travel restriction|1|||
33519067|NCT02772276|101796711|FG000|Overall Study|Lost to Follow-up|0|||
33519068|NCT02772276|101796712|FG001|Overall Study|Lost to Follow-up|0|||
33519069|NCT02772276|101796713|FG002|Overall Study|Lost to Follow-up|0|||
33519070|NCT02772276|101796714|FG003|Overall Study|Lost to Follow-up|0|||
33519071|NCT02772276|101796715|FG004|Overall Study|Lost to Follow-up|0|||
33519072|NCT02772276|101796716|FG005|Overall Study|Lost to Follow-up|0|||
33608383|NCT00395850|102115074|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
33608384|NCT00395850|102115071|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
33608385|NCT00395850|102115072|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
33608386|NCT00395850|102115073|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
33608387|NCT00395850|102115074|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
33608388|NCT00395850|102115071|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
33608389|NCT00395850|102115072|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
33608390|NCT00395850|102115073|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
33608391|NCT00395850|102115074|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
33608392|NCT01555125|102115077|FG000|Induction Period|Lost to Follow-up|0|||
33608393|NCT01555125|102115078|FG001|Induction Period|Lost to Follow-up|2|||
33608394|NCT01555125|102115079|FG002|Induction Period|Lost to Follow-up|0|||
33608395|NCT01555125|102115080|FG003|Induction Period|Lost to Follow-up|0|||
33608396|NCT01555125|102115081|FG004|Induction Period|Lost to Follow-up|0|||
33608397|NCT01555125|102115077|FG000|Induction Period|Adverse Event|0|||
33608398|NCT01555125|102115078|FG001|Induction Period|Adverse Event|1|||
33327424|NCT02665052|101094249|FG001|Overall Study|Lost to Follow-up|0|||
33327425|NCT02665052|101094250|FG002|Overall Study|Lost to Follow-up|0|||
33327426|NCT02665052|101094251|FG003|Overall Study|Lost to Follow-up|0|||
33327427|NCT02665052|101094248|FG000|Overall Study|Withdrawal by Subject|1|||
33519073|NCT02772276|101796717|FG006|Overall Study|Lost to Follow-up|1|||
33519074|NCT02772276|101796718|FG007|Overall Study|Lost to Follow-up|0|||
33519075|NCT02772276|101796719|FG008|Overall Study|Lost to Follow-up|0|||
33519076|NCT02772276|101796720|FG009|Overall Study|Lost to Follow-up|0|||
33519077|NCT02772276|101796721|FG010|Overall Study|Lost to Follow-up|0|||
33519078|NCT02772276|101796722|FG011|Overall Study|Lost to Follow-up|0|||
33519079|NCT02772276|101796723|FG012|Overall Study|Lost to Follow-up|0|||
33519080|NCT02772276|101796711|FG000|Overall Study|Withdrew consent|0|||
33519081|NCT02772276|101796712|FG001|Overall Study|Withdrew consent|0|||
33519082|NCT02772276|101796713|FG002|Overall Study|Withdrew consent|0|||
33519083|NCT02772276|101796714|FG003|Overall Study|Withdrew consent|0|||
33519084|NCT02772276|101796715|FG004|Overall Study|Withdrew consent|0|||
33519085|NCT02772276|101796716|FG005|Overall Study|Withdrew consent|0|||
33519086|NCT02772276|101796717|FG006|Overall Study|Withdrew consent|0|||
33519087|NCT02772276|101796718|FG007|Overall Study|Withdrew consent|1|||
33519088|NCT02772276|101796719|FG008|Overall Study|Withdrew consent|0|||
33519089|NCT02772276|101796720|FG009|Overall Study|Withdrew consent|0|||
33519090|NCT02772276|101796721|FG010|Overall Study|Withdrew consent|0|||
33519091|NCT02772276|101796722|FG011|Overall Study|Withdrew consent|0|||
33519092|NCT02772276|101796723|FG012|Overall Study|Withdrew consent|0|||
33519093|NCT01853696|101796724|FG000|Overall Study|Withdrawal by Subject|1|||
33519094|NCT01853696|101796725|FG001|Overall Study|Withdrawal by Subject|1|||
33519095|NCT01853696|101796724|FG000|Overall Study|Lost to Follow-up|5|||
33519096|NCT01853696|101796725|FG001|Overall Study|Lost to Follow-up|4|||
33519097|NCT01254721|101796726|FG000|Overall Study|Lost to Follow-up|0|||
33519098|NCT01254721|101796727|FG001|Overall Study|Lost to Follow-up|4|||
33519099|NCT01254721|101796726|FG000|Overall Study|Lack of Efficacy|4|||
33519100|NCT01254721|101796727|FG001|Overall Study|Lack of Efficacy|2|||
33519101|NCT01254721|101796726|FG000|Overall Study|Death|0|||
33519102|NCT01254721|101796727|FG001|Overall Study|Death|1|||
33519103|NCT01254721|101796726|FG000|Overall Study|technical problum|1|||
33519104|NCT01254721|101796727|FG001|Overall Study|technical problum|0|||
33519105|NCT01254721|101796726|FG000|Overall Study|Adverse Event|2|||
33519106|NCT01254721|101796727|FG001|Overall Study|Adverse Event|3|||
33608399|NCT01555125|102115079|FG002|Induction Period|Adverse Event|0|||
33608400|NCT01555125|102115080|FG003|Induction Period|Adverse Event|0|||
33608401|NCT01555125|102115081|FG004|Induction Period|Adverse Event|1|||
33608402|NCT01555125|102115077|FG000|Induction Period|Subject / guardian decision|0|||
33200206|NCT02667912|100638222|FG000|Overall Study|Withdrawal by Subject|1|||
33519107|NCT01254721|101796726|FG000|Overall Study|Withdrawal by Subject|8|||
33519108|NCT01254721|101796727|FG001|Overall Study|Withdrawal by Subject|11|||
33519109|NCT01254721|101796726|FG000|Overall Study|Wrongly randomization|0|||
33519110|NCT01254721|101796727|FG001|Overall Study|Wrongly randomization|1|||
33200207|NCT02667912|100638223|FG001|Overall Study|Withdrawal by Subject|0|||
33200208|NCT00766415|100638224|FG000|Overall Study|Withdrawal by Subject|0|||
33519111|NCT01490697|101796728|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
33519112|NCT01490697|101796729|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
33608403|NCT01555125|102115078|FG001|Induction Period|Subject / guardian decision|0|||
33608404|NCT01555125|102115079|FG002|Induction Period|Subject / guardian decision|0|||
33327428|NCT02665052|101094249|FG001|Overall Study|Withdrawal by Subject|1|||
33519113|NCT00583102|101796734|FG000|Overall Study|Adverse Event|3|||
33519114|NCT00096993|101796739|FG000|Overall Study|Death|1|||
33519115|NCT00096993|101796740|FG001|Overall Study|Death|0|||
33519116|NCT00096993|101796739|FG000|Overall Study|Disease progression|56|||
33519117|NCT00096993|101796740|FG001|Overall Study|Disease progression|53|||
33519118|NCT00096993|101796739|FG000|Overall Study|Adverse Event|2|||
33519119|NCT00096993|101796740|FG001|Overall Study|Adverse Event|8|||
33519120|NCT00096993|101796739|FG000|Overall Study|Subject's decision|3|||
33519121|NCT00096993|101796740|FG001|Overall Study|Subject's decision|1|||
33519122|NCT00096993|101796739|FG000|Overall Study|Physician Decision|2|||
33519123|NCT00096993|101796740|FG001|Overall Study|Physician Decision|1|||
33519124|NCT00096993|101796739|FG000|Overall Study|Non-compliance|0|||
33519125|NCT00096993|101796740|FG001|Overall Study|Non-compliance|1|||
33519126|NCT00096993|101796739|FG000|Overall Study|Other unspecified|1|||
33519127|NCT00096993|101796740|FG001|Overall Study|Other unspecified|1|||
33519128|NCT01900431|101796745|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
33519129|NCT01900431|101796746|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
33519130|NCT01900431|101796747|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
33519131|NCT01900431|101796745|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
33519132|NCT01900431|101796746|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
33519133|NCT01900431|101796747|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
33519134|NCT01900431|101796745|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
33519135|NCT01900431|101796746|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
33519136|NCT01900431|101796747|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
33519137|NCT01900431|101796745|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
33519138|NCT01900431|101796746|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
33519139|NCT01900431|101796747|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
33519140|NCT01900431|101796745|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
33519141|NCT01900431|101796746|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
33519142|NCT01900431|101796747|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
33519143|NCT01900431|101796745|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
33519144|NCT01900431|101796746|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
33519145|NCT01900431|101796747|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
33519146|NCT01900431|101796745|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
33519147|NCT01900431|101796746|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
33519148|NCT01900431|101796747|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
33519149|NCT01900431|101796745|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
33519150|NCT01900431|101796746|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
33519151|NCT01900431|101796747|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
33519152|NCT01900431|101796745|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
33519153|NCT01900431|101796746|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
33519154|NCT01900431|101796747|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
33519155|NCT01618019|101796748|FG000|Overall Study|Withdrawal by Subject|14|||
33519156|NCT01618019|101796749|FG001|Overall Study|Withdrawal by Subject|14|||
33519157|NCT03427268|101796750|FG000|Overall Study|Progressive disease|25|||
33519158|NCT03427268|101796750|FG000|Overall Study|Never treated|2|||
33519159|NCT03427268|101796750|FG000|Overall Study|Compassionate use|1|||
33519160|NCT03427268|101796750|FG000|Overall Study|Withdrawal by Subject|1|||
33519161|NCT03427268|101796750|FG000|Overall Study|Adverse Event|3|||
33519162|NCT01752634|101796755|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
33519163|NCT01752634|101796756|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
33519164|NCT01752634|101796757|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
33519165|NCT01752634|101796758|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
33519166|NCT01752634|101796759|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
33519167|NCT01752634|101796760|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
33519168|NCT01752634|101796755|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
33519169|NCT01752634|101796756|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
33519170|NCT01752634|101796757|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
33519171|NCT01752634|101796758|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
33327429|NCT02665052|101094250|FG002|Overall Study|Withdrawal by Subject|0|||
33327430|NCT02665052|101094251|FG003|Overall Study|Withdrawal by Subject|5|||
33519172|NCT01752634|101796759|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
33519173|NCT01752634|101796760|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
33519174|NCT01752634|101796755|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
33519175|NCT01752634|101796756|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
33519176|NCT01752634|101796757|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
33519177|NCT01752634|101796758|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
33519178|NCT01752634|101796759|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
33519179|NCT01752634|101796760|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
33327431|NCT02665052|101094248|FG000|Overall Study|Adverse Event|1|||
33519180|NCT01752634|101796755|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
33519181|NCT01752634|101796756|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
33519182|NCT01752634|101796757|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
33519183|NCT01752634|101796758|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
33519184|NCT01752634|101796759|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
33519185|NCT01752634|101796760|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
33519186|NCT01752634|101796755|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
33519187|NCT01752634|101796756|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
33519188|NCT01752634|101796757|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
33519189|NCT01752634|101796758|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
33519190|NCT01752634|101796759|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
33519191|NCT01752634|101796760|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
33519192|NCT01752634|101796755|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
33519193|NCT01752634|101796756|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
33519194|NCT01752634|101796757|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
33519195|NCT01752634|101796758|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
33519196|NCT01752634|101796759|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
33519197|NCT01752634|101796760|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
33519198|NCT01752634|101796755|FG000|Week 24 to Week 260|Physician Decision|1|||
33519199|NCT01752634|101796756|FG001|Week 24 to Week 260|Physician Decision|2|||
33519200|NCT01752634|101796757|FG002|Week 24 to Week 260|Physician Decision|4|||
33519201|NCT01752634|101796758|FG003|Week 24 to Week 260|Physician Decision|2|||
33519202|NCT01752634|101796759|FG004|Week 24 to Week 260|Physician Decision|1|||
33519203|NCT01752634|101796760|FG005|Week 24 to Week 260|Physician Decision|0|||
33519204|NCT01752634|101796755|FG000|Week 24 to Week 260|Death|0|||
33519205|NCT01752634|101796756|FG001|Week 24 to Week 260|Death|1|||
33519206|NCT01752634|101796757|FG002|Week 24 to Week 260|Death|0|||
33519207|NCT01752634|101796758|FG003|Week 24 to Week 260|Death|0|||
33608405|NCT01555125|102115080|FG003|Induction Period|Subject / guardian decision|0|||
33608406|NCT01555125|102115081|FG004|Induction Period|Subject / guardian decision|2|||
33608407|NCT01555125|102115077|FG000|Induction Period|Death|1|||
33608408|NCT01555125|102115078|FG001|Induction Period|Death|0|||
33608409|NCT01555125|102115079|FG002|Induction Period|Death|0|||
33608410|NCT01555125|102115080|FG003|Induction Period|Death|0|||
33608411|NCT01555125|102115081|FG004|Induction Period|Death|0|||
33608412|NCT01555125|102115077|FG000|Maintenance Period|Adverse Event|1|||
33608413|NCT01555125|102115078|FG001|Maintenance Period|Adverse Event|1|||
33608414|NCT01555125|102115079|FG002|Maintenance Period|Adverse Event|0|||
33519208|NCT01752634|101796759|FG004|Week 24 to Week 260|Death|0|||
33519209|NCT01752634|101796760|FG005|Week 24 to Week 260|Death|0|||
33519210|NCT01752634|101796755|FG000|Week 24 to Week 260|Pregnancy|0|||
33519211|NCT01752634|101796756|FG001|Week 24 to Week 260|Pregnancy|0|||
33519212|NCT01752634|101796757|FG002|Week 24 to Week 260|Pregnancy|1|||
33519213|NCT01752634|101796758|FG003|Week 24 to Week 260|Pregnancy|0|||
33519214|NCT01752634|101796759|FG004|Week 24 to Week 260|Pregnancy|0|||
33519215|NCT01752634|101796760|FG005|Week 24 to Week 260|Pregnancy|0|||
33519216|NCT01752634|101796755|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
33519217|NCT01752634|101796756|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
33519218|NCT01752634|101796757|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
33608415|NCT01555125|102115080|FG003|Maintenance Period|Adverse Event|0|||
33519219|NCT01752634|101796758|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
33519220|NCT01752634|101796759|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
33519221|NCT01752634|101796760|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
33519222|NCT01752634|101796755|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
33608416|NCT01555125|102115081|FG004|Maintenance Period|Adverse Event|0|||
33608417|NCT01555125|102115077|FG000|Maintenance Period|Subject / guardian decision|1|||
33519223|NCT01752634|101796756|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
33608418|NCT01555125|102115078|FG001|Maintenance Period|Subject / guardian decision|2|||
33519224|NCT01752634|101796757|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
33519225|NCT01752634|101796758|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
33519226|NCT01752634|101796759|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
33519227|NCT01752634|101796760|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
33519228|NCT01752634|101796755|FG000|Week 24 to Week 260|Adverse Event|4|||
33519229|NCT01752634|101796756|FG001|Week 24 to Week 260|Adverse Event|8|||
33519230|NCT01752634|101796757|FG002|Week 24 to Week 260|Adverse Event|8|||
33519231|NCT01752634|101796758|FG003|Week 24 to Week 260|Adverse Event|4|||
33519232|NCT01752634|101796759|FG004|Week 24 to Week 260|Adverse Event|2|||
33519233|NCT01752634|101796760|FG005|Week 24 to Week 260|Adverse Event|0|||
33519234|NCT01068626|101796762|FG000|Overall Study|Adverse Event|3|||
33519235|NCT01068626|101796763|FG001|Overall Study|Adverse Event|0|||
33519236|NCT01068626|101796762|FG000|Overall Study|Withdrawal by Subject|0|||
33519237|NCT01068626|101796763|FG001|Overall Study|Withdrawal by Subject|2|||
33519238|NCT00306787|101796765|FG000|Overall Study|Discontinued without taking study drug|208|||
33519239|NCT00306787|101796766|FG001|Overall Study|Discontinued without taking study drug|215|||
33519240|NCT00306787|101796765|FG000|Overall Study|Adverse Event|1|||
33519241|NCT00306787|101796766|FG001|Overall Study|Adverse Event|1|||
33519242|NCT00306787|101796765|FG000|Overall Study|Lack of Efficacy|1|||
33519243|NCT00306787|101796766|FG001|Overall Study|Lack of Efficacy|0|||
33519244|NCT00306787|101796765|FG000|Overall Study|Protocol Violation|8|||
33519245|NCT00306787|101796766|FG001|Overall Study|Protocol Violation|10|||
33519246|NCT00306787|101796765|FG000|Overall Study|Withdrawal by Subject|2|||
33519247|NCT00306787|101796766|FG001|Overall Study|Withdrawal by Subject|9|||
33519248|NCT00306787|101796765|FG000|Overall Study|Lost to Follow-up|9|||
33519249|NCT00306787|101796766|FG001|Overall Study|Lost to Follow-up|6|||
33519250|NCT00306787|101796765|FG000|Overall Study|Administrative problems|4|||
33519251|NCT00306787|101796766|FG001|Overall Study|Administrative problems|0|||
33519252|NCT00306787|101796765|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33519253|NCT00306787|101796766|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33519254|NCT00539032|101796767|FG000|Overall Study|Withdrawal by Subject|2|||
33519255|NCT00539032|101796768|FG001|Overall Study|Withdrawal by Subject|1|||
33519256|NCT03946670|101796769|FG000|Overall Study|Progressive Disease|26|||
33519257|NCT03946670|101796770|FG001|Overall Study|Progressive Disease|23|||
33519258|NCT03946670|101796769|FG000|Overall Study|Adverse Event|7|||
33519259|NCT03946670|101796770|FG001|Overall Study|Adverse Event|9|||
33519260|NCT03946670|101796769|FG000|Overall Study|Death|5|||
33519261|NCT03946670|101796770|FG001|Overall Study|Death|6|||
33519262|NCT03946670|101796769|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
33519263|NCT03946670|101796770|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
33519264|NCT03946670|101796769|FG000|Overall Study|Subject Decision|4|||
33519265|NCT03946670|101796770|FG001|Overall Study|Subject Decision|4|||
33519266|NCT03946670|101796769|FG000|Overall Study|Physician Decision|3|||
33519267|NCT03946670|101796770|FG001|Overall Study|Physician Decision|3|||
33519268|NCT03946670|101796769|FG000|Overall Study|New Therapy for Study Indication|1|||
33519269|NCT03946670|101796770|FG001|Overall Study|New Therapy for Study Indication|0|||
33519270|NCT03946670|101796769|FG000|Overall Study|Not treated|1|||
33519271|NCT03946670|101796770|FG001|Overall Study|Not treated|1|||
33519272|NCT01237327|101796771|FG000|Overall Study|Protocol Violation: Core Study|1|||
33519273|NCT01237327|101796772|FG001|Overall Study|Protocol Violation: Core Study|0|||
33519274|NCT01237327|101796771|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
33519275|NCT01237327|101796772|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
33519276|NCT01237327|101796771|FG000|Overall Study|Progression of Disease: Core Study|18|||
33519277|NCT01237327|101796772|FG001|Overall Study|Progression of Disease: Core Study|22|||
33519278|NCT01237327|101796771|FG000|Overall Study|Progression of Disease: Extension Study|15|||
33519279|NCT01237327|101796772|FG001|Overall Study|Progression of Disease: Extension Study|13|||
33519280|NCT01237327|101796771|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
33519281|NCT01237327|101796772|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
33519282|NCT01237327|101796771|FG000|Overall Study|Withdrawal by Subject|1|||
33519283|NCT01237327|101796772|FG001|Overall Study|Withdrawal by Subject|3|||
33519284|NCT01237327|101796771|FG000|Overall Study|Lost to Follow-up|3|||
33519285|NCT01237327|101796772|FG001|Overall Study|Lost to Follow-up|0|||
33200209|NCT00766415|100638225|FG001|Overall Study|Withdrawal by Subject|1|||
33519286|NCT00932451|101796780|FG000|Overall Study|Withdrawal by Subject|69|||
33519287|NCT00932451|101796780|FG000|Overall Study|Lost to Follow-up|22|||
33519288|NCT00932451|101796780|FG000|Overall Study|Death|726|||
33519289|NCT00932451|101796780|FG000|Overall Study|Other reasons|5|||
33519290|NCT02612610|101796781|FG000|Overall Study|Withdrawal by Subject|1|||
33519291|NCT02612610|101796782|FG001|Overall Study|Withdrawal by Subject|1|||
33519292|NCT02612610|101796783|FG002|Overall Study|Withdrawal by Subject|0|||
33519293|NCT02612610|101796784|FG003|Overall Study|Withdrawal by Subject|2|||
33519294|NCT02612610|101796781|FG000|Overall Study|Adverse Event|2|||
33519295|NCT02612610|101796782|FG001|Overall Study|Adverse Event|2|||
33519296|NCT02612610|101796783|FG002|Overall Study|Adverse Event|3|||
33519297|NCT02612610|101796784|FG003|Overall Study|Adverse Event|10|||
33519298|NCT02612610|101796781|FG000|Overall Study|Lost to Follow-up|0|||
33519299|NCT02612610|101796782|FG001|Overall Study|Lost to Follow-up|1|||
33519300|NCT02612610|101796783|FG002|Overall Study|Lost to Follow-up|0|||
33519301|NCT02612610|101796784|FG003|Overall Study|Lost to Follow-up|0|||
33519302|NCT02612610|101796781|FG000|Overall Study|Protocol Violation|0|||
33519303|NCT02612610|101796782|FG001|Overall Study|Protocol Violation|1|||
33519304|NCT02612610|101796783|FG002|Overall Study|Protocol Violation|1|||
33519305|NCT02612610|101796784|FG003|Overall Study|Protocol Violation|0|||
33519306|NCT02612610|101796781|FG000|Overall Study|Lack of Efficacy|1|||
33519307|NCT02612610|101796782|FG001|Overall Study|Lack of Efficacy|2|||
33519308|NCT02612610|101796783|FG002|Overall Study|Lack of Efficacy|0|||
33519309|NCT02612610|101796784|FG003|Overall Study|Lack of Efficacy|1|||
33608419|NCT01555125|102115079|FG002|Maintenance Period|Subject / guardian decision|0|||
33608420|NCT01555125|102115080|FG003|Maintenance Period|Subject / guardian decision|0|||
33519310|NCT02612610|101796781|FG000|Overall Study|Physician Decision|0|||
33519311|NCT02612610|101796782|FG001|Overall Study|Physician Decision|1|||
33519312|NCT02612610|101796783|FG002|Overall Study|Physician Decision|0|||
33519313|NCT02612610|101796784|FG003|Overall Study|Physician Decision|0|||
33519314|NCT02612610|101796781|FG000|Overall Study|Noncompliance|1|||
33519315|NCT02612610|101796782|FG001|Overall Study|Noncompliance|0|||
33519316|NCT02612610|101796783|FG002|Overall Study|Noncompliance|0|||
33519317|NCT02612610|101796784|FG003|Overall Study|Noncompliance|0|||
33519318|NCT02612610|101796781|FG000|Overall Study|Cough Improvement|0|||
33608421|NCT01555125|102115081|FG004|Maintenance Period|Subject / guardian decision|0|||
33608422|NCT01555125|102115077|FG000|Maintenance Period|Lost to Follow-up|2|||
33608423|NCT01555125|102115078|FG001|Maintenance Period|Lost to Follow-up|0|||
33608424|NCT01555125|102115079|FG002|Maintenance Period|Lost to Follow-up|0|||
33608425|NCT01555125|102115080|FG003|Maintenance Period|Lost to Follow-up|1|||
33200210|NCT00127608|100638236|FG000|Overall Study|VZV DNA negative|1|||
33519319|NCT02612610|101796782|FG001|Overall Study|Cough Improvement|0|||
33519320|NCT02612610|101796783|FG002|Overall Study|Cough Improvement|1|||
33519321|NCT02612610|101796784|FG003|Overall Study|Cough Improvement|0|||
33519322|NCT01702532|101796786|FG000|Overall Study|Adverse Event|0|||
33519323|NCT01702532|101796787|FG001|Overall Study|Adverse Event|1|||
33519324|NCT00431067|101796788|FG000|Overall Study|Other Adverse Event|9|||
33519325|NCT00431067|101796788|FG000|Overall Study|Progressive disease|30|||
33519326|NCT00431067|101796788|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
33519327|NCT01522235|101796789|FG000|Overall Study|Physician Decision|1|||
33519328|NCT01522235|101796790|FG001|Overall Study|Physician Decision|1|||
33519329|NCT04984278|101796793|FG000|Period 1|Withdrawal by Subject|1|||
33519330|NCT04984278|101796794|FG001|Period 1|Withdrawal by Subject|0|||
33519331|NCT04984278|101796793|FG000|Period 1|Other|0|||
33519332|NCT04984278|101796794|FG001|Period 1|Other|1|||
33519333|NCT04984278|101796793|FG000|Period 2|Adverse Event|1|||
33519334|NCT04984278|101796794|FG001|Period 2|Adverse Event|0|||
33519335|NCT04984278|101796793|FG000|Period 2|Other|0|||
33519336|NCT04984278|101796794|FG001|Period 2|Other|1|||
33519337|NCT02172040|101796795|FG000|Overall Study|Adverse Event|0|||
33519338|NCT02172040|101796796|FG001|Overall Study|Adverse Event|2|||
33519339|NCT02172040|101796797|FG002|Overall Study|Adverse Event|0|||
33519340|NCT02172040|101796798|FG003|Overall Study|Adverse Event|0|||
33519341|NCT02172040|101796795|FG000|Overall Study|Protocol Violation|0|||
33519342|NCT02172040|101796796|FG001|Overall Study|Protocol Violation|1|||
33519343|NCT02172040|101796797|FG002|Overall Study|Protocol Violation|0|||
33519344|NCT02172040|101796798|FG003|Overall Study|Protocol Violation|0|||
33519345|NCT02172040|101796795|FG000|Overall Study|Withdrawal by Subject|0|||
33519346|NCT02172040|101796796|FG001|Overall Study|Withdrawal by Subject|0|||
33519347|NCT02172040|101796797|FG002|Overall Study|Withdrawal by Subject|1|||
33519348|NCT02172040|101796798|FG003|Overall Study|Withdrawal by Subject|0|||
33519349|NCT02172040|101796795|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
33608426|NCT01555125|102115081|FG004|Maintenance Period|Lost to Follow-up|0|||
33608427|NCT01555125|102115077|FG000|Maintenance Period|Lack of Efficacy|6|||
33608428|NCT01555125|102115078|FG001|Maintenance Period|Lack of Efficacy|1|||
33608429|NCT01555125|102115079|FG002|Maintenance Period|Lack of Efficacy|3|||
33200211|NCT03811912|100638239|FG000|Overall Study|Withdrew Consent|4|||
33327432|NCT02665052|101094249|FG001|Overall Study|Adverse Event|1|||
33327433|NCT02665052|101094250|FG002|Overall Study|Adverse Event|0|||
33519350|NCT02172040|101796796|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
33519351|NCT02172040|101796797|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
33519352|NCT02172040|101796798|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
33519353|NCT02172040|101796795|FG000|Overall Study|Family emergency abroad|0|||
33519354|NCT02172040|101796796|FG001|Overall Study|Family emergency abroad|0|||
33519355|NCT02172040|101796797|FG002|Overall Study|Family emergency abroad|0|||
33519356|NCT02172040|101796798|FG003|Overall Study|Family emergency abroad|1|||
33519357|NCT01877551|101796799|FG000|Overall Study|Physician Decision|0|||
33519358|NCT01877551|101796800|FG001|Overall Study|Physician Decision|1|||
33519359|NCT01714609|101796802|FG000|Overall Study|Protocol Violation|1|||
33608430|NCT01555125|102115080|FG003|Maintenance Period|Lack of Efficacy|0|||
33519360|NCT01714609|101796803|FG001|Overall Study|Protocol Violation|0|||
33519361|NCT00455520|101796804|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
33519362|NCT00455520|101796805|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
33519363|NCT00455520|101796804|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
33519364|NCT00455520|101796805|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
33519365|NCT00455520|101796804|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
33519366|NCT00455520|101796805|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
33519367|NCT00455520|101796804|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
33519368|NCT00455520|101796805|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
33519369|NCT00455520|101796804|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
33519370|NCT00455520|101796805|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
33519371|NCT00455520|101796804|FG000|Open Label Tapentadol Extended Release|All other|33|||
33519372|NCT00455520|101796805|FG001|Open Label Tapentadol Extended Release|All other|0|||
33519373|NCT00455520|101796804|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
33519374|NCT00455520|101796805|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
33519375|NCT00455520|101796804|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
33519376|NCT00455520|101796805|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
33519377|NCT00455520|101796804|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
33519378|NCT00455520|101796805|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
33519379|NCT00455520|101796804|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
33519380|NCT00455520|101796805|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
33519381|NCT00455520|101796804|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
33519382|NCT00455520|101796805|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
33519383|NCT00455520|101796804|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
33519384|NCT00455520|101796805|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
33519385|NCT03617861|101796806|FG000|Second Intervention (1 Day)|Adverse Event|0|||
33519386|NCT03617861|101796807|FG001|Second Intervention (1 Day)|Adverse Event|0|||
33519387|NCT03617861|101796808|FG002|Second Intervention (1 Day)|Adverse Event|1|||
33519388|NCT03617861|101796809|FG003|Second Intervention (1 Day)|Adverse Event|0|||
33519389|NCT02638129|101796810|FG000|Overall Study|Study terminated|28|||
33519390|NCT02638129|101796811|FG001|Overall Study|Study terminated|30|||
33519391|NCT00478699|101796818|FG000|Overall Study|Inclusion Error|1|||
33519392|NCT00478699|101796819|FG001|Overall Study|Inclusion Error|7|||
33519393|NCT00478699|101796818|FG000|Overall Study|Not receive study treatment|6|||
33519394|NCT00478699|101796819|FG001|Overall Study|Not receive study treatment|30|||
33519395|NCT05119569|101800050|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
33519396|NCT05119569|101800051|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
33519397|NCT05119569|101800052|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
33519398|NCT05119569|101800053|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
33519399|NCT05119569|101800050|FG000|Double Blind Treatment Phase|Adverse Event|6|||
33519400|NCT05119569|101800051|FG001|Double Blind Treatment Phase|Adverse Event|0|||
33519401|NCT05119569|101800052|FG002|Double Blind Treatment Phase|Adverse Event|0|||
33519402|NCT05119569|101800053|FG003|Double Blind Treatment Phase|Adverse Event|0|||
33519403|NCT05119569|101800050|FG000|Open Label Extension Phase|Ongoing in the study|0|||
33519404|NCT05119569|101800051|FG001|Open Label Extension Phase|Ongoing in the study|0|||
33519405|NCT05119569|101800052|FG002|Open Label Extension Phase|Ongoing in the study|65|||
33519406|NCT05119569|101800053|FG003|Open Label Extension Phase|Ongoing in the study|34|||
33519407|NCT03913104|101800061|FG000|Overall Study|Lost to Follow-up|20|||
33519408|NCT03913104|101800061|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
33519409|NCT03913104|101800061|FG000|Overall Study|Withdrawal by Subject|2|||
33519410|NCT00958412|101800062|FG000|Overall Study|Study prematurely terminated|18|||
33519411|NCT03535194|101800066|FG000|Induction Period|Adverse Event|2|||
33519412|NCT03535194|101800067|FG001|Induction Period|Adverse Event|2|||
33519413|NCT03535194|101800068|FG002|Induction Period|Adverse Event|1|||
33519414|NCT03535194|101800069|FG003|Induction Period|Adverse Event|3|||
33519415|NCT03535194|101800070|FG004|Induction Period|Adverse Event|0|||
33519416|NCT03535194|101800066|FG000|Induction Period|Death|0|||
33519417|NCT03535194|101800067|FG001|Induction Period|Death|1|||
33519418|NCT03535194|101800068|FG002|Induction Period|Death|0|||
33519419|NCT03535194|101800069|FG003|Induction Period|Death|0|||
33519420|NCT03535194|101800070|FG004|Induction Period|Death|0|||
33519421|NCT03535194|101800066|FG000|Induction Period|Lack of Efficacy|1|||
33519422|NCT03535194|101800067|FG001|Induction Period|Lack of Efficacy|3|||
33519423|NCT03535194|101800068|FG002|Induction Period|Lack of Efficacy|2|||
33519424|NCT03535194|101800069|FG003|Induction Period|Lack of Efficacy|2|||
33519425|NCT03535194|101800070|FG004|Induction Period|Lack of Efficacy|0|||
33519426|NCT03535194|101800066|FG000|Induction Period|Lost to Follow-up|3|||
33519427|NCT03535194|101800067|FG001|Induction Period|Lost to Follow-up|5|||
33519428|NCT03535194|101800068|FG002|Induction Period|Lost to Follow-up|2|||
33519429|NCT03535194|101800069|FG003|Induction Period|Lost to Follow-up|3|||
33200212|NCT03811912|100638240|FG001|Overall Study|Withdrew Consent|2|||
33608431|NCT01555125|102115081|FG004|Maintenance Period|Lack of Efficacy|0|||
33608432|NCT01555125|102115077|FG000|Maintenance Period|Physician Decision|0|||
33608433|NCT01555125|102115078|FG001|Maintenance Period|Physician Decision|0|||
33608434|NCT01555125|102115079|FG002|Maintenance Period|Physician Decision|1|||
33608435|NCT01555125|102115080|FG003|Maintenance Period|Physician Decision|0|||
33608436|NCT01555125|102115081|FG004|Maintenance Period|Physician Decision|0|||
33608437|NCT01555125|102115077|FG000|Maintenance Period|Death|0|||
33608438|NCT01555125|102115078|FG001|Maintenance Period|Death|0|||
33608439|NCT01555125|102115079|FG002|Maintenance Period|Death|0|||
33608440|NCT01555125|102115080|FG003|Maintenance Period|Death|1|||
33608441|NCT01555125|102115081|FG004|Maintenance Period|Death|0|||
33608442|NCT01555125|102115077|FG000|Extension|Adverse Event|1|||
33608443|NCT01555125|102115078|FG001|Extension|Adverse Event|2|||
33608444|NCT01555125|102115079|FG002|Extension|Adverse Event|1|||
33608445|NCT01555125|102115080|FG003|Extension|Adverse Event|1|||
33608446|NCT01555125|102115081|FG004|Extension|Adverse Event|0|||
33608447|NCT01555125|102115077|FG000|Extension|Protocol deviation|1|||
33608448|NCT01555125|102115078|FG001|Extension|Protocol deviation|0|||
33608449|NCT01555125|102115079|FG002|Extension|Protocol deviation|0|||
33608450|NCT01555125|102115080|FG003|Extension|Protocol deviation|0|||
33608451|NCT01555125|102115081|FG004|Extension|Protocol deviation|0|||
33327434|NCT02665052|101094251|FG003|Overall Study|Adverse Event|0|||
33327435|NCT01376778|101094253|FG000|Overall Study|Lost to Follow-up|3|||
33327436|NCT01376778|101094254|FG001|Overall Study|Lost to Follow-up|2|||
33327437|NCT01357655|101094256|FG000|Overall Study|Administrative Reason by Sponsor|45|||
33327438|NCT01357655|101094257|FG001|Overall Study|Administrative Reason by Sponsor|0|||
33327439|NCT01357655|101094256|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
33519430|NCT03535194|101800070|FG004|Induction Period|Lost to Follow-up|0|||
33519431|NCT03535194|101800066|FG000|Induction Period|Physician Decision|1|||
33519432|NCT03535194|101800067|FG001|Induction Period|Physician Decision|1|||
33327440|NCT01357655|101094257|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33327441|NCT01357655|101094256|FG000|Overall Study|Disease Progression|1|||
33519433|NCT03535194|101800068|FG002|Induction Period|Physician Decision|0|||
33519434|NCT03535194|101800069|FG003|Induction Period|Physician Decision|0|||
33519435|NCT03535194|101800070|FG004|Induction Period|Physician Decision|0|||
33519436|NCT03535194|101800066|FG000|Induction Period|Protocol Violation|1|||
33519437|NCT03535194|101800067|FG001|Induction Period|Protocol Violation|0|||
33519438|NCT03535194|101800068|FG002|Induction Period|Protocol Violation|0|||
33519439|NCT03535194|101800069|FG003|Induction Period|Protocol Violation|1|||
33519440|NCT03535194|101800070|FG004|Induction Period|Protocol Violation|0|||
33519441|NCT03535194|101800066|FG000|Induction Period|Screen Failure|0|||
33519442|NCT03535194|101800067|FG001|Induction Period|Screen Failure|1|||
33519443|NCT03535194|101800068|FG002|Induction Period|Screen Failure|0|||
33519444|NCT03535194|101800069|FG003|Induction Period|Screen Failure|0|||
33519445|NCT03535194|101800070|FG004|Induction Period|Screen Failure|0|||
33519446|NCT03535194|101800066|FG000|Induction Period|Withdrawal by Subject|3|||
33519447|NCT03535194|101800067|FG001|Induction Period|Withdrawal by Subject|4|||
33519448|NCT03535194|101800068|FG002|Induction Period|Withdrawal by Subject|3|||
33519449|NCT03535194|101800069|FG003|Induction Period|Withdrawal by Subject|2|||
33519450|NCT03535194|101800070|FG004|Induction Period|Withdrawal by Subject|0|||
33519451|NCT03535194|101800066|FG000|Maintenance Period|Adverse Event|6|||
33519452|NCT03535194|101800067|FG001|Maintenance Period|Adverse Event|5|||
33519453|NCT03535194|101800068|FG002|Maintenance Period|Adverse Event|1|||
33327442|NCT01357655|101094257|FG001|Overall Study|Disease Progression|0|||
33327443|NCT01357655|101094256|FG000|Overall Study|Lost to Follow-up|2|||
33327444|NCT01357655|101094257|FG001|Overall Study|Lost to Follow-up|0|||
33327445|NCT01357655|101094256|FG000|Overall Study|Maximum Clinical Benefit|2|||
33519454|NCT03535194|101800069|FG003|Maintenance Period|Adverse Event|11|||
33519455|NCT03535194|101800070|FG004|Maintenance Period|Adverse Event|4|||
33519456|NCT03535194|101800066|FG000|Maintenance Period|Lack of Efficacy|3|||
33608452|NCT01555125|102115077|FG000|Extension|Lack of Efficacy|7|||
33608453|NCT01555125|102115078|FG001|Extension|Lack of Efficacy|6|||
33608454|NCT01555125|102115079|FG002|Extension|Lack of Efficacy|3|||
33519457|NCT03535194|101800067|FG001|Maintenance Period|Lack of Efficacy|2|||
33519458|NCT03535194|101800068|FG002|Maintenance Period|Lack of Efficacy|5|||
33608455|NCT01555125|102115080|FG003|Extension|Lack of Efficacy|0|||
33608456|NCT01555125|102115081|FG004|Extension|Lack of Efficacy|0|||
33608457|NCT01555125|102115077|FG000|Extension|Lost to Follow-up|2|||
33608458|NCT01555125|102115078|FG001|Extension|Lost to Follow-up|1|||
33519459|NCT03535194|101800069|FG003|Maintenance Period|Lack of Efficacy|9|||
33608459|NCT01555125|102115079|FG002|Extension|Lost to Follow-up|2|||
33327446|NCT01357655|101094257|FG001|Overall Study|Maximum Clinical Benefit|0|||
33327447|NCT01357655|101094256|FG000|Overall Study|Reason Unspecified|1|||
33519460|NCT03535194|101800070|FG004|Maintenance Period|Lack of Efficacy|0|||
33519461|NCT03535194|101800066|FG000|Maintenance Period|Lost to Follow-up|4|||
33608460|NCT01555125|102115080|FG003|Extension|Lost to Follow-up|0|||
33400908|NCT00554229|101356864|FG000|Overall Study|Protocol Violation|3|||
33400909|NCT00554229|101356865|FG001|Overall Study|Protocol Violation|3|||
33400910|NCT00554229|101356864|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
33400911|NCT00554229|101356865|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
33400912|NCT00554229|101356864|FG000|Overall Study|Randomised but no treatment received|1|||
33400913|NCT00554229|101356865|FG001|Overall Study|Randomised but no treatment received|0|||
33400914|NCT00679354|101356870|FG000|Overall Study|Death|3|||
33400915|NCT00679354|101356870|FG000|Overall Study|Lack of Efficacy|22|||
33400916|NCT00679354|101356870|FG000|Overall Study|Physician Decision|4|||
33400917|NCT00679354|101356870|FG000|Overall Study|Ineligible|1|||
33400918|NCT02807376|101356871|FG000|Overall Study|Intra-operative exclusion criteria|3|||
33400919|NCT02807376|101356872|FG001|Overall Study|Intra-operative exclusion criteria|0|||
33400920|NCT02807376|101356871|FG000|Overall Study|Lost to Follow-up|0|||
33400921|NCT02807376|101356872|FG001|Overall Study|Lost to Follow-up|1|||
33400922|NCT03452397|101356873|FG000|Overall Study|Adverse Event|1|||
33400923|NCT03452397|101356874|FG001|Overall Study|Adverse Event|0|||
33400924|NCT03452397|101356875|FG002|Overall Study|Adverse Event|0|||
33400925|NCT03452397|101356876|FG003|Overall Study|Adverse Event|0|||
33400926|NCT03452397|101356873|FG000|Overall Study|Administrative reason|0|||
33400927|NCT03452397|101356874|FG001|Overall Study|Administrative reason|0|||
33400928|NCT03452397|101356875|FG002|Overall Study|Administrative reason|1|||
33400929|NCT03452397|101356876|FG003|Overall Study|Administrative reason|1|||
33519462|NCT03535194|101800067|FG001|Maintenance Period|Lost to Follow-up|2|||
33519463|NCT03535194|101800068|FG002|Maintenance Period|Lost to Follow-up|1|||
33519464|NCT03535194|101800069|FG003|Maintenance Period|Lost to Follow-up|5|||
33519465|NCT03535194|101800070|FG004|Maintenance Period|Lost to Follow-up|2|||
33519466|NCT03535194|101800066|FG000|Maintenance Period|Other|1|||
33519467|NCT03535194|101800067|FG001|Maintenance Period|Other|2|||
33519468|NCT03535194|101800068|FG002|Maintenance Period|Other|0|||
33608461|NCT01555125|102115081|FG004|Extension|Lost to Follow-up|0|||
33608462|NCT01555125|102115077|FG000|Extension|Study terminated by sponsor|32|||
33608463|NCT01555125|102115078|FG001|Extension|Study terminated by sponsor|33|||
33608464|NCT01555125|102115079|FG002|Extension|Study terminated by sponsor|16|||
33608465|NCT01555125|102115080|FG003|Extension|Study terminated by sponsor|20|||
33608466|NCT01555125|102115081|FG004|Extension|Study terminated by sponsor|0|||
33608467|NCT01555125|102115077|FG000|Extension|Subject/guardian decision|1|||
33608468|NCT01555125|102115078|FG001|Extension|Subject/guardian decision|9|||
33608469|NCT01555125|102115079|FG002|Extension|Subject/guardian decision|1|||
33608470|NCT01555125|102115080|FG003|Extension|Subject/guardian decision|0|||
33608471|NCT01555125|102115081|FG004|Extension|Subject/guardian decision|0|||
33608472|NCT01555125|102115077|FG000|Extension|Technical Problems|1|||
33608473|NCT01555125|102115078|FG001|Extension|Technical Problems|0|||
33608474|NCT01555125|102115079|FG002|Extension|Technical Problems|0|||
33400930|NCT03452397|101356873|FG000|Overall Study|Withdrawal by Subject|0|||
33400931|NCT03452397|101356874|FG001|Overall Study|Withdrawal by Subject|0|||
33400932|NCT03452397|101356875|FG002|Overall Study|Withdrawal by Subject|1|||
33400933|NCT03452397|101356876|FG003|Overall Study|Withdrawal by Subject|0|||
33519469|NCT03535194|101800069|FG003|Maintenance Period|Other|0|||
33400934|NCT03557801|101356879|FG000|Overall Study|Protocol Violation|1|||
33400935|NCT03557801|101356880|FG001|Overall Study|Protocol Violation|0|||
33400936|NCT03557801|101356881|FG002|Overall Study|Protocol Violation|0|||
33400937|NCT03557801|101356879|FG000|Overall Study|Withdrawal by Subject|1|||
33400938|NCT03557801|101356880|FG001|Overall Study|Withdrawal by Subject|0|||
33400939|NCT03557801|101356881|FG002|Overall Study|Withdrawal by Subject|3|||
33400940|NCT03557801|101356879|FG000|Overall Study|Lost to Follow-up|0|||
33400941|NCT03557801|101356880|FG001|Overall Study|Lost to Follow-up|1|||
33400942|NCT03557801|101356881|FG002|Overall Study|Lost to Follow-up|0|||
33400943|NCT01524900|101356882|FG000|Overall Study|Lost to Follow-up|3|||
33400944|NCT01524900|101356883|FG001|Overall Study|Lost to Follow-up|12|||
33519470|NCT03535194|101800070|FG004|Maintenance Period|Other|0|||
33519471|NCT03535194|101800066|FG000|Maintenance Period|Physician Decision|1|||
33519472|NCT03535194|101800067|FG001|Maintenance Period|Physician Decision|2|||
33608475|NCT01555125|102115080|FG003|Extension|Technical Problems|1|||
33608476|NCT01555125|102115081|FG004|Extension|Technical Problems|0|||
33608477|NCT01555125|102115077|FG000|Follow-Up Period|Lost to Follow-up|1|||
33608478|NCT01555125|102115078|FG001|Follow-Up Period|Lost to Follow-up|0|||
33608479|NCT01555125|102115079|FG002|Follow-Up Period|Lost to Follow-up|0|||
33608480|NCT01555125|102115080|FG003|Follow-Up Period|Lost to Follow-up|0|||
33608481|NCT01555125|102115081|FG004|Follow-Up Period|Lost to Follow-up|0|||
33608482|NCT01555125|102115077|FG000|Follow-Up Period|Subject / guardian decision|3|||
33400945|NCT01524900|101356884|FG002|Overall Study|Lost to Follow-up|1|||
33400946|NCT01524900|101356885|FG003|Overall Study|Lost to Follow-up|0|||
33400947|NCT01524900|101356886|FG004|Overall Study|Lost to Follow-up|0|||
33400948|NCT01524900|101356882|FG000|Overall Study|Other reason than stated above|1|||
33400949|NCT01524900|101356883|FG001|Overall Study|Other reason than stated above|1|||
33400950|NCT01524900|101356884|FG002|Overall Study|Other reason than stated above|0|||
33519473|NCT03535194|101800068|FG002|Maintenance Period|Physician Decision|0|||
33519474|NCT03535194|101800069|FG003|Maintenance Period|Physician Decision|2|||
33519475|NCT03535194|101800070|FG004|Maintenance Period|Physician Decision|0|||
33519476|NCT03535194|101800066|FG000|Maintenance Period|Pregnancy|0|||
33519477|NCT03535194|101800067|FG001|Maintenance Period|Pregnancy|0|||
33519478|NCT03535194|101800068|FG002|Maintenance Period|Pregnancy|0|||
33519479|NCT03535194|101800069|FG003|Maintenance Period|Pregnancy|2|||
33519480|NCT03535194|101800070|FG004|Maintenance Period|Pregnancy|0|||
33519481|NCT03535194|101800066|FG000|Maintenance Period|Protocol Violation|0|||
33519482|NCT03535194|101800067|FG001|Maintenance Period|Protocol Violation|1|||
33519483|NCT03535194|101800068|FG002|Maintenance Period|Protocol Violation|0|||
33519484|NCT03535194|101800069|FG003|Maintenance Period|Protocol Violation|0|||
33519485|NCT03535194|101800070|FG004|Maintenance Period|Protocol Violation|0|||
33519486|NCT03535194|101800066|FG000|Maintenance Period|Withdrawal by Subject|7|||
33519487|NCT03535194|101800067|FG001|Maintenance Period|Withdrawal by Subject|2|||
33519488|NCT03535194|101800068|FG002|Maintenance Period|Withdrawal by Subject|1|||
33519489|NCT03535194|101800069|FG003|Maintenance Period|Withdrawal by Subject|8|||
33519490|NCT03535194|101800070|FG004|Maintenance Period|Withdrawal by Subject|0|||
33519491|NCT03535194|101800066|FG000|Post-Treatment Followup Period|Adverse Event|4|||
33519492|NCT03535194|101800067|FG001|Post-Treatment Followup Period|Adverse Event|5|||
33519493|NCT03535194|101800068|FG002|Post-Treatment Followup Period|Adverse Event|1|||
33519494|NCT03535194|101800069|FG003|Post-Treatment Followup Period|Adverse Event|8|||
33519495|NCT03535194|101800070|FG004|Post-Treatment Followup Period|Adverse Event|0|||
33519496|NCT03535194|101800066|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
33519497|NCT03535194|101800067|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
33519498|NCT03535194|101800068|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
33519499|NCT03535194|101800069|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
33519500|NCT03535194|101800070|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
33519501|NCT03535194|101800066|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
33519502|NCT03535194|101800067|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
33519503|NCT03535194|101800068|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
33519504|NCT03535194|101800069|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
33519505|NCT03535194|101800070|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
33519506|NCT03535194|101800066|FG000|Post-Treatment Followup Period|Other|1|||
33519507|NCT03535194|101800067|FG001|Post-Treatment Followup Period|Other|0|||
33519508|NCT03535194|101800068|FG002|Post-Treatment Followup Period|Other|0|||
33519509|NCT03535194|101800069|FG003|Post-Treatment Followup Period|Other|5|||
33519510|NCT03535194|101800070|FG004|Post-Treatment Followup Period|Other|0|||
33519511|NCT03535194|101800066|FG000|Post-Treatment Followup Period|Physician Decision|0|||
33519512|NCT03535194|101800067|FG001|Post-Treatment Followup Period|Physician Decision|2|||
33519513|NCT03535194|101800068|FG002|Post-Treatment Followup Period|Physician Decision|1|||
33519514|NCT03535194|101800069|FG003|Post-Treatment Followup Period|Physician Decision|1|||
33519515|NCT03535194|101800070|FG004|Post-Treatment Followup Period|Physician Decision|0|||
33519516|NCT03535194|101800066|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
33519517|NCT03535194|101800067|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
33519518|NCT03535194|101800068|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
33519519|NCT03535194|101800069|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
33519520|NCT03535194|101800070|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33519521|NCT01094782|101800071|FG000|Overall Study|Withdrawal by Subject|5|||
33519522|NCT01094782|101800072|FG001|Overall Study|Withdrawal by Subject|5|||
33519523|NCT01094782|101800073|FG002|Overall Study|Withdrawal by Subject|1|||
33519524|NCT01094782|101800074|FG003|Overall Study|Withdrawal by Subject|5|||
33519525|NCT01094782|101800075|FG004|Overall Study|Withdrawal by Subject|5|||
33519526|NCT01094782|101800076|FG005|Overall Study|Withdrawal by Subject|0|||
33519527|NCT01094782|101800071|FG000|Overall Study|Lost to Follow-up|1|||
33519528|NCT01094782|101800072|FG001|Overall Study|Lost to Follow-up|0|||
33519529|NCT01094782|101800073|FG002|Overall Study|Lost to Follow-up|0|||
33519530|NCT01094782|101800074|FG003|Overall Study|Lost to Follow-up|2|||
33519531|NCT01094782|101800075|FG004|Overall Study|Lost to Follow-up|1|||
33519532|NCT01094782|101800076|FG005|Overall Study|Lost to Follow-up|4|||
33519533|NCT01094782|101800071|FG000|Overall Study|Positive Drug Screen|2|||
33519534|NCT01094782|101800072|FG001|Overall Study|Positive Drug Screen|2|||
33519535|NCT01094782|101800073|FG002|Overall Study|Positive Drug Screen|1|||
33519536|NCT01094782|101800074|FG003|Overall Study|Positive Drug Screen|1|||
33519537|NCT01094782|101800075|FG004|Overall Study|Positive Drug Screen|3|||
33519538|NCT01094782|101800076|FG005|Overall Study|Positive Drug Screen|2|||
33519539|NCT01094782|101800071|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
33200213|NCT01751568|100638253|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
33519540|NCT01094782|101800072|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
33519541|NCT01094782|101800073|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
33519542|NCT01094782|101800074|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
33519543|NCT01094782|101800075|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
33519544|NCT01094782|101800076|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
33519545|NCT01094782|101800071|FG000|Overall Study|Unable to Complete Questionnaires|0|||
33519546|NCT01094782|101800072|FG001|Overall Study|Unable to Complete Questionnaires|1|||
33519547|NCT01094782|101800073|FG002|Overall Study|Unable to Complete Questionnaires|0|||
33519548|NCT01094782|101800074|FG003|Overall Study|Unable to Complete Questionnaires|0|||
33519549|NCT01094782|101800075|FG004|Overall Study|Unable to Complete Questionnaires|0|||
33519550|NCT01094782|101800076|FG005|Overall Study|Unable to Complete Questionnaires|0|||
33519551|NCT01094782|101800071|FG000|Overall Study|Healthy Subject Had Pain|0|||
33519552|NCT01094782|101800072|FG001|Overall Study|Healthy Subject Had Pain|1|||
33519553|NCT01094782|101800073|FG002|Overall Study|Healthy Subject Had Pain|0|||
33519554|NCT01094782|101800074|FG003|Overall Study|Healthy Subject Had Pain|0|||
33519555|NCT01094782|101800075|FG004|Overall Study|Healthy Subject Had Pain|0|||
33519556|NCT01094782|101800076|FG005|Overall Study|Healthy Subject Had Pain|0|||
33519557|NCT01094782|101800071|FG000|Overall Study|Hypertension|0|||
33519558|NCT01094782|101800072|FG001|Overall Study|Hypertension|0|||
33519559|NCT01094782|101800073|FG002|Overall Study|Hypertension|1|||
33519560|NCT01094782|101800074|FG003|Overall Study|Hypertension|0|||
33519561|NCT01094782|101800075|FG004|Overall Study|Hypertension|0|||
33519562|NCT01094782|101800076|FG005|Overall Study|Hypertension|0|||
33519563|NCT01094782|101800071|FG000|Overall Study|Wrong Pain Condition|0|||
33519564|NCT01094782|101800072|FG001|Overall Study|Wrong Pain Condition|0|||
33519565|NCT01094782|101800073|FG002|Overall Study|Wrong Pain Condition|0|||
33519566|NCT01094782|101800074|FG003|Overall Study|Wrong Pain Condition|2|||
33519567|NCT01094782|101800075|FG004|Overall Study|Wrong Pain Condition|1|||
33519568|NCT01094782|101800076|FG005|Overall Study|Wrong Pain Condition|1|||
33519569|NCT01094782|101800071|FG000|Overall Study|Recent Interventional Injection|0|||
33519570|NCT01094782|101800072|FG001|Overall Study|Recent Interventional Injection|0|||
33519571|NCT01094782|101800073|FG002|Overall Study|Recent Interventional Injection|0|||
33519572|NCT01094782|101800074|FG003|Overall Study|Recent Interventional Injection|0|||
33519573|NCT01094782|101800075|FG004|Overall Study|Recent Interventional Injection|0|||
33519574|NCT01094782|101800076|FG005|Overall Study|Recent Interventional Injection|1|||
33519575|NCT01094782|101800071|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
33519576|NCT01094782|101800072|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
33519577|NCT01094782|101800073|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
33327448|NCT01357655|101094257|FG001|Overall Study|Reason Unspecified|0|||
33327449|NCT01357655|101094256|FG000|Overall Study|Study Drug Toxicity|11|||
33519578|NCT01094782|101800074|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
33519579|NCT01094782|101800075|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
33519580|NCT01094782|101800076|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
33519581|NCT01094782|101800071|FG000|Overall Study|Noncompliance With Study Schedule|0|||
33519582|NCT01094782|101800072|FG001|Overall Study|Noncompliance With Study Schedule|0|||
33327450|NCT01357655|101094257|FG001|Overall Study|Study Drug Toxicity|0|||
33327451|NCT01357655|101094256|FG000|Overall Study|Subject Withdrew Consent|1|||
33327452|NCT01357655|101094257|FG001|Overall Study|Subject Withdrew Consent|0|||
33327453|NCT02982590|101094258|FG000|Overall Study|Lost to Follow-up|0|||
33327454|NCT02982590|101094259|FG001|Overall Study|Lost to Follow-up|1|||
33400951|NCT01524900|101356885|FG003|Overall Study|Other reason than stated above|0|||
33519583|NCT01094782|101800073|FG002|Overall Study|Noncompliance With Study Schedule|0|||
33519584|NCT01094782|101800074|FG003|Overall Study|Noncompliance With Study Schedule|1|||
33519585|NCT01094782|101800075|FG004|Overall Study|Noncompliance With Study Schedule|0|||
33519586|NCT01094782|101800076|FG005|Overall Study|Noncompliance With Study Schedule|0|||
33519587|NCT02636439|101800077|FG000|Overall Study|Adverse Event|2|||
33519588|NCT02636439|101800078|FG001|Overall Study|Adverse Event|2|||
33519589|NCT02636439|101800077|FG000|Overall Study|Lost to Follow-up|1|||
33519590|NCT02636439|101800078|FG001|Overall Study|Lost to Follow-up|0|||
33519591|NCT02636439|101800077|FG000|Overall Study|Non-compliance|1|||
33519592|NCT02636439|101800078|FG001|Overall Study|Non-compliance|1|||
33519593|NCT02636439|101800077|FG000|Overall Study|Personal reasons|2|||
33519594|NCT02636439|101800078|FG001|Overall Study|Personal reasons|0|||
33519595|NCT04607980|101800079|FG000|Overall Study|Adverse Event|3|||
33327455|NCT02982590|101094258|FG000|Overall Study|Death|4|||
33327456|NCT02982590|101094259|FG001|Overall Study|Death|0|||
33519596|NCT04607980|101800080|FG001|Overall Study|Adverse Event|4|||
33519597|NCT04607980|101800079|FG000|Overall Study|Death|0|||
33519598|NCT04607980|101800080|FG001|Overall Study|Death|1|||
33327457|NCT01226459|101094262|FG000|Overall Study|Adverse Event|2|||
33519599|NCT04607980|101800079|FG000|Overall Study|Withdrawal by Subject|2|||
33519600|NCT04607980|101800080|FG001|Overall Study|Withdrawal by Subject|5|||
33519601|NCT04607980|101800079|FG000|Overall Study|Lost to Follow-up|4|||
33519602|NCT04607980|101800080|FG001|Overall Study|Lost to Follow-up|8|||
33519603|NCT04607980|101800079|FG000|Overall Study|Protocol Violation|0|||
33327458|NCT01226459|101094263|FG001|Overall Study|Adverse Event|8|||
33327459|NCT01226459|101094262|FG000|Overall Study|Protocol Violation|4|||
33327460|NCT01226459|101094263|FG001|Overall Study|Protocol Violation|3|||
33327461|NCT01226459|101094262|FG000|Overall Study|Withdrawal by Subject|10|||
33327462|NCT01226459|101094263|FG001|Overall Study|Withdrawal by Subject|13|||
33327463|NCT01226459|101094262|FG000|Overall Study|Lost to Follow-up|4|||
33327464|NCT01226459|101094263|FG001|Overall Study|Lost to Follow-up|8|||
33608483|NCT01555125|102115078|FG001|Follow-Up Period|Subject / guardian decision|1|||
33608484|NCT01555125|102115079|FG002|Follow-Up Period|Subject / guardian decision|1|||
33519604|NCT04607980|101800080|FG001|Overall Study|Protocol Violation|3|||
33519605|NCT04607980|101800079|FG000|Overall Study|Other|3|||
33519606|NCT04607980|101800080|FG001|Overall Study|Other|0|||
33519607|NCT02945254|101800081|FG000|Overall Study|Lost to Follow-up|1|||
33519608|NCT02945254|101800082|FG001|Overall Study|Lost to Follow-up|0|||
33519609|NCT02945254|101800081|FG000|Overall Study|Withdrawal by Subject|1|||
33608485|NCT01555125|102115080|FG003|Follow-Up Period|Subject / guardian decision|1|||
33608486|NCT01555125|102115081|FG004|Follow-Up Period|Subject / guardian decision|0|||
33608487|NCT00599638|102115082|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
33608488|NCT00599638|102115083|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
33608489|NCT00599638|102115084|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
33608490|NCT00599638|102115085|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
33519610|NCT02945254|101800082|FG001|Overall Study|Withdrawal by Subject|0|||
33519611|NCT02223364|101800083|FG000|Overall Study|Protocol Violation|3|||
33519612|NCT02223364|101800084|FG001|Overall Study|Protocol Violation|0|||
33519613|NCT02223364|101800085|FG002|Overall Study|Protocol Violation|3|||
33519614|NCT02223364|101800083|FG000|Overall Study|subject expired before surgery|1|||
33519615|NCT02223364|101800084|FG001|Overall Study|subject expired before surgery|0|||
33519616|NCT02223364|101800085|FG002|Overall Study|subject expired before surgery|0|||
33519617|NCT02223364|101800083|FG000|Overall Study|Physician Decision|1|||
33519618|NCT02223364|101800084|FG001|Overall Study|Physician Decision|0|||
33519619|NCT02223364|101800085|FG002|Overall Study|Physician Decision|0|||
33519620|NCT01731470|101800088|FG000|Overall Study|Withdrawal by Subject|1|||
33519621|NCT01731470|101800088|FG000|Overall Study|Did not meet study criteria|1|||
33519622|NCT03004924|101800089|FG000|Overall Study|Adverse Event|6|||
33519623|NCT03004924|101800090|FG001|Overall Study|Adverse Event|5|||
33519624|NCT03004924|101800091|FG002|Overall Study|Adverse Event|10|||
33519625|NCT03004924|101800089|FG000|Overall Study|Protocol Violation|4|||
33519626|NCT03004924|101800090|FG001|Overall Study|Protocol Violation|0|||
33519627|NCT03004924|101800091|FG002|Overall Study|Protocol Violation|1|||
33519628|NCT03004924|101800089|FG000|Overall Study|Withdrawal by Subject|5|||
33519629|NCT03004924|101800090|FG001|Overall Study|Withdrawal by Subject|3|||
33519630|NCT03004924|101800091|FG002|Overall Study|Withdrawal by Subject|5|||
33519631|NCT03004924|101800089|FG000|Overall Study|Lost to Follow-up|6|||
33519632|NCT03004924|101800090|FG001|Overall Study|Lost to Follow-up|1|||
33608491|NCT00599638|102115082|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
33608492|NCT00599638|102115083|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
33608493|NCT00599638|102115084|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
33519633|NCT03004924|101800091|FG002|Overall Study|Lost to Follow-up|4|||
33519634|NCT03004924|101800089|FG000|Overall Study|Lack of Efficacy|2|||
33519635|NCT03004924|101800090|FG001|Overall Study|Lack of Efficacy|4|||
33519636|NCT03004924|101800091|FG002|Overall Study|Lack of Efficacy|2|||
33519637|NCT03004924|101800089|FG000|Overall Study|Physician Decision|1|||
33519638|NCT03004924|101800090|FG001|Overall Study|Physician Decision|0|||
33519639|NCT03004924|101800091|FG002|Overall Study|Physician Decision|1|||
33519640|NCT03004924|101800089|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33200214|NCT01751568|100638254|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
33200215|NCT01751568|100638255|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
33519641|NCT03004924|101800090|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33519642|NCT03004924|101800091|FG002|Overall Study|Withdrawal by parent/guardian|2|||
33519643|NCT03004924|101800089|FG000|Overall Study|Screen Failure|1|||
33519644|NCT03004924|101800090|FG001|Overall Study|Screen Failure|0|||
33519645|NCT03004924|101800091|FG002|Overall Study|Screen Failure|0|||
33519646|NCT03004924|101800089|FG000|Overall Study|Pregnancy|0|||
33519647|NCT03004924|101800090|FG001|Overall Study|Pregnancy|1|||
33519648|NCT03004924|101800091|FG002|Overall Study|Pregnancy|0|||
33200216|NCT00766376|100638256|FG000|Overall Study|Withdrawal by Subject|27|||
33519649|NCT03004924|101800089|FG000|Overall Study|Terminated by Sponsor|0|||
33519650|NCT03004924|101800090|FG001|Overall Study|Terminated by Sponsor|0|||
33519651|NCT03004924|101800091|FG002|Overall Study|Terminated by Sponsor|1|||
33519652|NCT03004924|101800089|FG000|Overall Study|Missed Study Visit|0|||
33519653|NCT03004924|101800090|FG001|Overall Study|Missed Study Visit|0|||
33519654|NCT03004924|101800091|FG002|Overall Study|Missed Study Visit|2|||
33519655|NCT03004924|101800089|FG000|Overall Study|HSV1 Positive|1|||
33519656|NCT03004924|101800090|FG001|Overall Study|HSV1 Positive|0|||
33519657|NCT03004924|101800091|FG002|Overall Study|HSV1 Positive|0|||
33519658|NCT00312572|101800092|FG000|Overall Study|Adverse Event|10|||
33519659|NCT00312572|101800093|FG001|Overall Study|Adverse Event|16|||
33519660|NCT00312572|101800092|FG000|Overall Study|Lost to Follow-up|1|||
33200217|NCT00659646|100638257|FG000|Overall Study|Protocol Violation|12|||
33400952|NCT01524900|101356886|FG004|Overall Study|Other reason than stated above|0|||
33519661|NCT00312572|101800093|FG001|Overall Study|Lost to Follow-up|1|||
33200218|NCT00659646|100638258|FG001|Overall Study|Protocol Violation|8|||
33200219|NCT00659646|100638257|FG000|Overall Study|Adverse Event|1|||
33519662|NCT00312572|101800092|FG000|Overall Study|Administrative|4|||
33519663|NCT00312572|101800093|FG001|Overall Study|Administrative|2|||
33519664|NCT00312572|101800092|FG000|Overall Study|Lack of Efficacy|1|||
33519665|NCT00312572|101800093|FG001|Overall Study|Lack of Efficacy|2|||
33519666|NCT00934856|101800099|FG000|Feasibility Part|Progressive disease|4|||
33519667|NCT00934856|101800100|FG001|Feasibility Part|Progressive disease|4|||
33608494|NCT00599638|102115085|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
33608495|NCT00599638|102115082|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
33608496|NCT00599638|102115083|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
33608497|NCT00599638|102115084|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
33200220|NCT00659646|100638258|FG001|Overall Study|Adverse Event|0|||
33200221|NCT00659646|100638257|FG000|Overall Study|Lost to Follow-up|1|||
33200222|NCT00659646|100638258|FG001|Overall Study|Lost to Follow-up|0|||
33519668|NCT00934856|101800101|FG002|Feasibility Part|Progressive disease|2|||
33519669|NCT00934856|101800102|FG003|Feasibility Part|Progressive disease|3|||
33519670|NCT00934856|101800103|FG004|Feasibility Part|Progressive disease|0|||
33519671|NCT00934856|101800104|FG005|Feasibility Part|Progressive disease|0|||
33519672|NCT00934856|101800099|FG000|Feasibility Part|Physician Decision|0|||
33608498|NCT00599638|102115085|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
33608499|NCT00599638|102115082|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
33608500|NCT00599638|102115083|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
33608501|NCT00599638|102115084|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
33608502|NCT00599638|102115085|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
33608503|NCT00599638|102115082|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
33608504|NCT00599638|102115083|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
33608505|NCT00599638|102115084|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
33608506|NCT00599638|102115085|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
33608507|NCT00599638|102115082|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
33608508|NCT00599638|102115083|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
33608509|NCT00599638|102115084|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
33608510|NCT00599638|102115085|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
33608511|NCT00599638|102115082|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
33519673|NCT00934856|101800100|FG001|Feasibility Part|Physician Decision|0|||
33519674|NCT00934856|101800101|FG002|Feasibility Part|Physician Decision|1|||
33519675|NCT00934856|101800102|FG003|Feasibility Part|Physician Decision|0|||
33519676|NCT00934856|101800103|FG004|Feasibility Part|Physician Decision|0|||
33519677|NCT00934856|101800104|FG005|Feasibility Part|Physician Decision|0|||
33519678|NCT00934856|101800099|FG000|Feasibility Part|Adverse Event|1|||
33519679|NCT00934856|101800100|FG001|Feasibility Part|Adverse Event|1|||
33519680|NCT00934856|101800101|FG002|Feasibility Part|Adverse Event|0|||
33519681|NCT00934856|101800102|FG003|Feasibility Part|Adverse Event|1|||
33200223|NCT00659646|100638257|FG000|Overall Study|protocol noncompliance after randomized|1|||
33200224|NCT00659646|100638258|FG001|Overall Study|protocol noncompliance after randomized|0|||
33200225|NCT00630877|100638259|FG000|Overall Study|Adverse Event|11|||
33200226|NCT00630877|100638260|FG001|Overall Study|Adverse Event|8|||
33200227|NCT00630877|100638261|FG002|Overall Study|Adverse Event|7|||
33200228|NCT00630877|100638259|FG000|Overall Study|Withdrawal by Subject|3|||
33200229|NCT00630877|100638260|FG001|Overall Study|Withdrawal by Subject|4|||
33200230|NCT00630877|100638261|FG002|Overall Study|Withdrawal by Subject|0|||
33400953|NCT01524900|101356882|FG000|Overall Study|No reason documented|2|||
33400954|NCT01524900|101356883|FG001|Overall Study|No reason documented|1|||
33608512|NCT00599638|102115083|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
33608513|NCT00599638|102115084|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
33608514|NCT00599638|102115085|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
33400955|NCT01524900|101356884|FG002|Overall Study|No reason documented|0|||
33519682|NCT00934856|101800103|FG004|Feasibility Part|Adverse Event|0|||
33327465|NCT01226459|101094262|FG000|Overall Study|Pregnancy|1|||
33327466|NCT01226459|101094263|FG001|Overall Study|Pregnancy|0|||
33327467|NCT01490450|101094264|FG000|Period 1|Lack of Efficacy|2|||
33519683|NCT00934856|101800104|FG005|Feasibility Part|Adverse Event|2|||
33519684|NCT00934856|101800099|FG000|Feasibility Part|Withdrawal by Subject|0|||
33519685|NCT00934856|101800100|FG001|Feasibility Part|Withdrawal by Subject|0|||
33519686|NCT00934856|101800101|FG002|Feasibility Part|Withdrawal by Subject|0|||
33519687|NCT00934856|101800102|FG003|Feasibility Part|Withdrawal by Subject|1|||
33327468|NCT01490450|101094265|FG001|Period 1|Lack of Efficacy|0|||
33327469|NCT01490450|101094266|FG002|Period 1|Lack of Efficacy|3|||
33327470|NCT01490450|101094267|FG003|Period 1|Lack of Efficacy|0|||
33327471|NCT01490450|101094264|FG000|Period 1|Adverse Event|0|||
33327472|NCT01490450|101094265|FG001|Period 1|Adverse Event|0|||
33327473|NCT01490450|101094266|FG002|Period 1|Adverse Event|0|||
33327474|NCT01490450|101094267|FG003|Period 1|Adverse Event|5|||
33327475|NCT01490450|101094264|FG000|Period 1|Request to discontinue treatment|1|||
33400956|NCT01524900|101356885|FG003|Overall Study|No reason documented|1|||
33400957|NCT01524900|101356886|FG004|Overall Study|No reason documented|0|||
33400958|NCT01365468|101356889|FG000|Overall Study|Physician Decision|1|||
33400959|NCT01365468|101356890|FG001|Overall Study|Physician Decision|0|||
33400960|NCT01365468|101356889|FG000|Overall Study|Disease progression|1|||
33400961|NCT01365468|101356890|FG001|Overall Study|Disease progression|0|||
33400962|NCT01365468|101356889|FG000|Overall Study|Lost to Follow-up|2|||
33327476|NCT01490450|101094265|FG001|Period 1|Request to discontinue treatment|0|||
33327477|NCT01490450|101094266|FG002|Period 1|Request to discontinue treatment|0|||
33327478|NCT01490450|101094267|FG003|Period 1|Request to discontinue treatment|0|||
33327479|NCT01490450|101094264|FG000|Period 1|Withdrawal by Subject|0|||
33327480|NCT01490450|101094265|FG001|Period 1|Withdrawal by Subject|0|||
33327481|NCT01490450|101094266|FG002|Period 1|Withdrawal by Subject|0|||
33327482|NCT01490450|101094267|FG003|Period 1|Withdrawal by Subject|3|||
33327483|NCT01490450|101094264|FG000|Period 1|No longer met study criteria|0|||
33327484|NCT01490450|101094265|FG001|Period 1|No longer met study criteria|1|||
33327485|NCT01490450|101094266|FG002|Period 1|No longer met study criteria|1|||
33400963|NCT01365468|101356890|FG001|Overall Study|Lost to Follow-up|0|||
33400964|NCT00307736|101356893|FG000|Overall Study|Adverse Event|0|||
33400965|NCT00307736|101356894|FG001|Overall Study|Adverse Event|0|||
33400966|NCT00307736|101356895|FG002|Overall Study|Adverse Event|1|||
33400967|NCT00307736|101356896|FG003|Overall Study|Adverse Event|3|||
33400968|NCT00307736|101356893|FG000|Overall Study|Withdrawal by Subject|0|||
33400969|NCT00307736|101356894|FG001|Overall Study|Withdrawal by Subject|0|||
33400970|NCT00307736|101356895|FG002|Overall Study|Withdrawal by Subject|2|||
33400971|NCT00307736|101356896|FG003|Overall Study|Withdrawal by Subject|0|||
33400972|NCT00554840|101356897|FG000|Overall Study|Physician Decision|0|||
33400973|NCT00554840|101356898|FG001|Overall Study|Physician Decision|1|||
33327486|NCT01490450|101094267|FG003|Period 1|No longer met study criteria|0|||
33327487|NCT01490450|101094264|FG000|Period 2|Lack of Efficacy|0|||
33327488|NCT01490450|101094265|FG001|Period 2|Lack of Efficacy|0|||
33327489|NCT01490450|101094266|FG002|Period 2|Lack of Efficacy|0|||
33327490|NCT01490450|101094267|FG003|Period 2|Lack of Efficacy|1|||
33327491|NCT01490450|101094264|FG000|Period 2|Adverse Event|1|||
33327492|NCT01490450|101094265|FG001|Period 2|Adverse Event|1|||
33327493|NCT01490450|101094266|FG002|Period 2|Adverse Event|0|||
33327494|NCT01490450|101094267|FG003|Period 2|Adverse Event|1|||
33327495|NCT01490450|101094264|FG000|Period 2|Withdrawal by Subject|1|||
33400974|NCT03137433|101356899|FG000|Overall Study|Withdrawal by Subject|11|||
33327496|NCT01490450|101094265|FG001|Period 2|Withdrawal by Subject|0|||
33327497|NCT01490450|101094266|FG002|Period 2|Withdrawal by Subject|0|||
33327498|NCT01490450|101094267|FG003|Period 2|Withdrawal by Subject|0|||
33327499|NCT01490450|101094264|FG000|Period 2|Lost to Follow-up|0|||
33327500|NCT01490450|101094265|FG001|Period 2|Lost to Follow-up|0|||
33327501|NCT01490450|101094266|FG002|Period 2|Lost to Follow-up|0|||
33327502|NCT01490450|101094267|FG003|Period 2|Lost to Follow-up|2|||
33327503|NCT00383084|101094268|FG000|Overall Study|Withdrawal by Subject|12|||
33327504|NCT00383084|101094269|FG001|Overall Study|Withdrawal by Subject|10|||
33327505|NCT02536313|101094270|FG000|Overall Study|Lack of Efficacy|0|||
33400975|NCT03137433|101356900|FG001|Overall Study|Withdrawal by Subject|11|||
33400976|NCT03137433|101356899|FG000|Overall Study|Lost to Follow-up|5|||
33400977|NCT03137433|101356900|FG001|Overall Study|Lost to Follow-up|6|||
33400978|NCT03137433|101356899|FG000|Overall Study|Physician Decision|2|||
33400979|NCT03137433|101356900|FG001|Overall Study|Physician Decision|0|||
33519688|NCT00934856|101800103|FG004|Feasibility Part|Withdrawal by Subject|0|||
33519689|NCT00934856|101800104|FG005|Feasibility Part|Withdrawal by Subject|1|||
33519690|NCT00934856|101800099|FG000|Extension Part|Adverse Event|0|||
33519691|NCT00934856|101800100|FG001|Extension Part|Adverse Event|0|||
33519692|NCT00934856|101800101|FG002|Extension Part|Adverse Event|0|||
33519693|NCT00934856|101800102|FG003|Extension Part|Adverse Event|1|||
33519694|NCT00934856|101800103|FG004|Extension Part|Adverse Event|4|||
33519695|NCT00934856|101800104|FG005|Extension Part|Adverse Event|4|||
33519696|NCT00934856|101800099|FG000|Extension Part|Progressive disease|0|||
33519697|NCT00934856|101800100|FG001|Extension Part|Progressive disease|0|||
33519698|NCT00934856|101800101|FG002|Extension Part|Progressive disease|0|||
33519699|NCT00934856|101800102|FG003|Extension Part|Progressive disease|1|||
33519700|NCT00934856|101800103|FG004|Extension Part|Progressive disease|0|||
33519701|NCT00934856|101800104|FG005|Extension Part|Progressive disease|0|||
33519702|NCT00934856|101800099|FG000|Extension Part|Non-compliance with drug|0|||
33400980|NCT03137433|101356899|FG000|Overall Study|Moved out of study area|1|||
33519703|NCT00934856|101800100|FG001|Extension Part|Non-compliance with drug|0|||
33519704|NCT00934856|101800101|FG002|Extension Part|Non-compliance with drug|0|||
33519705|NCT00934856|101800102|FG003|Extension Part|Non-compliance with drug|0|||
33519706|NCT00934856|101800103|FG004|Extension Part|Non-compliance with drug|0|||
33519707|NCT00934856|101800104|FG005|Extension Part|Non-compliance with drug|1|||
33519708|NCT03403621|101800109|FG000|Overall Study|Withdrawal by Subject|2|||
33608515|NCT00599638|102115082|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
33608516|NCT00599638|102115083|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
33608517|NCT00599638|102115084|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
33608518|NCT00599638|102115085|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
33608519|NCT00599638|102115082|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
33608520|NCT00599638|102115083|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
33608521|NCT00599638|102115084|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
33608522|NCT00599638|102115085|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
33608523|NCT03157037|102115086|FG000|Overall Study|Death|1|||
33608524|NCT02678923|102115087|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
33608525|NCT02678923|102115088|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
33608526|NCT02678923|102115087|FG000|Overall Study|Withdrawal by Subject|3|||
33608527|NCT02678923|102115088|FG001|Overall Study|Withdrawal by Subject|2|||
33608528|NCT02678923|102115087|FG000|Overall Study|Lost to Follow-up|1|||
33608529|NCT02678923|102115088|FG001|Overall Study|Lost to Follow-up|0|||
33608530|NCT02678923|102115087|FG000|Overall Study|Did Not Return for Study Visits|1|||
33608531|NCT02678923|102115088|FG001|Overall Study|Did Not Return for Study Visits|0|||
33519709|NCT03403621|101800110|FG001|Overall Study|Withdrawal by Subject|2|||
33519710|NCT04811664|101800118|FG000|Overall Study|Lost to Follow-up|78|||
33519711|NCT04811664|101800119|FG001|Overall Study|Lost to Follow-up|125|||
33519712|NCT04811664|101800120|FG002|Overall Study|Lost to Follow-up|46|||
33519713|NCT04811664|101800118|FG000|Overall Study|Withdrawal by Subject|39|||
33519714|NCT04811664|101800119|FG001|Overall Study|Withdrawal by Subject|76|||
33519715|NCT04811664|101800120|FG002|Overall Study|Withdrawal by Subject|12|||
33519716|NCT04811664|101800118|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
33519717|NCT04811664|101800119|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
33519718|NCT04811664|101800120|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
33519719|NCT04811664|101800118|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
33519720|NCT04811664|101800119|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
33519721|NCT04811664|101800120|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
33519722|NCT04811664|101800118|FG000|Overall Study|Protocol Violation|0|||
33519723|NCT04811664|101800119|FG001|Overall Study|Protocol Violation|5|||
33519724|NCT04811664|101800120|FG002|Overall Study|Protocol Violation|11|||
33519725|NCT04811664|101800118|FG000|Overall Study|Study Terminated by Sponsor|4|||
33519726|NCT04811664|101800119|FG001|Overall Study|Study Terminated by Sponsor|3|||
33519727|NCT04811664|101800120|FG002|Overall Study|Study Terminated by Sponsor|34|||
33519728|NCT04811664|101800118|FG000|Overall Study|Early Study Closure|3|||
33519729|NCT04811664|101800119|FG001|Overall Study|Early Study Closure|7|||
33608532|NCT01008904|102115091|FG000|Overall Study|Lost to Follow-up|1|||
33608533|NCT01008904|102115091|FG000|Overall Study|Adverse Event|2|||
33608534|NCT01008904|102115091|FG000|Overall Study|unexpected unrelated surgery|1|||
33608535|NCT01504204|102115092|FG000|Overall Study|Lost to Follow-up|1|||
33608536|NCT01504204|102115093|FG001|Overall Study|Lost to Follow-up|1|||
33608537|NCT00488826|102115094|FG000|Overall Study|Withdrawal by Subject|40|||
33608538|NCT00488826|102115095|FG001|Overall Study|Withdrawal by Subject|35|||
33608539|NCT00488826|102115096|FG002|Overall Study|Withdrawal by Subject|19|||
33608540|NCT00488826|102115094|FG000|Overall Study|Protocol Violation|0|||
33608541|NCT00488826|102115095|FG001|Overall Study|Protocol Violation|0|||
33519730|NCT04811664|101800120|FG002|Overall Study|Early Study Closure|79|||
33519731|NCT04811664|101800118|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
33519732|NCT04811664|101800119|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
33327506|NCT02536313|101094271|FG001|Overall Study|Lack of Efficacy|1|||
33327507|NCT00820950|101094284|FG000|Overall Study|Scheduling Conflict|0|||
33327508|NCT00820950|101094285|FG001|Overall Study|Scheduling Conflict|0|||
33327509|NCT00820950|101094286|FG002|Overall Study|Scheduling Conflict|0|||
33327510|NCT00820950|101094287|FG003|Overall Study|Scheduling Conflict|0|||
33327511|NCT00820950|101094288|FG004|Overall Study|Scheduling Conflict|0|||
33327512|NCT00820950|101094289|FG005|Overall Study|Scheduling Conflict|0|||
33327513|NCT00820950|101094290|FG006|Overall Study|Scheduling Conflict|1|||
33327514|NCT00820950|101094291|FG007|Overall Study|Scheduling Conflict|1|||
33327515|NCT00820950|101094292|FG008|Overall Study|Scheduling Conflict|0|||
33327516|NCT00820950|101094293|FG009|Overall Study|Scheduling Conflict|0|||
33327517|NCT00820950|101094284|FG000|Overall Study|Protocol Violation|1|||
33327518|NCT00820950|101094285|FG001|Overall Study|Protocol Violation|1|||
33327519|NCT00820950|101094286|FG002|Overall Study|Protocol Violation|0|||
33327520|NCT00820950|101094287|FG003|Overall Study|Protocol Violation|0|||
33327521|NCT00820950|101094288|FG004|Overall Study|Protocol Violation|0|||
33327522|NCT00820950|101094289|FG005|Overall Study|Protocol Violation|0|||
33327523|NCT00820950|101094290|FG006|Overall Study|Protocol Violation|0|||
33327524|NCT00820950|101094291|FG007|Overall Study|Protocol Violation|0|||
33327525|NCT00820950|101094292|FG008|Overall Study|Protocol Violation|0|||
33519733|NCT04811664|101800120|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
33519734|NCT01810783|101800122|FG000|Overall Study|Adverse Event|32|||
33519735|NCT01810783|101800122|FG000|Overall Study|Withdrawal by Subject|22|||
33519736|NCT01810783|101800122|FG000|Overall Study|Lack of Efficacy|12|||
33519737|NCT01810783|101800122|FG000|Overall Study|Lost to Follow-up|10|||
33519738|NCT01810783|101800122|FG000|Overall Study|Protocol Violation|5|||
33519739|NCT01810783|101800122|FG000|Overall Study|Non-compliance with IMP|4|||
33519740|NCT01810783|101800122|FG000|Overall Study|Adminstrative or other reason(s)|23|||
33519741|NCT01810783|101800122|FG000|Overall Study|Enrolled, not treated|1|||
33519742|NCT03796676|101800123|FG000|Overall Study|Adverse Event|2|||
33519743|NCT03796676|101800124|FG001|Overall Study|Adverse Event|1|||
33519744|NCT03796676|101800125|FG002|Overall Study|Adverse Event|2|||
33519745|NCT03796676|101800123|FG000|Overall Study|Lost to Follow-up|2|||
33519746|NCT03796676|101800124|FG001|Overall Study|Lost to Follow-up|1|||
33519747|NCT03796676|101800125|FG002|Overall Study|Lost to Follow-up|0|||
33519748|NCT03796676|101800123|FG000|Overall Study|Protocol Violation|0|||
33519749|NCT03796676|101800124|FG001|Overall Study|Protocol Violation|0|||
33519750|NCT03796676|101800125|FG002|Overall Study|Protocol Violation|1|||
33519751|NCT03796676|101800123|FG000|Overall Study|Withdrawal by Subject|1|||
33519752|NCT03796676|101800124|FG001|Overall Study|Withdrawal by Subject|1|||
33519753|NCT03796676|101800125|FG002|Overall Study|Withdrawal by Subject|0|||
33519754|NCT03796676|101800123|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
33519755|NCT03796676|101800124|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
33519756|NCT03796676|101800125|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
33519757|NCT02700698|101800130|FG000|Overall Study|Withdrawal by Subject|1|||
33519758|NCT02700698|101800131|FG001|Overall Study|Withdrawal by Subject|0|||
33519759|NCT03681184|101800132|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
33519760|NCT03681184|101800133|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
33519761|NCT05645432|101800134|FG000|Overall Study|Withdrawal by Subject|1|||
33519762|NCT01458951|101800136|FG000|Overall Study|Other|1|||
33519763|NCT01458951|101800137|FG001|Overall Study|Other|0|||
33519764|NCT01458951|101800138|FG002|Overall Study|Other|0|||
33608542|NCT00488826|102115096|FG002|Overall Study|Protocol Violation|2|||
33327526|NCT00820950|101094293|FG009|Overall Study|Protocol Violation|0|||
33327527|NCT04206020|101094296|FG000|Overall Study|Adverse Event|1|||
33327528|NCT04206020|101094297|FG001|Overall Study|Adverse Event|4|||
33327529|NCT04206020|101094296|FG000|Overall Study|Protocol Violation|2|||
33327530|NCT04206020|101094297|FG001|Overall Study|Protocol Violation|0|||
33519765|NCT01458951|101800136|FG000|Overall Study|Protocol Violation|5|||
33519766|NCT01458951|101800137|FG001|Overall Study|Protocol Violation|1|||
33519767|NCT01458951|101800138|FG002|Overall Study|Protocol Violation|0|||
33608543|NCT00488826|102115094|FG000|Overall Study|Adverse Event|9|||
33608544|NCT00488826|102115095|FG001|Overall Study|Adverse Event|15|||
33608545|NCT00488826|102115096|FG002|Overall Study|Adverse Event|4|||
33608546|NCT00488826|102115094|FG000|Overall Study|Lost to Follow-up|5|||
33608547|NCT00488826|102115095|FG001|Overall Study|Lost to Follow-up|1|||
33327531|NCT04206020|101094296|FG000|Overall Study|Withdrawal by Subject|2|||
33519768|NCT01458951|101800136|FG000|Overall Study|Withdrawal by Subject|2|||
33608548|NCT00488826|102115096|FG002|Overall Study|Lost to Follow-up|0|||
33327532|NCT04206020|101094297|FG001|Overall Study|Withdrawal by Subject|0|||
33327533|NCT04206020|101094296|FG000|Overall Study|Lost to Follow-up|2|||
33327534|NCT04206020|101094297|FG001|Overall Study|Lost to Follow-up|0|||
33327535|NCT04206020|101094296|FG000|Overall Study|Pregnancy|0|||
33327536|NCT04206020|101094297|FG001|Overall Study|Pregnancy|1|||
33327537|NCT04206020|101094296|FG000|Overall Study|Unable to attend visits|1|||
33327538|NCT04206020|101094297|FG001|Overall Study|Unable to attend visits|2|||
33327539|NCT00003702|101094304|FG000|Overall Study|Ineligible cell types|2|||
33327540|NCT00003702|101094305|FG001|Overall Study|Ineligible cell types|2|||
33327541|NCT00003702|101094304|FG000|Overall Study|Did not meet criteria for persistence|8|||
33327542|NCT00003702|101094305|FG001|Overall Study|Did not meet criteria for persistence|5|||
33327543|NCT00003702|101094304|FG000|Overall Study|WHO score > 6|2|||
33327544|NCT00003702|101094305|FG001|Overall Study|WHO score > 6|1|||
33327545|NCT00003702|101094304|FG000|Overall Study|Inadequate documentation of disease|1|||
33327546|NCT00003702|101094305|FG001|Overall Study|Inadequate documentation of disease|3|||
33519769|NCT01458951|101800137|FG001|Overall Study|Withdrawal by Subject|0|||
33519770|NCT01458951|101800138|FG002|Overall Study|Withdrawal by Subject|2|||
33519771|NCT01458951|101800136|FG000|Overall Study|Adverse Event|7|||
33519772|NCT01458951|101800137|FG001|Overall Study|Adverse Event|0|||
33519773|NCT01458951|101800138|FG002|Overall Study|Adverse Event|2|||
33519774|NCT01458951|101800136|FG000|Overall Study|Insufficient Clinical Response|17|||
33327547|NCT00003895|101094306|FG000|Overall Study|Adverse Event|4|||
33327548|NCT00003895|101094307|FG001|Overall Study|Adverse Event|0|||
33327549|NCT00003895|101094306|FG000|Overall Study|Lack of Efficacy|1|||
33327550|NCT00003895|101094307|FG001|Overall Study|Lack of Efficacy|1|||
33327551|NCT00003895|101094306|FG000|Overall Study|Patient Vacation|2|||
33327552|NCT00003895|101094307|FG001|Overall Study|Patient Vacation|0|||
33519775|NCT01458951|101800137|FG001|Overall Study|Insufficient Clinical Response|0|||
33519776|NCT01458951|101800138|FG002|Overall Study|Insufficient Clinical Response|11|||
33519777|NCT03338569|101800140|FG000|Overall Study|Physician Decision|8|||
33519778|NCT03338569|101800141|FG001|Overall Study|Physician Decision|3|||
33519779|NCT03338569|101800140|FG000|Overall Study|Withdrawal by Subject|0|||
33519780|NCT03338569|101800141|FG001|Overall Study|Withdrawal by Subject|1|||
33519781|NCT03338569|101800140|FG000|Overall Study|Lost to Follow-up|0|||
33519782|NCT03338569|101800141|FG001|Overall Study|Lost to Follow-up|1|||
33519783|NCT05020899|101800142|FG000|8 Week Follow-up|Lost to Follow-up|3|||
33519784|NCT05020899|101800143|FG001|8 Week Follow-up|Lost to Follow-up|6|||
33519785|NCT05020899|101800142|FG000|12 Week Follow-up|Lost to Follow-up|1|||
33519786|NCT05020899|101800143|FG001|12 Week Follow-up|Lost to Follow-up|0|||
33519787|NCT05020899|101800142|FG000|12 Week Follow-up|Death|0|||
33519788|NCT05020899|101800143|FG001|12 Week Follow-up|Death|1|||
33519789|NCT00586508|101800146|FG000|Overall Study|Progressive disease|52|||
33519790|NCT00586508|101800147|FG001|Overall Study|Progressive disease|8|||
33519791|NCT00586508|101800146|FG000|Overall Study|Death|0|||
33519792|NCT00586508|101800147|FG001|Overall Study|Death|1|||
33519793|NCT00586508|101800146|FG000|Overall Study|Adverse Event|12|||
33519794|NCT00586508|101800147|FG001|Overall Study|Adverse Event|4|||
33519795|NCT00586508|101800146|FG000|Overall Study|Withdrawal by Subject|4|||
33519796|NCT00586508|101800147|FG001|Overall Study|Withdrawal by Subject|0|||
33519797|NCT03747302|101800149|FG000|Overall Study|Withdrawal by Subject|1|||
33519798|NCT03747302|101800150|FG001|Overall Study|Withdrawal by Subject|2|||
33519799|NCT01651000|101800152|FG000|Overall Study|Adverse Event|2|||
33608549|NCT00488826|102115094|FG000|Overall Study|Protocol Deviations|2|||
33608550|NCT00488826|102115095|FG001|Overall Study|Protocol Deviations|1|||
33608551|NCT00488826|102115096|FG002|Overall Study|Protocol Deviations|1|||
33608552|NCT04058886|102115097|FG000|Overall Study|Withdrawal by Subject|4|||
33608553|NCT04058886|102115097|FG000|Overall Study|Inadequate deafness interpreter service|1|||
33608554|NCT01371305|102115099|FG000|Overall Study|Adverse Event|0|||
33519800|NCT01651000|101800153|FG001|Overall Study|Adverse Event|8|||
33519801|NCT01651000|101800152|FG000|Overall Study|Lost to Follow-up|3|||
33519802|NCT01651000|101800153|FG001|Overall Study|Lost to Follow-up|2|||
33519803|NCT01651000|101800152|FG000|Overall Study|Protocol Violation|0|||
33519804|NCT01651000|101800153|FG001|Overall Study|Protocol Violation|3|||
33519805|NCT01651000|101800152|FG000|Overall Study|Withdrawal by Subject|2|||
33519806|NCT01651000|101800153|FG001|Overall Study|Withdrawal by Subject|10|||
33519807|NCT01651000|101800152|FG000|Overall Study|Subject noncompliance|0|||
33519808|NCT01651000|101800153|FG001|Overall Study|Subject noncompliance|3|||
33519809|NCT01651000|101800152|FG000|Overall Study|Lack of Efficacy|1|||
33608555|NCT01371305|102115100|FG001|Overall Study|Adverse Event|0|||
33608556|NCT01371305|102115101|FG002|Overall Study|Adverse Event|0|||
33327553|NCT00003895|101094306|FG000|Overall Study|Withdrawal by Subject|0|||
33608557|NCT01371305|102115102|FG003|Overall Study|Adverse Event|2|||
33608558|NCT01371305|102115103|FG004|Overall Study|Adverse Event|1|||
33327554|NCT00003895|101094307|FG001|Overall Study|Withdrawal by Subject|3|||
33327555|NCT00175877|101094308|FG000|Overall Study|Adverse Event|136|||
33608559|NCT01371305|102115104|FG005|Overall Study|Adverse Event|0|||
33327556|NCT00175877|101094308|FG000|Overall Study|Withdrawal by Subject|141|||
33327557|NCT00175877|101094308|FG000|Overall Study|Lost to Follow-up|9|||
33327558|NCT00175877|101094308|FG000|Overall Study|Lack of Efficacy|26|||
33327559|NCT00175877|101094308|FG000|Overall Study|Protocol Violation|15|||
33519810|NCT01651000|101800153|FG001|Overall Study|Lack of Efficacy|1|||
33519811|NCT01651000|101800152|FG000|Overall Study|Physician Decision|1|||
33519812|NCT01651000|101800153|FG001|Overall Study|Physician Decision|0|||
33519813|NCT01651000|101800152|FG000|Overall Study|Administrative reason|1|||
33519814|NCT01651000|101800153|FG001|Overall Study|Administrative reason|0|||
33519815|NCT01651000|101800152|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
33519816|NCT01651000|101800153|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
33519817|NCT00380718|101800156|FG000|Overall Study|Adverse Event|1|||
33519818|NCT00380718|101800156|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
33519819|NCT01738191|101800157|FG000|Overall Study|Withdrawal by Subject|4|||
33519820|NCT01738191|101800158|FG001|Overall Study|Withdrawal by Subject|1|||
33519821|NCT02179749|101800159|FG000|Overall Study|Adverse Event|0|||
33519822|NCT02179749|101800160|FG001|Overall Study|Adverse Event|0|||
33519823|NCT02179749|101800161|FG002|Overall Study|Adverse Event|1|||
33519824|NCT02179749|101800159|FG000|Overall Study|Withdrawal by Subject|0|||
33519825|NCT02179749|101800160|FG001|Overall Study|Withdrawal by Subject|0|||
33519826|NCT02179749|101800161|FG002|Overall Study|Withdrawal by Subject|1|||
33519827|NCT02431806|101800162|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
33519828|NCT02431806|101800163|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
33519829|NCT02431806|101800164|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
33519830|NCT02431806|101800165|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
33519831|NCT02431806|101800162|FG000|Double-blind Treatment Period|Adverse Event|4|||
33519832|NCT02431806|101800163|FG001|Double-blind Treatment Period|Adverse Event|7|||
33519833|NCT02431806|101800164|FG002|Double-blind Treatment Period|Adverse Event|11|||
33519834|NCT02431806|101800165|FG003|Double-blind Treatment Period|Adverse Event|7|||
33519835|NCT02431806|101800162|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
33519836|NCT02431806|101800163|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
33519837|NCT02431806|101800164|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
33519838|NCT02431806|101800165|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
33519839|NCT02431806|101800162|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
33519840|NCT02431806|101800163|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
33519841|NCT02431806|101800164|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
33519842|NCT02431806|101800165|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
33519843|NCT02431806|101800162|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
33519844|NCT02431806|101800163|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
33519845|NCT02431806|101800164|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
33519846|NCT02431806|101800165|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
33519847|NCT02431806|101800162|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
33519848|NCT02431806|101800163|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
33519849|NCT02431806|101800164|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
33519850|NCT02431806|101800165|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
33519851|NCT02431806|101800162|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
33519852|NCT02431806|101800163|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
33519853|NCT02431806|101800164|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
33519854|NCT02431806|101800165|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
33519855|NCT00382109|101800166|FG000|Overall Study|Adverse Event|3|||
33519856|NCT00382109|101800167|FG001|Overall Study|Adverse Event|0|||
33519857|NCT00382109|101800166|FG000|Overall Study|Physician Decision|6|||
33519858|NCT00382109|101800167|FG001|Overall Study|Physician Decision|1|||
33519859|NCT00382109|101800166|FG000|Overall Study|Withdrawal by Subject|1|||
33519860|NCT00382109|101800167|FG001|Overall Study|Withdrawal by Subject|0|||
33519861|NCT00382109|101800166|FG000|Overall Study|ineligible|2|||
33519862|NCT00382109|101800167|FG001|Overall Study|ineligible|0|||
33519863|NCT00382109|101800166|FG000|Overall Study|Other|0|||
33519864|NCT00382109|101800167|FG001|Overall Study|Other|2|||
33519865|NCT00382109|101800166|FG000|Overall Study|consent withdrawal|0|||
33519866|NCT00382109|101800167|FG001|Overall Study|consent withdrawal|1|||
33519867|NCT03099694|101800170|FG000|Overall Study|Withdrawal by Subject|11|||
33519868|NCT03099694|101800171|FG001|Overall Study|Withdrawal by Subject|13|||
33519869|NCT03099694|101800170|FG000|Overall Study|Lost to Follow-up|9|||
33519870|NCT03099694|101800171|FG001|Overall Study|Lost to Follow-up|5|||
33519871|NCT02003963|101800172|FG000|Overall Study|Lost to Follow-up|2|||
33519872|NCT02003963|101800173|FG001|Overall Study|Lost to Follow-up|1|||
33519873|NCT00743288|101800177|FG000|Overall Study|Adverse Event|1|||
33519874|NCT00743288|101800178|FG001|Overall Study|Adverse Event|1|||
33519875|NCT00743288|101800179|FG002|Overall Study|Adverse Event|2|||
33519876|NCT00743288|101800180|FG003|Overall Study|Adverse Event|2|||
33519877|NCT00743288|101800181|FG004|Overall Study|Adverse Event|1|||
33519878|NCT00743288|101800182|FG005|Overall Study|Adverse Event|1|||
33519879|NCT00743288|101800183|FG006|Overall Study|Adverse Event|2|||
33519880|NCT00743288|101800177|FG000|Overall Study|Withdrawal by Subject|0|||
33519881|NCT00743288|101800178|FG001|Overall Study|Withdrawal by Subject|0|||
33519882|NCT00743288|101800179|FG002|Overall Study|Withdrawal by Subject|1|||
33519883|NCT00743288|101800180|FG003|Overall Study|Withdrawal by Subject|0|||
33519884|NCT00743288|101800181|FG004|Overall Study|Withdrawal by Subject|0|||
33519885|NCT00743288|101800182|FG005|Overall Study|Withdrawal by Subject|1|||
33608560|NCT01371305|102115099|FG000|Overall Study|Study terminated by sponsor|0|||
33519886|NCT00743288|101800183|FG006|Overall Study|Withdrawal by Subject|1|||
33519887|NCT00743288|101800177|FG000|Overall Study|Progressive disease (PD)|2|||
33608561|NCT01371305|102115100|FG001|Overall Study|Study terminated by sponsor|0|||
33608562|NCT01371305|102115101|FG002|Overall Study|Study terminated by sponsor|0|||
33608563|NCT01371305|102115102|FG003|Overall Study|Study terminated by sponsor|0|||
33608564|NCT01371305|102115103|FG004|Overall Study|Study terminated by sponsor|3|||
33608565|NCT01371305|102115104|FG005|Overall Study|Study terminated by sponsor|1|||
33608566|NCT01371305|102115099|FG000|Overall Study|Subject request|0|||
33608567|NCT01371305|102115100|FG001|Overall Study|Subject request|0|||
33608568|NCT01371305|102115101|FG002|Overall Study|Subject request|0|||
33608569|NCT01371305|102115102|FG003|Overall Study|Subject request|0|||
33608570|NCT01371305|102115103|FG004|Overall Study|Subject request|0|||
33608571|NCT01371305|102115104|FG005|Overall Study|Subject request|1|||
33608572|NCT03194438|102115105|FG000|Overall Study|Withdrawal by Subject|2|||
33608573|NCT02540993|102115106|FG000|Overall Study|Lost to Follow-up|5|||
33608574|NCT02540993|102115107|FG001|Overall Study|Lost to Follow-up|3|||
33608575|NCT02540993|102115106|FG000|Overall Study|Withdrawal by Subject|4|||
33608576|NCT02540993|102115107|FG001|Overall Study|Withdrawal by Subject|6|||
33608577|NCT02540993|102115106|FG000|Overall Study|GCP violations|33|||
33608578|NCT02540993|102115107|FG001|Overall Study|GCP violations|27|||
33400981|NCT03137433|101356900|FG001|Overall Study|Moved out of study area|0|||
33400982|NCT03137433|101356899|FG000|Overall Study|Too far out of window due to COVID|0|||
33400983|NCT03137433|101356900|FG001|Overall Study|Too far out of window due to COVID|1|||
33400984|NCT03322540|101356907|FG000|Overall Study|Death|21|||
33400985|NCT03322540|101356908|FG001|Overall Study|Death|28|||
33400986|NCT03322540|101356907|FG000|Overall Study|Lost to Follow-up|0|||
33400987|NCT03322540|101356908|FG001|Overall Study|Lost to Follow-up|1|||
33400988|NCT03322540|101356907|FG000|Overall Study|Physician Decision|7|||
33400989|NCT03322540|101356908|FG001|Overall Study|Physician Decision|6|||
33400990|NCT03322540|101356907|FG000|Overall Study|Withdrawal by Subject|3|||
33400991|NCT03322540|101356908|FG001|Overall Study|Withdrawal by Subject|1|||
33400992|NCT03322540|101356907|FG000|Overall Study|Study terminated by sponsor|0|||
33400993|NCT03322540|101356908|FG001|Overall Study|Study terminated by sponsor|1|||
33400994|NCT00959192|101356909|FG000|Overall Study|Adverse Event|1|||
33400995|NCT00959192|101356910|FG001|Overall Study|Adverse Event|1|||
33400996|NCT00959192|101356911|FG002|Overall Study|Adverse Event|1|||
33519888|NCT00743288|101800178|FG001|Overall Study|Progressive disease (PD)|0|||
33519889|NCT00743288|101800179|FG002|Overall Study|Progressive disease (PD)|1|||
33519890|NCT00743288|101800180|FG003|Overall Study|Progressive disease (PD)|4|||
33519891|NCT00743288|101800181|FG004|Overall Study|Progressive disease (PD)|5|||
33608579|NCT00695864|102115112|FG000|Placebo|Withdrawal by Subject|1|||
33608580|NCT00695864|102115112|FG000|Placebo|Physician Decision|4|||
33608581|NCT00269633|102115121|FG000|Overall Study|Withdrawal by Subject|1|||
33608582|NCT00269633|102115122|FG001|Overall Study|Withdrawal by Subject|0|||
33519892|NCT00743288|101800182|FG005|Overall Study|Progressive disease (PD)|3|||
33519893|NCT00743288|101800183|FG006|Overall Study|Progressive disease (PD)|6|||
33608583|NCT02337634|102115123|FG000|Overall Study|Protocol Violation|3|||
33327560|NCT00175877|101094308|FG000|Overall Study|Other Reason|20|||
33327561|NCT00175877|101094308|FG000|Overall Study|AE & Other|1|||
33327562|NCT00175877|101094308|FG000|Overall Study|Withdrawal by subject & Other|1|||
33327563|NCT00847145|101094309|FG000|Overall Study|AE or Death|0|||
33327564|NCT00847145|101094310|FG001|Overall Study|AE or Death|1|||
33327565|NCT00847145|101094311|FG002|Overall Study|AE or Death|1|||
33327566|NCT00847145|101094312|FG003|Overall Study|AE or Death|0|||
33327567|NCT00847145|101094313|FG004|Overall Study|AE or Death|0|||
33327568|NCT00847145|101094314|FG005|Overall Study|AE or Death|0|||
33327569|NCT00847145|101094315|FG006|Overall Study|AE or Death|0|||
33327570|NCT00847145|101094316|FG007|Overall Study|AE or Death|0|||
33327571|NCT00847145|101094309|FG000|Overall Study|Withdrawal by Subject|3|||
33327572|NCT00847145|101094310|FG001|Overall Study|Withdrawal by Subject|4|||
33400997|NCT00959192|101356912|FG003|Overall Study|Adverse Event|0|||
33400998|NCT00959192|101356909|FG000|Overall Study|Investigator Request|1|||
33519894|NCT00743288|101800177|FG000|Overall Study|Worsening of condition (Not PD)|0|||
33519895|NCT00743288|101800178|FG001|Overall Study|Worsening of condition (Not PD)|2|||
33519896|NCT00743288|101800179|FG002|Overall Study|Worsening of condition (Not PD)|1|||
33608584|NCT02337634|102115124|FG001|Overall Study|Protocol Violation|1|||
33608585|NCT02337634|102115123|FG000|Overall Study|Lost to Follow-up|1|||
33608586|NCT02337634|102115124|FG001|Overall Study|Lost to Follow-up|0|||
33608587|NCT00835341|102115125|FG000|Overall Study|Lost to Follow-up|3|||
33608588|NCT00835341|102115126|FG001|Overall Study|Lost to Follow-up|12|||
33327573|NCT00847145|101094311|FG002|Overall Study|Withdrawal by Subject|6|||
33327574|NCT00847145|101094312|FG003|Overall Study|Withdrawal by Subject|1|||
33327575|NCT00847145|101094313|FG004|Overall Study|Withdrawal by Subject|0|||
33327576|NCT00847145|101094314|FG005|Overall Study|Withdrawal by Subject|0|||
33327577|NCT00847145|101094315|FG006|Overall Study|Withdrawal by Subject|1|||
33327578|NCT00847145|101094316|FG007|Overall Study|Withdrawal by Subject|1|||
33400999|NCT00959192|101356910|FG001|Overall Study|Investigator Request|0|||
33401000|NCT00959192|101356911|FG002|Overall Study|Investigator Request|0|||
33401001|NCT00959192|101356912|FG003|Overall Study|Investigator Request|0|||
33401002|NCT00959192|101356909|FG000|Overall Study|Caregiver Request|0|||
33519897|NCT00743288|101800180|FG003|Overall Study|Worsening of condition (Not PD)|1|||
33519898|NCT00743288|101800181|FG004|Overall Study|Worsening of condition (Not PD)|0|||
33519899|NCT00743288|101800182|FG005|Overall Study|Worsening of condition (Not PD)|0|||
33519900|NCT00743288|101800183|FG006|Overall Study|Worsening of condition (Not PD)|0|||
33519901|NCT00985426|101800184|FG000|Overall Study|Adverse Event|0|||
33519902|NCT00985426|101800185|FG001|Overall Study|Adverse Event|1|||
33519903|NCT00985426|101800184|FG000|Overall Study|Subject Non-Compliance|3|||
33519904|NCT00985426|101800185|FG001|Overall Study|Subject Non-Compliance|3|||
33519905|NCT00985426|101800184|FG000|Overall Study|Withdrawal by Subject|12|||
33519906|NCT00985426|101800185|FG001|Overall Study|Withdrawal by Subject|16|||
33519907|NCT00985426|101800184|FG000|Overall Study|Lost to Follow-up|8|||
33519908|NCT00985426|101800185|FG001|Overall Study|Lost to Follow-up|10|||
33519909|NCT00985426|101800184|FG000|Overall Study|Death|7|||
33519910|NCT00985426|101800185|FG001|Overall Study|Death|3|||
33519911|NCT00985426|101800184|FG000|Overall Study|Protocol Violation|2|||
33519912|NCT00985426|101800185|FG001|Overall Study|Protocol Violation|0|||
33519913|NCT00985426|101800184|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
33519914|NCT00985426|101800185|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
33519915|NCT03564795|101800186|FG000|Overall Study|Withdrawal by Subject|3|||
33519916|NCT03564795|101800186|FG000|Overall Study|Lost to Follow-up|6|||
33519917|NCT03564795|101800186|FG000|Overall Study|Physician Decision|2|||
33519918|NCT03436199|101800190|FG000|Overall Study|Adverse Event|15|||
33519919|NCT03436199|101800191|FG001|Overall Study|Adverse Event|40|||
33519920|NCT03436199|101800192|FG002|Overall Study|Adverse Event|7|||
33519921|NCT03436199|101800190|FG000|Overall Study|Withdrawal by Subject|4|||
33519922|NCT03436199|101800191|FG001|Overall Study|Withdrawal by Subject|10|||
33519923|NCT03436199|101800192|FG002|Overall Study|Withdrawal by Subject|3|||
33519924|NCT03436199|101800190|FG000|Overall Study|Lost to Follow-up|1|||
33519925|NCT03436199|101800191|FG001|Overall Study|Lost to Follow-up|0|||
33519926|NCT03436199|101800192|FG002|Overall Study|Lost to Follow-up|2|||
33519927|NCT03436199|101800190|FG000|Overall Study|Protocol Violation|1|||
33519928|NCT03436199|101800191|FG001|Overall Study|Protocol Violation|1|||
33519929|NCT03436199|101800192|FG002|Overall Study|Protocol Violation|0|||
33519930|NCT03436199|101800190|FG000|Overall Study|Physician Decision|0|||
33519931|NCT03436199|101800191|FG001|Overall Study|Physician Decision|1|||
33519932|NCT03436199|101800192|FG002|Overall Study|Physician Decision|0|||
33519933|NCT03436199|101800190|FG000|Overall Study|Could not return to clinic|1|||
33519934|NCT03436199|101800191|FG001|Overall Study|Could not return to clinic|0|||
33519935|NCT03436199|101800192|FG002|Overall Study|Could not return to clinic|0|||
33519936|NCT03436199|101800190|FG000|Overall Study|Withdrawn per physician|0|||
33519937|NCT03436199|101800191|FG001|Overall Study|Withdrawn per physician|1|||
33519938|NCT03436199|101800192|FG002|Overall Study|Withdrawn per physician|0|||
33519939|NCT00006305|101800194|FG000|Overall Study|Withdrawal by Subject|17|||
33519940|NCT00006305|101800195|FG001|Overall Study|Withdrawal by Subject|10|||
33519941|NCT00006305|101800196|FG002|Overall Study|Withdrawal by Subject|15|||
33519942|NCT00006305|101800197|FG003|Overall Study|Withdrawal by Subject|14|||
33519943|NCT02494401|101800198|FG000|Overall Study|Lost to Follow-up|22|||
33519944|NCT02494401|101800199|FG001|Overall Study|Lost to Follow-up|25|||
33519945|NCT02494401|101800198|FG000|Overall Study|Withdrawal by Subject|3|||
33519946|NCT02494401|101800199|FG001|Overall Study|Withdrawal by Subject|2|||
33519947|NCT03217968|101800200|FG000|Overall Study|Withdrawal by Subject|4|||
33519948|NCT03217968|101800200|FG000|Overall Study|Lost to Follow-up|1|||
33519949|NCT03217968|101800200|FG000|Overall Study|Protocol Violation|6|||
33519950|NCT00869557|101800202|FG000|Randomized Phase|Lost to Follow-up|2|||
33519951|NCT00869557|101800203|FG001|Randomized Phase|Lost to Follow-up|1|||
33519952|NCT00869557|101800202|FG000|Randomized Phase|Investigator's Discretion|1|||
33519953|NCT00869557|101800203|FG001|Randomized Phase|Investigator's Discretion|0|||
33519954|NCT00869557|101800202|FG000|Randomized Phase|Withdrew Consent|0|||
33519955|NCT00869557|101800203|FG001|Randomized Phase|Withdrew Consent|1|||
33519956|NCT00869557|101800202|FG000|Extension Phase|Adverse Event|2|||
33519957|NCT00869557|101800203|FG001|Extension Phase|Adverse Event|2|||
33519958|NCT00869557|101800202|FG000|Extension Phase|Lack of Efficacy|1|||
33519959|NCT00869557|101800203|FG001|Extension Phase|Lack of Efficacy|0|||
33519960|NCT00869557|101800202|FG000|Extension Phase|Lost to Follow-up|3|||
33519961|NCT00869557|101800203|FG001|Extension Phase|Lost to Follow-up|1|||
33519962|NCT00869557|101800202|FG000|Extension Phase|Investigator's Discretion|2|||
33519963|NCT00869557|101800203|FG001|Extension Phase|Investigator's Discretion|0|||
33519964|NCT00869557|101800202|FG000|Extension Phase|Withdrew Consent|2|||
33519965|NCT00869557|101800203|FG001|Extension Phase|Withdrew Consent|0|||
33519966|NCT00636636|101800204|FG000|Overall Study|Other reason|4|||
33519967|NCT00636636|101800205|FG001|Overall Study|Other reason|6|||
33519968|NCT00636636|101800204|FG000|Overall Study|Adverse Event|19|||
33519969|NCT00636636|101800205|FG001|Overall Study|Adverse Event|8|||
33519970|NCT00636636|101800204|FG000|Overall Study|Lack of Efficacy|7|||
33519971|NCT00636636|101800205|FG001|Overall Study|Lack of Efficacy|12|||
33519972|NCT00636636|101800204|FG000|Overall Study|Protocol Violation|2|||
33519973|NCT00636636|101800205|FG001|Overall Study|Protocol Violation|2|||
33519974|NCT00636636|101800204|FG000|Overall Study|Lost to Follow-up|0|||
33519975|NCT00636636|101800205|FG001|Overall Study|Lost to Follow-up|1|||
33519976|NCT00636636|101800204|FG000|Overall Study|Death|0|||
33519977|NCT00636636|101800205|FG001|Overall Study|Death|1|||
33519978|NCT00636636|101800204|FG000|Overall Study|Withdrawal by Subject|4|||
33519979|NCT00636636|101800205|FG001|Overall Study|Withdrawal by Subject|9|||
33519980|NCT02839876|101800206|FG000|Overall Study|Protocol Violation|10|||
33519981|NCT02839876|101800207|FG001|Overall Study|Protocol Violation|11|||
33519982|NCT00483704|101800208|FG000|Randomization|Withdrawal by Subject|19|||
33519983|NCT00483704|101800209|FG001|Randomization|Withdrawal by Subject|28|||
33519984|NCT00483704|101800210|FG002|Randomization|Withdrawal by Subject|18|||
33519985|NCT00483704|101800208|FG000|Randomization|Protocol Violation|14|||
33519986|NCT00483704|101800209|FG001|Randomization|Protocol Violation|25|||
33327579|NCT00847145|101094309|FG000|Overall Study|Lost to Follow-up|3|||
33327580|NCT00847145|101094310|FG001|Overall Study|Lost to Follow-up|1|||
33327581|NCT00847145|101094311|FG002|Overall Study|Lost to Follow-up|1|||
33327582|NCT00847145|101094312|FG003|Overall Study|Lost to Follow-up|0|||
33327583|NCT00847145|101094313|FG004|Overall Study|Lost to Follow-up|4|||
33327584|NCT00847145|101094314|FG005|Overall Study|Lost to Follow-up|4|||
33327585|NCT00847145|101094315|FG006|Overall Study|Lost to Follow-up|8|||
33327586|NCT00847145|101094316|FG007|Overall Study|Lost to Follow-up|2|||
33327587|NCT00847145|101094309|FG000|Overall Study|Inappropriate enrollment|0|||
33327588|NCT00847145|101094310|FG001|Overall Study|Inappropriate enrollment|0|||
33327589|NCT00847145|101094311|FG002|Overall Study|Inappropriate enrollment|0|||
33327590|NCT00847145|101094312|FG003|Overall Study|Inappropriate enrollment|0|||
33327591|NCT00847145|101094313|FG004|Overall Study|Inappropriate enrollment|1|||
33327592|NCT00847145|101094314|FG005|Overall Study|Inappropriate enrollment|0|||
33519987|NCT00483704|101800210|FG002|Randomization|Protocol Violation|22|||
33519988|NCT00483704|101800208|FG000|Randomization|Lost to Follow-up|14|||
33519989|NCT00483704|101800209|FG001|Randomization|Lost to Follow-up|14|||
33519990|NCT00483704|101800210|FG002|Randomization|Lost to Follow-up|19|||
33519991|NCT00483704|101800208|FG000|Randomization|Pregnancy|1|||
33519992|NCT00483704|101800209|FG001|Randomization|Pregnancy|0|||
33519993|NCT00483704|101800210|FG002|Randomization|Pregnancy|0|||
33519994|NCT00483704|101800208|FG000|Randomization|Physician Decision|2|||
33519995|NCT00483704|101800209|FG001|Randomization|Physician Decision|4|||
33519996|NCT00483704|101800210|FG002|Randomization|Physician Decision|0|||
33519997|NCT00483704|101800208|FG000|Randomization|Progressive disease|0|||
33519998|NCT00483704|101800209|FG001|Randomization|Progressive disease|0|||
33519999|NCT00483704|101800210|FG002|Randomization|Progressive disease|1|||
33520000|NCT00483704|101800208|FG000|Randomization|Lack of qualifying migraines|21|||
33520001|NCT00483704|101800209|FG001|Randomization|Lack of qualifying migraines|25|||
33520002|NCT00483704|101800210|FG002|Randomization|Lack of qualifying migraines|31|||
33520003|NCT00483704|101800208|FG000|Treatment|Lack of qualifying migraines|101|||
33520004|NCT00483704|101800209|FG001|Treatment|Lack of qualifying migraines|99|||
33520005|NCT00483704|101800210|FG002|Treatment|Lack of qualifying migraines|116|||
33520006|NCT00483704|101800208|FG000|Treatment|Adverse Event|3|||
33520007|NCT00483704|101800209|FG001|Treatment|Adverse Event|5|||
33520008|NCT00483704|101800210|FG002|Treatment|Adverse Event|4|||
33520009|NCT00483704|101800208|FG000|Treatment|Withdrawal by Subject|16|||
33520010|NCT00483704|101800209|FG001|Treatment|Withdrawal by Subject|12|||
33520011|NCT00483704|101800210|FG002|Treatment|Withdrawal by Subject|21|||
33520012|NCT00483704|101800208|FG000|Treatment|Protocol Violation|6|||
33520013|NCT00483704|101800209|FG001|Treatment|Protocol Violation|3|||
33520014|NCT00483704|101800210|FG002|Treatment|Protocol Violation|5|||
33520015|NCT00483704|101800208|FG000|Treatment|Lost to Follow-up|2|||
33520016|NCT00483704|101800209|FG001|Treatment|Lost to Follow-up|7|||
33520017|NCT00483704|101800210|FG002|Treatment|Lost to Follow-up|5|||
33520018|NCT00483704|101800208|FG000|Treatment|Lack of Efficacy|1|||
33520019|NCT00483704|101800209|FG001|Treatment|Lack of Efficacy|1|||
33520020|NCT00483704|101800210|FG002|Treatment|Lack of Efficacy|1|||
33520021|NCT00483704|101800208|FG000|Treatment|Pregnancy|0|||
33520022|NCT00483704|101800209|FG001|Treatment|Pregnancy|1|||
33520023|NCT00483704|101800210|FG002|Treatment|Pregnancy|0|||
33520024|NCT00483704|101800208|FG000|Treatment|Physician Decision|0|||
33520025|NCT00483704|101800209|FG001|Treatment|Physician Decision|1|||
33327593|NCT00847145|101094315|FG006|Overall Study|Inappropriate enrollment|0|||
33327594|NCT00847145|101094316|FG007|Overall Study|Inappropriate enrollment|0|||
33327595|NCT00847145|101094309|FG000|Overall Study|Protocol Violation|0|||
33327596|NCT00847145|101094310|FG001|Overall Study|Protocol Violation|0|||
33520026|NCT00483704|101800210|FG002|Treatment|Physician Decision|4|||
33520027|NCT00195494|101800211|FG000|Year 1|Adverse Event|0|||
33520028|NCT00195494|101800212|FG001|Year 1|Adverse Event|0|||
33520029|NCT00195494|101800213|FG002|Year 1|Adverse Event|0|||
33520030|NCT00195494|101800214|FG003|Year 1|Adverse Event|0|||
33520031|NCT00195494|101800215|FG004|Year 1|Adverse Event|34|||
33520032|NCT00195494|101800216|FG005|Year 1|Adverse Event|27|||
33520033|NCT00195494|101800211|FG000|Year 1|System Toxicity|0|||
33520034|NCT00195494|101800212|FG001|Year 1|System Toxicity|0|||
33520035|NCT00195494|101800213|FG002|Year 1|System Toxicity|0|||
33327597|NCT00847145|101094311|FG002|Overall Study|Protocol Violation|3|||
33327598|NCT00847145|101094312|FG003|Overall Study|Protocol Violation|0|||
33520036|NCT00195494|101800214|FG003|Year 1|System Toxicity|0|||
33520037|NCT00195494|101800215|FG004|Year 1|System Toxicity|0|||
33520038|NCT00195494|101800216|FG005|Year 1|System Toxicity|1|||
33520039|NCT00195494|101800211|FG000|Year 1|Lack of Efficacy|0|||
33520040|NCT00195494|101800212|FG001|Year 1|Lack of Efficacy|0|||
33520041|NCT00195494|101800213|FG002|Year 1|Lack of Efficacy|0|||
33520042|NCT00195494|101800214|FG003|Year 1|Lack of Efficacy|0|||
33520043|NCT00195494|101800215|FG004|Year 1|Lack of Efficacy|24|||
33520044|NCT00195494|101800216|FG005|Year 1|Lack of Efficacy|9|||
33520045|NCT00195494|101800211|FG000|Year 1|Compliance|0|||
33520046|NCT00195494|101800212|FG001|Year 1|Compliance|0|||
33520047|NCT00195494|101800213|FG002|Year 1|Compliance|0|||
33520048|NCT00195494|101800214|FG003|Year 1|Compliance|0|||
33520049|NCT00195494|101800215|FG004|Year 1|Compliance|5|||
33520050|NCT00195494|101800216|FG005|Year 1|Compliance|1|||
33520051|NCT00195494|101800211|FG000|Year 1|Lost to Follow-up|0|||
33520052|NCT00195494|101800212|FG001|Year 1|Lost to Follow-up|0|||
33520053|NCT00195494|101800213|FG002|Year 1|Lost to Follow-up|0|||
33520054|NCT00195494|101800214|FG003|Year 1|Lost to Follow-up|0|||
33520055|NCT00195494|101800215|FG004|Year 1|Lost to Follow-up|1|||
33520056|NCT00195494|101800216|FG005|Year 1|Lost to Follow-up|0|||
33520057|NCT00195494|101800211|FG000|Year 1|Missed >4 consecutive doses|0|||
33520058|NCT00195494|101800212|FG001|Year 1|Missed >4 consecutive doses|0|||
33520059|NCT00195494|101800213|FG002|Year 1|Missed >4 consecutive doses|0|||
33520060|NCT00195494|101800214|FG003|Year 1|Missed >4 consecutive doses|0|||
33520061|NCT00195494|101800215|FG004|Year 1|Missed >4 consecutive doses|3|||
33520062|NCT00195494|101800216|FG005|Year 1|Missed >4 consecutive doses|2|||
33520063|NCT00195494|101800211|FG000|Year 1|Protocol deviation|0|||
33520064|NCT00195494|101800212|FG001|Year 1|Protocol deviation|0|||
33520065|NCT00195494|101800213|FG002|Year 1|Protocol deviation|0|||
33520066|NCT00195494|101800214|FG003|Year 1|Protocol deviation|0|||
33520067|NCT00195494|101800215|FG004|Year 1|Protocol deviation|2|||
33520068|NCT00195494|101800216|FG005|Year 1|Protocol deviation|3|||
33520069|NCT00195494|101800211|FG000|Year 1|Physician Decision|0|||
33520070|NCT00195494|101800212|FG001|Year 1|Physician Decision|0|||
33327599|NCT00847145|101094313|FG004|Overall Study|Protocol Violation|1|||
33327600|NCT00847145|101094314|FG005|Overall Study|Protocol Violation|0|||
33327601|NCT00847145|101094315|FG006|Overall Study|Protocol Violation|0|||
33327602|NCT00847145|101094316|FG007|Overall Study|Protocol Violation|1|||
33327603|NCT02047253|101094317|FG000|Overall Study|Lost to Follow-up|8|||
33327604|NCT00636675|101094320|FG000|Overall Study|Lost to Follow-up|121|||
33327605|NCT00636675|101094321|FG001|Overall Study|Lost to Follow-up|31|||
33327606|NCT00636675|101094320|FG000|Overall Study|Withdrawal by Subject|19|||
33327607|NCT00636675|101094321|FG001|Overall Study|Withdrawal by Subject|10|||
33327608|NCT01979536|101094322|FG000|Overall Study|Physician Decision|2|||
33327609|NCT01979536|101094323|FG001|Overall Study|Physician Decision|3|||
33327610|NCT01979536|101094322|FG000|Overall Study|Withdrawal by Subject|0|||
33327611|NCT01979536|101094323|FG001|Overall Study|Withdrawal by Subject|1|||
33327612|NCT01979536|101094322|FG000|Overall Study|Refusal|0|||
33520071|NCT00195494|101800213|FG002|Year 1|Physician Decision|0|||
33520072|NCT00195494|101800214|FG003|Year 1|Physician Decision|0|||
33520073|NCT00195494|101800215|FG004|Year 1|Physician Decision|1|||
33520074|NCT00195494|101800216|FG005|Year 1|Physician Decision|0|||
33520075|NCT00195494|101800211|FG000|Year 1|Withdrawal by Subject|0|||
33520076|NCT00195494|101800212|FG001|Year 1|Withdrawal by Subject|0|||
33520077|NCT00195494|101800213|FG002|Year 1|Withdrawal by Subject|0|||
33200231|NCT00630877|100638259|FG000|Overall Study|Lost to Follow-up|2|||
33327613|NCT01979536|101094323|FG001|Overall Study|Refusal|1|||
33520078|NCT00195494|101800214|FG003|Year 1|Withdrawal by Subject|0|||
33520079|NCT00195494|101800215|FG004|Year 1|Withdrawal by Subject|8|||
33520080|NCT00195494|101800216|FG005|Year 1|Withdrawal by Subject|9|||
33520081|NCT00195494|101800211|FG000|Year 1|Protocol Violation|0|||
33520082|NCT00195494|101800212|FG001|Year 1|Protocol Violation|0|||
33327614|NCT01979536|101094322|FG000|Overall Study|Relapse|0|||
33327615|NCT01979536|101094323|FG001|Overall Study|Relapse|1|||
33327616|NCT01979536|101094322|FG000|Overall Study|Study terminated by Sponsor|0|||
33327617|NCT01979536|101094323|FG001|Overall Study|Study terminated by Sponsor|1|||
33520083|NCT00195494|101800213|FG002|Year 1|Protocol Violation|0|||
33520084|NCT00195494|101800214|FG003|Year 1|Protocol Violation|0|||
33520085|NCT00195494|101800215|FG004|Year 1|Protocol Violation|1|||
33520086|NCT00195494|101800216|FG005|Year 1|Protocol Violation|1|||
33520087|NCT00195494|101800211|FG000|Year 2|Adverse Event|3|||
33520088|NCT00195494|101800212|FG001|Year 2|Adverse Event|7|||
33520089|NCT00195494|101800213|FG002|Year 2|Adverse Event|5|||
33327618|NCT01979536|101094322|FG000|Overall Study|Did not start treatment|0|||
33520090|NCT00195494|101800214|FG003|Year 2|Adverse Event|9|||
33520091|NCT00195494|101800215|FG004|Year 2|Adverse Event|0|||
33520092|NCT00195494|101800216|FG005|Year 2|Adverse Event|0|||
33520093|NCT00195494|101800211|FG000|Year 2|Lack of Efficacy|0|||
33327619|NCT01979536|101094323|FG001|Overall Study|Did not start treatment|1|||
33327620|NCT03198520|101094324|FG000|Overall Study|Physician Decision|2|||
33200232|NCT00630877|100638260|FG001|Overall Study|Lost to Follow-up|0|||
33200233|NCT00630877|100638261|FG002|Overall Study|Lost to Follow-up|0|||
33200234|NCT00630877|100638259|FG000|Overall Study|Noncompliance|2|||
33200235|NCT00630877|100638260|FG001|Overall Study|Noncompliance|3|||
33200236|NCT00630877|100638261|FG002|Overall Study|Noncompliance|1|||
33200237|NCT00630877|100638259|FG000|Overall Study|Protocol violation|1|||
33200238|NCT00630877|100638260|FG001|Overall Study|Protocol violation|0|||
33200239|NCT00630877|100638261|FG002|Overall Study|Protocol violation|1|||
33200240|NCT00630877|100638259|FG000|Overall Study|Personal reasons|0|||
33200241|NCT00630877|100638260|FG001|Overall Study|Personal reasons|0|||
33200242|NCT00630877|100638261|FG002|Overall Study|Personal reasons|1|||
33200243|NCT01682837|100638262|FG000|Baseline|Withdrawal by Subject|5|||
33200244|NCT03891524|100638263|FG000|Overall Study|Death|0|||
33200245|NCT03891524|100638264|FG001|Overall Study|Death|0|||
33200246|NCT03891524|100638265|FG002|Overall Study|Death|0|||
33200247|NCT03891524|100638266|FG003|Overall Study|Death|0|||
33200248|NCT03891524|100638267|FG004|Overall Study|Death|0|||
33200249|NCT03891524|100638268|FG005|Overall Study|Death|0|||
33200250|NCT03891524|100638269|FG006|Overall Study|Death|0|||
33327621|NCT03198520|101094324|FG000|Overall Study|Protocol Violation|2|||
33327622|NCT03198520|101094324|FG000|Overall Study|Withdrawal by Subject|1|||
33200251|NCT03891524|100638270|FG007|Overall Study|Death|1|||
33200252|NCT03891524|100638263|FG000|Overall Study|Withdrawal by Subject|0|||
33200253|NCT03891524|100638264|FG001|Overall Study|Withdrawal by Subject|1|||
33200254|NCT03891524|100638265|FG002|Overall Study|Withdrawal by Subject|2|||
33200255|NCT03891524|100638266|FG003|Overall Study|Withdrawal by Subject|1|||
33200256|NCT03891524|100638267|FG004|Overall Study|Withdrawal by Subject|2|||
33200257|NCT03891524|100638268|FG005|Overall Study|Withdrawal by Subject|2|||
33200258|NCT03891524|100638269|FG006|Overall Study|Withdrawal by Subject|2|||
33327623|NCT03198520|101094324|FG000|Overall Study|Study Ended|1|||
33327624|NCT01670539|101094325|FG000|Overall Study|Death|3|||
33327625|NCT01670539|101094326|FG001|Overall Study|Death|5|||
33327626|NCT01670539|101094325|FG000|Overall Study|Withdrawal by Subject|3|||
33327627|NCT01670539|101094326|FG001|Overall Study|Withdrawal by Subject|0|||
33520094|NCT00195494|101800212|FG001|Year 2|Lack of Efficacy|1|||
33520095|NCT00195494|101800213|FG002|Year 2|Lack of Efficacy|7|||
33520096|NCT00195494|101800214|FG003|Year 2|Lack of Efficacy|7|||
33520097|NCT00195494|101800215|FG004|Year 2|Lack of Efficacy|0|||
33520098|NCT00195494|101800216|FG005|Year 2|Lack of Efficacy|0|||
33520099|NCT00195494|101800211|FG000|Year 2|Compliance|1|||
33520100|NCT00195494|101800212|FG001|Year 2|Compliance|0|||
33520101|NCT00195494|101800213|FG002|Year 2|Compliance|0|||
33520102|NCT00195494|101800214|FG003|Year 2|Compliance|2|||
33520103|NCT00195494|101800215|FG004|Year 2|Compliance|0|||
33520104|NCT00195494|101800216|FG005|Year 2|Compliance|0|||
33520105|NCT00195494|101800211|FG000|Year 2|Lost to Follow-up|0|||
33520106|NCT00195494|101800212|FG001|Year 2|Lost to Follow-up|0|||
33520107|NCT00195494|101800213|FG002|Year 2|Lost to Follow-up|1|||
33520108|NCT00195494|101800214|FG003|Year 2|Lost to Follow-up|1|||
33520109|NCT00195494|101800215|FG004|Year 2|Lost to Follow-up|0|||
33520110|NCT00195494|101800216|FG005|Year 2|Lost to Follow-up|0|||
33520111|NCT00195494|101800211|FG000|Year 2|Missed >4 consecutive doses|1|||
33520112|NCT00195494|101800212|FG001|Year 2|Missed >4 consecutive doses|1|||
33520113|NCT00195494|101800213|FG002|Year 2|Missed >4 consecutive doses|1|||
33608589|NCT02927938|102115127|FG000|Overall Study|Death|0|||
33200259|NCT03891524|100638270|FG007|Overall Study|Withdrawal by Subject|1|||
33200260|NCT03217136|100638271|FG000|Overall Study|Lost to Follow-up|2|||
33200261|NCT03217136|100638272|FG001|Overall Study|Lost to Follow-up|1|||
33200262|NCT03217136|100638271|FG000|Overall Study|Site Randomized Participant in Error|0|||
33327628|NCT01436084|101094327|FG000|Overall Study|Disease Progression|2|||
33327629|NCT01436084|101094327|FG000|Overall Study|Withdrawal by Subject|1|||
33520114|NCT00195494|101800214|FG003|Year 2|Missed >4 consecutive doses|0|||
33200263|NCT03217136|100638272|FG001|Overall Study|Site Randomized Participant in Error|1|||
33200264|NCT03217136|100638271|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
33327630|NCT01436084|101094327|FG000|Overall Study|Early Closure of Study|1|||
33520115|NCT00195494|101800215|FG004|Year 2|Missed >4 consecutive doses|0|||
33608590|NCT02927938|102115128|FG001|Overall Study|Death|1|||
33327631|NCT00754793|101094328|FG000|Overall Study|voluntary withdrawn from study|0|||
33520116|NCT00195494|101800216|FG005|Year 2|Missed >4 consecutive doses|0|||
33520117|NCT00195494|101800211|FG000|Year 2|Protocol deviation|0|||
33200265|NCT03217136|100638272|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
33200266|NCT03217136|100638271|FG000|Overall Study|Dispensing Error|1|||
33200267|NCT03217136|100638272|FG001|Overall Study|Dispensing Error|0|||
33200268|NCT03217136|100638271|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
33200269|NCT03217136|100638272|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33200270|NCT02660359|100638273|FG000|Overall Study|Protocol Deviation|0|||
33200271|NCT02660359|100638274|FG001|Overall Study|Protocol Deviation|0|||
33200272|NCT02660359|100638275|FG002|Overall Study|Protocol Deviation|1|||
33200273|NCT02660359|100638273|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
33200274|NCT02660359|100638274|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
33327632|NCT00754793|101094329|FG001|Overall Study|voluntary withdrawn from study|1|||
33520118|NCT00195494|101800212|FG001|Year 2|Protocol deviation|1|||
33520119|NCT00195494|101800213|FG002|Year 2|Protocol deviation|0|||
33520120|NCT00195494|101800214|FG003|Year 2|Protocol deviation|0|||
33520121|NCT00195494|101800215|FG004|Year 2|Protocol deviation|0|||
33327633|NCT01490814|101094330|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
33520122|NCT00195494|101800216|FG005|Year 2|Protocol deviation|0|||
33520123|NCT00195494|101800211|FG000|Year 2|Physician Decision|1|||
33520124|NCT00195494|101800212|FG001|Year 2|Physician Decision|1|||
33200275|NCT02660359|100638275|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
33520125|NCT00195494|101800213|FG002|Year 2|Physician Decision|0|||
33520126|NCT00195494|101800214|FG003|Year 2|Physician Decision|0|||
33520127|NCT00195494|101800215|FG004|Year 2|Physician Decision|0|||
33520128|NCT00195494|101800216|FG005|Year 2|Physician Decision|0|||
33520129|NCT00195494|101800211|FG000|Year 2|Withdrawal by Subject|1|||
33520130|NCT00195494|101800212|FG001|Year 2|Withdrawal by Subject|5|||
33520131|NCT00195494|101800213|FG002|Year 2|Withdrawal by Subject|4|||
33520132|NCT00195494|101800214|FG003|Year 2|Withdrawal by Subject|3|||
33520133|NCT00195494|101800215|FG004|Year 2|Withdrawal by Subject|0|||
33520134|NCT00195494|101800216|FG005|Year 2|Withdrawal by Subject|0|||
33520135|NCT00195494|101800211|FG000|Year 2|System toxicity|0|||
33520136|NCT00195494|101800212|FG001|Year 2|System toxicity|0|||
33520137|NCT00195494|101800213|FG002|Year 2|System toxicity|0|||
33520138|NCT00195494|101800214|FG003|Year 2|System toxicity|1|||
33520139|NCT00195494|101800215|FG004|Year 2|System toxicity|0|||
33520140|NCT00195494|101800216|FG005|Year 2|System toxicity|0|||
33520141|NCT05940077|101800217|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
33520142|NCT00308750|101800218|FG000|Overall Study|Adverse Event|9|||
33520143|NCT00308750|101800219|FG001|Overall Study|Adverse Event|9|||
33520144|NCT00308750|101800220|FG002|Overall Study|Adverse Event|13|||
33520145|NCT00308750|101800218|FG000|Overall Study|Withdrawal by Subject|6|||
33520146|NCT00308750|101800219|FG001|Overall Study|Withdrawal by Subject|2|||
33520147|NCT00308750|101800220|FG002|Overall Study|Withdrawal by Subject|3|||
33520148|NCT00308750|101800218|FG000|Overall Study|Physician Decision|3|||
33520149|NCT00308750|101800219|FG001|Overall Study|Physician Decision|4|||
33520150|NCT00308750|101800220|FG002|Overall Study|Physician Decision|3|||
33520151|NCT00308750|101800218|FG000|Overall Study|Sponsor Decision|1|||
33520152|NCT00308750|101800219|FG001|Overall Study|Sponsor Decision|0|||
33520153|NCT00308750|101800220|FG002|Overall Study|Sponsor Decision|0|||
33520154|NCT00308750|101800218|FG000|Overall Study|Disease Progression|47|||
33520155|NCT00308750|101800219|FG001|Overall Study|Disease Progression|24|||
33520156|NCT00308750|101800220|FG002|Overall Study|Disease Progression|28|||
33520157|NCT00308750|101800218|FG000|Overall Study|Unrelated Complication|3|||
33520158|NCT00308750|101800219|FG001|Overall Study|Unrelated Complication|0|||
33520159|NCT00308750|101800220|FG002|Overall Study|Unrelated Complication|1|||
33520160|NCT00308750|101800218|FG000|Overall Study|Death|1|||
33520161|NCT00308750|101800219|FG001|Overall Study|Death|0|||
33520162|NCT00308750|101800220|FG002|Overall Study|Death|1|||
33520163|NCT00308750|101800218|FG000|Overall Study|Protocol Violation|1|||
33520164|NCT00308750|101800219|FG001|Overall Study|Protocol Violation|0|||
33520165|NCT00308750|101800220|FG002|Overall Study|Protocol Violation|0|||
33520166|NCT00308750|101800218|FG000|Overall Study|New Primary Disease Identified|1|||
33520167|NCT00308750|101800219|FG001|Overall Study|New Primary Disease Identified|1|||
33520168|NCT00308750|101800220|FG002|Overall Study|New Primary Disease Identified|0|||
33520169|NCT02565706|101800223|FG000|Overall Study|Withdrawal by Subject|5|||
33520170|NCT02565706|101800224|FG001|Overall Study|Withdrawal by Subject|7|||
33520171|NCT02565706|101800225|FG002|Overall Study|Withdrawal by Subject|7|||
33520172|NCT02565706|101800226|FG003|Overall Study|Withdrawal by Subject|11|||
33520173|NCT02565706|101800223|FG000|Overall Study|Lost to Follow-up|72|||
33520174|NCT02565706|101800224|FG001|Overall Study|Lost to Follow-up|75|||
33520175|NCT02565706|101800225|FG002|Overall Study|Lost to Follow-up|82|||
33520176|NCT02565706|101800226|FG003|Overall Study|Lost to Follow-up|74|||
33520177|NCT01273155|101800227|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
33520178|NCT01273155|101800228|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
33520179|NCT01273155|101800229|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
33520180|NCT01273155|101800230|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
33520181|NCT01273155|101800231|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
33520182|NCT01273155|101800232|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
33520183|NCT01273155|101800233|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
33520184|NCT01273155|101800227|FG000|Overall Study|Change in liver function/no longer eval.|0|||
33520185|NCT01273155|101800228|FG001|Overall Study|Change in liver function/no longer eval.|1|||
33520186|NCT01273155|101800229|FG002|Overall Study|Change in liver function/no longer eval.|0|||
33608591|NCT02927938|102115129|FG002|Overall Study|Death|0|||
33608592|NCT02927938|102115130|FG003|Overall Study|Death|4|||
33608593|NCT02927938|102115127|FG000|Overall Study|Early Study Termination|1|||
33608594|NCT02927938|102115128|FG001|Overall Study|Early Study Termination|5|||
33608595|NCT02927938|102115129|FG002|Overall Study|Early Study Termination|4|||
33327634|NCT01490814|101094331|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
33520187|NCT01273155|101800230|FG003|Overall Study|Change in liver function/no longer eval.|0|||
33520188|NCT01273155|101800231|FG004|Overall Study|Change in liver function/no longer eval.|1|||
33520189|NCT01273155|101800232|FG005|Overall Study|Change in liver function/no longer eval.|0|||
33520190|NCT01273155|101800233|FG006|Overall Study|Change in liver function/no longer eval.|0|||
33520191|NCT01273155|101800227|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
33520192|NCT01273155|101800228|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
33520193|NCT01273155|101800229|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
33520194|NCT01273155|101800230|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
33608596|NCT02927938|102115130|FG003|Overall Study|Early Study Termination|3|||
33200276|NCT02660359|100638273|FG000|Overall Study|Lack of Efficacy|1|||
33327635|NCT01490814|101094330|FG000|Overall Study|Physician Decision|1|||
33327636|NCT01490814|101094331|FG001|Overall Study|Physician Decision|0|||
33520195|NCT01273155|101800231|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
33520196|NCT01273155|101800232|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
33327637|NCT01490814|101094330|FG000|Overall Study|Withdrawal by Subject|0|||
33327638|NCT01490814|101094331|FG001|Overall Study|Withdrawal by Subject|5|||
33401003|NCT00959192|101356910|FG001|Overall Study|Caregiver Request|0|||
33401004|NCT00959192|101356911|FG002|Overall Study|Caregiver Request|2|||
33401005|NCT00959192|101356912|FG003|Overall Study|Caregiver Request|1|||
33401006|NCT05060003|101356915|FG000|Overall Study|ctDNA negative|7|||
33401007|NCT02425891|101356919|FG000|Overall Study|Death|333|||
33401008|NCT02425891|101356920|FG001|Overall Study|Death|314|||
33401009|NCT02425891|101356919|FG000|Overall Study|Lost to Follow-up|4|||
33401010|NCT02425891|101356920|FG001|Overall Study|Lost to Follow-up|6|||
33520197|NCT01273155|101800233|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
33520198|NCT01273155|101800227|FG000|Overall Study|Died during Cycle 1|0|||
33520199|NCT01273155|101800228|FG001|Overall Study|Died during Cycle 1|0|||
33327639|NCT02354222|101094332|FG000|Overall Study|Adverse Event|0|||
33327640|NCT02354222|101094333|FG001|Overall Study|Adverse Event|3|||
33327641|NCT02354222|101094332|FG000|Overall Study|Physician Decision|1|||
33327642|NCT02354222|101094333|FG001|Overall Study|Physician Decision|1|||
33401011|NCT02425891|101356919|FG000|Overall Study|Non-Compliance|1|||
33401012|NCT02425891|101356920|FG001|Overall Study|Non-Compliance|1|||
33520200|NCT01273155|101800229|FG002|Overall Study|Died during Cycle 1|1|||
33520201|NCT01273155|101800230|FG003|Overall Study|Died during Cycle 1|1|||
33520202|NCT01273155|101800231|FG004|Overall Study|Died during Cycle 1|0|||
33520203|NCT01273155|101800232|FG005|Overall Study|Died during Cycle 1|2|||
33520204|NCT01273155|101800233|FG006|Overall Study|Died during Cycle 1|2|||
33520205|NCT01273155|101800227|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
33520206|NCT01273155|101800228|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
33200277|NCT02660359|100638274|FG001|Overall Study|Lack of Efficacy|1|||
33200278|NCT02660359|100638275|FG002|Overall Study|Lack of Efficacy|1|||
33200279|NCT02660359|100638273|FG000|Overall Study|Adverse Event|0|||
33200280|NCT02660359|100638274|FG001|Overall Study|Adverse Event|1|||
33200281|NCT02660359|100638275|FG002|Overall Study|Adverse Event|0|||
33200282|NCT02660359|100638273|FG000|Overall Study|Other|2|||
33200283|NCT02660359|100638274|FG001|Overall Study|Other|1|||
33327643|NCT02354222|101094332|FG000|Overall Study|Pregnancy|1|||
33327644|NCT02354222|101094333|FG001|Overall Study|Pregnancy|0|||
33401013|NCT02425891|101356919|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
33200284|NCT02660359|100638275|FG002|Overall Study|Other|3|||
33327645|NCT02354222|101094332|FG000|Overall Study|Withdrawal by Subject|2|||
33401014|NCT02425891|101356920|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
33608597|NCT03729245|102115131|FG000|Overall Study|Lost to Follow-up|5|||
33200285|NCT02660359|100638273|FG000|Overall Study|Withdrawal by Subject|7|||
33327646|NCT02354222|101094333|FG001|Overall Study|Withdrawal by Subject|3|||
33401015|NCT02425891|101356919|FG000|Overall Study|Physician Decision|0|||
33401016|NCT02425891|101356920|FG001|Overall Study|Physician Decision|1|||
33401017|NCT02425891|101356919|FG000|Overall Study|Protocol Violation|1|||
33327647|NCT02354222|101094332|FG000|Overall Study|Conflict with the stopping criteria|0|||
33327648|NCT02354222|101094333|FG001|Overall Study|Conflict with the stopping criteria|4|||
33327649|NCT01537198|101094334|FG000|Overall Study|RSV infection|2|||
33327650|NCT01537198|101094334|FG000|Overall Study|Adverse Event|4|||
33327651|NCT01537198|101094334|FG000|Overall Study|No Further Visits to the Clinic|37|||
33327652|NCT01537198|101094334|FG000|Overall Study|Other|111|||
33327653|NCT00382720|101094335|FG000|Overall Study|Adverse Event|21|||
33327654|NCT00382720|101094336|FG001|Overall Study|Adverse Event|23|||
33327655|NCT00382720|101094337|FG002|Overall Study|Adverse Event|15|||
33327656|NCT00382720|101094335|FG000|Overall Study|Protocol Violation|2|||
33327657|NCT00382720|101094336|FG001|Overall Study|Protocol Violation|5|||
33327658|NCT00382720|101094337|FG002|Overall Study|Protocol Violation|1|||
33327659|NCT00382720|101094335|FG000|Overall Study|Death|0|||
33327660|NCT00382720|101094336|FG001|Overall Study|Death|1|||
33327661|NCT00382720|101094337|FG002|Overall Study|Death|2|||
33327662|NCT00382720|101094335|FG000|Overall Study|Progressive disease|37|||
33327663|NCT00382720|101094336|FG001|Overall Study|Progressive disease|28|||
33327664|NCT00382720|101094337|FG002|Overall Study|Progressive disease|38|||
33327665|NCT00382720|101094335|FG000|Overall Study|Withdrew consent|1|||
33327666|NCT00382720|101094336|FG001|Overall Study|Withdrew consent|1|||
33327667|NCT00382720|101094337|FG002|Overall Study|Withdrew consent|2|||
33327668|NCT00382720|101094335|FG000|Overall Study|Withdrawal by Subject|11|||
33327669|NCT00382720|101094336|FG001|Overall Study|Withdrawal by Subject|20|||
33327670|NCT00382720|101094337|FG002|Overall Study|Withdrawal by Subject|12|||
33327671|NCT00382720|101094335|FG000|Overall Study|Surgery|1|||
33327672|NCT00382720|101094336|FG001|Overall Study|Surgery|1|||
33327673|NCT00382720|101094337|FG002|Overall Study|Surgery|4|||
33327674|NCT00382720|101094335|FG000|Overall Study|Patient did not receive study medication|1|||
33327675|NCT00382720|101094336|FG001|Overall Study|Patient did not receive study medication|1|||
33327676|NCT00382720|101094337|FG002|Overall Study|Patient did not receive study medication|4|||
33327677|NCT00382720|101094335|FG000|Overall Study|Clinically progressive disease|0|||
33327678|NCT00382720|101094336|FG001|Overall Study|Clinically progressive disease|1|||
33327679|NCT00382720|101094337|FG002|Overall Study|Clinically progressive disease|0|||
33327680|NCT00382720|101094335|FG000|Overall Study|Good prognosis|0|||
33327681|NCT00382720|101094336|FG001|Overall Study|Good prognosis|1|||
33327682|NCT00382720|101094337|FG002|Overall Study|Good prognosis|0|||
33327683|NCT00382720|101094335|FG000|Overall Study|Investigator/Clinical decision|5|||
33327684|NCT00382720|101094336|FG001|Overall Study|Investigator/Clinical decision|6|||
33327685|NCT00382720|101094337|FG002|Overall Study|Investigator/Clinical decision|6|||
33327686|NCT00382720|101094335|FG000|Overall Study|Discontinued at end of study|0|||
33327687|NCT00382720|101094336|FG001|Overall Study|Discontinued at end of study|1|||
33327688|NCT00382720|101094337|FG002|Overall Study|Discontinued at end of study|2|||
33327689|NCT00257166|101094338|FG000|Overall Study|Adverse Event|18|||
33327690|NCT00257166|101094339|FG001|Overall Study|Adverse Event|13|||
33327691|NCT00257166|101094338|FG000|Overall Study|Laboratory abnormality|1|||
33327692|NCT00257166|101094339|FG001|Overall Study|Laboratory abnormality|0|||
33327693|NCT00257166|101094338|FG000|Overall Study|Lost to Follow-up|8|||
33327694|NCT00257166|101094339|FG001|Overall Study|Lost to Follow-up|1|||
33327695|NCT00257166|101094338|FG000|Overall Study|Withdrawal by Subject|9|||
33327696|NCT00257166|101094339|FG001|Overall Study|Withdrawal by Subject|2|||
33327697|NCT00257166|101094338|FG000|Overall Study|Other|16|||
33520207|NCT01273155|101800229|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
33520208|NCT01273155|101800230|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
33520209|NCT01273155|101800231|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
33520210|NCT01273155|101800232|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
33520211|NCT01273155|101800233|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
33520212|NCT00568334|101800234|FG000|Overall Study|Withdrawal by Subject|0|||
33327698|NCT00257166|101094339|FG001|Overall Study|Other|21|||
33327699|NCT00257166|101094338|FG000|Overall Study|Randomized, but not treated|1|||
33520213|NCT00568334|101800235|FG001|Overall Study|Withdrawal by Subject|1|||
33608598|NCT03729245|102115132|FG001|Overall Study|Lost to Follow-up|6|||
33608599|NCT03729245|102115131|FG000|Overall Study|Withdrawal by Subject|16|||
33327700|NCT00257166|101094339|FG001|Overall Study|Randomized, but not treated|0|||
33327701|NCT00424749|101094340|FG000|Overall Study|Withdrawal by Subject|1|||
33327702|NCT01205230|101094341|FG000|Overall Study|Adverse Event|4|||
33520214|NCT00568334|101800234|FG000|Overall Study|Lost to Follow-up|1|||
33520215|NCT00568334|101800235|FG001|Overall Study|Lost to Follow-up|0|||
33520216|NCT04526574|101800237|FG000|Overall Study|Protocol Violation|3|||
33520217|NCT04526574|101800238|FG001|Overall Study|Protocol Violation|1|||
33327703|NCT01205230|101094342|FG001|Overall Study|Adverse Event|0|||
33327704|NCT01205230|101094341|FG000|Overall Study|Physician Decision|1|||
33327705|NCT01205230|101094342|FG001|Overall Study|Physician Decision|0|||
33327706|NCT01186796|101094343|FG000|Overall Study|Adverse Event|3|||
33520218|NCT04526574|101800237|FG000|Overall Study|Withdrawal by Subject|12|||
33327707|NCT01186796|101094344|FG001|Overall Study|Adverse Event|0|||
33327708|NCT01186796|101094343|FG000|Overall Study|Withdrawal by Subject|1|||
33327709|NCT01186796|101094344|FG001|Overall Study|Withdrawal by Subject|1|||
33327710|NCT01186796|101094343|FG000|Overall Study|Protocol Violation|0|||
33520219|NCT04526574|101800238|FG001|Overall Study|Withdrawal by Subject|9|||
33520220|NCT04526574|101800237|FG000|Overall Study|Other|1|||
33520221|NCT04526574|101800238|FG001|Overall Study|Other|2|||
33520222|NCT04526574|101800237|FG000|Overall Study|Adverse Event|1|||
33520223|NCT04526574|101800238|FG001|Overall Study|Adverse Event|1|||
33520224|NCT04526574|101800237|FG000|Overall Study|Death|2|||
33520225|NCT04526574|101800238|FG001|Overall Study|Death|3|||
33520226|NCT04526574|101800237|FG000|Overall Study|Lost to Follow-up|9|||
33520227|NCT04526574|101800238|FG001|Overall Study|Lost to Follow-up|9|||
33520228|NCT04526574|101800237|FG000|Overall Study|No longer meets eligibility criteria|8|||
33327711|NCT01186796|101094344|FG001|Overall Study|Protocol Violation|1|||
33327712|NCT02819635|101097214|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
33327713|NCT02819635|101097215|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
33327714|NCT02819635|101097216|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
33327715|NCT02819635|101097217|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
33327716|NCT02819635|101097218|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
33327717|NCT02819635|101097219|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
33327718|NCT02819635|101097220|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
33327719|NCT02819635|101097221|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
33327720|NCT02819635|101097222|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
33327721|NCT02819635|101097223|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
33327722|NCT02819635|101097224|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
33327723|NCT02819635|101097225|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
33327724|NCT02819635|101097214|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33327725|NCT02819635|101097215|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33327726|NCT02819635|101097216|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33327727|NCT02819635|101097217|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33327728|NCT02819635|101097218|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
33327729|NCT02819635|101097219|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
33327730|NCT02819635|101097220|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
33327731|NCT02819635|101097221|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33327732|NCT02819635|101097222|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33327733|NCT02819635|101097223|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33327734|NCT02819635|101097224|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33327735|NCT02819635|101097225|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
33327736|NCT02819635|101097214|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33327737|NCT02819635|101097215|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33327738|NCT02819635|101097216|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33327739|NCT02819635|101097217|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33327740|NCT02819635|101097218|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33327741|NCT02819635|101097219|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
33327742|NCT02819635|101097220|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
33327743|NCT02819635|101097221|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33327744|NCT02819635|101097222|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33327745|NCT02819635|101097223|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33327746|NCT02819635|101097224|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33327747|NCT02819635|101097225|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
33327748|NCT02819635|101097214|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33327749|NCT02819635|101097215|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33327750|NCT02819635|101097216|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33327751|NCT02819635|101097217|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33327752|NCT02819635|101097218|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33327753|NCT02819635|101097219|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33327754|NCT02819635|101097220|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
33327755|NCT02819635|101097221|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33327756|NCT02819635|101097222|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33520229|NCT04526574|101800238|FG001|Overall Study|No longer meets eligibility criteria|8|||
33520230|NCT00106639|101800241|FG000|Overall Study|Adverse Event|3|||
33520231|NCT00106639|101800242|FG001|Overall Study|Adverse Event|4|||
33520232|NCT00106639|101800243|FG002|Overall Study|Adverse Event|1|||
33520233|NCT00106639|101800241|FG000|Overall Study|Protocol Violation|0|||
33520234|NCT00106639|101800242|FG001|Overall Study|Protocol Violation|1|||
33520235|NCT00106639|101800243|FG002|Overall Study|Protocol Violation|0|||
33520236|NCT00106639|101800241|FG000|Overall Study|Withdrawal by Subject|0|||
33520237|NCT00106639|101800242|FG001|Overall Study|Withdrawal by Subject|1|||
33520238|NCT00106639|101800243|FG002|Overall Study|Withdrawal by Subject|0|||
33520239|NCT00106639|101800241|FG000|Overall Study|Participant defaulted|0|||
33520240|NCT00106639|101800242|FG001|Overall Study|Participant defaulted|1|||
33520241|NCT00106639|101800243|FG002|Overall Study|Participant defaulted|1|||
33520242|NCT01764659|101800244|FG000|Overall Study|Death|1|||
33520243|NCT01764659|101800244|FG000|Overall Study|Physician Decision|1|||
33520244|NCT02305446|101800245|FG000|Overall Study|Adverse Event|1|||
33520245|NCT00830518|101800246|FG000|Overall Study|Progressive Disease|18|||
33520246|NCT00830518|101800247|FG001|Overall Study|Progressive Disease|8|||
33520247|NCT00830518|101800246|FG000|Overall Study|Symptomatic Deterioration|4|||
33608600|NCT03729245|102115132|FG001|Overall Study|Withdrawal by Subject|19|||
33200286|NCT02660359|100638274|FG001|Overall Study|Withdrawal by Subject|5|||
33327757|NCT02819635|101097223|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33327758|NCT02819635|101097224|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33327759|NCT02819635|101097225|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
33327760|NCT02819635|101097214|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
33327761|NCT02819635|101097215|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
33327762|NCT02819635|101097216|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
33327763|NCT02819635|101097217|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
33327764|NCT02819635|101097218|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
33327765|NCT02819635|101097219|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
33327766|NCT02819635|101097220|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
33327767|NCT02819635|101097221|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
33327768|NCT02819635|101097222|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
33327769|NCT02819635|101097223|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
33327770|NCT02819635|101097224|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
33327771|NCT02819635|101097225|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
33327772|NCT02819635|101097214|FG000|Substudy 2, Part 2|Adverse Event|0|||
33327773|NCT02819635|101097215|FG001|Substudy 2, Part 2|Adverse Event|0|||
33327774|NCT02819635|101097216|FG002|Substudy 2, Part 2|Adverse Event|0|||
33327775|NCT02819635|101097217|FG003|Substudy 2, Part 2|Adverse Event|0|||
33520248|NCT00830518|101800247|FG001|Overall Study|Symptomatic Deterioration|1|||
33608601|NCT03729245|102115131|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
33200287|NCT02660359|100638275|FG002|Overall Study|Withdrawal by Subject|8|||
33200288|NCT02660359|100638273|FG000|Overall Study|Lost to Follow-up|3|||
33200289|NCT02660359|100638274|FG001|Overall Study|Lost to Follow-up|3|||
33200290|NCT02660359|100638275|FG002|Overall Study|Lost to Follow-up|0|||
33200291|NCT04095858|100638276|FG000|Overall Study|Death|1|||
33200292|NCT04095858|100638277|FG001|Overall Study|Death|0|||
33200293|NCT04095858|100638276|FG000|Overall Study|Study terminated by Sponsor|2|||
33200294|NCT04095858|100638277|FG001|Overall Study|Study terminated by Sponsor|4|||
33200295|NCT02573324|100638278|FG000|Overall Study|Withdrawal by Subject|26|||
33200296|NCT02573324|100638279|FG001|Overall Study|Withdrawal by Subject|23|||
33200297|NCT02573324|100638280|FG002|Overall Study|Withdrawal by Subject|3|||
33200298|NCT02573324|100638278|FG000|Overall Study|Lost to Follow-up|4|||
33200299|NCT02573324|100638279|FG001|Overall Study|Lost to Follow-up|5|||
33200300|NCT02573324|100638280|FG002|Overall Study|Lost to Follow-up|0|||
33200301|NCT02573324|100638278|FG000|Overall Study|Study Terminated by Sponsor|107|||
33200302|NCT02573324|100638279|FG001|Overall Study|Study Terminated by Sponsor|89|||
33200303|NCT02573324|100638280|FG002|Overall Study|Study Terminated by Sponsor|2|||
33200304|NCT02573324|100638278|FG000|Overall Study|Death|182|||
33200305|NCT02573324|100638279|FG001|Overall Study|Death|200|||
33200306|NCT02573324|100638280|FG002|Overall Study|Death|1|||
33200307|NCT02573324|100638278|FG000|Overall Study|Other, Not Specified|20|||
33200308|NCT02573324|100638279|FG001|Overall Study|Other, Not Specified|27|||
33200309|NCT02573324|100638280|FG002|Overall Study|Other, Not Specified|0|||
33200310|NCT02573324|100638278|FG000|Overall Study|Unknown Reason|2|||
33200311|NCT02573324|100638279|FG001|Overall Study|Unknown Reason|0|||
33200312|NCT02573324|100638280|FG002|Overall Study|Unknown Reason|0|||
33200313|NCT01059617|100638283|FG000|Overall Study|Other|7|||
33200314|NCT01059617|100638284|FG001|Overall Study|Other|1|||
33200315|NCT01059617|100638285|FG002|Overall Study|Other|8|||
33200316|NCT01059617|100638286|FG003|Overall Study|Other|6|||
33200317|NCT01877421|100638295|FG000|Phase 2|Lost to Follow-up|0|||
33200318|NCT01877421|100638296|FG001|Phase 2|Lost to Follow-up|0|||
33200319|NCT01877421|100638297|FG002|Phase 2|Lost to Follow-up|0|||
33200320|NCT01877421|100638298|FG003|Phase 2|Lost to Follow-up|0|||
33200321|NCT01877421|100638299|FG004|Phase 2|Lost to Follow-up|0|||
33200322|NCT01877421|100638300|FG005|Phase 2|Lost to Follow-up|0|||
33520249|NCT00830518|101800246|FG000|Overall Study|Adverse Event|14|||
33520250|NCT00830518|101800247|FG001|Overall Study|Adverse Event|1|||
33520251|NCT00830518|101800246|FG000|Overall Study|Withdrawal by Patient|2|||
33200323|NCT01877421|100638301|FG006|Phase 2|Lost to Follow-up|1|||
33200324|NCT01877421|100638302|FG007|Phase 2|Lost to Follow-up|0|||
33608602|NCT03729245|102115132|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
33608603|NCT03689855|102115133|FG000|Overall Study|Adverse Event|3|||
33200325|NCT01877421|100638303|FG008|Phase 2|Lost to Follow-up|0|||
33200326|NCT01877421|100638304|FG009|Phase 2|Lost to Follow-up|0|||
33200327|NCT01877421|100638305|FG010|Phase 2|Lost to Follow-up|0|||
33200328|NCT01877421|100638306|FG011|Phase 2|Lost to Follow-up|0|||
33200329|NCT01877421|100638307|FG012|Phase 2|Lost to Follow-up|0|||
33200330|NCT01877421|100638308|FG013|Phase 2|Lost to Follow-up|0|||
33200331|NCT01877421|100638309|FG014|Phase 2|Lost to Follow-up|0|||
33200332|NCT01877421|100638310|FG015|Phase 2|Lost to Follow-up|0|||
33200333|NCT01877421|100638311|FG016|Phase 2|Lost to Follow-up|0|||
33200334|NCT01877421|100638312|FG017|Phase 2|Lost to Follow-up|0|||
33200335|NCT01877421|100638295|FG000|Phase 2|Withdrawal by Subject|0|||
33200336|NCT01877421|100638296|FG001|Phase 2|Withdrawal by Subject|0|||
33200337|NCT01877421|100638297|FG002|Phase 2|Withdrawal by Subject|0|||
33200338|NCT01877421|100638298|FG003|Phase 2|Withdrawal by Subject|0|||
33200339|NCT01877421|100638299|FG004|Phase 2|Withdrawal by Subject|0|||
33200340|NCT01877421|100638300|FG005|Phase 2|Withdrawal by Subject|0|||
33200341|NCT01877421|100638301|FG006|Phase 2|Withdrawal by Subject|0|||
33200342|NCT01877421|100638302|FG007|Phase 2|Withdrawal by Subject|0|||
33200343|NCT01877421|100638303|FG008|Phase 2|Withdrawal by Subject|1|||
33200344|NCT01877421|100638304|FG009|Phase 2|Withdrawal by Subject|0|||
33327776|NCT02819635|101097218|FG004|Substudy 2, Part 2|Adverse Event|0|||
33327777|NCT02819635|101097219|FG005|Substudy 2, Part 2|Adverse Event|4|||
33327778|NCT02819635|101097220|FG006|Substudy 2, Part 2|Adverse Event|0|||
33520252|NCT00830518|101800247|FG001|Overall Study|Withdrawal by Patient|0|||
33520253|NCT00830518|101800246|FG000|Overall Study|Reason not Specified|8|||
33520254|NCT00830518|101800247|FG001|Overall Study|Reason not Specified|1|||
33520255|NCT02912455|101800248|FG000|Overall Study|Withdrawal by Subject|0|||
33520256|NCT02912455|101800249|FG001|Overall Study|Withdrawal by Subject|1|||
33520257|NCT02912455|101800248|FG000|Overall Study|Lack of Efficacy|0|||
33520258|NCT02912455|101800249|FG001|Overall Study|Lack of Efficacy|1|||
33608604|NCT03689855|102115133|FG000|Overall Study|Withdrawal by Subject|1|||
33608605|NCT01439373|102115134|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
33608606|NCT01439373|102115135|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
33608607|NCT01439373|102115134|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
33608608|NCT01439373|102115135|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
33608609|NCT02725866|102115138|FG000|Overall Study|Failure to return|6|||
33608610|NCT02725866|102115138|FG000|Overall Study|Withdrew consent|3|||
33608611|NCT02725866|102115138|FG000|Overall Study|Insufficient virological response|1|||
33608612|NCT02725866|102115138|FG000|Overall Study|Other, not specified|4|||
33608613|NCT03244826|102115143|FG000|Overall Study|Withdrawal by Subject|2|||
33200345|NCT01877421|100638305|FG010|Phase 2|Withdrawal by Subject|1|||
33200346|NCT01877421|100638306|FG011|Phase 2|Withdrawal by Subject|0|||
33200347|NCT01877421|100638307|FG012|Phase 2|Withdrawal by Subject|1|||
33200348|NCT01877421|100638308|FG013|Phase 2|Withdrawal by Subject|0|||
33200349|NCT01877421|100638309|FG014|Phase 2|Withdrawal by Subject|0|||
33200350|NCT01877421|100638310|FG015|Phase 2|Withdrawal by Subject|1|||
33200351|NCT01877421|100638311|FG016|Phase 2|Withdrawal by Subject|0|||
33200352|NCT01877421|100638312|FG017|Phase 2|Withdrawal by Subject|0|||
33200353|NCT01877421|100638295|FG000|Phase 2|Protocol Violation|0|||
33520259|NCT02912455|101800248|FG000|Overall Study|Lost to Follow-up|2|||
33520260|NCT02912455|101800249|FG001|Overall Study|Lost to Follow-up|1|||
33520261|NCT00269477|101800250|FG000|Overall Study|Protocol Violation|5|||
33520262|NCT00269477|101800251|FG001|Overall Study|Protocol Violation|5|||
33520263|NCT00269477|101800252|FG002|Overall Study|Protocol Violation|1|||
33200354|NCT01877421|100638296|FG001|Phase 2|Protocol Violation|0|||
33200355|NCT01877421|100638297|FG002|Phase 2|Protocol Violation|0|||
33200356|NCT01877421|100638298|FG003|Phase 2|Protocol Violation|0|||
33200357|NCT01877421|100638299|FG004|Phase 2|Protocol Violation|0|||
33200358|NCT01877421|100638300|FG005|Phase 2|Protocol Violation|0|||
33327779|NCT02819635|101097221|FG007|Substudy 2, Part 2|Adverse Event|0|||
33520264|NCT00269477|101800253|FG003|Overall Study|Protocol Violation|0|||
33520265|NCT00269477|101800250|FG000|Overall Study|Missed post-vaccination blood draw|0|||
33608614|NCT03244826|102115144|FG001|Overall Study|Withdrawal by Subject|0|||
33608615|NCT03244826|102115143|FG000|Overall Study|Transplant delayed or withdrawn|12|||
33200359|NCT01877421|100638301|FG006|Phase 2|Protocol Violation|0|||
33327780|NCT02819635|101097222|FG008|Substudy 2, Part 2|Adverse Event|0|||
33327781|NCT02819635|101097223|FG009|Substudy 2, Part 2|Adverse Event|0|||
33327782|NCT02819635|101097224|FG010|Substudy 2, Part 2|Adverse Event|0|||
33327783|NCT02819635|101097225|FG011|Substudy 2, Part 2|Adverse Event|0|||
33327784|NCT02819635|101097214|FG000|Substudy 2, Part 2|Withdrew consent|0|||
33327785|NCT02819635|101097215|FG001|Substudy 2, Part 2|Withdrew consent|0|||
33327786|NCT02819635|101097216|FG002|Substudy 2, Part 2|Withdrew consent|0|||
33327787|NCT02819635|101097217|FG003|Substudy 2, Part 2|Withdrew consent|0|||
33327788|NCT02819635|101097218|FG004|Substudy 2, Part 2|Withdrew consent|0|||
33327789|NCT02819635|101097219|FG005|Substudy 2, Part 2|Withdrew consent|3|||
33327790|NCT02819635|101097220|FG006|Substudy 2, Part 2|Withdrew consent|1|||
33520266|NCT00269477|101800251|FG001|Overall Study|Missed post-vaccination blood draw|1|||
33608616|NCT03244826|102115144|FG001|Overall Study|Transplant delayed or withdrawn|10|||
33608617|NCT02126839|102115145|FG000|Overall Study|Adverse Event|0|||
33608618|NCT02126839|102115146|FG001|Overall Study|Adverse Event|1|||
33327791|NCT02819635|101097221|FG007|Substudy 2, Part 2|Withdrew consent|0|||
33327792|NCT02819635|101097222|FG008|Substudy 2, Part 2|Withdrew consent|0|||
33327793|NCT02819635|101097223|FG009|Substudy 2, Part 2|Withdrew consent|0|||
33520267|NCT00269477|101800252|FG002|Overall Study|Missed post-vaccination blood draw|0|||
33520268|NCT00269477|101800253|FG003|Overall Study|Missed post-vaccination blood draw|0|||
33520269|NCT03769194|101800256|FG000|Overall Study|Withdrawal by Subject|0|||
33520270|NCT03769194|101800257|FG001|Overall Study|Withdrawal by Subject|7|||
33520271|NCT03769194|101800258|FG002|Overall Study|Withdrawal by Subject|4|||
33520272|NCT03769194|101800259|FG003|Overall Study|Withdrawal by Subject|1|||
33520273|NCT03769194|101800256|FG000|Overall Study|moved from study area|0|||
33520274|NCT03769194|101800257|FG001|Overall Study|moved from study area|2|||
33520275|NCT03769194|101800258|FG002|Overall Study|moved from study area|1|||
33520276|NCT03769194|101800259|FG003|Overall Study|moved from study area|1|||
33520277|NCT03769194|101800256|FG000|Overall Study|Lost to Follow-up|3|||
33520278|NCT03769194|101800257|FG001|Overall Study|Lost to Follow-up|6|||
33520279|NCT03769194|101800258|FG002|Overall Study|Lost to Follow-up|3|||
33520280|NCT03769194|101800259|FG003|Overall Study|Lost to Follow-up|6|||
33520281|NCT03769194|101800256|FG000|Overall Study|other|1|||
33520282|NCT03769194|101800257|FG001|Overall Study|other|3|||
33520283|NCT03769194|101800258|FG002|Overall Study|other|0|||
33520284|NCT03769194|101800259|FG003|Overall Study|other|1|||
33520285|NCT02028169|101800262|FG000|Overall Study|Lost to Follow-up|21|||
33520286|NCT02028169|101800262|FG000|Overall Study|Lack of Efficacy|2|||
33520287|NCT02028169|101800262|FG000|Overall Study|Withdrawal by Subject|2|||
33520288|NCT02028169|101800262|FG000|Overall Study|Adverse Event|1|||
33520289|NCT02028169|101800262|FG000|Overall Study|Cessation of Drug|1|||
33520290|NCT02028169|101800262|FG000|Overall Study|Concomitant Medication Usage|1|||
33520291|NCT01618916|101800267|FG000|Overall Study|Adverse Event|1|||
33608619|NCT02126839|102115145|FG000|Overall Study|Withdrawal by Subject|1|||
33608620|NCT02126839|102115146|FG001|Overall Study|Withdrawal by Subject|0|||
33608621|NCT02126839|102115145|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33608622|NCT02126839|102115146|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33608623|NCT02126839|102115145|FG000|Overall Study|Protocol Violation|2|||
33608624|NCT02126839|102115146|FG001|Overall Study|Protocol Violation|3|||
33608625|NCT02126839|102115145|FG000|Overall Study|Sponsor request|0|||
33608626|NCT02126839|102115146|FG001|Overall Study|Sponsor request|1|||
33608627|NCT02126839|102115145|FG000|Overall Study|Lost to Follow-up|1|||
33608628|NCT02126839|102115146|FG001|Overall Study|Lost to Follow-up|4|||
33608629|NCT02126839|102115145|FG000|Overall Study|Other|5|||
33608630|NCT02126839|102115146|FG001|Overall Study|Other|5|||
33608631|NCT02936284|102115147|FG000|Overall Study|Withdrawal by Subject|3|||
33608632|NCT02936284|102115148|FG001|Overall Study|Withdrawal by Subject|1|||
33608633|NCT02936284|102115147|FG000|Overall Study|Lost to Follow-up|7|||
33608634|NCT02936284|102115148|FG001|Overall Study|Lost to Follow-up|8|||
33608635|NCT04544683|102115149|FG000|Overall Study|Lost to Follow-up|2|||
33608636|NCT04544683|102115149|FG000|Overall Study|Underwent cervical spine surgery|6|||
33608637|NCT03916484|102115152|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
33608638|NCT03916484|102115153|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
33608639|NCT03916484|102115154|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
33520292|NCT01618916|101800268|FG001|Overall Study|Adverse Event|0|||
33520293|NCT01618916|101800269|FG002|Overall Study|Adverse Event|0|||
33520294|NCT01618916|101800270|FG003|Overall Study|Adverse Event|0|||
33520295|NCT01618916|101800271|FG004|Overall Study|Adverse Event|0|||
33520296|NCT01618916|101800272|FG005|Overall Study|Adverse Event|0|||
33520297|NCT01618916|101800267|FG000|Overall Study|Withdrawal by Subject|0|||
33520298|NCT01618916|101800268|FG001|Overall Study|Withdrawal by Subject|1|||
33520299|NCT01618916|101800269|FG002|Overall Study|Withdrawal by Subject|1|||
33520300|NCT01618916|101800270|FG003|Overall Study|Withdrawal by Subject|0|||
33520301|NCT01618916|101800271|FG004|Overall Study|Withdrawal by Subject|1|||
33520302|NCT01618916|101800272|FG005|Overall Study|Withdrawal by Subject|0|||
33520303|NCT01618916|101800267|FG000|Overall Study|Lost to Follow-up|1|||
33520304|NCT01618916|101800268|FG001|Overall Study|Lost to Follow-up|0|||
33520305|NCT01618916|101800269|FG002|Overall Study|Lost to Follow-up|0|||
33520306|NCT01618916|101800270|FG003|Overall Study|Lost to Follow-up|2|||
33520307|NCT01618916|101800271|FG004|Overall Study|Lost to Follow-up|0|||
33520308|NCT01618916|101800272|FG005|Overall Study|Lost to Follow-up|0|||
33520309|NCT01926197|101800273|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
33520310|NCT01926197|101800274|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
33520311|NCT01926197|101800273|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
33520312|NCT01926197|101800274|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
33520313|NCT02685072|101800275|FG000|Treatment Period|Lost to Follow-up|12|||
33520314|NCT02685072|101800276|FG001|Treatment Period|Lost to Follow-up|6|||
33520315|NCT02685072|101800275|FG000|Treatment Period|Withdrawal by Subject|1|||
33520316|NCT02685072|101800276|FG001|Treatment Period|Withdrawal by Subject|3|||
33520317|NCT02685072|101800275|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
33520318|NCT02685072|101800276|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
33520319|NCT00659776|101800278|FG000|Overall Study|Withdrawal by Subject|12|||
33520320|NCT00659776|101800279|FG001|Overall Study|Withdrawal by Subject|2|||
33520321|NCT00659776|101800280|FG002|Overall Study|Withdrawal by Subject|0|||
33520322|NCT01210144|101800285|FG000|Overall Study|Lack of ovarian response|1|||
33520323|NCT01210144|101800286|FG001|Overall Study|Lack of ovarian response|0|||
33520324|NCT01210144|101800285|FG000|Overall Study|No fertilization|1|||
33520325|NCT01210144|101800286|FG001|Overall Study|No fertilization|0|||
33520326|NCT01210144|101800285|FG000|Overall Study|No transfer|1|||
33520327|NCT01210144|101800286|FG001|Overall Study|No transfer|0|||
33520328|NCT04150068|101800287|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
33520329|NCT04150068|101800288|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
33520330|NCT04150068|101800289|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
33520331|NCT04150068|101800287|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
33520332|NCT04150068|101800288|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
33520333|NCT04150068|101800289|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
33520334|NCT01285492|101800290|FG000|Overall Study|Adverse Event|11|||
33520335|NCT01285492|101800291|FG001|Overall Study|Adverse Event|0|||
33520336|NCT01285492|101800290|FG000|Overall Study|Protocol Violation|3|||
33520337|NCT01285492|101800291|FG001|Overall Study|Protocol Violation|0|||
33520338|NCT01285492|101800290|FG000|Overall Study|Withdrawal by Subject|2|||
33200360|NCT01877421|100638302|FG007|Phase 2|Protocol Violation|0|||
33520339|NCT01285492|101800291|FG001|Overall Study|Withdrawal by Subject|1|||
33520340|NCT01285492|101800290|FG000|Overall Study|Death|1|||
33608640|NCT03916484|102115155|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
33608641|NCT03916484|102115152|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
33608642|NCT03916484|102115153|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
33608643|NCT03916484|102115154|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
33520341|NCT01285492|101800291|FG001|Overall Study|Death|0|||
33200361|NCT01877421|100638303|FG008|Phase 2|Protocol Violation|0|||
33200362|NCT01877421|100638304|FG009|Phase 2|Protocol Violation|0|||
33200363|NCT01877421|100638305|FG010|Phase 2|Protocol Violation|1|||
33200364|NCT01877421|100638306|FG011|Phase 2|Protocol Violation|0|||
33327794|NCT02819635|101097224|FG010|Substudy 2, Part 2|Withdrew consent|0|||
33327795|NCT02819635|101097225|FG011|Substudy 2, Part 2|Withdrew consent|0|||
33200365|NCT01877421|100638307|FG012|Phase 2|Protocol Violation|0|||
33200366|NCT01877421|100638308|FG013|Phase 2|Protocol Violation|0|||
33200367|NCT01877421|100638309|FG014|Phase 2|Protocol Violation|0|||
33200368|NCT01877421|100638310|FG015|Phase 2|Protocol Violation|0|||
33200369|NCT01877421|100638311|FG016|Phase 2|Protocol Violation|0|||
33200370|NCT01877421|100638312|FG017|Phase 2|Protocol Violation|0|||
33200371|NCT02158039|100638313|FG000|Overall Study|Withdrawal by Subject|1|||
33200372|NCT02158039|100638313|FG000|Overall Study|Screen Failure|9|||
33200373|NCT03295201|100638314|FG000|Overall Study|Lost to Follow-up|1|||
33200374|NCT03295201|100638315|FG001|Overall Study|Lost to Follow-up|1|||
33200375|NCT03295201|100638314|FG000|Overall Study|Hospital admission|0|||
33200376|NCT03295201|100638315|FG001|Overall Study|Hospital admission|1|||
33200377|NCT00384085|100638326|FG000|Overall Study|Adverse Event|5|||
33327796|NCT02819635|101097214|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
33327797|NCT02819635|101097215|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
33327798|NCT02819635|101097216|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
33327799|NCT02819635|101097217|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
33327800|NCT02819635|101097218|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
33327801|NCT02819635|101097219|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
33327802|NCT02819635|101097220|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
33327803|NCT02819635|101097221|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
33327804|NCT02819635|101097222|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
33327805|NCT02819635|101097223|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
33327806|NCT02819635|101097224|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
33327807|NCT02819635|101097225|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
33327808|NCT02819635|101097214|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33327809|NCT02819635|101097215|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33327810|NCT02819635|101097216|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33327811|NCT02819635|101097217|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33327812|NCT02819635|101097218|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33327813|NCT02819635|101097219|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33327814|NCT02819635|101097220|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
33520342|NCT00494221|101800293|FG000|Overall Study|Death|15|||
33520343|NCT00494221|101800294|FG001|Overall Study|Death|9|||
33520344|NCT00494221|101800295|FG002|Overall Study|Death|14|||
33520345|NCT00494221|101800293|FG000|Overall Study|Withdrawal by Subject|1|||
33200378|NCT00384085|100638327|FG001|Overall Study|Adverse Event|5|||
33200379|NCT00384085|100638328|FG002|Overall Study|Adverse Event|4|||
33200380|NCT00384085|100638326|FG000|Overall Study|Lack of Efficacy|0|||
33200381|NCT00384085|100638327|FG001|Overall Study|Lack of Efficacy|3|||
33200382|NCT00384085|100638328|FG002|Overall Study|Lack of Efficacy|2|||
33327815|NCT02819635|101097221|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33327816|NCT02819635|101097222|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33327817|NCT02819635|101097223|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33327818|NCT02819635|101097224|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33200383|NCT00384085|100638326|FG000|Overall Study|No longer Requires Study Treatment|1|||
33520346|NCT00494221|101800294|FG001|Overall Study|Withdrawal by Subject|2|||
33520347|NCT00494221|101800295|FG002|Overall Study|Withdrawal by Subject|0|||
33520348|NCT01366638|101800296|FG000|Overall Study|Withdrawal by Subject|0|||
33520349|NCT01366638|101800297|FG001|Overall Study|Withdrawal by Subject|0|||
33520350|NCT01366638|101800298|FG002|Overall Study|Withdrawal by Subject|6|||
33520351|NCT01366638|101800296|FG000|Overall Study|Other|1|||
33520352|NCT01366638|101800297|FG001|Overall Study|Other|0|||
33520353|NCT01366638|101800298|FG002|Overall Study|Other|0|||
33520354|NCT03611582|101800303|FG000|Overall Study|Adverse Event|26|||
33520355|NCT03611582|101800304|FG001|Overall Study|Adverse Event|6|||
33520356|NCT03611582|101800303|FG000|Overall Study|Protocol Violation|0|||
33520357|NCT03611582|101800304|FG001|Overall Study|Protocol Violation|1|||
33520358|NCT03611582|101800303|FG000|Overall Study|Pregnancy|1|||
33520359|NCT03611582|101800304|FG001|Overall Study|Pregnancy|2|||
33520360|NCT03611582|101800303|FG000|Overall Study|Lack of Efficacy|0|||
33520361|NCT03611582|101800304|FG001|Overall Study|Lack of Efficacy|1|||
33520362|NCT03611582|101800303|FG000|Overall Study|At the discretion of the investigator|1|||
33520363|NCT03611582|101800304|FG001|Overall Study|At the discretion of the investigator|0|||
33520364|NCT03611582|101800303|FG000|Overall Study|Safety concern as judged by the investigator|1|||
33520365|NCT03611582|101800304|FG001|Overall Study|Safety concern as judged by the investigator|2|||
33520366|NCT03611582|101800303|FG000|Overall Study|Withdrawal by Subject|4|||
33520367|NCT03611582|101800304|FG001|Overall Study|Withdrawal by Subject|3|||
33520368|NCT03611582|101800303|FG000|Overall Study|Lost to Follow-up|18|||
33520369|NCT03611582|101800304|FG001|Overall Study|Lost to Follow-up|7|||
33520370|NCT03611582|101800303|FG000|Overall Study|other|17|||
33520371|NCT03611582|101800304|FG001|Overall Study|other|16|||
33520372|NCT03877224|101800308|FG000|Overall Study|Death|3|||
33520373|NCT03877224|101800309|FG001|Overall Study|Death|2|||
33520374|NCT03877224|101800308|FG000|Overall Study|Withdrawal by Subject|1|||
33520375|NCT03877224|101800309|FG001|Overall Study|Withdrawal by Subject|6|||
33520376|NCT03877224|101800308|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
33520377|NCT03877224|101800309|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
33520378|NCT02147067|101800321|FG000|Overall Study|Withdrawal by Subject|2|||
33520379|NCT02147067|101800322|FG001|Overall Study|Withdrawal by Subject|2|||
33520380|NCT01627782|101800326|FG000|Overall Study|Adverse Event|1|||
33520381|NCT01627782|101800327|FG001|Overall Study|Adverse Event|2|||
33520382|NCT01627782|101800328|FG002|Overall Study|Adverse Event|0|||
33520383|NCT01627782|101800329|FG003|Overall Study|Adverse Event|1|||
33520384|NCT01627782|101800326|FG000|Overall Study|Lack of Efficacy|11|||
33520385|NCT01627782|101800327|FG001|Overall Study|Lack of Efficacy|1|||
33520386|NCT01627782|101800328|FG002|Overall Study|Lack of Efficacy|15|||
33520387|NCT01627782|101800329|FG003|Overall Study|Lack of Efficacy|2|||
33520388|NCT01627782|101800326|FG000|Overall Study|Protocol Violation|1|||
33520389|NCT01627782|101800327|FG001|Overall Study|Protocol Violation|0|||
33520390|NCT01627782|101800328|FG002|Overall Study|Protocol Violation|0|||
33520391|NCT01627782|101800329|FG003|Overall Study|Protocol Violation|0|||
33520392|NCT01627782|101800326|FG000|Overall Study|Withdrawal by Subject|2|||
33520393|NCT01627782|101800327|FG001|Overall Study|Withdrawal by Subject|1|||
33520394|NCT01627782|101800328|FG002|Overall Study|Withdrawal by Subject|0|||
33520395|NCT01627782|101800329|FG003|Overall Study|Withdrawal by Subject|0|||
33520396|NCT01627782|101800326|FG000|Overall Study|Other|0|||
33520397|NCT01627782|101800327|FG001|Overall Study|Other|2|||
33520398|NCT01627782|101800328|FG002|Overall Study|Other|0|||
33520399|NCT01627782|101800329|FG003|Overall Study|Other|3|||
33520400|NCT01627782|101800326|FG000|Overall Study|Randomized But Not Treated|1|||
33520401|NCT01627782|101800327|FG001|Overall Study|Randomized But Not Treated|0|||
33520402|NCT01627782|101800328|FG002|Overall Study|Randomized But Not Treated|0|||
33520403|NCT01627782|101800329|FG003|Overall Study|Randomized But Not Treated|0|||
33520404|NCT01333956|101800346|FG000|Overall Study|Lost to Follow-up|1|||
33401018|NCT02425891|101356920|FG001|Overall Study|Protocol Violation|1|||
33401019|NCT02425891|101356919|FG000|Overall Study|Study Terminated By Sponsor|85|||
33401020|NCT02425891|101356920|FG001|Overall Study|Study Terminated By Sponsor|95|||
33401021|NCT02425891|101356919|FG000|Overall Study|Withdrawal by Subject|27|||
33401022|NCT02425891|101356920|FG001|Overall Study|Withdrawal by Subject|32|||
33401023|NCT00672139|101356921|FG000|Overall Study|Death|14|||
33520405|NCT01333956|101800347|FG001|Overall Study|Lost to Follow-up|2|||
33520406|NCT01333956|101800348|FG002|Overall Study|Lost to Follow-up|0|||
33520407|NCT01333956|101800349|FG003|Overall Study|Lost to Follow-up|1|||
33520408|NCT01333956|101800346|FG000|Overall Study|Unable to complete study procedure|1|||
33520409|NCT01333956|101800347|FG001|Overall Study|Unable to complete study procedure|0|||
33520410|NCT01333956|101800348|FG002|Overall Study|Unable to complete study procedure|0|||
33520411|NCT01333956|101800349|FG003|Overall Study|Unable to complete study procedure|1|||
33520412|NCT01333956|101800346|FG000|Overall Study|Withdrawal by Subject|0|||
33520413|NCT01333956|101800347|FG001|Overall Study|Withdrawal by Subject|2|||
33520414|NCT01333956|101800348|FG002|Overall Study|Withdrawal by Subject|1|||
33520415|NCT01333956|101800349|FG003|Overall Study|Withdrawal by Subject|0|||
33520416|NCT04490018|101803206|FG000|Overall Study|Protocol Violation|0|||
33520417|NCT04490018|101803207|FG001|Overall Study|Protocol Violation|2|||
33520418|NCT04490018|101803208|FG002|Overall Study|Protocol Violation|1|||
33520419|NCT04490018|101803206|FG000|Overall Study|Lost to Follow-up|2|||
33520420|NCT04490018|101803207|FG001|Overall Study|Lost to Follow-up|2|||
33520421|NCT04490018|101803208|FG002|Overall Study|Lost to Follow-up|0|||
33520422|NCT04490018|101803206|FG000|Overall Study|Withdrawal by Subject|2|||
33520423|NCT04490018|101803207|FG001|Overall Study|Withdrawal by Subject|1|||
33520424|NCT04490018|101803208|FG002|Overall Study|Withdrawal by Subject|0|||
33520425|NCT04490018|101803206|FG000|Overall Study|Withdrawal by parent/guardian|2|||
33520426|NCT04490018|101803207|FG001|Overall Study|Withdrawal by parent/guardian|3|||
33520427|NCT04490018|101803208|FG002|Overall Study|Withdrawal by parent/guardian|0|||
33520428|NCT02696434|101803209|FG000|Overall Study|Adverse Event|3|||
33520429|NCT02696434|101803210|FG001|Overall Study|Adverse Event|1|||
33520430|NCT02696434|101803209|FG000|Overall Study|Lost to Follow-up|5|||
33520431|NCT02696434|101803210|FG001|Overall Study|Lost to Follow-up|4|||
33520432|NCT02696434|101803209|FG000|Overall Study|Withdrawal by Subject|14|||
33520433|NCT02696434|101803210|FG001|Overall Study|Withdrawal by Subject|12|||
33520434|NCT02696434|101803209|FG000|Overall Study|Physician Decision|0|||
33520435|NCT02696434|101803210|FG001|Overall Study|Physician Decision|1|||
33520436|NCT00426660|101803213|FG000|Overall Study|Death|14|||
33520437|NCT00426660|101803213|FG000|Overall Study|Adverse Event|23|||
33520438|NCT00426660|101803213|FG000|Overall Study|Insufficient Clinical Response|22|||
33520439|NCT00426660|101803213|FG000|Overall Study|Lost to Follow-up|15|||
33520440|NCT00426660|101803213|FG000|Overall Study|Other|23|||
33520441|NCT00426660|101803213|FG000|Overall Study|Withdrawal by Subject|18|||
33520442|NCT00426660|101803213|FG000|Overall Study|Protocol Violation|1|||
33520443|NCT00426660|101803213|FG000|Overall Study|Enrolled Not Treated|15|||
33608644|NCT03916484|102115155|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
33327819|NCT02819635|101097225|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
33327820|NCT02819635|101097214|FG000|Substudy 2, Part 2|Other, not specified|0|||
33327821|NCT02819635|101097215|FG001|Substudy 2, Part 2|Other, not specified|0|||
33327822|NCT02819635|101097216|FG002|Substudy 2, Part 2|Other, not specified|0|||
33327823|NCT02819635|101097217|FG003|Substudy 2, Part 2|Other, not specified|0|||
33327824|NCT02819635|101097218|FG004|Substudy 2, Part 2|Other, not specified|0|||
33327825|NCT02819635|101097219|FG005|Substudy 2, Part 2|Other, not specified|4|||
33327826|NCT02819635|101097220|FG006|Substudy 2, Part 2|Other, not specified|8|||
33327827|NCT02819635|101097221|FG007|Substudy 2, Part 2|Other, not specified|0|||
33327828|NCT02819635|101097222|FG008|Substudy 2, Part 2|Other, not specified|0|||
33327829|NCT02819635|101097223|FG009|Substudy 2, Part 2|Other, not specified|0|||
33327830|NCT02819635|101097224|FG010|Substudy 2, Part 2|Other, not specified|0|||
33327831|NCT02819635|101097225|FG011|Substudy 2, Part 2|Other, not specified|0|||
33327832|NCT02819635|101097214|FG000|Substudy 3|Adverse Event|0|||
33327833|NCT02819635|101097215|FG001|Substudy 3|Adverse Event|0|||
33327834|NCT02819635|101097216|FG002|Substudy 3|Adverse Event|0|||
33327835|NCT02819635|101097217|FG003|Substudy 3|Adverse Event|0|||
33327836|NCT02819635|101097218|FG004|Substudy 3|Adverse Event|0|||
33327837|NCT02819635|101097219|FG005|Substudy 3|Adverse Event|0|||
33327838|NCT02819635|101097220|FG006|Substudy 3|Adverse Event|0|||
33327839|NCT02819635|101097221|FG007|Substudy 3|Adverse Event|0|||
33327840|NCT02819635|101097222|FG008|Substudy 3|Adverse Event|32|||
33327841|NCT02819635|101097223|FG009|Substudy 3|Adverse Event|3|||
33327842|NCT02819635|101097224|FG010|Substudy 3|Adverse Event|12|||
33327843|NCT02819635|101097225|FG011|Substudy 3|Adverse Event|18|||
33327844|NCT02819635|101097214|FG000|Substudy 3|Withdrew consent|0|||
33327845|NCT02819635|101097215|FG001|Substudy 3|Withdrew consent|0|||
33327846|NCT02819635|101097216|FG002|Substudy 3|Withdrew consent|0|||
33327847|NCT02819635|101097217|FG003|Substudy 3|Withdrew consent|0|||
33327848|NCT02819635|101097218|FG004|Substudy 3|Withdrew consent|0|||
33327849|NCT02819635|101097219|FG005|Substudy 3|Withdrew consent|0|||
33327850|NCT02819635|101097220|FG006|Substudy 3|Withdrew consent|0|||
33327851|NCT02819635|101097221|FG007|Substudy 3|Withdrew consent|0|||
33327852|NCT02819635|101097222|FG008|Substudy 3|Withdrew consent|11|||
33327853|NCT02819635|101097223|FG009|Substudy 3|Withdrew consent|1|||
33327854|NCT02819635|101097224|FG010|Substudy 3|Withdrew consent|4|||
33327855|NCT02819635|101097225|FG011|Substudy 3|Withdrew consent|9|||
33401024|NCT00672139|101356922|FG001|Overall Study|Death|23|||
33327856|NCT02819635|101097214|FG000|Substudy 3|Lost to Follow-up|0|||
33327857|NCT02819635|101097215|FG001|Substudy 3|Lost to Follow-up|0|||
33520444|NCT01739764|101803214|FG000|Overall Study|Adverse Event|0|||
33520445|NCT01739764|101803215|FG001|Overall Study|Adverse Event|3|||
33520446|NCT01739764|101803216|FG002|Overall Study|Adverse Event|4|||
33520447|NCT01739764|101803214|FG000|Overall Study|Death|4|||
33520448|NCT01739764|101803215|FG001|Overall Study|Death|6|||
33520449|NCT01739764|101803216|FG002|Overall Study|Death|38|||
33520450|NCT01739764|101803214|FG000|Overall Study|Lost to Follow-up|0|||
33520451|NCT01739764|101803215|FG001|Overall Study|Lost to Follow-up|0|||
33520452|NCT01739764|101803216|FG002|Overall Study|Lost to Follow-up|5|||
33520453|NCT01739764|101803214|FG000|Overall Study|Non-Compliance|0|||
33520454|NCT01739764|101803215|FG001|Overall Study|Non-Compliance|0|||
33520455|NCT01739764|101803216|FG002|Overall Study|Non-Compliance|1|||
33520456|NCT01739764|101803214|FG000|Overall Study|Multiple Reasons|3|||
33520457|NCT01739764|101803215|FG001|Overall Study|Multiple Reasons|2|||
33520458|NCT01739764|101803216|FG002|Overall Study|Multiple Reasons|3|||
33520459|NCT01739764|101803214|FG000|Overall Study|Physician Decision|2|||
33520460|NCT01739764|101803215|FG001|Overall Study|Physician Decision|2|||
33520461|NCT01739764|101803216|FG002|Overall Study|Physician Decision|4|||
33520462|NCT01739764|101803214|FG000|Overall Study|Progressive Disease|3|||
33520463|NCT01739764|101803215|FG001|Overall Study|Progressive Disease|5|||
33520464|NCT01739764|101803216|FG002|Overall Study|Progressive Disease|16|||
33520465|NCT01739764|101803214|FG000|Overall Study|Protocol Violation|0|||
33520466|NCT01739764|101803215|FG001|Overall Study|Protocol Violation|0|||
33520467|NCT01739764|101803216|FG002|Overall Study|Protocol Violation|2|||
33520468|NCT01739764|101803214|FG000|Overall Study|Study Terminated by Sponsor|8|||
33520469|NCT01739764|101803215|FG001|Overall Study|Study Terminated by Sponsor|13|||
33520470|NCT01739764|101803216|FG002|Overall Study|Study Terminated by Sponsor|26|||
33520471|NCT01739764|101803214|FG000|Overall Study|Withdrawal by Subject|6|||
33520472|NCT01739764|101803215|FG001|Overall Study|Withdrawal by Subject|5|||
33520473|NCT01739764|101803216|FG002|Overall Study|Withdrawal by Subject|27|||
33520474|NCT02735096|101803217|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
33520475|NCT01389258|101803221|FG000|Overall Study|Lost to Follow-up|5|||
33520476|NCT02971800|101803222|FG000|Overall Study|Protocol Violation|1|||
33520477|NCT02971800|101803222|FG000|Overall Study|Withdrawal by Subject|1|||
33520478|NCT02971800|101803222|FG000|Overall Study|Exclusion criteria prior intervention|1|||
33520479|NCT02971800|101803222|FG000|Overall Study|Number evaluable participant already reached|4|||
33520480|NCT02536781|101803223|FG000|Overall Study|Lost to Follow-up|2|||
33520481|NCT02536781|101803224|FG001|Overall Study|Lost to Follow-up|0|||
33520482|NCT01903993|101803225|FG000|Overall Study|Death|118|||
33520483|NCT01903993|101803226|FG001|Overall Study|Death|121|||
33520484|NCT01903993|101803225|FG000|Overall Study|Withdrawal by Subject|15|||
33520485|NCT01903993|101803226|FG001|Overall Study|Withdrawal by Subject|4|||
33520486|NCT01903993|101803225|FG000|Overall Study|Lost to Follow-up|2|||
33520487|NCT01903993|101803226|FG001|Overall Study|Lost to Follow-up|3|||
33520488|NCT01903993|101803225|FG000|Overall Study|Study Terminated by Sponsor|8|||
33520489|NCT01903993|101803226|FG001|Overall Study|Study Terminated by Sponsor|14|||
33520490|NCT01903993|101803225|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
33520491|NCT01903993|101803226|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
33520492|NCT00862459|101803227|FG000|Overall Study|Lost to Follow-up|1|||
33520493|NCT00862459|101803228|FG001|Overall Study|Lost to Follow-up|2|||
33520494|NCT00862459|101803229|FG002|Overall Study|Lost to Follow-up|2|||
33520495|NCT00862459|101803227|FG000|Overall Study|Protocol Violation|1|||
33520496|NCT00862459|101803228|FG001|Overall Study|Protocol Violation|0|||
33520497|NCT00862459|101803229|FG002|Overall Study|Protocol Violation|0|||
33520498|NCT00862459|101803227|FG000|Overall Study|Withdrawal by Subject|1|||
33520499|NCT00862459|101803228|FG001|Overall Study|Withdrawal by Subject|1|||
33520500|NCT00862459|101803229|FG002|Overall Study|Withdrawal by Subject|3|||
33520501|NCT00862459|101803227|FG000|Overall Study|Adverse Event|0|||
33520502|NCT00862459|101803228|FG001|Overall Study|Adverse Event|1|||
33520503|NCT00862459|101803229|FG002|Overall Study|Adverse Event|0|||
33520504|NCT00862459|101803227|FG000|Overall Study|Personal reasons|1|||
33520505|NCT00862459|101803228|FG001|Overall Study|Personal reasons|0|||
33520506|NCT00862459|101803229|FG002|Overall Study|Personal reasons|0|||
33520507|NCT00862459|101803227|FG000|Overall Study|Operation|1|||
33520508|NCT00862459|101803228|FG001|Overall Study|Operation|1|||
33520509|NCT00862459|101803229|FG002|Overall Study|Operation|0|||
33520510|NCT00862459|101803227|FG000|Overall Study|Intravenous (IV) site problems|1|||
33520511|NCT00862459|101803228|FG001|Overall Study|Intravenous (IV) site problems|0|||
33608645|NCT01140061|102115156|FG000|Part I|Adverse Event|1|||
33608646|NCT01140061|102115157|FG001|Part I|Adverse Event|0|||
33327858|NCT02819635|101097216|FG002|Substudy 3|Lost to Follow-up|0|||
33327859|NCT02819635|101097217|FG003|Substudy 3|Lost to Follow-up|0|||
33327860|NCT02819635|101097218|FG004|Substudy 3|Lost to Follow-up|0|||
33608647|NCT01140061|102115158|FG002|Part I|Adverse Event|0|||
33608648|NCT01140061|102115159|FG003|Part I|Adverse Event|0|||
33327861|NCT02819635|101097219|FG005|Substudy 3|Lost to Follow-up|0|||
33327862|NCT02819635|101097220|FG006|Substudy 3|Lost to Follow-up|0|||
33520512|NCT00862459|101803229|FG002|Overall Study|Intravenous (IV) site problems|1|||
33520513|NCT00862459|101803227|FG000|Overall Study|Unable to hold still for imaging|0|||
33520514|NCT00862459|101803228|FG001|Overall Study|Unable to hold still for imaging|1|||
33520515|NCT00862459|101803229|FG002|Overall Study|Unable to hold still for imaging|0|||
33520516|NCT00862459|101803227|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
33520517|NCT00862459|101803228|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
33520518|NCT00862459|101803229|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
33520519|NCT00862459|101803227|FG000|Overall Study|Administrative problems|0|||
33520520|NCT00862459|101803228|FG001|Overall Study|Administrative problems|1|||
33520521|NCT00862459|101803229|FG002|Overall Study|Administrative problems|0|||
33608649|NCT01140061|102115160|FG004|Part I|Adverse Event|0|||
33520522|NCT00396383|101803230|FG000|Overall Study|Death|2|||
33520523|NCT00396383|101803230|FG000|Overall Study|Lost to Follow-up|1|||
33520524|NCT00577005|101803231|FG000|Overall Study|Lost to Follow-up|3|||
33520525|NCT00577005|101803232|FG001|Overall Study|Lost to Follow-up|2|||
33520526|NCT00577005|101803231|FG000|Overall Study|Withdrawal by Subject|2|||
33608650|NCT01140061|102115161|FG005|Part I|Adverse Event|0|||
33608651|NCT01140061|102115162|FG006|Part I|Adverse Event|0|||
33608652|NCT01140061|102115163|FG007|Part I|Adverse Event|0|||
33327863|NCT02819635|101097221|FG007|Substudy 3|Lost to Follow-up|0|||
33520527|NCT00577005|101803232|FG001|Overall Study|Withdrawal by Subject|1|||
33520528|NCT02787083|101803240|FG000|Overall Study|Adverse Event|1|||
33520529|NCT02787083|101803241|FG001|Overall Study|Adverse Event|0|||
33520530|NCT02787083|101803240|FG000|Overall Study|Withdrawal by Subject|2|||
33520531|NCT02787083|101803241|FG001|Overall Study|Withdrawal by Subject|2|||
33520532|NCT02273908|101803242|FG000|Overall Study|Adverse Event|16|||
33520533|NCT02273908|101803243|FG001|Overall Study|Adverse Event|0|||
33520534|NCT02273908|101803242|FG000|Overall Study|Lost to Follow-up|10|||
33520535|NCT02273908|101803243|FG001|Overall Study|Lost to Follow-up|1|||
33520536|NCT02273908|101803242|FG000|Overall Study|Did not meet entrance criteria|3|||
33520537|NCT02273908|101803243|FG001|Overall Study|Did not meet entrance criteria|2|||
33520538|NCT02273908|101803242|FG000|Overall Study|Withdrawal by Subject|4|||
33520539|NCT02273908|101803243|FG001|Overall Study|Withdrawal by Subject|2|||
33520540|NCT02083653|101803244|FG000|Overall Study|Randomized but not Treated|0|||
33520541|NCT02083653|101803245|FG001|Overall Study|Randomized but not Treated|2|||
33520542|NCT02083653|101803246|FG002|Overall Study|Randomized but not Treated|7|||
33520543|NCT02083653|101803244|FG000|Overall Study|Adverse Event|12|||
33520544|NCT02083653|101803245|FG001|Overall Study|Adverse Event|5|||
33520545|NCT02083653|101803246|FG002|Overall Study|Adverse Event|4|||
33520546|NCT02083653|101803244|FG000|Overall Study|Lost to Follow-up|1|||
33520547|NCT02083653|101803245|FG001|Overall Study|Lost to Follow-up|0|||
33520548|NCT02083653|101803246|FG002|Overall Study|Lost to Follow-up|0|||
33520549|NCT02083653|101803244|FG000|Overall Study|Death|2|||
33520550|NCT02083653|101803245|FG001|Overall Study|Death|2|||
33520551|NCT02083653|101803246|FG002|Overall Study|Death|2|||
33520552|NCT02083653|101803244|FG000|Overall Study|Progressive Disease|65|||
33520553|NCT02083653|101803245|FG001|Overall Study|Progressive Disease|73|||
33520554|NCT02083653|101803246|FG002|Overall Study|Progressive Disease|63|||
33520555|NCT02083653|101803244|FG000|Overall Study|Withdrawal by Subject|2|||
33520556|NCT02083653|101803245|FG001|Overall Study|Withdrawal by Subject|1|||
33520557|NCT02083653|101803246|FG002|Overall Study|Withdrawal by Subject|2|||
33520558|NCT02083653|101803244|FG000|Overall Study|Other Events|0|||
33520559|NCT02083653|101803245|FG001|Overall Study|Other Events|2|||
33520560|NCT02083653|101803246|FG002|Overall Study|Other Events|2|||
33520561|NCT02083653|101803244|FG000|Overall Study|Reason Missing|0|||
33520562|NCT02083653|101803245|FG001|Overall Study|Reason Missing|0|||
33520563|NCT02083653|101803246|FG002|Overall Study|Reason Missing|4|||
33520564|NCT00422292|101803251|FG000|Overall Study|Serious adverse events|1|||
33520565|NCT00422292|101803252|FG001|Overall Study|Serious adverse events|4|||
33520566|NCT00422292|101803253|FG002|Overall Study|Serious adverse events|0|||
33520567|NCT00422292|101803254|FG003|Overall Study|Serious adverse events|0|||
33520568|NCT00422292|101803251|FG000|Overall Study|Adverse Event|1|||
33520569|NCT00422292|101803252|FG001|Overall Study|Adverse Event|0|||
33520570|NCT00422292|101803253|FG002|Overall Study|Adverse Event|1|||
33520571|NCT00422292|101803254|FG003|Overall Study|Adverse Event|0|||
33520572|NCT00422292|101803251|FG000|Overall Study|Protocol Violation|4|||
33520573|NCT00422292|101803252|FG001|Overall Study|Protocol Violation|25|||
33520574|NCT00422292|101803253|FG002|Overall Study|Protocol Violation|8|||
33520575|NCT00422292|101803254|FG003|Overall Study|Protocol Violation|5|||
33520576|NCT00422292|101803251|FG000|Overall Study|Lost to Follow-up|6|||
33520577|NCT00422292|101803252|FG001|Overall Study|Lost to Follow-up|12|||
33520578|NCT00422292|101803253|FG002|Overall Study|Lost to Follow-up|6|||
33608653|NCT01140061|102115164|FG008|Part I|Adverse Event|0|||
33520579|NCT00422292|101803254|FG003|Overall Study|Lost to Follow-up|6|||
33608654|NCT01140061|102115165|FG009|Part I|Adverse Event|0|||
33327864|NCT02819635|101097222|FG008|Substudy 3|Lost to Follow-up|1|||
33608655|NCT01140061|102115156|FG000|Extension|Laboratory Adverse Event|0|||
33327865|NCT02819635|101097223|FG009|Substudy 3|Lost to Follow-up|0|||
33520580|NCT00422292|101803251|FG000|Overall Study|Withdrawal by Subject|6|||
33520581|NCT00422292|101803252|FG001|Overall Study|Withdrawal by Subject|25|||
33520582|NCT00422292|101803253|FG002|Overall Study|Withdrawal by Subject|7|||
33520583|NCT00422292|101803254|FG003|Overall Study|Withdrawal by Subject|13|||
33520584|NCT01156051|101803257|FG000|Overall Study|Lost to Follow-up|1|||
33520585|NCT01156051|101803258|FG001|Overall Study|Lost to Follow-up|0|||
33520586|NCT01156051|101803257|FG000|Overall Study|patient not compliant with protocol|0|||
33520587|NCT01156051|101803258|FG001|Overall Study|patient not compliant with protocol|1|||
33520588|NCT05095311|101803260|FG000|Overall Study|Lost to Follow-up|7|||
33520589|NCT05095311|101803261|FG001|Overall Study|Lost to Follow-up|0|||
33520590|NCT05095311|101803262|FG002|Overall Study|Lost to Follow-up|0|||
33520591|NCT00520767|101803264|FG000|Overall Study|Death|2|||
33608656|NCT01140061|102115157|FG001|Extension|Laboratory Adverse Event|0|||
33520592|NCT02661061|101803268|FG000|Overall Study|Lack of Efficacy|1|||
33520593|NCT02661061|101803269|FG001|Overall Study|Lack of Efficacy|1|||
33520594|NCT02661061|101803268|FG000|Overall Study|Withdrawal by Subject|1|||
33520595|NCT02661061|101803269|FG001|Overall Study|Withdrawal by Subject|1|||
33520596|NCT02045732|101803272|FG000|Overall Study|At the discretion of the investigator|1|||
33520597|NCT02045732|101803273|FG001|Overall Study|At the discretion of the investigator|1|||
33520598|NCT00586898|101803275|FG000|Overall Study|Adverse Event|1|||
33520599|NCT00586898|101803275|FG000|Overall Study|Patiemt Non-compliance|1|||
33520600|NCT00586898|101803275|FG000|Overall Study|Evaluable for Toxicity Only|5|||
33520601|NCT01250171|101803276|FG000|Overall Study|Administrative reasons|1|||
33520602|NCT01250171|101803277|FG001|Overall Study|Administrative reasons|0|||
33520603|NCT01250171|101803278|FG002|Overall Study|Administrative reasons|0|||
33520604|NCT00628927|101803279|FG000|Overall Study|Problems performing blood draw|6|||
33520605|NCT00628927|101803280|FG001|Overall Study|Problems performing blood draw|0|||
33520606|NCT00628927|101803279|FG000|Overall Study|Lost to Follow-up|1|||
33520607|NCT00628927|101803280|FG001|Overall Study|Lost to Follow-up|0|||
33520608|NCT00628927|101803279|FG000|Overall Study|Equipment failure|1|||
33520609|NCT00628927|101803280|FG001|Overall Study|Equipment failure|0|||
33520610|NCT03597139|101803281|FG000|Overall Study|Adverse Event|3|||
33520611|NCT03597139|101803282|FG001|Overall Study|Adverse Event|0|||
33520612|NCT03597139|101803281|FG000|Overall Study|Protocol Non-compliance|1|||
33520613|NCT03597139|101803282|FG001|Overall Study|Protocol Non-compliance|0|||
33520614|NCT03970200|101803287|FG000|Overall Study|Death|2|||
33520615|NCT03970200|101803288|FG001|Overall Study|Death|2|||
33520616|NCT03970200|101803289|FG002|Overall Study|Death|1|||
33520617|NCT03970200|101803287|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
33520618|NCT03970200|101803288|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
33520619|NCT03970200|101803289|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
33520620|NCT01935128|101803290|FG000|Overall Study|Death|1|||
33520621|NCT01935128|101803290|FG000|Overall Study|Adverse Event|6|||
33520622|NCT00636961|101803293|FG000|Period 1|Administrative problems|1|||
33520623|NCT00636961|101803294|FG001|Period 1|Administrative problems|1|||
33520624|NCT00636961|101803293|FG000|Period 2|Adverse Event|1|||
33520625|NCT00636961|101803294|FG001|Period 2|Adverse Event|0|||
33520626|NCT03760458|101803297|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
33520627|NCT03760458|101803298|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
33520628|NCT03760458|101803299|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
33520629|NCT03760458|101803300|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
33520630|NCT03760458|101803301|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
33520631|NCT01451164|101803302|FG000|Overall Study|Adverse Event|19|||
33520632|NCT01451164|101803303|FG001|Overall Study|Adverse Event|12|||
33520633|NCT01451164|101803304|FG002|Overall Study|Adverse Event|18|||
33520634|NCT01451164|101803305|FG003|Overall Study|Adverse Event|21|||
33520635|NCT01451164|101803302|FG000|Overall Study|Withdrawal Criteria|1|||
33520636|NCT01451164|101803303|FG001|Overall Study|Withdrawal Criteria|1|||
33520637|NCT01451164|101803304|FG002|Overall Study|Withdrawal Criteria|1|||
33520638|NCT01451164|101803305|FG003|Overall Study|Withdrawal Criteria|1|||
33520639|NCT01451164|101803302|FG000|Overall Study|Physician Decision|2|||
33520640|NCT01451164|101803303|FG001|Overall Study|Physician Decision|0|||
33520641|NCT01451164|101803304|FG002|Overall Study|Physician Decision|1|||
33520642|NCT01451164|101803305|FG003|Overall Study|Physician Decision|0|||
33520643|NCT01451164|101803302|FG000|Overall Study|Withdrawal by Subject|14|||
33520644|NCT01451164|101803303|FG001|Overall Study|Withdrawal by Subject|11|||
33520645|NCT01451164|101803304|FG002|Overall Study|Withdrawal by Subject|16|||
33520646|NCT01451164|101803305|FG003|Overall Study|Withdrawal by Subject|17|||
33520647|NCT01451164|101803302|FG000|Overall Study|Protocol Violation|0|||
33520648|NCT01451164|101803303|FG001|Overall Study|Protocol Violation|1|||
33520649|NCT01451164|101803304|FG002|Overall Study|Protocol Violation|0|||
33520650|NCT01451164|101803305|FG003|Overall Study|Protocol Violation|0|||
33520651|NCT01451164|101803302|FG000|Overall Study|Lack of Efficacy|7|||
33520652|NCT01451164|101803303|FG001|Overall Study|Lack of Efficacy|9|||
33520653|NCT01451164|101803304|FG002|Overall Study|Lack of Efficacy|9|||
33520654|NCT01451164|101803305|FG003|Overall Study|Lack of Efficacy|7|||
33520655|NCT00089635|101803308|FG000|Overall Study|Adverse Event|2|||
33608657|NCT01140061|102115158|FG002|Extension|Laboratory Adverse Event|0|||
33520656|NCT00089635|101803308|FG000|Overall Study|Death|17|||
33520657|NCT00089635|101803308|FG000|Overall Study|Disease Progression|12|||
33520658|NCT00089635|101803308|FG000|Overall Study|Lost to Follow-up|3|||
33520659|NCT00089635|101803308|FG000|Overall Study|Withdrawal by Subject|6|||
33520660|NCT00089635|101803308|FG000|Overall Study|Ineligibility determined|1|||
33520661|NCT00089635|101803308|FG000|Overall Study|Other|2|||
33520662|NCT01790516|101803309|FG000|Overall Study|Physician Decision|1|||
33520663|NCT01790516|101803310|FG001|Overall Study|Physician Decision|0|||
33520664|NCT01593254|101803312|FG000|Overall Study|Disease progression|2|||
33520665|NCT01593254|101803313|FG001|Overall Study|Disease progression|7|||
33520666|NCT01593254|101803312|FG000|Overall Study|Study drug toxicity|6|||
33520667|NCT01593254|101803313|FG001|Overall Study|Study drug toxicity|20|||
33520668|NCT01593254|101803312|FG000|Overall Study|Death|3|||
33520669|NCT01593254|101803313|FG001|Overall Study|Death|3|||
33200384|NCT00384085|100638327|FG001|Overall Study|No longer Requires Study Treatment|0|||
33200385|NCT00384085|100638328|FG002|Overall Study|No longer Requires Study Treatment|1|||
33200386|NCT00384085|100638326|FG000|Overall Study|Protocol Violation|2|||
33200387|NCT00384085|100638327|FG001|Overall Study|Protocol Violation|2|||
33200388|NCT00384085|100638328|FG002|Overall Study|Protocol Violation|2|||
33200389|NCT00384085|100638326|FG000|Overall Study|Lost to Follow-up|9|||
33200390|NCT00384085|100638327|FG001|Overall Study|Lost to Follow-up|9|||
33200391|NCT00384085|100638328|FG002|Overall Study|Lost to Follow-up|10|||
33200392|NCT00384085|100638326|FG000|Overall Study|Progressive Disease|0|||
33200393|NCT00384085|100638327|FG001|Overall Study|Progressive Disease|1|||
33200394|NCT00384085|100638328|FG002|Overall Study|Progressive Disease|0|||
33200395|NCT00384085|100638326|FG000|Overall Study|Withdrawal by Subject|14|||
33200396|NCT00384085|100638327|FG001|Overall Study|Withdrawal by Subject|19|||
33200397|NCT00384085|100638328|FG002|Overall Study|Withdrawal by Subject|29|||
33200398|NCT00384085|100638326|FG000|Overall Study|Patient non-compliant|4|||
33200399|NCT00384085|100638327|FG001|Overall Study|Patient non-compliant|4|||
33200400|NCT00384085|100638328|FG002|Overall Study|Patient non-compliant|5|||
33200401|NCT00384085|100638326|FG000|Overall Study|Physician Decision|1|||
33200402|NCT00384085|100638327|FG001|Overall Study|Physician Decision|0|||
33200403|NCT00384085|100638328|FG002|Overall Study|Physician Decision|0|||
33200404|NCT00384085|100638326|FG000|Overall Study|Loss of site personnel|1|||
33200405|NCT00384085|100638327|FG001|Overall Study|Loss of site personnel|0|||
33200406|NCT00384085|100638328|FG002|Overall Study|Loss of site personnel|1|||
33200407|NCT00384085|100638326|FG000|Overall Study|Sponsor decision|1|||
33200408|NCT00384085|100638327|FG001|Overall Study|Sponsor decision|2|||
33200409|NCT00384085|100638328|FG002|Overall Study|Sponsor decision|1|||
33200410|NCT00384085|100638326|FG000|Overall Study|Patient moved|1|||
33200411|NCT00384085|100638327|FG001|Overall Study|Patient moved|0|||
33200412|NCT00384085|100638328|FG002|Overall Study|Patient moved|1|||
33200413|NCT00384085|100638326|FG000|Overall Study|Patient required surgery|0|||
33200414|NCT00384085|100638327|FG001|Overall Study|Patient required surgery|1|||
33200415|NCT00384085|100638328|FG002|Overall Study|Patient required surgery|0|||
33200416|NCT02161718|100638331|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
33200417|NCT02161718|100638332|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
33200418|NCT02161718|100638333|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
33200419|NCT02161718|100638331|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
33200420|NCT02161718|100638332|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
33200421|NCT02161718|100638333|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
33520670|NCT01593254|101803312|FG000|Overall Study|AE unrelated to study drug|0|||
33520671|NCT01593254|101803313|FG001|Overall Study|AE unrelated to study drug|1|||
33520672|NCT01593254|101803312|FG000|Overall Study|participant request to discontinue study treatment|1|||
33520673|NCT01593254|101803313|FG001|Overall Study|participant request to discontinue study treatment|3|||
33520674|NCT01593254|101803312|FG000|Overall Study|participant withdrew consent|0|||
33520675|NCT01593254|101803313|FG001|Overall Study|participant withdrew consent|9|||
33520676|NCT01593254|101803312|FG000|Overall Study|lost to follow up|1|||
33520677|NCT01593254|101803313|FG001|Overall Study|lost to follow up|6|||
33520678|NCT01593254|101803312|FG000|Overall Study|maximum clinical benefit|1|||
33520679|NCT01593254|101803313|FG001|Overall Study|maximum clinical benefit|2|||
33520680|NCT01593254|101803312|FG000|Overall Study|Poor/non compliance|1|||
33520681|NCT01593254|101803313|FG001|Overall Study|Poor/non compliance|1|||
33520682|NCT01593254|101803312|FG000|Overall Study|Pregnancy|0|||
33520683|NCT01593254|101803313|FG001|Overall Study|Pregnancy|3|||
33520684|NCT01593254|101803312|FG000|Overall Study|participant no longer meets study criteria|1|||
33520685|NCT01593254|101803313|FG001|Overall Study|participant no longer meets study criteria|1|||
33520686|NCT01593254|101803312|FG000|Overall Study|Admin reason by sponsor|7|||
33520687|NCT01593254|101803313|FG001|Overall Study|Admin reason by sponsor|3|||
33520688|NCT01593254|101803312|FG000|Overall Study|Imatinib treatment failure|2|||
33520689|NCT01593254|101803313|FG001|Overall Study|Imatinib treatment failure|0|||
33520690|NCT01593254|101803312|FG000|Overall Study|Other Reasons|61|||
33200422|NCT02161718|100638331|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
33200423|NCT02161718|100638332|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
33200424|NCT02161718|100638333|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
33200425|NCT02161718|100638331|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
33200426|NCT02161718|100638332|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
33200427|NCT02161718|100638333|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
33520691|NCT01593254|101803313|FG001|Overall Study|Other Reasons|115|||
33520692|NCT00422422|101803317|FG000|Overall Study|Lack of Efficacy|1|||
33520693|NCT00422422|101803317|FG000|Overall Study|Protocol Violation|1|||
33520694|NCT00422422|101803317|FG000|Overall Study|Withdrawal by Subject|2|||
33520695|NCT00422422|101803317|FG000|Overall Study|SAE, non-fatal|1|||
33200428|NCT02161718|100638331|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
33200429|NCT02161718|100638332|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
33200430|NCT02161718|100638333|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
33200431|NCT02161718|100638331|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
33200432|NCT02161718|100638332|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
33200433|NCT02161718|100638333|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
33327866|NCT02819635|101097224|FG010|Substudy 3|Lost to Follow-up|1|||
33327867|NCT02819635|101097225|FG011|Substudy 3|Lost to Follow-up|1|||
33327868|NCT02819635|101097214|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
33327869|NCT02819635|101097215|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
33327870|NCT02819635|101097216|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
33327871|NCT02819635|101097217|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
33327872|NCT02819635|101097218|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
33327873|NCT02819635|101097219|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
33327874|NCT02819635|101097220|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
33327875|NCT02819635|101097221|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
33327876|NCT02819635|101097222|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
33327877|NCT02819635|101097223|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
33327878|NCT02819635|101097224|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
33520696|NCT00422422|101803317|FG000|Overall Study|AE, non-serious non-fatal|5|||
33520697|NCT00099632|101803321|FG000|Overall Study|Lost to Follow-up|1|||
33520698|NCT00099632|101803322|FG001|Overall Study|Lost to Follow-up|0|||
33608658|NCT01140061|102115159|FG003|Extension|Laboratory Adverse Event|0|||
33608659|NCT01140061|102115160|FG004|Extension|Laboratory Adverse Event|0|||
33608660|NCT01140061|102115161|FG005|Extension|Laboratory Adverse Event|0|||
33608661|NCT01140061|102115162|FG006|Extension|Laboratory Adverse Event|0|||
33608662|NCT01140061|102115163|FG007|Extension|Laboratory Adverse Event|0|||
33608663|NCT01140061|102115164|FG008|Extension|Laboratory Adverse Event|0|||
33608664|NCT01140061|102115165|FG009|Extension|Laboratory Adverse Event|1|||
33608665|NCT00084487|102118429|FG000|Overall Study|Death|1|||
33608666|NCT00400569|102118431|FG000|Overall Study|Death|1|||
33608667|NCT00699335|102118432|FG000|Overall Study|Combination of multiple reasons|176|||
33608668|NCT00699335|102118432|FG000|Overall Study|Missing data|52|||
33608669|NCT02540265|102118433|FG000|Overall Study|Lost to Follow-up|0|||
33608670|NCT02540265|102118434|FG001|Overall Study|Lost to Follow-up|0|||
33608671|NCT02540265|102118435|FG002|Overall Study|Lost to Follow-up|1|||
33608672|NCT00148941|102118438|FG000|Overall Study|Lost to Follow-up|17|||
33608673|NCT00148941|102118439|FG001|Overall Study|Lost to Follow-up|24|||
33608674|NCT00148941|102118440|FG002|Overall Study|Lost to Follow-up|18|||
33608675|NCT00148941|102118441|FG003|Overall Study|Lost to Follow-up|22|||
33608676|NCT00148941|102118438|FG000|Overall Study|Withdrawal by Subject|1|||
33608677|NCT00148941|102118439|FG001|Overall Study|Withdrawal by Subject|0|||
33608678|NCT00148941|102118440|FG002|Overall Study|Withdrawal by Subject|1|||
33608679|NCT00148941|102118441|FG003|Overall Study|Withdrawal by Subject|0|||
33608680|NCT00148941|102118438|FG000|Overall Study|Other|0|||
33608681|NCT00148941|102118439|FG001|Overall Study|Other|0|||
33608682|NCT00148941|102118440|FG002|Overall Study|Other|1|||
33608683|NCT00148941|102118441|FG003|Overall Study|Other|2|||
33608684|NCT01990859|102118442|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
33608685|NCT01990859|102118442|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
33608686|NCT03667690|102118443|FG000|Overall Study|Adverse Event|0|||
33608687|NCT03667690|102118444|FG001|Overall Study|Adverse Event|3|||
33608688|NCT03667690|102118443|FG000|Overall Study|Death|22|||
33608689|NCT03667690|102118444|FG001|Overall Study|Death|21|||
33608690|NCT03667690|102118443|FG000|Overall Study|Lost to Follow-up|4|||
33608691|NCT03667690|102118444|FG001|Overall Study|Lost to Follow-up|5|||
33520699|NCT00099632|101803323|FG002|Overall Study|Lost to Follow-up|3|||
33520700|NCT00099632|101803324|FG003|Overall Study|Lost to Follow-up|1|||
33520701|NCT00099632|101803325|FG004|Overall Study|Lost to Follow-up|1|||
33520702|NCT00099632|101803326|FG005|Overall Study|Lost to Follow-up|0|||
33608692|NCT03667690|102118443|FG000|Overall Study|Withdrawal by Subject|7|||
33608693|NCT03667690|102118444|FG001|Overall Study|Withdrawal by Subject|8|||
33608694|NCT03667690|102118443|FG000|Overall Study|Subject could not return for additional investigational product|1|||
33608695|NCT03667690|102118444|FG001|Overall Study|Subject could not return for additional investigational product|0|||
33608696|NCT03667690|102118443|FG000|Overall Study|Subject discharged to hospice care|2|||
33608697|NCT03667690|102118444|FG001|Overall Study|Subject discharged to hospice care|0|||
33608698|NCT03667690|102118443|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
33520703|NCT00099632|101803321|FG000|Overall Study|Withdrawal by Subject|0|||
33520704|NCT00099632|101803322|FG001|Overall Study|Withdrawal by Subject|1|||
33520705|NCT00099632|101803323|FG002|Overall Study|Withdrawal by Subject|0|||
33520706|NCT00099632|101803324|FG003|Overall Study|Withdrawal by Subject|0|||
33520707|NCT00099632|101803325|FG004|Overall Study|Withdrawal by Subject|0|||
33520708|NCT00099632|101803326|FG005|Overall Study|Withdrawal by Subject|1|||
33520709|NCT00099632|101803321|FG000|Overall Study|Protocol Violation|0|||
33520710|NCT00099632|101803322|FG001|Overall Study|Protocol Violation|0|||
33520711|NCT00099632|101803323|FG002|Overall Study|Protocol Violation|0|||
33520712|NCT00099632|101803324|FG003|Overall Study|Protocol Violation|0|||
33520713|NCT00099632|101803325|FG004|Overall Study|Protocol Violation|0|||
33520714|NCT00099632|101803326|FG005|Overall Study|Protocol Violation|1|||
33520715|NCT04521114|101803327|FG000|Overall Study|Lost to Follow-up|1|||
33520716|NCT04521114|101803328|FG001|Overall Study|Lost to Follow-up|2|||
33520717|NCT04521114|101803329|FG002|Overall Study|Lost to Follow-up|0|||
33520718|NCT04521114|101803327|FG000|Overall Study|Withdrawal by Subject|1|||
33520719|NCT04521114|101803328|FG001|Overall Study|Withdrawal by Subject|2|||
33520720|NCT04521114|101803329|FG002|Overall Study|Withdrawal by Subject|2|||
33520721|NCT04521114|101803327|FG000|Overall Study|Adverse Event|1|||
33520722|NCT04521114|101803328|FG001|Overall Study|Adverse Event|0|||
33520723|NCT04521114|101803329|FG002|Overall Study|Adverse Event|0|||
33520724|NCT04521114|101803327|FG000|Overall Study|Sponsor Wish|1|||
33520725|NCT04521114|101803328|FG001|Overall Study|Sponsor Wish|0|||
33520726|NCT04521114|101803329|FG002|Overall Study|Sponsor Wish|0|||
33520727|NCT04521114|101803327|FG000|Overall Study|Withdrawal of Consent|2|||
33520728|NCT04521114|101803328|FG001|Overall Study|Withdrawal of Consent|2|||
33520729|NCT04521114|101803329|FG002|Overall Study|Withdrawal of Consent|0|||
33520730|NCT01260584|101803330|FG000|Period 1|Protocol Violation|0|||
33520731|NCT01260584|101803331|FG001|Period 1|Protocol Violation|0|||
33520732|NCT01260584|101803332|FG002|Period 1|Protocol Violation|1|||
33520733|NCT01260584|101803333|FG003|Period 1|Protocol Violation|1|||
33520734|NCT01260584|101803330|FG000|Period 1|Adverse Event|0|||
33520735|NCT01260584|101803331|FG001|Period 1|Adverse Event|0|||
33520736|NCT01260584|101803332|FG002|Period 1|Adverse Event|1|||
33520737|NCT01260584|101803333|FG003|Period 1|Adverse Event|0|||
33520738|NCT01260584|101803330|FG000|Period 2|Protocol Violation|0|||
33520739|NCT01260584|101803331|FG001|Period 2|Protocol Violation|2|||
33520740|NCT01260584|101803332|FG002|Period 2|Protocol Violation|3|||
33520741|NCT01260584|101803333|FG003|Period 2|Protocol Violation|1|||
33520742|NCT01260584|101803330|FG000|Period 2|Adverse Event|1|||
33520743|NCT01260584|101803331|FG001|Period 2|Adverse Event|0|||
33520744|NCT01260584|101803332|FG002|Period 2|Adverse Event|2|||
33520745|NCT01260584|101803333|FG003|Period 2|Adverse Event|0|||
33520746|NCT01260584|101803330|FG000|Period 2|Withdrawal by Subject|0|||
33520747|NCT01260584|101803331|FG001|Period 2|Withdrawal by Subject|1|||
33520748|NCT01260584|101803332|FG002|Period 2|Withdrawal by Subject|0|||
33520749|NCT01260584|101803333|FG003|Period 2|Withdrawal by Subject|0|||
33520750|NCT00395642|101803334|FG000|Overall Study|Death|4|||
33520751|NCT00395642|101803334|FG000|Overall Study|Lost to Follow-up|1|||
33520752|NCT00395642|101803334|FG000|Overall Study|Physician Decision|7|||
33520753|NCT00395642|101803334|FG000|Overall Study|Withdrawal by Subject|1|||
33520754|NCT04318132|101803335|FG000|Overall Study|Protocol Violation|0|||
33520755|NCT04318132|101803336|FG001|Overall Study|Protocol Violation|0|||
33520756|NCT04318132|101803337|FG002|Overall Study|Protocol Violation|3|||
33520757|NCT04318132|101803338|FG003|Overall Study|Protocol Violation|0|||
33520758|NCT00473824|101803339|FG000|Overall Study|Virologic Breakthrough|1|||
33520759|NCT00473824|101803340|FG001|Overall Study|Virologic Breakthrough|0|||
33608699|NCT03667690|102118444|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
33608700|NCT03667690|102118443|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
33608701|NCT03667690|102118444|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
33608702|NCT03667690|102118443|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
33608703|NCT03667690|102118444|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
33327879|NCT02819635|101097225|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
33520760|NCT00473824|101803339|FG000|Overall Study|Adverse Event|1|||
33520761|NCT00473824|101803340|FG001|Overall Study|Adverse Event|0|||
33327880|NCT02819635|101097214|FG000|Substudy 3|Other, not specified|0|||
33608704|NCT03667690|102118443|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
33327881|NCT02819635|101097215|FG001|Substudy 3|Other, not specified|0|||
33520762|NCT00473824|101803339|FG000|Overall Study|Death|1|||
33520763|NCT00473824|101803340|FG001|Overall Study|Death|0|||
33520764|NCT00473824|101803339|FG000|Overall Study|Lost to Follow-up|1|||
33520765|NCT00473824|101803340|FG001|Overall Study|Lost to Follow-up|0|||
33520766|NCT00473824|101803339|FG000|Overall Study|Withdrawal by physician|1|||
33520767|NCT00473824|101803340|FG001|Overall Study|Withdrawal by physician|0|||
33520768|NCT02440854|101803343|FG000|Overall Study|Relocation of patient|1|||
33520769|NCT02440854|101803343|FG000|Overall Study|Death|6|||
33520770|NCT02440854|101803343|FG000|Overall Study|Lost to Follow-up|10|||
33520771|NCT02440854|101803343|FG000|Overall Study|Afatinib discontinuation|46|||
33520772|NCT02440854|101803343|FG000|Overall Study|stopped study at earlier timepoint|14|||
33520773|NCT02440854|101803343|FG000|Overall Study|Study medication not received|1|||
33200434|NCT02161718|100638331|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
33200435|NCT02161718|100638332|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
33401025|NCT00672139|101356921|FG000|Overall Study|Withdrawal by Subject|2|||
33520774|NCT02440854|101803343|FG000|Overall Study|Violation of inclusion criteria|2|||
33520775|NCT01955109|101803347|FG000|Overall Study|Adverse Event|2|||
33520776|NCT01955109|101803348|FG001|Overall Study|Adverse Event|0|||
33608705|NCT03667690|102118444|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
33608706|NCT03667690|102118443|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
33608707|NCT03667690|102118444|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
33608708|NCT04407234|102118447|FG000|Overall Study|Adverse Event|3|||
33608709|NCT04407234|102118448|FG001|Overall Study|Adverse Event|3|||
33608710|NCT00470418|102118449|FG000|Overall Study|Withdrawal by Subject|1|||
33608711|NCT00470418|102118450|FG001|Overall Study|Withdrawal by Subject|0|||
33608712|NCT00330681|102118452|FG000|Overall Study|Adverse Event|3|||
33608713|NCT00330681|102118453|FG001|Overall Study|Adverse Event|6|||
33608714|NCT00330681|102118452|FG000|Overall Study|Protocol Violation|0|||
33520777|NCT01955109|101803347|FG000|Overall Study|Participant unwilling to continue|35|||
33520778|NCT01955109|101803348|FG001|Overall Study|Participant unwilling to continue|7|||
33520779|NCT01955109|101803347|FG000|Overall Study|Physician Decision|2|||
33520780|NCT01955109|101803348|FG001|Overall Study|Physician Decision|0|||
33520781|NCT01955109|101803347|FG000|Overall Study|Lost to Follow-up|3|||
33520782|NCT01955109|101803348|FG001|Overall Study|Lost to Follow-up|1|||
33520783|NCT01955109|101803347|FG000|Overall Study|Non-compliance|3|||
33520784|NCT01955109|101803348|FG001|Overall Study|Non-compliance|1|||
33520785|NCT01092637|101803364|FG000|Overall Study|Death|47|||
33520786|NCT01092637|101803365|FG001|Overall Study|Death|49|||
33520787|NCT00204477|101803366|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
33520788|NCT00204477|101803367|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
33520789|NCT00204477|101803366|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
33520790|NCT00204477|101803367|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
33520791|NCT00463840|101803369|FG000|Overall Study|Disease progression|7|||
33520792|NCT00463840|101803369|FG000|Overall Study|Withdrawal by Subject|2|||
33520793|NCT00463840|101803369|FG000|Overall Study|Adverse Event|3|||
33520794|NCT00438256|101803370|FG000|Overall Study|Ineligible for Resection|2|||
33520795|NCT00438256|101803371|FG001|Overall Study|Ineligible for Resection|1|||
33520796|NCT00438256|101803372|FG002|Overall Study|Ineligible for Resection|1|||
33520797|NCT00438256|101803373|FG003|Overall Study|Ineligible for Resection|7|||
33520798|NCT00438256|101803370|FG000|Overall Study|Excluded final Diagnosis|0|||
33520799|NCT00438256|101803371|FG001|Overall Study|Excluded final Diagnosis|0|||
33520800|NCT00438256|101803372|FG002|Overall Study|Excluded final Diagnosis|0|||
33520801|NCT00438256|101803373|FG003|Overall Study|Excluded final Diagnosis|2|||
33520802|NCT02578940|101803376|FG000|Overall Study|Screening failure|5|||
33520803|NCT02578940|101803376|FG000|Overall Study|Lost to Follow-up|1|||
33520804|NCT02634983|101803379|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
33520805|NCT02634983|101803380|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
33520806|NCT00957905|101803381|FG000|Part B|Not Treated|0|||
33520807|NCT00957905|101803382|FG001|Part B|Not Treated|1|||
33520808|NCT00957905|101803381|FG000|Part B|Physician Decision|0|||
33520809|NCT00957905|101803382|FG001|Part B|Physician Decision|1|||
33520810|NCT00957905|101803381|FG000|Part B|Death|0|||
33520811|NCT00957905|101803382|FG001|Part B|Death|1|||
33520812|NCT00957905|101803381|FG000|Part B|Protocol Violation|0|||
33520813|NCT00957905|101803382|FG001|Part B|Protocol Violation|1|||
33520814|NCT03887117|101803384|FG000|Overall Study|Discontinued prematurely|0|||
33520815|NCT03887117|101803385|FG001|Overall Study|Discontinued prematurely|1|||
33520816|NCT03887117|101803386|FG002|Overall Study|Discontinued prematurely|1|||
33520817|NCT03887117|101803387|FG003|Overall Study|Discontinued prematurely|2|||
33520818|NCT00821015|101803389|FG000|Overall Study|Lost to Follow-up|12|||
33608715|NCT00330681|102118453|FG001|Overall Study|Protocol Violation|1|||
33608716|NCT00330681|102118452|FG000|Overall Study|Withdrawal by Subject|5|||
33520819|NCT00856843|101803390|FG000|Overall Study|Withdrawal by Subject|1|||
33608717|NCT00330681|102118453|FG001|Overall Study|Withdrawal by Subject|5|||
33608718|NCT00330681|102118452|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
33327882|NCT02819635|101097216|FG002|Substudy 3|Other, not specified|0|||
33520820|NCT00856843|101803391|FG001|Overall Study|Withdrawal by Subject|5|||
33520821|NCT00856843|101803390|FG000|Overall Study|Lack of Efficacy|1|||
33520822|NCT00856843|101803391|FG001|Overall Study|Lack of Efficacy|0|||
33520823|NCT02772809|101803394|FG000|Overall Study|not completed some tasks|6|||
33520824|NCT03885999|101803395|FG000|Overall Study|Adverse Event|1|||
33520825|NCT00085098|101803400|FG000|Overall Study|Withdrawal by Subject|0|||
33520826|NCT00085098|101803401|FG001|Overall Study|Withdrawal by Subject|1|||
33520827|NCT00085098|101803400|FG000|Overall Study|Ineligible|1|||
33520828|NCT00085098|101803401|FG001|Overall Study|Ineligible|1|||
33520829|NCT00002525|101803404|FG000|Overall Study|Adverse Event|36|||
33520830|NCT00002525|101803405|FG001|Overall Study|Adverse Event|0|||
33520831|NCT00002525|101803404|FG000|Overall Study|Death|5|||
33520832|NCT00002525|101803405|FG001|Overall Study|Death|0|||
33520833|NCT00002525|101803404|FG000|Overall Study|Withdrawal by Subject|11|||
33520834|NCT00002525|101803405|FG001|Overall Study|Withdrawal by Subject|0|||
33520835|NCT00002525|101803404|FG000|Overall Study|Start non-protocol therapy|1|||
33520836|NCT00002525|101803405|FG001|Overall Study|Start non-protocol therapy|0|||
33520837|NCT00002525|101803404|FG000|Overall Study|Other complicating disease|1|||
33520838|NCT00002525|101803405|FG001|Overall Study|Other complicating disease|0|||
33520839|NCT00002525|101803404|FG000|Overall Study|Duke's A, B1, D disease|92|||
33520840|NCT00002525|101803405|FG001|Overall Study|Duke's A, B1, D disease|0|||
33520841|NCT00002525|101803404|FG000|Overall Study|Error|6|||
33520842|NCT00002525|101803405|FG001|Overall Study|Error|0|||
33520843|NCT00002525|101803404|FG000|Overall Study|Other|26|||
33520844|NCT00002525|101803405|FG001|Overall Study|Other|0|||
33520845|NCT00002525|101803404|FG000|Overall Study|Never start protocol therapy|8|||
33608719|NCT00330681|102118453|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
33608720|NCT02081599|102118456|FG000|Period 1：Double-blind Period|Adverse Event|3|||
33608721|NCT02081599|102118457|FG001|Period 1：Double-blind Period|Adverse Event|0|||
33608722|NCT02081599|102118456|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
33608723|NCT02081599|102118457|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
33608724|NCT02081599|102118456|FG000|Period 1：Double-blind Period|Physician Decision|1|||
33520846|NCT00002525|101803405|FG001|Overall Study|Never start protocol therapy|0|||
33520847|NCT02717442|101803408|FG000|Overall Study|Study Terminated by Sponsor|31|||
33520848|NCT02717442|101803409|FG001|Overall Study|Study Terminated by Sponsor|29|||
33520849|NCT02717442|101803408|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
33520850|NCT02717442|101803409|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
33520851|NCT02717442|101803408|FG000|Overall Study|Other - Not Specified|2|||
33520852|NCT02717442|101803409|FG001|Overall Study|Other - Not Specified|0|||
33520853|NCT01868165|101803410|FG000|Overall Study|Withdrawal by Subject|36|||
33520854|NCT01868165|101803410|FG000|Overall Study|Physician Decision|2|||
33520855|NCT01868165|101803410|FG000|Overall Study|Lost to Follow-up|3|||
33520856|NCT01868165|101803410|FG000|Overall Study|Death|4|||
33520857|NCT04631107|101803411|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
33520858|NCT04631107|101803411|FG000|Second Intervention (1 Night)|Adverse Event|1|||
33520859|NCT04631107|101803411|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
33520860|NCT04631107|101803411|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
33520861|NCT02474355|101803416|FG000|Overall Study|Other|43|||
33608725|NCT02081599|102118457|FG001|Period 1：Double-blind Period|Physician Decision|0|||
33608726|NCT02081599|102118456|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
33608727|NCT02081599|102118457|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
33608728|NCT02081599|102118456|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
33608729|NCT02081599|102118457|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
33608730|NCT02081599|102118456|FG000|Period 1：Double-blind Period|stopping criteria|1|||
33608731|NCT02081599|102118457|FG001|Period 1：Double-blind Period|stopping criteria|0|||
33608732|NCT02081599|102118456|FG000|Period 2：Open-label Period|Adverse Event|1|||
33608733|NCT02081599|102118457|FG001|Period 2：Open-label Period|Adverse Event|0|||
33608734|NCT02081599|102118456|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
33608735|NCT02081599|102118457|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
33608736|NCT02081599|102118456|FG000|Period 2：Open-label Period|Physician Decision|1|||
33608737|NCT02081599|102118457|FG001|Period 2：Open-label Period|Physician Decision|0|||
33608738|NCT02081599|102118456|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
33608739|NCT02081599|102118457|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
33608740|NCT00082381|102118458|FG000|Overall Study|Adverse Event|27|||
33608741|NCT00082381|102118459|FG001|Overall Study|Adverse Event|2|||
33608742|NCT00082381|102118458|FG000|Overall Study|Lost to Follow-up|5|||
33608743|NCT00082381|102118459|FG001|Overall Study|Lost to Follow-up|7|||
33608744|NCT00082381|102118458|FG000|Overall Study|Patient Decision|8|||
33608745|NCT00082381|102118459|FG001|Overall Study|Patient Decision|4|||
33608746|NCT00082381|102118458|FG000|Overall Study|Physician Decision|1|||
33608747|NCT00082381|102118459|FG001|Overall Study|Physician Decision|2|||
33608748|NCT00082381|102118458|FG000|Overall Study|Protocol Violation|10|||
33327883|NCT02819635|101097217|FG003|Substudy 3|Other, not specified|0|||
33520862|NCT02474355|101803416|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
33520863|NCT02474355|101803416|FG000|Overall Study|Lost to Follow-up|98|||
33520864|NCT02474355|101803416|FG000|Overall Study|Withdrawal by Subject|124|||
33520865|NCT02474355|101803416|FG000|Overall Study|Death|1361|||
33520866|NCT00369161|101803417|FG000|Overall Study|Adverse Event|15|||
33520867|NCT00369161|101803418|FG001|Overall Study|Adverse Event|13|||
33520868|NCT00369161|101803417|FG000|Overall Study|Abnormal laboratory value|0|||
33520869|NCT00369161|101803418|FG001|Overall Study|Abnormal laboratory value|1|||
33608749|NCT00082381|102118459|FG001|Overall Study|Protocol Violation|11|||
33608750|NCT00082381|102118458|FG000|Overall Study|Loss of Glucose Control|4|||
33608751|NCT00082381|102118459|FG001|Overall Study|Loss of Glucose Control|0|||
33608752|NCT03517566|102118465|FG000|Overall Study|Adverse Event|5|||
33608753|NCT03517566|102118466|FG001|Overall Study|Adverse Event|2|||
33520870|NCT00369161|101803417|FG000|Overall Study|Lack of Efficacy|3|||
33520871|NCT00369161|101803418|FG001|Overall Study|Lack of Efficacy|1|||
33520872|NCT00369161|101803417|FG000|Overall Study|Protocol Violation|0|||
33520873|NCT00369161|101803418|FG001|Overall Study|Protocol Violation|2|||
33520874|NCT00369161|101803417|FG000|Overall Study|Withdrawal by Subject|2|||
33520875|NCT00369161|101803418|FG001|Overall Study|Withdrawal by Subject|3|||
33520876|NCT00369161|101803417|FG000|Overall Study|Death|1|||
33520877|NCT00369161|101803418|FG001|Overall Study|Death|2|||
33520878|NCT00369161|101803417|FG000|Overall Study|Graft loss|4|||
33520879|NCT00369161|101803418|FG001|Overall Study|Graft loss|0|||
33327884|NCT02819635|101097218|FG004|Substudy 3|Other, not specified|0|||
33327885|NCT02819635|101097219|FG005|Substudy 3|Other, not specified|0|||
33327886|NCT02819635|101097220|FG006|Substudy 3|Other, not specified|0|||
33327887|NCT02819635|101097221|FG007|Substudy 3|Other, not specified|0|||
33327888|NCT02819635|101097222|FG008|Substudy 3|Other, not specified|202|||
33327889|NCT02819635|101097223|FG009|Substudy 3|Other, not specified|5|||
33327890|NCT02819635|101097224|FG010|Substudy 3|Other, not specified|89|||
33327891|NCT02819635|101097225|FG011|Substudy 3|Other, not specified|39|||
33327892|NCT03069352|101097227|FG000|Overall Study|Ongoing|12|||
33327893|NCT03069352|101097228|FG001|Overall Study|Ongoing|40|||
33327894|NCT03199040|101097229|FG000|Overall Study|Lack of Efficacy|2|||
33327895|NCT03199040|101097230|FG001|Overall Study|Lack of Efficacy|0|||
33327896|NCT03199040|101097229|FG000|Overall Study|Withdrawal by Subject|2|||
33327897|NCT03199040|101097230|FG001|Overall Study|Withdrawal by Subject|0|||
33327898|NCT03199040|101097229|FG000|Overall Study|Adverse Event|0|||
33520880|NCT00369161|101803417|FG000|Overall Study|Administrative Problem|2|||
33327899|NCT03199040|101097230|FG001|Overall Study|Adverse Event|1|||
33327900|NCT03199040|101097229|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
33327901|NCT03199040|101097230|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
33327902|NCT00501007|101097231|FG000|Overall Study|Inclusion criteria not met.|29|||
33327903|NCT00501007|101097232|FG001|Overall Study|Inclusion criteria not met.|25|||
33327904|NCT00843518|101097235|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
33327905|NCT00843518|101097236|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
33327906|NCT00843518|101097235|FG000|Period 2 (Double-blind Treatment)|Death|0|||
33327907|NCT00843518|101097236|FG001|Period 2 (Double-blind Treatment)|Death|1|||
33327908|NCT00843518|101097235|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
33327909|NCT00843518|101097236|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
33327910|NCT00843518|101097235|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
33327911|NCT00843518|101097236|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
33327912|NCT00843518|101097235|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
33327913|NCT00843518|101097236|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
33327914|NCT00843518|101097235|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
33327915|NCT00843518|101097236|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
33327916|NCT00843518|101097235|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
33327917|NCT00843518|101097236|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
33327918|NCT05418673|101097237|FG000|Overall Study|Study Terminated by Sponsor|2|||
33327919|NCT05418673|101097238|FG001|Overall Study|Study Terminated by Sponsor|4|||
33327920|NCT05418673|101097237|FG000|Overall Study|Lost to Follow-up|1|||
33327921|NCT05418673|101097238|FG001|Overall Study|Lost to Follow-up|0|||
33327922|NCT05038020|101097241|FG000|Overall Study|Early Termination|3|||
33327923|NCT05038020|101097242|FG001|Overall Study|Early Termination|0|||
33327924|NCT05376215|101097245|FG000|Overall Study|Withdrawal by Subject|2|||
33327925|NCT05376215|101097246|FG001|Overall Study|Withdrawal by Subject|1|||
33327926|NCT05376215|101097245|FG000|Overall Study|Lost to Follow-up|0|||
33327927|NCT05376215|101097246|FG001|Overall Study|Lost to Follow-up|1|||
33327928|NCT00096785|101097247|FG000|Overall Study|Lost to Follow-up|1|||
33327929|NCT00096785|101097248|FG001|Overall Study|Lost to Follow-up|0|||
33327930|NCT00096785|101097247|FG000|Overall Study|Withdrawal by Subject|0|||
33327931|NCT00096785|101097248|FG001|Overall Study|Withdrawal by Subject|1|||
33327932|NCT00096785|101097247|FG000|Overall Study|Relocated|1|||
33327933|NCT00096785|101097248|FG001|Overall Study|Relocated|0|||
33327934|NCT04667377|101097251|FG000|Dose Escalation Period|Other not specified below|3|||
33327935|NCT04667377|101097252|FG001|Dose Escalation Period|Other not specified below|3|||
33327936|NCT04667377|101097253|FG002|Dose Escalation Period|Other not specified below|2|||
33327937|NCT04667377|101097254|FG003|Dose Escalation Period|Other not specified below|1|||
33327938|NCT04667377|101097255|FG004|Dose Escalation Period|Other not specified below|3|||
33327939|NCT04667377|101097251|FG000|Dose Escalation Period|Protocol Violation|2|||
33520881|NCT00369161|101803418|FG001|Overall Study|Administrative Problem|2|||
33520882|NCT01085084|101803419|FG000|Overall Study|Withdrawal by Subject|1|||
33520883|NCT01085084|101803420|FG001|Overall Study|Withdrawal by Subject|0|||
33520884|NCT01085084|101803421|FG002|Overall Study|Withdrawal by Subject|0|||
33520885|NCT01085084|101803419|FG000|Overall Study|Lost to Follow-up|2|||
33520886|NCT01085084|101803420|FG001|Overall Study|Lost to Follow-up|1|||
33520887|NCT01085084|101803421|FG002|Overall Study|Lost to Follow-up|1|||
33520888|NCT01085084|101803419|FG000|Overall Study|Adverse Event|4|||
33520889|NCT01085084|101803420|FG001|Overall Study|Adverse Event|3|||
33520890|NCT01085084|101803421|FG002|Overall Study|Adverse Event|6|||
33520891|NCT01085084|101803419|FG000|Overall Study|Treatment Failure|0|||
33520892|NCT01085084|101803420|FG001|Overall Study|Treatment Failure|1|||
33520893|NCT01085084|101803421|FG002|Overall Study|Treatment Failure|2|||
33520894|NCT00448812|101803422|FG000|Year 2|Missed visit but remained in study|4|||
33520895|NCT00448812|101803423|FG001|Year 2|Missed visit but remained in study|1|||
33520896|NCT00448812|101803422|FG000|Year 3|Withdrawal by Subject|1|||
33520897|NCT00448812|101803423|FG001|Year 3|Withdrawal by Subject|3|||
33520898|NCT00448812|101803422|FG000|Year 3|Lost to Follow-up|1|||
33520899|NCT00448812|101803423|FG001|Year 3|Lost to Follow-up|0|||
33520900|NCT00448812|101803422|FG000|Year 3|Missed visit but remained in study|2|||
33520901|NCT00448812|101803423|FG001|Year 3|Missed visit but remained in study|0|||
33520902|NCT00448812|101803422|FG000|Year 5|Missed visit but remained in study|1|||
33520903|NCT00448812|101803423|FG001|Year 5|Missed visit but remained in study|0|||
33520904|NCT05020366|101803426|FG000|Overall Study|Lost to Follow-up|2|||
33520905|NCT05020366|101803427|FG001|Overall Study|Lost to Follow-up|0|||
33520906|NCT05020366|101803426|FG000|Overall Study|Withdrawal by Subject|2|||
33520907|NCT05020366|101803427|FG001|Overall Study|Withdrawal by Subject|0|||
33520908|NCT00224406|101803428|FG000|Overall Study|Re-transplant|0|||
33520909|NCT00224406|101803429|FG001|Overall Study|Re-transplant|2|||
33520910|NCT00224406|101803428|FG000|Overall Study|Death|0|||
33520911|NCT00224406|101803429|FG001|Overall Study|Death|1|||
33520912|NCT00224406|101803428|FG000|Overall Study|Transplant cancelled|0|||
33520913|NCT00224406|101803429|FG001|Overall Study|Transplant cancelled|4|||
33520914|NCT00224406|101803428|FG000|Overall Study|Drug not delivered|2|||
33520915|NCT00224406|101803429|FG001|Overall Study|Drug not delivered|0|||
33520916|NCT00224406|101803428|FG000|Overall Study|Other|4|||
33520917|NCT00224406|101803429|FG001|Overall Study|Other|0|||
33520918|NCT00224406|101803428|FG000|Overall Study|Transplant cancelled|3|||
33520919|NCT00224406|101803429|FG001|Overall Study|Transplant cancelled|0|||
33520920|NCT02552888|101803433|FG000|Overall Study|Lost to Follow-up|1|||
33520921|NCT02552888|101803434|FG001|Overall Study|Lost to Follow-up|1|||
33520922|NCT03000530|101803438|FG000|Overall Study|Adverse Event|0|||
33520923|NCT03000530|101803439|FG001|Overall Study|Adverse Event|0|||
33520924|NCT03000530|101803440|FG002|Overall Study|Adverse Event|2|||
33520925|NCT03000530|101803438|FG000|Overall Study|Lost to Follow-up|0|||
33520926|NCT03000530|101803439|FG001|Overall Study|Lost to Follow-up|3|||
33327940|NCT04667377|101097252|FG001|Dose Escalation Period|Protocol Violation|2|||
33327941|NCT04667377|101097253|FG002|Dose Escalation Period|Protocol Violation|0|||
33327942|NCT04667377|101097254|FG003|Dose Escalation Period|Protocol Violation|2|||
33327943|NCT04667377|101097255|FG004|Dose Escalation Period|Protocol Violation|1|||
33327944|NCT04667377|101097251|FG000|Dose Escalation Period|Burden of study procedures|2|||
33327945|NCT04667377|101097252|FG001|Dose Escalation Period|Burden of study procedures|1|||
33520927|NCT03000530|101803440|FG002|Overall Study|Lost to Follow-up|1|||
33520928|NCT03000530|101803438|FG000|Overall Study|Withdrawal by Subject|0|||
33520929|NCT03000530|101803439|FG001|Overall Study|Withdrawal by Subject|2|||
33520930|NCT03000530|101803440|FG002|Overall Study|Withdrawal by Subject|1|||
33520931|NCT00938587|101803441|FG000|Overall Study|Adverse Event|2|||
33520932|NCT00938587|101803442|FG001|Overall Study|Adverse Event|0|||
33520933|NCT00938587|101803443|FG002|Overall Study|Adverse Event|0|||
33520934|NCT00938587|101803444|FG003|Overall Study|Adverse Event|2|||
33327946|NCT04667377|101097253|FG002|Dose Escalation Period|Burden of study procedures|1|||
33327947|NCT04667377|101097254|FG003|Dose Escalation Period|Burden of study procedures|1|||
33520935|NCT00938587|101803441|FG000|Overall Study|Did not meet entrance criteria|0|||
33520936|NCT00938587|101803442|FG001|Overall Study|Did not meet entrance criteria|0|||
33327948|NCT04667377|101097255|FG004|Dose Escalation Period|Burden of study procedures|5|||
33327949|NCT04667377|101097251|FG000|Dose Escalation Period|Change of residence|0|||
33327950|NCT04667377|101097252|FG001|Dose Escalation Period|Change of residence|0|||
33520937|NCT00938587|101803443|FG002|Overall Study|Did not meet entrance criteria|1|||
33520938|NCT00938587|101803444|FG003|Overall Study|Did not meet entrance criteria|0|||
33520939|NCT00938587|101803441|FG000|Overall Study|Withdrawal by Subject|1|||
33520940|NCT00938587|101803442|FG001|Overall Study|Withdrawal by Subject|1|||
33520941|NCT00938587|101803443|FG002|Overall Study|Withdrawal by Subject|0|||
33520942|NCT00938587|101803444|FG003|Overall Study|Withdrawal by Subject|0|||
33520943|NCT01603394|101803445|FG000|Overall Study|Adverse Event|1|||
33520944|NCT03882957|101807468|FG000|Overall Study|Did not complete all three arms|1|||
33520945|NCT01603407|101807469|FG000|Overall Study|Adverse Event|1|||
33520946|NCT01603407|101807470|FG001|Overall Study|Adverse Event|1|||
33520947|NCT01603407|101807471|FG002|Overall Study|Adverse Event|1|||
33520948|NCT01603407|101807469|FG000|Overall Study|Protocol Violation|2|||
33520949|NCT01603407|101807470|FG001|Overall Study|Protocol Violation|2|||
33520950|NCT01603407|101807471|FG002|Overall Study|Protocol Violation|0|||
33520951|NCT01603407|101807469|FG000|Overall Study|Withdrawal by Subject|8|||
33520952|NCT01603407|101807470|FG001|Overall Study|Withdrawal by Subject|5|||
33520953|NCT01603407|101807471|FG002|Overall Study|Withdrawal by Subject|7|||
33520954|NCT01603407|101807469|FG000|Overall Study|Lost to Follow-up|0|||
33520955|NCT01603407|101807470|FG001|Overall Study|Lost to Follow-up|3|||
33520956|NCT01603407|101807471|FG002|Overall Study|Lost to Follow-up|2|||
33520957|NCT00492232|101807473|FG000|Placebo Run-in|Adverse Event|0|||
33520958|NCT00492232|101807474|FG001|Placebo Run-in|Adverse Event|2|||
33520959|NCT00492232|101807473|FG000|Placebo Run-in|Protocol Violation|0|||
33520960|NCT00492232|101807474|FG001|Placebo Run-in|Protocol Violation|3|||
33520961|NCT00492232|101807473|FG000|Placebo Run-in|Lost to Follow-up|0|||
33520962|NCT00492232|101807474|FG001|Placebo Run-in|Lost to Follow-up|3|||
33520963|NCT00492232|101807473|FG000|Placebo Run-in|Withdrawal by Subject|0|||
33520964|NCT00492232|101807474|FG001|Placebo Run-in|Withdrawal by Subject|8|||
33520965|NCT00492232|101807473|FG000|Placebo Run-in|Pregnancy|0|||
33520966|NCT00492232|101807474|FG001|Placebo Run-in|Pregnancy|1|||
33520967|NCT00492232|101807473|FG000|Placebo Run-in|Entrance criteria not met|0|||
33520968|NCT00492232|101807474|FG001|Placebo Run-in|Entrance criteria not met|45|||
33520969|NCT00492232|101807473|FG000|Placebo Run-in|Other|0|||
33520970|NCT00492232|101807474|FG001|Placebo Run-in|Other|6|||
33520971|NCT00492232|101807473|FG000|Placebo Run-in|Missing|0|||
33520972|NCT00492232|101807474|FG001|Placebo Run-in|Missing|2|||
33520973|NCT00492232|101807473|FG000|Double-Blind Treatment|Adverse Event|1|||
33520974|NCT00492232|101807474|FG001|Double-Blind Treatment|Adverse Event|2|||
33520975|NCT00492232|101807473|FG000|Double-Blind Treatment|Protocol Violation|3|||
33520976|NCT00492232|101807474|FG001|Double-Blind Treatment|Protocol Violation|7|||
33520977|NCT00492232|101807473|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
33520978|NCT00492232|101807474|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
33520979|NCT00492232|101807473|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
33520980|NCT00492232|101807474|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
33520981|NCT00492232|101807473|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
33520982|NCT00492232|101807474|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
33520983|NCT00492232|101807473|FG000|Double-Blind Treatment|Other|6|||
33520984|NCT00492232|101807474|FG001|Double-Blind Treatment|Other|5|||
33520985|NCT00492232|101807473|FG000|Double-Blind Treatment|Randomized not treated|1|||
33520986|NCT00492232|101807474|FG001|Double-Blind Treatment|Randomized not treated|0|||
33520987|NCT00492232|101807473|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
33520988|NCT00492232|101807474|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
33520989|NCT02012959|101807477|FG000|Treatment Phase A|Adverse Event|2|||
33520990|NCT02012959|101807478|FG001|Treatment Phase A|Adverse Event|0|||
33520991|NCT02012959|101807479|FG002|Treatment Phase A|Adverse Event|0|||
33520992|NCT02012959|101807480|FG003|Treatment Phase A|Adverse Event|0|||
33520993|NCT02012959|101807481|FG004|Treatment Phase A|Adverse Event|0|||
33520994|NCT02854605|101807482|FG000|Overall Study|Adverse Event|1|||
33520995|NCT02854605|101807483|FG001|Overall Study|Adverse Event|5|||
33520996|NCT02854605|101807484|FG002|Overall Study|Adverse Event|2|||
33520997|NCT02854605|101807482|FG000|Overall Study|Lost to Follow-up|0|||
33520998|NCT02854605|101807483|FG001|Overall Study|Lost to Follow-up|2|||
33520999|NCT02854605|101807484|FG002|Overall Study|Lost to Follow-up|0|||
33521000|NCT02854605|101807482|FG000|Overall Study|Withdrew Consent|1|||
33521001|NCT02854605|101807483|FG001|Overall Study|Withdrew Consent|0|||
33521002|NCT02854605|101807484|FG002|Overall Study|Withdrew Consent|1|||
33521003|NCT02854605|101807482|FG000|Overall Study|Investigator's Discretion|1|||
33521004|NCT02854605|101807483|FG001|Overall Study|Investigator's Discretion|0|||
33521005|NCT02854605|101807484|FG002|Overall Study|Investigator's Discretion|0|||
33521006|NCT02854605|101807482|FG000|Overall Study|Protocol Violation|0|||
33521007|NCT02854605|101807483|FG001|Overall Study|Protocol Violation|0|||
33521008|NCT02854605|101807484|FG002|Overall Study|Protocol Violation|1|||
33521009|NCT02570750|101807485|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
33521010|NCT02570750|101807486|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
33521011|NCT02570750|101807485|FG000|Overall Study|Protocol deviation|4|||
33521012|NCT02570750|101807486|FG001|Overall Study|Protocol deviation|2|||
33521013|NCT02570750|101807485|FG000|Overall Study|Withdrawal by Subject|5|||
33521014|NCT02570750|101807486|FG001|Overall Study|Withdrawal by Subject|0|||
33521015|NCT02570750|101807485|FG000|Overall Study|Lost to Follow-up|2|||
33521016|NCT02570750|101807486|FG001|Overall Study|Lost to Follow-up|2|||
33521017|NCT02570750|101807485|FG000|Overall Study|Adverse Event|2|||
33521018|NCT02570750|101807486|FG001|Overall Study|Adverse Event|1|||
33521019|NCT01897571|101807487|FG000|Overall Study|Lost to Follow-up|3|||
33521020|NCT01897571|101807488|FG001|Overall Study|Lost to Follow-up|0|||
33521021|NCT01897571|101807489|FG002|Overall Study|Lost to Follow-up|0|||
33521022|NCT01897571|101807490|FG003|Overall Study|Lost to Follow-up|0|||
33521023|NCT01897571|101807491|FG004|Overall Study|Lost to Follow-up|2|||
33521024|NCT01897571|101807492|FG005|Overall Study|Lost to Follow-up|0|||
33521025|NCT01897571|101807493|FG006|Overall Study|Lost to Follow-up|0|||
33521026|NCT01897571|101807494|FG007|Overall Study|Lost to Follow-up|0|||
33521027|NCT01897571|101807495|FG008|Overall Study|Lost to Follow-up|1|||
33521028|NCT01897571|101807496|FG009|Overall Study|Lost to Follow-up|2|||
33521029|NCT01897571|101807497|FG010|Overall Study|Lost to Follow-up|4|||
33521030|NCT01897571|101807487|FG000|Overall Study|Withdrawal by Subject|0|||
33521031|NCT01897571|101807488|FG001|Overall Study|Withdrawal by Subject|0|||
33521032|NCT01897571|101807489|FG002|Overall Study|Withdrawal by Subject|0|||
33521033|NCT01897571|101807490|FG003|Overall Study|Withdrawal by Subject|0|||
33521034|NCT01897571|101807491|FG004|Overall Study|Withdrawal by Subject|0|||
33521035|NCT01897571|101807492|FG005|Overall Study|Withdrawal by Subject|0|||
33521036|NCT01897571|101807493|FG006|Overall Study|Withdrawal by Subject|0|||
33521037|NCT01897571|101807494|FG007|Overall Study|Withdrawal by Subject|1|||
33521038|NCT01897571|101807495|FG008|Overall Study|Withdrawal by Subject|4|||
33521039|NCT01897571|101807496|FG009|Overall Study|Withdrawal by Subject|3|||
33521040|NCT01897571|101807497|FG010|Overall Study|Withdrawal by Subject|1|||
33521041|NCT01897571|101807487|FG000|Overall Study|Other|1|||
33521042|NCT01897571|101807488|FG001|Overall Study|Other|0|||
33521043|NCT01897571|101807489|FG002|Overall Study|Other|0|||
33521044|NCT01897571|101807490|FG003|Overall Study|Other|3|||
33521045|NCT01897571|101807491|FG004|Overall Study|Other|3|||
33521046|NCT01897571|101807492|FG005|Overall Study|Other|4|||
33521047|NCT01897571|101807493|FG006|Overall Study|Other|7|||
33521048|NCT01897571|101807494|FG007|Overall Study|Other|0|||
33521049|NCT01897571|101807495|FG008|Overall Study|Other|0|||
33521050|NCT01897571|101807496|FG009|Overall Study|Other|0|||
33521051|NCT01897571|101807497|FG010|Overall Study|Other|0|||
33521052|NCT01897571|101807487|FG000|Overall Study|Enrolled in rollover study|0|||
33521053|NCT01897571|101807488|FG001|Overall Study|Enrolled in rollover study|0|||
33521054|NCT01897571|101807489|FG002|Overall Study|Enrolled in rollover study|0|||
33521055|NCT01897571|101807490|FG003|Overall Study|Enrolled in rollover study|0|||
33521056|NCT01897571|101807491|FG004|Overall Study|Enrolled in rollover study|0|||
33521057|NCT01897571|101807492|FG005|Overall Study|Enrolled in rollover study|0|||
33521058|NCT01897571|101807493|FG006|Overall Study|Enrolled in rollover study|0|||
33521059|NCT01897571|101807494|FG007|Overall Study|Enrolled in rollover study|9|||
33521060|NCT01897571|101807495|FG008|Overall Study|Enrolled in rollover study|7|||
33521061|NCT01897571|101807496|FG009|Overall Study|Enrolled in rollover study|9|||
33521062|NCT01897571|101807497|FG010|Overall Study|Enrolled in rollover study|1|||
33521063|NCT01897571|101807487|FG000|Overall Study|Death|2|||
33327951|NCT04667377|101097253|FG002|Dose Escalation Period|Change of residence|1|||
33327952|NCT04667377|101097254|FG003|Dose Escalation Period|Change of residence|0|||
33327953|NCT04667377|101097255|FG004|Dose Escalation Period|Change of residence|0|||
33327954|NCT04667377|101097251|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
33327955|NCT04667377|101097252|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
33327956|NCT04667377|101097253|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
33327957|NCT04667377|101097254|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
33327958|NCT04667377|101097255|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
33327959|NCT04667377|101097251|FG000|Dose Escalation Period|Adverse Event|9|||
33327960|NCT04667377|101097252|FG001|Dose Escalation Period|Adverse Event|10|||
33327961|NCT04667377|101097253|FG002|Dose Escalation Period|Adverse Event|12|||
33327962|NCT04667377|101097254|FG003|Dose Escalation Period|Adverse Event|17|||
33327963|NCT04667377|101097255|FG004|Dose Escalation Period|Adverse Event|3|||
33327964|NCT04667377|101097251|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
33327965|NCT04667377|101097252|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
33327966|NCT04667377|101097253|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
33327967|NCT04667377|101097254|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
33327968|NCT04667377|101097255|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
33327969|NCT04667377|101097251|FG000|Dose Escalation Period|Not treated|1|||
33327970|NCT04667377|101097252|FG001|Dose Escalation Period|Not treated|0|||
33327971|NCT04667377|101097253|FG002|Dose Escalation Period|Not treated|0|||
33327972|NCT04667377|101097254|FG003|Dose Escalation Period|Not treated|0|||
33327973|NCT04667377|101097255|FG004|Dose Escalation Period|Not treated|0|||
33327974|NCT04667377|101097251|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
33327975|NCT04667377|101097252|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
33327976|NCT04667377|101097253|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
33401026|NCT00672139|101356922|FG001|Overall Study|Withdrawal by Subject|11|||
33401027|NCT00672139|101356921|FG000|Overall Study|Adverse Event|4|||
33521064|NCT01897571|101807488|FG001|Overall Study|Death|2|||
33521065|NCT01897571|101807489|FG002|Overall Study|Death|3|||
33521066|NCT01897571|101807490|FG003|Overall Study|Death|6|||
33521067|NCT01897571|101807491|FG004|Overall Study|Death|7|||
33521068|NCT01897571|101807492|FG005|Overall Study|Death|9|||
33521069|NCT01897571|101807493|FG006|Overall Study|Death|5|||
33521070|NCT01897571|101807494|FG007|Overall Study|Death|22|||
33521071|NCT01897571|101807495|FG008|Overall Study|Death|23|||
33521072|NCT01897571|101807496|FG009|Overall Study|Death|129|||
33327977|NCT04667377|101097254|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
33401028|NCT00672139|101356922|FG001|Overall Study|Adverse Event|7|||
33521073|NCT01897571|101807497|FG010|Overall Study|Death|59|||
33521074|NCT00253370|101807498|FG000|Overall Study|Adverse Event|18|||
33521075|NCT00253370|101807498|FG000|Overall Study|Disease progression|13|||
33521076|NCT00253370|101807498|FG000|Overall Study|Death|2|||
33521077|NCT00253370|101807498|FG000|Overall Study|Withdrawal by Subject|6|||
33521078|NCT00253370|101807498|FG000|Overall Study|Non-protocol therapy|1|||
33521079|NCT00253370|101807498|FG000|Overall Study|Physician Decision|1|||
33521080|NCT00253370|101807498|FG000|Overall Study|Protocol Violation|1|||
33521081|NCT00253370|101807498|FG000|Overall Study|Abdominal pain due to disease|1|||
33521082|NCT00575510|101807502|FG000|Overall Study|Lost to Follow-up|4|||
33521083|NCT00575510|101807503|FG001|Overall Study|Lost to Follow-up|6|||
33521084|NCT00575510|101807504|FG002|Overall Study|Lost to Follow-up|9|||
33521085|NCT00575510|101807502|FG000|Overall Study|Withdrawal by Subject|1|||
33521086|NCT00575510|101807503|FG001|Overall Study|Withdrawal by Subject|0|||
33521087|NCT00575510|101807504|FG002|Overall Study|Withdrawal by Subject|0|||
33521088|NCT00575510|101807502|FG000|Overall Study|Clinic Called Patient|7|||
33521089|NCT00575510|101807503|FG001|Overall Study|Clinic Called Patient|7|||
33521090|NCT00575510|101807504|FG002|Overall Study|Clinic Called Patient|7|||
33521091|NCT00575510|101807502|FG000|Overall Study|Pregnancy|0|||
33521092|NCT00575510|101807503|FG001|Overall Study|Pregnancy|0|||
33521093|NCT00575510|101807504|FG002|Overall Study|Pregnancy|1|||
33521094|NCT02453256|101807505|FG000|Double Blind Period|Death|1|||
33521095|NCT02453256|101807506|FG001|Double Blind Period|Death|1|||
33521096|NCT02453256|101807505|FG000|Double Blind Period|Adverse Event|3|||
33521097|NCT02453256|101807506|FG001|Double Blind Period|Adverse Event|2|||
33521098|NCT02453256|101807505|FG000|Double Blind Period|Withdrawal by Subject|9|||
33521099|NCT02453256|101807506|FG001|Double Blind Period|Withdrawal by Subject|5|||
33521100|NCT02453256|101807505|FG000|Double Blind Period|Other|0|||
33521101|NCT02453256|101807506|FG001|Double Blind Period|Other|1|||
33521102|NCT02453256|101807505|FG000|Open Label Period|Adverse Event|1|||
33521103|NCT02453256|101807506|FG001|Open Label Period|Adverse Event|3|||
33521104|NCT02453256|101807505|FG000|Open Label Period|Death|0|||
33521105|NCT02453256|101807506|FG001|Open Label Period|Death|1|||
33521106|NCT02453256|101807505|FG000|Open Label Period|Lost to Follow-up|1|||
33521107|NCT02453256|101807506|FG001|Open Label Period|Lost to Follow-up|0|||
33521108|NCT02453256|101807505|FG000|Open Label Period|Other|0|||
33521109|NCT02453256|101807506|FG001|Open Label Period|Other|2|||
33521110|NCT02453256|101807505|FG000|Open Label Period|Withdrawal by Subject|5|||
33521111|NCT02453256|101807506|FG001|Open Label Period|Withdrawal by Subject|1|||
33521112|NCT04769739|101807507|FG000|Overall Study|Colorectal cancer obstruction|2|||
33521113|NCT04769739|101807508|FG001|Overall Study|Colorectal cancer obstruction|0|||
33521114|NCT04769739|101807509|FG002|Overall Study|Colorectal cancer obstruction|0|||
33521115|NCT04769739|101807510|FG003|Overall Study|Colorectal cancer obstruction|0|||
33521116|NCT04769739|101807507|FG000|Overall Study|Failed cecal intubation|1|||
33200436|NCT02161718|100638333|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
33200437|NCT02161718|100638331|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
33327978|NCT04667377|101097255|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
33521117|NCT04769739|101807508|FG001|Overall Study|Failed cecal intubation|0|||
33521118|NCT04769739|101807509|FG002|Overall Study|Failed cecal intubation|0|||
33521119|NCT04769739|101807510|FG003|Overall Study|Failed cecal intubation|1|||
33521120|NCT04769739|101807507|FG000|Overall Study|Poor bowel preparation|0|||
33521121|NCT04769739|101807508|FG001|Overall Study|Poor bowel preparation|0|||
33521122|NCT04769739|101807509|FG002|Overall Study|Poor bowel preparation|0|||
33521123|NCT04769739|101807510|FG003|Overall Study|Poor bowel preparation|1|||
33521124|NCT00184093|101807511|FG000|Overall Study|Adverse Event|3|||
33521125|NCT00184093|101807511|FG000|Overall Study|Lost to Follow-up|3|||
33521126|NCT00184093|101807511|FG000|Overall Study|Physician Decision|1|||
33327979|NCT04667377|101097251|FG000|Dose Escalation Period|Lost to Follow-up|0|||
33327980|NCT04667377|101097252|FG001|Dose Escalation Period|Lost to Follow-up|1|||
33327981|NCT04667377|101097253|FG002|Dose Escalation Period|Lost to Follow-up|0|||
33327982|NCT04667377|101097254|FG003|Dose Escalation Period|Lost to Follow-up|0|||
33327983|NCT04667377|101097255|FG004|Dose Escalation Period|Lost to Follow-up|0|||
33327984|NCT04667377|101097251|FG000|Maintenance Period|Perceived lack of efficacy|0|||
33327985|NCT04667377|101097252|FG001|Maintenance Period|Perceived lack of efficacy|2|||
33327986|NCT04667377|101097253|FG002|Maintenance Period|Perceived lack of efficacy|1|||
33327987|NCT04667377|101097254|FG003|Maintenance Period|Perceived lack of efficacy|0|||
33327988|NCT04667377|101097255|FG004|Maintenance Period|Perceived lack of efficacy|1|||
33327989|NCT04667377|101097251|FG000|Maintenance Period|Adverse Event|2|||
33327990|NCT04667377|101097252|FG001|Maintenance Period|Adverse Event|8|||
33327991|NCT04667377|101097253|FG002|Maintenance Period|Adverse Event|5|||
33327992|NCT04667377|101097254|FG003|Maintenance Period|Adverse Event|4|||
33327993|NCT04667377|101097255|FG004|Maintenance Period|Adverse Event|1|||
33327994|NCT04667377|101097251|FG000|Maintenance Period|Adverse event: COVID infection|0|||
33327995|NCT04667377|101097252|FG001|Maintenance Period|Adverse event: COVID infection|1|||
33327996|NCT04667377|101097253|FG002|Maintenance Period|Adverse event: COVID infection|0|||
33327997|NCT04667377|101097254|FG003|Maintenance Period|Adverse event: COVID infection|0|||
33327998|NCT04667377|101097255|FG004|Maintenance Period|Adverse event: COVID infection|0|||
33327999|NCT04667377|101097251|FG000|Maintenance Period|COVID-related|0|||
33328000|NCT04667377|101097252|FG001|Maintenance Period|COVID-related|0|||
33328001|NCT04667377|101097253|FG002|Maintenance Period|COVID-related|1|||
33328002|NCT04667377|101097254|FG003|Maintenance Period|COVID-related|1|||
33328003|NCT04667377|101097255|FG004|Maintenance Period|COVID-related|0|||
33401029|NCT00672139|101356921|FG000|Overall Study|Physician Decision|2|||
33401030|NCT00672139|101356922|FG001|Overall Study|Physician Decision|0|||
33401031|NCT00672139|101356921|FG000|Overall Study|Lack of Efficacy|4|||
33608754|NCT03517566|102118467|FG002|Overall Study|Adverse Event|2|||
33608755|NCT03517566|102118468|FG003|Overall Study|Adverse Event|8|||
33608756|NCT03517566|102118469|FG004|Overall Study|Adverse Event|7|||
33608757|NCT03517566|102118465|FG000|Overall Study|Lack of Efficacy|3|||
33608758|NCT03517566|102118466|FG001|Overall Study|Lack of Efficacy|2|||
33608759|NCT03517566|102118467|FG002|Overall Study|Lack of Efficacy|1|||
33608760|NCT03517566|102118468|FG003|Overall Study|Lack of Efficacy|1|||
33608761|NCT03517566|102118469|FG004|Overall Study|Lack of Efficacy|4|||
33608762|NCT03517566|102118465|FG000|Overall Study|Lost to Follow-up|3|||
33608763|NCT03517566|102118466|FG001|Overall Study|Lost to Follow-up|1|||
33608764|NCT03517566|102118467|FG002|Overall Study|Lost to Follow-up|1|||
33608765|NCT03517566|102118468|FG003|Overall Study|Lost to Follow-up|1|||
33608766|NCT03517566|102118469|FG004|Overall Study|Lost to Follow-up|0|||
33608767|NCT03517566|102118465|FG000|Overall Study|Physician Decision|1|||
33608768|NCT03517566|102118466|FG001|Overall Study|Physician Decision|1|||
33608769|NCT03517566|102118467|FG002|Overall Study|Physician Decision|0|||
33608770|NCT03517566|102118468|FG003|Overall Study|Physician Decision|1|||
33608771|NCT03517566|102118469|FG004|Overall Study|Physician Decision|0|||
33608772|NCT03517566|102118465|FG000|Overall Study|Pregnancy|0|||
33608773|NCT03517566|102118466|FG001|Overall Study|Pregnancy|1|||
33608774|NCT03517566|102118467|FG002|Overall Study|Pregnancy|0|||
33608775|NCT03517566|102118468|FG003|Overall Study|Pregnancy|0|||
33608776|NCT03517566|102118469|FG004|Overall Study|Pregnancy|0|||
33608777|NCT03517566|102118465|FG000|Overall Study|Protocol Deviation|0|||
33608778|NCT03517566|102118466|FG001|Overall Study|Protocol Deviation|1|||
33608779|NCT03517566|102118467|FG002|Overall Study|Protocol Deviation|0|||
33608780|NCT03517566|102118468|FG003|Overall Study|Protocol Deviation|1|||
33608781|NCT03517566|102118469|FG004|Overall Study|Protocol Deviation|1|||
33608782|NCT03517566|102118465|FG000|Overall Study|Study terminated by Sponsor|11|||
33608783|NCT03517566|102118466|FG001|Overall Study|Study terminated by Sponsor|5|||
33328004|NCT04667377|101097251|FG000|Maintenance Period|Protocol Violation|1|||
33328005|NCT04667377|101097252|FG001|Maintenance Period|Protocol Violation|0|||
33401032|NCT00672139|101356922|FG001|Overall Study|Lack of Efficacy|1|||
33608784|NCT03517566|102118467|FG002|Overall Study|Study terminated by Sponsor|6|||
33608785|NCT03517566|102118468|FG003|Overall Study|Study terminated by Sponsor|14|||
33608786|NCT03517566|102118469|FG004|Overall Study|Study terminated by Sponsor|12|||
33608787|NCT03517566|102118465|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
33328006|NCT04667377|101097253|FG002|Maintenance Period|Protocol Violation|0|||
33608788|NCT03517566|102118466|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
33608789|NCT03517566|102118467|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
33328007|NCT04667377|101097254|FG003|Maintenance Period|Protocol Violation|0|||
33328008|NCT04667377|101097255|FG004|Maintenance Period|Protocol Violation|1|||
33328009|NCT04667377|101097251|FG000|Maintenance Period|Burden of study procedures|1|||
33401033|NCT00672139|101356921|FG000|Overall Study|Protocol Violation|1|||
33401034|NCT00672139|101356922|FG001|Overall Study|Protocol Violation|1|||
33608790|NCT03517566|102118468|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
33328010|NCT04667377|101097252|FG001|Maintenance Period|Burden of study procedures|2|||
33328011|NCT04667377|101097253|FG002|Maintenance Period|Burden of study procedures|0|||
33328012|NCT04667377|101097254|FG003|Maintenance Period|Burden of study procedures|1|||
33328013|NCT04667377|101097255|FG004|Maintenance Period|Burden of study procedures|0|||
33328014|NCT04667377|101097251|FG000|Maintenance Period|Change of residence|0|||
33328015|NCT04667377|101097252|FG001|Maintenance Period|Change of residence|1|||
33328016|NCT04667377|101097253|FG002|Maintenance Period|Change of residence|0|||
33328017|NCT04667377|101097254|FG003|Maintenance Period|Change of residence|0|||
33328018|NCT04667377|101097255|FG004|Maintenance Period|Change of residence|1|||
33328019|NCT04667377|101097251|FG000|Maintenance Period|Missing|1|||
33328020|NCT04667377|101097252|FG001|Maintenance Period|Missing|0|||
33328021|NCT04667377|101097253|FG002|Maintenance Period|Missing|0|||
33328022|NCT04667377|101097254|FG003|Maintenance Period|Missing|0|||
33328023|NCT04667377|101097255|FG004|Maintenance Period|Missing|0|||
33328024|NCT04667377|101097251|FG000|Maintenance Period|Other than listed above|2|||
33328025|NCT04667377|101097252|FG001|Maintenance Period|Other than listed above|0|||
33521127|NCT00184093|101807511|FG000|Overall Study|Withdrawal by Subject|2|||
33521128|NCT02864316|101807512|FG000|Overall Study|Progressive Disease|2|||
33521129|NCT02864316|101807513|FG001|Overall Study|Progressive Disease|1|||
33521130|NCT02864316|101807512|FG000|Overall Study|Adverse Event|0|||
33521131|NCT02864316|101807513|FG001|Overall Study|Adverse Event|1|||
33521132|NCT00980655|101807518|FG000|Overall Study|Adverse Event|13|||
33521133|NCT00980655|101807519|FG001|Overall Study|Adverse Event|31|||
33521134|NCT00980655|101807518|FG000|Overall Study|Death|0|||
33521135|NCT00980655|101807519|FG001|Overall Study|Death|7|||
33521136|NCT00980655|101807518|FG000|Overall Study|Protocol Violation|2|||
33521137|NCT00980655|101807519|FG001|Overall Study|Protocol Violation|7|||
33521138|NCT00980655|101807518|FG000|Overall Study|Withdrawal by Subject|0|||
33521139|NCT00980655|101807519|FG001|Overall Study|Withdrawal by Subject|4|||
33521140|NCT00980655|101807518|FG000|Overall Study|Lost to Follow-up|0|||
33521141|NCT00980655|101807519|FG001|Overall Study|Lost to Follow-up|1|||
33521142|NCT00980655|101807518|FG000|Overall Study|Parent/legal guardian request|1|||
33521143|NCT00980655|101807519|FG001|Overall Study|Parent/legal guardian request|0|||
33521144|NCT00980655|101807518|FG000|Overall Study|Other|0|||
33521145|NCT00980655|101807519|FG001|Overall Study|Other|1|||
33521146|NCT00236899|101807520|FG000|Overall Study|Adverse Event (Study Related)|1|||
33521147|NCT00236899|101807521|FG001|Overall Study|Adverse Event (Study Related)|1|||
33521148|NCT00236899|101807522|FG002|Overall Study|Adverse Event (Study Related)|2|||
33521149|NCT00236899|101807523|FG003|Overall Study|Adverse Event (Study Related)|1|||
33521150|NCT00236899|101807520|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
33521151|NCT00236899|101807521|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
33521152|NCT00236899|101807522|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
33521153|NCT00236899|101807523|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
33521154|NCT00236899|101807520|FG000|Overall Study|Death (Study Disease)|1|||
33224367|NCT05044325|100721818|FG007|Part A:Treatment Period 1|Adverse Event|1|||
33328026|NCT04667377|101097253|FG002|Maintenance Period|Other than listed above|3|||
33328027|NCT04667377|101097254|FG003|Maintenance Period|Other than listed above|2|||
33328028|NCT04667377|101097255|FG004|Maintenance Period|Other than listed above|6|||
33328029|NCT04667377|101097251|FG000|Maintenance Period|Withdrawal by Subject|0|||
33328030|NCT04667377|101097252|FG001|Maintenance Period|Withdrawal by Subject|1|||
33328031|NCT04667377|101097253|FG002|Maintenance Period|Withdrawal by Subject|0|||
33328032|NCT04667377|101097254|FG003|Maintenance Period|Withdrawal by Subject|0|||
33328033|NCT04667377|101097255|FG004|Maintenance Period|Withdrawal by Subject|0|||
33328034|NCT04667377|101097251|FG000|Maintenance Period|Lost to Follow-up|1|||
33328035|NCT04667377|101097252|FG001|Maintenance Period|Lost to Follow-up|0|||
33328036|NCT04667377|101097253|FG002|Maintenance Period|Lost to Follow-up|1|||
33328037|NCT04667377|101097254|FG003|Maintenance Period|Lost to Follow-up|0|||
33328038|NCT04667377|101097255|FG004|Maintenance Period|Lost to Follow-up|1|||
33401035|NCT00672139|101356921|FG000|Overall Study|hospice discharge, caregiver requests|3|||
33401036|NCT00672139|101356922|FG001|Overall Study|hospice discharge, caregiver requests|2|||
33401037|NCT02192190|101356929|FG000|Overall Study|Adverse Event|1|||
33521155|NCT00236899|101807521|FG001|Overall Study|Death (Study Disease)|4|||
33521156|NCT00236899|101807522|FG002|Overall Study|Death (Study Disease)|0|||
33521157|NCT00236899|101807523|FG003|Overall Study|Death (Study Disease)|0|||
33521158|NCT00236899|101807520|FG000|Overall Study|Death (Not Study Related)|2|||
33521159|NCT00236899|101807521|FG001|Overall Study|Death (Not Study Related)|0|||
33521160|NCT00236899|101807522|FG002|Overall Study|Death (Not Study Related)|0|||
33328039|NCT04305275|101097256|FG000|Overall Study|Adverse Event|4|||
33328040|NCT04305275|101097257|FG001|Overall Study|Adverse Event|0|||
33328041|NCT04305275|101097256|FG000|Overall Study|Lost to Follow-up|1|||
33328042|NCT04305275|101097257|FG001|Overall Study|Lost to Follow-up|1|||
33328043|NCT04305275|101097256|FG000|Overall Study|Withdrawal by Participant|8|||
33328044|NCT04305275|101097257|FG001|Overall Study|Withdrawal by Participant|1|||
33328045|NCT00359021|101097258|FG000|Overall Study|Adverse Event|26|||
33521161|NCT00236899|101807523|FG003|Overall Study|Death (Not Study Related)|0|||
33328046|NCT00359021|101097259|FG001|Overall Study|Adverse Event|8|||
33328047|NCT00359021|101097258|FG000|Overall Study|Subject Non-Compliant|1|||
33328048|NCT00359021|101097259|FG001|Overall Study|Subject Non-Compliant|2|||
33328049|NCT00359021|101097258|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
33328050|NCT00359021|101097259|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
33328051|NCT00359021|101097258|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
33328052|NCT00359021|101097259|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
33328053|NCT00359021|101097258|FG000|Overall Study|Withdrawal by Subject|2|||
33328054|NCT00359021|101097259|FG001|Overall Study|Withdrawal by Subject|9|||
33328055|NCT00359021|101097258|FG000|Overall Study|Lost to Follow-up|1|||
33328056|NCT00359021|101097259|FG001|Overall Study|Lost to Follow-up|0|||
33608791|NCT03517566|102118469|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
33608792|NCT02708485|102118470|FG000|Overall Study|Withdrawal by Subject|3|||
33521162|NCT00236899|101807520|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
33521163|NCT00236899|101807521|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
33521164|NCT00236899|101807522|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
33521165|NCT00236899|101807523|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
33521166|NCT00236899|101807520|FG000|Overall Study|Lost to Follow-up|0|||
33521167|NCT00236899|101807521|FG001|Overall Study|Lost to Follow-up|1|||
33521168|NCT00236899|101807522|FG002|Overall Study|Lost to Follow-up|0|||
33521169|NCT00236899|101807523|FG003|Overall Study|Lost to Follow-up|0|||
33521170|NCT00236899|101807520|FG000|Overall Study|Entry Criteria Exclusion|0|||
33521171|NCT00236899|101807521|FG001|Overall Study|Entry Criteria Exclusion|1|||
33521172|NCT00236899|101807522|FG002|Overall Study|Entry Criteria Exclusion|1|||
33608793|NCT02708485|102118471|FG001|Overall Study|Withdrawal by Subject|2|||
33608794|NCT03228212|102118472|FG000|Period 1|Adverse Event|1|||
33608795|NCT03228212|102118473|FG001|Period 1|Adverse Event|0|||
33608796|NCT03228212|102118472|FG000|Period 1|no longer meets eligibility criteria|0|||
33608797|NCT03228212|102118473|FG001|Period 1|no longer meets eligibility criteria|1|||
33608798|NCT03228212|102118472|FG000|Period 2|Lost to Follow-up|1|||
33608799|NCT03228212|102118473|FG001|Period 2|Lost to Follow-up|0|||
33608800|NCT01079936|102118474|FG000|Phase I: MTD|First Remission Status|2|||
33608801|NCT01079936|102118475|FG001|Phase I: MTD|First Remission Status|0|||
33608802|NCT01079936|102118476|FG002|Phase I: MTD|First Remission Status|0|||
33608803|NCT01079936|102118477|FG003|Phase I: MTD|First Remission Status|0|||
33608804|NCT01079936|102118478|FG004|Phase I: MTD|First Remission Status|0|||
33608805|NCT01079936|102118474|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
33608806|NCT01079936|102118475|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
33608807|NCT01079936|102118476|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
33608808|NCT01079936|102118477|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
33328057|NCT00359021|101097258|FG000|Overall Study|Other|4|||
33401038|NCT02192190|101356930|FG001|Overall Study|Adverse Event|1|||
33401039|NCT02192190|101356931|FG002|Overall Study|Adverse Event|0|||
33401040|NCT02192190|101356932|FG003|Overall Study|Adverse Event|0|||
33401041|NCT02192190|101356933|FG004|Overall Study|Adverse Event|0|||
33401042|NCT02192190|101356934|FG005|Overall Study|Adverse Event|0|||
33401043|NCT02192190|101356929|FG000|Overall Study|Lost to Follow-up|3|||
33401044|NCT02192190|101356930|FG001|Overall Study|Lost to Follow-up|3|||
33401045|NCT02192190|101356931|FG002|Overall Study|Lost to Follow-up|2|||
33401046|NCT02192190|101356932|FG003|Overall Study|Lost to Follow-up|1|||
33521173|NCT00236899|101807523|FG003|Overall Study|Entry Criteria Exclusion|0|||
33521174|NCT00236899|101807520|FG000|Overall Study|Protocol Violation|1|||
33608809|NCT01079936|102118478|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
33608810|NCT01079936|102118474|FG000|Phase II|Adverse Event|0|||
33608811|NCT01079936|102118475|FG001|Phase II|Adverse Event|0|||
33608812|NCT01079936|102118476|FG002|Phase II|Adverse Event|1|||
33608813|NCT01079936|102118477|FG003|Phase II|Adverse Event|0|||
33608814|NCT01079936|102118478|FG004|Phase II|Adverse Event|0|||
33608815|NCT01079936|102118474|FG000|Phase II|Insurance Issue|0|||
33328058|NCT00359021|101097259|FG001|Overall Study|Other|1|||
33328059|NCT00359021|101097258|FG000|Overall Study|Pregnancy|1|||
33328060|NCT00359021|101097259|FG001|Overall Study|Pregnancy|0|||
33328061|NCT01892163|101097266|FG000|Overall Study|Death|1|||
33521175|NCT00236899|101807521|FG001|Overall Study|Protocol Violation|0|||
33521176|NCT00236899|101807522|FG002|Overall Study|Protocol Violation|0|||
33521177|NCT00236899|101807523|FG003|Overall Study|Protocol Violation|0|||
33608816|NCT01079936|102118475|FG001|Phase II|Insurance Issue|0|||
33608817|NCT01079936|102118476|FG002|Phase II|Insurance Issue|0|||
33608818|NCT01079936|102118477|FG003|Phase II|Insurance Issue|0|||
33608819|NCT01079936|102118478|FG004|Phase II|Insurance Issue|1|||
33608820|NCT02161757|102118479|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
33608821|NCT02161757|102118480|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
33608822|NCT02161757|102118481|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
33328062|NCT01892163|101097267|FG001|Overall Study|Death|1|||
33328063|NCT01892163|101097266|FG000|Overall Study|Lost to Follow-up|1|||
33401047|NCT02192190|101356933|FG004|Overall Study|Lost to Follow-up|4|||
33401048|NCT02192190|101356934|FG005|Overall Study|Lost to Follow-up|3|||
33521178|NCT00236899|101807520|FG000|Overall Study|Withdrawal by Subject|6|||
33608823|NCT02161757|102118479|FG000|Treatment Through Study Completion|Adverse Event|1|||
33401049|NCT02192190|101356929|FG000|Overall Study|Physician Decision|2|||
33401050|NCT02192190|101356930|FG001|Overall Study|Physician Decision|0|||
33401051|NCT02192190|101356931|FG002|Overall Study|Physician Decision|0|||
33401052|NCT02192190|101356932|FG003|Overall Study|Physician Decision|0|||
33401053|NCT02192190|101356933|FG004|Overall Study|Physician Decision|0|||
33401054|NCT02192190|101356934|FG005|Overall Study|Physician Decision|0|||
33401055|NCT02192190|101356929|FG000|Overall Study|Terminated by Sponsor|43|||
33401056|NCT02192190|101356930|FG001|Overall Study|Terminated by Sponsor|23|||
33401057|NCT02192190|101356931|FG002|Overall Study|Terminated by Sponsor|20|||
33401058|NCT02192190|101356932|FG003|Overall Study|Terminated by Sponsor|23|||
33401059|NCT02192190|101356933|FG004|Overall Study|Terminated by Sponsor|21|||
33401060|NCT02192190|101356934|FG005|Overall Study|Terminated by Sponsor|23|||
33401061|NCT02192190|101356929|FG000|Overall Study|Withdrawal by Subject|4|||
33401062|NCT02192190|101356930|FG001|Overall Study|Withdrawal by Subject|1|||
33401063|NCT02192190|101356931|FG002|Overall Study|Withdrawal by Subject|2|||
33401064|NCT02192190|101356932|FG003|Overall Study|Withdrawal by Subject|1|||
33401065|NCT02192190|101356933|FG004|Overall Study|Withdrawal by Subject|5|||
33401066|NCT02192190|101356934|FG005|Overall Study|Withdrawal by Subject|3|||
33401067|NCT02192190|101356929|FG000|Overall Study|Could not Keep Visit Schedule|1|||
33401068|NCT02192190|101356930|FG001|Overall Study|Could not Keep Visit Schedule|0|||
33401069|NCT02192190|101356931|FG002|Overall Study|Could not Keep Visit Schedule|0|||
33401070|NCT02192190|101356932|FG003|Overall Study|Could not Keep Visit Schedule|0|||
33401071|NCT02192190|101356933|FG004|Overall Study|Could not Keep Visit Schedule|0|||
33401072|NCT02192190|101356934|FG005|Overall Study|Could not Keep Visit Schedule|0|||
33401073|NCT02192190|101356929|FG000|Overall Study|Positive Drug Screen|0|||
33401074|NCT02192190|101356930|FG001|Overall Study|Positive Drug Screen|0|||
33608824|NCT02161757|102118480|FG001|Treatment Through Study Completion|Adverse Event|1|||
33608825|NCT02161757|102118481|FG002|Treatment Through Study Completion|Adverse Event|0|||
33608826|NCT02161757|102118479|FG000|Treatment Through Study Completion|Protocol Violation|0|||
33608827|NCT02161757|102118480|FG001|Treatment Through Study Completion|Protocol Violation|1|||
33608828|NCT02161757|102118481|FG002|Treatment Through Study Completion|Protocol Violation|2|||
33608829|NCT02161757|102118479|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
33608830|NCT02161757|102118480|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
33608831|NCT02161757|102118481|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
33608832|NCT02161757|102118479|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
33608833|NCT02161757|102118480|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
33608834|NCT02161757|102118481|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
33608835|NCT02161757|102118479|FG000|Treatment Through Study Completion|Other|20|||
33608836|NCT02161757|102118480|FG001|Treatment Through Study Completion|Other|19|||
33608837|NCT02161757|102118481|FG002|Treatment Through Study Completion|Other|12|||
33608838|NCT02161757|102118479|FG000|Treatment Through Study Completion|Death|2|||
33608839|NCT02161757|102118480|FG001|Treatment Through Study Completion|Death|1|||
33608840|NCT02161757|102118481|FG002|Treatment Through Study Completion|Death|1|||
33608841|NCT00527319|102118482|FG000|Overall Study|Withdrawal by Subject|5|||
33608842|NCT00527319|102118483|FG001|Overall Study|Withdrawal by Subject|0|||
33608843|NCT00527319|102118484|FG002|Overall Study|Withdrawal by Subject|1|||
33608844|NCT00527319|102118482|FG000|Overall Study|Lost to Follow-up|1|||
33328064|NCT01892163|101097267|FG001|Overall Study|Lost to Follow-up|0|||
33328065|NCT01392677|101097272|FG000|Overall Study|Adverse Event|3|||
33328066|NCT01392677|101097273|FG001|Overall Study|Adverse Event|1|||
33328067|NCT01392677|101097272|FG000|Overall Study|Withdrawal by Subject|0|||
33328068|NCT01392677|101097273|FG001|Overall Study|Withdrawal by Subject|2|||
33328069|NCT01392677|101097272|FG000|Overall Study|Incorrect enrollment|2|||
33328070|NCT01392677|101097273|FG001|Overall Study|Incorrect enrollment|3|||
33328071|NCT01392677|101097272|FG000|Overall Study|Other reason|3|||
33328072|NCT01392677|101097273|FG001|Overall Study|Other reason|2|||
33328073|NCT02142738|101097276|FG000|Overall Study|Adverse Event|13|||
33328074|NCT02142738|101097277|FG001|Overall Study|Adverse Event|9|||
33328075|NCT02142738|101097276|FG000|Overall Study|Death|92|||
33328076|NCT02142738|101097277|FG001|Overall Study|Death|112|||
33328077|NCT02142738|101097276|FG000|Overall Study|Lost to Follow-up|0|||
33328078|NCT02142738|101097277|FG001|Overall Study|Lost to Follow-up|3|||
33328079|NCT02142738|101097276|FG000|Overall Study|Withdrawal by Subject|6|||
33401075|NCT02192190|101356931|FG002|Overall Study|Positive Drug Screen|0|||
33608845|NCT00527319|102118483|FG001|Overall Study|Lost to Follow-up|0|||
33608846|NCT00527319|102118484|FG002|Overall Study|Lost to Follow-up|0|||
33401076|NCT02192190|101356932|FG003|Overall Study|Positive Drug Screen|1|||
33401077|NCT02192190|101356933|FG004|Overall Study|Positive Drug Screen|0|||
33608847|NCT00527319|102118482|FG000|Overall Study|Death|0|||
33608848|NCT00527319|102118483|FG001|Overall Study|Death|3|||
33401078|NCT02192190|101356934|FG005|Overall Study|Positive Drug Screen|0|||
33401079|NCT02192190|101356929|FG000|Overall Study|Inadequate Pain Relief|0|||
33401080|NCT02192190|101356930|FG001|Overall Study|Inadequate Pain Relief|1|||
33401081|NCT02192190|101356931|FG002|Overall Study|Inadequate Pain Relief|1|||
33608849|NCT00527319|102118484|FG002|Overall Study|Death|1|||
33608850|NCT00527319|102118482|FG000|Overall Study|Intercurrent Medical Illness|0|||
33608851|NCT00527319|102118483|FG001|Overall Study|Intercurrent Medical Illness|1|||
33608852|NCT00527319|102118484|FG002|Overall Study|Intercurrent Medical Illness|3|||
33401082|NCT02192190|101356932|FG003|Overall Study|Inadequate Pain Relief|0|||
33401083|NCT02192190|101356933|FG004|Overall Study|Inadequate Pain Relief|0|||
33401084|NCT02192190|101356934|FG005|Overall Study|Inadequate Pain Relief|0|||
33401085|NCT02607735|101356939|FG000|Primary Study|Randomized but Never Treated|1|||
33401086|NCT02607735|101356940|FG001|Primary Study|Randomized but Never Treated|0|||
33401087|NCT02607735|101356941|FG002|Primary Study|Randomized but Never Treated|0|||
33401088|NCT02607735|101356939|FG000|Primary Study|Lost to Follow-up|4|||
33401089|NCT02607735|101356940|FG001|Primary Study|Lost to Follow-up|0|||
33401090|NCT02607735|101356941|FG002|Primary Study|Lost to Follow-up|0|||
33401091|NCT02607735|101356939|FG000|Primary Study|Withdrew Consent|2|||
33401092|NCT02607735|101356940|FG001|Primary Study|Withdrew Consent|0|||
33328080|NCT02142738|101097277|FG001|Overall Study|Withdrawal by Subject|7|||
33328081|NCT02142738|101097276|FG000|Overall Study|Follow up ended by sponsor|43|||
33328082|NCT02142738|101097277|FG001|Overall Study|Follow up ended by sponsor|20|||
33328083|NCT03349775|101097285|FG000|Overall Study|Side Effects|1|||
33328084|NCT03349775|101097286|FG001|Overall Study|Side Effects|2|||
33328085|NCT03349775|101097285|FG000|Overall Study|Withdrawal by Subject|1|||
33328086|NCT03349775|101097286|FG001|Overall Study|Withdrawal by Subject|1|||
33521179|NCT00236899|101807521|FG001|Overall Study|Withdrawal by Subject|4|||
33521180|NCT00236899|101807522|FG002|Overall Study|Withdrawal by Subject|5|||
33521181|NCT00236899|101807523|FG003|Overall Study|Withdrawal by Subject|2|||
33521182|NCT00236899|101807520|FG000|Overall Study|Physician Decision|7|||
33521183|NCT00236899|101807521|FG001|Overall Study|Physician Decision|8|||
33521184|NCT00236899|101807522|FG002|Overall Study|Physician Decision|7|||
33521185|NCT00236899|101807523|FG003|Overall Study|Physician Decision|6|||
33328087|NCT03349775|101097285|FG000|Overall Study|No primary outcome measurements|0|||
33328088|NCT03349775|101097286|FG001|Overall Study|No primary outcome measurements|1|||
33328089|NCT04037748|101097289|FG000|Treatment Period 1|Withdrawal by Subject|3|||
33328090|NCT04037748|101097290|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33521186|NCT00236899|101807520|FG000|Overall Study|Satisfactory Response|2|||
33521187|NCT00236899|101807521|FG001|Overall Study|Satisfactory Response|0|||
33521188|NCT00236899|101807522|FG002|Overall Study|Satisfactory Response|0|||
33521189|NCT00236899|101807523|FG003|Overall Study|Satisfactory Response|1|||
33521190|NCT00236899|101807520|FG000|Overall Study|Lack of Efficacy|18|||
33608853|NCT00527319|102118482|FG000|Overall Study|Adverse Event|0|||
33608854|NCT00527319|102118483|FG001|Overall Study|Adverse Event|0|||
33608855|NCT00527319|102118484|FG002|Overall Study|Adverse Event|1|||
33608856|NCT00095173|102118486|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
33608857|NCT00095173|102118487|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
33200438|NCT02161718|100638332|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
33328091|NCT04037748|101097289|FG000|Treatment Period 1|Adverse Event|1|||
33328092|NCT04037748|101097290|FG001|Treatment Period 1|Adverse Event|1|||
33328093|NCT04037748|101097289|FG000|Treatment Period 1|Protocol Violation|4|||
33328094|NCT04037748|101097290|FG001|Treatment Period 1|Protocol Violation|5|||
33328095|NCT04037748|101097289|FG000|Treatment Period 2|Adverse Event|0|||
33328096|NCT04037748|101097290|FG001|Treatment Period 2|Adverse Event|1|||
33328097|NCT04037748|101097289|FG000|Treatment Period 2|Protocol Violation|2|||
33401093|NCT02607735|101356941|FG002|Primary Study|Withdrew Consent|0|||
33401094|NCT02607735|101356939|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
33401095|NCT02607735|101356940|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
33401096|NCT02607735|101356941|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
33401097|NCT02607735|101356939|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
33401098|NCT02607735|101356940|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
33401099|NCT02607735|101356941|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
33401100|NCT01326481|101356948|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
33521191|NCT00236899|101807521|FG001|Overall Study|Lack of Efficacy|18|||
33521192|NCT00236899|101807522|FG002|Overall Study|Lack of Efficacy|25|||
33521193|NCT00236899|101807523|FG003|Overall Study|Lack of Efficacy|23|||
33608858|NCT00095173|102118488|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
33328098|NCT04037748|101097290|FG001|Treatment Period 2|Protocol Violation|0|||
33328099|NCT04869345|101097291|FG000|Overall Study|Lost to Follow-up|8|||
33608859|NCT00095173|102118489|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
33328100|NCT04869345|101097292|FG001|Overall Study|Lost to Follow-up|3|||
33328101|NCT01469182|101097295|FG000|Overall Study|Adverse Event|21|||
33328102|NCT01469182|101097296|FG001|Overall Study|Adverse Event|3|||
33401101|NCT00638989|101356952|FG000|Overall Study|Lost to Follow-up|0|||
33401102|NCT00638989|101356953|FG001|Overall Study|Lost to Follow-up|0|||
33401103|NCT00638989|101356954|FG002|Overall Study|Lost to Follow-up|1|||
33401104|NCT03812224|101356955|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
33401105|NCT03812224|101356956|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
33521194|NCT01492101|101807524|FG000|Overall Study|Death|323|||
33521195|NCT01492101|101807525|FG001|Overall Study|Death|322|||
33328103|NCT01469182|101097295|FG000|Overall Study|Lost to Follow-up|3|||
33328104|NCT01469182|101097296|FG001|Overall Study|Lost to Follow-up|0|||
33328105|NCT01469182|101097295|FG000|Overall Study|Withdrawal by Subject|4|||
33328106|NCT01469182|101097296|FG001|Overall Study|Withdrawal by Subject|1|||
33328107|NCT01469182|101097295|FG000|Overall Study|Protocol Violation|4|||
33328108|NCT01469182|101097296|FG001|Overall Study|Protocol Violation|2|||
33328109|NCT01469182|101097295|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
33328110|NCT01469182|101097296|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
33328111|NCT01471015|101097298|FG000|Overall Study|Death|0|||
33328112|NCT01471015|101097299|FG001|Overall Study|Death|1|||
33401106|NCT03812224|101356955|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
33401107|NCT03812224|101356956|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
33401108|NCT03812224|101356955|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
33401109|NCT03812224|101356956|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
33401110|NCT03812224|101356955|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
33401111|NCT03812224|101356956|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
33401112|NCT00621764|101356957|FG000|Overall Study|Protocol Violation|0|||
33401113|NCT00621764|101356958|FG001|Overall Study|Protocol Violation|0|||
33401114|NCT00621764|101356959|FG002|Overall Study|Protocol Violation|0|||
33401115|NCT00621764|101356960|FG003|Overall Study|Protocol Violation|1|||
33401116|NCT01906489|101356962|FG000|Overall Study|Adverse Event|10|||
33401117|NCT01906489|101356963|FG001|Overall Study|Adverse Event|3|||
33401118|NCT01906489|101356962|FG000|Overall Study|Worsening of CKD|6|||
33401119|NCT01906489|101356963|FG001|Overall Study|Worsening of CKD|4|||
33401120|NCT01906489|101356962|FG000|Overall Study|Withdrawal by Subject|5|||
33328113|NCT01471015|101097300|FG002|Overall Study|Death|1|||
33328114|NCT03697720|101097306|FG000|Overall Study|Lost to Follow-up|7|||
33328115|NCT00808236|101097307|FG000|Overall Study|Was not resuscitated|50|||
33328116|NCT00808236|101097308|FG001|Overall Study|Was not resuscitated|56|||
33328117|NCT00808236|101097307|FG000|Overall Study|Pre-defined exclusion|13|||
33328118|NCT00808236|101097308|FG001|Overall Study|Pre-defined exclusion|3|||
33328119|NCT00808236|101097307|FG000|Overall Study|Lost to Follow-up|1|||
33328120|NCT00808236|101097308|FG001|Overall Study|Lost to Follow-up|1|||
33328121|NCT00808236|101097307|FG000|Overall Study|Physician Decision|0|||
33328122|NCT00808236|101097308|FG001|Overall Study|Physician Decision|1|||
33328123|NCT00808236|101097307|FG000|Overall Study|Death|18|||
33328124|NCT00808236|101097308|FG001|Overall Study|Death|30|||
33328125|NCT00427349|101097309|FG000|Overall Study|Lack of Efficacy|23|||
33328126|NCT00427349|101097309|FG000|Overall Study|Adverse Event|14|||
33328127|NCT00427349|101097309|FG000|Overall Study|Death|1|||
33328128|NCT00427349|101097309|FG000|Overall Study|Withdrawal by Subject|3|||
33328129|NCT00427349|101097309|FG000|Overall Study|Alternative therapy|1|||
33328130|NCT00427349|101097309|FG000|Overall Study|Other|2|||
33328131|NCT00427349|101097309|FG000|Overall Study|Ineligible|1|||
33328132|NCT00427349|101097309|FG000|Overall Study|Never started therapy|1|||
33328133|NCT02667275|101097310|FG000|Overall Study|Protocol Violation|11|||
33328134|NCT02667275|101097311|FG001|Overall Study|Protocol Violation|7|||
33328135|NCT02667275|101097310|FG000|Overall Study|Lost to Follow-up|0|||
33328136|NCT02667275|101097311|FG001|Overall Study|Lost to Follow-up|2|||
33328137|NCT02667275|101097310|FG000|Overall Study|Withdrawal by Subject|0|||
33401121|NCT01906489|101356963|FG001|Overall Study|Withdrawal by Subject|0|||
33401122|NCT01906489|101356962|FG000|Overall Study|Worsening of Anemia|1|||
33401123|NCT01906489|101356963|FG001|Overall Study|Worsening of Anemia|0|||
33521196|NCT01492101|101807524|FG000|Overall Study|Withdrawal by Subject|14|||
33521197|NCT01492101|101807525|FG001|Overall Study|Withdrawal by Subject|18|||
33521198|NCT01492101|101807524|FG000|Overall Study|Lost to Follow-up|0|||
33521199|NCT01492101|101807525|FG001|Overall Study|Lost to Follow-up|2|||
33521200|NCT00359294|101807526|FG000|Overall Study|Progressive disease|1|||
33521201|NCT00359294|101807527|FG001|Overall Study|Progressive disease|1|||
33521202|NCT00359294|101807528|FG002|Overall Study|Progressive disease|2|||
33521203|NCT00359294|101807529|FG003|Overall Study|Progressive disease|3|||
33328138|NCT02667275|101097311|FG001|Overall Study|Withdrawal by Subject|5|||
33328139|NCT02667275|101097310|FG000|Overall Study|Discontinued early without completing|0|||
33328140|NCT02667275|101097311|FG001|Overall Study|Discontinued early without completing|1|||
33328141|NCT02953639|101097314|FG000|Overall Study|Adverse Event|2|||
33328142|NCT02953639|101097315|FG001|Overall Study|Adverse Event|0|||
33328143|NCT02953639|101097316|FG002|Overall Study|Adverse Event|1|||
33328144|NCT02953639|101097314|FG000|Overall Study|Lost to Follow-up|8|||
33328145|NCT02953639|101097315|FG001|Overall Study|Lost to Follow-up|4|||
33328146|NCT02953639|101097316|FG002|Overall Study|Lost to Follow-up|3|||
33328147|NCT02953639|101097314|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33328148|NCT02953639|101097315|FG001|Overall Study|Non-Compliance With Study Drug|2|||
33328149|NCT02953639|101097316|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33401124|NCT01906489|101356962|FG000|Overall Study|Protocol Violation|0|||
33401125|NCT01906489|101356963|FG001|Overall Study|Protocol Violation|1|||
33401126|NCT01906489|101356962|FG000|Overall Study|Non- Compliance|1|||
33401127|NCT01906489|101356963|FG001|Overall Study|Non- Compliance|0|||
33521204|NCT00359294|101807530|FG004|Overall Study|Progressive disease|2|||
33328150|NCT02953639|101097314|FG000|Overall Study|Multiple Reasons|1|||
33328151|NCT02953639|101097315|FG001|Overall Study|Multiple Reasons|0|||
33328152|NCT02953639|101097316|FG002|Overall Study|Multiple Reasons|1|||
33328153|NCT02953639|101097314|FG000|Overall Study|Physician Decision|1|||
33328154|NCT02953639|101097315|FG001|Overall Study|Physician Decision|0|||
33328155|NCT02953639|101097316|FG002|Overall Study|Physician Decision|0|||
33328156|NCT02953639|101097314|FG000|Overall Study|Withdrawal by Subject|7|||
33328157|NCT02953639|101097315|FG001|Overall Study|Withdrawal by Subject|8|||
33328158|NCT02953639|101097316|FG002|Overall Study|Withdrawal by Subject|10|||
33328159|NCT02953639|101097314|FG000|Overall Study|Completed or Discontinued information is missing|1|||
33328160|NCT02953639|101097315|FG001|Overall Study|Completed or Discontinued information is missing|0|||
33328161|NCT02953639|101097316|FG002|Overall Study|Completed or Discontinued information is missing|0|||
33328162|NCT00528021|101097317|FG000|Overall Study|Lack of Efficacy|17|||
33328163|NCT00528021|101097318|FG001|Overall Study|Lack of Efficacy|13|||
33328164|NCT00528021|101097319|FG002|Overall Study|Lack of Efficacy|7|||
33328165|NCT00528021|101097320|FG003|Overall Study|Lack of Efficacy|9|||
33328166|NCT01961349|101097321|FG000|Overall Study|Withdrawal by Subject|1|||
33328167|NCT01961349|101097322|FG001|Overall Study|Withdrawal by Subject|4|||
33328168|NCT01961349|101097323|FG002|Overall Study|Withdrawal by Subject|0|||
33328169|NCT01961349|101097321|FG000|Overall Study|Adverse Event|0|||
33328170|NCT01961349|101097322|FG001|Overall Study|Adverse Event|0|||
33328171|NCT01961349|101097323|FG002|Overall Study|Adverse Event|1|||
33328172|NCT01961349|101097321|FG000|Overall Study|registration error, personal reason etc|2|||
33328173|NCT01961349|101097322|FG001|Overall Study|registration error, personal reason etc|2|||
33328174|NCT01961349|101097323|FG002|Overall Study|registration error, personal reason etc|1|||
33328175|NCT02663453|101097328|FG000|Overall Study|Death|4|||
33401128|NCT01906489|101356962|FG000|Overall Study|Sponsor Decision|1|||
33401129|NCT01906489|101356963|FG001|Overall Study|Sponsor Decision|0|||
33401130|NCT01906489|101356962|FG000|Overall Study|Lost to Follow-up|1|||
33401131|NCT01906489|101356963|FG001|Overall Study|Lost to Follow-up|1|||
33401132|NCT01906489|101356962|FG000|Overall Study|Other|1|||
33401133|NCT01906489|101356963|FG001|Overall Study|Other|0|||
33401134|NCT02909504|101356964|FG000|Overall Study|Adverse Event|2|||
33401135|NCT02909504|101356964|FG000|Overall Study|Lack of Efficacy|3|||
33401136|NCT02909504|101356964|FG000|Overall Study|Withdrawal by Subject|4|||
33401137|NCT02909504|101356964|FG000|Overall Study|Pregnancy|1|||
33401138|NCT02909504|101356964|FG000|Overall Study|Subject moved|1|||
33401139|NCT02909504|101356964|FG000|Overall Study|Lost to Follow-up|1|||
33401140|NCT00955682|101356965|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
33401141|NCT00955682|101356966|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
33401142|NCT02561273|101356970|FG000|Overall Study|Protocol Violation|1|||
33401143|NCT02561273|101356971|FG001|Overall Study|Protocol Violation|0|||
33401144|NCT00137267|101356972|FG000|Overall Study|Lost to Follow-up|15|||
33401145|NCT00137267|101356973|FG001|Overall Study|Lost to Follow-up|21|||
33401146|NCT00696774|101356974|FG000|Period II|Adverse Event|0|||
33401147|NCT00696774|101356975|FG001|Period II|Adverse Event|0|||
33401148|NCT00696774|101356976|FG002|Period II|Adverse Event|15|||
33401149|NCT00696774|101356974|FG000|Period II|Lost to Follow-up|0|||
33401150|NCT00696774|101356975|FG001|Period II|Lost to Follow-up|0|||
33401151|NCT00696774|101356976|FG002|Period II|Lost to Follow-up|4|||
33401152|NCT00696774|101356974|FG000|Period II|Protocol Violation|0|||
33401153|NCT00696774|101356975|FG001|Period II|Protocol Violation|0|||
33401154|NCT00696774|101356976|FG002|Period II|Protocol Violation|11|||
33401155|NCT00696774|101356974|FG000|Period II|Withdrawal by Subject|0|||
33401156|NCT00696774|101356975|FG001|Period II|Withdrawal by Subject|0|||
33328176|NCT02663453|101097329|FG001|Overall Study|Death|4|||
33328177|NCT02663453|101097328|FG000|Overall Study|Withdrawal by Subject|1|||
33328178|NCT02663453|101097329|FG001|Overall Study|Withdrawal by Subject|0|||
33328179|NCT05289570|101097330|FG000|Overall Study|Physician Decision|1|||
33328180|NCT02285777|101097331|FG000|Overall Study|Withdrawal by Subject|1|||
33401157|NCT00696774|101356976|FG002|Period II|Withdrawal by Subject|4|||
33328181|NCT02285777|101097332|FG001|Overall Study|Withdrawal by Subject|1|||
33328182|NCT02285777|101097331|FG000|Overall Study|Lost to Follow-up|4|||
33328183|NCT02285777|101097332|FG001|Overall Study|Lost to Follow-up|2|||
33328184|NCT01225731|101097333|FG000|Part 1|Did not meet eligibility criteria|1|||
33328185|NCT01225731|101097334|FG001|Part 1|Did not meet eligibility criteria|0|||
33328186|NCT01225731|101097335|FG002|Part 1|Did not meet eligibility criteria|0|||
33328187|NCT01225731|101097336|FG003|Part 1|Did not meet eligibility criteria|0|||
33328188|NCT01225731|101097337|FG004|Part 1|Did not meet eligibility criteria|1|||
33328189|NCT01225731|101097338|FG005|Part 1|Did not meet eligibility criteria|0|||
33401158|NCT00696774|101356974|FG000|Period II|Sponsor Decision|0|||
33401159|NCT00696774|101356975|FG001|Period II|Sponsor Decision|0|||
33401160|NCT00696774|101356976|FG002|Period II|Sponsor Decision|0|||
33401161|NCT00696774|101356974|FG000|Period II|Lack of Efficacy|0|||
33401162|NCT00696774|101356975|FG001|Period II|Lack of Efficacy|0|||
33401163|NCT00696774|101356976|FG002|Period II|Lack of Efficacy|2|||
33401164|NCT00696774|101356974|FG000|Period III|Adverse Event|1|||
33401165|NCT00696774|101356975|FG001|Period III|Adverse Event|1|||
33401166|NCT00696774|101356976|FG002|Period III|Adverse Event|0|||
33608860|NCT00095173|102118490|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
33608861|NCT00095173|102118491|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
33608862|NCT00095173|102118486|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
33608863|NCT00095173|102118487|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
33608864|NCT00095173|102118488|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
33608865|NCT00095173|102118489|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
33608866|NCT00095173|102118490|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
33608867|NCT00095173|102118491|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
33608868|NCT00095173|102118486|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
33608869|NCT00095173|102118487|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
33608870|NCT00095173|102118488|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
33608871|NCT00095173|102118489|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
33328190|NCT01225731|101097339|FG006|Part 1|Did not meet eligibility criteria|0|||
33521205|NCT00359294|101807526|FG000|Overall Study|Withdrawal by Subject|0|||
33521206|NCT00359294|101807527|FG001|Overall Study|Withdrawal by Subject|0|||
33521207|NCT00359294|101807528|FG002|Overall Study|Withdrawal by Subject|0|||
33521208|NCT00359294|101807529|FG003|Overall Study|Withdrawal by Subject|0|||
33521209|NCT00359294|101807530|FG004|Overall Study|Withdrawal by Subject|1|||
33521210|NCT00359294|101807526|FG000|Overall Study|Not treated|0|||
33521211|NCT00359294|101807527|FG001|Overall Study|Not treated|0|||
33521212|NCT00359294|101807528|FG002|Overall Study|Not treated|0|||
33521213|NCT00359294|101807529|FG003|Overall Study|Not treated|1|||
33521214|NCT00359294|101807530|FG004|Overall Study|Not treated|0|||
33521215|NCT00359294|101807526|FG000|Overall Study|Physician Decision|0|||
33521216|NCT00359294|101807527|FG001|Overall Study|Physician Decision|0|||
33521217|NCT00359294|101807528|FG002|Overall Study|Physician Decision|1|||
33521218|NCT00359294|101807529|FG003|Overall Study|Physician Decision|0|||
33521219|NCT00359294|101807530|FG004|Overall Study|Physician Decision|0|||
33521220|NCT01797094|101807531|FG000|Overall Study|Adverse Event|1|||
33521221|NCT01797094|101807532|FG001|Overall Study|Adverse Event|1|||
33521222|NCT01797094|101807531|FG000|Overall Study|Personal Reasons|4|||
33521223|NCT01797094|101807532|FG001|Overall Study|Personal Reasons|0|||
33521224|NCT01797094|101807531|FG000|Overall Study|Protocol Violation|0|||
33521225|NCT01797094|101807532|FG001|Overall Study|Protocol Violation|1|||
33521226|NCT01797094|101807531|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33608872|NCT00095173|102118490|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
33200439|NCT02161718|100638333|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
33200440|NCT02161718|100638331|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
33200441|NCT02161718|100638332|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
33200442|NCT02161718|100638333|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
33200443|NCT02161718|100638331|FG000|Post- Randomization Period|Lost to Follow-up|0|||
33200444|NCT02161718|100638332|FG001|Post- Randomization Period|Lost to Follow-up|9|||
33200445|NCT02161718|100638333|FG002|Post- Randomization Period|Lost to Follow-up|15|||
33200446|NCT02161718|100638331|FG000|Post- Randomization Period|Adverse Event|0|||
33200447|NCT02161718|100638332|FG001|Post- Randomization Period|Adverse Event|9|||
33200448|NCT02161718|100638333|FG002|Post- Randomization Period|Adverse Event|10|||
33200449|NCT02161718|100638331|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
33200450|NCT02161718|100638332|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
33200451|NCT02161718|100638333|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
33200452|NCT02161718|100638331|FG000|Post- Randomization Period|Physician Decision|0|||
33200453|NCT02161718|100638332|FG001|Post- Randomization Period|Physician Decision|2|||
33200454|NCT02161718|100638333|FG002|Post- Randomization Period|Physician Decision|4|||
33200455|NCT02161718|100638331|FG000|Post- Randomization Period|Protocol Violation|0|||
33200456|NCT02161718|100638332|FG001|Post- Randomization Period|Protocol Violation|2|||
33200457|NCT02161718|100638333|FG002|Post- Randomization Period|Protocol Violation|3|||
33200458|NCT02161718|100638331|FG000|Post- Randomization Period|Lack of Efficacy|0|||
33200459|NCT02161718|100638332|FG001|Post- Randomization Period|Lack of Efficacy|0|||
33200460|NCT02161718|100638333|FG002|Post- Randomization Period|Lack of Efficacy|1|||
33200461|NCT02161718|100638331|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
33200462|NCT02161718|100638332|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
33200463|NCT02161718|100638333|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
33200464|NCT02161718|100638331|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
33200465|NCT02161718|100638332|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
33200466|NCT02161718|100638333|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
33328191|NCT01225731|101097340|FG007|Part 1|Did not meet eligibility criteria|0|||
33328192|NCT01225731|101097341|FG008|Part 1|Did not meet eligibility criteria|0|||
33521227|NCT01797094|101807532|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33521228|NCT00513357|101807534|FG000|Overall Study|did not receive allocated placebo|2|||
33521229|NCT00513357|101807535|FG001|Overall Study|did not receive allocated placebo|3|||
33521230|NCT00513357|101807534|FG000|Overall Study|Adverse Event|4|||
33521231|NCT00513357|101807535|FG001|Overall Study|Adverse Event|2|||
33521232|NCT00513357|101807534|FG000|Overall Study|Death|2|||
33401167|NCT00696774|101356974|FG000|Period III|Lost to Follow-up|2|||
33401168|NCT00696774|101356975|FG001|Period III|Lost to Follow-up|1|||
33401169|NCT00696774|101356976|FG002|Period III|Lost to Follow-up|0|||
33401170|NCT00696774|101356974|FG000|Period III|Protocol Violation|1|||
33401171|NCT00696774|101356975|FG001|Period III|Protocol Violation|1|||
33401172|NCT00696774|101356976|FG002|Period III|Protocol Violation|0|||
33401173|NCT00696774|101356974|FG000|Period III|Withdrawal by Subject|1|||
33401174|NCT00696774|101356975|FG001|Period III|Withdrawal by Subject|2|||
33401175|NCT00696774|101356976|FG002|Period III|Withdrawal by Subject|0|||
33401176|NCT00696774|101356974|FG000|Period III|Sponsor Decision|2|||
33401177|NCT00696774|101356975|FG001|Period III|Sponsor Decision|0|||
33401178|NCT00696774|101356976|FG002|Period III|Sponsor Decision|0|||
33401179|NCT00696774|101356974|FG000|Period III|Lack of Efficacy|0|||
33401180|NCT00696774|101356975|FG001|Period III|Lack of Efficacy|2|||
33401181|NCT00696774|101356976|FG002|Period III|Lack of Efficacy|0|||
33401182|NCT01536418|101356977|FG000|Overall Study|Protocol Violation|2|||
33401183|NCT01536418|101356978|FG001|Overall Study|Protocol Violation|3|||
33401184|NCT01536418|101356977|FG000|Overall Study|Physician Decision|1|||
33401185|NCT01536418|101356978|FG001|Overall Study|Physician Decision|3|||
33401186|NCT01536418|101356977|FG000|Overall Study|Study closed/terminated|41|||
33200467|NCT02161718|100638331|FG000|Post- Randomization Period|Relocation|0|||
33401187|NCT01536418|101356978|FG001|Overall Study|Study closed/terminated|37|||
33401188|NCT01536418|101356977|FG000|Overall Study|Lack of Efficacy|10|||
33401189|NCT01536418|101356978|FG001|Overall Study|Lack of Efficacy|16|||
33401190|NCT01536418|101356977|FG000|Overall Study|Adverse Event|9|||
33401191|NCT01536418|101356978|FG001|Overall Study|Adverse Event|4|||
33401192|NCT01536418|101356977|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
33401193|NCT01536418|101356978|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
33401194|NCT01536418|101356977|FG000|Overall Study|Withdrawal by Subject|5|||
33401195|NCT01536418|101356978|FG001|Overall Study|Withdrawal by Subject|3|||
33401196|NCT04880642|101356979|FG000|Randomization|Withdrawal by Subject|2|||
33401197|NCT04880642|101356980|FG001|Randomization|Withdrawal by Subject|3|||
33401198|NCT04880642|101356979|FG000|Treatment Period|Adverse Event|0|||
33401199|NCT04880642|101356980|FG001|Treatment Period|Adverse Event|1|||
33401200|NCT04880642|101356979|FG000|Treatment Period|Death|6|||
33401201|NCT04880642|101356980|FG001|Treatment Period|Death|6|||
33401202|NCT04880642|101356979|FG000|Treatment Period|Lost to Follow-up|1|||
33401203|NCT04880642|101356980|FG001|Treatment Period|Lost to Follow-up|0|||
33401204|NCT04880642|101356979|FG000|Treatment Period|Protocol Violation|0|||
33401205|NCT04880642|101356980|FG001|Treatment Period|Protocol Violation|1|||
33401206|NCT04880642|101356979|FG000|Treatment Period|Withdrawal by Subject|5|||
33401207|NCT04880642|101356980|FG001|Treatment Period|Withdrawal by Subject|3|||
33401208|NCT04880642|101356979|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
33401209|NCT04880642|101356980|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
33401210|NCT04880642|101356979|FG000|Follow-up|Death|4|||
33521233|NCT00513357|101807535|FG001|Overall Study|Death|0|||
33521234|NCT00513357|101807534|FG000|Overall Study|Withdrawal by Subject|5|||
33521235|NCT00513357|101807535|FG001|Overall Study|Withdrawal by Subject|4|||
33521236|NCT00513357|101807534|FG000|Overall Study|Disease Progression|2|||
33521237|NCT00513357|101807535|FG001|Overall Study|Disease Progression|1|||
33521238|NCT00723697|101807538|FG000|Overall Study|Physician questionnaires not received|2|||
33521239|NCT00723697|101807538|FG000|Overall Study|Missing Informed Consent Form|10|||
33521240|NCT00723697|101807538|FG000|Overall Study|Other exclusion criteria applied|6|||
33521241|NCT00337779|101807545|FG000|Overall Study|Withdrawal by Subject|10|||
33200468|NCT02161718|100638332|FG001|Post- Randomization Period|Relocation|3|||
33200469|NCT02161718|100638333|FG002|Post- Randomization Period|Relocation|0|||
33200470|NCT02823145|100638334|FG000|Enrollment|Other|1|||
33200471|NCT02823145|100638335|FG001|Enrollment|Other|0|||
33200472|NCT02823145|100638334|FG000|Treatment|Adverse Event|0|||
33200473|NCT02823145|100638335|FG001|Treatment|Adverse Event|11|||
33200474|NCT02823145|100638334|FG000|Treatment|Death|0|||
33200475|NCT02823145|100638335|FG001|Treatment|Death|3|||
33401211|NCT04880642|101356980|FG001|Follow-up|Death|3|||
33401212|NCT04880642|101356979|FG000|Follow-up|Withdrawal by Subject|1|||
33401213|NCT04880642|101356980|FG001|Follow-up|Withdrawal by Subject|0|||
33401214|NCT02098733|101356989|FG000|Overall Study|Data Not Available|5|||
33401215|NCT02098733|101356989|FG000|Overall Study|Lost to Follow-up|5|||
33401216|NCT01969565|101356992|FG000|Overall Study|Withdrawal by Subject|1|||
33401217|NCT00718887|101356993|FG000|Overall Study|Withdrawal by Subject|3|||
33401218|NCT00718887|101356994|FG001|Overall Study|Withdrawal by Subject|2|||
33401219|NCT00718887|101356993|FG000|Overall Study|Not identified|2|||
33521242|NCT00337779|101807546|FG001|Overall Study|Withdrawal by Subject|12|||
33521243|NCT00337779|101807545|FG000|Overall Study|Sponsor decision|1|||
33521244|NCT00337779|101807546|FG001|Overall Study|Sponsor decision|1|||
33521245|NCT00337779|101807545|FG000|Overall Study|Physician Decision|3|||
33521246|NCT00337779|101807546|FG001|Overall Study|Physician Decision|6|||
33521247|NCT00337779|101807545|FG000|Overall Study|Protocol Violation|1|||
33521248|NCT00337779|101807546|FG001|Overall Study|Protocol Violation|1|||
33521249|NCT00337779|101807545|FG000|Overall Study|Lost to Follow-up|6|||
33521250|NCT00337779|101807546|FG001|Overall Study|Lost to Follow-up|5|||
33521251|NCT00337779|101807545|FG000|Overall Study|Adverse Event|28|||
33521252|NCT00337779|101807546|FG001|Overall Study|Adverse Event|51|||
33521253|NCT00337779|101807545|FG000|Overall Study|Pregnancy|3|||
33521254|NCT00337779|101807546|FG001|Overall Study|Pregnancy|2|||
33521255|NCT00337779|101807545|FG000|Overall Study|Death|0|||
33521256|NCT00337779|101807546|FG001|Overall Study|Death|1|||
33521257|NCT02069093|101807548|FG000|Overall Study|Disease progression|14|||
33521258|NCT02069093|101807548|FG000|Overall Study|New cancer therapy|1|||
33521259|NCT02069093|101807548|FG000|Overall Study|Death|1|||
33521260|NCT02069093|101807548|FG000|Overall Study|Administrative problems|1|||
33521261|NCT02069093|101807548|FG000|Overall Study|Withdrawal by Subject|2|||
33521262|NCT02069093|101807548|FG000|Overall Study|Abnormal laboratory values|1|||
33521263|NCT02069093|101807548|FG000|Overall Study|Adverse Event|10|||
33521264|NCT03084315|101807551|FG000|Overall Study|Lost to Follow-up|8|||
33521265|NCT03084315|101807552|FG001|Overall Study|Lost to Follow-up|7|||
33521266|NCT03084315|101807551|FG000|Overall Study|Withdrawal by Subject|2|||
33521267|NCT03084315|101807552|FG001|Overall Study|Withdrawal by Subject|2|||
33521268|NCT01994902|101807554|FG000|Test Period 1|Withdrawal by Subject|3|||
33521269|NCT01994902|101807555|FG001|Test Period 1|Withdrawal by Subject|0|||
33521270|NCT01994902|101807554|FG000|Test Period 1|device deficiency with adverse event|0|||
33521271|NCT01994902|101807555|FG001|Test Period 1|device deficiency with adverse event|1|||
33521272|NCT01994902|101807554|FG000|Test Period 1|Adverse Event|2|||
33608873|NCT00095173|102118491|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
33608874|NCT00095173|102118486|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
33608875|NCT00095173|102118487|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
33608876|NCT00095173|102118488|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
33608877|NCT00095173|102118489|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
33608878|NCT00095173|102118490|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
33608879|NCT00095173|102118491|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
33608880|NCT00095173|102118486|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
33608881|NCT00095173|102118487|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
33608882|NCT00095173|102118488|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
33608883|NCT00095173|102118489|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
33608884|NCT00095173|102118490|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
33608885|NCT00095173|102118491|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
33608886|NCT00095173|102118486|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
33608887|NCT00095173|102118487|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
33608888|NCT00095173|102118488|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
33608889|NCT00095173|102118489|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
33608890|NCT00095173|102118490|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
33608891|NCT00095173|102118491|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
33521273|NCT01994902|101807555|FG001|Test Period 1|Adverse Event|1|||
33521274|NCT01994902|101807554|FG000|Test Period 1|Lack of Efficacy|0|||
33521275|NCT01994902|101807555|FG001|Test Period 1|Lack of Efficacy|1|||
33521276|NCT01994902|101807554|FG000|Test Period 1|bag too small|1|||
33608892|NCT00095173|102118486|FG000|Open-Label Extension Phase (Period C)|Death|0|||
33521277|NCT01994902|101807555|FG001|Test Period 1|bag too small|0|||
33521278|NCT01994902|101807554|FG000|Test Period 2|Withdrawal by Subject|0|||
33521279|NCT01994902|101807555|FG001|Test Period 2|Withdrawal by Subject|2|||
33521280|NCT01994902|101807554|FG000|Test Period 2|Lack of Efficacy|0|||
33608893|NCT00095173|102118487|FG001|Open-Label Extension Phase (Period C)|Death|0|||
33521281|NCT01994902|101807555|FG001|Test Period 2|Lack of Efficacy|1|||
33521282|NCT01994902|101807554|FG000|Test Period 2|Other|0|||
33521283|NCT01994902|101807555|FG001|Test Period 2|Other|3|||
33608894|NCT00095173|102118488|FG002|Open-Label Extension Phase (Period C)|Death|0|||
33608895|NCT00095173|102118489|FG003|Open-Label Extension Phase (Period C)|Death|0|||
33608896|NCT00095173|102118490|FG004|Open-Label Extension Phase (Period C)|Death|0|||
33608897|NCT00095173|102118491|FG005|Open-Label Extension Phase (Period C)|Death|1|||
33608898|NCT00095173|102118486|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
33608899|NCT00095173|102118487|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
33608900|NCT00095173|102118488|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
33608901|NCT00095173|102118489|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
33608902|NCT00095173|102118490|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
33608903|NCT00095173|102118491|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
33608904|NCT00095173|102118486|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
33608905|NCT00095173|102118487|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
33608906|NCT00095173|102118488|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
33608907|NCT00095173|102118489|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
33608908|NCT00095173|102118490|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
33608909|NCT00095173|102118491|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
33608910|NCT00095173|102118486|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
33608911|NCT00095173|102118487|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
33608912|NCT00095173|102118488|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
33608913|NCT00095173|102118489|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
33608914|NCT00095173|102118490|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
33608915|NCT00095173|102118491|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
33608916|NCT00095173|102118486|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
33608917|NCT00095173|102118487|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
33608918|NCT00095173|102118488|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
33401220|NCT00718887|101356994|FG001|Overall Study|Not identified|7|||
33401221|NCT00082628|101356997|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
33401222|NCT00082628|101356998|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
33401223|NCT00082628|101356999|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
33401224|NCT00082628|101357000|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
33401225|NCT00082628|101357001|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
33401226|NCT00082628|101356997|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
33521284|NCT00427999|101807556|FG000|Overall Study|Adverse Event|6|||
33521285|NCT00427999|101807556|FG000|Overall Study|Abnormal laboratory values|1|||
33521286|NCT00427999|101807556|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
33521287|NCT00427999|101807556|FG000|Overall Study|Protocol Violation|2|||
33521288|NCT00427999|101807556|FG000|Overall Study|Withdrawal by Subject|9|||
33521289|NCT00427999|101807556|FG000|Overall Study|Death|1|||
33521290|NCT01711619|101807559|FG000|Overall Study|Early study termination|10|||
33521291|NCT01711619|101807560|FG001|Overall Study|Early study termination|14|||
33521292|NCT01711619|101807559|FG000|Overall Study|Withdrawal by Subject|3|||
33521293|NCT01711619|101807560|FG001|Overall Study|Withdrawal by Subject|7|||
33608919|NCT00095173|102118489|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
33608920|NCT00095173|102118490|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
33608921|NCT00095173|102118491|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
33608922|NCT00095173|102118486|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
33608923|NCT00095173|102118487|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
33608924|NCT00095173|102118488|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
33608925|NCT00095173|102118489|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
33521294|NCT01711619|101807559|FG000|Overall Study|Protocol Violation|2|||
33521295|NCT01711619|101807560|FG001|Overall Study|Protocol Violation|3|||
33521296|NCT01711619|101807559|FG000|Overall Study|Adverse Event|2|||
33521297|NCT01711619|101807560|FG001|Overall Study|Adverse Event|0|||
33521298|NCT01711619|101807559|FG000|Overall Study|Lost to Follow-up|1|||
33521299|NCT01711619|101807560|FG001|Overall Study|Lost to Follow-up|0|||
33521300|NCT03951753|101807561|FG000|Overall Study|Adverse Event|1|||
33521301|NCT03951753|101807562|FG001|Overall Study|Adverse Event|0|||
33521302|NCT03951753|101807563|FG002|Overall Study|Adverse Event|3|||
33521303|NCT03951753|101807561|FG000|Overall Study|Withdrawal by Subject|3|||
33521304|NCT03951753|101807562|FG001|Overall Study|Withdrawal by Subject|1|||
33608926|NCT00095173|102118490|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
33200476|NCT02823145|100638334|FG000|Treatment|Family Decision|0|||
33521305|NCT03951753|101807563|FG002|Overall Study|Withdrawal by Subject|0|||
33521306|NCT03951753|101807561|FG000|Overall Study|Lost to Follow-up|0|||
33521307|NCT03951753|101807562|FG001|Overall Study|Lost to Follow-up|0|||
33608927|NCT00095173|102118491|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
33608928|NCT00095173|102118486|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
33521308|NCT03951753|101807563|FG002|Overall Study|Lost to Follow-up|1|||
33608929|NCT00095173|102118487|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
33608930|NCT00095173|102118488|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
33608931|NCT00095173|102118489|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
33608932|NCT00095173|102118490|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
33521309|NCT00467558|101807564|FG000|Overall Study|Lost to Follow-up|2|||
33521310|NCT00467558|101807565|FG001|Overall Study|Lost to Follow-up|0|||
33521311|NCT02282163|101807566|FG000|Overall Study|Protocol Violation|1|||
33521312|NCT02669667|101807567|FG000|Overall Study|Lost to Follow-up|0|||
33521313|NCT02669667|101807568|FG001|Overall Study|Lost to Follow-up|0|||
33521314|NCT02669667|101807569|FG002|Overall Study|Lost to Follow-up|0|||
33521315|NCT02669667|101807570|FG003|Overall Study|Lost to Follow-up|0|||
33521316|NCT02669667|101807571|FG004|Overall Study|Lost to Follow-up|0|||
33521317|NCT02669667|101807572|FG005|Overall Study|Lost to Follow-up|1|||
33521318|NCT02669667|101807573|FG006|Overall Study|Lost to Follow-up|0|||
33521319|NCT02943785|101807574|FG000|Overall Study|Adverse Event|112|||
33521320|NCT02943785|101807575|FG001|Overall Study|Adverse Event|97|||
33521321|NCT02943785|101807574|FG000|Overall Study|Withdrawal by Subject|63|||
33521322|NCT02943785|101807575|FG001|Overall Study|Withdrawal by Subject|126|||
33521323|NCT02943785|101807574|FG000|Overall Study|Physician Decision|23|||
33521324|NCT02943785|101807575|FG001|Overall Study|Physician Decision|47|||
33521325|NCT02943785|101807574|FG000|Overall Study|Death|46|||
33521326|NCT02943785|101807575|FG001|Overall Study|Death|46|||
33521327|NCT02943785|101807574|FG000|Overall Study|Lost to Follow-up|1|||
33521328|NCT02943785|101807575|FG001|Overall Study|Lost to Follow-up|0|||
33608933|NCT00095173|102118491|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
33608934|NCT00095173|102118486|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
33608935|NCT00095173|102118487|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
33608936|NCT00095173|102118488|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
33608937|NCT00095173|102118489|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
33608938|NCT00095173|102118490|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
33608939|NCT00095173|102118491|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
33608940|NCT00095173|102118486|FG000|Open-Label Extension Phase (Period C)|Other|0|||
33608941|NCT00095173|102118487|FG001|Open-Label Extension Phase (Period C)|Other|0|||
33608942|NCT00095173|102118488|FG002|Open-Label Extension Phase (Period C)|Other|0|||
33608943|NCT00095173|102118489|FG003|Open-Label Extension Phase (Period C)|Other|4|||
33608944|NCT00095173|102118490|FG004|Open-Label Extension Phase (Period C)|Other|6|||
33608945|NCT00095173|102118491|FG005|Open-Label Extension Phase (Period C)|Other|8|||
33608946|NCT02301624|102118493|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
33608947|NCT02301624|102118494|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
33608948|NCT02301624|102118493|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
33608949|NCT02301624|102118494|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
33608950|NCT02301624|102118493|FG000|Open-label Maintenance Phase|Adverse Event|2|||
33608951|NCT02301624|102118494|FG001|Open-label Maintenance Phase|Adverse Event|5|||
33608952|NCT02301624|102118493|FG000|Open-label Maintenance Phase|Physician Decision|3|||
33608953|NCT02301624|102118494|FG001|Open-label Maintenance Phase|Physician Decision|3|||
33608954|NCT02301624|102118493|FG000|Open-label Maintenance Phase|Death|2|||
33608955|NCT02301624|102118494|FG001|Open-label Maintenance Phase|Death|1|||
33608956|NCT02301624|102118493|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
33608957|NCT02301624|102118494|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
33200477|NCT02823145|100638335|FG001|Treatment|Family Decision|1|||
33328193|NCT01225731|101097342|FG009|Part 1|Did not meet eligibility criteria|0|||
33328194|NCT01225731|101097343|FG010|Part 1|Did not meet eligibility criteria|0|||
33328195|NCT01225731|101097344|FG011|Part 1|Did not meet eligibility criteria|0|||
33328196|NCT01225731|101097345|FG012|Part 1|Did not meet eligibility criteria|0|||
33328197|NCT01225731|101097333|FG000|Part 1|Adverse Event|1|||
33328198|NCT01225731|101097334|FG001|Part 1|Adverse Event|2|||
33328199|NCT01225731|101097335|FG002|Part 1|Adverse Event|1|||
33521329|NCT02943785|101807574|FG000|Overall Study|Other|16|||
33521330|NCT02943785|101807575|FG001|Overall Study|Other|19|||
33521331|NCT02943785|101807574|FG000|Overall Study|Did not receive any study medication|21|||
33521332|NCT02943785|101807575|FG001|Overall Study|Did not receive any study medication|28|||
33521333|NCT03013985|101807576|FG000|Overall Study|Protocol Violation|2|||
33521334|NCT03013985|101807577|FG001|Overall Study|Protocol Violation|2|||
33608958|NCT01183468|102118497|FG000|Overall Study|Lost to Follow-up|2|||
33608959|NCT01183468|102118498|FG001|Overall Study|Lost to Follow-up|1|||
33328200|NCT01225731|101097336|FG003|Part 1|Adverse Event|1|||
33328201|NCT01225731|101097337|FG004|Part 1|Adverse Event|1|||
33328202|NCT01225731|101097338|FG005|Part 1|Adverse Event|0|||
33328203|NCT01225731|101097339|FG006|Part 1|Adverse Event|0|||
33521335|NCT03013985|101807576|FG000|Overall Study|Withdrawal by Subject|14|||
33328204|NCT01225731|101097340|FG007|Part 1|Adverse Event|0|||
33328205|NCT01225731|101097341|FG008|Part 1|Adverse Event|0|||
33328206|NCT01225731|101097342|FG009|Part 1|Adverse Event|0|||
33328207|NCT01225731|101097343|FG010|Part 1|Adverse Event|0|||
33521336|NCT03013985|101807577|FG001|Overall Study|Withdrawal by Subject|17|||
33521337|NCT00404924|101807578|FG000|Overall Study|Adverse Event|75|||
33521338|NCT00404924|101807579|FG001|Overall Study|Adverse Event|16|||
33521339|NCT00404924|101807578|FG000|Overall Study|Condition under investigation worsened|475|||
33521340|NCT00404924|101807579|FG001|Overall Study|Condition under investigation worsened|264|||
33521341|NCT00404924|101807578|FG000|Overall Study|Lost to Follow-up|1|||
33521342|NCT00404924|101807579|FG001|Overall Study|Lost to Follow-up|1|||
33521343|NCT00404924|101807578|FG000|Overall Study|Withdrawal by Subject|26|||
33521344|NCT00404924|101807579|FG001|Overall Study|Withdrawal by Subject|13|||
33521345|NCT00404924|101807578|FG000|Overall Study|Other|25|||
33521346|NCT00404924|101807579|FG001|Overall Study|Other|11|||
33521347|NCT00404924|101807578|FG000|Overall Study|Randomised but not received treatment|1|||
33521348|NCT00404924|101807579|FG001|Overall Study|Randomised but not received treatment|1|||
33521349|NCT03124537|101807580|FG000|Overall Study|Lost to Follow-up|3|||
33521350|NCT03124537|101807581|FG001|Overall Study|Lost to Follow-up|5|||
33521351|NCT03124537|101807580|FG000|Overall Study|App Crash, Incomplete Data|7|||
33521352|NCT03124537|101807581|FG001|Overall Study|App Crash, Incomplete Data|8|||
33521353|NCT01658904|101807583|FG000|Overall Study|Principal Investigator discretion|2|||
33521354|NCT01658904|101807584|FG001|Overall Study|Principal Investigator discretion|0|||
33328208|NCT01225731|101097344|FG011|Part 1|Adverse Event|0|||
33328209|NCT01225731|101097345|FG012|Part 1|Adverse Event|0|||
33328210|NCT01225731|101097333|FG000|Part 1|Withdrawal by Subject|0|||
33328211|NCT01225731|101097334|FG001|Part 1|Withdrawal by Subject|3|||
33328212|NCT01225731|101097335|FG002|Part 1|Withdrawal by Subject|0|||
33328213|NCT01225731|101097336|FG003|Part 1|Withdrawal by Subject|0|||
33328214|NCT01225731|101097337|FG004|Part 1|Withdrawal by Subject|4|||
33328215|NCT01225731|101097338|FG005|Part 1|Withdrawal by Subject|0|||
33328216|NCT01225731|101097339|FG006|Part 1|Withdrawal by Subject|0|||
33328217|NCT01225731|101097340|FG007|Part 1|Withdrawal by Subject|0|||
33328218|NCT01225731|101097341|FG008|Part 1|Withdrawal by Subject|0|||
33328219|NCT01225731|101097342|FG009|Part 1|Withdrawal by Subject|0|||
33328220|NCT01225731|101097343|FG010|Part 1|Withdrawal by Subject|0|||
33328221|NCT01225731|101097344|FG011|Part 1|Withdrawal by Subject|0|||
33328222|NCT01225731|101097345|FG012|Part 1|Withdrawal by Subject|0|||
33328223|NCT01225731|101097333|FG000|Part 1|Protocol Violation|0|||
33328224|NCT01225731|101097334|FG001|Part 1|Protocol Violation|0|||
33521355|NCT01658904|101807585|FG002|Overall Study|Principal Investigator discretion|0|||
33521356|NCT01911780|101807586|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
33521357|NCT01911780|101807587|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
33521358|NCT01911780|101807586|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
33521359|NCT01911780|101807587|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
33521360|NCT01911780|101807586|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
33521361|NCT01911780|101807587|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
33521362|NCT01911780|101807586|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
33521363|NCT01911780|101807587|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
33521364|NCT01911780|101807586|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
33521365|NCT01911780|101807587|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
33521366|NCT01911780|101807586|FG000|Extension Period (52 Weeks)|Personal reason|1|||
33521367|NCT01911780|101807587|FG001|Extension Period (52 Weeks)|Personal reason|1|||
33521368|NCT01180049|101807588|FG000|Overall Study|Other|9|||
33521369|NCT01180049|101807589|FG001|Overall Study|Other|7|||
33521370|NCT01180049|101807588|FG000|Overall Study|Lost to Follow-up|8|||
33521371|NCT01180049|101807589|FG001|Overall Study|Lost to Follow-up|6|||
33521372|NCT01180049|101807588|FG000|Overall Study|Death|36|||
33521373|NCT01180049|101807589|FG001|Overall Study|Death|35|||
33521374|NCT00524680|101807594|FG000|Overall Study|progression|0|||
33521375|NCT00524680|101807595|FG001|Overall Study|progression|0|||
33521376|NCT00524680|101807596|FG002|Overall Study|progression|0|||
33521377|NCT00524680|101807597|FG003|Overall Study|progression|1|||
33521378|NCT00524680|101807594|FG000|Overall Study|Adverse Event|2|||
33521379|NCT00524680|101807595|FG001|Overall Study|Adverse Event|0|||
33521380|NCT00524680|101807596|FG002|Overall Study|Adverse Event|0|||
33608960|NCT01183468|102118499|FG002|Overall Study|Lost to Follow-up|0|||
33521381|NCT00524680|101807597|FG003|Overall Study|Adverse Event|1|||
33521382|NCT00524680|101807594|FG000|Overall Study|Other|0|||
33521383|NCT00524680|101807595|FG001|Overall Study|Other|1|||
33521384|NCT00524680|101807596|FG002|Overall Study|Other|2|||
33608961|NCT01183468|102118500|FG003|Overall Study|Lost to Follow-up|0|||
33328225|NCT01225731|101097335|FG002|Part 1|Protocol Violation|0|||
33328226|NCT01225731|101097336|FG003|Part 1|Protocol Violation|1|||
33328227|NCT01225731|101097337|FG004|Part 1|Protocol Violation|0|||
33328228|NCT01225731|101097338|FG005|Part 1|Protocol Violation|0|||
33328229|NCT01225731|101097339|FG006|Part 1|Protocol Violation|0|||
33328230|NCT01225731|101097340|FG007|Part 1|Protocol Violation|0|||
33521385|NCT00524680|101807597|FG003|Overall Study|Other|3|||
33521386|NCT00524680|101807594|FG000|Overall Study|Withdrawal by Subject|1|||
33608962|NCT01183468|102118497|FG000|Overall Study|Physician Decision|1|||
33328231|NCT01225731|101097341|FG008|Part 1|Protocol Violation|0|||
33328232|NCT01225731|101097342|FG009|Part 1|Protocol Violation|0|||
33401227|NCT00082628|101356998|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
33401228|NCT00082628|101356999|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
33401229|NCT00082628|101357000|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
33521387|NCT00524680|101807595|FG001|Overall Study|Withdrawal by Subject|0|||
33521388|NCT00524680|101807596|FG002|Overall Study|Withdrawal by Subject|1|||
33521389|NCT00524680|101807597|FG003|Overall Study|Withdrawal by Subject|1|||
33521390|NCT01964716|101807607|FG000|Overall Study|Withdrawal by Subject|2|||
33521391|NCT01964716|101807608|FG001|Overall Study|Withdrawal by Subject|3|||
33521392|NCT01964716|101807607|FG000|Overall Study|Lost to Follow-up|1|||
33521393|NCT01964716|101807608|FG001|Overall Study|Lost to Follow-up|2|||
33521394|NCT01964716|101807607|FG000|Overall Study|No longer met eligibility criteria|1|||
33521395|NCT01964716|101807608|FG001|Overall Study|No longer met eligibility criteria|1|||
33521396|NCT01964716|101807607|FG000|Overall Study|Death|1|||
33521397|NCT01964716|101807608|FG001|Overall Study|Death|0|||
33521398|NCT01653327|101807609|FG000|Overall Study|Withdrawal by Subject|1|||
33521399|NCT01080391|101807610|FG000|Overall Study|Randomized but not treated|7|||
33521400|NCT01080391|101807611|FG001|Overall Study|Randomized but not treated|4|||
33521401|NCT00791492|101807612|FG000|Overall Study|Withdrawal by Subject|1|||
33521402|NCT00791492|101807613|FG001|Overall Study|Withdrawal by Subject|2|||
33521403|NCT00791492|101807612|FG000|Overall Study|Liver transplantation|5|||
33521404|NCT00791492|101807613|FG001|Overall Study|Liver transplantation|1|||
33521405|NCT01672294|101807615|FG000|Overall Study|Withdrawal by Subject|4|||
33521406|NCT01672294|101807616|FG001|Overall Study|Withdrawal by Subject|4|||
33521407|NCT01672294|101807617|FG002|Overall Study|Withdrawal by Subject|4|||
33521408|NCT01672294|101807618|FG003|Overall Study|Withdrawal by Subject|4|||
33521409|NCT01672294|101807615|FG000|Overall Study|Excluded by study|1|||
33521410|NCT01672294|101807616|FG001|Overall Study|Excluded by study|1|||
33521411|NCT01672294|101807617|FG002|Overall Study|Excluded by study|0|||
33521412|NCT01672294|101807618|FG003|Overall Study|Excluded by study|0|||
33521413|NCT01672294|101807615|FG000|Overall Study|Lost to Follow-up|1|||
33521414|NCT01672294|101807616|FG001|Overall Study|Lost to Follow-up|16|||
33521415|NCT01672294|101807617|FG002|Overall Study|Lost to Follow-up|7|||
33521416|NCT01672294|101807618|FG003|Overall Study|Lost to Follow-up|9|||
33521417|NCT02588664|101807619|FG000|Overall Study|Death|56|||
33521418|NCT02588664|101807620|FG001|Overall Study|Death|55|||
33521419|NCT02588664|101807619|FG000|Overall Study|Lost to Follow-up|1305|||
33521420|NCT02588664|101807620|FG001|Overall Study|Lost to Follow-up|990|||
33521421|NCT05268016|101807621|FG000|Overall Study|Unacceptable toxicity or AE|2|||
33521422|NCT05268016|101807622|FG001|Overall Study|Unacceptable toxicity or AE|2|||
33521423|NCT05268016|101807623|FG002|Overall Study|Unacceptable toxicity or AE|4|||
33521424|NCT05268016|101807624|FG003|Overall Study|Unacceptable toxicity or AE|3|||
33521425|NCT05268016|101807625|FG004|Overall Study|Unacceptable toxicity or AE|1|||
33521426|NCT05268016|101807621|FG000|Overall Study|Withdrawal by Subject|1|||
33521427|NCT05268016|101807622|FG001|Overall Study|Withdrawal by Subject|3|||
33521428|NCT05268016|101807623|FG002|Overall Study|Withdrawal by Subject|2|||
33401230|NCT00082628|101357001|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
33401231|NCT00082628|101356997|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
33401232|NCT00082628|101356998|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
33401233|NCT00082628|101356999|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
33401234|NCT00082628|101357000|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
33401235|NCT00082628|101357001|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
33401236|NCT00082628|101356997|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
33401237|NCT00082628|101356998|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
33401238|NCT00082628|101356999|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
33401239|NCT00082628|101357000|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
33521429|NCT05268016|101807624|FG003|Overall Study|Withdrawal by Subject|2|||
33521430|NCT05268016|101807625|FG004|Overall Study|Withdrawal by Subject|1|||
33521431|NCT05268016|101807621|FG000|Overall Study|Lost to Follow-up|4|||
33521432|NCT05268016|101807622|FG001|Overall Study|Lost to Follow-up|7|||
33521433|NCT05268016|101807623|FG002|Overall Study|Lost to Follow-up|1|||
33521434|NCT05268016|101807624|FG003|Overall Study|Lost to Follow-up|3|||
33521435|NCT05268016|101807625|FG004|Overall Study|Lost to Follow-up|5|||
33521436|NCT05268016|101807621|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
33521437|NCT05268016|101807622|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
33521438|NCT05268016|101807623|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
33521439|NCT05268016|101807624|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
33521440|NCT05268016|101807625|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
33521441|NCT05268016|101807621|FG000|Overall Study|Lack of Efficacy|0|||
33521442|NCT05268016|101807622|FG001|Overall Study|Lack of Efficacy|0|||
33521443|NCT05268016|101807623|FG002|Overall Study|Lack of Efficacy|0|||
33521444|NCT05268016|101807624|FG003|Overall Study|Lack of Efficacy|0|||
33521445|NCT05268016|101807625|FG004|Overall Study|Lack of Efficacy|4|||
33521446|NCT05268016|101807621|FG000|Overall Study|Physician Decision|0|||
33521447|NCT05268016|101807622|FG001|Overall Study|Physician Decision|0|||
33521448|NCT05268016|101807623|FG002|Overall Study|Physician Decision|0|||
33521449|NCT05268016|101807624|FG003|Overall Study|Physician Decision|1|||
33521450|NCT05268016|101807625|FG004|Overall Study|Physician Decision|0|||
33521451|NCT05268016|101807621|FG000|Overall Study|Other|1|||
33521452|NCT05268016|101807622|FG001|Overall Study|Other|0|||
33521453|NCT05268016|101807623|FG002|Overall Study|Other|1|||
33521454|NCT05268016|101807624|FG003|Overall Study|Other|2|||
33521455|NCT05268016|101807625|FG004|Overall Study|Other|0|||
33521456|NCT01289574|101807626|FG000|Overall Study|Lack of Efficacy|4|||
33521457|NCT01289574|101807627|FG001|Overall Study|Lack of Efficacy|0|||
33521458|NCT01289574|101807628|FG002|Overall Study|Lack of Efficacy|1|||
33521459|NCT01289574|101807626|FG000|Overall Study|Lost to Follow-up|2|||
33521460|NCT01289574|101807627|FG001|Overall Study|Lost to Follow-up|0|||
33521461|NCT01289574|101807628|FG002|Overall Study|Lost to Follow-up|1|||
33521462|NCT01289574|101807626|FG000|Overall Study|Withdrawal by Subject|1|||
33521463|NCT01289574|101807627|FG001|Overall Study|Withdrawal by Subject|1|||
33521464|NCT01289574|101807628|FG002|Overall Study|Withdrawal by Subject|1|||
33521465|NCT01289574|101807626|FG000|Overall Study|Adverse Event|0|||
33521466|NCT01289574|101807627|FG001|Overall Study|Adverse Event|1|||
33521467|NCT01289574|101807628|FG002|Overall Study|Adverse Event|0|||
33521468|NCT01289574|101807626|FG000|Overall Study|Subject wanted alternate treatment|0|||
33521469|NCT01289574|101807627|FG001|Overall Study|Subject wanted alternate treatment|1|||
33521470|NCT01289574|101807628|FG002|Overall Study|Subject wanted alternate treatment|0|||
33521471|NCT03749109|101807629|FG000|Overall Study|Adverse Event|2|||
33521472|NCT03749109|101807630|FG001|Overall Study|Adverse Event|0|||
33521473|NCT01870297|101807633|FG000|Overall Study|Adverse Event|0|||
33521474|NCT01870297|101807634|FG001|Overall Study|Adverse Event|0|||
33521475|NCT01870297|101807635|FG002|Overall Study|Adverse Event|0|||
33521476|NCT01870297|101807636|FG003|Overall Study|Adverse Event|0|||
33521477|NCT01870297|101807637|FG004|Overall Study|Adverse Event|2|||
33521478|NCT01870297|101807638|FG005|Overall Study|Adverse Event|0|||
33521479|NCT01870297|101807639|FG006|Overall Study|Adverse Event|0|||
33521480|NCT01870297|101807633|FG000|Overall Study|Lost to Follow-up|0|||
33521481|NCT01870297|101807634|FG001|Overall Study|Lost to Follow-up|1|||
33521482|NCT01870297|101807635|FG002|Overall Study|Lost to Follow-up|1|||
33521483|NCT01870297|101807636|FG003|Overall Study|Lost to Follow-up|0|||
33521484|NCT01870297|101807637|FG004|Overall Study|Lost to Follow-up|0|||
33521485|NCT01870297|101807638|FG005|Overall Study|Lost to Follow-up|0|||
33521486|NCT01870297|101807639|FG006|Overall Study|Lost to Follow-up|0|||
33521487|NCT01870297|101807633|FG000|Overall Study|Withdrawal by Subject|0|||
33521488|NCT01870297|101807634|FG001|Overall Study|Withdrawal by Subject|0|||
33521489|NCT01870297|101807635|FG002|Overall Study|Withdrawal by Subject|0|||
33521490|NCT01870297|101807636|FG003|Overall Study|Withdrawal by Subject|0|||
33521491|NCT01870297|101807637|FG004|Overall Study|Withdrawal by Subject|1|||
33521492|NCT01870297|101807638|FG005|Overall Study|Withdrawal by Subject|1|||
33521493|NCT01870297|101807639|FG006|Overall Study|Withdrawal by Subject|1|||
33521494|NCT01870297|101807633|FG000|Overall Study|Sponsor Decision|0|||
33521495|NCT01870297|101807634|FG001|Overall Study|Sponsor Decision|6|||
33521496|NCT01870297|101807635|FG002|Overall Study|Sponsor Decision|0|||
33521497|NCT01870297|101807636|FG003|Overall Study|Sponsor Decision|0|||
33328233|NCT01225731|101097343|FG010|Part 1|Protocol Violation|0|||
33328234|NCT01225731|101097344|FG011|Part 1|Protocol Violation|0|||
33417251|NCT04856917|101420243|FG002|Overall Study|Withdrawal by Subject|1|||
33521498|NCT01870297|101807637|FG004|Overall Study|Sponsor Decision|0|||
33521499|NCT01870297|101807638|FG005|Overall Study|Sponsor Decision|0|||
33521500|NCT01870297|101807639|FG006|Overall Study|Sponsor Decision|1|||
33521501|NCT02380859|101807640|FG000|Overall Study|Withdrawal by Subject|2|||
33521502|NCT02380859|101807641|FG001|Overall Study|Withdrawal by Subject|0|||
33521503|NCT02452554|101807646|FG000|Overall Study|Death|2|||
33521504|NCT02452554|101807647|FG001|Overall Study|Death|1|||
33521505|NCT02452554|101807648|FG002|Overall Study|Death|0|||
33521506|NCT02452554|101807649|FG003|Overall Study|Death|0|||
33521507|NCT02452554|101807650|FG004|Overall Study|Death|0|||
33521508|NCT02452554|101807651|FG005|Overall Study|Death|0|||
33521509|NCT02452554|101807646|FG000|Overall Study|Lack of Efficacy|13|||
33328235|NCT01225731|101097345|FG012|Part 1|Protocol Violation|0|||
33328236|NCT01225731|101097333|FG000|Part 2|Protocol Violation|0|||
33521510|NCT02452554|101807647|FG001|Overall Study|Lack of Efficacy|14|||
33521511|NCT02452554|101807648|FG002|Overall Study|Lack of Efficacy|9|||
33521512|NCT02452554|101807649|FG003|Overall Study|Lack of Efficacy|1|||
33521513|NCT02452554|101807650|FG004|Overall Study|Lack of Efficacy|5|||
33521514|NCT02452554|101807651|FG005|Overall Study|Lack of Efficacy|8|||
33521515|NCT02452554|101807646|FG000|Overall Study|Physician Decision|0|||
33521516|NCT02452554|101807647|FG001|Overall Study|Physician Decision|1|||
33521517|NCT02452554|101807648|FG002|Overall Study|Physician Decision|0|||
33521518|NCT02452554|101807649|FG003|Overall Study|Physician Decision|0|||
33521519|NCT02452554|101807650|FG004|Overall Study|Physician Decision|0|||
33521520|NCT02452554|101807651|FG005|Overall Study|Physician Decision|0|||
33328237|NCT01225731|101097334|FG001|Part 2|Protocol Violation|0|||
33328238|NCT01225731|101097335|FG002|Part 2|Protocol Violation|0|||
33328239|NCT01225731|101097336|FG003|Part 2|Protocol Violation|0|||
33328240|NCT01225731|101097337|FG004|Part 2|Protocol Violation|0|||
33328241|NCT01225731|101097338|FG005|Part 2|Protocol Violation|1|||
33328242|NCT01225731|101097339|FG006|Part 2|Protocol Violation|0|||
33328243|NCT01225731|101097340|FG007|Part 2|Protocol Violation|0|||
33328244|NCT01225731|101097341|FG008|Part 2|Protocol Violation|1|||
33328245|NCT01225731|101097342|FG009|Part 2|Protocol Violation|0|||
33328246|NCT01225731|101097343|FG010|Part 2|Protocol Violation|0|||
33328247|NCT01225731|101097344|FG011|Part 2|Protocol Violation|0|||
33328248|NCT01225731|101097345|FG012|Part 2|Protocol Violation|0|||
33328249|NCT01225731|101097333|FG000|Part 2|Adverse Event|0|||
33328250|NCT01225731|101097334|FG001|Part 2|Adverse Event|0|||
33328251|NCT01225731|101097335|FG002|Part 2|Adverse Event|0|||
33328252|NCT01225731|101097336|FG003|Part 2|Adverse Event|0|||
33328253|NCT01225731|101097337|FG004|Part 2|Adverse Event|0|||
33328254|NCT01225731|101097338|FG005|Part 2|Adverse Event|0|||
33328255|NCT01225731|101097339|FG006|Part 2|Adverse Event|4|||
33401240|NCT00082628|101357001|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
33401241|NCT00082628|101356997|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
33401242|NCT00082628|101356998|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
33401243|NCT00082628|101356999|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
33401244|NCT00082628|101357000|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
33401245|NCT00082628|101357001|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
33401246|NCT00082628|101356997|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
33401247|NCT00082628|101356998|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
33401248|NCT00082628|101356999|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
33401249|NCT00082628|101357000|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
33401250|NCT00082628|101357001|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
33401251|NCT00082628|101356997|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
33521521|NCT02452554|101807646|FG000|Overall Study|Withdrawal by Subject|1|||
33521522|NCT02452554|101807647|FG001|Overall Study|Withdrawal by Subject|0|||
33521523|NCT02452554|101807648|FG002|Overall Study|Withdrawal by Subject|2|||
33521524|NCT02452554|101807649|FG003|Overall Study|Withdrawal by Subject|0|||
33521525|NCT02452554|101807650|FG004|Overall Study|Withdrawal by Subject|0|||
33521526|NCT02452554|101807651|FG005|Overall Study|Withdrawal by Subject|1|||
33521527|NCT02452554|101807646|FG000|Overall Study|Ineligible|0|||
33521528|NCT02452554|101807647|FG001|Overall Study|Ineligible|1|||
33521529|NCT02452554|101807648|FG002|Overall Study|Ineligible|0|||
33521530|NCT02452554|101807649|FG003|Overall Study|Ineligible|0|||
33521531|NCT02452554|101807650|FG004|Overall Study|Ineligible|0|||
33521532|NCT02452554|101807651|FG005|Overall Study|Ineligible|0|||
33521533|NCT02452554|101807646|FG000|Overall Study|Never Received Treatment|1|||
33521534|NCT02452554|101807647|FG001|Overall Study|Never Received Treatment|0|||
33521535|NCT02452554|101807648|FG002|Overall Study|Never Received Treatment|0|||
33521536|NCT02452554|101807649|FG003|Overall Study|Never Received Treatment|0|||
33521537|NCT02452554|101807650|FG004|Overall Study|Never Received Treatment|0|||
33521538|NCT02452554|101807651|FG005|Overall Study|Never Received Treatment|0|||
33401252|NCT00082628|101356998|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
33401253|NCT00082628|101356999|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
33401254|NCT00082628|101357000|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
33401255|NCT00082628|101357001|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
33521539|NCT02327013|101807654|FG000|Overall Study|Adverse Event|4|||
33608963|NCT01183468|102118498|FG001|Overall Study|Physician Decision|0|||
33608964|NCT01183468|102118499|FG002|Overall Study|Physician Decision|0|||
33328256|NCT01225731|101097340|FG007|Part 2|Adverse Event|4|||
33401256|NCT01412333|101357003|FG000|Overall Study|Adverse Event|40|||
33401257|NCT01412333|101357004|FG001|Overall Study|Adverse Event|42|||
33401258|NCT01412333|101357003|FG000|Overall Study|Death|5|||
33401259|NCT01412333|101357004|FG001|Overall Study|Death|6|||
33401260|NCT01412333|101357003|FG000|Overall Study|Lack of Efficacy|22|||
33521540|NCT02327013|101807655|FG001|Overall Study|Adverse Event|4|||
33521541|NCT02327013|101807656|FG002|Overall Study|Adverse Event|3|||
33521542|NCT02327013|101807657|FG003|Overall Study|Adverse Event|0|||
33521543|NCT02327013|101807658|FG004|Overall Study|Adverse Event|1|||
33521544|NCT02327013|101807654|FG000|Overall Study|Lack of Efficacy|2|||
33608965|NCT01183468|102118500|FG003|Overall Study|Physician Decision|0|||
33328257|NCT01225731|101097341|FG008|Part 2|Adverse Event|2|||
33328258|NCT01225731|101097342|FG009|Part 2|Adverse Event|0|||
33328259|NCT01225731|101097343|FG010|Part 2|Adverse Event|0|||
33328260|NCT01225731|101097344|FG011|Part 2|Adverse Event|0|||
33328261|NCT01225731|101097345|FG012|Part 2|Adverse Event|0|||
33328262|NCT01225731|101097333|FG000|Part 2|Lack of Efficacy|0|||
33328263|NCT01225731|101097334|FG001|Part 2|Lack of Efficacy|0|||
33328264|NCT01225731|101097335|FG002|Part 2|Lack of Efficacy|0|||
33328265|NCT01225731|101097336|FG003|Part 2|Lack of Efficacy|0|||
33200478|NCT02823145|100638334|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
33200479|NCT02823145|100638335|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
33200480|NCT02823145|100638334|FG000|Treatment|Lack of Efficacy|0|||
33200481|NCT02823145|100638335|FG001|Treatment|Lack of Efficacy|48|||
33200482|NCT02823145|100638334|FG000|Treatment|Non-Compliance With E-Diary|0|||
33200483|NCT02823145|100638335|FG001|Treatment|Non-Compliance With E-Diary|1|||
33200484|NCT02823145|100638334|FG000|Treatment|Physician Decision|0|||
33200485|NCT02823145|100638335|FG001|Treatment|Physician Decision|2|||
33200486|NCT02823145|100638334|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
33200487|NCT02823145|100638335|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
33200488|NCT02823145|100638334|FG000|Treatment|Subject needed to take prohibited medication|0|||
33200489|NCT02823145|100638335|FG001|Treatment|Subject needed to take prohibited medication|1|||
33200490|NCT02823145|100638334|FG000|Treatment|Subject transferred to direct access programme|0|||
33200491|NCT02823145|100638335|FG001|Treatment|Subject transferred to direct access programme|1|||
33200492|NCT02823145|100638334|FG000|Treatment|Switching to commercially available drug|0|||
33200493|NCT02823145|100638335|FG001|Treatment|Switching to commercially available drug|11|||
33521545|NCT02327013|101807655|FG001|Overall Study|Lack of Efficacy|0|||
33521546|NCT02327013|101807656|FG002|Overall Study|Lack of Efficacy|5|||
33521547|NCT02327013|101807657|FG003|Overall Study|Lack of Efficacy|0|||
33521548|NCT02327013|101807658|FG004|Overall Study|Lack of Efficacy|1|||
33521549|NCT02327013|101807654|FG000|Overall Study|Non-compliance with IMP|1|||
33521550|NCT02327013|101807655|FG001|Overall Study|Non-compliance with IMP|2|||
33521551|NCT02327013|101807656|FG002|Overall Study|Non-compliance with IMP|7|||
33521552|NCT02327013|101807657|FG003|Overall Study|Non-compliance with IMP|0|||
33521553|NCT02327013|101807658|FG004|Overall Study|Non-compliance with IMP|0|||
33521554|NCT02327013|101807654|FG000|Overall Study|Withdrawal of Consent|1|||
33521555|NCT02327013|101807655|FG001|Overall Study|Withdrawal of Consent|0|||
33521556|NCT02327013|101807656|FG002|Overall Study|Withdrawal of Consent|3|||
33521557|NCT02327013|101807657|FG003|Overall Study|Withdrawal of Consent|0|||
33521558|NCT02327013|101807658|FG004|Overall Study|Withdrawal of Consent|0|||
33521559|NCT02327013|101807654|FG000|Overall Study|Lost to Follow-up|2|||
33521560|NCT02327013|101807655|FG001|Overall Study|Lost to Follow-up|4|||
33521561|NCT02327013|101807656|FG002|Overall Study|Lost to Follow-up|5|||
33521562|NCT02327013|101807657|FG003|Overall Study|Lost to Follow-up|0|||
33521563|NCT02327013|101807658|FG004|Overall Study|Lost to Follow-up|0|||
33521564|NCT02327013|101807654|FG000|Overall Study|Administrative or other reason(s)|1|||
33521565|NCT02327013|101807655|FG001|Overall Study|Administrative or other reason(s)|5|||
33521566|NCT02327013|101807656|FG002|Overall Study|Administrative or other reason(s)|11|||
33521567|NCT02327013|101807657|FG003|Overall Study|Administrative or other reason(s)|1|||
33521568|NCT02327013|101807658|FG004|Overall Study|Administrative or other reason(s)|1|||
33521569|NCT02327013|101807654|FG000|Overall Study|Protocol Violation|0|||
33521570|NCT02327013|101807655|FG001|Overall Study|Protocol Violation|0|||
33521571|NCT02327013|101807656|FG002|Overall Study|Protocol Violation|3|||
33521572|NCT02327013|101807657|FG003|Overall Study|Protocol Violation|0|||
33521573|NCT02327013|101807658|FG004|Overall Study|Protocol Violation|1|||
33521574|NCT02327013|101807654|FG000|Overall Study|Withdrawal before treatment|2|||
33521575|NCT02327013|101807655|FG001|Overall Study|Withdrawal before treatment|1|||
33521576|NCT02327013|101807656|FG002|Overall Study|Withdrawal before treatment|5|||
33521577|NCT02327013|101807657|FG003|Overall Study|Withdrawal before treatment|0|||
33521578|NCT02327013|101807658|FG004|Overall Study|Withdrawal before treatment|0|||
33521579|NCT00926536|101807659|FG000|Overall Study|Physician Decision|1|||
33521580|NCT00926536|101807660|FG001|Overall Study|Physician Decision|2|||
33521581|NCT04126317|101807661|FG000|Overall Study|Adverse Event|0|||
33521582|NCT04126317|101807662|FG001|Overall Study|Adverse Event|1|||
33521583|NCT04126317|101807661|FG000|Overall Study|Withdrawal by Subject|4|||
33521584|NCT04126317|101807662|FG001|Overall Study|Withdrawal by Subject|1|||
33521585|NCT01133288|101807663|FG000|Eligibility Assessment|met exclusion criteria|5|||
33521586|NCT01133288|101807663|FG000|Intervention Allocation|study terminated|2|||
33521587|NCT02005627|101807664|FG000|Overall Study|Lost to Follow-up|1|||
33521588|NCT02005627|101807665|FG001|Overall Study|Lost to Follow-up|2|||
33521589|NCT02005627|101807664|FG000|Overall Study|Withdrawal by Subject|1|||
33521590|NCT02005627|101807665|FG001|Overall Study|Withdrawal by Subject|2|||
33521591|NCT00594386|101807669|FG000|Overall Study|Major protocol violation|2|||
33521592|NCT00594386|101807669|FG000|Overall Study|Lack of Efficacy|12|||
33521593|NCT00594386|101807669|FG000|Overall Study|Adverse Event|68|||
33521594|NCT00594386|101807669|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
33521595|NCT00594386|101807669|FG000|Overall Study|Subject withdrew consent|35|||
33521596|NCT00594386|101807669|FG000|Overall Study|Study ended per sponsor|115|||
33521597|NCT00594386|101807669|FG000|Overall Study|Lost to Follow-up|6|||
33521598|NCT00594386|101807669|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
33200494|NCT02823145|100638334|FG000|Treatment|Transitioned to commercial supply of medication|0|||
33200495|NCT02823145|100638335|FG001|Treatment|Transitioned to commercial supply of medication|1|||
33200496|NCT02823145|100638334|FG000|Treatment|Withdrawal By Caregiver|0|||
33200497|NCT02823145|100638335|FG001|Treatment|Withdrawal By Caregiver|1|||
33200498|NCT02823145|100638334|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
33200499|NCT02823145|100638335|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
33200500|NCT02823145|100638334|FG000|Treatment|Withdrawal by Subject|0|||
33200501|NCT02823145|100638335|FG001|Treatment|Withdrawal by Subject|16|||
33200502|NCT02823145|100638334|FG000|Treatment|Reason unknown|0|||
33200503|NCT02823145|100638335|FG001|Treatment|Reason unknown|1|||
33200504|NCT01337245|100638336|FG000|Overall Study|Lost to Follow-up|1|||
33200505|NCT00499889|100638337|FG000|Overall Study|Infection prior to treatment|1|||
33200506|NCT01640301|100638338|FG000|Overall Study|Death|0|||
33200507|NCT01640301|100638339|FG001|Overall Study|Death|8|||
33200508|NCT03791398|100638340|FG000|Overall Study|Progression of Disease Under Study|2|||
33200509|NCT03791398|100638341|FG001|Overall Study|Progression of Disease Under Study|0|||
33200510|NCT03791398|100638342|FG002|Overall Study|Progression of Disease Under Study|0|||
33200511|NCT02480621|100638347|FG000|Randomization|Withdrawal by Subject|1|||
33200512|NCT02480621|100638348|FG001|Randomization|Withdrawal by Subject|0|||
33200513|NCT02480621|100638347|FG000|Randomization|Surgeon did not give intervention|0|||
33200514|NCT02480621|100638348|FG001|Randomization|Surgeon did not give intervention|1|||
33200515|NCT02480621|100638347|FG000|Follow Up|Lost to Follow-up|4|||
33200516|NCT02480621|100638348|FG001|Follow Up|Lost to Follow-up|2|||
33200517|NCT01925183|100638349|FG000|Overall Study|Adverse Event|1|||
33200518|NCT01925183|100638350|FG001|Overall Study|Adverse Event|0|||
33200519|NCT04572633|100638351|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
33200520|NCT02866682|100638352|FG000|Overall Study|Death|0|||
33200521|NCT02866682|100638353|FG001|Overall Study|Death|1|||
33200522|NCT02866682|100638352|FG000|Overall Study|Lost to Follow-up|0|||
33200523|NCT02866682|100638353|FG001|Overall Study|Lost to Follow-up|4|||
33200524|NCT02866682|100638352|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
33200525|NCT02866682|100638353|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
33200526|NCT02866682|100638352|FG000|Overall Study|Other|0|||
33608966|NCT01183468|102118497|FG000|Overall Study|Withdrawal by Subject|0|||
33608967|NCT01183468|102118498|FG001|Overall Study|Withdrawal by Subject|1|||
33608968|NCT01183468|102118499|FG002|Overall Study|Withdrawal by Subject|0|||
33608969|NCT01183468|102118500|FG003|Overall Study|Withdrawal by Subject|0|||
33608970|NCT03688620|102118501|FG000|Overall Study|Other|0|||
33608971|NCT03688620|102118502|FG001|Overall Study|Other|0|||
33608972|NCT03688620|102118503|FG002|Overall Study|Other|1|||
33608973|NCT03688620|102118501|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
33608974|NCT03688620|102118502|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
33608975|NCT03688620|102118503|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
33608976|NCT03688620|102118501|FG000|Overall Study|Lost to Follow-up|16|||
33608977|NCT03688620|102118502|FG001|Overall Study|Lost to Follow-up|0|||
33200527|NCT02866682|100638353|FG001|Overall Study|Other|1|||
33200528|NCT00363766|100638355|FG000|Overall Study|Progressive Disease|15|||
33200529|NCT00363766|100638356|FG001|Overall Study|Progressive Disease|9|||
33200530|NCT00363766|100638355|FG000|Overall Study|Adverse Event|10|||
33200531|NCT00363766|100638356|FG001|Overall Study|Adverse Event|2|||
33200532|NCT00363766|100638355|FG000|Overall Study|Disease Related Death|1|||
33200533|NCT00363766|100638356|FG001|Overall Study|Disease Related Death|3|||
33328266|NCT01225731|101097337|FG004|Part 2|Lack of Efficacy|0|||
33200534|NCT00363766|100638355|FG000|Overall Study|Not Disease Related Death|3|||
33200535|NCT00363766|100638356|FG001|Overall Study|Not Disease Related Death|4|||
33200536|NCT00363766|100638355|FG000|Overall Study|Withdrawal by Subject|2|||
33200537|NCT00363766|100638356|FG001|Overall Study|Withdrawal by Subject|0|||
33200538|NCT00363766|100638355|FG000|Overall Study|Physician Decision|1|||
33200539|NCT00363766|100638356|FG001|Overall Study|Physician Decision|2|||
33200540|NCT03224468|100638364|FG000|Overall Study|Did not obtain MM card|53|||
33200541|NCT03224468|100638365|FG001|Overall Study|Did not obtain MM card|0|||
33200542|NCT03224468|100638364|FG000|Overall Study|Lost to Follow-up|4|||
33200543|NCT03224468|100638365|FG001|Overall Study|Lost to Follow-up|11|||
33200544|NCT03224468|100638364|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
33200545|NCT03224468|100638365|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
33200546|NCT01831089|100638366|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
33200547|NCT01831089|100638367|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
33200548|NCT01831089|100638368|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
33200549|NCT01831089|100638369|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
33200550|NCT01831089|100638370|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
33200551|NCT01831089|100638371|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
33200552|NCT01831089|100638366|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
33200553|NCT01831089|100638367|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
33200554|NCT01831089|100638368|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
33200555|NCT01831089|100638369|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
33200556|NCT01831089|100638370|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
33200557|NCT01831089|100638371|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
33200558|NCT01831089|100638366|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
33200559|NCT01831089|100638367|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
33200560|NCT01831089|100638368|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
33200561|NCT01831089|100638369|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
33200562|NCT01831089|100638370|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
33200563|NCT01831089|100638371|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
33200564|NCT01831089|100638366|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
33200565|NCT01831089|100638367|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
33200566|NCT01831089|100638368|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
33200567|NCT01831089|100638369|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
33200568|NCT01831089|100638370|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
33200569|NCT01831089|100638371|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
33200570|NCT01831089|100638366|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
33328267|NCT01225731|101097338|FG005|Part 2|Lack of Efficacy|1|||
33328268|NCT01225731|101097339|FG006|Part 2|Lack of Efficacy|0|||
33328269|NCT01225731|101097340|FG007|Part 2|Lack of Efficacy|12|||
33328270|NCT01225731|101097341|FG008|Part 2|Lack of Efficacy|3|||
33328271|NCT01225731|101097342|FG009|Part 2|Lack of Efficacy|0|||
33328272|NCT01225731|101097343|FG010|Part 2|Lack of Efficacy|0|||
33328273|NCT01225731|101097344|FG011|Part 2|Lack of Efficacy|0|||
33328274|NCT01225731|101097345|FG012|Part 2|Lack of Efficacy|0|||
33328275|NCT01225731|101097333|FG000|Part 2|Pregnancy|0|||
33328276|NCT01225731|101097334|FG001|Part 2|Pregnancy|0|||
33328277|NCT01225731|101097335|FG002|Part 2|Pregnancy|0|||
33328278|NCT01225731|101097336|FG003|Part 2|Pregnancy|0|||
33328279|NCT01225731|101097337|FG004|Part 2|Pregnancy|0|||
33328280|NCT01225731|101097338|FG005|Part 2|Pregnancy|0|||
33328281|NCT01225731|101097339|FG006|Part 2|Pregnancy|1|||
33328282|NCT01225731|101097340|FG007|Part 2|Pregnancy|0|||
33328283|NCT01225731|101097341|FG008|Part 2|Pregnancy|1|||
33401261|NCT01412333|101357004|FG001|Overall Study|Lack of Efficacy|10|||
33521599|NCT00594386|101807669|FG000|Overall Study|Other: Subject moved to Seattle|1|||
33521600|NCT00594386|101807669|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
33521601|NCT00594386|101807669|FG000|Overall Study|Other: Study terminated per investigator|2|||
33521602|NCT00594386|101807669|FG000|Overall Study|Other: Sponsor closure of study|1|||
33521603|NCT00594386|101807669|FG000|Overall Study|Other: Site terminated participation|1|||
33521604|NCT00594386|101807669|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
33200571|NCT01831089|100638367|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
33200572|NCT01831089|100638368|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
33200573|NCT01831089|100638369|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
33200574|NCT01831089|100638370|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
33200575|NCT01831089|100638371|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
33200576|NCT01831089|100638366|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
33200577|NCT01831089|100638367|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
33328284|NCT01225731|101097342|FG009|Part 2|Pregnancy|0|||
33328285|NCT01225731|101097343|FG010|Part 2|Pregnancy|0|||
33328286|NCT01225731|101097344|FG011|Part 2|Pregnancy|0|||
33328287|NCT01225731|101097345|FG012|Part 2|Pregnancy|0|||
33608978|NCT03688620|102118503|FG002|Overall Study|Lost to Follow-up|1|||
33328288|NCT01225731|101097333|FG000|Part 2|Lost to Follow-up|0|||
33328289|NCT01225731|101097334|FG001|Part 2|Lost to Follow-up|0|||
33328290|NCT01225731|101097335|FG002|Part 2|Lost to Follow-up|0|||
33328291|NCT01225731|101097336|FG003|Part 2|Lost to Follow-up|0|||
33328292|NCT01225731|101097337|FG004|Part 2|Lost to Follow-up|0|||
33328293|NCT01225731|101097338|FG005|Part 2|Lost to Follow-up|0|||
33328294|NCT01225731|101097339|FG006|Part 2|Lost to Follow-up|0|||
33328295|NCT01225731|101097340|FG007|Part 2|Lost to Follow-up|3|||
33328296|NCT01225731|101097341|FG008|Part 2|Lost to Follow-up|1|||
33328297|NCT01225731|101097342|FG009|Part 2|Lost to Follow-up|0|||
33328298|NCT01225731|101097343|FG010|Part 2|Lost to Follow-up|0|||
33328299|NCT01225731|101097344|FG011|Part 2|Lost to Follow-up|0|||
33328300|NCT01225731|101097345|FG012|Part 2|Lost to Follow-up|0|||
33328301|NCT01225731|101097333|FG000|Part 2|Physician Decision|0|||
33328302|NCT01225731|101097334|FG001|Part 2|Physician Decision|0|||
33401262|NCT01412333|101357003|FG000|Overall Study|Lost to Follow-up|15|||
33401263|NCT01412333|101357004|FG001|Overall Study|Lost to Follow-up|12|||
33401264|NCT01412333|101357003|FG000|Overall Study|Non-Compliance|3|||
33401265|NCT01412333|101357004|FG001|Overall Study|Non-Compliance|7|||
33401266|NCT01412333|101357003|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33401267|NCT01412333|101357004|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33401268|NCT01412333|101357003|FG000|Overall Study|Other|30|||
33401269|NCT01412333|101357004|FG001|Overall Study|Other|33|||
33401270|NCT01412333|101357003|FG000|Overall Study|Physician Decision|11|||
33401271|NCT01412333|101357004|FG001|Overall Study|Physician Decision|16|||
33401272|NCT01412333|101357003|FG000|Overall Study|Pregnancy|6|||
33401273|NCT01412333|101357004|FG001|Overall Study|Pregnancy|4|||
33328303|NCT01225731|101097335|FG002|Part 2|Physician Decision|0|||
33328304|NCT01225731|101097336|FG003|Part 2|Physician Decision|0|||
33328305|NCT01225731|101097337|FG004|Part 2|Physician Decision|0|||
33328306|NCT01225731|101097338|FG005|Part 2|Physician Decision|0|||
33328307|NCT01225731|101097339|FG006|Part 2|Physician Decision|0|||
33328308|NCT01225731|101097340|FG007|Part 2|Physician Decision|2|||
33401274|NCT01412333|101357003|FG000|Overall Study|Protocol Violation|1|||
33401275|NCT01412333|101357004|FG001|Overall Study|Protocol Violation|2|||
33401276|NCT01412333|101357003|FG000|Overall Study|Study Terminated By Sponsor|3|||
33401277|NCT01412333|101357004|FG001|Overall Study|Study Terminated By Sponsor|2|||
33401278|NCT01412333|101357003|FG000|Overall Study|Withdrawal by Subject|51|||
33401279|NCT01412333|101357004|FG001|Overall Study|Withdrawal by Subject|54|||
33401280|NCT01412333|101357003|FG000|Overall Study|Missing|1|||
33401281|NCT01412333|101357004|FG001|Overall Study|Missing|3|||
33401282|NCT03037489|101357005|FG000|Overall Study|Adverse Event|4|||
33401283|NCT03037489|101357006|FG001|Overall Study|Adverse Event|0|||
33401284|NCT03037489|101357005|FG000|Overall Study|Withdrawal by Subject|3|||
33401285|NCT03037489|101357006|FG001|Overall Study|Withdrawal by Subject|0|||
33401286|NCT00963469|101357007|FG000|Overall Study|Adverse Event|15|||
33401287|NCT00963469|101357008|FG001|Overall Study|Adverse Event|11|||
33401288|NCT00963469|101357009|FG002|Overall Study|Adverse Event|1|||
33401289|NCT00963469|101357007|FG000|Overall Study|Lack of Efficacy|10|||
33401290|NCT00963469|101357008|FG001|Overall Study|Lack of Efficacy|7|||
33401291|NCT00963469|101357009|FG002|Overall Study|Lack of Efficacy|2|||
33401292|NCT00963469|101357007|FG000|Overall Study|Lost to Follow-up|1|||
33401293|NCT00963469|101357008|FG001|Overall Study|Lost to Follow-up|1|||
33401294|NCT00963469|101357009|FG002|Overall Study|Lost to Follow-up|0|||
33401295|NCT00963469|101357007|FG000|Overall Study|Protocol Violation|5|||
33521605|NCT00594386|101807669|FG000|Overall Study|Other: Loss of drivers license|1|||
33521606|NCT02070978|101807670|FG000|Overall Study|Adverse Event|6|||
33521607|NCT02070978|101807671|FG001|Overall Study|Adverse Event|2|||
33521608|NCT02070978|101807672|FG002|Overall Study|Adverse Event|0|||
33521609|NCT02070978|101807670|FG000|Overall Study|Lost to Follow-up|1|||
33521610|NCT02070978|101807671|FG001|Overall Study|Lost to Follow-up|3|||
33521611|NCT02070978|101807672|FG002|Overall Study|Lost to Follow-up|4|||
33521612|NCT02070978|101807670|FG000|Overall Study|Withdrawal by Subject|3|||
33521613|NCT02070978|101807671|FG001|Overall Study|Withdrawal by Subject|5|||
33608979|NCT03688620|102118501|FG000|Overall Study|Withdrawal by Subject|0|||
33401296|NCT00963469|101357008|FG001|Overall Study|Protocol Violation|5|||
33401297|NCT00963469|101357009|FG002|Overall Study|Protocol Violation|3|||
33521614|NCT02070978|101807672|FG002|Overall Study|Withdrawal by Subject|3|||
33521615|NCT02070978|101807670|FG000|Overall Study|Protocol Violation|1|||
33521616|NCT02070978|101807671|FG001|Overall Study|Protocol Violation|0|||
33521617|NCT02070978|101807672|FG002|Overall Study|Protocol Violation|3|||
33328309|NCT01225731|101097341|FG008|Part 2|Physician Decision|2|||
33328310|NCT01225731|101097342|FG009|Part 2|Physician Decision|0|||
33328311|NCT01225731|101097343|FG010|Part 2|Physician Decision|0|||
33328312|NCT01225731|101097344|FG011|Part 2|Physician Decision|0|||
33328313|NCT01225731|101097345|FG012|Part 2|Physician Decision|0|||
33328314|NCT01225731|101097333|FG000|Part 2|Withdrawal by Subject|0|||
33401298|NCT00963469|101357007|FG000|Overall Study|Withdrawal by Subject|4|||
33401299|NCT00963469|101357008|FG001|Overall Study|Withdrawal by Subject|1|||
33401300|NCT00963469|101357009|FG002|Overall Study|Withdrawal by Subject|1|||
33401301|NCT00963469|101357007|FG000|Overall Study|Pre-randomization Adverse Event|1|||
33401302|NCT00963469|101357008|FG001|Overall Study|Pre-randomization Adverse Event|2|||
33401303|NCT00963469|101357009|FG002|Overall Study|Pre-randomization Adverse Event|0|||
33328315|NCT01225731|101097334|FG001|Part 2|Withdrawal by Subject|0|||
33328316|NCT01225731|101097335|FG002|Part 2|Withdrawal by Subject|0|||
33200578|NCT01831089|100638368|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
33200579|NCT01831089|100638369|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
33328317|NCT01225731|101097336|FG003|Part 2|Withdrawal by Subject|0|||
33328318|NCT01225731|101097337|FG004|Part 2|Withdrawal by Subject|0|||
33328319|NCT01225731|101097338|FG005|Part 2|Withdrawal by Subject|1|||
33328320|NCT01225731|101097339|FG006|Part 2|Withdrawal by Subject|3|||
33328321|NCT01225731|101097340|FG007|Part 2|Withdrawal by Subject|4|||
33328322|NCT01225731|101097341|FG008|Part 2|Withdrawal by Subject|1|||
33328323|NCT01225731|101097342|FG009|Part 2|Withdrawal by Subject|0|||
33328324|NCT01225731|101097343|FG010|Part 2|Withdrawal by Subject|0|||
33328325|NCT01225731|101097344|FG011|Part 2|Withdrawal by Subject|0|||
33328326|NCT01225731|101097345|FG012|Part 2|Withdrawal by Subject|0|||
33328327|NCT01225731|101097333|FG000|Part 3|Adverse Event|0|||
33328328|NCT01225731|101097334|FG001|Part 3|Adverse Event|0|||
33328329|NCT01225731|101097335|FG002|Part 3|Adverse Event|0|||
33328330|NCT01225731|101097336|FG003|Part 3|Adverse Event|0|||
33328331|NCT01225731|101097337|FG004|Part 3|Adverse Event|0|||
33328332|NCT01225731|101097338|FG005|Part 3|Adverse Event|0|||
33328333|NCT01225731|101097339|FG006|Part 3|Adverse Event|0|||
33328334|NCT01225731|101097340|FG007|Part 3|Adverse Event|0|||
33328335|NCT01225731|101097341|FG008|Part 3|Adverse Event|0|||
33328336|NCT01225731|101097342|FG009|Part 3|Adverse Event|0|||
33328337|NCT01225731|101097343|FG010|Part 3|Adverse Event|1|||
33328338|NCT01225731|101097344|FG011|Part 3|Adverse Event|1|||
33328339|NCT01225731|101097345|FG012|Part 3|Adverse Event|0|||
33328340|NCT01225731|101097333|FG000|Part 3|Lost to Follow-up|0|||
33328341|NCT01225731|101097334|FG001|Part 3|Lost to Follow-up|0|||
33200580|NCT01831089|100638370|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
33200581|NCT01831089|100638371|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
33200582|NCT01831089|100638366|FG000|Cohort III: Dose Level 3|Global end of study|0|||
33200583|NCT01831089|100638367|FG001|Cohort III: Dose Level 3|Global end of study|0|||
33328342|NCT01225731|101097335|FG002|Part 3|Lost to Follow-up|0|||
33328343|NCT01225731|101097336|FG003|Part 3|Lost to Follow-up|0|||
33328344|NCT01225731|101097337|FG004|Part 3|Lost to Follow-up|0|||
33328345|NCT01225731|101097338|FG005|Part 3|Lost to Follow-up|0|||
33328346|NCT01225731|101097339|FG006|Part 3|Lost to Follow-up|0|||
33328347|NCT01225731|101097340|FG007|Part 3|Lost to Follow-up|0|||
33328348|NCT01225731|101097341|FG008|Part 3|Lost to Follow-up|0|||
33328349|NCT01225731|101097342|FG009|Part 3|Lost to Follow-up|0|||
33328350|NCT01225731|101097343|FG010|Part 3|Lost to Follow-up|1|||
33328351|NCT01225731|101097344|FG011|Part 3|Lost to Follow-up|2|||
33328352|NCT01225731|101097345|FG012|Part 3|Lost to Follow-up|1|||
33328353|NCT01225731|101097333|FG000|Part 3|Physician Decision|0|||
33521618|NCT02070978|101807670|FG000|Overall Study|Lack of Efficacy|0|||
33521619|NCT02070978|101807671|FG001|Overall Study|Lack of Efficacy|1|||
33521620|NCT02070978|101807672|FG002|Overall Study|Lack of Efficacy|0|||
33521621|NCT02070978|101807670|FG000|Overall Study|Death|0|||
33328354|NCT01225731|101097334|FG001|Part 3|Physician Decision|0|||
33328355|NCT01225731|101097335|FG002|Part 3|Physician Decision|0|||
33328356|NCT01225731|101097336|FG003|Part 3|Physician Decision|0|||
33328357|NCT01225731|101097337|FG004|Part 3|Physician Decision|0|||
33328358|NCT01225731|101097338|FG005|Part 3|Physician Decision|0|||
33521622|NCT02070978|101807671|FG001|Overall Study|Death|0|||
33521623|NCT02070978|101807672|FG002|Overall Study|Death|2|||
33521624|NCT02070978|101807670|FG000|Overall Study|Un-specified|3|||
33521625|NCT02070978|101807671|FG001|Overall Study|Un-specified|2|||
33521626|NCT02070978|101807672|FG002|Overall Study|Un-specified|2|||
33521627|NCT02070978|101807670|FG000|Overall Study|Terminated by Sponsor|33|||
33521628|NCT02070978|101807671|FG001|Overall Study|Terminated by Sponsor|40|||
33521629|NCT02070978|101807672|FG002|Overall Study|Terminated by Sponsor|39|||
33521630|NCT02907619|101807673|FG000|Overall Study|Study terminated by sponsor|18|||
33521631|NCT02907619|101807674|FG001|Overall Study|Study terminated by sponsor|18|||
33521632|NCT02907619|101807675|FG002|Overall Study|Study terminated by sponsor|19|||
33200584|NCT01831089|100638368|FG002|Cohort III: Dose Level 3|Global end of study|1|||
33328359|NCT01225731|101097339|FG006|Part 3|Physician Decision|0|||
33328360|NCT01225731|101097340|FG007|Part 3|Physician Decision|0|||
33328361|NCT01225731|101097341|FG008|Part 3|Physician Decision|0|||
33328362|NCT01225731|101097342|FG009|Part 3|Physician Decision|0|||
33328363|NCT01225731|101097343|FG010|Part 3|Physician Decision|0|||
33328364|NCT01225731|101097344|FG011|Part 3|Physician Decision|1|||
33328365|NCT01225731|101097345|FG012|Part 3|Physician Decision|2|||
33328366|NCT01225731|101097333|FG000|Part 3|Withdrawal by Subject|0|||
33328367|NCT01225731|101097334|FG001|Part 3|Withdrawal by Subject|0|||
33328368|NCT01225731|101097335|FG002|Part 3|Withdrawal by Subject|0|||
33328369|NCT01225731|101097336|FG003|Part 3|Withdrawal by Subject|0|||
33328370|NCT01225731|101097337|FG004|Part 3|Withdrawal by Subject|0|||
33328371|NCT01225731|101097338|FG005|Part 3|Withdrawal by Subject|0|||
33328372|NCT01225731|101097339|FG006|Part 3|Withdrawal by Subject|0|||
33328373|NCT01225731|101097340|FG007|Part 3|Withdrawal by Subject|0|||
33328374|NCT01225731|101097341|FG008|Part 3|Withdrawal by Subject|0|||
33521633|NCT02907619|101807673|FG000|Overall Study|Death|0|||
33521634|NCT02907619|101807674|FG001|Overall Study|Death|0|||
33521635|NCT02907619|101807675|FG002|Overall Study|Death|1|||
33328375|NCT01225731|101097342|FG009|Part 3|Withdrawal by Subject|0|||
33328376|NCT01225731|101097343|FG010|Part 3|Withdrawal by Subject|4|||
33328377|NCT01225731|101097344|FG011|Part 3|Withdrawal by Subject|6|||
33328378|NCT01225731|101097345|FG012|Part 3|Withdrawal by Subject|4|||
33328379|NCT00827606|101097348|FG000|Overall Study|Protocol Violation|4|||
33328380|NCT00827606|101097349|FG001|Overall Study|Protocol Violation|3|||
33328381|NCT00827606|101097348|FG000|Overall Study|Lost to Follow-up|3|||
33328382|NCT00827606|101097349|FG001|Overall Study|Lost to Follow-up|1|||
33608980|NCT03688620|102118502|FG001|Overall Study|Withdrawal by Subject|0|||
33608981|NCT03688620|102118503|FG002|Overall Study|Withdrawal by Subject|6|||
33608982|NCT01123395|102118504|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
33608983|NCT01123395|102118505|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
33608984|NCT00687531|102118506|FG000|Overall Study|Did not meet protocol eligibility|104|||
33328383|NCT00827606|101097348|FG000|Overall Study|Withdrawal by Subject|7|||
33328384|NCT00827606|101097349|FG001|Overall Study|Withdrawal by Subject|6|||
33328385|NCT00827606|101097348|FG000|Overall Study|Pregnancy|0|||
33328386|NCT00827606|101097349|FG001|Overall Study|Pregnancy|1|||
33328387|NCT00827606|101097348|FG000|Overall Study|Other|5|||
33328388|NCT00827606|101097349|FG001|Overall Study|Other|13|||
33328389|NCT00827606|101097348|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
33328390|NCT00827606|101097349|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
33328391|NCT00827606|101097348|FG000|Overall Study|Adverse Event|4|||
33328392|NCT00827606|101097349|FG001|Overall Study|Adverse Event|2|||
33328393|NCT04251910|101097350|FG000|Overall Study|Covid 19 lockdown|0|||
33328394|NCT04251910|101097351|FG001|Overall Study|Covid 19 lockdown|5|||
33328395|NCT04251910|101097352|FG002|Overall Study|Covid 19 lockdown|0|||
33328396|NCT04251910|101097353|FG003|Overall Study|Covid 19 lockdown|4|||
33328397|NCT04251910|101097354|FG004|Overall Study|Covid 19 lockdown|0|||
33328398|NCT04251910|101097355|FG005|Overall Study|Covid 19 lockdown|0|||
33328399|NCT04251910|101097350|FG000|Overall Study|Assisted living facility was closed|0|||
33328400|NCT04251910|101097351|FG001|Overall Study|Assisted living facility was closed|0|||
33328401|NCT04251910|101097352|FG002|Overall Study|Assisted living facility was closed|0|||
33328402|NCT04251910|101097353|FG003|Overall Study|Assisted living facility was closed|0|||
33328403|NCT04251910|101097354|FG004|Overall Study|Assisted living facility was closed|1|||
33328404|NCT04251910|101097355|FG005|Overall Study|Assisted living facility was closed|0|||
33328405|NCT01075412|101097358|FG000|Overall Study|Withdrawal by Subject|0|||
33328406|NCT01075412|101097359|FG001|Overall Study|Withdrawal by Subject|1|||
33521636|NCT02907619|101807673|FG000|Overall Study|Withdrawal by Subject|1|||
33521637|NCT02907619|101807674|FG001|Overall Study|Withdrawal by Subject|1|||
33521638|NCT02907619|101807675|FG002|Overall Study|Withdrawal by Subject|0|||
33521639|NCT02907619|101807673|FG000|Overall Study|Other|0|||
33521640|NCT02907619|101807674|FG001|Overall Study|Other|1|||
33521641|NCT02907619|101807675|FG002|Overall Study|Other|0|||
33521642|NCT01832818|101807677|FG000|Overall Study|Lost to Follow-up|6|||
33521643|NCT01438814|101807678|FG000|Overall Study|Adverse Event|3|||
33521644|NCT01438814|101807679|FG001|Overall Study|Adverse Event|3|||
33521645|NCT01438814|101807678|FG000|Overall Study|Protocol Violation|1|||
33521646|NCT01438814|101807679|FG001|Overall Study|Protocol Violation|2|||
33521647|NCT01438814|101807678|FG000|Overall Study|Lost to Follow-up|4|||
33328407|NCT01585272|101097360|FG000|Overall Study|Adverse Event|22|||
33328408|NCT01585272|101097360|FG000|Overall Study|Protocol Violation|7|||
33328409|NCT01585272|101097360|FG000|Overall Study|Withdrawal by Subject|10|||
33328410|NCT00388973|101097361|FG000|Overall Study|Adverse Event|16|||
33328411|NCT00388973|101097362|FG001|Overall Study|Adverse Event|6|||
33328412|NCT00388973|101097361|FG000|Overall Study|Lack of Efficacy|1|||
33328413|NCT00388973|101097362|FG001|Overall Study|Lack of Efficacy|12|||
33328414|NCT00388973|101097361|FG000|Overall Study|Protocol Violation|3|||
33328415|NCT00388973|101097362|FG001|Overall Study|Protocol Violation|0|||
33328416|NCT00388973|101097361|FG000|Overall Study|Withdrawal by Subject|14|||
33328417|NCT00388973|101097362|FG001|Overall Study|Withdrawal by Subject|17|||
33328418|NCT00388973|101097361|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
33608985|NCT00687531|102118506|FG000|Overall Study|Adverse Event|5|||
33608986|NCT00687531|102118506|FG000|Overall Study|Lost to Follow-up|26|||
33328419|NCT00388973|101097362|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
33328420|NCT00388973|101097361|FG000|Overall Study|Did not complete 61 days of treatment|5|||
33328421|NCT00388973|101097362|FG001|Overall Study|Did not complete 61 days of treatment|4|||
33328422|NCT00388973|101097361|FG000|Overall Study|Left region|0|||
33328423|NCT00388973|101097362|FG001|Overall Study|Left region|1|||
33328424|NCT00388973|101097361|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
33328425|NCT00388973|101097362|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
33328426|NCT02116777|101097368|FG000|Overall Study|Adverse Event|0|||
33328427|NCT02116777|101097369|FG001|Overall Study|Adverse Event|0|||
33328428|NCT02116777|101097370|FG002|Overall Study|Adverse Event|0|||
33328429|NCT02116777|101097371|FG003|Overall Study|Adverse Event|0|||
33521648|NCT01438814|101807679|FG001|Overall Study|Lost to Follow-up|3|||
33521649|NCT01438814|101807678|FG000|Overall Study|Withdrawal by Subject|4|||
33521650|NCT01438814|101807679|FG001|Overall Study|Withdrawal by Subject|2|||
33328430|NCT02116777|101097372|FG004|Overall Study|Adverse Event|2|||
33328431|NCT02116777|101097373|FG005|Overall Study|Adverse Event|2|||
33328432|NCT02116777|101097374|FG006|Overall Study|Adverse Event|0|||
33328433|NCT02116777|101097368|FG000|Overall Study|Death|0|||
33521651|NCT01438814|101807678|FG000|Overall Study|Other|2|||
33200585|NCT01831089|100638369|FG003|Cohort III: Dose Level 3|Global end of study|0|||
33200586|NCT01831089|100638370|FG004|Cohort III: Dose Level 3|Global end of study|0|||
33521652|NCT01438814|101807679|FG001|Overall Study|Other|4|||
33521653|NCT00396877|101807680|FG000|Overall Study|Lost to Follow-up|2|||
33521654|NCT00396877|101807681|FG001|Overall Study|Lost to Follow-up|1|||
33521655|NCT00396877|101807680|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
33521656|NCT00396877|101807681|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
33521657|NCT01636947|101807682|FG000|Overall Study|Not Treated|2|||
33200587|NCT01831089|100638371|FG005|Cohort III: Dose Level 3|Global end of study|0|||
33200588|NCT01831089|100638366|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
33200589|NCT01831089|100638367|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
33200590|NCT01831089|100638368|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
33200591|NCT01831089|100638369|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
33200592|NCT01831089|100638370|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
33200593|NCT01831089|100638371|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
33521658|NCT01636947|101807683|FG001|Overall Study|Not Treated|2|||
33521659|NCT01636947|101807682|FG000|Overall Study|Lost to Follow-up|4|||
33521660|NCT01636947|101807683|FG001|Overall Study|Lost to Follow-up|0|||
33521661|NCT01636947|101807682|FG000|Overall Study|Protocol Violation|1|||
33521662|NCT01636947|101807683|FG001|Overall Study|Protocol Violation|1|||
33521663|NCT01636947|101807682|FG000|Overall Study|Withdrawal by Subject|3|||
33521664|NCT01636947|101807683|FG001|Overall Study|Withdrawal by Subject|3|||
33521665|NCT01636947|101807682|FG000|Overall Study|Adverse Event|1|||
33521666|NCT01636947|101807683|FG001|Overall Study|Adverse Event|1|||
33521667|NCT01636947|101807682|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
33521668|NCT01636947|101807683|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
33521669|NCT00957424|101807685|FG000|Overall Study|Lost to Follow-up|19|||
33521670|NCT00957424|101807685|FG000|Overall Study|Protocol Violation|3|||
33521671|NCT00957424|101807685|FG000|Overall Study|Withdrawal by Subject|1|||
33521672|NCT03035916|101807686|FG000|Overall Study|Puncture failed|0|||
33521673|NCT03035916|101807687|FG001|Overall Study|Puncture failed|2|||
33521674|NCT03035916|101807688|FG002|Overall Study|Puncture failed|0|||
33200594|NCT01831089|100638366|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
33200595|NCT01831089|100638367|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
33200596|NCT01831089|100638368|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
33200597|NCT01831089|100638369|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
33200598|NCT01831089|100638370|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
33200599|NCT01831089|100638371|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
33200600|NCT01831089|100638366|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
33200601|NCT01831089|100638367|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
33200602|NCT01831089|100638368|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
33200603|NCT01831089|100638369|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
33200604|NCT01831089|100638370|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
33200605|NCT01831089|100638371|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
33200606|NCT01831089|100638366|FG000|Cohort V: Dose Level 5|Death|0|||
33328434|NCT02116777|101097369|FG001|Overall Study|Death|0|||
33328435|NCT02116777|101097370|FG002|Overall Study|Death|0|||
33328436|NCT02116777|101097371|FG003|Overall Study|Death|1|||
33521675|NCT04093492|101807693|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
33521676|NCT04093492|101807694|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
33521677|NCT04093492|101807695|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
33521678|NCT04093492|101807696|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
33521679|NCT04093492|101807693|FG000|25 Weeks Gestational Age (GA)|No response|5|||
33521680|NCT04093492|101807694|FG001|25 Weeks Gestational Age (GA)|No response|5|||
33200607|NCT01831089|100638367|FG001|Cohort V: Dose Level 5|Death|0|||
33200608|NCT01831089|100638368|FG002|Cohort V: Dose Level 5|Death|0|||
33200609|NCT01831089|100638369|FG003|Cohort V: Dose Level 5|Death|0|||
33200610|NCT01831089|100638370|FG004|Cohort V: Dose Level 5|Death|1|||
33200611|NCT01831089|100638371|FG005|Cohort V: Dose Level 5|Death|0|||
33200612|NCT01831089|100638366|FG000|Cohort V: Dose Level 5|Global end of study|0|||
33328437|NCT02116777|101097372|FG004|Overall Study|Death|0|||
33401304|NCT00963469|101357007|FG000|Overall Study|Moved|1|||
33521681|NCT04093492|101807695|FG002|25 Weeks Gestational Age (GA)|No response|5|||
33521682|NCT04093492|101807696|FG003|25 Weeks Gestational Age (GA)|No response|2|||
33521683|NCT04093492|101807693|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
33521684|NCT04093492|101807694|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
33521685|NCT04093492|101807695|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
33200613|NCT01831089|100638367|FG001|Cohort V: Dose Level 5|Global end of study|0|||
33200614|NCT01831089|100638368|FG002|Cohort V: Dose Level 5|Global end of study|0|||
33328438|NCT02116777|101097373|FG005|Overall Study|Death|0|||
33328439|NCT02116777|101097374|FG006|Overall Study|Death|0|||
33328440|NCT02116777|101097368|FG000|Overall Study|Lack of Efficacy|3|||
33328441|NCT02116777|101097369|FG001|Overall Study|Lack of Efficacy|3|||
33328442|NCT02116777|101097370|FG002|Overall Study|Lack of Efficacy|3|||
33328443|NCT02116777|101097371|FG003|Overall Study|Lack of Efficacy|8|||
33328444|NCT02116777|101097372|FG004|Overall Study|Lack of Efficacy|4|||
33328445|NCT02116777|101097373|FG005|Overall Study|Lack of Efficacy|1|||
33328446|NCT02116777|101097374|FG006|Overall Study|Lack of Efficacy|9|||
33328447|NCT02116777|101097368|FG000|Overall Study|Physician Decision|0|||
33401305|NCT00963469|101357008|FG001|Overall Study|Moved|0|||
33401306|NCT00963469|101357009|FG002|Overall Study|Moved|0|||
33328448|NCT02116777|101097369|FG001|Overall Study|Physician Decision|0|||
33328449|NCT02116777|101097370|FG002|Overall Study|Physician Decision|0|||
33328450|NCT02116777|101097371|FG003|Overall Study|Physician Decision|2|||
33328451|NCT02116777|101097372|FG004|Overall Study|Physician Decision|0|||
33328452|NCT02116777|101097373|FG005|Overall Study|Physician Decision|0|||
33328453|NCT02116777|101097374|FG006|Overall Study|Physician Decision|0|||
33328454|NCT02116777|101097368|FG000|Overall Study|Protocol Violation|0|||
33328455|NCT02116777|101097369|FG001|Overall Study|Protocol Violation|0|||
33328456|NCT02116777|101097370|FG002|Overall Study|Protocol Violation|0|||
33328457|NCT02116777|101097371|FG003|Overall Study|Protocol Violation|1|||
33328458|NCT02116777|101097372|FG004|Overall Study|Protocol Violation|0|||
33328459|NCT02116777|101097373|FG005|Overall Study|Protocol Violation|0|||
33328460|NCT02116777|101097374|FG006|Overall Study|Protocol Violation|0|||
33401307|NCT00963469|101357007|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
33401308|NCT00963469|101357008|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
33401309|NCT00963469|101357009|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
33401310|NCT01024946|101357010|FG000|Overall Study|Screen Failure|3|||
33401311|NCT01024946|101357010|FG000|Overall Study|Withdrawal by Subject|1|||
33401312|NCT01024946|101357010|FG000|Overall Study|Adverse Event|1|||
33401313|NCT02610231|101357011|FG000|Overall Study|Withdrawal by Subject|27|||
33401314|NCT02610231|101357011|FG000|Overall Study|Adverse Event|20|||
33401315|NCT02610231|101357011|FG000|Overall Study|Death|5|||
33401316|NCT02610231|101357011|FG000|Overall Study|Surgery|2|||
33401317|NCT02610231|101357011|FG000|Overall Study|Physician Decision|1|||
33401318|NCT02610231|101357011|FG000|Overall Study|Non Compliance|2|||
33401319|NCT02610231|101357011|FG000|Overall Study|Other|3|||
33401320|NCT03529162|101357012|FG000|Overall Study|Lost to Follow-up|2|||
33401321|NCT03529162|101357013|FG001|Overall Study|Lost to Follow-up|2|||
33401322|NCT01432756|101357016|FG000|Overall Study|Lost to Follow-up|1|||
33401323|NCT01432756|101357017|FG001|Overall Study|Lost to Follow-up|0|||
33401324|NCT01432756|101357018|FG002|Overall Study|Lost to Follow-up|2|||
33401325|NCT01432756|101357019|FG003|Overall Study|Lost to Follow-up|1|||
33401326|NCT02500706|101357020|FG000|Overall Study|Adverse Event|0|||
33401327|NCT02500706|101357021|FG001|Overall Study|Adverse Event|0|||
33401328|NCT02500706|101357022|FG002|Overall Study|Adverse Event|1|||
33328461|NCT02116777|101097368|FG000|Overall Study|Withdrawal by Subject|0|||
33328462|NCT02116777|101097369|FG001|Overall Study|Withdrawal by Subject|0|||
33328463|NCT02116777|101097370|FG002|Overall Study|Withdrawal by Subject|0|||
33328464|NCT02116777|101097371|FG003|Overall Study|Withdrawal by Subject|1|||
33328465|NCT02116777|101097372|FG004|Overall Study|Withdrawal by Subject|0|||
33328466|NCT02116777|101097373|FG005|Overall Study|Withdrawal by Subject|0|||
33328467|NCT02116777|101097374|FG006|Overall Study|Withdrawal by Subject|0|||
33328468|NCT04770389|101097384|FG000|Overall Study|Adverse Event|1|||
33328469|NCT04770389|101097385|FG001|Overall Study|Adverse Event|2|||
33328470|NCT04770389|101097386|FG002|Overall Study|Adverse Event|0|||
33328471|NCT04770389|101097387|FG003|Overall Study|Adverse Event|1|||
33401329|NCT02500706|101357020|FG000|Overall Study|Lost to Follow-up|0|||
33328472|NCT04770389|101097384|FG000|Overall Study|Withdrawal by Subject|0|||
33328473|NCT04770389|101097385|FG001|Overall Study|Withdrawal by Subject|2|||
33328474|NCT04770389|101097386|FG002|Overall Study|Withdrawal by Subject|1|||
33328475|NCT04770389|101097387|FG003|Overall Study|Withdrawal by Subject|0|||
33328476|NCT04770389|101097384|FG000|Overall Study|Failed attempt to draw blood|1|||
33328477|NCT04770389|101097385|FG001|Overall Study|Failed attempt to draw blood|0|||
33328478|NCT04770389|101097386|FG002|Overall Study|Failed attempt to draw blood|0|||
33401330|NCT02500706|101357021|FG001|Overall Study|Lost to Follow-up|1|||
33328479|NCT04770389|101097387|FG003|Overall Study|Failed attempt to draw blood|0|||
33328480|NCT04770389|101097384|FG000|Overall Study|Left the country|0|||
33328481|NCT04770389|101097385|FG001|Overall Study|Left the country|0|||
33328482|NCT04770389|101097386|FG002|Overall Study|Left the country|1|||
33328483|NCT04770389|101097387|FG003|Overall Study|Left the country|2|||
33328484|NCT04770389|101097384|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
33401331|NCT02500706|101357022|FG002|Overall Study|Lost to Follow-up|1|||
33401332|NCT02500706|101357020|FG000|Overall Study|Withdrawal by Subject|4|||
33401333|NCT02500706|101357021|FG001|Overall Study|Withdrawal by Subject|6|||
33328485|NCT04770389|101097385|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
33328486|NCT04770389|101097386|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
33328487|NCT04770389|101097387|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
33328488|NCT04770389|101097384|FG000|Overall Study|Lost to Follow-up|0|||
33328489|NCT04770389|101097385|FG001|Overall Study|Lost to Follow-up|0|||
33328490|NCT04770389|101097386|FG002|Overall Study|Lost to Follow-up|0|||
33328491|NCT04770389|101097387|FG003|Overall Study|Lost to Follow-up|1|||
33328492|NCT04770389|101097384|FG000|Overall Study|Moved away from study site|0|||
33328493|NCT04770389|101097385|FG001|Overall Study|Moved away from study site|1|||
33328494|NCT04770389|101097386|FG002|Overall Study|Moved away from study site|0|||
33328495|NCT04770389|101097387|FG003|Overall Study|Moved away from study site|0|||
33328496|NCT01301950|101097388|FG000|Overall Study|Surgery was cancelled by patient|0|||
33328497|NCT01301950|101097389|FG001|Overall Study|Surgery was cancelled by patient|1|||
33328498|NCT03418129|101097392|FG000|Overall Study|Lost to Follow-up|11|||
33328499|NCT03418129|101097393|FG001|Overall Study|Lost to Follow-up|20|||
33328500|NCT03418129|101097394|FG002|Overall Study|Lost to Follow-up|15|||
33328501|NCT03418129|101097392|FG000|Overall Study|Withdrawal by Subject|3|||
33328502|NCT03418129|101097393|FG001|Overall Study|Withdrawal by Subject|6|||
33328503|NCT03418129|101097394|FG002|Overall Study|Withdrawal by Subject|4|||
33328504|NCT01210807|101097395|FG000|Overall Study|Lost to Follow-up|1|||
33328505|NCT01210807|101097396|FG001|Overall Study|Lost to Follow-up|2|||
33328506|NCT01210807|101097395|FG000|Overall Study|Not implanted bilaterally|2|||
33328507|NCT01210807|101097396|FG001|Overall Study|Not implanted bilaterally|1|||
33328508|NCT03370120|101097397|FG000|Overall Study|Adverse event, non-fatal|24|||
33328509|NCT03370120|101097397|FG000|Overall Study|Withdrawal by Subject|6|||
33328510|NCT03370120|101097397|FG000|Overall Study|Lost to Follow-up|1|||
33328511|NCT03370120|101097397|FG000|Overall Study|Lack of Efficacy|37|||
33328512|NCT03370120|101097397|FG000|Overall Study|Per sponsor's instructions|1|||
33328513|NCT03370120|101097397|FG000|Overall Study|Study was terminated by parent company UCB|2|||
33328514|NCT03370120|101097397|FG000|Overall Study|The study was ended by the promoter|3|||
33328515|NCT03370120|101097397|FG000|Overall Study|Discontinuation of drug development|3|||
33328516|NCT03370120|101097397|FG000|Overall Study|End of project|2|||
33328517|NCT03370120|101097397|FG000|Overall Study|Premature study closure|2|||
33328518|NCT03370120|101097397|FG000|Overall Study|Premature program termination|1|||
33328519|NCT03370120|101097397|FG000|Overall Study|Premature study termination|7|||
33328520|NCT03370120|101097397|FG000|Overall Study|Trial terminated by sponsor|2|||
33401334|NCT02500706|101357022|FG002|Overall Study|Withdrawal by Subject|4|||
33401335|NCT02500706|101357020|FG000|Overall Study|Unclassified|0|||
33401336|NCT02500706|101357021|FG001|Overall Study|Unclassified|0|||
33401337|NCT02500706|101357022|FG002|Overall Study|Unclassified|1|||
33401338|NCT04601194|101357031|FG000|Overall Study|Lost to Follow-up|7|||
33521686|NCT04093492|101807696|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
33521687|NCT04093492|101807693|FG000|30 Weeks GA|Delivered before assessment|1|||
33521688|NCT04093492|101807694|FG001|30 Weeks GA|Delivered before assessment|2|||
33521689|NCT04093492|101807695|FG002|30 Weeks GA|Delivered before assessment|0|||
33521690|NCT04093492|101807696|FG003|30 Weeks GA|Delivered before assessment|0|||
33521691|NCT04093492|101807693|FG000|30 Weeks GA|No response|7|||
33521692|NCT04093492|101807694|FG001|30 Weeks GA|No response|5|||
33521693|NCT04093492|101807695|FG002|30 Weeks GA|No response|5|||
33521694|NCT04093492|101807696|FG003|30 Weeks GA|No response|2|||
33521695|NCT04093492|101807693|FG000|30 Weeks GA|Lost to Follow-up|0|||
33521696|NCT04093492|101807694|FG001|30 Weeks GA|Lost to Follow-up|1|||
33521697|NCT04093492|101807695|FG002|30 Weeks GA|Lost to Follow-up|0|||
33521698|NCT04093492|101807696|FG003|30 Weeks GA|Lost to Follow-up|0|||
33521699|NCT04093492|101807693|FG000|34 Weeks GA|Delivered before assessment|6|||
33521700|NCT04093492|101807694|FG001|34 Weeks GA|Delivered before assessment|3|||
33521701|NCT04093492|101807695|FG002|34 Weeks GA|Delivered before assessment|0|||
33328521|NCT03370120|101097397|FG000|Overall Study|Trial discontinued by sponsor|2|||
33328522|NCT03370120|101097397|FG000|Overall Study|Study ended|15|||
33328523|NCT03370120|101097397|FG000|Overall Study|Clinical trial has been cancelled|1|||
33328524|NCT03370120|101097397|FG000|Overall Study|End of study per sponsor decision|2|||
33328525|NCT03370120|101097397|FG000|Overall Study|Promoter's decision|2|||
33401339|NCT04604015|101357036|FG000|Overall Study|Incomplete Data Collection|33|||
33401340|NCT04524507|101357039|FG000|Overall Study|Lost to Follow-up|2|||
33401341|NCT04524507|101357040|FG001|Overall Study|Lost to Follow-up|4|||
33401342|NCT04524507|101357039|FG000|Overall Study|Withdrawal by Subject|2|||
33401343|NCT04524507|101357040|FG001|Overall Study|Withdrawal by Subject|9|||
33521702|NCT04093492|101807696|FG003|34 Weeks GA|Delivered before assessment|0|||
33521703|NCT04093492|101807693|FG000|34 Weeks GA|No response|0|||
33328526|NCT03370120|101097397|FG000|Overall Study|The trial has been suspended|3|||
33328527|NCT03370120|101097397|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
33328528|NCT03370120|101097397|FG000|Overall Study|Early termination by order of sponsor|2|||
33401344|NCT04524507|101357039|FG000|Overall Study|Death|2|||
33401345|NCT04524507|101357040|FG001|Overall Study|Death|10|||
33401346|NCT00808132|101357041|FG000|Overall Study|Adverse Event|34|||
33401347|NCT00808132|101357042|FG001|Overall Study|Adverse Event|33|||
33200615|NCT01831089|100638369|FG003|Cohort V: Dose Level 5|Global end of study|0|||
33200616|NCT01831089|100638370|FG004|Cohort V: Dose Level 5|Global end of study|2|||
33200617|NCT01831089|100638371|FG005|Cohort V: Dose Level 5|Global end of study|0|||
33521704|NCT04093492|101807694|FG001|34 Weeks GA|No response|7|||
33521705|NCT04093492|101807695|FG002|34 Weeks GA|No response|5|||
33521706|NCT04093492|101807696|FG003|34 Weeks GA|No response|3|||
33521707|NCT04093492|101807693|FG000|34 Weeks GA|Lost to Follow-up|0|||
33521708|NCT04093492|101807694|FG001|34 Weeks GA|Lost to Follow-up|1|||
33521709|NCT04093492|101807695|FG002|34 Weeks GA|Lost to Follow-up|0|||
33521710|NCT04093492|101807696|FG003|34 Weeks GA|Lost to Follow-up|0|||
33521711|NCT00553358|101807697|FG000|Overall Study|Randomized but did not receive treatment|3|||
33521712|NCT00553358|101807698|FG001|Overall Study|Randomized but did not receive treatment|3|||
33521713|NCT00553358|101807699|FG002|Overall Study|Randomized but did not receive treatment|1|||
33521714|NCT00553358|101807697|FG000|Overall Study|Lost to Follow-up|22|||
33521715|NCT00553358|101807698|FG001|Overall Study|Lost to Follow-up|26|||
33521716|NCT00553358|101807699|FG002|Overall Study|Lost to Follow-up|18|||
33521717|NCT00553358|101807697|FG000|Overall Study|Withdrew completely|23|||
33521718|NCT00553358|101807698|FG001|Overall Study|Withdrew completely|33|||
33521719|NCT00553358|101807699|FG002|Overall Study|Withdrew completely|34|||
33521720|NCT00553358|101807697|FG000|Overall Study|Died during clinical follow-up|25|||
33521721|NCT00553358|101807698|FG001|Overall Study|Died during clinical follow-up|29|||
33521722|NCT00553358|101807699|FG002|Overall Study|Died during clinical follow-up|32|||
33521723|NCT00553358|101807697|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
33521724|NCT00553358|101807698|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
33521725|NCT00553358|101807699|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
33521726|NCT00553358|101807697|FG000|Overall Study|Died after clinical follow-up ended|1|||
33521727|NCT00553358|101807698|FG001|Overall Study|Died after clinical follow-up ended|2|||
33521728|NCT00553358|101807699|FG002|Overall Study|Died after clinical follow-up ended|0|||
33521729|NCT00553358|101807697|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
33521730|NCT00553358|101807698|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
33521731|NCT00553358|101807699|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
33521732|NCT02649426|101807700|FG000|Overall Study|Follow-up on going|1|||
33521733|NCT02649426|101807701|FG001|Overall Study|Follow-up on going|26|||
33521734|NCT02649426|101807702|FG002|Overall Study|Follow-up on going|28|||
33521735|NCT02649426|101807703|FG003|Overall Study|Follow-up on going|31|||
33521736|NCT03301831|101807706|FG000|Overall Study|Lost to Follow-up|5|||
33521737|NCT03301831|101807707|FG001|Overall Study|Lost to Follow-up|3|||
33521738|NCT03301831|101807706|FG000|Overall Study|Protocol Violation|4|||
33521739|NCT03301831|101807707|FG001|Overall Study|Protocol Violation|0|||
33521740|NCT03301831|101807706|FG000|Overall Study|Withdrawal by Subject|11|||
33521741|NCT03301831|101807707|FG001|Overall Study|Withdrawal by Subject|0|||
33521742|NCT03871829|101807708|FG000|Overall Study|Lost to Follow-up|0|||
33521743|NCT03871829|101807709|FG001|Overall Study|Lost to Follow-up|1|||
33521744|NCT03871829|101807708|FG000|Overall Study|Withdrawal by Subject|1|||
33200618|NCT01831089|100638366|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
33200619|NCT01831089|100638367|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
33200620|NCT01831089|100638368|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
33200621|NCT01831089|100638369|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
33200622|NCT01831089|100638370|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
33200623|NCT01831089|100638371|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
33200624|NCT01831089|100638366|FG000|Cohort B: Arm B|Progressive disease|0|||
33200625|NCT01831089|100638367|FG001|Cohort B: Arm B|Progressive disease|0|||
33200626|NCT01831089|100638368|FG002|Cohort B: Arm B|Progressive disease|0|||
33200627|NCT01831089|100638369|FG003|Cohort B: Arm B|Progressive disease|0|||
33328529|NCT03370120|101097397|FG000|Overall Study|Discontinuation of the study|5|||
33521745|NCT03871829|101807709|FG001|Overall Study|Withdrawal by Subject|1|||
33521746|NCT03871829|101807708|FG000|Overall Study|Death|12|||
33521747|NCT03871829|101807709|FG001|Overall Study|Death|8|||
33521748|NCT03871829|101807708|FG000|Overall Study|Study terminated by sponsor|31|||
33521749|NCT03871829|101807709|FG001|Overall Study|Study terminated by sponsor|34|||
33521750|NCT01717391|101807710|FG000|Overall Study|Withdrawal by Subject|5|||
33521751|NCT01717391|101807710|FG000|Overall Study|Physician Decision|1|||
33521752|NCT01717391|101807710|FG000|Overall Study|FLT technical failure|3|||
33521753|NCT02000882|101807711|FG000|Overall Study|Adverse Event|3|||
33521754|NCT02000882|101807711|FG000|Overall Study|Physician Decision|2|||
33521755|NCT02000882|101807711|FG000|Overall Study|Withdrawal by Subject|1|||
33521756|NCT03810235|101807712|FG000|Overall Study|Withdrawal by Subject|2|||
33200628|NCT01831089|100638370|FG004|Cohort B: Arm B|Progressive disease|0|||
33200629|NCT01831089|100638371|FG005|Cohort B: Arm B|Progressive disease|8|||
33200630|NCT01831089|100638366|FG000|Cohort B: Arm B|Physician Decision|0|||
33328530|NCT03370120|101097397|FG000|Overall Study|End of clinical trial discontinuation|1|||
33200631|NCT01831089|100638367|FG001|Cohort B: Arm B|Physician Decision|0|||
33328531|NCT03370120|101097397|FG000|Overall Study|Because the clinical trial ended halfway|4|||
33521757|NCT03810235|101807713|FG001|Overall Study|Withdrawal by Subject|0|||
33521758|NCT03373461|101807716|FG000|Part 2|Adverse Event|0|||
33521759|NCT03373461|101807717|FG001|Part 2|Adverse Event|1|||
33521760|NCT03373461|101807718|FG002|Part 2|Adverse Event|0|||
33521761|NCT03373461|101807719|FG003|Part 2|Adverse Event|0|||
33521762|NCT03373461|101807720|FG004|Part 2|Adverse Event|1|||
33521763|NCT00282152|101807721|FG000|Overall Study|Withdrawal by Subject|1|||
33521764|NCT00282152|101807722|FG001|Overall Study|Withdrawal by Subject|0|||
33521765|NCT00750919|101807724|FG000|Overall Study|Adverse Event|9|||
33521766|NCT00750919|101807724|FG000|Overall Study|Withdrawal by Subject|1|||
33521767|NCT00750919|101807724|FG000|Overall Study|Lack of Efficacy|8|||
33521768|NCT00750919|101807724|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
33521769|NCT00750919|101807724|FG000|Overall Study|Other|36|||
33521770|NCT01402986|101807732|FG000|Overall Study|Withdrawal by Subject|7|||
33521771|NCT01402986|101807733|FG001|Overall Study|Withdrawal by Subject|10|||
33521772|NCT01402986|101807734|FG002|Overall Study|Withdrawal by Subject|7|||
33521773|NCT01402986|101807735|FG003|Overall Study|Withdrawal by Subject|13|||
33521774|NCT01402986|101807732|FG000|Overall Study|Death|0|||
33521775|NCT01402986|101807733|FG001|Overall Study|Death|0|||
33521776|NCT01402986|101807734|FG002|Overall Study|Death|0|||
33521777|NCT01402986|101807735|FG003|Overall Study|Death|2|||
33521778|NCT01402986|101807732|FG000|Overall Study|Lost to Follow-up|0|||
33521779|NCT01402986|101807733|FG001|Overall Study|Lost to Follow-up|0|||
33521780|NCT01402986|101807734|FG002|Overall Study|Lost to Follow-up|0|||
33521781|NCT01402986|101807735|FG003|Overall Study|Lost to Follow-up|1|||
33521782|NCT01402986|101807732|FG000|Overall Study|Other|2|||
33521783|NCT01402986|101807733|FG001|Overall Study|Other|5|||
33521784|NCT01402986|101807734|FG002|Overall Study|Other|1|||
33521785|NCT01402986|101807735|FG003|Overall Study|Other|6|||
33521786|NCT01027897|101807736|FG000|Overall Study|Protocol Violation|1|||
33521787|NCT01027897|101807736|FG000|Overall Study|Withdrawal by Subject|1|||
33521788|NCT02427802|101807737|FG000|Overall Study|Adverse Event|11|||
33521789|NCT02427802|101807738|FG001|Overall Study|Adverse Event|3|||
33521790|NCT02427802|101807739|FG002|Overall Study|Adverse Event|7|||
33521791|NCT02427802|101807737|FG000|Overall Study|Death|0|||
33521792|NCT02427802|101807738|FG001|Overall Study|Death|4|||
33521793|NCT02427802|101807739|FG002|Overall Study|Death|1|||
33521794|NCT02427802|101807737|FG000|Overall Study|Lost to Follow-up|13|||
33521795|NCT02427802|101807738|FG001|Overall Study|Lost to Follow-up|8|||
33521796|NCT02427802|101807739|FG002|Overall Study|Lost to Follow-up|8|||
33521797|NCT02427802|101807737|FG000|Overall Study|Physician Decision|4|||
33521798|NCT02427802|101807738|FG001|Overall Study|Physician Decision|2|||
33521799|NCT02427802|101807739|FG002|Overall Study|Physician Decision|4|||
33521800|NCT02427802|101807737|FG000|Overall Study|Withdrawal by Subject|10|||
33521801|NCT02427802|101807738|FG001|Overall Study|Withdrawal by Subject|5|||
33521802|NCT02427802|101807739|FG002|Overall Study|Withdrawal by Subject|11|||
33521803|NCT02427802|101807737|FG000|Overall Study|Protocol Violation|3|||
33521804|NCT02427802|101807738|FG001|Overall Study|Protocol Violation|1|||
33521805|NCT02427802|101807739|FG002|Overall Study|Protocol Violation|1|||
33521806|NCT02427802|101807737|FG000|Overall Study|protocol specific treatment unrelated|18|||
33521807|NCT02427802|101807738|FG001|Overall Study|protocol specific treatment unrelated|11|||
33521808|NCT02427802|101807739|FG002|Overall Study|protocol specific treatment unrelated|11|||
33521809|NCT05052697|101807740|FG000|Substudy A|Lost to Follow-up|0|||
33521810|NCT05052697|101807741|FG001|Substudy A|Lost to Follow-up|0|||
33521811|NCT05052697|101807742|FG002|Substudy A|Lost to Follow-up|0|||
33521812|NCT05052697|101807743|FG003|Substudy A|Lost to Follow-up|0|||
33521813|NCT05052697|101807744|FG004|Substudy A|Lost to Follow-up|0|||
33521814|NCT05052697|101807745|FG005|Substudy A|Lost to Follow-up|1|||
33200632|NCT01831089|100638368|FG002|Cohort B: Arm B|Physician Decision|0|||
33521815|NCT05052697|101807746|FG006|Substudy A|Lost to Follow-up|0|||
33521816|NCT05052697|101807747|FG007|Substudy A|Lost to Follow-up|0|||
33521817|NCT05052697|101807748|FG008|Substudy A|Lost to Follow-up|0|||
33401348|NCT00808132|101357043|FG002|Overall Study|Adverse Event|16|||
33521818|NCT05052697|101807749|FG009|Substudy A|Lost to Follow-up|0|||
33521819|NCT05052697|101807750|FG010|Substudy A|Lost to Follow-up|0|||
33521820|NCT05052697|101807751|FG011|Substudy A|Lost to Follow-up|0|||
33521821|NCT05052697|101807752|FG012|Substudy A|Lost to Follow-up|0|||
33521822|NCT05052697|101807753|FG013|Substudy A|Lost to Follow-up|0|||
33521823|NCT05052697|101807754|FG014|Substudy A|Lost to Follow-up|0|||
33521824|NCT05052697|101807755|FG015|Substudy A|Lost to Follow-up|2|||
33521825|NCT05052697|101807756|FG016|Substudy A|Lost to Follow-up|0|||
33521826|NCT05052697|101807757|FG017|Substudy A|Lost to Follow-up|0|||
33521827|NCT05052697|101807758|FG018|Substudy A|Lost to Follow-up|0|||
33521828|NCT05052697|101807759|FG019|Substudy A|Lost to Follow-up|0|||
33521829|NCT05052697|101807760|FG020|Substudy A|Lost to Follow-up|0|||
33521830|NCT05052697|101807761|FG021|Substudy A|Lost to Follow-up|0|||
33521831|NCT05052697|101807762|FG022|Substudy A|Lost to Follow-up|0|||
33200633|NCT01831089|100638369|FG003|Cohort B: Arm B|Physician Decision|0|||
33200634|NCT01831089|100638370|FG004|Cohort B: Arm B|Physician Decision|0|||
33200635|NCT01831089|100638371|FG005|Cohort B: Arm B|Physician Decision|2|||
33200636|NCT01831089|100638366|FG000|Cohort B: Arm B|Never treated|0|||
33521832|NCT05052697|101807763|FG023|Substudy A|Lost to Follow-up|0|||
33521833|NCT05052697|101807764|FG024|Substudy A|Lost to Follow-up|0|||
33200637|NCT01831089|100638367|FG001|Cohort B: Arm B|Never treated|0|||
33200638|NCT01831089|100638368|FG002|Cohort B: Arm B|Never treated|0|||
33200639|NCT01831089|100638369|FG003|Cohort B: Arm B|Never treated|0|||
33200640|NCT01831089|100638370|FG004|Cohort B: Arm B|Never treated|0|||
33200641|NCT01831089|100638371|FG005|Cohort B: Arm B|Never treated|2|||
33200642|NCT01831089|100638366|FG000|Cohort B: Arm B|Adverse Event|0|||
33200643|NCT01831089|100638367|FG001|Cohort B: Arm B|Adverse Event|0|||
33200644|NCT01831089|100638368|FG002|Cohort B: Arm B|Adverse Event|0|||
33200645|NCT01831089|100638369|FG003|Cohort B: Arm B|Adverse Event|0|||
33200646|NCT01831089|100638370|FG004|Cohort B: Arm B|Adverse Event|0|||
33200647|NCT01831089|100638371|FG005|Cohort B: Arm B|Adverse Event|1|||
33200648|NCT01831089|100638366|FG000|Cohort B: Arm B|Global end of study|0|||
33200649|NCT01831089|100638367|FG001|Cohort B: Arm B|Global end of study|0|||
33200650|NCT01831089|100638368|FG002|Cohort B: Arm B|Global end of study|0|||
33200651|NCT01831089|100638369|FG003|Cohort B: Arm B|Global end of study|0|||
33200652|NCT01831089|100638370|FG004|Cohort B: Arm B|Global end of study|0|||
33200653|NCT01831089|100638371|FG005|Cohort B: Arm B|Global end of study|1|||
33200654|NCT01694706|100638372|FG000|Overall Study|Adverse Event|0|||
33200655|NCT01694706|100638373|FG001|Overall Study|Adverse Event|1|||
33200656|NCT01694706|100638374|FG002|Overall Study|Adverse Event|0|||
33200657|NCT01694706|100638372|FG000|Overall Study|other reason not defined above|1|||
33200658|NCT01694706|100638373|FG001|Overall Study|other reason not defined above|0|||
33200659|NCT01694706|100638374|FG002|Overall Study|other reason not defined above|0|||
33200660|NCT04193202|100638375|FG000|Overall Study|Adverse Event|2|||
33200661|NCT04193202|100638376|FG001|Overall Study|Adverse Event|1|||
33521834|NCT05052697|101807765|FG025|Substudy A|Lost to Follow-up|0|||
33521835|NCT05052697|101807766|FG026|Substudy A|Lost to Follow-up|0|||
33521836|NCT05052697|101807767|FG027|Substudy A|Lost to Follow-up|0|||
33521837|NCT05052697|101807768|FG028|Substudy A|Lost to Follow-up|0|||
33521838|NCT05052697|101807769|FG029|Substudy A|Lost to Follow-up|0|||
33521839|NCT05052697|101807770|FG030|Substudy A|Lost to Follow-up|0|||
33521840|NCT05052697|101807771|FG031|Substudy A|Lost to Follow-up|0|||
33521841|NCT05052697|101807772|FG032|Substudy A|Lost to Follow-up|0|||
33521842|NCT05052697|101807773|FG033|Substudy A|Lost to Follow-up|0|||
33521843|NCT05052697|101807740|FG000|Substudy A|No longer met eligibility criteria|0|||
33521844|NCT05052697|101807741|FG001|Substudy A|No longer met eligibility criteria|0|||
33521845|NCT05052697|101807742|FG002|Substudy A|No longer met eligibility criteria|0|||
33521846|NCT05052697|101807743|FG003|Substudy A|No longer met eligibility criteria|0|||
33521847|NCT05052697|101807744|FG004|Substudy A|No longer met eligibility criteria|0|||
33521848|NCT05052697|101807745|FG005|Substudy A|No longer met eligibility criteria|0|||
33521849|NCT05052697|101807746|FG006|Substudy A|No longer met eligibility criteria|0|||
33521850|NCT05052697|101807747|FG007|Substudy A|No longer met eligibility criteria|0|||
33521851|NCT05052697|101807748|FG008|Substudy A|No longer met eligibility criteria|0|||
33521852|NCT05052697|101807749|FG009|Substudy A|No longer met eligibility criteria|0|||
33521853|NCT05052697|101807750|FG010|Substudy A|No longer met eligibility criteria|0|||
33200662|NCT04193202|100638375|FG000|Overall Study|Death|0|||
33200663|NCT04193202|100638376|FG001|Overall Study|Death|1|||
33200664|NCT04193202|100638375|FG000|Overall Study|Physician Decision|1|||
33200665|NCT04193202|100638376|FG001|Overall Study|Physician Decision|1|||
33200666|NCT04193202|100638375|FG000|Overall Study|Protocol Violation|2|||
33200667|NCT04193202|100638376|FG001|Overall Study|Protocol Violation|2|||
33200668|NCT04193202|100638375|FG000|Overall Study|Withdrawal by Subject|11|||
33200669|NCT04193202|100638376|FG001|Overall Study|Withdrawal by Subject|5|||
33200670|NCT01071395|100638380|FG000|Overall Study|Withdrawal by Subject|2|||
33200671|NCT01071395|100638381|FG001|Overall Study|Withdrawal by Subject|1|||
33200672|NCT01071395|100638380|FG000|Overall Study|Adverse Event|3|||
33200673|NCT01071395|100638381|FG001|Overall Study|Adverse Event|1|||
33200674|NCT03207750|100638382|FG000|Overall Study|Adverse Event|3|||
33200675|NCT03207750|100638383|FG001|Overall Study|Adverse Event|2|||
33200676|NCT03207750|100638382|FG000|Overall Study|Lost to Follow-up|21|||
33200677|NCT03207750|100638383|FG001|Overall Study|Lost to Follow-up|29|||
33200678|NCT03207750|100638382|FG000|Overall Study|Protocol Violation|0|||
33521854|NCT05052697|101807751|FG011|Substudy A|No longer met eligibility criteria|0|||
33200679|NCT03207750|100638383|FG001|Overall Study|Protocol Violation|1|||
33200680|NCT03207750|100638382|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
33200681|NCT03207750|100638383|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
33401349|NCT00808132|101357044|FG003|Overall Study|Adverse Event|31|||
33521855|NCT05052697|101807752|FG012|Substudy A|No longer met eligibility criteria|0|||
33521856|NCT05052697|101807753|FG013|Substudy A|No longer met eligibility criteria|1|||
33521857|NCT05052697|101807754|FG014|Substudy A|No longer met eligibility criteria|0|||
33521858|NCT05052697|101807755|FG015|Substudy A|No longer met eligibility criteria|0|||
33521859|NCT05052697|101807756|FG016|Substudy A|No longer met eligibility criteria|0|||
33521860|NCT05052697|101807757|FG017|Substudy A|No longer met eligibility criteria|0|||
33521861|NCT05052697|101807758|FG018|Substudy A|No longer met eligibility criteria|0|||
33521862|NCT05052697|101807759|FG019|Substudy A|No longer met eligibility criteria|0|||
33521863|NCT05052697|101807760|FG020|Substudy A|No longer met eligibility criteria|0|||
33521864|NCT05052697|101807761|FG021|Substudy A|No longer met eligibility criteria|0|||
33521865|NCT05052697|101807762|FG022|Substudy A|No longer met eligibility criteria|0|||
33521866|NCT05052697|101807763|FG023|Substudy A|No longer met eligibility criteria|0|||
33521867|NCT05052697|101807764|FG024|Substudy A|No longer met eligibility criteria|0|||
33521868|NCT05052697|101807765|FG025|Substudy A|No longer met eligibility criteria|0|||
33521869|NCT05052697|101807766|FG026|Substudy A|No longer met eligibility criteria|0|||
33521870|NCT05052697|101807767|FG027|Substudy A|No longer met eligibility criteria|0|||
33521871|NCT05052697|101807768|FG028|Substudy A|No longer met eligibility criteria|0|||
33521872|NCT05052697|101807769|FG029|Substudy A|No longer met eligibility criteria|0|||
33521873|NCT05052697|101807770|FG030|Substudy A|No longer met eligibility criteria|0|||
33521874|NCT05052697|101807771|FG031|Substudy A|No longer met eligibility criteria|0|||
33521875|NCT05052697|101807772|FG032|Substudy A|No longer met eligibility criteria|0|||
33521876|NCT05052697|101807773|FG033|Substudy A|No longer met eligibility criteria|0|||
33521877|NCT05052697|101807740|FG000|Substudy A|Not vaccinated|0|||
33521878|NCT05052697|101807741|FG001|Substudy A|Not vaccinated|0|||
33521879|NCT05052697|101807742|FG002|Substudy A|Not vaccinated|0|||
33521880|NCT05052697|101807743|FG003|Substudy A|Not vaccinated|1|||
33521881|NCT05052697|101807744|FG004|Substudy A|Not vaccinated|0|||
33521882|NCT05052697|101807745|FG005|Substudy A|Not vaccinated|0|||
33521883|NCT05052697|101807746|FG006|Substudy A|Not vaccinated|0|||
33521884|NCT05052697|101807747|FG007|Substudy A|Not vaccinated|0|||
33521885|NCT05052697|101807748|FG008|Substudy A|Not vaccinated|1|||
33521886|NCT05052697|101807749|FG009|Substudy A|Not vaccinated|0|||
33521887|NCT05052697|101807750|FG010|Substudy A|Not vaccinated|0|||
33521888|NCT05052697|101807751|FG011|Substudy A|Not vaccinated|0|||
33521889|NCT05052697|101807752|FG012|Substudy A|Not vaccinated|0|||
33521890|NCT05052697|101807753|FG013|Substudy A|Not vaccinated|0|||
33521891|NCT05052697|101807754|FG014|Substudy A|Not vaccinated|0|||
33521892|NCT05052697|101807755|FG015|Substudy A|Not vaccinated|0|||
33521893|NCT05052697|101807756|FG016|Substudy A|Not vaccinated|0|||
33521894|NCT05052697|101807757|FG017|Substudy A|Not vaccinated|0|||
33521895|NCT05052697|101807758|FG018|Substudy A|Not vaccinated|0|||
33521896|NCT05052697|101807759|FG019|Substudy A|Not vaccinated|0|||
33521897|NCT05052697|101807760|FG020|Substudy A|Not vaccinated|0|||
33521898|NCT05052697|101807761|FG021|Substudy A|Not vaccinated|0|||
33521899|NCT05052697|101807762|FG022|Substudy A|Not vaccinated|0|||
33521900|NCT05052697|101807763|FG023|Substudy A|Not vaccinated|0|||
33521901|NCT05052697|101807764|FG024|Substudy A|Not vaccinated|0|||
33521902|NCT05052697|101807765|FG025|Substudy A|Not vaccinated|0|||
33521903|NCT05052697|101807766|FG026|Substudy A|Not vaccinated|0|||
33521904|NCT05052697|101807767|FG027|Substudy A|Not vaccinated|0|||
33521905|NCT05052697|101807768|FG028|Substudy A|Not vaccinated|0|||
33521906|NCT05052697|101807769|FG029|Substudy A|Not vaccinated|0|||
33521907|NCT05052697|101807770|FG030|Substudy A|Not vaccinated|0|||
33521908|NCT05052697|101807771|FG031|Substudy A|Not vaccinated|0|||
33521909|NCT05052697|101807772|FG032|Substudy A|Not vaccinated|0|||
33521910|NCT05052697|101807773|FG033|Substudy A|Not vaccinated|0|||
33521911|NCT05052697|101807740|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521912|NCT05052697|101807741|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521913|NCT05052697|101807742|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521914|NCT05052697|101807743|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521915|NCT05052697|101807744|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521916|NCT05052697|101807745|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521917|NCT05052697|101807746|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521918|NCT05052697|101807747|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521919|NCT05052697|101807748|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521920|NCT05052697|101807749|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521921|NCT05052697|101807750|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521922|NCT05052697|101807751|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33200682|NCT03207750|100638382|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
33521923|NCT05052697|101807752|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521924|NCT05052697|101807753|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521925|NCT05052697|101807754|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521926|NCT05052697|101807755|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521927|NCT05052697|101807756|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521928|NCT05052697|101807757|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521929|NCT05052697|101807758|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
33521930|NCT05052697|101807759|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
33521931|NCT05052697|101807760|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521932|NCT05052697|101807761|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
33521933|NCT05052697|101807762|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
33521934|NCT05052697|101807763|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521935|NCT05052697|101807764|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521936|NCT05052697|101807765|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521937|NCT05052697|101807766|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521938|NCT05052697|101807767|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521939|NCT05052697|101807768|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521940|NCT05052697|101807769|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521941|NCT05052697|101807770|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521942|NCT05052697|101807771|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521943|NCT05052697|101807772|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521944|NCT05052697|101807773|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
33521945|NCT05052697|101807740|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521946|NCT05052697|101807741|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521947|NCT05052697|101807742|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521948|NCT05052697|101807743|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521949|NCT05052697|101807744|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521950|NCT05052697|101807745|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521951|NCT05052697|101807746|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521952|NCT05052697|101807747|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521953|NCT05052697|101807748|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521954|NCT05052697|101807749|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521955|NCT05052697|101807750|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521956|NCT05052697|101807751|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521957|NCT05052697|101807752|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
33608987|NCT01183065|102118511|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
33608988|NCT00965419|102118512|FG000|Open Label Treatment for Responders|Adverse Event|33|||
33608989|NCT00965419|102118512|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
33608990|NCT00965419|102118512|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
33608991|NCT00965419|102118512|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
33608992|NCT00965419|102118512|FG000|Open Label Treatment for Responders|Physician Decision|6|||
33608993|NCT00965419|102118512|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
33608994|NCT00965419|102118512|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
33608995|NCT00965419|102118512|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
33608996|NCT00965419|102118512|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
33200683|NCT03207750|100638383|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
33200684|NCT03207750|100638382|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
33200685|NCT03207750|100638383|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
33200686|NCT03207750|100638382|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
33200687|NCT03207750|100638383|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
33200688|NCT03207750|100638382|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
33328532|NCT03370120|101097397|FG000|Overall Study|Development discontinued|5|||
33328533|NCT03370120|101097397|FG000|Overall Study|Padsenovil program closed|3|||
33608997|NCT00965419|102118512|FG000|Follow-up Phase|Adverse Event|9|||
33608998|NCT00965419|102118512|FG000|Follow-up Phase|Protocol Violation|4|||
33608999|NCT00965419|102118512|FG000|Follow-up Phase|Withdrawal by Subject|8|||
33200689|NCT03207750|100638383|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
33200690|NCT01669343|100638384|FG000|Part A: All Patients|Withdrawal by Subject|7|||
33328534|NCT03370120|101097397|FG000|Overall Study|End of project|2|||
33609000|NCT00965419|102118512|FG000|Follow-up Phase|Physician Decision|4|||
33609001|NCT00965419|102118512|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
33609002|NCT00965419|102118512|FG000|Follow-up Phase|Lack of Efficacy|28|||
33609003|NCT02943915|102118517|FG000|Overall Study|Withdrawal by Subject|2|||
33609004|NCT02943915|102118518|FG001|Overall Study|Withdrawal by Subject|1|||
33609005|NCT02943915|102118519|FG002|Overall Study|Withdrawal by Subject|0|||
33609006|NCT02943915|102118520|FG003|Overall Study|Withdrawal by Subject|0|||
33609007|NCT02943915|102118517|FG000|Overall Study|Lost to Follow-up|3|||
33328535|NCT03370120|101097397|FG000|Overall Study|Termination of project|1|||
33328536|NCT03370120|101097397|FG000|Overall Study|The study was interrupted by sponsor|4|||
33328537|NCT03370120|101097397|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
33328538|NCT03370120|101097397|FG000|Overall Study|End of sponsor decision|1|||
33328539|NCT03370120|101097397|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
33328540|NCT03370120|101097397|FG000|Overall Study|Early termination of studies|5|||
33328541|NCT03370120|101097397|FG000|Overall Study|This study is ended early|1|||
33328542|NCT03370120|101097397|FG000|Overall Study|End of padsevonil program|2|||
33328543|NCT03370120|101097397|FG000|Overall Study|Decision of sponsor|6|||
33328544|NCT03370120|101097397|FG000|Overall Study|Asked by the sponsor|3|||
33328545|NCT03370120|101097397|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
33328546|NCT03370120|101097397|FG000|Overall Study|PI decision poor compliance from participant|1|||
33328547|NCT03370120|101097397|FG000|Overall Study|Promoter ended the study|3|||
33328548|NCT03370120|101097397|FG000|Overall Study|Premature study close by sponsor's decision|4|||
33328549|NCT03370120|101097397|FG000|Overall Study|Study terminated by sponsor|33|||
33401350|NCT00808132|101357045|FG004|Overall Study|Adverse Event|33|||
33401351|NCT00808132|101357041|FG000|Overall Study|Death|0|||
33609008|NCT02943915|102118518|FG001|Overall Study|Lost to Follow-up|1|||
33609009|NCT02943915|102118519|FG002|Overall Study|Lost to Follow-up|0|||
33328550|NCT03370120|101097397|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
33328551|NCT03370120|101097397|FG000|Overall Study|Sponsor decision to terminate study|63|||
33401352|NCT00808132|101357042|FG001|Overall Study|Death|0|||
33401353|NCT00808132|101357043|FG002|Overall Study|Death|0|||
33328552|NCT03370120|101097397|FG000|Overall Study|Program closure|3|||
33328553|NCT03370120|101097397|FG000|Overall Study|Study ended prematurely|1|||
33328554|NCT03370120|101097397|FG000|Overall Study|Study stopped by sponsor|2|||
33328555|NCT03370120|101097397|FG000|Overall Study|Program termination|55|||
33328556|NCT03370120|101097397|FG000|Overall Study|Sponsor decision|62|||
33328557|NCT03370120|101097397|FG000|Overall Study|Sponsor study closure|10|||
33328558|NCT01543152|101097400|FG000|Overall Study|Withdrawal by Subject|0|||
33328559|NCT01543152|101097401|FG001|Overall Study|Withdrawal by Subject|2|||
33328560|NCT01543152|101097402|FG002|Overall Study|Withdrawal by Subject|0|||
33328561|NCT01543152|101097403|FG003|Overall Study|Withdrawal by Subject|0|||
33328562|NCT01543152|101097404|FG004|Overall Study|Withdrawal by Subject|0|||
33328563|NCT03719690|101097414|FG000|Overall Study|Withdrawal by Subject|5|||
33200691|NCT01669343|100638384|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
33200692|NCT01669343|100638384|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
33200693|NCT01669343|100638384|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
33200694|NCT01669343|100638384|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
33200695|NCT01148810|100638385|FG000|Overall Study|Adverse Event|0|||
33200696|NCT01148810|100638386|FG001|Overall Study|Adverse Event|2|||
33200697|NCT01148810|100638385|FG000|Overall Study|Lack of Efficacy|0|||
33200698|NCT01148810|100638386|FG001|Overall Study|Lack of Efficacy|1|||
33200699|NCT01148810|100638385|FG000|Overall Study|Withdrawal by Subject|0|||
33200700|NCT01148810|100638386|FG001|Overall Study|Withdrawal by Subject|2|||
33200701|NCT01148810|100638385|FG000|Overall Study|Protocol Violation|1|||
33200702|NCT01148810|100638386|FG001|Overall Study|Protocol Violation|0|||
33200703|NCT03483623|100638387|FG000|Overall Study|43 complete sets achieved|1|||
33200704|NCT00153101|100638394|FG000|Overall Study|Lost to Follow-up|14|||
33200705|NCT00153101|100638395|FG001|Overall Study|Lost to Follow-up|14|||
33200706|NCT00153101|100638396|FG002|Overall Study|Lost to Follow-up|12|||
33200707|NCT00153101|100638397|FG003|Overall Study|Lost to Follow-up|5|||
33200708|NCT00153101|100638398|FG004|Overall Study|Lost to Follow-up|5|||
33200709|NCT00153101|100638394|FG000|Overall Study|Withdrawal by Subject|3|||
33200710|NCT00153101|100638395|FG001|Overall Study|Withdrawal by Subject|4|||
33200711|NCT00153101|100638396|FG002|Overall Study|Withdrawal by Subject|3|||
33200712|NCT00153101|100638397|FG003|Overall Study|Withdrawal by Subject|3|||
33200713|NCT00153101|100638398|FG004|Overall Study|Withdrawal by Subject|5|||
33200714|NCT01954017|100638401|FG000|Overall Study|Adverse Event|0|||
33200715|NCT01954017|100638402|FG001|Overall Study|Adverse Event|0|||
33200716|NCT01954017|100638403|FG002|Overall Study|Adverse Event|1|||
33200717|NCT01954017|100638401|FG000|Overall Study|Death|2|||
33200718|NCT01954017|100638402|FG001|Overall Study|Death|1|||
33200719|NCT01954017|100638403|FG002|Overall Study|Death|1|||
33200720|NCT01954017|100638401|FG000|Overall Study|Withdrawal by Subject|0|||
33200721|NCT01954017|100638402|FG001|Overall Study|Withdrawal by Subject|1|||
33200722|NCT01954017|100638403|FG002|Overall Study|Withdrawal by Subject|0|||
33200723|NCT01954017|100638401|FG000|Overall Study|Protocol Violation|0|||
33200724|NCT01954017|100638402|FG001|Overall Study|Protocol Violation|3|||
33200725|NCT01954017|100638403|FG002|Overall Study|Protocol Violation|2|||
33200726|NCT01954017|100638401|FG000|Overall Study|Necrotizing enterocolitis|1|||
33200727|NCT01954017|100638402|FG001|Overall Study|Necrotizing enterocolitis|0|||
33200728|NCT01954017|100638403|FG002|Overall Study|Necrotizing enterocolitis|1|||
33200729|NCT01954017|100638401|FG000|Overall Study|Enteral intake stopped >7 days|0|||
33328564|NCT03719690|101097415|FG001|Overall Study|Withdrawal by Subject|10|||
33328565|NCT03719690|101097414|FG000|Overall Study|Death|40|||
33328566|NCT03719690|101097415|FG001|Overall Study|Death|149|||
33328567|NCT03719690|101097414|FG000|Overall Study|Miscellaneous|12|||
33328568|NCT03719690|101097415|FG001|Overall Study|Miscellaneous|56|||
33200730|NCT01954017|100638402|FG001|Overall Study|Enteral intake stopped >7 days|1|||
33200731|NCT01954017|100638403|FG002|Overall Study|Enteral intake stopped >7 days|1|||
33200732|NCT01954017|100638401|FG000|Overall Study|All other reasons|2|||
33200733|NCT01954017|100638402|FG001|Overall Study|All other reasons|2|||
33200734|NCT01954017|100638403|FG002|Overall Study|All other reasons|7|||
33200735|NCT03669081|100638404|FG000|Overall Study|Data could not be validated|1|||
33200736|NCT03669081|100638405|FG001|Overall Study|Data could not be validated|1|||
33200737|NCT04574362|100638415|FG000|Overall Study|Other|0|||
33200738|NCT04574362|100638416|FG001|Overall Study|Other|5|||
33200739|NCT04574362|100638415|FG000|Overall Study|COVID-19|0|||
33200740|NCT04574362|100638416|FG001|Overall Study|COVID-19|1|||
33328569|NCT03719690|101097414|FG000|Overall Study|Lost to Follow-up|2|||
33328570|NCT03719690|101097415|FG001|Overall Study|Lost to Follow-up|18|||
33328571|NCT03719690|101097414|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
33328572|NCT03719690|101097415|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
33200741|NCT04574362|100638415|FG000|Overall Study|Adverse Event|1|||
33200742|NCT04574362|100638416|FG001|Overall Study|Adverse Event|1|||
33200743|NCT04574362|100638415|FG000|Overall Study|Withdrawal by Subject|2|||
33200744|NCT04574362|100638416|FG001|Overall Study|Withdrawal by Subject|4|||
33200745|NCT04574362|100638415|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
33200746|NCT04574362|100638416|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
33200747|NCT04574362|100638415|FG000|Overall Study|Participant refused to come to the hospital|1|||
33200748|NCT04574362|100638416|FG001|Overall Study|Participant refused to come to the hospital|0|||
33200749|NCT04574362|100638415|FG000|Overall Study|Participant refused the visit|1|||
33200750|NCT04574362|100638416|FG001|Overall Study|Participant refused the visit|0|||
33200751|NCT04574362|100638415|FG000|Overall Study|Participant quit early because of business trip|1|||
33200752|NCT04574362|100638416|FG001|Overall Study|Participant quit early because of business trip|0|||
33200753|NCT02066298|100638417|FG000|Overall Study|Lost to Follow-up|3|||
33200754|NCT02066298|100638418|FG001|Overall Study|Lost to Follow-up|2|||
33200755|NCT02066298|100638419|FG002|Overall Study|Lost to Follow-up|3|||
33200756|NCT02066298|100638420|FG003|Overall Study|Lost to Follow-up|2|||
33200757|NCT02066298|100638421|FG004|Overall Study|Lost to Follow-up|3|||
33200758|NCT02066298|100638422|FG005|Overall Study|Lost to Follow-up|4|||
33200759|NCT02066298|100638417|FG000|Overall Study|Withdrawal by Subject|6|||
33200760|NCT02066298|100638418|FG001|Overall Study|Withdrawal by Subject|6|||
33200761|NCT02066298|100638419|FG002|Overall Study|Withdrawal by Subject|6|||
33200762|NCT02066298|100638420|FG003|Overall Study|Withdrawal by Subject|4|||
33200763|NCT02066298|100638421|FG004|Overall Study|Withdrawal by Subject|5|||
33200764|NCT02066298|100638422|FG005|Overall Study|Withdrawal by Subject|8|||
33200765|NCT02066298|100638417|FG000|Overall Study|Physician Decision|0|||
33609010|NCT02943915|102118520|FG003|Overall Study|Lost to Follow-up|0|||
33609011|NCT02943915|102118517|FG000|Overall Study|excluded|0|||
33609012|NCT02943915|102118518|FG001|Overall Study|excluded|1|||
33609013|NCT02943915|102118519|FG002|Overall Study|excluded|0|||
33200766|NCT02066298|100638418|FG001|Overall Study|Physician Decision|0|||
33200767|NCT02066298|100638419|FG002|Overall Study|Physician Decision|1|||
33200768|NCT02066298|100638420|FG003|Overall Study|Physician Decision|0|||
33200769|NCT02066298|100638421|FG004|Overall Study|Physician Decision|1|||
33200770|NCT02066298|100638422|FG005|Overall Study|Physician Decision|0|||
33200771|NCT02352493|100638427|FG000|Overall Study|Pregnancy|0|||
33200772|NCT02352493|100638428|FG001|Overall Study|Pregnancy|0|||
33200773|NCT02352493|100638429|FG002|Overall Study|Pregnancy|0|||
33200774|NCT02352493|100638430|FG003|Overall Study|Pregnancy|0|||
33200775|NCT02352493|100638431|FG004|Overall Study|Pregnancy|0|||
33200776|NCT02352493|100638432|FG005|Overall Study|Pregnancy|0|||
33200777|NCT02352493|100638433|FG006|Overall Study|Pregnancy|1|||
33200778|NCT02352493|100638434|FG007|Overall Study|Pregnancy|0|||
33609014|NCT02943915|102118520|FG003|Overall Study|excluded|0|||
33609015|NCT01918332|102118521|FG000|Overall Study|Adverse Event|0|||
33200779|NCT02352493|100638435|FG008|Overall Study|Pregnancy|1|||
33200780|NCT02352493|100638436|FG009|Overall Study|Pregnancy|0|||
33200781|NCT02352493|100638437|FG010|Overall Study|Pregnancy|0|||
33200782|NCT02352493|100638438|FG011|Overall Study|Pregnancy|0|||
33200783|NCT02352493|100638439|FG012|Overall Study|Pregnancy|0|||
33200784|NCT02352493|100638440|FG013|Overall Study|Pregnancy|0|||
33200785|NCT02352493|100638441|FG014|Overall Study|Pregnancy|0|||
33200786|NCT02352493|100638442|FG015|Overall Study|Pregnancy|0|||
33200787|NCT02352493|100638443|FG016|Overall Study|Pregnancy|0|||
33200788|NCT02352493|100638444|FG017|Overall Study|Pregnancy|0|||
33200789|NCT02352493|100638427|FG000|Overall Study|Withdrawal by Subject|0|||
33200790|NCT02352493|100638428|FG001|Overall Study|Withdrawal by Subject|0|||
33200791|NCT02352493|100638429|FG002|Overall Study|Withdrawal by Subject|0|||
33200792|NCT02352493|100638430|FG003|Overall Study|Withdrawal by Subject|0|||
33200793|NCT02352493|100638431|FG004|Overall Study|Withdrawal by Subject|0|||
33200794|NCT02352493|100638432|FG005|Overall Study|Withdrawal by Subject|0|||
33200795|NCT02352493|100638433|FG006|Overall Study|Withdrawal by Subject|0|||
33200796|NCT02352493|100638434|FG007|Overall Study|Withdrawal by Subject|0|||
33200797|NCT02352493|100638435|FG008|Overall Study|Withdrawal by Subject|1|||
33200798|NCT02352493|100638436|FG009|Overall Study|Withdrawal by Subject|0|||
33200799|NCT02352493|100638437|FG010|Overall Study|Withdrawal by Subject|0|||
33200800|NCT02352493|100638438|FG011|Overall Study|Withdrawal by Subject|0|||
33200801|NCT02352493|100638439|FG012|Overall Study|Withdrawal by Subject|0|||
33200802|NCT02352493|100638440|FG013|Overall Study|Withdrawal by Subject|0|||
33200803|NCT02352493|100638441|FG014|Overall Study|Withdrawal by Subject|1|||
33609016|NCT01918332|102118522|FG001|Overall Study|Adverse Event|0|||
33200804|NCT02352493|100638442|FG015|Overall Study|Withdrawal by Subject|0|||
33200805|NCT02352493|100638443|FG016|Overall Study|Withdrawal by Subject|0|||
33200806|NCT02352493|100638444|FG017|Overall Study|Withdrawal by Subject|0|||
33200807|NCT02352493|100638427|FG000|Overall Study|Lost to Follow-up|0|||
33200808|NCT02352493|100638428|FG001|Overall Study|Lost to Follow-up|0|||
33200809|NCT02352493|100638429|FG002|Overall Study|Lost to Follow-up|0|||
33200810|NCT02352493|100638430|FG003|Overall Study|Lost to Follow-up|0|||
33200811|NCT02352493|100638431|FG004|Overall Study|Lost to Follow-up|0|||
33200812|NCT02352493|100638432|FG005|Overall Study|Lost to Follow-up|0|||
33200813|NCT02352493|100638433|FG006|Overall Study|Lost to Follow-up|0|||
33200814|NCT02352493|100638434|FG007|Overall Study|Lost to Follow-up|0|||
33200815|NCT02352493|100638435|FG008|Overall Study|Lost to Follow-up|0|||
33200816|NCT02352493|100638436|FG009|Overall Study|Lost to Follow-up|1|||
33200817|NCT02352493|100638437|FG010|Overall Study|Lost to Follow-up|0|||
33200818|NCT02352493|100638438|FG011|Overall Study|Lost to Follow-up|0|||
33200819|NCT02352493|100638439|FG012|Overall Study|Lost to Follow-up|1|||
33200820|NCT02352493|100638440|FG013|Overall Study|Lost to Follow-up|2|||
33200821|NCT02352493|100638441|FG014|Overall Study|Lost to Follow-up|0|||
33200822|NCT02352493|100638442|FG015|Overall Study|Lost to Follow-up|0|||
33200823|NCT02352493|100638443|FG016|Overall Study|Lost to Follow-up|0|||
33200824|NCT02352493|100638444|FG017|Overall Study|Lost to Follow-up|0|||
33200825|NCT00439777|100638448|FG000|Treatment Period|Death|29|||
33200826|NCT00439777|100638449|FG001|Treatment Period|Death|21|||
33200827|NCT00439777|100638448|FG000|Treatment Period|Study terminated by sponsor|125|||
33200828|NCT00439777|100638449|FG001|Treatment Period|Study terminated by sponsor|132|||
33200829|NCT00439777|100638448|FG000|Treatment Period|Site closed by investigator|0|||
33200830|NCT00439777|100638449|FG001|Treatment Period|Site closed by investigator|1|||
33200831|NCT00439777|100638448|FG000|Treatment Period|Did not take study treatment|7|||
33200832|NCT00439777|100638449|FG001|Treatment Period|Did not take study treatment|8|||
33200833|NCT00439777|100638448|FG000|Treatment Period|Adverse Event|111|||
33200834|NCT00439777|100638449|FG001|Treatment Period|Adverse Event|92|||
33200835|NCT00439777|100638448|FG000|Treatment Period|Protocol Violation|23|||
33200836|NCT00439777|100638449|FG001|Treatment Period|Protocol Violation|30|||
33200837|NCT00439777|100638448|FG000|Treatment Period|Withdrawal by Subject|66|||
33200838|NCT00439777|100638449|FG001|Treatment Period|Withdrawal by Subject|118|||
33200839|NCT00439777|100638448|FG000|Treatment Period|Lack of Efficacy|1|||
33200840|NCT00439777|100638449|FG001|Treatment Period|Lack of Efficacy|4|||
33200841|NCT00439777|100638448|FG000|Treatment Period|Lost to Follow-up|8|||
33200842|NCT00439777|100638449|FG001|Treatment Period|Lost to Follow-up|10|||
33200843|NCT00439777|100638448|FG000|Treatment Period|Protocol driven decision point|1|||
33200844|NCT00439777|100638449|FG001|Treatment Period|Protocol driven decision point|3|||
33200845|NCT00439777|100638448|FG000|Treatment Period|Physician Decision|7|||
33200846|NCT00439777|100638449|FG001|Treatment Period|Physician Decision|18|||
33200847|NCT00439777|100638448|FG000|Treatment Period|Clinical endpoint reached|26|||
33200848|NCT00439777|100638449|FG001|Treatment Period|Clinical endpoint reached|13|||
33200849|NCT00439777|100638448|FG000|Treatment Period|Technical problems|3|||
33200850|NCT00439777|100638449|FG001|Treatment Period|Technical problems|1|||
33200851|NCT00439777|100638448|FG000|Treatment Period|Participant convenience|12|||
33200852|NCT00439777|100638449|FG001|Treatment Period|Participant convenience|8|||
33200853|NCT00439777|100638448|FG000|Observational Period|Protocol Violation|0|||
33200854|NCT00439777|100638449|FG001|Observational Period|Protocol Violation|2|||
33200855|NCT00439777|100638448|FG000|Observational Period|Withdrawal by Subject|9|||
33200856|NCT00439777|100638449|FG001|Observational Period|Withdrawal by Subject|5|||
33200857|NCT00439777|100638448|FG000|Observational Period|Lost to Follow-up|1|||
33200858|NCT00439777|100638449|FG001|Observational Period|Lost to Follow-up|11|||
33200859|NCT00439777|100638448|FG000|Observational Period|Death|27|||
33200860|NCT00439777|100638449|FG001|Observational Period|Death|20|||
33200861|NCT00439777|100638448|FG000|Observational Period|Study terminated by sponsor|3|||
33200862|NCT00439777|100638449|FG001|Observational Period|Study terminated by sponsor|1|||
33200863|NCT00439777|100638448|FG000|Observational Period|Protocol driven decision point|0|||
33200864|NCT00439777|100638449|FG001|Observational Period|Protocol driven decision point|1|||
33200865|NCT00439777|100638448|FG000|Observational Period|Lack of Efficacy|1|||
33200866|NCT00439777|100638449|FG001|Observational Period|Lack of Efficacy|0|||
33200867|NCT00439777|100638448|FG000|Observational Period|Technical problems|0|||
33200868|NCT00439777|100638449|FG001|Observational Period|Technical problems|1|||
33200869|NCT02401672|100638450|FG000|Overall Study|Withdrawal by Subject|1|||
33200870|NCT02401672|100638451|FG001|Overall Study|Withdrawal by Subject|3|||
33200871|NCT00781326|100638458|FG000|Phase I|Adverse Event|1|||
33200872|NCT00781326|100638458|FG000|Phase I|Withdrawal by Subject|1|||
33200873|NCT00781326|100638458|FG000|Phase I|Physician Decision|2|||
33200874|NCT03073603|100638459|FG000|Overall Study|Noncompliance|3|||
33200875|NCT03073603|100638460|FG001|Overall Study|Noncompliance|1|||
33200876|NCT03073603|100638459|FG000|Overall Study|Adverse Event|5|||
33328573|NCT01033825|101097419|FG000|Overall Study|Withdrawal by Subject|2|||
33328574|NCT01033825|101097420|FG001|Overall Study|Withdrawal by Subject|3|||
33328575|NCT01033825|101097421|FG002|Overall Study|Withdrawal by Subject|2|||
33328576|NCT01033825|101097422|FG003|Overall Study|Withdrawal by Subject|1|||
33328577|NCT01033825|101097423|FG004|Overall Study|Withdrawal by Subject|1|||
33609017|NCT01918332|102118523|FG002|Overall Study|Adverse Event|0|||
33609018|NCT01918332|102118524|FG003|Overall Study|Adverse Event|1|||
33328578|NCT01033825|101097424|FG005|Overall Study|Withdrawal by Subject|0|||
33328579|NCT01033825|101097425|FG006|Overall Study|Withdrawal by Subject|0|||
33328580|NCT01033825|101097419|FG000|Overall Study|Adverse Event|0|||
33328581|NCT01033825|101097420|FG001|Overall Study|Adverse Event|0|||
33328582|NCT01033825|101097421|FG002|Overall Study|Adverse Event|0|||
33328583|NCT01033825|101097422|FG003|Overall Study|Adverse Event|1|||
33328584|NCT01033825|101097423|FG004|Overall Study|Adverse Event|0|||
33328585|NCT01033825|101097424|FG005|Overall Study|Adverse Event|0|||
33328586|NCT01033825|101097425|FG006|Overall Study|Adverse Event|0|||
33328587|NCT01033825|101097419|FG000|Overall Study|Protocol Violation|1|||
33328588|NCT01033825|101097420|FG001|Overall Study|Protocol Violation|0|||
33328589|NCT01033825|101097421|FG002|Overall Study|Protocol Violation|0|||
33328590|NCT01033825|101097422|FG003|Overall Study|Protocol Violation|0|||
33328591|NCT01033825|101097423|FG004|Overall Study|Protocol Violation|0|||
33328592|NCT01033825|101097424|FG005|Overall Study|Protocol Violation|0|||
33328593|NCT01033825|101097425|FG006|Overall Study|Protocol Violation|0|||
33328594|NCT01033825|101097419|FG000|Overall Study|Other|0|||
33328595|NCT01033825|101097420|FG001|Overall Study|Other|0|||
33328596|NCT01033825|101097421|FG002|Overall Study|Other|0|||
33328597|NCT01033825|101097422|FG003|Overall Study|Other|0|||
33328598|NCT01033825|101097423|FG004|Overall Study|Other|1|||
33328599|NCT01033825|101097424|FG005|Overall Study|Other|0|||
33328600|NCT01033825|101097425|FG006|Overall Study|Other|0|||
33328601|NCT01838616|101097428|FG000|Titration Period|Adverse Event|18|||
33328602|NCT01838616|101097429|FG001|Titration Period|Adverse Event|48|||
33328603|NCT01838616|101097428|FG000|Titration Period|Lack of Efficacy|5|||
33328604|NCT01838616|101097429|FG001|Titration Period|Lack of Efficacy|12|||
33328605|NCT01838616|101097428|FG000|Titration Period|Withdrawal by Subject|5|||
33328606|NCT01838616|101097429|FG001|Titration Period|Withdrawal by Subject|5|||
33328607|NCT01838616|101097428|FG000|Titration Period|Technical problems|1|||
33328608|NCT01838616|101097429|FG001|Titration Period|Technical problems|0|||
33328609|NCT01838616|101097428|FG000|Titration Period|Other|1|||
33328610|NCT01838616|101097429|FG001|Titration Period|Other|0|||
33328611|NCT01838616|101097428|FG000|Titration Period|Protocol Violation|0|||
33328612|NCT01838616|101097429|FG001|Titration Period|Protocol Violation|1|||
33328613|NCT01838616|101097428|FG000|Continuation Period|Lack of Efficacy|3|||
33328614|NCT01838616|101097429|FG001|Continuation Period|Lack of Efficacy|5|||
33328615|NCT01838616|101097428|FG000|Continuation Period|Adverse Event|8|||
33328616|NCT01838616|101097429|FG001|Continuation Period|Adverse Event|4|||
33328617|NCT01838616|101097428|FG000|Continuation Period|Protocol Violation|2|||
33328618|NCT01838616|101097429|FG001|Continuation Period|Protocol Violation|0|||
33328619|NCT01838616|101097428|FG000|Continuation Period|Lost to Follow-up|1|||
33328620|NCT01838616|101097429|FG001|Continuation Period|Lost to Follow-up|0|||
33328621|NCT01838616|101097428|FG000|Continuation Period|Withdrawal by Subject|0|||
33328622|NCT01838616|101097429|FG001|Continuation Period|Withdrawal by Subject|4|||
33328623|NCT01838616|101097428|FG000|Continuation Period|Technical problems|0|||
33328624|NCT01838616|101097429|FG001|Continuation Period|Technical problems|1|||
33328625|NCT01838616|101097428|FG000|Pick-up Arm|Lack of Efficacy|4|||
33328626|NCT01838616|101097429|FG001|Pick-up Arm|Lack of Efficacy|0|||
33328627|NCT01838616|101097428|FG000|Pick-up Arm|Adverse Event|9|||
33328628|NCT01838616|101097429|FG001|Pick-up Arm|Adverse Event|0|||
33328629|NCT01838616|101097428|FG000|Pick-up Arm|Withdrawal by Subject|1|||
33609019|NCT01918332|102118521|FG000|Overall Study|Withdrawal by Subject|2|||
33328630|NCT01838616|101097429|FG001|Pick-up Arm|Withdrawal by Subject|0|||
33328631|NCT01838616|101097428|FG000|Pick-up Arm|Technical problems|1|||
33328632|NCT01838616|101097429|FG001|Pick-up Arm|Technical problems|0|||
33328633|NCT02700412|101097437|FG000|Overall Study|Adverse Event|6|||
33328634|NCT02700412|101097437|FG000|Overall Study|Death|1|||
33328635|NCT02700412|101097437|FG000|Overall Study|Lack of Efficacy|19|||
33328636|NCT02700412|101097437|FG000|Overall Study|Protocol Violation|5|||
33328637|NCT02700412|101097437|FG000|Overall Study|Withdrawal by Subject|2|||
33328638|NCT02664272|101097438|FG000|Overall Study|Fluoroscopic images not made available|2|||
33328639|NCT01365039|101097439|FG000|Overall Study|Study related symptoms and complaints|1|||
33328640|NCT01365039|101097440|FG001|Overall Study|Study related symptoms and complaints|0|||
33328641|NCT00545298|101097441|FG000|Overall Study|Issues with Standard of Care|2|||
33328642|NCT00545298|101097442|FG001|Overall Study|Issues with Standard of Care|0|||
33328643|NCT00545298|101097443|FG002|Overall Study|Issues with Standard of Care|1|||
33328644|NCT02437864|101097449|FG000|Overall Study|Protocol Violation|4|||
33328645|NCT02437864|101097450|FG001|Overall Study|Protocol Violation|0|||
33328646|NCT00710879|101097451|FG000|Overall Study|Lost to Follow-up|2|||
33328647|NCT00710879|101097452|FG001|Overall Study|Lost to Follow-up|1|||
33328648|NCT00710879|101097451|FG000|Overall Study|Protocol Violation|0|||
33328649|NCT00710879|101097452|FG001|Overall Study|Protocol Violation|3|||
33328650|NCT03996876|101097453|FG000|Overall Study|Incomplete Data|2|||
33328651|NCT03996876|101097454|FG001|Overall Study|Incomplete Data|4|||
33328652|NCT03159091|101097455|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
33328653|NCT03159091|101097456|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
33328654|NCT03159091|101097455|FG000|Overall Study|Patient has taken no dose of study drug|0|||
33328655|NCT03159091|101097456|FG001|Overall Study|Patient has taken no dose of study drug|1|||
33328656|NCT03680911|101097459|FG000|At Home Treatment|Study Termination|3|||
33328657|NCT03680911|101097460|FG001|At Home Treatment|Study Termination|0|||
33328658|NCT03680911|101097459|FG000|At Home Treatment|Lost to Follow-up|0|||
33328659|NCT03680911|101097460|FG001|At Home Treatment|Lost to Follow-up|1|||
33328660|NCT03680911|101097459|FG000|At Home Treatment|Withdrawal by Subject|0|||
33328661|NCT03680911|101097460|FG001|At Home Treatment|Withdrawal by Subject|2|||
33328662|NCT03680911|101097459|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
33328663|NCT03680911|101097460|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
33328664|NCT03700320|101097461|FG000|Overall Study|Adverse Event|5|||
33328665|NCT03700320|101097462|FG001|Overall Study|Adverse Event|31|||
33328666|NCT03700320|101097461|FG000|Overall Study|Lack of Efficacy|2|||
33328667|NCT03700320|101097462|FG001|Overall Study|Lack of Efficacy|5|||
33328668|NCT03700320|101097461|FG000|Overall Study|Withdrawal by Subject|29|||
33328669|NCT03700320|101097462|FG001|Overall Study|Withdrawal by Subject|75|||
33328670|NCT03700320|101097461|FG000|Overall Study|Lost to Follow-up|16|||
33328671|NCT03700320|101097462|FG001|Overall Study|Lost to Follow-up|23|||
33328672|NCT03700320|101097461|FG000|Overall Study|Pregnancy|2|||
33328673|NCT03700320|101097462|FG001|Overall Study|Pregnancy|4|||
33328674|NCT03700320|101097461|FG000|Overall Study|Protocol Deviation|7|||
33328675|NCT03700320|101097462|FG001|Overall Study|Protocol Deviation|31|||
33328676|NCT03700320|101097461|FG000|Overall Study|Non-compliance with Study Drug|1|||
33328677|NCT03700320|101097462|FG001|Overall Study|Non-compliance with Study Drug|3|||
33328678|NCT03700320|101097461|FG000|Overall Study|Reason not Specified|0|||
33328679|NCT03700320|101097462|FG001|Overall Study|Reason not Specified|1|||
33328680|NCT00552175|101097463|FG000|Overall Study|Lack of Efficacy|2|||
33328681|NCT00552175|101097464|FG001|Overall Study|Lack of Efficacy|0|||
33328682|NCT00552175|101097465|FG002|Overall Study|Lack of Efficacy|1|||
33328683|NCT00552175|101097463|FG000|Overall Study|Adverse Event|9|||
33328684|NCT00552175|101097464|FG001|Overall Study|Adverse Event|9|||
33401354|NCT00808132|101357044|FG003|Overall Study|Death|0|||
33328685|NCT00552175|101097465|FG002|Overall Study|Adverse Event|10|||
33328686|NCT00552175|101097463|FG000|Overall Study|Withdrawal by Subject|2|||
33328687|NCT00552175|101097464|FG001|Overall Study|Withdrawal by Subject|2|||
33401355|NCT00808132|101357045|FG004|Overall Study|Death|1|||
33328688|NCT00552175|101097465|FG002|Overall Study|Withdrawal by Subject|1|||
33328689|NCT00552175|101097463|FG000|Overall Study|Lost to Follow-up|0|||
33328690|NCT00552175|101097464|FG001|Overall Study|Lost to Follow-up|0|||
33328691|NCT00552175|101097465|FG002|Overall Study|Lost to Follow-up|1|||
33328692|NCT00552175|101097463|FG000|Overall Study|Entry Criteria Not Met|1|||
33328693|NCT00552175|101097464|FG001|Overall Study|Entry Criteria Not Met|1|||
33328694|NCT00552175|101097465|FG002|Overall Study|Entry Criteria Not Met|0|||
33328695|NCT00552175|101097463|FG000|Overall Study|Reason Not Specified|3|||
33328696|NCT00552175|101097464|FG001|Overall Study|Reason Not Specified|1|||
33328697|NCT00552175|101097465|FG002|Overall Study|Reason Not Specified|1|||
33328698|NCT01994382|101097466|FG000|Overall Study|Informed consent withdrawn|0|||
33328699|NCT01994382|101097467|FG001|Overall Study|Informed consent withdrawn|0|||
33328700|NCT01994382|101097468|FG002|Overall Study|Informed consent withdrawn|0|||
33328701|NCT01994382|101097469|FG003|Overall Study|Informed consent withdrawn|0|||
33328702|NCT01994382|101097470|FG004|Overall Study|Informed consent withdrawn|0|||
33328703|NCT01994382|101097471|FG005|Overall Study|Informed consent withdrawn|0|||
33328704|NCT01994382|101097472|FG006|Overall Study|Informed consent withdrawn|1|||
33328705|NCT01994382|101097473|FG007|Overall Study|Informed consent withdrawn|0|||
33328706|NCT01994382|101097474|FG008|Overall Study|Informed consent withdrawn|0|||
33328707|NCT01994382|101097475|FG009|Overall Study|Informed consent withdrawn|0|||
33328708|NCT01994382|101097476|FG010|Overall Study|Informed consent withdrawn|0|||
33328709|NCT01994382|101097477|FG011|Overall Study|Informed consent withdrawn|0|||
33328710|NCT01994382|101097478|FG012|Overall Study|Informed consent withdrawn|0|||
33328711|NCT01994382|101097479|FG013|Overall Study|Informed consent withdrawn|0|||
33328712|NCT01994382|101097480|FG014|Overall Study|Informed consent withdrawn|0|||
33328713|NCT01994382|101097481|FG015|Overall Study|Informed consent withdrawn|0|||
33328714|NCT01994382|101097482|FG016|Overall Study|Informed consent withdrawn|0|||
33328715|NCT01994382|101097466|FG000|Overall Study|Progressive disease|3|||
33328716|NCT01994382|101097467|FG001|Overall Study|Progressive disease|4|||
33328717|NCT01994382|101097468|FG002|Overall Study|Progressive disease|4|||
33328718|NCT01994382|101097469|FG003|Overall Study|Progressive disease|3|||
33328719|NCT01994382|101097470|FG004|Overall Study|Progressive disease|2|||
33328720|NCT01994382|101097471|FG005|Overall Study|Progressive disease|3|||
33328721|NCT01994382|101097472|FG006|Overall Study|Progressive disease|3|||
33328722|NCT01994382|101097473|FG007|Overall Study|Progressive disease|6|||
33328723|NCT01994382|101097474|FG008|Overall Study|Progressive disease|2|||
33328724|NCT01994382|101097475|FG009|Overall Study|Progressive disease|2|||
33328725|NCT01994382|101097476|FG010|Overall Study|Progressive disease|13|||
33328726|NCT01994382|101097477|FG011|Overall Study|Progressive disease|8|||
33328727|NCT01994382|101097478|FG012|Overall Study|Progressive disease|7|||
33328728|NCT01994382|101097479|FG013|Overall Study|Progressive disease|3|||
33328729|NCT01994382|101097480|FG014|Overall Study|Progressive disease|6|||
33328730|NCT01994382|101097481|FG015|Overall Study|Progressive disease|44|||
33328731|NCT01994382|101097482|FG016|Overall Study|Progressive disease|28|||
33328732|NCT01994382|101097466|FG000|Overall Study|Physician Decision|0|||
33328733|NCT01994382|101097467|FG001|Overall Study|Physician Decision|1|||
33328734|NCT01994382|101097468|FG002|Overall Study|Physician Decision|0|||
33328735|NCT01994382|101097469|FG003|Overall Study|Physician Decision|0|||
33328736|NCT01994382|101097470|FG004|Overall Study|Physician Decision|0|||
33328737|NCT01994382|101097471|FG005|Overall Study|Physician Decision|0|||
33328738|NCT01994382|101097472|FG006|Overall Study|Physician Decision|0|||
33328739|NCT01994382|101097473|FG007|Overall Study|Physician Decision|0|||
33328740|NCT01994382|101097474|FG008|Overall Study|Physician Decision|0|||
33328741|NCT01994382|101097475|FG009|Overall Study|Physician Decision|0|||
33328742|NCT01994382|101097476|FG010|Overall Study|Physician Decision|3|||
33328743|NCT01994382|101097477|FG011|Overall Study|Physician Decision|1|||
33328744|NCT01994382|101097478|FG012|Overall Study|Physician Decision|1|||
33328745|NCT01994382|101097479|FG013|Overall Study|Physician Decision|0|||
33328746|NCT01994382|101097480|FG014|Overall Study|Physician Decision|1|||
33328747|NCT01994382|101097481|FG015|Overall Study|Physician Decision|4|||
33328748|NCT01994382|101097482|FG016|Overall Study|Physician Decision|2|||
33328749|NCT01994382|101097466|FG000|Overall Study|Death|0|||
33328750|NCT01994382|101097467|FG001|Overall Study|Death|0|||
33328751|NCT01994382|101097468|FG002|Overall Study|Death|0|||
33328752|NCT01994382|101097469|FG003|Overall Study|Death|0|||
33328753|NCT01994382|101097470|FG004|Overall Study|Death|1|||
33328754|NCT01994382|101097471|FG005|Overall Study|Death|0|||
33328755|NCT01994382|101097472|FG006|Overall Study|Death|0|||
33328756|NCT01994382|101097473|FG007|Overall Study|Death|0|||
33328757|NCT01994382|101097474|FG008|Overall Study|Death|1|||
33328758|NCT01994382|101097475|FG009|Overall Study|Death|1|||
33328759|NCT01994382|101097476|FG010|Overall Study|Death|0|||
33328760|NCT01994382|101097477|FG011|Overall Study|Death|0|||
33328761|NCT01994382|101097478|FG012|Overall Study|Death|0|||
33328762|NCT01994382|101097479|FG013|Overall Study|Death|0|||
33328763|NCT01994382|101097480|FG014|Overall Study|Death|0|||
33328764|NCT01994382|101097481|FG015|Overall Study|Death|1|||
33328765|NCT01994382|101097482|FG016|Overall Study|Death|0|||
33328766|NCT01994382|101097466|FG000|Overall Study|Adverse Event|0|||
33328767|NCT01994382|101097467|FG001|Overall Study|Adverse Event|1|||
33328768|NCT01994382|101097468|FG002|Overall Study|Adverse Event|2|||
33328769|NCT01994382|101097469|FG003|Overall Study|Adverse Event|0|||
33328770|NCT01994382|101097470|FG004|Overall Study|Adverse Event|0|||
33328771|NCT01994382|101097471|FG005|Overall Study|Adverse Event|0|||
33328772|NCT01994382|101097472|FG006|Overall Study|Adverse Event|0|||
33328773|NCT01994382|101097473|FG007|Overall Study|Adverse Event|0|||
33328774|NCT01994382|101097474|FG008|Overall Study|Adverse Event|0|||
33328775|NCT01994382|101097475|FG009|Overall Study|Adverse Event|0|||
33328776|NCT01994382|101097476|FG010|Overall Study|Adverse Event|15|||
33328777|NCT01994382|101097477|FG011|Overall Study|Adverse Event|2|||
33328778|NCT01994382|101097478|FG012|Overall Study|Adverse Event|7|||
33328779|NCT01994382|101097479|FG013|Overall Study|Adverse Event|3|||
33328780|NCT01994382|101097480|FG014|Overall Study|Adverse Event|17|||
33328781|NCT01994382|101097481|FG015|Overall Study|Adverse Event|6|||
33328782|NCT01994382|101097482|FG016|Overall Study|Adverse Event|3|||
33328783|NCT01994382|101097466|FG000|Overall Study|Other than specified|0|||
33328784|NCT01994382|101097467|FG001|Overall Study|Other than specified|0|||
33609020|NCT01918332|102118522|FG001|Overall Study|Withdrawal by Subject|3|||
33609021|NCT01918332|102118523|FG002|Overall Study|Withdrawal by Subject|2|||
33609022|NCT01918332|102118524|FG003|Overall Study|Withdrawal by Subject|3|||
33609023|NCT01918332|102118521|FG000|Overall Study|Protocol Violation|6|||
33609024|NCT01918332|102118522|FG001|Overall Study|Protocol Violation|2|||
33609025|NCT01918332|102118523|FG002|Overall Study|Protocol Violation|6|||
33609026|NCT01918332|102118524|FG003|Overall Study|Protocol Violation|3|||
33609027|NCT01918332|102118521|FG000|Overall Study|lipid result by central lab did not meet|0|||
33401356|NCT00808132|101357041|FG000|Overall Study|Physician Decision|0|||
33401357|NCT00808132|101357042|FG001|Overall Study|Physician Decision|1|||
33401358|NCT00808132|101357043|FG002|Overall Study|Physician Decision|0|||
33401359|NCT00808132|101357044|FG003|Overall Study|Physician Decision|0|||
33401360|NCT00808132|101357045|FG004|Overall Study|Physician Decision|0|||
33401361|NCT00808132|101357041|FG000|Overall Study|Lost to Follow-up|8|||
33401362|NCT00808132|101357042|FG001|Overall Study|Lost to Follow-up|10|||
33609028|NCT01918332|102118522|FG001|Overall Study|lipid result by central lab did not meet|0|||
33609029|NCT01918332|102118523|FG002|Overall Study|lipid result by central lab did not meet|1|||
33609030|NCT01918332|102118524|FG003|Overall Study|lipid result by central lab did not meet|0|||
33609031|NCT02831933|102118529|FG000|Overall Study|Physician Decision|11|||
33609032|NCT01374178|102118530|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
33609033|NCT01374178|102118531|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
33609034|NCT01374178|102118530|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
33609035|NCT01374178|102118531|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
33609036|NCT02974842|102118532|FG000|Overall Study|Withdrawal by Subject|4|||
33609037|NCT02974842|102118532|FG000|Overall Study|Screen failures|4|||
33609038|NCT02702414|102118534|FG000|Overall Study|Death|96|||
33609039|NCT02702414|102118535|FG001|Overall Study|Death|42|||
33609040|NCT02702414|102118534|FG000|Overall Study|Lost to Follow-up|0|||
33609041|NCT02702414|102118535|FG001|Overall Study|Lost to Follow-up|1|||
33401363|NCT00808132|101357043|FG002|Overall Study|Lost to Follow-up|11|||
33401364|NCT00808132|101357044|FG003|Overall Study|Lost to Follow-up|8|||
33401365|NCT00808132|101357045|FG004|Overall Study|Lost to Follow-up|9|||
33401366|NCT00808132|101357041|FG000|Overall Study|Protocol Violation|8|||
33401367|NCT00808132|101357042|FG001|Overall Study|Protocol Violation|9|||
33401368|NCT00808132|101357043|FG002|Overall Study|Protocol Violation|4|||
33401369|NCT00808132|101357044|FG003|Overall Study|Protocol Violation|9|||
33401370|NCT00808132|101357045|FG004|Overall Study|Protocol Violation|5|||
33401371|NCT00808132|101357041|FG000|Overall Study|Withdrawal by Subject|27|||
33401372|NCT00808132|101357042|FG001|Overall Study|Withdrawal by Subject|18|||
33401373|NCT00808132|101357043|FG002|Overall Study|Withdrawal by Subject|2|||
33401374|NCT00808132|101357044|FG003|Overall Study|Withdrawal by Subject|7|||
33401375|NCT00808132|101357045|FG004|Overall Study|Withdrawal by Subject|16|||
33401376|NCT00808132|101357041|FG000|Overall Study|Other|6|||
33401377|NCT00808132|101357042|FG001|Overall Study|Other|4|||
33401378|NCT00808132|101357043|FG002|Overall Study|Other|6|||
33401379|NCT00808132|101357044|FG003|Overall Study|Other|2|||
33401380|NCT00808132|101357045|FG004|Overall Study|Other|15|||
33401381|NCT00808132|101357041|FG000|Overall Study|Randomized, but not treated|10|||
33401382|NCT00808132|101357042|FG001|Overall Study|Randomized, but not treated|7|||
33401383|NCT00808132|101357043|FG002|Overall Study|Randomized, but not treated|9|||
33609042|NCT02702414|102118534|FG000|Overall Study|Withdrawal by Subject|0|||
33609043|NCT02702414|102118535|FG001|Overall Study|Withdrawal by Subject|1|||
33401384|NCT00808132|101357044|FG003|Overall Study|Randomized, but not treated|8|||
33200877|NCT03073603|100638460|FG001|Overall Study|Adverse Event|3|||
33401385|NCT00808132|101357045|FG004|Overall Study|Randomized, but not treated|9|||
33401386|NCT00808132|101357041|FG000|Overall Study|Unsatisfactory response|5|||
33401387|NCT00808132|101357042|FG001|Overall Study|Unsatisfactory response|6|||
33401388|NCT00808132|101357043|FG002|Overall Study|Unsatisfactory response|6|||
33401389|NCT00808132|101357044|FG003|Overall Study|Unsatisfactory response|4|||
33401390|NCT00808132|101357045|FG004|Overall Study|Unsatisfactory response|12|||
33200878|NCT03073603|100638459|FG000|Overall Study|Physician Decision|1|||
33200879|NCT03073603|100638460|FG001|Overall Study|Physician Decision|2|||
33200880|NCT03073603|100638459|FG000|Overall Study|Required treatment not allowed by protocol|1|||
33200881|NCT03073603|100638460|FG001|Overall Study|Required treatment not allowed by protocol|0|||
33200882|NCT03073603|100638459|FG000|Overall Study|Financial or insurance-related|8|||
33200883|NCT03073603|100638460|FG001|Overall Study|Financial or insurance-related|0|||
33401391|NCT02908841|101357046|FG000|Overall Study|Physician Decision|4|||
33401392|NCT02908841|101357047|FG001|Overall Study|Physician Decision|0|||
33609044|NCT02702414|102118534|FG000|Overall Study|Protocol Violation|1|||
33609045|NCT02702414|102118535|FG001|Overall Study|Protocol Violation|0|||
33609046|NCT02702414|102118534|FG000|Overall Study|Sponsor Decision|8|||
33609047|NCT02702414|102118535|FG001|Overall Study|Sponsor Decision|7|||
33609048|NCT01532869|102118536|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
33609049|NCT01532869|102118537|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
33200884|NCT03073603|100638459|FG000|Overall Study|Withdrawal by Subject|0|||
33200885|NCT03073603|100638460|FG001|Overall Study|Withdrawal by Subject|1|||
33328785|NCT01994382|101097468|FG002|Overall Study|Other than specified|0|||
33200886|NCT03073603|100638459|FG000|Overall Study|Discontinued DMT|4|||
33328786|NCT01994382|101097469|FG003|Overall Study|Other than specified|0|||
33200887|NCT03073603|100638460|FG001|Overall Study|Discontinued DMT|0|||
33609050|NCT01532869|102118536|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
33609051|NCT01532869|102118537|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
33609052|NCT01532869|102118536|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
33609053|NCT01532869|102118537|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
33609054|NCT01532869|102118536|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
33328787|NCT01994382|101097470|FG004|Overall Study|Other than specified|0|||
33328788|NCT01994382|101097471|FG005|Overall Study|Other than specified|0|||
33328789|NCT01994382|101097472|FG006|Overall Study|Other than specified|0|||
33328790|NCT01994382|101097473|FG007|Overall Study|Other than specified|0|||
33328791|NCT01994382|101097474|FG008|Overall Study|Other than specified|0|||
33328792|NCT01994382|101097475|FG009|Overall Study|Other than specified|0|||
33328793|NCT01994382|101097476|FG010|Overall Study|Other than specified|2|||
33328794|NCT01994382|101097477|FG011|Overall Study|Other than specified|0|||
33328795|NCT01994382|101097478|FG012|Overall Study|Other than specified|2|||
33328796|NCT01994382|101097479|FG013|Overall Study|Other than specified|0|||
33328797|NCT01994382|101097480|FG014|Overall Study|Other than specified|0|||
33328798|NCT01994382|101097481|FG015|Overall Study|Other than specified|4|||
33328799|NCT01994382|101097482|FG016|Overall Study|Other than specified|4|||
33328800|NCT01994382|101097466|FG000|Overall Study|Withdrawal by Subject|0|||
33328801|NCT01994382|101097467|FG001|Overall Study|Withdrawal by Subject|0|||
33328802|NCT01994382|101097468|FG002|Overall Study|Withdrawal by Subject|0|||
33328803|NCT01994382|101097469|FG003|Overall Study|Withdrawal by Subject|0|||
33328804|NCT01994382|101097470|FG004|Overall Study|Withdrawal by Subject|0|||
33328805|NCT01994382|101097471|FG005|Overall Study|Withdrawal by Subject|0|||
33328806|NCT01994382|101097472|FG006|Overall Study|Withdrawal by Subject|0|||
33328807|NCT01994382|101097473|FG007|Overall Study|Withdrawal by Subject|0|||
33328808|NCT01994382|101097474|FG008|Overall Study|Withdrawal by Subject|0|||
33609055|NCT01532869|102118537|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
33609056|NCT01532869|102118536|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
33328809|NCT01994382|101097475|FG009|Overall Study|Withdrawal by Subject|0|||
33328810|NCT01994382|101097476|FG010|Overall Study|Withdrawal by Subject|6|||
33328811|NCT01994382|101097477|FG011|Overall Study|Withdrawal by Subject|0|||
33609057|NCT01532869|102118537|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
33609058|NCT01532869|102118536|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
33328812|NCT01994382|101097478|FG012|Overall Study|Withdrawal by Subject|2|||
33328813|NCT01994382|101097479|FG013|Overall Study|Withdrawal by Subject|0|||
33328814|NCT01994382|101097480|FG014|Overall Study|Withdrawal by Subject|4|||
33328815|NCT01994382|101097481|FG015|Overall Study|Withdrawal by Subject|3|||
33328816|NCT01994382|101097482|FG016|Overall Study|Withdrawal by Subject|0|||
33328817|NCT01994382|101097466|FG000|Overall Study|Lost to Follow-up|0|||
33328818|NCT01994382|101097467|FG001|Overall Study|Lost to Follow-up|0|||
33328819|NCT01994382|101097468|FG002|Overall Study|Lost to Follow-up|0|||
33328820|NCT01994382|101097469|FG003|Overall Study|Lost to Follow-up|0|||
33328821|NCT01994382|101097470|FG004|Overall Study|Lost to Follow-up|0|||
33328822|NCT01994382|101097471|FG005|Overall Study|Lost to Follow-up|0|||
33328823|NCT01994382|101097472|FG006|Overall Study|Lost to Follow-up|0|||
33328824|NCT01994382|101097473|FG007|Overall Study|Lost to Follow-up|0|||
33328825|NCT01994382|101097474|FG008|Overall Study|Lost to Follow-up|0|||
33328826|NCT01994382|101097475|FG009|Overall Study|Lost to Follow-up|0|||
33328827|NCT01994382|101097476|FG010|Overall Study|Lost to Follow-up|1|||
33328828|NCT01994382|101097477|FG011|Overall Study|Lost to Follow-up|0|||
33328829|NCT01994382|101097478|FG012|Overall Study|Lost to Follow-up|0|||
33328830|NCT01994382|101097479|FG013|Overall Study|Lost to Follow-up|0|||
33328831|NCT01994382|101097480|FG014|Overall Study|Lost to Follow-up|0|||
33328832|NCT01994382|101097481|FG015|Overall Study|Lost to Follow-up|0|||
33328833|NCT01994382|101097482|FG016|Overall Study|Lost to Follow-up|0|||
33328834|NCT01994382|101097466|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33328835|NCT01994382|101097467|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33401393|NCT01474993|101357048|FG000|Overall Study|Lost to Follow-up|1|||
33401394|NCT01474993|101357049|FG001|Overall Study|Lost to Follow-up|2|||
33401395|NCT01474993|101357048|FG000|Overall Study|Adverse Event|0|||
33401396|NCT01474993|101357049|FG001|Overall Study|Adverse Event|1|||
33328836|NCT01994382|101097468|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33328837|NCT01994382|101097469|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33328838|NCT01994382|101097470|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33328839|NCT01994382|101097471|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33328840|NCT01994382|101097472|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33328841|NCT01994382|101097473|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33328842|NCT01994382|101097474|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33328843|NCT01994382|101097475|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33328844|NCT01994382|101097476|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
33328845|NCT01994382|101097477|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33328846|NCT01994382|101097478|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
33328847|NCT01994382|101097479|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33328848|NCT01994382|101097480|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
33328849|NCT01994382|101097481|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
33328850|NCT01994382|101097482|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
33328851|NCT01994382|101097466|FG000|Overall Study|Protocol violation/noncompliance|0|||
33328852|NCT01994382|101097467|FG001|Overall Study|Protocol violation/noncompliance|0|||
33401397|NCT03347279|101357050|FG000|Overall Study|Withdrawal by Subject|8|||
33401398|NCT03347279|101357051|FG001|Overall Study|Withdrawal by Subject|15|||
33401399|NCT03347279|101357050|FG000|Overall Study|Death|0|||
33401400|NCT03347279|101357051|FG001|Overall Study|Death|2|||
33401401|NCT03347279|101357050|FG000|Overall Study|Lost to Follow-up|5|||
33401402|NCT03347279|101357051|FG001|Overall Study|Lost to Follow-up|2|||
33401403|NCT03347279|101357050|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
33401404|NCT03347279|101357051|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
33401405|NCT00095836|101357053|FG000|Overall Study|Lost to Follow-up|1|||
33401406|NCT00095836|101357053|FG000|Overall Study|Adverse Event|1|||
33401407|NCT00095836|101357053|FG000|Overall Study|Death|2|||
33401408|NCT00736385|101357055|FG000|Overall Study|Withdrawal by Subject|2|||
33401409|NCT00736385|101357056|FG001|Overall Study|Withdrawal by Subject|2|||
33328853|NCT01994382|101097468|FG002|Overall Study|Protocol violation/noncompliance|0|||
33328854|NCT01994382|101097469|FG003|Overall Study|Protocol violation/noncompliance|0|||
33328855|NCT01994382|101097470|FG004|Overall Study|Protocol violation/noncompliance|0|||
33328856|NCT01994382|101097471|FG005|Overall Study|Protocol violation/noncompliance|0|||
33328857|NCT01994382|101097472|FG006|Overall Study|Protocol violation/noncompliance|0|||
33328858|NCT01994382|101097473|FG007|Overall Study|Protocol violation/noncompliance|0|||
33328859|NCT01994382|101097474|FG008|Overall Study|Protocol violation/noncompliance|0|||
33328860|NCT01994382|101097475|FG009|Overall Study|Protocol violation/noncompliance|0|||
33328861|NCT01994382|101097476|FG010|Overall Study|Protocol violation/noncompliance|0|||
33328862|NCT01994382|101097477|FG011|Overall Study|Protocol violation/noncompliance|1|||
33328863|NCT01994382|101097478|FG012|Overall Study|Protocol violation/noncompliance|0|||
33328864|NCT01994382|101097479|FG013|Overall Study|Protocol violation/noncompliance|0|||
33328865|NCT01994382|101097480|FG014|Overall Study|Protocol violation/noncompliance|0|||
33328866|NCT01994382|101097481|FG015|Overall Study|Protocol violation/noncompliance|0|||
33328867|NCT01994382|101097482|FG016|Overall Study|Protocol violation/noncompliance|2|||
33328868|NCT01994382|101097466|FG000|Overall Study|Rolled over to Phase 2a|0|||
33328869|NCT01994382|101097467|FG001|Overall Study|Rolled over to Phase 2a|0|||
33328870|NCT01994382|101097468|FG002|Overall Study|Rolled over to Phase 2a|1|||
33328871|NCT01994382|101097469|FG003|Overall Study|Rolled over to Phase 2a|0|||
33328872|NCT01994382|101097470|FG004|Overall Study|Rolled over to Phase 2a|0|||
33328873|NCT01994382|101097471|FG005|Overall Study|Rolled over to Phase 2a|0|||
33328874|NCT01994382|101097472|FG006|Overall Study|Rolled over to Phase 2a|0|||
33328875|NCT01994382|101097473|FG007|Overall Study|Rolled over to Phase 2a|0|||
33328876|NCT01994382|101097474|FG008|Overall Study|Rolled over to Phase 2a|0|||
33328877|NCT01994382|101097475|FG009|Overall Study|Rolled over to Phase 2a|2|||
33328878|NCT01994382|101097476|FG010|Overall Study|Rolled over to Phase 2a|0|||
33328879|NCT01994382|101097477|FG011|Overall Study|Rolled over to Phase 2a|0|||
33328880|NCT01994382|101097478|FG012|Overall Study|Rolled over to Phase 2a|0|||
33328881|NCT01994382|101097479|FG013|Overall Study|Rolled over to Phase 2a|0|||
33328882|NCT01994382|101097480|FG014|Overall Study|Rolled over to Phase 2a|0|||
33401410|NCT00736385|101357055|FG000|Overall Study|Adverse Event|0|||
33328883|NCT01994382|101097481|FG015|Overall Study|Rolled over to Phase 2a|0|||
33328884|NCT01994382|101097482|FG016|Overall Study|Rolled over to Phase 2a|0|||
33401411|NCT00736385|101357056|FG001|Overall Study|Adverse Event|1|||
33200888|NCT03073603|100638459|FG000|Overall Study|Restarted DMT|0|||
33200889|NCT03073603|100638460|FG001|Overall Study|Restarted DMT|1|||
33609059|NCT01532869|102118537|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
33609060|NCT01532869|102118536|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
33609061|NCT01532869|102118537|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
33609062|NCT01532869|102118536|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
33609063|NCT01532869|102118537|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
33609064|NCT01532869|102118536|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
33609065|NCT01532869|102118537|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
33609066|NCT01532869|102118536|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
33609067|NCT01532869|102118537|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
33609068|NCT01532869|102118536|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
33609069|NCT01532869|102118537|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
33609070|NCT01532869|102118536|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
33609071|NCT01532869|102118537|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
33609072|NCT01532869|102118536|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
33609073|NCT01532869|102118537|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
33200890|NCT02117570|100638461|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
33200891|NCT02117570|100638462|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
33200892|NCT02117570|100638463|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
33521958|NCT05052697|101807753|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521959|NCT05052697|101807754|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521960|NCT05052697|101807755|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521961|NCT05052697|101807756|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521962|NCT05052697|101807757|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
33521963|NCT05052697|101807758|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521964|NCT05052697|101807759|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
33328885|NCT02713542|101097483|FG000|Overall Study|Use of prohibited medication|14|||
33328886|NCT02713542|101097484|FG001|Overall Study|Use of prohibited medication|5|||
33328887|NCT02713542|101097483|FG000|Overall Study|Withdrawal by Subject|4|||
33521965|NCT05052697|101807760|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521966|NCT05052697|101807761|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521967|NCT05052697|101807762|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521968|NCT05052697|101807763|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521969|NCT05052697|101807764|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521970|NCT05052697|101807765|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521971|NCT05052697|101807766|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521972|NCT05052697|101807767|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521973|NCT05052697|101807768|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521974|NCT05052697|101807769|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521975|NCT05052697|101807770|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521976|NCT05052697|101807771|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521977|NCT05052697|101807772|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521978|NCT05052697|101807773|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
33521979|NCT05052697|101807740|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521980|NCT05052697|101807741|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521981|NCT05052697|101807742|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521982|NCT05052697|101807743|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33328888|NCT02713542|101097484|FG001|Overall Study|Withdrawal by Subject|1|||
33328889|NCT00974675|101097485|FG000|Overall Study|Adverse Event|2|||
33328890|NCT00974675|101097486|FG001|Overall Study|Adverse Event|1|||
33328891|NCT00974675|101097487|FG002|Overall Study|Adverse Event|1|||
33328892|NCT00974675|101097488|FG003|Overall Study|Adverse Event|1|||
33328893|NCT00974675|101097485|FG000|Overall Study|Physician Decision|0|||
33328894|NCT00974675|101097486|FG001|Overall Study|Physician Decision|0|||
33328895|NCT00974675|101097487|FG002|Overall Study|Physician Decision|1|||
33328896|NCT00974675|101097488|FG003|Overall Study|Physician Decision|0|||
33521983|NCT05052697|101807744|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521984|NCT05052697|101807745|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521985|NCT05052697|101807746|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521986|NCT05052697|101807747|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521987|NCT05052697|101807748|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521988|NCT05052697|101807749|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521989|NCT05052697|101807750|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521990|NCT05052697|101807751|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521991|NCT05052697|101807752|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521992|NCT05052697|101807753|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521993|NCT05052697|101807754|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521994|NCT05052697|101807755|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521995|NCT05052697|101807756|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521996|NCT05052697|101807757|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521997|NCT05052697|101807758|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33521998|NCT05052697|101807759|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
33521999|NCT05052697|101807760|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33522000|NCT05052697|101807761|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33522001|NCT05052697|101807762|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33522002|NCT05052697|101807763|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33522003|NCT05052697|101807764|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33522004|NCT05052697|101807765|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33522005|NCT05052697|101807766|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33328897|NCT00974675|101097485|FG000|Overall Study|Participant on holiday; unable to attend|0|||
33328898|NCT00974675|101097486|FG001|Overall Study|Participant on holiday; unable to attend|0|||
33328899|NCT00974675|101097487|FG002|Overall Study|Participant on holiday; unable to attend|0|||
33522006|NCT05052697|101807767|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33522007|NCT05052697|101807768|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33522008|NCT05052697|101807769|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33522009|NCT05052697|101807770|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33522010|NCT05052697|101807771|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33522011|NCT05052697|101807772|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33522012|NCT05052697|101807773|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
33522013|NCT05052697|101807740|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522014|NCT05052697|101807741|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522015|NCT05052697|101807742|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522016|NCT05052697|101807743|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522017|NCT05052697|101807744|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522018|NCT05052697|101807745|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522019|NCT05052697|101807746|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522020|NCT05052697|101807747|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522021|NCT05052697|101807748|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522022|NCT05052697|101807749|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522023|NCT05052697|101807750|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522024|NCT05052697|101807751|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522025|NCT05052697|101807752|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522026|NCT05052697|101807753|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522027|NCT05052697|101807754|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522028|NCT05052697|101807755|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522029|NCT05052697|101807756|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522030|NCT05052697|101807757|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
33522031|NCT05052697|101807758|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522032|NCT05052697|101807759|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522033|NCT05052697|101807760|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522034|NCT05052697|101807761|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522035|NCT05052697|101807762|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522036|NCT05052697|101807763|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33609074|NCT01532869|102118536|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
33522037|NCT05052697|101807764|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522038|NCT05052697|101807765|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
33522039|NCT05052697|101807766|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522040|NCT05052697|101807767|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
33522041|NCT05052697|101807768|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522042|NCT05052697|101807769|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522043|NCT05052697|101807770|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522044|NCT05052697|101807771|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522045|NCT05052697|101807772|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522046|NCT05052697|101807773|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
33522047|NCT05052697|101807740|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522048|NCT05052697|101807741|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522049|NCT05052697|101807742|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522050|NCT05052697|101807743|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522051|NCT05052697|101807744|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522052|NCT05052697|101807745|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522053|NCT05052697|101807746|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522054|NCT05052697|101807747|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522055|NCT05052697|101807748|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522056|NCT05052697|101807749|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522057|NCT05052697|101807750|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522058|NCT05052697|101807751|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522059|NCT05052697|101807752|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522060|NCT05052697|101807753|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522061|NCT05052697|101807754|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522062|NCT05052697|101807755|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33609075|NCT01532869|102118537|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
33609076|NCT01532869|102118536|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
33609077|NCT01532869|102118537|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
33522063|NCT05052697|101807756|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33609078|NCT01532869|102118536|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
33609079|NCT01532869|102118537|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
33522064|NCT05052697|101807757|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522065|NCT05052697|101807758|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522066|NCT05052697|101807759|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522067|NCT05052697|101807760|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522068|NCT05052697|101807761|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522069|NCT05052697|101807762|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522070|NCT05052697|101807763|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522071|NCT05052697|101807764|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522072|NCT05052697|101807765|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522073|NCT05052697|101807766|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522074|NCT05052697|101807767|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522075|NCT05052697|101807768|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
33522076|NCT05052697|101807769|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522077|NCT05052697|101807770|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
33522078|NCT05052697|101807771|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
33522079|NCT05052697|101807772|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
33522080|NCT05052697|101807773|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
33522081|NCT05052697|101807740|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33328900|NCT00974675|101097488|FG003|Overall Study|Participant on holiday; unable to attend|1|||
33328901|NCT02285998|101097496|FG000|Overall Study|Adverse Event|9|||
33328902|NCT02285998|101097497|FG001|Overall Study|Adverse Event|8|||
33522082|NCT05052697|101807741|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522083|NCT05052697|101807742|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522084|NCT05052697|101807743|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522085|NCT05052697|101807744|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522086|NCT05052697|101807745|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522087|NCT05052697|101807746|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522088|NCT05052697|101807747|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33328903|NCT02285998|101097496|FG000|Overall Study|Physician Decision|1|||
33328904|NCT02285998|101097497|FG001|Overall Study|Physician Decision|2|||
33522089|NCT05052697|101807748|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522090|NCT05052697|101807749|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522091|NCT05052697|101807750|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522092|NCT05052697|101807751|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522093|NCT05052697|101807752|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522094|NCT05052697|101807753|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33328905|NCT02285998|101097496|FG000|Overall Study|Lost to Follow-up|176|||
33522095|NCT05052697|101807754|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522096|NCT05052697|101807755|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522097|NCT05052697|101807756|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522098|NCT05052697|101807757|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522099|NCT05052697|101807758|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522100|NCT05052697|101807759|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522101|NCT05052697|101807760|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522102|NCT05052697|101807761|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522103|NCT05052697|101807762|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522104|NCT05052697|101807763|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33328906|NCT02285998|101097497|FG001|Overall Study|Lost to Follow-up|172|||
33328907|NCT02285998|101097496|FG000|Overall Study|Withdrawal by Subject|53|||
33328908|NCT02285998|101097497|FG001|Overall Study|Withdrawal by Subject|61|||
33328909|NCT02285998|101097496|FG000|Overall Study|Other Reasons|7|||
33328910|NCT02285998|101097497|FG001|Overall Study|Other Reasons|10|||
33328911|NCT00589420|101097498|FG000|Overall Study|screen failure|1|||
33328912|NCT01328951|101097499|FG000|Overall Study|Disease Progression|17|||
33328913|NCT01328951|101097500|FG001|Overall Study|Disease Progression|14|||
33328914|NCT01328951|101097499|FG000|Overall Study|Adverse Event|2|||
33328915|NCT01328951|101097500|FG001|Overall Study|Adverse Event|0|||
33328916|NCT01328951|101097499|FG000|Overall Study|Death|243|||
33328917|NCT01328951|101097500|FG001|Overall Study|Death|258|||
33328918|NCT01328951|101097499|FG000|Overall Study|Lost to Follow-up|6|||
33328919|NCT01328951|101097500|FG001|Overall Study|Lost to Follow-up|7|||
33328920|NCT01328951|101097499|FG000|Overall Study|Withdrawal by Subject|6|||
33522105|NCT05052697|101807764|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522106|NCT05052697|101807765|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522107|NCT05052697|101807766|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522108|NCT05052697|101807767|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522109|NCT05052697|101807768|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
33522110|NCT05052697|101807769|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
33328921|NCT01328951|101097500|FG001|Overall Study|Withdrawal by Subject|6|||
33522111|NCT05052697|101807770|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
33328922|NCT01328951|101097499|FG000|Overall Study|Study Closed by the Sponsor|36|||
33328923|NCT01328951|101097500|FG001|Overall Study|Study Closed by the Sponsor|31|||
33328924|NCT01328951|101097499|FG000|Overall Study|Other|11|||
33328925|NCT01328951|101097500|FG001|Overall Study|Other|6|||
33401412|NCT02200510|101357058|FG000|Overall Study|Death|1|||
33401413|NCT02200510|101357059|FG001|Overall Study|Death|1|||
33401414|NCT02200510|101357058|FG000|Overall Study|Protocol Violation|0|||
33401415|NCT02200510|101357059|FG001|Overall Study|Protocol Violation|1|||
33401416|NCT02200510|101357058|FG000|Overall Study|Lost to Follow-up|7|||
33401417|NCT02200510|101357059|FG001|Overall Study|Lost to Follow-up|1|||
33401418|NCT02200510|101357058|FG000|Overall Study|potential COI - joined study team|1|||
33522112|NCT05052697|101807771|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
33522113|NCT05052697|101807772|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
33522114|NCT05052697|101807773|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
33522115|NCT05052697|101807740|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522116|NCT05052697|101807741|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522117|NCT05052697|101807742|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522118|NCT05052697|101807743|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522119|NCT05052697|101807744|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522120|NCT05052697|101807745|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522121|NCT05052697|101807746|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522122|NCT05052697|101807747|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522123|NCT05052697|101807748|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522124|NCT05052697|101807749|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522125|NCT05052697|101807750|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522126|NCT05052697|101807751|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522127|NCT05052697|101807752|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522128|NCT05052697|101807753|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522129|NCT05052697|101807754|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522130|NCT05052697|101807755|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522131|NCT05052697|101807756|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522132|NCT05052697|101807757|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522133|NCT05052697|101807758|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522134|NCT05052697|101807759|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522135|NCT05052697|101807760|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522136|NCT05052697|101807761|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522137|NCT05052697|101807762|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522138|NCT05052697|101807763|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522139|NCT05052697|101807764|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522140|NCT05052697|101807765|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522141|NCT05052697|101807766|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522142|NCT05052697|101807767|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522143|NCT05052697|101807768|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522144|NCT05052697|101807769|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33328926|NCT02865018|101097501|FG000|Overall Study|Withdrawal by Subject|1|||
33328927|NCT01877187|101097503|FG000|Overall Study|Death|2|||
33328928|NCT01877187|101097503|FG000|Overall Study|Withdrawal by Subject|4|||
33328929|NCT01877187|101097503|FG000|Overall Study|Lost to Follow-up|3|||
33328930|NCT01877187|101097503|FG000|Overall Study|Declining clinical status|11|||
33328931|NCT01877187|101097503|FG000|Overall Study|Liver transplant|2|||
33328932|NCT00254501|101097510|FG000|Overall Study|Lost to Follow-up|1|||
33328933|NCT00254501|101097511|FG001|Overall Study|Lost to Follow-up|1|||
33328934|NCT00219284|101097512|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
33328935|NCT00219284|101097513|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
33328936|NCT00219284|101097512|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
33328937|NCT00219284|101097513|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
33328938|NCT00219284|101097512|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
33328939|NCT00219284|101097513|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
33328940|NCT00219284|101097512|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
33328941|NCT00219284|101097513|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
33328942|NCT00219284|101097512|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
33328943|NCT00219284|101097513|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
33401419|NCT02200510|101357059|FG001|Overall Study|potential COI - joined study team|0|||
33522145|NCT05052697|101807770|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33328944|NCT00219284|101097512|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
33328945|NCT00219284|101097513|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
33401420|NCT03233308|101357060|FG000|Overall Study|Adverse Event|1|||
33401421|NCT03233308|101357060|FG000|Overall Study|Protocol Violation|1|||
33522146|NCT05052697|101807771|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33522147|NCT05052697|101807772|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
33522148|NCT05052697|101807773|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
33609080|NCT01532869|102118536|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
33200893|NCT02117570|100638461|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
33200894|NCT02117570|100638462|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
33200895|NCT02117570|100638463|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
33200896|NCT02117570|100638461|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
33200897|NCT02117570|100638462|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
33200898|NCT02117570|100638463|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
33200899|NCT02117570|100638461|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
33328946|NCT00219284|101097512|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
33328947|NCT00219284|101097513|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
33328948|NCT00219284|101097512|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
33328949|NCT00219284|101097513|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
33328950|NCT00219284|101097512|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
33328951|NCT00219284|101097513|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
33328952|NCT04544475|101097515|FG000|Overall Study|Withdrawal by Subject|1|||
33328953|NCT04544475|101097516|FG001|Overall Study|Withdrawal by Subject|3|||
33328954|NCT01648790|101097517|FG000|Treatment 3|Withdrawal by Subject|0|||
33328955|NCT01648790|101097518|FG001|Treatment 3|Withdrawal by Subject|0|||
33328956|NCT01648790|101097519|FG002|Treatment 3|Withdrawal by Subject|0|||
33328957|NCT01648790|101097520|FG003|Treatment 3|Withdrawal by Subject|1|||
33609081|NCT01532869|102118537|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
33609082|NCT01105377|102118546|FG000|Overall Study|Withdrawal by Subject|0|||
33609083|NCT01105377|102118547|FG001|Overall Study|Withdrawal by Subject|1|||
33609084|NCT03761810|102118550|FG000|Overall Study|Adverse Event|12|||
33328958|NCT01648790|101097521|FG004|Treatment 3|Withdrawal by Subject|0|||
33328959|NCT00761306|101097522|FG000|Overall Study|Adverse Event|5|||
33328960|NCT00761306|101097522|FG000|Overall Study|Lack of Efficacy|4|||
33328961|NCT00761306|101097522|FG000|Overall Study|Protocol Violation|2|||
33328962|NCT00761306|101097522|FG000|Overall Study|Withdrawal of Consent|3|||
33328963|NCT00761306|101097522|FG000|Overall Study|Lost to Follow-up|1|||
33328964|NCT00761306|101097522|FG000|Overall Study|Administrative or Other Reasons|5|||
33328965|NCT05162027|101100976|FG000|Overall Study|Adverse Event|1|||
33328966|NCT05162027|101100977|FG001|Overall Study|Adverse Event|0|||
33328967|NCT01816061|101100980|FG000|Overall Study|Lost to Follow-up|13|||
33328968|NCT01816061|101100981|FG001|Overall Study|Lost to Follow-up|24|||
33328969|NCT00806195|101100985|FG000|Overall Study|Death|6|||
33328970|NCT00806195|101100986|FG001|Overall Study|Death|0|||
33328971|NCT00806195|101100987|FG002|Overall Study|Death|1|||
33328972|NCT00806195|101100988|FG003|Overall Study|Death|0|||
33328973|NCT00806195|101100985|FG000|Overall Study|Adverse Event|25|||
33328974|NCT00806195|101100986|FG001|Overall Study|Adverse Event|5|||
33328975|NCT00806195|101100987|FG002|Overall Study|Adverse Event|11|||
33328976|NCT00806195|101100988|FG003|Overall Study|Adverse Event|2|||
33328977|NCT00806195|101100985|FG000|Overall Study|Withdrawal by Subject|119|||
33328978|NCT00806195|101100986|FG001|Overall Study|Withdrawal by Subject|31|||
33328979|NCT00806195|101100987|FG002|Overall Study|Withdrawal by Subject|76|||
33328980|NCT00806195|101100988|FG003|Overall Study|Withdrawal by Subject|35|||
33328981|NCT00806195|101100985|FG000|Overall Study|Lost to Follow-up|217|||
33522149|NCT05052697|101807740|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522150|NCT05052697|101807741|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522151|NCT05052697|101807742|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522152|NCT05052697|101807743|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522153|NCT05052697|101807744|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522154|NCT05052697|101807745|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33401422|NCT01875731|101357065|FG000|Overall Study|Fail to obtain lab sample|1|||
33522155|NCT05052697|101807746|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522156|NCT05052697|101807747|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522157|NCT05052697|101807748|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33609085|NCT03761810|102118551|FG001|Overall Study|Adverse Event|0|||
33609086|NCT03761810|102118550|FG000|Overall Study|Lost to Follow-up|15|||
33609087|NCT03761810|102118551|FG001|Overall Study|Lost to Follow-up|7|||
33609088|NCT03761810|102118550|FG000|Overall Study|Pregnancy|1|||
33609089|NCT03761810|102118551|FG001|Overall Study|Pregnancy|0|||
33328982|NCT00806195|101100986|FG001|Overall Study|Lost to Follow-up|66|||
33328983|NCT00806195|101100987|FG002|Overall Study|Lost to Follow-up|90|||
33328984|NCT00806195|101100988|FG003|Overall Study|Lost to Follow-up|34|||
33609090|NCT03761810|102118550|FG000|Overall Study|Withdrawal by Subject|14|||
33328985|NCT00806195|101100985|FG000|Overall Study|Inappropriate Enrollment|0|||
33328986|NCT00806195|101100986|FG001|Overall Study|Inappropriate Enrollment|1|||
33328987|NCT00806195|101100987|FG002|Overall Study|Inappropriate Enrollment|0|||
33328988|NCT00806195|101100988|FG003|Overall Study|Inappropriate Enrollment|0|||
33328989|NCT00806195|101100985|FG000|Overall Study|Administrative Reason|113|||
33328990|NCT00806195|101100986|FG001|Overall Study|Administrative Reason|35|||
33328991|NCT00806195|101100987|FG002|Overall Study|Administrative Reason|66|||
33328992|NCT00806195|101100988|FG003|Overall Study|Administrative Reason|26|||
33328993|NCT00806195|101100985|FG000|Overall Study|Protocol Violation|34|||
33328994|NCT00806195|101100986|FG001|Overall Study|Protocol Violation|24|||
33328995|NCT00806195|101100987|FG002|Overall Study|Protocol Violation|26|||
33328996|NCT00806195|101100988|FG003|Overall Study|Protocol Violation|9|||
33328997|NCT01793142|101100989|FG000|Overall Study|Randomized not treated|7|||
33328998|NCT04206605|101100992|FG000|Overall Study|Adverse Event|0|||
33328999|NCT04206605|101100993|FG001|Overall Study|Adverse Event|1|||
33401423|NCT01875731|101357066|FG001|Overall Study|Fail to obtain lab sample|0|||
33401424|NCT01373294|101357070|FG000|Overall Study|Adverse Event|1|||
33522158|NCT05052697|101807749|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522159|NCT05052697|101807750|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522160|NCT05052697|101807751|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522161|NCT05052697|101807752|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522162|NCT05052697|101807753|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522163|NCT05052697|101807754|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522164|NCT05052697|101807755|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522165|NCT05052697|101807756|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522166|NCT05052697|101807757|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522167|NCT05052697|101807758|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522168|NCT05052697|101807759|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522169|NCT05052697|101807760|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522170|NCT05052697|101807761|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522171|NCT05052697|101807762|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522172|NCT05052697|101807763|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522173|NCT05052697|101807764|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522174|NCT05052697|101807765|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522175|NCT05052697|101807766|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522176|NCT05052697|101807767|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522177|NCT05052697|101807768|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
33522178|NCT05052697|101807769|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
33522179|NCT05052697|101807770|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
33522180|NCT05052697|101807771|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522181|NCT05052697|101807772|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522182|NCT05052697|101807773|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
33522183|NCT00435188|101807774|FG000|Overall Study|Death|1|||
33522184|NCT00435188|101807775|FG001|Overall Study|Death|6|||
33522185|NCT00435188|101807774|FG000|Overall Study|Withdrawal by Subject|16|||
33522186|NCT00435188|101807775|FG001|Overall Study|Withdrawal by Subject|11|||
33522187|NCT00435188|101807774|FG000|Overall Study|Lost to Follow-up|5|||
33522188|NCT00435188|101807775|FG001|Overall Study|Lost to Follow-up|6|||
33522189|NCT02385110|101807776|FG000|Overall Study|Early Death|1|||
33522190|NCT02385110|101807777|FG001|Overall Study|Early Death|0|||
33522191|NCT04933617|101807779|FG000|Dose Escalation|Early closure of study|0|||
33522192|NCT04933617|101807780|FG001|Dose Escalation|Early closure of study|3|||
33522193|NCT04933617|101807781|FG002|Dose Escalation|Early closure of study|0|||
33522194|NCT04933617|101807782|FG003|Dose Escalation|Early closure of study|0|||
33522195|NCT04933617|101807783|FG004|Dose Escalation|Early closure of study|0|||
33522196|NCT04575584|101807784|FG000|Overall Study|Death|6|||
33522197|NCT04575584|101807785|FG001|Overall Study|Death|4|||
33522198|NCT04575584|101807786|FG002|Overall Study|Death|6|||
33522199|NCT04575584|101807787|FG003|Overall Study|Death|2|||
33522200|NCT04575584|101807788|FG004|Overall Study|Death|0|||
33522201|NCT04575584|101807789|FG005|Overall Study|Death|0|||
33522202|NCT04575584|101807784|FG000|Overall Study|Lost to Follow-up|1|||
33522203|NCT04575584|101807785|FG001|Overall Study|Lost to Follow-up|1|||
33609091|NCT03761810|102118551|FG001|Overall Study|Withdrawal by Subject|5|||
33609092|NCT03761810|102118550|FG000|Overall Study|Physician Decision|1|||
33609093|NCT03761810|102118551|FG001|Overall Study|Physician Decision|0|||
33522204|NCT04575584|101807786|FG002|Overall Study|Lost to Follow-up|1|||
33522205|NCT04575584|101807787|FG003|Overall Study|Lost to Follow-up|1|||
33522206|NCT04575584|101807788|FG004|Overall Study|Lost to Follow-up|0|||
33522207|NCT04575584|101807789|FG005|Overall Study|Lost to Follow-up|0|||
33522208|NCT04575584|101807784|FG000|Overall Study|Physician Decision|0|||
33329000|NCT04206605|101100992|FG000|Overall Study|Withdrawal by Subject|1|||
33329001|NCT04206605|101100993|FG001|Overall Study|Withdrawal by Subject|0|||
33329002|NCT02428855|101100995|FG000|Overall Study|Withdrawal by Subject|2|||
33401425|NCT01373294|101357071|FG001|Overall Study|Adverse Event|0|||
33609094|NCT03761810|102118550|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
33609095|NCT03761810|102118551|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33609096|NCT03761810|102118550|FG000|Overall Study|Other Than Specified|1|||
33329003|NCT02830776|101100996|FG000|Overall Study|Lost to Follow-up|1|||
33329004|NCT02592551|101100997|FG000|Overall Study|Not evaluable|1|||
33329005|NCT02592551|101100998|FG001|Overall Study|Not evaluable|3|||
33329006|NCT02592551|101100999|FG002|Overall Study|Not evaluable|0|||
33329007|NCT00199836|101101002|FG000|Overall Study|Progressive Disease|5|||
33329008|NCT00199836|101101002|FG000|Overall Study|Death|1|||
33329009|NCT04202679|101101003|FG000|Overall Study|Adverse Event|2|||
33329010|NCT04202679|101101004|FG001|Overall Study|Adverse Event|0|||
33329011|NCT04202679|101101003|FG000|Overall Study|Poor compliance to protocol|1|||
33329012|NCT04202679|101101004|FG001|Overall Study|Poor compliance to protocol|0|||
33329013|NCT04202679|101101003|FG000|Overall Study|Withdrawal by Subject|23|||
33329014|NCT04202679|101101004|FG001|Overall Study|Withdrawal by Subject|6|||
33329015|NCT03610724|101101005|FG000|Overall Study|Death|17|||
33329016|NCT03610724|101101005|FG000|Overall Study|Lost to Follow-up|1|||
33329017|NCT03610724|101101005|FG000|Overall Study|Physician Decision|1|||
33329018|NCT03610724|101101005|FG000|Overall Study|Died prior to infusion|1|||
33329019|NCT00715026|101101006|FG000|Overall Study|Withdrawal by Subject|5|||
33329020|NCT00715026|101101006|FG000|Overall Study|Lost to Follow-up|3|||
33329021|NCT00715026|101101006|FG000|Overall Study|Protocol Violation|1|||
33329022|NCT00715026|101101006|FG000|Overall Study|Surgery done on non-study consented hip|1|||
33329023|NCT04912245|101101009|FG000|Overall Study|Withdrawal by Subject|21|||
33329024|NCT04912245|101101010|FG001|Overall Study|Withdrawal by Subject|4|||
33329025|NCT04912245|101101009|FG000|Overall Study|Lost to Follow-up|5|||
33329026|NCT04912245|101101010|FG001|Overall Study|Lost to Follow-up|11|||
33329027|NCT01840579|101101011|FG000|Overall Study|Status not recorded|0|||
33329028|NCT01840579|101101012|FG001|Overall Study|Status not recorded|0|||
33329029|NCT01840579|101101013|FG002|Overall Study|Status not recorded|2|||
33329030|NCT01840579|101101014|FG003|Overall Study|Status not recorded|3|||
33329031|NCT01840579|101101015|FG004|Overall Study|Status not recorded|4|||
33522209|NCT04575584|101807785|FG001|Overall Study|Physician Decision|1|||
33609097|NCT03761810|102118551|FG001|Overall Study|Other Than Specified|0|||
33329032|NCT01840579|101101016|FG005|Overall Study|Status not recorded|3|||
33329033|NCT01840579|101101017|FG006|Overall Study|Status not recorded|0|||
33329034|NCT01840579|101101018|FG007|Overall Study|Status not recorded|3|||
33329035|NCT01840579|101101019|FG008|Overall Study|Status not recorded|3|||
33522210|NCT04575584|101807786|FG002|Overall Study|Physician Decision|1|||
33609098|NCT01729208|102118555|FG000|Baseline|Physician Decision|5|||
33329036|NCT01840579|101101020|FG009|Overall Study|Status not recorded|3|||
33329037|NCT01840579|101101011|FG000|Overall Study|Progressive disease|3|||
33329038|NCT01840579|101101012|FG001|Overall Study|Progressive disease|5|||
33329039|NCT01840579|101101013|FG002|Overall Study|Progressive disease|0|||
33329040|NCT01840579|101101014|FG003|Overall Study|Progressive disease|0|||
33329041|NCT01840579|101101015|FG004|Overall Study|Progressive disease|0|||
33329042|NCT01840579|101101016|FG005|Overall Study|Progressive disease|0|||
33329043|NCT01840579|101101017|FG006|Overall Study|Progressive disease|0|||
33329044|NCT01840579|101101018|FG007|Overall Study|Progressive disease|0|||
33329045|NCT01840579|101101019|FG008|Overall Study|Progressive disease|0|||
33329046|NCT01840579|101101020|FG009|Overall Study|Progressive disease|0|||
33329047|NCT01840579|101101011|FG000|Overall Study|Ongoing in study|0|||
33329048|NCT01840579|101101012|FG001|Overall Study|Ongoing in study|1|||
33522211|NCT04575584|101807787|FG003|Overall Study|Physician Decision|1|||
33522212|NCT04575584|101807788|FG004|Overall Study|Physician Decision|0|||
33522213|NCT04575584|101807789|FG005|Overall Study|Physician Decision|0|||
33522214|NCT04575584|101807784|FG000|Overall Study|Withdrawal by Subject|7|||
33522215|NCT04575584|101807785|FG001|Overall Study|Withdrawal by Subject|9|||
33522216|NCT04575584|101807786|FG002|Overall Study|Withdrawal by Subject|5|||
33522217|NCT04575584|101807787|FG003|Overall Study|Withdrawal by Subject|3|||
33522218|NCT04575584|101807788|FG004|Overall Study|Withdrawal by Subject|0|||
33522219|NCT04575584|101807789|FG005|Overall Study|Withdrawal by Subject|0|||
33522220|NCT04575584|101807784|FG000|Overall Study|Not recorded|0|||
33329049|NCT01840579|101101013|FG002|Overall Study|Ongoing in study|0|||
33329050|NCT01840579|101101014|FG003|Overall Study|Ongoing in study|0|||
33329051|NCT01840579|101101015|FG004|Overall Study|Ongoing in study|0|||
33329052|NCT01840579|101101016|FG005|Overall Study|Ongoing in study|0|||
33522221|NCT04575584|101807785|FG001|Overall Study|Not recorded|0|||
33522222|NCT04575584|101807786|FG002|Overall Study|Not recorded|0|||
33329053|NCT01840579|101101017|FG006|Overall Study|Ongoing in study|0|||
33329054|NCT01840579|101101018|FG007|Overall Study|Ongoing in study|0|||
33329055|NCT01840579|101101019|FG008|Overall Study|Ongoing in study|0|||
33200900|NCT02117570|100638462|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
33401426|NCT03793010|101357079|FG000|Overall Study|Withdrawal by Subject|5|||
33522223|NCT04575584|101807787|FG003|Overall Study|Not recorded|1|||
33522224|NCT04575584|101807788|FG004|Overall Study|Not recorded|0|||
33401427|NCT03793010|101357080|FG001|Overall Study|Withdrawal by Subject|7|||
33401428|NCT03793010|101357079|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
33401429|NCT03793010|101357080|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
33401430|NCT03793010|101357079|FG000|Overall Study|Lost to Follow-up|1|||
33401431|NCT03793010|101357080|FG001|Overall Study|Lost to Follow-up|2|||
33401432|NCT03793010|101357079|FG000|Overall Study|Patient couldn't sit still for injection|1|||
33401433|NCT03793010|101357080|FG001|Overall Study|Patient couldn't sit still for injection|0|||
33401434|NCT03793010|101357079|FG000|Overall Study|Withdrew to pursue other treatment|1|||
33401435|NCT03793010|101357080|FG001|Overall Study|Withdrew to pursue other treatment|0|||
33401436|NCT03793010|101357079|FG000|Overall Study|Did not meet eligibility criteria|1|||
33401437|NCT03793010|101357080|FG001|Overall Study|Did not meet eligibility criteria|0|||
33401438|NCT03125902|101357082|FG000|Overall Study|Adverse Event|0|||
33401439|NCT03125902|101357083|FG001|Overall Study|Adverse Event|1|||
33401440|NCT03125902|101357082|FG000|Overall Study|Death|119|||
33401441|NCT03125902|101357083|FG001|Overall Study|Death|229|||
33401442|NCT03125902|101357082|FG000|Overall Study|Lost to Follow-up|4|||
33401443|NCT03125902|101357083|FG001|Overall Study|Lost to Follow-up|13|||
33522225|NCT04575584|101807789|FG005|Overall Study|Not recorded|0|||
33522226|NCT01210352|101807792|FG000|Overall Study|Adverse Event|0|||
33401444|NCT03125902|101357082|FG000|Overall Study|Other|0|||
33401445|NCT03125902|101357083|FG001|Overall Study|Other|4|||
33401446|NCT03125902|101357082|FG000|Overall Study|Physician Decision|2|||
33401447|NCT03125902|101357083|FG001|Overall Study|Physician Decision|1|||
33401448|NCT03125902|101357082|FG000|Overall Study|Progressive Disease|0|||
33401449|NCT03125902|101357083|FG001|Overall Study|Progressive Disease|3|||
33522227|NCT01210352|101807793|FG001|Overall Study|Adverse Event|0|||
33522228|NCT01210352|101807794|FG002|Overall Study|Adverse Event|0|||
33522229|NCT01210352|101807795|FG003|Overall Study|Adverse Event|0|||
33522230|NCT01210352|101807796|FG004|Overall Study|Adverse Event|0|||
33522231|NCT01210352|101807797|FG005|Overall Study|Adverse Event|0|||
33522232|NCT01210352|101807798|FG006|Overall Study|Adverse Event|0|||
33522233|NCT01210352|101807799|FG007|Overall Study|Adverse Event|2|||
33522234|NCT01210352|101807800|FG008|Overall Study|Adverse Event|1|||
33522235|NCT01210352|101807792|FG000|Overall Study|Lack of Efficacy|0|||
33522236|NCT01210352|101807793|FG001|Overall Study|Lack of Efficacy|0|||
33522237|NCT01210352|101807794|FG002|Overall Study|Lack of Efficacy|0|||
33522238|NCT01210352|101807795|FG003|Overall Study|Lack of Efficacy|0|||
33522239|NCT01210352|101807796|FG004|Overall Study|Lack of Efficacy|0|||
33522240|NCT01210352|101807797|FG005|Overall Study|Lack of Efficacy|0|||
33522241|NCT01210352|101807798|FG006|Overall Study|Lack of Efficacy|1|||
33522242|NCT01210352|101807799|FG007|Overall Study|Lack of Efficacy|0|||
33522243|NCT01210352|101807800|FG008|Overall Study|Lack of Efficacy|0|||
33522244|NCT01210352|101807792|FG000|Overall Study|Physician Decision|0|||
33522245|NCT01210352|101807793|FG001|Overall Study|Physician Decision|0|||
33522246|NCT01210352|101807794|FG002|Overall Study|Physician Decision|0|||
33609099|NCT01729208|102118556|FG001|Baseline|Physician Decision|4|||
33401450|NCT03125902|101357082|FG000|Overall Study|Study Terminated By Sponsor|74|||
33401451|NCT03125902|101357083|FG001|Overall Study|Study Terminated By Sponsor|143|||
33401452|NCT03125902|101357082|FG000|Overall Study|Withdrawal by Subject|21|||
33401453|NCT03125902|101357083|FG001|Overall Study|Withdrawal by Subject|37|||
33522247|NCT01210352|101807795|FG003|Overall Study|Physician Decision|0|||
33401454|NCT00606021|101357084|FG000|Induction Phase|Death|73|||
33401455|NCT00606021|101357085|FG001|Induction Phase|Death|0|||
33401456|NCT00606021|101357086|FG002|Induction Phase|Death|0|||
33401457|NCT00606021|101357084|FG000|Induction Phase|Physician Decision|2|||
33401458|NCT00606021|101357085|FG001|Induction Phase|Physician Decision|0|||
33401459|NCT00606021|101357086|FG002|Induction Phase|Physician Decision|0|||
33401460|NCT00606021|101357084|FG000|Induction Phase|Withdrawal by Subject|2|||
33401461|NCT00606021|101357085|FG001|Induction Phase|Withdrawal by Subject|0|||
33401462|NCT00606021|101357086|FG002|Induction Phase|Withdrawal by Subject|0|||
33401463|NCT00606021|101357084|FG000|Induction Phase|Lost to Follow-up|10|||
33401464|NCT00606021|101357085|FG001|Induction Phase|Lost to Follow-up|0|||
33401465|NCT00606021|101357086|FG002|Induction Phase|Lost to Follow-up|0|||
33401466|NCT00606021|101357084|FG000|Maintenance Phase|Death|0|||
33401467|NCT00606021|101357085|FG001|Maintenance Phase|Death|17|||
33401468|NCT00606021|101357086|FG002|Maintenance Phase|Death|15|||
33522248|NCT01210352|101807796|FG004|Overall Study|Physician Decision|0|||
33522249|NCT01210352|101807797|FG005|Overall Study|Physician Decision|0|||
33522250|NCT01210352|101807798|FG006|Overall Study|Physician Decision|0|||
33522251|NCT01210352|101807799|FG007|Overall Study|Physician Decision|1|||
33522252|NCT01210352|101807800|FG008|Overall Study|Physician Decision|2|||
33522253|NCT01210352|101807792|FG000|Overall Study|Withdrawal by Subject|0|||
33522254|NCT01210352|101807793|FG001|Overall Study|Withdrawal by Subject|0|||
33609100|NCT01729208|102118555|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
33609101|NCT01729208|102118556|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
33609102|NCT01729208|102118555|FG000|12 Months Follow-up|Lost to Follow-up|3|||
33609103|NCT01729208|102118556|FG001|12 Months Follow-up|Lost to Follow-up|3|||
33609104|NCT01729208|102118555|FG000|24 Months Follow-up|Lost to Follow-up|3|||
33609105|NCT01729208|102118556|FG001|24 Months Follow-up|Lost to Follow-up|0|||
33609106|NCT01729208|102118555|FG000|36 Months Follow-up|Physician Decision|1|||
33609107|NCT01729208|102118556|FG001|36 Months Follow-up|Physician Decision|0|||
33609108|NCT01729208|102118555|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
33609109|NCT01729208|102118556|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
33609110|NCT02252965|102118557|FG000|Overall Study|Adverse Event|9|||
33609111|NCT02252965|102118558|FG001|Overall Study|Adverse Event|14|||
33609112|NCT02252965|102118557|FG000|Overall Study|Lost to Follow-up|16|||
33609113|NCT02252965|102118558|FG001|Overall Study|Lost to Follow-up|8|||
33609114|NCT02252965|102118557|FG000|Overall Study|Protocol Violation|4|||
33609115|NCT02252965|102118558|FG001|Overall Study|Protocol Violation|5|||
33609116|NCT02252965|102118557|FG000|Overall Study|Lack of Efficacy|0|||
33609117|NCT02252965|102118558|FG001|Overall Study|Lack of Efficacy|2|||
33609118|NCT02252965|102118557|FG000|Overall Study|Withdrawal by Subject|7|||
33609119|NCT02252965|102118558|FG001|Overall Study|Withdrawal by Subject|9|||
33609120|NCT02252965|102118557|FG000|Overall Study|Other|4|||
33609121|NCT02252965|102118558|FG001|Overall Study|Other|5|||
33609122|NCT02921087|102118562|FG000|Overall Study|Withdrawal by Subject|0|||
33609123|NCT02921087|102118563|FG001|Overall Study|Withdrawal by Subject|1|||
33609124|NCT02211313|102118564|FG000|Overall Study|Treatment Failure|5|||
33609125|NCT02211313|102118565|FG001|Overall Study|Treatment Failure|2|||
33609126|NCT02211313|102118564|FG000|Overall Study|No Follow up Questionnaires|1|||
33329056|NCT01840579|101101020|FG009|Overall Study|Ongoing in study|0|||
33329057|NCT01840579|101101011|FG000|Overall Study|Death|0|||
33329058|NCT01840579|101101012|FG001|Overall Study|Death|0|||
33522255|NCT01210352|101807794|FG002|Overall Study|Withdrawal by Subject|1|||
33329059|NCT01840579|101101013|FG002|Overall Study|Death|0|||
33329060|NCT01840579|101101014|FG003|Overall Study|Death|0|||
33522256|NCT01210352|101807795|FG003|Overall Study|Withdrawal by Subject|0|||
33522257|NCT01210352|101807796|FG004|Overall Study|Withdrawal by Subject|0|||
33329061|NCT01840579|101101015|FG004|Overall Study|Death|0|||
33329062|NCT01840579|101101016|FG005|Overall Study|Death|1|||
33329063|NCT01840579|101101017|FG006|Overall Study|Death|0|||
33329064|NCT01840579|101101018|FG007|Overall Study|Death|0|||
33401469|NCT00606021|101357084|FG000|Maintenance Phase|Physician Decision|0|||
33401470|NCT00606021|101357085|FG001|Maintenance Phase|Physician Decision|1|||
33522258|NCT01210352|101807797|FG005|Overall Study|Withdrawal by Subject|0|||
33522259|NCT01210352|101807798|FG006|Overall Study|Withdrawal by Subject|1|||
33609127|NCT02211313|102118565|FG001|Overall Study|No Follow up Questionnaires|1|||
33609128|NCT03369236|102118566|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
33609129|NCT03369236|102118567|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
33609130|NCT03369236|102118566|FG000|Open-label Extension Period|Lack of Efficacy|2|||
33329065|NCT01840579|101101019|FG008|Overall Study|Death|0|||
33329066|NCT01840579|101101020|FG009|Overall Study|Death|0|||
33329067|NCT01840579|101101011|FG000|Overall Study|Adverse Event|0|||
33329068|NCT01840579|101101012|FG001|Overall Study|Adverse Event|1|||
33329069|NCT01840579|101101013|FG002|Overall Study|Adverse Event|0|||
33401471|NCT00606021|101357086|FG002|Maintenance Phase|Physician Decision|0|||
33401472|NCT00606021|101357084|FG000|Maintenance Phase|Lost to Follow-up|0|||
33401473|NCT00606021|101357085|FG001|Maintenance Phase|Lost to Follow-up|5|||
33401474|NCT00606021|101357086|FG002|Maintenance Phase|Lost to Follow-up|2|||
33401475|NCT00695318|101357087|FG000|Overall Study|Lost to Follow-up|1|||
33329070|NCT01840579|101101014|FG003|Overall Study|Adverse Event|0|||
33329071|NCT01840579|101101015|FG004|Overall Study|Adverse Event|0|||
33401476|NCT00695318|101357088|FG001|Overall Study|Lost to Follow-up|0|||
33401477|NCT00695318|101357087|FG000|Overall Study|Withdrawal by Subject|2|||
33401478|NCT00695318|101357088|FG001|Overall Study|Withdrawal by Subject|0|||
33401479|NCT00695318|101357087|FG000|Overall Study|Death|1|||
33401480|NCT00695318|101357088|FG001|Overall Study|Death|1|||
33401481|NCT00695318|101357087|FG000|Overall Study|Study Terminated|1|||
33401482|NCT00695318|101357088|FG001|Overall Study|Study Terminated|0|||
33401483|NCT01766401|101357090|FG000|Overall Study|Adverse Event|7|||
33401484|NCT01766401|101357091|FG001|Overall Study|Adverse Event|22|||
33401485|NCT01766401|101357090|FG000|Overall Study|Lack of Efficacy|1|||
33401486|NCT01766401|101357091|FG001|Overall Study|Lack of Efficacy|2|||
33401487|NCT01766401|101357090|FG000|Overall Study|Protocol Violation|3|||
33401488|NCT01766401|101357091|FG001|Overall Study|Protocol Violation|8|||
33401489|NCT01766401|101357090|FG000|Overall Study|Withdrawal by Subject|15|||
33329072|NCT01840579|101101016|FG005|Overall Study|Adverse Event|0|||
33329073|NCT01840579|101101017|FG006|Overall Study|Adverse Event|0|||
33329074|NCT01840579|101101018|FG007|Overall Study|Adverse Event|0|||
33329075|NCT01840579|101101019|FG008|Overall Study|Adverse Event|0|||
33329076|NCT01840579|101101020|FG009|Overall Study|Adverse Event|0|||
33329077|NCT01840579|101101011|FG000|Overall Study|Follow-up ended by Sponsor|0|||
33329078|NCT01840579|101101012|FG001|Overall Study|Follow-up ended by Sponsor|0|||
33329079|NCT01840579|101101013|FG002|Overall Study|Follow-up ended by Sponsor|0|||
33329080|NCT01840579|101101014|FG003|Overall Study|Follow-up ended by Sponsor|0|||
33329081|NCT01840579|101101015|FG004|Overall Study|Follow-up ended by Sponsor|0|||
33329082|NCT01840579|101101016|FG005|Overall Study|Follow-up ended by Sponsor|0|||
33329083|NCT01840579|101101017|FG006|Overall Study|Follow-up ended by Sponsor|2|||
33329084|NCT01840579|101101018|FG007|Overall Study|Follow-up ended by Sponsor|0|||
33329085|NCT01840579|101101019|FG008|Overall Study|Follow-up ended by Sponsor|0|||
33329086|NCT01840579|101101020|FG009|Overall Study|Follow-up ended by Sponsor|0|||
33329087|NCT00577642|101101027|FG000|Overall Study|Clinical Disease Progression|1|||
33329088|NCT03335163|101101028|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
33329089|NCT03335163|101101028|FG000|Overall Study|Withdrawal by Subject|18|||
33329090|NCT01858532|101101029|FG000|Overall Study|Adverse Event|58|||
33329091|NCT01858532|101101030|FG001|Overall Study|Adverse Event|50|||
33329092|NCT01858532|101101031|FG002|Overall Study|Adverse Event|23|||
33329093|NCT01858532|101101032|FG003|Overall Study|Adverse Event|28|||
33329094|NCT01858532|101101029|FG000|Overall Study|Withdrew consent|71|||
33329095|NCT01858532|101101030|FG001|Overall Study|Withdrew consent|93|||
33329096|NCT01858532|101101031|FG002|Overall Study|Withdrew consent|46|||
33329097|NCT01858532|101101032|FG003|Overall Study|Withdrew consent|27|||
33329098|NCT01858532|101101029|FG000|Overall Study|Lost to Follow-up|17|||
33329099|NCT01858532|101101030|FG001|Overall Study|Lost to Follow-up|26|||
33329100|NCT01858532|101101031|FG002|Overall Study|Lost to Follow-up|11|||
33329101|NCT01858532|101101032|FG003|Overall Study|Lost to Follow-up|14|||
33329102|NCT01858532|101101029|FG000|Overall Study|Deterioration of medical status|3|||
33329103|NCT01858532|101101030|FG001|Overall Study|Deterioration of medical status|4|||
33329104|NCT01858532|101101031|FG002|Overall Study|Deterioration of medical status|3|||
33329105|NCT01858532|101101032|FG003|Overall Study|Deterioration of medical status|7|||
33329106|NCT01858532|101101029|FG000|Overall Study|Investigator request|3|||
33329107|NCT01858532|101101030|FG001|Overall Study|Investigator request|4|||
33329108|NCT01858532|101101031|FG002|Overall Study|Investigator request|2|||
33329109|NCT01858532|101101032|FG003|Overall Study|Investigator request|6|||
33329110|NCT01858532|101101029|FG000|Overall Study|Other, not specified|29|||
33329111|NCT01858532|101101030|FG001|Overall Study|Other, not specified|15|||
33329112|NCT01858532|101101031|FG002|Overall Study|Other, not specified|13|||
33329113|NCT01858532|101101032|FG003|Overall Study|Other, not specified|11|||
33329114|NCT00496730|101101036|FG000|Overall Study|Lost to Follow-up|4|||
33401490|NCT01766401|101357091|FG001|Overall Study|Withdrawal by Subject|12|||
33401491|NCT01766401|101357090|FG000|Overall Study|Lost to Follow-up|10|||
33329115|NCT00496730|101101037|FG001|Overall Study|Lost to Follow-up|3|||
33200901|NCT02117570|100638463|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
33329116|NCT00496730|101101036|FG000|Overall Study|Withdrawal by Subject|2|||
33329117|NCT00496730|101101037|FG001|Overall Study|Withdrawal by Subject|2|||
33329118|NCT04640272|101101040|FG000|Overall Study|Subject moved out of area|1|||
33329119|NCT00912028|101101043|FG000|Overall Study|Lost to Follow-up|2|||
33329120|NCT00912028|101101044|FG001|Overall Study|Lost to Follow-up|3|||
33329121|NCT00912028|101101045|FG002|Overall Study|Lost to Follow-up|0|||
33329122|NCT00912028|101101046|FG003|Overall Study|Lost to Follow-up|1|||
33329123|NCT00912028|101101047|FG004|Overall Study|Lost to Follow-up|3|||
33401492|NCT01766401|101357091|FG001|Overall Study|Lost to Follow-up|11|||
33401493|NCT01766401|101357090|FG000|Overall Study|Pregnancy|1|||
33401494|NCT01766401|101357091|FG001|Overall Study|Pregnancy|1|||
33401495|NCT00087594|101357092|FG000|Overall Study|Adverse Event|2|||
33401496|NCT00087594|101357093|FG001|Overall Study|Adverse Event|3|||
33401497|NCT00087594|101357092|FG000|Overall Study|Lost to Follow-up|0|||
33401498|NCT00087594|101357093|FG001|Overall Study|Lost to Follow-up|2|||
33401499|NCT00087594|101357092|FG000|Overall Study|Withdrawal by Subject|4|||
33401500|NCT00087594|101357093|FG001|Overall Study|Withdrawal by Subject|2|||
33401501|NCT00087594|101357092|FG000|Overall Study|Lack of Efficacy|2|||
33401502|NCT00087594|101357093|FG001|Overall Study|Lack of Efficacy|5|||
33401503|NCT00925522|101357094|FG000|Overall Study|study closed -- business decision|20|||
33401504|NCT01218477|101357096|FG000|Overall Study|Disease progression|2|||
33401505|NCT01218477|101357097|FG001|Overall Study|Disease progression|3|||
33401506|NCT01218477|101357098|FG002|Overall Study|Disease progression|6|||
33401507|NCT01218477|101357099|FG003|Overall Study|Disease progression|2|||
33401508|NCT01218477|101357096|FG000|Overall Study|Study drug toxicity|0|||
33401509|NCT01218477|101357097|FG001|Overall Study|Study drug toxicity|2|||
33401510|NCT01218477|101357098|FG002|Overall Study|Study drug toxicity|5|||
33401511|NCT01218477|101357099|FG003|Overall Study|Study drug toxicity|0|||
33401512|NCT01218477|101357096|FG000|Overall Study|No longer meets study criteria|1|||
33401513|NCT01218477|101357097|FG001|Overall Study|No longer meets study criteria|0|||
33401514|NCT01218477|101357098|FG002|Overall Study|No longer meets study criteria|0|||
33401515|NCT01218477|101357099|FG003|Overall Study|No longer meets study criteria|0|||
33401516|NCT01218477|101357096|FG000|Overall Study|Withdrawal by Subject|0|||
33401517|NCT01218477|101357097|FG001|Overall Study|Withdrawal by Subject|0|||
33401518|NCT01218477|101357098|FG002|Overall Study|Withdrawal by Subject|1|||
33401519|NCT01218477|101357099|FG003|Overall Study|Withdrawal by Subject|0|||
33401520|NCT01218477|101357096|FG000|Overall Study|Prepared for cell transplantation|0|||
33401521|NCT01218477|101357097|FG001|Overall Study|Prepared for cell transplantation|1|||
33401522|NCT01218477|101357098|FG002|Overall Study|Prepared for cell transplantation|1|||
33401523|NCT01218477|101357099|FG003|Overall Study|Prepared for cell transplantation|0|||
33401524|NCT01218477|101357096|FG000|Overall Study|Administrative reason by sponsor|0|||
33401525|NCT01218477|101357097|FG001|Overall Study|Administrative reason by sponsor|0|||
33401526|NCT01218477|101357098|FG002|Overall Study|Administrative reason by sponsor|1|||
33401527|NCT01218477|101357099|FG003|Overall Study|Administrative reason by sponsor|0|||
33401528|NCT01218477|101357096|FG000|Overall Study|Maximum clinical benefit|0|||
33401529|NCT01218477|101357097|FG001|Overall Study|Maximum clinical benefit|2|||
33401530|NCT01218477|101357098|FG002|Overall Study|Maximum clinical benefit|0|||
33401531|NCT01218477|101357099|FG003|Overall Study|Maximum clinical benefit|0|||
33401532|NCT02987205|101357102|FG000|Overall Study|Adverse Event|1|||
33401533|NCT02987205|101357102|FG000|Overall Study|Withdrawal by Subject|3|||
33401534|NCT00661362|101357103|FG000|Overall Study|Adverse Event|5|||
33401535|NCT00661362|101357104|FG001|Overall Study|Adverse Event|4|||
33401536|NCT00661362|101357103|FG000|Overall Study|Incorrect enrollment|2|||
33401537|NCT00661362|101357104|FG001|Overall Study|Incorrect enrollment|0|||
33401538|NCT00661362|101357103|FG000|Overall Study|Study specific discontinuation criteria|4|||
33401539|NCT00661362|101357104|FG001|Overall Study|Study specific discontinuation criteria|11|||
33401540|NCT00661362|101357103|FG000|Overall Study|Withdrawal by Subject|13|||
33401541|NCT00661362|101357104|FG001|Overall Study|Withdrawal by Subject|23|||
33401542|NCT00661362|101357103|FG000|Overall Study|Lost to Follow-up|3|||
33401543|NCT00661362|101357104|FG001|Overall Study|Lost to Follow-up|1|||
33401544|NCT00661362|101357103|FG000|Overall Study|Severe non-compliance to protocol|0|||
33401545|NCT00661362|101357104|FG001|Overall Study|Severe non-compliance to protocol|1|||
33401546|NCT00661362|101357103|FG000|Overall Study|Safety reasons|1|||
33401547|NCT00661362|101357104|FG001|Overall Study|Safety reasons|0|||
33401548|NCT00661362|101357103|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
33401549|NCT00661362|101357104|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
33401550|NCT04657003|101357107|FG000|Overall Study|Adverse Event|5|||
33401551|NCT04657003|101357108|FG001|Overall Study|Adverse Event|1|||
33401552|NCT04657003|101357109|FG002|Overall Study|Adverse Event|5|||
33401553|NCT04657003|101357107|FG000|Overall Study|Death|0|||
33401554|NCT04657003|101357108|FG001|Overall Study|Death|2|||
33401555|NCT04657003|101357109|FG002|Overall Study|Death|0|||
33401556|NCT04657003|101357107|FG000|Overall Study|Lost to Follow-up|8|||
33200902|NCT02117570|100638461|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
33200903|NCT02117570|100638462|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
33200904|NCT02117570|100638463|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
33200905|NCT02117570|100638461|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
33609131|NCT03369236|102118567|FG001|Open-label Extension Period|Lack of Efficacy|1|||
33200906|NCT02117570|100638462|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
33401557|NCT04657003|101357108|FG001|Overall Study|Lost to Follow-up|4|||
33401558|NCT04657003|101357109|FG002|Overall Study|Lost to Follow-up|10|||
33401559|NCT04657003|101357107|FG000|Overall Study|Other - As Reported by Investigator|3|||
33401560|NCT04657003|101357108|FG001|Overall Study|Other - As Reported by Investigator|2|||
33401561|NCT04657003|101357109|FG002|Overall Study|Other - As Reported by Investigator|2|||
33401562|NCT04657003|101357107|FG000|Overall Study|Pregnancy|2|||
33401563|NCT04657003|101357108|FG001|Overall Study|Pregnancy|0|||
33401564|NCT04657003|101357109|FG002|Overall Study|Pregnancy|2|||
33401565|NCT04657003|101357107|FG000|Overall Study|Withdrawal by Subject|16|||
33329124|NCT00912028|101101043|FG000|Overall Study|Withdrawal by Subject|3|||
33329125|NCT00912028|101101044|FG001|Overall Study|Withdrawal by Subject|0|||
33329126|NCT00912028|101101045|FG002|Overall Study|Withdrawal by Subject|0|||
33329127|NCT00912028|101101046|FG003|Overall Study|Withdrawal by Subject|0|||
33329128|NCT00912028|101101047|FG004|Overall Study|Withdrawal by Subject|0|||
33329129|NCT04688775|101101051|FG000|Placebo-controlled Period|Randomized, not treated|1|||
33329130|NCT04688775|101101052|FG001|Placebo-controlled Period|Randomized, not treated|1|||
33329131|NCT04688775|101101053|FG002|Placebo-controlled Period|Randomized, not treated|0|||
33329132|NCT04688775|101101054|FG003|Placebo-controlled Period|Randomized, not treated|0|||
33329133|NCT04688775|101101051|FG000|Placebo-controlled Period|Adverse Event|2|||
33329134|NCT04688775|101101052|FG001|Placebo-controlled Period|Adverse Event|0|||
33329135|NCT04688775|101101053|FG002|Placebo-controlled Period|Adverse Event|0|||
33329136|NCT04688775|101101054|FG003|Placebo-controlled Period|Adverse Event|0|||
33329137|NCT04688775|101101051|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
33329138|NCT04688775|101101052|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
33329139|NCT04688775|101101053|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
33329140|NCT04688775|101101054|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
33329141|NCT04688775|101101051|FG000|Placebo-controlled Period|Protocol Violation|0|||
33329142|NCT04688775|101101052|FG001|Placebo-controlled Period|Protocol Violation|1|||
33329143|NCT04688775|101101053|FG002|Placebo-controlled Period|Protocol Violation|0|||
33329144|NCT04688775|101101054|FG003|Placebo-controlled Period|Protocol Violation|0|||
33329145|NCT04688775|101101051|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
33329146|NCT04688775|101101052|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
33329147|NCT04688775|101101053|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
33329148|NCT04688775|101101054|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
33329149|NCT04688775|101101051|FG000|Placebo-controlled Period|Other reasons|0|||
33329150|NCT04688775|101101052|FG001|Placebo-controlled Period|Other reasons|1|||
33329151|NCT04688775|101101053|FG002|Placebo-controlled Period|Other reasons|0|||
33329152|NCT04688775|101101054|FG003|Placebo-controlled Period|Other reasons|0|||
33329153|NCT04688775|101101051|FG000|Delayed Start Period|Adverse Event|0|||
33329154|NCT04688775|101101052|FG001|Delayed Start Period|Adverse Event|0|||
33329155|NCT04688775|101101053|FG002|Delayed Start Period|Adverse Event|1|||
33329156|NCT04688775|101101054|FG003|Delayed Start Period|Adverse Event|0|||
33329157|NCT04688775|101101051|FG000|Delayed Start Period|Lack of Efficacy|0|||
33329158|NCT04688775|101101052|FG001|Delayed Start Period|Lack of Efficacy|0|||
33329159|NCT04688775|101101053|FG002|Delayed Start Period|Lack of Efficacy|0|||
33329160|NCT04688775|101101054|FG003|Delayed Start Period|Lack of Efficacy|3|||
33329161|NCT04688775|101101051|FG000|Delayed Start Period|Withdrawal by Subject|0|||
33329162|NCT04688775|101101052|FG001|Delayed Start Period|Withdrawal by Subject|0|||
33329163|NCT04688775|101101053|FG002|Delayed Start Period|Withdrawal by Subject|2|||
33329164|NCT04688775|101101054|FG003|Delayed Start Period|Withdrawal by Subject|4|||
33329165|NCT04688775|101101051|FG000|Delayed Start Period|Lost to Follow-up|0|||
33329166|NCT04688775|101101052|FG001|Delayed Start Period|Lost to Follow-up|0|||
33329167|NCT04688775|101101053|FG002|Delayed Start Period|Lost to Follow-up|2|||
33329168|NCT04688775|101101054|FG003|Delayed Start Period|Lost to Follow-up|1|||
33329169|NCT04688775|101101051|FG000|Delayed Start Period|other reasons|0|||
33329170|NCT04688775|101101052|FG001|Delayed Start Period|other reasons|0|||
33329171|NCT04688775|101101053|FG002|Delayed Start Period|other reasons|1|||
33329172|NCT04688775|101101054|FG003|Delayed Start Period|other reasons|0|||
33329173|NCT00833053|101101055|FG000|Overall Study|Adverse Event|4|||
33329174|NCT00833053|101101056|FG001|Overall Study|Adverse Event|0|||
33329175|NCT00833053|101101055|FG000|Overall Study|Treatment Failure|3|||
33329176|NCT00833053|101101056|FG001|Overall Study|Treatment Failure|1|||
33329177|NCT00833053|101101055|FG000|Overall Study|Withdrawal by Subject|0|||
33329178|NCT00833053|101101056|FG001|Overall Study|Withdrawal by Subject|1|||
33329179|NCT00833053|101101055|FG000|Overall Study|Protocol Violation|2|||
33329180|NCT00833053|101101056|FG001|Overall Study|Protocol Violation|1|||
33329181|NCT03807349|101101064|FG000|Overall Study|Early Study Termination|9|||
33329182|NCT03044249|101101067|FG000|Overall Study|Adverse Event|4|||
33329183|NCT03044249|101101068|FG001|Overall Study|Adverse Event|9|||
33329184|NCT03044249|101101067|FG000|Overall Study|Lost to Follow-up|1|||
33329185|NCT03044249|101101068|FG001|Overall Study|Lost to Follow-up|0|||
33329186|NCT03044249|101101067|FG000|Overall Study|Non-compliance with Study Drug|1|||
33329187|NCT03044249|101101068|FG001|Overall Study|Non-compliance with Study Drug|0|||
33329188|NCT03044249|101101067|FG000|Overall Study|Study Terminated by Sponsor|2|||
33329189|NCT03044249|101101068|FG001|Overall Study|Study Terminated by Sponsor|0|||
33329190|NCT03044249|101101067|FG000|Overall Study|Withdrawal by Subject|2|||
33329191|NCT03044249|101101068|FG001|Overall Study|Withdrawal by Subject|5|||
33329192|NCT02625233|101101069|FG000|Overall Study|Adverse Event|2|||
33329193|NCT02625233|101101070|FG001|Overall Study|Adverse Event|0|||
33329194|NCT03693625|101101072|FG000|Overall Study|Adverse Event|2|||
33329195|NCT03693625|101101073|FG001|Overall Study|Adverse Event|0|||
33329196|NCT03693625|101101072|FG000|Overall Study|Study Terminated By Sponsor|20|||
33329197|NCT03693625|101101073|FG001|Overall Study|Study Terminated By Sponsor|7|||
33329198|NCT03693625|101101072|FG000|Overall Study|Withdrawal by Subject|1|||
33329199|NCT03693625|101101073|FG001|Overall Study|Withdrawal by Subject|1|||
33329200|NCT01439555|101101085|FG000|Overall Study|Protocol Violation|1|||
33329201|NCT00631020|101101086|FG000|Overall Study|Lost to Follow-up|7|||
33329202|NCT00631020|101101086|FG000|Overall Study|Incarcerated|1|||
33329203|NCT00530270|101101089|FG000|Overall Study|Protocol Violation|1|||
33329204|NCT00530270|101101090|FG001|Overall Study|Protocol Violation|0|||
33329205|NCT03215771|101101098|FG000|Overall Study|Withdrawal by Subject|2|||
33329206|NCT03215771|101101098|FG000|Overall Study|Physician Decision|1|||
33329207|NCT00677820|101101099|FG000|Overall Study|Lost to Follow-up|1|||
33329208|NCT00677820|101101100|FG001|Overall Study|Lost to Follow-up|0|||
33329209|NCT04066491|101101107|FG000|Overall Study|Randomized, not treated|0|||
33401566|NCT04657003|101357108|FG001|Overall Study|Withdrawal by Subject|7|||
33329210|NCT04066491|101101108|FG001|Overall Study|Randomized, not treated|0|||
33401567|NCT04657003|101357109|FG002|Overall Study|Withdrawal by Subject|10|||
33401568|NCT03395704|101357110|FG000|Overall Study|Adverse Event|2|||
33401569|NCT03395704|101357111|FG001|Overall Study|Adverse Event|1|||
33401570|NCT03395704|101357110|FG000|Overall Study|Withdrawal by Subject|2|||
33401571|NCT03395704|101357111|FG001|Overall Study|Withdrawal by Subject|1|||
33401572|NCT03395704|101357110|FG000|Overall Study|Physician Decision|0|||
33401573|NCT03395704|101357111|FG001|Overall Study|Physician Decision|1|||
33401574|NCT01066546|101357112|FG000|Overall Study|Study terminated by sponsor|5|||
33401575|NCT03524664|101357113|FG000|Overall Study|Withdrawal by Subject|1|||
33401576|NCT03524664|101357114|FG001|Overall Study|Withdrawal by Subject|2|||
33401577|NCT03524664|101357113|FG000|Overall Study|Lost to Follow-up|4|||
33401578|NCT03524664|101357114|FG001|Overall Study|Lost to Follow-up|13|||
33401579|NCT04249076|101357115|FG000|Overall Study|Adverse Event|1|||
33401580|NCT04249076|101357116|FG001|Overall Study|Adverse Event|1|||
33401581|NCT04249076|101357115|FG000|Overall Study|Protocol Violation|1|||
33401582|NCT04249076|101357116|FG001|Overall Study|Protocol Violation|2|||
33401583|NCT04249076|101357115|FG000|Overall Study|Lack of Efficacy|0|||
33401584|NCT04249076|101357116|FG001|Overall Study|Lack of Efficacy|1|||
33401585|NCT04249076|101357115|FG000|Overall Study|Withdrawal by Subject|0|||
33401586|NCT04249076|101357116|FG001|Overall Study|Withdrawal by Subject|1|||
33401587|NCT02943577|101357117|FG000|Overall Study|Protocol Violation|0|||
33401588|NCT02943577|101357118|FG001|Overall Study|Protocol Violation|1|||
33401589|NCT02943577|101357117|FG000|Overall Study|Adverse Event|3|||
33401590|NCT02943577|101357118|FG001|Overall Study|Adverse Event|2|||
33401591|NCT02943577|101357117|FG000|Overall Study|Lost to Follow-up|0|||
33401592|NCT02943577|101357118|FG001|Overall Study|Lost to Follow-up|1|||
33401593|NCT02943577|101357117|FG000|Overall Study|Withdrawal by Subject|1|||
33401594|NCT02943577|101357118|FG001|Overall Study|Withdrawal by Subject|1|||
33401595|NCT02943577|101357117|FG000|Overall Study|Pregnancy|1|||
33401596|NCT02943577|101357118|FG001|Overall Study|Pregnancy|0|||
33401597|NCT04806334|101361433|FG000|Overall Study|Withdrawal by Subject|1|||
33401598|NCT01944462|101361434|FG000|PPPP Educational Program|Lost to Follow-up|60|||
33401599|NCT00504595|101361437|FG000|Overall Study|Lack of Efficacy|1|||
33401600|NCT00504595|101361438|FG001|Overall Study|Lack of Efficacy|0|||
33401601|NCT00504595|101361439|FG002|Overall Study|Lack of Efficacy|0|||
33401602|NCT00504595|101361440|FG003|Overall Study|Lack of Efficacy|0|||
33522260|NCT01210352|101807799|FG007|Overall Study|Withdrawal by Subject|0|||
33522261|NCT01210352|101807800|FG008|Overall Study|Withdrawal by Subject|1|||
33522262|NCT01210352|101807792|FG000|Overall Study|Patient Discharged Early|0|||
33522263|NCT01210352|101807793|FG001|Overall Study|Patient Discharged Early|0|||
33522264|NCT01210352|101807794|FG002|Overall Study|Patient Discharged Early|1|||
33522265|NCT01210352|101807795|FG003|Overall Study|Patient Discharged Early|0|||
33522266|NCT01210352|101807796|FG004|Overall Study|Patient Discharged Early|0|||
33522267|NCT01210352|101807797|FG005|Overall Study|Patient Discharged Early|0|||
33522268|NCT01210352|101807798|FG006|Overall Study|Patient Discharged Early|0|||
33522269|NCT01210352|101807799|FG007|Overall Study|Patient Discharged Early|0|||
33522270|NCT01210352|101807800|FG008|Overall Study|Patient Discharged Early|0|||
33522271|NCT00590538|101807801|FG000|Overall Study|Study terminated before completed|2|||
33522272|NCT02483572|101807802|FG000|Overall Study|Withdrawal by Subject|1|||
33522273|NCT02483572|101807803|FG001|Overall Study|Withdrawal by Subject|0|||
33522274|NCT02483572|101807802|FG000|Overall Study|Lost to Follow-up|1|||
33522275|NCT02483572|101807803|FG001|Overall Study|Lost to Follow-up|0|||
33329211|NCT04066491|101101109|FG002|Overall Study|Randomized, not treated|2|||
33329212|NCT00609986|101101110|FG000|Overall Study|Did not receive transplant or treatment|8|||
33522276|NCT02483572|101807802|FG000|Overall Study|Physician Decision|0|||
33329213|NCT00609986|101101111|FG001|Overall Study|Did not receive transplant or treatment|3|||
33401603|NCT00504595|101361437|FG000|Overall Study|Other|0|||
33401604|NCT00504595|101361438|FG001|Overall Study|Other|0|||
33401605|NCT00504595|101361439|FG002|Overall Study|Other|2|||
33401606|NCT00504595|101361440|FG003|Overall Study|Other|0|||
33401607|NCT02381795|101361441|FG000|Overall Study|Withdrawal by Subject|1|||
33401608|NCT02381795|101361441|FG000|Overall Study|Study Terminated|2|||
33401609|NCT02145429|101361442|FG000|Overall Study|Death|4|||
33401610|NCT02145429|101361443|FG001|Overall Study|Death|5|||
33401611|NCT02145429|101361442|FG000|Overall Study|Lost to Follow-up|4|||
33522277|NCT02483572|101807803|FG001|Overall Study|Physician Decision|1|||
33522278|NCT04908475|101811511|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
33522279|NCT04908475|101811512|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
33522280|NCT04908475|101811513|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
33522281|NCT04908475|101811514|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
33522282|NCT04908475|101811515|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
33522283|NCT04908475|101811516|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
33609132|NCT03369236|102118566|FG000|Open-label Extension Period|Adverse Event|0|||
33609133|NCT03369236|102118567|FG001|Open-label Extension Period|Adverse Event|1|||
33609134|NCT03369236|102118566|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
33609135|NCT03369236|102118567|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
33609136|NCT02879578|102118572|FG000|Overall Study|Adverse Event|1|||
33609137|NCT02879578|102118573|FG001|Overall Study|Adverse Event|2|||
33609138|NCT02879578|102118574|FG002|Overall Study|Adverse Event|14|||
33609139|NCT02879578|102118572|FG000|Overall Study|Protocol Violation|0|||
33609140|NCT02879578|102118573|FG001|Overall Study|Protocol Violation|1|||
33609141|NCT02879578|102118574|FG002|Overall Study|Protocol Violation|1|||
33609142|NCT02879578|102118572|FG000|Overall Study|Withdrawal by Subject|8|||
33329214|NCT02347098|101101113|FG000|Overall Study|Death|1|||
33329215|NCT02347098|101101114|FG001|Overall Study|Death|0|||
33329216|NCT02347098|101101113|FG000|Overall Study|Withdrawal by Subject|1|||
33329217|NCT02347098|101101114|FG001|Overall Study|Withdrawal by Subject|0|||
33329218|NCT02347098|101101113|FG000|Overall Study|Lost to Follow-up|2|||
33522284|NCT04908475|101811511|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
33522285|NCT04908475|101811512|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
33522286|NCT04908475|101811513|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
33522287|NCT04908475|101811514|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
33522288|NCT04908475|101811515|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
33522289|NCT04908475|101811516|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
33522290|NCT04908475|101811511|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
33522291|NCT04908475|101811512|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
33522292|NCT04908475|101811513|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
33522293|NCT04908475|101811514|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
33522294|NCT04908475|101811515|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
33522295|NCT04908475|101811516|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
33522296|NCT04908475|101811511|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
33522297|NCT04908475|101811512|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
33522298|NCT04908475|101811513|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
33522299|NCT04908475|101811514|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
33522300|NCT04908475|101811515|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
33522301|NCT04908475|101811516|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
33522302|NCT04908475|101811511|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
33522303|NCT04908475|101811512|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
33522304|NCT04908475|101811513|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
33329219|NCT02347098|101101114|FG001|Overall Study|Lost to Follow-up|2|||
33329220|NCT02347098|101101113|FG000|Overall Study|Refuse Follow-up Visit|1|||
33329221|NCT02347098|101101114|FG001|Overall Study|Refuse Follow-up Visit|5|||
33329222|NCT02347098|101101113|FG000|Overall Study|no visit due to illness|2|||
33329223|NCT02347098|101101114|FG001|Overall Study|no visit due to illness|1|||
33329224|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
33329225|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
33329226|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
33329227|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
33329228|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
33329229|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
33329230|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
33329231|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
33329232|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
33522305|NCT04908475|101811514|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
33609143|NCT02879578|102118573|FG001|Overall Study|Withdrawal by Subject|6|||
33329233|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
33329234|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
33401612|NCT02145429|101361443|FG001|Overall Study|Lost to Follow-up|3|||
33401613|NCT02145429|101361442|FG000|Overall Study|Withdrawal by Subject|8|||
33522306|NCT04908475|101811515|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
33609144|NCT02879578|102118574|FG002|Overall Study|Withdrawal by Subject|9|||
33329235|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
33522307|NCT04908475|101811516|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
33522308|NCT04908475|101811511|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
33609145|NCT02879578|102118572|FG000|Overall Study|Lost to Follow-up|1|||
33522309|NCT04908475|101811512|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
33522310|NCT04908475|101811513|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
33522311|NCT04908475|101811514|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
33522312|NCT04908475|101811515|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
33522313|NCT04908475|101811516|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
33522314|NCT01556932|101811518|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
33522315|NCT01556932|101811519|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
33522316|NCT01162122|101811520|FG000|Overall Study|Withdrawal by Subject|52|||
33522317|NCT01162122|101811521|FG001|Overall Study|Withdrawal by Subject|43|||
33522318|NCT01162122|101811520|FG000|Overall Study|Lost to Follow-up|73|||
33522319|NCT01162122|101811521|FG001|Overall Study|Lost to Follow-up|91|||
33522320|NCT01162122|101811520|FG000|Overall Study|Adverse Event|3|||
33522321|NCT01162122|101811521|FG001|Overall Study|Adverse Event|2|||
33522322|NCT01162122|101811520|FG000|Overall Study|Death|51|||
33522323|NCT01162122|101811521|FG001|Overall Study|Death|46|||
33522324|NCT01162122|101811520|FG000|Overall Study|Protocol Violation|2|||
33522325|NCT01162122|101811521|FG001|Overall Study|Protocol Violation|2|||
33522326|NCT01162122|101811520|FG000|Overall Study|Inappropriate enrollment|5|||
33522327|NCT01162122|101811521|FG001|Overall Study|Inappropriate enrollment|4|||
33522328|NCT01162122|101811520|FG000|Overall Study|Administrative reason|1|||
33522329|NCT01162122|101811521|FG001|Overall Study|Administrative reason|1|||
33329236|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
33329237|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
33329238|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
33329239|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
33329240|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
33329241|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
33329242|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
33329243|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
33329244|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
33329245|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
33329246|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
33329247|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
33329248|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
33329249|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
33329250|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
33329251|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
33329252|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
33329253|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
33329254|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
33329255|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
33329256|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
33329257|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
33329258|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
33329259|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
33329260|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
33329261|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
33329262|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
33329263|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
33329264|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
33329265|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
33329266|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
33329267|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
33329268|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
33329269|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
33329270|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
33417252|NCT04856917|101420241|FG000|Overall Study|Lost to Follow-up|3|||
33417253|NCT04856917|101420242|FG001|Overall Study|Lost to Follow-up|1|||
33417254|NCT04856917|101420243|FG002|Overall Study|Lost to Follow-up|1|||
33522330|NCT01162122|101811520|FG000|Overall Study|Unable to classify|3|||
33522331|NCT01162122|101811521|FG001|Overall Study|Unable to classify|7|||
33522332|NCT01162122|101811520|FG000|Overall Study|Missing primary reason|1|||
33609146|NCT02879578|102118573|FG001|Overall Study|Lost to Follow-up|0|||
33609147|NCT02879578|102118574|FG002|Overall Study|Lost to Follow-up|4|||
33417255|NCT04856917|101420241|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
33417256|NCT04856917|101420242|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
33417257|NCT04856917|101420243|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
33417258|NCT04856917|101420241|FG000|Overall Study|Other|1|||
33417259|NCT04856917|101420242|FG001|Overall Study|Other|1|||
33522333|NCT01162122|101811521|FG001|Overall Study|Missing primary reason|0|||
33522334|NCT00262002|101811523|FG000|Overall Study|Adverse Event|2|||
33522335|NCT00262002|101811524|FG001|Overall Study|Adverse Event|1|||
33522336|NCT00262002|101811525|FG002|Overall Study|Adverse Event|0|||
33522337|NCT00262002|101811526|FG003|Overall Study|Adverse Event|0|||
33522338|NCT00262002|101811527|FG004|Overall Study|Adverse Event|0|||
33522339|NCT00262002|101811528|FG005|Overall Study|Adverse Event|1|||
33522340|NCT00262002|101811529|FG006|Overall Study|Adverse Event|0|||
33522341|NCT00262002|101811523|FG000|Overall Study|Withdrawal by Subject|4|||
33522342|NCT00262002|101811524|FG001|Overall Study|Withdrawal by Subject|2|||
33522343|NCT00262002|101811525|FG002|Overall Study|Withdrawal by Subject|0|||
33522344|NCT00262002|101811526|FG003|Overall Study|Withdrawal by Subject|1|||
33522345|NCT00262002|101811527|FG004|Overall Study|Withdrawal by Subject|2|||
33522346|NCT00262002|101811528|FG005|Overall Study|Withdrawal by Subject|2|||
33522347|NCT00262002|101811529|FG006|Overall Study|Withdrawal by Subject|2|||
33522348|NCT00262002|101811523|FG000|Overall Study|Lost to Follow-up|2|||
33522349|NCT00262002|101811524|FG001|Overall Study|Lost to Follow-up|0|||
33522350|NCT00262002|101811525|FG002|Overall Study|Lost to Follow-up|0|||
33522351|NCT00262002|101811526|FG003|Overall Study|Lost to Follow-up|2|||
33522352|NCT00262002|101811527|FG004|Overall Study|Lost to Follow-up|0|||
33522353|NCT00262002|101811528|FG005|Overall Study|Lost to Follow-up|1|||
33522354|NCT00262002|101811529|FG006|Overall Study|Lost to Follow-up|0|||
33522355|NCT00262002|101811523|FG000|Overall Study|Inapropriate enrollment|0|||
33522356|NCT00262002|101811524|FG001|Overall Study|Inapropriate enrollment|1|||
33522357|NCT00262002|101811525|FG002|Overall Study|Inapropriate enrollment|0|||
33522358|NCT00262002|101811526|FG003|Overall Study|Inapropriate enrollment|0|||
33522359|NCT00262002|101811527|FG004|Overall Study|Inapropriate enrollment|0|||
33522360|NCT00262002|101811528|FG005|Overall Study|Inapropriate enrollment|0|||
33522361|NCT00262002|101811529|FG006|Overall Study|Inapropriate enrollment|0|||
33522362|NCT00262002|101811523|FG000|Overall Study|Protocol Violation|3|||
33522363|NCT00262002|101811524|FG001|Overall Study|Protocol Violation|2|||
33522364|NCT00262002|101811525|FG002|Overall Study|Protocol Violation|0|||
33522365|NCT00262002|101811526|FG003|Overall Study|Protocol Violation|2|||
33522366|NCT00262002|101811527|FG004|Overall Study|Protocol Violation|5|||
33522367|NCT00262002|101811528|FG005|Overall Study|Protocol Violation|3|||
33522368|NCT00262002|101811529|FG006|Overall Study|Protocol Violation|2|||
33522369|NCT00262002|101811523|FG000|Overall Study|Unable to classify|0|||
33522370|NCT00262002|101811524|FG001|Overall Study|Unable to classify|0|||
33522371|NCT00262002|101811525|FG002|Overall Study|Unable to classify|0|||
33522372|NCT00262002|101811526|FG003|Overall Study|Unable to classify|0|||
33522373|NCT00262002|101811527|FG004|Overall Study|Unable to classify|0|||
33522374|NCT00262002|101811528|FG005|Overall Study|Unable to classify|0|||
33522375|NCT00262002|101811529|FG006|Overall Study|Unable to classify|2|||
33522376|NCT01941537|101811531|FG000|Overall Study|Lack of Efficacy|1|||
33522377|NCT01941537|101811532|FG001|Overall Study|Lack of Efficacy|2|||
33522378|NCT01941537|101811531|FG000|Overall Study|Lost to Follow-up|1|||
33522379|NCT01941537|101811532|FG001|Overall Study|Lost to Follow-up|0|||
33522380|NCT01941537|101811531|FG000|Overall Study|Pregnancy|1|||
33522381|NCT01941537|101811532|FG001|Overall Study|Pregnancy|0|||
33522382|NCT01941537|101811531|FG000|Overall Study|Adverse Event|1|||
33522383|NCT01941537|101811532|FG001|Overall Study|Adverse Event|0|||
33522384|NCT01941537|101811531|FG000|Overall Study|Withdrawal by Subject|0|||
33522385|NCT01941537|101811532|FG001|Overall Study|Withdrawal by Subject|1|||
33522386|NCT01857102|101811537|FG000|Period 1|No longer meets Eligibility Criteria|0|||
33522387|NCT01857102|101811538|FG001|Period 1|No longer meets Eligibility Criteria|2|||
33609148|NCT02879578|102118572|FG000|Overall Study|Physician Decision|0|||
33609149|NCT02879578|102118573|FG001|Overall Study|Physician Decision|0|||
33609150|NCT02879578|102118574|FG002|Overall Study|Physician Decision|4|||
33609151|NCT00445770|102118576|FG000|Overall Study|Adverse Event|9|||
33522388|NCT01857102|101811537|FG000|Period 1|Lost to Follow-up|0|||
33522389|NCT01857102|101811538|FG001|Period 1|Lost to Follow-up|3|||
33522390|NCT01857102|101811537|FG000|Period 1|Unsatisfactory Lens Fit|1|||
33609152|NCT00445770|102118577|FG001|Overall Study|Adverse Event|15|||
33522391|NCT01857102|101811538|FG001|Period 1|Unsatisfactory Lens Fit|0|||
33522392|NCT01857102|101811537|FG000|Period 1|Unsatisfactory Visual Response|1|||
33522393|NCT01857102|101811538|FG001|Period 1|Unsatisfactory Visual Response|0|||
33522394|NCT01857102|101811537|FG000|Period 1|Physician Decision|1|||
33609153|NCT00445770|102118578|FG002|Overall Study|Adverse Event|19|||
33609154|NCT00445770|102118576|FG000|Overall Study|Lack of Efficacy|38|||
33522395|NCT01857102|101811538|FG001|Period 1|Physician Decision|0|||
33522396|NCT01857102|101811537|FG000|Period 2|Lens Discomfort|1|||
33609155|NCT00445770|102118577|FG001|Overall Study|Lack of Efficacy|13|||
33522397|NCT01857102|101811538|FG001|Period 2|Lens Discomfort|0|||
33522398|NCT01857102|101811537|FG000|Period 2|Unsatisfactory Lens Fit|1|||
33522399|NCT01857102|101811538|FG001|Period 2|Unsatisfactory Lens Fit|0|||
33522400|NCT01074255|101811539|FG000|Overall Study|Did not receive EMEND|2|||
33522401|NCT01256385|101811563|FG000|Overall Study|Physician Decision|1|||
33522402|NCT01256385|101811564|FG001|Overall Study|Physician Decision|1|||
33522403|NCT01256385|101811563|FG000|Overall Study|Withdrawal by Subject|2|||
33522404|NCT01256385|101811564|FG001|Overall Study|Withdrawal by Subject|2|||
33522405|NCT00153816|101811565|FG000|Overall Study|Death|6|||
33522406|NCT00153816|101811566|FG001|Overall Study|Death|5|||
33522407|NCT00153816|101811567|FG002|Overall Study|Death|4|||
33522408|NCT00153816|101811568|FG003|Overall Study|Death|6|||
33522409|NCT00153816|101811569|FG004|Overall Study|Death|0|||
33522410|NCT00153816|101811570|FG005|Overall Study|Death|2|||
33522411|NCT00153816|101811565|FG000|Overall Study|Lost to Follow-up|7|||
33609156|NCT00445770|102118578|FG002|Overall Study|Lack of Efficacy|6|||
33609157|NCT00445770|102118576|FG000|Overall Study|Lost to Follow-up|0|||
33609158|NCT00445770|102118577|FG001|Overall Study|Lost to Follow-up|2|||
33609159|NCT00445770|102118578|FG002|Overall Study|Lost to Follow-up|0|||
33609160|NCT00445770|102118576|FG000|Overall Study|Other|6|||
33609161|NCT00445770|102118577|FG001|Overall Study|Other|5|||
33609162|NCT00445770|102118578|FG002|Overall Study|Other|6|||
33609163|NCT02798471|102118580|FG000|Overall Study|Adverse Event|7|||
33609164|NCT02798471|102118581|FG001|Overall Study|Adverse Event|2|||
33609165|NCT02798471|102118580|FG000|Overall Study|Physician Decision|3|||
33522412|NCT00153816|101811566|FG001|Overall Study|Lost to Follow-up|8|||
33522413|NCT00153816|101811567|FG002|Overall Study|Lost to Follow-up|5|||
33522414|NCT00153816|101811568|FG003|Overall Study|Lost to Follow-up|8|||
33522415|NCT00153816|101811569|FG004|Overall Study|Lost to Follow-up|7|||
33522416|NCT00153816|101811570|FG005|Overall Study|Lost to Follow-up|9|||
33522417|NCT00153816|101811565|FG000|Overall Study|Withdrawal by Subject|9|||
33522418|NCT00153816|101811566|FG001|Overall Study|Withdrawal by Subject|9|||
33522419|NCT00153816|101811567|FG002|Overall Study|Withdrawal by Subject|9|||
33522420|NCT00153816|101811568|FG003|Overall Study|Withdrawal by Subject|4|||
33522421|NCT00153816|101811569|FG004|Overall Study|Withdrawal by Subject|1|||
33522422|NCT00153816|101811570|FG005|Overall Study|Withdrawal by Subject|5|||
33522423|NCT00153816|101811565|FG000|Overall Study|Follow-up exam not done|8|||
33522424|NCT00153816|101811566|FG001|Overall Study|Follow-up exam not done|7|||
33522425|NCT00153816|101811567|FG002|Overall Study|Follow-up exam not done|11|||
33522426|NCT00153816|101811568|FG003|Overall Study|Follow-up exam not done|10|||
33522427|NCT00153816|101811569|FG004|Overall Study|Follow-up exam not done|8|||
33522428|NCT00153816|101811570|FG005|Overall Study|Follow-up exam not done|9|||
33522429|NCT00153816|101811565|FG000|Overall Study|Follow-up exam done, histology missing|2|||
33522430|NCT00153816|101811566|FG001|Overall Study|Follow-up exam done, histology missing|3|||
33522431|NCT00153816|101811567|FG002|Overall Study|Follow-up exam done, histology missing|3|||
33522432|NCT00153816|101811568|FG003|Overall Study|Follow-up exam done, histology missing|3|||
33522433|NCT00153816|101811569|FG004|Overall Study|Follow-up exam done, histology missing|1|||
33522434|NCT00153816|101811570|FG005|Overall Study|Follow-up exam done, histology missing|2|||
33522435|NCT02749799|101811571|FG000|Overall Study|Adverse Event|2|||
33522436|NCT02749799|101811571|FG000|Overall Study|Lost to Follow-up|4|||
33522437|NCT02749799|101811571|FG000|Overall Study|Protocol Violation|1|||
33522438|NCT02749799|101811571|FG000|Overall Study|Withdrawal by Subject|1|||
33522439|NCT00904917|101811574|FG000|Overall Study|Lost to Follow-up|2|||
33522440|NCT00904917|101811575|FG001|Overall Study|Lost to Follow-up|2|||
33522441|NCT00904917|101811576|FG002|Overall Study|Lost to Follow-up|2|||
33522442|NCT00904917|101811577|FG003|Overall Study|Lost to Follow-up|2|||
33522443|NCT04122625|101811578|FG000|Part A (up to 2.92 Years)|Death|2|||
33522444|NCT04122625|101811579|FG001|Part A (up to 2.92 Years)|Death|4|||
33522445|NCT04122625|101811580|FG002|Part A (up to 2.92 Years)|Death|0|||
33522446|NCT04122625|101811581|FG003|Part A (up to 2.92 Years)|Death|0|||
33522447|NCT04122625|101811582|FG004|Part A (up to 2.92 Years)|Death|0|||
33522448|NCT04122625|101811583|FG005|Part A (up to 2.92 Years)|Death|0|||
33522449|NCT04122625|101811578|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
33522450|NCT04122625|101811579|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
33522451|NCT04122625|101811580|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
33522452|NCT04122625|101811581|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
33522453|NCT04122625|101811582|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
33522454|NCT04122625|101811583|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
33522455|NCT04122625|101811578|FG000|Part B (up to 2.33 Years)|Death|0|||
33609166|NCT02798471|102118581|FG001|Overall Study|Physician Decision|7|||
33609167|NCT02798471|102118580|FG000|Overall Study|Death|2|||
33522456|NCT04122625|101811579|FG001|Part B (up to 2.33 Years)|Death|0|||
33522457|NCT04122625|101811580|FG002|Part B (up to 2.33 Years)|Death|5|||
33522458|NCT04122625|101811581|FG003|Part B (up to 2.33 Years)|Death|7|||
33522459|NCT04122625|101811582|FG004|Part B (up to 2.33 Years)|Death|6|||
33522460|NCT04122625|101811583|FG005|Part B (up to 2.33 Years)|Death|7|||
33609168|NCT02798471|102118581|FG001|Overall Study|Death|3|||
33609169|NCT02798471|102118580|FG000|Overall Study|Lost to Follow-up|0|||
33609170|NCT02798471|102118581|FG001|Overall Study|Lost to Follow-up|1|||
33522461|NCT04401202|101811584|FG000|Overall Study|Lost to Follow-up|2|||
33522462|NCT04401202|101811585|FG001|Overall Study|Lost to Follow-up|2|||
33522463|NCT04401202|101811584|FG000|Overall Study|Adverse Event|0|||
33522464|NCT04401202|101811585|FG001|Overall Study|Adverse Event|1|||
33522465|NCT04401202|101811584|FG000|Overall Study|Hospitalized|4|||
33609171|NCT02798471|102118580|FG000|Overall Study|Other|5|||
33522466|NCT04401202|101811585|FG001|Overall Study|Hospitalized|1|||
33522467|NCT03015194|101811589|FG000|Overall Study|Death|10|||
33522468|NCT03015194|101811589|FG000|Overall Study|Withdrawal by Subject|2|||
33522469|NCT03472521|101811595|FG000|Overall Study|Lost to Follow-up|3|||
33522470|NCT03472521|101811596|FG001|Overall Study|Lost to Follow-up|2|||
33522471|NCT03472521|101811595|FG000|Overall Study|Discontinued intervention|3|||
33522472|NCT03472521|101811596|FG001|Overall Study|Discontinued intervention|1|||
33522473|NCT02603107|101811597|FG000|Randomized Phase|Withdrew consent|8|||
33522474|NCT02603107|101811598|FG001|Randomized Phase|Withdrew consent|15|||
33522475|NCT02603107|101811597|FG000|Randomized Phase|Lost to Follow-up|1|||
33522476|NCT02603107|101811598|FG001|Randomized Phase|Lost to Follow-up|3|||
33522477|NCT02603107|101811597|FG000|Randomized Phase|Adverse Event|2|||
33401614|NCT02145429|101361443|FG001|Overall Study|Withdrawal by Subject|3|||
33329271|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
33329272|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
33329273|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
33329274|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
33329275|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
33329276|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
33329277|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
33329278|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
33329279|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
33329280|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
33329281|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
33329282|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
33329283|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
33329284|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
33401615|NCT00424463|101361446|FG000|Overall Study|Adverse Event|2|||
33401616|NCT00424463|101361447|FG001|Overall Study|Adverse Event|3|||
33401617|NCT00424463|101361448|FG002|Overall Study|Adverse Event|2|||
33401618|NCT00424463|101361446|FG000|Overall Study|Physician Decision|0|||
33401619|NCT00424463|101361447|FG001|Overall Study|Physician Decision|2|||
33401620|NCT00424463|101361448|FG002|Overall Study|Physician Decision|2|||
33401621|NCT00424463|101361446|FG000|Overall Study|Withdrawal by Subject|4|||
33401622|NCT00424463|101361447|FG001|Overall Study|Withdrawal by Subject|2|||
33401623|NCT00424463|101361448|FG002|Overall Study|Withdrawal by Subject|5|||
33401624|NCT00424463|101361446|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
33401625|NCT00424463|101361447|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
33401626|NCT00424463|101361448|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
33401627|NCT00424463|101361446|FG000|Overall Study|Patient's convenience|0|||
33401628|NCT00424463|101361447|FG001|Overall Study|Patient's convenience|0|||
33401629|NCT00424463|101361448|FG002|Overall Study|Patient's convenience|1|||
33401630|NCT01904760|101361449|FG000|Overall Study|Protocol Violation|1|||
33401631|NCT01904760|101361450|FG001|Overall Study|Protocol Violation|0|||
33401632|NCT01539720|101361451|FG000|Overall Study|Screen Fail|15|||
33401633|NCT01539720|101361452|FG001|Overall Study|Screen Fail|3|||
33401634|NCT01539720|101361451|FG000|Overall Study|Lost to Follow-up|14|||
33401635|NCT01539720|101361452|FG001|Overall Study|Lost to Follow-up|7|||
33401636|NCT01521494|101361458|FG000|Overall Study|Adverse Event|1|||
33522478|NCT02603107|101811598|FG001|Randomized Phase|Adverse Event|0|||
33522479|NCT02603107|101811597|FG000|Randomized Phase|Death|1|||
33522480|NCT02603107|101811598|FG001|Randomized Phase|Death|1|||
33522481|NCT02603107|101811597|FG000|Randomized Phase|Non-compliance with study drug|1|||
33522482|NCT02603107|101811598|FG001|Randomized Phase|Non-compliance with study drug|1|||
33522483|NCT02603107|101811597|FG000|Randomized Phase|Investigator's discretion|0|||
33522484|NCT02603107|101811598|FG001|Randomized Phase|Investigator's discretion|1|||
33522485|NCT02603107|101811597|FG000|Randomized Phase|Lack of Efficacy|1|||
33522486|NCT02603107|101811598|FG001|Randomized Phase|Lack of Efficacy|0|||
33522487|NCT02603107|101811597|FG000|Randomized Phase|Protocol Violation|1|||
33522488|NCT02603107|101811598|FG001|Randomized Phase|Protocol Violation|0|||
33522489|NCT02603107|101811597|FG000|Optional Extension Phase|Lost to Follow-up|3|||
33329285|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
33522490|NCT02603107|101811598|FG001|Optional Extension Phase|Lost to Follow-up|3|||
33401637|NCT01521494|101361459|FG001|Overall Study|Adverse Event|2|||
33401638|NCT01521494|101361460|FG002|Overall Study|Adverse Event|9|||
33401639|NCT01521494|101361461|FG003|Overall Study|Adverse Event|6|||
33401640|NCT01521494|101361462|FG004|Overall Study|Adverse Event|2|||
33522491|NCT02603107|101811597|FG000|Optional Extension Phase|Withdrew consent|3|||
33522492|NCT02603107|101811598|FG001|Optional Extension Phase|Withdrew consent|2|||
33522493|NCT02603107|101811597|FG000|Optional Extension Phase|Investigator's discretion|2|||
33401641|NCT01521494|101361458|FG000|Overall Study|Lack of Efficacy|0|||
33401642|NCT01521494|101361459|FG001|Overall Study|Lack of Efficacy|0|||
33401643|NCT01521494|101361460|FG002|Overall Study|Lack of Efficacy|0|||
33522494|NCT02603107|101811598|FG001|Optional Extension Phase|Investigator's discretion|2|||
33522495|NCT02603107|101811597|FG000|Optional Extension Phase|Pregnancy|0|||
33522496|NCT02603107|101811598|FG001|Optional Extension Phase|Pregnancy|3|||
33522497|NCT02603107|101811597|FG000|Optional Extension Phase|Adverse Event|0|||
33522498|NCT02603107|101811598|FG001|Optional Extension Phase|Adverse Event|2|||
33522499|NCT02603107|101811597|FG000|Optional Extension Phase|Not treated in extension phase|0|||
33522500|NCT02603107|101811598|FG001|Optional Extension Phase|Not treated in extension phase|1|||
33522501|NCT02603107|101811597|FG000|Optional Extension Phase|Protocol Violation|1|||
33522502|NCT02603107|101811598|FG001|Optional Extension Phase|Protocol Violation|0|||
33522503|NCT01146561|101811599|FG000|Overall Study|Withdrawal by Subject|1|||
33522504|NCT01146561|101811599|FG000|Overall Study|Lost to Follow-up|1|||
33522505|NCT02131636|101811600|FG000|Overall Study|Personal Reasons|4|||
33522506|NCT02131636|101811601|FG001|Overall Study|Personal Reasons|4|||
33522507|NCT02131636|101811600|FG000|Overall Study|Lost to Follow-up|4|||
33522508|NCT02131636|101811601|FG001|Overall Study|Lost to Follow-up|0|||
33522509|NCT02131636|101811600|FG000|Overall Study|Adverse Event|4|||
33522510|NCT02131636|101811601|FG001|Overall Study|Adverse Event|1|||
33522511|NCT01937715|101811602|FG000|Overall Study|Death|0|||
33522512|NCT01937715|101811603|FG001|Overall Study|Death|0|||
33329286|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
33329287|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
33329288|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
33329289|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
33329290|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
33329291|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
33522513|NCT01937715|101811604|FG002|Overall Study|Death|0|||
33522514|NCT01937715|101811605|FG003|Overall Study|Death|1|||
33522515|NCT01937715|101811606|FG004|Overall Study|Death|0|||
33522516|NCT01937715|101811602|FG000|Overall Study|Withdrawal by Subject|0|||
33522517|NCT01937715|101811603|FG001|Overall Study|Withdrawal by Subject|1|||
33522518|NCT01937715|101811604|FG002|Overall Study|Withdrawal by Subject|0|||
33522519|NCT01937715|101811605|FG003|Overall Study|Withdrawal by Subject|0|||
33522520|NCT01937715|101811606|FG004|Overall Study|Withdrawal by Subject|2|||
33522521|NCT01937715|101811602|FG000|Overall Study|Other|0|||
33522522|NCT01937715|101811603|FG001|Overall Study|Other|0|||
33522523|NCT01937715|101811604|FG002|Overall Study|Other|0|||
33522524|NCT01937715|101811605|FG003|Overall Study|Other|3|||
33522525|NCT01937715|101811606|FG004|Overall Study|Other|0|||
33522526|NCT02007278|101811607|FG000|Overall Study|Failure to comply with an eligibility|0|||
33522527|NCT02007278|101811608|FG001|Overall Study|Failure to comply with an eligibility|1|||
33522528|NCT02007278|101811607|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
33522529|NCT02007278|101811608|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
33522530|NCT02007278|101811607|FG000|Overall Study|Incorrect medication administration|1|||
33522531|NCT02007278|101811608|FG001|Overall Study|Incorrect medication administration|0|||
33522532|NCT02007278|101811607|FG000|Overall Study|Mis-randomization|1|||
33522533|NCT02007278|101811608|FG001|Overall Study|Mis-randomization|1|||
33522534|NCT03275389|101811613|FG000|Overall Study|Lost to Follow-up|10|||
33522535|NCT03275389|101811614|FG001|Overall Study|Lost to Follow-up|10|||
33522536|NCT03275389|101811615|FG002|Overall Study|Lost to Follow-up|19|||
33522537|NCT03275389|101811616|FG003|Overall Study|Lost to Follow-up|12|||
33329292|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
33401644|NCT01521494|101361461|FG003|Overall Study|Lack of Efficacy|0|||
33401645|NCT01521494|101361462|FG004|Overall Study|Lack of Efficacy|2|||
33401646|NCT01521494|101361458|FG000|Overall Study|Withdrawal by Subject|1|||
33522538|NCT03275389|101811617|FG004|Overall Study|Lost to Follow-up|11|||
33522539|NCT03275389|101811618|FG005|Overall Study|Lost to Follow-up|12|||
33522540|NCT03275389|101811619|FG006|Overall Study|Lost to Follow-up|21|||
33522541|NCT03275389|101811620|FG007|Overall Study|Lost to Follow-up|15|||
33522542|NCT03275389|101811621|FG008|Overall Study|Lost to Follow-up|12|||
33522543|NCT03275389|101811622|FG009|Overall Study|Lost to Follow-up|14|||
33522544|NCT03275389|101811613|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33522545|NCT03275389|101811614|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33401647|NCT01521494|101361459|FG001|Overall Study|Withdrawal by Subject|1|||
33522546|NCT03275389|101811615|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33522547|NCT03275389|101811616|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33522548|NCT03275389|101811617|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33522549|NCT03275389|101811618|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
33522550|NCT03275389|101811619|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33522551|NCT03275389|101811620|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33522552|NCT03275389|101811621|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
33522553|NCT03275389|101811622|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
33522554|NCT03275389|101811613|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
33522555|NCT03275389|101811614|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33522556|NCT03275389|101811615|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33522557|NCT03275389|101811616|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
33522558|NCT03275389|101811617|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
33522559|NCT03275389|101811618|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
33522560|NCT03275389|101811619|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
33522561|NCT03275389|101811620|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
33522562|NCT03275389|101811621|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
33522563|NCT03275389|101811622|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
33522564|NCT03275389|101811613|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33522565|NCT03275389|101811614|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
33522566|NCT03275389|101811615|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33522567|NCT03275389|101811616|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
33522568|NCT03275389|101811617|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33522569|NCT03275389|101811618|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33522570|NCT03275389|101811619|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33522571|NCT03275389|101811620|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33522572|NCT03275389|101811621|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33522573|NCT03275389|101811622|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33522574|NCT03275389|101811613|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33522575|NCT03275389|101811614|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33522576|NCT03275389|101811615|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
33522577|NCT03275389|101811616|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33522578|NCT03275389|101811617|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33522579|NCT03275389|101811618|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33522580|NCT03275389|101811619|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33522581|NCT03275389|101811620|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33522582|NCT03275389|101811621|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33522583|NCT03275389|101811622|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
33522584|NCT03275389|101811613|FG000|Overall Study|Other|0|||
33522585|NCT03275389|101811614|FG001|Overall Study|Other|4|||
33522586|NCT03275389|101811615|FG002|Overall Study|Other|3|||
33522587|NCT03275389|101811616|FG003|Overall Study|Other|2|||
33522588|NCT03275389|101811617|FG004|Overall Study|Other|2|||
33522589|NCT03275389|101811618|FG005|Overall Study|Other|2|||
33522590|NCT03275389|101811619|FG006|Overall Study|Other|0|||
33522591|NCT03275389|101811620|FG007|Overall Study|Other|0|||
33522592|NCT03275389|101811621|FG008|Overall Study|Other|1|||
33522593|NCT03275389|101811622|FG009|Overall Study|Other|0|||
33522594|NCT00893971|101811623|FG000|Overall Study|Physician Decision|3|||
33522595|NCT00423813|101811627|FG000|Overall Study|Adverse Event|11|||
33522596|NCT00423813|101811628|FG001|Overall Study|Adverse Event|30|||
33522597|NCT00423813|101811629|FG002|Overall Study|Adverse Event|40|||
33522598|NCT00423813|101811627|FG000|Overall Study|Withdrawal by Subject|6|||
33522599|NCT00423813|101811628|FG001|Overall Study|Withdrawal by Subject|8|||
33522600|NCT00423813|101811629|FG002|Overall Study|Withdrawal by Subject|5|||
33522601|NCT00423813|101811627|FG000|Overall Study|Lost to Follow-up|5|||
33522602|NCT00423813|101811628|FG001|Overall Study|Lost to Follow-up|4|||
33522603|NCT00423813|101811629|FG002|Overall Study|Lost to Follow-up|4|||
33522604|NCT00423813|101811627|FG000|Overall Study|Lack of Efficacy|23|||
33522605|NCT00423813|101811628|FG001|Overall Study|Lack of Efficacy|18|||
33522606|NCT00423813|101811629|FG002|Overall Study|Lack of Efficacy|19|||
33522607|NCT00423813|101811627|FG000|Overall Study|Physician Decision|2|||
33522608|NCT00423813|101811628|FG001|Overall Study|Physician Decision|0|||
33522609|NCT00423813|101811629|FG002|Overall Study|Physician Decision|0|||
33522610|NCT00423813|101811627|FG000|Overall Study|Sponsor Decision|0|||
33522611|NCT00423813|101811628|FG001|Overall Study|Sponsor Decision|1|||
33522612|NCT00423813|101811629|FG002|Overall Study|Sponsor Decision|0|||
33522613|NCT00423813|101811627|FG000|Overall Study|Protocol Violation|9|||
33522614|NCT00423813|101811628|FG001|Overall Study|Protocol Violation|4|||
33522615|NCT00423813|101811629|FG002|Overall Study|Protocol Violation|4|||
33522616|NCT00423813|101811627|FG000|Overall Study|Pregnancy|0|||
33522617|NCT00423813|101811628|FG001|Overall Study|Pregnancy|0|||
33522618|NCT00423813|101811629|FG002|Overall Study|Pregnancy|1|||
33522619|NCT00423813|101811627|FG000|Overall Study|Subject started night shift work|1|||
33522620|NCT00423813|101811628|FG001|Overall Study|Subject started night shift work|0|||
33522621|NCT00423813|101811629|FG002|Overall Study|Subject started night shift work|0|||
33522622|NCT00423813|101811627|FG000|Overall Study|Will start exclusionary medications|0|||
33329293|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
33401648|NCT01521494|101361460|FG002|Overall Study|Withdrawal by Subject|0|||
33522623|NCT00423813|101811628|FG001|Overall Study|Will start exclusionary medications|1|||
33522624|NCT00423813|101811629|FG002|Overall Study|Will start exclusionary medications|0|||
33522625|NCT00423813|101811627|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
33522626|NCT00423813|101811628|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
33522627|NCT00423813|101811629|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
33609172|NCT02798471|102118581|FG001|Overall Study|Other|3|||
33522628|NCT01900899|101811630|FG000|Overall Study|Withdrawal by Subject|7|||
33329294|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
33329295|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
33522629|NCT01900899|101811631|FG001|Overall Study|Withdrawal by Subject|1|||
33329296|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
33329297|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
33329298|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
33329299|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
33329300|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
33329301|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
33329302|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
33329303|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
33329304|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
33329305|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
33329306|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
33329307|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
33329308|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
33329309|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
33329310|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
33329311|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
33329312|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
33329313|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
33329314|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
33329315|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
33329316|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
33329317|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
33329318|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
33329319|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
33329320|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
33329321|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
33329322|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
33522630|NCT01900899|101811630|FG000|Overall Study|Migrated from study area|2|||
33522631|NCT01900899|101811631|FG001|Overall Study|Migrated from study area|0|||
33522632|NCT02557516|101811632|FG000|Overall Study|Adverse Event|1|||
33522633|NCT02557516|101811633|FG001|Overall Study|Adverse Event|0|||
33522634|NCT02557516|101811634|FG002|Overall Study|Adverse Event|2|||
33522635|NCT02557516|101811635|FG003|Overall Study|Adverse Event|1|||
33522636|NCT02557516|101811632|FG000|Overall Study|Disease progression|0|||
33522637|NCT02557516|101811633|FG001|Overall Study|Disease progression|2|||
33522638|NCT02557516|101811634|FG002|Overall Study|Disease progression|0|||
33522639|NCT02557516|101811635|FG003|Overall Study|Disease progression|0|||
33522640|NCT02557516|101811632|FG000|Overall Study|Physician Decision|0|||
33522641|NCT02557516|101811633|FG001|Overall Study|Physician Decision|2|||
33522642|NCT02557516|101811634|FG002|Overall Study|Physician Decision|0|||
33522643|NCT02557516|101811635|FG003|Overall Study|Physician Decision|0|||
33522644|NCT02557516|101811632|FG000|Overall Study|Sponsor decision|0|||
33522645|NCT02557516|101811633|FG001|Overall Study|Sponsor decision|1|||
33522646|NCT02557516|101811634|FG002|Overall Study|Sponsor decision|2|||
33522647|NCT02557516|101811635|FG003|Overall Study|Sponsor decision|8|||
33522648|NCT02334384|101811638|FG000|Overall Study|Lost to Follow-up|1|||
33522649|NCT02334384|101811639|FG001|Overall Study|Lost to Follow-up|1|||
33522650|NCT03055494|101811640|FG000|Overall Study|Lost to Follow-up|6|||
33522651|NCT03055494|101811641|FG001|Overall Study|Lost to Follow-up|0|||
33522652|NCT03055494|101811640|FG000|Overall Study|Physician Decision|2|||
33522653|NCT03055494|101811641|FG001|Overall Study|Physician Decision|0|||
33522654|NCT03055494|101811640|FG000|Overall Study|Withdrawal by Subject|1|||
33522655|NCT03055494|101811641|FG001|Overall Study|Withdrawal by Subject|0|||
33522656|NCT03055494|101811640|FG000|Overall Study|Adverse Event|0|||
33522657|NCT03055494|101811641|FG001|Overall Study|Adverse Event|1|||
33609173|NCT02798471|102118580|FG000|Overall Study|Subject withdrew consent|0|||
33609174|NCT02798471|102118581|FG001|Overall Study|Subject withdrew consent|6|||
33609175|NCT02798471|102118580|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
33200907|NCT02117570|100638463|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
33200908|NCT02117570|100638461|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
33522658|NCT03055494|101811640|FG000|Overall Study|Non-compliance with study treatment|1|||
33522659|NCT03055494|101811641|FG001|Overall Study|Non-compliance with study treatment|0|||
33522660|NCT02584959|101811642|FG000|Period 1|Withdrawn from study|3|||
33522661|NCT02584959|101811643|FG001|Period 1|Withdrawn from study|4|||
33522662|NCT02584959|101811644|FG002|Period 1|Withdrawn from study|0|||
33522663|NCT02584959|101811642|FG000|Period 2|Withdrawn from study|6|||
33522664|NCT02584959|101811643|FG001|Period 2|Withdrawn from study|1|||
33522665|NCT02584959|101811644|FG002|Period 2|Withdrawn from study|2|||
33522666|NCT03774394|101811647|FG000|Overall Study|Withdrawal by Subject|2|||
33522667|NCT03774394|101811648|FG001|Overall Study|Withdrawal by Subject|0|||
33522668|NCT04114656|101811649|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
33522669|NCT04114656|101811650|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
33522670|NCT04114656|101811649|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
33522671|NCT04114656|101811650|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
33522672|NCT04114656|101811649|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
33522673|NCT04114656|101811650|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
33522674|NCT04114656|101811649|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
33522675|NCT04114656|101811650|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
33522676|NCT04114656|101811649|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
33522677|NCT04114656|101811650|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
33522678|NCT03066778|101811651|FG000|Overall Study|Death|195|||
33522679|NCT03066778|101811652|FG001|Overall Study|Death|205|||
33522680|NCT03066778|101811651|FG000|Overall Study|Withdrawal by Subject|5|||
33522681|NCT03066778|101811652|FG001|Overall Study|Withdrawal by Subject|7|||
33522682|NCT01348100|101811653|FG000|Overall Study|Subject Withdrew Consent|0|||
33522683|NCT01348100|101811654|FG001|Overall Study|Subject Withdrew Consent|0|||
33522684|NCT01348100|101811655|FG002|Overall Study|Subject Withdrew Consent|2|||
33522685|NCT01348100|101811656|FG003|Overall Study|Subject Withdrew Consent|0|||
33522686|NCT01348100|101811657|FG004|Overall Study|Subject Withdrew Consent|1|||
33522687|NCT01348100|101811658|FG005|Overall Study|Subject Withdrew Consent|0|||
33522688|NCT01348100|101811659|FG006|Overall Study|Subject Withdrew Consent|1|||
33522689|NCT01348100|101811653|FG000|Overall Study|Protocol Deviation|0|||
33522690|NCT01348100|101811654|FG001|Overall Study|Protocol Deviation|0|||
33522691|NCT01348100|101811655|FG002|Overall Study|Protocol Deviation|0|||
33522692|NCT01348100|101811656|FG003|Overall Study|Protocol Deviation|1|||
33522693|NCT01348100|101811657|FG004|Overall Study|Protocol Deviation|0|||
33522694|NCT01348100|101811658|FG005|Overall Study|Protocol Deviation|0|||
33522695|NCT01348100|101811659|FG006|Overall Study|Protocol Deviation|0|||
33522696|NCT01348100|101811653|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33522697|NCT01348100|101811654|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33522698|NCT01348100|101811655|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33522699|NCT01348100|101811656|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33522700|NCT01348100|101811657|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33522701|NCT01348100|101811658|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
33522702|NCT01348100|101811659|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33522703|NCT01348100|101811653|FG000|Overall Study|Lost to Follow-up|0|||
33522704|NCT01348100|101811654|FG001|Overall Study|Lost to Follow-up|0|||
33522705|NCT01348100|101811655|FG002|Overall Study|Lost to Follow-up|0|||
33522706|NCT01348100|101811656|FG003|Overall Study|Lost to Follow-up|0|||
33522707|NCT01348100|101811657|FG004|Overall Study|Lost to Follow-up|0|||
33522708|NCT01348100|101811658|FG005|Overall Study|Lost to Follow-up|0|||
33522709|NCT01348100|101811659|FG006|Overall Study|Lost to Follow-up|1|||
33522710|NCT01348100|101811653|FG000|Overall Study|Administrative Problems|0|||
33522711|NCT01348100|101811654|FG001|Overall Study|Administrative Problems|0|||
33522712|NCT01348100|101811655|FG002|Overall Study|Administrative Problems|0|||
33522713|NCT01348100|101811656|FG003|Overall Study|Administrative Problems|0|||
33522714|NCT01348100|101811657|FG004|Overall Study|Administrative Problems|0|||
33522715|NCT01348100|101811658|FG005|Overall Study|Administrative Problems|1|||
33522716|NCT01348100|101811659|FG006|Overall Study|Administrative Problems|1|||
33522717|NCT02509078|101811665|FG000|Overall Study|Protocol Violation|1|||
33522718|NCT02509078|101811666|FG001|Overall Study|Protocol Violation|1|||
33522719|NCT03209518|101811674|FG000|Overall Study|Case Report Forms Uncollected|1|||
33522720|NCT03209518|101811674|FG000|Overall Study|Protocol Deviation|1|||
33522721|NCT04527978|101811679|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
33522722|NCT04527978|101811680|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
33522723|NCT00350779|101811683|FG000|Overall Study|Adverse Event|4|||
33522724|NCT00350779|101811684|FG001|Overall Study|Adverse Event|2|||
33522725|NCT00350779|101811683|FG000|Overall Study|Lack of Efficacy|0|||
33522726|NCT00350779|101811684|FG001|Overall Study|Lack of Efficacy|4|||
33522727|NCT00350779|101811683|FG000|Overall Study|Lost to Follow-up|2|||
33522728|NCT00350779|101811684|FG001|Overall Study|Lost to Follow-up|0|||
33522729|NCT00350779|101811683|FG000|Overall Study|Physician Decision|2|||
33329323|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
33522730|NCT00350779|101811684|FG001|Overall Study|Physician Decision|4|||
33329324|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
33329325|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
33522731|NCT00350779|101811683|FG000|Overall Study|Protocol Violation|3|||
33522732|NCT00350779|101811684|FG001|Overall Study|Protocol Violation|1|||
33200909|NCT02117570|100638462|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
33200910|NCT02117570|100638463|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
33200911|NCT01045447|100638464|FG000|Overall Study|Adverse Event|0|||
33329326|NCT00111800|101101120|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
33329327|NCT00111800|101101121|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
33329328|NCT00111800|101101122|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
33329329|NCT00111800|101101123|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
33329330|NCT00111800|101101124|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
33329331|NCT00111800|101101125|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
33329332|NCT00111800|101101120|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
33329333|NCT00111800|101101121|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
33329334|NCT00111800|101101122|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
33329335|NCT00111800|101101123|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
33329336|NCT00111800|101101124|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
33522733|NCT00350779|101811683|FG000|Overall Study|Withdrawal by Subject|9|||
33522734|NCT00350779|101811684|FG001|Overall Study|Withdrawal by Subject|8|||
33522735|NCT00350779|101811683|FG000|Overall Study|Patient Moved|2|||
33329337|NCT00111800|101101125|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
33522736|NCT00350779|101811684|FG001|Overall Study|Patient Moved|1|||
33522737|NCT00350779|101811683|FG000|Overall Study|Non-compliance with study procedures|0|||
33522738|NCT00350779|101811684|FG001|Overall Study|Non-compliance with study procedures|1|||
33522739|NCT00530790|101811686|FG000|Overall Study|Adverse Event|2|||
33522740|NCT00530790|101811686|FG000|Overall Study|Withdrawal by Subject|2|||
33522741|NCT00530790|101811686|FG000|Overall Study|Physician Decision|1|||
33522742|NCT01410240|101811687|FG000|Overall Study|Physician Decision|0|||
33522743|NCT01410240|101811688|FG001|Overall Study|Physician Decision|0|||
33522744|NCT01410240|101811689|FG002|Overall Study|Physician Decision|1|||
33329338|NCT00111800|101101120|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
33329339|NCT00111800|101101121|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
33329340|NCT00111800|101101122|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
33329341|NCT00111800|101101123|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
33329342|NCT00111800|101101124|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
33329343|NCT00111800|101101125|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
33329344|NCT00111800|101101120|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
33329345|NCT00111800|101101121|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
33329346|NCT00111800|101101122|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
33329347|NCT00111800|101101123|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
33329348|NCT00111800|101101124|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
33329349|NCT00111800|101101125|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
33329350|NCT00111800|101101120|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
33329351|NCT00111800|101101121|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
33329352|NCT00111800|101101122|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
33329353|NCT00111800|101101123|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
33329354|NCT00111800|101101124|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
33329355|NCT00111800|101101125|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
33329356|NCT00111800|101101120|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
33329357|NCT00111800|101101121|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
33329358|NCT00111800|101101122|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
33329359|NCT00111800|101101123|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
33329360|NCT00111800|101101124|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
33329361|NCT00111800|101101125|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
33522745|NCT01410240|101811687|FG000|Overall Study|Missed week 6 assessments|1|||
33522746|NCT01410240|101811688|FG001|Overall Study|Missed week 6 assessments|1|||
33522747|NCT01410240|101811689|FG002|Overall Study|Missed week 6 assessments|1|||
33609176|NCT02798471|102118581|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
33329362|NCT00111800|101101120|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
33329363|NCT00111800|101101121|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
33329364|NCT00111800|101101122|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
33329365|NCT00111800|101101123|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
33329366|NCT00111800|101101124|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
33329367|NCT00111800|101101125|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
33329368|NCT00111800|101101120|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
33329369|NCT00111800|101101121|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
33329370|NCT00111800|101101122|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
33329371|NCT00111800|101101123|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
33329372|NCT00111800|101101124|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
33329373|NCT00111800|101101125|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
33329374|NCT00111800|101101120|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
33329375|NCT00111800|101101121|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
33329376|NCT00111800|101101122|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
33329377|NCT00111800|101101123|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
33329378|NCT00111800|101101124|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
33401649|NCT01521494|101361461|FG003|Overall Study|Withdrawal by Subject|2|||
33401650|NCT01521494|101361462|FG004|Overall Study|Withdrawal by Subject|0|||
33401651|NCT01521494|101361458|FG000|Overall Study|Decrease in serum phosphate|0|||
33401652|NCT01521494|101361459|FG001|Overall Study|Decrease in serum phosphate|2|||
33401653|NCT01521494|101361460|FG002|Overall Study|Decrease in serum phosphate|3|||
33401654|NCT01521494|101361461|FG003|Overall Study|Decrease in serum phosphate|12|||
33401655|NCT01521494|101361462|FG004|Overall Study|Decrease in serum phosphate|0|||
33401656|NCT01521494|101361458|FG000|Overall Study|Decrease in serum calcium|0|||
33329379|NCT00111800|101101125|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
33329380|NCT04649255|101101129|FG000|Overall Study|Death|9|||
33329381|NCT04649255|101101129|FG000|Overall Study|Withdrawal by Subject|1|||
33329382|NCT02231164|101101132|FG000|Overall Study|Adverse Event|1|||
33329383|NCT02231164|101101133|FG001|Overall Study|Adverse Event|1|||
33329384|NCT02231164|101101132|FG000|Overall Study|Lack of Efficacy|4|||
33329385|NCT02231164|101101133|FG001|Overall Study|Lack of Efficacy|3|||
33329386|NCT02231164|101101132|FG000|Overall Study|Withdrawal by Subject|1|||
33329387|NCT02231164|101101133|FG001|Overall Study|Withdrawal by Subject|2|||
33329388|NCT02230384|101101136|FG000|Phase 1|Lost to Follow-up|1|||
33329389|NCT02230384|101101137|FG001|Phase 1|Lost to Follow-up|0|||
33329390|NCT02230384|101101136|FG000|Phase 1|Physician Decision|0|||
33329391|NCT02230384|101101137|FG001|Phase 1|Physician Decision|1|||
33329392|NCT02230384|101101136|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
33329393|NCT02230384|101101137|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
33329394|NCT02230384|101101136|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
33329395|NCT02230384|101101137|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
33329396|NCT02230384|101101136|FG000|Phase 2 - Switch|Adverse Event|2|||
33329397|NCT02230384|101101137|FG001|Phase 2 - Switch|Adverse Event|0|||
33329398|NCT01835015|101101140|FG000|Overall Study|Adverse Event|0|||
33329399|NCT01835015|101101141|FG001|Overall Study|Adverse Event|0|||
33329400|NCT01835015|101101142|FG002|Overall Study|Adverse Event|1|||
33329401|NCT01835015|101101143|FG003|Overall Study|Adverse Event|0|||
33329402|NCT01835015|101101144|FG004|Overall Study|Adverse Event|0|||
33329403|NCT02969187|101101156|FG000|Overall Study|Physician Decision|12|||
33329404|NCT02969187|101101157|FG001|Overall Study|Physician Decision|13|||
33329405|NCT02553265|101101158|FG000|Enrollment|Death|0|||
33329406|NCT02553265|101101159|FG001|Enrollment|Death|0|||
33329407|NCT02553265|101101160|FG002|Enrollment|Death|1|||
33329408|NCT02553265|101101158|FG000|First Intervention (28 Days)|Adverse Event|1|||
33329409|NCT02553265|101101159|FG001|First Intervention (28 Days)|Adverse Event|0|||
33329410|NCT02553265|101101160|FG002|First Intervention (28 Days)|Adverse Event|0|||
33329411|NCT02553265|101101158|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
33329412|NCT02553265|101101159|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
33609177|NCT02798471|102118580|FG000|Overall Study|Randomized, but not treated|0|||
33329413|NCT02553265|101101160|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
33329414|NCT02553265|101101158|FG000|Second Intervention (28 Days)|Adverse Event|1|||
33329415|NCT02553265|101101159|FG001|Second Intervention (28 Days)|Adverse Event|0|||
33329416|NCT02553265|101101160|FG002|Second Intervention (28 Days)|Adverse Event|0|||
33329417|NCT02553265|101101158|FG000|Third Intervention (28 Days)|Adverse Event|1|||
33329418|NCT02553265|101101159|FG001|Third Intervention (28 Days)|Adverse Event|0|||
33329419|NCT02553265|101101160|FG002|Third Intervention (28 Days)|Adverse Event|0|||
33329420|NCT02553265|101101158|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
33401657|NCT01521494|101361459|FG001|Overall Study|Decrease in serum calcium|0|||
33609178|NCT02798471|102118581|FG001|Overall Study|Randomized, but not treated|2|||
33329421|NCT02553265|101101159|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
33329422|NCT02553265|101101160|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
33329423|NCT00708123|101101162|FG000|Period 1|Protocol Violation|0|||
33329424|NCT00708123|101101163|FG001|Period 1|Protocol Violation|1|||
33329425|NCT00708123|101101164|FG002|Period 1|Protocol Violation|0|||
33329426|NCT00708123|101101165|FG003|Period 1|Protocol Violation|1|||
33329427|NCT00708123|101101166|FG004|Period 1|Protocol Violation|0|||
33329428|NCT00708123|101101162|FG000|Period 1|Adverse Event|0|||
33329429|NCT00708123|101101163|FG001|Period 1|Adverse Event|0|||
33329430|NCT00708123|101101164|FG002|Period 1|Adverse Event|1|||
33329431|NCT00708123|101101165|FG003|Period 1|Adverse Event|0|||
33329432|NCT00708123|101101166|FG004|Period 1|Adverse Event|0|||
33329433|NCT00708123|101101162|FG000|Period 2|Protocol Violation|0|||
33329434|NCT00708123|101101163|FG001|Period 2|Protocol Violation|0|||
33329435|NCT00708123|101101164|FG002|Period 2|Protocol Violation|0|||
33329436|NCT00708123|101101165|FG003|Period 2|Protocol Violation|1|||
33329437|NCT00708123|101101166|FG004|Period 2|Protocol Violation|0|||
33329438|NCT00708123|101101162|FG000|Period 2|Other Reason|1|||
33329439|NCT00708123|101101163|FG001|Period 2|Other Reason|0|||
33329440|NCT00708123|101101164|FG002|Period 2|Other Reason|0|||
33329441|NCT00708123|101101165|FG003|Period 2|Other Reason|0|||
33329442|NCT00708123|101101166|FG004|Period 2|Other Reason|0|||
33329443|NCT00708123|101101162|FG000|Period 3|Lost to Follow-up|0|||
33329444|NCT00708123|101101163|FG001|Period 3|Lost to Follow-up|0|||
33522748|NCT00840034|101811692|FG000|Acute Treatment Phase|Adverse Event|6|||
33329445|NCT00708123|101101164|FG002|Period 3|Lost to Follow-up|1|||
33329446|NCT00708123|101101165|FG003|Period 3|Lost to Follow-up|1|||
33329447|NCT00708123|101101166|FG004|Period 3|Lost to Follow-up|0|||
33329448|NCT00708123|101101162|FG000|Period 4|Protocol Violation|0|||
33329449|NCT00708123|101101163|FG001|Period 4|Protocol Violation|1|||
33329450|NCT00708123|101101164|FG002|Period 4|Protocol Violation|0|||
33329451|NCT00708123|101101165|FG003|Period 4|Protocol Violation|0|||
33522749|NCT00840034|101811693|FG001|Acute Treatment Phase|Adverse Event|8|||
33329452|NCT00708123|101101166|FG004|Period 4|Protocol Violation|0|||
33329453|NCT00434421|101101169|FG000|Overall Study|Withdrawal by Subject|1|||
33329454|NCT00434421|101101169|FG000|Overall Study|Non-compliance with study treatment|1|||
33329455|NCT02255409|101101170|FG000|Overall Study|Administrative Reason|3|||
33329456|NCT02255409|101101171|FG001|Overall Study|Administrative Reason|7|||
33329457|NCT02255409|101101170|FG000|Overall Study|Withdrawal by Subject|1|||
33329458|NCT02255409|101101171|FG001|Overall Study|Withdrawal by Subject|5|||
33329459|NCT02255409|101101170|FG000|Overall Study|Lost to Follow-up|10|||
33329460|NCT02255409|101101171|FG001|Overall Study|Lost to Follow-up|19|||
33329461|NCT01438489|101101172|FG000|Overall Study|Lost to Follow-up|4|||
33329462|NCT01438489|101101173|FG001|Overall Study|Lost to Follow-up|2|||
33329463|NCT01438489|101101174|FG002|Overall Study|Lost to Follow-up|2|||
33329464|NCT01438489|101101172|FG000|Overall Study|Withdrawal by Subject|11|||
33329465|NCT01438489|101101173|FG001|Overall Study|Withdrawal by Subject|3|||
33329466|NCT01438489|101101174|FG002|Overall Study|Withdrawal by Subject|8|||
33522750|NCT00840034|101811692|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
33522751|NCT00840034|101811693|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
33522752|NCT00840034|101811692|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
33522753|NCT00840034|101811693|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
33522754|NCT00840034|101811692|FG000|Acute Treatment Phase|Physician Decision|0|||
33522755|NCT00840034|101811693|FG001|Acute Treatment Phase|Physician Decision|1|||
33522756|NCT00840034|101811692|FG000|Acute Treatment Phase|Protocol Violation|2|||
33522757|NCT00840034|101811693|FG001|Acute Treatment Phase|Protocol Violation|4|||
33522758|NCT00840034|101811692|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
33522759|NCT00840034|101811693|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
33522760|NCT00840034|101811692|FG000|Taper Phase|Adverse Event|1|||
33522761|NCT00840034|101811693|FG001|Taper Phase|Adverse Event|0|||
33329467|NCT01438489|101101172|FG000|Overall Study|Death|0|||
33329468|NCT01438489|101101173|FG001|Overall Study|Death|0|||
33329469|NCT01438489|101101174|FG002|Overall Study|Death|1|||
33329470|NCT01438489|101101172|FG000|Overall Study|Sponsor decision|4|||
33329471|NCT01438489|101101173|FG001|Overall Study|Sponsor decision|1|||
33329472|NCT01438489|101101174|FG002|Overall Study|Sponsor decision|4|||
33522762|NCT00840034|101811692|FG000|Taper Phase|Lost to Follow-up|1|||
33329473|NCT01438489|101101172|FG000|Overall Study|Subject choice/Subject moved|2|||
33329474|NCT01438489|101101173|FG001|Overall Study|Subject choice/Subject moved|1|||
33329475|NCT01438489|101101174|FG002|Overall Study|Subject choice/Subject moved|1|||
33329476|NCT01438489|101101172|FG000|Overall Study|Investigator decision|0|||
33329477|NCT01438489|101101173|FG001|Overall Study|Investigator decision|1|||
33329478|NCT01438489|101101174|FG002|Overall Study|Investigator decision|0|||
33329479|NCT01438489|101101172|FG000|Overall Study|AE/SAEs|2|||
33329480|NCT01438489|101101173|FG001|Overall Study|AE/SAEs|1|||
33329481|NCT01438489|101101174|FG002|Overall Study|AE/SAEs|1|||
33329482|NCT01438489|101101172|FG000|Overall Study|Received prohibited medication|1|||
33522763|NCT00840034|101811693|FG001|Taper Phase|Lost to Follow-up|1|||
33329483|NCT01438489|101101173|FG001|Overall Study|Received prohibited medication|0|||
33329484|NCT01438489|101101174|FG002|Overall Study|Received prohibited medication|0|||
33609179|NCT02476006|102118582|FG000|Overall Study|Death|4|||
33200912|NCT01045447|100638465|FG001|Overall Study|Adverse Event|1|||
33401658|NCT01521494|101361460|FG002|Overall Study|Decrease in serum calcium|0|||
33401659|NCT01521494|101361461|FG003|Overall Study|Decrease in serum calcium|1|||
33401660|NCT01521494|101361462|FG004|Overall Study|Decrease in serum calcium|1|||
33401661|NCT01521494|101361458|FG000|Overall Study|Physician Decision|0|||
33401662|NCT01521494|101361459|FG001|Overall Study|Physician Decision|0|||
33401663|NCT01521494|101361460|FG002|Overall Study|Physician Decision|0|||
33401664|NCT01521494|101361461|FG003|Overall Study|Physician Decision|0|||
33401665|NCT01521494|101361462|FG004|Overall Study|Physician Decision|2|||
33401666|NCT01222767|101361463|FG000|Overall Study|Progressive disease|13|||
33401667|NCT01222767|101361463|FG000|Overall Study|Adverse Event|2|||
33401668|NCT01222767|101361463|FG000|Overall Study|Surgical resection|1|||
33401669|NCT01222767|101361463|FG000|Overall Study|Never treated|1|||
33401670|NCT01853397|101361469|FG000|Overall Study|Withdrawal by Subject|0|||
33401671|NCT01853397|101361470|FG001|Overall Study|Withdrawal by Subject|0|||
33401672|NCT01853397|101361471|FG002|Overall Study|Withdrawal by Subject|0|||
33401673|NCT01853397|101361472|FG003|Overall Study|Withdrawal by Subject|1|||
33401674|NCT01853397|101361469|FG000|Overall Study|Subject Noncompliance|0|||
33401675|NCT01853397|101361470|FG001|Overall Study|Subject Noncompliance|0|||
33401676|NCT01853397|101361471|FG002|Overall Study|Subject Noncompliance|0|||
33401677|NCT01853397|101361472|FG003|Overall Study|Subject Noncompliance|1|||
33401678|NCT02583399|101361473|FG000|Overall Study|Able to be discharged|3|||
33401679|NCT02583399|101361473|FG000|Overall Study|Wanted to use a restricted medication|3|||
33401680|NCT00982111|101361479|FG000|Overall Study|Adverse Event|1|||
33401681|NCT00982111|101361480|FG001|Overall Study|Adverse Event|1|||
33401682|NCT00982111|101361479|FG000|Overall Study|Progressive Disease|46|||
33401683|NCT00982111|101361480|FG001|Overall Study|Progressive Disease|39|||
33401684|NCT00982111|101361479|FG000|Overall Study|Lost to Follow-up|9|||
33401685|NCT00982111|101361480|FG001|Overall Study|Lost to Follow-up|6|||
33401686|NCT00982111|101361479|FG000|Overall Study|New Anti-Cancer Therapy|5|||
33401687|NCT00982111|101361480|FG001|Overall Study|New Anti-Cancer Therapy|5|||
33401688|NCT00982111|101361479|FG000|Overall Study|Medical Decision|1|||
33401689|NCT00982111|101361480|FG001|Overall Study|Medical Decision|0|||
33401690|NCT00982111|101361479|FG000|Overall Study|Withdrawal by Subject|17|||
33401691|NCT00982111|101361480|FG001|Overall Study|Withdrawal by Subject|19|||
33401692|NCT00982111|101361479|FG000|Overall Study|Global Study End|0|||
33401693|NCT00982111|101361480|FG001|Overall Study|Global Study End|1|||
33401694|NCT00982111|101361479|FG000|Overall Study|Sponsor's Decision|0|||
33401695|NCT00982111|101361480|FG001|Overall Study|Sponsor's Decision|1|||
33401696|NCT00758394|101361481|FG000|2nd Intervention Order|Lost to Follow-up|0|||
33401697|NCT00758394|101361482|FG001|2nd Intervention Order|Lost to Follow-up|1|||
33401698|NCT00758394|101361483|FG002|2nd Intervention Order|Lost to Follow-up|0|||
33401699|NCT00758394|101361484|FG003|2nd Intervention Order|Lost to Follow-up|0|||
33401700|NCT00758394|101361481|FG000|3rd Intervention|Lost to Follow-up|1|||
33401701|NCT00758394|101361482|FG001|3rd Intervention|Lost to Follow-up|0|||
33401702|NCT00758394|101361483|FG002|3rd Intervention|Lost to Follow-up|0|||
33401703|NCT00758394|101361484|FG003|3rd Intervention|Lost to Follow-up|1|||
33401704|NCT02576951|101361485|FG000|Overall Study|Lost to Follow-up|0|||
33401705|NCT02576951|101361486|FG001|Overall Study|Lost to Follow-up|0|||
33401706|NCT02576951|101361487|FG002|Overall Study|Lost to Follow-up|2|||
33401707|NCT02576951|101361488|FG003|Overall Study|Lost to Follow-up|2|||
33401708|NCT02576951|101361485|FG000|Overall Study|Withdrawal by Subject|1|||
33401709|NCT02576951|101361486|FG001|Overall Study|Withdrawal by Subject|0|||
33401710|NCT02576951|101361487|FG002|Overall Study|Withdrawal by Subject|0|||
33401711|NCT02576951|101361488|FG003|Overall Study|Withdrawal by Subject|2|||
33401712|NCT02576951|101361485|FG000|Overall Study|Protocol Violation|0|||
33401713|NCT02576951|101361486|FG001|Overall Study|Protocol Violation|0|||
33401714|NCT02576951|101361487|FG002|Overall Study|Protocol Violation|0|||
33401715|NCT02576951|101361488|FG003|Overall Study|Protocol Violation|1|||
33401716|NCT00303719|101361489|FG000|Overall Study|Not evaluable, prior therapies|0|||
33401717|NCT00303719|101361490|FG001|Overall Study|Not evaluable, prior therapies|30|||
33401718|NCT00303719|101361489|FG000|Overall Study|Lost to Follow-up|0|||
33401719|NCT00303719|101361490|FG001|Overall Study|Lost to Follow-up|7|||
33401720|NCT02400281|101361491|FG000|Overall Study|Adverse Event|0|||
33401721|NCT02400281|101361492|FG001|Overall Study|Adverse Event|0|||
33401722|NCT02400281|101361493|FG002|Overall Study|Adverse Event|1|||
33401723|NCT02400281|101361494|FG003|Overall Study|Adverse Event|0|||
33401724|NCT02400281|101361495|FG004|Overall Study|Adverse Event|1|||
33401725|NCT02400281|101361496|FG005|Overall Study|Adverse Event|0|||
33401726|NCT02400281|101361491|FG000|Overall Study|Physician Decision|0|||
33401727|NCT02400281|101361492|FG001|Overall Study|Physician Decision|0|||
33401728|NCT02400281|101361493|FG002|Overall Study|Physician Decision|1|||
33401729|NCT02400281|101361494|FG003|Overall Study|Physician Decision|0|||
33401730|NCT02400281|101361495|FG004|Overall Study|Physician Decision|0|||
33401731|NCT02400281|101361496|FG005|Overall Study|Physician Decision|0|||
33401732|NCT02795182|101361497|FG000|Overall Study|Death|5|||
33401733|NCT02795182|101361498|FG001|Overall Study|Death|4|||
33609180|NCT02476006|102118582|FG000|Overall Study|Lack of treatment efficacy|2|||
33401734|NCT02795182|101361499|FG002|Overall Study|Death|4|||
33401735|NCT02795182|101361500|FG003|Overall Study|Death|18|||
33401736|NCT02795182|101361497|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
33401737|NCT02795182|101361498|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
33522764|NCT00840034|101811692|FG000|Taper Phase|Withdrawal by Subject|1|||
33522765|NCT00840034|101811693|FG001|Taper Phase|Withdrawal by Subject|1|||
33522766|NCT02417961|101811694|FG000|Overall Study|Adverse Event|1|||
33522767|NCT02417961|101811694|FG000|Overall Study|Lost to Follow-up|1|||
33401738|NCT02795182|101361499|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
33401739|NCT02795182|101361500|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
33401740|NCT02795182|101361497|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
33329485|NCT01438489|101101172|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
33401741|NCT02795182|101361498|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
33401742|NCT02795182|101361499|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
33401743|NCT02795182|101361500|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
33401744|NCT02795182|101361497|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
33401745|NCT02795182|101361498|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
33401746|NCT02795182|101361499|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
33401747|NCT02795182|101361500|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
33401748|NCT02795182|101361497|FG000|Overall Study|Withdrawal by Subject|4|||
33401749|NCT02795182|101361498|FG001|Overall Study|Withdrawal by Subject|0|||
33401750|NCT02795182|101361499|FG002|Overall Study|Withdrawal by Subject|0|||
33401751|NCT02795182|101361500|FG003|Overall Study|Withdrawal by Subject|3|||
33401752|NCT02795182|101361497|FG000|Overall Study|Lost to Follow-up|0|||
33401753|NCT02795182|101361498|FG001|Overall Study|Lost to Follow-up|0|||
33401754|NCT02795182|101361499|FG002|Overall Study|Lost to Follow-up|1|||
33401755|NCT02795182|101361500|FG003|Overall Study|Lost to Follow-up|1|||
33401756|NCT02795182|101361497|FG000|Overall Study|Roll Over to Long Term Extension|3|||
33522768|NCT02417961|101811694|FG000|Overall Study|Withdrawal by Subject|2|||
33522769|NCT01393106|101811695|FG000|Overall Study|Adverse Event|3|||
33522770|NCT01393106|101811695|FG000|Overall Study|Withdrawal by Subject|1|||
33522771|NCT01393106|101811695|FG000|Overall Study|Lack of Efficacy|1|||
33329486|NCT01438489|101101173|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
33329487|NCT01438489|101101174|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
33329488|NCT01438489|101101172|FG000|Overall Study|Inadequate venous access|0|||
33329489|NCT01438489|101101173|FG001|Overall Study|Inadequate venous access|2|||
33329490|NCT01438489|101101174|FG002|Overall Study|Inadequate venous access|0|||
33329491|NCT01986920|101101175|FG000|A- 101 25%|Withdrawal by Subject|1|||
33329492|NCT01986920|101101176|FG001|A- 101 25%|Withdrawal by Subject|0|||
33329493|NCT01986920|101101177|FG002|A- 101 25%|Withdrawal by Subject|0|||
33329494|NCT01986920|101101178|FG003|A- 101 25%|Withdrawal by Subject|0|||
33329495|NCT01986920|101101175|FG000|A-101 32.5%|Withdrawal by Subject|0|||
33329496|NCT01986920|101101176|FG001|A-101 32.5%|Withdrawal by Subject|1|||
33329497|NCT01986920|101101177|FG002|A-101 32.5%|Withdrawal by Subject|0|||
33329498|NCT01986920|101101178|FG003|A-101 32.5%|Withdrawal by Subject|0|||
33329499|NCT01986920|101101175|FG000|A-101 40%|Withdrawal by Subject|0|||
33329500|NCT01986920|101101176|FG001|A-101 40%|Withdrawal by Subject|0|||
33329501|NCT01986920|101101177|FG002|A-101 40%|Withdrawal by Subject|1|||
33329502|NCT01986920|101101178|FG003|A-101 40%|Withdrawal by Subject|0|||
33329503|NCT01986920|101101175|FG000|Placebo|Withdrawal by Subject|0|||
33329504|NCT01986920|101101176|FG001|Placebo|Withdrawal by Subject|0|||
33329505|NCT01986920|101101177|FG002|Placebo|Withdrawal by Subject|0|||
33329506|NCT01986920|101101178|FG003|Placebo|Withdrawal by Subject|1|||
33329507|NCT02374099|101101181|FG000|Overall Study|Adverse Event|1|||
33329508|NCT02374099|101101182|FG001|Overall Study|Adverse Event|0|||
33401757|NCT02795182|101361498|FG001|Overall Study|Roll Over to Long Term Extension|3|||
33522772|NCT00715520|101811696|FG000|Overall Study|Screen failure|8|||
33329509|NCT02374099|101101181|FG000|Overall Study|Progressive Disease|35|||
33329510|NCT02374099|101101182|FG001|Overall Study|Progressive Disease|40|||
33329511|NCT02374099|101101181|FG000|Overall Study|Withdrawal by Subject|5|||
33329512|NCT02374099|101101182|FG001|Overall Study|Withdrawal by Subject|1|||
33329513|NCT02374099|101101181|FG000|Overall Study|Miscellaneous|2|||
33329514|NCT02374099|101101182|FG001|Overall Study|Miscellaneous|3|||
33329515|NCT02374099|101101181|FG000|Overall Study|Randomized, but not treated|2|||
33329516|NCT02374099|101101182|FG001|Overall Study|Randomized, but not treated|1|||
33329517|NCT02374099|101101181|FG000|Overall Study|Study Terminated by Sponsor|3|||
33329518|NCT02374099|101101182|FG001|Overall Study|Study Terminated by Sponsor|4|||
33329519|NCT01066585|101101183|FG000|Overall Study|Protocol Violation|1|||
33401758|NCT02795182|101361499|FG002|Overall Study|Roll Over to Long Term Extension|2|||
33401759|NCT02795182|101361500|FG003|Overall Study|Roll Over to Long Term Extension|5|||
33401760|NCT02795182|101361497|FG000|Overall Study|Progressive Disease|0|||
33401761|NCT02795182|101361498|FG001|Overall Study|Progressive Disease|1|||
33401762|NCT02795182|101361499|FG002|Overall Study|Progressive Disease|0|||
33401763|NCT02795182|101361500|FG003|Overall Study|Progressive Disease|4|||
33401764|NCT02795182|101361497|FG000|Overall Study|Physician Decision|0|||
33401765|NCT02795182|101361498|FG001|Overall Study|Physician Decision|0|||
33401766|NCT02795182|101361499|FG002|Overall Study|Physician Decision|0|||
33401767|NCT02795182|101361500|FG003|Overall Study|Physician Decision|1|||
33401768|NCT04369742|101361502|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
33401769|NCT04369742|101361503|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
33401770|NCT04369742|101361502|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
33401771|NCT04369742|101361503|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
33609181|NCT02476006|102118582|FG000|Overall Study|Pregnancy|1|||
33609182|NCT02476006|102118582|FG000|Overall Study|Participant did not wish to continue|39|||
33609183|NCT02476006|102118582|FG000|Overall Study|Adverse Event|41|||
33609184|NCT02476006|102118582|FG000|Overall Study|Poor compliance to study protocol|3|||
33609185|NCT02476006|102118582|FG000|Overall Study|Sponsor decision|6|||
33609186|NCT02476006|102118582|FG000|Overall Study|Lost to Follow-up|5|||
33609187|NCT02476006|102118582|FG000|Overall Study|Physician Decision|5|||
33609188|NCT02476006|102118582|FG000|Overall Study|Study ended treatment not available|4|||
33609189|NCT02476006|102118582|FG000|Overall Study|Switched to commercial drug|4|||
33609190|NCT02476006|102118582|FG000|Overall Study|Excluded from study|1|||
33609191|NCT02476006|102118582|FG000|Overall Study|Protocol Violation|1|||
33609192|NCT02476006|102118582|FG000|Overall Study|Enrolled but not treated|4|||
33609193|NCT00392990|102118583|FG000|Treatment on Study|Adverse Event|3|||
33609194|NCT00392990|102118584|FG001|Treatment on Study|Adverse Event|1|||
33609195|NCT00392990|102118583|FG000|Follow up for 2 Years|Death|4|||
33329520|NCT01066585|101101184|FG001|Overall Study|Protocol Violation|0|||
33329521|NCT01066585|101101183|FG000|Overall Study|Withdrawal by Subject|0|||
33329522|NCT01066585|101101184|FG001|Overall Study|Withdrawal by Subject|3|||
33329523|NCT03829657|101101188|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
33329524|NCT03829657|101101189|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
33329525|NCT03829657|101101190|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
33329526|NCT03829657|101101191|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
33329527|NCT03829657|101101192|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
33329528|NCT03829657|101101188|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
33329529|NCT03829657|101101189|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
33329530|NCT03829657|101101190|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
33329531|NCT03829657|101101191|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
33329532|NCT03829657|101101192|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
33401772|NCT00286234|101361505|FG000|Overall Study|Protocol Violation|1|||
33609196|NCT00392990|102118584|FG001|Follow up for 2 Years|Death|0|||
33609197|NCT03647267|102118587|FG000|Overall Study|Lost to Follow-up|1|||
33609198|NCT03647267|102118588|FG001|Overall Study|Lost to Follow-up|0|||
33329533|NCT03829657|101101188|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
33329534|NCT03829657|101101189|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
33329535|NCT03829657|101101190|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
33329536|NCT03829657|101101191|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
33329537|NCT03829657|101101192|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
33401773|NCT00286234|101361506|FG001|Overall Study|Protocol Violation|2|||
33522773|NCT00715520|101811697|FG001|Overall Study|Screen failure|1|||
33522774|NCT00715520|101811698|FG002|Overall Study|Screen failure|1|||
33522775|NCT00715520|101811696|FG000|Overall Study|Withdrawal by Subject|2|||
33522776|NCT00715520|101811697|FG001|Overall Study|Withdrawal by Subject|0|||
33522777|NCT00715520|101811698|FG002|Overall Study|Withdrawal by Subject|1|||
33522778|NCT01863732|101811699|FG000|Overall Study|Adverse Event|2|||
33522779|NCT01863732|101811700|FG001|Overall Study|Adverse Event|0|||
33609199|NCT01019369|102118589|FG000|Overall Study|Lost to Follow-up|10|||
33401774|NCT00286234|101361507|FG002|Overall Study|Protocol Violation|0|||
33401775|NCT00286234|101361508|FG003|Overall Study|Protocol Violation|1|||
33401776|NCT00286234|101361505|FG000|Overall Study|Physician Decision|1|||
33401777|NCT00286234|101361506|FG001|Overall Study|Physician Decision|0|||
33401778|NCT00286234|101361507|FG002|Overall Study|Physician Decision|0|||
33522780|NCT01863732|101811701|FG002|Overall Study|Adverse Event|3|||
33522781|NCT01863732|101811702|FG003|Overall Study|Adverse Event|3|||
33522782|NCT01863732|101811699|FG000|Overall Study|Lack of Efficacy|1|||
33609200|NCT01019369|102118590|FG001|Overall Study|Lost to Follow-up|6|||
33609201|NCT01019369|102118589|FG000|Overall Study|Withdrawal by Subject|0|||
33609202|NCT01019369|102118590|FG001|Overall Study|Withdrawal by Subject|1|||
33609203|NCT01818284|102118597|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
33609204|NCT01818284|102118598|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
33609205|NCT01818284|102118597|FG000|Overall Study|Death|0|||
33609206|NCT01818284|102118598|FG001|Overall Study|Death|2|||
33609207|NCT00679172|102118599|FG000|Overall Study|Non-compliance|1|||
33609208|NCT00679172|102118600|FG001|Overall Study|Non-compliance|1|||
33609209|NCT00679172|102118601|FG002|Overall Study|Non-compliance|0|||
33609210|NCT00679172|102118602|FG003|Overall Study|Non-compliance|1|||
33609211|NCT00679172|102118603|FG004|Overall Study|Non-compliance|0|||
33609212|NCT00679172|102118599|FG000|Overall Study|Other not specified|0|||
33609213|NCT00679172|102118600|FG001|Overall Study|Other not specified|0|||
33609214|NCT00679172|102118601|FG002|Overall Study|Other not specified|1|||
33609215|NCT00679172|102118602|FG003|Overall Study|Other not specified|0|||
33609216|NCT00679172|102118603|FG004|Overall Study|Other not specified|0|||
33609217|NCT03887221|102118604|FG000|Overall Study|Protocol Violation|1|||
33609218|NCT03887221|102118605|FG001|Overall Study|Protocol Violation|0|||
33609219|NCT01008449|102118606|FG000|Overall Study|Lost to Follow-up|29|||
33522783|NCT01863732|101811700|FG001|Overall Study|Lack of Efficacy|0|||
33522784|NCT01863732|101811701|FG002|Overall Study|Lack of Efficacy|2|||
33200913|NCT01045447|100638464|FG000|Overall Study|Lack of Efficacy|3|||
33200914|NCT01045447|100638465|FG001|Overall Study|Lack of Efficacy|1|||
33200915|NCT01045447|100638464|FG000|Overall Study|Protocol Violation|6|||
33200916|NCT01045447|100638465|FG001|Overall Study|Protocol Violation|3|||
33200917|NCT01045447|100638464|FG000|Overall Study|Withdrawal Criteria|10|||
33200918|NCT01045447|100638465|FG001|Overall Study|Withdrawal Criteria|10|||
33200919|NCT01045447|100638464|FG000|Overall Study|Unclassified|17|||
33200920|NCT01045447|100638465|FG001|Overall Study|Unclassified|13|||
33200921|NCT02033889|100638471|FG000|Overall Study|Adverse Event|3|||
33200922|NCT02033889|100638472|FG001|Overall Study|Adverse Event|1|||
33522785|NCT01863732|101811702|FG003|Overall Study|Lack of Efficacy|1|||
33522786|NCT01863732|101811699|FG000|Overall Study|Lost to Follow-up|2|||
33522787|NCT01863732|101811700|FG001|Overall Study|Lost to Follow-up|2|||
33522788|NCT01863732|101811701|FG002|Overall Study|Lost to Follow-up|1|||
33522789|NCT01863732|101811702|FG003|Overall Study|Lost to Follow-up|1|||
33522790|NCT01863732|101811699|FG000|Overall Study|Physician Decision|1|||
33522791|NCT01863732|101811700|FG001|Overall Study|Physician Decision|0|||
33522792|NCT01863732|101811701|FG002|Overall Study|Physician Decision|1|||
33522793|NCT01863732|101811702|FG003|Overall Study|Physician Decision|0|||
33522794|NCT01863732|101811699|FG000|Overall Study|Pregnancy|0|||
33522795|NCT01863732|101811700|FG001|Overall Study|Pregnancy|0|||
33609220|NCT01008449|102118607|FG001|Overall Study|Lost to Follow-up|19|||
33609221|NCT01440881|102118608|FG000|Overall Study|Death|0|||
33609222|NCT01440881|102118609|FG001|Overall Study|Death|1|||
33609223|NCT03178669|102118610|FG000|Overall Study|Adverse Event|4|||
33609224|NCT03178669|102118611|FG001|Overall Study|Adverse Event|1|||
33609225|NCT03178669|102118612|FG002|Overall Study|Adverse Event|4|||
33609226|NCT03178669|102118613|FG003|Overall Study|Adverse Event|2|||
33609227|NCT03178669|102118614|FG004|Overall Study|Adverse Event|2|||
33609228|NCT03178669|102118610|FG000|Overall Study|Lack of Efficacy|0|||
33609229|NCT03178669|102118611|FG001|Overall Study|Lack of Efficacy|0|||
33609230|NCT03178669|102118612|FG002|Overall Study|Lack of Efficacy|2|||
33609231|NCT03178669|102118613|FG003|Overall Study|Lack of Efficacy|0|||
33609232|NCT03178669|102118614|FG004|Overall Study|Lack of Efficacy|1|||
33609233|NCT03178669|102118610|FG000|Overall Study|Physician Decision|0|||
33609234|NCT03178669|102118611|FG001|Overall Study|Physician Decision|0|||
33609235|NCT03178669|102118612|FG002|Overall Study|Physician Decision|0|||
33609236|NCT03178669|102118613|FG003|Overall Study|Physician Decision|0|||
33609237|NCT03178669|102118614|FG004|Overall Study|Physician Decision|1|||
33609238|NCT03178669|102118610|FG000|Overall Study|Withdrawal by Subject|1|||
33609239|NCT03178669|102118611|FG001|Overall Study|Withdrawal by Subject|0|||
33200923|NCT02033889|100638473|FG002|Overall Study|Adverse Event|3|||
33200924|NCT02033889|100638471|FG000|Overall Study|Death|3|||
33522796|NCT01863732|101811701|FG002|Overall Study|Pregnancy|0|||
33200925|NCT02033889|100638472|FG001|Overall Study|Death|1|||
33200926|NCT02033889|100638473|FG002|Overall Study|Death|2|||
33522797|NCT01863732|101811702|FG003|Overall Study|Pregnancy|1|||
33522798|NCT01863732|101811699|FG000|Overall Study|Technical problems|0|||
33522799|NCT01863732|101811700|FG001|Overall Study|Technical problems|1|||
33522800|NCT01863732|101811701|FG002|Overall Study|Technical problems|1|||
33609240|NCT03178669|102118612|FG002|Overall Study|Withdrawal by Subject|1|||
33609241|NCT03178669|102118613|FG003|Overall Study|Withdrawal by Subject|1|||
33609242|NCT03178669|102118614|FG004|Overall Study|Withdrawal by Subject|0|||
33522801|NCT01863732|101811702|FG003|Overall Study|Technical problems|0|||
33522802|NCT01863732|101811699|FG000|Overall Study|Subject/guardian decision|6|||
33522803|NCT01863732|101811700|FG001|Overall Study|Subject/guardian decision|9|||
33522804|NCT01863732|101811701|FG002|Overall Study|Subject/guardian decision|3|||
33522805|NCT01863732|101811702|FG003|Overall Study|Subject/guardian decision|1|||
33522806|NCT01863732|101811699|FG000|Overall Study|Death|1|||
33522807|NCT01863732|101811700|FG001|Overall Study|Death|0|||
33522808|NCT01863732|101811701|FG002|Overall Study|Death|0|||
33522809|NCT01863732|101811702|FG003|Overall Study|Death|1|||
33522810|NCT01172808|101811703|FG000|Overall Study|Adverse Event|8|||
33522811|NCT01172808|101811704|FG001|Overall Study|Adverse Event|4|||
33522812|NCT01172808|101811705|FG002|Overall Study|Adverse Event|8|||
33522813|NCT01172808|101811706|FG003|Overall Study|Adverse Event|3|||
33522814|NCT01172808|101811703|FG000|Overall Study|Lack of Efficacy|1|||
33522815|NCT01172808|101811704|FG001|Overall Study|Lack of Efficacy|0|||
33522816|NCT01172808|101811705|FG002|Overall Study|Lack of Efficacy|0|||
33522817|NCT01172808|101811706|FG003|Overall Study|Lack of Efficacy|0|||
33522818|NCT01172808|101811703|FG000|Overall Study|Protocol Violation|2|||
33522819|NCT01172808|101811704|FG001|Overall Study|Protocol Violation|2|||
33522820|NCT01172808|101811705|FG002|Overall Study|Protocol Violation|2|||
33522821|NCT01172808|101811706|FG003|Overall Study|Protocol Violation|0|||
33522822|NCT01172808|101811703|FG000|Overall Study|Lost to Follow-up|0|||
33522823|NCT01172808|101811704|FG001|Overall Study|Lost to Follow-up|1|||
33522824|NCT01172808|101811705|FG002|Overall Study|Lost to Follow-up|1|||
33522825|NCT01172808|101811706|FG003|Overall Study|Lost to Follow-up|3|||
33522826|NCT01172808|101811703|FG000|Overall Study|Withdrawal by Subject|4|||
33522827|NCT01172808|101811704|FG001|Overall Study|Withdrawal by Subject|1|||
33522828|NCT01172808|101811705|FG002|Overall Study|Withdrawal by Subject|3|||
33522829|NCT01172808|101811706|FG003|Overall Study|Withdrawal by Subject|2|||
33522830|NCT01172808|101811703|FG000|Overall Study|Other|6|||
33522831|NCT01172808|101811704|FG001|Overall Study|Other|5|||
33522832|NCT01172808|101811705|FG002|Overall Study|Other|9|||
33522833|NCT01172808|101811706|FG003|Overall Study|Other|7|||
33522834|NCT04399538|101811707|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
33522835|NCT04399538|101811708|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
33522836|NCT04399538|101811709|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
33522837|NCT04399538|101811710|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
33522838|NCT04399538|101811711|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
33522839|NCT04399538|101811707|FG000|Double-Blind Treatment|Adverse Event|0|||
33522840|NCT04399538|101811708|FG001|Double-Blind Treatment|Adverse Event|0|||
33522841|NCT04399538|101811709|FG002|Double-Blind Treatment|Adverse Event|0|||
33522842|NCT04399538|101811710|FG003|Double-Blind Treatment|Adverse Event|0|||
33522843|NCT04399538|101811711|FG004|Double-Blind Treatment|Adverse Event|1|||
33522844|NCT04399538|101811707|FG000|Follow-Up|Adverse Event|0|||
33522845|NCT04399538|101811708|FG001|Follow-Up|Adverse Event|0|||
33522846|NCT04399538|101811709|FG002|Follow-Up|Adverse Event|0|||
33522847|NCT04399538|101811710|FG003|Follow-Up|Adverse Event|0|||
33522848|NCT04399538|101811711|FG004|Follow-Up|Adverse Event|1|||
33522849|NCT04399538|101811707|FG000|Follow-Up|Withdrawal by Subject|0|||
33522850|NCT04399538|101811708|FG001|Follow-Up|Withdrawal by Subject|0|||
33522851|NCT04399538|101811709|FG002|Follow-Up|Withdrawal by Subject|0|||
33522852|NCT04399538|101811710|FG003|Follow-Up|Withdrawal by Subject|2|||
33522853|NCT04399538|101811711|FG004|Follow-Up|Withdrawal by Subject|0|||
33522854|NCT00549601|101811716|FG000|Randomized|Protocol Violation|0|||
33522855|NCT00549601|101811717|FG001|Randomized|Protocol Violation|0|||
33522856|NCT00549601|101811718|FG002|Randomized|Protocol Violation|1|||
33522857|NCT00549601|101811716|FG000|Randomized|Withdrawal by Subject|0|||
33522858|NCT00549601|101811717|FG001|Randomized|Withdrawal by Subject|1|||
33522859|NCT00549601|101811718|FG002|Randomized|Withdrawal by Subject|1|||
33522860|NCT00549601|101811716|FG000|Received Study Drug|Adverse Event|2|||
33522861|NCT00549601|101811717|FG001|Received Study Drug|Adverse Event|5|||
33522862|NCT00549601|101811718|FG002|Received Study Drug|Adverse Event|1|||
33522863|NCT00549601|101811716|FG000|Received Study Drug|Death|0|||
33522864|NCT00549601|101811717|FG001|Received Study Drug|Death|1|||
33522865|NCT00549601|101811718|FG002|Received Study Drug|Death|0|||
33522866|NCT00549601|101811716|FG000|Received Study Drug|Lost to Follow-up|0|||
33522867|NCT00549601|101811717|FG001|Received Study Drug|Lost to Follow-up|1|||
33522868|NCT00549601|101811718|FG002|Received Study Drug|Lost to Follow-up|1|||
33522869|NCT00549601|101811716|FG000|Received Study Drug|Protocol Violation|3|||
33522870|NCT00549601|101811717|FG001|Received Study Drug|Protocol Violation|4|||
33522871|NCT00549601|101811718|FG002|Received Study Drug|Protocol Violation|1|||
33522872|NCT00549601|101811716|FG000|Received Study Drug|Withdrawal by Subject|2|||
33522873|NCT00549601|101811717|FG001|Received Study Drug|Withdrawal by Subject|0|||
33522874|NCT00549601|101811718|FG002|Received Study Drug|Withdrawal by Subject|1|||
33522875|NCT01464619|101811723|FG000|Overall Study|Lost to Follow-up|3|||
33522876|NCT01464619|101811724|FG001|Overall Study|Lost to Follow-up|4|||
33522877|NCT02886884|101811735|FG000|Follow-up|Withdrawal by Subject|0|||
33522878|NCT02886884|101811736|FG001|Follow-up|Withdrawal by Subject|0|||
33522879|NCT02886884|101811737|FG002|Follow-up|Withdrawal by Subject|0|||
33329538|NCT03829657|101101188|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
33329539|NCT03829657|101101189|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
33329540|NCT03829657|101101190|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
33329541|NCT03829657|101101191|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
33522880|NCT02886884|101811738|FG003|Follow-up|Withdrawal by Subject|1|||
33522881|NCT02510820|101811739|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
33522882|NCT02510820|101811740|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
33522883|NCT02510820|101811739|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
33522884|NCT02510820|101811740|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
33522885|NCT03046056|101811741|FG000|Overall Study|Non-responder at Week 10|6|||
33522886|NCT03046056|101811742|FG001|Overall Study|Non-responder at Week 10|6|||
33522887|NCT03046056|101811743|FG002|Overall Study|Non-responder at Week 10|4|||
33522888|NCT03046056|101811741|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
33522889|NCT03046056|101811742|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
33522890|NCT03046056|101811743|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
33522891|NCT03046056|101811741|FG000|Overall Study|Adverse Event|1|||
33522892|NCT03046056|101811742|FG001|Overall Study|Adverse Event|5|||
33522893|NCT03046056|101811743|FG002|Overall Study|Adverse Event|0|||
33522894|NCT03046056|101811741|FG000|Overall Study|Non-compliance With Study Drug|0|||
33522895|NCT03046056|101811742|FG001|Overall Study|Non-compliance With Study Drug|0|||
33522896|NCT03046056|101811743|FG002|Overall Study|Non-compliance With Study Drug|2|||
33522897|NCT03046056|101811741|FG000|Overall Study|Protocol Violation|1|||
33522898|NCT03046056|101811742|FG001|Overall Study|Protocol Violation|1|||
33522899|NCT03046056|101811743|FG002|Overall Study|Protocol Violation|0|||
33522900|NCT03046056|101811741|FG000|Overall Study|Investigator's Discretion|0|||
33522901|NCT03046056|101811742|FG001|Overall Study|Investigator's Discretion|1|||
33522902|NCT03046056|101811743|FG002|Overall Study|Investigator's Discretion|0|||
33522903|NCT03046056|101811741|FG000|Overall Study|Withdrew Consent|1|||
33522904|NCT03046056|101811742|FG001|Overall Study|Withdrew Consent|0|||
33522905|NCT03046056|101811743|FG002|Overall Study|Withdrew Consent|0|||
33522906|NCT00742027|101811744|FG000|Overall Study|Disease Progression|76|||
33522907|NCT00742027|101811744|FG000|Overall Study|New Cancer Therapy|19|||
33522908|NCT00742027|101811744|FG000|Overall Study|Withdrawal by Subject|18|||
33522909|NCT00742027|101811744|FG000|Overall Study|Death|7|||
33522910|NCT00742027|101811744|FG000|Overall Study|Lost to Follow-up|4|||
33522911|NCT00742027|101811744|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
33522912|NCT00742027|101811744|FG000|Overall Study|Missing|2|||
33522913|NCT00742027|101811744|FG000|Overall Study|Administrative Problems|1|||
33522914|NCT00703118|101811747|FG000|Overall Study|Adverse Event|1|||
33522915|NCT00703118|101811748|FG001|Overall Study|Adverse Event|2|||
33522916|NCT00703118|101811749|FG002|Overall Study|Adverse Event|2|||
33522917|NCT00703118|101811747|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
33522918|NCT00703118|101811748|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
33522919|NCT00703118|101811749|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
33522920|NCT00703118|101811747|FG000|Overall Study|Lost to Follow-up|6|||
33522921|NCT00703118|101811748|FG001|Overall Study|Lost to Follow-up|4|||
33522922|NCT00703118|101811749|FG002|Overall Study|Lost to Follow-up|4|||
33522923|NCT00703118|101811747|FG000|Overall Study|Withdrawal by Subject|8|||
33522924|NCT00703118|101811748|FG001|Overall Study|Withdrawal by Subject|7|||
33522925|NCT00703118|101811749|FG002|Overall Study|Withdrawal by Subject|13|||
33522926|NCT00703118|101811747|FG000|Overall Study|Other|0|||
33522927|NCT00703118|101811748|FG001|Overall Study|Other|0|||
33522928|NCT00703118|101811749|FG002|Overall Study|Other|1|||
33522929|NCT03230838|101811751|FG000|Overall Study|Withdrawal by Subject|3|||
33522930|NCT03230838|101811752|FG001|Overall Study|Withdrawal by Subject|0|||
33522931|NCT03230838|101811751|FG000|Overall Study|Temperature excursion|1|||
33522932|NCT03230838|101811752|FG001|Overall Study|Temperature excursion|0|||
33522933|NCT01313221|101811757|FG000|Overall Study|Protocol Violation|0|||
33522934|NCT01313221|101811758|FG001|Overall Study|Protocol Violation|1|||
33329542|NCT03829657|101101192|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
33522935|NCT01313221|101811759|FG002|Overall Study|Protocol Violation|1|||
33522936|NCT01313221|101811757|FG000|Overall Study|Non-compliance|3|||
33522937|NCT01313221|101811758|FG001|Overall Study|Non-compliance|0|||
33522938|NCT01313221|101811759|FG002|Overall Study|Non-compliance|2|||
33522939|NCT01313221|101811757|FG000|Overall Study|Withdrawal by Subject|2|||
33522940|NCT01313221|101811758|FG001|Overall Study|Withdrawal by Subject|3|||
33522941|NCT01313221|101811759|FG002|Overall Study|Withdrawal by Subject|5|||
33522942|NCT01313221|101811757|FG000|Overall Study|Requirement for alternative therapy|0|||
33522943|NCT01313221|101811758|FG001|Overall Study|Requirement for alternative therapy|1|||
33522944|NCT01313221|101811759|FG002|Overall Study|Requirement for alternative therapy|1|||
33522945|NCT01313221|101811757|FG000|Overall Study|Lost to Follow-up|6|||
33522946|NCT01313221|101811758|FG001|Overall Study|Lost to Follow-up|3|||
33522947|NCT01313221|101811759|FG002|Overall Study|Lost to Follow-up|1|||
33522948|NCT01313221|101811757|FG000|Overall Study|Other|1|||
33522949|NCT01313221|101811758|FG001|Overall Study|Other|0|||
33522950|NCT01313221|101811759|FG002|Overall Study|Other|0|||
33522951|NCT01313221|101811757|FG000|Overall Study|Adverse Event|0|||
33522952|NCT01313221|101811758|FG001|Overall Study|Adverse Event|0|||
33522953|NCT01313221|101811759|FG002|Overall Study|Adverse Event|7|||
33522954|NCT01313221|101811757|FG000|Overall Study|Disease progression|0|||
33522955|NCT01313221|101811758|FG001|Overall Study|Disease progression|0|||
33522956|NCT01313221|101811759|FG002|Overall Study|Disease progression|2|||
33522957|NCT01313221|101811757|FG000|Overall Study|Physician Decision|0|||
33522958|NCT01313221|101811758|FG001|Overall Study|Physician Decision|0|||
33522959|NCT01313221|101811759|FG002|Overall Study|Physician Decision|2|||
33522960|NCT01313221|101811757|FG000|Overall Study|Pregnancy|0|||
33522961|NCT01313221|101811758|FG001|Overall Study|Pregnancy|0|||
33522962|NCT01313221|101811759|FG002|Overall Study|Pregnancy|2|||
33522963|NCT02412878|101811760|FG000|Overall Study|Withdrawal by Subject|19|||
33522964|NCT02412878|101811761|FG001|Overall Study|Withdrawal by Subject|10|||
33522965|NCT02412878|101811760|FG000|Overall Study|Lost to Follow-up|2|||
33522966|NCT02412878|101811761|FG001|Overall Study|Lost to Follow-up|3|||
33522967|NCT00908596|101811762|FG000|Overall Study|Other reasons|46|||
33522968|NCT00908596|101811763|FG001|Overall Study|Other reasons|6|||
33522969|NCT00908596|101811764|FG002|Overall Study|Other reasons|2|||
33522970|NCT00908596|101811765|FG003|Overall Study|Other reasons|0|||
33522971|NCT00908596|101811762|FG000|Overall Study|Lost to Follow-up|0|||
33522972|NCT00908596|101811763|FG001|Overall Study|Lost to Follow-up|1|||
33522973|NCT00908596|101811764|FG002|Overall Study|Lost to Follow-up|12|||
33522974|NCT00908596|101811765|FG003|Overall Study|Lost to Follow-up|4|||
33522975|NCT00908596|101811762|FG000|Overall Study|Death|0|||
33609243|NCT03178669|102118610|FG000|Overall Study|Lost to Follow-up|0|||
33609244|NCT03178669|102118611|FG001|Overall Study|Lost to Follow-up|0|||
33609245|NCT03178669|102118612|FG002|Overall Study|Lost to Follow-up|0|||
33609246|NCT03178669|102118613|FG003|Overall Study|Lost to Follow-up|1|||
33609247|NCT03178669|102118614|FG004|Overall Study|Lost to Follow-up|0|||
33609248|NCT01620944|102118615|FG000|Overall Study|Early termination of Study|2|||
33609249|NCT01620944|102118616|FG001|Overall Study|Early termination of Study|1|||
33609250|NCT04541628|102118617|FG000|Overall Study|Study Terminated|1|||
33609251|NCT04541628|102118618|FG001|Overall Study|Study Terminated|1|||
33609252|NCT04541628|102118619|FG002|Overall Study|Study Terminated|1|||
33609253|NCT03088813|102118620|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
33609254|NCT03088813|102118621|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
33609255|NCT03088813|102118622|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
33522976|NCT00908596|101811763|FG001|Overall Study|Death|5|||
33522977|NCT00908596|101811764|FG002|Overall Study|Death|57|||
33522978|NCT00908596|101811765|FG003|Overall Study|Death|32|||
33522979|NCT00908596|101811762|FG000|Overall Study|Protocol Violation|1|||
33522980|NCT00908596|101811763|FG001|Overall Study|Protocol Violation|0|||
33522981|NCT00908596|101811764|FG002|Overall Study|Protocol Violation|0|||
33522982|NCT00908596|101811765|FG003|Overall Study|Protocol Violation|0|||
33522983|NCT00908596|101811762|FG000|Overall Study|Withdrawal by Subject|0|||
33522984|NCT00908596|101811763|FG001|Overall Study|Withdrawal by Subject|1|||
33522985|NCT00908596|101811764|FG002|Overall Study|Withdrawal by Subject|3|||
33522986|NCT00908596|101811765|FG003|Overall Study|Withdrawal by Subject|1|||
33522987|NCT01243177|101811766|FG000|Overall Study|Lack of Efficacy|47|||
33522988|NCT01243177|101811767|FG001|Overall Study|Lack of Efficacy|31|||
33522989|NCT01243177|101811766|FG000|Overall Study|Protocol Violation|11|||
33522990|NCT01243177|101811767|FG001|Overall Study|Protocol Violation|10|||
33522991|NCT01243177|101811766|FG000|Overall Study|Lost to Follow-up|15|||
33522992|NCT01243177|101811767|FG001|Overall Study|Lost to Follow-up|18|||
33522993|NCT01243177|101811766|FG000|Overall Study|Withdrawal by Subject|46|||
33522994|NCT01243177|101811767|FG001|Overall Study|Withdrawal by Subject|38|||
33522995|NCT01243177|101811766|FG000|Overall Study|AE, serious fatal|0|||
33522996|NCT01243177|101811767|FG001|Overall Study|AE, serious fatal|1|||
33522997|NCT01243177|101811766|FG000|Overall Study|SAE, non-fatal|7|||
33609256|NCT03088813|102118623|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
33609257|NCT03088813|102118620|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
33522998|NCT01243177|101811767|FG001|Overall Study|SAE, non-fatal|9|||
33522999|NCT01243177|101811766|FG000|Overall Study|AE, non-serious non-fatal|40|||
33523000|NCT01243177|101811767|FG001|Overall Study|AE, non-serious non-fatal|58|||
33523001|NCT01243177|101811766|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
33523002|NCT01243177|101811767|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
33523003|NCT01243177|101811766|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
33523004|NCT01243177|101811767|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
33523005|NCT01243177|101811766|FG000|Overall Study|Other Reason|11|||
33523006|NCT01243177|101811767|FG001|Overall Study|Other Reason|12|||
33523007|NCT02020512|101811772|FG000|Overall Study|Adverse Event|1|||
33200927|NCT02033889|100638471|FG000|Overall Study|Excluded Medication|1|||
33200928|NCT02033889|100638472|FG001|Overall Study|Excluded Medication|1|||
33200929|NCT02033889|100638473|FG002|Overall Study|Excluded Medication|0|||
33200930|NCT02033889|100638471|FG000|Overall Study|Lost to Follow-up|8|||
33200931|NCT02033889|100638472|FG001|Overall Study|Lost to Follow-up|5|||
33200932|NCT02033889|100638473|FG002|Overall Study|Lost to Follow-up|6|||
33200933|NCT02033889|100638471|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33200934|NCT02033889|100638472|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33200935|NCT02033889|100638473|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33200936|NCT02033889|100638471|FG000|Overall Study|Physician Decision|0|||
33200937|NCT02033889|100638472|FG001|Overall Study|Physician Decision|1|||
33200938|NCT02033889|100638473|FG002|Overall Study|Physician Decision|1|||
33200939|NCT02033889|100638471|FG000|Overall Study|Participant moved|0|||
33200940|NCT02033889|100638472|FG001|Overall Study|Participant moved|1|||
33200941|NCT02033889|100638473|FG002|Overall Study|Participant moved|0|||
33200942|NCT02033889|100638471|FG000|Overall Study|Withdrawal by Subject|18|||
33200943|NCT02033889|100638472|FG001|Overall Study|Withdrawal by Subject|10|||
33200944|NCT02033889|100638473|FG002|Overall Study|Withdrawal by Subject|13|||
33200945|NCT05282004|100638474|FG000|Overall Study|Adverse Event|2|||
33200946|NCT00723801|100638477|FG000|Overall Study|Lost to Follow-up|1|||
33200947|NCT00723801|100638478|FG001|Overall Study|Lost to Follow-up|2|||
33200948|NCT00723801|100638477|FG000|Overall Study|Protocol Violation|2|||
33200949|NCT00723801|100638478|FG001|Overall Study|Protocol Violation|1|||
33200950|NCT00182689|100638479|FG000|Overall Study|Adverse Event|8|||
33200951|NCT00182689|100638480|FG001|Overall Study|Adverse Event|11|||
33200952|NCT00182689|100638479|FG000|Overall Study|Withdrawal by Subject|2|||
33200953|NCT00182689|100638480|FG001|Overall Study|Withdrawal by Subject|2|||
33200954|NCT00182689|100638479|FG000|Overall Study|Progression|27|||
33200955|NCT00182689|100638480|FG001|Overall Study|Progression|29|||
33200956|NCT00182689|100638479|FG000|Overall Study|Death|1|||
33200957|NCT00182689|100638480|FG001|Overall Study|Death|0|||
33200958|NCT00182689|100638479|FG000|Overall Study|not protocol specified|0|||
33200959|NCT00182689|100638480|FG001|Overall Study|not protocol specified|3|||
33200960|NCT00182689|100638479|FG000|Overall Study|Ineligible|1|||
33200961|NCT00182689|100638480|FG001|Overall Study|Ineligible|4|||
33200962|NCT00182689|100638479|FG000|Overall Study|Never received treatment|1|||
33200963|NCT00182689|100638480|FG001|Overall Study|Never received treatment|0|||
33200964|NCT01040130|100638484|FG000|Overall Study|Adverse Event|1|||
33200965|NCT01040130|100638485|FG001|Overall Study|Adverse Event|1|||
33200966|NCT01040130|100638486|FG002|Overall Study|Adverse Event|0|||
33200967|NCT01040130|100638487|FG003|Overall Study|Adverse Event|5|||
33200968|NCT01040130|100638488|FG004|Overall Study|Adverse Event|0|||
33200969|NCT01040130|100638489|FG005|Overall Study|Adverse Event|3|||
33200970|NCT01040130|100638484|FG000|Overall Study|Protocol Violation|0|||
33200971|NCT01040130|100638485|FG001|Overall Study|Protocol Violation|0|||
33200972|NCT01040130|100638486|FG002|Overall Study|Protocol Violation|2|||
33200973|NCT01040130|100638487|FG003|Overall Study|Protocol Violation|0|||
33200974|NCT01040130|100638488|FG004|Overall Study|Protocol Violation|0|||
33200975|NCT01040130|100638489|FG005|Overall Study|Protocol Violation|0|||
33609258|NCT03088813|102118621|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
33609259|NCT03088813|102118622|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
33609260|NCT03088813|102118623|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
33329543|NCT03829657|101101188|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
33329544|NCT03829657|101101189|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
33329545|NCT03829657|101101190|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
33329546|NCT03829657|101101191|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
33329547|NCT03829657|101101192|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
33329548|NCT03829657|101101188|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
33329549|NCT03829657|101101189|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
33329550|NCT03829657|101101190|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
33329551|NCT03829657|101101191|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
33329552|NCT03829657|101101192|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
33329553|NCT03829657|101101188|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
33329554|NCT03829657|101101189|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
33329555|NCT03829657|101101190|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
33329556|NCT03829657|101101191|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
33329557|NCT03829657|101101192|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
33329558|NCT03829657|101101188|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
33329559|NCT03829657|101101189|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
33329560|NCT03829657|101101190|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
33329561|NCT03829657|101101191|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
33329562|NCT03829657|101101192|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
33329563|NCT03829657|101101188|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
33329564|NCT03829657|101101189|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
33329565|NCT03829657|101101190|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
33329566|NCT03829657|101101191|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
33329567|NCT03829657|101101192|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
33329568|NCT03829657|101101188|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
33329569|NCT03829657|101101189|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
33329570|NCT03829657|101101190|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
33329571|NCT03829657|101101191|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
33329572|NCT03829657|101101192|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
33329573|NCT02187172|101101195|FG000|Overall Study|Lost to Follow-up|1|||
33329574|NCT02187172|101101196|FG001|Overall Study|Lost to Follow-up|2|||
33329575|NCT02187172|101101195|FG000|Overall Study|Lack of Efficacy|1|||
33329576|NCT02187172|101101196|FG001|Overall Study|Lack of Efficacy|2|||
33329577|NCT02187172|101101195|FG000|Overall Study|Adverse Event|0|||
33329578|NCT02187172|101101196|FG001|Overall Study|Adverse Event|1|||
33329579|NCT02187172|101101195|FG000|Overall Study|Physician Decision|1|||
33329580|NCT02187172|101101196|FG001|Overall Study|Physician Decision|1|||
33329581|NCT01843842|101101197|FG000|Overall Study|Do not meet inclusion criteria|1|||
33329582|NCT01843842|101101198|FG001|Overall Study|Do not meet inclusion criteria|1|||
33329583|NCT03357731|101101199|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
33329584|NCT03357731|101101200|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
33329585|NCT03357731|101101201|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
33329586|NCT03357731|101101202|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
33329587|NCT03357731|101101203|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
33329588|NCT03357731|101101204|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
33329589|NCT03357731|101101199|FG000|Overall Study|Acute bradycardia and hypotension|0|||
33329590|NCT03357731|101101200|FG001|Overall Study|Acute bradycardia and hypotension|0|||
33329591|NCT03357731|101101201|FG002|Overall Study|Acute bradycardia and hypotension|0|||
33329592|NCT03357731|101101202|FG003|Overall Study|Acute bradycardia and hypotension|1|||
33329593|NCT03357731|101101203|FG004|Overall Study|Acute bradycardia and hypotension|0|||
33329594|NCT03357731|101101204|FG005|Overall Study|Acute bradycardia and hypotension|0|||
33329595|NCT03357731|101101199|FG000|Overall Study|Adverse Event|0|||
33329596|NCT03357731|101101200|FG001|Overall Study|Adverse Event|0|||
33329597|NCT03357731|101101201|FG002|Overall Study|Adverse Event|0|||
33329598|NCT03357731|101101202|FG003|Overall Study|Adverse Event|0|||
33329599|NCT03357731|101101203|FG004|Overall Study|Adverse Event|0|||
33609261|NCT03088813|102118620|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
33609262|NCT03088813|102118621|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
33329600|NCT03357731|101101204|FG005|Overall Study|Adverse Event|1|||
33329601|NCT03357731|101101199|FG000|Overall Study|Hypotension|0|||
33329602|NCT03357731|101101200|FG001|Overall Study|Hypotension|0|||
33609263|NCT03088813|102118622|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
33329603|NCT03357731|101101201|FG002|Overall Study|Hypotension|1|||
33329604|NCT03357731|101101202|FG003|Overall Study|Hypotension|1|||
33609264|NCT03088813|102118623|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
33609265|NCT03088813|102118620|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
33609266|NCT03088813|102118621|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
33609267|NCT03088813|102118622|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
33609268|NCT03088813|102118623|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
33609269|NCT03088813|102118620|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
33609270|NCT03088813|102118621|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
33609271|NCT03088813|102118622|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
33609272|NCT03088813|102118623|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
33609273|NCT03088813|102118620|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
33609274|NCT03088813|102118621|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
33609275|NCT03088813|102118622|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
33609276|NCT03088813|102118623|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
33609277|NCT03088813|102118620|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
33609278|NCT03088813|102118621|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
33609279|NCT03088813|102118622|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
33609280|NCT03088813|102118623|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
33609281|NCT02123576|102118624|FG000|Overall Study|Adverse Event|1|||
33609282|NCT02123576|102118625|FG001|Overall Study|Adverse Event|0|||
33609283|NCT02986854|102118626|FG000|Overall Study|Withdrawal by Subject|0|||
33609284|NCT02986854|102118627|FG001|Overall Study|Withdrawal by Subject|1|||
33609285|NCT02986854|102118628|FG002|Overall Study|Withdrawal by Subject|1|||
33609286|NCT02986854|102118626|FG000|Overall Study|Lost to Follow-up|3|||
33609287|NCT02986854|102118627|FG001|Overall Study|Lost to Follow-up|11|||
33609288|NCT02986854|102118628|FG002|Overall Study|Lost to Follow-up|2|||
33609289|NCT03576716|102118637|FG000|Overall Study|Withdrawal by Subject|0|||
33609290|NCT03576716|102118638|FG001|Overall Study|Withdrawal by Subject|1|||
33609291|NCT00830180|102118639|FG000|Overall Study|Adverse Event|6|||
33609292|NCT00830180|102118639|FG000|Overall Study|Death|11|||
33609293|NCT00830180|102118639|FG000|Overall Study|Insufficient clinical response|1|||
33609294|NCT00830180|102118639|FG000|Overall Study|Withdrawal by Subject|5|||
33609295|NCT00830180|102118639|FG000|Overall Study|Progressive disease|2|||
33609296|NCT00830180|102118639|FG000|Overall Study|Other - Unspecified|1|||
33609297|NCT00455143|102118644|FG000|Overall Study|Physician Decision|1|||
33609298|NCT00455143|102118644|FG000|Overall Study|Withdrawal by Subject|1|||
33609299|NCT00455143|102118644|FG000|Overall Study|Staff was not avail to follow patient|2|||
33609300|NCT00455143|102118644|FG000|Overall Study|No longer met Inclusion Criteria|1|||
33609301|NCT00455143|102118644|FG000|Overall Study|Surgical time, staff not available|1|||
33609302|NCT02249182|102118647|FG000|Treatment Phase|Lost to Follow-up|4|||
33609303|NCT02249182|102118648|FG001|Treatment Phase|Lost to Follow-up|0|||
33609304|NCT02249182|102118649|FG002|Treatment Phase|Lost to Follow-up|0|||
33609305|NCT02249182|102118650|FG003|Treatment Phase|Lost to Follow-up|0|||
33609306|NCT02249182|102118651|FG004|Treatment Phase|Lost to Follow-up|0|||
33609307|NCT04294147|102118652|FG000|Overall Study|Protocol Violation|2|||
33609308|NCT04294147|102118653|FG001|Overall Study|Protocol Violation|0|||
33609309|NCT00494507|102118654|FG000|Double-Blind Phase|Adverse Event|2|||
33609310|NCT00494507|102118655|FG001|Double-Blind Phase|Adverse Event|0|||
33609311|NCT00494507|102118656|FG002|Double-Blind Phase|Adverse Event|1|||
33609312|NCT00494507|102118657|FG003|Double-Blind Phase|Adverse Event|0|||
33609313|NCT00494507|102118654|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
33609314|NCT00494507|102118655|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
33609315|NCT00494507|102118656|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
33609316|NCT00494507|102118657|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
33609317|NCT00494507|102118654|FG000|Double-Blind Phase|Subject Non-compliance|0|||
33609318|NCT00494507|102118655|FG001|Double-Blind Phase|Subject Non-compliance|0|||
33609319|NCT00494507|102118656|FG002|Double-Blind Phase|Subject Non-compliance|1|||
33609320|NCT00494507|102118657|FG003|Double-Blind Phase|Subject Non-compliance|0|||
33609321|NCT00494507|102118654|FG000|Double-Blind Phase|Negative DNA test|0|||
33609322|NCT00494507|102118655|FG001|Double-Blind Phase|Negative DNA test|0|||
33609323|NCT00494507|102118656|FG002|Double-Blind Phase|Negative DNA test|0|||
33609324|NCT00494507|102118657|FG003|Double-Blind Phase|Negative DNA test|1|||
33609325|NCT00494507|102118654|FG000|Open-Label Phase|Adverse Event|0|||
33609326|NCT00494507|102118655|FG001|Open-Label Phase|Adverse Event|1|||
33609327|NCT00494507|102118656|FG002|Open-Label Phase|Adverse Event|5|||
33401779|NCT00286234|101361508|FG003|Overall Study|Physician Decision|1|||
33609328|NCT00494507|102118657|FG003|Open-Label Phase|Adverse Event|3|||
33523008|NCT02020512|101811772|FG000|Overall Study|Lost to Follow-up|3|||
33609329|NCT00494507|102118654|FG000|Open-Label Phase|Worsening Disease|0|||
33609330|NCT00494507|102118655|FG001|Open-Label Phase|Worsening Disease|0|||
33609331|NCT00494507|102118656|FG002|Open-Label Phase|Worsening Disease|0|||
33609332|NCT00494507|102118657|FG003|Open-Label Phase|Worsening Disease|2|||
33609333|NCT02687581|102118660|FG000|Overall Study|Withdrawal by Subject|1|||
33200976|NCT01040130|100638484|FG000|Overall Study|Withdrawal by Subject|0|||
33200977|NCT01040130|100638485|FG001|Overall Study|Withdrawal by Subject|2|||
33200978|NCT01040130|100638486|FG002|Overall Study|Withdrawal by Subject|0|||
33200979|NCT01040130|100638487|FG003|Overall Study|Withdrawal by Subject|0|||
33200980|NCT01040130|100638488|FG004|Overall Study|Withdrawal by Subject|0|||
33200981|NCT01040130|100638489|FG005|Overall Study|Withdrawal by Subject|1|||
33200982|NCT01040130|100638484|FG000|Overall Study|Other reasons not listed above|2|||
33200983|NCT01040130|100638485|FG001|Overall Study|Other reasons not listed above|0|||
33200984|NCT01040130|100638486|FG002|Overall Study|Other reasons not listed above|0|||
33200985|NCT01040130|100638487|FG003|Overall Study|Other reasons not listed above|0|||
33200986|NCT01040130|100638488|FG004|Overall Study|Other reasons not listed above|0|||
33200987|NCT01040130|100638489|FG005|Overall Study|Other reasons not listed above|0|||
33200988|NCT01931839|100638495|FG000|Overall Study|Death|0|||
33200989|NCT01931839|100638496|FG001|Overall Study|Death|1|||
33200990|NCT01931839|100638497|FG002|Overall Study|Death|2|||
33200991|NCT01931839|100638498|FG003|Overall Study|Death|0|||
33200992|NCT01931839|100638499|FG004|Overall Study|Death|0|||
33200993|NCT01931839|100638500|FG005|Overall Study|Death|0|||
33200994|NCT01931839|100638501|FG006|Overall Study|Death|0|||
33200995|NCT01931839|100638495|FG000|Overall Study|Physician Decision|1|||
33200996|NCT01931839|100638496|FG001|Overall Study|Physician Decision|0|||
33200997|NCT01931839|100638497|FG002|Overall Study|Physician Decision|1|||
33200998|NCT01931839|100638498|FG003|Overall Study|Physician Decision|0|||
33200999|NCT01931839|100638499|FG004|Overall Study|Physician Decision|0|||
33201000|NCT01931839|100638500|FG005|Overall Study|Physician Decision|0|||
33201001|NCT01931839|100638501|FG006|Overall Study|Physician Decision|1|||
33201002|NCT01931839|100638495|FG000|Overall Study|Withdrawal of consent|0|||
33201003|NCT01931839|100638496|FG001|Overall Study|Withdrawal of consent|0|||
33201004|NCT01931839|100638497|FG002|Overall Study|Withdrawal of consent|0|||
33201005|NCT01931839|100638498|FG003|Overall Study|Withdrawal of consent|0|||
33201006|NCT01931839|100638499|FG004|Overall Study|Withdrawal of consent|1|||
33201007|NCT01931839|100638500|FG005|Overall Study|Withdrawal of consent|0|||
33201008|NCT01931839|100638501|FG006|Overall Study|Withdrawal of consent|0|||
33201009|NCT01931839|100638495|FG000|Overall Study|Adverse Event|9|||
33201010|NCT01931839|100638496|FG001|Overall Study|Adverse Event|4|||
33201011|NCT01931839|100638497|FG002|Overall Study|Adverse Event|1|||
33201012|NCT01931839|100638498|FG003|Overall Study|Adverse Event|3|||
33201013|NCT01931839|100638499|FG004|Overall Study|Adverse Event|0|||
33201014|NCT01931839|100638500|FG005|Overall Study|Adverse Event|0|||
33201015|NCT01931839|100638501|FG006|Overall Study|Adverse Event|1|||
33201016|NCT01931839|100638495|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
33201017|NCT01931839|100638496|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
33329605|NCT03357731|101101203|FG004|Overall Study|Hypotension|0|||
33329606|NCT03357731|101101204|FG005|Overall Study|Hypotension|0|||
33329607|NCT03357731|101101199|FG000|Overall Study|Lost to Follow-up|0|||
33329608|NCT03357731|101101200|FG001|Overall Study|Lost to Follow-up|0|||
33329609|NCT03357731|101101201|FG002|Overall Study|Lost to Follow-up|0|||
33609334|NCT02687581|102118661|FG001|Overall Study|Withdrawal by Subject|0|||
33201018|NCT01931839|100638497|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
33201019|NCT01931839|100638498|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
33201020|NCT01931839|100638499|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
33201021|NCT01931839|100638500|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
33201022|NCT01931839|100638501|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
33201023|NCT01931839|100638495|FG000|Overall Study|Other non-compliance|15|||
33201024|NCT01931839|100638496|FG001|Overall Study|Other non-compliance|9|||
33201025|NCT01931839|100638497|FG002|Overall Study|Other non-compliance|12|||
33201026|NCT01931839|100638498|FG003|Overall Study|Other non-compliance|3|||
33201027|NCT01931839|100638499|FG004|Overall Study|Other non-compliance|0|||
33201028|NCT01931839|100638500|FG005|Overall Study|Other non-compliance|3|||
33201029|NCT01931839|100638501|FG006|Overall Study|Other non-compliance|0|||
33201030|NCT01931839|100638495|FG000|Overall Study|Lost to Follow-up|1|||
33201031|NCT01931839|100638496|FG001|Overall Study|Lost to Follow-up|2|||
33201032|NCT01931839|100638497|FG002|Overall Study|Lost to Follow-up|4|||
33201033|NCT01931839|100638498|FG003|Overall Study|Lost to Follow-up|5|||
33201034|NCT01931839|100638499|FG004|Overall Study|Lost to Follow-up|0|||
33201035|NCT01931839|100638500|FG005|Overall Study|Lost to Follow-up|0|||
33201036|NCT01931839|100638501|FG006|Overall Study|Lost to Follow-up|0|||
33201037|NCT01931839|100638495|FG000|Overall Study|Other|4|||
33201038|NCT01931839|100638496|FG001|Overall Study|Other|2|||
33201039|NCT01931839|100638497|FG002|Overall Study|Other|6|||
33201040|NCT01931839|100638498|FG003|Overall Study|Other|0|||
33201041|NCT01931839|100638499|FG004|Overall Study|Other|0|||
33329610|NCT03357731|101101202|FG003|Overall Study|Lost to Follow-up|1|||
33201042|NCT01931839|100638500|FG005|Overall Study|Other|0|||
33201043|NCT01931839|100638501|FG006|Overall Study|Other|0|||
33201044|NCT02223390|100638502|FG000|Overall Study|Lost to Follow-up|9|||
33201045|NCT02223390|100638503|FG001|Overall Study|Lost to Follow-up|4|||
33329611|NCT03357731|101101203|FG004|Overall Study|Lost to Follow-up|0|||
33201046|NCT00793910|100638504|FG000|Overall Study|discarded study pills|0|||
33609335|NCT02687581|102118662|FG002|Overall Study|Withdrawal by Subject|0|||
33609336|NCT02687581|102118663|FG003|Overall Study|Withdrawal by Subject|1|||
33609337|NCT02687581|102118660|FG000|Overall Study|Lost to Follow-up|2|||
33609338|NCT02687581|102118661|FG001|Overall Study|Lost to Follow-up|2|||
33609339|NCT02687581|102118662|FG002|Overall Study|Lost to Follow-up|0|||
33609340|NCT02687581|102118663|FG003|Overall Study|Lost to Follow-up|0|||
33329612|NCT03357731|101101204|FG005|Overall Study|Lost to Follow-up|0|||
33329613|NCT03221751|101101205|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
33329614|NCT03221751|101101206|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
33329615|NCT00652366|101101211|FG000|Overall Study|Adverse Event|8|||
33329616|NCT00652366|101101212|FG001|Overall Study|Adverse Event|4|||
33329617|NCT00652366|101101213|FG002|Overall Study|Adverse Event|7|||
33329618|NCT00652366|101101214|FG003|Overall Study|Adverse Event|17|||
33329619|NCT00652366|101101215|FG004|Overall Study|Adverse Event|13|||
33329620|NCT00652366|101101211|FG000|Overall Study|Death|5|||
33329621|NCT00652366|101101212|FG001|Overall Study|Death|4|||
33329622|NCT00652366|101101213|FG002|Overall Study|Death|1|||
33329623|NCT00652366|101101214|FG003|Overall Study|Death|8|||
33329624|NCT00652366|101101215|FG004|Overall Study|Death|5|||
33329625|NCT00652366|101101211|FG000|Overall Study|Lack of Efficacy|84|||
33609341|NCT02687581|102118660|FG000|Overall Study|the device is too small for the patient.|1|||
33609342|NCT02687581|102118661|FG001|Overall Study|the device is too small for the patient.|0|||
33609343|NCT02687581|102118662|FG002|Overall Study|the device is too small for the patient.|0|||
33609344|NCT02687581|102118663|FG003|Overall Study|the device is too small for the patient.|0|||
33609345|NCT02104947|102118664|FG000|Overall Study|Withdrawal by Subject|10|||
33609346|NCT02104947|102118665|FG001|Overall Study|Withdrawal by Subject|3|||
33609347|NCT02104947|102118664|FG000|Overall Study|Lost to Follow-up|4|||
33609348|NCT02104947|102118665|FG001|Overall Study|Lost to Follow-up|4|||
33609349|NCT02104947|102118664|FG000|Overall Study|Protocol Violation|6|||
33609350|NCT02104947|102118665|FG001|Overall Study|Protocol Violation|8|||
33609351|NCT02104947|102118664|FG000|Overall Study|Adverse Event|57|||
33609352|NCT02104947|102118665|FG001|Overall Study|Adverse Event|38|||
33609353|NCT02104947|102118664|FG000|Overall Study|Other than stated above|2|||
33609354|NCT02104947|102118665|FG001|Overall Study|Other than stated above|3|||
33609355|NCT02188849|102118669|FG000|Overall Study|Lost to Follow-up|3|||
33609356|NCT02188849|102118670|FG001|Overall Study|Lost to Follow-up|8|||
33609357|NCT00375518|102118671|FG000|Overall Study|Withdrawal by Subject|2|||
33609358|NCT00375518|102118672|FG001|Overall Study|Withdrawal by Subject|10|||
33609359|NCT00375518|102118671|FG000|Overall Study|Patient Not Treated|6|||
33609360|NCT00375518|102118672|FG001|Overall Study|Patient Not Treated|6|||
33609361|NCT00375518|102118671|FG000|Overall Study|Death|0|||
33609362|NCT00375518|102118672|FG001|Overall Study|Death|1|||
33609363|NCT04384523|102118674|FG000|Overall Study|Lost to Follow-up|0|||
33609364|NCT04384523|102118675|FG001|Overall Study|Lost to Follow-up|0|||
33609365|NCT04384523|102118676|FG002|Overall Study|Lost to Follow-up|0|||
33609366|NCT04384523|102118677|FG003|Overall Study|Lost to Follow-up|0|||
33609367|NCT04384523|102118678|FG004|Overall Study|Lost to Follow-up|0|||
33609368|NCT04384523|102118679|FG005|Overall Study|Lost to Follow-up|1|||
33609369|NCT04384523|102118674|FG000|Overall Study|Protocol Violation|0|||
33609370|NCT04384523|102118675|FG001|Overall Study|Protocol Violation|1|||
33609371|NCT04384523|102118676|FG002|Overall Study|Protocol Violation|0|||
33609372|NCT04384523|102118677|FG003|Overall Study|Protocol Violation|0|||
33609373|NCT04384523|102118678|FG004|Overall Study|Protocol Violation|0|||
33609374|NCT04384523|102118679|FG005|Overall Study|Protocol Violation|0|||
33609375|NCT04384523|102118674|FG000|Overall Study|Withdrawal by Subject|1|||
33609376|NCT04384523|102118675|FG001|Overall Study|Withdrawal by Subject|0|||
33609377|NCT04384523|102118676|FG002|Overall Study|Withdrawal by Subject|0|||
33609378|NCT04384523|102118677|FG003|Overall Study|Withdrawal by Subject|0|||
33609379|NCT04384523|102118678|FG004|Overall Study|Withdrawal by Subject|0|||
33609380|NCT04384523|102118679|FG005|Overall Study|Withdrawal by Subject|0|||
33609381|NCT01153698|102118681|FG000|Overall Study|Adverse Event|12|||
33201047|NCT00793910|100638505|FG001|Overall Study|discarded study pills|1|||
33609382|NCT01153698|102118681|FG000|Overall Study|Lost to Follow-up|4|||
33609383|NCT01153698|102118681|FG000|Overall Study|Withdrawal by Subject|2|||
33609384|NCT01153698|102118681|FG000|Overall Study|Switch to other anticoagulants|4|||
33609385|NCT01153698|102118681|FG000|Overall Study|Other|2|||
33609386|NCT01153698|102118681|FG000|Overall Study|Not treated with Pradaxa|5|||
33609387|NCT01748825|102118682|FG000|Dose Escalation|Refused further treatment|2|||
33609388|NCT01748825|102118683|FG001|Dose Escalation|Refused further treatment|2|||
33609389|NCT01748825|102118684|FG002|Dose Escalation|Refused further treatment|0|||
33609390|NCT01748825|102118685|FG003|Dose Escalation|Refused further treatment|0|||
33329626|NCT00652366|101101212|FG001|Overall Study|Lack of Efficacy|58|||
33329627|NCT00652366|101101213|FG002|Overall Study|Lack of Efficacy|53|||
33329628|NCT00652366|101101214|FG003|Overall Study|Lack of Efficacy|133|||
33609391|NCT01748825|102118686|FG004|Dose Escalation|Refused further treatment|1|||
33609392|NCT01748825|102118687|FG005|Dose Escalation|Refused further treatment|2|||
33609393|NCT01748825|102118688|FG006|Dose Escalation|Refused further treatment|0|||
33609394|NCT01748825|102118689|FG007|Dose Escalation|Refused further treatment|0|||
33609395|NCT01748825|102118690|FG008|Dose Escalation|Refused further treatment|0|||
33609396|NCT01748825|102118691|FG009|Dose Escalation|Refused further treatment|0|||
33609397|NCT01748825|102118682|FG000|Dose Escalation|Switched to alternative treatment|0|||
33609398|NCT01748825|102118683|FG001|Dose Escalation|Switched to alternative treatment|0|||
33609399|NCT01748825|102118684|FG002|Dose Escalation|Switched to alternative treatment|0|||
33609400|NCT01748825|102118685|FG003|Dose Escalation|Switched to alternative treatment|1|||
33609401|NCT01748825|102118686|FG004|Dose Escalation|Switched to alternative treatment|0|||
33609402|NCT01748825|102118687|FG005|Dose Escalation|Switched to alternative treatment|0|||
33523009|NCT02020512|101811772|FG000|Overall Study|Protocol Violation|4|||
33523010|NCT02304380|101811778|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
33523011|NCT02304380|101811779|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
33523012|NCT02304380|101811780|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
33523013|NCT02304380|101811781|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
33523014|NCT02304380|101811782|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
33523015|NCT02304380|101811783|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
33523016|NCT01693185|101811784|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
33523017|NCT01693185|101811785|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
33609403|NCT01748825|102118688|FG006|Dose Escalation|Switched to alternative treatment|0|||
33609404|NCT01748825|102118689|FG007|Dose Escalation|Switched to alternative treatment|0|||
33329629|NCT00652366|101101215|FG004|Overall Study|Lack of Efficacy|13|||
33609405|NCT01748825|102118690|FG008|Dose Escalation|Switched to alternative treatment|0|||
33609406|NCT01748825|102118691|FG009|Dose Escalation|Switched to alternative treatment|0|||
33609407|NCT01748825|102118682|FG000|Dose Escalation|Adverse Event|0|||
33609408|NCT01748825|102118683|FG001|Dose Escalation|Adverse Event|0|||
33609409|NCT01748825|102118684|FG002|Dose Escalation|Adverse Event|0|||
33609410|NCT01748825|102118685|FG003|Dose Escalation|Adverse Event|0|||
33609411|NCT01748825|102118686|FG004|Dose Escalation|Adverse Event|0|||
33609412|NCT01748825|102118687|FG005|Dose Escalation|Adverse Event|0|||
33609413|NCT01748825|102118688|FG006|Dose Escalation|Adverse Event|1|||
33609414|NCT01748825|102118689|FG007|Dose Escalation|Adverse Event|0|||
33609415|NCT01748825|102118690|FG008|Dose Escalation|Adverse Event|0|||
33609416|NCT01748825|102118691|FG009|Dose Escalation|Adverse Event|0|||
33609417|NCT01748825|102118682|FG000|Dose Expansion|Refused further treatment|0|||
33609418|NCT01748825|102118683|FG001|Dose Expansion|Refused further treatment|0|||
33609419|NCT01748825|102118684|FG002|Dose Expansion|Refused further treatment|0|||
33329630|NCT00652366|101101211|FG000|Overall Study|Violation of Selection Criteria|0|||
33329631|NCT00652366|101101212|FG001|Overall Study|Violation of Selection Criteria|0|||
33329632|NCT00652366|101101213|FG002|Overall Study|Violation of Selection Criteria|1|||
33329633|NCT00652366|101101214|FG003|Overall Study|Violation of Selection Criteria|0|||
33329634|NCT00652366|101101215|FG004|Overall Study|Violation of Selection Criteria|0|||
33329635|NCT00652366|101101211|FG000|Overall Study|Protocol Violation|1|||
33329636|NCT00652366|101101212|FG001|Overall Study|Protocol Violation|0|||
33329637|NCT00652366|101101213|FG002|Overall Study|Protocol Violation|0|||
33329638|NCT00652366|101101214|FG003|Overall Study|Protocol Violation|0|||
33329639|NCT00652366|101101215|FG004|Overall Study|Protocol Violation|0|||
33329640|NCT00652366|101101211|FG000|Overall Study|Refused treatment|3|||
33329641|NCT00652366|101101212|FG001|Overall Study|Refused treatment|7|||
33329642|NCT00652366|101101213|FG002|Overall Study|Refused treatment|6|||
33609420|NCT01748825|102118685|FG003|Dose Expansion|Refused further treatment|0|||
33609421|NCT01748825|102118686|FG004|Dose Expansion|Refused further treatment|0|||
33609422|NCT01748825|102118687|FG005|Dose Expansion|Refused further treatment|0|||
33401780|NCT00286234|101361505|FG000|Overall Study|Adverse Event|0|||
33401781|NCT00286234|101361506|FG001|Overall Study|Adverse Event|0|||
33401782|NCT00286234|101361507|FG002|Overall Study|Adverse Event|0|||
33401783|NCT00286234|101361508|FG003|Overall Study|Adverse Event|1|||
33401784|NCT00286234|101361505|FG000|Overall Study|Adverse Event|0|||
33401785|NCT00286234|101361506|FG001|Overall Study|Adverse Event|0|||
33523018|NCT04750278|101811786|FG000|Overall Study|Death|9|||
33609423|NCT01748825|102118688|FG006|Dose Expansion|Refused further treatment|0|||
33523019|NCT04750278|101811787|FG001|Overall Study|Death|10|||
33401786|NCT00286234|101361507|FG002|Overall Study|Adverse Event|0|||
33523020|NCT04750278|101811788|FG002|Overall Study|Death|10|||
33523021|NCT04750278|101811786|FG000|Overall Study|Withdrawal by Subject|4|||
33609424|NCT01748825|102118689|FG007|Dose Expansion|Refused further treatment|0|||
33609425|NCT01748825|102118690|FG008|Dose Expansion|Refused further treatment|1|||
33609426|NCT01748825|102118691|FG009|Dose Expansion|Refused further treatment|1|||
33609427|NCT01748825|102118682|FG000|Dose Expansion|Switched to alternative treatment|0|||
33329643|NCT00652366|101101214|FG003|Overall Study|Refused treatment|17|||
33401787|NCT00286234|101361508|FG003|Overall Study|Adverse Event|1|||
33609428|NCT01748825|102118683|FG001|Dose Expansion|Switched to alternative treatment|0|||
33609429|NCT01748825|102118684|FG002|Dose Expansion|Switched to alternative treatment|0|||
33609430|NCT01748825|102118685|FG003|Dose Expansion|Switched to alternative treatment|0|||
33609431|NCT01748825|102118686|FG004|Dose Expansion|Switched to alternative treatment|0|||
33609432|NCT01748825|102118687|FG005|Dose Expansion|Switched to alternative treatment|0|||
33609433|NCT01748825|102118688|FG006|Dose Expansion|Switched to alternative treatment|0|||
33609434|NCT01748825|102118689|FG007|Dose Expansion|Switched to alternative treatment|0|||
33609435|NCT01748825|102118690|FG008|Dose Expansion|Switched to alternative treatment|0|||
33609436|NCT01748825|102118691|FG009|Dose Expansion|Switched to alternative treatment|1|||
33609437|NCT01748825|102118682|FG000|Dose Expansion|Adverse Event|0|||
33609438|NCT01748825|102118683|FG001|Dose Expansion|Adverse Event|0|||
33609439|NCT01748825|102118684|FG002|Dose Expansion|Adverse Event|0|||
33609440|NCT01748825|102118685|FG003|Dose Expansion|Adverse Event|0|||
33609441|NCT01748825|102118686|FG004|Dose Expansion|Adverse Event|0|||
33609442|NCT01748825|102118687|FG005|Dose Expansion|Adverse Event|0|||
33609443|NCT01748825|102118688|FG006|Dose Expansion|Adverse Event|0|||
33609444|NCT01748825|102118689|FG007|Dose Expansion|Adverse Event|0|||
33609445|NCT01748825|102118690|FG008|Dose Expansion|Adverse Event|0|||
33329644|NCT00652366|101101215|FG004|Overall Study|Refused treatment|5|||
33329645|NCT00652366|101101211|FG000|Overall Study|Other|5|||
33329646|NCT00652366|101101212|FG001|Overall Study|Other|2|||
33329647|NCT00652366|101101213|FG002|Overall Study|Other|3|||
33609446|NCT01748825|102118691|FG009|Dose Expansion|Adverse Event|3|||
33609447|NCT01748825|102118682|FG000|Dose Expansion|Physician Decision|0|||
33609448|NCT01748825|102118683|FG001|Dose Expansion|Physician Decision|0|||
33609449|NCT01748825|102118684|FG002|Dose Expansion|Physician Decision|0|||
33609450|NCT01748825|102118685|FG003|Dose Expansion|Physician Decision|0|||
33609451|NCT01748825|102118686|FG004|Dose Expansion|Physician Decision|0|||
33609452|NCT01748825|102118687|FG005|Dose Expansion|Physician Decision|0|||
33609453|NCT01748825|102118688|FG006|Dose Expansion|Physician Decision|0|||
33609454|NCT01748825|102118689|FG007|Dose Expansion|Physician Decision|0|||
33609455|NCT01748825|102118690|FG008|Dose Expansion|Physician Decision|1|||
33609456|NCT01748825|102118691|FG009|Dose Expansion|Physician Decision|0|||
33523022|NCT04750278|101811787|FG001|Overall Study|Withdrawal by Subject|1|||
33523023|NCT04750278|101811788|FG002|Overall Study|Withdrawal by Subject|2|||
33523024|NCT04750278|101811786|FG000|Overall Study|Lost to Follow-up|1|||
33523025|NCT04750278|101811787|FG001|Overall Study|Lost to Follow-up|1|||
33523026|NCT04750278|101811788|FG002|Overall Study|Lost to Follow-up|1|||
33523027|NCT04750278|101811786|FG000|Overall Study|Pregnancy|1|||
33523028|NCT04750278|101811787|FG001|Overall Study|Pregnancy|0|||
33523029|NCT04750278|101811788|FG002|Overall Study|Pregnancy|0|||
33523030|NCT04750278|101811786|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
33523031|NCT04750278|101811787|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
33523032|NCT04750278|101811788|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
33523033|NCT04750278|101811786|FG000|Overall Study|Non-compliance|0|||
33523034|NCT04750278|101811787|FG001|Overall Study|Non-compliance|0|||
33523035|NCT04750278|101811788|FG002|Overall Study|Non-compliance|1|||
33523036|NCT04750278|101811786|FG000|Overall Study|Transfer to Outside Facility|0|||
33523037|NCT04750278|101811787|FG001|Overall Study|Transfer to Outside Facility|2|||
33329648|NCT00652366|101101214|FG003|Overall Study|Other|4|||
33329649|NCT00652366|101101215|FG004|Overall Study|Other|0|||
33329650|NCT01756040|101101216|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
33329651|NCT01756040|101101216|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
33329652|NCT01756040|101101216|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
33329653|NCT02737852|101101220|FG000|Overall Study|Withdrawal by Subject|2|||
33523038|NCT04750278|101811788|FG002|Overall Study|Transfer to Outside Facility|1|||
33523039|NCT04750278|101811786|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
33523040|NCT04750278|101811787|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
33609457|NCT02690714|102118692|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
33609458|NCT02690714|102118692|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
33609459|NCT04390841|102118693|FG000|Overall Study|Withdrawal by Subject|2|||
33609460|NCT03270891|102118694|FG000|Overall Study|Lost to Follow-up|3|||
33609461|NCT03270891|102118695|FG001|Overall Study|Lost to Follow-up|6|||
33609462|NCT03270891|102118696|FG002|Overall Study|Lost to Follow-up|0|||
33201048|NCT00793910|100638504|FG000|Overall Study|did not pick up medications|1|||
33201049|NCT00793910|100638505|FG001|Overall Study|did not pick up medications|1|||
33329654|NCT00433914|101101223|FG000|Overall Study|Withdrawal by Subject|0|||
33609463|NCT03270891|102118694|FG000|Overall Study|Withdrawal by Subject|1|||
33609464|NCT03270891|102118695|FG001|Overall Study|Withdrawal by Subject|0|||
33609465|NCT03270891|102118696|FG002|Overall Study|Withdrawal by Subject|0|||
33609466|NCT03270891|102118694|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
33329655|NCT00433914|101101224|FG001|Overall Study|Withdrawal by Subject|2|||
33523041|NCT04750278|101811788|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
33523042|NCT04750278|101811786|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
33523043|NCT04750278|101811787|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
33523044|NCT04750278|101811788|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
33523045|NCT02208050|101811789|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
33523046|NCT02208050|101811790|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
33523047|NCT02087943|101811791|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
33523048|NCT02087943|101811792|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
33523049|NCT02087943|101811793|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
33523050|NCT02087943|101811794|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
33523051|NCT02087943|101811795|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
33523052|NCT02087943|101811791|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
33523053|NCT02087943|101811792|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
33523054|NCT02087943|101811793|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
33523055|NCT02087943|101811794|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
33523056|NCT02087943|101811795|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
33523057|NCT02087943|101811791|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
33523058|NCT02087943|101811792|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
33523059|NCT02087943|101811793|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
33523060|NCT02087943|101811794|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
33523061|NCT02087943|101811795|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
33523062|NCT02087943|101811791|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
33523063|NCT02087943|101811792|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
33523064|NCT02087943|101811793|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
33523065|NCT02087943|101811794|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
33523066|NCT02087943|101811795|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
33523067|NCT02087943|101811791|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
33523068|NCT02087943|101811792|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
33523069|NCT02087943|101811793|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
33523070|NCT02087943|101811794|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
33523071|NCT02087943|101811795|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
33523072|NCT02087943|101811791|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
33523073|NCT02087943|101811792|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
33523074|NCT02087943|101811793|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
33523075|NCT02087943|101811794|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
33523076|NCT02087943|101811795|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
33523077|NCT02087943|101811791|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
33523078|NCT02087943|101811792|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
33523079|NCT02087943|101811793|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
33523080|NCT02087943|101811794|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
33523081|NCT02087943|101811795|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
33609467|NCT03270891|102118695|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
33609468|NCT03270891|102118696|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
33609469|NCT01123707|102118697|FG000|Overall Study|Lost to Follow-up|3|||
33329656|NCT00433914|101101223|FG000|Overall Study|Lost to Follow-up|0|||
33329657|NCT00433914|101101224|FG001|Overall Study|Lost to Follow-up|1|||
33329658|NCT04329702|101101227|FG000|Overall Study|illness|3|||
33329659|NCT04329702|101101228|FG001|Overall Study|illness|4|||
33329660|NCT04329702|101101229|FG002|Overall Study|illness|0|||
33329661|NCT04329702|101101227|FG000|Overall Study|Lost to Follow-up|0|||
33329662|NCT04329702|101101228|FG001|Overall Study|Lost to Follow-up|0|||
33329663|NCT04329702|101101229|FG002|Overall Study|Lost to Follow-up|2|||
33329664|NCT04329702|101101227|FG000|Overall Study|Death|0|||
33609470|NCT01123707|102118698|FG001|Overall Study|Lost to Follow-up|1|||
33609471|NCT01123707|102118699|FG002|Overall Study|Lost to Follow-up|3|||
33609472|NCT01123707|102118700|FG003|Overall Study|Lost to Follow-up|2|||
33609473|NCT01123707|102118697|FG000|Overall Study|Adverse Event|5|||
33609474|NCT01123707|102118698|FG001|Overall Study|Adverse Event|7|||
33609475|NCT01123707|102118699|FG002|Overall Study|Adverse Event|5|||
33609476|NCT01123707|102118700|FG003|Overall Study|Adverse Event|3|||
33329665|NCT04329702|101101228|FG001|Overall Study|Death|2|||
33329666|NCT04329702|101101229|FG002|Overall Study|Death|0|||
33329667|NCT01786603|101101231|FG000|Overall Study|Death|5|||
33329668|NCT01786603|101101232|FG001|Overall Study|Death|1|||
33401788|NCT02475564|101361514|FG000|Overall Study|Withdrawal by Subject|1|||
33523082|NCT02087943|101811791|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
33609477|NCT01123707|102118697|FG000|Overall Study|Sponsor Discontinued Study|30|||
33609478|NCT01123707|102118698|FG001|Overall Study|Sponsor Discontinued Study|24|||
33329669|NCT01786603|101101231|FG000|Overall Study|Adverse Event|6|||
33329670|NCT01786603|101101232|FG001|Overall Study|Adverse Event|2|||
33329671|NCT01786603|101101231|FG000|Overall Study|Physician decision to withdraw|6|||
33523083|NCT02087943|101811792|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
33329672|NCT01786603|101101232|FG001|Overall Study|Physician decision to withdraw|7|||
33329673|NCT01786603|101101231|FG000|Overall Study|Lost to Follow-up|1|||
33201050|NCT00793910|100638504|FG000|Overall Study|ineligible based on entry criteria|2|||
33201051|NCT00793910|100638505|FG001|Overall Study|ineligible based on entry criteria|3|||
33523084|NCT02087943|101811793|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
33523085|NCT02087943|101811794|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
33523086|NCT02087943|101811795|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
33523087|NCT02087943|101811791|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
33523088|NCT02087943|101811792|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
33523089|NCT02087943|101811793|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
33523090|NCT02087943|101811794|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
33523091|NCT02087943|101811795|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
33523092|NCT02087943|101811791|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
33523093|NCT02087943|101811792|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
33523094|NCT02087943|101811793|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
33523095|NCT02087943|101811794|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
33523096|NCT02087943|101811795|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
33523097|NCT03268005|101811798|FG000|Overall Study|Death|2|||
33523098|NCT03268005|101811799|FG001|Overall Study|Death|1|||
33523099|NCT03268005|101811798|FG000|Overall Study|Lost to Follow-up|2|||
33523100|NCT03268005|101811799|FG001|Overall Study|Lost to Follow-up|2|||
33401789|NCT02475564|101361515|FG001|Overall Study|Withdrawal by Subject|0|||
33401790|NCT02475564|101361514|FG000|Overall Study|Lost to Follow-up|2|||
33401791|NCT02475564|101361515|FG001|Overall Study|Lost to Follow-up|1|||
33401792|NCT02475564|101361514|FG000|Overall Study|Intense Menstrual bleeding|1|||
33609479|NCT01123707|102118699|FG002|Overall Study|Sponsor Discontinued Study|25|||
33609480|NCT01123707|102118700|FG003|Overall Study|Sponsor Discontinued Study|40|||
33609481|NCT01123707|102118697|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
33609482|NCT01123707|102118698|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
33609483|NCT01123707|102118699|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
33609484|NCT01123707|102118700|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
33201052|NCT00793910|100638504|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
33201053|NCT00793910|100638505|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
33201054|NCT00793910|100638504|FG000|Overall Study|Withdrawal by Subject|0|||
33201055|NCT00793910|100638505|FG001|Overall Study|Withdrawal by Subject|1|||
33201056|NCT02371369|100638506|FG000|Part 1|Physician Decision|0|||
33201057|NCT02371369|100638507|FG001|Part 1|Physician Decision|3|||
33401793|NCT02475564|101361515|FG001|Overall Study|Intense Menstrual bleeding|0|||
33401794|NCT03824704|101361518|FG000|Overall Study|Study Terminated by Sponsor|1|||
33401795|NCT03044730|101361520|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
33523101|NCT03268005|101811798|FG000|Overall Study|Withdrawal by Subject|11|||
33523102|NCT03268005|101811799|FG001|Overall Study|Withdrawal by Subject|11|||
33523103|NCT00731731|101811804|FG000|Overall Study|Protocol Violation|0|||
33523104|NCT00731731|101811805|FG001|Overall Study|Protocol Violation|0|||
33523105|NCT00731731|101811806|FG002|Overall Study|Protocol Violation|1|||
33523106|NCT00731731|101811804|FG000|Overall Study|Cancel prior to treatment|0|||
33523107|NCT00731731|101811805|FG001|Overall Study|Cancel prior to treatment|0|||
33523108|NCT00731731|101811806|FG002|Overall Study|Cancel prior to treatment|2|||
33523109|NCT01048099|101811807|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
33523110|NCT01048099|101811807|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
33201058|NCT02371369|100638506|FG000|Part 1|Adverse Event|8|||
33201059|NCT02371369|100638507|FG001|Part 1|Adverse Event|0|||
33201060|NCT02371369|100638506|FG000|Part 1|Withdrawal by Subject|1|||
33201061|NCT02371369|100638507|FG001|Part 1|Withdrawal by Subject|6|||
33329674|NCT01786603|101101232|FG001|Overall Study|Lost to Follow-up|2|||
33329675|NCT04143009|101101233|FG000|Pilot Trial|Lost to Follow-up|0|||
33329676|NCT04143009|101101234|FG001|Pilot Trial|Lost to Follow-up|1|||
33329677|NCT04143009|101101235|FG002|Pilot Trial|Lost to Follow-up|1|||
33329678|NCT02004262|101101241|FG000|Overall Study|Death|67|||
33329679|NCT02004262|101101242|FG001|Overall Study|Death|64|||
33329680|NCT02004262|101101243|FG002|Overall Study|Death|66|||
33329681|NCT02004262|101101244|FG003|Overall Study|Death|28|||
33401796|NCT03044730|101361520|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
33401797|NCT03044730|101361520|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
33523111|NCT01066871|101811808|FG000|Overall Study|Lost to Follow-up|0|||
33523112|NCT01066871|101811809|FG001|Overall Study|Lost to Follow-up|2|||
33609485|NCT01123707|102118697|FG000|Overall Study|Investigator Withdrew Participant|0|||
33201062|NCT02371369|100638506|FG000|Part 1|Disease progression|0|||
33201063|NCT02371369|100638507|FG001|Part 1|Disease progression|1|||
33401798|NCT03044730|101361520|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
33523113|NCT01066871|101811810|FG002|Overall Study|Lost to Follow-up|2|||
33523114|NCT01066871|101811811|FG003|Overall Study|Lost to Follow-up|0|||
33523115|NCT01066871|101811808|FG000|Overall Study|Protocol Violation|1|||
33523116|NCT01066871|101811809|FG001|Overall Study|Protocol Violation|0|||
33523117|NCT01066871|101811810|FG002|Overall Study|Protocol Violation|3|||
33523118|NCT01066871|101811811|FG003|Overall Study|Protocol Violation|2|||
33523119|NCT01066871|101811808|FG000|Overall Study|Lack of Efficacy|0|||
33523120|NCT01066871|101811809|FG001|Overall Study|Lack of Efficacy|0|||
33523121|NCT01066871|101811810|FG002|Overall Study|Lack of Efficacy|0|||
33523122|NCT01066871|101811811|FG003|Overall Study|Lack of Efficacy|1|||
33523123|NCT01066871|101811808|FG000|Overall Study|Withdrawal by Subject|3|||
33523124|NCT01066871|101811809|FG001|Overall Study|Withdrawal by Subject|1|||
33523125|NCT01066871|101811810|FG002|Overall Study|Withdrawal by Subject|0|||
33523126|NCT01066871|101811811|FG003|Overall Study|Withdrawal by Subject|0|||
33523127|NCT01066871|101811808|FG000|Overall Study|Other|0|||
33523128|NCT01066871|101811809|FG001|Overall Study|Other|2|||
33609486|NCT01123707|102118698|FG001|Overall Study|Investigator Withdrew Participant|1|||
33609487|NCT01123707|102118699|FG002|Overall Study|Investigator Withdrew Participant|1|||
33609488|NCT01123707|102118700|FG003|Overall Study|Investigator Withdrew Participant|1|||
33609489|NCT01123707|102118697|FG000|Overall Study|Subject Withdrew Consent|4|||
33609490|NCT01123707|102118698|FG001|Overall Study|Subject Withdrew Consent|5|||
33609491|NCT01123707|102118699|FG002|Overall Study|Subject Withdrew Consent|1|||
33609492|NCT01123707|102118700|FG003|Overall Study|Subject Withdrew Consent|2|||
33609493|NCT01123707|102118697|FG000|Overall Study|Lack of Efficacy|1|||
33609494|NCT01123707|102118698|FG001|Overall Study|Lack of Efficacy|2|||
33609495|NCT01123707|102118699|FG002|Overall Study|Lack of Efficacy|1|||
33201064|NCT02371369|100638506|FG000|Part 1|Protocol Violation|0|||
33201065|NCT02371369|100638507|FG001|Part 1|Protocol Violation|1|||
33201066|NCT02371369|100638506|FG000|Part 2|Adverse Event|6|||
33201067|NCT02371369|100638507|FG001|Part 2|Adverse Event|5|||
33201068|NCT02371369|100638506|FG000|Part 2|Withdrawal by Subject|16|||
33329682|NCT02004262|101101245|FG004|Overall Study|Death|29|||
33329683|NCT02004262|101101246|FG005|Overall Study|Death|22|||
33329684|NCT02004262|101101241|FG000|Overall Study|Withdrawal by Subject|1|||
33329685|NCT02004262|101101242|FG001|Overall Study|Withdrawal by Subject|0|||
33609496|NCT01123707|102118700|FG003|Overall Study|Lack of Efficacy|0|||
33609497|NCT01123707|102118697|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
33609498|NCT01123707|102118698|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
33609499|NCT01123707|102118699|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
33609500|NCT01123707|102118700|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
33609501|NCT02202538|102118701|FG000|Overall Study|Withdrawal by Subject|5|||
33609502|NCT02202538|102118701|FG000|Overall Study|Did not meet all inclusion criteria|2|||
33609503|NCT02202538|102118701|FG000|Overall Study|Investigator Decision|1|||
33609504|NCT00924508|102118706|FG000|Overall Study|Withdrawal by Subject|3|||
33609505|NCT02593825|102118707|FG000|Intervention|Lost to Follow-up|10|||
33609506|NCT02593825|102118708|FG001|Intervention|Lost to Follow-up|12|||
33609507|NCT04167137|102118724|FG000|Overall Study|Disease progression|1|||
33609508|NCT04167137|102118725|FG001|Overall Study|Disease progression|1|||
33609509|NCT04167137|102118726|FG002|Overall Study|Disease progression|3|||
33609510|NCT04167137|102118727|FG003|Overall Study|Disease progression|3|||
33609511|NCT04167137|102118728|FG004|Overall Study|Disease progression|2|||
33609512|NCT04167137|102118729|FG005|Overall Study|Disease progression|3|||
33609513|NCT04167137|102118730|FG006|Overall Study|Disease progression|2|||
33609514|NCT04167137|102118731|FG007|Overall Study|Disease progression|2|||
33609515|NCT04167137|102118724|FG000|Overall Study|Withdrawal by Subject|1|||
33609516|NCT04167137|102118725|FG001|Overall Study|Withdrawal by Subject|0|||
33609517|NCT04167137|102118726|FG002|Overall Study|Withdrawal by Subject|0|||
33609518|NCT04167137|102118727|FG003|Overall Study|Withdrawal by Subject|1|||
33609519|NCT04167137|102118728|FG004|Overall Study|Withdrawal by Subject|0|||
33609520|NCT04167137|102118729|FG005|Overall Study|Withdrawal by Subject|2|||
33201069|NCT02371369|100638507|FG001|Part 2|Withdrawal by Subject|6|||
33201070|NCT02371369|100638506|FG000|Part 2|Investigator decision|1|||
33201071|NCT02371369|100638507|FG001|Part 2|Investigator decision|2|||
33201072|NCT02371369|100638506|FG000|Part 2|Death|0|||
33523129|NCT01066871|101811810|FG002|Overall Study|Other|1|||
33523130|NCT01066871|101811811|FG003|Overall Study|Other|2|||
33523131|NCT04702997|101811812|FG000|Overall Study|Withdrawal by Subject|1|||
33523132|NCT04702997|101811813|FG001|Overall Study|Withdrawal by Subject|1|||
33609521|NCT04167137|102118730|FG006|Overall Study|Withdrawal by Subject|1|||
33609522|NCT04167137|102118731|FG007|Overall Study|Withdrawal by Subject|0|||
33609523|NCT04167137|102118724|FG000|Overall Study|Adverse Event|0|||
33609524|NCT04167137|102118725|FG001|Overall Study|Adverse Event|0|||
33609525|NCT04167137|102118726|FG002|Overall Study|Adverse Event|0|||
33201073|NCT02371369|100638507|FG001|Part 2|Death|1|||
33609526|NCT04167137|102118727|FG003|Overall Study|Adverse Event|0|||
33609527|NCT04167137|102118728|FG004|Overall Study|Adverse Event|0|||
33201074|NCT02371369|100638506|FG000|Part 2|Disease progression|1|||
33201075|NCT02371369|100638507|FG001|Part 2|Disease progression|0|||
33201076|NCT02371369|100638506|FG000|Part 2|Subject Noncompliance|1|||
33201077|NCT02371369|100638507|FG001|Part 2|Subject Noncompliance|0|||
33201078|NCT02371369|100638506|FG000|Part 2|Lost to Follow-up|1|||
33201079|NCT02371369|100638507|FG001|Part 2|Lost to Follow-up|1|||
33201080|NCT02371369|100638506|FG000|Part 2|Subject transitioned to commercial supply|6|||
33201081|NCT02371369|100638507|FG001|Part 2|Subject transitioned to commercial supply|4|||
33201082|NCT02371369|100638506|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
33201083|NCT02371369|100638507|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
33201084|NCT02371369|100638506|FG000|Part 2|Surgical resection of tumor|1|||
33201085|NCT02371369|100638507|FG001|Part 2|Surgical resection of tumor|1|||
33201086|NCT02371369|100638506|FG000|Part 2|Other|0|||
33201087|NCT02371369|100638507|FG001|Part 2|Other|1|||
33201088|NCT01978119|100638510|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
33201089|NCT01978119|100638511|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
33201090|NCT01978119|100638510|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
33201091|NCT01978119|100638511|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33201092|NCT01978119|100638510|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33201093|NCT01978119|100638511|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
33201094|NCT00856856|100638514|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
33201095|NCT00856856|100638514|FG000|4-year Clinical Follow-up|Missed visit|1|||
33201096|NCT03036566|100638516|FG000|Overall Study|Lost to Follow-up|3|||
33201097|NCT02417246|100642580|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
33201098|NCT02417246|100642581|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
33201099|NCT02417246|100642580|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
33201100|NCT02417246|100642581|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
33201101|NCT02417246|100642580|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
33201102|NCT02417246|100642581|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
33201103|NCT02417246|100642580|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
33201104|NCT02417246|100642581|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
33201105|NCT01465334|100642582|FG000|Overall Study|Disease Progression|1|||
33201106|NCT01465334|100642583|FG001|Overall Study|Disease Progression|0|||
33201107|NCT01465334|100642582|FG000|Overall Study|Adverse Event|1|||
33201108|NCT01465334|100642583|FG001|Overall Study|Adverse Event|0|||
33201109|NCT01465334|100642582|FG000|Overall Study|Richter's transformation|0|||
33201110|NCT01465334|100642583|FG001|Overall Study|Richter's transformation|3|||
33201111|NCT01465334|100642582|FG000|Overall Study|Refractory Disease|0|||
33201112|NCT01465334|100642583|FG001|Overall Study|Refractory Disease|3|||
33201113|NCT04964089|100642584|FG000|Overall Study|Adverse Event|8|||
33201114|NCT04964089|100642585|FG001|Overall Study|Adverse Event|6|||
33201115|NCT04964089|100642584|FG000|Overall Study|Non-compliance with study schedule|1|||
33201116|NCT04964089|100642585|FG001|Overall Study|Non-compliance with study schedule|0|||
33201117|NCT04964089|100642584|FG000|Overall Study|Withdrawal by Subject|6|||
33201118|NCT04964089|100642585|FG001|Overall Study|Withdrawal by Subject|5|||
33201119|NCT04964089|100642584|FG000|Overall Study|Lost to Follow-up|1|||
33201120|NCT04964089|100642585|FG001|Overall Study|Lost to Follow-up|1|||
33201121|NCT04964089|100642584|FG000|Overall Study|Progressive disease|4|||
33201122|NCT04964089|100642585|FG001|Overall Study|Progressive disease|0|||
33201123|NCT04964089|100642584|FG000|Overall Study|Physician Decision|1|||
33201124|NCT04964089|100642585|FG001|Overall Study|Physician Decision|0|||
33201125|NCT04964089|100642584|FG000|Overall Study|Participant did not want to continue study treatment|1|||
33201126|NCT04964089|100642585|FG001|Overall Study|Participant did not want to continue study treatment|0|||
33201127|NCT04964089|100642584|FG000|Overall Study|Participant moved to different state|1|||
33201128|NCT04964089|100642585|FG001|Overall Study|Participant moved to different state|0|||
33201129|NCT04964089|100642584|FG000|Overall Study|Participant decided to discontinue|0|||
33201130|NCT04964089|100642585|FG001|Overall Study|Participant decided to discontinue|1|||
33201131|NCT00932893|100642586|FG000|Overall Study|Death|115|||
33201132|NCT00932893|100642587|FG001|Overall Study|Death|24|||
33201133|NCT00932893|100642586|FG000|Overall Study|Lost to Follow-up|8|||
33201134|NCT00932893|100642587|FG001|Overall Study|Lost to Follow-up|0|||
33201135|NCT00932893|100642586|FG000|Overall Study|Withdrawal by Subject|5|||
33201136|NCT00932893|100642587|FG001|Overall Study|Withdrawal by Subject|2|||
33201137|NCT00932893|100642586|FG000|Overall Study|Other|5|||
33201138|NCT00932893|100642587|FG001|Overall Study|Other|144|||
33201139|NCT02138214|100642588|FG000|Overall Study|Withdrawal by Subject|0|||
33201140|NCT02138214|100642589|FG001|Overall Study|Withdrawal by Subject|1|||
33201141|NCT02138214|100642590|FG002|Overall Study|Withdrawal by Subject|0|||
33201142|NCT02138214|100642588|FG000|Overall Study|Lost to Follow-up|0|||
33201143|NCT02138214|100642589|FG001|Overall Study|Lost to Follow-up|2|||
33201144|NCT02138214|100642590|FG002|Overall Study|Lost to Follow-up|4|||
33609528|NCT04167137|102118729|FG005|Overall Study|Adverse Event|1|||
33201145|NCT02138214|100642588|FG000|Overall Study|Screen Failure|0|||
33201146|NCT02138214|100642589|FG001|Overall Study|Screen Failure|1|||
33201147|NCT02138214|100642590|FG002|Overall Study|Screen Failure|0|||
33201148|NCT01358526|100642593|FG000|Open-label Titration Period|Adverse Event|95|||
33201149|NCT01358526|100642594|FG001|Open-label Titration Period|Adverse Event|0|||
33201150|NCT01358526|100642595|FG002|Open-label Titration Period|Adverse Event|0|||
33201151|NCT01358526|100642593|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
33201152|NCT01358526|100642594|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
33201153|NCT01358526|100642595|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
33201154|NCT01358526|100642593|FG000|Open-label Titration Period|Lost to Follow-up|25|||
33201155|NCT01358526|100642594|FG001|Open-label Titration Period|Lost to Follow-up|0|||
33201156|NCT01358526|100642595|FG002|Open-label Titration Period|Lost to Follow-up|0|||
33201157|NCT01358526|100642593|FG000|Open-label Titration Period|Lack of Efficacy|107|||
33201158|NCT01358526|100642594|FG001|Open-label Titration Period|Lack of Efficacy|0|||
33201159|NCT01358526|100642595|FG002|Open-label Titration Period|Lack of Efficacy|0|||
33201160|NCT01358526|100642593|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
33201161|NCT01358526|100642594|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
33201162|NCT01358526|100642595|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
33201163|NCT01358526|100642593|FG000|Open-label Titration Period|Administrative|8|||
33201164|NCT01358526|100642594|FG001|Open-label Titration Period|Administrative|0|||
33201165|NCT01358526|100642595|FG002|Open-label Titration Period|Administrative|0|||
33201166|NCT01358526|100642593|FG000|Open-label Titration Period|Did not qualify|178|||
33201167|NCT01358526|100642594|FG001|Open-label Titration Period|Did not qualify|0|||
33201168|NCT01358526|100642595|FG002|Open-label Titration Period|Did not qualify|0|||
33201169|NCT01358526|100642593|FG000|Double-blind Phase|Adverse Event|0|||
33201170|NCT01358526|100642594|FG001|Double-blind Phase|Adverse Event|24|||
33201171|NCT01358526|100642595|FG002|Double-blind Phase|Adverse Event|23|||
33201172|NCT01358526|100642593|FG000|Double-blind Phase|Withdrawal by Subject|0|||
33201173|NCT01358526|100642594|FG001|Double-blind Phase|Withdrawal by Subject|10|||
33201174|NCT01358526|100642595|FG002|Double-blind Phase|Withdrawal by Subject|8|||
33201175|NCT01358526|100642593|FG000|Double-blind Phase|Lost to Follow-up|0|||
33201176|NCT01358526|100642594|FG001|Double-blind Phase|Lost to Follow-up|4|||
33201177|NCT01358526|100642595|FG002|Double-blind Phase|Lost to Follow-up|1|||
33201178|NCT01358526|100642593|FG000|Double-blind Phase|Lack of Efficacy|0|||
33201179|NCT01358526|100642594|FG001|Double-blind Phase|Lack of Efficacy|31|||
33201180|NCT01358526|100642595|FG002|Double-blind Phase|Lack of Efficacy|73|||
33201181|NCT01358526|100642593|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
33201182|NCT01358526|100642594|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
33201183|NCT01358526|100642595|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
33201184|NCT01358526|100642593|FG000|Double-blind Phase|Administrative|0|||
33201185|NCT01358526|100642594|FG001|Double-blind Phase|Administrative|6|||
33201186|NCT01358526|100642595|FG002|Double-blind Phase|Administrative|10|||
33201187|NCT03892889|100642596|FG000|Overall Study|Adverse Event|17|||
33201188|NCT03892889|100642596|FG000|Overall Study|Lack of Efficacy|1|||
33201189|NCT03892889|100642596|FG000|Overall Study|Lost to Follow-up|46|||
33201190|NCT03892889|100642596|FG000|Overall Study|Non-compliance with study drug|22|||
33201191|NCT03892889|100642596|FG000|Overall Study|Pregnancy|1|||
33201192|NCT03892889|100642596|FG000|Overall Study|Protocol Deviation|3|||
33201193|NCT03892889|100642596|FG000|Overall Study|Withdrawal by Subject|50|||
33201194|NCT03892889|100642596|FG000|Overall Study|Withdrawal by Caregiver|1|||
33201195|NCT03892889|100642596|FG000|Overall Study|Study Terminated by Sponsor|50|||
33201196|NCT03892889|100642596|FG000|Overall Study|Physician Decision|8|||
33201197|NCT03892889|100642596|FG000|Overall Study|Reason not Specified|5|||
33201198|NCT02806986|100642597|FG000|Treatment Stage 1|Adverse Event|1|||
33201199|NCT02806986|100642597|FG000|Treatment Stage 2|Adverse Event|3|||
33201200|NCT02806986|100642597|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
33201201|NCT03283670|100642600|FG000|Placebo Gas|Withdrawal by Subject|2|||
33201202|NCT03283670|100642600|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
33201203|NCT03283670|100642600|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
33201204|NCT01542528|100642607|FG000|Overall Study|Lost to Follow-up|2|||
33201205|NCT01542528|100642608|FG001|Overall Study|Lost to Follow-up|1|||
33201206|NCT01542528|100642607|FG000|Overall Study|Physician Decision|1|||
33609529|NCT04167137|102118730|FG006|Overall Study|Adverse Event|0|||
33201207|NCT01542528|100642608|FG001|Overall Study|Physician Decision|0|||
33329686|NCT02004262|101101243|FG002|Overall Study|Withdrawal by Subject|4|||
33609530|NCT04167137|102118731|FG007|Overall Study|Adverse Event|1|||
33201208|NCT01542528|100642607|FG000|Overall Study|Withdrawal by Subject|9|||
33201209|NCT01542528|100642608|FG001|Overall Study|Withdrawal by Subject|6|||
33201210|NCT03095417|100642609|FG000|Overall Study|missed|1|||
33201211|NCT03095417|100642610|FG001|Overall Study|missed|2|||
33201212|NCT03095417|100642611|FG002|Overall Study|missed|0|||
33201213|NCT03095417|100642612|FG003|Overall Study|missed|1|||
33201214|NCT03095417|100642609|FG000|Overall Study|Lost to Follow-up|2|||
33201215|NCT03095417|100642610|FG001|Overall Study|Lost to Follow-up|2|||
33201216|NCT03095417|100642611|FG002|Overall Study|Lost to Follow-up|1|||
33201217|NCT03095417|100642612|FG003|Overall Study|Lost to Follow-up|0|||
33201218|NCT03095417|100642609|FG000|Overall Study|refusal|0|||
33417260|NCT04856917|101420243|FG002|Overall Study|Other|0|||
33201219|NCT03095417|100642610|FG001|Overall Study|refusal|1|||
33609531|NCT04167137|102118724|FG000|Overall Study|Physician Decision|0|||
33201220|NCT03095417|100642611|FG002|Overall Study|refusal|0|||
33201221|NCT03095417|100642612|FG003|Overall Study|refusal|1|||
33201222|NCT03095417|100642609|FG000|Overall Study|Withdrawal by Subject|8|||
33201223|NCT03095417|100642610|FG001|Overall Study|Withdrawal by Subject|2|||
33201224|NCT03095417|100642611|FG002|Overall Study|Withdrawal by Subject|5|||
33201225|NCT03095417|100642612|FG003|Overall Study|Withdrawal by Subject|4|||
33201226|NCT03095417|100642609|FG000|Overall Study|Physician Decision|1|||
33201227|NCT03095417|100642610|FG001|Overall Study|Physician Decision|2|||
33201228|NCT03095417|100642611|FG002|Overall Study|Physician Decision|2|||
33201229|NCT03095417|100642612|FG003|Overall Study|Physician Decision|2|||
33201230|NCT03095417|100642609|FG000|Overall Study|Death|1|||
33201231|NCT03095417|100642610|FG001|Overall Study|Death|2|||
33201232|NCT03095417|100642611|FG002|Overall Study|Death|1|||
33201233|NCT03095417|100642612|FG003|Overall Study|Death|3|||
33201234|NCT01265953|100642613|FG000|Overall Study|Non compliance|5|||
33201235|NCT01265953|100642614|FG001|Overall Study|Non compliance|3|||
33201236|NCT02032901|100642615|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
33201237|NCT02032901|100642616|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
33201238|NCT02032901|100642615|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
33201239|NCT02032901|100642616|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
33201240|NCT00701051|100642617|FG000|Screening|Failed Screening|40|||
33201241|NCT00701051|100642618|FG001|Screening|Failed Screening|0|||
33201242|NCT00701051|100642619|FG002|Screening|Failed Screening|0|||
33201243|NCT00701051|100642617|FG000|Screening|Time conflicts|19|||
33201244|NCT00701051|100642618|FG001|Screening|Time conflicts|0|||
33201245|NCT00701051|100642619|FG002|Screening|Time conflicts|0|||
33201246|NCT00701051|100642617|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
33329687|NCT02004262|101101244|FG003|Overall Study|Withdrawal by Subject|0|||
33329688|NCT02004262|101101245|FG004|Overall Study|Withdrawal by Subject|1|||
33201247|NCT00701051|100642618|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
33201248|NCT00701051|100642619|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
33201249|NCT02805257|100642625|FG000|Overall Study|Lost to Follow-up|7|||
33201250|NCT02805257|100642626|FG001|Overall Study|Lost to Follow-up|6|||
33201251|NCT02805257|100642625|FG000|Overall Study|Death|0|||
33201252|NCT02805257|100642626|FG001|Overall Study|Death|1|||
33201253|NCT02641080|100642627|FG000|Overall Study|Physician Decision|2|||
33609532|NCT04167137|102118725|FG001|Overall Study|Physician Decision|0|||
33609533|NCT04167137|102118726|FG002|Overall Study|Physician Decision|0|||
33609534|NCT04167137|102118727|FG003|Overall Study|Physician Decision|1|||
33609535|NCT04167137|102118728|FG004|Overall Study|Physician Decision|0|||
33201254|NCT02641080|100642628|FG001|Overall Study|Physician Decision|0|||
33201255|NCT02641080|100642627|FG000|Overall Study|Withdrawal by Subject|0|||
33201256|NCT02641080|100642628|FG001|Overall Study|Withdrawal by Subject|1|||
33201257|NCT02641080|100642627|FG000|Overall Study|Rehab Center denied use of pumps|0|||
33609536|NCT04167137|102118729|FG005|Overall Study|Physician Decision|0|||
33609537|NCT04167137|102118730|FG006|Overall Study|Physician Decision|1|||
33609538|NCT04167137|102118731|FG007|Overall Study|Physician Decision|0|||
33609539|NCT04167137|102118724|FG000|Overall Study|Death|0|||
33609540|NCT04167137|102118725|FG001|Overall Study|Death|1|||
33609541|NCT04167137|102118726|FG002|Overall Study|Death|0|||
33329689|NCT02004262|101101246|FG005|Overall Study|Withdrawal by Subject|3|||
33329690|NCT02004262|101101241|FG000|Overall Study|Lost to Follow-up|1|||
33609542|NCT04167137|102118727|FG003|Overall Study|Death|0|||
33609543|NCT04167137|102118728|FG004|Overall Study|Death|0|||
33201258|NCT02641080|100642628|FG001|Overall Study|Rehab Center denied use of pumps|3|||
33201259|NCT02641080|100642627|FG000|Overall Study|Lost to Follow-up|0|||
33201260|NCT02641080|100642628|FG001|Overall Study|Lost to Follow-up|3|||
33201261|NCT01722331|100642632|FG000|Part 1|Adverse Event|5|||
33201262|NCT01722331|100642633|FG001|Part 1|Adverse Event|0|||
33609544|NCT04167137|102118729|FG005|Overall Study|Death|0|||
33609545|NCT04167137|102118730|FG006|Overall Study|Death|0|||
33609546|NCT04167137|102118731|FG007|Overall Study|Death|0|||
33201263|NCT01722331|100642634|FG002|Part 1|Adverse Event|0|||
33329691|NCT02004262|101101242|FG001|Overall Study|Lost to Follow-up|1|||
33201264|NCT01722331|100642635|FG003|Part 1|Adverse Event|0|||
33201265|NCT01722331|100642636|FG004|Part 1|Adverse Event|0|||
33201266|NCT01722331|100642637|FG005|Part 1|Adverse Event|0|||
33201267|NCT01722331|100642638|FG006|Part 1|Adverse Event|0|||
33201268|NCT01722331|100642632|FG000|Part 1|Lack of Efficacy|0|||
33201269|NCT01722331|100642633|FG001|Part 1|Lack of Efficacy|0|||
33201270|NCT01722331|100642634|FG002|Part 1|Lack of Efficacy|1|||
33201271|NCT01722331|100642635|FG003|Part 1|Lack of Efficacy|0|||
33201272|NCT01722331|100642636|FG004|Part 1|Lack of Efficacy|2|||
33201273|NCT01722331|100642637|FG005|Part 1|Lack of Efficacy|0|||
33201274|NCT01722331|100642638|FG006|Part 1|Lack of Efficacy|0|||
33609547|NCT04167137|102118724|FG000|Overall Study|Study terminated by Sponsor|0|||
33609548|NCT04167137|102118725|FG001|Overall Study|Study terminated by Sponsor|0|||
33201275|NCT01722331|100642632|FG000|Part 1|Lost to Follow-up|1|||
33609549|NCT04167137|102118726|FG002|Overall Study|Study terminated by Sponsor|0|||
33609550|NCT04167137|102118727|FG003|Overall Study|Study terminated by Sponsor|0|||
33201276|NCT01722331|100642633|FG001|Part 1|Lost to Follow-up|0|||
33201277|NCT01722331|100642634|FG002|Part 1|Lost to Follow-up|2|||
33201278|NCT01722331|100642635|FG003|Part 1|Lost to Follow-up|0|||
33201279|NCT01722331|100642636|FG004|Part 1|Lost to Follow-up|1|||
33201280|NCT01722331|100642637|FG005|Part 1|Lost to Follow-up|0|||
33201281|NCT01722331|100642638|FG006|Part 1|Lost to Follow-up|0|||
33201282|NCT01722331|100642632|FG000|Part 1|Physician Decision|0|||
33201283|NCT01722331|100642633|FG001|Part 1|Physician Decision|0|||
33201284|NCT01722331|100642634|FG002|Part 1|Physician Decision|3|||
33201285|NCT01722331|100642635|FG003|Part 1|Physician Decision|0|||
33523133|NCT02109445|101811815|FG000|Overall Study|Symptomatic deterioration|2|||
33523134|NCT02109445|101811815|FG000|Overall Study|Adverse Event|1|||
33523135|NCT04710368|101811826|FG000|Overall Study|Withdrawal by Subject|9|||
33523136|NCT04710368|101811826|FG000|Overall Study|Lost to Follow-up|4|||
33523137|NCT04710368|101811826|FG000|Overall Study|Death|2|||
33523138|NCT04710368|101811826|FG000|Overall Study|Patient preference|11|||
33523139|NCT04710368|101811826|FG000|Overall Study|Treatment discontinuation|1|||
33523140|NCT01066793|101811827|FG000|Overall Study|Death|4|||
33523141|NCT01066793|101811828|FG001|Overall Study|Death|1|||
33523142|NCT01066793|101811829|FG002|Overall Study|Death|1|||
33523143|NCT01066793|101811830|FG003|Overall Study|Death|0|||
33523144|NCT01066793|101811831|FG004|Overall Study|Death|0|||
33523145|NCT01066793|101811832|FG005|Overall Study|Death|0|||
33523146|NCT01066793|101811827|FG000|Overall Study|Lack of Efficacy|2|||
33523147|NCT01066793|101811828|FG001|Overall Study|Lack of Efficacy|1|||
33523148|NCT01066793|101811829|FG002|Overall Study|Lack of Efficacy|0|||
33523149|NCT01066793|101811830|FG003|Overall Study|Lack of Efficacy|0|||
33523150|NCT01066793|101811831|FG004|Overall Study|Lack of Efficacy|0|||
33523151|NCT01066793|101811832|FG005|Overall Study|Lack of Efficacy|0|||
33523152|NCT01066793|101811827|FG000|Overall Study|Lost to Follow-up|180|||
33201286|NCT01722331|100642636|FG004|Part 1|Physician Decision|1|||
33201287|NCT01722331|100642637|FG005|Part 1|Physician Decision|0|||
33609551|NCT04167137|102118728|FG004|Overall Study|Study terminated by Sponsor|0|||
33609552|NCT04167137|102118729|FG005|Overall Study|Study terminated by Sponsor|0|||
33201288|NCT01722331|100642638|FG006|Part 1|Physician Decision|0|||
33201289|NCT01722331|100642632|FG000|Part 1|Pregnancy|1|||
33201290|NCT01722331|100642633|FG001|Part 1|Pregnancy|0|||
33201291|NCT01722331|100642634|FG002|Part 1|Pregnancy|0|||
33201292|NCT01722331|100642635|FG003|Part 1|Pregnancy|0|||
33201293|NCT01722331|100642636|FG004|Part 1|Pregnancy|0|||
33201294|NCT01722331|100642637|FG005|Part 1|Pregnancy|0|||
33201295|NCT01722331|100642638|FG006|Part 1|Pregnancy|0|||
33201296|NCT01722331|100642632|FG000|Part 1|Progressive Disease|0|||
33201297|NCT01722331|100642633|FG001|Part 1|Progressive Disease|0|||
33523153|NCT01066793|101811828|FG001|Overall Study|Lost to Follow-up|39|||
33523154|NCT01066793|101811829|FG002|Overall Study|Lost to Follow-up|82|||
33523155|NCT01066793|101811830|FG003|Overall Study|Lost to Follow-up|16|||
33609553|NCT04167137|102118730|FG006|Overall Study|Study terminated by Sponsor|0|||
33201298|NCT01722331|100642634|FG002|Part 1|Progressive Disease|0|||
33201299|NCT01722331|100642635|FG003|Part 1|Progressive Disease|0|||
33201300|NCT01722331|100642636|FG004|Part 1|Progressive Disease|1|||
33201301|NCT01722331|100642637|FG005|Part 1|Progressive Disease|0|||
33329692|NCT02004262|101101243|FG002|Overall Study|Lost to Follow-up|0|||
33329693|NCT02004262|101101244|FG003|Overall Study|Lost to Follow-up|0|||
33329694|NCT02004262|101101245|FG004|Overall Study|Lost to Follow-up|0|||
33329695|NCT02004262|101101246|FG005|Overall Study|Lost to Follow-up|0|||
33329696|NCT02004262|101101241|FG000|Overall Study|Study Terminated by Sponsor|4|||
33329697|NCT02004262|101101242|FG001|Overall Study|Study Terminated by Sponsor|3|||
33329698|NCT02004262|101101243|FG002|Overall Study|Study Terminated by Sponsor|2|||
33329699|NCT02004262|101101244|FG003|Overall Study|Study Terminated by Sponsor|1|||
33329700|NCT02004262|101101245|FG004|Overall Study|Study Terminated by Sponsor|1|||
33329701|NCT02004262|101101246|FG005|Overall Study|Study Terminated by Sponsor|5|||
33523156|NCT01066793|101811831|FG004|Overall Study|Lost to Follow-up|0|||
33523157|NCT01066793|101811832|FG005|Overall Study|Lost to Follow-up|1|||
33523158|NCT01066793|101811827|FG000|Overall Study|Physician Decision|3|||
33609554|NCT04167137|102118731|FG007|Overall Study|Study terminated by Sponsor|1|||
33609555|NCT01300572|102118732|FG000|Overall Study|HAMA + post dosimetry|1|||
33609556|NCT00360568|102118735|FG000|Overall Study|Adverse Event|1|||
33201302|NCT01722331|100642638|FG006|Part 1|Progressive Disease|0|||
33201303|NCT01722331|100642632|FG000|Part 1|Protocol Violation|1|||
33201304|NCT01722331|100642633|FG001|Part 1|Protocol Violation|0|||
33201305|NCT01722331|100642634|FG002|Part 1|Protocol Violation|0|||
33201306|NCT01722331|100642635|FG003|Part 1|Protocol Violation|0|||
33201307|NCT01722331|100642636|FG004|Part 1|Protocol Violation|1|||
33201308|NCT01722331|100642637|FG005|Part 1|Protocol Violation|0|||
33201309|NCT01722331|100642638|FG006|Part 1|Protocol Violation|0|||
33201310|NCT01722331|100642632|FG000|Part 1|Withdrawal by Subject|2|||
33201311|NCT01722331|100642633|FG001|Part 1|Withdrawal by Subject|0|||
33201312|NCT01722331|100642634|FG002|Part 1|Withdrawal by Subject|3|||
33201313|NCT01722331|100642635|FG003|Part 1|Withdrawal by Subject|0|||
33523159|NCT01066793|101811828|FG001|Overall Study|Physician Decision|0|||
33523160|NCT01066793|101811829|FG002|Overall Study|Physician Decision|0|||
33523161|NCT01066793|101811830|FG003|Overall Study|Physician Decision|0|||
33201314|NCT01722331|100642636|FG004|Part 1|Withdrawal by Subject|3|||
33201315|NCT01722331|100642637|FG005|Part 1|Withdrawal by Subject|0|||
33201316|NCT01722331|100642638|FG006|Part 1|Withdrawal by Subject|0|||
33201317|NCT01722331|100642632|FG000|Part 2|Adverse Event|3|||
33201318|NCT01722331|100642633|FG001|Part 2|Adverse Event|0|||
33201319|NCT01722331|100642634|FG002|Part 2|Adverse Event|0|||
33201320|NCT01722331|100642635|FG003|Part 2|Adverse Event|0|||
33201321|NCT01722331|100642636|FG004|Part 2|Adverse Event|0|||
33201322|NCT01722331|100642637|FG005|Part 2|Adverse Event|1|||
33201323|NCT01722331|100642638|FG006|Part 2|Adverse Event|0|||
33201324|NCT01722331|100642632|FG000|Part 2|Lack of Efficacy|3|||
33201325|NCT01722331|100642633|FG001|Part 2|Lack of Efficacy|0|||
33201326|NCT01722331|100642634|FG002|Part 2|Lack of Efficacy|11|||
33201327|NCT01722331|100642635|FG003|Part 2|Lack of Efficacy|0|||
33201328|NCT01722331|100642636|FG004|Part 2|Lack of Efficacy|0|||
33201329|NCT01722331|100642637|FG005|Part 2|Lack of Efficacy|3|||
33201330|NCT01722331|100642638|FG006|Part 2|Lack of Efficacy|3|||
33329702|NCT00788372|101101249|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
33329703|NCT00788372|101101249|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
33329704|NCT00788372|101101249|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
33329705|NCT00788372|101101249|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
33329706|NCT00788372|101101249|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
33329707|NCT00788372|101101249|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
33523162|NCT01066793|101811831|FG004|Overall Study|Physician Decision|0|||
33523163|NCT01066793|101811832|FG005|Overall Study|Physician Decision|0|||
33523164|NCT01066793|101811827|FG000|Overall Study|Protocol Violation|3|||
33523165|NCT01066793|101811828|FG001|Overall Study|Protocol Violation|2|||
33523166|NCT01066793|101811829|FG002|Overall Study|Protocol Violation|2|||
33201331|NCT01722331|100642632|FG000|Part 2|Lost to Follow-up|0|||
33201332|NCT01722331|100642633|FG001|Part 2|Lost to Follow-up|0|||
33201333|NCT01722331|100642634|FG002|Part 2|Lost to Follow-up|3|||
33201334|NCT01722331|100642635|FG003|Part 2|Lost to Follow-up|0|||
33523167|NCT01066793|101811830|FG003|Overall Study|Protocol Violation|0|||
33523168|NCT01066793|101811831|FG004|Overall Study|Protocol Violation|0|||
33523169|NCT01066793|101811832|FG005|Overall Study|Protocol Violation|0|||
33523170|NCT01066793|101811827|FG000|Overall Study|Withdrawal by Subject|7|||
33523171|NCT01066793|101811828|FG001|Overall Study|Withdrawal by Subject|4|||
33523172|NCT01066793|101811829|FG002|Overall Study|Withdrawal by Subject|1|||
33523173|NCT01066793|101811830|FG003|Overall Study|Withdrawal by Subject|0|||
33523174|NCT01066793|101811831|FG004|Overall Study|Withdrawal by Subject|0|||
33523175|NCT01066793|101811832|FG005|Overall Study|Withdrawal by Subject|0|||
33523176|NCT01066793|101811827|FG000|Overall Study|Early Termination|3|||
33523177|NCT01066793|101811828|FG001|Overall Study|Early Termination|0|||
33523178|NCT01066793|101811829|FG002|Overall Study|Early Termination|0|||
33523179|NCT01066793|101811830|FG003|Overall Study|Early Termination|0|||
33523180|NCT01066793|101811831|FG004|Overall Study|Early Termination|0|||
33523181|NCT01066793|101811832|FG005|Overall Study|Early Termination|0|||
33523182|NCT01066793|101811827|FG000|Overall Study|Lab test not done|7|||
33523183|NCT01066793|101811828|FG001|Overall Study|Lab test not done|0|||
33523184|NCT01066793|101811829|FG002|Overall Study|Lab test not done|0|||
33523185|NCT01066793|101811830|FG003|Overall Study|Lab test not done|1|||
33523186|NCT01066793|101811831|FG004|Overall Study|Lab test not done|0|||
33523187|NCT01066793|101811832|FG005|Overall Study|Lab test not done|0|||
33523188|NCT01066793|101811827|FG000|Overall Study|Miscellaneous|4|||
33523189|NCT01066793|101811828|FG001|Overall Study|Miscellaneous|5|||
33523190|NCT01066793|101811829|FG002|Overall Study|Miscellaneous|6|||
33523191|NCT01066793|101811830|FG003|Overall Study|Miscellaneous|0|||
33523192|NCT01066793|101811831|FG004|Overall Study|Miscellaneous|0|||
33201335|NCT01722331|100642636|FG004|Part 2|Lost to Follow-up|0|||
33329708|NCT00788372|101101249|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
33329709|NCT00432042|101101250|FG000|Overall Study|Protocol Violation|2|||
33329710|NCT00432042|101101251|FG001|Overall Study|Protocol Violation|0|||
33329711|NCT00432042|101101252|FG002|Overall Study|Protocol Violation|0|||
33329712|NCT00432042|101101250|FG000|Overall Study|Withdrawal by Subject|0|||
33523193|NCT01066793|101811832|FG005|Overall Study|Miscellaneous|0|||
33201336|NCT01722331|100642637|FG005|Part 2|Lost to Follow-up|1|||
33201337|NCT01722331|100642638|FG006|Part 2|Lost to Follow-up|1|||
33201338|NCT01722331|100642632|FG000|Part 2|Non-Compliance with Study Drug|1|||
33201339|NCT01722331|100642633|FG001|Part 2|Non-Compliance with Study Drug|0|||
33201340|NCT01722331|100642634|FG002|Part 2|Non-Compliance with Study Drug|1|||
33201341|NCT01722331|100642635|FG003|Part 2|Non-Compliance with Study Drug|0|||
33201342|NCT01722331|100642636|FG004|Part 2|Non-Compliance with Study Drug|0|||
33523194|NCT01066793|101811827|FG000|Overall Study|Non-responders|104|||
33523195|NCT01066793|101811828|FG001|Overall Study|Non-responders|5|||
33523196|NCT01066793|101811829|FG002|Overall Study|Non-responders|11|||
33523197|NCT01066793|101811830|FG003|Overall Study|Non-responders|25|||
33523198|NCT01066793|101811831|FG004|Overall Study|Non-responders|0|||
33523199|NCT01066793|101811832|FG005|Overall Study|Non-responders|0|||
33523200|NCT01066793|101811827|FG000|Overall Study|Other|15|||
33523201|NCT01066793|101811828|FG001|Overall Study|Other|5|||
33523202|NCT01066793|101811829|FG002|Overall Study|Other|6|||
33201343|NCT01722331|100642637|FG005|Part 2|Non-Compliance with Study Drug|0|||
33201344|NCT01722331|100642638|FG006|Part 2|Non-Compliance with Study Drug|0|||
33201345|NCT01722331|100642632|FG000|Part 2|Physician Decision|0|||
33201346|NCT01722331|100642633|FG001|Part 2|Physician Decision|0|||
33201347|NCT01722331|100642634|FG002|Part 2|Physician Decision|2|||
33201348|NCT01722331|100642635|FG003|Part 2|Physician Decision|0|||
33201349|NCT01722331|100642636|FG004|Part 2|Physician Decision|0|||
33201350|NCT01722331|100642637|FG005|Part 2|Physician Decision|0|||
33201351|NCT01722331|100642638|FG006|Part 2|Physician Decision|0|||
33201352|NCT01722331|100642632|FG000|Part 2|Pregnancy|0|||
33201353|NCT01722331|100642633|FG001|Part 2|Pregnancy|0|||
33201354|NCT01722331|100642634|FG002|Part 2|Pregnancy|0|||
33201355|NCT01722331|100642635|FG003|Part 2|Pregnancy|0|||
33201356|NCT01722331|100642636|FG004|Part 2|Pregnancy|0|||
33201357|NCT01722331|100642637|FG005|Part 2|Pregnancy|1|||
33201358|NCT01722331|100642638|FG006|Part 2|Pregnancy|0|||
33201359|NCT01722331|100642632|FG000|Part 2|Progressive Disease|0|||
33201360|NCT01722331|100642633|FG001|Part 2|Progressive Disease|0|||
33201361|NCT01722331|100642634|FG002|Part 2|Progressive Disease|1|||
33201362|NCT01722331|100642635|FG003|Part 2|Progressive Disease|0|||
33201363|NCT01722331|100642636|FG004|Part 2|Progressive Disease|0|||
33201364|NCT01722331|100642637|FG005|Part 2|Progressive Disease|0|||
33201365|NCT01722331|100642638|FG006|Part 2|Progressive Disease|0|||
33201366|NCT01722331|100642632|FG000|Part 2|Protocol Violation|1|||
33201367|NCT01722331|100642633|FG001|Part 2|Protocol Violation|0|||
33201368|NCT01722331|100642634|FG002|Part 2|Protocol Violation|0|||
33201369|NCT01722331|100642635|FG003|Part 2|Protocol Violation|0|||
33201370|NCT01722331|100642636|FG004|Part 2|Protocol Violation|0|||
33201371|NCT01722331|100642637|FG005|Part 2|Protocol Violation|0|||
33201372|NCT01722331|100642638|FG006|Part 2|Protocol Violation|0|||
33201373|NCT01722331|100642632|FG000|Part 2|Withdrawal by Subject|5|||
33201374|NCT01722331|100642633|FG001|Part 2|Withdrawal by Subject|0|||
33201375|NCT01722331|100642634|FG002|Part 2|Withdrawal by Subject|3|||
33201376|NCT01722331|100642635|FG003|Part 2|Withdrawal by Subject|0|||
33201377|NCT01722331|100642636|FG004|Part 2|Withdrawal by Subject|0|||
33201378|NCT01722331|100642637|FG005|Part 2|Withdrawal by Subject|2|||
33201379|NCT01722331|100642638|FG006|Part 2|Withdrawal by Subject|2|||
33201380|NCT01722331|100642632|FG000|Part 2|Other Protocol Specified Criteria|6|||
33201381|NCT01722331|100642633|FG001|Part 2|Other Protocol Specified Criteria|0|||
33201382|NCT01722331|100642634|FG002|Part 2|Other Protocol Specified Criteria|10|||
33201383|NCT01722331|100642635|FG003|Part 2|Other Protocol Specified Criteria|0|||
33201384|NCT01722331|100642636|FG004|Part 2|Other Protocol Specified Criteria|0|||
33201385|NCT01722331|100642637|FG005|Part 2|Other Protocol Specified Criteria|2|||
33201386|NCT01722331|100642638|FG006|Part 2|Other Protocol Specified Criteria|1|||
33201387|NCT01722331|100642632|FG000|Part 3|Adverse Event|2|||
33201388|NCT01722331|100642633|FG001|Part 3|Adverse Event|2|||
33201389|NCT01722331|100642634|FG002|Part 3|Adverse Event|0|||
33201390|NCT01722331|100642635|FG003|Part 3|Adverse Event|1|||
33201391|NCT01722331|100642636|FG004|Part 3|Adverse Event|0|||
33201392|NCT01722331|100642637|FG005|Part 3|Adverse Event|0|||
33201393|NCT01722331|100642638|FG006|Part 3|Adverse Event|0|||
33329713|NCT00432042|101101251|FG001|Overall Study|Withdrawal by Subject|0|||
33329714|NCT00432042|101101252|FG002|Overall Study|Withdrawal by Subject|2|||
33523203|NCT01066793|101811830|FG003|Overall Study|Other|2|||
33523204|NCT01066793|101811831|FG004|Overall Study|Other|0|||
33523205|NCT01066793|101811832|FG005|Overall Study|Other|0|||
33523206|NCT01066793|101811827|FG000|Overall Study|Relapse|20|||
33523207|NCT01066793|101811828|FG001|Overall Study|Relapse|8|||
33523208|NCT01066793|101811829|FG002|Overall Study|Relapse|2|||
33523209|NCT01066793|101811830|FG003|Overall Study|Relapse|3|||
33523210|NCT01066793|101811831|FG004|Overall Study|Relapse|0|||
33523211|NCT01066793|101811832|FG005|Overall Study|Relapse|0|||
33523212|NCT01066793|101811827|FG000|Overall Study|Result Not Available|1|||
33523213|NCT01066793|101811828|FG001|Overall Study|Result Not Available|0|||
33201394|NCT01722331|100642632|FG000|Part 3|Death|1|||
33201395|NCT01722331|100642633|FG001|Part 3|Death|0|||
33523214|NCT01066793|101811829|FG002|Overall Study|Result Not Available|0|||
33609557|NCT00360568|102118736|FG001|Overall Study|Adverse Event|2|||
33201396|NCT01722331|100642634|FG002|Part 3|Death|0|||
33201397|NCT01722331|100642635|FG003|Part 3|Death|0|||
33201398|NCT01722331|100642636|FG004|Part 3|Death|0|||
33201399|NCT01722331|100642637|FG005|Part 3|Death|0|||
33201400|NCT01722331|100642638|FG006|Part 3|Death|0|||
33201401|NCT01722331|100642632|FG000|Part 3|Lack of Efficacy|1|||
33201402|NCT01722331|100642633|FG001|Part 3|Lack of Efficacy|0|||
33201403|NCT01722331|100642634|FG002|Part 3|Lack of Efficacy|0|||
33201404|NCT01722331|100642635|FG003|Part 3|Lack of Efficacy|0|||
33201405|NCT01722331|100642636|FG004|Part 3|Lack of Efficacy|0|||
33201406|NCT01722331|100642637|FG005|Part 3|Lack of Efficacy|0|||
33201407|NCT01722331|100642638|FG006|Part 3|Lack of Efficacy|0|||
33201408|NCT01722331|100642632|FG000|Part 3|Lost to Follow-up|3|||
33201409|NCT01722331|100642633|FG001|Part 3|Lost to Follow-up|4|||
33523215|NCT01066793|101811830|FG003|Overall Study|Result Not Available|0|||
33523216|NCT01066793|101811831|FG004|Overall Study|Result Not Available|0|||
33609558|NCT00360568|102118735|FG000|Overall Study|Lack of Efficacy|1|||
33609559|NCT00360568|102118736|FG001|Overall Study|Lack of Efficacy|0|||
33609560|NCT00360568|102118735|FG000|Overall Study|Withdrawal by Subject|0|||
33609561|NCT00360568|102118736|FG001|Overall Study|Withdrawal by Subject|3|||
33609562|NCT04186871|102118737|FG000|Overall Study|Lack of Efficacy|0|||
33609563|NCT04186871|102118738|FG001|Overall Study|Lack of Efficacy|1|||
33609564|NCT04186871|102118739|FG002|Overall Study|Lack of Efficacy|0|||
33609565|NCT04186871|102118740|FG003|Overall Study|Lack of Efficacy|0|||
33609566|NCT04186871|102118741|FG004|Overall Study|Lack of Efficacy|1|||
33609567|NCT04186871|102118742|FG005|Overall Study|Lack of Efficacy|1|||
33609568|NCT04186871|102118737|FG000|Overall Study|Adverse Event|1|||
33609569|NCT04186871|102118738|FG001|Overall Study|Adverse Event|1|||
33609570|NCT04186871|102118739|FG002|Overall Study|Adverse Event|0|||
33609571|NCT04186871|102118740|FG003|Overall Study|Adverse Event|0|||
33609572|NCT04186871|102118741|FG004|Overall Study|Adverse Event|0|||
33609573|NCT04186871|102118742|FG005|Overall Study|Adverse Event|2|||
33609574|NCT04186871|102118737|FG000|Overall Study|Study terminated by sponsor|1|||
33609575|NCT04186871|102118738|FG001|Overall Study|Study terminated by sponsor|2|||
33609576|NCT04186871|102118739|FG002|Overall Study|Study terminated by sponsor|0|||
33609577|NCT04186871|102118740|FG003|Overall Study|Study terminated by sponsor|1|||
33609578|NCT04186871|102118741|FG004|Overall Study|Study terminated by sponsor|0|||
33609579|NCT04186871|102118742|FG005|Overall Study|Study terminated by sponsor|0|||
33609580|NCT04186871|102118737|FG000|Overall Study|Other reasons|0|||
33609581|NCT04186871|102118738|FG001|Overall Study|Other reasons|0|||
33609582|NCT04186871|102118739|FG002|Overall Study|Other reasons|0|||
33609583|NCT04186871|102118740|FG003|Overall Study|Other reasons|0|||
33329715|NCT00432042|101101250|FG000|Overall Study|Lost to Follow-up|5|||
33329716|NCT00432042|101101251|FG001|Overall Study|Lost to Follow-up|1|||
33523217|NCT01066793|101811832|FG005|Overall Study|Result Not Available|0|||
33523218|NCT01066793|101811827|FG000|Overall Study|Treatment Interrupted|1|||
33523219|NCT01066793|101811828|FG001|Overall Study|Treatment Interrupted|1|||
33523220|NCT01066793|101811829|FG002|Overall Study|Treatment Interrupted|0|||
33523221|NCT01066793|101811830|FG003|Overall Study|Treatment Interrupted|0|||
33523222|NCT01066793|101811831|FG004|Overall Study|Treatment Interrupted|0|||
33329717|NCT00432042|101101252|FG002|Overall Study|Lost to Follow-up|0|||
33329718|NCT03127384|101101253|FG000|Overall Study|Lost to Follow-up|4|||
33329719|NCT03127384|101101253|FG000|Overall Study|Subject request|2|||
33329720|NCT01422915|101101254|FG000|Overall Study|Adverse Event|1|||
33329721|NCT00550680|101101257|FG000|Overall Study|Administrative Reasons|1|||
33329722|NCT00550680|101101257|FG000|Overall Study|Adverse Event|5|||
33329723|NCT00550680|101101257|FG000|Overall Study|Death|3|||
33329724|NCT00550680|101101257|FG000|Overall Study|Early Improvement|1|||
33329725|NCT00550680|101101257|FG000|Overall Study|Lost to Follow-up|3|||
33329726|NCT00550680|101101257|FG000|Overall Study|Lack of Efficacy|1|||
33329727|NCT00550680|101101257|FG000|Overall Study|Other|10|||
33329728|NCT00550680|101101257|FG000|Overall Study|Protocol Violation|7|||
33329729|NCT00550680|101101257|FG000|Overall Study|Refused Treatment|19|||
33329730|NCT00550680|101101257|FG000|Overall Study|Screen Failure|6|||
33329731|NCT03861936|101101258|FG000|Overall Study|Withdrawal by Subject|4|||
33329732|NCT03861936|101101259|FG001|Overall Study|Withdrawal by Subject|1|||
33329733|NCT03861936|101101260|FG002|Overall Study|Withdrawal by Subject|3|||
33329734|NCT03861936|101101258|FG000|Overall Study|Lost to Follow-up|5|||
33329735|NCT03861936|101101259|FG001|Overall Study|Lost to Follow-up|3|||
33329736|NCT03861936|101101260|FG002|Overall Study|Lost to Follow-up|3|||
33329737|NCT03861936|101101258|FG000|Overall Study|Physician Decision|0|||
33329738|NCT03861936|101101259|FG001|Overall Study|Physician Decision|1|||
33329739|NCT03861936|101101260|FG002|Overall Study|Physician Decision|0|||
33329740|NCT03861936|101101258|FG000|Overall Study|Protocol Deviation|0|||
33329741|NCT03861936|101101259|FG001|Overall Study|Protocol Deviation|0|||
33329742|NCT03861936|101101260|FG002|Overall Study|Protocol Deviation|1|||
33329743|NCT03861936|101101258|FG000|Overall Study|Reason not Specified|5|||
33329744|NCT03861936|101101259|FG001|Overall Study|Reason not Specified|5|||
33329745|NCT03861936|101101260|FG002|Overall Study|Reason not Specified|3|||
33329746|NCT01449461|101101261|FG000|Overall Study|Adverse Event|0|||
33329747|NCT01449461|101101262|FG001|Overall Study|Adverse Event|3|||
33329748|NCT01449461|101101263|FG002|Overall Study|Adverse Event|2|||
33329749|NCT01449461|101101264|FG003|Overall Study|Adverse Event|3|||
33329750|NCT01449461|101101265|FG004|Overall Study|Adverse Event|4|||
33401799|NCT03044730|101361520|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
33523223|NCT01066793|101811832|FG005|Overall Study|Treatment Interrupted|0|||
33523224|NCT01066793|101811827|FG000|Overall Study|Treatment Never Started|18|||
33609584|NCT04186871|102118741|FG004|Overall Study|Other reasons|0|||
33609585|NCT04186871|102118742|FG005|Overall Study|Other reasons|1|||
33609586|NCT04186871|102118737|FG000|Overall Study|Withdrawal by Subject|0|||
33609587|NCT04186871|102118738|FG001|Overall Study|Withdrawal by Subject|0|||
33609588|NCT04186871|102118739|FG002|Overall Study|Withdrawal by Subject|0|||
33609589|NCT04186871|102118740|FG003|Overall Study|Withdrawal by Subject|0|||
33523225|NCT01066793|101811828|FG001|Overall Study|Treatment Never Started|5|||
33523226|NCT01066793|101811829|FG002|Overall Study|Treatment Never Started|4|||
33523227|NCT01066793|101811830|FG003|Overall Study|Treatment Never Started|1|||
33523228|NCT01066793|101811831|FG004|Overall Study|Treatment Never Started|0|||
33523229|NCT01066793|101811832|FG005|Overall Study|Treatment Never Started|0|||
33523230|NCT01066793|101811827|FG000|Overall Study|Treatment Stopped|2|||
33523231|NCT01066793|101811828|FG001|Overall Study|Treatment Stopped|1|||
33523232|NCT01066793|101811829|FG002|Overall Study|Treatment Stopped|0|||
33523233|NCT01066793|101811830|FG003|Overall Study|Treatment Stopped|1|||
33523234|NCT01066793|101811831|FG004|Overall Study|Treatment Stopped|0|||
33523235|NCT01066793|101811832|FG005|Overall Study|Treatment Stopped|0|||
33523236|NCT01030718|101816107|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
33523237|NCT01030718|101816108|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
33523238|NCT01030718|101816109|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
33523239|NCT01030718|101816107|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
33523240|NCT01030718|101816108|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
33523241|NCT01030718|101816109|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
33523242|NCT01030718|101816107|FG000|Studies CA180-031 and -036 Combined|Death|0|||
33523243|NCT01030718|101816108|FG001|Studies CA180-031 and -036 Combined|Death|1|||
33523244|NCT01030718|101816109|FG002|Studies CA180-031 and -036 Combined|Death|0|||
33523245|NCT01030718|101816107|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
33523246|NCT01030718|101816108|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
33523247|NCT01030718|101816109|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
33523248|NCT01030718|101816107|FG000|Study CA180-036 Only|insufficient effect|1|||
33523249|NCT01030718|101816108|FG001|Study CA180-036 Only|insufficient effect|1|||
33523250|NCT01030718|101816109|FG002|Study CA180-036 Only|insufficient effect|5|||
33523251|NCT01030718|101816107|FG000|Study CA180-036 Only|Adverse Event|2|||
33523252|NCT01030718|101816108|FG001|Study CA180-036 Only|Adverse Event|3|||
33523253|NCT01030718|101816109|FG002|Study CA180-036 Only|Adverse Event|0|||
33523254|NCT01030718|101816107|FG000|Study CA180-036 Only|Death|0|||
33523255|NCT01030718|101816108|FG001|Study CA180-036 Only|Death|1|||
33523256|NCT01030718|101816109|FG002|Study CA180-036 Only|Death|0|||
33523257|NCT01030718|101816107|FG000|Study CA180-036 Only|Other Reasons|0|||
33523258|NCT01030718|101816108|FG001|Study CA180-036 Only|Other Reasons|2|||
33523259|NCT01030718|101816109|FG002|Study CA180-036 Only|Other Reasons|0|||
33523260|NCT03699540|101816110|FG000|Overall Study|Lost to Follow-up|1|||
33523261|NCT02933528|101816111|FG000|Overall Study|Lost to Follow-up|2|||
33523262|NCT03420222|101816118|FG000|Overall Study|Withdrawal by Subject|5|||
33523263|NCT03420222|101816119|FG001|Overall Study|Withdrawal by Subject|0|||
33523264|NCT03420222|101816118|FG000|Overall Study|Physician Decision|0|||
33523265|NCT03420222|101816119|FG001|Overall Study|Physician Decision|1|||
33523266|NCT00441363|101816127|FG000|Overall Study|Adverse Event|4|||
33523267|NCT00441363|101816128|FG001|Overall Study|Adverse Event|2|||
33523268|NCT00441363|101816127|FG000|Overall Study|Withdrawal by Subject|3|||
33523269|NCT00441363|101816128|FG001|Overall Study|Withdrawal by Subject|4|||
33523270|NCT00441363|101816127|FG000|Overall Study|Physician Decision|6|||
33523271|NCT00441363|101816128|FG001|Overall Study|Physician Decision|7|||
33523272|NCT00441363|101816127|FG000|Overall Study|Lost to Follow-up|2|||
33523273|NCT00441363|101816128|FG001|Overall Study|Lost to Follow-up|2|||
33523274|NCT00441363|101816127|FG000|Overall Study|Other|2|||
33523275|NCT00441363|101816128|FG001|Overall Study|Other|0|||
33523276|NCT03594955|101816129|FG000|Overall Study|Adverse Event|1|||
33609590|NCT04186871|102118741|FG004|Overall Study|Withdrawal by Subject|0|||
33609591|NCT04186871|102118742|FG005|Overall Study|Withdrawal by Subject|1|||
33609592|NCT04186871|102118737|FG000|Overall Study|Lost to Follow-up|0|||
33609593|NCT04186871|102118738|FG001|Overall Study|Lost to Follow-up|0|||
33609594|NCT04186871|102118739|FG002|Overall Study|Lost to Follow-up|0|||
33609595|NCT04186871|102118740|FG003|Overall Study|Lost to Follow-up|0|||
33609596|NCT04186871|102118741|FG004|Overall Study|Lost to Follow-up|0|||
33609597|NCT04186871|102118742|FG005|Overall Study|Lost to Follow-up|1|||
33609598|NCT03040986|102123065|FG000|Overall Study|Hospice|1|||
33329751|NCT01449461|101101266|FG005|Overall Study|Adverse Event|4|||
33401800|NCT03044730|101361520|FG000|Cycles 4 and Beyond|Adverse Event|1|||
33523277|NCT03594955|101816129|FG000|Overall Study|Progressive disease|5|||
33523278|NCT03594955|101816129|FG000|Overall Study|Sponsor's decision|1|||
33523279|NCT02362425|101816130|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
33523280|NCT02362425|101816131|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
33609599|NCT03040986|102123066|FG001|Overall Study|Hospice|0|||
33609600|NCT03040986|102123065|FG000|Overall Study|Adverse Event|2|||
33609601|NCT03040986|102123066|FG001|Overall Study|Adverse Event|1|||
33609602|NCT03040986|102123065|FG000|Overall Study|Disease progression on study|3|||
33609603|NCT03040986|102123066|FG001|Overall Study|Disease progression on study|1|||
33523281|NCT02362425|101816132|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
33523282|NCT02362425|101816133|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
33523283|NCT02362425|101816130|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
33609604|NCT01113580|102123070|FG000|Overall Study|Protocol Violation|1|||
33609605|NCT01113580|102123071|FG001|Overall Study|Protocol Violation|0|||
33609606|NCT04378114|102123073|FG000|Overall Study|Withdrawal by Subject|5|||
33609607|NCT02409342|102123076|FG000|Overall Study|Death|211|||
33609608|NCT02409342|102123077|FG001|Overall Study|Death|201|||
33401801|NCT03044730|101361520|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
33523284|NCT02362425|101816131|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
33523285|NCT02362425|101816132|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
33523286|NCT02362425|101816133|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
33523287|NCT02362425|101816130|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
33523288|NCT02362425|101816131|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
33523289|NCT02362425|101816132|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
33523290|NCT02362425|101816133|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
33523291|NCT02362425|101816130|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
33523292|NCT02362425|101816131|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
33523293|NCT02362425|101816132|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
33523294|NCT02362425|101816133|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
33523295|NCT02362425|101816130|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
33401802|NCT03044730|101361520|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
33401803|NCT03044730|101361520|FG000|On Follow-up for 2 Years|Death|17|||
33401804|NCT03575975|101361521|FG000|Overall Study|Lost to Follow-up|1|||
33401805|NCT03575975|101361522|FG001|Overall Study|Lost to Follow-up|0|||
33401806|NCT03575975|101361523|FG002|Overall Study|Lost to Follow-up|0|||
33401807|NCT01108068|101361524|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
33401808|NCT01108068|101361525|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
33401809|NCT02679222|101361535|FG000|Overall Study|No time for project|1|||
33401810|NCT04005885|101361540|FG000|First Intervention|Withdrawal by Subject|1|||
33401811|NCT04005885|101361541|FG001|First Intervention|Withdrawal by Subject|1|||
33401812|NCT04005885|101361540|FG000|Second Intervention|Withdrawal by Subject|0|||
33401813|NCT04005885|101361541|FG001|Second Intervention|Withdrawal by Subject|2|||
33401814|NCT00963820|101361548|FG000|Dose Escalation Phase|Progressive Disease|3|||
33523296|NCT02362425|101816131|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
33523297|NCT02362425|101816132|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
33523298|NCT02362425|101816133|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
33523299|NCT02362425|101816130|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
33523300|NCT02362425|101816131|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
33523301|NCT02362425|101816132|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
33523302|NCT02362425|101816133|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
33523303|NCT02362425|101816130|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
33523304|NCT02362425|101816131|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
33523305|NCT02362425|101816132|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
33523306|NCT02362425|101816133|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
33523307|NCT02362425|101816130|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
33523308|NCT02362425|101816131|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
33523309|NCT02362425|101816132|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
33523310|NCT02362425|101816133|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
33523311|NCT03484403|101816135|FG000|Overall Study|Withdrawal by Subject|6|||
33609609|NCT02409342|102123076|FG000|Overall Study|Withdrawal by Subject|24|||
33609610|NCT02409342|102123077|FG001|Overall Study|Withdrawal by Subject|17|||
33329752|NCT01449461|101101261|FG000|Overall Study|Death|0|||
33329753|NCT01449461|101101262|FG001|Overall Study|Death|2|||
33329754|NCT01449461|101101263|FG002|Overall Study|Death|0|||
33329755|NCT01449461|101101264|FG003|Overall Study|Death|0|||
33329756|NCT01449461|101101265|FG004|Overall Study|Death|7|||
33329757|NCT01449461|101101266|FG005|Overall Study|Death|1|||
33329758|NCT01449461|101101261|FG000|Overall Study|Physician Decision|0|||
33329759|NCT01449461|101101262|FG001|Overall Study|Physician Decision|1|||
33401815|NCT00963820|101361549|FG001|Dose Escalation Phase|Progressive Disease|3|||
33609611|NCT02409342|102123076|FG000|Overall Study|Study Terminated By Sponsor|48|||
33609612|NCT02409342|102123077|FG001|Overall Study|Study Terminated By Sponsor|59|||
33609613|NCT02409342|102123076|FG000|Overall Study|Lost to Follow-up|3|||
33609614|NCT02409342|102123077|FG001|Overall Study|Lost to Follow-up|5|||
33609615|NCT02409342|102123076|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
33609616|NCT02409342|102123077|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
33329760|NCT01449461|101101263|FG002|Overall Study|Physician Decision|0|||
33609617|NCT02409342|102123076|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
33609618|NCT02409342|102123077|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
33401816|NCT00963820|101361550|FG002|Dose Escalation Phase|Progressive Disease|3|||
33329761|NCT01449461|101101264|FG003|Overall Study|Physician Decision|4|||
33401817|NCT00963820|101361551|FG003|Dose Escalation Phase|Progressive Disease|3|||
33401818|NCT00963820|101361552|FG004|Dose Escalation Phase|Progressive Disease|4|||
33401819|NCT00963820|101361553|FG005|Dose Escalation Phase|Progressive Disease|3|||
33401820|NCT00963820|101361554|FG006|Dose Escalation Phase|Progressive Disease|3|||
33201410|NCT01722331|100642634|FG002|Part 3|Lost to Follow-up|0|||
33201411|NCT01722331|100642635|FG003|Part 3|Lost to Follow-up|0|||
33201412|NCT01722331|100642636|FG004|Part 3|Lost to Follow-up|0|||
33201413|NCT01722331|100642637|FG005|Part 3|Lost to Follow-up|1|||
33201414|NCT01722331|100642638|FG006|Part 3|Lost to Follow-up|0|||
33201415|NCT01722331|100642632|FG000|Part 3|Non-Compliance with Study Drug|0|||
33201416|NCT01722331|100642633|FG001|Part 3|Non-Compliance with Study Drug|1|||
33201417|NCT01722331|100642634|FG002|Part 3|Non-Compliance with Study Drug|0|||
33401821|NCT00963820|101361555|FG007|Dose Escalation Phase|Progressive Disease|2|||
33401822|NCT00963820|101361556|FG008|Dose Escalation Phase|Progressive Disease|0|||
33401823|NCT00963820|101361557|FG009|Dose Escalation Phase|Progressive Disease|0|||
33401824|NCT00963820|101361558|FG010|Dose Escalation Phase|Progressive Disease|0|||
33201418|NCT01722331|100642635|FG003|Part 3|Non-Compliance with Study Drug|0|||
33201419|NCT01722331|100642636|FG004|Part 3|Non-Compliance with Study Drug|0|||
33201420|NCT01722331|100642637|FG005|Part 3|Non-Compliance with Study Drug|0|||
33201421|NCT01722331|100642638|FG006|Part 3|Non-Compliance with Study Drug|0|||
33201422|NCT01722331|100642632|FG000|Part 3|Physician Decision|1|||
33201423|NCT01722331|100642633|FG001|Part 3|Physician Decision|1|||
33201424|NCT01722331|100642634|FG002|Part 3|Physician Decision|0|||
33201425|NCT01722331|100642635|FG003|Part 3|Physician Decision|0|||
33401825|NCT00963820|101361559|FG011|Dose Escalation Phase|Progressive Disease|0|||
33401826|NCT00963820|101361548|FG000|Dose Escalation Phase|Adverse Event|0|||
33401827|NCT00963820|101361549|FG001|Dose Escalation Phase|Adverse Event|0|||
33401828|NCT00963820|101361550|FG002|Dose Escalation Phase|Adverse Event|0|||
33201426|NCT01722331|100642636|FG004|Part 3|Physician Decision|0|||
33201427|NCT01722331|100642637|FG005|Part 3|Physician Decision|0|||
33201428|NCT01722331|100642638|FG006|Part 3|Physician Decision|1|||
33201429|NCT01722331|100642632|FG000|Part 3|Protocol Violation|2|||
33201430|NCT01722331|100642633|FG001|Part 3|Protocol Violation|1|||
33201431|NCT01722331|100642634|FG002|Part 3|Protocol Violation|0|||
33201432|NCT01722331|100642635|FG003|Part 3|Protocol Violation|0|||
33201433|NCT01722331|100642636|FG004|Part 3|Protocol Violation|0|||
33201434|NCT01722331|100642637|FG005|Part 3|Protocol Violation|0|||
33201435|NCT01722331|100642638|FG006|Part 3|Protocol Violation|0|||
33201436|NCT01722331|100642632|FG000|Part 3|Withdrawal by Subject|4|||
33201437|NCT01722331|100642633|FG001|Part 3|Withdrawal by Subject|7|||
33201438|NCT01722331|100642634|FG002|Part 3|Withdrawal by Subject|0|||
33201439|NCT01722331|100642635|FG003|Part 3|Withdrawal by Subject|0|||
33201440|NCT01722331|100642636|FG004|Part 3|Withdrawal by Subject|0|||
33201441|NCT01722331|100642637|FG005|Part 3|Withdrawal by Subject|2|||
33201442|NCT01722331|100642638|FG006|Part 3|Withdrawal by Subject|1|||
33201443|NCT01722331|100642632|FG000|Part 3|Other Protocol Specified Criteria|1|||
33201444|NCT01722331|100642633|FG001|Part 3|Other Protocol Specified Criteria|1|||
33201445|NCT01722331|100642634|FG002|Part 3|Other Protocol Specified Criteria|0|||
33201446|NCT01722331|100642635|FG003|Part 3|Other Protocol Specified Criteria|0|||
33201447|NCT01722331|100642636|FG004|Part 3|Other Protocol Specified Criteria|0|||
33201448|NCT01722331|100642637|FG005|Part 3|Other Protocol Specified Criteria|0|||
33201449|NCT01722331|100642638|FG006|Part 3|Other Protocol Specified Criteria|0|||
33201450|NCT02473614|100642639|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
33201451|NCT02473614|100642640|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
33201452|NCT01114646|100642644|FG000|Overall Study|Withdrawal by Subject|3|||
33201453|NCT01114646|100642645|FG001|Overall Study|Withdrawal by Subject|2|||
33201454|NCT00982020|100642646|FG000|Overall Study|Adverse Event|19|||
33201455|NCT00982020|100642647|FG001|Overall Study|Adverse Event|15|||
33201456|NCT00982020|100642646|FG000|Overall Study|Withdrawal by Subject|11|||
33201457|NCT00982020|100642647|FG001|Overall Study|Withdrawal by Subject|14|||
33201458|NCT00982020|100642646|FG000|Overall Study|Lost to Follow-up|5|||
33201459|NCT00982020|100642647|FG001|Overall Study|Lost to Follow-up|11|||
33201460|NCT00982020|100642646|FG000|Overall Study|Lack of Efficacy|10|||
33201461|NCT00982020|100642647|FG001|Overall Study|Lack of Efficacy|4|||
33201462|NCT00982020|100642646|FG000|Overall Study|Parent/Caregiver Decision|5|||
33201463|NCT00982020|100642647|FG001|Overall Study|Parent/Caregiver Decision|5|||
33201464|NCT00982020|100642646|FG000|Overall Study|Treatment Non-compliance|3|||
33201465|NCT00982020|100642647|FG001|Overall Study|Treatment Non-compliance|6|||
33201466|NCT00982020|100642646|FG000|Overall Study|Physician Decision|2|||
33201467|NCT00982020|100642647|FG001|Overall Study|Physician Decision|5|||
33201468|NCT00982020|100642646|FG000|Overall Study|Entry Criteria Not Met|2|||
33201469|NCT00982020|100642647|FG001|Overall Study|Entry Criteria Not Met|1|||
33201470|NCT00982020|100642646|FG000|Overall Study|Protocol Violation|0|||
33201471|NCT00982020|100642647|FG001|Overall Study|Protocol Violation|2|||
33201472|NCT00982020|100642646|FG000|Overall Study|Clinical Relapse|0|||
33201473|NCT00982020|100642647|FG001|Overall Study|Clinical Relapse|1|||
33201474|NCT03794089|100642648|FG000|Overall Study|Lost to Follow-up|4|||
33201475|NCT03794089|100642649|FG001|Overall Study|Lost to Follow-up|1|||
33201476|NCT03794089|100642648|FG000|Overall Study|Withdrawal by Subject|2|||
33201477|NCT03794089|100642649|FG001|Overall Study|Withdrawal by Subject|0|||
33609619|NCT02409342|102123076|FG000|Overall Study|Sponsor Decision|1|||
33609620|NCT02409342|102123077|FG001|Overall Study|Sponsor Decision|0|||
33609621|NCT03615066|102123082|FG000|Main Study|Withdrew Consent|0|||
33609622|NCT03615066|102123083|FG001|Main Study|Withdrew Consent|1|||
33609623|NCT03615066|102123084|FG002|Main Study|Withdrew Consent|1|||
33329762|NCT01449461|101101265|FG004|Overall Study|Physician Decision|1|||
33329763|NCT01449461|101101266|FG005|Overall Study|Physician Decision|0|||
33609624|NCT03615066|102123082|FG000|Main Study|Lost to Follow-up|0|||
33609625|NCT03615066|102123083|FG001|Main Study|Lost to Follow-up|0|||
33609626|NCT03615066|102123084|FG002|Main Study|Lost to Follow-up|1|||
33609627|NCT03615066|102123082|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
33609628|NCT03615066|102123083|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
33609629|NCT03615066|102123084|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
33609630|NCT03615066|102123082|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
33201478|NCT03855189|100642650|FG000|Overall Study|Adverse Event|5|||
33329764|NCT01449461|101101261|FG000|Overall Study|Documented Progressive Disease|4|||
33201479|NCT03855189|100642651|FG001|Overall Study|Adverse Event|2|||
33609631|NCT03615066|102123083|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
33609632|NCT03615066|102123084|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
33609633|NCT03615066|102123082|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
33609634|NCT03615066|102123083|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
33201480|NCT03855189|100642652|FG002|Overall Study|Adverse Event|4|||
33201481|NCT03855189|100642650|FG000|Overall Study|Treatment Failure|1|||
33201482|NCT03855189|100642651|FG001|Overall Study|Treatment Failure|1|||
33201483|NCT03855189|100642652|FG002|Overall Study|Treatment Failure|2|||
33201484|NCT03855189|100642650|FG000|Overall Study|Noncompliance with Protocol|0|||
33201485|NCT03855189|100642651|FG001|Overall Study|Noncompliance with Protocol|1|||
33201486|NCT03855189|100642652|FG002|Overall Study|Noncompliance with Protocol|0|||
33201487|NCT03855189|100642650|FG000|Overall Study|Did Not Return|4|||
33417261|NCT02628418|101420244|FG000|Overall Study|Lost to Follow-up|1|||
33201488|NCT03855189|100642651|FG001|Overall Study|Did Not Return|3|||
33201489|NCT03855189|100642652|FG002|Overall Study|Did Not Return|0|||
33201490|NCT01731171|100642653|FG000|Overall Study|Withdrawal by Subject|4|||
33201491|NCT01731171|100642654|FG001|Overall Study|Withdrawal by Subject|1|||
33201492|NCT01731171|100642653|FG000|Overall Study|Lost to Follow-up|3|||
33401829|NCT00963820|101361551|FG003|Dose Escalation Phase|Adverse Event|0|||
33401830|NCT00963820|101361552|FG004|Dose Escalation Phase|Adverse Event|0|||
33523312|NCT03484403|101816136|FG001|Overall Study|Withdrawal by Subject|4|||
33523313|NCT01210222|101816137|FG000|Overall Study|Ineligible|2|||
33523314|NCT01210222|101816137|FG000|Overall Study|Never treated|1|||
33523315|NCT02432144|101816146|FG000|Overall Study|Participant Non-Compliance|1|||
33523316|NCT01915771|101816147|FG000|Day 1|Withdrawal by Subject|1|||
33523317|NCT01915771|101816147|FG000|Day 15|Withdrawal by Subject|1|||
33523318|NCT01026818|101816155|FG000|Screening Period|Entry Criteria Not Met|105|||
33523319|NCT01026818|101816156|FG001|Screening Period|Entry Criteria Not Met|0|||
33523320|NCT01026818|101816157|FG002|Screening Period|Entry Criteria Not Met|0|||
33523321|NCT01026818|101816158|FG003|Screening Period|Entry Criteria Not Met|0|||
33523322|NCT01026818|101816155|FG000|Screening Period|Withdrawal by Subject|49|||
33523323|NCT01026818|101816156|FG001|Screening Period|Withdrawal by Subject|0|||
33201493|NCT01731171|100642654|FG001|Overall Study|Lost to Follow-up|2|||
33201494|NCT01731171|100642653|FG000|Overall Study|Moved out of Area|0|||
33201495|NCT01731171|100642654|FG001|Overall Study|Moved out of Area|2|||
33201496|NCT01731171|100642653|FG000|Overall Study|Terminated for Lack of Adherence|0|||
33201497|NCT01731171|100642654|FG001|Overall Study|Terminated for Lack of Adherence|1|||
33201498|NCT01731171|100642653|FG000|Overall Study|Terminated for Safety Reasons|0|||
33201499|NCT01731171|100642654|FG001|Overall Study|Terminated for Safety Reasons|1|||
33401831|NCT00963820|101361553|FG005|Dose Escalation Phase|Adverse Event|0|||
33401832|NCT00963820|101361554|FG006|Dose Escalation Phase|Adverse Event|3|||
33401833|NCT00963820|101361555|FG007|Dose Escalation Phase|Adverse Event|1|||
33401834|NCT00963820|101361556|FG008|Dose Escalation Phase|Adverse Event|0|||
33401835|NCT00963820|101361557|FG009|Dose Escalation Phase|Adverse Event|0|||
33401836|NCT00963820|101361558|FG010|Dose Escalation Phase|Adverse Event|0|||
33401837|NCT00963820|101361559|FG011|Dose Escalation Phase|Adverse Event|0|||
33401838|NCT00963820|101361548|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
33401839|NCT00963820|101361549|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
33401840|NCT00963820|101361550|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
33201500|NCT01539291|100642655|FG000|Study GS-US-312-0116|Adverse Event|9|||
33201501|NCT01539291|100642656|FG001|Study GS-US-312-0116|Adverse Event|0|||
33201502|NCT01539291|100642657|FG002|Study GS-US-312-0116|Adverse Event|0|||
33201503|NCT01539291|100642658|FG003|Study GS-US-312-0116|Adverse Event|0|||
33201504|NCT01539291|100642655|FG000|Study GS-US-312-0116|Physician Decision|1|||
33201505|NCT01539291|100642656|FG001|Study GS-US-312-0116|Physician Decision|0|||
33201506|NCT01539291|100642657|FG002|Study GS-US-312-0116|Physician Decision|0|||
33201507|NCT01539291|100642658|FG003|Study GS-US-312-0116|Physician Decision|0|||
33201508|NCT01539291|100642655|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
33201509|NCT01539291|100642656|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
33201510|NCT01539291|100642657|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
33201511|NCT01539291|100642658|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
33201512|NCT01539291|100642655|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
33201513|NCT01539291|100642656|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
33201514|NCT01539291|100642657|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
33201515|NCT01539291|100642658|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
33201516|NCT01539291|100642655|FG000|Study GS-US-312-0116|Other|1|||
33201517|NCT01539291|100642656|FG001|Study GS-US-312-0116|Other|0|||
33201518|NCT01539291|100642657|FG002|Study GS-US-312-0116|Other|0|||
33201519|NCT01539291|100642658|FG003|Study GS-US-312-0116|Other|0|||
33201520|NCT01539291|100642655|FG000|Study GS-US-312-0117|Adverse Event|22|||
33201521|NCT01539291|100642656|FG001|Study GS-US-312-0117|Adverse Event|1|||
33201522|NCT01539291|100642657|FG002|Study GS-US-312-0117|Adverse Event|9|||
33201523|NCT01539291|100642658|FG003|Study GS-US-312-0117|Adverse Event|12|||
33201524|NCT01539291|100642655|FG000|Study GS-US-312-0117|Physician Decision|9|||
33401841|NCT00963820|101361551|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
33401842|NCT00963820|101361552|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
33401843|NCT00963820|101361553|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
33201525|NCT01539291|100642656|FG001|Study GS-US-312-0117|Physician Decision|0|||
33417262|NCT02628418|101420245|FG001|Overall Study|Lost to Follow-up|2|||
33523324|NCT01026818|101816157|FG002|Screening Period|Withdrawal by Subject|0|||
33523325|NCT01026818|101816158|FG003|Screening Period|Withdrawal by Subject|0|||
33523326|NCT01026818|101816155|FG000|Screening Period|Protocol Deviation|3|||
33201526|NCT01539291|100642657|FG002|Study GS-US-312-0117|Physician Decision|6|||
33201527|NCT01539291|100642658|FG003|Study GS-US-312-0117|Physician Decision|4|||
33201528|NCT01539291|100642655|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
33201529|NCT01539291|100642656|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
33201530|NCT01539291|100642657|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
33201531|NCT01539291|100642658|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
33401844|NCT00963820|101361554|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
33401845|NCT00963820|101361555|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
33401846|NCT00963820|101361556|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
33401847|NCT00963820|101361557|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
33401848|NCT00963820|101361558|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
33401849|NCT00963820|101361559|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
33401850|NCT00963820|101361548|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33401851|NCT00963820|101361549|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33401852|NCT00963820|101361550|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33401853|NCT00963820|101361551|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33401854|NCT00963820|101361552|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33401855|NCT00963820|101361553|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33401856|NCT00963820|101361554|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
33401857|NCT00963820|101361555|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33401858|NCT00963820|101361556|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33401859|NCT00963820|101361557|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33401860|NCT00963820|101361558|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33201532|NCT01539291|100642655|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
33201533|NCT01539291|100642656|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
33201534|NCT01539291|100642657|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
33201535|NCT01539291|100642658|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
33329765|NCT01449461|101101262|FG001|Overall Study|Documented Progressive Disease|7|||
33401861|NCT00963820|101361559|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33401862|NCT00963820|101361548|FG000|Expansion Phase|Progressive Disease|0|||
33401863|NCT00963820|101361549|FG001|Expansion Phase|Progressive Disease|0|||
33401864|NCT00963820|101361550|FG002|Expansion Phase|Progressive Disease|0|||
33329766|NCT01449461|101101263|FG002|Overall Study|Documented Progressive Disease|14|||
33329767|NCT01449461|101101264|FG003|Overall Study|Documented Progressive Disease|15|||
33401865|NCT00963820|101361551|FG003|Expansion Phase|Progressive Disease|0|||
33523327|NCT01026818|101816156|FG001|Screening Period|Protocol Deviation|0|||
33523328|NCT01026818|101816157|FG002|Screening Period|Protocol Deviation|0|||
33523329|NCT01026818|101816158|FG003|Screening Period|Protocol Deviation|0|||
33523330|NCT01026818|101816155|FG000|Screening Period|Adverse Event|2|||
33523331|NCT01026818|101816156|FG001|Screening Period|Adverse Event|0|||
33523332|NCT01026818|101816157|FG002|Screening Period|Adverse Event|0|||
33523333|NCT01026818|101816158|FG003|Screening Period|Adverse Event|0|||
33523334|NCT01026818|101816155|FG000|Screening Period|Physician Decision|1|||
33523335|NCT01026818|101816156|FG001|Screening Period|Physician Decision|0|||
33201536|NCT01539291|100642655|FG000|Study GS-US-312-0117|Other|2|||
33201537|NCT01539291|100642656|FG001|Study GS-US-312-0117|Other|1|||
33201538|NCT01539291|100642657|FG002|Study GS-US-312-0117|Other|1|||
33201539|NCT01539291|100642658|FG003|Study GS-US-312-0117|Other|1|||
33329768|NCT01449461|101101265|FG004|Overall Study|Documented Progressive Disease|24|||
33329769|NCT01449461|101101266|FG005|Overall Study|Documented Progressive Disease|5|||
33329770|NCT01449461|101101261|FG000|Overall Study|Clinical Progressive Disease|2|||
33329771|NCT01449461|101101262|FG001|Overall Study|Clinical Progressive Disease|2|||
33329772|NCT01449461|101101263|FG002|Overall Study|Clinical Progressive Disease|0|||
33329773|NCT01449461|101101264|FG003|Overall Study|Clinical Progressive Disease|3|||
33329774|NCT01449461|101101265|FG004|Overall Study|Clinical Progressive Disease|4|||
33329775|NCT01449461|101101266|FG005|Overall Study|Clinical Progressive Disease|2|||
33329776|NCT01449461|101101261|FG000|Overall Study|Protocol Violation|0|||
33201540|NCT00840970|100642669|FG000|Overall Study|Adverse Event|0|||
33201541|NCT00840970|100642670|FG001|Overall Study|Adverse Event|0|||
33201542|NCT00840970|100642671|FG002|Overall Study|Adverse Event|1|||
33201543|NCT01312909|100642672|FG000|Overall Study|Randomized but not treated|1|||
33201544|NCT01312909|100642673|FG001|Overall Study|Randomized but not treated|3|||
33201545|NCT01312909|100642674|FG002|Overall Study|Randomized but not treated|1|||
33329777|NCT01449461|101101262|FG001|Overall Study|Protocol Violation|0|||
33401866|NCT00963820|101361552|FG004|Expansion Phase|Progressive Disease|0|||
33401867|NCT00963820|101361553|FG005|Expansion Phase|Progressive Disease|0|||
33401868|NCT00963820|101361554|FG006|Expansion Phase|Progressive Disease|0|||
33401869|NCT00963820|101361555|FG007|Expansion Phase|Progressive Disease|0|||
33523336|NCT01026818|101816157|FG002|Screening Period|Physician Decision|0|||
33523337|NCT01026818|101816158|FG003|Screening Period|Physician Decision|0|||
33523338|NCT01026818|101816155|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
33523339|NCT01026818|101816156|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
33201546|NCT01312909|100642672|FG000|Overall Study|Adverse Event|1|||
33201547|NCT01312909|100642673|FG001|Overall Study|Adverse Event|0|||
33201548|NCT01312909|100642674|FG002|Overall Study|Adverse Event|3|||
33329778|NCT01449461|101101263|FG002|Overall Study|Protocol Violation|0|||
33523340|NCT01026818|101816157|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
33523341|NCT01026818|101816158|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
33523342|NCT01026818|101816155|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
33523343|NCT01026818|101816156|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
33523344|NCT01026818|101816157|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
33523345|NCT01026818|101816158|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
33523346|NCT01026818|101816155|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
33523347|NCT01026818|101816156|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
33523348|NCT01026818|101816157|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
33523349|NCT01026818|101816158|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
33523350|NCT01026818|101816155|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
33523351|NCT01026818|101816156|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
33523352|NCT01026818|101816157|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
33523353|NCT01026818|101816158|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
33523354|NCT01026818|101816155|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
33523355|NCT01026818|101816156|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
33523356|NCT01026818|101816157|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
33523357|NCT01026818|101816158|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
33523358|NCT01026818|101816155|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
33523359|NCT01026818|101816156|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
33523360|NCT01026818|101816157|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
33523361|NCT01026818|101816158|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
33523362|NCT01026818|101816155|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
33523363|NCT01026818|101816156|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
33523364|NCT01026818|101816157|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
33523365|NCT01026818|101816158|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
33523366|NCT01026818|101816155|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
33523367|NCT01026818|101816156|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
33523368|NCT01026818|101816157|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
33523369|NCT01026818|101816158|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
33523370|NCT01026818|101816155|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
33523371|NCT01026818|101816156|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
33523372|NCT01026818|101816157|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
33523373|NCT01026818|101816158|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
33523374|NCT01026818|101816155|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
33523375|NCT01026818|101816156|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
33523376|NCT01026818|101816157|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
33523377|NCT01026818|101816158|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
33523378|NCT01026818|101816155|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
33523379|NCT01026818|101816156|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
33523380|NCT01026818|101816157|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
33523381|NCT01026818|101816158|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
33523382|NCT01026818|101816155|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
33523383|NCT01026818|101816156|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
33523384|NCT01026818|101816157|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
33523385|NCT01026818|101816158|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
33523386|NCT01026818|101816155|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
33329779|NCT01449461|101101264|FG003|Overall Study|Protocol Violation|1|||
33329780|NCT01449461|101101265|FG004|Overall Study|Protocol Violation|0|||
33329781|NCT01449461|101101266|FG005|Overall Study|Protocol Violation|0|||
33329782|NCT01449461|101101261|FG000|Overall Study|Site Terminated by Sponsor|0|||
33329783|NCT01449461|101101262|FG001|Overall Study|Site Terminated by Sponsor|1|||
33329784|NCT01449461|101101263|FG002|Overall Study|Site Terminated by Sponsor|2|||
33523387|NCT01026818|101816156|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
33609635|NCT03615066|102123084|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
33329785|NCT01449461|101101264|FG003|Overall Study|Site Terminated by Sponsor|3|||
33329786|NCT01449461|101101265|FG004|Overall Study|Site Terminated by Sponsor|4|||
33523388|NCT01026818|101816157|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
33523389|NCT01026818|101816158|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
33523390|NCT01026818|101816155|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
33523391|NCT01026818|101816156|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
33329787|NCT01449461|101101266|FG005|Overall Study|Site Terminated by Sponsor|1|||
33329788|NCT01449461|101101261|FG000|Overall Study|Withdrawal by Subject|0|||
33329789|NCT01449461|101101262|FG001|Overall Study|Withdrawal by Subject|1|||
33329790|NCT01449461|101101263|FG002|Overall Study|Withdrawal by Subject|0|||
33329791|NCT01449461|101101264|FG003|Overall Study|Withdrawal by Subject|0|||
33329792|NCT01449461|101101265|FG004|Overall Study|Withdrawal by Subject|2|||
33329793|NCT01449461|101101266|FG005|Overall Study|Withdrawal by Subject|1|||
33329794|NCT01449461|101101261|FG000|Overall Study|Reason not Specified|0|||
33329795|NCT01449461|101101262|FG001|Overall Study|Reason not Specified|1|||
33329796|NCT01449461|101101263|FG002|Overall Study|Reason not Specified|0|||
33329797|NCT01449461|101101264|FG003|Overall Study|Reason not Specified|3|||
33329798|NCT01449461|101101265|FG004|Overall Study|Reason not Specified|2|||
33329799|NCT01449461|101101266|FG005|Overall Study|Reason not Specified|1|||
33329800|NCT00139776|101101267|FG000|Period I|Did not enter Period II|575|||
33329801|NCT00139776|101101268|FG001|Period I|Did not enter Period II|0|||
33329802|NCT00139776|101101269|FG002|Period I|Did not enter Period II|0|||
33329803|NCT00139776|101101270|FG003|Period I|Did not enter Period II|0|||
33329804|NCT00139776|101101267|FG000|Period II|Not Randomized into Period III|0|||
33329805|NCT00139776|101101268|FG001|Period II|Not Randomized into Period III|322|||
33329806|NCT00139776|101101269|FG002|Period II|Not Randomized into Period III|0|||
33523392|NCT01026818|101816157|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
33523393|NCT01026818|101816158|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
33523394|NCT01026818|101816155|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
33523395|NCT01026818|101816156|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
33523396|NCT01026818|101816157|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
33523397|NCT01026818|101816158|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
33523398|NCT01026818|101816155|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
33523399|NCT01026818|101816156|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
33523400|NCT01026818|101816157|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
33523401|NCT01026818|101816158|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
33329807|NCT00139776|101101270|FG003|Period II|Not Randomized into Period III|0|||
33329808|NCT00139776|101101267|FG000|Period III|Adverse Event|0|||
33329809|NCT00139776|101101268|FG001|Period III|Adverse Event|0|||
33329810|NCT00139776|101101269|FG002|Period III|Adverse Event|22|||
33329811|NCT00139776|101101270|FG003|Period III|Adverse Event|23|||
33329812|NCT00139776|101101267|FG000|Period III|Other|0|||
33329813|NCT00139776|101101268|FG001|Period III|Other|0|||
33329814|NCT00139776|101101269|FG002|Period III|Other|23|||
33329815|NCT00139776|101101270|FG003|Period III|Other|34|||
33329816|NCT00139776|101101267|FG000|Period III|Lack of Efficacy|0|||
33329817|NCT00139776|101101268|FG001|Period III|Lack of Efficacy|0|||
33329818|NCT00139776|101101269|FG002|Period III|Lack of Efficacy|10|||
33401870|NCT00963820|101361556|FG008|Expansion Phase|Progressive Disease|8|||
33401871|NCT00963820|101361557|FG009|Expansion Phase|Progressive Disease|6|||
33401872|NCT00963820|101361558|FG010|Expansion Phase|Progressive Disease|4|||
33401873|NCT00963820|101361559|FG011|Expansion Phase|Progressive Disease|2|||
33401874|NCT00963820|101361548|FG000|Expansion Phase|Adverse Event|0|||
33401875|NCT00963820|101361549|FG001|Expansion Phase|Adverse Event|0|||
33401876|NCT00963820|101361550|FG002|Expansion Phase|Adverse Event|0|||
33523402|NCT01026818|101816155|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
33523403|NCT01026818|101816156|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
33523404|NCT01026818|101816157|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
33523405|NCT01026818|101816158|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
33523406|NCT01026818|101816155|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
33201549|NCT01312909|100642672|FG000|Overall Study|Protocol Violation|2|||
33201550|NCT01312909|100642673|FG001|Overall Study|Protocol Violation|0|||
33201551|NCT01312909|100642674|FG002|Overall Study|Protocol Violation|2|||
33329819|NCT00139776|101101270|FG003|Period III|Lack of Efficacy|24|||
33329820|NCT00139776|101101267|FG000|Period III|Lost to Follow-up|0|||
33329821|NCT00139776|101101268|FG001|Period III|Lost to Follow-up|0|||
33401877|NCT00963820|101361551|FG003|Expansion Phase|Adverse Event|0|||
33401878|NCT00963820|101361552|FG004|Expansion Phase|Adverse Event|0|||
33329822|NCT00139776|101101269|FG002|Period III|Lost to Follow-up|5|||
33329823|NCT00139776|101101270|FG003|Period III|Lost to Follow-up|4|||
33329824|NCT00139776|101101267|FG000|Period III|Withdrawal by Subject|0|||
33329825|NCT00139776|101101268|FG001|Period III|Withdrawal by Subject|0|||
33329826|NCT00139776|101101269|FG002|Period III|Withdrawal by Subject|16|||
33329827|NCT00139776|101101270|FG003|Period III|Withdrawal by Subject|21|||
33329828|NCT02614859|101101272|FG000|Overall Study|Physician Decision|0|||
33523407|NCT01026818|101816156|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
33523408|NCT01026818|101816157|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
33523409|NCT01026818|101816158|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
33523410|NCT01026818|101816155|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
33523411|NCT01026818|101816156|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
33523412|NCT01026818|101816157|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
33523413|NCT01026818|101816158|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
33523414|NCT03326518|101816166|FG000|Overall Study|Protocol Violation|1|||
33523415|NCT03326518|101816167|FG001|Overall Study|Protocol Violation|0|||
33523416|NCT03326518|101816168|FG002|Overall Study|Protocol Violation|0|||
33523417|NCT03326518|101816166|FG000|Overall Study|Withdrawal by Subject|1|||
33523418|NCT03326518|101816167|FG001|Overall Study|Withdrawal by Subject|0|||
33523419|NCT03326518|101816168|FG002|Overall Study|Withdrawal by Subject|0|||
33523420|NCT03326518|101816166|FG000|Overall Study|Lost to Follow-up|1|||
33523421|NCT03326518|101816167|FG001|Overall Study|Lost to Follow-up|0|||
33523422|NCT03326518|101816168|FG002|Overall Study|Lost to Follow-up|1|||
33523423|NCT00433017|101816169|FG000|Overall Study|Adverse Event|5|||
33523424|NCT00433017|101816170|FG001|Overall Study|Adverse Event|3|||
33523425|NCT00433017|101816169|FG000|Overall Study|Withdrawal by Subject|4|||
33523426|NCT00433017|101816170|FG001|Overall Study|Withdrawal by Subject|5|||
33523427|NCT00433017|101816169|FG000|Overall Study|Lost to Follow-up|3|||
33523428|NCT00433017|101816170|FG001|Overall Study|Lost to Follow-up|4|||
33523429|NCT00433017|101816169|FG000|Overall Study|Administrative problems|80|||
33523430|NCT00433017|101816170|FG001|Overall Study|Administrative problems|86|||
33201552|NCT01312909|100642672|FG000|Overall Study|Other|9|||
33201553|NCT01312909|100642673|FG001|Overall Study|Other|6|||
33201554|NCT01312909|100642674|FG002|Overall Study|Other|11|||
33201555|NCT01312909|100642672|FG000|Overall Study|Withdrawal by Subject|8|||
33201556|NCT01312909|100642673|FG001|Overall Study|Withdrawal by Subject|10|||
33201557|NCT01312909|100642674|FG002|Overall Study|Withdrawal by Subject|7|||
33201558|NCT01312909|100642672|FG000|Overall Study|Lost to Follow-up|21|||
33201559|NCT01312909|100642673|FG001|Overall Study|Lost to Follow-up|17|||
33201560|NCT01312909|100642674|FG002|Overall Study|Lost to Follow-up|20|||
33201561|NCT01312909|100642672|FG000|Overall Study|Insufficient clinical response|0|||
33201562|NCT01312909|100642673|FG001|Overall Study|Insufficient clinical response|0|||
33201563|NCT01312909|100642674|FG002|Overall Study|Insufficient clinical response|1|||
33201564|NCT01312909|100642672|FG000|Overall Study|Entrance criteria not met|0|||
33201565|NCT01312909|100642673|FG001|Overall Study|Entrance criteria not met|0|||
33201566|NCT01312909|100642674|FG002|Overall Study|Entrance criteria not met|2|||
33329829|NCT02614859|101101273|FG001|Overall Study|Physician Decision|1|||
33329830|NCT01197521|101101274|FG000|Overall Study|Not reported|24|||
33329831|NCT01197521|101101275|FG001|Overall Study|Not reported|25|||
33329832|NCT01197521|101101276|FG002|Overall Study|Not reported|21|||
33329833|NCT01197521|101101274|FG000|Overall Study|Enrolment in long term extension|42|||
33329834|NCT01197521|101101275|FG001|Overall Study|Enrolment in long term extension|36|||
33329835|NCT01197521|101101276|FG002|Overall Study|Enrolment in long term extension|87|||
33329836|NCT01197521|101101274|FG000|Overall Study|Severe non-compliance to protocol|1|||
33329837|NCT01197521|101101275|FG001|Overall Study|Severe non-compliance to protocol|3|||
33329838|NCT01197521|101101276|FG002|Overall Study|Severe non-compliance to protocol|3|||
33329839|NCT01197521|101101274|FG000|Overall Study|Lack of therapeutic response|2|||
33401879|NCT00963820|101361553|FG005|Expansion Phase|Adverse Event|0|||
33401880|NCT00963820|101361554|FG006|Expansion Phase|Adverse Event|0|||
33401881|NCT00963820|101361555|FG007|Expansion Phase|Adverse Event|0|||
33401882|NCT00963820|101361556|FG008|Expansion Phase|Adverse Event|1|||
33401883|NCT00963820|101361557|FG009|Expansion Phase|Adverse Event|3|||
33401884|NCT00963820|101361558|FG010|Expansion Phase|Adverse Event|0|||
33401885|NCT00963820|101361559|FG011|Expansion Phase|Adverse Event|0|||
33201567|NCT01172938|100642675|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
33401886|NCT00963820|101361548|FG000|Expansion Phase|Withdrawal by Subject|0|||
33401887|NCT00963820|101361549|FG001|Expansion Phase|Withdrawal by Subject|0|||
33401888|NCT00963820|101361550|FG002|Expansion Phase|Withdrawal by Subject|0|||
33201568|NCT01172938|100642676|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
33201569|NCT01172938|100642677|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
33201570|NCT01172938|100642678|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33329840|NCT01197521|101101275|FG001|Overall Study|Lack of therapeutic response|3|||
33329841|NCT01197521|101101276|FG002|Overall Study|Lack of therapeutic response|4|||
33401889|NCT00963820|101361551|FG003|Expansion Phase|Withdrawal by Subject|0|||
33329842|NCT01197521|101101274|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
33201571|NCT01172938|100642679|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33329843|NCT01197521|101101275|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
33523431|NCT00433017|101816169|FG000|Overall Study|Protocol Violation|1|||
33523432|NCT00433017|101816170|FG001|Overall Study|Protocol Violation|0|||
33523433|NCT00433017|101816169|FG000|Overall Study|Death|2|||
33523434|NCT00433017|101816170|FG001|Overall Study|Death|2|||
33523435|NCT00433017|101816169|FG000|Overall Study|Subject no longer requires study drug|1|||
33201572|NCT01172938|100642680|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33401890|NCT00963820|101361552|FG004|Expansion Phase|Withdrawal by Subject|0|||
33401891|NCT00963820|101361553|FG005|Expansion Phase|Withdrawal by Subject|0|||
33329844|NCT01197521|101101276|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
33329845|NCT01197521|101101274|FG000|Overall Study|Lost to Follow-up|3|||
33329846|NCT01197521|101101275|FG001|Overall Study|Lost to Follow-up|2|||
33329847|NCT01197521|101101276|FG002|Overall Study|Lost to Follow-up|2|||
33401892|NCT00963820|101361554|FG006|Expansion Phase|Withdrawal by Subject|0|||
33401893|NCT00963820|101361555|FG007|Expansion Phase|Withdrawal by Subject|0|||
33401894|NCT00963820|101361556|FG008|Expansion Phase|Withdrawal by Subject|1|||
33401895|NCT00963820|101361557|FG009|Expansion Phase|Withdrawal by Subject|0|||
33401896|NCT00963820|101361558|FG010|Expansion Phase|Withdrawal by Subject|1|||
33401897|NCT00963820|101361559|FG011|Expansion Phase|Withdrawal by Subject|1|||
33401898|NCT00963820|101361548|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33401899|NCT00963820|101361549|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33401900|NCT00963820|101361550|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33401901|NCT00963820|101361551|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33401902|NCT00963820|101361552|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33401903|NCT00963820|101361553|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33401904|NCT00963820|101361554|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33401905|NCT00963820|101361555|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33401906|NCT00963820|101361556|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33329848|NCT01197521|101101274|FG000|Overall Study|Adverse Event|25|||
33329849|NCT01197521|101101275|FG001|Overall Study|Adverse Event|28|||
33329850|NCT01197521|101101276|FG002|Overall Study|Adverse Event|24|||
33329851|NCT02634151|101101277|FG000|Overall Study|Withdrawal by Subject|1|||
33329852|NCT02634151|101101278|FG001|Overall Study|Withdrawal by Subject|0|||
33329853|NCT02634151|101101277|FG000|Overall Study|Non-Compliance|0|||
33329854|NCT02634151|101101278|FG001|Overall Study|Non-Compliance|1|||
33329855|NCT02634151|101101277|FG000|Overall Study|Other|0|||
33329856|NCT02634151|101101278|FG001|Overall Study|Other|1|||
33329857|NCT01380730|101101279|FG000|Overall Study|Death|0|||
33329858|NCT01380730|101101280|FG001|Overall Study|Death|0|||
33329859|NCT01380730|101101281|FG002|Overall Study|Death|0|||
33329860|NCT01380730|101101282|FG003|Overall Study|Death|0|||
33329861|NCT01380730|101101283|FG004|Overall Study|Death|1|||
33329862|NCT01380730|101101284|FG005|Overall Study|Death|0|||
33329863|NCT01380730|101101285|FG006|Overall Study|Death|0|||
33329864|NCT01380730|101101286|FG007|Overall Study|Death|0|||
33329865|NCT01476475|101101289|FG000|Overall Study|Adverse Event|6|||
33329866|NCT01476475|101101290|FG001|Overall Study|Adverse Event|0|||
33329867|NCT01476475|101101289|FG000|Overall Study|Poor compliance to protocol|1|||
33329868|NCT01476475|101101290|FG001|Overall Study|Poor compliance to protocol|1|||
33329869|NCT01476475|101101289|FG000|Overall Study|Other reasons|4|||
33329870|NCT01476475|101101290|FG001|Overall Study|Other reasons|2|||
33329871|NCT03028870|101101291|FG000|Overall Study|Adverse Event|7|||
33329872|NCT03028870|101101292|FG001|Overall Study|Adverse Event|4|||
33329873|NCT03028870|101101293|FG002|Overall Study|Adverse Event|3|||
33329874|NCT03028870|101101294|FG003|Overall Study|Adverse Event|3|||
33329875|NCT03028870|101101291|FG000|Overall Study|Withdrawal by Subject|1|||
33329876|NCT03028870|101101292|FG001|Overall Study|Withdrawal by Subject|1|||
33329877|NCT03028870|101101293|FG002|Overall Study|Withdrawal by Subject|1|||
33329878|NCT03028870|101101294|FG003|Overall Study|Withdrawal by Subject|2|||
33329879|NCT03028870|101101291|FG000|Overall Study|Lost to Follow-up|1|||
33329880|NCT03028870|101101292|FG001|Overall Study|Lost to Follow-up|0|||
33329881|NCT03028870|101101293|FG002|Overall Study|Lost to Follow-up|0|||
33329882|NCT03028870|101101294|FG003|Overall Study|Lost to Follow-up|0|||
33401907|NCT00963820|101361557|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33401908|NCT00963820|101361558|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33401909|NCT00963820|101361559|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
33329883|NCT03028870|101101291|FG000|Overall Study|Lack of Efficacy|3|||
33329884|NCT03028870|101101292|FG001|Overall Study|Lack of Efficacy|0|||
33329885|NCT03028870|101101293|FG002|Overall Study|Lack of Efficacy|0|||
33329886|NCT03028870|101101294|FG003|Overall Study|Lack of Efficacy|0|||
33329887|NCT03028870|101101291|FG000|Overall Study|Administrative|5|||
33401910|NCT00352027|101361560|FG000|Overall Study|Progressive disease|3|||
33329888|NCT03028870|101101292|FG001|Overall Study|Administrative|5|||
33329889|NCT03028870|101101293|FG002|Overall Study|Administrative|12|||
33401911|NCT02269709|101361561|FG000|Time of Enrollment|Withdrawal by Subject|3|||
33329890|NCT03028870|101101294|FG003|Overall Study|Administrative|4|||
33329891|NCT02322125|101101301|FG000|Overall Study|Withdrawal by Subject|2|||
33329892|NCT04050670|101101302|FG000|Period 3|Physician Decision|0|||
33329893|NCT04050670|101101303|FG001|Period 3|Physician Decision|1|||
33329894|NCT04050670|101101304|FG002|Period 3|Physician Decision|0|||
33329895|NCT01617070|101101305|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
33329896|NCT00880399|101101308|FG000|Overall Study|Adverse Event|4|||
33329897|NCT00880399|101101309|FG001|Overall Study|Adverse Event|6|||
33329898|NCT00880399|101101310|FG002|Overall Study|Adverse Event|5|||
33401912|NCT02269709|101361561|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
33401913|NCT02269709|101361561|FG000|Six Month Follow-up|Lost to Follow-up|12|||
33401914|NCT02993731|101361562|FG000|Overall Study|Study Termination|101|||
33401915|NCT02993731|101361563|FG001|Overall Study|Study Termination|105|||
33401916|NCT03091920|101361579|FG000|Overall Study|Adverse Event|0|||
33401917|NCT03091920|101361580|FG001|Overall Study|Adverse Event|1|||
33401918|NCT03091920|101361581|FG002|Overall Study|Adverse Event|0|||
33401919|NCT01117428|101361587|FG000|Overall Study|Lack of Efficacy|1|||
33201573|NCT01172938|100642681|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33201574|NCT01172938|100642682|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33329899|NCT00880399|101101308|FG000|Overall Study|Lack of Efficacy|1|||
33329900|NCT00880399|101101309|FG001|Overall Study|Lack of Efficacy|4|||
33329901|NCT00880399|101101310|FG002|Overall Study|Lack of Efficacy|2|||
33329902|NCT00880399|101101308|FG000|Overall Study|Protocol Violation|4|||
33329903|NCT00880399|101101309|FG001|Overall Study|Protocol Violation|4|||
33329904|NCT00880399|101101310|FG002|Overall Study|Protocol Violation|6|||
33401920|NCT01117428|101361588|FG001|Overall Study|Lack of Efficacy|0|||
33401921|NCT01117428|101361589|FG002|Overall Study|Lack of Efficacy|0|||
33401922|NCT01117428|101361590|FG003|Overall Study|Lack of Efficacy|0|||
33401923|NCT01117428|101361591|FG004|Overall Study|Lack of Efficacy|0|||
33401924|NCT01117428|101361592|FG005|Overall Study|Lack of Efficacy|0|||
33401925|NCT01117428|101361587|FG000|Overall Study|Adverse Event|4|||
33401926|NCT01117428|101361588|FG001|Overall Study|Adverse Event|0|||
33401927|NCT01117428|101361589|FG002|Overall Study|Adverse Event|0|||
33523436|NCT00433017|101816170|FG001|Overall Study|Subject no longer requires study drug|1|||
33523437|NCT01375374|101816171|FG000|Overall Study|Adverse Event|1|||
33401928|NCT01117428|101361590|FG003|Overall Study|Adverse Event|0|||
33401929|NCT01117428|101361591|FG004|Overall Study|Adverse Event|1|||
33523438|NCT02797678|101816172|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
33401930|NCT01117428|101361592|FG005|Overall Study|Adverse Event|2|||
33401931|NCT01117428|101361587|FG000|Overall Study|Death|0|||
33401932|NCT01117428|101361588|FG001|Overall Study|Death|1|||
33401933|NCT01117428|101361589|FG002|Overall Study|Death|2|||
33401934|NCT01117428|101361590|FG003|Overall Study|Death|0|||
33401935|NCT01117428|101361591|FG004|Overall Study|Death|0|||
33401936|NCT01117428|101361592|FG005|Overall Study|Death|1|||
33401937|NCT01117428|101361587|FG000|Overall Study|Physician Decision|0|||
33401938|NCT01117428|101361588|FG001|Overall Study|Physician Decision|1|||
33401939|NCT01117428|101361589|FG002|Overall Study|Physician Decision|0|||
33401940|NCT01117428|101361590|FG003|Overall Study|Physician Decision|0|||
33401941|NCT01117428|101361591|FG004|Overall Study|Physician Decision|0|||
33401942|NCT01117428|101361592|FG005|Overall Study|Physician Decision|0|||
33401943|NCT01117428|101361587|FG000|Overall Study|Withdrawal by Subject|0|||
33401944|NCT01117428|101361588|FG001|Overall Study|Withdrawal by Subject|0|||
33523439|NCT02797678|101816173|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
33401945|NCT01117428|101361589|FG002|Overall Study|Withdrawal by Subject|1|||
33401946|NCT01117428|101361590|FG003|Overall Study|Withdrawal by Subject|0|||
33401947|NCT01117428|101361591|FG004|Overall Study|Withdrawal by Subject|0|||
33401948|NCT01117428|101361592|FG005|Overall Study|Withdrawal by Subject|0|||
33401949|NCT01117428|101361587|FG000|Overall Study|Progressive disease|15|||
33401950|NCT01117428|101361588|FG001|Overall Study|Progressive disease|27|||
33401951|NCT01117428|101361589|FG002|Overall Study|Progressive disease|10|||
33401952|NCT01117428|101361590|FG003|Overall Study|Progressive disease|12|||
33401953|NCT01117428|101361591|FG004|Overall Study|Progressive disease|16|||
33401954|NCT01117428|101361592|FG005|Overall Study|Progressive disease|17|||
33401955|NCT00104299|101361593|FG000|Overall Study|Adverse Event|3|||
33401956|NCT00104299|101361594|FG001|Overall Study|Adverse Event|1|||
33523440|NCT02797678|101816174|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
33201575|NCT01172938|100642683|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33201576|NCT01172938|100642675|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
33201577|NCT01172938|100642676|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
33329905|NCT00880399|101101308|FG000|Overall Study|Study closed/terminated|3|||
33329906|NCT00880399|101101309|FG001|Overall Study|Study closed/terminated|7|||
33401957|NCT00104299|101361593|FG000|Overall Study|Death|2|||
33401958|NCT00104299|101361594|FG001|Overall Study|Death|2|||
33401959|NCT00104299|101361593|FG000|Overall Study|Withdrawal by Subject|2|||
33401960|NCT00104299|101361594|FG001|Overall Study|Withdrawal by Subject|6|||
33401961|NCT00104299|101361593|FG000|Overall Study|Physician Decision|1|||
33401962|NCT00104299|101361594|FG001|Overall Study|Physician Decision|1|||
33401963|NCT00104299|101361593|FG000|Overall Study|To have renal transplant|1|||
33401964|NCT00104299|101361594|FG001|Overall Study|To have renal transplant|0|||
33401965|NCT02194699|101361597|FG000|Randomised|Did not receive treatment|1|||
33401966|NCT02194699|101361598|FG001|Randomised|Did not receive treatment|5|||
33329907|NCT00880399|101101310|FG002|Overall Study|Study closed/terminated|4|||
33401967|NCT02194699|101361597|FG000|Randomised|Without potential for 52 weeks of IP|5|||
33401968|NCT02194699|101361598|FG001|Randomised|Without potential for 52 weeks of IP|5|||
33401969|NCT02194699|101361597|FG000|Randomised|Duplicate patient|2|||
33523441|NCT02797678|101816175|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
33523442|NCT02797678|101816172|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
33523443|NCT02797678|101816173|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
33523444|NCT02797678|101816174|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
33523445|NCT02797678|101816175|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
33523446|NCT02797678|101816172|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
33523447|NCT02797678|101816173|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
33523448|NCT02797678|101816174|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
33523449|NCT02797678|101816175|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
33523450|NCT04571385|101816176|FG000|Overall Study|Participant non-compliance|1|||
33523451|NCT04571385|101816177|FG001|Overall Study|Participant non-compliance|0|||
33523452|NCT04571385|101816178|FG002|Overall Study|Participant non-compliance|0|||
33523453|NCT04571385|101816176|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
33523454|NCT04571385|101816177|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
33523455|NCT04571385|101816178|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
33523456|NCT04571385|101816176|FG000|Overall Study|Screen failure|0|||
33523457|NCT04571385|101816177|FG001|Overall Study|Screen failure|0|||
33523458|NCT04571385|101816178|FG002|Overall Study|Screen failure|1|||
33523459|NCT01533688|101816183|FG000|Overall Study|Withdrawal by Subject|5|||
33523460|NCT01533688|101816184|FG001|Overall Study|Withdrawal by Subject|4|||
33523461|NCT01533688|101816185|FG002|Overall Study|Withdrawal by Subject|3|||
33609636|NCT03216746|102123085|FG000|Overall Study|Lost to Follow-up|6|||
33609637|NCT03216746|102123086|FG001|Overall Study|Lost to Follow-up|8|||
33609638|NCT03216746|102123087|FG002|Overall Study|Lost to Follow-up|5|||
33609639|NCT03216746|102123088|FG003|Overall Study|Lost to Follow-up|6|||
33609640|NCT02593318|102123090|FG000|Overall Study|Withdrawal by Subject|1|||
33609641|NCT02593318|102123091|FG001|Overall Study|Withdrawal by Subject|1|||
33609642|NCT01052077|102123092|FG000|Phase A|Lost to Follow-up|22|||
33609643|NCT01052077|102123093|FG001|Phase A|Lost to Follow-up|0|||
33329908|NCT00880399|101101308|FG000|Overall Study|Lost to Follow-up|8|||
33329909|NCT00880399|101101309|FG001|Overall Study|Lost to Follow-up|5|||
33523462|NCT01533688|101816183|FG000|Overall Study|Medically unstable|1|||
33523463|NCT01533688|101816184|FG001|Overall Study|Medically unstable|3|||
33523464|NCT01533688|101816185|FG002|Overall Study|Medically unstable|3|||
33523465|NCT01533688|101816183|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
33523466|NCT01533688|101816184|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
33523467|NCT01533688|101816185|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
33523468|NCT03423147|101816186|FG000|Overall Study|Lost to Follow-up|5|||
33523469|NCT03423147|101816187|FG001|Overall Study|Lost to Follow-up|8|||
33523470|NCT03423147|101816186|FG000|Overall Study|Withdrawal by Subject|1|||
33523471|NCT03423147|101816187|FG001|Overall Study|Withdrawal by Subject|0|||
33523472|NCT03423147|101816186|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
33523473|NCT03423147|101816187|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
33523474|NCT03423147|101816186|FG000|Overall Study|Age < 18|1|||
33523475|NCT03423147|101816187|FG001|Overall Study|Age < 18|0|||
33523476|NCT03423147|101816186|FG000|Overall Study|No Trial of Labor|0|||
33523477|NCT03423147|101816187|FG001|Overall Study|No Trial of Labor|1|||
33523478|NCT00496587|101816188|FG000|Overall Study|Adverse Event|2|||
33523479|NCT00496587|101816188|FG000|Overall Study|Progressive Disease|24|||
33523480|NCT00496587|101816188|FG000|Overall Study|Withdrawal by Subject|2|||
33523481|NCT00496587|101816188|FG000|Overall Study|Death|1|||
33523482|NCT00496587|101816188|FG000|Overall Study|Complications unrelated|2|||
33523483|NCT01778751|101816195|FG000|Overall Study|Lost to Follow-up|1|||
33523484|NCT01778751|101816196|FG001|Overall Study|Lost to Follow-up|0|||
33523485|NCT01778751|101816195|FG000|Overall Study|Withdrawal by Subject|0|||
33523486|NCT01778751|101816196|FG001|Overall Study|Withdrawal by Subject|2|||
33523487|NCT01778751|101816195|FG000|Overall Study|Transfered care|1|||
33329910|NCT00880399|101101310|FG002|Overall Study|Lost to Follow-up|3|||
33329911|NCT00880399|101101308|FG000|Overall Study|Physician Decision|5|||
33329912|NCT00880399|101101309|FG001|Overall Study|Physician Decision|0|||
33329913|NCT00880399|101101310|FG002|Overall Study|Physician Decision|3|||
33523488|NCT01778751|101816196|FG001|Overall Study|Transfered care|0|||
33523489|NCT01125813|101816197|FG000|Overall Study|Death|1|||
33523490|NCT01125813|101816197|FG000|Overall Study|Withdrawal by Subject|1|||
33523491|NCT01125813|101816197|FG000|Overall Study|Screen Failures|4|||
33523492|NCT02697734|101816198|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
33609644|NCT01052077|102123094|FG002|Phase A|Lost to Follow-up|0|||
33609645|NCT01052077|102123095|FG003|Phase A|Lost to Follow-up|0|||
33609646|NCT01052077|102123092|FG000|Phase A|Adverse Event|32|||
33609647|NCT01052077|102123093|FG001|Phase A|Adverse Event|0|||
33329914|NCT00880399|101101308|FG000|Overall Study|Withdrawal by Subject|6|||
33523493|NCT02697734|101816199|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
33609648|NCT01052077|102123094|FG002|Phase A|Adverse Event|0|||
33329915|NCT00880399|101101309|FG001|Overall Study|Withdrawal by Subject|3|||
33523494|NCT02697734|101816198|FG000|Core Phase - up to Week 48|Adverse Event|1|||
33523495|NCT02697734|101816199|FG001|Core Phase - up to Week 48|Adverse Event|2|||
33523496|NCT02697734|101816198|FG000|Core Phase - up to Week 48|Physician Decision|1|||
33523497|NCT02697734|101816199|FG001|Core Phase - up to Week 48|Physician Decision|0|||
33523498|NCT02697734|101816198|FG000|Optional Extension Phase|Adverse Event|5|||
33523499|NCT02697734|101816199|FG001|Optional Extension Phase|Adverse Event|1|||
33523500|NCT02697734|101816198|FG000|Optional Extension Phase|Physician Decision|0|||
33523501|NCT02697734|101816199|FG001|Optional Extension Phase|Physician Decision|1|||
33523502|NCT03519919|101816200|FG000|Overall Study|Withdrawal by Subject|1|||
33523503|NCT03519919|101816200|FG000|Overall Study|Lack of Efficacy|1|||
33523504|NCT03519919|101816200|FG000|Overall Study|Screen Failure|1|||
33523505|NCT01470144|101816201|FG000|Overall Study|Adverse Event|2|||
33523506|NCT01470144|101816201|FG000|Overall Study|Death|1|||
33523507|NCT01470144|101816201|FG000|Overall Study|Lung transplant|6|||
33523508|NCT01470144|101816201|FG000|Overall Study|Patient's and investigator's decision|1|||
33523509|NCT00290693|101816202|FG000|Overall Study|Withdrawal by Subject|2|||
33523510|NCT03754972|101816209|FG000|Overall Study|Protocol Violation|25|||
33523511|NCT02191046|101816210|FG000|Overall Study|low compliance|5|||
33523512|NCT02191046|101816211|FG001|Overall Study|low compliance|1|||
33523513|NCT00560703|101816212|FG000|Overall Study|Adverse Event|0|||
33523514|NCT00560703|101816213|FG001|Overall Study|Adverse Event|2|||
33523515|NCT00560703|101816212|FG000|Overall Study|Protocol Violation|0|||
33523516|NCT00560703|101816213|FG001|Overall Study|Protocol Violation|2|||
33523517|NCT00560703|101816212|FG000|Overall Study|Withdrawal by Subject|0|||
33523518|NCT00560703|101816213|FG001|Overall Study|Withdrawal by Subject|1|||
33523519|NCT00560703|101816212|FG000|Overall Study|non-compliance|0|||
33523520|NCT00560703|101816213|FG001|Overall Study|non-compliance|1|||
33523521|NCT00303472|101816214|FG000|Treatment Period|Adverse Event|0|||
33523522|NCT00303472|101816215|FG001|Treatment Period|Adverse Event|0|||
33523523|NCT00303472|101816216|FG002|Treatment Period|Adverse Event|0|||
33523524|NCT00303472|101816217|FG003|Treatment Period|Adverse Event|0|||
33523525|NCT00303472|101816218|FG004|Treatment Period|Adverse Event|1|||
33523526|NCT00303472|101816219|FG005|Treatment Period|Adverse Event|0|||
33523527|NCT00303472|101816220|FG006|Treatment Period|Adverse Event|0|||
33523528|NCT00303472|101816214|FG000|Treatment Period|Death|0|||
33523529|NCT00303472|101816215|FG001|Treatment Period|Death|0|||
33523530|NCT00303472|101816216|FG002|Treatment Period|Death|0|||
33523531|NCT00303472|101816217|FG003|Treatment Period|Death|1|||
33523532|NCT00303472|101816218|FG004|Treatment Period|Death|0|||
33523533|NCT00303472|101816219|FG005|Treatment Period|Death|0|||
33523534|NCT00303472|101816220|FG006|Treatment Period|Death|1|||
33523535|NCT00303472|101816214|FG000|Treatment Period|Withdrawal by Subject|0|||
33523536|NCT00303472|101816215|FG001|Treatment Period|Withdrawal by Subject|0|||
33523537|NCT00303472|101816216|FG002|Treatment Period|Withdrawal by Subject|0|||
33523538|NCT00303472|101816217|FG003|Treatment Period|Withdrawal by Subject|1|||
33523539|NCT00303472|101816218|FG004|Treatment Period|Withdrawal by Subject|0|||
33523540|NCT00303472|101816219|FG005|Treatment Period|Withdrawal by Subject|1|||
33523541|NCT00303472|101816220|FG006|Treatment Period|Withdrawal by Subject|0|||
33523542|NCT00303472|101816214|FG000|Treatment Period|Other|0|||
33523543|NCT00303472|101816215|FG001|Treatment Period|Other|0|||
33523544|NCT00303472|101816216|FG002|Treatment Period|Other|0|||
33523545|NCT00303472|101816217|FG003|Treatment Period|Other|0|||
33523546|NCT00303472|101816218|FG004|Treatment Period|Other|1|||
33523547|NCT00303472|101816219|FG005|Treatment Period|Other|0|||
33523548|NCT00303472|101816220|FG006|Treatment Period|Other|1|||
33523549|NCT00303472|101816214|FG000|Treatment Period|Disease Progression (to AML)|0|||
33523550|NCT00303472|101816215|FG001|Treatment Period|Disease Progression (to AML)|0|||
33523551|NCT00303472|101816216|FG002|Treatment Period|Disease Progression (to AML)|0|||
33523552|NCT00303472|101816217|FG003|Treatment Period|Disease Progression (to AML)|0|||
33523553|NCT00303472|101816218|FG004|Treatment Period|Disease Progression (to AML)|1|||
33523554|NCT00303472|101816219|FG005|Treatment Period|Disease Progression (to AML)|0|||
33523555|NCT00303472|101816220|FG006|Treatment Period|Disease Progression (to AML)|0|||
33523556|NCT00303472|101816214|FG000|Treatment Extension (Optional)|Adverse Event|1|||
33523557|NCT00303472|101816215|FG001|Treatment Extension (Optional)|Adverse Event|0|||
33523558|NCT00303472|101816216|FG002|Treatment Extension (Optional)|Adverse Event|1|||
33523559|NCT00303472|101816217|FG003|Treatment Extension (Optional)|Adverse Event|0|||
33523560|NCT00303472|101816218|FG004|Treatment Extension (Optional)|Adverse Event|0|||
33523561|NCT00303472|101816219|FG005|Treatment Extension (Optional)|Adverse Event|0|||
33523562|NCT00303472|101816220|FG006|Treatment Extension (Optional)|Adverse Event|0|||
33523563|NCT00303472|101816214|FG000|Treatment Extension (Optional)|Death|2|||
33523564|NCT00303472|101816215|FG001|Treatment Extension (Optional)|Death|0|||
33523565|NCT00303472|101816216|FG002|Treatment Extension (Optional)|Death|1|||
33523566|NCT00303472|101816217|FG003|Treatment Extension (Optional)|Death|0|||
33523567|NCT00303472|101816218|FG004|Treatment Extension (Optional)|Death|0|||
33523568|NCT00303472|101816219|FG005|Treatment Extension (Optional)|Death|0|||
33523569|NCT00303472|101816220|FG006|Treatment Extension (Optional)|Death|0|||
33523570|NCT00303472|101816214|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
33329916|NCT00880399|101101310|FG002|Overall Study|Withdrawal by Subject|3|||
33329917|NCT01924182|101101311|FG000|Overall Study|Withdrawal by Subject|1|||
33329918|NCT01924182|101101312|FG001|Overall Study|Withdrawal by Subject|0|||
33329919|NCT03785925|101101318|FG000|Overall Study|Withdrawal by Subject|15|||
33329920|NCT03785925|101101318|FG000|Overall Study|Lost to Follow-up|1|||
33329921|NCT01516970|101101323|FG000|Overall Study|Lost to Follow-up|7|||
33329922|NCT01516970|101101324|FG001|Overall Study|Lost to Follow-up|8|||
33329923|NCT01516970|101101323|FG000|Overall Study|Adverse Event|1|||
33329924|NCT01516970|101101324|FG001|Overall Study|Adverse Event|5|||
33329925|NCT01516970|101101323|FG000|Overall Study|Withdrawal by Subject|1|||
33329926|NCT01516970|101101324|FG001|Overall Study|Withdrawal by Subject|1|||
33329927|NCT01516970|101101323|FG000|Overall Study|Other|9|||
33329928|NCT01516970|101101324|FG001|Overall Study|Other|7|||
33329929|NCT02871778|101101325|FG000|Part A: Treatment Period 1|Adverse Event|1|||
33329930|NCT02871778|101101326|FG001|Part A: Treatment Period 1|Adverse Event|1|||
33523571|NCT00303472|101816215|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
33523572|NCT00303472|101816216|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
33523573|NCT00303472|101816217|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
33329931|NCT02871778|101101327|FG002|Part A: Treatment Period 1|Adverse Event|1|||
33329932|NCT02871778|101101328|FG003|Part A: Treatment Period 1|Adverse Event|0|||
33329933|NCT02871778|101101329|FG004|Part A: Treatment Period 1|Adverse Event|0|||
33329934|NCT02871778|101101330|FG005|Part A: Treatment Period 1|Adverse Event|0|||
33329935|NCT02871778|101101331|FG006|Part A: Treatment Period 1|Adverse Event|0|||
33329936|NCT02871778|101101332|FG007|Part A: Treatment Period 1|Adverse Event|0|||
33329937|NCT02871778|101101325|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
33329938|NCT02871778|101101326|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
33329939|NCT02871778|101101327|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
33329940|NCT02871778|101101328|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
33329941|NCT02871778|101101329|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
33329942|NCT02871778|101101330|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
33329943|NCT02871778|101101331|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
33329944|NCT02871778|101101332|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
33329945|NCT02871778|101101325|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
33329946|NCT02871778|101101326|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
33329947|NCT02871778|101101327|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
33329948|NCT02871778|101101328|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
33329949|NCT02871778|101101329|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
33329950|NCT02871778|101101330|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
33329951|NCT02871778|101101331|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
33329952|NCT02871778|101101332|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
33329953|NCT02871778|101101325|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
33329954|NCT02871778|101101326|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
33329955|NCT02871778|101101327|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
33329956|NCT02871778|101101328|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
33523574|NCT00303472|101816218|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
33523575|NCT00303472|101816219|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
33523576|NCT00303472|101816220|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
33523577|NCT00303472|101816214|FG000|Treatment Extension (Optional)|Physician Decision|0|||
33523578|NCT00303472|101816215|FG001|Treatment Extension (Optional)|Physician Decision|4|||
33523579|NCT00303472|101816216|FG002|Treatment Extension (Optional)|Physician Decision|2|||
33523580|NCT00303472|101816217|FG003|Treatment Extension (Optional)|Physician Decision|3|||
33523581|NCT00303472|101816218|FG004|Treatment Extension (Optional)|Physician Decision|2|||
33523582|NCT00303472|101816219|FG005|Treatment Extension (Optional)|Physician Decision|0|||
33523583|NCT00303472|101816220|FG006|Treatment Extension (Optional)|Physician Decision|0|||
33523584|NCT00303472|101816214|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
33523585|NCT00303472|101816215|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
33523586|NCT00303472|101816216|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
33523587|NCT00303472|101816217|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
33523588|NCT00303472|101816218|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
33523589|NCT00303472|101816219|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
33523590|NCT00303472|101816220|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
33609649|NCT01052077|102123095|FG003|Phase A|Adverse Event|0|||
33329957|NCT02871778|101101329|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
33329958|NCT02871778|101101330|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
33329959|NCT02871778|101101331|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
33401970|NCT02194699|101361598|FG001|Randomised|Duplicate patient|1|||
33401971|NCT02194699|101361597|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
33523591|NCT00303472|101816214|FG000|Treatment Extension (Optional)|Other|0|||
33609650|NCT01052077|102123092|FG000|Phase A|Met Withdrawal Criteria|26|||
33329960|NCT02871778|101101332|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
33329961|NCT02871778|101101325|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
33329962|NCT02871778|101101326|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
33329963|NCT02871778|101101327|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
33329964|NCT02871778|101101328|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
33329965|NCT02871778|101101329|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
33329966|NCT02871778|101101330|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
33329967|NCT02871778|101101331|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
33523592|NCT00303472|101816215|FG001|Treatment Extension (Optional)|Other|2|||
33523593|NCT00303472|101816216|FG002|Treatment Extension (Optional)|Other|4|||
33523594|NCT00303472|101816217|FG003|Treatment Extension (Optional)|Other|2|||
33523595|NCT00303472|101816218|FG004|Treatment Extension (Optional)|Other|1|||
33523596|NCT00303472|101816219|FG005|Treatment Extension (Optional)|Other|0|||
33523597|NCT00303472|101816220|FG006|Treatment Extension (Optional)|Other|0|||
33523598|NCT00303472|101816214|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
33523599|NCT00303472|101816215|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
33523600|NCT00303472|101816216|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
33523601|NCT00303472|101816217|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
33523602|NCT00303472|101816218|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
33523603|NCT00303472|101816219|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
33523604|NCT00303472|101816220|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
33523605|NCT02560623|101816221|FG000|Overall Study|Unable to swallow sponge|0|||
33523606|NCT02560623|101816222|FG001|Overall Study|Unable to swallow sponge|1|||
33523607|NCT02560623|101816223|FG002|Overall Study|Unable to swallow sponge|0|||
33523608|NCT02560623|101816224|FG003|Overall Study|Unable to swallow sponge|0|||
33523609|NCT02560623|101816221|FG000|Overall Study|Intervention prior to sponge administration|0|||
33523610|NCT02560623|101816222|FG001|Overall Study|Intervention prior to sponge administration|1|||
33523611|NCT02560623|101816223|FG002|Overall Study|Intervention prior to sponge administration|0|||
33523612|NCT02560623|101816224|FG003|Overall Study|Intervention prior to sponge administration|0|||
33523613|NCT01690299|101816226|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
33523614|NCT01690299|101816227|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
33523615|NCT01690299|101816228|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
33523616|NCT01690299|101816229|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
33523617|NCT01690299|101816230|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
33523618|NCT01690299|101816231|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
33523619|NCT01690299|101816226|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
33523620|NCT01690299|101816227|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33523621|NCT01690299|101816228|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33523622|NCT01690299|101816229|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33523623|NCT01690299|101816230|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33523624|NCT01690299|101816231|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33523625|NCT01690299|101816226|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
33523626|NCT01690299|101816227|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
33523627|NCT01690299|101816228|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33523628|NCT01690299|101816229|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33523629|NCT01690299|101816230|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33523630|NCT01690299|101816231|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33523631|NCT01690299|101816226|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
33523632|NCT01690299|101816227|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
33523633|NCT01690299|101816228|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
33523634|NCT01690299|101816229|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
33523635|NCT01690299|101816230|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
33523636|NCT01690299|101816231|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
33523637|NCT01690299|101816226|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
33523638|NCT01690299|101816227|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
33523639|NCT01690299|101816228|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
33523640|NCT01690299|101816229|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
33523641|NCT01690299|101816230|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
33523642|NCT01690299|101816231|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
33523643|NCT01690299|101816226|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
33523644|NCT01690299|101816227|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
33523645|NCT01690299|101816228|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
33523646|NCT01690299|101816229|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
33523647|NCT01690299|101816230|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
33523648|NCT01690299|101816231|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
33329968|NCT02871778|101101332|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
33329969|NCT02871778|101101325|FG000|Part A: Treatment Period 2|Adverse Event|2|||
33329970|NCT02871778|101101326|FG001|Part A: Treatment Period 2|Adverse Event|2|||
33329971|NCT02871778|101101327|FG002|Part A: Treatment Period 2|Adverse Event|0|||
33329972|NCT02871778|101101328|FG003|Part A: Treatment Period 2|Adverse Event|0|||
33329973|NCT02871778|101101329|FG004|Part A: Treatment Period 2|Adverse Event|0|||
33329974|NCT02871778|101101330|FG005|Part A: Treatment Period 2|Adverse Event|0|||
33329975|NCT02871778|101101331|FG006|Part A: Treatment Period 2|Adverse Event|0|||
33329976|NCT02871778|101101332|FG007|Part A: Treatment Period 2|Adverse Event|0|||
33329977|NCT02871778|101101325|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
33329978|NCT02871778|101101326|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
33329979|NCT02871778|101101327|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
33329980|NCT02871778|101101328|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
33329981|NCT02871778|101101329|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
33329982|NCT02871778|101101330|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
33523649|NCT01690299|101816226|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
33523650|NCT01690299|101816227|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
33523651|NCT01690299|101816228|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
33609651|NCT01052077|102123093|FG001|Phase A|Met Withdrawal Criteria|0|||
33609652|NCT01052077|102123094|FG002|Phase A|Met Withdrawal Criteria|0|||
33609653|NCT01052077|102123095|FG003|Phase A|Met Withdrawal Criteria|0|||
33609654|NCT01052077|102123092|FG000|Phase A|Physician Decision|10|||
33609655|NCT01052077|102123093|FG001|Phase A|Physician Decision|0|||
33609656|NCT01052077|102123094|FG002|Phase A|Physician Decision|0|||
33609657|NCT01052077|102123095|FG003|Phase A|Physician Decision|0|||
33201578|NCT01172938|100642677|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
33201579|NCT01172938|100642678|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33201580|NCT01172938|100642679|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33523652|NCT01690299|101816229|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
33523653|NCT01690299|101816230|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
33523654|NCT01690299|101816231|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
33523655|NCT01690299|101816226|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
33523656|NCT01690299|101816227|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
33201581|NCT01172938|100642680|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33201582|NCT01172938|100642681|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33201583|NCT01172938|100642682|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33201584|NCT01172938|100642683|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33201585|NCT01172938|100642675|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33201586|NCT01172938|100642676|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
33201587|NCT01172938|100642677|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
33201588|NCT01172938|100642678|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33201589|NCT01172938|100642679|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33201590|NCT01172938|100642680|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33201591|NCT01172938|100642681|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33201592|NCT01172938|100642682|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33201593|NCT01172938|100642683|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33201594|NCT01172938|100642675|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
33201595|NCT01172938|100642676|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
33201596|NCT01172938|100642677|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
33201597|NCT01172938|100642678|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33201598|NCT01172938|100642679|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33201599|NCT01172938|100642680|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33201600|NCT01172938|100642681|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33201601|NCT01172938|100642682|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33201602|NCT01172938|100642683|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33201603|NCT01172938|100642675|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
33201604|NCT01172938|100642676|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
33201605|NCT01172938|100642677|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
33201606|NCT01172938|100642678|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
33201607|NCT01172938|100642679|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
33201608|NCT01172938|100642680|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
33329983|NCT02871778|101101331|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
33329984|NCT02871778|101101332|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
33329985|NCT02871778|101101325|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
33329986|NCT02871778|101101326|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
33523657|NCT01690299|101816228|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
33609658|NCT01052077|102123092|FG000|Phase A|Withdrawal by Subject|29|||
33609659|NCT01052077|102123093|FG001|Phase A|Withdrawal by Subject|0|||
33609660|NCT01052077|102123094|FG002|Phase A|Withdrawal by Subject|0|||
33609661|NCT01052077|102123095|FG003|Phase A|Withdrawal by Subject|0|||
33609662|NCT01052077|102123092|FG000|Phase A|Protocol Deviation|27|||
33609663|NCT01052077|102123093|FG001|Phase A|Protocol Deviation|0|||
33609664|NCT01052077|102123094|FG002|Phase A|Protocol Deviation|0|||
33609665|NCT01052077|102123095|FG003|Phase A|Protocol Deviation|0|||
33609666|NCT01052077|102123092|FG000|Phase B|Lost to Follow-up|0|||
33609667|NCT01052077|102123093|FG001|Phase B|Lost to Follow-up|2|||
33609668|NCT01052077|102123094|FG002|Phase B|Lost to Follow-up|3|||
33609669|NCT01052077|102123095|FG003|Phase B|Lost to Follow-up|0|||
33401972|NCT02194699|101361598|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
33523658|NCT01690299|101816229|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
33523659|NCT01690299|101816230|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
33523660|NCT01690299|101816231|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
33523661|NCT01690299|101816226|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
33523662|NCT01690299|101816227|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
33523663|NCT01690299|101816228|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
33523664|NCT01690299|101816229|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
33523665|NCT01690299|101816230|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
33523666|NCT01690299|101816231|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
33523667|NCT01690299|101816226|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
33523668|NCT01690299|101816227|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
33523669|NCT01690299|101816228|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
33523670|NCT01690299|101816229|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
33523671|NCT01690299|101816230|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
33523672|NCT01690299|101816231|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
33523673|NCT03816007|101816236|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
33523674|NCT03816007|101816237|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
33523675|NCT03816007|101816236|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
33523676|NCT03816007|101816237|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
33523677|NCT03816007|101816236|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
33523678|NCT03816007|101816237|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
33523679|NCT03092791|101816244|FG000|Overall Study|Lost to Follow-up|0|||
33523680|NCT03092791|101816245|FG001|Overall Study|Lost to Follow-up|0|||
33523681|NCT03092791|101816246|FG002|Overall Study|Lost to Follow-up|0|||
33523682|NCT03092791|101816247|FG003|Overall Study|Lost to Follow-up|0|||
33523683|NCT03092791|101816248|FG004|Overall Study|Lost to Follow-up|0|||
33401973|NCT02194699|101361597|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
33523684|NCT03092791|101816249|FG005|Overall Study|Lost to Follow-up|0|||
33523685|NCT03092791|101816250|FG006|Overall Study|Lost to Follow-up|1|||
33523686|NCT03092791|101816251|FG007|Overall Study|Lost to Follow-up|0|||
33609670|NCT01052077|102123092|FG000|Phase B|Adverse Event|0|||
33609671|NCT01052077|102123093|FG001|Phase B|Adverse Event|9|||
33609672|NCT01052077|102123094|FG002|Phase B|Adverse Event|2|||
33609673|NCT01052077|102123095|FG003|Phase B|Adverse Event|0|||
33609674|NCT01052077|102123092|FG000|Phase B|Met Withdrawal Criteria|0|||
33609675|NCT01052077|102123093|FG001|Phase B|Met Withdrawal Criteria|2|||
33609676|NCT01052077|102123094|FG002|Phase B|Met Withdrawal Criteria|1|||
33609677|NCT01052077|102123095|FG003|Phase B|Met Withdrawal Criteria|0|||
33329987|NCT02871778|101101327|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
33329988|NCT02871778|101101328|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
33329989|NCT02871778|101101329|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
33329990|NCT02871778|101101330|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
33329991|NCT02871778|101101331|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
33329992|NCT02871778|101101332|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
33329993|NCT02871778|101101325|FG000|Part B: Treatment Period 3|Adverse Event|0|||
33329994|NCT02871778|101101326|FG001|Part B: Treatment Period 3|Adverse Event|0|||
33329995|NCT02871778|101101327|FG002|Part B: Treatment Period 3|Adverse Event|0|||
33329996|NCT02871778|101101328|FG003|Part B: Treatment Period 3|Adverse Event|0|||
33329997|NCT02871778|101101329|FG004|Part B: Treatment Period 3|Adverse Event|1|||
33329998|NCT02871778|101101330|FG005|Part B: Treatment Period 3|Adverse Event|1|||
33329999|NCT02871778|101101331|FG006|Part B: Treatment Period 3|Adverse Event|1|||
33330000|NCT02871778|101101332|FG007|Part B: Treatment Period 3|Adverse Event|0|||
33330001|NCT01517893|101104010|FG000|Overall Study|Withdrawal by Subject|3|||
33330002|NCT01517893|101104011|FG001|Overall Study|Withdrawal by Subject|0|||
33330003|NCT01999465|101104012|FG000|Overall Study|Lost to Follow-up|0|||
33330004|NCT01999465|101104013|FG001|Overall Study|Lost to Follow-up|2|||
33330005|NCT01999465|101104012|FG000|Overall Study|Protocol Violation|0|||
33523687|NCT03092791|101816244|FG000|Overall Study|Withdrawal of Consent|0|||
33523688|NCT03092791|101816245|FG001|Overall Study|Withdrawal of Consent|0|||
33609678|NCT01052077|102123092|FG000|Phase B|Physician Decision|0|||
33609679|NCT01052077|102123093|FG001|Phase B|Physician Decision|1|||
33609680|NCT01052077|102123094|FG002|Phase B|Physician Decision|1|||
33523689|NCT03092791|101816246|FG002|Overall Study|Withdrawal of Consent|0|||
33523690|NCT03092791|101816247|FG003|Overall Study|Withdrawal of Consent|0|||
33523691|NCT03092791|101816248|FG004|Overall Study|Withdrawal of Consent|4|||
33523692|NCT03092791|101816249|FG005|Overall Study|Withdrawal of Consent|12|||
33523693|NCT03092791|101816250|FG006|Overall Study|Withdrawal of Consent|6|||
33523694|NCT03092791|101816251|FG007|Overall Study|Withdrawal of Consent|4|||
33523695|NCT03092791|101816244|FG000|Overall Study|Study Termination|0|||
33523696|NCT03092791|101816245|FG001|Overall Study|Study Termination|0|||
33523697|NCT03092791|101816246|FG002|Overall Study|Study Termination|0|||
33330006|NCT01999465|101104013|FG001|Overall Study|Protocol Violation|1|||
33330007|NCT00876187|101104015|FG000|Overall Study|Adverse Event|14|||
33330008|NCT00876187|101104016|FG001|Overall Study|Adverse Event|12|||
33523698|NCT03092791|101816247|FG003|Overall Study|Study Termination|0|||
33523699|NCT03092791|101816248|FG004|Overall Study|Study Termination|55|||
33523700|NCT03092791|101816249|FG005|Overall Study|Study Termination|46|||
33523701|NCT03092791|101816250|FG006|Overall Study|Study Termination|53|||
33523702|NCT03092791|101816251|FG007|Overall Study|Study Termination|55|||
33523703|NCT03092791|101816244|FG000|Overall Study|Death|0|||
33523704|NCT03092791|101816245|FG001|Overall Study|Death|0|||
33401974|NCT02194699|101361598|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
33401975|NCT02194699|101361597|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
33401976|NCT02194699|101361598|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
33401977|NCT02194699|101361597|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
33401978|NCT02194699|101361598|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
33401979|NCT02194699|101361597|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
33401980|NCT02194699|101361598|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
33401981|NCT02194699|101361597|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
33401982|NCT02194699|101361598|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
33401983|NCT02698176|101361603|FG000|Overall Study|Progressive disease|4|||
33401984|NCT02698176|101361604|FG001|Overall Study|Progressive disease|3|||
33401985|NCT02698176|101361605|FG002|Overall Study|Progressive disease|1|||
33523705|NCT03092791|101816246|FG002|Overall Study|Death|0|||
33523706|NCT03092791|101816247|FG003|Overall Study|Death|0|||
33523707|NCT03092791|101816248|FG004|Overall Study|Death|0|||
33523708|NCT03092791|101816249|FG005|Overall Study|Death|1|||
33523709|NCT03092791|101816250|FG006|Overall Study|Death|0|||
33523710|NCT03092791|101816251|FG007|Overall Study|Death|1|||
33330009|NCT00876187|101104017|FG002|Overall Study|Adverse Event|19|||
33330010|NCT00876187|101104018|FG003|Overall Study|Adverse Event|29|||
33330011|NCT00876187|101104019|FG004|Overall Study|Adverse Event|10|||
33330012|NCT00876187|101104015|FG000|Overall Study|Lack of Efficacy|59|||
33330013|NCT00876187|101104016|FG001|Overall Study|Lack of Efficacy|34|||
33330014|NCT00876187|101104017|FG002|Overall Study|Lack of Efficacy|45|||
33330015|NCT00876187|101104018|FG003|Overall Study|Lack of Efficacy|34|||
33330016|NCT00876187|101104019|FG004|Overall Study|Lack of Efficacy|59|||
33330017|NCT00876187|101104015|FG000|Overall Study|Lost to Follow-up|9|||
33330018|NCT00876187|101104016|FG001|Overall Study|Lost to Follow-up|10|||
33401986|NCT02698176|101361606|FG003|Overall Study|Progressive disease|0|||
33523711|NCT03092791|101816244|FG000|Overall Study|Reason Not Specified|0|||
33523712|NCT03092791|101816245|FG001|Overall Study|Reason Not Specified|0|||
33523713|NCT03092791|101816246|FG002|Overall Study|Reason Not Specified|0|||
33523714|NCT03092791|101816247|FG003|Overall Study|Reason Not Specified|0|||
33523715|NCT03092791|101816248|FG004|Overall Study|Reason Not Specified|1|||
33523716|NCT03092791|101816249|FG005|Overall Study|Reason Not Specified|1|||
33523717|NCT03092791|101816250|FG006|Overall Study|Reason Not Specified|0|||
33523718|NCT03092791|101816251|FG007|Overall Study|Reason Not Specified|0|||
33523719|NCT01554163|101816253|FG000|Overall Study|Adverse Event|3|||
33523720|NCT01554163|101816254|FG001|Overall Study|Adverse Event|0|||
33523721|NCT01554163|101816253|FG000|Overall Study|Lack of Efficacy|1|||
33523722|NCT01554163|101816254|FG001|Overall Study|Lack of Efficacy|0|||
33523723|NCT01554163|101816253|FG000|Overall Study|Lost to Follow-up|1|||
33523724|NCT01554163|101816254|FG001|Overall Study|Lost to Follow-up|0|||
33523725|NCT01554163|101816253|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33523726|NCT01554163|101816254|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33523727|NCT01554163|101816253|FG000|Overall Study|Protocol Violation|0|||
33330019|NCT00876187|101104017|FG002|Overall Study|Lost to Follow-up|8|||
33330020|NCT00876187|101104018|FG003|Overall Study|Lost to Follow-up|8|||
33330021|NCT00876187|101104019|FG004|Overall Study|Lost to Follow-up|11|||
33401987|NCT02698176|101361603|FG000|Overall Study|Adverse Event|2|||
33523728|NCT01554163|101816254|FG001|Overall Study|Protocol Violation|4|||
33330022|NCT00876187|101104015|FG000|Overall Study|Protocol Violation|6|||
33330023|NCT00876187|101104016|FG001|Overall Study|Protocol Violation|7|||
33330024|NCT00876187|101104017|FG002|Overall Study|Protocol Violation|7|||
33523729|NCT01554163|101816253|FG000|Overall Study|Withdrawal by Subject|1|||
33523730|NCT01554163|101816254|FG001|Overall Study|Withdrawal by Subject|5|||
33523731|NCT01554163|101816253|FG000|Overall Study|Not Treated|1|||
33523732|NCT01554163|101816254|FG001|Overall Study|Not Treated|0|||
33523733|NCT03170609|101816255|FG000|Overall Study|Death|0|||
33523734|NCT03170609|101816256|FG001|Overall Study|Death|0|||
33523735|NCT03170609|101816257|FG002|Overall Study|Death|1|||
33523736|NCT03170609|101816258|FG003|Overall Study|Death|0|||
33523737|NCT03170609|101816259|FG004|Overall Study|Death|0|||
33523738|NCT03170609|101816260|FG005|Overall Study|Death|0|||
33523739|NCT03170609|101816261|FG006|Overall Study|Death|0|||
33523740|NCT03170609|101816255|FG000|Overall Study|Withdrawal by Subject|1|||
33523741|NCT03170609|101816256|FG001|Overall Study|Withdrawal by Subject|2|||
33523742|NCT03170609|101816257|FG002|Overall Study|Withdrawal by Subject|0|||
33523743|NCT03170609|101816258|FG003|Overall Study|Withdrawal by Subject|0|||
33523744|NCT03170609|101816259|FG004|Overall Study|Withdrawal by Subject|0|||
33523745|NCT03170609|101816260|FG005|Overall Study|Withdrawal by Subject|0|||
33523746|NCT03170609|101816261|FG006|Overall Study|Withdrawal by Subject|1|||
33523747|NCT03170609|101816255|FG000|Overall Study|Lost to Follow-up|1|||
33523748|NCT03170609|101816256|FG001|Overall Study|Lost to Follow-up|0|||
33523749|NCT03170609|101816257|FG002|Overall Study|Lost to Follow-up|5|||
33523750|NCT03170609|101816258|FG003|Overall Study|Lost to Follow-up|2|||
33523751|NCT03170609|101816259|FG004|Overall Study|Lost to Follow-up|1|||
33523752|NCT03170609|101816260|FG005|Overall Study|Lost to Follow-up|1|||
33523753|NCT03170609|101816261|FG006|Overall Study|Lost to Follow-up|0|||
33523754|NCT03170609|101816255|FG000|Overall Study|Other|1|||
33523755|NCT03170609|101816256|FG001|Overall Study|Other|0|||
33523756|NCT03170609|101816257|FG002|Overall Study|Other|0|||
33523757|NCT03170609|101816258|FG003|Overall Study|Other|0|||
33523758|NCT03170609|101816259|FG004|Overall Study|Other|0|||
33609681|NCT01052077|102123095|FG003|Phase B|Physician Decision|0|||
33609682|NCT01052077|102123092|FG000|Phase B|Withdrawal by Subject|0|||
33609683|NCT01052077|102123093|FG001|Phase B|Withdrawal by Subject|0|||
33609684|NCT01052077|102123094|FG002|Phase B|Withdrawal by Subject|5|||
33609685|NCT01052077|102123095|FG003|Phase B|Withdrawal by Subject|0|||
33609686|NCT01052077|102123092|FG000|Phase B|Protocol Deviation|0|||
33609687|NCT01052077|102123093|FG001|Phase B|Protocol Deviation|3|||
33609688|NCT01052077|102123094|FG002|Phase B|Protocol Deviation|4|||
33609689|NCT01052077|102123095|FG003|Phase B|Protocol Deviation|0|||
33609690|NCT01052077|102123092|FG000|Phase B|Lack of Efficacy|0|||
33609691|NCT01052077|102123093|FG001|Phase B|Lack of Efficacy|1|||
33201609|NCT01172938|100642681|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
33201610|NCT01172938|100642682|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
33330025|NCT00876187|101104018|FG003|Overall Study|Protocol Violation|6|||
33330026|NCT00876187|101104019|FG004|Overall Study|Protocol Violation|3|||
33330027|NCT00876187|101104015|FG000|Overall Study|Withdrawal by Subject|16|||
33330028|NCT00876187|101104016|FG001|Overall Study|Withdrawal by Subject|26|||
33330029|NCT00876187|101104017|FG002|Overall Study|Withdrawal by Subject|32|||
33330030|NCT00876187|101104018|FG003|Overall Study|Withdrawal by Subject|38|||
33330031|NCT00876187|101104019|FG004|Overall Study|Withdrawal by Subject|37|||
33330032|NCT00876187|101104015|FG000|Overall Study|Entered extension study|101|||
33330033|NCT00876187|101104016|FG001|Overall Study|Entered extension study|120|||
33401988|NCT02698176|101361604|FG001|Overall Study|Adverse Event|0|||
33401989|NCT02698176|101361605|FG002|Overall Study|Adverse Event|0|||
33401990|NCT02698176|101361606|FG003|Overall Study|Adverse Event|0|||
33401991|NCT02698176|101361603|FG000|Overall Study|Clinical progression|3|||
33401992|NCT02698176|101361604|FG001|Overall Study|Clinical progression|0|||
33401993|NCT02698176|101361605|FG002|Overall Study|Clinical progression|0|||
33401994|NCT02698176|101361606|FG003|Overall Study|Clinical progression|0|||
33330034|NCT00876187|101104017|FG002|Overall Study|Entered extension study|156|||
33330035|NCT00876187|101104018|FG003|Overall Study|Entered extension study|151|||
33330036|NCT00876187|101104019|FG004|Overall Study|Entered extension study|144|||
33330037|NCT00876187|101104015|FG000|Overall Study|Randomized but not treated|3|||
33523759|NCT03170609|101816260|FG005|Overall Study|Other|1|||
33523760|NCT03170609|101816261|FG006|Overall Study|Other|0|||
33523761|NCT02187029|101816262|FG000|Overall Study|Adverse Event|0|||
33523762|NCT02187029|101816263|FG001|Overall Study|Adverse Event|1|||
33523763|NCT02187029|101816264|FG002|Overall Study|Adverse Event|1|||
33523764|NCT02187029|101816265|FG003|Overall Study|Adverse Event|0|||
33523765|NCT02187029|101816262|FG000|Overall Study|Study Terminated by Sponsor|0|||
33523766|NCT02187029|101816263|FG001|Overall Study|Study Terminated by Sponsor|0|||
33609692|NCT01052077|102123094|FG002|Phase B|Lack of Efficacy|0|||
33609693|NCT01052077|102123095|FG003|Phase B|Lack of Efficacy|0|||
33609694|NCT01052077|102123092|FG000|Phase A+|Lost to Follow-up|0|||
33609695|NCT01052077|102123093|FG001|Phase A+|Lost to Follow-up|0|||
33609696|NCT01052077|102123094|FG002|Phase A+|Lost to Follow-up|0|||
33201611|NCT01172938|100642683|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
33330038|NCT00876187|101104016|FG001|Overall Study|Randomized but not treated|1|||
33401995|NCT01920061|101361608|FG000|Overall Study|Death|1|||
33401996|NCT01920061|101361609|FG001|Overall Study|Death|1|||
33401997|NCT01920061|101361610|FG002|Overall Study|Death|0|||
33523767|NCT02187029|101816264|FG002|Overall Study|Study Terminated by Sponsor|10|||
33523768|NCT02187029|101816265|FG003|Overall Study|Study Terminated by Sponsor|3|||
33609697|NCT01052077|102123095|FG003|Phase A+|Lost to Follow-up|8|||
33609698|NCT01052077|102123092|FG000|Phase A+|Adverse Event|0|||
33330039|NCT00876187|101104017|FG002|Overall Study|Randomized but not treated|3|||
33330040|NCT00876187|101104018|FG003|Overall Study|Randomized but not treated|2|||
33330041|NCT00876187|101104019|FG004|Overall Study|Randomized but not treated|3|||
33330042|NCT00876187|101104015|FG000|Overall Study|Other|2|||
33330043|NCT00876187|101104016|FG001|Overall Study|Other|5|||
33330044|NCT00876187|101104017|FG002|Overall Study|Other|9|||
33523769|NCT02187029|101816262|FG000|Overall Study|Withdrawal by Subject|1|||
33523770|NCT02187029|101816263|FG001|Overall Study|Withdrawal by Subject|0|||
33523771|NCT02187029|101816264|FG002|Overall Study|Withdrawal by Subject|0|||
33523772|NCT02187029|101816265|FG003|Overall Study|Withdrawal by Subject|0|||
33523773|NCT03337048|101816269|FG000|Overall Study|Withdrawal by Subject|2|||
33523774|NCT03337048|101816270|FG001|Overall Study|Withdrawal by Subject|0|||
33523775|NCT03337048|101816271|FG002|Overall Study|Withdrawal by Subject|0|||
33523776|NCT01588405|101816272|FG000|Overall Study|Adverse Event|1|||
33523777|NCT01588405|101816272|FG000|Overall Study|Clinical Worsening|1|||
33201612|NCT01172938|100642675|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
33201613|NCT01172938|100642676|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33201614|NCT01172938|100642677|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33330045|NCT00876187|101104018|FG003|Overall Study|Other|7|||
33330046|NCT00876187|101104019|FG004|Overall Study|Other|4|||
33523778|NCT00994214|101816275|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
33523779|NCT00994214|101816276|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
33523780|NCT00994214|101816277|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
33523781|NCT00994214|101816278|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
33523782|NCT00994214|101816275|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
33523783|NCT00994214|101816276|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
33523784|NCT00994214|101816277|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
33523785|NCT00994214|101816278|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
33523786|NCT00994214|101816275|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
33523787|NCT00994214|101816276|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
33523788|NCT00994214|101816277|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
33523789|NCT00994214|101816278|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
33523790|NCT00994214|101816275|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
33523791|NCT00994214|101816276|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
33523792|NCT00994214|101816277|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
33523793|NCT00994214|101816278|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
33523794|NCT00994214|101816275|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
33523795|NCT00994214|101816276|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
33523796|NCT00994214|101816277|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
33523797|NCT00994214|101816278|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
33523798|NCT00994214|101816275|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
33523799|NCT00994214|101816276|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
33523800|NCT00994214|101816277|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
33523801|NCT00994214|101816278|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
33523802|NCT01270321|101816279|FG000|Overall Study|Death|3|||
33523803|NCT01270321|101816280|FG001|Overall Study|Death|1|||
33523804|NCT01270321|101816281|FG002|Overall Study|Death|4|||
33523805|NCT01270321|101816279|FG000|Overall Study|Adverse Event|7|||
33523806|NCT01270321|101816280|FG001|Overall Study|Adverse Event|9|||
33523807|NCT01270321|101816281|FG002|Overall Study|Adverse Event|5|||
33523808|NCT01017601|101816282|FG000|Overall Study|Disease Progression|12|||
33523809|NCT01017601|101816283|FG001|Overall Study|Disease Progression|12|||
33523810|NCT01017601|101816282|FG000|Overall Study|Withdrawal by Subject|0|||
33523811|NCT01017601|101816283|FG001|Overall Study|Withdrawal by Subject|1|||
33523812|NCT01390428|101816284|FG000|Overall Study|Elective Surgery|0|||
33523813|NCT01390428|101816285|FG001|Overall Study|Elective Surgery|0|||
33523814|NCT01390428|101816286|FG002|Overall Study|Elective Surgery|0|||
33523815|NCT01390428|101816287|FG003|Overall Study|Elective Surgery|0|||
33523816|NCT01390428|101816288|FG004|Overall Study|Elective Surgery|1|||
33330047|NCT03200366|101104020|FG000|Patient Navigation Intervention Given|Death|0|||
33330048|NCT03200366|101104021|FG001|Patient Navigation Intervention Given|Death|2|||
33330049|NCT03200366|101104022|FG002|Patient Navigation Intervention Given|Death|0|||
33201615|NCT01172938|100642678|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33201616|NCT01172938|100642679|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33330050|NCT03200366|101104020|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
33330051|NCT03200366|101104021|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
33330052|NCT03200366|101104022|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
33330053|NCT03200366|101104020|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
33330054|NCT03200366|101104021|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
33330055|NCT03200366|101104022|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
33330056|NCT03200366|101104020|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
33330057|NCT03200366|101104021|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
33201617|NCT01172938|100642680|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33201618|NCT01172938|100642681|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33201619|NCT01172938|100642682|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33201620|NCT01172938|100642683|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33201621|NCT01172938|100642675|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
33201622|NCT01172938|100642676|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
33201623|NCT01172938|100642677|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
33330058|NCT03200366|101104022|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
33330059|NCT03200366|101104020|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
33330060|NCT03200366|101104021|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
33330061|NCT03200366|101104022|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
33330062|NCT03200366|101104020|FG000|6 Month Post-Baseline Interview|Death|1|||
33523817|NCT01390428|101816289|FG005|Overall Study|Elective Surgery|0|||
33523818|NCT01390428|101816284|FG000|Overall Study|Withdrawal by Subject|0|||
33523819|NCT01390428|101816285|FG001|Overall Study|Withdrawal by Subject|0|||
33523820|NCT01390428|101816286|FG002|Overall Study|Withdrawal by Subject|1|||
33523821|NCT01390428|101816287|FG003|Overall Study|Withdrawal by Subject|0|||
33523822|NCT01390428|101816288|FG004|Overall Study|Withdrawal by Subject|0|||
33523823|NCT01390428|101816289|FG005|Overall Study|Withdrawal by Subject|0|||
33523824|NCT00913770|101816290|FG000|Overall Study|Unable to contact|24|||
33523825|NCT00913770|101816291|FG001|Overall Study|Unable to contact|19|||
33523826|NCT00913770|101816292|FG002|Overall Study|Unable to contact|13|||
33330063|NCT03200366|101104021|FG001|6 Month Post-Baseline Interview|Death|1|||
33330064|NCT03200366|101104022|FG002|6 Month Post-Baseline Interview|Death|1|||
33330065|NCT03200366|101104020|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
33330066|NCT03200366|101104021|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
33330067|NCT03200366|101104022|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
33330068|NCT03200366|101104020|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
33330069|NCT03200366|101104021|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
33523827|NCT00913770|101816290|FG000|Overall Study|Refused|11|||
33523828|NCT00913770|101816291|FG001|Overall Study|Refused|10|||
33523829|NCT00913770|101816292|FG002|Overall Study|Refused|8|||
33330070|NCT03200366|101104022|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
33330071|NCT03200366|101104020|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
33330072|NCT03200366|101104021|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
33330073|NCT03200366|101104022|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
33330074|NCT03200366|101104020|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
33330075|NCT03200366|101104021|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
33330076|NCT03200366|101104022|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
33330077|NCT03200366|101104020|FG000|9 Month Post-Baseline Interview|Death|1|||
33330078|NCT03200366|101104021|FG001|9 Month Post-Baseline Interview|Death|1|||
33330079|NCT03200366|101104022|FG002|9 Month Post-Baseline Interview|Death|1|||
33330080|NCT03200366|101104020|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
33330081|NCT03200366|101104021|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
33330082|NCT03200366|101104022|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
33401998|NCT01920061|101361611|FG003|Overall Study|Death|1|||
33523830|NCT02913105|101816293|FG000|Overall Study|Adverse Event|11|||
33523831|NCT02913105|101816294|FG001|Overall Study|Adverse Event|0|||
33523832|NCT02913105|101816295|FG002|Overall Study|Adverse Event|4|||
33523833|NCT02913105|101816293|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33523834|NCT02913105|101816294|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33523835|NCT02913105|101816295|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33523836|NCT02913105|101816293|FG000|Overall Study|Reason Not Specified|3|||
33523837|NCT02913105|101816294|FG001|Overall Study|Reason Not Specified|1|||
33523838|NCT02913105|101816295|FG002|Overall Study|Reason Not Specified|1|||
33523839|NCT02913105|101816293|FG000|Overall Study|Physician Decision|1|||
33201624|NCT01172938|100642678|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
33201625|NCT01172938|100642679|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
33201626|NCT01172938|100642680|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
33523840|NCT02913105|101816294|FG001|Overall Study|Physician Decision|1|||
33523841|NCT02913105|101816295|FG002|Overall Study|Physician Decision|0|||
33523842|NCT02913105|101816293|FG000|Overall Study|Withdrawal by Subject|0|||
33523843|NCT02913105|101816294|FG001|Overall Study|Withdrawal by Subject|3|||
33523844|NCT02913105|101816295|FG002|Overall Study|Withdrawal by Subject|1|||
33523845|NCT01038752|101816296|FG000|Overall Study|Tumor Progression|2|||
33523846|NCT01038752|101816297|FG001|Overall Study|Tumor Progression|2|||
33523847|NCT01038752|101816296|FG000|Overall Study|Lost to Follow-up|3|||
33523848|NCT01038752|101816297|FG001|Overall Study|Lost to Follow-up|3|||
33523849|NCT00135356|101816298|FG000|Overall Study|Adverse Event|6|||
33523850|NCT00135356|101816299|FG001|Overall Study|Adverse Event|2|||
33523851|NCT00135356|101816298|FG000|Overall Study|Lack of Efficacy|2|||
33523852|NCT00135356|101816299|FG001|Overall Study|Lack of Efficacy|0|||
33523853|NCT00135356|101816298|FG000|Overall Study|Lost to Follow-up|3|||
33523854|NCT00135356|101816299|FG001|Overall Study|Lost to Follow-up|1|||
33523855|NCT00135356|101816298|FG000|Overall Study|Surgery for abdominal fat|1|||
33523856|NCT00135356|101816299|FG001|Overall Study|Surgery for abdominal fat|0|||
33523857|NCT00135356|101816298|FG000|Overall Study|Change in antiviral regimen|0|||
33523858|NCT00135356|101816299|FG001|Overall Study|Change in antiviral regimen|1|||
33523859|NCT00135356|101816298|FG000|Overall Study|Poor/noncompliance|1|||
33523860|NCT00135356|101816299|FG001|Overall Study|Poor/noncompliance|1|||
33523861|NCT00135356|101816298|FG000|Overall Study|No longer meets study criteria|2|||
33523862|NCT00135356|101816299|FG001|Overall Study|No longer meets study criteria|0|||
33523863|NCT00135356|101816298|FG000|Overall Study|Withdrawal by Subject|2|||
33523864|NCT00135356|101816299|FG001|Overall Study|Withdrawal by Subject|4|||
33523865|NCT02155322|101816304|FG000|Overall Study|Adverse Event|1|||
33523866|NCT02155322|101816304|FG000|Overall Study|Physician Decision|1|||
33523867|NCT02155322|101816304|FG000|Overall Study|Relapse/Recurrence|8|||
33523868|NCT02155322|101816304|FG000|Overall Study|Withdrawal by Subject|4|||
33523869|NCT01108237|101816305|FG000|Overall Study|No alignment data|2|||
33523870|NCT01108237|101816306|FG001|Overall Study|No alignment data|15|||
33523871|NCT01108237|101816305|FG000|Overall Study|Did not meet criteria for analysis|7|||
33523872|NCT01108237|101816306|FG001|Overall Study|Did not meet criteria for analysis|0|||
33523873|NCT03628716|101816307|FG000|Overall Study|Adverse Event|1|||
33523874|NCT03628716|101816308|FG001|Overall Study|Adverse Event|1|||
33201627|NCT01172938|100642681|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
33330083|NCT03200366|101104020|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
33330084|NCT03200366|101104021|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
33330085|NCT03200366|101104022|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
33523875|NCT03628716|101816307|FG000|Overall Study|Death|1|||
33523876|NCT03628716|101816308|FG001|Overall Study|Death|0|||
33523877|NCT03628716|101816307|FG000|Overall Study|Lack of Efficacy|15|||
33523878|NCT03628716|101816308|FG001|Overall Study|Lack of Efficacy|20|||
33523879|NCT03628716|101816307|FG000|Overall Study|Withdrawal by Subject|1|||
33523880|NCT03628716|101816308|FG001|Overall Study|Withdrawal by Subject|2|||
33609699|NCT01052077|102123093|FG001|Phase A+|Adverse Event|0|||
33609700|NCT01052077|102123094|FG002|Phase A+|Adverse Event|0|||
33609701|NCT01052077|102123095|FG003|Phase A+|Adverse Event|4|||
33330086|NCT03200366|101104020|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
33330087|NCT03200366|101104021|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
33330088|NCT03200366|101104022|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
33330089|NCT00800436|101104023|FG000|Overall Study|Withdrawal by Subject|0|||
33330090|NCT00800436|101104024|FG001|Overall Study|Withdrawal by Subject|0|||
33330091|NCT00800436|101104025|FG002|Overall Study|Withdrawal by Subject|1|||
33330092|NCT00800436|101104026|FG003|Overall Study|Withdrawal by Subject|1|||
33330093|NCT00800436|101104027|FG004|Overall Study|Withdrawal by Subject|0|||
33330094|NCT00800436|101104028|FG005|Overall Study|Withdrawal by Subject|0|||
33330095|NCT00800436|101104029|FG006|Overall Study|Withdrawal by Subject|0|||
33330096|NCT00841568|101104030|FG000|Overall Study|Adverse Event|1|||
33330097|NCT00841568|101104030|FG000|Overall Study|Death|1|||
33330098|NCT00841568|101104030|FG000|Overall Study|Withdrawal by Subject|2|||
33330099|NCT00841568|101104030|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
33330100|NCT00632099|101104035|FG000|Overall Study|Lost to Follow-up|3|||
33523881|NCT03628716|101816307|FG000|Overall Study|Study Terminated by Sponsor|1|||
33523882|NCT03628716|101816308|FG001|Overall Study|Study Terminated by Sponsor|0|||
33523883|NCT03313310|101816309|FG000|Phase 2|Lost to Follow-up|4|||
33523884|NCT03313310|101816310|FG001|Phase 2|Lost to Follow-up|0|||
33609702|NCT01052077|102123092|FG000|Phase A+|Met Withdrawal Criteria|0|||
33523885|NCT03313310|101816309|FG000|Phase 3|Lost to Follow-up|0|||
33523886|NCT03313310|101816310|FG001|Phase 3|Lost to Follow-up|1|||
33523887|NCT02588092|101816315|FG000|Overall Study|Death|4|||
33523888|NCT02588092|101816316|FG001|Overall Study|Death|3|||
33523889|NCT02588092|101816317|FG002|Overall Study|Death|3|||
33523890|NCT02588092|101816318|FG003|Overall Study|Death|3|||
33523891|NCT02588092|101816319|FG004|Overall Study|Death|2|||
33523892|NCT02588092|101816320|FG005|Overall Study|Death|2|||
33523893|NCT02588092|101816321|FG006|Overall Study|Death|2|||
33523894|NCT02588092|101816322|FG007|Overall Study|Death|1|||
33609703|NCT01052077|102123093|FG001|Phase A+|Met Withdrawal Criteria|0|||
33330101|NCT00632099|101104036|FG001|Overall Study|Lost to Follow-up|3|||
33330102|NCT00473343|101104038|FG000|Overall Study|Adverse Event|9|||
33330103|NCT00473343|101104038|FG000|Overall Study|Lost to Follow-up|8|||
33330104|NCT00473343|101104038|FG000|Overall Study|Treatment failure|27|||
33330105|NCT00473343|101104038|FG000|Overall Study|Withdrew consent|3|||
33330106|NCT00473343|101104038|FG000|Overall Study|Other un-specified reason|3|||
33330107|NCT04518462|101104039|FG000|Overall Study|Withdrawal by Subject|0|||
33330108|NCT04518462|101104040|FG001|Overall Study|Withdrawal by Subject|0|||
33330109|NCT04518462|101104041|FG002|Overall Study|Withdrawal by Subject|1|||
33330110|NCT04518462|101104039|FG000|Overall Study|Physician Decision|1|||
33330111|NCT04518462|101104040|FG001|Overall Study|Physician Decision|1|||
33330112|NCT04518462|101104041|FG002|Overall Study|Physician Decision|0|||
33330113|NCT00402649|101104043|FG000|Overall Study|Lost to Follow-up|1|||
33330114|NCT00402649|101104043|FG000|Overall Study|Withdrawal by Subject|1|||
33523895|NCT02588092|101816323|FG008|Overall Study|Death|5|||
33523896|NCT02588092|101816324|FG009|Overall Study|Death|2|||
33523897|NCT02588092|101816315|FG000|Overall Study|Withdrawal by Subject|0|||
33523898|NCT02588092|101816316|FG001|Overall Study|Withdrawal by Subject|0|||
33523899|NCT02588092|101816317|FG002|Overall Study|Withdrawal by Subject|0|||
33523900|NCT02588092|101816318|FG003|Overall Study|Withdrawal by Subject|0|||
33523901|NCT02588092|101816319|FG004|Overall Study|Withdrawal by Subject|0|||
33523902|NCT02588092|101816320|FG005|Overall Study|Withdrawal by Subject|1|||
33523903|NCT02588092|101816321|FG006|Overall Study|Withdrawal by Subject|1|||
33523904|NCT02588092|101816322|FG007|Overall Study|Withdrawal by Subject|2|||
33523905|NCT02588092|101816323|FG008|Overall Study|Withdrawal by Subject|0|||
33523906|NCT02588092|101816324|FG009|Overall Study|Withdrawal by Subject|0|||
33523907|NCT02588092|101816315|FG000|Overall Study|Started Another Treatment|0|||
33523908|NCT02588092|101816316|FG001|Overall Study|Started Another Treatment|0|||
33523909|NCT02588092|101816317|FG002|Overall Study|Started Another Treatment|0|||
33523910|NCT02588092|101816318|FG003|Overall Study|Started Another Treatment|0|||
33523911|NCT02588092|101816319|FG004|Overall Study|Started Another Treatment|1|||
33523912|NCT02588092|101816320|FG005|Overall Study|Started Another Treatment|0|||
33523913|NCT02588092|101816321|FG006|Overall Study|Started Another Treatment|0|||
33523914|NCT02588092|101816322|FG007|Overall Study|Started Another Treatment|1|||
33523915|NCT02588092|101816323|FG008|Overall Study|Started Another Treatment|0|||
33523916|NCT02588092|101816324|FG009|Overall Study|Started Another Treatment|0|||
33523917|NCT02588092|101816315|FG000|Overall Study|Sponsor Decision|0|||
33523918|NCT02588092|101816316|FG001|Overall Study|Sponsor Decision|0|||
33523919|NCT02588092|101816317|FG002|Overall Study|Sponsor Decision|0|||
33523920|NCT02588092|101816318|FG003|Overall Study|Sponsor Decision|0|||
33523921|NCT02588092|101816319|FG004|Overall Study|Sponsor Decision|0|||
33523922|NCT02588092|101816320|FG005|Overall Study|Sponsor Decision|0|||
33523923|NCT02588092|101816321|FG006|Overall Study|Sponsor Decision|0|||
33330115|NCT02839265|101104044|FG000|Overall Study|Screen Failure|2|||
33330116|NCT02839265|101104044|FG000|Overall Study|Death|1|||
33330117|NCT02839265|101104044|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
33330118|NCT00393887|101104046|FG000|Overall Study|Physician Decision|5|||
33401999|NCT01920061|101361612|FG004|Overall Study|Death|1|||
33402000|NCT01920061|101361613|FG005|Overall Study|Death|0|||
33402001|NCT01920061|101361614|FG006|Overall Study|Death|0|||
33402002|NCT01920061|101361615|FG007|Overall Study|Death|1|||
33402003|NCT01920061|101361616|FG008|Overall Study|Death|0|||
33402004|NCT01920061|101361617|FG009|Overall Study|Death|1|||
33402005|NCT01920061|101361618|FG010|Overall Study|Death|0|||
33402006|NCT01920061|101361619|FG011|Overall Study|Death|1|||
33402007|NCT01920061|101361620|FG012|Overall Study|Death|0|||
33402008|NCT01920061|101361621|FG013|Overall Study|Death|2|||
33402009|NCT01920061|101361622|FG014|Overall Study|Death|0|||
33330119|NCT00393887|101104047|FG001|Overall Study|Physician Decision|0|||
33330120|NCT00393887|101104046|FG000|Overall Study|Lost to Follow-up|11|||
33330121|NCT00393887|101104047|FG001|Overall Study|Lost to Follow-up|9|||
33330122|NCT03631784|101104050|FG000|Overall Study|Death|48|||
33330123|NCT03631784|101104051|FG001|Overall Study|Death|28|||
33330124|NCT03631784|101104050|FG000|Overall Study|Lost to Follow-up|1|||
33330125|NCT03631784|101104051|FG001|Overall Study|Lost to Follow-up|0|||
33523924|NCT02588092|101816322|FG007|Overall Study|Sponsor Decision|0|||
33523925|NCT02588092|101816323|FG008|Overall Study|Sponsor Decision|1|||
33523926|NCT02588092|101816324|FG009|Overall Study|Sponsor Decision|1|||
33330126|NCT03631784|101104050|FG000|Overall Study|Withdrawal by Subject|0|||
33330127|NCT03631784|101104051|FG001|Overall Study|Withdrawal by Subject|3|||
33402010|NCT01920061|101361623|FG015|Overall Study|Death|0|||
33402011|NCT01920061|101361624|FG016|Overall Study|Death|0|||
33402012|NCT01920061|101361625|FG017|Overall Study|Death|0|||
33523927|NCT03034135|101816325|FG000|Overall Study|Withdrawal by Subject|2|||
33523928|NCT02769312|101816326|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
33523929|NCT02769312|101816327|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
33523930|NCT02769312|101816326|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
33523931|NCT02769312|101816327|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
33402013|NCT01920061|101361626|FG018|Overall Study|Death|1|||
33402014|NCT01920061|101361627|FG019|Overall Study|Death|0|||
33402015|NCT01920061|101361608|FG000|Overall Study|Lost to Follow-up|0|||
33402016|NCT01920061|101361609|FG001|Overall Study|Lost to Follow-up|2|||
33330128|NCT03631784|101104050|FG000|Overall Study|Participants Ongoing|63|||
33330129|NCT03631784|101104051|FG001|Overall Study|Participants Ongoing|71|||
33330130|NCT00923130|101104052|FG000|Overall Study|Stopped treatment due to progression|17|||
33330131|NCT00923130|101104052|FG000|Overall Study|Death|1|||
33330132|NCT00923130|101104052|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
33330133|NCT00923130|101104052|FG000|Overall Study|Switched to alternative treatment|2|||
33330134|NCT00923130|101104052|FG000|Overall Study|Refused further treatment|2|||
33330135|NCT00257725|101104053|FG000|Overall Study|Adverse Event|3|||
33330136|NCT02716987|101104054|FG000|Overall Study|Ligand synthesis failure|0|||
33330137|NCT02716987|101104055|FG001|Overall Study|Ligand synthesis failure|0|||
33330138|NCT02716987|101104056|FG002|Overall Study|Ligand synthesis failure|1|||
33330139|NCT02716987|101104057|FG003|Overall Study|Ligand synthesis failure|0|||
33330140|NCT02716987|101104058|FG004|Overall Study|Ligand synthesis failure|0|||
33523932|NCT02769312|101816326|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
33523933|NCT02769312|101816327|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
33523934|NCT02769312|101816326|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
33523935|NCT02769312|101816327|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
33523936|NCT02769312|101816326|FG000|Follow-up|Lost to Follow-up|1|||
33523937|NCT02769312|101816327|FG001|Follow-up|Lost to Follow-up|1|||
33523938|NCT03089853|101816328|FG000|Overall Study|Lost to Follow-up|2|||
33523939|NCT03089853|101816329|FG001|Overall Study|Lost to Follow-up|1|||
33523940|NCT01204918|101816332|FG000|Overall Study|Withdrawal by Subject|4|||
33523941|NCT01204918|101816333|FG001|Overall Study|Withdrawal by Subject|10|||
33523942|NCT01204918|101816334|FG002|Overall Study|Withdrawal by Subject|5|||
33523943|NCT04424914|101816337|FG000|Overall Study|Other|0|||
33523944|NCT04424914|101816338|FG001|Overall Study|Other|0|||
33523945|NCT04424914|101816339|FG002|Overall Study|Other|28|||
33523946|NCT04424914|101816337|FG000|Overall Study|Withdrawal by Subject|3|||
33402017|NCT01920061|101361610|FG002|Overall Study|Lost to Follow-up|0|||
33402018|NCT01920061|101361611|FG003|Overall Study|Lost to Follow-up|0|||
33402019|NCT01920061|101361612|FG004|Overall Study|Lost to Follow-up|0|||
33523947|NCT04424914|101816338|FG001|Overall Study|Withdrawal by Subject|0|||
33609704|NCT01052077|102123094|FG002|Phase A+|Met Withdrawal Criteria|0|||
33609705|NCT01052077|102123095|FG003|Phase A+|Met Withdrawal Criteria|2|||
33609706|NCT01052077|102123092|FG000|Phase A+|Withdrawal by Subject|0|||
33609707|NCT01052077|102123093|FG001|Phase A+|Withdrawal by Subject|0|||
33609708|NCT01052077|102123094|FG002|Phase A+|Withdrawal by Subject|0|||
33609709|NCT01052077|102123095|FG003|Phase A+|Withdrawal by Subject|7|||
33330141|NCT02716987|101104059|FG005|Overall Study|Ligand synthesis failure|0|||
33330142|NCT02716987|101104054|FG000|Overall Study|Withdrawal by Subject|0|||
33523948|NCT04424914|101816339|FG002|Overall Study|Withdrawal by Subject|0|||
33523949|NCT04424914|101816337|FG000|Overall Study|Study terminated by sponsor|23|||
33523950|NCT04424914|101816338|FG001|Overall Study|Study terminated by sponsor|7|||
33523951|NCT04424914|101816339|FG002|Overall Study|Study terminated by sponsor|0|||
33523952|NCT04424914|101816337|FG000|Overall Study|Lost to Follow-up|0|||
33330143|NCT02716987|101104055|FG001|Overall Study|Withdrawal by Subject|0|||
33523953|NCT04424914|101816338|FG001|Overall Study|Lost to Follow-up|0|||
33523954|NCT04424914|101816339|FG002|Overall Study|Lost to Follow-up|1|||
33523955|NCT04424914|101816337|FG000|Overall Study|Death|3|||
33523956|NCT04424914|101816338|FG001|Overall Study|Death|1|||
33523957|NCT04424914|101816339|FG002|Overall Study|Death|0|||
33523958|NCT01777139|101816341|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
33523959|NCT01777139|101816342|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
33523960|NCT01777139|101816341|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
33523961|NCT01777139|101816342|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
33523962|NCT01777139|101816341|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
33523963|NCT01777139|101816342|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
33523964|NCT01777139|101816341|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
33523965|NCT01777139|101816342|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
33523966|NCT01777139|101816341|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
33609710|NCT00527982|102123098|FG000|Overall Study|Physician Decision|1|||
33330144|NCT02716987|101104056|FG002|Overall Study|Withdrawal by Subject|0|||
33330145|NCT02716987|101104057|FG003|Overall Study|Withdrawal by Subject|0|||
33330146|NCT02716987|101104058|FG004|Overall Study|Withdrawal by Subject|1|||
33330147|NCT02716987|101104059|FG005|Overall Study|Withdrawal by Subject|1|||
33402020|NCT01920061|101361613|FG005|Overall Study|Lost to Follow-up|0|||
33523967|NCT01777139|101816342|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
33523968|NCT01777139|101816341|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
33523969|NCT01777139|101816342|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
33523970|NCT01777139|101816341|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
33609711|NCT00527982|102123099|FG001|Overall Study|Physician Decision|0|||
33330148|NCT01560780|101104064|FG000|Overall Study|Death|2|||
33330149|NCT01560780|101104065|FG001|Overall Study|Death|1|||
33330150|NCT01560780|101104064|FG000|Overall Study|Patient Preference|11|||
33330151|NCT01560780|101104065|FG001|Overall Study|Patient Preference|11|||
33330152|NCT01230242|101104070|FG000|Overall Study|Physician Decision|2|||
33330153|NCT01230242|101104070|FG000|Overall Study|Withdrawal by Subject|1|||
33330154|NCT02369848|101104073|FG000|Overall Study|Death|1|||
33330155|NCT02369848|101104073|FG000|Overall Study|Withdrawal by Subject|2|||
33330156|NCT02369848|101104073|FG000|Overall Study|Lost to Follow-up|1|||
33330157|NCT02159729|101104076|FG000|Overall Study|Adverse Event|0|||
33330158|NCT02159729|101104077|FG001|Overall Study|Adverse Event|1|||
33330159|NCT02159729|101104076|FG000|Overall Study|Subject's Request|13|||
33330160|NCT02159729|101104077|FG001|Overall Study|Subject's Request|10|||
33330161|NCT02159729|101104076|FG000|Overall Study|Lost to Follow-up|24|||
33330162|NCT02159729|101104077|FG001|Overall Study|Lost to Follow-up|9|||
33330163|NCT02159729|101104076|FG000|Overall Study|Non compliance|2|||
33330164|NCT02159729|101104077|FG001|Overall Study|Non compliance|0|||
33330165|NCT02159729|101104076|FG000|Overall Study|Other Unspecified|3|||
33330166|NCT02159729|101104077|FG001|Overall Study|Other Unspecified|1|||
33330167|NCT00825162|101104078|FG000|Overall Study|Withdrawal by Subject|11|||
33330168|NCT00825162|101104079|FG001|Overall Study|Withdrawal by Subject|13|||
33330169|NCT00825162|101104080|FG002|Overall Study|Withdrawal by Subject|3|||
33523971|NCT01777139|101816342|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
33523972|NCT01777139|101816341|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
33523973|NCT01777139|101816342|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
33523974|NCT01905592|101816343|FG000|Overall Study|Disease Progression|51|||
33523975|NCT01905592|101816344|FG001|Overall Study|Disease Progression|110|||
33523976|NCT01905592|101816343|FG000|Overall Study|Toxicity|1|||
33402021|NCT01920061|101361614|FG006|Overall Study|Lost to Follow-up|1|||
33402022|NCT01920061|101361615|FG007|Overall Study|Lost to Follow-up|0|||
33402023|NCT01920061|101361616|FG008|Overall Study|Lost to Follow-up|0|||
33402024|NCT01920061|101361617|FG009|Overall Study|Lost to Follow-up|0|||
33523977|NCT01905592|101816344|FG001|Overall Study|Toxicity|16|||
33523978|NCT01905592|101816343|FG000|Overall Study|Physician Decision|0|||
33330170|NCT00825162|101104078|FG000|Overall Study|Lost to Follow-up|9|||
33330171|NCT00825162|101104079|FG001|Overall Study|Lost to Follow-up|6|||
33330172|NCT00825162|101104080|FG002|Overall Study|Lost to Follow-up|3|||
33330173|NCT00825162|101104078|FG000|Overall Study|Physician Decision|2|||
33330174|NCT00825162|101104079|FG001|Overall Study|Physician Decision|0|||
33330175|NCT00825162|101104080|FG002|Overall Study|Physician Decision|0|||
33330176|NCT00825162|101104078|FG000|Overall Study|Move away from the study area|1|||
33330177|NCT00825162|101104079|FG001|Overall Study|Move away from the study area|0|||
33330178|NCT00825162|101104080|FG002|Overall Study|Move away from the study area|0|||
33330179|NCT00825162|101104078|FG000|Overall Study|Unable to attend the study visit|5|||
33330180|NCT00825162|101104079|FG001|Overall Study|Unable to attend the study visit|2|||
33330181|NCT00825162|101104080|FG002|Overall Study|Unable to attend the study visit|0|||
33330182|NCT04013529|101104081|FG000|Overall Study|Withdrawal by Subject|1|||
33330183|NCT04013529|101104082|FG001|Overall Study|Withdrawal by Subject|1|||
33330184|NCT03016325|101104083|FG000|Treatment Period|Participant withdrew consent|0|||
33330185|NCT03016325|101104084|FG001|Treatment Period|Participant withdrew consent|1|||
33330186|NCT03016325|101104085|FG002|Treatment Period|Participant withdrew consent|0|||
33330187|NCT03016325|101104086|FG003|Treatment Period|Participant withdrew consent|0|||
33330188|NCT03016325|101104087|FG004|Treatment Period|Participant withdrew consent|0|||
33330189|NCT03016325|101104088|FG005|Treatment Period|Participant withdrew consent|0|||
33330190|NCT03016325|101104089|FG006|Treatment Period|Participant withdrew consent|0|||
33330191|NCT03016325|101104090|FG007|Treatment Period|Participant withdrew consent|0|||
33330192|NCT03016325|101104083|FG000|Treatment Period|Death|0|||
33330193|NCT03016325|101104084|FG001|Treatment Period|Death|0|||
33330194|NCT03016325|101104085|FG002|Treatment Period|Death|0|||
33330195|NCT03016325|101104086|FG003|Treatment Period|Death|0|||
33330196|NCT03016325|101104087|FG004|Treatment Period|Death|2|||
33330197|NCT03016325|101104088|FG005|Treatment Period|Death|0|||
33330198|NCT03016325|101104089|FG006|Treatment Period|Death|0|||
33330199|NCT03016325|101104090|FG007|Treatment Period|Death|0|||
33330200|NCT03016325|101104083|FG000|Treatment Period|Participant refuses assessments|0|||
33330201|NCT03016325|101104084|FG001|Treatment Period|Participant refuses assessments|0|||
33330202|NCT03016325|101104085|FG002|Treatment Period|Participant refuses assessments|1|||
33330203|NCT03016325|101104086|FG003|Treatment Period|Participant refuses assessments|0|||
33330204|NCT03016325|101104087|FG004|Treatment Period|Participant refuses assessments|0|||
33330205|NCT03016325|101104088|FG005|Treatment Period|Participant refuses assessments|0|||
33402025|NCT01920061|101361618|FG010|Overall Study|Lost to Follow-up|3|||
33523979|NCT01905592|101816344|FG001|Overall Study|Physician Decision|2|||
33523980|NCT01905592|101816343|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
33609712|NCT01406015|102123100|FG000|Overall Study|Withdrawal by Subject|3|||
33330206|NCT03016325|101104089|FG006|Treatment Period|Participant refuses assessments|0|||
33330207|NCT03016325|101104090|FG007|Treatment Period|Participant refuses assessments|0|||
33330208|NCT03016325|101104083|FG000|32-Day Follow-Up Period|Death|2|||
33330209|NCT03016325|101104084|FG001|32-Day Follow-Up Period|Death|0|||
33330210|NCT03016325|101104085|FG002|32-Day Follow-Up Period|Death|5|||
33330211|NCT03016325|101104086|FG003|32-Day Follow-Up Period|Death|6|||
33330212|NCT03016325|101104087|FG004|32-Day Follow-Up Period|Death|3|||
33330213|NCT03016325|101104088|FG005|32-Day Follow-Up Period|Death|0|||
33330214|NCT03016325|101104089|FG006|32-Day Follow-Up Period|Death|0|||
33330215|NCT03016325|101104090|FG007|32-Day Follow-Up Period|Death|0|||
33330216|NCT03016325|101104083|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
33330217|NCT03016325|101104084|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
33330218|NCT03016325|101104085|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
33330219|NCT03016325|101104086|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
33330220|NCT03016325|101104087|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
33330221|NCT03016325|101104088|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
33330222|NCT03016325|101104089|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
33330223|NCT03016325|101104090|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
33330224|NCT03016325|101104083|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
33330225|NCT03016325|101104084|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
33330226|NCT03016325|101104085|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
33330227|NCT03016325|101104086|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
33330228|NCT03016325|101104087|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
33330229|NCT03016325|101104088|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
33330230|NCT03016325|101104089|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
33330231|NCT03016325|101104090|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
33330232|NCT03016325|101104083|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
33402026|NCT01920061|101361619|FG011|Overall Study|Lost to Follow-up|0|||
33402027|NCT01920061|101361620|FG012|Overall Study|Lost to Follow-up|0|||
33402028|NCT01920061|101361621|FG013|Overall Study|Lost to Follow-up|0|||
33402029|NCT01920061|101361622|FG014|Overall Study|Lost to Follow-up|0|||
33402030|NCT01920061|101361623|FG015|Overall Study|Lost to Follow-up|0|||
33523981|NCT01905592|101816344|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
33523982|NCT01905592|101816343|FG000|Overall Study|Protocol Violation|0|||
33523983|NCT01905592|101816344|FG001|Overall Study|Protocol Violation|1|||
33523984|NCT01905592|101816343|FG000|Overall Study|Sponsor's decision|1|||
33523985|NCT01905592|101816344|FG001|Overall Study|Sponsor's decision|1|||
33201628|NCT01172938|100642682|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
33330233|NCT03016325|101104084|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
33523986|NCT01905592|101816343|FG000|Overall Study|Not treated|7|||
33523987|NCT01905592|101816344|FG001|Overall Study|Not treated|3|||
33523988|NCT01905592|101816343|FG000|Overall Study|Withdrawal by Subject|10|||
33523989|NCT01905592|101816344|FG001|Overall Study|Withdrawal by Subject|2|||
33523990|NCT02324699|101816345|FG000|Overall Study|study terminated|1|||
33523991|NCT01607346|101816346|FG000|Overall Study|Adverse Event|3|||
33523992|NCT04165135|101816348|FG000|Overall Study|Protocol Violation|10|||
33523993|NCT04165135|101816348|FG000|Overall Study|Participants withdrawal of consent|5|||
33523994|NCT00548249|101816351|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
33523995|NCT00548249|101816352|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
33523996|NCT00548249|101816353|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
33523997|NCT00548249|101816354|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
33523998|NCT00548249|101816355|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
33523999|NCT00548249|101816351|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
33524000|NCT00548249|101816352|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
33524001|NCT00548249|101816353|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
33524002|NCT00548249|101816354|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
33524003|NCT00548249|101816355|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
33524004|NCT00548249|101816351|FG000|Overall Study|Protocol Violation|1|||
33524005|NCT00548249|101816352|FG001|Overall Study|Protocol Violation|1|||
33524006|NCT00548249|101816353|FG002|Overall Study|Protocol Violation|4|||
33524007|NCT00548249|101816354|FG003|Overall Study|Protocol Violation|0|||
33524008|NCT00548249|101816355|FG004|Overall Study|Protocol Violation|3|||
33524009|NCT00548249|101816351|FG000|Overall Study|Miscellaneous|2|||
33524010|NCT00548249|101816352|FG001|Overall Study|Miscellaneous|3|||
33524011|NCT00548249|101816353|FG002|Overall Study|Miscellaneous|2|||
33524012|NCT00548249|101816354|FG003|Overall Study|Miscellaneous|0|||
33330234|NCT03016325|101104085|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
33330235|NCT03016325|101104086|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
33402031|NCT01920061|101361624|FG016|Overall Study|Lost to Follow-up|0|||
33524013|NCT00548249|101816355|FG004|Overall Study|Miscellaneous|2|||
33524014|NCT00548249|101816351|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
33330236|NCT03016325|101104087|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
33402032|NCT01920061|101361625|FG017|Overall Study|Lost to Follow-up|1|||
33524015|NCT00548249|101816352|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
33524016|NCT00548249|101816353|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
33524017|NCT00548249|101816354|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
33524018|NCT00548249|101816355|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
33524019|NCT00548249|101816351|FG000|Overall Study|Adverse Event|2|||
33330237|NCT03016325|101104088|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
33330238|NCT03016325|101104089|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
33330239|NCT03016325|101104090|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
33330240|NCT03016325|101104083|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
33330241|NCT03016325|101104084|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
33524020|NCT00548249|101816352|FG001|Overall Study|Adverse Event|2|||
33330242|NCT03016325|101104085|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
33330243|NCT03016325|101104086|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
33330244|NCT03016325|101104087|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
33330245|NCT03016325|101104088|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
33330246|NCT03016325|101104089|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
33330247|NCT03016325|101104090|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
33330248|NCT03016325|101104083|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
33330249|NCT03016325|101104084|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
33330250|NCT03016325|101104085|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
33330251|NCT03016325|101104086|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
33330252|NCT03016325|101104087|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
33330253|NCT03016325|101104088|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
33330254|NCT03016325|101104089|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
33330255|NCT03016325|101104090|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
33330256|NCT03016325|101104083|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
33524021|NCT00548249|101816353|FG002|Overall Study|Adverse Event|0|||
33524022|NCT00548249|101816354|FG003|Overall Study|Adverse Event|1|||
33524023|NCT00548249|101816355|FG004|Overall Study|Adverse Event|1|||
33524024|NCT00548249|101816351|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
33524025|NCT00548249|101816352|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
33524026|NCT00548249|101816353|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
33524027|NCT00548249|101816354|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
33524028|NCT00548249|101816355|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
33524029|NCT00548249|101816351|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
33524030|NCT00548249|101816352|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
33524031|NCT00548249|101816353|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
33524032|NCT00548249|101816354|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
33524033|NCT00548249|101816355|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
33524034|NCT00548249|101816351|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
33524035|NCT00548249|101816352|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
33524036|NCT00548249|101816353|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
33524037|NCT00548249|101816354|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
33524038|NCT00548249|101816355|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
33609713|NCT01406015|102123101|FG001|Overall Study|Withdrawal by Subject|3|||
33609714|NCT03995355|102123106|FG000|Overall Study|Adverse Event|1|||
33609715|NCT03995355|102123107|FG001|Overall Study|Adverse Event|0|||
33609716|NCT03995355|102123106|FG000|Overall Study|Withdrawal by Subject|1|||
33609717|NCT03995355|102123107|FG001|Overall Study|Withdrawal by Subject|0|||
33609718|NCT03995355|102123106|FG000|Overall Study|Scheduling Issues|0|||
33609719|NCT03995355|102123107|FG001|Overall Study|Scheduling Issues|1|||
33609720|NCT03245398|102123111|FG000|Overall Study|Travelled to another island|1|||
33609721|NCT03245398|102123112|FG001|Overall Study|Travelled to another island|0|||
33609722|NCT04230213|102123113|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
33609723|NCT04230213|102123114|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
33609724|NCT04230213|102123115|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
33609725|NCT04230213|102123113|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
33609726|NCT04230213|102123114|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
33609727|NCT04230213|102123115|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
33609728|NCT04230213|102123113|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
33330257|NCT03016325|101104084|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
33330258|NCT03016325|101104085|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
33330259|NCT03016325|101104086|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
33330260|NCT03016325|101104087|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
33330261|NCT03016325|101104088|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
33524039|NCT00548249|101816351|FG000|Overall Study|Prolonged hospitalization|0|||
33524040|NCT00548249|101816352|FG001|Overall Study|Prolonged hospitalization|0|||
33524041|NCT00548249|101816353|FG002|Overall Study|Prolonged hospitalization|2|||
33524042|NCT00548249|101816354|FG003|Overall Study|Prolonged hospitalization|1|||
33524043|NCT00548249|101816355|FG004|Overall Study|Prolonged hospitalization|0|||
33524044|NCT00548249|101816351|FG000|Overall Study|Withdrawal by Subject|2|||
33609729|NCT04230213|102123114|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
33609730|NCT04230213|102123115|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
33609731|NCT04230213|102123113|FG000|TP2: Week 10 to Week 16|Other|0|||
33609732|NCT04230213|102123114|FG001|TP2: Week 10 to Week 16|Other|2|||
33609733|NCT04230213|102123115|FG002|TP2: Week 10 to Week 16|Other|1|||
33609734|NCT04230213|102123113|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
33609735|NCT04230213|102123114|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
33609736|NCT04230213|102123115|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
33609737|NCT04230213|102123113|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
33609738|NCT04230213|102123114|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
33609739|NCT04230213|102123115|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
33609740|NCT04230213|102123113|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
33609741|NCT04230213|102123114|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
33609742|NCT04230213|102123115|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
33524045|NCT00548249|101816352|FG001|Overall Study|Withdrawal by Subject|0|||
33524046|NCT00548249|101816353|FG002|Overall Study|Withdrawal by Subject|0|||
33524047|NCT00548249|101816354|FG003|Overall Study|Withdrawal by Subject|0|||
33524048|NCT00548249|101816355|FG004|Overall Study|Withdrawal by Subject|0|||
33524049|NCT00548249|101816351|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
33524050|NCT00548249|101816352|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
33524051|NCT00548249|101816353|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
33524052|NCT00548249|101816354|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
33524053|NCT00548249|101816355|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
33524054|NCT00548249|101816351|FG000|Overall Study|Sponsor's request|0|||
33524055|NCT00548249|101816352|FG001|Overall Study|Sponsor's request|0|||
33524056|NCT00548249|101816353|FG002|Overall Study|Sponsor's request|0|||
33524057|NCT00548249|101816354|FG003|Overall Study|Sponsor's request|1|||
33524058|NCT00548249|101816355|FG004|Overall Study|Sponsor's request|0|||
33524059|NCT02107313|101816356|FG000|Overall Study|One participant did not do the FED cohor|0|||
33524060|NCT02107313|101816357|FG001|Overall Study|One participant did not do the FED cohor|1|||
33524061|NCT02182830|101816358|FG000|Overall Study|Not Treated|1|||
33524062|NCT02182830|101816359|FG001|Overall Study|Not Treated|1|||
33524063|NCT02182830|101816358|FG000|Overall Study|Trial stopped, reason missing|3|||
33524064|NCT02182830|101816359|FG001|Overall Study|Trial stopped, reason missing|3|||
33524065|NCT02182830|101816358|FG000|Overall Study|Consent withdrawn|8|||
33524066|NCT02182830|101816359|FG001|Overall Study|Consent withdrawn|8|||
33524067|NCT02182830|101816358|FG000|Overall Study|Lost to Follow-up|3|||
33524068|NCT02182830|101816359|FG001|Overall Study|Lost to Follow-up|3|||
33524069|NCT03544281|101816364|FG000|Overall Study|Death|3|||
33524070|NCT03544281|101816365|FG001|Overall Study|Death|2|||
33524071|NCT03544281|101816366|FG002|Overall Study|Death|6|||
33524072|NCT03544281|101816367|FG003|Overall Study|Death|8|||
33524073|NCT03544281|101816368|FG004|Overall Study|Death|4|||
33524074|NCT03544281|101816369|FG005|Overall Study|Death|2|||
33524075|NCT03544281|101816370|FG006|Overall Study|Death|4|||
33524076|NCT03544281|101816371|FG007|Overall Study|Death|5|||
33524077|NCT03544281|101816372|FG008|Overall Study|Death|5|||
33524078|NCT03544281|101816373|FG009|Overall Study|Death|8|||
33524079|NCT03544281|101816374|FG010|Overall Study|Death|6|||
33524080|NCT03544281|101816375|FG011|Overall Study|Death|4|||
33524081|NCT03544281|101816364|FG000|Overall Study|Lost to Follow-up|0|||
33524082|NCT03544281|101816365|FG001|Overall Study|Lost to Follow-up|0|||
33524083|NCT03544281|101816366|FG002|Overall Study|Lost to Follow-up|0|||
33524084|NCT03544281|101816367|FG003|Overall Study|Lost to Follow-up|0|||
33524085|NCT03544281|101816368|FG004|Overall Study|Lost to Follow-up|0|||
33524086|NCT03544281|101816369|FG005|Overall Study|Lost to Follow-up|0|||
33524087|NCT03544281|101816370|FG006|Overall Study|Lost to Follow-up|0|||
33524088|NCT03544281|101816371|FG007|Overall Study|Lost to Follow-up|0|||
33524089|NCT03544281|101816372|FG008|Overall Study|Lost to Follow-up|0|||
33524090|NCT03544281|101816373|FG009|Overall Study|Lost to Follow-up|0|||
33524091|NCT03544281|101816374|FG010|Overall Study|Lost to Follow-up|1|||
33524092|NCT03544281|101816375|FG011|Overall Study|Lost to Follow-up|0|||
33609743|NCT04230213|102123113|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
33609744|NCT04230213|102123114|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
33609745|NCT04230213|102123115|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
33524093|NCT03544281|101816364|FG000|Overall Study|Physician Decision|0|||
33524094|NCT03544281|101816365|FG001|Overall Study|Physician Decision|0|||
33524095|NCT03544281|101816366|FG002|Overall Study|Physician Decision|0|||
33524096|NCT03544281|101816367|FG003|Overall Study|Physician Decision|0|||
33609746|NCT04230213|102123113|FG000|TP3: Week 16 to Week 22|Other|0|||
33524097|NCT03544281|101816368|FG004|Overall Study|Physician Decision|0|||
33524098|NCT03544281|101816369|FG005|Overall Study|Physician Decision|0|||
33524099|NCT03544281|101816370|FG006|Overall Study|Physician Decision|0|||
33524100|NCT03544281|101816371|FG007|Overall Study|Physician Decision|1|||
33524101|NCT03544281|101816372|FG008|Overall Study|Physician Decision|0|||
33524102|NCT03544281|101816373|FG009|Overall Study|Physician Decision|0|||
33524103|NCT03544281|101816374|FG010|Overall Study|Physician Decision|0|||
33524104|NCT03544281|101816375|FG011|Overall Study|Physician Decision|0|||
33402033|NCT01920061|101361626|FG018|Overall Study|Lost to Follow-up|4|||
33524105|NCT03544281|101816364|FG000|Overall Study|Withdrawal by Subject|2|||
33524106|NCT03544281|101816365|FG001|Overall Study|Withdrawal by Subject|0|||
33524107|NCT03544281|101816366|FG002|Overall Study|Withdrawal by Subject|1|||
33524108|NCT03544281|101816367|FG003|Overall Study|Withdrawal by Subject|2|||
33524109|NCT03544281|101816368|FG004|Overall Study|Withdrawal by Subject|0|||
33524110|NCT03544281|101816369|FG005|Overall Study|Withdrawal by Subject|0|||
33402034|NCT01920061|101361627|FG019|Overall Study|Lost to Follow-up|3|||
33402035|NCT01920061|101361608|FG000|Overall Study|Other|1|||
33402036|NCT01920061|101361609|FG001|Overall Study|Other|1|||
33402037|NCT01920061|101361610|FG002|Overall Study|Other|2|||
33402038|NCT01920061|101361611|FG003|Overall Study|Other|1|||
33402039|NCT01920061|101361612|FG004|Overall Study|Other|0|||
33201629|NCT01172938|100642683|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
33201630|NCT01172938|100642675|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
33330262|NCT03016325|101104089|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
33330263|NCT03016325|101104090|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
33330264|NCT03016325|101104083|FG000|182-Day Follow-Up Period|Death|3|||
33330265|NCT03016325|101104084|FG001|182-Day Follow-Up Period|Death|3|||
33330266|NCT03016325|101104085|FG002|182-Day Follow-Up Period|Death|11|||
33524111|NCT03544281|101816370|FG006|Overall Study|Withdrawal by Subject|0|||
33609747|NCT04230213|102123114|FG001|TP3: Week 16 to Week 22|Other|1|||
33330267|NCT03016325|101104086|FG003|182-Day Follow-Up Period|Death|12|||
33330268|NCT03016325|101104087|FG004|182-Day Follow-Up Period|Death|9|||
33609748|NCT04230213|102123115|FG002|TP3: Week 16 to Week 22|Other|3|||
33609749|NCT04230213|102123113|FG000|TP4: Week 22 to Week 32|Other|0|||
33609750|NCT04230213|102123114|FG001|TP4: Week 22 to Week 32|Other|5|||
33609751|NCT04230213|102123115|FG002|TP4: Week 22 to Week 32|Other|5|||
33609752|NCT04230213|102123113|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
33609753|NCT04230213|102123114|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
33609754|NCT04230213|102123115|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
33609755|NCT04230213|102123113|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
33609756|NCT04230213|102123114|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
33609757|NCT04230213|102123115|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
33609758|NCT04230213|102123113|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
33609759|NCT04230213|102123114|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
33609760|NCT04230213|102123115|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
33609761|NCT04230213|102123113|FG000|Follow up: Week 32 to Week 36|Other|0|||
33609762|NCT04230213|102123114|FG001|Follow up: Week 32 to Week 36|Other|1|||
33609763|NCT04230213|102123115|FG002|Follow up: Week 32 to Week 36|Other|1|||
33609764|NCT00565136|102123116|FG000|Overall Study|Lost to Follow-up|1|||
33609765|NCT00565136|102123116|FG000|Overall Study|Withdrawal by Subject|1|||
33609766|NCT00565136|102123116|FG000|Overall Study|Protocol Violation|1|||
33609767|NCT01894022|102123117|FG000|Overall Study|Death|1|||
33609768|NCT01894022|102123118|FG001|Overall Study|Death|0|||
33609769|NCT01894022|102123117|FG000|Overall Study|Adverse Event, non-fatal|1|||
33609770|NCT01894022|102123118|FG001|Overall Study|Adverse Event, non-fatal|0|||
33609771|NCT01894022|102123117|FG000|Overall Study|Study Closed/terminated|7|||
33609772|NCT01894022|102123118|FG001|Overall Study|Study Closed/terminated|10|||
33609773|NCT02596945|102123120|FG000|Overall Study|No documentation of study drug dosing|3|||
33609774|NCT02596945|102123120|FG000|Overall Study|Other|32|||
33609775|NCT02596945|102123120|FG000|Overall Study|Change to hemodialysis|15|||
33609776|NCT02596945|102123120|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
33609777|NCT02596945|102123120|FG000|Overall Study|Withdrawal by Subject|1|||
33609778|NCT02596945|102123120|FG000|Overall Study|Missing|1|||
33330269|NCT03016325|101104088|FG005|182-Day Follow-Up Period|Death|0|||
33201631|NCT01172938|100642676|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
33330270|NCT03016325|101104089|FG006|182-Day Follow-Up Period|Death|0|||
33330271|NCT03016325|101104090|FG007|182-Day Follow-Up Period|Death|1|||
33402040|NCT01920061|101361613|FG005|Overall Study|Other|1|||
33402041|NCT01920061|101361614|FG006|Overall Study|Other|0|||
33609779|NCT03262441|102123124|FG000|Overall Study|Withdrawal by Subject|1|||
33609780|NCT00923845|102123125|FG000|Induction Therapy|Poor performance status|0|||
33609781|NCT00923845|102123126|FG001|Induction Therapy|Poor performance status|2|||
33609782|NCT02853435|102123127|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
33609783|NCT02853435|102123128|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
33609784|NCT02853435|102123129|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
33609785|NCT02853435|102123130|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
33330272|NCT03016325|101104083|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
33330273|NCT03016325|101104084|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
33402042|NCT01920061|101361615|FG007|Overall Study|Other|0|||
33402043|NCT01920061|101361616|FG008|Overall Study|Other|0|||
33402044|NCT01920061|101361617|FG009|Overall Study|Other|1|||
33402045|NCT01920061|101361618|FG010|Overall Study|Other|1|||
33524112|NCT03544281|101816371|FG007|Overall Study|Withdrawal by Subject|0|||
33524113|NCT03544281|101816372|FG008|Overall Study|Withdrawal by Subject|2|||
33524114|NCT03544281|101816373|FG009|Overall Study|Withdrawal by Subject|3|||
33524115|NCT03544281|101816374|FG010|Overall Study|Withdrawal by Subject|0|||
33524116|NCT03544281|101816375|FG011|Overall Study|Withdrawal by Subject|4|||
33524117|NCT03544281|101816364|FG000|Overall Study|Ongoing at the time of analysis|7|||
33524118|NCT03544281|101816365|FG001|Overall Study|Ongoing at the time of analysis|2|||
33524119|NCT03544281|101816366|FG002|Overall Study|Ongoing at the time of analysis|6|||
33524120|NCT03544281|101816367|FG003|Overall Study|Ongoing at the time of analysis|6|||
33524121|NCT03544281|101816368|FG004|Overall Study|Ongoing at the time of analysis|8|||
33524122|NCT03544281|101816369|FG005|Overall Study|Ongoing at the time of analysis|10|||
33524123|NCT03544281|101816370|FG006|Overall Study|Ongoing at the time of analysis|8|||
33524124|NCT03544281|101816371|FG007|Overall Study|Ongoing at the time of analysis|6|||
33524125|NCT03544281|101816372|FG008|Overall Study|Ongoing at the time of analysis|6|||
33524126|NCT03544281|101816373|FG009|Overall Study|Ongoing at the time of analysis|6|||
33524127|NCT03544281|101816374|FG010|Overall Study|Ongoing at the time of analysis|5|||
33524128|NCT03544281|101816375|FG011|Overall Study|Ongoing at the time of analysis|8|||
33524129|NCT03544281|101816364|FG000|Overall Study|Investigator Site Closed|0|||
33524130|NCT03544281|101816365|FG001|Overall Study|Investigator Site Closed|0|||
33524131|NCT03544281|101816366|FG002|Overall Study|Investigator Site Closed|0|||
33524132|NCT03544281|101816367|FG003|Overall Study|Investigator Site Closed|0|||
33524133|NCT03544281|101816368|FG004|Overall Study|Investigator Site Closed|0|||
33524134|NCT03544281|101816369|FG005|Overall Study|Investigator Site Closed|0|||
33524135|NCT03544281|101816370|FG006|Overall Study|Investigator Site Closed|0|||
33524136|NCT03544281|101816371|FG007|Overall Study|Investigator Site Closed|0|||
33524137|NCT03544281|101816372|FG008|Overall Study|Investigator Site Closed|0|||
33524138|NCT03544281|101816373|FG009|Overall Study|Investigator Site Closed|1|||
33524139|NCT03544281|101816374|FG010|Overall Study|Investigator Site Closed|0|||
33524140|NCT03544281|101816375|FG011|Overall Study|Investigator Site Closed|0|||
33524141|NCT03544281|101816364|FG000|Overall Study|Did not receive study treatment|0|||
33524142|NCT03544281|101816365|FG001|Overall Study|Did not receive study treatment|0|||
33524143|NCT03544281|101816366|FG002|Overall Study|Did not receive study treatment|0|||
33524144|NCT03544281|101816367|FG003|Overall Study|Did not receive study treatment|0|||
33330274|NCT03016325|101104085|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
33330275|NCT03016325|101104086|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
33330276|NCT03016325|101104087|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
33330277|NCT03016325|101104088|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
33330278|NCT03016325|101104089|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
33330279|NCT03016325|101104090|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
33330280|NCT03016325|101104083|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
33330281|NCT03016325|101104084|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
33330282|NCT03016325|101104085|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
33330283|NCT03016325|101104086|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
33330284|NCT03016325|101104087|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
33330285|NCT03016325|101104088|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
33330286|NCT03016325|101104089|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
33330287|NCT03016325|101104090|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
33330288|NCT03016325|101104083|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
33330289|NCT03016325|101104084|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
33330290|NCT03016325|101104085|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
33330291|NCT03016325|101104086|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
33330292|NCT03016325|101104087|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
33330293|NCT03016325|101104088|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
33330294|NCT03016325|101104089|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
33330295|NCT03016325|101104090|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
33330296|NCT03016325|101104083|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
33330297|NCT03016325|101104084|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
33330298|NCT03016325|101104085|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
33330299|NCT03016325|101104086|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
33330300|NCT03016325|101104087|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
33330301|NCT03016325|101104088|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
33330302|NCT03016325|101104089|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
33330303|NCT03016325|101104090|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
33330304|NCT03016325|101104083|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
33402046|NCT01920061|101361619|FG011|Overall Study|Other|2|||
33524145|NCT03544281|101816368|FG004|Overall Study|Did not receive study treatment|0|||
33524146|NCT03544281|101816369|FG005|Overall Study|Did not receive study treatment|0|||
33524147|NCT03544281|101816370|FG006|Overall Study|Did not receive study treatment|1|||
33524148|NCT03544281|101816371|FG007|Overall Study|Did not receive study treatment|0|||
33524149|NCT03544281|101816372|FG008|Overall Study|Did not receive study treatment|0|||
33524150|NCT03544281|101816373|FG009|Overall Study|Did not receive study treatment|0|||
33402047|NCT01920061|101361620|FG012|Overall Study|Other|1|||
33402048|NCT01920061|101361621|FG013|Overall Study|Other|4|||
33524151|NCT03544281|101816374|FG010|Overall Study|Did not receive study treatment|0|||
33524152|NCT03544281|101816375|FG011|Overall Study|Did not receive study treatment|0|||
33524153|NCT00759655|101816376|FG000|Overall Study|Termination of the study by sponsor|1|||
33524154|NCT02651688|101816379|FG000|Overall Study|Non-compliance|0|||
33330305|NCT03016325|101104084|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
33330306|NCT03016325|101104085|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
33330307|NCT03016325|101104086|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
33330308|NCT03016325|101104087|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
33330309|NCT03016325|101104088|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
33330310|NCT03016325|101104089|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
33330311|NCT03016325|101104090|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
33330312|NCT03016325|101104083|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
33330313|NCT03016325|101104084|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
33330314|NCT03016325|101104085|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
33330315|NCT03016325|101104086|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
33330316|NCT03016325|101104087|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
33330317|NCT03016325|101104088|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
33524155|NCT02651688|101816380|FG001|Overall Study|Non-compliance|0|||
33524156|NCT02651688|101816381|FG002|Overall Study|Non-compliance|1|||
33524157|NCT02651688|101816379|FG000|Overall Study|Principal Investigator (PI) decision|0|||
33524158|NCT02651688|101816380|FG001|Overall Study|Principal Investigator (PI) decision|2|||
33524159|NCT02651688|101816381|FG002|Overall Study|Principal Investigator (PI) decision|0|||
33524160|NCT02651688|101816379|FG000|Overall Study|Lost to Follow-up|1|||
33524161|NCT02651688|101816380|FG001|Overall Study|Lost to Follow-up|3|||
33524162|NCT02651688|101816381|FG002|Overall Study|Lost to Follow-up|0|||
33524163|NCT02651688|101816379|FG000|Overall Study|Withdrawal by Subject|1|||
33524164|NCT02651688|101816380|FG001|Overall Study|Withdrawal by Subject|0|||
33524165|NCT02651688|101816381|FG002|Overall Study|Withdrawal by Subject|2|||
33524166|NCT00791700|101816385|FG000|Overall Study|Insufficient clinical response|1|||
33330318|NCT03016325|101104089|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
33330319|NCT03016325|101104090|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
33330320|NCT03016325|101104083|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
33330321|NCT03016325|101104084|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
33330322|NCT03016325|101104085|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
33330323|NCT03016325|101104086|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
33330324|NCT03016325|101104087|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
33330325|NCT03016325|101104088|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
33330326|NCT03016325|101104089|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
33330327|NCT03016325|101104090|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
33330328|NCT00549939|101104098|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
33330329|NCT00549939|101104099|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
33330330|NCT00549939|101104100|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
33330331|NCT00549939|101104098|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
33330332|NCT00549939|101104099|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
33330333|NCT00549939|101104100|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
33330334|NCT00549939|101104098|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
33402049|NCT01920061|101361622|FG014|Overall Study|Other|0|||
33402050|NCT01920061|101361623|FG015|Overall Study|Other|1|||
33402051|NCT01920061|101361624|FG016|Overall Study|Other|1|||
33524167|NCT00791700|101816386|FG001|Overall Study|Insufficient clinical response|4|||
33524168|NCT00791700|101816387|FG002|Overall Study|Insufficient clinical response|1|||
33524169|NCT00791700|101816388|FG003|Overall Study|Insufficient clinical response|8|||
33524170|NCT00791700|101816385|FG000|Overall Study|No longer willing to participate|1|||
33524171|NCT00791700|101816386|FG001|Overall Study|No longer willing to participate|1|||
33524172|NCT00791700|101816387|FG002|Overall Study|No longer willing to participate|0|||
33524173|NCT00791700|101816388|FG003|Overall Study|No longer willing to participate|8|||
33524174|NCT00791700|101816385|FG000|Overall Study|Non-compliance with study treatment|0|||
33524175|NCT00791700|101816386|FG001|Overall Study|Non-compliance with study treatment|2|||
33524176|NCT00791700|101816387|FG002|Overall Study|Non-compliance with study treatment|0|||
33524177|NCT00791700|101816388|FG003|Overall Study|Non-compliance with study treatment|4|||
33524178|NCT00791700|101816385|FG000|Overall Study|Withdrawn due to pregnancy|0|||
33524179|NCT00791700|101816386|FG001|Overall Study|Withdrawn due to pregnancy|0|||
33524180|NCT00791700|101816387|FG002|Overall Study|Withdrawn due to pregnancy|0|||
33402052|NCT01920061|101361625|FG017|Overall Study|Other|0|||
33524181|NCT00791700|101816388|FG003|Overall Study|Withdrawn due to pregnancy|1|||
33524182|NCT00791700|101816385|FG000|Overall Study|Other|0|||
33524183|NCT00791700|101816386|FG001|Overall Study|Other|1|||
33524184|NCT00791700|101816387|FG002|Overall Study|Other|0|||
33330335|NCT00549939|101104099|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
33330336|NCT00549939|101104100|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
33330337|NCT00549939|101104098|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
33330338|NCT00549939|101104099|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
33330339|NCT00549939|101104100|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
33330340|NCT00549939|101104098|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
33330341|NCT00549939|101104099|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
33524185|NCT00791700|101816388|FG003|Overall Study|Other|1|||
33524186|NCT00791700|101816385|FG000|Overall Study|Death|0|||
33524187|NCT00791700|101816386|FG001|Overall Study|Death|0|||
33524188|NCT00791700|101816387|FG002|Overall Study|Death|0|||
33524189|NCT00791700|101816388|FG003|Overall Study|Death|1|||
33524190|NCT00791700|101816385|FG000|Overall Study|Lost to Follow-up|4|||
33524191|NCT00791700|101816386|FG001|Overall Study|Lost to Follow-up|3|||
33524192|NCT00791700|101816387|FG002|Overall Study|Lost to Follow-up|4|||
33524193|NCT00791700|101816388|FG003|Overall Study|Lost to Follow-up|6|||
33524194|NCT00791700|101816385|FG000|Overall Study|Adverse Event|0|||
33524195|NCT00791700|101816386|FG001|Overall Study|Adverse Event|0|||
33524196|NCT00791700|101816387|FG002|Overall Study|Adverse Event|1|||
33524197|NCT00791700|101816388|FG003|Overall Study|Adverse Event|1|||
33524198|NCT01447719|101816389|FG000|Overall Study|Image acquisition failure|2|||
33524199|NCT01447719|101816389|FG000|Overall Study|Invalid image or not imaged|3|||
33524200|NCT01447719|101816389|FG000|Overall Study|Subject still living at end of study|79|||
33524201|NCT01447719|101816389|FG000|Overall Study|Withdrawal by Subject|2|||
33524202|NCT01447719|101816389|FG000|Overall Study|Family withdrew autopsy consent|7|||
33524203|NCT01908582|101816390|FG000|Period 2|Physician Decision|1|||
33524204|NCT01908582|101816390|FG000|Period 2|Withdrawal by Subject|1|||
33524205|NCT00508157|101816391|FG000|Overall Study|Adverse Event|0|||
33524206|NCT00508157|101816392|FG001|Overall Study|Adverse Event|1|||
33524207|NCT00508157|101816391|FG000|Overall Study|Subject Withdrew Consent|1|||
33524208|NCT00508157|101816392|FG001|Overall Study|Subject Withdrew Consent|0|||
33524209|NCT00508157|101816391|FG000|Overall Study|Lost to Follow-up|1|||
33524210|NCT00508157|101816392|FG001|Overall Study|Lost to Follow-up|0|||
33524211|NCT00508157|101816391|FG000|Overall Study|Subject no longer met study criteria|0|||
33524212|NCT00508157|101816392|FG001|Overall Study|Subject no longer met study criteria|1|||
33524213|NCT00508157|101816391|FG000|Overall Study|Other known cause|0|||
33524214|NCT00508157|101816392|FG001|Overall Study|Other known cause|1|||
33524215|NCT03251482|101816393|FG000|Overall Study|Withdrawal by Subject|0|||
33524216|NCT03251482|101816394|FG001|Overall Study|Withdrawal by Subject|1|||
33524217|NCT03251482|101816395|FG002|Overall Study|Withdrawal by Subject|0|||
33524218|NCT03251482|101816396|FG003|Overall Study|Withdrawal by Subject|0|||
33524219|NCT03251482|101816397|FG004|Overall Study|Withdrawal by Subject|0|||
33524220|NCT00080483|101816398|FG000|Overall Study|Lost to Follow-up|1|||
33524221|NCT00080483|101816399|FG001|Overall Study|Lost to Follow-up|1|||
33524222|NCT00080483|101816398|FG000|Overall Study|Physician Decision|1|||
33524223|NCT00080483|101816399|FG001|Overall Study|Physician Decision|1|||
33524224|NCT01358578|101816400|FG000|Induction Period|Adverse Event|2|||
33524225|NCT01358578|101816401|FG001|Induction Period|Adverse Event|4|||
33330342|NCT00549939|101104100|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
33330343|NCT00549939|101104098|FG000|40-week Open Label Treatment Period|Other|0|||
33524226|NCT01358578|101816402|FG002|Induction Period|Adverse Event|2|||
33524227|NCT01358578|101816403|FG003|Induction Period|Adverse Event|6|||
33524228|NCT01358578|101816404|FG004|Induction Period|Adverse Event|0|||
33524229|NCT01358578|101816405|FG005|Induction Period|Adverse Event|0|||
33524230|NCT01358578|101816400|FG000|Induction Period|Lack of Efficacy|0|||
33524231|NCT01358578|101816401|FG001|Induction Period|Lack of Efficacy|0|||
33524232|NCT01358578|101816402|FG002|Induction Period|Lack of Efficacy|9|||
33524233|NCT01358578|101816403|FG003|Induction Period|Lack of Efficacy|1|||
33524234|NCT01358578|101816404|FG004|Induction Period|Lack of Efficacy|0|||
33330344|NCT00549939|101104099|FG001|40-week Open Label Treatment Period|Other|1|||
33524235|NCT01358578|101816405|FG005|Induction Period|Lack of Efficacy|0|||
33524236|NCT01358578|101816400|FG000|Induction Period|Lost to Follow-up|0|||
33524237|NCT01358578|101816401|FG001|Induction Period|Lost to Follow-up|0|||
33330345|NCT00549939|101104100|FG002|40-week Open Label Treatment Period|Other|4|||
33524238|NCT01358578|101816402|FG002|Induction Period|Lost to Follow-up|1|||
33524239|NCT01358578|101816403|FG003|Induction Period|Lost to Follow-up|4|||
33524240|NCT01358578|101816404|FG004|Induction Period|Lost to Follow-up|0|||
33330346|NCT03901079|101104101|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
33524241|NCT01358578|101816405|FG005|Induction Period|Lost to Follow-up|0|||
33524242|NCT01358578|101816400|FG000|Induction Period|Physician Decision|2|||
33524243|NCT01358578|101816401|FG001|Induction Period|Physician Decision|1|||
33524244|NCT01358578|101816402|FG002|Induction Period|Physician Decision|2|||
33524245|NCT01358578|101816403|FG003|Induction Period|Physician Decision|0|||
33524246|NCT01358578|101816404|FG004|Induction Period|Physician Decision|0|||
33524247|NCT01358578|101816405|FG005|Induction Period|Physician Decision|0|||
33524248|NCT01358578|101816400|FG000|Induction Period|Protocol Deviation|3|||
33524249|NCT01358578|101816401|FG001|Induction Period|Protocol Deviation|5|||
33524250|NCT01358578|101816402|FG002|Induction Period|Protocol Deviation|0|||
33524251|NCT01358578|101816403|FG003|Induction Period|Protocol Deviation|3|||
33524252|NCT01358578|101816404|FG004|Induction Period|Protocol Deviation|0|||
33524253|NCT01358578|101816405|FG005|Induction Period|Protocol Deviation|0|||
33524254|NCT01358578|101816400|FG000|Induction Period|technical problems|0|||
33524255|NCT01358578|101816401|FG001|Induction Period|technical problems|0|||
33524256|NCT01358578|101816402|FG002|Induction Period|technical problems|1|||
33524257|NCT01358578|101816403|FG003|Induction Period|technical problems|1|||
33524258|NCT01358578|101816404|FG004|Induction Period|technical problems|0|||
33524259|NCT01358578|101816405|FG005|Induction Period|technical problems|0|||
33524260|NCT01358578|101816400|FG000|Induction Period|Withdrawal by Subject|5|||
33524261|NCT01358578|101816401|FG001|Induction Period|Withdrawal by Subject|5|||
33524262|NCT01358578|101816402|FG002|Induction Period|Withdrawal by Subject|10|||
33524263|NCT01358578|101816403|FG003|Induction Period|Withdrawal by Subject|6|||
33524264|NCT01358578|101816404|FG004|Induction Period|Withdrawal by Subject|0|||
33524265|NCT01358578|101816405|FG005|Induction Period|Withdrawal by Subject|0|||
33524266|NCT01358578|101816400|FG000|Maintenance Period|Adverse Event|2|||
33524267|NCT01358578|101816401|FG001|Maintenance Period|Adverse Event|7|||
33524268|NCT01358578|101816402|FG002|Maintenance Period|Adverse Event|0|||
33524269|NCT01358578|101816403|FG003|Maintenance Period|Adverse Event|6|||
33524270|NCT01358578|101816404|FG004|Maintenance Period|Adverse Event|4|||
33524271|NCT01358578|101816405|FG005|Maintenance Period|Adverse Event|3|||
33524272|NCT01358578|101816400|FG000|Maintenance Period|Lack of Efficacy|10|||
33524273|NCT01358578|101816401|FG001|Maintenance Period|Lack of Efficacy|2|||
33524274|NCT01358578|101816402|FG002|Maintenance Period|Lack of Efficacy|0|||
33524275|NCT01358578|101816403|FG003|Maintenance Period|Lack of Efficacy|11|||
33524276|NCT01358578|101816404|FG004|Maintenance Period|Lack of Efficacy|3|||
33524277|NCT01358578|101816405|FG005|Maintenance Period|Lack of Efficacy|0|||
33524278|NCT01358578|101816400|FG000|Maintenance Period|Lost to Follow-up|4|||
33524279|NCT01358578|101816401|FG001|Maintenance Period|Lost to Follow-up|0|||
33524280|NCT01358578|101816402|FG002|Maintenance Period|Lost to Follow-up|0|||
33524281|NCT01358578|101816403|FG003|Maintenance Period|Lost to Follow-up|5|||
33524282|NCT01358578|101816404|FG004|Maintenance Period|Lost to Follow-up|1|||
33524283|NCT01358578|101816405|FG005|Maintenance Period|Lost to Follow-up|1|||
33524284|NCT01358578|101816400|FG000|Maintenance Period|Non-compliance with study treatment|3|||
33524285|NCT01358578|101816401|FG001|Maintenance Period|Non-compliance with study treatment|1|||
33524286|NCT01358578|101816402|FG002|Maintenance Period|Non-compliance with study treatment|0|||
33524287|NCT01358578|101816403|FG003|Maintenance Period|Non-compliance with study treatment|2|||
33524288|NCT01358578|101816404|FG004|Maintenance Period|Non-compliance with study treatment|1|||
33524289|NCT01358578|101816405|FG005|Maintenance Period|Non-compliance with study treatment|2|||
33524290|NCT01358578|101816400|FG000|Maintenance Period|Physician Decision|0|||
33524291|NCT01358578|101816401|FG001|Maintenance Period|Physician Decision|1|||
33524292|NCT01358578|101816402|FG002|Maintenance Period|Physician Decision|0|||
33524293|NCT01358578|101816403|FG003|Maintenance Period|Physician Decision|1|||
33524294|NCT01358578|101816404|FG004|Maintenance Period|Physician Decision|0|||
33524295|NCT01358578|101816405|FG005|Maintenance Period|Physician Decision|0|||
33524296|NCT01358578|101816400|FG000|Maintenance Period|Pregnancy|1|||
33524297|NCT01358578|101816401|FG001|Maintenance Period|Pregnancy|0|||
33524298|NCT01358578|101816402|FG002|Maintenance Period|Pregnancy|0|||
33524299|NCT01358578|101816403|FG003|Maintenance Period|Pregnancy|0|||
33524300|NCT01358578|101816404|FG004|Maintenance Period|Pregnancy|0|||
33524301|NCT01358578|101816405|FG005|Maintenance Period|Pregnancy|0|||
33524302|NCT01358578|101816400|FG000|Maintenance Period|Protocol deviation|7|||
33524303|NCT01358578|101816401|FG001|Maintenance Period|Protocol deviation|4|||
33524304|NCT01358578|101816402|FG002|Maintenance Period|Protocol deviation|0|||
33201632|NCT01172938|100642677|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
33524305|NCT01358578|101816403|FG003|Maintenance Period|Protocol deviation|2|||
33524306|NCT01358578|101816404|FG004|Maintenance Period|Protocol deviation|2|||
33524307|NCT01358578|101816405|FG005|Maintenance Period|Protocol deviation|2|||
33524308|NCT01358578|101816400|FG000|Maintenance Period|Withdrawal by Subject|12|||
33524309|NCT01358578|101816401|FG001|Maintenance Period|Withdrawal by Subject|7|||
33524310|NCT01358578|101816402|FG002|Maintenance Period|Withdrawal by Subject|2|||
33524311|NCT01358578|101816403|FG003|Maintenance Period|Withdrawal by Subject|15|||
33524312|NCT01358578|101816404|FG004|Maintenance Period|Withdrawal by Subject|6|||
33201633|NCT01172938|100642678|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
33524313|NCT01358578|101816405|FG005|Maintenance Period|Withdrawal by Subject|3|||
33524314|NCT01358578|101816400|FG000|Follow-up Period|Adverse Event|1|||
33524315|NCT01358578|101816401|FG001|Follow-up Period|Adverse Event|1|||
33524316|NCT01358578|101816402|FG002|Follow-up Period|Adverse Event|0|||
33524317|NCT01358578|101816403|FG003|Follow-up Period|Adverse Event|0|||
33524318|NCT01358578|101816404|FG004|Follow-up Period|Adverse Event|0|||
33524319|NCT01358578|101816405|FG005|Follow-up Period|Adverse Event|0|||
33524320|NCT01358578|101816400|FG000|Follow-up Period|Lack of Efficacy|3|||
33330347|NCT01087775|101104107|FG000|Overall Study|failed inclusion criteria|2|||
33330348|NCT00094770|101104108|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
33330349|NCT00094770|101104109|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
33330350|NCT00094770|101104108|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
33330351|NCT00094770|101104109|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
33524321|NCT01358578|101816401|FG001|Follow-up Period|Lack of Efficacy|0|||
33524322|NCT01358578|101816402|FG002|Follow-up Period|Lack of Efficacy|4|||
33524323|NCT01358578|101816403|FG003|Follow-up Period|Lack of Efficacy|1|||
33524324|NCT01358578|101816404|FG004|Follow-up Period|Lack of Efficacy|0|||
33524325|NCT01358578|101816405|FG005|Follow-up Period|Lack of Efficacy|0|||
33524326|NCT01358578|101816400|FG000|Follow-up Period|Lost to Follow-up|0|||
33524327|NCT01358578|101816401|FG001|Follow-up Period|Lost to Follow-up|1|||
33524328|NCT01358578|101816402|FG002|Follow-up Period|Lost to Follow-up|0|||
33524329|NCT01358578|101816403|FG003|Follow-up Period|Lost to Follow-up|4|||
33524330|NCT01358578|101816404|FG004|Follow-up Period|Lost to Follow-up|0|||
33524331|NCT01358578|101816405|FG005|Follow-up Period|Lost to Follow-up|0|||
33524332|NCT01358578|101816400|FG000|Follow-up Period|non- compliance with study treatment|1|||
33524333|NCT01358578|101816401|FG001|Follow-up Period|non- compliance with study treatment|0|||
33524334|NCT01358578|101816402|FG002|Follow-up Period|non- compliance with study treatment|0|||
33524335|NCT01358578|101816403|FG003|Follow-up Period|non- compliance with study treatment|0|||
33524336|NCT01358578|101816404|FG004|Follow-up Period|non- compliance with study treatment|0|||
33524337|NCT01358578|101816405|FG005|Follow-up Period|non- compliance with study treatment|0|||
33524338|NCT01358578|101816400|FG000|Follow-up Period|Pregnancy|1|||
33524339|NCT01358578|101816401|FG001|Follow-up Period|Pregnancy|0|||
33524340|NCT01358578|101816402|FG002|Follow-up Period|Pregnancy|0|||
33524341|NCT01358578|101816403|FG003|Follow-up Period|Pregnancy|0|||
33524342|NCT01358578|101816404|FG004|Follow-up Period|Pregnancy|0|||
33524343|NCT01358578|101816405|FG005|Follow-up Period|Pregnancy|0|||
33524344|NCT01358578|101816400|FG000|Follow-up Period|Withdrawal by Subject|3|||
33524345|NCT01358578|101816401|FG001|Follow-up Period|Withdrawal by Subject|3|||
33524346|NCT01358578|101816402|FG002|Follow-up Period|Withdrawal by Subject|1|||
33524347|NCT01358578|101816403|FG003|Follow-up Period|Withdrawal by Subject|12|||
33524348|NCT01358578|101816404|FG004|Follow-up Period|Withdrawal by Subject|0|||
33524349|NCT01358578|101816405|FG005|Follow-up Period|Withdrawal by Subject|0|||
33524350|NCT01358578|101816400|FG000|Follow-up Period|Physician Decision|1|||
33524351|NCT01358578|101816401|FG001|Follow-up Period|Physician Decision|1|||
33524352|NCT01358578|101816402|FG002|Follow-up Period|Physician Decision|0|||
33524353|NCT01358578|101816403|FG003|Follow-up Period|Physician Decision|2|||
33524354|NCT01358578|101816404|FG004|Follow-up Period|Physician Decision|0|||
33524355|NCT01358578|101816405|FG005|Follow-up Period|Physician Decision|0|||
33524356|NCT00802672|101816407|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
33524357|NCT00802672|101816408|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
33524358|NCT00802672|101816409|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
33524359|NCT00802672|101816407|FG000|Overall Study|Adverse Event|1|||
33524360|NCT00802672|101816408|FG001|Overall Study|Adverse Event|1|||
33524361|NCT00802672|101816409|FG002|Overall Study|Adverse Event|1|||
33524362|NCT00802672|101816407|FG000|Overall Study|Protocol Violation|2|||
33201634|NCT01172938|100642679|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
33201635|NCT01172938|100642680|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
33201636|NCT01172938|100642681|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
33201637|NCT01172938|100642682|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
33201638|NCT01172938|100642683|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
33201639|NCT01172938|100642675|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
33524363|NCT00802672|101816408|FG001|Overall Study|Protocol Violation|1|||
33609786|NCT02853435|102123131|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
33201640|NCT01172938|100642676|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
33201641|NCT01172938|100642677|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
33201642|NCT01172938|100642678|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
33201643|NCT01172938|100642679|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
33330352|NCT00094770|101104108|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
33402053|NCT01920061|101361626|FG018|Overall Study|Other|1|||
33524364|NCT00802672|101816409|FG002|Overall Study|Protocol Violation|1|||
33524365|NCT00802672|101816407|FG000|Overall Study|Lost to Follow-up|5|||
33524366|NCT00802672|101816408|FG001|Overall Study|Lost to Follow-up|5|||
33524367|NCT00802672|101816409|FG002|Overall Study|Lost to Follow-up|3|||
33524368|NCT00802672|101816407|FG000|Overall Study|Withdrawal by Subject|1|||
33609787|NCT02853435|102123132|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
33201644|NCT01172938|100642680|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
33330353|NCT00094770|101104109|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
33330354|NCT00094770|101104108|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
33402054|NCT01920061|101361627|FG019|Overall Study|Other|1|||
33524369|NCT00802672|101816408|FG001|Overall Study|Withdrawal by Subject|1|||
33524370|NCT00802672|101816409|FG002|Overall Study|Withdrawal by Subject|2|||
33524371|NCT00802672|101816407|FG000|Overall Study|other|3|||
33524372|NCT00802672|101816408|FG001|Overall Study|other|1|||
33524373|NCT00802672|101816409|FG002|Overall Study|other|2|||
33524374|NCT02226120|101816416|FG000|Overall Study|Adverse Event|60|||
33524375|NCT02226120|101816416|FG000|Overall Study|Death|172|||
33524376|NCT02226120|101816416|FG000|Overall Study|Study terminated by sponsor|1|||
33524377|NCT02226120|101816416|FG000|Overall Study|Technical problems|4|||
33524378|NCT02226120|101816416|FG000|Overall Study|Lost to Follow-up|13|||
33524379|NCT02226120|101816416|FG000|Overall Study|Physician Decision|21|||
33524380|NCT02226120|101816416|FG000|Overall Study|Withdrawal by parent/guardian|36|||
33524381|NCT02226120|101816416|FG000|Overall Study|Non-compliance with study drug|10|||
33524382|NCT02226120|101816416|FG000|Overall Study|Protocol deviation|1|||
33524383|NCT02226120|101816416|FG000|Overall Study|missing treatment disposition pages|2|||
33524384|NCT03469999|101816417|FG000|Overall Study|Lost to Follow-up|2|||
33524385|NCT02437188|101816418|FG000|Overall Study|Randomized but did not receive surgery|4|||
33524386|NCT02437188|101816419|FG001|Overall Study|Randomized but did not receive surgery|8|||
33524387|NCT02437188|101816418|FG000|Overall Study|Adverse Event|0|||
33524388|NCT02437188|101816419|FG001|Overall Study|Adverse Event|1|||
33524389|NCT03853291|101816421|FG000|Overall Study|Lost to Follow-up|1|||
33524390|NCT03853291|101816422|FG001|Overall Study|Lost to Follow-up|2|||
33524391|NCT03853291|101816423|FG002|Overall Study|Lost to Follow-up|0|||
33524392|NCT03853291|101816424|FG003|Overall Study|Lost to Follow-up|0|||
33524393|NCT03853291|101816425|FG004|Overall Study|Lost to Follow-up|0|||
33524394|NCT03853291|101816426|FG005|Overall Study|Lost to Follow-up|0|||
33524395|NCT03853291|101816421|FG000|Overall Study|Determined to be ineligible|1|||
33524396|NCT03853291|101816422|FG001|Overall Study|Determined to be ineligible|1|||
33524397|NCT03853291|101816423|FG002|Overall Study|Determined to be ineligible|0|||
33524398|NCT03853291|101816424|FG003|Overall Study|Determined to be ineligible|0|||
33524399|NCT03853291|101816425|FG004|Overall Study|Determined to be ineligible|0|||
33524400|NCT03853291|101816426|FG005|Overall Study|Determined to be ineligible|0|||
33524401|NCT01121536|101816427|FG000|Overall Study|Adverse Event|63|||
33524402|NCT01121536|101816427|FG000|Overall Study|Lack of Efficacy|35|||
33524403|NCT01121536|101816427|FG000|Overall Study|Withdrawal by Subject|65|||
33524404|NCT01121536|101816427|FG000|Overall Study|Protocol Violation|20|||
33524405|NCT01121536|101816427|FG000|Overall Study|Noncompliance with study medication|12|||
33524406|NCT01121536|101816427|FG000|Overall Study|Noncompliance with study procedures|9|||
33524407|NCT01121536|101816427|FG000|Overall Study|Lost to Follow-up|39|||
33524408|NCT01121536|101816427|FG000|Overall Study|Other|118|||
33524409|NCT02315664|101816428|FG000|Overall Study|Lost to Follow-up|1|||
33524410|NCT02315664|101816429|FG001|Overall Study|Lost to Follow-up|1|||
33201645|NCT01172938|100642681|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
33201646|NCT01172938|100642682|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
33201647|NCT01172938|100642683|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
33201648|NCT01172938|100642675|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33201649|NCT01172938|100642676|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33201650|NCT01172938|100642677|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
33201651|NCT01172938|100642678|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33201652|NCT01172938|100642679|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33201653|NCT01172938|100642680|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33201654|NCT01172938|100642681|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33201655|NCT01172938|100642682|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33201656|NCT01172938|100642683|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
33201657|NCT01172938|100642675|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
33201658|NCT01172938|100642676|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
33201659|NCT01172938|100642677|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
33201660|NCT01172938|100642678|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
33201661|NCT01172938|100642679|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
33201662|NCT01172938|100642680|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
33201663|NCT01172938|100642681|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
33330355|NCT00094770|101104109|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
33524411|NCT02315664|101816428|FG000|Overall Study|Withdrawal by Subject|0|||
33524412|NCT02315664|101816429|FG001|Overall Study|Withdrawal by Subject|3|||
33524413|NCT01483599|101816430|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
33524414|NCT01483599|101816431|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33524415|NCT01483599|101816432|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33524416|NCT01483599|101816433|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
33524417|NCT01483599|101816434|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
33524418|NCT01483599|101816435|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
33524419|NCT01483599|101816436|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
33524420|NCT01483599|101816437|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33524421|NCT01483599|101816438|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33201664|NCT01172938|100642682|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
33201665|NCT01172938|100642683|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
33201666|NCT01172938|100642675|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
33201667|NCT01172938|100642676|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
33201668|NCT01172938|100642677|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
33201669|NCT01172938|100642678|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
33330356|NCT00094770|101104108|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
33330357|NCT00094770|101104109|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
33330358|NCT00094770|101104108|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
33330359|NCT00094770|101104109|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
33330360|NCT00094770|101104108|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
33330361|NCT00094770|101104109|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
33330362|NCT00094770|101104108|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
33330363|NCT00094770|101104109|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
33330364|NCT00094770|101104108|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
33330365|NCT00094770|101104109|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
33330366|NCT00094770|101104108|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
33330367|NCT00094770|101104109|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
33330368|NCT00094770|101104108|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
33330369|NCT00094770|101104109|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
33330370|NCT00094770|101104108|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
33330371|NCT00094770|101104109|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
33330372|NCT00094770|101104108|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
33402055|NCT01920061|101361608|FG000|Overall Study|Participant refused further follow-up|0|||
33402056|NCT01920061|101361609|FG001|Overall Study|Participant refused further follow-up|0|||
33402057|NCT01920061|101361610|FG002|Overall Study|Participant refused further follow-up|0|||
33609788|NCT01300260|102123134|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
33609789|NCT01300260|102123135|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
33609790|NCT01300260|102123134|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
33330373|NCT00094770|101104109|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
33402058|NCT01920061|101361611|FG003|Overall Study|Participant refused further follow-up|0|||
33402059|NCT01920061|101361612|FG004|Overall Study|Participant refused further follow-up|1|||
33524422|NCT01483599|101816439|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33524423|NCT01483599|101816440|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33524424|NCT01483599|101816441|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33524425|NCT01483599|101816442|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33524426|NCT01483599|101816443|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
33524427|NCT01483599|101816430|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33524428|NCT01483599|101816431|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
33524429|NCT01483599|101816432|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33524430|NCT01483599|101816433|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
33524431|NCT01483599|101816434|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33524432|NCT01483599|101816435|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33524433|NCT01483599|101816436|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
33524434|NCT01483599|101816437|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33524435|NCT01483599|101816438|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33524436|NCT01483599|101816439|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33524437|NCT01483599|101816440|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33524438|NCT01483599|101816441|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33524439|NCT01483599|101816442|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33524440|NCT01483599|101816443|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
33524441|NCT01483599|101816430|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
33330374|NCT00094770|101104108|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
33330375|NCT00094770|101104109|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
33330376|NCT00094770|101104108|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
33330377|NCT00094770|101104109|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
33330378|NCT00094770|101104108|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
33330379|NCT00094770|101104109|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
33524442|NCT01483599|101816431|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33524443|NCT01483599|101816432|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33524444|NCT01483599|101816433|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33609791|NCT01300260|102123135|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
33330380|NCT00094770|101104108|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
33330381|NCT00094770|101104109|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
33330382|NCT00094770|101104108|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
33402060|NCT01920061|101361613|FG005|Overall Study|Participant refused further follow-up|1|||
33402061|NCT01920061|101361614|FG006|Overall Study|Participant refused further follow-up|0|||
33201670|NCT01172938|100642679|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
33201671|NCT01172938|100642680|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
33201672|NCT01172938|100642681|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
33201673|NCT01172938|100642682|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
33201674|NCT01172938|100642683|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
33201675|NCT01172938|100642675|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
33201676|NCT01172938|100642676|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
33201677|NCT01172938|100642677|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
33201678|NCT01172938|100642678|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
33201679|NCT01172938|100642679|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
33201680|NCT01172938|100642680|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
33201681|NCT01172938|100642681|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
33201682|NCT01172938|100642682|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
33201683|NCT01172938|100642683|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
33201684|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
33201685|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
33201686|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
33330383|NCT00094770|101104109|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
33330384|NCT04247061|101104115|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
33330385|NCT04247061|101104115|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
33330386|NCT04247061|101104115|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
33330387|NCT00889265|101104116|FG000|Overall Study|Adverse Event|1|||
33330388|NCT00889265|101104116|FG000|Overall Study|Lost to Follow-up|5|||
33330389|NCT00889265|101104116|FG000|Overall Study|Protocol Violation|1|||
33330390|NCT01940471|101104117|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
33330391|NCT01940471|101104118|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
33330392|NCT01940471|101104119|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
33330393|NCT01940471|101104120|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
33330394|NCT01940471|101104117|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
33330395|NCT01940471|101104118|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
33330396|NCT01940471|101104119|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
33330397|NCT01940471|101104120|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
33330398|NCT01940471|101104117|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
33330399|NCT01940471|101104118|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
33330400|NCT01940471|101104119|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
33330401|NCT01940471|101104120|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
33330402|NCT01940471|101104117|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
33330403|NCT01940471|101104118|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
33330404|NCT01940471|101104119|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
33330405|NCT01940471|101104120|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
33330406|NCT01940471|101104117|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
33330407|NCT01940471|101104118|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
33330408|NCT01940471|101104119|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
33330409|NCT01940471|101104120|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
33330410|NCT01940471|101104117|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
33330411|NCT01940471|101104118|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
33330412|NCT01940471|101104119|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
33330413|NCT01940471|101104120|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
33330414|NCT01940471|101104117|FG000|Period 1: Double-blind Phase|Death|2|||
33330415|NCT01940471|101104118|FG001|Period 1: Double-blind Phase|Death|1|||
33330416|NCT01940471|101104119|FG002|Period 1: Double-blind Phase|Death|0|||
33330417|NCT01940471|101104120|FG003|Period 1: Double-blind Phase|Death|0|||
33330418|NCT01940471|101104117|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
33330419|NCT01940471|101104118|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
33330420|NCT01940471|101104119|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
33330421|NCT01940471|101104120|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
33330422|NCT01940471|101104117|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
33330423|NCT01940471|101104118|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
33524445|NCT01483599|101816434|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33524446|NCT01483599|101816435|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33524447|NCT01483599|101816436|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33524448|NCT01483599|101816437|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33524449|NCT01483599|101816438|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33524450|NCT01483599|101816439|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33330424|NCT01940471|101104119|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
33330425|NCT01940471|101104120|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
33330426|NCT01940471|101104117|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
33330427|NCT01940471|101104118|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
33330428|NCT01940471|101104119|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
33330429|NCT01940471|101104120|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
33330430|NCT01940471|101104117|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
33330431|NCT01940471|101104118|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
33330432|NCT01940471|101104119|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
33330433|NCT01940471|101104120|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
33330434|NCT01940471|101104117|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
33330435|NCT01940471|101104118|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
33330436|NCT01940471|101104119|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
33330437|NCT01940471|101104120|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
33330438|NCT01940471|101104117|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
33330439|NCT01940471|101104118|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
33330440|NCT01940471|101104119|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
33330441|NCT01940471|101104120|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
33330442|NCT01940471|101104117|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
33330443|NCT01940471|101104118|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
33330444|NCT01940471|101104119|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
33330445|NCT01940471|101104120|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
33330446|NCT01940471|101104117|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
33330447|NCT01940471|101104118|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
33330448|NCT01940471|101104119|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
33330449|NCT01940471|101104120|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
33330450|NCT01940471|101104117|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
33330451|NCT01940471|101104118|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
33330452|NCT01940471|101104119|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
33330453|NCT01940471|101104120|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
33330454|NCT01940471|101104117|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
33330455|NCT01940471|101104118|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
33330456|NCT01940471|101104119|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
33330457|NCT01940471|101104120|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
33330458|NCT01940471|101104117|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
33330459|NCT01940471|101104118|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
33330460|NCT01940471|101104119|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
33330461|NCT01940471|101104120|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
33330462|NCT01940471|101104117|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
33330463|NCT01940471|101104118|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
33330464|NCT01940471|101104119|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
33330465|NCT01940471|101104120|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
33330466|NCT01940471|101104117|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
33330467|NCT01940471|101104118|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
33330468|NCT01940471|101104119|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
33330469|NCT01940471|101104120|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
33330470|NCT01940471|101104117|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
33330471|NCT01940471|101104118|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
33330472|NCT01940471|101104119|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
33330473|NCT01940471|101104120|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
33330474|NCT02349048|101104121|FG000|Overall Study|Withdrawal by Subject|4|||
33330475|NCT02349048|101104122|FG001|Overall Study|Withdrawal by Subject|0|||
33330476|NCT02349048|101104121|FG000|Overall Study|Lost to Follow-up|1|||
33330477|NCT02349048|101104122|FG001|Overall Study|Lost to Follow-up|0|||
33330478|NCT02943564|101104123|FG000|Overall Study|Miscellaneous Reasons|0|||
33330479|NCT02943564|101104124|FG001|Overall Study|Miscellaneous Reasons|0|||
33330480|NCT02943564|101104125|FG002|Overall Study|Miscellaneous Reasons|3|||
33330481|NCT02943564|101104123|FG000|Overall Study|Site terminated by sponsor|0|||
33330482|NCT02943564|101104124|FG001|Overall Study|Site terminated by sponsor|1|||
33524451|NCT01483599|101816440|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33524452|NCT01483599|101816441|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33524453|NCT01483599|101816442|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33524454|NCT01483599|101816443|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
33524455|NCT01483599|101816430|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
33524456|NCT01483599|101816431|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
33524457|NCT01483599|101816432|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
33524458|NCT01483599|101816433|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
33609792|NCT01300260|102123134|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
33609793|NCT01300260|102123135|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
33609794|NCT03203291|102123136|FG000|Overall Study|Withdrawal by Subject|1|||
33609795|NCT01717326|102123141|FG000|Overall Study|Death|0|||
33609796|NCT01717326|102123142|FG001|Overall Study|Death|0|||
33609797|NCT01717326|102123143|FG002|Overall Study|Death|0|||
33609798|NCT01717326|102123144|FG003|Overall Study|Death|0|||
33609799|NCT01717326|102123145|FG004|Overall Study|Death|0|||
33609800|NCT01717326|102123146|FG005|Overall Study|Death|0|||
33609801|NCT01717326|102123147|FG006|Overall Study|Death|0|||
33609802|NCT01717326|102123148|FG007|Overall Study|Death|0|||
33609803|NCT01717326|102123149|FG008|Overall Study|Death|0|||
33609804|NCT01717326|102123150|FG009|Overall Study|Death|0|||
33609805|NCT01717326|102123151|FG010|Overall Study|Death|1|||
33609806|NCT01717326|102123152|FG011|Overall Study|Death|0|||
33609807|NCT01717326|102123153|FG012|Overall Study|Death|0|||
33609808|NCT01717326|102123154|FG013|Overall Study|Death|0|||
33609809|NCT01717326|102123155|FG014|Overall Study|Death|0|||
33609810|NCT01717326|102123156|FG015|Overall Study|Death|0|||
33609811|NCT01717326|102123157|FG016|Overall Study|Death|0|||
33609812|NCT01717326|102123158|FG017|Overall Study|Death|0|||
33330483|NCT02943564|101104125|FG002|Overall Study|Site terminated by sponsor|0|||
33330484|NCT02943564|101104123|FG000|Overall Study|Non-compliance with study drug|0|||
33524459|NCT01483599|101816434|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
33609813|NCT01717326|102123159|FG018|Overall Study|Death|0|||
33330485|NCT02943564|101104124|FG001|Overall Study|Non-compliance with study drug|1|||
33330486|NCT02943564|101104125|FG002|Overall Study|Non-compliance with study drug|0|||
33330487|NCT02943564|101104123|FG000|Overall Study|Pregnancy|0|||
33330488|NCT02943564|101104124|FG001|Overall Study|Pregnancy|1|||
33330489|NCT02943564|101104125|FG002|Overall Study|Pregnancy|1|||
33330490|NCT02943564|101104123|FG000|Overall Study|Protocol Violation|2|||
33330491|NCT02943564|101104124|FG001|Overall Study|Protocol Violation|2|||
33609814|NCT01717326|102123160|FG019|Overall Study|Death|0|||
33609815|NCT01717326|102123141|FG000|Overall Study|Lost to Follow-up|3|||
33609816|NCT01717326|102123142|FG001|Overall Study|Lost to Follow-up|0|||
33609817|NCT01717326|102123143|FG002|Overall Study|Lost to Follow-up|0|||
33609818|NCT01717326|102123144|FG003|Overall Study|Lost to Follow-up|2|||
33524460|NCT01483599|101816435|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
33524461|NCT01483599|101816436|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
33524462|NCT01483599|101816437|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
33524463|NCT01483599|101816438|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
33524464|NCT01483599|101816439|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
33524465|NCT01483599|101816440|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
33524466|NCT01483599|101816441|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
33524467|NCT01483599|101816442|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
33524468|NCT01483599|101816443|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
33524469|NCT01483599|101816430|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
33524470|NCT01483599|101816431|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
33524471|NCT01483599|101816432|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
33524472|NCT01483599|101816433|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
33524473|NCT01483599|101816434|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
33524474|NCT01483599|101816435|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
33524475|NCT01483599|101816436|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
33524476|NCT01483599|101816437|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
33524477|NCT01483599|101816438|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
33524478|NCT01483599|101816439|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
33524479|NCT01483599|101816440|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
33524480|NCT01483599|101816441|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
33524481|NCT01483599|101816442|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
33524482|NCT01483599|101816443|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
33524483|NCT01483599|101816430|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33524484|NCT01483599|101816431|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33524485|NCT01483599|101816432|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33524486|NCT01483599|101816433|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33524487|NCT01483599|101816434|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33330492|NCT02943564|101104125|FG002|Overall Study|Protocol Violation|2|||
33330493|NCT02943564|101104123|FG000|Overall Study|Lost to Follow-up|1|||
33609819|NCT01717326|102123145|FG004|Overall Study|Lost to Follow-up|1|||
33609820|NCT01717326|102123146|FG005|Overall Study|Lost to Follow-up|0|||
33330494|NCT02943564|101104124|FG001|Overall Study|Lost to Follow-up|0|||
33609821|NCT01717326|102123147|FG006|Overall Study|Lost to Follow-up|1|||
33330495|NCT02943564|101104125|FG002|Overall Study|Lost to Follow-up|0|||
33330496|NCT02943564|101104123|FG000|Overall Study|Withdrawal by Subject|6|||
33609822|NCT01717326|102123148|FG007|Overall Study|Lost to Follow-up|0|||
33609823|NCT01717326|102123149|FG008|Overall Study|Lost to Follow-up|0|||
33609824|NCT01717326|102123150|FG009|Overall Study|Lost to Follow-up|0|||
33524488|NCT01483599|101816435|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33524489|NCT01483599|101816436|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33524490|NCT01483599|101816437|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
33524491|NCT01483599|101816438|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
33524492|NCT01483599|101816439|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33524493|NCT01483599|101816440|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33524494|NCT01483599|101816441|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
33524495|NCT01483599|101816442|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
33524496|NCT01483599|101816443|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
33524497|NCT01483599|101816430|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33524498|NCT01483599|101816431|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33524499|NCT01483599|101816432|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33524500|NCT01483599|101816433|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33524501|NCT01483599|101816434|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33524502|NCT01483599|101816435|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33524503|NCT01483599|101816436|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33524504|NCT01483599|101816437|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33524505|NCT01483599|101816438|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
33524506|NCT01483599|101816439|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33524507|NCT01483599|101816440|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33524508|NCT01483599|101816441|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
33524509|NCT01483599|101816442|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
33524510|NCT01483599|101816443|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
33524511|NCT01483599|101816430|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33524512|NCT01483599|101816431|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33524513|NCT01483599|101816432|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33524514|NCT01483599|101816433|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33524515|NCT01483599|101816434|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33524516|NCT01483599|101816435|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33524517|NCT01483599|101816436|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33524518|NCT01483599|101816437|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33524519|NCT01483599|101816438|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
33524520|NCT01483599|101816439|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33524521|NCT01483599|101816440|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
33524522|NCT01483599|101816441|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33524523|NCT01483599|101816442|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
33524524|NCT01483599|101816443|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
33524525|NCT01483599|101816430|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33524526|NCT01483599|101816431|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33524527|NCT01483599|101816432|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33609825|NCT01717326|102123151|FG010|Overall Study|Lost to Follow-up|1|||
33609826|NCT01717326|102123152|FG011|Overall Study|Lost to Follow-up|0|||
33609827|NCT01717326|102123153|FG012|Overall Study|Lost to Follow-up|0|||
33609828|NCT01717326|102123154|FG013|Overall Study|Lost to Follow-up|0|||
33609829|NCT01717326|102123155|FG014|Overall Study|Lost to Follow-up|0|||
33609830|NCT01717326|102123156|FG015|Overall Study|Lost to Follow-up|2|||
33609831|NCT01717326|102123157|FG016|Overall Study|Lost to Follow-up|1|||
33609832|NCT01717326|102123158|FG017|Overall Study|Lost to Follow-up|0|||
33609833|NCT01717326|102123159|FG018|Overall Study|Lost to Follow-up|2|||
33609834|NCT01717326|102123160|FG019|Overall Study|Lost to Follow-up|3|||
33609835|NCT01717326|102123141|FG000|Overall Study|Physician Decision|0|||
33609836|NCT01717326|102123142|FG001|Overall Study|Physician Decision|0|||
33609837|NCT01717326|102123143|FG002|Overall Study|Physician Decision|0|||
33609838|NCT01717326|102123144|FG003|Overall Study|Physician Decision|0|||
33609839|NCT01717326|102123145|FG004|Overall Study|Physician Decision|0|||
33609840|NCT01717326|102123146|FG005|Overall Study|Physician Decision|0|||
33402062|NCT01920061|101361615|FG007|Overall Study|Participant refused further follow-up|0|||
33402063|NCT01920061|101361616|FG008|Overall Study|Participant refused further follow-up|1|||
33402064|NCT01920061|101361617|FG009|Overall Study|Participant refused further follow-up|0|||
33402065|NCT01920061|101361618|FG010|Overall Study|Participant refused further follow-up|1|||
33402066|NCT01920061|101361619|FG011|Overall Study|Participant refused further follow-up|0|||
33402067|NCT01920061|101361620|FG012|Overall Study|Participant refused further follow-up|1|||
33402068|NCT01920061|101361621|FG013|Overall Study|Participant refused further follow-up|0|||
33402069|NCT01920061|101361622|FG014|Overall Study|Participant refused further follow-up|1|||
33402070|NCT01920061|101361623|FG015|Overall Study|Participant refused further follow-up|2|||
33402071|NCT01920061|101361624|FG016|Overall Study|Participant refused further follow-up|1|||
33417263|NCT01248130|101420246|FG000|Overall Study|Protocol Violation|1|||
33201687|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
33201688|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
33201689|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
33201690|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
33201691|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
33201692|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
33201693|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
33201694|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
33201695|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
33201696|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
33201697|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
33201698|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
33201699|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
33201700|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
33201701|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
33201702|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33201703|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33201704|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
33201705|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33201706|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33201707|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33201708|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33201709|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33201710|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
33201711|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
33201712|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
33201713|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
33201714|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
33201715|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
33201716|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
33201717|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
33201718|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
33201719|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
33201720|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33201721|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33201722|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
33201723|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33201724|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33201725|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33201726|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33201727|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33201728|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
33201729|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
33201730|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
33201731|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
33201732|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
33201733|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
33201734|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
33201735|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
33201736|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
33201737|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
33201738|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
33201739|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
33201740|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
33201741|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
33402072|NCT01920061|101361625|FG017|Overall Study|Participant refused further follow-up|1|||
33524528|NCT01483599|101816433|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33524529|NCT01483599|101816434|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33524530|NCT01483599|101816435|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33524531|NCT01483599|101816436|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33524532|NCT01483599|101816437|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33524533|NCT01483599|101816438|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
33524534|NCT01483599|101816439|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33524535|NCT01483599|101816440|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33330497|NCT02943564|101104124|FG001|Overall Study|Withdrawal by Subject|5|||
33330498|NCT02943564|101104125|FG002|Overall Study|Withdrawal by Subject|2|||
33330499|NCT02943564|101104123|FG000|Overall Study|Adverse Event|1|||
33330500|NCT02943564|101104124|FG001|Overall Study|Adverse Event|2|||
33330501|NCT02943564|101104125|FG002|Overall Study|Adverse Event|1|||
33330502|NCT02943564|101104123|FG000|Overall Study|Lack of Efficacy|0|||
33330503|NCT02943564|101104124|FG001|Overall Study|Lack of Efficacy|1|||
33330504|NCT02943564|101104125|FG002|Overall Study|Lack of Efficacy|0|||
33330505|NCT01231659|101104126|FG000|Overall Study|Adverse Event|9|||
33330506|NCT01231659|101104126|FG000|Overall Study|Disease Progression|48|||
33330507|NCT01231659|101104126|FG000|Overall Study|Death|2|||
33330508|NCT01231659|101104126|FG000|Overall Study|Patient refused to complete study visit|1|||
33330509|NCT01231659|101104126|FG000|Overall Study|Other protocol defined criteria|12|||
33330510|NCT04744207|101104127|FG000|Treatment|Withdrawal by Subject|2|||
33330511|NCT04744207|101104128|FG001|Treatment|Withdrawal by Subject|0|||
33330512|NCT04744207|101104127|FG000|Treatment|Adverse Event|1|||
33330513|NCT04744207|101104128|FG001|Treatment|Adverse Event|2|||
33330514|NCT00939783|101104134|FG000|Overall Study|Death|6|||
33330515|NCT00939783|101104134|FG000|Overall Study|Adverse Event|39|||
33330516|NCT00939783|101104134|FG000|Overall Study|Study Terminated by Sponsor|498|||
33330517|NCT00939783|101104134|FG000|Overall Study|Withdrawal by Subject|78|||
33330518|NCT00939783|101104134|FG000|Overall Study|Other|16|||
33330519|NCT00939783|101104134|FG000|Overall Study|Lost to Follow-up|8|||
33330520|NCT00939783|101104134|FG000|Overall Study|Protocol Violation|3|||
33330521|NCT00939783|101104134|FG000|Overall Study|Enrolled but not treated|1|||
33330522|NCT03523728|101104135|FG000|Stage 1 (24 Months)|Adverse Event|2|||
33330523|NCT03523728|101104136|FG001|Stage 1 (24 Months)|Adverse Event|2|||
33330524|NCT03523728|101104137|FG002|Stage 1 (24 Months)|Adverse Event|4|||
33330525|NCT03523728|101104138|FG003|Stage 1 (24 Months)|Adverse Event|0|||
33330526|NCT03523728|101104139|FG004|Stage 1 (24 Months)|Adverse Event|0|||
33330527|NCT03523728|101104135|FG000|Stage 1 (24 Months)|Progressive disease|0|||
33330528|NCT03523728|101104136|FG001|Stage 1 (24 Months)|Progressive disease|0|||
33330529|NCT03523728|101104137|FG002|Stage 1 (24 Months)|Progressive disease|1|||
33330530|NCT03523728|101104138|FG003|Stage 1 (24 Months)|Progressive disease|0|||
33524536|NCT01483599|101816441|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
33524537|NCT01483599|101816442|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
33524538|NCT01483599|101816443|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
33524539|NCT01483599|101816430|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
33524540|NCT01483599|101816431|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
33524541|NCT01483599|101816432|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
33524542|NCT01483599|101816433|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
33524543|NCT01483599|101816434|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
33524544|NCT01483599|101816435|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
33524545|NCT01483599|101816436|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
33524546|NCT01483599|101816437|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
33524547|NCT01483599|101816438|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
33524548|NCT01483599|101816439|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
33524549|NCT01483599|101816440|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
33524550|NCT01483599|101816441|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
33524551|NCT01483599|101816442|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
33524552|NCT01483599|101816443|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
33524553|NCT02985021|101816444|FG000|Overall Study|Inability to comply with study procedures|1|||
33524554|NCT02756364|101816446|FG000|Overall Study|Site Terminated by Sponsor|24|||
33524555|NCT02756364|101816447|FG001|Overall Study|Site Terminated by Sponsor|30|||
33524556|NCT02756364|101816448|FG002|Overall Study|Site Terminated by Sponsor|21|||
33524557|NCT02756364|101816446|FG000|Overall Study|Death|20|||
33524558|NCT02756364|101816447|FG001|Overall Study|Death|15|||
33524559|NCT02756364|101816448|FG002|Overall Study|Death|18|||
33524560|NCT02756364|101816446|FG000|Overall Study|Withdrawal by Patient|2|||
33524561|NCT02756364|101816447|FG001|Overall Study|Withdrawal by Patient|1|||
33524562|NCT02756364|101816448|FG002|Overall Study|Withdrawal by Patient|8|||
33524563|NCT02756364|101816446|FG000|Overall Study|Lost to Follow-up|0|||
33330531|NCT03523728|101104139|FG004|Stage 1 (24 Months)|Progressive disease|0|||
33330532|NCT03523728|101104135|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
33330533|NCT03523728|101104136|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
33524564|NCT02756364|101816447|FG001|Overall Study|Lost to Follow-up|1|||
33524565|NCT02756364|101816448|FG002|Overall Study|Lost to Follow-up|1|||
33524566|NCT00073008|101819689|FG000|Overall Study|Missing|6|||
33524567|NCT00073008|101819690|FG001|Overall Study|Missing|6|||
33524568|NCT00073008|101819689|FG000|Overall Study|Withdrawal by Subject|2|||
33524569|NCT00073008|101819690|FG001|Overall Study|Withdrawal by Subject|2|||
33330534|NCT03523728|101104137|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
33330535|NCT03523728|101104138|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
33330536|NCT03523728|101104139|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
33330537|NCT03523728|101104135|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
33330538|NCT03523728|101104136|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
33330539|NCT03523728|101104137|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
33330540|NCT03523728|101104138|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
33330541|NCT03523728|101104139|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
33330542|NCT03523728|101104135|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
33330543|NCT03523728|101104136|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
33330544|NCT03523728|101104137|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
33330545|NCT03523728|101104138|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
33330546|NCT03523728|101104139|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
33330547|NCT03523728|101104135|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
33330548|NCT03523728|101104136|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
33330549|NCT03523728|101104137|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
33330550|NCT03523728|101104138|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
33330551|NCT03523728|101104139|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
33330552|NCT03523728|101104135|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
33330553|NCT03523728|101104136|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
33330554|NCT03523728|101104137|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
33330555|NCT03523728|101104138|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
33330556|NCT03523728|101104139|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
33330557|NCT03523728|101104135|FG000|Stage 2 (24 Months)|Adverse Event|0|||
33330558|NCT03523728|101104136|FG001|Stage 2 (24 Months)|Adverse Event|0|||
33330559|NCT03523728|101104137|FG002|Stage 2 (24 Months)|Adverse Event|0|||
33330560|NCT03523728|101104138|FG003|Stage 2 (24 Months)|Adverse Event|1|||
33330561|NCT03523728|101104139|FG004|Stage 2 (24 Months)|Adverse Event|2|||
33330562|NCT03523728|101104135|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
33330563|NCT03523728|101104136|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
33330564|NCT03523728|101104137|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
33330565|NCT03523728|101104138|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
33330566|NCT03523728|101104139|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
33330567|NCT03523728|101104135|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
33330568|NCT03523728|101104136|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
33402073|NCT01920061|101361626|FG018|Overall Study|Participant refused further follow-up|0|||
33402074|NCT01920061|101361627|FG019|Overall Study|Participant refused further follow-up|0|||
33402075|NCT03055806|101361628|FG000|Overall Study|Adverse Event|0|||
33402076|NCT03055806|101361629|FG001|Overall Study|Adverse Event|0|||
33402077|NCT03055806|101361630|FG002|Overall Study|Adverse Event|1|||
33402078|NCT03055806|101361631|FG003|Overall Study|Adverse Event|1|||
33402079|NCT03055806|101361628|FG000|Overall Study|Lost to Follow-up|0|||
33402080|NCT03055806|101361629|FG001|Overall Study|Lost to Follow-up|3|||
33524570|NCT00073008|101819689|FG000|Overall Study|Lost to Follow-up|1|||
33524571|NCT00073008|101819690|FG001|Overall Study|Lost to Follow-up|3|||
33524572|NCT00073008|101819689|FG000|Overall Study|Death|46|||
33524573|NCT00073008|101819690|FG001|Overall Study|Death|47|||
33524574|NCT00073008|101819689|FG000|Overall Study|"Other selected on Case Report Form"|7|||
33524575|NCT00073008|101819690|FG001|Overall Study|"Other selected on Case Report Form"|5|||
33524576|NCT03162328|101819691|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
33524577|NCT03162328|101819692|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
33524578|NCT03162328|101819693|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
33524579|NCT03162328|101819691|FG000|Screening Period|Withdrawal by Subject|1|||
33524580|NCT03162328|101819692|FG001|Screening Period|Withdrawal by Subject|0|||
33524581|NCT03162328|101819693|FG002|Screening Period|Withdrawal by Subject|0|||
33524582|NCT03162328|101819691|FG000|Study Period|Withdrawal by Subject|0|||
33524583|NCT03162328|101819692|FG001|Study Period|Withdrawal by Subject|0|||
33524584|NCT03162328|101819693|FG002|Study Period|Withdrawal by Subject|1|||
33524585|NCT00845676|101819694|FG000|Overall Study|Virologic breakthrough at week 20|1|||
33524586|NCT00845676|101819694|FG000|Overall Study|Adverse Event|1|||
33524587|NCT00419159|101819695|FG000|Overall Study|Adverse Event|7|||
33524588|NCT00419159|101819696|FG001|Overall Study|Adverse Event|15|||
33524589|NCT00419159|101819695|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33524590|NCT00419159|101819696|FG001|Overall Study|Abnormal laboratory value(s)|2|||
33524591|NCT00419159|101819695|FG000|Overall Study|Subject's no longer requires study drug|0|||
33524592|NCT00419159|101819696|FG001|Overall Study|Subject's no longer requires study drug|1|||
33201742|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
33330569|NCT03523728|101104137|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
33330570|NCT03523728|101104138|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
33330571|NCT03523728|101104139|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
33330572|NCT03523728|101104135|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
33330573|NCT03523728|101104136|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
33330574|NCT03523728|101104137|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
33330575|NCT03523728|101104138|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
33402081|NCT03055806|101361630|FG002|Overall Study|Lost to Follow-up|6|||
33402082|NCT03055806|101361631|FG003|Overall Study|Lost to Follow-up|7|||
33402083|NCT03055806|101361628|FG000|Overall Study|Physician Decision|1|||
33524593|NCT00419159|101819695|FG000|Overall Study|Protocol Violation|1|||
33330576|NCT03523728|101104139|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
33524594|NCT00419159|101819696|FG001|Overall Study|Protocol Violation|0|||
33524595|NCT00419159|101819695|FG000|Overall Study|Withdrawal by Subject|10|||
33524596|NCT00419159|101819696|FG001|Overall Study|Withdrawal by Subject|3|||
33524597|NCT00419159|101819695|FG000|Overall Study|Lost to Follow-up|0|||
33524598|NCT00419159|101819696|FG001|Overall Study|Lost to Follow-up|1|||
33524599|NCT00419159|101819695|FG000|Overall Study|Death|2|||
33524600|NCT00419159|101819696|FG001|Overall Study|Death|2|||
33524601|NCT00419159|101819695|FG000|Overall Study|Disease progression|79|||
33201743|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
33201744|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
33201745|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
33201746|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
33201747|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33201748|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
33330577|NCT03523728|101104135|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
33524602|NCT00419159|101819696|FG001|Overall Study|Disease progression|76|||
33524603|NCT00621517|101819699|FG000|Overall Study|Lost to Follow-up|3|||
33524604|NCT00621517|101819700|FG001|Overall Study|Lost to Follow-up|3|||
33524605|NCT00621517|101819699|FG000|Overall Study|Withdrawal by Subject|3|||
33524606|NCT00621517|101819700|FG001|Overall Study|Withdrawal by Subject|4|||
33330578|NCT03523728|101104136|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
33330579|NCT03523728|101104137|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
33330580|NCT03523728|101104138|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
33330581|NCT03523728|101104139|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
33330582|NCT00441974|101104140|FG000|Overall Study|Adverse Event|6|||
33330583|NCT00441974|101104140|FG000|Overall Study|Consent Withdrawn|35|||
33330584|NCT00441974|101104140|FG000|Overall Study|Lost to Follow-up|80|||
33330585|NCT00441974|101104140|FG000|Overall Study|Protocol Violation|7|||
33330586|NCT00645593|101104141|FG000|Overall Study|Later found to be ineligible|1|||
33330587|NCT00645593|101104142|FG001|Overall Study|Later found to be ineligible|0|||
33524607|NCT00621517|101819699|FG000|Overall Study|Adverse Event|1|||
33524608|NCT00621517|101819700|FG001|Overall Study|Adverse Event|0|||
33524609|NCT01119846|101819707|FG000|Overall Study|Adverse Event|1|||
33524610|NCT01119846|101819708|FG001|Overall Study|Adverse Event|0|||
33524611|NCT01119846|101819709|FG002|Overall Study|Adverse Event|6|||
33524612|NCT01119846|101819707|FG000|Overall Study|Physician Decision|1|||
33524613|NCT01119846|101819708|FG001|Overall Study|Physician Decision|0|||
33524614|NCT01119846|101819709|FG002|Overall Study|Physician Decision|0|||
33524615|NCT01119846|101819707|FG000|Overall Study|Protocol Violation|0|||
33524616|NCT01119846|101819708|FG001|Overall Study|Protocol Violation|0|||
33402084|NCT03055806|101361629|FG001|Overall Study|Physician Decision|0|||
33402085|NCT03055806|101361630|FG002|Overall Study|Physician Decision|0|||
33402086|NCT03055806|101361631|FG003|Overall Study|Physician Decision|1|||
33402087|NCT03055806|101361628|FG000|Overall Study|Protocol Violation|1|||
33402088|NCT03055806|101361629|FG001|Overall Study|Protocol Violation|0|||
33402089|NCT03055806|101361630|FG002|Overall Study|Protocol Violation|0|||
33402090|NCT03055806|101361631|FG003|Overall Study|Protocol Violation|0|||
33402091|NCT03055806|101361628|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
33402092|NCT03055806|101361629|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
33402093|NCT03055806|101361630|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
33402094|NCT03055806|101361631|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
33402095|NCT03055806|101361628|FG000|Overall Study|Withdrawal of consent to continue study|2|||
33402096|NCT03055806|101361629|FG001|Overall Study|Withdrawal of consent to continue study|3|||
33402097|NCT03055806|101361630|FG002|Overall Study|Withdrawal of consent to continue study|4|||
33402098|NCT03055806|101361631|FG003|Overall Study|Withdrawal of consent to continue study|6|||
33402099|NCT03055806|101361628|FG000|Overall Study|Partner not willing to try intercourse|1|||
33402100|NCT03055806|101361629|FG001|Overall Study|Partner not willing to try intercourse|0|||
33402101|NCT03055806|101361630|FG002|Overall Study|Partner not willing to try intercourse|0|||
33402102|NCT03055806|101361631|FG003|Overall Study|Partner not willing to try intercourse|0|||
33402103|NCT02813681|101361632|FG000|Overall Study|Physician Decision|5|||
33402104|NCT02813681|101361633|FG001|Overall Study|Physician Decision|5|||
33402105|NCT02813681|101361634|FG002|Overall Study|Physician Decision|0|||
33402106|NCT02813681|101361632|FG000|Overall Study|Lost to Follow-up|0|||
33402107|NCT02813681|101361633|FG001|Overall Study|Lost to Follow-up|1|||
33402108|NCT02813681|101361634|FG002|Overall Study|Lost to Follow-up|0|||
33402109|NCT03969589|101361635|FG000|Overall Study|Lost to Follow-up|3|||
33402110|NCT03969589|101361636|FG001|Overall Study|Lost to Follow-up|2|||
33402111|NCT03969589|101361635|FG000|Overall Study|Declined Follow-Up|0|||
33402112|NCT03969589|101361636|FG001|Overall Study|Declined Follow-Up|1|||
33402113|NCT01952041|101361645|FG000|Overall Study|Lost to Follow-up|9|||
33402114|NCT01952041|101361646|FG001|Overall Study|Lost to Follow-up|16|||
33402115|NCT01952041|101361645|FG000|Overall Study|Withdrawal by Subject|7|||
33402116|NCT01952041|101361646|FG001|Overall Study|Withdrawal by Subject|5|||
33402117|NCT01952041|101361645|FG000|Overall Study|Death|1|||
33402118|NCT01952041|101361646|FG001|Overall Study|Death|0|||
33402119|NCT03143855|101361647|FG000|Overall Study|Withdrawal by Subject|4|||
33402120|NCT03143855|101361648|FG001|Overall Study|Withdrawal by Subject|3|||
33402121|NCT03143855|101361647|FG000|Overall Study|Protocol Violation|1|||
33402122|NCT03143855|101361648|FG001|Overall Study|Protocol Violation|0|||
33402123|NCT03143855|101361647|FG000|Overall Study|Participant experienced withdrawal|0|||
33402124|NCT03143855|101361648|FG001|Overall Study|Participant experienced withdrawal|1|||
33402125|NCT02363322|101361649|FG000|Overall Study|Lost to Follow-up|1|||
33402126|NCT02363322|101361650|FG001|Overall Study|Lost to Follow-up|0|||
33402127|NCT01711359|101361654|FG000|Treatment Period|Withdrawal by Subject|18|||
33402128|NCT01711359|101361655|FG001|Treatment Period|Withdrawal by Subject|7|||
33402129|NCT01711359|101361656|FG002|Treatment Period|Withdrawal by Subject|13|||
33402130|NCT01711359|101361654|FG000|Treatment Period|Lack of Efficacy|13|||
33402131|NCT01711359|101361655|FG001|Treatment Period|Lack of Efficacy|2|||
33402132|NCT01711359|101361656|FG002|Treatment Period|Lack of Efficacy|2|||
33402133|NCT01711359|101361654|FG000|Treatment Period|Adverse Event|8|||
33402134|NCT01711359|101361655|FG001|Treatment Period|Adverse Event|10|||
33402135|NCT01711359|101361656|FG002|Treatment Period|Adverse Event|24|||
33402136|NCT01711359|101361654|FG000|Treatment Period|Physician Decision|4|||
33402137|NCT01711359|101361655|FG001|Treatment Period|Physician Decision|3|||
33402138|NCT01711359|101361656|FG002|Treatment Period|Physician Decision|2|||
33524617|NCT01119846|101819709|FG002|Overall Study|Protocol Violation|1|||
33402139|NCT01711359|101361654|FG000|Treatment Period|Death|3|||
33402140|NCT01711359|101361655|FG001|Treatment Period|Death|0|||
33402141|NCT01711359|101361656|FG002|Treatment Period|Death|0|||
33402142|NCT01711359|101361654|FG000|Treatment Period|Entry Criteria Not Met|1|||
33402143|NCT01711359|101361655|FG001|Treatment Period|Entry Criteria Not Met|0|||
33402144|NCT01711359|101361656|FG002|Treatment Period|Entry Criteria Not Met|0|||
33402145|NCT01711359|101361654|FG000|Treatment Period|Sponsor Decision|1|||
33402146|NCT01711359|101361655|FG001|Treatment Period|Sponsor Decision|0|||
33402147|NCT01711359|101361656|FG002|Treatment Period|Sponsor Decision|0|||
33402148|NCT01711359|101361654|FG000|Treatment Period|Lost to Follow-up|1|||
33402149|NCT01711359|101361655|FG001|Treatment Period|Lost to Follow-up|1|||
33402150|NCT01711359|101361656|FG002|Treatment Period|Lost to Follow-up|1|||
33402151|NCT01711359|101361654|FG000|Treatment Period|Randomized, Not Treated|3|||
33402152|NCT01711359|101361655|FG001|Treatment Period|Randomized, Not Treated|1|||
33402153|NCT01711359|101361656|FG002|Treatment Period|Randomized, Not Treated|0|||
33402154|NCT03604159|101361661|FG000|Overall Study|Lost to Follow-up|6|||
33524618|NCT01119846|101819707|FG000|Overall Study|Withdrawal by Subject|0|||
33524619|NCT01119846|101819708|FG001|Overall Study|Withdrawal by Subject|0|||
33524620|NCT01119846|101819709|FG002|Overall Study|Withdrawal by Subject|4|||
33524621|NCT00048165|101819712|FG000|Completed 6 Months Study|Administration/Other|8|||
33524622|NCT00048165|101819713|FG001|Completed 6 Months Study|Administration/Other|8|||
33609841|NCT01717326|102123147|FG006|Overall Study|Physician Decision|0|||
33609842|NCT01717326|102123148|FG007|Overall Study|Physician Decision|0|||
33609843|NCT01717326|102123149|FG008|Overall Study|Physician Decision|0|||
33609844|NCT01717326|102123150|FG009|Overall Study|Physician Decision|1|||
33609845|NCT01717326|102123151|FG010|Overall Study|Physician Decision|0|||
33609846|NCT01717326|102123152|FG011|Overall Study|Physician Decision|0|||
33609847|NCT01717326|102123153|FG012|Overall Study|Physician Decision|0|||
33609848|NCT01717326|102123154|FG013|Overall Study|Physician Decision|0|||
33609849|NCT01717326|102123155|FG014|Overall Study|Physician Decision|0|||
33609850|NCT01717326|102123156|FG015|Overall Study|Physician Decision|0|||
33609851|NCT01717326|102123157|FG016|Overall Study|Physician Decision|0|||
33609852|NCT01717326|102123158|FG017|Overall Study|Physician Decision|0|||
33609853|NCT01717326|102123159|FG018|Overall Study|Physician Decision|0|||
33524623|NCT00048165|101819712|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
33524624|NCT00048165|101819713|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
33524625|NCT00048165|101819712|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
33524626|NCT00048165|101819713|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
33524627|NCT00048165|101819712|FG000|Completed 6 Months Study|Death|12|||
33524628|NCT00048165|101819713|FG001|Completed 6 Months Study|Death|6|||
33524629|NCT00048165|101819712|FG000|Completed 6 Months Study|Insufficient therapy|1|||
33524630|NCT00048165|101819713|FG001|Completed 6 Months Study|Insufficient therapy|4|||
33524631|NCT00048165|101819712|FG000|Completed 6 Months Study|Other violation|4|||
33524632|NCT00048165|101819713|FG001|Completed 6 Months Study|Other violation|6|||
33524633|NCT00048165|101819712|FG000|Completed 6 Months Study|Refused treatment|5|||
33524634|NCT00048165|101819713|FG001|Completed 6 Months Study|Refused treatment|5|||
33524635|NCT00048165|101819712|FG000|Completed 6 Months Study|Violation criteria|0|||
33524636|NCT00048165|101819713|FG001|Completed 6 Months Study|Violation criteria|2|||
33524637|NCT00048165|101819712|FG000|Completed 6 Months Study|Did not receive study drug|6|||
33524638|NCT00048165|101819713|FG001|Completed 6 Months Study|Did not receive study drug|6|||
33524639|NCT00048165|101819712|FG000|Completed 12 Months Study|Administration/Other|0|||
33524640|NCT00048165|101819713|FG001|Completed 12 Months Study|Administration/Other|2|||
33524641|NCT00048165|101819712|FG000|Completed 12 Months Study|Death|2|||
33524642|NCT00048165|101819713|FG001|Completed 12 Months Study|Death|1|||
33524643|NCT00048165|101819712|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
33524644|NCT00048165|101819713|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
33524645|NCT00528372|101819715|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
33524646|NCT00528372|101819716|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33524647|NCT00528372|101819717|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33524648|NCT00528372|101819718|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33524649|NCT00528372|101819719|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33524650|NCT00528372|101819720|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33524651|NCT00528372|101819721|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33524652|NCT00528372|101819722|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33524653|NCT00528372|101819723|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
33524654|NCT00528372|101819715|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
33524655|NCT00528372|101819716|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
33524656|NCT00528372|101819717|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
33524657|NCT00528372|101819718|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
33524658|NCT00528372|101819719|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
33609854|NCT01717326|102123160|FG019|Overall Study|Physician Decision|0|||
33609855|NCT01717326|102123141|FG000|Overall Study|Protocol Violation|0|||
33330588|NCT02121262|101104145|FG000|Overall Study|Adverse Event|6|||
33330589|NCT02121262|101104146|FG001|Overall Study|Adverse Event|3|||
33330590|NCT02121262|101104145|FG000|Overall Study|Lack of Efficacy|3|||
33330591|NCT02121262|101104146|FG001|Overall Study|Lack of Efficacy|0|||
33330592|NCT02121262|101104145|FG000|Overall Study|Personal Reasons|19|||
33330593|NCT02121262|101104146|FG001|Overall Study|Personal Reasons|5|||
33330594|NCT02121262|101104145|FG000|Overall Study|Protocol Violation|1|||
33330595|NCT02121262|101104146|FG001|Overall Study|Protocol Violation|1|||
33330596|NCT02121262|101104145|FG000|Overall Study|Participant Dropped-out|0|||
33330597|NCT02121262|101104146|FG001|Overall Study|Participant Dropped-out|1|||
33330598|NCT02121262|101104145|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
33330599|NCT02121262|101104146|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
33330600|NCT02121262|101104145|FG000|Overall Study|Consent Withdrawn|1|||
33330601|NCT02121262|101104146|FG001|Overall Study|Consent Withdrawn|0|||
33524659|NCT00528372|101819720|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
33609856|NCT01717326|102123142|FG001|Overall Study|Protocol Violation|0|||
33330602|NCT00365456|101104147|FG000|Trial Period I (12 Months)|Adverse Event|84|||
33330603|NCT00365456|101104148|FG001|Trial Period I (12 Months)|Adverse Event|0|||
33524660|NCT00528372|101819721|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
33524661|NCT00528372|101819722|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
33524662|NCT00528372|101819723|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
33524663|NCT00528372|101819715|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
33524664|NCT00528372|101819716|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
33524665|NCT00528372|101819717|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
33524666|NCT00528372|101819718|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
33524667|NCT00528372|101819719|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
33524668|NCT00528372|101819720|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
33524669|NCT00528372|101819721|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
33524670|NCT00528372|101819722|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
33524671|NCT00528372|101819723|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
33524672|NCT00528372|101819715|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
33524673|NCT00528372|101819716|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
33524674|NCT00528372|101819717|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
33524675|NCT00528372|101819718|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
33524676|NCT00528372|101819719|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
33201749|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33201750|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33201751|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33201752|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33201753|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33201754|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33201755|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
33201756|NCT01172938|100642675|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33201757|NCT01172938|100642676|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33201758|NCT01172938|100642677|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33330604|NCT00365456|101104147|FG000|Trial Period I (12 Months)|Non-compliance|3|||
33524677|NCT00528372|101819720|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
33524678|NCT00528372|101819721|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
33524679|NCT00528372|101819722|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
33524680|NCT00528372|101819723|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
33524681|NCT00528372|101819715|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
33524682|NCT00528372|101819716|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
33330605|NCT00365456|101104148|FG001|Trial Period I (12 Months)|Non-compliance|0|||
33330606|NCT00365456|101104147|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
33330607|NCT00365456|101104148|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
33330608|NCT00365456|101104147|FG000|Trial Period I (12 Months)|Other|11|||
33330609|NCT00365456|101104148|FG001|Trial Period I (12 Months)|Other|0|||
33330610|NCT00365456|101104147|FG000|Trial Period II (12 Months)|Adverse Event|0|||
33330611|NCT00365456|101104148|FG001|Trial Period II (12 Months)|Adverse Event|6|||
33330612|NCT00365456|101104147|FG000|Trial Period II (12 Months)|Non-compliance|0|||
33330613|NCT00365456|101104148|FG001|Trial Period II (12 Months)|Non-compliance|2|||
33330614|NCT00365456|101104147|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
33330615|NCT00365456|101104148|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
33330616|NCT00365456|101104147|FG000|Trial Period II (12 Months)|Other|0|||
33330617|NCT00365456|101104148|FG001|Trial Period II (12 Months)|Other|1|||
33524683|NCT00528372|101819717|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
33524684|NCT00528372|101819718|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
33524685|NCT00528372|101819719|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
33201759|NCT01172938|100642678|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33524686|NCT00528372|101819720|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
33524687|NCT00528372|101819721|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
33524688|NCT00528372|101819722|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
33524689|NCT00528372|101819723|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
33524690|NCT00528372|101819715|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
33524691|NCT00528372|101819716|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
33201760|NCT01172938|100642679|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33201761|NCT01172938|100642680|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33201762|NCT01172938|100642681|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33330618|NCT00365456|101104147|FG000|Trial Period III (12 Months)|Adverse Event|13|||
33330619|NCT00365456|101104148|FG001|Trial Period III (12 Months)|Adverse Event|3|||
33524692|NCT00528372|101819717|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
33524693|NCT00528372|101819718|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
33524694|NCT00528372|101819719|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
33524695|NCT00528372|101819720|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
33524696|NCT00528372|101819721|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
33524697|NCT00528372|101819722|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
33524698|NCT00528372|101819723|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
33330620|NCT00365456|101104147|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
33330621|NCT00365456|101104148|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
33330622|NCT00365456|101104147|FG000|Trial Period III (12 Months)|Other|1|||
33330623|NCT00365456|101104148|FG001|Trial Period III (12 Months)|Other|1|||
33330624|NCT02113436|101104157|FG000|Period 1: 8 Weeks|Adverse Event|1|||
33330625|NCT02113436|101104158|FG001|Period 1: 8 Weeks|Adverse Event|0|||
33330626|NCT02113436|101104159|FG002|Period 1: 8 Weeks|Adverse Event|0|||
33330627|NCT02113436|101104160|FG003|Period 1: 8 Weeks|Adverse Event|0|||
33330628|NCT02113436|101104157|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
33330629|NCT02113436|101104158|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
33330630|NCT02113436|101104159|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
33330631|NCT02113436|101104160|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
33330632|NCT02113436|101104157|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
33330633|NCT02113436|101104158|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
33330634|NCT02113436|101104159|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
33330635|NCT02113436|101104160|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
33330636|NCT02113436|101104157|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
33330637|NCT02113436|101104158|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
33330638|NCT02113436|101104159|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
33330639|NCT02113436|101104160|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
33330640|NCT02113436|101104157|FG000|Period 2: 16 Weeks|Adverse Event|0|||
33330641|NCT02113436|101104158|FG001|Period 2: 16 Weeks|Adverse Event|0|||
33330642|NCT02113436|101104159|FG002|Period 2: 16 Weeks|Adverse Event|4|||
33330643|NCT02113436|101104160|FG003|Period 2: 16 Weeks|Adverse Event|5|||
33330644|NCT02113436|101104157|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
33330645|NCT02113436|101104158|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
33330646|NCT02113436|101104159|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
33330647|NCT02113436|101104160|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
33330648|NCT02113436|101104157|FG000|Period 2: 16 Weeks|Physician Decision|0|||
33330649|NCT02113436|101104158|FG001|Period 2: 16 Weeks|Physician Decision|0|||
33330650|NCT02113436|101104159|FG002|Period 2: 16 Weeks|Physician Decision|2|||
33330651|NCT02113436|101104160|FG003|Period 2: 16 Weeks|Physician Decision|0|||
33330652|NCT02113436|101104157|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
33330653|NCT02113436|101104158|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
33330654|NCT02113436|101104159|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
33330655|NCT02113436|101104160|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
33330656|NCT00282334|101104163|FG000|Overall Study|Withdrawal by Subject|8|||
33330657|NCT00282334|101104164|FG001|Overall Study|Withdrawal by Subject|5|||
33330658|NCT04854434|101104165|FG000|Overall Study|Death|1|||
33330659|NCT04854434|101104166|FG001|Overall Study|Death|3|||
33330660|NCT04854434|101104167|FG002|Overall Study|Death|4|||
33330661|NCT04854434|101104165|FG000|Overall Study|Study Terminated by Sponsor|2|||
33330662|NCT04854434|101104166|FG001|Overall Study|Study Terminated by Sponsor|0|||
33330663|NCT04854434|101104167|FG002|Overall Study|Study Terminated by Sponsor|0|||
33330664|NCT04854434|101104165|FG000|Overall Study|Other|1|||
33330665|NCT04854434|101104166|FG001|Overall Study|Other|1|||
33330666|NCT04854434|101104167|FG002|Overall Study|Other|0|||
33330667|NCT01417195|101104168|FG000|Overall Study|Stimulation failure|1|||
33330668|NCT01417195|101104169|FG001|Overall Study|Stimulation failure|0|||
33330669|NCT01417195|101104168|FG000|Overall Study|No embryos for transfer|0|||
33201763|NCT01172938|100642682|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
33201764|NCT01172938|100642683|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
33201765|NCT01172938|100642675|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
33201766|NCT01172938|100642676|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
33201767|NCT01172938|100642677|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
33201768|NCT01172938|100642678|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
33524699|NCT00528372|101819715|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
33524700|NCT00528372|101819716|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
33524701|NCT00528372|101819717|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
33201769|NCT01172938|100642679|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
33609857|NCT01717326|102123143|FG002|Overall Study|Protocol Violation|0|||
33609858|NCT01717326|102123144|FG003|Overall Study|Protocol Violation|0|||
33609859|NCT01717326|102123145|FG004|Overall Study|Protocol Violation|1|||
33609860|NCT01717326|102123146|FG005|Overall Study|Protocol Violation|0|||
33609861|NCT01717326|102123147|FG006|Overall Study|Protocol Violation|0|||
33609862|NCT01717326|102123148|FG007|Overall Study|Protocol Violation|0|||
33609863|NCT01717326|102123149|FG008|Overall Study|Protocol Violation|0|||
33609864|NCT01717326|102123150|FG009|Overall Study|Protocol Violation|0|||
33609865|NCT01717326|102123151|FG010|Overall Study|Protocol Violation|0|||
33609866|NCT01717326|102123152|FG011|Overall Study|Protocol Violation|0|||
33201770|NCT01172938|100642680|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
33201771|NCT01172938|100642681|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
33524702|NCT00528372|101819718|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
33524703|NCT00528372|101819719|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
33609867|NCT01717326|102123153|FG012|Overall Study|Protocol Violation|0|||
33609868|NCT01717326|102123154|FG013|Overall Study|Protocol Violation|0|||
33524704|NCT00528372|101819720|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
33609869|NCT01717326|102123155|FG014|Overall Study|Protocol Violation|0|||
33609870|NCT01717326|102123156|FG015|Overall Study|Protocol Violation|0|||
33609871|NCT01717326|102123157|FG016|Overall Study|Protocol Violation|0|||
33201772|NCT01172938|100642682|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
33524705|NCT00528372|101819721|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
33524706|NCT00528372|101819722|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
33524707|NCT00528372|101819723|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
33524708|NCT00528372|101819715|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
33201773|NCT01172938|100642683|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
33201774|NCT01172938|100642675|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
33201775|NCT01172938|100642676|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
33201776|NCT01172938|100642677|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
33201777|NCT01172938|100642678|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
33524709|NCT00528372|101819716|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
33524710|NCT00528372|101819717|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
33201778|NCT01172938|100642679|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
33201779|NCT01172938|100642680|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
33201780|NCT01172938|100642681|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
33201781|NCT01172938|100642682|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
33201782|NCT01172938|100642683|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
33201783|NCT01172938|100642675|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
33201784|NCT01172938|100642676|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
33201785|NCT01172938|100642677|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
33201786|NCT01172938|100642678|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
33201787|NCT01172938|100642679|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
33201788|NCT01172938|100642680|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
33201789|NCT01172938|100642681|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
33201790|NCT01172938|100642682|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
33201791|NCT01172938|100642683|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
33524711|NCT00528372|101819718|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
33524712|NCT00528372|101819719|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
33524713|NCT00528372|101819720|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
33201792|NCT01172938|100642675|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33201793|NCT01172938|100642676|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
33201794|NCT01172938|100642677|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33201795|NCT01172938|100642678|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33524714|NCT00528372|101819721|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
33609872|NCT01717326|102123158|FG017|Overall Study|Protocol Violation|0|||
33609873|NCT01717326|102123159|FG018|Overall Study|Protocol Violation|0|||
33201796|NCT01172938|100642679|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33201797|NCT01172938|100642680|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33524715|NCT00528372|101819722|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
33201798|NCT01172938|100642681|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33201799|NCT01172938|100642682|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33201800|NCT01172938|100642683|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
33201801|NCT01172938|100642675|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33201802|NCT01172938|100642676|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33201803|NCT01172938|100642677|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
33201804|NCT01172938|100642678|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33201805|NCT01172938|100642679|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33201806|NCT01172938|100642680|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33201807|NCT01172938|100642681|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33330670|NCT01417195|101104169|FG001|Overall Study|No embryos for transfer|1|||
33330671|NCT01417195|101104168|FG000|Overall Study|No transfer due to risk of OHSS|1|||
33330672|NCT01417195|101104169|FG001|Overall Study|No transfer due to risk of OHSS|0|||
33330673|NCT01417195|101104168|FG000|Overall Study|No transfer due to elevated progesterone|1|||
33330674|NCT01417195|101104169|FG001|Overall Study|No transfer due to elevated progesterone|0|||
33330675|NCT00607386|101104174|FG000|Overall Study|Physician Decision|1|||
33524716|NCT00528372|101819723|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
33524717|NCT00528372|101819715|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
33524718|NCT00528372|101819716|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
33524719|NCT00528372|101819717|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
33524720|NCT00528372|101819718|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
33524721|NCT00528372|101819719|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
33524722|NCT00528372|101819720|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
33524723|NCT00528372|101819721|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
33524724|NCT00528372|101819722|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
33524725|NCT00528372|101819723|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
33524726|NCT00528372|101819715|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
33524727|NCT00528372|101819716|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
33524728|NCT00528372|101819717|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
33524729|NCT00528372|101819718|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
33524730|NCT00528372|101819719|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
33524731|NCT00528372|101819720|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
33524732|NCT00528372|101819721|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
33524733|NCT00528372|101819722|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
33524734|NCT00528372|101819723|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
33524735|NCT00528372|101819715|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
33524736|NCT00528372|101819716|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
33524737|NCT00528372|101819717|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
33524738|NCT00528372|101819718|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
33524739|NCT00528372|101819719|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
33524740|NCT00528372|101819720|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
33524741|NCT00528372|101819721|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
33524742|NCT00528372|101819722|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
33524743|NCT00528372|101819723|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
33524744|NCT00528372|101819715|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
33524745|NCT00528372|101819716|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
33524746|NCT00528372|101819717|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
33524747|NCT00528372|101819718|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
33524748|NCT00528372|101819719|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
33524749|NCT00528372|101819720|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
33524750|NCT00528372|101819721|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
33524751|NCT00528372|101819722|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
33524752|NCT00528372|101819723|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
33524753|NCT00528372|101819715|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
33524754|NCT00528372|101819716|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
33524755|NCT00528372|101819717|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
33524756|NCT00528372|101819718|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
33524757|NCT00528372|101819719|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
33524758|NCT00528372|101819720|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
33524759|NCT00528372|101819721|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
33201808|NCT01172938|100642682|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33402155|NCT03604159|101361662|FG001|Overall Study|Lost to Follow-up|7|||
33201809|NCT01172938|100642683|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
33330676|NCT00917150|101104175|FG000|Overall Study|Adverse Event|12|||
33402156|NCT02555722|101361663|FG000|Week 2|Adverse Event|0|||
33402157|NCT02555722|101361664|FG001|Week 2|Adverse Event|1|||
33402158|NCT02555722|101361663|FG000|Week 2|Withdrawal by Subject|1|||
33402159|NCT02555722|101361664|FG001|Week 2|Withdrawal by Subject|0|||
33402160|NCT02555722|101361663|FG000|Month 1|Lens Discomfort|1|||
33402161|NCT02555722|101361664|FG001|Month 1|Lens Discomfort|0|||
33402162|NCT02555722|101361663|FG000|Month 2|Withdrawal by Subject|3|||
33402163|NCT02555722|101361664|FG001|Month 2|Withdrawal by Subject|0|||
33402164|NCT02555722|101361663|FG000|Month 2|Lost to Follow-up|1|||
33402165|NCT02555722|101361664|FG001|Month 2|Lost to Follow-up|0|||
33402166|NCT02743494|101361665|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
33402167|NCT02743494|101361666|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
33402168|NCT02743494|101361665|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
33524760|NCT00528372|101819722|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
33524761|NCT00528372|101819723|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
33524762|NCT00528372|101819715|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
33524763|NCT00528372|101819716|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
33524764|NCT00528372|101819717|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
33524765|NCT00528372|101819718|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
33524766|NCT00528372|101819719|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
33524767|NCT00528372|101819720|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
33524768|NCT00528372|101819721|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
33524769|NCT00528372|101819722|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
33524770|NCT00528372|101819723|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
33524771|NCT00528372|101819715|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
33524772|NCT00528372|101819716|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
33524773|NCT00528372|101819717|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
33524774|NCT00528372|101819718|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
33524775|NCT00528372|101819719|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
33524776|NCT00528372|101819720|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
33524777|NCT00528372|101819721|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
33524778|NCT00528372|101819722|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
33524779|NCT00528372|101819723|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
33201810|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
33201811|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
33201812|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
33201813|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
33201814|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
33201815|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
33201816|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
33201817|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
33201818|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
33330677|NCT00917150|101104176|FG001|Overall Study|Adverse Event|7|||
33524780|NCT03430856|101819724|FG000|Overall Study|Adverse Event|0|||
33524781|NCT03430856|101819725|FG001|Overall Study|Adverse Event|1|||
33524782|NCT03430856|101819726|FG002|Overall Study|Adverse Event|0|||
33524783|NCT03430856|101819724|FG000|Overall Study|Rescue criteria|1|||
33524784|NCT03430856|101819725|FG001|Overall Study|Rescue criteria|1|||
33201819|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
33201820|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
33201821|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
33330678|NCT00917150|101104177|FG002|Overall Study|Adverse Event|12|||
33330679|NCT00917150|101104178|FG003|Overall Study|Adverse Event|11|||
33330680|NCT00917150|101104175|FG000|Overall Study|Death|1|||
33330681|NCT00917150|101104176|FG001|Overall Study|Death|4|||
33330682|NCT00917150|101104177|FG002|Overall Study|Death|3|||
33330683|NCT00917150|101104178|FG003|Overall Study|Death|2|||
33330684|NCT00917150|101104175|FG000|Overall Study|Lost to Follow-up|1|||
33330685|NCT00917150|101104176|FG001|Overall Study|Lost to Follow-up|0|||
33402169|NCT02743494|101361666|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
33201822|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
33201823|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
33330686|NCT00917150|101104177|FG002|Overall Study|Lost to Follow-up|4|||
33402170|NCT02743494|101361665|FG000|Treatment Period|Completed treatment|229|||
33330687|NCT00917150|101104178|FG003|Overall Study|Lost to Follow-up|2|||
33402171|NCT02743494|101361666|FG001|Treatment Period|Completed treatment|99|||
33402172|NCT02743494|101361665|FG000|Treatment Period|Disease recurrence|149|||
33402173|NCT02743494|101361666|FG001|Treatment Period|Disease recurrence|113|||
33402174|NCT02743494|101361665|FG000|Treatment Period|Study drug toxicity|57|||
33402175|NCT02743494|101361666|FG001|Treatment Period|Study drug toxicity|8|||
33402176|NCT02743494|101361665|FG000|Treatment Period|Death|1|||
33524785|NCT03430856|101819726|FG002|Overall Study|Rescue criteria|0|||
33524786|NCT03430856|101819724|FG000|Overall Study|Voluntary withdrawal of consent|1|||
33524787|NCT03430856|101819725|FG001|Overall Study|Voluntary withdrawal of consent|1|||
33524788|NCT03430856|101819726|FG002|Overall Study|Voluntary withdrawal of consent|1|||
33524789|NCT00055497|101819727|FG000|Overall Study|Adverse Event|1|||
33524790|NCT00055497|101819728|FG001|Overall Study|Adverse Event|1|||
33524791|NCT00055497|101819729|FG002|Overall Study|Adverse Event|1|||
33524792|NCT00055497|101819730|FG003|Overall Study|Adverse Event|28|||
33524793|NCT00055497|101819727|FG000|Overall Study|Withdrawal by Subject|3|||
33524794|NCT00055497|101819728|FG001|Overall Study|Withdrawal by Subject|1|||
33524795|NCT00055497|101819729|FG002|Overall Study|Withdrawal by Subject|1|||
33524796|NCT00055497|101819730|FG003|Overall Study|Withdrawal by Subject|15|||
33524797|NCT00055497|101819727|FG000|Overall Study|Lost to Follow-up|0|||
33524798|NCT00055497|101819728|FG001|Overall Study|Lost to Follow-up|1|||
33524799|NCT00055497|101819729|FG002|Overall Study|Lost to Follow-up|0|||
33524800|NCT00055497|101819730|FG003|Overall Study|Lost to Follow-up|5|||
33524801|NCT00055497|101819727|FG000|Overall Study|Protocol Violation|0|||
33524802|NCT00055497|101819728|FG001|Overall Study|Protocol Violation|0|||
33524803|NCT00055497|101819729|FG002|Overall Study|Protocol Violation|0|||
33524804|NCT00055497|101819730|FG003|Overall Study|Protocol Violation|3|||
33524805|NCT00055497|101819727|FG000|Overall Study|Lack of Efficacy|1|||
33524806|NCT00055497|101819728|FG001|Overall Study|Lack of Efficacy|0|||
33524807|NCT00055497|101819729|FG002|Overall Study|Lack of Efficacy|0|||
33524808|NCT00055497|101819730|FG003|Overall Study|Lack of Efficacy|27|||
33524809|NCT00055497|101819727|FG000|Overall Study|Administrative Reasons|0|||
33524810|NCT00055497|101819728|FG001|Overall Study|Administrative Reasons|0|||
33524811|NCT00055497|101819729|FG002|Overall Study|Administrative Reasons|0|||
33524812|NCT00055497|101819730|FG003|Overall Study|Administrative Reasons|1|||
33524813|NCT00055497|101819727|FG000|Overall Study|Other|0|||
33524814|NCT00055497|101819728|FG001|Overall Study|Other|0|||
33524815|NCT00055497|101819729|FG002|Overall Study|Other|0|||
33524816|NCT00055497|101819730|FG003|Overall Study|Other|11|||
33524817|NCT00966355|101819731|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
33524818|NCT00966355|101819732|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
33524819|NCT00966355|101819733|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
33524820|NCT00966355|101819731|FG000|Overall Study|newly diagnosed advanced HCC|11|||
33524821|NCT00966355|101819732|FG001|Overall Study|newly diagnosed advanced HCC|12|||
33524822|NCT00966355|101819733|FG002|Overall Study|newly diagnosed advanced HCC|10|||
33524823|NCT00966355|101819731|FG000|Overall Study|Lost to Follow-up|5|||
33524824|NCT00966355|101819732|FG001|Overall Study|Lost to Follow-up|4|||
33524825|NCT00966355|101819733|FG002|Overall Study|Lost to Follow-up|3|||
33524826|NCT02187861|101819737|FG000|Overall Study|Adverse Event|2|||
33524827|NCT02187861|101819738|FG001|Overall Study|Adverse Event|1|||
33524828|NCT02187861|101819739|FG002|Overall Study|Adverse Event|2|||
33524829|NCT02187861|101819740|FG003|Overall Study|Adverse Event|1|||
33524830|NCT02187861|101819737|FG000|Overall Study|Death|0|||
33524831|NCT02187861|101819738|FG001|Overall Study|Death|3|||
33524832|NCT02187861|101819739|FG002|Overall Study|Death|1|||
33524833|NCT02187861|101819740|FG003|Overall Study|Death|2|||
33524834|NCT02187861|101819737|FG000|Overall Study|Physician Decision|0|||
33524835|NCT02187861|101819738|FG001|Overall Study|Physician Decision|1|||
33524836|NCT02187861|101819739|FG002|Overall Study|Physician Decision|0|||
33330688|NCT00917150|101104175|FG000|Overall Study|Physician Decision|0|||
33330689|NCT00917150|101104176|FG001|Overall Study|Physician Decision|2|||
33330690|NCT00917150|101104177|FG002|Overall Study|Physician Decision|0|||
33330691|NCT00917150|101104178|FG003|Overall Study|Physician Decision|1|||
33330692|NCT00917150|101104175|FG000|Overall Study|Protocol Violation|5|||
33330693|NCT00917150|101104176|FG001|Overall Study|Protocol Violation|5|||
33524837|NCT02187861|101819740|FG003|Overall Study|Physician Decision|3|||
33524838|NCT02187861|101819737|FG000|Overall Study|Progressive Disease|4|||
33524839|NCT02187861|101819738|FG001|Overall Study|Progressive Disease|42|||
33524840|NCT02187861|101819739|FG002|Overall Study|Progressive Disease|19|||
33524841|NCT02187861|101819740|FG003|Overall Study|Progressive Disease|22|||
33524842|NCT02187861|101819737|FG000|Overall Study|Withdrawal by Subject|0|||
33330694|NCT00917150|101104177|FG002|Overall Study|Protocol Violation|3|||
33330695|NCT00917150|101104178|FG003|Overall Study|Protocol Violation|5|||
33524843|NCT02187861|101819738|FG001|Overall Study|Withdrawal by Subject|0|||
33524844|NCT02187861|101819739|FG002|Overall Study|Withdrawal by Subject|3|||
33524845|NCT02187861|101819740|FG003|Overall Study|Withdrawal by Subject|3|||
33524846|NCT02187861|101819737|FG000|Overall Study|Other|0|||
33524847|NCT02187861|101819738|FG001|Overall Study|Other|1|||
33524848|NCT02187861|101819739|FG002|Overall Study|Other|7|||
33524849|NCT02187861|101819740|FG003|Overall Study|Other|1|||
33524850|NCT00076999|101819744|FG000|Overall Study|Adverse Event|2|||
33524851|NCT00076999|101819745|FG001|Overall Study|Adverse Event|8|||
33330696|NCT00917150|101104175|FG000|Overall Study|Withdrawal by Subject|15|||
33524852|NCT00076999|101819746|FG002|Overall Study|Adverse Event|6|||
33524853|NCT00076999|101819747|FG003|Overall Study|Adverse Event|0|||
33330697|NCT00917150|101104176|FG001|Overall Study|Withdrawal by Subject|16|||
33201824|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
33201825|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
33201826|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
33201827|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
33609874|NCT01717326|102123160|FG019|Overall Study|Protocol Violation|0|||
33609875|NCT01717326|102123141|FG000|Overall Study|Withdrawal by Subject|0|||
33609876|NCT01717326|102123142|FG001|Overall Study|Withdrawal by Subject|1|||
33609877|NCT01717326|102123143|FG002|Overall Study|Withdrawal by Subject|0|||
33201828|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
33201829|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
33201830|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
33201831|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
33201832|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
33201833|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
33201834|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
33201835|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
33201836|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
33201837|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
33201838|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
33201839|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
33201840|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
33201841|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
33201842|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
33201843|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
33201844|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
33201845|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
33201846|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33330698|NCT00917150|101104177|FG002|Overall Study|Withdrawal by Subject|18|||
33330699|NCT00917150|101104178|FG003|Overall Study|Withdrawal by Subject|11|||
33330700|NCT00917150|101104175|FG000|Overall Study|Other than specified|3|||
33330701|NCT00917150|101104176|FG001|Overall Study|Other than specified|3|||
33330702|NCT00917150|101104177|FG002|Overall Study|Other than specified|2|||
33330703|NCT00917150|101104178|FG003|Overall Study|Other than specified|2|||
33330704|NCT05003622|101104179|FG000|Overall Study|Progressive disease|2|||
33609878|NCT01717326|102123144|FG003|Overall Study|Withdrawal by Subject|0|||
33609879|NCT01717326|102123145|FG004|Overall Study|Withdrawal by Subject|0|||
33609880|NCT01717326|102123146|FG005|Overall Study|Withdrawal by Subject|0|||
33609881|NCT01717326|102123147|FG006|Overall Study|Withdrawal by Subject|0|||
33609882|NCT01717326|102123148|FG007|Overall Study|Withdrawal by Subject|0|||
33609883|NCT01717326|102123149|FG008|Overall Study|Withdrawal by Subject|0|||
33609884|NCT01717326|102123150|FG009|Overall Study|Withdrawal by Subject|1|||
33609885|NCT01717326|102123151|FG010|Overall Study|Withdrawal by Subject|0|||
33609886|NCT01717326|102123152|FG011|Overall Study|Withdrawal by Subject|0|||
33609887|NCT01717326|102123153|FG012|Overall Study|Withdrawal by Subject|1|||
33609888|NCT01717326|102123154|FG013|Overall Study|Withdrawal by Subject|0|||
33609889|NCT01717326|102123155|FG014|Overall Study|Withdrawal by Subject|0|||
33330705|NCT05003622|101104179|FG000|Overall Study|Withdrawal by Subject|1|||
33330706|NCT01785160|101104180|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
33330707|NCT01785160|101104180|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
33330708|NCT00131469|101104181|FG000|Overall Study|Withdrawal by Subject|3|||
33330709|NCT00131469|101104182|FG001|Overall Study|Withdrawal by Subject|4|||
33330710|NCT00131469|101104181|FG000|Overall Study|Protocol Violation|3|||
33524854|NCT00076999|101819748|FG004|Overall Study|Adverse Event|2|||
33524855|NCT00076999|101819744|FG000|Overall Study|Protocol Violation|0|||
33524856|NCT00076999|101819745|FG001|Overall Study|Protocol Violation|3|||
33524857|NCT00076999|101819746|FG002|Overall Study|Protocol Violation|4|||
33524858|NCT00076999|101819747|FG003|Overall Study|Protocol Violation|0|||
33524859|NCT00076999|101819748|FG004|Overall Study|Protocol Violation|9|||
33524860|NCT00076999|101819744|FG000|Overall Study|Lost to Follow-up|2|||
33524861|NCT00076999|101819745|FG001|Overall Study|Lost to Follow-up|1|||
33524862|NCT00076999|101819746|FG002|Overall Study|Lost to Follow-up|0|||
33524863|NCT00076999|101819747|FG003|Overall Study|Lost to Follow-up|0|||
33609890|NCT01717326|102123156|FG015|Overall Study|Withdrawal by Subject|1|||
33609891|NCT01717326|102123157|FG016|Overall Study|Withdrawal by Subject|0|||
33609892|NCT01717326|102123158|FG017|Overall Study|Withdrawal by Subject|0|||
33609893|NCT01717326|102123159|FG018|Overall Study|Withdrawal by Subject|2|||
33609894|NCT01717326|102123160|FG019|Overall Study|Withdrawal by Subject|3|||
33609895|NCT00950742|102123161|FG000|Overall Study|Other Adverse Event|1|||
33330711|NCT00131469|101104182|FG001|Overall Study|Protocol Violation|1|||
33609896|NCT00950742|102123162|FG001|Overall Study|Other Adverse Event|0|||
33524864|NCT00076999|101819748|FG004|Overall Study|Lost to Follow-up|0|||
33524865|NCT00076999|101819744|FG000|Overall Study|Withdrawal by Subject|0|||
33524866|NCT00076999|101819745|FG001|Overall Study|Withdrawal by Subject|4|||
33524867|NCT00076999|101819746|FG002|Overall Study|Withdrawal by Subject|3|||
33524868|NCT00076999|101819747|FG003|Overall Study|Withdrawal by Subject|0|||
33524869|NCT00076999|101819748|FG004|Overall Study|Withdrawal by Subject|1|||
33524870|NCT00076999|101819744|FG000|Overall Study|Other reason (not specified)|8|||
33524871|NCT00076999|101819745|FG001|Overall Study|Other reason (not specified)|8|||
33524872|NCT00076999|101819746|FG002|Overall Study|Other reason (not specified)|4|||
33524873|NCT00076999|101819747|FG003|Overall Study|Other reason (not specified)|1|||
33524874|NCT00076999|101819748|FG004|Overall Study|Other reason (not specified)|13|||
33524875|NCT01754766|101819754|FG000|Overall Study|Personal reasons|1|||
33524876|NCT01754766|101819755|FG001|Overall Study|Personal reasons|1|||
33524877|NCT01754766|101819756|FG002|Overall Study|Personal reasons|0|||
33524878|NCT02137226|101819757|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
33524879|NCT02137226|101819758|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
33524880|NCT02137226|101819759|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
33524881|NCT02137226|101819760|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
33524882|NCT02137226|101819761|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
33524883|NCT02137226|101819757|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
33524884|NCT02137226|101819758|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
33524885|NCT02137226|101819759|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
33524886|NCT02137226|101819760|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
33524887|NCT02137226|101819761|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
33524888|NCT02137226|101819757|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
33524889|NCT02137226|101819758|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
33524890|NCT02137226|101819759|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
33524891|NCT02137226|101819760|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
33524892|NCT02137226|101819761|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
33524893|NCT02137226|101819757|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
33524894|NCT02137226|101819758|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
33524895|NCT02137226|101819759|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
33609897|NCT00950742|102123161|FG000|Overall Study|Withdrawal by Subject|3|||
33609898|NCT00950742|102123162|FG001|Overall Study|Withdrawal by Subject|0|||
33609899|NCT00950742|102123161|FG000|Overall Study|Progressive Disease|6|||
33609900|NCT00950742|102123162|FG001|Overall Study|Progressive Disease|2|||
33609901|NCT00950742|102123161|FG000|Overall Study|Dose limiting toxicity|6|||
33609902|NCT00950742|102123162|FG001|Overall Study|Dose limiting toxicity|0|||
33330712|NCT00131469|101104181|FG000|Overall Study|Death|0|||
33330713|NCT00131469|101104182|FG001|Overall Study|Death|1|||
33330714|NCT00131469|101104181|FG000|Overall Study|Lost to Follow-up|0|||
33330715|NCT00131469|101104182|FG001|Overall Study|Lost to Follow-up|1|||
33330716|NCT00131469|101104181|FG000|Overall Study|scan not analyzable|3|||
33524896|NCT02137226|101819760|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
33524897|NCT02137226|101819761|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
33524898|NCT02137226|101819757|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
33524899|NCT02137226|101819758|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
33524900|NCT02137226|101819759|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
33524901|NCT02137226|101819760|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
33609903|NCT02353728|102123163|FG000|Overall Study|Subject non-compliance|1|||
33524902|NCT02137226|101819761|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
33524903|NCT02137226|101819757|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
33524904|NCT02137226|101819758|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
33524905|NCT02137226|101819759|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
33524906|NCT02137226|101819760|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
33524907|NCT02137226|101819761|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
33524908|NCT02137226|101819757|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
33524909|NCT02137226|101819758|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
33524910|NCT02137226|101819759|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
33524911|NCT02137226|101819760|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
33609904|NCT01953913|102123166|FG000|Overall Study|Disease Progression|349|||
33609905|NCT01953913|102123166|FG000|Overall Study|Worsening of underlying cancer|22|||
33524912|NCT02137226|101819761|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
33524913|NCT02137226|101819757|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
33609906|NCT01953913|102123166|FG000|Overall Study|Adverse Event|20|||
33609907|NCT01953913|102123166|FG000|Overall Study|Protocol Violation|6|||
33609908|NCT01953913|102123166|FG000|Overall Study|Lost to Follow-up|4|||
33609909|NCT01953913|102123166|FG000|Overall Study|Withdrawal by Subject|32|||
33609910|NCT01953913|102123166|FG000|Overall Study|Other than listed|108|||
33609911|NCT01953913|102123166|FG000|Overall Study|Not Treated|1|||
33609912|NCT05096312|102123167|FG000|Overall Study|Lost to Follow-up|2|||
33609913|NCT05096312|102123168|FG001|Overall Study|Lost to Follow-up|4|||
33330717|NCT00131469|101104182|FG001|Overall Study|scan not analyzable|6|||
33330718|NCT02290873|101104183|FG000|Overall Study|Withdrawal by Subject|0|||
33201847|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33201848|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33201849|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33201850|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33201851|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33201852|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33201853|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
33330719|NCT02290873|101104184|FG001|Overall Study|Withdrawal by Subject|1|||
33524914|NCT02137226|101819758|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
33524915|NCT02137226|101819759|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
33524916|NCT02137226|101819760|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
33524917|NCT02137226|101819761|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
33524918|NCT02137226|101819757|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
33524919|NCT02137226|101819758|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
33330720|NCT02290873|101104185|FG002|Overall Study|Withdrawal by Subject|1|||
33330721|NCT02290873|101104183|FG000|Overall Study|Nellcor device error|1|||
33330722|NCT02290873|101104184|FG001|Overall Study|Nellcor device error|0|||
33609914|NCT05096312|102123167|FG000|Overall Study|Adverse Event|1|||
33609915|NCT05096312|102123168|FG001|Overall Study|Adverse Event|0|||
33609916|NCT02294734|102123169|FG000|Overall Study|Adverse Event|5|||
33609917|NCT02294734|102123170|FG001|Overall Study|Adverse Event|5|||
33330723|NCT02290873|101104185|FG002|Overall Study|Nellcor device error|0|||
33330724|NCT02290873|101104183|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
33609918|NCT02294734|102123169|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
33609919|NCT02294734|102123170|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
33609920|NCT02294734|102123169|FG000|Overall Study|Lost to Follow-up|2|||
33201854|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
33330725|NCT02290873|101104184|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
33330726|NCT02290873|101104185|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
33330727|NCT02290873|101104183|FG000|Overall Study|Protocol Violation|0|||
33330728|NCT02290873|101104184|FG001|Overall Study|Protocol Violation|0|||
33330729|NCT02290873|101104185|FG002|Overall Study|Protocol Violation|1|||
33330730|NCT02164929|101104190|FG000|Overall Study|Converted to open procedure|1|||
33330731|NCT02164929|101104191|FG001|Overall Study|Converted to open procedure|0|||
33524920|NCT02137226|101819759|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
33524921|NCT02137226|101819760|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
33524922|NCT02137226|101819761|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
33524923|NCT02137226|101819757|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
33330732|NCT02164929|101104192|FG002|Overall Study|Converted to open procedure|0|||
33330733|NCT02164929|101104193|FG003|Overall Study|Converted to open procedure|2|||
33524924|NCT02137226|101819758|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
33524925|NCT02137226|101819759|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
33524926|NCT02137226|101819760|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
33524927|NCT02137226|101819761|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
33524928|NCT02137226|101819757|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
33524929|NCT02137226|101819758|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
33524930|NCT02137226|101819759|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
33524931|NCT02137226|101819760|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
33524932|NCT02137226|101819761|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
33524933|NCT02137226|101819757|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
33524934|NCT02137226|101819758|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
33524935|NCT02137226|101819759|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
33524936|NCT02137226|101819760|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
33524937|NCT02137226|101819761|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
33524938|NCT01578499|101819762|FG000|Overall Study|Reason not Specified|0|||
33330734|NCT02164929|101104190|FG000|Overall Study|Failed regional block|0|||
33330735|NCT02164929|101104191|FG001|Overall Study|Failed regional block|0|||
33330736|NCT02164929|101104192|FG002|Overall Study|Failed regional block|1|||
33330737|NCT02164929|101104193|FG003|Overall Study|Failed regional block|0|||
33330738|NCT00960843|101104196|FG000|Overall Study|Lost to Follow-up|2|||
33330739|NCT00960843|101104197|FG001|Overall Study|Lost to Follow-up|0|||
33330740|NCT00960843|101104196|FG000|Overall Study|Protocol Violation|0|||
33330741|NCT00960843|101104197|FG001|Overall Study|Protocol Violation|4|||
33330742|NCT00960843|101104196|FG000|Overall Study|Repeated needle dislodgment|0|||
33330743|NCT00960843|101104197|FG001|Overall Study|Repeated needle dislodgment|1|||
33330744|NCT04050982|101104200|FG000|Overall Study|Did not meet eligibility criteria|0|||
33201855|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
33330745|NCT04050982|101104201|FG001|Overall Study|Did not meet eligibility criteria|1|||
33330746|NCT04050982|101104202|FG002|Overall Study|Did not meet eligibility criteria|0|||
33524939|NCT01578499|101819763|FG001|Overall Study|Reason not Specified|1|||
33609921|NCT02294734|102123170|FG001|Overall Study|Lost to Follow-up|0|||
33201856|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
33524940|NCT01578499|101819762|FG000|Overall Study|Lost to Follow-up|2|||
33524941|NCT01578499|101819763|FG001|Overall Study|Lost to Follow-up|1|||
33524942|NCT01578499|101819762|FG000|Overall Study|Withdrawal by Subject|10|||
33524943|NCT01578499|101819763|FG001|Overall Study|Withdrawal by Subject|16|||
33524944|NCT01578499|101819762|FG000|Overall Study|Death|20|||
33524945|NCT01578499|101819763|FG001|Overall Study|Death|25|||
33524946|NCT01578499|101819762|FG000|Overall Study|Died and End of Study Page not Completed|2|||
33524947|NCT01578499|101819763|FG001|Overall Study|Died and End of Study Page not Completed|0|||
33524948|NCT00162097|101819764|FG000|Overall Study|Participant no longer met study criteria|0|||
33524949|NCT00162097|101819765|FG001|Overall Study|Participant no longer met study criteria|0|||
33524950|NCT00162097|101819766|FG002|Overall Study|Participant no longer met study criteria|0|||
33609922|NCT02294734|102123169|FG000|Overall Study|Physician Decision|2|||
33330747|NCT04050982|101104200|FG000|Overall Study|Withdrawal by Subject|1|||
33330748|NCT04050982|101104201|FG001|Overall Study|Withdrawal by Subject|0|||
33330749|NCT04050982|101104202|FG002|Overall Study|Withdrawal by Subject|0|||
33330750|NCT04050982|101104200|FG000|Overall Study|Unable to enroll on platform|1|||
33330751|NCT04050982|101104201|FG001|Overall Study|Unable to enroll on platform|0|||
33330752|NCT04050982|101104202|FG002|Overall Study|Unable to enroll on platform|0|||
33330753|NCT01349465|101104208|FG000|Overall Study|Adverse Event|1|||
33330754|NCT01349465|101104209|FG001|Overall Study|Adverse Event|0|||
33330755|NCT01349465|101104208|FG000|Overall Study|Death|3|||
33330756|NCT01349465|101104209|FG001|Overall Study|Death|0|||
33330757|NCT01349465|101104208|FG000|Overall Study|Lost to Follow-up|10|||
33330758|NCT01349465|101104209|FG001|Overall Study|Lost to Follow-up|1|||
33330759|NCT01349465|101104208|FG000|Overall Study|Withdrawal by Subject|4|||
33330760|NCT01349465|101104209|FG001|Overall Study|Withdrawal by Subject|2|||
33330761|NCT01349465|101104208|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
33330762|NCT01349465|101104209|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
33330763|NCT02311153|101104215|FG000|Overall Study|Lost to Follow-up|5|||
33330764|NCT02311153|101104216|FG001|Overall Study|Lost to Follow-up|7|||
33330765|NCT00844753|101104217|FG000|Overall Study|Lack of Efficacy|1|||
33330766|NCT00844753|101104218|FG001|Overall Study|Lack of Efficacy|0|||
33330767|NCT00844753|101104219|FG002|Overall Study|Lack of Efficacy|2|||
33330768|NCT00844753|101104220|FG003|Overall Study|Lack of Efficacy|2|||
33330769|NCT00844753|101104217|FG000|Overall Study|Adverse Event|3|||
33330770|NCT00844753|101104218|FG001|Overall Study|Adverse Event|2|||
33609923|NCT02294734|102123170|FG001|Overall Study|Physician Decision|1|||
33609924|NCT02294734|102123169|FG000|Overall Study|Withdrawal by Subject|4|||
33609925|NCT02294734|102123170|FG001|Overall Study|Withdrawal by Subject|2|||
33609926|NCT02220712|102123171|FG000|Overall Study|Adverse Event|1|||
33609927|NCT02220712|102123171|FG000|Overall Study|Withdrawal by Subject|2|||
33609928|NCT02220712|102123171|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
33609929|NCT04405076|102123172|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
33609930|NCT04405076|102123173|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
33609931|NCT04405076|102123174|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
33609932|NCT04405076|102123175|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
33609933|NCT04405076|102123176|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
33609934|NCT04405076|102123177|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
33609935|NCT04405076|102123178|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
33609936|NCT04405076|102123179|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
33609937|NCT04405076|102123180|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
33609938|NCT04405076|102123172|FG000|Part A (Blinded Phase)|Physician Decision|1|||
33609939|NCT04405076|102123173|FG001|Part A (Blinded Phase)|Physician Decision|2|||
33609940|NCT04405076|102123174|FG002|Part A (Blinded Phase)|Physician Decision|0|||
33201857|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
33524951|NCT00162097|101819767|FG003|Overall Study|Participant no longer met study criteria|1|||
33609941|NCT04405076|102123175|FG003|Part A (Blinded Phase)|Physician Decision|0|||
33609942|NCT04405076|102123176|FG004|Part A (Blinded Phase)|Physician Decision|0|||
33609943|NCT04405076|102123177|FG005|Part A (Blinded Phase)|Physician Decision|0|||
33609944|NCT04405076|102123178|FG006|Part A (Blinded Phase)|Physician Decision|0|||
33609945|NCT04405076|102123179|FG007|Part A (Blinded Phase)|Physician Decision|0|||
33609946|NCT04405076|102123180|FG008|Part A (Blinded Phase)|Physician Decision|0|||
33609947|NCT04405076|102123172|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
33609948|NCT04405076|102123173|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
33609949|NCT04405076|102123174|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
33609950|NCT04405076|102123175|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
33609951|NCT04405076|102123176|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
33609952|NCT04405076|102123177|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
33609953|NCT04405076|102123178|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
33609954|NCT04405076|102123179|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
33609955|NCT04405076|102123180|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
33609956|NCT04405076|102123172|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
33330771|NCT00844753|101104219|FG002|Overall Study|Adverse Event|5|||
33330772|NCT00844753|101104220|FG003|Overall Study|Adverse Event|5|||
33524952|NCT00849290|101819768|FG000|Overall Study|Adverse Event|3|||
33524953|NCT00849290|101819768|FG000|Overall Study|Death|14|||
33524954|NCT00849290|101819768|FG000|Overall Study|Withdrawal by Subject|11|||
33524955|NCT00849290|101819768|FG000|Overall Study|Lost to Follow-up|2|||
33524956|NCT00849290|101819768|FG000|Overall Study|Protocol Violation|5|||
33524957|NCT00849290|101819768|FG000|Overall Study|Disease Progression|20|||
33524958|NCT01990768|101819771|FG000|Intervention Started|Found to be ineligible|14|||
33524959|NCT01990768|101819772|FG001|Intervention Started|Found to be ineligible|13|||
33524960|NCT01990768|101819773|FG002|Intervention Started|Found to be ineligible|11|||
33524961|NCT01990768|101819771|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
33524962|NCT01990768|101819772|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
33524963|NCT01990768|101819773|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
33524964|NCT01990768|101819771|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
33524965|NCT01990768|101819772|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
33524966|NCT01990768|101819773|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
33524967|NCT01990768|101819771|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
33524968|NCT01990768|101819772|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
33524969|NCT01990768|101819773|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
33524970|NCT01990768|101819771|FG000|Intervention Started|Patient care priority|1|||
33524971|NCT01990768|101819772|FG001|Intervention Started|Patient care priority|2|||
33524972|NCT01990768|101819773|FG002|Intervention Started|Patient care priority|3|||
33524973|NCT01990768|101819771|FG000|Intervention Started|IV lost|2|||
33524974|NCT01990768|101819772|FG001|Intervention Started|IV lost|2|||
33524975|NCT01990768|101819773|FG002|Intervention Started|IV lost|2|||
33524976|NCT01990768|101819771|FG000|Intervention Started|Required CPR|1|||
33524977|NCT01990768|101819772|FG001|Intervention Started|Required CPR|1|||
33524978|NCT01990768|101819773|FG002|Intervention Started|Required CPR|0|||
33524979|NCT01990768|101819771|FG000|Intervention Started|Seizure or hx of seizure|0|||
33524980|NCT01990768|101819772|FG001|Intervention Started|Seizure or hx of seizure|0|||
33524981|NCT01990768|101819773|FG002|Intervention Started|Seizure or hx of seizure|2|||
33524982|NCT01990768|101819771|FG000|Intervention Started|Discovered to be pregnant|0|||
33524983|NCT01990768|101819772|FG001|Intervention Started|Discovered to be pregnant|1|||
33524984|NCT01990768|101819773|FG002|Intervention Started|Discovered to be pregnant|0|||
33524985|NCT01990768|101819771|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
33524986|NCT01990768|101819772|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
33524987|NCT01990768|101819773|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
33524988|NCT01990768|101819771|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
33524989|NCT01990768|101819772|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
33524990|NCT01990768|101819773|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
33524991|NCT01990768|101819771|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
33524992|NCT01990768|101819772|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
33524993|NCT01990768|101819773|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
33524994|NCT01990768|101819771|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
33524995|NCT01990768|101819772|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
33524996|NCT01990768|101819773|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
33609957|NCT04405076|102123173|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33609958|NCT04405076|102123174|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33524997|NCT01990768|101819771|FG000|Prehospital Study Drug Infusion|Death|3|||
33524998|NCT01990768|101819772|FG001|Prehospital Study Drug Infusion|Death|1|||
33524999|NCT01990768|101819773|FG002|Prehospital Study Drug Infusion|Death|1|||
33525000|NCT01990768|101819771|FG000|Prehospital Study Drug Infusion|Discharged|2|||
33525001|NCT01990768|101819772|FG001|Prehospital Study Drug Infusion|Discharged|1|||
33525002|NCT01990768|101819773|FG002|Prehospital Study Drug Infusion|Discharged|0|||
33525003|NCT01990768|101819771|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
33525004|NCT01990768|101819772|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
33609959|NCT04405076|102123175|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33609960|NCT04405076|102123176|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33609961|NCT04405076|102123177|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33609962|NCT04405076|102123178|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33609963|NCT04405076|102123179|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33609964|NCT04405076|102123180|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
33609965|NCT04405076|102123172|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
33609966|NCT04405076|102123173|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
33330773|NCT00844753|101104217|FG000|Overall Study|Lost to Follow-up|1|||
33609967|NCT04405076|102123174|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
33609968|NCT04405076|102123175|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
33330774|NCT00844753|101104218|FG001|Overall Study|Lost to Follow-up|1|||
33330775|NCT00844753|101104219|FG002|Overall Study|Lost to Follow-up|0|||
33609969|NCT04405076|102123176|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
33609970|NCT04405076|102123177|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
33609971|NCT04405076|102123178|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
33609972|NCT04405076|102123179|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
33609973|NCT04405076|102123180|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
33402177|NCT02743494|101361666|FG001|Treatment Period|Death|0|||
33402178|NCT02743494|101361665|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
33402179|NCT02743494|101361666|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
33402180|NCT02743494|101361665|FG000|Treatment Period|Participant request to discontinue treatment|30|||
33402181|NCT02743494|101361666|FG001|Treatment Period|Participant request to discontinue treatment|5|||
33402182|NCT02743494|101361665|FG000|Treatment Period|Participant withdrew consent|12|||
33402183|NCT02743494|101361666|FG001|Treatment Period|Participant withdrew consent|4|||
33402184|NCT02743494|101361665|FG000|Treatment Period|Lost to Follow-up|0|||
33402185|NCT02743494|101361666|FG001|Treatment Period|Lost to Follow-up|1|||
33402186|NCT02743494|101361665|FG000|Treatment Period|Poor/Non-compliance|1|||
33402187|NCT02743494|101361666|FG001|Treatment Period|Poor/Non-compliance|0|||
33330776|NCT00844753|101104220|FG003|Overall Study|Lost to Follow-up|1|||
33330777|NCT00844753|101104217|FG000|Overall Study|could not swallow medication|2|||
33330778|NCT00844753|101104218|FG001|Overall Study|could not swallow medication|0|||
33330779|NCT00844753|101104219|FG002|Overall Study|could not swallow medication|0|||
33330780|NCT00844753|101104220|FG003|Overall Study|could not swallow medication|0|||
33330781|NCT00844753|101104217|FG000|Overall Study|Withdrawal by Subject|1|||
33330782|NCT00844753|101104218|FG001|Overall Study|Withdrawal by Subject|0|||
33330783|NCT00844753|101104219|FG002|Overall Study|Withdrawal by Subject|0|||
33330784|NCT00844753|101104220|FG003|Overall Study|Withdrawal by Subject|3|||
33330785|NCT02039375|101104221|FG000|Overall Study|Lost to Follow-up|2|||
33330786|NCT03077685|101104228|FG000|Overall Study|Lost to Follow-up|0|||
33330787|NCT03077685|101104229|FG001|Overall Study|Lost to Follow-up|0|||
33330788|NCT03077685|101104230|FG002|Overall Study|Lost to Follow-up|0|||
33330789|NCT03077685|101104231|FG003|Overall Study|Lost to Follow-up|0|||
33330790|NCT03077685|101104232|FG004|Overall Study|Lost to Follow-up|1|||
33330791|NCT03077685|101104228|FG000|Overall Study|Death|0|||
33330792|NCT03077685|101104229|FG001|Overall Study|Death|0|||
33330793|NCT03077685|101104230|FG002|Overall Study|Death|1|||
33330794|NCT03077685|101104231|FG003|Overall Study|Death|1|||
33330795|NCT03077685|101104232|FG004|Overall Study|Death|3|||
33330796|NCT03077685|101104228|FG000|Overall Study|Withdrawal by Subject|0|||
33330797|NCT03077685|101104229|FG001|Overall Study|Withdrawal by Subject|0|||
33330798|NCT03077685|101104230|FG002|Overall Study|Withdrawal by Subject|0|||
33330799|NCT03077685|101104231|FG003|Overall Study|Withdrawal by Subject|2|||
33330800|NCT03077685|101104232|FG004|Overall Study|Withdrawal by Subject|1|||
33330801|NCT03077685|101104228|FG000|Overall Study|Physician Decision|0|||
33330802|NCT03077685|101104229|FG001|Overall Study|Physician Decision|0|||
33330803|NCT03077685|101104230|FG002|Overall Study|Physician Decision|1|||
33330804|NCT03077685|101104231|FG003|Overall Study|Physician Decision|0|||
33330805|NCT03077685|101104232|FG004|Overall Study|Physician Decision|3|||
33330806|NCT03077685|101104228|FG000|Overall Study|Disease Progression|1|||
33330807|NCT03077685|101104229|FG001|Overall Study|Disease Progression|0|||
33330808|NCT03077685|101104230|FG002|Overall Study|Disease Progression|0|||
33330809|NCT03077685|101104231|FG003|Overall Study|Disease Progression|2|||
33330810|NCT03077685|101104232|FG004|Overall Study|Disease Progression|1|||
33330811|NCT03077685|101104228|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
33330812|NCT03077685|101104229|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
33330813|NCT03077685|101104230|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
33330814|NCT03077685|101104231|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
33330815|NCT03077685|101104232|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
33330816|NCT03077685|101104228|FG000|Overall Study|Subject entered hospice care|0|||
33402188|NCT02743494|101361665|FG000|Treatment Period|Other reasons|7|||
33201858|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
33330817|NCT03077685|101104229|FG001|Overall Study|Subject entered hospice care|0|||
33330818|NCT03077685|101104230|FG002|Overall Study|Subject entered hospice care|0|||
33330819|NCT03077685|101104231|FG003|Overall Study|Subject entered hospice care|0|||
33330820|NCT03077685|101104232|FG004|Overall Study|Subject entered hospice care|1|||
33330821|NCT03029143|101104233|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
33330822|NCT03029143|101104234|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
33330823|NCT03029143|101104235|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
33402189|NCT02743494|101361666|FG001|Treatment Period|Other reasons|2|||
33402190|NCT00568399|101361667|FG000|Overall Study|Death|2|||
33402191|NCT00568399|101361667|FG000|Overall Study|Adverse Event|5|||
33330824|NCT03029143|101104233|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
33417264|NCT01248130|101420247|FG001|Overall Study|Protocol Violation|0|||
33330825|NCT03029143|101104234|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
33330826|NCT03029143|101104235|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
33330827|NCT03029143|101104233|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
33330828|NCT03029143|101104234|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
33330829|NCT03029143|101104235|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
33330830|NCT03029143|101104233|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
33330831|NCT03029143|101104234|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
33330832|NCT03029143|101104235|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
33330833|NCT03029143|101104233|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
33330834|NCT03029143|101104234|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
33330835|NCT03029143|101104235|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
33330836|NCT03029143|101104233|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
33330837|NCT03029143|101104234|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
33330838|NCT03029143|101104235|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
33330839|NCT03029143|101104233|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
33330840|NCT03029143|101104234|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
33330841|NCT03029143|101104235|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
33330842|NCT03029143|101104233|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33330843|NCT03029143|101104234|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
33330844|NCT03029143|101104235|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
33330845|NCT03029143|101104233|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
33330846|NCT03029143|101104234|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
33330847|NCT03029143|101104235|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
33330848|NCT03029143|101104233|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
33330849|NCT03029143|101104234|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
33330850|NCT03029143|101104235|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
33330851|NCT03029143|101104233|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
33330852|NCT03029143|101104234|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
33330853|NCT03029143|101104235|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
33330854|NCT02431702|101104236|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
33330855|NCT02431702|101104237|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
33330856|NCT02431702|101104238|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
33330857|NCT02431702|101104239|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
33330858|NCT02431702|101104240|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
33330859|NCT02431702|101104241|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
33330860|NCT02431702|101104242|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
33330861|NCT02431702|101104236|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
33330862|NCT02431702|101104237|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
33330863|NCT02431702|101104238|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
33330864|NCT02431702|101104239|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
33330865|NCT02431702|101104240|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
33330866|NCT02431702|101104241|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
33330867|NCT02431702|101104242|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
33330868|NCT02431702|101104236|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
33330869|NCT02431702|101104237|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
33330870|NCT02431702|101104238|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
33330871|NCT02431702|101104239|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
33330872|NCT02431702|101104240|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
33330873|NCT02431702|101104241|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
33330874|NCT02431702|101104242|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
33330875|NCT02431702|101104236|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
33330876|NCT02431702|101104237|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
33330877|NCT02431702|101104238|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
33330878|NCT02431702|101104239|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
33402192|NCT00568399|101361667|FG000|Overall Study|Withdrawal by Subject|8|||
33402193|NCT00412360|101361668|FG000|Overall Study|Lost to Follow-up|0|||
33609974|NCT04405076|102123172|FG000|Part A (Blinded Phase)|Other than Specified|0|||
33609975|NCT04405076|102123173|FG001|Part A (Blinded Phase)|Other than Specified|0|||
33609976|NCT04405076|102123174|FG002|Part A (Blinded Phase)|Other than Specified|3|||
33402194|NCT00412360|101361669|FG001|Overall Study|Lost to Follow-up|1|||
33525005|NCT01990768|101819773|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
33330879|NCT02431702|101104240|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
33609977|NCT04405076|102123175|FG003|Part A (Blinded Phase)|Other than Specified|0|||
33609978|NCT04405076|102123176|FG004|Part A (Blinded Phase)|Other than Specified|0|||
33609979|NCT04405076|102123177|FG005|Part A (Blinded Phase)|Other than Specified|0|||
33330880|NCT02431702|101104241|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
33330881|NCT02431702|101104242|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
33402195|NCT00412360|101361668|FG000|Overall Study|Not Transplanted|1|||
33402196|NCT00412360|101361669|FG001|Overall Study|Not Transplanted|2|||
33402197|NCT02500901|101361670|FG000|Overall Study|Disease ProgressionDD|2|||
33525006|NCT01990768|101819771|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
33525007|NCT01990768|101819772|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
33525008|NCT01990768|101819773|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
33525009|NCT01990768|101819771|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
33525010|NCT01990768|101819772|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
33525011|NCT01990768|101819773|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
33402198|NCT03417999|101361671|FG000|Overall Study|Withdrawal by Subject|1|||
33402199|NCT03417999|101361672|FG001|Overall Study|Withdrawal by Subject|0|||
33525012|NCT01990768|101819771|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
33330882|NCT02431702|101104236|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
33330883|NCT02431702|101104237|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
33330884|NCT02431702|101104238|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
33330885|NCT02431702|101104239|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
33330886|NCT02431702|101104240|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
33330887|NCT02431702|101104241|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
33330888|NCT02431702|101104242|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
33330889|NCT02431702|101104236|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
33330890|NCT02431702|101104237|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
33402200|NCT03417999|101361673|FG002|Overall Study|Withdrawal by Subject|0|||
33525013|NCT01990768|101819772|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
33525014|NCT01990768|101819773|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
33525015|NCT01990768|101819771|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
33525016|NCT01990768|101819772|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
33525017|NCT01990768|101819773|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
33525018|NCT01990768|101819771|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
33525019|NCT01990768|101819772|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
33525020|NCT01990768|101819773|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
33525021|NCT01990768|101819771|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
33525022|NCT01990768|101819772|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
33525023|NCT01990768|101819773|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
33609980|NCT04405076|102123178|FG006|Part A (Blinded Phase)|Other than Specified|0|||
33609981|NCT04405076|102123179|FG007|Part A (Blinded Phase)|Other than Specified|0|||
33609982|NCT04405076|102123180|FG008|Part A (Blinded Phase)|Other than Specified|0|||
33609983|NCT04405076|102123172|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
33609984|NCT04405076|102123173|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
33609985|NCT04405076|102123174|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
33609986|NCT04405076|102123175|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
33609987|NCT04405076|102123176|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
33609988|NCT04405076|102123177|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
33609989|NCT04405076|102123178|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
33609990|NCT04405076|102123179|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
33609991|NCT04405076|102123180|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
33609992|NCT04405076|102123172|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33609993|NCT04405076|102123173|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33330891|NCT02431702|101104238|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
33402201|NCT03417999|101361671|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
33402202|NCT03417999|101361672|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
33402203|NCT03417999|101361673|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
33402204|NCT03417999|101361671|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
33402205|NCT03417999|101361672|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
33402206|NCT03417999|101361673|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
33402207|NCT03417999|101361671|FG000|Overall Study|Inadequate study staff available to process samples|0|||
33402208|NCT03417999|101361672|FG001|Overall Study|Inadequate study staff available to process samples|0|||
33402209|NCT03417999|101361673|FG002|Overall Study|Inadequate study staff available to process samples|1|||
33402210|NCT02358863|101361674|FG000|Overall Study|Physician Decision|3|||
33330892|NCT02431702|101104239|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
33402211|NCT01747655|101361675|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
33402212|NCT01747655|101361676|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
33402213|NCT01747655|101361675|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
33402214|NCT01747655|101361676|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
33417265|NCT01248130|101420246|FG000|Overall Study|Ineligible|1|||
33525024|NCT01990768|101819771|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
33525025|NCT01990768|101819772|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
33525026|NCT01990768|101819773|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
33525027|NCT01990768|101819771|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
33525028|NCT01990768|101819772|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
33525029|NCT01990768|101819773|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
33525030|NCT01990768|101819771|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
33525031|NCT01990768|101819772|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
33525032|NCT01990768|101819773|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
33330893|NCT02431702|101104240|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
33201859|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
33201860|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
33201861|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
33201862|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
33201863|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
33402215|NCT01747655|101361675|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
33402216|NCT01747655|101361676|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
33402217|NCT01259388|101361677|FG000|Overall Study|Adverse Event|3|||
33402218|NCT01259388|101361678|FG001|Overall Study|Adverse Event|0|||
33402219|NCT01259388|101361677|FG000|Overall Study|Withdrawal by Subject|1|||
33402220|NCT01259388|101361678|FG001|Overall Study|Withdrawal by Subject|1|||
33402221|NCT01259388|101361677|FG000|Overall Study|Physician Decision|1|||
33402222|NCT01259388|101361678|FG001|Overall Study|Physician Decision|0|||
33402223|NCT00805142|101361683|FG000|Titration Period|Adverse Event|3|||
33402224|NCT00805142|101361684|FG001|Titration Period|Adverse Event|3|||
33402225|NCT00805142|101361683|FG000|Titration Period|Lack of Efficacy|1|||
33402226|NCT00805142|101361684|FG001|Titration Period|Lack of Efficacy|1|||
33525033|NCT01990768|101819771|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
33525034|NCT01990768|101819772|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
33402227|NCT00805142|101361683|FG000|Titration Period|Lost to Follow-up|0|||
33402228|NCT00805142|101361684|FG001|Titration Period|Lost to Follow-up|1|||
33330894|NCT02431702|101104241|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
33330895|NCT02431702|101104242|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
33330896|NCT02431702|101104236|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
33330897|NCT02431702|101104237|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
33330898|NCT02431702|101104238|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
33330899|NCT02431702|101104239|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
33330900|NCT02431702|101104240|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
33330901|NCT02431702|101104241|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
33330902|NCT02431702|101104242|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
33330903|NCT02431702|101104236|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
33525035|NCT01990768|101819773|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
33525036|NCT01990768|101819771|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
33525037|NCT01990768|101819772|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
33609994|NCT04405076|102123174|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33609995|NCT04405076|102123175|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33609996|NCT04405076|102123176|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
33609997|NCT04405076|102123177|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33609998|NCT04405076|102123178|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33330904|NCT02431702|101104237|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
33402229|NCT00805142|101361683|FG000|Titration Period|Disease Progression|2|||
33609999|NCT04405076|102123179|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33610000|NCT04405076|102123180|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
33610001|NCT04405076|102123172|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
33402230|NCT00805142|101361684|FG001|Titration Period|Disease Progression|1|||
33402231|NCT00805142|101361683|FG000|Titration Period|Withdrawal of consent|0|||
33402232|NCT00805142|101361684|FG001|Titration Period|Withdrawal of consent|1|||
33402233|NCT00805142|101361683|FG000|Titration Period|Other|0|||
33402234|NCT00805142|101361684|FG001|Titration Period|Other|3|||
33330905|NCT02431702|101104238|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
33330906|NCT02431702|101104239|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
33330907|NCT02431702|101104240|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
33525038|NCT01990768|101819773|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
33525039|NCT01990768|101819771|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
33525040|NCT01990768|101819772|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
33525041|NCT01990768|101819773|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
33525042|NCT01990768|101819771|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
33525043|NCT01990768|101819772|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
33525044|NCT01990768|101819773|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
33525045|NCT01990768|101819771|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
33525046|NCT01990768|101819772|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
33525047|NCT01990768|101819773|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
33525048|NCT01990768|101819771|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
33525049|NCT01990768|101819772|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
33525050|NCT01990768|101819773|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
33610002|NCT04405076|102123173|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
33610003|NCT04405076|102123174|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
33610004|NCT04405076|102123175|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
33330908|NCT02431702|101104241|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
33330909|NCT02431702|101104242|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
33330910|NCT02431702|101104236|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
33330911|NCT02431702|101104237|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
33330912|NCT02431702|101104238|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
33330913|NCT02431702|101104239|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
33330914|NCT02431702|101104240|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
33330915|NCT02431702|101104241|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
33330916|NCT02431702|101104242|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
33330917|NCT02431702|101104236|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
33330918|NCT02431702|101104237|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
33330919|NCT02431702|101104238|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
33330920|NCT02431702|101104239|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
33330921|NCT02431702|101104240|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
33330922|NCT02431702|101104241|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
33330923|NCT02431702|101104242|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
33330924|NCT02431702|101104236|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
33330925|NCT02431702|101104237|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
33330926|NCT02431702|101104238|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
33330927|NCT02431702|101104239|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
33330928|NCT02431702|101104240|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
33330929|NCT02431702|101104241|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
33330930|NCT02431702|101104242|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
33330931|NCT02431702|101104236|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
33330932|NCT02431702|101104237|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
33330933|NCT02431702|101104238|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
33330934|NCT02431702|101104239|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
33330935|NCT02431702|101104240|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
33330936|NCT02431702|101104241|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
33330937|NCT02431702|101104242|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
33330938|NCT02431702|101104236|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
33330939|NCT02431702|101104237|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
33330940|NCT02431702|101104238|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
33330941|NCT02431702|101104239|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
33330942|NCT02431702|101104240|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
33330943|NCT02431702|101104241|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
33330944|NCT02431702|101104242|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
33330945|NCT02431702|101104236|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
33330946|NCT02431702|101104237|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
33330947|NCT02431702|101104238|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
33330948|NCT02431702|101104239|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
33330949|NCT02431702|101104240|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
33402235|NCT00805142|101361683|FG000|Maintenance Period|Adverse Event|0|||
33610005|NCT04405076|102123176|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
33525051|NCT01990768|101819771|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
33525052|NCT01990768|101819772|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
33525053|NCT01990768|101819773|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
33525054|NCT01990768|101819771|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
33525055|NCT01990768|101819772|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
33525056|NCT01990768|101819773|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
33525057|NCT01990768|101819771|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
33525058|NCT01990768|101819772|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
33525059|NCT01990768|101819773|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
33330950|NCT02431702|101104241|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
33330951|NCT02431702|101104242|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
33330952|NCT02431702|101104236|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
33330953|NCT02431702|101104237|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
33330954|NCT02431702|101104238|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
33330955|NCT02431702|101104239|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
33330956|NCT02431702|101104240|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
33330957|NCT02431702|101104241|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
33330958|NCT02431702|101104242|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
33330959|NCT01347554|101104245|FG000|Overall Study|Lack of Efficacy|7|||
33330960|NCT01347554|101104246|FG001|Overall Study|Lack of Efficacy|11|||
33330961|NCT04194528|101104247|FG000|Overall Study|Adverse Event|1|||
33330962|NCT00143312|101104248|FG000|Overall Study|Death|11|||
33330963|NCT00143312|101104248|FG000|Overall Study|Adverse Event|2|||
33330964|NCT00143312|101104248|FG000|Overall Study|Lost to Follow-up|1|||
33330965|NCT00143312|101104248|FG000|Overall Study|Other|1|||
33330966|NCT00143312|101104248|FG000|Overall Study|Withdrawal by Subject|1|||
33330967|NCT01508702|101104250|FG000|Overall Study|Adverse Event|7|||
33330968|NCT01508702|101104251|FG001|Overall Study|Adverse Event|3|||
33330969|NCT01508702|101104250|FG000|Overall Study|Gout flare|2|||
33610006|NCT04405076|102123177|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
33610007|NCT04405076|102123178|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
33330970|NCT01508702|101104251|FG001|Overall Study|Gout flare|0|||
33330971|NCT01508702|101104250|FG000|Overall Study|Protocol Violation|2|||
33330972|NCT01508702|101104251|FG001|Overall Study|Protocol Violation|1|||
33330973|NCT01508702|101104250|FG000|Overall Study|Lost to Follow-up|1|||
33330974|NCT01508702|101104251|FG001|Overall Study|Lost to Follow-up|2|||
33330975|NCT01508702|101104250|FG000|Overall Study|Withdrawal by Subject|11|||
33330976|NCT01508702|101104251|FG001|Overall Study|Withdrawal by Subject|7|||
33330977|NCT03134599|101104252|FG000|Week 1|Lost to Follow-up|0|||
33330978|NCT03134599|101104253|FG001|Week 1|Lost to Follow-up|0|||
33330979|NCT03134599|101104254|FG002|Week 1|Lost to Follow-up|0|||
33330980|NCT03134599|101104255|FG003|Week 1|Lost to Follow-up|0|||
33330981|NCT03134599|101104256|FG004|Week 1|Lost to Follow-up|1|||
33330982|NCT03134599|101104257|FG005|Week 1|Lost to Follow-up|0|||
33330983|NCT03134599|101104252|FG000|Week 2|Lost to Follow-up|1|||
33330984|NCT03134599|101104253|FG001|Week 2|Lost to Follow-up|0|||
33525060|NCT01990768|101819771|FG000|6-Month Follow-up|No contact information|5|||
33610008|NCT04405076|102123179|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
33610009|NCT04405076|102123180|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
33610010|NCT04405076|102123172|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
33610011|NCT04405076|102123173|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
33610012|NCT04405076|102123174|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
33610013|NCT04405076|102123175|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
33610014|NCT04405076|102123176|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
33330985|NCT03134599|101104254|FG002|Week 2|Lost to Follow-up|0|||
33330986|NCT03134599|101104255|FG003|Week 2|Lost to Follow-up|1|||
33330987|NCT03134599|101104256|FG004|Week 2|Lost to Follow-up|1|||
33330988|NCT03134599|101104257|FG005|Week 2|Lost to Follow-up|0|||
33330989|NCT03134599|101104252|FG000|Week 3|Lost to Follow-up|0|||
33330990|NCT03134599|101104253|FG001|Week 3|Lost to Follow-up|0|||
33330991|NCT03134599|101104254|FG002|Week 3|Lost to Follow-up|0|||
33330992|NCT03134599|101104255|FG003|Week 3|Lost to Follow-up|1|||
33402236|NCT00805142|101361684|FG001|Maintenance Period|Adverse Event|1|||
33330993|NCT03134599|101104256|FG004|Week 3|Lost to Follow-up|0|||
33330994|NCT03134599|101104257|FG005|Week 3|Lost to Follow-up|1|||
33330995|NCT00766038|101104258|FG000|Overall Study|Lost to Follow-up|15|||
33330996|NCT00766038|101104259|FG001|Overall Study|Lost to Follow-up|14|||
33330997|NCT01923285|101104260|FG000|Overall Study|Withdrawal by Subject|7|||
33330998|NCT01923285|101104261|FG001|Overall Study|Withdrawal by Subject|6|||
33330999|NCT01236573|101104262|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33610015|NCT04405076|102123177|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
33610016|NCT04405076|102123178|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
33610017|NCT04405076|102123179|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
33610018|NCT04405076|102123180|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
33610019|NCT04405076|102123172|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33610020|NCT04405076|102123173|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33610021|NCT04405076|102123174|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33610022|NCT04405076|102123175|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33610023|NCT04405076|102123176|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33610024|NCT04405076|102123177|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33610025|NCT04405076|102123178|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
33610026|NCT04405076|102123179|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33610027|NCT04405076|102123180|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
33610028|NCT00986362|102123181|FG000|Overall Study|Death|2|||
33610029|NCT00986362|102123182|FG001|Overall Study|Death|0|||
33610030|NCT00986362|102123181|FG000|Overall Study|Lost to Follow-up|0|||
33610031|NCT00986362|102123182|FG001|Overall Study|Lost to Follow-up|1|||
33610032|NCT01844778|102123183|FG000|Overall Study|Protocol deviation|0|||
33610033|NCT01844778|102123184|FG001|Overall Study|Protocol deviation|1|||
33610034|NCT01844778|102123185|FG002|Overall Study|Protocol deviation|2|||
33610035|NCT01844778|102123183|FG000|Overall Study|Withdrawal by Subject|2|||
33610036|NCT01844778|102123184|FG001|Overall Study|Withdrawal by Subject|0|||
33610037|NCT01844778|102123185|FG002|Overall Study|Withdrawal by Subject|0|||
33610038|NCT01844778|102123183|FG000|Overall Study|Adverse Event|0|||
33610039|NCT01844778|102123184|FG001|Overall Study|Adverse Event|2|||
33610040|NCT01844778|102123185|FG002|Overall Study|Adverse Event|2|||
33610041|NCT03160885|102123186|FG000|Initial Treatment Period|Not dosed|2|||
33610042|NCT03160885|102123187|FG001|Initial Treatment Period|Not dosed|0|||
33610043|NCT03160885|102123188|FG002|Initial Treatment Period|Not dosed|0|||
33610044|NCT03160885|102123189|FG003|Initial Treatment Period|Not dosed|0|||
33610045|NCT03160885|102123190|FG004|Initial Treatment Period|Not dosed|0|||
33610046|NCT03160885|102123191|FG005|Initial Treatment Period|Not dosed|0|||
33610047|NCT03160885|102123192|FG006|Initial Treatment Period|Not dosed|0|||
33610048|NCT03160885|102123186|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
33610049|NCT03160885|102123187|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
33610050|NCT03160885|102123188|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33610051|NCT03160885|102123189|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33610052|NCT03160885|102123190|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33610053|NCT03160885|102123191|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33610054|NCT03160885|102123192|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33610055|NCT03160885|102123186|FG000|Open-label Treatment|Not dosed|0|||
33610056|NCT03160885|102123187|FG001|Open-label Treatment|Not dosed|0|||
33610057|NCT03160885|102123188|FG002|Open-label Treatment|Not dosed|0|||
33610058|NCT03160885|102123189|FG003|Open-label Treatment|Not dosed|0|||
33610059|NCT03160885|102123190|FG004|Open-label Treatment|Not dosed|0|||
33610060|NCT03160885|102123191|FG005|Open-label Treatment|Not dosed|0|||
33331000|NCT01236573|101104263|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33331001|NCT01236573|101104264|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33331002|NCT01236573|101104265|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33331003|NCT01236573|101104266|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33331004|NCT01236573|101104267|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33331005|NCT01236573|101104268|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
33331006|NCT01236573|101104269|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33331007|NCT01236573|101104270|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
33331008|NCT01236573|101104271|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
33331009|NCT01236573|101104272|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
33331010|NCT01236573|101104262|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33331011|NCT01236573|101104263|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33331012|NCT01236573|101104264|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33331013|NCT01236573|101104265|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33331014|NCT01236573|101104266|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33402237|NCT00805142|101361683|FG000|Maintenance Period|Other|0|||
33610061|NCT03160885|102123192|FG006|Open-label Treatment|Not dosed|2|||
33610062|NCT03160885|102123186|FG000|Open-label Treatment|Discontinued IMP|0|||
33610063|NCT03160885|102123187|FG001|Open-label Treatment|Discontinued IMP|0|||
33610064|NCT03160885|102123188|FG002|Open-label Treatment|Discontinued IMP|0|||
33331015|NCT01236573|101104267|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33610065|NCT03160885|102123189|FG003|Open-label Treatment|Discontinued IMP|0|||
33610066|NCT03160885|102123190|FG004|Open-label Treatment|Discontinued IMP|0|||
33610067|NCT03160885|102123191|FG005|Open-label Treatment|Discontinued IMP|0|||
33610068|NCT03160885|102123192|FG006|Open-label Treatment|Discontinued IMP|131|||
33610069|NCT03160885|102123186|FG000|Open-label Treatment|Completed Week 50|0|||
33610070|NCT03160885|102123187|FG001|Open-label Treatment|Completed Week 50|0|||
33610071|NCT03160885|102123188|FG002|Open-label Treatment|Completed Week 50|0|||
33610072|NCT03160885|102123189|FG003|Open-label Treatment|Completed Week 50|0|||
33610073|NCT03160885|102123190|FG004|Open-label Treatment|Completed Week 50|0|||
33610074|NCT03160885|102123191|FG005|Open-label Treatment|Completed Week 50|0|||
33610075|NCT03160885|102123192|FG006|Open-label Treatment|Completed Week 50|4|||
33610076|NCT03160885|102123186|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
33610077|NCT03160885|102123187|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
33610078|NCT03160885|102123188|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
33331016|NCT01236573|101104268|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33331017|NCT01236573|101104269|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33331018|NCT01236573|101104270|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
33331019|NCT01236573|101104271|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33610079|NCT03160885|102123189|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
33610080|NCT03160885|102123190|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
33610081|NCT03160885|102123191|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
33331020|NCT01236573|101104272|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
33331021|NCT01236573|101104262|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33331022|NCT01236573|101104263|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33331023|NCT01236573|101104264|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33331024|NCT01236573|101104265|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33331025|NCT01236573|101104266|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33331026|NCT01236573|101104267|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33331027|NCT01236573|101104268|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33331028|NCT01236573|101104269|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33331029|NCT01236573|101104270|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33525061|NCT01990768|101819772|FG001|6-Month Follow-up|No contact information|6|||
33525062|NCT01990768|101819773|FG002|6-Month Follow-up|No contact information|5|||
33331030|NCT01236573|101104271|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
33331031|NCT01236573|101104272|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
33525063|NCT01990768|101819771|FG000|6-Month Follow-up|Homeless|4|||
33525064|NCT01990768|101819772|FG001|6-Month Follow-up|Homeless|3|||
33525065|NCT01990768|101819773|FG002|6-Month Follow-up|Homeless|6|||
33525066|NCT01990768|101819771|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
33525067|NCT01990768|101819772|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
33525068|NCT01990768|101819773|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
33525069|NCT01990768|101819771|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
33525070|NCT01990768|101819772|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
33525071|NCT01990768|101819773|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
33525072|NCT01990768|101819771|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
33525073|NCT01990768|101819772|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
33525074|NCT01990768|101819773|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
33525075|NCT00631163|101819774|FG000|Number of Participants in Year 1|Adverse Event|12|||
33525076|NCT00631163|101819774|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
33525077|NCT00631163|101819774|FG000|Number of Participants in Year 1|Death|6|||
33525078|NCT00631163|101819774|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
33525079|NCT00631163|101819774|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
33525080|NCT00631163|101819774|FG000|Number of Participants in Year 1|Administrative problems|6|||
33525081|NCT00631163|101819774|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
33525082|NCT00631163|101819774|FG000|Number of Participants in Year 2|Adverse Event|1|||
33525083|NCT00631163|101819774|FG000|Number of Participants in Year 2|Protocol Violation|1|||
33525084|NCT00631163|101819774|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
33525085|NCT00978341|101819775|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
33525086|NCT00978341|101819776|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
33525087|NCT00154375|101819777|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
33610082|NCT03160885|102123192|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
33610083|NCT03160885|102123186|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
33610084|NCT03160885|102123187|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
33402238|NCT00805142|101361684|FG001|Maintenance Period|Other|1|||
33402239|NCT01990339|101361703|FG000|Overall Study|Data Not Available|49|||
33402240|NCT01990339|101361703|FG000|Overall Study|Voluntary Withdrawal|1402|||
33402241|NCT01990339|101361703|FG000|Overall Study|Lost to Follow-up|861|||
33402242|NCT00364351|101361715|FG000|Overall Study|Adverse Event|90|||
33402243|NCT00364351|101361716|FG001|Overall Study|Adverse Event|44|||
33402244|NCT00364351|101361715|FG000|Overall Study|Condition under investigation worsened|469|||
33402245|NCT00364351|101361716|FG001|Overall Study|Condition under investigation worsened|497|||
33402246|NCT00364351|101361715|FG000|Overall Study|Prohibited concomitant medication|0|||
33402247|NCT00364351|101361716|FG001|Overall Study|Prohibited concomitant medication|2|||
33525088|NCT00154375|101819778|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
33525089|NCT00154375|101819777|FG000|Overall Study|Adverse Event|18|||
33525090|NCT00154375|101819778|FG001|Overall Study|Adverse Event|20|||
33525091|NCT00154375|101819777|FG000|Overall Study|Withdrawal by Subject|14|||
33525092|NCT00154375|101819778|FG001|Overall Study|Withdrawal by Subject|10|||
33525093|NCT00154375|101819777|FG000|Overall Study|Death|5|||
33525094|NCT00154375|101819778|FG001|Overall Study|Death|13|||
33525095|NCT00154375|101819777|FG000|Overall Study|Study drug no longer required|5|||
33525096|NCT00154375|101819778|FG001|Overall Study|Study drug no longer required|3|||
33525097|NCT00154375|101819777|FG000|Overall Study|Lost to Follow-up|2|||
33525098|NCT00154375|101819778|FG001|Overall Study|Lost to Follow-up|1|||
33525099|NCT00154375|101819777|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33525100|NCT00154375|101819778|FG001|Overall Study|Abnormal laboratory value(s)|2|||
33525101|NCT00154375|101819777|FG000|Overall Study|Protocol Violation|0|||
33525102|NCT00154375|101819778|FG001|Overall Study|Protocol Violation|1|||
33525103|NCT00154375|101819777|FG000|Overall Study|Suspected progression of disease|44|||
33525104|NCT00154375|101819778|FG001|Overall Study|Suspected progression of disease|30|||
33525105|NCT02869893|101819779|FG000|Overall Study|participant aversion to IV|5|||
33525106|NCT02869893|101819779|FG000|Overall Study|participant fear of MRI scanner|2|||
33525107|NCT03488563|101819780|FG000|Overall Study|Lost to Follow-up|7|||
33525108|NCT03488563|101819781|FG001|Overall Study|Lost to Follow-up|6|||
33525109|NCT03488563|101819782|FG002|Overall Study|Lost to Follow-up|7|||
33525110|NCT03488563|101819780|FG000|Overall Study|Withdrawal by Subject|8|||
33525111|NCT03488563|101819781|FG001|Overall Study|Withdrawal by Subject|7|||
33525112|NCT03488563|101819782|FG002|Overall Study|Withdrawal by Subject|7|||
33525113|NCT03488563|101819780|FG000|Overall Study|Physician Decision|0|||
33525114|NCT03488563|101819781|FG001|Overall Study|Physician Decision|0|||
33525115|NCT03488563|101819782|FG002|Overall Study|Physician Decision|1|||
33525116|NCT03488563|101819780|FG000|Overall Study|Protocol Violation|3|||
33525117|NCT03488563|101819781|FG001|Overall Study|Protocol Violation|2|||
33525118|NCT03488563|101819782|FG002|Overall Study|Protocol Violation|6|||
33525119|NCT03488563|101819780|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
33525120|NCT03488563|101819781|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
33201864|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33402248|NCT00364351|101361715|FG000|Overall Study|Lost to Follow-up|1|||
33402249|NCT00364351|101361716|FG001|Overall Study|Lost to Follow-up|1|||
33402250|NCT00364351|101361715|FG000|Overall Study|Withdrawal by Subject|30|||
33402251|NCT00364351|101361716|FG001|Overall Study|Withdrawal by Subject|29|||
33402252|NCT00364351|101361715|FG000|Overall Study|Incorrect enrollment|1|||
33402253|NCT00364351|101361716|FG001|Overall Study|Incorrect enrollment|1|||
33402254|NCT00364351|101361715|FG000|Overall Study|Sponsor decision|1|||
33402255|NCT00364351|101361716|FG001|Overall Study|Sponsor decision|0|||
33402256|NCT00364351|101361715|FG000|Overall Study|Poor treatment compliance|0|||
33402257|NCT00364351|101361716|FG001|Overall Study|Poor treatment compliance|3|||
33402258|NCT00364351|101361715|FG000|Overall Study|Investigator error|0|||
33402259|NCT00364351|101361716|FG001|Overall Study|Investigator error|2|||
33402260|NCT00364351|101361715|FG000|Overall Study|Patient could not travel to site|0|||
33402261|NCT00364351|101361716|FG001|Overall Study|Patient could not travel to site|1|||
33402262|NCT00364351|101361715|FG000|Overall Study|Randomised treatment not started|0|||
33402263|NCT00364351|101361716|FG001|Overall Study|Randomised treatment not started|3|||
33525121|NCT03488563|101819782|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
33525122|NCT03488563|101819780|FG000|Overall Study|Use of prohibited medication|2|||
33525123|NCT03488563|101819781|FG001|Overall Study|Use of prohibited medication|0|||
33525124|NCT03488563|101819782|FG002|Overall Study|Use of prohibited medication|0|||
33525125|NCT03488563|101819780|FG000|Overall Study|Adverse Event|1|||
33525126|NCT03488563|101819781|FG001|Overall Study|Adverse Event|0|||
33201865|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33402264|NCT01797302|101361719|FG000|Overall Study|Lost to Follow-up|16|||
33402265|NCT01797302|101361720|FG001|Overall Study|Lost to Follow-up|23|||
33402266|NCT01797302|101361721|FG002|Overall Study|Lost to Follow-up|22|||
33402267|NCT01797302|101361719|FG000|Overall Study|Withdrawal by Subject|1|||
33402268|NCT01797302|101361720|FG001|Overall Study|Withdrawal by Subject|3|||
33402269|NCT01797302|101361721|FG002|Overall Study|Withdrawal by Subject|4|||
33525127|NCT03488563|101819782|FG002|Overall Study|Adverse Event|1|||
33525128|NCT03488563|101819780|FG000|Overall Study|Subject returned for ET visit|0|||
33201866|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
33201867|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33201868|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33201869|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33201870|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33201871|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33201872|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
33201873|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
33201874|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
33201875|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
33201876|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
33201877|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
33201878|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
33201879|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
33201880|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
33201881|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
33201882|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
33201883|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
33201884|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
33201885|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
33201886|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
33201887|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
33201888|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
33331032|NCT03765138|101104273|FG000|Overall Study|Lost to Follow-up|1|||
33331033|NCT00957528|101104274|FG000|Overall Study|Protocol Violation|0|||
33331034|NCT00957528|101104275|FG001|Overall Study|Protocol Violation|1|||
33331035|NCT00957528|101104276|FG002|Overall Study|Protocol Violation|0|||
33331036|NCT00957528|101104274|FG000|Overall Study|Withdrawal by Subject|0|||
33402270|NCT02041533|101361724|FG000|Pre-Treatment Period|Disease Progression|1|||
33402271|NCT02041533|101361725|FG001|Pre-Treatment Period|Disease Progression|1|||
33402272|NCT02041533|101361724|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
33402273|NCT02041533|101361725|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
33402274|NCT02041533|101361724|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
33402275|NCT02041533|101361725|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
33402276|NCT02041533|101361724|FG000|Treatment Period|Disease progression|189|||
33402277|NCT02041533|101361725|FG001|Treatment Period|Disease progression|146|||
33402278|NCT02041533|101361724|FG000|Treatment Period|Study drug toxicity|30|||
33402279|NCT02041533|101361725|FG001|Treatment Period|Study drug toxicity|34|||
33402280|NCT02041533|101361724|FG000|Treatment Period|Death|1|||
33402281|NCT02041533|101361725|FG001|Treatment Period|Death|0|||
33402282|NCT02041533|101361724|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
33402283|NCT02041533|101361725|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
33402284|NCT02041533|101361724|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
33402285|NCT02041533|101361725|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
33402286|NCT02041533|101361724|FG000|Treatment Period|Participant withdrew consent|2|||
33402287|NCT02041533|101361725|FG001|Treatment Period|Participant withdrew consent|2|||
33402288|NCT02041533|101361724|FG000|Treatment Period|Maximum clinical benefit|0|||
33402289|NCT02041533|101361725|FG001|Treatment Period|Maximum clinical benefit|18|||
33402290|NCT02041533|101361724|FG000|Treatment Period|Poor/Non-compliance|1|||
33402291|NCT02041533|101361725|FG001|Treatment Period|Poor/Non-compliance|0|||
33525129|NCT03488563|101819781|FG001|Overall Study|Subject returned for ET visit|1|||
33201889|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
33331037|NCT00957528|101104275|FG001|Overall Study|Withdrawal by Subject|0|||
33331038|NCT00957528|101104276|FG002|Overall Study|Withdrawal by Subject|1|||
33331039|NCT02250274|101104277|FG000|Overall Study|Insufficient blood draw amount|7|||
33331040|NCT02250274|101104278|FG001|Overall Study|Insufficient blood draw amount|6|||
33331041|NCT01131676|101104281|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
33402292|NCT02041533|101361724|FG000|Treatment Period|Administrative reason by sponsor|1|||
33402293|NCT02041533|101361725|FG001|Treatment Period|Administrative reason by sponsor|0|||
33525130|NCT03488563|101819782|FG002|Overall Study|Subject returned for ET visit|0|||
33201890|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
33331042|NCT01131676|101104282|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
33331043|NCT01131676|101104283|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
33402294|NCT02041533|101361724|FG000|Treatment Period|Other reasons|9|||
33402295|NCT02041533|101361725|FG001|Treatment Period|Other reasons|2|||
33402296|NCT02041533|101361724|FG000|Treatment Period|Not Reported|0|||
33402297|NCT02041533|101361725|FG001|Treatment Period|Not Reported|1|||
33525131|NCT03488563|101819780|FG000|Overall Study|Sponsor's decision|0|||
33201891|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33201892|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33201893|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
33201894|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33201895|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33201896|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33201897|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33201898|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33201899|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
33201900|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33201901|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33201902|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
33201903|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33201904|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33331044|NCT01131676|101104281|FG000|Discontinuation From Treatment|Not treated|4|||
33331045|NCT01131676|101104282|FG001|Discontinuation From Treatment|Not treated|2|||
33331046|NCT01131676|101104283|FG002|Discontinuation From Treatment|Not treated|2|||
33331047|NCT01131676|101104281|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
33331048|NCT01131676|101104282|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
33331049|NCT01131676|101104283|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
33331050|NCT01131676|101104281|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
33331051|NCT01131676|101104282|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
33331052|NCT01131676|101104283|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
33331053|NCT01131676|101104281|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
33331054|NCT01131676|101104282|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
33331055|NCT01131676|101104283|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
33331056|NCT01131676|101104281|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
33331057|NCT01131676|101104282|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
33331058|NCT01131676|101104283|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
33331059|NCT01131676|101104281|FG000|Discontinuation From Treatment|Other than those specified|162|||
33331060|NCT01131676|101104282|FG001|Discontinuation From Treatment|Other than those specified|142|||
33331061|NCT01131676|101104283|FG002|Discontinuation From Treatment|Other than those specified|125|||
33525132|NCT03488563|101819781|FG001|Overall Study|Sponsor's decision|0|||
33525133|NCT03488563|101819782|FG002|Overall Study|Sponsor's decision|1|||
33525134|NCT02849171|101819784|FG000|Overall Study|Withdrawal by Subject|1|||
33525135|NCT02849171|101819784|FG000|Overall Study|Not treated|1|||
33525136|NCT00255840|101819792|FG000|Overall Study|Lost to Follow-up|10|||
33525137|NCT00255840|101819793|FG001|Overall Study|Lost to Follow-up|14|||
33525138|NCT00255840|101819792|FG000|Overall Study|Discontinued intervention|53|||
33525139|NCT00255840|101819793|FG001|Overall Study|Discontinued intervention|56|||
33525140|NCT02113007|101819796|FG000|Overall Study|Progressive disease|2|||
33525141|NCT00329745|101819797|FG000|Overall Study|Protocol Violation|1|||
33525142|NCT00329745|101819798|FG001|Overall Study|Protocol Violation|0|||
33201905|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33201906|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33201907|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33201908|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
33201909|NCT01172938|100642675|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33201910|NCT01172938|100642676|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33201911|NCT01172938|100642677|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33201912|NCT01172938|100642678|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33201913|NCT01172938|100642679|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33201914|NCT01172938|100642680|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33201915|NCT01172938|100642681|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33201916|NCT01172938|100642682|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
33201917|NCT01172938|100642683|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
33201918|NCT05101252|100642688|FG000|Overall Study|Unsatisfactory Test Article|1|||
33201919|NCT05101252|100642689|FG001|Overall Study|Unsatisfactory Test Article|0|||
33201920|NCT05101252|100642688|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
33201921|NCT05101252|100642689|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
33201922|NCT05101252|100642688|FG000|Overall Study|Withdrew Consent during study|0|||
33201923|NCT05101252|100642689|FG001|Overall Study|Withdrew Consent during study|1|||
33201924|NCT05101252|100642688|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
33331062|NCT01131676|101104281|FG000|Discontinuation From Treatment|Adverse Event|303|||
33201925|NCT05101252|100642689|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
33331063|NCT01131676|101104282|FG001|Discontinuation From Treatment|Adverse Event|267|||
33331064|NCT01131676|101104283|FG002|Discontinuation From Treatment|Adverse Event|273|||
33525143|NCT00329745|101819797|FG000|Overall Study|Withdrawal by Subject|0|||
33525144|NCT00329745|101819798|FG001|Overall Study|Withdrawal by Subject|1|||
33201926|NCT00345397|100642690|FG000|Overall Study|Death|1|||
33201927|NCT01525082|100642693|FG000|Overall Study|Death|1|||
33201928|NCT01252251|100642698|FG000|Overall Study|Withdrawal by Subject|1|||
33201929|NCT00262834|100642699|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
33201930|NCT00262834|100642700|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
33201931|NCT01055639|100642701|FG000|Overall Study|Adverse Event|0|||
33201932|NCT01055639|100642702|FG001|Overall Study|Adverse Event|1|||
33331065|NCT01131676|101104281|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
33331066|NCT01131676|101104282|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
33331067|NCT01131676|101104283|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
33331068|NCT01131676|101104281|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
33402298|NCT02694562|101361726|FG000|Overall Study|Death|8|||
33402299|NCT02694562|101361726|FG000|Overall Study|Protocol Violation|4|||
33402300|NCT02694562|101361726|FG000|Overall Study|Lost to Follow-up|3|||
33402301|NCT02694562|101361726|FG000|Overall Study|Screen Failure|2|||
33402302|NCT02694562|101361726|FG000|Overall Study|Physician Decision|1|||
33402303|NCT03558503|101361741|FG000|Overall Study|Adverse Event|1|||
33402304|NCT03558503|101361741|FG000|Overall Study|Death|1|||
33402305|NCT03558503|101361741|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
33402306|NCT01231620|101361742|FG000|Overall Study|Physician Decision|3|||
33402307|NCT01231620|101361743|FG001|Overall Study|Physician Decision|5|||
33402308|NCT01231620|101361744|FG002|Overall Study|Physician Decision|10|||
33402309|NCT01231620|101361742|FG000|Overall Study|Death|12|||
33402310|NCT01231620|101361743|FG001|Overall Study|Death|14|||
33402311|NCT01231620|101361744|FG002|Overall Study|Death|11|||
33402312|NCT01231620|101361742|FG000|Overall Study|Adverse Event|2|||
33402313|NCT01231620|101361743|FG001|Overall Study|Adverse Event|2|||
33331069|NCT01131676|101104282|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
33331070|NCT01131676|101104283|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
33402314|NCT01231620|101361744|FG002|Overall Study|Adverse Event|1|||
33402315|NCT01231620|101361742|FG000|Overall Study|Withdrawal by Subject|6|||
33402316|NCT01231620|101361743|FG001|Overall Study|Withdrawal by Subject|6|||
33402317|NCT01231620|101361744|FG002|Overall Study|Withdrawal by Subject|8|||
33402318|NCT01231620|101361742|FG000|Overall Study|Lost to Follow-up|3|||
33402319|NCT01231620|101361743|FG001|Overall Study|Lost to Follow-up|4|||
33402320|NCT01231620|101361744|FG002|Overall Study|Lost to Follow-up|9|||
33402321|NCT00591786|101361745|FG000|Overall Study|Withdrawal of Informed Consent|0|||
33402322|NCT00591786|101361746|FG001|Overall Study|Withdrawal of Informed Consent|0|||
33402323|NCT00591786|101361747|FG002|Overall Study|Withdrawal of Informed Consent|1|||
33525145|NCT00329745|101819797|FG000|Overall Study|Lost to Follow-up|86|||
33525146|NCT00329745|101819798|FG001|Overall Study|Lost to Follow-up|101|||
33525147|NCT03538691|101819799|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
33525148|NCT03538691|101819800|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
33525149|NCT03538691|101819801|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
33525150|NCT03538691|101819802|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
33525151|NCT03538691|101819799|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
33525152|NCT03538691|101819800|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
33331071|NCT01131676|101104281|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
33331072|NCT01131676|101104282|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
33331073|NCT01131676|101104283|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
33331074|NCT01131676|101104281|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
33331075|NCT01131676|101104282|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
33331076|NCT01131676|101104283|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
33331077|NCT01131676|101104281|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
33331078|NCT01131676|101104282|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
33331079|NCT01131676|101104283|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
33331080|NCT01131676|101104281|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
33331081|NCT01131676|101104282|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
33331082|NCT01131676|101104283|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
33331083|NCT00574288|101104284|FG000|Overall Study|Adverse Event|2|||
33402324|NCT00591786|101361748|FG003|Overall Study|Withdrawal of Informed Consent|0|||
33525153|NCT03538691|101819801|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
33402325|NCT00591786|101361749|FG004|Overall Study|Withdrawal of Informed Consent|0|||
33402326|NCT00591786|101361750|FG005|Overall Study|Withdrawal of Informed Consent|0|||
33402327|NCT00591786|101361751|FG006|Overall Study|Withdrawal of Informed Consent|0|||
33402328|NCT00591786|101361752|FG007|Overall Study|Withdrawal of Informed Consent|0|||
33610085|NCT03160885|102123188|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
33201933|NCT01055639|100642701|FG000|Overall Study|Lack of Efficacy|0|||
33201934|NCT01055639|100642702|FG001|Overall Study|Lack of Efficacy|1|||
33201935|NCT01055639|100642701|FG000|Overall Study|Lost to Follow-up|8|||
33201936|NCT01055639|100642702|FG001|Overall Study|Lost to Follow-up|11|||
33201937|NCT01055639|100642701|FG000|Overall Study|Protocol Violation|5|||
33201938|NCT01055639|100642702|FG001|Overall Study|Protocol Violation|5|||
33201939|NCT01055639|100642701|FG000|Overall Study|Withdrawal by Subject|8|||
33201940|NCT01055639|100642702|FG001|Overall Study|Withdrawal by Subject|11|||
33201941|NCT03086447|100642705|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33201942|NCT03086447|100642706|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
33201943|NCT03086447|100642705|FG000|Overall Study|Lost Lens|2|||
33201944|NCT03086447|100642706|FG001|Overall Study|Lost Lens|5|||
33201945|NCT03086447|100642705|FG000|Overall Study|Product quality complaint|0|||
33201946|NCT03086447|100642706|FG001|Overall Study|Product quality complaint|1|||
33201947|NCT03086447|100642705|FG000|Overall Study|Lens Damage|1|||
33201948|NCT03086447|100642706|FG001|Overall Study|Lens Damage|6|||
33201949|NCT03086447|100642705|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
33201950|NCT03086447|100642706|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
33201951|NCT03086447|100642705|FG000|Overall Study|Test Article No Longer Available|1|||
33201952|NCT03086447|100642706|FG001|Overall Study|Test Article No Longer Available|0|||
33201953|NCT03086447|100642705|FG000|Overall Study|Protocol Violation|2|||
33201954|NCT03086447|100642706|FG001|Overall Study|Protocol Violation|4|||
33201955|NCT03086447|100642705|FG000|Overall Study|Lost to Follow-up|0|||
33201956|NCT03086447|100642706|FG001|Overall Study|Lost to Follow-up|1|||
33201957|NCT03086447|100642705|FG000|Overall Study|Adverse Event|3|||
33201958|NCT03086447|100642706|FG001|Overall Study|Adverse Event|0|||
33201959|NCT03086447|100642705|FG000|Overall Study|Lens Discomfort|2|||
33201960|NCT03086447|100642706|FG001|Overall Study|Lens Discomfort|1|||
33201961|NCT00023452|100642707|FG000|Overall Study|Ineligible for Study|163|||
33201962|NCT00023452|100642708|FG001|Overall Study|Ineligible for Study|159|||
33201963|NCT00023452|100642707|FG000|Overall Study|Out of Window|129|||
33201964|NCT00023452|100642708|FG001|Overall Study|Out of Window|69|||
33201965|NCT00023452|100642707|FG000|Overall Study|Death|2|||
33201966|NCT00023452|100642708|FG001|Overall Study|Death|0|||
33201967|NCT00023452|100642707|FG000|Overall Study|Withdrawal by Subject|66|||
33201968|NCT00023452|100642708|FG001|Overall Study|Withdrawal by Subject|54|||
33201969|NCT00023452|100642707|FG000|Overall Study|Adverse Event|139|||
33201970|NCT00023452|100642708|FG001|Overall Study|Adverse Event|196|||
33201971|NCT00023452|100642707|FG000|Overall Study|Lost to Follow-up|293|||
33201972|NCT00023452|100642708|FG001|Overall Study|Lost to Follow-up|60|||
33201973|NCT00023452|100642707|FG000|Overall Study|Physician Decision|49|||
33201974|NCT00023452|100642708|FG001|Overall Study|Physician Decision|21|||
33201975|NCT00023452|100642707|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
33201976|NCT00023452|100642708|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
33201977|NCT00023452|100642707|FG000|Overall Study|Pregnant|53|||
33201978|NCT00023452|100642708|FG001|Overall Study|Pregnant|20|||
33201979|NCT00023452|100642707|FG000|Overall Study|Other|204|||
33201980|NCT00023452|100642708|FG001|Overall Study|Other|69|||
33201981|NCT05819749|100642709|FG000|Overall Study|Lost to Follow-up|1|||
33201982|NCT01255358|100642710|FG000|Overall Study|Adverse Event|2|||
33201983|NCT01255358|100642710|FG000|Overall Study|Protocol Violation|2|||
33201984|NCT00616967|100642721|FG000|Overall Study|Withdrawal by Subject|0|||
33201985|NCT00616967|100642722|FG001|Overall Study|Withdrawal by Subject|0|||
33201986|NCT00616967|100642723|FG002|Overall Study|Withdrawal by Subject|1|||
33201987|NCT00352534|100642726|FG000|Initial Staging|Ineligible|8|||
33201988|NCT00352534|100642727|FG001|Initial Staging|Ineligible|9|||
33201989|NCT00352534|100642728|FG002|Initial Staging|Ineligible|0|||
33201990|NCT00352534|100642729|FG003|Initial Staging|Ineligible|0|||
33201991|NCT00352534|100642730|FG004|Initial Staging|Ineligible|0|||
33201992|NCT00352534|100642731|FG005|Initial Staging|Ineligible|0|||
33201993|NCT00352534|100642732|FG006|Initial Staging|Ineligible|0|||
33201994|NCT00352534|100642726|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
33201995|NCT00352534|100642727|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
33201996|NCT00352534|100642728|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
33331084|NCT00574288|101104285|FG001|Overall Study|Adverse Event|0|||
33331085|NCT00574288|101104286|FG002|Overall Study|Adverse Event|0|||
33201997|NCT00352534|100642729|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
33201998|NCT00352534|100642730|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
33201999|NCT00352534|100642731|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
33202000|NCT00352534|100642732|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
33202001|NCT00352534|100642726|FG000|Final Risk Group Assignment|Physician Decision|0|||
33202002|NCT00352534|100642727|FG001|Final Risk Group Assignment|Physician Decision|0|||
33202003|NCT00352534|100642728|FG002|Final Risk Group Assignment|Physician Decision|0|||
33202004|NCT00352534|100642729|FG003|Final Risk Group Assignment|Physician Decision|0|||
33202005|NCT00352534|100642730|FG004|Final Risk Group Assignment|Physician Decision|0|||
33202006|NCT00352534|100642731|FG005|Final Risk Group Assignment|Physician Decision|8|||
33202007|NCT00352534|100642732|FG006|Final Risk Group Assignment|Physician Decision|0|||
33331086|NCT00574288|101104287|FG003|Overall Study|Adverse Event|0|||
33202008|NCT00352534|100642726|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
33202009|NCT00352534|100642727|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
33202010|NCT00352534|100642728|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
33202011|NCT00352534|100642729|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
33202012|NCT00352534|100642730|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
33202013|NCT00352534|100642731|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
33202014|NCT00352534|100642732|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
33202015|NCT00352534|100642726|FG000|Final Risk Group Assignment|Ineligible|0|||
33202016|NCT00352534|100642727|FG001|Final Risk Group Assignment|Ineligible|0|||
33202017|NCT00352534|100642728|FG002|Final Risk Group Assignment|Ineligible|3|||
33202018|NCT00352534|100642729|FG003|Final Risk Group Assignment|Ineligible|1|||
33202019|NCT00352534|100642730|FG004|Final Risk Group Assignment|Ineligible|0|||
33202020|NCT00352534|100642731|FG005|Final Risk Group Assignment|Ineligible|13|||
33202021|NCT00352534|100642732|FG006|Final Risk Group Assignment|Ineligible|0|||
33202022|NCT00352534|100642726|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
33202023|NCT00352534|100642727|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
33202024|NCT00352534|100642728|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
33202025|NCT00352534|100642729|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
33202026|NCT00352534|100642730|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
33202027|NCT00352534|100642731|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
33202028|NCT00352534|100642732|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
33202029|NCT00352534|100642726|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
33202030|NCT00352534|100642727|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
33202031|NCT00352534|100642728|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
33202032|NCT00352534|100642729|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
33202033|NCT00352534|100642730|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
33525154|NCT03538691|101819802|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
33525155|NCT03538691|101819799|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
33525156|NCT03538691|101819800|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
33525157|NCT03538691|101819801|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
33525158|NCT03538691|101819802|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
33525159|NCT03538691|101819799|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
33525160|NCT03538691|101819800|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
33525161|NCT03538691|101819801|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
33525162|NCT03538691|101819802|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
33525163|NCT03538691|101819799|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
33525164|NCT03538691|101819800|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
33525165|NCT03538691|101819801|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
33525166|NCT03538691|101819802|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
33525167|NCT03538691|101819799|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
33525168|NCT03538691|101819800|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
33525169|NCT03538691|101819801|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
33202034|NCT00352534|100642731|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
33202035|NCT00352534|100642732|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
33331087|NCT00574288|101104288|FG004|Overall Study|Adverse Event|1|||
33331088|NCT00574288|101104289|FG005|Overall Study|Adverse Event|0|||
33331089|NCT00574288|101104290|FG006|Overall Study|Adverse Event|0|||
33331090|NCT00574288|101104284|FG000|Overall Study|Death|0|||
33331091|NCT00574288|101104285|FG001|Overall Study|Death|0|||
33331092|NCT00574288|101104286|FG002|Overall Study|Death|0|||
33331093|NCT00574288|101104287|FG003|Overall Study|Death|0|||
33331094|NCT00574288|101104288|FG004|Overall Study|Death|0|||
33331095|NCT00574288|101104289|FG005|Overall Study|Death|25|||
33331096|NCT00574288|101104290|FG006|Overall Study|Death|21|||
33331097|NCT00574288|101104284|FG000|Overall Study|Lost to Follow-up|0|||
33331098|NCT00574288|101104285|FG001|Overall Study|Lost to Follow-up|0|||
33331099|NCT00574288|101104286|FG002|Overall Study|Lost to Follow-up|0|||
33331100|NCT00574288|101104287|FG003|Overall Study|Lost to Follow-up|0|||
33331101|NCT00574288|101104288|FG004|Overall Study|Lost to Follow-up|0|||
33331102|NCT00574288|101104289|FG005|Overall Study|Lost to Follow-up|1|||
33331103|NCT00574288|101104290|FG006|Overall Study|Lost to Follow-up|2|||
33331104|NCT00574288|101104284|FG000|Overall Study|Study Terminated By Sponsor|0|||
33331105|NCT00574288|101104285|FG001|Overall Study|Study Terminated By Sponsor|0|||
33331106|NCT00574288|101104286|FG002|Overall Study|Study Terminated By Sponsor|0|||
33331107|NCT00574288|101104287|FG003|Overall Study|Study Terminated By Sponsor|0|||
33402329|NCT00591786|101361753|FG008|Overall Study|Withdrawal of Informed Consent|0|||
33202036|NCT00352534|100642726|FG000|Final Risk Group Assignment|Death|0|||
33331108|NCT00574288|101104288|FG004|Overall Study|Study Terminated By Sponsor|0|||
33331109|NCT00574288|101104289|FG005|Overall Study|Study Terminated By Sponsor|0|||
33525170|NCT03538691|101819802|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
33525171|NCT03538691|101819799|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
33525172|NCT03538691|101819800|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
33525173|NCT03538691|101819801|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
33525174|NCT03538691|101819802|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
33525175|NCT03538691|101819799|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
33525176|NCT03538691|101819800|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
33525177|NCT03538691|101819801|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
33525178|NCT03538691|101819802|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
33525179|NCT03538691|101819799|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
33525180|NCT03538691|101819800|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
33525181|NCT03538691|101819801|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
33525182|NCT03538691|101819802|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
33525183|NCT03538691|101819799|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
33525184|NCT03538691|101819800|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
33525185|NCT03538691|101819801|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
33525186|NCT03538691|101819802|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
33525187|NCT03538691|101819799|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
33525188|NCT03538691|101819800|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
33525189|NCT03538691|101819801|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
33525190|NCT03538691|101819802|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
33525191|NCT03538691|101819799|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
33525192|NCT03538691|101819800|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
33525193|NCT03538691|101819801|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
33525194|NCT03538691|101819802|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
33525195|NCT03538691|101819799|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
33525196|NCT03538691|101819800|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
33525197|NCT03538691|101819801|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
33525198|NCT03538691|101819802|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
33331110|NCT00574288|101104290|FG006|Overall Study|Study Terminated By Sponsor|5|||
33331111|NCT00574288|101104284|FG000|Overall Study|Progressive Disease|17|||
33331112|NCT00574288|101104285|FG001|Overall Study|Progressive Disease|2|||
33331113|NCT00574288|101104286|FG002|Overall Study|Progressive Disease|3|||
33331114|NCT00574288|101104287|FG003|Overall Study|Progressive Disease|2|||
33331115|NCT00574288|101104288|FG004|Overall Study|Progressive Disease|1|||
33331116|NCT00574288|101104289|FG005|Overall Study|Progressive Disease|0|||
33331117|NCT00574288|101104290|FG006|Overall Study|Progressive Disease|0|||
33331118|NCT00574288|101104284|FG000|Overall Study|Other|1|||
33331119|NCT00574288|101104285|FG001|Overall Study|Other|1|||
33331120|NCT00574288|101104286|FG002|Overall Study|Other|0|||
33331121|NCT00574288|101104287|FG003|Overall Study|Other|0|||
33331122|NCT00574288|101104288|FG004|Overall Study|Other|0|||
33331123|NCT00574288|101104289|FG005|Overall Study|Other|0|||
33331124|NCT00574288|101104290|FG006|Overall Study|Other|0|||
33331125|NCT00840086|101104291|FG000|Overall Study|Adverse Event|1|||
33331126|NCT00840086|101104291|FG000|Overall Study|Protocol Violation|2|||
33331127|NCT00840086|101104291|FG000|Overall Study|Lost to Follow-up|1|||
33331128|NCT00490451|101104292|FG000|Overall Study|Adverse Event|3|||
33331129|NCT00490451|101104293|FG001|Overall Study|Adverse Event|3|||
33331130|NCT00490451|101104292|FG000|Overall Study|Death|3|||
33331131|NCT00490451|101104293|FG001|Overall Study|Death|1|||
33331132|NCT00490451|101104292|FG000|Overall Study|Withdrawal by Subject|2|||
33331133|NCT00490451|101104293|FG001|Overall Study|Withdrawal by Subject|0|||
33331134|NCT00490451|101104292|FG000|Overall Study|Investigator Decision|1|||
33331135|NCT00490451|101104293|FG001|Overall Study|Investigator Decision|0|||
33331136|NCT00490451|101104292|FG000|Overall Study|Protocol Violation|1|||
33331137|NCT00490451|101104293|FG001|Overall Study|Protocol Violation|0|||
33331138|NCT00490451|101104292|FG000|Overall Study|Progressive Disease|53|||
33331139|NCT00490451|101104293|FG001|Overall Study|Progressive Disease|34|||
33331140|NCT04053868|101104294|FG000|Overall Study|Withdrawal by Subject|1|||
33331141|NCT04053868|101104295|FG001|Overall Study|Withdrawal by Subject|0|||
33331142|NCT01967628|101104296|FG000|Overall Study|Withdrawal by Subject|2|||
33331143|NCT01967628|101104297|FG001|Overall Study|Withdrawal by Subject|0|||
33331144|NCT01967628|101104296|FG000|Overall Study|Unable to complete bronchoscopy|4|||
33331145|NCT01967628|101104297|FG001|Overall Study|Unable to complete bronchoscopy|6|||
33331146|NCT01967628|101104296|FG000|Overall Study|Lost to Follow-up|1|||
33331147|NCT01967628|101104297|FG001|Overall Study|Lost to Follow-up|0|||
33331148|NCT01967628|101104296|FG000|Overall Study|Low protein concentration in sample|20|||
33331149|NCT01967628|101104297|FG001|Overall Study|Low protein concentration in sample|25|||
33202037|NCT00352534|100642727|FG001|Final Risk Group Assignment|Death|0|||
33202038|NCT00352534|100642728|FG002|Final Risk Group Assignment|Death|0|||
33202039|NCT00352534|100642729|FG003|Final Risk Group Assignment|Death|0|||
33202040|NCT00352534|100642730|FG004|Final Risk Group Assignment|Death|0|||
33202041|NCT00352534|100642731|FG005|Final Risk Group Assignment|Death|2|||
33202042|NCT00352534|100642732|FG006|Final Risk Group Assignment|Death|0|||
33202043|NCT01921348|100642739|FG000|Overall Study|Withdrawal by Subject|1|||
33202044|NCT01921348|100642740|FG001|Overall Study|Withdrawal by Subject|0|||
33202045|NCT01921348|100642739|FG000|Overall Study|Lost to Follow-up|0|||
33202046|NCT01921348|100642740|FG001|Overall Study|Lost to Follow-up|2|||
33202047|NCT00795600|100642741|FG000|Overall Study|Adverse Event|1|||
33202048|NCT00795600|100642742|FG001|Overall Study|Adverse Event|1|||
33202049|NCT00795600|100642741|FG000|Overall Study|Protocol Violation|1|||
33202050|NCT00795600|100642742|FG001|Overall Study|Protocol Violation|2|||
33202051|NCT00795600|100642741|FG000|Overall Study|Withdrawal by Subject|1|||
33202052|NCT00795600|100642742|FG001|Overall Study|Withdrawal by Subject|0|||
33202053|NCT00795600|100642741|FG000|Overall Study|Unclassified|1|||
33202054|NCT00795600|100642742|FG001|Overall Study|Unclassified|1|||
33202055|NCT00099983|100642745|FG000|Overall Study|Lost to Follow-up|2|||
33202056|NCT00099983|100642746|FG001|Overall Study|Lost to Follow-up|3|||
33202057|NCT00099983|100642745|FG000|Overall Study|Missing Source Documents|14|||
33202058|NCT00099983|100642746|FG001|Overall Study|Missing Source Documents|15|||
33202059|NCT00099983|100642745|FG000|Overall Study|Withdrawal by Subject|3|||
33202060|NCT00099983|100642746|FG001|Overall Study|Withdrawal by Subject|2|||
33202061|NCT00099983|100642745|FG000|Overall Study|Adverse Event|1|||
33202062|NCT00099983|100642746|FG001|Overall Study|Adverse Event|1|||
33202063|NCT00099983|100642745|FG000|Overall Study|Lack of Efficacy|0|||
33202064|NCT00099983|100642746|FG001|Overall Study|Lack of Efficacy|1|||
33202065|NCT00099983|100642745|FG000|Overall Study|Unable to return for appointments|1|||
33202066|NCT00099983|100642746|FG001|Overall Study|Unable to return for appointments|1|||
33202067|NCT00099983|100642745|FG000|Overall Study|Moved|1|||
33202068|NCT00099983|100642746|FG001|Overall Study|Moved|0|||
33202069|NCT00099983|100642745|FG000|Overall Study|Other psychiatric problem|1|||
33202070|NCT00099983|100642746|FG001|Overall Study|Other psychiatric problem|0|||
33331150|NCT03688880|101104302|FG000|Overall Study|Withdrawal by Subject|0|||
33331151|NCT03688880|101104303|FG001|Overall Study|Withdrawal by Subject|2|||
33331152|NCT03688880|101104302|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
33331153|NCT03688880|101104303|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
33331154|NCT03688880|101104302|FG000|Overall Study|Lost to Follow-up|4|||
33331155|NCT03688880|101104303|FG001|Overall Study|Lost to Follow-up|7|||
33331156|NCT03688880|101104302|FG000|Overall Study|Adverse Event|0|||
33331157|NCT03688880|101104303|FG001|Overall Study|Adverse Event|2|||
33331158|NCT03688880|101104302|FG000|Overall Study|Device deficiencies|0|||
33331159|NCT03688880|101104303|FG001|Overall Study|Device deficiencies|2|||
33331160|NCT03688880|101104302|FG000|Overall Study|Other|10|||
33610086|NCT03160885|102123189|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
33610087|NCT03160885|102123190|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
33610088|NCT03160885|102123191|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
33610089|NCT03160885|102123192|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
33610090|NCT03160885|102123186|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
33331161|NCT03688880|101104303|FG001|Overall Study|Other|16|||
33417266|NCT01248130|101420247|FG001|Overall Study|Ineligible|0|||
33525199|NCT03538691|101819799|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
33525200|NCT03538691|101819800|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
33525201|NCT03538691|101819801|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
33525202|NCT03538691|101819802|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
33525203|NCT03538691|101819799|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
33525204|NCT03538691|101819800|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
33525205|NCT03538691|101819801|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
33525206|NCT03538691|101819802|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
33610091|NCT03160885|102123187|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
33610092|NCT03160885|102123188|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
33610093|NCT03160885|102123189|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
33202071|NCT00099983|100642745|FG000|Overall Study|Incarcerated|0|||
33202072|NCT00099983|100642746|FG001|Overall Study|Incarcerated|1|||
33202073|NCT00099983|100642745|FG000|Overall Study|Intolerant of burden of visits|0|||
33202074|NCT00099983|100642746|FG001|Overall Study|Intolerant of burden of visits|1|||
33202075|NCT00099983|100642745|FG000|Overall Study|Other issue|1|||
33202076|NCT00099983|100642746|FG001|Overall Study|Other issue|0|||
33331162|NCT01430455|101104304|FG000|Overall Study|Withdrawal by Subject|1|||
33331163|NCT01430455|101104304|FG000|Overall Study|Switched to follow-up phase|1|||
33202077|NCT04258020|100642747|FG000|Overall Study|Withdrawal by Subject|1|||
33202078|NCT04258020|100642748|FG001|Overall Study|Withdrawal by Subject|0|||
33331164|NCT02054897|101104307|FG000|Overall Study|Withdrawal by Subject|2|||
33331165|NCT02054897|101104308|FG001|Overall Study|Withdrawal by Subject|0|||
33202079|NCT01808313|100642749|FG000|Overall Study|Adverse Event|5|||
33202080|NCT01808313|100642749|FG000|Overall Study|Protocol Violation|2|||
33202081|NCT01808313|100642749|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33202082|NCT01808313|100642749|FG000|Overall Study|Lost to Follow-up|1|||
33202083|NCT01808313|100642749|FG000|Overall Study|Physician Decision|1|||
33202084|NCT01490060|100642755|FG000|Cycle 1|Change of Treatment|0|||
33202085|NCT01490060|100642756|FG001|Cycle 1|Change of Treatment|1|||
33202086|NCT01490060|100642757|FG002|Cycle 1|Change of Treatment|1|||
33202087|NCT01490060|100642758|FG003|Cycle 1|Change of Treatment|1|||
33202088|NCT01490060|100642755|FG000|Cycle 1|Insurance Denied|0|||
33202089|NCT01490060|100642756|FG001|Cycle 1|Insurance Denied|0|||
33202090|NCT01490060|100642757|FG002|Cycle 1|Insurance Denied|2|||
33202091|NCT01490060|100642758|FG003|Cycle 1|Insurance Denied|0|||
33202092|NCT01490060|100642755|FG000|Cycle 1|Withdrawal by Subject|0|||
33202093|NCT01490060|100642756|FG001|Cycle 1|Withdrawal by Subject|0|||
33202094|NCT01490060|100642757|FG002|Cycle 1|Withdrawal by Subject|0|||
33202095|NCT01490060|100642758|FG003|Cycle 1|Withdrawal by Subject|1|||
33202096|NCT01490060|100642755|FG000|Cycle 1|Treatment at Another Facility|0|||
33202097|NCT01490060|100642756|FG001|Cycle 1|Treatment at Another Facility|0|||
33202098|NCT01490060|100642757|FG002|Cycle 1|Treatment at Another Facility|0|||
33202099|NCT01490060|100642758|FG003|Cycle 1|Treatment at Another Facility|1|||
33202100|NCT01490060|100642755|FG000|Cycle 2|Change of Treatment|1|||
33331166|NCT02054897|101104309|FG002|Overall Study|Withdrawal by Subject|2|||
33331167|NCT02054897|101104307|FG000|Overall Study|Missing follow-up information|3|||
33331168|NCT02054897|101104308|FG001|Overall Study|Missing follow-up information|5|||
33331169|NCT02054897|101104309|FG002|Overall Study|Missing follow-up information|3|||
33331170|NCT02054897|101104307|FG000|Overall Study|Lost to Follow-up|4|||
33202101|NCT01490060|100642756|FG001|Cycle 2|Change of Treatment|1|||
33202102|NCT01490060|100642757|FG002|Cycle 2|Change of Treatment|0|||
33202103|NCT01490060|100642758|FG003|Cycle 2|Change of Treatment|0|||
33202104|NCT01490060|100642755|FG000|Cycle 2|Non-Compliance|0|||
33202105|NCT01490060|100642756|FG001|Cycle 2|Non-Compliance|0|||
33202106|NCT01490060|100642757|FG002|Cycle 2|Non-Compliance|1|||
33202107|NCT01490060|100642758|FG003|Cycle 2|Non-Compliance|0|||
33202108|NCT01490060|100642755|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
33202109|NCT01490060|100642756|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
33202110|NCT01490060|100642757|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
33202111|NCT01490060|100642758|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
33202112|NCT02473952|100642759|FG000|Overall Study|Adverse Event|2|||
33202113|NCT02473952|100642760|FG001|Overall Study|Adverse Event|2|||
33202114|NCT02473952|100642759|FG000|Overall Study|Withdrawal by Subject|0|||
33202115|NCT02473952|100642760|FG001|Overall Study|Withdrawal by Subject|6|||
33202116|NCT01272934|100642761|FG000|Overall Study|Adverse Event|0|||
33202117|NCT01272934|100642762|FG001|Overall Study|Adverse Event|1|||
33202118|NCT01272934|100642761|FG000|Overall Study|Abnormal Laboratory Value|0|||
33202119|NCT01272934|100642762|FG001|Overall Study|Abnormal Laboratory Value|1|||
33202120|NCT01046643|100642763|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
33202121|NCT01046643|100642764|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
33202122|NCT01046643|100642765|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
33202123|NCT01046643|100642766|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
33202124|NCT02348216|100642769|FG000|Overall Study|Death|5|||
33202125|NCT02348216|100642770|FG001|Overall Study|Death|53|||
33202126|NCT02348216|100642771|FG002|Overall Study|Death|11|||
33202127|NCT02348216|100642772|FG003|Overall Study|Death|20|||
33202128|NCT02348216|100642773|FG004|Overall Study|Death|16|||
33202129|NCT02348216|100642774|FG005|Overall Study|Death|32|||
33202130|NCT02348216|100642775|FG006|Overall Study|Death|17|||
33202131|NCT02348216|100642769|FG000|Overall Study|Full consent withdrawal|0|||
33202132|NCT02348216|100642770|FG001|Overall Study|Full consent withdrawal|0|||
33202133|NCT02348216|100642771|FG002|Overall Study|Full consent withdrawal|0|||
33610094|NCT03160885|102123190|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
33610095|NCT03160885|102123191|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
33610096|NCT03160885|102123192|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
33202134|NCT02348216|100642772|FG003|Overall Study|Full consent withdrawal|1|||
33202135|NCT02348216|100642773|FG004|Overall Study|Full consent withdrawal|3|||
33202136|NCT02348216|100642774|FG005|Overall Study|Full consent withdrawal|0|||
33202137|NCT02348216|100642775|FG006|Overall Study|Full consent withdrawal|3|||
33202138|NCT02348216|100642769|FG000|Overall Study|Lost to Follow-up|0|||
33202139|NCT02348216|100642770|FG001|Overall Study|Lost to Follow-up|5|||
33202140|NCT02348216|100642771|FG002|Overall Study|Lost to Follow-up|2|||
33202141|NCT02348216|100642772|FG003|Overall Study|Lost to Follow-up|0|||
33202142|NCT02348216|100642773|FG004|Overall Study|Lost to Follow-up|1|||
33202143|NCT02348216|100642774|FG005|Overall Study|Lost to Follow-up|1|||
33202144|NCT02348216|100642775|FG006|Overall Study|Lost to Follow-up|1|||
33202145|NCT02348216|100642769|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
33331171|NCT02054897|101104308|FG001|Overall Study|Lost to Follow-up|2|||
33331172|NCT02054897|101104309|FG002|Overall Study|Lost to Follow-up|7|||
33202146|NCT02348216|100642770|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
33202147|NCT02348216|100642771|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
33202148|NCT02348216|100642772|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
33202149|NCT02348216|100642773|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
33202150|NCT02348216|100642774|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
33202151|NCT02348216|100642775|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
33202152|NCT02348216|100642769|FG000|Overall Study|Reason not specified|2|||
33202153|NCT02348216|100642770|FG001|Overall Study|Reason not specified|19|||
33202154|NCT02348216|100642771|FG002|Overall Study|Reason not specified|11|||
33202155|NCT02348216|100642772|FG003|Overall Study|Reason not specified|17|||
33202156|NCT02348216|100642773|FG004|Overall Study|Reason not specified|21|||
33202157|NCT02348216|100642774|FG005|Overall Study|Reason not specified|17|||
33202158|NCT02348216|100642775|FG006|Overall Study|Reason not specified|19|||
33202159|NCT02162810|100642776|FG000|Overall Study|Protocol Violation|1|||
33202160|NCT02162810|100642777|FG001|Overall Study|Protocol Violation|0|||
33202161|NCT02162810|100642776|FG000|Overall Study|patients did not report compliance|4|||
33202162|NCT02162810|100642777|FG001|Overall Study|patients did not report compliance|1|||
33202163|NCT03738865|100642781|FG000|Overall Study|Withdrawal by Subject|3|||
33202164|NCT03738865|100642782|FG001|Overall Study|Withdrawal by Subject|3|||
33202165|NCT03738865|100642781|FG000|Overall Study|Adverse Event|2|||
33202166|NCT03738865|100642782|FG001|Overall Study|Adverse Event|0|||
33202167|NCT03738865|100642781|FG000|Overall Study|Physician Decision|0|||
33202168|NCT03738865|100642782|FG001|Overall Study|Physician Decision|1|||
33202169|NCT04287920|100642783|FG000|Overall Study|Lost to Follow-up|1|||
33202170|NCT04287920|100642784|FG001|Overall Study|Lost to Follow-up|1|||
33202171|NCT04287920|100642783|FG000|Overall Study|Withdrawal by Subject|0|||
33202172|NCT04287920|100642784|FG001|Overall Study|Withdrawal by Subject|3|||
33202173|NCT00922428|100642785|FG000|Overall Study|retrospective/extremely implausible data|2|||
33202174|NCT00922428|100642785|FG000|Overall Study|no medication use or questionable use|13|||
33202175|NCT01870843|100642787|FG000|Overall Study|Adverse Event|10|||
33202176|NCT01870843|100642787|FG000|Overall Study|Lost to Follow-up|24|||
33202177|NCT01870843|100642787|FG000|Overall Study|Death|1|||
33202178|NCT01870843|100642787|FG000|Overall Study|Withdrawal by Subject|18|||
33202179|NCT02819726|100642791|FG000|Part A (All Participants)|Lost to Follow-up|0|||
33202180|NCT02819726|100642792|FG001|Part A (All Participants)|Lost to Follow-up|1|||
33202181|NCT02819726|100642793|FG002|Part A (All Participants)|Lost to Follow-up|0|||
33202182|NCT02819726|100642794|FG003|Part A (All Participants)|Lost to Follow-up|0|||
33202183|NCT02819726|100642791|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
33202184|NCT02819726|100642792|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
33202185|NCT02819726|100642793|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
33202186|NCT02819726|100642794|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
33202187|NCT02819726|100642791|FG000|Part A (All Participants)|Protocol non-compliance|3|||
33202188|NCT02819726|100642792|FG001|Part A (All Participants)|Protocol non-compliance|4|||
33202189|NCT02819726|100642793|FG002|Part A (All Participants)|Protocol non-compliance|5|||
33202190|NCT02819726|100642794|FG003|Part A (All Participants)|Protocol non-compliance|0|||
33202191|NCT02819726|100642791|FG000|Part B (All Participants)|Lost to Follow-up|1|||
33202192|NCT02819726|100642792|FG001|Part B (All Participants)|Lost to Follow-up|1|||
33202193|NCT02819726|100642793|FG002|Part B (All Participants)|Lost to Follow-up|2|||
33202194|NCT02819726|100642794|FG003|Part B (All Participants)|Lost to Follow-up|2|||
33202195|NCT02819726|100642791|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
33202196|NCT02819726|100642792|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
33202197|NCT02819726|100642793|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
33202198|NCT02819726|100642794|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
33202199|NCT02819726|100642791|FG000|Part B (All Participants)|Protocol non-compliance|0|||
33202200|NCT02819726|100642792|FG001|Part B (All Participants)|Protocol non-compliance|0|||
33202201|NCT02819726|100642793|FG002|Part B (All Participants)|Protocol non-compliance|1|||
33202202|NCT02819726|100642794|FG003|Part B (All Participants)|Protocol non-compliance|0|||
33402330|NCT00591786|101361754|FG009|Overall Study|Withdrawal of Informed Consent|0|||
33402331|NCT02918006|101361755|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
33402332|NCT02918006|101361756|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
33402333|NCT02918006|101361757|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
33402334|NCT02918006|101361755|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
33402335|NCT02918006|101361756|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
33402336|NCT02918006|101361757|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
33402337|NCT02918006|101361755|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
33202203|NCT03965052|100642795|FG000|Overall Study|Protocol Violation|1|||
33202204|NCT03965052|100642796|FG001|Overall Study|Protocol Violation|0|||
33202205|NCT01748994|100642803|FG000|Overall Study|Lost to Follow-up|8|||
33202206|NCT01748994|100642804|FG001|Overall Study|Lost to Follow-up|6|||
33202207|NCT00661492|100642805|FG000|Overall Study|Adverse Event|16|||
33331173|NCT02054897|101104307|FG000|Overall Study|Randomized but not exposed|1|||
33202208|NCT00661492|100642806|FG001|Overall Study|Adverse Event|13|||
33402338|NCT02918006|101361756|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
33402339|NCT02918006|101361757|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
33402340|NCT02918006|101361755|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
33402341|NCT02918006|101361756|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
33525207|NCT03538691|101819799|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
33202209|NCT00661492|100642805|FG000|Overall Study|Disease Progression|44|||
33202210|NCT00661492|100642806|FG001|Overall Study|Disease Progression|14|||
33202211|NCT00661492|100642805|FG000|Overall Study|Patient Request|6|||
33202212|NCT00661492|100642806|FG001|Overall Study|Patient Request|1|||
33202213|NCT00661492|100642805|FG000|Overall Study|Investigator Request|1|||
33202214|NCT00661492|100642806|FG001|Overall Study|Investigator Request|0|||
33202215|NCT00661492|100642805|FG000|Overall Study|Lost to Follow-up|0|||
33525208|NCT03538691|101819800|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
33525209|NCT03538691|101819801|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
33525210|NCT03538691|101819802|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
33525211|NCT03538691|101819799|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
33525212|NCT03538691|101819800|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
33525213|NCT03538691|101819801|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
33525214|NCT03538691|101819802|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
33610097|NCT03160885|102123186|FG000|Maintenance Treatment Period|Completed Week 50|0|||
33202216|NCT00661492|100642806|FG001|Overall Study|Lost to Follow-up|1|||
33202217|NCT00661492|100642805|FG000|Overall Study|Other|1|||
33202218|NCT00661492|100642806|FG001|Overall Study|Other|0|||
33202219|NCT01202773|100642807|FG000|Overall Study|Adverse Event|4|||
33202220|NCT01202773|100642808|FG001|Overall Study|Adverse Event|5|||
33202221|NCT01202773|100642809|FG002|Overall Study|Adverse Event|5|||
33202222|NCT01202773|100642807|FG000|Overall Study|Lack of Efficacy|5|||
33202223|NCT01202773|100642808|FG001|Overall Study|Lack of Efficacy|4|||
33202224|NCT01202773|100642809|FG002|Overall Study|Lack of Efficacy|9|||
33202225|NCT01202773|100642807|FG000|Overall Study|Entry Criteria Not Met|2|||
33202226|NCT01202773|100642808|FG001|Overall Study|Entry Criteria Not Met|0|||
33202227|NCT01202773|100642809|FG002|Overall Study|Entry Criteria Not Met|1|||
33202228|NCT01202773|100642807|FG000|Overall Study|Lost to Follow-up|1|||
33202229|NCT01202773|100642808|FG001|Overall Study|Lost to Follow-up|2|||
33202230|NCT01202773|100642809|FG002|Overall Study|Lost to Follow-up|2|||
33202231|NCT01202773|100642807|FG000|Overall Study|Withdrawal by Subject|13|||
33202232|NCT01202773|100642808|FG001|Overall Study|Withdrawal by Subject|6|||
33202233|NCT01202773|100642809|FG002|Overall Study|Withdrawal by Subject|5|||
33202234|NCT01202773|100642807|FG000|Overall Study|Physician Decision|2|||
33202235|NCT01202773|100642808|FG001|Overall Study|Physician Decision|0|||
33202236|NCT01202773|100642809|FG002|Overall Study|Physician Decision|0|||
33202237|NCT01202773|100642807|FG000|Overall Study|Protocol Violation|11|||
33202238|NCT01202773|100642808|FG001|Overall Study|Protocol Violation|6|||
33202239|NCT01202773|100642809|FG002|Overall Study|Protocol Violation|10|||
33202240|NCT01202773|100642807|FG000|Overall Study|Sponsor Decision|19|||
33202241|NCT01202773|100642808|FG001|Overall Study|Sponsor Decision|20|||
33202242|NCT01202773|100642809|FG002|Overall Study|Sponsor Decision|23|||
33202243|NCT03346759|100642810|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
33202244|NCT03346759|100642811|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
33202245|NCT03346759|100642810|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
33202246|NCT03346759|100642811|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
33331174|NCT02054897|101104308|FG001|Overall Study|Randomized but not exposed|0|||
33331175|NCT02054897|101104309|FG002|Overall Study|Randomized but not exposed|0|||
33331176|NCT01911442|101104310|FG000|Overall Study|Adverse Event|2|||
33331177|NCT01911442|101104311|FG001|Overall Study|Adverse Event|2|||
33331178|NCT01911442|101104312|FG002|Overall Study|Adverse Event|4|||
33331179|NCT01911442|101104310|FG000|Overall Study|Lack of Efficacy|1|||
33331180|NCT01911442|101104311|FG001|Overall Study|Lack of Efficacy|1|||
33331181|NCT01911442|101104312|FG002|Overall Study|Lack of Efficacy|1|||
33402342|NCT02918006|101361757|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
33402343|NCT02918006|101361755|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
33610098|NCT03160885|102123187|FG001|Maintenance Treatment Period|Completed Week 50|0|||
33610099|NCT03160885|102123188|FG002|Maintenance Treatment Period|Completed Week 50|1|||
33610100|NCT03160885|102123189|FG003|Maintenance Treatment Period|Completed Week 50|0|||
33202247|NCT03346759|100642810|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
33202248|NCT03346759|100642811|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
33202249|NCT01607905|100642812|FG000|Overall Study|Withdrawal by participant|7|||
33202250|NCT01607905|100642813|FG001|Overall Study|Withdrawal by participant|2|||
33202251|NCT01607905|100642814|FG002|Overall Study|Withdrawal by participant|4|||
33202252|NCT01607905|100642815|FG003|Overall Study|Withdrawal by participant|6|||
33202253|NCT01607905|100642816|FG004|Overall Study|Withdrawal by participant|0|||
33331182|NCT01911442|101104310|FG000|Overall Study|Lost to Follow-up|2|||
33331183|NCT01911442|101104311|FG001|Overall Study|Lost to Follow-up|0|||
33331184|NCT01911442|101104312|FG002|Overall Study|Lost to Follow-up|1|||
33202254|NCT01607905|100642817|FG005|Overall Study|Withdrawal by participant|4|||
33202255|NCT01607905|100642818|FG006|Overall Study|Withdrawal by participant|12|||
33202256|NCT01607905|100642812|FG000|Overall Study|Incidence or severity of AEs|5|||
33202257|NCT01607905|100642813|FG001|Overall Study|Incidence or severity of AEs|1|||
33202258|NCT01607905|100642814|FG002|Overall Study|Incidence or severity of AEs|1|||
33202259|NCT01607905|100642815|FG003|Overall Study|Incidence or severity of AEs|3|||
33202260|NCT01607905|100642816|FG004|Overall Study|Incidence or severity of AEs|0|||
33202261|NCT01607905|100642817|FG005|Overall Study|Incidence or severity of AEs|2|||
33202262|NCT01607905|100642818|FG006|Overall Study|Incidence or severity of AEs|8|||
33202263|NCT01607905|100642812|FG000|Overall Study|Disease progression|44|||
33202264|NCT01607905|100642813|FG001|Overall Study|Disease progression|16|||
33202265|NCT01607905|100642814|FG002|Overall Study|Disease progression|15|||
33202266|NCT01607905|100642815|FG003|Overall Study|Disease progression|11|||
33202267|NCT01607905|100642816|FG004|Overall Study|Disease progression|6|||
33202268|NCT01607905|100642817|FG005|Overall Study|Disease progression|7|||
33202269|NCT01607905|100642818|FG006|Overall Study|Disease progression|21|||
33202270|NCT01607905|100642812|FG000|Overall Study|Non-compliance with study procedures|0|||
33202271|NCT01607905|100642813|FG001|Overall Study|Non-compliance with study procedures|0|||
33202272|NCT01607905|100642814|FG002|Overall Study|Non-compliance with study procedures|0|||
33202273|NCT01607905|100642815|FG003|Overall Study|Non-compliance with study procedures|0|||
33202274|NCT01607905|100642816|FG004|Overall Study|Non-compliance with study procedures|0|||
33202275|NCT01607905|100642817|FG005|Overall Study|Non-compliance with study procedures|0|||
33202276|NCT01607905|100642818|FG006|Overall Study|Non-compliance with study procedures|1|||
33202277|NCT01607905|100642812|FG000|Overall Study|Death|1|||
33202278|NCT01607905|100642813|FG001|Overall Study|Death|1|||
33202279|NCT01607905|100642814|FG002|Overall Study|Death|1|||
33525215|NCT03538691|101819799|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
33202280|NCT01607905|100642815|FG003|Overall Study|Death|1|||
33202281|NCT01607905|100642816|FG004|Overall Study|Death|0|||
33202282|NCT01607905|100642817|FG005|Overall Study|Death|0|||
33202283|NCT01607905|100642818|FG006|Overall Study|Death|3|||
33202284|NCT01607905|100642812|FG000|Overall Study|Other treatments become available|1|||
33202285|NCT01607905|100642813|FG001|Overall Study|Other treatments become available|0|||
33202286|NCT01607905|100642814|FG002|Overall Study|Other treatments become available|0|||
33202287|NCT01607905|100642815|FG003|Overall Study|Other treatments become available|0|||
33202288|NCT01607905|100642816|FG004|Overall Study|Other treatments become available|0|||
33202289|NCT01607905|100642817|FG005|Overall Study|Other treatments become available|0|||
33202290|NCT01607905|100642818|FG006|Overall Study|Other treatments become available|1|||
33202291|NCT01607905|100642812|FG000|Overall Study|Investigator discretion|0|||
33202292|NCT01607905|100642813|FG001|Overall Study|Investigator discretion|0|||
33202293|NCT01607905|100642814|FG002|Overall Study|Investigator discretion|0|||
33202294|NCT01607905|100642815|FG003|Overall Study|Investigator discretion|0|||
33202295|NCT01607905|100642816|FG004|Overall Study|Investigator discretion|0|||
33202296|NCT01607905|100642817|FG005|Overall Study|Investigator discretion|1|||
33202297|NCT01607905|100642818|FG006|Overall Study|Investigator discretion|0|||
33202298|NCT01607905|100642812|FG000|Overall Study|Other|1|||
33202299|NCT01607905|100642813|FG001|Overall Study|Other|0|||
33202300|NCT01607905|100642814|FG002|Overall Study|Other|0|||
33202301|NCT01607905|100642815|FG003|Overall Study|Other|0|||
33202302|NCT01607905|100642816|FG004|Overall Study|Other|0|||
33202303|NCT01607905|100642817|FG005|Overall Study|Other|0|||
33202304|NCT01607905|100642818|FG006|Overall Study|Other|1|||
33402344|NCT02918006|101361756|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
33402345|NCT02918006|101361757|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
33402346|NCT02918006|101361755|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
33402347|NCT02918006|101361756|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
33402348|NCT02918006|101361757|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
33402349|NCT02918006|101361755|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
33402350|NCT02918006|101361756|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
33402351|NCT02918006|101361757|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
33402352|NCT02918006|101361755|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
33402353|NCT02918006|101361756|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
33525216|NCT03538691|101819800|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
33525217|NCT03538691|101819801|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
33525218|NCT03538691|101819802|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
33402354|NCT02918006|101361757|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
33402355|NCT02918006|101361755|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
33402356|NCT02918006|101361756|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
33417267|NCT01721200|101420248|FG000|Overall Study|Lost to Follow-up|3|||
33202305|NCT01607905|100642812|FG000|Overall Study|Randomized but not treated|1|||
33202306|NCT01607905|100642813|FG001|Overall Study|Randomized but not treated|0|||
33202307|NCT01607905|100642814|FG002|Overall Study|Randomized but not treated|0|||
33202308|NCT01607905|100642815|FG003|Overall Study|Randomized but not treated|0|||
33525219|NCT03538691|101819799|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
33525220|NCT03538691|101819800|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
33610101|NCT03160885|102123190|FG004|Maintenance Treatment Period|Completed Week 50|0|||
33610102|NCT03160885|102123191|FG005|Maintenance Treatment Period|Completed Week 50|0|||
33610103|NCT03160885|102123192|FG006|Maintenance Treatment Period|Completed Week 50|0|||
33610104|NCT03508609|102123193|FG000|Overall Study|Withdrawal by Subject|1|||
33610105|NCT02777827|102123194|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
33610106|NCT02777827|102123195|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
33610107|NCT02777827|102123196|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
33610108|NCT02777827|102123197|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
33610109|NCT02777827|102123198|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
33610110|NCT02777827|102123199|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
33610111|NCT00847197|102123200|FG000|Overall Study|Adverse Event|21|||
33610112|NCT00847197|102123201|FG001|Overall Study|Adverse Event|3|||
33610113|NCT00847197|102123200|FG000|Overall Study|Protocol Violation|0|||
33610114|NCT00847197|102123201|FG001|Overall Study|Protocol Violation|1|||
33610115|NCT00847197|102123200|FG000|Overall Study|Withdrawal by Subject|3|||
33610116|NCT00847197|102123201|FG001|Overall Study|Withdrawal by Subject|1|||
33610117|NCT02428205|102123202|FG000|Overall Study|Lack of Efficacy|1|||
33610118|NCT02428205|102123203|FG001|Overall Study|Lack of Efficacy|0|||
33610119|NCT02428205|102123202|FG000|Overall Study|Lost to Follow-up|1|||
33610120|NCT02428205|102123203|FG001|Overall Study|Lost to Follow-up|1|||
33610121|NCT02428205|102123202|FG000|Overall Study|Worse behavior|0|||
33610122|NCT02428205|102123203|FG001|Overall Study|Worse behavior|1|||
33610123|NCT00064792|102123206|FG000|Overall Study|Withdrawal by Subject|2|||
33610124|NCT00064792|102123207|FG001|Overall Study|Withdrawal by Subject|0|||
33610125|NCT00064792|102123206|FG000|Overall Study|Adverse Event|3|||
33610126|NCT00064792|102123207|FG001|Overall Study|Adverse Event|0|||
33610127|NCT00705146|102123214|FG000|Overall Study|Lost to Follow-up|1|||
33610128|NCT00705146|102123215|FG001|Overall Study|Lost to Follow-up|1|||
33610129|NCT00391625|102123221|FG000|Month 14|Withdrawal by Subject|1|||
33610130|NCT00391625|102123221|FG000|Month 50|Physician Decision|1|||
33610131|NCT02479139|102123222|FG000|Overall Study|Lost to Follow-up|2|||
33610132|NCT02479139|102123223|FG001|Overall Study|Lost to Follow-up|4|||
33610133|NCT02479139|102123224|FG002|Overall Study|Lost to Follow-up|4|||
33610134|NCT02479139|102123225|FG003|Overall Study|Lost to Follow-up|2|||
33610135|NCT02479139|102123226|FG004|Overall Study|Lost to Follow-up|3|||
33610136|NCT02479139|102123227|FG005|Overall Study|Lost to Follow-up|5|||
33610137|NCT02479139|102123222|FG000|Overall Study|Withdrew Consent|5|||
33610138|NCT02479139|102123223|FG001|Overall Study|Withdrew Consent|6|||
33525221|NCT03538691|101819801|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
33525222|NCT03538691|101819802|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
33525223|NCT03538691|101819799|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
33525224|NCT03538691|101819800|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
33525225|NCT03538691|101819801|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
33525226|NCT03538691|101819802|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
33525227|NCT03538691|101819799|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
33525228|NCT03538691|101819800|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
33525229|NCT03538691|101819801|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
33525230|NCT03538691|101819802|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
33525231|NCT03538691|101819799|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
33525232|NCT03538691|101819800|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
33525233|NCT03538691|101819801|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
33610139|NCT02479139|102123224|FG002|Overall Study|Withdrew Consent|1|||
33610140|NCT02479139|102123225|FG003|Overall Study|Withdrew Consent|4|||
33610141|NCT02479139|102123226|FG004|Overall Study|Withdrew Consent|1|||
33610142|NCT02479139|102123227|FG005|Overall Study|Withdrew Consent|1|||
33610143|NCT02479139|102123222|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
33610144|NCT02479139|102123223|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
33610145|NCT02479139|102123224|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
33610146|NCT02479139|102123225|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
33610147|NCT02479139|102123226|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
33610148|NCT02479139|102123227|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
33610149|NCT02479139|102123222|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33610150|NCT02479139|102123223|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33610151|NCT02479139|102123224|FG002|Overall Study|Other Miscellaneous Reasons|1|||
33610152|NCT02479139|102123225|FG003|Overall Study|Other Miscellaneous Reasons|1|||
33610153|NCT02479139|102123226|FG004|Overall Study|Other Miscellaneous Reasons|1|||
33610154|NCT02479139|102123227|FG005|Overall Study|Other Miscellaneous Reasons|0|||
33610155|NCT00293020|102123230|FG000|Overall Study|Withdrawal by Subject|34|||
33610156|NCT00293020|102123230|FG000|Overall Study|Adverse Event|30|||
33610157|NCT00293020|102123230|FG000|Overall Study|Death|32|||
33610158|NCT00293020|102123230|FG000|Overall Study|Lack of Efficacy|12|||
33610159|NCT00293020|102123230|FG000|Overall Study|Lost to Follow-up|4|||
33610160|NCT00293020|102123230|FG000|Overall Study|Protocol Violation|6|||
33610161|NCT00293020|102123230|FG000|Overall Study|Physician Decision|21|||
33525234|NCT03538691|101819802|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
33525235|NCT03538691|101819799|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
33525236|NCT03538691|101819800|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
33525237|NCT03538691|101819801|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
33525238|NCT03538691|101819802|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
33525239|NCT03538691|101819799|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
33525240|NCT03538691|101819800|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
33525241|NCT03538691|101819801|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
33525242|NCT03538691|101819802|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
33525243|NCT03538691|101819799|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
33525244|NCT03538691|101819800|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
33525245|NCT03538691|101819801|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
33525246|NCT03538691|101819802|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
33525247|NCT03538691|101819799|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
33525248|NCT03538691|101819800|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
33525249|NCT03538691|101819801|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
33525250|NCT03538691|101819802|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
33525251|NCT03538691|101819799|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
33525252|NCT03538691|101819800|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
33525253|NCT03538691|101819801|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
33610162|NCT00293020|102123230|FG000|Overall Study|Other Reason|22|||
33610163|NCT00293020|102123230|FG000|Overall Study|No dose taken|1|||
33610164|NCT02513472|102123231|FG000|Overall Study|Radiological Disease Progression|45|||
33525254|NCT03538691|101819802|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
33525255|NCT03538691|101819799|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
33525256|NCT03538691|101819800|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
33525257|NCT03538691|101819801|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
33525258|NCT03538691|101819802|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
33525259|NCT03411902|101819812|FG000|Overall Study|Lost to Follow-up|3|||
33525260|NCT03411902|101819813|FG001|Overall Study|Lost to Follow-up|0|||
33525261|NCT01911793|101819821|FG000|Overall Study|Physician Decision|1|||
33525262|NCT01911793|101819822|FG001|Overall Study|Physician Decision|5|||
33525263|NCT00264290|101819825|FG000|Intervention (8 Weeks)|Adverse Event|1|||
33402357|NCT02918006|101361757|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
33402358|NCT00689611|101361764|FG000|Overall Study|Death|6|||
33525264|NCT00264290|101819826|FG001|Intervention (8 Weeks)|Adverse Event|0|||
33525265|NCT02669043|101819827|FG000|Overall Study|Didn't meet I/E criteria|4|||
33525266|NCT01882803|101819831|FG000|Overall Study|Disease Progression|1|||
33525267|NCT01882803|101819831|FG000|Overall Study|Withdrawal by Subject|9|||
33525268|NCT01882803|101819831|FG000|Overall Study|Death|68|||
33525269|NCT01882803|101819831|FG000|Overall Study|Physician Decision|3|||
33525270|NCT01882803|101819831|FG000|Overall Study|Lost to Follow-up|3|||
33525271|NCT01882803|101819831|FG000|Overall Study|Follow-up Completed|39|||
33525272|NCT01882803|101819831|FG000|Overall Study|Study Terminated by the Sponsor|6|||
33525273|NCT01370616|101819832|FG000|Overall Study|Adverse Event|11|||
33525274|NCT01370616|101819833|FG001|Overall Study|Adverse Event|16|||
33525275|NCT01370616|101819832|FG000|Overall Study|Death|1|||
33525276|NCT01370616|101819833|FG001|Overall Study|Death|0|||
33525277|NCT01370616|101819832|FG000|Overall Study|Lack of Efficacy|6|||
33525278|NCT01370616|101819833|FG001|Overall Study|Lack of Efficacy|2|||
33525279|NCT01370616|101819832|FG000|Overall Study|Lost to Follow-up|0|||
33525280|NCT01370616|101819833|FG001|Overall Study|Lost to Follow-up|3|||
33525281|NCT01370616|101819832|FG000|Overall Study|Physician Decision|6|||
33525282|NCT01370616|101819833|FG001|Overall Study|Physician Decision|6|||
33525283|NCT01370616|101819832|FG000|Overall Study|Progressive Disease|0|||
33525284|NCT01370616|101819833|FG001|Overall Study|Progressive Disease|1|||
33525285|NCT01370616|101819832|FG000|Overall Study|Recovery|1|||
33402359|NCT00689611|101361765|FG001|Overall Study|Death|9|||
33610165|NCT02513472|102123232|FG001|Overall Study|Radiological Disease Progression|57|||
33610166|NCT02513472|102123231|FG000|Overall Study|Clinical Disease Progression|5|||
33610167|NCT02513472|102123232|FG001|Overall Study|Clinical Disease Progression|13|||
33525286|NCT01370616|101819833|FG001|Overall Study|Recovery|0|||
33402360|NCT00689611|101361764|FG000|Overall Study|Withdrawal by Subject|8|||
33525287|NCT01370616|101819832|FG000|Overall Study|Technical Problems|3|||
33525288|NCT01370616|101819833|FG001|Overall Study|Technical Problems|5|||
33525289|NCT01370616|101819832|FG000|Overall Study|Withdrawal by Subject|34|||
33525290|NCT01370616|101819833|FG001|Overall Study|Withdrawal by Subject|34|||
33525291|NCT00585325|101819836|FG000|Overall Study|Withdrawal by Subject|1|||
33525292|NCT00585325|101819837|FG001|Overall Study|Withdrawal by Subject|1|||
33525293|NCT02824562|101819838|FG000|Overall Study|Lost to Follow-up|3|||
33525294|NCT02824562|101819839|FG001|Overall Study|Lost to Follow-up|4|||
33525295|NCT02824562|101819838|FG000|Overall Study|Death|0|||
33525296|NCT02824562|101819839|FG001|Overall Study|Death|1|||
33525297|NCT02227368|101819847|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
33525298|NCT02227368|101819848|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
33525299|NCT02227368|101819847|FG000|Overall Study|Lost to Follow-up|1|||
33525300|NCT02227368|101819848|FG001|Overall Study|Lost to Follow-up|0|||
33525301|NCT02227368|101819847|FG000|Overall Study|Adverse Event|1|||
33525302|NCT02227368|101819848|FG001|Overall Study|Adverse Event|0|||
33525303|NCT03178851|101819849|FG000|Overall Study|Death|48|||
33525304|NCT03178851|101819850|FG001|Overall Study|Death|2|||
33525305|NCT03178851|101819851|FG002|Overall Study|Death|25|||
33525306|NCT03178851|101819849|FG000|Overall Study|Withdrawal by Subject|8|||
33525307|NCT03178851|101819850|FG001|Overall Study|Withdrawal by Subject|0|||
33525308|NCT03178851|101819851|FG002|Overall Study|Withdrawal by Subject|0|||
33525309|NCT03178851|101819849|FG000|Overall Study|Lost to Follow-up|5|||
33525310|NCT03178851|101819850|FG001|Overall Study|Lost to Follow-up|2|||
33525311|NCT03178851|101819851|FG002|Overall Study|Lost to Follow-up|0|||
33525312|NCT03178851|101819849|FG000|Overall Study|Adverse Event|0|||
33525313|NCT03178851|101819850|FG001|Overall Study|Adverse Event|0|||
33525314|NCT03178851|101819851|FG002|Overall Study|Adverse Event|1|||
33525315|NCT03178851|101819849|FG000|Overall Study|Study Termination by Sponsor|31|||
33525316|NCT03178851|101819850|FG001|Overall Study|Study Termination by Sponsor|7|||
33525317|NCT03178851|101819851|FG002|Overall Study|Study Termination by Sponsor|26|||
33525318|NCT01796301|101819852|FG000|Overall Study|Withdrawal by Subject|15|||
33525319|NCT01796301|101819853|FG001|Overall Study|Withdrawal by Subject|15|||
33525320|NCT01796301|101819852|FG000|Overall Study|Lost to Follow-up|3|||
33525321|NCT01796301|101819853|FG001|Overall Study|Lost to Follow-up|3|||
33525322|NCT01796301|101819852|FG000|Overall Study|Death|0|||
33525323|NCT01796301|101819853|FG001|Overall Study|Death|1|||
33525324|NCT01796301|101819852|FG000|Overall Study|Decision by Sponsor|0|||
33525325|NCT01796301|101819853|FG001|Overall Study|Decision by Sponsor|1|||
33525326|NCT01398358|101819854|FG000|Overall Study|Lost to Follow-up|11|||
33525327|NCT01398358|101819855|FG001|Overall Study|Lost to Follow-up|21|||
33331185|NCT01911442|101104310|FG000|Overall Study|Withdrawal by Subject|1|||
33331186|NCT01911442|101104311|FG001|Overall Study|Withdrawal by Subject|0|||
33331187|NCT01911442|101104312|FG002|Overall Study|Withdrawal by Subject|6|||
33331188|NCT01911442|101104310|FG000|Overall Study|Mother's Work Schedule|0|||
33331189|NCT01911442|101104311|FG001|Overall Study|Mother's Work Schedule|1|||
33331190|NCT01911442|101104312|FG002|Overall Study|Mother's Work Schedule|0|||
33331191|NCT02234479|101104314|FG000|Overall Study|Withdrawal by Subject|1|||
33331192|NCT02234479|101104315|FG001|Overall Study|Withdrawal by Subject|3|||
33331193|NCT00405067|101107484|FG000|Overall Study|Adverse Event|4|||
33331194|NCT00405067|101107485|FG001|Overall Study|Adverse Event|9|||
33331195|NCT00405067|101107486|FG002|Overall Study|Adverse Event|4|||
33402361|NCT00689611|101361765|FG001|Overall Study|Withdrawal by Subject|9|||
33402362|NCT00689611|101361764|FG000|Overall Study|Lost to Follow-up|27|||
33402363|NCT00689611|101361765|FG001|Overall Study|Lost to Follow-up|28|||
33402364|NCT02545504|101361769|FG000|Overall Study|Death|174|||
33402365|NCT02545504|101361770|FG001|Overall Study|Death|168|||
33402366|NCT02545504|101361769|FG000|Overall Study|Unknown reason|30|||
33402367|NCT02545504|101361770|FG001|Overall Study|Unknown reason|32|||
33402368|NCT02545504|101361769|FG000|Overall Study|Withdrew consent|9|||
33525328|NCT01398358|101819856|FG002|Overall Study|Lost to Follow-up|18|||
33525329|NCT01398358|101819854|FG000|Overall Study|Withdrawal by Subject|3|||
33525330|NCT01398358|101819855|FG001|Overall Study|Withdrawal by Subject|2|||
33525331|NCT01398358|101819856|FG002|Overall Study|Withdrawal by Subject|2|||
33525332|NCT01398358|101819854|FG000|Overall Study|no longer eligible|1|||
33525333|NCT01398358|101819855|FG001|Overall Study|no longer eligible|0|||
33525334|NCT01398358|101819856|FG002|Overall Study|no longer eligible|1|||
33525335|NCT03042910|101819857|FG000|Overall Study|Adverse Event|1|||
33331196|NCT00405067|101107484|FG000|Overall Study|Lost to Follow-up|0|||
33525336|NCT03042910|101819857|FG000|Overall Study|Disease Progression|2|||
33525337|NCT03042910|101819857|FG000|Overall Study|Withdrawal by Subject|3|||
33525338|NCT03042910|101819857|FG000|Overall Study|Enrolled but not treated|1|||
33525339|NCT02328937|101819858|FG000|Period 1|Lost to Follow-up|0|||
33525340|NCT02328937|101819859|FG001|Period 1|Lost to Follow-up|0|||
33525341|NCT02328937|101819860|FG002|Period 1|Lost to Follow-up|0|||
33331197|NCT00405067|101107485|FG001|Overall Study|Lost to Follow-up|0|||
33331198|NCT00405067|101107486|FG002|Overall Study|Lost to Follow-up|1|||
33402369|NCT02545504|101361770|FG001|Overall Study|Withdrew consent|11|||
33402370|NCT02545504|101361769|FG000|Overall Study|Investigator's discretion|3|||
33402371|NCT02545504|101361770|FG001|Overall Study|Investigator's discretion|1|||
33402372|NCT02545504|101361769|FG000|Overall Study|Lost to Follow-up|2|||
33525342|NCT02328937|101819861|FG003|Period 1|Lost to Follow-up|1|||
33525343|NCT02328937|101819862|FG004|Period 1|Lost to Follow-up|0|||
33525344|NCT02328937|101819863|FG005|Period 1|Lost to Follow-up|0|||
33525345|NCT02328937|101819858|FG000|Period 2|Adverse Event|0|||
33331199|NCT02316340|101107487|FG000|First Progression|Clinical progression|2|||
33202309|NCT01607905|100642816|FG004|Overall Study|Randomized but not treated|1|||
33202310|NCT01607905|100642817|FG005|Overall Study|Randomized but not treated|1|||
33202311|NCT01607905|100642818|FG006|Overall Study|Randomized but not treated|0|||
33202312|NCT03165045|100642819|FG000|Visit 1|No registration after visit 1|9|||
33202313|NCT03165045|100642819|FG000|Visit 1|No treatment documented|10|||
33202314|NCT03165045|100642819|FG000|Visit 1|No visit 1|10|||
33331200|NCT02316340|101107488|FG001|First Progression|Clinical progression|1|||
33331201|NCT02316340|101107487|FG000|First Progression|Withdrawal by Subject|1|||
33202315|NCT03165045|100642819|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
33202316|NCT03165045|100642819|FG000|Visit 2|No available total CCQ score at all|29|||
33202317|NCT03165045|100642819|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
33202318|NCT02691455|100642820|FG000|Overall Study|Withdrawal by Subject|1|||
33331202|NCT02316340|101107488|FG001|First Progression|Withdrawal by Subject|0|||
33331203|NCT02603120|101107491|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
33525346|NCT02328937|101819859|FG001|Period 2|Adverse Event|0|||
33525347|NCT02328937|101819860|FG002|Period 2|Adverse Event|1|||
33525348|NCT02328937|101819861|FG003|Period 2|Adverse Event|0|||
33525349|NCT02328937|101819862|FG004|Period 2|Adverse Event|0|||
33525350|NCT02328937|101819863|FG005|Period 2|Adverse Event|0|||
33525351|NCT01763203|101819869|FG000|Overall Study|Death|4|||
33525352|NCT01763203|101819870|FG001|Overall Study|Death|7|||
33525353|NCT01763203|101819869|FG000|Overall Study|Lost to Follow-up|12|||
33525354|NCT01763203|101819870|FG001|Overall Study|Lost to Follow-up|12|||
33525355|NCT01763203|101819869|FG000|Overall Study|Withdrawal by Subject|8|||
33525356|NCT01763203|101819870|FG001|Overall Study|Withdrawal by Subject|12|||
33525357|NCT01763203|101819869|FG000|Overall Study|Moved out of study region|7|||
33525358|NCT01763203|101819870|FG001|Overall Study|Moved out of study region|10|||
33525359|NCT01763203|101819869|FG000|Overall Study|Physician Decision|2|||
33331204|NCT02603120|101107492|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
33331205|NCT02603120|101107491|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
33331206|NCT02603120|101107492|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
33331207|NCT02603120|101107491|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
33331208|NCT02603120|101107492|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
33331209|NCT02603120|101107491|FG000|Double-Blind Treatment Phase|Death|2|||
33331210|NCT02603120|101107492|FG001|Double-Blind Treatment Phase|Death|0|||
33331211|NCT02603120|101107491|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
33331212|NCT02603120|101107492|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
33331213|NCT02603120|101107491|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
33331214|NCT02603120|101107492|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
33331215|NCT02603120|101107491|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
33331216|NCT02603120|101107492|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
33331217|NCT02603120|101107491|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
33525360|NCT01763203|101819870|FG001|Overall Study|Physician Decision|1|||
33525361|NCT00645671|101819876|FG000|Overall Study|Protocol Violation|1|||
33525362|NCT00645671|101819877|FG001|Overall Study|Protocol Violation|0|||
33525363|NCT00645671|101819876|FG000|Overall Study|Withdrawal by Subject|0|||
33525364|NCT00645671|101819877|FG001|Overall Study|Withdrawal by Subject|4|||
33525365|NCT00645671|101819876|FG000|Overall Study|Adverse Event|0|||
33525366|NCT00645671|101819877|FG001|Overall Study|Adverse Event|1|||
33525367|NCT00645671|101819876|FG000|Overall Study|Physician Decision|0|||
33525368|NCT00645671|101819877|FG001|Overall Study|Physician Decision|1|||
33331218|NCT02603120|101107492|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
33331219|NCT02603120|101107491|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
33331220|NCT02603120|101107492|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
33331221|NCT02603120|101107491|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
33331222|NCT02603120|101107492|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
33331223|NCT02603120|101107491|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
33331224|NCT02603120|101107492|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
33331225|NCT02603120|101107491|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
33331226|NCT02603120|101107492|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
33331227|NCT02603120|101107491|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
33525369|NCT00593606|101819879|FG000|Overall Study|Adverse Event|13|||
33202319|NCT02691455|100642821|FG001|Overall Study|Withdrawal by Subject|2|||
33202320|NCT02691455|100642820|FG000|Overall Study|Lost to Follow-up|15|||
33525370|NCT00593606|101819879|FG000|Overall Study|Withdrawal by Subject|1|||
33525371|NCT00593606|101819879|FG000|Overall Study|Protocol Violation|3|||
33525372|NCT00593606|101819879|FG000|Overall Study|Lost to Follow-up|2|||
33202321|NCT02691455|100642821|FG001|Overall Study|Lost to Follow-up|15|||
33202322|NCT02318329|100642824|FG000|Overall Study|Progressive Disease|2|||
33202323|NCT02318329|100642825|FG001|Overall Study|Progressive Disease|3|||
33202324|NCT02318329|100642826|FG002|Overall Study|Progressive Disease|2|||
33202325|NCT02318329|100642827|FG003|Overall Study|Progressive Disease|3|||
33202326|NCT02318329|100642828|FG004|Overall Study|Progressive Disease|3|||
33202327|NCT02318329|100642829|FG005|Overall Study|Progressive Disease|3|||
33202328|NCT02318329|100642830|FG006|Overall Study|Progressive Disease|1|||
33202329|NCT02318329|100642831|FG007|Overall Study|Progressive Disease|1|||
33202330|NCT02318329|100642832|FG008|Overall Study|Progressive Disease|5|||
33202331|NCT02318329|100642833|FG009|Overall Study|Progressive Disease|39|||
33202332|NCT02318329|100642824|FG000|Overall Study|Death|0|||
33202333|NCT02318329|100642825|FG001|Overall Study|Death|0|||
33202334|NCT02318329|100642826|FG002|Overall Study|Death|0|||
33202335|NCT02318329|100642827|FG003|Overall Study|Death|0|||
33202336|NCT02318329|100642828|FG004|Overall Study|Death|0|||
33202337|NCT02318329|100642829|FG005|Overall Study|Death|0|||
33202338|NCT02318329|100642830|FG006|Overall Study|Death|0|||
33202339|NCT02318329|100642831|FG007|Overall Study|Death|0|||
33202340|NCT02318329|100642832|FG008|Overall Study|Death|0|||
33202341|NCT02318329|100642833|FG009|Overall Study|Death|5|||
33202342|NCT02318329|100642824|FG000|Overall Study|Lost to Follow-up|0|||
33202343|NCT02318329|100642825|FG001|Overall Study|Lost to Follow-up|0|||
33202344|NCT02318329|100642826|FG002|Overall Study|Lost to Follow-up|0|||
33202345|NCT02318329|100642827|FG003|Overall Study|Lost to Follow-up|0|||
33331228|NCT02603120|101107492|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
33525373|NCT00593606|101819879|FG000|Overall Study|Run-In Failure|5|||
33525374|NCT00593606|101819879|FG000|Overall Study|Screen Failure|3|||
33525375|NCT02178358|101819880|FG000|Overall Study|Withdrawal by Subject|0|||
33525376|NCT02178358|101819881|FG001|Overall Study|Withdrawal by Subject|2|||
33525377|NCT02178358|101819882|FG002|Overall Study|Withdrawal by Subject|2|||
33525378|NCT02178358|101819880|FG000|Overall Study|Lost to Follow-up|1|||
33525379|NCT02178358|101819881|FG001|Overall Study|Lost to Follow-up|0|||
33525380|NCT02178358|101819882|FG002|Overall Study|Lost to Follow-up|0|||
33525381|NCT03824366|101819885|FG000|Overall Study|Death|1|||
33202346|NCT02318329|100642828|FG004|Overall Study|Lost to Follow-up|0|||
33331229|NCT02603120|101107491|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
33402373|NCT02545504|101361770|FG001|Overall Study|Lost to Follow-up|2|||
33402374|NCT03289676|101361773|FG000|Overall Study|Withdrawal by Subject|2|||
33525382|NCT03824366|101819885|FG000|Overall Study|Previously unidentified metal artifact|1|||
33202347|NCT02318329|100642829|FG005|Overall Study|Lost to Follow-up|0|||
33202348|NCT02318329|100642830|FG006|Overall Study|Lost to Follow-up|0|||
33525383|NCT03824366|101819885|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
33202349|NCT02318329|100642831|FG007|Overall Study|Lost to Follow-up|0|||
33202350|NCT02318329|100642832|FG008|Overall Study|Lost to Follow-up|0|||
33202351|NCT02318329|100642833|FG009|Overall Study|Lost to Follow-up|1|||
33202352|NCT02318329|100642824|FG000|Overall Study|Withdrawal by Subject|0|||
33202353|NCT02318329|100642825|FG001|Overall Study|Withdrawal by Subject|0|||
33202354|NCT02318329|100642826|FG002|Overall Study|Withdrawal by Subject|0|||
33202355|NCT02318329|100642827|FG003|Overall Study|Withdrawal by Subject|0|||
33202356|NCT02318329|100642828|FG004|Overall Study|Withdrawal by Subject|0|||
33202357|NCT02318329|100642829|FG005|Overall Study|Withdrawal by Subject|0|||
33202358|NCT02318329|100642830|FG006|Overall Study|Withdrawal by Subject|0|||
33202359|NCT02318329|100642831|FG007|Overall Study|Withdrawal by Subject|0|||
33202360|NCT02318329|100642832|FG008|Overall Study|Withdrawal by Subject|0|||
33202361|NCT02318329|100642833|FG009|Overall Study|Withdrawal by Subject|6|||
33202362|NCT02318329|100642824|FG000|Overall Study|Other|1|||
33202363|NCT02318329|100642825|FG001|Overall Study|Other|1|||
33202364|NCT02318329|100642826|FG002|Overall Study|Other|1|||
33202365|NCT02318329|100642827|FG003|Overall Study|Other|0|||
33202366|NCT02318329|100642828|FG004|Overall Study|Other|0|||
33202367|NCT02318329|100642829|FG005|Overall Study|Other|0|||
33202368|NCT02318329|100642830|FG006|Overall Study|Other|0|||
33202369|NCT02318329|100642831|FG007|Overall Study|Other|0|||
33202370|NCT02318329|100642832|FG008|Overall Study|Other|1|||
33202371|NCT02318329|100642833|FG009|Overall Study|Other|1|||
33202372|NCT00226941|100642834|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
33202373|NCT00226941|100642835|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
33202374|NCT00226941|100642836|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
33202375|NCT00226941|100642837|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
33202376|NCT00226941|100642834|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
33202377|NCT00226941|100642835|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
33202378|NCT00226941|100642836|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
33202379|NCT00226941|100642837|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
33202380|NCT01105533|100642838|FG000|Overall Study|Death|0|||
33202381|NCT01105533|100642839|FG001|Overall Study|Death|0|||
33202382|NCT01105533|100642840|FG002|Overall Study|Death|0|||
33202383|NCT01105533|100642841|FG003|Overall Study|Death|0|||
33202384|NCT01105533|100642842|FG004|Overall Study|Death|1|||
33202385|NCT01105533|100642843|FG005|Overall Study|Death|0|||
33202386|NCT01105533|100642844|FG006|Overall Study|Death|0|||
33202387|NCT01105533|100642845|FG007|Overall Study|Death|0|||
33202388|NCT01105533|100642846|FG008|Overall Study|Death|0|||
33202389|NCT01105533|100642838|FG000|Overall Study|Lack of Efficacy|1|||
33202390|NCT01105533|100642839|FG001|Overall Study|Lack of Efficacy|1|||
33202391|NCT01105533|100642840|FG002|Overall Study|Lack of Efficacy|3|||
33202392|NCT01105533|100642841|FG003|Overall Study|Lack of Efficacy|3|||
33202393|NCT01105533|100642842|FG004|Overall Study|Lack of Efficacy|4|||
33202394|NCT01105533|100642843|FG005|Overall Study|Lack of Efficacy|5|||
33202395|NCT01105533|100642844|FG006|Overall Study|Lack of Efficacy|3|||
33202396|NCT01105533|100642845|FG007|Overall Study|Lack of Efficacy|2|||
33202397|NCT01105533|100642846|FG008|Overall Study|Lack of Efficacy|9|||
33202398|NCT01105533|100642838|FG000|Overall Study|Adverse Event|0|||
33202399|NCT01105533|100642839|FG001|Overall Study|Adverse Event|0|||
33202400|NCT01105533|100642840|FG002|Overall Study|Adverse Event|0|||
33202401|NCT01105533|100642841|FG003|Overall Study|Adverse Event|0|||
33202402|NCT01105533|100642842|FG004|Overall Study|Adverse Event|1|||
33202403|NCT01105533|100642843|FG005|Overall Study|Adverse Event|2|||
33202404|NCT01105533|100642844|FG006|Overall Study|Adverse Event|2|||
33202405|NCT01105533|100642845|FG007|Overall Study|Adverse Event|0|||
33202406|NCT01105533|100642846|FG008|Overall Study|Adverse Event|1|||
33202407|NCT01105533|100642838|FG000|Overall Study|Other|0|||
33202408|NCT01105533|100642839|FG001|Overall Study|Other|0|||
33202409|NCT01105533|100642840|FG002|Overall Study|Other|0|||
33202410|NCT01105533|100642841|FG003|Overall Study|Other|0|||
33202411|NCT01105533|100642842|FG004|Overall Study|Other|1|||
33202412|NCT01105533|100642843|FG005|Overall Study|Other|0|||
33202413|NCT01105533|100642844|FG006|Overall Study|Other|3|||
33202414|NCT01105533|100642845|FG007|Overall Study|Other|1|||
33202415|NCT01105533|100642846|FG008|Overall Study|Other|2|||
33202416|NCT01105533|100642838|FG000|Overall Study|Physician Decision|0|||
33202417|NCT01105533|100642839|FG001|Overall Study|Physician Decision|0|||
33202418|NCT01105533|100642840|FG002|Overall Study|Physician Decision|0|||
33202419|NCT01105533|100642841|FG003|Overall Study|Physician Decision|0|||
33202420|NCT01105533|100642842|FG004|Overall Study|Physician Decision|0|||
33202421|NCT01105533|100642843|FG005|Overall Study|Physician Decision|0|||
33202422|NCT01105533|100642844|FG006|Overall Study|Physician Decision|0|||
33202423|NCT01105533|100642845|FG007|Overall Study|Physician Decision|1|||
33202424|NCT01105533|100642846|FG008|Overall Study|Physician Decision|0|||
33202425|NCT00558285|100642847|FG000|Overall Study|Adverse Event|1|||
33202426|NCT00558285|100642848|FG001|Overall Study|Adverse Event|1|||
33202427|NCT00558285|100642849|FG002|Overall Study|Adverse Event|4|||
33202428|NCT00558285|100642850|FG003|Overall Study|Adverse Event|1|||
33202429|NCT00558285|100642851|FG004|Overall Study|Adverse Event|2|||
33202430|NCT00558285|100642847|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33202431|NCT00558285|100642848|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33202432|NCT00558285|100642849|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33202433|NCT00558285|100642850|FG003|Overall Study|Abnormal test procedure result(s)|0|||
33202434|NCT00558285|100642851|FG004|Overall Study|Abnormal test procedure result(s)|0|||
33202435|NCT00558285|100642847|FG000|Overall Study|Subject withdrew consent|2|||
33202436|NCT00558285|100642848|FG001|Overall Study|Subject withdrew consent|0|||
33202437|NCT00558285|100642849|FG002|Overall Study|Subject withdrew consent|1|||
33202438|NCT00558285|100642850|FG003|Overall Study|Subject withdrew consent|1|||
33202439|NCT00558285|100642851|FG004|Overall Study|Subject withdrew consent|1|||
33202440|NCT00558285|100642847|FG000|Overall Study|Lost to Follow-up|1|||
33202441|NCT00558285|100642848|FG001|Overall Study|Lost to Follow-up|1|||
33202442|NCT00558285|100642849|FG002|Overall Study|Lost to Follow-up|0|||
33202443|NCT00558285|100642850|FG003|Overall Study|Lost to Follow-up|0|||
33202444|NCT00558285|100642851|FG004|Overall Study|Lost to Follow-up|0|||
33202445|NCT00558285|100642847|FG000|Overall Study|Administrative problems|0|||
33202446|NCT00558285|100642848|FG001|Overall Study|Administrative problems|0|||
33202447|NCT00558285|100642849|FG002|Overall Study|Administrative problems|0|||
33202448|NCT00558285|100642850|FG003|Overall Study|Administrative problems|1|||
33202449|NCT00558285|100642851|FG004|Overall Study|Administrative problems|1|||
33331230|NCT02603120|101107492|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
33331231|NCT03317795|101107493|FG000|Overall Study|IUD Expulsion|1|||
33331232|NCT03317795|101107494|FG001|Overall Study|IUD Expulsion|0|||
33331233|NCT03317795|101107493|FG000|Overall Study|Lost to Follow-up|1|||
33331234|NCT03317795|101107494|FG001|Overall Study|Lost to Follow-up|3|||
33331235|NCT03317795|101107493|FG000|Overall Study|Treatment change|0|||
33331236|NCT03317795|101107494|FG001|Overall Study|Treatment change|3|||
33331237|NCT03317795|101107493|FG000|Overall Study|Intolerance of medication|0|||
33331238|NCT03317795|101107494|FG001|Overall Study|Intolerance of medication|1|||
33331239|NCT00814892|101107497|FG000|Overall Study|Disease Progression|1|||
33331240|NCT00814892|101107497|FG000|Overall Study|Study Termination|1|||
33331241|NCT00906087|101107498|FG000|Initial Washout|Withdrawal by Subject|1|||
33331242|NCT00906087|101107498|FG000|Initial Washout|Physician Decision|1|||
33331243|NCT02025907|101107499|FG000|Overall Study|Lack of Efficacy|1|||
33331244|NCT02025907|101107500|FG001|Overall Study|Lack of Efficacy|0|||
33331245|NCT02025907|101107499|FG000|Overall Study|Withdrawal by Subject|15|||
33331246|NCT02025907|101107500|FG001|Overall Study|Withdrawal by Subject|8|||
33331247|NCT02025907|101107499|FG000|Overall Study|Protocol Violation|2|||
33331248|NCT02025907|101107500|FG001|Overall Study|Protocol Violation|0|||
33331249|NCT02025907|101107499|FG000|Overall Study|Physician Decision|2|||
33331250|NCT02025907|101107500|FG001|Overall Study|Physician Decision|0|||
33331251|NCT02025907|101107499|FG000|Overall Study|Lost to Follow-up|2|||
33331252|NCT02025907|101107500|FG001|Overall Study|Lost to Follow-up|2|||
33331253|NCT02025907|101107499|FG000|Overall Study|Adverse Event|3|||
33331254|NCT02025907|101107500|FG001|Overall Study|Adverse Event|1|||
33331255|NCT02025907|101107499|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
33525384|NCT03824366|101819885|FG000|Overall Study|Withdrawal by Subject|1|||
33202450|NCT00558285|100642847|FG000|Overall Study|Protocol deviation|1|||
33202451|NCT00558285|100642848|FG001|Overall Study|Protocol deviation|1|||
33202452|NCT00558285|100642849|FG002|Overall Study|Protocol deviation|0|||
33202453|NCT00558285|100642850|FG003|Overall Study|Protocol deviation|1|||
33202454|NCT00558285|100642851|FG004|Overall Study|Protocol deviation|0|||
33202455|NCT03465540|100642852|FG000|Overall Study|Withdrawal by Subject|0|||
33202456|NCT03465540|100642853|FG001|Overall Study|Withdrawal by Subject|0|||
33202457|NCT03465540|100642854|FG002|Overall Study|Withdrawal by Subject|1|||
33202458|NCT03465540|100642855|FG003|Overall Study|Withdrawal by Subject|1|||
33202459|NCT03465540|100642856|FG004|Overall Study|Withdrawal by Subject|1|||
33202460|NCT03465540|100642857|FG005|Overall Study|Withdrawal by Subject|0|||
33202461|NCT03465540|100642852|FG000|Overall Study|Lost to Follow-up|0|||
33202462|NCT03465540|100642853|FG001|Overall Study|Lost to Follow-up|1|||
33202463|NCT03465540|100642854|FG002|Overall Study|Lost to Follow-up|0|||
33610168|NCT02513472|102123231|FG000|Overall Study|Adverse Event|8|||
33610169|NCT02513472|102123232|FG001|Overall Study|Adverse Event|11|||
33331256|NCT02025907|101107500|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
33331257|NCT02953340|101107501|FG000|Overall Study|Death|0|||
33331258|NCT02953340|101107502|FG001|Overall Study|Death|1|||
33331259|NCT02953340|101107501|FG000|Overall Study|Investigator Decision|3|||
33331260|NCT02953340|101107502|FG001|Overall Study|Investigator Decision|3|||
33525385|NCT00313586|101819887|FG000|Overall Study|Disease progression|14|||
33202464|NCT03465540|100642855|FG003|Overall Study|Lost to Follow-up|0|||
33202465|NCT03465540|100642856|FG004|Overall Study|Lost to Follow-up|1|||
33202466|NCT03465540|100642857|FG005|Overall Study|Lost to Follow-up|0|||
33202467|NCT03465540|100642852|FG000|Overall Study|Death|1|||
33202468|NCT03465540|100642853|FG001|Overall Study|Death|1|||
33202469|NCT03465540|100642854|FG002|Overall Study|Death|0|||
33202470|NCT03465540|100642855|FG003|Overall Study|Death|2|||
33202471|NCT03465540|100642856|FG004|Overall Study|Death|0|||
33202472|NCT03465540|100642857|FG005|Overall Study|Death|2|||
33202473|NCT03465540|100642852|FG000|Overall Study|Protocol specified criteria|0|||
33202474|NCT03465540|100642853|FG001|Overall Study|Protocol specified criteria|2|||
33202475|NCT03465540|100642854|FG002|Overall Study|Protocol specified criteria|2|||
33202476|NCT03465540|100642855|FG003|Overall Study|Protocol specified criteria|0|||
33202477|NCT03465540|100642856|FG004|Overall Study|Protocol specified criteria|2|||
33202478|NCT03465540|100642857|FG005|Overall Study|Protocol specified criteria|0|||
33202479|NCT02019719|100642860|FG000|Overall Study|Adverse Event|1|||
33202480|NCT02019719|100642861|FG001|Overall Study|Adverse Event|0|||
33202481|NCT02019719|100642862|FG002|Overall Study|Adverse Event|0|||
33202482|NCT02019719|100642863|FG003|Overall Study|Adverse Event|1|||
33202483|NCT02019719|100642864|FG004|Overall Study|Adverse Event|1|||
33202484|NCT02019719|100642860|FG000|Overall Study|Protocol Violation|1|||
33202485|NCT02019719|100642861|FG001|Overall Study|Protocol Violation|1|||
33202486|NCT02019719|100642862|FG002|Overall Study|Protocol Violation|0|||
33202487|NCT02019719|100642863|FG003|Overall Study|Protocol Violation|0|||
33202488|NCT02019719|100642864|FG004|Overall Study|Protocol Violation|0|||
33202489|NCT02019719|100642860|FG000|Overall Study|Protocol defined stopping criteria|2|||
33202490|NCT02019719|100642861|FG001|Overall Study|Protocol defined stopping criteria|0|||
33202491|NCT02019719|100642862|FG002|Overall Study|Protocol defined stopping criteria|0|||
33202492|NCT02019719|100642863|FG003|Overall Study|Protocol defined stopping criteria|1|||
33202493|NCT02019719|100642864|FG004|Overall Study|Protocol defined stopping criteria|1|||
33202494|NCT02019719|100642860|FG000|Overall Study|Physician Decision|2|||
33202495|NCT02019719|100642861|FG001|Overall Study|Physician Decision|0|||
33202496|NCT02019719|100642862|FG002|Overall Study|Physician Decision|0|||
33202497|NCT02019719|100642863|FG003|Overall Study|Physician Decision|0|||
33202498|NCT02019719|100642864|FG004|Overall Study|Physician Decision|0|||
33202499|NCT02696850|100642865|FG000|Overall Study|Withdrawal by Subject|3|||
33202500|NCT02696850|100642866|FG001|Overall Study|Withdrawal by Subject|3|||
33202501|NCT02696850|100642865|FG000|Overall Study|Lost to Follow-up|8|||
33202502|NCT02696850|100642866|FG001|Overall Study|Lost to Follow-up|5|||
33202503|NCT00835406|100642867|FG000|Period: First Intervention|Adverse Event|0|||
33202504|NCT00835406|100642868|FG001|Period: First Intervention|Adverse Event|1|||
33202505|NCT00835406|100642867|FG000|Period: First Intervention|Withdrawal by Subject|2|||
33202506|NCT00835406|100642868|FG001|Period: First Intervention|Withdrawal by Subject|0|||
33202507|NCT00835406|100642867|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
33202508|NCT00835406|100642868|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
33202509|NCT03864900|100642869|FG000|Overall Study|Withdrawal by Subject|1|||
33202510|NCT03864900|100642870|FG001|Overall Study|Withdrawal by Subject|1|||
33202511|NCT03864900|100642869|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
33202512|NCT03864900|100642870|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
33202513|NCT00406029|100642871|FG000|Overall Study|Adverse Event|12|||
33202514|NCT00406029|100642872|FG001|Overall Study|Adverse Event|2|||
33202515|NCT00406029|100642873|FG002|Overall Study|Adverse Event|5|||
33202516|NCT00406029|100642874|FG003|Overall Study|Adverse Event|10|||
33202517|NCT00406029|100642875|FG004|Overall Study|Adverse Event|7|||
33202518|NCT00406029|100642871|FG000|Overall Study|Withdrawal by Subject|3|||
33202519|NCT00406029|100642872|FG001|Overall Study|Withdrawal by Subject|4|||
33202520|NCT00406029|100642873|FG002|Overall Study|Withdrawal by Subject|2|||
33202521|NCT00406029|100642874|FG003|Overall Study|Withdrawal by Subject|2|||
33202522|NCT00406029|100642875|FG004|Overall Study|Withdrawal by Subject|0|||
33202523|NCT00406029|100642871|FG000|Overall Study|Protocol Violation|1|||
33202524|NCT00406029|100642872|FG001|Overall Study|Protocol Violation|2|||
33202525|NCT00406029|100642873|FG002|Overall Study|Protocol Violation|0|||
33202526|NCT00406029|100642874|FG003|Overall Study|Protocol Violation|2|||
33202527|NCT00406029|100642875|FG004|Overall Study|Protocol Violation|0|||
33202528|NCT00406029|100642871|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
33202529|NCT00406029|100642872|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
33202530|NCT00406029|100642873|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
33202531|NCT00406029|100642874|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
33202532|NCT00406029|100642875|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
33202533|NCT00406029|100642871|FG000|Overall Study|Randomized in Error|0|||
33202534|NCT00406029|100642872|FG001|Overall Study|Randomized in Error|0|||
33202535|NCT00406029|100642873|FG002|Overall Study|Randomized in Error|2|||
33202536|NCT00406029|100642874|FG003|Overall Study|Randomized in Error|3|||
33331261|NCT02953340|101107501|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
33402375|NCT03289676|101361774|FG001|Overall Study|Withdrawal by Subject|0|||
33202537|NCT00406029|100642875|FG004|Overall Study|Randomized in Error|1|||
33202538|NCT02886572|100642877|FG000|Overall Study|Death|8|||
33202539|NCT00924950|100642878|FG000|Overall Study|Lost to Follow-up|2|||
33202540|NCT00803634|100642879|FG000|Overall Study|Withdrew Consent|1|||
33202541|NCT00803634|100642880|FG001|Overall Study|Withdrew Consent|0|||
33202542|NCT00803634|100642879|FG000|Overall Study|Lost to Follow-up|2|||
33202543|NCT00803634|100642880|FG001|Overall Study|Lost to Follow-up|3|||
33202544|NCT00803634|100642879|FG000|Overall Study|Death|3|||
33202545|NCT00803634|100642880|FG001|Overall Study|Death|2|||
33202546|NCT00022516|100642881|FG000|Overall Study|Adverse Event|0|||
33202547|NCT00022516|100642882|FG001|Overall Study|Adverse Event|59|||
33202548|NCT00022516|100642881|FG000|Overall Study|Lack of Efficacy|0|||
33202549|NCT00022516|100642882|FG001|Overall Study|Lack of Efficacy|27|||
33202550|NCT00022516|100642881|FG000|Overall Study|Physician Decision|0|||
33525386|NCT00313586|101819888|FG001|Overall Study|Disease progression|19|||
33525387|NCT00313586|101819889|FG002|Overall Study|Disease progression|10|||
33525388|NCT00313586|101819890|FG003|Overall Study|Disease progression|3|||
33525389|NCT00313586|101819887|FG000|Overall Study|Adverse Event|12|||
33525390|NCT00313586|101819888|FG001|Overall Study|Adverse Event|18|||
33202551|NCT00022516|100642882|FG001|Overall Study|Physician Decision|1|||
33202552|NCT00022516|100642881|FG000|Overall Study|Protocol Violation|1|||
33202553|NCT00022516|100642882|FG001|Overall Study|Protocol Violation|3|||
33202554|NCT00022516|100642881|FG000|Overall Study|Withdrawal by Subject|2|||
33202555|NCT00022516|100642882|FG001|Overall Study|Withdrawal by Subject|113|||
33202556|NCT00022516|100642881|FG000|Overall Study|Incomplete documentation|0|||
33202557|NCT00022516|100642882|FG001|Overall Study|Incomplete documentation|27|||
33202558|NCT00560833|100642883|FG000|Overall Study|Adverse Event|16|||
33202559|NCT00560833|100642884|FG001|Overall Study|Adverse Event|10|||
33202560|NCT00560833|100642885|FG002|Overall Study|Adverse Event|25|||
33331262|NCT02953340|101107502|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
33331263|NCT02953340|101107501|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
33331264|NCT02953340|101107502|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
33331265|NCT02953340|101107501|FG000|Overall Study|Withdrawal by Subject|9|||
33331266|NCT02953340|101107502|FG001|Overall Study|Withdrawal by Subject|9|||
33331267|NCT02953340|101107501|FG000|Overall Study|Sponsor decision|0|||
33331268|NCT02953340|101107502|FG001|Overall Study|Sponsor decision|2|||
33331269|NCT02953340|101107501|FG000|Overall Study|Lost to Follow-up|3|||
33331270|NCT02953340|101107502|FG001|Overall Study|Lost to Follow-up|2|||
33331271|NCT02953340|101107501|FG000|Overall Study|Reason not specified|2|||
33331272|NCT02953340|101107502|FG001|Overall Study|Reason not specified|2|||
33331273|NCT00176605|101107504|FG000|Overall Study|Withdrawal by Subject|2|||
33331274|NCT02234284|101107511|FG000|Overall Study|Death|4|||
33331275|NCT02234284|101107512|FG001|Overall Study|Death|2|||
33331276|NCT02234284|101107511|FG000|Overall Study|Withdrawal by Subject|1|||
33331277|NCT02234284|101107512|FG001|Overall Study|Withdrawal by Subject|0|||
33331278|NCT02234284|101107511|FG000|Overall Study|Lost to Follow-up|20|||
33331279|NCT02234284|101107512|FG001|Overall Study|Lost to Follow-up|7|||
33331280|NCT03462576|101107516|FG000|Overall Study|Protocol Violation|5|||
33331281|NCT03462576|101107517|FG001|Overall Study|Protocol Violation|11|||
33402376|NCT03289676|101361773|FG000|Overall Study|Protocol Violation|2|||
33402377|NCT03289676|101361774|FG001|Overall Study|Protocol Violation|0|||
33402378|NCT03289676|101361773|FG000|Overall Study|Lost to Follow-up|0|||
33402379|NCT03289676|101361774|FG001|Overall Study|Lost to Follow-up|1|||
33402380|NCT00579527|101361777|FG000|Overall Study|Death|4|||
33402381|NCT01552408|101361779|FG000|Overall Study|Lost to Follow-up|2|||
33402382|NCT01552408|101361780|FG001|Overall Study|Lost to Follow-up|0|||
33402383|NCT01552408|101361779|FG000|Overall Study|Relocation|0|||
33525391|NCT00313586|101819889|FG002|Overall Study|Adverse Event|3|||
33610170|NCT02513472|102123231|FG000|Overall Study|Withdrawal by Subject|0|||
33610171|NCT02513472|102123232|FG001|Overall Study|Withdrawal by Subject|4|||
33610172|NCT02513472|102123231|FG000|Overall Study|Subject Choice|2|||
33610173|NCT02513472|102123232|FG001|Overall Study|Subject Choice|7|||
33202561|NCT00560833|100642886|FG003|Overall Study|Adverse Event|23|||
33202562|NCT00560833|100642887|FG004|Overall Study|Adverse Event|35|||
33202563|NCT00560833|100642883|FG000|Overall Study|Lost to Follow-up|0|||
33202564|NCT00560833|100642884|FG001|Overall Study|Lost to Follow-up|0|||
33331282|NCT03462576|101107518|FG002|Overall Study|Protocol Violation|7|||
33331283|NCT03462576|101107516|FG000|Overall Study|Device Malfunction|0|||
33331284|NCT03462576|101107517|FG001|Overall Study|Device Malfunction|0|||
33331285|NCT03462576|101107518|FG002|Overall Study|Device Malfunction|1|||
33331286|NCT01439282|101107519|FG000|Overall Study|Adverse Event|5|||
33331287|NCT01439282|101107520|FG001|Overall Study|Adverse Event|0|||
33331288|NCT01439282|101107519|FG000|Overall Study|Withdrawal by Subject|2|||
33331289|NCT01439282|101107520|FG001|Overall Study|Withdrawal by Subject|0|||
33331290|NCT01439282|101107519|FG000|Overall Study|Other|1|||
33202565|NCT00560833|100642885|FG002|Overall Study|Lost to Follow-up|1|||
33202566|NCT00560833|100642886|FG003|Overall Study|Lost to Follow-up|0|||
33202567|NCT00560833|100642887|FG004|Overall Study|Lost to Follow-up|0|||
33402384|NCT01552408|101361780|FG001|Overall Study|Relocation|1|||
33402385|NCT01552408|101361779|FG000|Overall Study|Withdrawal by Subject|2|||
33525392|NCT00313586|101819890|FG003|Overall Study|Adverse Event|10|||
33525393|NCT00313586|101819887|FG000|Overall Study|Death|11|||
33331291|NCT01439282|101107520|FG001|Overall Study|Other|1|||
33331292|NCT03891264|101107527|FG000|Overall Study|Adverse Event|1|||
33331293|NCT03891264|101107527|FG000|Overall Study|Withdrawal by Subject|2|||
33331294|NCT03891264|101107527|FG000|Overall Study|Physician Decision|2|||
33331295|NCT01439204|101107528|FG000|Overall Study|Withdrawal by Subject|0|||
33331296|NCT01439204|101107529|FG001|Overall Study|Withdrawal by Subject|1|||
33331297|NCT01439204|101107528|FG000|Overall Study|Lost to Follow-up|0|||
33331298|NCT01439204|101107529|FG001|Overall Study|Lost to Follow-up|2|||
33331299|NCT01439204|101107528|FG000|Overall Study|No longer meets study criteria|1|||
33331300|NCT01439204|101107529|FG001|Overall Study|No longer meets study criteria|0|||
33331301|NCT01439204|101107528|FG000|Overall Study|poor/non-compliance|3|||
33331302|NCT01439204|101107529|FG001|Overall Study|poor/non-compliance|0|||
33331303|NCT04712110|101107530|FG000|Overall Study|Lost to Follow-up|0|||
33331304|NCT04712110|101107531|FG001|Overall Study|Lost to Follow-up|1|||
33331305|NCT04712110|101107530|FG000|Overall Study|Withdrawal by Subject|0|||
33331306|NCT04712110|101107531|FG001|Overall Study|Withdrawal by Subject|4|||
33331307|NCT04712110|101107530|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
33331308|NCT04712110|101107531|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
33331309|NCT02703311|101107532|FG000|Overall Study|Death|5|||
33331310|NCT02703311|101107532|FG000|Overall Study|Withdrawal by Subject|3|||
33331311|NCT03962101|101107540|FG000|Overall Study|Adverse Event|1|||
33331312|NCT03962101|101107540|FG000|Overall Study|Physician Decision|2|||
33331313|NCT03962101|101107540|FG000|Overall Study|Not related to medical events|1|||
33331314|NCT00133991|101107541|FG000|Overall Study|Death|4|||
33331315|NCT03921424|101107542|FG000|Overall Study|Lost to Follow-up|0|||
33331316|NCT03921424|101107543|FG001|Overall Study|Lost to Follow-up|1|||
33331317|NCT03921424|101107542|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
33331318|NCT03921424|101107543|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
33331319|NCT01227044|101107554|FG000|Overall Study|Lost to Follow-up|5|||
33331320|NCT01227044|101107555|FG001|Overall Study|Lost to Follow-up|7|||
33331321|NCT01227044|101107554|FG000|Overall Study|Discontinued Intervention|1|||
33331322|NCT01227044|101107555|FG001|Overall Study|Discontinued Intervention|2|||
33331323|NCT01502709|101107556|FG000|Overall Study|Lost to Follow-up|4|||
33331324|NCT01502709|101107557|FG001|Overall Study|Lost to Follow-up|0|||
33331325|NCT02813694|101107558|FG000|Overall Study|Physician Decision|0|||
33331326|NCT02813694|101107559|FG001|Overall Study|Physician Decision|1|||
33331327|NCT02813694|101107558|FG000|Overall Study|Withdrawal by Subject|10|||
33331328|NCT02813694|101107559|FG001|Overall Study|Withdrawal by Subject|9|||
33331329|NCT02813694|101107558|FG000|Overall Study|Lost to Follow-up|1|||
33331330|NCT02813694|101107559|FG001|Overall Study|Lost to Follow-up|1|||
33331331|NCT02813694|101107558|FG000|Overall Study|Death|3|||
33331332|NCT02813694|101107559|FG001|Overall Study|Death|3|||
33331333|NCT02813694|101107558|FG000|Overall Study|Randomized- did not receive study drug|2|||
33331334|NCT02813694|101107559|FG001|Overall Study|Randomized- did not receive study drug|0|||
33331335|NCT02813694|101107558|FG000|Overall Study|Patient hospitalized|1|||
33331336|NCT02813694|101107559|FG001|Overall Study|Patient hospitalized|0|||
33331337|NCT01246583|101107562|FG000|Overall Study|Lost to Follow-up|0|||
33331338|NCT01246583|101107563|FG001|Overall Study|Lost to Follow-up|0|||
33331339|NCT01246583|101107564|FG002|Overall Study|Lost to Follow-up|0|||
33331340|NCT01246583|101107565|FG003|Overall Study|Lost to Follow-up|1|||
33331341|NCT01246583|101107562|FG000|Overall Study|Protocol Violation|0|||
33331342|NCT01246583|101107563|FG001|Overall Study|Protocol Violation|0|||
33331343|NCT01246583|101107564|FG002|Overall Study|Protocol Violation|1|||
33610174|NCT02513472|102123231|FG000|Overall Study|Treatment Completed as per Protocol|3|||
33610175|NCT02513472|102123232|FG001|Overall Study|Treatment Completed as per Protocol|3|||
33610176|NCT02513472|102123231|FG000|Overall Study|Other|3|||
33610177|NCT02513472|102123232|FG001|Overall Study|Other|6|||
33610178|NCT02834247|102123233|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
33610179|NCT02834247|102123234|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
33610180|NCT02834247|102123235|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
33610181|NCT02834247|102123236|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
33610182|NCT02834247|102123233|FG000|Dose Escalation Phase|Death|5|||
33610183|NCT02834247|102123234|FG001|Dose Escalation Phase|Death|6|||
33331344|NCT01246583|101107565|FG003|Overall Study|Protocol Violation|0|||
33331345|NCT01246583|101107562|FG000|Overall Study|Withdrawal by Subject|1|||
33331346|NCT01246583|101107563|FG001|Overall Study|Withdrawal by Subject|0|||
33331347|NCT01246583|101107564|FG002|Overall Study|Withdrawal by Subject|0|||
33331348|NCT01246583|101107565|FG003|Overall Study|Withdrawal by Subject|0|||
33331349|NCT02577146|101107566|FG000|Overall Study|Lost to Follow-up|8|||
33331350|NCT02577146|101107566|FG000|Overall Study|Physician Decision|3|||
33331351|NCT02577146|101107566|FG000|Overall Study|Screen Failure|17|||
33331352|NCT02255422|101107567|FG000|Overall Study|Withdrawal by Subject|0|||
33331353|NCT02255422|101107568|FG001|Overall Study|Withdrawal by Subject|0|||
33331354|NCT02255422|101107569|FG002|Overall Study|Withdrawal by Subject|0|||
33610184|NCT02834247|102123235|FG002|Dose Escalation Phase|Death|5|||
33610185|NCT02834247|102123236|FG003|Dose Escalation Phase|Death|0|||
33331355|NCT02255422|101107570|FG003|Overall Study|Withdrawal by Subject|0|||
33202568|NCT00560833|100642883|FG000|Overall Study|Lack of Efficacy|22|||
33202569|NCT00560833|100642884|FG001|Overall Study|Lack of Efficacy|9|||
33202570|NCT00560833|100642885|FG002|Overall Study|Lack of Efficacy|6|||
33202571|NCT00560833|100642886|FG003|Overall Study|Lack of Efficacy|4|||
33202572|NCT00560833|100642887|FG004|Overall Study|Lack of Efficacy|4|||
33202573|NCT00560833|100642883|FG000|Overall Study|Participant uncooperative|5|||
33202574|NCT00560833|100642884|FG001|Overall Study|Participant uncooperative|5|||
33202575|NCT00560833|100642885|FG002|Overall Study|Participant uncooperative|4|||
33202576|NCT00560833|100642886|FG003|Overall Study|Participant uncooperative|4|||
33202577|NCT00560833|100642887|FG004|Overall Study|Participant uncooperative|2|||
33202578|NCT00560833|100642883|FG000|Overall Study|Other|1|||
33202579|NCT00560833|100642884|FG001|Overall Study|Other|1|||
33202580|NCT00560833|100642885|FG002|Overall Study|Other|3|||
33202581|NCT00560833|100642886|FG003|Overall Study|Other|0|||
33202582|NCT00560833|100642887|FG004|Overall Study|Other|0|||
33202583|NCT00560833|100642883|FG000|Overall Study|Never received drug|0|||
33202584|NCT00560833|100642884|FG001|Overall Study|Never received drug|1|||
33202585|NCT00560833|100642885|FG002|Overall Study|Never received drug|0|||
33202586|NCT00560833|100642886|FG003|Overall Study|Never received drug|0|||
33202587|NCT00560833|100642887|FG004|Overall Study|Never received drug|1|||
33202588|NCT01557946|100642891|FG000|Overall Study|Adverse Event|3|||
33202589|NCT01557946|100642892|FG001|Overall Study|Adverse Event|0|||
33202590|NCT03328897|100642893|FG000|Randomized-treatment Epoch|Adverse Event|4|||
33202591|NCT03328897|100642894|FG001|Randomized-treatment Epoch|Adverse Event|1|||
33202592|NCT03328897|100642895|FG002|Randomized-treatment Epoch|Adverse Event|1|||
33202593|NCT03328897|100642893|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
33202594|NCT03328897|100642894|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
33202595|NCT03328897|100642895|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
33202596|NCT03328897|100642893|FG000|Randomized-treatment Epoch|Pregnancy|3|||
33202597|NCT03328897|100642894|FG001|Randomized-treatment Epoch|Pregnancy|0|||
33202598|NCT03328897|100642895|FG002|Randomized-treatment Epoch|Pregnancy|0|||
33202599|NCT03328897|100642893|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
33202600|NCT03328897|100642894|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
33202601|NCT03328897|100642895|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
33202602|NCT03328897|100642893|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
33331356|NCT02255422|101107571|FG004|Overall Study|Withdrawal by Subject|0|||
33331357|NCT02255422|101107572|FG005|Overall Study|Withdrawal by Subject|0|||
33331358|NCT02255422|101107573|FG006|Overall Study|Withdrawal by Subject|2|||
33331359|NCT02255422|101107567|FG000|Overall Study|Lost to Follow-up|0|||
33331360|NCT02255422|101107568|FG001|Overall Study|Lost to Follow-up|0|||
33331361|NCT02255422|101107569|FG002|Overall Study|Lost to Follow-up|1|||
33331362|NCT02255422|101107570|FG003|Overall Study|Lost to Follow-up|0|||
33402386|NCT01552408|101361780|FG001|Overall Study|Withdrawal by Subject|1|||
33402387|NCT01293123|101361784|FG000|Overall Study|Lost to Follow-up|0|||
33525394|NCT00313586|101819888|FG001|Overall Study|Death|8|||
33525395|NCT00313586|101819889|FG002|Overall Study|Death|1|||
33525396|NCT00313586|101819890|FG003|Overall Study|Death|7|||
33525397|NCT00313586|101819887|FG000|Overall Study|Withdrawal by Subject|13|||
33525398|NCT00313586|101819888|FG001|Overall Study|Withdrawal by Subject|6|||
33525399|NCT00313586|101819889|FG002|Overall Study|Withdrawal by Subject|6|||
33525400|NCT00313586|101819890|FG003|Overall Study|Withdrawal by Subject|2|||
33525401|NCT00313586|101819887|FG000|Overall Study|Alternative therapy|3|||
33525402|NCT00313586|101819888|FG001|Overall Study|Alternative therapy|6|||
33525403|NCT00313586|101819889|FG002|Overall Study|Alternative therapy|2|||
33525404|NCT00313586|101819890|FG003|Overall Study|Alternative therapy|0|||
33525405|NCT00313586|101819887|FG000|Overall Study|Other complicating disease|2|||
33525406|NCT00313586|101819888|FG001|Overall Study|Other complicating disease|2|||
33525407|NCT00313586|101819889|FG002|Overall Study|Other complicating disease|0|||
33525408|NCT00313586|101819890|FG003|Overall Study|Other complicating disease|0|||
33525409|NCT00313586|101819887|FG000|Overall Study|Did not achieve HI-major/better response|10|||
33525410|NCT00313586|101819888|FG001|Overall Study|Did not achieve HI-major/better response|7|||
33525411|NCT00313586|101819889|FG002|Overall Study|Did not achieve HI-major/better response|2|||
33525412|NCT00313586|101819890|FG003|Overall Study|Did not achieve HI-major/better response|1|||
33331363|NCT02255422|101107571|FG004|Overall Study|Lost to Follow-up|0|||
33331364|NCT02255422|101107572|FG005|Overall Study|Lost to Follow-up|0|||
33202603|NCT03328897|100642894|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
33202604|NCT03328897|100642895|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
33202605|NCT03328897|100642893|FG000|Follow-up Epoch|Adverse Event|4|||
33202606|NCT03328897|100642894|FG001|Follow-up Epoch|Adverse Event|0|||
33331365|NCT02255422|101107573|FG006|Overall Study|Lost to Follow-up|0|||
33202607|NCT03328897|100642895|FG002|Follow-up Epoch|Adverse Event|1|||
33202608|NCT03328897|100642893|FG000|Follow-up Epoch|Lack of Efficacy|1|||
33525413|NCT00313586|101819887|FG000|Overall Study|Physician Decision|2|||
33525414|NCT00313586|101819888|FG001|Overall Study|Physician Decision|1|||
33525415|NCT00313586|101819889|FG002|Overall Study|Physician Decision|0|||
33525416|NCT00313586|101819890|FG003|Overall Study|Physician Decision|0|||
33202609|NCT03328897|100642894|FG001|Follow-up Epoch|Lack of Efficacy|1|||
33202610|NCT03328897|100642895|FG002|Follow-up Epoch|Lack of Efficacy|1|||
33202611|NCT03328897|100642893|FG000|Follow-up Epoch|Lost to Follow-up|0|||
33202612|NCT03328897|100642894|FG001|Follow-up Epoch|Lost to Follow-up|1|||
33202613|NCT03328897|100642895|FG002|Follow-up Epoch|Lost to Follow-up|0|||
33202614|NCT03328897|100642893|FG000|Follow-up Epoch|Pregnancy|1|||
33202615|NCT03328897|100642894|FG001|Follow-up Epoch|Pregnancy|0|||
33202616|NCT03328897|100642895|FG002|Follow-up Epoch|Pregnancy|0|||
33202617|NCT03328897|100642893|FG000|Follow-up Epoch|Patient/guardian decision|2|||
33202618|NCT03328897|100642894|FG001|Follow-up Epoch|Patient/guardian decision|1|||
33202619|NCT03328897|100642895|FG002|Follow-up Epoch|Patient/guardian decision|0|||
33202620|NCT01992536|100642896|FG000|Overall Study|Administrative Reason|0|||
33202621|NCT01992536|100642897|FG001|Overall Study|Administrative Reason|0|||
33202622|NCT01992536|100642898|FG002|Overall Study|Administrative Reason|0|||
33202623|NCT01992536|100642899|FG003|Overall Study|Administrative Reason|0|||
33202624|NCT01992536|100642900|FG004|Overall Study|Administrative Reason|0|||
33202625|NCT01992536|100642901|FG005|Overall Study|Administrative Reason|0|||
33202626|NCT01992536|100642902|FG006|Overall Study|Administrative Reason|7|||
33202627|NCT01992536|100642903|FG007|Overall Study|Administrative Reason|0|||
33202628|NCT01992536|100642904|FG008|Overall Study|Administrative Reason|0|||
33202629|NCT01992536|100642905|FG009|Overall Study|Administrative Reason|0|||
33202630|NCT01992536|100642896|FG000|Overall Study|Lost to Follow-up|4|||
33202631|NCT01992536|100642897|FG001|Overall Study|Lost to Follow-up|2|||
33202632|NCT01992536|100642898|FG002|Overall Study|Lost to Follow-up|1|||
33202633|NCT01992536|100642899|FG003|Overall Study|Lost to Follow-up|0|||
33202634|NCT01992536|100642900|FG004|Overall Study|Lost to Follow-up|0|||
33202635|NCT01992536|100642901|FG005|Overall Study|Lost to Follow-up|1|||
33202636|NCT01992536|100642902|FG006|Overall Study|Lost to Follow-up|0|||
33202637|NCT01992536|100642903|FG007|Overall Study|Lost to Follow-up|0|||
33202638|NCT01992536|100642904|FG008|Overall Study|Lost to Follow-up|1|||
33202639|NCT01992536|100642905|FG009|Overall Study|Lost to Follow-up|1|||
33202640|NCT01992536|100642896|FG000|Overall Study|Withdrawal by Subject|0|||
33202641|NCT01992536|100642897|FG001|Overall Study|Withdrawal by Subject|1|||
33202642|NCT01992536|100642898|FG002|Overall Study|Withdrawal by Subject|0|||
33202643|NCT01992536|100642899|FG003|Overall Study|Withdrawal by Subject|2|||
33202644|NCT01992536|100642900|FG004|Overall Study|Withdrawal by Subject|0|||
33202645|NCT01992536|100642901|FG005|Overall Study|Withdrawal by Subject|0|||
33202646|NCT01992536|100642902|FG006|Overall Study|Withdrawal by Subject|0|||
33202647|NCT01992536|100642903|FG007|Overall Study|Withdrawal by Subject|0|||
33202648|NCT01992536|100642904|FG008|Overall Study|Withdrawal by Subject|0|||
33202649|NCT01992536|100642905|FG009|Overall Study|Withdrawal by Subject|0|||
33202650|NCT01774903|100642906|FG000|Overall Study|Adverse Event|7|||
33202651|NCT01774903|100642906|FG000|Overall Study|Withdrawal by Subject|2|||
33202652|NCT01774903|100642906|FG000|Overall Study|Lack of Efficacy|1|||
33202653|NCT01774903|100642906|FG000|Overall Study|Ineligible to continue the trial|1|||
33202654|NCT00432380|100642907|FG000|Overall Study|Migrated/moved from study area|3|||
33202655|NCT00432380|100642908|FG001|Overall Study|Migrated/moved from study area|4|||
33331366|NCT00440947|101107574|FG000|36-Week Induction Phase|Adverse Event|16|||
33331367|NCT00440947|101107575|FG001|36-Week Induction Phase|Adverse Event|0|||
33331368|NCT00440947|101107576|FG002|36-Week Induction Phase|Adverse Event|0|||
33331369|NCT00440947|101107577|FG003|36-Week Induction Phase|Adverse Event|0|||
33331370|NCT00440947|101107578|FG004|36-Week Induction Phase|Adverse Event|0|||
33525417|NCT00313586|101819887|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
33525418|NCT00313586|101819888|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
33202656|NCT00432380|100642909|FG002|Overall Study|Migrated/moved from study area|1|||
33202657|NCT00432380|100642907|FG000|Overall Study|Adverse Event|1|||
33202658|NCT00432380|100642908|FG001|Overall Study|Adverse Event|0|||
33202659|NCT00432380|100642909|FG002|Overall Study|Adverse Event|0|||
33202660|NCT01854554|100642914|FG000|Overall Study|Denial of Insurance Coverage|12|||
33202661|NCT01854554|100642915|FG001|Overall Study|Denial of Insurance Coverage|0|||
33331371|NCT00440947|101107574|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
33331372|NCT00440947|101107575|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
33202662|NCT01854554|100642914|FG000|Overall Study|Decided to get treatment locally|1|||
33202663|NCT01854554|100642915|FG001|Overall Study|Decided to get treatment locally|5|||
33202664|NCT01854554|100642914|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
33202665|NCT01854554|100642915|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
33202666|NCT01854554|100642914|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
33202667|NCT01854554|100642915|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
33202668|NCT01854554|100642914|FG000|Overall Study|Progression|0|||
33331373|NCT00440947|101107576|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
33331374|NCT00440947|101107577|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
33202669|NCT01854554|100642915|FG001|Overall Study|Progression|1|||
33331375|NCT00440947|101107578|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
33525419|NCT00313586|101819889|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
33331376|NCT00440947|101107574|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
33202670|NCT01854554|100642914|FG000|Overall Study|Lost to Follow-up|0|||
33202671|NCT01854554|100642915|FG001|Overall Study|Lost to Follow-up|1|||
33202672|NCT00148343|100642917|FG000|Overall Study|Withdrawal by Subject|12|||
33202673|NCT00148343|100642918|FG001|Overall Study|Withdrawal by Subject|7|||
33202674|NCT00148343|100642917|FG000|Overall Study|Physician Decision|3|||
33202675|NCT00148343|100642918|FG001|Overall Study|Physician Decision|4|||
33202676|NCT04443218|100642919|FG000|Overall Study|Exited study for other reasons|9|||
33202677|NCT04443218|100642919|FG000|Overall Study|Withdrawal by Subject|1|||
33202678|NCT04443218|100642919|FG000|Overall Study|Lost to Follow-up|4|||
33202679|NCT04443218|100642919|FG000|Overall Study|Death|19|||
33202680|NCT03893448|100642920|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
33202681|NCT03893448|100642921|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
33202682|NCT03893448|100642920|FG000|Overall Study|Physician Decision|8|||
33202683|NCT03893448|100642921|FG001|Overall Study|Physician Decision|14|||
33202684|NCT03893448|100642920|FG000|Overall Study|Lost to Follow-up|34|||
33202685|NCT03893448|100642921|FG001|Overall Study|Lost to Follow-up|27|||
33202686|NCT03893448|100642920|FG000|Overall Study|Death|1|||
33202687|NCT03893448|100642921|FG001|Overall Study|Death|0|||
33202688|NCT02660944|100642922|FG000|Overall Study|Adverse Event|3|||
33202689|NCT02660944|100642923|FG001|Overall Study|Adverse Event|4|||
33202690|NCT02660944|100642922|FG000|Overall Study|Physician Decision|3|||
33202691|NCT02660944|100642923|FG001|Overall Study|Physician Decision|1|||
33202692|NCT02660944|100642922|FG000|Overall Study|Withdrawal by Subject|5|||
33202693|NCT02660944|100642923|FG001|Overall Study|Withdrawal by Subject|3|||
33202694|NCT02660944|100642922|FG000|Overall Study|Lost to Follow-up|4|||
33202695|NCT02660944|100642923|FG001|Overall Study|Lost to Follow-up|1|||
33202696|NCT02660944|100642922|FG000|Overall Study|Subject schedule|0|||
33202697|NCT02660944|100642923|FG001|Overall Study|Subject schedule|1|||
33202698|NCT02660944|100642922|FG000|Overall Study|Exclusion criteria met|2|||
33202699|NCT02660944|100642923|FG001|Overall Study|Exclusion criteria met|0|||
33202700|NCT01913041|100642926|FG000|Overall Study|Protocol Violation|35|||
33202701|NCT01913041|100642926|FG000|Overall Study|Withdrawal by Subject|3|||
33525420|NCT00313586|101819890|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
33525421|NCT00313586|101819887|FG000|Overall Study|Lost insurance|0|||
33202702|NCT01913041|100642926|FG000|Overall Study|Physician Decision|1|||
33202703|NCT01762761|100642927|FG000|Overall Study|Adverse Event|15|||
33202704|NCT01762761|100642928|FG001|Overall Study|Adverse Event|17|||
33202705|NCT01762761|100642927|FG000|Overall Study|Lack of Efficacy|9|||
33202706|NCT01762761|100642928|FG001|Overall Study|Lack of Efficacy|25|||
33202707|NCT01762761|100642927|FG000|Overall Study|Protocol Violation|1|||
33202708|NCT01762761|100642928|FG001|Overall Study|Protocol Violation|1|||
33331377|NCT00440947|101107575|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
33331378|NCT00440947|101107576|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
33331379|NCT00440947|101107577|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
33331380|NCT00440947|101107578|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
33331381|NCT00440947|101107574|FG000|36-Week Induction Phase|Non-compliance|10|||
33331382|NCT00440947|101107575|FG001|36-Week Induction Phase|Non-compliance|0|||
33331383|NCT00440947|101107576|FG002|36-Week Induction Phase|Non-compliance|0|||
33202709|NCT01762761|100642927|FG000|Overall Study|Study closed/terminated|0|||
33202710|NCT01762761|100642928|FG001|Overall Study|Study closed/terminated|2|||
33202711|NCT01762761|100642927|FG000|Overall Study|Lost to Follow-up|3|||
33202712|NCT01762761|100642928|FG001|Overall Study|Lost to Follow-up|6|||
33331384|NCT00440947|101107577|FG003|36-Week Induction Phase|Non-compliance|0|||
33331385|NCT00440947|101107578|FG004|36-Week Induction Phase|Non-compliance|0|||
33331386|NCT00440947|101107574|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
33331387|NCT00440947|101107575|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
33331388|NCT00440947|101107576|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
33331389|NCT00440947|101107577|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
33331390|NCT00440947|101107578|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
33331391|NCT00440947|101107574|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
33331392|NCT00440947|101107575|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
33331393|NCT00440947|101107576|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
33331394|NCT00440947|101107577|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
33331395|NCT00440947|101107578|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
33331396|NCT00440947|101107574|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
33331397|NCT00440947|101107575|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
33331398|NCT00440947|101107576|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
33331399|NCT00440947|101107577|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
33331400|NCT00440947|101107578|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
33331401|NCT00440947|101107574|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
33331402|NCT00440947|101107575|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
33331403|NCT00440947|101107576|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
33331404|NCT00440947|101107577|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
33331405|NCT00440947|101107578|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
33331406|NCT00440947|101107574|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
33331407|NCT00440947|101107575|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
33331408|NCT00440947|101107576|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
33331409|NCT00440947|101107577|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
33331410|NCT00440947|101107578|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
33331411|NCT00440947|101107574|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
33331412|NCT00440947|101107575|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
33331413|NCT00440947|101107576|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
33331414|NCT00440947|101107577|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
33331415|NCT00440947|101107578|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
33331416|NCT00440947|101107574|FG000|36-Week Induction Phase|Incarceration|3|||
33331417|NCT00440947|101107575|FG001|36-Week Induction Phase|Incarceration|0|||
33525422|NCT00313586|101819888|FG001|Overall Study|Lost insurance|1|||
33525423|NCT00313586|101819889|FG002|Overall Study|Lost insurance|0|||
33525424|NCT00313586|101819890|FG003|Overall Study|Lost insurance|0|||
33525425|NCT00313586|101819887|FG000|Overall Study|Moved|0|||
33525426|NCT00313586|101819888|FG001|Overall Study|Moved|1|||
33525427|NCT00313586|101819889|FG002|Overall Study|Moved|0|||
33525428|NCT00313586|101819890|FG003|Overall Study|Moved|0|||
33525429|NCT00313586|101819887|FG000|Overall Study|Death before starting treatment|1|||
33525430|NCT00313586|101819888|FG001|Overall Study|Death before starting treatment|0|||
33525431|NCT00313586|101819889|FG002|Overall Study|Death before starting treatment|0|||
33525432|NCT00313586|101819890|FG003|Overall Study|Death before starting treatment|0|||
33525433|NCT03859648|101819891|FG000|Overall Study|Lost to Follow-up|1|||
33525434|NCT03859648|101819891|FG000|Overall Study|Adverse Event|1|||
33525435|NCT00564395|101819892|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
33610186|NCT02834247|102123233|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
33610187|NCT02834247|102123234|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
33610188|NCT02834247|102123235|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
33610189|NCT02834247|102123236|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
33610190|NCT02834247|102123233|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
33331418|NCT00440947|101107576|FG002|36-Week Induction Phase|Incarceration|0|||
33331419|NCT00440947|101107577|FG003|36-Week Induction Phase|Incarceration|0|||
33331420|NCT00440947|101107578|FG004|36-Week Induction Phase|Incarceration|0|||
33331421|NCT00440947|101107574|FG000|36-Week Induction Phase|Pregnancy|1|||
33331422|NCT00440947|101107575|FG001|36-Week Induction Phase|Pregnancy|0|||
33331423|NCT00440947|101107576|FG002|36-Week Induction Phase|Pregnancy|0|||
33331424|NCT00440947|101107577|FG003|36-Week Induction Phase|Pregnancy|0|||
33331425|NCT00440947|101107578|FG004|36-Week Induction Phase|Pregnancy|0|||
33331426|NCT00440947|101107574|FG000|48-Week Randomization Phase|Adverse Event|0|||
33331427|NCT00440947|101107575|FG001|48-Week Randomization Phase|Adverse Event|2|||
33331428|NCT00440947|101107576|FG002|48-Week Randomization Phase|Adverse Event|5|||
33331429|NCT00440947|101107577|FG003|48-Week Randomization Phase|Adverse Event|0|||
33331430|NCT00440947|101107578|FG004|48-Week Randomization Phase|Adverse Event|0|||
33331431|NCT00440947|101107574|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
33331432|NCT00440947|101107575|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
33331433|NCT00440947|101107576|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
33525436|NCT00564395|101819893|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
33525437|NCT00564395|101819892|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
33331434|NCT00440947|101107577|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
33331435|NCT00440947|101107578|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
33331436|NCT00440947|101107574|FG000|48-Week Randomization Phase|Non-compliance|0|||
33331437|NCT00440947|101107575|FG001|48-Week Randomization Phase|Non-compliance|3|||
33331438|NCT00440947|101107576|FG002|48-Week Randomization Phase|Non-compliance|4|||
33331439|NCT00440947|101107577|FG003|48-Week Randomization Phase|Non-compliance|0|||
33331440|NCT00440947|101107578|FG004|48-Week Randomization Phase|Non-compliance|0|||
33331441|NCT00440947|101107574|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
33331442|NCT00440947|101107575|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
33331443|NCT00440947|101107576|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
33331444|NCT00440947|101107577|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
33331445|NCT00440947|101107578|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
33331446|NCT00440947|101107574|FG000|48-Week Randomization Phase|Protocol Violation|0|||
33331447|NCT00440947|101107575|FG001|48-Week Randomization Phase|Protocol Violation|0|||
33331448|NCT00440947|101107576|FG002|48-Week Randomization Phase|Protocol Violation|1|||
33331449|NCT00440947|101107577|FG003|48-Week Randomization Phase|Protocol Violation|0|||
33331450|NCT00440947|101107578|FG004|48-Week Randomization Phase|Protocol Violation|0|||
33331451|NCT00440947|101107574|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
33331452|NCT00440947|101107575|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
33331453|NCT00440947|101107576|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
33331454|NCT00440947|101107577|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
33331455|NCT00440947|101107578|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
33331456|NCT00440947|101107574|FG000|48-Week Randomization Phase|Pregnancy|0|||
33331457|NCT00440947|101107575|FG001|48-Week Randomization Phase|Pregnancy|0|||
33331458|NCT00440947|101107576|FG002|48-Week Randomization Phase|Pregnancy|1|||
33331459|NCT00440947|101107577|FG003|48-Week Randomization Phase|Pregnancy|0|||
33331460|NCT00440947|101107578|FG004|48-Week Randomization Phase|Pregnancy|0|||
33331461|NCT00440947|101107574|FG000|48-Week Randomization Phase|Incarceration|0|||
33331462|NCT00440947|101107575|FG001|48-Week Randomization Phase|Incarceration|3|||
33331463|NCT00440947|101107576|FG002|48-Week Randomization Phase|Incarceration|0|||
33331464|NCT00440947|101107577|FG003|48-Week Randomization Phase|Incarceration|0|||
33331465|NCT00440947|101107578|FG004|48-Week Randomization Phase|Incarceration|0|||
33331466|NCT00440947|101107574|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
33331467|NCT00440947|101107575|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
33331468|NCT00440947|101107576|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
33331469|NCT00440947|101107577|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
33525438|NCT00564395|101819893|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
33525439|NCT00048997|101819894|FG000|Overall Study|Protocol Violation|7|||
33525440|NCT00048997|101819895|FG001|Overall Study|Protocol Violation|2|||
33331470|NCT00440947|101107578|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
33331471|NCT00440947|101107574|FG000|48-Week Randomization Phase|Physician Decision|0|||
33331472|NCT00440947|101107575|FG001|48-Week Randomization Phase|Physician Decision|2|||
33331473|NCT00440947|101107576|FG002|48-Week Randomization Phase|Physician Decision|0|||
33331474|NCT00440947|101107577|FG003|48-Week Randomization Phase|Physician Decision|0|||
33331475|NCT00440947|101107578|FG004|48-Week Randomization Phase|Physician Decision|0|||
33331476|NCT00440947|101107574|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
33525441|NCT00048997|101819894|FG000|Overall Study|Withdrawal by Subject|6|||
33525442|NCT00048997|101819895|FG001|Overall Study|Withdrawal by Subject|1|||
33331477|NCT00440947|101107575|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
33331478|NCT00440947|101107576|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
33331479|NCT00440947|101107577|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
33331480|NCT00440947|101107578|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
33525443|NCT03041467|101819896|FG000|Overall Study|Death|46|||
33331481|NCT00440947|101107574|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
33331482|NCT00440947|101107575|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
33331483|NCT00440947|101107576|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
33331484|NCT00440947|101107577|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
33331485|NCT00440947|101107578|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
33331486|NCT00440947|101107574|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
33331487|NCT00440947|101107575|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
33331488|NCT00440947|101107576|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
33402388|NCT01293123|101361785|FG001|Overall Study|Lost to Follow-up|1|||
33402389|NCT03384316|101361787|FG000|Overall Study|Screen failure|0|||
33402390|NCT03384316|101361788|FG001|Overall Study|Screen failure|1|||
33402391|NCT03432819|101361794|FG000|Overall Study|Lost to Follow-up|2|||
33402392|NCT03432819|101361795|FG001|Overall Study|Lost to Follow-up|2|||
33402393|NCT03432819|101361794|FG000|Overall Study|Withdrawal by Subject|5|||
33402394|NCT03432819|101361795|FG001|Overall Study|Withdrawal by Subject|3|||
33402395|NCT01362062|101361796|FG000|Overall Study|Adverse Event|1|||
33402396|NCT01362062|101361797|FG001|Overall Study|Adverse Event|0|||
33402397|NCT01362062|101361796|FG000|Overall Study|Lost to Follow-up|11|||
33402398|NCT01362062|101361797|FG001|Overall Study|Lost to Follow-up|0|||
33402399|NCT01362062|101361796|FG000|Overall Study|Withdrawal by Subject|2|||
33402400|NCT01362062|101361797|FG001|Overall Study|Withdrawal by Subject|0|||
33402401|NCT01362062|101361796|FG000|Overall Study|Non-compliant participant|2|||
33402402|NCT01362062|101361797|FG001|Overall Study|Non-compliant participant|0|||
33402403|NCT01362062|101361796|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
33402404|NCT01362062|101361797|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
33402405|NCT01362062|101361796|FG000|Overall Study|Had significant improvement|9|||
33402406|NCT01362062|101361797|FG001|Overall Study|Had significant improvement|0|||
33402407|NCT01716585|101361799|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
33402408|NCT01716585|101361800|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
33402409|NCT01716585|101361799|FG000|Double-blind Treatment|Adverse Event|2|||
33402410|NCT01716585|101361800|FG001|Double-blind Treatment|Adverse Event|1|||
33402411|NCT01716585|101361799|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
33402412|NCT01716585|101361800|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
33402413|NCT01716585|101361799|FG000|Double-blind Treatment|Lost to Follow-up|2|||
33402414|NCT01716585|101361800|FG001|Double-blind Treatment|Lost to Follow-up|0|||
33402415|NCT01716585|101361799|FG000|Double-blind Treatment|Subject Noncompliant|1|||
33402416|NCT01716585|101361800|FG001|Double-blind Treatment|Subject Noncompliant|0|||
33402417|NCT01716585|101361799|FG000|Double-blind Treatment|Other|1|||
33402418|NCT01716585|101361800|FG001|Double-blind Treatment|Other|0|||
33402419|NCT01716585|101361799|FG000|Open-label Treatment|Adverse Event|0|||
33402420|NCT01716585|101361800|FG001|Open-label Treatment|Adverse Event|2|||
33331489|NCT00440947|101107577|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
33331490|NCT00440947|101107578|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
33331491|NCT00440947|101107574|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
33331492|NCT00440947|101107575|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
33331493|NCT00440947|101107576|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
33331494|NCT00440947|101107577|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
33331495|NCT00440947|101107578|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
33402421|NCT01716585|101361799|FG000|Open-label Treatment|Virologic Failure|0|||
33402422|NCT01716585|101361800|FG001|Open-label Treatment|Virologic Failure|2|||
33402423|NCT01716585|101361799|FG000|Open-label Treatment|Withdrawal by Subject|0|||
33402424|NCT01716585|101361800|FG001|Open-label Treatment|Withdrawal by Subject|3|||
33402425|NCT03769753|101361801|FG000|Overall Study|Not Treated|6|||
33402426|NCT03769753|101361801|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
33402427|NCT01683058|101361802|FG000|Overall Study|Lost to Follow-up|9|||
33402428|NCT01683058|101361802|FG000|Overall Study|Adverse Event|6|||
33402429|NCT01683058|101361802|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
33525444|NCT03041467|101819897|FG001|Overall Study|Death|39|||
33525445|NCT03041467|101819896|FG000|Overall Study|Withdrawal by Subject|36|||
33525446|NCT03041467|101819897|FG001|Overall Study|Withdrawal by Subject|37|||
33525447|NCT03041467|101819896|FG000|Overall Study|Lost to Follow-up|6|||
33525448|NCT03041467|101819897|FG001|Overall Study|Lost to Follow-up|8|||
33525449|NCT03041467|101819896|FG000|Overall Study|Declined consent for study extension|21|||
33525450|NCT03041467|101819897|FG001|Overall Study|Declined consent for study extension|33|||
33525451|NCT03041467|101819896|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
33525452|NCT03041467|101819897|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
33525453|NCT01709864|101819898|FG000|Overall Study|Physician Decision|0|||
33525454|NCT01709864|101819899|FG001|Overall Study|Physician Decision|1|||
33402430|NCT01683058|101361802|FG000|Overall Study|Withdrawal by Subject|7|||
33402431|NCT01683058|101361802|FG000|Overall Study|Lack of Efficacy|2|||
33525455|NCT01709864|101819898|FG000|Overall Study|subject/guardian decision|5|||
33525456|NCT01709864|101819899|FG001|Overall Study|subject/guardian decision|6|||
33331496|NCT00440947|101107574|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
33331497|NCT00440947|101107575|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
33331498|NCT00440947|101107576|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
33331499|NCT00440947|101107577|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
33331500|NCT00440947|101107578|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
33331501|NCT00440947|101107574|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
33331502|NCT00440947|101107575|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
33331503|NCT00440947|101107576|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
33331504|NCT00440947|101107577|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
33331505|NCT00440947|101107578|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
33331506|NCT00440947|101107574|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
33331507|NCT00440947|101107575|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
33331508|NCT00440947|101107576|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
33331509|NCT00440947|101107577|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
33331510|NCT00440947|101107578|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
33331511|NCT00440947|101107574|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
33331512|NCT00440947|101107575|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
33331513|NCT00440947|101107576|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
33331514|NCT00440947|101107577|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
33331515|NCT00440947|101107578|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
33331516|NCT00440947|101107574|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
33331517|NCT00440947|101107575|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
33525457|NCT01709864|101819898|FG000|Overall Study|Lost to Follow-up|1|||
33525458|NCT01709864|101819899|FG001|Overall Study|Lost to Follow-up|0|||
33525459|NCT01709864|101819898|FG000|Overall Study|non-compliance with study treatment|1|||
33525460|NCT01709864|101819899|FG001|Overall Study|non-compliance with study treatment|1|||
33525461|NCT01709864|101819898|FG000|Overall Study|Adverse Event|0|||
33525462|NCT01709864|101819899|FG001|Overall Study|Adverse Event|2|||
33525463|NCT01709864|101819898|FG000|Overall Study|Death|0|||
33525464|NCT01709864|101819899|FG001|Overall Study|Death|1|||
33525465|NCT01281956|101819900|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
33525466|NCT01281956|101819901|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
33525467|NCT03585712|101819902|FG000|Treatment Period 1|Protocol Violation|1|||
33525468|NCT03585712|101819903|FG001|Treatment Period 1|Protocol Violation|0|||
33525469|NCT03585712|101819904|FG002|Treatment Period 1|Protocol Violation|0|||
33525470|NCT03585712|101819902|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
33525471|NCT03585712|101819903|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
33525472|NCT03585712|101819904|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
33525473|NCT03585712|101819902|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
33525474|NCT03585712|101819903|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
33525475|NCT03585712|101819904|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
33525476|NCT03585712|101819902|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
33525477|NCT03585712|101819903|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
33525478|NCT03585712|101819904|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
33525479|NCT02732015|101819905|FG000|Overall Study|Lost to Follow-up|0|||
33525480|NCT02732015|101819906|FG001|Overall Study|Lost to Follow-up|1|||
33525481|NCT04202965|101819909|FG000|Overall Study|Adverse Event|3|||
33525482|NCT04202965|101819909|FG000|Overall Study|Did not meet inclusion criteria|1|||
33525483|NCT01084538|101819910|FG000|Overall Study|Drug not available|30|||
33525484|NCT01084538|101819910|FG000|Overall Study|Adverse Event|9|||
33525485|NCT01084538|101819910|FG000|Overall Study|Kidney transplant|6|||
33525486|NCT01084538|101819910|FG000|Overall Study|Serious Adverse Event|3|||
33525487|NCT01084538|101819910|FG000|Overall Study|Lack of effectiveness|2|||
33525488|NCT01084538|101819910|FG000|Overall Study|Patient noncompliance|2|||
33525489|NCT01084538|101819910|FG000|Overall Study|Hyperphosphatemia|2|||
33525490|NCT01084538|101819910|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
33525491|NCT01084538|101819910|FG000|Overall Study|Change of residence|2|||
33525492|NCT01084538|101819910|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
33525493|NCT01084538|101819910|FG000|Overall Study|Reason unknown|8|||
33525494|NCT00627926|101819911|FG000|Overall Study|Adverse Event|26|||
33525495|NCT00627926|101819912|FG001|Overall Study|Adverse Event|37|||
33525496|NCT00627926|101819913|FG002|Overall Study|Adverse Event|36|||
33525497|NCT00627926|101819911|FG000|Overall Study|Death|1|||
33525498|NCT00627926|101819912|FG001|Overall Study|Death|0|||
33525499|NCT00627926|101819913|FG002|Overall Study|Death|0|||
33525500|NCT00627926|101819911|FG000|Overall Study|Lost to Follow-up|4|||
33525501|NCT00627926|101819912|FG001|Overall Study|Lost to Follow-up|3|||
33525502|NCT00627926|101819913|FG002|Overall Study|Lost to Follow-up|4|||
33525503|NCT00627926|101819911|FG000|Overall Study|Withdrawal by Subject|2|||
33525504|NCT00627926|101819912|FG001|Overall Study|Withdrawal by Subject|1|||
33402432|NCT01385098|101361803|FG000|Overall Study|Adverse Event|10|||
33525505|NCT00627926|101819913|FG002|Overall Study|Withdrawal by Subject|0|||
33525506|NCT00627926|101819911|FG000|Overall Study|Lack of Efficacy|118|||
33331518|NCT00440947|101107576|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
33331519|NCT00440947|101107577|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
33331520|NCT00440947|101107578|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
33331521|NCT00440947|101107574|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
33331522|NCT00440947|101107575|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
33331523|NCT00440947|101107576|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
33331524|NCT00440947|101107577|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
33331525|NCT00440947|101107578|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
33331526|NCT00440947|101107574|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
33331527|NCT00440947|101107575|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
33331528|NCT00440947|101107576|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
33331529|NCT00440947|101107577|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
33331530|NCT00440947|101107578|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
33331531|NCT00440947|101107574|FG000|Optional 60-Week Extension Phase|Other|0|||
33331532|NCT00440947|101107575|FG001|Optional 60-Week Extension Phase|Other|0|||
33331533|NCT00440947|101107576|FG002|Optional 60-Week Extension Phase|Other|0|||
33525507|NCT00627926|101819912|FG001|Overall Study|Lack of Efficacy|40|||
33525508|NCT00627926|101819913|FG002|Overall Study|Lack of Efficacy|38|||
33525509|NCT00627926|101819911|FG000|Overall Study|Noncompliance/unspecified|8|||
33525510|NCT00627926|101819912|FG001|Overall Study|Noncompliance/unspecified|23|||
33525511|NCT00627926|101819913|FG002|Overall Study|Noncompliance/unspecified|17|||
33525512|NCT02383355|101819914|FG000|Overall Study|Adverse Event|2|||
33525513|NCT02383355|101819915|FG001|Overall Study|Adverse Event|0|||
33525514|NCT00316914|101819916|FG000|Overall Study|Withdrawal by Subject|5|||
33331534|NCT00440947|101107577|FG003|Optional 60-Week Extension Phase|Other|1|||
33331535|NCT00440947|101107578|FG004|Optional 60-Week Extension Phase|Other|0|||
33331536|NCT00440947|101107574|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
33331537|NCT00440947|101107575|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
33331538|NCT00440947|101107576|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
33331539|NCT00440947|101107577|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
33331540|NCT00440947|101107578|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
33331541|NCT00440947|101107574|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
33331542|NCT00440947|101107575|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
33525515|NCT00316914|101819917|FG001|Overall Study|Withdrawal by Subject|3|||
33525516|NCT00316914|101819916|FG000|Overall Study|Adverse Event|8|||
33525517|NCT00316914|101819917|FG001|Overall Study|Adverse Event|7|||
33525518|NCT00316914|101819916|FG000|Overall Study|Other Problems|6|||
33525519|NCT00316914|101819917|FG001|Overall Study|Other Problems|11|||
33525520|NCT00316914|101819916|FG000|Overall Study|Missing end of treatment documentation|14|||
33525521|NCT00316914|101819917|FG001|Overall Study|Missing end of treatment documentation|15|||
33525522|NCT01937884|101819918|FG000|Overall Study|Withdrawal by Subject|1|||
33525523|NCT01937884|101819919|FG001|Overall Study|Withdrawal by Subject|0|||
33525524|NCT01004432|101819920|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
33525525|NCT01004432|101819921|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
33525526|NCT01004432|101819922|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
33525527|NCT01004432|101819923|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
33525528|NCT01004432|101819924|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
33525529|NCT01004432|101819920|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
33525530|NCT01004432|101819921|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
33525531|NCT01004432|101819922|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
33525532|NCT01004432|101819923|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
33525533|NCT01004432|101819924|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
33525534|NCT01004432|101819920|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
33525535|NCT01004432|101819921|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
33525536|NCT01004432|101819922|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
33525537|NCT01004432|101819923|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
33525538|NCT01004432|101819924|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
33525539|NCT01004432|101819920|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
33525540|NCT01004432|101819921|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
33525541|NCT01004432|101819922|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
33525542|NCT01004432|101819923|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
33525543|NCT01004432|101819924|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
33525544|NCT01004432|101819920|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
33525545|NCT01004432|101819921|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
33331543|NCT00440947|101107576|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
33525546|NCT01004432|101819922|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
33525547|NCT01004432|101819923|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
33331544|NCT00440947|101107577|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
33331545|NCT00440947|101107578|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
33610191|NCT02834247|102123234|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
33331546|NCT01549002|101107579|FG000|Overall Study|Excessive pain|0|||
33331547|NCT01549002|101107580|FG001|Overall Study|Excessive pain|2|||
33331548|NCT01549002|101107579|FG000|Overall Study|Moderate sedation required|0|||
33331549|NCT01549002|101107580|FG001|Overall Study|Moderate sedation required|2|||
33331550|NCT02263079|101107583|FG000|Overall Study|Physician Decision|1|||
33331551|NCT02263079|101107584|FG001|Overall Study|Physician Decision|0|||
33331552|NCT02263079|101107585|FG002|Overall Study|Physician Decision|0|||
33331553|NCT02263079|101107583|FG000|Overall Study|Withdrawal by Subject|2|||
33331554|NCT02263079|101107584|FG001|Overall Study|Withdrawal by Subject|8|||
33331555|NCT02263079|101107585|FG002|Overall Study|Withdrawal by Subject|0|||
33331556|NCT00714285|101107586|FG000|Overall Study|Lost to Follow-up|0|||
33331557|NCT00714285|101107587|FG001|Overall Study|Lost to Follow-up|2|||
33331558|NCT00714285|101107588|FG002|Overall Study|Lost to Follow-up|0|||
33331559|NCT00714285|101107589|FG003|Overall Study|Lost to Follow-up|1|||
33331560|NCT00714285|101107586|FG000|Overall Study|Migrated/moved from study area|0|||
33331561|NCT00714285|101107587|FG001|Overall Study|Migrated/moved from study area|1|||
33331562|NCT00714285|101107588|FG002|Overall Study|Migrated/moved from study area|0|||
33331563|NCT00714285|101107589|FG003|Overall Study|Migrated/moved from study area|0|||
33331564|NCT01140451|101107590|FG000|Overall Study|Withdrawal by Subject|26|||
33331565|NCT01140451|101107591|FG001|Overall Study|Withdrawal by Subject|33|||
33331566|NCT01140451|101107590|FG000|Overall Study|Adverse Event|2|||
33331567|NCT01140451|101107591|FG001|Overall Study|Adverse Event|6|||
33331568|NCT01140451|101107590|FG000|Overall Study|Physician Decision|5|||
33331569|NCT01140451|101107591|FG001|Overall Study|Physician Decision|3|||
33331570|NCT01140451|101107590|FG000|Overall Study|Lost to Follow-up|2|||
33331571|NCT01140451|101107591|FG001|Overall Study|Lost to Follow-up|0|||
33331572|NCT01140451|101107590|FG000|Overall Study|Participants Planning Pregnancy|3|||
33331573|NCT01140451|101107591|FG001|Overall Study|Participants Planning Pregnancy|0|||
33331574|NCT02289742|101107595|FG000|First Wear Period|Adverse event prior to treatment|0|||
33331575|NCT02289742|101107596|FG001|First Wear Period|Adverse event prior to treatment|1|||
33331576|NCT02289742|101107597|FG002|First Wear Period|Adverse event prior to treatment|0|||
33331577|NCT02289742|101107598|FG003|First Wear Period|Adverse event prior to treatment|0|||
33331578|NCT02289742|101107595|FG000|First Wear Period|Adverse Event|0|||
33331579|NCT02289742|101107596|FG001|First Wear Period|Adverse Event|0|||
33331580|NCT02289742|101107597|FG002|First Wear Period|Adverse Event|1|||
33331581|NCT02289742|101107598|FG003|First Wear Period|Adverse Event|0|||
33331582|NCT02289742|101107595|FG000|First Wear Period|Other prior to treatment|0|||
33331583|NCT02289742|101107596|FG001|First Wear Period|Other prior to treatment|0|||
33331584|NCT02289742|101107597|FG002|First Wear Period|Other prior to treatment|0|||
33331585|NCT02289742|101107598|FG003|First Wear Period|Other prior to treatment|1|||
33331586|NCT02289742|101107595|FG000|Third Wear Period|Adverse Event|0|||
33331587|NCT02289742|101107596|FG001|Third Wear Period|Adverse Event|1|||
33331588|NCT02289742|101107597|FG002|Third Wear Period|Adverse Event|0|||
33331589|NCT02289742|101107598|FG003|Third Wear Period|Adverse Event|0|||
33331590|NCT02289742|101107595|FG000|Third Wear Period|Reason not given|0|||
33331591|NCT02289742|101107596|FG001|Third Wear Period|Reason not given|0|||
33331592|NCT02289742|101107597|FG002|Third Wear Period|Reason not given|0|||
33331593|NCT02289742|101107598|FG003|Third Wear Period|Reason not given|1|||
33331594|NCT03024970|101107599|FG000|First Intervention|Adverse Event|1|||
33331595|NCT03024970|101107600|FG001|First Intervention|Adverse Event|0|||
33331596|NCT03024970|101107599|FG000|Second Intervention|Lost to Follow-up|1|||
33331597|NCT03024970|101107600|FG001|Second Intervention|Lost to Follow-up|0|||
33331598|NCT00562354|101107603|FG000|Overall Study|Physician Decision|0|||
33331599|NCT00562354|101107604|FG001|Overall Study|Physician Decision|1|||
33331600|NCT00562354|101107603|FG000|Overall Study|Lost to Follow-up|0|||
33331601|NCT00562354|101107604|FG001|Overall Study|Lost to Follow-up|1|||
33331602|NCT01265797|101107610|FG000|Run-in Month|Withdrawal by Subject|0|||
33610192|NCT02834247|102123235|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
33610193|NCT02834247|102123236|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
33610194|NCT02834247|102123233|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
33610195|NCT02834247|102123234|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
33610196|NCT02834247|102123235|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
33610197|NCT02834247|102123236|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
33331603|NCT01265797|101107611|FG001|Run-in Month|Withdrawal by Subject|4|||
33610198|NCT02834247|102123233|FG000|Dose Expansion Phase|Death|0|||
33331604|NCT01265797|101107610|FG000|Run-in Month|1st seizure during run-in month|0|||
33331605|NCT01265797|101107611|FG001|Run-in Month|1st seizure during run-in month|1|||
33331606|NCT01265797|101107610|FG000|Blinded Month|Lack of Efficacy|5|||
33331607|NCT01265797|101107611|FG001|Blinded Month|Lack of Efficacy|0|||
33331608|NCT01265797|101107610|FG000|Blinded Month|Lost to Follow-up|1|||
33331609|NCT01265797|101107611|FG001|Blinded Month|Lost to Follow-up|0|||
33610199|NCT02834247|102123234|FG001|Dose Expansion Phase|Death|0|||
33610200|NCT02834247|102123235|FG002|Dose Expansion Phase|Death|0|||
33202713|NCT01762761|100642927|FG000|Overall Study|Physician Decision|4|||
33331610|NCT01265797|101107610|FG000|Blinded Month|Protocol Violation|2|||
33331611|NCT01265797|101107611|FG001|Blinded Month|Protocol Violation|1|||
33331612|NCT01265797|101107610|FG000|Blinded Month|Adverse Event|2|||
33331613|NCT01265797|101107611|FG001|Blinded Month|Adverse Event|0|||
33331614|NCT01265797|101107610|FG000|Blinded Month|Diary data incomplete|0|||
33331615|NCT01265797|101107611|FG001|Blinded Month|Diary data incomplete|1|||
33331616|NCT01265797|101107610|FG000|Open Label Month|Lost to Follow-up|0|||
33331617|NCT01265797|101107611|FG001|Open Label Month|Lost to Follow-up|1|||
33331618|NCT03882970|101107612|FG000|Overall Study|Adverse Event|5|||
33331619|NCT03882970|101107613|FG001|Overall Study|Adverse Event|7|||
33331620|NCT03882970|101107614|FG002|Overall Study|Adverse Event|3|||
33331621|NCT03882970|101107615|FG003|Overall Study|Adverse Event|1|||
33331622|NCT03882970|101107612|FG000|Overall Study|Death|1|||
33331623|NCT03882970|101107613|FG001|Overall Study|Death|2|||
33331624|NCT03882970|101107614|FG002|Overall Study|Death|1|||
33331625|NCT03882970|101107615|FG003|Overall Study|Death|1|||
33331626|NCT03882970|101107612|FG000|Overall Study|Lost to Follow-up|8|||
33331627|NCT03882970|101107613|FG001|Overall Study|Lost to Follow-up|9|||
33331628|NCT03882970|101107614|FG002|Overall Study|Lost to Follow-up|5|||
33331629|NCT03882970|101107615|FG003|Overall Study|Lost to Follow-up|5|||
33331630|NCT03882970|101107612|FG000|Overall Study|Physician Decision|0|||
33331631|NCT03882970|101107613|FG001|Overall Study|Physician Decision|2|||
33331632|NCT03882970|101107614|FG002|Overall Study|Physician Decision|2|||
33331633|NCT03882970|101107615|FG003|Overall Study|Physician Decision|2|||
33331634|NCT03882970|101107612|FG000|Overall Study|Protocol Violation|2|||
33331635|NCT03882970|101107613|FG001|Overall Study|Protocol Violation|0|||
33331636|NCT03882970|101107614|FG002|Overall Study|Protocol Violation|0|||
33331637|NCT03882970|101107615|FG003|Overall Study|Protocol Violation|0|||
33331638|NCT03882970|101107612|FG000|Overall Study|Withdrawal by Subject|8|||
33331639|NCT03882970|101107613|FG001|Overall Study|Withdrawal by Subject|17|||
33331640|NCT03882970|101107614|FG002|Overall Study|Withdrawal by Subject|7|||
33331641|NCT03882970|101107615|FG003|Overall Study|Withdrawal by Subject|22|||
33331642|NCT03882970|101107612|FG000|Overall Study|Personal Reason|2|||
33331643|NCT03882970|101107613|FG001|Overall Study|Personal Reason|3|||
33331644|NCT03882970|101107614|FG002|Overall Study|Personal Reason|1|||
33331645|NCT03882970|101107615|FG003|Overall Study|Personal Reason|3|||
33331646|NCT02554019|101107622|FG000|Overall Study|Withdrawal by Subject|1|||
33331647|NCT02554019|101107623|FG001|Overall Study|Withdrawal by Subject|0|||
33331648|NCT02554019|101107624|FG002|Overall Study|Withdrawal by Subject|2|||
33331649|NCT02554019|101107622|FG000|Overall Study|Adverse Event|1|||
33331650|NCT02554019|101107623|FG001|Overall Study|Adverse Event|0|||
33331651|NCT02554019|101107624|FG002|Overall Study|Adverse Event|0|||
33331652|NCT01848288|101107625|FG000|Overall Study|Death|1|||
33331653|NCT01848288|101107625|FG000|Overall Study|Protocol Violation|1|||
33331654|NCT01848288|101107625|FG000|Overall Study|Withdrawal by Subject|1|||
33331655|NCT00606320|101107627|FG000|Overall Study|Adverse Event|3|||
33331656|NCT00606320|101107627|FG000|Overall Study|Lack of Efficacy|5|||
33331657|NCT00606320|101107627|FG000|Overall Study|Physician Decision|7|||
33610201|NCT02834247|102123236|FG003|Dose Expansion Phase|Death|8|||
33610202|NCT02834247|102123233|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
33610203|NCT02834247|102123234|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
33610204|NCT02834247|102123235|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
33610205|NCT02834247|102123236|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
33202714|NCT01762761|100642928|FG001|Overall Study|Physician Decision|6|||
33331658|NCT00606320|101107627|FG000|Overall Study|Protocol Violation|8|||
33331659|NCT00606320|101107627|FG000|Overall Study|Withdrawal by Subject|10|||
33331660|NCT00606320|101107627|FG000|Overall Study|Progression to depressive phase|4|||
33331661|NCT00761514|101107640|FG000|Overall Study|Adverse Event|1|||
33331662|NCT00761514|101107640|FG000|Overall Study|Withdrawal by Subject|2|||
33331663|NCT00761514|101107640|FG000|Overall Study|Lost to Follow-up|1|||
33331664|NCT00761514|101107640|FG000|Overall Study|Health insurance didn't cover study drug|1|||
33331665|NCT00761514|101107640|FG000|Overall Study|Problem complying with study visit|1|||
33331666|NCT00761514|101107640|FG000|Overall Study|Unable to pay for medications|1|||
33331667|NCT05054114|101107647|FG000|Overall Study|Protocol Violation|13|||
33331668|NCT05054114|101107648|FG001|Overall Study|Protocol Violation|1|||
33331669|NCT05054114|101107647|FG000|Overall Study|Pregnancy|0|||
33331670|NCT05054114|101107648|FG001|Overall Study|Pregnancy|1|||
33331671|NCT00677014|101107656|FG000|Overall Study|Lost to Follow-up|20|||
33331672|NCT00677014|101107657|FG001|Overall Study|Lost to Follow-up|12|||
33525548|NCT01004432|101819924|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
33610206|NCT02834247|102123233|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
33610207|NCT02834247|102123234|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
33331673|NCT00677014|101107658|FG002|Overall Study|Lost to Follow-up|24|||
33331674|NCT00677014|101107656|FG000|Overall Study|Death|6|||
33331675|NCT00677014|101107657|FG001|Overall Study|Death|15|||
33331676|NCT00677014|101107658|FG002|Overall Study|Death|7|||
33331677|NCT00677014|101107656|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
33331678|NCT00677014|101107657|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
33610208|NCT02834247|102123235|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
33331679|NCT00677014|101107658|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
33331680|NCT01692275|101107661|FG000|Overall Study|Lost to Follow-up|57|||
33331681|NCT01692275|101107662|FG001|Overall Study|Lost to Follow-up|48|||
33331682|NCT01692275|101107661|FG000|Overall Study|Withdrawal by Subject|9|||
33331683|NCT01692275|101107662|FG001|Overall Study|Withdrawal by Subject|11|||
33331684|NCT04419610|101107667|FG000|Overall Study|Withdrawal by Subject|3|||
33331685|NCT04419610|101107668|FG001|Overall Study|Withdrawal by Subject|1|||
33331686|NCT04419610|101107667|FG000|Overall Study|Adverse Event|1|||
33331687|NCT04419610|101107668|FG001|Overall Study|Adverse Event|0|||
33331688|NCT04419610|101107667|FG000|Overall Study|discharged early|1|||
33331689|NCT04419610|101107668|FG001|Overall Study|discharged early|1|||
33331690|NCT01294579|101107669|FG000|Overall Study|Disease progression|12|||
33331691|NCT01294579|101107669|FG000|Overall Study|Adverse Event|11|||
33331692|NCT01294579|101107669|FG000|Overall Study|Study closed/terminated|3|||
33331693|NCT01294579|101107669|FG000|Overall Study|Lost to Follow-up|1|||
33331694|NCT01294579|101107669|FG000|Overall Study|Physician Decision|3|||
33331695|NCT01294579|101107669|FG000|Overall Study|Withdrawal by Subject|5|||
33525549|NCT01004432|101819920|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
33525550|NCT01004432|101819921|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
33525551|NCT01004432|101819922|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
33525552|NCT01004432|101819923|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
33525553|NCT01004432|101819924|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
33525554|NCT01004432|101819920|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
33525555|NCT01004432|101819921|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
33525556|NCT01004432|101819922|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
33525557|NCT01004432|101819923|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
33525558|NCT01004432|101819924|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
33525559|NCT01004432|101819920|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
33525560|NCT01004432|101819921|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
33525561|NCT01004432|101819922|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
33525562|NCT01004432|101819923|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
33525563|NCT01004432|101819924|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
33525564|NCT01004432|101819920|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
33525565|NCT01004432|101819921|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
33525566|NCT01004432|101819922|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
33525567|NCT01004432|101819923|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
33525568|NCT01004432|101819924|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
33525569|NCT01004432|101819920|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
33525570|NCT01004432|101819921|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
33525571|NCT01004432|101819922|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
33525572|NCT01004432|101819923|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
33525573|NCT01004432|101819924|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
33525574|NCT01004432|101819920|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
33525575|NCT01004432|101819921|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
33525576|NCT01004432|101819922|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
33525577|NCT01004432|101819923|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
33525578|NCT01004432|101819924|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
33525579|NCT01004432|101819920|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
33525580|NCT01004432|101819921|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
33525581|NCT01004432|101819922|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
33525582|NCT01004432|101819923|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
33525583|NCT01004432|101819924|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
33525584|NCT01004432|101819920|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
33525585|NCT01004432|101819921|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
33525586|NCT01004432|101819922|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
33525587|NCT01004432|101819923|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
33525588|NCT01004432|101819924|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
33525589|NCT01004432|101819920|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
33525590|NCT01004432|101819921|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
33525591|NCT01004432|101819922|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
33525592|NCT01004432|101819923|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
33525593|NCT01004432|101819924|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
33331696|NCT00950664|101107676|FG000|First Intervention|Lost to Follow-up|1|||
33331697|NCT00950664|101107677|FG001|First Intervention|Lost to Follow-up|3|||
33331698|NCT00950664|101107676|FG000|First Intervention|Withdrawal by Subject|2|||
33331699|NCT00950664|101107677|FG001|First Intervention|Withdrawal by Subject|2|||
33331700|NCT02184195|101107678|FG000|Overall Study|Patient decision|5|||
33331701|NCT02184195|101107679|FG001|Overall Study|Patient decision|2|||
33331702|NCT02184195|101107678|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33202715|NCT01762761|100642927|FG000|Overall Study|Withdrawal by Subject|7|||
33202716|NCT01762761|100642928|FG001|Overall Study|Withdrawal by Subject|8|||
33202717|NCT04726709|100642929|FG000|Overall Study|Withdrawal by Subject|2|||
33202718|NCT04726709|100642930|FG001|Overall Study|Withdrawal by Subject|2|||
33202719|NCT03349710|100645712|FG000|Treatment Period|Death|0|||
33202720|NCT03349710|100645713|FG001|Treatment Period|Death|0|||
33202721|NCT03349710|100645714|FG002|Treatment Period|Death|1|||
33202722|NCT03349710|100645715|FG003|Treatment Period|Death|0|||
33202723|NCT03349710|100645712|FG000|Treatment Period|Disease Progression|0|||
33202724|NCT03349710|100645713|FG001|Treatment Period|Disease Progression|2|||
33202725|NCT03349710|100645714|FG002|Treatment Period|Disease Progression|0|||
33202726|NCT03349710|100645715|FG003|Treatment Period|Disease Progression|1|||
33202727|NCT03349710|100645712|FG000|Treatment Period|Study Drug Toxicity|1|||
33202728|NCT03349710|100645713|FG001|Treatment Period|Study Drug Toxicity|0|||
33202729|NCT03349710|100645714|FG002|Treatment Period|Study Drug Toxicity|1|||
33202730|NCT03349710|100645715|FG003|Treatment Period|Study Drug Toxicity|1|||
33331703|NCT02184195|101107679|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33331704|NCT02184195|101107678|FG000|Overall Study|Death|67|||
33331705|NCT02184195|101107679|FG001|Overall Study|Death|44|||
33331706|NCT02184195|101107678|FG000|Overall Study|Lost to Follow-up|1|||
33331707|NCT02184195|101107679|FG001|Overall Study|Lost to Follow-up|5|||
33331708|NCT02184195|101107678|FG000|Overall Study|Other|0|||
33331709|NCT02184195|101107679|FG001|Overall Study|Other|3|||
33331710|NCT01390272|101107680|FG000|Overall Study|Death|3|||
33331711|NCT01390272|101107681|FG001|Overall Study|Death|2|||
33331712|NCT01390272|101107680|FG000|Overall Study|Withdrawal by Subject|9|||
33331713|NCT01390272|101107681|FG001|Overall Study|Withdrawal by Subject|5|||
33331714|NCT01390272|101107680|FG000|Overall Study|Patient moved, no longer eligible|5|||
33331715|NCT01390272|101107681|FG001|Overall Study|Patient moved, no longer eligible|8|||
33331716|NCT03803059|101107682|FG000|Overall Study|Protocol Violation|2|||
33331717|NCT03803059|101107682|FG000|Overall Study|Lost to Follow-up|1|||
33402433|NCT01385098|101361803|FG000|Overall Study|Lost to Follow-up|4|||
33402434|NCT01513460|101361810|FG000|Overall Study|Death|0|||
33402435|NCT01513460|101361811|FG001|Overall Study|Death|0|||
33402436|NCT01513460|101361812|FG002|Overall Study|Death|1|||
33402437|NCT01513460|101361810|FG000|Overall Study|Lost to Follow-up|0|||
33402438|NCT01513460|101361811|FG001|Overall Study|Lost to Follow-up|0|||
33402439|NCT01513460|101361812|FG002|Overall Study|Lost to Follow-up|2|||
33402440|NCT01513460|101361810|FG000|Overall Study|Abnormal laboratory value|1|||
33402441|NCT01513460|101361811|FG001|Overall Study|Abnormal laboratory value|0|||
33402442|NCT01513460|101361812|FG002|Overall Study|Abnormal laboratory value|1|||
33402443|NCT01513460|101361810|FG000|Overall Study|Lack of Efficacy|1|||
33402444|NCT01513460|101361811|FG001|Overall Study|Lack of Efficacy|2|||
33402445|NCT01513460|101361812|FG002|Overall Study|Lack of Efficacy|5|||
33525594|NCT01004432|101819920|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
33525595|NCT01004432|101819921|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
33525596|NCT01004432|101819922|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
33525597|NCT01004432|101819923|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
33525598|NCT01004432|101819924|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
33202731|NCT03349710|100645712|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
33202732|NCT03349710|100645713|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
33202733|NCT03349710|100645714|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
33202734|NCT03349710|100645715|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
33202735|NCT03349710|100645712|FG000|Treatment Period|admin reason by sponsor|0|||
33525599|NCT00624832|101819925|FG000|Overall Study|Adverse Event|0|||
33525600|NCT00624832|101819926|FG001|Overall Study|Adverse Event|1|||
33525601|NCT00624832|101819927|FG002|Overall Study|Adverse Event|0|||
33525602|NCT00624832|101819928|FG003|Overall Study|Adverse Event|1|||
33525603|NCT00624832|101819925|FG000|Overall Study|Abnormal Laboratory Value|2|||
33525604|NCT00624832|101819926|FG001|Overall Study|Abnormal Laboratory Value|0|||
33525605|NCT00624832|101819927|FG002|Overall Study|Abnormal Laboratory Value|0|||
33525606|NCT00624832|101819928|FG003|Overall Study|Abnormal Laboratory Value|0|||
33525607|NCT04348500|101819931|FG000|Overall Study|Death|2|||
33525608|NCT04348500|101819932|FG001|Overall Study|Death|2|||
33525609|NCT04348500|101819931|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
33525610|NCT04348500|101819932|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
33202736|NCT03349710|100645713|FG001|Treatment Period|admin reason by sponsor|7|||
33202737|NCT03349710|100645714|FG002|Treatment Period|admin reason by sponsor|0|||
33331718|NCT00807742|101107683|FG000|Overall Study|Death|9|||
33331719|NCT00807742|101107684|FG001|Overall Study|Death|2|||
33331720|NCT00807742|101107683|FG000|Overall Study|Withdrawal by Subject|2|||
33331721|NCT00807742|101107684|FG001|Overall Study|Withdrawal by Subject|1|||
33202738|NCT03349710|100645715|FG003|Treatment Period|admin reason by sponsor|19|||
33202739|NCT03349710|100645712|FG000|Treatment Period|Other Reason|2|||
33331722|NCT00807742|101107683|FG000|Overall Study|Lost to Follow-up|35|||
33402446|NCT01513460|101361810|FG000|Overall Study|Protocol deviations|3|||
33402447|NCT01513460|101361811|FG001|Overall Study|Protocol deviations|4|||
33402448|NCT01513460|101361812|FG002|Overall Study|Protocol deviations|3|||
33402449|NCT01513460|101361810|FG000|Overall Study|Withdrawal by Subject|7|||
33402450|NCT01513460|101361811|FG001|Overall Study|Withdrawal by Subject|8|||
33402451|NCT01513460|101361812|FG002|Overall Study|Withdrawal by Subject|21|||
33402452|NCT01513460|101361810|FG000|Overall Study|Adverse Event|16|||
33402453|NCT01513460|101361811|FG001|Overall Study|Adverse Event|18|||
33402454|NCT01513460|101361812|FG002|Overall Study|Adverse Event|23|||
33402455|NCT01513460|101361810|FG000|Overall Study|Abnormal test procedure|1|||
33402456|NCT01513460|101361811|FG001|Overall Study|Abnormal test procedure|0|||
33402457|NCT01513460|101361812|FG002|Overall Study|Abnormal test procedure|0|||
33402458|NCT00283062|101361813|FG000|Overall Study|Did not receive any study medication|5|||
33402459|NCT00283062|101361814|FG001|Overall Study|Did not receive any study medication|4|||
33402460|NCT00283062|101361815|FG002|Overall Study|Did not receive any study medication|36|||
33402461|NCT00283062|101361816|FG003|Overall Study|Did not receive any study medication|45|||
33402462|NCT00283062|101361813|FG000|Overall Study|Adverse Event|2|||
33402463|NCT00283062|101361814|FG001|Overall Study|Adverse Event|0|||
33402464|NCT00283062|101361815|FG002|Overall Study|Adverse Event|1|||
33402465|NCT00283062|101361816|FG003|Overall Study|Adverse Event|0|||
33402466|NCT00283062|101361813|FG000|Overall Study|Lost to Follow-up|1|||
33402467|NCT00283062|101361814|FG001|Overall Study|Lost to Follow-up|0|||
33402468|NCT00283062|101361815|FG002|Overall Study|Lost to Follow-up|1|||
33402469|NCT00283062|101361816|FG003|Overall Study|Lost to Follow-up|0|||
33402470|NCT00283062|101361813|FG000|Overall Study|Progressive disease|0|||
33402471|NCT00283062|101361814|FG001|Overall Study|Progressive disease|0|||
33402472|NCT00283062|101361815|FG002|Overall Study|Progressive disease|1|||
33610209|NCT02834247|102123236|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
33610210|NCT04079114|102123237|FG000|Overall Study|Study prematuely terminated.|166|||
33610211|NCT01868477|102123238|FG000|Overall Study|Adverse Event|2|||
33610212|NCT01868477|102123239|FG001|Overall Study|Adverse Event|4|||
33610213|NCT01868477|102123238|FG000|Overall Study|Disease progression|1|||
33610214|NCT01868477|102123239|FG001|Overall Study|Disease progression|1|||
33610215|NCT01868477|102123238|FG000|Overall Study|Withdrawal by Subject|1|||
33610216|NCT01868477|102123239|FG001|Overall Study|Withdrawal by Subject|0|||
33610217|NCT02868229|102123240|FG000|Overall Study|Adverse Event|1|||
33610218|NCT02868229|102123241|FG001|Overall Study|Adverse Event|0|||
33610219|NCT02868229|102123242|FG002|Overall Study|Adverse Event|0|||
33331723|NCT00807742|101107684|FG001|Overall Study|Lost to Follow-up|51|||
33331724|NCT00964743|101107685|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
33331725|NCT02124564|101107688|FG000|Treatment Period|Adverse Event|2|||
33331726|NCT02124564|101107688|FG000|Treatment Period|Lack of Efficacy|3|||
33331727|NCT02124564|101107688|FG000|Treatment Period|Withdrawal by Subject|2|||
33331728|NCT03332498|101107690|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
33331729|NCT03332498|101107691|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
33331730|NCT03332498|101107692|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
33331731|NCT04179734|101107693|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
33331732|NCT04179734|101107694|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
33331733|NCT04179734|101107693|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
33331734|NCT04179734|101107694|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
33331735|NCT03703102|101107696|FG000|Overall Study|Adverse Event|4|||
33331736|NCT03703102|101107697|FG001|Overall Study|Adverse Event|3|||
33331737|NCT03703102|101107698|FG002|Overall Study|Adverse Event|7|||
33331738|NCT03703102|101107699|FG003|Overall Study|Adverse Event|3|||
33331739|NCT03703102|101107700|FG004|Overall Study|Adverse Event|13|||
33331740|NCT03703102|101107696|FG000|Overall Study|Lack of Efficacy|4|||
33331741|NCT03703102|101107697|FG001|Overall Study|Lack of Efficacy|0|||
33331742|NCT03703102|101107698|FG002|Overall Study|Lack of Efficacy|1|||
33331743|NCT03703102|101107699|FG003|Overall Study|Lack of Efficacy|4|||
33331744|NCT03703102|101107700|FG004|Overall Study|Lack of Efficacy|1|||
33331745|NCT03703102|101107696|FG000|Overall Study|Lost to Follow-up|0|||
33331746|NCT03703102|101107697|FG001|Overall Study|Lost to Follow-up|0|||
33610220|NCT02868229|102123243|FG003|Overall Study|Adverse Event|1|||
33610221|NCT02868229|102123240|FG000|Overall Study|Death|0|||
33610222|NCT02868229|102123241|FG001|Overall Study|Death|0|||
33610223|NCT02868229|102123242|FG002|Overall Study|Death|1|||
33331747|NCT03703102|101107698|FG002|Overall Study|Lost to Follow-up|1|||
33331748|NCT03703102|101107699|FG003|Overall Study|Lost to Follow-up|2|||
33402473|NCT00283062|101361816|FG003|Overall Study|Progressive disease|0|||
33402474|NCT00283062|101361813|FG000|Overall Study|Participant did not wish to continue|3|||
33402475|NCT00283062|101361814|FG001|Overall Study|Participant did not wish to continue|2|||
33610224|NCT02868229|102123243|FG003|Overall Study|Death|1|||
33610225|NCT02868229|102123240|FG000|Overall Study|Missed dose|0|||
33331749|NCT03703102|101107700|FG004|Overall Study|Lost to Follow-up|2|||
33402476|NCT00283062|101361815|FG002|Overall Study|Participant did not wish to continue|1|||
33402477|NCT00283062|101361816|FG003|Overall Study|Participant did not wish to continue|0|||
33610226|NCT02868229|102123241|FG001|Overall Study|Missed dose|0|||
33610227|NCT02868229|102123242|FG002|Overall Study|Missed dose|0|||
33331750|NCT03703102|101107696|FG000|Overall Study|Physician Decision|2|||
33331751|NCT03703102|101107697|FG001|Overall Study|Physician Decision|2|||
33331752|NCT03703102|101107698|FG002|Overall Study|Physician Decision|2|||
33331753|NCT03703102|101107699|FG003|Overall Study|Physician Decision|2|||
33331754|NCT03703102|101107700|FG004|Overall Study|Physician Decision|4|||
33331755|NCT03703102|101107696|FG000|Overall Study|Withdrawal by Subject|7|||
33331756|NCT03703102|101107697|FG001|Overall Study|Withdrawal by Subject|5|||
33331757|NCT03703102|101107698|FG002|Overall Study|Withdrawal by Subject|5|||
33331758|NCT03703102|101107699|FG003|Overall Study|Withdrawal by Subject|5|||
33331759|NCT03703102|101107700|FG004|Overall Study|Withdrawal by Subject|9|||
33331760|NCT03703102|101107696|FG000|Overall Study|Ineligibility|0|||
33331761|NCT03703102|101107697|FG001|Overall Study|Ineligibility|0|||
33525611|NCT02065518|101819937|FG000|Overall Study|Lost to Follow-up|3|||
33610228|NCT02868229|102123243|FG003|Overall Study|Missed dose|3|||
33610229|NCT01298765|102123244|FG000|Titration Period|Adverse Event|26|||
33610230|NCT01298765|102123244|FG000|Titration Period|Death|1|||
33525612|NCT02065518|101819938|FG001|Overall Study|Lost to Follow-up|4|||
33525613|NCT02065518|101819939|FG002|Overall Study|Lost to Follow-up|0|||
33525614|NCT02065518|101819940|FG003|Overall Study|Lost to Follow-up|3|||
33525615|NCT02065518|101819937|FG000|Overall Study|Withdrawal by Subject|3|||
33525616|NCT02065518|101819938|FG001|Overall Study|Withdrawal by Subject|4|||
33525617|NCT02065518|101819939|FG002|Overall Study|Withdrawal by Subject|9|||
33525618|NCT02065518|101819940|FG003|Overall Study|Withdrawal by Subject|2|||
33525619|NCT05459558|101819941|FG000|Overall Study|Adverse Event|1|||
33525620|NCT05459558|101819942|FG001|Overall Study|Adverse Event|0|||
33525621|NCT05459558|101819943|FG002|Overall Study|Adverse Event|0|||
33525622|NCT05459558|101819941|FG000|Overall Study|Scheduling issue|0|||
33525623|NCT05459558|101819942|FG001|Overall Study|Scheduling issue|1|||
33525624|NCT05459558|101819943|FG002|Overall Study|Scheduling issue|3|||
33525625|NCT05459558|101819941|FG000|Overall Study|Withdrawal by Subject|0|||
33525626|NCT05459558|101819942|FG001|Overall Study|Withdrawal by Subject|0|||
33525627|NCT05459558|101819943|FG002|Overall Study|Withdrawal by Subject|2|||
33525628|NCT01687283|101819944|FG000|Overall Study|Adverse Event|11|||
33525629|NCT01687283|101819945|FG001|Overall Study|Adverse Event|4|||
33525630|NCT01687283|101819944|FG000|Overall Study|Lack of Efficacy|3|||
33525631|NCT01687283|101819945|FG001|Overall Study|Lack of Efficacy|1|||
33525632|NCT01687283|101819944|FG000|Overall Study|Protocol Violation|1|||
33525633|NCT01687283|101819945|FG001|Overall Study|Protocol Violation|3|||
33525634|NCT01687283|101819944|FG000|Overall Study|protocol defined stopping criteria|8|||
33525635|NCT01687283|101819945|FG001|Overall Study|protocol defined stopping criteria|10|||
33525636|NCT01687283|101819944|FG000|Overall Study|Lost to Follow-up|1|||
33525637|NCT01687283|101819945|FG001|Overall Study|Lost to Follow-up|1|||
33525638|NCT01687283|101819944|FG000|Overall Study|Investigator discretion|2|||
33525639|NCT01687283|101819945|FG001|Overall Study|Investigator discretion|0|||
33525640|NCT01687283|101819944|FG000|Overall Study|Withdrawal by Subject|9|||
33525641|NCT01687283|101819945|FG001|Overall Study|Withdrawal by Subject|8|||
33525642|NCT02626000|101819946|FG000|Overall Study|Decision by Sponsor|1|||
33525643|NCT02626000|101819946|FG000|Overall Study|Death|29|||
33525644|NCT03060291|101819947|FG000|3-month Follow-up|Declined to respond|8|||
33525645|NCT03060291|101819948|FG001|3-month Follow-up|Declined to respond|10|||
33525646|NCT03060291|101819949|FG002|3-month Follow-up|Declined to respond|2|||
33525647|NCT03060291|101819947|FG000|6-month Follow-up|Declined to respond|7|||
33525648|NCT03060291|101819948|FG001|6-month Follow-up|Declined to respond|13|||
33525649|NCT03060291|101819949|FG002|6-month Follow-up|Declined to respond|4|||
33525650|NCT03060291|101819947|FG000|12-month Follow-up|Declined to respond|7|||
33525651|NCT03060291|101819948|FG001|12-month Follow-up|Declined to respond|16|||
33525652|NCT03060291|101819949|FG002|12-month Follow-up|Declined to respond|6|||
33525653|NCT02112877|101819950|FG000|Overall Study|Withdrawal by Subject|1|||
33525654|NCT02112877|101819951|FG001|Overall Study|Withdrawal by Subject|7|||
33525655|NCT02112877|101819950|FG000|Overall Study|Visit Missed|1|||
33525656|NCT02112877|101819951|FG001|Overall Study|Visit Missed|6|||
33525657|NCT01215435|101819952|FG000|Overall Study|Adverse Event|1|||
33525658|NCT01215435|101819953|FG001|Overall Study|Adverse Event|0|||
33525659|NCT01215435|101819952|FG000|Overall Study|Protocol Violation|2|||
33610231|NCT01298765|102123244|FG000|Titration Period|Lack of Efficacy|21|||
33610232|NCT01298765|102123244|FG000|Titration Period|Lost to Follow-up|9|||
33525660|NCT01215435|101819953|FG001|Overall Study|Protocol Violation|0|||
33525661|NCT01215435|101819952|FG000|Overall Study|Withdrawal Criteria|8|||
33525662|NCT01215435|101819953|FG001|Overall Study|Withdrawal Criteria|11|||
33525663|NCT01215435|101819952|FG000|Overall Study|Lost to Follow-up|3|||
33610233|NCT01298765|102123244|FG000|Titration Period|Physician Decision|1|||
33202740|NCT03349710|100645713|FG001|Treatment Period|Other Reason|0|||
33525664|NCT01215435|101819953|FG001|Overall Study|Lost to Follow-up|0|||
33331762|NCT03703102|101107698|FG002|Overall Study|Ineligibility|1|||
33331763|NCT03703102|101107699|FG003|Overall Study|Ineligibility|0|||
33525665|NCT01215435|101819952|FG000|Overall Study|Unclassified|5|||
33525666|NCT01215435|101819953|FG001|Overall Study|Unclassified|5|||
33610234|NCT01298765|102123244|FG000|Titration Period|Withdrawal by Subject|10|||
33402478|NCT00283062|101361813|FG000|Overall Study|Undefined|0|||
33402479|NCT00283062|101361814|FG001|Overall Study|Undefined|1|||
33402480|NCT00283062|101361815|FG002|Overall Study|Undefined|1|||
33402481|NCT00283062|101361816|FG003|Overall Study|Undefined|4|||
33402482|NCT00283062|101361813|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
33402483|NCT00283062|101361814|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
33402484|NCT00283062|101361815|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
33402485|NCT00283062|101361816|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
33402486|NCT01482598|101361821|FG000|Overall Study|Death|7|||
33402487|NCT01482598|101361822|FG001|Overall Study|Death|10|||
33402488|NCT01482598|101361821|FG000|Overall Study|Physician Decision|0|||
33402489|NCT01482598|101361822|FG001|Overall Study|Physician Decision|3|||
33402490|NCT01482598|101361821|FG000|Overall Study|Withdrawal by Subject|4|||
33402491|NCT01482598|101361822|FG001|Overall Study|Withdrawal by Subject|5|||
33402492|NCT01482598|101361821|FG000|Overall Study|Lost to Follow-up|5|||
33402493|NCT01482598|101361822|FG001|Overall Study|Lost to Follow-up|4|||
33402494|NCT04097925|101361823|FG000|Overall Study|Withdrawal by Subject|1|||
33402495|NCT01488994|101361824|FG000|Overall Study|Withdrawal by Subject|0|||
33525667|NCT03148067|101819955|FG000|Overall Study|Lost to Follow-up|3|||
33525668|NCT03148067|101819955|FG000|Overall Study|Death|1|||
33525669|NCT01548768|101819956|FG000|Overall Study|Withdrawal by Subject|0|||
33525670|NCT01548768|101819957|FG001|Overall Study|Withdrawal by Subject|2|||
33525671|NCT01548768|101819958|FG002|Overall Study|Withdrawal by Subject|1|||
33525672|NCT01548768|101819959|FG003|Overall Study|Withdrawal by Subject|0|||
33525673|NCT01548768|101819956|FG000|Overall Study|Physician Decision|1|||
33331764|NCT03703102|101107700|FG004|Overall Study|Ineligibility|0|||
33331765|NCT03703102|101107696|FG000|Overall Study|Protocol Deviation|4|||
33331766|NCT03703102|101107697|FG001|Overall Study|Protocol Deviation|4|||
33331767|NCT03703102|101107698|FG002|Overall Study|Protocol Deviation|3|||
33331768|NCT03703102|101107699|FG003|Overall Study|Protocol Deviation|0|||
33331769|NCT03703102|101107700|FG004|Overall Study|Protocol Deviation|0|||
33331770|NCT03703102|101107696|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33331771|NCT03703102|101107697|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33331772|NCT03703102|101107698|FG002|Overall Study|Non-Compliance with Study Drug|2|||
33331773|NCT03703102|101107699|FG003|Overall Study|Non-Compliance with Study Drug|1|||
33331774|NCT03703102|101107700|FG004|Overall Study|Non-Compliance with Study Drug|4|||
33402496|NCT01488994|101361825|FG001|Overall Study|Withdrawal by Subject|1|||
33402497|NCT03525613|101361826|FG000|Overall Study|Adverse Event|11|||
33402498|NCT03525613|101361827|FG001|Overall Study|Adverse Event|8|||
33525674|NCT01548768|101819957|FG001|Overall Study|Physician Decision|0|||
33525675|NCT01548768|101819958|FG002|Overall Study|Physician Decision|0|||
33525676|NCT01548768|101819959|FG003|Overall Study|Physician Decision|0|||
33525677|NCT01548768|101819956|FG000|Overall Study|Adverse Event|0|||
33525678|NCT01548768|101819957|FG001|Overall Study|Adverse Event|0|||
33525679|NCT01548768|101819958|FG002|Overall Study|Adverse Event|0|||
33525680|NCT01548768|101819959|FG003|Overall Study|Adverse Event|1|||
33525681|NCT01548768|101819956|FG000|Overall Study|Non-Compliance|0|||
33525682|NCT01548768|101819957|FG001|Overall Study|Non-Compliance|0|||
33525683|NCT01548768|101819958|FG002|Overall Study|Non-Compliance|0|||
33525684|NCT01548768|101819959|FG003|Overall Study|Non-Compliance|3|||
33525685|NCT03396822|101819960|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
33525686|NCT03396822|101819960|FG000|Overall Study|Physician Decision|1|||
33525687|NCT01386944|101819961|FG000|Overall Study|Adverse Event|26|||
33525688|NCT01386944|101819961|FG000|Overall Study|Lack of Efficacy|14|||
33525689|NCT01386944|101819961|FG000|Overall Study|Lost to Follow-up|8|||
33525690|NCT01386944|101819961|FG000|Overall Study|Unspecified reason|8|||
33525691|NCT04186221|101819962|FG000|Overall Study|Death|1|||
33525692|NCT00272844|101819964|FG000|Overall Study|Withdrawal by Subject|5|||
33525693|NCT00534105|101819965|FG000|Overall Study|Lost to Follow-up|23|||
33331775|NCT00514514|101107701|FG000|Pre-phase|Death|10|||
33402499|NCT03525613|101361828|FG002|Overall Study|Adverse Event|3|||
33402500|NCT03525613|101361829|FG003|Overall Study|Adverse Event|3|||
33525694|NCT00534105|101819966|FG001|Overall Study|Lost to Follow-up|39|||
33525695|NCT02937636|101819967|FG000|Overall Study|Other (Not specified)|3|||
33525696|NCT02937636|101819968|FG001|Overall Study|Other (Not specified)|2|||
33525697|NCT00741598|101819971|FG000|Overall Study|Lost to Follow-up|3|||
33525698|NCT00741598|101819972|FG001|Overall Study|Lost to Follow-up|4|||
33525699|NCT00741598|101819971|FG000|Overall Study|Lack of Efficacy|1|||
33525700|NCT00741598|101819972|FG001|Overall Study|Lack of Efficacy|2|||
33402501|NCT03525613|101361826|FG000|Overall Study|Lost to Follow-up|4|||
33402502|NCT03525613|101361827|FG001|Overall Study|Lost to Follow-up|5|||
33525701|NCT00741598|101819971|FG000|Overall Study|Physician Decision|1|||
33525702|NCT00741598|101819972|FG001|Overall Study|Physician Decision|1|||
33525703|NCT00741598|101819971|FG000|Overall Study|Pregnancy|1|||
33525704|NCT00741598|101819972|FG001|Overall Study|Pregnancy|0|||
33525705|NCT00741598|101819971|FG000|Overall Study|Withdrawal by Subject|3|||
33331776|NCT00514514|101107702|FG001|Pre-phase|Death|0|||
33331777|NCT00514514|101107703|FG002|Pre-phase|Death|0|||
33331778|NCT00514514|101107701|FG000|Pre-phase|administrative problems|2|||
33331779|NCT00514514|101107702|FG001|Pre-phase|administrative problems|0|||
33331780|NCT00514514|101107703|FG002|Pre-phase|administrative problems|0|||
33331781|NCT00514514|101107701|FG000|Pre-phase|Protocol Violation|6|||
33331782|NCT00514514|101107702|FG001|Pre-phase|Protocol Violation|0|||
33331783|NCT00514514|101107703|FG002|Pre-phase|Protocol Violation|0|||
33525706|NCT00741598|101819972|FG001|Overall Study|Withdrawal by Subject|2|||
33525707|NCT02688764|101819973|FG000|Overall Study|Adverse Event|3|||
33525708|NCT02688764|101819974|FG001|Overall Study|Adverse Event|3|||
33525709|NCT02688764|101819973|FG000|Overall Study|AE/Kidney transplant|1|||
33525710|NCT02688764|101819974|FG001|Overall Study|AE/Kidney transplant|0|||
33525711|NCT02688764|101819973|FG000|Overall Study|AE/Lack of efficacy|1|||
33525712|NCT02688764|101819974|FG001|Overall Study|AE/Lack of efficacy|0|||
33525713|NCT02688764|101819973|FG000|Overall Study|AE/Non-compl.|1|||
33525714|NCT02688764|101819974|FG001|Overall Study|AE/Non-compl.|0|||
33525715|NCT02688764|101819973|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
33525716|NCT02688764|101819974|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
33525717|NCT02688764|101819973|FG000|Overall Study|AE/Other|0|||
33525718|NCT02688764|101819974|FG001|Overall Study|AE/Other|1|||
33525719|NCT02688764|101819973|FG000|Overall Study|AE/Physician decision|1|||
33525720|NCT02688764|101819974|FG001|Overall Study|AE/Physician decision|0|||
33525721|NCT02688764|101819973|FG000|Overall Study|AE/Withd. parent|3|||
33525722|NCT02688764|101819974|FG001|Overall Study|AE/Withd. parent|0|||
33525723|NCT02688764|101819973|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
33525724|NCT02688764|101819974|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
33525725|NCT02688764|101819973|FG000|Overall Study|AE/Withd. subject|1|||
33525726|NCT02688764|101819974|FG001|Overall Study|AE/Withd. subject|0|||
33525727|NCT02688764|101819973|FG000|Overall Study|Kidney transplant|10|||
33525728|NCT02688764|101819974|FG001|Overall Study|Kidney transplant|4|||
33525729|NCT02688764|101819973|FG000|Overall Study|Lack of Efficacy|3|||
33525730|NCT02688764|101819974|FG001|Overall Study|Lack of Efficacy|2|||
33525731|NCT02688764|101819973|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
33525732|NCT02688764|101819974|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
33525733|NCT02688764|101819973|FG000|Overall Study|Non-compliance with study drug|4|||
33525734|NCT02688764|101819974|FG001|Overall Study|Non-compliance with study drug|0|||
33525735|NCT02688764|101819973|FG000|Overall Study|Non-compl./Physician decision|2|||
33525736|NCT02688764|101819974|FG001|Overall Study|Non-compl./Physician decision|0|||
33525737|NCT02688764|101819973|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
33525738|NCT02688764|101819974|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
33525739|NCT02688764|101819973|FG000|Overall Study|Non-compl./Withd. subject|0|||
33525740|NCT02688764|101819974|FG001|Overall Study|Non-compl./Withd. subject|2|||
33525741|NCT02688764|101819973|FG000|Overall Study|Phosphorus level outside safe range|0|||
33525742|NCT02688764|101819974|FG001|Overall Study|Phosphorus level outside safe range|1|||
33525743|NCT02688764|101819973|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
33525744|NCT02688764|101819974|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
33525745|NCT02688764|101819973|FG000|Overall Study|Study drug taste/Withd. parent|1|||
33525746|NCT02688764|101819974|FG001|Overall Study|Study drug taste/Withd. parent|0|||
33525747|NCT02688764|101819973|FG000|Overall Study|Subject moving out|2|||
33525748|NCT02688764|101819974|FG001|Overall Study|Subject moving out|0|||
33525749|NCT02688764|101819973|FG000|Overall Study|Subject taken off dialysis|1|||
33525750|NCT02688764|101819974|FG001|Overall Study|Subject taken off dialysis|0|||
33525751|NCT02688764|101819973|FG000|Overall Study|Withdrawal by parent|3|||
33525752|NCT02688764|101819974|FG001|Overall Study|Withdrawal by parent|0|||
33525753|NCT00255164|101819975|FG000|Overall Study|Adverse Event|10|||
33525754|NCT00255164|101819976|FG001|Overall Study|Adverse Event|6|||
33525755|NCT00255164|101819977|FG002|Overall Study|Adverse Event|9|||
33525756|NCT00255164|101819975|FG000|Overall Study|Lost to Follow-up|4|||
33525757|NCT00255164|101819976|FG001|Overall Study|Lost to Follow-up|3|||
33525758|NCT00255164|101819977|FG002|Overall Study|Lost to Follow-up|4|||
33525759|NCT00255164|101819975|FG000|Overall Study|Withdrawal by Subject|18|||
33525760|NCT00255164|101819976|FG001|Overall Study|Withdrawal by Subject|17|||
33525761|NCT00255164|101819977|FG002|Overall Study|Withdrawal by Subject|8|||
33525762|NCT00255164|101819975|FG000|Overall Study|Noncompliance|0|||
33525763|NCT00255164|101819976|FG001|Overall Study|Noncompliance|1|||
33525764|NCT00255164|101819977|FG002|Overall Study|Noncompliance|2|||
33525765|NCT00255164|101819975|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
33610235|NCT01298765|102123244|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
33610236|NCT01298765|102123244|FG000|Long-Term Treatment Period|Adverse Event|19|||
33610237|NCT01298765|102123244|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
33331784|NCT00514514|101107701|FG000|Pre-phase|condition no longer requires study drug|7|||
33525766|NCT00255164|101819976|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
33331785|NCT00514514|101107702|FG001|Pre-phase|condition no longer requires study drug|0|||
33331786|NCT00514514|101107703|FG002|Pre-phase|condition no longer requires study drug|0|||
33525767|NCT00255164|101819977|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
33525768|NCT00255164|101819975|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
33331787|NCT00514514|101107701|FG000|Pre-phase|abnormal test procedure results|15|||
33331788|NCT00514514|101107702|FG001|Pre-phase|abnormal test procedure results|0|||
33331789|NCT00514514|101107703|FG002|Pre-phase|abnormal test procedure results|0|||
33331790|NCT00514514|101107701|FG000|Pre-phase|Lost to Follow-up|2|||
33331791|NCT00514514|101107702|FG001|Pre-phase|Lost to Follow-up|0|||
33331792|NCT00514514|101107703|FG002|Pre-phase|Lost to Follow-up|0|||
33331793|NCT00514514|101107701|FG000|Pre-phase|abnormal lab values|23|||
33331794|NCT00514514|101107702|FG001|Pre-phase|abnormal lab values|0|||
33331795|NCT00514514|101107703|FG002|Pre-phase|abnormal lab values|0|||
33331796|NCT00514514|101107701|FG000|Pre-phase|Lack of Efficacy|35|||
33331797|NCT00514514|101107702|FG001|Pre-phase|Lack of Efficacy|0|||
33331798|NCT00514514|101107703|FG002|Pre-phase|Lack of Efficacy|0|||
33331799|NCT00514514|101107701|FG000|Pre-phase|Adverse Event|137|||
33331800|NCT00514514|101107702|FG001|Pre-phase|Adverse Event|0|||
33331801|NCT00514514|101107703|FG002|Pre-phase|Adverse Event|0|||
33331802|NCT00514514|101107701|FG000|Pre-phase|Withdrawal by Subject|66|||
33331803|NCT00514514|101107702|FG001|Pre-phase|Withdrawal by Subject|0|||
33331804|NCT00514514|101107703|FG002|Pre-phase|Withdrawal by Subject|0|||
33331805|NCT00514514|101107701|FG000|Randomized - 9 Month|Death|3|||
33331806|NCT00514514|101107702|FG001|Randomized - 9 Month|Death|2|||
33331807|NCT00514514|101107703|FG002|Randomized - 9 Month|Death|2|||
33331808|NCT00514514|101107701|FG000|Randomized - 9 Month|Administrative problems|1|||
33331809|NCT00514514|101107702|FG001|Randomized - 9 Month|Administrative problems|1|||
33331810|NCT00514514|101107703|FG002|Randomized - 9 Month|Administrative problems|2|||
33331811|NCT00514514|101107701|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
33331812|NCT00514514|101107702|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
33331813|NCT00514514|101107703|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
33331814|NCT00514514|101107701|FG000|Randomized - 9 Month|Protocol Violation|1|||
33331815|NCT00514514|101107702|FG001|Randomized - 9 Month|Protocol Violation|1|||
33331816|NCT00514514|101107703|FG002|Randomized - 9 Month|Protocol Violation|0|||
33331817|NCT00514514|101107701|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
33331818|NCT00514514|101107702|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
33331819|NCT00514514|101107703|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
33331820|NCT00514514|101107701|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
33331821|NCT00514514|101107702|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
33331822|NCT00514514|101107703|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
33331823|NCT00514514|101107701|FG000|Randomized - 9 Month|Adverse Event|25|||
33331824|NCT00514514|101107702|FG001|Randomized - 9 Month|Adverse Event|44|||
33331825|NCT00514514|101107703|FG002|Randomized - 9 Month|Adverse Event|27|||
33331826|NCT00514514|101107701|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
33331827|NCT00514514|101107702|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
33331828|NCT00514514|101107703|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
33331829|NCT00514514|101107701|FG000|Extension - 4 Years|Lost to Follow-up|12|||
33331830|NCT00514514|101107702|FG001|Extension - 4 Years|Lost to Follow-up|10|||
33331831|NCT00514514|101107703|FG002|Extension - 4 Years|Lost to Follow-up|9|||
33525769|NCT00255164|101819976|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
33525770|NCT00255164|101819977|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
33525771|NCT00255164|101819975|FG000|Overall Study|Possible Barrett's Esophagus|1|||
33525772|NCT00255164|101819976|FG001|Overall Study|Possible Barrett's Esophagus|3|||
33525773|NCT00255164|101819977|FG002|Overall Study|Possible Barrett's Esophagus|8|||
33525774|NCT00255164|101819975|FG000|Overall Study|Esophageal Stricture|0|||
33525775|NCT00255164|101819976|FG001|Overall Study|Esophageal Stricture|0|||
33525776|NCT00255164|101819977|FG002|Overall Study|Esophageal Stricture|1|||
33525777|NCT00255164|101819975|FG000|Overall Study|Therapeutic Failure|11|||
33525778|NCT00255164|101819976|FG001|Overall Study|Therapeutic Failure|2|||
33525779|NCT00255164|101819977|FG002|Overall Study|Therapeutic Failure|3|||
33525780|NCT01090050|101819980|FG000|Overall Study|Lost to Follow-up|0|||
33331832|NCT00514514|101107701|FG000|Extension - 4 Years|Administrative problems|3|||
33331833|NCT00514514|101107702|FG001|Extension - 4 Years|Administrative problems|1|||
33331834|NCT00514514|101107703|FG002|Extension - 4 Years|Administrative problems|1|||
33331835|NCT00514514|101107701|FG000|Extension - 4 Years|Death|8|||
33331836|NCT00514514|101107702|FG001|Extension - 4 Years|Death|3|||
33331837|NCT00514514|101107703|FG002|Extension - 4 Years|Death|6|||
33331838|NCT00514514|101107701|FG000|Extension - 4 Years|Adverse Event|9|||
33331839|NCT00514514|101107702|FG001|Extension - 4 Years|Adverse Event|6|||
33331840|NCT00514514|101107703|FG002|Extension - 4 Years|Adverse Event|3|||
33525781|NCT01090050|101819981|FG001|Overall Study|Lost to Follow-up|1|||
33525782|NCT01090050|101819980|FG000|Overall Study|Lack of Efficacy|1|||
33331841|NCT01765920|101107704|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
33331842|NCT01765920|101107705|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
33525783|NCT01090050|101819981|FG001|Overall Study|Lack of Efficacy|5|||
33525784|NCT01090050|101819980|FG000|Overall Study|Physician Decision|0|||
33525785|NCT01090050|101819981|FG001|Overall Study|Physician Decision|1|||
33331843|NCT01765920|101107704|FG000|Overall Study|Patient code disclosure|0|||
33331844|NCT01765920|101107705|FG001|Overall Study|Patient code disclosure|1|||
33331845|NCT00361270|101107708|FG000|Overall Study|Death|0|||
33331846|NCT00361270|101107709|FG001|Overall Study|Death|0|||
33331847|NCT00361270|101107710|FG002|Overall Study|Death|0|||
33525786|NCT04625413|101823309|FG000|Overall Study|Hospice|2|||
33525787|NCT04625413|101823309|FG000|Overall Study|Distress|1|||
33525788|NCT04625413|101823309|FG000|Overall Study|Not feeling well|1|||
33525789|NCT01641471|101823321|FG000|Overall Study|Withdrawal by Subject|19|||
33610238|NCT01298765|102123244|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
33610239|NCT01298765|102123244|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
33610240|NCT01298765|102123244|FG000|Long-Term Treatment Period|Physician Decision|1|||
33610241|NCT01298765|102123244|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
33610242|NCT02540668|102123245|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
33610243|NCT02540668|102123246|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
33610244|NCT03772665|102123247|FG000|Overall Study|Protocol Violation|1|||
33610245|NCT03772665|102123248|FG001|Overall Study|Protocol Violation|0|||
33610246|NCT01364389|102123251|FG000|Overall Study|Withdrawal by Subject|0|||
33610247|NCT01364389|102123252|FG001|Overall Study|Withdrawal by Subject|1|||
33610248|NCT01364389|102123253|FG002|Overall Study|Withdrawal by Subject|0|||
33610249|NCT01364389|102123251|FG000|Overall Study|Protocol deviation|0|||
33610250|NCT01364389|102123252|FG001|Overall Study|Protocol deviation|0|||
33610251|NCT01364389|102123253|FG002|Overall Study|Protocol deviation|1|||
33610252|NCT01364389|102123251|FG000|Overall Study|Administrative problems|1|||
33331848|NCT00361270|101107711|FG003|Overall Study|Death|2|||
33331849|NCT00361270|101107708|FG000|Overall Study|Lost to Follow-up|4|||
33331850|NCT00361270|101107709|FG001|Overall Study|Lost to Follow-up|1|||
33331851|NCT00361270|101107710|FG002|Overall Study|Lost to Follow-up|0|||
33331852|NCT00361270|101107711|FG003|Overall Study|Lost to Follow-up|0|||
33331853|NCT00361270|101107708|FG000|Overall Study|Physician Decision|0|||
33331854|NCT00361270|101107709|FG001|Overall Study|Physician Decision|0|||
33331855|NCT00361270|101107710|FG002|Overall Study|Physician Decision|1|||
33525790|NCT01641471|101823322|FG001|Overall Study|Withdrawal by Subject|19|||
33610253|NCT01364389|102123252|FG001|Overall Study|Administrative problems|0|||
33610254|NCT01364389|102123253|FG002|Overall Study|Administrative problems|0|||
33610255|NCT01364389|102123251|FG000|Overall Study|Adverse Event|1|||
33610256|NCT01364389|102123252|FG001|Overall Study|Adverse Event|0|||
33610257|NCT01364389|102123253|FG002|Overall Study|Adverse Event|0|||
33610258|NCT01336023|102123254|FG000|Week 0 to Week 26|Adverse Event|8|||
33610259|NCT01336023|102123255|FG001|Week 0 to Week 26|Adverse Event|10|||
33610260|NCT01336023|102123256|FG002|Week 0 to Week 26|Adverse Event|24|||
33610261|NCT01336023|102123254|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
33610262|NCT01336023|102123255|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
33610263|NCT01336023|102123256|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
33610264|NCT01336023|102123254|FG000|Week 0 to Week 26|Protocol Violation|1|||
33610265|NCT01336023|102123255|FG001|Week 0 to Week 26|Protocol Violation|2|||
33610266|NCT01336023|102123256|FG002|Week 0 to Week 26|Protocol Violation|0|||
33610267|NCT01336023|102123254|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
33610268|NCT01336023|102123255|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
33610269|NCT01336023|102123256|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
33610270|NCT01336023|102123254|FG000|Week 0 to Week 26|Unclassified|5|||
33610271|NCT01336023|102123255|FG001|Week 0 to Week 26|Unclassified|16|||
33610272|NCT01336023|102123256|FG002|Week 0 to Week 26|Unclassified|9|||
33610273|NCT01336023|102123254|FG000|Week 27 to 52|Adverse Event|1|||
33610274|NCT01336023|102123255|FG001|Week 27 to 52|Adverse Event|5|||
33610275|NCT01336023|102123256|FG002|Week 27 to 52|Adverse Event|2|||
33610276|NCT01336023|102123254|FG000|Week 27 to 52|Protocol Violation|0|||
33610277|NCT01336023|102123255|FG001|Week 27 to 52|Protocol Violation|2|||
33331856|NCT00361270|101107711|FG003|Overall Study|Physician Decision|0|||
33525791|NCT01641471|101823321|FG000|Overall Study|Lost to Follow-up|2|||
33525792|NCT01641471|101823322|FG001|Overall Study|Lost to Follow-up|4|||
33525793|NCT01641471|101823321|FG000|Overall Study|Protocol Violation|2|||
33525794|NCT01641471|101823322|FG001|Overall Study|Protocol Violation|4|||
33525795|NCT02782377|101823323|FG000|Overall Study|Physician Decision|5|||
33525796|NCT02697591|101823324|FG000|Overall Study|Lost to Follow-up|0|||
33525797|NCT02697591|101823325|FG001|Overall Study|Lost to Follow-up|0|||
33525798|NCT02697591|101823326|FG002|Overall Study|Lost to Follow-up|0|||
33525799|NCT02697591|101823327|FG003|Overall Study|Lost to Follow-up|0|||
33525800|NCT02697591|101823328|FG004|Overall Study|Lost to Follow-up|0|||
33610278|NCT01336023|102123256|FG002|Week 27 to 52|Protocol Violation|1|||
33610279|NCT01336023|102123254|FG000|Week 27 to 52|Withdrawal Criteria|14|||
33610280|NCT01336023|102123255|FG001|Week 27 to 52|Withdrawal Criteria|19|||
33610281|NCT01336023|102123256|FG002|Week 27 to 52|Withdrawal Criteria|16|||
33610282|NCT01336023|102123254|FG000|Week 27 to 52|Unclassified|13|||
33610283|NCT01336023|102123255|FG001|Week 27 to 52|Unclassified|18|||
33610284|NCT01336023|102123256|FG002|Week 27 to 52|Unclassified|9|||
33610285|NCT00527904|102123258|FG000|Overall Study|Adverse Event|45|||
33610286|NCT00527904|102123258|FG000|Overall Study|Withdrawal by Subject|21|||
33610287|NCT00527904|102123258|FG000|Overall Study|Lost to Follow-up|8|||
33610288|NCT00527904|102123258|FG000|Overall Study|misc|22|||
33331857|NCT00361270|101107708|FG000|Overall Study|Protocol Violation|9|||
33331858|NCT00361270|101107709|FG001|Overall Study|Protocol Violation|4|||
33331859|NCT00361270|101107710|FG002|Overall Study|Protocol Violation|5|||
33525801|NCT02697591|101823329|FG005|Overall Study|Lost to Follow-up|1|||
33331860|NCT00361270|101107711|FG003|Overall Study|Protocol Violation|4|||
33331861|NCT00361270|101107708|FG000|Overall Study|Withdrawal by Subject|6|||
33331862|NCT00361270|101107709|FG001|Overall Study|Withdrawal by Subject|6|||
33331863|NCT00361270|101107710|FG002|Overall Study|Withdrawal by Subject|3|||
33525802|NCT02697591|101823330|FG006|Overall Study|Lost to Follow-up|1|||
33525803|NCT02697591|101823331|FG007|Overall Study|Lost to Follow-up|0|||
33525804|NCT02697591|101823332|FG008|Overall Study|Lost to Follow-up|0|||
33525805|NCT02697591|101823333|FG009|Overall Study|Lost to Follow-up|1|||
33525806|NCT02697591|101823324|FG000|Overall Study|Withdrawal by Subject|1|||
33525807|NCT02697591|101823325|FG001|Overall Study|Withdrawal by Subject|1|||
33525808|NCT02697591|101823326|FG002|Overall Study|Withdrawal by Subject|2|||
33525809|NCT02697591|101823327|FG003|Overall Study|Withdrawal by Subject|1|||
33525810|NCT02697591|101823328|FG004|Overall Study|Withdrawal by Subject|7|||
33525811|NCT02697591|101823329|FG005|Overall Study|Withdrawal by Subject|6|||
33525812|NCT02697591|101823330|FG006|Overall Study|Withdrawal by Subject|9|||
33202741|NCT03349710|100645714|FG002|Treatment Period|Other Reason|2|||
33202742|NCT03349710|100645715|FG003|Treatment Period|Other Reason|1|||
33202743|NCT03349710|100645712|FG000|Treatment Period|completed|6|||
33202744|NCT03349710|100645713|FG001|Treatment Period|completed|0|||
33331864|NCT00361270|101107711|FG003|Overall Study|Withdrawal by Subject|7|||
33331865|NCT00361270|101107708|FG000|Overall Study|Afraid of Hypnosis|1|||
33331866|NCT00361270|101107709|FG001|Overall Study|Afraid of Hypnosis|2|||
33331867|NCT00361270|101107710|FG002|Overall Study|Afraid of Hypnosis|0|||
33331868|NCT00361270|101107711|FG003|Overall Study|Afraid of Hypnosis|0|||
33331869|NCT00361270|101107708|FG000|Overall Study|Problems with Transportation|4|||
33331870|NCT00361270|101107709|FG001|Overall Study|Problems with Transportation|0|||
33331871|NCT00361270|101107710|FG002|Overall Study|Problems with Transportation|0|||
33331872|NCT00361270|101107711|FG003|Overall Study|Problems with Transportation|0|||
33331873|NCT00361270|101107708|FG000|Overall Study|Adverse Event|0|||
33331874|NCT00361270|101107709|FG001|Overall Study|Adverse Event|1|||
33331875|NCT00361270|101107710|FG002|Overall Study|Adverse Event|1|||
33331876|NCT00361270|101107711|FG003|Overall Study|Adverse Event|0|||
33331877|NCT00885703|101107712|FG000|Overall Study|Death|9|||
33331878|NCT00885703|101107713|FG001|Overall Study|Death|7|||
33331879|NCT00885703|101107714|FG002|Overall Study|Death|8|||
33331880|NCT00885703|101107715|FG003|Overall Study|Death|7|||
33331881|NCT00885703|101107716|FG004|Overall Study|Death|7|||
33331882|NCT00885703|101107717|FG005|Overall Study|Death|8|||
33331883|NCT00885703|101107718|FG006|Overall Study|Death|4|||
33331884|NCT00885703|101107712|FG000|Overall Study|Lost to Follow-up|0|||
33331885|NCT00885703|101107713|FG001|Overall Study|Lost to Follow-up|0|||
33331886|NCT00885703|101107714|FG002|Overall Study|Lost to Follow-up|1|||
33331887|NCT00885703|101107715|FG003|Overall Study|Lost to Follow-up|0|||
33331888|NCT00885703|101107716|FG004|Overall Study|Lost to Follow-up|0|||
33331889|NCT00885703|101107717|FG005|Overall Study|Lost to Follow-up|1|||
33331890|NCT00885703|101107718|FG006|Overall Study|Lost to Follow-up|0|||
33331891|NCT00885703|101107712|FG000|Overall Study|Withdrawal by Subject|0|||
33331892|NCT00885703|101107713|FG001|Overall Study|Withdrawal by Subject|0|||
33331893|NCT00885703|101107714|FG002|Overall Study|Withdrawal by Subject|0|||
33331894|NCT00885703|101107715|FG003|Overall Study|Withdrawal by Subject|1|||
33331895|NCT00885703|101107716|FG004|Overall Study|Withdrawal by Subject|3|||
33331896|NCT00885703|101107717|FG005|Overall Study|Withdrawal by Subject|1|||
33331897|NCT00885703|101107718|FG006|Overall Study|Withdrawal by Subject|1|||
33331898|NCT00885703|101107712|FG000|Overall Study|Ineligible (no CM)|1|||
33331899|NCT00885703|101107713|FG001|Overall Study|Ineligible (no CM)|3|||
33331900|NCT00885703|101107714|FG002|Overall Study|Ineligible (no CM)|2|||
33331901|NCT00885703|101107715|FG003|Overall Study|Ineligible (no CM)|1|||
33331902|NCT00885703|101107716|FG004|Overall Study|Ineligible (no CM)|2|||
33331903|NCT00885703|101107717|FG005|Overall Study|Ineligible (no CM)|3|||
33331904|NCT00885703|101107718|FG006|Overall Study|Ineligible (no CM)|1|||
33331905|NCT01827670|101107719|FG000|Overall Study|Withdrawal of Consent|3|||
33331906|NCT01827670|101107720|FG001|Overall Study|Withdrawal of Consent|2|||
33331907|NCT01827670|101107719|FG000|Overall Study|Lost to Follow-up|0|||
33331908|NCT01827670|101107720|FG001|Overall Study|Lost to Follow-up|1|||
33525813|NCT02697591|101823331|FG007|Overall Study|Withdrawal by Subject|1|||
33525814|NCT02697591|101823332|FG008|Overall Study|Withdrawal by Subject|6|||
33525815|NCT02697591|101823333|FG009|Overall Study|Withdrawal by Subject|10|||
33525816|NCT02697591|101823324|FG000|Overall Study|Physician Decision|1|||
33525817|NCT02697591|101823325|FG001|Overall Study|Physician Decision|0|||
33525818|NCT02697591|101823326|FG002|Overall Study|Physician Decision|0|||
33331909|NCT00781911|101107721|FG000|Overall Study|Adverse Event|4|||
33331910|NCT00781911|101107722|FG001|Overall Study|Adverse Event|4|||
33331911|NCT00781911|101107721|FG000|Overall Study|Withdrawal by Subject|1|||
33331912|NCT00781911|101107722|FG001|Overall Study|Withdrawal by Subject|2|||
33331913|NCT00781911|101107721|FG000|Overall Study|Physician Decision|0|||
33331914|NCT00781911|101107722|FG001|Overall Study|Physician Decision|2|||
33331915|NCT00781911|101107721|FG000|Overall Study|Sponsor Decision|1|||
33331916|NCT00781911|101107722|FG001|Overall Study|Sponsor Decision|0|||
33331917|NCT03723707|101107742|FG000|Overall Study|Death|32|||
33202745|NCT03349710|100645714|FG002|Treatment Period|completed|18|||
33202746|NCT03349710|100645715|FG003|Treatment Period|completed|1|||
33202747|NCT03349710|100645712|FG000|Treatment Period|participant request to discontinue|0|||
33202748|NCT03349710|100645713|FG001|Treatment Period|participant request to discontinue|0|||
33331918|NCT03723707|101107743|FG001|Overall Study|Death|32|||
33331919|NCT03723707|101107742|FG000|Overall Study|Admitted to long term care|12|||
33331920|NCT03723707|101107743|FG001|Overall Study|Admitted to long term care|12|||
33331921|NCT03723707|101107742|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
33331922|NCT03723707|101107743|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
33331923|NCT03723707|101107742|FG000|Overall Study|Lost to Follow-up|40|||
33331924|NCT03723707|101107743|FG001|Overall Study|Lost to Follow-up|22|||
33331925|NCT03723707|101107742|FG000|Overall Study|Discontinued after study closure|24|||
33331926|NCT03723707|101107743|FG001|Overall Study|Discontinued after study closure|12|||
33331927|NCT02573870|101107744|FG000|Overall Study|Adverse Event|0|||
33331928|NCT02573870|101107745|FG001|Overall Study|Adverse Event|2|||
33331929|NCT02573870|101107744|FG000|Overall Study|Lack of Efficacy|0|||
33331930|NCT02573870|101107745|FG001|Overall Study|Lack of Efficacy|1|||
33331931|NCT02573870|101107744|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
33331932|NCT02573870|101107745|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
33525819|NCT02697591|101823327|FG003|Overall Study|Physician Decision|0|||
33525820|NCT02697591|101823328|FG004|Overall Study|Physician Decision|1|||
33525821|NCT02697591|101823329|FG005|Overall Study|Physician Decision|2|||
33525822|NCT02697591|101823330|FG006|Overall Study|Physician Decision|0|||
33525823|NCT02697591|101823331|FG007|Overall Study|Physician Decision|0|||
33525824|NCT02697591|101823332|FG008|Overall Study|Physician Decision|1|||
33525825|NCT02697591|101823333|FG009|Overall Study|Physician Decision|1|||
33525826|NCT02697591|101823324|FG000|Overall Study|Death|2|||
33525827|NCT02697591|101823325|FG001|Overall Study|Death|3|||
33525828|NCT02697591|101823326|FG002|Overall Study|Death|1|||
33525829|NCT02697591|101823327|FG003|Overall Study|Death|1|||
33525830|NCT02697591|101823328|FG004|Overall Study|Death|4|||
33525831|NCT02697591|101823329|FG005|Overall Study|Death|5|||
33525832|NCT02697591|101823330|FG006|Overall Study|Death|3|||
33525833|NCT02697591|101823331|FG007|Overall Study|Death|1|||
33525834|NCT02697591|101823332|FG008|Overall Study|Death|1|||
33525835|NCT02697591|101823333|FG009|Overall Study|Death|5|||
33525836|NCT02697591|101823324|FG000|Overall Study|Reason not Specified|0|||
33525837|NCT02697591|101823325|FG001|Overall Study|Reason not Specified|0|||
33525838|NCT02697591|101823326|FG002|Overall Study|Reason not Specified|0|||
33525839|NCT02697591|101823327|FG003|Overall Study|Reason not Specified|1|||
33525840|NCT02697591|101823328|FG004|Overall Study|Reason not Specified|1|||
33525841|NCT02697591|101823329|FG005|Overall Study|Reason not Specified|2|||
33525842|NCT02697591|101823330|FG006|Overall Study|Reason not Specified|3|||
33525843|NCT02697591|101823331|FG007|Overall Study|Reason not Specified|1|||
33525844|NCT02697591|101823332|FG008|Overall Study|Reason not Specified|1|||
33525845|NCT02697591|101823333|FG009|Overall Study|Reason not Specified|3|||
33525846|NCT01134393|101823334|FG000|Overall Study|Adverse Event|18|||
33525847|NCT01134393|101823334|FG000|Overall Study|Lack of Efficacy|2|||
33525848|NCT01134393|101823334|FG000|Overall Study|Protocol Violation|12|||
33525849|NCT01134393|101823334|FG000|Overall Study|Lost to Follow-up|3|||
33525850|NCT01134393|101823334|FG000|Overall Study|Withdrawal by Subject|11|||
33525851|NCT01134393|101823334|FG000|Overall Study|Other|6|||
33525852|NCT00703326|101823337|FG000|Overall Study|Lost to Follow-up|47|||
33525853|NCT00703326|101823338|FG001|Overall Study|Lost to Follow-up|18|||
33525854|NCT00703326|101823337|FG000|Overall Study|Withdrawal by Subject|54|||
33525855|NCT00703326|101823338|FG001|Overall Study|Withdrawal by Subject|20|||
33525856|NCT00703326|101823337|FG000|Overall Study|Adverse Event|1|||
33525857|NCT00703326|101823338|FG001|Overall Study|Adverse Event|0|||
33610289|NCT01073930|102123259|FG000|Overall Study|Withdrawal by Subject|3|||
33610290|NCT01073930|102123260|FG001|Overall Study|Withdrawal by Subject|2|||
33610291|NCT01073930|102123259|FG000|Overall Study|Lost to Follow-up|0|||
33610292|NCT01073930|102123260|FG001|Overall Study|Lost to Follow-up|1|||
33610293|NCT01073930|102123259|FG000|Overall Study|Adverse Event|0|||
33202749|NCT03349710|100645714|FG002|Treatment Period|participant request to discontinue|4|||
33202750|NCT03349710|100645715|FG003|Treatment Period|participant request to discontinue|0|||
33202751|NCT03349710|100645712|FG000|Treatment Period|participant withdrew consent|1|||
33525858|NCT00694356|101823339|FG000|Overall Study|Adverse Event|1|||
33202752|NCT03349710|100645713|FG001|Treatment Period|participant withdrew consent|0|||
33331933|NCT02573870|101107744|FG000|Overall Study|Lost to Follow-up|0|||
33331934|NCT02573870|101107745|FG001|Overall Study|Lost to Follow-up|1|||
33525859|NCT00694356|101823340|FG001|Overall Study|Adverse Event|0|||
33525860|NCT00694356|101823341|FG002|Overall Study|Adverse Event|0|||
33525861|NCT00694356|101823339|FG000|Overall Study|Progressive Disease|2|||
33525862|NCT00694356|101823340|FG001|Overall Study|Progressive Disease|6|||
33202753|NCT03349710|100645714|FG002|Treatment Period|participant withdrew consent|0|||
33331935|NCT02573870|101107744|FG000|Overall Study|Other: Fail to Meet Visit|0|||
33525863|NCT00694356|101823341|FG002|Overall Study|Progressive Disease|6|||
33525864|NCT02290925|101823342|FG000|First Period of Three Months|Lost to Follow-up|2|||
33525865|NCT02290925|101823343|FG001|First Period of Three Months|Lost to Follow-up|1|||
33525866|NCT02290925|101823342|FG000|First Period of Three Months|Death|1|||
33525867|NCT02290925|101823343|FG001|First Period of Three Months|Death|0|||
33525868|NCT02290925|101823342|FG000|First Period of Three Months|Insulin Started|1|||
33525869|NCT02290925|101823343|FG001|First Period of Three Months|Insulin Started|1|||
33525870|NCT02290925|101823342|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
33525871|NCT02290925|101823343|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
33525872|NCT02290925|101823342|FG000|Second Period of 3 Months|insulin started|0|||
33525873|NCT02290925|101823343|FG001|Second Period of 3 Months|insulin started|1|||
33525874|NCT03333486|101823344|FG000|Overall Study|Withdrawal by Subject|1|||
33331936|NCT02573870|101107745|FG001|Overall Study|Other: Fail to Meet Visit|2|||
33331937|NCT03594227|101107747|FG000|Overall Study|Adverse Event|2|||
33331938|NCT03594227|101107748|FG001|Overall Study|Adverse Event|1|||
33331939|NCT03594227|101107749|FG002|Overall Study|Adverse Event|0|||
33402503|NCT03525613|101361828|FG002|Overall Study|Lost to Follow-up|3|||
33331940|NCT03594227|101107750|FG003|Overall Study|Adverse Event|2|||
33331941|NCT03594227|101107747|FG000|Overall Study|Lost to Follow-up|1|||
33331942|NCT03594227|101107748|FG001|Overall Study|Lost to Follow-up|1|||
33331943|NCT03594227|101107749|FG002|Overall Study|Lost to Follow-up|1|||
33331944|NCT03594227|101107750|FG003|Overall Study|Lost to Follow-up|0|||
33331945|NCT03594227|101107747|FG000|Overall Study|Withdrawal by Subject|1|||
33331946|NCT03594227|101107748|FG001|Overall Study|Withdrawal by Subject|1|||
33331947|NCT03594227|101107749|FG002|Overall Study|Withdrawal by Subject|1|||
33331948|NCT03594227|101107750|FG003|Overall Study|Withdrawal by Subject|1|||
33331949|NCT03594227|101107747|FG000|Overall Study|Pregnancy|0|||
33331950|NCT03594227|101107748|FG001|Overall Study|Pregnancy|1|||
33331951|NCT03594227|101107749|FG002|Overall Study|Pregnancy|0|||
33331952|NCT03594227|101107750|FG003|Overall Study|Pregnancy|0|||
33331953|NCT03594227|101107747|FG000|Overall Study|Sponsor Decision|0|||
33331954|NCT03594227|101107748|FG001|Overall Study|Sponsor Decision|0|||
33331955|NCT03594227|101107749|FG002|Overall Study|Sponsor Decision|0|||
33331956|NCT03594227|101107750|FG003|Overall Study|Sponsor Decision|1|||
33331957|NCT03594227|101107747|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
33331958|NCT03594227|101107748|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
33331959|NCT03594227|101107749|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
33331960|NCT03594227|101107750|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
33331961|NCT00736255|101107751|FG000|Overall Study|Adverse Event|1|||
33331962|NCT00736255|101107752|FG001|Overall Study|Adverse Event|0|||
33331963|NCT00736255|101107751|FG000|Overall Study|Physician Decision|1|||
33331964|NCT00736255|101107752|FG001|Overall Study|Physician Decision|0|||
33331965|NCT00736255|101107751|FG000|Overall Study|Non-compliance|1|||
33331966|NCT00736255|101107752|FG001|Overall Study|Non-compliance|1|||
33331967|NCT01087905|101107753|FG000|Overall Study|Lost to Follow-up|24|||
33402504|NCT03525613|101361829|FG003|Overall Study|Lost to Follow-up|2|||
33402505|NCT03525613|101361826|FG000|Overall Study|Physician Decision|0|||
33402506|NCT03525613|101361827|FG001|Overall Study|Physician Decision|1|||
33402507|NCT03525613|101361828|FG002|Overall Study|Physician Decision|0|||
33402508|NCT03525613|101361829|FG003|Overall Study|Physician Decision|1|||
33402509|NCT03525613|101361826|FG000|Overall Study|Consent Withdrawal|25|||
33402510|NCT03525613|101361827|FG001|Overall Study|Consent Withdrawal|16|||
33402511|NCT03525613|101361828|FG002|Overall Study|Consent Withdrawal|12|||
33402512|NCT03525613|101361829|FG003|Overall Study|Consent Withdrawal|9|||
33402513|NCT03525613|101361826|FG000|Overall Study|Death|20|||
33402514|NCT03525613|101361827|FG001|Overall Study|Death|9|||
33402515|NCT03525613|101361828|FG002|Overall Study|Death|7|||
33402516|NCT03525613|101361829|FG003|Overall Study|Death|1|||
33402517|NCT03525613|101361826|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
33402518|NCT03525613|101361827|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
33402519|NCT03525613|101361828|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
33402520|NCT03525613|101361829|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
33402521|NCT01535638|101361830|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
33402522|NCT01535638|101361831|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
33402523|NCT01535638|101361832|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
33402524|NCT01535638|101361833|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
33402525|NCT01535638|101361834|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
33402526|NCT01535638|101361835|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
33331968|NCT01087905|101107754|FG001|Overall Study|Lost to Follow-up|28|||
33331969|NCT01087905|101107755|FG002|Overall Study|Lost to Follow-up|18|||
33331970|NCT01087905|101107756|FG003|Overall Study|Lost to Follow-up|31|||
33402527|NCT01535638|101361830|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
33402528|NCT01535638|101361831|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
33525875|NCT03333486|101823344|FG000|Overall Study|Lost to Follow-up|1|||
33525876|NCT01031004|101823346|FG000|Overall Study|Protocol Violation|0|||
33402529|NCT01535638|101361832|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
33331971|NCT01087905|101107757|FG004|Overall Study|Lost to Follow-up|27|||
33331972|NCT01087905|101107758|FG005|Overall Study|Lost to Follow-up|25|||
33331973|NCT01087905|101107759|FG006|Overall Study|Lost to Follow-up|20|||
33331974|NCT01087905|101107760|FG007|Overall Study|Lost to Follow-up|24|||
33331975|NCT01087905|101107753|FG000|Overall Study|Withdrawal by Subject|5|||
33331976|NCT01087905|101107754|FG001|Overall Study|Withdrawal by Subject|4|||
33331977|NCT01087905|101107755|FG002|Overall Study|Withdrawal by Subject|4|||
33331978|NCT01087905|101107756|FG003|Overall Study|Withdrawal by Subject|5|||
33331979|NCT01087905|101107757|FG004|Overall Study|Withdrawal by Subject|4|||
33331980|NCT01087905|101107758|FG005|Overall Study|Withdrawal by Subject|3|||
33331981|NCT01087905|101107759|FG006|Overall Study|Withdrawal by Subject|3|||
33331982|NCT01087905|101107760|FG007|Overall Study|Withdrawal by Subject|5|||
33331983|NCT03061175|101107765|FG000|Baseline|Participant was deemed ineligible|1|||
33331984|NCT03061175|101107766|FG001|Baseline|Participant was deemed ineligible|0|||
33331985|NCT03061175|101107765|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
33331986|NCT03061175|101107766|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
33331987|NCT03061175|101107765|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
33331988|NCT03061175|101107766|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
33331989|NCT03061175|101107765|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
33331990|NCT03061175|101107766|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
33331991|NCT01471782|101107767|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
33331992|NCT01471782|101107768|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
33331993|NCT01471782|101107769|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
33331994|NCT01471782|101107770|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
33331995|NCT01471782|101107771|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
33331996|NCT01471782|101107772|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
33331997|NCT01471782|101107767|FG000|Overall Study|Lack of Efficacy|1|||
33331998|NCT01471782|101107768|FG001|Overall Study|Lack of Efficacy|2|||
33331999|NCT01471782|101107769|FG002|Overall Study|Lack of Efficacy|1|||
33332000|NCT01471782|101107770|FG003|Overall Study|Lack of Efficacy|1|||
33332001|NCT01471782|101107771|FG004|Overall Study|Lack of Efficacy|5|||
33332002|NCT01471782|101107772|FG005|Overall Study|Lack of Efficacy|18|||
33332003|NCT01471782|101107767|FG000|Overall Study|Adverse Event|1|||
33332004|NCT01471782|101107768|FG001|Overall Study|Adverse Event|1|||
33332005|NCT01471782|101107769|FG002|Overall Study|Adverse Event|2|||
33332006|NCT01471782|101107770|FG003|Overall Study|Adverse Event|2|||
33332007|NCT01471782|101107771|FG004|Overall Study|Adverse Event|3|||
33332008|NCT01471782|101107772|FG005|Overall Study|Adverse Event|1|||
33332009|NCT01471782|101107767|FG000|Overall Study|Other|0|||
33332010|NCT01471782|101107768|FG001|Overall Study|Other|0|||
33332011|NCT01471782|101107769|FG002|Overall Study|Other|1|||
33332012|NCT01471782|101107770|FG003|Overall Study|Other|1|||
33332013|NCT01471782|101107771|FG004|Overall Study|Other|6|||
33332014|NCT01471782|101107772|FG005|Overall Study|Other|5|||
33332015|NCT01471782|101107767|FG000|Overall Study|Change of Chemotherapy|1|||
33332016|NCT01471782|101107768|FG001|Overall Study|Change of Chemotherapy|1|||
33332017|NCT01471782|101107769|FG002|Overall Study|Change of Chemotherapy|0|||
33332018|NCT01471782|101107770|FG003|Overall Study|Change of Chemotherapy|0|||
33332019|NCT01471782|101107771|FG004|Overall Study|Change of Chemotherapy|1|||
33332020|NCT01471782|101107772|FG005|Overall Study|Change of Chemotherapy|4|||
33332021|NCT01471782|101107767|FG000|Overall Study|Disease Relapse|0|||
33332022|NCT01471782|101107768|FG001|Overall Study|Disease Relapse|0|||
33332023|NCT01471782|101107769|FG002|Overall Study|Disease Relapse|0|||
33332024|NCT01471782|101107770|FG003|Overall Study|Disease Relapse|1|||
33332025|NCT01471782|101107771|FG004|Overall Study|Disease Relapse|2|||
33332026|NCT01471782|101107772|FG005|Overall Study|Disease Relapse|1|||
33332027|NCT01471782|101107767|FG000|Overall Study|Physician Decision|0|||
33332028|NCT01471782|101107768|FG001|Overall Study|Physician Decision|0|||
33332029|NCT01471782|101107769|FG002|Overall Study|Physician Decision|0|||
33332030|NCT01471782|101107770|FG003|Overall Study|Physician Decision|0|||
33332031|NCT01471782|101107771|FG004|Overall Study|Physician Decision|3|||
33332032|NCT01471782|101107772|FG005|Overall Study|Physician Decision|8|||
33332033|NCT01471782|101107767|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33332034|NCT01471782|101107768|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33332035|NCT01471782|101107769|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
33332036|NCT01471782|101107770|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
33332037|NCT01471782|101107771|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
33332038|NCT01471782|101107772|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
33332039|NCT01471782|101107767|FG000|Overall Study|Death|0|||
33332040|NCT01471782|101107768|FG001|Overall Study|Death|0|||
33332041|NCT01471782|101107769|FG002|Overall Study|Death|0|||
33332042|NCT01471782|101107770|FG003|Overall Study|Death|0|||
33402530|NCT01535638|101361833|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
33402531|NCT01535638|101361834|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
33332043|NCT01471782|101107771|FG004|Overall Study|Death|0|||
33332044|NCT01471782|101107772|FG005|Overall Study|Death|1|||
33332045|NCT00823823|101107775|FG000|Overall Study|Lost to Follow-up|3|||
33202754|NCT03349710|100645715|FG003|Treatment Period|participant withdrew consent|0|||
33332046|NCT00823823|101107776|FG001|Overall Study|Lost to Follow-up|1|||
33332047|NCT00823823|101107775|FG000|Overall Study|Protocol Violation|5|||
33525877|NCT01031004|101823347|FG001|Overall Study|Protocol Violation|1|||
33525878|NCT01031004|101823346|FG000|Overall Study|Lost to Follow-up|1|||
33525879|NCT01031004|101823347|FG001|Overall Study|Lost to Follow-up|0|||
33610294|NCT01073930|102123260|FG001|Overall Study|Adverse Event|1|||
33610295|NCT01073930|102123259|FG000|Overall Study|Noncompliance with study drug|0|||
33610296|NCT01073930|102123260|FG001|Overall Study|Noncompliance with study drug|1|||
33610297|NCT01073930|102123259|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
33610298|NCT01073930|102123260|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
33610299|NCT01320202|102123262|FG000|Overall Study|Adverse Event|5|||
33610300|NCT01320202|102123263|FG001|Overall Study|Adverse Event|5|||
33525880|NCT01760447|101823354|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
33525881|NCT01760447|101823355|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
33525882|NCT01760447|101823356|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
33525883|NCT01760447|101823357|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
33525884|NCT01760447|101823354|FG000|Weeks 0-20|Withdrawal by Subject|2|||
33525885|NCT01760447|101823355|FG001|Weeks 0-20|Withdrawal by Subject|0|||
33525886|NCT01760447|101823356|FG002|Weeks 0-20|Withdrawal by Subject|1|||
33525887|NCT01760447|101823357|FG003|Weeks 0-20|Withdrawal by Subject|0|||
33525888|NCT01760447|101823354|FG000|Weeks 0-20|Lost to Follow-up|1|||
33525889|NCT01760447|101823355|FG001|Weeks 0-20|Lost to Follow-up|0|||
33525890|NCT01760447|101823356|FG002|Weeks 0-20|Lost to Follow-up|1|||
33525891|NCT01760447|101823357|FG003|Weeks 0-20|Lost to Follow-up|1|||
33525892|NCT01760447|101823354|FG000|Weeks 0-20|Randomized but not treated|0|||
33525893|NCT01760447|101823355|FG001|Weeks 0-20|Randomized but not treated|0|||
33525894|NCT01760447|101823356|FG002|Weeks 0-20|Randomized but not treated|2|||
33525895|NCT01760447|101823357|FG003|Weeks 0-20|Randomized but not treated|0|||
33525896|NCT01760447|101823354|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
33525897|NCT01760447|101823355|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
33525898|NCT01760447|101823356|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
33525899|NCT01760447|101823357|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
33525900|NCT01760447|101823354|FG000|Weeks 20-54|Withdrawal by Subject|2|||
33525901|NCT01760447|101823355|FG001|Weeks 20-54|Withdrawal by Subject|1|||
33525902|NCT01760447|101823356|FG002|Weeks 20-54|Withdrawal by Subject|1|||
33525903|NCT01760447|101823357|FG003|Weeks 20-54|Withdrawal by Subject|2|||
33525904|NCT01760447|101823354|FG000|Weeks 20-54|Lost to Follow-up|0|||
33525905|NCT01760447|101823355|FG001|Weeks 20-54|Lost to Follow-up|0|||
33525906|NCT01760447|101823356|FG002|Weeks 20-54|Lost to Follow-up|1|||
33525907|NCT01760447|101823357|FG003|Weeks 20-54|Lost to Follow-up|2|||
33525908|NCT00493311|101823358|FG000|Overall Study|Need for rescue medication|2|||
33525909|NCT00493311|101823359|FG001|Overall Study|Need for rescue medication|2|||
33525910|NCT00298363|101823360|FG000|Overall Study|Lost to Follow-up|0|||
33610301|NCT01320202|102123262|FG000|Overall Study|Death|5|||
33610302|NCT01320202|102123263|FG001|Overall Study|Death|3|||
33202755|NCT02627677|100645716|FG000|Overall Study|Adverse event (not progressive disease)|1|||
33202756|NCT02627677|100645717|FG001|Overall Study|Adverse event (not progressive disease)|4|||
33202757|NCT02627677|100645718|FG002|Overall Study|Adverse event (not progressive disease)|1|||
33610303|NCT01320202|102123262|FG000|Overall Study|Lost to Follow-up|1|||
33610304|NCT01320202|102123263|FG001|Overall Study|Lost to Follow-up|0|||
33610305|NCT01320202|102123262|FG000|Overall Study|Physician Decision|3|||
33610306|NCT01320202|102123263|FG001|Overall Study|Physician Decision|1|||
33610307|NCT01320202|102123262|FG000|Overall Study|Protocol Violation|2|||
33610308|NCT01320202|102123263|FG001|Overall Study|Protocol Violation|1|||
33610309|NCT01320202|102123262|FG000|Overall Study|Withdrawal by Subject|10|||
33610310|NCT01320202|102123263|FG001|Overall Study|Withdrawal by Subject|3|||
33610311|NCT01320202|102123262|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
33610312|NCT01320202|102123263|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
33202758|NCT02627677|100645716|FG000|Overall Study|Progressive disease|1|||
33202759|NCT02627677|100645717|FG001|Overall Study|Progressive disease|3|||
33202760|NCT02627677|100645718|FG002|Overall Study|Progressive disease|0|||
33202761|NCT02627677|100645716|FG000|Overall Study|Lack of Efficacy|1|||
33525911|NCT00298363|101823361|FG001|Overall Study|Lost to Follow-up|0|||
33525912|NCT00298363|101823362|FG002|Overall Study|Lost to Follow-up|1|||
33525913|NCT00298363|101823360|FG000|Overall Study|Physician Decision|4|||
33525914|NCT00298363|101823361|FG001|Overall Study|Physician Decision|1|||
33525915|NCT00298363|101823362|FG002|Overall Study|Physician Decision|0|||
33525916|NCT00298363|101823360|FG000|Overall Study|Protocol Violation|1|||
33525917|NCT00298363|101823361|FG001|Overall Study|Protocol Violation|1|||
33525918|NCT00298363|101823362|FG002|Overall Study|Protocol Violation|0|||
33525919|NCT00298363|101823360|FG000|Overall Study|Withdrawal by Subject|5|||
33525920|NCT00298363|101823361|FG001|Overall Study|Withdrawal by Subject|1|||
33525921|NCT00298363|101823362|FG002|Overall Study|Withdrawal by Subject|3|||
33525922|NCT00298363|101823360|FG000|Overall Study|Adverse Event|5|||
33610313|NCT01320202|102123262|FG000|Overall Study|kidney transplant|1|||
33610314|NCT01320202|102123263|FG001|Overall Study|kidney transplant|2|||
33202762|NCT02627677|100645717|FG001|Overall Study|Lack of Efficacy|2|||
33202763|NCT02627677|100645718|FG002|Overall Study|Lack of Efficacy|0|||
33525923|NCT00298363|101823361|FG001|Overall Study|Adverse Event|2|||
33202764|NCT02627677|100645716|FG000|Overall Study|Lost to Follow-up|0|||
33202765|NCT02627677|100645717|FG001|Overall Study|Lost to Follow-up|0|||
33202766|NCT02627677|100645718|FG002|Overall Study|Lost to Follow-up|1|||
33202767|NCT02627677|100645716|FG000|Overall Study|Pregnancy|0|||
33202768|NCT02627677|100645717|FG001|Overall Study|Pregnancy|1|||
33202769|NCT02627677|100645718|FG002|Overall Study|Pregnancy|0|||
33202770|NCT02627677|100645716|FG000|Overall Study|Study Terminated by Sponsor|5|||
33202771|NCT02627677|100645717|FG001|Overall Study|Study Terminated by Sponsor|10|||
33202772|NCT02627677|100645718|FG002|Overall Study|Study Terminated by Sponsor|6|||
33202773|NCT02627677|100645716|FG000|Overall Study|Physician Decision|0|||
33202774|NCT02627677|100645717|FG001|Overall Study|Physician Decision|0|||
33202775|NCT02627677|100645718|FG002|Overall Study|Physician Decision|2|||
33202776|NCT02627677|100645716|FG000|Overall Study|Withdrawal by Subject|2|||
33202777|NCT02627677|100645717|FG001|Overall Study|Withdrawal by Subject|1|||
33202778|NCT02627677|100645718|FG002|Overall Study|Withdrawal by Subject|1|||
33202779|NCT02627677|100645716|FG000|Overall Study|Reason not Specified|0|||
33202780|NCT02627677|100645717|FG001|Overall Study|Reason not Specified|0|||
33202781|NCT02627677|100645718|FG002|Overall Study|Reason not Specified|1|||
33202782|NCT02627677|100645716|FG000|Overall Study|Randomized but not Treated|1|||
33202783|NCT02627677|100645717|FG001|Overall Study|Randomized but not Treated|0|||
33202784|NCT02627677|100645718|FG002|Overall Study|Randomized but not Treated|0|||
33202785|NCT02663817|100645732|FG000|Overall Study|Screen failure|2|||
33202786|NCT02338362|100645733|FG000|Overall Study|Withdrawal by Subject|1|||
33202787|NCT02338362|100645734|FG001|Overall Study|Withdrawal by Subject|1|||
33202788|NCT01233817|100645748|FG000|Overall Study|Lost to Follow-up|1|||
33202789|NCT01233817|100645748|FG000|Overall Study|Withdrawal by Subject|2|||
33202790|NCT03268811|100645749|FG000|Overall Study|Adverse Event|0|||
33202791|NCT03268811|100645750|FG001|Overall Study|Adverse Event|1|||
33202792|NCT00389324|100645764|FG000|Run-In Phase|Adverse Event|1|||
33202793|NCT00389324|100645764|FG000|Run-In Phase|Lost to Follow-up|1|||
33202794|NCT00389324|100645764|FG000|Run-In Phase|Withdrawal by Subject|1|||
33202795|NCT00389324|100645764|FG000|Subcutaneous Phase|Adverse Event|2|||
33202796|NCT00389324|100645764|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
33202797|NCT00389324|100645764|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
33202798|NCT00389324|100645764|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
33202799|NCT04757649|100645765|FG000|Overall Study|Withdrawal by Subject|1|||
33202800|NCT04757649|100645765|FG000|Overall Study|Adverse Event|1|||
33202801|NCT01198600|100645767|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
33202802|NCT01198600|100645768|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
33202803|NCT01198600|100645769|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
33202804|NCT01198600|100645770|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
33202805|NCT01198600|100645767|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
33202806|NCT01198600|100645768|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
33202807|NCT01198600|100645769|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
33202808|NCT01198600|100645770|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
33202809|NCT01198600|100645767|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
33202810|NCT01198600|100645768|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
33202811|NCT01198600|100645769|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
33202812|NCT01198600|100645770|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
33202813|NCT01198600|100645767|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
33202814|NCT01198600|100645768|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
33202815|NCT01198600|100645769|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
33202816|NCT01198600|100645770|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
33202817|NCT01198600|100645767|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
33202818|NCT01198600|100645768|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
33202819|NCT01198600|100645769|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
33202820|NCT01198600|100645770|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
33202821|NCT01198600|100645767|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
33202822|NCT01198600|100645768|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
33202823|NCT01198600|100645769|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
33202824|NCT01198600|100645770|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
33525924|NCT00298363|101823362|FG002|Overall Study|Adverse Event|2|||
33525925|NCT00298363|101823360|FG000|Overall Study|Lack of Efficacy|2|||
33202825|NCT01198600|100645767|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
33202826|NCT01198600|100645768|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
33202827|NCT01198600|100645769|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
33202828|NCT01198600|100645770|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
33525926|NCT00298363|101823361|FG001|Overall Study|Lack of Efficacy|3|||
33202829|NCT03067441|100645771|FG000|Overall Study|Withdrawal by Subject|16|||
33202830|NCT03067441|100645772|FG001|Overall Study|Withdrawal by Subject|34|||
33332048|NCT00823823|101107776|FG001|Overall Study|Protocol Violation|5|||
33332049|NCT04995055|101107777|FG000|Period 1|COVID-19 Related|1|||
33525927|NCT00298363|101823362|FG002|Overall Study|Lack of Efficacy|0|||
33525928|NCT02173379|101823363|FG000|Overall Study|Lost to Follow-up|89|||
33525929|NCT02173379|101823364|FG001|Overall Study|Lost to Follow-up|81|||
33525930|NCT02173379|101823363|FG000|Overall Study|Withdrawal by Subject|24|||
33525931|NCT02173379|101823364|FG001|Overall Study|Withdrawal by Subject|29|||
33525932|NCT02173379|101823363|FG000|Overall Study|Physician Decision|8|||
33525933|NCT02173379|101823364|FG001|Overall Study|Physician Decision|8|||
33525934|NCT02173379|101823363|FG000|Overall Study|Death|75|||
33525935|NCT02173379|101823364|FG001|Overall Study|Death|72|||
33525936|NCT02173379|101823363|FG000|Overall Study|Other Reason|1|||
33525937|NCT02173379|101823364|FG001|Overall Study|Other Reason|0|||
33525938|NCT00551525|101823365|FG000|Overall Study|Protocol Violation|5|||
33525939|NCT01118663|101823368|FG000|Overall Study|Adverse Event|2|||
33525940|NCT01118663|101823369|FG001|Overall Study|Adverse Event|1|||
33525941|NCT01118663|101823368|FG000|Overall Study|Withdrawal by Subject|0|||
33525942|NCT01118663|101823369|FG001|Overall Study|Withdrawal by Subject|1|||
33525943|NCT01308463|101823370|FG000|Overall Study|Study Discontinued|23|||
33525944|NCT01308463|101823370|FG000|Overall Study|Death|4|||
33525945|NCT01308463|101823370|FG000|Overall Study|Revision|2|||
33525946|NCT02309723|101823373|FG000|Overall Study|Withdrawal by Subject|24|||
33525947|NCT02309723|101823374|FG001|Overall Study|Withdrawal by Subject|23|||
33525948|NCT02309723|101823375|FG002|Overall Study|Withdrawal by Subject|24|||
33525949|NCT03332095|101823378|FG000|Overall Study|Lost to Follow-up|1|||
33525950|NCT03332095|101823379|FG001|Overall Study|Lost to Follow-up|0|||
33525951|NCT03332095|101823378|FG000|Overall Study|Pregnancy|0|||
33525952|NCT03332095|101823379|FG001|Overall Study|Pregnancy|1|||
33525953|NCT00045734|101823380|FG000|Overall Study|Protocol Violation|1|||
33525954|NCT01429441|101823381|FG000|Overall Study|Adverse Event|5|||
33525955|NCT01429441|101823382|FG001|Overall Study|Adverse Event|1|||
33525956|NCT01429441|101823381|FG000|Overall Study|Death|0|||
33525957|NCT01429441|101823382|FG001|Overall Study|Death|2|||
33525958|NCT01429441|101823381|FG000|Overall Study|Lost to Follow-up|5|||
33525959|NCT01429441|101823382|FG001|Overall Study|Lost to Follow-up|2|||
33525960|NCT01429441|101823381|FG000|Overall Study|Physician Decision|1|||
33525961|NCT01429441|101823382|FG001|Overall Study|Physician Decision|0|||
33525962|NCT01429441|101823381|FG000|Overall Study|Withdrawal by Subject|27|||
33525963|NCT01429441|101823382|FG001|Overall Study|Withdrawal by Subject|18|||
33525964|NCT02263729|101823383|FG000|Overall Study|Lost to Follow-up|1|||
33525965|NCT02263729|101823384|FG001|Overall Study|Lost to Follow-up|1|||
33525966|NCT02496039|101823387|FG000|Overall Study|Adverse Event|3|||
33525967|NCT02496039|101823387|FG000|Overall Study|Protocol Violation|1|||
33525968|NCT03297021|101823388|FG000|Overall Study|Incomplete/illegible data sheet|4|||
33525969|NCT03297021|101823389|FG001|Overall Study|Incomplete/illegible data sheet|2|||
33525970|NCT03297021|101823390|FG002|Overall Study|Incomplete/illegible data sheet|3|||
33525971|NCT03297021|101823388|FG000|Overall Study|Missing Post-Op Data|1|||
33402532|NCT01535638|101361835|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
33402533|NCT00540228|101365335|FG000|Overall Study|Adverse Event|2|||
33525972|NCT03297021|101823389|FG001|Overall Study|Missing Post-Op Data|2|||
33525973|NCT03297021|101823390|FG002|Overall Study|Missing Post-Op Data|1|||
33525974|NCT02609984|101823391|FG000|Overall Study|Death|29|||
33525975|NCT02609984|101823392|FG001|Overall Study|Death|26|||
33525976|NCT02609984|101823391|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
33525977|NCT02609984|101823392|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
33525978|NCT02609984|101823391|FG000|Overall Study|Lost to Follow-up|1|||
33525979|NCT02609984|101823392|FG001|Overall Study|Lost to Follow-up|2|||
33525980|NCT02609984|101823391|FG000|Overall Study|Withdrawal by Subject|0|||
33525981|NCT02609984|101823392|FG001|Overall Study|Withdrawal by Subject|1|||
33525982|NCT02609984|101823391|FG000|Overall Study|Disease Progression|2|||
33525983|NCT02609984|101823392|FG001|Overall Study|Disease Progression|0|||
33525984|NCT03782571|101823395|FG000|Period 1|Withdrawal by Subject|1|||
33525985|NCT03782571|101823396|FG001|Period 1|Withdrawal by Subject|0|||
33525986|NCT03782571|101823397|FG002|Period 1|Withdrawal by Subject|0|||
33525987|NCT03782571|101823398|FG003|Period 1|Withdrawal by Subject|0|||
33525988|NCT03782571|101823395|FG000|Period 3|Subject Unable to Attend V5|1|||
33525989|NCT03782571|101823396|FG001|Period 3|Subject Unable to Attend V5|0|||
33525990|NCT03782571|101823397|FG002|Period 3|Subject Unable to Attend V5|0|||
33525991|NCT03782571|101823398|FG003|Period 3|Subject Unable to Attend V5|0|||
33525992|NCT03782571|101823395|FG000|Period 3|Adverse Event|1|||
33525993|NCT03782571|101823396|FG001|Period 3|Adverse Event|0|||
33402534|NCT00540228|101365336|FG001|Overall Study|Adverse Event|0|||
33525994|NCT03782571|101823397|FG002|Period 3|Adverse Event|0|||
33525995|NCT03782571|101823398|FG003|Period 3|Adverse Event|0|||
33525996|NCT01424241|101823399|FG000|Overall Study|Withdrawal by Subject|1|||
33402535|NCT00540228|101365337|FG002|Overall Study|Adverse Event|0|||
33525997|NCT01424241|101823399|FG000|Overall Study|Time constraints|2|||
33525998|NCT00564278|101823402|FG000|Overall Study|Lost to Follow-up|35|||
33525999|NCT00564278|101823403|FG001|Overall Study|Lost to Follow-up|33|||
33526000|NCT00564278|101823402|FG000|Overall Study|Physician Decision|1|||
33526001|NCT00564278|101823403|FG001|Overall Study|Physician Decision|2|||
33526002|NCT00564278|101823402|FG000|Overall Study|Withdrawal by Subject|11|||
33526003|NCT00564278|101823403|FG001|Overall Study|Withdrawal by Subject|7|||
33526004|NCT01502033|101823406|FG000|Overall Study|1 participant had scalp discomfort|1|||
33526005|NCT01502033|101823406|FG000|Overall Study|1 participant had worsening depression|1|||
33526006|NCT01502033|101823406|FG000|Overall Study|1 participant went back to school|1|||
33526007|NCT00809094|101823407|FG000|Overall Study|Lost to Follow-up|0|||
33526008|NCT00809094|101823408|FG001|Overall Study|Lost to Follow-up|1|||
33526009|NCT03762681|101823409|FG000|Part 1|Withdrawal by Subject|0|||
33202831|NCT03067441|100645771|FG000|Overall Study|Lost to Follow-up|7|||
33202832|NCT03067441|100645772|FG001|Overall Study|Lost to Follow-up|5|||
33202833|NCT03067441|100645771|FG000|Overall Study|Adverse Event|7|||
33202834|NCT03067441|100645772|FG001|Overall Study|Adverse Event|14|||
33202835|NCT03067441|100645771|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
33202836|NCT03067441|100645772|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
33202837|NCT03067441|100645771|FG000|Overall Study|Physician Decision|1|||
33202838|NCT03067441|100645772|FG001|Overall Study|Physician Decision|3|||
33202839|NCT03067441|100645771|FG000|Overall Study|Other|1|||
33202840|NCT03067441|100645772|FG001|Overall Study|Other|1|||
33202841|NCT04408469|100645775|FG000|Overall Study|Lost to Follow-up|6|||
33202842|NCT04408469|100645776|FG001|Overall Study|Lost to Follow-up|9|||
33202843|NCT04408469|100645775|FG000|Overall Study|Withdrawal by Subject|6|||
33202844|NCT04408469|100645776|FG001|Overall Study|Withdrawal by Subject|1|||
33202845|NCT04408469|100645775|FG000|Overall Study|Dismissal due to ineligibility|0|||
33202846|NCT04408469|100645776|FG001|Overall Study|Dismissal due to ineligibility|1|||
33202847|NCT03359096|100645777|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
33202848|NCT03359096|100645778|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
33202849|NCT03359096|100645777|FG000|First Intervention (4 Weeks)|Death|1|||
33202850|NCT03359096|100645778|FG001|First Intervention (4 Weeks)|Death|0|||
33202851|NCT03359096|100645777|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
33202852|NCT03359096|100645778|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
33202853|NCT01286779|100645779|FG000|Overall Study|Withdrawal by Subject|9|||
33202854|NCT01286779|100645779|FG000|Overall Study|Protocol Violation|5|||
33202855|NCT01286779|100645779|FG000|Overall Study|Physician Decision|2|||
33202856|NCT01286779|100645779|FG000|Overall Study|Participant had scheduled surgery|1|||
33202857|NCT01286779|100645779|FG000|Overall Study|Participant moved to another country|1|||
33202858|NCT01286779|100645779|FG000|Overall Study|Discontinued by sponsor|1|||
33202859|NCT00383435|100645780|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
33202860|NCT00383435|100645781|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
33202861|NCT00383435|100645782|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
33202862|NCT00383435|100645783|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
33202863|NCT00383435|100645784|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
33202864|NCT00383435|100645780|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
33202865|NCT00383435|100645781|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
33202866|NCT00383435|100645782|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
33202867|NCT00383435|100645783|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
33202868|NCT00383435|100645784|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
33202869|NCT00383435|100645780|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
33202870|NCT00383435|100645781|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
33202871|NCT00383435|100645782|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
33202872|NCT00383435|100645783|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
33202873|NCT00383435|100645784|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
33202874|NCT00383435|100645780|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
33202875|NCT00383435|100645781|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
33202876|NCT00383435|100645782|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
33202877|NCT00383435|100645783|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
33202878|NCT00383435|100645784|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
33202879|NCT00383435|100645780|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
33202880|NCT00383435|100645781|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
33202881|NCT00383435|100645782|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
33202882|NCT00383435|100645783|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
33202883|NCT00383435|100645784|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
33202884|NCT00383435|100645780|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
33202885|NCT00383435|100645781|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
33202886|NCT00383435|100645782|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
33332050|NCT04995055|101107778|FG001|Period 1|COVID-19 Related|0|||
33332051|NCT04995055|101107777|FG000|Period 1|Withdrawal by Subject|0|||
33402536|NCT00540228|101365338|FG003|Overall Study|Adverse Event|0|||
33526010|NCT03762681|101823410|FG001|Part 1|Withdrawal by Subject|0|||
33526011|NCT03762681|101823411|FG002|Part 1|Withdrawal by Subject|0|||
33526012|NCT03762681|101823412|FG003|Part 1|Withdrawal by Subject|1|||
33526013|NCT03762681|101823413|FG004|Part 1|Withdrawal by Subject|0|||
33202887|NCT00383435|100645783|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
33202888|NCT00383435|100645784|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
33202889|NCT00383435|100645780|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
33202890|NCT00383435|100645781|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
33202891|NCT00383435|100645782|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
33202892|NCT00383435|100645783|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
33202893|NCT00383435|100645784|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
33202894|NCT00383435|100645780|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
33202895|NCT00383435|100645781|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
33202896|NCT00383435|100645782|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
33202897|NCT00383435|100645783|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
33202898|NCT00383435|100645784|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
33202899|NCT00383435|100645780|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
33202900|NCT00383435|100645781|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
33202901|NCT00383435|100645782|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
33202902|NCT00383435|100645783|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
33202903|NCT00383435|100645784|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
33202904|NCT00383435|100645780|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
33202905|NCT00383435|100645781|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
33202906|NCT00383435|100645782|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
33202907|NCT00383435|100645783|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
33202908|NCT00383435|100645784|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
33202909|NCT00383435|100645780|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
33202910|NCT00383435|100645781|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
33202911|NCT00383435|100645782|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
33402537|NCT00540228|101365339|FG004|Overall Study|Adverse Event|0|||
33402538|NCT00540228|101365335|FG000|Overall Study|Lost to Follow-up|1|||
33526014|NCT03762681|101823414|FG005|Part 1|Withdrawal by Subject|0|||
33526015|NCT03762681|101823415|FG006|Part 1|Withdrawal by Subject|0|||
33526016|NCT03762681|101823416|FG007|Part 1|Withdrawal by Subject|0|||
33526017|NCT03762681|101823409|FG000|Part 2a|Pandemic Travel Restrictions|0|||
33526018|NCT03762681|101823410|FG001|Part 2a|Pandemic Travel Restrictions|0|||
33526019|NCT03762681|101823411|FG002|Part 2a|Pandemic Travel Restrictions|0|||
33610315|NCT01320202|102123262|FG000|Overall Study|blood transfusion|1|||
33610316|NCT01320202|102123263|FG001|Overall Study|blood transfusion|7|||
33610317|NCT01320202|102123262|FG000|Overall Study|moved/changed dialysis|5|||
33610318|NCT01320202|102123263|FG001|Overall Study|moved/changed dialysis|2|||
33610319|NCT01320202|102123262|FG000|Overall Study|sponsor request|2|||
33610320|NCT01320202|102123263|FG001|Overall Study|sponsor request|0|||
33610321|NCT01320202|102123262|FG000|Overall Study|ineligible|3|||
33610322|NCT01320202|102123263|FG001|Overall Study|ineligible|0|||
33610323|NCT01320202|102123262|FG000|Overall Study|regained renal function|1|||
33610324|NCT01320202|102123263|FG001|Overall Study|regained renal function|0|||
33610325|NCT00782483|102123268|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
33526020|NCT03762681|101823412|FG003|Part 2a|Pandemic Travel Restrictions|0|||
33526021|NCT03762681|101823413|FG004|Part 2a|Pandemic Travel Restrictions|0|||
33526022|NCT03762681|101823414|FG005|Part 2a|Pandemic Travel Restrictions|0|||
33610326|NCT02332291|102123269|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
33610327|NCT02332291|102123270|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
33610328|NCT02332291|102123269|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
33610329|NCT02332291|102123270|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
33610330|NCT02332291|102123269|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
33610331|NCT02332291|102123270|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
33610332|NCT02332291|102123269|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
33610333|NCT02332291|102123270|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
33610334|NCT02332291|102123269|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
33610335|NCT02332291|102123270|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
33610336|NCT02332291|102123269|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
33610337|NCT02332291|102123270|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
33610338|NCT00186901|102123273|FG000|Overall Study|Pregnancy|6|||
33610339|NCT00186901|102123274|FG001|Overall Study|Pregnancy|3|||
33610340|NCT00186901|102123275|FG002|Overall Study|Pregnancy|0|||
33610341|NCT00186901|102123273|FG000|Overall Study|Lost to Follow-up|6|||
33332052|NCT04995055|101107778|FG001|Period 1|Withdrawal by Subject|1|||
33526023|NCT03762681|101823415|FG006|Part 2a|Pandemic Travel Restrictions|0|||
33526024|NCT03762681|101823416|FG007|Part 2a|Pandemic Travel Restrictions|1|||
33526025|NCT01317004|101823417|FG000|Overall Study|Withdrawal by Subject|1|||
33526026|NCT01317004|101823418|FG001|Overall Study|Withdrawal by Subject|4|||
33610342|NCT00186901|102123274|FG001|Overall Study|Lost to Follow-up|3|||
33610343|NCT00186901|102123275|FG002|Overall Study|Lost to Follow-up|0|||
33202912|NCT00383435|100645783|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
33202913|NCT00383435|100645784|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
33202914|NCT00383435|100645780|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
33202915|NCT00383435|100645781|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
33202916|NCT00383435|100645782|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
33202917|NCT00383435|100645783|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
33202918|NCT00383435|100645784|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
33202919|NCT00383435|100645780|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
33202920|NCT00383435|100645781|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
33202921|NCT00383435|100645782|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
33202922|NCT00383435|100645783|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
33202923|NCT00383435|100645784|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
33202924|NCT00383435|100645780|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
33202925|NCT00383435|100645781|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
33202926|NCT00383435|100645782|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
33202927|NCT00383435|100645783|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
33202928|NCT00383435|100645784|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
33202929|NCT00383435|100645780|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
33202930|NCT00383435|100645781|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
33202931|NCT00383435|100645782|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
33202932|NCT00383435|100645783|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
33202933|NCT00383435|100645784|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
33202934|NCT00383435|100645780|FG000|26-Week Treatment Safety Extension|Administrative|1|||
33202935|NCT00383435|100645781|FG001|26-Week Treatment Safety Extension|Administrative|1|||
33202936|NCT00383435|100645782|FG002|26-Week Treatment Safety Extension|Administrative|0|||
33202937|NCT00383435|100645783|FG003|26-Week Treatment Safety Extension|Administrative|1|||
33202938|NCT00383435|100645784|FG004|26-Week Treatment Safety Extension|Administrative|0|||
33202939|NCT02055352|100645785|FG000|Overall Study|Adverse Event|0|||
33202940|NCT02055352|100645786|FG001|Overall Study|Adverse Event|1|||
33202941|NCT02055352|100645785|FG000|Overall Study|Non-eligible|0|||
33202942|NCT02055352|100645786|FG001|Overall Study|Non-eligible|1|||
33202943|NCT02055352|100645785|FG000|Overall Study|Poor compliance|1|||
33202944|NCT02055352|100645786|FG001|Overall Study|Poor compliance|1|||
33202945|NCT02055352|100645785|FG000|Overall Study|Death|1|||
33202946|NCT02055352|100645786|FG001|Overall Study|Death|2|||
33202947|NCT02055352|100645785|FG000|Overall Study|Patient decision|1|||
33202948|NCT02055352|100645786|FG001|Overall Study|Patient decision|1|||
33202949|NCT02055352|100645785|FG000|Overall Study|Use of prohibited treatment|0|||
33202950|NCT02055352|100645786|FG001|Overall Study|Use of prohibited treatment|3|||
33202951|NCT02055352|100645785|FG000|Overall Study|AE, study drug would be detrimental|1|||
33202952|NCT02055352|100645786|FG001|Overall Study|AE, study drug would be detrimental|3|||
33202953|NCT02055352|100645785|FG000|Overall Study|Withdrawal of informed consent|1|||
33202954|NCT02055352|100645786|FG001|Overall Study|Withdrawal of informed consent|0|||
33202955|NCT02055352|100645785|FG000|Overall Study|Reason unknown|1|||
33202956|NCT02055352|100645786|FG001|Overall Study|Reason unknown|5|||
33202957|NCT02553330|100645787|FG000|Overall Study|Study Terminated by Sponsor|2|||
33202958|NCT02553330|100645788|FG001|Overall Study|Study Terminated by Sponsor|13|||
33202959|NCT02553330|100645789|FG002|Overall Study|Study Terminated by Sponsor|12|||
33202960|NCT02553330|100645787|FG000|Overall Study|Withdrawal by Subject|3|||
33202961|NCT02553330|100645788|FG001|Overall Study|Withdrawal by Subject|19|||
33202962|NCT02553330|100645789|FG002|Overall Study|Withdrawal by Subject|21|||
33202963|NCT02553330|100645787|FG000|Overall Study|Other|0|||
33202964|NCT02553330|100645788|FG001|Overall Study|Other|1|||
33202965|NCT02553330|100645789|FG002|Overall Study|Other|0|||
33202966|NCT02553330|100645787|FG000|Overall Study|Non compliance to study treatment|0|||
33202967|NCT02553330|100645788|FG001|Overall Study|Non compliance to study treatment|1|||
33202968|NCT02553330|100645789|FG002|Overall Study|Non compliance to study treatment|0|||
33202969|NCT02553330|100645787|FG000|Overall Study|Adverse Event|0|||
33202970|NCT02553330|100645788|FG001|Overall Study|Adverse Event|1|||
33202971|NCT02553330|100645789|FG002|Overall Study|Adverse Event|0|||
33202972|NCT02553330|100645787|FG000|Overall Study|Lost to Follow-up|0|||
33332053|NCT04995055|101107777|FG000|Period 1|Subject discontinued due to timing|4|||
33332054|NCT04995055|101107778|FG001|Period 1|Subject discontinued due to timing|4|||
33332055|NCT01918007|101107779|FG000|Overall Study|Baseline oximetry not acceptable|11|||
33332056|NCT01918007|101107780|FG001|Overall Study|Baseline oximetry not acceptable|7|||
33202973|NCT02553330|100645788|FG001|Overall Study|Lost to Follow-up|4|||
33202974|NCT02553330|100645789|FG002|Overall Study|Lost to Follow-up|4|||
33202975|NCT04558346|100645790|FG000|Overall Study|Withdrawal by Subject|2|||
33402539|NCT00540228|101365336|FG001|Overall Study|Lost to Follow-up|1|||
33402540|NCT00540228|101365337|FG002|Overall Study|Lost to Follow-up|0|||
33202976|NCT04558346|100645791|FG001|Overall Study|Withdrawal by Subject|0|||
33610344|NCT00186901|102123273|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
33610345|NCT00186901|102123274|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
33610346|NCT00186901|102123275|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
33610347|NCT00186901|102123273|FG000|Overall Study|ALL relapse or second malignancy|1|||
33610348|NCT00186901|102123274|FG001|Overall Study|ALL relapse or second malignancy|2|||
33610349|NCT00186901|102123275|FG002|Overall Study|ALL relapse or second malignancy|0|||
33610350|NCT00186901|102123273|FG000|Overall Study|Withdrawal by Subject|4|||
33610351|NCT00186901|102123274|FG001|Overall Study|Withdrawal by Subject|5|||
33610352|NCT00186901|102123275|FG002|Overall Study|Withdrawal by Subject|0|||
33610353|NCT00186901|102123273|FG000|Overall Study|Open label|3|||
33610354|NCT00186901|102123274|FG001|Overall Study|Open label|2|||
33610355|NCT00186901|102123275|FG002|Overall Study|Open label|0|||
33610356|NCT00186901|102123273|FG000|Overall Study|Limited adherence to study requirements|20|||
33332057|NCT01918007|101107779|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
33332058|NCT01918007|101107780|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
33610357|NCT00186901|102123274|FG001|Overall Study|Limited adherence to study requirements|23|||
33610358|NCT00186901|102123275|FG002|Overall Study|Limited adherence to study requirements|0|||
33610359|NCT00186901|102123273|FG000|Overall Study|Bone Mineral Density > 0|0|||
33610360|NCT00186901|102123274|FG001|Overall Study|Bone Mineral Density > 0|0|||
33610361|NCT00186901|102123275|FG002|Overall Study|Bone Mineral Density > 0|149|||
33610362|NCT01068769|102123276|FG000|Overall Study|Ineligible|1|||
33610363|NCT01161537|102123277|FG000|Part B|Withdrawal by Subject|2|||
33610364|NCT04412707|102123279|FG000|Cycle 1|Death|0|||
33610365|NCT04412707|102123280|FG001|Cycle 1|Death|3|||
33610366|NCT04412707|102123279|FG000|Cycle 1|Disease progression|1|||
33610367|NCT04412707|102123280|FG001|Cycle 1|Disease progression|2|||
33610368|NCT04412707|102123279|FG000|Cycle 2|Death|0|||
33610369|NCT04412707|102123280|FG001|Cycle 2|Death|1|||
33610370|NCT04412707|102123279|FG000|Cycle 2|Disease progression|3|||
33610371|NCT04412707|102123280|FG001|Cycle 2|Disease progression|0|||
33610372|NCT04412707|102123279|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
33610373|NCT04412707|102123280|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
33610374|NCT04412707|102123279|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
33610375|NCT04412707|102123280|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
33610376|NCT04412707|102123279|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
33610377|NCT04412707|102123280|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
33610378|NCT04412707|102123279|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
33332059|NCT01918007|101107779|FG000|Overall Study|Lost to Follow-up|4|||
33332060|NCT01918007|101107780|FG001|Overall Study|Lost to Follow-up|7|||
33332061|NCT01549275|101107781|FG000|Overall Study|Lost to Follow-up|1|||
33332062|NCT01549275|101107782|FG001|Overall Study|Lost to Follow-up|0|||
33332063|NCT01372384|101111467|FG000|Overall Study|Progression of disease|3|||
33332064|NCT00492752|101111468|FG000|Double Blind Treatment|Death|13|||
33610379|NCT04412707|102123280|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
33610380|NCT00983385|102123286|FG000|Observation Period|Not eligible to be dosed|20|||
33610381|NCT00983385|102123286|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
33610382|NCT01114438|102123287|FG000|Overall Study|Adverse Event|10|||
33610383|NCT01114438|102123287|FG000|Overall Study|concomitant medication|1|||
33610384|NCT01114438|102123287|FG000|Overall Study|Physician Decision|1|||
33610385|NCT01114438|102123287|FG000|Overall Study|Withdrawal by Subject|2|||
33610386|NCT01069705|102123299|FG000|Overall Study|Adverse Event|1|||
33610387|NCT01069705|102123299|FG000|Overall Study|Withdrawal by Subject|2|||
33610388|NCT01948063|102123300|FG000|Overall Study|Boston MCI halted research protocol|0|||
33610389|NCT01948063|102123301|FG001|Overall Study|Boston MCI halted research protocol|1|||
33610390|NCT01948063|102123300|FG000|Overall Study|Discovered an enrollment in other study|0|||
33610391|NCT01948063|102123301|FG001|Overall Study|Discovered an enrollment in other study|1|||
33610392|NCT01948063|102123300|FG000|Overall Study|Blood samples were accidentally thawed|1|||
33202977|NCT04558346|100645790|FG000|Overall Study|Lost to Follow-up|0|||
33202978|NCT04558346|100645791|FG001|Overall Study|Lost to Follow-up|1|||
33202979|NCT04558346|100645790|FG000|Overall Study|Adverse Event|0|||
33332065|NCT00492752|101111469|FG001|Double Blind Treatment|Death|0|||
33332066|NCT00492752|101111470|FG002|Double Blind Treatment|Death|2|||
33202980|NCT04558346|100645791|FG001|Overall Study|Adverse Event|1|||
33332067|NCT00492752|101111471|FG003|Double Blind Treatment|Death|0|||
33610393|NCT01948063|102123301|FG001|Overall Study|Blood samples were accidentally thawed|0|||
33610394|NCT04038567|102123304|FG000|Overall Study|Lost to Follow-up|6|||
33610395|NCT04038567|102123305|FG001|Overall Study|Lost to Follow-up|4|||
33610396|NCT04038567|102123306|FG002|Overall Study|Lost to Follow-up|5|||
33610397|NCT04038567|102123307|FG003|Overall Study|Lost to Follow-up|4|||
33610398|NCT04038567|102123308|FG004|Overall Study|Lost to Follow-up|6|||
33202981|NCT01332305|100645792|FG000|Overall Study|Adverse Event|1|||
33332068|NCT00492752|101111468|FG000|Double Blind Treatment|Adverse Event|1|||
33402541|NCT00540228|101365338|FG003|Overall Study|Lost to Follow-up|0|||
33610399|NCT04038567|102123309|FG005|Overall Study|Lost to Follow-up|4|||
33610400|NCT04038567|102123310|FG006|Overall Study|Lost to Follow-up|4|||
33610401|NCT04038567|102123311|FG007|Overall Study|Lost to Follow-up|1|||
33610402|NCT04038567|102123304|FG000|Overall Study|Withdrawal by Subject|2|||
33610403|NCT04038567|102123305|FG001|Overall Study|Withdrawal by Subject|1|||
33610404|NCT04038567|102123306|FG002|Overall Study|Withdrawal by Subject|1|||
33610405|NCT04038567|102123307|FG003|Overall Study|Withdrawal by Subject|1|||
33610406|NCT04038567|102123308|FG004|Overall Study|Withdrawal by Subject|4|||
33610407|NCT04038567|102123309|FG005|Overall Study|Withdrawal by Subject|1|||
33610408|NCT04038567|102123310|FG006|Overall Study|Withdrawal by Subject|1|||
33610409|NCT04038567|102123311|FG007|Overall Study|Withdrawal by Subject|1|||
33332069|NCT00492752|101111469|FG001|Double Blind Treatment|Adverse Event|0|||
33610410|NCT04038567|102123304|FG000|Overall Study|missed survey window|1|||
33610411|NCT04038567|102123305|FG001|Overall Study|missed survey window|2|||
33610412|NCT04038567|102123306|FG002|Overall Study|missed survey window|0|||
33610413|NCT04038567|102123307|FG003|Overall Study|missed survey window|0|||
33610414|NCT04038567|102123308|FG004|Overall Study|missed survey window|1|||
33610415|NCT04038567|102123309|FG005|Overall Study|missed survey window|1|||
33610416|NCT04038567|102123310|FG006|Overall Study|missed survey window|2|||
33610417|NCT04038567|102123311|FG007|Overall Study|missed survey window|2|||
33610418|NCT04038567|102123304|FG000|Overall Study|technical issues|0|||
33610419|NCT04038567|102123305|FG001|Overall Study|technical issues|0|||
33202982|NCT01332305|100645793|FG001|Overall Study|Adverse Event|4|||
33202983|NCT01332305|100645794|FG002|Overall Study|Adverse Event|6|||
33332070|NCT00492752|101111470|FG002|Double Blind Treatment|Adverse Event|0|||
33332071|NCT00492752|101111471|FG003|Double Blind Treatment|Adverse Event|0|||
33332072|NCT00492752|101111468|FG000|Double Blind Treatment|Protocol Violation|0|||
33332073|NCT00492752|101111469|FG001|Double Blind Treatment|Protocol Violation|0|||
33332074|NCT00492752|101111470|FG002|Double Blind Treatment|Protocol Violation|1|||
33332075|NCT00492752|101111471|FG003|Double Blind Treatment|Protocol Violation|0|||
33202984|NCT01332305|100645795|FG003|Overall Study|Adverse Event|3|||
33332076|NCT00492752|101111468|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
33332077|NCT00492752|101111469|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
33332078|NCT00492752|101111470|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
33332079|NCT00492752|101111471|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
33332080|NCT00492752|101111468|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
33332081|NCT00492752|101111469|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
33332082|NCT00492752|101111470|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
33332083|NCT00492752|101111471|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
33402542|NCT00540228|101365339|FG004|Overall Study|Lost to Follow-up|0|||
33402543|NCT00087685|101365340|FG000|Overall Study|Adverse Event|5|||
33402544|NCT00087685|101365340|FG000|Overall Study|Non-Compliance|1|||
33332084|NCT00492752|101111468|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
33332085|NCT00492752|101111469|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
33332086|NCT00492752|101111470|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
33332087|NCT00492752|101111471|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
33332088|NCT00492752|101111468|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
33402545|NCT00087685|101365340|FG000|Overall Study|Progressive Disease|5|||
33402546|NCT00087685|101365340|FG000|Overall Study|Withdrawal by Subject|3|||
33332089|NCT00492752|101111469|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
33332090|NCT00492752|101111470|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
33332091|NCT00492752|101111471|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
33332092|NCT00492752|101111468|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
33332093|NCT00492752|101111469|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
33332094|NCT00492752|101111470|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
33332095|NCT00492752|101111471|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
33332096|NCT00492752|101111468|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
33402547|NCT01454531|101365341|FG000|Overall Study|Adverse Event|14|||
33402548|NCT01454531|101365341|FG000|Overall Study|Withdrawal by Subject|5|||
33402549|NCT01454531|101365341|FG000|Overall Study|Lost to Follow-up|1|||
33402550|NCT01454531|101365341|FG000|Overall Study|Physician Decision|1|||
33402551|NCT01454531|101365341|FG000|Overall Study|Delay in IMP administration|1|||
33402552|NCT01454531|101365341|FG000|Overall Study|Other|1|||
33402553|NCT02608099|101365342|FG000|Overall Study|Ablation procedure not initiated|3|||
33526027|NCT01317004|101823417|FG000|Overall Study|Protocol Violation|0|||
33402554|NCT02608099|101365343|FG001|Overall Study|Ablation procedure not initiated|2|||
33402555|NCT00141297|101365345|FG000|Overall Study|Adverse Event|0|||
33526028|NCT01317004|101823418|FG001|Overall Study|Protocol Violation|2|||
33526029|NCT01317004|101823417|FG000|Overall Study|Adverse Event|3|||
33526030|NCT01317004|101823418|FG001|Overall Study|Adverse Event|3|||
33526031|NCT02776670|101823419|FG000|Overall Study|Adverse Event|0|||
33526032|NCT02776670|101823420|FG001|Overall Study|Adverse Event|2|||
33526033|NCT02776670|101823419|FG000|Overall Study|Protocol Violation|0|||
33526034|NCT02776670|101823420|FG001|Overall Study|Protocol Violation|2|||
33610420|NCT04038567|102123306|FG002|Overall Study|technical issues|0|||
33610421|NCT04038567|102123307|FG003|Overall Study|technical issues|0|||
33332097|NCT00492752|101111469|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
33332098|NCT00492752|101111470|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
33332099|NCT00492752|101111471|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
33332100|NCT00492752|101111468|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
33526035|NCT02776670|101823419|FG000|Overall Study|Withdrawal by Subject|0|||
33526036|NCT02776670|101823420|FG001|Overall Study|Withdrawal by Subject|1|||
33526037|NCT02776670|101823419|FG000|Overall Study|Other - Reason not given|0|||
33526038|NCT02776670|101823420|FG001|Overall Study|Other - Reason not given|1|||
33526039|NCT00660595|101823421|FG000|Overall Study|Lost to Follow-up|0|||
33526040|NCT00660595|101823422|FG001|Overall Study|Lost to Follow-up|1|||
33526041|NCT00660595|101823421|FG000|Overall Study|Did not consent to participate in study|12|||
33526042|NCT00660595|101823422|FG001|Overall Study|Did not consent to participate in study|8|||
33526043|NCT00660595|101823421|FG000|Overall Study|Participant left hospital|1|||
33526044|NCT00660595|101823422|FG001|Overall Study|Participant left hospital|0|||
33526045|NCT00660595|101823421|FG000|Overall Study|Non Specified reasons|5|||
33526046|NCT00660595|101823422|FG001|Overall Study|Non Specified reasons|0|||
33526047|NCT00069823|101823424|FG000|Overall Study|Did not have follow-up diary cards|6|||
33526048|NCT00069823|101823425|FG001|Overall Study|Did not have follow-up diary cards|3|||
33526049|NCT01663857|101823426|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
33526050|NCT01663857|101823427|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
33526051|NCT01663857|101823428|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
33526052|NCT01663857|101823429|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
33526053|NCT01663857|101823426|FG000|Overall Study|Lost to Follow-up|0|||
33526054|NCT01663857|101823427|FG001|Overall Study|Lost to Follow-up|0|||
33526055|NCT01663857|101823428|FG002|Overall Study|Lost to Follow-up|3|||
33526056|NCT01663857|101823429|FG003|Overall Study|Lost to Follow-up|1|||
33526057|NCT01042392|101823430|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
33526058|NCT01042392|101823431|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
33526059|NCT01042392|101823432|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
33332101|NCT00492752|101111469|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
33332102|NCT00492752|101111470|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
33332103|NCT00492752|101111471|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
33332104|NCT00492752|101111468|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
33332105|NCT00492752|101111469|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
33332106|NCT00492752|101111470|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
33332107|NCT00492752|101111471|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
33332108|NCT00766532|101111472|FG000|Overall Study|Protocol Violation|2|||
33332109|NCT03923426|101111473|FG000|Overall Study|Other|19|||
33332110|NCT03923426|101111473|FG000|Overall Study|Lost to Follow-up|16|||
33332111|NCT03923426|101111473|FG000|Overall Study|Death|107|||
33332112|NCT03923426|101111473|FG000|Overall Study|Incomplete response to question|13|||
33332113|NCT00894556|101111474|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
33332114|NCT00894556|101111475|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
33332115|NCT00894556|101111476|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
33332116|NCT00894556|101111477|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
33332117|NCT00894556|101111474|FG000|Treatment Phase|Lost to Follow-up|2|||
33332118|NCT00894556|101111475|FG001|Treatment Phase|Lost to Follow-up|3|||
33332119|NCT00894556|101111476|FG002|Treatment Phase|Lost to Follow-up|1|||
33332120|NCT00894556|101111477|FG003|Treatment Phase|Lost to Follow-up|0|||
33332121|NCT00894556|101111474|FG000|Treatment Phase|Lack of Qualifying Event|2|||
33332122|NCT00894556|101111475|FG001|Treatment Phase|Lack of Qualifying Event|1|||
33332123|NCT00894556|101111476|FG002|Treatment Phase|Lack of Qualifying Event|0|||
33332124|NCT00894556|101111477|FG003|Treatment Phase|Lack of Qualifying Event|0|||
33332125|NCT01834274|101111478|FG000|Overall Study|Study Termination|41|||
33332126|NCT01834274|101111479|FG001|Overall Study|Study Termination|38|||
33332127|NCT01834274|101111478|FG000|Overall Study|Withdrawal by Subject|1|||
33332128|NCT01834274|101111479|FG001|Overall Study|Withdrawal by Subject|1|||
33332129|NCT01834274|101111478|FG000|Overall Study|Lost to Follow-up|3|||
33332130|NCT01834274|101111479|FG001|Overall Study|Lost to Follow-up|1|||
33332131|NCT01834274|101111478|FG000|Overall Study|Other|2|||
33332132|NCT01834274|101111479|FG001|Overall Study|Other|1|||
33402556|NCT00141297|101365346|FG001|Overall Study|Adverse Event|0|||
33526060|NCT01042392|101823433|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
33526061|NCT01042392|101823430|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
33526062|NCT01042392|101823431|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
33526063|NCT01042392|101823432|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
33332133|NCT00769184|101111480|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
33332134|NCT00769184|101111481|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
33332135|NCT00769184|101111480|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
33332136|NCT00769184|101111481|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
33402557|NCT00141297|101365347|FG002|Overall Study|Adverse Event|1|||
33402558|NCT00141297|101365348|FG003|Overall Study|Adverse Event|0|||
33402559|NCT00141297|101365349|FG004|Overall Study|Adverse Event|1|||
33402560|NCT00141297|101365350|FG005|Overall Study|Adverse Event|1|||
33402561|NCT00141297|101365351|FG006|Overall Study|Adverse Event|0|||
33526064|NCT01042392|101823433|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
33526065|NCT01042392|101823430|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
33526066|NCT01042392|101823431|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
33526067|NCT01042392|101823432|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
33526068|NCT01042392|101823433|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
33526069|NCT01042392|101823430|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
33526070|NCT01042392|101823431|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
33526071|NCT01042392|101823432|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
33526072|NCT01042392|101823433|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
33526073|NCT01042392|101823430|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
33526074|NCT01042392|101823431|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
33526075|NCT01042392|101823432|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
33526076|NCT01042392|101823433|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
33526077|NCT01042392|101823430|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
33526078|NCT01042392|101823431|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
33526079|NCT01042392|101823432|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
33526080|NCT01042392|101823433|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
33526081|NCT01042392|101823430|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
33526082|NCT01042392|101823431|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
33526083|NCT01042392|101823432|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
33202985|NCT01332305|100645796|FG004|Overall Study|Adverse Event|5|||
33202986|NCT01332305|100645792|FG000|Overall Study|Withdrawal by Subject|6|||
33202987|NCT01332305|100645793|FG001|Overall Study|Withdrawal by Subject|5|||
33202988|NCT01332305|100645794|FG002|Overall Study|Withdrawal by Subject|4|||
33202989|NCT01332305|100645795|FG003|Overall Study|Withdrawal by Subject|1|||
33202990|NCT01332305|100645796|FG004|Overall Study|Withdrawal by Subject|0|||
33202991|NCT01332305|100645792|FG000|Overall Study|Lost to Follow-up|0|||
33202992|NCT01332305|100645793|FG001|Overall Study|Lost to Follow-up|2|||
33202993|NCT01332305|100645794|FG002|Overall Study|Lost to Follow-up|3|||
33202994|NCT01332305|100645795|FG003|Overall Study|Lost to Follow-up|2|||
33202995|NCT01332305|100645796|FG004|Overall Study|Lost to Follow-up|3|||
33202996|NCT01332305|100645792|FG000|Overall Study|Protocol Violation|1|||
33202997|NCT01332305|100645793|FG001|Overall Study|Protocol Violation|2|||
33202998|NCT01332305|100645794|FG002|Overall Study|Protocol Violation|1|||
33202999|NCT01332305|100645795|FG003|Overall Study|Protocol Violation|0|||
33203000|NCT01332305|100645796|FG004|Overall Study|Protocol Violation|3|||
33203001|NCT01332305|100645792|FG000|Overall Study|Withdrawal by Sponsor|1|||
33203002|NCT01332305|100645793|FG001|Overall Study|Withdrawal by Sponsor|0|||
33203003|NCT01332305|100645794|FG002|Overall Study|Withdrawal by Sponsor|0|||
33203004|NCT01332305|100645795|FG003|Overall Study|Withdrawal by Sponsor|1|||
33203005|NCT01332305|100645796|FG004|Overall Study|Withdrawal by Sponsor|1|||
33203006|NCT01332305|100645792|FG000|Overall Study|Treatment Failure|1|||
33203007|NCT01332305|100645793|FG001|Overall Study|Treatment Failure|1|||
33203008|NCT01332305|100645794|FG002|Overall Study|Treatment Failure|0|||
33203009|NCT01332305|100645795|FG003|Overall Study|Treatment Failure|0|||
33203010|NCT01332305|100645796|FG004|Overall Study|Treatment Failure|0|||
33203011|NCT01332305|100645792|FG000|Overall Study|Physician Decision|0|||
33203012|NCT01332305|100645793|FG001|Overall Study|Physician Decision|0|||
33203013|NCT01332305|100645794|FG002|Overall Study|Physician Decision|0|||
33203014|NCT01332305|100645795|FG003|Overall Study|Physician Decision|1|||
33203015|NCT01332305|100645796|FG004|Overall Study|Physician Decision|0|||
33203016|NCT00462384|100645797|FG000|Overall Study|Adverse Event|2|||
33203017|NCT00462384|100645797|FG000|Overall Study|Death|2|||
33203018|NCT00462384|100645797|FG000|Overall Study|Withdrawal by Subject|1|||
33203019|NCT00462384|100645797|FG000|Overall Study|Other|4|||
33203020|NCT00253864|100645798|FG000|Overall Study|Lost to Follow-up|5|||
33203021|NCT00253864|100645799|FG001|Overall Study|Lost to Follow-up|8|||
33610422|NCT04038567|102123308|FG004|Overall Study|technical issues|0|||
33203022|NCT01226745|100645800|FG000|Overall Study|Did not complete schedule of assessments|8|||
33203023|NCT01226745|100645801|FG001|Overall Study|Did not complete schedule of assessments|3|||
33203024|NCT01226745|100645802|FG002|Overall Study|Did not complete schedule of assessments|6|||
33203025|NCT01226745|100645803|FG003|Overall Study|Did not complete schedule of assessments|0|||
33203026|NCT01226745|100645804|FG004|Overall Study|Did not complete schedule of assessments|0|||
33203027|NCT01226745|100645805|FG005|Overall Study|Did not complete schedule of assessments|1|||
33203028|NCT01226745|100645800|FG000|Overall Study|Lost to Follow-up|2|||
33402562|NCT00141297|101365352|FG007|Overall Study|Adverse Event|1|||
33203029|NCT01226745|100645801|FG001|Overall Study|Lost to Follow-up|6|||
33203030|NCT01226745|100645802|FG002|Overall Study|Lost to Follow-up|6|||
33332137|NCT00769184|101111480|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
33332138|NCT00769184|101111481|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
33402563|NCT00141297|101365353|FG008|Overall Study|Adverse Event|1|||
33402564|NCT00141297|101365354|FG009|Overall Study|Adverse Event|0|||
33402565|NCT00141297|101365345|FG000|Overall Study|Death|1|||
33332139|NCT02081534|101111488|FG000|Overall Study|Adverse Event|5|||
33332140|NCT02081534|101111489|FG001|Overall Study|Adverse Event|4|||
33332141|NCT02081534|101111490|FG002|Overall Study|Adverse Event|3|||
33332142|NCT02081534|101111491|FG003|Overall Study|Adverse Event|10|||
33332143|NCT02081534|101111492|FG004|Overall Study|Adverse Event|2|||
33332144|NCT02081534|101111493|FG005|Overall Study|Adverse Event|8|||
33332145|NCT02081534|101111494|FG006|Overall Study|Adverse Event|2|||
33332146|NCT02081534|101111488|FG000|Overall Study|Withdrawal by Subject|0|||
33332147|NCT02081534|101111489|FG001|Overall Study|Withdrawal by Subject|1|||
33332148|NCT02081534|101111490|FG002|Overall Study|Withdrawal by Subject|1|||
33332149|NCT02081534|101111491|FG003|Overall Study|Withdrawal by Subject|1|||
33332150|NCT02081534|101111492|FG004|Overall Study|Withdrawal by Subject|1|||
33332151|NCT02081534|101111493|FG005|Overall Study|Withdrawal by Subject|0|||
33332152|NCT02081534|101111494|FG006|Overall Study|Withdrawal by Subject|1|||
33332153|NCT02081534|101111488|FG000|Overall Study|Protocol Violation|0|||
33332154|NCT02081534|101111489|FG001|Overall Study|Protocol Violation|3|||
33332155|NCT02081534|101111490|FG002|Overall Study|Protocol Violation|0|||
33332156|NCT02081534|101111491|FG003|Overall Study|Protocol Violation|0|||
33332157|NCT02081534|101111492|FG004|Overall Study|Protocol Violation|0|||
33332158|NCT02081534|101111493|FG005|Overall Study|Protocol Violation|0|||
33332159|NCT02081534|101111494|FG006|Overall Study|Protocol Violation|1|||
33332160|NCT02081534|101111488|FG000|Overall Study|Lost to Follow-up|0|||
33332161|NCT02081534|101111489|FG001|Overall Study|Lost to Follow-up|0|||
33332162|NCT02081534|101111490|FG002|Overall Study|Lost to Follow-up|0|||
33332163|NCT02081534|101111491|FG003|Overall Study|Lost to Follow-up|2|||
33332164|NCT02081534|101111492|FG004|Overall Study|Lost to Follow-up|1|||
33332165|NCT02081534|101111493|FG005|Overall Study|Lost to Follow-up|1|||
33332166|NCT02081534|101111494|FG006|Overall Study|Lost to Follow-up|0|||
33332167|NCT02807480|101111495|FG000|Overall Study|Withdrawal by Subject|14|||
33526084|NCT01042392|101823433|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
33526085|NCT01042392|101823430|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
33526086|NCT01042392|101823431|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
33526087|NCT01042392|101823432|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
33526088|NCT01042392|101823433|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
33526089|NCT01042392|101823430|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
33526090|NCT01042392|101823431|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
33526091|NCT01042392|101823432|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
33526092|NCT01042392|101823433|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
33402566|NCT00141297|101365346|FG001|Overall Study|Death|0|||
33402567|NCT00141297|101365347|FG002|Overall Study|Death|0|||
33402568|NCT00141297|101365348|FG003|Overall Study|Death|0|||
33402569|NCT00141297|101365349|FG004|Overall Study|Death|0|||
33402570|NCT00141297|101365350|FG005|Overall Study|Death|0|||
33526093|NCT01616758|101823434|FG000|Overall Study|Adverse Event|1|||
33332168|NCT02807480|101111496|FG001|Overall Study|Withdrawal by Subject|10|||
33526094|NCT01616758|101823434|FG000|Overall Study|Withdrawal by Subject|2|||
33526095|NCT01616758|101823434|FG000|Overall Study|Disease progression|18|||
33526096|NCT01616758|101823434|FG000|Overall Study|Study termination by Sponsor|1|||
33526097|NCT02168777|101823438|FG000|Overall Study|Withdrawal by Subject|1|||
33526098|NCT02168777|101823439|FG001|Overall Study|Withdrawal by Subject|0|||
33610423|NCT04038567|102123309|FG005|Overall Study|technical issues|0|||
33332169|NCT00777101|101111502|FG000|Overall Study|Death|48|||
33332170|NCT00777101|101111503|FG001|Overall Study|Death|43|||
33332171|NCT00777101|101111502|FG000|Overall Study|Withdrawal by Subject|11|||
33402571|NCT00141297|101365351|FG006|Overall Study|Death|0|||
33402572|NCT00141297|101365352|FG007|Overall Study|Death|0|||
33526099|NCT02168777|101823440|FG002|Overall Study|Withdrawal by Subject|2|||
33332172|NCT00777101|101111503|FG001|Overall Study|Withdrawal by Subject|6|||
33332173|NCT00777101|101111502|FG000|Overall Study|Lost to Follow-up|2|||
33332174|NCT00777101|101111503|FG001|Overall Study|Lost to Follow-up|1|||
33332175|NCT00777101|101111502|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
33332176|NCT00777101|101111503|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
33332177|NCT00777101|101111502|FG000|Overall Study|Failed to Return|0|||
33332178|NCT00777101|101111503|FG001|Overall Study|Failed to Return|1|||
33332179|NCT00961220|101111504|FG000|Overall Study|Adverse Event|3|||
33526100|NCT02168777|101823438|FG000|Overall Study|Adverse Event|1|||
33526101|NCT02168777|101823439|FG001|Overall Study|Adverse Event|0|||
33332180|NCT00961220|101111504|FG000|Overall Study|Lack of Efficacy|1|||
33332181|NCT00961220|101111504|FG000|Overall Study|No IV access for O6BG|1|||
33332182|NCT00961220|101111504|FG000|Overall Study|O6BG no longer supplied|1|||
33402573|NCT00141297|101365353|FG008|Overall Study|Death|1|||
33402574|NCT00141297|101365354|FG009|Overall Study|Death|0|||
33526102|NCT02168777|101823440|FG002|Overall Study|Adverse Event|1|||
33526103|NCT02168777|101823438|FG000|Overall Study|Disease recurrence|0|||
33526104|NCT02168777|101823439|FG001|Overall Study|Disease recurrence|0|||
33526105|NCT02168777|101823440|FG002|Overall Study|Disease recurrence|1|||
33526106|NCT02168777|101823438|FG000|Overall Study|Radiological disease progression|0|||
33526107|NCT02168777|101823439|FG001|Overall Study|Radiological disease progression|5|||
33526108|NCT02168777|101823440|FG002|Overall Study|Radiological disease progression|5|||
33526109|NCT02168777|101823438|FG000|Overall Study|Clinical disease progression|0|||
33526110|NCT02168777|101823439|FG001|Overall Study|Clinical disease progression|1|||
33526111|NCT02168777|101823440|FG002|Overall Study|Clinical disease progression|2|||
33526112|NCT02168777|101823438|FG000|Overall Study|Other reason|0|||
33526113|NCT02168777|101823439|FG001|Overall Study|Other reason|1|||
33526114|NCT02168777|101823440|FG002|Overall Study|Other reason|0|||
33526115|NCT00662311|101823443|FG000|Overall Study|Respiratory Infection|1|||
33526116|NCT00662311|101823444|FG001|Overall Study|Respiratory Infection|0|||
33526117|NCT00662311|101823445|FG002|Overall Study|Respiratory Infection|0|||
33526118|NCT00003896|101823446|FG000|Overall Study|Adverse Event|16|||
33526119|NCT00003896|101823446|FG000|Overall Study|Withdrawal by Subject|1|||
33526120|NCT00003896|101823446|FG000|Overall Study|Lack of Efficacy|1|||
33526121|NCT00003896|101823446|FG000|Overall Study|Death|3|||
33526122|NCT00003896|101823446|FG000|Overall Study|not protocol specified|3|||
33526123|NCT00003896|101823446|FG000|Overall Study|ineligible|5|||
33526124|NCT03307837|101823450|FG000|Overall Study|Withdrawal by Subject|0|||
33526125|NCT03307837|101823451|FG001|Overall Study|Withdrawal by Subject|0|||
33526126|NCT03307837|101823452|FG002|Overall Study|Withdrawal by Subject|1|||
33526127|NCT03307837|101823453|FG003|Overall Study|Withdrawal by Subject|0|||
33526128|NCT03307837|101823454|FG004|Overall Study|Withdrawal by Subject|0|||
33526129|NCT03307837|101823455|FG005|Overall Study|Withdrawal by Subject|1|||
33526130|NCT03307837|101823450|FG000|Overall Study|Lost to Follow-up|1|||
33526131|NCT03307837|101823451|FG001|Overall Study|Lost to Follow-up|1|||
33526132|NCT03307837|101823452|FG002|Overall Study|Lost to Follow-up|0|||
33526133|NCT03307837|101823453|FG003|Overall Study|Lost to Follow-up|0|||
33526134|NCT03307837|101823454|FG004|Overall Study|Lost to Follow-up|0|||
33526135|NCT03307837|101823455|FG005|Overall Study|Lost to Follow-up|1|||
33526136|NCT00572455|101823456|FG000|Stage I (14 Days)|Adverse Event|0|||
33526137|NCT00572455|101823457|FG001|Stage I (14 Days)|Adverse Event|0|||
33526138|NCT00572455|101823458|FG002|Stage I (14 Days)|Adverse Event|0|||
33526139|NCT00572455|101823459|FG003|Stage I (14 Days)|Adverse Event|0|||
33526140|NCT00572455|101823460|FG004|Stage I (14 Days)|Adverse Event|0|||
33526141|NCT00572455|101823461|FG005|Stage I (14 Days)|Adverse Event|3|||
33526142|NCT00572455|101823462|FG006|Stage I (14 Days)|Adverse Event|0|||
33526143|NCT00572455|101823463|FG007|Stage I (14 Days)|Adverse Event|0|||
33526144|NCT00572455|101823464|FG008|Stage I (14 Days)|Adverse Event|0|||
33526145|NCT00572455|101823465|FG009|Stage I (14 Days)|Adverse Event|0|||
33526146|NCT00572455|101823466|FG010|Stage I (14 Days)|Adverse Event|0|||
33526147|NCT00572455|101823467|FG011|Stage I (14 Days)|Adverse Event|0|||
33526148|NCT00572455|101823468|FG012|Stage I (14 Days)|Adverse Event|0|||
33526149|NCT00572455|101823469|FG013|Stage I (14 Days)|Adverse Event|0|||
33526150|NCT00572455|101823456|FG000|Stage I (14 Days)|Other|0|||
33526151|NCT00572455|101823457|FG001|Stage I (14 Days)|Other|0|||
33526152|NCT00572455|101823458|FG002|Stage I (14 Days)|Other|0|||
33526153|NCT00572455|101823459|FG003|Stage I (14 Days)|Other|0|||
33526154|NCT00572455|101823460|FG004|Stage I (14 Days)|Other|1|||
33526155|NCT00572455|101823461|FG005|Stage I (14 Days)|Other|0|||
33526156|NCT00572455|101823462|FG006|Stage I (14 Days)|Other|0|||
33526157|NCT00572455|101823463|FG007|Stage I (14 Days)|Other|0|||
33526158|NCT00572455|101823464|FG008|Stage I (14 Days)|Other|0|||
33526159|NCT00572455|101823465|FG009|Stage I (14 Days)|Other|0|||
33526160|NCT00572455|101823466|FG010|Stage I (14 Days)|Other|0|||
33526161|NCT00572455|101823467|FG011|Stage I (14 Days)|Other|0|||
33526162|NCT00572455|101823468|FG012|Stage I (14 Days)|Other|0|||
33526163|NCT00572455|101823469|FG013|Stage I (14 Days)|Other|0|||
33526164|NCT00572455|101823456|FG000|Stage II (28 Days)|Adverse Event|0|||
33203031|NCT01226745|100645803|FG003|Overall Study|Lost to Follow-up|1|||
33402575|NCT00141297|101365345|FG000|Overall Study|Withdrawal by Subject|0|||
33402576|NCT00141297|101365346|FG001|Overall Study|Withdrawal by Subject|0|||
33526165|NCT00572455|101823457|FG001|Stage II (28 Days)|Adverse Event|0|||
33526166|NCT00572455|101823458|FG002|Stage II (28 Days)|Adverse Event|0|||
33526167|NCT00572455|101823459|FG003|Stage II (28 Days)|Adverse Event|0|||
33526168|NCT00572455|101823460|FG004|Stage II (28 Days)|Adverse Event|0|||
33526169|NCT00572455|101823461|FG005|Stage II (28 Days)|Adverse Event|0|||
33526170|NCT00572455|101823462|FG006|Stage II (28 Days)|Adverse Event|0|||
33526171|NCT00572455|101823463|FG007|Stage II (28 Days)|Adverse Event|0|||
33526172|NCT00572455|101823464|FG008|Stage II (28 Days)|Adverse Event|1|||
33526173|NCT00572455|101823465|FG009|Stage II (28 Days)|Adverse Event|3|||
33526174|NCT00572455|101823466|FG010|Stage II (28 Days)|Adverse Event|3|||
33526175|NCT00572455|101823467|FG011|Stage II (28 Days)|Adverse Event|4|||
33526176|NCT00572455|101823468|FG012|Stage II (28 Days)|Adverse Event|5|||
33526177|NCT00572455|101823469|FG013|Stage II (28 Days)|Adverse Event|1|||
33526178|NCT00572455|101823456|FG000|Stage II (28 Days)|Death|0|||
33526179|NCT00572455|101823457|FG001|Stage II (28 Days)|Death|0|||
33526180|NCT00572455|101823458|FG002|Stage II (28 Days)|Death|0|||
33526181|NCT00572455|101823459|FG003|Stage II (28 Days)|Death|0|||
33526182|NCT00572455|101823460|FG004|Stage II (28 Days)|Death|0|||
33526183|NCT00572455|101823461|FG005|Stage II (28 Days)|Death|0|||
33526184|NCT00572455|101823462|FG006|Stage II (28 Days)|Death|0|||
33526185|NCT00572455|101823463|FG007|Stage II (28 Days)|Death|0|||
33526186|NCT00572455|101823464|FG008|Stage II (28 Days)|Death|1|||
33526187|NCT00572455|101823465|FG009|Stage II (28 Days)|Death|0|||
33526188|NCT00572455|101823466|FG010|Stage II (28 Days)|Death|0|||
33526189|NCT00572455|101823467|FG011|Stage II (28 Days)|Death|0|||
33526190|NCT00572455|101823468|FG012|Stage II (28 Days)|Death|0|||
33526191|NCT00572455|101823469|FG013|Stage II (28 Days)|Death|0|||
33526192|NCT00572455|101823456|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
33526193|NCT00572455|101823457|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
33203032|NCT01226745|100645804|FG004|Overall Study|Lost to Follow-up|1|||
33203033|NCT01226745|100645805|FG005|Overall Study|Lost to Follow-up|2|||
33203034|NCT01226745|100645800|FG000|Overall Study|Death|1|||
33332183|NCT00961220|101111504|FG000|Overall Study|Complete Response prior to 12 courses|1|||
33332184|NCT02257372|101111505|FG000|Overall Study|Adverse Event|3|||
33332185|NCT02257372|101111506|FG001|Overall Study|Adverse Event|7|||
33332186|NCT02257372|101111505|FG000|Overall Study|Lack of Efficacy|2|||
33332187|NCT02257372|101111506|FG001|Overall Study|Lack of Efficacy|1|||
33332188|NCT02257372|101111505|FG000|Overall Study|Protocol Violation|1|||
33332189|NCT02257372|101111506|FG001|Overall Study|Protocol Violation|1|||
33332190|NCT02257372|101111505|FG000|Overall Study|Lost to Follow-up|0|||
33332191|NCT02257372|101111506|FG001|Overall Study|Lost to Follow-up|1|||
33332192|NCT02257372|101111505|FG000|Overall Study|Withdrew consent|1|||
33332193|NCT02257372|101111506|FG001|Overall Study|Withdrew consent|0|||
33332194|NCT01251653|101111511|FG000|Overall Study|Progressive Disease|1|||
33332195|NCT01251653|101111512|FG001|Overall Study|Progressive Disease|7|||
33332196|NCT01251653|101111513|FG002|Overall Study|Progressive Disease|16|||
33332197|NCT01251653|101111514|FG003|Overall Study|Progressive Disease|4|||
33332198|NCT01251653|101111515|FG004|Overall Study|Progressive Disease|0|||
33332199|NCT01251653|101111516|FG005|Overall Study|Progressive Disease|17|||
33332200|NCT01251653|101111517|FG006|Overall Study|Progressive Disease|14|||
33332201|NCT01251653|101111518|FG007|Overall Study|Progressive Disease|7|||
33332202|NCT01251653|101111519|FG008|Overall Study|Progressive Disease|5|||
33332203|NCT01251653|101111511|FG000|Overall Study|Dose-limiting toxicity|0|||
33332204|NCT01251653|101111512|FG001|Overall Study|Dose-limiting toxicity|1|||
33332205|NCT01251653|101111513|FG002|Overall Study|Dose-limiting toxicity|1|||
33332206|NCT01251653|101111514|FG003|Overall Study|Dose-limiting toxicity|1|||
33332207|NCT01251653|101111515|FG004|Overall Study|Dose-limiting toxicity|0|||
33332208|NCT01251653|101111516|FG005|Overall Study|Dose-limiting toxicity|0|||
33332209|NCT01251653|101111517|FG006|Overall Study|Dose-limiting toxicity|2|||
33332210|NCT01251653|101111518|FG007|Overall Study|Dose-limiting toxicity|0|||
33332211|NCT01251653|101111519|FG008|Overall Study|Dose-limiting toxicity|0|||
33332212|NCT01251653|101111511|FG000|Overall Study|Adverse Event|1|||
33332213|NCT01251653|101111512|FG001|Overall Study|Adverse Event|0|||
33332214|NCT01251653|101111513|FG002|Overall Study|Adverse Event|2|||
33332215|NCT01251653|101111514|FG003|Overall Study|Adverse Event|1|||
33332216|NCT01251653|101111515|FG004|Overall Study|Adverse Event|1|||
33332217|NCT01251653|101111516|FG005|Overall Study|Adverse Event|0|||
33332218|NCT01251653|101111517|FG006|Overall Study|Adverse Event|2|||
33332219|NCT01251653|101111518|FG007|Overall Study|Adverse Event|2|||
33332220|NCT01251653|101111519|FG008|Overall Study|Adverse Event|1|||
33332221|NCT01251653|101111511|FG000|Overall Study|Withdrawal by Subject|1|||
33332222|NCT01251653|101111512|FG001|Overall Study|Withdrawal by Subject|0|||
33332223|NCT01251653|101111513|FG002|Overall Study|Withdrawal by Subject|1|||
33332224|NCT01251653|101111514|FG003|Overall Study|Withdrawal by Subject|0|||
33332225|NCT01251653|101111515|FG004|Overall Study|Withdrawal by Subject|1|||
33332226|NCT01251653|101111516|FG005|Overall Study|Withdrawal by Subject|1|||
33332227|NCT01251653|101111517|FG006|Overall Study|Withdrawal by Subject|0|||
33332228|NCT01251653|101111518|FG007|Overall Study|Withdrawal by Subject|1|||
33332229|NCT01251653|101111519|FG008|Overall Study|Withdrawal by Subject|0|||
33332230|NCT01251653|101111511|FG000|Overall Study|Other reason not mentioned above|0|||
33332231|NCT01251653|101111512|FG001|Overall Study|Other reason not mentioned above|0|||
33526194|NCT00572455|101823458|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
33526195|NCT00572455|101823459|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
33526196|NCT00572455|101823460|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
33332232|NCT01251653|101111513|FG002|Overall Study|Other reason not mentioned above|0|||
33332233|NCT01251653|101111514|FG003|Overall Study|Other reason not mentioned above|0|||
33332234|NCT01251653|101111515|FG004|Overall Study|Other reason not mentioned above|0|||
33332235|NCT01251653|101111516|FG005|Overall Study|Other reason not mentioned above|0|||
33332236|NCT01251653|101111517|FG006|Overall Study|Other reason not mentioned above|0|||
33526197|NCT00572455|101823461|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
33526198|NCT00572455|101823462|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
33526199|NCT00572455|101823463|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
33526200|NCT00572455|101823464|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
33526201|NCT00572455|101823465|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
33332237|NCT01251653|101111518|FG007|Overall Study|Other reason not mentioned above|2|||
33332238|NCT01251653|101111519|FG008|Overall Study|Other reason not mentioned above|0|||
33332239|NCT01500278|101111520|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
33332240|NCT01500278|101111521|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
33332241|NCT01500278|101111520|FG000|Week 0 - Week 12|Protocol Violation|10|||
33332242|NCT01500278|101111521|FG001|Week 0 - Week 12|Protocol Violation|16|||
33332243|NCT01500278|101111520|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
33332244|NCT01500278|101111521|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
33332245|NCT01500278|101111520|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
33332246|NCT01500278|101111521|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
33332247|NCT01500278|101111520|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
33332248|NCT01500278|101111521|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
33332249|NCT01500278|101111520|FG000|Week 0 - Week 12|Patient decision|1|||
33332250|NCT01500278|101111521|FG001|Week 0 - Week 12|Patient decision|0|||
33332251|NCT01500278|101111520|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
33332252|NCT01500278|101111521|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
33332253|NCT01500278|101111520|FG000|Week 0 - Week 12|Investigator decision|1|||
33332254|NCT01500278|101111521|FG001|Week 0 - Week 12|Investigator decision|0|||
33332255|NCT01500278|101111520|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
33332256|NCT01500278|101111521|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
33332257|NCT01500278|101111520|FG000|Week 0 - Week 12|Sponsor decision|1|||
33332258|NCT01500278|101111521|FG001|Week 0 - Week 12|Sponsor decision|0|||
33332259|NCT01500278|101111520|FG000|Week 0 - Week 12|Personal reason|0|||
33332260|NCT01500278|101111521|FG001|Week 0 - Week 12|Personal reason|1|||
33332261|NCT01500278|101111520|FG000|Week 0 - Week 12|Other serious disease|0|||
33332262|NCT01500278|101111521|FG001|Week 0 - Week 12|Other serious disease|1|||
33402577|NCT00141297|101365347|FG002|Overall Study|Withdrawal by Subject|0|||
33402578|NCT00141297|101365348|FG003|Overall Study|Withdrawal by Subject|0|||
33402579|NCT00141297|101365349|FG004|Overall Study|Withdrawal by Subject|0|||
33402580|NCT00141297|101365350|FG005|Overall Study|Withdrawal by Subject|0|||
33332263|NCT01500278|101111520|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
33332264|NCT01500278|101111521|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
33332265|NCT01500278|101111520|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
33332266|NCT01500278|101111521|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
33402581|NCT00141297|101365351|FG006|Overall Study|Withdrawal by Subject|0|||
33402582|NCT00141297|101365352|FG007|Overall Study|Withdrawal by Subject|0|||
33332267|NCT01500278|101111520|FG000|Week 13 - Week 104|Protocol Violation|6|||
33332268|NCT01500278|101111521|FG001|Week 13 - Week 104|Protocol Violation|6|||
33332269|NCT01500278|101111520|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
33332270|NCT01500278|101111521|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
33332271|NCT01500278|101111520|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
33332272|NCT01500278|101111521|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
33332273|NCT01500278|101111520|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
33332274|NCT01500278|101111521|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
33332275|NCT01500278|101111520|FG000|Week 13 - Week 104|Non/bad compliance|7|||
33332276|NCT01500278|101111521|FG001|Week 13 - Week 104|Non/bad compliance|5|||
33332277|NCT01500278|101111520|FG000|Week 13 - Week 104|Recurrent infections|1|||
33402583|NCT00141297|101365353|FG008|Overall Study|Withdrawal by Subject|1|||
33402584|NCT00141297|101365354|FG009|Overall Study|Withdrawal by Subject|0|||
33526202|NCT00572455|101823466|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
33526203|NCT00572455|101823467|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
33526204|NCT00572455|101823468|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
33526205|NCT00572455|101823469|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
33526206|NCT00572455|101823456|FG000|Stage II (28 Days)|Other|0|||
33526207|NCT00572455|101823457|FG001|Stage II (28 Days)|Other|0|||
33526208|NCT00572455|101823458|FG002|Stage II (28 Days)|Other|0|||
33526209|NCT00572455|101823459|FG003|Stage II (28 Days)|Other|0|||
33526210|NCT00572455|101823460|FG004|Stage II (28 Days)|Other|0|||
33526211|NCT00572455|101823461|FG005|Stage II (28 Days)|Other|0|||
33526212|NCT00572455|101823462|FG006|Stage II (28 Days)|Other|0|||
33526213|NCT00572455|101823463|FG007|Stage II (28 Days)|Other|0|||
33526214|NCT00572455|101823464|FG008|Stage II (28 Days)|Other|1|||
33526215|NCT00572455|101823465|FG009|Stage II (28 Days)|Other|0|||
33610424|NCT04038567|102123310|FG006|Overall Study|technical issues|1|||
33610425|NCT04038567|102123311|FG007|Overall Study|technical issues|0|||
33332278|NCT01500278|101111521|FG001|Week 13 - Week 104|Recurrent infections|0|||
33332279|NCT01500278|101111520|FG000|Week 13 - Week 104|False positive test|1|||
33332280|NCT01500278|101111521|FG001|Week 13 - Week 104|False positive test|2|||
33332281|NCT01500278|101111520|FG000|Week 13 - Week 104|Sponsor request|4|||
33332282|NCT01500278|101111521|FG001|Week 13 - Week 104|Sponsor request|0|||
33402585|NCT00141297|101365345|FG000|Overall Study|Other|0|||
33332283|NCT01500278|101111520|FG000|Week 13 - Week 104|Withdrawn in error|1|||
33332284|NCT01500278|101111521|FG001|Week 13 - Week 104|Withdrawn in error|0|||
33526216|NCT00572455|101823466|FG010|Stage II (28 Days)|Other|0|||
33526217|NCT00572455|101823467|FG011|Stage II (28 Days)|Other|0|||
33402586|NCT00141297|101365346|FG001|Overall Study|Other|0|||
33526218|NCT00572455|101823468|FG012|Stage II (28 Days)|Other|0|||
33526219|NCT00572455|101823469|FG013|Stage II (28 Days)|Other|0|||
33526220|NCT00572455|101823456|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
33526221|NCT00572455|101823457|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
33526222|NCT00572455|101823458|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
33526223|NCT00572455|101823459|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
33526224|NCT00572455|101823460|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
33526225|NCT00572455|101823461|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
33526226|NCT00572455|101823462|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
33526227|NCT00572455|101823463|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
33526228|NCT00572455|101823464|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
33526229|NCT00572455|101823465|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
33526230|NCT00572455|101823466|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
33526231|NCT00572455|101823467|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
33526232|NCT00572455|101823468|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
33526233|NCT00572455|101823469|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
33526234|NCT02442206|101823473|FG000|Period 1|Adverse Event|1|||
33526235|NCT02442206|101823474|FG001|Period 1|Adverse Event|1|||
33526236|NCT02442206|101823473|FG000|Period 1|withdrew consent|0|||
33526237|NCT02442206|101823474|FG001|Period 1|withdrew consent|1|||
33526238|NCT02442206|101823473|FG000|Period 1|COPD exacerbation|0|||
33526239|NCT02442206|101823474|FG001|Period 1|COPD exacerbation|1|||
33526240|NCT02442206|101823473|FG000|Period 2|Adverse Event|1|||
33526241|NCT02442206|101823474|FG001|Period 2|Adverse Event|0|||
33526242|NCT03131687|101823475|FG000|Overall Study|Adverse Event|0|||
33526243|NCT03131687|101823476|FG001|Overall Study|Adverse Event|1|||
33526244|NCT03131687|101823477|FG002|Overall Study|Adverse Event|0|||
33526245|NCT03131687|101823478|FG003|Overall Study|Adverse Event|1|||
33526246|NCT03131687|101823479|FG004|Overall Study|Adverse Event|2|||
33526247|NCT03131687|101823480|FG005|Overall Study|Adverse Event|2|||
33526248|NCT03131687|101823475|FG000|Overall Study|Death|1|||
33526249|NCT03131687|101823476|FG001|Overall Study|Death|0|||
33526250|NCT03131687|101823477|FG002|Overall Study|Death|0|||
33526251|NCT03131687|101823478|FG003|Overall Study|Death|0|||
33526252|NCT03131687|101823479|FG004|Overall Study|Death|0|||
33526253|NCT03131687|101823480|FG005|Overall Study|Death|0|||
33526254|NCT03131687|101823475|FG000|Overall Study|Withdrawal by Subject|3|||
33526255|NCT03131687|101823476|FG001|Overall Study|Withdrawal by Subject|3|||
33526256|NCT03131687|101823477|FG002|Overall Study|Withdrawal by Subject|3|||
33332285|NCT01500278|101111520|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
33526257|NCT03131687|101823478|FG003|Overall Study|Withdrawal by Subject|1|||
33526258|NCT03131687|101823479|FG004|Overall Study|Withdrawal by Subject|2|||
33526259|NCT03131687|101823480|FG005|Overall Study|Withdrawal by Subject|1|||
33526260|NCT03131687|101823475|FG000|Overall Study|Lost to Follow-up|1|||
33526261|NCT03131687|101823476|FG001|Overall Study|Lost to Follow-up|4|||
33526262|NCT03131687|101823477|FG002|Overall Study|Lost to Follow-up|0|||
33526263|NCT03131687|101823478|FG003|Overall Study|Lost to Follow-up|1|||
33526264|NCT03131687|101823479|FG004|Overall Study|Lost to Follow-up|4|||
33526265|NCT03131687|101823480|FG005|Overall Study|Lost to Follow-up|2|||
33526266|NCT03131687|101823475|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
33203035|NCT01226745|100645801|FG001|Overall Study|Death|0|||
33332286|NCT01500278|101111521|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
33332287|NCT01500278|101111520|FG000|Week 13 - Week 104|Protocol deviation|1|||
33332288|NCT01500278|101111521|FG001|Week 13 - Week 104|Protocol deviation|0|||
33332289|NCT01500278|101111520|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
33332290|NCT01500278|101111521|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
33332291|NCT01500278|101111520|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
33332292|NCT01500278|101111521|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
33332293|NCT01500278|101111520|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
33332294|NCT01500278|101111521|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
33332295|NCT01500278|101111520|FG000|Week 13 - Week 104|Relocation|0|||
33332296|NCT01500278|101111521|FG001|Week 13 - Week 104|Relocation|1|||
33332297|NCT01500278|101111520|FG000|Week 13 - Week 104|Sponsor decision|0|||
33332298|NCT01500278|101111521|FG001|Week 13 - Week 104|Sponsor decision|2|||
33332299|NCT01500278|101111520|FG000|Week 13 - Week 104|Medical monitor decision|0|||
33332300|NCT01500278|101111521|FG001|Week 13 - Week 104|Medical monitor decision|2|||
33332301|NCT01500278|101111520|FG000|Week 13 - Week 104|Personal reason|0|||
33332302|NCT01500278|101111521|FG001|Week 13 - Week 104|Personal reason|1|||
33332303|NCT01500278|101111520|FG000|Week 13 - Week 104|Not completed|0|||
33526267|NCT03131687|101823476|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
33526268|NCT03131687|101823477|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
33526269|NCT03131687|101823478|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
33526270|NCT03131687|101823479|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
33526271|NCT03131687|101823480|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
33526272|NCT03131687|101823475|FG000|Overall Study|Principle Investigator Decision|0|||
33526273|NCT03131687|101823476|FG001|Overall Study|Principle Investigator Decision|1|||
33526274|NCT03131687|101823477|FG002|Overall Study|Principle Investigator Decision|0|||
33526275|NCT03131687|101823478|FG003|Overall Study|Principle Investigator Decision|0|||
33526276|NCT03131687|101823479|FG004|Overall Study|Principle Investigator Decision|0|||
33526277|NCT03131687|101823480|FG005|Overall Study|Principle Investigator Decision|0|||
33526278|NCT03131687|101823475|FG000|Overall Study|Inadvertent Enrollment|0|||
33526279|NCT03131687|101823476|FG001|Overall Study|Inadvertent Enrollment|0|||
33526280|NCT03131687|101823477|FG002|Overall Study|Inadvertent Enrollment|0|||
33526281|NCT03131687|101823478|FG003|Overall Study|Inadvertent Enrollment|1|||
33526282|NCT03131687|101823479|FG004|Overall Study|Inadvertent Enrollment|0|||
33526283|NCT03131687|101823480|FG005|Overall Study|Inadvertent Enrollment|0|||
33332304|NCT01500278|101111521|FG001|Week 13 - Week 104|Not completed|1|||
33332305|NCT01500278|101111520|FG000|Week 13 - Week 104|Death|2|||
33332306|NCT01500278|101111521|FG001|Week 13 - Week 104|Death|4|||
33332307|NCT01500278|101111520|FG000|Week 13 - Week 104|Adverse Event|54|||
33332308|NCT01500278|101111521|FG001|Week 13 - Week 104|Adverse Event|54|||
33332309|NCT03363321|101111522|FG000|Overall Study|Withdrawal by Subject|0|||
33332310|NCT03363321|101111523|FG001|Overall Study|Withdrawal by Subject|1|||
33332311|NCT03363321|101111524|FG002|Overall Study|Withdrawal by Subject|0|||
33332312|NCT03363321|101111525|FG003|Overall Study|Withdrawal by Subject|1|||
33332313|NCT03363321|101111526|FG004|Overall Study|Withdrawal by Subject|0|||
33332314|NCT01505634|101111528|FG000|Overall Study|Withdrawal by Subject|2|||
33332315|NCT01505634|101111529|FG001|Overall Study|Withdrawal by Subject|5|||
33332316|NCT01505634|101111530|FG002|Overall Study|Withdrawal by Subject|1|||
33332317|NCT01505634|101111528|FG000|Overall Study|Physician Decision|1|||
33526284|NCT01677182|101823481|FG000|Overall Study|Adverse Event|2|||
33526285|NCT01677182|101823482|FG001|Overall Study|Adverse Event|1|||
33526286|NCT01677182|101823483|FG002|Overall Study|Adverse Event|8|||
33526287|NCT01677182|101823481|FG000|Overall Study|Protocol Violation|5|||
33526288|NCT01677182|101823482|FG001|Overall Study|Protocol Violation|1|||
33526289|NCT01677182|101823483|FG002|Overall Study|Protocol Violation|4|||
33526290|NCT01677182|101823481|FG000|Overall Study|Lost to Follow-up|4|||
33526291|NCT01677182|101823482|FG001|Overall Study|Lost to Follow-up|0|||
33526292|NCT01677182|101823483|FG002|Overall Study|Lost to Follow-up|3|||
33526293|NCT01677182|101823481|FG000|Overall Study|Withdrawal by Subject|7|||
33526294|NCT01677182|101823482|FG001|Overall Study|Withdrawal by Subject|12|||
33526295|NCT01677182|101823483|FG002|Overall Study|Withdrawal by Subject|10|||
33526296|NCT01677182|101823481|FG000|Overall Study|Study termination|12|||
33526297|NCT01677182|101823482|FG001|Overall Study|Study termination|9|||
33526298|NCT01677182|101823483|FG002|Overall Study|Study termination|11|||
33526299|NCT01677182|101823481|FG000|Overall Study|Lack of Efficacy|3|||
33526300|NCT01677182|101823482|FG001|Overall Study|Lack of Efficacy|0|||
33526301|NCT01677182|101823483|FG002|Overall Study|Lack of Efficacy|1|||
33526302|NCT01677182|101823481|FG000|Overall Study|Other reasons|1|||
33526303|NCT01677182|101823482|FG001|Overall Study|Other reasons|5|||
33526304|NCT01677182|101823483|FG002|Overall Study|Other reasons|2|||
33526305|NCT00625183|101823490|FG000|Overall Study|Disease Progression|1|||
33526306|NCT01928199|101823497|FG000|Overall Study|Lost to Follow-up|2|||
33526307|NCT01928199|101823498|FG001|Overall Study|Lost to Follow-up|1|||
33526308|NCT01928199|101823497|FG000|Overall Study|Withdrawal by Subject|3|||
33526309|NCT01928199|101823498|FG001|Overall Study|Withdrawal by Subject|5|||
33526310|NCT02779075|101823499|FG000|Overall Study|Withdrawal by Subject|1|||
33526311|NCT02779075|101823500|FG001|Overall Study|Withdrawal by Subject|3|||
33610426|NCT04038567|102123304|FG000|Overall Study|Medical issues (i.e., illness)|0|||
33332318|NCT01505634|101111529|FG001|Overall Study|Physician Decision|1|||
33610427|NCT04038567|102123305|FG001|Overall Study|Medical issues (i.e., illness)|1|||
33610428|NCT04038567|102123306|FG002|Overall Study|Medical issues (i.e., illness)|2|||
33332319|NCT01505634|101111530|FG002|Overall Study|Physician Decision|0|||
33332320|NCT01505634|101111528|FG000|Overall Study|Adverse Event|1|||
33332321|NCT01505634|101111529|FG001|Overall Study|Adverse Event|0|||
33332322|NCT01505634|101111530|FG002|Overall Study|Adverse Event|0|||
33332323|NCT01505634|101111528|FG000|Overall Study|Insufficient supply of drug at site|1|||
33526312|NCT02779075|101823499|FG000|Overall Study|IV lost during 2nd study|1|||
33526313|NCT02779075|101823500|FG001|Overall Study|IV lost during 2nd study|0|||
33526314|NCT01006590|101823501|FG000|Overall Study|Adverse Event|2|||
33526315|NCT01006590|101823502|FG001|Overall Study|Adverse Event|3|||
33610429|NCT04038567|102123307|FG003|Overall Study|Medical issues (i.e., illness)|1|||
33332324|NCT01505634|101111529|FG001|Overall Study|Insufficient supply of drug at site|0|||
33332325|NCT01505634|101111530|FG002|Overall Study|Insufficient supply of drug at site|0|||
33332326|NCT01505634|101111528|FG000|Overall Study|Protocol Violation|2|||
33526316|NCT01006590|101823501|FG000|Overall Study|Death|1|||
33526317|NCT01006590|101823502|FG001|Overall Study|Death|1|||
33526318|NCT01006590|101823501|FG000|Overall Study|Lost to Follow-up|1|||
33526319|NCT01006590|101823502|FG001|Overall Study|Lost to Follow-up|1|||
33526320|NCT01006590|101823501|FG000|Overall Study|Protocol Violation|1|||
33526321|NCT01006590|101823502|FG001|Overall Study|Protocol Violation|0|||
33332327|NCT01505634|101111529|FG001|Overall Study|Protocol Violation|0|||
33526322|NCT01006590|101823501|FG000|Overall Study|Withdrawal by Subject|4|||
33526323|NCT01006590|101823502|FG001|Overall Study|Withdrawal by Subject|2|||
33526324|NCT01006590|101823501|FG000|Overall Study|Study specific discontinuation criteria|16|||
33526325|NCT01006590|101823502|FG001|Overall Study|Study specific discontinuation criteria|23|||
33526326|NCT01006590|101823501|FG000|Overall Study|Other|3|||
33526327|NCT01006590|101823502|FG001|Overall Study|Other|2|||
33526328|NCT03539484|101823503|FG000|Overall Study|Death|1|||
33526329|NCT03539484|101823504|FG001|Overall Study|Death|0|||
33526330|NCT03539484|101823505|FG002|Overall Study|Death|0|||
33526331|NCT03539484|101823506|FG003|Overall Study|Death|2|||
33526332|NCT03539484|101823507|FG004|Overall Study|Death|8|||
33526333|NCT03539484|101823508|FG005|Overall Study|Death|3|||
33526334|NCT03539484|101823509|FG006|Overall Study|Death|0|||
33526335|NCT03539484|101823503|FG000|Overall Study|Lost to Follow-up|0|||
33526336|NCT03539484|101823504|FG001|Overall Study|Lost to Follow-up|1|||
33526337|NCT03539484|101823505|FG002|Overall Study|Lost to Follow-up|0|||
33526338|NCT03539484|101823506|FG003|Overall Study|Lost to Follow-up|0|||
33526339|NCT03539484|101823507|FG004|Overall Study|Lost to Follow-up|1|||
33526340|NCT03539484|101823508|FG005|Overall Study|Lost to Follow-up|0|||
33526341|NCT03539484|101823509|FG006|Overall Study|Lost to Follow-up|0|||
33526342|NCT03539484|101823503|FG000|Overall Study|Withdrawal by Subject|0|||
33526343|NCT03539484|101823504|FG001|Overall Study|Withdrawal by Subject|0|||
33526344|NCT03539484|101823505|FG002|Overall Study|Withdrawal by Subject|0|||
33526345|NCT03539484|101823506|FG003|Overall Study|Withdrawal by Subject|0|||
33526346|NCT03539484|101823507|FG004|Overall Study|Withdrawal by Subject|2|||
33526347|NCT03539484|101823508|FG005|Overall Study|Withdrawal by Subject|0|||
33526348|NCT03539484|101823509|FG006|Overall Study|Withdrawal by Subject|1|||
33526349|NCT03539484|101823503|FG000|Overall Study|Study Terminated by Sponsor|0|||
33526350|NCT03539484|101823504|FG001|Overall Study|Study Terminated by Sponsor|0|||
33526351|NCT03539484|101823505|FG002|Overall Study|Study Terminated by Sponsor|1|||
33526352|NCT03539484|101823506|FG003|Overall Study|Study Terminated by Sponsor|1|||
33526353|NCT03539484|101823507|FG004|Overall Study|Study Terminated by Sponsor|2|||
33526354|NCT03539484|101823508|FG005|Overall Study|Study Terminated by Sponsor|2|||
33526355|NCT03539484|101823509|FG006|Overall Study|Study Terminated by Sponsor|1|||
33526356|NCT01148459|101823514|FG000|Overall Study|Serious Adverse Event|5|||
33526357|NCT01148459|101823515|FG001|Overall Study|Serious Adverse Event|4|||
33526358|NCT01148459|101823514|FG000|Overall Study|Withdrawal by Subject|1|||
33526359|NCT01148459|101823515|FG001|Overall Study|Withdrawal by Subject|0|||
33526360|NCT01148459|101823514|FG000|Overall Study|Migrated/moved from study area|3|||
33526361|NCT01148459|101823515|FG001|Overall Study|Migrated/moved from study area|6|||
33526362|NCT01148459|101823514|FG000|Overall Study|Lost to Follow-up|2|||
33526363|NCT01148459|101823515|FG001|Overall Study|Lost to Follow-up|0|||
33526364|NCT01148459|101823514|FG000|Overall Study|Refusal|1|||
33526365|NCT01148459|101823515|FG001|Overall Study|Refusal|0|||
33526366|NCT01148459|101823514|FG000|Overall Study|Failure to comply with study procedures|0|||
33526367|NCT01148459|101823515|FG001|Overall Study|Failure to comply with study procedures|1|||
33526368|NCT00187278|101823523|FG000|Overall Study|Protocol Violation|10|||
33526369|NCT00187278|101823524|FG001|Overall Study|Protocol Violation|13|||
33526370|NCT01306214|101823527|FG000|Overall Study|Death|0|||
33526371|NCT01306214|101823528|FG001|Overall Study|Death|0|||
33526372|NCT01306214|101823529|FG002|Overall Study|Death|1|||
33526373|NCT01306214|101823527|FG000|Overall Study|Lost to Follow-up|3|||
33526374|NCT01306214|101823528|FG001|Overall Study|Lost to Follow-up|5|||
33526375|NCT01306214|101823529|FG002|Overall Study|Lost to Follow-up|4|||
33526376|NCT01306214|101823527|FG000|Overall Study|Withdrawal by Subject|24|||
33526377|NCT01306214|101823528|FG001|Overall Study|Withdrawal by Subject|22|||
33526378|NCT01306214|101823529|FG002|Overall Study|Withdrawal by Subject|16|||
33526379|NCT01306214|101823527|FG000|Overall Study|Not treated|1|||
33526380|NCT01306214|101823528|FG001|Overall Study|Not treated|1|||
33526381|NCT01306214|101823529|FG002|Overall Study|Not treated|1|||
33526382|NCT01490840|101823530|FG000|Phase 1|Lost to Follow-up|1|||
33526383|NCT01490840|101823531|FG001|Phase 1|Lost to Follow-up|0|||
33526384|NCT01490840|101823530|FG000|Phase 1|Adverse Event|2|||
33610430|NCT04038567|102123308|FG004|Overall Study|Medical issues (i.e., illness)|1|||
33610431|NCT04038567|102123309|FG005|Overall Study|Medical issues (i.e., illness)|1|||
33526385|NCT01490840|101823531|FG001|Phase 1|Adverse Event|1|||
33526386|NCT01490840|101823530|FG000|Phase 1|Withdrawal by Subject|6|||
33526387|NCT01490840|101823531|FG001|Phase 1|Withdrawal by Subject|5|||
33526388|NCT01490840|101823530|FG000|Phase 1|Visit 6a omitted|1|||
33526389|NCT01490840|101823531|FG001|Phase 1|Visit 6a omitted|0|||
33526390|NCT01490840|101823530|FG000|Phase 2|Withdrawal by Subject|4|||
33526391|NCT01490840|101823531|FG001|Phase 2|Withdrawal by Subject|3|||
33526392|NCT01490840|101823530|FG000|Phase 2|Permanent interruption of fingolimod|0|||
33526393|NCT01490840|101823531|FG001|Phase 2|Permanent interruption of fingolimod|1|||
33526394|NCT01490840|101823530|FG000|Phase 2|Lost to Follow-up|1|||
33526395|NCT01490840|101823531|FG001|Phase 2|Lost to Follow-up|1|||
33526396|NCT01490840|101823530|FG000|Phase 2|Adverse Event|1|||
33526397|NCT01490840|101823531|FG001|Phase 2|Adverse Event|1|||
33526398|NCT01301079|101823535|FG000|Overall Study|Lost to Follow-up|2|||
33526399|NCT01301079|101823536|FG001|Overall Study|Lost to Follow-up|2|||
33526400|NCT01949142|101823540|FG000|Overall Study|Withdrawal of consent|1|||
33526401|NCT01949142|101823541|FG001|Overall Study|Withdrawal of consent|0|||
33526402|NCT01949142|101823540|FG000|Overall Study|Lost to Follow-up|1|||
33526403|NCT01949142|101823541|FG001|Overall Study|Lost to Follow-up|1|||
33526404|NCT01949142|101823540|FG000|Overall Study|Parent changed their mind|1|||
33526405|NCT01949142|101823541|FG001|Overall Study|Parent changed their mind|0|||
33526406|NCT01516736|101823542|FG000|Overall Study|Withdrawal by Subject|10|||
33526407|NCT01516736|101823543|FG001|Overall Study|Withdrawal by Subject|4|||
33526408|NCT01516736|101823542|FG000|Overall Study|Adverse Event|4|||
33526409|NCT01516736|101823543|FG001|Overall Study|Adverse Event|5|||
33332328|NCT01505634|101111530|FG002|Overall Study|Protocol Violation|0|||
33332329|NCT01505634|101111528|FG000|Overall Study|Lost to Follow-up|1|||
33332330|NCT01505634|101111529|FG001|Overall Study|Lost to Follow-up|4|||
33332331|NCT01505634|101111530|FG002|Overall Study|Lost to Follow-up|4|||
33332332|NCT01505634|101111528|FG000|Overall Study|Death|1|||
33332333|NCT01505634|101111529|FG001|Overall Study|Death|0|||
33332334|NCT01505634|101111530|FG002|Overall Study|Death|0|||
33332335|NCT01505634|101111528|FG000|Overall Study|In a conflict zone|0|||
33332336|NCT01505634|101111529|FG001|Overall Study|In a conflict zone|0|||
33332337|NCT01505634|101111530|FG002|Overall Study|In a conflict zone|1|||
33332338|NCT01199042|101111532|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
33332339|NCT01199042|101111532|FG000|At Home (3 Months)|Lost to Follow-up|1|||
33332340|NCT00914927|101111533|FG000|Overall Study|Adverse Event|0|||
33332341|NCT00914927|101111534|FG001|Overall Study|Adverse Event|0|||
33332342|NCT00914927|101111535|FG002|Overall Study|Adverse Event|0|||
33332343|NCT00914927|101111536|FG003|Overall Study|Adverse Event|0|||
33332344|NCT00914927|101111537|FG004|Overall Study|Adverse Event|1|||
33332345|NCT00914927|101111538|FG005|Overall Study|Adverse Event|0|||
33332346|NCT00914927|101111539|FG006|Overall Study|Adverse Event|0|||
33332347|NCT00914927|101111533|FG000|Overall Study|Withdrawal by Subject|0|||
33332348|NCT00914927|101111534|FG001|Overall Study|Withdrawal by Subject|1|||
33332349|NCT00914927|101111535|FG002|Overall Study|Withdrawal by Subject|0|||
33332350|NCT00914927|101111536|FG003|Overall Study|Withdrawal by Subject|1|||
33332351|NCT00914927|101111537|FG004|Overall Study|Withdrawal by Subject|0|||
33332352|NCT00914927|101111538|FG005|Overall Study|Withdrawal by Subject|0|||
33332353|NCT00914927|101111539|FG006|Overall Study|Withdrawal by Subject|0|||
33332354|NCT00914927|101111533|FG000|Overall Study|Lost to Follow-up|0|||
33332355|NCT00914927|101111534|FG001|Overall Study|Lost to Follow-up|0|||
33332356|NCT00914927|101111535|FG002|Overall Study|Lost to Follow-up|0|||
33332357|NCT00914927|101111536|FG003|Overall Study|Lost to Follow-up|1|||
33332358|NCT00914927|101111537|FG004|Overall Study|Lost to Follow-up|0|||
33332359|NCT00914927|101111538|FG005|Overall Study|Lost to Follow-up|0|||
33332360|NCT00914927|101111539|FG006|Overall Study|Lost to Follow-up|0|||
33332361|NCT00914927|101111533|FG000|Overall Study|Administrative/Other|2|||
33332362|NCT00914927|101111534|FG001|Overall Study|Administrative/Other|1|||
33332363|NCT00914927|101111535|FG002|Overall Study|Administrative/Other|0|||
33332364|NCT00914927|101111536|FG003|Overall Study|Administrative/Other|0|||
33332365|NCT00914927|101111537|FG004|Overall Study|Administrative/Other|1|||
33332366|NCT00914927|101111538|FG005|Overall Study|Administrative/Other|0|||
33332367|NCT00914927|101111539|FG006|Overall Study|Administrative/Other|0|||
33332368|NCT00075400|101111548|FG000|Overall Study|Ineligible: wrong primary|1|||
33332369|NCT00075400|101111548|FG000|Overall Study|Never treated|2|||
33332370|NCT01278745|101111549|FG000|Overall Study|Death|2|||
33332371|NCT01278745|101111550|FG001|Overall Study|Death|5|||
33332372|NCT01278745|101111551|FG002|Overall Study|Death|7|||
33332373|NCT01278745|101111552|FG003|Overall Study|Death|0|||
33332374|NCT01278745|101111549|FG000|Overall Study|Physician Decision|1|||
33332375|NCT01278745|101111550|FG001|Overall Study|Physician Decision|0|||
33332376|NCT01278745|101111551|FG002|Overall Study|Physician Decision|0|||
33332377|NCT01278745|101111552|FG003|Overall Study|Physician Decision|9|||
33402587|NCT00141297|101365347|FG002|Overall Study|Other|0|||
33526410|NCT01516736|101823542|FG000|Overall Study|Death|3|||
33526411|NCT01516736|101823543|FG001|Overall Study|Death|1|||
33526412|NCT01516736|101823542|FG000|Overall Study|Physician Decision|2|||
33203036|NCT01226745|100645802|FG002|Overall Study|Death|0|||
33332378|NCT01278745|101111549|FG000|Overall Study|Withdrawal by Subject|1|||
33332379|NCT01278745|101111550|FG001|Overall Study|Withdrawal by Subject|1|||
33402588|NCT00141297|101365348|FG003|Overall Study|Other|1|||
33526413|NCT01516736|101823543|FG001|Overall Study|Physician Decision|1|||
33332380|NCT01278745|101111551|FG002|Overall Study|Withdrawal by Subject|5|||
33332381|NCT01278745|101111552|FG003|Overall Study|Withdrawal by Subject|1|||
33332382|NCT01278745|101111549|FG000|Overall Study|Sponsor Decision|1|||
33332383|NCT01278745|101111550|FG001|Overall Study|Sponsor Decision|0|||
33332384|NCT01278745|101111551|FG002|Overall Study|Sponsor Decision|62|||
33332385|NCT01278745|101111552|FG003|Overall Study|Sponsor Decision|6|||
33332386|NCT01278745|101111549|FG000|Overall Study|Ineligible|0|||
33332387|NCT01278745|101111550|FG001|Overall Study|Ineligible|0|||
33332388|NCT01278745|101111551|FG002|Overall Study|Ineligible|42|||
33332389|NCT01278745|101111552|FG003|Overall Study|Ineligible|61|||
33526414|NCT01516736|101823542|FG000|Overall Study|Lack of Efficacy|1|||
33526415|NCT01516736|101823543|FG001|Overall Study|Lack of Efficacy|0|||
33526416|NCT01516736|101823542|FG000|Overall Study|Protocol Violation|0|||
33526417|NCT01516736|101823543|FG001|Overall Study|Protocol Violation|1|||
33526418|NCT01516736|101823542|FG000|Overall Study|Other (not specified)|0|||
33526419|NCT01516736|101823543|FG001|Overall Study|Other (not specified)|1|||
33526420|NCT02347072|101823546|FG000|Overall Study|Adverse Event|2|||
33526421|NCT02347072|101823546|FG000|Overall Study|Withdrawal by Subject|6|||
33526422|NCT02347072|101823546|FG000|Overall Study|Physician Decision|1|||
33526423|NCT02347072|101823546|FG000|Overall Study|Lost to Follow-up|2|||
33526424|NCT02347072|101823546|FG000|Overall Study|Protocol Violation|1|||
33526425|NCT02347072|101823546|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
33526426|NCT01887678|101823547|FG000|Overall Study|Adverse Event|4|||
33526427|NCT01887678|101823548|FG001|Overall Study|Adverse Event|6|||
33526428|NCT01887678|101823547|FG000|Overall Study|Exceeded rescue medication dosage|4|||
33526429|NCT01887678|101823548|FG001|Overall Study|Exceeded rescue medication dosage|5|||
33526430|NCT01887678|101823547|FG000|Overall Study|Withdrawal of consent|3|||
33526431|NCT01887678|101823548|FG001|Overall Study|Withdrawal of consent|4|||
33526432|NCT01887678|101823547|FG000|Overall Study|Lost to Follow-up|4|||
33526433|NCT01887678|101823548|FG001|Overall Study|Lost to Follow-up|2|||
33526434|NCT01887678|101823547|FG000|Overall Study|Deterioration of clinical condition|0|||
33526435|NCT01887678|101823548|FG001|Overall Study|Deterioration of clinical condition|4|||
33526436|NCT01887678|101823547|FG000|Overall Study|Lack of Efficacy|1|||
33526437|NCT01887678|101823548|FG001|Overall Study|Lack of Efficacy|2|||
33203037|NCT01226745|100645803|FG003|Overall Study|Death|0|||
33203038|NCT01226745|100645804|FG004|Overall Study|Death|0|||
33203039|NCT01226745|100645805|FG005|Overall Study|Death|1|||
33203040|NCT01226745|100645800|FG000|Overall Study|Other|6|||
33203041|NCT01226745|100645801|FG001|Overall Study|Other|7|||
33203042|NCT01226745|100645802|FG002|Overall Study|Other|8|||
33203043|NCT01226745|100645803|FG003|Overall Study|Other|4|||
33203044|NCT01226745|100645804|FG004|Overall Study|Other|3|||
33203045|NCT01226745|100645805|FG005|Overall Study|Other|1|||
33203046|NCT01519206|100645808|FG000|Overall Study|Lost to Follow-up|3|||
33203047|NCT01519206|100645808|FG000|Overall Study|Missed Visit|2|||
33203048|NCT02546544|100645809|FG000|Overall Study|Disease Progression|14|||
33203049|NCT02546544|100645809|FG000|Overall Study|Adverse Event|1|||
33203050|NCT02546544|100645809|FG000|Overall Study|Withdrawal by Subject|1|||
33526438|NCT01887678|101823547|FG000|Overall Study|Non-compliance|0|||
33526439|NCT01887678|101823548|FG001|Overall Study|Non-compliance|3|||
33526440|NCT01887678|101823547|FG000|Overall Study|Specified|1|||
33526441|NCT01887678|101823548|FG001|Overall Study|Specified|2|||
33526442|NCT01048944|101823549|FG000|Overall Study|Protocol Violation|8|||
33526443|NCT01048944|101823550|FG001|Overall Study|Protocol Violation|10|||
33526444|NCT01048944|101823551|FG002|Overall Study|Protocol Violation|10|||
33526445|NCT01048944|101823552|FG003|Overall Study|Protocol Violation|2|||
33526446|NCT03959488|101823553|FG000|Season 1|Other|6|||
33526447|NCT03959488|101823554|FG001|Season 1|Other|7|||
33526448|NCT03959488|101823555|FG002|Season 1|Other|0|||
33526449|NCT03959488|101823556|FG003|Season 1|Other|0|||
33526450|NCT03959488|101823557|FG004|Season 1|Other|0|||
33526451|NCT03959488|101823553|FG000|Season 1|Withdrawal by parent/guardian|43|||
33203051|NCT03564496|100645813|FG000|Overall Study|Withdrawal by Subject|1|||
33203052|NCT03564496|100645814|FG001|Overall Study|Withdrawal by Subject|1|||
33203053|NCT03564496|100645815|FG002|Overall Study|Withdrawal by Subject|0|||
33526452|NCT03959488|101823554|FG001|Season 1|Withdrawal by parent/guardian|28|||
33203054|NCT03564496|100645813|FG000|Overall Study|Screen failure|0|||
33203055|NCT03564496|100645814|FG001|Overall Study|Screen failure|3|||
33203056|NCT03564496|100645815|FG002|Overall Study|Screen failure|0|||
33526453|NCT03959488|101823555|FG002|Season 1|Withdrawal by parent/guardian|0|||
33526454|NCT03959488|101823556|FG003|Season 1|Withdrawal by parent/guardian|0|||
33526455|NCT03959488|101823557|FG004|Season 1|Withdrawal by parent/guardian|0|||
33526456|NCT03959488|101823553|FG000|Season 1|Due to COVID-19 pandemic|2|||
33526457|NCT03959488|101823554|FG001|Season 1|Due to COVID-19 pandemic|3|||
33526458|NCT03959488|101823555|FG002|Season 1|Due to COVID-19 pandemic|0|||
33526459|NCT03959488|101823556|FG003|Season 1|Due to COVID-19 pandemic|0|||
33203057|NCT00965523|100645819|FG000|Study 221|Progressive Disease|4|||
33203058|NCT00965523|100645819|FG000|Study 221|Physician Decision|3|||
33203059|NCT00965523|100645819|FG000|Study 224|Progressive Disease|5|||
33203060|NCT00965523|100645819|FG000|Study 224|Physician Decision|1|||
33203061|NCT00003498|100645820|FG000|Overall Study|Not evaluable.|4|||
33203062|NCT02194621|100645821|FG000|Overall Study|6 withdrew prior to randomization|2|||
33203063|NCT02194621|100645822|FG001|Overall Study|6 withdrew prior to randomization|2|||
33203064|NCT02194621|100645823|FG002|Overall Study|6 withdrew prior to randomization|2|||
33203065|NCT02194621|100645821|FG000|Overall Study|Withdrawal by Subject|4|||
33203066|NCT02194621|100645822|FG001|Overall Study|Withdrawal by Subject|4|||
33203067|NCT02194621|100645823|FG002|Overall Study|Withdrawal by Subject|7|||
33203068|NCT02331134|100645824|FG000|Overall Study|Withdrawal by Subject|1|||
33203069|NCT03832946|100645825|FG000|Overall Study|Adverse Event|3|||
33203070|NCT03832946|100645826|FG001|Overall Study|Adverse Event|1|||
33203071|NCT03832946|100645825|FG000|Overall Study|Lost to Follow-up|1|||
33203072|NCT03832946|100645826|FG001|Overall Study|Lost to Follow-up|0|||
33203073|NCT03832946|100645825|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
33203074|NCT03832946|100645826|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
33203075|NCT03832946|100645825|FG000|Overall Study|Lack of Efficacy|1|||
33203076|NCT03832946|100645826|FG001|Overall Study|Lack of Efficacy|0|||
33203077|NCT03832946|100645825|FG000|Overall Study|Withdrawal by Subject|12|||
33203078|NCT03832946|100645826|FG001|Overall Study|Withdrawal by Subject|9|||
33203079|NCT01136291|100645828|FG000|Overall Study|Lost to Follow-up|1|||
33203080|NCT01136291|100645829|FG001|Overall Study|Lost to Follow-up|1|||
33203081|NCT00093145|100645830|FG000|Overall Study|Unacceptable Toxicity Only|2|||
33203082|NCT00093145|100645830|FG000|Overall Study|Physician Decision|5|||
33203083|NCT00093145|100645830|FG000|Overall Study|Withdrawal by Subject|9|||
33203084|NCT00093145|100645830|FG000|Overall Study|Other|1|||
33203085|NCT01218646|100645834|FG000|Overall Study|Adverse Event|0|||
33203086|NCT01218646|100645835|FG001|Overall Study|Adverse Event|0|||
33203087|NCT01218646|100645836|FG002|Overall Study|Adverse Event|1|||
33203088|NCT01218646|100645837|FG003|Overall Study|Adverse Event|0|||
33203089|NCT01218646|100645834|FG000|Overall Study|Lost to Follow-up|1|||
33203090|NCT01218646|100645835|FG001|Overall Study|Lost to Follow-up|0|||
33203091|NCT01218646|100645836|FG002|Overall Study|Lost to Follow-up|0|||
33203092|NCT01218646|100645837|FG003|Overall Study|Lost to Follow-up|0|||
33332390|NCT01278745|101111549|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
33332391|NCT01278745|101111550|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
33332392|NCT01278745|101111551|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
33332393|NCT01278745|101111552|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
33203093|NCT01218646|100645834|FG000|Overall Study|Protocol Violation|0|||
33332394|NCT00531752|101111554|FG000|First Double-blind Intervention Period|Adverse Event|2|||
33526460|NCT03959488|101823557|FG004|Season 1|Due to COVID-19 pandemic|0|||
33203094|NCT01218646|100645835|FG001|Overall Study|Protocol Violation|0|||
33203095|NCT01218646|100645836|FG002|Overall Study|Protocol Violation|1|||
33203096|NCT01218646|100645837|FG003|Overall Study|Protocol Violation|1|||
33203097|NCT02707055|100645838|FG000|Phase 1|Withdrawal by Subject|1|||
33402589|NCT00141297|101365349|FG004|Overall Study|Other|5|||
33203098|NCT02707055|100645839|FG001|Phase 1|Withdrawal by Subject|2|||
33203099|NCT02707055|100645838|FG000|Phase 1|Physician Decision|0|||
33203100|NCT02707055|100645839|FG001|Phase 1|Physician Decision|1|||
33203101|NCT02707055|100645838|FG000|Phase 2|Adverse Event|1|||
33203102|NCT02707055|100645839|FG001|Phase 2|Adverse Event|2|||
33203103|NCT04602624|100645840|FG000|Overall Study|Protocol Deviation|1|||
33203104|NCT04602624|100645840|FG000|Overall Study|Withdrawal by Participant|1|||
33203105|NCT00353704|100645841|FG000|Overall Study|Protocol Violation|3|||
33203106|NCT00353704|100645842|FG001|Overall Study|Protocol Violation|1|||
33203107|NCT00214136|100645843|FG000|Overall Study|Death|5|||
33203108|NCT00613951|100645844|FG000|Overall Study|Adverse Event|1|||
33203109|NCT00613951|100645845|FG001|Overall Study|Adverse Event|0|||
33203110|NCT00613951|100645846|FG002|Overall Study|Adverse Event|1|||
33203111|NCT00613951|100645844|FG000|Overall Study|Lack of Efficacy|0|||
33203112|NCT00613951|100645845|FG001|Overall Study|Lack of Efficacy|1|||
33203113|NCT00613951|100645846|FG002|Overall Study|Lack of Efficacy|1|||
33203114|NCT00613951|100645844|FG000|Overall Study|Protocol Violation|1|||
33203115|NCT00613951|100645845|FG001|Overall Study|Protocol Violation|1|||
33203116|NCT00613951|100645846|FG002|Overall Study|Protocol Violation|1|||
33203117|NCT00613951|100645844|FG000|Overall Study|Unclassified|5|||
33203118|NCT00613951|100645845|FG001|Overall Study|Unclassified|3|||
33203119|NCT00613951|100645846|FG002|Overall Study|Unclassified|2|||
33203120|NCT02239510|100645847|FG000|Overall Study|Lost to Follow-up|2|||
33203121|NCT02239510|100645848|FG001|Overall Study|Lost to Follow-up|1|||
33203122|NCT02899728|100645849|FG000|Overall Study|Withdrawal by Subject|1|||
33203123|NCT02899728|100645850|FG001|Overall Study|Withdrawal by Subject|1|||
33203124|NCT02308033|100645851|FG000|Overall Study|Normal Gram stain at Baseline|13|||
33203125|NCT02308033|100645852|FG001|Overall Study|Normal Gram stain at Baseline|10|||
33203126|NCT02308033|100645851|FG000|Overall Study|Positive for STD at Baseline|7|||
33203127|NCT02308033|100645852|FG001|Overall Study|Positive for STD at Baseline|4|||
33203128|NCT02308033|100645851|FG000|Overall Study|Lost to Follow-up|6|||
33203129|NCT02308033|100645852|FG001|Overall Study|Lost to Follow-up|5|||
33203130|NCT04102501|100645857|FG000|Overall Study|Withdrawal by Subject|7|||
33203131|NCT04102501|100645858|FG001|Overall Study|Withdrawal by Subject|9|||
33203132|NCT04102501|100645857|FG000|Overall Study|Adverse Event|1|||
33203133|NCT04102501|100645858|FG001|Overall Study|Adverse Event|3|||
33203134|NCT02807948|100645871|FG000|Overall Study|Physician Decision|1|||
33203135|NCT02807948|100645872|FG001|Overall Study|Physician Decision|0|||
33203136|NCT01043874|100645873|FG000|Overall Study|Adverse Event|3|||
33203137|NCT01043874|100645873|FG000|Overall Study|Withdrawal by Subject|1|||
33203138|NCT01043874|100645873|FG000|Overall Study|Lack of Efficacy|1|||
33203139|NCT01043874|100645873|FG000|Overall Study|Administrative Problems|1|||
33203140|NCT02039505|100645874|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
33203141|NCT02039505|100645875|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
33203142|NCT02039505|100645876|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
33203143|NCT02039505|100645877|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
33203144|NCT02039505|100645878|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
33203145|NCT02039505|100645879|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
33203146|NCT02039505|100645880|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
33203147|NCT02039505|100645874|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
33203148|NCT02039505|100645875|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
33203149|NCT02039505|100645876|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
33203150|NCT02039505|100645877|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
33203151|NCT02039505|100645878|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
33203152|NCT02039505|100645879|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
33203153|NCT02039505|100645880|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
33203154|NCT02039505|100645874|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
33203155|NCT02039505|100645875|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
33203156|NCT02039505|100645876|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
33402590|NCT00141297|101365350|FG005|Overall Study|Other|0|||
33402591|NCT00141297|101365351|FG006|Overall Study|Other|0|||
33402592|NCT00141297|101365352|FG007|Overall Study|Other|0|||
33203157|NCT02039505|100645877|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
33203158|NCT02039505|100645878|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
33203159|NCT02039505|100645879|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
33203160|NCT02039505|100645880|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
33203161|NCT02039505|100645874|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
33203162|NCT02039505|100645875|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
33203163|NCT02039505|100645876|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
33203164|NCT02039505|100645877|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
33526461|NCT03959488|101823553|FG000|Season 1|Lost to Follow-up|17|||
33203165|NCT02039505|100645878|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
33402593|NCT00141297|101365353|FG008|Overall Study|Other|2|||
33203166|NCT02039505|100645879|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
33203167|NCT02039505|100645880|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
33203168|NCT02039505|100645874|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
33203169|NCT02039505|100645875|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
33203170|NCT02039505|100645876|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
33203171|NCT02039505|100645877|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
33203172|NCT02039505|100645878|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
33203173|NCT02039505|100645879|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
33203174|NCT02039505|100645880|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
33203175|NCT02039505|100645874|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
33203176|NCT02039505|100645875|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
33203177|NCT02039505|100645876|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
33203178|NCT02039505|100645877|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
33203179|NCT02039505|100645878|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
33203180|NCT02039505|100645879|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
33203181|NCT02039505|100645880|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
33203182|NCT02039505|100645874|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
33203183|NCT02039505|100645875|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
33203184|NCT02039505|100645876|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
33203185|NCT02039505|100645877|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
33203186|NCT02039505|100645878|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
33203187|NCT02039505|100645879|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
33203188|NCT02039505|100645880|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
33203189|NCT02039505|100645874|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
33203190|NCT02039505|100645875|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
33203191|NCT02039505|100645876|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
33203192|NCT02039505|100645877|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
33203193|NCT02039505|100645878|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
33332395|NCT00531752|101111555|FG001|First Double-blind Intervention Period|Adverse Event|0|||
33203194|NCT02039505|100645879|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
33203195|NCT02039505|100645880|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
33203196|NCT02039505|100645874|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
33203197|NCT02039505|100645875|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
33203198|NCT02039505|100645876|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
33203199|NCT02039505|100645877|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
33203200|NCT02039505|100645878|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
33203201|NCT02039505|100645879|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
33203202|NCT02039505|100645880|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
33203203|NCT02039505|100645874|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
33203204|NCT02039505|100645875|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
33203205|NCT02039505|100645876|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
33203206|NCT02039505|100645877|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
33203207|NCT02039505|100645878|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
33203208|NCT02039505|100645879|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
33203209|NCT02039505|100645880|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
33203210|NCT02039505|100645874|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
33203211|NCT02039505|100645875|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
33203212|NCT02039505|100645876|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
33203213|NCT02039505|100645877|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
33203214|NCT02039505|100645878|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
33203215|NCT02039505|100645879|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
33203216|NCT02039505|100645880|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
33203217|NCT02548962|100645885|FG000|Overall Study|Withdrawal by Subject|1|||
33203218|NCT02548962|100645886|FG001|Overall Study|Withdrawal by Subject|0|||
33203219|NCT01143259|100645887|FG000|Overall Study|Withdrawal by Subject|3|||
33332396|NCT00531752|101111556|FG002|First Double-blind Intervention Period|Adverse Event|1|||
33332397|NCT00531752|101111557|FG003|First Double-blind Intervention Period|Adverse Event|1|||
33203220|NCT01143259|100645888|FG001|Overall Study|Withdrawal by Subject|2|||
33203221|NCT01143259|100645887|FG000|Overall Study|Protocol Violation|13|||
33203222|NCT01143259|100645888|FG001|Overall Study|Protocol Violation|9|||
33203223|NCT01143259|100645887|FG000|Overall Study|Screen Failure|7|||
33332398|NCT00531752|101111554|FG000|First Double-blind Intervention Period|Other|1|||
33526462|NCT03959488|101823554|FG001|Season 1|Lost to Follow-up|7|||
33526463|NCT03959488|101823555|FG002|Season 1|Lost to Follow-up|0|||
33526464|NCT03959488|101823556|FG003|Season 1|Lost to Follow-up|0|||
33203224|NCT01143259|100645888|FG001|Overall Study|Screen Failure|9|||
33203225|NCT03936244|100645889|FG000|Overall Study|Lost to Follow-up|5|||
33203226|NCT03936244|100645890|FG001|Overall Study|Lost to Follow-up|1|||
33203227|NCT03936244|100645889|FG000|Overall Study|Physician Decision|7|||
33203228|NCT03936244|100645890|FG001|Overall Study|Physician Decision|3|||
33203229|NCT03314987|100645898|FG000|Overall Study|Lost to Follow-up|13|||
33203230|NCT03314987|100645899|FG001|Overall Study|Lost to Follow-up|13|||
33203231|NCT00968669|100645900|FG000|Overall Study|Lost to Follow-up|5|||
33203232|NCT00968669|100645901|FG001|Overall Study|Lost to Follow-up|2|||
33203233|NCT00968669|100645902|FG002|Overall Study|Lost to Follow-up|1|||
33203234|NCT00968669|100645903|FG003|Overall Study|Lost to Follow-up|4|||
33203235|NCT00968669|100645900|FG000|Overall Study|Withdrawal by Subject|9|||
33203236|NCT00968669|100645901|FG001|Overall Study|Withdrawal by Subject|7|||
33203237|NCT00968669|100645902|FG002|Overall Study|Withdrawal by Subject|5|||
33203238|NCT00968669|100645903|FG003|Overall Study|Withdrawal by Subject|3|||
33203239|NCT00968669|100645900|FG000|Overall Study|Pregnancy|0|||
33203240|NCT00968669|100645901|FG001|Overall Study|Pregnancy|0|||
33203241|NCT00968669|100645902|FG002|Overall Study|Pregnancy|2|||
33203242|NCT00968669|100645903|FG003|Overall Study|Pregnancy|0|||
33203243|NCT00968669|100645900|FG000|Overall Study|AE|1|||
33203244|NCT00968669|100645901|FG001|Overall Study|AE|0|||
33203245|NCT00968669|100645902|FG002|Overall Study|AE|0|||
33203246|NCT00968669|100645903|FG003|Overall Study|AE|0|||
33203247|NCT00968669|100645900|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
33203248|NCT00968669|100645901|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
33203249|NCT00968669|100645902|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
33203250|NCT00968669|100645903|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
33203251|NCT00968669|100645900|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
33203252|NCT00968669|100645901|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
33203253|NCT00968669|100645902|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
33203254|NCT00968669|100645903|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
33203255|NCT00968669|100645900|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
33203256|NCT00968669|100645901|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
33203257|NCT00968669|100645902|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
33203258|NCT00968669|100645903|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
33203259|NCT00968669|100645900|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
33203260|NCT00968669|100645901|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
33203261|NCT00968669|100645902|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
33203262|NCT00968669|100645903|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
33203263|NCT00968669|100645900|FG000|Overall Study|EARLY WITHDRAWAL|0|||
33203264|NCT00968669|100645901|FG001|Overall Study|EARLY WITHDRAWAL|1|||
33203265|NCT00968669|100645902|FG002|Overall Study|EARLY WITHDRAWAL|0|||
33203266|NCT00968669|100645903|FG003|Overall Study|EARLY WITHDRAWAL|0|||
33203267|NCT00968669|100645900|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
33203268|NCT00968669|100645901|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
33203269|NCT00968669|100645902|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
33203270|NCT00968669|100645903|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
33203271|NCT00968669|100645900|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
33203272|NCT00968669|100645901|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
33203273|NCT00968669|100645902|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
33203274|NCT00968669|100645903|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
33203275|NCT00968669|100645900|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
33203276|NCT00968669|100645901|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
33332399|NCT00531752|101111555|FG001|First Double-blind Intervention Period|Other|4|||
33332400|NCT00531752|101111556|FG002|First Double-blind Intervention Period|Other|4|||
33332401|NCT00531752|101111557|FG003|First Double-blind Intervention Period|Other|0|||
33332402|NCT00531752|101111554|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
33332403|NCT00531752|101111555|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
33332404|NCT00531752|101111556|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
33332405|NCT00531752|101111557|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
33332406|NCT00531752|101111554|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
33332407|NCT00531752|101111555|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
33332408|NCT00531752|101111556|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
33332409|NCT00531752|101111557|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
33610432|NCT04038567|102123310|FG006|Overall Study|Medical issues (i.e., illness)|0|||
33610433|NCT04038567|102123311|FG007|Overall Study|Medical issues (i.e., illness)|0|||
33610434|NCT04038567|102123304|FG000|Overall Study|Death|0|||
33203277|NCT00968669|100645902|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
33203278|NCT00968669|100645903|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
33203279|NCT00968669|100645900|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
33203280|NCT00968669|100645901|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
33332410|NCT00531752|101111554|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
33610435|NCT04038567|102123305|FG001|Overall Study|Death|0|||
33332411|NCT00531752|101111555|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
33332412|NCT00531752|101111556|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
33332413|NCT00531752|101111557|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
33332414|NCT00531752|101111554|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
33332415|NCT00531752|101111555|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
33332416|NCT00531752|101111556|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
33332417|NCT00531752|101111557|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
33332418|NCT00531752|101111554|FG000|Second Double-blind Intervention Period|Other|1|||
33332419|NCT00531752|101111555|FG001|Second Double-blind Intervention Period|Other|1|||
33332420|NCT00531752|101111556|FG002|Second Double-blind Intervention Period|Other|0|||
33332421|NCT00531752|101111557|FG003|Second Double-blind Intervention Period|Other|0|||
33332422|NCT00531752|101111554|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
33332423|NCT00531752|101111555|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
33332424|NCT00531752|101111556|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
33332425|NCT00531752|101111557|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
33332426|NCT00531752|101111554|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
33332427|NCT00531752|101111555|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
33332428|NCT00531752|101111556|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
33332429|NCT00531752|101111557|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
33332430|NCT00530894|101111558|FG000|Overall Study|Death|84|||
33332431|NCT00530894|101111559|FG001|Overall Study|Death|89|||
33402594|NCT00141297|101365354|FG009|Overall Study|Other|0|||
33402595|NCT00141297|101365345|FG000|Overall Study|Progressive Disease|2|||
33402596|NCT00141297|101365346|FG001|Overall Study|Progressive Disease|3|||
33402597|NCT00141297|101365347|FG002|Overall Study|Progressive Disease|6|||
33402598|NCT00141297|101365348|FG003|Overall Study|Progressive Disease|2|||
33332432|NCT00530894|101111560|FG002|Overall Study|Death|55|||
33332433|NCT00530894|101111561|FG003|Overall Study|Death|89|||
33332434|NCT00530894|101111558|FG000|Overall Study|Lost to Follow-up|1|||
33332435|NCT00530894|101111559|FG001|Overall Study|Lost to Follow-up|3|||
33332436|NCT00530894|101111560|FG002|Overall Study|Lost to Follow-up|0|||
33332437|NCT00530894|101111561|FG003|Overall Study|Lost to Follow-up|0|||
33332438|NCT00530894|101111558|FG000|Overall Study|Withdrawal by Subject|1|||
33332439|NCT00530894|101111559|FG001|Overall Study|Withdrawal by Subject|23|||
33332440|NCT00530894|101111560|FG002|Overall Study|Withdrawal by Subject|0|||
33332441|NCT00530894|101111561|FG003|Overall Study|Withdrawal by Subject|5|||
33332442|NCT00530894|101111558|FG000|Overall Study|Alive and censored prior to 1 year|2|||
33332443|NCT00530894|101111559|FG001|Overall Study|Alive and censored prior to 1 year|0|||
33402599|NCT00141297|101365349|FG004|Overall Study|Progressive Disease|15|||
33402600|NCT00141297|101365350|FG005|Overall Study|Progressive Disease|2|||
33402601|NCT00141297|101365351|FG006|Overall Study|Progressive Disease|3|||
33402602|NCT00141297|101365352|FG007|Overall Study|Progressive Disease|3|||
33402603|NCT00141297|101365353|FG008|Overall Study|Progressive Disease|15|||
33402604|NCT00141297|101365354|FG009|Overall Study|Progressive Disease|6|||
33402605|NCT00141297|101365345|FG000|Overall Study|Transitioned|0|||
33402606|NCT00141297|101365346|FG001|Overall Study|Transitioned|0|||
33402607|NCT00141297|101365347|FG002|Overall Study|Transitioned|0|||
33402608|NCT00141297|101365348|FG003|Overall Study|Transitioned|0|||
33402609|NCT00141297|101365349|FG004|Overall Study|Transitioned|1|||
33402610|NCT00141297|101365350|FG005|Overall Study|Transitioned|0|||
33402611|NCT00141297|101365351|FG006|Overall Study|Transitioned|0|||
33402612|NCT00141297|101365352|FG007|Overall Study|Transitioned|0|||
33402613|NCT00141297|101365353|FG008|Overall Study|Transitioned|0|||
33402614|NCT00141297|101365354|FG009|Overall Study|Transitioned|0|||
33402615|NCT01191190|101365356|FG000|Overall Study|Withdrawal by Subject|1|||
33402616|NCT00374452|101365357|FG000|Overall Study|Left clinic before intervention started|4|||
33402617|NCT00374452|101365358|FG001|Overall Study|Left clinic before intervention started|1|||
33402618|NCT00374452|101365357|FG000|Overall Study|Change in job role before intervention|0|||
33402619|NCT00374452|101365358|FG001|Overall Study|Change in job role before intervention|1|||
33402620|NCT00374452|101365357|FG000|Overall Study|Left clinic after intervention started|1|||
33402621|NCT00374452|101365358|FG001|Overall Study|Left clinic after intervention started|1|||
33402622|NCT00374452|101365357|FG000|Overall Study|Withdrawal by Subject|0|||
33402623|NCT00374452|101365358|FG001|Overall Study|Withdrawal by Subject|2|||
33402624|NCT01333865|101365359|FG000|Overall Study|Adverse Event|2|||
33402625|NCT02117024|101365360|FG000|Overall Study|Progressive Disease|26|||
33402626|NCT02117024|101365361|FG001|Overall Study|Progressive Disease|9|||
33526465|NCT03959488|101823557|FG004|Season 1|Lost to Follow-up|0|||
33332444|NCT00530894|101111560|FG002|Overall Study|Alive and censored prior to 1 year|0|||
33332445|NCT00530894|101111561|FG003|Overall Study|Alive and censored prior to 1 year|0|||
33332446|NCT01462435|101111564|FG000|Overall Study|Lack of Efficacy|1|||
33402627|NCT02117024|101365360|FG000|Overall Study|Significant Clinical Progression|7|||
33402628|NCT02117024|101365361|FG001|Overall Study|Significant Clinical Progression|4|||
33402629|NCT02117024|101365360|FG000|Overall Study|Death|5|||
33402630|NCT02117024|101365361|FG001|Overall Study|Death|0|||
33402631|NCT02117024|101365360|FG000|Overall Study|Withdrawal by Subject|3|||
33402632|NCT02117024|101365361|FG001|Overall Study|Withdrawal by Subject|1|||
33402633|NCT02117024|101365360|FG000|Overall Study|Protocol Violation|1|||
33402634|NCT02117024|101365361|FG001|Overall Study|Protocol Violation|0|||
33402635|NCT02117024|101365360|FG000|Overall Study|Adverse Event|1|||
33402636|NCT02117024|101365361|FG001|Overall Study|Adverse Event|2|||
33402637|NCT02117024|101365360|FG000|Overall Study|Randomized in Error|1|||
33402638|NCT02117024|101365361|FG001|Overall Study|Randomized in Error|0|||
33402639|NCT02117024|101365360|FG000|Overall Study|Patient returned to primary oncologist|0|||
33402640|NCT02117024|101365361|FG001|Overall Study|Patient returned to primary oncologist|1|||
33402641|NCT02117024|101365360|FG000|Overall Study|Patient took treatment break|0|||
33402642|NCT02117024|101365361|FG001|Overall Study|Patient took treatment break|1|||
33402643|NCT02117024|101365360|FG000|Overall Study|Physician Decision|0|||
33402644|NCT02117024|101365361|FG001|Overall Study|Physician Decision|2|||
33402645|NCT00103207|101365362|FG000|Overall Study|Adverse Event|3|||
33402646|NCT00103207|101365362|FG000|Overall Study|Death|1|||
33402647|NCT00103207|101365362|FG000|Overall Study|Withdrawal by Subject|2|||
33402648|NCT00103207|101365362|FG000|Overall Study|Other complicating disease|1|||
33402649|NCT00103207|101365362|FG000|Overall Study|Ineligible|4|||
33402650|NCT00103207|101365362|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
33402651|NCT02146352|101365363|FG000|Overall Study|Death|1|||
33332447|NCT01462435|101111565|FG001|Overall Study|Lack of Efficacy|0|||
33332448|NCT01462435|101111566|FG002|Overall Study|Lack of Efficacy|0|||
33332449|NCT01462435|101111567|FG003|Overall Study|Lack of Efficacy|3|||
33332450|NCT01462435|101111564|FG000|Overall Study|Physician Decision|0|||
33402652|NCT02146352|101365363|FG000|Overall Study|Patient entered hospice care|1|||
33402653|NCT01497899|101365364|FG000|Double-Blind Phase|Randomized but not Treated|1|||
33402654|NCT01497899|101365365|FG001|Double-Blind Phase|Randomized but not Treated|0|||
33402655|NCT01497899|101365366|FG002|Double-Blind Phase|Randomized but not Treated|0|||
33402656|NCT01497899|101365367|FG003|Double-Blind Phase|Randomized but not Treated|0|||
33402657|NCT01497899|101365364|FG000|Double-Blind Phase|Adverse Event|1|||
33332451|NCT01462435|101111565|FG001|Overall Study|Physician Decision|0|||
33332452|NCT01462435|101111566|FG002|Overall Study|Physician Decision|1|||
33332453|NCT01462435|101111567|FG003|Overall Study|Physician Decision|0|||
33332454|NCT01462435|101111564|FG000|Overall Study|Withdrawal by Subject|0|||
33402658|NCT01497899|101365365|FG001|Double-Blind Phase|Adverse Event|0|||
33402659|NCT01497899|101365366|FG002|Double-Blind Phase|Adverse Event|0|||
33402660|NCT01497899|101365367|FG003|Double-Blind Phase|Adverse Event|0|||
33402661|NCT01497899|101365364|FG000|Double-Blind Phase|Lack of Efficacy|0|||
33402662|NCT01497899|101365365|FG001|Double-Blind Phase|Lack of Efficacy|1|||
33402663|NCT01497899|101365366|FG002|Double-Blind Phase|Lack of Efficacy|0|||
33402664|NCT01497899|101365367|FG003|Double-Blind Phase|Lack of Efficacy|0|||
33402665|NCT01497899|101365364|FG000|Double-Blind Phase|Investigator's Discretion|1|||
33402666|NCT01497899|101365365|FG001|Double-Blind Phase|Investigator's Discretion|0|||
33402667|NCT01497899|101365366|FG002|Double-Blind Phase|Investigator's Discretion|0|||
33402668|NCT01497899|101365367|FG003|Double-Blind Phase|Investigator's Discretion|0|||
33402669|NCT01497899|101365364|FG000|Double-Blind Phase|Withdrew Consent|0|||
33402670|NCT01497899|101365365|FG001|Double-Blind Phase|Withdrew Consent|1|||
33402671|NCT01497899|101365366|FG002|Double-Blind Phase|Withdrew Consent|0|||
33402672|NCT01497899|101365367|FG003|Double-Blind Phase|Withdrew Consent|0|||
33402673|NCT01497899|101365364|FG000|Double-Blind Phase|Lost to Follow-up|3|||
33402674|NCT01497899|101365365|FG001|Double-Blind Phase|Lost to Follow-up|2|||
33402675|NCT01497899|101365366|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33402676|NCT01497899|101365367|FG003|Double-Blind Phase|Lost to Follow-up|0|||
33402677|NCT01497899|101365364|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
33402678|NCT01497899|101365365|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
33402679|NCT01497899|101365366|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
33402680|NCT01497899|101365367|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
33402681|NCT01497899|101365364|FG000|Open-Label Extension Phase|Adverse Event|1|||
33402682|NCT01497899|101365365|FG001|Open-Label Extension Phase|Adverse Event|0|||
33402683|NCT01497899|101365366|FG002|Open-Label Extension Phase|Adverse Event|0|||
33402684|NCT01497899|101365367|FG003|Open-Label Extension Phase|Adverse Event|0|||
33402685|NCT01497899|101365364|FG000|Open-Label Extension Phase|Death|1|||
33402686|NCT01497899|101365365|FG001|Open-Label Extension Phase|Death|0|||
33402687|NCT01497899|101365366|FG002|Open-Label Extension Phase|Death|0|||
33402688|NCT01497899|101365367|FG003|Open-Label Extension Phase|Death|0|||
33402689|NCT01497899|101365364|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
33332455|NCT01462435|101111565|FG001|Overall Study|Withdrawal by Subject|0|||
33332456|NCT01462435|101111566|FG002|Overall Study|Withdrawal by Subject|0|||
33402690|NCT01497899|101365365|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
33402691|NCT01497899|101365366|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
33402692|NCT01497899|101365367|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
33402693|NCT01497899|101365364|FG000|Open-Label Extension Phase|Pregnancy|0|||
33402694|NCT01497899|101365365|FG001|Open-Label Extension Phase|Pregnancy|1|||
33203281|NCT00968669|100645902|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
33203282|NCT00968669|100645903|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
33203283|NCT00968669|100645900|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
33203284|NCT00968669|100645901|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
33203285|NCT00968669|100645902|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
33203286|NCT00968669|100645903|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
33203287|NCT00968669|100645900|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
33203288|NCT00968669|100645901|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
33203289|NCT00968669|100645902|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
33203290|NCT00968669|100645903|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
33203291|NCT00968669|100645900|FG000|Overall Study|SPONSOR DECISION|0|||
33203292|NCT00968669|100645901|FG001|Overall Study|SPONSOR DECISION|1|||
33203293|NCT00968669|100645902|FG002|Overall Study|SPONSOR DECISION|0|||
33203294|NCT00968669|100645903|FG003|Overall Study|SPONSOR DECISION|0|||
33203295|NCT00968669|100645900|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
33203296|NCT00968669|100645901|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
33203297|NCT00968669|100645902|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
33203298|NCT00968669|100645903|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
33203299|NCT00968669|100645900|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
33203300|NCT00968669|100645901|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
33203301|NCT00968669|100645902|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
33203302|NCT00968669|100645903|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
33203303|NCT00968669|100645900|FG000|Overall Study|SUBJECT INCARCERATED|0|||
33203304|NCT00968669|100645901|FG001|Overall Study|SUBJECT INCARCERATED|1|||
33203305|NCT00968669|100645902|FG002|Overall Study|SUBJECT INCARCERATED|0|||
33203306|NCT00968669|100645903|FG003|Overall Study|SUBJECT INCARCERATED|0|||
33203307|NCT00968669|100645900|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
33203308|NCT00968669|100645901|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
33203309|NCT00968669|100645902|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
33203310|NCT00968669|100645903|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
33203311|NCT00968669|100645900|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
33203312|NCT00968669|100645901|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
33203313|NCT00968669|100645902|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
33203314|NCT00968669|100645903|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
33203315|NCT01076400|100645904|FG000|Overall Study|Adverse Event|2|||
33203316|NCT01076400|100645905|FG001|Overall Study|Adverse Event|0|||
33203317|NCT01076400|100645906|FG002|Overall Study|Adverse Event|0|||
33203318|NCT01076400|100645904|FG000|Overall Study|Progressive Disease|5|||
33203319|NCT01076400|100645905|FG001|Overall Study|Progressive Disease|0|||
33203320|NCT01076400|100645906|FG002|Overall Study|Progressive Disease|0|||
33203321|NCT00724971|100645907|FG000|Overall Study|Adverse Event|5|||
33203322|NCT00724971|100645907|FG000|Overall Study|Withdrawal by Subject|1|||
33203323|NCT02114892|100645908|FG000|Overall Study|Lost to Follow-up|1|||
33203324|NCT02114892|100645909|FG001|Overall Study|Lost to Follow-up|2|||
33203325|NCT02013765|100645911|FG000|Overall Study|Trial was terminated by sponsor|1|||
33203326|NCT02343458|100645920|FG000|Overall Study|Adverse Event|15|||
33332457|NCT01462435|101111567|FG003|Overall Study|Withdrawal by Subject|1|||
33332458|NCT01462435|101111564|FG000|Overall Study|Lost to Follow-up|0|||
33332459|NCT01462435|101111565|FG001|Overall Study|Lost to Follow-up|0|||
33332460|NCT01462435|101111566|FG002|Overall Study|Lost to Follow-up|0|||
33332461|NCT01462435|101111567|FG003|Overall Study|Lost to Follow-up|1|||
33332462|NCT00003535|101111568|FG000|Overall Study|Not evaluable|5|||
33332463|NCT02289950|101111569|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
33332464|NCT02289950|101111570|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
33402695|NCT01497899|101365366|FG002|Open-Label Extension Phase|Pregnancy|1|||
33402696|NCT01497899|101365367|FG003|Open-Label Extension Phase|Pregnancy|0|||
33332465|NCT02289950|101111569|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
33332466|NCT02289950|101111570|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
33402697|NCT01497899|101365364|FG000|Open-Label Extension Phase|Protocol Violation|0|||
33402698|NCT01497899|101365365|FG001|Open-Label Extension Phase|Protocol Violation|0|||
33402699|NCT01497899|101365366|FG002|Open-Label Extension Phase|Protocol Violation|1|||
33402700|NCT01497899|101365367|FG003|Open-Label Extension Phase|Protocol Violation|0|||
33203327|NCT02343458|100645921|FG001|Overall Study|Adverse Event|14|||
33203328|NCT02343458|100645922|FG002|Overall Study|Adverse Event|15|||
33203329|NCT02343458|100645923|FG003|Overall Study|Adverse Event|3|||
33203330|NCT02343458|100645920|FG000|Overall Study|Lack of Efficacy|3|||
33203331|NCT02343458|100645921|FG001|Overall Study|Lack of Efficacy|8|||
33332467|NCT02289950|101111569|FG000|Overall Study|Lost to Follow-up|1|||
33332468|NCT02289950|101111570|FG001|Overall Study|Lost to Follow-up|0|||
33402701|NCT01497899|101365364|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
33402702|NCT01497899|101365365|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
33203332|NCT02343458|100645922|FG002|Overall Study|Lack of Efficacy|4|||
33203333|NCT02343458|100645923|FG003|Overall Study|Lack of Efficacy|8|||
33203334|NCT02343458|100645920|FG000|Overall Study|Withdrawal by Subject|18|||
33402703|NCT01497899|101365366|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
33332469|NCT02289950|101111569|FG000|Overall Study|Physician Decision|9|||
33332470|NCT02289950|101111570|FG001|Overall Study|Physician Decision|3|||
33332471|NCT02289950|101111569|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
33332472|NCT02289950|101111570|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
33332473|NCT02289950|101111569|FG000|Overall Study|Withdrawal by Subject|1|||
33332474|NCT02289950|101111570|FG001|Overall Study|Withdrawal by Subject|3|||
33402704|NCT01497899|101365367|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
33402705|NCT00760994|101365372|FG000|Overall Study|Lost to Follow-up|4|||
33402706|NCT00760994|101365373|FG001|Overall Study|Lost to Follow-up|4|||
33402707|NCT00760994|101365374|FG002|Overall Study|Lost to Follow-up|3|||
33402708|NCT02584660|101365376|FG000|Overall Study|Adverse Event|4|||
33402709|NCT02584660|101365377|FG001|Overall Study|Adverse Event|0|||
33402710|NCT02584660|101365376|FG000|Overall Study|Lost to Follow-up|3|||
33402711|NCT02584660|101365377|FG001|Overall Study|Lost to Follow-up|4|||
33332475|NCT02289950|101111569|FG000|Overall Study|Test article held for greater than 28 days|0|||
33332476|NCT02289950|101111570|FG001|Overall Study|Test article held for greater than 28 days|1|||
33332477|NCT02289950|101111569|FG000|Overall Study|Adverse Event|11|||
33332478|NCT02289950|101111570|FG001|Overall Study|Adverse Event|3|||
33332479|NCT02289950|101111569|FG000|Overall Study|Death|1|||
33332480|NCT02289950|101111570|FG001|Overall Study|Death|1|||
33332481|NCT02289950|101111569|FG000|Overall Study|Other|5|||
33332482|NCT02289950|101111570|FG001|Overall Study|Other|2|||
33332483|NCT02289950|101111569|FG000|Overall Study|Not Treated|2|||
33332484|NCT02289950|101111570|FG001|Overall Study|Not Treated|1|||
33332485|NCT02846532|101111571|FG000|Overall Study|Lost to Follow-up|0|||
33332486|NCT02846532|101111572|FG001|Overall Study|Lost to Follow-up|1|||
33402712|NCT02584660|101365376|FG000|Overall Study|Protocol Violation|0|||
33402713|NCT02584660|101365377|FG001|Overall Study|Protocol Violation|1|||
33402714|NCT02584660|101365376|FG000|Overall Study|Withdrawal by Subject|0|||
33402715|NCT02584660|101365377|FG001|Overall Study|Withdrawal by Subject|2|||
33402716|NCT02584660|101365376|FG000|Overall Study|Other|0|||
33402717|NCT02584660|101365377|FG001|Overall Study|Other|1|||
33402718|NCT00917553|101365380|FG000|Overall Study|Lost to Follow-up|2|||
33402719|NCT00917553|101365381|FG001|Overall Study|Lost to Follow-up|1|||
33402720|NCT01230489|101365382|FG000|Overall Study|Death|2|||
33402721|NCT01230489|101365382|FG000|Overall Study|Adverse Event|2|||
33402722|NCT01230489|101365382|FG000|Overall Study|Treatment modality changed|1|||
33402723|NCT01005875|101365383|FG000|Overall Study|Death|3|||
33402724|NCT00386152|101365391|FG000|Overall Study|Adverse Event|6|||
33402725|NCT00386152|101365392|FG001|Overall Study|Adverse Event|5|||
33402726|NCT00386152|101365393|FG002|Overall Study|Adverse Event|4|||
33402727|NCT00386152|101365391|FG000|Overall Study|Chang from original chemo stratification|4|||
33402728|NCT00386152|101365392|FG001|Overall Study|Chang from original chemo stratification|5|||
33402729|NCT00386152|101365393|FG002|Overall Study|Chang from original chemo stratification|6|||
33402730|NCT00386152|101365391|FG000|Overall Study|Death|3|||
33402731|NCT00386152|101365392|FG001|Overall Study|Death|0|||
33402732|NCT00386152|101365393|FG002|Overall Study|Death|1|||
33402733|NCT00386152|101365391|FG000|Overall Study|Disease progression|7|||
33402734|NCT00386152|101365392|FG001|Overall Study|Disease progression|4|||
33402735|NCT00386152|101365393|FG002|Overall Study|Disease progression|5|||
33402736|NCT00386152|101365391|FG000|Overall Study|Physician Decision|13|||
33402737|NCT00386152|101365392|FG001|Overall Study|Physician Decision|10|||
33402738|NCT00386152|101365393|FG002|Overall Study|Physician Decision|4|||
33402739|NCT00386152|101365391|FG000|Overall Study|Lost to Follow-up|1|||
33402740|NCT00386152|101365392|FG001|Overall Study|Lost to Follow-up|0|||
33402741|NCT00386152|101365393|FG002|Overall Study|Lost to Follow-up|0|||
33402742|NCT00386152|101365391|FG000|Overall Study|Completed chemotherapy|4|||
33203335|NCT02343458|100645921|FG001|Overall Study|Withdrawal by Subject|17|||
33332487|NCT02846532|101111573|FG002|Overall Study|Lost to Follow-up|1|||
33402743|NCT00386152|101365392|FG001|Overall Study|Completed chemotherapy|5|||
33402744|NCT00386152|101365393|FG002|Overall Study|Completed chemotherapy|1|||
33402745|NCT00386152|101365391|FG000|Overall Study|Protocol Violation|3|||
33402746|NCT00386152|101365392|FG001|Overall Study|Protocol Violation|5|||
33402747|NCT00386152|101365393|FG002|Overall Study|Protocol Violation|2|||
33402748|NCT00386152|101365391|FG000|Overall Study|Withdrawal by Subject|3|||
33402749|NCT00386152|101365392|FG001|Overall Study|Withdrawal by Subject|6|||
33402750|NCT00386152|101365393|FG002|Overall Study|Withdrawal by Subject|10|||
33332488|NCT02846532|101111571|FG000|Overall Study|Withdrawal by Subject|1|||
33332489|NCT02846532|101111572|FG001|Overall Study|Withdrawal by Subject|2|||
33402751|NCT02728804|101365394|FG000|Overall Study|Ineligible|3|||
33402752|NCT02728804|101365394|FG000|Overall Study|Did not complete baseline questionnaire|9|||
33402753|NCT02728804|101365394|FG000|Overall Study|Death|99|||
33402754|NCT01097057|101365395|FG000|Overall Study|Physician Decision|3|||
33402755|NCT01130831|101365396|FG000|Overall Study|Withdrawal by Subject|7|||
33402756|NCT01130831|101365396|FG000|Overall Study|Death|4|||
33402757|NCT01130831|101365396|FG000|Overall Study|Information was missing|3|||
33402758|NCT00372905|101365404|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
33402759|NCT00372905|101365405|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
33402760|NCT00372905|101365406|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
33402761|NCT00372905|101365407|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
33402762|NCT00372905|101365404|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
33402763|NCT00372905|101365405|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
33402764|NCT00372905|101365406|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
33402765|NCT00372905|101365407|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
33402766|NCT00372905|101365404|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
33402767|NCT00372905|101365405|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
33402768|NCT00372905|101365406|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
33402769|NCT00372905|101365407|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
33402770|NCT00372905|101365404|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
33402771|NCT00372905|101365405|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
33402772|NCT00372905|101365406|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
33402773|NCT00372905|101365407|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
33402774|NCT00372905|101365404|FG000|Follow up Until Relapse or Progression|Study closed|0|||
33402775|NCT00372905|101365405|FG001|Follow up Until Relapse or Progression|Study closed|0|||
33402776|NCT00372905|101365406|FG002|Follow up Until Relapse or Progression|Study closed|0|||
33402777|NCT00372905|101365407|FG003|Follow up Until Relapse or Progression|Study closed|3|||
33402778|NCT00372905|101365404|FG000|Follow up Until Relapse or Progression|Other|0|||
33402779|NCT00372905|101365405|FG001|Follow up Until Relapse or Progression|Other|1|||
33402780|NCT00372905|101365406|FG002|Follow up Until Relapse or Progression|Other|0|||
33402781|NCT00372905|101365407|FG003|Follow up Until Relapse or Progression|Other|0|||
33402782|NCT00962780|101365419|FG000|Overall Study|Death|0|||
33402783|NCT00962780|101365420|FG001|Overall Study|Death|1|||
33402784|NCT00962780|101365419|FG000|Overall Study|Protocol Violation|9|||
33402785|NCT00962780|101365420|FG001|Overall Study|Protocol Violation|4|||
33402786|NCT00962780|101365419|FG000|Overall Study|Withdrawal by Subject|1|||
33402787|NCT00962780|101365420|FG001|Overall Study|Withdrawal by Subject|8|||
33402788|NCT00962780|101365419|FG000|Overall Study|Other|0|||
33402789|NCT00962780|101365420|FG001|Overall Study|Other|1|||
33402790|NCT00784836|101365425|FG000|Overall Study|Early Study Termination|3|||
33402791|NCT03763942|101365426|FG000|Overall Study|Lost to Follow-up|114|||
33402792|NCT03763942|101365427|FG001|Overall Study|Lost to Follow-up|54|||
33402793|NCT03763942|101365426|FG000|Overall Study|Protocol Violation|1|||
33402794|NCT03763942|101365427|FG001|Overall Study|Protocol Violation|0|||
33402795|NCT03763942|101365426|FG000|Overall Study|Withdrawal by Subject|2|||
33402796|NCT03763942|101365427|FG001|Overall Study|Withdrawal by Subject|0|||
33402797|NCT03763942|101365426|FG000|Overall Study|Other|2|||
33402798|NCT03763942|101365427|FG001|Overall Study|Other|3|||
33402799|NCT01611558|101365428|FG000|Induction Phase|Study drug toxicity|15|||
33402800|NCT01611558|101365428|FG000|Induction Phase|Disease progression|18|||
33402801|NCT01611558|101365428|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
33402802|NCT01611558|101365428|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
33402803|NCT01611558|101365428|FG000|Induction Phase|Death|1|||
33402804|NCT01611558|101365428|FG000|Maintenance Phase|Withdrawal by Subject|1|||
33402805|NCT01611558|101365428|FG000|Maintenance Phase|Elevated Uric acid|1|||
33332490|NCT02846532|101111573|FG002|Overall Study|Withdrawal by Subject|0|||
33332491|NCT05121480|101111574|FG000|Overall Study|Lack of Efficacy|2|||
33332492|NCT05121480|101111575|FG001|Overall Study|Lack of Efficacy|2|||
33332493|NCT05121480|101111576|FG002|Overall Study|Lack of Efficacy|1|||
33332494|NCT05121480|101111577|FG003|Overall Study|Lack of Efficacy|4|||
33402806|NCT01982942|101365430|FG000|Overall Study|Adverse Event|10|||
33402807|NCT01982942|101365431|FG001|Overall Study|Adverse Event|5|||
33402808|NCT01982942|101365430|FG000|Overall Study|Lost to Follow-up|4|||
33332495|NCT05121480|101111578|FG004|Overall Study|Lack of Efficacy|0|||
33332496|NCT05121480|101111579|FG005|Overall Study|Lack of Efficacy|1|||
33332497|NCT05121480|101111580|FG006|Overall Study|Lack of Efficacy|0|||
33332498|NCT05121480|101111581|FG007|Overall Study|Lack of Efficacy|2|||
33332499|NCT05121480|101111574|FG000|Overall Study|Treatment Failure|0|||
33203336|NCT02343458|100645922|FG002|Overall Study|Withdrawal by Subject|23|||
33332500|NCT05121480|101111575|FG001|Overall Study|Treatment Failure|2|||
33402809|NCT01982942|101365431|FG001|Overall Study|Lost to Follow-up|3|||
33402810|NCT01982942|101365430|FG000|Overall Study|Multiple sclerosis progression|3|||
33402811|NCT01982942|101365431|FG001|Overall Study|Multiple sclerosis progression|2|||
33402812|NCT01982942|101365430|FG000|Overall Study|Wanted to try therapy not permitted|1|||
33402813|NCT01982942|101365431|FG001|Overall Study|Wanted to try therapy not permitted|0|||
33203337|NCT02343458|100645923|FG003|Overall Study|Withdrawal by Subject|14|||
33332501|NCT05121480|101111576|FG002|Overall Study|Treatment Failure|0|||
33402814|NCT01982942|101365430|FG000|Overall Study|Subject declined future visits|0|||
33402815|NCT01982942|101365431|FG001|Overall Study|Subject declined future visits|1|||
33402816|NCT01982942|101365430|FG000|Overall Study|Left geographical area|2|||
33402817|NCT01982942|101365431|FG001|Overall Study|Left geographical area|0|||
33332502|NCT05121480|101111577|FG003|Overall Study|Treatment Failure|1|||
33332503|NCT05121480|101111578|FG004|Overall Study|Treatment Failure|0|||
33332504|NCT05121480|101111579|FG005|Overall Study|Treatment Failure|0|||
33332505|NCT05121480|101111580|FG006|Overall Study|Treatment Failure|0|||
33332506|NCT05121480|101111581|FG007|Overall Study|Treatment Failure|0|||
33332507|NCT05121480|101111574|FG000|Overall Study|Adverse Event|0|||
33332508|NCT05121480|101111575|FG001|Overall Study|Adverse Event|1|||
33332509|NCT05121480|101111576|FG002|Overall Study|Adverse Event|0|||
33332510|NCT05121480|101111577|FG003|Overall Study|Adverse Event|5|||
33332511|NCT05121480|101111578|FG004|Overall Study|Adverse Event|3|||
33402818|NCT01982942|101365430|FG000|Overall Study|Too many pills|1|||
33402819|NCT01982942|101365431|FG001|Overall Study|Too many pills|0|||
33402820|NCT01982942|101365430|FG000|Overall Study|MS Relapse|0|||
33402821|NCT01982942|101365431|FG001|Overall Study|MS Relapse|1|||
33402822|NCT01982942|101365430|FG000|Overall Study|Chose to join a stem cell trial|0|||
33402823|NCT01982942|101365431|FG001|Overall Study|Chose to join a stem cell trial|1|||
33402824|NCT01982942|101365430|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
33402825|NCT01982942|101365431|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
33402826|NCT00426842|101365432|FG000|Overall Study|Lost to Follow-up|1|||
33402827|NCT01140646|101365435|FG000|Overall Study|Adverse Event|4|||
33402828|NCT01140646|101365435|FG000|Overall Study|Refused Further Treatment|5|||
33402829|NCT01453439|101365436|FG000|Treatment Phase|Withdrawal by Subject|13|||
33402830|NCT01453439|101365437|FG001|Treatment Phase|Withdrawal by Subject|10|||
33402831|NCT01453439|101365436|FG000|Treatment Phase|Suicidal Ideation|2|||
33402832|NCT01453439|101365437|FG001|Treatment Phase|Suicidal Ideation|0|||
33402833|NCT01453439|101365436|FG000|Treatment Phase|Need for higher level of care|1|||
33402834|NCT01453439|101365437|FG001|Treatment Phase|Need for higher level of care|1|||
33402835|NCT01453439|101365436|FG000|Treatment Phase|Therapist conflict of interest|1|||
33402836|NCT01453439|101365437|FG001|Treatment Phase|Therapist conflict of interest|0|||
33402837|NCT01453439|101365436|FG000|Follow-up|Withdrawal by Subject|0|||
33402838|NCT01453439|101365437|FG001|Follow-up|Withdrawal by Subject|1|||
33402839|NCT01453439|101365436|FG000|Follow-up|Lost to Follow-up|5|||
33402840|NCT01453439|101365437|FG001|Follow-up|Lost to Follow-up|10|||
33402841|NCT01070381|101365443|FG000|Period 2, 1 Week of Wear|Handling|0|||
33402842|NCT01070381|101365444|FG001|Period 2, 1 Week of Wear|Handling|1|||
33402843|NCT01070381|101365443|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
33402844|NCT01070381|101365444|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
33402845|NCT00842829|101365445|FG000|Dose Titration Period|Adverse Event|11|||
33402846|NCT00842829|101365446|FG001|Dose Titration Period|Adverse Event|10|||
33402847|NCT00842829|101365447|FG002|Dose Titration Period|Adverse Event|0|||
33402848|NCT00842829|101365445|FG000|Dose Titration Period|Lack of Efficacy|4|||
33402849|NCT00842829|101365446|FG001|Dose Titration Period|Lack of Efficacy|1|||
33402850|NCT00842829|101365447|FG002|Dose Titration Period|Lack of Efficacy|0|||
33402851|NCT00842829|101365445|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
33526466|NCT03959488|101823553|FG000|Season 1|Death|5|||
33526467|NCT03959488|101823554|FG001|Season 1|Death|1|||
33526468|NCT03959488|101823555|FG002|Season 1|Death|0|||
33526469|NCT03959488|101823556|FG003|Season 1|Death|0|||
33526470|NCT03959488|101823557|FG004|Season 1|Death|0|||
33526471|NCT03959488|101823553|FG000|Season 2|Other|0|||
33526472|NCT03959488|101823554|FG001|Season 2|Other|0|||
33610436|NCT04038567|102123306|FG002|Overall Study|Death|0|||
33526473|NCT03959488|101823555|FG002|Season 2|Other|2|||
33526474|NCT03959488|101823556|FG003|Season 2|Other|0|||
33526475|NCT03959488|101823557|FG004|Season 2|Other|0|||
33526476|NCT03959488|101823553|FG000|Season 2|Withdrawal by parent/guardian|0|||
33610437|NCT04038567|102123307|FG003|Overall Study|Death|1|||
33610438|NCT04038567|102123308|FG004|Overall Study|Death|1|||
33610439|NCT04038567|102123309|FG005|Overall Study|Death|0|||
33610440|NCT04038567|102123310|FG006|Overall Study|Death|0|||
33610441|NCT04038567|102123311|FG007|Overall Study|Death|1|||
33332512|NCT05121480|101111579|FG005|Overall Study|Adverse Event|2|||
33332513|NCT05121480|101111580|FG006|Overall Study|Adverse Event|0|||
33402852|NCT00842829|101365446|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
33402853|NCT00842829|101365447|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
33402854|NCT00842829|101365445|FG000|Dose Titration Period|Withdrawal by Subject|2|||
33402855|NCT00842829|101365446|FG001|Dose Titration Period|Withdrawal by Subject|6|||
33402856|NCT00842829|101365447|FG002|Dose Titration Period|Withdrawal by Subject|0|||
33402857|NCT00842829|101365445|FG000|Dose Titration Period|Other|5|||
33402858|NCT00842829|101365446|FG001|Dose Titration Period|Other|4|||
33402859|NCT00842829|101365447|FG002|Dose Titration Period|Other|0|||
33402860|NCT00842829|101365445|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
33526477|NCT03959488|101823554|FG001|Season 2|Withdrawal by parent/guardian|0|||
33526478|NCT03959488|101823555|FG002|Season 2|Withdrawal by parent/guardian|3|||
33610442|NCT03916081|102123315|FG000|Overall Study|Adverse Event|1|||
33610443|NCT03916081|102123316|FG001|Overall Study|Adverse Event|0|||
33610444|NCT03916081|102123317|FG002|Overall Study|Adverse Event|0|||
33610445|NCT03916081|102123315|FG000|Overall Study|Physician Decision|0|||
33610446|NCT03916081|102123316|FG001|Overall Study|Physician Decision|0|||
33610447|NCT03916081|102123317|FG002|Overall Study|Physician Decision|1|||
33610448|NCT03916081|102123315|FG000|Overall Study|Lost to Follow-up|0|||
33610449|NCT03916081|102123316|FG001|Overall Study|Lost to Follow-up|1|||
33610450|NCT03916081|102123317|FG002|Overall Study|Lost to Follow-up|0|||
33610451|NCT03916081|102123315|FG000|Overall Study|Withdrawal by Subject|3|||
33610452|NCT03916081|102123316|FG001|Overall Study|Withdrawal by Subject|0|||
33610453|NCT03916081|102123317|FG002|Overall Study|Withdrawal by Subject|1|||
33610454|NCT03916081|102123315|FG000|Overall Study|Worsening of AD|0|||
33610455|NCT03916081|102123316|FG001|Overall Study|Worsening of AD|0|||
33610456|NCT03916081|102123317|FG002|Overall Study|Worsening of AD|1|||
33610457|NCT03364738|102123318|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
33610458|NCT03364738|102123318|FG000|Overall Study|Withdrawal by Subject|1|||
33610459|NCT03364738|102123318|FG000|Overall Study|Adverse Event|1|||
33610460|NCT03182907|102123320|FG000|Overall Study|Death|3|||
33610461|NCT03182907|102123321|FG001|Overall Study|Death|0|||
33610462|NCT03182907|102123320|FG000|Overall Study|Protocol Violation|4|||
33610463|NCT03182907|102123321|FG001|Overall Study|Protocol Violation|0|||
33610464|NCT03182907|102123320|FG000|Overall Study|Lost to Follow-up|1|||
33610465|NCT03182907|102123321|FG001|Overall Study|Lost to Follow-up|0|||
33610466|NCT03182907|102123320|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33610467|NCT03182907|102123321|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
33610468|NCT03170193|102123325|FG000|Overall Study|Withdrawal by Subject|0|||
33610469|NCT03170193|102123326|FG001|Overall Study|Withdrawal by Subject|0|||
33610470|NCT03170193|102123327|FG002|Overall Study|Withdrawal by Subject|0|||
33610471|NCT03170193|102123328|FG003|Overall Study|Withdrawal by Subject|1|||
33610472|NCT03170193|102123329|FG004|Overall Study|Withdrawal by Subject|0|||
33610473|NCT03170193|102123330|FG005|Overall Study|Withdrawal by Subject|0|||
33610474|NCT03170193|102123331|FG006|Overall Study|Withdrawal by Subject|0|||
33610475|NCT03170193|102123325|FG000|Overall Study|Lost to Follow-up|1|||
33610476|NCT03170193|102123326|FG001|Overall Study|Lost to Follow-up|1|||
33610477|NCT03170193|102123327|FG002|Overall Study|Lost to Follow-up|0|||
33610478|NCT03170193|102123328|FG003|Overall Study|Lost to Follow-up|0|||
33610479|NCT03170193|102123329|FG004|Overall Study|Lost to Follow-up|0|||
33610480|NCT03170193|102123330|FG005|Overall Study|Lost to Follow-up|0|||
33610481|NCT03170193|102123331|FG006|Overall Study|Lost to Follow-up|0|||
33610482|NCT00377364|102123332|FG000|Overall Study|Lost to Follow-up|1|||
33610483|NCT00377364|102123333|FG001|Overall Study|Lost to Follow-up|0|||
33610484|NCT00377364|102123332|FG000|Overall Study|Withdrawal by Subject|1|||
33610485|NCT00377364|102123333|FG001|Overall Study|Withdrawal by Subject|0|||
33610486|NCT05392803|102123334|FG000|Overall Study|Lost to Follow-up|0|||
33610487|NCT05392803|102123335|FG001|Overall Study|Lost to Follow-up|2|||
33610488|NCT03172130|102123336|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
33402861|NCT00842829|101365446|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
33402862|NCT00842829|101365447|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
33402863|NCT00842829|101365445|FG000|Dose Titration Period|Non-compliance to study drug|2|||
33203338|NCT02343458|100645920|FG000|Overall Study|Physician Decision|1|||
33402864|NCT00842829|101365446|FG001|Dose Titration Period|Non-compliance to study drug|1|||
33610489|NCT03172130|102123337|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
33610490|NCT01727336|102123338|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
33610491|NCT01727336|102123339|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
33610492|NCT01727336|102123340|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
33610493|NCT01727336|102123341|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
33610494|NCT01727336|102123342|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
33610495|NCT01727336|102123343|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
33610496|NCT01727336|102123338|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
33417268|NCT01721200|101420249|FG001|Overall Study|Lost to Follow-up|5|||
33526479|NCT03959488|101823556|FG003|Season 2|Withdrawal by parent/guardian|1|||
33526480|NCT03959488|101823557|FG004|Season 2|Withdrawal by parent/guardian|1|||
33526481|NCT03959488|101823553|FG000|Season 2|Lost to Follow-up|0|||
33526482|NCT03959488|101823554|FG001|Season 2|Lost to Follow-up|0|||
33526483|NCT03959488|101823555|FG002|Season 2|Lost to Follow-up|1|||
33526484|NCT03959488|101823556|FG003|Season 2|Lost to Follow-up|0|||
33526485|NCT03959488|101823557|FG004|Season 2|Lost to Follow-up|1|||
33332514|NCT05121480|101111581|FG007|Overall Study|Adverse Event|4|||
33332515|NCT05121480|101111574|FG000|Overall Study|Withdrawal by Subject|4|||
33332516|NCT05121480|101111575|FG001|Overall Study|Withdrawal by Subject|9|||
33332517|NCT05121480|101111576|FG002|Overall Study|Withdrawal by Subject|1|||
33332518|NCT05121480|101111577|FG003|Overall Study|Withdrawal by Subject|8|||
33332519|NCT05121480|101111578|FG004|Overall Study|Withdrawal by Subject|0|||
33332520|NCT05121480|101111579|FG005|Overall Study|Withdrawal by Subject|9|||
33332521|NCT05121480|101111580|FG006|Overall Study|Withdrawal by Subject|0|||
33332522|NCT05121480|101111581|FG007|Overall Study|Withdrawal by Subject|4|||
33332523|NCT05121480|101111574|FG000|Overall Study|Non-compliance with the protocol|0|||
33332524|NCT05121480|101111575|FG001|Overall Study|Non-compliance with the protocol|0|||
33332525|NCT05121480|101111576|FG002|Overall Study|Non-compliance with the protocol|0|||
33332526|NCT05121480|101111577|FG003|Overall Study|Non-compliance with the protocol|0|||
33332527|NCT05121480|101111578|FG004|Overall Study|Non-compliance with the protocol|1|||
33332528|NCT05121480|101111579|FG005|Overall Study|Non-compliance with the protocol|6|||
33332529|NCT05121480|101111580|FG006|Overall Study|Non-compliance with the protocol|0|||
33332530|NCT05121480|101111581|FG007|Overall Study|Non-compliance with the protocol|1|||
33332531|NCT05121480|101111574|FG000|Overall Study|Lost to Follow-up|0|||
33332532|NCT05121480|101111575|FG001|Overall Study|Lost to Follow-up|4|||
33332533|NCT05121480|101111576|FG002|Overall Study|Lost to Follow-up|1|||
33332534|NCT05121480|101111577|FG003|Overall Study|Lost to Follow-up|3|||
33332535|NCT05121480|101111578|FG004|Overall Study|Lost to Follow-up|1|||
33332536|NCT05121480|101111579|FG005|Overall Study|Lost to Follow-up|1|||
33332537|NCT05121480|101111580|FG006|Overall Study|Lost to Follow-up|1|||
33203339|NCT02343458|100645921|FG001|Overall Study|Physician Decision|4|||
33203340|NCT02343458|100645922|FG002|Overall Study|Physician Decision|2|||
33203341|NCT02343458|100645923|FG003|Overall Study|Physician Decision|2|||
33332538|NCT05121480|101111581|FG007|Overall Study|Lost to Follow-up|4|||
33332539|NCT05121480|101111574|FG000|Overall Study|Physician Decision|0|||
33332540|NCT05121480|101111575|FG001|Overall Study|Physician Decision|0|||
33332541|NCT05121480|101111576|FG002|Overall Study|Physician Decision|0|||
33332542|NCT05121480|101111577|FG003|Overall Study|Physician Decision|0|||
33332543|NCT05121480|101111578|FG004|Overall Study|Physician Decision|0|||
33332544|NCT05121480|101111579|FG005|Overall Study|Physician Decision|1|||
33332545|NCT05121480|101111580|FG006|Overall Study|Physician Decision|0|||
33332546|NCT05121480|101111581|FG007|Overall Study|Physician Decision|1|||
33332547|NCT05121480|101111574|FG000|Overall Study|Other Reason|0|||
33526486|NCT01134263|101823564|FG000|Overall Study|Serious adverse event|2|||
33526487|NCT01134263|101823565|FG001|Overall Study|Serious adverse event|1|||
33526488|NCT01134263|101823566|FG002|Overall Study|Serious adverse event|1|||
33332548|NCT05121480|101111575|FG001|Overall Study|Other Reason|0|||
33332549|NCT05121480|101111576|FG002|Overall Study|Other Reason|0|||
33332550|NCT05121480|101111577|FG003|Overall Study|Other Reason|0|||
33526489|NCT01134263|101823567|FG003|Overall Study|Serious adverse event|1|||
33203342|NCT02343458|100645920|FG000|Overall Study|Lost to Follow-up|5|||
33332551|NCT05121480|101111578|FG004|Overall Study|Other Reason|0|||
33526490|NCT01134263|101823568|FG004|Overall Study|Serious adverse event|1|||
33526491|NCT01134263|101823564|FG000|Overall Study|Other adverse event|1|||
33526492|NCT01134263|101823565|FG001|Overall Study|Other adverse event|2|||
33526493|NCT01134263|101823566|FG002|Overall Study|Other adverse event|5|||
33203343|NCT02343458|100645921|FG001|Overall Study|Lost to Follow-up|5|||
33402865|NCT00842829|101365447|FG002|Dose Titration Period|Non-compliance to study drug|0|||
33402866|NCT00842829|101365445|FG000|Treatment Period|Adverse Event|0|||
33402867|NCT00842829|101365446|FG001|Treatment Period|Adverse Event|0|||
33402868|NCT00842829|101365447|FG002|Treatment Period|Adverse Event|15|||
33402869|NCT00842829|101365445|FG000|Treatment Period|Lack of Efficacy|0|||
33402870|NCT00842829|101365446|FG001|Treatment Period|Lack of Efficacy|0|||
33402871|NCT00842829|101365447|FG002|Treatment Period|Lack of Efficacy|6|||
33402872|NCT00842829|101365445|FG000|Treatment Period|Unstable persistent cancer pain|0|||
33402873|NCT00842829|101365446|FG001|Treatment Period|Unstable persistent cancer pain|0|||
33402874|NCT00842829|101365447|FG002|Treatment Period|Unstable persistent cancer pain|5|||
33402875|NCT00842829|101365445|FG000|Treatment Period|Withdrawal by Subject|0|||
33402876|NCT00842829|101365446|FG001|Treatment Period|Withdrawal by Subject|0|||
33402877|NCT00842829|101365447|FG002|Treatment Period|Withdrawal by Subject|11|||
33402878|NCT00842829|101365445|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
33402879|NCT00842829|101365446|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
33402880|NCT00842829|101365447|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
33402881|NCT00842829|101365445|FG000|Treatment Period|Protocol Violation|0|||
33402882|NCT00842829|101365446|FG001|Treatment Period|Protocol Violation|0|||
33402883|NCT00842829|101365447|FG002|Treatment Period|Protocol Violation|2|||
33402884|NCT00842829|101365445|FG000|Treatment Period|Other|0|||
33402885|NCT00842829|101365446|FG001|Treatment Period|Other|0|||
33402886|NCT00842829|101365447|FG002|Treatment Period|Other|18|||
33402887|NCT00842829|101365445|FG000|Treatment Period|Non-compliance to study procedures|0|||
33402888|NCT00842829|101365446|FG001|Treatment Period|Non-compliance to study procedures|0|||
33402889|NCT00842829|101365447|FG002|Treatment Period|Non-compliance to study procedures|4|||
33402890|NCT00842829|101365445|FG000|Treatment Period|Unclear completion status|0|||
33402891|NCT00842829|101365446|FG001|Treatment Period|Unclear completion status|0|||
33402892|NCT00842829|101365447|FG002|Treatment Period|Unclear completion status|1|||
33402893|NCT00842829|101365445|FG000|Continuation Period|Adverse Event|0|||
33402894|NCT00842829|101365446|FG001|Continuation Period|Adverse Event|0|||
33402895|NCT00842829|101365447|FG002|Continuation Period|Adverse Event|32|||
33402896|NCT00842829|101365445|FG000|Continuation Period|Lack of Efficacy|0|||
33402897|NCT00842829|101365446|FG001|Continuation Period|Lack of Efficacy|0|||
33402898|NCT00842829|101365447|FG002|Continuation Period|Lack of Efficacy|6|||
33402899|NCT00842829|101365445|FG000|Continuation Period|Unstable persistent cancer pain|0|||
33402900|NCT00842829|101365446|FG001|Continuation Period|Unstable persistent cancer pain|0|||
33402901|NCT00842829|101365447|FG002|Continuation Period|Unstable persistent cancer pain|3|||
33526494|NCT01134263|101823567|FG003|Overall Study|Other adverse event|3|||
33526495|NCT01134263|101823568|FG004|Overall Study|Other adverse event|0|||
33526496|NCT01134263|101823564|FG000|Overall Study|Protocol Violation|8|||
33526497|NCT01134263|101823565|FG001|Overall Study|Protocol Violation|7|||
33526498|NCT01134263|101823566|FG002|Overall Study|Protocol Violation|2|||
33526499|NCT01134263|101823567|FG003|Overall Study|Protocol Violation|4|||
33526500|NCT01134263|101823568|FG004|Overall Study|Protocol Violation|2|||
33526501|NCT01134263|101823564|FG000|Overall Study|Lost to Follow-up|4|||
33526502|NCT01134263|101823565|FG001|Overall Study|Lost to Follow-up|3|||
33526503|NCT01134263|101823566|FG002|Overall Study|Lost to Follow-up|5|||
33526504|NCT01134263|101823567|FG003|Overall Study|Lost to Follow-up|3|||
33526505|NCT01134263|101823568|FG004|Overall Study|Lost to Follow-up|1|||
33526506|NCT01134263|101823564|FG000|Overall Study|Withdrawal by Subject|8|||
33526507|NCT01134263|101823565|FG001|Overall Study|Withdrawal by Subject|6|||
33526508|NCT01134263|101823566|FG002|Overall Study|Withdrawal by Subject|16|||
33526509|NCT01134263|101823567|FG003|Overall Study|Withdrawal by Subject|7|||
33526510|NCT01134263|101823568|FG004|Overall Study|Withdrawal by Subject|5|||
33526511|NCT01134263|101823564|FG000|Overall Study|Enrolled, but not treated|1|||
33526512|NCT01134263|101823565|FG001|Overall Study|Enrolled, but not treated|1|||
33526513|NCT01134263|101823566|FG002|Overall Study|Enrolled, but not treated|0|||
33526514|NCT01134263|101823567|FG003|Overall Study|Enrolled, but not treated|1|||
33526515|NCT01134263|101823568|FG004|Overall Study|Enrolled, but not treated|0|||
33526516|NCT01421147|101823569|FG000|Treatment Period|Adverse Event|2|||
33526517|NCT01421147|101823570|FG001|Treatment Period|Adverse Event|3|||
33526518|NCT01421147|101823569|FG000|Treatment Period|Lost to Follow-up|2|||
33526519|NCT01421147|101823570|FG001|Treatment Period|Lost to Follow-up|1|||
33402902|NCT00842829|101365445|FG000|Continuation Period|Withdrawal by Subject|0|||
33402903|NCT00842829|101365446|FG001|Continuation Period|Withdrawal by Subject|0|||
33402904|NCT00842829|101365447|FG002|Continuation Period|Withdrawal by Subject|10|||
33402905|NCT00842829|101365445|FG000|Continuation Period|Other|0|||
33402906|NCT00842829|101365446|FG001|Continuation Period|Other|0|||
33402907|NCT00842829|101365447|FG002|Continuation Period|Other|7|||
33402908|NCT00842829|101365445|FG000|Continuation Period|Non-compliance to study procedures|0|||
33526520|NCT01421147|101823569|FG000|Treatment Period|Physician Decision|2|||
33526521|NCT01421147|101823570|FG001|Treatment Period|Physician Decision|2|||
33526522|NCT01421147|101823569|FG000|Treatment Period|Withdrawal by Subject|10|||
33526523|NCT01421147|101823570|FG001|Treatment Period|Withdrawal by Subject|5|||
33526524|NCT01421147|101823569|FG000|Extension Period|Adverse Event|0|||
33526525|NCT01421147|101823570|FG001|Extension Period|Adverse Event|2|||
33526526|NCT01421147|101823569|FG000|Extension Period|Death|0|||
33332552|NCT05121480|101111579|FG005|Overall Study|Other Reason|1|||
33332553|NCT05121480|101111580|FG006|Overall Study|Other Reason|1|||
33332554|NCT05121480|101111581|FG007|Overall Study|Other Reason|1|||
33332555|NCT02411539|101111585|FG000|Overall Study|Lost to Follow-up|2|||
33332556|NCT02411539|101111586|FG001|Overall Study|Lost to Follow-up|0|||
33332557|NCT02411539|101111585|FG000|Overall Study|Confounding medical condition|0|||
33332558|NCT02411539|101111586|FG001|Overall Study|Confounding medical condition|1|||
33526527|NCT01421147|101823570|FG001|Extension Period|Death|1|||
33332559|NCT01576549|101111587|FG000|Overall Study|Sponsor Decision|2|||
33332560|NCT02055820|101111591|FG000|Phase I: Dose-Finding|Death|1|||
33332561|NCT02055820|101111592|FG001|Phase I: Dose-Finding|Death|0|||
33332562|NCT02055820|101111593|FG002|Phase I: Dose-Finding|Death|1|||
33332563|NCT02055820|101111594|FG003|Phase I: Dose-Finding|Death|2|||
33332564|NCT02055820|101111595|FG004|Phase I: Dose-Finding|Death|0|||
33332565|NCT02055820|101111596|FG005|Phase I: Dose-Finding|Death|1|||
33332566|NCT02055820|101111597|FG006|Phase I: Dose-Finding|Death|1|||
33332567|NCT02055820|101111598|FG007|Phase I: Dose-Finding|Death|0|||
33526528|NCT01421147|101823569|FG000|Extension Period|Lost to Follow-up|2|||
33526529|NCT01421147|101823570|FG001|Extension Period|Lost to Follow-up|5|||
33526530|NCT01421147|101823569|FG000|Extension Period|Physician Decision|1|||
33526531|NCT01421147|101823570|FG001|Extension Period|Physician Decision|0|||
33526532|NCT01421147|101823569|FG000|Extension Period|Withdrawal by Subject|5|||
33526533|NCT01421147|101823570|FG001|Extension Period|Withdrawal by Subject|3|||
33526534|NCT00004088|101823572|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
33610497|NCT01727336|102123339|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
33610498|NCT01727336|102123340|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
33610499|NCT01727336|102123341|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
33610500|NCT01727336|102123342|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
33610501|NCT01727336|102123343|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
33610502|NCT01727336|102123338|FG000|Part 2 Blinded|Death|0|||
33610503|NCT01727336|102123339|FG001|Part 2 Blinded|Death|0|||
33610504|NCT01727336|102123340|FG002|Part 2 Blinded|Death|0|||
33610505|NCT01727336|102123341|FG003|Part 2 Blinded|Death|0|||
33610506|NCT01727336|102123342|FG004|Part 2 Blinded|Death|20|||
33610507|NCT01727336|102123343|FG005|Part 2 Blinded|Death|16|||
33610508|NCT01727336|102123338|FG000|Part 2 Blinded|Lack of Efficacy|0|||
33610509|NCT01727336|102123339|FG001|Part 2 Blinded|Lack of Efficacy|0|||
33610510|NCT01727336|102123340|FG002|Part 2 Blinded|Lack of Efficacy|0|||
33610511|NCT01727336|102123341|FG003|Part 2 Blinded|Lack of Efficacy|0|||
33203344|NCT02343458|100645922|FG002|Overall Study|Lost to Follow-up|3|||
33332568|NCT02055820|101111599|FG008|Phase I: Dose-Finding|Death|0|||
33332569|NCT02055820|101111600|FG009|Phase I: Dose-Finding|Death|0|||
33332570|NCT02055820|101111591|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33332571|NCT02055820|101111592|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33332572|NCT02055820|101111593|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33332573|NCT02055820|101111594|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33526535|NCT00004088|101823572|FG000|Overall Study|Withdrawal by Subject|1|||
33526536|NCT00004088|101823572|FG000|Overall Study|Protocol Violation|3|||
33526537|NCT00004088|101823572|FG000|Overall Study|Physician Decision|1|||
33526538|NCT02756819|101823573|FG000|Overall Study|Lost for observation|23|||
33526539|NCT02756819|101823573|FG000|Overall Study|Patient's unwillingness|16|||
33332574|NCT02055820|101111595|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33332575|NCT02055820|101111596|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
33332576|NCT02055820|101111597|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33332577|NCT02055820|101111598|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33332578|NCT02055820|101111599|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33332579|NCT02055820|101111600|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
33332580|NCT02055820|101111591|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
33332581|NCT02055820|101111592|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
33332582|NCT02055820|101111593|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
33332583|NCT02055820|101111594|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
33332584|NCT02055820|101111595|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
33526540|NCT02756819|101823573|FG000|Overall Study|Insufficient efficacy|2|||
33526541|NCT02756819|101823573|FG000|Overall Study|Adverse Event|2|||
33526542|NCT02756819|101823573|FG000|Overall Study|Reason not Specified|9|||
33526543|NCT02348008|101823574|FG000|Overall Study|Adverse Event|2|||
33526544|NCT02348008|101823575|FG001|Overall Study|Adverse Event|3|||
33610512|NCT01727336|102123342|FG004|Part 2 Blinded|Lack of Efficacy|42|||
33610513|NCT01727336|102123343|FG005|Part 2 Blinded|Lack of Efficacy|44|||
33610514|NCT01727336|102123338|FG000|Part 2 Blinded|Lost to Follow-up|0|||
33610515|NCT01727336|102123339|FG001|Part 2 Blinded|Lost to Follow-up|0|||
33332585|NCT02055820|101111596|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
33332586|NCT02055820|101111597|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
33332587|NCT02055820|101111598|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
33332588|NCT02055820|101111599|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
33332589|NCT02055820|101111600|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
33332590|NCT02055820|101111591|FG000|Phase II: Expansion|Death|0|||
33332591|NCT02055820|101111592|FG001|Phase II: Expansion|Death|0|||
33332592|NCT02055820|101111593|FG002|Phase II: Expansion|Death|0|||
33332593|NCT02055820|101111594|FG003|Phase II: Expansion|Death|0|||
33332594|NCT02055820|101111595|FG004|Phase II: Expansion|Death|33|||
33332595|NCT02055820|101111596|FG005|Phase II: Expansion|Death|0|||
33332596|NCT02055820|101111597|FG006|Phase II: Expansion|Death|0|||
33332597|NCT02055820|101111598|FG007|Phase II: Expansion|Death|0|||
33332598|NCT02055820|101111599|FG008|Phase II: Expansion|Death|0|||
33332599|NCT02055820|101111600|FG009|Phase II: Expansion|Death|0|||
33332600|NCT02055820|101111591|FG000|Phase II: Expansion|Lost to Follow-up|0|||
33332601|NCT02055820|101111592|FG001|Phase II: Expansion|Lost to Follow-up|0|||
33332602|NCT02055820|101111593|FG002|Phase II: Expansion|Lost to Follow-up|0|||
33332603|NCT02055820|101111594|FG003|Phase II: Expansion|Lost to Follow-up|0|||
33332604|NCT02055820|101111595|FG004|Phase II: Expansion|Lost to Follow-up|4|||
33332605|NCT02055820|101111596|FG005|Phase II: Expansion|Lost to Follow-up|0|||
33332606|NCT02055820|101111597|FG006|Phase II: Expansion|Lost to Follow-up|0|||
33332607|NCT02055820|101111598|FG007|Phase II: Expansion|Lost to Follow-up|0|||
33332608|NCT02055820|101111599|FG008|Phase II: Expansion|Lost to Follow-up|0|||
33332609|NCT02055820|101111600|FG009|Phase II: Expansion|Lost to Follow-up|0|||
33332610|NCT02055820|101111591|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
33332611|NCT02055820|101111592|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
33332612|NCT02055820|101111593|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
33332613|NCT02055820|101111594|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
33332614|NCT02055820|101111595|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
33332615|NCT02055820|101111596|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
33332616|NCT02055820|101111597|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
33332617|NCT02055820|101111598|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
33332618|NCT02055820|101111599|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
33332619|NCT02055820|101111600|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
33332620|NCT02037295|101111601|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
33332621|NCT02037295|101111602|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
33332622|NCT02037295|101111603|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
33332623|NCT02037295|101111604|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
33332624|NCT00784654|101111605|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
33332625|NCT00784654|101111606|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
33332626|NCT00784654|101111607|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
33332627|NCT00784654|101111605|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
33526545|NCT02348008|101823576|FG002|Overall Study|Adverse Event|3|||
33526546|NCT02348008|101823574|FG000|Overall Study|Disease Progression|1|||
33526547|NCT02348008|101823575|FG001|Overall Study|Disease Progression|5|||
33526548|NCT02348008|101823576|FG002|Overall Study|Disease Progression|16|||
33526549|NCT02348008|101823574|FG000|Overall Study|Withdrawal by Subject|0|||
33526550|NCT02348008|101823575|FG001|Overall Study|Withdrawal by Subject|1|||
33526551|NCT02348008|101823576|FG002|Overall Study|Withdrawal by Subject|0|||
33526552|NCT02348008|101823574|FG000|Overall Study|Symptomatic Deterioration|0|||
33526553|NCT02348008|101823575|FG001|Overall Study|Symptomatic Deterioration|1|||
33526554|NCT02348008|101823576|FG002|Overall Study|Symptomatic Deterioration|0|||
33526555|NCT01597492|101823577|FG000|Overall Study|Withdrawal by Subject|1|||
33526556|NCT01597492|101823578|FG001|Overall Study|Withdrawal by Subject|2|||
33526557|NCT01597492|101823577|FG000|Overall Study|Adverse Event|3|||
33526558|NCT01597492|101823578|FG001|Overall Study|Adverse Event|0|||
33526559|NCT01597492|101823577|FG000|Overall Study|Lost to Follow-up|0|||
33526560|NCT01597492|101823578|FG001|Overall Study|Lost to Follow-up|2|||
33610516|NCT01727336|102123340|FG002|Part 2 Blinded|Lost to Follow-up|0|||
33203345|NCT02343458|100645923|FG003|Overall Study|Lost to Follow-up|1|||
33332628|NCT00784654|101111606|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
33332629|NCT00784654|101111607|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
33332630|NCT00784654|101111605|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
33332631|NCT00784654|101111606|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
33332632|NCT00784654|101111607|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
33332633|NCT00784654|101111605|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
33332634|NCT00784654|101111606|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
33332635|NCT00784654|101111607|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
33332636|NCT00784654|101111605|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
33332637|NCT00784654|101111606|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
33332638|NCT00784654|101111607|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
33332639|NCT00784654|101111605|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
33332640|NCT00784654|101111606|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
33526561|NCT01597492|101823577|FG000|Overall Study|Other Reason|2|||
33526562|NCT01597492|101823578|FG001|Overall Study|Other Reason|0|||
33526563|NCT01216332|101823579|FG000|Overall Study|Withdrawal by Subject|4|||
33526564|NCT01216332|101823580|FG001|Overall Study|Withdrawal by Subject|0|||
33526565|NCT02075008|101823581|FG000|Overall Study|Technical problems|1|||
33526566|NCT02075008|101823581|FG000|Overall Study|Pregnancy|1|||
33526567|NCT02075008|101823581|FG000|Overall Study|Physician Decision|1|||
33526568|NCT02075008|101823581|FG000|Overall Study|Lost to Follow-up|1|||
33526569|NCT02075008|101823581|FG000|Overall Study|Lack of Efficacy|1|||
33526570|NCT02075008|101823581|FG000|Overall Study|Death|1|||
33526571|NCT02075008|101823581|FG000|Overall Study|Adverse Event|5|||
33526572|NCT02075008|101823581|FG000|Overall Study|Withdrawal by Subject|6|||
33526573|NCT02075008|101823581|FG000|Overall Study|Study terminated by Sponsor|159|||
33526574|NCT01716520|101823582|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
33526575|NCT01716520|101823583|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
33526576|NCT01716520|101823584|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
33526577|NCT01716520|101823585|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
33526578|NCT01716520|101823586|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
33526579|NCT01716520|101823587|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
33526580|NCT01716520|101823582|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
33526581|NCT01716520|101823583|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
33526582|NCT01716520|101823584|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
33526583|NCT01716520|101823585|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
33526584|NCT01716520|101823586|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
33526585|NCT01716520|101823587|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
33526586|NCT01716520|101823582|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33526587|NCT01716520|101823583|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33526588|NCT01716520|101823584|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33526589|NCT01716520|101823585|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33526590|NCT01716520|101823586|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33526591|NCT01716520|101823587|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33526592|NCT01716520|101823582|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
33332641|NCT00784654|101111607|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
33332642|NCT00784654|101111605|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
33332643|NCT00784654|101111606|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
33332644|NCT00784654|101111607|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
33332645|NCT00784654|101111605|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
33332646|NCT00784654|101111606|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
33332647|NCT00784654|101111607|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
33332648|NCT00784654|101111605|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
33332649|NCT00784654|101111606|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
33332650|NCT00784654|101111607|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
33332651|NCT00784654|101111605|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
33332652|NCT00784654|101111606|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
33332653|NCT00784654|101111607|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
33332654|NCT00784654|101111605|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
33332655|NCT00784654|101111606|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
33332656|NCT00784654|101111607|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
33332657|NCT00784654|101111605|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
33332658|NCT00784654|101111606|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
33332659|NCT00784654|101111607|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
33332660|NCT00784654|101111605|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
33332661|NCT00784654|101111606|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
33402909|NCT00842829|101365446|FG001|Continuation Period|Non-compliance to study procedures|0|||
33402910|NCT00842829|101365447|FG002|Continuation Period|Non-compliance to study procedures|2|||
33402911|NCT00842829|101365445|FG000|Continuation Period|Non-compliance to study drug|0|||
33402912|NCT00842829|101365446|FG001|Continuation Period|Non-compliance to study drug|0|||
33402913|NCT00842829|101365447|FG002|Continuation Period|Non-compliance to study drug|1|||
33402914|NCT01728194|101365452|FG000|Overall Study|Lost to Follow-up|4|||
33402915|NCT01728194|101365453|FG001|Overall Study|Lost to Follow-up|3|||
33402916|NCT01728194|101365452|FG000|Overall Study|Physician Decision|4|||
33402917|NCT01728194|101365453|FG001|Overall Study|Physician Decision|0|||
33402918|NCT01728194|101365452|FG000|Overall Study|Withdrawal by Subject|7|||
33402919|NCT01728194|101365453|FG001|Overall Study|Withdrawal by Subject|3|||
33526593|NCT01716520|101823583|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
33526594|NCT01716520|101823584|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
33610517|NCT01727336|102123341|FG003|Part 2 Blinded|Lost to Follow-up|0|||
33610518|NCT01727336|102123342|FG004|Part 2 Blinded|Lost to Follow-up|0|||
33332662|NCT00784654|101111607|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
33332663|NCT00784654|101111605|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33332664|NCT00784654|101111606|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
33332665|NCT00784654|101111607|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
33332666|NCT00784654|101111605|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
33526595|NCT01716520|101823585|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
33526596|NCT01716520|101823586|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
33526597|NCT01716520|101823587|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
33526598|NCT01716520|101823582|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33526599|NCT01716520|101823583|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33526600|NCT01716520|101823584|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33526601|NCT01716520|101823585|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33526602|NCT01716520|101823586|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
33526603|NCT01716520|101823587|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
33526604|NCT01716520|101823582|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
33526605|NCT01716520|101823583|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
33526606|NCT01716520|101823584|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
33526607|NCT01716520|101823585|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
33526608|NCT01716520|101823586|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
33526609|NCT01716520|101823587|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
33526610|NCT01716520|101823582|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
33332667|NCT00784654|101111606|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
33332668|NCT00784654|101111607|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
33332669|NCT00784654|101111605|FG000|Randomized Withdrawal Period|Adverse Event|0|||
33332670|NCT00784654|101111606|FG001|Randomized Withdrawal Period|Adverse Event|1|||
33332671|NCT00784654|101111607|FG002|Randomized Withdrawal Period|Adverse Event|1|||
33332672|NCT00784654|101111605|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
33332673|NCT00784654|101111606|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
33332674|NCT00784654|101111607|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
33332675|NCT00784654|101111605|FG000|Randomized Withdrawal Period|Family reasons|0|||
33332676|NCT00784654|101111606|FG001|Randomized Withdrawal Period|Family reasons|0|||
33332677|NCT00784654|101111607|FG002|Randomized Withdrawal Period|Family reasons|1|||
33332678|NCT00884273|101111608|FG000|Overall Study|Adverse Event|0|||
33332679|NCT00884273|101111609|FG001|Overall Study|Adverse Event|2|||
33332680|NCT00884273|101111608|FG000|Overall Study|Protocol Violation|1|||
33332681|NCT00884273|101111609|FG001|Overall Study|Protocol Violation|3|||
33332682|NCT00884273|101111608|FG000|Overall Study|Practical reasons|1|||
33332683|NCT00884273|101111609|FG001|Overall Study|Practical reasons|0|||
33332684|NCT01032915|101111610|FG000|Overall Study|Adverse Event|2|||
33332685|NCT01032915|101111611|FG001|Overall Study|Adverse Event|2|||
33332686|NCT01032915|101111612|FG002|Overall Study|Adverse Event|1|||
33332687|NCT01032915|101111613|FG003|Overall Study|Adverse Event|1|||
33332688|NCT01032915|101111610|FG000|Overall Study|Abnormal test procedure result|0|||
33332689|NCT01032915|101111611|FG001|Overall Study|Abnormal test procedure result|0|||
33332690|NCT01032915|101111612|FG002|Overall Study|Abnormal test procedure result|1|||
33332691|NCT01032915|101111613|FG003|Overall Study|Abnormal test procedure result|0|||
33332692|NCT01032915|101111610|FG000|Overall Study|Withdrawal by Subject|0|||
33332693|NCT01032915|101111611|FG001|Overall Study|Withdrawal by Subject|3|||
33332694|NCT01032915|101111612|FG002|Overall Study|Withdrawal by Subject|1|||
33332695|NCT01032915|101111613|FG003|Overall Study|Withdrawal by Subject|1|||
33526611|NCT01716520|101823583|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
33526612|NCT01716520|101823584|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
33526613|NCT01716520|101823585|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
33526614|NCT01716520|101823586|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
33203346|NCT02343458|100645920|FG000|Overall Study|Protocol Violation|2|||
33332696|NCT01032915|101111610|FG000|Overall Study|Administrative reasons|5|||
33332697|NCT01032915|101111611|FG001|Overall Study|Administrative reasons|6|||
33332698|NCT01032915|101111612|FG002|Overall Study|Administrative reasons|4|||
33332699|NCT01032915|101111613|FG003|Overall Study|Administrative reasons|4|||
33332700|NCT01032915|101111610|FG000|Overall Study|Protocol Violation|1|||
33332701|NCT01032915|101111611|FG001|Overall Study|Protocol Violation|0|||
33332702|NCT01032915|101111612|FG002|Overall Study|Protocol Violation|0|||
33526615|NCT01716520|101823587|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
33332703|NCT01032915|101111613|FG003|Overall Study|Protocol Violation|1|||
33332704|NCT00708500|101111614|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
33332705|NCT00708500|101111615|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
33332706|NCT00708500|101111616|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
33332707|NCT00708500|101111614|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
33332708|NCT00708500|101111615|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
33332709|NCT00708500|101111616|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
33526616|NCT01716520|101823582|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33526617|NCT01716520|101823583|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33526618|NCT01716520|101823584|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33526619|NCT01716520|101823585|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33526620|NCT01716520|101823586|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
33526621|NCT01716520|101823587|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33526622|NCT01716520|101823582|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
33526623|NCT01716520|101823583|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
33332710|NCT00708500|101111614|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
33332711|NCT00708500|101111615|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
33332712|NCT00708500|101111616|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
33332713|NCT00708500|101111614|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
33332714|NCT00708500|101111615|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
33332715|NCT00708500|101111616|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
33332716|NCT00708500|101111614|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
33332717|NCT00708500|101111615|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
33332718|NCT00708500|101111616|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
33332719|NCT00708500|101111614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
33332720|NCT00708500|101111615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
33526624|NCT01716520|101823584|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
33526625|NCT01716520|101823585|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
33526626|NCT01716520|101823586|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
33526627|NCT01716520|101823587|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
33526628|NCT01716520|101823582|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
33526629|NCT01716520|101823583|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
33526630|NCT01716520|101823584|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
33332721|NCT00708500|101111616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
33332722|NCT00708500|101111614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
33332723|NCT00708500|101111615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
33332724|NCT00708500|101111616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
33332725|NCT00708500|101111614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
33332726|NCT00708500|101111615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
33332727|NCT00708500|101111616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
33332728|NCT00708500|101111614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
33332729|NCT00708500|101111615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
33332730|NCT00708500|101111616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
33332731|NCT00708500|101111614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
33332732|NCT00708500|101111615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
33332733|NCT00708500|101111616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
33332734|NCT00708500|101111614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
33332735|NCT00708500|101111615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
33332736|NCT00708500|101111616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
33332737|NCT00708500|101111614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
33332738|NCT00708500|101111615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
33332739|NCT00708500|101111616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
33332740|NCT00708500|101111614|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
33332741|NCT00708500|101111615|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
33332742|NCT00708500|101111616|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
33332743|NCT00708500|101111614|FG000|FOLLOWUP|Adverse Event|0|||
33332744|NCT00708500|101111615|FG001|FOLLOWUP|Adverse Event|1|||
33332745|NCT00708500|101111616|FG002|FOLLOWUP|Adverse Event|0|||
33332746|NCT00708500|101111614|FG000|FOLLOWUP|Lost to Follow-up|1|||
33332747|NCT00708500|101111615|FG001|FOLLOWUP|Lost to Follow-up|6|||
33332748|NCT00708500|101111616|FG002|FOLLOWUP|Lost to Follow-up|4|||
33332749|NCT00708500|101111614|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
33332750|NCT00708500|101111615|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
33332751|NCT00708500|101111616|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
33332752|NCT00708500|101111614|FG000|FOLLOWUP|Subject withdrew consent|31|||
33332753|NCT00708500|101111615|FG001|FOLLOWUP|Subject withdrew consent|4|||
33402920|NCT01728194|101365452|FG000|Overall Study|Perceived Medication Side Effects|4|||
33402921|NCT01728194|101365453|FG001|Overall Study|Perceived Medication Side Effects|0|||
33402922|NCT01728194|101365452|FG000|Overall Study|Family Member Request|1|||
33402923|NCT01728194|101365453|FG001|Overall Study|Family Member Request|0|||
33526631|NCT01716520|101823585|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
33526632|NCT01716520|101823586|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
33526633|NCT01716520|101823587|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
33526634|NCT01716520|101823582|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
33332754|NCT00708500|101111616|FG002|FOLLOWUP|Subject withdrew consent|5|||
33526635|NCT01716520|101823583|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
33526636|NCT01716520|101823584|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
33526637|NCT01716520|101823585|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
33526638|NCT01716520|101823586|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
33526639|NCT01716520|101823587|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
33526640|NCT01716520|101823582|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
33526641|NCT01716520|101823583|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
33526642|NCT01716520|101823584|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
33526643|NCT01716520|101823585|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
33332755|NCT00708500|101111614|FG000|FOLLOWUP|Non-compliance with protocol|5|||
33332756|NCT00708500|101111615|FG001|FOLLOWUP|Non-compliance with protocol|0|||
33332757|NCT00708500|101111616|FG002|FOLLOWUP|Non-compliance with protocol|1|||
33332758|NCT04360551|101111619|FG000|Overall Study|Withdrawal by Subject|1|||
33332759|NCT04360551|101111620|FG001|Overall Study|Withdrawal by Subject|0|||
33332760|NCT01888640|101111621|FG000|Overall Study|Lost to Follow-up|1|||
33332761|NCT01888640|101111622|FG001|Overall Study|Lost to Follow-up|2|||
33332762|NCT01888640|101111623|FG002|Overall Study|Lost to Follow-up|0|||
33332763|NCT01888640|101111621|FG000|Overall Study|Withdrawal by Subject|15|||
33332764|NCT01888640|101111622|FG001|Overall Study|Withdrawal by Subject|11|||
33332765|NCT01888640|101111623|FG002|Overall Study|Withdrawal by Subject|4|||
33332766|NCT01888640|101111621|FG000|Overall Study|Minimum dose not met|10|||
33332767|NCT01888640|101111622|FG001|Overall Study|Minimum dose not met|16|||
33332768|NCT01888640|101111623|FG002|Overall Study|Minimum dose not met|0|||
33332769|NCT01888640|101111621|FG000|Overall Study|Given wrong unit (placebo)|1|||
33332770|NCT01888640|101111622|FG001|Overall Study|Given wrong unit (placebo)|0|||
33332771|NCT01888640|101111623|FG002|Overall Study|Given wrong unit (placebo)|0|||
33332772|NCT01888640|101111621|FG000|Overall Study|Excluded for prior TENS|0|||
33332773|NCT01888640|101111622|FG001|Overall Study|Excluded for prior TENS|1|||
33332774|NCT01888640|101111623|FG002|Overall Study|Excluded for prior TENS|0|||
33332775|NCT01888640|101111621|FG000|Overall Study|Researcher Termination of Participant|0|||
33332776|NCT01888640|101111622|FG001|Overall Study|Researcher Termination of Participant|1|||
33332777|NCT01888640|101111623|FG002|Overall Study|Researcher Termination of Participant|1|||
33332778|NCT03084536|101111624|FG000|Overall Study|Determined to be ineligible|0|||
33332779|NCT03084536|101111625|FG001|Overall Study|Determined to be ineligible|0|||
33332780|NCT03084536|101111626|FG002|Overall Study|Determined to be ineligible|16|||
33332781|NCT03084536|101111624|FG000|Overall Study|Withdrawal by Subject|0|||
33332782|NCT03084536|101111625|FG001|Overall Study|Withdrawal by Subject|0|||
33332783|NCT03084536|101111626|FG002|Overall Study|Withdrawal by Subject|4|||
33332784|NCT03084536|101111624|FG000|Overall Study|Physician Decision|0|||
33332785|NCT03084536|101111625|FG001|Overall Study|Physician Decision|0|||
33332786|NCT03084536|101111626|FG002|Overall Study|Physician Decision|3|||
33332787|NCT03084536|101111624|FG000|Overall Study|Death|0|||
33332788|NCT03084536|101111625|FG001|Overall Study|Death|0|||
33332789|NCT03084536|101111626|FG002|Overall Study|Death|1|||
33332790|NCT03084536|101111624|FG000|Overall Study|Lost to Follow-up|0|||
33332791|NCT03084536|101111625|FG001|Overall Study|Lost to Follow-up|0|||
33332792|NCT03084536|101111626|FG002|Overall Study|Lost to Follow-up|1|||
33332793|NCT03084536|101111624|FG000|Overall Study|Protocol Violation|0|||
33332794|NCT03084536|101111625|FG001|Overall Study|Protocol Violation|0|||
33332795|NCT03084536|101111626|FG002|Overall Study|Protocol Violation|1|||
33332796|NCT03084536|101111624|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
33332797|NCT03084536|101111625|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
33332798|NCT03084536|101111626|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
33526644|NCT01716520|101823586|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
33526645|NCT01716520|101823587|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
33526646|NCT01716520|101823582|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
33526647|NCT01716520|101823583|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
33526648|NCT01716520|101823584|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
33526649|NCT01716520|101823585|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
33526650|NCT01716520|101823586|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
33526651|NCT01716520|101823587|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
33526652|NCT01716520|101823582|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33526653|NCT01716520|101823583|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33610519|NCT01727336|102123343|FG005|Part 2 Blinded|Lost to Follow-up|1|||
33610520|NCT01727336|102123338|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
33332799|NCT00450723|101111629|FG000|Overall Study|Physician Decision|5|||
33610521|NCT01727336|102123339|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
33332800|NCT02636582|101111630|FG000|Overall Study|Surgical Pathology|1|||
33332801|NCT02636582|101111631|FG001|Overall Study|Surgical Pathology|0|||
33332802|NCT03917823|101111632|FG000|Overall Study|Lost to Follow-up|1|||
33332803|NCT03917823|101111633|FG001|Overall Study|Lost to Follow-up|1|||
33332804|NCT03917823|101111632|FG000|Overall Study|Withdrawal by Subject|0|||
33526654|NCT01716520|101823584|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33526655|NCT01716520|101823585|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33526656|NCT01716520|101823586|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
33526657|NCT01716520|101823587|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
33526658|NCT01716520|101823582|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33526659|NCT01716520|101823583|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33526660|NCT01716520|101823584|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
33526661|NCT01716520|101823585|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33526662|NCT01716520|101823586|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33526663|NCT01716520|101823587|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
33526664|NCT00642954|101823596|FG000|Overall Study|Progressive Disease|3|||
33526665|NCT00642954|101823597|FG001|Overall Study|Progressive Disease|3|||
33526666|NCT00642954|101823598|FG002|Overall Study|Progressive Disease|3|||
33526667|NCT00642954|101823599|FG003|Overall Study|Progressive Disease|3|||
33526668|NCT00642954|101823600|FG004|Overall Study|Progressive Disease|9|||
33526669|NCT00642954|101823596|FG000|Overall Study|Withdrawal by Subject|0|||
33526670|NCT00642954|101823597|FG001|Overall Study|Withdrawal by Subject|0|||
33526671|NCT00642954|101823598|FG002|Overall Study|Withdrawal by Subject|0|||
33526672|NCT00642954|101823599|FG003|Overall Study|Withdrawal by Subject|0|||
33526673|NCT00642954|101823600|FG004|Overall Study|Withdrawal by Subject|1|||
33526674|NCT00642954|101823596|FG000|Overall Study|Adverse Event|1|||
33526675|NCT00642954|101823597|FG001|Overall Study|Adverse Event|1|||
33526676|NCT00642954|101823598|FG002|Overall Study|Adverse Event|0|||
33526677|NCT00642954|101823599|FG003|Overall Study|Adverse Event|0|||
33526678|NCT00642954|101823600|FG004|Overall Study|Adverse Event|6|||
33526679|NCT04105842|101823604|FG000|Overall Study|Withdrawal by Subject|2|||
33526680|NCT01066663|101823605|FG000|Overall Study|Adverse Event|0|||
33526681|NCT01066663|101823606|FG001|Overall Study|Adverse Event|0|||
33526682|NCT01066663|101823607|FG002|Overall Study|Adverse Event|1|||
33526683|NCT01210482|101823608|FG000|Overall Study|Protocol Violation|1|||
33526684|NCT01210482|101823608|FG000|Overall Study|Case Report Forms were not collected|18|||
33526685|NCT01210482|101823608|FG000|Overall Study|Duplicated|2|||
33526686|NCT01210482|101823608|FG000|Overall Study|No Drug Administration|28|||
33526687|NCT00632125|101827045|FG000|Overall Study|Death|82|||
33526688|NCT00632125|101827045|FG000|Overall Study|Withdrawal by Subject|44|||
33526689|NCT00632125|101827045|FG000|Overall Study|Adverse Event|36|||
33526690|NCT00632125|101827045|FG000|Overall Study|Renal transplantation|17|||
33526691|NCT00632125|101827045|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
33526692|NCT00632125|101827045|FG000|Overall Study|Non-compliance|8|||
33526693|NCT00632125|101827045|FG000|Overall Study|Development of uncontrolled hypertension|5|||
33526694|NCT00632125|101827045|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
33526695|NCT01605825|101827046|FG000|Overall Study|Adverse Event|4|||
33526696|NCT01605825|101827047|FG001|Overall Study|Adverse Event|2|||
33526697|NCT01605825|101827046|FG000|Overall Study|Withdrawal by Subject|0|||
33526698|NCT01605825|101827047|FG001|Overall Study|Withdrawal by Subject|1|||
33526699|NCT01605825|101827046|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
33203347|NCT02343458|100645921|FG001|Overall Study|Protocol Violation|5|||
33203348|NCT02343458|100645922|FG002|Overall Study|Protocol Violation|2|||
33203349|NCT02343458|100645923|FG003|Overall Study|Protocol Violation|2|||
33203350|NCT02343458|100645920|FG000|Overall Study|Protocol Specified Criteria|17|||
33203351|NCT02343458|100645921|FG001|Overall Study|Protocol Specified Criteria|13|||
33203352|NCT02343458|100645922|FG002|Overall Study|Protocol Specified Criteria|14|||
33203353|NCT02343458|100645923|FG003|Overall Study|Protocol Specified Criteria|8|||
33203354|NCT03701555|100645924|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
33203355|NCT03701555|100645925|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
33203356|NCT03701555|100645926|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
33203357|NCT03701555|100645927|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
33203358|NCT03701555|100645928|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
33203359|NCT03701555|100645929|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
33203360|NCT03701555|100645930|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
33203361|NCT03701555|100645931|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
33203362|NCT03701555|100645932|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
33203363|NCT03701555|100645933|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
33402924|NCT05047601|101365454|FG000|Overall Study|Lost to Follow-up|9|||
33526700|NCT01605825|101827047|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
33526701|NCT01605825|101827046|FG000|Overall Study|Non-Compliance with Protocol|3|||
33526702|NCT01605825|101827047|FG001|Overall Study|Non-Compliance with Protocol|0|||
33203364|NCT03701555|100645934|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
33526703|NCT01808261|101827052|FG000|Overall Study|Physician Decision|0|||
33526704|NCT01808261|101827053|FG001|Overall Study|Physician Decision|2|||
33526705|NCT01808261|101827052|FG000|Overall Study|Study Closed/Terminated|25|||
33526706|NCT01808261|101827053|FG001|Overall Study|Study Closed/Terminated|23|||
33526707|NCT01808261|101827052|FG000|Overall Study|Adverse event, non-fatal|2|||
33203365|NCT03701555|100645935|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
33203366|NCT03701555|100645936|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
33203367|NCT03701555|100645937|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
33203368|NCT03701555|100645938|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
33203369|NCT03701555|100645939|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
33203370|NCT03701555|100645940|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
33203371|NCT03701555|100645941|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
33203372|NCT03701555|100645942|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
33203373|NCT03701555|100645943|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
33203374|NCT03701555|100645944|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
33203375|NCT03701555|100645945|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
33203376|NCT03701555|100645946|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
33203377|NCT03701555|100645947|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
33203378|NCT03701555|100645948|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
33203379|NCT03701555|100645949|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
33203380|NCT03701555|100645950|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
33203381|NCT03701555|100645951|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
33203382|NCT03701555|100645952|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
33203383|NCT03701555|100645953|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
33203384|NCT03701555|100645954|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
33203385|NCT03701555|100645955|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
33203386|NCT03701555|100645956|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
33203387|NCT03701555|100645957|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
33203388|NCT03701555|100645958|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
33203389|NCT03701555|100645959|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
33203390|NCT03701555|100645924|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
33203391|NCT03701555|100645925|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
33203392|NCT03701555|100645926|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
33203393|NCT03701555|100645927|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
33203394|NCT03701555|100645928|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
33203395|NCT03701555|100645929|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
33332805|NCT03917823|101111633|FG001|Overall Study|Withdrawal by Subject|1|||
33526708|NCT01808261|101827053|FG001|Overall Study|Adverse event, non-fatal|0|||
33526709|NCT01808261|101827052|FG000|Overall Study|Consent withdrawn by subject|6|||
33526710|NCT01808261|101827053|FG001|Overall Study|Consent withdrawn by subject|7|||
33526711|NCT01808261|101827052|FG000|Overall Study|Lost to Follow-up|3|||
33526712|NCT01808261|101827053|FG001|Overall Study|Lost to Follow-up|1|||
33526713|NCT01408901|101827056|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
33526714|NCT01408901|101827057|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
33526715|NCT01408901|101827058|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
33526716|NCT01408901|101827059|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
33526717|NCT01408901|101827056|FG000|6-Week Follow-Up|Death|1|||
33526718|NCT01408901|101827057|FG001|6-Week Follow-Up|Death|0|||
33526719|NCT01408901|101827058|FG002|6-Week Follow-Up|Death|0|||
33526720|NCT01408901|101827059|FG003|6-Week Follow-Up|Death|0|||
33526721|NCT01408901|101827056|FG000|6-Week Follow-Up|Cancelled visit|0|||
33526722|NCT01408901|101827057|FG001|6-Week Follow-Up|Cancelled visit|1|||
33526723|NCT01408901|101827058|FG002|6-Week Follow-Up|Cancelled visit|0|||
33526724|NCT01408901|101827059|FG003|6-Week Follow-Up|Cancelled visit|2|||
33526725|NCT01408901|101827056|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
33526726|NCT01408901|101827057|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
33526727|NCT01408901|101827058|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
33332806|NCT01263483|101111634|FG000|Overall Study|Adverse Event|4|||
33332807|NCT01263483|101111635|FG001|Overall Study|Adverse Event|0|||
33332808|NCT01263483|101111636|FG002|Overall Study|Adverse Event|3|||
33332809|NCT01263483|101111634|FG000|Overall Study|Withdrawal by Subject|1|||
33332810|NCT01263483|101111635|FG001|Overall Study|Withdrawal by Subject|0|||
33332811|NCT01263483|101111636|FG002|Overall Study|Withdrawal by Subject|0|||
33526728|NCT01408901|101827059|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
33526729|NCT01408901|101827056|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
33526730|NCT01408901|101827057|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
33526731|NCT01408901|101827058|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
33526732|NCT01408901|101827059|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
33526733|NCT01408901|101827056|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
33203396|NCT03701555|100645930|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
33203397|NCT03701555|100645931|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
33203398|NCT03701555|100645932|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
33203399|NCT03701555|100645933|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
33203400|NCT03701555|100645934|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
33526734|NCT01408901|101827057|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
33526735|NCT01408901|101827058|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
33526736|NCT01408901|101827059|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
33526737|NCT01408901|101827056|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
33203401|NCT03701555|100645935|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
33203402|NCT03701555|100645936|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
33203403|NCT03701555|100645937|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
33203404|NCT03701555|100645938|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
33203405|NCT03701555|100645939|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
33332812|NCT01263483|101111634|FG000|Overall Study|Lack of Efficacy|2|||
33332813|NCT01263483|101111635|FG001|Overall Study|Lack of Efficacy|0|||
33332814|NCT01263483|101111636|FG002|Overall Study|Lack of Efficacy|0|||
33332815|NCT01263483|101111634|FG000|Overall Study|Protocol Violation|0|||
33332816|NCT01263483|101111635|FG001|Overall Study|Protocol Violation|1|||
33332817|NCT01263483|101111636|FG002|Overall Study|Protocol Violation|1|||
33402925|NCT05047601|101365455|FG001|Overall Study|Lost to Follow-up|11|||
33402926|NCT05047601|101365456|FG002|Overall Study|Lost to Follow-up|7|||
33402927|NCT05047601|101365454|FG000|Overall Study|Withdrawal by Subject|25|||
33402928|NCT05047601|101365455|FG001|Overall Study|Withdrawal by Subject|36|||
33526738|NCT01408901|101827057|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
33402929|NCT05047601|101365456|FG002|Overall Study|Withdrawal by Subject|23|||
33402930|NCT05047601|101365454|FG000|Overall Study|Other|10|||
33402931|NCT05047601|101365455|FG001|Overall Study|Other|6|||
33402932|NCT05047601|101365456|FG002|Overall Study|Other|5|||
33402933|NCT02452034|101365458|FG000|Overall Study|Adverse Event|0|||
33402934|NCT02452034|101365459|FG001|Overall Study|Adverse Event|0|||
33402935|NCT02452034|101365460|FG002|Overall Study|Adverse Event|0|||
33402936|NCT02452034|101365461|FG003|Overall Study|Adverse Event|0|||
33402937|NCT02452034|101365462|FG004|Overall Study|Adverse Event|0|||
33402938|NCT02452034|101365463|FG005|Overall Study|Adverse Event|1|||
33402939|NCT02452034|101365458|FG000|Overall Study|Death|0|||
33402940|NCT02452034|101365459|FG001|Overall Study|Death|0|||
33402941|NCT02452034|101365460|FG002|Overall Study|Death|0|||
33402942|NCT02452034|101365461|FG003|Overall Study|Death|0|||
33402943|NCT02452034|101365462|FG004|Overall Study|Death|1|||
33402944|NCT02452034|101365463|FG005|Overall Study|Death|1|||
33402945|NCT02452034|101365458|FG000|Overall Study|Physician Decision|0|||
33402946|NCT02452034|101365459|FG001|Overall Study|Physician Decision|1|||
33402947|NCT02452034|101365460|FG002|Overall Study|Physician Decision|1|||
33402948|NCT02452034|101365461|FG003|Overall Study|Physician Decision|0|||
33402949|NCT02452034|101365462|FG004|Overall Study|Physician Decision|0|||
33402950|NCT02452034|101365463|FG005|Overall Study|Physician Decision|0|||
33402951|NCT02452034|101365458|FG000|Overall Study|Protocol Violation|0|||
33402952|NCT02452034|101365459|FG001|Overall Study|Protocol Violation|0|||
33402953|NCT02452034|101365460|FG002|Overall Study|Protocol Violation|0|||
33402954|NCT02452034|101365461|FG003|Overall Study|Protocol Violation|0|||
33402955|NCT02452034|101365462|FG004|Overall Study|Protocol Violation|0|||
33402956|NCT02452034|101365463|FG005|Overall Study|Protocol Violation|1|||
33402957|NCT02452034|101365458|FG000|Overall Study|Screen Failure|1|||
33402958|NCT02452034|101365459|FG001|Overall Study|Screen Failure|0|||
33402959|NCT02452034|101365460|FG002|Overall Study|Screen Failure|0|||
33402960|NCT02452034|101365461|FG003|Overall Study|Screen Failure|1|||
33402961|NCT02452034|101365462|FG004|Overall Study|Screen Failure|0|||
33402962|NCT02452034|101365463|FG005|Overall Study|Screen Failure|0|||
33402963|NCT02452034|101365458|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
33402964|NCT02452034|101365459|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
33402965|NCT02452034|101365460|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
33402966|NCT02452034|101365461|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
33402967|NCT02452034|101365462|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
33402968|NCT02452034|101365463|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
33526739|NCT01408901|101827058|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
33526740|NCT01408901|101827059|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
33203406|NCT03701555|100645940|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
33332818|NCT01263483|101111634|FG000|Overall Study|Participant Unavailability|0|||
33332819|NCT01263483|101111635|FG001|Overall Study|Participant Unavailability|1|||
33332820|NCT01263483|101111636|FG002|Overall Study|Participant Unavailability|1|||
33332821|NCT01081912|101111637|FG000|Conversion/Titration|Adverse Event|47|||
33526741|NCT01408901|101827056|FG000|26-Week Follow-Up|Death|0|||
33332822|NCT01081912|101111638|FG001|Conversion/Titration|Adverse Event|0|||
33402969|NCT04419558|101365468|FG000|DB Period (48 Weeks)|Adverse Event|6|||
33402970|NCT04419558|101365469|FG001|DB Period (48 Weeks)|Adverse Event|6|||
33402971|NCT04419558|101365468|FG000|DB Period (48 Weeks)|Death|14|||
33402972|NCT04419558|101365469|FG001|DB Period (48 Weeks)|Death|11|||
33402973|NCT04419558|101365468|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
33402974|NCT04419558|101365469|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
33402975|NCT04419558|101365468|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
33402976|NCT04419558|101365469|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
33402977|NCT04419558|101365468|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
33402978|NCT04419558|101365469|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
33402979|NCT04419558|101365468|FG000|DB Period (48 Weeks)|Disease Progression|1|||
33526742|NCT01408901|101827057|FG001|26-Week Follow-Up|Death|1|||
33332823|NCT01081912|101111639|FG002|Conversion/Titration|Adverse Event|0|||
33332824|NCT01081912|101111637|FG000|Conversion/Titration|Lack of Efficacy|17|||
33332825|NCT01081912|101111638|FG001|Conversion/Titration|Lack of Efficacy|0|||
33332826|NCT01081912|101111639|FG002|Conversion/Titration|Lack of Efficacy|0|||
33332827|NCT01081912|101111637|FG000|Conversion/Titration|Lost to Follow-up|5|||
33332828|NCT01081912|101111638|FG001|Conversion/Titration|Lost to Follow-up|0|||
33332829|NCT01081912|101111639|FG002|Conversion/Titration|Lost to Follow-up|0|||
33332830|NCT01081912|101111637|FG000|Conversion/Titration|Physician Decision|2|||
33332831|NCT01081912|101111638|FG001|Conversion/Titration|Physician Decision|0|||
33526743|NCT01408901|101827058|FG002|26-Week Follow-Up|Death|0|||
33526744|NCT01408901|101827059|FG003|26-Week Follow-Up|Death|0|||
33526745|NCT02020889|101827060|FG000|Overall Study|Adverse Event|0|||
33526746|NCT02020889|101827061|FG001|Overall Study|Adverse Event|1|||
33526747|NCT02020889|101827060|FG000|Overall Study|Lack of Efficacy|1|||
33526748|NCT02020889|101827061|FG001|Overall Study|Lack of Efficacy|0|||
33526749|NCT02020889|101827060|FG000|Overall Study|Lost to Follow-up|1|||
33526750|NCT02020889|101827061|FG001|Overall Study|Lost to Follow-up|0|||
33526751|NCT02020889|101827060|FG000|Overall Study|Physician Decision|2|||
33526752|NCT02020889|101827061|FG001|Overall Study|Physician Decision|0|||
33526753|NCT02020889|101827060|FG000|Overall Study|Withdrawal by Subject|3|||
33526754|NCT02020889|101827061|FG001|Overall Study|Withdrawal by Subject|2|||
33526755|NCT01342445|101827062|FG000|Overall Study|Experienced side effects|0|||
33526756|NCT01342445|101827063|FG001|Overall Study|Experienced side effects|2|||
33526757|NCT01491841|101827066|FG000|Overall Study|Screen Failure|10|||
33526758|NCT01491841|101827066|FG000|Overall Study|Withdrawal by Subject|1|||
33526759|NCT01884545|101827067|FG000|Overall Study|Lost to Follow-up|6|||
33526760|NCT01884545|101827068|FG001|Overall Study|Lost to Follow-up|4|||
33332832|NCT01081912|101111639|FG002|Conversion/Titration|Physician Decision|0|||
33332833|NCT01081912|101111637|FG000|Conversion/Titration|Protocol Violation|67|||
33332834|NCT01081912|101111638|FG001|Conversion/Titration|Protocol Violation|0|||
33332835|NCT01081912|101111639|FG002|Conversion/Titration|Protocol Violation|0|||
33332836|NCT01081912|101111637|FG000|Conversion/Titration|Withdrawal by Subject|23|||
33332837|NCT01081912|101111638|FG001|Conversion/Titration|Withdrawal by Subject|0|||
33332838|NCT01081912|101111639|FG002|Conversion/Titration|Withdrawal by Subject|0|||
33332839|NCT01081912|101111637|FG000|Conversion/Titration|Non-Compliance|47|||
33332840|NCT01081912|101111638|FG001|Conversion/Titration|Non-Compliance|0|||
33332841|NCT01081912|101111639|FG002|Conversion/Titration|Non-Compliance|0|||
33332842|NCT01081912|101111637|FG000|Maintenance Treatment|Adverse Event|0|||
33332843|NCT01081912|101111638|FG001|Maintenance Treatment|Adverse Event|2|||
33332844|NCT01081912|101111639|FG002|Maintenance Treatment|Adverse Event|12|||
33332845|NCT01081912|101111637|FG000|Maintenance Treatment|Lack of Efficacy|0|||
33332846|NCT01081912|101111638|FG001|Maintenance Treatment|Lack of Efficacy|14|||
33332847|NCT01081912|101111639|FG002|Maintenance Treatment|Lack of Efficacy|64|||
33332848|NCT01081912|101111637|FG000|Maintenance Treatment|Lost to Follow-up|0|||
33526761|NCT01884545|101827069|FG002|Overall Study|Lost to Follow-up|9|||
33526762|NCT01884545|101827070|FG003|Overall Study|Lost to Follow-up|4|||
33332849|NCT01081912|101111638|FG001|Maintenance Treatment|Lost to Follow-up|1|||
33332850|NCT01081912|101111639|FG002|Maintenance Treatment|Lost to Follow-up|0|||
33610522|NCT01727336|102123340|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
33610523|NCT01727336|102123341|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
33610524|NCT01727336|102123342|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
33332851|NCT01081912|101111637|FG000|Maintenance Treatment|Physician Decision|0|||
33332852|NCT01081912|101111638|FG001|Maintenance Treatment|Physician Decision|0|||
33332853|NCT01081912|101111639|FG002|Maintenance Treatment|Physician Decision|1|||
33332854|NCT01081912|101111637|FG000|Maintenance Treatment|Protocol Violation|0|||
33332855|NCT01081912|101111638|FG001|Maintenance Treatment|Protocol Violation|1|||
33332856|NCT01081912|101111639|FG002|Maintenance Treatment|Protocol Violation|2|||
33332857|NCT01081912|101111637|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
33332858|NCT01081912|101111638|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
33332859|NCT01081912|101111639|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
33332860|NCT01081912|101111637|FG000|Maintenance Treatment|Non-Compliance|0|||
33332861|NCT01081912|101111638|FG001|Maintenance Treatment|Non-Compliance|4|||
33332862|NCT01081912|101111639|FG002|Maintenance Treatment|Non-Compliance|7|||
33332863|NCT01081912|101111637|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
33332864|NCT01081912|101111638|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
33332865|NCT01081912|101111639|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
33332866|NCT03152019|101111642|FG000|Overall Study|Adverse Event|0|||
33332867|NCT03152019|101111643|FG001|Overall Study|Adverse Event|1|||
33526763|NCT01884545|101827067|FG000|Overall Study|Patient withdrawn|7|||
33526764|NCT01884545|101827068|FG001|Overall Study|Patient withdrawn|12|||
33526765|NCT01884545|101827069|FG002|Overall Study|Patient withdrawn|5|||
33526766|NCT01884545|101827070|FG003|Overall Study|Patient withdrawn|5|||
33526767|NCT01884545|101827067|FG000|Overall Study|Non-adherence|0|||
33526768|NCT01884545|101827068|FG001|Overall Study|Non-adherence|2|||
33526769|NCT01884545|101827069|FG002|Overall Study|Non-adherence|0|||
33526770|NCT01884545|101827070|FG003|Overall Study|Non-adherence|0|||
33526771|NCT01709409|101827073|FG000|Overall Study|Protocol Violation|1|||
33526772|NCT01709409|101827074|FG001|Overall Study|Protocol Violation|0|||
33402980|NCT04419558|101365469|FG001|DB Period (48 Weeks)|Disease Progression|0|||
33402981|NCT04419558|101365468|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
33402982|NCT04419558|101365469|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
33402983|NCT04419558|101365468|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
33526773|NCT01087203|101827075|FG000|Overall Study|Lost to Follow-up|2|||
33526774|NCT01087203|101827076|FG001|Overall Study|Lost to Follow-up|0|||
33526775|NCT01087203|101827075|FG000|Overall Study|Withdrawal by Subject|2|||
33526776|NCT01087203|101827076|FG001|Overall Study|Withdrawal by Subject|6|||
33526777|NCT01087203|101827075|FG000|Overall Study|Lack of Efficacy|1|||
33526778|NCT01087203|101827076|FG001|Overall Study|Lack of Efficacy|2|||
33526779|NCT01087203|101827075|FG000|Overall Study|Study terminated by sponsor|27|||
33526780|NCT01087203|101827076|FG001|Overall Study|Study terminated by sponsor|27|||
33526781|NCT01299896|101827077|FG000|Overall Study|Withdrawal by Subject|1|||
33526782|NCT01299896|101827078|FG001|Overall Study|Withdrawal by Subject|7|||
33526783|NCT01299896|101827077|FG000|Overall Study|Lost to Follow-up|0|||
33526784|NCT01299896|101827078|FG001|Overall Study|Lost to Follow-up|11|||
33526785|NCT03173456|101827079|FG000|Baseline|Medication dispensing system malfunction'|0|||
33526786|NCT03173456|101827080|FG001|Baseline|Medication dispensing system malfunction'|1|||
33526787|NCT03173456|101827081|FG002|Baseline|Medication dispensing system malfunction'|0|||
33526788|NCT03173456|101827082|FG003|Baseline|Medication dispensing system malfunction'|0|||
33526789|NCT03173456|101827083|FG004|Baseline|Medication dispensing system malfunction'|2|||
33526790|NCT03173456|101827079|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
33526791|NCT03173456|101827080|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
33526792|NCT03173456|101827081|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
33526793|NCT03173456|101827082|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
33526794|NCT03173456|101827083|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
33526795|NCT00948922|101827085|FG000|Overall Study|Did not start study treatment|2|||
33526796|NCT00948922|101827086|FG001|Overall Study|Did not start study treatment|5|||
33526797|NCT00948922|101827087|FG002|Overall Study|Did not start study treatment|0|||
33526798|NCT00948922|101827085|FG000|Overall Study|Withdrawal by Subject|0|||
33526799|NCT00948922|101827086|FG001|Overall Study|Withdrawal by Subject|2|||
33526800|NCT00948922|101827087|FG002|Overall Study|Withdrawal by Subject|1|||
33526801|NCT00948922|101827085|FG000|Overall Study|Death|3|||
33526802|NCT00948922|101827086|FG001|Overall Study|Death|0|||
33526803|NCT00948922|101827087|FG002|Overall Study|Death|0|||
33526804|NCT00948922|101827085|FG000|Overall Study|Disease progression|0|||
33526805|NCT00948922|101827086|FG001|Overall Study|Disease progression|1|||
33526806|NCT00948922|101827087|FG002|Overall Study|Disease progression|0|||
33526807|NCT00948922|101827085|FG000|Overall Study|Insurance issues|1|||
33526808|NCT00948922|101827086|FG001|Overall Study|Insurance issues|0|||
33526809|NCT00948922|101827087|FG002|Overall Study|Insurance issues|0|||
33526810|NCT00948922|101827085|FG000|Overall Study|Transplant eligibility issues|2|||
33526811|NCT00948922|101827086|FG001|Overall Study|Transplant eligibility issues|3|||
33526812|NCT00948922|101827087|FG002|Overall Study|Transplant eligibility issues|0|||
33526813|NCT00948922|101827085|FG000|Overall Study|Not evaluable at time of analysis|0|||
33526814|NCT00948922|101827086|FG001|Overall Study|Not evaluable at time of analysis|3|||
33526815|NCT00948922|101827087|FG002|Overall Study|Not evaluable at time of analysis|0|||
33526816|NCT02906579|101827089|FG000|Overall Study|Adverse Event|1|||
33526817|NCT02906579|101827089|FG000|Overall Study|Physician Decision|1|||
33526818|NCT04074330|101827090|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
33526819|NCT04074330|101827091|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
33526820|NCT04074330|101827092|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
33526821|NCT04074330|101827093|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
33526822|NCT04074330|101827094|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
33526823|NCT04074330|101827095|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
33526824|NCT04074330|101827096|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
33526825|NCT04074330|101827097|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
33526826|NCT04074330|101827098|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
33402984|NCT04419558|101365469|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
33526827|NCT04074330|101827099|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
33526828|NCT04074330|101827090|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
33526829|NCT04074330|101827091|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
33526830|NCT04074330|101827092|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
33526831|NCT04074330|101827093|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
33526832|NCT04074330|101827094|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
33526833|NCT04074330|101827095|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
33526834|NCT04074330|101827096|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
33526835|NCT04074330|101827097|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
33526836|NCT04074330|101827098|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
33526837|NCT04074330|101827099|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
33402985|NCT04419558|101365468|FG000|DB Period (48 Weeks)|Participant Decision|4|||
33526838|NCT04074330|101827090|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
33526839|NCT04074330|101827091|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
33526840|NCT04074330|101827092|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
33526841|NCT04074330|101827093|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
33526842|NCT04074330|101827094|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
33526843|NCT04074330|101827095|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
33526844|NCT04074330|101827096|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
33526845|NCT04074330|101827097|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
33526846|NCT04074330|101827098|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
33526847|NCT04074330|101827099|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
33526848|NCT04074330|101827090|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
33526849|NCT04074330|101827091|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
33526850|NCT04074330|101827092|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
33526851|NCT04074330|101827093|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
33526852|NCT04074330|101827094|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
33526853|NCT04074330|101827095|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
33526854|NCT04074330|101827096|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
33526855|NCT04074330|101827097|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
33526856|NCT04074330|101827098|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
33526857|NCT04074330|101827099|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
33402986|NCT04419558|101365469|FG001|DB Period (48 Weeks)|Participant Decision|3|||
33402987|NCT04419558|101365468|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
33402988|NCT04419558|101365469|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
33526858|NCT04074330|101827090|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
33526859|NCT04074330|101827091|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
33526860|NCT04074330|101827092|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
33526861|NCT04074330|101827093|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
33526862|NCT04074330|101827094|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
33526863|NCT04074330|101827095|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
33402989|NCT04419558|101365468|FG000|OLE Period (48 Weeks)|Death|4|||
33402990|NCT04419558|101365469|FG001|OLE Period (48 Weeks)|Death|6|||
33526864|NCT04074330|101827096|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
33526865|NCT04074330|101827097|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
33526866|NCT04074330|101827098|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
33526867|NCT04074330|101827099|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
33526868|NCT04074330|101827090|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
33526869|NCT04074330|101827091|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
33526870|NCT04074330|101827092|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
33526871|NCT04074330|101827093|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
33526872|NCT04074330|101827094|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
33526873|NCT04074330|101827095|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
33526874|NCT04074330|101827096|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
33526875|NCT04074330|101827097|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
33526876|NCT04074330|101827098|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
33526877|NCT04074330|101827099|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
33526878|NCT04074330|101827090|FG000|Dose Expansion (up to 42 Months)|Death|0|||
33526879|NCT04074330|101827091|FG001|Dose Expansion (up to 42 Months)|Death|0|||
33526880|NCT04074330|101827092|FG002|Dose Expansion (up to 42 Months)|Death|0|||
33526881|NCT04074330|101827093|FG003|Dose Expansion (up to 42 Months)|Death|0|||
33526882|NCT04074330|101827094|FG004|Dose Expansion (up to 42 Months)|Death|0|||
33526883|NCT04074330|101827095|FG005|Dose Expansion (up to 42 Months)|Death|0|||
33526884|NCT04074330|101827096|FG006|Dose Expansion (up to 42 Months)|Death|0|||
33526885|NCT04074330|101827097|FG007|Dose Expansion (up to 42 Months)|Death|0|||
33526886|NCT04074330|101827098|FG008|Dose Expansion (up to 42 Months)|Death|1|||
33332868|NCT00117598|101111644|FG000|Prior to Treatment Cross Over|Death|40|||
33332869|NCT00117598|101111645|FG001|Prior to Treatment Cross Over|Death|41|||
33332870|NCT00117598|101111646|FG002|Prior to Treatment Cross Over|Death|37|||
33332871|NCT00117598|101111647|FG003|Prior to Treatment Cross Over|Death|0|||
33332872|NCT00117598|101111648|FG004|Prior to Treatment Cross Over|Death|0|||
33332873|NCT00117598|101111644|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
33332874|NCT00117598|101111645|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
33332875|NCT00117598|101111646|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
33402991|NCT04419558|101365468|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
33526887|NCT04074330|101827099|FG009|Dose Expansion (up to 42 Months)|Death|0|||
33332876|NCT00117598|101111647|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
33526888|NCT04074330|101827090|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
33526889|NCT04074330|101827091|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
33526890|NCT04074330|101827092|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
33526891|NCT04074330|101827093|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
33526892|NCT04074330|101827094|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
33526893|NCT04074330|101827095|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
33526894|NCT04074330|101827096|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
33526895|NCT04074330|101827097|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
33332877|NCT00117598|101111648|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
33332878|NCT00117598|101111644|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
33332879|NCT00117598|101111645|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
33332880|NCT00117598|101111646|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
33332881|NCT00117598|101111647|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
33332882|NCT00117598|101111648|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
33332883|NCT00117598|101111644|FG000|Prior to Treatment Cross Over|Other|15|||
33332884|NCT00117598|101111645|FG001|Prior to Treatment Cross Over|Other|9|||
33332885|NCT00117598|101111646|FG002|Prior to Treatment Cross Over|Other|9|||
33332886|NCT00117598|101111647|FG003|Prior to Treatment Cross Over|Other|0|||
33402992|NCT04419558|101365469|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
33402993|NCT04419558|101365468|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
33402994|NCT04419558|101365469|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
33402995|NCT00298766|101365470|FG000|Overall Study|Adverse Event|18|||
33402996|NCT00298766|101365470|FG000|Overall Study|Death|2|||
33402997|NCT00298766|101365470|FG000|Overall Study|Withdrawal by Subject|9|||
33402998|NCT00298766|101365470|FG000|Overall Study|Treatment ongoing|4|||
33402999|NCT00298766|101365470|FG000|Overall Study|Progression of amyloid markers|4|||
33403000|NCT00298766|101365470|FG000|Overall Study|Deterioration in KPS and organ function|1|||
33403001|NCT00298766|101365470|FG000|Overall Study|Subjects overall condition deterioration|4|||
33403002|NCT00298766|101365470|FG000|Overall Study|Other|4|||
33403003|NCT01562327|101365471|FG000|Overall Study|Adverse Event|2|||
33332887|NCT00117598|101111648|FG004|Prior to Treatment Cross Over|Other|0|||
33526896|NCT04074330|101827098|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
33526897|NCT04074330|101827099|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
33526898|NCT04336475|101827100|FG000|Overall Study|pain|1|||
33526899|NCT04336475|101827101|FG001|Overall Study|pain|0|||
33526900|NCT04336475|101827100|FG000|Overall Study|upper respiratory infection|1|||
33526901|NCT04336475|101827101|FG001|Overall Study|upper respiratory infection|0|||
33526902|NCT04336475|101827100|FG000|Overall Study|Lost to Follow-up|0|||
33526903|NCT04336475|101827101|FG001|Overall Study|Lost to Follow-up|2|||
33526904|NCT01509664|101827108|FG000|Overall Study|Lost to Follow-up|15|||
33526905|NCT01509664|101827109|FG001|Overall Study|Lost to Follow-up|21|||
33332888|NCT00117598|101111644|FG000|After Treament Cross Over|Death|0|||
33332889|NCT00117598|101111645|FG001|After Treament Cross Over|Death|0|||
33332890|NCT00117598|101111646|FG002|After Treament Cross Over|Death|0|||
33332891|NCT00117598|101111647|FG003|After Treament Cross Over|Death|1|||
33332892|NCT00117598|101111648|FG004|After Treament Cross Over|Death|2|||
33332893|NCT00117598|101111644|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
33332894|NCT00117598|101111645|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
33332895|NCT00117598|101111646|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
33332896|NCT00117598|101111647|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
33332897|NCT00117598|101111648|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
33332898|NCT00117598|101111644|FG000|After Treament Cross Over|Other|0|||
33332899|NCT00117598|101111645|FG001|After Treament Cross Over|Other|0|||
33403004|NCT01562327|101365471|FG000|Overall Study|Lack of Efficacy|1|||
33403005|NCT01562327|101365471|FG000|Overall Study|Participant drop-out|1|||
33403006|NCT01562327|101365471|FG000|Overall Study|Infusion not received at 6 month window|4|||
33403007|NCT01371721|101365472|FG000|Overall Study|Adverse Event|5|||
33403008|NCT01371721|101365473|FG001|Overall Study|Adverse Event|4|||
33403009|NCT01371721|101365474|FG002|Overall Study|Adverse Event|5|||
33526906|NCT01887288|101827117|FG000|Overall Study|The study was terminated and the PI has|16|||
33526907|NCT02098395|101827129|FG000|Overall Study|Protocol Violation|2|||
33403010|NCT01371721|101365472|FG000|Overall Study|Protocol Violation|6|||
33403011|NCT01371721|101365473|FG001|Overall Study|Protocol Violation|4|||
33526908|NCT02098395|101827130|FG001|Overall Study|Protocol Violation|2|||
33526909|NCT02098395|101827131|FG002|Overall Study|Protocol Violation|0|||
33526910|NCT02098395|101827132|FG003|Overall Study|Protocol Violation|7|||
33332900|NCT00117598|101111646|FG002|After Treament Cross Over|Other|0|||
33332901|NCT00117598|101111647|FG003|After Treament Cross Over|Other|1|||
33332902|NCT00117598|101111648|FG004|After Treament Cross Over|Other|2|||
33332903|NCT03972969|101111653|FG000|3-month Follow-up|Death|1|||
33403012|NCT01371721|101365474|FG002|Overall Study|Protocol Violation|5|||
33403013|NCT01371721|101365472|FG000|Overall Study|Lost to Follow-up|8|||
33403014|NCT01371721|101365473|FG001|Overall Study|Lost to Follow-up|2|||
33403015|NCT01371721|101365474|FG002|Overall Study|Lost to Follow-up|6|||
33403016|NCT01371721|101365472|FG000|Overall Study|Withdrawal by Subject|5|||
33403017|NCT01371721|101365473|FG001|Overall Study|Withdrawal by Subject|7|||
33403018|NCT01371721|101365474|FG002|Overall Study|Withdrawal by Subject|11|||
33403019|NCT01371721|101365472|FG000|Overall Study|Other|2|||
33403020|NCT01371721|101365473|FG001|Overall Study|Other|3|||
33403021|NCT01371721|101365474|FG002|Overall Study|Other|0|||
33403022|NCT01371721|101365472|FG000|Overall Study|Lack of Efficacy|2|||
33403023|NCT01371721|101365473|FG001|Overall Study|Lack of Efficacy|4|||
33403024|NCT01371721|101365474|FG002|Overall Study|Lack of Efficacy|3|||
33403025|NCT01371721|101365472|FG000|Overall Study|Randomized but not treated|1|||
33403026|NCT01371721|101365473|FG001|Overall Study|Randomized but not treated|0|||
33526911|NCT02098395|101827129|FG000|Overall Study|Withdrawal by Subject|10|||
33526912|NCT02098395|101827130|FG001|Overall Study|Withdrawal by Subject|10|||
33526913|NCT02098395|101827131|FG002|Overall Study|Withdrawal by Subject|5|||
33526914|NCT02098395|101827132|FG003|Overall Study|Withdrawal by Subject|13|||
33403027|NCT01371721|101365474|FG002|Overall Study|Randomized but not treated|0|||
33403028|NCT03655951|101365475|FG000|Overall Study|Lost to Follow-up|39|||
33403029|NCT03655951|101365476|FG001|Overall Study|Lost to Follow-up|20|||
33403030|NCT03655951|101365475|FG000|Overall Study|Withdrawal by Subject|0|||
33403031|NCT03655951|101365476|FG001|Overall Study|Withdrawal by Subject|1|||
33403032|NCT03958149|101365477|FG000|Overall Study|Withdrawal by Subject|0|||
33403033|NCT03958149|101365478|FG001|Overall Study|Withdrawal by Subject|1|||
33526915|NCT02098395|101827129|FG000|Overall Study|Adverse Event|12|||
33526916|NCT02098395|101827130|FG001|Overall Study|Adverse Event|19|||
33526917|NCT02098395|101827131|FG002|Overall Study|Adverse Event|34|||
33526918|NCT02098395|101827132|FG003|Overall Study|Adverse Event|2|||
33526919|NCT02098395|101827129|FG000|Overall Study|Lost to Follow-up|2|||
33526920|NCT02098395|101827130|FG001|Overall Study|Lost to Follow-up|1|||
33526921|NCT02098395|101827131|FG002|Overall Study|Lost to Follow-up|0|||
33610525|NCT01727336|102123343|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
33403034|NCT00495794|101365484|FG000|Overall Study|Pharmacist did not activate patient|522|||
33403035|NCT00495794|101365485|FG001|Overall Study|Pharmacist did not activate patient|0|||
33403036|NCT01284127|101365486|FG000|Overall Study|Adverse Event|2|||
33403037|NCT01284127|101365486|FG000|Overall Study|Withdrawal by Subject|4|||
33403038|NCT01284127|101365486|FG000|Overall Study|Physician Decision|1|||
33403039|NCT00626327|101365487|FG000|Overall Study|Withdrawal by Subject|21|||
33526922|NCT02098395|101827132|FG003|Overall Study|Lost to Follow-up|3|||
33526923|NCT02098395|101827129|FG000|Overall Study|Unclassified|0|||
33526924|NCT02098395|101827130|FG001|Overall Study|Unclassified|0|||
33526925|NCT02098395|101827131|FG002|Overall Study|Unclassified|3|||
33526926|NCT02098395|101827132|FG003|Overall Study|Unclassified|2|||
33526927|NCT02190721|101827135|FG000|Overall Study|Patient was out of the city|0|||
33526928|NCT02190721|101827136|FG001|Overall Study|Patient was out of the city|1|||
33526929|NCT02190721|101827137|FG002|Overall Study|Patient was out of the city|0|||
33526930|NCT01737879|101827138|FG000|Overall Study|Death|1|||
33526931|NCT01737879|101827138|FG000|Overall Study|Sponsor decision|40|||
33526932|NCT00460746|101827174|FG000|Overall Study|Adverse Event|1|||
33526933|NCT00460746|101827174|FG000|Overall Study|Lost to Follow-up|1|||
33526934|NCT00807612|101827175|FG000|Overall Study|Death|8|||
33526935|NCT00807612|101827175|FG000|Overall Study|Study early termination|5|||
33526936|NCT00807612|101827175|FG000|Overall Study|Withdrawal by Subject|1|||
33526937|NCT01404949|101827176|FG000|Overall Study|Not Treated|1|||
33526938|NCT03117361|101827177|FG000|Overall Study|Progressive disease|5|||
33526939|NCT03117361|101827177|FG000|Overall Study|Death|1|||
33526940|NCT03117361|101827177|FG000|Overall Study|Physician Decision|2|||
33526941|NCT03117361|101827177|FG000|Overall Study|On study treatment at the end of study|1|||
33526942|NCT03117361|101827177|FG000|Overall Study|Treatment-related adverse event|1|||
33526943|NCT02501161|101827178|FG000|Overall Study|Adverse Event|2|||
33610526|NCT01727336|102123338|FG000|Part 2 Blinded|use of prohibited medications|0|||
33403040|NCT00626327|101365488|FG001|Overall Study|Withdrawal by Subject|29|||
33403041|NCT00626327|101365489|FG002|Overall Study|Withdrawal by Subject|30|||
33403042|NCT00626327|101365487|FG000|Overall Study|Adverse Event|1|||
33403043|NCT00626327|101365488|FG001|Overall Study|Adverse Event|0|||
33526944|NCT02501161|101827179|FG001|Overall Study|Adverse Event|6|||
33526945|NCT02501161|101827178|FG000|Overall Study|Lost to Follow-up|7|||
33526946|NCT02501161|101827179|FG001|Overall Study|Lost to Follow-up|4|||
33526947|NCT02501161|101827178|FG000|Overall Study|Withdrawal by Subject|10|||
33526948|NCT02501161|101827179|FG001|Overall Study|Withdrawal by Subject|15|||
33526949|NCT02501161|101827178|FG000|Overall Study|Other|3|||
33526950|NCT02501161|101827179|FG001|Overall Study|Other|0|||
33526951|NCT00582426|101827180|FG000|Overall Study|Lost to Follow-up|0|||
33610527|NCT01727336|102123339|FG001|Part 2 Blinded|use of prohibited medications|0|||
33403044|NCT00626327|101365489|FG002|Overall Study|Adverse Event|0|||
33403045|NCT00626327|101365487|FG000|Overall Study|Lost to Follow-up|24|||
33403046|NCT00626327|101365488|FG001|Overall Study|Lost to Follow-up|21|||
33403047|NCT00626327|101365489|FG002|Overall Study|Lost to Follow-up|23|||
33403048|NCT00626327|101365487|FG000|Overall Study|Inappropriate enrollment|4|||
33403049|NCT00626327|101365488|FG001|Overall Study|Inappropriate enrollment|5|||
33332904|NCT03972969|101111654|FG001|3-month Follow-up|Death|1|||
33526952|NCT00582426|101827181|FG001|Overall Study|Lost to Follow-up|2|||
33526953|NCT00582426|101827180|FG000|Overall Study|Adverse Event|4|||
33526954|NCT00582426|101827181|FG001|Overall Study|Adverse Event|2|||
33526955|NCT00582426|101827180|FG000|Overall Study|Protocol Violation|6|||
33526956|NCT00582426|101827181|FG001|Overall Study|Protocol Violation|2|||
33526957|NCT00582426|101827180|FG000|Overall Study|Death|4|||
33526958|NCT00582426|101827181|FG001|Overall Study|Death|3|||
33526959|NCT00582426|101827180|FG000|Overall Study|Withdrawal by Subject|3|||
33526960|NCT00582426|101827181|FG001|Overall Study|Withdrawal by Subject|2|||
33526961|NCT00582426|101827180|FG000|Overall Study|Disease Progression|2|||
33526962|NCT00582426|101827181|FG001|Overall Study|Disease Progression|2|||
33203407|NCT03701555|100645941|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
33203408|NCT03701555|100645942|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
33203409|NCT03701555|100645943|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
33203410|NCT03701555|100645944|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
33203411|NCT03701555|100645945|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
33203412|NCT03701555|100645946|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
33203413|NCT03701555|100645947|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
33203414|NCT03701555|100645948|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
33332905|NCT03972969|101111655|FG002|3-month Follow-up|Death|0|||
33332906|NCT03972969|101111653|FG000|6-month Follow-up|Death|1|||
33332907|NCT03972969|101111654|FG001|6-month Follow-up|Death|1|||
33332908|NCT03972969|101111655|FG002|6-month Follow-up|Death|1|||
33332909|NCT03972969|101111653|FG000|6-month Follow-up|Lost to Follow-up|2|||
33332910|NCT03972969|101111654|FG001|6-month Follow-up|Lost to Follow-up|2|||
33332911|NCT03972969|101111655|FG002|6-month Follow-up|Lost to Follow-up|2|||
33332912|NCT00346073|101111658|FG000|Overall Study|Serious Adverse Event|2|||
33332913|NCT00346073|101111659|FG001|Overall Study|Serious Adverse Event|0|||
33332914|NCT00346073|101111658|FG000|Overall Study|Lost to Follow-up|39|||
33332915|NCT00346073|101111659|FG001|Overall Study|Lost to Follow-up|24|||
33332916|NCT01097746|101111660|FG000|Overall Study|Adverse Event|4|||
33332917|NCT01097746|101111660|FG000|Overall Study|taken off study before any treatment given|1|||
33332918|NCT00294060|101111668|FG000|Overall Study|Death|225|||
33332919|NCT00294060|101111668|FG000|Overall Study|Other|59|||
33332920|NCT00294060|101111668|FG000|Overall Study|Lost to Follow-up|55|||
33332921|NCT00294060|101111668|FG000|Overall Study|Withdrawal by Subject|11|||
33332922|NCT00294060|101111668|FG000|Overall Study|Physician Decision|797|||
33332923|NCT00294060|101111668|FG000|Overall Study|Medical condition|3|||
33332924|NCT00294060|101111668|FG000|Overall Study|Device explanted/not replaced|23|||
33332925|NCT00271596|101111671|FG000|Overall Study|Protocol Violation|1|||
33332926|NCT00271596|101111672|FG001|Overall Study|Protocol Violation|0|||
33332927|NCT00271596|101111671|FG000|Overall Study|Withdrawal by Subject|0|||
33332928|NCT00271596|101111672|FG001|Overall Study|Withdrawal by Subject|1|||
33332929|NCT02581202|101111673|FG000|Overall Study|Lack of Efficacy|2|||
33332930|NCT02581202|101111673|FG000|Overall Study|Withdrawal by Subject|4|||
33332931|NCT02581202|101111673|FG000|Overall Study|Lost to Follow-up|5|||
33332932|NCT02581202|101111673|FG000|Overall Study|Pregnancy|3|||
33332933|NCT03581786|101111674|FG000|Overall Study|Death|17|||
33332934|NCT03581786|101111675|FG001|Overall Study|Death|12|||
33332935|NCT03581786|101111674|FG000|Overall Study|Withdrawal by Subject|2|||
33332936|NCT03581786|101111675|FG001|Overall Study|Withdrawal by Subject|4|||
33332937|NCT03581786|101111674|FG000|Overall Study|Lost to Follow-up|1|||
33332938|NCT03581786|101111675|FG001|Overall Study|Lost to Follow-up|0|||
33332939|NCT03581786|101111674|FG000|Overall Study|reason other than specified above|0|||
33332940|NCT03581786|101111675|FG001|Overall Study|reason other than specified above|1|||
33332941|NCT03581786|101111674|FG000|Overall Study|Ongoing in the study|123|||
33332942|NCT03581786|101111675|FG001|Overall Study|Ongoing in the study|129|||
33332943|NCT00930761|101111676|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
33332944|NCT00930761|101111677|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
33332945|NCT00930761|101111676|FG000|Overall Study|less than 3 music therapy sessions|0|||
33332946|NCT00930761|101111677|FG001|Overall Study|less than 3 music therapy sessions|3|||
33332947|NCT03709654|101111678|FG000|Overall Study|Lost to Follow-up|1|||
33526963|NCT00582426|101827180|FG000|Overall Study|Use of illicit drugs|1|||
33526964|NCT00582426|101827181|FG001|Overall Study|Use of illicit drugs|0|||
33526965|NCT02757625|101827182|FG000|Overall Study|Investigator's discretion|0|||
33332948|NCT03709654|101111679|FG001|Overall Study|Lost to Follow-up|1|||
33332949|NCT03709654|101111678|FG000|Overall Study|Withdrawal by Subject|1|||
33526966|NCT02757625|101827183|FG001|Overall Study|Investigator's discretion|0|||
33526967|NCT02757625|101827184|FG002|Overall Study|Investigator's discretion|1|||
33526968|NCT02757625|101827185|FG003|Overall Study|Investigator's discretion|0|||
33526969|NCT02757625|101827182|FG000|Overall Study|Adverse Event|0|||
33526970|NCT02757625|101827183|FG001|Overall Study|Adverse Event|0|||
33526971|NCT02757625|101827184|FG002|Overall Study|Adverse Event|1|||
33526972|NCT02757625|101827185|FG003|Overall Study|Adverse Event|0|||
33403050|NCT00626327|101365489|FG002|Overall Study|Inappropriate enrollment|3|||
33526973|NCT01831427|101827186|FG000|Overall Study|Adverse Event|0|||
33526974|NCT01831427|101827187|FG001|Overall Study|Adverse Event|1|||
33332950|NCT03709654|101111679|FG001|Overall Study|Withdrawal by Subject|1|||
33332951|NCT03709654|101111678|FG000|Overall Study|Adverse Event|1|||
33332952|NCT03709654|101111679|FG001|Overall Study|Adverse Event|0|||
33332953|NCT00317109|101111680|FG000|Overall Study|Withdrawal by Subject|2|||
33332954|NCT00317109|101111681|FG001|Overall Study|Withdrawal by Subject|0|||
33332955|NCT00317109|101111680|FG000|Overall Study|Migated/moved from study area|1|||
33332956|NCT00317109|101111681|FG001|Overall Study|Migated/moved from study area|0|||
33332957|NCT00925015|101111682|FG000|Overall Study|Adverse Event|1|||
33332958|NCT00925015|101111683|FG001|Overall Study|Adverse Event|2|||
33332959|NCT00925015|101111684|FG002|Overall Study|Adverse Event|1|||
33332960|NCT00925015|101111682|FG000|Overall Study|Physician Decision|0|||
33332961|NCT00925015|101111683|FG001|Overall Study|Physician Decision|1|||
33332962|NCT00925015|101111684|FG002|Overall Study|Physician Decision|0|||
33332963|NCT00925015|101111682|FG000|Overall Study|Progressive Disease|7|||
33332964|NCT00925015|101111683|FG001|Overall Study|Progressive Disease|3|||
33332965|NCT00925015|101111684|FG002|Overall Study|Progressive Disease|4|||
33332966|NCT00925015|101111682|FG000|Overall Study|Withdrawal by Subject|0|||
33332967|NCT00925015|101111683|FG001|Overall Study|Withdrawal by Subject|0|||
33332968|NCT00925015|101111684|FG002|Overall Study|Withdrawal by Subject|1|||
33332969|NCT02770547|101111685|FG000|Overall Study|Patient non-compliant|1|||
33332970|NCT02770547|101111686|FG001|Overall Study|Patient non-compliant|0|||
33332971|NCT02770547|101111685|FG000|Overall Study|Adverse Event|0|||
33332972|NCT02770547|101111686|FG001|Overall Study|Adverse Event|1|||
33332973|NCT01485627|101111687|FG000|Overall Study|Patient withdrew|6|||
33332974|NCT01485627|101111688|FG001|Overall Study|Patient withdrew|5|||
33332975|NCT01485627|101111687|FG000|Overall Study|Patient died|3|||
33332976|NCT01485627|101111688|FG001|Overall Study|Patient died|1|||
33332977|NCT01485627|101111687|FG000|Overall Study|Patient lost to followup|0|||
33332978|NCT01485627|101111688|FG001|Overall Study|Patient lost to followup|1|||
33332979|NCT01485627|101111687|FG000|Overall Study|Caregiver withdrew|3|||
33332980|NCT01485627|101111688|FG001|Overall Study|Caregiver withdrew|3|||
33332981|NCT01485627|101111687|FG000|Overall Study|Caregiver lost to follow up|11|||
33332982|NCT01485627|101111688|FG001|Overall Study|Caregiver lost to follow up|12|||
33332983|NCT01485627|101111687|FG000|Overall Study|Caregiver died|1|||
33332984|NCT01485627|101111688|FG001|Overall Study|Caregiver died|0|||
33332985|NCT01485627|101111687|FG000|Overall Study|caregiver was not bereaved|42|||
33332986|NCT01485627|101111688|FG001|Overall Study|caregiver was not bereaved|35|||
33332987|NCT00960661|101111689|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
33332988|NCT00960661|101111690|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
33332989|NCT00960661|101111691|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
33332990|NCT00960661|101111689|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
33332991|NCT00960661|101111690|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
33332992|NCT00960661|101111691|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
33332993|NCT00960661|101111689|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
33332994|NCT00960661|101111690|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
33332995|NCT00960661|101111691|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
33332996|NCT00960661|101111689|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
33332997|NCT00960661|101111690|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
33332998|NCT00960661|101111691|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
33526975|NCT01831427|101827188|FG002|Overall Study|Adverse Event|0|||
33526976|NCT01831427|101827189|FG003|Overall Study|Adverse Event|0|||
33526977|NCT01831427|101827190|FG004|Overall Study|Adverse Event|0|||
33332999|NCT00960661|101111689|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
33333000|NCT00960661|101111690|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
33203415|NCT03701555|100645949|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
33333001|NCT00960661|101111691|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
33333002|NCT00960661|101111689|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
33333003|NCT00960661|101111690|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
33333004|NCT00960661|101111691|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
33403051|NCT00626327|101365487|FG000|Overall Study|Administrative Reason|2|||
33526978|NCT01831427|101827191|FG005|Overall Study|Adverse Event|1|||
33526979|NCT01831427|101827192|FG006|Overall Study|Adverse Event|0|||
33403052|NCT00626327|101365488|FG001|Overall Study|Administrative Reason|0|||
33403053|NCT00626327|101365489|FG002|Overall Study|Administrative Reason|6|||
33403054|NCT00626327|101365487|FG000|Overall Study|Protocol Violation|26|||
33403055|NCT00626327|101365488|FG001|Overall Study|Protocol Violation|4|||
33403056|NCT00626327|101365489|FG002|Overall Study|Protocol Violation|26|||
33403057|NCT00702949|101365490|FG000|Overall Study|Refusal|3|||
33403058|NCT00702949|101365491|FG001|Overall Study|Refusal|2|||
33403059|NCT00702949|101365492|FG002|Overall Study|Refusal|2|||
33403060|NCT00702949|101365490|FG000|Overall Study|Adverse Event|1|||
33403061|NCT00702949|101365491|FG001|Overall Study|Adverse Event|6|||
33403062|NCT00702949|101365492|FG002|Overall Study|Adverse Event|3|||
33403063|NCT00702949|101365490|FG000|Overall Study|Other Medical Reason/unknown|1|||
33403064|NCT00702949|101365491|FG001|Overall Study|Other Medical Reason/unknown|1|||
33403065|NCT00702949|101365492|FG002|Overall Study|Other Medical Reason/unknown|3|||
33403066|NCT00526227|101365493|FG000|Overall Study|Device not implanted|1|||
33403067|NCT00526227|101365493|FG000|Overall Study|Death|1|||
33403068|NCT02155660|101365498|FG000|Overall Study|Other Reason|8|||
33403069|NCT02155660|101365499|FG001|Overall Study|Other Reason|6|||
33403070|NCT02155660|101365500|FG002|Overall Study|Other Reason|10|||
33403071|NCT02155660|101365501|FG003|Overall Study|Other Reason|10|||
33403072|NCT02155660|101365498|FG000|Overall Study|Study-specific withdrawal criteria|0|||
33403073|NCT02155660|101365499|FG001|Overall Study|Study-specific withdrawal criteria|1|||
33403074|NCT02155660|101365500|FG002|Overall Study|Study-specific withdrawal criteria|1|||
33403075|NCT02155660|101365501|FG003|Overall Study|Study-specific withdrawal criteria|1|||
33403076|NCT02155660|101365498|FG000|Overall Study|Severe non-compliance|0|||
33403077|NCT02155660|101365499|FG001|Overall Study|Severe non-compliance|4|||
33403078|NCT02155660|101365500|FG002|Overall Study|Severe non-compliance|0|||
33403079|NCT02155660|101365501|FG003|Overall Study|Severe non-compliance|1|||
33403080|NCT02155660|101365498|FG000|Overall Study|Adverse Event|2|||
33403081|NCT02155660|101365499|FG001|Overall Study|Adverse Event|6|||
33403082|NCT02155660|101365500|FG002|Overall Study|Adverse Event|3|||
33403083|NCT02155660|101365501|FG003|Overall Study|Adverse Event|1|||
33403084|NCT02155660|101365498|FG000|Overall Study|Lost to Follow-up|3|||
33403085|NCT02155660|101365499|FG001|Overall Study|Lost to Follow-up|6|||
33403086|NCT02155660|101365500|FG002|Overall Study|Lost to Follow-up|5|||
33403087|NCT02155660|101365501|FG003|Overall Study|Lost to Follow-up|8|||
33403088|NCT02155660|101365498|FG000|Overall Study|Death|17|||
33403089|NCT02155660|101365499|FG001|Overall Study|Death|19|||
33403090|NCT02155660|101365500|FG002|Overall Study|Death|17|||
33403091|NCT02155660|101365501|FG003|Overall Study|Death|19|||
33403092|NCT02155660|101365498|FG000|Overall Study|Withdrawal by Subject|28|||
33403093|NCT02155660|101365499|FG001|Overall Study|Withdrawal by Subject|31|||
33403094|NCT02155660|101365500|FG002|Overall Study|Withdrawal by Subject|24|||
33403095|NCT02155660|101365501|FG003|Overall Study|Withdrawal by Subject|21|||
33403096|NCT00129220|101365502|FG000|Study Period II|Adverse Event|9|||
33403097|NCT00129220|101365503|FG001|Study Period II|Adverse Event|5|||
33403098|NCT00129220|101365504|FG002|Study Period II|Adverse Event|7|||
33403099|NCT00129220|101365502|FG000|Study Period II|Lack of Efficacy|15|||
33403100|NCT00129220|101365503|FG001|Study Period II|Lack of Efficacy|1|||
33403101|NCT00129220|101365504|FG002|Study Period II|Lack of Efficacy|28|||
33403102|NCT00129220|101365502|FG000|Study Period II|Entry Criteria Not Met|2|||
33333005|NCT00960661|101111689|FG000|Interventional Phase|Adverse Event|0|||
33333006|NCT00960661|101111690|FG001|Interventional Phase|Adverse Event|17|||
33333007|NCT00960661|101111691|FG002|Interventional Phase|Adverse Event|8|||
33333008|NCT00960661|101111689|FG000|Interventional Phase|Death|0|||
33333009|NCT00960661|101111690|FG001|Interventional Phase|Death|1|||
33333010|NCT00960661|101111691|FG002|Interventional Phase|Death|0|||
33333011|NCT00960661|101111689|FG000|Interventional Phase|Lost to Follow-up|0|||
33333012|NCT00960661|101111690|FG001|Interventional Phase|Lost to Follow-up|0|||
33403103|NCT00129220|101365503|FG001|Study Period II|Entry Criteria Not Met|0|||
33403104|NCT00129220|101365504|FG002|Study Period II|Entry Criteria Not Met|2|||
33403105|NCT00129220|101365502|FG000|Study Period II|Protocol Violation|4|||
33403106|NCT00129220|101365503|FG001|Study Period II|Protocol Violation|2|||
33403107|NCT00129220|101365504|FG002|Study Period II|Protocol Violation|1|||
33333013|NCT00960661|101111691|FG002|Interventional Phase|Lost to Follow-up|2|||
33403108|NCT00129220|101365502|FG000|Study Period II|Physician Decision|0|||
33403109|NCT00129220|101365503|FG001|Study Period II|Physician Decision|1|||
33403110|NCT00129220|101365504|FG002|Study Period II|Physician Decision|0|||
33403111|NCT00129220|101365502|FG000|Study Period II|Withdrawal by Subject|1|||
33526980|NCT01831427|101827193|FG007|Overall Study|Adverse Event|1|||
33333014|NCT00960661|101111689|FG000|Interventional Phase|entry criteria not met|0|||
33403112|NCT00129220|101365503|FG001|Study Period II|Withdrawal by Subject|3|||
33403113|NCT00129220|101365504|FG002|Study Period II|Withdrawal by Subject|4|||
33403114|NCT00129220|101365502|FG000|Study Period II|Reason Not Specified|2|||
33403115|NCT00129220|101365503|FG001|Study Period II|Reason Not Specified|0|||
33403116|NCT00129220|101365504|FG002|Study Period II|Reason Not Specified|5|||
33403117|NCT00129220|101365502|FG000|Study Period III|Adverse Event|1|||
33403118|NCT00129220|101365503|FG001|Study Period III|Adverse Event|0|||
33526981|NCT01831427|101827194|FG008|Overall Study|Adverse Event|0|||
33526982|NCT01831427|101827195|FG009|Overall Study|Adverse Event|0|||
33526983|NCT01831427|101827196|FG010|Overall Study|Adverse Event|2|||
33526984|NCT01831427|101827186|FG000|Overall Study|Investigator's Discretion|0|||
33526985|NCT01831427|101827187|FG001|Overall Study|Investigator's Discretion|0|||
33526986|NCT01831427|101827188|FG002|Overall Study|Investigator's Discretion|0|||
33526987|NCT01831427|101827189|FG003|Overall Study|Investigator's Discretion|1|||
33526988|NCT01831427|101827190|FG004|Overall Study|Investigator's Discretion|0|||
33526989|NCT01831427|101827191|FG005|Overall Study|Investigator's Discretion|0|||
33526990|NCT01831427|101827192|FG006|Overall Study|Investigator's Discretion|0|||
33526991|NCT01831427|101827193|FG007|Overall Study|Investigator's Discretion|0|||
33526992|NCT01831427|101827194|FG008|Overall Study|Investigator's Discretion|0|||
33526993|NCT01831427|101827195|FG009|Overall Study|Investigator's Discretion|0|||
33526994|NCT01831427|101827196|FG010|Overall Study|Investigator's Discretion|0|||
33526995|NCT01831427|101827186|FG000|Overall Study|Withdrew Consent|0|||
33526996|NCT01831427|101827187|FG001|Overall Study|Withdrew Consent|0|||
33333015|NCT00960661|101111690|FG001|Interventional Phase|entry criteria not met|3|||
33333016|NCT00960661|101111691|FG002|Interventional Phase|entry criteria not met|0|||
33333017|NCT00960661|101111689|FG000|Interventional Phase|Protocol Violation|0|||
33333018|NCT00960661|101111690|FG001|Interventional Phase|Protocol Violation|7|||
33333019|NCT00960661|101111691|FG002|Interventional Phase|Protocol Violation|2|||
33333020|NCT00960661|101111689|FG000|Interventional Phase|Withdrawal by Subject|0|||
33333021|NCT00960661|101111690|FG001|Interventional Phase|Withdrawal by Subject|18|||
33333022|NCT00960661|101111691|FG002|Interventional Phase|Withdrawal by Subject|29|||
33333023|NCT00960661|101111689|FG000|Interventional Phase|Physician Decision|0|||
33333024|NCT00960661|101111690|FG001|Interventional Phase|Physician Decision|3|||
33333025|NCT00960661|101111691|FG002|Interventional Phase|Physician Decision|5|||
33333026|NCT00960661|101111689|FG000|Interventional Phase|sponsor decision|0|||
33333027|NCT00960661|101111690|FG001|Interventional Phase|sponsor decision|1|||
33333028|NCT00960661|101111691|FG002|Interventional Phase|sponsor decision|0|||
33333029|NCT00960661|101111689|FG000|Interventional Phase|Lack of Efficacy|0|||
33333030|NCT00960661|101111690|FG001|Interventional Phase|Lack of Efficacy|2|||
33333031|NCT00960661|101111691|FG002|Interventional Phase|Lack of Efficacy|0|||
33333032|NCT00971178|101111692|FG000|Overall Study|Lost to Follow-up|2|||
33333033|NCT00971178|101111693|FG001|Overall Study|Lost to Follow-up|2|||
33333034|NCT00971178|101111694|FG002|Overall Study|Lost to Follow-up|2|||
33333035|NCT03548935|101111695|FG000|Overall Study|Withdrawal by Subject|26|||
33333036|NCT03548935|101111696|FG001|Overall Study|Withdrawal by Subject|17|||
33333037|NCT03548935|101111695|FG000|Overall Study|Lost to Follow-up|39|||
33333038|NCT03548935|101111696|FG001|Overall Study|Lost to Follow-up|28|||
33333039|NCT03548935|101111695|FG000|Overall Study|Death|1|||
33333040|NCT03548935|101111696|FG001|Overall Study|Death|1|||
33333041|NCT01611974|101111701|FG000|Overall Study|Death|10|||
33333042|NCT01611974|101111702|FG001|Overall Study|Death|12|||
33333043|NCT01611974|101111703|FG002|Overall Study|Death|10|||
33333044|NCT01611974|101111701|FG000|Overall Study|Lost to Follow-up|0|||
33333045|NCT01611974|101111702|FG001|Overall Study|Lost to Follow-up|1|||
33333046|NCT01611974|101111703|FG002|Overall Study|Lost to Follow-up|0|||
33333047|NCT01611974|101111701|FG000|Overall Study|Physician Decision|5|||
33333048|NCT01611974|101111702|FG001|Overall Study|Physician Decision|1|||
33333049|NCT01611974|101111703|FG002|Overall Study|Physician Decision|2|||
33333050|NCT01611974|101111701|FG000|Overall Study|Withdrawal by Subject|0|||
33333051|NCT01611974|101111702|FG001|Overall Study|Withdrawal by Subject|1|||
33333052|NCT01611974|101111703|FG002|Overall Study|Withdrawal by Subject|4|||
33333053|NCT00535132|101111704|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
33333054|NCT00535132|101111705|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
33333055|NCT00535132|101111704|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
33333056|NCT00535132|101111705|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
33333057|NCT01157364|101111706|FG000|Overall Study|Other Reasons|1|||
33333058|NCT01157364|101111707|FG001|Overall Study|Other Reasons|1|||
33333059|NCT01157364|101111708|FG002|Overall Study|Other Reasons|2|||
33333060|NCT01157364|101111709|FG003|Overall Study|Other Reasons|1|||
33333061|NCT01157364|101111710|FG004|Overall Study|Other Reasons|0|||
33333062|NCT01157364|101111711|FG005|Overall Study|Other Reasons|0|||
33333063|NCT01157364|101111706|FG000|Overall Study|Personal Reasons|0|||
33333064|NCT01157364|101111707|FG001|Overall Study|Personal Reasons|2|||
33333065|NCT01157364|101111708|FG002|Overall Study|Personal Reasons|0|||
33333066|NCT01157364|101111709|FG003|Overall Study|Personal Reasons|0|||
33333067|NCT01157364|101111710|FG004|Overall Study|Personal Reasons|1|||
33333068|NCT01157364|101111711|FG005|Overall Study|Personal Reasons|1|||
33333069|NCT01157364|101111706|FG000|Overall Study|Lost to Follow-up|1|||
33333070|NCT01157364|101111707|FG001|Overall Study|Lost to Follow-up|0|||
33333071|NCT01157364|101111708|FG002|Overall Study|Lost to Follow-up|1|||
33333072|NCT01157364|101111709|FG003|Overall Study|Lost to Follow-up|0|||
33526997|NCT01831427|101827188|FG002|Overall Study|Withdrew Consent|0|||
33610528|NCT01727336|102123340|FG002|Part 2 Blinded|use of prohibited medications|0|||
33333073|NCT01157364|101111710|FG004|Overall Study|Lost to Follow-up|0|||
33526998|NCT01831427|101827189|FG003|Overall Study|Withdrew Consent|0|||
33526999|NCT01831427|101827190|FG004|Overall Study|Withdrew Consent|0|||
33527000|NCT01831427|101827191|FG005|Overall Study|Withdrew Consent|0|||
33527001|NCT01831427|101827192|FG006|Overall Study|Withdrew Consent|2|||
33527002|NCT01831427|101827193|FG007|Overall Study|Withdrew Consent|0|||
33527003|NCT01831427|101827194|FG008|Overall Study|Withdrew Consent|0|||
33527004|NCT01831427|101827195|FG009|Overall Study|Withdrew Consent|1|||
33527005|NCT01831427|101827196|FG010|Overall Study|Withdrew Consent|1|||
33527006|NCT00805129|101827202|FG000|Overall Study|Not treated|1|||
33527007|NCT03442088|101827203|FG000|Overall Study|Adverse Event|1|||
33527008|NCT03442088|101827203|FG000|Overall Study|Lack of Efficacy|2|||
33527009|NCT03442088|101827203|FG000|Overall Study|Lost to Follow-up|2|||
33527010|NCT02497404|101827204|FG000|Overall Study|Adverse Event|1|||
33527011|NCT05446142|101827205|FG000|Period 2|Adverse Event|1|||
33527012|NCT05446142|101827206|FG001|Period 2|Adverse Event|0|||
33527013|NCT05446142|101827207|FG002|Period 2|Adverse Event|0|||
33527014|NCT05446142|101827208|FG003|Period 2|Adverse Event|0|||
33527015|NCT05446142|101827209|FG004|Period 2|Adverse Event|0|||
33527016|NCT05446142|101827210|FG005|Period 2|Adverse Event|0|||
33527017|NCT02634801|101827211|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
33527018|NCT02634801|101827212|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
33527019|NCT02634801|101827213|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
33527020|NCT02634801|101827211|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
33527021|NCT02634801|101827212|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
33527022|NCT02634801|101827213|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
33527023|NCT02634801|101827211|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
33527024|NCT02634801|101827212|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
33527025|NCT02634801|101827213|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
33527026|NCT02634801|101827211|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
33527027|NCT02634801|101827212|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
33527028|NCT02634801|101827213|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
33527029|NCT02634801|101827211|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
33527030|NCT02634801|101827212|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
33527031|NCT02634801|101827213|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
33527032|NCT02634801|101827211|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
33527033|NCT02634801|101827212|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
33527034|NCT02634801|101827213|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
33527035|NCT02634801|101827211|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
33527036|NCT02634801|101827212|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
33527037|NCT02634801|101827213|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
33527038|NCT02634801|101827211|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
33527039|NCT02634801|101827212|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
33527040|NCT02634801|101827213|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
33527041|NCT02634801|101827211|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
33527042|NCT02634801|101827212|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
33527043|NCT02634801|101827213|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
33527044|NCT02634801|101827211|FG000|Follow-up Period|Lost to Follow-up|3|||
33527045|NCT02634801|101827212|FG001|Follow-up Period|Lost to Follow-up|1|||
33527046|NCT02634801|101827213|FG002|Follow-up Period|Lost to Follow-up|2|||
33527047|NCT02634801|101827211|FG000|Follow-up Period|Physician Decision|0|||
33527048|NCT02634801|101827212|FG001|Follow-up Period|Physician Decision|0|||
33527049|NCT02634801|101827213|FG002|Follow-up Period|Physician Decision|1|||
33527050|NCT02634801|101827211|FG000|Follow-up Period|Withdrawal by Subject|1|||
33527051|NCT02634801|101827212|FG001|Follow-up Period|Withdrawal by Subject|2|||
33527052|NCT02634801|101827213|FG002|Follow-up Period|Withdrawal by Subject|5|||
33527053|NCT02634801|101827211|FG000|Follow-up Period|Adverse Event|1|||
33527054|NCT02634801|101827212|FG001|Follow-up Period|Adverse Event|5|||
33527055|NCT02634801|101827213|FG002|Follow-up Period|Adverse Event|0|||
33527056|NCT00103662|101827215|FG000|Overall Study|Entered Rescue Procedure|0|||
33527057|NCT00103662|101827216|FG001|Overall Study|Entered Rescue Procedure|7|||
33527058|NCT00103662|101827215|FG000|Overall Study|Death|7|||
33527059|NCT00103662|101827216|FG001|Overall Study|Death|7|||
33527060|NCT00103662|101827215|FG000|Overall Study|Elective Withdrawal|5|||
33527061|NCT00103662|101827216|FG001|Overall Study|Elective Withdrawal|5|||
33527062|NCT00103662|101827215|FG000|Overall Study|Lost to Follow-up|0|||
33527063|NCT00103662|101827216|FG001|Overall Study|Lost to Follow-up|1|||
33527064|NCT00103662|101827215|FG000|Overall Study|Other|6|||
33333074|NCT01157364|101111711|FG005|Overall Study|Lost to Follow-up|0|||
33333075|NCT01157364|101111706|FG000|Overall Study|Lack of Efficacy|0|||
33333076|NCT01157364|101111707|FG001|Overall Study|Lack of Efficacy|0|||
33527065|NCT00103662|101827216|FG001|Overall Study|Other|9|||
33527066|NCT00103662|101827215|FG000|Overall Study|Failed mobilization|0|||
33527067|NCT00103662|101827216|FG001|Overall Study|Failed mobilization|4|||
33610529|NCT01727336|102123341|FG003|Part 2 Blinded|use of prohibited medications|0|||
33527068|NCT00103662|101827215|FG000|Overall Study|Intercurrent illness|1|||
33527069|NCT00103662|101827216|FG001|Overall Study|Intercurrent illness|0|||
33527070|NCT02781818|101827221|FG000|Overall Study|Lost to Follow-up|4|||
33527071|NCT02781818|101827222|FG001|Overall Study|Lost to Follow-up|2|||
33527072|NCT02781818|101827223|FG002|Overall Study|Lost to Follow-up|1|||
33527073|NCT04676724|101827226|FG000|Overall Study|Adverse Event|2|||
33527074|NCT04676724|101827227|FG001|Overall Study|Adverse Event|0|||
33527075|NCT04676724|101827226|FG000|Overall Study|Lost to Follow-up|1|||
33527076|NCT04676724|101827227|FG001|Overall Study|Lost to Follow-up|0|||
33527077|NCT04676724|101827226|FG000|Overall Study|Physician Decision|0|||
33527078|NCT04676724|101827227|FG001|Overall Study|Physician Decision|1|||
33527079|NCT04676724|101827226|FG000|Overall Study|Withdrawal by Subject|3|||
33527080|NCT04676724|101827227|FG001|Overall Study|Withdrawal by Subject|2|||
33527081|NCT01121263|101827232|FG000|Overall Study|Death|3|||
33527082|NCT01121263|101827233|FG001|Overall Study|Death|2|||
33527083|NCT01121263|101827232|FG000|Overall Study|Lost to Follow-up|22|||
33527084|NCT01121263|101827233|FG001|Overall Study|Lost to Follow-up|12|||
33527085|NCT01121263|101827232|FG000|Overall Study|Withdrawal by Subject|0|||
33527086|NCT01121263|101827233|FG001|Overall Study|Withdrawal by Subject|1|||
33527087|NCT05114564|101827237|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
33527088|NCT05114564|101827238|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
33527089|NCT05114564|101827237|FG000|First Intervention|Adverse Event|0|||
33527090|NCT05114564|101827238|FG001|First Intervention|Adverse Event|1|||
33527091|NCT02784288|101827240|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
33527092|NCT02683239|101827241|FG000|Overall Study|Protocol Violation|35|||
33527093|NCT02683239|101827242|FG001|Overall Study|Protocol Violation|23|||
33527094|NCT02683239|101827243|FG002|Overall Study|Protocol Violation|26|||
33527095|NCT02683239|101827244|FG003|Overall Study|Protocol Violation|4|||
33527096|NCT02683239|101827245|FG004|Overall Study|Protocol Violation|35|||
33527097|NCT02683239|101827246|FG005|Overall Study|Protocol Violation|4|||
33403119|NCT00129220|101365504|FG002|Study Period III|Adverse Event|3|||
33527098|NCT02683239|101827247|FG006|Overall Study|Protocol Violation|5|||
33527099|NCT02683239|101827241|FG000|Overall Study|Adverse Event|64|||
33527100|NCT02683239|101827242|FG001|Overall Study|Adverse Event|39|||
33527101|NCT02683239|101827243|FG002|Overall Study|Adverse Event|42|||
33527102|NCT02683239|101827244|FG003|Overall Study|Adverse Event|16|||
33527103|NCT02683239|101827245|FG004|Overall Study|Adverse Event|189|||
33527104|NCT02683239|101827246|FG005|Overall Study|Adverse Event|9|||
33333077|NCT01157364|101111708|FG002|Overall Study|Lack of Efficacy|0|||
33333078|NCT01157364|101111709|FG003|Overall Study|Lack of Efficacy|1|||
33333079|NCT01157364|101111710|FG004|Overall Study|Lack of Efficacy|0|||
33333080|NCT01157364|101111711|FG005|Overall Study|Lack of Efficacy|0|||
33333081|NCT01157364|101111706|FG000|Overall Study|Adverse Event|0|||
33333082|NCT01157364|101111707|FG001|Overall Study|Adverse Event|1|||
33333083|NCT01157364|101111708|FG002|Overall Study|Adverse Event|1|||
33333084|NCT01157364|101111709|FG003|Overall Study|Adverse Event|0|||
33333085|NCT01157364|101111710|FG004|Overall Study|Adverse Event|1|||
33333086|NCT01157364|101111711|FG005|Overall Study|Adverse Event|0|||
33333087|NCT00845650|101111712|FG000|Overall Study|Withdrawal by Subject|0|||
33333088|NCT00845650|101111713|FG001|Overall Study|Withdrawal by Subject|0|||
33333089|NCT00845650|101111714|FG002|Overall Study|Withdrawal by Subject|0|||
33333090|NCT00845650|101111715|FG003|Overall Study|Withdrawal by Subject|0|||
33333091|NCT00845650|101111716|FG004|Overall Study|Withdrawal by Subject|2|||
33333092|NCT00845650|101111717|FG005|Overall Study|Withdrawal by Subject|0|||
33333093|NCT00845650|101111712|FG000|Overall Study|Lost to Follow-up|0|||
33333094|NCT00845650|101111713|FG001|Overall Study|Lost to Follow-up|0|||
33333095|NCT00845650|101111714|FG002|Overall Study|Lost to Follow-up|3|||
33403120|NCT00129220|101365502|FG000|Study Period III|Protocol Violation|1|||
33403121|NCT00129220|101365503|FG001|Study Period III|Protocol Violation|1|||
33403122|NCT00129220|101365504|FG002|Study Period III|Protocol Violation|2|||
33403123|NCT00129220|101365502|FG000|Study Period III|Withdrawal by Subject|1|||
33403124|NCT00129220|101365503|FG001|Study Period III|Withdrawal by Subject|0|||
33403125|NCT00129220|101365504|FG002|Study Period III|Withdrawal by Subject|3|||
33527105|NCT02683239|101827247|FG006|Overall Study|Adverse Event|9|||
33527106|NCT02683239|101827241|FG000|Overall Study|Physician Decision|38|||
33527107|NCT02683239|101827242|FG001|Overall Study|Physician Decision|19|||
33527108|NCT02683239|101827243|FG002|Overall Study|Physician Decision|14|||
33527109|NCT02683239|101827244|FG003|Overall Study|Physician Decision|73|||
33527110|NCT02683239|101827245|FG004|Overall Study|Physician Decision|143|||
33333096|NCT00845650|101111715|FG003|Overall Study|Lost to Follow-up|1|||
33527111|NCT02683239|101827246|FG005|Overall Study|Physician Decision|14|||
33203416|NCT03701555|100645950|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
33333097|NCT00845650|101111716|FG004|Overall Study|Lost to Follow-up|0|||
33333098|NCT00845650|101111717|FG005|Overall Study|Lost to Follow-up|1|||
33333099|NCT00845650|101111712|FG000|Overall Study|Sponsor hold on dosing|0|||
33527112|NCT02683239|101827247|FG006|Overall Study|Physician Decision|15|||
33403126|NCT00129220|101365502|FG000|Study Period III|Sponsor Decision|1|||
33527113|NCT02683239|101827241|FG000|Overall Study|Withdrawal by Subject|187|||
33527114|NCT02683239|101827242|FG001|Overall Study|Withdrawal by Subject|99|||
33527115|NCT02683239|101827243|FG002|Overall Study|Withdrawal by Subject|91|||
33527116|NCT02683239|101827244|FG003|Overall Study|Withdrawal by Subject|18|||
33527117|NCT02683239|101827245|FG004|Overall Study|Withdrawal by Subject|248|||
33527118|NCT02683239|101827246|FG005|Overall Study|Withdrawal by Subject|22|||
33527119|NCT02683239|101827247|FG006|Overall Study|Withdrawal by Subject|28|||
33527120|NCT02683239|101827241|FG000|Overall Study|Lost to Follow-up|77|||
33527121|NCT02683239|101827242|FG001|Overall Study|Lost to Follow-up|24|||
33527122|NCT02683239|101827243|FG002|Overall Study|Lost to Follow-up|25|||
33527123|NCT02683239|101827244|FG003|Overall Study|Lost to Follow-up|7|||
33527124|NCT02683239|101827245|FG004|Overall Study|Lost to Follow-up|88|||
33527125|NCT02683239|101827246|FG005|Overall Study|Lost to Follow-up|8|||
33527126|NCT02683239|101827247|FG006|Overall Study|Lost to Follow-up|11|||
33527127|NCT02683239|101827241|FG000|Overall Study|Death|9|||
33527128|NCT02683239|101827242|FG001|Overall Study|Death|5|||
33527129|NCT02683239|101827243|FG002|Overall Study|Death|8|||
33527130|NCT02683239|101827244|FG003|Overall Study|Death|0|||
33527131|NCT02683239|101827245|FG004|Overall Study|Death|12|||
33527132|NCT02683239|101827246|FG005|Overall Study|Death|1|||
33527133|NCT02683239|101827247|FG006|Overall Study|Death|0|||
33527134|NCT02683239|101827241|FG000|Overall Study|Lack of Efficacy|50|||
33527135|NCT02683239|101827242|FG001|Overall Study|Lack of Efficacy|23|||
33527136|NCT02683239|101827243|FG002|Overall Study|Lack of Efficacy|12|||
33527137|NCT02683239|101827244|FG003|Overall Study|Lack of Efficacy|2|||
33527138|NCT02683239|101827245|FG004|Overall Study|Lack of Efficacy|29|||
33527139|NCT02683239|101827246|FG005|Overall Study|Lack of Efficacy|2|||
33527140|NCT02683239|101827247|FG006|Overall Study|Lack of Efficacy|3|||
33527141|NCT02683239|101827241|FG000|Overall Study|Missing data|0|||
33527142|NCT02683239|101827242|FG001|Overall Study|Missing data|1|||
33527143|NCT02683239|101827243|FG002|Overall Study|Missing data|1|||
33527144|NCT02683239|101827244|FG003|Overall Study|Missing data|0|||
33527145|NCT02683239|101827245|FG004|Overall Study|Missing data|1|||
33527146|NCT02683239|101827246|FG005|Overall Study|Missing data|0|||
33527147|NCT02683239|101827247|FG006|Overall Study|Missing data|0|||
33527148|NCT00385827|101827250|FG000|Part 1|Adverse Event|1|||
33527149|NCT00385827|101827251|FG001|Part 1|Adverse Event|0|||
33527150|NCT00385827|101827252|FG002|Part 1|Adverse Event|0|||
33527151|NCT00385827|101827250|FG000|Part 1|Death|2|||
33527152|NCT00385827|101827251|FG001|Part 1|Death|0|||
33527153|NCT00385827|101827252|FG002|Part 1|Death|0|||
33527154|NCT00385827|101827250|FG000|Part 1|Lack of Efficacy|5|||
33527155|NCT00385827|101827251|FG001|Part 1|Lack of Efficacy|0|||
33527156|NCT00385827|101827252|FG002|Part 1|Lack of Efficacy|0|||
33527157|NCT00385827|101827250|FG000|Part 1|Other|1|||
33527158|NCT00385827|101827251|FG001|Part 1|Other|0|||
33527159|NCT00385827|101827252|FG002|Part 1|Other|0|||
33203417|NCT03701555|100645951|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
33203418|NCT03701555|100645952|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
33203419|NCT03701555|100645953|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
33527160|NCT00385827|101827250|FG000|Part 2|Adverse Event|0|||
33527161|NCT00385827|101827251|FG001|Part 2|Adverse Event|6|||
33527162|NCT00385827|101827252|FG002|Part 2|Adverse Event|10|||
33527163|NCT00385827|101827250|FG000|Part 2|Death|0|||
33527164|NCT00385827|101827251|FG001|Part 2|Death|0|||
33527165|NCT00385827|101827252|FG002|Part 2|Death|2|||
33527166|NCT00385827|101827250|FG000|Part 2|Lack of Efficacy|0|||
33527167|NCT00385827|101827251|FG001|Part 2|Lack of Efficacy|14|||
33527168|NCT00385827|101827252|FG002|Part 2|Lack of Efficacy|13|||
33527169|NCT00385827|101827250|FG000|Part 2|Randomized but not treated|0|||
33203420|NCT03701555|100645954|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
33403127|NCT00129220|101365503|FG001|Study Period III|Sponsor Decision|0|||
33403128|NCT00129220|101365504|FG002|Study Period III|Sponsor Decision|0|||
33527170|NCT00385827|101827251|FG001|Part 2|Randomized but not treated|2|||
33527171|NCT00385827|101827252|FG002|Part 2|Randomized but not treated|2|||
33527172|NCT00385827|101827250|FG000|Part 2|Other|0|||
33527173|NCT00385827|101827251|FG001|Part 2|Other|11|||
33527174|NCT00385827|101827252|FG002|Part 2|Other|21|||
33527175|NCT03743025|101827253|FG000|Overall Study|Surgery was cancelled|2|||
33527176|NCT03743025|101827254|FG001|Overall Study|Surgery was cancelled|1|||
33527177|NCT02144077|101827256|FG000|Overall Study|Withdrawal by Subject|3|||
33527178|NCT02144077|101827257|FG001|Overall Study|Withdrawal by Subject|3|||
33527179|NCT02144077|101827256|FG000|Overall Study|Adverse Event|2|||
33527180|NCT02144077|101827257|FG001|Overall Study|Adverse Event|3|||
33527181|NCT02144077|101827256|FG000|Overall Study|Lost to Follow-up|2|||
33527182|NCT02144077|101827257|FG001|Overall Study|Lost to Follow-up|2|||
33527183|NCT02144077|101827256|FG000|Overall Study|Protocol Violation|1|||
33527184|NCT02144077|101827257|FG001|Overall Study|Protocol Violation|2|||
33527185|NCT02144077|101827256|FG000|Overall Study|Death|0|||
33527186|NCT02144077|101827257|FG001|Overall Study|Death|1|||
33527187|NCT02144077|101827256|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
33527188|NCT02144077|101827257|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
33527189|NCT02401035|101827258|FG000|Overall Study|Withdrawal by Subject|1|||
33527190|NCT02401035|101827259|FG001|Overall Study|Withdrawal by Subject|0|||
33527191|NCT00734656|101827263|FG000|Lab Session 1|Withdrawal by Subject|2|||
33527192|NCT00734656|101827264|FG001|Lab Session 1|Withdrawal by Subject|0|||
33527193|NCT00734656|101827265|FG002|Lab Session 1|Withdrawal by Subject|0|||
33527194|NCT00734656|101827266|FG003|Lab Session 1|Withdrawal by Subject|0|||
33527195|NCT00734656|101827263|FG000|Washout 1|Withdrawal by Subject|1|||
33527196|NCT00734656|101827264|FG001|Washout 1|Withdrawal by Subject|5|||
33527197|NCT00734656|101827265|FG002|Washout 1|Withdrawal by Subject|2|||
33527198|NCT00734656|101827266|FG003|Washout 1|Withdrawal by Subject|3|||
33527199|NCT00734656|101827263|FG000|Lab Session 2|Withdrawal by Subject|1|||
33527200|NCT00734656|101827264|FG001|Lab Session 2|Withdrawal by Subject|0|||
33527201|NCT00734656|101827265|FG002|Lab Session 2|Withdrawal by Subject|0|||
33527202|NCT00734656|101827266|FG003|Lab Session 2|Withdrawal by Subject|1|||
33527203|NCT00734656|101827263|FG000|Washout 2|Withdrawal by Subject|1|||
33527204|NCT00734656|101827264|FG001|Washout 2|Withdrawal by Subject|1|||
33527205|NCT00734656|101827265|FG002|Washout 2|Withdrawal by Subject|1|||
33527206|NCT00734656|101827266|FG003|Washout 2|Withdrawal by Subject|0|||
33527207|NCT00734656|101827263|FG000|Washout 3|Withdrawal by Subject|1|||
33527208|NCT00734656|101827264|FG001|Washout 3|Withdrawal by Subject|0|||
33527209|NCT00734656|101827265|FG002|Washout 3|Withdrawal by Subject|0|||
33527210|NCT00734656|101827266|FG003|Washout 3|Withdrawal by Subject|1|||
33527211|NCT00734656|101827263|FG000|Lab Session 4|Withdrawal by Subject|0|||
33527212|NCT00734656|101827264|FG001|Lab Session 4|Withdrawal by Subject|0|||
33527213|NCT00734656|101827265|FG002|Lab Session 4|Withdrawal by Subject|0|||
33527214|NCT00734656|101827266|FG003|Lab Session 4|Withdrawal by Subject|1|||
33527215|NCT02815267|101827270|FG000|Double-Blind Phase|Adverse Event|0|||
33527216|NCT02815267|101827271|FG001|Double-Blind Phase|Adverse Event|3|||
33527217|NCT02815267|101827270|FG000|Double-Blind Phase|Lost to Follow-up|17|||
33527218|NCT02815267|101827271|FG001|Double-Blind Phase|Lost to Follow-up|9|||
33527219|NCT02815267|101827270|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
33527220|NCT02815267|101827271|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
33527221|NCT02815267|101827270|FG000|Double-Blind Phase|Protocol Violation|3|||
33527222|NCT02815267|101827271|FG001|Double-Blind Phase|Protocol Violation|2|||
33527223|NCT02815267|101827270|FG000|Double-Blind Phase|Site withdrawal|1|||
33527224|NCT02815267|101827271|FG001|Double-Blind Phase|Site withdrawal|6|||
33527225|NCT02815267|101827270|FG000|Double-Blind Phase|Received a disallowed medication|1|||
33527226|NCT02815267|101827271|FG001|Double-Blind Phase|Received a disallowed medication|1|||
33527227|NCT02815267|101827270|FG000|Open-Label Phase|Adverse Event|1|||
33527228|NCT02815267|101827271|FG001|Open-Label Phase|Adverse Event|1|||
33527229|NCT02815267|101827270|FG000|Open-Label Phase|Lost to Follow-up|23|||
33527230|NCT02815267|101827271|FG001|Open-Label Phase|Lost to Follow-up|9|||
33527231|NCT02815267|101827270|FG000|Open-Label Phase|Withdrawal by Subject|24|||
33527232|NCT02815267|101827271|FG001|Open-Label Phase|Withdrawal by Subject|13|||
33527233|NCT02815267|101827270|FG000|Open-Label Phase|Protocol Violation|0|||
33203421|NCT03701555|100645955|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
33203422|NCT03701555|100645956|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
33203423|NCT03701555|100645957|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
33203424|NCT03701555|100645958|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
33203425|NCT03701555|100645959|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
33203426|NCT03701555|100645924|FG000|Part 2 (Day 1)|Other|0|||
33203427|NCT03701555|100645925|FG001|Part 2 (Day 1)|Other|0|||
33203428|NCT03701555|100645926|FG002|Part 2 (Day 1)|Other|0|||
33203429|NCT03701555|100645927|FG003|Part 2 (Day 1)|Other|0|||
33203430|NCT03701555|100645928|FG004|Part 2 (Day 1)|Other|0|||
33203431|NCT03701555|100645929|FG005|Part 2 (Day 1)|Other|0|||
33203432|NCT03701555|100645930|FG006|Part 2 (Day 1)|Other|0|||
33203433|NCT03701555|100645931|FG007|Part 2 (Day 1)|Other|0|||
33203434|NCT03701555|100645932|FG008|Part 2 (Day 1)|Other|0|||
33203435|NCT03701555|100645933|FG009|Part 2 (Day 1)|Other|0|||
33203436|NCT03701555|100645934|FG010|Part 2 (Day 1)|Other|3|||
33203437|NCT03701555|100645935|FG011|Part 2 (Day 1)|Other|1|||
33203438|NCT03701555|100645936|FG012|Part 2 (Day 1)|Other|0|||
33403129|NCT00129220|101365502|FG000|Study Period III|Reason Not Specified|9|||
33403130|NCT00129220|101365503|FG001|Study Period III|Reason Not Specified|0|||
33527234|NCT02815267|101827271|FG001|Open-Label Phase|Protocol Violation|1|||
33527235|NCT02815267|101827270|FG000|Open-Label Phase|Administrative|21|||
33527236|NCT02815267|101827271|FG001|Open-Label Phase|Administrative|12|||
33527237|NCT02815267|101827270|FG000|Open-Label Phase|Other|2|||
33527238|NCT02815267|101827271|FG001|Open-Label Phase|Other|5|||
33527239|NCT01310127|101827274|FG000|Overall Study|Protocol Violation|1|||
33527240|NCT01310127|101827275|FG001|Overall Study|Protocol Violation|1|||
33527241|NCT01310127|101827274|FG000|Overall Study|advanced psc cataract outlier|1|||
33527242|NCT01310127|101827275|FG001|Overall Study|advanced psc cataract outlier|0|||
33527243|NCT03883477|101827276|FG000|Overall Study|Death|1|||
33527244|NCT03883477|101827277|FG001|Overall Study|Death|0|||
33527245|NCT03883477|101827276|FG000|Overall Study|Protocol Violation|0|||
33203439|NCT03701555|100645937|FG013|Part 2 (Day 1)|Other|1|||
33203440|NCT03701555|100645938|FG014|Part 2 (Day 1)|Other|0|||
33203441|NCT03701555|100645939|FG015|Part 2 (Day 1)|Other|2|||
33203442|NCT03701555|100645940|FG016|Part 2 (Day 1)|Other|2|||
33527246|NCT03883477|101827277|FG001|Overall Study|Protocol Violation|1|||
33527247|NCT03374488|101827284|FG000|Overall Study|Death|13|||
33527248|NCT03374488|101827285|FG001|Overall Study|Death|13|||
33527249|NCT03374488|101827284|FG000|Overall Study|Withdrawal by Subject|3|||
33610530|NCT01727336|102123342|FG004|Part 2 Blinded|use of prohibited medications|1|||
33610531|NCT01727336|102123343|FG005|Part 2 Blinded|use of prohibited medications|3|||
33610532|NCT01534195|102123348|FG000|Overall Study|Withdrawal by Subject|1|||
33610533|NCT01534195|102123349|FG001|Overall Study|Withdrawal by Subject|1|||
33610534|NCT03235089|102123351|FG000|Overall Study|Lost to Follow-up|1|||
33527250|NCT03374488|101827285|FG001|Overall Study|Withdrawal by Subject|1|||
33527251|NCT03374488|101827284|FG000|Overall Study|Physician Decision|3|||
33527252|NCT03374488|101827285|FG001|Overall Study|Physician Decision|0|||
33527253|NCT02081001|101827288|FG000|Overall Study|Adverse Event|0|||
33527254|NCT02081001|101827289|FG001|Overall Study|Adverse Event|0|||
33527255|NCT02081001|101827290|FG002|Overall Study|Adverse Event|0|||
33527256|NCT02081001|101827291|FG003|Overall Study|Adverse Event|0|||
33527257|NCT02081001|101827292|FG004|Overall Study|Adverse Event|1|||
33527258|NCT02081001|101827293|FG005|Overall Study|Adverse Event|0|||
33527259|NCT02081001|101827294|FG006|Overall Study|Adverse Event|0|||
33527260|NCT02081001|101827295|FG007|Overall Study|Adverse Event|0|||
33527261|NCT02081001|101827296|FG008|Overall Study|Adverse Event|0|||
33527262|NCT02081001|101827297|FG009|Overall Study|Adverse Event|0|||
33527263|NCT02081001|101827298|FG010|Overall Study|Adverse Event|0|||
33527264|NCT02081001|101827299|FG011|Overall Study|Adverse Event|0|||
33527265|NCT01931397|101827300|FG000|Overall Study|Physician Decision|2|||
33527266|NCT01931397|101827300|FG000|Overall Study|Withdrawal by Subject|8|||
33527267|NCT01931397|101827300|FG000|Overall Study|moved out of state|1|||
33527268|NCT03272347|101827301|FG000|Overall Study|Death|0|||
33527269|NCT03272347|101827302|FG001|Overall Study|Death|0|||
33527270|NCT03272347|101827303|FG002|Overall Study|Death|0|||
33527271|NCT03272347|101827304|FG003|Overall Study|Death|1|||
33527272|NCT03272347|101827301|FG000|Overall Study|Lost to Follow-up|1|||
33527273|NCT03272347|101827302|FG001|Overall Study|Lost to Follow-up|3|||
33527274|NCT03272347|101827303|FG002|Overall Study|Lost to Follow-up|5|||
33527275|NCT03272347|101827304|FG003|Overall Study|Lost to Follow-up|1|||
33527276|NCT03272347|101827301|FG000|Overall Study|Physician Decision|4|||
33527277|NCT03272347|101827302|FG001|Overall Study|Physician Decision|2|||
33527278|NCT03272347|101827303|FG002|Overall Study|Physician Decision|5|||
33527279|NCT03272347|101827304|FG003|Overall Study|Physician Decision|4|||
33527280|NCT03272347|101827301|FG000|Overall Study|Screen Failure|1|||
33527281|NCT03272347|101827302|FG001|Overall Study|Screen Failure|0|||
33527282|NCT03272347|101827303|FG002|Overall Study|Screen Failure|0|||
33527283|NCT03272347|101827304|FG003|Overall Study|Screen Failure|0|||
33203443|NCT03701555|100645941|FG017|Part 2 (Day 1)|Other|0|||
33203444|NCT03701555|100645942|FG018|Part 2 (Day 1)|Other|0|||
33203445|NCT03701555|100645943|FG019|Part 2 (Day 1)|Other|0|||
33203446|NCT03701555|100645944|FG020|Part 2 (Day 1)|Other|0|||
33203447|NCT03701555|100645945|FG021|Part 2 (Day 1)|Other|0|||
33203448|NCT03701555|100645946|FG022|Part 2 (Day 1)|Other|0|||
33203449|NCT03701555|100645947|FG023|Part 2 (Day 1)|Other|0|||
33527284|NCT03272347|101827301|FG000|Overall Study|Withdrawal by Subject|5|||
33527285|NCT03272347|101827302|FG001|Overall Study|Withdrawal by Subject|1|||
33203450|NCT03701555|100645948|FG024|Part 2 (Day 1)|Other|0|||
33203451|NCT03701555|100645949|FG025|Part 2 (Day 1)|Other|0|||
33527286|NCT03272347|101827303|FG002|Overall Study|Withdrawal by Subject|2|||
33527287|NCT03272347|101827304|FG003|Overall Study|Withdrawal by Subject|1|||
33527288|NCT02532283|101827308|FG000|Overall Study|Adverse Event|0|||
33527289|NCT02532283|101827309|FG001|Overall Study|Adverse Event|1|||
33527290|NCT02532283|101827308|FG000|Overall Study|Death|1|||
33527291|NCT02532283|101827309|FG001|Overall Study|Death|0|||
33527292|NCT02532283|101827308|FG000|Overall Study|Lost to Follow-up|0|||
33527293|NCT02532283|101827309|FG001|Overall Study|Lost to Follow-up|1|||
33527294|NCT02532283|101827308|FG000|Overall Study|Withdrawal by Subject|8|||
33610535|NCT03235089|102123352|FG001|Overall Study|Lost to Follow-up|1|||
33610536|NCT03235089|102123351|FG000|Overall Study|Physician Decision|2|||
33527295|NCT02532283|101827309|FG001|Overall Study|Withdrawal by Subject|3|||
33527296|NCT03134911|101827310|FG000|Overall Study|Screen failure|31|||
33203452|NCT03701555|100645950|FG026|Part 2 (Day 1)|Other|0|||
33203453|NCT03701555|100645951|FG027|Part 2 (Day 1)|Other|0|||
33203454|NCT03701555|100645952|FG028|Part 2 (Day 1)|Other|0|||
33203455|NCT03701555|100645953|FG029|Part 2 (Day 1)|Other|0|||
33527297|NCT03134911|101827310|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
33527298|NCT02903420|101827311|FG000|Overall Study|Death|3|||
33527299|NCT00547157|101827312|FG000|Overall Study|Other|1|||
33527300|NCT00547157|101827313|FG001|Overall Study|Other|0|||
33527301|NCT00547157|101827312|FG000|Overall Study|Death|38|||
33527302|NCT00547157|101827313|FG001|Overall Study|Death|18|||
33527303|NCT00547157|101827312|FG000|Overall Study|Withdrawal by Subject|3|||
33527304|NCT00547157|101827313|FG001|Overall Study|Withdrawal by Subject|1|||
33527305|NCT00547157|101827312|FG000|Overall Study|Administrative decision|3|||
33527306|NCT00547157|101827313|FG001|Overall Study|Administrative decision|2|||
33527307|NCT00547157|101827312|FG000|Overall Study|Lost to Follow-up|4|||
33527308|NCT00547157|101827313|FG001|Overall Study|Lost to Follow-up|2|||
33527309|NCT00070564|101827314|FG000|Overall Study|Progression|2|||
33527310|NCT00070564|101827315|FG001|Overall Study|Progression|4|||
33527311|NCT00070564|101827316|FG002|Overall Study|Progression|7|||
33527312|NCT00070564|101827317|FG003|Overall Study|Progression|7|||
33527313|NCT00070564|101827318|FG004|Overall Study|Progression|1|||
33527314|NCT00070564|101827319|FG005|Overall Study|Progression|0|||
33527315|NCT00070564|101827314|FG000|Overall Study|Delinquent|1|||
33527316|NCT00070564|101827315|FG001|Overall Study|Delinquent|4|||
33527317|NCT00070564|101827316|FG002|Overall Study|Delinquent|2|||
33527318|NCT00070564|101827317|FG003|Overall Study|Delinquent|0|||
33527319|NCT00070564|101827318|FG004|Overall Study|Delinquent|0|||
33527320|NCT00070564|101827319|FG005|Overall Study|Delinquent|0|||
33527321|NCT00070564|101827314|FG000|Overall Study|Adverse Event|150|||
33527322|NCT00070564|101827315|FG001|Overall Study|Adverse Event|142|||
33527323|NCT00070564|101827316|FG002|Overall Study|Adverse Event|120|||
33527324|NCT00070564|101827317|FG003|Overall Study|Adverse Event|108|||
33527325|NCT00070564|101827318|FG004|Overall Study|Adverse Event|63|||
33527326|NCT00070564|101827319|FG005|Overall Study|Adverse Event|36|||
33527327|NCT00070564|101827314|FG000|Overall Study|Death|4|||
33527328|NCT00070564|101827315|FG001|Overall Study|Death|1|||
33527329|NCT00070564|101827316|FG002|Overall Study|Death|5|||
33527330|NCT00070564|101827317|FG003|Overall Study|Death|3|||
33527331|NCT00070564|101827318|FG004|Overall Study|Death|0|||
33527332|NCT00070564|101827319|FG005|Overall Study|Death|1|||
33527333|NCT00070564|101827314|FG000|Overall Study|Other, not protocol specified|17|||
33527334|NCT00070564|101827315|FG001|Overall Study|Other, not protocol specified|15|||
33527335|NCT00070564|101827316|FG002|Overall Study|Other, not protocol specified|14|||
33527336|NCT00070564|101827317|FG003|Overall Study|Other, not protocol specified|19|||
33527337|NCT00070564|101827318|FG004|Overall Study|Other, not protocol specified|6|||
33527338|NCT00070564|101827319|FG005|Overall Study|Other, not protocol specified|7|||
33527339|NCT00070564|101827314|FG000|Overall Study|Withdrawal by Subject|26|||
33527340|NCT00070564|101827315|FG001|Overall Study|Withdrawal by Subject|37|||
33527341|NCT00070564|101827316|FG002|Overall Study|Withdrawal by Subject|23|||
33527342|NCT00070564|101827317|FG003|Overall Study|Withdrawal by Subject|30|||
33527343|NCT00070564|101827318|FG004|Overall Study|Withdrawal by Subject|8|||
33527344|NCT00070564|101827319|FG005|Overall Study|Withdrawal by Subject|8|||
33527345|NCT00070564|101827314|FG000|Overall Study|Not reported|0|||
33527346|NCT00070564|101827315|FG001|Overall Study|Not reported|0|||
33527347|NCT00070564|101827316|FG002|Overall Study|Not reported|0|||
33527348|NCT00070564|101827317|FG003|Overall Study|Not reported|0|||
33527349|NCT00070564|101827318|FG004|Overall Study|Not reported|1|||
33527350|NCT00070564|101827319|FG005|Overall Study|Not reported|0|||
33527351|NCT02849704|101827323|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
33527352|NCT02849704|101827324|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
33527353|NCT02849704|101827323|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
33527354|NCT02849704|101827324|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
33527355|NCT02849704|101827323|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
33527356|NCT02849704|101827324|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
33527357|NCT02500719|101827327|FG000|Overall Study|Lost to Follow-up|2|||
33527358|NCT02500719|101827328|FG001|Overall Study|Lost to Follow-up|3|||
33527359|NCT02500719|101827327|FG000|Overall Study|Trauma history|1|||
33527360|NCT02500719|101827328|FG001|Overall Study|Trauma history|0|||
33527361|NCT02500719|101827327|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
33527362|NCT02500719|101827328|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
33527363|NCT02500719|101827327|FG000|Overall Study|Did not meet criteria for PTSD|0|||
33527364|NCT02500719|101827328|FG001|Overall Study|Did not meet criteria for PTSD|1|||
33527365|NCT02500719|101827327|FG000|Overall Study|Claustrophobia|0|||
33527366|NCT02500719|101827328|FG001|Overall Study|Claustrophobia|1|||
33527367|NCT02500719|101827327|FG000|Overall Study|History of head trauma|0|||
33333100|NCT00845650|101111713|FG001|Overall Study|Sponsor hold on dosing|0|||
33527368|NCT02500719|101827328|FG001|Overall Study|History of head trauma|1|||
33527369|NCT01502956|101827331|FG000|Overall Study|Death|0|||
33527370|NCT01502956|101827332|FG001|Overall Study|Death|2|||
33527371|NCT01502956|101827331|FG000|Overall Study|Lost to Follow-up|14|||
33527372|NCT01502956|101827332|FG001|Overall Study|Lost to Follow-up|11|||
33527373|NCT01502956|101827331|FG000|Overall Study|Physician Decision|2|||
33527374|NCT01502956|101827332|FG001|Overall Study|Physician Decision|3|||
33527375|NCT01502956|101827331|FG000|Overall Study|Withdrawal by Subject|8|||
33527376|NCT01502956|101827332|FG001|Overall Study|Withdrawal by Subject|10|||
33527377|NCT04153565|101827333|FG000|Overall Study|Death|13|||
33527378|NCT01639703|101827334|FG000|Overall Study|Withdrawal by Subject|5|||
33527379|NCT01639703|101827334|FG000|Overall Study|Other reason|7|||
33527380|NCT00985686|101827342|FG000|Overall Study|Lost to Follow-up|1|||
33527381|NCT00985686|101827343|FG001|Overall Study|Lost to Follow-up|1|||
33527382|NCT00985686|101827344|FG002|Overall Study|Lost to Follow-up|0|||
33527383|NCT00985686|101827345|FG003|Overall Study|Lost to Follow-up|2|||
33527384|NCT00186485|101827346|FG000|Overall Study|Lost to Follow-up|3|||
33527385|NCT03334188|101827347|FG000|Overall Study|Withdrawal by Subject|0|||
33527386|NCT03334188|101827348|FG001|Overall Study|Withdrawal by Subject|1|||
33527387|NCT03334188|101827347|FG000|Overall Study|Death|1|||
33527388|NCT03334188|101827348|FG001|Overall Study|Death|0|||
33527389|NCT03334188|101827347|FG000|Overall Study|Never had qualifying clinic visit|7|||
33527390|NCT03334188|101827348|FG001|Overall Study|Never had qualifying clinic visit|7|||
33527391|NCT04003623|101827351|FG000|Overall Study|Withdrawal by Subject|1|||
33527392|NCT04003623|101827352|FG001|Overall Study|Withdrawal by Subject|0|||
33527393|NCT01744483|101827353|FG000|Overall Study|Death|9|||
33527394|NCT01744483|101827354|FG001|Overall Study|Death|4|||
33527395|NCT01744483|101827355|FG002|Overall Study|Death|11|||
33527396|NCT01744483|101827353|FG000|Overall Study|Lost to Follow-up|8|||
33527397|NCT01744483|101827354|FG001|Overall Study|Lost to Follow-up|9|||
33527398|NCT01744483|101827355|FG002|Overall Study|Lost to Follow-up|11|||
33527399|NCT01744483|101827353|FG000|Overall Study|Protocol Violation|1|||
33527400|NCT01744483|101827354|FG001|Overall Study|Protocol Violation|2|||
33527401|NCT01744483|101827355|FG002|Overall Study|Protocol Violation|1|||
33527402|NCT01744483|101827353|FG000|Overall Study|Withdrawal by Subject|4|||
33527403|NCT01744483|101827354|FG001|Overall Study|Withdrawal by Subject|6|||
33527404|NCT01744483|101827355|FG002|Overall Study|Withdrawal by Subject|2|||
33527405|NCT01744483|101827353|FG000|Overall Study|No ICU Admit|5|||
33527406|NCT01744483|101827354|FG001|Overall Study|No ICU Admit|1|||
33527407|NCT01744483|101827355|FG002|Overall Study|No ICU Admit|2|||
33527408|NCT01744483|101827353|FG000|Overall Study|Routed to OSH|2|||
33527409|NCT01744483|101827354|FG001|Overall Study|Routed to OSH|0|||
33527410|NCT01744483|101827355|FG002|Overall Study|Routed to OSH|1|||
33527411|NCT00199849|101827358|FG000|Overall Study|Unrelated illness or complication|0|||
33527412|NCT00199849|101827359|FG001|Overall Study|Unrelated illness or complication|1|||
33527413|NCT00199849|101827360|FG002|Overall Study|Unrelated illness or complication|0|||
33527414|NCT00199849|101827358|FG000|Overall Study|Progressive disease requiring intervention|0|||
33527415|NCT00199849|101827359|FG001|Overall Study|Progressive disease requiring intervention|0|||
33527416|NCT00199849|101827360|FG002|Overall Study|Progressive disease requiring intervention|1|||
33527417|NCT00199849|101827358|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
33527418|NCT00199849|101827359|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
33527419|NCT00199849|101827360|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
33527420|NCT02308228|101827366|FG000|Overall Study|Adverse Event|3|||
33527421|NCT02308228|101827367|FG001|Overall Study|Adverse Event|4|||
33527422|NCT02308228|101827366|FG000|Overall Study|Withdrawal by Subject|5|||
33527423|NCT02308228|101827367|FG001|Overall Study|Withdrawal by Subject|3|||
33527424|NCT00885378|101827371|FG000|Overall Study|Lack of Efficacy|2|||
33527425|NCT00885378|101827372|FG001|Overall Study|Lack of Efficacy|2|||
33527426|NCT00885378|101827371|FG000|Overall Study|Withdrawal by Subject|1|||
33527427|NCT00885378|101827372|FG001|Overall Study|Withdrawal by Subject|2|||
33527428|NCT00885378|101827371|FG000|Overall Study|Lost to Follow-up|1|||
33527429|NCT00885378|101827372|FG001|Overall Study|Lost to Follow-up|2|||
33527430|NCT00885378|101827371|FG000|Overall Study|Poor/Noncompliance|2|||
33527431|NCT00885378|101827372|FG001|Overall Study|Poor/Noncompliance|2|||
33527432|NCT00885378|101827371|FG000|Overall Study|Protocol Violation|2|||
33527433|NCT00885378|101827372|FG001|Overall Study|Protocol Violation|0|||
33527434|NCT04446429|101827373|FG000|Overall Study|Lost to Follow-up|6|||
33527435|NCT04446429|101827374|FG001|Overall Study|Lost to Follow-up|0|||
33527436|NCT01962948|101827382|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
33527437|NCT01962948|101827383|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
33527438|NCT01962948|101827384|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
33527439|NCT01962948|101827385|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
33527440|NCT03465709|101827387|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
33527441|NCT03465709|101827387|FG000|Overall Study|Withdrawal by Subject|3|||
33527442|NCT01808222|101827391|FG000|Overall Study|mpMR scan was not performed|1|||
33527443|NCT01563913|101827393|FG000|Overall Study|Physician Decision|1|||
33527444|NCT01563913|101827394|FG001|Overall Study|Physician Decision|0|||
33527445|NCT01563913|101827393|FG000|Overall Study|Spouse Passed Away|1|||
33527446|NCT01563913|101827394|FG001|Overall Study|Spouse Passed Away|0|||
33527447|NCT03246061|101827395|FG000|Overall Study|Still in follow-up|15|||
33527448|NCT03246061|101827396|FG001|Overall Study|Still in follow-up|21|||
33527449|NCT00824655|101827397|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
33527450|NCT00824655|101827398|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
33527451|NCT00824655|101827397|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
33527452|NCT00824655|101827398|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
33610537|NCT03235089|102123352|FG001|Overall Study|Physician Decision|2|||
33610538|NCT01563172|102123353|FG000|Overall Study|Adverse Event|5|||
33610539|NCT01563172|102123353|FG000|Overall Study|Lost to Follow-up|2|||
33610540|NCT01563172|102123353|FG000|Overall Study|Other (Protocol deviation)|5|||
33610541|NCT01563172|102123353|FG000|Overall Study|Other (Not specified)|1|||
33610542|NCT04369950|102123354|FG000|Overall Study|Protocol Violation|2|||
33610543|NCT04369950|102123355|FG001|Overall Study|Protocol Violation|2|||
33610544|NCT01912339|102123356|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
33610545|NCT01912339|102123357|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
33610546|NCT01912339|102123358|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
33610547|NCT01912339|102123356|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
33610548|NCT01912339|102123357|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
33610549|NCT01912339|102123358|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
33610550|NCT01912339|102123356|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
33610551|NCT01912339|102123357|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
33610552|NCT01912339|102123358|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
33610553|NCT01912339|102123356|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
33203456|NCT03701555|100645954|FG030|Part 2 (Day 1)|Other|0|||
33333101|NCT00845650|101111714|FG002|Overall Study|Sponsor hold on dosing|0|||
33527453|NCT01980628|101827408|FG000|Overall Study|Adverse Event|12|||
33527454|NCT01980628|101827408|FG000|Overall Study|Physician Decision|5|||
33527455|NCT01980628|101827408|FG000|Overall Study|Withdrawal by Subject|4|||
33527456|NCT01980628|101827408|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
33527457|NCT04999085|101830249|FG000|Overall Study|Death|1|||
33527458|NCT04754542|101830250|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
33527459|NCT04754542|101830251|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
33527460|NCT03373760|101830252|FG000|Overall Study|Adverse Event|8|||
33610554|NCT01912339|102123357|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
33610555|NCT01912339|102123358|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
33610556|NCT01912339|102123356|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
33610557|NCT01912339|102123357|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
33610558|NCT01912339|102123358|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
33610559|NCT01912339|102123356|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
33610560|NCT01912339|102123357|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
33610561|NCT01912339|102123358|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
33610562|NCT01912339|102123356|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
33527461|NCT03373760|101830252|FG000|Overall Study|Disease Progression|46|||
33203457|NCT03701555|100645955|FG031|Part 2 (Day 1)|Other|0|||
33203458|NCT03701555|100645956|FG032|Part 2 (Day 1)|Other|0|||
33203459|NCT03701555|100645957|FG033|Part 2 (Day 1)|Other|0|||
33203460|NCT03701555|100645958|FG034|Part 2 (Day 1)|Other|0|||
33203461|NCT03701555|100645959|FG035|Part 2 (Day 1)|Other|0|||
33203462|NCT03701555|100645924|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
33203463|NCT03701555|100645925|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
33203464|NCT03701555|100645926|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
33203465|NCT03701555|100645927|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
33203466|NCT03701555|100645928|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
33203467|NCT03701555|100645929|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
33203468|NCT03701555|100645930|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
33203469|NCT03701555|100645931|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
33203470|NCT03701555|100645932|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
33203471|NCT03701555|100645933|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
33203472|NCT03701555|100645934|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
33203473|NCT03701555|100645935|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
33203474|NCT03701555|100645936|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
33203475|NCT03701555|100645937|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
33203476|NCT03701555|100645938|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
33203477|NCT03701555|100645939|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
33203478|NCT03701555|100645940|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
33203479|NCT03701555|100645941|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
33203480|NCT03701555|100645942|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
33203481|NCT03701555|100645943|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
33203482|NCT03701555|100645944|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
33203483|NCT03701555|100645945|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
33203484|NCT03701555|100645946|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
33203485|NCT03701555|100645947|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
33203486|NCT03701555|100645948|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
33203487|NCT03701555|100645949|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
33203488|NCT03701555|100645950|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
33203489|NCT03701555|100645951|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
33203490|NCT03701555|100645952|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
33333102|NCT00845650|101111715|FG003|Overall Study|Sponsor hold on dosing|0|||
33333103|NCT00845650|101111716|FG004|Overall Study|Sponsor hold on dosing|1|||
33333104|NCT00845650|101111717|FG005|Overall Study|Sponsor hold on dosing|1|||
33333105|NCT00845650|101111712|FG000|Overall Study|Unable to access IV line|1|||
33333106|NCT00845650|101111713|FG001|Overall Study|Unable to access IV line|0|||
33333107|NCT00845650|101111714|FG002|Overall Study|Unable to access IV line|0|||
33333108|NCT00845650|101111715|FG003|Overall Study|Unable to access IV line|0|||
33333109|NCT00845650|101111716|FG004|Overall Study|Unable to access IV line|0|||
33333110|NCT00845650|101111717|FG005|Overall Study|Unable to access IV line|0|||
33333111|NCT01358864|101111722|FG000|Overall Study|Adverse Event|0|||
33333112|NCT01358864|101111723|FG001|Overall Study|Adverse Event|6|||
33333113|NCT01358864|101111724|FG002|Overall Study|Adverse Event|9|||
33333114|NCT01358864|101111725|FG003|Overall Study|Adverse Event|0|||
33333115|NCT01358864|101111726|FG004|Overall Study|Adverse Event|4|||
33333116|NCT01358864|101111727|FG005|Overall Study|Adverse Event|8|||
33333117|NCT01358864|101111728|FG006|Overall Study|Adverse Event|12|||
33333118|NCT01358864|101111729|FG007|Overall Study|Adverse Event|7|||
33333119|NCT01358864|101111722|FG000|Overall Study|Lack of Efficacy|26|||
33333120|NCT01358864|101111723|FG001|Overall Study|Lack of Efficacy|3|||
33333121|NCT01358864|101111724|FG002|Overall Study|Lack of Efficacy|4|||
33333122|NCT01358864|101111725|FG003|Overall Study|Lack of Efficacy|19|||
33333123|NCT01358864|101111726|FG004|Overall Study|Lack of Efficacy|7|||
33333124|NCT01358864|101111727|FG005|Overall Study|Lack of Efficacy|4|||
33333125|NCT01358864|101111728|FG006|Overall Study|Lack of Efficacy|49|||
33333126|NCT01358864|101111729|FG007|Overall Study|Lack of Efficacy|44|||
33333127|NCT01358864|101111722|FG000|Overall Study|Lost to Follow-up|0|||
33333128|NCT01358864|101111723|FG001|Overall Study|Lost to Follow-up|0|||
33333129|NCT01358864|101111724|FG002|Overall Study|Lost to Follow-up|1|||
33203491|NCT03701555|100645953|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
33203492|NCT03701555|100645954|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
33203493|NCT03701555|100645955|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
33333130|NCT01358864|101111725|FG003|Overall Study|Lost to Follow-up|0|||
33333131|NCT01358864|101111726|FG004|Overall Study|Lost to Follow-up|0|||
33333132|NCT01358864|101111727|FG005|Overall Study|Lost to Follow-up|0|||
33333133|NCT01358864|101111728|FG006|Overall Study|Lost to Follow-up|0|||
33333134|NCT01358864|101111729|FG007|Overall Study|Lost to Follow-up|1|||
33333135|NCT01358864|101111722|FG000|Overall Study|Withdrawal by Subject|3|||
33203494|NCT03701555|100645956|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
33203495|NCT03701555|100645957|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
33203496|NCT03701555|100645958|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
33203497|NCT03701555|100645959|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
33203498|NCT03701555|100645924|FG000|Part 3 (Day 1)|Subject Decision|0|||
33333136|NCT01358864|101111723|FG001|Overall Study|Withdrawal by Subject|4|||
33333137|NCT01358864|101111724|FG002|Overall Study|Withdrawal by Subject|2|||
33203499|NCT03701555|100645925|FG001|Part 3 (Day 1)|Subject Decision|0|||
33203500|NCT03701555|100645926|FG002|Part 3 (Day 1)|Subject Decision|0|||
33403131|NCT00129220|101365504|FG002|Study Period III|Reason Not Specified|2|||
33403132|NCT01265511|101365505|FG000|Overall Study|Lack of Efficacy|2|||
33403133|NCT01265511|101365506|FG001|Overall Study|Lack of Efficacy|1|||
33403134|NCT01265511|101365505|FG000|Overall Study|Met stopping rules|0|||
33403135|NCT01265511|101365506|FG001|Overall Study|Met stopping rules|2|||
33403136|NCT00877929|101365507|FG000|Overall Study|Adverse Event|11|||
33403137|NCT00877929|101365508|FG001|Overall Study|Adverse Event|20|||
33403138|NCT00877929|101365507|FG000|Overall Study|Protocol Violation|3|||
33403139|NCT00877929|101365508|FG001|Overall Study|Protocol Violation|3|||
33403140|NCT00877929|101365507|FG000|Overall Study|Lost to Follow-up|0|||
33403141|NCT00877929|101365508|FG001|Overall Study|Lost to Follow-up|1|||
33403142|NCT00877929|101365507|FG000|Overall Study|Withdrawal by Subject|4|||
33403143|NCT00877929|101365508|FG001|Overall Study|Withdrawal by Subject|4|||
33403144|NCT00877929|101365507|FG000|Overall Study|Lack of Efficacy|0|||
33403145|NCT00877929|101365508|FG001|Overall Study|Lack of Efficacy|1|||
33403146|NCT00877929|101365507|FG000|Overall Study|Other reason (not specified)|2|||
33403147|NCT00877929|101365508|FG001|Overall Study|Other reason (not specified)|6|||
33403148|NCT01854918|101365509|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
33403149|NCT01854918|101365510|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
33403150|NCT01854918|101365509|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
33403151|NCT01854918|101365510|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
33403152|NCT01854918|101365509|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
33403153|NCT01854918|101365510|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
33403154|NCT01854918|101365509|FG000|SOC-controlled Period (Year 1)|Death|5|||
33403155|NCT01854918|101365510|FG001|SOC-controlled Period (Year 1)|Death|5|||
33403156|NCT01854918|101365509|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
33403157|NCT01854918|101365510|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
33403158|NCT01854918|101365509|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
33403159|NCT01854918|101365510|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
33403160|NCT01854918|101365509|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
33403161|NCT01854918|101365510|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
33403162|NCT01854918|101365509|FG000|All-IP Period (Years 2 and 3)|Death|5|||
33403163|NCT01854918|101365510|FG001|All-IP Period (Years 2 and 3)|Death|16|||
33403164|NCT03490734|101365511|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
33403165|NCT03490734|101365512|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
33403166|NCT03490734|101365513|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
33403167|NCT03490734|101365514|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
33403168|NCT03490734|101365511|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
33403169|NCT03490734|101365512|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
33403170|NCT03490734|101365513|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
33403171|NCT03490734|101365514|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
33403172|NCT03490734|101365511|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
33403173|NCT03490734|101365512|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
33403174|NCT03490734|101365513|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
33403175|NCT03490734|101365514|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
33403176|NCT03490734|101365511|FG000|Post-intervention Scan Visit|Adverse Event|2|||
33403177|NCT03490734|101365512|FG001|Post-intervention Scan Visit|Adverse Event|0|||
33527462|NCT03373760|101830252|FG000|Overall Study|Death|4|||
33527463|NCT00571103|101830253|FG000|Overall Study|Withdrawal by Subject|1|||
33527464|NCT00571103|101830253|FG000|Overall Study|Lost to Follow-up|1|||
33527465|NCT01212159|101830254|FG000|Overall Study|Withdrawal by Subject|12|||
33527466|NCT01212159|101830255|FG001|Overall Study|Withdrawal by Subject|12|||
33527467|NCT02469168|101830260|FG000|Overall Study|Trial closed|1|||
33527468|NCT02469168|101830261|FG001|Overall Study|Trial closed|0|||
33203501|NCT03701555|100645927|FG003|Part 3 (Day 1)|Subject Decision|0|||
33203502|NCT03701555|100645928|FG004|Part 3 (Day 1)|Subject Decision|0|||
33403178|NCT03490734|101365513|FG002|Post-intervention Scan Visit|Adverse Event|0|||
33403179|NCT03490734|101365514|FG003|Post-intervention Scan Visit|Adverse Event|0|||
33403180|NCT03490734|101365511|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
33403181|NCT03490734|101365512|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
33403182|NCT03490734|101365513|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
33403183|NCT03490734|101365514|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
33403184|NCT03490734|101365511|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
33403185|NCT03490734|101365512|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
33403186|NCT03490734|101365513|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
33403187|NCT03490734|101365514|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
33403188|NCT01638546|101365521|FG000|Overall Study|Adverse Event|1|||
33403189|NCT01638546|101365522|FG001|Overall Study|Adverse Event|3|||
33403190|NCT00242658|101365523|FG000|Overall Study|Lost to Follow-up|22|||
33527469|NCT01698268|101830264|FG000|Overall Study|Physician Decision|2|||
33203503|NCT03701555|100645929|FG005|Part 3 (Day 1)|Subject Decision|0|||
33333138|NCT01358864|101111725|FG003|Overall Study|Withdrawal by Subject|0|||
33333139|NCT01358864|101111726|FG004|Overall Study|Withdrawal by Subject|0|||
33527470|NCT01698268|101830265|FG001|Overall Study|Physician Decision|1|||
33527471|NCT00376532|101830266|FG000|Overall Study|Lack sufficient blood sample|6|||
33333140|NCT01358864|101111727|FG005|Overall Study|Withdrawal by Subject|1|||
33333141|NCT01358864|101111728|FG006|Overall Study|Withdrawal by Subject|1|||
33333142|NCT01358864|101111729|FG007|Overall Study|Withdrawal by Subject|3|||
33333143|NCT01358864|101111722|FG000|Overall Study|Other reason not defined above|2|||
33333144|NCT01358864|101111723|FG001|Overall Study|Other reason not defined above|0|||
33333145|NCT01358864|101111724|FG002|Overall Study|Other reason not defined above|0|||
33333146|NCT01358864|101111725|FG003|Overall Study|Other reason not defined above|0|||
33333147|NCT01358864|101111726|FG004|Overall Study|Other reason not defined above|0|||
33333148|NCT01358864|101111727|FG005|Overall Study|Other reason not defined above|0|||
33333149|NCT01358864|101111728|FG006|Overall Study|Other reason not defined above|2|||
33333150|NCT01358864|101111729|FG007|Overall Study|Other reason not defined above|0|||
33333151|NCT01358864|101111722|FG000|Overall Study|Not treated|0|||
33333152|NCT01358864|101111723|FG001|Overall Study|Not treated|0|||
33333153|NCT01358864|101111724|FG002|Overall Study|Not treated|0|||
33333154|NCT01358864|101111725|FG003|Overall Study|Not treated|0|||
33333155|NCT01358864|101111726|FG004|Overall Study|Not treated|0|||
33333156|NCT01358864|101111727|FG005|Overall Study|Not treated|0|||
33333157|NCT01358864|101111728|FG006|Overall Study|Not treated|1|||
33333158|NCT01358864|101111729|FG007|Overall Study|Not treated|0|||
33333159|NCT02463409|101111730|FG000|Overall Study|Withdrawal by Subject|1|||
33333160|NCT02463409|101111730|FG000|Overall Study|Screen failure|1|||
33333161|NCT01709149|101111731|FG000|Open-label Lead-in Phase|Adverse Event|109|||
33333162|NCT01709149|101111732|FG001|Open-label Lead-in Phase|Adverse Event|0|||
33333163|NCT01709149|101111733|FG002|Open-label Lead-in Phase|Adverse Event|0|||
33333164|NCT01709149|101111731|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
33333165|NCT01709149|101111732|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
33333166|NCT01709149|101111733|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
33333167|NCT01709149|101111731|FG000|Open-label Lead-in Phase|Death|1|||
33333168|NCT01709149|101111732|FG001|Open-label Lead-in Phase|Death|0|||
33333169|NCT01709149|101111733|FG002|Open-label Lead-in Phase|Death|0|||
33333170|NCT01709149|101111731|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
33333171|NCT01709149|101111732|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
33333172|NCT01709149|101111733|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
33333173|NCT01709149|101111731|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
33333174|NCT01709149|101111732|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
33333175|NCT01709149|101111733|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
33333176|NCT01709149|101111731|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33333177|NCT01709149|101111732|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
33333178|NCT01709149|101111733|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
33527472|NCT00376532|101830267|FG001|Overall Study|Lack sufficient blood sample|6|||
33527473|NCT02105285|101830275|FG000|Overall Study|Adverse Event|1|||
33527474|NCT02105285|101830276|FG001|Overall Study|Adverse Event|1|||
33527475|NCT02105285|101830277|FG002|Overall Study|Adverse Event|0|||
33527476|NCT02105285|101830275|FG000|Overall Study|Protocol Violation|0|||
33527477|NCT02105285|101830276|FG001|Overall Study|Protocol Violation|1|||
33527478|NCT02105285|101830277|FG002|Overall Study|Protocol Violation|0|||
33527479|NCT02105285|101830275|FG000|Overall Study|Withdrawal by Subject|1|||
33527480|NCT02105285|101830276|FG001|Overall Study|Withdrawal by Subject|0|||
33527481|NCT02105285|101830277|FG002|Overall Study|Withdrawal by Subject|0|||
33527482|NCT02149264|101830281|FG000|Overall Study|Withdrawal by Subject|9|||
33527483|NCT02149264|101830281|FG000|Overall Study|Adverse Event|7|||
33527484|NCT02149264|101830281|FG000|Overall Study|Physician Decision|3|||
33527485|NCT02149264|101830281|FG000|Overall Study|Protocol Violation|1|||
33527486|NCT04227405|101830282|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
33527487|NCT04227405|101830283|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
33527488|NCT04227405|101830282|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
33610563|NCT01912339|102123357|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
33610564|NCT01912339|102123358|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
33333179|NCT01709149|101111731|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
33333180|NCT01709149|101111732|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
33333181|NCT01709149|101111733|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
33333182|NCT01709149|101111731|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
33333183|NCT01709149|101111732|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
33333184|NCT01709149|101111733|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
33527489|NCT04227405|101830283|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
33527490|NCT04227405|101830282|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
33527491|NCT04227405|101830283|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
33527492|NCT00992017|101830284|FG000|Overall Study|Lost to Follow-up|2|||
33403191|NCT00242658|101365524|FG001|Overall Study|Lost to Follow-up|19|||
33403192|NCT00166504|101365527|FG000|Overall Study|Adverse Event|3|||
33403193|NCT00166504|101365528|FG001|Overall Study|Adverse Event|3|||
33403194|NCT00166504|101365527|FG000|Overall Study|Lost to Follow-up|1|||
33403195|NCT00166504|101365528|FG001|Overall Study|Lost to Follow-up|1|||
33403196|NCT00166504|101365527|FG000|Overall Study|Withdrawal by Subject|1|||
33403197|NCT00166504|101365528|FG001|Overall Study|Withdrawal by Subject|0|||
33403198|NCT04118127|101365529|FG000|Overall Study|Trial terminated by sponsor|0|||
33403199|NCT04118127|101365530|FG001|Overall Study|Trial terminated by sponsor|12|||
33403200|NCT04118127|101365529|FG000|Overall Study|Adverse Event|1|||
33403201|NCT04118127|101365530|FG001|Overall Study|Adverse Event|2|||
33403202|NCT04118127|101365529|FG000|Overall Study|Physician Decision|0|||
33403203|NCT04118127|101365530|FG001|Overall Study|Physician Decision|1|||
33403204|NCT04118127|101365529|FG000|Overall Study|Withdrawal by Subject|2|||
33403205|NCT04118127|101365530|FG001|Overall Study|Withdrawal by Subject|1|||
33403206|NCT02275052|101365533|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33403207|NCT02275052|101365534|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
33403208|NCT02275052|101365535|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33403209|NCT02275052|101365536|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33403210|NCT02275052|101365533|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
33403211|NCT02275052|101365534|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
33403212|NCT02275052|101365535|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
33403213|NCT02275052|101365536|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
33403214|NCT02275052|101365533|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
33403215|NCT02275052|101365534|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
33403216|NCT02275052|101365535|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33403217|NCT02275052|101365536|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33333185|NCT01709149|101111731|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
33333186|NCT01709149|101111732|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
33333187|NCT01709149|101111733|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
33333188|NCT01709149|101111731|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33333189|NCT01709149|101111732|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
33333190|NCT01709149|101111733|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33333191|NCT00081159|101111734|FG000|Overall Study|Withdrawal by Subject|0|||
33333192|NCT00081159|101111735|FG001|Overall Study|Withdrawal by Subject|3|||
33333193|NCT00081159|101111734|FG000|Overall Study|Myelosuppression prior to treatment|0|||
33333194|NCT00081159|101111735|FG001|Overall Study|Myelosuppression prior to treatment|1|||
33333195|NCT00081159|101111734|FG000|Overall Study|Lost to Follow-up|2|||
33333196|NCT00081159|101111735|FG001|Overall Study|Lost to Follow-up|1|||
33333197|NCT02898259|101111737|FG000|Overall Study|Adverse Event|0|||
33403218|NCT02275052|101365533|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
33403219|NCT02275052|101365534|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
33403220|NCT02275052|101365535|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
33403221|NCT02275052|101365536|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
33403222|NCT02275052|101365533|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
33403223|NCT02275052|101365534|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
33403224|NCT02275052|101365535|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
33403225|NCT02275052|101365536|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
33403226|NCT02275052|101365533|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
33403227|NCT02275052|101365534|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
33403228|NCT02275052|101365535|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
33403229|NCT02275052|101365536|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
33403230|NCT02275052|101365533|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
33403231|NCT02275052|101365534|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
33403232|NCT02275052|101365535|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
33403233|NCT02275052|101365536|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
33403234|NCT02275052|101365533|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
33403235|NCT02275052|101365534|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
33403236|NCT02275052|101365535|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
33403237|NCT02275052|101365536|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
33333198|NCT02898259|101111738|FG001|Overall Study|Adverse Event|0|||
33333199|NCT02898259|101111739|FG002|Overall Study|Adverse Event|1|||
33403238|NCT02275052|101365533|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33403239|NCT02275052|101365534|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33403240|NCT02275052|101365535|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33403241|NCT02275052|101365536|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
33403242|NCT02275052|101365533|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
33403243|NCT02275052|101365534|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
33333200|NCT02898259|101111740|FG003|Overall Study|Adverse Event|0|||
33333201|NCT02898259|101111741|FG004|Overall Study|Adverse Event|0|||
33333202|NCT02898259|101111737|FG000|Overall Study|Lack of Efficacy|1|||
33333203|NCT02898259|101111738|FG001|Overall Study|Lack of Efficacy|1|||
33333204|NCT02898259|101111739|FG002|Overall Study|Lack of Efficacy|3|||
33333205|NCT02898259|101111740|FG003|Overall Study|Lack of Efficacy|0|||
33333206|NCT02898259|101111741|FG004|Overall Study|Lack of Efficacy|0|||
33333207|NCT02898259|101111737|FG000|Overall Study|Lost to Follow-up|0|||
33333208|NCT02898259|101111738|FG001|Overall Study|Lost to Follow-up|0|||
33333209|NCT02898259|101111739|FG002|Overall Study|Lost to Follow-up|1|||
33333210|NCT02898259|101111740|FG003|Overall Study|Lost to Follow-up|0|||
33333211|NCT02898259|101111741|FG004|Overall Study|Lost to Follow-up|0|||
33333212|NCT02898259|101111737|FG000|Overall Study|Transformation before study began|0|||
33333213|NCT02898259|101111738|FG001|Overall Study|Transformation before study began|0|||
33333214|NCT02898259|101111739|FG002|Overall Study|Transformation before study began|0|||
33333215|NCT02898259|101111740|FG003|Overall Study|Transformation before study began|1|||
33333216|NCT02898259|101111741|FG004|Overall Study|Transformation before study began|0|||
33333217|NCT01379274|101111748|FG000|Overall Study|funding withdrawn|1|||
33333218|NCT01187953|101111749|FG000|Overall Study|Death|11|||
33333219|NCT01187953|101111750|FG001|Overall Study|Death|13|||
33333220|NCT01187953|101111749|FG000|Overall Study|Adverse Event|1|||
33333221|NCT01187953|101111750|FG001|Overall Study|Adverse Event|2|||
33333222|NCT01187953|101111749|FG000|Overall Study|Lost to Follow-up|0|||
33333223|NCT01187953|101111750|FG001|Overall Study|Lost to Follow-up|3|||
33333224|NCT01187953|101111749|FG000|Overall Study|Withdrawal by Subject|3|||
33333225|NCT01187953|101111750|FG001|Overall Study|Withdrawal by Subject|3|||
33333226|NCT01761292|101111751|FG000|Part 1|Adverse Event|1|||
33333227|NCT01761292|101111751|FG000|Part 1|not receiving treatment in Part 1|1|||
33403244|NCT02275052|101365535|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
33333228|NCT01761292|101111751|FG000|Extension 1|Withdrawal by Subject|1|||
33333229|NCT01227187|101111754|FG000|Overall Study|Physician Decision|0|||
33333230|NCT01227187|101111755|FG001|Overall Study|Physician Decision|0|||
33333231|NCT01227187|101111756|FG002|Overall Study|Physician Decision|0|||
33403245|NCT02275052|101365536|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
33403246|NCT02275052|101365533|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33403247|NCT02275052|101365534|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33403248|NCT02275052|101365535|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33403249|NCT02275052|101365536|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
33403250|NCT02132312|101365537|FG000|Overall Study|Adverse Event|2|||
33403251|NCT02132312|101365538|FG001|Overall Study|Adverse Event|0|||
33403252|NCT02132312|101365537|FG000|Overall Study|Physician Decision|1|||
33403253|NCT02132312|101365538|FG001|Overall Study|Physician Decision|1|||
33403254|NCT02132312|101365537|FG000|Overall Study|Protocol Violation|0|||
33403255|NCT02132312|101365538|FG001|Overall Study|Protocol Violation|1|||
33403256|NCT02132312|101365537|FG000|Overall Study|Withdrawal by Subject|1|||
33333232|NCT01227187|101111757|FG003|Overall Study|Physician Decision|1|||
33333233|NCT01399788|101111758|FG000|First Intervention Period|Adverse Event|1|||
33333234|NCT01399788|101111759|FG001|First Intervention Period|Adverse Event|0|||
33333235|NCT00343889|101111764|FG000|Overall Study|Lost to Follow-up|2|||
33403257|NCT02132312|101365538|FG001|Overall Study|Withdrawal by Subject|0|||
33333236|NCT00343889|101111765|FG001|Overall Study|Lost to Follow-up|0|||
33333237|NCT00343889|101111764|FG000|Overall Study|Withdrawal by Subject|0|||
33333238|NCT00343889|101111765|FG001|Overall Study|Withdrawal by Subject|1|||
33333239|NCT00343889|101111764|FG000|Overall Study|Protocol Violation|1|||
33333240|NCT00343889|101111765|FG001|Overall Study|Protocol Violation|0|||
33333241|NCT03782376|101111766|FG000|Overall Study|Lost to Follow-up|2|||
33333242|NCT03782376|101111767|FG001|Overall Study|Lost to Follow-up|2|||
33333243|NCT03782376|101111766|FG000|Overall Study|Withdrawal by Subject|7|||
33333244|NCT03782376|101111767|FG001|Overall Study|Withdrawal by Subject|11|||
33403258|NCT02132312|101365537|FG000|Overall Study|Lost to Follow-up|2|||
33403259|NCT02132312|101365538|FG001|Overall Study|Lost to Follow-up|1|||
33527493|NCT00992017|101830284|FG000|Overall Study|Withdrawal by Subject|2|||
33333245|NCT03782376|101111766|FG000|Overall Study|Death|1|||
33333246|NCT03782376|101111767|FG001|Overall Study|Death|0|||
33333247|NCT03782376|101111766|FG000|Overall Study|Other|16|||
33333248|NCT03782376|101111767|FG001|Overall Study|Other|17|||
33333249|NCT04342871|101111768|FG000|Overall Study|Death|4|||
33333250|NCT04342871|101111768|FG000|Overall Study|Clinical deterioration/illness progression|2|||
33333251|NCT04342871|101111768|FG000|Overall Study|Did not complete baseline assessments|5|||
33333252|NCT04342871|101111768|FG000|Overall Study|Lost to Follow-up|13|||
33333253|NCT00750737|101111769|FG000|Overall Study|Withdrawal by Subject|3|||
33333254|NCT00750737|101111770|FG001|Overall Study|Withdrawal by Subject|3|||
33333255|NCT02053168|101111773|FG000|Overall Study|Withdrawal by Subject|1|||
33333256|NCT02053168|101111773|FG000|Overall Study|Physician Decision|1|||
33333257|NCT02053168|101111773|FG000|Overall Study|Lost to Follow-up|1|||
33403260|NCT01736176|101365539|FG000|Overall Study|Adverse Event|3|||
33527494|NCT00992017|101830284|FG000|Overall Study|Unable to get to clinic|5|||
33333258|NCT01624662|101111778|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
33333259|NCT01624662|101111779|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
33333260|NCT01624662|101111780|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
33333261|NCT01624662|101111781|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
33333262|NCT01624662|101111778|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
33333263|NCT01624662|101111779|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
33333264|NCT01624662|101111780|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
33333265|NCT01624662|101111781|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
33333266|NCT01624662|101111778|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
33333267|NCT01624662|101111779|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
33333268|NCT01624662|101111780|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
33333269|NCT01624662|101111781|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
33333270|NCT01624662|101111778|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
33333271|NCT01624662|101111779|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
33333272|NCT01624662|101111780|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
33333273|NCT01624662|101111781|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
33333274|NCT01624662|101111778|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
33333275|NCT01624662|101111779|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
33333276|NCT01624662|101111780|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
33333277|NCT01624662|101111781|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
33333278|NCT01624662|101111778|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
33333279|NCT01624662|101111779|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
33333280|NCT01624662|101111780|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
33333281|NCT01624662|101111781|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
33333282|NCT01624662|101111778|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
33333283|NCT01624662|101111779|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
33333284|NCT01624662|101111780|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
33333285|NCT01624662|101111781|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
33333286|NCT03201458|101111794|FG000|Overall Study|No longer eligible|2|||
33333287|NCT03201458|101111795|FG001|Overall Study|No longer eligible|5|||
33333288|NCT03201458|101111794|FG000|Overall Study|Health event before starting|1|||
33333289|NCT03201458|101111795|FG001|Overall Study|Health event before starting|0|||
33333290|NCT03201458|101111794|FG000|Overall Study|Physician Decision|1|||
33333291|NCT03201458|101111795|FG001|Overall Study|Physician Decision|0|||
33333292|NCT03703882|101111803|FG000|Overall Study|Adverse Event|1|||
33403261|NCT01736176|101365539|FG000|Overall Study|Withdrawal by Subject|4|||
33403262|NCT01736176|101365539|FG000|Overall Study|Lack of Efficacy|3|||
33403263|NCT01736176|101365539|FG000|Overall Study|Unable to Complete PEG Placement|1|||
33403264|NCT00983827|101365540|FG000|Overall Study|Withdrawal by Subject|1|||
33403265|NCT03798366|101365544|FG000|Overall Study|Lost to Follow-up|0|||
33403266|NCT03798366|101365545|FG001|Overall Study|Lost to Follow-up|1|||
33403267|NCT03370133|101365546|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
33403268|NCT03370133|101365547|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
33403269|NCT03370133|101365548|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
33403270|NCT03370133|101365549|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
33403271|NCT03370133|101365550|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
33403272|NCT03370133|101365551|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
33403273|NCT03370133|101365546|FG000|Initial Treatment Period (WK 16)|Death|1|||
33403274|NCT03370133|101365547|FG001|Initial Treatment Period (WK 16)|Death|1|||
33403275|NCT03370133|101365548|FG002|Initial Treatment Period (WK 16)|Death|1|||
33403276|NCT03370133|101365549|FG003|Initial Treatment Period (WK 16)|Death|0|||
33403277|NCT03370133|101365550|FG004|Initial Treatment Period (WK 16)|Death|0|||
33403278|NCT03370133|101365551|FG005|Initial Treatment Period (WK 16)|Death|0|||
33403279|NCT03370133|101365546|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
33403280|NCT03370133|101365547|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
33403281|NCT03370133|101365548|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
33403282|NCT03370133|101365549|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
33403283|NCT03370133|101365550|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
33403284|NCT03370133|101365551|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
33403285|NCT03370133|101365546|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
33403286|NCT03370133|101365547|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
33403287|NCT03370133|101365548|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
33403288|NCT03370133|101365549|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
33403289|NCT03370133|101365550|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
33403290|NCT03370133|101365551|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
33403291|NCT03370133|101365546|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
33403292|NCT03370133|101365547|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
33403293|NCT03370133|101365548|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
33333293|NCT03703882|101111804|FG001|Overall Study|Adverse Event|0|||
33333294|NCT03703882|101111803|FG000|Overall Study|Lost to Follow-up|0|||
33333295|NCT03703882|101111804|FG001|Overall Study|Lost to Follow-up|2|||
33333296|NCT03703882|101111803|FG000|Overall Study|Non-compliance with study drug|0|||
33333297|NCT03703882|101111804|FG001|Overall Study|Non-compliance with study drug|1|||
33333298|NCT03703882|101111803|FG000|Overall Study|Physician Decision|0|||
33333299|NCT03703882|101111804|FG001|Overall Study|Physician Decision|1|||
33333300|NCT03703882|101111803|FG000|Overall Study|Progressive disease|1|||
33333301|NCT03703882|101111804|FG001|Overall Study|Progressive disease|0|||
33333302|NCT03703882|101111803|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33333303|NCT03703882|101111804|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33333304|NCT03703882|101111803|FG000|Overall Study|Starting another treatment|0|||
33333305|NCT03703882|101111804|FG001|Overall Study|Starting another treatment|1|||
33333306|NCT03703882|101111803|FG000|Overall Study|noncompliance with study procedures|0|||
33333307|NCT03703882|101111804|FG001|Overall Study|noncompliance with study procedures|1|||
33333308|NCT00271817|101111805|FG000|Part 1|Adverse Event|68|||
33333309|NCT00271817|101111806|FG001|Part 1|Adverse Event|25|||
33333310|NCT00271817|101111807|FG002|Part 1|Adverse Event|156|||
33333311|NCT00271817|101111805|FG000|Part 1|Lost to Follow-up|6|||
33333312|NCT00271817|101111806|FG001|Part 1|Lost to Follow-up|8|||
33333313|NCT00271817|101111807|FG002|Part 1|Lost to Follow-up|24|||
33403294|NCT03370133|101365549|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
33333314|NCT00271817|101111805|FG000|Part 1|Protocol Violation|5|||
33403295|NCT03370133|101365550|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
33403296|NCT03370133|101365551|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
33403297|NCT03370133|101365546|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
33403298|NCT03370133|101365547|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
33403299|NCT03370133|101365548|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
33403300|NCT03370133|101365549|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
33403301|NCT03370133|101365550|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
33403302|NCT03370133|101365551|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
33403303|NCT03370133|101365546|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
33403304|NCT03370133|101365547|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
33403305|NCT03370133|101365548|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
33403306|NCT03370133|101365549|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
33403307|NCT03370133|101365550|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
33403308|NCT03370133|101365551|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
33403309|NCT03370133|101365546|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
33403310|NCT03370133|101365547|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
33403311|NCT03370133|101365548|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
33403312|NCT03370133|101365549|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
33403313|NCT03370133|101365550|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
33403314|NCT03370133|101365551|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
33403315|NCT03370133|101365546|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
33403316|NCT03370133|101365547|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
33403317|NCT03370133|101365548|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
33403318|NCT03370133|101365549|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
33403319|NCT03370133|101365550|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
33403320|NCT03370133|101365551|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
33403321|NCT03370133|101365546|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
33403322|NCT03370133|101365547|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
33403323|NCT03370133|101365548|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
33403324|NCT03370133|101365549|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
33527495|NCT00992017|101830284|FG000|Overall Study|Not adhere to study requirements|1|||
33527496|NCT00171158|101830288|FG000|Core Study|Death|27|||
33527497|NCT00171158|101830288|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
33527498|NCT00171158|101830288|FG000|Core Study|Protocol Violation|4|||
33527499|NCT00171158|101830288|FG000|Core Study|Administrative problems|1|||
33527500|NCT00171158|101830288|FG000|Core Study|Adverse event, non-fatal|21|||
33527501|NCT00171158|101830288|FG000|Core Study|Consent withdrawn by subject|6|||
33527502|NCT00171158|101830288|FG000|Core Study|No longer required drug (BMT)|14|||
33527503|NCT00171158|101830288|FG000|Core Study|Abnormal Laboratory Values|2|||
33203504|NCT03701555|100645930|FG006|Part 3 (Day 1)|Subject Decision|0|||
33333315|NCT00271817|101111806|FG001|Part 1|Protocol Violation|4|||
33333316|NCT00271817|101111807|FG002|Part 1|Protocol Violation|7|||
33333317|NCT00271817|101111805|FG000|Part 1|Patient Moved|3|||
33333318|NCT00271817|101111806|FG001|Part 1|Patient Moved|1|||
33403325|NCT03370133|101365550|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
33403326|NCT03370133|101365551|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
33403327|NCT03370133|101365546|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
33527504|NCT00171158|101830288|FG000|Core Study|Lost to Follow-up|1|||
33333319|NCT00271817|101111807|FG002|Part 1|Patient Moved|5|||
33333320|NCT00271817|101111805|FG000|Part 1|Withdrawal by Subject|23|||
33203505|NCT03701555|100645931|FG007|Part 3 (Day 1)|Subject Decision|0|||
33203506|NCT03701555|100645932|FG008|Part 3 (Day 1)|Subject Decision|0|||
33203507|NCT03701555|100645933|FG009|Part 3 (Day 1)|Subject Decision|0|||
33203508|NCT03701555|100645934|FG010|Part 3 (Day 1)|Subject Decision|0|||
33203509|NCT03701555|100645935|FG011|Part 3 (Day 1)|Subject Decision|0|||
33333321|NCT00271817|101111806|FG001|Part 1|Withdrawal by Subject|17|||
33333322|NCT00271817|101111807|FG002|Part 1|Withdrawal by Subject|45|||
33333323|NCT00271817|101111805|FG000|Part 1|LDL < 50 mg/dL|1|||
33333324|NCT00271817|101111806|FG001|Part 1|LDL < 50 mg/dL|4|||
33333325|NCT00271817|101111807|FG002|Part 1|LDL < 50 mg/dL|48|||
33333326|NCT00271817|101111805|FG000|Part 2|Adverse Event|0|||
33203510|NCT03701555|100645936|FG012|Part 3 (Day 1)|Subject Decision|0|||
33203511|NCT03701555|100645937|FG013|Part 3 (Day 1)|Subject Decision|0|||
33333327|NCT00271817|101111806|FG001|Part 2|Adverse Event|17|||
33333328|NCT00271817|101111807|FG002|Part 2|Adverse Event|33|||
33333329|NCT00271817|101111805|FG000|Part 2|Lack of Efficacy|0|||
33333330|NCT00271817|101111806|FG001|Part 2|Lack of Efficacy|1|||
33203512|NCT03701555|100645938|FG014|Part 3 (Day 1)|Subject Decision|0|||
33203513|NCT03701555|100645939|FG015|Part 3 (Day 1)|Subject Decision|0|||
33203514|NCT03701555|100645940|FG016|Part 3 (Day 1)|Subject Decision|0|||
33203515|NCT03701555|100645941|FG017|Part 3 (Day 1)|Subject Decision|0|||
33203516|NCT03701555|100645942|FG018|Part 3 (Day 1)|Subject Decision|0|||
33203517|NCT03701555|100645943|FG019|Part 3 (Day 1)|Subject Decision|0|||
33203518|NCT03701555|100645944|FG020|Part 3 (Day 1)|Subject Decision|0|||
33203519|NCT03701555|100645945|FG021|Part 3 (Day 1)|Subject Decision|0|||
33203520|NCT03701555|100645946|FG022|Part 3 (Day 1)|Subject Decision|0|||
33203521|NCT03701555|100645947|FG023|Part 3 (Day 1)|Subject Decision|0|||
33203522|NCT03701555|100645948|FG024|Part 3 (Day 1)|Subject Decision|0|||
33203523|NCT03701555|100645949|FG025|Part 3 (Day 1)|Subject Decision|0|||
33203524|NCT03701555|100645950|FG026|Part 3 (Day 1)|Subject Decision|1|||
33203525|NCT03701555|100645951|FG027|Part 3 (Day 1)|Subject Decision|0|||
33203526|NCT03701555|100645952|FG028|Part 3 (Day 1)|Subject Decision|0|||
33203527|NCT03701555|100645953|FG029|Part 3 (Day 1)|Subject Decision|0|||
33203528|NCT03701555|100645954|FG030|Part 3 (Day 1)|Subject Decision|0|||
33203529|NCT03701555|100645955|FG031|Part 3 (Day 1)|Subject Decision|2|||
33203530|NCT03701555|100645956|FG032|Part 3 (Day 1)|Subject Decision|1|||
33203531|NCT03701555|100645957|FG033|Part 3 (Day 1)|Subject Decision|1|||
33203532|NCT03701555|100645958|FG034|Part 3 (Day 1)|Subject Decision|0|||
33203533|NCT03701555|100645959|FG035|Part 3 (Day 1)|Subject Decision|0|||
33203534|NCT03701555|100645924|FG000|Part 3 (Day 1)|Other|0|||
33203535|NCT03701555|100645925|FG001|Part 3 (Day 1)|Other|0|||
33203536|NCT03701555|100645926|FG002|Part 3 (Day 1)|Other|0|||
33203537|NCT03701555|100645927|FG003|Part 3 (Day 1)|Other|0|||
33203538|NCT03701555|100645928|FG004|Part 3 (Day 1)|Other|0|||
33203539|NCT03701555|100645929|FG005|Part 3 (Day 1)|Other|0|||
33203540|NCT03701555|100645930|FG006|Part 3 (Day 1)|Other|0|||
33203541|NCT03701555|100645931|FG007|Part 3 (Day 1)|Other|0|||
33203542|NCT03701555|100645932|FG008|Part 3 (Day 1)|Other|0|||
33203543|NCT03701555|100645933|FG009|Part 3 (Day 1)|Other|0|||
33333331|NCT00271817|101111807|FG002|Part 2|Lack of Efficacy|6|||
33333332|NCT00271817|101111805|FG000|Part 2|Lost to Follow-up|0|||
33333333|NCT00271817|101111806|FG001|Part 2|Lost to Follow-up|6|||
33610565|NCT01912339|102123356|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
33610566|NCT01912339|102123357|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
33610567|NCT01912339|102123358|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
33610568|NCT01912339|102123356|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
33203544|NCT03701555|100645934|FG010|Part 3 (Day 1)|Other|0|||
33203545|NCT03701555|100645935|FG011|Part 3 (Day 1)|Other|0|||
33203546|NCT03701555|100645936|FG012|Part 3 (Day 1)|Other|0|||
33203547|NCT03701555|100645937|FG013|Part 3 (Day 1)|Other|0|||
33333334|NCT00271817|101111807|FG002|Part 2|Lost to Follow-up|18|||
33333335|NCT00271817|101111805|FG000|Part 2|Protocol Violation|0|||
33203548|NCT03701555|100645938|FG014|Part 3 (Day 1)|Other|0|||
33203549|NCT03701555|100645939|FG015|Part 3 (Day 1)|Other|0|||
33203550|NCT03701555|100645940|FG016|Part 3 (Day 1)|Other|0|||
33610569|NCT01912339|102123357|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
33203551|NCT03701555|100645941|FG017|Part 3 (Day 1)|Other|0|||
33203552|NCT03701555|100645942|FG018|Part 3 (Day 1)|Other|0|||
33203553|NCT03701555|100645943|FG019|Part 3 (Day 1)|Other|0|||
33203554|NCT03701555|100645944|FG020|Part 3 (Day 1)|Other|0|||
33203555|NCT03701555|100645945|FG021|Part 3 (Day 1)|Other|0|||
33203556|NCT03701555|100645946|FG022|Part 3 (Day 1)|Other|0|||
33203557|NCT03701555|100645947|FG023|Part 3 (Day 1)|Other|0|||
33203558|NCT03701555|100645948|FG024|Part 3 (Day 1)|Other|1|||
33203559|NCT03701555|100645949|FG025|Part 3 (Day 1)|Other|1|||
33203560|NCT03701555|100645950|FG026|Part 3 (Day 1)|Other|0|||
33203561|NCT03701555|100645951|FG027|Part 3 (Day 1)|Other|0|||
33203562|NCT03701555|100645952|FG028|Part 3 (Day 1)|Other|0|||
33333336|NCT00271817|101111806|FG001|Part 2|Protocol Violation|3|||
33333337|NCT00271817|101111807|FG002|Part 2|Protocol Violation|5|||
33333338|NCT00271817|101111805|FG000|Part 2|Patient Moved|0|||
33333339|NCT00271817|101111806|FG001|Part 2|Patient Moved|0|||
33333340|NCT00271817|101111807|FG002|Part 2|Patient Moved|5|||
33333341|NCT00271817|101111805|FG000|Part 2|Withdrawal by Subject|0|||
33333342|NCT00271817|101111806|FG001|Part 2|Withdrawal by Subject|2|||
33333343|NCT00271817|101111807|FG002|Part 2|Withdrawal by Subject|13|||
33333344|NCT00271817|101111805|FG000|Part 2|LDL < 50 mg/dL|0|||
33333345|NCT00271817|101111806|FG001|Part 2|LDL < 50 mg/dL|3|||
33333346|NCT00271817|101111807|FG002|Part 2|LDL < 50 mg/dL|4|||
33333347|NCT03440814|101111808|FG000|Overall Study|Adverse Event|2|||
33333348|NCT03440814|101111809|FG001|Overall Study|Adverse Event|1|||
33333349|NCT03440814|101111808|FG000|Overall Study|Lost to Follow-up|2|||
33203563|NCT03701555|100645953|FG029|Part 3 (Day 1)|Other|1|||
33203564|NCT03701555|100645954|FG030|Part 3 (Day 1)|Other|1|||
33203565|NCT03701555|100645955|FG031|Part 3 (Day 1)|Other|0|||
33203566|NCT03701555|100645956|FG032|Part 3 (Day 1)|Other|1|||
33203567|NCT03701555|100645957|FG033|Part 3 (Day 1)|Other|1|||
33203568|NCT03701555|100645958|FG034|Part 3 (Day 1)|Other|0|||
33203569|NCT03701555|100645959|FG035|Part 3 (Day 1)|Other|0|||
33203570|NCT01303627|100645963|FG000|Overall Study|the failure while performing URS|0|||
33203571|NCT01303627|100645964|FG001|Overall Study|the failure while performing URS|1|||
33203572|NCT03783923|100645971|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
33333350|NCT03440814|101111809|FG001|Overall Study|Lost to Follow-up|0|||
33333351|NCT03440814|101111808|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
33333352|NCT03440814|101111809|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
33333353|NCT01026831|101114678|FG000|Overall Study|Adverse Event|4|||
33333354|NCT01026831|101114679|FG001|Overall Study|Adverse Event|3|||
33333355|NCT01026831|101114678|FG000|Overall Study|Lost to Follow-up|2|||
33333356|NCT01026831|101114679|FG001|Overall Study|Lost to Follow-up|0|||
33333357|NCT01026831|101114678|FG000|Overall Study|Physician Decision|1|||
33333358|NCT01026831|101114679|FG001|Overall Study|Physician Decision|1|||
33333359|NCT01026831|101114678|FG000|Overall Study|Protocol Violation|0|||
33333360|NCT01026831|101114679|FG001|Overall Study|Protocol Violation|2|||
33333361|NCT01026831|101114678|FG000|Overall Study|Withdrawal by Subject|7|||
33333362|NCT01026831|101114679|FG001|Overall Study|Withdrawal by Subject|5|||
33333363|NCT00563186|101114680|FG000|Overall Study|LOS<48 hours|97|||
33333364|NCT00563186|101114681|FG001|Overall Study|LOS<48 hours|74|||
33333365|NCT00563186|101114680|FG000|Overall Study|Incomplete data|1|||
33333366|NCT00563186|101114681|FG001|Overall Study|Incomplete data|1|||
33333367|NCT03075527|101114682|FG000|Overall Study|Ongoing treatment|2|||
33333368|NCT04718974|101114690|FG000|Overall Study|Death|0|||
33333369|NCT04718974|101114691|FG001|Overall Study|Death|2|||
33333370|NCT04718974|101114690|FG000|Overall Study|Lost to Follow-up|10|||
33333371|NCT04718974|101114691|FG001|Overall Study|Lost to Follow-up|20|||
33333372|NCT04718974|101114690|FG000|Overall Study|Transferred out|2|||
33333373|NCT04718974|101114691|FG001|Overall Study|Transferred out|4|||
33333374|NCT01577186|101114692|FG000|Overall Study|Adverse Event|23|||
33333375|NCT01577186|101114692|FG000|Overall Study|Death|1|||
33333376|NCT01577186|101114692|FG000|Overall Study|Lost to Follow-up|28|||
33333377|NCT01577186|101114692|FG000|Overall Study|Withdrawal by Subject|35|||
33333378|NCT01577186|101114692|FG000|Overall Study|Insufficient Response|18|||
33333379|NCT01577186|101114692|FG000|Overall Study|Ineligible to Continue|15|||
33333380|NCT01577186|101114692|FG000|Overall Study|Non-Compliant|8|||
33333381|NCT01577186|101114692|FG000|Overall Study|Other|2|||
33333382|NCT01265550|101114699|FG000|Pre Randomization|Withdrawal by Subject|0|||
33333383|NCT01265550|101114700|FG001|Pre Randomization|Withdrawal by Subject|0|||
33333384|NCT01265550|101114701|FG002|Pre Randomization|Withdrawal by Subject|0|||
33333385|NCT01265550|101114702|FG003|Pre Randomization|Withdrawal by Subject|70|||
33333386|NCT01265550|101114699|FG000|Pre Randomization|Technical Exclusions|0|||
33333387|NCT01265550|101114700|FG001|Pre Randomization|Technical Exclusions|0|||
33333388|NCT01265550|101114701|FG002|Pre Randomization|Technical Exclusions|0|||
33333389|NCT01265550|101114702|FG003|Pre Randomization|Technical Exclusions|54|||
33333390|NCT01265550|101114699|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
33333391|NCT01265550|101114700|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
33333392|NCT01265550|101114701|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
33333393|NCT01265550|101114702|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
33333394|NCT01265550|101114699|FG000|Pre Randomization|Non-GERD organic disorders|0|||
33610570|NCT01912339|102123358|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
33333395|NCT01265550|101114700|FG001|Pre Randomization|Non-GERD organic disorders|0|||
33203573|NCT03783923|100645972|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
33333396|NCT01265550|101114701|FG002|Pre Randomization|Non-GERD organic disorders|0|||
33333397|NCT01265550|101114702|FG003|Pre Randomization|Non-GERD organic disorders|23|||
33333398|NCT01265550|101114699|FG000|Pre Randomization|Functional heartburn|0|||
33333399|NCT01265550|101114700|FG001|Pre Randomization|Functional heartburn|0|||
33203574|NCT03783923|100645971|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
33333400|NCT01265550|101114701|FG002|Pre Randomization|Functional heartburn|0|||
33333401|NCT01265550|101114702|FG003|Pre Randomization|Functional heartburn|99|||
33203575|NCT03783923|100645972|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
33333402|NCT02424253|101114703|FG000|Overall Study|Other, unspecified|1|||
33333403|NCT02424253|101114704|FG001|Overall Study|Other, unspecified|0|||
33333404|NCT02424253|101114703|FG000|Overall Study|Compliance problems|1|||
33333405|NCT02424253|101114704|FG001|Overall Study|Compliance problems|0|||
33333406|NCT02424253|101114703|FG000|Overall Study|Physician Decision|2|||
33333407|NCT02424253|101114704|FG001|Overall Study|Physician Decision|0|||
33333408|NCT02424253|101114703|FG000|Overall Study|Lack of Efficacy|0|||
33333409|NCT02424253|101114704|FG001|Overall Study|Lack of Efficacy|7|||
33333410|NCT02424253|101114703|FG000|Overall Study|Adverse Event|2|||
33333411|NCT02424253|101114704|FG001|Overall Study|Adverse Event|0|||
33333412|NCT02424253|101114703|FG000|Overall Study|Consent withdrawn by subject|4|||
33333413|NCT02424253|101114704|FG001|Overall Study|Consent withdrawn by subject|1|||
33333414|NCT02424253|101114703|FG000|Overall Study|Lost to Follow-up|1|||
33333415|NCT02424253|101114704|FG001|Overall Study|Lost to Follow-up|1|||
33333416|NCT01136655|101114705|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
33333417|NCT01136655|101114705|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
33333418|NCT01136655|101114705|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
33333419|NCT01136655|101114705|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
33333420|NCT01321710|101114706|FG000|Overall Study|Lost to Follow-up|4|||
33333421|NCT01321710|101114707|FG001|Overall Study|Lost to Follow-up|5|||
33333422|NCT01321710|101114708|FG002|Overall Study|Lost to Follow-up|0|||
33333423|NCT02728830|101114709|FG000|Overall Study|Exclusionary Surgery|9|||
33333424|NCT02728830|101114709|FG000|Overall Study|Exclusionary Pathology|6|||
33333425|NCT02728830|101114709|FG000|Overall Study|Physician Decision|3|||
33333426|NCT02728830|101114709|FG000|Overall Study|Withdrawal by Subject|2|||
33333427|NCT02728830|101114709|FG000|Overall Study|Lost to Follow-up|1|||
33333428|NCT02728830|101114709|FG000|Overall Study|Exclusionary Lab Values|1|||
33333429|NCT02728830|101114709|FG000|Overall Study|Contraindicated Illness|1|||
33333430|NCT02728830|101114709|FG000|Overall Study|Language Barrier|1|||
33333431|NCT00066703|101114715|FG000|Overall Study|Adverse Event|80|||
33333432|NCT00066703|101114716|FG001|Overall Study|Adverse Event|111|||
33333433|NCT00066703|101114715|FG000|Overall Study|Death|3|||
33333434|NCT00066703|101114716|FG001|Overall Study|Death|0|||
33333435|NCT00066703|101114715|FG000|Overall Study|Lack of Efficacy|114|||
33333436|NCT00066703|101114716|FG001|Overall Study|Lack of Efficacy|69|||
33333437|NCT00066703|101114715|FG000|Overall Study|Lost to Follow-up|31|||
33333438|NCT00066703|101114716|FG001|Overall Study|Lost to Follow-up|28|||
33333439|NCT00066703|101114715|FG000|Overall Study|Withdrawal by Subject|38|||
33333440|NCT00066703|101114716|FG001|Overall Study|Withdrawal by Subject|63|||
33333441|NCT00066703|101114715|FG000|Overall Study|Treatment ongoing|346|||
33333442|NCT00066703|101114716|FG001|Overall Study|Treatment ongoing|311|||
33333443|NCT03861559|101114725|FG000|Overall Study|Adverse Event|0|||
33333444|NCT03861559|101114726|FG001|Overall Study|Adverse Event|2|||
33333445|NCT03861559|101114725|FG000|Overall Study|Treatment failure|0|||
33333446|NCT03861559|101114726|FG001|Overall Study|Treatment failure|2|||
33333447|NCT03861559|101114725|FG000|Overall Study|Noncompliance|1|||
33333448|NCT03861559|101114726|FG001|Overall Study|Noncompliance|1|||
33333449|NCT03861559|101114725|FG000|Overall Study|Did not meet eligibility requirements|1|||
33333450|NCT03861559|101114726|FG001|Overall Study|Did not meet eligibility requirements|0|||
33333451|NCT00129766|101114727|FG000|Overall Study|Death|3|||
33333452|NCT00129766|101114728|FG001|Overall Study|Death|8|||
33333453|NCT00129766|101114727|FG000|Overall Study|Withdrawal of consent|31|||
33333454|NCT00129766|101114728|FG001|Overall Study|Withdrawal of consent|30|||
33333455|NCT00129766|101114727|FG000|Overall Study|Lost to Follow-up|26|||
33333456|NCT00129766|101114728|FG001|Overall Study|Lost to Follow-up|21|||
33333457|NCT02199080|101114729|FG000|Overall Study|Protocol Violation|12|||
33333458|NCT02915523|101114730|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
33333459|NCT02915523|101114731|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
33333460|NCT02915523|101114732|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
33333461|NCT02915523|101114733|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
33333462|NCT02915523|101114730|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
33333463|NCT02915523|101114731|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
33333464|NCT02915523|101114732|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
33333465|NCT02915523|101114733|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
33403328|NCT03370133|101365547|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
33403329|NCT03370133|101365548|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
33403330|NCT03370133|101365549|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
33403331|NCT03370133|101365550|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
33403332|NCT03370133|101365551|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
33333466|NCT02915523|101114730|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
33333467|NCT02915523|101114731|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
33527505|NCT00171158|101830288|FG000|E2 Extension|Other|7|||
33333468|NCT02915523|101114732|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
33403333|NCT03370133|101365546|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
33333469|NCT02915523|101114733|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
33333470|NCT02915523|101114730|FG000|Expansion Phase (Phase 2)|Death|0|||
33333471|NCT02915523|101114731|FG001|Expansion Phase (Phase 2)|Death|0|||
33333472|NCT02915523|101114732|FG002|Expansion Phase (Phase 2)|Death|26|||
33527506|NCT00531947|101830289|FG000|Overall Study|Adverse Event|5|||
33527507|NCT00531947|101830290|FG001|Overall Study|Adverse Event|10|||
33527508|NCT00531947|101830289|FG000|Overall Study|Lost to Follow-up|12|||
33527509|NCT00531947|101830290|FG001|Overall Study|Lost to Follow-up|9|||
33527510|NCT00531947|101830289|FG000|Overall Study|Withdrawal by Subject|14|||
33527511|NCT00531947|101830290|FG001|Overall Study|Withdrawal by Subject|19|||
33333473|NCT02915523|101114733|FG003|Expansion Phase (Phase 2)|Death|53|||
33333474|NCT02915523|101114730|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
33333475|NCT02915523|101114731|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
33333476|NCT02915523|101114732|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
33333477|NCT02915523|101114733|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
33333478|NCT02915523|101114730|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
33333479|NCT02915523|101114731|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
33333480|NCT02915523|101114732|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
33333481|NCT02915523|101114733|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
33333482|NCT02915523|101114730|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
33333483|NCT02915523|101114731|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
33333484|NCT02915523|101114732|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
33333485|NCT02915523|101114733|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
33333486|NCT01118351|101114734|FG000|Overall Study|Adverse Event|3|||
33333487|NCT01118351|101114734|FG000|Overall Study|Withdrawal by Subject|1|||
33333488|NCT00644787|101114735|FG000|Period 1: Titration Phase|Adverse Event|11|||
33333489|NCT00644787|101114736|FG001|Period 1: Titration Phase|Adverse Event|0|||
33333490|NCT00644787|101114737|FG002|Period 1: Titration Phase|Adverse Event|0|||
33333491|NCT00644787|101114735|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
33333492|NCT00644787|101114736|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
33333493|NCT00644787|101114737|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
33333494|NCT00644787|101114735|FG000|Period 1: Titration Phase|Physician Decision|1|||
33333495|NCT00644787|101114736|FG001|Period 1: Titration Phase|Physician Decision|0|||
33333496|NCT00644787|101114737|FG002|Period 1: Titration Phase|Physician Decision|0|||
33333497|NCT00644787|101114735|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
33333498|NCT00644787|101114736|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
33333499|NCT00644787|101114737|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
33333500|NCT00644787|101114735|FG000|Period 1: Titration Phase|Worsening of complications|1|||
33333501|NCT00644787|101114736|FG001|Period 1: Titration Phase|Worsening of complications|0|||
33333502|NCT00644787|101114737|FG002|Period 1: Titration Phase|Worsening of complications|0|||
33333503|NCT00644787|101114735|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
33333504|NCT00644787|101114736|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
33333505|NCT00644787|101114737|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
33333506|NCT00644787|101114735|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
33333507|NCT00644787|101114736|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
33333508|NCT00644787|101114737|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
33333509|NCT00644787|101114735|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
33333510|NCT00644787|101114736|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
33333511|NCT00644787|101114737|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
33333512|NCT00644787|101114735|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
33333513|NCT00644787|101114736|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
33333514|NCT00644787|101114737|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
33527512|NCT00531947|101830289|FG000|Overall Study|Protocol Violation|2|||
33203576|NCT03783923|100645971|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
33203577|NCT03783923|100645972|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
33203578|NCT03783923|100645971|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
33203579|NCT03783923|100645972|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
33203580|NCT03783923|100645971|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
33203581|NCT03783923|100645972|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
33203582|NCT02121847|100645973|FG000|Overall Study|Administrative Reasons|1|||
33203583|NCT02121847|100645973|FG000|Overall Study|Adverse Event|2|||
33203584|NCT04000165|100645974|FG000|Overall Study|Physician Decision|1|||
33203585|NCT04000165|100645974|FG000|Overall Study|Withdrawal by Subject|1|||
33203586|NCT01592708|100645977|FG000|Overall Study|Protocol Violation|3|||
33203587|NCT01592708|100645978|FG001|Overall Study|Protocol Violation|0|||
33203588|NCT04755595|100645979|FG000|Overall Study|Lost to Follow-up|1|||
33203589|NCT00434057|100645980|FG000|Overall Study|Withdrawal by Subject|1|||
33203590|NCT00408993|100645981|FG000|Overall Study|Adverse Event|15|||
33333515|NCT00644787|101114735|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
33203591|NCT00408993|100645982|FG001|Overall Study|Adverse Event|4|||
33527513|NCT00531947|101830290|FG001|Overall Study|Protocol Violation|1|||
33527514|NCT00531947|101830289|FG000|Overall Study|Non-Compliance|4|||
33333516|NCT00644787|101114736|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
33333517|NCT00644787|101114737|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
33203592|NCT00408993|100645981|FG000|Overall Study|Protocol Violation|1|||
33333518|NCT00644787|101114735|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
33333519|NCT00644787|101114736|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
33333520|NCT00644787|101114737|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
33333521|NCT00644787|101114735|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
33333522|NCT00644787|101114736|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
33333523|NCT00644787|101114737|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
33333524|NCT02980224|101114738|FG000|Overall Study|Adverse Event|4|||
33333525|NCT02980224|101114739|FG001|Overall Study|Adverse Event|1|||
33333526|NCT02980224|101114738|FG000|Overall Study|Withdrawal by Subject|0|||
33333527|NCT02980224|101114739|FG001|Overall Study|Withdrawal by Subject|2|||
33333528|NCT00258674|101114740|FG000|Overall Study|Death|32|||
33333529|NCT00258674|101114741|FG001|Overall Study|Death|53|||
33333530|NCT00258674|101114742|FG002|Overall Study|Death|34|||
33333531|NCT00137111|101114743|FG000|Total Therapy|Death|35|||
33333532|NCT00137111|101114744|FG001|Total Therapy|Death|0|||
33333533|NCT00137111|101114745|FG002|Total Therapy|Death|0|||
33333534|NCT00137111|101114746|FG003|Total Therapy|Death|0|||
33333535|NCT00137111|101114743|FG000|Total Therapy|Non Compliance|5|||
33333536|NCT00137111|101114744|FG001|Total Therapy|Non Compliance|0|||
33333537|NCT00137111|101114745|FG002|Total Therapy|Non Compliance|0|||
33333538|NCT00137111|101114746|FG003|Total Therapy|Non Compliance|0|||
33333539|NCT03073980|101114753|FG000|Overall Study|Lost to Follow-up|10|||
33527515|NCT00531947|101830290|FG001|Overall Study|Non-Compliance|7|||
33527516|NCT00531947|101830289|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
33527517|NCT00531947|101830290|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
33527518|NCT00314808|101830293|FG000|Overall Study|Disease Progression without AE|4|||
33527519|NCT00314808|101830293|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
33527520|NCT00158262|101830294|FG000|Overall Study|Lost to Follow-up|1|||
33527521|NCT00158262|101830295|FG001|Overall Study|Lost to Follow-up|1|||
33527522|NCT00703677|101830298|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
33527523|NCT00435461|101830299|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
33527524|NCT00435461|101830300|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
33527525|NCT00435461|101830301|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
33527526|NCT00435461|101830299|FG000|Overall Study|Protocol Violation|6|||
33527527|NCT00435461|101830300|FG001|Overall Study|Protocol Violation|9|||
33527528|NCT00435461|101830301|FG002|Overall Study|Protocol Violation|10|||
33527529|NCT00435461|101830299|FG000|Overall Study|Participant randomized(inadequate score)|1|||
33527530|NCT00435461|101830300|FG001|Overall Study|Participant randomized(inadequate score)|0|||
33527531|NCT00435461|101830301|FG002|Overall Study|Participant randomized(inadequate score)|0|||
33527532|NCT00435461|101830299|FG000|Overall Study|Compliance less than 80 percent|1|||
33527533|NCT00435461|101830300|FG001|Overall Study|Compliance less than 80 percent|0|||
33527534|NCT00435461|101830301|FG002|Overall Study|Compliance less than 80 percent|0|||
33527535|NCT00435461|101830299|FG000|Overall Study|In error, two study medications switched|1|||
33527536|NCT00435461|101830300|FG001|Overall Study|In error, two study medications switched|0|||
33527537|NCT00435461|101830301|FG002|Overall Study|In error, two study medications switched|0|||
33527538|NCT00435461|101830299|FG000|Overall Study|Lack of Efficacy|2|||
33333540|NCT03073980|101114754|FG001|Overall Study|Lost to Follow-up|2|||
33333541|NCT03073980|101114755|FG002|Overall Study|Lost to Follow-up|9|||
33527539|NCT00435461|101830300|FG001|Overall Study|Lack of Efficacy|1|||
33527540|NCT00435461|101830301|FG002|Overall Study|Lack of Efficacy|0|||
33527541|NCT00435461|101830299|FG000|Overall Study|Withdrawal by Subject|1|||
33333542|NCT03073980|101114753|FG000|Overall Study|No post-procedure data|0|||
33333543|NCT03073980|101114754|FG001|Overall Study|No post-procedure data|0|||
33333544|NCT03073980|101114755|FG002|Overall Study|No post-procedure data|2|||
33333545|NCT02287623|101114760|FG000|Overall Study|Protocol Violation|0|||
33333546|NCT02287623|101114761|FG001|Overall Study|Protocol Violation|1|||
33333547|NCT04096274|101114766|FG000|Phase I|Lost to Follow-up|5|||
33527542|NCT00435461|101830300|FG001|Overall Study|Withdrawal by Subject|0|||
33527543|NCT00435461|101830301|FG002|Overall Study|Withdrawal by Subject|2|||
33527544|NCT00435461|101830299|FG000|Overall Study|Randomized in error|1|||
33527545|NCT00435461|101830300|FG001|Overall Study|Randomized in error|0|||
33527546|NCT00435461|101830301|FG002|Overall Study|Randomized in error|0|||
33527547|NCT00435461|101830299|FG000|Overall Study|Participant could not tolerate symptoms|0|||
33527548|NCT00435461|101830300|FG001|Overall Study|Participant could not tolerate symptoms|0|||
33527549|NCT00435461|101830301|FG002|Overall Study|Participant could not tolerate symptoms|1|||
33527550|NCT00435461|101830299|FG000|Overall Study|Participant could not swallow capsule|0|||
33527551|NCT00435461|101830300|FG001|Overall Study|Participant could not swallow capsule|0|||
33527552|NCT00435461|101830301|FG002|Overall Study|Participant could not swallow capsule|1|||
33527553|NCT00435461|101830299|FG000|Overall Study|Pregnancy|2|||
33527554|NCT00435461|101830300|FG001|Overall Study|Pregnancy|0|||
33610571|NCT01912339|102123356|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
33203593|NCT00408993|100645982|FG001|Overall Study|Protocol Violation|6|||
33203594|NCT00408993|100645981|FG000|Overall Study|Lack of Efficacy|1|||
33203595|NCT00408993|100645982|FG001|Overall Study|Lack of Efficacy|4|||
33203596|NCT00408993|100645981|FG000|Overall Study|Withdrawal by Subject|2|||
33203597|NCT00408993|100645982|FG001|Overall Study|Withdrawal by Subject|3|||
33203598|NCT00659269|100645986|FG000|Overall Study|Physician Decision|1|||
33203599|NCT00659269|100645987|FG001|Overall Study|Physician Decision|1|||
33203600|NCT02863991|100645988|FG000|Overall Study|Death|0|||
33203601|NCT02863991|100645989|FG001|Overall Study|Death|3|||
33203602|NCT02863991|100645988|FG000|Overall Study|Lack of Efficacy|0|||
33203603|NCT02863991|100645989|FG001|Overall Study|Lack of Efficacy|1|||
33203604|NCT02863991|100645988|FG000|Overall Study|Study Terminated|2|||
33203605|NCT02863991|100645989|FG001|Overall Study|Study Terminated|8|||
33203606|NCT00759109|100645993|FG000|Overall Study|Adverse Event|17|||
33203607|NCT00759109|100645994|FG001|Overall Study|Adverse Event|12|||
33203608|NCT00759109|100645993|FG000|Overall Study|Inability to comply|1|||
33203609|NCT00759109|100645994|FG001|Overall Study|Inability to comply|1|||
33203610|NCT00759109|100645993|FG000|Overall Study|Withdrawal by Subject|9|||
33203611|NCT00759109|100645994|FG001|Overall Study|Withdrawal by Subject|5|||
33203612|NCT00759109|100645993|FG000|Overall Study|Death|4|||
33203613|NCT00759109|100645994|FG001|Overall Study|Death|3|||
33203614|NCT00759109|100645993|FG000|Overall Study|Lost to Follow-up|4|||
33203615|NCT00759109|100645994|FG001|Overall Study|Lost to Follow-up|6|||
33203616|NCT00759109|100645993|FG000|Overall Study|Started new therapy|2|||
33203617|NCT00759109|100645994|FG001|Overall Study|Started new therapy|6|||
33203618|NCT00759109|100645993|FG000|Overall Study|HCV RNA negative|1|||
33203619|NCT00759109|100645994|FG001|Overall Study|HCV RNA negative|0|||
33203620|NCT00759109|100645993|FG000|Overall Study|Participant moved to a different city|0|||
33203621|NCT00759109|100645994|FG001|Overall Study|Participant moved to a different city|1|||
33203622|NCT00759109|100645993|FG000|Overall Study|Participant had a liver transplant|0|||
33203623|NCT00759109|100645994|FG001|Overall Study|Participant had a liver transplant|1|||
33203624|NCT00759109|100645993|FG000|Overall Study|Lost during study|1|||
33203625|NCT00759109|100645994|FG001|Overall Study|Lost during study|0|||
33203626|NCT01153633|100645998|FG000|Overall Study|Protocol Violation|1|||
33203627|NCT01153633|100645999|FG001|Overall Study|Protocol Violation|1|||
33203628|NCT01153633|100645998|FG000|Overall Study|Therapeutic failure|3|||
33203629|NCT01153633|100645999|FG001|Overall Study|Therapeutic failure|3|||
33203630|NCT00809757|100646002|FG000|Overall Study|Adverse Event|2|||
33203631|NCT00809757|100646003|FG001|Overall Study|Adverse Event|3|||
33203632|NCT00809757|100646004|FG002|Overall Study|Adverse Event|3|||
33203633|NCT00809757|100646002|FG000|Overall Study|Lost to Follow-up|0|||
33203634|NCT00809757|100646003|FG001|Overall Study|Lost to Follow-up|0|||
33203635|NCT00809757|100646004|FG002|Overall Study|Lost to Follow-up|1|||
33203636|NCT00809757|100646002|FG000|Overall Study|Protocol Violation|1|||
33203637|NCT00809757|100646003|FG001|Overall Study|Protocol Violation|1|||
33203638|NCT00809757|100646004|FG002|Overall Study|Protocol Violation|1|||
33203639|NCT00809757|100646002|FG000|Overall Study|Withdrawal by Subject|2|||
33203640|NCT00809757|100646003|FG001|Overall Study|Withdrawal by Subject|1|||
33203641|NCT00809757|100646004|FG002|Overall Study|Withdrawal by Subject|3|||
33203642|NCT00809757|100646002|FG000|Overall Study|Subject Uncooperative|1|||
33527555|NCT00435461|101830301|FG002|Overall Study|Pregnancy|0|||
33527556|NCT00435461|101830299|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
33527557|NCT00435461|101830300|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
33527558|NCT00435461|101830301|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
33203643|NCT00809757|100646003|FG001|Overall Study|Subject Uncooperative|0|||
33203644|NCT00809757|100646004|FG002|Overall Study|Subject Uncooperative|2|||
33203645|NCT00809757|100646002|FG000|Overall Study|Noncompliance with Medication|0|||
33203646|NCT00809757|100646003|FG001|Overall Study|Noncompliance with Medication|0|||
33203647|NCT00809757|100646004|FG002|Overall Study|Noncompliance with Medication|1|||
33203648|NCT05077267|100646005|FG000|Treatment Period|Lost to Follow-up|0|||
33203649|NCT05077267|100646006|FG001|Treatment Period|Lost to Follow-up|1|||
33203650|NCT05077267|100646007|FG002|Treatment Period|Lost to Follow-up|0|||
33203651|NCT05077267|100646005|FG000|Treatment Period|Withdrawal by Subject|0|||
33203652|NCT05077267|100646006|FG001|Treatment Period|Withdrawal by Subject|1|||
33203653|NCT05077267|100646007|FG002|Treatment Period|Withdrawal by Subject|0|||
33203654|NCT05077267|100646005|FG000|Follow-up Period|Lost to Follow-up|0|||
33203655|NCT05077267|100646006|FG001|Follow-up Period|Lost to Follow-up|5|||
33203656|NCT05077267|100646007|FG002|Follow-up Period|Lost to Follow-up|7|||
33203657|NCT05077267|100646005|FG000|Follow-up Period|Withdrawal by Subject|0|||
33203658|NCT05077267|100646006|FG001|Follow-up Period|Withdrawal by Subject|2|||
33203659|NCT05077267|100646007|FG002|Follow-up Period|Withdrawal by Subject|5|||
33203660|NCT05077267|100646005|FG000|Follow-up Period|Study terminated by sponsor|0|||
33203661|NCT05077267|100646006|FG001|Follow-up Period|Study terminated by sponsor|27|||
33203662|NCT05077267|100646007|FG002|Follow-up Period|Study terminated by sponsor|23|||
33203663|NCT05077267|100646005|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
33203664|NCT05077267|100646006|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
33203665|NCT05077267|100646007|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
33203666|NCT05077267|100646005|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
33203667|NCT05077267|100646006|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
33203668|NCT05077267|100646007|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
33203669|NCT02564198|100648468|FG000|Overall Study|Withdrawal by Subject|2|||
33203670|NCT02564198|100648469|FG001|Overall Study|Withdrawal by Subject|4|||
33203671|NCT02564198|100648470|FG002|Overall Study|Withdrawal by Subject|0|||
33203672|NCT02564198|100648468|FG000|Overall Study|Adverse Event|0|||
33203673|NCT02564198|100648469|FG001|Overall Study|Adverse Event|1|||
33203674|NCT02564198|100648470|FG002|Overall Study|Adverse Event|0|||
33203675|NCT00736996|100648471|FG000|Overall Study|Lost to Follow-up|1|||
33203676|NCT00736996|100648472|FG001|Overall Study|Lost to Follow-up|9|||
33333548|NCT04096274|101114767|FG001|Phase I|Lost to Follow-up|5|||
33333549|NCT04096274|101114766|FG000|Phase II|Lost to Follow-up|11|||
33333550|NCT04096274|101114767|FG001|Phase II|Lost to Follow-up|11|||
33527559|NCT00435461|101830299|FG000|Overall Study|Participant ended study one day early|1|||
33527560|NCT00435461|101830300|FG001|Overall Study|Participant ended study one day early|0|||
33527561|NCT00435461|101830301|FG002|Overall Study|Participant ended study one day early|0|||
33527562|NCT00435461|101830299|FG000|Overall Study|Noncompliance with study requirements|1|||
33527563|NCT00435461|101830300|FG001|Overall Study|Noncompliance with study requirements|1|||
33527564|NCT00435461|101830301|FG002|Overall Study|Noncompliance with study requirements|1|||
33527565|NCT00435461|101830299|FG000|Overall Study|Adverse Event|1|||
33527566|NCT00435461|101830300|FG001|Overall Study|Adverse Event|2|||
33527567|NCT00435461|101830301|FG002|Overall Study|Adverse Event|6|||
33527568|NCT00435461|101830299|FG000|Overall Study|Non-Compliance of diary|2|||
33527569|NCT00435461|101830300|FG001|Overall Study|Non-Compliance of diary|0|||
33527570|NCT00435461|101830301|FG002|Overall Study|Non-Compliance of diary|1|||
33527571|NCT00435461|101830299|FG000|Overall Study|Lost to Follow-up|1|||
33527572|NCT00435461|101830300|FG001|Overall Study|Lost to Follow-up|1|||
33203677|NCT00736996|100648473|FG002|Overall Study|Lost to Follow-up|2|||
33203678|NCT00618514|100648476|FG000|Overall Study|Lost to Follow-up|11|||
33203679|NCT00618514|100648477|FG001|Overall Study|Lost to Follow-up|12|||
33203680|NCT00618514|100648478|FG002|Overall Study|Lost to Follow-up|4|||
33203681|NCT02536508|100648481|FG000|Overall Study|Withdrawal by Subject|18|||
33203682|NCT02536508|100648482|FG001|Overall Study|Withdrawal by Subject|13|||
33333551|NCT00457015|101114768|FG000|Overall Study|Left study site against medical advice|0|||
33333552|NCT00457015|101114769|FG001|Overall Study|Left study site against medical advice|1|||
33333553|NCT03099187|101114770|FG000|Double-blind Treatment|Adverse Event|19|||
33203683|NCT02536508|100648483|FG002|Overall Study|Withdrawal by Subject|7|||
33203684|NCT02536508|100648481|FG000|Overall Study|Adverse Event|14|||
33203685|NCT02536508|100648482|FG001|Overall Study|Adverse Event|13|||
33203686|NCT02536508|100648483|FG002|Overall Study|Adverse Event|6|||
33203687|NCT02536508|100648481|FG000|Overall Study|Lost to Follow-up|12|||
33403334|NCT03370133|101365547|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
33403335|NCT03370133|101365548|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
33403336|NCT03370133|101365549|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
33403337|NCT03370133|101365550|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
33403338|NCT03370133|101365551|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
33403339|NCT03370133|101365546|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
33403340|NCT03370133|101365547|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
33403341|NCT03370133|101365548|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
33403342|NCT03370133|101365549|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
33403343|NCT03370133|101365550|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
33403344|NCT03370133|101365551|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
33403345|NCT03370133|101365546|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
33403346|NCT03370133|101365547|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
33403347|NCT03370133|101365548|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
33403348|NCT03370133|101365549|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
33403349|NCT03370133|101365550|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
33403350|NCT03370133|101365551|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
33403351|NCT03370133|101365546|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
33403352|NCT03370133|101365547|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
33403353|NCT03370133|101365548|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
33403354|NCT03370133|101365549|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
33403355|NCT03370133|101365550|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
33403356|NCT03370133|101365551|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
33403357|NCT02519777|101365554|FG000|Overall Study|Death|1|||
33403358|NCT02519777|101365555|FG001|Overall Study|Death|0|||
33403359|NCT02519777|101365556|FG002|Overall Study|Death|0|||
33403360|NCT02519777|101365554|FG000|Overall Study|Lost to Follow-up|0|||
33403361|NCT02519777|101365555|FG001|Overall Study|Lost to Follow-up|4|||
33403362|NCT02519777|101365556|FG002|Overall Study|Lost to Follow-up|2|||
33403363|NCT02519777|101365554|FG000|Overall Study|Withdrawal by Subject|3|||
33403364|NCT02519777|101365555|FG001|Overall Study|Withdrawal by Subject|1|||
33403365|NCT02519777|101365556|FG002|Overall Study|Withdrawal by Subject|0|||
33403366|NCT02519777|101365554|FG000|Overall Study|Severe Debilitation|1|||
33403367|NCT02519777|101365555|FG001|Overall Study|Severe Debilitation|1|||
33403368|NCT02519777|101365556|FG002|Overall Study|Severe Debilitation|1|||
33403369|NCT02519777|101365554|FG000|Overall Study|Not able to get to clinic|1|||
33403370|NCT02519777|101365555|FG001|Overall Study|Not able to get to clinic|2|||
33403371|NCT02519777|101365556|FG002|Overall Study|Not able to get to clinic|1|||
33527573|NCT00435461|101830301|FG002|Overall Study|Lost to Follow-up|2|||
33527574|NCT00790556|101830302|FG000|Treatment Period 1|Physician Decision|1|||
33527575|NCT00790556|101830303|FG001|Treatment Period 1|Physician Decision|0|||
33527576|NCT00790556|101830302|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33527577|NCT00790556|101830303|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33527578|NCT01853748|101830304|FG000|Allocation|Withdrawal by Subject|1|||
33527579|NCT01853748|101830305|FG001|Allocation|Withdrawal by Subject|13|||
33527580|NCT01853748|101830304|FG000|Allocation|not sufficient to receive intervention|0|||
33403372|NCT00723489|101365557|FG000|Overall Study|Physician Decision|0|||
33403373|NCT00723489|101365558|FG001|Overall Study|Physician Decision|1|||
33403374|NCT00723489|101365559|FG002|Overall Study|Physician Decision|0|||
33403375|NCT00723489|101365560|FG003|Overall Study|Physician Decision|0|||
33403376|NCT00723489|101365557|FG000|Overall Study|Pregnancy|0|||
33403377|NCT00723489|101365558|FG001|Overall Study|Pregnancy|0|||
33403378|NCT00723489|101365559|FG002|Overall Study|Pregnancy|0|||
33527581|NCT01853748|101830305|FG001|Allocation|not sufficient to receive intervention|1|||
33527582|NCT01853748|101830304|FG000|Follow-Up|Withdrawal by Subject|7|||
33527583|NCT01853748|101830305|FG001|Follow-Up|Withdrawal by Subject|6|||
33527584|NCT01853748|101830304|FG000|Follow-Up|Adverse Event|67|||
33403379|NCT00723489|101365560|FG003|Overall Study|Pregnancy|1|||
33403380|NCT00723489|101365557|FG000|Overall Study|Withdrawal by Subject|0|||
33403381|NCT00723489|101365558|FG001|Overall Study|Withdrawal by Subject|0|||
33403382|NCT00723489|101365559|FG002|Overall Study|Withdrawal by Subject|0|||
33403383|NCT00723489|101365560|FG003|Overall Study|Withdrawal by Subject|1|||
33403384|NCT00723489|101365557|FG000|Overall Study|Seropositive at baseline|1|||
33403385|NCT00723489|101365558|FG001|Overall Study|Seropositive at baseline|0|||
33403386|NCT00723489|101365559|FG002|Overall Study|Seropositive at baseline|0|||
33403387|NCT00723489|101365560|FG003|Overall Study|Seropositive at baseline|0|||
33403388|NCT00723489|101365557|FG000|Overall Study|Prohibited Medication|0|||
33403389|NCT00723489|101365558|FG001|Overall Study|Prohibited Medication|0|||
33403390|NCT00723489|101365559|FG002|Overall Study|Prohibited Medication|0|||
33403391|NCT00723489|101365560|FG003|Overall Study|Prohibited Medication|1|||
33403392|NCT00723489|101365557|FG000|Overall Study|Samples Collected Out of Window|0|||
33403393|NCT00723489|101365558|FG001|Overall Study|Samples Collected Out of Window|3|||
33403394|NCT00723489|101365559|FG002|Overall Study|Samples Collected Out of Window|0|||
33403395|NCT00723489|101365560|FG003|Overall Study|Samples Collected Out of Window|0|||
33403396|NCT01029691|101365561|FG000|Continued APAP to Delivery|Death|0|||
33403397|NCT01029691|101365562|FG001|Continued APAP to Delivery|Death|0|||
33403398|NCT01029691|101365563|FG002|Continued APAP to Delivery|Death|1|||
33403399|NCT00186121|101365564|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
33403400|NCT00186121|101365564|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
33403401|NCT00186121|101365564|FG000|Overall Study|Not eligible (no treatment)|1|||
33403402|NCT00465894|101365565|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
33403403|NCT00465894|101365566|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
33403404|NCT00465894|101365565|FG000|Treatment For 12 Weeks|Family Issues|1|||
33403405|NCT00465894|101365566|FG001|Treatment For 12 Weeks|Family Issues|1|||
33403406|NCT00465894|101365565|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
33403407|NCT00465894|101365566|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
33403408|NCT00665002|101365567|FG000|Overall Study|Progression/relapse during treatment|11|||
33403409|NCT00665002|101365567|FG000|Overall Study|Cytogenetic resistance|1|||
33403410|NCT01475214|101365568|FG000|Overall Study|Lost to Follow-up|1|||
33403411|NCT01475214|101365569|FG001|Overall Study|Lost to Follow-up|0|||
33403412|NCT01475214|101365570|FG002|Overall Study|Lost to Follow-up|1|||
33403413|NCT01475214|101365568|FG000|Overall Study|Physician Decision|2|||
33403414|NCT01475214|101365569|FG001|Overall Study|Physician Decision|0|||
33403415|NCT01475214|101365570|FG002|Overall Study|Physician Decision|0|||
33403416|NCT01475214|101365568|FG000|Overall Study|Withdrawal by Subject|2|||
33403417|NCT01475214|101365569|FG001|Overall Study|Withdrawal by Subject|4|||
33403418|NCT01475214|101365570|FG002|Overall Study|Withdrawal by Subject|1|||
33403419|NCT02242305|101365573|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
33527585|NCT01853748|101830305|FG001|Follow-Up|Adverse Event|7|||
33527586|NCT01853748|101830304|FG000|Follow-Up|not available for data collection|16|||
33403420|NCT02242305|101365574|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
33403421|NCT02242305|101365573|FG000|Overall Study|Adverse Event|1|||
33527587|NCT01853748|101830305|FG001|Follow-Up|not available for data collection|4|||
33527588|NCT02335346|101830309|FG000|Overall Study|Adverse Event|11|||
33527589|NCT02335346|101830309|FG000|Overall Study|Withdrawal by Subject|1|||
33403422|NCT02242305|101365574|FG001|Overall Study|Adverse Event|0|||
33403423|NCT02242305|101365573|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
33403424|NCT02242305|101365574|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
33403425|NCT02242305|101365573|FG000|Overall Study|Subject withdraws inform consent|0|||
33403426|NCT02242305|101365574|FG001|Overall Study|Subject withdraws inform consent|4|||
33403427|NCT02242305|101365573|FG000|Overall Study|Lost to Follow-up|2|||
33403428|NCT02242305|101365574|FG001|Overall Study|Lost to Follow-up|0|||
33527590|NCT04472494|101830310|FG000|Pre-treatment|Other reasons|2|||
33527591|NCT04472494|101830311|FG001|Pre-treatment|Other reasons|0|||
33527592|NCT04472494|101830310|FG000|Treatment|Death|5|||
33527593|NCT04472494|101830311|FG001|Treatment|Death|2|||
33527594|NCT04472494|101830310|FG000|Treatment|Hospital discharge|1|||
33527595|NCT04472494|101830311|FG001|Treatment|Hospital discharge|1|||
33527596|NCT01497067|101830312|FG000|Overall Study|Lost to Follow-up|56|||
33527597|NCT01497067|101830312|FG000|Overall Study|Adverse Event|3|||
33527598|NCT01497067|101830312|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
33527599|NCT01497067|101830312|FG000|Overall Study|Other|13|||
33527600|NCT03076515|101830313|FG000|Overall Study|DMC decision based on interim analysis|25|||
33403429|NCT00417248|101365575|FG000|Overall Study|Study Terminated|6|||
33403430|NCT00417248|101365575|FG000|Overall Study|Death|1|||
33403431|NCT00417248|101365575|FG000|Overall Study|Lack of Efficacy|1|||
33403432|NCT00106626|101365576|FG000|Overall Study|Adverse Event|5|||
33403433|NCT00106626|101365577|FG001|Overall Study|Adverse Event|4|||
33403434|NCT00106626|101365578|FG002|Overall Study|Adverse Event|3|||
33403435|NCT00106626|101365579|FG003|Overall Study|Adverse Event|3|||
33403436|NCT00106626|101365576|FG000|Overall Study|Progressive Disease|4|||
33403437|NCT00106626|101365577|FG001|Overall Study|Progressive Disease|1|||
33403438|NCT00106626|101365578|FG002|Overall Study|Progressive Disease|9|||
33403439|NCT00106626|101365579|FG003|Overall Study|Progressive Disease|10|||
33403440|NCT00106626|101365576|FG000|Overall Study|Received radiation on new therapy|1|||
33403441|NCT00106626|101365577|FG001|Overall Study|Received radiation on new therapy|0|||
33403442|NCT00106626|101365578|FG002|Overall Study|Received radiation on new therapy|0|||
33403443|NCT00106626|101365579|FG003|Overall Study|Received radiation on new therapy|0|||
33403444|NCT00106626|101365576|FG000|Overall Study|> 14 day delay in therapy start|0|||
33403445|NCT00106626|101365577|FG001|Overall Study|> 14 day delay in therapy start|1|||
33403446|NCT00106626|101365578|FG002|Overall Study|> 14 day delay in therapy start|0|||
33403447|NCT00106626|101365579|FG003|Overall Study|> 14 day delay in therapy start|0|||
33403448|NCT02354599|101365581|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33403449|NCT02354599|101365582|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
33403450|NCT02354599|101365583|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
33403451|NCT02354599|101365584|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
33403452|NCT02354599|101365585|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
33403453|NCT02354599|101365586|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
33527601|NCT03076515|101830314|FG001|Overall Study|DMC decision based on interim analysis|29|||
33527602|NCT00520039|101830318|FG000|Overall Study|Exclusion criteria met at first visit|7|||
33527603|NCT00520039|101830319|FG001|Overall Study|Exclusion criteria met at first visit|5|||
33527604|NCT03518086|101830320|FG000|Overall Study|Adverse Event|23|||
33527605|NCT03518086|101830321|FG001|Overall Study|Adverse Event|15|||
33527606|NCT03518086|101830322|FG002|Overall Study|Adverse Event|0|||
33527607|NCT03518086|101830323|FG003|Overall Study|Adverse Event|0|||
33527608|NCT03518086|101830320|FG000|Overall Study|Withdrawal by Subject|8|||
33527609|NCT03518086|101830321|FG001|Overall Study|Withdrawal by Subject|5|||
33527610|NCT03518086|101830322|FG002|Overall Study|Withdrawal by Subject|0|||
33333554|NCT03099187|101114771|FG001|Double-blind Treatment|Adverse Event|1|||
33333555|NCT03099187|101114772|FG002|Double-blind Treatment|Adverse Event|0|||
33333556|NCT03099187|101114773|FG003|Double-blind Treatment|Adverse Event|0|||
33333557|NCT03099187|101114770|FG000|Double-blind Treatment|Death|1|||
33333558|NCT03099187|101114771|FG001|Double-blind Treatment|Death|3|||
33333559|NCT03099187|101114772|FG002|Double-blind Treatment|Death|0|||
33333560|NCT03099187|101114773|FG003|Double-blind Treatment|Death|0|||
33333561|NCT03099187|101114770|FG000|Double-blind Treatment|Lack of Efficacy|1|||
33333562|NCT03099187|101114771|FG001|Double-blind Treatment|Lack of Efficacy|0|||
33333563|NCT03099187|101114772|FG002|Double-blind Treatment|Lack of Efficacy|0|||
33333564|NCT03099187|101114773|FG003|Double-blind Treatment|Lack of Efficacy|0|||
33333565|NCT03099187|101114770|FG000|Double-blind Treatment|Physician Decision|2|||
33333566|NCT03099187|101114771|FG001|Double-blind Treatment|Physician Decision|1|||
33333567|NCT03099187|101114772|FG002|Double-blind Treatment|Physician Decision|0|||
33333568|NCT03099187|101114773|FG003|Double-blind Treatment|Physician Decision|0|||
33333569|NCT03099187|101114770|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
33333570|NCT03099187|101114771|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
33333571|NCT03099187|101114772|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
33333572|NCT03099187|101114773|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
33333573|NCT03099187|101114770|FG000|Double-blind Treatment|Lung transplantation|0|||
33333574|NCT03099187|101114771|FG001|Double-blind Treatment|Lung transplantation|1|||
33333575|NCT03099187|101114772|FG002|Double-blind Treatment|Lung transplantation|0|||
33333576|NCT03099187|101114773|FG003|Double-blind Treatment|Lung transplantation|0|||
33333577|NCT03099187|101114770|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
33333578|NCT03099187|101114771|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
33333579|NCT03099187|101114772|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
33333580|NCT03099187|101114773|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
33333581|NCT03099187|101114770|FG000|Double-blind Treatment|Disease progression|0|||
33333582|NCT03099187|101114771|FG001|Double-blind Treatment|Disease progression|1|||
33333583|NCT03099187|101114772|FG002|Double-blind Treatment|Disease progression|0|||
33333584|NCT03099187|101114773|FG003|Double-blind Treatment|Disease progression|0|||
33333585|NCT03099187|101114770|FG000|Double-blind Treatment|Randomization error|0|||
33403454|NCT02354599|101365581|FG000|Overall Study|Withdrawal by Subject|1|||
33403455|NCT02354599|101365582|FG001|Overall Study|Withdrawal by Subject|1|||
33403456|NCT02354599|101365583|FG002|Overall Study|Withdrawal by Subject|0|||
33610572|NCT01912339|102123357|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
33203688|NCT02536508|100648482|FG001|Overall Study|Lost to Follow-up|4|||
33333586|NCT03099187|101114771|FG001|Double-blind Treatment|Randomization error|2|||
33403457|NCT02354599|101365584|FG003|Overall Study|Withdrawal by Subject|0|||
33403458|NCT02354599|101365585|FG004|Overall Study|Withdrawal by Subject|0|||
33610573|NCT01912339|102123358|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
33610574|NCT01912339|102123356|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
33610575|NCT01912339|102123357|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
33610576|NCT01912339|102123358|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
33610577|NCT01912339|102123356|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
33610578|NCT01912339|102123357|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
33610579|NCT01912339|102123358|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
33610580|NCT01912339|102123356|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
33610581|NCT01912339|102123357|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
33610582|NCT01912339|102123358|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
33610583|NCT00534976|102123365|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
33610584|NCT00534976|102123366|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
33610585|NCT00534976|102123365|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
33610586|NCT00534976|102123366|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
33610587|NCT00534976|102123365|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
33333587|NCT03099187|101114772|FG002|Double-blind Treatment|Randomization error|0|||
33333588|NCT03099187|101114773|FG003|Double-blind Treatment|Randomization error|0|||
33333589|NCT03099187|101114770|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
33333590|NCT03099187|101114771|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
33333591|NCT03099187|101114772|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
33333592|NCT03099187|101114773|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
33333593|NCT03099187|101114770|FG000|12-month Safety Follow-up|Adverse Event|0|||
33333594|NCT03099187|101114771|FG001|12-month Safety Follow-up|Adverse Event|0|||
33333595|NCT03099187|101114772|FG002|12-month Safety Follow-up|Adverse Event|5|||
33333596|NCT03099187|101114773|FG003|12-month Safety Follow-up|Adverse Event|12|||
33333597|NCT03099187|101114770|FG000|12-month Safety Follow-up|Death|0|||
33333598|NCT03099187|101114771|FG001|12-month Safety Follow-up|Death|0|||
33333599|NCT03099187|101114772|FG002|12-month Safety Follow-up|Death|7|||
33333600|NCT03099187|101114773|FG003|12-month Safety Follow-up|Death|9|||
33333601|NCT03099187|101114770|FG000|12-month Safety Follow-up|Lung transplantation|0|||
33333602|NCT03099187|101114771|FG001|12-month Safety Follow-up|Lung transplantation|0|||
33333603|NCT03099187|101114772|FG002|12-month Safety Follow-up|Lung transplantation|2|||
33333604|NCT03099187|101114773|FG003|12-month Safety Follow-up|Lung transplantation|1|||
33333605|NCT03099187|101114770|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
33333606|NCT03099187|101114771|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
33333607|NCT03099187|101114772|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
33333608|NCT03099187|101114773|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
33333609|NCT03099187|101114770|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
33333610|NCT03099187|101114771|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
33333611|NCT03099187|101114772|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
33333612|NCT03099187|101114773|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
33333613|NCT03099187|101114770|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
33333614|NCT03099187|101114771|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
33527611|NCT03518086|101830323|FG003|Overall Study|Withdrawal by Subject|0|||
33527612|NCT03518086|101830320|FG000|Overall Study|Lack of Efficacy|5|||
33527613|NCT03518086|101830321|FG001|Overall Study|Lack of Efficacy|5|||
33527614|NCT03518086|101830322|FG002|Overall Study|Lack of Efficacy|0|||
33527615|NCT03518086|101830323|FG003|Overall Study|Lack of Efficacy|0|||
33527616|NCT03518086|101830320|FG000|Overall Study|Protocol Violation|1|||
33527617|NCT03518086|101830321|FG001|Overall Study|Protocol Violation|5|||
33527618|NCT03518086|101830322|FG002|Overall Study|Protocol Violation|0|||
33527619|NCT03518086|101830323|FG003|Overall Study|Protocol Violation|0|||
33527620|NCT03518086|101830320|FG000|Overall Study|Lost to Follow-up|0|||
33527621|NCT03518086|101830321|FG001|Overall Study|Lost to Follow-up|3|||
33527622|NCT03518086|101830322|FG002|Overall Study|Lost to Follow-up|0|||
33527623|NCT03518086|101830323|FG003|Overall Study|Lost to Follow-up|0|||
33527624|NCT03518086|101830320|FG000|Overall Study|Insufficient Diary Data|0|||
33527625|NCT03518086|101830321|FG001|Overall Study|Insufficient Diary Data|2|||
33527626|NCT03518086|101830322|FG002|Overall Study|Insufficient Diary Data|0|||
33527627|NCT03518086|101830323|FG003|Overall Study|Insufficient Diary Data|0|||
33527628|NCT03518086|101830320|FG000|Overall Study|Non- compliance to Protocol|0|||
33527629|NCT03518086|101830321|FG001|Overall Study|Non- compliance to Protocol|1|||
33333615|NCT03099187|101114772|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
33527630|NCT03518086|101830322|FG002|Overall Study|Non- compliance to Protocol|0|||
33527631|NCT03518086|101830323|FG003|Overall Study|Non- compliance to Protocol|0|||
33527632|NCT03518086|101830320|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
33527633|NCT03518086|101830321|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
33527634|NCT03518086|101830322|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
33610588|NCT00534976|102123366|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
33610589|NCT02292706|102123370|FG000|Overall Study|Lost to Follow-up|20|||
33610590|NCT02292706|102123371|FG001|Overall Study|Lost to Follow-up|44|||
33610591|NCT02292706|102123372|FG002|Overall Study|Lost to Follow-up|24|||
33610592|NCT02292706|102123373|FG003|Overall Study|Lost to Follow-up|61|||
33610593|NCT02292706|102123374|FG004|Overall Study|Lost to Follow-up|21|||
33610594|NCT02292706|102123375|FG005|Overall Study|Lost to Follow-up|52|||
33610595|NCT02292706|102123376|FG006|Overall Study|Lost to Follow-up|25|||
33527635|NCT03518086|101830323|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
33527636|NCT03518086|101830320|FG000|Overall Study|Site Terminated by Sponsor|0|||
33527637|NCT03518086|101830321|FG001|Overall Study|Site Terminated by Sponsor|1|||
33527638|NCT03518086|101830322|FG002|Overall Study|Site Terminated by Sponsor|0|||
33527639|NCT03518086|101830323|FG003|Overall Study|Site Terminated by Sponsor|0|||
33527640|NCT01775787|101830329|FG000|First 7-10 Days|Adverse Event|0|||
33527641|NCT01775787|101830330|FG001|First 7-10 Days|Adverse Event|1|||
33527642|NCT01775787|101830329|FG000|First 7-10 Days|family emergency|0|||
33527643|NCT01775787|101830330|FG001|First 7-10 Days|family emergency|1|||
33527644|NCT01775787|101830329|FG000|First 7-10 Days|time commitment|0|||
33527645|NCT01775787|101830330|FG001|First 7-10 Days|time commitment|2|||
33610596|NCT02292706|102123377|FG007|Overall Study|Lost to Follow-up|0|||
33610597|NCT02292706|102123370|FG000|Overall Study|Withdrew consent|15|||
33610598|NCT02292706|102123371|FG001|Overall Study|Withdrew consent|56|||
33610599|NCT02292706|102123372|FG002|Overall Study|Withdrew consent|43|||
33610600|NCT02292706|102123373|FG003|Overall Study|Withdrew consent|36|||
33610601|NCT02292706|102123374|FG004|Overall Study|Withdrew consent|13|||
33610602|NCT02292706|102123375|FG005|Overall Study|Withdrew consent|51|||
33610603|NCT02292706|102123376|FG006|Overall Study|Withdrew consent|20|||
33610604|NCT02292706|102123377|FG007|Overall Study|Withdrew consent|0|||
33610605|NCT02292706|102123370|FG000|Overall Study|Death|3|||
33610606|NCT02292706|102123371|FG001|Overall Study|Death|11|||
33527646|NCT01775787|101830329|FG000|First 7-10 Days|concerns with using IV|1|||
33527647|NCT01775787|101830330|FG001|First 7-10 Days|concerns with using IV|2|||
33527648|NCT01775787|101830329|FG000|Second 7-10 Days|time commitment|0|||
33527649|NCT01775787|101830330|FG001|Second 7-10 Days|time commitment|1|||
33527650|NCT01775787|101830329|FG000|Second 7-10 Days|concerns with using IV|0|||
33527651|NCT01775787|101830330|FG001|Second 7-10 Days|concerns with using IV|1|||
33527652|NCT01939223|101830331|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
33527653|NCT01939223|101830332|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
33527654|NCT01939223|101830331|FG000|Overall Study|Disease recurrence (radiological)|1|||
33527655|NCT01939223|101830332|FG001|Overall Study|Disease recurrence (radiological)|3|||
33527656|NCT01939223|101830331|FG000|Overall Study|Study stopped by Sponsor|5|||
33610607|NCT02292706|102123372|FG002|Overall Study|Death|16|||
33610608|NCT02292706|102123373|FG003|Overall Study|Death|22|||
33610609|NCT02292706|102123374|FG004|Overall Study|Death|8|||
33610610|NCT02292706|102123375|FG005|Overall Study|Death|17|||
33527657|NCT01939223|101830332|FG001|Overall Study|Study stopped by Sponsor|7|||
33527658|NCT01939223|101830331|FG000|Overall Study|Withdrawal by Subject|6|||
33527659|NCT01939223|101830332|FG001|Overall Study|Withdrawal by Subject|0|||
33610611|NCT02292706|102123376|FG006|Overall Study|Death|3|||
33610612|NCT02292706|102123377|FG007|Overall Study|Death|0|||
33610613|NCT02292706|102123370|FG000|Overall Study|Study terminated by sponsor|0|||
33610614|NCT02292706|102123371|FG001|Overall Study|Study terminated by sponsor|9|||
33610615|NCT02292706|102123372|FG002|Overall Study|Study terminated by sponsor|4|||
33333616|NCT03099187|101114773|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
33333617|NCT03099187|101114770|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
33333618|NCT03099187|101114771|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
33333619|NCT03099187|101114772|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
33333620|NCT03099187|101114773|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
33333621|NCT00371865|101114775|FG000|Overall Study|Lack of Efficacy|0|||
33333622|NCT00371865|101114776|FG001|Overall Study|Lack of Efficacy|2|||
33333623|NCT00371865|101114775|FG000|Overall Study|Protocol Violation|3|||
33333624|NCT00371865|101114776|FG001|Overall Study|Protocol Violation|2|||
33333625|NCT00371865|101114775|FG000|Overall Study|Withdrawal by Subject|12|||
33333626|NCT00371865|101114776|FG001|Overall Study|Withdrawal by Subject|10|||
33333627|NCT01006265|101114777|FG000|Overall Study|Lost to Follow-up|1|||
33527660|NCT02080364|101830335|FG000|Baseline Period|Protocol Violation|2|||
33527661|NCT02080364|101830336|FG001|Baseline Period|Protocol Violation|1|||
33527662|NCT02080364|101830337|FG002|Baseline Period|Protocol Violation|0|||
33527663|NCT02080364|101830338|FG003|Baseline Period|Protocol Violation|0|||
33527664|NCT02080364|101830335|FG000|Baseline Period|Other|0|||
33610616|NCT02292706|102123373|FG003|Overall Study|Study terminated by sponsor|21|||
33610617|NCT02292706|102123374|FG004|Overall Study|Study terminated by sponsor|11|||
33610618|NCT02292706|102123375|FG005|Overall Study|Study terminated by sponsor|13|||
33610619|NCT02292706|102123376|FG006|Overall Study|Study terminated by sponsor|3|||
33610620|NCT02292706|102123377|FG007|Overall Study|Study terminated by sponsor|0|||
33610621|NCT02292706|102123370|FG000|Overall Study|Investigator's discretion|4|||
33610622|NCT02292706|102123371|FG001|Overall Study|Investigator's discretion|9|||
33610623|NCT02292706|102123372|FG002|Overall Study|Investigator's discretion|7|||
33610624|NCT02292706|102123373|FG003|Overall Study|Investigator's discretion|11|||
33610625|NCT02292706|102123374|FG004|Overall Study|Investigator's discretion|4|||
33610626|NCT02292706|102123375|FG005|Overall Study|Investigator's discretion|10|||
33610627|NCT02292706|102123376|FG006|Overall Study|Investigator's discretion|1|||
33610628|NCT02292706|102123377|FG007|Overall Study|Investigator's discretion|0|||
33610629|NCT02292706|102123370|FG000|Overall Study|Liver transplant|1|||
33610630|NCT02292706|102123371|FG001|Overall Study|Liver transplant|1|||
33610631|NCT02292706|102123372|FG002|Overall Study|Liver transplant|11|||
33610632|NCT02292706|102123373|FG003|Overall Study|Liver transplant|16|||
33610633|NCT02292706|102123374|FG004|Overall Study|Liver transplant|5|||
33610634|NCT02292706|102123375|FG005|Overall Study|Liver transplant|6|||
33610635|NCT02292706|102123376|FG006|Overall Study|Liver transplant|5|||
33610636|NCT02292706|102123377|FG007|Overall Study|Liver transplant|0|||
33610637|NCT02292706|102123370|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
33610638|NCT02292706|102123371|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
33610639|NCT02292706|102123372|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
33610640|NCT02292706|102123373|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
33610641|NCT02292706|102123374|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
33610642|NCT02292706|102123375|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
33610643|NCT02292706|102123376|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
33610644|NCT02292706|102123377|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
33610645|NCT02292706|102123370|FG000|Overall Study|Subject terminated by sponsor|1|||
33610646|NCT02292706|102123371|FG001|Overall Study|Subject terminated by sponsor|0|||
33610647|NCT02292706|102123372|FG002|Overall Study|Subject terminated by sponsor|0|||
33610648|NCT02292706|102123373|FG003|Overall Study|Subject terminated by sponsor|2|||
33610649|NCT02292706|102123374|FG004|Overall Study|Subject terminated by sponsor|1|||
33610650|NCT02292706|102123375|FG005|Overall Study|Subject terminated by sponsor|0|||
33610651|NCT02292706|102123376|FG006|Overall Study|Subject terminated by sponsor|0|||
33610652|NCT02292706|102123377|FG007|Overall Study|Subject terminated by sponsor|0|||
33610653|NCT02292706|102123370|FG000|Overall Study|Missing|0|||
33610654|NCT02292706|102123371|FG001|Overall Study|Missing|0|||
33610655|NCT02292706|102123372|FG002|Overall Study|Missing|1|||
33610656|NCT02292706|102123373|FG003|Overall Study|Missing|1|||
33610657|NCT02292706|102123374|FG004|Overall Study|Missing|0|||
33610658|NCT02292706|102123375|FG005|Overall Study|Missing|1|||
33610659|NCT02292706|102123376|FG006|Overall Study|Missing|0|||
33610660|NCT02292706|102123377|FG007|Overall Study|Missing|0|||
33610661|NCT02292706|102123370|FG000|Overall Study|Virologic relapse or reinfection|1|||
33610662|NCT02292706|102123371|FG001|Overall Study|Virologic relapse or reinfection|0|||
33610663|NCT02292706|102123372|FG002|Overall Study|Virologic relapse or reinfection|0|||
33610664|NCT02292706|102123373|FG003|Overall Study|Virologic relapse or reinfection|1|||
33610665|NCT02292706|102123374|FG004|Overall Study|Virologic relapse or reinfection|0|||
33610666|NCT02292706|102123375|FG005|Overall Study|Virologic relapse or reinfection|1|||
33610667|NCT02292706|102123376|FG006|Overall Study|Virologic relapse or reinfection|0|||
33610668|NCT02292706|102123377|FG007|Overall Study|Virologic relapse or reinfection|0|||
33610669|NCT01620762|102123382|FG000|Overall Study|Protocol Violation|1|||
33610670|NCT01620762|102123383|FG001|Overall Study|Protocol Violation|1|||
33610671|NCT01620762|102123384|FG002|Overall Study|Protocol Violation|1|||
33610672|NCT01620762|102123382|FG000|Overall Study|Adverse Event|9|||
33527665|NCT02080364|101830336|FG001|Baseline Period|Other|1|||
33527666|NCT02080364|101830337|FG002|Baseline Period|Other|1|||
33527667|NCT02080364|101830338|FG003|Baseline Period|Other|0|||
33527668|NCT02080364|101830335|FG000|Treatment Period|Adverse Event|10|||
33527669|NCT02080364|101830336|FG001|Treatment Period|Adverse Event|15|||
33527670|NCT02080364|101830337|FG002|Treatment Period|Adverse Event|11|||
33527671|NCT02080364|101830338|FG003|Treatment Period|Adverse Event|14|||
33527672|NCT02080364|101830335|FG000|Treatment Period|Lost to Follow-up|2|||
33527673|NCT02080364|101830336|FG001|Treatment Period|Lost to Follow-up|3|||
33527674|NCT02080364|101830337|FG002|Treatment Period|Lost to Follow-up|5|||
33527675|NCT02080364|101830338|FG003|Treatment Period|Lost to Follow-up|0|||
33527676|NCT02080364|101830335|FG000|Treatment Period|Protocol Violation|5|||
33527677|NCT02080364|101830336|FG001|Treatment Period|Protocol Violation|3|||
33527678|NCT02080364|101830337|FG002|Treatment Period|Protocol Violation|5|||
33527679|NCT02080364|101830338|FG003|Treatment Period|Protocol Violation|1|||
33610673|NCT01620762|102123383|FG001|Overall Study|Adverse Event|5|||
33527680|NCT02080364|101830335|FG000|Treatment Period|Withdrawal by Subject|16|||
33527681|NCT02080364|101830336|FG001|Treatment Period|Withdrawal by Subject|16|||
33610674|NCT01620762|102123384|FG002|Overall Study|Adverse Event|2|||
33610675|NCT01620762|102123382|FG000|Overall Study|Withdrawal by Subject|23|||
33610676|NCT01620762|102123383|FG001|Overall Study|Withdrawal by Subject|26|||
33527682|NCT02080364|101830337|FG002|Treatment Period|Withdrawal by Subject|15|||
33610677|NCT01620762|102123384|FG002|Overall Study|Withdrawal by Subject|27|||
33610678|NCT01620762|102123382|FG000|Overall Study|Lost to Follow-up|11|||
33203689|NCT02536508|100648483|FG002|Overall Study|Lost to Follow-up|0|||
33527683|NCT02080364|101830338|FG003|Treatment Period|Withdrawal by Subject|10|||
33527684|NCT02080364|101830335|FG000|Treatment Period|Study Terminated by Sponsor|0|||
33610679|NCT01620762|102123383|FG001|Overall Study|Lost to Follow-up|17|||
33610680|NCT01620762|102123384|FG002|Overall Study|Lost to Follow-up|10|||
33610681|NCT01620762|102123382|FG000|Overall Study|Protocol deviation|1|||
33610682|NCT01620762|102123383|FG001|Overall Study|Protocol deviation|1|||
33610683|NCT01620762|102123384|FG002|Overall Study|Protocol deviation|6|||
33610684|NCT01620762|102123382|FG000|Overall Study|Subject deterioration|0|||
33203690|NCT02536508|100648481|FG000|Overall Study|Lack of Efficacy|3|||
33203691|NCT02536508|100648482|FG001|Overall Study|Lack of Efficacy|5|||
33333628|NCT01006265|101114778|FG001|Overall Study|Lost to Follow-up|0|||
33403459|NCT02354599|101365586|FG005|Overall Study|Withdrawal by Subject|0|||
33403460|NCT02058966|101365587|FG000|Open-Label Methamphetamine|Adverse Event|1|||
33403461|NCT02058966|101365587|FG000|First Intervention|Withdrawal by Subject|1|||
33403462|NCT02612194|101365591|FG000|Overall Study|Death|5|||
33403463|NCT02612194|101365592|FG001|Overall Study|Death|0|||
33403464|NCT02612194|101365593|FG002|Overall Study|Death|2|||
33403465|NCT02612194|101365591|FG000|Overall Study|Early Study Termination|1|||
33527685|NCT02080364|101830336|FG001|Treatment Period|Study Terminated by Sponsor|0|||
33527686|NCT02080364|101830337|FG002|Treatment Period|Study Terminated by Sponsor|180|||
33527687|NCT02080364|101830338|FG003|Treatment Period|Study Terminated by Sponsor|183|||
33527688|NCT02080364|101830335|FG000|Treatment Period|Other|14|||
33527689|NCT02080364|101830336|FG001|Treatment Period|Other|12|||
33333629|NCT01006265|101114779|FG002|Overall Study|Lost to Follow-up|1|||
33333630|NCT01006265|101114780|FG003|Overall Study|Lost to Follow-up|0|||
33333631|NCT01006265|101114777|FG000|Overall Study|Withdrawal by Subject|4|||
33333632|NCT01006265|101114778|FG001|Overall Study|Withdrawal by Subject|7|||
33333633|NCT01006265|101114779|FG002|Overall Study|Withdrawal by Subject|5|||
33333634|NCT01006265|101114780|FG003|Overall Study|Withdrawal by Subject|5|||
33333635|NCT01006265|101114777|FG000|Overall Study|Administrative reason|1|||
33333636|NCT01006265|101114778|FG001|Overall Study|Administrative reason|2|||
33333637|NCT01006265|101114779|FG002|Overall Study|Administrative reason|3|||
33333638|NCT01006265|101114780|FG003|Overall Study|Administrative reason|0|||
33333639|NCT04288154|101114781|FG000|Overall Study|Withdrawal by Subject|9|||
33333640|NCT04288154|101114782|FG001|Overall Study|Withdrawal by Subject|9|||
33333641|NCT01277549|101114783|FG000|Overall Study|Failed to meet eligibility criteria|13|||
33527690|NCT02080364|101830337|FG002|Treatment Period|Other|21|||
33527691|NCT02080364|101830338|FG003|Treatment Period|Other|16|||
33527692|NCT03026283|101830341|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
33527693|NCT03026283|101830342|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
33527694|NCT03026283|101830343|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
33527695|NCT03026283|101830344|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
33527696|NCT03026283|101830345|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
33527697|NCT03026283|101830346|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
33527698|NCT03026283|101830347|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
33527699|NCT03026283|101830348|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
33527700|NCT03026283|101830341|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
33527701|NCT03026283|101830342|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
33527702|NCT03026283|101830343|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
33527703|NCT03026283|101830344|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
33527704|NCT03026283|101830345|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
33527705|NCT03026283|101830346|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
33527706|NCT03026283|101830347|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
33527707|NCT03026283|101830348|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
33527708|NCT03026283|101830341|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
33527709|NCT03026283|101830342|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
33527710|NCT03026283|101830343|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
33527711|NCT03026283|101830344|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
33527712|NCT03026283|101830345|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
33527713|NCT03026283|101830346|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
33527714|NCT03026283|101830347|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
33527715|NCT03026283|101830348|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
33527716|NCT03026283|101830341|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
33527717|NCT03026283|101830342|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
33527718|NCT03026283|101830343|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
33203692|NCT02536508|100648483|FG002|Overall Study|Lack of Efficacy|4|||
33333642|NCT01277549|101114784|FG001|Overall Study|Failed to meet eligibility criteria|9|||
33333643|NCT01277549|101114783|FG000|Overall Study|Withdrawal by Subject|1|||
33527719|NCT03026283|101830344|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
33527720|NCT03026283|101830345|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
33333644|NCT01277549|101114784|FG001|Overall Study|Withdrawal by Subject|3|||
33333645|NCT01277549|101114783|FG000|Overall Study|Protocol Violation|10|||
33403466|NCT02612194|101365592|FG001|Overall Study|Early Study Termination|0|||
33403467|NCT02612194|101365593|FG002|Overall Study|Early Study Termination|0|||
33610685|NCT01620762|102123383|FG001|Overall Study|Subject deterioration|1|||
33403468|NCT01230827|101365594|FG000|Overall Study|Lost to Follow-up|0|||
33403469|NCT01230827|101365595|FG001|Overall Study|Lost to Follow-up|0|||
33403470|NCT01230827|101365596|FG002|Overall Study|Lost to Follow-up|1|||
33403471|NCT01230827|101365597|FG003|Overall Study|Lost to Follow-up|3|||
33403472|NCT01230827|101365594|FG000|Overall Study|Withdrawal by Subject|1|||
33403473|NCT01230827|101365595|FG001|Overall Study|Withdrawal by Subject|0|||
33403474|NCT01230827|101365596|FG002|Overall Study|Withdrawal by Subject|3|||
33403475|NCT01230827|101365597|FG003|Overall Study|Withdrawal by Subject|2|||
33403476|NCT01230827|101365594|FG000|Overall Study|Lack of Efficacy|14|||
33403477|NCT01230827|101365595|FG001|Overall Study|Lack of Efficacy|1|||
33403478|NCT01230827|101365596|FG002|Overall Study|Lack of Efficacy|2|||
33403479|NCT01230827|101365597|FG003|Overall Study|Lack of Efficacy|3|||
33403480|NCT01230827|101365594|FG000|Overall Study|Adverse Event|4|||
33403481|NCT01230827|101365595|FG001|Overall Study|Adverse Event|2|||
33403482|NCT01230827|101365596|FG002|Overall Study|Adverse Event|3|||
33403483|NCT01230827|101365597|FG003|Overall Study|Adverse Event|7|||
33403484|NCT01230827|101365594|FG000|Overall Study|Recovery|0|||
33403485|NCT01230827|101365595|FG001|Overall Study|Recovery|6|||
33403486|NCT01230827|101365596|FG002|Overall Study|Recovery|0|||
33403487|NCT01230827|101365597|FG003|Overall Study|Recovery|0|||
33403488|NCT01230827|101365594|FG000|Overall Study|Study terminated by Sponsor|0|||
33403489|NCT01230827|101365595|FG001|Overall Study|Study terminated by Sponsor|2|||
33403490|NCT01230827|101365596|FG002|Overall Study|Study terminated by Sponsor|56|||
33403491|NCT01230827|101365597|FG003|Overall Study|Study terminated by Sponsor|63|||
33403492|NCT01592773|101365604|FG000|Overall Study|Study Terminated by Sponsor|582|||
33403493|NCT01592773|101365604|FG000|Overall Study|Withdrawal by Subject|35|||
33403494|NCT01592773|101365604|FG000|Overall Study|Lost to Follow-up|19|||
33403495|NCT01592773|101365604|FG000|Overall Study|Adverse Event|17|||
33403496|NCT01592773|101365604|FG000|Overall Study|Lack of Efficacy|9|||
33403497|NCT01592773|101365604|FG000|Overall Study|Protocol Violation|2|||
33403498|NCT01592773|101365604|FG000|Overall Study|Inclusion/exclusion not meet|1|||
33403499|NCT01592773|101365604|FG000|Overall Study|Other Reason|1|||
33403500|NCT04450394|101365606|FG000|Overall Study|Adverse Event|2|||
33403501|NCT04450394|101365607|FG001|Overall Study|Adverse Event|0|||
33403502|NCT04450394|101365608|FG002|Overall Study|Adverse Event|0|||
33403503|NCT04450394|101365606|FG000|Overall Study|Death|0|||
33403504|NCT04450394|101365607|FG001|Overall Study|Death|1|||
33403505|NCT04450394|101365608|FG002|Overall Study|Death|0|||
33403506|NCT04450394|101365606|FG000|Overall Study|Lost to Follow-up|0|||
33403507|NCT04450394|101365607|FG001|Overall Study|Lost to Follow-up|3|||
33403508|NCT04450394|101365608|FG002|Overall Study|Lost to Follow-up|0|||
33403509|NCT04450394|101365606|FG000|Overall Study|Physician Decision|0|||
33403510|NCT04450394|101365607|FG001|Overall Study|Physician Decision|1|||
33403511|NCT04450394|101365608|FG002|Overall Study|Physician Decision|0|||
33403512|NCT04450394|101365606|FG000|Overall Study|Protocol Violation|2|||
33403513|NCT04450394|101365607|FG001|Overall Study|Protocol Violation|0|||
33403514|NCT04450394|101365608|FG002|Overall Study|Protocol Violation|0|||
33403515|NCT04450394|101365606|FG000|Overall Study|Withdrawal by Subject|6|||
33403516|NCT04450394|101365607|FG001|Overall Study|Withdrawal by Subject|9|||
33403517|NCT04450394|101365608|FG002|Overall Study|Withdrawal by Subject|0|||
33403518|NCT01673373|101365611|FG000|Overall Study|Death|2|||
33403519|NCT02055976|101365615|FG000|Overall Study|Other|0|||
33403520|NCT02055976|101365616|FG001|Overall Study|Other|0|||
33403521|NCT02055976|101365617|FG002|Overall Study|Other|1|||
33527721|NCT03026283|101830346|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
33527722|NCT03026283|101830347|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
33527723|NCT03026283|101830348|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
33527724|NCT03026283|101830341|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
33403522|NCT02055976|101365618|FG003|Overall Study|Other|0|||
33403523|NCT02055976|101365619|FG004|Overall Study|Other|0|||
33403524|NCT02055976|101365620|FG005|Overall Study|Other|0|||
33403525|NCT02055976|101365621|FG006|Overall Study|Other|0|||
33403526|NCT02055976|101365622|FG007|Overall Study|Other|0|||
33403527|NCT02055976|101365623|FG008|Overall Study|Other|0|||
33403528|NCT02055976|101365615|FG000|Overall Study|Adverse Event|0|||
33403529|NCT02055976|101365616|FG001|Overall Study|Adverse Event|0|||
33403530|NCT02055976|101365617|FG002|Overall Study|Adverse Event|0|||
33403531|NCT02055976|101365618|FG003|Overall Study|Adverse Event|0|||
33403532|NCT02055976|101365619|FG004|Overall Study|Adverse Event|0|||
33403533|NCT02055976|101365620|FG005|Overall Study|Adverse Event|1|||
33403534|NCT02055976|101365621|FG006|Overall Study|Adverse Event|1|||
33403535|NCT02055976|101365622|FG007|Overall Study|Adverse Event|0|||
33403536|NCT02055976|101365623|FG008|Overall Study|Adverse Event|0|||
33403537|NCT02055976|101365615|FG000|Overall Study|Does not meet entrance criteria|0|||
33403538|NCT02055976|101365616|FG001|Overall Study|Does not meet entrance criteria|0|||
33403539|NCT02055976|101365617|FG002|Overall Study|Does not meet entrance criteria|0|||
33403540|NCT02055976|101365618|FG003|Overall Study|Does not meet entrance criteria|0|||
33403541|NCT02055976|101365619|FG004|Overall Study|Does not meet entrance criteria|0|||
33403542|NCT02055976|101365620|FG005|Overall Study|Does not meet entrance criteria|0|||
33403543|NCT02055976|101365621|FG006|Overall Study|Does not meet entrance criteria|1|||
33403544|NCT02055976|101365622|FG007|Overall Study|Does not meet entrance criteria|0|||
33403545|NCT02055976|101365623|FG008|Overall Study|Does not meet entrance criteria|0|||
33403546|NCT02055976|101365615|FG000|Overall Study|Lost to Follow-up|0|||
33403547|NCT02055976|101365616|FG001|Overall Study|Lost to Follow-up|0|||
33403548|NCT02055976|101365617|FG002|Overall Study|Lost to Follow-up|0|||
33403549|NCT02055976|101365618|FG003|Overall Study|Lost to Follow-up|1|||
33403550|NCT02055976|101365619|FG004|Overall Study|Lost to Follow-up|0|||
33403551|NCT02055976|101365620|FG005|Overall Study|Lost to Follow-up|0|||
33403552|NCT02055976|101365621|FG006|Overall Study|Lost to Follow-up|0|||
33403553|NCT02055976|101365622|FG007|Overall Study|Lost to Follow-up|0|||
33403554|NCT02055976|101365623|FG008|Overall Study|Lost to Follow-up|0|||
33403555|NCT03480360|101365624|FG000|Overall Study|Death|2|||
33403556|NCT00003389|101365625|FG000|Overall Study|Disease progression|6|||
33403557|NCT00003389|101365626|FG001|Overall Study|Disease progression|1|||
33527725|NCT03026283|101830342|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
33527726|NCT03026283|101830343|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
33527727|NCT03026283|101830344|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
33527728|NCT03026283|101830345|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
33527729|NCT03026283|101830346|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
33527730|NCT03026283|101830347|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
33527731|NCT03026283|101830348|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
33527732|NCT03026283|101830341|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
33527733|NCT03026283|101830342|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
33527734|NCT03026283|101830343|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
33527735|NCT03026283|101830344|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
33527736|NCT03026283|101830345|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
33527737|NCT03026283|101830346|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
33527738|NCT03026283|101830347|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
33527739|NCT03026283|101830348|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
33527740|NCT03026283|101830341|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
33527741|NCT03026283|101830342|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
33527742|NCT03026283|101830343|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
33527743|NCT03026283|101830344|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
33527744|NCT03026283|101830345|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
33527745|NCT03026283|101830346|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
33333646|NCT01277549|101114784|FG001|Overall Study|Protocol Violation|1|||
33333647|NCT01277549|101114783|FG000|Overall Study|Physician Decision|2|||
33333648|NCT01277549|101114784|FG001|Overall Study|Physician Decision|1|||
33333649|NCT01627899|101114785|FG000|Overall Study|Study terminated early by sponsor.|5|||
33333650|NCT03116698|101114790|FG000|Overall Study|Adverse Event|1|||
33333651|NCT03116698|101114791|FG001|Overall Study|Adverse Event|1|||
33333652|NCT03116698|101114792|FG002|Overall Study|Adverse Event|1|||
33333653|NCT03116698|101114793|FG003|Overall Study|Adverse Event|0|||
33333654|NCT03116698|101114790|FG000|Overall Study|Withdrawal by Subject|1|||
33333655|NCT03116698|101114791|FG001|Overall Study|Withdrawal by Subject|4|||
33333656|NCT03116698|101114792|FG002|Overall Study|Withdrawal by Subject|5|||
33333657|NCT03116698|101114793|FG003|Overall Study|Withdrawal by Subject|2|||
33333658|NCT03116698|101114790|FG000|Overall Study|Lost to Follow-up|2|||
33333659|NCT03116698|101114791|FG001|Overall Study|Lost to Follow-up|0|||
33333660|NCT03116698|101114792|FG002|Overall Study|Lost to Follow-up|0|||
33333661|NCT03116698|101114793|FG003|Overall Study|Lost to Follow-up|0|||
33333662|NCT03116698|101114790|FG000|Overall Study|Physician Decision|1|||
33333663|NCT03116698|101114791|FG001|Overall Study|Physician Decision|1|||
33333664|NCT03116698|101114792|FG002|Overall Study|Physician Decision|0|||
33333665|NCT03116698|101114793|FG003|Overall Study|Physician Decision|0|||
33333666|NCT03116698|101114790|FG000|Overall Study|Protocol Violation|1|||
33333667|NCT03116698|101114791|FG001|Overall Study|Protocol Violation|0|||
33333668|NCT03116698|101114792|FG002|Overall Study|Protocol Violation|0|||
33333669|NCT03116698|101114793|FG003|Overall Study|Protocol Violation|0|||
33403558|NCT00003389|101365625|FG000|Overall Study|Adverse Event|13|||
33403559|NCT00003389|101365626|FG001|Overall Study|Adverse Event|2|||
33403560|NCT00003389|101365625|FG000|Overall Study|Death|0|||
33403561|NCT00003389|101365626|FG001|Overall Study|Death|3|||
33403562|NCT00003389|101365625|FG000|Overall Study|Withdrawal by Subject|12|||
33333670|NCT03116698|101114790|FG000|Overall Study|Death|0|||
33333671|NCT03116698|101114791|FG001|Overall Study|Death|0|||
33333672|NCT03116698|101114792|FG002|Overall Study|Death|2|||
33333673|NCT03116698|101114793|FG003|Overall Study|Death|0|||
33333674|NCT00794677|101114802|FG000|First Intervention|Withdrawal by Subject|2|||
33403563|NCT00003389|101365626|FG001|Overall Study|Withdrawal by Subject|5|||
33403564|NCT00003389|101365625|FG000|Overall Study|Alternative therapy|2|||
33403565|NCT00003389|101365626|FG001|Overall Study|Alternative therapy|1|||
33527746|NCT03026283|101830347|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
33527747|NCT03026283|101830348|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
33527748|NCT03026283|101830341|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
33527749|NCT03026283|101830342|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
33527750|NCT03026283|101830343|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
33527751|NCT03026283|101830344|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
33527752|NCT03026283|101830345|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
33527753|NCT03026283|101830346|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
33527754|NCT03026283|101830347|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
33527755|NCT03026283|101830348|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
33333675|NCT00794677|101114803|FG001|First Intervention|Withdrawal by Subject|0|||
33333676|NCT01230307|101114805|FG000|Overall Study|LVAD Placement|0|||
33333677|NCT01230307|101114806|FG001|Overall Study|LVAD Placement|2|||
33333678|NCT01152021|101114807|FG000|Overall Study|Adverse Event|4|||
33333679|NCT01152021|101114808|FG001|Overall Study|Adverse Event|4|||
33333680|NCT01152021|101114807|FG000|Overall Study|Study drug had expired|1|||
33333681|NCT01152021|101114808|FG001|Overall Study|Study drug had expired|0|||
33333682|NCT01152021|101114807|FG000|Overall Study|Physician Decision|1|||
33333683|NCT01152021|101114808|FG001|Overall Study|Physician Decision|1|||
33333684|NCT01152021|101114807|FG000|Overall Study|No access to study drug in Pharmacy|0|||
33527756|NCT03026283|101830341|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
33527757|NCT03026283|101830342|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
33527758|NCT03026283|101830343|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
33527759|NCT03026283|101830344|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
33527760|NCT03026283|101830345|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
33527761|NCT03026283|101830346|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
33527762|NCT03026283|101830347|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
33527763|NCT03026283|101830348|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
33527764|NCT01972464|101830349|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
33527765|NCT01972464|101830350|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
33527766|NCT01972464|101830349|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
33527767|NCT01972464|101830350|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
33527768|NCT01972464|101830349|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
33527769|NCT01972464|101830350|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
33527770|NCT01972464|101830349|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
33527771|NCT01972464|101830350|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
33527772|NCT00524771|101830353|FG000|Overall Study|Protocol Violation|220|||
33527773|NCT00524771|101830354|FG001|Overall Study|Protocol Violation|585|||
33527774|NCT02716584|101830355|FG000|Overall Study|Lost to Follow-up|8|||
33527775|NCT02716584|101830356|FG001|Overall Study|Lost to Follow-up|5|||
33527776|NCT04039204|101830358|FG000|Overall Study|Withdrawal by Subject|0|||
33527777|NCT04039204|101830359|FG001|Overall Study|Withdrawal by Subject|2|||
33527778|NCT02281955|101830360|FG000|Overall Study|Death|1|||
33527779|NCT04854057|101830366|FG000|Overall Study|Adverse Event|0|||
33527780|NCT04854057|101830367|FG001|Overall Study|Adverse Event|1|||
33527781|NCT01471444|101830368|FG000|Overall Study|Physician Decision|3|||
33527782|NCT01471444|101830369|FG001|Overall Study|Physician Decision|2|||
33527783|NCT01471444|101830368|FG000|Overall Study|Withdrawal by Subject|0|||
33527784|NCT01471444|101830369|FG001|Overall Study|Withdrawal by Subject|1|||
33527785|NCT02072941|101830370|FG000|Overall Study|Withdrawal by Subject|29|||
33527786|NCT02072941|101830371|FG001|Overall Study|Withdrawal by Subject|21|||
33527787|NCT02072941|101830370|FG000|Overall Study|Lost to Follow-up|4|||
33527788|NCT02072941|101830371|FG001|Overall Study|Lost to Follow-up|4|||
33527789|NCT02072941|101830370|FG000|Overall Study|Death|3|||
33527790|NCT02072941|101830371|FG001|Overall Study|Death|2|||
33527791|NCT02072941|101830370|FG000|Overall Study|Removed by Study Staff|2|||
33527792|NCT02072941|101830371|FG001|Overall Study|Removed by Study Staff|2|||
33527793|NCT02819440|101830372|FG000|Overall Study|Adverse Event|3|||
33527794|NCT02819440|101830373|FG001|Overall Study|Adverse Event|1|||
33333685|NCT01152021|101114808|FG001|Overall Study|No access to study drug in Pharmacy|1|||
33333686|NCT02833974|101114809|FG000|Overall Study|Lost to Follow-up|1|||
33333687|NCT02833974|101114810|FG001|Overall Study|Lost to Follow-up|0|||
33333688|NCT02833974|101114809|FG000|Overall Study|Adverse Event|0|||
33527795|NCT02819440|101830372|FG000|Overall Study|Lost to Follow-up|1|||
33527796|NCT02819440|101830373|FG001|Overall Study|Lost to Follow-up|3|||
33527797|NCT02819440|101830372|FG000|Overall Study|Withdrawal by Subject|9|||
33527798|NCT02819440|101830373|FG001|Overall Study|Withdrawal by Subject|8|||
33527799|NCT04501952|101830374|FG000|Overall Study|Adverse Event|0|||
33333689|NCT02833974|101114810|FG001|Overall Study|Adverse Event|3|||
33333690|NCT01486927|101114811|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
33333691|NCT01486927|101114811|FG000|Overall Study|Physician Decision|1|||
33203693|NCT02536508|100648481|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
33203694|NCT02536508|100648482|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
33203695|NCT02536508|100648483|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
33203696|NCT02536508|100648481|FG000|Overall Study|Physician Decision|0|||
33203697|NCT02536508|100648482|FG001|Overall Study|Physician Decision|4|||
33203698|NCT02536508|100648483|FG002|Overall Study|Physician Decision|2|||
33203699|NCT02536508|100648481|FG000|Overall Study|Major Protocol Deviation|2|||
33203700|NCT02536508|100648482|FG001|Overall Study|Major Protocol Deviation|2|||
33203701|NCT02536508|100648483|FG002|Overall Study|Major Protocol Deviation|2|||
33203702|NCT02536508|100648481|FG000|Overall Study|Administrative Reasons|0|||
33203703|NCT02536508|100648482|FG001|Overall Study|Administrative Reasons|1|||
33333692|NCT01486927|101114811|FG000|Overall Study|50 Exposure days not reached|2|||
33333693|NCT01486927|101114811|FG000|Overall Study|Withdrawal by Subject|8|||
33333694|NCT01486927|101114811|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
33333695|NCT00772954|101114812|FG000|Overall Study|Adverse Event|0|||
33333696|NCT00772954|101114813|FG001|Overall Study|Adverse Event|0|||
33333697|NCT00772954|101114814|FG002|Overall Study|Adverse Event|1|||
33333698|NCT02829138|101114817|FG000|Overall Study|Withdrawal by Subject|1|||
33333699|NCT02829138|101114818|FG001|Overall Study|Withdrawal by Subject|0|||
33333700|NCT02318667|101114820|FG000|Overall Study|Adverse Event|1|||
33333701|NCT02318667|101114820|FG000|Overall Study|Lack of Efficacy|6|||
33333702|NCT02318667|101114820|FG000|Overall Study|Protocol Violation|2|||
33333703|NCT01326546|101114821|FG000|Overall Study|Lost to Follow-up|8|||
33333704|NCT01326546|101114822|FG001|Overall Study|Lost to Follow-up|7|||
33333705|NCT01326546|101114821|FG000|Overall Study|Protocol Violation|3|||
33333706|NCT01326546|101114822|FG001|Overall Study|Protocol Violation|4|||
33333707|NCT01326546|101114821|FG000|Overall Study|Pregnancy|0|||
33333708|NCT01326546|101114822|FG001|Overall Study|Pregnancy|1|||
33333709|NCT01326546|101114821|FG000|Overall Study|Adverse Event|1|||
33333710|NCT01326546|101114822|FG001|Overall Study|Adverse Event|0|||
33333711|NCT01326546|101114821|FG000|Overall Study|Withdrawal by Subject|5|||
33333712|NCT01326546|101114822|FG001|Overall Study|Withdrawal by Subject|1|||
33333713|NCT01714687|101114826|FG000|Overall Study|Withdrawal by Subject|1|||
33333714|NCT01714687|101114827|FG001|Overall Study|Withdrawal by Subject|0|||
33333715|NCT01714687|101114826|FG000|Overall Study|Lost to Follow-up|2|||
33333716|NCT01714687|101114827|FG001|Overall Study|Lost to Follow-up|4|||
33333717|NCT00794157|101114828|FG000|Overall Study|Adverse Event|4|||
33333718|NCT00794157|101114829|FG001|Overall Study|Adverse Event|1|||
33333719|NCT00794157|101114830|FG002|Overall Study|Adverse Event|8|||
33333720|NCT00794157|101114828|FG000|Overall Study|Subject withdrew consent|2|||
33333721|NCT00794157|101114829|FG001|Overall Study|Subject withdrew consent|0|||
33333722|NCT00794157|101114830|FG002|Overall Study|Subject withdrew consent|3|||
33333723|NCT00794157|101114828|FG000|Overall Study|Lost to Follow-up|2|||
33333724|NCT00794157|101114829|FG001|Overall Study|Lost to Follow-up|0|||
33333725|NCT00794157|101114830|FG002|Overall Study|Lost to Follow-up|1|||
33333726|NCT00794157|101114828|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33333727|NCT00794157|101114829|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33333728|NCT00794157|101114830|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
33333729|NCT00794157|101114828|FG000|Overall Study|Administrative problems|1|||
33333730|NCT00794157|101114829|FG001|Overall Study|Administrative problems|7|||
33333731|NCT00794157|101114830|FG002|Overall Study|Administrative problems|4|||
33333732|NCT00794157|101114828|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33333733|NCT00794157|101114829|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33333734|NCT00794157|101114830|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33333735|NCT00794157|101114828|FG000|Overall Study|Protocol deviation|0|||
33333736|NCT00794157|101114829|FG001|Overall Study|Protocol deviation|1|||
33333737|NCT00794157|101114830|FG002|Overall Study|Protocol deviation|1|||
33333738|NCT02228590|101114833|FG000|Overall Study|Withdrawal by Subject|1|||
33333739|NCT04315181|101114838|FG000|Overall Study|Non-responsive to drug conditions.|1|||
33333740|NCT00886600|101114839|FG000|Double-blind Monotherapy|Adverse Event|1|||
33333741|NCT00886600|101114840|FG001|Double-blind Monotherapy|Adverse Event|1|||
33333742|NCT00886600|101114841|FG002|Double-blind Monotherapy|Adverse Event|1|||
33527800|NCT04501952|101830375|FG001|Overall Study|Adverse Event|3|||
33527801|NCT04501952|101830374|FG000|Overall Study|Investigator's Discretion|0|||
33333743|NCT00886600|101114842|FG003|Double-blind Monotherapy|Adverse Event|1|||
33333744|NCT00886600|101114839|FG000|Double-blind Monotherapy|Protocol Violation|0|||
33333745|NCT00886600|101114840|FG001|Double-blind Monotherapy|Protocol Violation|0|||
33333746|NCT00886600|101114841|FG002|Double-blind Monotherapy|Protocol Violation|0|||
33333747|NCT00886600|101114842|FG003|Double-blind Monotherapy|Protocol Violation|1|||
33333748|NCT00886600|101114839|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
33203704|NCT02536508|100648483|FG002|Overall Study|Administrative Reasons|0|||
33333749|NCT00886600|101114840|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
33333750|NCT00886600|101114841|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
33333751|NCT00886600|101114842|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
33333752|NCT00886600|101114839|FG000|Combination Therapy Period|Adverse Event|0|||
33333753|NCT00886600|101114840|FG001|Combination Therapy Period|Adverse Event|0|||
33527802|NCT04501952|101830375|FG001|Overall Study|Investigator's Discretion|1|||
33527803|NCT04501952|101830374|FG000|Overall Study|Protocol Violation|1|||
33527804|NCT04501952|101830375|FG001|Overall Study|Protocol Violation|1|||
33527805|NCT04501952|101830374|FG000|Overall Study|Withdrew Consent|5|||
33527806|NCT04501952|101830375|FG001|Overall Study|Withdrew Consent|4|||
33527807|NCT04501952|101830374|FG000|Overall Study|Lost to Follow-up|7|||
33527808|NCT04501952|101830375|FG001|Overall Study|Lost to Follow-up|2|||
33527809|NCT04501952|101830374|FG000|Overall Study|Randomized and Never Treated|13|||
33527810|NCT04501952|101830375|FG001|Overall Study|Randomized and Never Treated|9|||
33527811|NCT03504189|101830376|FG000|Overall Study|Withdrawal by Subject|1|||
33527812|NCT03504189|101830376|FG000|Overall Study|Screening Failure|1|||
33527813|NCT03504189|101830376|FG000|Overall Study|Device Failure|2|||
33527814|NCT03061188|101830377|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
33527815|NCT03061188|101830378|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
33527816|NCT03061188|101830379|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
33527817|NCT03061188|101830380|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
33527818|NCT03061188|101830377|FG000|On Follow-up for 3 Years|Death|0|||
33527819|NCT03061188|101830378|FG001|On Follow-up for 3 Years|Death|3|||
33527820|NCT03061188|101830379|FG002|On Follow-up for 3 Years|Death|5|||
33527821|NCT03061188|101830380|FG003|On Follow-up for 3 Years|Death|4|||
33527822|NCT03061188|101830377|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
33527823|NCT03061188|101830378|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
33527824|NCT03061188|101830379|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
33527825|NCT03061188|101830380|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
33527826|NCT00869128|101830381|FG000|Overall Study|lack of Compliance|6|||
33527827|NCT00869128|101830382|FG001|Overall Study|lack of Compliance|6|||
33527828|NCT00565604|101830384|FG000|Overall Study|Failure to treat|2|||
33527829|NCT00565604|101830384|FG000|Overall Study|Lost to Follow-up|2|||
33527830|NCT01843803|101830385|FG000|Overall Study|not a Veteran, did not see provider|1|||
33527831|NCT01843803|101830386|FG001|Overall Study|not a Veteran, did not see provider|3|||
33527832|NCT00460239|101830387|FG000|Overall Study|Physician Decision|0|||
33527833|NCT00460239|101830388|FG001|Overall Study|Physician Decision|1|||
33527834|NCT00460239|101830389|FG002|Overall Study|Physician Decision|0|||
33527835|NCT00460239|101830390|FG003|Overall Study|Physician Decision|0|||
33527836|NCT00460239|101830391|FG004|Overall Study|Physician Decision|0|||
33527837|NCT00460239|101830392|FG005|Overall Study|Physician Decision|2|||
33527838|NCT00460239|101830393|FG006|Overall Study|Physician Decision|0|||
33527839|NCT00460239|101830394|FG007|Overall Study|Physician Decision|0|||
33527840|NCT00460239|101830395|FG008|Overall Study|Physician Decision|0|||
33527841|NCT00460239|101830387|FG000|Overall Study|Withdrawal by Subject|0|||
33527842|NCT00460239|101830388|FG001|Overall Study|Withdrawal by Subject|0|||
33527843|NCT00460239|101830389|FG002|Overall Study|Withdrawal by Subject|0|||
33527844|NCT00460239|101830390|FG003|Overall Study|Withdrawal by Subject|0|||
33527845|NCT00460239|101830391|FG004|Overall Study|Withdrawal by Subject|0|||
33527846|NCT00460239|101830392|FG005|Overall Study|Withdrawal by Subject|1|||
33527847|NCT00460239|101830393|FG006|Overall Study|Withdrawal by Subject|0|||
33527848|NCT00460239|101830394|FG007|Overall Study|Withdrawal by Subject|0|||
33527849|NCT00460239|101830395|FG008|Overall Study|Withdrawal by Subject|0|||
33527850|NCT01765569|101830396|FG000|Period B|Withdrawal by Subject|1|||
33527851|NCT01765569|101830396|FG000|Period C|Death|1|||
33527852|NCT00391872|101830405|FG000|Overall Study|Protocol Violation|7|||
33527853|NCT00391872|101830406|FG001|Overall Study|Protocol Violation|2|||
33527854|NCT00391872|101830405|FG000|Overall Study|Withdrawal by Subject|296|||
33527855|NCT00391872|101830406|FG001|Overall Study|Withdrawal by Subject|249|||
33527856|NCT00391872|101830405|FG000|Overall Study|Reason unknown|2|||
33527857|NCT00391872|101830406|FG001|Overall Study|Reason unknown|4|||
33527858|NCT00391872|101830405|FG000|Overall Study|Lost to Follow-up|2|||
33527859|NCT00391872|101830406|FG001|Overall Study|Lost to Follow-up|0|||
33527860|NCT04035499|101830411|FG000|Overall Study|Death|2|||
33527861|NCT04035499|101830411|FG000|Overall Study|Withdrawal by Subject|1|||
33527862|NCT02697916|101830415|FG000|Overall Study|Death|357|||
33527863|NCT02697916|101830416|FG001|Overall Study|Death|315|||
33527864|NCT02697916|101830415|FG000|Overall Study|Withdrawal by Subject|221|||
33527865|NCT02697916|101830416|FG001|Overall Study|Withdrawal by Subject|393|||
33527866|NCT02499263|101830419|FG000|Overall Study|Lost to Follow-up|9|||
33527867|NCT02499263|101830419|FG000|Overall Study|Participant's withdrawal of consent|4|||
33527868|NCT02499263|101830419|FG000|Overall Study|Lack of Efficacy|22|||
33610686|NCT01620762|102123384|FG002|Overall Study|Subject deterioration|1|||
33527869|NCT02499263|101830419|FG000|Overall Study|investigator's judgment|12|||
33527870|NCT02499263|101830419|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
33527871|NCT02499263|101830419|FG000|Overall Study|Participant's decision|3|||
33527872|NCT02499263|101830419|FG000|Overall Study|Pregnancy|1|||
33527873|NCT03665077|101830422|FG000|Overall Study|Lost to Follow-up|2|||
33527874|NCT03665077|101830422|FG000|Overall Study|Physician Decision|2|||
33527875|NCT05464420|101830428|FG000|Overall Study|Death|0|||
33527876|NCT05464420|101830429|FG001|Overall Study|Death|0|||
33527877|NCT05464420|101830430|FG002|Overall Study|Death|0|||
33527878|NCT05464420|101830431|FG003|Overall Study|Death|1|||
33527879|NCT05464420|101830428|FG000|Overall Study|Lost to Follow-up|16|||
33527880|NCT05464420|101830429|FG001|Overall Study|Lost to Follow-up|11|||
33527881|NCT05464420|101830430|FG002|Overall Study|Lost to Follow-up|11|||
33527882|NCT05464420|101830431|FG003|Overall Study|Lost to Follow-up|11|||
33527883|NCT05464420|101830428|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
33527884|NCT05464420|101830429|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
33527885|NCT05464420|101830430|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
33527886|NCT05464420|101830431|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
33527887|NCT05464420|101830428|FG000|Overall Study|Withdrawal by Subject|4|||
33527888|NCT05464420|101830429|FG001|Overall Study|Withdrawal by Subject|8|||
33527889|NCT05464420|101830430|FG002|Overall Study|Withdrawal by Subject|3|||
33527890|NCT05464420|101830431|FG003|Overall Study|Withdrawal by Subject|1|||
33527891|NCT05464420|101830428|FG000|Overall Study|Protocol Violation|0|||
33527892|NCT05464420|101830429|FG001|Overall Study|Protocol Violation|0|||
33527893|NCT05464420|101830430|FG002|Overall Study|Protocol Violation|1|||
33527894|NCT05464420|101830431|FG003|Overall Study|Protocol Violation|1|||
33527895|NCT05464420|101830428|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
33527896|NCT05464420|101830429|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
33527897|NCT05464420|101830430|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
33527898|NCT05464420|101830431|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
33527899|NCT02447328|101830432|FG000|Overall Study|Withdrawal by Subject|1|||
33527900|NCT03334422|101830436|FG000|Overall Study|Adverse Event|1|||
33527901|NCT03334422|101830437|FG001|Overall Study|Adverse Event|3|||
33527902|NCT03334422|101830438|FG002|Overall Study|Adverse Event|2|||
33527903|NCT03334422|101830439|FG003|Overall Study|Adverse Event|2|||
33527904|NCT03334422|101830436|FG000|Overall Study|Lack of Efficacy|10|||
33527905|NCT03334422|101830437|FG001|Overall Study|Lack of Efficacy|2|||
33527906|NCT03334422|101830438|FG002|Overall Study|Lack of Efficacy|7|||
33527907|NCT03334422|101830439|FG003|Overall Study|Lack of Efficacy|3|||
33527908|NCT03334422|101830436|FG000|Overall Study|Withdrawal by Subject|8|||
33527909|NCT03334422|101830437|FG001|Overall Study|Withdrawal by Subject|3|||
33527910|NCT03334422|101830438|FG002|Overall Study|Withdrawal by Subject|1|||
33527911|NCT03334422|101830439|FG003|Overall Study|Withdrawal by Subject|0|||
33333754|NCT00886600|101114841|FG002|Combination Therapy Period|Adverse Event|1|||
33333755|NCT00886600|101114842|FG003|Combination Therapy Period|Adverse Event|0|||
33333756|NCT00886600|101114839|FG000|Combination Therapy Period|Protocol Violation|0|||
33333757|NCT00886600|101114840|FG001|Combination Therapy Period|Protocol Violation|0|||
33333758|NCT00886600|101114841|FG002|Combination Therapy Period|Protocol Violation|1|||
33333759|NCT00886600|101114842|FG003|Combination Therapy Period|Protocol Violation|0|||
33333760|NCT00545064|101114844|FG000|Overall Study|Lost to Follow-up|3|||
33333761|NCT00545064|101114844|FG000|Overall Study|Withdrawal by Subject|2|||
33333762|NCT00545064|101114844|FG000|Overall Study|did not complete course of treatment|1|||
33333763|NCT00545064|101114844|FG000|Overall Study|cancel all appointments, no rebooking|1|||
33333764|NCT00545064|101114844|FG000|Overall Study|inclement weather|1|||
33333765|NCT01181011|101114845|FG000|Overall Study|Adverse Event|2|||
33333766|NCT01181011|101114845|FG000|Overall Study|Lost to Follow-up|1|||
33333767|NCT01934556|101114847|FG000|Overall Study|Withdrawal by Subject|0|||
33333768|NCT01934556|101114848|FG001|Overall Study|Withdrawal by Subject|1|||
33333769|NCT01934556|101114849|FG002|Overall Study|Withdrawal by Subject|1|||
33333770|NCT01934556|101114847|FG000|Overall Study|Lost to Follow-up|4|||
33333771|NCT01934556|101114848|FG001|Overall Study|Lost to Follow-up|10|||
33527912|NCT03334422|101830436|FG000|Overall Study|Lost to Follow-up|0|||
33527913|NCT03334422|101830437|FG001|Overall Study|Lost to Follow-up|0|||
33527914|NCT03334422|101830438|FG002|Overall Study|Lost to Follow-up|0|||
33527915|NCT03334422|101830439|FG003|Overall Study|Lost to Follow-up|1|||
33527916|NCT03334422|101830436|FG000|Overall Study|Inability to obtain laboratory samples|0|||
33527917|NCT03334422|101830437|FG001|Overall Study|Inability to obtain laboratory samples|1|||
33527918|NCT03334422|101830438|FG002|Overall Study|Inability to obtain laboratory samples|0|||
33527919|NCT03334422|101830439|FG003|Overall Study|Inability to obtain laboratory samples|0|||
33527920|NCT03334422|101830436|FG000|Overall Study|Pregnancy|0|||
33527921|NCT03334422|101830437|FG001|Overall Study|Pregnancy|1|||
33527922|NCT03334422|101830438|FG002|Overall Study|Pregnancy|0|||
33527923|NCT03334422|101830439|FG003|Overall Study|Pregnancy|0|||
33527924|NCT02095197|101830440|FG000|Overall Study|Lost to Follow-up|0|||
33527925|NCT02095197|101830441|FG001|Overall Study|Lost to Follow-up|3|||
33527926|NCT01189461|101830442|FG000|Overall Study|Lack of Efficacy|13|||
33333772|NCT01934556|101114849|FG002|Overall Study|Lost to Follow-up|7|||
33333773|NCT01934556|101114847|FG000|Overall Study|Death|1|||
33333774|NCT01934556|101114848|FG001|Overall Study|Death|5|||
33333775|NCT01934556|101114849|FG002|Overall Study|Death|2|||
33527927|NCT01189461|101830442|FG000|Overall Study|Lost to Follow-up|1|||
33527928|NCT01189461|101830442|FG000|Overall Study|Withdrawal by Subject|6|||
33527929|NCT01189461|101830442|FG000|Overall Study|Protocol Violation|1|||
33527930|NCT01189461|101830442|FG000|Overall Study|Adverse Event|2|||
33527931|NCT01189461|101830442|FG000|Overall Study|Did not meet entrance criteria|3|||
33527932|NCT01189461|101830442|FG000|Overall Study|Other|8|||
33610687|NCT01620762|102123382|FG000|Overall Study|Non-specified|3|||
33527933|NCT00398047|101830443|FG000|Overall Study|all patient progressed before completion|3|||
33527934|NCT02559570|101830448|FG000|Overall Study|Adverse Event|0|||
33527935|NCT02559570|101830449|FG001|Overall Study|Adverse Event|2|||
33527936|NCT02559570|101830450|FG002|Overall Study|Adverse Event|0|||
33527937|NCT02559570|101830451|FG003|Overall Study|Adverse Event|1|||
33527938|NCT02559570|101830452|FG004|Overall Study|Adverse Event|0|||
33527939|NCT02559570|101830448|FG000|Overall Study|Withdrawal of Consent|0|||
33527940|NCT02559570|101830449|FG001|Overall Study|Withdrawal of Consent|0|||
33527941|NCT02559570|101830450|FG002|Overall Study|Withdrawal of Consent|1|||
33527942|NCT02559570|101830451|FG003|Overall Study|Withdrawal of Consent|2|||
33527943|NCT02559570|101830452|FG004|Overall Study|Withdrawal of Consent|1|||
33527944|NCT02559570|101830448|FG000|Overall Study|Lost to Follow-up|1|||
33527945|NCT02559570|101830449|FG001|Overall Study|Lost to Follow-up|0|||
33527946|NCT02559570|101830450|FG002|Overall Study|Lost to Follow-up|0|||
33527947|NCT02559570|101830451|FG003|Overall Study|Lost to Follow-up|0|||
33527948|NCT02559570|101830452|FG004|Overall Study|Lost to Follow-up|0|||
33527949|NCT02559570|101830448|FG000|Overall Study|Protocol Violation|1|||
33527950|NCT02559570|101830449|FG001|Overall Study|Protocol Violation|0|||
33527951|NCT02559570|101830450|FG002|Overall Study|Protocol Violation|0|||
33527952|NCT02559570|101830451|FG003|Overall Study|Protocol Violation|0|||
33527953|NCT02559570|101830452|FG004|Overall Study|Protocol Violation|1|||
33527954|NCT02559570|101830448|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33527955|NCT02559570|101830449|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33527956|NCT02559570|101830450|FG002|Overall Study|Other Miscellaneous Reasons|1|||
33527957|NCT02559570|101830451|FG003|Overall Study|Other Miscellaneous Reasons|0|||
33527958|NCT02559570|101830452|FG004|Overall Study|Other Miscellaneous Reasons|0|||
33527959|NCT03091738|101830453|FG000|Overall Study|Adverse Event|1|||
33527960|NCT03091738|101830453|FG000|Overall Study|Lost to Follow-up|1|||
33527961|NCT02686814|101830461|FG000|Overall Study|Physician Decision|14|||
33527962|NCT02686814|101830461|FG000|Overall Study|Withdrawal by Subject|4|||
33333776|NCT02941627|101114856|FG000|Overall Study|Death|1|||
33333777|NCT02941627|101114856|FG000|Overall Study|Surgical failure|1|||
33333778|NCT02941627|101114856|FG000|Overall Study|cholesteatoma prevented implantation|1|||
33333779|NCT01308008|101114857|FG000|4 Weeks|Illness, disinterest, time|9|||
33333780|NCT01308008|101114858|FG001|4 Weeks|Illness, disinterest, time|2|||
33333781|NCT02270242|101114859|FG000|Overall Study|Withdrawal by Subject|18|||
33333782|NCT02270242|101114860|FG001|Overall Study|Withdrawal by Subject|25|||
33333783|NCT02270242|101114859|FG000|Overall Study|Lost to Follow-up|41|||
33333784|NCT02270242|101114860|FG001|Overall Study|Lost to Follow-up|27|||
33333785|NCT02270242|101114859|FG000|Overall Study|Physician Decision|0|||
33333786|NCT02270242|101114860|FG001|Overall Study|Physician Decision|1|||
33333787|NCT01356407|101114861|FG000|Overall Study|Lost to Follow-up|2|||
33333788|NCT01356407|101114862|FG001|Overall Study|Lost to Follow-up|0|||
33333789|NCT01356407|101114861|FG000|Overall Study|Patient Withdrew Consent|2|||
33333790|NCT01356407|101114862|FG001|Overall Study|Patient Withdrew Consent|1|||
33333791|NCT01356407|101114861|FG000|Overall Study|Could not afford IMP administration|0|||
33333792|NCT01356407|101114862|FG001|Overall Study|Could not afford IMP administration|1|||
33333793|NCT01356407|101114861|FG000|Overall Study|Not complete Endoscopy|2|||
33333794|NCT01356407|101114862|FG001|Overall Study|Not complete Endoscopy|2|||
33527963|NCT02686814|101830461|FG000|Overall Study|Death|1|||
33527964|NCT03872843|101830465|FG000|Overall Study|Lost to Follow-up|5|||
33527965|NCT03872843|101830466|FG001|Overall Study|Lost to Follow-up|7|||
33527966|NCT01135524|101830467|FG000|Overall Study|Withdrawal by Subject|14|||
33610688|NCT01620762|102123383|FG001|Overall Study|Non-specified|6|||
33610689|NCT01620762|102123384|FG002|Overall Study|Non-specified|5|||
33333795|NCT04225923|101114864|FG000|Overall Study|Protocol Violation|1|||
33333796|NCT04225923|101114865|FG001|Overall Study|Protocol Violation|0|||
33333797|NCT04225923|101114866|FG002|Overall Study|Protocol Violation|1|||
33333798|NCT04225923|101114864|FG000|Overall Study|Withdrawal by Subject|4|||
33333799|NCT04225923|101114865|FG001|Overall Study|Withdrawal by Subject|1|||
33527967|NCT01135524|101830467|FG000|Overall Study|Adverse Event|20|||
33527968|NCT01135524|101830467|FG000|Overall Study|Lost to Follow-up|3|||
33527969|NCT01135524|101830467|FG000|Overall Study|Administrative|151|||
33527970|NCT01135524|101830467|FG000|Overall Study|Lack of Efficacy|8|||
33610690|NCT01620762|102123382|FG000|Overall Study|Use of prohibted therapies|0|||
33527971|NCT02734862|101830473|FG000|Part A|Death|3|||
33527972|NCT02734862|101830474|FG001|Part A|Death|4|||
33527973|NCT02734862|101830475|FG002|Part A|Death|6|||
33527974|NCT02734862|101830473|FG000|Part A|Lost to Follow-up|2|||
33527975|NCT02734862|101830474|FG001|Part A|Lost to Follow-up|1|||
33527976|NCT02734862|101830475|FG002|Part A|Lost to Follow-up|1|||
33527977|NCT02734862|101830473|FG000|Part A|Withdrawal by Subject|1|||
33527978|NCT02734862|101830474|FG001|Part A|Withdrawal by Subject|1|||
33527979|NCT02734862|101830475|FG002|Part A|Withdrawal by Subject|2|||
33333800|NCT04225923|101114866|FG002|Overall Study|Withdrawal by Subject|3|||
33333801|NCT04225923|101114864|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
33364966|NCT04760314|101223696|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
33527980|NCT02734862|101830473|FG000|Part A|Physician Decision|2|||
33610691|NCT01620762|102123383|FG001|Overall Study|Use of prohibted therapies|1|||
33333802|NCT04225923|101114865|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
33333803|NCT04225923|101114866|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
33333804|NCT00790907|101114867|FG000|Overall Study|Adverse Event|9|||
33527981|NCT02734862|101830474|FG001|Part A|Physician Decision|0|||
33527982|NCT02734862|101830475|FG002|Part A|Physician Decision|1|||
33527983|NCT02734862|101830473|FG000|Part A|Adverse Event|2|||
33527984|NCT02734862|101830474|FG001|Part A|Adverse Event|0|||
33527985|NCT02734862|101830475|FG002|Part A|Adverse Event|1|||
33527986|NCT02734862|101830473|FG000|Part A|Noncompliance|1|||
33527987|NCT02734862|101830474|FG001|Part A|Noncompliance|1|||
33527988|NCT02734862|101830475|FG002|Part A|Noncompliance|0|||
33527989|NCT02734862|101830473|FG000|Part A|Other|1|||
33527990|NCT02734862|101830474|FG001|Part A|Other|1|||
33527991|NCT02734862|101830475|FG002|Part A|Other|3|||
33527992|NCT02734862|101830473|FG000|Part B|Death|8|||
33333805|NCT00790907|101114868|FG001|Overall Study|Adverse Event|7|||
33333806|NCT00790907|101114869|FG002|Overall Study|Adverse Event|6|||
33333807|NCT00790907|101114867|FG000|Overall Study|Physician Decision|304|||
33333808|NCT00790907|101114868|FG001|Overall Study|Physician Decision|271|||
33333809|NCT00790907|101114869|FG002|Overall Study|Physician Decision|255|||
33333810|NCT00790907|101114867|FG000|Overall Study|Withdrawal by Subject|1|||
33333811|NCT00790907|101114868|FG001|Overall Study|Withdrawal by Subject|7|||
33333812|NCT00790907|101114869|FG002|Overall Study|Withdrawal by Subject|5|||
33333813|NCT00790907|101114867|FG000|Overall Study|Bleeding Event|11|||
33333814|NCT00790907|101114868|FG001|Overall Study|Bleeding Event|16|||
33333815|NCT00790907|101114869|FG002|Overall Study|Bleeding Event|21|||
33333816|NCT00790907|101114867|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
33333817|NCT00790907|101114868|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
33333818|NCT00790907|101114869|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
33333819|NCT00790907|101114867|FG000|Overall Study|Qualifying Condition Not Present|29|||
33333820|NCT00790907|101114868|FG001|Overall Study|Qualifying Condition Not Present|14|||
33333821|NCT00790907|101114869|FG002|Overall Study|Qualifying Condition Not Present|16|||
33333822|NCT00790907|101114867|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
33333823|NCT00790907|101114868|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
33333824|NCT00790907|101114869|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
33333825|NCT00790907|101114867|FG000|Overall Study|Did Not Receive Study Drug|10|||
33333826|NCT00790907|101114868|FG001|Overall Study|Did Not Receive Study Drug|0|||
33333827|NCT00790907|101114869|FG002|Overall Study|Did Not Receive Study Drug|0|||
33333828|NCT01081249|101114870|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
33527993|NCT02734862|101830474|FG001|Part B|Death|3|||
33527994|NCT02734862|101830475|FG002|Part B|Death|5|||
33527995|NCT02734862|101830473|FG000|Part B|Lost to Follow-up|2|||
33527996|NCT02734862|101830474|FG001|Part B|Lost to Follow-up|2|||
33527997|NCT02734862|101830475|FG002|Part B|Lost to Follow-up|0|||
33610692|NCT01620762|102123384|FG002|Overall Study|Use of prohibted therapies|1|||
33610693|NCT01329939|102123385|FG000|Overall Study|Lost to Follow-up|3|||
33610694|NCT01329939|102123386|FG001|Overall Study|Lost to Follow-up|0|||
33333829|NCT01081249|101114871|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
33333830|NCT00879645|101114872|FG000|Overall Study|Adverse Event|1|||
33333831|NCT00879645|101114873|FG001|Overall Study|Adverse Event|0|||
33333832|NCT00879645|101114874|FG002|Overall Study|Adverse Event|0|||
33333833|NCT00879645|101114875|FG003|Overall Study|Adverse Event|0|||
33333834|NCT03374189|101114878|FG000|Overall Study|Lost to Follow-up|1|||
33203705|NCT01181921|100648484|FG000|Overall Study|Lost to Follow-up|1|||
33203706|NCT01196975|100648485|FG000|Overall Study|Adverse Event|2|||
33203707|NCT01196975|100648486|FG001|Overall Study|Adverse Event|2|||
33333835|NCT03374189|101114879|FG001|Overall Study|Lost to Follow-up|0|||
33333836|NCT02343159|101114880|FG000|Overall Study|Early Study Termination|16|||
33333837|NCT02343159|101114881|FG001|Overall Study|Early Study Termination|19|||
33333838|NCT02343159|101114882|FG002|Overall Study|Early Study Termination|23|||
33333839|NCT02343159|101114880|FG000|Overall Study|Physician Decision|2|||
33333840|NCT02343159|101114881|FG001|Overall Study|Physician Decision|0|||
33333841|NCT02343159|101114882|FG002|Overall Study|Physician Decision|1|||
33610695|NCT01329939|102123387|FG002|Overall Study|Lost to Follow-up|1|||
33203708|NCT01196975|100648487|FG002|Overall Study|Adverse Event|0|||
33203709|NCT01196975|100648488|FG003|Overall Study|Adverse Event|0|||
33203710|NCT01196975|100648489|FG004|Overall Study|Adverse Event|2|||
33203711|NCT01196975|100648485|FG000|Overall Study|Withdrawal by Subject|2|||
33333842|NCT02343159|101114880|FG000|Overall Study|Withdrawal by Subject|3|||
33333843|NCT02343159|101114881|FG001|Overall Study|Withdrawal by Subject|0|||
33333844|NCT02343159|101114882|FG002|Overall Study|Withdrawal by Subject|2|||
33333845|NCT02343159|101114880|FG000|Overall Study|Lost to Follow-up|0|||
33527998|NCT02734862|101830473|FG000|Part B|Withdrawal by Subject|3|||
33527999|NCT02734862|101830474|FG001|Part B|Withdrawal by Subject|1|||
33528000|NCT02734862|101830475|FG002|Part B|Withdrawal by Subject|0|||
33528001|NCT02734862|101830473|FG000|Part B|Other|0|||
33528002|NCT02734862|101830474|FG001|Part B|Other|1|||
33528003|NCT02734862|101830475|FG002|Part B|Other|0|||
33528004|NCT02585713|101830476|FG000|Overall Study|Withdrew prior to treatment|2|||
33610696|NCT01329939|102123388|FG003|Overall Study|Lost to Follow-up|2|||
33203712|NCT01196975|100648486|FG001|Overall Study|Withdrawal by Subject|1|||
33528005|NCT02585713|101830477|FG001|Overall Study|Withdrew prior to treatment|7|||
33528006|NCT02585713|101830476|FG000|Overall Study|Other|3|||
33528007|NCT02585713|101830477|FG001|Overall Study|Other|1|||
33528008|NCT00540644|101830479|FG000|Overall Study|Adverse Event|3|||
33528009|NCT00540644|101830480|FG001|Overall Study|Adverse Event|1|||
33528010|NCT00540644|101830479|FG000|Overall Study|Disease Progression|3|||
33528011|NCT00540644|101830480|FG001|Overall Study|Disease Progression|1|||
33528012|NCT00540644|101830479|FG000|Overall Study|Physician Decision|0|||
33610697|NCT01329939|102123385|FG000|Overall Study|Withdrawal by Subject|0|||
33203713|NCT01196975|100648487|FG002|Overall Study|Withdrawal by Subject|0|||
33203714|NCT01196975|100648488|FG003|Overall Study|Withdrawal by Subject|1|||
33203715|NCT01196975|100648489|FG004|Overall Study|Withdrawal by Subject|0|||
33203716|NCT01196975|100648485|FG000|Overall Study|Lost to Follow-up|11|||
33203717|NCT01196975|100648486|FG001|Overall Study|Lost to Follow-up|6|||
33203718|NCT01196975|100648487|FG002|Overall Study|Lost to Follow-up|5|||
33203719|NCT01196975|100648488|FG003|Overall Study|Lost to Follow-up|5|||
33203720|NCT01196975|100648489|FG004|Overall Study|Lost to Follow-up|11|||
33203721|NCT00437489|100648490|FG000|Overall Study|Study terminated by sponsor|23|||
33203722|NCT00437489|100648491|FG001|Overall Study|Study terminated by sponsor|21|||
33203723|NCT00437489|100648490|FG000|Overall Study|Lost to Follow-up|0|||
33333846|NCT02343159|101114881|FG001|Overall Study|Lost to Follow-up|2|||
33203724|NCT00437489|100648491|FG001|Overall Study|Lost to Follow-up|1|||
33203725|NCT00003457|100648492|FG000|Overall Study|Not evaluable|9|||
33203726|NCT01296568|100648493|FG000|Continued Access Phase|Lost to Follow-up|1|||
33203727|NCT01296568|100648493|FG000|Continued Access Phase|Withdrawal by Subject|1|||
33203728|NCT01296568|100648493|FG000|Continued Access Phase|Disease Progression|1|||
33203729|NCT01165281|100648495|FG000|Overall Study|Adverse Event|12|||
33203730|NCT01165281|100648496|FG001|Overall Study|Adverse Event|14|||
33203731|NCT01165281|100648495|FG000|Overall Study|Death|3|||
33203732|NCT01165281|100648496|FG001|Overall Study|Death|4|||
33203733|NCT01165281|100648495|FG000|Overall Study|Lack of Efficacy|4|||
33203734|NCT01165281|100648496|FG001|Overall Study|Lack of Efficacy|1|||
33203735|NCT01165281|100648495|FG000|Overall Study|Lost to Follow-up|0|||
33203736|NCT01165281|100648496|FG001|Overall Study|Lost to Follow-up|1|||
33203737|NCT01165281|100648495|FG000|Overall Study|Physician Decision|8|||
33203738|NCT01165281|100648496|FG001|Overall Study|Physician Decision|1|||
33203739|NCT01165281|100648495|FG000|Overall Study|Protocol Violation|6|||
33203740|NCT01165281|100648496|FG001|Overall Study|Protocol Violation|5|||
33203741|NCT01165281|100648495|FG000|Overall Study|Withdrawal by Subject|8|||
33203742|NCT01165281|100648496|FG001|Overall Study|Withdrawal by Subject|7|||
33203743|NCT01165281|100648495|FG000|Overall Study|Noncompliance with Study Drug|1|||
33203744|NCT01165281|100648496|FG001|Overall Study|Noncompliance with Study Drug|4|||
33203745|NCT01165281|100648495|FG000|Overall Study|Progressive Disease|10|||
33203746|NCT01165281|100648496|FG001|Overall Study|Progressive Disease|14|||
33203747|NCT01165281|100648495|FG000|Overall Study|Other|6|||
33203748|NCT01165281|100648496|FG001|Overall Study|Other|0|||
33203749|NCT02519504|100648499|FG000|Overall Study|Protocol Violation|6|||
33203750|NCT02519504|100648500|FG001|Overall Study|Protocol Violation|5|||
33203751|NCT02519504|100648499|FG000|Overall Study|Ineligible for direct testing|12|||
33203752|NCT02519504|100648500|FG001|Overall Study|Ineligible for direct testing|12|||
33203753|NCT02519504|100648499|FG000|Overall Study|Did not participate in direct testing|95|||
33203754|NCT02519504|100648500|FG001|Overall Study|Did not participate in direct testing|86|||
33203755|NCT00680407|100648501|FG000|Overall Study|Lost to Follow-up|3|||
33203756|NCT00680407|100648502|FG001|Overall Study|Lost to Follow-up|3|||
33203757|NCT00680407|100648503|FG002|Overall Study|Lost to Follow-up|1|||
33203758|NCT00680407|100648501|FG000|Overall Study|Withdrawal by Subject|5|||
33203759|NCT00680407|100648502|FG001|Overall Study|Withdrawal by Subject|2|||
33333847|NCT02343159|101114882|FG002|Overall Study|Lost to Follow-up|2|||
33528013|NCT00540644|101830480|FG001|Overall Study|Physician Decision|5|||
33610698|NCT01329939|102123386|FG001|Overall Study|Withdrawal by Subject|1|||
33203760|NCT00680407|100648503|FG002|Overall Study|Withdrawal by Subject|2|||
33203761|NCT04798781|100648504|FG000|Overall Study|Withdrawal by Subject|1|||
33203762|NCT02613481|100648507|FG000|Overall Study|Lost to Follow-up|7|||
33203763|NCT02613481|100648507|FG000|Overall Study|Withdrawal by Subject|2|||
33203764|NCT03867734|100648509|FG000|Overall Study|Lost to Follow-up|2|||
33203765|NCT02525133|100648510|FG000|Overall Study|Adverse Event|0|||
33203766|NCT02525133|100648511|FG001|Overall Study|Adverse Event|1|||
33203767|NCT02525133|100648510|FG000|Overall Study|Death|0|||
33203768|NCT02525133|100648511|FG001|Overall Study|Death|1|||
33203769|NCT02525133|100648510|FG000|Overall Study|did not meet randomization criteria|1|||
33203770|NCT02525133|100648511|FG001|Overall Study|did not meet randomization criteria|0|||
33203771|NCT02525133|100648510|FG000|Overall Study|Lost to Follow-up|5|||
33203772|NCT02525133|100648511|FG001|Overall Study|Lost to Follow-up|1|||
33528014|NCT00540644|101830479|FG000|Overall Study|Withdrawal by Subject|2|||
33528015|NCT00540644|101830480|FG001|Overall Study|Withdrawal by Subject|2|||
33528016|NCT00540644|101830479|FG000|Overall Study|Noncomplilance|1|||
33203773|NCT02525133|100648510|FG000|Overall Study|randomized not enrolled|3|||
33203774|NCT02525133|100648511|FG001|Overall Study|randomized not enrolled|0|||
33203775|NCT02525133|100648510|FG000|Overall Study|Withdrawal by Subject|1|||
33203776|NCT02525133|100648511|FG001|Overall Study|Withdrawal by Subject|0|||
33203777|NCT01617629|100648512|FG000|Overall Study|Death|2|||
33203778|NCT01617629|100648512|FG000|Overall Study|Investigator's Clinical Judgement|1|||
33203779|NCT01617629|100648512|FG000|Overall Study|Reason Not Specified|1|||
33203780|NCT01617629|100648512|FG000|Overall Study|Participant Withdrew Consent|2|||
33203781|NCT02646423|100648515|FG000|Overall Study|Adverse Event|5|||
33203782|NCT02646423|100648516|FG001|Overall Study|Adverse Event|7|||
33203783|NCT02646423|100648515|FG000|Overall Study|Ineligible|2|||
33203784|NCT02646423|100648516|FG001|Overall Study|Ineligible|1|||
33203785|NCT00504829|100648517|FG000|Overall Study|Protocol Violation|6|||
33203786|NCT00504829|100648518|FG001|Overall Study|Protocol Violation|4|||
33203787|NCT00504829|100648519|FG002|Overall Study|Protocol Violation|10|||
33203788|NCT04329104|100648520|FG000|Efficacy Study|Withdrawal by Subject|0|||
33203789|NCT04329104|100648521|FG001|Efficacy Study|Withdrawal by Subject|0|||
33203790|NCT04329104|100648522|FG002|Efficacy Study|Withdrawal by Subject|0|||
33203791|NCT04329104|100648523|FG003|Efficacy Study|Withdrawal by Subject|5|||
33203792|NCT04329104|100648524|FG004|Efficacy Study|Withdrawal by Subject|6|||
33203793|NCT04329104|100648525|FG005|Efficacy Study|Withdrawal by Subject|8|||
33203794|NCT00673049|100648528|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
33203795|NCT00673049|100648529|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
33203796|NCT00673049|100648530|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
33203797|NCT00673049|100648531|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
33203798|NCT00673049|100648528|FG000|Before Progression on Erlotinib|Death|235|||
33203799|NCT00673049|100648529|FG001|Before Progression on Erlotinib|Death|167|||
33203800|NCT00673049|100648530|FG002|Before Progression on Erlotinib|Death|1|||
33203801|NCT00673049|100648531|FG003|Before Progression on Erlotinib|Death|0|||
33203802|NCT00673049|100648528|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
33203803|NCT00673049|100648529|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
33203804|NCT00673049|100648530|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
33203805|NCT00673049|100648531|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
33203806|NCT00673049|100648528|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
33203807|NCT00673049|100648529|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
33203808|NCT00673049|100648530|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
33203809|NCT00673049|100648531|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
33203810|NCT00673049|100648528|FG000|Before Progression on Erlotinib|Other|1|||
33203811|NCT00673049|100648529|FG001|Before Progression on Erlotinib|Other|2|||
33203812|NCT00673049|100648530|FG002|Before Progression on Erlotinib|Other|0|||
33203813|NCT00673049|100648531|FG003|Before Progression on Erlotinib|Other|0|||
33203814|NCT00673049|100648528|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
33203815|NCT00673049|100648529|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
33203816|NCT00673049|100648530|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
33203817|NCT00673049|100648531|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
33203818|NCT00673049|100648528|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
33203819|NCT00673049|100648529|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
33203820|NCT00673049|100648530|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
33203821|NCT00673049|100648531|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
33203822|NCT00673049|100648528|FG000|After Progression on Erlotinib|Death|0|||
33203823|NCT00673049|100648529|FG001|After Progression on Erlotinib|Death|0|||
33203824|NCT00673049|100648530|FG002|After Progression on Erlotinib|Death|0|||
33203825|NCT00673049|100648531|FG003|After Progression on Erlotinib|Death|71|||
33203826|NCT00673049|100648528|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
33203827|NCT00673049|100648529|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
33203828|NCT00673049|100648530|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
33203829|NCT00673049|100648531|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
33203830|NCT00673049|100648528|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
33203831|NCT00673049|100648529|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
33203832|NCT00673049|100648530|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
33203833|NCT00673049|100648531|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
33203834|NCT00673049|100648528|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
33203835|NCT00673049|100648529|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
33203836|NCT00673049|100648530|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
33610699|NCT01329939|102123387|FG002|Overall Study|Withdrawal by Subject|0|||
33203837|NCT00673049|100648531|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
33203838|NCT02763384|100648532|FG000|Overall Study|Physician Decision|1|||
33203839|NCT02763384|100648532|FG000|Overall Study|Rapid decline - went on hospice|1|||
33203840|NCT01329029|100648535|FG000|Overall Study|Withdrawal by Subject|117|||
33203841|NCT01329029|100648536|FG001|Overall Study|Withdrawal by Subject|87|||
33333848|NCT02343159|101114880|FG000|Overall Study|Adverse Event|4|||
33203842|NCT01329029|100648535|FG000|Overall Study|Adverse Event|82|||
33203843|NCT01329029|100648536|FG001|Overall Study|Adverse Event|29|||
33203844|NCT01329029|100648535|FG000|Overall Study|Death|16|||
33203845|NCT01329029|100648536|FG001|Overall Study|Death|19|||
33203846|NCT01329029|100648535|FG000|Overall Study|Other|14|||
33203847|NCT01329029|100648536|FG001|Overall Study|Other|20|||
33203848|NCT01329029|100648535|FG000|Overall Study|COPD Exacerbation|11|||
33203849|NCT01329029|100648536|FG001|Overall Study|COPD Exacerbation|18|||
33203850|NCT01329029|100648535|FG000|Overall Study|Physician Decision|16|||
33203851|NCT01329029|100648536|FG001|Overall Study|Physician Decision|13|||
33203852|NCT01329029|100648535|FG000|Overall Study|Lost to Follow-up|8|||
33203853|NCT01329029|100648536|FG001|Overall Study|Lost to Follow-up|5|||
33203854|NCT01329029|100648535|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
33203855|NCT01329029|100648536|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
33203856|NCT02571452|100648541|FG000|Overall Study Treatment|Protocol Violation|0|||
33203857|NCT02571452|100648542|FG001|Overall Study Treatment|Protocol Violation|1|||
33203858|NCT02571452|100648541|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
33203859|NCT02571452|100648542|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
33203860|NCT02571452|100648541|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
33203861|NCT02571452|100648542|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
33203862|NCT00898677|100648543|FG000|Overall Study|Adverse Event|0|||
33203863|NCT00898677|100648544|FG001|Overall Study|Adverse Event|0|||
33203864|NCT00898677|100648545|FG002|Overall Study|Adverse Event|1|||
33203865|NCT00898677|100648546|FG003|Overall Study|Adverse Event|0|||
33203866|NCT00898677|100648543|FG000|Overall Study|Lost to Follow-up|0|||
33203867|NCT00898677|100648544|FG001|Overall Study|Lost to Follow-up|0|||
33203868|NCT00898677|100648545|FG002|Overall Study|Lost to Follow-up|2|||
33203869|NCT00898677|100648546|FG003|Overall Study|Lost to Follow-up|0|||
33203870|NCT00898677|100648543|FG000|Overall Study|Protocol Violation|1|||
33203871|NCT00898677|100648544|FG001|Overall Study|Protocol Violation|1|||
33203872|NCT00898677|100648545|FG002|Overall Study|Protocol Violation|2|||
33203873|NCT00898677|100648546|FG003|Overall Study|Protocol Violation|0|||
33203874|NCT00898677|100648543|FG000|Overall Study|Withdrawal by Subject|0|||
33203875|NCT00898677|100648544|FG001|Overall Study|Withdrawal by Subject|0|||
33203876|NCT00898677|100648545|FG002|Overall Study|Withdrawal by Subject|0|||
33203877|NCT00898677|100648546|FG003|Overall Study|Withdrawal by Subject|1|||
33203878|NCT00898677|100648543|FG000|Overall Study|Not Treated: Adverse Event|0|||
33203879|NCT00898677|100648544|FG001|Overall Study|Not Treated: Adverse Event|2|||
33203880|NCT00898677|100648545|FG002|Overall Study|Not Treated: Adverse Event|1|||
33203881|NCT00898677|100648546|FG003|Overall Study|Not Treated: Adverse Event|0|||
33203882|NCT00898677|100648543|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
33203883|NCT00898677|100648544|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
33203884|NCT00898677|100648545|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
33203885|NCT00898677|100648546|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
33203886|NCT00898677|100648543|FG000|Overall Study|Not Treated: Pregnancy|0|||
33203887|NCT00898677|100648544|FG001|Overall Study|Not Treated: Pregnancy|0|||
33203888|NCT00898677|100648545|FG002|Overall Study|Not Treated: Pregnancy|1|||
33203889|NCT00898677|100648546|FG003|Overall Study|Not Treated: Pregnancy|0|||
33203890|NCT00898677|100648543|FG000|Overall Study|Not Treated: Protocol Violation|2|||
33203891|NCT00898677|100648544|FG001|Overall Study|Not Treated: Protocol Violation|0|||
33203892|NCT00898677|100648545|FG002|Overall Study|Not Treated: Protocol Violation|2|||
33203893|NCT00898677|100648546|FG003|Overall Study|Not Treated: Protocol Violation|0|||
33203894|NCT00898677|100648543|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
33203895|NCT00898677|100648544|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
33203896|NCT00898677|100648545|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
33203897|NCT00898677|100648546|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
33203898|NCT00898677|100648543|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
33203899|NCT00898677|100648544|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
33203900|NCT00898677|100648545|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
33203901|NCT00898677|100648546|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
33203902|NCT00898677|100648543|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
33203903|NCT00898677|100648544|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
33203904|NCT00898677|100648545|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
33333849|NCT02343159|101114881|FG001|Overall Study|Adverse Event|4|||
33333850|NCT02343159|101114882|FG002|Overall Study|Adverse Event|2|||
33333851|NCT02343159|101114880|FG000|Overall Study|Sponsor Decision|0|||
33333852|NCT02343159|101114881|FG001|Overall Study|Sponsor Decision|1|||
33333853|NCT02343159|101114882|FG002|Overall Study|Sponsor Decision|0|||
33203905|NCT00898677|100648546|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
33333854|NCT02343159|101114880|FG000|Overall Study|Enrollment Error|1|||
33333855|NCT02343159|101114881|FG001|Overall Study|Enrollment Error|0|||
33203906|NCT00898677|100648543|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
33333856|NCT02343159|101114882|FG002|Overall Study|Enrollment Error|0|||
33333857|NCT02258451|101114883|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
33364967|NCT04760314|101223697|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
33203907|NCT00898677|100648544|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
33203908|NCT00898677|100648545|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
33203909|NCT00898677|100648546|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
33203910|NCT00898677|100648543|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
33203911|NCT00898677|100648544|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
33203912|NCT00898677|100648545|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
33203913|NCT00898677|100648546|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
33203914|NCT00898677|100648543|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
33203915|NCT00898677|100648544|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
33203916|NCT00898677|100648545|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
33203917|NCT00898677|100648546|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
33203918|NCT00898677|100648543|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
33203919|NCT00898677|100648544|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
33203920|NCT00898677|100648545|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
33203921|NCT00898677|100648546|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
33203922|NCT00710424|100648547|FG000|Overall Study|Adverse Event|30|||
33203923|NCT00710424|100648548|FG001|Overall Study|Adverse Event|12|||
33203924|NCT00710424|100648547|FG000|Overall Study|Lack of Efficacy|4|||
33203925|NCT00710424|100648548|FG001|Overall Study|Lack of Efficacy|5|||
33203926|NCT00710424|100648547|FG000|Overall Study|Withdrawal by Subject|5|||
33203927|NCT00710424|100648548|FG001|Overall Study|Withdrawal by Subject|3|||
33203928|NCT00710424|100648547|FG000|Overall Study|Lost to Follow-up|0|||
33203929|NCT00710424|100648548|FG001|Overall Study|Lost to Follow-up|1|||
33203930|NCT00710424|100648547|FG000|Overall Study|Refused medication, no side effects|1|||
33203931|NCT00710424|100648548|FG001|Overall Study|Refused medication, no side effects|0|||
33203932|NCT00710424|100648547|FG000|Overall Study|Non-compliance with stable analgesia|1|||
33203933|NCT00710424|100648548|FG001|Overall Study|Non-compliance with stable analgesia|0|||
33203934|NCT00710424|100648547|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
33203935|NCT00710424|100648548|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
33203936|NCT00710424|100648547|FG000|Overall Study|Subject thought medication changed|1|||
33203937|NCT00710424|100648548|FG001|Overall Study|Subject thought medication changed|0|||
33203938|NCT00710424|100648547|FG000|Overall Study|Ceased treatment due to travel|1|||
33203939|NCT00710424|100648548|FG001|Overall Study|Ceased treatment due to travel|0|||
33203940|NCT00710424|100648547|FG000|Overall Study|Subject preferred paracetamol|0|||
33203941|NCT00710424|100648548|FG001|Overall Study|Subject preferred paracetamol|1|||
33203942|NCT00710424|100648547|FG000|Overall Study|Felt good so stopped treatment|0|||
33203943|NCT00710424|100648548|FG001|Overall Study|Felt good so stopped treatment|1|||
33203944|NCT04389840|100648553|FG000|Overall Study|Adverse Event|0|||
33203945|NCT04389840|100648554|FG001|Overall Study|Adverse Event|0|||
33203946|NCT04389840|100648555|FG002|Overall Study|Adverse Event|0|||
33203947|NCT04389840|100648556|FG003|Overall Study|Adverse Event|1|||
33203948|NCT04389840|100648557|FG004|Overall Study|Adverse Event|0|||
33203949|NCT04389840|100648558|FG005|Overall Study|Adverse Event|0|||
33203950|NCT04389840|100648553|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
33203951|NCT04389840|100648554|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
33333858|NCT02258451|101114884|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
33333859|NCT02258451|101114883|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
33333860|NCT02258451|101114884|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
33333861|NCT02258451|101114883|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
33333862|NCT02258451|101114884|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
33333863|NCT02258451|101114883|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
33333864|NCT02258451|101114884|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
33333865|NCT02258451|101114883|FG000|Overall Study|Discontinuation all treatment due to death|4|||
33333866|NCT02258451|101114884|FG001|Overall Study|Discontinuation all treatment due to death|3|||
33333867|NCT02258451|101114883|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
33403566|NCT00003389|101365625|FG000|Overall Study|Complicating disease|1|||
33528017|NCT00540644|101830480|FG001|Overall Study|Noncomplilance|0|||
33528018|NCT02306850|101830483|FG000|Overall Study|Lack of Efficacy|2|||
33528019|NCT01093586|101830485|FG000|Overall Study|Failed to engraft|3|||
33610700|NCT01329939|102123388|FG003|Overall Study|Withdrawal by Subject|0|||
33203952|NCT04389840|100648555|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
33203953|NCT04389840|100648556|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
33203954|NCT04389840|100648557|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
33203955|NCT04389840|100648558|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
33203956|NCT04389840|100648553|FG000|Overall Study|Death|0|||
33203957|NCT04389840|100648554|FG001|Overall Study|Death|1|||
33203958|NCT04389840|100648555|FG002|Overall Study|Death|0|||
33528020|NCT02579382|101830486|FG000|Main Study Phase|Lost to Follow-up|0|||
33528021|NCT02579382|101830487|FG001|Main Study Phase|Lost to Follow-up|0|||
33528022|NCT02579382|101830488|FG002|Main Study Phase|Lost to Follow-up|2|||
33528023|NCT02579382|101830489|FG003|Main Study Phase|Lost to Follow-up|0|||
33528024|NCT02579382|101830486|FG000|Main Study Phase|Withdrew Consent|0|||
33528025|NCT02579382|101830487|FG001|Main Study Phase|Withdrew Consent|0|||
33528026|NCT02579382|101830488|FG002|Main Study Phase|Withdrew Consent|0|||
33528027|NCT02579382|101830489|FG003|Main Study Phase|Withdrew Consent|2|||
33528028|NCT02579382|101830486|FG000|Main Study Phase|Lack of Efficacy|0|||
33528029|NCT02579382|101830487|FG001|Main Study Phase|Lack of Efficacy|0|||
33528030|NCT02579382|101830488|FG002|Main Study Phase|Lack of Efficacy|0|||
33528031|NCT02579382|101830489|FG003|Main Study Phase|Lack of Efficacy|1|||
33528032|NCT02579382|101830486|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
33528033|NCT02579382|101830487|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
33528034|NCT02579382|101830488|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
33528035|NCT02579382|101830489|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
33528036|NCT02579382|101830486|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
33528037|NCT02579382|101830487|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
33528038|NCT02579382|101830488|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
33528039|NCT02579382|101830489|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
33528040|NCT02579382|101830486|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
33528041|NCT02579382|101830487|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
33528042|NCT02579382|101830488|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
33528043|NCT02579382|101830489|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
33528044|NCT02579382|101830486|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
33528045|NCT02579382|101830487|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
33528046|NCT02579382|101830488|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
33528047|NCT02579382|101830489|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
33528048|NCT02579382|101830486|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
33528049|NCT02579382|101830487|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
33528050|NCT02579382|101830488|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
33528051|NCT02579382|101830489|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
33528052|NCT02579382|101830486|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
33528053|NCT02579382|101830487|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
33528054|NCT02579382|101830488|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
33528055|NCT02579382|101830489|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
33528056|NCT02087670|101830492|FG000|Overall Study|Withdrawal by Subject|3|||
33528057|NCT02087670|101830493|FG001|Overall Study|Withdrawal by Subject|2|||
33528058|NCT03300050|101830494|FG000|Overall Study|Lost to Follow-up|2|||
33528059|NCT03300050|101830495|FG001|Overall Study|Lost to Follow-up|1|||
33528060|NCT03300050|101830496|FG002|Overall Study|Lost to Follow-up|0|||
33528061|NCT03300050|101830497|FG003|Overall Study|Lost to Follow-up|0|||
33528062|NCT03300050|101830498|FG004|Overall Study|Lost to Follow-up|1|||
33528063|NCT03300050|101830494|FG000|Overall Study|Withdrawal by Subject|1|||
33528064|NCT03300050|101830495|FG001|Overall Study|Withdrawal by Subject|1|||
33528065|NCT03300050|101830496|FG002|Overall Study|Withdrawal by Subject|1|||
33528066|NCT03300050|101830497|FG003|Overall Study|Withdrawal by Subject|0|||
33528067|NCT03300050|101830498|FG004|Overall Study|Withdrawal by Subject|0|||
33528068|NCT03300050|101830494|FG000|Overall Study|Death|0|||
33528069|NCT03300050|101830495|FG001|Overall Study|Death|0|||
33528070|NCT03300050|101830496|FG002|Overall Study|Death|1|||
33528071|NCT03300050|101830497|FG003|Overall Study|Death|0|||
33528072|NCT03300050|101830498|FG004|Overall Study|Death|0|||
33528073|NCT03300050|101830494|FG000|Overall Study|Not Eligible at Randomization|0|||
33528074|NCT03300050|101830495|FG001|Overall Study|Not Eligible at Randomization|0|||
33528075|NCT03300050|101830496|FG002|Overall Study|Not Eligible at Randomization|1|||
33528076|NCT03300050|101830497|FG003|Overall Study|Not Eligible at Randomization|1|||
33528077|NCT03300050|101830498|FG004|Overall Study|Not Eligible at Randomization|0|||
33528078|NCT01827592|101830499|FG000|Overall Study|Adverse Event|11|||
33528079|NCT01827592|101830500|FG001|Overall Study|Adverse Event|9|||
33528080|NCT01827592|101830501|FG002|Overall Study|Adverse Event|2|||
33528081|NCT01827592|101830499|FG000|Overall Study|Physician Decision|0|||
33528082|NCT01827592|101830500|FG001|Overall Study|Physician Decision|2|||
33528083|NCT01827592|101830501|FG002|Overall Study|Physician Decision|1|||
33528084|NCT01827592|101830499|FG000|Overall Study|Protocol Violation|2|||
33528085|NCT01827592|101830500|FG001|Overall Study|Protocol Violation|1|||
33528086|NCT01827592|101830501|FG002|Overall Study|Protocol Violation|0|||
33528087|NCT01827592|101830499|FG000|Overall Study|Lost to Follow-up|1|||
33528088|NCT01827592|101830500|FG001|Overall Study|Lost to Follow-up|2|||
33528089|NCT01827592|101830501|FG002|Overall Study|Lost to Follow-up|2|||
33333868|NCT02258451|101114884|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
33333869|NCT02258451|101114883|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
33333870|NCT02258451|101114884|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
33333871|NCT02258451|101114883|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
33333872|NCT02258451|101114884|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
33333873|NCT02258451|101114883|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
33333874|NCT02258451|101114884|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
33333875|NCT02258451|101114883|FG000|Overall Study|Other reason|1|||
33333876|NCT02258451|101114884|FG001|Overall Study|Other reason|1|||
33333877|NCT02258451|101114883|FG000|Overall Study|Never treated|2|||
33528090|NCT01827592|101830499|FG000|Overall Study|Withdrawal by Subject|12|||
33528091|NCT01827592|101830500|FG001|Overall Study|Withdrawal by Subject|11|||
33528092|NCT01827592|101830501|FG002|Overall Study|Withdrawal by Subject|11|||
33528093|NCT01827592|101830499|FG000|Overall Study|Patient's substantial non-compliance|1|||
33333878|NCT02258451|101114884|FG001|Overall Study|Never treated|3|||
33333879|NCT01970995|101114886|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
33333880|NCT01970995|101114887|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
33333881|NCT01970995|101114888|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
33333882|NCT01970995|101114886|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
33333883|NCT01970995|101114887|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
33333884|NCT01970995|101114888|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
33333885|NCT04486950|101114889|FG000|Overall Study|Lost to Follow-up|0|||
33333886|NCT04486950|101114890|FG001|Overall Study|Lost to Follow-up|0|||
33333887|NCT04486950|101114891|FG002|Overall Study|Lost to Follow-up|0|||
33333888|NCT04486950|101114892|FG003|Overall Study|Lost to Follow-up|0|||
33333889|NCT04486950|101114893|FG004|Overall Study|Lost to Follow-up|0|||
33333890|NCT04486950|101114894|FG005|Overall Study|Lost to Follow-up|1|||
33333891|NCT04486950|101114895|FG006|Overall Study|Lost to Follow-up|0|||
33333892|NCT04677959|101114896|FG000|Overall Study|Adverse Event|1|||
33333893|NCT04677959|101114897|FG001|Overall Study|Adverse Event|9|||
33333894|NCT04677959|101114896|FG000|Overall Study|Withdrawal by Subject|2|||
33333895|NCT04677959|101114897|FG001|Overall Study|Withdrawal by Subject|15|||
33333896|NCT04677959|101114896|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33333897|NCT04677959|101114897|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33333898|NCT04677959|101114896|FG000|Overall Study|Non-compliance with study drug|0|||
33333899|NCT04677959|101114897|FG001|Overall Study|Non-compliance with study drug|2|||
33333900|NCT04677959|101114896|FG000|Overall Study|Protocol deviation|0|||
33333901|NCT04677959|101114897|FG001|Overall Study|Protocol deviation|11|||
33333902|NCT04677959|101114896|FG000|Overall Study|Lost to Follow-up|9|||
33333903|NCT04677959|101114897|FG001|Overall Study|Lost to Follow-up|13|||
33333904|NCT04677959|101114896|FG000|Overall Study|Other than specified|0|||
33333905|NCT04677959|101114897|FG001|Overall Study|Other than specified|8|||
33333906|NCT00464334|101114898|FG000|Overall Study|Adverse Event|0|||
33528094|NCT01827592|101830500|FG001|Overall Study|Patient's substantial non-compliance|1|||
33528095|NCT01827592|101830501|FG002|Overall Study|Patient's substantial non-compliance|6|||
33528096|NCT01827592|101830499|FG000|Overall Study|Trial terminated by Sponsor|47|||
33528097|NCT01827592|101830500|FG001|Overall Study|Trial terminated by Sponsor|53|||
33528098|NCT01827592|101830501|FG002|Overall Study|Trial terminated by Sponsor|51|||
33528099|NCT01827592|101830499|FG000|Overall Study|Others|0|||
33528100|NCT01827592|101830500|FG001|Overall Study|Others|1|||
33528101|NCT01827592|101830501|FG002|Overall Study|Others|3|||
33528102|NCT04304508|101830502|FG000|Overall Study|Subject Decision|29|||
33528103|NCT04304508|101830503|FG001|Overall Study|Subject Decision|39|||
33528104|NCT04304508|101830504|FG002|Overall Study|Subject Decision|37|||
33528105|NCT04304508|101830505|FG003|Overall Study|Subject Decision|48|||
33528106|NCT04304508|101830502|FG000|Overall Study|Death|6|||
33528107|NCT04304508|101830503|FG001|Overall Study|Death|1|||
33528108|NCT04304508|101830504|FG002|Overall Study|Death|8|||
33528109|NCT04304508|101830505|FG003|Overall Study|Death|5|||
33333907|NCT00464334|101114899|FG001|Overall Study|Adverse Event|0|||
33333908|NCT00464334|101114900|FG002|Overall Study|Adverse Event|0|||
33333909|NCT00464334|101114901|FG003|Overall Study|Adverse Event|1|||
33528110|NCT04304508|101830502|FG000|Overall Study|Non-compliance With Study Drug|3|||
33528111|NCT04304508|101830503|FG001|Overall Study|Non-compliance With Study Drug|1|||
33333910|NCT00464334|101114902|FG004|Overall Study|Adverse Event|1|||
33333911|NCT00464334|101114903|FG005|Overall Study|Adverse Event|1|||
33333912|NCT00464334|101114904|FG006|Overall Study|Adverse Event|0|||
33333913|NCT00464334|101114905|FG007|Overall Study|Adverse Event|0|||
33333914|NCT00464334|101114906|FG008|Overall Study|Adverse Event|2|||
33333915|NCT00464334|101114907|FG009|Overall Study|Adverse Event|1|||
33333916|NCT00464334|101114908|FG010|Overall Study|Adverse Event|2|||
33528112|NCT04304508|101830504|FG002|Overall Study|Non-compliance With Study Drug|2|||
33528113|NCT04304508|101830505|FG003|Overall Study|Non-compliance With Study Drug|0|||
33528114|NCT04304508|101830502|FG000|Overall Study|Switching To Other Therapy|1|||
33528115|NCT04304508|101830503|FG001|Overall Study|Switching To Other Therapy|1|||
33528116|NCT04304508|101830504|FG002|Overall Study|Switching To Other Therapy|1|||
33528117|NCT04304508|101830505|FG003|Overall Study|Switching To Other Therapy|2|||
33528118|NCT04304508|101830502|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
33528119|NCT04304508|101830503|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
33528120|NCT04304508|101830504|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
33528121|NCT04304508|101830505|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
33528122|NCT04304508|101830502|FG000|Overall Study|Withdrawal by Subject|7|||
33528123|NCT04304508|101830503|FG001|Overall Study|Withdrawal by Subject|5|||
33528124|NCT04304508|101830504|FG002|Overall Study|Withdrawal by Subject|11|||
33528125|NCT04304508|101830505|FG003|Overall Study|Withdrawal by Subject|6|||
33528126|NCT04304508|101830502|FG000|Overall Study|Logistical Difficulties|2|||
33528127|NCT04304508|101830503|FG001|Overall Study|Logistical Difficulties|2|||
33528128|NCT04304508|101830504|FG002|Overall Study|Logistical Difficulties|3|||
33528129|NCT04304508|101830505|FG003|Overall Study|Logistical Difficulties|2|||
33528130|NCT04304508|101830502|FG000|Overall Study|Missing Information|1|||
33528131|NCT04304508|101830503|FG001|Overall Study|Missing Information|2|||
33528132|NCT04304508|101830504|FG002|Overall Study|Missing Information|1|||
33528133|NCT04304508|101830505|FG003|Overall Study|Missing Information|3|||
33528134|NCT04304508|101830502|FG000|Overall Study|Other|7|||
33528135|NCT04304508|101830503|FG001|Overall Study|Other|6|||
33528136|NCT04304508|101830504|FG002|Overall Study|Other|5|||
33528137|NCT04304508|101830505|FG003|Overall Study|Other|4|||
33528138|NCT04304508|101830502|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
33528139|NCT04304508|101830503|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
33528140|NCT04304508|101830504|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
33528141|NCT04304508|101830505|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
33528142|NCT04304508|101830502|FG000|Overall Study|Physician Decision|3|||
33528143|NCT04304508|101830503|FG001|Overall Study|Physician Decision|4|||
33528144|NCT04304508|101830504|FG002|Overall Study|Physician Decision|9|||
33528145|NCT04304508|101830505|FG003|Overall Study|Physician Decision|7|||
33528146|NCT04304508|101830502|FG000|Overall Study|Study drug never administered|10|||
33528147|NCT04304508|101830503|FG001|Overall Study|Study drug never administered|4|||
33528148|NCT04304508|101830504|FG002|Overall Study|Study drug never administered|4|||
33333917|NCT00464334|101114898|FG000|Overall Study|Lack of Efficacy|0|||
33333918|NCT00464334|101114899|FG001|Overall Study|Lack of Efficacy|1|||
33333919|NCT00464334|101114900|FG002|Overall Study|Lack of Efficacy|0|||
33333920|NCT00464334|101114901|FG003|Overall Study|Lack of Efficacy|0|||
33333921|NCT00464334|101114902|FG004|Overall Study|Lack of Efficacy|0|||
33333922|NCT00464334|101114903|FG005|Overall Study|Lack of Efficacy|0|||
33333923|NCT00464334|101114904|FG006|Overall Study|Lack of Efficacy|0|||
33333924|NCT00464334|101114905|FG007|Overall Study|Lack of Efficacy|0|||
33333925|NCT00464334|101114906|FG008|Overall Study|Lack of Efficacy|0|||
33528149|NCT04304508|101830505|FG003|Overall Study|Study drug never administered|4|||
33528150|NCT04304508|101830502|FG000|Overall Study|Adverse Event|49|||
33528151|NCT04304508|101830503|FG001|Overall Study|Adverse Event|50|||
33528152|NCT04304508|101830504|FG002|Overall Study|Adverse Event|51|||
33528153|NCT04304508|101830505|FG003|Overall Study|Adverse Event|56|||
33528154|NCT04304508|101830502|FG000|Overall Study|Lost to Follow-up|1|||
33528155|NCT04304508|101830503|FG001|Overall Study|Lost to Follow-up|5|||
33528156|NCT04304508|101830504|FG002|Overall Study|Lost to Follow-up|2|||
33528157|NCT04304508|101830505|FG003|Overall Study|Lost to Follow-up|3|||
33528158|NCT01859949|101830508|FG000|Overall Study|Family Matters|0|||
33528159|NCT01859949|101830509|FG001|Overall Study|Family Matters|1|||
33528160|NCT01859949|101830508|FG000|Overall Study|Physician Decision|2|||
33528161|NCT01859949|101830509|FG001|Overall Study|Physician Decision|4|||
33528162|NCT01859949|101830508|FG000|Overall Study|Withdrawal by Subject|11|||
33528163|NCT01859949|101830509|FG001|Overall Study|Withdrawal by Subject|10|||
33528164|NCT01859949|101830508|FG000|Overall Study|Protocol Violation|1|||
33528165|NCT01859949|101830509|FG001|Overall Study|Protocol Violation|1|||
33528166|NCT01859949|101830508|FG000|Overall Study|Adverse Event|0|||
33333926|NCT00464334|101114907|FG009|Overall Study|Lack of Efficacy|0|||
33333927|NCT00464334|101114908|FG010|Overall Study|Lack of Efficacy|0|||
33333928|NCT00464334|101114898|FG000|Overall Study|Lost to Follow-up|0|||
33203959|NCT04389840|100648556|FG003|Overall Study|Death|0|||
33203960|NCT04389840|100648557|FG004|Overall Study|Death|0|||
33333929|NCT00464334|101114899|FG001|Overall Study|Lost to Follow-up|0|||
33333930|NCT00464334|101114900|FG002|Overall Study|Lost to Follow-up|1|||
33333931|NCT00464334|101114901|FG003|Overall Study|Lost to Follow-up|0|||
33528167|NCT01859949|101830509|FG001|Overall Study|Adverse Event|1|||
33528168|NCT05568797|101830510|FG000|Overall Study|Adverse Event|0|||
33528169|NCT05568797|101830511|FG001|Overall Study|Adverse Event|8|||
33528170|NCT05568797|101830510|FG000|Overall Study|Lost to Follow-up|2|||
33528171|NCT05568797|101830511|FG001|Overall Study|Lost to Follow-up|3|||
33528172|NCT05568797|101830510|FG000|Overall Study|Withdrawal by Subject|1|||
33528173|NCT05568797|101830511|FG001|Overall Study|Withdrawal by Subject|10|||
33528174|NCT05568797|101830510|FG000|Overall Study|Other|2|||
33528175|NCT05568797|101830511|FG001|Overall Study|Other|2|||
33528176|NCT00760487|101833890|FG000|Overall Study|Unilateral implantation|3|||
33528177|NCT02768792|101833891|FG000|Overall Study|Adverse Event|1|||
33528178|NCT02164318|101833892|FG000|Overall Study|Withdrawal by Subject|0|||
33528179|NCT02164318|101833893|FG001|Overall Study|Withdrawal by Subject|1|||
33333932|NCT00464334|101114902|FG004|Overall Study|Lost to Follow-up|1|||
33333933|NCT00464334|101114903|FG005|Overall Study|Lost to Follow-up|0|||
33333934|NCT00464334|101114904|FG006|Overall Study|Lost to Follow-up|1|||
33333935|NCT00464334|101114905|FG007|Overall Study|Lost to Follow-up|0|||
33333936|NCT00464334|101114906|FG008|Overall Study|Lost to Follow-up|0|||
33333937|NCT00464334|101114907|FG009|Overall Study|Lost to Follow-up|0|||
33333938|NCT00464334|101114908|FG010|Overall Study|Lost to Follow-up|2|||
33333939|NCT00464334|101114898|FG000|Overall Study|Progressive Disease|0|||
33333940|NCT00464334|101114899|FG001|Overall Study|Progressive Disease|0|||
33333941|NCT00464334|101114900|FG002|Overall Study|Progressive Disease|0|||
33333942|NCT00464334|101114901|FG003|Overall Study|Progressive Disease|0|||
33333943|NCT00464334|101114902|FG004|Overall Study|Progressive Disease|0|||
33333944|NCT00464334|101114903|FG005|Overall Study|Progressive Disease|1|||
33333945|NCT00464334|101114904|FG006|Overall Study|Progressive Disease|0|||
33333946|NCT00464334|101114905|FG007|Overall Study|Progressive Disease|0|||
33333947|NCT00464334|101114906|FG008|Overall Study|Progressive Disease|1|||
33333948|NCT00464334|101114907|FG009|Overall Study|Progressive Disease|0|||
33333949|NCT00464334|101114908|FG010|Overall Study|Progressive Disease|0|||
33333950|NCT00464334|101114898|FG000|Overall Study|Study Terminated by Sponsor|0|||
33333951|NCT00464334|101114899|FG001|Overall Study|Study Terminated by Sponsor|0|||
33333952|NCT00464334|101114900|FG002|Overall Study|Study Terminated by Sponsor|0|||
33333953|NCT00464334|101114901|FG003|Overall Study|Study Terminated by Sponsor|1|||
33333954|NCT00464334|101114902|FG004|Overall Study|Study Terminated by Sponsor|0|||
33333955|NCT00464334|101114903|FG005|Overall Study|Study Terminated by Sponsor|0|||
33333956|NCT00464334|101114904|FG006|Overall Study|Study Terminated by Sponsor|0|||
33333957|NCT00464334|101114905|FG007|Overall Study|Study Terminated by Sponsor|0|||
33333958|NCT00464334|101114906|FG008|Overall Study|Study Terminated by Sponsor|0|||
33333959|NCT00464334|101114907|FG009|Overall Study|Study Terminated by Sponsor|0|||
33333960|NCT00464334|101114908|FG010|Overall Study|Study Terminated by Sponsor|0|||
33333961|NCT00464334|101114898|FG000|Overall Study|Withdrawal by Subject|1|||
33333962|NCT00464334|101114899|FG001|Overall Study|Withdrawal by Subject|7|||
33333963|NCT00464334|101114900|FG002|Overall Study|Withdrawal by Subject|4|||
33333964|NCT00464334|101114901|FG003|Overall Study|Withdrawal by Subject|2|||
33333965|NCT00464334|101114902|FG004|Overall Study|Withdrawal by Subject|2|||
33333966|NCT00464334|101114903|FG005|Overall Study|Withdrawal by Subject|2|||
33333967|NCT00464334|101114904|FG006|Overall Study|Withdrawal by Subject|2|||
33333968|NCT00464334|101114905|FG007|Overall Study|Withdrawal by Subject|1|||
33333969|NCT00464334|101114906|FG008|Overall Study|Withdrawal by Subject|3|||
33333970|NCT00464334|101114907|FG009|Overall Study|Withdrawal by Subject|0|||
33333971|NCT00464334|101114908|FG010|Overall Study|Withdrawal by Subject|0|||
33333972|NCT03631732|101114909|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
33333973|NCT03631732|101114910|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
33333974|NCT03631732|101114909|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
33333975|NCT03631732|101114910|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
33333976|NCT03631732|101114909|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
33333977|NCT03631732|101114910|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
33333978|NCT03631732|101114909|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
33333979|NCT03631732|101114910|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
33333980|NCT03631732|101114909|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
33333981|NCT03631732|101114910|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
33333982|NCT03631732|101114909|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
33333983|NCT03631732|101114910|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
33528180|NCT02164318|101833894|FG002|Overall Study|Withdrawal by Subject|0|||
33528181|NCT02164318|101833895|FG003|Overall Study|Withdrawal by Subject|1|||
33528182|NCT01409915|101833896|FG000|Overall Study|Adverse Event|0|||
33528183|NCT01409915|101833897|FG001|Overall Study|Adverse Event|2|||
33528184|NCT01409915|101833896|FG000|Overall Study|Withdrawal by Subject|0|||
33528185|NCT01409915|101833897|FG001|Overall Study|Withdrawal by Subject|1|||
33528186|NCT01409915|101833896|FG000|Overall Study|Protocol Violation|1|||
33333984|NCT03631732|101114909|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
33333985|NCT03631732|101114910|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
33333986|NCT03631732|101114909|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
33333987|NCT03631732|101114910|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
33528187|NCT01409915|101833897|FG001|Overall Study|Protocol Violation|0|||
33528188|NCT00397189|101833898|FG000|3 Weeks Period|Lost to Follow-up|5|||
33203961|NCT04389840|100648558|FG005|Overall Study|Death|0|||
33333988|NCT03631732|101114909|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
33333989|NCT03631732|101114910|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
33528189|NCT00397189|101833899|FG001|3 Weeks Period|Lost to Follow-up|4|||
33528190|NCT00397189|101833898|FG000|3 Weeks Period|Adverse Event|3|||
33333990|NCT03631732|101114909|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
33333991|NCT03631732|101114910|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
33333992|NCT00075023|101114911|FG000|Pilot Study|Physician Decision|1|||
33333993|NCT00075023|101114912|FG001|Pilot Study|Physician Decision|2|||
33333994|NCT00075023|101114911|FG000|Pilot Study|Withdrawal by Subject|1|||
33333995|NCT00075023|101114912|FG001|Pilot Study|Withdrawal by Subject|0|||
33333996|NCT02966509|101114913|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
33333997|NCT02966509|101114914|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
33333998|NCT02966509|101114913|FG000|Baseline Satisfaction Survey|Death|0|||
33333999|NCT02966509|101114914|FG001|Baseline Satisfaction Survey|Death|1|||
33334000|NCT02966509|101114913|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
33334001|NCT02966509|101114914|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
33334002|NCT02966509|101114913|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
33334003|NCT02966509|101114914|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
33334004|NCT02966509|101114913|FG000|6 Month Satisfaction Decision Survey|Death|22|||
33334005|NCT02966509|101114914|FG001|6 Month Satisfaction Decision Survey|Death|25|||
33334006|NCT02966509|101114913|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
33334007|NCT02966509|101114914|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
33334008|NCT02966509|101114913|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
33334009|NCT02966509|101114914|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
33334010|NCT02966509|101114913|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
33334011|NCT02966509|101114914|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
33334012|NCT02966509|101114913|FG000|6 Month Satisfaction Survey|Death|36|||
33334013|NCT02966509|101114914|FG001|6 Month Satisfaction Survey|Death|33|||
33334014|NCT02966509|101114913|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
33334015|NCT02966509|101114914|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
33334016|NCT02966509|101114913|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
33334017|NCT02966509|101114914|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
33334018|NCT02966509|101114913|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
33334019|NCT02966509|101114914|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
33334020|NCT02966509|101114913|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
33334021|NCT02966509|101114914|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
33334022|NCT02966509|101114913|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
33334023|NCT02966509|101114914|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
33334024|NCT04294719|101114919|FG000|Overall Study|Withdrawal by Subject|1|||
33334025|NCT04169373|101114920|FG000|Week 1 to Week 14|Adverse Event|1|||
33334026|NCT04169373|101114921|FG001|Week 1 to Week 14|Adverse Event|0|||
33334027|NCT04169373|101114922|FG002|Week 1 to Week 14|Adverse Event|1|||
33334028|NCT04169373|101114923|FG003|Week 1 to Week 14|Adverse Event|2|||
33334029|NCT04169373|101114920|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
33334030|NCT04169373|101114921|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
33334031|NCT04169373|101114922|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
33334032|NCT04169373|101114923|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
33334033|NCT04169373|101114920|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
33334034|NCT04169373|101114921|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
33334035|NCT04169373|101114922|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
33334036|NCT04169373|101114923|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
33334037|NCT04169373|101114920|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
33334038|NCT04169373|101114921|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
33334039|NCT04169373|101114922|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
33334040|NCT04169373|101114923|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
33528191|NCT00397189|101833899|FG001|3 Weeks Period|Adverse Event|2|||
33528192|NCT00397189|101833898|FG000|3 Weeks Period|Withdrawal by Subject|13|||
33528193|NCT00397189|101833899|FG001|3 Weeks Period|Withdrawal by Subject|9|||
33528194|NCT00397189|101833898|FG000|3 Weeks Period|Physician Decision|0|||
33528195|NCT00397189|101833899|FG001|3 Weeks Period|Physician Decision|2|||
33528196|NCT00397189|101833898|FG000|3 Weeks Period|Protocol Violation|0|||
33528197|NCT00397189|101833899|FG001|3 Weeks Period|Protocol Violation|3|||
33528198|NCT00397189|101833898|FG000|3 Weeks Period|Other|0|||
33334041|NCT04169373|101114920|FG000|Week 1 to Week 14|Other|1|||
33334042|NCT04169373|101114921|FG001|Week 1 to Week 14|Other|3|||
33334043|NCT04169373|101114922|FG002|Week 1 to Week 14|Other|3|||
33528199|NCT00397189|101833899|FG001|3 Weeks Period|Other|2|||
33528200|NCT04577794|101833904|FG000|Overall Study|Adverse Event|1|||
33203962|NCT04598152|100648560|FG000|Overall Study|Lost to Follow-up|0|||
33203963|NCT04598152|100648561|FG001|Overall Study|Lost to Follow-up|1|||
33203964|NCT01131312|100648563|FG000|Overall Study|Lost to Follow-up|425|||
33334044|NCT04169373|101114923|FG003|Week 1 to Week 14|Other|5|||
33334045|NCT04169373|101114920|FG000|Week 14 to Week 52|Adverse Event|1|||
33334046|NCT04169373|101114921|FG001|Week 14 to Week 52|Adverse Event|0|||
33334047|NCT04169373|101114922|FG002|Week 14 to Week 52|Adverse Event|0|||
33334048|NCT04169373|101114923|FG003|Week 14 to Week 52|Adverse Event|1|||
33528201|NCT04577794|101833905|FG001|Overall Study|Adverse Event|1|||
33203965|NCT01131312|100648564|FG001|Overall Study|Lost to Follow-up|229|||
33203966|NCT01131312|100648565|FG002|Overall Study|Lost to Follow-up|351|||
33203967|NCT01259713|100648566|FG000|Overall Study|Adverse Event|54|||
33203968|NCT01259713|100648567|FG001|Overall Study|Adverse Event|23|||
33528202|NCT00321906|101833907|FG000|Overall Study|Adverse Event|36|||
33528203|NCT00321906|101833908|FG001|Overall Study|Adverse Event|44|||
33203969|NCT01259713|100648566|FG000|Overall Study|Death Not Related to IFI|8|||
33203970|NCT01259713|100648567|FG001|Overall Study|Death Not Related to IFI|1|||
33203971|NCT01259713|100648566|FG000|Overall Study|Investigators Discretion|14|||
33203972|NCT01259713|100648567|FG001|Overall Study|Investigators Discretion|6|||
33203973|NCT01259713|100648566|FG000|Overall Study|Lack of Efficacy|2|||
33203974|NCT01259713|100648567|FG001|Overall Study|Lack of Efficacy|0|||
33203975|NCT01259713|100648566|FG000|Overall Study|Protocol Violation|5|||
33528204|NCT00321906|101833907|FG000|Overall Study|Death|9|||
33203976|NCT01259713|100648567|FG001|Overall Study|Protocol Violation|4|||
33203977|NCT01259713|100648566|FG000|Overall Study|Subject Withdrew Consent|12|||
33203978|NCT01259713|100648567|FG001|Overall Study|Subject Withdrew Consent|7|||
33528205|NCT00321906|101833908|FG001|Overall Study|Death|6|||
33528206|NCT00321906|101833907|FG000|Overall Study|Lost to Follow-up|1|||
33528207|NCT00321906|101833908|FG001|Overall Study|Lost to Follow-up|2|||
33528208|NCT00321906|101833907|FG000|Overall Study|Withdrawal by Subject|0|||
33528209|NCT00321906|101833908|FG001|Overall Study|Withdrawal by Subject|4|||
33528210|NCT01877668|101833910|FG000|Overall Study|Death|0|||
33528211|NCT01877668|101833911|FG001|Overall Study|Death|0|||
33528212|NCT01877668|101833912|FG002|Overall Study|Death|0|||
33528213|NCT01877668|101833913|FG003|Overall Study|Death|1|||
33528214|NCT01877668|101833914|FG004|Overall Study|Death|0|||
33528215|NCT01877668|101833910|FG000|Overall Study|No longer met study criteria|1|||
33528216|NCT01877668|101833911|FG001|Overall Study|No longer met study criteria|0|||
33528217|NCT01877668|101833912|FG002|Overall Study|No longer met study criteria|1|||
33528218|NCT01877668|101833913|FG003|Overall Study|No longer met study criteria|0|||
33528219|NCT01877668|101833914|FG004|Overall Study|No longer met study criteria|0|||
33528220|NCT01877668|101833910|FG000|Overall Study|Insufficient clinical response|0|||
33528221|NCT01877668|101833911|FG001|Overall Study|Insufficient clinical response|1|||
33528222|NCT01877668|101833912|FG002|Overall Study|Insufficient clinical response|2|||
33203979|NCT02621606|100648570|FG000|Overall Study|Withdrawal by Subject|0|||
33203980|NCT02621606|100648571|FG001|Overall Study|Withdrawal by Subject|1|||
33203981|NCT02621606|100648572|FG002|Overall Study|Withdrawal by Subject|0|||
33203982|NCT05348681|100648573|FG000|Overall Study|Study terminated by Sponsor|8|||
33203983|NCT05348681|100648574|FG001|Overall Study|Study terminated by Sponsor|3|||
33528223|NCT01877668|101833913|FG003|Overall Study|Insufficient clinical response|2|||
33528224|NCT01877668|101833914|FG004|Overall Study|Insufficient clinical response|0|||
33203984|NCT05348681|100648573|FG000|Overall Study|Withdrawal by Subject|1|||
33203985|NCT05348681|100648574|FG001|Overall Study|Withdrawal by Subject|1|||
33203986|NCT05348681|100648573|FG000|Overall Study|Lost to Follow-up|1|||
33203987|NCT05348681|100648574|FG001|Overall Study|Lost to Follow-up|1|||
33203988|NCT05348681|100648573|FG000|Overall Study|Adverse Event|1|||
33203989|NCT05348681|100648574|FG001|Overall Study|Adverse Event|0|||
33203990|NCT05348681|100648573|FG000|Overall Study|Other|2|||
33203991|NCT05348681|100648574|FG001|Overall Study|Other|1|||
33203992|NCT03870763|100648575|FG000|Overall Study|Study terminated by sponsor|0|||
33203993|NCT03870763|100648576|FG001|Overall Study|Study terminated by sponsor|2|||
33203994|NCT03870763|100648577|FG002|Overall Study|Study terminated by sponsor|0|||
33528225|NCT01877668|101833910|FG000|Overall Study|Lost to Follow-up|0|||
33528226|NCT01877668|101833911|FG001|Overall Study|Lost to Follow-up|2|||
33203995|NCT03870763|100648575|FG000|Overall Study|Withdrawal by Subject|0|||
33203996|NCT03870763|100648576|FG001|Overall Study|Withdrawal by Subject|1|||
33203997|NCT03870763|100648577|FG002|Overall Study|Withdrawal by Subject|0|||
33203998|NCT03870763|100648575|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
33203999|NCT03870763|100648576|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
33204000|NCT03870763|100648577|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
33204001|NCT00993447|100648578|FG000|Overall Study|Withdrawal by Subject|23|||
33204002|NCT00993447|100648579|FG001|Overall Study|Withdrawal by Subject|8|||
33204003|NCT00993447|100648578|FG000|Overall Study|Protocol Violation|12|||
33204004|NCT00993447|100648579|FG001|Overall Study|Protocol Violation|8|||
33204005|NCT00993447|100648578|FG000|Overall Study|Lost to Follow-up|1|||
33204006|NCT00993447|100648579|FG001|Overall Study|Lost to Follow-up|3|||
33204007|NCT00993447|100648578|FG000|Overall Study|Adverse Event|1|||
33204008|NCT00993447|100648579|FG001|Overall Study|Adverse Event|0|||
33204009|NCT01308580|100648589|FG000|Overall Study|Lost to Follow-up|12|||
33204010|NCT01308580|100648590|FG001|Overall Study|Lost to Follow-up|7|||
33204011|NCT02802345|100648591|FG000|Overall Study|Not Treated|0|||
33204012|NCT02802345|100648592|FG001|Overall Study|Not Treated|1|||
33204013|NCT02802345|100648591|FG000|Overall Study|Adverse Event|28|||
33204014|NCT02802345|100648592|FG001|Overall Study|Adverse Event|20|||
33204015|NCT02802345|100648591|FG000|Overall Study|Withdrawal by Subject|3|||
33204016|NCT02802345|100648592|FG001|Overall Study|Withdrawal by Subject|3|||
33204017|NCT02802345|100648591|FG000|Overall Study|Protocol Violation|0|||
33204018|NCT02802345|100648592|FG001|Overall Study|Protocol Violation|1|||
33204019|NCT02802345|100648591|FG000|Overall Study|Other than listed|1|||
33204020|NCT02802345|100648592|FG001|Overall Study|Other than listed|5|||
33204021|NCT01389973|100648593|FG000|Overall Study|Lost to Follow-up|1|||
33204022|NCT01389973|100648593|FG000|Overall Study|Trial Stopped by Sponsor|9|||
33204023|NCT01389973|100648593|FG000|Overall Study|Other|10|||
33204024|NCT01760954|100648594|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
33204025|NCT01760954|100648595|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
33204026|NCT01760954|100648596|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
33204027|NCT01760954|100648597|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
33204028|NCT01760954|100648594|FG000|Treatment Period (6 Months)|Adverse Event|5|||
33204029|NCT01760954|100648595|FG001|Treatment Period (6 Months)|Adverse Event|3|||
33204030|NCT01760954|100648596|FG002|Treatment Period (6 Months)|Adverse Event|4|||
33204031|NCT01760954|100648597|FG003|Treatment Period (6 Months)|Adverse Event|10|||
33204032|NCT01760954|100648594|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
33204033|NCT01760954|100648595|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
33204034|NCT01760954|100648596|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
33204035|NCT01760954|100648597|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
33204036|NCT01760954|100648594|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
33204037|NCT01760954|100648595|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
33204038|NCT01760954|100648596|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
33204039|NCT01760954|100648597|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
33204040|NCT01760954|100648594|FG000|Treatment Period (6 Months)|Pregnancy|5|||
33204041|NCT01760954|100648595|FG001|Treatment Period (6 Months)|Pregnancy|0|||
33204042|NCT01760954|100648596|FG002|Treatment Period (6 Months)|Pregnancy|3|||
33204043|NCT01760954|100648597|FG003|Treatment Period (6 Months)|Pregnancy|2|||
33204044|NCT01760954|100648594|FG000|Treatment Period (6 Months)|Non-compliance|1|||
33204045|NCT01760954|100648595|FG001|Treatment Period (6 Months)|Non-compliance|4|||
33204046|NCT01760954|100648596|FG002|Treatment Period (6 Months)|Non-compliance|0|||
33204047|NCT01760954|100648597|FG003|Treatment Period (6 Months)|Non-compliance|3|||
33204048|NCT01760954|100648594|FG000|Treatment Period (6 Months)|Other|0|||
33204049|NCT01760954|100648595|FG001|Treatment Period (6 Months)|Other|3|||
33204050|NCT01760954|100648596|FG002|Treatment Period (6 Months)|Other|3|||
33204051|NCT01760954|100648597|FG003|Treatment Period (6 Months)|Other|1|||
33204052|NCT01760954|100648594|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
33204053|NCT01760954|100648595|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
33204054|NCT01760954|100648596|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
33204055|NCT01760954|100648597|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
33204056|NCT01760954|100648594|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
33204057|NCT01760954|100648595|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
33204058|NCT01760954|100648596|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
33204059|NCT01760954|100648597|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
33528227|NCT01877668|101833912|FG002|Overall Study|Lost to Follow-up|1|||
33204060|NCT01760954|100648594|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
33204061|NCT01760954|100648595|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
33204062|NCT01760954|100648596|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
33204063|NCT01760954|100648597|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
33204064|NCT01760954|100648594|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
33204065|NCT01760954|100648595|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
33204066|NCT01760954|100648596|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
33204067|NCT01760954|100648597|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
33204068|NCT01760954|100648594|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
33204069|NCT01760954|100648595|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
33204070|NCT01760954|100648596|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
33204071|NCT01760954|100648597|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
33204072|NCT01760954|100648594|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
33204073|NCT01760954|100648595|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
33204074|NCT01760954|100648596|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
33204075|NCT01760954|100648597|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
33204076|NCT01760954|100648594|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
33204077|NCT01760954|100648595|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
33334049|NCT04169373|101114920|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
33334050|NCT04169373|101114921|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
33334051|NCT04169373|101114922|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
33334052|NCT04169373|101114923|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
33334053|NCT04169373|101114920|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
33334054|NCT04169373|101114921|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
33334055|NCT04169373|101114922|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
33334056|NCT04169373|101114923|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
33334057|NCT04169373|101114920|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
33204078|NCT01760954|100648596|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
33204079|NCT01760954|100648597|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
33204080|NCT01760954|100648594|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
33204081|NCT01760954|100648595|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
33204082|NCT01760954|100648596|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
33204083|NCT01760954|100648597|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
33610701|NCT01329939|102123385|FG000|Overall Study|Adverse Event|0|||
33610702|NCT01329939|102123386|FG001|Overall Study|Adverse Event|0|||
33204084|NCT01075074|100648598|FG000|Overall Study|Surgeon changed to open incisional case|1|||
33204085|NCT01075074|100648599|FG001|Overall Study|Surgeon changed to open incisional case|2|||
33204086|NCT01075074|100648600|FG002|Overall Study|Surgeon changed to open incisional case|2|||
33204087|NCT05799495|100648603|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
33204088|NCT05799495|100648604|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
33204089|NCT05799495|100648605|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
33204090|NCT05799495|100648606|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
33204091|NCT05799495|100648603|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
33204092|NCT05799495|100648604|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
33204093|NCT05799495|100648605|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
33204094|NCT05799495|100648606|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
33204095|NCT05799495|100648603|FG000|Treatment (Up to 5 Days)|Other|0|||
33204096|NCT05799495|100648604|FG001|Treatment (Up to 5 Days)|Other|1|||
33204097|NCT05799495|100648605|FG002|Treatment (Up to 5 Days)|Other|0|||
33204098|NCT05799495|100648606|FG003|Treatment (Up to 5 Days)|Other|0|||
33204099|NCT05799495|100648603|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
33204100|NCT05799495|100648604|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
33204101|NCT05799495|100648605|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
33204102|NCT05799495|100648606|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
33204103|NCT05799495|100648603|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
33204104|NCT05799495|100648604|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
33204105|NCT05799495|100648605|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
33204106|NCT05799495|100648606|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
33204107|NCT05799495|100648603|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
33204108|NCT05799495|100648604|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
33204109|NCT05799495|100648605|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
33334058|NCT04169373|101114921|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
33204110|NCT05799495|100648606|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
33334059|NCT04169373|101114922|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
33334060|NCT04169373|101114923|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
33334061|NCT04169373|101114920|FG000|Week 14 to Week 52|Other|4|||
33334062|NCT04169373|101114921|FG001|Week 14 to Week 52|Other|5|||
33334063|NCT04169373|101114922|FG002|Week 14 to Week 52|Other|4|||
33204111|NCT01205685|100648607|FG000|Overall Study|Disease Progression|10|||
33204112|NCT01205685|100648607|FG000|Overall Study|Withdrawal by Subject|1|||
33204113|NCT04773587|100648609|FG000|Overall Study|Lost to Follow-up|11|||
33204114|NCT04773587|100648610|FG001|Overall Study|Lost to Follow-up|3|||
33204115|NCT04773587|100648609|FG000|Overall Study|Adverse Event|6|||
33204116|NCT04773587|100648610|FG001|Overall Study|Adverse Event|3|||
33204117|NCT04773587|100648609|FG000|Overall Study|Lack of Efficacy|5|||
33204118|NCT04773587|100648610|FG001|Overall Study|Lack of Efficacy|2|||
33204119|NCT04773587|100648609|FG000|Overall Study|Withdrawal by Subject|4|||
33204120|NCT04773587|100648610|FG001|Overall Study|Withdrawal by Subject|5|||
33204121|NCT04773587|100648609|FG000|Overall Study|Noncompliance|1|||
33204122|NCT04773587|100648610|FG001|Overall Study|Noncompliance|0|||
33204123|NCT04773587|100648609|FG000|Overall Study|Protocol Violation|1|||
33204124|NCT04773587|100648610|FG001|Overall Study|Protocol Violation|0|||
33204125|NCT04773587|100648609|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
33204126|NCT04773587|100648610|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
33204127|NCT03836053|100648620|FG000|Overall Study|Protocol-specified criteria|0|||
33204128|NCT03836053|100648621|FG001|Overall Study|Protocol-specified criteria|2|||
33204129|NCT03836053|100648622|FG002|Overall Study|Protocol-specified criteria|1|||
33204130|NCT03836053|100648620|FG000|Overall Study|Death|1|||
33204131|NCT03836053|100648621|FG001|Overall Study|Death|6|||
33204132|NCT03836053|100648622|FG002|Overall Study|Death|4|||
33204133|NCT03836053|100648620|FG000|Overall Study|Withdrawal of consent from study|0|||
33204134|NCT03836053|100648621|FG001|Overall Study|Withdrawal of consent from study|0|||
33204135|NCT03836053|100648622|FG002|Overall Study|Withdrawal of consent from study|1|||
33204136|NCT03836053|100648620|FG000|Overall Study|Decision by sponsor|0|||
33204137|NCT03836053|100648621|FG001|Overall Study|Decision by sponsor|2|||
33204138|NCT03836053|100648622|FG002|Overall Study|Decision by sponsor|4|||
33204139|NCT00659334|100648625|FG000|Overall Study|Screen Failure|8|||
33204140|NCT00659334|100648626|FG001|Overall Study|Screen Failure|5|||
33204141|NCT00659334|100648627|FG002|Overall Study|Screen Failure|0|||
33204142|NCT00659334|100648628|FG003|Overall Study|Screen Failure|0|||
33204143|NCT00659334|100648629|FG004|Overall Study|Screen Failure|0|||
33204144|NCT00659334|100648630|FG005|Overall Study|Screen Failure|0|||
33204145|NCT00659334|100648631|FG006|Overall Study|Screen Failure|1|||
33204146|NCT00874029|100648632|FG000|Overall Study|Withdrawal by Subject|10|||
33204147|NCT00874029|100648632|FG000|Overall Study|Pregnancy|4|||
33204148|NCT00874029|100648632|FG000|Overall Study|Physician Decision|1|||
33204149|NCT00874029|100648632|FG000|Overall Study|Adverse Event|1|||
33204150|NCT00874029|100648632|FG000|Overall Study|Lost to Follow-up|5|||
33204151|NCT02276482|100648645|FG000|Overall Study|Adverse Event|1|||
33204152|NCT02276482|100648646|FG001|Overall Study|Adverse Event|0|||
33204153|NCT02276482|100648645|FG000|Overall Study|Withdrawal by Subject|1|||
33204154|NCT02276482|100648646|FG001|Overall Study|Withdrawal by Subject|0|||
33204155|NCT02276482|100648645|FG000|Overall Study|Gram-negative infection|1|||
33204156|NCT02276482|100648646|FG001|Overall Study|Gram-negative infection|0|||
33204157|NCT02276482|100648645|FG000|Overall Study|Reason not specified|0|||
33204158|NCT02276482|100648646|FG001|Overall Study|Reason not specified|1|||
33204159|NCT00796718|100648653|FG000|Overall Study|Adverse Event|2|||
33204160|NCT00796718|100648653|FG000|Overall Study|Exclusion Criteria|1|||
33204161|NCT00796718|100648653|FG000|Overall Study|Lost to Follow-up|5|||
33204162|NCT00796718|100648653|FG000|Overall Study|Withdrawal by Informed Consent|1|||
33204163|NCT02696317|100648654|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
33204164|NCT02696317|100648655|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
33204165|NCT02696317|100648654|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
33204166|NCT02696317|100648655|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
33334064|NCT04169373|101114923|FG003|Week 14 to Week 52|Other|5|||
33334065|NCT04169373|101114920|FG000|Week 14 to Week 52|Ongoing|0|||
33334066|NCT04169373|101114921|FG001|Week 14 to Week 52|Ongoing|1|||
33334067|NCT04169373|101114922|FG002|Week 14 to Week 52|Ongoing|0|||
33334068|NCT04169373|101114923|FG003|Week 14 to Week 52|Ongoing|0|||
33204167|NCT01054729|100648661|FG000|Overall Study|Randomized but Not Treated|0|||
33204168|NCT01054729|100648662|FG001|Overall Study|Randomized but Not Treated|1|||
33334069|NCT02457637|101114927|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
33204169|NCT01054729|100648663|FG002|Overall Study|Randomized but Not Treated|0|||
33204170|NCT01054729|100648664|FG003|Overall Study|Randomized but Not Treated|0|||
33334070|NCT01111851|101114928|FG000|Overall Study|All planned PET scans were not obtained.|2|||
33204171|NCT01054729|100648661|FG000|Overall Study|Adverse Event|1|||
33204172|NCT01054729|100648662|FG001|Overall Study|Adverse Event|1|||
33204173|NCT01054729|100648663|FG002|Overall Study|Adverse Event|2|||
33204174|NCT01054729|100648664|FG003|Overall Study|Adverse Event|1|||
33204175|NCT01054729|100648661|FG000|Overall Study|Withdrawal by Subject|1|||
33334071|NCT01111851|101114929|FG001|Overall Study|All planned PET scans were not obtained.|0|||
33204176|NCT01054729|100648662|FG001|Overall Study|Withdrawal by Subject|0|||
33204177|NCT01054729|100648663|FG002|Overall Study|Withdrawal by Subject|1|||
33204178|NCT01054729|100648664|FG003|Overall Study|Withdrawal by Subject|0|||
33334072|NCT00574275|101114932|FG000|Overall Study|Randomized but not treated|2|||
33334073|NCT00574275|101114933|FG001|Overall Study|Randomized but not treated|3|||
33334074|NCT00574275|101114932|FG000|Overall Study|Adverse Event|32|||
33334075|NCT00574275|101114933|FG001|Overall Study|Adverse Event|76|||
33334076|NCT00574275|101114932|FG000|Overall Study|Disease progression|160|||
33334077|NCT00574275|101114933|FG001|Overall Study|Disease progression|146|||
33334078|NCT00574275|101114932|FG000|Overall Study|Lost to Follow-up|2|||
33334079|NCT00574275|101114933|FG001|Overall Study|Lost to Follow-up|1|||
33334080|NCT00574275|101114932|FG000|Overall Study|Study stopped based on DMC decision|62|||
33528228|NCT01877668|101833913|FG003|Overall Study|Lost to Follow-up|0|||
33528229|NCT01877668|101833914|FG004|Overall Study|Lost to Follow-up|0|||
33528230|NCT01877668|101833910|FG000|Overall Study|Withdrawal by Subject|2|||
33528231|NCT01877668|101833911|FG001|Overall Study|Withdrawal by Subject|0|||
33528232|NCT01877668|101833912|FG002|Overall Study|Withdrawal by Subject|3|||
33528233|NCT01877668|101833913|FG003|Overall Study|Withdrawal by Subject|2|||
33528234|NCT01877668|101833914|FG004|Overall Study|Withdrawal by Subject|2|||
33528235|NCT01877668|101833910|FG000|Overall Study|Other|1|||
33528236|NCT01877668|101833911|FG001|Overall Study|Other|1|||
33528237|NCT01877668|101833912|FG002|Overall Study|Other|1|||
33528238|NCT01877668|101833913|FG003|Overall Study|Other|1|||
33610703|NCT01329939|102123387|FG002|Overall Study|Adverse Event|0|||
33204179|NCT01054729|100648661|FG000|Overall Study|Lost to Follow-up|0|||
33334081|NCT00574275|101114933|FG001|Overall Study|Study stopped based on DMC decision|23|||
33610704|NCT01329939|102123388|FG003|Overall Study|Adverse Event|3|||
33610705|NCT03208088|102123389|FG000|Period 2|Withdrawal by Subject|0|||
33610706|NCT03208088|102123390|FG001|Period 2|Withdrawal by Subject|0|||
33610707|NCT03208088|102123391|FG002|Period 2|Withdrawal by Subject|0|||
33610708|NCT03208088|102123392|FG003|Period 2|Withdrawal by Subject|0|||
33610709|NCT03208088|102123393|FG004|Period 2|Withdrawal by Subject|0|||
33610710|NCT03208088|102123394|FG005|Period 2|Withdrawal by Subject|0|||
33610711|NCT03208088|102123395|FG006|Period 2|Withdrawal by Subject|0|||
33610712|NCT03208088|102123396|FG007|Period 2|Withdrawal by Subject|0|||
33610713|NCT03208088|102123397|FG008|Period 2|Withdrawal by Subject|1|||
33610714|NCT03208088|102123398|FG009|Period 2|Withdrawal by Subject|0|||
33610715|NCT03208088|102123389|FG000|Period 3|Unsatisfactory Test Article|0|||
33610716|NCT03208088|102123390|FG001|Period 3|Unsatisfactory Test Article|0|||
33610717|NCT03208088|102123391|FG002|Period 3|Unsatisfactory Test Article|0|||
33610718|NCT03208088|102123392|FG003|Period 3|Unsatisfactory Test Article|1|||
33204180|NCT01054729|100648662|FG001|Overall Study|Lost to Follow-up|1|||
33334082|NCT00574275|101114932|FG000|Overall Study|Withdrawal by Subject|15|||
33334083|NCT00574275|101114933|FG001|Overall Study|Withdrawal by Subject|17|||
33334084|NCT00574275|101114932|FG000|Overall Study|Error calculating tumor measurement|1|||
33528239|NCT01877668|101833914|FG004|Overall Study|Other|3|||
33528240|NCT01877668|101833910|FG000|Overall Study|Protocol Violation|1|||
33528241|NCT01877668|101833911|FG001|Overall Study|Protocol Violation|1|||
33528242|NCT01877668|101833912|FG002|Overall Study|Protocol Violation|0|||
33204181|NCT01054729|100648663|FG002|Overall Study|Lost to Follow-up|0|||
33334085|NCT00574275|101114933|FG001|Overall Study|Error calculating tumor measurement|0|||
33334086|NCT00574275|101114932|FG000|Overall Study|Physician Decision|1|||
33334087|NCT00574275|101114933|FG001|Overall Study|Physician Decision|1|||
33334088|NCT00574275|101114932|FG000|Overall Study|Protocol Violation|0|||
33334089|NCT00574275|101114933|FG001|Overall Study|Protocol Violation|1|||
33528243|NCT01877668|101833913|FG003|Overall Study|Protocol Violation|0|||
33528244|NCT01877668|101833914|FG004|Overall Study|Protocol Violation|3|||
33528245|NCT01877668|101833910|FG000|Overall Study|Adverse event related to study drug|2|||
33334090|NCT00574275|101114932|FG000|Overall Study|Patient and Investigator decision|0|||
33528246|NCT01877668|101833911|FG001|Overall Study|Adverse event related to study drug|2|||
33610719|NCT03208088|102123393|FG004|Period 3|Unsatisfactory Test Article|0|||
33610720|NCT03208088|102123394|FG005|Period 3|Unsatisfactory Test Article|0|||
33610721|NCT03208088|102123395|FG006|Period 3|Unsatisfactory Test Article|0|||
33610722|NCT03208088|102123396|FG007|Period 3|Unsatisfactory Test Article|0|||
33204182|NCT01054729|100648664|FG003|Overall Study|Lost to Follow-up|0|||
33334091|NCT00574275|101114933|FG001|Overall Study|Patient and Investigator decision|1|||
33334092|NCT00574275|101114932|FG000|Overall Study|Insurance change|0|||
33528247|NCT01877668|101833912|FG002|Overall Study|Adverse event related to study drug|2|||
33610723|NCT03208088|102123397|FG008|Period 3|Unsatisfactory Test Article|0|||
33334093|NCT00574275|101114933|FG001|Overall Study|Insurance change|1|||
33334094|NCT00574275|101114932|FG000|Overall Study|Operation for curative intent|0|||
33334095|NCT00574275|101114933|FG001|Overall Study|Operation for curative intent|1|||
33334096|NCT00326209|101114938|FG000|Overall Study|Adverse Event|28|||
33334097|NCT00326209|101114938|FG000|Overall Study|Withdrawal by Subject|22|||
33334098|NCT00326209|101114938|FG000|Overall Study|Lack of Efficacy|31|||
33334099|NCT00326209|101114938|FG000|Overall Study|Lost to Follow-up|18|||
33334100|NCT00326209|101114938|FG000|Overall Study|Participant non-compliant|6|||
33334101|NCT00326209|101114938|FG000|Overall Study|Sponsor closed study|173|||
33528248|NCT01877668|101833913|FG003|Overall Study|Adverse event related to study drug|2|||
33528249|NCT01877668|101833914|FG004|Overall Study|Adverse event related to study drug|1|||
33528250|NCT01877668|101833910|FG000|Overall Study|Adverse event unrelated to study drug|4|||
33528251|NCT01877668|101833911|FG001|Overall Study|Adverse event unrelated to study drug|1|||
33528252|NCT01877668|101833912|FG002|Overall Study|Adverse event unrelated to study drug|2|||
33528253|NCT01877668|101833913|FG003|Overall Study|Adverse event unrelated to study drug|0|||
33528254|NCT01877668|101833914|FG004|Overall Study|Adverse event unrelated to study drug|1|||
33528255|NCT00587795|101833915|FG000|Overall Study|Withdrawal by Subject|1|||
33528256|NCT00587795|101833916|FG001|Overall Study|Withdrawal by Subject|0|||
33528257|NCT03339713|101833917|FG000|Overall Study|Lost to Follow-up|2|||
33334102|NCT00326209|101114938|FG000|Overall Study|Prohibited medication use|1|||
33334103|NCT00326209|101114938|FG000|Overall Study|Violation of entry criteria|1|||
33334104|NCT00326209|101114938|FG000|Overall Study|Withdrawn in error|1|||
33528258|NCT03339713|101833918|FG001|Overall Study|Lost to Follow-up|1|||
33528259|NCT03339713|101833917|FG000|Overall Study|Protocol Violation|1|||
33528260|NCT03339713|101833918|FG001|Overall Study|Protocol Violation|0|||
33528261|NCT03339713|101833917|FG000|Overall Study|Withdrawal by Subject|1|||
33528262|NCT03339713|101833918|FG001|Overall Study|Withdrawal by Subject|1|||
33528263|NCT03130959|101833919|FG000|Overall Study|Disease progression|19|||
33528264|NCT03130959|101833920|FG001|Overall Study|Disease progression|7|||
33528265|NCT03130959|101833921|FG002|Overall Study|Disease progression|12|||
33528266|NCT03130959|101833922|FG003|Overall Study|Disease progression|7|||
33528267|NCT03130959|101833923|FG004|Overall Study|Disease progression|12|||
33528268|NCT03130959|101833924|FG005|Overall Study|Disease progression|3|||
33528269|NCT03130959|101833925|FG006|Overall Study|Disease progression|6|||
33528270|NCT03130959|101833926|FG007|Overall Study|Disease progression|3|||
33528271|NCT03130959|101833927|FG008|Overall Study|Disease progression|15|||
33528272|NCT03130959|101833928|FG009|Overall Study|Disease progression|8|||
33528273|NCT03130959|101833919|FG000|Overall Study|Study drug toxicity|2|||
33528274|NCT03130959|101833920|FG001|Overall Study|Study drug toxicity|2|||
33528275|NCT03130959|101833921|FG002|Overall Study|Study drug toxicity|1|||
33528276|NCT03130959|101833922|FG003|Overall Study|Study drug toxicity|2|||
33528277|NCT03130959|101833923|FG004|Overall Study|Study drug toxicity|1|||
33528278|NCT03130959|101833924|FG005|Overall Study|Study drug toxicity|1|||
33528279|NCT03130959|101833925|FG006|Overall Study|Study drug toxicity|3|||
33528280|NCT03130959|101833926|FG007|Overall Study|Study drug toxicity|0|||
33528281|NCT03130959|101833927|FG008|Overall Study|Study drug toxicity|3|||
33528282|NCT03130959|101833928|FG009|Overall Study|Study drug toxicity|3|||
33528283|NCT03130959|101833919|FG000|Overall Study|Other reasons|0|||
33528284|NCT03130959|101833920|FG001|Overall Study|Other reasons|0|||
33528285|NCT03130959|101833921|FG002|Overall Study|Other reasons|0|||
33528286|NCT03130959|101833922|FG003|Overall Study|Other reasons|0|||
33528287|NCT03130959|101833923|FG004|Overall Study|Other reasons|0|||
33528288|NCT03130959|101833924|FG005|Overall Study|Other reasons|1|||
33528289|NCT03130959|101833925|FG006|Overall Study|Other reasons|1|||
33528290|NCT03130959|101833926|FG007|Overall Study|Other reasons|0|||
33334105|NCT00326209|101114938|FG000|Overall Study|Pregnancy|1|||
33334106|NCT00975156|101114940|FG000|Overall Study|Protocol Violation|0|||
33334107|NCT00975156|101114941|FG001|Overall Study|Protocol Violation|1|||
33528291|NCT03130959|101833927|FG008|Overall Study|Other reasons|0|||
33528292|NCT03130959|101833928|FG009|Overall Study|Other reasons|0|||
33528293|NCT03130959|101833919|FG000|Overall Study|Subject request to discontinue therapy|0|||
33528294|NCT03130959|101833920|FG001|Overall Study|Subject request to discontinue therapy|0|||
33528295|NCT03130959|101833921|FG002|Overall Study|Subject request to discontinue therapy|1|||
33528296|NCT03130959|101833922|FG003|Overall Study|Subject request to discontinue therapy|1|||
33528297|NCT03130959|101833923|FG004|Overall Study|Subject request to discontinue therapy|0|||
33528298|NCT03130959|101833924|FG005|Overall Study|Subject request to discontinue therapy|0|||
33528299|NCT03130959|101833925|FG006|Overall Study|Subject request to discontinue therapy|1|||
33528300|NCT03130959|101833926|FG007|Overall Study|Subject request to discontinue therapy|1|||
33528301|NCT03130959|101833927|FG008|Overall Study|Subject request to discontinue therapy|0|||
33528302|NCT03130959|101833928|FG009|Overall Study|Subject request to discontinue therapy|0|||
33204183|NCT01054729|100648661|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
33334108|NCT00542269|101114944|FG000|Overall Study|Adverse Event|10|||
33334109|NCT00542269|101114945|FG001|Overall Study|Adverse Event|4|||
33528303|NCT03130959|101833919|FG000|Overall Study|Not reported|0|||
33528304|NCT03130959|101833920|FG001|Overall Study|Not reported|0|||
33204184|NCT01054729|100648662|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
33204185|NCT01054729|100648663|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
33204186|NCT01054729|100648664|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
33204187|NCT01054729|100648661|FG000|Overall Study|Non-responder|1|||
33204188|NCT01054729|100648662|FG001|Overall Study|Non-responder|0|||
33204189|NCT01054729|100648663|FG002|Overall Study|Non-responder|1|||
33204190|NCT01054729|100648664|FG003|Overall Study|Non-responder|1|||
33204191|NCT01054729|100648661|FG000|Overall Study|PEG/RBV Non-responder|1|||
33204192|NCT01054729|100648662|FG001|Overall Study|PEG/RBV Non-responder|0|||
33204193|NCT01054729|100648663|FG002|Overall Study|PEG/RBV Non-responder|1|||
33204194|NCT01054729|100648664|FG003|Overall Study|PEG/RBV Non-responder|0|||
33204195|NCT01054729|100648661|FG000|Overall Study|Personal/Obligations|0|||
33204196|NCT01054729|100648662|FG001|Overall Study|Personal/Obligations|1|||
33204197|NCT01054729|100648663|FG002|Overall Study|Personal/Obligations|0|||
33204198|NCT01054729|100648664|FG003|Overall Study|Personal/Obligations|0|||
33204199|NCT01054729|100648661|FG000|Overall Study|Subject moved|0|||
33204200|NCT01054729|100648662|FG001|Overall Study|Subject moved|0|||
33204201|NCT01054729|100648663|FG002|Overall Study|Subject moved|1|||
33528305|NCT03130959|101833921|FG002|Overall Study|Not reported|0|||
33528306|NCT03130959|101833922|FG003|Overall Study|Not reported|1|||
33528307|NCT03130959|101833923|FG004|Overall Study|Not reported|0|||
33528308|NCT03130959|101833924|FG005|Overall Study|Not reported|1|||
33528309|NCT03130959|101833925|FG006|Overall Study|Not reported|0|||
33528310|NCT03130959|101833926|FG007|Overall Study|Not reported|0|||
33528311|NCT03130959|101833927|FG008|Overall Study|Not reported|0|||
33528312|NCT03130959|101833928|FG009|Overall Study|Not reported|1|||
33204202|NCT01054729|100648664|FG003|Overall Study|Subject moved|0|||
33204203|NCT01054729|100648661|FG000|Overall Study|Lack of Efficacy|0|||
33204204|NCT01054729|100648662|FG001|Overall Study|Lack of Efficacy|0|||
33204205|NCT01054729|100648663|FG002|Overall Study|Lack of Efficacy|0|||
33204206|NCT01054729|100648664|FG003|Overall Study|Lack of Efficacy|1|||
33204207|NCT01615029|100648667|FG000|Overall Study|Adverse Event|0|||
33204208|NCT01615029|100648668|FG001|Overall Study|Adverse Event|0|||
33204209|NCT01615029|100648669|FG002|Overall Study|Adverse Event|0|||
33204210|NCT01615029|100648670|FG003|Overall Study|Adverse Event|0|||
33204211|NCT01615029|100648671|FG004|Overall Study|Adverse Event|1|||
33204212|NCT01615029|100648667|FG000|Overall Study|Death|0|||
33204213|NCT01615029|100648668|FG001|Overall Study|Death|0|||
33204214|NCT01615029|100648669|FG002|Overall Study|Death|0|||
33204215|NCT01615029|100648670|FG003|Overall Study|Death|0|||
33204216|NCT01615029|100648671|FG004|Overall Study|Death|1|||
33204217|NCT01615029|100648667|FG000|Overall Study|Lost to Follow-up|0|||
33204218|NCT01615029|100648668|FG001|Overall Study|Lost to Follow-up|0|||
33204219|NCT01615029|100648669|FG002|Overall Study|Lost to Follow-up|0|||
33204220|NCT01615029|100648670|FG003|Overall Study|Lost to Follow-up|0|||
33204221|NCT01615029|100648671|FG004|Overall Study|Lost to Follow-up|1|||
33204222|NCT01615029|100648667|FG000|Overall Study|Progressive disease|2|||
33204223|NCT01615029|100648668|FG001|Overall Study|Progressive disease|1|||
33204224|NCT01615029|100648669|FG002|Overall Study|Progressive disease|1|||
33204225|NCT01615029|100648670|FG003|Overall Study|Progressive disease|1|||
33204226|NCT01615029|100648671|FG004|Overall Study|Progressive disease|5|||
33204227|NCT01615029|100648667|FG000|Overall Study|Physician Decision|0|||
33528313|NCT03130959|101833919|FG000|Overall Study|Adverse Event unrelated to drug|0|||
33528314|NCT03130959|101833920|FG001|Overall Study|Adverse Event unrelated to drug|0|||
33204228|NCT01615029|100648668|FG001|Overall Study|Physician Decision|0|||
33528315|NCT03130959|101833921|FG002|Overall Study|Adverse Event unrelated to drug|1|||
33528316|NCT03130959|101833922|FG003|Overall Study|Adverse Event unrelated to drug|1|||
33528317|NCT03130959|101833923|FG004|Overall Study|Adverse Event unrelated to drug|1|||
33528318|NCT03130959|101833924|FG005|Overall Study|Adverse Event unrelated to drug|0|||
33528319|NCT03130959|101833925|FG006|Overall Study|Adverse Event unrelated to drug|1|||
33528320|NCT03130959|101833926|FG007|Overall Study|Adverse Event unrelated to drug|0|||
33528321|NCT03130959|101833927|FG008|Overall Study|Adverse Event unrelated to drug|1|||
33528322|NCT03130959|101833928|FG009|Overall Study|Adverse Event unrelated to drug|1|||
33528323|NCT03130959|101833919|FG000|Overall Study|Participant withdrew consent|0|||
33528324|NCT03130959|101833920|FG001|Overall Study|Participant withdrew consent|1|||
33528325|NCT03130959|101833921|FG002|Overall Study|Participant withdrew consent|0|||
33528326|NCT03130959|101833922|FG003|Overall Study|Participant withdrew consent|2|||
33528327|NCT03130959|101833923|FG004|Overall Study|Participant withdrew consent|1|||
33528328|NCT03130959|101833924|FG005|Overall Study|Participant withdrew consent|0|||
33528329|NCT03130959|101833925|FG006|Overall Study|Participant withdrew consent|0|||
33528330|NCT03130959|101833926|FG007|Overall Study|Participant withdrew consent|0|||
33528331|NCT03130959|101833927|FG008|Overall Study|Participant withdrew consent|0|||
33528332|NCT03130959|101833928|FG009|Overall Study|Participant withdrew consent|2|||
33528333|NCT03130959|101833919|FG000|Overall Study|Administrative reason by sponsor|1|||
33528334|NCT03130959|101833920|FG001|Overall Study|Administrative reason by sponsor|0|||
33528335|NCT03130959|101833921|FG002|Overall Study|Administrative reason by sponsor|1|||
33528336|NCT03130959|101833922|FG003|Overall Study|Administrative reason by sponsor|0|||
33528337|NCT03130959|101833923|FG004|Overall Study|Administrative reason by sponsor|0|||
33528338|NCT03130959|101833924|FG005|Overall Study|Administrative reason by sponsor|0|||
33528339|NCT03130959|101833925|FG006|Overall Study|Administrative reason by sponsor|0|||
33528340|NCT03130959|101833926|FG007|Overall Study|Administrative reason by sponsor|0|||
33204229|NCT01615029|100648669|FG002|Overall Study|Physician Decision|0|||
33204230|NCT01615029|100648670|FG003|Overall Study|Physician Decision|0|||
33204231|NCT01615029|100648671|FG004|Overall Study|Physician Decision|1|||
33204232|NCT01615029|100648667|FG000|Overall Study|Ongoing|1|||
33204233|NCT01615029|100648668|FG001|Overall Study|Ongoing|2|||
33204234|NCT01615029|100648669|FG002|Overall Study|Ongoing|3|||
33204235|NCT01615029|100648670|FG003|Overall Study|Ongoing|2|||
33204236|NCT01615029|100648671|FG004|Overall Study|Ongoing|23|||
33204237|NCT00512135|100648672|FG000|Overall Study|Not Treated|5|||
33204238|NCT00512135|100648672|FG000|Overall Study|Lack of Efficacy|2|||
33204239|NCT00512135|100648672|FG000|Overall Study|Adverse Event|6|||
33204240|NCT00512135|100648672|FG000|Overall Study|Withdrawal by Subject|22|||
33204241|NCT00512135|100648672|FG000|Overall Study|Lost to Follow-up|27|||
33204242|NCT00512135|100648672|FG000|Overall Study|Other|22|||
33204243|NCT03579459|100648678|FG000|Overall Study|Adverse Event|7|||
33204244|NCT03579459|100648679|FG001|Overall Study|Adverse Event|6|||
33204245|NCT03579459|100648680|FG002|Overall Study|Adverse Event|2|||
33204246|NCT03579459|100648681|FG003|Overall Study|Adverse Event|6|||
33204247|NCT03579459|100648678|FG000|Overall Study|Death|1|||
33204248|NCT03579459|100648679|FG001|Overall Study|Death|0|||
33204249|NCT03579459|100648680|FG002|Overall Study|Death|1|||
33204250|NCT03579459|100648681|FG003|Overall Study|Death|2|||
33204251|NCT03579459|100648678|FG000|Overall Study|Lost to Follow-up|6|||
33204252|NCT03579459|100648679|FG001|Overall Study|Lost to Follow-up|2|||
33204253|NCT03579459|100648680|FG002|Overall Study|Lost to Follow-up|4|||
33204254|NCT03579459|100648681|FG003|Overall Study|Lost to Follow-up|1|||
33528341|NCT03130959|101833927|FG008|Overall Study|Administrative reason by sponsor|0|||
33528342|NCT03130959|101833928|FG009|Overall Study|Administrative reason by sponsor|0|||
33528343|NCT03130959|101833919|FG000|Overall Study|Lost to Follow-up|1|||
33528344|NCT03130959|101833920|FG001|Overall Study|Lost to Follow-up|0|||
33528345|NCT03130959|101833921|FG002|Overall Study|Lost to Follow-up|0|||
33528346|NCT03130959|101833922|FG003|Overall Study|Lost to Follow-up|0|||
33204255|NCT03579459|100648678|FG000|Overall Study|Physician Decision|0|||
33204256|NCT03579459|100648679|FG001|Overall Study|Physician Decision|1|||
33204257|NCT03579459|100648680|FG002|Overall Study|Physician Decision|0|||
33204258|NCT03579459|100648681|FG003|Overall Study|Physician Decision|1|||
33204259|NCT03579459|100648678|FG000|Overall Study|Protocol Violation|1|||
33204260|NCT03579459|100648679|FG001|Overall Study|Protocol Violation|2|||
33204261|NCT03579459|100648680|FG002|Overall Study|Protocol Violation|3|||
33204262|NCT03579459|100648681|FG003|Overall Study|Protocol Violation|5|||
33204263|NCT03579459|100648678|FG000|Overall Study|Withdrawal by Subject|12|||
33204264|NCT03579459|100648679|FG001|Overall Study|Withdrawal by Subject|8|||
33204265|NCT03579459|100648680|FG002|Overall Study|Withdrawal by Subject|11|||
33204266|NCT03579459|100648681|FG003|Overall Study|Withdrawal by Subject|8|||
33204267|NCT03579459|100648678|FG000|Overall Study|Medication error without associated adverse event|2|||
33204268|NCT03579459|100648679|FG001|Overall Study|Medication error without associated adverse event|1|||
33204269|NCT03579459|100648680|FG002|Overall Study|Medication error without associated adverse event|1|||
33204270|NCT03579459|100648681|FG003|Overall Study|Medication error without associated adverse event|0|||
33204271|NCT03579459|100648678|FG000|Overall Study|Other|0|||
33204272|NCT03579459|100648679|FG001|Overall Study|Other|1|||
33204273|NCT03579459|100648680|FG002|Overall Study|Other|1|||
33204274|NCT03579459|100648681|FG003|Overall Study|Other|0|||
33204275|NCT03579459|100648678|FG000|Overall Study|Randomized not vaccinated|0|||
33204276|NCT03579459|100648679|FG001|Overall Study|Randomized not vaccinated|2|||
33204277|NCT03579459|100648680|FG002|Overall Study|Randomized not vaccinated|0|||
33204278|NCT03579459|100648681|FG003|Overall Study|Randomized not vaccinated|1|||
33204279|NCT00581945|100648682|FG000|Overall Study|Adverse Event|4|||
33204280|NCT00581945|100648683|FG001|Overall Study|Adverse Event|4|||
33204281|NCT00581945|100648682|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33204282|NCT00581945|100648683|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33204283|NCT00581945|100648682|FG000|Overall Study|Withdrawal by Subject|2|||
33204284|NCT00581945|100648683|FG001|Overall Study|Withdrawal by Subject|6|||
33204285|NCT00581945|100648682|FG000|Overall Study|Death|1|||
33204286|NCT00581945|100648683|FG001|Overall Study|Death|0|||
33204287|NCT01343056|100648686|FG000|Overall Study|Lost to Follow-up|7|||
33204288|NCT01343056|100648687|FG001|Overall Study|Lost to Follow-up|5|||
33204289|NCT01343056|100648688|FG002|Overall Study|Lost to Follow-up|3|||
33204290|NCT01343056|100648689|FG003|Overall Study|Lost to Follow-up|9|||
33204291|NCT01753193|100648691|FG000|Overall Study|Withdrawal by Subject|23|||
33204292|NCT01753193|100648691|FG000|Overall Study|Lost to Follow-up|6|||
33204293|NCT01753193|100648691|FG000|Overall Study|Death|1|||
33204294|NCT01753193|100648691|FG000|Overall Study|Other|16|||
33204295|NCT01024387|100648692|FG000|Overall Study|Radiographic Progression|29|||
33204296|NCT01024387|100648692|FG000|Overall Study|Symptomatic Progression|10|||
33204297|NCT01024387|100648692|FG000|Overall Study|Physician Decision|5|||
33204298|NCT01024387|100648692|FG000|Overall Study|Withdrawal by Subject|5|||
33204299|NCT01024387|100648692|FG000|Overall Study|Death|2|||
33204300|NCT01024387|100648692|FG000|Overall Study|Prolonged Treatment Delay|1|||
33204301|NCT01024387|100648692|FG000|Overall Study|Adverse Event|3|||
33204302|NCT01024387|100648692|FG000|Overall Study|Other|5|||
33204303|NCT03087591|100648693|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
33204304|NCT03087591|100648693|FG000|Overall Study|Withdrawal by Subject|1|||
33204305|NCT00627705|100648694|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
33204306|NCT00627705|100648695|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
33204307|NCT00627705|100648694|FG000|Overall Study|Adverse Event|1|||
33204308|NCT00627705|100648695|FG001|Overall Study|Adverse Event|0|||
33204309|NCT00627705|100648694|FG000|Overall Study|Withdrawal by Subject|0|||
33204310|NCT00627705|100648695|FG001|Overall Study|Withdrawal by Subject|2|||
33204311|NCT00627705|100648694|FG000|Overall Study|Lost to Follow-up|0|||
33204312|NCT00627705|100648695|FG001|Overall Study|Lost to Follow-up|1|||
33204313|NCT01910519|100648696|FG000|Overall Study|Withdrawal by Subject|2|||
33204314|NCT01910519|100648697|FG001|Overall Study|Withdrawal by Subject|0|||
33204315|NCT01910519|100648696|FG000|Overall Study|Adverse Event|2|||
33204316|NCT01910519|100648697|FG001|Overall Study|Adverse Event|0|||
33334110|NCT00542269|101114946|FG002|Overall Study|Adverse Event|5|||
33204317|NCT00714168|100648698|FG000|Overall Study|Pregnancy|5|||
33204318|NCT00714168|100648699|FG001|Overall Study|Pregnancy|4|||
33204319|NCT00714168|100648698|FG000|Overall Study|Lost to Follow-up|32|||
33204320|NCT00714168|100648699|FG001|Overall Study|Lost to Follow-up|50|||
33204321|NCT00714168|100648698|FG000|Overall Study|Relocation|4|||
33334111|NCT00542269|101114944|FG000|Overall Study|Protocol Violation|1|||
33204322|NCT00714168|100648699|FG001|Overall Study|Relocation|3|||
33204323|NCT00714168|100648698|FG000|Overall Study|Non-study medical condition|3|||
33204324|NCT00714168|100648699|FG001|Overall Study|Non-study medical condition|2|||
33204325|NCT02265237|100648700|FG000|As Treated (Overall Study)|Adverse Event|1|||
33204326|NCT02265237|100648701|FG001|As Treated (Overall Study)|Adverse Event|1|||
33204327|NCT02265237|100648702|FG002|As Treated (Overall Study)|Adverse Event|0|||
33334112|NCT00542269|101114945|FG001|Overall Study|Protocol Violation|1|||
33204328|NCT02265237|100648703|FG003|As Treated (Overall Study)|Adverse Event|0|||
33204329|NCT02265237|100648700|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
33204330|NCT02265237|100648701|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
33204331|NCT02265237|100648702|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
33204332|NCT02265237|100648703|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
33204333|NCT02265237|100648700|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
33204334|NCT02265237|100648701|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
33204335|NCT02265237|100648702|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
33204336|NCT02265237|100648703|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
33204337|NCT02265237|100648700|FG000|As Treated (Overall Study)|Other|2|||
33204338|NCT02265237|100648701|FG001|As Treated (Overall Study)|Other|0|||
33204339|NCT02265237|100648702|FG002|As Treated (Overall Study)|Other|3|||
33204340|NCT02265237|100648703|FG003|As Treated (Overall Study)|Other|1|||
33204341|NCT00086346|100648706|FG000|Randomization|Did not receive test article|4|||
33204342|NCT00086346|100648707|FG001|Randomization|Did not receive test article|4|||
33204343|NCT00086346|100648706|FG000|Patients Dosed With Test Article|Adverse Event|94|||
33204344|NCT00086346|100648707|FG001|Patients Dosed With Test Article|Adverse Event|11|||
33204345|NCT00086346|100648706|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
33204346|NCT00086346|100648707|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
33204347|NCT00086346|100648706|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
33204348|NCT00086346|100648707|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
33204349|NCT00086346|100648706|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
33204350|NCT00086346|100648707|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
33204351|NCT00086346|100648706|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
33204352|NCT00086346|100648707|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
33204353|NCT00086346|100648706|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
33204354|NCT00086346|100648707|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
33204355|NCT01344460|100648708|FG000|Overall Study|Withdrawal by Subject|1|||
33204356|NCT01344460|100648708|FG000|Overall Study|Lost to Follow-up|2|||
33204357|NCT00129987|100648710|FG000|1st Educational Session|Withdrawal by Subject|141|||
33204358|NCT00129987|100648711|FG001|1st Educational Session|Withdrawal by Subject|109|||
33204359|NCT00129987|100648710|FG000|1 Year|Withdrawal by Subject|32|||
33204360|NCT00129987|100648711|FG001|1 Year|Withdrawal by Subject|21|||
33204361|NCT00572572|100648718|FG000|Overall Study|Withdrawal by Subject|3|||
33204362|NCT00572572|100648719|FG001|Overall Study|Withdrawal by Subject|6|||
33204363|NCT00435370|100648720|FG000|Overall Study|Adverse Event|8|||
33204364|NCT00435370|100648721|FG001|Overall Study|Adverse Event|8|||
33204365|NCT00435370|100648720|FG000|Overall Study|Withdrawal by Subject|10|||
33204366|NCT00435370|100648721|FG001|Overall Study|Withdrawal by Subject|10|||
33204367|NCT00435370|100648720|FG000|Overall Study|Antipsychotic medication changed|4|||
33204368|NCT00435370|100648721|FG001|Overall Study|Antipsychotic medication changed|2|||
33204369|NCT04001829|100648724|FG000|Overall Study|Never start protocol therapy|5|||
33204370|NCT04001829|100648725|FG001|Overall Study|Never start protocol therapy|5|||
33204371|NCT04001829|100648724|FG000|Overall Study|Adverse Event|11|||
33204372|NCT04001829|100648725|FG001|Overall Study|Adverse Event|7|||
33204373|NCT04001829|100648724|FG000|Overall Study|Alternative therapy|1|||
33204374|NCT04001829|100648725|FG001|Overall Study|Alternative therapy|2|||
33204375|NCT04001829|100648724|FG000|Overall Study|Disease progression/relapse|2|||
33204376|NCT04001829|100648725|FG001|Overall Study|Disease progression/relapse|1|||
33204377|NCT04001829|100648724|FG000|Overall Study|Other complicating disease|1|||
33204378|NCT04001829|100648725|FG001|Overall Study|Other complicating disease|0|||
33204379|NCT04001829|100648724|FG000|Overall Study|Withdrawal by Subject|1|||
33204380|NCT04001829|100648725|FG001|Overall Study|Withdrawal by Subject|4|||
33204381|NCT04001829|100648724|FG000|Overall Study|Ineligible|2|||
33204382|NCT04001829|100648725|FG001|Overall Study|Ineligible|2|||
33204383|NCT04001829|100648724|FG000|Overall Study|Reason missing due to delinquent data|1|||
33204384|NCT04001829|100648725|FG001|Overall Study|Reason missing due to delinquent data|0|||
33204385|NCT00583557|100648727|FG000|Overall Study|Withdrawal by Subject|18|||
33334113|NCT00542269|101114946|FG002|Overall Study|Protocol Violation|0|||
33334114|NCT00542269|101114944|FG000|Overall Study|Withdrawal by Subject|1|||
33334115|NCT00542269|101114945|FG001|Overall Study|Withdrawal by Subject|0|||
33528347|NCT03130959|101833923|FG004|Overall Study|Lost to Follow-up|0|||
33528348|NCT03130959|101833924|FG005|Overall Study|Lost to Follow-up|0|||
33528349|NCT03130959|101833925|FG006|Overall Study|Lost to Follow-up|0|||
33528350|NCT03130959|101833926|FG007|Overall Study|Lost to Follow-up|0|||
33610724|NCT03208088|102123398|FG009|Period 3|Unsatisfactory Test Article|0|||
33204386|NCT00583557|100648727|FG000|Overall Study|Adverse Event|9|||
33204387|NCT00583557|100648727|FG000|Overall Study|Lack of Efficacy|31|||
33204388|NCT00583557|100648727|FG000|Overall Study|Lack of Compliance|5|||
33334116|NCT00542269|101114946|FG002|Overall Study|Withdrawal by Subject|0|||
33204389|NCT00583557|100648727|FG000|Overall Study|Other|5|||
33204390|NCT00583557|100648727|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
33204391|NCT00941603|100648732|FG000|Overall Study|Adverse Event|10|||
33204392|NCT00941603|100648733|FG001|Overall Study|Adverse Event|15|||
33204393|NCT00941603|100648734|FG002|Overall Study|Adverse Event|5|||
33204394|NCT00941603|100648735|FG003|Overall Study|Adverse Event|1|||
33528351|NCT03130959|101833927|FG008|Overall Study|Lost to Follow-up|0|||
33610725|NCT03208088|102123389|FG000|Period 4|Unsatisfactory Test Article|0|||
33204395|NCT00941603|100648736|FG004|Overall Study|Adverse Event|4|||
33204396|NCT00941603|100648737|FG005|Overall Study|Adverse Event|0|||
33204397|NCT00941603|100648732|FG000|Overall Study|Lost to Follow-up|0|||
33204398|NCT00941603|100648733|FG001|Overall Study|Lost to Follow-up|0|||
33204399|NCT00941603|100648734|FG002|Overall Study|Lost to Follow-up|0|||
33204400|NCT00941603|100648735|FG003|Overall Study|Lost to Follow-up|1|||
33204401|NCT00941603|100648736|FG004|Overall Study|Lost to Follow-up|0|||
33204402|NCT00941603|100648737|FG005|Overall Study|Lost to Follow-up|2|||
33204403|NCT00941603|100648732|FG000|Overall Study|Withdrawal by Subject|0|||
33204404|NCT00941603|100648733|FG001|Overall Study|Withdrawal by Subject|0|||
33204405|NCT00941603|100648734|FG002|Overall Study|Withdrawal by Subject|0|||
33204406|NCT00941603|100648735|FG003|Overall Study|Withdrawal by Subject|2|||
33204407|NCT00941603|100648736|FG004|Overall Study|Withdrawal by Subject|0|||
33204408|NCT00941603|100648737|FG005|Overall Study|Withdrawal by Subject|1|||
33204409|NCT00941603|100648732|FG000|Overall Study|Protocol Violation|0|||
33204410|NCT00941603|100648733|FG001|Overall Study|Protocol Violation|1|||
33204411|NCT00941603|100648734|FG002|Overall Study|Protocol Violation|0|||
33204412|NCT00941603|100648735|FG003|Overall Study|Protocol Violation|0|||
33204413|NCT00941603|100648736|FG004|Overall Study|Protocol Violation|0|||
33204414|NCT00941603|100648737|FG005|Overall Study|Protocol Violation|0|||
33204415|NCT00941603|100648732|FG000|Overall Study|Did not meet protocol eligibility|1|||
33204416|NCT00941603|100648733|FG001|Overall Study|Did not meet protocol eligibility|0|||
33204417|NCT00941603|100648734|FG002|Overall Study|Did not meet protocol eligibility|0|||
33204418|NCT00941603|100648735|FG003|Overall Study|Did not meet protocol eligibility|0|||
33204419|NCT00941603|100648736|FG004|Overall Study|Did not meet protocol eligibility|0|||
33204420|NCT00941603|100648737|FG005|Overall Study|Did not meet protocol eligibility|0|||
33204421|NCT01337089|100648744|FG000|Overall Study|Adverse Event|237|||
33204422|NCT01337089|100648744|FG000|Overall Study|Withdrawal by Subject|129|||
33204423|NCT01337089|100648744|FG000|Overall Study|Withdrawal by Investigator|33|||
33204424|NCT01337089|100648744|FG000|Overall Study|Met Withdrawal Criteria|3|||
33204425|NCT01337089|100648744|FG000|Overall Study|Lost to Follow-up|2|||
33204426|NCT04782323|100648745|FG000|Overall Study|Death|1|||
33204427|NCT04782323|100648746|FG001|Overall Study|Death|0|||
33204428|NCT04782323|100648747|FG002|Overall Study|Death|0|||
33204429|NCT04782323|100648748|FG003|Overall Study|Death|0|||
33204430|NCT04782323|100648749|FG004|Overall Study|Death|1|||
33204431|NCT04782323|100648750|FG005|Overall Study|Death|1|||
33204432|NCT04782323|100648751|FG006|Overall Study|Death|1|||
33204433|NCT04782323|100648752|FG007|Overall Study|Death|0|||
33204434|NCT04782323|100648745|FG000|Overall Study|Withdrawal by Subject|0|||
33204435|NCT04782323|100648746|FG001|Overall Study|Withdrawal by Subject|0|||
33204436|NCT04782323|100648747|FG002|Overall Study|Withdrawal by Subject|1|||
33204437|NCT04782323|100648748|FG003|Overall Study|Withdrawal by Subject|0|||
33204438|NCT04782323|100648749|FG004|Overall Study|Withdrawal by Subject|0|||
33204439|NCT04782323|100648750|FG005|Overall Study|Withdrawal by Subject|1|||
33204440|NCT04782323|100648751|FG006|Overall Study|Withdrawal by Subject|0|||
33204441|NCT04782323|100648752|FG007|Overall Study|Withdrawal by Subject|1|||
33204442|NCT04782323|100648745|FG000|Overall Study|Lost to Follow-up|0|||
33204443|NCT04782323|100648746|FG001|Overall Study|Lost to Follow-up|1|||
33204444|NCT04782323|100648747|FG002|Overall Study|Lost to Follow-up|1|||
33334117|NCT00542269|101114944|FG000|Overall Study|Administrative problems|1|||
33334118|NCT00542269|101114945|FG001|Overall Study|Administrative problems|1|||
33334119|NCT00542269|101114946|FG002|Overall Study|Administrative problems|1|||
33334120|NCT01394627|101114947|FG000|First Intervention (1 Day)|poor intravenous access|0|||
33334121|NCT01394627|101114948|FG001|First Intervention (1 Day)|poor intravenous access|1|||
33334122|NCT01394627|101114947|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
33334123|NCT01394627|101114948|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
33334124|NCT01360554|101114949|FG000|Overall Study|Death|359|||
33334125|NCT01360554|101114950|FG001|Overall Study|Death|371|||
33334126|NCT01360554|101114949|FG000|Overall Study|Lost to Follow-up|4|||
33334127|NCT01360554|101114950|FG001|Overall Study|Lost to Follow-up|4|||
33204445|NCT04782323|100648748|FG003|Overall Study|Lost to Follow-up|0|||
33204446|NCT04782323|100648749|FG004|Overall Study|Lost to Follow-up|0|||
33204447|NCT04782323|100648750|FG005|Overall Study|Lost to Follow-up|1|||
33204448|NCT04782323|100648751|FG006|Overall Study|Lost to Follow-up|1|||
33204449|NCT04782323|100648752|FG007|Overall Study|Lost to Follow-up|2|||
33204450|NCT04782323|100648745|FG000|Overall Study|randomization in error|1|||
33204451|NCT04782323|100648746|FG001|Overall Study|randomization in error|0|||
33204452|NCT04782323|100648747|FG002|Overall Study|randomization in error|0|||
33204453|NCT04782323|100648748|FG003|Overall Study|randomization in error|0|||
33204454|NCT04782323|100648749|FG004|Overall Study|randomization in error|0|||
33204455|NCT04782323|100648750|FG005|Overall Study|randomization in error|0|||
33334128|NCT01360554|101114949|FG000|Overall Study|Withdrawal by Subject|23|||
33334129|NCT01360554|101114950|FG001|Overall Study|Withdrawal by Subject|24|||
33204456|NCT04782323|100648751|FG006|Overall Study|randomization in error|0|||
33204457|NCT04782323|100648752|FG007|Overall Study|randomization in error|0|||
33204458|NCT03277313|100651269|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
33204459|NCT03277313|100651270|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
33204460|NCT03277313|100651269|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
33204461|NCT03277313|100651270|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
33334130|NCT01360554|101114949|FG000|Overall Study|Study terminated by sponsor|49|||
33528352|NCT03130959|101833928|FG009|Overall Study|Lost to Follow-up|0|||
33528353|NCT00705341|101833929|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
33204462|NCT03277313|100651269|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
33204463|NCT03277313|100651270|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
33204464|NCT03277313|100651269|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
33204465|NCT03277313|100651270|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
33204466|NCT03277313|100651269|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
33204467|NCT03277313|100651270|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
33528354|NCT00705341|101833930|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
33528355|NCT00705341|101833931|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
33528356|NCT00705341|101833932|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
33204468|NCT00364858|100651271|FG000|Overall Study|Adverse Event|1|||
33204469|NCT00364858|100651272|FG001|Overall Study|Adverse Event|5|||
33204470|NCT00364858|100651271|FG000|Overall Study|Withdrawal by Subject|1|||
33204471|NCT00364858|100651272|FG001|Overall Study|Withdrawal by Subject|1|||
33204472|NCT00364858|100651271|FG000|Overall Study|Pregnancy|1|||
33204473|NCT00364858|100651272|FG001|Overall Study|Pregnancy|1|||
33204474|NCT00364858|100651271|FG000|Overall Study|Clinical failure|2|||
33204475|NCT00364858|100651272|FG001|Overall Study|Clinical failure|13|||
33204476|NCT00364858|100651271|FG000|Overall Study|Discontinuation at baseline|1|||
33204477|NCT00364858|100651272|FG001|Overall Study|Discontinuation at baseline|0|||
33204478|NCT00364858|100651271|FG000|Overall Study|Non-compliant|1|||
33204479|NCT00364858|100651272|FG001|Overall Study|Non-compliant|0|||
33204480|NCT00364858|100651271|FG000|Overall Study|Return to Q2 regimen|0|||
33204481|NCT00364858|100651272|FG001|Overall Study|Return to Q2 regimen|1|||
33204482|NCT00364858|100651271|FG000|Overall Study|Clinical baseline issue|0|||
33204483|NCT00364858|100651272|FG001|Overall Study|Clinical baseline issue|1|||
33204484|NCT01863680|100651273|FG000|Overall Study|Adverse Event|17|||
33204485|NCT01863680|100651273|FG000|Overall Study|Risk of OHSS|17|||
33204486|NCT01863680|100651273|FG000|Overall Study|Spontaneous pregnancy|2|||
33204487|NCT01863680|100651273|FG000|Overall Study|Withdrawal by Subject|1|||
33204488|NCT01863680|100651273|FG000|Overall Study|Did not undergo IVF/ET|14|||
33204489|NCT01863680|100651273|FG000|Overall Study|Other|6|||
33204490|NCT03264989|100651275|FG000|Overall Study|Lost to Follow-up|1|||
33204491|NCT03264989|100651276|FG001|Overall Study|Lost to Follow-up|0|||
33204492|NCT03264989|100651275|FG000|Overall Study|New Therapy for study Indication|1|||
33204493|NCT03264989|100651276|FG001|Overall Study|New Therapy for study Indication|0|||
33204494|NCT03264989|100651275|FG000|Overall Study|Protocol Violation|0|||
33204495|NCT03264989|100651276|FG001|Overall Study|Protocol Violation|1|||
33204496|NCT03264989|100651275|FG000|Overall Study|Patient decision|13|||
33204497|NCT03264989|100651276|FG001|Overall Study|Patient decision|0|||
33204498|NCT03264989|100651275|FG000|Overall Study|Physician Decision|6|||
33204499|NCT03264989|100651276|FG001|Overall Study|Physician Decision|4|||
33204500|NCT03264989|100651275|FG000|Overall Study|Adverse Event|2|||
33204501|NCT03264989|100651276|FG001|Overall Study|Adverse Event|1|||
33204502|NCT03264989|100651275|FG000|Overall Study|Death|1|||
33204503|NCT03264989|100651276|FG001|Overall Study|Death|1|||
33204504|NCT03264989|100651275|FG000|Overall Study|Pregnancy|2|||
33334131|NCT01360554|101114950|FG001|Overall Study|Study terminated by sponsor|37|||
33334132|NCT01360554|101114949|FG000|Overall Study|Other, not specified|1|||
33334133|NCT01360554|101114950|FG001|Overall Study|Other, not specified|0|||
33334134|NCT01360554|101114949|FG000|Overall Study|Randomized but not treated.|3|||
33528357|NCT00705341|101833929|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
33528358|NCT00705341|101833930|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
33528359|NCT00705341|101833931|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
33204505|NCT03264989|100651276|FG001|Overall Study|Pregnancy|0|||
33204506|NCT03264989|100651275|FG000|Overall Study|End of Study|19|||
33204507|NCT03264989|100651276|FG001|Overall Study|End of Study|5|||
33204508|NCT01175668|100651277|FG000|Overall Study|Withdrawal by Subject|2|||
33204509|NCT01175668|100651278|FG001|Overall Study|Withdrawal by Subject|0|||
33204510|NCT03647501|100651279|FG000|Overall Study|Lost to Follow-up|1|||
33204511|NCT03647501|100651280|FG001|Overall Study|Lost to Follow-up|1|||
33528360|NCT00705341|101833932|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
33204512|NCT03647501|100651279|FG000|Overall Study|Withdrawal by Subject|0|||
33204513|NCT03647501|100651280|FG001|Overall Study|Withdrawal by Subject|1|||
33204514|NCT02043782|100651281|FG000|Period 1|Adverse Event|0|||
33204515|NCT02043782|100651282|FG001|Period 1|Adverse Event|0|||
33204516|NCT02043782|100651283|FG002|Period 1|Adverse Event|1|||
33334135|NCT01360554|101114950|FG001|Overall Study|Randomized but not treated.|3|||
33528361|NCT04676152|101833935|FG000|Overall Study|screen fail|9|||
33204517|NCT02043782|100651284|FG003|Period 1|Adverse Event|0|||
33204518|NCT02043782|100651285|FG004|Period 1|Adverse Event|0|||
33204519|NCT02043782|100651286|FG005|Period 1|Adverse Event|0|||
33204520|NCT01660763|100651287|FG000|Overall Study|Lack of Efficacy|45|||
33204521|NCT01660763|100651288|FG001|Overall Study|Lack of Efficacy|50|||
33204522|NCT01660763|100651287|FG000|Overall Study|Adverse Event|22|||
33204523|NCT01660763|100651288|FG001|Overall Study|Adverse Event|7|||
33204524|NCT01660763|100651287|FG000|Overall Study|Protocol Violation|1|||
33204525|NCT01660763|100651288|FG001|Overall Study|Protocol Violation|0|||
33204526|NCT01660763|100651287|FG000|Overall Study|Withdrawal by Subject|4|||
33204527|NCT01660763|100651288|FG001|Overall Study|Withdrawal by Subject|0|||
33204528|NCT01660763|100651287|FG000|Overall Study|Patient ready for early discharge|28|||
33204529|NCT01660763|100651288|FG001|Overall Study|Patient ready for early discharge|4|||
33204530|NCT00817089|100651292|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
33334136|NCT01820364|101114951|FG000|Part I: LGX818|Death|1|||
33334137|NCT01820364|101114952|FG001|Part I: LGX818|Death|0|||
33334138|NCT01820364|101114951|FG000|Part I: LGX818|Administrative Problems|3|||
33334139|NCT01820364|101114952|FG001|Part I: LGX818|Administrative Problems|0|||
33334140|NCT01820364|101114951|FG000|Part I: LGX818|Adverse Event|6|||
33334141|NCT01820364|101114952|FG001|Part I: LGX818|Adverse Event|0|||
33334142|NCT01820364|101114951|FG000|Part I: LGX818|Disease Progression|4|||
33334143|NCT01820364|101114952|FG001|Part I: LGX818|Disease Progression|0|||
33334144|NCT01820364|101114951|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
33334145|NCT01820364|101114952|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
33334146|NCT01744665|101114953|FG000|Monitoring Phase|Adverse Event|4|||
33334147|NCT01744665|101114953|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
33334148|NCT01744665|101114953|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
33334149|NCT01744665|101114953|FG000|Monitoring Phase|Withdrawal by Subject|5|||
33334150|NCT01744665|101114953|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
33334151|NCT01744665|101114953|FG000|Consolidation Phase|Adverse Event|2|||
33334152|NCT01744665|101114953|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
33334153|NCT01744665|101114953|FG000|Consolidation Phase|Withdrawal by Subject|4|||
33334154|NCT01744665|101114953|FG000|Consolidation Phase|Administrative problems|9|||
33334155|NCT01744665|101114953|FG000|Re-initiation Phase|Administrative problems|10|||
33334156|NCT01744665|101114953|FG000|Re-initiation Phase|Adverse Event|1|||
33334157|NCT01744665|101114953|FG000|Re-initiation Phase|No longer required treatment|1|||
33334158|NCT01744665|101114953|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
33334159|NCT01970501|101114954|FG000|Overall Study|Discontinuation of study by sponsor|16|||
33334160|NCT01970501|101114955|FG001|Overall Study|Discontinuation of study by sponsor|14|||
33334161|NCT01970501|101114954|FG000|Overall Study|Withdrawal by Subject|6|||
33334162|NCT01970501|101114955|FG001|Overall Study|Withdrawal by Subject|7|||
33334163|NCT01970501|101114954|FG000|Overall Study|Adverse Event|2|||
33334164|NCT01970501|101114955|FG001|Overall Study|Adverse Event|4|||
33334165|NCT01970501|101114954|FG000|Overall Study|Death|1|||
33334166|NCT01970501|101114955|FG001|Overall Study|Death|3|||
33334167|NCT01970501|101114954|FG000|Overall Study|Physician Decision|2|||
33334168|NCT01970501|101114955|FG001|Overall Study|Physician Decision|0|||
33334169|NCT02232802|101114956|FG000|Period 1|Sponsor request|1|||
33334170|NCT02232802|101114957|FG001|Period 1|Sponsor request|0|||
33334171|NCT02232802|101114956|FG000|Period 1|Adverse Event|1|||
33334172|NCT02232802|101114957|FG001|Period 1|Adverse Event|1|||
33334173|NCT01183143|101114960|FG000|Overall Study|Protocol Violation|115|||
33334174|NCT01183143|101114960|FG000|Overall Study|Withdrawal by Subject|19|||
33528362|NCT00593918|101833936|FG000|Overall Study|Withdrawal by Subject|5|||
33528363|NCT00593918|101833937|FG001|Overall Study|Withdrawal by Subject|24|||
33528364|NCT01223937|101833938|FG000|Overall Study|Withdrawal by Subject|3|||
33204531|NCT00817089|100651293|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
33334175|NCT01183143|101114960|FG000|Overall Study|Subject Questionnaires not returned|5|||
33334176|NCT01183143|101114960|FG000|Overall Study|Subjects enrolled, but not treated|11|||
33334177|NCT03577730|101114961|FG000|Overall Study|Physician Decision|3|||
33204532|NCT00817089|100651294|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
33204533|NCT00817089|100651295|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
33204534|NCT00817089|100651292|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
33204535|NCT00817089|100651293|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
33204536|NCT00817089|100651294|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
33204537|NCT00817089|100651295|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
33204538|NCT00237744|100651296|FG000|Overall Study|Withdrawal by Subject|3|||
33204539|NCT00237744|100651297|FG001|Overall Study|Withdrawal by Subject|1|||
33204540|NCT00237744|100651298|FG002|Overall Study|Withdrawal by Subject|0|||
33204541|NCT02219932|100651299|FG000|Overall Study|Other|5|||
33204542|NCT02219932|100651300|FG001|Overall Study|Other|11|||
33204543|NCT02219932|100651299|FG000|Overall Study|Death|1|||
33204544|NCT02219932|100651300|FG001|Overall Study|Death|1|||
33204545|NCT02219932|100651299|FG000|Overall Study|Investigator Decision|0|||
33204546|NCT02219932|100651300|FG001|Overall Study|Investigator Decision|1|||
33204547|NCT02219932|100651299|FG000|Overall Study|Consent Withdrawn|11|||
33204548|NCT02219932|100651300|FG001|Overall Study|Consent Withdrawn|7|||
33204549|NCT02219932|100651299|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
33204550|NCT02219932|100651300|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
33204551|NCT02219932|100651299|FG000|Overall Study|Protocol Violation|10|||
33204552|NCT02219932|100651300|FG001|Overall Study|Protocol Violation|6|||
33528365|NCT01223937|101833939|FG001|Overall Study|Withdrawal by Subject|2|||
33528366|NCT01223937|101833938|FG000|Overall Study|Lost to Follow-up|1|||
33528367|NCT01223937|101833939|FG001|Overall Study|Lost to Follow-up|4|||
33528368|NCT01223937|101833938|FG000|Overall Study|Adverse Event|1|||
33528369|NCT01223937|101833939|FG001|Overall Study|Adverse Event|4|||
33528370|NCT01223937|101833938|FG000|Overall Study|Protocol Violation|8|||
33528371|NCT01223937|101833939|FG001|Overall Study|Protocol Violation|7|||
33528372|NCT01223937|101833938|FG000|Overall Study|Other|4|||
33528373|NCT01223937|101833939|FG001|Overall Study|Other|1|||
33528374|NCT00549549|101833942|FG000|Overall Study|Adverse Event|5|||
33528375|NCT00549549|101833943|FG001|Overall Study|Adverse Event|3|||
33528376|NCT00549549|101833944|FG002|Overall Study|Adverse Event|1|||
33528377|NCT00549549|101833945|FG003|Overall Study|Adverse Event|9|||
33528378|NCT00549549|101833942|FG000|Overall Study|Lack of Efficacy|9|||
33528379|NCT00549549|101833943|FG001|Overall Study|Lack of Efficacy|6|||
33528380|NCT00549549|101833944|FG002|Overall Study|Lack of Efficacy|4|||
33528381|NCT00549549|101833945|FG003|Overall Study|Lack of Efficacy|2|||
33528382|NCT00549549|101833942|FG000|Overall Study|Lost to Follow-up|1|||
33528383|NCT00549549|101833943|FG001|Overall Study|Lost to Follow-up|0|||
33610726|NCT03208088|102123390|FG001|Period 4|Unsatisfactory Test Article|0|||
33610727|NCT03208088|102123391|FG002|Period 4|Unsatisfactory Test Article|0|||
33610728|NCT03208088|102123392|FG003|Period 4|Unsatisfactory Test Article|1|||
33610729|NCT03208088|102123393|FG004|Period 4|Unsatisfactory Test Article|0|||
33610730|NCT03208088|102123394|FG005|Period 4|Unsatisfactory Test Article|0|||
33610731|NCT03208088|102123395|FG006|Period 4|Unsatisfactory Test Article|0|||
33610732|NCT03208088|102123396|FG007|Period 4|Unsatisfactory Test Article|0|||
33610733|NCT03208088|102123397|FG008|Period 4|Unsatisfactory Test Article|0|||
33610734|NCT03208088|102123398|FG009|Period 4|Unsatisfactory Test Article|0|||
33610735|NCT00659230|102123399|FG000|Overall Study|Lost to Follow-up|2|||
33610736|NCT00659230|102123400|FG001|Overall Study|Lost to Follow-up|5|||
33610737|NCT00659230|102123399|FG000|Overall Study|Lost source documentation|5|||
33204553|NCT02219932|100651299|FG000|Overall Study|Pregnancy|1|||
33610738|NCT00659230|102123400|FG001|Overall Study|Lost source documentation|4|||
33610739|NCT00659230|102123399|FG000|Overall Study|Did not return post-randomization|2|||
33610740|NCT00659230|102123400|FG001|Overall Study|Did not return post-randomization|3|||
33610741|NCT00061633|102123401|FG000|Overall Study|Adverse Event|1|||
33610742|NCT00061633|102123402|FG001|Overall Study|Adverse Event|2|||
33610743|NCT00061633|102123401|FG000|Overall Study|Withdrawal by Subject|2|||
33204554|NCT02219932|100651300|FG001|Overall Study|Pregnancy|0|||
33204555|NCT02219932|100651299|FG000|Overall Study|Lost to Follow-up|4|||
33528384|NCT00549549|101833944|FG002|Overall Study|Lost to Follow-up|1|||
33528385|NCT00549549|101833945|FG003|Overall Study|Lost to Follow-up|2|||
33610744|NCT00061633|102123402|FG001|Overall Study|Withdrawal by Subject|2|||
33204556|NCT02219932|100651300|FG001|Overall Study|Lost to Follow-up|2|||
33204557|NCT02219932|100651299|FG000|Overall Study|Adverse Event|23|||
33204558|NCT02219932|100651300|FG001|Overall Study|Adverse Event|21|||
33204559|NCT02730819|100651303|FG000|Overall Study|Lost to Follow-up|9|||
33528386|NCT00549549|101833942|FG000|Overall Study|Withdrawal by Subject|0|||
33528387|NCT00549549|101833943|FG001|Overall Study|Withdrawal by Subject|4|||
33610745|NCT00061633|102123401|FG000|Overall Study|Lost to Follow-up|1|||
33610746|NCT00061633|102123402|FG001|Overall Study|Lost to Follow-up|4|||
33528388|NCT00549549|101833944|FG002|Overall Study|Withdrawal by Subject|1|||
33528389|NCT00549549|101833945|FG003|Overall Study|Withdrawal by Subject|0|||
33610747|NCT00061633|102123401|FG000|Overall Study|Other|1|||
33610748|NCT00061633|102123402|FG001|Overall Study|Other|1|||
33204560|NCT00709722|100651304|FG000|Overall Study|Adverse Event|1|||
33528390|NCT00549549|101833942|FG000|Overall Study|Other|9|||
33334178|NCT03577730|101114962|FG001|Overall Study|Physician Decision|1|||
33334179|NCT03577730|101114961|FG000|Overall Study|Did not receive allocated intervention|1|||
33334180|NCT03577730|101114962|FG001|Overall Study|Did not receive allocated intervention|0|||
33334181|NCT00053417|101114963|FG000|Overall Study|Adverse Event|1|||
33334182|NCT00053417|101114964|FG001|Overall Study|Adverse Event|0|||
33334183|NCT00053417|101114965|FG002|Overall Study|Adverse Event|1|||
33334184|NCT00053417|101114966|FG003|Overall Study|Adverse Event|5|||
33334185|NCT00053417|101114963|FG000|Overall Study|Non-Compliance|0|||
33334186|NCT00053417|101114964|FG001|Overall Study|Non-Compliance|0|||
33334187|NCT00053417|101114965|FG002|Overall Study|Non-Compliance|0|||
33334188|NCT00053417|101114966|FG003|Overall Study|Non-Compliance|1|||
33334189|NCT00053417|101114963|FG000|Overall Study|Withdrawal by Subject|0|||
33334190|NCT00053417|101114964|FG001|Overall Study|Withdrawal by Subject|1|||
33334191|NCT00053417|101114965|FG002|Overall Study|Withdrawal by Subject|0|||
33334192|NCT00053417|101114966|FG003|Overall Study|Withdrawal by Subject|0|||
33334193|NCT00053417|101114963|FG000|Overall Study|Lost to Follow-up|1|||
33334194|NCT00053417|101114964|FG001|Overall Study|Lost to Follow-up|1|||
33334195|NCT00053417|101114965|FG002|Overall Study|Lost to Follow-up|0|||
33334196|NCT00053417|101114966|FG003|Overall Study|Lost to Follow-up|0|||
33334197|NCT00805480|101114967|FG000|Overall Study|Withdrawal by Subject|13|||
33334198|NCT00805480|101114968|FG001|Overall Study|Withdrawal by Subject|5|||
33334199|NCT00805480|101114969|FG002|Overall Study|Withdrawal by Subject|11|||
33334200|NCT00805480|101114970|FG003|Overall Study|Withdrawal by Subject|5|||
33334201|NCT00805480|101114967|FG000|Overall Study|Lost to Follow-up|1|||
33334202|NCT00805480|101114968|FG001|Overall Study|Lost to Follow-up|2|||
33334203|NCT00805480|101114969|FG002|Overall Study|Lost to Follow-up|0|||
33334204|NCT00805480|101114970|FG003|Overall Study|Lost to Follow-up|0|||
33334205|NCT00805480|101114967|FG000|Overall Study|Adverse Event|0|||
33334206|NCT00805480|101114968|FG001|Overall Study|Adverse Event|0|||
33334207|NCT00805480|101114969|FG002|Overall Study|Adverse Event|1|||
33334208|NCT00805480|101114970|FG003|Overall Study|Adverse Event|0|||
33334209|NCT00763815|101114971|FG000|Overall Study|Adverse Event|14|||
33334210|NCT00763815|101114972|FG001|Overall Study|Adverse Event|29|||
33334211|NCT00763815|101114971|FG000|Overall Study|Lack of Efficacy|10|||
33334212|NCT00763815|101114972|FG001|Overall Study|Lack of Efficacy|11|||
33334213|NCT00763815|101114971|FG000|Overall Study|Poor Compliance to Protocol|6|||
33334214|NCT00763815|101114972|FG001|Overall Study|Poor Compliance to Protocol|6|||
33334215|NCT00763815|101114971|FG000|Overall Study|Lost to Follow-up|2|||
33334216|NCT00763815|101114972|FG001|Overall Study|Lost to Follow-up|4|||
33334217|NCT00763815|101114971|FG000|Overall Study|Early Termination|1|||
33334218|NCT00763815|101114972|FG001|Overall Study|Early Termination|0|||
33334219|NCT00763815|101114971|FG000|Overall Study|Familial and Personal Reasons|9|||
33334220|NCT00763815|101114972|FG001|Overall Study|Familial and Personal Reasons|16|||
33334221|NCT00763815|101114971|FG000|Overall Study|Physician Decision|1|||
33334222|NCT00763815|101114972|FG001|Overall Study|Physician Decision|0|||
33334223|NCT00763815|101114971|FG000|Overall Study|Withdrawal by Subject|7|||
33334224|NCT00763815|101114972|FG001|Overall Study|Withdrawal by Subject|12|||
33334225|NCT00763815|101114971|FG000|Overall Study|Protocol Violation|2|||
33334226|NCT00763815|101114972|FG001|Overall Study|Protocol Violation|5|||
33334227|NCT00763815|101114971|FG000|Overall Study|Sponsor's Decision|0|||
33334228|NCT00763815|101114972|FG001|Overall Study|Sponsor's Decision|1|||
33334229|NCT02256540|101114975|FG000|Overall Study|Withdrawal by Subject|0|||
33334230|NCT02256540|101114976|FG001|Overall Study|Withdrawal by Subject|1|||
33403567|NCT00003389|101365626|FG001|Overall Study|Complicating disease|0|||
33528391|NCT00549549|101833943|FG001|Overall Study|Other|9|||
33528392|NCT00549549|101833944|FG002|Overall Study|Other|9|||
33528393|NCT00549549|101833945|FG003|Overall Study|Other|11|||
33528394|NCT00549549|101833942|FG000|Overall Study|Randomized but not treated|0|||
33528395|NCT00549549|101833943|FG001|Overall Study|Randomized but not treated|0|||
33334231|NCT02256540|101114977|FG002|Overall Study|Withdrawal by Subject|1|||
33334232|NCT02256540|101114975|FG000|Overall Study|Back pain preventing exercise|0|||
33334233|NCT02256540|101114976|FG001|Overall Study|Back pain preventing exercise|0|||
33334234|NCT02256540|101114977|FG002|Overall Study|Back pain preventing exercise|1|||
33334235|NCT01239342|101114978|FG000|Overall Study|Adverse Event|1|||
33334236|NCT01239342|101114979|FG001|Overall Study|Adverse Event|0|||
33334237|NCT01239342|101114978|FG000|Overall Study|Withdrawal by Subject|1|||
33334238|NCT01239342|101114979|FG001|Overall Study|Withdrawal by Subject|5|||
33334239|NCT01239342|101114978|FG000|Overall Study|Reason Unknown|1|||
33334240|NCT01239342|101114979|FG001|Overall Study|Reason Unknown|1|||
33403568|NCT00003389|101365625|FG000|Overall Study|Off-treatment reason missing|31|||
33403569|NCT00003389|101365626|FG001|Overall Study|Off-treatment reason missing|21|||
33403570|NCT00003389|101365625|FG000|Overall Study|Ineligible|33|||
33403571|NCT00003389|101365626|FG001|Overall Study|Ineligible|27|||
33528396|NCT00549549|101833944|FG002|Overall Study|Randomized but not treated|1|||
33334241|NCT03681119|101114980|FG000|Overall Study|No specific reason|4|||
33334242|NCT03681119|101114981|FG001|Overall Study|No specific reason|0|||
33528397|NCT00549549|101833945|FG003|Overall Study|Randomized but not treated|1|||
33334243|NCT03681119|101114980|FG000|Overall Study|Sickness|2|||
33334244|NCT03681119|101114981|FG001|Overall Study|Sickness|0|||
33334245|NCT00250835|101114982|FG000|Overall Study|Withdrawal by Subject|1|||
33334246|NCT00088374|101114983|FG000|Overall Study|patient did not receive any 17AAG|1|||
33334247|NCT00088374|101114983|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
33334248|NCT02443883|101114984|FG000|Overall Study|Adverse Event|0|||
33334249|NCT02443883|101114985|FG001|Overall Study|Adverse Event|1|||
33334250|NCT02443883|101114986|FG002|Overall Study|Adverse Event|0|||
33334251|NCT02443883|101114987|FG003|Overall Study|Adverse Event|0|||
33334252|NCT02443883|101114984|FG000|Overall Study|Lost to Follow-up|3|||
33334253|NCT02443883|101114985|FG001|Overall Study|Lost to Follow-up|2|||
33334254|NCT02443883|101114986|FG002|Overall Study|Lost to Follow-up|1|||
33334255|NCT02443883|101114987|FG003|Overall Study|Lost to Follow-up|0|||
33334256|NCT02443883|101114984|FG000|Overall Study|Physician Decision|1|||
33334257|NCT02443883|101114985|FG001|Overall Study|Physician Decision|1|||
33334258|NCT02443883|101114986|FG002|Overall Study|Physician Decision|0|||
33334259|NCT02443883|101114987|FG003|Overall Study|Physician Decision|3|||
33334260|NCT02443883|101114984|FG000|Overall Study|Withdrawal by Subject|1|||
33334261|NCT02443883|101114985|FG001|Overall Study|Withdrawal by Subject|0|||
33334262|NCT02443883|101114986|FG002|Overall Study|Withdrawal by Subject|0|||
33334263|NCT02443883|101114987|FG003|Overall Study|Withdrawal by Subject|2|||
33334264|NCT02443883|101114984|FG000|Overall Study|Randomized, but never treated|1|||
33334265|NCT02443883|101114985|FG001|Overall Study|Randomized, but never treated|0|||
33334266|NCT02443883|101114986|FG002|Overall Study|Randomized, but never treated|0|||
33334267|NCT02443883|101114987|FG003|Overall Study|Randomized, but never treated|0|||
33334268|NCT04707157|101118062|FG000|Overall Study|Adverse Event|12|||
33334269|NCT04707157|101118063|FG001|Overall Study|Adverse Event|3|||
33334270|NCT04707157|101118062|FG000|Overall Study|Lost to Follow-up|2|||
33334271|NCT04707157|101118063|FG001|Overall Study|Lost to Follow-up|0|||
33334272|NCT04707157|101118062|FG000|Overall Study|Sponsor's decision|1|||
33334273|NCT04707157|101118063|FG001|Overall Study|Sponsor's decision|0|||
33334274|NCT04707157|101118062|FG000|Overall Study|Physician Decision|8|||
33334275|NCT04707157|101118063|FG001|Overall Study|Physician Decision|5|||
33334276|NCT04707157|101118062|FG000|Overall Study|Protocol Deviation|1|||
33334277|NCT04707157|101118063|FG001|Overall Study|Protocol Deviation|0|||
33334278|NCT04707157|101118062|FG000|Overall Study|Withdrawal by Subject|1|||
33334279|NCT04707157|101118063|FG001|Overall Study|Withdrawal by Subject|1|||
33334280|NCT01389752|101118064|FG000|Study Period 1|Sponsor decision|0|||
33334281|NCT01389752|101118065|FG001|Study Period 1|Sponsor decision|2|||
33334282|NCT01389752|101118064|FG000|Study Period 2|Sponsor decision|1|||
33334283|NCT01389752|101118065|FG001|Study Period 2|Sponsor decision|0|||
33334284|NCT00583362|101118066|FG000|Overall Study|Adverse Event|44|||
33334285|NCT00583362|101118066|FG000|Overall Study|Lack of Efficacy|22|||
33334286|NCT00583362|101118066|FG000|Overall Study|Lost to Follow-up|4|||
33334287|NCT00583362|101118066|FG000|Overall Study|Non-compliance with study drug|28|||
33334288|NCT00583362|101118066|FG000|Overall Study|Pregnancy|7|||
33334289|NCT00583362|101118066|FG000|Overall Study|Miscommunication of visit window|5|||
33334290|NCT00583362|101118066|FG000|Overall Study|Current site closed|7|||
33334291|NCT00583362|101118066|FG000|Overall Study|Subject not dosed in LBSL99|1|||
33334292|NCT00583362|101118066|FG000|Overall Study|Subject moved out of the country/state|2|||
33334293|NCT00583362|101118066|FG000|Overall Study|Missed visits due to staff changes|1|||
33334294|NCT00583362|101118066|FG000|Overall Study|Misunderstanding of protocol|1|||
33334295|NCT00583362|101118066|FG000|Overall Study|Behavioral problems and non-compliance|1|||
33334296|NCT00583362|101118066|FG000|Overall Study|Sponsor request due to missed doses|1|||
33334297|NCT00583362|101118066|FG000|Overall Study|Physician Decision|19|||
33334298|NCT00583362|101118066|FG000|Overall Study|Protocol Violation|2|||
33403572|NCT01004159|101365629|FG000|Overall Study|Adverse Event|2|||
33403573|NCT01004159|101365629|FG000|Overall Study|Disease Progression|18|||
33403574|NCT01823991|101365630|FG000|Overall Study|Withdrawal by Subject|8|||
33403575|NCT01823991|101365631|FG001|Overall Study|Withdrawal by Subject|5|||
33403576|NCT00620815|101365634|FG000|Overall Study|Adverse Event|1|||
33403577|NCT00620815|101365635|FG001|Overall Study|Adverse Event|1|||
33403578|NCT00620815|101365636|FG002|Overall Study|Adverse Event|2|||
33403579|NCT00620815|101365634|FG000|Overall Study|Withdrawal by Subject|1|||
33334299|NCT00583362|101118066|FG000|Overall Study|Withdrawal by Subject|57|||
33334300|NCT03775421|101118070|FG000|Overall Study|Lost to Follow-up|2|||
33334301|NCT03775421|101118070|FG000|Overall Study|Withdrawal by Subject|10|||
33334302|NCT03775421|101118070|FG000|Overall Study|Physician Decision|3|||
33334303|NCT03775421|101118070|FG000|Overall Study|Death|1|||
33334304|NCT03775421|101118070|FG000|Overall Study|Study Terminated by Sponsor|94|||
33334305|NCT00562588|101118072|FG000|Overall Study|Adverse Event|40|||
33403580|NCT00620815|101365635|FG001|Overall Study|Withdrawal by Subject|2|||
33334306|NCT00562588|101118073|FG001|Overall Study|Adverse Event|58|||
33334307|NCT00562588|101118072|FG000|Overall Study|Protocol Violation|30|||
33334308|NCT00562588|101118073|FG001|Overall Study|Protocol Violation|26|||
33334309|NCT00562588|101118072|FG000|Overall Study|Lost to Follow-up|12|||
33403581|NCT00620815|101365636|FG002|Overall Study|Withdrawal by Subject|0|||
33403582|NCT00620815|101365634|FG000|Overall Study|Lost to Follow-up|1|||
33204561|NCT03943095|100651309|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
33204562|NCT03943095|100651310|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
33204563|NCT03943095|100651309|FG000|Overall Study|Withdrawal by Subject|1|||
33204564|NCT03943095|100651310|FG001|Overall Study|Withdrawal by Subject|0|||
33204565|NCT02014116|100651311|FG000|Overall Study|Progressive Disease|3|||
33204566|NCT02014116|100651312|FG001|Overall Study|Progressive Disease|4|||
33204567|NCT02014116|100651313|FG002|Overall Study|Progressive Disease|2|||
33204568|NCT02014116|100651314|FG003|Overall Study|Progressive Disease|6|||
33204569|NCT02014116|100651315|FG004|Overall Study|Progressive Disease|1|||
33204570|NCT02014116|100651316|FG005|Overall Study|Progressive Disease|13|||
33204571|NCT02014116|100651317|FG006|Overall Study|Progressive Disease|1|||
33334310|NCT00562588|101118073|FG001|Overall Study|Lost to Follow-up|4|||
33334311|NCT00562588|101118072|FG000|Overall Study|Withdrawal by Subject|10|||
33334312|NCT00562588|101118073|FG001|Overall Study|Withdrawal by Subject|9|||
33334313|NCT00562588|101118072|FG000|Overall Study|Other|0|||
33334314|NCT00562588|101118073|FG001|Overall Study|Other|2|||
33334315|NCT00631371|101118075|FG000|Overall Study|Lost to Follow-up|24|||
33334316|NCT00631371|101118076|FG001|Overall Study|Lost to Follow-up|19|||
33334317|NCT00631371|101118075|FG000|Overall Study|Other reason|5|||
33334318|NCT00631371|101118076|FG001|Overall Study|Other reason|12|||
33334319|NCT00631371|101118075|FG000|Overall Study|subject request|38|||
33334320|NCT00631371|101118076|FG001|Overall Study|subject request|45|||
33334321|NCT00631371|101118075|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
33334322|NCT00631371|101118076|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
33334323|NCT00631371|101118075|FG000|Overall Study|Death|263|||
33334324|NCT00631371|101118076|FG001|Overall Study|Death|239|||
33334325|NCT00205855|101118077|FG000|Overall Study|Only received temporary implants|16|||
33334326|NCT00205855|101118077|FG000|Overall Study|Withdrawal by Subject|5|||
33334327|NCT02193074|101118083|FG000|Overall Study|Withdrawal by Subject|1|||
33334328|NCT02193074|101118084|FG001|Overall Study|Withdrawal by Subject|2|||
33334329|NCT02193074|101118083|FG000|Overall Study|Adverse Event|16|||
33528398|NCT02256917|101833949|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
33528399|NCT02256917|101833949|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
33334330|NCT02193074|101118084|FG001|Overall Study|Adverse Event|13|||
33528400|NCT02256917|101833949|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
33528401|NCT02256917|101833949|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
33528402|NCT02256917|101833949|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
33528403|NCT01763827|101833950|FG000|Overall Study|Withdrawal by Subject|1|||
33528404|NCT01763827|101833951|FG001|Overall Study|Withdrawal by Subject|0|||
33528405|NCT01763827|101833952|FG002|Overall Study|Withdrawal by Subject|0|||
33528406|NCT01763827|101833953|FG003|Overall Study|Withdrawal by Subject|0|||
33528407|NCT01763827|101833954|FG004|Overall Study|Withdrawal by Subject|2|||
33528408|NCT01763827|101833955|FG005|Overall Study|Withdrawal by Subject|0|||
33528409|NCT01763827|101833950|FG000|Overall Study|Decision by sponsor|2|||
33528410|NCT01763827|101833951|FG001|Overall Study|Decision by sponsor|0|||
33528411|NCT01763827|101833952|FG002|Overall Study|Decision by sponsor|3|||
33528412|NCT01763827|101833953|FG003|Overall Study|Decision by sponsor|0|||
33528413|NCT01763827|101833954|FG004|Overall Study|Decision by sponsor|2|||
33528414|NCT01763827|101833955|FG005|Overall Study|Decision by sponsor|1|||
33528415|NCT01763827|101833950|FG000|Overall Study|Lost to Follow-up|0|||
33528416|NCT01763827|101833951|FG001|Overall Study|Lost to Follow-up|1|||
33528417|NCT01763827|101833952|FG002|Overall Study|Lost to Follow-up|1|||
33528418|NCT01763827|101833953|FG003|Overall Study|Lost to Follow-up|1|||
33528419|NCT01763827|101833954|FG004|Overall Study|Lost to Follow-up|2|||
33528420|NCT01763827|101833955|FG005|Overall Study|Lost to Follow-up|1|||
33528421|NCT01904032|101833956|FG000|Overall Study|Adverse Event|3|||
33528422|NCT01904032|101833957|FG001|Overall Study|Adverse Event|1|||
33528423|NCT01904032|101833956|FG000|Overall Study|Lost to Follow-up|4|||
33528424|NCT01904032|101833957|FG001|Overall Study|Lost to Follow-up|2|||
33528425|NCT00534638|101833958|FG000|Overall Study|Withdrawal by Subject|3|||
33528426|NCT00534638|101833959|FG001|Overall Study|Withdrawal by Subject|4|||
33528427|NCT00534638|101833958|FG000|Overall Study|Migrated/moved from study area|13|||
33528428|NCT00534638|101833959|FG001|Overall Study|Migrated/moved from study area|11|||
33528429|NCT00534638|101833958|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
33334331|NCT01014689|101118085|FG000|Overall Study|Lack of Efficacy|0|||
33528430|NCT00534638|101833959|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
33528431|NCT00534638|101833958|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
33528432|NCT00534638|101833959|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
33528433|NCT00534638|101833958|FG000|Overall Study|Other|1685|||
33528434|NCT00534638|101833959|FG001|Overall Study|Other|902|||
33528435|NCT00184002|101833960|FG000|Overall Study|Adverse Event|9|||
33204572|NCT02014116|100651318|FG007|Overall Study|Progressive Disease|3|||
33204573|NCT02014116|100651319|FG008|Overall Study|Progressive Disease|7|||
33204574|NCT02014116|100651311|FG000|Overall Study|Adverse Event|0|||
33204575|NCT02014116|100651312|FG001|Overall Study|Adverse Event|0|||
33334332|NCT01014689|101118086|FG001|Overall Study|Lack of Efficacy|1|||
33334333|NCT01014689|101118085|FG000|Overall Study|Adverse Event|3|||
33334334|NCT01014689|101118086|FG001|Overall Study|Adverse Event|0|||
33334335|NCT01014689|101118085|FG000|Overall Study|Withdrawal by Subject|5|||
33334336|NCT01014689|101118086|FG001|Overall Study|Withdrawal by Subject|4|||
33334337|NCT01014689|101118085|FG000|Overall Study|Protocol Violation|1|||
33334338|NCT01014689|101118086|FG001|Overall Study|Protocol Violation|1|||
33334339|NCT01014689|101118085|FG000|Overall Study|Lost to Follow-up|3|||
33334340|NCT01014689|101118086|FG001|Overall Study|Lost to Follow-up|7|||
33334341|NCT01014689|101118085|FG000|Overall Study|Pregnancy|1|||
33334342|NCT01014689|101118086|FG001|Overall Study|Pregnancy|0|||
33610749|NCT00061633|102123401|FG000|Overall Study|Never received study treatment|0|||
33204576|NCT02014116|100651313|FG002|Overall Study|Adverse Event|0|||
33204577|NCT02014116|100651314|FG003|Overall Study|Adverse Event|0|||
33204578|NCT02014116|100651315|FG004|Overall Study|Adverse Event|1|||
33204579|NCT02014116|100651316|FG005|Overall Study|Adverse Event|0|||
33204580|NCT02014116|100651317|FG006|Overall Study|Adverse Event|0|||
33204581|NCT02014116|100651318|FG007|Overall Study|Adverse Event|1|||
33204582|NCT02014116|100651319|FG008|Overall Study|Adverse Event|0|||
33204583|NCT02014116|100651311|FG000|Overall Study|Lost to Follow-up|0|||
33204584|NCT02014116|100651312|FG001|Overall Study|Lost to Follow-up|0|||
33204585|NCT02014116|100651313|FG002|Overall Study|Lost to Follow-up|0|||
33204586|NCT02014116|100651314|FG003|Overall Study|Lost to Follow-up|0|||
33204587|NCT02014116|100651315|FG004|Overall Study|Lost to Follow-up|0|||
33204588|NCT02014116|100651316|FG005|Overall Study|Lost to Follow-up|1|||
33204589|NCT02014116|100651317|FG006|Overall Study|Lost to Follow-up|0|||
33204590|NCT02014116|100651318|FG007|Overall Study|Lost to Follow-up|0|||
33204591|NCT02014116|100651319|FG008|Overall Study|Lost to Follow-up|1|||
33204592|NCT02014116|100651311|FG000|Overall Study|Death|0|||
33204593|NCT02014116|100651312|FG001|Overall Study|Death|0|||
33204594|NCT02014116|100651313|FG002|Overall Study|Death|0|||
33204595|NCT02014116|100651314|FG003|Overall Study|Death|0|||
33204596|NCT02014116|100651315|FG004|Overall Study|Death|0|||
33204597|NCT02014116|100651316|FG005|Overall Study|Death|0|||
33204598|NCT02014116|100651317|FG006|Overall Study|Death|0|||
33204599|NCT02014116|100651318|FG007|Overall Study|Death|1|||
33204600|NCT02014116|100651319|FG008|Overall Study|Death|1|||
33204601|NCT02014116|100651311|FG000|Overall Study|Withdrawal by Subject|0|||
33204602|NCT02014116|100651312|FG001|Overall Study|Withdrawal by Subject|0|||
33204603|NCT02014116|100651313|FG002|Overall Study|Withdrawal by Subject|1|||
33334343|NCT01033734|101118087|FG000|Overall Study|Withdrawal by Subject|1|||
33610750|NCT00061633|102123402|FG001|Overall Study|Never received study treatment|2|||
33610751|NCT01209078|102123405|FG000|Overall Study|Adverse Event|5|||
33610752|NCT01209078|102123406|FG001|Overall Study|Adverse Event|0|||
33610753|NCT01209078|102123405|FG000|Overall Study|Lost to Follow-up|4|||
33610754|NCT01209078|102123406|FG001|Overall Study|Lost to Follow-up|0|||
33610755|NCT01209078|102123405|FG000|Overall Study|Physician Decision|5|||
33610756|NCT01209078|102123406|FG001|Overall Study|Physician Decision|2|||
33610757|NCT01209078|102123405|FG000|Overall Study|Withdrawal by Subject|2|||
33610758|NCT01209078|102123406|FG001|Overall Study|Withdrawal by Subject|1|||
33610759|NCT00646399|102123411|FG000|Overall Study|Death|63|||
33610760|NCT00646399|102123412|FG001|Overall Study|Death|53|||
33610761|NCT00646399|102123411|FG000|Overall Study|Withdrawal by Subject|9|||
33610762|NCT00646399|102123412|FG001|Overall Study|Withdrawal by Subject|10|||
33610763|NCT00646399|102123411|FG000|Overall Study|Other Reason|11|||
33610764|NCT00646399|102123412|FG001|Overall Study|Other Reason|11|||
33610765|NCT01299116|102123415|FG000|Overall Study|Lost to Follow-up|65|||
33610766|NCT01299116|102123416|FG001|Overall Study|Lost to Follow-up|9|||
33610767|NCT01299116|102123417|FG002|Overall Study|Lost to Follow-up|11|||
33610768|NCT00411632|102123418|FG000|Overall Study|Death|1|||
33610769|NCT00773747|102123419|FG000|Overall Study|Lack of Efficacy|112|||
33610770|NCT00773747|102123420|FG001|Overall Study|Lack of Efficacy|144|||
33610771|NCT00773747|102123419|FG000|Overall Study|Physician Decision|26|||
33204604|NCT02014116|100651314|FG003|Overall Study|Withdrawal by Subject|1|||
33204605|NCT02014116|100651315|FG004|Overall Study|Withdrawal by Subject|0|||
33204606|NCT02014116|100651316|FG005|Overall Study|Withdrawal by Subject|1|||
33204607|NCT02014116|100651317|FG006|Overall Study|Withdrawal by Subject|0|||
33204608|NCT02014116|100651318|FG007|Overall Study|Withdrawal by Subject|0|||
33204609|NCT02014116|100651319|FG008|Overall Study|Withdrawal by Subject|0|||
33204610|NCT02014116|100651311|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
33204611|NCT02014116|100651312|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
33204612|NCT02014116|100651313|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
33334344|NCT00903175|101118088|FG000|Period 1 - First Line|Adverse Event|36|||
33610772|NCT00773747|102123420|FG001|Overall Study|Physician Decision|18|||
33610773|NCT00773747|102123419|FG000|Overall Study|Lost to Follow-up|0|||
33610774|NCT00773747|102123420|FG001|Overall Study|Lost to Follow-up|1|||
33610775|NCT00773747|102123419|FG000|Overall Study|Protocol Violation|2|||
33610776|NCT00773747|102123420|FG001|Overall Study|Protocol Violation|2|||
33610777|NCT00773747|102123419|FG000|Overall Study|Withdrawal by Subject|89|||
33204613|NCT02014116|100651314|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
33204614|NCT02014116|100651315|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
33403583|NCT00620815|101365635|FG001|Overall Study|Lost to Follow-up|6|||
33610778|NCT00773747|102123420|FG001|Overall Study|Withdrawal by Subject|61|||
33610779|NCT00773747|102123419|FG000|Overall Study|Adverse Event|61|||
33610780|NCT00773747|102123420|FG001|Overall Study|Adverse Event|62|||
33610781|NCT00773747|102123419|FG000|Overall Study|Death|5|||
33204615|NCT02014116|100651316|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
33204616|NCT02014116|100651317|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
33204617|NCT02014116|100651318|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
33204618|NCT02014116|100651319|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
33204619|NCT02014116|100651311|FG000|Overall Study|Physician Decision|0|||
33204620|NCT02014116|100651312|FG001|Overall Study|Physician Decision|0|||
33204621|NCT02014116|100651313|FG002|Overall Study|Physician Decision|0|||
33204622|NCT02014116|100651314|FG003|Overall Study|Physician Decision|0|||
33204623|NCT02014116|100651315|FG004|Overall Study|Physician Decision|0|||
33204624|NCT02014116|100651316|FG005|Overall Study|Physician Decision|0|||
33204625|NCT02014116|100651317|FG006|Overall Study|Physician Decision|0|||
33204626|NCT02014116|100651318|FG007|Overall Study|Physician Decision|0|||
33204627|NCT02014116|100651319|FG008|Overall Study|Physician Decision|1|||
33204628|NCT03043664|100651325|FG000|Overall Study|Lost to Follow-up|1|||
33204629|NCT01568047|100651326|FG000|Overall Study|Ineligibility|1|||
33204630|NCT01568047|100651327|FG001|Overall Study|Ineligibility|0|||
33334345|NCT00903175|101118089|FG001|Period 1 - First Line|Adverse Event|50|||
33610782|NCT00773747|102123420|FG001|Overall Study|Death|8|||
33610783|NCT00773747|102123419|FG000|Overall Study|Not Treated|2|||
33610784|NCT00773747|102123420|FG001|Overall Study|Not Treated|0|||
33610785|NCT00367835|102123421|FG000|Overall Study|Adverse Event|14|||
33610786|NCT00367835|102123422|FG001|Overall Study|Adverse Event|1|||
33610787|NCT00367835|102123421|FG000|Overall Study|Protocol Violation|1|||
33610788|NCT00367835|102123422|FG001|Overall Study|Protocol Violation|7|||
33610789|NCT00367835|102123421|FG000|Overall Study|Withdrawal by Subject|7|||
33610790|NCT00367835|102123422|FG001|Overall Study|Withdrawal by Subject|6|||
33610791|NCT00367835|102123421|FG000|Overall Study|Lost to Follow-up|1|||
33610792|NCT00367835|102123422|FG001|Overall Study|Lost to Follow-up|4|||
33610793|NCT00367835|102123421|FG000|Overall Study|Lack of Efficacy|3|||
33610794|NCT00367835|102123422|FG001|Overall Study|Lack of Efficacy|12|||
33610795|NCT00367835|102123421|FG000|Overall Study|Subject in juvenile detention center|1|||
33610796|NCT00367835|102123422|FG001|Overall Study|Subject in juvenile detention center|0|||
33610797|NCT00367835|102123421|FG000|Overall Study|refused blood collection|1|||
33610798|NCT00367835|102123422|FG001|Overall Study|refused blood collection|0|||
33610799|NCT00367835|102123421|FG000|Overall Study|Did not respond to calls|1|||
33610800|NCT00367835|102123422|FG001|Overall Study|Did not respond to calls|0|||
33610801|NCT00367835|102123421|FG000|Overall Study|History of lead poisoning|0|||
33610802|NCT00367835|102123422|FG001|Overall Study|History of lead poisoning|1|||
33610803|NCT00802893|102123423|FG000|Overall Study|study terminated|3|||
33610804|NCT02516592|102123424|FG000|Overall Study|Patient withdrew consent|5|||
33610805|NCT02516592|102123425|FG001|Overall Study|Patient withdrew consent|2|||
33610806|NCT02516592|102123424|FG000|Overall Study|Protocol deviation|4|||
33610807|NCT02516592|102123425|FG001|Overall Study|Protocol deviation|4|||
33610808|NCT02516592|102123424|FG000|Overall Study|Lost to Follow-up|2|||
33610809|NCT02516592|102123425|FG001|Overall Study|Lost to Follow-up|3|||
33610810|NCT02516592|102123424|FG000|Overall Study|Patient/guardian decision|2|||
33610811|NCT02516592|102123425|FG001|Overall Study|Patient/guardian decision|1|||
33610812|NCT02516592|102123424|FG000|Overall Study|Adverse Event|1|||
33610813|NCT02516592|102123425|FG001|Overall Study|Adverse Event|2|||
33610814|NCT02516592|102123424|FG000|Overall Study|Abnormal test procedure result|1|||
33610815|NCT02516592|102123425|FG001|Overall Study|Abnormal test procedure result|0|||
33610816|NCT02516592|102123424|FG000|Overall Study|Death|1|||
33204631|NCT01568047|100651328|FG002|Overall Study|Ineligibility|0|||
33204632|NCT01568047|100651329|FG003|Overall Study|Ineligibility|0|||
33204633|NCT01568047|100651326|FG000|Overall Study|Withdrawal by Subject|0|||
33204634|NCT01568047|100651327|FG001|Overall Study|Withdrawal by Subject|1|||
33610817|NCT02516592|102123425|FG001|Overall Study|Death|1|||
33610818|NCT01853878|102123430|FG000|Overall Study|Recurrence|2|||
33610819|NCT01853878|102123431|FG001|Overall Study|Recurrence|0|||
33610820|NCT01853878|102123430|FG000|Overall Study|Adverse Event|2|||
33610821|NCT01853878|102123431|FG001|Overall Study|Adverse Event|0|||
33204635|NCT01568047|100651328|FG002|Overall Study|Withdrawal by Subject|0|||
33204636|NCT01568047|100651329|FG003|Overall Study|Withdrawal by Subject|0|||
33204637|NCT01568047|100651326|FG000|Overall Study|Adverse Event|0|||
33610822|NCT01853878|102123430|FG000|Overall Study|Withdrawal by Subject|3|||
33610823|NCT01853878|102123431|FG001|Overall Study|Withdrawal by Subject|1|||
33403584|NCT00620815|101365636|FG002|Overall Study|Lost to Follow-up|3|||
33403585|NCT00620815|101365634|FG000|Overall Study|Inappropriate enrolment|0|||
33403586|NCT00620815|101365635|FG001|Overall Study|Inappropriate enrolment|0|||
33403587|NCT00620815|101365636|FG002|Overall Study|Inappropriate enrolment|1|||
33403588|NCT00620815|101365634|FG000|Overall Study|Protocol Violation|1|||
33403589|NCT00620815|101365635|FG001|Overall Study|Protocol Violation|2|||
33403590|NCT00620815|101365636|FG002|Overall Study|Protocol Violation|1|||
33334346|NCT00903175|101118088|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
33334347|NCT00903175|101118089|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
33334348|NCT00903175|101118088|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
33334349|NCT00903175|101118089|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
33334350|NCT00903175|101118088|FG000|Period 1 - First Line|Protocol Violation|3|||
33334351|NCT00903175|101118089|FG001|Period 1 - First Line|Protocol Violation|3|||
33403591|NCT02408016|101369293|FG000|Overall Study|Death|6|||
33403592|NCT02408016|101369294|FG001|Overall Study|Death|1|||
33403593|NCT02408016|101369295|FG002|Overall Study|Death|0|||
33403594|NCT02408016|101369293|FG000|Overall Study|Physician Decision|0|||
33403595|NCT02408016|101369294|FG001|Overall Study|Physician Decision|2|||
33403596|NCT02408016|101369295|FG002|Overall Study|Physician Decision|0|||
33403597|NCT02785588|101369299|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
33403598|NCT02785588|101369299|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
33403599|NCT00851721|101369315|FG000|Overall Study|planned surgery|1|||
33403600|NCT00851721|101369316|FG001|Overall Study|planned surgery|0|||
33403601|NCT00851721|101369315|FG000|Overall Study|Death|1|||
33334352|NCT00903175|101118088|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
33403602|NCT00851721|101369316|FG001|Overall Study|Death|0|||
33334353|NCT00903175|101118089|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
33334354|NCT00903175|101118088|FG000|Period 1 - First Line|Administrative problems|12|||
33334355|NCT00903175|101118089|FG001|Period 1 - First Line|Administrative problems|13|||
33334356|NCT00903175|101118088|FG000|Period 1 - First Line|Death|17|||
33334357|NCT00903175|101118089|FG001|Period 1 - First Line|Death|10|||
33334358|NCT00903175|101118088|FG000|Period 2 - Second Line|Missing|1|||
33334359|NCT00903175|101118089|FG001|Period 2 - Second Line|Missing|0|||
33334360|NCT00903175|101118088|FG000|Period 2 - Second Line|Adverse Event|16|||
33334361|NCT00903175|101118089|FG001|Period 2 - Second Line|Adverse Event|20|||
33334362|NCT00903175|101118088|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
33334363|NCT00903175|101118089|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
33334364|NCT00903175|101118088|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
33334365|NCT00903175|101118089|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
33334366|NCT00903175|101118088|FG000|Period 2 - Second Line|Administrative problems|19|||
33334367|NCT00903175|101118089|FG001|Period 2 - Second Line|Administrative problems|9|||
33334368|NCT00903175|101118088|FG000|Period 2 - Second Line|Death|5|||
33334369|NCT00903175|101118089|FG001|Period 2 - Second Line|Death|2|||
33334370|NCT00408694|101118096|FG000|Overall Study|Ineligible|1|||
33334371|NCT00408694|101118096|FG000|Overall Study|No protocol treatment|1|||
33334372|NCT00573430|101118099|FG000|Overall Study|Incorrect enrollment of randomization|0|||
33334373|NCT00573430|101118100|FG001|Overall Study|Incorrect enrollment of randomization|4|||
33334374|NCT00573430|101118101|FG002|Overall Study|Incorrect enrollment of randomization|3|||
33334375|NCT00573430|101118099|FG000|Overall Study|Adverse Event|0|||
33334376|NCT00573430|101118100|FG001|Overall Study|Adverse Event|0|||
33334377|NCT00573430|101118101|FG002|Overall Study|Adverse Event|2|||
33334378|NCT00573430|101118099|FG000|Overall Study|Withdrawal by Subject|1|||
33334379|NCT00573430|101118100|FG001|Overall Study|Withdrawal by Subject|0|||
33334380|NCT00573430|101118101|FG002|Overall Study|Withdrawal by Subject|1|||
33334381|NCT00573430|101118099|FG000|Overall Study|Protocol Violation|0|||
33403603|NCT00851721|101369315|FG000|Overall Study|Adverse Event|0|||
33528436|NCT00184002|101833960|FG000|Overall Study|Death|3|||
33528437|NCT00184002|101833960|FG000|Overall Study|Physician Decision|1|||
33528438|NCT00184002|101833960|FG000|Overall Study|Withdrawal by Subject|4|||
33528439|NCT01300247|101833961|FG000|Overall Study|Death|1|||
33528440|NCT01300247|101833962|FG001|Overall Study|Death|1|||
33528441|NCT01300247|101833961|FG000|Overall Study|Lost to Follow-up|2|||
33528442|NCT01300247|101833962|FG001|Overall Study|Lost to Follow-up|0|||
33528443|NCT01300247|101833961|FG000|Overall Study|Withdrawal by Subject|1|||
33334382|NCT00573430|101118100|FG001|Overall Study|Protocol Violation|1|||
33528444|NCT01300247|101833962|FG001|Overall Study|Withdrawal by Subject|0|||
33528445|NCT01300247|101833961|FG000|Overall Study|Non-Compliance|0|||
33334383|NCT00573430|101118101|FG002|Overall Study|Protocol Violation|1|||
33403604|NCT00851721|101369316|FG001|Overall Study|Adverse Event|1|||
33528446|NCT01300247|101833962|FG001|Overall Study|Non-Compliance|1|||
33334384|NCT00573430|101118099|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33334385|NCT00573430|101118100|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33334386|NCT00573430|101118101|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
33403605|NCT00027027|101369317|FG000|Overall Study|Adverse Event|0|||
33403606|NCT00027027|101369318|FG001|Overall Study|Adverse Event|0|||
33334387|NCT00446511|101118107|FG000|Overall Study|Adverse Event|7|||
33334388|NCT00446511|101118108|FG001|Overall Study|Adverse Event|2|||
33334389|NCT00446511|101118109|FG002|Overall Study|Adverse Event|3|||
33334390|NCT00446511|101118110|FG003|Overall Study|Adverse Event|1|||
33334391|NCT00446511|101118107|FG000|Overall Study|Protocol Violation|0|||
33334392|NCT00446511|101118108|FG001|Overall Study|Protocol Violation|0|||
33334393|NCT00446511|101118109|FG002|Overall Study|Protocol Violation|0|||
33334394|NCT00446511|101118110|FG003|Overall Study|Protocol Violation|1|||
33334395|NCT00446511|101118107|FG000|Overall Study|Withdrawal by Subject|0|||
33334396|NCT00446511|101118108|FG001|Overall Study|Withdrawal by Subject|0|||
33334397|NCT00446511|101118109|FG002|Overall Study|Withdrawal by Subject|0|||
33334398|NCT00446511|101118110|FG003|Overall Study|Withdrawal by Subject|3|||
33334399|NCT00446511|101118107|FG000|Overall Study|Administrative Problems|3|||
33334400|NCT00446511|101118108|FG001|Overall Study|Administrative Problems|0|||
33334401|NCT00446511|101118109|FG002|Overall Study|Administrative Problems|4|||
33334402|NCT00446511|101118110|FG003|Overall Study|Administrative Problems|1|||
33334403|NCT00333359|101118112|FG000|Overall Study|Adverse Event|29|||
33334404|NCT00333359|101118113|FG001|Overall Study|Adverse Event|35|||
33334405|NCT00333359|101118112|FG000|Overall Study|Withdrawal by Subject|19|||
33334406|NCT00333359|101118113|FG001|Overall Study|Withdrawal by Subject|37|||
33334407|NCT00333359|101118112|FG000|Overall Study|Physician Decision|2|||
33334408|NCT00333359|101118113|FG001|Overall Study|Physician Decision|2|||
33334409|NCT00333359|101118112|FG000|Overall Study|Protocol Non-compliance|2|||
33334410|NCT00333359|101118113|FG001|Overall Study|Protocol Non-compliance|8|||
33334411|NCT00333359|101118112|FG000|Overall Study|Lost to Follow-up|15|||
33334412|NCT00333359|101118113|FG001|Overall Study|Lost to Follow-up|25|||
33334413|NCT00333359|101118112|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
33334414|NCT00333359|101118113|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
33334415|NCT00333359|101118112|FG000|Overall Study|Treatment Failure|3|||
33204638|NCT01568047|100651327|FG001|Overall Study|Adverse Event|0|||
33204639|NCT01568047|100651328|FG002|Overall Study|Adverse Event|1|||
33334416|NCT00333359|101118113|FG001|Overall Study|Treatment Failure|8|||
33334417|NCT00333359|101118112|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
33334418|NCT00333359|101118113|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
33334419|NCT03505021|101118114|FG000|Overall Study|Protocol Violation|1|||
33334420|NCT03505021|101118115|FG001|Overall Study|Protocol Violation|0|||
33334421|NCT03505021|101118114|FG000|Overall Study|Death|9|||
33334422|NCT03505021|101118115|FG001|Overall Study|Death|8|||
33334423|NCT03505021|101118114|FG000|Overall Study|Consent withdrawn by subject|6|||
33334424|NCT03505021|101118115|FG001|Overall Study|Consent withdrawn by subject|1|||
33334425|NCT03505021|101118114|FG000|Overall Study|Lost to Follow-up|5|||
33334426|NCT03505021|101118115|FG001|Overall Study|Lost to Follow-up|3|||
33334427|NCT03505021|101118114|FG000|Overall Study|Adverse Event|26|||
33334428|NCT03505021|101118115|FG001|Overall Study|Adverse Event|9|||
33334429|NCT03505021|101118114|FG000|Overall Study|Disease progression|33|||
33334430|NCT03505021|101118115|FG001|Overall Study|Disease progression|17|||
33334431|NCT03505021|101118114|FG000|Overall Study|Other|11|||
33334432|NCT03505021|101118115|FG001|Overall Study|Other|5|||
33334433|NCT03505021|101118114|FG000|Overall Study|Personal reason|21|||
33334434|NCT03505021|101118115|FG001|Overall Study|Personal reason|12|||
33334435|NCT03223428|101118116|FG000|Overall Study|No longer taking Xermelo|27|||
33334436|NCT03223428|101118116|FG000|Overall Study|Declined Consent|1|||
33334437|NCT03223428|101118116|FG000|Overall Study|Non-responders|56|||
33334438|NCT03223428|101118116|FG000|Overall Study|Withdrawal by Subject|14|||
33334439|NCT03287219|101118117|FG000|Overall Study|Protocol Violation|0|||
33334440|NCT03287219|101118118|FG001|Overall Study|Protocol Violation|2|||
33334441|NCT00094055|101118119|FG000|Overall Study|Adverse Event|11|||
33334442|NCT00094055|101118119|FG000|Overall Study|Death|4|||
33334443|NCT00094055|101118119|FG000|Overall Study|Lack of Efficacy|17|||
33528447|NCT01957579|101833963|FG000|Overall Study|Withdrawal of concent|0|||
33334444|NCT00094055|101118119|FG000|Overall Study|Lost to Follow-up|2|||
33334445|NCT00094055|101118119|FG000|Overall Study|progressive disease|2|||
33334446|NCT00094055|101118119|FG000|Overall Study|clinical progression|1|||
33334447|NCT00094055|101118119|FG000|Overall Study|roll-over to another study|14|||
33334448|NCT00094055|101118119|FG000|Overall Study|Withdrawal by Subject|9|||
33528448|NCT01957579|101833964|FG001|Overall Study|Withdrawal of concent|1|||
33528449|NCT01957579|101833965|FG002|Overall Study|Withdrawal of concent|0|||
33204640|NCT01568047|100651329|FG003|Overall Study|Adverse Event|1|||
33204641|NCT00319098|100651330|FG000|Overall Study|Serious adverse event|3|||
33204642|NCT00319098|100651331|FG001|Overall Study|Serious adverse event|0|||
33334449|NCT02788747|101118126|FG000|Overall Study|Adverse Event|1|||
33334450|NCT02788747|101118127|FG001|Overall Study|Adverse Event|0|||
33334451|NCT02788747|101118128|FG002|Overall Study|Adverse Event|0|||
33334452|NCT04818593|101118131|FG000|Overall Study|Low Oocyte Yield|8|||
33334453|NCT04818593|101118132|FG001|Overall Study|Low Oocyte Yield|8|||
33334454|NCT04818593|101118131|FG000|Overall Study|Not ICSI Insemination|7|||
33334455|NCT04818593|101118132|FG001|Overall Study|Not ICSI Insemination|7|||
33334456|NCT04818593|101118131|FG000|Overall Study|Poor Sperm Quality|2|||
33334457|NCT04818593|101118132|FG001|Overall Study|Poor Sperm Quality|2|||
33334458|NCT04818593|101118131|FG000|Overall Study|Withdrawal by Subject|2|||
33334459|NCT04818593|101118132|FG001|Overall Study|Withdrawal by Subject|2|||
33334460|NCT04818593|101118131|FG000|Overall Study|Conversion to IUI due to low response|1|||
33334461|NCT04818593|101118132|FG001|Overall Study|Conversion to IUI due to low response|1|||
33334462|NCT00513500|101118135|FG000|Overall Study|Lost to Follow-up|35|||
33334463|NCT00513500|101118136|FG001|Overall Study|Lost to Follow-up|39|||
33334464|NCT00513500|101118135|FG000|Overall Study|Death|2|||
33334465|NCT00513500|101118136|FG001|Overall Study|Death|1|||
33334466|NCT00513500|101118135|FG000|Overall Study|Hospitalized|4|||
33334467|NCT00513500|101118136|FG001|Overall Study|Hospitalized|14|||
33334468|NCT00996944|101118137|FG000|Double-blind Treatment Period|Adverse Event|2|||
33334469|NCT00996944|101118138|FG001|Double-blind Treatment Period|Adverse Event|1|||
33334470|NCT00996944|101118137|FG000|Double-blind Treatment Period|Protocol Violation|1|||
33334471|NCT00996944|101118138|FG001|Double-blind Treatment Period|Protocol Violation|0|||
33334472|NCT00996944|101118137|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
33334473|NCT00996944|101118138|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
33334474|NCT00996944|101118137|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
33334475|NCT00996944|101118138|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
33403607|NCT00027027|101369319|FG002|Overall Study|Adverse Event|1|||
33403608|NCT00027027|101369320|FG003|Overall Study|Adverse Event|0|||
33403609|NCT00027027|101369321|FG004|Overall Study|Adverse Event|1|||
33403610|NCT00027027|101369317|FG000|Overall Study|Admitted for Signs of PD|0|||
33403611|NCT00027027|101369318|FG001|Overall Study|Admitted for Signs of PD|0|||
33403612|NCT00027027|101369319|FG002|Overall Study|Admitted for Signs of PD|0|||
33403613|NCT00027027|101369320|FG003|Overall Study|Admitted for Signs of PD|0|||
33403614|NCT00027027|101369321|FG004|Overall Study|Admitted for Signs of PD|1|||
33204643|NCT00319098|100651330|FG000|Overall Study|Adverse Event|20|||
33204644|NCT00319098|100651331|FG001|Overall Study|Adverse Event|1|||
33204645|NCT00319098|100651330|FG000|Overall Study|Withdrawal by Subject|37|||
33334476|NCT00996944|101118137|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
33334477|NCT00996944|101118138|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
33334478|NCT00183274|101118139|FG000|Phase 1: Open-Label|Adverse Event|31|||
33403615|NCT00027027|101369317|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
33403616|NCT00027027|101369318|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
33403617|NCT00027027|101369319|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
33403618|NCT00027027|101369320|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
33403619|NCT00027027|101369321|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
33403620|NCT00027027|101369317|FG000|Overall Study|PD Requiring Surgery|0|||
33403621|NCT00027027|101369318|FG001|Overall Study|PD Requiring Surgery|0|||
33403622|NCT00027027|101369319|FG002|Overall Study|PD Requiring Surgery|1|||
33403623|NCT00027027|101369320|FG003|Overall Study|PD Requiring Surgery|0|||
33403624|NCT00027027|101369321|FG004|Overall Study|PD Requiring Surgery|0|||
33403625|NCT00027027|101369317|FG000|Overall Study|Physician Decision Due To PD|2|||
33403626|NCT00027027|101369318|FG001|Overall Study|Physician Decision Due To PD|3|||
33403627|NCT00027027|101369319|FG002|Overall Study|Physician Decision Due To PD|2|||
33403628|NCT00027027|101369320|FG003|Overall Study|Physician Decision Due To PD|3|||
33403629|NCT00027027|101369321|FG004|Overall Study|Physician Decision Due To PD|5|||
33528450|NCT01957579|101833966|FG003|Overall Study|Withdrawal of concent|0|||
33334479|NCT00183274|101118140|FG001|Phase 1: Open-Label|Adverse Event|0|||
33334480|NCT00183274|101118141|FG002|Phase 1: Open-Label|Adverse Event|0|||
33334481|NCT00183274|101118142|FG003|Phase 1: Open-Label|Adverse Event|0|||
33334482|NCT00183274|101118143|FG004|Phase 1: Open-Label|Adverse Event|0|||
33334483|NCT00183274|101118144|FG005|Phase 1: Open-Label|Adverse Event|0|||
33334484|NCT00183274|101118139|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
33334485|NCT00183274|101118140|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
33334486|NCT00183274|101118141|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
33334487|NCT00183274|101118142|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
33334488|NCT00183274|101118143|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
33334489|NCT00183274|101118144|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
33334490|NCT00183274|101118139|FG000|Phase 1: Open-Label|Protocol Violation|11|||
33403630|NCT00027027|101369317|FG000|Overall Study|Withdrawal by Subject|0|||
33403631|NCT00027027|101369318|FG001|Overall Study|Withdrawal by Subject|0|||
33204646|NCT00319098|100651331|FG001|Overall Study|Withdrawal by Subject|8|||
33204647|NCT00319098|100651330|FG000|Overall Study|Migrated/moved from study area|2|||
33204648|NCT00319098|100651331|FG001|Overall Study|Migrated/moved from study area|1|||
33204649|NCT00319098|100651330|FG000|Overall Study|Lost to Follow-up|37|||
33204650|NCT00319098|100651331|FG001|Overall Study|Lost to Follow-up|13|||
33204651|NCT00319098|100651330|FG000|Overall Study|Others|33|||
33204652|NCT00319098|100651331|FG001|Overall Study|Others|8|||
33204653|NCT00319098|100651330|FG000|Overall Study|Protocol Violation|3|||
33204654|NCT00319098|100651331|FG001|Overall Study|Protocol Violation|1|||
33204655|NCT02843568|100651332|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
33204656|NCT02843568|100651333|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
33204657|NCT02843568|100651332|FG000|Overall Study|Death|3|||
33204658|NCT02843568|100651333|FG001|Overall Study|Death|3|||
33204659|NCT02843568|100651332|FG000|Overall Study|Withdrawal by Subject|1|||
33204660|NCT02843568|100651333|FG001|Overall Study|Withdrawal by Subject|1|||
33204661|NCT02843568|100651332|FG000|Overall Study|Lost to Follow-up|2|||
33204662|NCT02843568|100651333|FG001|Overall Study|Lost to Follow-up|0|||
33204663|NCT03321981|100651362|FG000|Overall Study|Progressive Disease (PD)|15|||
33204664|NCT03321981|100651363|FG001|Overall Study|Progressive Disease (PD)|30|||
33204665|NCT03321981|100651364|FG002|Overall Study|Progressive Disease (PD)|47|||
33204666|NCT03321981|100651362|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
33204667|NCT03321981|100651363|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
33204668|NCT03321981|100651364|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
33204669|NCT03321981|100651362|FG000|Overall Study|Adverse Event|0|||
33204670|NCT03321981|100651363|FG001|Overall Study|Adverse Event|0|||
33204671|NCT03321981|100651364|FG002|Overall Study|Adverse Event|2|||
33204672|NCT03321981|100651362|FG000|Overall Study|symptomatic deterioration|0|||
33204673|NCT03321981|100651363|FG001|Overall Study|symptomatic deterioration|1|||
33204674|NCT03321981|100651364|FG002|Overall Study|symptomatic deterioration|1|||
33204675|NCT03321981|100651362|FG000|Overall Study|Lack of compliance|0|||
33204676|NCT03321981|100651363|FG001|Overall Study|Lack of compliance|1|||
33204677|NCT03321981|100651364|FG002|Overall Study|Lack of compliance|0|||
33204678|NCT03321981|100651362|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
33204679|NCT03321981|100651363|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
33204680|NCT03321981|100651364|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
33204681|NCT03321981|100651362|FG000|Overall Study|Death|0|||
33204682|NCT03321981|100651363|FG001|Overall Study|Death|1|||
33334491|NCT00183274|101118140|FG001|Phase 1: Open-Label|Protocol Violation|0|||
33334492|NCT00183274|101118141|FG002|Phase 1: Open-Label|Protocol Violation|0|||
33334493|NCT00183274|101118142|FG003|Phase 1: Open-Label|Protocol Violation|0|||
33334494|NCT00183274|101118143|FG004|Phase 1: Open-Label|Protocol Violation|0|||
33334495|NCT00183274|101118144|FG005|Phase 1: Open-Label|Protocol Violation|0|||
33528451|NCT01957579|101833963|FG000|Overall Study|Death|0|||
33528452|NCT01957579|101833964|FG001|Overall Study|Death|0|||
33528453|NCT01957579|101833965|FG002|Overall Study|Death|2|||
33528454|NCT01957579|101833966|FG003|Overall Study|Death|0|||
33204683|NCT03321981|100651364|FG002|Overall Study|Death|0|||
33204684|NCT03321981|100651362|FG000|Overall Study|Subject withdrawal of investigational product|0|||
33204685|NCT03321981|100651363|FG001|Overall Study|Subject withdrawal of investigational product|1|||
33204686|NCT03321981|100651364|FG002|Overall Study|Subject withdrawal of investigational product|0|||
33334496|NCT00183274|101118139|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
33334497|NCT00183274|101118140|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
33334498|NCT00183274|101118141|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
33204687|NCT03321981|100651362|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
33204688|NCT03321981|100651363|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
33224368|NCT05044325|100721819|FG008|Part A:Treatment Period 1|Adverse Event|0|||
33528455|NCT00996034|101833973|FG000|Overall Study|Lost to Follow-up|2|||
33334499|NCT00183274|101118142|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
33334500|NCT00183274|101118143|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
33334501|NCT00183274|101118144|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
33334502|NCT00183274|101118139|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
33334503|NCT00183274|101118140|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
33334504|NCT00183274|101118141|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
33334505|NCT00183274|101118142|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
33334506|NCT00183274|101118143|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
33334507|NCT00183274|101118144|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
33334508|NCT00183274|101118139|FG000|Phase 1: Open-Label|Other|9|||
33334509|NCT00183274|101118140|FG001|Phase 1: Open-Label|Other|0|||
33334510|NCT00183274|101118141|FG002|Phase 1: Open-Label|Other|0|||
33334511|NCT00183274|101118142|FG003|Phase 1: Open-Label|Other|0|||
33334512|NCT00183274|101118143|FG004|Phase 1: Open-Label|Other|0|||
33334513|NCT00183274|101118144|FG005|Phase 1: Open-Label|Other|0|||
33334514|NCT00183274|101118139|FG000|Phase 2: Double-Blind|Relapsed|0|||
33334515|NCT00183274|101118140|FG001|Phase 2: Double-Blind|Relapsed|8|||
33334516|NCT00183274|101118141|FG002|Phase 2: Double-Blind|Relapsed|29|||
33334517|NCT00183274|101118142|FG003|Phase 2: Double-Blind|Relapsed|0|||
33334518|NCT00183274|101118143|FG004|Phase 2: Double-Blind|Relapsed|0|||
33334519|NCT00183274|101118144|FG005|Phase 2: Double-Blind|Relapsed|0|||
33334520|NCT00183274|101118139|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
33334521|NCT00183274|101118140|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
33334522|NCT00183274|101118141|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
33334523|NCT00183274|101118142|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
33334524|NCT00183274|101118143|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
33334525|NCT00183274|101118144|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
33334526|NCT00183274|101118139|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
33334527|NCT00183274|101118140|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
33334528|NCT00183274|101118141|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
33334529|NCT00183274|101118142|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
33528456|NCT00996034|101833973|FG000|Overall Study|withdrawn by PI|1|||
33528457|NCT03536663|101833975|FG000|Endexo|Protocol Violation|1|||
33528458|NCT00217581|101833976|FG000|Overall Study|Withdrawal by Subject|1|||
33528459|NCT02821416|101833977|FG000|Overall Study|Adverse Event|0|||
33528460|NCT02821416|101833978|FG001|Overall Study|Adverse Event|1|||
33528461|NCT02821416|101833977|FG000|Overall Study|Withdrawal by Subject|2|||
33528462|NCT02821416|101833978|FG001|Overall Study|Withdrawal by Subject|0|||
33528463|NCT02821416|101833977|FG000|Overall Study|Lost to Follow-up|1|||
33528464|NCT02821416|101833978|FG001|Overall Study|Lost to Follow-up|0|||
33610824|NCT01853878|102123430|FG000|Overall Study|Migrated/moved from the study area|1|||
33610825|NCT01853878|102123431|FG001|Overall Study|Migrated/moved from the study area|0|||
33334530|NCT00183274|101118143|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
33334531|NCT00183274|101118144|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
33334532|NCT00183274|101118139|FG000|Phase 3: Double-Blind|Relapsed|0|||
33334533|NCT00183274|101118140|FG001|Phase 3: Double-Blind|Relapsed|0|||
33334534|NCT00183274|101118141|FG002|Phase 3: Double-Blind|Relapsed|0|||
33334535|NCT00183274|101118142|FG003|Phase 3: Double-Blind|Relapsed|1|||
33334536|NCT00183274|101118143|FG004|Phase 3: Double-Blind|Relapsed|11|||
33334537|NCT00183274|101118144|FG005|Phase 3: Double-Blind|Relapsed|2|||
33334538|NCT02595723|101118145|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
33334539|NCT02595723|101118146|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
33334540|NCT02595723|101118147|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
33334541|NCT02595723|101118145|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
33334542|NCT02595723|101118146|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
33334543|NCT02595723|101118147|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
33334544|NCT02821715|101118148|FG000|Overall Study|Protocol Violation|1|||
33334545|NCT02821715|101118149|FG001|Overall Study|Protocol Violation|0|||
33334546|NCT02821715|101118150|FG002|Overall Study|Protocol Violation|0|||
33334547|NCT02821715|101118151|FG003|Overall Study|Protocol Violation|0|||
33334548|NCT02821715|101118152|FG004|Overall Study|Protocol Violation|0|||
33334549|NCT02821715|101118153|FG005|Overall Study|Protocol Violation|0|||
33334550|NCT03655756|101118154|FG000|Overall Study|Death|1|||
33610826|NCT01853878|102123430|FG000|Overall Study|Other|55|||
33610827|NCT01853878|102123431|FG001|Overall Study|Other|43|||
33610828|NCT00372697|102123432|FG000|Overall Study|Protocol Violation|1|||
33334551|NCT01967537|101118182|FG000|Overall Study|Withdrawal by Subject|52|||
33334552|NCT01967537|101118182|FG000|Overall Study|Refuse treatment|2|||
33528465|NCT01670045|101833985|FG000|Overall Study|Withdrawal by Subject|3|||
33610829|NCT00372697|102123433|FG001|Overall Study|Protocol Violation|1|||
33334553|NCT01967537|101118182|FG000|Overall Study|Lost to Follow-up|6|||
33334554|NCT00390546|101118183|FG000|Overall Study|Renal impairment|1|||
33334555|NCT00390546|101118184|FG001|Overall Study|Renal impairment|0|||
33528466|NCT01670045|101833985|FG000|Overall Study|Adverse Event|1|||
33528467|NCT01670045|101833985|FG000|Overall Study|Death|1|||
33610830|NCT02651220|102123434|FG000|Overall Study|Adverse Event|1|||
33528468|NCT01670045|101833985|FG000|Overall Study|Lost to Follow-up|11|||
33610831|NCT02651220|102123435|FG001|Overall Study|Adverse Event|5|||
33204689|NCT03321981|100651364|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
33204690|NCT03321981|100651362|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
33610832|NCT02651220|102123436|FG002|Overall Study|Adverse Event|1|||
33610833|NCT02651220|102123434|FG000|Overall Study|Lost to Follow-up|8|||
33610834|NCT02651220|102123435|FG001|Overall Study|Lost to Follow-up|14|||
33610835|NCT02651220|102123436|FG002|Overall Study|Lost to Follow-up|14|||
33610836|NCT02651220|102123434|FG000|Overall Study|Non-Compliance with Study Drug|4|||
33610837|NCT02651220|102123435|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33528469|NCT01990573|101833988|FG000|Overall Study|Physician Decision|0|||
33528470|NCT01990573|101833989|FG001|Overall Study|Physician Decision|0|||
33528471|NCT01990573|101833990|FG002|Overall Study|Physician Decision|1|||
33528472|NCT03959527|101833991|FG000|Overall Study|Withdrawal by Subject|8|||
33528473|NCT03959527|101833992|FG001|Overall Study|Withdrawal by Subject|3|||
33528474|NCT03959527|101833991|FG000|Overall Study|Lost to Follow-up|31|||
33528475|NCT03959527|101833992|FG001|Overall Study|Lost to Follow-up|15|||
33528476|NCT03959527|101833991|FG000|Overall Study|Did not meet eligibility criteria|1|||
33528477|NCT03959527|101833992|FG001|Overall Study|Did not meet eligibility criteria|1|||
33610838|NCT02651220|102123436|FG002|Overall Study|Non-Compliance with Study Drug|1|||
33610839|NCT02651220|102123434|FG000|Overall Study|Pregnancy|1|||
33610840|NCT02651220|102123435|FG001|Overall Study|Pregnancy|0|||
33610841|NCT02651220|102123436|FG002|Overall Study|Pregnancy|1|||
33610842|NCT02651220|102123434|FG000|Overall Study|Protocol Violation|0|||
33610843|NCT02651220|102123435|FG001|Overall Study|Protocol Violation|0|||
33610844|NCT02651220|102123436|FG002|Overall Study|Protocol Violation|1|||
33610845|NCT02651220|102123434|FG000|Overall Study|Withdrawal by Subject|5|||
33610846|NCT02651220|102123435|FG001|Overall Study|Withdrawal by Subject|6|||
33610847|NCT02651220|102123436|FG002|Overall Study|Withdrawal by Subject|8|||
33610848|NCT02651220|102123434|FG000|Overall Study|Miscellaneous|4|||
33610849|NCT02651220|102123435|FG001|Overall Study|Miscellaneous|1|||
33610850|NCT02651220|102123436|FG002|Overall Study|Miscellaneous|2|||
33204691|NCT03321981|100651363|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
33204692|NCT03321981|100651364|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
33204693|NCT00839072|100651365|FG000|First Intervention Period|Withdrawal by Subject|1|||
33204694|NCT00839072|100651366|FG001|First Intervention Period|Withdrawal by Subject|0|||
33204695|NCT00839072|100651365|FG000|First Intervention Period|Adverse Event|1|||
33204696|NCT00839072|100651366|FG001|First Intervention Period|Adverse Event|1|||
33334556|NCT00390546|101118183|FG000|Overall Study|Physician Decision|5|||
33403632|NCT00027027|101369319|FG002|Overall Study|Withdrawal by Subject|0|||
33403633|NCT00027027|101369320|FG003|Overall Study|Withdrawal by Subject|0|||
33403634|NCT00027027|101369321|FG004|Overall Study|Withdrawal by Subject|1|||
33403635|NCT00508001|101369322|FG000|Overall Study|Adverse Event|2|||
33403636|NCT00508001|101369323|FG001|Overall Study|Adverse Event|0|||
33528478|NCT03959527|101833991|FG000|Overall Study|Protocol Violation|10|||
33528479|NCT03959527|101833992|FG001|Overall Study|Protocol Violation|5|||
33528480|NCT02090283|101833993|FG000|Overall Study|Withdrawal by Subject|6|||
33528481|NCT02090283|101833994|FG001|Overall Study|Withdrawal by Subject|6|||
33528482|NCT02090283|101833995|FG002|Overall Study|Withdrawal by Subject|6|||
33528483|NCT02090283|101833993|FG000|Overall Study|Sponsor Terminated Study|6|||
33528484|NCT02090283|101833994|FG001|Overall Study|Sponsor Terminated Study|6|||
33528485|NCT02090283|101833995|FG002|Overall Study|Sponsor Terminated Study|1|||
33528486|NCT02090283|101833993|FG000|Overall Study|Lost to Follow-up|2|||
33528487|NCT02090283|101833994|FG001|Overall Study|Lost to Follow-up|2|||
33528488|NCT02090283|101833995|FG002|Overall Study|Lost to Follow-up|3|||
33610851|NCT02651220|102123434|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33528489|NCT02090283|101833993|FG000|Overall Study|Adverse Event|1|||
33528490|NCT02090283|101833994|FG001|Overall Study|Adverse Event|1|||
33528491|NCT02090283|101833995|FG002|Overall Study|Adverse Event|0|||
33528492|NCT02090283|101833993|FG000|Overall Study|Protocol Violation|2|||
33528493|NCT02090283|101833994|FG001|Overall Study|Protocol Violation|0|||
33610852|NCT02651220|102123435|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33610853|NCT02651220|102123436|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
33610854|NCT02697435|102126769|FG000|Overall Study|Withdrawal by Subject|1|||
33610855|NCT02697435|102126770|FG001|Overall Study|Withdrawal by Subject|0|||
33204697|NCT00839072|100651365|FG000|Second Intervention Period|Withdrawal by Subject|1|||
33403637|NCT00508001|101369324|FG002|Overall Study|Adverse Event|4|||
33403638|NCT00508001|101369322|FG000|Overall Study|condition under investigation worsened|13|||
33403639|NCT00508001|101369323|FG001|Overall Study|condition under investigation worsened|7|||
33610856|NCT02697435|102126769|FG000|Overall Study|Physician Decision|0|||
33610857|NCT02697435|102126770|FG001|Overall Study|Physician Decision|4|||
33610858|NCT00615030|102126771|FG000|Period I|Administrative problem|0|||
33610859|NCT00615030|102126772|FG001|Period I|Administrative problem|0|||
33610860|NCT00615030|102126773|FG002|Period I|Administrative problem|0|||
33610861|NCT00615030|102126774|FG003|Period I|Administrative problem|0|||
33610862|NCT00615030|102126775|FG004|Period I|Administrative problem|1|||
33610863|NCT00615030|102126776|FG005|Period I|Administrative problem|0|||
33610864|NCT00615030|102126777|FG006|Period I|Administrative problem|0|||
33610865|NCT00615030|102126778|FG007|Period I|Administrative problem|0|||
33403640|NCT00508001|101369324|FG002|Overall Study|condition under investigation worsened|1|||
33403641|NCT00508001|101369322|FG000|Overall Study|Death|0|||
33528494|NCT02090283|101833995|FG002|Overall Study|Protocol Violation|0|||
33528495|NCT01098162|101833996|FG000|Overall Study|Adverse Event|37|||
33610866|NCT00615030|102126779|FG008|Period I|Administrative problem|0|||
33610867|NCT00615030|102126780|FG009|Period I|Administrative problem|0|||
33610868|NCT00615030|102126781|FG010|Period I|Administrative problem|0|||
33610869|NCT00615030|102126782|FG011|Period I|Administrative problem|0|||
33610870|NCT00615030|102126771|FG000|Period I|Protocol deviation|1|||
33610871|NCT00615030|102126772|FG001|Period I|Protocol deviation|0|||
33610872|NCT00615030|102126773|FG002|Period I|Protocol deviation|0|||
33610873|NCT00615030|102126774|FG003|Period I|Protocol deviation|0|||
33610874|NCT00615030|102126775|FG004|Period I|Protocol deviation|0|||
33610875|NCT00615030|102126776|FG005|Period I|Protocol deviation|0|||
33610876|NCT00615030|102126777|FG006|Period I|Protocol deviation|0|||
33610877|NCT00615030|102126778|FG007|Period I|Protocol deviation|0|||
33610878|NCT00615030|102126779|FG008|Period I|Protocol deviation|0|||
33610879|NCT00615030|102126780|FG009|Period I|Protocol deviation|0|||
33610880|NCT00615030|102126781|FG010|Period I|Protocol deviation|0|||
33610881|NCT00615030|102126782|FG011|Period I|Protocol deviation|0|||
33610882|NCT00615030|102126771|FG000|Period I|Subject withdrew consent|0|||
33610883|NCT00615030|102126772|FG001|Period I|Subject withdrew consent|0|||
33610884|NCT00615030|102126773|FG002|Period I|Subject withdrew consent|0|||
33610885|NCT00615030|102126774|FG003|Period I|Subject withdrew consent|0|||
33610886|NCT00615030|102126775|FG004|Period I|Subject withdrew consent|0|||
33610887|NCT00615030|102126776|FG005|Period I|Subject withdrew consent|0|||
33610888|NCT00615030|102126777|FG006|Period I|Subject withdrew consent|0|||
33610889|NCT00615030|102126778|FG007|Period I|Subject withdrew consent|0|||
33610890|NCT00615030|102126779|FG008|Period I|Subject withdrew consent|1|||
33204698|NCT00839072|100651366|FG001|Second Intervention Period|Withdrawal by Subject|0|||
33204699|NCT00966940|100651370|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
33334557|NCT00390546|101118184|FG001|Overall Study|Physician Decision|5|||
33403642|NCT00508001|101369323|FG001|Overall Study|Death|1|||
33528496|NCT01098162|101833996|FG000|Overall Study|Lack of Efficacy|4|||
33528497|NCT01098162|101833996|FG000|Overall Study|Wish of Patient|7|||
33528498|NCT01098162|101833996|FG000|Overall Study|Lost to Follow-up|9|||
33528499|NCT01098162|101833996|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
33528500|NCT01098162|101833996|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
33528501|NCT01098162|101833996|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
33528502|NCT01098162|101833996|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
33528503|NCT01098162|101833996|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
33528504|NCT01098162|101833996|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
33528505|NCT01098162|101833996|FG000|Overall Study|Other Reason|1|||
33528506|NCT01098162|101833996|FG000|Overall Study|Reason Unknown|26|||
33334558|NCT03368170|101118185|FG000|Overall Study|Adverse Event|2|||
33334559|NCT03368170|101118186|FG001|Overall Study|Adverse Event|1|||
33528507|NCT00765817|101833997|FG000|Overall Study|Adverse Event|13|||
33528508|NCT00765817|101833998|FG001|Overall Study|Adverse Event|1|||
33528509|NCT00765817|101833997|FG000|Overall Study|Death|0|||
33528510|NCT00765817|101833998|FG001|Overall Study|Death|1|||
33610891|NCT00615030|102126780|FG009|Period I|Subject withdrew consent|0|||
33610892|NCT00615030|102126781|FG010|Period I|Subject withdrew consent|1|||
33528511|NCT00765817|101833997|FG000|Overall Study|Entry criteria not met|2|||
33528512|NCT00765817|101833998|FG001|Overall Study|Entry criteria not met|2|||
33528513|NCT00765817|101833997|FG000|Overall Study|Loss of glucose control|0|||
33610893|NCT00615030|102126782|FG011|Period I|Subject withdrew consent|1|||
33610894|NCT00615030|102126771|FG000|Period I|Abnormal laboratory value(s)|0|||
33610895|NCT00615030|102126772|FG001|Period I|Abnormal laboratory value(s)|0|||
33610896|NCT00615030|102126773|FG002|Period I|Abnormal laboratory value(s)|0|||
33610897|NCT00615030|102126774|FG003|Period I|Abnormal laboratory value(s)|0|||
33610898|NCT00615030|102126775|FG004|Period I|Abnormal laboratory value(s)|0|||
33610899|NCT00615030|102126776|FG005|Period I|Abnormal laboratory value(s)|1|||
33610900|NCT00615030|102126777|FG006|Period I|Abnormal laboratory value(s)|0|||
33610901|NCT00615030|102126778|FG007|Period I|Abnormal laboratory value(s)|0|||
33610902|NCT00615030|102126779|FG008|Period I|Abnormal laboratory value(s)|0|||
33610903|NCT00615030|102126780|FG009|Period I|Abnormal laboratory value(s)|0|||
33610904|NCT00615030|102126781|FG010|Period I|Abnormal laboratory value(s)|0|||
33610905|NCT00615030|102126782|FG011|Period I|Abnormal laboratory value(s)|0|||
33610906|NCT00615030|102126771|FG000|Period II|Adverse Event|0|||
33610907|NCT00615030|102126772|FG001|Period II|Adverse Event|0|||
33610908|NCT00615030|102126773|FG002|Period II|Adverse Event|1|||
33610909|NCT00615030|102126774|FG003|Period II|Adverse Event|0|||
33610910|NCT00615030|102126775|FG004|Period II|Adverse Event|0|||
33610911|NCT00615030|102126776|FG005|Period II|Adverse Event|0|||
33610912|NCT00615030|102126777|FG006|Period II|Adverse Event|0|||
33610913|NCT00615030|102126778|FG007|Period II|Adverse Event|0|||
33204700|NCT00966940|100651371|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
33204701|NCT00966940|100651370|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
33204702|NCT00966940|100651371|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
33204703|NCT01248884|100651375|FG000|Overall Study|Withdrawal by Subject|1|||
33204704|NCT01248884|100651376|FG001|Overall Study|Withdrawal by Subject|3|||
33204705|NCT01248884|100651377|FG002|Overall Study|Withdrawal by Subject|1|||
33204706|NCT01248884|100651375|FG000|Overall Study|Adverse Event|1|||
33528514|NCT00765817|101833998|FG001|Overall Study|Loss of glucose control|2|||
33528515|NCT00765817|101833997|FG000|Overall Study|Lost to Follow-up|1|||
33528516|NCT00765817|101833998|FG001|Overall Study|Lost to Follow-up|3|||
33204707|NCT01248884|100651376|FG001|Overall Study|Adverse Event|0|||
33204708|NCT01248884|100651377|FG002|Overall Study|Adverse Event|0|||
33204709|NCT01127178|100651379|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
33204710|NCT01127178|100651380|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
33204711|NCT01127178|100651379|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
33204712|NCT01127178|100651380|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
33204713|NCT01127178|100651379|FG000|Dose Escalation: Treatment Phase|Other|2|||
33204714|NCT01127178|100651380|FG001|Dose Escalation: Treatment Phase|Other|0|||
33204715|NCT01127178|100651379|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
33204716|NCT01127178|100651380|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
33204717|NCT01127178|100651379|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
33204718|NCT01127178|100651380|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
33204719|NCT01127178|100651379|FG000|Dose Escalation: Extension Phase|Other|1|||
33204720|NCT01127178|100651380|FG001|Dose Escalation: Extension Phase|Other|0|||
33204721|NCT00724282|100651383|FG000|Overall Study|Withdrawal by Subject|3|||
33204722|NCT00724282|100651383|FG000|Overall Study|Physician Decision|1|||
33204723|NCT02328326|100651384|FG000|Overall Study|Withdrawal by Subject|10|||
33204724|NCT02328326|100651385|FG001|Overall Study|Withdrawal by Subject|3|||
33204725|NCT02328326|100651384|FG000|Overall Study|Death|2|||
33204726|NCT02328326|100651385|FG001|Overall Study|Death|1|||
33204727|NCT02328326|100651384|FG000|Overall Study|Lost to Follow-up|10|||
33204728|NCT02328326|100651385|FG001|Overall Study|Lost to Follow-up|4|||
33204729|NCT02246998|100651386|FG000|Overall Study|Adverse Event|0|||
33204730|NCT02246998|100651387|FG001|Overall Study|Adverse Event|1|||
33204731|NCT02246998|100651388|FG002|Overall Study|Adverse Event|1|||
33204732|NCT02246998|100651389|FG003|Overall Study|Adverse Event|0|||
33528517|NCT00765817|101833997|FG000|Overall Study|Physician Decision|2|||
33528518|NCT00765817|101833998|FG001|Overall Study|Physician Decision|1|||
33528519|NCT00765817|101833997|FG000|Overall Study|Protocol Violation|1|||
33528520|NCT00765817|101833998|FG001|Overall Study|Protocol Violation|1|||
33528521|NCT00765817|101833997|FG000|Overall Study|Subject decision|7|||
33528522|NCT00765817|101833998|FG001|Overall Study|Subject decision|11|||
33528523|NCT03746405|101833999|FG000|Overall Study|Withdrawal by Subject|3|||
33528524|NCT03746405|101834000|FG001|Overall Study|Withdrawal by Subject|0|||
33610914|NCT00615030|102126779|FG008|Period II|Adverse Event|1|||
33610915|NCT00615030|102126780|FG009|Period II|Adverse Event|0|||
33204733|NCT02246998|100651386|FG000|Overall Study|Lost to Follow-up|1|||
33204734|NCT02246998|100651387|FG001|Overall Study|Lost to Follow-up|0|||
33204735|NCT02246998|100651388|FG002|Overall Study|Lost to Follow-up|0|||
33528525|NCT03746405|101833999|FG000|Overall Study|technical difficulties|0|||
33204736|NCT02246998|100651389|FG003|Overall Study|Lost to Follow-up|1|||
33204737|NCT02246998|100651386|FG000|Overall Study|Randomized but Never Dosed|1|||
33528526|NCT03746405|101834000|FG001|Overall Study|technical difficulties|2|||
33528527|NCT00972283|101834001|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
33528528|NCT00972283|101834002|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
33610916|NCT00615030|102126781|FG010|Period II|Adverse Event|0|||
33204738|NCT02246998|100651387|FG001|Overall Study|Randomized but Never Dosed|2|||
33204739|NCT02246998|100651388|FG002|Overall Study|Randomized but Never Dosed|2|||
33610917|NCT00615030|102126782|FG011|Period II|Adverse Event|0|||
33610918|NCT00615030|102126771|FG000|Period II|Subject withdrew consent|0|||
33610919|NCT00615030|102126772|FG001|Period II|Subject withdrew consent|0|||
33610920|NCT00615030|102126773|FG002|Period II|Subject withdrew consent|0|||
33610921|NCT00615030|102126774|FG003|Period II|Subject withdrew consent|1|||
33610922|NCT00615030|102126775|FG004|Period II|Subject withdrew consent|0|||
33610923|NCT00615030|102126776|FG005|Period II|Subject withdrew consent|0|||
33610924|NCT00615030|102126777|FG006|Period II|Subject withdrew consent|1|||
33610925|NCT00615030|102126778|FG007|Period II|Subject withdrew consent|0|||
33610926|NCT00615030|102126779|FG008|Period II|Subject withdrew consent|0|||
33528529|NCT00972283|101834001|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
33528530|NCT00972283|101834002|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
33204740|NCT02246998|100651389|FG003|Overall Study|Randomized but Never Dosed|1|||
33204741|NCT03321019|100651390|FG000|Overall Study|Withdrawal by Subject|0|||
33334560|NCT03031301|101118187|FG000|Overall Study|Protocol Violation|4|||
33528531|NCT00972283|101834001|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
33528532|NCT00972283|101834002|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
33528533|NCT00972283|101834001|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
33528534|NCT00972283|101834002|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
33528535|NCT00972283|101834001|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
33528536|NCT00972283|101834002|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
33528537|NCT00972283|101834001|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
33528538|NCT00972283|101834002|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
33528539|NCT00972283|101834001|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
33610927|NCT00615030|102126780|FG009|Period II|Subject withdrew consent|0|||
33334561|NCT03031301|101118188|FG001|Overall Study|Protocol Violation|8|||
33334562|NCT03031301|101118187|FG000|Overall Study|Withdrawal by Subject|7|||
33334563|NCT03031301|101118188|FG001|Overall Study|Withdrawal by Subject|4|||
33334564|NCT03031301|101118187|FG000|Overall Study|Lost to Follow-up|4|||
33334565|NCT03031301|101118188|FG001|Overall Study|Lost to Follow-up|12|||
33334566|NCT03031301|101118187|FG000|Overall Study|Noncompliance|1|||
33334567|NCT03031301|101118188|FG001|Overall Study|Noncompliance|3|||
33334568|NCT03031301|101118187|FG000|Overall Study|Technical issue|1|||
33334569|NCT03031301|101118188|FG001|Overall Study|Technical issue|1|||
33334570|NCT03031301|101118187|FG000|Overall Study|Adverse Event|1|||
33334571|NCT03031301|101118188|FG001|Overall Study|Adverse Event|0|||
33334572|NCT04839380|101118189|FG000|Overall Study|Withdrawal by Subject|2|||
33334573|NCT04839380|101118189|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
33334574|NCT00811135|101118190|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
33334575|NCT00811135|101118190|FG000|Overall Study|Death|3|||
33334576|NCT00811135|101118190|FG000|Overall Study|Protocol Violation|2|||
33334577|NCT00811135|101118190|FG000|Overall Study|Violation of Selection Criteria|1|||
33334578|NCT00811135|101118190|FG000|Overall Study|Refused Treatment|1|||
33334579|NCT00811135|101118190|FG000|Overall Study|Withdrawal by Subject|3|||
33334580|NCT00811135|101118190|FG000|Overall Study|Administrative/Other Unspecified|11|||
33334581|NCT00811135|101118190|FG000|Overall Study|Ongoing|59|||
33334582|NCT03002155|101118191|FG000|Overall Study|Lost to Follow-up|1|||
33334583|NCT03002155|101118192|FG001|Overall Study|Lost to Follow-up|2|||
33334584|NCT03002155|101118191|FG000|Overall Study|Withdrawal by Subject|1|||
33334585|NCT03002155|101118192|FG001|Overall Study|Withdrawal by Subject|0|||
33334586|NCT03002155|101118191|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
33334587|NCT03002155|101118192|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
33334588|NCT04091087|101118196|FG000|Overall Study|Not treated|1|||
33334589|NCT04091087|101118197|FG001|Overall Study|Not treated|0|||
33334590|NCT04091087|101118196|FG000|Overall Study|Adverse Event|4|||
33334591|NCT04091087|101118197|FG001|Overall Study|Adverse Event|4|||
33528540|NCT00972283|101834002|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
33528541|NCT00972283|101834001|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
33528542|NCT00972283|101834002|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
33528543|NCT00972283|101834001|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
33610928|NCT00615030|102126781|FG010|Period II|Subject withdrew consent|0|||
33610929|NCT00615030|102126782|FG011|Period II|Subject withdrew consent|0|||
33610930|NCT00615030|102126771|FG000|Period III|Administrative problems|1|||
33610931|NCT00615030|102126772|FG001|Period III|Administrative problems|0|||
33610932|NCT00615030|102126773|FG002|Period III|Administrative problems|0|||
33610933|NCT00615030|102126774|FG003|Period III|Administrative problems|1|||
33610934|NCT00615030|102126775|FG004|Period III|Administrative problems|0|||
33610935|NCT00615030|102126776|FG005|Period III|Administrative problems|0|||
33610936|NCT00615030|102126777|FG006|Period III|Administrative problems|0|||
33610937|NCT00615030|102126778|FG007|Period III|Administrative problems|0|||
33610938|NCT00615030|102126779|FG008|Period III|Administrative problems|0|||
33204742|NCT03321019|100651391|FG001|Overall Study|Withdrawal by Subject|6|||
33334592|NCT04091087|101118196|FG000|Overall Study|Protocol Violation|0|||
33610939|NCT00615030|102126780|FG009|Period III|Administrative problems|0|||
33610940|NCT00615030|102126781|FG010|Period III|Administrative problems|0|||
33334593|NCT04091087|101118197|FG001|Overall Study|Protocol Violation|1|||
33334594|NCT04091087|101118196|FG000|Overall Study|Withdrawal by Subject|5|||
33610941|NCT00615030|102126782|FG011|Period III|Administrative problems|0|||
33610942|NCT03043651|102126783|FG000|Overall Study|Death|1|||
33610943|NCT03043651|102126783|FG000|Overall Study|Progressive Disease|2|||
33610944|NCT03043651|102126783|FG000|Overall Study|Adverse Event|2|||
33610945|NCT03043651|102126783|FG000|Overall Study|Withdrawal by Subject|4|||
33528544|NCT00972283|101834002|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
33528545|NCT00972283|101834001|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
33528546|NCT00972283|101834002|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
33528547|NCT01535443|101834003|FG000|Overall Study|Physician Decision|3|||
33610946|NCT03043651|102126783|FG000|Overall Study|Study Terminated by Sponsor|39|||
33610947|NCT03052049|102126786|FG000|Overall Study|Withdrawal by Subject|2|||
33610948|NCT00320424|102126789|FG000|Overall Study|Adverse Event|3|||
33528548|NCT02748057|101834004|FG000|Overall Study|Adverse Event|1|||
33528549|NCT02748057|101834005|FG001|Overall Study|Adverse Event|0|||
33528550|NCT02748057|101834004|FG000|Overall Study|Physician Decision|0|||
33528551|NCT02748057|101834005|FG001|Overall Study|Physician Decision|1|||
33528552|NCT02748057|101834004|FG000|Overall Study|Protocol Violation|2|||
33528553|NCT02748057|101834005|FG001|Overall Study|Protocol Violation|1|||
33528554|NCT02748057|101834004|FG000|Overall Study|Participant Moved|1|||
33528555|NCT02748057|101834005|FG001|Overall Study|Participant Moved|0|||
33528556|NCT02748057|101834004|FG000|Overall Study|Withdrawal by Subject|1|||
33528557|NCT02748057|101834005|FG001|Overall Study|Withdrawal by Subject|0|||
33528558|NCT01190189|101834013|FG000|Overall Study|Lost to Follow-up|4|||
33528559|NCT01190189|101834013|FG000|Overall Study|Withdrawal by Subject|1|||
33528560|NCT01190189|101834013|FG000|Overall Study|Migrated/moved from study area|1|||
33528561|NCT02384538|101834015|FG000|Overall Study|Adverse Event|1|||
33528562|NCT02384538|101834016|FG001|Overall Study|Adverse Event|4|||
33528563|NCT02384538|101834015|FG000|Overall Study|Lack of Efficacy|4|||
33528564|NCT02384538|101834016|FG001|Overall Study|Lack of Efficacy|4|||
33528565|NCT02384538|101834015|FG000|Overall Study|Withdrew Consent|0|||
33528566|NCT02384538|101834016|FG001|Overall Study|Withdrew Consent|4|||
33528567|NCT02384538|101834015|FG000|Overall Study|Other|1|||
33528568|NCT02384538|101834016|FG001|Overall Study|Other|3|||
33528569|NCT04877990|101834022|FG000|Treatment|Other reasons|3|||
33528570|NCT04877990|101834023|FG001|Treatment|Other reasons|1|||
33528571|NCT04877990|101834022|FG000|Treatment|Administrative reasons by sponsor|17|||
33528572|NCT04877990|101834023|FG001|Treatment|Administrative reasons by sponsor|33|||
33528573|NCT04877990|101834022|FG000|Treatment|Withdrawal by Subject|2|||
33528574|NCT04877990|101834023|FG001|Treatment|Withdrawal by Subject|6|||
33528575|NCT04877990|101834022|FG000|Treatment|Adverse Event|2|||
33528576|NCT04877990|101834023|FG001|Treatment|Adverse Event|1|||
33528577|NCT05225389|101834024|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
33528578|NCT04727528|101834027|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
33528579|NCT04727528|101834028|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
33528580|NCT04727528|101834027|FG000|Open-label Period|Randomized who did not receive treatment|1|||
33528581|NCT04727528|101834028|FG001|Open-label Period|Randomized who did not receive treatment|0|||
33528582|NCT04727528|101834027|FG000|Double-blind Treatment Phase|Adverse Event|0|||
33528583|NCT04727528|101834028|FG001|Double-blind Treatment Phase|Adverse Event|1|||
33528584|NCT04727528|101834027|FG000|Double-blind Treatment Phase|Death|0|||
33528585|NCT04727528|101834028|FG001|Double-blind Treatment Phase|Death|1|||
33528586|NCT04727528|101834027|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
33528587|NCT04727528|101834028|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
33528588|NCT04727528|101834027|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
33528589|NCT04727528|101834028|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
33528590|NCT04727528|101834027|FG000|Double-blind Treatment Phase|Physician Decision|0|||
33528591|NCT04727528|101834028|FG001|Double-blind Treatment Phase|Physician Decision|1|||
33528592|NCT04727528|101834027|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
33528593|NCT04727528|101834028|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33528594|NCT04058028|101834029|FG000|Overall Study|Withdrawal of Consent from Study|12|||
33528595|NCT04058028|101834030|FG001|Overall Study|Withdrawal of Consent from Study|8|||
33610949|NCT00320424|102126789|FG000|Overall Study|Other|3|||
33610950|NCT01805037|102126792|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
33334595|NCT04091087|101118197|FG001|Overall Study|Withdrawal by Subject|2|||
33610951|NCT01805037|102126793|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
33334596|NCT02970292|101118202|FG000|Overall Study|Physician Decision|1|||
33334597|NCT02970292|101118203|FG001|Overall Study|Physician Decision|1|||
33334598|NCT02970292|101118202|FG000|Overall Study|Withdrawal by Subject|11|||
33334599|NCT02970292|101118203|FG001|Overall Study|Withdrawal by Subject|5|||
33403643|NCT00508001|101369324|FG002|Overall Study|Death|1|||
33528596|NCT04058028|101834031|FG002|Overall Study|Withdrawal of Consent from Study|6|||
33528597|NCT04058028|101834032|FG003|Overall Study|Withdrawal of Consent from Study|7|||
33528598|NCT04058028|101834029|FG000|Overall Study|Decision by Sponsor|13|||
33403644|NCT00508001|101369322|FG000|Overall Study|Withdrawal by Subject|4|||
33403645|NCT00508001|101369323|FG001|Overall Study|Withdrawal by Subject|4|||
33403646|NCT00508001|101369324|FG002|Overall Study|Withdrawal by Subject|1|||
33403647|NCT00461552|101369325|FG000|Overall Study|Drug Dispensing error|0|||
33403648|NCT00461552|101369326|FG001|Overall Study|Drug Dispensing error|2|||
33403649|NCT02561572|101369333|FG000|Overall Study|Inadequate time before surgery|2|||
33403650|NCT02561572|101369334|FG001|Overall Study|Inadequate time before surgery|1|||
33403651|NCT02561572|101369333|FG000|Overall Study|Protocol Violation|0|||
33403652|NCT02561572|101369334|FG001|Overall Study|Protocol Violation|1|||
33403653|NCT00931515|101369339|FG000|Overall Study|Lost to Follow-up|2|||
33403654|NCT00931515|101369340|FG001|Overall Study|Lost to Follow-up|5|||
33403655|NCT00408408|101369341|FG000|Overall Study|No follow up data|2|||
33403656|NCT00408408|101369342|FG001|Overall Study|No follow up data|3|||
33403657|NCT00408408|101369343|FG002|Overall Study|No follow up data|0|||
33403658|NCT00408408|101369344|FG003|Overall Study|No follow up data|7|||
33403659|NCT00408408|101369345|FG004|Overall Study|No follow up data|5|||
33403660|NCT00408408|101369346|FG005|Overall Study|No follow up data|3|||
33403661|NCT00765726|101369347|FG000|Overall Study|Withdrawal by Subject|1|||
33403662|NCT00765726|101369347|FG000|Overall Study|Discontinuation of study by sponsor|8|||
33403663|NCT00348686|101369348|FG000|Overall Study|Withdrawal by Subject|45|||
33403664|NCT00348686|101369348|FG000|Overall Study|Adverse Event|5|||
33403665|NCT00348686|101369348|FG000|Overall Study|Protocol Violation|6|||
33403666|NCT00348686|101369348|FG000|Overall Study|Lost to Follow-up|2|||
33403667|NCT00348686|101369348|FG000|Overall Study|Multiple Reasons|8|||
33403668|NCT01038609|101369353|FG000|Overall Study|Adverse Event|0|||
33403669|NCT01038609|101369354|FG001|Overall Study|Adverse Event|0|||
33403670|NCT01038609|101369355|FG002|Overall Study|Adverse Event|1|||
33403671|NCT01038609|101369356|FG003|Overall Study|Adverse Event|0|||
33403672|NCT01038609|101369357|FG004|Overall Study|Adverse Event|0|||
33403673|NCT01038609|101369353|FG000|Overall Study|Dosing Error|0|||
33403674|NCT01038609|101369354|FG001|Overall Study|Dosing Error|0|||
33403675|NCT01038609|101369355|FG002|Overall Study|Dosing Error|0|||
33403676|NCT01038609|101369356|FG003|Overall Study|Dosing Error|1|||
33204743|NCT03321019|100651390|FG000|Overall Study|Lost to Follow-up|0|||
33204744|NCT03321019|100651391|FG001|Overall Study|Lost to Follow-up|22|||
33403677|NCT01038609|101369357|FG004|Overall Study|Dosing Error|1|||
33403678|NCT01038609|101369353|FG000|Overall Study|Death in the Family|1|||
33403679|NCT01038609|101369354|FG001|Overall Study|Death in the Family|0|||
33403680|NCT01038609|101369355|FG002|Overall Study|Death in the Family|0|||
33403681|NCT01038609|101369356|FG003|Overall Study|Death in the Family|0|||
33403682|NCT01038609|101369357|FG004|Overall Study|Death in the Family|0|||
33403683|NCT01038609|101369353|FG000|Overall Study|Refusal of Blood Draws|0|||
33403684|NCT01038609|101369354|FG001|Overall Study|Refusal of Blood Draws|1|||
33403685|NCT01038609|101369355|FG002|Overall Study|Refusal of Blood Draws|0|||
33528599|NCT04058028|101834030|FG001|Overall Study|Decision by Sponsor|4|||
33528600|NCT04058028|101834031|FG002|Overall Study|Decision by Sponsor|1|||
33528601|NCT04058028|101834032|FG003|Overall Study|Decision by Sponsor|35|||
33528602|NCT04058028|101834029|FG000|Overall Study|Lost to Follow-up|1|||
33528603|NCT04058028|101834030|FG001|Overall Study|Lost to Follow-up|1|||
33528604|NCT04058028|101834031|FG002|Overall Study|Lost to Follow-up|1|||
33528605|NCT04058028|101834032|FG003|Overall Study|Lost to Follow-up|0|||
33528606|NCT04058028|101834029|FG000|Overall Study|Death|0|||
33528607|NCT04058028|101834030|FG001|Overall Study|Death|1|||
33528608|NCT04058028|101834031|FG002|Overall Study|Death|0|||
33528609|NCT04058028|101834032|FG003|Overall Study|Death|0|||
33528610|NCT00940888|101834033|FG000|Overall Study|Unsuccessful Implant|4|||
33528611|NCT00940888|101834033|FG000|Overall Study|Death|461|||
33528612|NCT00940888|101834033|FG000|Overall Study|Withdrawn - Non-Death|364|||
33528613|NCT00940888|101834033|FG000|Overall Study|Lost to Follow-up|6|||
33528614|NCT02964338|101834038|FG000|Overall Study|Sponsor terminated study for futility|12|||
33528615|NCT02964338|101834039|FG001|Overall Study|Sponsor terminated study for futility|15|||
33528616|NCT02964338|101834040|FG002|Overall Study|Sponsor terminated study for futility|14|||
33528617|NCT02964338|101834038|FG000|Overall Study|Lack of Efficacy|0|||
33204745|NCT01159938|100651392|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
33403686|NCT01038609|101369356|FG003|Overall Study|Refusal of Blood Draws|0|||
33403687|NCT01038609|101369357|FG004|Overall Study|Refusal of Blood Draws|0|||
33403688|NCT00635804|101369358|FG000|Overall Study|Adverse Event|0|||
33528618|NCT02964338|101834039|FG001|Overall Study|Lack of Efficacy|3|||
33528619|NCT02964338|101834040|FG002|Overall Study|Lack of Efficacy|0|||
33528620|NCT02964338|101834038|FG000|Overall Study|Lost to Follow-up|1|||
33403689|NCT00635804|101369359|FG001|Overall Study|Adverse Event|0|||
33403690|NCT00635804|101369360|FG002|Overall Study|Adverse Event|0|||
33528621|NCT02964338|101834039|FG001|Overall Study|Lost to Follow-up|0|||
33528622|NCT02964338|101834040|FG002|Overall Study|Lost to Follow-up|3|||
33403691|NCT00635804|101369361|FG003|Overall Study|Adverse Event|0|||
33403692|NCT00635804|101369362|FG004|Overall Study|Adverse Event|0|||
33403693|NCT00635804|101369363|FG005|Overall Study|Adverse Event|1|||
33610952|NCT01805037|102126792|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
33610953|NCT01805037|102126793|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
33610954|NCT01805037|102126792|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
33610955|NCT01805037|102126793|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
33610956|NCT01805037|102126792|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
33610957|NCT01805037|102126793|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
33610958|NCT01805037|102126792|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
33610959|NCT01805037|102126793|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
33610960|NCT01805037|102126792|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
33610961|NCT01805037|102126793|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
33334600|NCT02970292|101118202|FG000|Overall Study|Noncompliance with study drug|2|||
33334601|NCT02970292|101118203|FG001|Overall Study|Noncompliance with study drug|2|||
33334602|NCT02970292|101118202|FG000|Overall Study|Adverse Event|5|||
33334603|NCT02970292|101118203|FG001|Overall Study|Adverse Event|0|||
33528623|NCT02964338|101834038|FG000|Overall Study|Protocol Violation|0|||
33528624|NCT02964338|101834039|FG001|Overall Study|Protocol Violation|1|||
33528625|NCT02964338|101834040|FG002|Overall Study|Protocol Violation|0|||
33528626|NCT02964338|101834038|FG000|Overall Study|Withdrawal by Subject|1|||
33528627|NCT02964338|101834039|FG001|Overall Study|Withdrawal by Subject|3|||
33528628|NCT02964338|101834040|FG002|Overall Study|Withdrawal by Subject|1|||
33528629|NCT02964338|101834038|FG000|Overall Study|Adverse Event|2|||
33528630|NCT02964338|101834039|FG001|Overall Study|Adverse Event|1|||
33528631|NCT02964338|101834040|FG002|Overall Study|Adverse Event|1|||
33528632|NCT02964338|101834038|FG000|Overall Study|Non-compliant with e-diary|0|||
33528633|NCT02964338|101834039|FG001|Overall Study|Non-compliant with e-diary|1|||
33528634|NCT02964338|101834040|FG002|Overall Study|Non-compliant with e-diary|0|||
33528635|NCT02964338|101834038|FG000|Overall Study|Did not meet criteria|1|||
33528636|NCT02964338|101834039|FG001|Overall Study|Did not meet criteria|0|||
33528637|NCT02964338|101834040|FG002|Overall Study|Did not meet criteria|0|||
33528638|NCT01844817|101834041|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
33528639|NCT01844817|101834042|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
33528640|NCT01844817|101834041|FG000|Treatment|Progressive Disease|27|||
33528641|NCT01844817|101834042|FG001|Treatment|Progressive Disease|36|||
33528642|NCT01844817|101834041|FG000|Treatment|Adverse Event|17|||
33528643|NCT01844817|101834042|FG001|Treatment|Adverse Event|9|||
33528644|NCT01844817|101834041|FG000|Treatment|Withdrawal by Subject|10|||
33528645|NCT01844817|101834042|FG001|Treatment|Withdrawal by Subject|6|||
33528646|NCT01844817|101834041|FG000|Treatment|Death|10|||
33528647|NCT01844817|101834042|FG001|Treatment|Death|8|||
33528648|NCT01844817|101834041|FG000|Treatment|Lost to Follow-up|0|||
33528649|NCT01844817|101834042|FG001|Treatment|Lost to Follow-up|1|||
33528650|NCT01844817|101834041|FG000|Treatment|Other|0|||
33528651|NCT01844817|101834042|FG001|Treatment|Other|3|||
33528652|NCT01467271|101834045|FG000|Overall Study|Death|84|||
33528653|NCT01467271|101834045|FG000|Overall Study|Lost to Follow-up|83|||
33528654|NCT01467271|101834045|FG000|Overall Study|Retraction of patient's consent|21|||
33528655|NCT01467271|101834045|FG000|Overall Study|Other reason|14|||
33610962|NCT01805037|102126792|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
33334604|NCT02970292|101118202|FG000|Overall Study|Lack of Efficacy|1|||
33334605|NCT02970292|101118203|FG001|Overall Study|Lack of Efficacy|0|||
33334606|NCT02970292|101118202|FG000|Overall Study|Lost to Follow-up|1|||
33334607|NCT02970292|101118203|FG001|Overall Study|Lost to Follow-up|0|||
33334608|NCT02970292|101118202|FG000|Overall Study|Protocol Violation|2|||
33334609|NCT02970292|101118203|FG001|Overall Study|Protocol Violation|0|||
33334610|NCT02970292|101118202|FG000|Overall Study|Other|1|||
33334611|NCT02970292|101118203|FG001|Overall Study|Other|0|||
33334612|NCT02500121|101118204|FG000|Overall Study|Lost to Follow-up|0|||
33334613|NCT02500121|101118205|FG001|Overall Study|Lost to Follow-up|1|||
33334614|NCT02500121|101118204|FG000|Overall Study|Withdrawal by Subject|1|||
33334615|NCT02500121|101118205|FG001|Overall Study|Withdrawal by Subject|1|||
33334616|NCT02500121|101118204|FG000|Overall Study|Death|26|||
33334617|NCT02500121|101118205|FG001|Overall Study|Death|24|||
33334618|NCT01452152|101118206|FG000|Overall Study|Study termination by sponsor|5|||
33528656|NCT02499120|101834050|FG000|Overall Study|Death|52|||
33528657|NCT02499120|101834051|FG001|Overall Study|Death|43|||
33528658|NCT02499120|101834050|FG000|Overall Study|Lost to Follow-up|1|||
33528659|NCT02499120|101834051|FG001|Overall Study|Lost to Follow-up|2|||
33334619|NCT01452152|101118207|FG001|Overall Study|Study termination by sponsor|0|||
33334620|NCT01452152|101118208|FG002|Overall Study|Study termination by sponsor|4|||
33334621|NCT00522431|101118210|FG000|Overall Study|Adverse Event|5|||
33334622|NCT00522431|101118210|FG000|Overall Study|Protocol Violation|2|||
33334623|NCT00522431|101118210|FG000|Overall Study|Withdrawal by Subject|2|||
33528660|NCT02499120|101834050|FG000|Overall Study|Participant refused further follow-up|1|||
33528661|NCT02499120|101834051|FG001|Overall Study|Participant refused further follow-up|0|||
33528662|NCT02499120|101834050|FG000|Overall Study|Withdrawal by Subject|2|||
33528663|NCT02499120|101834051|FG001|Overall Study|Withdrawal by Subject|5|||
33528664|NCT02499120|101834050|FG000|Overall Study|Other|9|||
33528665|NCT02499120|101834051|FG001|Overall Study|Other|10|||
33334624|NCT00522431|101118210|FG000|Overall Study|Subject non-compliance|1|||
33334625|NCT00522431|101118210|FG000|Overall Study|Other/unknown|1|||
33334626|NCT01437397|101118215|FG000|Overall Study|Lost to Follow-up|9|||
33334627|NCT01437397|101118216|FG001|Overall Study|Lost to Follow-up|4|||
33334628|NCT01437397|101118217|FG002|Overall Study|Lost to Follow-up|2|||
33334629|NCT01437397|101118218|FG003|Overall Study|Lost to Follow-up|4|||
33334630|NCT01437397|101118219|FG004|Overall Study|Lost to Follow-up|5|||
33334631|NCT01437397|101118215|FG000|Overall Study|Withdrawal by Subject|11|||
33528666|NCT03214679|101834055|FG000|Overall Study|Lost to Follow-up|12|||
33528667|NCT03214679|101834056|FG001|Overall Study|Lost to Follow-up|14|||
33528668|NCT03214679|101834055|FG000|Overall Study|not eligible|2|||
33528669|NCT03214679|101834056|FG001|Overall Study|not eligible|0|||
33528670|NCT00905632|101834057|FG000|Overall Study|Adverse Event|0|||
33528671|NCT00905632|101834058|FG001|Overall Study|Adverse Event|0|||
33528672|NCT00905632|101834059|FG002|Overall Study|Adverse Event|0|||
33528673|NCT00905632|101834060|FG003|Overall Study|Adverse Event|0|||
33528674|NCT00905632|101834061|FG004|Overall Study|Adverse Event|0|||
33528675|NCT00905632|101834062|FG005|Overall Study|Adverse Event|1|||
33528676|NCT00905632|101834063|FG006|Overall Study|Adverse Event|4|||
33528677|NCT05359952|101834064|FG000|Overall Study|Lost to Follow-up|1|||
33528678|NCT05359952|101834065|FG001|Overall Study|Lost to Follow-up|0|||
33528679|NCT02840474|101834066|FG000|Overall Study|Lost to Follow-up|1|||
33528680|NCT02840474|101834067|FG001|Overall Study|Lost to Follow-up|0|||
33528681|NCT01909973|101834070|FG000|Overall Study|Lost to Follow-up|1|||
33528682|NCT01909973|101834071|FG001|Overall Study|Lost to Follow-up|0|||
33528683|NCT02232061|101834076|FG000|Overall Study|Administrative problems|1|||
33528684|NCT02232061|101834076|FG000|Overall Study|Withdrawal by Subject|1|||
33610963|NCT01805037|102126793|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
33610964|NCT01805037|102126792|FG000|Follow Up (up to 3 Years)|Death|0|||
33610965|NCT01805037|102126793|FG001|Follow Up (up to 3 Years)|Death|2|||
33610966|NCT01805037|102126792|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
33610967|NCT01805037|102126793|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
33610968|NCT01805037|102126792|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
33610969|NCT01805037|102126793|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
33610970|NCT00999518|102126794|FG000|Overall Study|Adverse Event|1|||
33610971|NCT00999518|102126795|FG001|Overall Study|Adverse Event|6|||
33610972|NCT00999518|102126796|FG002|Overall Study|Adverse Event|3|||
33610973|NCT00999518|102126797|FG003|Overall Study|Adverse Event|1|||
33610974|NCT00999518|102126798|FG004|Overall Study|Adverse Event|2|||
33610975|NCT00999518|102126794|FG000|Overall Study|Lack of Efficacy|2|||
33610976|NCT00999518|102126795|FG001|Overall Study|Lack of Efficacy|0|||
33610977|NCT00999518|102126796|FG002|Overall Study|Lack of Efficacy|0|||
33610978|NCT00999518|102126797|FG003|Overall Study|Lack of Efficacy|2|||
33610979|NCT00999518|102126798|FG004|Overall Study|Lack of Efficacy|2|||
33610980|NCT00999518|102126794|FG000|Overall Study|Lost to Follow-up|0|||
33610981|NCT00999518|102126795|FG001|Overall Study|Lost to Follow-up|0|||
33610982|NCT00999518|102126796|FG002|Overall Study|Lost to Follow-up|0|||
33610983|NCT00999518|102126797|FG003|Overall Study|Lost to Follow-up|4|||
33610984|NCT00999518|102126798|FG004|Overall Study|Lost to Follow-up|1|||
33610985|NCT00999518|102126794|FG000|Overall Study|Did not meet entrance criteria|0|||
33610986|NCT00999518|102126795|FG001|Overall Study|Did not meet entrance criteria|0|||
33610987|NCT00999518|102126796|FG002|Overall Study|Did not meet entrance criteria|0|||
33610988|NCT00999518|102126797|FG003|Overall Study|Did not meet entrance criteria|0|||
33610989|NCT00999518|102126798|FG004|Overall Study|Did not meet entrance criteria|1|||
33610990|NCT00999518|102126794|FG000|Overall Study|Study terminated by sponsor|10|||
33610991|NCT00999518|102126795|FG001|Overall Study|Study terminated by sponsor|6|||
33610992|NCT00999518|102126796|FG002|Overall Study|Study terminated by sponsor|5|||
33610993|NCT00999518|102126797|FG003|Overall Study|Study terminated by sponsor|5|||
33610994|NCT00999518|102126798|FG004|Overall Study|Study terminated by sponsor|9|||
33610995|NCT00999518|102126794|FG000|Overall Study|Pregnancy|0|||
33610996|NCT00999518|102126795|FG001|Overall Study|Pregnancy|0|||
33610997|NCT00999518|102126796|FG002|Overall Study|Pregnancy|1|||
33610998|NCT00999518|102126797|FG003|Overall Study|Pregnancy|0|||
33334632|NCT01437397|101118216|FG001|Overall Study|Withdrawal by Subject|12|||
33528685|NCT03052920|101834078|FG000|Overall Study|Withdrawal by Subject|1|||
33528686|NCT03077607|101834079|FG000|Period 1 (15 Days)|Adverse Event|1|||
33610999|NCT00999518|102126798|FG004|Overall Study|Pregnancy|0|||
33611000|NCT00999518|102126794|FG000|Overall Study|Protocol Violation|0|||
33611001|NCT00999518|102126795|FG001|Overall Study|Protocol Violation|1|||
33528687|NCT03077607|101834080|FG001|Period 1 (15 Days)|Adverse Event|0|||
33528688|NCT03077607|101834079|FG000|Period 1 (15 Days)|Death|1|||
33611002|NCT00999518|102126796|FG002|Overall Study|Protocol Violation|0|||
33528689|NCT03077607|101834080|FG001|Period 1 (15 Days)|Death|0|||
33611003|NCT00999518|102126797|FG003|Overall Study|Protocol Violation|0|||
33334633|NCT01437397|101118217|FG002|Overall Study|Withdrawal by Subject|24|||
33528690|NCT03077607|101834079|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
33528691|NCT03077607|101834080|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
33611004|NCT00999518|102126798|FG004|Overall Study|Protocol Violation|2|||
33611005|NCT00999518|102126794|FG000|Overall Study|Withdrawal by Subject|5|||
33334634|NCT01437397|101118218|FG003|Overall Study|Withdrawal by Subject|11|||
33334635|NCT01437397|101118219|FG004|Overall Study|Withdrawal by Subject|22|||
33334636|NCT01437397|101118215|FG000|Overall Study|Protocol Violation|10|||
33334637|NCT01437397|101118216|FG001|Overall Study|Protocol Violation|12|||
33334638|NCT01437397|101118217|FG002|Overall Study|Protocol Violation|13|||
33334639|NCT01437397|101118218|FG003|Overall Study|Protocol Violation|21|||
33334640|NCT01437397|101118219|FG004|Overall Study|Protocol Violation|19|||
33334641|NCT01437397|101118215|FG000|Overall Study|Lack of Efficacy|5|||
33334642|NCT01437397|101118216|FG001|Overall Study|Lack of Efficacy|4|||
33334643|NCT01437397|101118217|FG002|Overall Study|Lack of Efficacy|8|||
33334644|NCT01437397|101118218|FG003|Overall Study|Lack of Efficacy|10|||
33334645|NCT01437397|101118219|FG004|Overall Study|Lack of Efficacy|20|||
33334646|NCT01437397|101118215|FG000|Overall Study|Adverse Event|21|||
33334647|NCT01437397|101118216|FG001|Overall Study|Adverse Event|22|||
33334648|NCT01437397|101118217|FG002|Overall Study|Adverse Event|16|||
33334649|NCT01437397|101118218|FG003|Overall Study|Adverse Event|14|||
33334650|NCT01437397|101118219|FG004|Overall Study|Adverse Event|21|||
33334651|NCT01437397|101118215|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
33334652|NCT01437397|101118216|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
33334653|NCT01437397|101118217|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
33334654|NCT01437397|101118218|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
33528692|NCT03077607|101834079|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
33528693|NCT03077607|101834080|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
33528694|NCT01133704|101834081|FG000|Overall Study|Death|44|||
33528695|NCT01133704|101834082|FG001|Overall Study|Death|26|||
33528696|NCT01133704|101834081|FG000|Overall Study|Patient refused to continue|4|||
33528697|NCT01133704|101834082|FG001|Overall Study|Patient refused to continue|0|||
33528698|NCT01133704|101834081|FG000|Overall Study|Study Closure|1|||
33528699|NCT01133704|101834082|FG001|Overall Study|Study Closure|0|||
33528700|NCT05227118|101834083|FG000|Overall Study|Adverse Event|0|||
33528701|NCT05227118|101834084|FG001|Overall Study|Adverse Event|0|||
33528702|NCT05227118|101834085|FG002|Overall Study|Adverse Event|1|||
33528703|NCT05227118|101834086|FG003|Overall Study|Adverse Event|0|||
33528704|NCT05227118|101834083|FG000|Overall Study|Withdrawal by Subject|0|||
33528705|NCT05227118|101834084|FG001|Overall Study|Withdrawal by Subject|0|||
33528706|NCT05227118|101834085|FG002|Overall Study|Withdrawal by Subject|2|||
33528707|NCT05227118|101834086|FG003|Overall Study|Withdrawal by Subject|0|||
33528708|NCT04668209|101834087|FG000|Overall Study|Withdrawal by Subject|2|||
33528709|NCT04668209|101834088|FG001|Overall Study|Withdrawal by Subject|2|||
33611006|NCT00999518|102126795|FG001|Overall Study|Withdrawal by Subject|4|||
33611007|NCT00999518|102126796|FG002|Overall Study|Withdrawal by Subject|10|||
33611008|NCT00999518|102126797|FG003|Overall Study|Withdrawal by Subject|6|||
33611009|NCT00999518|102126798|FG004|Overall Study|Withdrawal by Subject|1|||
33611010|NCT00999518|102126794|FG000|Overall Study|Other|5|||
33611011|NCT00999518|102126795|FG001|Overall Study|Other|7|||
33611012|NCT00999518|102126796|FG002|Overall Study|Other|1|||
33611013|NCT00999518|102126797|FG003|Overall Study|Other|4|||
33611014|NCT00999518|102126798|FG004|Overall Study|Other|5|||
33611015|NCT00999518|102126794|FG000|Overall Study|Randomized but not Treated|1|||
33611016|NCT00999518|102126795|FG001|Overall Study|Randomized but not Treated|1|||
33611017|NCT00999518|102126796|FG002|Overall Study|Randomized but not Treated|2|||
33611018|NCT00999518|102126797|FG003|Overall Study|Randomized but not Treated|0|||
33611019|NCT00999518|102126798|FG004|Overall Study|Randomized but not Treated|1|||
33611020|NCT02283788|102126800|FG000|Overall Study|Adverse Event|1|||
33611021|NCT02283788|102126801|FG001|Overall Study|Adverse Event|3|||
33611022|NCT02283788|102126802|FG002|Overall Study|Adverse Event|5|||
33611023|NCT02283788|102126803|FG003|Overall Study|Adverse Event|1|||
33611024|NCT02283788|102126800|FG000|Overall Study|Withdrawal by Subject|0|||
33611025|NCT02283788|102126801|FG001|Overall Study|Withdrawal by Subject|1|||
33611026|NCT02283788|102126802|FG002|Overall Study|Withdrawal by Subject|0|||
33611027|NCT02283788|102126803|FG003|Overall Study|Withdrawal by Subject|1|||
33611028|NCT00924443|102126804|FG000|Overall Study|Physician Decision|2|||
33611029|NCT00924443|102126804|FG000|Overall Study|Protocol Violation|1|||
33611030|NCT02690649|102126805|FG000|Overall Study|Withdrawal by Subject|1|||
33334655|NCT01437397|101118219|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
33334656|NCT00385255|101118222|FG000|Overall Study|Serious Adverse Event|1|||
33334657|NCT00385255|101118223|FG001|Overall Study|Serious Adverse Event|2|||
33334658|NCT00385255|101118222|FG000|Overall Study|Protocol Violation|0|||
33334659|NCT00385255|101118223|FG001|Overall Study|Protocol Violation|4|||
33334660|NCT00385255|101118222|FG000|Overall Study|Withdrawal by Subject|0|||
33528710|NCT04668209|101834087|FG000|Overall Study|Lost to Follow-up|3|||
33611031|NCT02690649|102126806|FG001|Overall Study|Withdrawal by Subject|1|||
33528711|NCT04668209|101834088|FG001|Overall Study|Lost to Follow-up|4|||
33528712|NCT04668209|101834087|FG000|Overall Study|Subject Expired|2|||
33611032|NCT02690649|102126805|FG000|Overall Study|Protocol Violation|0|||
33611033|NCT02690649|102126806|FG001|Overall Study|Protocol Violation|3|||
33611034|NCT04856904|102126807|FG000|Overall Study|Physician Decision|1|||
33334661|NCT00385255|101118223|FG001|Overall Study|Withdrawal by Subject|8|||
33334662|NCT00385255|101118222|FG000|Overall Study|Migrated/moved from study area|0|||
33334663|NCT00385255|101118223|FG001|Overall Study|Migrated/moved from study area|1|||
33334664|NCT00385255|101118222|FG000|Overall Study|Lost to Follow-up|20|||
33334665|NCT00385255|101118223|FG001|Overall Study|Lost to Follow-up|58|||
33403694|NCT00635804|101369364|FG006|Overall Study|Adverse Event|0|||
33334666|NCT03652662|101118225|FG000|Overall Study|Withdrawal by Subject|2|||
33334667|NCT03652662|101118226|FG001|Overall Study|Withdrawal by Subject|1|||
33334668|NCT03652662|101118225|FG000|Overall Study|Lost to Follow-up|1|||
33334669|NCT03652662|101118226|FG001|Overall Study|Lost to Follow-up|0|||
33334670|NCT00993928|101118227|FG000|Overall Study|Withdrawal by Subject|4|||
33334671|NCT00993928|101118228|FG001|Overall Study|Withdrawal by Subject|7|||
33334672|NCT00993928|101118227|FG000|Overall Study|ineligible|1|||
33334673|NCT00993928|101118228|FG001|Overall Study|ineligible|0|||
33334674|NCT00004259|101118230|FG000|Overall Study|Protocol Violation|1|||
33334675|NCT00004259|101118231|FG001|Overall Study|Protocol Violation|2|||
33334676|NCT00004259|101118232|FG002|Overall Study|Protocol Violation|0|||
33334677|NCT00004259|101118233|FG003|Overall Study|Protocol Violation|0|||
33403695|NCT00635804|101369365|FG007|Overall Study|Adverse Event|0|||
33403696|NCT00635804|101369358|FG000|Overall Study|Withdrawal by Subject|1|||
33403697|NCT00635804|101369359|FG001|Overall Study|Withdrawal by Subject|0|||
33403698|NCT00635804|101369360|FG002|Overall Study|Withdrawal by Subject|0|||
33403699|NCT00635804|101369361|FG003|Overall Study|Withdrawal by Subject|0|||
33403700|NCT00635804|101369362|FG004|Overall Study|Withdrawal by Subject|0|||
33403701|NCT00635804|101369363|FG005|Overall Study|Withdrawal by Subject|0|||
33403702|NCT00635804|101369364|FG006|Overall Study|Withdrawal by Subject|0|||
33403703|NCT00635804|101369365|FG007|Overall Study|Withdrawal by Subject|0|||
33403704|NCT01066819|101369366|FG000|Overall Study|Adverse Event|18|||
33403705|NCT01066819|101369367|FG001|Overall Study|Adverse Event|1|||
33403706|NCT01066819|101369368|FG002|Overall Study|Adverse Event|6|||
33528713|NCT04668209|101834088|FG001|Overall Study|Subject Expired|0|||
33528714|NCT04668209|101834087|FG000|Overall Study|Withdrawn from study|0|||
33528715|NCT04668209|101834088|FG001|Overall Study|Withdrawn from study|1|||
33528716|NCT04668209|101834087|FG000|Overall Study|Adverse Event|0|||
33528717|NCT04668209|101834088|FG001|Overall Study|Adverse Event|1|||
33528718|NCT02716779|101834092|FG000|Monotherapy|Adverse Event|0|||
33528719|NCT02716779|101834093|FG001|Monotherapy|Adverse Event|1|||
33528720|NCT02716779|101834094|FG002|Monotherapy|Adverse Event|1|||
33334678|NCT00004259|101118230|FG000|Overall Study|Withdrawal by Subject|0|||
33334679|NCT00004259|101118231|FG001|Overall Study|Withdrawal by Subject|2|||
33334680|NCT00004259|101118232|FG002|Overall Study|Withdrawal by Subject|0|||
33334681|NCT00004259|101118233|FG003|Overall Study|Withdrawal by Subject|0|||
33334682|NCT00082888|101118235|FG000|Overall Study|Ineligible|1|||
33334683|NCT00082888|101118236|FG001|Overall Study|Ineligible|0|||
33334684|NCT00082888|101118237|FG002|Overall Study|Ineligible|0|||
33334685|NCT02370615|101118239|FG000|Overall Study|Adverse Event|1|||
33334686|NCT02370615|101118240|FG001|Overall Study|Adverse Event|0|||
33334687|NCT01883635|101118241|FG000|Overall Study|Withdrawal by Subject|4|||
33334688|NCT01883635|101118242|FG001|Overall Study|Withdrawal by Subject|0|||
33334689|NCT02937818|101118244|FG000|Overall Study|Participants decision|2|||
33334690|NCT02937818|101118245|FG001|Overall Study|Participants decision|1|||
33334691|NCT02937818|101118246|FG002|Overall Study|Participants decision|1|||
33334692|NCT02937818|101118247|FG003|Overall Study|Participants decision|1|||
33334693|NCT02937818|101118244|FG000|Overall Study|Adverse Event|2|||
33528721|NCT02716779|101834092|FG000|Combination Therapy|Adverse Event|0|||
33528722|NCT02716779|101834093|FG001|Combination Therapy|Adverse Event|2|||
33528723|NCT02716779|101834094|FG002|Combination Therapy|Adverse Event|1|||
33334694|NCT02937818|101118245|FG001|Overall Study|Adverse Event|4|||
33334695|NCT02937818|101118246|FG002|Overall Study|Adverse Event|1|||
33334696|NCT02937818|101118247|FG003|Overall Study|Adverse Event|1|||
33403707|NCT01066819|101369369|FG003|Overall Study|Adverse Event|0|||
33403708|NCT01066819|101369370|FG004|Overall Study|Adverse Event|0|||
33403709|NCT01066819|101369371|FG005|Overall Study|Adverse Event|0|||
33528724|NCT03315455|101834097|FG000|Overall Study|Ongoing in the Study|13|||
33528725|NCT03315455|101834098|FG001|Overall Study|Ongoing in the Study|24|||
33528726|NCT03315455|101834099|FG002|Overall Study|Ongoing in the Study|17|||
33334697|NCT02937818|101118244|FG000|Overall Study|Disease progression|17|||
33528727|NCT03315455|101834100|FG003|Overall Study|Ongoing in the Study|15|||
33334698|NCT02937818|101118245|FG001|Overall Study|Disease progression|15|||
33334699|NCT02937818|101118246|FG002|Overall Study|Disease progression|7|||
33334700|NCT02937818|101118247|FG003|Overall Study|Disease progression|19|||
33334701|NCT02937818|101118244|FG000|Overall Study|Condition under investigation worsened|0|||
33403710|NCT01066819|101369366|FG000|Overall Study|Death|5|||
33403711|NCT01066819|101369367|FG001|Overall Study|Death|0|||
33403712|NCT01066819|101369368|FG002|Overall Study|Death|1|||
33403713|NCT01066819|101369369|FG003|Overall Study|Death|0|||
33403714|NCT01066819|101369370|FG004|Overall Study|Death|0|||
33403715|NCT01066819|101369371|FG005|Overall Study|Death|0|||
33403716|NCT01066819|101369366|FG000|Overall Study|Lack of Efficacy|22|||
33403717|NCT01066819|101369367|FG001|Overall Study|Lack of Efficacy|1|||
33403718|NCT01066819|101369368|FG002|Overall Study|Lack of Efficacy|2|||
33403719|NCT01066819|101369369|FG003|Overall Study|Lack of Efficacy|1|||
33403720|NCT01066819|101369370|FG004|Overall Study|Lack of Efficacy|0|||
33528728|NCT03315455|101834097|FG000|Overall Study|Withdrawal by Subject|0|||
33528729|NCT03315455|101834098|FG001|Overall Study|Withdrawal by Subject|1|||
33528730|NCT03315455|101834099|FG002|Overall Study|Withdrawal by Subject|0|||
33528731|NCT03315455|101834100|FG003|Overall Study|Withdrawal by Subject|0|||
33334702|NCT02937818|101118245|FG001|Overall Study|Condition under investigation worsened|0|||
33334703|NCT02937818|101118246|FG002|Overall Study|Condition under investigation worsened|1|||
33334704|NCT02937818|101118247|FG003|Overall Study|Condition under investigation worsened|0|||
33334705|NCT02646982|101118248|FG000|Overall Study|Adverse Event|1|||
33334706|NCT02646982|101118249|FG001|Overall Study|Adverse Event|1|||
33334707|NCT02646982|101118248|FG000|Overall Study|Withdrawal by Subject|2|||
33334708|NCT02646982|101118249|FG001|Overall Study|Withdrawal by Subject|1|||
33334709|NCT01058096|101118250|FG000|Double-blind Treatment Phase|Adverse Event|11|||
33334710|NCT01058096|101118251|FG001|Double-blind Treatment Phase|Adverse Event|15|||
33334711|NCT01058096|101118250|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
33334712|NCT01058096|101118251|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
33334713|NCT01058096|101118250|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
33334714|NCT01058096|101118251|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
33528732|NCT04441788|101834101|FG000|Overall Study|Voluntary Withdrawl|0|||
33528733|NCT04441788|101834102|FG001|Overall Study|Voluntary Withdrawl|1|||
33528734|NCT04441788|101834103|FG002|Overall Study|Voluntary Withdrawl|0|||
33528735|NCT04441788|101834101|FG000|Overall Study|Ineligibility|1|||
33528736|NCT04441788|101834102|FG001|Overall Study|Ineligibility|0|||
33528737|NCT04441788|101834103|FG002|Overall Study|Ineligibility|0|||
33528738|NCT04441788|101834101|FG000|Overall Study|Adverse Event|0|||
33528739|NCT04441788|101834102|FG001|Overall Study|Adverse Event|0|||
33528740|NCT04441788|101834103|FG002|Overall Study|Adverse Event|4|||
33528741|NCT04441788|101834101|FG000|Overall Study|Study Terminated by Sponsor|16|||
33528742|NCT04441788|101834102|FG001|Overall Study|Study Terminated by Sponsor|16|||
33528743|NCT04441788|101834103|FG002|Overall Study|Study Terminated by Sponsor|12|||
33528744|NCT01951573|101834106|FG000|Washout Period|Adverse Event|0|||
33528745|NCT01951573|101834107|FG001|Washout Period|Adverse Event|1|||
33528746|NCT01344759|101834113|FG000|Overall Study|Patients failed to reach sedation level|0|||
33528747|NCT01344759|101834114|FG001|Overall Study|Patients failed to reach sedation level|2|||
33528748|NCT01768559|101834126|FG000|Overall Study|Randomized but not treated|0|||
33528749|NCT01768559|101834127|FG001|Overall Study|Randomized but not treated|0|||
33528750|NCT01768559|101834128|FG002|Overall Study|Randomized but not treated|1|||
33528751|NCT01768559|101834126|FG000|Overall Study|Adverse Event|15|||
33528752|NCT01768559|101834127|FG001|Overall Study|Adverse Event|2|||
33528753|NCT01768559|101834128|FG002|Overall Study|Adverse Event|5|||
33528754|NCT01768559|101834126|FG000|Overall Study|Lack of Efficacy|6|||
33528755|NCT01768559|101834127|FG001|Overall Study|Lack of Efficacy|4|||
33528756|NCT01768559|101834128|FG002|Overall Study|Lack of Efficacy|0|||
33528757|NCT01768559|101834126|FG000|Overall Study|Poor compliance to protocol|0|||
33528758|NCT01768559|101834127|FG001|Overall Study|Poor compliance to protocol|3|||
33528759|NCT01768559|101834128|FG002|Overall Study|Poor compliance to protocol|2|||
33528760|NCT01768559|101834126|FG000|Overall Study|Other than specified|9|||
33528761|NCT01768559|101834127|FG001|Overall Study|Other than specified|8|||
33528762|NCT01768559|101834128|FG002|Overall Study|Other than specified|5|||
33528763|NCT02029274|101834129|FG000|Overall Study|Adverse Event|1|||
33528764|NCT02029274|101834130|FG001|Overall Study|Adverse Event|0|||
33528765|NCT02029274|101834131|FG002|Overall Study|Adverse Event|2|||
33528766|NCT02029274|101834132|FG003|Overall Study|Adverse Event|2|||
33528767|NCT03915626|101834133|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
33528768|NCT01601496|101834134|FG000|Overall Study|Physician Decision|1|||
33528769|NCT01601496|101834134|FG000|Overall Study|Withdrawal by Subject|1|||
33528770|NCT01601496|101834134|FG000|Overall Study|Lost to Follow-up|6|||
33528771|NCT01601496|101834134|FG000|Overall Study|Death|4|||
33334715|NCT01058096|101118250|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
33528772|NCT01601496|101834134|FG000|Overall Study|Other: patient refusal to continue|3|||
33528773|NCT02714036|101834136|FG000|Overall Study|Adverse Event|9|||
33528774|NCT02714036|101834137|FG001|Overall Study|Adverse Event|2|||
33334716|NCT01058096|101118251|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
33334717|NCT01058096|101118250|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
33528775|NCT02714036|101834136|FG000|Overall Study|Withdrawal by Subject|3|||
33611035|NCT04856904|102126808|FG001|Overall Study|Physician Decision|1|||
33334718|NCT01058096|101118251|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
33403721|NCT01066819|101369371|FG005|Overall Study|Lack of Efficacy|0|||
33403722|NCT01066819|101369366|FG000|Overall Study|Physician Decision|6|||
33334719|NCT01058096|101118250|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
33334720|NCT01058096|101118251|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
33334721|NCT02787863|101118252|FG000|Overall Study|Death|1|||
33334722|NCT02787863|101118253|FG001|Overall Study|Death|0|||
33334723|NCT02787863|101118254|FG002|Overall Study|Death|1|||
33334724|NCT02787863|101118255|FG003|Overall Study|Death|0|||
33334725|NCT02787863|101118256|FG004|Overall Study|Death|0|||
33204746|NCT01159938|100651393|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
33204747|NCT01159938|100651394|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
33204748|NCT01159938|100651395|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
33204749|NCT01159938|100651396|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
33334726|NCT02787863|101118257|FG005|Overall Study|Death|0|||
33334727|NCT02787863|101118258|FG006|Overall Study|Death|0|||
33334728|NCT02787863|101118259|FG007|Overall Study|Death|0|||
33611036|NCT04856904|102126807|FG000|Overall Study|Withdrawal by Subject|13|||
33611037|NCT04856904|102126808|FG001|Overall Study|Withdrawal by Subject|13|||
33611038|NCT04856904|102126807|FG000|Overall Study|Adverse Event|1|||
33611039|NCT04856904|102126808|FG001|Overall Study|Adverse Event|1|||
33611040|NCT04856904|102126807|FG000|Overall Study|Non-compliance with study drug|1|||
33611041|NCT04856904|102126808|FG001|Overall Study|Non-compliance with study drug|1|||
33611042|NCT04856904|102126807|FG000|Overall Study|Lost to Follow-up|4|||
33611043|NCT04856904|102126808|FG001|Overall Study|Lost to Follow-up|4|||
33611044|NCT04856904|102126807|FG000|Overall Study|Withdrawal by Subject|1|||
33611045|NCT04856904|102126808|FG001|Overall Study|Withdrawal by Subject|1|||
33611046|NCT04856904|102126807|FG000|Overall Study|Protocol Violation|1|||
33611047|NCT04856904|102126808|FG001|Overall Study|Protocol Violation|1|||
33204750|NCT00355082|100651397|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
33204751|NCT00355082|100651398|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
33204752|NCT00355082|100651399|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
33334729|NCT02787863|101118252|FG000|Overall Study|Withdrawal by Subject|0|||
33334730|NCT02787863|101118253|FG001|Overall Study|Withdrawal by Subject|1|||
33334731|NCT02787863|101118254|FG002|Overall Study|Withdrawal by Subject|1|||
33334732|NCT02787863|101118255|FG003|Overall Study|Withdrawal by Subject|0|||
33334733|NCT02787863|101118256|FG004|Overall Study|Withdrawal by Subject|0|||
33334734|NCT02787863|101118257|FG005|Overall Study|Withdrawal by Subject|0|||
33334735|NCT02787863|101118258|FG006|Overall Study|Withdrawal by Subject|0|||
33334736|NCT02787863|101118259|FG007|Overall Study|Withdrawal by Subject|0|||
33334737|NCT00586495|101118260|FG000|Treatment Period|Adverse Event|11|||
33334738|NCT00586495|101118260|FG000|Treatment Period|Death|1|||
33334739|NCT00586495|101118260|FG000|Treatment Period|Protocol Violation|1|||
33334740|NCT00586495|101118260|FG000|Treatment Period|Withdrawal by Subject|1|||
33334741|NCT00586495|101118260|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
33334742|NCT00586495|101118260|FG000|Treatment Period|Switch to commercial drug|10|||
33334743|NCT00586495|101118260|FG000|Follow-up|Death|40|||
33334744|NCT00586495|101118260|FG000|Follow-up|Lost to Follow-up|1|||
33334745|NCT00586495|101118260|FG000|Follow-up|Withdrawal by Subject|4|||
33334746|NCT00586495|101118260|FG000|Follow-up|Protocol driven decision point|37|||
33334747|NCT00586495|101118260|FG000|Follow-up|Switch to commercial drug|10|||
33334748|NCT04191382|101118261|FG000|Overall Study|Withdrawal by Subject|1|||
33334749|NCT04191382|101118262|FG001|Overall Study|Withdrawal by Subject|0|||
33334750|NCT04191382|101118263|FG002|Overall Study|Withdrawal by Subject|0|||
33334751|NCT01425008|101118264|FG000|Dose Escalation Phase|Progressive Disease|2|||
33334752|NCT01425008|101118265|FG001|Dose Escalation Phase|Progressive Disease|3|||
33334753|NCT01425008|101118266|FG002|Dose Escalation Phase|Progressive Disease|2|||
33334754|NCT01425008|101118267|FG003|Dose Escalation Phase|Progressive Disease|3|||
33334755|NCT01425008|101118268|FG004|Dose Escalation Phase|Progressive Disease|5|||
33528776|NCT02714036|101834137|FG001|Overall Study|Withdrawal by Subject|2|||
33528777|NCT02937740|101834138|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
33528778|NCT02937740|101834139|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
33334756|NCT01425008|101118269|FG005|Dose Escalation Phase|Progressive Disease|4|||
33528779|NCT02937740|101834138|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
33528780|NCT02937740|101834139|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
33528781|NCT02937740|101834138|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
33528782|NCT02937740|101834139|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
33528783|NCT02937740|101834138|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
33334757|NCT01425008|101118270|FG006|Dose Escalation Phase|Progressive Disease|0|||
33334758|NCT01425008|101118271|FG007|Dose Escalation Phase|Progressive Disease|2|||
33334759|NCT01425008|101118272|FG008|Dose Escalation Phase|Progressive Disease|6|||
33334760|NCT01425008|101118273|FG009|Dose Escalation Phase|Progressive Disease|2|||
33334761|NCT01425008|101118274|FG010|Dose Escalation Phase|Progressive Disease|0|||
33334762|NCT01425008|101118275|FG011|Dose Escalation Phase|Progressive Disease|0|||
33611048|NCT02409719|102126809|FG000|Overall Study|Lost to Follow-up|3|||
33611049|NCT02409719|102126810|FG001|Overall Study|Lost to Follow-up|3|||
33611050|NCT03068767|102126821|FG000|Overall Study|Lost to Follow-up|7|||
33334763|NCT01425008|101118276|FG012|Dose Escalation Phase|Progressive Disease|0|||
33334764|NCT01425008|101118277|FG013|Dose Escalation Phase|Progressive Disease|0|||
33334765|NCT01425008|101118278|FG014|Dose Escalation Phase|Progressive Disease|0|||
33334766|NCT01425008|101118279|FG015|Dose Escalation Phase|Progressive Disease|0|||
33334767|NCT01425008|101118280|FG016|Dose Escalation Phase|Progressive Disease|0|||
33334768|NCT01425008|101118281|FG017|Dose Escalation Phase|Progressive Disease|0|||
33334769|NCT01425008|101118282|FG018|Dose Escalation Phase|Progressive Disease|0|||
33334770|NCT01425008|101118264|FG000|Dose Escalation Phase|Adverse Event|2|||
33334771|NCT01425008|101118265|FG001|Dose Escalation Phase|Adverse Event|0|||
33334772|NCT01425008|101118266|FG002|Dose Escalation Phase|Adverse Event|0|||
33528784|NCT02937740|101834139|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
33528785|NCT02937740|101834138|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
33334773|NCT01425008|101118267|FG003|Dose Escalation Phase|Adverse Event|0|||
33334774|NCT01425008|101118268|FG004|Dose Escalation Phase|Adverse Event|0|||
33334775|NCT01425008|101118269|FG005|Dose Escalation Phase|Adverse Event|2|||
33334776|NCT01425008|101118270|FG006|Dose Escalation Phase|Adverse Event|0|||
33528786|NCT02937740|101834139|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
33528787|NCT02937740|101834138|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
33528788|NCT02937740|101834139|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
33528789|NCT02155309|101834140|FG000|Overall Study|Protocol Violation|0|||
33528790|NCT02155309|101834141|FG001|Overall Study|Protocol Violation|0|||
33528791|NCT02155309|101834142|FG002|Overall Study|Protocol Violation|1|||
33528792|NCT05027815|101834144|FG000|Overall Study|Death|2|||
33528793|NCT05027815|101834145|FG001|Overall Study|Death|1|||
33528794|NCT02421419|101834146|FG000|Overall Study|Physician Decision|0|||
33528795|NCT02421419|101834147|FG001|Overall Study|Physician Decision|0|||
33528796|NCT02421419|101834148|FG002|Overall Study|Physician Decision|1|||
33528797|NCT01211145|101834150|FG000|Overall Study|Reason not specified|3|||
33528798|NCT01211145|101834151|FG001|Overall Study|Reason not specified|2|||
33528799|NCT01211145|101834152|FG002|Overall Study|Reason not specified|2|||
33334777|NCT01425008|101118271|FG007|Dose Escalation Phase|Adverse Event|0|||
33334778|NCT01425008|101118272|FG008|Dose Escalation Phase|Adverse Event|2|||
33528800|NCT01211145|101834153|FG003|Overall Study|Reason not specified|1|||
33528801|NCT01211145|101834150|FG000|Overall Study|Lost to Follow-up|3|||
33528802|NCT01211145|101834151|FG001|Overall Study|Lost to Follow-up|2|||
33528803|NCT01211145|101834152|FG002|Overall Study|Lost to Follow-up|1|||
33528804|NCT01211145|101834153|FG003|Overall Study|Lost to Follow-up|2|||
33528805|NCT01211145|101834150|FG000|Overall Study|Study-specific withdrawal criteria|1|||
33528806|NCT01211145|101834151|FG001|Overall Study|Study-specific withdrawal criteria|0|||
33528807|NCT01211145|101834152|FG002|Overall Study|Study-specific withdrawal criteria|0|||
33528808|NCT01211145|101834153|FG003|Overall Study|Study-specific withdrawal criteria|0|||
33528809|NCT01211145|101834150|FG000|Overall Study|Severe noncompliance to protocol|1|||
33528810|NCT01211145|101834151|FG001|Overall Study|Severe noncompliance to protocol|0|||
33528811|NCT01211145|101834152|FG002|Overall Study|Severe noncompliance to protocol|0|||
33528812|NCT01211145|101834153|FG003|Overall Study|Severe noncompliance to protocol|0|||
33528813|NCT01211145|101834150|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
33528814|NCT01211145|101834151|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
33528815|NCT01211145|101834152|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
33528816|NCT01211145|101834153|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
33528817|NCT01211145|101834150|FG000|Overall Study|Patient decision|2|||
33611051|NCT03068767|102126822|FG001|Overall Study|Lost to Follow-up|3|||
33611052|NCT03068767|102126821|FG000|Overall Study|Protocol Violation|3|||
33611053|NCT03068767|102126822|FG001|Overall Study|Protocol Violation|0|||
33611054|NCT01630889|102126823|FG000|Overall Study|Death|2|||
33611055|NCT01630889|102126823|FG000|Overall Study|Withdrawal by Subject|1|||
33611056|NCT01630889|102126823|FG000|Overall Study|Other than Specified|2|||
33611057|NCT01630889|102126823|FG000|Overall Study|Lost to Follow-up|4|||
33611058|NCT01630889|102126823|FG000|Overall Study|Other|1|||
33611059|NCT02673684|102126829|FG000|Overall Study|Study not completed d/t loss of funding|9|||
33611060|NCT02673684|102126830|FG001|Overall Study|Study not completed d/t loss of funding|8|||
33611061|NCT03997825|102126831|FG000|Overall Study|Death|3|||
33611062|NCT03997825|102126831|FG000|Overall Study|Lost to Follow-up|10|||
33528818|NCT01211145|101834151|FG001|Overall Study|Patient decision|1|||
33611063|NCT03997825|102126831|FG000|Overall Study|Withdrawal by Subject|3|||
33611064|NCT03997825|102126831|FG000|Overall Study|Refused participation|1|||
33611065|NCT04583956|102126841|FG000|Overall Study|Death|9|||
33611066|NCT04583956|102126842|FG001|Overall Study|Death|11|||
33611067|NCT04583956|102126841|FG000|Overall Study|Lost to Follow-up|7|||
33403723|NCT01066819|101369367|FG001|Overall Study|Physician Decision|2|||
33334779|NCT01425008|101118273|FG009|Dose Escalation Phase|Adverse Event|0|||
33334780|NCT01425008|101118274|FG010|Dose Escalation Phase|Adverse Event|0|||
33334781|NCT01425008|101118275|FG011|Dose Escalation Phase|Adverse Event|0|||
33528819|NCT01211145|101834152|FG002|Overall Study|Patient decision|0|||
33528820|NCT01211145|101834153|FG003|Overall Study|Patient decision|2|||
33528821|NCT05285787|101834158|FG000|Overall Study|Withdrawal by Subject|1|||
33528822|NCT05176717|101834159|FG000|Overall Study|Sponsor Decision|1|||
33528823|NCT05176717|101834160|FG001|Overall Study|Sponsor Decision|2|||
33528824|NCT05176717|101834161|FG002|Overall Study|Sponsor Decision|2|||
33528825|NCT01395810|101834162|FG000|Overall Study|Adverse Event|0|||
33528826|NCT01395810|101834163|FG001|Overall Study|Adverse Event|1|||
33528827|NCT01395810|101834164|FG002|Overall Study|Adverse Event|0|||
33528828|NCT01395810|101834165|FG003|Overall Study|Adverse Event|0|||
33528829|NCT01395810|101834162|FG000|Overall Study|Lack of Efficacy|0|||
33528830|NCT01395810|101834163|FG001|Overall Study|Lack of Efficacy|1|||
33528831|NCT01395810|101834164|FG002|Overall Study|Lack of Efficacy|0|||
33528832|NCT01395810|101834165|FG003|Overall Study|Lack of Efficacy|0|||
33528833|NCT01395810|101834162|FG000|Overall Study|Withdrawal criteria|0|||
33528834|NCT01395810|101834163|FG001|Overall Study|Withdrawal criteria|2|||
33528835|NCT01395810|101834164|FG002|Overall Study|Withdrawal criteria|0|||
33528836|NCT01395810|101834165|FG003|Overall Study|Withdrawal criteria|0|||
33528837|NCT01395810|101834162|FG000|Overall Study|Unclassified|2|||
33528838|NCT01395810|101834163|FG001|Overall Study|Unclassified|0|||
33528839|NCT01395810|101834164|FG002|Overall Study|Unclassified|0|||
33528840|NCT01395810|101834165|FG003|Overall Study|Unclassified|0|||
33528841|NCT00905567|101834166|FG000|Washout|Withdrawal by Subject|0|||
33528842|NCT00905567|101834167|FG001|Washout|Withdrawal by Subject|1|||
33528843|NCT00707980|101834180|FG000|Overall Study|Adverse Event|49|||
33528844|NCT00707980|101834180|FG000|Overall Study|Lack of Efficacy|35|||
33528845|NCT00707980|101834180|FG000|Overall Study|Non-Compliance with Study Drug|28|||
33334782|NCT01425008|101118276|FG012|Dose Escalation Phase|Adverse Event|0|||
33334783|NCT01425008|101118277|FG013|Dose Escalation Phase|Adverse Event|0|||
33528846|NCT00707980|101834180|FG000|Overall Study|Protocol Deviations|19|||
33528847|NCT00707980|101834180|FG000|Overall Study|Withdrawal of Consent|81|||
33528848|NCT00707980|101834180|FG000|Overall Study|Lost to Follow-up|59|||
33611068|NCT04583956|102126842|FG001|Overall Study|Lost to Follow-up|9|||
33611069|NCT04583956|102126841|FG000|Overall Study|Protocol Violation|2|||
33611070|NCT04583956|102126842|FG001|Overall Study|Protocol Violation|0|||
33611071|NCT04583956|102126841|FG000|Overall Study|Withdrawal by Subject|0|||
33611072|NCT04583956|102126842|FG001|Overall Study|Withdrawal by Subject|2|||
33611073|NCT04583956|102126841|FG000|Overall Study|Randomized but not dosed|2|||
33611074|NCT04583956|102126842|FG001|Overall Study|Randomized but not dosed|3|||
33611075|NCT04583956|102126841|FG000|Overall Study|Withdrawal of consent before product administration|1|||
33611076|NCT04583956|102126842|FG001|Overall Study|Withdrawal of consent before product administration|0|||
33611077|NCT02828020|102126845|FG000|Treatment Period|Adverse Event|3|||
33611078|NCT02828020|102126846|FG001|Treatment Period|Adverse Event|1|||
33611079|NCT02828020|102126847|FG002|Treatment Period|Adverse Event|1|||
33611080|NCT02828020|102126845|FG000|Treatment Period|Withdrawal of Consent|10|||
33611081|NCT02828020|102126846|FG001|Treatment Period|Withdrawal of Consent|14|||
33611082|NCT02828020|102126847|FG002|Treatment Period|Withdrawal of Consent|9|||
33611083|NCT02828020|102126845|FG000|Treatment Period|Lost to Follow-up|21|||
33611084|NCT02828020|102126846|FG001|Treatment Period|Lost to Follow-up|24|||
33611085|NCT02828020|102126847|FG002|Treatment Period|Lost to Follow-up|18|||
33611086|NCT02828020|102126845|FG000|Treatment Period|Lack of Qualifying Event|44|||
33611087|NCT02828020|102126846|FG001|Treatment Period|Lack of Qualifying Event|53|||
33611088|NCT02828020|102126847|FG002|Treatment Period|Lack of Qualifying Event|43|||
33611089|NCT02828020|102126845|FG000|Treatment Period|Pregnancy|0|||
33611090|NCT02828020|102126846|FG001|Treatment Period|Pregnancy|2|||
33611091|NCT02828020|102126847|FG002|Treatment Period|Pregnancy|0|||
33611092|NCT02828020|102126845|FG000|Treatment Period|Protocol Violation|2|||
33611093|NCT02828020|102126846|FG001|Treatment Period|Protocol Violation|4|||
33611094|NCT02828020|102126847|FG002|Treatment Period|Protocol Violation|7|||
33611095|NCT02828020|102126845|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
33334784|NCT01425008|101118278|FG014|Dose Escalation Phase|Adverse Event|0|||
33403724|NCT01066819|101369368|FG002|Overall Study|Physician Decision|3|||
33528849|NCT00707980|101834180|FG000|Overall Study|Other|39|||
33528850|NCT01153009|101834182|FG000|Overall Study|Adverse Event|4|||
33528851|NCT01153009|101834183|FG001|Overall Study|Adverse Event|14|||
33611096|NCT02828020|102126846|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
33611097|NCT02828020|102126847|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
33611098|NCT02828020|102126845|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
33611099|NCT02828020|102126846|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
33334785|NCT01425008|101118279|FG015|Dose Escalation Phase|Adverse Event|0|||
33528852|NCT01153009|101834184|FG002|Overall Study|Adverse Event|14|||
33528853|NCT01153009|101834185|FG003|Overall Study|Adverse Event|10|||
33528854|NCT01153009|101834182|FG000|Overall Study|Lack of Efficacy|9|||
33528855|NCT01153009|101834183|FG001|Overall Study|Lack of Efficacy|0|||
33334786|NCT01425008|101118280|FG016|Dose Escalation Phase|Adverse Event|0|||
33334787|NCT01425008|101118281|FG017|Dose Escalation Phase|Adverse Event|0|||
33334788|NCT01425008|101118282|FG018|Dose Escalation Phase|Adverse Event|0|||
33334789|NCT01425008|101118264|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33334790|NCT01425008|101118265|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33334791|NCT01425008|101118266|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33334792|NCT01425008|101118267|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33334793|NCT01425008|101118268|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
33334794|NCT01425008|101118269|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33334795|NCT01425008|101118270|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
33334796|NCT01425008|101118271|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
33334797|NCT01425008|101118272|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
33334798|NCT01425008|101118273|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33334799|NCT01425008|101118274|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33334800|NCT01425008|101118275|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33528856|NCT01153009|101834184|FG002|Overall Study|Lack of Efficacy|2|||
33334801|NCT01425008|101118276|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33334802|NCT01425008|101118277|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33528857|NCT01153009|101834185|FG003|Overall Study|Lack of Efficacy|1|||
33334803|NCT01425008|101118278|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33334804|NCT01425008|101118279|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33528858|NCT01153009|101834182|FG000|Overall Study|Noncompliance with Study Medication|1|||
33528859|NCT01153009|101834183|FG001|Overall Study|Noncompliance with Study Medication|3|||
33528860|NCT01153009|101834184|FG002|Overall Study|Noncompliance with Study Medication|4|||
33528861|NCT01153009|101834185|FG003|Overall Study|Noncompliance with Study Medication|1|||
33528862|NCT01153009|101834182|FG000|Overall Study|Protocol Deviations|4|||
33528863|NCT01153009|101834183|FG001|Overall Study|Protocol Deviations|3|||
33528864|NCT01153009|101834184|FG002|Overall Study|Protocol Deviations|3|||
33528865|NCT01153009|101834185|FG003|Overall Study|Protocol Deviations|2|||
33528866|NCT01153009|101834182|FG000|Overall Study|Withdrawal of Consent|5|||
33528867|NCT01153009|101834183|FG001|Overall Study|Withdrawal of Consent|5|||
33611100|NCT02828020|102126847|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
33611101|NCT02828020|102126845|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
33611102|NCT02828020|102126846|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
33611103|NCT02828020|102126847|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
33403725|NCT01066819|101369369|FG003|Overall Study|Physician Decision|0|||
33528868|NCT01153009|101834184|FG002|Overall Study|Withdrawal of Consent|4|||
33528869|NCT01153009|101834185|FG003|Overall Study|Withdrawal of Consent|6|||
33528870|NCT01153009|101834182|FG000|Overall Study|Lost to Follow-up|8|||
33528871|NCT01153009|101834183|FG001|Overall Study|Lost to Follow-up|8|||
33528872|NCT01153009|101834184|FG002|Overall Study|Lost to Follow-up|11|||
33528873|NCT01153009|101834185|FG003|Overall Study|Lost to Follow-up|15|||
33528874|NCT01153009|101834182|FG000|Overall Study|Other|1|||
33528875|NCT01153009|101834183|FG001|Overall Study|Other|1|||
33528876|NCT01153009|101834184|FG002|Overall Study|Other|3|||
33528877|NCT01153009|101834185|FG003|Overall Study|Other|2|||
33528878|NCT01054222|101834188|FG000|Overall Study|Lack of Efficacy|1|||
33528879|NCT01054222|101834188|FG000|Overall Study|Lost to Follow-up|4|||
33528880|NCT01054222|101834188|FG000|Overall Study|Withdrawal by Subject|6|||
33528881|NCT05415462|101834193|FG000|Overall Study|Death|18|||
33528882|NCT05415462|101834194|FG001|Overall Study|Death|10|||
33528883|NCT05415462|101834193|FG000|Overall Study|Lost to Follow-up|72|||
33528884|NCT05415462|101834194|FG001|Overall Study|Lost to Follow-up|64|||
33528885|NCT05415462|101834193|FG000|Overall Study|Physician Decision|5|||
33528886|NCT05415462|101834194|FG001|Overall Study|Physician Decision|5|||
33528887|NCT05415462|101834193|FG000|Overall Study|Protocol Deviation|1|||
33528888|NCT05415462|101834194|FG001|Overall Study|Protocol Deviation|0|||
33528889|NCT05415462|101834193|FG000|Overall Study|Withdrawal by Subject|129|||
33528890|NCT05415462|101834194|FG001|Overall Study|Withdrawal by Subject|101|||
33528891|NCT05415462|101834193|FG000|Overall Study|Other Than Specified|8|||
33403726|NCT01066819|101369370|FG004|Overall Study|Physician Decision|0|||
33528892|NCT05415462|101834194|FG001|Overall Study|Other Than Specified|8|||
33611104|NCT02828020|102126845|FG000|Safety Follow-up Period|Protocol Violation|0|||
33204753|NCT00355082|100651397|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
33334805|NCT01425008|101118280|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33334806|NCT01425008|101118281|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33528893|NCT00339833|101834195|FG000|Overall Study|Withdrawal by Subject|1|||
33528894|NCT00339833|101834196|FG001|Overall Study|Withdrawal by Subject|2|||
33334807|NCT01425008|101118282|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
33403727|NCT01066819|101369371|FG005|Overall Study|Physician Decision|0|||
33528895|NCT00339833|101834195|FG000|Overall Study|toothache|0|||
33528896|NCT00339833|101834196|FG001|Overall Study|toothache|1|||
33528897|NCT00339833|101834195|FG000|Overall Study|indigestion|0|||
33528898|NCT00339833|101834196|FG001|Overall Study|indigestion|1|||
33528899|NCT00339833|101834195|FG000|Overall Study|Chest pain|0|||
33334808|NCT01425008|101118264|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
33334809|NCT01425008|101118265|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
33334810|NCT01425008|101118266|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
33334811|NCT01425008|101118267|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
33334812|NCT01425008|101118268|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
33334813|NCT01425008|101118269|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
33334814|NCT01425008|101118270|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
33334815|NCT01425008|101118271|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
33334816|NCT01425008|101118272|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
33334817|NCT01425008|101118273|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
33334818|NCT01425008|101118274|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
33334819|NCT01425008|101118275|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
33528900|NCT00339833|101834196|FG001|Overall Study|Chest pain|1|||
33528901|NCT00339833|101834195|FG000|Overall Study|minor infection|0|||
33528902|NCT00339833|101834196|FG001|Overall Study|minor infection|1|||
33528903|NCT00339833|101834195|FG000|Overall Study|Poor venous access|2|||
33528904|NCT00339833|101834196|FG001|Overall Study|Poor venous access|2|||
33528905|NCT00339833|101834195|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
33528906|NCT00339833|101834196|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
33528907|NCT00339833|101834195|FG000|Overall Study|Error in data records|1|||
33528908|NCT00339833|101834196|FG001|Overall Study|Error in data records|0|||
33528909|NCT00770913|101834197|FG000|Overall Study|Adverse Event|1|||
33528910|NCT00770913|101834198|FG001|Overall Study|Adverse Event|3|||
33528911|NCT00770913|101834199|FG002|Overall Study|Adverse Event|6|||
33528912|NCT00770913|101834197|FG000|Overall Study|Refusal to continue participation|6|||
33528913|NCT00770913|101834198|FG001|Overall Study|Refusal to continue participation|4|||
33528914|NCT00770913|101834199|FG002|Overall Study|Refusal to continue participation|5|||
33528915|NCT00770913|101834197|FG000|Overall Study|Physician Decision|0|||
33334820|NCT01425008|101118276|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
33334821|NCT01425008|101118277|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
33334822|NCT01425008|101118278|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
33334823|NCT01425008|101118279|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
33334824|NCT01425008|101118280|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
33334825|NCT01425008|101118281|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
33528916|NCT00770913|101834198|FG001|Overall Study|Physician Decision|1|||
33528917|NCT00770913|101834199|FG002|Overall Study|Physician Decision|1|||
33528918|NCT00770913|101834197|FG000|Overall Study|Protocol Violation|3|||
33611105|NCT02828020|102126846|FG001|Safety Follow-up Period|Protocol Violation|2|||
33611106|NCT02828020|102126847|FG002|Safety Follow-up Period|Protocol Violation|1|||
33611107|NCT02828020|102126845|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
33334826|NCT01425008|101118282|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
33334827|NCT01425008|101118264|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334828|NCT01425008|101118265|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334829|NCT01425008|101118266|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
33528919|NCT00770913|101834198|FG001|Overall Study|Protocol Violation|0|||
33611108|NCT02828020|102126846|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
33204754|NCT00355082|100651398|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
33204755|NCT00355082|100651399|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
33204756|NCT00355082|100651397|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
33204757|NCT00355082|100651398|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
33204758|NCT00355082|100651399|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
33204759|NCT00355082|100651397|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
33204760|NCT00355082|100651398|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
33204761|NCT00355082|100651399|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
33204762|NCT00355082|100651397|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
33204763|NCT00355082|100651398|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
33204764|NCT00355082|100651399|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
33204765|NCT00355082|100651397|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
33204766|NCT00355082|100651398|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
33204767|NCT00355082|100651399|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
33204768|NCT00355082|100651397|FG000|Continuation Phase|Adverse Event|2|||
33204769|NCT00355082|100651398|FG001|Continuation Phase|Adverse Event|0|||
33528920|NCT00770913|101834199|FG002|Overall Study|Protocol Violation|1|||
33528921|NCT00770913|101834197|FG000|Overall Study|Incorrect drug was allocated|1|||
33611109|NCT02828020|102126847|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
33611110|NCT03659136|102126850|FG000|Overall Study|Not treated|2|||
33334830|NCT01425008|101118267|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334831|NCT01425008|101118268|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334832|NCT01425008|101118269|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
33528922|NCT00770913|101834198|FG001|Overall Study|Incorrect drug was allocated|0|||
33528923|NCT00770913|101834199|FG002|Overall Study|Incorrect drug was allocated|0|||
33528924|NCT02998151|101834200|FG000|Overall Study|Withdrawal by Subject|3|||
33334833|NCT01425008|101118270|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334834|NCT01425008|101118271|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334835|NCT01425008|101118272|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
33334836|NCT01425008|101118273|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
33334837|NCT01425008|101118274|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334838|NCT01425008|101118275|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334839|NCT01425008|101118276|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334840|NCT01425008|101118277|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334841|NCT01425008|101118278|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334842|NCT01425008|101118279|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334843|NCT01425008|101118280|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334844|NCT01425008|101118281|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334845|NCT01425008|101118282|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
33334846|NCT01425008|101118264|FG000|Dose Escalation Phase|Other|0|||
33334847|NCT01425008|101118265|FG001|Dose Escalation Phase|Other|0|||
33334848|NCT01425008|101118266|FG002|Dose Escalation Phase|Other|0|||
33334849|NCT01425008|101118267|FG003|Dose Escalation Phase|Other|0|||
33334850|NCT01425008|101118268|FG004|Dose Escalation Phase|Other|0|||
33334851|NCT01425008|101118269|FG005|Dose Escalation Phase|Other|0|||
33334852|NCT01425008|101118270|FG006|Dose Escalation Phase|Other|0|||
33334853|NCT01425008|101118271|FG007|Dose Escalation Phase|Other|0|||
33334854|NCT01425008|101118272|FG008|Dose Escalation Phase|Other|1|||
33334855|NCT01425008|101118273|FG009|Dose Escalation Phase|Other|0|||
33334856|NCT01425008|101118274|FG010|Dose Escalation Phase|Other|0|||
33334857|NCT01425008|101118275|FG011|Dose Escalation Phase|Other|0|||
33334858|NCT01425008|101118276|FG012|Dose Escalation Phase|Other|0|||
33334859|NCT01425008|101118277|FG013|Dose Escalation Phase|Other|0|||
33334860|NCT01425008|101118278|FG014|Dose Escalation Phase|Other|0|||
33334861|NCT01425008|101118279|FG015|Dose Escalation Phase|Other|0|||
33334862|NCT01425008|101118280|FG016|Dose Escalation Phase|Other|0|||
33528925|NCT02998151|101834200|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
33528926|NCT02998151|101834200|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
33528927|NCT02131233|101834201|FG000|Overall Study|Not Treated|2|||
33528928|NCT02131233|101834202|FG001|Overall Study|Not Treated|3|||
33528929|NCT02131233|101834201|FG000|Overall Study|Adverse Event|7|||
33528930|NCT02131233|101834202|FG001|Overall Study|Adverse Event|6|||
33528931|NCT02131233|101834201|FG000|Overall Study|Death|0|||
33528932|NCT02131233|101834202|FG001|Overall Study|Death|1|||
33528933|NCT02131233|101834201|FG000|Overall Study|Lack of Efficacy|6|||
33528934|NCT02131233|101834202|FG001|Overall Study|Lack of Efficacy|3|||
33528935|NCT02131233|101834201|FG000|Overall Study|Lost to Follow-up|14|||
33528936|NCT02131233|101834202|FG001|Overall Study|Lost to Follow-up|13|||
33528937|NCT02131233|101834201|FG000|Overall Study|Non-Compliance With Study Drug|8|||
33528938|NCT02131233|101834202|FG001|Overall Study|Non-Compliance With Study Drug|5|||
33528939|NCT02131233|101834201|FG000|Overall Study|Physician Decision|7|||
33528940|NCT02131233|101834202|FG001|Overall Study|Physician Decision|0|||
33528941|NCT02131233|101834201|FG000|Overall Study|Pregnancy|4|||
33528942|NCT02131233|101834202|FG001|Overall Study|Pregnancy|0|||
33528943|NCT02131233|101834201|FG000|Overall Study|Withdrawal by Subject|18|||
33528944|NCT02131233|101834202|FG001|Overall Study|Withdrawal by Subject|11|||
33528945|NCT04152083|101834208|FG000|Overall Study|Lost to Follow-up|2|||
33528946|NCT04152083|101834209|FG001|Overall Study|Lost to Follow-up|1|||
33528947|NCT04152083|101834208|FG000|Overall Study|Adverse Event|1|||
33528948|NCT04152083|101834209|FG001|Overall Study|Adverse Event|0|||
33528949|NCT04152083|101834208|FG000|Overall Study|Randomized but not treated|3|||
33528950|NCT04152083|101834209|FG001|Overall Study|Randomized but not treated|2|||
33528951|NCT04235504|101834210|FG000|Study Phase|Withdrawal by Subject|5|||
33528952|NCT04235504|101834211|FG001|Study Phase|Withdrawal by Subject|2|||
33528953|NCT04235504|101834212|FG002|Study Phase|Withdrawal by Subject|0|||
33528954|NCT04235504|101834213|FG003|Study Phase|Withdrawal by Subject|0|||
33528955|NCT04235504|101834210|FG000|Continuation Phase|Withdrawal by Subject|0|||
33528956|NCT04235504|101834211|FG001|Continuation Phase|Withdrawal by Subject|4|||
33528957|NCT04235504|101834212|FG002|Continuation Phase|Withdrawal by Subject|0|||
33528958|NCT04235504|101834213|FG003|Continuation Phase|Withdrawal by Subject|0|||
33528959|NCT04235504|101834210|FG000|Continuation Phase|Adverse Event|0|||
33528960|NCT04235504|101834211|FG001|Continuation Phase|Adverse Event|1|||
33528961|NCT04235504|101834212|FG002|Continuation Phase|Adverse Event|0|||
33528962|NCT04235504|101834213|FG003|Continuation Phase|Adverse Event|0|||
33528963|NCT04235504|101834210|FG000|Continuation Phase|Physician Decision|1|||
33528964|NCT04235504|101834211|FG001|Continuation Phase|Physician Decision|2|||
33528965|NCT04235504|101834212|FG002|Continuation Phase|Physician Decision|1|||
33334863|NCT01425008|101118281|FG017|Dose Escalation Phase|Other|0|||
33334864|NCT01425008|101118282|FG018|Dose Escalation Phase|Other|0|||
33334865|NCT01425008|101118264|FG000|Dose Expansion Phase|Progressive Disease|0|||
33334866|NCT01425008|101118265|FG001|Dose Expansion Phase|Progressive Disease|0|||
33334867|NCT01425008|101118266|FG002|Dose Expansion Phase|Progressive Disease|0|||
33528966|NCT04235504|101834213|FG003|Continuation Phase|Physician Decision|0|||
33204770|NCT00355082|100651399|FG002|Continuation Phase|Adverse Event|1|||
33204771|NCT00355082|100651397|FG000|Continuation Phase|Lost to Follow-up|2|||
33204772|NCT00355082|100651398|FG001|Continuation Phase|Lost to Follow-up|0|||
33204773|NCT00355082|100651399|FG002|Continuation Phase|Lost to Follow-up|1|||
33204774|NCT00355082|100651397|FG000|Continuation Phase|Protocol Violation|1|||
33204775|NCT00355082|100651398|FG001|Continuation Phase|Protocol Violation|0|||
33204776|NCT00355082|100651399|FG002|Continuation Phase|Protocol Violation|1|||
33204777|NCT00355082|100651397|FG000|Continuation Phase|Withdrawal by Subject|4|||
33204778|NCT00355082|100651398|FG001|Continuation Phase|Withdrawal by Subject|0|||
33204779|NCT00355082|100651399|FG002|Continuation Phase|Withdrawal by Subject|0|||
33204780|NCT00355082|100651397|FG000|Continuation Phase|Lack of Efficacy|5|||
33204781|NCT00355082|100651398|FG001|Continuation Phase|Lack of Efficacy|0|||
33204782|NCT00355082|100651399|FG002|Continuation Phase|Lack of Efficacy|0|||
33204783|NCT00355082|100651397|FG000|Continuation Phase|Site Closed by Sponsor|8|||
33204784|NCT00355082|100651398|FG001|Continuation Phase|Site Closed by Sponsor|0|||
33204785|NCT00355082|100651399|FG002|Continuation Phase|Site Closed by Sponsor|0|||
33204786|NCT00355082|100651397|FG000|Continuation Phase|Scheduling Error|1|||
33204787|NCT00355082|100651398|FG001|Continuation Phase|Scheduling Error|0|||
33204788|NCT00355082|100651399|FG002|Continuation Phase|Scheduling Error|0|||
33204789|NCT00355082|100651397|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
33204790|NCT00355082|100651398|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
33204791|NCT00355082|100651399|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
33204792|NCT01782131|100651402|FG000|Overall Study|Death|93|||
33204793|NCT01782131|100651403|FG001|Overall Study|Death|96|||
33204794|NCT01782131|100651402|FG000|Overall Study|Lost to Follow-up|1|||
33204795|NCT01782131|100651403|FG001|Overall Study|Lost to Follow-up|3|||
33204796|NCT01782131|100651402|FG000|Overall Study|Withdrawal by Subject|10|||
33204797|NCT01782131|100651403|FG001|Overall Study|Withdrawal by Subject|10|||
33204798|NCT01782131|100651402|FG000|Overall Study|Randomized but not treated|5|||
33204799|NCT01782131|100651403|FG001|Overall Study|Randomized but not treated|5|||
33204800|NCT01782131|100651402|FG000|Overall Study|Reason not provided|0|||
33204801|NCT01782131|100651403|FG001|Overall Study|Reason not provided|1|||
33204802|NCT00566228|100651404|FG000|Overall Study|Withdrawal by Subject|1|||
33204803|NCT00566228|100651405|FG001|Overall Study|Withdrawal by Subject|0|||
33204804|NCT00566228|100651404|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
33204805|NCT00566228|100651405|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
33204806|NCT00566228|100651404|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
33204807|NCT00566228|100651405|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
33204808|NCT00566228|100651404|FG000|Overall Study|progressed before infusion could occur|0|||
33204809|NCT00566228|100651405|FG001|Overall Study|progressed before infusion could occur|1|||
33204810|NCT04313634|100651406|FG000|Overall Study|Adverse Event|2|||
33204811|NCT04313634|100651407|FG001|Overall Study|Adverse Event|2|||
33204812|NCT04313634|100651408|FG002|Overall Study|Adverse Event|0|||
33204813|NCT04313634|100651406|FG000|Overall Study|Withdrawal by Subject|1|||
33204814|NCT04313634|100651407|FG001|Overall Study|Withdrawal by Subject|0|||
33204815|NCT04313634|100651408|FG002|Overall Study|Withdrawal by Subject|1|||
33204816|NCT04313634|100651406|FG000|Overall Study|Protocol Violation|0|||
33204817|NCT04313634|100651407|FG001|Overall Study|Protocol Violation|0|||
33204818|NCT04313634|100651408|FG002|Overall Study|Protocol Violation|1|||
33611111|NCT03659136|102126851|FG001|Overall Study|Not treated|0|||
33611112|NCT03659136|102126850|FG000|Overall Study|Covid-19 related|1|||
33611113|NCT03659136|102126851|FG001|Overall Study|Covid-19 related|1|||
33611114|NCT03659136|102126850|FG000|Overall Study|Withdrawal by Subject|1|||
33611115|NCT03659136|102126851|FG001|Overall Study|Withdrawal by Subject|6|||
33611116|NCT03659136|102126850|FG000|Overall Study|Adverse Event|4|||
33204819|NCT01793792|100651409|FG000|Overall Study|Death|5|||
33204820|NCT01793792|100651409|FG000|Overall Study|Lost to Follow-up|5|||
33204821|NCT01793792|100651409|FG000|Overall Study|Withdrawal by Subject|1|||
33204822|NCT01793792|100651409|FG000|Overall Study|Device Not Implanted|1|||
33204823|NCT02624804|100651410|FG000|Overall Study|Screen Failure|5|||
33204824|NCT04307186|100651413|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
33334868|NCT01425008|101118267|FG003|Dose Expansion Phase|Progressive Disease|0|||
33528967|NCT01540981|101834214|FG000|Overall Study|Withdrawal by Subject|1|||
33528968|NCT01540981|101834215|FG001|Overall Study|Withdrawal by Subject|0|||
33528969|NCT00656175|101838159|FG000|Overall Study|Adverse Event|1|||
33528970|NCT00656175|101838160|FG001|Overall Study|Adverse Event|0|||
33528971|NCT00656175|101838159|FG000|Overall Study|Transportation issues|0|||
33528972|NCT00656175|101838160|FG001|Overall Study|Transportation issues|1|||
33528973|NCT00420628|101838161|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
33528974|NCT00420628|101838162|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
33528975|NCT00420628|101838161|FG000|Overall Study|Lost to Follow-up|3|||
33528976|NCT00420628|101838162|FG001|Overall Study|Lost to Follow-up|2|||
33528977|NCT00420628|101838161|FG000|Overall Study|Adverse Event|1|||
33204825|NCT04307186|100651413|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
33204826|NCT04307186|100651413|FG000|Washout 3-14 Days|Progressive disease|1|||
33528978|NCT00420628|101838162|FG001|Overall Study|Adverse Event|0|||
33528979|NCT04391842|101838171|FG000|Overall Study|Withdrawal by Subject|2|||
33334869|NCT01425008|101118268|FG004|Dose Expansion Phase|Progressive Disease|0|||
33334870|NCT01425008|101118269|FG005|Dose Expansion Phase|Progressive Disease|0|||
33334871|NCT01425008|101118270|FG006|Dose Expansion Phase|Progressive Disease|0|||
33334872|NCT01425008|101118271|FG007|Dose Expansion Phase|Progressive Disease|0|||
33334873|NCT01425008|101118272|FG008|Dose Expansion Phase|Progressive Disease|0|||
33334874|NCT01425008|101118273|FG009|Dose Expansion Phase|Progressive Disease|0|||
33334875|NCT01425008|101118274|FG010|Dose Expansion Phase|Progressive Disease|10|||
33334876|NCT01425008|101118275|FG011|Dose Expansion Phase|Progressive Disease|4|||
33334877|NCT01425008|101118276|FG012|Dose Expansion Phase|Progressive Disease|12|||
33334878|NCT01425008|101118277|FG013|Dose Expansion Phase|Progressive Disease|1|||
33334879|NCT01425008|101118278|FG014|Dose Expansion Phase|Progressive Disease|5|||
33334880|NCT01425008|101118279|FG015|Dose Expansion Phase|Progressive Disease|8|||
33334881|NCT01425008|101118280|FG016|Dose Expansion Phase|Progressive Disease|9|||
33334882|NCT01425008|101118281|FG017|Dose Expansion Phase|Progressive Disease|2|||
33334883|NCT01425008|101118282|FG018|Dose Expansion Phase|Progressive Disease|10|||
33334884|NCT01425008|101118264|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
33334885|NCT01425008|101118265|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
33334886|NCT01425008|101118266|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
33334887|NCT01425008|101118267|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
33334888|NCT01425008|101118268|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
33334889|NCT01425008|101118269|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
33334890|NCT01425008|101118270|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
33334891|NCT01425008|101118271|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
33334892|NCT01425008|101118272|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
33334893|NCT01425008|101118273|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
33334894|NCT01425008|101118274|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
33334895|NCT01425008|101118275|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
33334896|NCT01425008|101118276|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
33334897|NCT01425008|101118277|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
33334898|NCT01425008|101118278|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
33334899|NCT01425008|101118279|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
33334900|NCT01425008|101118280|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
33334901|NCT01425008|101118281|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
33334902|NCT01425008|101118282|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
33334903|NCT01425008|101118264|FG000|Dose Expansion Phase|Other|0|||
33334904|NCT01425008|101118265|FG001|Dose Expansion Phase|Other|0|||
33334905|NCT01425008|101118266|FG002|Dose Expansion Phase|Other|0|||
33334906|NCT01425008|101118267|FG003|Dose Expansion Phase|Other|0|||
33334907|NCT01425008|101118268|FG004|Dose Expansion Phase|Other|0|||
33334908|NCT01425008|101118269|FG005|Dose Expansion Phase|Other|0|||
33334909|NCT01425008|101118270|FG006|Dose Expansion Phase|Other|0|||
33334910|NCT01425008|101118271|FG007|Dose Expansion Phase|Other|0|||
33334911|NCT01425008|101118272|FG008|Dose Expansion Phase|Other|0|||
33334912|NCT01425008|101118273|FG009|Dose Expansion Phase|Other|0|||
33334913|NCT01425008|101118274|FG010|Dose Expansion Phase|Other|0|||
33334914|NCT01425008|101118275|FG011|Dose Expansion Phase|Other|0|||
33334915|NCT01425008|101118276|FG012|Dose Expansion Phase|Other|1|||
33334916|NCT01425008|101118277|FG013|Dose Expansion Phase|Other|0|||
33334917|NCT01425008|101118278|FG014|Dose Expansion Phase|Other|0|||
33334918|NCT01425008|101118279|FG015|Dose Expansion Phase|Other|0|||
33334919|NCT01425008|101118280|FG016|Dose Expansion Phase|Other|2|||
33334920|NCT01425008|101118281|FG017|Dose Expansion Phase|Other|0|||
33334921|NCT01425008|101118282|FG018|Dose Expansion Phase|Other|4|||
33334922|NCT01425008|101118264|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
33334923|NCT01425008|101118265|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
33334924|NCT01425008|101118266|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
33334925|NCT01425008|101118267|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
33334926|NCT01425008|101118268|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
33528980|NCT00426764|101838173|FG000|Overall Study|Protocol Violation|1|||
33528981|NCT00426764|101838173|FG000|Overall Study|Withdrawal by Subject|4|||
33528982|NCT00426764|101838173|FG000|Overall Study|Physician Decision|6|||
33528983|NCT00426764|101838173|FG000|Overall Study|Compassionate Use|1|||
33334927|NCT01425008|101118269|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
33334928|NCT01425008|101118270|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
33334929|NCT01425008|101118271|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
33334930|NCT01425008|101118272|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
33334931|NCT01425008|101118273|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
33334932|NCT01425008|101118274|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
33334933|NCT01425008|101118275|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
33334934|NCT01425008|101118276|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
33334935|NCT01425008|101118277|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
33334936|NCT01425008|101118278|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
33403728|NCT01066819|101369366|FG000|Overall Study|Protocol Violation|12|||
33528984|NCT00426764|101838173|FG000|Overall Study|Progressive Disease|83|||
33528985|NCT00426764|101838173|FG000|Overall Study|Adverse Event|24|||
33528986|NCT00426764|101838173|FG000|Overall Study|Other|1|||
33528987|NCT00426764|101838173|FG000|Overall Study|Death|1|||
33528988|NCT00426764|101838173|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
33528989|NCT00878800|101838176|FG000|Overall Study|Adverse Event|0|||
33528990|NCT00878800|101838177|FG001|Overall Study|Adverse Event|0|||
33528991|NCT00878800|101838178|FG002|Overall Study|Adverse Event|2|||
33528992|NCT00878800|101838179|FG003|Overall Study|Adverse Event|0|||
33528993|NCT00878800|101838180|FG004|Overall Study|Adverse Event|1|||
33528994|NCT00878800|101838176|FG000|Overall Study|Progressive disease|1|||
33528995|NCT00878800|101838177|FG001|Overall Study|Progressive disease|5|||
33528996|NCT00878800|101838178|FG002|Overall Study|Progressive disease|6|||
33528997|NCT00878800|101838179|FG003|Overall Study|Progressive disease|5|||
33528998|NCT00878800|101838180|FG004|Overall Study|Progressive disease|13|||
33528999|NCT00878800|101838176|FG000|Overall Study|Withdrew consent|1|||
33529000|NCT00878800|101838177|FG001|Overall Study|Withdrew consent|1|||
33529001|NCT00878800|101838178|FG002|Overall Study|Withdrew consent|0|||
33529002|NCT00878800|101838179|FG003|Overall Study|Withdrew consent|1|||
33529003|NCT00878800|101838180|FG004|Overall Study|Withdrew consent|1|||
33529004|NCT00878800|101838176|FG000|Overall Study|Death|0|||
33611117|NCT03659136|102126851|FG001|Overall Study|Adverse Event|6|||
33611118|NCT03659136|102126850|FG000|Overall Study|Progressive disease|37|||
33611119|NCT03659136|102126851|FG001|Overall Study|Progressive disease|31|||
33611120|NCT03659136|102126850|FG000|Overall Study|Study closure|2|||
33611121|NCT03659136|102126851|FG001|Overall Study|Study closure|2|||
33611122|NCT03659136|102126850|FG000|Overall Study|Sponsor decision/recommendation|3|||
33611123|NCT03659136|102126851|FG001|Overall Study|Sponsor decision/recommendation|2|||
33611124|NCT03659136|102126850|FG000|Overall Study|Switched to other drug/therapy|2|||
33611125|NCT03659136|102126851|FG001|Overall Study|Switched to other drug/therapy|2|||
33611126|NCT03659136|102126850|FG000|Overall Study|Lack of clinical benefit|0|||
33204827|NCT04307186|100651413|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
33204828|NCT04307186|100651413|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
33334937|NCT01425008|101118279|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
33334938|NCT01425008|101118280|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
33334939|NCT01425008|101118281|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
33334940|NCT01425008|101118282|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
33334941|NCT01425008|101118264|FG000|Dose Expansion Phase|Adverse Event|0|||
33334942|NCT01425008|101118265|FG001|Dose Expansion Phase|Adverse Event|0|||
33334943|NCT01425008|101118266|FG002|Dose Expansion Phase|Adverse Event|0|||
33334944|NCT01425008|101118267|FG003|Dose Expansion Phase|Adverse Event|0|||
33334945|NCT01425008|101118268|FG004|Dose Expansion Phase|Adverse Event|0|||
33334946|NCT01425008|101118269|FG005|Dose Expansion Phase|Adverse Event|0|||
33334947|NCT01425008|101118270|FG006|Dose Expansion Phase|Adverse Event|0|||
33334948|NCT01425008|101118271|FG007|Dose Expansion Phase|Adverse Event|0|||
33334949|NCT01425008|101118272|FG008|Dose Expansion Phase|Adverse Event|0|||
33334950|NCT01425008|101118273|FG009|Dose Expansion Phase|Adverse Event|0|||
33334951|NCT01425008|101118274|FG010|Dose Expansion Phase|Adverse Event|2|||
33334952|NCT01425008|101118275|FG011|Dose Expansion Phase|Adverse Event|3|||
33334953|NCT01425008|101118276|FG012|Dose Expansion Phase|Adverse Event|3|||
33334954|NCT01425008|101118277|FG013|Dose Expansion Phase|Adverse Event|0|||
33334955|NCT01425008|101118278|FG014|Dose Expansion Phase|Adverse Event|1|||
33334956|NCT01425008|101118279|FG015|Dose Expansion Phase|Adverse Event|1|||
33334957|NCT01425008|101118280|FG016|Dose Expansion Phase|Adverse Event|5|||
33334958|NCT01425008|101118281|FG017|Dose Expansion Phase|Adverse Event|0|||
33334959|NCT01425008|101118282|FG018|Dose Expansion Phase|Adverse Event|3|||
33334960|NCT01425008|101118264|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
33334961|NCT01425008|101118265|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
33334962|NCT01425008|101118266|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
33334963|NCT01425008|101118267|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
33334964|NCT01425008|101118268|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
33334965|NCT01425008|101118269|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
33334966|NCT01425008|101118270|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
33529005|NCT00878800|101838177|FG001|Overall Study|Death|0|||
33529006|NCT00878800|101838178|FG002|Overall Study|Death|1|||
33204829|NCT03434119|100651415|FG000|Overall Study|Randomized but not treated|1|||
33334967|NCT01425008|101118271|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
33334968|NCT01425008|101118272|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
33529007|NCT00878800|101838179|FG003|Overall Study|Death|0|||
33529008|NCT00878800|101838180|FG004|Overall Study|Death|0|||
33334969|NCT01425008|101118273|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
33334970|NCT01425008|101118274|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
33334971|NCT01425008|101118275|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
33334972|NCT01425008|101118276|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
33334973|NCT01425008|101118277|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
33529009|NCT00878800|101838176|FG000|Overall Study|Other|1|||
33611127|NCT03659136|102126851|FG001|Overall Study|Lack of clinical benefit|1|||
33529010|NCT00878800|101838177|FG001|Overall Study|Other|1|||
33529011|NCT00878800|101838178|FG002|Overall Study|Other|0|||
33529012|NCT00878800|101838179|FG003|Overall Study|Other|0|||
33529013|NCT00878800|101838180|FG004|Overall Study|Other|1|||
33529014|NCT01383018|101838181|FG000|Overall Study|Adverse Event|14|||
33529015|NCT01383018|101838181|FG000|Overall Study|Death|10|||
33611128|NCT01278797|102126852|FG000|Period 1|Adverse Event|0|||
33611129|NCT01278797|102126853|FG001|Period 1|Adverse Event|1|||
33611130|NCT01278797|102126852|FG000|Period 1|Protocol Violation|1|||
33611131|NCT01278797|102126853|FG001|Period 1|Protocol Violation|0|||
33611132|NCT00622388|102126854|FG000|Overall Study|Disease Progression|47|||
33611133|NCT00622388|102126854|FG000|Overall Study|Adverse Event|6|||
33611134|NCT00622388|102126854|FG000|Overall Study|Protocol Violation|3|||
33611135|NCT00622388|102126854|FG000|Overall Study|Participant Refusal|1|||
33611136|NCT00622388|102126854|FG000|Overall Study|Death|3|||
33611137|NCT00622388|102126854|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
33611138|NCT00622388|102126854|FG000|Overall Study|Took Prohibited Medication|2|||
33611139|NCT00622388|102126854|FG000|Overall Study|Withdrew Consent|1|||
33204830|NCT03434119|100651416|FG001|Overall Study|Randomized but not treated|0|||
33611140|NCT00622388|102126854|FG000|Overall Study|Insurance Expired|1|||
33611141|NCT03304873|102126855|FG000|Overall Study|Lost to Follow-up|1|||
33611142|NCT03304873|102126856|FG001|Overall Study|Lost to Follow-up|8|||
33611143|NCT02980133|102126863|FG000|Overall Study|Other than specified|1|||
33611144|NCT02980133|102126864|FG001|Overall Study|Other than specified|1|||
33611145|NCT02980133|102126865|FG002|Overall Study|Other than specified|2|||
33204831|NCT03434119|100651415|FG000|Overall Study|Adverse Event|1|||
33204832|NCT03434119|100651416|FG001|Overall Study|Adverse Event|0|||
33204833|NCT03434119|100651415|FG000|Overall Study|Poor Compliance to Protocol|0|||
33204834|NCT03434119|100651416|FG001|Overall Study|Poor Compliance to Protocol|1|||
33204835|NCT03434119|100651415|FG000|Overall Study|Study Terminated by Sponsor|91|||
33204836|NCT03434119|100651416|FG001|Overall Study|Study Terminated by Sponsor|102|||
33529016|NCT01383018|101838181|FG000|Overall Study|Lost to Follow-up|5|||
33529017|NCT01383018|101838181|FG000|Overall Study|Physician Decision|5|||
33529018|NCT01383018|101838181|FG000|Overall Study|Withdrawal by Subject|9|||
33529019|NCT01383018|101838181|FG000|Overall Study|Subject not implanted|76|||
33529020|NCT01383018|101838181|FG000|Overall Study|Missed Visit|247|||
33529021|NCT01383018|101838181|FG000|Overall Study|Site closed early-not compliance related|7|||
33529022|NCT01383018|101838181|FG000|Overall Study|Patient moved away from site|1|||
33611146|NCT02980133|102126866|FG003|Overall Study|Other than specified|2|||
33611147|NCT02980133|102126863|FG000|Overall Study|Lost to Follow-up|0|||
33611148|NCT02980133|102126864|FG001|Overall Study|Lost to Follow-up|0|||
33611149|NCT02980133|102126865|FG002|Overall Study|Lost to Follow-up|1|||
33204837|NCT03434119|100651415|FG000|Overall Study|Withdrawal by Subject|7|||
33204838|NCT03434119|100651416|FG001|Overall Study|Withdrawal by Subject|5|||
33204839|NCT03434119|100651415|FG000|Overall Study|Other than specified|7|||
33204840|NCT03434119|100651416|FG001|Overall Study|Other than specified|5|||
33204841|NCT03376321|100651417|FG000|Overall Study|Other|5|||
33204842|NCT03376321|100651418|FG001|Overall Study|Other|1|||
33334974|NCT01425008|101118278|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
33334975|NCT01425008|101118279|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
33334976|NCT01425008|101118280|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
33334977|NCT01425008|101118281|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
33334978|NCT01425008|101118282|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
33334979|NCT01425008|101118264|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334980|NCT01425008|101118265|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334981|NCT01425008|101118266|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334982|NCT01425008|101118267|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334983|NCT01425008|101118268|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334984|NCT01425008|101118269|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33403729|NCT01066819|101369367|FG001|Overall Study|Protocol Violation|6|||
33529023|NCT01383018|101838181|FG000|Overall Study|Subject Incarcerated|1|||
33529024|NCT04162795|101838182|FG000|Overall Study|Other|16|||
33204843|NCT03376321|100651417|FG000|Overall Study|Withdrawal by Subject|8|||
33403730|NCT01066819|101369368|FG002|Overall Study|Protocol Violation|0|||
33529025|NCT04162795|101838182|FG000|Overall Study|Screen failures|10|||
33529026|NCT00735943|101838185|FG000|Overall Study|Lost to Follow-up|1|||
33611150|NCT02980133|102126866|FG003|Overall Study|Lost to Follow-up|3|||
33611151|NCT02980133|102126863|FG000|Overall Study|Protocol Violation|0|||
33529027|NCT00735943|101838185|FG000|Overall Study|Adverse Event|1|||
33529028|NCT01188668|101838186|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
33529029|NCT01188668|101838186|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
33529030|NCT01188668|101838186|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
33529031|NCT03126786|101838187|FG000|Overall Study|Adverse Event|3|||
33529032|NCT03126786|101838188|FG001|Overall Study|Adverse Event|0|||
33529033|NCT03126786|101838187|FG000|Overall Study|Lost to Follow-up|0|||
33529034|NCT03126786|101838188|FG001|Overall Study|Lost to Follow-up|1|||
33334985|NCT01425008|101118270|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334986|NCT01425008|101118271|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334987|NCT01425008|101118272|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334988|NCT01425008|101118273|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33529035|NCT03126786|101838187|FG000|Overall Study|Withdrawal by Subject|3|||
33529036|NCT03126786|101838188|FG001|Overall Study|Withdrawal by Subject|1|||
33529037|NCT00547248|101838190|FG000|Overall Study|Protocol Violation|0|||
33529038|NCT00547248|101838191|FG001|Overall Study|Protocol Violation|0|||
33529039|NCT00547248|101838192|FG002|Overall Study|Protocol Violation|1|||
33529040|NCT00547248|101838193|FG003|Overall Study|Protocol Violation|1|||
33529041|NCT00547248|101838190|FG000|Overall Study|Migrated/moved from study area|0|||
33529042|NCT00547248|101838191|FG001|Overall Study|Migrated/moved from study area|0|||
33529043|NCT00547248|101838192|FG002|Overall Study|Migrated/moved from study area|2|||
33529044|NCT00547248|101838193|FG003|Overall Study|Migrated/moved from study area|0|||
33529045|NCT00547248|101838190|FG000|Overall Study|Withdrawal by Subject|0|||
33529046|NCT00547248|101838191|FG001|Overall Study|Withdrawal by Subject|0|||
33529047|NCT00547248|101838192|FG002|Overall Study|Withdrawal by Subject|7|||
33529048|NCT00547248|101838193|FG003|Overall Study|Withdrawal by Subject|1|||
33529049|NCT04399889|101838198|FG000|Overall Study|Death|5|||
33529050|NCT04399889|101838199|FG001|Overall Study|Death|1|||
33529051|NCT04399889|101838200|FG002|Overall Study|Death|1|||
33529052|NCT01964989|101838202|FG000|Overall Study|Protocol Violation|3|||
33529053|NCT01964989|101838203|FG001|Overall Study|Protocol Violation|4|||
33529054|NCT01964989|101838202|FG000|Overall Study|Administrative Reason|103|||
33334989|NCT01425008|101118274|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334990|NCT01425008|101118275|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334991|NCT01425008|101118276|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334992|NCT01425008|101118277|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334993|NCT01425008|101118278|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334994|NCT01425008|101118279|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334995|NCT01425008|101118280|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334996|NCT01425008|101118281|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
33334997|NCT01425008|101118282|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
33334998|NCT01982292|101118283|FG000|Overall Study|Adverse Event|2|||
33334999|NCT01982292|101118284|FG001|Overall Study|Adverse Event|0|||
33335000|NCT01982292|101118283|FG000|Overall Study|Death|1|||
33335001|NCT01982292|101118284|FG001|Overall Study|Death|0|||
33335002|NCT01982292|101118283|FG000|Overall Study|Lost to Follow-up|2|||
33335003|NCT01982292|101118284|FG001|Overall Study|Lost to Follow-up|0|||
33335004|NCT01982292|101118283|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
33335005|NCT01982292|101118284|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
33335006|NCT01982292|101118283|FG000|Overall Study|Protocol Deviation|1|||
33335007|NCT01982292|101118284|FG001|Overall Study|Protocol Deviation|0|||
33335008|NCT01982292|101118283|FG000|Overall Study|Patient/Guardian Decision|3|||
33335009|NCT01982292|101118284|FG001|Overall Study|Patient/Guardian Decision|1|||
33335010|NCT01982292|101118283|FG000|Overall Study|Technical Problems|2|||
33335011|NCT01982292|101118284|FG001|Overall Study|Technical Problems|0|||
33335012|NCT01445951|101118285|FG000|Overall Study|Adverse Event|16|||
33335013|NCT01445951|101118286|FG001|Overall Study|Adverse Event|9|||
33335014|NCT01445951|101118287|FG002|Overall Study|Adverse Event|0|||
33335015|NCT01445951|101118285|FG000|Overall Study|Protocol Violation|2|||
33335016|NCT01445951|101118286|FG001|Overall Study|Protocol Violation|2|||
33335017|NCT01445951|101118287|FG002|Overall Study|Protocol Violation|2|||
33529055|NCT01964989|101838203|FG001|Overall Study|Administrative Reason|95|||
33335018|NCT01445951|101118285|FG000|Overall Study|Withdrawal by Subject|21|||
33335019|NCT01445951|101118286|FG001|Overall Study|Withdrawal by Subject|16|||
33335020|NCT01445951|101118287|FG002|Overall Study|Withdrawal by Subject|8|||
33335021|NCT01445951|101118285|FG000|Overall Study|Physician Decision|3|||
33335022|NCT01445951|101118286|FG001|Overall Study|Physician Decision|1|||
33335023|NCT01445951|101118287|FG002|Overall Study|Physician Decision|0|||
33335024|NCT01445951|101118285|FG000|Overall Study|Lost to Follow-up|1|||
33335025|NCT01445951|101118286|FG001|Overall Study|Lost to Follow-up|2|||
33529056|NCT01964989|101838202|FG000|Overall Study|Adverse Event|0|||
33529057|NCT01964989|101838203|FG001|Overall Study|Adverse Event|1|||
33529058|NCT01964989|101838202|FG000|Overall Study|Death|1|||
33529059|NCT01964989|101838203|FG001|Overall Study|Death|3|||
33529060|NCT01964989|101838202|FG000|Overall Study|Withdrawal by Subject|156|||
33611152|NCT02980133|102126864|FG001|Overall Study|Protocol Violation|1|||
33611153|NCT02980133|102126865|FG002|Overall Study|Protocol Violation|0|||
33529061|NCT01964989|101838203|FG001|Overall Study|Withdrawal by Subject|160|||
33403731|NCT01066819|101369369|FG003|Overall Study|Protocol Violation|0|||
33403732|NCT01066819|101369370|FG004|Overall Study|Protocol Violation|0|||
33403733|NCT01066819|101369371|FG005|Overall Study|Protocol Violation|0|||
33529062|NCT01964989|101838202|FG000|Overall Study|Lost to Follow-up|254|||
33529063|NCT01964989|101838203|FG001|Overall Study|Lost to Follow-up|232|||
33611154|NCT02980133|102126866|FG003|Overall Study|Protocol Violation|0|||
33611155|NCT02980133|102126863|FG000|Overall Study|Withdrawal by parent/guardian|6|||
33611156|NCT02980133|102126864|FG001|Overall Study|Withdrawal by parent/guardian|3|||
33611157|NCT02980133|102126865|FG002|Overall Study|Withdrawal by parent/guardian|3|||
33204844|NCT03376321|100651418|FG001|Overall Study|Withdrawal by Subject|14|||
33529064|NCT01964989|101838202|FG000|Overall Study|Other|267|||
33529065|NCT01964989|101838203|FG001|Overall Study|Other|252|||
33529066|NCT04265261|101838204|FG000|Overall Study|Adverse Event|2|||
33529067|NCT04265261|101838205|FG001|Overall Study|Adverse Event|0|||
33204845|NCT03376321|100651417|FG000|Overall Study|Lost to Follow-up|1|||
33204846|NCT03376321|100651418|FG001|Overall Study|Lost to Follow-up|7|||
33204847|NCT03376321|100651417|FG000|Overall Study|Death|4|||
33204848|NCT03376321|100651418|FG001|Overall Study|Death|0|||
33204849|NCT03376321|100651417|FG000|Overall Study|Randomized, not treated|5|||
33335026|NCT01445951|101118287|FG002|Overall Study|Lost to Follow-up|4|||
33335027|NCT01445951|101118285|FG000|Overall Study|Pregnancy|0|||
33335028|NCT01445951|101118286|FG001|Overall Study|Pregnancy|1|||
33335029|NCT01445951|101118287|FG002|Overall Study|Pregnancy|4|||
33335030|NCT01445951|101118285|FG000|Overall Study|Death|0|||
33335031|NCT01445951|101118286|FG001|Overall Study|Death|0|||
33335032|NCT01445951|101118287|FG002|Overall Study|Death|1|||
33335033|NCT01445951|101118285|FG000|Overall Study|Non-compliance with study drug|1|||
33335034|NCT01445951|101118286|FG001|Overall Study|Non-compliance with study drug|2|||
33335035|NCT01445951|101118287|FG002|Overall Study|Non-compliance with study drug|0|||
33335036|NCT01445951|101118285|FG000|Overall Study|Non-compliance with protocol|0|||
33335037|NCT01445951|101118286|FG001|Overall Study|Non-compliance with protocol|1|||
33335038|NCT01445951|101118287|FG002|Overall Study|Non-compliance with protocol|0|||
33335039|NCT01445951|101118285|FG000|Overall Study|Sponsor decision - subject travel|0|||
33335040|NCT01445951|101118286|FG001|Overall Study|Sponsor decision - subject travel|1|||
33335041|NCT01445951|101118287|FG002|Overall Study|Sponsor decision - subject travel|0|||
33335042|NCT01445951|101118285|FG000|Overall Study|Cough|0|||
33335043|NCT01445951|101118286|FG001|Overall Study|Cough|1|||
33335044|NCT01445951|101118287|FG002|Overall Study|Cough|0|||
33335045|NCT00623428|101118292|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
33335046|NCT00623428|101118293|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
33335047|NCT00623428|101118292|FG000|Treatment Period|Death|0|||
33335048|NCT00623428|101118293|FG001|Treatment Period|Death|1|||
33335049|NCT00623428|101118292|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
33335050|NCT00623428|101118293|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
33335051|NCT00623428|101118292|FG000|Treatment Period|Insufficient therapeutic response|0|||
33335052|NCT00623428|101118293|FG001|Treatment Period|Insufficient therapeutic response|2|||
33403734|NCT01066819|101369366|FG000|Overall Study|Withdrawal by Subject|29|||
33529068|NCT04265261|101838206|FG002|Overall Study|Adverse Event|0|||
33529069|NCT04265261|101838204|FG000|Overall Study|Death|1|||
33529070|NCT04265261|101838205|FG001|Overall Study|Death|0|||
33529071|NCT04265261|101838206|FG002|Overall Study|Death|0|||
33335053|NCT00623428|101118292|FG000|Treatment Period|Other|0|||
33611158|NCT02980133|102126866|FG003|Overall Study|Withdrawal by parent/guardian|1|||
33611159|NCT02980133|102126863|FG000|Overall Study|Withdrawal by Subject|0|||
33611160|NCT02980133|102126864|FG001|Overall Study|Withdrawal by Subject|0|||
33611161|NCT02980133|102126865|FG002|Overall Study|Withdrawal by Subject|1|||
33611162|NCT02980133|102126866|FG003|Overall Study|Withdrawal by Subject|0|||
33611163|NCT00994643|102126877|FG000|Overall Study|Withdrawal by Subject|1|||
33611164|NCT00477152|102126880|FG000|Overall Study|Parent withdrew consent|2|||
33611165|NCT00477152|102126880|FG000|Overall Study|Adverse Event|1|||
33611166|NCT00428389|102126885|FG000|Core Phase|Adverse Event|6|||
33611167|NCT00428389|102126886|FG001|Core Phase|Adverse Event|4|||
33204850|NCT03376321|100651418|FG001|Overall Study|Randomized, not treated|3|||
33335054|NCT00623428|101118293|FG001|Treatment Period|Other|1|||
33335055|NCT00623428|101118292|FG000|Treatment Period|Withdrawal by Subject|0|||
33335056|NCT00623428|101118293|FG001|Treatment Period|Withdrawal by Subject|1|||
33335057|NCT00623428|101118292|FG000|Follow-up Period|Relapse post-treatment|11|||
33335058|NCT00623428|101118293|FG001|Follow-up Period|Relapse post-treatment|3|||
33529072|NCT04265261|101838204|FG000|Overall Study|Lost to Follow-up|4|||
33529073|NCT04265261|101838205|FG001|Overall Study|Lost to Follow-up|1|||
33529074|NCT04265261|101838206|FG002|Overall Study|Lost to Follow-up|3|||
33529075|NCT04265261|101838204|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33403735|NCT01066819|101369367|FG001|Overall Study|Withdrawal by Subject|11|||
33403736|NCT01066819|101369368|FG002|Overall Study|Withdrawal by Subject|6|||
33403737|NCT01066819|101369369|FG003|Overall Study|Withdrawal by Subject|0|||
33403738|NCT01066819|101369370|FG004|Overall Study|Withdrawal by Subject|0|||
33403739|NCT01066819|101369371|FG005|Overall Study|Withdrawal by Subject|0|||
33403740|NCT01066819|101369366|FG000|Overall Study|Administrative|6|||
33529076|NCT04265261|101838205|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33529077|NCT04265261|101838206|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33529078|NCT04265261|101838204|FG000|Overall Study|Physician Decision|0|||
33529079|NCT04265261|101838205|FG001|Overall Study|Physician Decision|0|||
33335059|NCT00623428|101118292|FG000|Follow-up Period|Failure to return|10|||
33335060|NCT00623428|101118293|FG001|Follow-up Period|Failure to return|2|||
33335061|NCT00623428|101118292|FG000|Follow-up Period|Patient withdrew consent|5|||
33335062|NCT00623428|101118293|FG001|Follow-up Period|Patient withdrew consent|4|||
33335063|NCT00623428|101118292|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
33335064|NCT00623428|101118293|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
33335065|NCT00623428|101118292|FG000|Follow-up Period|Did not cooperate|0|||
33335066|NCT00623428|101118293|FG001|Follow-up Period|Did not cooperate|3|||
33335067|NCT00623428|101118292|FG000|Follow-up Period|Reason not specified|1|||
33335068|NCT00623428|101118293|FG001|Follow-up Period|Reason not specified|1|||
33335069|NCT00623428|101118292|FG000|Follow-up Period|Death|0|||
33335070|NCT00623428|101118293|FG001|Follow-up Period|Death|1|||
33335071|NCT00193063|101118295|FG000|Overall Study|Lack of Efficacy|3|||
33529080|NCT04265261|101838206|FG002|Overall Study|Physician Decision|1|||
33529081|NCT04265261|101838204|FG000|Overall Study|Protocol Deviation|0|||
33529082|NCT04265261|101838205|FG001|Overall Study|Protocol Deviation|2|||
33529083|NCT04265261|101838206|FG002|Overall Study|Protocol Deviation|0|||
33529084|NCT04265261|101838204|FG000|Overall Study|Withdrawal by Subject|2|||
33335072|NCT00193063|101118295|FG000|Overall Study|Adverse Event|1|||
33335073|NCT00879697|101118296|FG000|Overall Study|Physician Decision|2|||
33335074|NCT00879697|101118297|FG001|Overall Study|Physician Decision|2|||
33335075|NCT03809611|101118298|FG000|Overall Study|Withdrawal by Subject|1|||
33335076|NCT03809611|101118299|FG001|Overall Study|Withdrawal by Subject|1|||
33335077|NCT01836783|101118311|FG000|Overall Study|Withdrawal by Subject|0|||
33335078|NCT01836783|101118312|FG001|Overall Study|Withdrawal by Subject|2|||
33335079|NCT00751400|101118313|FG000|Overall Study|Lost to Follow-up|10|||
33335080|NCT04766021|101118314|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
33335081|NCT04766021|101118314|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
33335082|NCT01318109|101118315|FG000|Overall Study|Adverse Event|0|||
33335083|NCT01318109|101118316|FG001|Overall Study|Adverse Event|2|||
33335084|NCT01318109|101118317|FG002|Overall Study|Adverse Event|0|||
33335085|NCT01318109|101118315|FG000|Overall Study|Withdrawal by Subject|1|||
33335086|NCT01318109|101118316|FG001|Overall Study|Withdrawal by Subject|0|||
33335087|NCT01318109|101118317|FG002|Overall Study|Withdrawal by Subject|0|||
33335088|NCT01318109|101118315|FG000|Overall Study|Schedule Conflict|0|||
33335089|NCT01318109|101118316|FG001|Overall Study|Schedule Conflict|1|||
33335090|NCT01318109|101118317|FG002|Overall Study|Schedule Conflict|0|||
33335091|NCT04418076|101118318|FG000|Overall Study|Death|1|||
33335092|NCT04418076|101118319|FG001|Overall Study|Death|0|||
33335093|NCT04418076|101118320|FG002|Overall Study|Death|0|||
33335094|NCT04418076|101118321|FG003|Overall Study|Death|0|||
33335095|NCT04418076|101118318|FG000|Overall Study|Lost to Follow-up|2|||
33335096|NCT04418076|101118319|FG001|Overall Study|Lost to Follow-up|5|||
33335097|NCT04418076|101118320|FG002|Overall Study|Lost to Follow-up|1|||
33335098|NCT04418076|101118321|FG003|Overall Study|Lost to Follow-up|2|||
33335099|NCT04418076|101118318|FG000|Overall Study|Withdrawal by Subject|1|||
33335100|NCT04418076|101118319|FG001|Overall Study|Withdrawal by Subject|0|||
33335101|NCT04418076|101118320|FG002|Overall Study|Withdrawal by Subject|1|||
33403741|NCT01066819|101369367|FG001|Overall Study|Administrative|4|||
33403742|NCT01066819|101369368|FG002|Overall Study|Administrative|2|||
33403743|NCT01066819|101369369|FG003|Overall Study|Administrative|0|||
33403744|NCT01066819|101369370|FG004|Overall Study|Administrative|0|||
33529085|NCT04265261|101838205|FG001|Overall Study|Withdrawal by Subject|1|||
33335102|NCT04418076|101118321|FG003|Overall Study|Withdrawal by Subject|1|||
33529086|NCT04265261|101838206|FG002|Overall Study|Withdrawal by Subject|4|||
33611168|NCT00428389|102126885|FG000|Core Phase|Lack of Efficacy|2|||
33335103|NCT04418076|101118318|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
33335104|NCT04418076|101118319|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
33335105|NCT04418076|101118320|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
33335106|NCT04418076|101118321|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
33335107|NCT00264238|101118322|FG000|Overall Study|Protocol Violation|1|||
33529087|NCT04004260|101838207|FG000|Overall Study|Withdrawal by Subject|7|||
33335108|NCT01250379|101118323|FG000|Overall Study|Death|141|||
33335109|NCT01250379|101118324|FG001|Overall Study|Death|148|||
33529088|NCT04004260|101838208|FG001|Overall Study|Withdrawal by Subject|3|||
33335110|NCT01250379|101118323|FG000|Overall Study|Withdrawal by Subject|32|||
33403745|NCT01066819|101369371|FG005|Overall Study|Administrative|0|||
33335111|NCT01250379|101118324|FG001|Overall Study|Withdrawal by Subject|20|||
33335112|NCT01250379|101118323|FG000|Overall Study|Physician Decision|11|||
33335113|NCT01250379|101118324|FG001|Overall Study|Physician Decision|3|||
33335114|NCT01250379|101118323|FG000|Overall Study|Protocol Violation|2|||
33335115|NCT01250379|101118324|FG001|Overall Study|Protocol Violation|8|||
33335116|NCT01250379|101118323|FG000|Overall Study|Lost to Follow-up|9|||
33335117|NCT01250379|101118324|FG001|Overall Study|Lost to Follow-up|6|||
33335118|NCT01250379|101118323|FG000|Overall Study|Adverse Event|5|||
33335119|NCT01250379|101118324|FG001|Overall Study|Adverse Event|4|||
33335120|NCT01250379|101118323|FG000|Overall Study|Other|0|||
33335121|NCT01250379|101118324|FG001|Overall Study|Other|4|||
33335122|NCT01250379|101118323|FG000|Overall Study|Participant noncompliance|2|||
33335123|NCT01250379|101118324|FG001|Overall Study|Participant noncompliance|0|||
33335124|NCT01604265|101118325|FG000|Overall Study|Adverse Event|1|||
33335125|NCT01604265|101118326|FG001|Overall Study|Adverse Event|0|||
33335126|NCT01604265|101118325|FG000|Overall Study|Withdrawal by Subject|1|||
33335127|NCT01604265|101118326|FG001|Overall Study|Withdrawal by Subject|0|||
33335128|NCT01566773|101118327|FG000|Overall Study|Protocol specified criteria|4|||
33335129|NCT01566773|101118327|FG000|Overall Study|Protocol Violation|4|||
33335130|NCT01566773|101118327|FG000|Overall Study|Withdrawal by Subject|9|||
33335131|NCT01566773|101118327|FG000|Overall Study|Administrative reason|1|||
33335132|NCT01566773|101118327|FG000|Overall Study|Adverse Event|10|||
33335133|NCT01566773|101118327|FG000|Overall Study|Physician Decision|2|||
33335134|NCT00414453|101118328|FG000|Overall Study|Abnormal lab work|16|||
33335135|NCT00401375|101118329|FG000|Overall Study|Protocol Violation|2|||
33335136|NCT00401375|101118330|FG001|Overall Study|Protocol Violation|2|||
33335137|NCT00401375|101118331|FG002|Overall Study|Protocol Violation|1|||
33335138|NCT00401375|101118329|FG000|Overall Study|Adverse Event|6|||
33335139|NCT00401375|101118330|FG001|Overall Study|Adverse Event|11|||
33335140|NCT00401375|101118331|FG002|Overall Study|Adverse Event|10|||
33335141|NCT00401375|101118329|FG000|Overall Study|Withdrawal by Subject|9|||
33335142|NCT00401375|101118330|FG001|Overall Study|Withdrawal by Subject|7|||
33335143|NCT00401375|101118331|FG002|Overall Study|Withdrawal by Subject|7|||
33335144|NCT00401375|101118329|FG000|Overall Study|Lost to Follow-up|0|||
33335145|NCT00401375|101118330|FG001|Overall Study|Lost to Follow-up|1|||
33335146|NCT00401375|101118331|FG002|Overall Study|Lost to Follow-up|1|||
33335147|NCT00401375|101118329|FG000|Overall Study|Other than specified|2|||
33335148|NCT00401375|101118330|FG001|Overall Study|Other than specified|1|||
33335149|NCT00401375|101118331|FG002|Overall Study|Other than specified|3|||
33335150|NCT00401375|101118329|FG000|Overall Study|Randomized but not treated|3|||
33335151|NCT00401375|101118330|FG001|Overall Study|Randomized but not treated|3|||
33335152|NCT00401375|101118331|FG002|Overall Study|Randomized but not treated|3|||
33335153|NCT00762892|101118332|FG000|Overall Study|Lost to Follow-up|2|||
33335154|NCT00762892|101118333|FG001|Overall Study|Lost to Follow-up|5|||
33335155|NCT00762892|101118332|FG000|Overall Study|Withdrawal by Subject|0|||
33335156|NCT00762892|101118333|FG001|Overall Study|Withdrawal by Subject|1|||
33335157|NCT00762892|101118332|FG000|Overall Study|Death|1|||
33335158|NCT00762892|101118333|FG001|Overall Study|Death|0|||
33335159|NCT00762892|101118332|FG000|Overall Study|Pregnancy|1|||
33335160|NCT00762892|101118333|FG001|Overall Study|Pregnancy|0|||
33335161|NCT00762892|101118332|FG000|Overall Study|Incarceration|1|||
33335162|NCT00762892|101118333|FG001|Overall Study|Incarceration|0|||
33335163|NCT01074190|101118334|FG000|Overall Study|Emergency Cesarean Delivery|1|||
33335164|NCT01074190|101118335|FG001|Overall Study|Emergency Cesarean Delivery|2|||
33335165|NCT01074190|101118336|FG002|Overall Study|Emergency Cesarean Delivery|1|||
33335166|NCT01074190|101118334|FG000|Overall Study|Protocol Violation|2|||
33335167|NCT01074190|101118335|FG001|Overall Study|Protocol Violation|1|||
33335168|NCT01074190|101118336|FG002|Overall Study|Protocol Violation|0|||
33335169|NCT01074190|101118334|FG000|Overall Study|Delivered in under 90 minutes|0|||
33529089|NCT04004260|101838207|FG000|Overall Study|Lost to Follow-up|22|||
33529090|NCT04004260|101838208|FG001|Overall Study|Lost to Follow-up|12|||
33529091|NCT04004260|101838207|FG000|Overall Study|Did not engage in intervention|13|||
33335170|NCT01074190|101118335|FG001|Overall Study|Delivered in under 90 minutes|2|||
33529092|NCT04004260|101838208|FG001|Overall Study|Did not engage in intervention|17|||
33335171|NCT01074190|101118336|FG002|Overall Study|Delivered in under 90 minutes|1|||
33335172|NCT01074190|101118334|FG000|Overall Study|Subject withdrew consent|1|||
33335173|NCT01074190|101118335|FG001|Overall Study|Subject withdrew consent|1|||
33529093|NCT01826981|101838212|FG000|Overall Study|Lack of Efficacy|0|||
33335174|NCT01074190|101118336|FG002|Overall Study|Subject withdrew consent|1|||
33335175|NCT04962022|101118344|FG000|Period 1|Withdrawal by Subject|1|||
33335176|NCT04962022|101118345|FG001|Period 1|Withdrawal by Subject|0|||
33335177|NCT01251367|101118346|FG000|Overall Study|Protocol Violation|1|||
33335178|NCT01251367|101118346|FG000|Overall Study|Lack of Efficacy|2|||
33335179|NCT01251367|101118346|FG000|Overall Study|Adverse Event|19|||
33335180|NCT01251367|101118346|FG000|Overall Study|Withdrawal by Subject|36|||
33335181|NCT01251367|101118346|FG000|Overall Study|Lost to Follow-up|5|||
33335182|NCT01251367|101118346|FG000|Overall Study|Subject Required Alternative Treatment|7|||
33204851|NCT00464542|100651419|FG000|Pre-treatment|Withdrawal by Subject|2|||
33204852|NCT03646513|100651423|FG000|Overall Study|Premature study termination|4|||
33204853|NCT02493127|100651424|FG000|Overall Study|Lost to Follow-up|1|||
33204854|NCT02493127|100651425|FG001|Overall Study|Lost to Follow-up|1|||
33204855|NCT04642638|100651426|FG000|Overall Study|Withdrawal by Subject|23|||
33204856|NCT04642638|100651427|FG001|Overall Study|Withdrawal by Subject|29|||
33204857|NCT04642638|100651428|FG002|Overall Study|Withdrawal by Subject|9|||
33204858|NCT04642638|100651429|FG003|Overall Study|Withdrawal by Subject|7|||
33204859|NCT04642638|100651430|FG004|Overall Study|Withdrawal by Subject|61|||
33204860|NCT04642638|100651431|FG005|Overall Study|Withdrawal by Subject|27|||
33204861|NCT04642638|100651426|FG000|Overall Study|Lost to Follow-up|17|||
33204862|NCT04642638|100651427|FG001|Overall Study|Lost to Follow-up|18|||
33204863|NCT04642638|100651428|FG002|Overall Study|Lost to Follow-up|5|||
33204864|NCT04642638|100651429|FG003|Overall Study|Lost to Follow-up|5|||
33204865|NCT04642638|100651430|FG004|Overall Study|Lost to Follow-up|6|||
33204866|NCT04642638|100651431|FG005|Overall Study|Lost to Follow-up|3|||
33204867|NCT04642638|100651426|FG000|Overall Study|Adverse Event|0|||
33204868|NCT04642638|100651427|FG001|Overall Study|Adverse Event|0|||
33204869|NCT04642638|100651428|FG002|Overall Study|Adverse Event|1|||
33204870|NCT04642638|100651429|FG003|Overall Study|Adverse Event|0|||
33204871|NCT04642638|100651430|FG004|Overall Study|Adverse Event|10|||
33204872|NCT04642638|100651431|FG005|Overall Study|Adverse Event|3|||
33204873|NCT04642638|100651426|FG000|Overall Study|Reason Not Specified|1|||
33204874|NCT04642638|100651427|FG001|Overall Study|Reason Not Specified|4|||
33204875|NCT04642638|100651428|FG002|Overall Study|Reason Not Specified|0|||
33204876|NCT04642638|100651429|FG003|Overall Study|Reason Not Specified|0|||
33204877|NCT04642638|100651430|FG004|Overall Study|Reason Not Specified|38|||
33204878|NCT04642638|100651431|FG005|Overall Study|Reason Not Specified|16|||
33204879|NCT04642638|100651426|FG000|Overall Study|Physician Decision|0|||
33204880|NCT04642638|100651427|FG001|Overall Study|Physician Decision|0|||
33204881|NCT04642638|100651428|FG002|Overall Study|Physician Decision|0|||
33204882|NCT04642638|100651429|FG003|Overall Study|Physician Decision|0|||
33204883|NCT04642638|100651430|FG004|Overall Study|Physician Decision|2|||
33204884|NCT04642638|100651431|FG005|Overall Study|Physician Decision|1|||
33204885|NCT04642638|100651426|FG000|Overall Study|Protocol Deviation|0|||
33204886|NCT04642638|100651427|FG001|Overall Study|Protocol Deviation|0|||
33204887|NCT04642638|100651428|FG002|Overall Study|Protocol Deviation|0|||
33204888|NCT04642638|100651429|FG003|Overall Study|Protocol Deviation|0|||
33204889|NCT04642638|100651430|FG004|Overall Study|Protocol Deviation|1|||
33204890|NCT04642638|100651431|FG005|Overall Study|Protocol Deviation|3|||
33204891|NCT04642638|100651426|FG000|Overall Study|Study Terminated|0|||
33204892|NCT04642638|100651427|FG001|Overall Study|Study Terminated|0|||
33204893|NCT04642638|100651428|FG002|Overall Study|Study Terminated|0|||
33204894|NCT04642638|100651429|FG003|Overall Study|Study Terminated|0|||
33529094|NCT01826981|101838213|FG001|Overall Study|Lack of Efficacy|1|||
33529095|NCT01826981|101838214|FG002|Overall Study|Lack of Efficacy|0|||
33529096|NCT01826981|101838215|FG003|Overall Study|Lack of Efficacy|0|||
33204895|NCT04642638|100651430|FG004|Overall Study|Study Terminated|484|||
33204896|NCT04642638|100651431|FG005|Overall Study|Study Terminated|250|||
33204897|NCT04642638|100651426|FG000|Overall Study|Pregnancy|0|||
33204898|NCT04642638|100651427|FG001|Overall Study|Pregnancy|0|||
33204899|NCT04642638|100651428|FG002|Overall Study|Pregnancy|0|||
33204900|NCT04642638|100651429|FG003|Overall Study|Pregnancy|0|||
33204901|NCT04642638|100651430|FG004|Overall Study|Pregnancy|1|||
33529097|NCT01826981|101838216|FG004|Overall Study|Lack of Efficacy|5|||
33529098|NCT01826981|101838217|FG005|Overall Study|Lack of Efficacy|0|||
33529099|NCT01826981|101838218|FG006|Overall Study|Lack of Efficacy|0|||
33529100|NCT01826981|101838219|FG007|Overall Study|Lack of Efficacy|8|||
33529101|NCT01826981|101838220|FG008|Overall Study|Lack of Efficacy|7|||
33529102|NCT01826981|101838221|FG009|Overall Study|Lack of Efficacy|0|||
33204902|NCT04642638|100651431|FG005|Overall Study|Pregnancy|0|||
33204903|NCT01934218|100651433|FG000|Double-blind Phase|Adverse Event|8|||
33204904|NCT01934218|100651434|FG001|Double-blind Phase|Adverse Event|8|||
33204905|NCT01934218|100651433|FG000|Double-blind Phase|Lack of Efficacy|6|||
33204906|NCT01934218|100651434|FG001|Double-blind Phase|Lack of Efficacy|7|||
33204907|NCT01934218|100651433|FG000|Double-blind Phase|Lost to Follow-up|7|||
33204908|NCT01934218|100651434|FG001|Double-blind Phase|Lost to Follow-up|14|||
33204909|NCT01934218|100651433|FG000|Double-blind Phase|Physician Decision|1|||
33403746|NCT01066819|101369366|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
33204910|NCT01934218|100651434|FG001|Double-blind Phase|Physician Decision|2|||
33204911|NCT01934218|100651433|FG000|Double-blind Phase|Protocol Violation|4|||
33204912|NCT01934218|100651434|FG001|Double-blind Phase|Protocol Violation|0|||
33204913|NCT01934218|100651433|FG000|Double-blind Phase|Withdrawal by Subject|16|||
33204914|NCT01934218|100651434|FG001|Double-blind Phase|Withdrawal by Subject|13|||
33204915|NCT01934218|100651433|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
33529103|NCT01826981|101838222|FG010|Overall Study|Lack of Efficacy|1|||
33204916|NCT01934218|100651434|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
33403747|NCT01066819|101369367|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
33529104|NCT01826981|101838223|FG011|Overall Study|Lack of Efficacy|0|||
33611169|NCT00428389|102126886|FG001|Core Phase|Lack of Efficacy|0|||
33611170|NCT00428389|102126885|FG000|Core Phase|Abnormal test procedure result(s)|0|||
33335183|NCT01251367|101118346|FG000|Overall Study|No Study Drug Available|1|||
33335184|NCT01251367|101118346|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
33335185|NCT01251367|101118346|FG000|Overall Study|End of Study Visit Performed in Error|1|||
33611171|NCT00428389|102126886|FG001|Core Phase|Abnormal test procedure result(s)|1|||
33611172|NCT00428389|102126885|FG000|Core Phase|Withdrawal by Subject|3|||
33611173|NCT00428389|102126886|FG001|Core Phase|Withdrawal by Subject|4|||
33611174|NCT00428389|102126885|FG000|Core Phase|Protocol deviation|0|||
33611175|NCT00428389|102126886|FG001|Core Phase|Protocol deviation|2|||
33204917|NCT01934218|100651433|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
33403748|NCT01066819|101369368|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
33403749|NCT01066819|101369369|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
33403750|NCT01066819|101369370|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
33403751|NCT01066819|101369371|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
33403752|NCT01066819|101369366|FG000|Overall Study|Early termination|2|||
33403753|NCT01066819|101369367|FG001|Overall Study|Early termination|0|||
33403754|NCT01066819|101369368|FG002|Overall Study|Early termination|0|||
33403755|NCT01066819|101369369|FG003|Overall Study|Early termination|0|||
33403756|NCT01066819|101369370|FG004|Overall Study|Early termination|0|||
33403757|NCT01066819|101369371|FG005|Overall Study|Early termination|0|||
33403758|NCT01066819|101369366|FG000|Overall Study|Failed to return|298|||
33529105|NCT01826981|101838224|FG012|Overall Study|Lack of Efficacy|0|||
33529106|NCT01826981|101838225|FG013|Overall Study|Lack of Efficacy|3|||
33529107|NCT01826981|101838226|FG014|Overall Study|Lack of Efficacy|0|||
33529108|NCT01826981|101838212|FG000|Overall Study|Lost to Follow-up|0|||
33529109|NCT01826981|101838213|FG001|Overall Study|Lost to Follow-up|0|||
33204918|NCT01934218|100651434|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
33204919|NCT01934218|100651433|FG000|Open-Label Phase|Adverse Event|2|||
33204920|NCT01934218|100651434|FG001|Open-Label Phase|Adverse Event|4|||
33204921|NCT01934218|100651433|FG000|Open-Label Phase|Lack of Efficacy|1|||
33204922|NCT01934218|100651434|FG001|Open-Label Phase|Lack of Efficacy|4|||
33204923|NCT01934218|100651433|FG000|Open-Label Phase|Lost to Follow-up|4|||
33335186|NCT00513409|101118347|FG000|Overall Study|Adverse Event|0|||
33335187|NCT00513409|101118348|FG001|Overall Study|Adverse Event|1|||
33335188|NCT00513409|101118347|FG000|Overall Study|Withdrawal by Subject|0|||
33335189|NCT00513409|101118348|FG001|Overall Study|Withdrawal by Subject|2|||
33335190|NCT00513409|101118347|FG000|Overall Study|Lost to Follow-up|0|||
33335191|NCT00513409|101118348|FG001|Overall Study|Lost to Follow-up|1|||
33529110|NCT01826981|101838214|FG002|Overall Study|Lost to Follow-up|0|||
33529111|NCT01826981|101838215|FG003|Overall Study|Lost to Follow-up|0|||
33335192|NCT00513409|101118347|FG000|Overall Study|Physician Decision|1|||
33335193|NCT00513409|101118348|FG001|Overall Study|Physician Decision|0|||
33335194|NCT00513409|101118347|FG000|Overall Study|Visit 3 not done|1|||
33335195|NCT00513409|101118348|FG001|Overall Study|Visit 3 not done|2|||
33335196|NCT02321436|101118349|FG000|Overall Study|Withdrawal by Subject|1|||
33611176|NCT00428389|102126885|FG000|Extension Phase|Adverse Event|17|||
33611177|NCT00428389|102126886|FG001|Extension Phase|Adverse Event|11|||
33611178|NCT00428389|102126885|FG000|Extension Phase|Lack of Efficacy|4|||
33611179|NCT00428389|102126886|FG001|Extension Phase|Lack of Efficacy|3|||
33611180|NCT00428389|102126885|FG000|Extension Phase|Withdrawal by Subject|6|||
33611181|NCT00428389|102126886|FG001|Extension Phase|Withdrawal by Subject|6|||
33611182|NCT00428389|102126885|FG000|Extension Phase|Lost to Follow-up|0|||
33611183|NCT00428389|102126886|FG001|Extension Phase|Lost to Follow-up|3|||
33611184|NCT00428389|102126885|FG000|Extension Phase|Death|1|||
33204924|NCT01934218|100651434|FG001|Open-Label Phase|Lost to Follow-up|2|||
33204925|NCT01934218|100651433|FG000|Open-Label Phase|Physician Decision|1|||
33204926|NCT01934218|100651434|FG001|Open-Label Phase|Physician Decision|0|||
33204927|NCT01934218|100651433|FG000|Open-Label Phase|Protocol Violation|1|||
33204928|NCT01934218|100651434|FG001|Open-Label Phase|Protocol Violation|0|||
33204929|NCT01934218|100651433|FG000|Open-Label Phase|Withdrawal by Subject|13|||
33335197|NCT02321436|101118350|FG001|Overall Study|Withdrawal by Subject|0|||
33335198|NCT02321436|101118349|FG000|Overall Study|Lost to Follow-up|0|||
33335199|NCT02321436|101118350|FG001|Overall Study|Lost to Follow-up|1|||
33403759|NCT01066819|101369367|FG001|Overall Study|Failed to return|107|||
33403760|NCT01066819|101369368|FG002|Overall Study|Failed to return|68|||
33403761|NCT01066819|101369369|FG003|Overall Study|Failed to return|7|||
33403762|NCT01066819|101369370|FG004|Overall Study|Failed to return|2|||
33335200|NCT01650636|101118351|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
33529112|NCT01826981|101838216|FG004|Overall Study|Lost to Follow-up|1|||
33529113|NCT01826981|101838217|FG005|Overall Study|Lost to Follow-up|1|||
33611185|NCT00428389|102126886|FG001|Extension Phase|Death|0|||
33611186|NCT00428389|102126885|FG000|Extension Phase|Protocol Violation|3|||
33204930|NCT01934218|100651434|FG001|Open-Label Phase|Withdrawal by Subject|11|||
33335201|NCT01650636|101118352|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
33403763|NCT01066819|101369371|FG005|Overall Study|Failed to return|3|||
33529114|NCT01826981|101838218|FG006|Overall Study|Lost to Follow-up|0|||
33529115|NCT01826981|101838219|FG007|Overall Study|Lost to Follow-up|1|||
33529116|NCT01826981|101838220|FG008|Overall Study|Lost to Follow-up|0|||
33529117|NCT01826981|101838221|FG009|Overall Study|Lost to Follow-up|1|||
33529118|NCT01826981|101838222|FG010|Overall Study|Lost to Follow-up|1|||
33529119|NCT01826981|101838223|FG011|Overall Study|Lost to Follow-up|1|||
33529120|NCT01826981|101838224|FG012|Overall Study|Lost to Follow-up|1|||
33529121|NCT01826981|101838225|FG013|Overall Study|Lost to Follow-up|0|||
33529122|NCT01826981|101838226|FG014|Overall Study|Lost to Follow-up|0|||
33529123|NCT01826981|101838212|FG000|Overall Study|Withdrew Consent|0|||
33529124|NCT01826981|101838213|FG001|Overall Study|Withdrew Consent|0|||
33529125|NCT01826981|101838214|FG002|Overall Study|Withdrew Consent|0|||
33529126|NCT01826981|101838215|FG003|Overall Study|Withdrew Consent|0|||
33529127|NCT01826981|101838216|FG004|Overall Study|Withdrew Consent|0|||
33529128|NCT01826981|101838217|FG005|Overall Study|Withdrew Consent|0|||
33529129|NCT01826981|101838218|FG006|Overall Study|Withdrew Consent|1|||
33403764|NCT01066819|101369366|FG000|Overall Study|Lab test not done|9|||
33403765|NCT01066819|101369367|FG001|Overall Study|Lab test not done|0|||
33529130|NCT01826981|101838219|FG007|Overall Study|Withdrew Consent|1|||
33529131|NCT01826981|101838220|FG008|Overall Study|Withdrew Consent|0|||
33529132|NCT01826981|101838221|FG009|Overall Study|Withdrew Consent|0|||
33529133|NCT01826981|101838222|FG010|Overall Study|Withdrew Consent|0|||
33529134|NCT01826981|101838223|FG011|Overall Study|Withdrew Consent|1|||
33529135|NCT01826981|101838224|FG012|Overall Study|Withdrew Consent|0|||
33529136|NCT01826981|101838225|FG013|Overall Study|Withdrew Consent|1|||
33204931|NCT01934218|100651433|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
33204932|NCT01934218|100651434|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
33204933|NCT01934218|100651433|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
33204934|NCT01934218|100651434|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
33204935|NCT00524134|100651435|FG000|Overall Study|Withdrawal by Subject|1|||
33204936|NCT00524134|100651435|FG000|Overall Study|Physician Decision|1|||
33204937|NCT00467870|100651436|FG000|Overall Study|Adverse Event|13|||
33204938|NCT00467870|100651437|FG001|Overall Study|Adverse Event|9|||
33204939|NCT00467870|100651438|FG002|Overall Study|Adverse Event|1|||
33204940|NCT00467870|100651439|FG003|Overall Study|Adverse Event|15|||
33204941|NCT00467870|100651440|FG004|Overall Study|Adverse Event|15|||
33204942|NCT00467870|100651441|FG005|Overall Study|Adverse Event|1|||
33204943|NCT00467870|100651436|FG000|Overall Study|Protocol Violation|2|||
33204944|NCT00467870|100651437|FG001|Overall Study|Protocol Violation|1|||
33204945|NCT00467870|100651438|FG002|Overall Study|Protocol Violation|1|||
33204946|NCT00467870|100651439|FG003|Overall Study|Protocol Violation|2|||
33204947|NCT00467870|100651440|FG004|Overall Study|Protocol Violation|0|||
33204948|NCT00467870|100651441|FG005|Overall Study|Protocol Violation|0|||
33204949|NCT00467870|100651436|FG000|Overall Study|Withdrawal by Subject|14|||
33204950|NCT00467870|100651437|FG001|Overall Study|Withdrawal by Subject|21|||
33204951|NCT00467870|100651438|FG002|Overall Study|Withdrawal by Subject|0|||
33204952|NCT00467870|100651439|FG003|Overall Study|Withdrawal by Subject|9|||
33403766|NCT01066819|101369368|FG002|Overall Study|Lab test not done|2|||
33529137|NCT01826981|101838226|FG014|Overall Study|Withdrew Consent|0|||
33529138|NCT01826981|101838212|FG000|Overall Study|Adverse Event|0|||
33529139|NCT01826981|101838213|FG001|Overall Study|Adverse Event|0|||
33529140|NCT01826981|101838214|FG002|Overall Study|Adverse Event|0|||
33529141|NCT01826981|101838215|FG003|Overall Study|Adverse Event|0|||
33529142|NCT01826981|101838216|FG004|Overall Study|Adverse Event|1|||
33529143|NCT01826981|101838217|FG005|Overall Study|Adverse Event|0|||
33529144|NCT01826981|101838218|FG006|Overall Study|Adverse Event|0|||
33529145|NCT01826981|101838219|FG007|Overall Study|Adverse Event|0|||
33529146|NCT01826981|101838220|FG008|Overall Study|Adverse Event|0|||
33529147|NCT01826981|101838221|FG009|Overall Study|Adverse Event|0|||
33403767|NCT01066819|101369369|FG003|Overall Study|Lab test not done|1|||
33529148|NCT01826981|101838222|FG010|Overall Study|Adverse Event|0|||
33529149|NCT01826981|101838223|FG011|Overall Study|Adverse Event|0|||
33529150|NCT01826981|101838224|FG012|Overall Study|Adverse Event|0|||
33204953|NCT00467870|100651440|FG004|Overall Study|Withdrawal by Subject|10|||
33204954|NCT00467870|100651441|FG005|Overall Study|Withdrawal by Subject|1|||
33204955|NCT00467870|100651436|FG000|Overall Study|Lost to Follow-up|5|||
33204956|NCT00467870|100651437|FG001|Overall Study|Lost to Follow-up|3|||
33529151|NCT01826981|101838225|FG013|Overall Study|Adverse Event|0|||
33529152|NCT01826981|101838226|FG014|Overall Study|Adverse Event|0|||
33529153|NCT01826981|101838212|FG000|Overall Study|Upper G-I Haemorrhage|0|||
33204957|NCT00467870|100651438|FG002|Overall Study|Lost to Follow-up|1|||
33403768|NCT01066819|101369370|FG004|Overall Study|Lab test not done|0|||
33529154|NCT01826981|101838213|FG001|Overall Study|Upper G-I Haemorrhage|0|||
33529155|NCT01826981|101838214|FG002|Overall Study|Upper G-I Haemorrhage|0|||
33529156|NCT01826981|101838215|FG003|Overall Study|Upper G-I Haemorrhage|0|||
33529157|NCT01826981|101838216|FG004|Overall Study|Upper G-I Haemorrhage|0|||
33529158|NCT01826981|101838217|FG005|Overall Study|Upper G-I Haemorrhage|0|||
33529159|NCT01826981|101838218|FG006|Overall Study|Upper G-I Haemorrhage|0|||
33529160|NCT01826981|101838219|FG007|Overall Study|Upper G-I Haemorrhage|0|||
33529161|NCT01826981|101838220|FG008|Overall Study|Upper G-I Haemorrhage|0|||
33529162|NCT01826981|101838221|FG009|Overall Study|Upper G-I Haemorrhage|0|||
33529163|NCT01826981|101838222|FG010|Overall Study|Upper G-I Haemorrhage|0|||
33529164|NCT01826981|101838223|FG011|Overall Study|Upper G-I Haemorrhage|0|||
33529165|NCT01826981|101838224|FG012|Overall Study|Upper G-I Haemorrhage|0|||
33529166|NCT01826981|101838225|FG013|Overall Study|Upper G-I Haemorrhage|1|||
33529167|NCT01826981|101838226|FG014|Overall Study|Upper G-I Haemorrhage|0|||
33529168|NCT01826981|101838212|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
33529169|NCT01826981|101838213|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
33529170|NCT01826981|101838214|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
33529171|NCT01826981|101838215|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
33529172|NCT01826981|101838216|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
33529173|NCT01826981|101838217|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
33529174|NCT01826981|101838218|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
33529175|NCT01826981|101838219|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
33529176|NCT01826981|101838220|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
33529177|NCT01826981|101838221|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
33335202|NCT01650636|101118351|FG000|Washout up to 5 Months|Physician Decision|2|||
33335203|NCT01650636|101118352|FG001|Washout up to 5 Months|Physician Decision|2|||
33335204|NCT01650636|101118351|FG000|Washout up to 5 Months|Death|1|||
33335205|NCT01650636|101118352|FG001|Washout up to 5 Months|Death|0|||
33335206|NCT01650636|101118351|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
33335207|NCT01650636|101118352|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
33335208|NCT01650636|101118351|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
33335209|NCT01650636|101118352|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
33335210|NCT01650636|101118351|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
33335211|NCT01650636|101118352|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
33335212|NCT00357500|101121141|FG000|Overall Study|Adverse Event|3|||
33335213|NCT00357500|101121141|FG000|Overall Study|Withdrawal by Subject|5|||
33335214|NCT00357500|101121141|FG000|Overall Study|Progressive Disease|65|||
33335215|NCT00357500|101121141|FG000|Overall Study|Not Started Protocol Therapy|4|||
33335216|NCT03033875|101121142|FG000|Overall Study|Withdrawal by Subject|5|||
33335217|NCT03033875|101121143|FG001|Overall Study|Withdrawal by Subject|9|||
33335218|NCT03033875|101121144|FG002|Overall Study|Withdrawal by Subject|4|||
33529178|NCT01826981|101838222|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
33529179|NCT01826981|101838223|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
33529180|NCT01826981|101838224|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
33529181|NCT01826981|101838225|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
33529182|NCT01826981|101838226|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
33529183|NCT00410072|101838229|FG000|Day 1 to Week 48|Adverse Event|1|||
33529184|NCT00410072|101838230|FG001|Day 1 to Week 48|Adverse Event|2|||
33529185|NCT00410072|101838229|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
33529186|NCT00410072|101838230|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
33529187|NCT00410072|101838229|FG000|Day 1 to Week 48|Other|0|||
33529188|NCT00410072|101838230|FG001|Day 1 to Week 48|Other|1|||
33529189|NCT00410072|101838229|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
33529190|NCT00410072|101838230|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
33529191|NCT00410072|101838229|FG000|Day 1 to Week 48|Pregnancy|0|||
33529192|NCT00410072|101838230|FG001|Day 1 to Week 48|Pregnancy|2|||
33529193|NCT00410072|101838229|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
33529194|NCT00410072|101838230|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
33529195|NCT00410072|101838229|FG000|After Week 48 to Week 96|Adverse Event|1|||
33529196|NCT00410072|101838230|FG001|After Week 48 to Week 96|Adverse Event|2|||
33529197|NCT00410072|101838229|FG000|After Week 48 to Week 96|Death|0|||
33529198|NCT00410072|101838230|FG001|After Week 48 to Week 96|Death|1|||
33529199|NCT00410072|101838229|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
33529200|NCT00410072|101838230|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
33529201|NCT00410072|101838229|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
33529202|NCT00410072|101838230|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
33204958|NCT00467870|100651439|FG003|Overall Study|Lost to Follow-up|1|||
33204959|NCT00467870|100651440|FG004|Overall Study|Lost to Follow-up|3|||
33204960|NCT00467870|100651441|FG005|Overall Study|Lost to Follow-up|0|||
33335219|NCT03033875|101121142|FG000|Overall Study|Other|14|||
33335220|NCT03033875|101121143|FG001|Overall Study|Other|15|||
33335221|NCT03033875|101121144|FG002|Overall Study|Other|8|||
33529203|NCT00410072|101838229|FG000|After Week 48 to Week 96|Other|2|||
33335222|NCT02484911|101121147|FG000|Overall Study|Withdrawal by Subject|2|||
33335223|NCT02484911|101121148|FG001|Overall Study|Withdrawal by Subject|1|||
33335224|NCT02484911|101121147|FG000|Overall Study|Protocol Violation|2|||
33529204|NCT00410072|101838230|FG001|After Week 48 to Week 96|Other|0|||
33529205|NCT00410072|101838229|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
33529206|NCT00410072|101838230|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
33529207|NCT00410072|101838229|FG000|After Week 48 to Week 96|Pregnancy|0|||
33529208|NCT00410072|101838230|FG001|After Week 48 to Week 96|Pregnancy|2|||
33529209|NCT00410072|101838229|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
33204961|NCT00467870|100651436|FG000|Overall Study|Subject Non-compliance|3|||
33529210|NCT00410072|101838230|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
33529211|NCT00105989|101838231|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
33204962|NCT00467870|100651437|FG001|Overall Study|Subject Non-compliance|4|||
33204963|NCT00467870|100651438|FG002|Overall Study|Subject Non-compliance|0|||
33204964|NCT00467870|100651439|FG003|Overall Study|Subject Non-compliance|1|||
33204965|NCT00467870|100651440|FG004|Overall Study|Subject Non-compliance|5|||
33204966|NCT00467870|100651441|FG005|Overall Study|Subject Non-compliance|0|||
33204967|NCT00467870|100651436|FG000|Overall Study|Other/Unknown|8|||
33204968|NCT00467870|100651437|FG001|Overall Study|Other/Unknown|5|||
33204969|NCT00467870|100651438|FG002|Overall Study|Other/Unknown|1|||
33204970|NCT00467870|100651439|FG003|Overall Study|Other/Unknown|5|||
33204971|NCT00467870|100651440|FG004|Overall Study|Other/Unknown|4|||
33204972|NCT00467870|100651441|FG005|Overall Study|Other/Unknown|0|||
33204973|NCT02896855|100651443|FG000|Overall Study|Death|50|||
33204974|NCT02896855|100651444|FG001|Overall Study|Death|40|||
33204975|NCT02896855|100651443|FG000|Overall Study|Lost to Follow-up|15|||
33204976|NCT02896855|100651444|FG001|Overall Study|Lost to Follow-up|9|||
33204977|NCT02896855|100651443|FG000|Overall Study|Withdrawal by Subject|7|||
33204978|NCT02896855|100651444|FG001|Overall Study|Withdrawal by Subject|4|||
33204979|NCT00563784|100651447|FG000|Overall Study|Withdrawal by Subject|2|||
33204980|NCT00563784|100651447|FG000|Overall Study|Screen Failures|20|||
33204981|NCT01773226|100651448|FG000|Overall Study|Withdrawal by Subject|1|||
33204982|NCT01306162|100651455|FG000|Period 1|Adverse Event|0|||
33204983|NCT01306162|100651456|FG001|Period 1|Adverse Event|0|||
33204984|NCT01306162|100651457|FG002|Period 1|Adverse Event|0|||
33204985|NCT01306162|100651458|FG003|Period 1|Adverse Event|1|||
33204986|NCT01306162|100651455|FG000|Washout 1|Non-compliance to protocol|0|||
33204987|NCT01306162|100651456|FG001|Washout 1|Non-compliance to protocol|1|||
33204988|NCT01306162|100651457|FG002|Washout 1|Non-compliance to protocol|0|||
33204989|NCT01306162|100651458|FG003|Washout 1|Non-compliance to protocol|0|||
33529212|NCT00105989|101838232|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
33529213|NCT00105989|101838231|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
33529214|NCT00105989|101838232|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
33529215|NCT00105989|101838231|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
33529216|NCT00105989|101838232|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
33529217|NCT00105989|101838231|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
33529218|NCT00105989|101838232|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
33529219|NCT00105989|101838231|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
33529220|NCT00105989|101838232|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
33529221|NCT00105989|101838231|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
33529222|NCT00105989|101838232|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
33529223|NCT00105989|101838231|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
33529224|NCT00105989|101838232|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
33529225|NCT00105989|101838231|FG000|Acute - Open Label: Week 0-10|Death|1|||
33529226|NCT00105989|101838232|FG001|Acute - Open Label: Week 0-10|Death|0|||
33529227|NCT00105989|101838231|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
33529228|NCT00105989|101838232|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
33529229|NCT00105989|101838231|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
33529230|NCT00105989|101838232|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
33529231|NCT00105989|101838231|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
33529232|NCT00105989|101838232|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
33529233|NCT00105989|101838231|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
33529234|NCT00105989|101838232|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
33529235|NCT00105989|101838231|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
33529236|NCT00105989|101838232|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
33529237|NCT00105989|101838231|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
33529238|NCT00105989|101838232|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
33529239|NCT00105989|101838231|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
33529240|NCT00105989|101838232|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
33529241|NCT00105989|101838231|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
33529242|NCT00105989|101838232|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
33529243|NCT00105989|101838231|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
33204990|NCT01944046|100651459|FG000|Randomized to DB|Adverse Event|5|||
33204991|NCT01944046|100651460|FG001|Randomized to DB|Adverse Event|2|||
33204992|NCT01944046|100651459|FG000|Randomized to DB|Clinical Worsening|3|||
33403769|NCT01066819|101369371|FG005|Overall Study|Lab test not done|0|||
33204993|NCT01944046|100651460|FG001|Randomized to DB|Clinical Worsening|2|||
33204994|NCT01944046|100651459|FG000|Randomized to DB|Lost to Follow-up|3|||
33204995|NCT01944046|100651460|FG001|Randomized to DB|Lost to Follow-up|3|||
33529244|NCT00105989|101838232|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
33529245|NCT00105989|101838231|FG000|Continuation - Open Label:Week 10-34|Death|0|||
33529246|NCT00105989|101838232|FG001|Continuation - Open Label:Week 10-34|Death|0|||
33529247|NCT00105989|101838231|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
33529248|NCT00105989|101838232|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
33529249|NCT00105989|101838231|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
33529250|NCT00105989|101838232|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
33529251|NCT00105989|101838231|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
33529252|NCT00105989|101838232|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
33529253|NCT00105989|101838231|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
33529254|NCT00105989|101838232|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
33529255|NCT00105989|101838231|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
33529256|NCT00105989|101838232|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
33529257|NCT00105989|101838231|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
33529258|NCT00105989|101838232|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
33529259|NCT00105989|101838231|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
33529260|NCT00105989|101838232|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
33529261|NCT00105989|101838231|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
33529262|NCT00105989|101838232|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
33529263|NCT00105989|101838231|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
33529264|NCT00105989|101838232|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
33529265|NCT00105989|101838231|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
33529266|NCT00105989|101838232|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
33529267|NCT00105989|101838231|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
33529268|NCT00105989|101838232|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
33529269|NCT00105989|101838231|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
33529270|NCT00105989|101838232|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
33529271|NCT01473940|101838234|FG000|Induction Therapy|Death|0|||
33529272|NCT01473940|101838235|FG001|Induction Therapy|Death|0|||
33529273|NCT01473940|101838236|FG002|Induction Therapy|Death|1|||
33529274|NCT01473940|101838237|FG003|Induction Therapy|Death|1|||
33529275|NCT01473940|101838234|FG000|Induction Therapy|Progressive Disease|0|||
33529276|NCT01473940|101838235|FG001|Induction Therapy|Progressive Disease|1|||
33529277|NCT01473940|101838236|FG002|Induction Therapy|Progressive Disease|1|||
33529278|NCT01473940|101838237|FG003|Induction Therapy|Progressive Disease|0|||
33529279|NCT01473940|101838234|FG000|Maintenance Therapy|Progressive Disease|1|||
33529280|NCT01473940|101838235|FG001|Maintenance Therapy|Progressive Disease|2|||
33335225|NCT02484911|101121148|FG001|Overall Study|Protocol Violation|1|||
33335226|NCT00847912|101121149|FG000|Overall Study|Protocol Violation|6|||
33335227|NCT00847912|101121150|FG001|Overall Study|Protocol Violation|7|||
33335228|NCT00847912|101121149|FG000|Overall Study|Withdrawal by Subject|3|||
33335229|NCT00847912|101121150|FG001|Overall Study|Withdrawal by Subject|6|||
33335230|NCT02595450|101121153|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
33335231|NCT02595450|101121153|FG000|Overall Study|Enrolled, but not treated|8|||
33335232|NCT02325219|101121155|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
33335233|NCT02325219|101121156|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
33335234|NCT02325219|101121157|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
33335235|NCT02325219|101121158|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
33335236|NCT02325219|101121159|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
33335237|NCT02325219|101121155|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
33335238|NCT02325219|101121156|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
33335239|NCT02325219|101121157|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33335240|NCT02325219|101121158|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33335241|NCT02325219|101121159|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33335242|NCT02325219|101121155|FG000|Controlled Period (Week 0 - 16)|Other|0|||
33335243|NCT02325219|101121156|FG001|Controlled Period (Week 0 - 16)|Other|0|||
33335244|NCT02325219|101121157|FG002|Controlled Period (Week 0 - 16)|Other|1|||
33335245|NCT02325219|101121158|FG003|Controlled Period (Week 0 - 16)|Other|0|||
33335246|NCT02325219|101121159|FG004|Controlled Period (Week 0 - 16)|Other|0|||
33335247|NCT02325219|101121155|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
33403770|NCT01066819|101369366|FG000|Overall Study|Miscellaneous|28|||
33335248|NCT02325219|101121156|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
33335249|NCT02325219|101121157|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
33335250|NCT02325219|101121158|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
33335251|NCT02325219|101121159|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
33403771|NCT01066819|101369367|FG001|Overall Study|Miscellaneous|10|||
33335252|NCT02325219|101121155|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
33335253|NCT02325219|101121156|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
33403772|NCT01066819|101369368|FG002|Overall Study|Miscellaneous|18|||
33335254|NCT02325219|101121157|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
33335255|NCT02325219|101121158|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
33335256|NCT02325219|101121159|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
33335257|NCT02325219|101121155|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
33204996|NCT01944046|100651459|FG000|Randomized to DB|Withdrawal by Subject|2|||
33204997|NCT01944046|100651460|FG001|Randomized to DB|Withdrawal by Subject|4|||
33204998|NCT01944046|100651459|FG000|Randomized to DB|Physician Decision|1|||
33204999|NCT01944046|100651460|FG001|Randomized to DB|Physician Decision|2|||
33205000|NCT01944046|100651459|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
33205001|NCT01944046|100651460|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
33205002|NCT01944046|100651459|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
33205003|NCT01944046|100651460|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
33205004|NCT01944046|100651459|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
33205005|NCT01944046|100651460|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
33205006|NCT01944046|100651459|FG000|Open Label Eligible and Consented|Adverse Event|6|||
33205007|NCT01944046|100651460|FG001|Open Label Eligible and Consented|Adverse Event|1|||
33205008|NCT01944046|100651459|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
33205009|NCT01944046|100651460|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
33205010|NCT01944046|100651459|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
33205011|NCT01944046|100651460|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
33205012|NCT02169674|100651461|FG000|Overall Study|Withdrawal by Subject|2|||
33205013|NCT02169674|100651462|FG001|Overall Study|Withdrawal by Subject|1|||
33205014|NCT02169674|100651461|FG000|Overall Study|Seroprotected|30|||
33205015|NCT02169674|100651462|FG001|Overall Study|Seroprotected|76|||
33205016|NCT02169674|100651461|FG000|Overall Study|Lost to Follow-up|0|||
33205017|NCT02169674|100651462|FG001|Overall Study|Lost to Follow-up|1|||
33205018|NCT02648698|100651463|FG000|Overall Study|Protocol Violation|1|||
33205019|NCT02648698|100651464|FG001|Overall Study|Protocol Violation|5|||
33205020|NCT02576574|100651465|FG000|Overall Study|still ongoing|65|||
33611187|NCT00428389|102126886|FG001|Extension Phase|Protocol Violation|2|||
33335258|NCT02325219|101121156|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
33335259|NCT02325219|101121157|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
33335260|NCT02325219|101121158|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
33335261|NCT02325219|101121159|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
33335262|NCT00498173|101121160|FG000|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2|||
33335263|NCT00498173|101121161|FG001|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1|||
33335264|NCT00498173|101121162|FG002|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0|||
33335265|NCT03113500|101121163|FG000|Overall Study|Withdrawal by Subject|1|||
33335266|NCT02597946|101121164|FG000|Overall Study|Withdrawal by Subject|1|||
33335267|NCT02597946|101121164|FG000|Overall Study|Progressive disease|16|||
33335268|NCT02597946|101121164|FG000|Overall Study|Other than above|1|||
33335269|NCT04317274|101121165|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
33335270|NCT04317274|101121166|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
33335271|NCT04317274|101121167|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
33335272|NCT04317274|101121168|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
33335273|NCT03313076|101121171|FG000|Overall Study|Withdrawal by Subject|2|||
33335274|NCT03313076|101121172|FG001|Overall Study|Withdrawal by Subject|0|||
33335275|NCT03313076|101121173|FG002|Overall Study|Withdrawal by Subject|0|||
33335276|NCT03313076|101121174|FG003|Overall Study|Withdrawal by Subject|0|||
33335277|NCT03313076|101121171|FG000|Overall Study|Lost to Follow-up|0|||
33335278|NCT03313076|101121172|FG001|Overall Study|Lost to Follow-up|2|||
33335279|NCT03313076|101121173|FG002|Overall Study|Lost to Follow-up|2|||
33335280|NCT03313076|101121174|FG003|Overall Study|Lost to Follow-up|2|||
33335281|NCT01081795|101121175|FG000|Overall Study|Adverse Event|18|||
33335282|NCT01081795|101121176|FG001|Overall Study|Adverse Event|23|||
33335283|NCT01081795|101121177|FG002|Overall Study|Adverse Event|6|||
33335284|NCT01081795|101121175|FG000|Overall Study|Lack of Efficacy|7|||
33335285|NCT01081795|101121176|FG001|Overall Study|Lack of Efficacy|5|||
33335286|NCT01081795|101121177|FG002|Overall Study|Lack of Efficacy|19|||
33335287|NCT01081795|101121175|FG000|Overall Study|Subject's schedule|1|||
33335288|NCT01081795|101121176|FG001|Overall Study|Subject's schedule|1|||
33205021|NCT02576574|100651466|FG001|Overall Study|still ongoing|66|||
33205022|NCT02576574|100651467|FG002|Overall Study|still ongoing|73|||
33335289|NCT01081795|101121177|FG002|Overall Study|Subject's schedule|2|||
33335290|NCT01081795|101121175|FG000|Overall Study|Revocation of informed consent|2|||
33335291|NCT01081795|101121176|FG001|Overall Study|Revocation of informed consent|0|||
33335292|NCT01081795|101121177|FG002|Overall Study|Revocation of informed consent|0|||
33335293|NCT01081795|101121175|FG000|Overall Study|Ineligible for participation|1|||
33611188|NCT00428389|102126885|FG000|Extension Phase|Administrative problems|1|||
33205023|NCT02576574|100651465|FG000|Overall Study|Randomized, not treated|5|||
33205024|NCT02576574|100651466|FG001|Overall Study|Randomized, not treated|4|||
33205025|NCT02576574|100651467|FG002|Overall Study|Randomized, not treated|26|||
33205026|NCT03694548|100651468|FG000|Part A Survey|Protocol Violation|3|||
33205027|NCT03694548|100651469|FG001|Part A Survey|Protocol Violation|3|||
33205028|NCT03694548|100651470|FG002|Part A Survey|Protocol Violation|0|||
33205029|NCT03694548|100651468|FG000|Part B Yoga Program|Protocol Violation|0|||
33205030|NCT03694548|100651469|FG001|Part B Yoga Program|Protocol Violation|0|||
33205031|NCT03694548|100651470|FG002|Part B Yoga Program|Protocol Violation|3|||
33205032|NCT03694548|100651468|FG000|Part B Yoga Program|Did not attend intervention|0|||
33205033|NCT03694548|100651469|FG001|Part B Yoga Program|Did not attend intervention|0|||
33205034|NCT03694548|100651470|FG002|Part B Yoga Program|Did not attend intervention|8|||
33205035|NCT01154166|100651471|FG000|Overall Study|Adverse Event|14|||
33205036|NCT01154166|100651472|FG001|Overall Study|Adverse Event|9|||
33205037|NCT01154166|100651471|FG000|Overall Study|Lost to Follow-up|1|||
33205038|NCT01154166|100651472|FG001|Overall Study|Lost to Follow-up|1|||
33205039|NCT01154166|100651471|FG000|Overall Study|Protocol Violation|4|||
33205040|NCT01154166|100651472|FG001|Overall Study|Protocol Violation|1|||
33205041|NCT01154166|100651471|FG000|Overall Study|Withdrawal by Subject|10|||
33205042|NCT01154166|100651472|FG001|Overall Study|Withdrawal by Subject|1|||
33205043|NCT01154166|100651471|FG000|Overall Study|Lack of Efficacy|3|||
33205044|NCT01154166|100651472|FG001|Overall Study|Lack of Efficacy|0|||
33205045|NCT01154166|100651471|FG000|Overall Study|Disease Progression|1|||
33205046|NCT01154166|100651472|FG001|Overall Study|Disease Progression|0|||
33205047|NCT01154166|100651471|FG000|Overall Study|Poor Compliance|1|||
33205048|NCT01154166|100651472|FG001|Overall Study|Poor Compliance|0|||
33205049|NCT00455195|100651473|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
33205050|NCT00455195|100651474|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
33205051|NCT00455195|100651473|FG000|Double-blind Study AGLU02704|Death|1|||
33205052|NCT00455195|100651474|FG001|Double-blind Study AGLU02704|Death|0|||
33205053|NCT00455195|100651473|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
33205054|NCT00455195|100651474|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
33205055|NCT00455195|100651473|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
33205056|NCT00455195|100651474|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
33205057|NCT01174342|100651475|FG000|Overall Study|Conversion to cesarean section|4|||
33205058|NCT01404312|100651476|FG000|Overall Study|Death|21|||
33205059|NCT01404312|100651477|FG001|Overall Study|Death|27|||
33205060|NCT01404312|100651476|FG000|Overall Study|Withdrawal by Subject|15|||
33205061|NCT01404312|100651477|FG001|Overall Study|Withdrawal by Subject|18|||
33335294|NCT01081795|101121176|FG001|Overall Study|Ineligible for participation|0|||
33335295|NCT01081795|101121177|FG002|Overall Study|Ineligible for participation|0|||
33335296|NCT01081795|101121175|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
33335297|NCT01081795|101121176|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
33335298|NCT01081795|101121177|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
33335299|NCT01081795|101121175|FG000|Overall Study|Using drug with restricted days of use|2|||
33335300|NCT01081795|101121176|FG001|Overall Study|Using drug with restricted days of use|3|||
33335301|NCT01081795|101121177|FG002|Overall Study|Using drug with restricted days of use|2|||
33335302|NCT01081795|101121175|FG000|Overall Study|Other|1|||
33335303|NCT01081795|101121176|FG001|Overall Study|Other|2|||
33335304|NCT01081795|101121177|FG002|Overall Study|Other|0|||
33335305|NCT00838331|101121183|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
33335306|NCT00835237|101121184|FG000|Overall Study|Lost to Follow-up|4|||
33335307|NCT00835237|101121185|FG001|Overall Study|Lost to Follow-up|0|||
33335308|NCT00835237|101121184|FG000|Overall Study|Withdrawal by Subject|2|||
33335309|NCT00835237|101121185|FG001|Overall Study|Withdrawal by Subject|0|||
33335310|NCT00927095|101121186|FG000|Overall Study|Adverse Event|3|||
33335311|NCT00927095|101121187|FG001|Overall Study|Adverse Event|1|||
33335312|NCT00927095|101121188|FG002|Overall Study|Adverse Event|0|||
33335313|NCT00927095|101121186|FG000|Overall Study|Withdrawal by Subject|2|||
33335314|NCT00927095|101121187|FG001|Overall Study|Withdrawal by Subject|1|||
33403773|NCT01066819|101369369|FG003|Overall Study|Miscellaneous|1|||
33335315|NCT00927095|101121188|FG002|Overall Study|Withdrawal by Subject|1|||
33335316|NCT00927095|101121186|FG000|Overall Study|Physician Decision|1|||
33403774|NCT01066819|101369370|FG004|Overall Study|Miscellaneous|0|||
33205062|NCT01404312|100651476|FG000|Overall Study|Participant Unable to get to clinic|93|||
33205063|NCT01404312|100651477|FG001|Overall Study|Participant Unable to get to clinic|103|||
33205064|NCT01404312|100651476|FG000|Overall Study|Lost to Follow-up|115|||
33205065|NCT01404312|100651477|FG001|Overall Study|Lost to Follow-up|111|||
33205066|NCT01404312|100651476|FG000|Overall Study|Site closed|22|||
33205067|NCT01404312|100651477|FG001|Overall Study|Site closed|21|||
33335317|NCT00927095|101121187|FG001|Overall Study|Physician Decision|2|||
33335318|NCT00927095|101121188|FG002|Overall Study|Physician Decision|1|||
33335319|NCT03461757|101121192|FG000|Overall Study|Adverse Event|1|||
33335320|NCT03461757|101121193|FG001|Overall Study|Adverse Event|0|||
33335321|NCT03461757|101121192|FG000|Overall Study|Lost to Follow-up|13|||
33335322|NCT03461757|101121193|FG001|Overall Study|Lost to Follow-up|7|||
33205068|NCT01404312|100651476|FG000|Overall Study|Participant not willing to adhere to req|31|||
33403775|NCT01066819|101369371|FG005|Overall Study|Miscellaneous|0|||
33335323|NCT03461757|101121192|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
33335324|NCT03461757|101121193|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
33335325|NCT03461757|101121192|FG000|Overall Study|Non-compliance with study treatment|0|||
33335326|NCT03461757|101121193|FG001|Overall Study|Non-compliance with study treatment|1|||
33335327|NCT03461757|101121192|FG000|Overall Study|Pregnancy|2|||
33335328|NCT03461757|101121193|FG001|Overall Study|Pregnancy|0|||
33335329|NCT03461757|101121192|FG000|Overall Study|Protocol Violation|1|||
33335330|NCT03461757|101121193|FG001|Overall Study|Protocol Violation|1|||
33335331|NCT03461757|101121192|FG000|Overall Study|Withdrawal by Subject|7|||
33335332|NCT03461757|101121193|FG001|Overall Study|Withdrawal by Subject|7|||
33335333|NCT03461757|101121192|FG000|Overall Study|Other Reasons|1|||
33335334|NCT03461757|101121193|FG001|Overall Study|Other Reasons|4|||
33335335|NCT02236520|101121200|FG000|Overall Study|Physician Decision|0|||
33335336|NCT02236520|101121201|FG001|Overall Study|Physician Decision|5|||
33335337|NCT02236520|101121202|FG002|Overall Study|Physician Decision|0|||
33335338|NCT02236520|101121203|FG003|Overall Study|Physician Decision|0|||
33335339|NCT02236520|101121200|FG000|Overall Study|Withdrawal by Subject|1|||
33335340|NCT02236520|101121201|FG001|Overall Study|Withdrawal by Subject|0|||
33335341|NCT02236520|101121202|FG002|Overall Study|Withdrawal by Subject|0|||
33335342|NCT02236520|101121203|FG003|Overall Study|Withdrawal by Subject|1|||
33335343|NCT02236520|101121200|FG000|Overall Study|Pregnancy|1|||
33335344|NCT02236520|101121201|FG001|Overall Study|Pregnancy|0|||
33335345|NCT02236520|101121202|FG002|Overall Study|Pregnancy|0|||
33335346|NCT02236520|101121203|FG003|Overall Study|Pregnancy|0|||
33335347|NCT00109707|101121206|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
33335348|NCT00109707|101121207|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
33335349|NCT00109707|101121208|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
33335350|NCT00109707|101121206|FG000|Overall Study|Abnormal laboratory values|1|||
33335351|NCT00109707|101121207|FG001|Overall Study|Abnormal laboratory values|0|||
33335352|NCT00109707|101121208|FG002|Overall Study|Abnormal laboratory values|0|||
33335353|NCT00109707|101121206|FG000|Overall Study|Administrative problems|2|||
33335354|NCT00109707|101121207|FG001|Overall Study|Administrative problems|0|||
33335355|NCT00109707|101121208|FG002|Overall Study|Administrative problems|1|||
33335356|NCT00109707|101121206|FG000|Overall Study|Adverse Event|10|||
33335357|NCT00109707|101121207|FG001|Overall Study|Adverse Event|2|||
33335358|NCT00109707|101121208|FG002|Overall Study|Adverse Event|3|||
33335359|NCT00109707|101121206|FG000|Overall Study|Death|4|||
33529281|NCT01473940|101838236|FG002|Maintenance Therapy|Progressive Disease|1|||
33529282|NCT01473940|101838237|FG003|Maintenance Therapy|Progressive Disease|4|||
33529283|NCT01254656|101838238|FG000|Overall Study|Discontinued due to termination of study|40|||
33529284|NCT01254656|101838239|FG001|Overall Study|Discontinued due to termination of study|39|||
33529285|NCT01254656|101838240|FG002|Overall Study|Discontinued due to termination of study|13|||
33529286|NCT01254656|101838238|FG000|Overall Study|Lack of Efficacy|3|||
33529287|NCT01254656|101838239|FG001|Overall Study|Lack of Efficacy|0|||
33529288|NCT01254656|101838240|FG002|Overall Study|Lack of Efficacy|0|||
33529289|NCT01254656|101838238|FG000|Overall Study|Lost to Follow-up|1|||
33529290|NCT01254656|101838239|FG001|Overall Study|Lost to Follow-up|0|||
33529291|NCT01254656|101838240|FG002|Overall Study|Lost to Follow-up|2|||
33529292|NCT01254656|101838238|FG000|Overall Study|Withdrawal by Subject|2|||
33529293|NCT01254656|101838239|FG001|Overall Study|Withdrawal by Subject|2|||
33529294|NCT01254656|101838240|FG002|Overall Study|Withdrawal by Subject|1|||
33529295|NCT01254656|101838238|FG000|Overall Study|Pregnancy|0|||
33529296|NCT01254656|101838239|FG001|Overall Study|Pregnancy|0|||
33529297|NCT01254656|101838240|FG002|Overall Study|Pregnancy|2|||
33529298|NCT01254656|101838238|FG000|Overall Study|Adverse Event|1|||
33529299|NCT01254656|101838239|FG001|Overall Study|Adverse Event|1|||
33529300|NCT01254656|101838240|FG002|Overall Study|Adverse Event|0|||
33529301|NCT01254656|101838238|FG000|Overall Study|Death|0|||
33529302|NCT01254656|101838239|FG001|Overall Study|Death|1|||
33529303|NCT01254656|101838240|FG002|Overall Study|Death|0|||
33529304|NCT03243305|101838246|FG000|Overall Study|Lost to Follow-up|250|||
33529305|NCT03243305|101838246|FG000|Overall Study|Withdrawal by Subject|170|||
33529306|NCT03243305|101838246|FG000|Overall Study|Pregnancy|104|||
33335360|NCT00109707|101121207|FG001|Overall Study|Death|0|||
33335361|NCT00109707|101121208|FG002|Overall Study|Death|0|||
33529307|NCT03243305|101838246|FG000|Overall Study|Non-Compliance with Study Drug|38|||
33529308|NCT03243305|101838246|FG000|Overall Study|Adverse Event|23|||
33335362|NCT00109707|101121206|FG000|Overall Study|Disease progression|12|||
33335363|NCT00109707|101121207|FG001|Overall Study|Disease progression|4|||
33335364|NCT00109707|101121208|FG002|Overall Study|Disease progression|3|||
33335365|NCT00109707|101121206|FG000|Overall Study|Lost to Follow-up|3|||
33335366|NCT00109707|101121207|FG001|Overall Study|Lost to Follow-up|0|||
33335367|NCT00109707|101121208|FG002|Overall Study|Lost to Follow-up|0|||
33335368|NCT00109707|101121206|FG000|Overall Study|Protocol Violation|1|||
33529309|NCT03243305|101838246|FG000|Overall Study|No sexually active|26|||
33529310|NCT03243305|101838246|FG000|Overall Study|Physician Decision|22|||
33529311|NCT03243305|101838246|FG000|Overall Study|Protocol Violation|22|||
33529312|NCT03243305|101838246|FG000|Overall Study|Study method no longer primary method|12|||
33529313|NCT03243305|101838246|FG000|Overall Study|Study Terminated by Sponsor|1|||
33529314|NCT03243305|101838246|FG000|Overall Study|Early terminations|267|||
33529315|NCT01720524|101838247|FG000|Part A|Insufficient Clinical Response|2|||
33529316|NCT01720524|101838248|FG001|Part A|Insufficient Clinical Response|4|||
33529317|NCT01720524|101838247|FG000|Part A|Adverse Event|2|||
33529318|NCT01720524|101838248|FG001|Part A|Adverse Event|2|||
33529319|NCT01720524|101838247|FG000|Part A|Death|2|||
33529320|NCT01720524|101838248|FG001|Part A|Death|1|||
33529321|NCT01720524|101838247|FG000|Part A|Lost to Follow-up|0|||
33529322|NCT01720524|101838248|FG001|Part A|Lost to Follow-up|1|||
33529323|NCT01720524|101838247|FG000|Part A|Missed 28 day follow-up visit|1|||
33529324|NCT01720524|101838248|FG001|Part A|Missed 28 day follow-up visit|1|||
33529325|NCT01720524|101838247|FG000|Part A|Withdrawal by Subject|0|||
33529326|NCT01720524|101838248|FG001|Part A|Withdrawal by Subject|1|||
33529327|NCT01720524|101838247|FG000|Part A|Other|0|||
33529328|NCT01720524|101838248|FG001|Part A|Other|1|||
33529329|NCT01720524|101838247|FG000|Part A|Lost to Follow-up|0|||
33529330|NCT01720524|101838248|FG001|Part A|Lost to Follow-up|1|||
33529331|NCT01720524|101838247|FG000|Part B|No longer willing to participate in study|1|||
33529332|NCT01720524|101838248|FG001|Part B|No longer willing to participate in study|4|||
33529333|NCT01720524|101838247|FG000|Part B|Other|2|||
33529334|NCT01720524|101838248|FG001|Part B|Other|0|||
33335369|NCT00109707|101121207|FG001|Overall Study|Protocol Violation|0|||
33335370|NCT00109707|101121208|FG002|Overall Study|Protocol Violation|0|||
33335371|NCT00109707|101121206|FG000|Overall Study|Patient withdrew consent|6|||
33335372|NCT00109707|101121207|FG001|Overall Study|Patient withdrew consent|1|||
33335373|NCT00109707|101121208|FG002|Overall Study|Patient withdrew consent|0|||
33335374|NCT04417894|101121209|FG000|Overall Study|Lost to Follow-up|3|||
33335375|NCT04417894|101121210|FG001|Overall Study|Lost to Follow-up|0|||
33335376|NCT04417894|101121209|FG000|Overall Study|Withdrawal by Subject|7|||
33335377|NCT04417894|101121210|FG001|Overall Study|Withdrawal by Subject|6|||
33335378|NCT04417894|101121209|FG000|Overall Study|Lack of Efficacy|3|||
33335379|NCT04417894|101121210|FG001|Overall Study|Lack of Efficacy|1|||
33335380|NCT00720109|101121212|FG000|Induction Period|Did not meet eligibility criteria|3|||
33335381|NCT00720109|101121213|FG001|Induction Period|Did not meet eligibility criteria|0|||
33335382|NCT00720109|101121214|FG002|Induction Period|Did not meet eligibility criteria|0|||
33335383|NCT00720109|101121212|FG000|Induction Period|Bone Marrow Transplant|2|||
33335384|NCT00720109|101121213|FG001|Induction Period|Bone Marrow Transplant|0|||
33335385|NCT00720109|101121214|FG002|Induction Period|Bone Marrow Transplant|0|||
33335386|NCT00720109|101121212|FG000|Induction Period|Physician Decision|1|||
33335387|NCT00720109|101121213|FG001|Induction Period|Physician Decision|0|||
33335388|NCT00720109|101121214|FG002|Induction Period|Physician Decision|0|||
33335389|NCT00720109|101121212|FG000|Risk Stratification Period|Adverse Event|0|||
33335390|NCT00720109|101121213|FG001|Risk Stratification Period|Adverse Event|1|||
33335391|NCT00720109|101121214|FG002|Risk Stratification Period|Adverse Event|0|||
33335392|NCT00720109|101121212|FG000|Risk Stratification Period|Physician Decision|0|||
33335393|NCT00720109|101121213|FG001|Risk Stratification Period|Physician Decision|2|||
33335394|NCT00720109|101121214|FG002|Risk Stratification Period|Physician Decision|1|||
33335395|NCT00720109|101121212|FG000|Risk Stratification Period|Bone marrow transplant|0|||
33335396|NCT00720109|101121213|FG001|Risk Stratification Period|Bone marrow transplant|9|||
33335397|NCT00720109|101121214|FG002|Risk Stratification Period|Bone marrow transplant|7|||
33335398|NCT00720109|101121212|FG000|Risk Stratification Period|Disease progression or relapse|0|||
33335399|NCT00720109|101121213|FG001|Risk Stratification Period|Disease progression or relapse|2|||
33529335|NCT01720524|101838247|FG000|Part B|Lost to Follow-up|2|||
33529336|NCT01720524|101838248|FG001|Part B|Lost to Follow-up|3|||
33529337|NCT01720524|101838247|FG000|Part B|Death|0|||
33529338|NCT01720524|101838248|FG001|Part B|Death|2|||
33335400|NCT00720109|101121214|FG002|Risk Stratification Period|Disease progression or relapse|0|||
33335401|NCT00720109|101121212|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
33335402|NCT00720109|101121213|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
33335403|NCT00720109|101121214|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
33335404|NCT01395394|101121217|FG000|Baseline Study Visit|Protocol Violation|1|||
33335405|NCT01395394|101121218|FG001|Baseline Study Visit|Protocol Violation|0|||
33529339|NCT03252145|101838253|FG000|Overall Study|Withdrawal by Subject|1|||
33529340|NCT03252145|101838254|FG001|Overall Study|Withdrawal by Subject|0|||
33529341|NCT03252145|101838253|FG000|Overall Study|Complicating Disease|1|||
33529342|NCT03252145|101838254|FG001|Overall Study|Complicating Disease|2|||
33335406|NCT01395394|101121219|FG002|Baseline Study Visit|Protocol Violation|0|||
33335407|NCT01135498|101121223|FG000|Overall Study|Adverse Event|20|||
33335408|NCT01135498|101121223|FG000|Overall Study|Progressive disease|38|||
33335409|NCT01135498|101121223|FG000|Overall Study|Investigator judgement|25|||
33335410|NCT01135498|101121223|FG000|Overall Study|Withdrawal by Subject|4|||
33335411|NCT01135498|101121223|FG000|Overall Study|Death|1|||
33335412|NCT01135498|101121223|FG000|Overall Study|Ongoing at time of analysis|2|||
33335413|NCT01984268|101121224|FG000|Overall Study|Study Terminated|15|||
33335414|NCT01535729|101121225|FG000|Overall Study|Withdrawal by Subject|2|||
33335415|NCT01535729|101121225|FG000|Overall Study|Disease progression|230|||
33335416|NCT01535729|101121225|FG000|Overall Study|Discontinued treatment|25|||
33335417|NCT01535729|101121225|FG000|Overall Study|Lost to Follow-up|8|||
33335418|NCT01535729|101121225|FG000|Overall Study|Death|52|||
33335419|NCT01535729|101121225|FG000|Overall Study|Other|19|||
33335420|NCT01535729|101121225|FG000|Overall Study|Did not sign informed consent|1|||
33335421|NCT01535729|101121225|FG000|Overall Study|No previous chemotherapy|33|||
33335422|NCT01535729|101121225|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
33335423|NCT01535729|101121225|FG000|Overall Study|Protocol Violation|11|||
33335424|NCT01535729|101121225|FG000|Overall Study|Screening failure|1|||
33335425|NCT01535729|101121225|FG000|Overall Study|Not treated|9|||
33335426|NCT01535729|101121225|FG000|Overall Study|No participant record available|5|||
33335427|NCT02300298|101121228|FG000|Disposition for Nintedanib|Progressive disease|10|||
33335428|NCT02300298|101121229|FG001|Disposition for Nintedanib|Progressive disease|0|||
33335429|NCT02300298|101121228|FG000|Disposition for Docetaxel|Progressive disease|0|||
33335430|NCT02300298|101121229|FG001|Disposition for Docetaxel|Progressive disease|6|||
33335431|NCT02300298|101121228|FG000|Disposition for Docetaxel|other adverse event|0|||
33335432|NCT02300298|101121229|FG001|Disposition for Docetaxel|other adverse event|4|||
33335433|NCT00143455|101121230|FG000|Cohort 1|Adverse Event|8|||
33335434|NCT00143455|101121231|FG001|Cohort 1|Adverse Event|4|||
33335435|NCT00143455|101121232|FG002|Cohort 1|Adverse Event|0|||
33335436|NCT00143455|101121233|FG003|Cohort 1|Adverse Event|0|||
33335437|NCT00143455|101121230|FG000|Cohort 1|Death|5|||
33335438|NCT00143455|101121231|FG001|Cohort 1|Death|2|||
33335439|NCT00143455|101121232|FG002|Cohort 1|Death|0|||
33403776|NCT01066819|101369366|FG000|Overall Study|Non responders|123|||
33403777|NCT01066819|101369367|FG001|Overall Study|Non responders|2|||
33403778|NCT01066819|101369368|FG002|Overall Study|Non responders|7|||
33403779|NCT01066819|101369369|FG003|Overall Study|Non responders|2|||
33403780|NCT01066819|101369370|FG004|Overall Study|Non responders|0|||
33403781|NCT01066819|101369371|FG005|Overall Study|Non responders|1|||
33403782|NCT01066819|101369366|FG000|Overall Study|Not categorised|9|||
33403783|NCT01066819|101369367|FG001|Overall Study|Not categorised|2|||
33403784|NCT01066819|101369368|FG002|Overall Study|Not categorised|6|||
33403785|NCT01066819|101369369|FG003|Overall Study|Not categorised|1|||
33403786|NCT01066819|101369370|FG004|Overall Study|Not categorised|0|||
33611189|NCT00428389|102126886|FG001|Extension Phase|Administrative problems|1|||
33611190|NCT05198843|102126889|FG000|Overall Study|Lack of Efficacy|1|||
33611191|NCT00250276|102126891|FG000|Overall Study|Serious Adverse Event|0|||
33611192|NCT00250276|102126892|FG001|Overall Study|Serious Adverse Event|0|||
33335440|NCT00143455|101121233|FG003|Cohort 1|Death|0|||
33335441|NCT00143455|101121230|FG000|Cohort 1|Progressive Disease|0|||
33335442|NCT00143455|101121231|FG001|Cohort 1|Progressive Disease|6|||
33335443|NCT00143455|101121232|FG002|Cohort 1|Progressive Disease|0|||
33335444|NCT00143455|101121233|FG003|Cohort 1|Progressive Disease|0|||
33335445|NCT00143455|101121230|FG000|Cohort 1|Withdrawal by Subject|1|||
33335446|NCT00143455|101121231|FG001|Cohort 1|Withdrawal by Subject|4|||
33335447|NCT00143455|101121232|FG002|Cohort 1|Withdrawal by Subject|0|||
33335448|NCT00143455|101121233|FG003|Cohort 1|Withdrawal by Subject|0|||
33335449|NCT00143455|101121230|FG000|Cohort 1|Randomized But Not Treated|0|||
33335450|NCT00143455|101121231|FG001|Cohort 1|Randomized But Not Treated|1|||
33335451|NCT00143455|101121232|FG002|Cohort 1|Randomized But Not Treated|0|||
33335452|NCT00143455|101121233|FG003|Cohort 1|Randomized But Not Treated|0|||
33403787|NCT01066819|101369371|FG005|Overall Study|Not categorised|0|||
33403788|NCT01066819|101369366|FG000|Overall Study|Relapse|16|||
33403789|NCT01066819|101369367|FG001|Overall Study|Relapse|4|||
33611193|NCT00250276|102126893|FG002|Overall Study|Serious Adverse Event|1|||
33611194|NCT00250276|102126894|FG003|Overall Study|Serious Adverse Event|0|||
33335453|NCT00143455|101121230|FG000|Cohort 2|Adverse Event|0|||
33335454|NCT00143455|101121231|FG001|Cohort 2|Adverse Event|0|||
33335455|NCT00143455|101121232|FG002|Cohort 2|Adverse Event|42|||
33335456|NCT00143455|101121233|FG003|Cohort 2|Adverse Event|30|||
33335457|NCT00143455|101121230|FG000|Cohort 2|No Longer Required Study Treatment|0|||
33335458|NCT00143455|101121231|FG001|Cohort 2|No Longer Required Study Treatment|0|||
33335459|NCT00143455|101121232|FG002|Cohort 2|No Longer Required Study Treatment|1|||
33335460|NCT00143455|101121233|FG003|Cohort 2|No Longer Required Study Treatment|0|||
33335461|NCT00143455|101121230|FG000|Cohort 2|Protocol Violation|0|||
33335462|NCT00143455|101121231|FG001|Cohort 2|Protocol Violation|0|||
33335463|NCT00143455|101121232|FG002|Cohort 2|Protocol Violation|1|||
33335464|NCT00143455|101121233|FG003|Cohort 2|Protocol Violation|1|||
33403790|NCT01066819|101369368|FG002|Overall Study|Relapse|3|||
33403791|NCT01066819|101369369|FG003|Overall Study|Relapse|0|||
33529343|NCT02058589|101838257|FG000|Overall Study|Serious Adverse Event|1|||
33529344|NCT02058589|101838258|FG001|Overall Study|Serious Adverse Event|1|||
33529345|NCT02058589|101838257|FG000|Overall Study|Non-Serious Adverse Event|1|||
33611195|NCT00250276|102126891|FG000|Overall Study|Non-serious Adverse Event|2|||
33611196|NCT00250276|102126892|FG001|Overall Study|Non-serious Adverse Event|0|||
33611197|NCT00250276|102126893|FG002|Overall Study|Non-serious Adverse Event|0|||
33611198|NCT00250276|102126894|FG003|Overall Study|Non-serious Adverse Event|2|||
33611199|NCT00250276|102126891|FG000|Overall Study|Protocol Violation|0|||
33611200|NCT00250276|102126892|FG001|Overall Study|Protocol Violation|1|||
33611201|NCT00250276|102126893|FG002|Overall Study|Protocol Violation|0|||
33611202|NCT00250276|102126894|FG003|Overall Study|Protocol Violation|0|||
33611203|NCT00250276|102126891|FG000|Overall Study|Withdrawal by Subject|1|||
33611204|NCT00250276|102126892|FG001|Overall Study|Withdrawal by Subject|2|||
33611205|NCT00250276|102126893|FG002|Overall Study|Withdrawal by Subject|3|||
33611206|NCT00250276|102126894|FG003|Overall Study|Withdrawal by Subject|2|||
33611207|NCT00250276|102126891|FG000|Overall Study|Migrated/moved from study area|3|||
33611208|NCT00250276|102126892|FG001|Overall Study|Migrated/moved from study area|0|||
33611209|NCT00250276|102126893|FG002|Overall Study|Migrated/moved from study area|2|||
33611210|NCT00250276|102126894|FG003|Overall Study|Migrated/moved from study area|7|||
33611211|NCT00250276|102126891|FG000|Overall Study|Lost to Follow-up|11|||
33611212|NCT00250276|102126892|FG001|Overall Study|Lost to Follow-up|18|||
33611213|NCT00250276|102126893|FG002|Overall Study|Lost to Follow-up|13|||
33611214|NCT00250276|102126894|FG003|Overall Study|Lost to Follow-up|8|||
33611215|NCT02508428|102126895|FG000|Overall Study|Death|32|||
33611216|NCT02508428|102126896|FG001|Overall Study|Death|33|||
33611217|NCT02508428|102126895|FG000|Overall Study|Liner revised|3|||
33611218|NCT02508428|102126896|FG001|Overall Study|Liner revised|19|||
33611219|NCT02508428|102126895|FG000|Overall Study|Incomplete follow-up|17|||
33611220|NCT02508428|102126896|FG001|Overall Study|Incomplete follow-up|15|||
33611221|NCT00417963|102126897|FG000|Overall Study|Lost to Follow-up|3|||
33611222|NCT00417963|102126897|FG000|Overall Study|Withdrawal by Subject|18|||
33403792|NCT01066819|101369370|FG004|Overall Study|Relapse|0|||
33403793|NCT01066819|101369371|FG005|Overall Study|Relapse|0|||
33403794|NCT01066819|101369366|FG000|Overall Study|Results not available|1|||
33403795|NCT01066819|101369367|FG001|Overall Study|Results not available|0|||
33335465|NCT00143455|101121230|FG000|Cohort 2|Lost to Follow-up|0|||
33335466|NCT00143455|101121231|FG001|Cohort 2|Lost to Follow-up|0|||
33335467|NCT00143455|101121232|FG002|Cohort 2|Lost to Follow-up|1|||
33335468|NCT00143455|101121233|FG003|Cohort 2|Lost to Follow-up|4|||
33335469|NCT00143455|101121230|FG000|Cohort 2|Death|0|||
33335470|NCT00143455|101121231|FG001|Cohort 2|Death|0|||
33403796|NCT01066819|101369368|FG002|Overall Study|Results not available|0|||
33335471|NCT00143455|101121232|FG002|Cohort 2|Death|20|||
33403797|NCT01066819|101369369|FG003|Overall Study|Results not available|0|||
33529346|NCT02058589|101838258|FG001|Overall Study|Non-Serious Adverse Event|0|||
33529347|NCT02058589|101838257|FG000|Overall Study|Withdrawal by Subject|0|||
33529348|NCT02058589|101838258|FG001|Overall Study|Withdrawal by Subject|1|||
33529349|NCT03084302|101838259|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
33529350|NCT03084302|101838259|FG000|Overall Study|No valid objective monitor data|6|||
33529351|NCT02091414|101838260|FG000|Overall Study|Withdrawal by Subject|2|||
33529352|NCT02091414|101838260|FG000|Overall Study|Death|2|||
33529353|NCT00960804|101838261|FG000|Overall Study|Adverse Event|1|||
33529354|NCT00960804|101838262|FG001|Overall Study|Adverse Event|0|||
33529355|NCT00960804|101838263|FG002|Overall Study|Adverse Event|0|||
33611223|NCT00417963|102126897|FG000|Overall Study|Death|17|||
33611224|NCT00417963|102126897|FG000|Overall Study|Study device could not be deployed|3|||
33611225|NCT01068158|102126899|FG000|Overall Study|Withdrawal by Subject|1|||
33611226|NCT01068158|102126900|FG001|Overall Study|Withdrawal by Subject|2|||
33611227|NCT01068158|102126899|FG000|Overall Study|Lost to Follow-up|7|||
33611228|NCT01068158|102126900|FG001|Overall Study|Lost to Follow-up|0|||
33611229|NCT01068158|102126899|FG000|Overall Study|Protocol Violation|0|||
33611230|NCT01068158|102126900|FG001|Overall Study|Protocol Violation|2|||
33335472|NCT00143455|101121233|FG003|Cohort 2|Death|12|||
33335473|NCT00143455|101121230|FG000|Cohort 2|Progressive Disease|0|||
33335474|NCT00143455|101121231|FG001|Cohort 2|Progressive Disease|0|||
33335475|NCT00143455|101121232|FG002|Cohort 2|Progressive Disease|20|||
33403798|NCT01066819|101369370|FG004|Overall Study|Results not available|0|||
33403799|NCT01066819|101369371|FG005|Overall Study|Results not available|0|||
33529356|NCT00960804|101838261|FG000|Overall Study|Withdrawal by Subject|1|||
33529357|NCT00960804|101838262|FG001|Overall Study|Withdrawal by Subject|0|||
33205069|NCT01404312|100651477|FG001|Overall Study|Participant not willing to adhere to req|29|||
33335476|NCT00143455|101121233|FG003|Cohort 2|Progressive Disease|27|||
33403800|NCT01066819|101369366|FG000|Overall Study|Screen failure|1|||
33529358|NCT00960804|101838263|FG002|Overall Study|Withdrawal by Subject|0|||
33529359|NCT00960804|101838261|FG000|Overall Study|Study terminated by the sponsor|5|||
33529360|NCT00960804|101838262|FG001|Overall Study|Study terminated by the sponsor|4|||
33529361|NCT00960804|101838263|FG002|Overall Study|Study terminated by the sponsor|10|||
33529362|NCT01005901|101838264|FG000|Overall Study|Withdrawal by Subject|38|||
33529363|NCT01005901|101838265|FG001|Overall Study|Withdrawal by Subject|14|||
33529364|NCT01005901|101838264|FG000|Overall Study|Adverse Event|30|||
33529365|NCT01005901|101838265|FG001|Overall Study|Adverse Event|16|||
33529366|NCT01005901|101838264|FG000|Overall Study|Administrative problems|21|||
33529367|NCT01005901|101838265|FG001|Overall Study|Administrative problems|13|||
33529368|NCT01005901|101838264|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
33529369|NCT01005901|101838265|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
33529370|NCT01005901|101838264|FG000|Overall Study|Protocol Violation|4|||
33529371|NCT01005901|101838265|FG001|Overall Study|Protocol Violation|3|||
33529372|NCT01005901|101838264|FG000|Overall Study|Death|2|||
33529373|NCT01005901|101838265|FG001|Overall Study|Death|3|||
33529374|NCT01005901|101838264|FG000|Overall Study|Lost to Follow-up|1|||
33529375|NCT01005901|101838265|FG001|Overall Study|Lost to Follow-up|2|||
33529376|NCT01005901|101838264|FG000|Overall Study|Patient's inability to use the device|1|||
33529377|NCT01005901|101838265|FG001|Overall Study|Patient's inability to use the device|1|||
33529378|NCT01005901|101838264|FG000|Overall Study|No longer requires study drug|0|||
33529379|NCT01005901|101838265|FG001|Overall Study|No longer requires study drug|1|||
33529380|NCT00401193|101838266|FG000|Overall Study|Adverse Event|1|||
33529381|NCT00401193|101838267|FG001|Overall Study|Adverse Event|3|||
33529382|NCT00401193|101838268|FG002|Overall Study|Adverse Event|1|||
33529383|NCT00401193|101838266|FG000|Overall Study|Protocol Violation|3|||
33529384|NCT00401193|101838267|FG001|Overall Study|Protocol Violation|1|||
33529385|NCT00401193|101838268|FG002|Overall Study|Protocol Violation|1|||
33529386|NCT00401193|101838266|FG000|Overall Study|Lost to Follow-up|6|||
33529387|NCT00401193|101838267|FG001|Overall Study|Lost to Follow-up|5|||
33529388|NCT00401193|101838268|FG002|Overall Study|Lost to Follow-up|1|||
33529389|NCT00401193|101838266|FG000|Overall Study|Withdrawal by Subject|2|||
33529390|NCT00401193|101838267|FG001|Overall Study|Withdrawal by Subject|0|||
33529391|NCT00401193|101838268|FG002|Overall Study|Withdrawal by Subject|1|||
33529392|NCT00401193|101838266|FG000|Overall Study|Other Event|3|||
33529393|NCT00401193|101838267|FG001|Overall Study|Other Event|2|||
33529394|NCT00401193|101838268|FG002|Overall Study|Other Event|2|||
33529395|NCT00672633|101838274|FG000|Overall Study|Withdrawal by Subject|0|||
33611231|NCT00106353|102126902|FG000|Part 1|Disease progression|3|||
33335477|NCT00143455|101121230|FG000|Cohort 2|Withdrawal by Subject|0|||
33335478|NCT00143455|101121231|FG001|Cohort 2|Withdrawal by Subject|0|||
33335479|NCT00143455|101121232|FG002|Cohort 2|Withdrawal by Subject|13|||
33335480|NCT00143455|101121233|FG003|Cohort 2|Withdrawal by Subject|12|||
33335481|NCT00143455|101121230|FG000|Cohort 2|Other|0|||
33335482|NCT00143455|101121231|FG001|Cohort 2|Other|0|||
33335483|NCT00143455|101121232|FG002|Cohort 2|Other|7|||
33335484|NCT00143455|101121233|FG003|Cohort 2|Other|6|||
33335485|NCT00143455|101121230|FG000|Cohort 2|Randomized But Not Treated|0|||
33335486|NCT00143455|101121231|FG001|Cohort 2|Randomized But Not Treated|0|||
33335487|NCT00143455|101121232|FG002|Cohort 2|Randomized But Not Treated|1|||
33335488|NCT00143455|101121233|FG003|Cohort 2|Randomized But Not Treated|1|||
33335489|NCT00075504|101121234|FG000|Overall Study|Withdrawal by Subject|9|||
33335490|NCT00075504|101121235|FG001|Overall Study|Withdrawal by Subject|7|||
33335491|NCT01634555|101121240|FG000|Overall Study|Adverse Event|3|||
33335492|NCT01634555|101121240|FG000|Overall Study|Physician Decision|1|||
33335493|NCT00732303|101121243|FG000|Overall Study|Study Terminated|2|||
33335494|NCT02551159|101121245|FG000|Overall Study|Death|352|||
33335495|NCT02551159|101121246|FG001|Overall Study|Death|174|||
33335496|NCT02551159|101121247|FG002|Overall Study|Death|161|||
33335497|NCT02551159|101121245|FG000|Overall Study|Withdrawal by Subject|8|||
33335498|NCT02551159|101121246|FG001|Overall Study|Withdrawal by Subject|5|||
33335499|NCT02551159|101121247|FG002|Overall Study|Withdrawal by Subject|16|||
33335500|NCT02551159|101121245|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
33335501|NCT02551159|101121246|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
33335502|NCT02551159|101121247|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
33335503|NCT02069899|101121248|FG000|Overall Study|Adverse Event|6|||
33335504|NCT02069899|101121249|FG001|Overall Study|Adverse Event|0|||
33335505|NCT02069899|101121250|FG002|Overall Study|Adverse Event|1|||
33335506|NCT02069899|101121248|FG000|Overall Study|Withdrawal by Participant|2|||
33403801|NCT01066819|101369367|FG001|Overall Study|Screen failure|0|||
33529396|NCT00672633|101838275|FG001|Overall Study|Withdrawal by Subject|1|||
33529397|NCT00758498|101838276|FG000|Overall Study|Adverse Event|2|||
33529398|NCT00758498|101838277|FG001|Overall Study|Adverse Event|2|||
33529399|NCT00758498|101838278|FG002|Overall Study|Adverse Event|3|||
33529400|NCT00758498|101838276|FG000|Overall Study|Subject legally detained out of state|1|||
33403802|NCT01066819|101369368|FG002|Overall Study|Screen failure|0|||
33403803|NCT01066819|101369369|FG003|Overall Study|Screen failure|0|||
33403804|NCT01066819|101369370|FG004|Overall Study|Screen failure|0|||
33403805|NCT01066819|101369371|FG005|Overall Study|Screen failure|0|||
33403806|NCT01066819|101369366|FG000|Overall Study|Spontaneous cure|1|||
33611232|NCT00106353|102126903|FG001|Part 1|Disease progression|4|||
33611233|NCT00106353|102126904|FG002|Part 1|Disease progression|1|||
33611234|NCT00106353|102126905|FG003|Part 1|Disease progression|3|||
33611235|NCT00106353|102126906|FG004|Part 1|Disease progression|0|||
33611236|NCT00106353|102126907|FG005|Part 1|Disease progression|0|||
33611237|NCT00106353|102126908|FG006|Part 1|Disease progression|0|||
33611238|NCT00106353|102126902|FG000|Part 1|Withdrawal by Subject|0|||
33611239|NCT00106353|102126903|FG001|Part 1|Withdrawal by Subject|0|||
33611240|NCT00106353|102126904|FG002|Part 1|Withdrawal by Subject|1|||
33611241|NCT00106353|102126905|FG003|Part 1|Withdrawal by Subject|2|||
33611242|NCT00106353|102126906|FG004|Part 1|Withdrawal by Subject|0|||
33611243|NCT00106353|102126907|FG005|Part 1|Withdrawal by Subject|0|||
33611244|NCT00106353|102126908|FG006|Part 1|Withdrawal by Subject|0|||
33611245|NCT00106353|102126902|FG000|Part 1|Symptomatic deterioration|0|||
33611246|NCT00106353|102126903|FG001|Part 1|Symptomatic deterioration|0|||
33611247|NCT00106353|102126904|FG002|Part 1|Symptomatic deterioration|1|||
33611248|NCT00106353|102126905|FG003|Part 1|Symptomatic deterioration|0|||
33611249|NCT00106353|102126906|FG004|Part 1|Symptomatic deterioration|0|||
33335507|NCT02069899|101121249|FG001|Overall Study|Withdrawal by Participant|0|||
33335508|NCT02069899|101121250|FG002|Overall Study|Withdrawal by Participant|0|||
33335509|NCT02069899|101121248|FG000|Overall Study|Lost to Follow-up|1|||
33403807|NCT01066819|101369367|FG001|Overall Study|Spontaneous cure|0|||
33403808|NCT01066819|101369368|FG002|Overall Study|Spontaneous cure|0|||
33403809|NCT01066819|101369369|FG003|Overall Study|Spontaneous cure|0|||
33403810|NCT01066819|101369370|FG004|Overall Study|Spontaneous cure|0|||
33403811|NCT01066819|101369371|FG005|Overall Study|Spontaneous cure|0|||
33403812|NCT01066819|101369366|FG000|Overall Study|Treatment never started|85|||
33403813|NCT01066819|101369367|FG001|Overall Study|Treatment never started|19|||
33403814|NCT01066819|101369368|FG002|Overall Study|Treatment never started|19|||
33403815|NCT01066819|101369369|FG003|Overall Study|Treatment never started|3|||
33403816|NCT01066819|101369370|FG004|Overall Study|Treatment never started|2|||
33403817|NCT01066819|101369371|FG005|Overall Study|Treatment never started|2|||
33403818|NCT01066819|101369366|FG000|Overall Study|Treatment stopped|12|||
33403819|NCT01066819|101369367|FG001|Overall Study|Treatment stopped|1|||
33403820|NCT01066819|101369368|FG002|Overall Study|Treatment stopped|2|||
33403821|NCT01066819|101369369|FG003|Overall Study|Treatment stopped|1|||
33611250|NCT00106353|102126907|FG005|Part 1|Symptomatic deterioration|0|||
33611251|NCT00106353|102126908|FG006|Part 1|Symptomatic deterioration|0|||
33611252|NCT00106353|102126902|FG000|Part 1|Entered follow-up phase|1|||
33335510|NCT02069899|101121249|FG001|Overall Study|Lost to Follow-up|0|||
33335511|NCT02069899|101121250|FG002|Overall Study|Lost to Follow-up|1|||
33335512|NCT02069899|101121248|FG000|Overall Study|Other|4|||
33335513|NCT02069899|101121249|FG001|Overall Study|Other|0|||
33335514|NCT02069899|101121250|FG002|Overall Study|Other|0|||
33335515|NCT02069899|101121248|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
33335516|NCT02069899|101121249|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
33335517|NCT02069899|101121250|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
33335518|NCT02069899|101121248|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
33335519|NCT02069899|101121249|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
33335520|NCT02069899|101121250|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
33335521|NCT03286842|101121251|FG000|Overall Study|Patients rolled over to another study|80|||
33335522|NCT03499028|101121262|FG000|Overall Study|Lost to Follow-up|12|||
33335523|NCT03499028|101121263|FG001|Overall Study|Lost to Follow-up|9|||
33335524|NCT03499028|101121262|FG000|Overall Study|Withdrawal by Subject|5|||
33335525|NCT03499028|101121263|FG001|Overall Study|Withdrawal by Subject|8|||
33611253|NCT00106353|102126903|FG001|Part 1|Entered follow-up phase|1|||
33611254|NCT00106353|102126904|FG002|Part 1|Entered follow-up phase|0|||
33611255|NCT00106353|102126905|FG003|Part 1|Entered follow-up phase|1|||
33611256|NCT00106353|102126906|FG004|Part 1|Entered follow-up phase|0|||
33611257|NCT00106353|102126907|FG005|Part 1|Entered follow-up phase|0|||
33611258|NCT00106353|102126908|FG006|Part 1|Entered follow-up phase|0|||
33611259|NCT00106353|102126902|FG000|Part 1|Adverse Event|0|||
33335526|NCT03499028|101121262|FG000|Overall Study|Unplanned SNF discharge|5|||
33335527|NCT03499028|101121263|FG001|Overall Study|Unplanned SNF discharge|8|||
33335528|NCT00817531|101121265|FG000|Overall Study|Adverse Event|1|||
33403822|NCT01066819|101369370|FG004|Overall Study|Treatment stopped|0|||
33403823|NCT01066819|101369371|FG005|Overall Study|Treatment stopped|0|||
33403824|NCT01066819|101369366|FG000|Overall Study|Other|5|||
33403825|NCT01066819|101369367|FG001|Overall Study|Other|1|||
33403826|NCT01066819|101369368|FG002|Overall Study|Other|1|||
33611260|NCT00106353|102126903|FG001|Part 1|Adverse Event|0|||
33611261|NCT00106353|102126904|FG002|Part 1|Adverse Event|0|||
33335529|NCT00817531|101121265|FG000|Overall Study|Lack of Efficacy|1|||
33335530|NCT00861744|101121266|FG000|Overall Study|Adverse Event|0|||
33335531|NCT00861744|101121267|FG001|Overall Study|Adverse Event|0|||
33335532|NCT00861744|101121268|FG002|Overall Study|Adverse Event|0|||
33335533|NCT00861744|101121269|FG003|Overall Study|Adverse Event|1|||
33335534|NCT00861744|101121266|FG000|Overall Study|Lost to Follow-up|7|||
33335535|NCT00861744|101121267|FG001|Overall Study|Lost to Follow-up|19|||
33335536|NCT00861744|101121268|FG002|Overall Study|Lost to Follow-up|17|||
33335537|NCT00861744|101121269|FG003|Overall Study|Lost to Follow-up|12|||
33335538|NCT00861744|101121266|FG000|Overall Study|Withdrawal by Subject|10|||
33335539|NCT00861744|101121267|FG001|Overall Study|Withdrawal by Subject|6|||
33335540|NCT00861744|101121268|FG002|Overall Study|Withdrawal by Subject|6|||
33335541|NCT00861744|101121269|FG003|Overall Study|Withdrawal by Subject|19|||
33335542|NCT00861744|101121266|FG000|Overall Study|Protocol Violation|0|||
33335543|NCT00861744|101121267|FG001|Overall Study|Protocol Violation|1|||
33335544|NCT00861744|101121268|FG002|Overall Study|Protocol Violation|0|||
33335545|NCT00861744|101121269|FG003|Overall Study|Protocol Violation|0|||
33529401|NCT00758498|101838277|FG001|Overall Study|Subject legally detained out of state|0|||
33529402|NCT00758498|101838278|FG002|Overall Study|Subject legally detained out of state|0|||
33529403|NCT00758498|101838276|FG000|Overall Study|Withdrawal by Subject|0|||
33529404|NCT00758498|101838277|FG001|Overall Study|Withdrawal by Subject|0|||
33529405|NCT00758498|101838278|FG002|Overall Study|Withdrawal by Subject|1|||
33529406|NCT00758498|101838276|FG000|Overall Study|Noncompliance to study procedures|0|||
33529407|NCT00758498|101838277|FG001|Overall Study|Noncompliance to study procedures|0|||
33529408|NCT00758498|101838278|FG002|Overall Study|Noncompliance to study procedures|1|||
33529409|NCT02213380|101838301|FG000|Underwent Randomization|Withdrawal by Subject|2|||
33529410|NCT02213380|101838302|FG001|Underwent Randomization|Withdrawal by Subject|0|||
33529411|NCT02213380|101838301|FG000|Underwent Randomization|Not treated|3|||
33529412|NCT02213380|101838302|FG001|Underwent Randomization|Not treated|3|||
33529413|NCT02213380|101838301|FG000|Per-protocol Analysis|Protocol Violation|32|||
33529414|NCT02213380|101838302|FG001|Per-protocol Analysis|Protocol Violation|36|||
33529415|NCT00762034|101838303|FG000|Induction Period|Protocol Violation|1|||
33529416|NCT00762034|101838304|FG001|Induction Period|Protocol Violation|2|||
33529417|NCT00762034|101838303|FG000|Induction Period|Entry Criterion Not Met|12|||
33529418|NCT00762034|101838304|FG001|Induction Period|Entry Criterion Not Met|11|||
33529419|NCT00762034|101838303|FG000|Induction Period|Adverse Event|27|||
33529420|NCT00762034|101838304|FG001|Induction Period|Adverse Event|38|||
33529421|NCT00762034|101838303|FG000|Induction Period|Lost to Follow-up|1|||
33529422|NCT00762034|101838304|FG001|Induction Period|Lost to Follow-up|1|||
33529423|NCT00762034|101838303|FG000|Induction Period|Progressive Disease|73|||
33529424|NCT00762034|101838304|FG001|Induction Period|Progressive Disease|55|||
33529425|NCT00762034|101838303|FG000|Induction Period|Physician Decision|21|||
33529426|NCT00762034|101838304|FG001|Induction Period|Physician Decision|20|||
33529427|NCT00762034|101838303|FG000|Induction Period|Withdrawal by Subject|15|||
33529428|NCT00762034|101838304|FG001|Induction Period|Withdrawal by Subject|19|||
33529429|NCT00762034|101838303|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
33529430|NCT00762034|101838304|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
33529431|NCT00762034|101838303|FG000|Induction Period|Deaths Due to Study Disease|9|||
33529432|NCT00762034|101838304|FG001|Induction Period|Deaths Due to Study Disease|9|||
33529433|NCT00762034|101838303|FG000|Maintenance Period|Protocol Violation|1|||
33529434|NCT00762034|101838304|FG001|Maintenance Period|Protocol Violation|3|||
33529435|NCT00762034|101838303|FG000|Maintenance Period|Entry Criterion Not Met|0|||
33529436|NCT00762034|101838304|FG001|Maintenance Period|Entry Criterion Not Met|2|||
33529437|NCT00762034|101838303|FG000|Maintenance Period|Adverse Event|42|||
33529438|NCT00762034|101838304|FG001|Maintenance Period|Adverse Event|26|||
33529439|NCT00762034|101838303|FG000|Maintenance Period|Progressive Disease|186|||
33529440|NCT00762034|101838304|FG001|Maintenance Period|Progressive Disease|224|||
33529441|NCT00762034|101838303|FG000|Maintenance Period|Physician Decision|25|||
33529442|NCT00762034|101838304|FG001|Maintenance Period|Physician Decision|20|||
33529443|NCT00762034|101838303|FG000|Maintenance Period|Withdrawal by Subject|34|||
33529444|NCT00762034|101838304|FG001|Maintenance Period|Withdrawal by Subject|14|||
33529445|NCT00762034|101838303|FG000|Maintenance Period|Death not due to study disease|2|||
33611262|NCT00106353|102126905|FG003|Part 1|Adverse Event|1|||
33611263|NCT00106353|102126906|FG004|Part 1|Adverse Event|0|||
33335546|NCT00861744|101121266|FG000|Overall Study|Migration from study area|0|||
33335547|NCT00861744|101121267|FG001|Overall Study|Migration from study area|3|||
33403827|NCT01066819|101369369|FG003|Overall Study|Other|0|||
33403828|NCT01066819|101369370|FG004|Overall Study|Other|0|||
33403829|NCT01066819|101369371|FG005|Overall Study|Other|0|||
33529446|NCT00762034|101838304|FG001|Maintenance Period|Death not due to study disease|5|||
33529447|NCT00762034|101838303|FG000|Maintenance Period|Death due to study disease|3|||
33529448|NCT00762034|101838304|FG001|Maintenance Period|Death due to study disease|3|||
33529449|NCT00762034|101838303|FG000|Maintenance Period|Other|1|||
33611264|NCT00106353|102126907|FG005|Part 1|Adverse Event|0|||
33335548|NCT00861744|101121268|FG002|Overall Study|Migration from study area|1|||
33403830|NCT02719028|101369372|FG000|Overall Study|Adverse Event|2|||
33529450|NCT00762034|101838304|FG001|Maintenance Period|Other|1|||
33529451|NCT02143024|101838305|FG000|Overall Study|Lost to Follow-up|1|||
33529452|NCT02143024|101838306|FG001|Overall Study|Lost to Follow-up|1|||
33529453|NCT02143024|101838305|FG000|Overall Study|Withdrawal by Subject|1|||
33529454|NCT02143024|101838306|FG001|Overall Study|Withdrawal by Subject|0|||
33529455|NCT00096538|101838308|FG000|Overall Study|Withdrawal by Subject|1|||
33529456|NCT01979523|101838309|FG000|Overall Study|Withdrawal by Subject|1|||
33529457|NCT01979523|101838310|FG001|Overall Study|Withdrawal by Subject|0|||
33529458|NCT01922258|101838328|FG000|Overall Study|Lost to Follow-up|1|||
33529459|NCT01922258|101838329|FG001|Overall Study|Lost to Follow-up|1|||
33529460|NCT01922258|101838328|FG000|Overall Study|Adverse Event|9|||
33529461|NCT01922258|101838329|FG001|Overall Study|Adverse Event|2|||
33529462|NCT01922258|101838328|FG000|Overall Study|Met Withdrawal Criteria|0|||
33529463|NCT01922258|101838329|FG001|Overall Study|Met Withdrawal Criteria|4|||
33529464|NCT01922258|101838328|FG000|Overall Study|Withdrawn by the Investigator|1|||
33529465|NCT01922258|101838329|FG001|Overall Study|Withdrawn by the Investigator|4|||
33335549|NCT00861744|101121269|FG003|Overall Study|Migration from study area|0|||
33335550|NCT00861744|101121266|FG000|Overall Study|Blood draws|0|||
33335551|NCT00861744|101121267|FG001|Overall Study|Blood draws|0|||
33335552|NCT00861744|101121268|FG002|Overall Study|Blood draws|0|||
33335553|NCT00861744|101121269|FG003|Overall Study|Blood draws|1|||
33529466|NCT01922258|101838328|FG000|Overall Study|Withdrawal by participant|5|||
33529467|NCT01922258|101838329|FG001|Overall Study|Withdrawal by participant|5|||
33529468|NCT02609386|101838332|FG000|Overall Study|Withdrawal by Subject|6|||
33529469|NCT02609386|101838333|FG001|Overall Study|Withdrawal by Subject|1|||
33529470|NCT02609386|101838332|FG000|Overall Study|Lost to Follow-up|3|||
33529471|NCT02609386|101838333|FG001|Overall Study|Lost to Follow-up|5|||
33529472|NCT02609386|101838332|FG000|Overall Study|Death|19|||
33529473|NCT02609386|101838333|FG001|Overall Study|Death|9|||
33529474|NCT02609386|101838332|FG000|Overall Study|Physician Decision|0|||
33529475|NCT02609386|101838333|FG001|Overall Study|Physician Decision|2|||
33529476|NCT00482170|101838336|FG000|Overall Study|Adverse Event|5|||
33529477|NCT00482170|101838337|FG001|Overall Study|Adverse Event|14|||
33529478|NCT00482170|101838336|FG000|Overall Study|Withdrawal by Subject|6|||
33529479|NCT00482170|101838337|FG001|Overall Study|Withdrawal by Subject|1|||
33529480|NCT00482170|101838336|FG000|Overall Study|Protocol Violation|2|||
33529481|NCT00482170|101838337|FG001|Overall Study|Protocol Violation|3|||
33529482|NCT00482170|101838336|FG000|Overall Study|Lost to Follow-up|2|||
33529483|NCT00482170|101838337|FG001|Overall Study|Lost to Follow-up|0|||
33529484|NCT00482170|101838336|FG000|Overall Study|Unspecified reason|0|||
33529485|NCT00482170|101838337|FG001|Overall Study|Unspecified reason|2|||
33529486|NCT01556997|101838338|FG000|Overall Study|Adverse Event|10|||
33529487|NCT01556997|101838339|FG001|Overall Study|Adverse Event|12|||
33529488|NCT01556997|101838340|FG002|Overall Study|Adverse Event|12|||
33529489|NCT01556997|101838338|FG000|Overall Study|Lost to Follow-up|6|||
33529490|NCT01556997|101838339|FG001|Overall Study|Lost to Follow-up|6|||
33529491|NCT01556997|101838340|FG002|Overall Study|Lost to Follow-up|4|||
33529492|NCT01556997|101838338|FG000|Overall Study|Physician Decision|1|||
33529493|NCT01556997|101838339|FG001|Overall Study|Physician Decision|1|||
33529494|NCT01556997|101838340|FG002|Overall Study|Physician Decision|1|||
33529495|NCT01556997|101838338|FG000|Overall Study|Withdrawal by Subject|7|||
33529496|NCT01556997|101838339|FG001|Overall Study|Withdrawal by Subject|6|||
33529497|NCT01556997|101838340|FG002|Overall Study|Withdrawal by Subject|8|||
33335554|NCT02699892|101121270|FG000|Overall Study|Other|36|||
33335555|NCT02018822|101121271|FG000|Overall Study|filling replaced by crown|0|||
33335556|NCT02018822|101121272|FG001|Overall Study|filling replaced by crown|1|||
33529498|NCT01556997|101838338|FG000|Overall Study|Other|2|||
33529499|NCT01556997|101838339|FG001|Overall Study|Other|3|||
33529500|NCT01556997|101838340|FG002|Overall Study|Other|7|||
33529501|NCT02019550|101838345|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
33529502|NCT02019550|101838346|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
33529503|NCT03479008|101838347|FG000|Overall Study|Withdrawal by Subject|3|||
33529504|NCT01465230|101838348|FG000|Overall Study|Withdrawal by Subject|2|||
33335557|NCT02018822|101121273|FG002|Overall Study|filling replaced by crown|0|||
33335558|NCT02018822|101121271|FG000|Overall Study|Physician Decision|0|||
33335559|NCT02018822|101121272|FG001|Overall Study|Physician Decision|1|||
33403831|NCT02719028|101369373|FG001|Overall Study|Adverse Event|1|||
33529505|NCT00977613|101838353|FG000|Overall Study|Lost to Follow-up|16|||
33529506|NCT01073163|101838359|FG000|Overall Study|Adverse Event|1|||
33529507|NCT01073163|101838359|FG000|Overall Study|Disease Progression|1|||
33529508|NCT01073163|101838359|FG000|Overall Study|Early termination|1|||
33529509|NCT03293394|101838360|FG000|Follow-up (6 Months)|Adverse Event|4|||
33529510|NCT03293394|101838361|FG001|Follow-up (6 Months)|Adverse Event|2|||
33403832|NCT02719028|101369374|FG002|Overall Study|Adverse Event|4|||
33403833|NCT02719028|101369375|FG003|Overall Study|Adverse Event|8|||
33403834|NCT02719028|101369372|FG000|Overall Study|Physician Decision|0|||
33403835|NCT02719028|101369373|FG001|Overall Study|Physician Decision|1|||
33403836|NCT02719028|101369374|FG002|Overall Study|Physician Decision|1|||
33403837|NCT02719028|101369375|FG003|Overall Study|Physician Decision|1|||
33403838|NCT02719028|101369372|FG000|Overall Study|Use of prohibited medication|0|||
33403839|NCT02719028|101369373|FG001|Overall Study|Use of prohibited medication|0|||
33403840|NCT02719028|101369374|FG002|Overall Study|Use of prohibited medication|1|||
33403841|NCT02719028|101369375|FG003|Overall Study|Use of prohibited medication|0|||
33611265|NCT00106353|102126908|FG006|Part 1|Adverse Event|0|||
33611266|NCT00106353|102126902|FG000|Part 2|Disease progression|0|||
33335560|NCT02018822|101121273|FG002|Overall Study|Physician Decision|1|||
33335561|NCT02018822|101121271|FG000|Overall Study|Lost to Follow-up|6|||
33335562|NCT02018822|101121272|FG001|Overall Study|Lost to Follow-up|6|||
33335563|NCT02018822|101121273|FG002|Overall Study|Lost to Follow-up|5|||
33335564|NCT02109484|101121274|FG000|Overall Study|Lost to Follow-up|0|||
33335565|NCT02109484|101121275|FG001|Overall Study|Lost to Follow-up|0|||
33335566|NCT02109484|101121276|FG002|Overall Study|Lost to Follow-up|0|||
33335567|NCT02109484|101121277|FG003|Overall Study|Lost to Follow-up|1|||
33335568|NCT02109484|101121278|FG004|Overall Study|Lost to Follow-up|1|||
33335569|NCT02109484|101121279|FG005|Overall Study|Lost to Follow-up|0|||
33335570|NCT02109484|101121280|FG006|Overall Study|Lost to Follow-up|1|||
33335571|NCT02109484|101121281|FG007|Overall Study|Lost to Follow-up|0|||
33335572|NCT02109484|101121274|FG000|Overall Study|Withdrawal by Subject|0|||
33335573|NCT02109484|101121275|FG001|Overall Study|Withdrawal by Subject|0|||
33335574|NCT02109484|101121276|FG002|Overall Study|Withdrawal by Subject|0|||
33335575|NCT02109484|101121277|FG003|Overall Study|Withdrawal by Subject|0|||
33335576|NCT02109484|101121278|FG004|Overall Study|Withdrawal by Subject|1|||
33335577|NCT02109484|101121279|FG005|Overall Study|Withdrawal by Subject|1|||
33335578|NCT02109484|101121280|FG006|Overall Study|Withdrawal by Subject|1|||
33335579|NCT02109484|101121281|FG007|Overall Study|Withdrawal by Subject|0|||
33335580|NCT02109484|101121274|FG000|Overall Study|Physician Decision|0|||
33335581|NCT02109484|101121275|FG001|Overall Study|Physician Decision|0|||
33335582|NCT02109484|101121276|FG002|Overall Study|Physician Decision|0|||
33335583|NCT02109484|101121277|FG003|Overall Study|Physician Decision|0|||
33335584|NCT02109484|101121278|FG004|Overall Study|Physician Decision|2|||
33335585|NCT02109484|101121279|FG005|Overall Study|Physician Decision|0|||
33335586|NCT02109484|101121280|FG006|Overall Study|Physician Decision|0|||
33335587|NCT02109484|101121281|FG007|Overall Study|Physician Decision|0|||
33335588|NCT02109484|101121274|FG000|Overall Study|Death|0|||
33335589|NCT02109484|101121275|FG001|Overall Study|Death|0|||
33335590|NCT02109484|101121276|FG002|Overall Study|Death|0|||
33335591|NCT02109484|101121277|FG003|Overall Study|Death|0|||
33335592|NCT02109484|101121278|FG004|Overall Study|Death|0|||
33335593|NCT02109484|101121279|FG005|Overall Study|Death|0|||
33335594|NCT02109484|101121280|FG006|Overall Study|Death|0|||
33335595|NCT02109484|101121281|FG007|Overall Study|Death|2|||
33335596|NCT02109484|101121274|FG000|Overall Study|Moved away from study area|0|||
33335597|NCT02109484|101121275|FG001|Overall Study|Moved away from study area|0|||
33335598|NCT02109484|101121276|FG002|Overall Study|Moved away from study area|0|||
33335599|NCT02109484|101121277|FG003|Overall Study|Moved away from study area|0|||
33335600|NCT02109484|101121278|FG004|Overall Study|Moved away from study area|0|||
33335601|NCT02109484|101121279|FG005|Overall Study|Moved away from study area|0|||
33403842|NCT02719028|101369372|FG000|Overall Study|Protocol Violation|0|||
33611267|NCT00106353|102126903|FG001|Part 2|Disease progression|0|||
33611268|NCT00106353|102126904|FG002|Part 2|Disease progression|0|||
33611269|NCT00106353|102126905|FG003|Part 2|Disease progression|0|||
33611270|NCT00106353|102126906|FG004|Part 2|Disease progression|8|||
33611271|NCT00106353|102126907|FG005|Part 2|Disease progression|14|||
33611272|NCT00106353|102126908|FG006|Part 2|Disease progression|13|||
33611273|NCT00106353|102126902|FG000|Part 2|Death|0|||
33335602|NCT02109484|101121280|FG006|Overall Study|Moved away from study area|1|||
33335603|NCT02109484|101121281|FG007|Overall Study|Moved away from study area|1|||
33335604|NCT01273883|101121282|FG000|First Intervention|Adverse Event|2|||
33335605|NCT01273883|101121283|FG001|First Intervention|Adverse Event|1|||
33335606|NCT01273883|101121282|FG000|Second Intervention|Lost to Follow-up|1|||
33335607|NCT01273883|101121283|FG001|Second Intervention|Lost to Follow-up|1|||
33335608|NCT01273883|101121282|FG000|Second Intervention|Lack of Efficacy|1|||
33335609|NCT01273883|101121283|FG001|Second Intervention|Lack of Efficacy|0|||
33335610|NCT00290433|101121287|FG000|Overall Study|Disease Progression|13|||
33611274|NCT00106353|102126903|FG001|Part 2|Death|0|||
33335611|NCT00290433|101121287|FG000|Overall Study|Adverse Event|14|||
33335612|NCT00290433|101121287|FG000|Overall Study|Withdrawal by Subject|1|||
33403843|NCT02719028|101369373|FG001|Overall Study|Protocol Violation|0|||
33403844|NCT02719028|101369374|FG002|Overall Study|Protocol Violation|0|||
33403845|NCT02719028|101369375|FG003|Overall Study|Protocol Violation|1|||
33403846|NCT00535236|101369376|FG000|Overall Study|Adverse Event|1|||
33403847|NCT00535236|101369377|FG001|Overall Study|Adverse Event|0|||
33403848|NCT00535236|101369378|FG002|Overall Study|Adverse Event|9|||
33403849|NCT00535236|101369379|FG003|Overall Study|Adverse Event|3|||
33403850|NCT00535236|101369380|FG004|Overall Study|Adverse Event|3|||
33403851|NCT00535236|101369381|FG005|Overall Study|Adverse Event|0|||
33403852|NCT00535236|101369382|FG006|Overall Study|Adverse Event|5|||
33403853|NCT00535236|101369383|FG007|Overall Study|Adverse Event|1|||
33403854|NCT00535236|101369384|FG008|Overall Study|Adverse Event|2|||
33403855|NCT00535236|101369385|FG009|Overall Study|Adverse Event|1|||
33611275|NCT00106353|102126904|FG002|Part 2|Death|0|||
33611276|NCT00106353|102126905|FG003|Part 2|Death|0|||
33611277|NCT00106353|102126906|FG004|Part 2|Death|3|||
33205070|NCT01404312|100651476|FG000|Overall Study|Severe debilitation, unable to continue|1|||
33205071|NCT01404312|100651477|FG001|Overall Study|Severe debilitation, unable to continue|2|||
33205072|NCT01412944|100651478|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
33205073|NCT01412944|100651479|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
33205074|NCT01412944|100651480|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
33205075|NCT01412944|100651481|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
33205076|NCT01412944|100651482|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
33205077|NCT01412944|100651483|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
33205078|NCT01412944|100651478|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
33205079|NCT01412944|100651479|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
33205080|NCT01412944|100651480|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
33205081|NCT01412944|100651481|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
33335613|NCT00290433|101121287|FG000|Overall Study|Non-Compliance|1|||
33335614|NCT00290433|101121287|FG000|Overall Study|Congestive Heart Failure|1|||
33335615|NCT00290433|101121287|FG000|Overall Study|Transplant in CR|5|||
33335616|NCT00290433|101121287|FG000|Overall Study|Unrelated Infection/Death|1|||
33335617|NCT00706134|101121291|FG000|Overall Study|Adverse Event|8|||
33335618|NCT00706134|101121292|FG001|Overall Study|Adverse Event|7|||
33335619|NCT00706134|101121293|FG002|Overall Study|Adverse Event|2|||
33335620|NCT00706134|101121294|FG003|Overall Study|Adverse Event|3|||
33335621|NCT00706134|101121291|FG000|Overall Study|Lost to Follow-up|0|||
33335622|NCT00706134|101121292|FG001|Overall Study|Lost to Follow-up|1|||
33335623|NCT00706134|101121293|FG002|Overall Study|Lost to Follow-up|0|||
33335624|NCT00706134|101121294|FG003|Overall Study|Lost to Follow-up|0|||
33335625|NCT00706134|101121291|FG000|Overall Study|Protocol Violation|0|||
33335626|NCT00706134|101121292|FG001|Overall Study|Protocol Violation|6|||
33335627|NCT00706134|101121293|FG002|Overall Study|Protocol Violation|0|||
33335628|NCT00706134|101121294|FG003|Overall Study|Protocol Violation|3|||
33335629|NCT00706134|101121291|FG000|Overall Study|Withdrawal by Subject|1|||
33335630|NCT00706134|101121292|FG001|Overall Study|Withdrawal by Subject|2|||
33335631|NCT00706134|101121293|FG002|Overall Study|Withdrawal by Subject|1|||
33335632|NCT00706134|101121294|FG003|Overall Study|Withdrawal by Subject|0|||
33335633|NCT00706134|101121291|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
33335634|NCT00706134|101121292|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33335635|NCT00706134|101121293|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
33335636|NCT00706134|101121294|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
33335637|NCT00706134|101121291|FG000|Overall Study|Did not meet study criteria|2|||
33335638|NCT00706134|101121292|FG001|Overall Study|Did not meet study criteria|0|||
33335639|NCT00706134|101121293|FG002|Overall Study|Did not meet study criteria|0|||
33335640|NCT00706134|101121294|FG003|Overall Study|Did not meet study criteria|0|||
33335641|NCT01661140|101121298|FG000|Open-Label Period|Adverse Event|44|||
33335642|NCT01661140|101121299|FG001|Open-Label Period|Adverse Event|0|||
33403856|NCT00535236|101369376|FG000|Overall Study|Lost to Follow-up|1|||
33403857|NCT00535236|101369377|FG001|Overall Study|Lost to Follow-up|2|||
33335643|NCT01661140|101121300|FG002|Open-Label Period|Adverse Event|0|||
33529511|NCT00320788|101838363|FG000|Overall Study|Adverse Event|0|||
33529512|NCT00320788|101838364|FG001|Overall Study|Adverse Event|0|||
33529513|NCT00320788|101838365|FG002|Overall Study|Adverse Event|0|||
33529514|NCT00320788|101838366|FG003|Overall Study|Adverse Event|1|||
33529515|NCT00320788|101838367|FG004|Overall Study|Adverse Event|0|||
33611278|NCT00106353|102126907|FG005|Part 2|Death|0|||
33335644|NCT01661140|101121298|FG000|Open-Label Period|Protocol Violation|3|||
33335645|NCT01661140|101121299|FG001|Open-Label Period|Protocol Violation|0|||
33335646|NCT01661140|101121300|FG002|Open-Label Period|Protocol Violation|0|||
33335647|NCT01661140|101121298|FG000|Open-Label Period|Withdrawal by Subject|5|||
33403858|NCT00535236|101369378|FG002|Overall Study|Lost to Follow-up|0|||
33403859|NCT00535236|101369379|FG003|Overall Study|Lost to Follow-up|0|||
33403860|NCT00535236|101369380|FG004|Overall Study|Lost to Follow-up|2|||
33403861|NCT00535236|101369381|FG005|Overall Study|Lost to Follow-up|0|||
33529516|NCT00320788|101838363|FG000|Overall Study|Death|0|||
33611279|NCT00106353|102126908|FG006|Part 2|Death|1|||
33611280|NCT00106353|102126902|FG000|Part 2|Symptomatic deterioration|0|||
33611281|NCT00106353|102126903|FG001|Part 2|Symptomatic deterioration|0|||
33611282|NCT00106353|102126904|FG002|Part 2|Symptomatic deterioration|0|||
33611283|NCT00106353|102126905|FG003|Part 2|Symptomatic deterioration|0|||
33611284|NCT00106353|102126906|FG004|Part 2|Symptomatic deterioration|3|||
33335648|NCT01661140|101121299|FG001|Open-Label Period|Withdrawal by Subject|0|||
33335649|NCT01661140|101121300|FG002|Open-Label Period|Withdrawal by Subject|0|||
33335650|NCT01661140|101121298|FG000|Open-Label Period|Investigator Decision|3|||
33335651|NCT01661140|101121299|FG001|Open-Label Period|Investigator Decision|0|||
33335652|NCT01661140|101121300|FG002|Open-Label Period|Investigator Decision|0|||
33335653|NCT01661140|101121298|FG000|Open-Label Period|Death|1|||
33335654|NCT01661140|101121299|FG001|Open-Label Period|Death|0|||
33335655|NCT01661140|101121300|FG002|Open-Label Period|Death|0|||
33335656|NCT01661140|101121298|FG000|Open-Label Period|Administrative/Other|1|||
33335657|NCT01661140|101121299|FG001|Open-Label Period|Administrative/Other|0|||
33335658|NCT01661140|101121300|FG002|Open-Label Period|Administrative/Other|0|||
33611285|NCT00106353|102126907|FG005|Part 2|Symptomatic deterioration|0|||
33611286|NCT00106353|102126908|FG006|Part 2|Symptomatic deterioration|0|||
33335659|NCT01661140|101121298|FG000|Open-Label Period|Sponsor termination|16|||
33335660|NCT01661140|101121299|FG001|Open-Label Period|Sponsor termination|0|||
33335661|NCT01661140|101121300|FG002|Open-Label Period|Sponsor termination|0|||
33335662|NCT01661140|101121298|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
33335663|NCT01661140|101121299|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
33335664|NCT01661140|101121300|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
33335665|NCT01661140|101121298|FG000|Open-Label Period|Lost to Follow-up|2|||
33335666|NCT01661140|101121299|FG001|Open-Label Period|Lost to Follow-up|0|||
33335667|NCT01661140|101121300|FG002|Open-Label Period|Lost to Follow-up|0|||
33335668|NCT01661140|101121298|FG000|Double-Blind Period|Refused Treatment|0|||
33335669|NCT01661140|101121299|FG001|Double-Blind Period|Refused Treatment|0|||
33335670|NCT01661140|101121300|FG002|Double-Blind Period|Refused Treatment|1|||
33335671|NCT01661140|101121298|FG000|Double-Blind Period|Adverse Event|0|||
33335672|NCT01661140|101121299|FG001|Double-Blind Period|Adverse Event|16|||
33335673|NCT01661140|101121300|FG002|Double-Blind Period|Adverse Event|18|||
33335674|NCT01661140|101121298|FG000|Double-Blind Period|Protocol Violation|0|||
33335675|NCT01661140|101121299|FG001|Double-Blind Period|Protocol Violation|2|||
33335676|NCT01661140|101121300|FG002|Double-Blind Period|Protocol Violation|3|||
33335677|NCT01661140|101121298|FG000|Double-Blind Period|Withdrawal by Subject|0|||
33335678|NCT01661140|101121299|FG001|Double-Blind Period|Withdrawal by Subject|1|||
33335679|NCT01661140|101121300|FG002|Double-Blind Period|Withdrawal by Subject|3|||
33335680|NCT01661140|101121298|FG000|Double-Blind Period|Investigator's Decision|0|||
33611287|NCT00106353|102126902|FG000|Part 2|Adverse Event|0|||
33611288|NCT00106353|102126903|FG001|Part 2|Adverse Event|0|||
33611289|NCT00106353|102126904|FG002|Part 2|Adverse Event|0|||
33611290|NCT00106353|102126905|FG003|Part 2|Adverse Event|0|||
33611291|NCT00106353|102126906|FG004|Part 2|Adverse Event|0|||
33611292|NCT00106353|102126907|FG005|Part 2|Adverse Event|2|||
33611293|NCT00106353|102126908|FG006|Part 2|Adverse Event|1|||
33611294|NCT00106353|102126902|FG000|Part 2|Other|0|||
33335681|NCT01661140|101121299|FG001|Double-Blind Period|Investigator's Decision|1|||
33335682|NCT01661140|101121300|FG002|Double-Blind Period|Investigator's Decision|2|||
33335683|NCT01661140|101121298|FG000|Double-Blind Period|Sponsor Termination|0|||
33611295|NCT00106353|102126903|FG001|Part 2|Other|0|||
33611296|NCT00106353|102126904|FG002|Part 2|Other|0|||
33611297|NCT00106353|102126905|FG003|Part 2|Other|0|||
33611298|NCT00106353|102126906|FG004|Part 2|Other|1|||
33611299|NCT00106353|102126907|FG005|Part 2|Other|1|||
33611300|NCT00106353|102126908|FG006|Part 2|Other|1|||
33611301|NCT00106353|102126902|FG000|Part 2|Withdrawal by Subject|0|||
33611302|NCT00106353|102126903|FG001|Part 2|Withdrawal by Subject|0|||
33611303|NCT00106353|102126904|FG002|Part 2|Withdrawal by Subject|0|||
33611304|NCT00106353|102126905|FG003|Part 2|Withdrawal by Subject|0|||
33611305|NCT00106353|102126906|FG004|Part 2|Withdrawal by Subject|1|||
33611306|NCT00106353|102126907|FG005|Part 2|Withdrawal by Subject|0|||
33611307|NCT00106353|102126908|FG006|Part 2|Withdrawal by Subject|0|||
33611308|NCT00106353|102126902|FG000|Part 2|Physician Decision|0|||
33335684|NCT01661140|101121299|FG001|Double-Blind Period|Sponsor Termination|14|||
33335685|NCT01661140|101121300|FG002|Double-Blind Period|Sponsor Termination|17|||
33335686|NCT01661140|101121298|FG000|Double-Blind Period|Administrative/Other|0|||
33335687|NCT01661140|101121299|FG001|Double-Blind Period|Administrative/Other|7|||
33335688|NCT01661140|101121300|FG002|Double-Blind Period|Administrative/Other|6|||
33335689|NCT04153188|101121301|FG000|Overall Study|Lost to Follow-up|1|||
33611309|NCT00106353|102126903|FG001|Part 2|Physician Decision|0|||
33611310|NCT00106353|102126904|FG002|Part 2|Physician Decision|0|||
33611311|NCT00106353|102126905|FG003|Part 2|Physician Decision|0|||
33611312|NCT00106353|102126906|FG004|Part 2|Physician Decision|0|||
33611313|NCT00106353|102126907|FG005|Part 2|Physician Decision|1|||
33611314|NCT00106353|102126908|FG006|Part 2|Physician Decision|0|||
33611315|NCT00167310|102126909|FG000|Overall Study|Protocol Violation|5|||
33529517|NCT00320788|101838364|FG001|Overall Study|Death|0|||
33529518|NCT00320788|101838365|FG002|Overall Study|Death|1|||
33529519|NCT00320788|101838366|FG003|Overall Study|Death|0|||
33529520|NCT00320788|101838367|FG004|Overall Study|Death|1|||
33529521|NCT00320788|101838363|FG000|Overall Study|Lost to Follow-up|0|||
33529522|NCT00320788|101838364|FG001|Overall Study|Lost to Follow-up|2|||
33529523|NCT00320788|101838365|FG002|Overall Study|Lost to Follow-up|1|||
33529524|NCT00320788|101838366|FG003|Overall Study|Lost to Follow-up|0|||
33529525|NCT00320788|101838367|FG004|Overall Study|Lost to Follow-up|0|||
33529526|NCT00320788|101838363|FG000|Overall Study|Decision by the Sponsor|1|||
33529527|NCT00320788|101838364|FG001|Overall Study|Decision by the Sponsor|1|||
33529528|NCT00320788|101838365|FG002|Overall Study|Decision by the Sponsor|0|||
33529529|NCT00320788|101838366|FG003|Overall Study|Decision by the Sponsor|0|||
33529530|NCT00320788|101838367|FG004|Overall Study|Decision by the Sponsor|1|||
33529531|NCT00320788|101838363|FG000|Overall Study|Other|1|||
33529532|NCT00320788|101838364|FG001|Overall Study|Other|2|||
33529533|NCT00320788|101838365|FG002|Overall Study|Other|1|||
33529534|NCT00320788|101838366|FG003|Overall Study|Other|1|||
33529535|NCT00320788|101838367|FG004|Overall Study|Other|1|||
33611316|NCT00167310|102126910|FG001|Overall Study|Protocol Violation|3|||
33611317|NCT00167310|102126909|FG000|Overall Study|Withdrawal by Subject|3|||
33205082|NCT01412944|100651482|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
33611318|NCT00167310|102126910|FG001|Overall Study|Withdrawal by Subject|7|||
33611319|NCT01138501|102126911|FG000|Overall Study|Protocol Violation|2|||
33611320|NCT01138501|102126911|FG000|Overall Study|Withdrawal by Subject|3|||
33611321|NCT00811174|102126912|FG000|Overall Study|Protocol Violation|2|||
33611322|NCT00811174|102126912|FG000|Overall Study|Sponsors Decision|1|||
33611323|NCT00211887|102126917|FG000|Overall Study|Adverse Event|8|||
33611324|NCT00211887|102126918|FG001|Overall Study|Adverse Event|4|||
33611325|NCT00211887|102126919|FG002|Overall Study|Adverse Event|6|||
33611326|NCT00211887|102126917|FG000|Overall Study|Death|1|||
33611327|NCT00211887|102126918|FG001|Overall Study|Death|1|||
33611328|NCT00211887|102126919|FG002|Overall Study|Death|1|||
33611329|NCT00211887|102126917|FG000|Overall Study|Lost to Follow-up|28|||
33611330|NCT00211887|102126918|FG001|Overall Study|Lost to Follow-up|13|||
33611331|NCT00211887|102126919|FG002|Overall Study|Lost to Follow-up|9|||
33611332|NCT00211887|102126917|FG000|Overall Study|Non-medical reason|31|||
33611333|NCT00211887|102126918|FG001|Overall Study|Non-medical reason|14|||
33611334|NCT00211887|102126919|FG002|Overall Study|Non-medical reason|8|||
33611335|NCT00211887|102126917|FG000|Overall Study|Other medical reason|15|||
33611336|NCT00211887|102126918|FG001|Overall Study|Other medical reason|11|||
33611337|NCT00211887|102126919|FG002|Overall Study|Other medical reason|7|||
33611338|NCT00211887|102126917|FG000|Overall Study|Side effects|19|||
33611339|NCT00211887|102126918|FG001|Overall Study|Side effects|13|||
33611340|NCT00211887|102126919|FG002|Overall Study|Side effects|5|||
33529536|NCT00320788|101838363|FG000|Overall Study|Physician Decision|1|||
33529537|NCT00320788|101838364|FG001|Overall Study|Physician Decision|1|||
33529538|NCT00320788|101838365|FG002|Overall Study|Physician Decision|0|||
33529539|NCT00320788|101838366|FG003|Overall Study|Physician Decision|0|||
33205083|NCT01412944|100651483|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
33611341|NCT01730586|102126920|FG000|Overall Study|Progressive Disease|2|||
33205084|NCT01412944|100651478|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
33611342|NCT01730586|102126920|FG000|Overall Study|Inadequate Trial|8|||
33611343|NCT01730586|102126920|FG000|Overall Study|Adverse Event|2|||
33529540|NCT00320788|101838367|FG004|Overall Study|Physician Decision|0|||
33529541|NCT00320788|101838363|FG000|Overall Study|Protocol Violation|0|||
33611344|NCT01730586|102126920|FG000|Overall Study|Hospice|1|||
33611345|NCT00895310|102126921|FG000|Overall Study|Withdrawal by Subject|1|||
33611346|NCT01971008|102126927|FG000|Overall Study|Protocol Violation|2|||
33611347|NCT01971008|102126928|FG001|Overall Study|Protocol Violation|1|||
33611348|NCT03878758|102126929|FG000|Overall Study|Withdrawal by Subject|1|||
33611349|NCT03878758|102126929|FG000|Overall Study|Protocol defined|2|||
33611350|NCT03878758|102126929|FG000|Overall Study|Improper consent documentation|1|||
33611351|NCT00151372|102126930|FG000|Overall Study|Death|12|||
33611352|NCT00151372|102126931|FG001|Overall Study|Death|11|||
33611353|NCT00151372|102126930|FG000|Overall Study|Lost to Follow-up|5|||
33335690|NCT04153188|101121302|FG001|Overall Study|Lost to Follow-up|1|||
33335691|NCT04153188|101121301|FG000|Overall Study|Withdrawal by Subject|2|||
33335692|NCT04153188|101121302|FG001|Overall Study|Withdrawal by Subject|0|||
33335693|NCT04153188|101121301|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
33335694|NCT04153188|101121302|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
33335695|NCT01709435|101121303|FG000|Overall Study|Adverse Event|1|||
33335696|NCT01709435|101121304|FG001|Overall Study|Adverse Event|1|||
33335697|NCT01709435|101121305|FG002|Overall Study|Adverse Event|1|||
33335698|NCT01709435|101121306|FG003|Overall Study|Adverse Event|0|||
33335699|NCT01709435|101121307|FG004|Overall Study|Adverse Event|0|||
33335700|NCT01709435|101121308|FG005|Overall Study|Adverse Event|1|||
33335701|NCT01709435|101121303|FG000|Overall Study|Lack of Efficacy|5|||
33335702|NCT01709435|101121304|FG001|Overall Study|Lack of Efficacy|7|||
33335703|NCT01709435|101121305|FG002|Overall Study|Lack of Efficacy|2|||
33335704|NCT01709435|101121306|FG003|Overall Study|Lack of Efficacy|2|||
33335705|NCT01709435|101121307|FG004|Overall Study|Lack of Efficacy|6|||
33335706|NCT01709435|101121308|FG005|Overall Study|Lack of Efficacy|3|||
33335707|NCT01709435|101121303|FG000|Overall Study|Physician Decision|0|||
33335708|NCT01709435|101121304|FG001|Overall Study|Physician Decision|1|||
33335709|NCT01709435|101121305|FG002|Overall Study|Physician Decision|0|||
33335710|NCT01709435|101121306|FG003|Overall Study|Physician Decision|1|||
33335711|NCT01709435|101121307|FG004|Overall Study|Physician Decision|2|||
33335712|NCT01709435|101121308|FG005|Overall Study|Physician Decision|0|||
33335713|NCT01709435|101121303|FG000|Overall Study|Withdrawal by Subject|0|||
33335714|NCT01709435|101121304|FG001|Overall Study|Withdrawal by Subject|0|||
33335715|NCT01709435|101121305|FG002|Overall Study|Withdrawal by Subject|3|||
33335716|NCT01709435|101121306|FG003|Overall Study|Withdrawal by Subject|0|||
33335717|NCT01709435|101121307|FG004|Overall Study|Withdrawal by Subject|2|||
33335718|NCT01709435|101121308|FG005|Overall Study|Withdrawal by Subject|2|||
33335719|NCT02425826|101121309|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
33335720|NCT02425826|101121310|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
33335721|NCT02425826|101121311|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
33335722|NCT02425826|101121309|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
33335723|NCT02425826|101121310|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
33335724|NCT02425826|101121311|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
33335725|NCT02425826|101121309|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
33335726|NCT02425826|101121310|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
33335727|NCT02425826|101121311|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
33335728|NCT02425826|101121309|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
33335729|NCT02425826|101121310|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
33335730|NCT02425826|101121311|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
33335731|NCT02425826|101121309|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
33335732|NCT02425826|101121310|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
33335733|NCT02425826|101121311|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
33335734|NCT02425826|101121309|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
33335735|NCT02425826|101121310|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
33335736|NCT02425826|101121311|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
33335737|NCT02425826|101121309|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
33335738|NCT02425826|101121310|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
33335739|NCT02425826|101121311|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
33335740|NCT02425826|101121309|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
33335741|NCT02425826|101121310|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
33335742|NCT02425826|101121311|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
33335743|NCT02425826|101121309|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
33335744|NCT02425826|101121310|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
33335745|NCT02425826|101121311|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
33335746|NCT02425826|101121309|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
33611354|NCT00151372|102126931|FG001|Overall Study|Lost to Follow-up|5|||
33335747|NCT02425826|101121310|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
33335748|NCT02425826|101121311|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
33335749|NCT00879229|101121312|FG000|Overall Study|Study terminated by Sponsor|13|||
33403862|NCT00535236|101369382|FG006|Overall Study|Lost to Follow-up|0|||
33611355|NCT00151372|102126930|FG000|Overall Study|Too sick medically to continue|5|||
33611356|NCT00151372|102126931|FG001|Overall Study|Too sick medically to continue|6|||
33335750|NCT00879229|101121313|FG001|Overall Study|Study terminated by Sponsor|12|||
33335751|NCT00879229|101121312|FG000|Overall Study|Death|4|||
33335752|NCT00879229|101121313|FG001|Overall Study|Death|2|||
33611357|NCT00151372|102126930|FG000|Overall Study|Withdrawal by Subject|7|||
33611358|NCT00151372|102126931|FG001|Overall Study|Withdrawal by Subject|7|||
33611359|NCT02421588|102126935|FG000|Overall Study|Non-treatment-related AE|8|||
33611360|NCT02421588|102126936|FG001|Overall Study|Non-treatment-related AE|8|||
33335753|NCT00879229|101121312|FG000|Overall Study|Adverse Event|2|||
33335754|NCT00879229|101121313|FG001|Overall Study|Adverse Event|0|||
33335755|NCT00879229|101121312|FG000|Overall Study|Withdrawal by Subject|1|||
33335756|NCT00879229|101121313|FG001|Overall Study|Withdrawal by Subject|0|||
33335757|NCT00879229|101121312|FG000|Overall Study|Clinical status did not improve|1|||
33335758|NCT00879229|101121313|FG001|Overall Study|Clinical status did not improve|0|||
33335759|NCT00879229|101121312|FG000|Overall Study|Other|1|||
33335760|NCT00879229|101121313|FG001|Overall Study|Other|0|||
33611361|NCT02421588|102126935|FG000|Overall Study|Progressive disease|152|||
33611362|NCT02421588|102126936|FG001|Overall Study|Progressive disease|135|||
33335761|NCT02590588|101121314|FG000|Overall Study|Adverse Event|1|||
33335762|NCT01652885|101121316|FG000|Overall Study|Adverse Event|1|||
33335763|NCT02363686|101121318|FG000|Overall Study|Withdrawal by Subject|22|||
33335764|NCT02363686|101121318|FG000|Overall Study|incomplete FEES examinations|13|||
33335765|NCT01967550|101121319|FG000|Overall Study|Withdrawal by Subject|1|||
33335766|NCT01967550|101121320|FG001|Overall Study|Withdrawal by Subject|0|||
33335767|NCT01967550|101121319|FG000|Overall Study|Adverse Event|2|||
33335768|NCT01967550|101121320|FG001|Overall Study|Adverse Event|0|||
33335769|NCT01967550|101121319|FG000|Overall Study|Protocol Violation|2|||
33335770|NCT01967550|101121320|FG001|Overall Study|Protocol Violation|1|||
33335771|NCT01967550|101121319|FG000|Overall Study|Non Compliance|0|||
33335772|NCT01967550|101121320|FG001|Overall Study|Non Compliance|1|||
33335773|NCT02982954|101121321|FG000|Overall Study|Death|55|||
33335774|NCT02982954|101121322|FG001|Overall Study|Death|29|||
33335775|NCT02982954|101121323|FG002|Overall Study|Death|15|||
33335776|NCT02982954|101121324|FG003|Overall Study|Death|20|||
33335777|NCT02982954|101121321|FG000|Overall Study|Lost to Follow-up|2|||
33335778|NCT02982954|101121322|FG001|Overall Study|Lost to Follow-up|1|||
33335779|NCT02982954|101121323|FG002|Overall Study|Lost to Follow-up|0|||
33403863|NCT00535236|101369383|FG007|Overall Study|Lost to Follow-up|0|||
33403864|NCT00535236|101369384|FG008|Overall Study|Lost to Follow-up|6|||
33403865|NCT00535236|101369385|FG009|Overall Study|Lost to Follow-up|1|||
33529542|NCT00320788|101838364|FG001|Overall Study|Protocol Violation|0|||
33611363|NCT02421588|102126935|FG000|Overall Study|Death|11|||
33611364|NCT02421588|102126936|FG001|Overall Study|Death|3|||
33611365|NCT02421588|102126935|FG000|Overall Study|Physician Decision|8|||
33611366|NCT02421588|102126936|FG001|Overall Study|Physician Decision|17|||
33611367|NCT02421588|102126935|FG000|Overall Study|Other reason not specified|3|||
33611368|NCT02421588|102126936|FG001|Overall Study|Other reason not specified|1|||
33335780|NCT02982954|101121324|FG003|Overall Study|Lost to Follow-up|0|||
33335781|NCT02982954|101121321|FG000|Overall Study|Participant withdrew consent|7|||
33335782|NCT02982954|101121322|FG001|Overall Study|Participant withdrew consent|5|||
33335783|NCT02982954|101121323|FG002|Overall Study|Participant withdrew consent|1|||
33335784|NCT02982954|101121324|FG003|Overall Study|Participant withdrew consent|1|||
33403866|NCT00535236|101369376|FG000|Overall Study|Physician Decision|0|||
33529543|NCT00320788|101838365|FG002|Overall Study|Protocol Violation|0|||
33529544|NCT00320788|101838366|FG003|Overall Study|Protocol Violation|0|||
33529545|NCT00320788|101838367|FG004|Overall Study|Protocol Violation|1|||
33529546|NCT00320788|101838363|FG000|Overall Study|Withdrawal by Subject|3|||
33529547|NCT00320788|101838364|FG001|Overall Study|Withdrawal by Subject|0|||
33529548|NCT00320788|101838365|FG002|Overall Study|Withdrawal by Subject|0|||
33529549|NCT00320788|101838366|FG003|Overall Study|Withdrawal by Subject|3|||
33611369|NCT02421588|102126935|FG000|Overall Study|Symptomatic deterioration|13|||
33611370|NCT02421588|102126936|FG001|Overall Study|Symptomatic deterioration|19|||
33335785|NCT02982954|101121321|FG000|Overall Study|Other reasons|42|||
33335786|NCT02982954|101121322|FG001|Overall Study|Other reasons|17|||
33403867|NCT00535236|101369377|FG001|Overall Study|Physician Decision|0|||
33205085|NCT01412944|100651479|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
33335787|NCT02982954|101121323|FG002|Overall Study|Other reasons|12|||
33335788|NCT02982954|101121324|FG003|Overall Study|Other reasons|3|||
33335789|NCT02982954|101121321|FG000|Overall Study|Premature site closure|0|||
33335790|NCT02982954|101121322|FG001|Overall Study|Premature site closure|0|||
33403868|NCT00535236|101369378|FG002|Overall Study|Physician Decision|0|||
33611371|NCT02421588|102126935|FG000|Overall Study|Treatment-related AE|10|||
33611372|NCT02421588|102126936|FG001|Overall Study|Treatment-related AE|14|||
33611373|NCT02421588|102126935|FG000|Overall Study|Withdrawal by Subject|14|||
33335791|NCT02982954|101121323|FG002|Overall Study|Premature site closure|0|||
33335792|NCT02982954|101121324|FG003|Overall Study|Premature site closure|1|||
33335793|NCT01391000|101121325|FG000|Overall Study|Lost to Follow-up|2|||
33335794|NCT01391000|101121326|FG001|Overall Study|Lost to Follow-up|0|||
33335795|NCT03670953|101121328|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
33335796|NCT03670953|101121329|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
33335797|NCT03670953|101121330|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
33335798|NCT03670953|101121331|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
33335799|NCT03670953|101121328|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
33335800|NCT03670953|101121329|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
33335801|NCT03670953|101121330|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
33335802|NCT03670953|101121331|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
33335803|NCT03670953|101121328|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
33335804|NCT03670953|101121329|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
33335805|NCT03670953|101121330|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
33335806|NCT03670953|101121331|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
33335807|NCT03670953|101121328|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
33335808|NCT03670953|101121329|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
33335809|NCT03670953|101121330|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
33335810|NCT03670953|101121331|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
33335811|NCT03670953|101121328|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
33335812|NCT03670953|101121329|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
33335813|NCT03670953|101121330|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
33335814|NCT03670953|101121331|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
33335815|NCT03670953|101121328|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
33335816|NCT03670953|101121329|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
33335817|NCT03670953|101121330|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
33335818|NCT03670953|101121331|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
33335819|NCT03670953|101121328|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
33335820|NCT03670953|101121329|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
33335821|NCT03670953|101121330|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
33335822|NCT03670953|101121331|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
33335823|NCT03670953|101121328|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
33335824|NCT03670953|101121329|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
33335825|NCT03670953|101121330|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
33335826|NCT03670953|101121331|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
33335827|NCT03670953|101121328|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
33335828|NCT03670953|101121329|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
33335829|NCT03670953|101121330|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
33335830|NCT03670953|101121331|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
33335831|NCT03670953|101121328|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
33335832|NCT03670953|101121329|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
33335833|NCT03670953|101121330|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
33335834|NCT03670953|101121331|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
33335835|NCT03670953|101121328|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
33403869|NCT00535236|101369379|FG003|Overall Study|Physician Decision|0|||
33403870|NCT00535236|101369380|FG004|Overall Study|Physician Decision|1|||
33403871|NCT00535236|101369381|FG005|Overall Study|Physician Decision|0|||
33403872|NCT00535236|101369382|FG006|Overall Study|Physician Decision|1|||
33335836|NCT03670953|101121329|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
33335837|NCT03670953|101121330|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
33335838|NCT03670953|101121331|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
33403873|NCT00535236|101369383|FG007|Overall Study|Physician Decision|0|||
33403874|NCT00535236|101369384|FG008|Overall Study|Physician Decision|0|||
33403875|NCT00535236|101369385|FG009|Overall Study|Physician Decision|0|||
33403876|NCT00535236|101369376|FG000|Overall Study|Protocol Violation|2|||
33403877|NCT00535236|101369377|FG001|Overall Study|Protocol Violation|0|||
33403878|NCT00535236|101369378|FG002|Overall Study|Protocol Violation|1|||
33403879|NCT00535236|101369379|FG003|Overall Study|Protocol Violation|0|||
33403880|NCT00535236|101369380|FG004|Overall Study|Protocol Violation|0|||
33403881|NCT00535236|101369381|FG005|Overall Study|Protocol Violation|0|||
33403882|NCT00535236|101369382|FG006|Overall Study|Protocol Violation|0|||
33335839|NCT03670953|101121328|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
33335840|NCT03670953|101121329|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
33335841|NCT03670953|101121330|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
33335842|NCT03670953|101121331|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
33335843|NCT03670953|101121328|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
33335844|NCT03670953|101121329|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
33403883|NCT00535236|101369383|FG007|Overall Study|Protocol Violation|0|||
33403884|NCT00535236|101369384|FG008|Overall Study|Protocol Violation|1|||
33611374|NCT02421588|102126936|FG001|Overall Study|Withdrawal by Subject|16|||
33403885|NCT00535236|101369385|FG009|Overall Study|Protocol Violation|0|||
33403886|NCT00535236|101369376|FG000|Overall Study|Withdrawal by Subject|3|||
33403887|NCT00535236|101369377|FG001|Overall Study|Withdrawal by Subject|0|||
33403888|NCT00535236|101369378|FG002|Overall Study|Withdrawal by Subject|2|||
33403889|NCT00535236|101369379|FG003|Overall Study|Withdrawal by Subject|1|||
33403890|NCT00535236|101369380|FG004|Overall Study|Withdrawal by Subject|6|||
33403891|NCT00535236|101369381|FG005|Overall Study|Withdrawal by Subject|1|||
33403892|NCT00535236|101369382|FG006|Overall Study|Withdrawal by Subject|5|||
33403893|NCT00535236|101369383|FG007|Overall Study|Withdrawal by Subject|0|||
33403894|NCT00535236|101369384|FG008|Overall Study|Withdrawal by Subject|4|||
33611375|NCT02421588|102126935|FG000|Overall Study|Not treated|2|||
33611376|NCT02421588|102126936|FG001|Overall Study|Not treated|8|||
33611377|NCT01368081|102126937|FG000|Overall Study|Adverse Event|4|||
33611378|NCT01368081|102126938|FG001|Overall Study|Adverse Event|4|||
33611379|NCT01368081|102126939|FG002|Overall Study|Adverse Event|3|||
33611380|NCT01368081|102126940|FG003|Overall Study|Adverse Event|2|||
33611381|NCT01368081|102126941|FG004|Overall Study|Adverse Event|2|||
33611382|NCT01368081|102126942|FG005|Overall Study|Adverse Event|5|||
33611383|NCT01368081|102126943|FG006|Overall Study|Adverse Event|6|||
33611384|NCT01368081|102126944|FG007|Overall Study|Adverse Event|2|||
33611385|NCT01368081|102126945|FG008|Overall Study|Adverse Event|3|||
33611386|NCT01368081|102126946|FG009|Overall Study|Adverse Event|5|||
33611387|NCT01368081|102126947|FG010|Overall Study|Adverse Event|6|||
33611388|NCT01368081|102126948|FG011|Overall Study|Adverse Event|1|||
33611389|NCT01368081|102126949|FG012|Overall Study|Adverse Event|3|||
33611390|NCT01368081|102126937|FG000|Overall Study|Lack of Efficacy|0|||
33611391|NCT01368081|102126938|FG001|Overall Study|Lack of Efficacy|1|||
33611392|NCT01368081|102126939|FG002|Overall Study|Lack of Efficacy|0|||
33611393|NCT01368081|102126940|FG003|Overall Study|Lack of Efficacy|1|||
33611394|NCT01368081|102126941|FG004|Overall Study|Lack of Efficacy|0|||
33611395|NCT01368081|102126942|FG005|Overall Study|Lack of Efficacy|0|||
33611396|NCT01368081|102126943|FG006|Overall Study|Lack of Efficacy|0|||
33611397|NCT01368081|102126944|FG007|Overall Study|Lack of Efficacy|2|||
33335845|NCT03670953|101121330|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
33335846|NCT03670953|101121331|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
33335847|NCT03670953|101121328|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
33335848|NCT03670953|101121329|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
33335849|NCT03670953|101121330|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
33335850|NCT03670953|101121331|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
33335851|NCT03670953|101121328|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
33335852|NCT03670953|101121329|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
33335853|NCT03670953|101121330|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
33335854|NCT03670953|101121331|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
33335855|NCT03670953|101121328|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
33335856|NCT03670953|101121329|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
33335857|NCT03670953|101121330|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
33335858|NCT03670953|101121331|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
33335859|NCT03670953|101121328|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
33335860|NCT03670953|101121329|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
33335861|NCT03670953|101121330|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
33335862|NCT03670953|101121331|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
33335863|NCT03670953|101121328|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
33335864|NCT03670953|101121329|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
33335865|NCT03670953|101121330|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
33335866|NCT03670953|101121331|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
33335867|NCT00135668|101121332|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
33335868|NCT00135668|101121333|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
33335869|NCT00135668|101121334|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
33335870|NCT00135668|101121335|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
33335871|NCT02192827|101121336|FG000|Overall Study|Lost to Follow-up|25|||
33335872|NCT02192827|101121337|FG001|Overall Study|Lost to Follow-up|27|||
33335873|NCT02192827|101121336|FG000|Overall Study|Given additional steroids with admission|13|||
33403895|NCT00535236|101369385|FG009|Overall Study|Withdrawal by Subject|2|||
33403896|NCT00634933|101369392|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
33403897|NCT00634933|101369393|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
33611398|NCT01368081|102126945|FG008|Overall Study|Lack of Efficacy|0|||
33205086|NCT01412944|100651480|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
33403898|NCT00634933|101369394|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
33529550|NCT00320788|101838367|FG004|Overall Study|Withdrawal by Subject|1|||
33611399|NCT01368081|102126946|FG009|Overall Study|Lack of Efficacy|0|||
33611400|NCT01368081|102126947|FG010|Overall Study|Lack of Efficacy|0|||
33611401|NCT01368081|102126948|FG011|Overall Study|Lack of Efficacy|0|||
33611402|NCT01368081|102126949|FG012|Overall Study|Lack of Efficacy|0|||
33335874|NCT02192827|101121337|FG001|Overall Study|Given additional steroids with admission|11|||
33335875|NCT04042103|101121340|FG000|Overall Study|Lost to Follow-up|1|||
33335876|NCT04042103|101121340|FG000|Overall Study|Withdrawal by Subject|1|||
33335877|NCT02182687|101121341|FG000|Overall Study|Withdrawal by Subject|4|||
33335878|NCT02182687|101121342|FG001|Overall Study|Withdrawal by Subject|0|||
33335879|NCT02182687|101121341|FG000|Overall Study|Adverse Event|1|||
33335880|NCT02182687|101121342|FG001|Overall Study|Adverse Event|0|||
33335881|NCT02182687|101121341|FG000|Overall Study|Lost to Follow-up|0|||
33335882|NCT02182687|101121342|FG001|Overall Study|Lost to Follow-up|1|||
33335883|NCT02429414|101121343|FG000|Overall Study|Physician Decision|0|||
33335884|NCT02429414|101121344|FG001|Overall Study|Physician Decision|1|||
33611403|NCT01368081|102126937|FG000|Overall Study|Protocol Violation|0|||
33611404|NCT01368081|102126938|FG001|Overall Study|Protocol Violation|0|||
33611405|NCT01368081|102126939|FG002|Overall Study|Protocol Violation|0|||
33611406|NCT01368081|102126940|FG003|Overall Study|Protocol Violation|0|||
33611407|NCT01368081|102126941|FG004|Overall Study|Protocol Violation|0|||
33403899|NCT00634933|101369395|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
33403900|NCT00634933|101369396|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
33403901|NCT00634933|101369392|FG000|Part A: Baseline to Week 24|Death|1|||
33403902|NCT00634933|101369393|FG001|Part A: Baseline to Week 24|Death|0|||
33403903|NCT00634933|101369394|FG002|Part A: Baseline to Week 24|Death|0|||
33335885|NCT01534533|101121345|FG000|Overall Study|Lost to Follow-up|3|||
33335886|NCT01534533|101121346|FG001|Overall Study|Lost to Follow-up|0|||
33335887|NCT01534533|101121347|FG002|Overall Study|Lost to Follow-up|4|||
33335888|NCT01534533|101121348|FG003|Overall Study|Lost to Follow-up|3|||
33335889|NCT01534533|101121345|FG000|Overall Study|Withdrawal by Subject|5|||
33335890|NCT01534533|101121346|FG001|Overall Study|Withdrawal by Subject|3|||
33335891|NCT01534533|101121347|FG002|Overall Study|Withdrawal by Subject|4|||
33335892|NCT01534533|101121348|FG003|Overall Study|Withdrawal by Subject|1|||
33335893|NCT00730639|101121350|FG000|Overall Study|Adverse Event|3|||
33335894|NCT00730639|101121351|FG001|Overall Study|Adverse Event|0|||
33335895|NCT00730639|101121352|FG002|Overall Study|Adverse Event|9|||
33335896|NCT00730639|101121353|FG003|Overall Study|Adverse Event|8|||
33335897|NCT00730639|101121354|FG004|Overall Study|Adverse Event|23|||
33335898|NCT00730639|101121350|FG000|Overall Study|Complete Response|0|||
33335899|NCT00730639|101121351|FG001|Overall Study|Complete Response|0|||
33335900|NCT00730639|101121352|FG002|Overall Study|Complete Response|2|||
33335901|NCT00730639|101121353|FG003|Overall Study|Complete Response|2|||
33335902|NCT00730639|101121354|FG004|Overall Study|Complete Response|1|||
33335903|NCT00730639|101121350|FG000|Overall Study|Completed Maximum Cycles|0|||
33335904|NCT00730639|101121351|FG001|Overall Study|Completed Maximum Cycles|0|||
33335905|NCT00730639|101121352|FG002|Overall Study|Completed Maximum Cycles|11|||
33335906|NCT00730639|101121353|FG003|Overall Study|Completed Maximum Cycles|3|||
33403904|NCT00634933|101369395|FG003|Part A: Baseline to Week 24|Death|0|||
33403905|NCT00634933|101369396|FG004|Part A: Baseline to Week 24|Death|0|||
33403906|NCT00634933|101369392|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
33403907|NCT00634933|101369393|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
33403908|NCT00634933|101369394|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
33403909|NCT00634933|101369395|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
33611408|NCT01368081|102126942|FG005|Overall Study|Protocol Violation|1|||
33611409|NCT01368081|102126943|FG006|Overall Study|Protocol Violation|0|||
33611410|NCT01368081|102126944|FG007|Overall Study|Protocol Violation|1|||
33611411|NCT01368081|102126945|FG008|Overall Study|Protocol Violation|0|||
33611412|NCT01368081|102126946|FG009|Overall Study|Protocol Violation|0|||
33611413|NCT01368081|102126947|FG010|Overall Study|Protocol Violation|0|||
33611414|NCT01368081|102126948|FG011|Overall Study|Protocol Violation|0|||
33611415|NCT01368081|102126949|FG012|Overall Study|Protocol Violation|0|||
33611416|NCT01368081|102126937|FG000|Overall Study|Lost to Follow-up|0|||
33611417|NCT01368081|102126938|FG001|Overall Study|Lost to Follow-up|0|||
33611418|NCT01368081|102126939|FG002|Overall Study|Lost to Follow-up|0|||
33611419|NCT01368081|102126940|FG003|Overall Study|Lost to Follow-up|0|||
33611420|NCT01368081|102126941|FG004|Overall Study|Lost to Follow-up|0|||
33611421|NCT01368081|102126942|FG005|Overall Study|Lost to Follow-up|0|||
33335907|NCT00730639|101121354|FG004|Overall Study|Completed Maximum Cycles|6|||
33335908|NCT00730639|101121350|FG000|Overall Study|Death|0|||
33335909|NCT00730639|101121351|FG001|Overall Study|Death|0|||
33335910|NCT00730639|101121352|FG002|Overall Study|Death|0|||
33335911|NCT00730639|101121353|FG003|Overall Study|Death|0|||
33335912|NCT00730639|101121354|FG004|Overall Study|Death|2|||
33335913|NCT00730639|101121350|FG000|Overall Study|Disease Progression|12|||
33335914|NCT00730639|101121351|FG001|Overall Study|Disease Progression|13|||
33335915|NCT00730639|101121352|FG002|Overall Study|Disease Progression|48|||
33335916|NCT00730639|101121353|FG003|Overall Study|Disease Progression|32|||
33403910|NCT00634933|101369396|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
33403911|NCT00634933|101369392|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
33611422|NCT01368081|102126943|FG006|Overall Study|Lost to Follow-up|0|||
33611423|NCT01368081|102126944|FG007|Overall Study|Lost to Follow-up|0|||
33335917|NCT00730639|101121354|FG004|Overall Study|Disease Progression|88|||
33335918|NCT00730639|101121350|FG000|Overall Study|non-specified|0|||
33335919|NCT00730639|101121351|FG001|Overall Study|non-specified|0|||
33335920|NCT00730639|101121352|FG002|Overall Study|non-specified|4|||
33335921|NCT00730639|101121353|FG003|Overall Study|non-specified|2|||
33335922|NCT00730639|101121354|FG004|Overall Study|non-specified|3|||
33335923|NCT00730639|101121350|FG000|Overall Study|Protocol Violation|0|||
33335924|NCT00730639|101121351|FG001|Overall Study|Protocol Violation|0|||
33335925|NCT00730639|101121352|FG002|Overall Study|Protocol Violation|1|||
33335926|NCT00730639|101121353|FG003|Overall Study|Protocol Violation|0|||
33335927|NCT00730639|101121354|FG004|Overall Study|Protocol Violation|0|||
33335928|NCT00730639|101121350|FG000|Overall Study|Withdrawal by Subject|0|||
33335929|NCT00730639|101121351|FG001|Overall Study|Withdrawal by Subject|0|||
33335930|NCT00730639|101121352|FG002|Overall Study|Withdrawal by Subject|6|||
33335931|NCT00730639|101121353|FG003|Overall Study|Withdrawal by Subject|3|||
33335932|NCT00730639|101121354|FG004|Overall Study|Withdrawal by Subject|4|||
33335933|NCT00730639|101121350|FG000|Overall Study|Treatment on-going|2|||
33335934|NCT00730639|101121351|FG001|Overall Study|Treatment on-going|5|||
33335935|NCT00730639|101121352|FG002|Overall Study|Treatment on-going|5|||
33335936|NCT00730639|101121353|FG003|Overall Study|Treatment on-going|4|||
33335937|NCT00730639|101121354|FG004|Overall Study|Treatment on-going|4|||
33335938|NCT02264990|101121355|FG000|Overall Study|Death|255|||
33335939|NCT02264990|101121356|FG001|Overall Study|Death|250|||
33335940|NCT02264990|101121355|FG000|Overall Study|Withdrawal by Subject|4|||
33335941|NCT02264990|101121356|FG001|Overall Study|Withdrawal by Subject|5|||
33335942|NCT02264990|101121355|FG000|Overall Study|Lost to Follow-up|1|||
33335943|NCT02264990|101121356|FG001|Overall Study|Lost to Follow-up|3|||
33335944|NCT02264990|101121355|FG000|Overall Study|Other|0|||
33335945|NCT02264990|101121356|FG001|Overall Study|Other|1|||
33335946|NCT01290692|101121358|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
33335947|NCT02919436|101121359|FG000|Overall Study|Did not undergo surgery|16|||
33335948|NCT02919436|101121360|FG001|Overall Study|Did not undergo surgery|20|||
33335949|NCT02919436|101121359|FG000|Overall Study|Enrolled before trial registration|44|||
33335950|NCT02919436|101121360|FG001|Overall Study|Enrolled before trial registration|33|||
33335951|NCT01391507|101121361|FG000|Overall Study|Death|0|||
33529551|NCT01419535|101838368|FG000|Overall Study|could not maintain iv line|1|||
33529552|NCT01419535|101838369|FG001|Overall Study|could not maintain iv line|1|||
33529553|NCT01419535|101838368|FG000|Overall Study|Withdrawal by Subject|0|||
33529554|NCT01419535|101838369|FG001|Overall Study|Withdrawal by Subject|1|||
33529555|NCT03076996|101838370|FG000|Overall Study|Withdrawal by Subject|2|||
33529556|NCT03076996|101838370|FG000|Overall Study|Lost to Follow-up|3|||
33529557|NCT03076996|101838370|FG000|Overall Study|Literacy precluded participation|1|||
33529558|NCT04068831|101838371|FG000|Overall Study|Disease Progression|10|||
33529559|NCT04068831|101838372|FG001|Overall Study|Disease Progression|8|||
33529560|NCT01272908|101838373|FG000|Initial Treatment Period|Adverse Event|1|||
33529561|NCT01272908|101838373|FG000|Initial Treatment Period|Lack of Efficacy|5|||
33529562|NCT01272908|101838373|FG000|Initial Treatment Period|Protocol Violation|1|||
33529563|NCT01272908|101838373|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
33529564|NCT01272908|101838373|FG000|Re-Treatment Period|Adverse Event|2|||
33529565|NCT01272908|101838373|FG000|Re-Treatment Period|Lack of Efficacy|3|||
33529566|NCT01272908|101838373|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
33529567|NCT00215644|101838380|FG000|Overall Study|Disease Progression|28|||
33529568|NCT00215644|101838381|FG001|Overall Study|Disease Progression|10|||
33529569|NCT00215644|101838380|FG000|Overall Study|Adverse Event|2|||
33529570|NCT00215644|101838381|FG001|Overall Study|Adverse Event|9|||
33529571|NCT00215644|101838380|FG000|Overall Study|Death|1|||
33529572|NCT00215644|101838381|FG001|Overall Study|Death|2|||
33529573|NCT00215644|101838380|FG000|Overall Study|Withdrawal by Subject|1|||
33529574|NCT00215644|101838381|FG001|Overall Study|Withdrawal by Subject|0|||
33529575|NCT00215644|101838380|FG000|Overall Study|Other|3|||
33529576|NCT00215644|101838381|FG001|Overall Study|Other|15|||
33529577|NCT00215644|101838380|FG000|Overall Study|Randomized but Not Treated|1|||
33529578|NCT00215644|101838381|FG001|Overall Study|Randomized but Not Treated|0|||
33529579|NCT01051557|101838382|FG000|Overall Study|Physician Decision|1|||
33529580|NCT01051557|101838383|FG001|Overall Study|Physician Decision|0|||
33529581|NCT01051557|101838384|FG002|Overall Study|Physician Decision|0|||
33529582|NCT01051557|101838385|FG003|Overall Study|Physician Decision|0|||
33611424|NCT01368081|102126945|FG008|Overall Study|Lost to Follow-up|0|||
33335952|NCT01391507|101121362|FG001|Overall Study|Death|0|||
33335953|NCT01391507|101121363|FG002|Overall Study|Death|0|||
33335954|NCT01391507|101121364|FG003|Overall Study|Death|1|||
33335955|NCT01391507|101121361|FG000|Overall Study|Adverse Event|1|||
33335956|NCT01391507|101121362|FG001|Overall Study|Adverse Event|1|||
33335957|NCT01391507|101121363|FG002|Overall Study|Adverse Event|2|||
33529583|NCT01051557|101838386|FG004|Overall Study|Physician Decision|0|||
33529584|NCT01051557|101838387|FG005|Overall Study|Physician Decision|0|||
33529585|NCT01051557|101838388|FG006|Overall Study|Physician Decision|0|||
33335958|NCT01391507|101121364|FG003|Overall Study|Adverse Event|2|||
33335959|NCT01391507|101121361|FG000|Overall Study|Withdrawal by Subject|1|||
33335960|NCT01391507|101121362|FG001|Overall Study|Withdrawal by Subject|2|||
33335961|NCT01391507|101121363|FG002|Overall Study|Withdrawal by Subject|1|||
33403912|NCT00634933|101369393|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
33403913|NCT00634933|101369394|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
33403914|NCT00634933|101369395|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
33403915|NCT00634933|101369396|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
33529586|NCT01051557|101838382|FG000|Overall Study|disease progression|3|||
33529587|NCT01051557|101838383|FG001|Overall Study|disease progression|3|||
33529588|NCT01051557|101838384|FG002|Overall Study|disease progression|5|||
33529589|NCT01051557|101838385|FG003|Overall Study|disease progression|2|||
33529590|NCT01051557|101838386|FG004|Overall Study|disease progression|4|||
33529591|NCT01051557|101838387|FG005|Overall Study|disease progression|3|||
33529592|NCT01051557|101838388|FG006|Overall Study|disease progression|1|||
33529593|NCT01051557|101838382|FG000|Overall Study|Withdrawal by Subject|0|||
33529594|NCT01051557|101838383|FG001|Overall Study|Withdrawal by Subject|0|||
33529595|NCT01051557|101838384|FG002|Overall Study|Withdrawal by Subject|1|||
33529596|NCT01051557|101838385|FG003|Overall Study|Withdrawal by Subject|0|||
33529597|NCT01051557|101838386|FG004|Overall Study|Withdrawal by Subject|2|||
33529598|NCT01051557|101838387|FG005|Overall Study|Withdrawal by Subject|0|||
33529599|NCT01051557|101838388|FG006|Overall Study|Withdrawal by Subject|1|||
33529600|NCT01051557|101838382|FG000|Overall Study|Adverse Event|0|||
33529601|NCT01051557|101838383|FG001|Overall Study|Adverse Event|0|||
33529602|NCT01051557|101838384|FG002|Overall Study|Adverse Event|0|||
33529603|NCT01051557|101838385|FG003|Overall Study|Adverse Event|1|||
33529604|NCT01051557|101838386|FG004|Overall Study|Adverse Event|1|||
33529605|NCT01051557|101838387|FG005|Overall Study|Adverse Event|3|||
33529606|NCT01051557|101838388|FG006|Overall Study|Adverse Event|4|||
33529607|NCT02420262|101838390|FG000|Overall Study|Adverse Event|1|||
33529608|NCT02420262|101838391|FG001|Overall Study|Adverse Event|0|||
33529609|NCT02420262|101838390|FG000|Overall Study|Withdrawal by Subject|1|||
33529610|NCT02420262|101838391|FG001|Overall Study|Withdrawal by Subject|4|||
33529611|NCT02420262|101838390|FG000|Overall Study|Unclassified|0|||
33529612|NCT02420262|101838391|FG001|Overall Study|Unclassified|1|||
33529613|NCT00905424|101838392|FG000|Overall Study|Lost to Follow-up|3|||
33529614|NCT00905424|101838393|FG001|Overall Study|Lost to Follow-up|3|||
33529615|NCT00905424|101838392|FG000|Overall Study|Withdrawal by Subject|1|||
33529616|NCT00905424|101838393|FG001|Overall Study|Withdrawal by Subject|2|||
33529617|NCT00905424|101838392|FG000|Overall Study|Adverse Event|4|||
33335962|NCT01391507|101121364|FG003|Overall Study|Withdrawal by Subject|1|||
33335963|NCT01391507|101121361|FG000|Overall Study|Lack of Efficacy|0|||
33335964|NCT01391507|101121362|FG001|Overall Study|Lack of Efficacy|0|||
33335965|NCT01391507|101121363|FG002|Overall Study|Lack of Efficacy|0|||
33335966|NCT01391507|101121364|FG003|Overall Study|Lack of Efficacy|1|||
33335967|NCT01391507|101121361|FG000|Overall Study|Protocol Violation|2|||
33335968|NCT01391507|101121362|FG001|Overall Study|Protocol Violation|1|||
33335969|NCT01391507|101121363|FG002|Overall Study|Protocol Violation|1|||
33335970|NCT01391507|101121364|FG003|Overall Study|Protocol Violation|2|||
33335971|NCT03571646|101121365|FG000|Overall Study|Adverse Event|1|||
33335972|NCT03571646|101121366|FG001|Overall Study|Adverse Event|0|||
33335973|NCT03571646|101121365|FG000|Overall Study|Withdrawal by Subject|1|||
33335974|NCT03571646|101121366|FG001|Overall Study|Withdrawal by Subject|1|||
33335975|NCT00916357|101121367|FG000|Period 1|Withdrawal by Subject|1|||
33335976|NCT00916357|101121368|FG001|Period 1|Withdrawal by Subject|0|||
33335977|NCT00916357|101121369|FG002|Period 1|Withdrawal by Subject|0|||
33335978|NCT00916357|101121370|FG003|Period 1|Withdrawal by Subject|0|||
33335979|NCT00916357|101121371|FG004|Period 1|Withdrawal by Subject|0|||
33335980|NCT00916357|101121372|FG005|Period 1|Withdrawal by Subject|0|||
33335981|NCT00916357|101121367|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
33335982|NCT00916357|101121368|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
33403916|NCT00634933|101369392|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
33403917|NCT00634933|101369393|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
33529618|NCT00905424|101838393|FG001|Overall Study|Adverse Event|2|||
33529619|NCT00905424|101838392|FG000|Overall Study|Non-compliance with study medication|2|||
33529620|NCT00905424|101838393|FG001|Overall Study|Non-compliance with study medication|0|||
33529621|NCT00905424|101838392|FG000|Overall Study|Sponsor decision|1|||
33529622|NCT00905424|101838393|FG001|Overall Study|Sponsor decision|0|||
33529623|NCT00905424|101838392|FG000|Overall Study|Positive urine drug screen|0|||
33335983|NCT00916357|101121369|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
33335984|NCT00916357|101121370|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
33335985|NCT00916357|101121371|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
33335986|NCT00916357|101121372|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
33335987|NCT00252057|101121375|FG000|Overall Study|Withdrawal by Subject|2|||
33335988|NCT00252057|101121376|FG001|Overall Study|Withdrawal by Subject|5|||
33335989|NCT00252057|101121375|FG000|Overall Study|Death|1|||
33335990|NCT00252057|101121376|FG001|Overall Study|Death|2|||
33335991|NCT00252057|101121375|FG000|Overall Study|Participant previously enrolled|0|||
33335992|NCT00252057|101121376|FG001|Overall Study|Participant previously enrolled|1|||
33335993|NCT01079182|101121377|FG000|Overall Study|Lost to Follow-up|1634|||
33403918|NCT00634933|101369394|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
33529624|NCT00905424|101838393|FG001|Overall Study|Positive urine drug screen|1|||
33529625|NCT00905424|101838392|FG000|Overall Study|Non-adherence to visit schedule|0|||
33529626|NCT00905424|101838393|FG001|Overall Study|Non-adherence to visit schedule|1|||
33529627|NCT03382418|101838396|FG000|Overall Study|Withdrawal by Subject|1|||
33529628|NCT03382418|101838397|FG001|Overall Study|Withdrawal by Subject|0|||
33529629|NCT03382418|101838398|FG002|Overall Study|Withdrawal by Subject|0|||
33529630|NCT03382418|101838396|FG000|Overall Study|Lost to Follow-up|2|||
33529631|NCT03382418|101838397|FG001|Overall Study|Lost to Follow-up|3|||
33529632|NCT03382418|101838398|FG002|Overall Study|Lost to Follow-up|0|||
33529633|NCT00490919|101838399|FG000|Open-label Run-in Period|Adverse Event|239|||
33529634|NCT00490919|101838400|FG001|Open-label Run-in Period|Adverse Event|0|||
33529635|NCT00490919|101838401|FG002|Open-label Run-in Period|Adverse Event|0|||
33529636|NCT00490919|101838399|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
33529637|NCT00490919|101838400|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
33529638|NCT00490919|101838401|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
33205087|NCT01412944|100651481|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
33529639|NCT00490919|101838399|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
33529640|NCT00490919|101838400|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
33529641|NCT00490919|101838401|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
33529642|NCT00490919|101838399|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
33529643|NCT00490919|101838400|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
33529644|NCT00490919|101838401|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
33529645|NCT00490919|101838399|FG000|Open-label Run-in Period|Administrative|40|||
33529646|NCT00490919|101838400|FG001|Open-label Run-in Period|Administrative|0|||
33529647|NCT00490919|101838401|FG002|Open-label Run-in Period|Administrative|0|||
33529648|NCT00490919|101838399|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
33529649|NCT00490919|101838400|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
33529650|NCT00490919|101838401|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
33529651|NCT00490919|101838399|FG000|Double-blind Phase|Adverse Event|0|||
33529652|NCT00490919|101838400|FG001|Double-blind Phase|Adverse Event|40|||
33529653|NCT00490919|101838401|FG002|Double-blind Phase|Adverse Event|20|||
33529654|NCT00490919|101838399|FG000|Double-blind Phase|Withdrawal by Subject|0|||
33529655|NCT00490919|101838400|FG001|Double-blind Phase|Withdrawal by Subject|10|||
33205088|NCT01412944|100651482|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
33205089|NCT01412944|100651483|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
33205090|NCT01412944|100651478|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
33205091|NCT01412944|100651479|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
33205092|NCT01412944|100651480|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
33205093|NCT01412944|100651481|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
33205094|NCT01412944|100651482|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
33335994|NCT01079182|101121377|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
33335995|NCT01079182|101121377|FG000|Overall Study|Lack of Efficacy|514|||
33335996|NCT01079182|101121377|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
33335997|NCT01079182|101121377|FG000|Overall Study|Reasons not Evaluated|271|||
33403919|NCT00634933|101369395|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
33403920|NCT00634933|101369396|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
33403921|NCT00634933|101369392|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
33529656|NCT00490919|101838401|FG002|Double-blind Phase|Withdrawal by Subject|11|||
33529657|NCT00490919|101838399|FG000|Double-blind Phase|Lost to Follow-up|0|||
33529658|NCT00490919|101838400|FG001|Double-blind Phase|Lost to Follow-up|8|||
33529659|NCT00490919|101838401|FG002|Double-blind Phase|Lost to Follow-up|11|||
33403922|NCT00634933|101369393|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
33403923|NCT00634933|101369394|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
33611425|NCT01368081|102126946|FG009|Overall Study|Lost to Follow-up|0|||
33611426|NCT01368081|102126947|FG010|Overall Study|Lost to Follow-up|0|||
33611427|NCT01368081|102126948|FG011|Overall Study|Lost to Follow-up|0|||
33611428|NCT01368081|102126949|FG012|Overall Study|Lost to Follow-up|1|||
33611429|NCT01368081|102126937|FG000|Overall Study|Withdrawal by Subject|4|||
33611430|NCT01368081|102126938|FG001|Overall Study|Withdrawal by Subject|4|||
33611431|NCT01368081|102126939|FG002|Overall Study|Withdrawal by Subject|1|||
33611432|NCT01368081|102126940|FG003|Overall Study|Withdrawal by Subject|1|||
33611433|NCT01368081|102126941|FG004|Overall Study|Withdrawal by Subject|0|||
33611434|NCT01368081|102126942|FG005|Overall Study|Withdrawal by Subject|3|||
33611435|NCT01368081|102126943|FG006|Overall Study|Withdrawal by Subject|4|||
33611436|NCT01368081|102126944|FG007|Overall Study|Withdrawal by Subject|2|||
33611437|NCT01368081|102126945|FG008|Overall Study|Withdrawal by Subject|5|||
33611438|NCT01368081|102126946|FG009|Overall Study|Withdrawal by Subject|4|||
33611439|NCT01368081|102126947|FG010|Overall Study|Withdrawal by Subject|3|||
33611440|NCT01368081|102126948|FG011|Overall Study|Withdrawal by Subject|2|||
33611441|NCT01368081|102126949|FG012|Overall Study|Withdrawal by Subject|0|||
33611442|NCT01368081|102126937|FG000|Overall Study|Other reason not defined above|2|||
33611443|NCT01368081|102126938|FG001|Overall Study|Other reason not defined above|0|||
33611444|NCT01368081|102126939|FG002|Overall Study|Other reason not defined above|0|||
33611445|NCT01368081|102126940|FG003|Overall Study|Other reason not defined above|1|||
33611446|NCT01368081|102126941|FG004|Overall Study|Other reason not defined above|0|||
33611447|NCT01368081|102126942|FG005|Overall Study|Other reason not defined above|1|||
33611448|NCT01368081|102126943|FG006|Overall Study|Other reason not defined above|2|||
33611449|NCT01368081|102126944|FG007|Overall Study|Other reason not defined above|0|||
33611450|NCT01368081|102126945|FG008|Overall Study|Other reason not defined above|0|||
33335998|NCT01146873|101121380|FG000|Overall Study|Transfer out|0|||
33335999|NCT01146873|101121381|FG001|Overall Study|Transfer out|6|||
33336000|NCT04697628|101121386|FG000|Overall Study|Withdrawal by Subject|17|||
33336001|NCT04697628|101121387|FG001|Overall Study|Withdrawal by Subject|23|||
33336002|NCT04697628|101121386|FG000|Overall Study|Lost to Follow-up|0|||
33336003|NCT04697628|101121387|FG001|Overall Study|Lost to Follow-up|4|||
33336004|NCT04697628|101121386|FG000|Overall Study|On-going in study|122|||
33336005|NCT04697628|101121387|FG001|Overall Study|On-going in study|91|||
33336006|NCT01309659|101121388|FG000|Overall Study|Protocol Violation|0|||
33336007|NCT01309659|101121389|FG001|Overall Study|Protocol Violation|1|||
33336008|NCT01262365|101121392|FG000|Overall Study|Lack of Efficacy|35|||
33336009|NCT01262365|101121393|FG001|Overall Study|Lack of Efficacy|30|||
33336010|NCT01262365|101121394|FG002|Overall Study|Lack of Efficacy|47|||
33336011|NCT01262365|101121392|FG000|Overall Study|Protocol Violation|3|||
33336012|NCT01262365|101121393|FG001|Overall Study|Protocol Violation|1|||
33336013|NCT01262365|101121394|FG002|Overall Study|Protocol Violation|1|||
33336014|NCT01262365|101121392|FG000|Overall Study|Lost to Follow-up|3|||
33336015|NCT01262365|101121393|FG001|Overall Study|Lost to Follow-up|7|||
33336016|NCT01262365|101121394|FG002|Overall Study|Lost to Follow-up|6|||
33336017|NCT01262365|101121392|FG000|Overall Study|Withdrawal by Subject|17|||
33336018|NCT01262365|101121393|FG001|Overall Study|Withdrawal by Subject|22|||
33336019|NCT01262365|101121394|FG002|Overall Study|Withdrawal by Subject|22|||
33336020|NCT01262365|101121392|FG000|Overall Study|Death|1|||
33336021|NCT01262365|101121393|FG001|Overall Study|Death|2|||
33336022|NCT01262365|101121394|FG002|Overall Study|Death|1|||
33336023|NCT01262365|101121392|FG000|Overall Study|Adverse Event|26|||
33336024|NCT01262365|101121393|FG001|Overall Study|Adverse Event|16|||
33336025|NCT01262365|101121394|FG002|Overall Study|Adverse Event|11|||
33336026|NCT01262365|101121392|FG000|Overall Study|sponsor decision|1|||
33611451|NCT01368081|102126946|FG009|Overall Study|Other reason not defined above|1|||
33611452|NCT01368081|102126947|FG010|Overall Study|Other reason not defined above|0|||
33611453|NCT01368081|102126948|FG011|Overall Study|Other reason not defined above|0|||
33336027|NCT01262365|101121393|FG001|Overall Study|sponsor decision|1|||
33336028|NCT01262365|101121394|FG002|Overall Study|sponsor decision|0|||
33336029|NCT01262365|101121392|FG000|Overall Study|Randomization error|1|||
33336030|NCT01262365|101121393|FG001|Overall Study|Randomization error|0|||
33336031|NCT01262365|101121394|FG002|Overall Study|Randomization error|2|||
33336032|NCT01262365|101121392|FG000|Overall Study|Non-compliance|1|||
33336033|NCT01262365|101121393|FG001|Overall Study|Non-compliance|0|||
33336034|NCT01262365|101121394|FG002|Overall Study|Non-compliance|2|||
33336035|NCT01262365|101121392|FG000|Overall Study|Suspected pregnancy|1|||
33336036|NCT01262365|101121393|FG001|Overall Study|Suspected pregnancy|0|||
33336037|NCT01262365|101121394|FG002|Overall Study|Suspected pregnancy|0|||
33336038|NCT01262365|101121392|FG000|Overall Study|Patient pregnant|1|||
33336039|NCT01262365|101121393|FG001|Overall Study|Patient pregnant|0|||
33336040|NCT01262365|101121394|FG002|Overall Study|Patient pregnant|1|||
33336041|NCT01262365|101121392|FG000|Overall Study|Toxicity related to study drug|0|||
33336042|NCT01262365|101121393|FG001|Overall Study|Toxicity related to study drug|1|||
33336043|NCT01262365|101121394|FG002|Overall Study|Toxicity related to study drug|0|||
33336044|NCT01262365|101121392|FG000|Overall Study|Cannot tolerate the protocol|0|||
33336045|NCT01262365|101121393|FG001|Overall Study|Cannot tolerate the protocol|1|||
33336046|NCT01262365|101121394|FG002|Overall Study|Cannot tolerate the protocol|0|||
33336047|NCT01262365|101121392|FG000|Overall Study|Patient unavailable|0|||
33336048|NCT01262365|101121393|FG001|Overall Study|Patient unavailable|0|||
33336049|NCT01262365|101121394|FG002|Overall Study|Patient unavailable|1|||
33336050|NCT04081363|101121395|FG000|Overall Study|Withdrawal by Subject|1|||
33336051|NCT04081363|101121396|FG001|Overall Study|Withdrawal by Subject|0|||
33336052|NCT00936208|101121404|FG000|Overall Study|Protocol Violation|37|||
33336053|NCT00936208|101121405|FG001|Overall Study|Protocol Violation|22|||
33336054|NCT02678390|101121406|FG000|AE (1 Day)|Withdrawal by Subject|0|||
33336055|NCT02678390|101121407|FG001|AE (1 Day)|Withdrawal by Subject|1|||
33336056|NCT01780662|101121408|FG000|Overall Study|Adverse Event|1|||
33336057|NCT01780662|101121409|FG001|Overall Study|Adverse Event|0|||
33336058|NCT01780662|101121410|FG002|Overall Study|Adverse Event|2|||
33336059|NCT01780662|101121408|FG000|Overall Study|Physician Decision|0|||
33336060|NCT01780662|101121409|FG001|Overall Study|Physician Decision|5|||
33336061|NCT01780662|101121410|FG002|Overall Study|Physician Decision|7|||
33336062|NCT01780662|101121408|FG000|Overall Study|Protocol Violation|0|||
33336063|NCT01780662|101121409|FG001|Overall Study|Protocol Violation|1|||
33336064|NCT01780662|101121410|FG002|Overall Study|Protocol Violation|0|||
33336065|NCT01780662|101121408|FG000|Overall Study|Ineligible|0|||
33336066|NCT01780662|101121409|FG001|Overall Study|Ineligible|0|||
33336067|NCT01780662|101121410|FG002|Overall Study|Ineligible|1|||
33336068|NCT01681433|101121411|FG000|Overall Study|Lack of Efficacy|23|||
33336069|NCT01681433|101121412|FG001|Overall Study|Lack of Efficacy|23|||
33336070|NCT01681433|101121411|FG000|Overall Study|Withdrawal by Subject|5|||
33336071|NCT01681433|101121412|FG001|Overall Study|Withdrawal by Subject|5|||
33336072|NCT01681433|101121411|FG000|Overall Study|Protocol Violation|2|||
33336073|NCT01681433|101121412|FG001|Overall Study|Protocol Violation|0|||
33336074|NCT01681433|101121411|FG000|Overall Study|Adverse Event|2|||
33336075|NCT01681433|101121412|FG001|Overall Study|Adverse Event|4|||
33336076|NCT01681433|101121411|FG000|Overall Study|Lost to Follow-up|0|||
33403924|NCT00634933|101369395|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
33529660|NCT00490919|101838399|FG000|Double-blind Phase|Lack of Efficacy|0|||
33529661|NCT00490919|101838400|FG001|Double-blind Phase|Lack of Efficacy|22|||
33529662|NCT00490919|101838401|FG002|Double-blind Phase|Lack of Efficacy|36|||
33529663|NCT00490919|101838399|FG000|Double-blind Phase|Administrative|0|||
33529664|NCT00490919|101838400|FG001|Double-blind Phase|Administrative|6|||
33529665|NCT00490919|101838401|FG002|Double-blind Phase|Administrative|6|||
33529666|NCT01738919|101838402|FG000|Overall Study|Lost to Follow-up|1|||
33529667|NCT01738919|101838403|FG001|Overall Study|Lost to Follow-up|0|||
33529668|NCT01738919|101838402|FG000|Overall Study|Immigrated|0|||
33529669|NCT01738919|101838403|FG001|Overall Study|Immigrated|1|||
33529670|NCT01738919|101838402|FG000|Overall Study|Withdrawal by Subject|0|||
33529671|NCT01738919|101838403|FG001|Overall Study|Withdrawal by Subject|1|||
33529672|NCT01738919|101838402|FG000|Overall Study|Not treated in accordance to guidelines|0|||
33529673|NCT01738919|101838403|FG001|Overall Study|Not treated in accordance to guidelines|1|||
33529674|NCT03365934|101838404|FG000|Overall Study|Adverse Event|1|||
33529675|NCT03365934|101838404|FG000|Overall Study|Withdrawal by Subject|1|||
33336077|NCT01681433|101121412|FG001|Overall Study|Lost to Follow-up|1|||
33336078|NCT04623242|101121413|FG000|Overall Study|Withdrawal by Subject|7|||
33529676|NCT04086121|101838405|FG000|Overall Study|Other than listed|8|||
33529677|NCT04086121|101838405|FG000|Overall Study|Withdrawal by Subject|3|||
33336079|NCT04623242|101121414|FG001|Overall Study|Withdrawal by Subject|12|||
33336080|NCT04623242|101121415|FG002|Overall Study|Withdrawal by Subject|5|||
33336081|NCT04623242|101121416|FG003|Overall Study|Withdrawal by Subject|7|||
33336082|NCT04623242|101121417|FG004|Overall Study|Withdrawal by Subject|0|||
33336083|NCT04623242|101121413|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
33336084|NCT04623242|101121414|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
33336085|NCT04623242|101121415|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
33336086|NCT04623242|101121416|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
33529678|NCT04086121|101838405|FG000|Overall Study|Lost to Follow-up|2|||
33529679|NCT04086121|101838405|FG000|Overall Study|Adverse Event|1|||
33611454|NCT01368081|102126949|FG012|Overall Study|Other reason not defined above|3|||
33611455|NCT01817959|102126950|FG000|Overall Study|Graft loss|1|||
33611456|NCT01817959|102126951|FG001|Overall Study|Graft loss|1|||
33611457|NCT01817959|102126950|FG000|Overall Study|forbidden medication|1|||
33611458|NCT01817959|102126951|FG001|Overall Study|forbidden medication|1|||
33611459|NCT01817959|102126950|FG000|Overall Study|Adverse Event|1|||
33611460|NCT01817959|102126951|FG001|Overall Study|Adverse Event|0|||
33611461|NCT01817959|102126950|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
33611462|NCT01817959|102126951|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
33611463|NCT02915978|102126952|FG000|Overall Study|Adverse Event|2|||
33611464|NCT02915978|102126953|FG001|Overall Study|Adverse Event|1|||
33611465|NCT02915978|102126954|FG002|Overall Study|Adverse Event|0|||
33611466|NCT03857542|102126958|FG000|Overall Study|Adverse Event|1|||
33611467|NCT03857542|102126959|FG001|Overall Study|Adverse Event|3|||
33611468|NCT03857542|102126958|FG000|Overall Study|Withdrawal by Subject|2|||
33611469|NCT03857542|102126959|FG001|Overall Study|Withdrawal by Subject|1|||
33611470|NCT03857542|102126958|FG000|Overall Study|Lost to Follow-up|2|||
33611471|NCT03857542|102126959|FG001|Overall Study|Lost to Follow-up|1|||
33611472|NCT03857542|102126958|FG000|Overall Study|Reason not Specified|1|||
33611473|NCT03857542|102126959|FG001|Overall Study|Reason not Specified|0|||
33611474|NCT04302545|102126960|FG000|Overall Study|Lost to Follow-up|3|||
33336087|NCT04623242|101121417|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
33529680|NCT02028507|101838406|FG000|Overall Study|Progressive Disease|122|||
33529681|NCT02028507|101838407|FG001|Overall Study|Progressive Disease|90|||
33529682|NCT02028507|101838408|FG002|Overall Study|Progressive Disease|102|||
33529683|NCT02028507|101838409|FG003|Overall Study|Progressive Disease|89|||
33529684|NCT02028507|101838406|FG000|Overall Study|Adverse Event|8|||
33529685|NCT02028507|101838407|FG001|Overall Study|Adverse Event|25|||
33529686|NCT02028507|101838408|FG002|Overall Study|Adverse Event|3|||
33529687|NCT02028507|101838409|FG003|Overall Study|Adverse Event|16|||
33529688|NCT02028507|101838406|FG000|Overall Study|Withdrawal by Subject|6|||
33529689|NCT02028507|101838407|FG001|Overall Study|Withdrawal by Subject|8|||
33529690|NCT02028507|101838408|FG002|Overall Study|Withdrawal by Subject|5|||
33529691|NCT02028507|101838409|FG003|Overall Study|Withdrawal by Subject|9|||
33529692|NCT02028507|101838406|FG000|Overall Study|Protocol Violation|2|||
33529693|NCT02028507|101838407|FG001|Overall Study|Protocol Violation|4|||
33529694|NCT02028507|101838408|FG002|Overall Study|Protocol Violation|1|||
33336088|NCT04623242|101121413|FG000|Overall Study|Subject unblinded to mutation status|0|||
33336089|NCT04623242|101121414|FG001|Overall Study|Subject unblinded to mutation status|0|||
33336090|NCT04623242|101121415|FG002|Overall Study|Subject unblinded to mutation status|0|||
33336091|NCT04623242|101121416|FG003|Overall Study|Subject unblinded to mutation status|13|||
33336092|NCT04623242|101121417|FG004|Overall Study|Subject unblinded to mutation status|0|||
33336093|NCT01192022|101121420|FG000|Overall Study|Withdrawal of Consent|3|||
33336094|NCT01192022|101121421|FG001|Overall Study|Withdrawal of Consent|1|||
33336095|NCT01192022|101121422|FG002|Overall Study|Withdrawal of Consent|0|||
33336096|NCT01192022|101121423|FG003|Overall Study|Withdrawal of Consent|0|||
33336097|NCT01192022|101121424|FG004|Overall Study|Withdrawal of Consent|0|||
33336098|NCT01192022|101121420|FG000|Overall Study|Lost to Follow-up|4|||
33336099|NCT01192022|101121421|FG001|Overall Study|Lost to Follow-up|2|||
33336100|NCT01192022|101121422|FG002|Overall Study|Lost to Follow-up|1|||
33336101|NCT01192022|101121423|FG003|Overall Study|Lost to Follow-up|1|||
33336102|NCT01192022|101121424|FG004|Overall Study|Lost to Follow-up|0|||
33336103|NCT01192022|101121420|FG000|Overall Study|Adverse Event|1|||
33336104|NCT01192022|101121421|FG001|Overall Study|Adverse Event|0|||
33336105|NCT01192022|101121422|FG002|Overall Study|Adverse Event|0|||
33336106|NCT01192022|101121423|FG003|Overall Study|Adverse Event|0|||
33336107|NCT01192022|101121424|FG004|Overall Study|Adverse Event|0|||
33336108|NCT01192022|101121420|FG000|Overall Study|Fatal Adverse Event|4|||
33336109|NCT01192022|101121421|FG001|Overall Study|Fatal Adverse Event|6|||
33336110|NCT01192022|101121422|FG002|Overall Study|Fatal Adverse Event|0|||
33529695|NCT02028507|101838409|FG003|Overall Study|Protocol Violation|3|||
33529696|NCT02028507|101838406|FG000|Overall Study|Physician Decision|0|||
33529697|NCT02028507|101838407|FG001|Overall Study|Physician Decision|4|||
33529698|NCT02028507|101838408|FG002|Overall Study|Physician Decision|0|||
33529699|NCT02028507|101838409|FG003|Overall Study|Physician Decision|0|||
33611475|NCT04302545|102126961|FG001|Overall Study|Lost to Follow-up|4|||
33611476|NCT01223183|102126963|FG000|Imaging Day 1|Physician Decision|0|||
33611477|NCT01223183|102126964|FG001|Imaging Day 1|Physician Decision|1|||
33611478|NCT01223183|102126963|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
33611479|NCT01223183|102126964|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
33611480|NCT01223183|102126963|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
33336111|NCT01192022|101121423|FG003|Overall Study|Fatal Adverse Event|0|||
33336112|NCT01192022|101121424|FG004|Overall Study|Fatal Adverse Event|1|||
33336113|NCT01192022|101121420|FG000|Overall Study|Physician withdrew-patient hardship|1|||
33336114|NCT01192022|101121421|FG001|Overall Study|Physician withdrew-patient hardship|0|||
33529700|NCT02028507|101838406|FG000|Overall Study|Death|1|||
33529701|NCT02028507|101838407|FG001|Overall Study|Death|0|||
33336115|NCT01192022|101121422|FG002|Overall Study|Physician withdrew-patient hardship|0|||
33336116|NCT01192022|101121423|FG003|Overall Study|Physician withdrew-patient hardship|0|||
33336117|NCT01192022|101121424|FG004|Overall Study|Physician withdrew-patient hardship|0|||
33336118|NCT01192022|101121420|FG000|Overall Study|Patient too sick from chemotherapy|0|||
33336119|NCT01192022|101121421|FG001|Overall Study|Patient too sick from chemotherapy|1|||
33336120|NCT01192022|101121422|FG002|Overall Study|Patient too sick from chemotherapy|0|||
33336121|NCT01192022|101121423|FG003|Overall Study|Patient too sick from chemotherapy|0|||
33403925|NCT00634933|101369396|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
33403926|NCT00634933|101369392|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
33403927|NCT00634933|101369393|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
33403928|NCT00634933|101369394|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
33403929|NCT00634933|101369395|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
33403930|NCT00634933|101369396|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
33403931|NCT00634933|101369392|FG000|Part A: Baseline to Week 24|Other|1|||
33403932|NCT00634933|101369393|FG001|Part A: Baseline to Week 24|Other|8|||
33403933|NCT00634933|101369394|FG002|Part A: Baseline to Week 24|Other|5|||
33403934|NCT00634933|101369395|FG003|Part A: Baseline to Week 24|Other|0|||
33403935|NCT00634933|101369396|FG004|Part A: Baseline to Week 24|Other|0|||
33403936|NCT00634933|101369392|FG000|Between Part A and Part B|Physician Decision|0|||
33403937|NCT00634933|101369393|FG001|Between Part A and Part B|Physician Decision|1|||
33403938|NCT00634933|101369394|FG002|Between Part A and Part B|Physician Decision|0|||
33403939|NCT00634933|101369395|FG003|Between Part A and Part B|Physician Decision|0|||
33403940|NCT00634933|101369396|FG004|Between Part A and Part B|Physician Decision|0|||
33403941|NCT00634933|101369392|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
33403942|NCT00634933|101369393|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
33403943|NCT00634933|101369394|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
33403944|NCT00634933|101369395|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
33403945|NCT00634933|101369396|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
33403946|NCT00634933|101369392|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
33403947|NCT00634933|101369393|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
33403948|NCT00634933|101369394|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
33403949|NCT00634933|101369395|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
33403950|NCT00634933|101369396|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
33403951|NCT00634933|101369392|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
33403952|NCT00634933|101369393|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
33403953|NCT00634933|101369394|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
33403954|NCT00634933|101369395|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
33403955|NCT00634933|101369396|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
33403956|NCT00634933|101369392|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
33403957|NCT00634933|101369393|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
33403958|NCT00634933|101369394|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
33403959|NCT00634933|101369395|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
33403960|NCT00634933|101369396|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
33403961|NCT00634933|101369392|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
33403962|NCT00634933|101369393|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
33403963|NCT00634933|101369394|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
33403964|NCT00634933|101369395|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
33403965|NCT00634933|101369396|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
33403966|NCT00634933|101369392|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
33403967|NCT00634933|101369393|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
33403968|NCT00634933|101369394|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
33403969|NCT00634933|101369395|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
33403970|NCT00634933|101369396|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
33403971|NCT00634933|101369392|FG000|Part B: Week 24 to Week 52|Other|0|||
33403972|NCT00634933|101369393|FG001|Part B: Week 24 to Week 52|Other|0|||
33403973|NCT00634933|101369394|FG002|Part B: Week 24 to Week 52|Other|5|||
33403974|NCT00634933|101369395|FG003|Part B: Week 24 to Week 52|Other|0|||
33403975|NCT00634933|101369396|FG004|Part B: Week 24 to Week 52|Other|1|||
33403976|NCT01049360|101369402|FG000|Period 1|Adverse Event|0|||
33403977|NCT01049360|101369403|FG001|Period 1|Adverse Event|1|||
33403978|NCT01049360|101369404|FG002|Period 1|Adverse Event|0|||
33403979|NCT01049360|101369405|FG003|Period 1|Adverse Event|1|||
33403980|NCT01049360|101369406|FG004|Period 1|Adverse Event|0|||
33403981|NCT01049360|101369407|FG005|Period 1|Adverse Event|0|||
33403982|NCT01049360|101369408|FG006|Period 1|Adverse Event|0|||
33403983|NCT01049360|101369409|FG007|Period 1|Adverse Event|1|||
33403984|NCT01049360|101369410|FG008|Period 1|Adverse Event|0|||
33403985|NCT01049360|101369411|FG009|Period 1|Adverse Event|0|||
33403986|NCT01049360|101369412|FG010|Period 1|Adverse Event|0|||
33403987|NCT01049360|101369413|FG011|Period 1|Adverse Event|0|||
33403988|NCT01049360|101369414|FG012|Period 1|Adverse Event|1|||
33403989|NCT01049360|101369415|FG013|Period 1|Adverse Event|1|||
33403990|NCT01049360|101369416|FG014|Period 1|Adverse Event|0|||
33403991|NCT01049360|101369417|FG015|Period 1|Adverse Event|0|||
33529702|NCT02028507|101838408|FG002|Overall Study|Death|1|||
33529703|NCT02028507|101838409|FG003|Overall Study|Death|3|||
33529704|NCT02028507|101838406|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
33529705|NCT02028507|101838407|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
33529706|NCT02028507|101838408|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
33529707|NCT02028507|101838409|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
33529708|NCT02028507|101838406|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
33529709|NCT02028507|101838407|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
33529710|NCT02028507|101838408|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
33529711|NCT02028507|101838409|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
33529712|NCT02028507|101838406|FG000|Overall Study|Randomized But Not Treated|3|||
33529713|NCT02028507|101838407|FG001|Overall Study|Randomized But Not Treated|6|||
33529714|NCT02028507|101838408|FG002|Overall Study|Randomized But Not Treated|0|||
33529715|NCT02028507|101838409|FG003|Overall Study|Randomized But Not Treated|4|||
33205095|NCT01412944|100651483|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
33205096|NCT01412944|100651478|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
33205097|NCT01412944|100651479|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
33205098|NCT01412944|100651480|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
33336122|NCT01192022|101121424|FG004|Overall Study|Patient too sick from chemotherapy|0|||
33336123|NCT01192022|101121420|FG000|Overall Study|Patient needed surgery|0|||
33336124|NCT01192022|101121421|FG001|Overall Study|Patient needed surgery|1|||
33403992|NCT01049360|101369418|FG016|Period 1|Adverse Event|1|||
33403993|NCT01049360|101369419|FG017|Period 1|Adverse Event|0|||
33403994|NCT01049360|101369420|FG018|Period 1|Adverse Event|1|||
33403995|NCT01049360|101369421|FG019|Period 1|Adverse Event|0|||
33403996|NCT01049360|101369402|FG000|Period 1|Did not meet inc/exc criteria|0|||
33403997|NCT01049360|101369403|FG001|Period 1|Did not meet inc/exc criteria|0|||
33403998|NCT01049360|101369404|FG002|Period 1|Did not meet inc/exc criteria|0|||
33403999|NCT01049360|101369405|FG003|Period 1|Did not meet inc/exc criteria|0|||
33529716|NCT02028507|101838406|FG000|Overall Study|Enzyme defect|0|||
33529717|NCT02028507|101838407|FG001|Overall Study|Enzyme defect|0|||
33529718|NCT02028507|101838408|FG002|Overall Study|Enzyme defect|0|||
33529719|NCT02028507|101838409|FG003|Overall Study|Enzyme defect|1|||
33529720|NCT02028507|101838406|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
33529721|NCT02028507|101838407|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
33529722|NCT02028507|101838408|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
33336125|NCT01192022|101121422|FG002|Overall Study|Patient needed surgery|0|||
33336126|NCT01192022|101121423|FG003|Overall Study|Patient needed surgery|0|||
33336127|NCT01192022|101121424|FG004|Overall Study|Patient needed surgery|0|||
33336128|NCT01192022|101121420|FG000|Overall Study|Parents did not allow all follow up|0|||
33404000|NCT01049360|101369406|FG004|Period 1|Did not meet inc/exc criteria|0|||
33404001|NCT01049360|101369407|FG005|Period 1|Did not meet inc/exc criteria|0|||
33404002|NCT01049360|101369408|FG006|Period 1|Did not meet inc/exc criteria|0|||
33404003|NCT01049360|101369409|FG007|Period 1|Did not meet inc/exc criteria|1|||
33404004|NCT01049360|101369410|FG008|Period 1|Did not meet inc/exc criteria|1|||
33404005|NCT01049360|101369411|FG009|Period 1|Did not meet inc/exc criteria|0|||
33404006|NCT01049360|101369412|FG010|Period 1|Did not meet inc/exc criteria|0|||
33404007|NCT01049360|101369413|FG011|Period 1|Did not meet inc/exc criteria|0|||
33404008|NCT01049360|101369414|FG012|Period 1|Did not meet inc/exc criteria|0|||
33404009|NCT01049360|101369415|FG013|Period 1|Did not meet inc/exc criteria|0|||
33404010|NCT01049360|101369416|FG014|Period 1|Did not meet inc/exc criteria|0|||
33404011|NCT01049360|101369417|FG015|Period 1|Did not meet inc/exc criteria|0|||
33404012|NCT01049360|101369418|FG016|Period 1|Did not meet inc/exc criteria|0|||
33404013|NCT01049360|101369419|FG017|Period 1|Did not meet inc/exc criteria|0|||
33336129|NCT01192022|101121421|FG001|Overall Study|Parents did not allow all follow up|0|||
33336130|NCT01192022|101121422|FG002|Overall Study|Parents did not allow all follow up|0|||
33336131|NCT01192022|101121423|FG003|Overall Study|Parents did not allow all follow up|1|||
33336132|NCT01192022|101121424|FG004|Overall Study|Parents did not allow all follow up|0|||
33336133|NCT03124563|101121425|FG000|Overall Study|Lost to Follow-up|1|||
33336134|NCT03124563|101121426|FG001|Overall Study|Lost to Follow-up|1|||
33336135|NCT03124563|101121425|FG000|Overall Study|Withdrawal by Subject|1|||
33404014|NCT01049360|101369420|FG018|Period 1|Did not meet inc/exc criteria|0|||
33404015|NCT01049360|101369421|FG019|Period 1|Did not meet inc/exc criteria|0|||
33529723|NCT02028507|101838409|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
33529724|NCT02028507|101838406|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
33529725|NCT02028507|101838407|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
33205099|NCT01412944|100651481|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
33404016|NCT01049360|101369402|FG000|Period 1|Withdrawal by Subject|0|||
33404017|NCT01049360|101369403|FG001|Period 1|Withdrawal by Subject|0|||
33336136|NCT03124563|101121426|FG001|Overall Study|Withdrawal by Subject|1|||
33336137|NCT00517829|101121429|FG000|Overall Study|Adverse Event|22|||
33404018|NCT01049360|101369404|FG002|Period 1|Withdrawal by Subject|0|||
33404019|NCT01049360|101369405|FG003|Period 1|Withdrawal by Subject|0|||
33529726|NCT02028507|101838408|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
33529727|NCT02028507|101838409|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
33529728|NCT00412932|101838410|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
33529729|NCT00412932|101838410|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
33529730|NCT00412932|101838410|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
33336138|NCT00517829|101121430|FG001|Overall Study|Adverse Event|34|||
33529731|NCT00412932|101838410|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
33529732|NCT00412932|101838410|FG000|Olmesartan (Olm) 20 mg|Other|1|||
33529733|NCT00412932|101838410|FG000|Olmesartan 40 mg|Adverse Event|4|||
33529734|NCT00412932|101838410|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
33529735|NCT00412932|101838410|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
33529736|NCT00412932|101838410|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
33529737|NCT00412932|101838410|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
33529738|NCT00412932|101838410|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
33529739|NCT00412932|101838410|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
33529740|NCT00169104|101838426|FG000|Overall Study|Withdrawal by Subject|2|||
33529741|NCT00169104|101838427|FG001|Overall Study|Withdrawal by Subject|0|||
33529742|NCT00169104|101838426|FG000|Overall Study|Protocol Violation|0|||
33529743|NCT00169104|101838427|FG001|Overall Study|Protocol Violation|1|||
33529744|NCT00169104|101838426|FG000|Overall Study|Physician Decision|0|||
33529745|NCT00169104|101838427|FG001|Overall Study|Physician Decision|1|||
33529746|NCT00618826|101838428|FG000|Overall Study|Adverse Event|1|||
33529747|NCT02757352|101838431|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
33529748|NCT02757352|101838432|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33529749|NCT02757352|101838433|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
33529750|NCT02757352|101838434|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33529751|NCT02757352|101838435|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33529752|NCT02757352|101838436|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33529753|NCT02757352|101838437|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33529754|NCT02757352|101838438|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33529755|NCT02757352|101838439|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33529756|NCT02757352|101838440|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
33529757|NCT02757352|101838431|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33336139|NCT00517829|101121429|FG000|Overall Study|Disease Progression|39|||
33529758|NCT02757352|101838432|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33529759|NCT02757352|101838433|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
33529760|NCT02757352|101838434|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33529761|NCT02757352|101838435|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33529762|NCT02757352|101838436|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33529763|NCT02757352|101838437|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33529764|NCT02757352|101838438|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33529765|NCT02757352|101838439|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33529766|NCT02757352|101838440|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
33529767|NCT02757352|101838431|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
33529768|NCT02757352|101838432|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
33529769|NCT02757352|101838433|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
33529770|NCT02757352|101838434|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
33529771|NCT02757352|101838435|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
33529772|NCT02757352|101838436|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
33529773|NCT02757352|101838437|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
33529774|NCT02757352|101838438|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
33529775|NCT02757352|101838439|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
33529776|NCT02757352|101838440|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
33529777|NCT02757352|101838431|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33529778|NCT02757352|101838432|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
33529779|NCT02757352|101838433|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33529780|NCT02757352|101838434|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33529781|NCT02757352|101838435|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33529782|NCT02757352|101838436|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33529783|NCT02757352|101838437|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33529784|NCT02757352|101838438|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33529785|NCT02757352|101838439|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33529786|NCT02757352|101838440|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
33529787|NCT02757352|101838431|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529788|NCT02757352|101838432|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
33529789|NCT02757352|101838433|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529790|NCT02757352|101838434|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529791|NCT02757352|101838435|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529792|NCT02757352|101838436|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529793|NCT02757352|101838437|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529794|NCT02757352|101838438|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529795|NCT02757352|101838439|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529796|NCT02757352|101838440|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529797|NCT02757352|101838431|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
33529798|NCT02757352|101838432|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
33529799|NCT02757352|101838433|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
33529800|NCT02757352|101838434|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33529801|NCT02757352|101838435|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33529802|NCT02757352|101838436|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33529803|NCT02757352|101838437|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33529804|NCT02757352|101838438|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33529805|NCT02757352|101838439|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33529806|NCT02757352|101838440|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33529807|NCT02757352|101838431|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
33529808|NCT02757352|101838432|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
33529809|NCT02757352|101838433|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
33529810|NCT02757352|101838434|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
33336140|NCT00517829|101121430|FG001|Overall Study|Disease Progression|32|||
33336141|NCT00517829|101121429|FG000|Overall Study|Patient Request|6|||
33336142|NCT00517829|101121430|FG001|Overall Study|Patient Request|5|||
33336143|NCT00517829|101121429|FG000|Overall Study|Investigator Request|5|||
33529811|NCT02757352|101838435|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
33529812|NCT02757352|101838436|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
33529813|NCT02757352|101838437|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
33529814|NCT02757352|101838438|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
33529815|NCT02757352|101838439|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
33529816|NCT02757352|101838440|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
33529817|NCT02757352|101838431|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33336144|NCT00517829|101121430|FG001|Overall Study|Investigator Request|3|||
33336145|NCT00517829|101121429|FG000|Overall Study|Other|3|||
33336146|NCT00517829|101121430|FG001|Overall Study|Other|1|||
33336147|NCT02222207|101121437|FG000|Overall Study|Death|1|||
33336148|NCT02222207|101121437|FG000|Overall Study|Other reasons|2|||
33336149|NCT02222207|101121437|FG000|Overall Study|Adverse Event|1|||
33336150|NCT01806779|101121438|FG000|Overall Study|Physician Decision|2|||
33336151|NCT01806779|101121439|FG001|Overall Study|Physician Decision|0|||
33336152|NCT01806779|101121440|FG002|Overall Study|Physician Decision|1|||
33336153|NCT01806779|101121438|FG000|Overall Study|Lack of Efficacy|1|||
33336154|NCT01806779|101121439|FG001|Overall Study|Lack of Efficacy|1|||
33336155|NCT01806779|101121440|FG002|Overall Study|Lack of Efficacy|0|||
33336156|NCT01806779|101121438|FG000|Overall Study|Lost to Follow-up|19|||
33336157|NCT01806779|101121439|FG001|Overall Study|Lost to Follow-up|20|||
33404020|NCT01049360|101369406|FG004|Period 1|Withdrawal by Subject|0|||
33529818|NCT02757352|101838432|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33529819|NCT02757352|101838433|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33529820|NCT02757352|101838434|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
33529821|NCT02757352|101838435|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33529822|NCT02757352|101838436|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
33529823|NCT02757352|101838437|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33404021|NCT01049360|101369407|FG005|Period 1|Withdrawal by Subject|0|||
33404022|NCT01049360|101369408|FG006|Period 1|Withdrawal by Subject|0|||
33529824|NCT02757352|101838438|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33529825|NCT02757352|101838439|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33529826|NCT02757352|101838440|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
33529827|NCT02757352|101838431|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529828|NCT02757352|101838432|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529829|NCT02757352|101838433|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529830|NCT02757352|101838434|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
33529831|NCT02757352|101838435|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
33529832|NCT02757352|101838436|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
33529833|NCT02757352|101838437|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529834|NCT02757352|101838438|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529835|NCT02757352|101838439|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529836|NCT02757352|101838440|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
33529837|NCT02757352|101838431|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33529838|NCT02757352|101838432|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33529839|NCT02757352|101838433|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33529840|NCT02757352|101838434|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33529841|NCT02757352|101838435|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
33529842|NCT02757352|101838436|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33529843|NCT02757352|101838437|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33529844|NCT02757352|101838438|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33529845|NCT02757352|101838439|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33529846|NCT02757352|101838440|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
33529847|NCT02757352|101838431|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33529848|NCT02757352|101838432|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33529849|NCT02757352|101838433|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33529850|NCT02757352|101838434|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33529851|NCT02757352|101838435|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33529852|NCT02757352|101838436|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
33529853|NCT02757352|101838437|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33529854|NCT02757352|101838438|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33404023|NCT01049360|101369409|FG007|Period 1|Withdrawal by Subject|0|||
33529855|NCT02757352|101838439|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33336158|NCT01806779|101121440|FG002|Overall Study|Lost to Follow-up|0|||
33336159|NCT01806779|101121438|FG000|Overall Study|Withdrawal by Subject|20|||
33336160|NCT01806779|101121439|FG001|Overall Study|Withdrawal by Subject|23|||
33336161|NCT01806779|101121440|FG002|Overall Study|Withdrawal by Subject|22|||
33529856|NCT02757352|101838440|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
33529857|NCT02757352|101838431|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33529858|NCT02757352|101838432|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33529859|NCT02757352|101838433|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33529860|NCT02757352|101838434|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
33529861|NCT02757352|101838435|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
33529862|NCT02757352|101838436|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
33529863|NCT02757352|101838437|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33529864|NCT02757352|101838438|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33529865|NCT02757352|101838439|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33205100|NCT01412944|100651482|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
33205101|NCT01412944|100651483|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
33205102|NCT01412944|100651478|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
33205103|NCT01412944|100651479|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
33205104|NCT01412944|100651480|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
33205105|NCT01412944|100651481|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
33205106|NCT01412944|100651482|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
33205107|NCT01412944|100651483|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
33205108|NCT01412944|100651478|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
33205109|NCT01412944|100651479|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
33205110|NCT01412944|100651480|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
33205111|NCT01412944|100651481|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
33205112|NCT01412944|100651482|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
33205113|NCT01412944|100651483|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
33205114|NCT01412944|100651478|FG000|Entire: IV + Maintenance|Adverse Event|0|||
33205115|NCT01412944|100651479|FG001|Entire: IV + Maintenance|Adverse Event|0|||
33205116|NCT01412944|100651480|FG002|Entire: IV + Maintenance|Adverse Event|0|||
33205117|NCT01412944|100651481|FG003|Entire: IV + Maintenance|Adverse Event|0|||
33205118|NCT01412944|100651482|FG004|Entire: IV + Maintenance|Adverse Event|1|||
33205119|NCT01412944|100651483|FG005|Entire: IV + Maintenance|Adverse Event|0|||
33205120|NCT01412944|100651478|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
33205121|NCT01412944|100651479|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
33205122|NCT01412944|100651480|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
33205123|NCT01412944|100651481|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
33205124|NCT01412944|100651482|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
33205125|NCT01412944|100651483|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
33205126|NCT01412944|100651478|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
33529866|NCT02757352|101838440|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
33529867|NCT02757352|101838431|FG000|Follow-Up Period|Adverse Event|0|||
33336162|NCT02751502|101121443|FG000|Overall Study|Lack of funding|4|||
33336163|NCT03325673|101121444|FG000|Overall Study|Adverse Event|4|||
33336164|NCT03325673|101121445|FG001|Overall Study|Adverse Event|0|||
33336165|NCT03311711|101121446|FG000|Overall Study|Death|1|||
33336166|NCT03311711|101121447|FG001|Overall Study|Death|0|||
33336167|NCT03311711|101121448|FG002|Overall Study|Death|0|||
33529868|NCT02757352|101838432|FG001|Follow-Up Period|Adverse Event|0|||
33529869|NCT02757352|101838433|FG002|Follow-Up Period|Adverse Event|0|||
33529870|NCT02757352|101838434|FG003|Follow-Up Period|Adverse Event|0|||
33529871|NCT02757352|101838435|FG004|Follow-Up Period|Adverse Event|0|||
33205127|NCT01412944|100651479|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
33205128|NCT01412944|100651480|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
33205129|NCT01412944|100651481|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
33205130|NCT01412944|100651482|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
33205131|NCT01412944|100651483|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
33205132|NCT01412944|100651478|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
33205133|NCT01412944|100651479|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
33336168|NCT03311711|101121449|FG003|Overall Study|Death|0|||
33336169|NCT03311711|101121450|FG004|Overall Study|Death|0|||
33529872|NCT02757352|101838436|FG005|Follow-Up Period|Adverse Event|0|||
33611481|NCT01223183|102126964|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
33611482|NCT01108523|102126970|FG000|Overall Study|Protocol Violation|4|||
33611483|NCT01345669|102126971|FG000|Overall Study|Primary tumour recurrence|53|||
33611484|NCT01345669|102126972|FG001|Overall Study|Primary tumour recurrence|32|||
33336170|NCT03311711|101121451|FG005|Overall Study|Death|0|||
33336171|NCT03311711|101121452|FG006|Overall Study|Death|1|||
33336172|NCT03311711|101121453|FG007|Overall Study|Death|0|||
33336173|NCT03311711|101121454|FG008|Overall Study|Death|1|||
33404024|NCT01049360|101369410|FG008|Period 1|Withdrawal by Subject|1|||
33404025|NCT01049360|101369411|FG009|Period 1|Withdrawal by Subject|0|||
33404026|NCT01049360|101369412|FG010|Period 1|Withdrawal by Subject|1|||
33529873|NCT02757352|101838437|FG006|Follow-Up Period|Adverse Event|1|||
33529874|NCT02757352|101838438|FG007|Follow-Up Period|Adverse Event|0|||
33336174|NCT03311711|101121455|FG009|Overall Study|Death|0|||
33205134|NCT01412944|100651480|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
33205135|NCT01412944|100651481|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
33336175|NCT03311711|101121446|FG000|Overall Study|Death of dyad partner|0|||
33336176|NCT03311711|101121447|FG001|Overall Study|Death of dyad partner|1|||
33529875|NCT02757352|101838439|FG008|Follow-Up Period|Adverse Event|2|||
33529876|NCT02757352|101838440|FG009|Follow-Up Period|Adverse Event|0|||
33611485|NCT01345669|102126971|FG000|Overall Study|Second primary tumour|4|||
33611486|NCT01345669|102126972|FG001|Overall Study|Second primary tumour|3|||
33611487|NCT01345669|102126971|FG000|Overall Study|Adverse Event|63|||
33611488|NCT01345669|102126972|FG001|Overall Study|Adverse Event|9|||
33529877|NCT02757352|101838431|FG000|Follow-Up Period|Lost to Follow-up|0|||
33529878|NCT02757352|101838432|FG001|Follow-Up Period|Lost to Follow-up|0|||
33529879|NCT02757352|101838433|FG002|Follow-Up Period|Lost to Follow-up|0|||
33529880|NCT02757352|101838434|FG003|Follow-Up Period|Lost to Follow-up|0|||
33529881|NCT02757352|101838435|FG004|Follow-Up Period|Lost to Follow-up|0|||
33529882|NCT02757352|101838436|FG005|Follow-Up Period|Lost to Follow-up|0|||
33529883|NCT02757352|101838437|FG006|Follow-Up Period|Lost to Follow-up|0|||
33529884|NCT02757352|101838438|FG007|Follow-Up Period|Lost to Follow-up|0|||
33529885|NCT02757352|101838439|FG008|Follow-Up Period|Lost to Follow-up|1|||
33529886|NCT02757352|101838440|FG009|Follow-Up Period|Lost to Follow-up|0|||
33529887|NCT02757352|101838431|FG000|Follow-Up Period|Lack of Efficacy|0|||
33529888|NCT02757352|101838432|FG001|Follow-Up Period|Lack of Efficacy|0|||
33529889|NCT02757352|101838433|FG002|Follow-Up Period|Lack of Efficacy|0|||
33529890|NCT02757352|101838434|FG003|Follow-Up Period|Lack of Efficacy|0|||
33529891|NCT02757352|101838435|FG004|Follow-Up Period|Lack of Efficacy|0|||
33529892|NCT02757352|101838436|FG005|Follow-Up Period|Lack of Efficacy|0|||
33529893|NCT02757352|101838437|FG006|Follow-Up Period|Lack of Efficacy|0|||
33529894|NCT02757352|101838438|FG007|Follow-Up Period|Lack of Efficacy|0|||
33529895|NCT02757352|101838439|FG008|Follow-Up Period|Lack of Efficacy|1|||
33529896|NCT02757352|101838440|FG009|Follow-Up Period|Lack of Efficacy|1|||
33529897|NCT02757352|101838431|FG000|Follow-Up Period|Withdrawal by Subject|0|||
33529898|NCT02757352|101838432|FG001|Follow-Up Period|Withdrawal by Subject|0|||
33529899|NCT02757352|101838433|FG002|Follow-Up Period|Withdrawal by Subject|0|||
33529900|NCT02757352|101838434|FG003|Follow-Up Period|Withdrawal by Subject|0|||
33529901|NCT02757352|101838435|FG004|Follow-Up Period|Withdrawal by Subject|0|||
33529902|NCT02757352|101838436|FG005|Follow-Up Period|Withdrawal by Subject|0|||
33529903|NCT02757352|101838437|FG006|Follow-Up Period|Withdrawal by Subject|0|||
33529904|NCT02757352|101838438|FG007|Follow-Up Period|Withdrawal by Subject|1|||
33529905|NCT02757352|101838439|FG008|Follow-Up Period|Withdrawal by Subject|6|||
33529906|NCT02757352|101838440|FG009|Follow-Up Period|Withdrawal by Subject|2|||
33529907|NCT05279131|101838441|FG000|Overall Study|Lost to Follow-up|1|||
33529908|NCT05279131|101838441|FG000|Overall Study|Death|1|||
33529909|NCT05279131|101838441|FG000|Overall Study|Physician Decision|1|||
33529910|NCT01435759|101838442|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
33529911|NCT01435759|101838443|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
33529912|NCT01435759|101838444|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
33529913|NCT01435759|101838445|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
33529914|NCT01435759|101838446|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
33529915|NCT01435759|101838447|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
33529916|NCT01435759|101838442|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
33529917|NCT01435759|101838443|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
33529918|NCT01435759|101838444|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
33529919|NCT01435759|101838445|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
33529920|NCT01435759|101838446|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
33529921|NCT01435759|101838447|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
33529922|NCT01435759|101838442|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
33529923|NCT01435759|101838443|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
33529924|NCT01435759|101838444|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
33529925|NCT01435759|101838445|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
33529926|NCT01435759|101838446|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
33529927|NCT01435759|101838447|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
33529928|NCT01435759|101838442|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
33529929|NCT01435759|101838443|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
33529930|NCT01435759|101838444|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
33529931|NCT01435759|101838445|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
33529932|NCT01435759|101838446|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
33611489|NCT01345669|102126971|FG000|Overall Study|Protocol Violation|3|||
33611490|NCT01345669|102126972|FG001|Overall Study|Protocol Violation|1|||
33611491|NCT01345669|102126971|FG000|Overall Study|Lost to Follow-up|1|||
33205136|NCT01412944|100651482|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
33529933|NCT01435759|101838447|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
33529934|NCT01435759|101838442|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
33529935|NCT01435759|101838443|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
33611492|NCT01345669|102126972|FG001|Overall Study|Lost to Follow-up|1|||
33529936|NCT01435759|101838444|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
33529937|NCT01435759|101838445|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
33529938|NCT01435759|101838446|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
33529939|NCT01435759|101838447|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
33529940|NCT01435759|101838442|FG000|Antidepressant Lead-in Phase|Other|119|||
33529941|NCT01435759|101838443|FG001|Antidepressant Lead-in Phase|Other|0|||
33529942|NCT01435759|101838444|FG002|Antidepressant Lead-in Phase|Other|0|||
33529943|NCT01435759|101838445|FG003|Antidepressant Lead-in Phase|Other|0|||
33529944|NCT01435759|101838446|FG004|Antidepressant Lead-in Phase|Other|0|||
33529945|NCT01435759|101838447|FG005|Antidepressant Lead-in Phase|Other|0|||
33529946|NCT01435759|101838442|FG000|Double-blind Phase|Adverse Event|7|||
33529947|NCT01435759|101838443|FG001|Double-blind Phase|Adverse Event|0|||
33529948|NCT01435759|101838444|FG002|Double-blind Phase|Adverse Event|1|||
33529949|NCT01435759|101838445|FG003|Double-blind Phase|Adverse Event|1|||
33529950|NCT01435759|101838446|FG004|Double-blind Phase|Adverse Event|1|||
33529951|NCT01435759|101838447|FG005|Double-blind Phase|Adverse Event|3|||
33529952|NCT01435759|101838442|FG000|Double-blind Phase|Protocol Violation|2|||
33529953|NCT01435759|101838443|FG001|Double-blind Phase|Protocol Violation|0|||
33529954|NCT01435759|101838444|FG002|Double-blind Phase|Protocol Violation|1|||
33529955|NCT01435759|101838445|FG003|Double-blind Phase|Protocol Violation|2|||
33529956|NCT01435759|101838446|FG004|Double-blind Phase|Protocol Violation|0|||
33529957|NCT01435759|101838447|FG005|Double-blind Phase|Protocol Violation|1|||
33529958|NCT01435759|101838442|FG000|Double-blind Phase|Withdrawal by Subject|17|||
33529959|NCT01435759|101838443|FG001|Double-blind Phase|Withdrawal by Subject|4|||
33529960|NCT01435759|101838444|FG002|Double-blind Phase|Withdrawal by Subject|3|||
33529961|NCT01435759|101838445|FG003|Double-blind Phase|Withdrawal by Subject|4|||
33611493|NCT01345669|102126971|FG000|Overall Study|Withdrawal by Subject|52|||
33611494|NCT01345669|102126972|FG001|Overall Study|Withdrawal by Subject|13|||
33205137|NCT01412944|100651483|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
33205138|NCT01412944|100651478|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
33205139|NCT01412944|100651479|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
33205140|NCT01412944|100651480|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
33205141|NCT01412944|100651481|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
33205142|NCT01412944|100651482|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
33205143|NCT01412944|100651483|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
33205144|NCT01412944|100651478|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
33205145|NCT01412944|100651479|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
33205146|NCT01412944|100651480|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
33205147|NCT01412944|100651481|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
33205148|NCT01412944|100651482|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
33205149|NCT01412944|100651483|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
33205150|NCT01412944|100651478|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
33205151|NCT01412944|100651479|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
33205152|NCT01412944|100651480|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
33205153|NCT01412944|100651481|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
33205154|NCT01412944|100651482|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
33205155|NCT01412944|100651483|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
33205156|NCT01412944|100651478|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
33205157|NCT01412944|100651479|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
33205158|NCT01412944|100651480|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
33205159|NCT01412944|100651481|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
33205160|NCT01412944|100651482|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
33205161|NCT01412944|100651483|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
33205162|NCT01412944|100651478|FG000|Entire: IV + Maintenance|Adverse Event|0|||
33205163|NCT01412944|100651479|FG001|Entire: IV + Maintenance|Adverse Event|1|||
33205164|NCT01412944|100651480|FG002|Entire: IV + Maintenance|Adverse Event|0|||
33205165|NCT01412944|100651481|FG003|Entire: IV + Maintenance|Adverse Event|0|||
33205166|NCT01412944|100651482|FG004|Entire: IV + Maintenance|Adverse Event|0|||
33529962|NCT01435759|101838446|FG004|Double-blind Phase|Withdrawal by Subject|2|||
33529963|NCT01435759|101838447|FG005|Double-blind Phase|Withdrawal by Subject|2|||
33529964|NCT01435759|101838442|FG000|Double-blind Phase|Lost to Follow-up|31|||
33529965|NCT01435759|101838443|FG001|Double-blind Phase|Lost to Follow-up|1|||
33529966|NCT01435759|101838444|FG002|Double-blind Phase|Lost to Follow-up|2|||
33529967|NCT01435759|101838445|FG003|Double-blind Phase|Lost to Follow-up|0|||
33529968|NCT01435759|101838446|FG004|Double-blind Phase|Lost to Follow-up|3|||
33529969|NCT01435759|101838447|FG005|Double-blind Phase|Lost to Follow-up|3|||
33336177|NCT03311711|101121448|FG002|Overall Study|Death of dyad partner|0|||
33336178|NCT03311711|101121449|FG003|Overall Study|Death of dyad partner|0|||
33205167|NCT01412944|100651483|FG005|Entire: IV + Maintenance|Adverse Event|0|||
33205168|NCT05245864|100651484|FG000|Overall Study|Withdrawal by Subject|1|||
33336179|NCT03311711|101121450|FG004|Overall Study|Death of dyad partner|0|||
33611495|NCT01345669|102126971|FG000|Overall Study|Other Reasons|111|||
33205169|NCT05245864|100651485|FG001|Overall Study|Withdrawal by Subject|1|||
33205170|NCT01365494|100651486|FG000|Overall Study|Adverse Event|1|||
33205171|NCT01365494|100651487|FG001|Overall Study|Adverse Event|0|||
33205172|NCT01365494|100651486|FG000|Overall Study|Withdrawal by Subject|0|||
33205173|NCT01365494|100651487|FG001|Overall Study|Withdrawal by Subject|1|||
33205174|NCT01365494|100651486|FG000|Overall Study|Lost to Follow-up|1|||
33205175|NCT01365494|100651487|FG001|Overall Study|Lost to Follow-up|2|||
33205176|NCT03131648|100651488|FG000|Initial Treatment Period|Not dosed|2|||
33205177|NCT03131648|100651489|FG001|Initial Treatment Period|Not dosed|2|||
33205178|NCT03131648|100651490|FG002|Initial Treatment Period|Not dosed|0|||
33205179|NCT03131648|100651491|FG003|Initial Treatment Period|Not dosed|0|||
33205180|NCT03131648|100651492|FG004|Initial Treatment Period|Not dosed|0|||
33205181|NCT03131648|100651493|FG005|Initial Treatment Period|Not dosed|0|||
33205182|NCT03131648|100651494|FG006|Initial Treatment Period|Not dosed|0|||
33205183|NCT03131648|100651495|FG007|Initial Treatment Period|Not dosed|0|||
33205184|NCT03131648|100651488|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
33336180|NCT03311711|101121451|FG005|Overall Study|Death of dyad partner|0|||
33336181|NCT03311711|101121452|FG006|Overall Study|Death of dyad partner|0|||
33529970|NCT01435759|101838442|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
33529971|NCT01435759|101838443|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
33529972|NCT01435759|101838444|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
33529973|NCT01435759|101838445|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
33529974|NCT01435759|101838446|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
33529975|NCT01435759|101838447|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
33205185|NCT03131648|100651489|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
33205186|NCT03131648|100651490|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33336182|NCT03311711|101121453|FG007|Overall Study|Death of dyad partner|1|||
33336183|NCT03311711|101121454|FG008|Overall Study|Death of dyad partner|0|||
33336184|NCT03311711|101121455|FG009|Overall Study|Death of dyad partner|1|||
33336185|NCT03311711|101121446|FG000|Overall Study|Lost to Follow-up|2|||
33336186|NCT03311711|101121447|FG001|Overall Study|Lost to Follow-up|2|||
33336187|NCT03311711|101121448|FG002|Overall Study|Lost to Follow-up|0|||
33336188|NCT03311711|101121449|FG003|Overall Study|Lost to Follow-up|0|||
33336189|NCT03311711|101121450|FG004|Overall Study|Lost to Follow-up|0|||
33336190|NCT03311711|101121451|FG005|Overall Study|Lost to Follow-up|0|||
33336191|NCT03311711|101121452|FG006|Overall Study|Lost to Follow-up|1|||
33336192|NCT03311711|101121453|FG007|Overall Study|Lost to Follow-up|1|||
33336193|NCT03311711|101121454|FG008|Overall Study|Lost to Follow-up|0|||
33336194|NCT03311711|101121455|FG009|Overall Study|Lost to Follow-up|0|||
33336195|NCT03311711|101121446|FG000|Overall Study|Withdrawal by Subject|1|||
33336196|NCT03311711|101121447|FG001|Overall Study|Withdrawal by Subject|1|||
33336197|NCT03311711|101121448|FG002|Overall Study|Withdrawal by Subject|0|||
33336198|NCT03311711|101121449|FG003|Overall Study|Withdrawal by Subject|0|||
33336199|NCT03311711|101121450|FG004|Overall Study|Withdrawal by Subject|0|||
33336200|NCT03311711|101121451|FG005|Overall Study|Withdrawal by Subject|0|||
33336201|NCT03311711|101121452|FG006|Overall Study|Withdrawal by Subject|3|||
33336202|NCT03311711|101121453|FG007|Overall Study|Withdrawal by Subject|3|||
33336203|NCT03311711|101121454|FG008|Overall Study|Withdrawal by Subject|0|||
33336204|NCT03311711|101121455|FG009|Overall Study|Withdrawal by Subject|0|||
33336205|NCT03074474|101121458|FG000|Overall Study|Lost to Follow-up|10|||
33336206|NCT03074474|101121458|FG000|Overall Study|Withdrawal by Subject|10|||
33336207|NCT03074474|101121458|FG000|Overall Study|Death|4|||
33336208|NCT03074474|101121458|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
33336209|NCT00283595|101124440|FG000|Overall Study|Withdrawal by Subject|1|||
33336210|NCT00283595|101124441|FG001|Overall Study|Withdrawal by Subject|2|||
33336211|NCT01121393|101124448|FG000|Overall Study|Progressive disease|201|||
33336212|NCT01121393|101124449|FG001|Overall Study|Progressive disease|20|||
33336213|NCT01121393|101124448|FG000|Overall Study|Other Adverse events|24|||
33336214|NCT01121393|101124449|FG001|Overall Study|Other Adverse events|45|||
33336215|NCT01121393|101124448|FG000|Overall Study|Non-compliant with protocol|0|||
33336216|NCT01121393|101124449|FG001|Overall Study|Non-compliant with protocol|3|||
33529976|NCT01435759|101838442|FG000|Double-blind Phase|Other|8|||
33529977|NCT01435759|101838443|FG001|Double-blind Phase|Other|2|||
33529978|NCT01435759|101838444|FG002|Double-blind Phase|Other|0|||
33336217|NCT01121393|101124448|FG000|Overall Study|Lost to Follow-up|1|||
33336218|NCT01121393|101124449|FG001|Overall Study|Lost to Follow-up|0|||
33336219|NCT01121393|101124448|FG000|Overall Study|Refused cont. medication|7|||
33336220|NCT01121393|101124449|FG001|Overall Study|Refused cont. medication|7|||
33336221|NCT01121393|101124448|FG000|Overall Study|Not treated|3|||
33336222|NCT01121393|101124449|FG001|Overall Study|Not treated|9|||
33336223|NCT01121393|101124448|FG000|Overall Study|Other than listed|6|||
33529979|NCT01435759|101838445|FG003|Double-blind Phase|Other|2|||
33529980|NCT01435759|101838446|FG004|Double-blind Phase|Other|0|||
33529981|NCT01435759|101838447|FG005|Double-blind Phase|Other|0|||
33336224|NCT01121393|101124449|FG001|Overall Study|Other than listed|0|||
33336225|NCT00746252|101124460|FG000|Overall Study|weight gain >7.5 %|1|||
33205187|NCT03131648|100651491|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33336226|NCT00746252|101124461|FG001|Overall Study|weight gain >7.5 %|2|||
33336227|NCT01464307|101124463|FG000|Main Period|Death|0|||
33336228|NCT01464307|101124464|FG001|Main Period|Death|1|||
33336229|NCT01464307|101124463|FG000|Main Period|Adverse Event|6|||
33336230|NCT01464307|101124464|FG001|Main Period|Adverse Event|1|||
33336231|NCT01464307|101124463|FG000|Main Period|Lack of Efficacy|2|||
33336232|NCT01464307|101124464|FG001|Main Period|Lack of Efficacy|0|||
33336233|NCT01464307|101124463|FG000|Main Period|Withdrawal by Subject|5|||
33336234|NCT01464307|101124464|FG001|Main Period|Withdrawal by Subject|2|||
33336235|NCT01464307|101124463|FG000|Main Period|Predefined discontinuation criteria|2|||
33336236|NCT01464307|101124464|FG001|Main Period|Predefined discontinuation criteria|1|||
33336237|NCT01464307|101124463|FG000|Open-Label Extension Period|Adverse Event|15|||
33336238|NCT01464307|101124464|FG001|Open-Label Extension Period|Adverse Event|0|||
33336239|NCT01464307|101124463|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
33336240|NCT01464307|101124464|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
33336241|NCT01464307|101124463|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
33336242|NCT01464307|101124464|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
33336243|NCT01464307|101124463|FG000|Open-Label Extension Period|Death|1|||
33336244|NCT01464307|101124464|FG001|Open-Label Extension Period|Death|0|||
33336245|NCT01464307|101124463|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
33336246|NCT01464307|101124464|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
33336247|NCT01464307|101124463|FG000|Open-Label Extension Period|Non-compliance|9|||
33336248|NCT01464307|101124464|FG001|Open-Label Extension Period|Non-compliance|0|||
33336249|NCT01464307|101124463|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
33336250|NCT01464307|101124464|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
33336251|NCT01773109|101124465|FG000|Overall Study|Symptomatic Progression|2|||
33336252|NCT01773109|101124465|FG000|Overall Study|Death|1|||
33529982|NCT02658669|101838448|FG000|Overall Study|Lost to Follow-up|7|||
33529983|NCT02658669|101838449|FG001|Overall Study|Lost to Follow-up|5|||
33529984|NCT02861664|101838452|FG000|Overall Study|Withdrawal of Consent|0|||
33529985|NCT02861664|101838453|FG001|Overall Study|Withdrawal of Consent|1|||
33529986|NCT00497146|101838454|FG000|Treatment Period|Adverse Event|6|||
33529987|NCT00497146|101838455|FG001|Treatment Period|Adverse Event|2|||
33529988|NCT00497146|101838454|FG000|Treatment Period|Withdrawal by Subject|5|||
33529989|NCT00497146|101838455|FG001|Treatment Period|Withdrawal by Subject|9|||
33529990|NCT00497146|101838454|FG000|Treatment Period|Lost to Follow-up|1|||
33529991|NCT00497146|101838455|FG001|Treatment Period|Lost to Follow-up|3|||
33529992|NCT00497146|101838454|FG000|Treatment Period|Required dialysis|4|||
33529993|NCT00497146|101838455|FG001|Treatment Period|Required dialysis|1|||
33529994|NCT00497146|101838454|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
33529995|NCT00497146|101838455|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
33529996|NCT00497146|101838454|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
33529997|NCT00497146|101838455|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
33529998|NCT00497146|101838454|FG000|Treatment Period|Other Reason|2|||
33529999|NCT00497146|101838455|FG001|Treatment Period|Other Reason|3|||
33530000|NCT00497146|101838454|FG000|Long-term Follow-up Period|Adverse Event|2|||
33530001|NCT00497146|101838455|FG001|Long-term Follow-up Period|Adverse Event|2|||
33530002|NCT00497146|101838454|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
33530003|NCT00497146|101838455|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
33530004|NCT00497146|101838454|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
33336253|NCT00915681|101124471|FG000|Overall Study|Screening failures|46|||
33336254|NCT00546052|101124472|FG000|Overall Study|Adverse Event|47|||
33336255|NCT00546052|101124472|FG000|Overall Study|Lost to Follow-up|144|||
33336256|NCT00546052|101124472|FG000|Overall Study|Protocol Violation|9|||
33336257|NCT00546052|101124472|FG000|Overall Study|Withdrawal by Subject|20|||
33336258|NCT00546052|101124472|FG000|Overall Study|Non Compliance|7|||
33336259|NCT00866307|101124485|FG000|Induction|Adverse Event|5|||
33336260|NCT00866307|101124486|FG001|Induction|Adverse Event|0|||
33336261|NCT00866307|101124487|FG002|Induction|Adverse Event|0|||
33336262|NCT00866307|101124485|FG000|Induction|Death|2|||
33530005|NCT00497146|101838455|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
33530006|NCT00497146|101838454|FG000|Long-term Follow-up Period|Other|0|||
33530007|NCT00497146|101838455|FG001|Long-term Follow-up Period|Other|1|||
33530008|NCT00621257|101838456|FG000|Overall Study|Lost to Follow-up|4|||
33336263|NCT00866307|101124486|FG001|Induction|Death|0|||
33530009|NCT00621257|101838457|FG001|Overall Study|Lost to Follow-up|0|||
33530010|NCT00621257|101838458|FG002|Overall Study|Lost to Follow-up|2|||
33530011|NCT00621257|101838459|FG003|Overall Study|Lost to Follow-up|4|||
33336264|NCT00866307|101124487|FG002|Induction|Death|0|||
33336265|NCT00866307|101124485|FG000|Induction|Physician Decision|5|||
33336266|NCT00866307|101124486|FG001|Induction|Physician Decision|0|||
33336267|NCT00866307|101124487|FG002|Induction|Physician Decision|0|||
33336268|NCT00866307|101124485|FG000|Induction|Progressive Disease|1|||
33530012|NCT00621257|101838460|FG004|Overall Study|Lost to Follow-up|7|||
33530013|NCT00621257|101838456|FG000|Overall Study|Adverse Event|0|||
33336269|NCT00866307|101124486|FG001|Induction|Progressive Disease|0|||
33336270|NCT00866307|101124487|FG002|Induction|Progressive Disease|0|||
33336271|NCT00866307|101124485|FG000|Induction|Identification of Patients with Day 29 M|3|||
33336272|NCT00866307|101124486|FG001|Induction|Identification of Patients with Day 29 M|0|||
33336273|NCT00866307|101124487|FG002|Induction|Identification of Patients with Day 29 M|0|||
33336274|NCT00866307|101124485|FG000|Induction|Inadequate cytognetic samples th|1|||
33336275|NCT00866307|101124486|FG001|Induction|Inadequate cytognetic samples th|0|||
33336276|NCT00866307|101124487|FG002|Induction|Inadequate cytognetic samples th|0|||
33336277|NCT00866307|101124485|FG000|Induction|Improper post-induction consent|2|||
33336278|NCT00866307|101124486|FG001|Induction|Improper post-induction consent|0|||
33336279|NCT00866307|101124487|FG002|Induction|Improper post-induction consent|0|||
33336280|NCT00866307|101124485|FG000|Induction|Study was closed at the time|1|||
33530014|NCT00621257|101838457|FG001|Overall Study|Adverse Event|1|||
33530015|NCT00621257|101838458|FG002|Overall Study|Adverse Event|1|||
33530016|NCT00621257|101838459|FG003|Overall Study|Adverse Event|0|||
33530017|NCT00621257|101838460|FG004|Overall Study|Adverse Event|0|||
33530018|NCT00621257|101838456|FG000|Overall Study|Physician Decision|0|||
33530019|NCT00621257|101838457|FG001|Overall Study|Physician Decision|2|||
33530020|NCT00621257|101838458|FG002|Overall Study|Physician Decision|0|||
33530021|NCT00621257|101838459|FG003|Overall Study|Physician Decision|1|||
33530022|NCT00621257|101838460|FG004|Overall Study|Physician Decision|1|||
33530023|NCT00621257|101838456|FG000|Overall Study|Withdrawal by Subject|0|||
33530024|NCT00621257|101838457|FG001|Overall Study|Withdrawal by Subject|0|||
33530025|NCT00621257|101838458|FG002|Overall Study|Withdrawal by Subject|0|||
33530026|NCT00621257|101838459|FG003|Overall Study|Withdrawal by Subject|1|||
33530027|NCT00621257|101838460|FG004|Overall Study|Withdrawal by Subject|1|||
33530028|NCT02035553|101838466|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
33530029|NCT02035553|101838467|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
33530030|NCT02035553|101838466|FG000|Overall Study|Adverse Event|10|||
33530031|NCT02035553|101838467|FG001|Overall Study|Adverse Event|6|||
33530032|NCT02035553|101838466|FG000|Overall Study|Physician Decision|3|||
33530033|NCT02035553|101838467|FG001|Overall Study|Physician Decision|2|||
33530034|NCT02035553|101838466|FG000|Overall Study|Lack of Efficacy|1|||
33530035|NCT02035553|101838467|FG001|Overall Study|Lack of Efficacy|1|||
33530036|NCT02035553|101838466|FG000|Overall Study|Withdrawal by Subject|4|||
33611496|NCT01345669|102126972|FG001|Overall Study|Other Reasons|60|||
33611497|NCT00408434|102126973|FG000|Overall Study|Adverse Event|0|||
33611498|NCT00408434|102126974|FG001|Overall Study|Adverse Event|0|||
33611499|NCT00408434|102126975|FG002|Overall Study|Adverse Event|1|||
33611500|NCT00408434|102126976|FG003|Overall Study|Adverse Event|0|||
33611501|NCT00408434|102126977|FG004|Overall Study|Adverse Event|0|||
33611502|NCT00408434|102126978|FG005|Overall Study|Adverse Event|0|||
33611503|NCT00408434|102126979|FG006|Overall Study|Adverse Event|0|||
33611504|NCT00408434|102126973|FG000|Overall Study|Progressive disease|6|||
33611505|NCT00408434|102126974|FG001|Overall Study|Progressive disease|3|||
33611506|NCT00408434|102126975|FG002|Overall Study|Progressive disease|4|||
33611507|NCT00408434|102126976|FG003|Overall Study|Progressive disease|3|||
33611508|NCT00408434|102126977|FG004|Overall Study|Progressive disease|3|||
33611509|NCT00408434|102126978|FG005|Overall Study|Progressive disease|1|||
33611510|NCT00408434|102126979|FG006|Overall Study|Progressive disease|4|||
33611511|NCT00408434|102126973|FG000|Overall Study|Other|0|||
33611512|NCT00408434|102126974|FG001|Overall Study|Other|0|||
33611513|NCT00408434|102126975|FG002|Overall Study|Other|1|||
33336281|NCT00866307|101124486|FG001|Induction|Study was closed at the time|0|||
33336282|NCT00866307|101124487|FG002|Induction|Study was closed at the time|0|||
33336283|NCT00866307|101124485|FG000|Consolidation/Maintenance|Adverse Event|0|||
33336284|NCT00866307|101124486|FG001|Consolidation/Maintenance|Adverse Event|0|||
33530037|NCT02035553|101838467|FG001|Overall Study|Withdrawal by Subject|7|||
33530038|NCT02035553|101838466|FG000|Overall Study|Non-compliance with Study Drug|0|||
33530039|NCT02035553|101838467|FG001|Overall Study|Non-compliance with Study Drug|1|||
33530040|NCT02035553|101838466|FG000|Overall Study|Lost to Follow-up|0|||
33530041|NCT02035553|101838467|FG001|Overall Study|Lost to Follow-up|1|||
33530042|NCT02035553|101838466|FG000|Overall Study|Other Reason|0|||
33336285|NCT00866307|101124487|FG002|Consolidation/Maintenance|Adverse Event|8|||
33530043|NCT02035553|101838467|FG001|Overall Study|Other Reason|4|||
33530044|NCT00807885|101838468|FG000|Overall Study|Lost to Follow-up|0|||
33611514|NCT00408434|102126976|FG003|Overall Study|Other|0|||
33404027|NCT01049360|101369413|FG011|Period 1|Withdrawal by Subject|0|||
33530045|NCT00807885|101838469|FG001|Overall Study|Lost to Follow-up|0|||
33530046|NCT00807885|101838470|FG002|Overall Study|Lost to Follow-up|0|||
33611515|NCT00408434|102126977|FG004|Overall Study|Other|2|||
33611516|NCT00408434|102126978|FG005|Overall Study|Other|1|||
33611517|NCT00408434|102126979|FG006|Overall Study|Other|0|||
33611518|NCT00408434|102126973|FG000|Overall Study|Terminated by Investigator|0|||
33530047|NCT00807885|101838471|FG003|Overall Study|Lost to Follow-up|0|||
33530048|NCT00807885|101838472|FG004|Overall Study|Lost to Follow-up|0|||
33611519|NCT00408434|102126974|FG001|Overall Study|Terminated by Investigator|0|||
33611520|NCT00408434|102126975|FG002|Overall Study|Terminated by Investigator|0|||
33530049|NCT00807885|101838473|FG005|Overall Study|Lost to Follow-up|1|||
33530050|NCT00807885|101838474|FG006|Overall Study|Lost to Follow-up|0|||
33530051|NCT00807885|101838475|FG007|Overall Study|Lost to Follow-up|0|||
33530052|NCT00807885|101838476|FG008|Overall Study|Lost to Follow-up|0|||
33530053|NCT03311841|101838477|FG000|14-day Wash-out|Adverse Event|0|||
33530054|NCT03311841|101838478|FG001|14-day Wash-out|Adverse Event|1|||
33530055|NCT03311841|101838479|FG002|14-day Wash-out|Adverse Event|0|||
33530056|NCT03311841|101838480|FG003|14-day Wash-out|Adverse Event|0|||
33530057|NCT03311841|101838481|FG004|14-day Wash-out|Adverse Event|0|||
33530058|NCT03311841|101838477|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
33530059|NCT03311841|101838478|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
33530060|NCT03311841|101838479|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
33530061|NCT03311841|101838480|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
33530062|NCT03311841|101838481|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
33530063|NCT04547140|101838504|FG000|Overall Study|Adverse Event|0|||
33530064|NCT04547140|101838505|FG001|Overall Study|Adverse Event|1|||
33530065|NCT04547140|101838504|FG000|Overall Study|Withdrawal by Subject|0|||
33530066|NCT04547140|101838505|FG001|Overall Study|Withdrawal by Subject|1|||
33530067|NCT04547140|101838504|FG000|Overall Study|Lost to Follow-up|3|||
33530068|NCT04547140|101838505|FG001|Overall Study|Lost to Follow-up|1|||
33530069|NCT04547140|101838504|FG000|Overall Study|Death|2|||
33530070|NCT04547140|101838505|FG001|Overall Study|Death|1|||
33530071|NCT04547140|101838504|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
33530072|NCT04547140|101838505|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
33530073|NCT04547140|101838504|FG000|Overall Study|Pregnancy|1|||
33530074|NCT04547140|101838505|FG001|Overall Study|Pregnancy|0|||
33530075|NCT04547140|101838504|FG000|Overall Study|Reason Not Specified|4|||
33530076|NCT04547140|101838505|FG001|Overall Study|Reason Not Specified|1|||
33530077|NCT00110357|101838506|FG000|Overall Study|Deterioration without progression|2|||
33530078|NCT00110357|101838507|FG001|Overall Study|Deterioration without progression|0|||
33530079|NCT00110357|101838506|FG000|Overall Study|Disease progression/relapse|20|||
33530080|NCT00110357|101838507|FG001|Overall Study|Disease progression/relapse|15|||
33530081|NCT00110357|101838506|FG000|Overall Study|Study Closure|1|||
33530082|NCT00110357|101838507|FG001|Overall Study|Study Closure|0|||
33530083|NCT00110357|101838506|FG000|Overall Study|Study Drug Toxicity|1|||
33530084|NCT00110357|101838507|FG001|Overall Study|Study Drug Toxicity|3|||
33530085|NCT00110357|101838506|FG000|Overall Study|Withdrawal by Subject|3|||
33530086|NCT00110357|101838507|FG001|Overall Study|Withdrawal by Subject|1|||
33530087|NCT02420119|101841628|FG000|Overall Study|insufficient laboratory data|5|||
33530088|NCT00872521|101841629|FG000|Completed PAD Induction|Patient choice|0|||
33530089|NCT00872521|101841630|FG001|Completed PAD Induction|Patient choice|1|||
33530090|NCT00872521|101841631|FG002|Completed PAD Induction|Patient choice|0|||
33530091|NCT00872521|101841629|FG000|Completed PAD Induction|Disease progression|0|||
33530092|NCT00872521|101841630|FG001|Completed PAD Induction|Disease progression|2|||
33530093|NCT00872521|101841631|FG002|Completed PAD Induction|Disease progression|0|||
33530094|NCT00872521|101841629|FG000|Completed PAD Induction|Adverse Event|4|||
33530095|NCT00872521|101841630|FG001|Completed PAD Induction|Adverse Event|0|||
33530096|NCT00872521|101841631|FG002|Completed PAD Induction|Adverse Event|0|||
33530097|NCT00872521|101841629|FG000|Completed PAD Induction|Death|1|||
33336286|NCT00866307|101124485|FG000|Consolidation/Maintenance|Death|0|||
33336287|NCT00866307|101124486|FG001|Consolidation/Maintenance|Death|0|||
33336288|NCT00866307|101124487|FG002|Consolidation/Maintenance|Death|1|||
33336289|NCT00866307|101124485|FG000|Consolidation/Maintenance|Physician Decision|0|||
33336290|NCT00866307|101124486|FG001|Consolidation/Maintenance|Physician Decision|3|||
33336291|NCT00866307|101124487|FG002|Consolidation/Maintenance|Physician Decision|2|||
33336292|NCT00866307|101124485|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
33530098|NCT00872521|101841630|FG001|Completed PAD Induction|Death|1|||
33404028|NCT01049360|101369414|FG012|Period 1|Withdrawal by Subject|1|||
33404029|NCT01049360|101369415|FG013|Period 1|Withdrawal by Subject|0|||
33530099|NCT00872521|101841631|FG002|Completed PAD Induction|Death|0|||
33530100|NCT00872521|101841629|FG000|Primary Endpoint Analysis|Other|1|||
33530101|NCT00872521|101841630|FG001|Primary Endpoint Analysis|Other|2|||
33530102|NCT00872521|101841631|FG002|Primary Endpoint Analysis|Other|0|||
33530103|NCT00872521|101841629|FG000|Primary Endpoint Analysis|Patient choice|0|||
33530104|NCT00872521|101841630|FG001|Primary Endpoint Analysis|Patient choice|1|||
33530105|NCT00872521|101841631|FG002|Primary Endpoint Analysis|Patient choice|0|||
33530106|NCT00872521|101841629|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
33530107|NCT00872521|101841630|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
33530108|NCT00872521|101841631|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
33530109|NCT00872521|101841629|FG000|Primary Endpoint Analysis|Patient response missing|0|||
33530110|NCT00872521|101841630|FG001|Primary Endpoint Analysis|Patient response missing|0|||
33530111|NCT00872521|101841631|FG002|Primary Endpoint Analysis|Patient response missing|1|||
33530112|NCT00872521|101841629|FG000|Completed 3-month Follow up|Other|0|||
33404030|NCT01049360|101369416|FG014|Period 1|Withdrawal by Subject|0|||
33404031|NCT01049360|101369417|FG015|Period 1|Withdrawal by Subject|0|||
33530113|NCT00872521|101841630|FG001|Completed 3-month Follow up|Other|2|||
33530114|NCT00872521|101841631|FG002|Completed 3-month Follow up|Other|0|||
33530115|NCT00872521|101841629|FG000|Completed 3-month Follow up|Physician Decision|0|||
33530116|NCT00872521|101841630|FG001|Completed 3-month Follow up|Physician Decision|1|||
33530117|NCT00872521|101841631|FG002|Completed 3-month Follow up|Physician Decision|0|||
33530118|NCT00872521|101841629|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
33530119|NCT00872521|101841630|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
33336293|NCT00866307|101124486|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
33336294|NCT00866307|101124487|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
33336295|NCT00866307|101124485|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
33336296|NCT00866307|101124486|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
33336297|NCT00866307|101124487|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
33336298|NCT00866307|101124485|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
33336299|NCT00866307|101124486|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
33336300|NCT00866307|101124487|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
33336301|NCT00866307|101124485|FG000|Consolidation/Maintenance|Therapy error|0|||
33336302|NCT00866307|101124486|FG001|Consolidation/Maintenance|Therapy error|1|||
33336303|NCT00866307|101124487|FG002|Consolidation/Maintenance|Therapy error|0|||
33336304|NCT00866307|101124485|FG000|Consolidation/Maintenance|Non-compliance|0|||
33336305|NCT00866307|101124486|FG001|Consolidation/Maintenance|Non-compliance|0|||
33336306|NCT00866307|101124487|FG002|Consolidation/Maintenance|Non-compliance|1|||
33336307|NCT00866307|101124485|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
33336308|NCT00866307|101124486|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
33336309|NCT00866307|101124487|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
33336310|NCT03021642|101124488|FG000|Washout Period (21 Days)|Adverse Event|1|||
33336311|NCT03021642|101124489|FG001|Washout Period (21 Days)|Adverse Event|1|||
33336312|NCT03355300|101124490|FG000|Overall Study|Physician Decision|0|||
33336313|NCT03355300|101124491|FG001|Overall Study|Physician Decision|1|||
33336314|NCT03355300|101124490|FG000|Overall Study|Lack of Efficacy|2|||
33336315|NCT03355300|101124491|FG001|Overall Study|Lack of Efficacy|1|||
33336316|NCT03355300|101124490|FG000|Overall Study|Other reason|1|||
33336317|NCT03355300|101124491|FG001|Overall Study|Other reason|0|||
33336318|NCT01895322|101124492|FG000|Overall Study|Adverse Event|1|||
33336319|NCT01895322|101124492|FG000|Overall Study|Withdrawal by Subject|2|||
33336320|NCT01895322|101124492|FG000|Overall Study|Protocol Violation|10|||
33336321|NCT00953758|101124495|FG000|Overall Study|Death|2|||
33336322|NCT00953758|101124496|FG001|Overall Study|Death|0|||
33336323|NCT00953758|101124497|FG002|Overall Study|Death|1|||
33336324|NCT00953758|101124498|FG003|Overall Study|Death|1|||
33336325|NCT00953758|101124499|FG004|Overall Study|Death|1|||
33336326|NCT00953758|101124500|FG005|Overall Study|Death|1|||
33336327|NCT00953758|101124501|FG006|Overall Study|Death|1|||
33336328|NCT00953758|101124502|FG007|Overall Study|Death|3|||
33336329|NCT00953758|101124503|FG008|Overall Study|Death|1|||
33336330|NCT00953758|101124504|FG009|Overall Study|Death|0|||
33336331|NCT00953758|101124495|FG000|Overall Study|Participant refused further follow-up|0|||
33336332|NCT00953758|101124496|FG001|Overall Study|Participant refused further follow-up|0|||
33336333|NCT00953758|101124497|FG002|Overall Study|Participant refused further follow-up|1|||
33336334|NCT00953758|101124498|FG003|Overall Study|Participant refused further follow-up|0|||
33336335|NCT00953758|101124499|FG004|Overall Study|Participant refused further follow-up|3|||
33336336|NCT00953758|101124500|FG005|Overall Study|Participant refused further follow-up|0|||
33336337|NCT00953758|101124501|FG006|Overall Study|Participant refused further follow-up|0|||
33336338|NCT00953758|101124502|FG007|Overall Study|Participant refused further follow-up|0|||
33336339|NCT00953758|101124503|FG008|Overall Study|Participant refused further follow-up|1|||
33336340|NCT00953758|101124504|FG009|Overall Study|Participant refused further follow-up|0|||
33336341|NCT00953758|101124495|FG000|Overall Study|Lost to Follow-up|0|||
33336342|NCT00953758|101124496|FG001|Overall Study|Lost to Follow-up|0|||
33336343|NCT00953758|101124497|FG002|Overall Study|Lost to Follow-up|0|||
33336344|NCT00953758|101124498|FG003|Overall Study|Lost to Follow-up|1|||
33336345|NCT00953758|101124499|FG004|Overall Study|Lost to Follow-up|0|||
33530120|NCT00872521|101841631|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
33336346|NCT00953758|101124500|FG005|Overall Study|Lost to Follow-up|0|||
33336347|NCT00953758|101124501|FG006|Overall Study|Lost to Follow-up|0|||
33530121|NCT01890759|101841632|FG000|Overall Study|Protocol Violation|0|||
33336348|NCT00953758|101124502|FG007|Overall Study|Lost to Follow-up|1|||
33336349|NCT00953758|101124503|FG008|Overall Study|Lost to Follow-up|0|||
33530122|NCT01890759|101841633|FG001|Overall Study|Protocol Violation|2|||
33530123|NCT01890759|101841632|FG000|Overall Study|Lost to Follow-up|0|||
33336350|NCT00953758|101124504|FG009|Overall Study|Lost to Follow-up|1|||
33404032|NCT01049360|101369418|FG016|Period 1|Withdrawal by Subject|0|||
33336351|NCT00953758|101124495|FG000|Overall Study|Physician Decision|0|||
33336352|NCT00953758|101124496|FG001|Overall Study|Physician Decision|0|||
33336353|NCT00953758|101124497|FG002|Overall Study|Physician Decision|0|||
33404033|NCT01049360|101369419|FG017|Period 1|Withdrawal by Subject|0|||
33404034|NCT01049360|101369420|FG018|Period 1|Withdrawal by Subject|0|||
33404035|NCT01049360|101369421|FG019|Period 1|Withdrawal by Subject|0|||
33404036|NCT01049360|101369402|FG000|Period 2|Protocol Violation|0|||
33404037|NCT01049360|101369403|FG001|Period 2|Protocol Violation|0|||
33404038|NCT01049360|101369404|FG002|Period 2|Protocol Violation|0|||
33404039|NCT01049360|101369405|FG003|Period 2|Protocol Violation|1|||
33404040|NCT01049360|101369406|FG004|Period 2|Protocol Violation|0|||
33404041|NCT01049360|101369407|FG005|Period 2|Protocol Violation|0|||
33404042|NCT01049360|101369408|FG006|Period 2|Protocol Violation|0|||
33404043|NCT01049360|101369409|FG007|Period 2|Protocol Violation|0|||
33404044|NCT01049360|101369410|FG008|Period 2|Protocol Violation|0|||
33404045|NCT01049360|101369411|FG009|Period 2|Protocol Violation|0|||
33404046|NCT01049360|101369412|FG010|Period 2|Protocol Violation|0|||
33404047|NCT01049360|101369413|FG011|Period 2|Protocol Violation|0|||
33404048|NCT01049360|101369414|FG012|Period 2|Protocol Violation|0|||
33404049|NCT01049360|101369415|FG013|Period 2|Protocol Violation|0|||
33404050|NCT01049360|101369416|FG014|Period 2|Protocol Violation|1|||
33404051|NCT01049360|101369417|FG015|Period 2|Protocol Violation|1|||
33404052|NCT01049360|101369418|FG016|Period 2|Protocol Violation|0|||
33404053|NCT01049360|101369419|FG017|Period 2|Protocol Violation|0|||
33404054|NCT01049360|101369420|FG018|Period 2|Protocol Violation|0|||
33404055|NCT01049360|101369421|FG019|Period 2|Protocol Violation|0|||
33404056|NCT01049360|101369402|FG000|Period 2|Adverse Event|0|||
33404057|NCT01049360|101369403|FG001|Period 2|Adverse Event|1|||
33404058|NCT01049360|101369404|FG002|Period 2|Adverse Event|0|||
33404059|NCT01049360|101369405|FG003|Period 2|Adverse Event|0|||
33404060|NCT01049360|101369406|FG004|Period 2|Adverse Event|0|||
33404061|NCT01049360|101369407|FG005|Period 2|Adverse Event|0|||
33404062|NCT01049360|101369408|FG006|Period 2|Adverse Event|0|||
33404063|NCT01049360|101369409|FG007|Period 2|Adverse Event|0|||
33404064|NCT01049360|101369410|FG008|Period 2|Adverse Event|1|||
33404065|NCT01049360|101369411|FG009|Period 2|Adverse Event|0|||
33404066|NCT01049360|101369412|FG010|Period 2|Adverse Event|0|||
33404067|NCT01049360|101369413|FG011|Period 2|Adverse Event|0|||
33404068|NCT01049360|101369414|FG012|Period 2|Adverse Event|0|||
33404069|NCT01049360|101369415|FG013|Period 2|Adverse Event|0|||
33530124|NCT01890759|101841633|FG001|Overall Study|Lost to Follow-up|2|||
33530125|NCT01890759|101841632|FG000|Overall Study|Withdrawal by Subject|2|||
33530126|NCT01890759|101841633|FG001|Overall Study|Withdrawal by Subject|8|||
33530127|NCT01462110|101841634|FG000|Overall Study|Adverse Event|1|||
33530128|NCT01462110|101841635|FG001|Overall Study|Adverse Event|0|||
33530129|NCT00436826|101841636|FG000|Double Blind Period (DBP)|Adverse Event|2|||
33530130|NCT00436826|101841637|FG001|Double Blind Period (DBP)|Adverse Event|0|||
33530131|NCT00436826|101841638|FG002|Double Blind Period (DBP)|Adverse Event|0|||
33530132|NCT00436826|101841639|FG003|Double Blind Period (DBP)|Adverse Event|0|||
33530133|NCT00436826|101841640|FG004|Double Blind Period (DBP)|Adverse Event|0|||
33530134|NCT00436826|101841641|FG005|Double Blind Period (DBP)|Adverse Event|0|||
33530135|NCT00436826|101841636|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
33530136|NCT00436826|101841637|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
33530137|NCT00436826|101841638|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
33336354|NCT00953758|101124498|FG003|Overall Study|Physician Decision|0|||
33336355|NCT00953758|101124499|FG004|Overall Study|Physician Decision|1|||
33336356|NCT00953758|101124500|FG005|Overall Study|Physician Decision|0|||
33336357|NCT00953758|101124501|FG006|Overall Study|Physician Decision|0|||
33336358|NCT00953758|101124502|FG007|Overall Study|Physician Decision|0|||
33336359|NCT00953758|101124503|FG008|Overall Study|Physician Decision|0|||
33336360|NCT00953758|101124504|FG009|Overall Study|Physician Decision|0|||
33336361|NCT00953758|101124495|FG000|Overall Study|Disease progression|0|||
33336362|NCT00953758|101124496|FG001|Overall Study|Disease progression|0|||
33336363|NCT00953758|101124497|FG002|Overall Study|Disease progression|0|||
33404070|NCT01049360|101369416|FG014|Period 2|Adverse Event|0|||
33404071|NCT01049360|101369417|FG015|Period 2|Adverse Event|0|||
33530138|NCT00436826|101841639|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
33530139|NCT00436826|101841640|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
33530140|NCT00436826|101841641|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
33404072|NCT01049360|101369418|FG016|Period 2|Adverse Event|0|||
33336364|NCT00953758|101124498|FG003|Overall Study|Disease progression|0|||
33404073|NCT01049360|101369419|FG017|Period 2|Adverse Event|0|||
33336365|NCT00953758|101124499|FG004|Overall Study|Disease progression|1|||
33336366|NCT00953758|101124500|FG005|Overall Study|Disease progression|0|||
33336367|NCT00953758|101124501|FG006|Overall Study|Disease progression|0|||
33404074|NCT01049360|101369420|FG018|Period 2|Adverse Event|0|||
33404075|NCT01049360|101369421|FG019|Period 2|Adverse Event|1|||
33404076|NCT01049360|101369402|FG000|Period 2|Withdrawal by Subject|0|||
33404077|NCT01049360|101369403|FG001|Period 2|Withdrawal by Subject|0|||
33404078|NCT01049360|101369404|FG002|Period 2|Withdrawal by Subject|0|||
33404079|NCT01049360|101369405|FG003|Period 2|Withdrawal by Subject|1|||
33530141|NCT00436826|101841636|FG000|Double Blind Period (DBP)|Other|10|||
33530142|NCT00436826|101841637|FG001|Double Blind Period (DBP)|Other|11|||
33530143|NCT00436826|101841638|FG002|Double Blind Period (DBP)|Other|0|||
33530144|NCT00436826|101841639|FG003|Double Blind Period (DBP)|Other|0|||
33530145|NCT00436826|101841640|FG004|Double Blind Period (DBP)|Other|0|||
33530146|NCT00436826|101841641|FG005|Double Blind Period (DBP)|Other|0|||
33530147|NCT00436826|101841636|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
33530148|NCT00436826|101841637|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
33530149|NCT00436826|101841638|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
33530150|NCT00436826|101841639|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
33530151|NCT00436826|101841640|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
33530152|NCT00436826|101841641|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
33530153|NCT00436826|101841636|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
33530154|NCT00436826|101841637|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
33530155|NCT00436826|101841638|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
33530156|NCT00436826|101841639|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
33530157|NCT00436826|101841640|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
33530158|NCT00436826|101841641|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
33530159|NCT00436826|101841636|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
33530160|NCT00436826|101841637|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
33530161|NCT00436826|101841638|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
33530162|NCT00436826|101841639|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
33530163|NCT00436826|101841640|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
33530164|NCT00436826|101841641|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
33530165|NCT02346877|101841645|FG000|Overall Study|Adverse Event|1|||
33530166|NCT02346877|101841646|FG001|Overall Study|Adverse Event|0|||
33530167|NCT02346877|101841645|FG000|Overall Study|Administrative Decision|1|||
33530168|NCT02346877|101841646|FG001|Overall Study|Administrative Decision|0|||
33530169|NCT02346877|101841645|FG000|Overall Study|Sponsor Decision|12|||
33530170|NCT02346877|101841646|FG001|Overall Study|Sponsor Decision|0|||
33530171|NCT02346877|101841645|FG000|Overall Study|Missing|5|||
33530172|NCT02346877|101841646|FG001|Overall Study|Missing|0|||
33530173|NCT03512353|101841647|FG000|Overall Study|Sponsor Decision|3|||
33530174|NCT03512353|101841647|FG000|Overall Study|Death|1|||
33530175|NCT03560869|101841648|FG000|Overall Study|Withdrawal by Subject|3|||
33530176|NCT03560869|101841649|FG001|Overall Study|Withdrawal by Subject|4|||
33530177|NCT03560869|101841648|FG000|Overall Study|Screening failure|4|||
33530178|NCT03560869|101841649|FG001|Overall Study|Screening failure|4|||
33530179|NCT03560869|101841648|FG000|Overall Study|Withdrawal by PI|0|||
33530180|NCT03560869|101841649|FG001|Overall Study|Withdrawal by PI|1|||
33530181|NCT03630705|101841650|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
33530182|NCT03630705|101841651|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
33530183|NCT03630705|101841652|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
33530184|NCT03630705|101841653|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
33530185|NCT03630705|101841650|FG000|Overall Study|Lost to Follow-up|1|||
33530186|NCT03630705|101841651|FG001|Overall Study|Lost to Follow-up|2|||
33530187|NCT03630705|101841652|FG002|Overall Study|Lost to Follow-up|0|||
33530188|NCT03630705|101841653|FG003|Overall Study|Lost to Follow-up|0|||
33611521|NCT00408434|102126976|FG003|Overall Study|Terminated by Investigator|0|||
33611522|NCT00408434|102126977|FG004|Overall Study|Terminated by Investigator|1|||
33611523|NCT00408434|102126978|FG005|Overall Study|Terminated by Investigator|1|||
33611524|NCT00408434|102126979|FG006|Overall Study|Terminated by Investigator|0|||
33611525|NCT01793883|102126980|FG000|Overall Study|Withdrawal by Subject|3|||
33530189|NCT00402727|101841654|FG000|Overall Study|Adverse Event|10|||
33530190|NCT00402727|101841655|FG001|Overall Study|Adverse Event|6|||
33530191|NCT00402727|101841654|FG000|Overall Study|Death|1|||
33530192|NCT00402727|101841655|FG001|Overall Study|Death|0|||
33611526|NCT01793883|102126981|FG001|Overall Study|Withdrawal by Subject|7|||
33404080|NCT01049360|101369406|FG004|Period 2|Withdrawal by Subject|0|||
33404081|NCT01049360|101369407|FG005|Period 2|Withdrawal by Subject|0|||
33530193|NCT00402727|101841654|FG000|Overall Study|Lack of Efficacy|1|||
33530194|NCT00402727|101841655|FG001|Overall Study|Lack of Efficacy|3|||
33530195|NCT00402727|101841654|FG000|Overall Study|Lost to Follow-up|24|||
33530196|NCT00402727|101841655|FG001|Overall Study|Lost to Follow-up|11|||
33530197|NCT00402727|101841654|FG000|Overall Study|Physician Decision|1|||
33530198|NCT00402727|101841655|FG001|Overall Study|Physician Decision|1|||
33530199|NCT00402727|101841654|FG000|Overall Study|Protocol Violation|0|||
33530200|NCT00402727|101841655|FG001|Overall Study|Protocol Violation|4|||
33530201|NCT00402727|101841654|FG000|Overall Study|Withdrawal by Subject|3|||
33530202|NCT00402727|101841655|FG001|Overall Study|Withdrawal by Subject|7|||
33530203|NCT00402727|101841654|FG000|Overall Study|supply problems|2|||
33530204|NCT00402727|101841655|FG001|Overall Study|supply problems|1|||
33530205|NCT00402727|101841654|FG000|Overall Study|non-compliance|0|||
33530206|NCT00402727|101841655|FG001|Overall Study|non-compliance|1|||
33530207|NCT02895295|101841660|FG000|Overall Study|Survey Non-response|71|||
33611527|NCT01793883|102126982|FG002|Overall Study|Withdrawal by Subject|3|||
33530208|NCT02895295|101841661|FG001|Overall Study|Survey Non-response|94|||
33530209|NCT02895295|101841662|FG002|Overall Study|Survey Non-response|92|||
33530210|NCT02793947|101841667|FG000|Overall Study|Death|1|||
33530211|NCT02793947|101841668|FG001|Overall Study|Death|0|||
33530212|NCT02793947|101841667|FG000|Overall Study|Physician Decision|1|||
33530213|NCT02793947|101841668|FG001|Overall Study|Physician Decision|5|||
33530214|NCT00536510|101841669|FG000|Overall Study|Adverse Event|27|||
33530215|NCT00536510|101841670|FG001|Overall Study|Adverse Event|4|||
33530216|NCT00536510|101841669|FG000|Overall Study|Lost to Follow-up|11|||
33530217|NCT00536510|101841670|FG001|Overall Study|Lost to Follow-up|8|||
33530218|NCT00536510|101841669|FG000|Overall Study|Protocol Violation|4|||
33530219|NCT00536510|101841670|FG001|Overall Study|Protocol Violation|5|||
33530220|NCT00536510|101841669|FG000|Overall Study|Withdrawal by Subject|16|||
33530221|NCT00536510|101841670|FG001|Overall Study|Withdrawal by Subject|9|||
33530222|NCT00536510|101841669|FG000|Overall Study|Flushing with Product|20|||
33530223|NCT00536510|101841670|FG001|Overall Study|Flushing with Product|0|||
33530224|NCT00536510|101841669|FG000|Overall Study|Laboratory Adverse Event|2|||
33530225|NCT00536510|101841670|FG001|Overall Study|Laboratory Adverse Event|1|||
33530226|NCT00536510|101841669|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
33530227|NCT00536510|101841670|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
33530228|NCT01152996|101841671|FG000|Overall Study|Withdrawal by Subject|142|||
33530229|NCT01152996|101841671|FG000|Overall Study|Adverse Event|115|||
33530230|NCT01152996|101841671|FG000|Overall Study|Lost to Follow-up|112|||
33530231|NCT01152996|101841671|FG000|Overall Study|Lack of Efficacy|68|||
33530232|NCT01152996|101841671|FG000|Overall Study|Noncompliance|41|||
33530233|NCT01152996|101841671|FG000|Overall Study|Other|36|||
33530234|NCT01152996|101841671|FG000|Overall Study|Protocol Violation|22|||
33530235|NCT01152996|101841671|FG000|Overall Study|Elevated liver enzymes|1|||
33530236|NCT00856999|101841674|FG000|Overall Study|Withdrawal by Subject|5|||
33530237|NCT01091246|101841675|FG000|Overall Study|Lost to Follow-up|23|||
33336368|NCT00953758|101124502|FG007|Overall Study|Disease progression|0|||
33336369|NCT00953758|101124503|FG008|Overall Study|Disease progression|0|||
33530238|NCT01091246|101841676|FG001|Overall Study|Lost to Follow-up|11|||
33530239|NCT01091246|101841677|FG002|Overall Study|Lost to Follow-up|7|||
33530240|NCT01091246|101841675|FG000|Overall Study|Adverse Event|1|||
33530241|NCT01091246|101841676|FG001|Overall Study|Adverse Event|0|||
33530242|NCT01091246|101841677|FG002|Overall Study|Adverse Event|1|||
33530243|NCT01091246|101841675|FG000|Overall Study|Withdrawal by Subject|9|||
33530244|NCT01091246|101841676|FG001|Overall Study|Withdrawal by Subject|5|||
33530245|NCT01091246|101841677|FG002|Overall Study|Withdrawal by Subject|4|||
33530246|NCT01091246|101841675|FG000|Overall Study|Subject not dosed|2|||
33530247|NCT01091246|101841676|FG001|Overall Study|Subject not dosed|0|||
33530248|NCT01091246|101841677|FG002|Overall Study|Subject not dosed|1|||
33530249|NCT03810456|101841678|FG000|Treatment|Urgent Family Matters|3|||
33530250|NCT03810456|101841679|FG001|Treatment|Urgent Family Matters|0|||
33530251|NCT03810456|101841680|FG002|Treatment|Urgent Family Matters|0|||
33530252|NCT03810456|101841678|FG000|Treatment|Scheduling Conflicts|0|||
33530253|NCT03810456|101841679|FG001|Treatment|Scheduling Conflicts|11|||
33530254|NCT03810456|101841680|FG002|Treatment|Scheduling Conflicts|0|||
33530255|NCT03810456|101841678|FG000|Treatment|No Longer Interested|0|||
33530256|NCT03810456|101841679|FG001|Treatment|No Longer Interested|12|||
33530257|NCT03810456|101841680|FG002|Treatment|No Longer Interested|0|||
33530258|NCT03810456|101841678|FG000|Treatment|Transportation Issues|0|||
33530259|NCT03810456|101841679|FG001|Treatment|Transportation Issues|1|||
33530260|NCT03810456|101841680|FG002|Treatment|Transportation Issues|0|||
33530261|NCT03810456|101841678|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
33336370|NCT00953758|101124504|FG009|Overall Study|Disease progression|0|||
33530262|NCT03810456|101841679|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
33530263|NCT03810456|101841680|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
33611528|NCT01793883|102126980|FG000|Overall Study|Subject noncompliance|0|||
33336371|NCT00953758|101124495|FG000|Overall Study|Participant went for transplant|0|||
33336372|NCT00953758|101124496|FG001|Overall Study|Participant went for transplant|0|||
33530264|NCT03810456|101841678|FG000|1 Month Follow-Up|Relocated to Different State|1|||
33530265|NCT03810456|101841679|FG001|1 Month Follow-Up|Relocated to Different State|0|||
33530266|NCT03810456|101841680|FG002|1 Month Follow-Up|Relocated to Different State|1|||
33530267|NCT03810456|101841678|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
33530268|NCT03810456|101841679|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
33530269|NCT03810456|101841680|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
33530270|NCT03810456|101841678|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
33530271|NCT03810456|101841679|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
33530272|NCT03810456|101841680|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
33530273|NCT03810456|101841678|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
33530274|NCT03810456|101841679|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
33611529|NCT01793883|102126981|FG001|Overall Study|Subject noncompliance|1|||
33530275|NCT03810456|101841680|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
33530276|NCT03810456|101841678|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
33530277|NCT03810456|101841679|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
33530278|NCT03810456|101841680|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
33530279|NCT03810456|101841678|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
33530280|NCT03810456|101841679|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
33530281|NCT03810456|101841680|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
33530282|NCT04978337|101841681|FG000|Overall Study|Withdrawal by Subject|0|||
33530283|NCT04978337|101841682|FG001|Overall Study|Withdrawal by Subject|1|||
33530284|NCT02155985|101841683|FG000|Overall Study|Withdrawal by Subject|0|||
33530285|NCT02155985|101841684|FG001|Overall Study|Withdrawal by Subject|0|||
33530286|NCT02155985|101841685|FG002|Overall Study|Withdrawal by Subject|1|||
33530287|NCT02155985|101841683|FG000|Overall Study|Lost to Follow-up|1|||
33530288|NCT02155985|101841684|FG001|Overall Study|Lost to Follow-up|0|||
33530289|NCT02155985|101841685|FG002|Overall Study|Lost to Follow-up|0|||
33530290|NCT02207400|101841686|FG000|Overall Study|Adverse Event|1|||
33530291|NCT02207400|101841687|FG001|Overall Study|Adverse Event|1|||
33530292|NCT02207400|101841686|FG000|Overall Study|Lost to Follow-up|6|||
33530293|NCT02207400|101841687|FG001|Overall Study|Lost to Follow-up|7|||
33530294|NCT02207400|101841686|FG000|Overall Study|Protocol Violation|1|||
33530295|NCT02207400|101841687|FG001|Overall Study|Protocol Violation|1|||
33530296|NCT02207400|101841686|FG000|Overall Study|Withdrawal by Subject|8|||
33530297|NCT02207400|101841687|FG001|Overall Study|Withdrawal by Subject|4|||
33530298|NCT02207400|101841686|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
33530299|NCT02207400|101841687|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
33530300|NCT03046953|101841689|FG000|Overall Study|Relapse/progressive disease|21|||
33530301|NCT03046953|101841689|FG000|Overall Study|Death|2|||
33336373|NCT00953758|101124497|FG002|Overall Study|Participant went for transplant|0|||
33336374|NCT00953758|101124498|FG003|Overall Study|Participant went for transplant|0|||
33336375|NCT00953758|101124499|FG004|Overall Study|Participant went for transplant|0|||
33530302|NCT03046953|101841689|FG000|Overall Study|Withdrawal by Subject|3|||
33530303|NCT01429298|101841690|FG000|Overall Study|Protocol Violation|4|||
33530304|NCT01429298|101841691|FG001|Overall Study|Protocol Violation|6|||
33530305|NCT02989402|101841698|FG000|Overall Study|Adverse event, or serious adverse event|4|||
33530306|NCT02989402|101841698|FG000|Overall Study|Death|2|||
33530307|NCT02989402|101841698|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
33530308|NCT02989402|101841698|FG000|Overall Study|Lost to Follow-up|8|||
33530309|NCT02989402|101841698|FG000|Overall Study|Patient no longer on monotherapy|1|||
33530310|NCT02989402|101841698|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
33530311|NCT02989402|101841698|FG000|Overall Study|Withdrawal by Subject|7|||
33530312|NCT02989402|101841698|FG000|Overall Study|Other|2|||
33530313|NCT01854697|101841699|FG000|Overall Study|Adverse Event|1|||
33530314|NCT01854697|101841700|FG001|Overall Study|Adverse Event|0|||
33530315|NCT01854697|101841701|FG002|Overall Study|Adverse Event|0|||
33530316|NCT01854697|101841702|FG003|Overall Study|Adverse Event|0|||
33530317|NCT01854697|101841703|FG004|Overall Study|Adverse Event|1|||
33530318|NCT01854697|101841699|FG000|Overall Study|Lost to Follow-up|4|||
33530319|NCT01854697|101841700|FG001|Overall Study|Lost to Follow-up|1|||
33530320|NCT01854697|101841701|FG002|Overall Study|Lost to Follow-up|1|||
33530321|NCT01854697|101841702|FG003|Overall Study|Lost to Follow-up|2|||
33530322|NCT01854697|101841703|FG004|Overall Study|Lost to Follow-up|0|||
33530323|NCT01854697|101841699|FG000|Overall Study|To enter another AbbVie study|1|||
33530324|NCT01854697|101841700|FG001|Overall Study|To enter another AbbVie study|0|||
33530325|NCT01854697|101841701|FG002|Overall Study|To enter another AbbVie study|0|||
33530326|NCT01854697|101841702|FG003|Overall Study|To enter another AbbVie study|0|||
33530327|NCT01854697|101841703|FG004|Overall Study|To enter another AbbVie study|1|||
33530328|NCT01854697|101841699|FG000|Overall Study|Withdrew Consent|0|||
33530329|NCT01854697|101841700|FG001|Overall Study|Withdrew Consent|1|||
33530330|NCT01854697|101841701|FG002|Overall Study|Withdrew Consent|0|||
33530331|NCT01854697|101841702|FG003|Overall Study|Withdrew Consent|1|||
33530332|NCT01854697|101841703|FG004|Overall Study|Withdrew Consent|0|||
33530333|NCT01854697|101841699|FG000|Overall Study|Other|0|||
33336376|NCT00953758|101124500|FG005|Overall Study|Participant went for transplant|0|||
33530334|NCT01854697|101841700|FG001|Overall Study|Other|1|||
33530335|NCT01854697|101841701|FG002|Overall Study|Other|1|||
33530336|NCT01854697|101841702|FG003|Overall Study|Other|0|||
33530337|NCT01854697|101841703|FG004|Overall Study|Other|0|||
33530338|NCT02581488|101841704|FG000|Overall Study|Adverse Event|6|||
33530339|NCT02581488|101841705|FG001|Overall Study|Adverse Event|7|||
33530340|NCT02581488|101841704|FG000|Overall Study|Lost to Follow-up|1|||
33530341|NCT02581488|101841705|FG001|Overall Study|Lost to Follow-up|0|||
33530342|NCT02581488|101841704|FG000|Overall Study|Withdrawal by Subject|1|||
33530343|NCT02581488|101841705|FG001|Overall Study|Withdrawal by Subject|0|||
33336377|NCT00953758|101124501|FG006|Overall Study|Participant went for transplant|0|||
33530344|NCT02581488|101841704|FG000|Overall Study|Non-Compliance|1|||
33530345|NCT02581488|101841705|FG001|Overall Study|Non-Compliance|0|||
33530346|NCT02581488|101841704|FG000|Overall Study|Protocol Violation|0|||
33530347|NCT02581488|101841705|FG001|Overall Study|Protocol Violation|4|||
33530348|NCT04878055|101841708|FG000|Overall Study|Patient transferred in another department|0|||
33530349|NCT04878055|101841709|FG001|Overall Study|Patient transferred in another department|2|||
33530350|NCT04878055|101841708|FG000|Overall Study|Physician Decision|1|||
33530351|NCT04878055|101841709|FG001|Overall Study|Physician Decision|1|||
33530352|NCT04878055|101841708|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
33530353|NCT04878055|101841709|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
33530354|NCT04878055|101841708|FG000|Overall Study|Adverse Event|12|||
33530355|NCT04878055|101841709|FG001|Overall Study|Adverse Event|7|||
33530356|NCT04878055|101841708|FG000|Overall Study|Other|5|||
33530357|NCT04878055|101841709|FG001|Overall Study|Other|0|||
33530358|NCT04878055|101841708|FG000|Overall Study|Withdrawal by Subject|7|||
33530359|NCT04878055|101841709|FG001|Overall Study|Withdrawal by Subject|3|||
33530360|NCT04878055|101841708|FG000|Overall Study|Lost to Follow-up|10|||
33530361|NCT04878055|101841709|FG001|Overall Study|Lost to Follow-up|1|||
33530362|NCT01004978|101841710|FG000|Overall Study|Disease progression|31|||
33530363|NCT01004978|101841711|FG001|Overall Study|Disease progression|48|||
33530364|NCT01004978|101841710|FG000|Overall Study|Adverse Event|42|||
33530365|NCT01004978|101841711|FG001|Overall Study|Adverse Event|22|||
33530366|NCT01004978|101841710|FG000|Overall Study|Death|3|||
33530367|NCT01004978|101841711|FG001|Overall Study|Death|2|||
33530368|NCT01004978|101841710|FG000|Overall Study|Withdrawal by Subject|16|||
33530369|NCT01004978|101841711|FG001|Overall Study|Withdrawal by Subject|16|||
33530370|NCT01004978|101841710|FG000|Overall Study|Alternative therapy|4|||
33530371|NCT01004978|101841711|FG001|Overall Study|Alternative therapy|8|||
33530372|NCT01004978|101841710|FG000|Overall Study|Physician Decision|6|||
33530373|NCT01004978|101841711|FG001|Overall Study|Physician Decision|3|||
33530374|NCT01004978|101841710|FG000|Overall Study|Other complicating disease|2|||
33530375|NCT01004978|101841711|FG001|Overall Study|Other complicating disease|2|||
33530376|NCT01004978|101841710|FG000|Overall Study|Protocol Violation|2|||
33530377|NCT01004978|101841711|FG001|Overall Study|Protocol Violation|3|||
33530378|NCT01004978|101841710|FG000|Overall Study|Non-compliance|3|||
33530379|NCT01004978|101841711|FG001|Overall Study|Non-compliance|2|||
33530380|NCT01004978|101841710|FG000|Overall Study|Ineligible|1|||
33530381|NCT01004978|101841711|FG001|Overall Study|Ineligible|0|||
33530382|NCT01004978|101841710|FG000|Overall Study|Unblinded|0|||
33530383|NCT01004978|101841711|FG001|Overall Study|Unblinded|1|||
33530384|NCT01004978|101841710|FG000|Overall Study|Performance status worsening|0|||
33530385|NCT01004978|101841711|FG001|Overall Study|Performance status worsening|1|||
33530386|NCT01004978|101841710|FG000|Overall Study|Never started treatment|8|||
33530387|NCT01004978|101841711|FG001|Overall Study|Never started treatment|9|||
33530388|NCT02710084|101841712|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
33530389|NCT02710084|101841713|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
33530390|NCT01968811|101841714|FG000|Overall Study|Protocol Violation|4|||
33530391|NCT01968811|101841714|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
33530392|NCT01128400|101841717|FG000|Overall Study|Lost to Follow-up|1|||
33530393|NCT01128400|101841718|FG001|Overall Study|Lost to Follow-up|0|||
33530394|NCT01128400|101841719|FG002|Overall Study|Lost to Follow-up|1|||
33530395|NCT01128400|101841717|FG000|Overall Study|Screening failure|1|||
33530396|NCT01128400|101841718|FG001|Overall Study|Screening failure|0|||
33530397|NCT01128400|101841719|FG002|Overall Study|Screening failure|0|||
33530398|NCT01128400|101841717|FG000|Overall Study|were not invited to participate on taste|0|||
33530399|NCT01128400|101841718|FG001|Overall Study|were not invited to participate on taste|0|||
33530400|NCT01128400|101841719|FG002|Overall Study|were not invited to participate on taste|15|||
33530401|NCT01128400|101841717|FG000|Overall Study|Excluded due to sinus problems|0|||
33530402|NCT01128400|101841718|FG001|Overall Study|Excluded due to sinus problems|1|||
33530403|NCT01128400|101841719|FG002|Overall Study|Excluded due to sinus problems|0|||
33530404|NCT02849080|101841722|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
33530405|NCT02849080|101841723|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
33530406|NCT02849080|101841724|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
33530407|NCT02849080|101841725|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
33530408|NCT02849080|101841722|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
33530409|NCT02849080|101841723|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
33530410|NCT02849080|101841724|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
33530411|NCT02849080|101841725|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
33530412|NCT02849080|101841722|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
33530413|NCT02849080|101841723|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
33530414|NCT02849080|101841724|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
33530415|NCT02849080|101841725|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
33530416|NCT02849080|101841722|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
33530417|NCT02849080|101841723|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
33530418|NCT02849080|101841724|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
33530419|NCT02849080|101841725|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
33205188|NCT03131648|100651492|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33205189|NCT03131648|100651493|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33205190|NCT03131648|100651494|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33530420|NCT02849080|101841722|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
33530421|NCT02849080|101841723|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
33530422|NCT02849080|101841724|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
33530423|NCT02849080|101841725|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
33530424|NCT02849080|101841722|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
33530425|NCT02849080|101841723|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
33530426|NCT02849080|101841724|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
33530427|NCT02849080|101841725|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
33530428|NCT00206427|101841726|FG000|Overall Study|Adverse Event|2|||
33205191|NCT03131648|100651495|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
33205192|NCT03131648|100651488|FG000|Open-label Treatment|Discontinued IMP|0|||
33205193|NCT03131648|100651489|FG001|Open-label Treatment|Discontinued IMP|0|||
33205194|NCT03131648|100651490|FG002|Open-label Treatment|Discontinued IMP|0|||
33404082|NCT01049360|101369408|FG006|Period 2|Withdrawal by Subject|0|||
33404083|NCT01049360|101369409|FG007|Period 2|Withdrawal by Subject|0|||
33404084|NCT01049360|101369410|FG008|Period 2|Withdrawal by Subject|0|||
33404085|NCT01049360|101369411|FG009|Period 2|Withdrawal by Subject|0|||
33404086|NCT01049360|101369412|FG010|Period 2|Withdrawal by Subject|0|||
33404087|NCT01049360|101369413|FG011|Period 2|Withdrawal by Subject|0|||
33404088|NCT01049360|101369414|FG012|Period 2|Withdrawal by Subject|0|||
33404089|NCT01049360|101369415|FG013|Period 2|Withdrawal by Subject|0|||
33404090|NCT01049360|101369416|FG014|Period 2|Withdrawal by Subject|1|||
33404091|NCT01049360|101369417|FG015|Period 2|Withdrawal by Subject|0|||
33205195|NCT03131648|100651491|FG003|Open-label Treatment|Discontinued IMP|0|||
33205196|NCT03131648|100651492|FG004|Open-label Treatment|Discontinued IMP|0|||
33205197|NCT03131648|100651493|FG005|Open-label Treatment|Discontinued IMP|0|||
33205198|NCT03131648|100651494|FG006|Open-label Treatment|Discontinued IMP|112|||
33205199|NCT03131648|100651495|FG007|Open-label Treatment|Discontinued IMP|0|||
33205200|NCT03131648|100651488|FG000|Open-label Treatment|Completed Week 50|0|||
33205201|NCT03131648|100651489|FG001|Open-label Treatment|Completed Week 50|0|||
33205202|NCT03131648|100651490|FG002|Open-label Treatment|Completed Week 50|0|||
33205203|NCT03131648|100651491|FG003|Open-label Treatment|Completed Week 50|0|||
33205204|NCT03131648|100651492|FG004|Open-label Treatment|Completed Week 50|0|||
33205205|NCT03131648|100651493|FG005|Open-label Treatment|Completed Week 50|0|||
33205206|NCT03131648|100651494|FG006|Open-label Treatment|Completed Week 50|6|||
33205207|NCT03131648|100651495|FG007|Open-label Treatment|Completed Week 50|0|||
33205208|NCT03131648|100651488|FG000|Maintenance Treatment Period|Not dosed|0|||
33205209|NCT03131648|100651489|FG001|Maintenance Treatment Period|Not dosed|0|||
33205210|NCT03131648|100651490|FG002|Maintenance Treatment Period|Not dosed|3|||
33205211|NCT03131648|100651491|FG003|Maintenance Treatment Period|Not dosed|2|||
33205212|NCT03131648|100651492|FG004|Maintenance Treatment Period|Not dosed|1|||
33205213|NCT03131648|100651493|FG005|Maintenance Treatment Period|Not dosed|0|||
33205214|NCT03131648|100651494|FG006|Maintenance Treatment Period|Not dosed|0|||
33205215|NCT03131648|100651495|FG007|Maintenance Treatment Period|Not dosed|0|||
33205216|NCT03131648|100651488|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
33205217|NCT03131648|100651489|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
33205218|NCT03131648|100651490|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
33205219|NCT03131648|100651491|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
33205220|NCT03131648|100651492|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
33205221|NCT03131648|100651493|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
33205222|NCT03131648|100651494|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
33205223|NCT03131648|100651495|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
33205224|NCT03131648|100651488|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
33205225|NCT03131648|100651489|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
33205226|NCT03131648|100651490|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
33205227|NCT03131648|100651491|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
33205228|NCT03131648|100651492|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
33205229|NCT03131648|100651493|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
33205230|NCT03131648|100651494|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
33205231|NCT03131648|100651495|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
33205232|NCT03131648|100651488|FG000|Maintenance Treatment Period|Completed Week 50|0|||
33205233|NCT03131648|100651489|FG001|Maintenance Treatment Period|Completed Week 50|0|||
33205234|NCT03131648|100651490|FG002|Maintenance Treatment Period|Completed Week 50|0|||
33404092|NCT01049360|101369418|FG016|Period 2|Withdrawal by Subject|0|||
33404093|NCT01049360|101369419|FG017|Period 2|Withdrawal by Subject|0|||
33530429|NCT00385918|101841727|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
33530430|NCT00385918|101841728|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
33530431|NCT00385918|101841729|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
33205235|NCT03131648|100651491|FG003|Maintenance Treatment Period|Completed Week 50|0|||
33205236|NCT03131648|100651492|FG004|Maintenance Treatment Period|Completed Week 50|1|||
33205237|NCT03131648|100651493|FG005|Maintenance Treatment Period|Completed Week 50|0|||
33205238|NCT03131648|100651494|FG006|Maintenance Treatment Period|Completed Week 50|0|||
33205239|NCT03131648|100651495|FG007|Maintenance Treatment Period|Completed Week 50|0|||
33205240|NCT03131648|100651488|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
33404094|NCT01049360|101369420|FG018|Period 2|Withdrawal by Subject|0|||
33205241|NCT03131648|100651489|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
33205242|NCT03131648|100651490|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
33205243|NCT03131648|100651491|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
33205244|NCT03131648|100651492|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
33205245|NCT03131648|100651493|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
33205246|NCT03131648|100651494|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
33205247|NCT03131648|100651495|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
33205248|NCT00856583|100651496|FG000|Overall Study|Lack of Efficacy|389|||
33205249|NCT00856583|100651497|FG001|Overall Study|Lack of Efficacy|377|||
33205250|NCT00856583|100651496|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
33205251|NCT00856583|100651497|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
33205252|NCT00856583|100651496|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
33205253|NCT00856583|100651497|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
33205254|NCT00856583|100651496|FG000|Overall Study|Non-compliance|305|||
33205255|NCT00856583|100651497|FG001|Overall Study|Non-compliance|262|||
33205256|NCT00856583|100651496|FG000|Overall Study|Withdrawal by Subject|1092|||
33205257|NCT00856583|100651497|FG001|Overall Study|Withdrawal by Subject|919|||
33205258|NCT00856583|100651496|FG000|Overall Study|Physician Decision|59|||
33205259|NCT00856583|100651497|FG001|Overall Study|Physician Decision|82|||
33205260|NCT00856583|100651496|FG000|Overall Study|Pregnancy|14|||
33205261|NCT00856583|100651497|FG001|Overall Study|Pregnancy|5|||
33205262|NCT00856583|100651496|FG000|Overall Study|Other|92|||
33205263|NCT00856583|100651497|FG001|Overall Study|Other|104|||
33205264|NCT00856583|100651496|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
33205265|NCT00856583|100651497|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
33205266|NCT04862143|100651505|FG000|Overall Study|Adverse Event|1|||
33205267|NCT04862143|100651505|FG000|Overall Study|Study terminated by sponsor|1|||
33205268|NCT02601313|100651508|FG000|Overall Study|Death|2|||
33205269|NCT02601313|100651509|FG001|Overall Study|Death|16|||
33205270|NCT02601313|100651510|FG002|Overall Study|Death|4|||
33205271|NCT02601313|100651508|FG000|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0|||
33205272|NCT02601313|100651509|FG001|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5|||
33205273|NCT02601313|100651510|FG002|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2|||
33205274|NCT02601313|100651508|FG000|Overall Study|Enrolled, did not initiate KTE-X19|0|||
33530432|NCT00385918|101841727|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
33205275|NCT02601313|100651509|FG001|Overall Study|Enrolled, did not initiate KTE-X19|1|||
33205276|NCT02601313|100651510|FG002|Overall Study|Enrolled, did not initiate KTE-X19|1|||
33205277|NCT02601313|100651508|FG000|Overall Study|Still on study|0|||
33205278|NCT02601313|100651509|FG001|Overall Study|Still on study|52|||
33205279|NCT02601313|100651510|FG002|Overall Study|Still on study|10|||
33205280|NCT02601313|100651508|FG000|Overall Study|Enrolled, did not initiate AC|4|||
33205281|NCT02601313|100651509|FG001|Overall Study|Enrolled, did not initiate AC|0|||
33205282|NCT02601313|100651510|FG002|Overall Study|Enrolled, did not initiate AC|0|||
33205283|NCT00254982|100651512|FG000|Overall Study|Other|2|||
33205284|NCT00254982|100651513|FG001|Overall Study|Other|1|||
33205285|NCT00254982|100651512|FG000|Overall Study|Lack of Efficacy|5|||
33205286|NCT00254982|100651513|FG001|Overall Study|Lack of Efficacy|3|||
33205287|NCT00254982|100651512|FG000|Overall Study|Lost to Follow-up|5|||
33205288|NCT00254982|100651513|FG001|Overall Study|Lost to Follow-up|3|||
33205289|NCT00254982|100651512|FG000|Overall Study|Adverse Event|18|||
33205290|NCT00254982|100651513|FG001|Overall Study|Adverse Event|16|||
33205291|NCT00254982|100651512|FG000|Overall Study|Withdrawal by Subject|1|||
33205292|NCT00254982|100651513|FG001|Overall Study|Withdrawal by Subject|1|||
33205293|NCT00254982|100651512|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
33205294|NCT00254982|100651513|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
33205295|NCT00254982|100651512|FG000|Overall Study|Protocol deviation|1|||
33205296|NCT00254982|100651513|FG001|Overall Study|Protocol deviation|1|||
33205297|NCT00254982|100651512|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
33205298|NCT00254982|100651513|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
33205299|NCT00254982|100651512|FG000|Overall Study|Malignancy|0|||
33205300|NCT00254982|100651513|FG001|Overall Study|Malignancy|2|||
33205301|NCT00254982|100651512|FG000|Overall Study|Opportunistic infection|1|||
33205302|NCT00254982|100651513|FG001|Overall Study|Opportunistic infection|0|||
33205303|NCT00254982|100651512|FG000|Overall Study|Abnormal liver function tests|2|||
33205304|NCT00254982|100651513|FG001|Overall Study|Abnormal liver function tests|1|||
33205305|NCT02528214|100651514|FG000|Overall Study|Protocol Violation|0|||
33205306|NCT02528214|100651515|FG001|Overall Study|Protocol Violation|1|||
33205307|NCT02528214|100651514|FG000|Overall Study|Adverse Event|0|||
33205308|NCT02528214|100651515|FG001|Overall Study|Adverse Event|1|||
33404095|NCT01049360|101369421|FG019|Period 2|Withdrawal by Subject|1|||
33530433|NCT00385918|101841728|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
33205309|NCT02528214|100651514|FG000|Overall Study|Other than specified above|0|||
33205310|NCT02528214|100651515|FG001|Overall Study|Other than specified above|1|||
33205311|NCT00970502|100651516|FG000|Overall Study|Withdrawal by Subject|1|||
33205312|NCT01197950|100651517|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
33205313|NCT01197950|100651518|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
33205314|NCT01197950|100651519|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
33205315|NCT02493361|100651520|FG000|Overall Study|Withdrawal by Subject|3|||
33205316|NCT04266028|100651521|FG000|Overall Study|Adverse Event|0|||
33205317|NCT04266028|100651522|FG001|Overall Study|Adverse Event|0|||
33205318|NCT04266028|100651523|FG002|Overall Study|Adverse Event|1|||
33205319|NCT04266028|100651524|FG003|Overall Study|Adverse Event|0|||
33205320|NCT04266028|100651525|FG004|Overall Study|Adverse Event|1|||
33205321|NCT04266028|100651526|FG005|Overall Study|Adverse Event|0|||
33205322|NCT04266028|100651527|FG006|Overall Study|Adverse Event|2|||
33205323|NCT04266028|100651528|FG007|Overall Study|Adverse Event|0|||
33205324|NCT04266028|100651521|FG000|Overall Study|temporary halt of the study|0|||
33205325|NCT04266028|100651522|FG001|Overall Study|temporary halt of the study|0|||
33205326|NCT04266028|100651523|FG002|Overall Study|temporary halt of the study|0|||
33205327|NCT04266028|100651524|FG003|Overall Study|temporary halt of the study|0|||
33205328|NCT04266028|100651525|FG004|Overall Study|temporary halt of the study|0|||
33205329|NCT04266028|100651526|FG005|Overall Study|temporary halt of the study|0|||
33205330|NCT04266028|100651527|FG006|Overall Study|temporary halt of the study|2|||
33205331|NCT04266028|100651528|FG007|Overall Study|temporary halt of the study|1|||
33205332|NCT04266028|100651521|FG000|Overall Study|Onset of birch pollen season|0|||
33205333|NCT04266028|100651522|FG001|Overall Study|Onset of birch pollen season|0|||
33205334|NCT04266028|100651523|FG002|Overall Study|Onset of birch pollen season|0|||
33205335|NCT04266028|100651524|FG003|Overall Study|Onset of birch pollen season|0|||
33205336|NCT04266028|100651525|FG004|Overall Study|Onset of birch pollen season|1|||
33205337|NCT04266028|100651526|FG005|Overall Study|Onset of birch pollen season|0|||
33205338|NCT04266028|100651527|FG006|Overall Study|Onset of birch pollen season|0|||
33404096|NCT01049360|101369402|FG000|Period 2|Lack of Efficacy|0|||
33404097|NCT01049360|101369403|FG001|Period 2|Lack of Efficacy|0|||
33404098|NCT01049360|101369404|FG002|Period 2|Lack of Efficacy|0|||
33404099|NCT01049360|101369405|FG003|Period 2|Lack of Efficacy|0|||
33404100|NCT01049360|101369406|FG004|Period 2|Lack of Efficacy|0|||
33404101|NCT01049360|101369407|FG005|Period 2|Lack of Efficacy|1|||
33530434|NCT00385918|101841729|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
33530435|NCT00385918|101841727|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
33530436|NCT00385918|101841728|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
33530437|NCT00385918|101841729|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
33530438|NCT00385918|101841727|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
33530439|NCT00385918|101841728|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
33530440|NCT00385918|101841729|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
33530441|NCT00385918|101841727|FG000|Intervention Phase After Randomization|Physician Decision|1|||
33530442|NCT00385918|101841728|FG001|Intervention Phase After Randomization|Physician Decision|0|||
33530443|NCT00385918|101841729|FG002|Intervention Phase After Randomization|Physician Decision|0|||
33530444|NCT00385918|101841727|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
33530445|NCT00385918|101841728|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
33530446|NCT00385918|101841729|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
33530447|NCT03284853|101841730|FG000|Overall Study|Adverse Event|40|||
33611530|NCT01793883|102126982|FG002|Overall Study|Subject noncompliance|1|||
33611531|NCT01793883|102126980|FG000|Overall Study|Lost to Follow-up|5|||
33611532|NCT01793883|102126981|FG001|Overall Study|Lost to Follow-up|1|||
33611533|NCT01793883|102126982|FG002|Overall Study|Lost to Follow-up|3|||
33611534|NCT01793883|102126980|FG000|Overall Study|Randomized in error|1|||
33611535|NCT01793883|102126981|FG001|Overall Study|Randomized in error|0|||
33611536|NCT01793883|102126982|FG002|Overall Study|Randomized in error|0|||
33611537|NCT01793883|102126980|FG000|Overall Study|Unable to complete spriometry|1|||
33611538|NCT01793883|102126981|FG001|Overall Study|Unable to complete spriometry|0|||
33611539|NCT01793883|102126982|FG002|Overall Study|Unable to complete spriometry|0|||
33611540|NCT01793883|102126980|FG000|Overall Study|Unable to complete measurements|1|||
33611541|NCT01793883|102126981|FG001|Overall Study|Unable to complete measurements|0|||
33611542|NCT01793883|102126982|FG002|Overall Study|Unable to complete measurements|0|||
33611543|NCT01793883|102126980|FG000|Overall Study|Met exclusion criteria|1|||
33611544|NCT01793883|102126981|FG001|Overall Study|Met exclusion criteria|0|||
33611545|NCT01793883|102126982|FG002|Overall Study|Met exclusion criteria|0|||
33611546|NCT01793883|102126980|FG000|Overall Study|Dosing error|0|||
33404102|NCT01049360|101369408|FG006|Period 2|Lack of Efficacy|0|||
33404103|NCT01049360|101369409|FG007|Period 2|Lack of Efficacy|0|||
33205339|NCT04266028|100651528|FG007|Overall Study|Onset of birch pollen season|0|||
33404104|NCT01049360|101369410|FG008|Period 2|Lack of Efficacy|0|||
33611547|NCT01793883|102126981|FG001|Overall Study|Dosing error|1|||
33611548|NCT01793883|102126982|FG002|Overall Study|Dosing error|0|||
33611549|NCT01793883|102126980|FG000|Overall Study|Respiratory distress during spirometry|0|||
33611550|NCT01793883|102126981|FG001|Overall Study|Respiratory distress during spirometry|0|||
33205340|NCT00506493|100651529|FG000|Overall Study|Death|6|||
33404105|NCT01049360|101369411|FG009|Period 2|Lack of Efficacy|0|||
33611551|NCT01793883|102126982|FG002|Overall Study|Respiratory distress during spirometry|1|||
33611552|NCT01628965|102126983|FG000|Overall Study|Adverse Event|30|||
33611553|NCT01628965|102126983|FG000|Overall Study|Lack of Efficacy|7|||
33611554|NCT01628965|102126983|FG000|Overall Study|Withdrawal by Subject|3|||
33611555|NCT01628965|102126983|FG000|Overall Study|Lost to Follow-up|1|||
33611556|NCT01628965|102126983|FG000|Overall Study|Discontinuation criteria|8|||
33611557|NCT01990612|102126984|FG000|Overall Study|Lost to Follow-up|2|||
33611558|NCT01990612|102126985|FG001|Overall Study|Lost to Follow-up|1|||
33611559|NCT01990612|102126984|FG000|Overall Study|Withdrawal by Subject|5|||
33611560|NCT01990612|102126985|FG001|Overall Study|Withdrawal by Subject|2|||
33611561|NCT01196416|102126986|FG000|Overall Study|Withdrawal by Subject|2|||
33611562|NCT02227199|102126989|FG000|Overall Study|Physician Decision|0|||
33611563|NCT02227199|102126990|FG001|Overall Study|Physician Decision|0|||
33611564|NCT02227199|102126991|FG002|Overall Study|Physician Decision|1|||
33611565|NCT02227199|102126989|FG000|Overall Study|Adverse Event|0|||
33611566|NCT02227199|102126990|FG001|Overall Study|Adverse Event|0|||
33611567|NCT02227199|102126991|FG002|Overall Study|Adverse Event|3|||
33611568|NCT00621140|102126995|FG000|Overall Study|Adverse Event|4|||
33611569|NCT00621140|102126996|FG001|Overall Study|Adverse Event|5|||
33611570|NCT00621140|102126995|FG000|Overall Study|Lost to Follow-up|1|||
33611571|NCT00621140|102126996|FG001|Overall Study|Lost to Follow-up|2|||
33611572|NCT00621140|102126995|FG000|Overall Study|Withdrawal by Subject|4|||
33611573|NCT00621140|102126996|FG001|Overall Study|Withdrawal by Subject|6|||
33611574|NCT00621140|102126995|FG000|Overall Study|Other incl. lack of efficacy|6|||
33611575|NCT00621140|102126996|FG001|Overall Study|Other incl. lack of efficacy|5|||
33611576|NCT04565951|102126997|FG000|Overall Study|Lost to Follow-up|66|||
33611577|NCT04565951|102126998|FG001|Overall Study|Lost to Follow-up|38|||
33611578|NCT04565951|102126997|FG000|Overall Study|Withdrawal by Subject|14|||
33611579|NCT04565951|102126998|FG001|Overall Study|Withdrawal by Subject|7|||
33611580|NCT04565951|102126997|FG000|Overall Study|Death|0|||
33611581|NCT04565951|102126998|FG001|Overall Study|Death|1|||
33611582|NCT00900029|102127005|FG000|Overall Study|Lost to Follow-up|0|||
33611583|NCT00900029|102127006|FG001|Overall Study|Lost to Follow-up|2|||
33611584|NCT00900029|102127007|FG002|Overall Study|Lost to Follow-up|1|||
33611585|NCT00900029|102127008|FG003|Overall Study|Lost to Follow-up|4|||
33336378|NCT00953758|101124502|FG007|Overall Study|Participant went for transplant|0|||
33336379|NCT00953758|101124503|FG008|Overall Study|Participant went for transplant|1|||
33336380|NCT00953758|101124504|FG009|Overall Study|Participant went for transplant|0|||
33336381|NCT02918864|101124505|FG000|Overall Study|Withdrawal by Subject|1|||
33336382|NCT02918864|101124506|FG001|Overall Study|Withdrawal by Subject|1|||
33530448|NCT03284853|101841731|FG001|Overall Study|Adverse Event|4|||
33530449|NCT03284853|101841730|FG000|Overall Study|Withdrawal by Subject|5|||
33336383|NCT02918864|101124505|FG000|Overall Study|Lost to Follow-up|3|||
33336384|NCT02918864|101124506|FG001|Overall Study|Lost to Follow-up|2|||
33336385|NCT03468855|101124507|FG000|Overall Study|Adverse Event|2|||
33336386|NCT03468855|101124507|FG000|Overall Study|Lost to Follow-up|5|||
33336387|NCT03468855|101124507|FG000|Overall Study|Withdrawal by Subject|3|||
33336388|NCT03468855|101124507|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
33336389|NCT03728309|101124508|FG000|Overall Study|Randomized but not Treated|0|||
33336390|NCT03728309|101124509|FG001|Overall Study|Randomized but not Treated|1|||
33336391|NCT03728309|101124508|FG000|Overall Study|Adverse Event|0|||
33336392|NCT03728309|101124509|FG001|Overall Study|Adverse Event|1|||
33530450|NCT03284853|101841731|FG001|Overall Study|Withdrawal by Subject|1|||
33530451|NCT03284853|101841730|FG000|Overall Study|Lost to Follow-up|1|||
33530452|NCT03284853|101841731|FG001|Overall Study|Lost to Follow-up|0|||
33530453|NCT03284853|101841730|FG000|Overall Study|Lack of Efficacy|1|||
33530454|NCT03284853|101841731|FG001|Overall Study|Lack of Efficacy|0|||
33530455|NCT03284853|101841730|FG000|Overall Study|Disallowed Concurrent Medication|1|||
33530456|NCT03284853|101841731|FG001|Overall Study|Disallowed Concurrent Medication|1|||
33530457|NCT03284853|101841730|FG000|Overall Study|Protocol Violation|3|||
33611586|NCT00900029|102127009|FG004|Overall Study|Lost to Follow-up|4|||
33611587|NCT00900029|102127005|FG000|Overall Study|Withdrawal by Subject|2|||
33611588|NCT00900029|102127006|FG001|Overall Study|Withdrawal by Subject|2|||
33336393|NCT03728309|101124508|FG000|Overall Study|Withdrawal by Subject|2|||
33336394|NCT03728309|101124509|FG001|Overall Study|Withdrawal by Subject|8|||
33336395|NCT03728309|101124508|FG000|Overall Study|Lost to Follow-up|9|||
33611589|NCT00900029|102127007|FG002|Overall Study|Withdrawal by Subject|1|||
33611590|NCT00900029|102127008|FG003|Overall Study|Withdrawal by Subject|1|||
33336396|NCT03728309|101124509|FG001|Overall Study|Lost to Follow-up|10|||
33530458|NCT03284853|101841731|FG001|Overall Study|Protocol Violation|3|||
33530459|NCT03284853|101841730|FG000|Overall Study|Death|0|||
33530460|NCT03284853|101841731|FG001|Overall Study|Death|1|||
33611591|NCT00900029|102127009|FG004|Overall Study|Withdrawal by Subject|1|||
33611592|NCT00900029|102127005|FG000|Overall Study|Adverse Event|0|||
33611593|NCT00900029|102127006|FG001|Overall Study|Adverse Event|0|||
33611594|NCT00900029|102127007|FG002|Overall Study|Adverse Event|1|||
33611595|NCT00900029|102127008|FG003|Overall Study|Adverse Event|1|||
33611596|NCT00900029|102127009|FG004|Overall Study|Adverse Event|1|||
33530461|NCT03284853|101841730|FG000|Overall Study|Other - Reason not reported in CSR|4|||
33530462|NCT03284853|101841731|FG001|Overall Study|Other - Reason not reported in CSR|3|||
33530463|NCT01676012|101841732|FG000|Overall Study|Adverse Event|2|||
33530464|NCT01676012|101841732|FG000|Overall Study|incomplete set of videos|1|||
33530465|NCT01938846|101841733|FG000|Overall Study|Progressive disease|26|||
33530466|NCT01938846|101841734|FG001|Overall Study|Progressive disease|18|||
33530467|NCT01938846|101841735|FG002|Overall Study|Progressive disease|16|||
33530468|NCT01938846|101841733|FG000|Overall Study|Adverse Event|8|||
33530469|NCT01938846|101841734|FG001|Overall Study|Adverse Event|4|||
33530470|NCT01938846|101841735|FG002|Overall Study|Adverse Event|3|||
33530471|NCT01938846|101841733|FG000|Overall Study|Withdrawal by Subject|2|||
33530472|NCT01938846|101841734|FG001|Overall Study|Withdrawal by Subject|2|||
33530473|NCT01938846|101841735|FG002|Overall Study|Withdrawal by Subject|1|||
33530474|NCT01938846|101841733|FG000|Overall Study|Other than listed|5|||
33530475|NCT01938846|101841734|FG001|Overall Study|Other than listed|1|||
33530476|NCT01938846|101841735|FG002|Overall Study|Other than listed|4|||
33611597|NCT00900029|102127005|FG000|Overall Study|Death|1|||
33611598|NCT00900029|102127006|FG001|Overall Study|Death|0|||
33611599|NCT00900029|102127007|FG002|Overall Study|Death|0|||
33611600|NCT00900029|102127008|FG003|Overall Study|Death|1|||
33611601|NCT00900029|102127009|FG004|Overall Study|Death|0|||
33611602|NCT04356352|102127010|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
33611603|NCT04356352|102127011|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
33611604|NCT04356352|102127012|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
33611605|NCT04356352|102127010|FG000|Overall Study|Protocol Violation|0|||
33611606|NCT04356352|102127011|FG001|Overall Study|Protocol Violation|3|||
33611607|NCT04356352|102127012|FG002|Overall Study|Protocol Violation|1|||
33611608|NCT01496846|102127017|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
33611609|NCT01496846|102127018|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
33611610|NCT01496846|102127019|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
33611611|NCT01496846|102127020|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
33611612|NCT01496846|102127021|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
33611613|NCT01496846|102127022|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
33611614|NCT01103063|102127023|FG000|Overall Study|Adverse Event|3|||
33611615|NCT01103063|102127024|FG001|Overall Study|Adverse Event|1|||
33611616|NCT01103063|102127023|FG000|Overall Study|Lost to Follow-up|68|||
33611617|NCT01103063|102127024|FG001|Overall Study|Lost to Follow-up|51|||
33611618|NCT01103063|102127023|FG000|Overall Study|Withdrawal by Subject|60|||
33611619|NCT01103063|102127024|FG001|Overall Study|Withdrawal by Subject|15|||
33611620|NCT01103063|102127023|FG000|Overall Study|Other|16|||
33611621|NCT01103063|102127024|FG001|Overall Study|Other|11|||
33611622|NCT01103063|102127023|FG000|Overall Study|Protocol Violation|1|||
33611623|NCT01103063|102127024|FG001|Overall Study|Protocol Violation|0|||
33611624|NCT01103063|102127023|FG000|Overall Study|Study terminated by Sponsor|326|||
33611625|NCT01103063|102127024|FG001|Overall Study|Study terminated by Sponsor|342|||
33611626|NCT01103063|102127023|FG000|Overall Study|Death|3|||
33611627|NCT01103063|102127024|FG001|Overall Study|Death|1|||
33611628|NCT00799591|102127025|FG000|Overall Study|De-escalation of doses|20|||
33611629|NCT00799591|102127025|FG000|Overall Study|Death|14|||
33611630|NCT00799591|102127025|FG000|Overall Study|Technical failure|12|||
33611631|NCT00799591|102127025|FG000|Overall Study|Resistant germ|11|||
33611632|NCT00799591|102127025|FG000|Overall Study|New infection|4|||
33611633|NCT00799591|102127025|FG000|Overall Study|Resistance germ and technical failure|2|||
33611634|NCT00799591|102127025|FG000|Overall Study|Persistance of fever undetermined origin|1|||
33611635|NCT00799591|102127025|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
33611636|NCT00799591|102127025|FG000|Overall Study|Infectious origin not probable|1|||
33611637|NCT02092025|102127030|FG000|Overall Study|Case Report Forms Uncollected|44|||
33611638|NCT02092025|102127030|FG000|Overall Study|Protocol Deviation|24|||
33611639|NCT01811186|102127031|FG000|Overall Study|Adverse Event|54|||
33611640|NCT01811186|102127032|FG001|Overall Study|Adverse Event|38|||
33611641|NCT01811186|102127031|FG000|Overall Study|Protocol Violation|5|||
33611642|NCT01811186|102127032|FG001|Overall Study|Protocol Violation|6|||
33611643|NCT01811186|102127031|FG000|Overall Study|Withdrawal by Subject|5|||
33611644|NCT01811186|102127032|FG001|Overall Study|Withdrawal by Subject|10|||
33530477|NCT03360019|101841736|FG000|Overall Study|Withdrawal by Subject|2|||
33530478|NCT03360019|101841737|FG001|Overall Study|Withdrawal by Subject|0|||
33530479|NCT03360019|101841738|FG002|Overall Study|Withdrawal by Subject|0|||
33611645|NCT01811186|102127031|FG000|Overall Study|Lack of Efficacy|3|||
33611646|NCT01811186|102127032|FG001|Overall Study|Lack of Efficacy|6|||
33611647|NCT01811186|102127031|FG000|Overall Study|Lost to Follow-up|4|||
33611648|NCT01811186|102127032|FG001|Overall Study|Lost to Follow-up|2|||
33611649|NCT02577016|102127033|FG000|Overall Study|Adverse Event|2|||
33611650|NCT02577016|102127034|FG001|Overall Study|Adverse Event|1|||
33404106|NCT01049360|101369412|FG010|Period 2|Lack of Efficacy|0|||
33336397|NCT03728309|101124508|FG000|Overall Study|Protocol Deviation|0|||
33336398|NCT03728309|101124509|FG001|Overall Study|Protocol Deviation|1|||
33336399|NCT03728309|101124508|FG000|Overall Study|Due to COVID|1|||
33336400|NCT03728309|101124509|FG001|Overall Study|Due to COVID|3|||
33336401|NCT01180660|101124510|FG000|Overall Study|Changed to open surgery|1|||
33336402|NCT01180660|101124511|FG001|Overall Study|Changed to open surgery|0|||
33336403|NCT02436876|101124512|FG000|Overall Study|Lost to Follow-up|0|||
33336404|NCT02436876|101124513|FG001|Overall Study|Lost to Follow-up|1|||
33336405|NCT02436876|101124514|FG002|Overall Study|Lost to Follow-up|1|||
33336406|NCT02436876|101124515|FG003|Overall Study|Lost to Follow-up|1|||
33336407|NCT02436876|101124512|FG000|Overall Study|Withdrawal by Subject|1|||
33336408|NCT02436876|101124513|FG001|Overall Study|Withdrawal by Subject|0|||
33336409|NCT02436876|101124514|FG002|Overall Study|Withdrawal by Subject|0|||
33336410|NCT02436876|101124515|FG003|Overall Study|Withdrawal by Subject|1|||
33336411|NCT02436876|101124512|FG000|Overall Study|Physician Decision|0|||
33336412|NCT02436876|101124513|FG001|Overall Study|Physician Decision|2|||
33336413|NCT02436876|101124514|FG002|Overall Study|Physician Decision|1|||
33336414|NCT02436876|101124515|FG003|Overall Study|Physician Decision|0|||
33336415|NCT02436876|101124512|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
33336416|NCT02436876|101124513|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
33336417|NCT02436876|101124514|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
33336418|NCT02436876|101124515|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
33336419|NCT00820898|101124516|FG000|Overall Study|Inelgible - wrong primary site|1|||
33336420|NCT00971945|101124518|FG000|Overall Study|Progressive Disease|3|||
33336421|NCT00971945|101124518|FG000|Overall Study|Change in treatment policy|1|||
33336422|NCT00971945|101124518|FG000|Overall Study|Other reasons|2|||
33336423|NCT00661531|101124519|FG000|Overall Study|Withdrawal by Subject|3|||
33336424|NCT02695628|101124520|FG000|Overall Study|Withdrawal by Subject|1|||
33336425|NCT02187471|101124522|FG000|Overall Study|Protocol Violation|4|||
33336426|NCT02187471|101124523|FG001|Overall Study|Protocol Violation|5|||
33336427|NCT02187471|101124524|FG002|Overall Study|Protocol Violation|4|||
33336428|NCT02187471|101124525|FG003|Overall Study|Protocol Violation|4|||
33336429|NCT02187471|101124522|FG000|Overall Study|Missing|0|||
33336430|NCT02187471|101124523|FG001|Overall Study|Missing|0|||
33336431|NCT02187471|101124524|FG002|Overall Study|Missing|0|||
33336432|NCT02187471|101124525|FG003|Overall Study|Missing|1|||
33336433|NCT02187471|101124522|FG000|Overall Study|Lack of Efficacy|18|||
33336434|NCT02187471|101124523|FG001|Overall Study|Lack of Efficacy|9|||
33336435|NCT02187471|101124524|FG002|Overall Study|Lack of Efficacy|13|||
33336436|NCT02187471|101124525|FG003|Overall Study|Lack of Efficacy|11|||
33336437|NCT02187471|101124522|FG000|Overall Study|Adverse Event|24|||
33336438|NCT02187471|101124523|FG001|Overall Study|Adverse Event|34|||
33336439|NCT02187471|101124524|FG002|Overall Study|Adverse Event|44|||
33336440|NCT02187471|101124525|FG003|Overall Study|Adverse Event|36|||
33336441|NCT02187471|101124522|FG000|Overall Study|Withdrawal by Subject|23|||
33336442|NCT02187471|101124523|FG001|Overall Study|Withdrawal by Subject|29|||
33336443|NCT02187471|101124524|FG002|Overall Study|Withdrawal by Subject|22|||
33336444|NCT02187471|101124525|FG003|Overall Study|Withdrawal by Subject|24|||
33336445|NCT02187471|101124522|FG000|Overall Study|Other|7|||
33336446|NCT02187471|101124523|FG001|Overall Study|Other|5|||
33611651|NCT02577016|102127033|FG000|Overall Study|Physician Decision|0|||
33611652|NCT02577016|102127034|FG001|Overall Study|Physician Decision|1|||
33611653|NCT02207491|102127037|FG000|Overall Study|Adverse Event|20|||
33611654|NCT02207491|102127038|FG001|Overall Study|Adverse Event|4|||
33611655|NCT02207491|102127037|FG000|Overall Study|Withdrawal by Subject|3|||
33611656|NCT02207491|102127038|FG001|Overall Study|Withdrawal by Subject|2|||
33611657|NCT02207491|102127037|FG000|Overall Study|Non-compliant|0|||
33611658|NCT02207491|102127038|FG001|Overall Study|Non-compliant|1|||
33611659|NCT02207491|102127037|FG000|Overall Study|Lost to Follow-up|0|||
33611660|NCT02207491|102127038|FG001|Overall Study|Lost to Follow-up|1|||
33336447|NCT02187471|101124524|FG002|Overall Study|Other|3|||
33336448|NCT02187471|101124525|FG003|Overall Study|Other|4|||
33336449|NCT01594853|101124526|FG000|Overall Study|Withdrawal by Subject|1|||
33336450|NCT01594853|101124527|FG001|Overall Study|Withdrawal by Subject|1|||
33336451|NCT01594853|101124526|FG000|Overall Study|Lost to Follow-up|1|||
33336452|NCT01594853|101124527|FG001|Overall Study|Lost to Follow-up|1|||
33336453|NCT01594853|101124526|FG000|Overall Study|noncompliance with exercise|0|||
33336454|NCT01594853|101124527|FG001|Overall Study|noncompliance with exercise|1|||
33336455|NCT03699007|101124528|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
33336456|NCT03699007|101124529|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
33404107|NCT01049360|101369413|FG011|Period 2|Lack of Efficacy|0|||
33611661|NCT02207491|102127037|FG000|Overall Study|Lack of Efficacy|3|||
33611662|NCT02207491|102127038|FG001|Overall Study|Lack of Efficacy|0|||
33336457|NCT03699007|101124528|FG000|6-month Follow Up|Lost to Follow-up|2|||
33611663|NCT02207491|102127037|FG000|Overall Study|Physician Decision|2|||
33611664|NCT02207491|102127038|FG001|Overall Study|Physician Decision|0|||
33530480|NCT03360019|101841736|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
33530481|NCT03360019|101841737|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
33530482|NCT03360019|101841738|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
33530483|NCT02372383|101841739|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
33530484|NCT02372383|101841740|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
33530485|NCT02372383|101841741|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
33530486|NCT03727841|101841743|FG000|Overall Study|Physician Decision|3|||
33530487|NCT03727841|101841744|FG001|Overall Study|Physician Decision|1|||
33530488|NCT00807365|101841745|FG000|Overall Study|Study Terminated|5|||
33530489|NCT02824224|101841746|FG000|Overall Study|Discontinued, IUS expulsion|0|||
33530490|NCT02824224|101841747|FG001|Overall Study|Discontinued, IUS expulsion|1|||
33530491|NCT02824224|101841746|FG000|Overall Study|Did not show up for allocation visit|2|||
33530492|NCT02824224|101841747|FG001|Overall Study|Did not show up for allocation visit|0|||
33530493|NCT00357877|101841748|FG000|Overall Study|Death|2|||
33530494|NCT00357877|101841749|FG001|Overall Study|Death|1|||
33530495|NCT00357877|101841748|FG000|Overall Study|Lost to Follow-up|20|||
33530496|NCT00357877|101841749|FG001|Overall Study|Lost to Follow-up|23|||
33530497|NCT00357877|101841748|FG000|Overall Study|Withdrawal by Subject|3|||
33530498|NCT00357877|101841749|FG001|Overall Study|Withdrawal by Subject|3|||
33530499|NCT00357877|101841748|FG000|Overall Study|Administrative withdrawal|1|||
33530500|NCT00357877|101841749|FG001|Overall Study|Administrative withdrawal|1|||
33530501|NCT00357877|101841748|FG000|Overall Study|Other|0|||
33530502|NCT00357877|101841749|FG001|Overall Study|Other|2|||
33530503|NCT02532257|101841755|FG000|Overall Study|Adverse Event|2|||
33530504|NCT02532257|101841755|FG000|Overall Study|Physician Decision|4|||
33530505|NCT02532257|101841755|FG000|Overall Study|Withdrawal by Subject|3|||
33530506|NCT02532257|101841755|FG000|Overall Study|Progressive Disease|10|||
33530507|NCT02299388|101841756|FG000|Overall Study|Withdrawal by Subject|0|||
33530508|NCT02299388|101841757|FG001|Overall Study|Withdrawal by Subject|1|||
33530509|NCT01265394|101841760|FG000|Overall Study|Subjects withdrawn|37|||
33530510|NCT02370511|101841761|FG000|Overall Study|Death|10|||
33530511|NCT02370511|101841762|FG001|Overall Study|Death|7|||
33530512|NCT02370511|101841763|FG002|Overall Study|Death|1|||
33530513|NCT02370511|101841761|FG000|Overall Study|Withdrawal by Subject|2|||
33530514|NCT02370511|101841762|FG001|Overall Study|Withdrawal by Subject|0|||
33530515|NCT02370511|101841763|FG002|Overall Study|Withdrawal by Subject|0|||
33530516|NCT02370511|101841761|FG000|Overall Study|Lost to Follow-up|0|||
33530517|NCT02370511|101841762|FG001|Overall Study|Lost to Follow-up|4|||
33530518|NCT02370511|101841763|FG002|Overall Study|Lost to Follow-up|0|||
33530519|NCT02576977|101841764|FG000|Overall Study|Adverse Event|13|||
33530520|NCT02576977|101841765|FG001|Overall Study|Adverse Event|2|||
33530521|NCT02576977|101841764|FG000|Overall Study|Death|73|||
33530522|NCT02576977|101841765|FG001|Overall Study|Death|60|||
33530523|NCT02576977|101841764|FG000|Overall Study|Screen failure|1|||
33530524|NCT02576977|101841765|FG001|Overall Study|Screen failure|0|||
33530525|NCT02576977|101841764|FG000|Overall Study|Study Terminated at Selected Sites|27|||
33530526|NCT02576977|101841765|FG001|Overall Study|Study Terminated at Selected Sites|50|||
33530527|NCT02576977|101841764|FG000|Overall Study|Withdrawal by Subject|11|||
33530528|NCT02576977|101841765|FG001|Overall Study|Withdrawal by Subject|11|||
33530529|NCT02576977|101841764|FG000|Overall Study|Final Disposition Unknown|0|||
33530530|NCT02576977|101841765|FG001|Overall Study|Final Disposition Unknown|1|||
33530531|NCT02576977|101841764|FG000|Overall Study|Lost to Follow-up|1|||
33530532|NCT02576977|101841765|FG001|Overall Study|Lost to Follow-up|0|||
33530533|NCT02576977|101841764|FG000|Overall Study|Progressive Disease|0|||
33530534|NCT02576977|101841765|FG001|Overall Study|Progressive Disease|1|||
33530535|NCT00673257|101841766|FG000|Overall Study|Withdrawal by Subject|4|||
33530536|NCT00673257|101841766|FG000|Overall Study|Unable to obtain specimen|1|||
33530537|NCT01673178|101841767|FG000|Overall Study|Lost to Follow-up|0|||
33530538|NCT01673178|101841768|FG001|Overall Study|Lost to Follow-up|1|||
33530539|NCT01673178|101841769|FG002|Overall Study|Lost to Follow-up|0|||
33530540|NCT01673178|101841770|FG003|Overall Study|Lost to Follow-up|0|||
33530541|NCT01673178|101841771|FG004|Overall Study|Lost to Follow-up|0|||
33530542|NCT01673178|101841767|FG000|Overall Study|Withdrawal by Subject|0|||
33530543|NCT01673178|101841768|FG001|Overall Study|Withdrawal by Subject|0|||
33530544|NCT01673178|101841769|FG002|Overall Study|Withdrawal by Subject|1|||
33530545|NCT01673178|101841770|FG003|Overall Study|Withdrawal by Subject|4|||
33530546|NCT01673178|101841771|FG004|Overall Study|Withdrawal by Subject|2|||
33530547|NCT01673178|101841767|FG000|Overall Study|Protocol Violation|1|||
33530548|NCT01673178|101841768|FG001|Overall Study|Protocol Violation|1|||
33530549|NCT01673178|101841769|FG002|Overall Study|Protocol Violation|0|||
33530550|NCT01673178|101841770|FG003|Overall Study|Protocol Violation|1|||
33530551|NCT01673178|101841771|FG004|Overall Study|Protocol Violation|0|||
33530552|NCT01673178|101841767|FG000|Overall Study|Adverse Event|1|||
33530553|NCT01673178|101841768|FG001|Overall Study|Adverse Event|0|||
33530554|NCT01673178|101841769|FG002|Overall Study|Adverse Event|0|||
33611665|NCT02207491|102127037|FG000|Overall Study|Protocol Violation|3|||
33611666|NCT02207491|102127038|FG001|Overall Study|Protocol Violation|5|||
33611667|NCT01887353|102127039|FG000|Overall Study|Study stopped early|4|||
33611668|NCT01887353|102127040|FG001|Overall Study|Study stopped early|3|||
33611669|NCT01266590|102127041|FG000|Overall Study|Adverse Event|3|||
33611670|NCT01266590|102127041|FG000|Overall Study|Lost to Follow-up|1|||
33611671|NCT01266590|102127041|FG000|Overall Study|Withdrawal by Subject|1|||
33611672|NCT01266590|102127041|FG000|Overall Study|Physician Decision|1|||
33611673|NCT01846741|102127042|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
33611674|NCT01673620|102127043|FG000|Overall Study|Adverse Event|1|||
33611675|NCT01673620|102127044|FG001|Overall Study|Adverse Event|0|||
33611676|NCT02713828|102127050|FG000|Overall Study|Death|2|||
33611677|NCT02713828|102127051|FG001|Overall Study|Death|0|||
33611678|NCT02713828|102127050|FG000|Overall Study|Withdrawal by Subject|1|||
33611679|NCT02713828|102127051|FG001|Overall Study|Withdrawal by Subject|0|||
33611680|NCT02713828|102127050|FG000|Overall Study|study terminated but patient allowed to|2|||
33611681|NCT02713828|102127051|FG001|Overall Study|study terminated but patient allowed to|0|||
33611682|NCT04371666|102127053|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
33611683|NCT04371666|102127054|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
33611684|NCT04371666|102127053|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
33611685|NCT04371666|102127054|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
33611686|NCT04371666|102127053|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
33611687|NCT04371666|102127054|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
33611688|NCT04371666|102127053|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
33611689|NCT04371666|102127054|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
33611690|NCT04371666|102127053|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
33611691|NCT04371666|102127054|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
33611692|NCT04371666|102127053|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
33611693|NCT04371666|102127054|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
33611694|NCT02241343|102127055|FG000|Overall Study|Adverse Event|1|||
33611695|NCT00410605|102127056|FG000|Overall Study|Adverse Event|12|||
33611696|NCT00410605|102127056|FG000|Overall Study|Physician Decision|3|||
33611697|NCT00410605|102127056|FG000|Overall Study|Withdrawal by Subject|5|||
33611698|NCT00410605|102127056|FG000|Overall Study|Started Non-Protocol Therapy|3|||
33611699|NCT00410605|102127056|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
33611700|NCT00410605|102127056|FG000|Overall Study|Transferred to another Institution|1|||
33611701|NCT03691571|102127057|FG000|Overall Study|Withdrawal by Subject|9|||
33611702|NCT03691571|102127058|FG001|Overall Study|Withdrawal by Subject|2|||
33611703|NCT00151476|102127063|FG000|FAP Identified Subjects|Protocol Violation|0|||
33611704|NCT00151476|102127064|FG001|FAP Identified Subjects|Protocol Violation|1|||
33611705|NCT00151476|102127063|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
33611706|NCT00151476|102127064|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
33611707|NCT00151476|102127063|FG000|FAP Analyzed Subjects|Other study participation|0|||
33611708|NCT00151476|102127064|FG001|FAP Analyzed Subjects|Other study participation|1|||
33611709|NCT01677858|102127066|FG000|Overall Study|Adverse Event|0|||
33611710|NCT01677858|102127067|FG001|Overall Study|Adverse Event|0|||
33611711|NCT01677858|102127068|FG002|Overall Study|Adverse Event|2|||
33611712|NCT01677858|102127069|FG003|Overall Study|Adverse Event|3|||
33611713|NCT01677858|102127070|FG004|Overall Study|Adverse Event|13|||
33611714|NCT01677858|102127066|FG000|Overall Study|Death|0|||
33611715|NCT01677858|102127067|FG001|Overall Study|Death|0|||
33611716|NCT01677858|102127068|FG002|Overall Study|Death|0|||
33611717|NCT01677858|102127069|FG003|Overall Study|Death|0|||
33611718|NCT01677858|102127070|FG004|Overall Study|Death|1|||
33611719|NCT01677858|102127066|FG000|Overall Study|Physician Decision|1|||
33611720|NCT01677858|102127067|FG001|Overall Study|Physician Decision|0|||
33611721|NCT01677858|102127068|FG002|Overall Study|Physician Decision|2|||
33611722|NCT01677858|102127069|FG003|Overall Study|Physician Decision|0|||
33611723|NCT01677858|102127070|FG004|Overall Study|Physician Decision|12|||
33611724|NCT01677858|102127066|FG000|Overall Study|Progressive Disease|2|||
33611725|NCT01677858|102127067|FG001|Overall Study|Progressive Disease|1|||
33404108|NCT01049360|101369414|FG012|Period 2|Lack of Efficacy|0|||
33205341|NCT00506493|100651529|FG000|Overall Study|Withdrawal by Subject|5|||
33404109|NCT01049360|101369415|FG013|Period 2|Lack of Efficacy|0|||
33611726|NCT01677858|102127068|FG002|Overall Study|Progressive Disease|9|||
33404110|NCT01049360|101369416|FG014|Period 2|Lack of Efficacy|0|||
33611727|NCT01677858|102127069|FG003|Overall Study|Progressive Disease|3|||
33611728|NCT01677858|102127070|FG004|Overall Study|Progressive Disease|43|||
33611729|NCT01677858|102127066|FG000|Overall Study|Withdrawal by Subject|0|||
33611730|NCT01677858|102127067|FG001|Overall Study|Withdrawal by Subject|1|||
33611731|NCT01677858|102127068|FG002|Overall Study|Withdrawal by Subject|1|||
33611732|NCT01677858|102127069|FG003|Overall Study|Withdrawal by Subject|0|||
33611733|NCT01677858|102127070|FG004|Overall Study|Withdrawal by Subject|15|||
33404111|NCT01049360|101369417|FG015|Period 2|Lack of Efficacy|0|||
33611734|NCT01677858|102127066|FG000|Overall Study|Lost to Follow-up|0|||
33611735|NCT01677858|102127067|FG001|Overall Study|Lost to Follow-up|0|||
33611736|NCT01677858|102127068|FG002|Overall Study|Lost to Follow-up|0|||
33611737|NCT01677858|102127069|FG003|Overall Study|Lost to Follow-up|0|||
33611738|NCT01677858|102127070|FG004|Overall Study|Lost to Follow-up|1|||
33611739|NCT00387725|102127071|FG000|Overall Study|Adverse Event|0|||
33611740|NCT00387725|102127072|FG001|Overall Study|Adverse Event|0|||
33611741|NCT00387725|102127073|FG002|Overall Study|Adverse Event|0|||
33611742|NCT00387725|102127074|FG003|Overall Study|Adverse Event|1|||
33611743|NCT00387725|102127071|FG000|Overall Study|Protocol Violation|0|||
33611744|NCT00387725|102127072|FG001|Overall Study|Protocol Violation|1|||
33611745|NCT00387725|102127073|FG002|Overall Study|Protocol Violation|0|||
33611746|NCT00387725|102127074|FG003|Overall Study|Protocol Violation|0|||
33611747|NCT00387725|102127071|FG000|Overall Study|Withdrawal by Subject|1|||
33611748|NCT00387725|102127072|FG001|Overall Study|Withdrawal by Subject|0|||
33611749|NCT00387725|102127073|FG002|Overall Study|Withdrawal by Subject|1|||
33404112|NCT01049360|101369418|FG016|Period 2|Lack of Efficacy|0|||
33404113|NCT01049360|101369419|FG017|Period 2|Lack of Efficacy|0|||
33404114|NCT01049360|101369420|FG018|Period 2|Lack of Efficacy|0|||
33404115|NCT01049360|101369421|FG019|Period 2|Lack of Efficacy|0|||
33404116|NCT01049360|101369402|FG000|Period 4|Protocol Violation|0|||
33404117|NCT01049360|101369403|FG001|Period 4|Protocol Violation|0|||
33404118|NCT01049360|101369404|FG002|Period 4|Protocol Violation|0|||
33404119|NCT01049360|101369405|FG003|Period 4|Protocol Violation|0|||
33404120|NCT01049360|101369406|FG004|Period 4|Protocol Violation|0|||
33404121|NCT01049360|101369407|FG005|Period 4|Protocol Violation|0|||
33404122|NCT01049360|101369408|FG006|Period 4|Protocol Violation|0|||
33530555|NCT01673178|101841770|FG003|Overall Study|Adverse Event|2|||
33530556|NCT01673178|101841771|FG004|Overall Study|Adverse Event|0|||
33530557|NCT01673178|101841767|FG000|Overall Study|Other|1|||
33530558|NCT01673178|101841768|FG001|Overall Study|Other|0|||
33530559|NCT01673178|101841769|FG002|Overall Study|Other|2|||
33530560|NCT01673178|101841770|FG003|Overall Study|Other|1|||
33530561|NCT01673178|101841771|FG004|Overall Study|Other|0|||
33530562|NCT00837967|101841772|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
33530563|NCT00837967|101841773|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
33530564|NCT04110314|101841774|FG000|Overall Study|Did not meet inclusion criteria|35255|||
33530565|NCT04110314|101841775|FG001|Overall Study|Did not meet inclusion criteria|35104|||
33530566|NCT04110314|101841776|FG002|Overall Study|Did not meet inclusion criteria|35636|||
33530567|NCT04110314|101841777|FG003|Overall Study|Did not meet inclusion criteria|35135|||
33530568|NCT04110314|101841778|FG004|Overall Study|Did not meet inclusion criteria|35247|||
33530569|NCT04110314|101841779|FG005|Overall Study|Did not meet inclusion criteria|35727|||
33530570|NCT02227784|101841780|FG000|Double-Blind Phase|Adverse Event|3|||
33530571|NCT02227784|101841781|FG001|Double-Blind Phase|Adverse Event|2|||
33530572|NCT02227784|101841782|FG002|Double-Blind Phase|Adverse Event|1|||
33530573|NCT02227784|101841783|FG003|Double-Blind Phase|Adverse Event|3|||
33530574|NCT02227784|101841784|FG004|Double-Blind Phase|Adverse Event|0|||
33530575|NCT02227784|101841780|FG000|Double-Blind Phase|Physician Decision|1|||
33530576|NCT02227784|101841781|FG001|Double-Blind Phase|Physician Decision|0|||
33530577|NCT02227784|101841782|FG002|Double-Blind Phase|Physician Decision|0|||
33530578|NCT02227784|101841783|FG003|Double-Blind Phase|Physician Decision|1|||
33530579|NCT02227784|101841784|FG004|Double-Blind Phase|Physician Decision|0|||
33530580|NCT02227784|101841780|FG000|Double-Blind Phase|Protocol Violation|0|||
33530581|NCT02227784|101841781|FG001|Double-Blind Phase|Protocol Violation|0|||
33530582|NCT02227784|101841782|FG002|Double-Blind Phase|Protocol Violation|1|||
33530583|NCT02227784|101841783|FG003|Double-Blind Phase|Protocol Violation|1|||
33530584|NCT02227784|101841784|FG004|Double-Blind Phase|Protocol Violation|0|||
33530585|NCT02227784|101841780|FG000|Double-Blind Phase|Sponsor Decision|34|||
33530586|NCT02227784|101841781|FG001|Double-Blind Phase|Sponsor Decision|15|||
33530587|NCT02227784|101841782|FG002|Double-Blind Phase|Sponsor Decision|14|||
33530588|NCT02227784|101841783|FG003|Double-Blind Phase|Sponsor Decision|32|||
33530589|NCT02227784|101841784|FG004|Double-Blind Phase|Sponsor Decision|0|||
33530590|NCT02227784|101841780|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
33530591|NCT02227784|101841781|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
33611750|NCT00387725|102127074|FG003|Overall Study|Withdrawal by Subject|0|||
33611751|NCT00387725|102127071|FG000|Overall Study|Parent/legal guardian request|0|||
33611752|NCT00387725|102127072|FG001|Overall Study|Parent/legal guardian request|0|||
33530592|NCT02227784|101841782|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
33611753|NCT00387725|102127073|FG002|Overall Study|Parent/legal guardian request|1|||
33611754|NCT00387725|102127074|FG003|Overall Study|Parent/legal guardian request|1|||
33611755|NCT04667104|102127075|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
33611756|NCT04667104|102127076|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
33611757|NCT04667104|102127077|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
33404123|NCT01049360|101369409|FG007|Period 4|Protocol Violation|0|||
33404124|NCT01049360|101369410|FG008|Period 4|Protocol Violation|0|||
33404125|NCT01049360|101369411|FG009|Period 4|Protocol Violation|0|||
33404126|NCT01049360|101369412|FG010|Period 4|Protocol Violation|0|||
33404127|NCT01049360|101369413|FG011|Period 4|Protocol Violation|0|||
33404128|NCT01049360|101369414|FG012|Period 4|Protocol Violation|0|||
33404129|NCT01049360|101369415|FG013|Period 4|Protocol Violation|0|||
33404130|NCT01049360|101369416|FG014|Period 4|Protocol Violation|0|||
33404131|NCT01049360|101369417|FG015|Period 4|Protocol Violation|0|||
33404132|NCT01049360|101369418|FG016|Period 4|Protocol Violation|0|||
33530593|NCT02227784|101841783|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
33530594|NCT02227784|101841784|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
33530595|NCT02227784|101841780|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
33530596|NCT02227784|101841781|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
33205342|NCT01610700|100651530|FG000|Overall Study|Adverse Event|3|||
33205343|NCT01610700|100651531|FG001|Overall Study|Adverse Event|1|||
33205344|NCT01610700|100651530|FG000|Overall Study|Withdrawal by Subject|0|||
33205345|NCT01610700|100651531|FG001|Overall Study|Withdrawal by Subject|1|||
33205346|NCT01610700|100651530|FG000|Overall Study|subject took one dose of street cannabis|0|||
33205347|NCT01610700|100651531|FG001|Overall Study|subject took one dose of street cannabis|1|||
33530597|NCT02227784|101841782|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
33530598|NCT02227784|101841783|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
33530599|NCT02227784|101841784|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
33530600|NCT02227784|101841780|FG000|Open-Label Extension Phase (OLE)|Death|0|||
33336458|NCT03699007|101124529|FG001|6-month Follow Up|Lost to Follow-up|3|||
33336459|NCT04951037|101124530|FG000|Overall Study|Lost to Follow-up|16|||
33336460|NCT04951037|101124530|FG000|Overall Study|Withdrawal by Subject|5|||
33336461|NCT04951037|101124530|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
33336462|NCT00783094|101124537|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
33336463|NCT00783094|101124538|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
33336464|NCT00783094|101124539|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
33336465|NCT00783094|101124537|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
33336466|NCT00783094|101124538|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
33336467|NCT00783094|101124539|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
33530601|NCT02227784|101841781|FG001|Open-Label Extension Phase (OLE)|Death|0|||
33530602|NCT02227784|101841782|FG002|Open-Label Extension Phase (OLE)|Death|0|||
33530603|NCT02227784|101841783|FG003|Open-Label Extension Phase (OLE)|Death|0|||
33530604|NCT02227784|101841784|FG004|Open-Label Extension Phase (OLE)|Death|1|||
33530605|NCT02227784|101841780|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
33530606|NCT02227784|101841781|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
33530607|NCT02227784|101841782|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
33530608|NCT02227784|101841783|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
33530609|NCT02227784|101841784|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
33205348|NCT01490632|100651532|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
33530610|NCT02227784|101841780|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
33530611|NCT02227784|101841781|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
33530612|NCT02227784|101841782|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
33530613|NCT02227784|101841783|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
33530614|NCT02227784|101841784|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
33530615|NCT00810069|101841790|FG000|Lead-in Period I|Adverse Event|43|||
33530616|NCT00810069|101841791|FG001|Lead-in Period I|Adverse Event|0|||
33530617|NCT00810069|101841792|FG002|Lead-in Period I|Adverse Event|0|||
33530618|NCT00810069|101841790|FG000|Lead-in Period I|Lack of Efficacy|1|||
33530619|NCT00810069|101841791|FG001|Lead-in Period I|Lack of Efficacy|0|||
33530620|NCT00810069|101841792|FG002|Lead-in Period I|Lack of Efficacy|0|||
33530621|NCT00810069|101841790|FG000|Lead-in Period I|Lost to Follow-up|19|||
33530622|NCT00810069|101841791|FG001|Lead-in Period I|Lost to Follow-up|0|||
33530623|NCT00810069|101841792|FG002|Lead-in Period I|Lost to Follow-up|0|||
33530624|NCT00810069|101841790|FG000|Lead-in Period I|Physician Decision|1|||
33530625|NCT00810069|101841791|FG001|Lead-in Period I|Physician Decision|0|||
33530626|NCT00810069|101841792|FG002|Lead-in Period I|Physician Decision|0|||
33530627|NCT00810069|101841790|FG000|Lead-in Period I|Protocol Violation|1|||
33530628|NCT00810069|101841791|FG001|Lead-in Period I|Protocol Violation|0|||
33530629|NCT00810069|101841792|FG002|Lead-in Period I|Protocol Violation|0|||
33530630|NCT00810069|101841790|FG000|Lead-in Period I|Withdrawal by Subject|46|||
33205349|NCT01490632|100651533|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
33205350|NCT01490632|100651534|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
33336468|NCT00783094|101124537|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
33336469|NCT00783094|101124538|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
33336470|NCT00783094|101124539|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
33336471|NCT00783094|101124537|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
33336472|NCT00783094|101124538|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
33404133|NCT01049360|101369419|FG017|Period 4|Protocol Violation|1|||
33404134|NCT01049360|101369420|FG018|Period 4|Protocol Violation|0|||
33530631|NCT00810069|101841791|FG001|Lead-in Period I|Withdrawal by Subject|0|||
33530632|NCT00810069|101841792|FG002|Lead-in Period I|Withdrawal by Subject|0|||
33530633|NCT00810069|101841790|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
33611758|NCT00761527|102127078|FG000|Overall Study|Adverse Event|3|||
33611759|NCT00761527|102127078|FG000|Overall Study|Poor Compliance|8|||
33611760|NCT00761527|102127078|FG000|Overall Study|Lost to Follow-up|9|||
33611761|NCT00761527|102127078|FG000|Overall Study|Unknown reason|2|||
33611762|NCT02783599|102127079|FG000|Overall Study|Progressive disease|23|||
33611763|NCT02783599|102127079|FG000|Overall Study|Surgical Resection|10|||
33611764|NCT02783599|102127079|FG000|Overall Study|Adverse Event|4|||
33611765|NCT02783599|102127079|FG000|Overall Study|Physician Decision|2|||
33611766|NCT02783599|102127079|FG000|Overall Study|Death|1|||
33611767|NCT02396589|102127080|FG000|Intervention|Lost to Follow-up|1|||
33611768|NCT02396589|102127081|FG001|Intervention|Lost to Follow-up|0|||
33611769|NCT02396589|102127080|FG000|6 Month Follow-up|change in health status|0|||
33611770|NCT02396589|102127081|FG001|6 Month Follow-up|change in health status|1|||
33336473|NCT00783094|101124539|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
33530634|NCT00810069|101841791|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
33530635|NCT00810069|101841792|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
33530636|NCT00810069|101841790|FG000|Lead-in Period I|Randomization criteria not met|158|||
33530637|NCT00810069|101841791|FG001|Lead-in Period I|Randomization criteria not met|0|||
33530638|NCT00810069|101841792|FG002|Lead-in Period I|Randomization criteria not met|0|||
33530639|NCT00810069|101841790|FG000|Double-Blind Period II|Adverse Event|0|||
33530640|NCT00810069|101841791|FG001|Double-Blind Period II|Adverse Event|9|||
33530641|NCT00810069|101841792|FG002|Double-Blind Period II|Adverse Event|8|||
33530642|NCT00810069|101841790|FG000|Double-Blind Period II|Lack of Efficacy|0|||
33530643|NCT00810069|101841791|FG001|Double-Blind Period II|Lack of Efficacy|7|||
33530644|NCT00810069|101841792|FG002|Double-Blind Period II|Lack of Efficacy|12|||
33530645|NCT00810069|101841790|FG000|Double-Blind Period II|Lost to Follow-up|0|||
33530646|NCT00810069|101841791|FG001|Double-Blind Period II|Lost to Follow-up|9|||
33530647|NCT00810069|101841792|FG002|Double-Blind Period II|Lost to Follow-up|9|||
33530648|NCT00810069|101841790|FG000|Double-Blind Period II|Physician Decision|0|||
33530649|NCT00810069|101841791|FG001|Double-Blind Period II|Physician Decision|0|||
33530650|NCT00810069|101841792|FG002|Double-Blind Period II|Physician Decision|1|||
33530651|NCT00810069|101841790|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
33530652|NCT00810069|101841791|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
33530653|NCT00810069|101841792|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
33530654|NCT00810069|101841790|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
33530655|NCT00810069|101841791|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
33530656|NCT00810069|101841792|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
33530657|NCT00810069|101841790|FG000|Double-Blind Period II|Clinical relapse|0|||
33530658|NCT00810069|101841791|FG001|Double-Blind Period II|Clinical relapse|3|||
33530659|NCT00810069|101841792|FG002|Double-Blind Period II|Clinical relapse|0|||
33530660|NCT00810069|101841790|FG000|Double-Blind Period II|Protocol Violation|0|||
33530661|NCT00810069|101841791|FG001|Double-Blind Period II|Protocol Violation|7|||
33530662|NCT00810069|101841792|FG002|Double-Blind Period II|Protocol Violation|6|||
33530663|NCT00130689|101841798|FG000|Overall Study|Progressive Disease|29|||
33530664|NCT00130689|101841798|FG000|Overall Study|Death|1|||
33530665|NCT00130689|101841798|FG000|Overall Study|Clinical Deterioration|4|||
33530666|NCT00130689|101841798|FG000|Overall Study|Withdrawal by Subject|3|||
33530667|NCT00130689|101841798|FG000|Overall Study|Ineligible|6|||
33530668|NCT04888494|101841801|FG000|Overall Study|Lost to Follow-up|2|||
33530669|NCT04888494|101841802|FG001|Overall Study|Lost to Follow-up|3|||
33530670|NCT04888494|101841801|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
33530671|NCT04888494|101841802|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
33530672|NCT00003471|101841809|FG000|Overall Study|Not evaluable|4|||
33530673|NCT01675492|101841815|FG000|Overall Study|study completed early - product approval|42|||
33530674|NCT01585246|101841816|FG000|Overall Study|Lost to Follow-up|0|||
33530675|NCT01585246|101841817|FG001|Overall Study|Lost to Follow-up|0|||
33530676|NCT01585246|101841818|FG002|Overall Study|Lost to Follow-up|2|||
33530677|NCT01585246|101841819|FG003|Overall Study|Lost to Follow-up|1|||
33530678|NCT01585246|101841820|FG004|Overall Study|Lost to Follow-up|0|||
33530679|NCT01585246|101841816|FG000|Overall Study|Protocol Violation|0|||
33530680|NCT01585246|101841817|FG001|Overall Study|Protocol Violation|0|||
33530681|NCT01585246|101841818|FG002|Overall Study|Protocol Violation|0|||
33611771|NCT02396589|102127080|FG000|9 Month Follow-up|Death|0|||
33336474|NCT00783094|101124537|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
33336475|NCT00783094|101124538|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
33530682|NCT01585246|101841819|FG003|Overall Study|Protocol Violation|0|||
33530683|NCT01585246|101841820|FG004|Overall Study|Protocol Violation|1|||
33530684|NCT01585246|101841816|FG000|Overall Study|Withdrawal by Subject|0|||
33530685|NCT01585246|101841817|FG001|Overall Study|Withdrawal by Subject|0|||
33530686|NCT01585246|101841818|FG002|Overall Study|Withdrawal by Subject|1|||
33530687|NCT01585246|101841819|FG003|Overall Study|Withdrawal by Subject|2|||
33530688|NCT01585246|101841820|FG004|Overall Study|Withdrawal by Subject|1|||
33611772|NCT02396589|102127081|FG001|9 Month Follow-up|Death|1|||
33611773|NCT02396589|102127080|FG000|12 Month Follow up|Lost to Follow-up|0|||
33611774|NCT02396589|102127081|FG001|12 Month Follow up|Lost to Follow-up|2|||
33611775|NCT00517361|102127085|FG000|Overall Study|Death|6|||
33611776|NCT00517361|102127085|FG000|Overall Study|The study was terminated|5|||
33611777|NCT02487030|102127092|FG000|Overall Study|Lack of Efficacy|2|||
33611778|NCT02487030|102127093|FG001|Overall Study|Lack of Efficacy|4|||
33611779|NCT02487030|102127094|FG002|Overall Study|Lack of Efficacy|1|||
33611780|NCT02487030|102127095|FG003|Overall Study|Lack of Efficacy|0|||
33611781|NCT02487030|102127096|FG004|Overall Study|Lack of Efficacy|1|||
33611782|NCT02487030|102127097|FG005|Overall Study|Lack of Efficacy|0|||
33611783|NCT02487030|102127098|FG006|Overall Study|Lack of Efficacy|0|||
33611784|NCT02487030|102127092|FG000|Overall Study|Lost to Follow-up|0|||
33205351|NCT01490632|100651535|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
33205352|NCT01490632|100651536|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
33205353|NCT01490632|100651537|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
33530689|NCT01585246|101841816|FG000|Overall Study|Other|0|||
33530690|NCT01585246|101841817|FG001|Overall Study|Other|1|||
33530691|NCT01585246|101841818|FG002|Overall Study|Other|1|||
33530692|NCT01585246|101841819|FG003|Overall Study|Other|1|||
33530693|NCT01585246|101841820|FG004|Overall Study|Other|0|||
33530694|NCT02360280|101841821|FG000|Overall Study|Withdrawal by Subject|2|||
33530695|NCT02360280|101841822|FG001|Overall Study|Withdrawal by Subject|0|||
33530696|NCT02360280|101841821|FG000|Overall Study|Adverse Event|0|||
33530697|NCT02360280|101841822|FG001|Overall Study|Adverse Event|1|||
33530698|NCT02360280|101841821|FG000|Overall Study|Lost to Follow-up|1|||
33530699|NCT02360280|101841822|FG001|Overall Study|Lost to Follow-up|0|||
33530700|NCT02472886|101841826|FG000|Overall Study|Lack of Efficacy|0|||
33530701|NCT02472886|101841827|FG001|Overall Study|Lack of Efficacy|2|||
33530702|NCT02472886|101841828|FG002|Overall Study|Lack of Efficacy|1|||
33530703|NCT04001803|101841829|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
33530704|NCT04001803|101841829|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
33530705|NCT04001803|101841829|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
33530706|NCT04001803|101841829|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
33530707|NCT04001803|101841829|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
33530708|NCT04001803|101841829|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
33530709|NCT04001803|101841829|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
33530710|NCT04001803|101841829|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
33530711|NCT04001803|101841829|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
33530712|NCT04001803|101841829|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
33530713|NCT02030119|101841830|FG000|Overall Study|Withdrawal by Subject|3|||
33530714|NCT02030119|101841831|FG001|Overall Study|Withdrawal by Subject|1|||
33530715|NCT02030119|101841832|FG002|Overall Study|Withdrawal by Subject|5|||
33530716|NCT02030119|101841833|FG003|Overall Study|Withdrawal by Subject|3|||
33530717|NCT02030119|101841830|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
33530718|NCT02030119|101841831|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
33530719|NCT02030119|101841832|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
33530720|NCT02030119|101841833|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
33611785|NCT02487030|102127093|FG001|Overall Study|Lost to Follow-up|0|||
33611786|NCT02487030|102127094|FG002|Overall Study|Lost to Follow-up|1|||
33611787|NCT02487030|102127095|FG003|Overall Study|Lost to Follow-up|1|||
33611788|NCT02487030|102127096|FG004|Overall Study|Lost to Follow-up|0|||
33611789|NCT02487030|102127097|FG005|Overall Study|Lost to Follow-up|1|||
33611790|NCT02487030|102127098|FG006|Overall Study|Lost to Follow-up|0|||
33611791|NCT02487030|102127092|FG000|Overall Study|Adverse Event|0|||
33611792|NCT02487030|102127093|FG001|Overall Study|Adverse Event|0|||
33611793|NCT02487030|102127094|FG002|Overall Study|Adverse Event|0|||
33611794|NCT02487030|102127095|FG003|Overall Study|Adverse Event|1|||
33611795|NCT02487030|102127096|FG004|Overall Study|Adverse Event|0|||
33611796|NCT02487030|102127097|FG005|Overall Study|Adverse Event|0|||
33611797|NCT02487030|102127098|FG006|Overall Study|Adverse Event|0|||
33205354|NCT01490632|100651538|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
33611798|NCT02487030|102127092|FG000|Overall Study|Death|0|||
33530721|NCT03283930|101841836|FG000|Overall Study|Scheduling conflict|8|||
33530722|NCT03283930|101841837|FG001|Overall Study|Scheduling conflict|10|||
33530723|NCT03283930|101841836|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
33530724|NCT03283930|101841837|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
33530725|NCT03283930|101841836|FG000|Overall Study|Technical software issue|2|||
33530726|NCT03283930|101841837|FG001|Overall Study|Technical software issue|2|||
33611799|NCT02487030|102127093|FG001|Overall Study|Death|0|||
33611800|NCT02487030|102127094|FG002|Overall Study|Death|0|||
33205355|NCT01490632|100651539|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
33611801|NCT02487030|102127095|FG003|Overall Study|Death|0|||
33611802|NCT02487030|102127096|FG004|Overall Study|Death|1|||
33611803|NCT02487030|102127097|FG005|Overall Study|Death|0|||
33611804|NCT02487030|102127098|FG006|Overall Study|Death|0|||
33611805|NCT01894243|102127099|FG000|Overall Study|Adverse Event|0|||
33611806|NCT01894243|102127100|FG001|Overall Study|Adverse Event|1|||
33530727|NCT01381926|101841838|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
33530728|NCT01381926|101841839|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
33530729|NCT01381926|101841838|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
33530730|NCT01381926|101841839|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
33530731|NCT04826484|101841842|FG000|Overall Study|Lost to Follow-up|2|||
33530732|NCT04826484|101841843|FG001|Overall Study|Lost to Follow-up|0|||
33530733|NCT02258659|101841849|FG000|Overall Study|Withdrawal by Subject|1|||
33336476|NCT00783094|101124539|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
33336477|NCT00783094|101124537|FG000|Open-Label Extension Period|Adverse Event|12|||
33336478|NCT00783094|101124538|FG001|Open-Label Extension Period|Adverse Event|7|||
33336479|NCT00783094|101124539|FG002|Open-Label Extension Period|Adverse Event|16|||
33530734|NCT05404711|101841852|FG000|Completed Study Visit|Withdrawal by Subject|1|||
33336480|NCT00783094|101124537|FG000|Open-Label Extension Period|Death|0|||
33336481|NCT00783094|101124538|FG001|Open-Label Extension Period|Death|0|||
33336482|NCT00783094|101124539|FG002|Open-Label Extension Period|Death|1|||
33336483|NCT00783094|101124537|FG000|Open-Label Extension Period|Protocol Violation|4|||
33336484|NCT00783094|101124538|FG001|Open-Label Extension Period|Protocol Violation|5|||
33336485|NCT00783094|101124539|FG002|Open-Label Extension Period|Protocol Violation|7|||
33336486|NCT00783094|101124537|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
33336487|NCT00783094|101124538|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
33205356|NCT01490632|100651540|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
33336488|NCT00783094|101124539|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
33336489|NCT00783094|101124537|FG000|Open-Label Extension Period|Physician Decision|4|||
33530735|NCT05404711|101841852|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
33530736|NCT05404711|101841852|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
33530737|NCT05404711|101841852|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
33530738|NCT05404711|101841852|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
33567610|NCT02723955|101973208|FG039|Crossover/ Re-treatment Phase|Death|32|||
33611807|NCT01894243|102127101|FG002|Overall Study|Adverse Event|2|||
33611808|NCT01894243|102127099|FG000|Overall Study|Death|0|||
33611809|NCT01894243|102127100|FG001|Overall Study|Death|0|||
33611810|NCT01894243|102127101|FG002|Overall Study|Death|3|||
33611811|NCT01894243|102127099|FG000|Overall Study|Lack of Efficacy|3|||
33611812|NCT01894243|102127100|FG001|Overall Study|Lack of Efficacy|3|||
33611813|NCT01894243|102127101|FG002|Overall Study|Lack of Efficacy|1|||
33611814|NCT01894243|102127099|FG000|Overall Study|Condition under investigation worsened|8|||
33611815|NCT01894243|102127100|FG001|Overall Study|Condition under investigation worsened|6|||
33611816|NCT01894243|102127101|FG002|Overall Study|Condition under investigation worsened|2|||
33611817|NCT01894243|102127099|FG000|Overall Study|Subject decision|1|||
33611818|NCT01894243|102127100|FG001|Overall Study|Subject decision|0|||
33404135|NCT01049360|101369421|FG019|Period 4|Protocol Violation|0|||
33530739|NCT05404711|101841852|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
33530740|NCT01639144|101841853|FG000|Overall Study|Withdrawal by Subject|4|||
33530741|NCT01639144|101841854|FG001|Overall Study|Withdrawal by Subject|2|||
33530742|NCT01639144|101841853|FG000|Overall Study|Physician Decision|2|||
33530743|NCT01639144|101841854|FG001|Overall Study|Physician Decision|0|||
33530744|NCT01639144|101841853|FG000|Overall Study|Met postoperative exclusion criteria|4|||
33530745|NCT01639144|101841854|FG001|Overall Study|Met postoperative exclusion criteria|3|||
33530746|NCT02998996|101841855|FG000|Overall Study|Lost to Follow-up|0|||
33530747|NCT02998996|101841856|FG001|Overall Study|Lost to Follow-up|0|||
33530748|NCT02998996|101841857|FG002|Overall Study|Lost to Follow-up|1|||
33530749|NCT02998996|101841858|FG003|Overall Study|Lost to Follow-up|0|||
33530750|NCT02998996|101841859|FG004|Overall Study|Lost to Follow-up|0|||
33530751|NCT02998996|101841860|FG005|Overall Study|Lost to Follow-up|0|||
33530752|NCT02998996|101841855|FG000|Overall Study|Pregnancy|0|||
33530753|NCT02998996|101841856|FG001|Overall Study|Pregnancy|1|||
33530754|NCT02998996|101841857|FG002|Overall Study|Pregnancy|0|||
33530755|NCT02998996|101841858|FG003|Overall Study|Pregnancy|0|||
33530756|NCT02998996|101841859|FG004|Overall Study|Pregnancy|0|||
33530757|NCT02998996|101841860|FG005|Overall Study|Pregnancy|0|||
33530758|NCT02998996|101841855|FG000|Overall Study|Family reasons|0|||
33530759|NCT02998996|101841856|FG001|Overall Study|Family reasons|0|||
33530760|NCT02998996|101841857|FG002|Overall Study|Family reasons|0|||
33530761|NCT02998996|101841858|FG003|Overall Study|Family reasons|0|||
33530762|NCT02998996|101841859|FG004|Overall Study|Family reasons|1|||
33530763|NCT02998996|101841860|FG005|Overall Study|Family reasons|0|||
33530764|NCT01673984|101841861|FG000|Overall Study|Adverse Event|1|||
33530765|NCT01673984|101841862|FG001|Overall Study|Adverse Event|0|||
33530766|NCT01673984|101841861|FG000|Overall Study|Study termination|9|||
33530767|NCT01673984|101841862|FG001|Overall Study|Study termination|6|||
33530768|NCT03280056|101841865|FG000|Overall Study|Withdrawal by Subject|12|||
33530769|NCT03280056|101841866|FG001|Overall Study|Withdrawal by Subject|14|||
33530770|NCT03280056|101841865|FG000|Overall Study|Death|9|||
33530771|NCT03280056|101841866|FG001|Overall Study|Death|2|||
33530772|NCT03280056|101841865|FG000|Overall Study|Adverse Event|1|||
33530773|NCT03280056|101841866|FG001|Overall Study|Adverse Event|3|||
33530774|NCT03280056|101841865|FG000|Overall Study|Lost to Follow-up|1|||
33530775|NCT03280056|101841866|FG001|Overall Study|Lost to Follow-up|1|||
33530776|NCT03280056|101841865|FG000|Overall Study|Physician Decision|0|||
33530777|NCT03280056|101841866|FG001|Overall Study|Physician Decision|1|||
33530778|NCT03280056|101841865|FG000|Overall Study|Early Discontinuation|1|||
33530779|NCT03280056|101841866|FG001|Overall Study|Early Discontinuation|0|||
33530780|NCT04147247|101841867|FG000|Overall Study|Progressive disease|3|||
33530781|NCT04147247|101841868|FG001|Overall Study|Progressive disease|3|||
33530782|NCT04147247|101841869|FG002|Overall Study|Progressive disease|4|||
33530783|NCT04147247|101841870|FG003|Overall Study|Progressive disease|4|||
33530784|NCT04147247|101841871|FG004|Overall Study|Progressive disease|3|||
33530785|NCT04147247|101841867|FG000|Overall Study|Physician Decision|0|||
33530786|NCT04147247|101841868|FG001|Overall Study|Physician Decision|1|||
33530787|NCT04147247|101841869|FG002|Overall Study|Physician Decision|0|||
33530788|NCT04147247|101841870|FG003|Overall Study|Physician Decision|0|||
33530789|NCT04147247|101841871|FG004|Overall Study|Physician Decision|0|||
33530790|NCT04147247|101841867|FG000|Overall Study|Clinical Disease Progression|0|||
33530791|NCT04147247|101841868|FG001|Overall Study|Clinical Disease Progression|0|||
33530792|NCT04147247|101841869|FG002|Overall Study|Clinical Disease Progression|0|||
33530793|NCT04147247|101841870|FG003|Overall Study|Clinical Disease Progression|0|||
33530794|NCT04147247|101841871|FG004|Overall Study|Clinical Disease Progression|1|||
33530795|NCT04147247|101841867|FG000|Overall Study|Adverse Event|0|||
33530796|NCT04147247|101841868|FG001|Overall Study|Adverse Event|0|||
33530797|NCT04147247|101841869|FG002|Overall Study|Adverse Event|1|||
33530798|NCT04147247|101841870|FG003|Overall Study|Adverse Event|0|||
33530799|NCT04147247|101841871|FG004|Overall Study|Adverse Event|1|||
33530800|NCT02324361|101841872|FG000|Overall Study|Lost to Follow-up|5|||
33530801|NCT02324361|101841873|FG001|Overall Study|Lost to Follow-up|2|||
33530802|NCT02959918|101841874|FG000|Overall Study|Adverse Event|1|||
33530803|NCT02959918|101841875|FG001|Overall Study|Adverse Event|1|||
33530804|NCT02959918|101841876|FG002|Overall Study|Adverse Event|2|||
33530805|NCT02959918|101841877|FG003|Overall Study|Adverse Event|0|||
33530806|NCT02959918|101841878|FG004|Overall Study|Adverse Event|0|||
33530807|NCT02959918|101841879|FG005|Overall Study|Adverse Event|2|||
33530808|NCT02959918|101841880|FG006|Overall Study|Adverse Event|2|||
33530809|NCT02959918|101841881|FG007|Overall Study|Adverse Event|1|||
33530810|NCT02959918|101841882|FG008|Overall Study|Adverse Event|2|||
33530811|NCT02959918|101841883|FG009|Overall Study|Adverse Event|1|||
33404136|NCT01049360|101369402|FG000|Period 4|Withdrawal by Subject|0|||
33530812|NCT02959918|101841884|FG010|Overall Study|Adverse Event|1|||
33404137|NCT01049360|101369403|FG001|Period 4|Withdrawal by Subject|0|||
33530813|NCT02959918|101841885|FG011|Overall Study|Adverse Event|3|||
33530814|NCT02959918|101841886|FG012|Overall Study|Adverse Event|2|||
33530815|NCT02959918|101841887|FG013|Overall Study|Adverse Event|4|||
33530816|NCT02959918|101841874|FG000|Overall Study|Lost to Follow-up|0|||
33530817|NCT02959918|101841875|FG001|Overall Study|Lost to Follow-up|0|||
33530818|NCT02959918|101841876|FG002|Overall Study|Lost to Follow-up|0|||
33530819|NCT02959918|101841877|FG003|Overall Study|Lost to Follow-up|0|||
33530820|NCT02959918|101841878|FG004|Overall Study|Lost to Follow-up|0|||
33530821|NCT02959918|101841879|FG005|Overall Study|Lost to Follow-up|0|||
33530822|NCT02959918|101841880|FG006|Overall Study|Lost to Follow-up|0|||
33530823|NCT02959918|101841881|FG007|Overall Study|Lost to Follow-up|0|||
33530824|NCT02959918|101841882|FG008|Overall Study|Lost to Follow-up|0|||
33530825|NCT02959918|101841883|FG009|Overall Study|Lost to Follow-up|1|||
33530826|NCT02959918|101841884|FG010|Overall Study|Lost to Follow-up|0|||
33530827|NCT02959918|101841885|FG011|Overall Study|Lost to Follow-up|0|||
33530828|NCT02959918|101841886|FG012|Overall Study|Lost to Follow-up|1|||
33530829|NCT02959918|101841887|FG013|Overall Study|Lost to Follow-up|0|||
33530830|NCT02959918|101841874|FG000|Overall Study|Withdrawal by Subject|0|||
33530831|NCT02959918|101841875|FG001|Overall Study|Withdrawal by Subject|0|||
33530832|NCT02959918|101841876|FG002|Overall Study|Withdrawal by Subject|1|||
33530833|NCT02959918|101841877|FG003|Overall Study|Withdrawal by Subject|2|||
33530834|NCT02959918|101841878|FG004|Overall Study|Withdrawal by Subject|0|||
33530835|NCT02959918|101841879|FG005|Overall Study|Withdrawal by Subject|0|||
33530836|NCT02959918|101841880|FG006|Overall Study|Withdrawal by Subject|1|||
33530837|NCT02959918|101841881|FG007|Overall Study|Withdrawal by Subject|0|||
33530838|NCT02959918|101841882|FG008|Overall Study|Withdrawal by Subject|1|||
33530839|NCT02959918|101841883|FG009|Overall Study|Withdrawal by Subject|1|||
33530840|NCT02959918|101841884|FG010|Overall Study|Withdrawal by Subject|2|||
33530841|NCT02959918|101841885|FG011|Overall Study|Withdrawal by Subject|3|||
33611819|NCT01894243|102127101|FG002|Overall Study|Subject decision|0|||
33205357|NCT01490632|100651541|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
33205358|NCT01490632|100651542|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
33205359|NCT01490632|100651543|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
33205360|NCT01490632|100651544|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
33205361|NCT01490632|100651545|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
33205362|NCT01490632|100651546|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
33205363|NCT01490632|100651547|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
33205364|NCT01490632|100651548|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
33205365|NCT01490632|100651549|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
33205366|NCT01490632|100651550|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
33205367|NCT01490632|100651551|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
33336490|NCT00783094|101124538|FG001|Open-Label Extension Period|Physician Decision|2|||
33336491|NCT00783094|101124539|FG002|Open-Label Extension Period|Physician Decision|3|||
33336492|NCT00783094|101124537|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
33336493|NCT00783094|101124538|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
33336494|NCT00783094|101124539|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
33336495|NCT01368835|101124540|FG000|Overall Study|Inclusion criteria/photography quality|22|||
33336496|NCT01368835|101124540|FG000|Overall Study|Lost to Follow-up|11|||
33336497|NCT03713944|101124541|FG000|Study Treatment|Patient non-compliance|1|||
33336498|NCT03713944|101124541|FG000|Study Treatment|Alternative Cancer Therapy|3|||
33336499|NCT03713944|101124541|FG000|Study Treatment|Disease Progression|18|||
33336500|NCT03713944|101124541|FG000|Study Treatment|AE/Side Effects/Complications|2|||
33336501|NCT03713944|101124541|FG000|Study Treatment|Death|2|||
33336502|NCT03713944|101124541|FG000|Study Treatment|Withdrawal by Subject|1|||
33336503|NCT03713944|101124541|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
33336504|NCT03713944|101124541|FG000|Study Treatment|Symptomatic Deterioration|2|||
33530842|NCT02959918|101841886|FG012|Overall Study|Withdrawal by Subject|1|||
33530843|NCT02959918|101841887|FG013|Overall Study|Withdrawal by Subject|1|||
33530844|NCT02959918|101841874|FG000|Overall Study|Protocol Violation|0|||
33530845|NCT02959918|101841875|FG001|Overall Study|Protocol Violation|0|||
33530846|NCT02959918|101841876|FG002|Overall Study|Protocol Violation|1|||
33530847|NCT02959918|101841877|FG003|Overall Study|Protocol Violation|0|||
33530848|NCT02959918|101841878|FG004|Overall Study|Protocol Violation|0|||
33530849|NCT02959918|101841879|FG005|Overall Study|Protocol Violation|1|||
33611820|NCT01894243|102127099|FG000|Overall Study|Other|1|||
33611821|NCT01894243|102127100|FG001|Overall Study|Other|0|||
33530850|NCT02959918|101841880|FG006|Overall Study|Protocol Violation|0|||
33530851|NCT02959918|101841881|FG007|Overall Study|Protocol Violation|0|||
33530852|NCT02959918|101841882|FG008|Overall Study|Protocol Violation|2|||
33611822|NCT01894243|102127101|FG002|Overall Study|Other|0|||
33404138|NCT01049360|101369404|FG002|Period 4|Withdrawal by Subject|0|||
33404139|NCT01049360|101369405|FG003|Period 4|Withdrawal by Subject|1|||
33404140|NCT01049360|101369406|FG004|Period 4|Withdrawal by Subject|0|||
33404141|NCT01049360|101369407|FG005|Period 4|Withdrawal by Subject|0|||
33404142|NCT01049360|101369408|FG006|Period 4|Withdrawal by Subject|0|||
33404143|NCT01049360|101369409|FG007|Period 4|Withdrawal by Subject|0|||
33404144|NCT01049360|101369410|FG008|Period 4|Withdrawal by Subject|0|||
33404145|NCT01049360|101369411|FG009|Period 4|Withdrawal by Subject|0|||
33404146|NCT01049360|101369412|FG010|Period 4|Withdrawal by Subject|0|||
33404147|NCT01049360|101369413|FG011|Period 4|Withdrawal by Subject|0|||
33404148|NCT01049360|101369414|FG012|Period 4|Withdrawal by Subject|0|||
33404149|NCT01049360|101369415|FG013|Period 4|Withdrawal by Subject|0|||
33404150|NCT01049360|101369416|FG014|Period 4|Withdrawal by Subject|0|||
33404151|NCT01049360|101369417|FG015|Period 4|Withdrawal by Subject|0|||
33404152|NCT01049360|101369418|FG016|Period 4|Withdrawal by Subject|0|||
33530853|NCT02959918|101841883|FG009|Overall Study|Protocol Violation|1|||
33530854|NCT02959918|101841884|FG010|Overall Study|Protocol Violation|0|||
33530855|NCT02959918|101841885|FG011|Overall Study|Protocol Violation|1|||
33404153|NCT01049360|101369419|FG017|Period 4|Withdrawal by Subject|0|||
33530856|NCT02959918|101841886|FG012|Overall Study|Protocol Violation|1|||
33530857|NCT02959918|101841887|FG013|Overall Study|Protocol Violation|0|||
33530858|NCT02959918|101841874|FG000|Overall Study|Stopping Rule Met|1|||
33530859|NCT02959918|101841875|FG001|Overall Study|Stopping Rule Met|0|||
33530860|NCT02959918|101841876|FG002|Overall Study|Stopping Rule Met|3|||
33530861|NCT02959918|101841877|FG003|Overall Study|Stopping Rule Met|4|||
33336505|NCT03713944|101124541|FG000|Follow up|Withdrawal by Subject|2|||
33336506|NCT03713944|101124541|FG000|Follow up|Death|11|||
33336507|NCT03713944|101124541|FG000|Follow up|Study Terminated|3|||
33336508|NCT00957008|101124544|FG000|Overall Study|Withdrawal by Subject|13|||
33336509|NCT00957008|101124545|FG001|Overall Study|Withdrawal by Subject|10|||
33336510|NCT00957008|101124546|FG002|Overall Study|Withdrawal by Subject|12|||
33336511|NCT00957008|101124547|FG003|Overall Study|Withdrawal by Subject|16|||
33336512|NCT00957008|101124544|FG000|Overall Study|Lost to Follow-up|3|||
33336513|NCT00957008|101124545|FG001|Overall Study|Lost to Follow-up|1|||
33336514|NCT00957008|101124546|FG002|Overall Study|Lost to Follow-up|3|||
33336515|NCT00957008|101124547|FG003|Overall Study|Lost to Follow-up|4|||
33336516|NCT00957008|101124544|FG000|Overall Study|Physician Decision|1|||
33336517|NCT00957008|101124545|FG001|Overall Study|Physician Decision|0|||
33336518|NCT00957008|101124546|FG002|Overall Study|Physician Decision|1|||
33336519|NCT00957008|101124547|FG003|Overall Study|Physician Decision|1|||
33336520|NCT00957008|101124544|FG000|Overall Study|Relocated; Family conflict|4|||
33336521|NCT00957008|101124545|FG001|Overall Study|Relocated; Family conflict|1|||
33336522|NCT00957008|101124546|FG002|Overall Study|Relocated; Family conflict|1|||
33336523|NCT00957008|101124547|FG003|Overall Study|Relocated; Family conflict|3|||
33336524|NCT01496066|101124551|FG000|Overall Study|Lost to Follow-up|8|||
33336525|NCT01496066|101124552|FG001|Overall Study|Lost to Follow-up|5|||
33336526|NCT01496066|101124551|FG000|Overall Study|Explant|3|||
33336527|NCT01496066|101124552|FG001|Overall Study|Explant|0|||
33336528|NCT01496066|101124551|FG000|Overall Study|Death|1|||
33336529|NCT01496066|101124552|FG001|Overall Study|Death|4|||
33336530|NCT04677712|101124553|FG000|Overall Study|Lost to Follow-up|0|||
33336531|NCT04677712|101124554|FG001|Overall Study|Lost to Follow-up|1|||
33336532|NCT04677712|101124555|FG002|Overall Study|Lost to Follow-up|0|||
33336533|NCT04677712|101124556|FG003|Overall Study|Lost to Follow-up|0|||
33336534|NCT04677712|101124557|FG004|Overall Study|Lost to Follow-up|0|||
33336535|NCT04677712|101124558|FG005|Overall Study|Lost to Follow-up|0|||
33336536|NCT01928381|101124559|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
33336537|NCT01928381|101124560|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
33336538|NCT01928381|101124561|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
33336539|NCT01928381|101124562|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
33336540|NCT01928381|101124563|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
33530862|NCT02959918|101841878|FG004|Overall Study|Stopping Rule Met|5|||
33530863|NCT02959918|101841879|FG005|Overall Study|Stopping Rule Met|3|||
33611823|NCT00605345|102127103|FG000|Overall Study|Withdrawal by Subject|1|||
33336541|NCT01928381|101124564|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
33336542|NCT01928381|101124565|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
33336543|NCT01928381|101124559|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
33336544|NCT01928381|101124560|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
33336545|NCT01928381|101124561|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
33404154|NCT01049360|101369420|FG018|Period 4|Withdrawal by Subject|0|||
33404155|NCT01049360|101369421|FG019|Period 4|Withdrawal by Subject|0|||
33404156|NCT03802331|101369422|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
33404157|NCT03802331|101369423|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
33404158|NCT02185040|101369427|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
33404159|NCT02185040|101369428|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
33404160|NCT02185040|101369429|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
33404161|NCT02185040|101369430|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
33404162|NCT02185040|101369431|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
33404163|NCT02185040|101369432|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
33404164|NCT02185040|101369433|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
33404165|NCT02185040|101369427|FG000|Part 1 Treatment Phase|Adverse Event|1|||
33404166|NCT02185040|101369428|FG001|Part 1 Treatment Phase|Adverse Event|0|||
33404167|NCT02185040|101369429|FG002|Part 1 Treatment Phase|Adverse Event|0|||
33404168|NCT02185040|101369430|FG003|Part 1 Treatment Phase|Adverse Event|2|||
33404169|NCT02185040|101369431|FG004|Part 1 Treatment Phase|Adverse Event|3|||
33530864|NCT02959918|101841880|FG006|Overall Study|Stopping Rule Met|2|||
33611824|NCT00605345|102127104|FG001|Overall Study|Withdrawal by Subject|0|||
33336546|NCT01928381|101124562|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
33336547|NCT01928381|101124563|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
33336548|NCT01928381|101124564|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
33404170|NCT02185040|101369432|FG005|Part 1 Treatment Phase|Adverse Event|0|||
33404171|NCT02185040|101369433|FG006|Part 1 Treatment Phase|Adverse Event|0|||
33404172|NCT02185040|101369427|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
33336549|NCT01928381|101124565|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
33336550|NCT01928381|101124559|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
33336551|NCT01928381|101124560|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
33336552|NCT01928381|101124561|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
33336553|NCT01928381|101124562|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
33336554|NCT01928381|101124563|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
33336555|NCT01928381|101124564|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
33336556|NCT01928381|101124565|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
33336557|NCT01928381|101124559|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
33336558|NCT01928381|101124560|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
33336559|NCT01928381|101124561|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
33336560|NCT01928381|101124562|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
33336561|NCT01928381|101124563|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
33336562|NCT01928381|101124564|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
33530865|NCT02959918|101841881|FG007|Overall Study|Stopping Rule Met|4|||
33530866|NCT02959918|101841882|FG008|Overall Study|Stopping Rule Met|1|||
33530867|NCT02959918|101841883|FG009|Overall Study|Stopping Rule Met|1|||
33530868|NCT02959918|101841884|FG010|Overall Study|Stopping Rule Met|3|||
33336563|NCT01928381|101124565|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
33336564|NCT01928381|101124559|FG000|Part 1 - Pain Training|Protocol Violation|1|||
33336565|NCT01928381|101124560|FG001|Part 1 - Pain Training|Protocol Violation|0|||
33336566|NCT01928381|101124561|FG002|Part 1 - Pain Training|Protocol Violation|0|||
33336567|NCT01928381|101124562|FG003|Part 1 - Pain Training|Protocol Violation|0|||
33336568|NCT01928381|101124563|FG004|Part 1 - Pain Training|Protocol Violation|0|||
33336569|NCT01928381|101124564|FG005|Part 1 - Pain Training|Protocol Violation|0|||
33336570|NCT01928381|101124565|FG006|Part 1 - Pain Training|Protocol Violation|0|||
33336571|NCT01928381|101124559|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
33336572|NCT01928381|101124560|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
33336573|NCT01928381|101124561|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
33336574|NCT01928381|101124562|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
33205368|NCT01490632|100651532|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
33205369|NCT01490632|100651533|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
33205370|NCT01490632|100651534|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
33205371|NCT01490632|100651535|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
33336575|NCT01928381|101124563|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
33336576|NCT01928381|101124564|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
33336577|NCT01928381|101124565|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
33336578|NCT01928381|101124559|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
33336579|NCT01928381|101124560|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
33336580|NCT01928381|101124561|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
33336581|NCT01928381|101124562|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
33336582|NCT01928381|101124563|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
33336583|NCT01928381|101124564|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
33336584|NCT01928381|101124565|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
33336585|NCT01928381|101124559|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
33404173|NCT02185040|101369428|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
33530869|NCT02959918|101841885|FG011|Overall Study|Stopping Rule Met|5|||
33205372|NCT01490632|100651536|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33530870|NCT02959918|101841886|FG012|Overall Study|Stopping Rule Met|2|||
33611825|NCT00605345|102127103|FG000|Overall Study|Adverse Event|0|||
33205373|NCT01490632|100651537|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33205374|NCT01490632|100651538|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33205375|NCT01490632|100651539|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33205376|NCT01490632|100651540|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33205377|NCT01490632|100651541|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33205378|NCT01490632|100651542|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33205379|NCT01490632|100651543|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33205380|NCT01490632|100651544|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33205381|NCT01490632|100651545|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33205382|NCT01490632|100651546|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33336586|NCT01928381|101124560|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
33336587|NCT01928381|101124561|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
33336588|NCT01928381|101124562|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
33336589|NCT01928381|101124563|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
33336590|NCT01928381|101124564|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
33404174|NCT02185040|101369429|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
33205383|NCT01490632|100651547|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33530871|NCT02959918|101841887|FG013|Overall Study|Stopping Rule Met|1|||
33530872|NCT02959918|101841874|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
33530873|NCT02959918|101841875|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
33336591|NCT01928381|101124565|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
33205384|NCT01490632|100651548|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33205385|NCT01490632|100651549|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33205386|NCT01490632|100651550|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33205387|NCT01490632|100651551|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
33205388|NCT01490632|100651532|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33530874|NCT02959918|101841876|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
33530875|NCT02959918|101841877|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
33530876|NCT02959918|101841878|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33530877|NCT02959918|101841879|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33530878|NCT02959918|101841880|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33530879|NCT02959918|101841881|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33530880|NCT02959918|101841882|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33530881|NCT02959918|101841883|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33530882|NCT02959918|101841884|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33530883|NCT02959918|101841885|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33530884|NCT02959918|101841886|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33530885|NCT02959918|101841887|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
33530886|NCT02959918|101841874|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33530887|NCT02959918|101841875|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33530888|NCT02959918|101841876|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33530889|NCT02959918|101841877|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33530890|NCT02959918|101841878|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33530891|NCT02959918|101841879|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33530892|NCT02959918|101841880|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33530893|NCT02959918|101841881|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
33530894|NCT02959918|101841882|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33530895|NCT02959918|101841883|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33530896|NCT02959918|101841884|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33530897|NCT02959918|101841885|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33530898|NCT02959918|101841886|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33530899|NCT02959918|101841887|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
33530900|NCT02959918|101841874|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33530901|NCT02959918|101841875|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33530902|NCT02959918|101841876|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33530903|NCT02959918|101841877|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33530904|NCT02959918|101841878|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33530905|NCT02959918|101841879|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33530906|NCT02959918|101841880|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33530907|NCT02959918|101841881|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33530908|NCT02959918|101841882|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
33530909|NCT02959918|101841883|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33530910|NCT02959918|101841884|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33530911|NCT02959918|101841885|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33404175|NCT02185040|101369430|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
33205389|NCT01490632|100651533|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33205390|NCT01490632|100651534|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
33611826|NCT00605345|102127104|FG001|Overall Study|Adverse Event|1|||
33611827|NCT00605345|102127103|FG000|Overall Study|Protocol Violation|0|||
33611828|NCT00605345|102127104|FG001|Overall Study|Protocol Violation|2|||
33611829|NCT01279681|102127105|FG000|Overall Study|Disease Progression|9|||
33611830|NCT01279681|102127106|FG001|Overall Study|Disease Progression|6|||
33611831|NCT01279681|102127105|FG000|Overall Study|Withdrawal by Subject|3|||
33611832|NCT01279681|102127106|FG001|Overall Study|Withdrawal by Subject|4|||
33611833|NCT01279681|102127105|FG000|Overall Study|Adverse Event|2|||
33404176|NCT02185040|101369431|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
33611834|NCT01279681|102127106|FG001|Overall Study|Adverse Event|3|||
33611835|NCT01279681|102127105|FG000|Overall Study|Death|0|||
33611836|NCT01279681|102127106|FG001|Overall Study|Death|1|||
33611837|NCT01279681|102127105|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
33611838|NCT01279681|102127106|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
33611839|NCT01279681|102127105|FG000|Overall Study|Physician Decision|1|||
33611840|NCT01279681|102127106|FG001|Overall Study|Physician Decision|0|||
33611841|NCT01279681|102127105|FG000|Overall Study|Other Reason|0|||
33611842|NCT01279681|102127106|FG001|Overall Study|Other Reason|2|||
33611843|NCT03319212|102127107|FG000|Overall Study|Discontinued as moving out of local area|0|||
33611844|NCT03319212|102127108|FG001|Overall Study|Discontinued as moving out of local area|1|||
33611845|NCT03319212|102127107|FG000|Overall Study|Adverse Event|2|||
33611846|NCT03319212|102127108|FG001|Overall Study|Adverse Event|2|||
33611847|NCT03319212|102127107|FG000|Overall Study|Withdrawal by Subject|0|||
33611848|NCT03319212|102127108|FG001|Overall Study|Withdrawal by Subject|1|||
33611849|NCT03319212|102127107|FG000|Overall Study|Lost to Follow-up|0|||
33611850|NCT03319212|102127108|FG001|Overall Study|Lost to Follow-up|1|||
33611851|NCT03319212|102127107|FG000|Overall Study|Physician Decision|1|||
33611852|NCT03319212|102127108|FG001|Overall Study|Physician Decision|0|||
33611853|NCT01114828|102127109|FG000|Overall Study|Adverse Event|1|||
33611854|NCT01114828|102127110|FG001|Overall Study|Adverse Event|1|||
33611855|NCT01114828|102127109|FG000|Overall Study|Lack of Efficacy|0|||
33611856|NCT01114828|102127110|FG001|Overall Study|Lack of Efficacy|2|||
33611857|NCT01114828|102127109|FG000|Overall Study|Protocol Violation|2|||
33611858|NCT01114828|102127110|FG001|Overall Study|Protocol Violation|0|||
33404177|NCT02185040|101369432|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
33404178|NCT02185040|101369433|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
33404179|NCT02185040|101369427|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
33611859|NCT01114828|102127109|FG000|Overall Study|Withdrawal by Subject|0|||
33611860|NCT01114828|102127110|FG001|Overall Study|Withdrawal by Subject|1|||
33611861|NCT01743040|102127111|FG000|Overall Study|Death|1|||
33611862|NCT01743040|102127111|FG000|Overall Study|Lost to Follow-up|66|||
33611863|NCT01743040|102127111|FG000|Overall Study|Physician Decision|40|||
33404180|NCT02185040|101369428|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
33404181|NCT02185040|101369429|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
33611864|NCT01743040|102127111|FG000|Overall Study|Protocol Violation|1|||
33611865|NCT01743040|102127111|FG000|Overall Study|Withdrawal by Subject|121|||
33611866|NCT03245775|102127112|FG000|Overall Study|Lost to Follow-up|25|||
33404182|NCT02185040|101369430|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
33404183|NCT02185040|101369431|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
33611867|NCT03245775|102127113|FG001|Overall Study|Lost to Follow-up|26|||
33611868|NCT03245775|102127114|FG002|Overall Study|Lost to Follow-up|16|||
33611869|NCT03245775|102127115|FG003|Overall Study|Lost to Follow-up|16|||
33611870|NCT02587819|102127116|FG000|Overall Study|Adverse Event|1|||
33611871|NCT02587819|102127116|FG000|Overall Study|Lost to Follow-up|1|||
33611872|NCT00568126|102127117|FG000|Overall Study|Adverse Event|3|||
33205391|NCT01490632|100651535|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
33205392|NCT01490632|100651536|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
33205393|NCT01490632|100651537|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33530912|NCT02959918|101841886|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33530913|NCT02959918|101841887|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
33205394|NCT01490632|100651538|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33205395|NCT01490632|100651539|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33530914|NCT02959918|101841874|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33205396|NCT01490632|100651540|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33205397|NCT01490632|100651541|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33205398|NCT01490632|100651542|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33205399|NCT01490632|100651543|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33205400|NCT01490632|100651544|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33205401|NCT01490632|100651545|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33205402|NCT01490632|100651546|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33205403|NCT01490632|100651547|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33205404|NCT01490632|100651548|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33205405|NCT01490632|100651549|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33205406|NCT01490632|100651550|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33205407|NCT01490632|100651551|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
33530915|NCT02959918|101841875|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33530916|NCT02959918|101841876|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33530917|NCT02959918|101841877|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33530918|NCT02959918|101841878|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33530919|NCT02959918|101841879|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33530920|NCT02959918|101841880|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33530921|NCT02959918|101841881|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33530922|NCT02959918|101841882|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33530923|NCT02959918|101841883|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
33530924|NCT02959918|101841884|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33530925|NCT02959918|101841885|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33530926|NCT02959918|101841886|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33530927|NCT02959918|101841887|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
33530928|NCT03677869|101841888|FG000|Overall Study|Withdrawal by Subject|1|||
33530929|NCT00534248|101841889|FG000|Overall Study|Adverse Event|19|||
33530930|NCT00534248|101841890|FG001|Overall Study|Adverse Event|29|||
33530931|NCT00534248|101841889|FG000|Overall Study|Lost to Follow-up|353|||
33530932|NCT00534248|101841890|FG001|Overall Study|Lost to Follow-up|375|||
33530933|NCT00534248|101841889|FG000|Overall Study|Other protocol specified criteria|13|||
33530934|NCT00534248|101841890|FG001|Overall Study|Other protocol specified criteria|3|||
33530935|NCT00534248|101841889|FG000|Overall Study|Physician Decision|10|||
33530936|NCT00534248|101841890|FG001|Overall Study|Physician Decision|7|||
33530937|NCT00534248|101841889|FG000|Overall Study|Protocol Violation|3|||
33530938|NCT00534248|101841890|FG001|Overall Study|Protocol Violation|4|||
33530939|NCT00534248|101841889|FG000|Overall Study|Withdrawal by Subject|263|||
33530940|NCT00534248|101841890|FG001|Overall Study|Withdrawal by Subject|255|||
33530941|NCT02983045|101841891|FG000|Overall Study|Withdrawal by Subject|0|||
33530942|NCT02983045|101841892|FG001|Overall Study|Withdrawal by Subject|1|||
33530943|NCT02983045|101841893|FG002|Overall Study|Withdrawal by Subject|0|||
33530944|NCT02983045|101841894|FG003|Overall Study|Withdrawal by Subject|5|||
33530945|NCT02983045|101841895|FG004|Overall Study|Withdrawal by Subject|0|||
33530946|NCT02983045|101841896|FG005|Overall Study|Withdrawal by Subject|72|||
33530947|NCT02983045|101841897|FG006|Overall Study|Withdrawal by Subject|0|||
33530948|NCT02983045|101841898|FG007|Overall Study|Withdrawal by Subject|0|||
33530949|NCT02983045|101841899|FG008|Overall Study|Withdrawal by Subject|0|||
33530950|NCT02983045|101841900|FG009|Overall Study|Withdrawal by Subject|2|||
33530951|NCT02983045|101841891|FG000|Overall Study|Lost to Follow-up|0|||
33530952|NCT02983045|101841892|FG001|Overall Study|Lost to Follow-up|0|||
33611873|NCT00568126|102127118|FG001|Overall Study|Adverse Event|0|||
33611874|NCT00568126|102127117|FG000|Overall Study|Withdrawal by Subject|2|||
33611875|NCT00568126|102127118|FG001|Overall Study|Withdrawal by Subject|3|||
33611876|NCT00568126|102127117|FG000|Overall Study|Lost to Follow-up|4|||
33611877|NCT00568126|102127118|FG001|Overall Study|Lost to Follow-up|3|||
33611878|NCT00568126|102127117|FG000|Overall Study|Lack of Efficacy|0|||
33611879|NCT00568126|102127118|FG001|Overall Study|Lack of Efficacy|1|||
33611880|NCT00568126|102127117|FG000|Overall Study|Physician Decision|2|||
33611881|NCT00568126|102127118|FG001|Overall Study|Physician Decision|2|||
33611882|NCT01088399|102127119|FG000|Overall Study|Adverse Event|211|||
33611883|NCT01088399|102127120|FG001|Overall Study|Adverse Event|16|||
33611884|NCT01088399|102127121|FG002|Overall Study|Adverse Event|0|||
33611885|NCT01088399|102127119|FG000|Overall Study|Death|204|||
33611886|NCT01088399|102127120|FG001|Overall Study|Death|45|||
33611887|NCT01088399|102127121|FG002|Overall Study|Death|0|||
33611888|NCT01088399|102127119|FG000|Overall Study|Lack of Efficacy|298|||
33611889|NCT01088399|102127120|FG001|Overall Study|Lack of Efficacy|7|||
33611890|NCT01088399|102127121|FG002|Overall Study|Lack of Efficacy|5|||
33611891|NCT01088399|102127119|FG000|Overall Study|Lost to Follow-up|1070|||
33611892|NCT01088399|102127120|FG001|Overall Study|Lost to Follow-up|278|||
33611893|NCT01088399|102127121|FG002|Overall Study|Lost to Follow-up|58|||
33611894|NCT01088399|102127119|FG000|Overall Study|Physician Decision|531|||
33611895|NCT01088399|102127120|FG001|Overall Study|Physician Decision|88|||
33205408|NCT01490632|100651532|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
33205409|NCT01490632|100651533|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
33205410|NCT01490632|100651534|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
33205411|NCT01490632|100651535|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
33205412|NCT01490632|100651536|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
33205413|NCT01490632|100651537|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
33205414|NCT01490632|100651538|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
33205415|NCT01490632|100651539|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
33205416|NCT01490632|100651540|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
33205417|NCT01490632|100651541|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
33205418|NCT01490632|100651542|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
33611896|NCT01088399|102127121|FG002|Overall Study|Physician Decision|16|||
33336592|NCT01928381|101124559|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
33611897|NCT01088399|102127119|FG000|Overall Study|Withdrawal by Subject|544|||
33611898|NCT01088399|102127120|FG001|Overall Study|Withdrawal by Subject|195|||
33611899|NCT01088399|102127121|FG002|Overall Study|Withdrawal by Subject|33|||
33611900|NCT01088399|102127119|FG000|Overall Study|Change to or start of somatropin therapy|234|||
33611901|NCT01088399|102127120|FG001|Overall Study|Change to or start of somatropin therapy|17|||
33611902|NCT01088399|102127121|FG002|Overall Study|Change to or start of somatropin therapy|12|||
33530953|NCT02983045|101841893|FG002|Overall Study|Lost to Follow-up|0|||
33530954|NCT02983045|101841894|FG003|Overall Study|Lost to Follow-up|0|||
33530955|NCT02983045|101841895|FG004|Overall Study|Lost to Follow-up|0|||
33530956|NCT02983045|101841896|FG005|Overall Study|Lost to Follow-up|10|||
33530957|NCT02983045|101841897|FG006|Overall Study|Lost to Follow-up|0|||
33530958|NCT02983045|101841898|FG007|Overall Study|Lost to Follow-up|0|||
33530959|NCT02983045|101841899|FG008|Overall Study|Lost to Follow-up|0|||
33530960|NCT02983045|101841900|FG009|Overall Study|Lost to Follow-up|0|||
33530961|NCT00766597|101841901|FG000|Overall Study|Unexpected closure of study|4|||
33530962|NCT00766597|101841901|FG000|Overall Study|Without CCR5-tropic virus|5|||
33530963|NCT00527826|101841903|FG000|Overall Study|Adverse Event|10|||
33530964|NCT00527826|101841904|FG001|Overall Study|Adverse Event|10|||
33530965|NCT00527826|101841903|FG000|Overall Study|Lost to Follow-up|3|||
33530966|NCT00527826|101841904|FG001|Overall Study|Lost to Follow-up|2|||
33611903|NCT01088399|102127119|FG000|Overall Study|Sponsor decision|1573|||
33611904|NCT01088399|102127120|FG001|Overall Study|Sponsor decision|298|||
33611905|NCT01088399|102127121|FG002|Overall Study|Sponsor decision|7|||
33611906|NCT01088399|102127119|FG000|Overall Study|Protocol Violation|10|||
33611907|NCT01088399|102127120|FG001|Overall Study|Protocol Violation|1|||
33611908|NCT01088399|102127121|FG002|Overall Study|Protocol Violation|0|||
33611909|NCT01088399|102127119|FG000|Overall Study|Enrollment criteria not met|48|||
33611910|NCT01088399|102127120|FG001|Overall Study|Enrollment criteria not met|119|||
33611911|NCT01088399|102127121|FG002|Overall Study|Enrollment criteria not met|70|||
33611912|NCT01088399|102127119|FG000|Overall Study|Study summary visit not completed|2398|||
33611913|NCT01088399|102127120|FG001|Overall Study|Study summary visit not completed|283|||
33611914|NCT01088399|102127121|FG002|Overall Study|Study summary visit not completed|80|||
33611915|NCT00856297|102127123|FG000|Overall Study|Unable to classify|2|||
33611916|NCT00856297|102127124|FG001|Overall Study|Unable to classify|0|||
33611917|NCT00856297|102127125|FG002|Overall Study|Unable to classify|0|||
33611918|NCT00856297|102127126|FG003|Overall Study|Unable to classify|0|||
33611919|NCT00856297|102127127|FG004|Overall Study|Unable to classify|0|||
33611920|NCT00528801|102127130|FG000|Overall Study|Withdrawal by Subject|1|||
33611921|NCT00528801|102127131|FG001|Overall Study|Withdrawal by Subject|1|||
33611922|NCT00528801|102127130|FG000|Overall Study|Protocol Violation|11|||
33611923|NCT00528801|102127131|FG001|Overall Study|Protocol Violation|5|||
33611924|NCT00528801|102127130|FG000|Overall Study|Lost to Follow-up|15|||
33611925|NCT00528801|102127131|FG001|Overall Study|Lost to Follow-up|4|||
33611926|NCT00528801|102127130|FG000|Overall Study|Administrative Reasons|0|||
33530967|NCT00527826|101841903|FG000|Overall Study|Withdrawal by Subject|5|||
33530968|NCT00527826|101841904|FG001|Overall Study|Withdrawal by Subject|8|||
33530969|NCT00527826|101841903|FG000|Overall Study|Inclusion Criteria Not Met|3|||
33611927|NCT00528801|102127131|FG001|Overall Study|Administrative Reasons|1|||
33205419|NCT01490632|100651543|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
33205420|NCT01490632|100651544|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
33205421|NCT01490632|100651545|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
33205422|NCT01490632|100651546|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
33205423|NCT01490632|100651547|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
33205424|NCT01490632|100651548|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
33205425|NCT01490632|100651549|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
33205426|NCT01490632|100651550|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
33205427|NCT01490632|100651551|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
33205428|NCT01490632|100651532|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
33205429|NCT01490632|100651533|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
33205430|NCT01490632|100651534|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
33205431|NCT01490632|100651535|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
33205432|NCT01490632|100651536|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
33205433|NCT01490632|100651537|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
33205434|NCT01490632|100651538|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
33530970|NCT00527826|101841904|FG001|Overall Study|Inclusion Criteria Not Met|3|||
33530971|NCT00527826|101841903|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
33530972|NCT00527826|101841904|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
33530973|NCT00527826|101841903|FG000|Overall Study|Additional Intake of Viani forte|0|||
33530974|NCT00527826|101841904|FG001|Overall Study|Additional Intake of Viani forte|1|||
33530975|NCT00527826|101841903|FG000|Overall Study|Participant moved away|0|||
33530976|NCT00527826|101841904|FG001|Overall Study|Participant moved away|1|||
33530977|NCT01421641|101841905|FG000|Overall Study|Protocol Violation|2|||
33530978|NCT01421641|101841906|FG001|Overall Study|Protocol Violation|2|||
33530979|NCT00196105|101841913|FG000|Overall Study|Lost to Follow-up|4|||
33530980|NCT00196105|101841914|FG001|Overall Study|Lost to Follow-up|5|||
33530981|NCT00196105|101841915|FG002|Overall Study|Lost to Follow-up|7|||
33530982|NCT00697593|101841916|FG000|Overall Study|Adverse Event|3|||
33530983|NCT00697593|101841916|FG000|Overall Study|Protocol Violation|1|||
33530984|NCT00697593|101841916|FG000|Overall Study|Lack of Efficacy|3|||
33530985|NCT00697593|101841916|FG000|Overall Study|Suspension of the study by sponsor|12|||
33530986|NCT00685360|101841917|FG000|Overall Study|Lost to Follow-up|0|||
33530987|NCT00685360|101841918|FG001|Overall Study|Lost to Follow-up|1|||
33530988|NCT00685360|101841919|FG002|Overall Study|Lost to Follow-up|2|||
33530989|NCT00685360|101841917|FG000|Overall Study|Adverse Event|4|||
33530990|NCT00685360|101841918|FG001|Overall Study|Adverse Event|6|||
33530991|NCT00685360|101841919|FG002|Overall Study|Adverse Event|4|||
33530992|NCT00685360|101841917|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
33205435|NCT01490632|100651539|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
33530993|NCT00685360|101841918|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
33530994|NCT00685360|101841919|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
33530995|NCT00685360|101841917|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
33611928|NCT00238238|102129995|FG000|Overall Study|Withdrawal by Subject|0|||
33611929|NCT00238238|102129996|FG001|Overall Study|Withdrawal by Subject|3|||
33611930|NCT00238238|102129997|FG002|Overall Study|Withdrawal by Subject|0|||
33205436|NCT01490632|100651540|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
33205437|NCT01490632|100651541|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
33205438|NCT01490632|100651542|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
33336593|NCT01928381|101124560|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
33336594|NCT01928381|101124561|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
33336595|NCT01928381|101124562|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
33336596|NCT01928381|101124563|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
33404184|NCT02185040|101369432|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
33404185|NCT02185040|101369433|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
33404186|NCT02185040|101369427|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
33404187|NCT02185040|101369428|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
33404188|NCT02185040|101369429|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
33404189|NCT02185040|101369430|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
33404190|NCT02185040|101369431|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
33404191|NCT02185040|101369432|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
33404192|NCT02185040|101369433|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
33404193|NCT02185040|101369427|FG000|Active Treatment Extension Phase|Adverse Event|0|||
33404194|NCT02185040|101369428|FG001|Active Treatment Extension Phase|Adverse Event|0|||
33611931|NCT01504841|102129998|FG000|Overall Study|Withdrawal by Subject|1|||
33404195|NCT02185040|101369429|FG002|Active Treatment Extension Phase|Adverse Event|0|||
33404196|NCT02185040|101369430|FG003|Active Treatment Extension Phase|Adverse Event|0|||
33404197|NCT02185040|101369431|FG004|Active Treatment Extension Phase|Adverse Event|0|||
33404198|NCT02185040|101369432|FG005|Active Treatment Extension Phase|Adverse Event|1|||
33404199|NCT02185040|101369433|FG006|Active Treatment Extension Phase|Adverse Event|4|||
33404200|NCT02185040|101369427|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
33404201|NCT02185040|101369428|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
33404202|NCT02185040|101369429|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
33404203|NCT02185040|101369430|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
33404204|NCT02185040|101369431|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
33404205|NCT02185040|101369432|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
33404206|NCT02185040|101369433|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
33404207|NCT02185040|101369427|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
33404208|NCT02185040|101369428|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
33404209|NCT02185040|101369429|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
33404210|NCT02185040|101369430|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
33404211|NCT02185040|101369431|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
33404212|NCT02185040|101369432|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
33404213|NCT02185040|101369433|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
33404214|NCT01731951|101369434|FG000|Overall Study|Documented Disease Progression|1|||
33611932|NCT01504841|102129999|FG001|Overall Study|Withdrawal by Subject|1|||
33611933|NCT01504841|102130000|FG002|Overall Study|Withdrawal by Subject|0|||
33611934|NCT01099397|102130004|FG000|Overall Study|Lost to Follow-up|4|||
33611935|NCT01099397|102130004|FG000|Overall Study|Protocol Violation|4|||
33611936|NCT01099397|102130004|FG000|Overall Study|Withdrawal by Subject|5|||
33611937|NCT01192412|102130009|FG000|Overall Study|Lost to Follow-up|2|||
33611938|NCT01192412|102130010|FG001|Overall Study|Lost to Follow-up|1|||
33611939|NCT01192412|102130009|FG000|Overall Study|Withdrawal by Subject|2|||
33336597|NCT01928381|101124564|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
33336598|NCT01928381|101124565|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
33336599|NCT01928381|101124559|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
33611940|NCT01192412|102130010|FG001|Overall Study|Withdrawal by Subject|1|||
33611941|NCT00296140|102130011|FG000|Overall Study|Lost to Follow-up|1|||
33611942|NCT00296140|102130012|FG001|Overall Study|Lost to Follow-up|0|||
33611943|NCT00296140|102130011|FG000|Overall Study|Withdrawal by Subject|1|||
33611944|NCT00296140|102130012|FG001|Overall Study|Withdrawal by Subject|0|||
33611945|NCT00296140|102130011|FG000|Overall Study|Discharge to Nursing Home|1|||
33611946|NCT00296140|102130012|FG001|Overall Study|Discharge to Nursing Home|0|||
33611947|NCT00348309|102130014|FG000|Overall Study|Adverse Event|56|||
33611948|NCT00348309|102130015|FG001|Overall Study|Adverse Event|28|||
33611949|NCT00348309|102130016|FG002|Overall Study|Adverse Event|63|||
33611950|NCT00348309|102130014|FG000|Overall Study|Lost to Follow-up|6|||
33611951|NCT00348309|102130015|FG001|Overall Study|Lost to Follow-up|7|||
33611952|NCT00348309|102130016|FG002|Overall Study|Lost to Follow-up|4|||
33611953|NCT00348309|102130014|FG000|Overall Study|Protocol Violation|7|||
33611954|NCT00348309|102130015|FG001|Overall Study|Protocol Violation|12|||
33611955|NCT00348309|102130016|FG002|Overall Study|Protocol Violation|7|||
33611956|NCT00348309|102130014|FG000|Overall Study|Withdrawal by Subject|33|||
33336600|NCT01928381|101124560|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
33336601|NCT01928381|101124561|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
33336602|NCT01928381|101124562|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
33336603|NCT01928381|101124563|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
33336604|NCT01928381|101124564|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
33336605|NCT01928381|101124565|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
33336606|NCT01928381|101124559|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
33336607|NCT01928381|101124560|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
33336608|NCT01928381|101124561|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
33336609|NCT01928381|101124562|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
33336610|NCT01928381|101124563|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
33336611|NCT01928381|101124564|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
33336612|NCT01928381|101124565|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
33336613|NCT01928381|101124559|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
33336614|NCT01928381|101124560|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
33336615|NCT01928381|101124561|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
33336616|NCT01928381|101124562|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
33336617|NCT01928381|101124563|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
33336618|NCT01928381|101124564|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
33336619|NCT01928381|101124565|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
33336620|NCT01928381|101124559|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
33336621|NCT01928381|101124560|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
33336622|NCT01928381|101124561|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
33336623|NCT01928381|101124562|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
33336624|NCT01928381|101124563|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
33336625|NCT01928381|101124564|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
33336626|NCT01928381|101124565|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
33336627|NCT01928381|101124559|FG000|Washout First Intervention|Protocol Violation|0|||
33336628|NCT01928381|101124560|FG001|Washout First Intervention|Protocol Violation|0|||
33336629|NCT01928381|101124561|FG002|Washout First Intervention|Protocol Violation|0|||
33336630|NCT01928381|101124562|FG003|Washout First Intervention|Protocol Violation|0|||
33205439|NCT01490632|100651543|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
33205440|NCT01490632|100651544|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
33404215|NCT01731951|101369435|FG001|Overall Study|Documented Disease Progression|0|||
33404216|NCT01731951|101369436|FG002|Overall Study|Documented Disease Progression|0|||
33404217|NCT01731951|101369437|FG003|Overall Study|Documented Disease Progression|0|||
33404218|NCT01731951|101369438|FG004|Overall Study|Documented Disease Progression|0|||
33404219|NCT01731951|101369439|FG005|Overall Study|Documented Disease Progression|0|||
33404220|NCT01731951|101369434|FG000|Overall Study|Lost to Follow-up|2|||
33404221|NCT01731951|101369435|FG001|Overall Study|Lost to Follow-up|0|||
33404222|NCT01731951|101369436|FG002|Overall Study|Lost to Follow-up|0|||
33336631|NCT01928381|101124563|FG004|Washout First Intervention|Protocol Violation|1|||
33336632|NCT01928381|101124564|FG005|Washout First Intervention|Protocol Violation|0|||
33336633|NCT01928381|101124565|FG006|Washout First Intervention|Protocol Violation|0|||
33336634|NCT01928381|101124559|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
33336635|NCT01928381|101124560|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
33205441|NCT01490632|100651545|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
33530996|NCT00685360|101841918|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
33530997|NCT00685360|101841919|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
33530998|NCT00685360|101841917|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
33530999|NCT00685360|101841918|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
33531000|NCT00685360|101841919|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
33531001|NCT00685360|101841917|FG000|Overall Study|Protocol Deviation|0|||
33205442|NCT01490632|100651546|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
33205443|NCT01490632|100651547|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
33205444|NCT01490632|100651548|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
33205445|NCT01490632|100651549|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
33205446|NCT01490632|100651550|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
33205447|NCT01490632|100651551|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
33531002|NCT00685360|101841918|FG001|Overall Study|Protocol Deviation|1|||
33531003|NCT00685360|101841919|FG002|Overall Study|Protocol Deviation|1|||
33531004|NCT03143101|101844821|FG000|Overall Study|Withdrawal by Subject|0|||
33205448|NCT01490632|100651532|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
33205449|NCT01490632|100651533|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
33205450|NCT01490632|100651534|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33205451|NCT01490632|100651535|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
33205452|NCT01490632|100651536|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
33205453|NCT01490632|100651537|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33205454|NCT01490632|100651538|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33205455|NCT01490632|100651539|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33531005|NCT03143101|101844822|FG001|Overall Study|Withdrawal by Subject|1|||
33336636|NCT01928381|101124561|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
33205456|NCT01490632|100651540|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33205457|NCT01490632|100651541|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33336637|NCT01928381|101124562|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
33336638|NCT01928381|101124563|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
33336639|NCT01928381|101124564|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
33336640|NCT01928381|101124565|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
33404223|NCT01731951|101369437|FG003|Overall Study|Lost to Follow-up|1|||
33205458|NCT01490632|100651542|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33205459|NCT01490632|100651543|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33205460|NCT01490632|100651544|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33205461|NCT01490632|100651545|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33205462|NCT01490632|100651546|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33205463|NCT01490632|100651547|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33205464|NCT01490632|100651548|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33205465|NCT01490632|100651549|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33205466|NCT01490632|100651550|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33531006|NCT03143101|101844823|FG002|Overall Study|Withdrawal by Subject|0|||
33531007|NCT03143101|101844821|FG000|Overall Study|Lost to Follow-up|2|||
33531008|NCT03143101|101844822|FG001|Overall Study|Lost to Follow-up|2|||
33531009|NCT03143101|101844823|FG002|Overall Study|Lost to Follow-up|0|||
33531010|NCT00792909|101844826|FG000|Overall Study|Withdrawal by Subject|0|||
33531011|NCT00792909|101844827|FG001|Overall Study|Withdrawal by Subject|1|||
33531012|NCT00792909|101844828|FG002|Overall Study|Withdrawal by Subject|0|||
33531013|NCT02526160|101844831|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
33531014|NCT02526160|101844832|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
33531015|NCT02526160|101844831|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
33531016|NCT02526160|101844832|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
33531017|NCT02526160|101844831|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
33531018|NCT02526160|101844832|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
33531019|NCT02526160|101844831|FG000|Open-Label Treatment Extension Period I|Death|0|||
33531020|NCT02526160|101844832|FG001|Open-Label Treatment Extension Period I|Death|1|||
33531021|NCT02526160|101844831|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
33531022|NCT02526160|101844832|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
33531023|NCT02526160|101844831|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
33531024|NCT02526160|101844832|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
33531025|NCT02526160|101844831|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
33531026|NCT02526160|101844832|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
33531027|NCT02526160|101844831|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
33531028|NCT02526160|101844832|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
33531029|NCT02465437|101844833|FG000|Overall Study|Physician Decision|0|||
33531030|NCT02465437|101844834|FG001|Overall Study|Physician Decision|0|||
33531031|NCT02465437|101844835|FG002|Overall Study|Physician Decision|1|||
33531032|NCT02465437|101844836|FG003|Overall Study|Physician Decision|0|||
33531033|NCT02465437|101844833|FG000|Overall Study|Withdrawal by Subject|1|||
33531034|NCT02465437|101844834|FG001|Overall Study|Withdrawal by Subject|0|||
33531035|NCT02465437|101844835|FG002|Overall Study|Withdrawal by Subject|0|||
33531036|NCT02465437|101844836|FG003|Overall Study|Withdrawal by Subject|1|||
33531037|NCT02465437|101844833|FG000|Overall Study|Adverse Event|0|||
33531038|NCT02465437|101844834|FG001|Overall Study|Adverse Event|1|||
33531039|NCT02465437|101844835|FG002|Overall Study|Adverse Event|0|||
33531040|NCT02465437|101844836|FG003|Overall Study|Adverse Event|0|||
33531041|NCT03113968|101844837|FG000|Overall Study|Withdrawal by Subject|31|||
33531042|NCT03113968|101844838|FG001|Overall Study|Withdrawal by Subject|4|||
33531043|NCT00943397|101844839|FG000|Overall Study|Adverse Event|0|||
33531044|NCT00943397|101844840|FG001|Overall Study|Adverse Event|6|||
33531045|NCT00943397|101844839|FG000|Overall Study|Lost to Follow-up|0|||
33531046|NCT00943397|101844840|FG001|Overall Study|Lost to Follow-up|4|||
33531047|NCT00943397|101844839|FG000|Overall Study|Protocol Violation|2|||
33531048|NCT00943397|101844840|FG001|Overall Study|Protocol Violation|5|||
33531049|NCT00943397|101844839|FG000|Overall Study|Withdrawal by Subject|1|||
33205467|NCT01490632|100651551|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
33531050|NCT00943397|101844840|FG001|Overall Study|Withdrawal by Subject|1|||
33531051|NCT00943397|101844839|FG000|Overall Study|Site terminated and other|12|||
33531052|NCT00943397|101844840|FG001|Overall Study|Site terminated and other|56|||
33531053|NCT03586050|101844844|FG000|Overall Study|Death|3|||
33531054|NCT03586050|101844844|FG000|Overall Study|Withdrawal by Subject|2|||
33531055|NCT02600923|101844845|FG000|Overall Study|Death|10|||
33531056|NCT02600923|101844845|FG000|Overall Study|Adverse Event|3|||
33404224|NCT01731951|101369438|FG004|Overall Study|Lost to Follow-up|3|||
33531057|NCT02600923|101844845|FG000|Overall Study|Global deterioration of health status|2|||
33531058|NCT02600923|101844845|FG000|Overall Study|Insufficient clinical response|6|||
33531059|NCT02600923|101844845|FG000|Overall Study|Lost to Follow-up|1|||
33531060|NCT02600923|101844845|FG000|Overall Study|Withdrawal by Subject|5|||
33531061|NCT02600923|101844845|FG000|Overall Study|Objective progression or relapse|50|||
33531062|NCT02600923|101844845|FG000|Overall Study|Study terminated by Sponsor|53|||
33531063|NCT02600923|101844845|FG000|Overall Study|Not treated|1|||
33531064|NCT03335813|101844846|FG000|Overall Study|Withdrawal by Subject|1|||
33531065|NCT01001520|101844848|FG000|Medication Period 1|Withdrawal by Subject|2|||
33336641|NCT01928381|101124559|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
33205468|NCT01490632|100651532|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205469|NCT01490632|100651533|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205470|NCT01490632|100651534|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33336642|NCT01928381|101124560|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
33336643|NCT01928381|101124561|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
33336644|NCT01928381|101124562|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
33336645|NCT01928381|101124563|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
33336646|NCT01928381|101124564|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
33336647|NCT01928381|101124565|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
33336648|NCT00278993|101124569|FG000|Overall Study|Adverse Event|24|||
33336649|NCT00278993|101124569|FG000|Overall Study|Withdrawal by Subject|5|||
33336650|NCT00278993|101124569|FG000|Overall Study|Progressive Disease|65|||
33336651|NCT00278993|101124569|FG000|Overall Study|Physician Decision|9|||
33336652|NCT00278993|101124569|FG000|Overall Study|Not Otherwise Specified|4|||
33336653|NCT01632566|101124570|FG000|Overall Study|Withdrawal by Subject|0|||
33336654|NCT01632566|101124571|FG001|Overall Study|Withdrawal by Subject|1|||
33336655|NCT01632566|101124572|FG002|Overall Study|Withdrawal by Subject|0|||
33336656|NCT01632566|101124573|FG003|Overall Study|Withdrawal by Subject|0|||
33336657|NCT01632566|101124574|FG004|Overall Study|Withdrawal by Subject|0|||
33336658|NCT01632566|101124570|FG000|Overall Study|Sponsor Decision|0|||
33336659|NCT01632566|101124571|FG001|Overall Study|Sponsor Decision|2|||
33336660|NCT01632566|101124572|FG002|Overall Study|Sponsor Decision|9|||
33336661|NCT01632566|101124573|FG003|Overall Study|Sponsor Decision|2|||
33336662|NCT01632566|101124574|FG004|Overall Study|Sponsor Decision|2|||
33336663|NCT00980200|101124575|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
33336664|NCT00980200|101124576|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
33336665|NCT00980200|101124577|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
33336666|NCT00980200|101124578|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
33336667|NCT00980200|101124579|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
33336668|NCT00980200|101124575|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
33336669|NCT00980200|101124576|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
33531066|NCT01001520|101844849|FG001|Medication Period 1|Withdrawal by Subject|2|||
33531067|NCT01001520|101844848|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
33531068|NCT01001520|101844849|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
33531069|NCT01001520|101844848|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
33531070|NCT01001520|101844849|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
33531071|NCT01001520|101844848|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
33531072|NCT01001520|101844849|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
33531073|NCT01001520|101844848|FG000|Washout Period|Withdrawal by Subject|2|||
33531074|NCT01001520|101844849|FG001|Washout Period|Withdrawal by Subject|1|||
33531075|NCT01001520|101844848|FG000|Medication Period 2|Withdrawal by Subject|0|||
33531076|NCT01001520|101844849|FG001|Medication Period 2|Withdrawal by Subject|3|||
33531077|NCT01307891|101844850|FG000|Overall Study|Progressive Disease|3|||
33531078|NCT01307891|101844851|FG001|Overall Study|Progressive Disease|1|||
33531079|NCT02111174|101844852|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
33531080|NCT02111174|101844853|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
33531081|NCT02111174|101844852|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
33531082|NCT02111174|101844853|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
33531083|NCT02111174|101844852|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
33531084|NCT02111174|101844853|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
33531085|NCT02111174|101844852|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
33531086|NCT02111174|101844853|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
33531087|NCT01869777|101844854|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
33531088|NCT01302418|101844855|FG000|Overall Study|Protocol Violation|9|||
33531089|NCT01302418|101844855|FG000|Overall Study|Non-evaluable|9|||
33531090|NCT01733121|101844856|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
33531091|NCT01733121|101844857|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
33531092|NCT01733121|101844856|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
33531093|NCT01733121|101844857|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
33531094|NCT01733121|101844856|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
33531095|NCT01733121|101844857|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
33531096|NCT01733121|101844856|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
33531097|NCT01733121|101844857|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
33531098|NCT01247350|101844861|FG000|Overall Study|Adverse Event|0|||
33531099|NCT01247350|101844862|FG001|Overall Study|Adverse Event|0|||
33531100|NCT01247350|101844863|FG002|Overall Study|Adverse Event|1|||
33531101|NCT01247350|101844864|FG003|Overall Study|Adverse Event|0|||
33531102|NCT01247350|101844865|FG004|Overall Study|Adverse Event|0|||
33531103|NCT01247350|101844861|FG000|Overall Study|Withdrawal by Subject|0|||
33531104|NCT01247350|101844862|FG001|Overall Study|Withdrawal by Subject|0|||
33531105|NCT01247350|101844863|FG002|Overall Study|Withdrawal by Subject|0|||
33531106|NCT01247350|101844864|FG003|Overall Study|Withdrawal by Subject|1|||
33531107|NCT01247350|101844865|FG004|Overall Study|Withdrawal by Subject|0|||
33531108|NCT01247350|101844861|FG000|Overall Study|Entry criteria not met|0|||
33531109|NCT01247350|101844862|FG001|Overall Study|Entry criteria not met|0|||
33531110|NCT01247350|101844863|FG002|Overall Study|Entry criteria not met|0|||
33531111|NCT01247350|101844864|FG003|Overall Study|Entry criteria not met|0|||
33531112|NCT01247350|101844865|FG004|Overall Study|Entry criteria not met|1|||
33531113|NCT00753675|101844868|FG000|Overall Study|other reason|11|||
33531114|NCT00753675|101844869|FG001|Overall Study|other reason|12|||
33531115|NCT00753675|101844870|FG002|Overall Study|other reason|13|||
33531116|NCT00753675|101844868|FG000|Overall Study|Death|1|||
33531117|NCT00753675|101844869|FG001|Overall Study|Death|2|||
33531118|NCT00753675|101844870|FG002|Overall Study|Death|4|||
33531119|NCT00753675|101844868|FG000|Overall Study|Adverse Event|11|||
33531120|NCT00753675|101844869|FG001|Overall Study|Adverse Event|9|||
33531121|NCT00753675|101844870|FG002|Overall Study|Adverse Event|4|||
33531122|NCT00753675|101844868|FG000|Overall Study|Objective progression of disease|35|||
33531123|NCT00753675|101844869|FG001|Overall Study|Objective progression of disease|35|||
33531124|NCT00753675|101844870|FG002|Overall Study|Objective progression of disease|35|||
33611957|NCT00348309|102130015|FG001|Overall Study|Withdrawal by Subject|37|||
33531125|NCT00753675|101844868|FG000|Overall Study|Withdrawal by Subject|0|||
33531126|NCT00753675|101844869|FG001|Overall Study|Withdrawal by Subject|1|||
33531127|NCT00753675|101844870|FG002|Overall Study|Withdrawal by Subject|0|||
33611958|NCT00348309|102130016|FG002|Overall Study|Withdrawal by Subject|40|||
33531128|NCT00753675|101844868|FG000|Overall Study|Lost to Follow-up|1|||
33531129|NCT00753675|101844869|FG001|Overall Study|Lost to Follow-up|0|||
33531130|NCT00753675|101844870|FG002|Overall Study|Lost to Follow-up|0|||
33531131|NCT00943592|101844873|FG000|Overall Study|Death|3|||
33531132|NCT02007720|101844874|FG000|Overall Study|Withdrawal by Subject|9|||
33531133|NCT02007720|101844875|FG001|Overall Study|Withdrawal by Subject|11|||
33611959|NCT00348309|102130014|FG000|Overall Study|Non-compliance|8|||
33531134|NCT02007720|101844874|FG000|Overall Study|study terminated by sponsor|58|||
33531135|NCT02007720|101844875|FG001|Overall Study|study terminated by sponsor|54|||
33531136|NCT02007720|101844874|FG000|Overall Study|technical problem|4|||
33531137|NCT02007720|101844875|FG001|Overall Study|technical problem|2|||
33531138|NCT02007720|101844874|FG000|Overall Study|patient followd less than 165 days|11|||
33531139|NCT02007720|101844875|FG001|Overall Study|patient followd less than 165 days|5|||
33531140|NCT04530838|101844882|FG000|Overall Study|Other|2|||
33531141|NCT04530838|101844883|FG001|Overall Study|Other|1|||
33531142|NCT04530838|101844884|FG002|Overall Study|Other|0|||
33531143|NCT04530838|101844882|FG000|Overall Study|Physician Decision|0|||
33531144|NCT04530838|101844883|FG001|Overall Study|Physician Decision|0|||
33531145|NCT04530838|101844884|FG002|Overall Study|Physician Decision|1|||
33531146|NCT04530838|101844882|FG000|Overall Study|Death|0|||
33531147|NCT04530838|101844883|FG001|Overall Study|Death|0|||
33531148|NCT04530838|101844884|FG002|Overall Study|Death|1|||
33531149|NCT04530838|101844882|FG000|Overall Study|Adverse Event|0|||
33531150|NCT04530838|101844883|FG001|Overall Study|Adverse Event|1|||
33531151|NCT04530838|101844884|FG002|Overall Study|Adverse Event|0|||
33531152|NCT04530838|101844882|FG000|Overall Study|No longer meets eligibility criteria|1|||
33531153|NCT04530838|101844883|FG001|Overall Study|No longer meets eligibility criteria|0|||
33531154|NCT04530838|101844884|FG002|Overall Study|No longer meets eligibility criteria|2|||
33531155|NCT04530838|101844882|FG000|Overall Study|Withdrawal by parent/guardian|5|||
33531156|NCT04530838|101844883|FG001|Overall Study|Withdrawal by parent/guardian|2|||
33531157|NCT04530838|101844884|FG002|Overall Study|Withdrawal by parent/guardian|2|||
33531158|NCT00666211|101844885|FG000|Overall Study|Withdrawal by Subject|10|||
33531159|NCT00666211|101844886|FG001|Overall Study|Withdrawal by Subject|13|||
33531160|NCT00666211|101844885|FG000|Overall Study|went off medication, no more pain|1|||
33531161|NCT00666211|101844886|FG001|Overall Study|went off medication, no more pain|0|||
33531162|NCT00666211|101844885|FG000|Overall Study|patient non-compliant|6|||
33531163|NCT00666211|101844886|FG001|Overall Study|patient non-compliant|6|||
33531164|NCT00666211|101844885|FG000|Overall Study|disease progression|1|||
33531165|NCT00666211|101844886|FG001|Overall Study|disease progression|8|||
33531166|NCT00666211|101844885|FG000|Overall Study|Lost to Follow-up|2|||
33531167|NCT00666211|101844886|FG001|Overall Study|Lost to Follow-up|0|||
33531168|NCT00666211|101844885|FG000|Overall Study|toxicity|0|||
33531169|NCT00666211|101844886|FG001|Overall Study|toxicity|2|||
33205471|NCT01490632|100651535|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205472|NCT01490632|100651536|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
33205473|NCT01490632|100651537|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205474|NCT01490632|100651538|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205475|NCT01490632|100651539|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205476|NCT01490632|100651540|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205477|NCT01490632|100651541|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205478|NCT01490632|100651542|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205479|NCT01490632|100651543|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33336670|NCT00980200|101124577|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
33336671|NCT00980200|101124578|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
33336672|NCT00980200|101124579|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
33336673|NCT01344876|101124580|FG000|Overall Study|Adverse Event|0|||
33336674|NCT01344876|101124581|FG001|Overall Study|Adverse Event|0|||
33336675|NCT01344876|101124582|FG002|Overall Study|Adverse Event|0|||
33336676|NCT01344876|101124583|FG003|Overall Study|Adverse Event|0|||
33336677|NCT01344876|101124584|FG004|Overall Study|Adverse Event|1|||
33336678|NCT01344876|101124580|FG000|Overall Study|Withdrawal by Subject|0|||
33336679|NCT01344876|101124581|FG001|Overall Study|Withdrawal by Subject|0|||
33531170|NCT00666211|101844885|FG000|Overall Study|hospital admission|0|||
33531171|NCT00666211|101844886|FG001|Overall Study|hospital admission|5|||
33531172|NCT00666211|101844885|FG000|Overall Study|Death|0|||
33531173|NCT00666211|101844886|FG001|Overall Study|Death|2|||
33531174|NCT00666211|101844885|FG000|Overall Study|off tx for other complicating disease|0|||
33531175|NCT00666211|101844886|FG001|Overall Study|off tx for other complicating disease|1|||
33531176|NCT00666211|101844885|FG000|Overall Study|Physician Decision|0|||
33531177|NCT00666211|101844886|FG001|Overall Study|Physician Decision|1|||
33531178|NCT01619878|101844896|FG000|6 Week Follow-up Phase|Adverse Event|1|||
33336680|NCT01344876|101124582|FG002|Overall Study|Withdrawal by Subject|1|||
33336681|NCT01344876|101124583|FG003|Overall Study|Withdrawal by Subject|0|||
33336682|NCT01344876|101124584|FG004|Overall Study|Withdrawal by Subject|0|||
33336683|NCT01344876|101124580|FG000|Overall Study|Definite progression of primary disease|1|||
33336684|NCT01344876|101124581|FG001|Overall Study|Definite progression of primary disease|0|||
33336685|NCT01344876|101124582|FG002|Overall Study|Definite progression of primary disease|0|||
33336686|NCT01344876|101124583|FG003|Overall Study|Definite progression of primary disease|3|||
33336687|NCT01344876|101124584|FG004|Overall Study|Definite progression of primary disease|0|||
33336688|NCT03189446|101124585|FG000|Overall Study|Adverse Event|2|||
33336689|NCT03189446|101124585|FG000|Overall Study|Withdrawal by Subject|2|||
33336690|NCT03189446|101124585|FG000|Overall Study|Physician Decision|1|||
33336691|NCT00419380|101124590|FG000|Overall Study|Lack of Efficacy|1|||
33336692|NCT00419380|101124591|FG001|Overall Study|Lack of Efficacy|7|||
33336693|NCT00419380|101124590|FG000|Overall Study|Physician Decision|0|||
33336694|NCT00419380|101124591|FG001|Overall Study|Physician Decision|1|||
33336695|NCT00419380|101124590|FG000|Overall Study|Lost to Follow-up|0|||
33336696|NCT00419380|101124591|FG001|Overall Study|Lost to Follow-up|1|||
33336697|NCT00419380|101124590|FG000|Overall Study|Withdrawal by Subject|0|||
33336698|NCT00419380|101124591|FG001|Overall Study|Withdrawal by Subject|1|||
33336699|NCT03864653|101124592|FG000|Overall Study|Withdrawal by Subject|1|||
33336700|NCT02706730|101124611|FG000|Overall Study|Adverse Event|3|||
33336701|NCT02706730|101124611|FG000|Overall Study|Lack of Efficacy|5|||
33336702|NCT02706730|101124611|FG000|Overall Study|Withdrawal by Subject|11|||
33336703|NCT02706730|101124611|FG000|Overall Study|Study Terminated by Sponsor|11|||
33336704|NCT02706730|101124611|FG000|Overall Study|Subject chose not to receive injection|3|||
33336705|NCT04312009|101124619|FG000|Overall Study|Withdrawal by Subject|2|||
33336706|NCT04312009|101124620|FG001|Overall Study|Withdrawal by Subject|1|||
33336707|NCT01324232|101124626|FG000|Overall Study|Protocol Violation|0|||
33336708|NCT01324232|101124627|FG001|Overall Study|Protocol Violation|0|||
33531179|NCT01619878|101844896|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
33531180|NCT01619878|101844896|FG000|Follow-up at 12 Months of Age|Death|2|||
33531181|NCT02542397|101844898|FG000|Overall Study|Death|2|||
33531182|NCT02542397|101844898|FG000|Overall Study|Physician Decision|6|||
33531183|NCT02542397|101844898|FG000|Overall Study|Withdrawal by Subject|6|||
33336709|NCT01324232|101124628|FG002|Overall Study|Protocol Violation|0|||
33336710|NCT01324232|101124629|FG003|Overall Study|Protocol Violation|2|||
33336711|NCT01324232|101124626|FG000|Overall Study|Missing|0|||
33336712|NCT01324232|101124627|FG001|Overall Study|Missing|0|||
33336713|NCT01324232|101124628|FG002|Overall Study|Missing|1|||
33336714|NCT01324232|101124629|FG003|Overall Study|Missing|0|||
33336715|NCT01324232|101124626|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
33336716|NCT01324232|101124627|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
33336717|NCT01324232|101124628|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
33336718|NCT01324232|101124629|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
33336719|NCT01324232|101124626|FG000|Overall Study|Lack of Efficacy|2|||
33336720|NCT01324232|101124627|FG001|Overall Study|Lack of Efficacy|1|||
33404225|NCT01731951|101369439|FG005|Overall Study|Lost to Follow-up|1|||
33404226|NCT01731951|101369434|FG000|Overall Study|Withdrawal of Consent|1|||
33404227|NCT01731951|101369435|FG001|Overall Study|Withdrawal of Consent|0|||
33404228|NCT01731951|101369436|FG002|Overall Study|Withdrawal of Consent|0|||
33404229|NCT01731951|101369437|FG003|Overall Study|Withdrawal of Consent|0|||
33404230|NCT01731951|101369438|FG004|Overall Study|Withdrawal of Consent|0|||
33404231|NCT01731951|101369439|FG005|Overall Study|Withdrawal of Consent|2|||
33404232|NCT01731951|101369434|FG000|Overall Study|Death|13|||
33404233|NCT01731951|101369435|FG001|Overall Study|Death|15|||
33404234|NCT01731951|101369436|FG002|Overall Study|Death|9|||
33404235|NCT01731951|101369437|FG003|Overall Study|Death|8|||
33404236|NCT01731951|101369438|FG004|Overall Study|Death|9|||
33404237|NCT01731951|101369439|FG005|Overall Study|Death|6|||
33404238|NCT00701064|101369440|FG000|Overall Study|Protocol Violation|1|||
33404239|NCT00701064|101369441|FG001|Overall Study|Protocol Violation|1|||
33404240|NCT00701064|101369440|FG000|Overall Study|Withdrawal by Subject|1|||
33404241|NCT00701064|101369441|FG001|Overall Study|Withdrawal by Subject|1|||
33404242|NCT00701064|101369440|FG000|Overall Study|initiated other PTSD treatment|2|||
33404243|NCT00701064|101369441|FG001|Overall Study|initiated other PTSD treatment|2|||
33404244|NCT02127970|101369442|FG000|Overall Study|Adverse Event|2|||
33531184|NCT02542397|101844898|FG000|Overall Study|Lost to Follow-up|2|||
33531185|NCT00762762|101844899|FG000|Overall Study|Did not return for appointments|6|||
33531186|NCT00762762|101844900|FG001|Overall Study|Did not return for appointments|8|||
33336721|NCT01324232|101124628|FG002|Overall Study|Lack of Efficacy|2|||
33336722|NCT01324232|101124629|FG003|Overall Study|Lack of Efficacy|2|||
33404245|NCT02127970|101369443|FG001|Overall Study|Adverse Event|1|||
33404246|NCT02127970|101369442|FG000|Overall Study|Death|1|||
33531187|NCT01405898|101844901|FG000|Overall Study|Withdrawal by Subject|2|||
33336723|NCT01324232|101124626|FG000|Overall Study|Participant Refused Medication|0|||
33404247|NCT02127970|101369443|FG001|Overall Study|Death|1|||
33404248|NCT02127970|101369442|FG000|Overall Study|Lost to Follow-up|14|||
33205480|NCT01490632|100651544|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205481|NCT01490632|100651545|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205482|NCT01490632|100651546|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205483|NCT01490632|100651547|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205484|NCT01490632|100651548|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205485|NCT01490632|100651549|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205486|NCT01490632|100651550|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205487|NCT01490632|100651551|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
33205488|NCT01490632|100651532|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205489|NCT01490632|100651533|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205490|NCT01490632|100651534|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205491|NCT01490632|100651535|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205492|NCT01490632|100651536|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205493|NCT01490632|100651537|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
33205494|NCT01490632|100651538|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
33205495|NCT01490632|100651539|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205496|NCT01490632|100651540|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205497|NCT01490632|100651541|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
33205498|NCT01490632|100651542|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
33205499|NCT01490632|100651543|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
33205500|NCT01490632|100651544|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205501|NCT01490632|100651545|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205502|NCT01490632|100651546|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205503|NCT01490632|100651547|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205504|NCT01490632|100651548|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205505|NCT01490632|100651549|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205506|NCT01490632|100651550|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205507|NCT01490632|100651551|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
33205508|NCT01490632|100651532|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205509|NCT01490632|100651533|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205510|NCT01490632|100651534|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205511|NCT01490632|100651535|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205512|NCT01490632|100651536|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205513|NCT01490632|100651537|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205514|NCT01490632|100651538|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
33205515|NCT01490632|100651539|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205516|NCT01490632|100651540|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
33205517|NCT01490632|100651541|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
33205518|NCT01490632|100651542|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
33205519|NCT01490632|100651543|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33336724|NCT01324232|101124627|FG001|Overall Study|Participant Refused Medication|1|||
33336725|NCT01324232|101124628|FG002|Overall Study|Participant Refused Medication|0|||
33336726|NCT01324232|101124629|FG003|Overall Study|Participant Refused Medication|0|||
33531188|NCT01405898|101844902|FG001|Overall Study|Withdrawal by Subject|2|||
33531189|NCT01951417|101844903|FG000|Overall Study|Withdrawal by Subject|1|||
33531190|NCT01951417|101844903|FG000|Overall Study|Protocol Violation|2|||
33531191|NCT01951417|101844903|FG000|Overall Study|Lost to Follow-up|6|||
33531192|NCT00991289|101844904|FG000|Overall Study|Adverse Event|1|||
33531193|NCT00991289|101844904|FG000|Overall Study|Physician Decision|2|||
33531194|NCT00991289|101844904|FG000|Overall Study|Withdrawal by Subject|3|||
33531195|NCT00991289|101844904|FG000|Overall Study|Lost to Follow-up|4|||
33531196|NCT00991289|101844904|FG000|Overall Study|Protocol Violation|2|||
33531197|NCT02907463|101844905|FG000|Overall Study|Lost to Follow-up|17|||
33531198|NCT02907463|101844905|FG000|Overall Study|Death|10|||
33205520|NCT01490632|100651544|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205521|NCT01490632|100651545|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205522|NCT01490632|100651546|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205523|NCT01490632|100651547|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205524|NCT01490632|100651548|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205525|NCT01490632|100651549|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205526|NCT01490632|100651550|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205527|NCT01490632|100651551|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
33205528|NCT01490632|100651532|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205529|NCT01490632|100651533|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205530|NCT01490632|100651534|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205531|NCT01490632|100651535|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205532|NCT01490632|100651536|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205533|NCT01490632|100651537|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205534|NCT01490632|100651538|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
33205535|NCT01490632|100651539|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205536|NCT01490632|100651540|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205537|NCT01490632|100651541|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
33205538|NCT01490632|100651542|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205539|NCT01490632|100651543|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205540|NCT01490632|100651544|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205541|NCT01490632|100651545|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205542|NCT01490632|100651546|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205543|NCT01490632|100651547|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205544|NCT01490632|100651548|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205545|NCT01490632|100651549|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205546|NCT01490632|100651550|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205547|NCT01490632|100651551|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
33205548|NCT01490632|100651532|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205549|NCT01490632|100651533|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205550|NCT01490632|100651534|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205551|NCT01490632|100651535|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205552|NCT01490632|100651536|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205553|NCT01490632|100651537|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205554|NCT01490632|100651538|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
33205555|NCT01490632|100651539|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205556|NCT01490632|100651540|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205557|NCT01490632|100651541|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205558|NCT01490632|100651542|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205559|NCT01490632|100651543|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205560|NCT01490632|100651544|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205561|NCT01490632|100651545|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205562|NCT01490632|100651546|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205563|NCT01490632|100651547|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205564|NCT01490632|100651548|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205565|NCT01490632|100651549|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205566|NCT01490632|100651550|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205567|NCT01490632|100651551|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
33205568|NCT01490632|100651532|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205569|NCT01490632|100651533|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205570|NCT01490632|100651534|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205571|NCT01490632|100651535|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205572|NCT01490632|100651536|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205573|NCT01490632|100651537|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
33205574|NCT01490632|100651538|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205575|NCT01490632|100651539|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205576|NCT01490632|100651540|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205577|NCT01490632|100651541|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205578|NCT01490632|100651542|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205579|NCT01490632|100651543|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205580|NCT01490632|100651544|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205581|NCT01490632|100651545|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205582|NCT01490632|100651546|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205583|NCT01490632|100651547|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205584|NCT01490632|100651548|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33404249|NCT02127970|101369443|FG001|Overall Study|Lost to Follow-up|14|||
33205585|NCT01490632|100651549|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205586|NCT01490632|100651550|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205587|NCT01490632|100651551|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
33205588|NCT01490632|100651532|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205589|NCT01490632|100651533|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205590|NCT01490632|100651534|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205591|NCT01490632|100651535|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205592|NCT01490632|100651536|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205593|NCT01490632|100651537|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205594|NCT01490632|100651538|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
33531199|NCT02907463|101844905|FG000|Overall Study|Withdrawal by Subject|4|||
33531200|NCT02907463|101844905|FG000|Overall Study|MIS Approach was not used|2|||
33205595|NCT01490632|100651539|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205596|NCT01490632|100651540|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
33205597|NCT01490632|100651541|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205598|NCT01490632|100651542|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
33205599|NCT01490632|100651543|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
33205600|NCT01490632|100651544|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205601|NCT01490632|100651545|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205602|NCT01490632|100651546|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205603|NCT01490632|100651547|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205604|NCT01490632|100651548|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205605|NCT01490632|100651549|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205606|NCT01490632|100651550|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205607|NCT01490632|100651551|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
33205608|NCT01490632|100651532|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33205609|NCT01490632|100651533|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33205610|NCT01490632|100651534|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33205611|NCT01490632|100651535|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33205612|NCT01490632|100651536|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33205613|NCT01490632|100651537|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
33205614|NCT01490632|100651538|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
33205615|NCT01490632|100651539|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
33224369|NCT05044325|100721820|FG009|Part A:Treatment Period 1|Adverse Event|0|||
33336727|NCT01324232|101124626|FG000|Overall Study|Intercurrent illness|0|||
33336728|NCT01324232|101124627|FG001|Overall Study|Intercurrent illness|0|||
33336729|NCT01324232|101124628|FG002|Overall Study|Intercurrent illness|0|||
33336730|NCT01324232|101124629|FG003|Overall Study|Intercurrent illness|1|||
33336731|NCT01324232|101124626|FG000|Overall Study|Adverse Event|2|||
33336732|NCT01324232|101124627|FG001|Overall Study|Adverse Event|5|||
33531201|NCT02907463|101844905|FG000|Overall Study|Not Implanted with Study Device|2|||
33531202|NCT02907463|101844905|FG000|Overall Study|Device Explanted|1|||
33531203|NCT02907463|101844905|FG000|Overall Study|Missing Exit Form|1|||
33531204|NCT01711983|101844907|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
33531205|NCT01711983|101844907|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
33531206|NCT01711983|101844907|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
33531207|NCT01711983|101844907|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
33531208|NCT00181883|101844916|FG000|Overall Study|Lack of Efficacy|2|||
33531209|NCT00181883|101844916|FG000|Overall Study|Treatment Limiting AEs|3|||
33531210|NCT00181883|101844916|FG000|Overall Study|Withdrawal by Subject|4|||
33531211|NCT00181883|101844916|FG000|Overall Study|Lost to Follow-up|1|||
33531212|NCT01697800|101844921|FG000|Overall Study|Death|0|||
33531213|NCT01697800|101844922|FG001|Overall Study|Death|1|||
33531214|NCT02061813|101844935|FG000|Overall Study|Withdrawal by Subject|1|||
33531215|NCT02061813|101844935|FG000|Overall Study|Protocol Violation|2|||
33336733|NCT01324232|101124628|FG002|Overall Study|Adverse Event|6|||
33336734|NCT01324232|101124629|FG003|Overall Study|Adverse Event|6|||
33336735|NCT01324232|101124626|FG000|Overall Study|Withdrawal by Subject|0|||
33336736|NCT01324232|101124627|FG001|Overall Study|Withdrawal by Subject|3|||
33336737|NCT01324232|101124628|FG002|Overall Study|Withdrawal by Subject|4|||
33336738|NCT01324232|101124629|FG003|Overall Study|Withdrawal by Subject|0|||
33531216|NCT02489448|101844941|FG000|Overall Study|Death|3|||
33531217|NCT02489448|101844941|FG000|Overall Study|Withdrawal by Subject|2|||
33531218|NCT00784719|101844947|FG000|Overall Study|Adverse Event|0|||
33531219|NCT00784719|101844948|FG001|Overall Study|Adverse Event|2|||
33531220|NCT00784719|101844949|FG002|Overall Study|Adverse Event|0|||
33531221|NCT00784719|101844950|FG003|Overall Study|Adverse Event|0|||
33531222|NCT00784719|101844951|FG004|Overall Study|Adverse Event|1|||
33531223|NCT00784719|101844952|FG005|Overall Study|Adverse Event|1|||
33336739|NCT01324232|101124626|FG000|Overall Study|Lost to Follow-up|1|||
33336740|NCT01324232|101124627|FG001|Overall Study|Lost to Follow-up|0|||
33336741|NCT01324232|101124628|FG002|Overall Study|Lost to Follow-up|0|||
33336742|NCT01324232|101124629|FG003|Overall Study|Lost to Follow-up|0|||
33336743|NCT00401752|101124630|FG000|Overall Study|Adverse Event|2|||
33336744|NCT00401752|101124631|FG001|Overall Study|Adverse Event|5|||
33336745|NCT00401752|101124630|FG000|Overall Study|Withdrawal by Subject|2|||
33336746|NCT00401752|101124631|FG001|Overall Study|Withdrawal by Subject|6|||
33531224|NCT00784719|101844953|FG006|Overall Study|Adverse Event|1|||
33531225|NCT00784719|101844947|FG000|Overall Study|Lost to Follow-up|0|||
33531226|NCT00784719|101844948|FG001|Overall Study|Lost to Follow-up|0|||
33531227|NCT00784719|101844949|FG002|Overall Study|Lost to Follow-up|0|||
33531228|NCT00784719|101844950|FG003|Overall Study|Lost to Follow-up|0|||
33336747|NCT00401752|101124630|FG000|Overall Study|Lost to Follow-up|1|||
33531229|NCT00784719|101844951|FG004|Overall Study|Lost to Follow-up|1|||
33531230|NCT00784719|101844952|FG005|Overall Study|Lost to Follow-up|1|||
33531231|NCT00784719|101844953|FG006|Overall Study|Lost to Follow-up|0|||
33531232|NCT00784719|101844947|FG000|Overall Study|Other|2|||
33531233|NCT00784719|101844948|FG001|Overall Study|Other|1|||
33531234|NCT00784719|101844949|FG002|Overall Study|Other|1|||
33531235|NCT00784719|101844950|FG003|Overall Study|Other|0|||
33531236|NCT00784719|101844951|FG004|Overall Study|Other|2|||
33531237|NCT00784719|101844952|FG005|Overall Study|Other|1|||
33531238|NCT00784719|101844953|FG006|Overall Study|Other|3|||
33611960|NCT00348309|102130015|FG001|Overall Study|Non-compliance|6|||
33336748|NCT00401752|101124631|FG001|Overall Study|Lost to Follow-up|4|||
33336749|NCT00401752|101124630|FG000|Overall Study|Development of any exclusion criteria|4|||
33336750|NCT00401752|101124631|FG001|Overall Study|Development of any exclusion criteria|2|||
33336751|NCT00401752|101124630|FG000|Overall Study|Physician Decision|1|||
33336752|NCT00401752|101124631|FG001|Overall Study|Physician Decision|1|||
33336753|NCT00307151|101124635|FG000|Overall Study|Death|4|||
33336754|NCT00307151|101124636|FG001|Overall Study|Death|3|||
33336755|NCT00307151|101124637|FG002|Overall Study|Death|10|||
33336756|NCT00307151|101124638|FG003|Overall Study|Death|3|||
33336757|NCT00307151|101124635|FG000|Overall Study|Severe debilitation, unable to continue|1|||
33336758|NCT00307151|101124636|FG001|Overall Study|Severe debilitation, unable to continue|0|||
33336759|NCT00307151|101124637|FG002|Overall Study|Severe debilitation, unable to continue|0|||
33336760|NCT00307151|101124638|FG003|Overall Study|Severe debilitation, unable to continue|0|||
33336761|NCT00307151|101124635|FG000|Overall Study|Subject unable to get to clinic|1|||
33336762|NCT00307151|101124636|FG001|Overall Study|Subject unable to get to clinic|0|||
33336763|NCT00307151|101124637|FG002|Overall Study|Subject unable to get to clinic|6|||
33336764|NCT00307151|101124638|FG003|Overall Study|Subject unable to get to clinic|2|||
33336765|NCT00307151|101124635|FG000|Overall Study|Withdrew consent|0|||
33336766|NCT00307151|101124636|FG001|Overall Study|Withdrew consent|1|||
33611961|NCT00348309|102130016|FG002|Overall Study|Non-compliance|8|||
33611962|NCT00348309|102130014|FG000|Overall Study|Death of caregiver|1|||
33611963|NCT00348309|102130015|FG001|Overall Study|Death of caregiver|0|||
33611964|NCT00348309|102130016|FG002|Overall Study|Death of caregiver|1|||
33336767|NCT00307151|101124637|FG002|Overall Study|Withdrew consent|1|||
33336768|NCT00307151|101124638|FG003|Overall Study|Withdrew consent|3|||
33336769|NCT00307151|101124635|FG000|Overall Study|Not willing to adhere to study reqs|2|||
33336770|NCT00307151|101124636|FG001|Overall Study|Not willing to adhere to study reqs|0|||
33336771|NCT00307151|101124637|FG002|Overall Study|Not willing to adhere to study reqs|2|||
33336772|NCT00307151|101124638|FG003|Overall Study|Not willing to adhere to study reqs|2|||
33336773|NCT00307151|101124635|FG000|Overall Study|Clinic unable to contact subject|3|||
33336774|NCT00307151|101124636|FG001|Overall Study|Clinic unable to contact subject|3|||
33336775|NCT00307151|101124637|FG002|Overall Study|Clinic unable to contact subject|1|||
33336776|NCT00307151|101124638|FG003|Overall Study|Clinic unable to contact subject|1|||
33336777|NCT02830880|101124642|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
33336778|NCT02830880|101124642|FG000|Overall Study|Death|1|||
33336779|NCT02830880|101124642|FG000|Overall Study|Physician Decision|1|||
33336780|NCT03776175|101124643|FG000|Treatment Period (42 Days)|Adverse Event|0|||
33336781|NCT03776175|101124644|FG001|Treatment Period (42 Days)|Adverse Event|1|||
33336782|NCT03776175|101124645|FG002|Treatment Period (42 Days)|Adverse Event|1|||
33336783|NCT03776175|101124646|FG003|Treatment Period (42 Days)|Adverse Event|0|||
33336784|NCT03776175|101124643|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
33336785|NCT03776175|101124644|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
33336786|NCT03776175|101124645|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
33336787|NCT03776175|101124646|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
33336788|NCT03776175|101124643|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
33336789|NCT03776175|101124644|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
33336790|NCT03776175|101124645|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
33336791|NCT03776175|101124646|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
33336792|NCT03776175|101124643|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
33336793|NCT03776175|101124644|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
33336794|NCT03776175|101124645|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
33336795|NCT03776175|101124646|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
33611965|NCT00348309|102130014|FG000|Overall Study|Lack of insight, dementia|1|||
33336796|NCT03776175|101124643|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
33336797|NCT03776175|101124644|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
33336798|NCT03776175|101124645|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
33336799|NCT03776175|101124646|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
33531239|NCT00784719|101844947|FG000|Overall Study|Withdrawal by Subject|1|||
33611966|NCT00348309|102130015|FG001|Overall Study|Lack of insight, dementia|0|||
33611967|NCT00348309|102130016|FG002|Overall Study|Lack of insight, dementia|0|||
33611968|NCT00348309|102130014|FG000|Overall Study|Wrong bottle allocated|1|||
33611969|NCT00348309|102130015|FG001|Overall Study|Wrong bottle allocated|0|||
33611970|NCT00348309|102130016|FG002|Overall Study|Wrong bottle allocated|0|||
33611971|NCT00348309|102130014|FG000|Overall Study|Caregiver sick|1|||
33611972|NCT00348309|102130015|FG001|Overall Study|Caregiver sick|0|||
33611973|NCT00348309|102130016|FG002|Overall Study|Caregiver sick|0|||
33611974|NCT00348309|102130014|FG000|Overall Study|Use of prohibited medication|5|||
33611975|NCT00348309|102130015|FG001|Overall Study|Use of prohibited medication|2|||
33611976|NCT00348309|102130016|FG002|Overall Study|Use of prohibited medication|2|||
33611977|NCT00348309|102130014|FG000|Overall Study|Caregiver withdrawal|3|||
33611978|NCT00348309|102130015|FG001|Overall Study|Caregiver withdrawal|0|||
33611979|NCT00348309|102130016|FG002|Overall Study|Caregiver withdrawal|7|||
33611980|NCT00348309|102130014|FG000|Overall Study|Unable to complete ET visit|1|||
33611981|NCT00348309|102130015|FG001|Overall Study|Unable to complete ET visit|0|||
33611982|NCT00348309|102130016|FG002|Overall Study|Unable to complete ET visit|0|||
33611983|NCT00348309|102130014|FG000|Overall Study|PI closing medical practice|1|||
33336800|NCT03776175|101124643|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
33336801|NCT03776175|101124644|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
33336802|NCT03776175|101124645|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
33336803|NCT03776175|101124646|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
33336804|NCT05779072|101124649|FG000|Overall Study|Lost to Follow-up|0|||
33336805|NCT05779072|101124650|FG001|Overall Study|Lost to Follow-up|1|||
33336806|NCT05779072|101124649|FG000|Overall Study|Withdrawal by Subject|1|||
33336807|NCT05779072|101124650|FG001|Overall Study|Withdrawal by Subject|5|||
33336808|NCT02286947|101124651|FG000|Overall Study|Withdrawal by Subject|2|||
33336809|NCT00744874|101124652|FG000|Overall Study|Lost to Follow-up|1|||
33336810|NCT00744874|101124652|FG000|Overall Study|Withdrawal by Subject|1|||
33336811|NCT00744874|101124652|FG000|Overall Study|Study Device not available at procedure|1|||
33336812|NCT00744874|101124652|FG000|Overall Study|Unable to accomodate schedule|1|||
33336813|NCT01029366|101124653|FG000|Overall Study|Withdrawal by Subject|1|||
33336814|NCT01029366|101124654|FG001|Overall Study|Withdrawal by Subject|0|||
33336815|NCT01029366|101124653|FG000|Overall Study|Death|1|||
33336816|NCT01029366|101124654|FG001|Overall Study|Death|1|||
33336817|NCT01029366|101124653|FG000|Overall Study|disease progression|2|||
33336818|NCT01029366|101124654|FG001|Overall Study|disease progression|0|||
33336819|NCT01029366|101124653|FG000|Overall Study|manufacturing failure|0|||
33336820|NCT01029366|101124654|FG001|Overall Study|manufacturing failure|1|||
33336821|NCT03603496|101124655|FG000|Overall Study|Death|19|||
33336822|NCT03603496|101124656|FG001|Overall Study|Death|24|||
33336823|NCT03603496|101124655|FG000|Overall Study|Lost to Follow-up|141|||
33336824|NCT03603496|101124656|FG001|Overall Study|Lost to Follow-up|141|||
33336825|NCT03603496|101124655|FG000|Overall Study|Withdrawal by Subject|26|||
33336826|NCT03603496|101124656|FG001|Overall Study|Withdrawal by Subject|20|||
33336827|NCT02135692|101124657|FG000|Overall Study|Adverse Event|3|||
33336828|NCT02135692|101124657|FG000|Overall Study|Lack of Efficacy|2|||
33336829|NCT02135692|101124657|FG000|Overall Study|Protocol Violation|2|||
33336830|NCT02135692|101124657|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
33336831|NCT02135692|101124657|FG000|Overall Study|Product commercially available|159|||
33336832|NCT02135692|101124657|FG000|Overall Study|Study closed/terminated|153|||
33336833|NCT02135692|101124657|FG000|Overall Study|Lost to Follow-up|4|||
33336834|NCT02135692|101124657|FG000|Overall Study|Withdrawal by Subject|15|||
33336835|NCT01665144|101124662|FG000|Core Part|Withdrawal by Subject|96|||
33336836|NCT01665144|101124663|FG001|Core Part|Withdrawal by Subject|77|||
33336837|NCT01665144|101124664|FG002|Core Part|Withdrawal by Subject|0|||
33336838|NCT01665144|101124662|FG000|Core Part|Adverse Event|45|||
33336839|NCT01665144|101124663|FG001|Core Part|Adverse Event|18|||
33336840|NCT01665144|101124664|FG002|Core Part|Adverse Event|0|||
33336841|NCT01665144|101124662|FG000|Core Part|Lack of Efficacy|16|||
33336842|NCT01665144|101124663|FG001|Core Part|Lack of Efficacy|11|||
33336843|NCT01665144|101124664|FG002|Core Part|Lack of Efficacy|0|||
33336844|NCT01665144|101124662|FG000|Core Part|Lost to Follow-up|9|||
33404250|NCT02127970|101369442|FG000|Overall Study|Reason not Specified|4|||
33404251|NCT02127970|101369443|FG001|Overall Study|Reason not Specified|7|||
33404252|NCT02127970|101369442|FG000|Overall Study|Pregnancy|0|||
33336845|NCT01665144|101124663|FG001|Core Part|Lost to Follow-up|8|||
33404253|NCT02127970|101369443|FG001|Overall Study|Pregnancy|1|||
33404254|NCT02127970|101369442|FG000|Overall Study|Subject Withdrew Consent|5|||
33336846|NCT01665144|101124664|FG002|Core Part|Lost to Follow-up|0|||
33336847|NCT01665144|101124662|FG000|Core Part|Physician Decision|13|||
33336848|NCT01665144|101124663|FG001|Core Part|Physician Decision|1|||
33336849|NCT01665144|101124664|FG002|Core Part|Physician Decision|0|||
33336850|NCT01665144|101124662|FG000|Core Part|Progressive disease|8|||
33336851|NCT01665144|101124663|FG001|Core Part|Progressive disease|4|||
33336852|NCT01665144|101124664|FG002|Core Part|Progressive disease|0|||
33336853|NCT01665144|101124662|FG000|Core Part|Non-compliance with study treatment|5|||
33336854|NCT01665144|101124663|FG001|Core Part|Non-compliance with study treatment|0|||
33336855|NCT01665144|101124664|FG002|Core Part|Non-compliance with study treatment|0|||
33336856|NCT01665144|101124662|FG000|Core Part|Death|3|||
33336857|NCT01665144|101124663|FG001|Core Part|Death|1|||
33336858|NCT01665144|101124664|FG002|Core Part|Death|0|||
33336859|NCT01665144|101124662|FG000|Core Part|Protocol deviation|3|||
33404255|NCT02127970|101369443|FG001|Overall Study|Subject Withdrew Consent|3|||
33205616|NCT01490632|100651540|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
33205617|NCT01490632|100651541|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
33205618|NCT01490632|100651542|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
33205619|NCT01490632|100651543|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
33205620|NCT01490632|100651544|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33205621|NCT01490632|100651545|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33205622|NCT01490632|100651546|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33205623|NCT01490632|100651547|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33336860|NCT01665144|101124663|FG001|Core Part|Protocol deviation|1|||
33404256|NCT01977573|101369445|FG000|Overall Study|Adverse Event|7|||
33404257|NCT01977573|101369446|FG001|Overall Study|Adverse Event|0|||
33404258|NCT01977573|101369447|FG002|Overall Study|Adverse Event|2|||
33404259|NCT01977573|101369448|FG003|Overall Study|Adverse Event|1|||
33404260|NCT01977573|101369445|FG000|Overall Study|Lost to Follow-up|1|||
33404261|NCT01977573|101369446|FG001|Overall Study|Lost to Follow-up|0|||
33404262|NCT01977573|101369447|FG002|Overall Study|Lost to Follow-up|0|||
33404263|NCT01977573|101369448|FG003|Overall Study|Lost to Follow-up|1|||
33404264|NCT01977573|101369445|FG000|Overall Study|Physician Decision|1|||
33336861|NCT01665144|101124664|FG002|Core Part|Protocol deviation|0|||
33404265|NCT01977573|101369446|FG001|Overall Study|Physician Decision|0|||
33404266|NCT01977573|101369447|FG002|Overall Study|Physician Decision|0|||
33404267|NCT01977573|101369448|FG003|Overall Study|Physician Decision|0|||
33404268|NCT01977573|101369445|FG000|Overall Study|Protocol Violation|3|||
33404269|NCT01977573|101369446|FG001|Overall Study|Protocol Violation|1|||
33404270|NCT01977573|101369447|FG002|Overall Study|Protocol Violation|0|||
33404271|NCT01977573|101369448|FG003|Overall Study|Protocol Violation|0|||
33404272|NCT01977573|101369445|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
33404273|NCT01977573|101369446|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
33404274|NCT01977573|101369447|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
33404275|NCT01977573|101369448|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
33404276|NCT01977573|101369445|FG000|Overall Study|Withdrawal by Subject|6|||
33404277|NCT01977573|101369446|FG001|Overall Study|Withdrawal by Subject|1|||
33404278|NCT01977573|101369447|FG002|Overall Study|Withdrawal by Subject|1|||
33404279|NCT01977573|101369448|FG003|Overall Study|Withdrawal by Subject|1|||
33404280|NCT02681094|101369449|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
33336862|NCT01665144|101124662|FG000|Core Part|New therapy for study indication|2|||
33336863|NCT01665144|101124663|FG001|Core Part|New therapy for study indication|1|||
33336864|NCT01665144|101124664|FG002|Core Part|New therapy for study indication|0|||
33336865|NCT01665144|101124662|FG000|Core Part|Technical problems|2|||
33336866|NCT01665144|101124663|FG001|Core Part|Technical problems|0|||
33336867|NCT01665144|101124664|FG002|Core Part|Technical problems|0|||
33336868|NCT01665144|101124662|FG000|Extension Part|Patient/guardian decision|180|||
33336869|NCT01665144|101124663|FG001|Extension Part|Patient/guardian decision|0|||
33336870|NCT01665144|101124664|FG002|Extension Part|Patient/guardian decision|98|||
33336871|NCT01665144|101124662|FG000|Extension Part|Adverse Event|104|||
33336872|NCT01665144|101124663|FG001|Extension Part|Adverse Event|0|||
33336873|NCT01665144|101124664|FG002|Extension Part|Adverse Event|59|||
33336874|NCT01665144|101124662|FG000|Extension Part|Study closed early|42|||
33336875|NCT01665144|101124663|FG001|Extension Part|Study closed early|0|||
33336876|NCT01665144|101124664|FG002|Extension Part|Study closed early|19|||
33336877|NCT01665144|101124662|FG000|Extension Part|Progressive disease|36|||
33336878|NCT01665144|101124663|FG001|Extension Part|Progressive disease|0|||
33336879|NCT01665144|101124664|FG002|Extension Part|Progressive disease|14|||
33336880|NCT01665144|101124662|FG000|Extension Part|Lack of Efficacy|37|||
33336881|NCT01665144|101124663|FG001|Extension Part|Lack of Efficacy|0|||
33336882|NCT01665144|101124664|FG002|Extension Part|Lack of Efficacy|12|||
33336883|NCT01665144|101124662|FG000|Extension Part|Physician Decision|29|||
33336884|NCT01665144|101124663|FG001|Extension Part|Physician Decision|0|||
33404281|NCT02681094|101369450|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
33404282|NCT02681094|101369451|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
33404283|NCT02681094|101369449|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
33404284|NCT02681094|101369450|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
33336885|NCT01665144|101124664|FG002|Extension Part|Physician Decision|13|||
33336886|NCT01665144|101124662|FG000|Extension Part|Technical problems|20|||
33336887|NCT01665144|101124663|FG001|Extension Part|Technical problems|0|||
33404285|NCT02681094|101369451|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
33336888|NCT01665144|101124664|FG002|Extension Part|Technical problems|8|||
33336889|NCT01665144|101124662|FG000|Extension Part|Death|20|||
33336890|NCT01665144|101124663|FG001|Extension Part|Death|0|||
33404286|NCT02681094|101369449|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
33404287|NCT02681094|101369450|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
33404288|NCT02681094|101369451|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
33404289|NCT02681094|101369449|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
33404290|NCT02681094|101369450|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
33404291|NCT02681094|101369451|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
33404292|NCT02681094|101369449|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
33404293|NCT02681094|101369450|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
33611984|NCT00348309|102130015|FG001|Overall Study|PI closing medical practice|0|||
33611985|NCT00348309|102130016|FG002|Overall Study|PI closing medical practice|0|||
33336891|NCT01665144|101124664|FG002|Extension Part|Death|4|||
33336892|NCT01665144|101124662|FG000|Extension Part|Missing|12|||
33336893|NCT01665144|101124663|FG001|Extension Part|Missing|0|||
33336894|NCT01665144|101124664|FG002|Extension Part|Missing|6|||
33336895|NCT01665144|101124662|FG000|Extension Part|Lost to Follow-up|9|||
33336896|NCT01665144|101124663|FG001|Extension Part|Lost to Follow-up|0|||
33336897|NCT01665144|101124664|FG002|Extension Part|Lost to Follow-up|5|||
33336898|NCT01665144|101124662|FG000|Extension Part|New therapy for study indication|3|||
33611986|NCT00348309|102130014|FG000|Overall Study|Principal investigator's decision|1|||
33611987|NCT00348309|102130015|FG001|Overall Study|Principal investigator's decision|0|||
33611988|NCT00348309|102130016|FG002|Overall Study|Principal investigator's decision|0|||
33336899|NCT01665144|101124663|FG001|Extension Part|New therapy for study indication|0|||
33611989|NCT00348309|102130014|FG000|Overall Study|No disponibility of medication|1|||
33611990|NCT00348309|102130015|FG001|Overall Study|No disponibility of medication|0|||
33611991|NCT00348309|102130016|FG002|Overall Study|No disponibility of medication|0|||
33611992|NCT00348309|102130014|FG000|Overall Study|Worsened neurodegenerative disease|1|||
33611993|NCT00348309|102130015|FG001|Overall Study|Worsened neurodegenerative disease|0|||
33611994|NCT00348309|102130016|FG002|Overall Study|Worsened neurodegenerative disease|0|||
33611995|NCT00348309|102130014|FG000|Overall Study|Cognitive and behaviour worsening|2|||
33611996|NCT00348309|102130015|FG001|Overall Study|Cognitive and behaviour worsening|0|||
33611997|NCT00348309|102130016|FG002|Overall Study|Cognitive and behaviour worsening|0|||
33611998|NCT00348309|102130014|FG000|Overall Study|Worsening of alzheimer|1|||
33611999|NCT00348309|102130015|FG001|Overall Study|Worsening of alzheimer|0|||
33612000|NCT00348309|102130016|FG002|Overall Study|Worsening of alzheimer|1|||
33612001|NCT00348309|102130014|FG000|Overall Study|Did not appear in time for Visit 3|1|||
33612002|NCT00348309|102130015|FG001|Overall Study|Did not appear in time for Visit 3|0|||
33612003|NCT00348309|102130016|FG002|Overall Study|Did not appear in time for Visit 3|0|||
33612004|NCT00348309|102130014|FG000|Overall Study|Participant died|2|||
33612005|NCT00348309|102130015|FG001|Overall Study|Participant died|1|||
33612006|NCT00348309|102130016|FG002|Overall Study|Participant died|1|||
33336900|NCT01665144|101124664|FG002|Extension Part|New therapy for study indication|2|||
33336901|NCT01665144|101124662|FG000|Extension Part|Protocol deviation|3|||
33404294|NCT02681094|101369451|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
33404295|NCT02681094|101369449|FG000|1 -Modified Enrolled Participants Set|Other|6|||
33404296|NCT02681094|101369450|FG001|1 -Modified Enrolled Participants Set|Other|6|||
33404297|NCT02681094|101369451|FG002|1 -Modified Enrolled Participants Set|Other|7|||
33404298|NCT02681094|101369449|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
33404299|NCT02681094|101369450|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
33404300|NCT02681094|101369451|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
33404301|NCT02681094|101369449|FG000|2 - Enrolled Participants Set|Participant decision|7|||
33404302|NCT02681094|101369450|FG001|2 - Enrolled Participants Set|Participant decision|10|||
33404303|NCT02681094|101369451|FG002|2 - Enrolled Participants Set|Participant decision|9|||
33404304|NCT02681094|101369449|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
33404305|NCT02681094|101369450|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
33336902|NCT01665144|101124663|FG001|Extension Part|Protocol deviation|0|||
33336903|NCT01665144|101124664|FG002|Extension Part|Protocol deviation|0|||
33336904|NCT01263639|101124665|FG000|Overall Study|Lost to Follow-up|66|||
33612007|NCT00348309|102130014|FG000|Overall Study|Decision of sponsor|1|||
33612008|NCT00348309|102130015|FG001|Overall Study|Decision of sponsor|0|||
33336905|NCT01263639|101124666|FG001|Overall Study|Lost to Follow-up|70|||
33336906|NCT01263639|101124665|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
33612009|NCT00348309|102130016|FG002|Overall Study|Decision of sponsor|0|||
33612010|NCT00348309|102130014|FG000|Overall Study|Ineffectiveness of treatment|0|||
33612011|NCT00348309|102130015|FG001|Overall Study|Ineffectiveness of treatment|1|||
33612012|NCT00348309|102130016|FG002|Overall Study|Ineffectiveness of treatment|0|||
33205624|NCT01490632|100651548|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33205625|NCT01490632|100651549|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33404306|NCT02681094|101369451|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
33336907|NCT01263639|101124666|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
33336908|NCT00689871|101124667|FG000|Overall Study|Lost to Follow-up|123|||
33531240|NCT00784719|101844948|FG001|Overall Study|Withdrawal by Subject|0|||
33531241|NCT00784719|101844949|FG002|Overall Study|Withdrawal by Subject|0|||
33531242|NCT00784719|101844950|FG003|Overall Study|Withdrawal by Subject|0|||
33531243|NCT00784719|101844951|FG004|Overall Study|Withdrawal by Subject|2|||
33531244|NCT00784719|101844952|FG005|Overall Study|Withdrawal by Subject|0|||
33531245|NCT00784719|101844953|FG006|Overall Study|Withdrawal by Subject|1|||
33531246|NCT00447902|101844954|FG000|Overall Study|Adverse Event|0|||
33531247|NCT00447902|101844955|FG001|Overall Study|Adverse Event|3|||
33205626|NCT01490632|100651550|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33205627|NCT01490632|100651551|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
33205628|NCT01490632|100651532|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
33205629|NCT01490632|100651533|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
33205630|NCT01490632|100651534|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
33205631|NCT01490632|100651535|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
33205632|NCT01490632|100651536|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
33336909|NCT00689871|101124668|FG001|Overall Study|Lost to Follow-up|13|||
33336910|NCT00689871|101124669|FG002|Overall Study|Lost to Follow-up|37|||
33336911|NCT00689871|101124670|FG003|Overall Study|Lost to Follow-up|1|||
33336912|NCT00689871|101124667|FG000|Overall Study|Explanted of All Study Devices|36|||
33336913|NCT00689871|101124668|FG001|Overall Study|Explanted of All Study Devices|25|||
33336914|NCT00689871|101124669|FG002|Overall Study|Explanted of All Study Devices|29|||
33336915|NCT00689871|101124670|FG003|Overall Study|Explanted of All Study Devices|3|||
33336916|NCT00689871|101124667|FG000|Overall Study|Withdrawal by Subject|13|||
33336917|NCT00689871|101124668|FG001|Overall Study|Withdrawal by Subject|3|||
33336918|NCT00689871|101124669|FG002|Overall Study|Withdrawal by Subject|4|||
33336919|NCT00689871|101124670|FG003|Overall Study|Withdrawal by Subject|1|||
33531248|NCT00447902|101844954|FG000|Overall Study|Protocol Violation|1|||
33531249|NCT00447902|101844955|FG001|Overall Study|Protocol Violation|0|||
33531250|NCT00447902|101844954|FG000|Overall Study|Withdrawal by Subject|0|||
33531251|NCT00447902|101844955|FG001|Overall Study|Withdrawal by Subject|1|||
33531252|NCT00447902|101844954|FG000|Overall Study|included patients who discontinued|1|||
33336920|NCT00689871|101124667|FG000|Overall Study|Death|1|||
33531253|NCT00447902|101844955|FG001|Overall Study|included patients who discontinued|1|||
33531254|NCT00447902|101844954|FG000|Overall Study|Lack of Efficacy|2|||
33531255|NCT00447902|101844955|FG001|Overall Study|Lack of Efficacy|1|||
33531256|NCT00707057|101844956|FG000|Overall Study|Withdrawal by Subject|8|||
33336921|NCT00689871|101124668|FG001|Overall Study|Death|10|||
33336922|NCT00689871|101124669|FG002|Overall Study|Death|2|||
33336923|NCT00689871|101124670|FG003|Overall Study|Death|2|||
33404307|NCT02681094|101369449|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
33404308|NCT02681094|101369450|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
33404309|NCT02681094|101369451|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
33531257|NCT00707057|101844957|FG001|Overall Study|Withdrawal by Subject|3|||
33531258|NCT00707057|101844956|FG000|Overall Study|Dosed incorrectly|0|||
33531259|NCT00707057|101844957|FG001|Overall Study|Dosed incorrectly|1|||
33531260|NCT03012841|101844960|FG000|Overall Study|Protocol Violation|0|||
33531261|NCT03012841|101844961|FG001|Overall Study|Protocol Violation|10|||
33531262|NCT03012841|101844960|FG000|Overall Study|Lost to Follow-up|6|||
33531263|NCT03012841|101844961|FG001|Overall Study|Lost to Follow-up|1|||
33612013|NCT00348309|102130014|FG000|Overall Study|A foul of exclusion criteria|0|||
33612014|NCT00348309|102130015|FG001|Overall Study|A foul of exclusion criteria|1|||
33404310|NCT02681094|101369449|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
33404311|NCT02681094|101369450|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
33531264|NCT03012841|101844960|FG000|Overall Study|Withdrawal by Subject|6|||
33531265|NCT03012841|101844961|FG001|Overall Study|Withdrawal by Subject|0|||
33531266|NCT03012841|101844960|FG000|Overall Study|Unable to complete 12 month visit|6|||
33404312|NCT02681094|101369451|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
33404313|NCT02681094|101369449|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
33404314|NCT02681094|101369450|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
33404315|NCT02681094|101369451|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
33205633|NCT01490632|100651537|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
33404316|NCT02681094|101369449|FG000|2 - Enrolled Participants Set|Other|6|||
33404317|NCT02681094|101369450|FG001|2 - Enrolled Participants Set|Other|6|||
33404318|NCT02681094|101369451|FG002|2 - Enrolled Participants Set|Other|7|||
33531267|NCT03012841|101844961|FG001|Overall Study|Unable to complete 12 month visit|0|||
33531268|NCT03012841|101844960|FG000|Overall Study|Subject relocation|1|||
33531269|NCT03012841|101844961|FG001|Overall Study|Subject relocation|0|||
33531270|NCT03012841|101844960|FG000|Overall Study|Seasonal winter travel|1|||
33531271|NCT03012841|101844961|FG001|Overall Study|Seasonal winter travel|0|||
33531272|NCT03012841|101844960|FG000|Overall Study|Physician Decision|0|||
33531273|NCT03012841|101844961|FG001|Overall Study|Physician Decision|2|||
33531274|NCT03012841|101844960|FG000|Overall Study|No ablation performed|0|||
33531275|NCT03012841|101844961|FG001|Overall Study|No ablation performed|2|||
33612015|NCT00348309|102130016|FG002|Overall Study|A foul of exclusion criteria|0|||
33612016|NCT00348309|102130014|FG000|Overall Study|Participant was hospitalized|0|||
33612017|NCT00348309|102130015|FG001|Overall Study|Participant was hospitalized|1|||
33205634|NCT01490632|100651538|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
33205635|NCT01490632|100651539|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
33205636|NCT01490632|100651540|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
33205637|NCT01490632|100651541|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
33205638|NCT01490632|100651542|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
33612018|NCT00348309|102130016|FG002|Overall Study|Participant was hospitalized|0|||
33612019|NCT00348309|102130014|FG000|Overall Study|Sponsor refuseal|0|||
33612020|NCT00348309|102130015|FG001|Overall Study|Sponsor refuseal|1|||
33612021|NCT00348309|102130016|FG002|Overall Study|Sponsor refuseal|1|||
33612022|NCT00348309|102130014|FG000|Overall Study|Forgot often medication|0|||
33612023|NCT00348309|102130015|FG001|Overall Study|Forgot often medication|1|||
33612024|NCT00348309|102130016|FG002|Overall Study|Forgot often medication|0|||
33612025|NCT00348309|102130014|FG000|Overall Study|Medical Monitor decision|0|||
33612026|NCT00348309|102130015|FG001|Overall Study|Medical Monitor decision|0|||
33612027|NCT00348309|102130016|FG002|Overall Study|Medical Monitor decision|1|||
33612028|NCT00348309|102130014|FG000|Overall Study|Increased dose of Aricept|0|||
33612029|NCT00348309|102130015|FG001|Overall Study|Increased dose of Aricept|0|||
33612030|NCT00348309|102130016|FG002|Overall Study|Increased dose of Aricept|1|||
33612031|NCT00348309|102130014|FG000|Overall Study|Site closure|0|||
33612032|NCT00348309|102130015|FG001|Overall Study|Site closure|0|||
33612033|NCT00348309|102130016|FG002|Overall Study|Site closure|1|||
33612034|NCT00348309|102130014|FG000|Overall Study|Adverse event not attended|0|||
33612035|NCT00348309|102130015|FG001|Overall Study|Adverse event not attended|0|||
33612036|NCT00348309|102130016|FG002|Overall Study|Adverse event not attended|1|||
33612037|NCT00348309|102130014|FG000|Overall Study|ECG abnormal|0|||
33612038|NCT00348309|102130015|FG001|Overall Study|ECG abnormal|0|||
33612039|NCT00348309|102130016|FG002|Overall Study|ECG abnormal|2|||
33612040|NCT00348309|102130014|FG000|Overall Study|Cardiologist recommendations|0|||
33612041|NCT00348309|102130015|FG001|Overall Study|Cardiologist recommendations|0|||
33612042|NCT00348309|102130016|FG002|Overall Study|Cardiologist recommendations|1|||
33612043|NCT00348309|102130014|FG000|Overall Study|HCV career|0|||
33612044|NCT00348309|102130015|FG001|Overall Study|HCV career|0|||
33205639|NCT01490632|100651543|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
33205640|NCT01490632|100651544|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
33531276|NCT03012841|101844960|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
33531277|NCT03012841|101844961|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
33531278|NCT03012841|101844960|FG000|Overall Study|Insurance change|0|||
33612045|NCT00348309|102130016|FG002|Overall Study|HCV career|1|||
33612046|NCT03129360|102130020|FG000|Overall Study|Did not meet entry criteria|0|||
33612047|NCT03129360|102130021|FG001|Overall Study|Did not meet entry criteria|2|||
33612048|NCT03129360|102130022|FG002|Overall Study|Did not meet entry criteria|1|||
33612049|NCT03129360|102130020|FG000|Overall Study|Excluded due to motion in scanner|1|||
33531279|NCT03012841|101844961|FG001|Overall Study|Insurance change|1|||
33531280|NCT03318003|101844964|FG000|Overall Study|Withdrawal by Subject|1|||
33531281|NCT03318003|101844965|FG001|Overall Study|Withdrawal by Subject|1|||
33531282|NCT03318003|101844964|FG000|Overall Study|fetal loss|0|||
33531283|NCT03318003|101844965|FG001|Overall Study|fetal loss|1|||
33531284|NCT01214668|101844966|FG000|Overall Study|Adverse Event|0|||
33531285|NCT01214668|101844967|FG001|Overall Study|Adverse Event|1|||
33531286|NCT01214668|101844968|FG002|Overall Study|Adverse Event|0|||
33531287|NCT01214668|101844969|FG003|Overall Study|Adverse Event|2|||
33531288|NCT01214668|101844970|FG004|Overall Study|Adverse Event|1|||
33531289|NCT01214668|101844971|FG005|Overall Study|Adverse Event|1|||
33531290|NCT01214668|101844966|FG000|Overall Study|Death|0|||
33531291|NCT01214668|101844967|FG001|Overall Study|Death|0|||
33531292|NCT01214668|101844968|FG002|Overall Study|Death|1|||
33531293|NCT01214668|101844969|FG003|Overall Study|Death|0|||
33531294|NCT01214668|101844970|FG004|Overall Study|Death|0|||
33531295|NCT01214668|101844971|FG005|Overall Study|Death|0|||
33531296|NCT01214668|101844966|FG000|Overall Study|Progressive Disease|4|||
33531297|NCT01214668|101844967|FG001|Overall Study|Progressive Disease|2|||
33531298|NCT01214668|101844968|FG002|Overall Study|Progressive Disease|5|||
33531299|NCT01214668|101844969|FG003|Overall Study|Progressive Disease|4|||
33531300|NCT01214668|101844970|FG004|Overall Study|Progressive Disease|4|||
33531301|NCT01214668|101844971|FG005|Overall Study|Progressive Disease|5|||
33531302|NCT01214668|101844966|FG000|Overall Study|Withdrawal by Subject|0|||
33531303|NCT01214668|101844967|FG001|Overall Study|Withdrawal by Subject|0|||
33531304|NCT01214668|101844968|FG002|Overall Study|Withdrawal by Subject|0|||
33531305|NCT01214668|101844969|FG003|Overall Study|Withdrawal by Subject|0|||
33531306|NCT01214668|101844970|FG004|Overall Study|Withdrawal by Subject|1|||
33531307|NCT01214668|101844971|FG005|Overall Study|Withdrawal by Subject|0|||
33531308|NCT02896569|101844980|FG000|Overall Study|Lost to Follow-up|2|||
33531309|NCT02896569|101844981|FG001|Overall Study|Lost to Follow-up|1|||
33531310|NCT02896569|101844980|FG000|Overall Study|Physician Decision|1|||
33531311|NCT02896569|101844981|FG001|Overall Study|Physician Decision|3|||
33531312|NCT02896569|101844980|FG000|Overall Study|Adverse Event|0|||
33531313|NCT02896569|101844981|FG001|Overall Study|Adverse Event|1|||
33531314|NCT02896569|101844980|FG000|Overall Study|Withdrawal by Subject|1|||
33531315|NCT02896569|101844981|FG001|Overall Study|Withdrawal by Subject|0|||
33531316|NCT05259163|101844984|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
33531317|NCT05259163|101844985|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
33531318|NCT00101868|101844986|FG000|Overall Study|Death|10|||
33531319|NCT00101868|101844987|FG001|Overall Study|Death|10|||
33531320|NCT00101868|101844986|FG000|Overall Study|Withdrawal by Subject|8|||
33531321|NCT00101868|101844987|FG001|Overall Study|Withdrawal by Subject|9|||
33531322|NCT00101868|101844986|FG000|Overall Study|Protocol Violation|3|||
33531323|NCT00101868|101844987|FG001|Overall Study|Protocol Violation|0|||
33531324|NCT00101868|101844986|FG000|Overall Study|Lost to Follow-up|8|||
33531325|NCT00101868|101844987|FG001|Overall Study|Lost to Follow-up|13|||
33531326|NCT02521792|101844988|FG000|Overall Study|Study Terminated|6|||
33531327|NCT03410992|101844989|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33531328|NCT03410992|101844990|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
33531329|NCT03410992|101844991|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33531330|NCT03410992|101844992|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33531331|NCT03410992|101844993|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33531332|NCT03410992|101844994|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33531333|NCT03410992|101844995|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33531334|NCT03410992|101844996|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33531335|NCT03410992|101844997|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33531336|NCT03410992|101844998|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33531337|NCT03410992|101844999|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
33531338|NCT03410992|101844989|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
33531339|NCT03410992|101844990|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
33531340|NCT03410992|101844991|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33531341|NCT03410992|101844992|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33531342|NCT03410992|101844993|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33531343|NCT03410992|101844994|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33531344|NCT03410992|101844995|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33531345|NCT03410992|101844996|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33531346|NCT03410992|101844997|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33531347|NCT03410992|101844998|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33531348|NCT03410992|101844999|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
33531349|NCT03410992|101844989|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
33531350|NCT03410992|101844990|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
33531351|NCT03410992|101844991|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33531352|NCT03410992|101844992|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33531353|NCT03410992|101844993|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33531354|NCT03410992|101844994|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33531355|NCT03410992|101844995|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33531356|NCT03410992|101844996|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33531357|NCT03410992|101844997|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33531358|NCT03410992|101844998|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33531359|NCT03410992|101844999|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
33531360|NCT03410992|101844989|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
33531361|NCT03410992|101844990|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33531362|NCT03410992|101844991|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33531363|NCT03410992|101844992|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33531364|NCT03410992|101844993|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33531365|NCT03410992|101844994|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33531366|NCT03410992|101844995|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33531367|NCT03410992|101844996|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33531368|NCT03410992|101844997|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33531369|NCT03410992|101844998|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33531370|NCT03410992|101844999|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
33531371|NCT03410992|101844989|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
33531372|NCT03410992|101844990|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
33531373|NCT03410992|101844991|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33531374|NCT03410992|101844992|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33531375|NCT03410992|101844993|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33531376|NCT03410992|101844994|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33531377|NCT03410992|101844995|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33531378|NCT03410992|101844996|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33531379|NCT03410992|101844997|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33531380|NCT03410992|101844998|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33531381|NCT03410992|101844999|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
33531382|NCT03410992|101844989|FG000|Week 16 Assessment|Incorrect escapers|0|||
33531383|NCT03410992|101844990|FG001|Week 16 Assessment|Incorrect escapers|6|||
33531384|NCT03410992|101844991|FG002|Week 16 Assessment|Incorrect escapers|0|||
33531385|NCT03410992|101844992|FG003|Week 16 Assessment|Incorrect escapers|0|||
33531386|NCT03410992|101844993|FG004|Week 16 Assessment|Incorrect escapers|0|||
33531387|NCT03410992|101844994|FG005|Week 16 Assessment|Incorrect escapers|0|||
33531388|NCT03410992|101844995|FG006|Week 16 Assessment|Incorrect escapers|0|||
33531389|NCT03410992|101844996|FG007|Week 16 Assessment|Incorrect escapers|0|||
33531390|NCT03410992|101844997|FG008|Week 16 Assessment|Incorrect escapers|0|||
33531391|NCT03410992|101844998|FG009|Week 16 Assessment|Incorrect escapers|0|||
33531392|NCT03410992|101844999|FG010|Week 16 Assessment|Incorrect escapers|0|||
33531393|NCT03410992|101844989|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33531394|NCT03410992|101844990|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33531395|NCT03410992|101844991|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33531396|NCT03410992|101844992|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
33531397|NCT03410992|101844993|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
33531398|NCT03410992|101844994|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33531399|NCT03410992|101844995|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33531400|NCT03410992|101844996|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33531401|NCT03410992|101844997|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33531402|NCT03410992|101844998|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33531403|NCT03410992|101844999|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
33531404|NCT03410992|101844989|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33531405|NCT03410992|101844990|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33531406|NCT03410992|101844991|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33531407|NCT03410992|101844992|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
33531408|NCT03410992|101844993|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
33531409|NCT03410992|101844994|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
33531410|NCT03410992|101844995|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33531411|NCT03410992|101844996|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33531412|NCT03410992|101844997|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33531413|NCT03410992|101844998|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33531414|NCT03410992|101844999|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
33531415|NCT03410992|101844989|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33531416|NCT03410992|101844990|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33531417|NCT03410992|101844991|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33531418|NCT03410992|101844992|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33531419|NCT03410992|101844993|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33531420|NCT03410992|101844994|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
33531421|NCT03410992|101844995|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33531422|NCT03410992|101844996|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33531423|NCT03410992|101844997|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33531424|NCT03410992|101844998|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33531425|NCT03410992|101844999|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
33531426|NCT03410992|101844989|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33531427|NCT03410992|101844990|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33531428|NCT03410992|101844991|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33531429|NCT03410992|101844992|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
33531430|NCT03410992|101844993|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
33531431|NCT03410992|101844994|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
33531432|NCT03410992|101844995|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33531433|NCT03410992|101844996|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33531434|NCT03410992|101844997|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33531435|NCT03410992|101844998|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33531436|NCT03410992|101844999|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
33531437|NCT03410992|101844989|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
33531438|NCT03410992|101844990|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
33531439|NCT03410992|101844991|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
33531440|NCT03410992|101844992|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
33531441|NCT03410992|101844993|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
33531442|NCT03410992|101844994|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
33531443|NCT03410992|101844995|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
33531444|NCT03410992|101844996|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
33531445|NCT03410992|101844997|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
33531446|NCT03410992|101844998|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
33531447|NCT03410992|101844999|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
33531448|NCT03410992|101844989|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33531449|NCT03410992|101844990|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33531450|NCT03410992|101844991|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33531451|NCT03410992|101844992|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33531452|NCT03410992|101844993|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33531453|NCT03410992|101844994|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33531454|NCT03410992|101844995|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33531455|NCT03410992|101844996|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33531456|NCT03410992|101844997|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
33531457|NCT03410992|101844998|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33531458|NCT03410992|101844999|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
33531459|NCT00379899|101845000|FG000|Overall Study|Adverse Event|7|||
33531460|NCT00379899|101845001|FG001|Overall Study|Adverse Event|3|||
33531461|NCT00379899|101845000|FG000|Overall Study|Death|10|||
33531462|NCT00379899|101845001|FG001|Overall Study|Death|10|||
33531463|NCT00379899|101845000|FG000|Overall Study|Lost to Follow-up|2|||
33531464|NCT00379899|101845001|FG001|Overall Study|Lost to Follow-up|4|||
33531465|NCT00379899|101845000|FG000|Overall Study|Physician Decision|3|||
33531466|NCT00379899|101845001|FG001|Overall Study|Physician Decision|4|||
33531467|NCT00379899|101845000|FG000|Overall Study|Withdrawal by Subject|5|||
33531468|NCT00379899|101845001|FG001|Overall Study|Withdrawal by Subject|5|||
33531469|NCT00379899|101845000|FG000|Overall Study|Ineligibility determined|0|||
33531470|NCT00379899|101845001|FG001|Overall Study|Ineligibility determined|1|||
33531471|NCT00379899|101845000|FG000|Overall Study|Noncompliance|1|||
33531472|NCT00379899|101845001|FG001|Overall Study|Noncompliance|1|||
33531473|NCT00379899|101845000|FG000|Overall Study|Parathyroidectomy|0|||
33531474|NCT00379899|101845001|FG001|Overall Study|Parathyroidectomy|2|||
33531475|NCT00379899|101845000|FG000|Overall Study|Renal transplantation|5|||
33531476|NCT00379899|101845001|FG001|Overall Study|Renal transplantation|4|||
33531477|NCT00379899|101845000|FG000|Overall Study|Coronary artery bypass graft|1|||
33531478|NCT00379899|101845001|FG001|Overall Study|Coronary artery bypass graft|1|||
33531479|NCT00379899|101845000|FG000|Overall Study|Other protocol-specified criteria|3|||
33531480|NCT00379899|101845001|FG001|Overall Study|Other protocol-specified criteria|4|||
33531481|NCT00379899|101845000|FG000|Overall Study|Other|3|||
33531482|NCT00379899|101845001|FG001|Overall Study|Other|1|||
33531483|NCT00613366|101845005|FG000|Overall Study|Withdrawal by Subject|3|||
33531484|NCT00613366|101845006|FG001|Overall Study|Withdrawal by Subject|2|||
33612050|NCT03129360|102130021|FG001|Overall Study|Excluded due to motion in scanner|0|||
33612051|NCT03129360|102130022|FG002|Overall Study|Excluded due to motion in scanner|0|||
33531485|NCT03014206|101845007|FG000|Overall Study|Registration Violation|12|||
33531486|NCT01971567|101845011|FG000|Overall Study|Withdrawal by Subject|3|||
33531487|NCT01971567|101845012|FG001|Overall Study|Withdrawal by Subject|2|||
33531488|NCT01971567|101845011|FG000|Overall Study|Lost to Follow-up|1|||
33531489|NCT01971567|101845012|FG001|Overall Study|Lost to Follow-up|0|||
33531490|NCT00751140|101845013|FG000|Overall Study|benign angioma excluded from analysis|1|||
33531491|NCT02688933|101845016|FG000|Overall Study|Adverse Event|3|||
33531492|NCT02688933|101845017|FG001|Overall Study|Adverse Event|1|||
33531493|NCT02688933|101845016|FG000|Overall Study|Lack of Efficacy|2|||
33531494|NCT02688933|101845017|FG001|Overall Study|Lack of Efficacy|2|||
33531495|NCT02688933|101845016|FG000|Overall Study|Poor compliance to protocol|7|||
33531496|NCT02688933|101845017|FG001|Overall Study|Poor compliance to protocol|4|||
33531497|NCT02688933|101845016|FG000|Overall Study|Hypoglycemia|2|||
33531498|NCT02688933|101845017|FG001|Overall Study|Hypoglycemia|0|||
33531499|NCT02688933|101845016|FG000|Overall Study|Other than Specified|14|||
33531500|NCT02688933|101845017|FG001|Overall Study|Other than Specified|25|||
33531501|NCT02688933|101845016|FG000|Overall Study|Lost to Follow-up|1|||
33531502|NCT02688933|101845017|FG001|Overall Study|Lost to Follow-up|5|||
33531503|NCT00327717|101845018|FG000|Overall Study|Adverse Event|6|||
33531504|NCT00327717|101845019|FG001|Overall Study|Adverse Event|6|||
33531505|NCT00327717|101845018|FG000|Overall Study|Lack of Efficacy|0|||
33531506|NCT00327717|101845019|FG001|Overall Study|Lack of Efficacy|1|||
33531507|NCT00327717|101845018|FG000|Overall Study|Withdrawal by Subject|3|||
33531508|NCT00327717|101845019|FG001|Overall Study|Withdrawal by Subject|7|||
33531509|NCT02620787|101845020|FG000|Overall Study|Adverse Event|1|||
33531510|NCT02620787|101845021|FG001|Overall Study|Adverse Event|0|||
33531511|NCT02620787|101845020|FG000|Overall Study|Eligibility Criteria Not Met|1|||
33531512|NCT02620787|101845021|FG001|Overall Study|Eligibility Criteria Not Met|0|||
33531513|NCT01158261|101845024|FG000|Overall Study|Lost to Follow-up|9|||
33531514|NCT01158261|101845024|FG000|Overall Study|Death|7|||
33531515|NCT01158261|101845024|FG000|Overall Study|Withdrawal by Subject|1|||
33531516|NCT00803712|101845028|FG000|Overall Study|Noncompliance|3|||
33531517|NCT00803712|101845029|FG001|Overall Study|Noncompliance|0|||
33531518|NCT00803712|101845028|FG000|Overall Study|Adverse Event|5|||
33531519|NCT00803712|101845029|FG001|Overall Study|Adverse Event|0|||
33531520|NCT00803712|101845028|FG000|Overall Study|Death|8|||
33531521|NCT00803712|101845029|FG001|Overall Study|Death|7|||
33531522|NCT00803712|101845028|FG000|Overall Study|Lost to Follow-up|3|||
33531523|NCT00803712|101845029|FG001|Overall Study|Lost to Follow-up|1|||
33531524|NCT00803712|101845028|FG000|Overall Study|Withdrawal by Subject|2|||
33531525|NCT00803712|101845029|FG001|Overall Study|Withdrawal by Subject|4|||
33531526|NCT00803712|101845028|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
33531527|NCT00803712|101845029|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
33531528|NCT00803712|101845028|FG000|Overall Study|Protocol criteria (other)|0|||
33531529|NCT00803712|101845029|FG001|Overall Study|Protocol criteria (other)|2|||
33531530|NCT00803712|101845028|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
33531531|NCT00803712|101845029|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
33531532|NCT00803712|101845028|FG000|Overall Study|Administrative decision|2|||
33531533|NCT00803712|101845029|FG001|Overall Study|Administrative decision|3|||
33531534|NCT00803712|101845028|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
33531535|NCT00803712|101845029|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
33531536|NCT00954122|101845030|FG000|Overall Study|Withdrawal by Subject|5|||
33531537|NCT00954122|101845030|FG000|Overall Study|Adverse Event|1|||
33531538|NCT00954122|101845030|FG000|Overall Study|Safety Reason|1|||
33531539|NCT00705757|101845033|FG000|Overall Study|Lack of Efficacy|5|||
33531540|NCT00705757|101845034|FG001|Overall Study|Lack of Efficacy|1|||
33531541|NCT00705757|101845035|FG002|Overall Study|Lack of Efficacy|3|||
33612052|NCT02147288|102130023|FG000|Overall Study|post-operative hematoma|1|||
33612053|NCT02147288|102130024|FG001|Overall Study|post-operative hematoma|1|||
33531542|NCT00705757|101845033|FG000|Overall Study|Lost to Follow-up|7|||
33531543|NCT00705757|101845034|FG001|Overall Study|Lost to Follow-up|6|||
33205641|NCT01490632|100651545|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
33531544|NCT00705757|101845035|FG002|Overall Study|Lost to Follow-up|6|||
33531545|NCT00705757|101845033|FG000|Overall Study|Withdrawal by Subject|1|||
33531546|NCT00705757|101845034|FG001|Overall Study|Withdrawal by Subject|1|||
33531547|NCT00705757|101845035|FG002|Overall Study|Withdrawal by Subject|2|||
33531548|NCT02493517|101845036|FG000|Overall Study|Protocol Violation|1|||
33531549|NCT02493517|101845037|FG001|Overall Study|Protocol Violation|2|||
33531550|NCT02493517|101845036|FG000|Overall Study|Withdrawal by Subject|1|||
33531551|NCT02493517|101845037|FG001|Overall Study|Withdrawal by Subject|2|||
33531552|NCT02493517|101845036|FG000|Overall Study|Adverse Event|0|||
33531553|NCT02493517|101845037|FG001|Overall Study|Adverse Event|2|||
33612054|NCT02147288|102130025|FG002|Overall Study|post-operative hematoma|0|||
33205642|NCT01490632|100651546|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
33205643|NCT01490632|100651547|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
33205644|NCT01490632|100651548|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
33205645|NCT01490632|100651549|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
33205646|NCT01490632|100651550|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
33205647|NCT01490632|100651551|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
33205648|NCT01490632|100651532|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205649|NCT01490632|100651533|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205650|NCT01490632|100651534|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205651|NCT01490632|100651535|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205652|NCT01490632|100651536|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205653|NCT01490632|100651537|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205654|NCT01490632|100651538|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205655|NCT01490632|100651539|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33531554|NCT02493517|101845036|FG000|Overall Study|Missed study visit|0|||
33205656|NCT01490632|100651540|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205657|NCT01490632|100651541|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205658|NCT01490632|100651542|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205659|NCT01490632|100651543|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205660|NCT01490632|100651544|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205661|NCT01490632|100651545|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
33205662|NCT01490632|100651546|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205663|NCT01490632|100651547|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205664|NCT01490632|100651548|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205665|NCT01490632|100651549|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205666|NCT01490632|100651550|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205667|NCT01490632|100651551|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
33205668|NCT01490632|100651532|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33205669|NCT01490632|100651533|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33336924|NCT00689871|101124667|FG000|Overall Study|Physician Decision|2|||
33531555|NCT02493517|101845037|FG001|Overall Study|Missed study visit|1|||
33404319|NCT02681094|101369449|FG000|2 - Enrolled Participants Set|No treatment given|0|||
33404320|NCT02681094|101369450|FG001|2 - Enrolled Participants Set|No treatment given|1|||
33404321|NCT02681094|101369451|FG002|2 - Enrolled Participants Set|No treatment given|1|||
33404322|NCT03417102|101369454|FG000|Overall Study|Adverse Event|0|||
33404323|NCT03417102|101369455|FG001|Overall Study|Adverse Event|1|||
33404324|NCT03417102|101369454|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
33404325|NCT03417102|101369455|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
33404326|NCT03417102|101369454|FG000|Overall Study|Other|0|||
33404327|NCT03417102|101369455|FG001|Overall Study|Other|1|||
33404328|NCT01667731|101369456|FG000|Overall Study|Enrolled but not treated|0|||
33404329|NCT01667731|101369457|FG001|Overall Study|Enrolled but not treated|0|||
33531556|NCT04613739|101845038|FG000|Overall Study|Lost to Follow-up|6|||
33531557|NCT04613739|101845039|FG001|Overall Study|Lost to Follow-up|9|||
33531558|NCT04613739|101845038|FG000|Overall Study|potentially duplicative/fraudulent|1|||
33531559|NCT04613739|101845039|FG001|Overall Study|potentially duplicative/fraudulent|3|||
33531560|NCT02259400|101845040|FG000|Overall Study|Death|0|||
33531561|NCT02259400|101845041|FG001|Overall Study|Death|2|||
33336925|NCT00689871|101124668|FG001|Overall Study|Physician Decision|1|||
33336926|NCT00689871|101124669|FG002|Overall Study|Physician Decision|1|||
33531562|NCT00522548|101845042|FG000|Overall Study|Adverse Event|2|||
33531563|NCT00522548|101845043|FG001|Overall Study|Adverse Event|2|||
33531564|NCT00522548|101845042|FG000|Overall Study|Withdrawal by Subject|0|||
33531565|NCT00522548|101845043|FG001|Overall Study|Withdrawal by Subject|2|||
33531566|NCT01051817|101845049|FG000|Overall Study|Adverse Event|0|||
33531567|NCT01051817|101845050|FG001|Overall Study|Adverse Event|2|||
33531568|NCT01051817|101845049|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
33531569|NCT01051817|101845050|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
33531570|NCT01051817|101845049|FG000|Overall Study|Withdrawal by Subject|3|||
33531571|NCT01051817|101845050|FG001|Overall Study|Withdrawal by Subject|5|||
33531572|NCT01051817|101845049|FG000|Overall Study|Protocol Violation|0|||
33531573|NCT01051817|101845050|FG001|Overall Study|Protocol Violation|1|||
33531574|NCT00237692|101845053|FG000|Overall Study|Lost to Follow-up|9|||
33531575|NCT00237692|101845054|FG001|Overall Study|Lost to Follow-up|3|||
33531576|NCT00237692|101845055|FG002|Overall Study|Lost to Follow-up|5|||
33531577|NCT00237692|101845056|FG003|Overall Study|Lost to Follow-up|3|||
33531578|NCT00237692|101845053|FG000|Overall Study|Death|1|||
33531579|NCT00237692|101845054|FG001|Overall Study|Death|2|||
33531580|NCT00237692|101845055|FG002|Overall Study|Death|2|||
33531581|NCT00237692|101845056|FG003|Overall Study|Death|3|||
33531582|NCT00237692|101845053|FG000|Overall Study|Excluded - did not meet criteria|4|||
33531583|NCT00237692|101845054|FG001|Overall Study|Excluded - did not meet criteria|3|||
33531584|NCT00237692|101845055|FG002|Overall Study|Excluded - did not meet criteria|5|||
33531585|NCT00237692|101845056|FG003|Overall Study|Excluded - did not meet criteria|9|||
33531586|NCT00237692|101845053|FG000|Overall Study|Withdrawal by Subject|4|||
33336927|NCT00689871|101124670|FG003|Overall Study|Physician Decision|0|||
33336928|NCT03691974|101124671|FG000|Overall Study|Physician Decision|1|||
33336929|NCT03691974|101124672|FG001|Overall Study|Physician Decision|0|||
33336930|NCT03691974|101124671|FG000|Overall Study|Adverse Event|1|||
33336931|NCT03691974|101124672|FG001|Overall Study|Adverse Event|0|||
33336932|NCT03691974|101124671|FG000|Overall Study|Withdrawal by Subject|11|||
33336933|NCT03691974|101124672|FG001|Overall Study|Withdrawal by Subject|9|||
33336934|NCT03691974|101124671|FG000|Overall Study|Protocol Violation|1|||
33336935|NCT03691974|101124672|FG001|Overall Study|Protocol Violation|0|||
33404330|NCT01667731|101369458|FG002|Overall Study|Enrolled but not treated|0|||
33531587|NCT00237692|101845054|FG001|Overall Study|Withdrawal by Subject|6|||
33531588|NCT00237692|101845055|FG002|Overall Study|Withdrawal by Subject|10|||
33531589|NCT00237692|101845056|FG003|Overall Study|Withdrawal by Subject|4|||
33531590|NCT04249362|101845057|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 30 March 2023.|34|||
33531591|NCT04249362|101845058|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 30 March 2023.|25|||
33531592|NCT01025284|101845059|FG000|Overall Study|Investigator Decision|0|||
33404331|NCT01667731|101369459|FG003|Overall Study|Enrolled but not treated|0|||
33404332|NCT01667731|101369460|FG004|Overall Study|Enrolled but not treated|1|||
33404333|NCT01667731|101369456|FG000|Overall Study|Efficacy Failure|1|||
33404334|NCT01667731|101369457|FG001|Overall Study|Efficacy Failure|12|||
33404335|NCT01667731|101369458|FG002|Overall Study|Efficacy Failure|0|||
33404336|NCT01667731|101369459|FG003|Overall Study|Efficacy Failure|1|||
33404337|NCT01667731|101369460|FG004|Overall Study|Efficacy Failure|24|||
33404338|NCT01667731|101369456|FG000|Overall Study|Lost to Follow-up|2|||
33404339|NCT01667731|101369457|FG001|Overall Study|Lost to Follow-up|3|||
33404340|NCT01667731|101369458|FG002|Overall Study|Lost to Follow-up|1|||
33404341|NCT01667731|101369459|FG003|Overall Study|Lost to Follow-up|1|||
33404342|NCT01667731|101369460|FG004|Overall Study|Lost to Follow-up|2|||
33404343|NCT01667731|101369456|FG000|Overall Study|Subject Withdrew Consent|2|||
33404344|NCT01667731|101369457|FG001|Overall Study|Subject Withdrew Consent|0|||
33404345|NCT01667731|101369458|FG002|Overall Study|Subject Withdrew Consent|1|||
33404346|NCT01667731|101369459|FG003|Overall Study|Subject Withdrew Consent|0|||
33404347|NCT01667731|101369460|FG004|Overall Study|Subject Withdrew Consent|1|||
33404348|NCT01667731|101369456|FG000|Overall Study|Death|0|||
33404349|NCT01667731|101369457|FG001|Overall Study|Death|1|||
33404350|NCT01667731|101369458|FG002|Overall Study|Death|0|||
33404351|NCT01667731|101369459|FG003|Overall Study|Death|0|||
33404352|NCT01667731|101369460|FG004|Overall Study|Death|0|||
33404353|NCT03145207|101369461|FG000|Overall Study|volunteer started taking allergy shots|1|||
33404354|NCT03145207|101369461|FG000|Overall Study|baseline blood pressure high|1|||
33404355|NCT01078389|101369466|FG000|Overall Study|Adverse Event|10|||
33404356|NCT01078389|101369467|FG001|Overall Study|Adverse Event|6|||
33404357|NCT01078389|101369466|FG000|Overall Study|Major Protocol Deviation|2|||
33404358|NCT01078389|101369467|FG001|Overall Study|Major Protocol Deviation|0|||
33404359|NCT01078389|101369466|FG000|Overall Study|Lost to Follow-up|23|||
33404360|NCT01078389|101369467|FG001|Overall Study|Lost to Follow-up|23|||
33404361|NCT01078389|101369466|FG000|Overall Study|Voluntary Withdrawal|20|||
33404362|NCT01078389|101369467|FG001|Overall Study|Voluntary Withdrawal|36|||
33404363|NCT01078389|101369466|FG000|Overall Study|Other|9|||
33404364|NCT01078389|101369467|FG001|Overall Study|Other|2|||
33404365|NCT01298661|101369468|FG000|Overall Study|Withdrawal by Subject|2|||
33404366|NCT01298661|101369469|FG001|Overall Study|Withdrawal by Subject|0|||
33404367|NCT01298661|101369470|FG002|Overall Study|Withdrawal by Subject|2|||
33404368|NCT01636076|101369473|FG000|Overall Study|Terminated by sponsor|1|||
33404369|NCT01636076|101369474|FG001|Overall Study|Terminated by sponsor|1|||
33404370|NCT01636076|101369473|FG000|Overall Study|Lack of Efficacy|0|||
33404371|NCT01636076|101369474|FG001|Overall Study|Lack of Efficacy|1|||
33404372|NCT01636076|101369473|FG000|Overall Study|Lost to Follow-up|1|||
33404373|NCT01636076|101369474|FG001|Overall Study|Lost to Follow-up|0|||
33404374|NCT01636076|101369473|FG000|Overall Study|Physician Decision|1|||
33404375|NCT01636076|101369474|FG001|Overall Study|Physician Decision|1|||
33404376|NCT01636076|101369473|FG000|Overall Study|Non-compliance with study treatment|1|||
33404377|NCT01636076|101369474|FG001|Overall Study|Non-compliance with study treatment|1|||
33404378|NCT01636076|101369473|FG000|Overall Study|Adverse Event|6|||
33404379|NCT01636076|101369474|FG001|Overall Study|Adverse Event|11|||
33404380|NCT01636076|101369473|FG000|Overall Study|Withdrawal by Subject|7|||
33404381|NCT01636076|101369474|FG001|Overall Study|Withdrawal by Subject|10|||
33531593|NCT01025284|101845060|FG001|Overall Study|Investigator Decision|1|||
33404382|NCT02074059|101369475|FG000|Overall Study|Death|0|||
33404383|NCT02074059|101369476|FG001|Overall Study|Death|0|||
33531594|NCT01025284|101845061|FG002|Overall Study|Investigator Decision|0|||
33531595|NCT01025284|101845059|FG000|Overall Study|Withdrawal by Subject|0|||
33404384|NCT02074059|101369477|FG002|Overall Study|Death|0|||
33404385|NCT02074059|101369478|FG003|Overall Study|Death|0|||
33404386|NCT02074059|101369479|FG004|Overall Study|Death|1|||
33404387|NCT02074059|101369480|FG005|Overall Study|Death|1|||
33404388|NCT00612456|101369481|FG000|Overall Study|Adverse Event|1|||
33404389|NCT00612456|101369482|FG001|Overall Study|Adverse Event|0|||
33404390|NCT00612456|101369483|FG002|Overall Study|Adverse Event|0|||
33404391|NCT00612456|101369481|FG000|Overall Study|Lack of Efficacy|1|||
33404392|NCT00612456|101369482|FG001|Overall Study|Lack of Efficacy|1|||
33404393|NCT00612456|101369483|FG002|Overall Study|Lack of Efficacy|0|||
33404394|NCT00612456|101369481|FG000|Overall Study|Withdrawal by Subject|0|||
33404395|NCT00612456|101369482|FG001|Overall Study|Withdrawal by Subject|1|||
33404396|NCT00612456|101369483|FG002|Overall Study|Withdrawal by Subject|0|||
33404397|NCT03907072|101369484|FG000|Overall Study|Study Terminated by Sponsor|2|||
33404398|NCT03907072|101369485|FG001|Overall Study|Study Terminated by Sponsor|2|||
33404399|NCT03907072|101369486|FG002|Overall Study|Study Terminated by Sponsor|2|||
33404400|NCT00361504|101369487|FG000|Overall Study|Withdrawal by Subject|94|||
33404401|NCT00361504|101369488|FG001|Overall Study|Withdrawal by Subject|31|||
33404402|NCT00361504|101369487|FG000|Overall Study|Lost to Follow-up|40|||
33404403|NCT00361504|101369488|FG001|Overall Study|Lost to Follow-up|7|||
33404404|NCT00361504|101369487|FG000|Overall Study|Adverse Event|203|||
33404405|NCT00361504|101369488|FG001|Overall Study|Adverse Event|82|||
33404406|NCT00361504|101369487|FG000|Overall Study|Lack of Efficacy|72|||
33404407|NCT00361504|101369488|FG001|Overall Study|Lack of Efficacy|7|||
33404408|NCT00361504|101369487|FG000|Overall Study|Resolution of Pain|2|||
33404409|NCT00361504|101369488|FG001|Overall Study|Resolution of Pain|0|||
33404410|NCT00361504|101369487|FG000|Overall Study|Study medication non compliant|42|||
33404411|NCT00361504|101369488|FG001|Overall Study|Study medication non compliant|15|||
33404412|NCT00361504|101369487|FG000|Overall Study|All other|28|||
33404413|NCT00361504|101369488|FG001|Overall Study|All other|3|||
33404414|NCT01632345|101369489|FG000|Treatment: Part I|Adverse Event|1|||
33404415|NCT01632345|101369490|FG001|Treatment: Part I|Adverse Event|4|||
33404416|NCT01632345|101369491|FG002|Treatment: Part I|Adverse Event|2|||
33404417|NCT01632345|101369492|FG003|Treatment: Part I|Adverse Event|1|||
33404418|NCT01632345|101369493|FG004|Treatment: Part I|Adverse Event|3|||
33404419|NCT01632345|101369494|FG005|Treatment: Part I|Adverse Event|0|||
33404420|NCT01632345|101369495|FG006|Treatment: Part I|Adverse Event|0|||
33404421|NCT01632345|101369489|FG000|Treatment: Part I|Lack of Efficacy|0|||
33404422|NCT01632345|101369490|FG001|Treatment: Part I|Lack of Efficacy|1|||
33404423|NCT01632345|101369491|FG002|Treatment: Part I|Lack of Efficacy|0|||
33404424|NCT01632345|101369492|FG003|Treatment: Part I|Lack of Efficacy|1|||
33404425|NCT01632345|101369493|FG004|Treatment: Part I|Lack of Efficacy|1|||
33404426|NCT01632345|101369494|FG005|Treatment: Part I|Lack of Efficacy|0|||
33404427|NCT01632345|101369495|FG006|Treatment: Part I|Lack of Efficacy|0|||
33404428|NCT01632345|101369489|FG000|Treatment: Part I|Lost to Follow-up|3|||
33404429|NCT01632345|101369490|FG001|Treatment: Part I|Lost to Follow-up|2|||
33531596|NCT01025284|101845060|FG001|Overall Study|Withdrawal by Subject|1|||
33531597|NCT01025284|101845061|FG002|Overall Study|Withdrawal by Subject|0|||
33531598|NCT02250300|101845068|FG000|Expansion Phase|Death|6|||
33531599|NCT02250300|101845069|FG001|Expansion Phase|Death|7|||
33531600|NCT02250300|101845070|FG002|Expansion Phase|Death|0|||
33531601|NCT02250300|101845071|FG003|Expansion Phase|Death|0|||
33531602|NCT02283658|101845072|FG000|Overall Study|Withdrawal by Subject|1|||
33531603|NCT00873730|101845073|FG000|Overall Study|Protocol Deviation|5|||
33531604|NCT00873730|101845074|FG001|Overall Study|Protocol Deviation|2|||
33531605|NCT00873730|101845073|FG000|Overall Study|Adverse Event|0|||
33531606|NCT00873730|101845074|FG001|Overall Study|Adverse Event|2|||
33531607|NCT00873730|101845073|FG000|Overall Study|Withdrawal by Subject|0|||
33531608|NCT00873730|101845074|FG001|Overall Study|Withdrawal by Subject|1|||
33531609|NCT00873730|101845073|FG000|Overall Study|Sponsor decision|1|||
33531610|NCT00873730|101845074|FG001|Overall Study|Sponsor decision|0|||
33531611|NCT02131064|101845075|FG000|Overall Study|Death|5|||
33531612|NCT02131064|101845076|FG001|Overall Study|Death|6|||
33531613|NCT02131064|101845075|FG000|Overall Study|Lost to Follow-up|4|||
33531614|NCT02131064|101845076|FG001|Overall Study|Lost to Follow-up|8|||
33531615|NCT02131064|101845075|FG000|Overall Study|Withdrawal by Subject|14|||
33531616|NCT02131064|101845076|FG001|Overall Study|Withdrawal by Subject|18|||
33531617|NCT02131064|101845075|FG000|Overall Study|Other|2|||
33531618|NCT02131064|101845076|FG001|Overall Study|Other|2|||
33404430|NCT01632345|101369491|FG002|Treatment: Part I|Lost to Follow-up|1|||
33404431|NCT01632345|101369492|FG003|Treatment: Part I|Lost to Follow-up|3|||
33404432|NCT01632345|101369493|FG004|Treatment: Part I|Lost to Follow-up|4|||
33404433|NCT01632345|101369494|FG005|Treatment: Part I|Lost to Follow-up|0|||
33404434|NCT01632345|101369495|FG006|Treatment: Part I|Lost to Follow-up|0|||
33404435|NCT01632345|101369489|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
33531619|NCT01628848|101845077|FG000|Overall Study|Adverse Event|9|||
33531620|NCT01628848|101845078|FG001|Overall Study|Adverse Event|7|||
33531621|NCT01628848|101845077|FG000|Overall Study|Lack of Efficacy|0|||
33531622|NCT01628848|101845078|FG001|Overall Study|Lack of Efficacy|4|||
33612055|NCT02147288|102130026|FG003|Overall Study|post-operative hematoma|0|||
33612056|NCT02147288|102130027|FG004|Overall Study|post-operative hematoma|0|||
33612057|NCT02147288|102130028|FG005|Overall Study|post-operative hematoma|0|||
33612058|NCT02147288|102130029|FG006|Overall Study|post-operative hematoma|0|||
33612059|NCT02147288|102130030|FG007|Overall Study|post-operative hematoma|0|||
33612060|NCT02147288|102130031|FG008|Overall Study|post-operative hematoma|0|||
33205670|NCT01490632|100651534|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33531623|NCT01628848|101845077|FG000|Overall Study|Withdrawal by Subject|0|||
33531624|NCT01628848|101845078|FG001|Overall Study|Withdrawal by Subject|2|||
33531625|NCT01628848|101845077|FG000|Overall Study|Physician Decision|3|||
33531626|NCT01628848|101845078|FG001|Overall Study|Physician Decision|1|||
33531627|NCT02689804|101845080|FG000|Overall Study|Withdrawal by Subject|2|||
33531628|NCT02689804|101845081|FG001|Overall Study|Withdrawal by Subject|0|||
33531629|NCT00398216|101845085|FG000|Overall Study|Adverse Event|4|||
33531630|NCT00398216|101845086|FG001|Overall Study|Adverse Event|2|||
33531631|NCT00398216|101845087|FG002|Overall Study|Adverse Event|5|||
33531632|NCT00398216|101845088|FG003|Overall Study|Adverse Event|7|||
33531633|NCT00398216|101845089|FG004|Overall Study|Adverse Event|2|||
33531634|NCT00398216|101845085|FG000|Overall Study|Protocol Violation|2|||
33531635|NCT00398216|101845086|FG001|Overall Study|Protocol Violation|4|||
33531636|NCT00398216|101845087|FG002|Overall Study|Protocol Violation|5|||
33531637|NCT00398216|101845088|FG003|Overall Study|Protocol Violation|7|||
33531638|NCT00398216|101845089|FG004|Overall Study|Protocol Violation|5|||
33531639|NCT00398216|101845085|FG000|Overall Study|Lost to Follow-up|1|||
33531640|NCT00398216|101845086|FG001|Overall Study|Lost to Follow-up|6|||
33531641|NCT00398216|101845087|FG002|Overall Study|Lost to Follow-up|4|||
33531642|NCT00398216|101845088|FG003|Overall Study|Lost to Follow-up|4|||
33531643|NCT00398216|101845089|FG004|Overall Study|Lost to Follow-up|1|||
33531644|NCT00398216|101845085|FG000|Overall Study|Death|0|||
33531645|NCT00398216|101845086|FG001|Overall Study|Death|3|||
33531646|NCT00398216|101845087|FG002|Overall Study|Death|0|||
33531647|NCT00398216|101845088|FG003|Overall Study|Death|0|||
33531648|NCT00398216|101845089|FG004|Overall Study|Death|0|||
33531649|NCT00398216|101845085|FG000|Overall Study|Withdrawal by Subject|1|||
33531650|NCT00398216|101845086|FG001|Overall Study|Withdrawal by Subject|0|||
33531651|NCT00398216|101845087|FG002|Overall Study|Withdrawal by Subject|3|||
33531652|NCT00398216|101845088|FG003|Overall Study|Withdrawal by Subject|1|||
33531653|NCT00398216|101845089|FG004|Overall Study|Withdrawal by Subject|2|||
33531654|NCT00398216|101845085|FG000|Overall Study|administrative reasons|3|||
33531655|NCT00398216|101845086|FG001|Overall Study|administrative reasons|4|||
33531656|NCT00398216|101845087|FG002|Overall Study|administrative reasons|4|||
33531657|NCT00398216|101845088|FG003|Overall Study|administrative reasons|3|||
33531658|NCT00398216|101845089|FG004|Overall Study|administrative reasons|3|||
33531659|NCT00398216|101845085|FG000|Overall Study|entrance criteria|0|||
33531660|NCT00398216|101845086|FG001|Overall Study|entrance criteria|0|||
33531661|NCT00398216|101845087|FG002|Overall Study|entrance criteria|0|||
33531662|NCT00398216|101845088|FG003|Overall Study|entrance criteria|0|||
33531663|NCT00398216|101845089|FG004|Overall Study|entrance criteria|2|||
33531664|NCT02169505|101845090|FG000|Overall Study|Withdrawal by Subject|1|||
33531665|NCT02326272|101845091|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33531666|NCT02326272|101845092|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
33531667|NCT02326272|101845093|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
33612061|NCT02147288|102130032|FG009|Overall Study|post-operative hematoma|0|||
33612062|NCT02147288|102130023|FG000|Overall Study|complications from concurrent hernia rep|0|||
33612063|NCT02147288|102130024|FG001|Overall Study|complications from concurrent hernia rep|1|||
33612064|NCT02147288|102130025|FG002|Overall Study|complications from concurrent hernia rep|0|||
33612065|NCT02147288|102130026|FG003|Overall Study|complications from concurrent hernia rep|0|||
33612066|NCT02147288|102130027|FG004|Overall Study|complications from concurrent hernia rep|0|||
33612067|NCT02147288|102130028|FG005|Overall Study|complications from concurrent hernia rep|0|||
33612068|NCT02147288|102130029|FG006|Overall Study|complications from concurrent hernia rep|0|||
33612069|NCT02147288|102130030|FG007|Overall Study|complications from concurrent hernia rep|0|||
33612070|NCT02147288|102130031|FG008|Overall Study|complications from concurrent hernia rep|0|||
33612071|NCT02147288|102130032|FG009|Overall Study|complications from concurrent hernia rep|0|||
33612072|NCT02038075|102130033|FG000|Overall Study|Withdrawal by Subject|3|||
33612073|NCT02038075|102130034|FG001|Overall Study|Withdrawal by Subject|0|||
33612074|NCT03188510|102130037|FG000|Overall Study|Inappropriate behavior with site staff|0|||
33612075|NCT03188510|102130038|FG001|Overall Study|Inappropriate behavior with site staff|1|||
33612076|NCT03188510|102130039|FG002|Overall Study|Inappropriate behavior with site staff|0|||
33612077|NCT01235234|102130061|FG000|Overall Study|Adverse Event|2|||
33612078|NCT01235234|102130062|FG001|Overall Study|Adverse Event|2|||
33612079|NCT01235234|102130063|FG002|Overall Study|Adverse Event|1|||
33612080|NCT01832532|102130064|FG000|Overall Study|Withdrawal by Subject|5|||
33612081|NCT01832532|102130065|FG001|Overall Study|Withdrawal by Subject|2|||
33612082|NCT00869518|102130066|FG000|Overall Study|Lost to Follow-up|1|||
33612083|NCT00869518|102130067|FG001|Overall Study|Lost to Follow-up|1|||
33612084|NCT03193736|102130074|FG000|Overall Study|Death|2|||
33612085|NCT03193736|102130074|FG000|Overall Study|Withdrawal by Subject|1|||
33612086|NCT03193736|102130074|FG000|Overall Study|Lost to Follow-up|1|||
33612087|NCT03193736|102130074|FG000|Overall Study|implant not received|1|||
33612088|NCT03078855|102130075|FG000|Overall Study|Lack of Efficacy|62|||
33612089|NCT03078855|102130076|FG001|Overall Study|Lack of Efficacy|31|||
33612090|NCT03078855|102130075|FG000|Overall Study|Death|1|||
33612091|NCT03078855|102130076|FG001|Overall Study|Death|0|||
33612092|NCT03078855|102130075|FG000|Overall Study|Withdrawal by Subject|12|||
33612093|NCT03078855|102130076|FG001|Overall Study|Withdrawal by Subject|6|||
33612094|NCT03078855|102130075|FG000|Overall Study|Physician Decision|3|||
33612095|NCT03078855|102130076|FG001|Overall Study|Physician Decision|2|||
33612096|NCT03078855|102130075|FG000|Overall Study|Second Malignancy|4|||
33612097|NCT03078855|102130076|FG001|Overall Study|Second Malignancy|0|||
33612098|NCT03078855|102130075|FG000|Overall Study|Ineligible|2|||
33612099|NCT03078855|102130076|FG001|Overall Study|Ineligible|0|||
33612100|NCT03078855|102130075|FG000|Overall Study|Withdrew before day 1 treatment|2|||
33612101|NCT03078855|102130076|FG001|Overall Study|Withdrew before day 1 treatment|1|||
33612102|NCT01192568|102130077|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
33612103|NCT01192568|102130078|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
33612104|NCT01192568|102130079|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
33612105|NCT01192568|102130080|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
33612106|NCT01192568|102130077|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
33531668|NCT02326272|101845094|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33531669|NCT02326272|101845095|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33531670|NCT02326272|101845096|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33612107|NCT01192568|102130078|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
33612108|NCT01192568|102130079|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
33612109|NCT01192568|102130080|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
33612110|NCT02464410|102130081|FG000|Overall Study|Death|3|||
33612111|NCT02464410|102130082|FG001|Overall Study|Death|4|||
33612112|NCT02464410|102130081|FG000|Overall Study|Lost to Follow-up|7|||
33531671|NCT02326272|101845097|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33612113|NCT02464410|102130082|FG001|Overall Study|Lost to Follow-up|9|||
33612114|NCT02464410|102130081|FG000|Overall Study|Withdrawal by Subject|12|||
33612115|NCT02464410|102130082|FG001|Overall Study|Withdrawal by Subject|3|||
33612116|NCT02873338|102130083|FG000|Overall Study|Adverse Event|0|||
33612117|NCT02873338|102130084|FG001|Overall Study|Adverse Event|2|||
33612118|NCT02873338|102130085|FG002|Overall Study|Adverse Event|1|||
33612119|NCT02873338|102130083|FG000|Overall Study|Death|2|||
33612120|NCT02873338|102130084|FG001|Overall Study|Death|1|||
33612121|NCT02873338|102130085|FG002|Overall Study|Death|1|||
33612122|NCT02873338|102130083|FG000|Overall Study|Withdrawal by Subject|2|||
33612123|NCT02873338|102130084|FG001|Overall Study|Withdrawal by Subject|1|||
33612124|NCT02873338|102130085|FG002|Overall Study|Withdrawal by Subject|3|||
33612125|NCT02873338|102130083|FG000|Overall Study|Lack of Efficacy|0|||
33612126|NCT02873338|102130084|FG001|Overall Study|Lack of Efficacy|2|||
33612127|NCT02873338|102130085|FG002|Overall Study|Lack of Efficacy|0|||
33612128|NCT02873338|102130083|FG000|Overall Study|Other or Missing|14|||
33612129|NCT02873338|102130084|FG001|Overall Study|Other or Missing|15|||
33612130|NCT02873338|102130085|FG002|Overall Study|Other or Missing|13|||
33612131|NCT02429791|102130086|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
33612132|NCT02429791|102130087|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
33612133|NCT02429791|102130086|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
33612134|NCT02429791|102130087|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
33612135|NCT02429791|102130086|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
33612136|NCT02429791|102130087|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
33612137|NCT02429791|102130086|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
33612138|NCT02429791|102130087|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
33205671|NCT01490632|100651535|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33205672|NCT01490632|100651536|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33205673|NCT01490632|100651537|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33205674|NCT01490632|100651538|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33205675|NCT01490632|100651539|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33205676|NCT01490632|100651540|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33531672|NCT02326272|101845098|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33531673|NCT02326272|101845099|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33205677|NCT01490632|100651541|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33205678|NCT01490632|100651542|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33531674|NCT02326272|101845100|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33531675|NCT02326272|101845101|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33531676|NCT02326272|101845102|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33531677|NCT02326272|101845103|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33531678|NCT02326272|101845104|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33531679|NCT02326272|101845105|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
33531680|NCT02326272|101845091|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
33531681|NCT02326272|101845092|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
33531682|NCT02326272|101845093|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33612139|NCT02429791|102130086|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
33612140|NCT02429791|102130087|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
33612141|NCT02429791|102130086|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
33612142|NCT02429791|102130087|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
33612143|NCT02429791|102130086|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
33612144|NCT02429791|102130087|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
33612145|NCT02429791|102130086|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
33612146|NCT02429791|102130087|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
33205679|NCT01490632|100651543|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33612147|NCT02429791|102130086|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
33531683|NCT02326272|101845094|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33531684|NCT02326272|101845095|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33531685|NCT02326272|101845096|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33531686|NCT02326272|101845097|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33531687|NCT02326272|101845098|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33531688|NCT02326272|101845099|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33531689|NCT02326272|101845100|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33531690|NCT02326272|101845101|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33612148|NCT02429791|102130087|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
33612149|NCT02429791|102130086|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
33612150|NCT02429791|102130087|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
33612151|NCT02429791|102130086|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
33612152|NCT02429791|102130087|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
33612153|NCT02429791|102130086|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
33612154|NCT02429791|102130087|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
33531691|NCT02326272|101845102|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33336936|NCT03691974|101124671|FG000|Overall Study|Lost to Follow-up|8|||
33336937|NCT03691974|101124672|FG001|Overall Study|Lost to Follow-up|7|||
33336938|NCT00812214|101124673|FG000|Overall Study|Lost to Follow-up|3|||
33612155|NCT02429791|102130086|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
33612156|NCT02429791|102130087|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
33612157|NCT02429791|102130086|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
33404436|NCT01632345|101369490|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
33404437|NCT01632345|101369491|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
33531692|NCT02326272|101845103|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33531693|NCT02326272|101845104|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33531694|NCT02326272|101845105|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
33531695|NCT02326272|101845091|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
33531696|NCT02326272|101845092|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
33531697|NCT02326272|101845093|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
33531698|NCT02326272|101845094|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33612158|NCT02429791|102130087|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
33612159|NCT02429791|102130086|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
33531699|NCT02326272|101845095|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33531700|NCT02326272|101845096|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33531701|NCT02326272|101845097|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33531702|NCT02326272|101845098|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33531703|NCT02326272|101845099|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33531704|NCT02326272|101845100|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33531705|NCT02326272|101845101|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33531706|NCT02326272|101845102|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33531707|NCT02326272|101845103|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33531708|NCT02326272|101845104|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33531709|NCT02326272|101845105|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
33612160|NCT02429791|102130087|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
33612161|NCT02429791|102130086|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
33612162|NCT02429791|102130087|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
33612163|NCT02429791|102130086|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
33612164|NCT02429791|102130087|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
33404438|NCT01632345|101369492|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
33404439|NCT01632345|101369493|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
33531710|NCT02326272|101845091|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33531711|NCT02326272|101845092|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33531712|NCT02326272|101845093|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
33531713|NCT02326272|101845094|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33531714|NCT02326272|101845095|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33531715|NCT02326272|101845096|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33531716|NCT02326272|101845097|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33531717|NCT02326272|101845098|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33531718|NCT02326272|101845099|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33531719|NCT02326272|101845100|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33531720|NCT02326272|101845101|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33531721|NCT02326272|101845102|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33612165|NCT02429791|102130086|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
33205680|NCT01490632|100651544|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33531722|NCT02326272|101845103|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33531723|NCT02326272|101845104|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33531724|NCT02326272|101845105|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
33531725|NCT02326272|101845091|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33531726|NCT02326272|101845092|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33531727|NCT02326272|101845093|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
33336939|NCT00812214|101124674|FG001|Overall Study|Lost to Follow-up|1|||
33336940|NCT04942925|101124675|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
33336941|NCT04942925|101124676|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
33336942|NCT04942925|101124675|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
33336943|NCT04942925|101124676|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
33336944|NCT01339559|101124681|FG000|Overall Study|Adverse Event|92|||
33336945|NCT01339559|101124681|FG000|Overall Study|Death|5|||
33336946|NCT01339559|101124681|FG000|Overall Study|Lack of Efficacy|164|||
33336947|NCT01339559|101124681|FG000|Overall Study|Lost to Follow-up|22|||
33336948|NCT01339559|101124681|FG000|Overall Study|Subject choice|89|||
33336949|NCT01339559|101124681|FG000|Overall Study|Protocol Violation|15|||
33336950|NCT01339559|101124681|FG000|Overall Study|Study closure at site|1|||
33336951|NCT01339559|101124681|FG000|Overall Study|Incarcerated|2|||
33336952|NCT01339559|101124681|FG000|Overall Study|Epilepsy surgery|1|||
33336953|NCT01339559|101124681|FG000|Overall Study|Pregnancy planned|2|||
33336954|NCT01339559|101124681|FG000|Overall Study|Left the country|1|||
33336955|NCT01339559|101124681|FG000|Overall Study|Investigator decision|2|||
33336956|NCT01339559|101124681|FG000|Overall Study|Patient didn't wish to continue|1|||
33336957|NCT01339559|101124681|FG000|Overall Study|PI decision|1|||
33336958|NCT01902290|101124683|FG000|Overall Study|Withdrawal by Subject|19|||
33336959|NCT01902290|101124684|FG001|Overall Study|Withdrawal by Subject|27|||
33336960|NCT01902290|101124683|FG000|Overall Study|Lost to Follow-up|2|||
33336961|NCT01902290|101124684|FG001|Overall Study|Lost to Follow-up|2|||
33336962|NCT01902290|101124683|FG000|Overall Study|Death|1|||
33336963|NCT01902290|101124684|FG001|Overall Study|Death|0|||
33336964|NCT01902290|101124683|FG000|Overall Study|Sponsor Decision|26|||
33336965|NCT01902290|101124684|FG001|Overall Study|Sponsor Decision|24|||
33336966|NCT00978029|101124685|FG000|Overall Study|Adverse Event|1|||
33336967|NCT00978029|101124686|FG001|Overall Study|Adverse Event|2|||
33336968|NCT00978029|101124687|FG002|Overall Study|Adverse Event|5|||
33336969|NCT00978029|101124685|FG000|Overall Study|Withdrawal by Subject|0|||
33336970|NCT00978029|101124686|FG001|Overall Study|Withdrawal by Subject|0|||
33336971|NCT00978029|101124687|FG002|Overall Study|Withdrawal by Subject|1|||
33205681|NCT01490632|100651545|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33205682|NCT01490632|100651546|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
33336972|NCT00978029|101124685|FG000|Overall Study|Protocol Violation|0|||
33336973|NCT00978029|101124686|FG001|Overall Study|Protocol Violation|1|||
33336974|NCT00978029|101124687|FG002|Overall Study|Protocol Violation|0|||
33531728|NCT02326272|101845094|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33531729|NCT02326272|101845095|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33531730|NCT02326272|101845096|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33531731|NCT02326272|101845097|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33531732|NCT02326272|101845098|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33531733|NCT02326272|101845099|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33531734|NCT02326272|101845100|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33531735|NCT02326272|101845101|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33531736|NCT02326272|101845102|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33531737|NCT02326272|101845103|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33531738|NCT02326272|101845104|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33531739|NCT02326272|101845105|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
33531740|NCT02326272|101845091|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33531741|NCT02326272|101845092|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33531742|NCT02326272|101845093|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
33531743|NCT02326272|101845094|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33531744|NCT02326272|101845095|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33531745|NCT02326272|101845096|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33531746|NCT02326272|101845097|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33531747|NCT02326272|101845098|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33531748|NCT02326272|101845099|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33531749|NCT02326272|101845100|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33531750|NCT02326272|101845101|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33531751|NCT02326272|101845102|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33531752|NCT02326272|101845103|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33531753|NCT02326272|101845104|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33531754|NCT02326272|101845105|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
33531755|NCT02326272|101845091|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33531756|NCT02326272|101845092|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33531757|NCT02326272|101845093|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
33531758|NCT02326272|101845094|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33531759|NCT02326272|101845095|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33531760|NCT02326272|101845096|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33531761|NCT02326272|101845097|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33531762|NCT02326272|101845098|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33531763|NCT02326272|101845099|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33531764|NCT02326272|101845100|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33531765|NCT02326272|101845101|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33531766|NCT02326272|101845102|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33531767|NCT02326272|101845103|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33531768|NCT02326272|101845104|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33531769|NCT02326272|101845105|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
33531770|NCT02326272|101845091|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33531771|NCT02326272|101845092|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33531772|NCT02326272|101845093|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33531773|NCT02326272|101845094|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33531774|NCT02326272|101845095|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
33531775|NCT02326272|101845096|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
33531776|NCT02326272|101845097|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
33531777|NCT02326272|101845098|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
33531778|NCT02326272|101845099|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
33531779|NCT02326272|101845100|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33531780|NCT02326272|101845101|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33531781|NCT02326272|101845102|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33531782|NCT02326272|101845103|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33531783|NCT02326272|101845104|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33531784|NCT02326272|101845105|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
33531785|NCT02326272|101845091|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33531786|NCT02326272|101845092|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33531787|NCT02326272|101845093|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33612166|NCT02429791|102130087|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
33531788|NCT02326272|101845094|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33531789|NCT02326272|101845095|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33531790|NCT02326272|101845096|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
33531791|NCT02326272|101845097|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
33531792|NCT02326272|101845098|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33531793|NCT02326272|101845099|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
33531794|NCT02326272|101845100|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
33531795|NCT02326272|101845101|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33531796|NCT02326272|101845102|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33531797|NCT02326272|101845103|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33531798|NCT02326272|101845104|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33531799|NCT02326272|101845105|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
33531800|NCT02326272|101845091|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33531801|NCT02326272|101845092|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33531802|NCT02326272|101845093|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33531803|NCT02326272|101845094|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33531804|NCT02326272|101845095|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33531805|NCT02326272|101845096|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
33531806|NCT02326272|101845097|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33531807|NCT02326272|101845098|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
33531808|NCT02326272|101845099|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33531809|NCT02326272|101845100|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33531810|NCT02326272|101845101|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33531811|NCT02326272|101845102|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33531812|NCT02326272|101845103|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33531813|NCT02326272|101845104|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33531814|NCT02326272|101845105|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
33531815|NCT02326272|101845091|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33531816|NCT02326272|101845092|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33531817|NCT02326272|101845093|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33531818|NCT02326272|101845094|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33531819|NCT02326272|101845095|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33531820|NCT02326272|101845096|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
33531821|NCT02326272|101845097|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33531822|NCT02326272|101845098|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33531823|NCT02326272|101845099|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33531824|NCT02326272|101845100|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
33531825|NCT02326272|101845101|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33531826|NCT02326272|101845102|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33531827|NCT02326272|101845103|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33531828|NCT02326272|101845104|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33531829|NCT02326272|101845105|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
33531830|NCT02326272|101845091|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33531831|NCT02326272|101845092|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33531832|NCT02326272|101845093|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33531833|NCT02326272|101845094|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33531834|NCT02326272|101845095|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33531835|NCT02326272|101845096|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33531836|NCT02326272|101845097|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33531837|NCT02326272|101845098|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
33531838|NCT02326272|101845099|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33531839|NCT02326272|101845100|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33531840|NCT02326272|101845101|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33531841|NCT02326272|101845102|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33531842|NCT02326272|101845103|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33531843|NCT02326272|101845104|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33531844|NCT02326272|101845105|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
33531845|NCT02326272|101845091|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33531846|NCT02326272|101845092|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33531847|NCT02326272|101845093|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33531848|NCT02326272|101845094|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33531849|NCT02326272|101845095|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33205683|NCT01490632|100651547|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
33612167|NCT04725500|102130092|FG000|Screening|Screen Failure|26|||
33612168|NCT04725500|102130092|FG000|Screening|Withdrawal by Subject|1|||
33612169|NCT04725500|102130092|FG000|2 Week Take Home|Screen Fail|5|||
33612170|NCT00764673|102130093|FG000|Overall Study|Death|1|||
33612171|NCT00764673|102130093|FG000|Overall Study|Lost to Follow-up|3|||
33612172|NCT00764673|102130093|FG000|Overall Study|Withdrawal by Subject|6|||
33612173|NCT00764673|102130093|FG000|Overall Study|Revision of Device|2|||
33612174|NCT00781859|102130094|FG000|Overall Study|Adverse Event|2|||
33612175|NCT00781859|102130095|FG001|Overall Study|Adverse Event|2|||
33612176|NCT00781859|102130094|FG000|Overall Study|Withdrawal by Subject|8|||
33612177|NCT00781859|102130095|FG001|Overall Study|Withdrawal by Subject|4|||
33612178|NCT00781859|102130094|FG000|Overall Study|Lost to Follow-up|6|||
33612179|NCT00781859|102130095|FG001|Overall Study|Lost to Follow-up|3|||
33612180|NCT00781859|102130094|FG000|Overall Study|Death|3|||
33612181|NCT00781859|102130095|FG001|Overall Study|Death|0|||
33612182|NCT00077649|102130097|FG000|Overall Study|Adverse Event|5|||
33612183|NCT00077649|102130098|FG001|Overall Study|Adverse Event|1|||
33612184|NCT00077649|102130099|FG002|Overall Study|Adverse Event|7|||
33612185|NCT00077649|102130100|FG003|Overall Study|Adverse Event|9|||
33612186|NCT00077649|102130097|FG000|Overall Study|Lack of Efficacy|5|||
33612187|NCT00077649|102130098|FG001|Overall Study|Lack of Efficacy|3|||
33612188|NCT00077649|102130099|FG002|Overall Study|Lack of Efficacy|3|||
33612189|NCT00077649|102130100|FG003|Overall Study|Lack of Efficacy|2|||
33612190|NCT00077649|102130097|FG000|Overall Study|Withdrawal by Subject|0|||
33612191|NCT00077649|102130098|FG001|Overall Study|Withdrawal by Subject|1|||
33612192|NCT00077649|102130099|FG002|Overall Study|Withdrawal by Subject|1|||
33612193|NCT00077649|102130100|FG003|Overall Study|Withdrawal by Subject|2|||
33612194|NCT00077649|102130097|FG000|Overall Study|Lost to Follow-up|2|||
33612195|NCT00077649|102130098|FG001|Overall Study|Lost to Follow-up|2|||
33612196|NCT00077649|102130099|FG002|Overall Study|Lost to Follow-up|3|||
33612197|NCT00077649|102130100|FG003|Overall Study|Lost to Follow-up|2|||
33612198|NCT00077649|102130097|FG000|Overall Study|Abnormality of Laboratory Test|1|||
33612199|NCT00077649|102130098|FG001|Overall Study|Abnormality of Laboratory Test|2|||
33612200|NCT00077649|102130099|FG002|Overall Study|Abnormality of Laboratory Test|1|||
33612201|NCT00077649|102130100|FG003|Overall Study|Abnormality of Laboratory Test|2|||
33612202|NCT00077649|102130097|FG000|Overall Study|Randomized but never dosed|1|||
33612203|NCT00077649|102130098|FG001|Overall Study|Randomized but never dosed|0|||
33612204|NCT00077649|102130099|FG002|Overall Study|Randomized but never dosed|0|||
33612205|NCT00077649|102130100|FG003|Overall Study|Randomized but never dosed|0|||
33612206|NCT01022424|102130101|FG000|Overall Study|Adverse Event|1|||
33612207|NCT01022424|102130101|FG000|Overall Study|Physician Decision|1|||
33612208|NCT01022424|102130101|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
33612209|NCT04310566|102130102|FG000|Period 1|Study Termination due to COVID-19|15|||
33612210|NCT04310566|102130103|FG001|Period 1|Study Termination due to COVID-19|17|||
33612211|NCT04310566|102130102|FG000|Period 1|Protocol Violation|0|||
33612212|NCT04310566|102130103|FG001|Period 1|Protocol Violation|1|||
33612213|NCT04310566|102130102|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
33612214|NCT04310566|102130103|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
33612215|NCT04310566|102130102|FG000|Period 1|Lost to Follow-up|1|||
33612216|NCT04310566|102130103|FG001|Period 1|Lost to Follow-up|0|||
33612217|NCT04310566|102130102|FG000|Period 1|Withdrawal by Subject|0|||
33612218|NCT04310566|102130103|FG001|Period 1|Withdrawal by Subject|1|||
33612219|NCT04310566|102130102|FG000|Period 2|Study Termination|7|||
33612220|NCT04310566|102130103|FG001|Period 2|Study Termination|5|||
33612221|NCT00880191|102130109|FG000|Overall Study|Refused further treatment|4|||
33205684|NCT01490632|100651548|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33205685|NCT01490632|100651549|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33205686|NCT01490632|100651550|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33205687|NCT01490632|100651551|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
33612222|NCT00880191|102130110|FG001|Overall Study|Refused further treatment|1|||
33612223|NCT00880191|102130109|FG000|Overall Study|Adverse Event|8|||
33612224|NCT00880191|102130110|FG001|Overall Study|Adverse Event|6|||
33612225|NCT00880191|102130109|FG000|Overall Study|Hospitalization/efficacy|1|||
33612226|NCT00880191|102130110|FG001|Overall Study|Hospitalization/efficacy|1|||
33612227|NCT01564732|102130114|FG000|Overall Study|Early termination by the study sponsor|6|||
33612228|NCT01564732|102130115|FG001|Overall Study|Early termination by the study sponsor|5|||
33612229|NCT03405818|102130121|FG000|Overall Study|Withdrawal by Subject|4|||
33612230|NCT03405818|102130121|FG000|Overall Study|Lost to Follow-up|4|||
33612231|NCT00483938|102130122|FG000|Overall Study|Protocol Violation|0|||
33612232|NCT00483938|102130123|FG001|Overall Study|Protocol Violation|0|||
33224370|NCT05044325|100721811|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
33612233|NCT00483938|102130124|FG002|Overall Study|Protocol Violation|0|||
33612234|NCT00483938|102130125|FG003|Overall Study|Protocol Violation|0|||
33612235|NCT00483938|102130126|FG004|Overall Study|Protocol Violation|0|||
33612236|NCT00483938|102130127|FG005|Overall Study|Protocol Violation|0|||
33612237|NCT00483938|102130128|FG006|Overall Study|Protocol Violation|3|||
33336975|NCT01784861|101124688|FG000|Overall Study|Adverse Event|0|||
33336976|NCT01784861|101124689|FG001|Overall Study|Adverse Event|0|||
33336977|NCT01784861|101124690|FG002|Overall Study|Adverse Event|1|||
33336978|NCT01784861|101124691|FG003|Overall Study|Adverse Event|2|||
33336979|NCT01784861|101124692|FG004|Overall Study|Adverse Event|1|||
33336980|NCT01784861|101124693|FG005|Overall Study|Adverse Event|0|||
33336981|NCT01784861|101124688|FG000|Overall Study|Withdrawal by Subject|0|||
33336982|NCT01784861|101124689|FG001|Overall Study|Withdrawal by Subject|0|||
33336983|NCT01784861|101124690|FG002|Overall Study|Withdrawal by Subject|0|||
33336984|NCT01784861|101124691|FG003|Overall Study|Withdrawal by Subject|1|||
33336985|NCT01784861|101124692|FG004|Overall Study|Withdrawal by Subject|0|||
33336986|NCT01784861|101124693|FG005|Overall Study|Withdrawal by Subject|0|||
33336987|NCT01784861|101124688|FG000|Overall Study|Physician Decision|0|||
33612238|NCT00483938|102130122|FG000|Overall Study|Withdrawal by Subject|1|||
33612239|NCT00483938|102130123|FG001|Overall Study|Withdrawal by Subject|6|||
33612240|NCT00483938|102130124|FG002|Overall Study|Withdrawal by Subject|0|||
33531850|NCT02326272|101845096|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33612241|NCT00483938|102130125|FG003|Overall Study|Withdrawal by Subject|0|||
33612242|NCT00483938|102130126|FG004|Overall Study|Withdrawal by Subject|1|||
33612243|NCT00483938|102130127|FG005|Overall Study|Withdrawal by Subject|3|||
33612244|NCT00483938|102130128|FG006|Overall Study|Withdrawal by Subject|2|||
33612245|NCT00483938|102130122|FG000|Overall Study|Lost to Follow-up|1|||
33612246|NCT00483938|102130123|FG001|Overall Study|Lost to Follow-up|2|||
33531851|NCT02326272|101845097|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
33531852|NCT02326272|101845098|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33531853|NCT02326272|101845099|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33531854|NCT02326272|101845100|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33531855|NCT02326272|101845101|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33531856|NCT02326272|101845102|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33531857|NCT02326272|101845103|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33531858|NCT02326272|101845104|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33531859|NCT02326272|101845105|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
33531860|NCT02326272|101845091|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33531861|NCT02326272|101845092|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33531862|NCT02326272|101845093|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33531863|NCT02326272|101845094|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33531864|NCT02326272|101845095|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33531865|NCT02326272|101845096|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33531866|NCT02326272|101845097|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33531867|NCT02326272|101845098|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33531868|NCT02326272|101845099|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
33531869|NCT02326272|101845100|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33531870|NCT02326272|101845101|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33531871|NCT02326272|101845102|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33531872|NCT02326272|101845103|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33531873|NCT02326272|101845104|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33531874|NCT02326272|101845105|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
33531875|NCT02326272|101845091|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33531876|NCT02326272|101845092|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33531877|NCT02326272|101845093|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33531878|NCT02326272|101845094|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33531879|NCT02326272|101845095|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33531880|NCT02326272|101845096|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
33612247|NCT00483938|102130124|FG002|Overall Study|Lost to Follow-up|0|||
33612248|NCT00483938|102130125|FG003|Overall Study|Lost to Follow-up|2|||
33612249|NCT00483938|102130126|FG004|Overall Study|Lost to Follow-up|1|||
33612250|NCT00483938|102130127|FG005|Overall Study|Lost to Follow-up|1|||
33612251|NCT00483938|102130128|FG006|Overall Study|Lost to Follow-up|3|||
33612252|NCT00483938|102130122|FG000|Overall Study|Death|0|||
33612253|NCT00483938|102130123|FG001|Overall Study|Death|2|||
33612254|NCT00483938|102130124|FG002|Overall Study|Death|0|||
33612255|NCT00483938|102130125|FG003|Overall Study|Death|0|||
33205688|NCT01490632|100651532|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205689|NCT01490632|100651533|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205690|NCT01490632|100651534|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33336988|NCT01784861|101124689|FG001|Overall Study|Physician Decision|0|||
33336989|NCT01784861|101124690|FG002|Overall Study|Physician Decision|0|||
33336990|NCT01784861|101124691|FG003|Overall Study|Physician Decision|2|||
33336991|NCT01784861|101124692|FG004|Overall Study|Physician Decision|0|||
33336992|NCT01784861|101124693|FG005|Overall Study|Physician Decision|1|||
33336993|NCT03436862|101124694|FG000|Overall Study|Adverse Event|4|||
33404440|NCT01632345|101369494|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
33612256|NCT00483938|102130126|FG004|Overall Study|Death|0|||
33612257|NCT00483938|102130127|FG005|Overall Study|Death|0|||
33612258|NCT00483938|102130128|FG006|Overall Study|Death|0|||
33612259|NCT00483938|102130122|FG000|Overall Study|Other|3|||
33612260|NCT00483938|102130123|FG001|Overall Study|Other|9|||
33404441|NCT01632345|101369495|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
33404442|NCT01632345|101369489|FG000|Treatment: Part I|Physician Decision|2|||
33404443|NCT01632345|101369490|FG001|Treatment: Part I|Physician Decision|1|||
33404444|NCT01632345|101369491|FG002|Treatment: Part I|Physician Decision|0|||
33404445|NCT01632345|101369492|FG003|Treatment: Part I|Physician Decision|0|||
33404446|NCT01632345|101369493|FG004|Treatment: Part I|Physician Decision|1|||
33404447|NCT01632345|101369494|FG005|Treatment: Part I|Physician Decision|0|||
33404448|NCT01632345|101369495|FG006|Treatment: Part I|Physician Decision|0|||
33404449|NCT01632345|101369489|FG000|Treatment: Part I|Pregnancy|0|||
33404450|NCT01632345|101369490|FG001|Treatment: Part I|Pregnancy|1|||
33404451|NCT01632345|101369491|FG002|Treatment: Part I|Pregnancy|0|||
33404452|NCT01632345|101369492|FG003|Treatment: Part I|Pregnancy|0|||
33404453|NCT01632345|101369493|FG004|Treatment: Part I|Pregnancy|0|||
33404454|NCT01632345|101369494|FG005|Treatment: Part I|Pregnancy|0|||
33404455|NCT01632345|101369495|FG006|Treatment: Part I|Pregnancy|0|||
33612261|NCT00483938|102130124|FG002|Overall Study|Other|0|||
33612262|NCT00483938|102130125|FG003|Overall Study|Other|4|||
33612263|NCT00483938|102130126|FG004|Overall Study|Other|0|||
33612264|NCT00483938|102130127|FG005|Overall Study|Other|4|||
33612265|NCT00483938|102130128|FG006|Overall Study|Other|32|||
33612266|NCT00588354|102130129|FG000|Baseline to 2 Weeks|Adverse Event|1|||
33612267|NCT00588354|102130130|FG001|Baseline to 2 Weeks|Adverse Event|0|||
33612268|NCT00588354|102130129|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
33612269|NCT00588354|102130130|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
33612270|NCT00588354|102130129|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
33612271|NCT00588354|102130130|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
33612272|NCT00989963|102130131|FG000|Overall Study|Adverse Event|1|||
33612273|NCT00989963|102130132|FG001|Overall Study|Adverse Event|1|||
33612274|NCT00989963|102130133|FG002|Overall Study|Adverse Event|1|||
33612275|NCT01023672|102130134|FG000|Overall Study|Worsening disease|2|||
33612276|NCT01023672|102130134|FG000|Overall Study|Death|1|||
33336994|NCT03436862|101124694|FG000|Overall Study|Progressive Disease|2|||
33336995|NCT01849874|101124695|FG000|Overall Study|Death|89|||
33336996|NCT01849874|101124696|FG001|Overall Study|Death|42|||
33336997|NCT01849874|101124695|FG000|Overall Study|Withdrawal by Subject|17|||
33336998|NCT01849874|101124696|FG001|Overall Study|Withdrawal by Subject|16|||
33336999|NCT01849874|101124695|FG000|Overall Study|Lost to Follow-up|3|||
33337000|NCT01849874|101124696|FG001|Overall Study|Lost to Follow-up|2|||
33337001|NCT01849874|101124695|FG000|Overall Study|Study Termination By Sponsor|93|||
33337002|NCT01849874|101124696|FG001|Overall Study|Study Termination By Sponsor|48|||
33337003|NCT01849874|101124695|FG000|Overall Study|Completed as per protocol amendment 6|3|||
33337004|NCT01849874|101124696|FG001|Overall Study|Completed as per protocol amendment 6|0|||
33337005|NCT01849874|101124695|FG000|Overall Study|Physician Decision|7|||
33337006|NCT01849874|101124696|FG001|Overall Study|Physician Decision|1|||
33337007|NCT01849874|101124695|FG000|Overall Study|Other|16|||
33337008|NCT01849874|101124696|FG001|Overall Study|Other|4|||
33612277|NCT02008773|102130135|FG000|Overall Study|Adverse Event|3|||
33612278|NCT02008773|102130136|FG001|Overall Study|Adverse Event|3|||
33612279|NCT02008773|102130137|FG002|Overall Study|Adverse Event|1|||
33612280|NCT02008773|102130138|FG003|Overall Study|Adverse Event|2|||
33612281|NCT02008773|102130135|FG000|Overall Study|Medication Non-compliance|2|||
33612282|NCT02008773|102130136|FG001|Overall Study|Medication Non-compliance|1|||
33612283|NCT02008773|102130137|FG002|Overall Study|Medication Non-compliance|3|||
33612284|NCT02008773|102130138|FG003|Overall Study|Medication Non-compliance|2|||
33612285|NCT02008773|102130135|FG000|Overall Study|Withdrawal by Subject|8|||
33612286|NCT02008773|102130136|FG001|Overall Study|Withdrawal by Subject|4|||
33612287|NCT02008773|102130137|FG002|Overall Study|Withdrawal by Subject|7|||
33205691|NCT01490632|100651535|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205692|NCT01490632|100651536|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205693|NCT01490632|100651537|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205694|NCT01490632|100651538|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205695|NCT01490632|100651539|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205696|NCT01490632|100651540|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205697|NCT01490632|100651541|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205698|NCT01490632|100651542|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205699|NCT01490632|100651543|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205700|NCT01490632|100651544|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
33205701|NCT01490632|100651545|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
33205702|NCT01490632|100651546|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
33205703|NCT01490632|100651547|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
33205704|NCT01490632|100651548|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205705|NCT01490632|100651549|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205706|NCT01490632|100651550|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205707|NCT01490632|100651551|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
33205708|NCT01490632|100651532|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
33205709|NCT01490632|100651533|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
33205710|NCT01490632|100651534|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
33205711|NCT01490632|100651535|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
33205712|NCT01490632|100651536|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
33205713|NCT01490632|100651537|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
33205714|NCT01490632|100651538|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
33205715|NCT01490632|100651539|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
33205716|NCT01490632|100651540|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
33205717|NCT01490632|100651541|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
33205718|NCT01490632|100651542|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
33531881|NCT02326272|101845097|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
33531882|NCT02326272|101845098|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
33531883|NCT02326272|101845099|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
33531884|NCT02326272|101845100|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33531885|NCT02326272|101845101|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33531886|NCT02326272|101845102|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33531887|NCT02326272|101845103|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33531888|NCT02326272|101845104|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33531889|NCT02326272|101845105|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
33531890|NCT02326272|101845091|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33531891|NCT02326272|101845092|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33531892|NCT02326272|101845093|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33531893|NCT02326272|101845094|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33531894|NCT02326272|101845095|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33531895|NCT02326272|101845096|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
33612288|NCT02008773|102130138|FG003|Overall Study|Withdrawal by Subject|6|||
33612289|NCT02008773|102130135|FG000|Overall Study|Lost to Follow-up|0|||
33612290|NCT02008773|102130136|FG001|Overall Study|Lost to Follow-up|1|||
33205719|NCT01490632|100651543|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
33205720|NCT01490632|100651544|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
33205721|NCT01490632|100651545|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
33205722|NCT01490632|100651546|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
33205723|NCT01490632|100651547|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
33205724|NCT01490632|100651548|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
33205725|NCT01490632|100651549|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
33205726|NCT01490632|100651550|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
33205727|NCT01490632|100651551|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
33205728|NCT01490632|100651532|FG000|Part D: Re-Treatment Period|Death|0|||
33205729|NCT01490632|100651533|FG001|Part D: Re-Treatment Period|Death|0|||
33205730|NCT01490632|100651534|FG002|Part D: Re-Treatment Period|Death|0|||
33205731|NCT01490632|100651535|FG003|Part D: Re-Treatment Period|Death|0|||
33205732|NCT01490632|100651536|FG004|Part D: Re-Treatment Period|Death|0|||
33205733|NCT01490632|100651537|FG005|Part D: Re-Treatment Period|Death|0|||
33205734|NCT01490632|100651538|FG006|Part D: Re-Treatment Period|Death|0|||
33205735|NCT01490632|100651539|FG007|Part D: Re-Treatment Period|Death|0|||
33205736|NCT01490632|100651540|FG008|Part D: Re-Treatment Period|Death|0|||
33205737|NCT01490632|100651541|FG009|Part D: Re-Treatment Period|Death|0|||
33205738|NCT01490632|100651542|FG010|Part D: Re-Treatment Period|Death|0|||
33205739|NCT01490632|100651543|FG011|Part D: Re-Treatment Period|Death|0|||
33205740|NCT01490632|100651544|FG012|Part D: Re-Treatment Period|Death|0|||
33205741|NCT01490632|100651545|FG013|Part D: Re-Treatment Period|Death|0|||
33205742|NCT01490632|100651546|FG014|Part D: Re-Treatment Period|Death|0|||
33205743|NCT01490632|100651547|FG015|Part D: Re-Treatment Period|Death|0|||
33205744|NCT01490632|100651548|FG016|Part D: Re-Treatment Period|Death|0|||
33205745|NCT01490632|100651549|FG017|Part D: Re-Treatment Period|Death|0|||
33205746|NCT01490632|100651550|FG018|Part D: Re-Treatment Period|Death|1|||
33205747|NCT01490632|100651551|FG019|Part D: Re-Treatment Period|Death|0|||
33205748|NCT01490632|100651532|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205749|NCT01490632|100651533|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205750|NCT01490632|100651534|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205751|NCT01490632|100651535|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205752|NCT01490632|100651536|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205753|NCT01490632|100651537|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205754|NCT01490632|100651538|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205755|NCT01490632|100651539|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205756|NCT01490632|100651540|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205757|NCT01490632|100651541|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205758|NCT01490632|100651542|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205759|NCT01490632|100651543|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205760|NCT01490632|100651544|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205761|NCT01490632|100651545|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205762|NCT01490632|100651546|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205763|NCT01490632|100651547|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205764|NCT01490632|100651548|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
33205765|NCT01490632|100651549|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
33205766|NCT01490632|100651550|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
33205767|NCT01490632|100651551|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
33205768|NCT01490632|100651532|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205769|NCT01490632|100651533|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205770|NCT01490632|100651534|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205771|NCT01490632|100651535|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205772|NCT01490632|100651536|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205773|NCT01490632|100651537|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205774|NCT01490632|100651538|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205775|NCT01490632|100651539|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205776|NCT01490632|100651540|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205777|NCT01490632|100651541|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205778|NCT01490632|100651542|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205779|NCT01490632|100651543|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205780|NCT01490632|100651544|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205781|NCT01490632|100651545|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205782|NCT01490632|100651546|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205783|NCT01490632|100651547|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205784|NCT01490632|100651548|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205785|NCT01490632|100651549|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205786|NCT01490632|100651550|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
33205787|NCT01490632|100651551|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
33205788|NCT01490632|100651532|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
33205789|NCT01490632|100651533|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
33205790|NCT01490632|100651534|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
33337009|NCT03259074|101124702|FG000|Overall Study|Adverse Event|9|||
33337010|NCT03259074|101124703|FG001|Overall Study|Adverse Event|12|||
33531896|NCT02326272|101845097|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33612291|NCT02008773|102130137|FG002|Overall Study|Lost to Follow-up|3|||
33612292|NCT02008773|102130138|FG003|Overall Study|Lost to Follow-up|2|||
33612293|NCT01371734|102130139|FG000|Overall Study|Other|2|||
33612294|NCT01371734|102130140|FG001|Overall Study|Other|1|||
33612295|NCT01371734|102130141|FG002|Overall Study|Other|2|||
33612296|NCT01371734|102130139|FG000|Overall Study|Withdrawal by Subject|3|||
33612297|NCT01371734|102130140|FG001|Overall Study|Withdrawal by Subject|4|||
33612298|NCT01371734|102130141|FG002|Overall Study|Withdrawal by Subject|9|||
33612299|NCT01371734|102130139|FG000|Overall Study|Lost to Follow-up|5|||
33612300|NCT01371734|102130140|FG001|Overall Study|Lost to Follow-up|3|||
33612301|NCT01371734|102130141|FG002|Overall Study|Lost to Follow-up|1|||
33612302|NCT01371734|102130139|FG000|Overall Study|Protocol Violation|3|||
33612303|NCT01371734|102130140|FG001|Overall Study|Protocol Violation|1|||
33612304|NCT01371734|102130141|FG002|Overall Study|Protocol Violation|2|||
33612305|NCT01371734|102130139|FG000|Overall Study|Adverse Event|8|||
33612306|NCT01371734|102130140|FG001|Overall Study|Adverse Event|8|||
33612307|NCT01371734|102130141|FG002|Overall Study|Adverse Event|3|||
33612308|NCT01371734|102130139|FG000|Overall Study|Lack of Efficacy|2|||
33612309|NCT01371734|102130140|FG001|Overall Study|Lack of Efficacy|2|||
33612310|NCT01371734|102130141|FG002|Overall Study|Lack of Efficacy|0|||
33612311|NCT00429169|102130148|FG000|Overall Study|Lost to Follow-up|0|||
33612312|NCT00429169|102130149|FG001|Overall Study|Lost to Follow-up|1|||
33612313|NCT00429169|102130148|FG000|Overall Study|Ineligibility discovered after entry|2|||
33612314|NCT00429169|102130149|FG001|Overall Study|Ineligibility discovered after entry|1|||
33612315|NCT02522325|102130150|FG000|Overall Study|Adverse Event|0|||
33612316|NCT02522325|102130151|FG001|Overall Study|Adverse Event|1|||
33612317|NCT01867086|102130152|FG000|Overall Study|Disease Progression|1|||
33612318|NCT00707954|102130155|FG000|Overall Study|Physician Decision|0|||
33531897|NCT02326272|101845098|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33531898|NCT02326272|101845099|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33531899|NCT02326272|101845100|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33531900|NCT02326272|101845101|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33531901|NCT02326272|101845102|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33531902|NCT02326272|101845103|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33531903|NCT02326272|101845104|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33531904|NCT02326272|101845105|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
33531905|NCT02326272|101845091|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33531906|NCT02326272|101845092|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33531907|NCT02326272|101845093|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33531908|NCT02326272|101845094|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33531909|NCT02326272|101845095|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33531910|NCT02326272|101845096|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33531911|NCT02326272|101845097|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
33531912|NCT02326272|101845098|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33531913|NCT02326272|101845099|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33531914|NCT02326272|101845100|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33531915|NCT02326272|101845101|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33531916|NCT02326272|101845102|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33531917|NCT02326272|101845103|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33531918|NCT02326272|101845104|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33531919|NCT02326272|101845105|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
33531920|NCT02326272|101845091|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
33531921|NCT02326272|101845092|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
33531922|NCT02326272|101845093|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
33531923|NCT02326272|101845094|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
33531924|NCT02326272|101845095|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
33531925|NCT02326272|101845096|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
33531926|NCT02326272|101845097|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
33612319|NCT00707954|102130156|FG001|Overall Study|Physician Decision|0|||
33612320|NCT00707954|102130157|FG002|Overall Study|Physician Decision|0|||
33612321|NCT00707954|102130158|FG003|Overall Study|Physician Decision|0|||
33612322|NCT00707954|102130159|FG004|Overall Study|Physician Decision|1|||
33612323|NCT00495625|102130162|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
33612324|NCT01380834|102130169|FG000|Overall Study|Physician Decision|1|||
33612325|NCT01380834|102130170|FG001|Overall Study|Physician Decision|0|||
33612326|NCT04736628|102130171|FG000|Overall Study|Not treated|0|||
33612327|NCT04736628|102130172|FG001|Overall Study|Not treated|0|||
33531927|NCT02326272|101845098|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
33531928|NCT02326272|101845099|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
33531929|NCT02326272|101845100|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
33531930|NCT02326272|101845101|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
33612328|NCT04736628|102130173|FG002|Overall Study|Not treated|0|||
33612329|NCT04736628|102130174|FG003|Overall Study|Not treated|2|||
33612330|NCT04736628|102130171|FG000|Overall Study|Other reason than listed|1|||
33612331|NCT04736628|102130172|FG001|Overall Study|Other reason than listed|2|||
33205791|NCT01490632|100651535|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
33205792|NCT01490632|100651536|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
33531931|NCT02326272|101845102|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
33531932|NCT02326272|101845103|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
33531933|NCT02326272|101845104|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
33531934|NCT02326272|101845105|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
33612332|NCT04736628|102130173|FG002|Overall Study|Other reason than listed|2|||
33612333|NCT04736628|102130174|FG003|Overall Study|Other reason than listed|3|||
33612334|NCT04736628|102130171|FG000|Overall Study|Protocol deviation|0|||
33205793|NCT01490632|100651537|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
33205794|NCT01490632|100651538|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
33205795|NCT01490632|100651539|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
33205796|NCT01490632|100651540|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
33205797|NCT01490632|100651541|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
33205798|NCT01490632|100651542|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
33205799|NCT01490632|100651543|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
33205800|NCT01490632|100651544|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
33205801|NCT01490632|100651545|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
33205802|NCT01490632|100651546|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
33205803|NCT01490632|100651547|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
33205804|NCT01490632|100651548|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
33205805|NCT01490632|100651549|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
33612335|NCT04736628|102130172|FG001|Overall Study|Protocol deviation|0|||
33612336|NCT04736628|102130173|FG002|Overall Study|Protocol deviation|0|||
33612337|NCT04736628|102130174|FG003|Overall Study|Protocol deviation|1|||
33612338|NCT04736628|102130171|FG000|Overall Study|Burden of study procedures|1|||
33612339|NCT04736628|102130172|FG001|Overall Study|Burden of study procedures|0|||
33612340|NCT04736628|102130173|FG002|Overall Study|Burden of study procedures|0|||
33612341|NCT04736628|102130174|FG003|Overall Study|Burden of study procedures|1|||
33612342|NCT04736628|102130171|FG000|Overall Study|Change of residence|0|||
33612343|NCT04736628|102130172|FG001|Overall Study|Change of residence|1|||
33612344|NCT04736628|102130173|FG002|Overall Study|Change of residence|0|||
33612345|NCT04736628|102130174|FG003|Overall Study|Change of residence|0|||
33612346|NCT04736628|102130171|FG000|Overall Study|Perceived lack of efficacy|1|||
33612347|NCT04736628|102130172|FG001|Overall Study|Perceived lack of efficacy|0|||
33612348|NCT04736628|102130173|FG002|Overall Study|Perceived lack of efficacy|0|||
33612349|NCT04736628|102130174|FG003|Overall Study|Perceived lack of efficacy|1|||
33612350|NCT04736628|102130171|FG000|Overall Study|Adverse Event|3|||
33612351|NCT04736628|102130172|FG001|Overall Study|Adverse Event|2|||
33612352|NCT04736628|102130173|FG002|Overall Study|Adverse Event|4|||
33612353|NCT04736628|102130174|FG003|Overall Study|Adverse Event|3|||
33612354|NCT02718716|102130175|FG000|Overall Study|Lack of Efficacy|1|||
33612355|NCT02718716|102130176|FG001|Overall Study|Lack of Efficacy|0|||
33612356|NCT02718716|102130177|FG002|Overall Study|Lack of Efficacy|0|||
33612357|NCT02718716|102130178|FG003|Overall Study|Lack of Efficacy|0|||
33612358|NCT02718716|102130179|FG004|Overall Study|Lack of Efficacy|0|||
33612359|NCT02315560|102130181|FG000|Overall Study|noncompliance by subjects|3|||
33612360|NCT00859937|102130182|FG000|Overall Study|Protocol Violation|1|||
33612361|NCT00859937|102130183|FG001|Overall Study|Protocol Violation|0|||
33612362|NCT05090852|102130184|FG000|Overall Study|Physician Decision|5|||
33205806|NCT01490632|100651550|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
33205807|NCT01490632|100651551|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
33205808|NCT01490632|100651532|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
33205809|NCT01490632|100651533|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
33205810|NCT01490632|100651534|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
33612363|NCT00235716|102130189|FG000|Overall Study|Death|26|||
33612364|NCT00235716|102130190|FG001|Overall Study|Death|39|||
33612365|NCT00235716|102130191|FG002|Overall Study|Death|32|||
33612366|NCT00235716|102130192|FG003|Overall Study|Death|31|||
33612367|NCT00235716|102130189|FG000|Overall Study|Withdrawal by Subject|23|||
33612368|NCT00235716|102130190|FG001|Overall Study|Withdrawal by Subject|19|||
33612369|NCT00235716|102130191|FG002|Overall Study|Withdrawal by Subject|17|||
33205811|NCT01490632|100651535|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
33205812|NCT01490632|100651536|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
33205813|NCT01490632|100651537|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
33205814|NCT01490632|100651538|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
33205815|NCT01490632|100651539|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
33205816|NCT01490632|100651540|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
33531935|NCT02326272|101845091|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33531936|NCT02326272|101845092|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33531937|NCT02326272|101845093|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33531938|NCT02326272|101845094|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33531939|NCT02326272|101845095|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33531940|NCT02326272|101845096|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33531941|NCT02326272|101845097|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33531942|NCT02326272|101845098|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33531943|NCT02326272|101845099|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33531944|NCT02326272|101845100|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33531945|NCT02326272|101845101|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
33531946|NCT02326272|101845102|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
33531947|NCT02326272|101845103|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
33531948|NCT02326272|101845104|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
33205817|NCT01490632|100651541|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
33531949|NCT02326272|101845105|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
33612370|NCT00235716|102130192|FG003|Overall Study|Withdrawal by Subject|18|||
33612371|NCT00235716|102130189|FG000|Overall Study|Lost to Follow-up|12|||
33404456|NCT01632345|101369489|FG000|Treatment: Part I|Protocol Deviation|0|||
33404457|NCT01632345|101369490|FG001|Treatment: Part I|Protocol Deviation|0|||
33404458|NCT01632345|101369491|FG002|Treatment: Part I|Protocol Deviation|1|||
33404459|NCT01632345|101369492|FG003|Treatment: Part I|Protocol Deviation|1|||
33404460|NCT01632345|101369493|FG004|Treatment: Part I|Protocol Deviation|0|||
33404461|NCT01632345|101369494|FG005|Treatment: Part I|Protocol Deviation|0|||
33404462|NCT01632345|101369495|FG006|Treatment: Part I|Protocol Deviation|0|||
33404463|NCT01632345|101369489|FG000|Treatment: Part I|Withdrawal by Subject|3|||
33404464|NCT01632345|101369490|FG001|Treatment: Part I|Withdrawal by Subject|4|||
33404465|NCT01632345|101369491|FG002|Treatment: Part I|Withdrawal by Subject|4|||
33404466|NCT01632345|101369492|FG003|Treatment: Part I|Withdrawal by Subject|1|||
33404467|NCT01632345|101369493|FG004|Treatment: Part I|Withdrawal by Subject|4|||
33404468|NCT01632345|101369494|FG005|Treatment: Part I|Withdrawal by Subject|0|||
33404469|NCT01632345|101369495|FG006|Treatment: Part I|Withdrawal by Subject|0|||
33404470|NCT01632345|101369489|FG000|Treatment: Part II|Adverse Event|0|||
33404471|NCT01632345|101369490|FG001|Treatment: Part II|Adverse Event|0|||
33404472|NCT01632345|101369491|FG002|Treatment: Part II|Adverse Event|0|||
33404473|NCT01632345|101369492|FG003|Treatment: Part II|Adverse Event|0|||
33404474|NCT01632345|101369493|FG004|Treatment: Part II|Adverse Event|0|||
33404475|NCT01632345|101369494|FG005|Treatment: Part II|Adverse Event|3|||
33404476|NCT01632345|101369495|FG006|Treatment: Part II|Adverse Event|8|||
33404477|NCT01632345|101369489|FG000|Treatment: Part II|Lost to Follow-up|0|||
33404478|NCT01632345|101369490|FG001|Treatment: Part II|Lost to Follow-up|0|||
33404479|NCT01632345|101369491|FG002|Treatment: Part II|Lost to Follow-up|0|||
33404480|NCT01632345|101369492|FG003|Treatment: Part II|Lost to Follow-up|0|||
33404481|NCT01632345|101369493|FG004|Treatment: Part II|Lost to Follow-up|0|||
33404482|NCT01632345|101369494|FG005|Treatment: Part II|Lost to Follow-up|3|||
33404483|NCT01632345|101369495|FG006|Treatment: Part II|Lost to Follow-up|1|||
33404484|NCT01632345|101369489|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
33205818|NCT01490632|100651542|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
33404485|NCT01632345|101369490|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
33404486|NCT01632345|101369491|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
33404487|NCT01632345|101369492|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
33404488|NCT01632345|101369493|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
33404489|NCT01632345|101369494|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
33404490|NCT01632345|101369495|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
33205819|NCT01490632|100651543|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
33612372|NCT00235716|102130190|FG001|Overall Study|Lost to Follow-up|7|||
33404491|NCT01632345|101369489|FG000|Treatment: Part II|Withdrawal by Subject|0|||
33404492|NCT01632345|101369490|FG001|Treatment: Part II|Withdrawal by Subject|0|||
33404493|NCT01632345|101369491|FG002|Treatment: Part II|Withdrawal by Subject|0|||
33404494|NCT01632345|101369492|FG003|Treatment: Part II|Withdrawal by Subject|0|||
33404495|NCT01632345|101369493|FG004|Treatment: Part II|Withdrawal by Subject|0|||
33404496|NCT01632345|101369494|FG005|Treatment: Part II|Withdrawal by Subject|2|||
33404497|NCT01632345|101369495|FG006|Treatment: Part II|Withdrawal by Subject|2|||
33404498|NCT00795717|101369496|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
33404499|NCT00795717|101369497|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
33404500|NCT00795717|101369496|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
33404501|NCT00795717|101369497|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
33404502|NCT00795717|101369496|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
33404503|NCT00795717|101369497|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
33404504|NCT00795717|101369496|FG000|Phase II|too busy|0|||
33404505|NCT00795717|101369497|FG001|Phase II|too busy|1|||
33404506|NCT00027846|101369498|FG000|Overall Study|Lost to Follow-up|0|||
33404507|NCT00027846|101369499|FG001|Overall Study|Lost to Follow-up|41|||
33404508|NCT00027846|101369500|FG002|Overall Study|Lost to Follow-up|9|||
33404509|NCT00027846|101369498|FG000|Overall Study|Withdrawal by Subject|0|||
33404510|NCT00027846|101369499|FG001|Overall Study|Withdrawal by Subject|14|||
33404511|NCT00027846|101369500|FG002|Overall Study|Withdrawal by Subject|7|||
33404512|NCT00027846|101369498|FG000|Overall Study|Ineligible for study|2|||
33612373|NCT00235716|102130191|FG002|Overall Study|Lost to Follow-up|14|||
33612374|NCT00235716|102130192|FG003|Overall Study|Lost to Follow-up|10|||
33612375|NCT00235716|102130189|FG000|Overall Study|Adverse Event|1|||
33612376|NCT00235716|102130190|FG001|Overall Study|Adverse Event|1|||
33612377|NCT00235716|102130191|FG002|Overall Study|Adverse Event|1|||
33404513|NCT00027846|101369499|FG001|Overall Study|Ineligible for study|6|||
33404514|NCT00027846|101369500|FG002|Overall Study|Ineligible for study|14|||
33404515|NCT00027846|101369498|FG000|Overall Study|Entry into another COG therapeutic study|0|||
33404516|NCT00027846|101369499|FG001|Overall Study|Entry into another COG therapeutic study|5|||
33404517|NCT00027846|101369500|FG002|Overall Study|Entry into another COG therapeutic study|2|||
33404518|NCT00027846|101369498|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
33404519|NCT00027846|101369499|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
33404520|NCT00027846|101369500|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
33404521|NCT00211536|101369505|FG000|Overall Study|Withdrawal by Subject|2|||
33404522|NCT00211536|101369506|FG001|Overall Study|Withdrawal by Subject|2|||
33531950|NCT02326272|101845091|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33531951|NCT02326272|101845092|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33531952|NCT02326272|101845093|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33531953|NCT02326272|101845094|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33531954|NCT02326272|101845095|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33531955|NCT02326272|101845096|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33531956|NCT02326272|101845097|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33531957|NCT02326272|101845098|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33531958|NCT02326272|101845099|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33531959|NCT02326272|101845100|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33531960|NCT02326272|101845101|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
33612378|NCT00235716|102130192|FG003|Overall Study|Adverse Event|0|||
33612379|NCT00235716|102130189|FG000|Overall Study|Physician Decision|0|||
33612380|NCT00235716|102130190|FG001|Overall Study|Physician Decision|1|||
33612381|NCT00235716|102130191|FG002|Overall Study|Physician Decision|1|||
33612382|NCT00235716|102130192|FG003|Overall Study|Physician Decision|3|||
33612383|NCT04752358|102130193|FG000|Overall Study|Death|2|||
33612384|NCT04752358|102130194|FG001|Overall Study|Death|1|||
33612385|NCT03472586|102130199|FG000|Overall Study|Physician Decision|6|||
33612386|NCT03472586|102130199|FG000|Overall Study|Death|6|||
33531961|NCT02326272|101845102|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33531962|NCT02326272|101845103|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
33404523|NCT00211536|101369505|FG000|Overall Study|Physician Decision|0|||
33404524|NCT00211536|101369506|FG001|Overall Study|Physician Decision|5|||
33612387|NCT03472586|102130199|FG000|Overall Study|Adverse Event|1|||
33612388|NCT01754493|102130207|FG000|Overall Study|Adverse Event|1|||
33612389|NCT01754493|102130207|FG000|Overall Study|Lost to Follow-up|3|||
33612390|NCT01754493|102130207|FG000|Overall Study|Withdrawal by Subject|1|||
33612391|NCT01754493|102130207|FG000|Overall Study|Moved out of town|1|||
33531963|NCT02326272|101845104|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33531964|NCT02326272|101845105|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
33205820|NCT01490632|100651544|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
33205821|NCT01490632|100651545|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
33205822|NCT01490632|100651546|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
33205823|NCT01490632|100651547|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
33205824|NCT01490632|100651548|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
33205825|NCT01490632|100651549|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
33205826|NCT01490632|100651550|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
33205827|NCT01490632|100651551|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
33205828|NCT01490632|100651532|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205829|NCT01490632|100651533|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205830|NCT01490632|100651534|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205831|NCT01490632|100651535|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205832|NCT01490632|100651536|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205833|NCT01490632|100651537|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205834|NCT01490632|100651538|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205835|NCT01490632|100651539|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205836|NCT01490632|100651540|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205837|NCT01490632|100651541|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205838|NCT01490632|100651542|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205839|NCT01490632|100651543|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205840|NCT01490632|100651544|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205841|NCT01490632|100651545|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205842|NCT01490632|100651546|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205843|NCT01490632|100651547|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205844|NCT01490632|100651548|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
33205845|NCT01490632|100651549|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
33205846|NCT01490632|100651550|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
33205847|NCT01490632|100651551|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
33205848|NCT04179032|100651559|FG000|Part B (Up to Week 52)|Adverse Event|1|||
33205849|NCT04179032|100651559|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
33205850|NCT04179032|100651559|FG000|Access Extension Phase|Ongoing|11|||
33205851|NCT02535065|100651560|FG000|Overall Study|Death|13|||
33205852|NCT02535065|100651560|FG000|Overall Study|Lost to Follow-up|1|||
33205853|NCT02535065|100651560|FG000|Overall Study|Withdrawal by Subject|6|||
33205854|NCT03985423|100655859|FG000|Overall Study|Adverse Event|1|||
33205855|NCT03985423|100655859|FG000|Overall Study|Death|2|||
33205856|NCT03985423|100655859|FG000|Overall Study|Physician Decision|1|||
33205857|NCT03985423|100655859|FG000|Overall Study|Withdrawal by Subject|2|||
33205858|NCT03985423|100655859|FG000|Overall Study|Lack of insurance and citizenship|1|||
33205859|NCT03859323|100655860|FG000|Overall Study|Lost to Follow-up|0|||
33205860|NCT03859323|100655861|FG001|Overall Study|Lost to Follow-up|0|||
33205861|NCT03859323|100655862|FG002|Overall Study|Lost to Follow-up|0|||
33205862|NCT03859323|100655863|FG003|Overall Study|Lost to Follow-up|0|||
33205863|NCT03859323|100655864|FG004|Overall Study|Lost to Follow-up|0|||
33205864|NCT03859323|100655865|FG005|Overall Study|Lost to Follow-up|0|||
33205865|NCT03859323|100655866|FG006|Overall Study|Lost to Follow-up|1|||
33205866|NCT03859323|100655867|FG007|Overall Study|Lost to Follow-up|0|||
33531965|NCT02326272|101845091|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33205867|NCT03859323|100655868|FG008|Overall Study|Lost to Follow-up|0|||
33205868|NCT03859323|100655869|FG009|Overall Study|Lost to Follow-up|0|||
33205869|NCT03859323|100655870|FG010|Overall Study|Lost to Follow-up|0|||
33205870|NCT03859323|100655871|FG011|Overall Study|Lost to Follow-up|0|||
33205871|NCT03859323|100655872|FG012|Overall Study|Lost to Follow-up|0|||
33531966|NCT02326272|101845092|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33531967|NCT02326272|101845093|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33531968|NCT02326272|101845094|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33531969|NCT02326272|101845095|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33531970|NCT02326272|101845096|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33531971|NCT02326272|101845097|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33531972|NCT02326272|101845098|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33531973|NCT02326272|101845099|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33612392|NCT01754493|102130207|FG000|Overall Study|Scheduling conflict|1|||
33612393|NCT03915470|102130208|FG000|Overall Study|Death|3|||
33612394|NCT03915470|102130209|FG001|Overall Study|Death|1|||
33337011|NCT03259074|101124704|FG002|Overall Study|Adverse Event|8|||
33337012|NCT03259074|101124702|FG000|Overall Study|Death|1|||
33337013|NCT03259074|101124703|FG001|Overall Study|Death|1|||
33337014|NCT03259074|101124704|FG002|Overall Study|Death|3|||
33531974|NCT02326272|101845100|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33531975|NCT02326272|101845101|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33531976|NCT02326272|101845102|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
33531977|NCT02326272|101845103|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33531978|NCT02326272|101845104|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33531979|NCT02326272|101845105|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
33531980|NCT02326272|101845091|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33531981|NCT02326272|101845092|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33531982|NCT02326272|101845093|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33531983|NCT02326272|101845094|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33531984|NCT02326272|101845095|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33531985|NCT02326272|101845096|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33531986|NCT02326272|101845097|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33531987|NCT02326272|101845098|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33531988|NCT02326272|101845099|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33531989|NCT02326272|101845100|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33531990|NCT02326272|101845101|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
33531991|NCT02326272|101845102|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33531992|NCT02326272|101845103|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
33531993|NCT02326272|101845104|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
33531994|NCT02326272|101845105|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
33531995|NCT02326272|101845091|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33531996|NCT02326272|101845092|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33531997|NCT02326272|101845093|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33531998|NCT02326272|101845094|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33531999|NCT02326272|101845095|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33532000|NCT02326272|101845096|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33612395|NCT03915470|102130208|FG000|Overall Study|Adverse Event|1|||
33612396|NCT03915470|102130209|FG001|Overall Study|Adverse Event|0|||
33337015|NCT03259074|101124702|FG000|Overall Study|Lost to Follow-up|2|||
33337016|NCT03259074|101124703|FG001|Overall Study|Lost to Follow-up|4|||
33337017|NCT03259074|101124704|FG002|Overall Study|Lost to Follow-up|3|||
33337018|NCT03259074|101124702|FG000|Overall Study|New Therapy For Study Indication|1|||
33337019|NCT03259074|101124703|FG001|Overall Study|New Therapy For Study Indication|2|||
33337020|NCT03259074|101124704|FG002|Overall Study|New Therapy For Study Indication|2|||
33337021|NCT03259074|101124702|FG000|Overall Study|Physician Decision|4|||
33337022|NCT03259074|101124703|FG001|Overall Study|Physician Decision|12|||
33337023|NCT03259074|101124704|FG002|Overall Study|Physician Decision|10|||
33337024|NCT03259074|101124702|FG000|Overall Study|Pregnancy|1|||
33337025|NCT03259074|101124703|FG001|Overall Study|Pregnancy|1|||
33337026|NCT03259074|101124704|FG002|Overall Study|Pregnancy|0|||
33337027|NCT03259074|101124702|FG000|Overall Study|Progressive Disease|1|||
33337028|NCT03259074|101124703|FG001|Overall Study|Progressive Disease|0|||
33337029|NCT03259074|101124704|FG002|Overall Study|Progressive Disease|0|||
33337030|NCT03259074|101124702|FG000|Overall Study|Protocol Deviation|1|||
33337031|NCT03259074|101124703|FG001|Overall Study|Protocol Deviation|1|||
33337032|NCT03259074|101124704|FG002|Overall Study|Protocol Deviation|3|||
33404525|NCT00211536|101369505|FG000|Overall Study|Adverse Event|2|||
33612397|NCT03915470|102130208|FG000|Overall Study|Physician Decision|1|||
33337033|NCT03259074|101124702|FG000|Overall Study|Subject/Guardian Decision|13|||
33337034|NCT03259074|101124703|FG001|Overall Study|Subject/Guardian Decision|16|||
33337035|NCT03259074|101124704|FG002|Overall Study|Subject/Guardian Decision|14|||
33404526|NCT00211536|101369506|FG001|Overall Study|Adverse Event|0|||
33337036|NCT01314716|101124705|FG000|Double-Blind Phase|Randomized but not treated|1|||
33612398|NCT03915470|102130209|FG001|Overall Study|Physician Decision|0|||
33612399|NCT03915470|102130208|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
33612400|NCT03915470|102130209|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
33612401|NCT00398320|102130210|FG000|Overall Study|Death|1|||
33612402|NCT00398320|102130210|FG000|Overall Study|Adverse Event|4|||
33612403|NCT00398320|102130210|FG000|Overall Study|Physician Decision|1|||
33612404|NCT02503501|102130211|FG000|Overall Study|Physician Decision|1|||
33612405|NCT02503501|102130212|FG001|Overall Study|Physician Decision|0|||
33612406|NCT02503501|102130211|FG000|Overall Study|Protocol Violation|0|||
33612407|NCT02503501|102130212|FG001|Overall Study|Protocol Violation|1|||
33612408|NCT02503501|102130211|FG000|Overall Study|Withdrawal by Subject|0|||
33612409|NCT02503501|102130212|FG001|Overall Study|Withdrawal by Subject|2|||
33612410|NCT01815840|102130215|FG000|Overall Study|Missing|1|||
33612411|NCT01815840|102130216|FG001|Overall Study|Missing|0|||
33612412|NCT01815840|102130215|FG000|Overall Study|Withdrew Consent|31|||
33612413|NCT01815840|102130216|FG001|Overall Study|Withdrew Consent|30|||
33612414|NCT01815840|102130215|FG000|Overall Study|Administrative/Other|1|||
33612415|NCT01815840|102130216|FG001|Overall Study|Administrative/Other|3|||
33612416|NCT01815840|102130215|FG000|Overall Study|Adverse Event|10|||
33612417|NCT01815840|102130216|FG001|Overall Study|Adverse Event|16|||
33612418|NCT01815840|102130215|FG000|Overall Study|Death|2|||
33612419|NCT01815840|102130216|FG001|Overall Study|Death|2|||
33612420|NCT01815840|102130215|FG000|Overall Study|Disease progression|3|||
33612421|NCT01815840|102130216|FG001|Overall Study|Disease progression|2|||
33612422|NCT01815840|102130215|FG000|Overall Study|Investigators Decision|2|||
33612423|NCT01815840|102130216|FG001|Overall Study|Investigators Decision|3|||
33612424|NCT01815840|102130215|FG000|Overall Study|Lost to Follow-up|3|||
33612425|NCT01815840|102130216|FG001|Overall Study|Lost to Follow-up|6|||
33612426|NCT01815840|102130215|FG000|Overall Study|Refused Treatment|5|||
33612427|NCT01815840|102130216|FG001|Overall Study|Refused Treatment|1|||
33612428|NCT01815840|102130215|FG000|Overall Study|Sponsor Termination Treatment|1|||
33612429|NCT01815840|102130216|FG001|Overall Study|Sponsor Termination Treatment|0|||
33612430|NCT01629953|102130219|FG000|Overall Study|Death|3|||
33612431|NCT01629953|102130220|FG001|Overall Study|Death|1|||
33612432|NCT01629953|102130219|FG000|Overall Study|Lost to Follow-up|10|||
33612433|NCT01629953|102130220|FG001|Overall Study|Lost to Follow-up|14|||
33612434|NCT01870726|102130221|FG000|Overall Study|Withdrawal of informed consent|0|||
33612435|NCT01870726|102130222|FG001|Overall Study|Withdrawal of informed consent|0|||
33612436|NCT01870726|102130223|FG002|Overall Study|Withdrawal of informed consent|0|||
33612437|NCT01870726|102130224|FG003|Overall Study|Withdrawal of informed consent|1|||
33612438|NCT01870726|102130225|FG004|Overall Study|Withdrawal of informed consent|0|||
33612439|NCT01870726|102130226|FG005|Overall Study|Withdrawal of informed consent|0|||
33612440|NCT01870726|102130227|FG006|Overall Study|Withdrawal of informed consent|0|||
33612441|NCT01870726|102130221|FG000|Overall Study|Withdrawal by Subject|0|||
33612442|NCT01870726|102130222|FG001|Overall Study|Withdrawal by Subject|1|||
33612443|NCT01870726|102130223|FG002|Overall Study|Withdrawal by Subject|0|||
33612444|NCT01870726|102130224|FG003|Overall Study|Withdrawal by Subject|0|||
33612445|NCT01870726|102130225|FG004|Overall Study|Withdrawal by Subject|0|||
33612446|NCT01870726|102130226|FG005|Overall Study|Withdrawal by Subject|0|||
33612447|NCT01870726|102130227|FG006|Overall Study|Withdrawal by Subject|0|||
33612448|NCT01870726|102130221|FG000|Overall Study|Adverse Event|0|||
33612449|NCT01870726|102130222|FG001|Overall Study|Adverse Event|0|||
33612450|NCT01870726|102130223|FG002|Overall Study|Adverse Event|0|||
33612451|NCT01870726|102130224|FG003|Overall Study|Adverse Event|0|||
33612452|NCT01870726|102130225|FG004|Overall Study|Adverse Event|1|||
33612453|NCT01870726|102130226|FG005|Overall Study|Adverse Event|1|||
33612454|NCT01870726|102130227|FG006|Overall Study|Adverse Event|0|||
33404527|NCT01654224|101369512|FG000|Overall Study|Lost to Follow-up|2|||
33612455|NCT01870726|102130221|FG000|Overall Study|Progressive disease|5|||
33612456|NCT01870726|102130222|FG001|Overall Study|Progressive disease|5|||
33612457|NCT01870726|102130223|FG002|Overall Study|Progressive disease|4|||
33612458|NCT01870726|102130224|FG003|Overall Study|Progressive disease|5|||
33612459|NCT01870726|102130225|FG004|Overall Study|Progressive disease|6|||
33612460|NCT01870726|102130226|FG005|Overall Study|Progressive disease|4|||
33612461|NCT01870726|102130227|FG006|Overall Study|Progressive disease|10|||
33612462|NCT00511238|102130231|FG000|Overall Study|Adverse Event|13|||
33612463|NCT00511238|102130232|FG001|Overall Study|Adverse Event|33|||
33612464|NCT00511238|102130231|FG000|Overall Study|Withdrawal by Subject|2|||
33612465|NCT00511238|102130232|FG001|Overall Study|Withdrawal by Subject|22|||
33612466|NCT00511238|102130231|FG000|Overall Study|Progressive Disease|23|||
33612467|NCT00511238|102130232|FG001|Overall Study|Progressive Disease|157|||
33612468|NCT00511238|102130231|FG000|Overall Study|various reasons|4|||
33612469|NCT00511238|102130232|FG001|Overall Study|various reasons|14|||
33612470|NCT00856544|102130235|FG000|Overall Study|Randomized but not treated|3|||
33612471|NCT00856544|102130236|FG001|Overall Study|Randomized but not treated|0|||
33612472|NCT00856544|102130237|FG002|Overall Study|Randomized but not treated|0|||
33612473|NCT00856544|102130238|FG003|Overall Study|Randomized but not treated|0|||
33612474|NCT00856544|102130235|FG000|Overall Study|Death|0|||
33612475|NCT00856544|102130236|FG001|Overall Study|Death|2|||
33612476|NCT00856544|102130237|FG002|Overall Study|Death|0|||
33612477|NCT00856544|102130238|FG003|Overall Study|Death|0|||
33612478|NCT00856544|102130235|FG000|Overall Study|Adverse Event|20|||
33612479|NCT00856544|102130236|FG001|Overall Study|Adverse Event|29|||
33337037|NCT01314716|101124706|FG001|Double-Blind Phase|Randomized but not treated|1|||
33337038|NCT01314716|101124705|FG000|Double-Blind Phase|Adverse Event|10|||
33337039|NCT01314716|101124706|FG001|Double-Blind Phase|Adverse Event|4|||
33337040|NCT01314716|101124705|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
33337041|NCT01314716|101124706|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
33337042|NCT01314716|101124705|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33337043|NCT01314716|101124706|FG001|Double-Blind Phase|Lost to Follow-up|1|||
33337044|NCT01314716|101124705|FG000|Double-Blind Phase|Sponsor request|1|||
33337045|NCT01314716|101124706|FG001|Double-Blind Phase|Sponsor request|2|||
33337046|NCT01314716|101124705|FG000|Double-Blind Phase|Physician Decision|0|||
33337047|NCT01314716|101124706|FG001|Double-Blind Phase|Physician Decision|1|||
33337048|NCT01314716|101124705|FG000|Open-Label Phase|Adverse Event|4|||
33337049|NCT01314716|101124706|FG001|Open-Label Phase|Adverse Event|6|||
33337050|NCT01314716|101124705|FG000|Open-Label Phase|Withdrawal by Subject|1|||
33337051|NCT01314716|101124706|FG001|Open-Label Phase|Withdrawal by Subject|2|||
33337052|NCT01314716|101124705|FG000|Open-Label Phase|Physician Decision|5|||
33337053|NCT01314716|101124706|FG001|Open-Label Phase|Physician Decision|4|||
33337054|NCT00769002|101124707|FG000|Overall Study|Study was not completed, no data|9|||
33337055|NCT00769002|101124708|FG001|Overall Study|Study was not completed, no data|9|||
33337056|NCT04036708|101124709|FG000|Overall Study|Lost to Follow-up|14|||
33337057|NCT04036708|101124710|FG001|Overall Study|Lost to Follow-up|4|||
33337058|NCT04036708|101124711|FG002|Overall Study|Lost to Follow-up|14|||
33337059|NCT04036708|101124712|FG003|Overall Study|Lost to Follow-up|4|||
33337060|NCT00506883|101124713|FG000|Overall Study|Lost to Follow-up|1|||
33337061|NCT00506883|101124714|FG001|Overall Study|Lost to Follow-up|1|||
33337062|NCT00506883|101124715|FG002|Overall Study|Lost to Follow-up|1|||
33337063|NCT00506883|101124713|FG000|Overall Study|Withdrawal by Subject|1|||
33337064|NCT00506883|101124714|FG001|Overall Study|Withdrawal by Subject|0|||
33337065|NCT00506883|101124715|FG002|Overall Study|Withdrawal by Subject|1|||
33337066|NCT00506883|101124713|FG000|Overall Study|Lack of Efficacy|0|||
33337067|NCT00506883|101124714|FG001|Overall Study|Lack of Efficacy|1|||
33337068|NCT00506883|101124715|FG002|Overall Study|Lack of Efficacy|1|||
33337069|NCT00506883|101124713|FG000|Overall Study|Other|5|||
33337070|NCT00506883|101124714|FG001|Overall Study|Other|1|||
33337071|NCT00506883|101124715|FG002|Overall Study|Other|1|||
33337072|NCT00797823|101124716|FG000|First Period (Initial Randomization)|Physician Decision|1|||
33337073|NCT00797823|101124717|FG001|First Period (Initial Randomization)|Physician Decision|0|||
33612480|NCT00856544|102130237|FG002|Overall Study|Adverse Event|2|||
33612481|NCT00856544|102130238|FG003|Overall Study|Adverse Event|3|||
33612482|NCT00856544|102130235|FG000|Overall Study|Lack of Efficacy|16|||
33612483|NCT00856544|102130236|FG001|Overall Study|Lack of Efficacy|12|||
33612484|NCT00856544|102130237|FG002|Overall Study|Lack of Efficacy|3|||
33337074|NCT00797823|101124718|FG002|First Period (Initial Randomization)|Physician Decision|0|||
33337075|NCT01100437|101124719|FG000|Titration/Stabilization|Adverse Event|0|||
33337076|NCT01100437|101124720|FG001|Titration/Stabilization|Adverse Event|0|||
33337077|NCT01100437|101124721|FG002|Titration/Stabilization|Adverse Event|4|||
33337078|NCT01100437|101124719|FG000|Titration/Stabilization|Non-compliance|0|||
33337079|NCT01100437|101124720|FG001|Titration/Stabilization|Non-compliance|0|||
33612485|NCT00856544|102130238|FG003|Overall Study|Lack of Efficacy|3|||
33612486|NCT00856544|102130235|FG000|Overall Study|Other|9|||
33612487|NCT00856544|102130236|FG001|Overall Study|Other|16|||
33612488|NCT00856544|102130237|FG002|Overall Study|Other|1|||
33404528|NCT01654224|101369513|FG001|Overall Study|Lost to Follow-up|2|||
33404529|NCT01654224|101369512|FG000|Overall Study|Did not receive allocation|1|||
33404530|NCT01654224|101369513|FG001|Overall Study|Did not receive allocation|8|||
33404531|NCT01654224|101369512|FG000|Overall Study|Insufficient blood sample|3|||
33404532|NCT01654224|101369513|FG001|Overall Study|Insufficient blood sample|2|||
33404533|NCT01724021|101369514|FG000|Overall Study|Adverse Event|11|||
33404534|NCT01724021|101369515|FG001|Overall Study|Adverse Event|6|||
33404535|NCT01724021|101369514|FG000|Overall Study|Death|46|||
33404536|NCT01724021|101369515|FG001|Overall Study|Death|58|||
33404537|NCT01724021|101369514|FG000|Overall Study|Participant request/ Withdrew consent|18|||
33404538|NCT01724021|101369515|FG001|Overall Study|Participant request/ Withdrew consent|14|||
33404539|NCT01724021|101369514|FG000|Overall Study|Lost to Follow-up|15|||
33404540|NCT01724021|101369515|FG001|Overall Study|Lost to Follow-up|15|||
33404541|NCT01724021|101369514|FG000|Overall Study|Reason Not Specified|36|||
33404542|NCT01724021|101369515|FG001|Overall Study|Reason Not Specified|39|||
33404543|NCT01724021|101369514|FG000|Overall Study|Missing|1|||
33404544|NCT01724021|101369515|FG001|Overall Study|Missing|1|||
33404545|NCT01397409|101369516|FG000|Stage 2|Adverse Event|0|||
33404546|NCT01397409|101369517|FG001|Stage 2|Adverse Event|0|||
33404547|NCT01397409|101369518|FG002|Stage 2|Adverse Event|0|||
33404548|NCT01397409|101369519|FG003|Stage 2|Adverse Event|0|||
33612489|NCT00856544|102130238|FG003|Overall Study|Other|6|||
33612490|NCT00856544|102130235|FG000|Overall Study|Lost to Follow-up|1|||
33612491|NCT00856544|102130236|FG001|Overall Study|Lost to Follow-up|2|||
33612492|NCT00856544|102130237|FG002|Overall Study|Lost to Follow-up|2|||
33612493|NCT00856544|102130238|FG003|Overall Study|Lost to Follow-up|0|||
33612494|NCT00856544|102130235|FG000|Overall Study|Withdrawal by Subject|8|||
33337080|NCT01100437|101124721|FG002|Titration/Stabilization|Non-compliance|1|||
33404549|NCT01397409|101369520|FG004|Stage 2|Adverse Event|6|||
33404550|NCT01397409|101369521|FG005|Stage 2|Adverse Event|3|||
33612495|NCT00856544|102130236|FG001|Overall Study|Withdrawal by Subject|5|||
33612496|NCT00856544|102130237|FG002|Overall Study|Withdrawal by Subject|0|||
33612497|NCT00856544|102130238|FG003|Overall Study|Withdrawal by Subject|1|||
33612498|NCT00422383|102130239|FG000|Overall Study|Adverse Event|5|||
33612499|NCT00422383|102130240|FG001|Overall Study|Adverse Event|3|||
33612500|NCT00422383|102130241|FG002|Overall Study|Adverse Event|1|||
33612501|NCT00422383|102130242|FG003|Overall Study|Adverse Event|1|||
33612502|NCT00422383|102130243|FG004|Overall Study|Adverse Event|0|||
33612503|NCT00422383|102130239|FG000|Overall Study|Lack of Efficacy|4|||
33612504|NCT00422383|102130240|FG001|Overall Study|Lack of Efficacy|4|||
33612505|NCT00422383|102130241|FG002|Overall Study|Lack of Efficacy|2|||
33612506|NCT00422383|102130242|FG003|Overall Study|Lack of Efficacy|1|||
33612507|NCT00422383|102130243|FG004|Overall Study|Lack of Efficacy|1|||
33612508|NCT00422383|102130239|FG000|Overall Study|Lost to Follow-up|0|||
33612509|NCT00422383|102130240|FG001|Overall Study|Lost to Follow-up|1|||
33612510|NCT00422383|102130241|FG002|Overall Study|Lost to Follow-up|0|||
33612511|NCT00422383|102130242|FG003|Overall Study|Lost to Follow-up|0|||
33612512|NCT00422383|102130243|FG004|Overall Study|Lost to Follow-up|1|||
33612513|NCT00422383|102130239|FG000|Overall Study|Protocol Violation|1|||
33612514|NCT00422383|102130240|FG001|Overall Study|Protocol Violation|1|||
33612515|NCT00422383|102130241|FG002|Overall Study|Protocol Violation|1|||
33612516|NCT00422383|102130242|FG003|Overall Study|Protocol Violation|0|||
33612517|NCT00422383|102130243|FG004|Overall Study|Protocol Violation|0|||
33337081|NCT01100437|101124719|FG000|Titration/Stabilization|Sponsor canceled study|0|||
33612518|NCT00422383|102130239|FG000|Overall Study|Withdrawal by Subject|5|||
33612519|NCT00422383|102130240|FG001|Overall Study|Withdrawal by Subject|5|||
33612520|NCT00422383|102130241|FG002|Overall Study|Withdrawal by Subject|0|||
33612521|NCT00422383|102130242|FG003|Overall Study|Withdrawal by Subject|0|||
33612522|NCT00422383|102130243|FG004|Overall Study|Withdrawal by Subject|1|||
33612523|NCT00615992|102130246|FG000|Overall Study|Protocol Violation|67|||
33404551|NCT01397409|101369522|FG006|Stage 2|Adverse Event|0|||
33404552|NCT01397409|101369523|FG007|Stage 2|Adverse Event|0|||
33404553|NCT01397409|101369524|FG008|Stage 2|Adverse Event|0|||
33404554|NCT01397409|101369525|FG009|Stage 2|Adverse Event|0|||
33532001|NCT02326272|101845097|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33612524|NCT03927144|102130247|FG000|Core Phase|Adverse Event|9|||
33404555|NCT01397409|101369516|FG000|Stage 2|Personal Reasons|0|||
33612525|NCT03927144|102130248|FG001|Core Phase|Adverse Event|5|||
33404556|NCT01397409|101369517|FG001|Stage 2|Personal Reasons|0|||
33404557|NCT01397409|101369518|FG002|Stage 2|Personal Reasons|0|||
33404558|NCT01397409|101369519|FG003|Stage 2|Personal Reasons|0|||
33404559|NCT01397409|101369520|FG004|Stage 2|Personal Reasons|1|||
33404560|NCT01397409|101369521|FG005|Stage 2|Personal Reasons|0|||
33404561|NCT01397409|101369522|FG006|Stage 2|Personal Reasons|0|||
33404562|NCT01397409|101369523|FG007|Stage 2|Personal Reasons|0|||
33404563|NCT01397409|101369524|FG008|Stage 2|Personal Reasons|0|||
33404564|NCT01397409|101369525|FG009|Stage 2|Personal Reasons|0|||
33404565|NCT01397409|101369516|FG000|Stage 2|Other Miscellaneous Reasons|0|||
33404566|NCT01397409|101369517|FG001|Stage 2|Other Miscellaneous Reasons|0|||
33404567|NCT01397409|101369518|FG002|Stage 2|Other Miscellaneous Reasons|0|||
33404568|NCT01397409|101369519|FG003|Stage 2|Other Miscellaneous Reasons|0|||
33404569|NCT01397409|101369520|FG004|Stage 2|Other Miscellaneous Reasons|1|||
33404570|NCT01397409|101369521|FG005|Stage 2|Other Miscellaneous Reasons|1|||
33404571|NCT01397409|101369522|FG006|Stage 2|Other Miscellaneous Reasons|0|||
33404572|NCT01397409|101369523|FG007|Stage 2|Other Miscellaneous Reasons|0|||
33404573|NCT01397409|101369524|FG008|Stage 2|Other Miscellaneous Reasons|0|||
33404574|NCT01397409|101369525|FG009|Stage 2|Other Miscellaneous Reasons|0|||
33404575|NCT01397409|101369516|FG000|Stage 3|Adverse Event|0|||
33612526|NCT03927144|102130247|FG000|Core Phase|Lost to Follow-up|3|||
33612527|NCT03927144|102130248|FG001|Core Phase|Lost to Follow-up|2|||
33612528|NCT03927144|102130247|FG000|Core Phase|New Therapy for Study Indication|0|||
33612529|NCT03927144|102130248|FG001|Core Phase|New Therapy for Study Indication|1|||
33612530|NCT03927144|102130247|FG000|Core Phase|No Longer Clinically Benefiting|4|||
33612531|NCT03927144|102130248|FG001|Core Phase|No Longer Clinically Benefiting|4|||
33612532|NCT03927144|102130247|FG000|Core Phase|Physician Decision|2|||
33612533|NCT03927144|102130248|FG001|Core Phase|Physician Decision|8|||
33612534|NCT03927144|102130247|FG000|Core Phase|Protocol Violation|2|||
33612535|NCT03927144|102130248|FG001|Core Phase|Protocol Violation|2|||
33612536|NCT03927144|102130247|FG000|Core Phase|Withdrawal by Subject|16|||
33612537|NCT03927144|102130248|FG001|Core Phase|Withdrawal by Subject|40|||
33612538|NCT03927144|102130247|FG000|Extension Phase|Adverse Event|2|||
33404576|NCT01397409|101369517|FG001|Stage 3|Adverse Event|0|||
33404577|NCT01397409|101369518|FG002|Stage 3|Adverse Event|0|||
33404578|NCT01397409|101369519|FG003|Stage 3|Adverse Event|0|||
33612539|NCT03927144|102130248|FG001|Extension Phase|Adverse Event|1|||
33612540|NCT03927144|102130247|FG000|Extension Phase|No longer clinically benefiting|4|||
33404579|NCT01397409|101369520|FG004|Stage 3|Adverse Event|0|||
33404580|NCT01397409|101369521|FG005|Stage 3|Adverse Event|0|||
33404581|NCT01397409|101369522|FG006|Stage 3|Adverse Event|0|||
33404582|NCT01397409|101369523|FG007|Stage 3|Adverse Event|1|||
33404583|NCT01397409|101369524|FG008|Stage 3|Adverse Event|0|||
33404584|NCT01397409|101369525|FG009|Stage 3|Adverse Event|0|||
33532002|NCT02326272|101845098|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33532003|NCT02326272|101845099|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33532004|NCT02326272|101845100|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33532005|NCT02326272|101845101|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33532006|NCT02326272|101845102|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
33532007|NCT02326272|101845103|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33532008|NCT02326272|101845104|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
33532009|NCT02326272|101845105|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
33532010|NCT02326272|101845091|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33532011|NCT02326272|101845092|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33532012|NCT02326272|101845093|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33532013|NCT02326272|101845094|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33532014|NCT02326272|101845095|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33532015|NCT02326272|101845096|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33532016|NCT02326272|101845097|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33532017|NCT02326272|101845098|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33532018|NCT02326272|101845099|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33532019|NCT02326272|101845100|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33532020|NCT02326272|101845101|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33532021|NCT02326272|101845102|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
33532022|NCT02326272|101845103|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
33532023|NCT02326272|101845104|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
33532024|NCT02326272|101845105|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
33532025|NCT02326272|101845091|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33532026|NCT02326272|101845092|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33404585|NCT01397409|101369516|FG000|Stage 3|Other Miscellaneous Reasons|0|||
33404586|NCT01397409|101369517|FG001|Stage 3|Other Miscellaneous Reasons|0|||
33532027|NCT02326272|101845093|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33532028|NCT02326272|101845094|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33532029|NCT02326272|101845095|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33532030|NCT02326272|101845096|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33612541|NCT03927144|102130248|FG001|Extension Phase|No longer clinically benefiting|5|||
33612542|NCT03927144|102130247|FG000|Extension Phase|Pregnancy|1|||
33612543|NCT03927144|102130248|FG001|Extension Phase|Pregnancy|0|||
33612544|NCT03927144|102130247|FG000|Extension Phase|Protocol Violation|0|||
33612545|NCT03927144|102130248|FG001|Extension Phase|Protocol Violation|1|||
33612546|NCT03927144|102130247|FG000|Extension Phase|Withdrawal by Subject|8|||
33612547|NCT03927144|102130248|FG001|Extension Phase|Withdrawal by Subject|3|||
33612548|NCT02161380|102130251|FG000|Overall Study|Lost to Follow-up|0|||
33612549|NCT02161380|102130252|FG001|Overall Study|Lost to Follow-up|1|||
33612550|NCT02161380|102130253|FG002|Overall Study|Lost to Follow-up|0|||
33612551|NCT02161380|102130254|FG003|Overall Study|Lost to Follow-up|0|||
33612552|NCT03437577|102130255|FG000|Pre-Randomization|Withdrawal by Subject|0|||
33612553|NCT03437577|102130256|FG001|Pre-Randomization|Withdrawal by Subject|0|||
33612554|NCT03437577|102130257|FG002|Pre-Randomization|Withdrawal by Subject|10|||
33612555|NCT03437577|102130255|FG000|Post-Randomization|Physician Decision|0|||
33612556|NCT03437577|102130256|FG001|Post-Randomization|Physician Decision|2|||
33612557|NCT03437577|102130257|FG002|Post-Randomization|Physician Decision|0|||
33612558|NCT03785964|102130258|FG000|Overall Study|Adverse Event|14|||
33612559|NCT03785964|102130259|FG001|Overall Study|Adverse Event|1|||
33612560|NCT03785964|102130258|FG000|Overall Study|Unqualified Clinical Progression|1|||
33612561|NCT03785964|102130259|FG001|Overall Study|Unqualified Clinical Progression|1|||
33612562|NCT03785964|102130258|FG000|Overall Study|Participant non-compliance|1|||
33612563|NCT03785964|102130259|FG001|Overall Study|Participant non-compliance|1|||
33612564|NCT03785964|102130258|FG000|Overall Study|Not treated|1|||
33612565|NCT03785964|102130259|FG001|Overall Study|Not treated|0|||
33612566|NCT03785964|102130258|FG000|Overall Study|Other reason|5|||
33612567|NCT03785964|102130259|FG001|Overall Study|Other reason|11|||
33612568|NCT03785964|102130258|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
33612569|NCT03785964|102130259|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
33612570|NCT04000581|102130260|FG000|Overall Study|Withdrawal by Subject|0|||
33612571|NCT04000581|102130261|FG001|Overall Study|Withdrawal by Subject|1|||
33612572|NCT00604695|102130267|FG000|Overall Study|Did not receive first bolus.|0|||
33612573|NCT00604695|102130268|FG001|Overall Study|Did not receive first bolus.|4|||
33612574|NCT01007838|102130269|FG000|Overall Study|Withdrawal by Subject|1|||
33612575|NCT01007838|102130270|FG001|Overall Study|Withdrawal by Subject|0|||
33612576|NCT01007838|102130271|FG002|Overall Study|Withdrawal by Subject|0|||
33612577|NCT01007838|102130272|FG003|Overall Study|Withdrawal by Subject|0|||
33612578|NCT01007838|102130269|FG000|Overall Study|Physician Decision|1|||
33612579|NCT01007838|102130270|FG001|Overall Study|Physician Decision|0|||
33612580|NCT01007838|102130271|FG002|Overall Study|Physician Decision|0|||
33337082|NCT01100437|101124720|FG001|Titration/Stabilization|Sponsor canceled study|0|||
33532031|NCT02326272|101845097|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33532032|NCT02326272|101845098|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33532033|NCT02326272|101845099|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33532034|NCT02326272|101845100|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33532035|NCT02326272|101845101|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33532036|NCT02326272|101845102|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
33532037|NCT02326272|101845103|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33532038|NCT02326272|101845104|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33532039|NCT02326272|101845105|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
33532040|NCT02326272|101845091|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33532041|NCT02326272|101845092|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33612581|NCT01007838|102130272|FG003|Overall Study|Physician Decision|0|||
33612582|NCT01007838|102130269|FG000|Overall Study|Started home haemodialysis|1|||
33612583|NCT01007838|102130270|FG001|Overall Study|Started home haemodialysis|0|||
33612584|NCT01007838|102130271|FG002|Overall Study|Started home haemodialysis|0|||
33612585|NCT01007838|102130272|FG003|Overall Study|Started home haemodialysis|0|||
33612586|NCT02141360|102130273|FG000|Overall Study|Withdrawal by Subject|6|||
33337083|NCT01100437|101124721|FG002|Titration/Stabilization|Sponsor canceled study|1|||
33337084|NCT01100437|101124719|FG000|Maintenance|Withdrawal by Subject|0|||
33337085|NCT01100437|101124720|FG001|Maintenance|Withdrawal by Subject|0|||
33337086|NCT01100437|101124721|FG002|Maintenance|Withdrawal by Subject|1|||
33337087|NCT01100437|101124719|FG000|Maintenance|Sponsor termination of study|0|||
33612587|NCT02141360|102130274|FG001|Overall Study|Withdrawal by Subject|0|||
33337088|NCT01100437|101124720|FG001|Maintenance|Sponsor termination of study|0|||
33612588|NCT02141360|102130275|FG002|Overall Study|Withdrawal by Subject|0|||
33532042|NCT02326272|101845093|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33532043|NCT02326272|101845094|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33532044|NCT02326272|101845095|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33532045|NCT02326272|101845096|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33532046|NCT02326272|101845097|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33532047|NCT02326272|101845098|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33532048|NCT02326272|101845099|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33532049|NCT02326272|101845100|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33205872|NCT03859323|100655860|FG000|Overall Study|Withdrawal by Subject|0|||
33205873|NCT03859323|100655861|FG001|Overall Study|Withdrawal by Subject|0|||
33205874|NCT03859323|100655862|FG002|Overall Study|Withdrawal by Subject|1|||
33205875|NCT03859323|100655863|FG003|Overall Study|Withdrawal by Subject|0|||
33205876|NCT03859323|100655864|FG004|Overall Study|Withdrawal by Subject|0|||
33205877|NCT03859323|100655865|FG005|Overall Study|Withdrawal by Subject|1|||
33205878|NCT03859323|100655866|FG006|Overall Study|Withdrawal by Subject|0|||
33205879|NCT03859323|100655867|FG007|Overall Study|Withdrawal by Subject|0|||
33532050|NCT02326272|101845101|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33532051|NCT02326272|101845102|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33532052|NCT02326272|101845103|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
33532053|NCT02326272|101845104|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33532054|NCT02326272|101845105|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
33532055|NCT00369343|101845107|FG000|Double-blind Phase|Adverse Event|19|||
33532056|NCT00369343|101845108|FG001|Double-blind Phase|Adverse Event|4|||
33532057|NCT00369343|101845107|FG000|Double-blind Phase|Failed to return|2|||
33532058|NCT00369343|101845108|FG001|Double-blind Phase|Failed to return|0|||
33532059|NCT00369343|101845107|FG000|Double-blind Phase|Lost to Follow-up|9|||
33532060|NCT00369343|101845108|FG001|Double-blind Phase|Lost to Follow-up|2|||
33532061|NCT00369343|101845107|FG000|Double-blind Phase|Protocol Violation|2|||
33532062|NCT00369343|101845108|FG001|Double-blind Phase|Protocol Violation|0|||
33532063|NCT00369343|101845107|FG000|Double-blind Phase|Withdrawal by Subject|8|||
33532064|NCT00369343|101845108|FG001|Double-blind Phase|Withdrawal by Subject|6|||
33532065|NCT00369343|101845107|FG000|Double-blind Phase|Lack of Efficacy|0|||
33532066|NCT00369343|101845108|FG001|Double-blind Phase|Lack of Efficacy|4|||
33532067|NCT00369343|101845107|FG000|Double-blind Phase|Protocol deviation|4|||
33532068|NCT00369343|101845108|FG001|Double-blind Phase|Protocol deviation|0|||
33532069|NCT00369343|101845107|FG000|Open-label Phase|Adverse Event|19|||
33532070|NCT00369343|101845108|FG001|Open-label Phase|Adverse Event|7|||
33532071|NCT00369343|101845107|FG000|Open-label Phase|Failed to return|4|||
33532072|NCT00369343|101845108|FG001|Open-label Phase|Failed to return|0|||
33532073|NCT00369343|101845107|FG000|Open-label Phase|Physician Decision|2|||
33532074|NCT00369343|101845108|FG001|Open-label Phase|Physician Decision|0|||
33532075|NCT00369343|101845107|FG000|Open-label Phase|Lost to Follow-up|5|||
33532076|NCT00369343|101845108|FG001|Open-label Phase|Lost to Follow-up|3|||
33532077|NCT00369343|101845107|FG000|Open-label Phase|inadvertently reported study completers|3|||
33532078|NCT00369343|101845108|FG001|Open-label Phase|inadvertently reported study completers|2|||
33532079|NCT00369343|101845107|FG000|Open-label Phase|Protocol Violation|1|||
33532080|NCT00369343|101845108|FG001|Open-label Phase|Protocol Violation|3|||
33532081|NCT00369343|101845107|FG000|Open-label Phase|Withdrawal by Subject|15|||
33205880|NCT03859323|100655868|FG008|Overall Study|Withdrawal by Subject|0|||
33532082|NCT00369343|101845108|FG001|Open-label Phase|Withdrawal by Subject|6|||
33532083|NCT00369343|101845107|FG000|Open-label Phase|Lack of Efficacy|4|||
33532084|NCT00369343|101845108|FG001|Open-label Phase|Lack of Efficacy|3|||
33532085|NCT00369343|101845107|FG000|Open-label Phase|Lack of continuance tolerability|3|||
33532086|NCT00369343|101845108|FG001|Open-label Phase|Lack of continuance tolerability|4|||
33532087|NCT00369343|101845107|FG000|Open-label Phase|did not take study drug|1|||
33532088|NCT00369343|101845108|FG001|Open-label Phase|did not take study drug|2|||
33532089|NCT00048035|101845109|FG000|Core Period|Early Withdrawals|4|||
33532090|NCT00048035|101845110|FG001|Core Period|Early Withdrawals|2|||
33532091|NCT00048035|101845111|FG002|Core Period|Early Withdrawals|1|||
33532092|NCT00048035|101845112|FG003|Core Period|Early Withdrawals|1|||
33532093|NCT00048035|101845113|FG004|Core Period|Early Withdrawals|1|||
33612589|NCT02141360|102130273|FG000|Overall Study|Study Terminated before Visit|1|||
33532094|NCT00048035|101845114|FG005|Core Period|Early Withdrawals|1|||
33532095|NCT00048035|101845115|FG006|Core Period|Early Withdrawals|0|||
33532096|NCT00048035|101845116|FG007|Core Period|Early Withdrawals|0|||
33532097|NCT00048035|101845109|FG000|Extension Year 1|Early Withdrawals|0|||
33205881|NCT03859323|100655869|FG009|Overall Study|Withdrawal by Subject|1|||
33532098|NCT00048035|101845110|FG001|Extension Year 1|Early Withdrawals|0|||
33532099|NCT00048035|101845111|FG002|Extension Year 1|Early Withdrawals|0|||
33532100|NCT00048035|101845112|FG003|Extension Year 1|Early Withdrawals|0|||
33612590|NCT02141360|102130274|FG001|Overall Study|Study Terminated before Visit|0|||
33205882|NCT03859323|100655870|FG010|Overall Study|Withdrawal by Subject|1|||
33404587|NCT01397409|101369518|FG002|Stage 3|Other Miscellaneous Reasons|0|||
33404588|NCT01397409|101369519|FG003|Stage 3|Other Miscellaneous Reasons|0|||
33404589|NCT01397409|101369520|FG004|Stage 3|Other Miscellaneous Reasons|0|||
33404590|NCT01397409|101369521|FG005|Stage 3|Other Miscellaneous Reasons|0|||
33404591|NCT01397409|101369522|FG006|Stage 3|Other Miscellaneous Reasons|0|||
33404592|NCT01397409|101369523|FG007|Stage 3|Other Miscellaneous Reasons|1|||
33612591|NCT02141360|102130275|FG002|Overall Study|Study Terminated before Visit|0|||
33612592|NCT00866814|102130276|FG000|Overall Study|Lost to Follow-up|12|||
33612593|NCT00866814|102130276|FG000|Overall Study|Adverse Event|2|||
33612594|NCT00866814|102130276|FG000|Overall Study|Physician Decision|1|||
33612595|NCT00866814|102130276|FG000|Overall Study|Death|1|||
33612596|NCT00866814|102130276|FG000|Overall Study|No longer wished to participate|1|||
33612597|NCT00866814|102130276|FG000|Overall Study|Unable to meet follow-up requirements|2|||
33612598|NCT00866814|102130276|FG000|Overall Study|Moved to area without study site|1|||
33612599|NCT00384332|102130277|FG000|Overall Study|Lost to Follow-up|4|||
33612600|NCT00384332|102130278|FG001|Overall Study|Lost to Follow-up|0|||
33612601|NCT04072887|102130279|FG000|Overall Study|Withdrawal by Subject|3|||
33612602|NCT04072887|102130280|FG001|Overall Study|Withdrawal by Subject|8|||
33612603|NCT04072887|102130281|FG002|Overall Study|Withdrawal by Subject|1|||
33612604|NCT04072887|102130282|FG003|Overall Study|Withdrawal by Subject|3|||
33612605|NCT04072887|102130283|FG004|Overall Study|Withdrawal by Subject|3|||
33612606|NCT04072887|102130284|FG005|Overall Study|Withdrawal by Subject|13|||
33612607|NCT04072887|102130279|FG000|Overall Study|Adverse Event|2|||
33612608|NCT04072887|102130280|FG001|Overall Study|Adverse Event|4|||
33612609|NCT04072887|102130281|FG002|Overall Study|Adverse Event|1|||
33612610|NCT04072887|102130282|FG003|Overall Study|Adverse Event|4|||
33612611|NCT04072887|102130283|FG004|Overall Study|Adverse Event|0|||
33612612|NCT04072887|102130284|FG005|Overall Study|Adverse Event|1|||
33612613|NCT04072887|102130279|FG000|Overall Study|Physician Decision|2|||
33612614|NCT04072887|102130280|FG001|Overall Study|Physician Decision|0|||
33612615|NCT04072887|102130281|FG002|Overall Study|Physician Decision|0|||
33612616|NCT04072887|102130282|FG003|Overall Study|Physician Decision|0|||
33612617|NCT04072887|102130283|FG004|Overall Study|Physician Decision|0|||
33612618|NCT04072887|102130284|FG005|Overall Study|Physician Decision|1|||
33612619|NCT04072887|102130279|FG000|Overall Study|Lost to Follow-up|1|||
33612620|NCT04072887|102130280|FG001|Overall Study|Lost to Follow-up|3|||
33612621|NCT04072887|102130281|FG002|Overall Study|Lost to Follow-up|0|||
33612622|NCT04072887|102130282|FG003|Overall Study|Lost to Follow-up|0|||
33612623|NCT04072887|102130283|FG004|Overall Study|Lost to Follow-up|0|||
33612624|NCT04072887|102130284|FG005|Overall Study|Lost to Follow-up|0|||
33612625|NCT04072887|102130279|FG000|Overall Study|Death|0|||
33612626|NCT04072887|102130280|FG001|Overall Study|Death|2|||
33404593|NCT01397409|101369524|FG008|Stage 3|Other Miscellaneous Reasons|0|||
33612627|NCT04072887|102130281|FG002|Overall Study|Death|0|||
33532101|NCT00048035|101845113|FG004|Extension Year 1|Early Withdrawals|0|||
33532102|NCT00048035|101845114|FG005|Extension Year 1|Early Withdrawals|0|||
33532103|NCT00048035|101845115|FG006|Extension Year 1|Early Withdrawals|11|||
33532104|NCT00048035|101845116|FG007|Extension Year 1|Early Withdrawals|11|||
33532105|NCT00048035|101845109|FG000|Extension Year 2|Early Withdrawals|0|||
33532106|NCT00048035|101845110|FG001|Extension Year 2|Early Withdrawals|0|||
33532107|NCT00048035|101845111|FG002|Extension Year 2|Early Withdrawals|0|||
33532108|NCT00048035|101845112|FG003|Extension Year 2|Early Withdrawals|0|||
33532109|NCT00048035|101845113|FG004|Extension Year 2|Early Withdrawals|0|||
33532110|NCT00048035|101845114|FG005|Extension Year 2|Early Withdrawals|0|||
33532111|NCT00048035|101845115|FG006|Extension Year 2|Early Withdrawals|3|||
33532112|NCT00048035|101845116|FG007|Extension Year 2|Early Withdrawals|3|||
33532113|NCT00463801|101845117|FG000|Overall Study|Protocol Violation|1|||
33532114|NCT00463801|101845117|FG000|Overall Study|Lack of Efficacy|2|||
33532115|NCT00463801|101845117|FG000|Overall Study|Adverse Event|4|||
33532116|NCT00463801|101845117|FG000|Overall Study|Lost to Follow-up|5|||
33532117|NCT00463801|101845117|FG000|Overall Study|No longer require therapy|1|||
33532118|NCT01411319|101845120|FG000|Overall Study|Lost to Follow-up|1|||
33532119|NCT00941304|101845121|FG000|Overall Study|Lost to Follow-up|1|||
33532120|NCT00941304|101845122|FG001|Overall Study|Lost to Follow-up|0|||
33532121|NCT00941304|101845123|FG002|Overall Study|Lost to Follow-up|0|||
33532122|NCT00941304|101845124|FG003|Overall Study|Lost to Follow-up|0|||
33532123|NCT00941304|101845125|FG004|Overall Study|Lost to Follow-up|0|||
33532124|NCT01000974|101849410|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
33532125|NCT01000974|101849411|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
33532126|NCT01000974|101849412|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
33532127|NCT01000974|101849410|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
33532128|NCT01000974|101849411|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
33532129|NCT01000974|101849412|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
33532130|NCT01000974|101849410|FG000|Primary Vaccination Phase|Protocol Violation|40|||
33532131|NCT01000974|101849411|FG001|Primary Vaccination Phase|Protocol Violation|3|||
33532132|NCT01000974|101849412|FG002|Primary Vaccination Phase|Protocol Violation|2|||
33532133|NCT01000974|101849410|FG000|Primary Vaccination Phase|Adverse Event|14|||
33532134|NCT01000974|101849411|FG001|Primary Vaccination Phase|Adverse Event|2|||
33532135|NCT01000974|101849412|FG002|Primary Vaccination Phase|Adverse Event|2|||
33532136|NCT01000974|101849410|FG000|Primary Vaccination Phase|Other|4|||
33532137|NCT01000974|101849411|FG001|Primary Vaccination Phase|Other|9|||
33532138|NCT01000974|101849412|FG002|Primary Vaccination Phase|Other|12|||
33532139|NCT01000974|101849410|FG000|Booster Vaccination Phase|Protocol Violation|0|||
33532140|NCT01000974|101849411|FG001|Booster Vaccination Phase|Protocol Violation|0|||
33532141|NCT01000974|101849412|FG002|Booster Vaccination Phase|Protocol Violation|2|||
33532142|NCT01000974|101849410|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
33532143|NCT01000974|101849411|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
33532144|NCT01000974|101849412|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
33532145|NCT01000974|101849410|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
33532146|NCT01000974|101849411|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
33532147|NCT01000974|101849412|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
33532148|NCT01000974|101849410|FG000|Booster Vaccination Phase|Other|24|||
33532149|NCT01000974|101849411|FG001|Booster Vaccination Phase|Other|6|||
33532150|NCT01000974|101849412|FG002|Booster Vaccination Phase|Other|4|||
33532151|NCT02864407|101849415|FG000|Overall Study|Protocol Violation|3|||
33532152|NCT02864407|101849415|FG000|Overall Study|Lost to Follow-up|115|||
33612628|NCT04072887|102130282|FG003|Overall Study|Death|2|||
33612629|NCT04072887|102130283|FG004|Overall Study|Death|3|||
33612630|NCT04072887|102130284|FG005|Overall Study|Death|0|||
33612631|NCT01943591|102130285|FG000|Overall Study|Lost to Follow-up|3|||
33612632|NCT01943591|102130286|FG001|Overall Study|Lost to Follow-up|4|||
33612633|NCT01943591|102130285|FG000|Overall Study|Death|2|||
33612634|NCT01943591|102130286|FG001|Overall Study|Death|7|||
33612635|NCT04680975|102130287|FG000|Overall Study|Adverse Event|3|||
33612636|NCT04680975|102130287|FG000|Overall Study|Death|1|||
33404594|NCT01397409|101369525|FG009|Stage 3|Other Miscellaneous Reasons|0|||
33404595|NCT03730987|101369526|FG000|Overall Study|Lost to Follow-up|2|||
33532153|NCT02864407|101849415|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
33532154|NCT02864407|101849415|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
33532155|NCT02864407|101849415|FG000|Overall Study|Consent prior to the contract date|1|||
33532156|NCT00667992|101849416|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
33532157|NCT00667992|101849417|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
33532158|NCT00667992|101849416|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
33612637|NCT04680975|102130287|FG000|Overall Study|Progressive Disease|1|||
33612638|NCT04680975|102130287|FG000|Overall Study|Withdrawal by Subject|1|||
33612639|NCT01408459|102130290|FG000|Overall Study|Withdrawal by Subject|1|||
33404596|NCT03730987|101369527|FG001|Overall Study|Lost to Follow-up|0|||
33404597|NCT03730987|101369528|FG002|Overall Study|Lost to Follow-up|2|||
33404598|NCT03730987|101369529|FG003|Overall Study|Lost to Follow-up|0|||
33404599|NCT03188991|101369531|FG000|Overall Study|Withdrawal by Subject|0|||
33404600|NCT03188991|101369532|FG001|Overall Study|Withdrawal by Subject|0|||
33404601|NCT03188991|101369533|FG002|Overall Study|Withdrawal by Subject|0|||
33404602|NCT03188991|101369534|FG003|Overall Study|Withdrawal by Subject|1|||
33404603|NCT00686894|101369535|FG000|Overall Study|Relapse|2|||
33404604|NCT00686894|101369535|FG000|Overall Study|Protocol Violation|4|||
33404605|NCT01790633|101369541|FG000|Overall Study|Protocol Violation|1|||
33404606|NCT01790633|101369542|FG001|Overall Study|Protocol Violation|2|||
33532159|NCT00667992|101849417|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
33205883|NCT03859323|100655871|FG011|Overall Study|Withdrawal by Subject|2|||
33205884|NCT03859323|100655872|FG012|Overall Study|Withdrawal by Subject|1|||
33205885|NCT03859323|100655860|FG000|Overall Study|Pregnancy|0|||
33205886|NCT03859323|100655861|FG001|Overall Study|Pregnancy|0|||
33205887|NCT03859323|100655862|FG002|Overall Study|Pregnancy|0|||
33205888|NCT03859323|100655863|FG003|Overall Study|Pregnancy|0|||
33205889|NCT03859323|100655864|FG004|Overall Study|Pregnancy|0|||
33205890|NCT03859323|100655865|FG005|Overall Study|Pregnancy|0|||
33337089|NCT01100437|101124721|FG002|Maintenance|Sponsor termination of study|1|||
33532160|NCT00667992|101849416|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
33612640|NCT01408459|102130291|FG001|Overall Study|Withdrawal by Subject|1|||
33612641|NCT04677504|102130301|FG000|Overall Study|Death|51|||
33612642|NCT04677504|102130302|FG001|Overall Study|Death|49|||
33612643|NCT04677504|102130301|FG000|Overall Study|Progressive Disease|1|||
33612644|NCT04677504|102130302|FG001|Overall Study|Progressive Disease|0|||
33612645|NCT04677504|102130301|FG000|Overall Study|Symptomatic Deterioration|1|||
33612646|NCT04677504|102130302|FG001|Overall Study|Symptomatic Deterioration|0|||
33532161|NCT00667992|101849417|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
33532162|NCT00667992|101849416|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
33532163|NCT00667992|101849417|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
33532164|NCT00667992|101849416|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
33532165|NCT00667992|101849417|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
33532166|NCT00667992|101849416|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
33532167|NCT00667992|101849417|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
33337090|NCT01294670|101124722|FG000|Overall Study|Not treated|1|||
33337091|NCT01294670|101124723|FG001|Overall Study|Not treated|0|||
33532168|NCT00667992|101849416|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
33532169|NCT00667992|101849417|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
33532170|NCT00667992|101849416|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
33532171|NCT00667992|101849417|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
33532172|NCT00667992|101849416|FG000|Wash-out|Not within one doubling dilution|4|||
33532173|NCT00667992|101849417|FG001|Wash-out|Not within one doubling dilution|3|||
33532174|NCT00667992|101849416|FG000|Wash-out|Failure to wash-out|2|||
33532175|NCT00667992|101849417|FG001|Wash-out|Failure to wash-out|2|||
33612647|NCT04677504|102130301|FG000|Overall Study|Withdrawal by Subject|2|||
33612648|NCT04677504|102130302|FG001|Overall Study|Withdrawal by Subject|5|||
33612649|NCT04677504|102130301|FG000|Overall Study|Study Terminated By Sponsor|28|||
33612650|NCT04677504|102130302|FG001|Overall Study|Study Terminated By Sponsor|24|||
33612651|NCT04677504|102130301|FG000|Overall Study|Adverse Event|0|||
33612652|NCT04677504|102130302|FG001|Overall Study|Adverse Event|1|||
33612653|NCT01546688|102130306|FG000|Overall Study|Adverse Event|0|||
33612654|NCT01546688|102130307|FG001|Overall Study|Adverse Event|4|||
33612655|NCT01546688|102130306|FG000|Overall Study|Withdrawal by Subject|2|||
33612656|NCT01546688|102130307|FG001|Overall Study|Withdrawal by Subject|1|||
33612657|NCT01546688|102130306|FG000|Overall Study|Lack of Efficacy|1|||
33612658|NCT01546688|102130307|FG001|Overall Study|Lack of Efficacy|0|||
33337092|NCT01294670|101124724|FG002|Overall Study|Not treated|0|||
33337093|NCT01294670|101124725|FG003|Overall Study|Not treated|0|||
33337094|NCT01294670|101124726|FG004|Overall Study|Not treated|0|||
33337095|NCT00411554|101124727|FG000|Overall Study|Adverse Event|2|||
33337096|NCT00411554|101124728|FG001|Overall Study|Adverse Event|4|||
33337097|NCT00411554|101124727|FG000|Overall Study|Lack of Efficacy|2|||
33337098|NCT00411554|101124728|FG001|Overall Study|Lack of Efficacy|5|||
33404607|NCT01790633|101369541|FG000|Overall Study|Did not have serology performed|47|||
33404608|NCT01790633|101369542|FG001|Overall Study|Did not have serology performed|0|||
33404609|NCT01790633|101369541|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
33205891|NCT03859323|100655866|FG006|Overall Study|Pregnancy|0|||
33205892|NCT03859323|100655867|FG007|Overall Study|Pregnancy|0|||
33337099|NCT00411554|101124727|FG000|Overall Study|Withdrawal by Subject|3|||
33337100|NCT00411554|101124728|FG001|Overall Study|Withdrawal by Subject|0|||
33532176|NCT00667992|101849416|FG000|Wash-out|Withdrawal by Subject|1|||
33532177|NCT00667992|101849417|FG001|Wash-out|Withdrawal by Subject|0|||
33532178|NCT00667992|101849416|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
33532179|NCT00667992|101849417|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
33532180|NCT00667992|101849416|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
33532181|NCT00667992|101849417|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
33532182|NCT00931632|101849418|FG000|Overall Study|Withdrawal by Subject|2|||
33532183|NCT00931632|101849419|FG001|Overall Study|Withdrawal by Subject|3|||
33532184|NCT00931632|101849418|FG000|Overall Study|Adverse Event|19|||
33404610|NCT01790633|101369542|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
33404611|NCT00453349|101369545|FG000|Randomized|Adverse Event|12|||
33404612|NCT00453349|101369546|FG001|Randomized|Adverse Event|11|||
33404613|NCT00453349|101369545|FG000|Randomized|Lack of Efficacy|2|||
33404614|NCT00453349|101369546|FG001|Randomized|Lack of Efficacy|1|||
33404615|NCT00453349|101369545|FG000|Randomized|Lost to Follow-up|7|||
33404616|NCT00453349|101369546|FG001|Randomized|Lost to Follow-up|5|||
33404617|NCT00453349|101369545|FG000|Randomized|Protocol Violation|1|||
33404618|NCT00453349|101369546|FG001|Randomized|Protocol Violation|1|||
33404619|NCT00453349|101369545|FG000|Randomized|Withdrawal by Subject|3|||
33404620|NCT00453349|101369546|FG001|Randomized|Withdrawal by Subject|5|||
33404621|NCT00453349|101369545|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
33404622|NCT00453349|101369546|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
33404623|NCT00453349|101369545|FG000|Completed Study|Adverse Event|12|||
33404624|NCT00453349|101369546|FG001|Completed Study|Adverse Event|11|||
33404625|NCT00453349|101369545|FG000|Completed Study|Lack of Efficacy|2|||
33404626|NCT00453349|101369546|FG001|Completed Study|Lack of Efficacy|1|||
33404627|NCT00453349|101369545|FG000|Completed Study|Lost to Follow-up|7|||
33404628|NCT00453349|101369546|FG001|Completed Study|Lost to Follow-up|5|||
33404629|NCT00453349|101369545|FG000|Completed Study|Protocol Violation|1|||
33404630|NCT00453349|101369546|FG001|Completed Study|Protocol Violation|1|||
33404631|NCT00453349|101369545|FG000|Completed Study|Withdrawal by Subject|3|||
33404632|NCT00453349|101369546|FG001|Completed Study|Withdrawal by Subject|5|||
33404633|NCT00453349|101369545|FG000|Completed Study|Lost to follow up after study treatment|2|||
33404634|NCT00453349|101369546|FG001|Completed Study|Lost to follow up after study treatment|11|||
33404635|NCT02828982|101369547|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33404636|NCT02828982|101369548|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33404637|NCT00669240|101369549|FG000|Overall Study|Lack of Efficacy|33|||
33404638|NCT00669240|101369549|FG000|Overall Study|Withdrawal by Subject|42|||
33404639|NCT00669240|101369549|FG000|Overall Study|Lost to Follow-up|34|||
33404640|NCT00669240|101369549|FG000|Overall Study|Adverse Event|21|||
33404641|NCT00669240|101369549|FG000|Overall Study|Other|19|||
33404642|NCT00669240|101369549|FG000|Overall Study|Enrolled but not treated|15|||
33404643|NCT00669240|101369549|FG000|Overall Study|Enrolled but no dosing record|1|||
33404644|NCT00740116|101369554|FG000|Overall Study|Withdrawal by Subject|1|||
33404645|NCT00740116|101369555|FG001|Overall Study|Withdrawal by Subject|1|||
33404646|NCT00740116|101369554|FG000|Overall Study|Protocol Violation|1|||
33404647|NCT00740116|101369555|FG001|Overall Study|Protocol Violation|4|||
33404648|NCT01177943|101369556|FG000|First Intervention|Withdrawal by Subject|2|||
33404649|NCT01177943|101369557|FG001|First Intervention|Withdrawal by Subject|0|||
33404650|NCT00598585|101369558|FG000|Overall Study|Lost to Follow-up|1|||
33404651|NCT00598585|101369559|FG001|Overall Study|Lost to Follow-up|0|||
33404652|NCT04354870|101369560|FG000|Overall Study|Lost to Follow-up|32|||
33404653|NCT04354870|101369561|FG001|Overall Study|Lost to Follow-up|12|||
33404654|NCT04354870|101369560|FG000|Overall Study|Withdrawal by Subject|10|||
33404655|NCT04354870|101369561|FG001|Overall Study|Withdrawal by Subject|16|||
33612659|NCT04698993|102130308|FG000|Overall Study|PCR results not accessible|2|||
33612660|NCT04698993|102130309|FG001|Overall Study|PCR results not accessible|7|||
33404656|NCT04354870|101369560|FG000|Overall Study|Did not complete all study visits|6|||
33404657|NCT04354870|101369561|FG001|Overall Study|Did not complete all study visits|5|||
33404658|NCT04212221|101369569|FG000|Overall Study|Remained on Treatment|0|||
33404659|NCT04212221|101369570|FG001|Overall Study|Remained on Treatment|0|||
33404660|NCT04212221|101369571|FG002|Overall Study|Remained on Treatment|0|||
33404661|NCT04212221|101369572|FG003|Overall Study|Remained on Treatment|1|||
33404662|NCT04212221|101369573|FG004|Overall Study|Remained on Treatment|0|||
33404663|NCT04212221|101369574|FG005|Overall Study|Remained on Treatment|0|||
33404664|NCT04212221|101369575|FG006|Overall Study|Remained on Treatment|3|||
33404665|NCT04212221|101369576|FG007|Overall Study|Remained on Treatment|9|||
33404666|NCT04212221|101369569|FG000|Overall Study|Adverse Event|0|||
33404667|NCT04212221|101369570|FG001|Overall Study|Adverse Event|0|||
33404668|NCT04212221|101369571|FG002|Overall Study|Adverse Event|0|||
33404669|NCT04212221|101369572|FG003|Overall Study|Adverse Event|0|||
33404670|NCT04212221|101369573|FG004|Overall Study|Adverse Event|0|||
33404671|NCT04212221|101369574|FG005|Overall Study|Adverse Event|0|||
33404672|NCT04212221|101369575|FG006|Overall Study|Adverse Event|2|||
33404673|NCT04212221|101369576|FG007|Overall Study|Adverse Event|3|||
33404674|NCT04212221|101369569|FG000|Overall Study|Death|0|||
33404675|NCT04212221|101369570|FG001|Overall Study|Death|0|||
33404676|NCT04212221|101369571|FG002|Overall Study|Death|0|||
33404677|NCT04212221|101369572|FG003|Overall Study|Death|0|||
33404678|NCT04212221|101369573|FG004|Overall Study|Death|0|||
33404679|NCT04212221|101369574|FG005|Overall Study|Death|0|||
33404680|NCT04212221|101369575|FG006|Overall Study|Death|0|||
33404681|NCT04212221|101369576|FG007|Overall Study|Death|2|||
33404682|NCT04212221|101369569|FG000|Overall Study|Disease progression according to irRECIST|1|||
33404683|NCT04212221|101369570|FG001|Overall Study|Disease progression according to irRECIST|2|||
33404684|NCT04212221|101369571|FG002|Overall Study|Disease progression according to irRECIST|3|||
33404685|NCT04212221|101369572|FG003|Overall Study|Disease progression according to irRECIST|3|||
33404686|NCT04212221|101369573|FG004|Overall Study|Disease progression according to irRECIST|2|||
33404687|NCT04212221|101369574|FG005|Overall Study|Disease progression according to irRECIST|2|||
33404688|NCT04212221|101369575|FG006|Overall Study|Disease progression according to irRECIST|21|||
33404689|NCT04212221|101369576|FG007|Overall Study|Disease progression according to irRECIST|17|||
33404690|NCT04212221|101369569|FG000|Overall Study|Global Deterioration of Health Status|0|||
33404691|NCT04212221|101369570|FG001|Overall Study|Global Deterioration of Health Status|0|||
33404692|NCT04212221|101369571|FG002|Overall Study|Global Deterioration of Health Status|0|||
33404693|NCT04212221|101369572|FG003|Overall Study|Global Deterioration of Health Status|0|||
33404694|NCT04212221|101369573|FG004|Overall Study|Global Deterioration of Health Status|0|||
33404695|NCT04212221|101369574|FG005|Overall Study|Global Deterioration of Health Status|0|||
33404696|NCT04212221|101369575|FG006|Overall Study|Global Deterioration of Health Status|0|||
33404697|NCT04212221|101369576|FG007|Overall Study|Global Deterioration of Health Status|2|||
33404698|NCT04212221|101369569|FG000|Overall Study|Investigator's Decision|0|||
33404699|NCT04212221|101369570|FG001|Overall Study|Investigator's Decision|0|||
33404700|NCT04212221|101369571|FG002|Overall Study|Investigator's Decision|0|||
33404701|NCT04212221|101369572|FG003|Overall Study|Investigator's Decision|1|||
33404702|NCT04212221|101369573|FG004|Overall Study|Investigator's Decision|0|||
33404703|NCT04212221|101369574|FG005|Overall Study|Investigator's Decision|0|||
33404704|NCT04212221|101369575|FG006|Overall Study|Investigator's Decision|3|||
33404705|NCT04212221|101369576|FG007|Overall Study|Investigator's Decision|0|||
33404706|NCT04212221|101369569|FG000|Overall Study|Participant refused to continue treatment|0|||
33404707|NCT04212221|101369570|FG001|Overall Study|Participant refused to continue treatment|1|||
33404708|NCT04212221|101369571|FG002|Overall Study|Participant refused to continue treatment|0|||
33404709|NCT04212221|101369572|FG003|Overall Study|Participant refused to continue treatment|1|||
33404710|NCT04212221|101369573|FG004|Overall Study|Participant refused to continue treatment|1|||
33404711|NCT04212221|101369574|FG005|Overall Study|Participant refused to continue treatment|2|||
33404712|NCT04212221|101369575|FG006|Overall Study|Participant refused to continue treatment|4|||
33404713|NCT04212221|101369576|FG007|Overall Study|Participant refused to continue treatment|2|||
33404714|NCT04212221|101369569|FG000|Overall Study|Protocol Violation|0|||
33404715|NCT04212221|101369570|FG001|Overall Study|Protocol Violation|0|||
33404716|NCT04212221|101369571|FG002|Overall Study|Protocol Violation|0|||
33404717|NCT04212221|101369572|FG003|Overall Study|Protocol Violation|0|||
33404718|NCT04212221|101369573|FG004|Overall Study|Protocol Violation|0|||
33404719|NCT04212221|101369574|FG005|Overall Study|Protocol Violation|0|||
33404720|NCT04212221|101369575|FG006|Overall Study|Protocol Violation|0|||
33404721|NCT04212221|101369576|FG007|Overall Study|Protocol Violation|1|||
33404722|NCT00805194|101369583|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
33404723|NCT00805194|101369584|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
33404724|NCT00805194|101369583|FG000|Overall Study|Worsening or AE of underlying disease|64|||
33404725|NCT00805194|101369584|FG001|Overall Study|Worsening or AE of underlying disease|70|||
33404726|NCT00805194|101369583|FG000|Overall Study|Other AE|84|||
33404727|NCT00805194|101369584|FG001|Overall Study|Other AE|73|||
33404728|NCT00805194|101369583|FG000|Overall Study|Protocol Violation|9|||
33404729|NCT00805194|101369584|FG001|Overall Study|Protocol Violation|9|||
33404730|NCT00805194|101369583|FG000|Overall Study|Lost to Follow-up|5|||
33404731|NCT00805194|101369584|FG001|Overall Study|Lost to Follow-up|5|||
33404732|NCT00805194|101369583|FG000|Overall Study|Withdrawal by Subject|60|||
33404733|NCT00805194|101369584|FG001|Overall Study|Withdrawal by Subject|42|||
33404734|NCT00805194|101369583|FG000|Overall Study|Not treated|3|||
33631279|NCT03279081|102202899|FG000|Overall Study|Reason not Specified|14|||
33404735|NCT00805194|101369584|FG001|Overall Study|Not treated|4|||
33404736|NCT00805194|101369583|FG000|Overall Study|Reasons other than stated above|20|||
33404737|NCT00805194|101369584|FG001|Overall Study|Reasons other than stated above|16|||
33404738|NCT00948389|101369585|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
33612661|NCT04698993|102130308|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
33612662|NCT04698993|102130309|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
33612663|NCT01240200|102130310|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
33404739|NCT00948389|101369586|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
33404740|NCT00948389|101369587|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
33404741|NCT00948389|101369588|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
33404742|NCT00948389|101369589|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
33404743|NCT00948389|101369585|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
33404744|NCT00948389|101369586|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
33404745|NCT00948389|101369587|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
33404746|NCT00948389|101369588|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
33532185|NCT00931632|101849419|FG001|Overall Study|Adverse Event|15|||
33404747|NCT00948389|101369589|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
33404748|NCT00948389|101369585|FG000|Overall Study|Both Progression and Toxicity|1|||
33532186|NCT03066830|101849420|FG000|Overall Study|At the Participant's own Request|16|||
33532187|NCT03066830|101849421|FG001|Overall Study|At the Participant's own Request|17|||
33532188|NCT03066830|101849420|FG000|Overall Study|Other|3|||
33612664|NCT01240200|102130311|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
33612665|NCT03100058|102133646|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
33612666|NCT03100058|102133647|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
33612667|NCT03100058|102133648|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
33404749|NCT00948389|101369586|FG001|Overall Study|Both Progression and Toxicity|0|||
33404750|NCT00948389|101369587|FG002|Overall Study|Both Progression and Toxicity|0|||
33404751|NCT00948389|101369588|FG003|Overall Study|Both Progression and Toxicity|0|||
33404752|NCT00948389|101369589|FG004|Overall Study|Both Progression and Toxicity|0|||
33404753|NCT03328325|101369590|FG000|Overall Study|Lost to Follow-up|4|||
33404754|NCT03328325|101369590|FG000|Overall Study|Physician Decision|1|||
33404755|NCT03328325|101369590|FG000|Overall Study|Withdrawal by Subject|3|||
33404756|NCT03328325|101369590|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
33404757|NCT00945945|101369594|FG000|Overall Study|Adverse Event|15|||
33404758|NCT00945945|101369595|FG001|Overall Study|Adverse Event|35|||
33532189|NCT03066830|101849421|FG001|Overall Study|Other|0|||
33404759|NCT00945945|101369594|FG000|Overall Study|Withdrawal by Subject|7|||
33404760|NCT00945945|101369595|FG001|Overall Study|Withdrawal by Subject|10|||
33404761|NCT00945945|101369594|FG000|Overall Study|Lost to Follow-up|4|||
33404762|NCT00945945|101369595|FG001|Overall Study|Lost to Follow-up|5|||
33404763|NCT00945945|101369594|FG000|Overall Study|Lack of Efficacy|6|||
33404764|NCT00945945|101369595|FG001|Overall Study|Lack of Efficacy|2|||
33404765|NCT00945945|101369594|FG000|Overall Study|Protocol Violation|4|||
33404766|NCT00945945|101369595|FG001|Overall Study|Protocol Violation|2|||
33532190|NCT03066830|101849420|FG000|Overall Study|Poor Compliance to Protocol|1|||
33532191|NCT03066830|101849421|FG001|Overall Study|Poor Compliance to Protocol|0|||
33532192|NCT03066830|101849420|FG000|Overall Study|Adverse Event|2|||
33532193|NCT03066830|101849421|FG001|Overall Study|Adverse Event|2|||
33532194|NCT03066830|101849420|FG000|Overall Study|Lost to Follow-up|11|||
33532195|NCT03066830|101849421|FG001|Overall Study|Lost to Follow-up|3|||
33532196|NCT02753816|101849426|FG000|Overall Study|Protocol Violation|0|||
33532197|NCT02753816|101849427|FG001|Overall Study|Protocol Violation|1|||
33532198|NCT02753816|101849428|FG002|Overall Study|Protocol Violation|0|||
33532199|NCT02106351|101849429|FG000|Treatment Cycle 1|Adverse Event|2|||
33532200|NCT02106351|101849430|FG001|Treatment Cycle 1|Adverse Event|0|||
33532201|NCT02106351|101849431|FG002|Treatment Cycle 1|Adverse Event|0|||
33532202|NCT02106351|101849429|FG000|Treatment Cycle 1|Consent withdrawn|1|||
33532203|NCT02106351|101849430|FG001|Treatment Cycle 1|Consent withdrawn|0|||
33532204|NCT02106351|101849431|FG002|Treatment Cycle 1|Consent withdrawn|2|||
33532205|NCT02106351|101849429|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
33532206|NCT02106351|101849430|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
33532207|NCT02106351|101849431|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
33532208|NCT02106351|101849429|FG000|Treatment Cycle 1|Other|0|||
33532209|NCT02106351|101849430|FG001|Treatment Cycle 1|Other|3|||
33532210|NCT02106351|101849431|FG002|Treatment Cycle 1|Other|1|||
33532211|NCT02106351|101849429|FG000|Treatment Cycle 1|Randomised but not treated|1|||
33532212|NCT02106351|101849430|FG001|Treatment Cycle 1|Randomised but not treated|0|||
33532213|NCT02106351|101849431|FG002|Treatment Cycle 1|Randomised but not treated|1|||
33532214|NCT02106351|101849429|FG000|Treatment Cycle 2|Adverse Event|0|||
33532215|NCT02106351|101849430|FG001|Treatment Cycle 2|Adverse Event|2|||
33532216|NCT02106351|101849431|FG002|Treatment Cycle 2|Adverse Event|0|||
33532217|NCT02106351|101849429|FG000|Treatment Cycle 2|Consent withdrawn|0|||
33532218|NCT02106351|101849430|FG001|Treatment Cycle 2|Consent withdrawn|1|||
33532219|NCT02106351|101849431|FG002|Treatment Cycle 2|Consent withdrawn|1|||
33532220|NCT02106351|101849429|FG000|Treatment Cycle 2|Other|0|||
33532221|NCT02106351|101849430|FG001|Treatment Cycle 2|Other|2|||
33532222|NCT02106351|101849431|FG002|Treatment Cycle 2|Other|2|||
33532223|NCT02106351|101849429|FG000|Treatment Cycle 3|Adverse Event|0|||
33532224|NCT02106351|101849430|FG001|Treatment Cycle 3|Adverse Event|1|||
33532225|NCT02106351|101849431|FG002|Treatment Cycle 3|Adverse Event|0|||
33532226|NCT02106351|101849429|FG000|Treatment Cycle 3|Consent withdrawn|0|||
33612668|NCT03100058|102133649|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
33532227|NCT02106351|101849430|FG001|Treatment Cycle 3|Consent withdrawn|0|||
33532228|NCT02106351|101849431|FG002|Treatment Cycle 3|Consent withdrawn|2|||
33532229|NCT02106351|101849429|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
33532230|NCT02106351|101849430|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
33532231|NCT02106351|101849431|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
33532232|NCT02106351|101849429|FG000|Treatment Cycle 3|Other|0|||
33532233|NCT02106351|101849430|FG001|Treatment Cycle 3|Other|2|||
33532234|NCT02106351|101849431|FG002|Treatment Cycle 3|Other|3|||
33404767|NCT00945945|101369594|FG000|Overall Study|Entry Criteria Not Met|0|||
33532235|NCT02106351|101849429|FG000|Treatment Cycle 4|Consent withdrawn|0|||
33404768|NCT00945945|101369595|FG001|Overall Study|Entry Criteria Not Met|1|||
33404769|NCT00545584|101369598|FG000|Overall Study|Only one reason for discontinuation|62|||
33532236|NCT02106351|101849430|FG001|Treatment Cycle 4|Consent withdrawn|0|||
33404770|NCT00545584|101369599|FG001|Overall Study|Only one reason for discontinuation|61|||
33404771|NCT00545584|101369600|FG002|Overall Study|Only one reason for discontinuation|48|||
33532237|NCT02106351|101849431|FG002|Treatment Cycle 4|Consent withdrawn|2|||
33532238|NCT02106351|101849429|FG000|Treatment Cycle 4|Other|0|||
33532239|NCT02106351|101849430|FG001|Treatment Cycle 4|Other|1|||
33532240|NCT02106351|101849431|FG002|Treatment Cycle 4|Other|0|||
33612669|NCT03100058|102133650|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
33612670|NCT03100058|102133651|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
33612671|NCT03100058|102133652|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
33612672|NCT03100058|102133653|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
33612673|NCT03100058|102133654|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
33612674|NCT03100058|102133655|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
33612675|NCT03100058|102133656|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
33532241|NCT02686164|101849433|FG000|Overall Study|Adverse Event|1|||
33532242|NCT02686164|101849433|FG000|Overall Study|Withdrawal of consent|1|||
33532243|NCT02686164|101849433|FG000|Overall Study|Clinical progression|1|||
33532244|NCT03797898|101849434|FG000|Overall Study|Lost to Follow-up|60|||
33532245|NCT03797898|101849435|FG001|Overall Study|Lost to Follow-up|69|||
33532246|NCT03797898|101849434|FG000|Overall Study|Withdrawal by Subject|9|||
33532247|NCT03797898|101849435|FG001|Overall Study|Withdrawal by Subject|7|||
33532248|NCT03797898|101849434|FG000|Overall Study|Became ineligible|5|||
33532249|NCT03797898|101849435|FG001|Overall Study|Became ineligible|2|||
33532250|NCT00571662|101849438|FG000|Overall Study|Withdrawal by Subject|2|||
33612676|NCT03100058|102133657|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
33205893|NCT03859323|100655868|FG008|Overall Study|Pregnancy|0|||
33532251|NCT00571662|101849438|FG000|Overall Study|psychiatric instability|1|||
33532252|NCT00571662|101849438|FG000|Overall Study|Adverse Event|5|||
33532253|NCT02630563|101849439|FG000|Overall Study|Administrative|1|||
33612677|NCT03100058|102133658|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
33404772|NCT00545584|101369598|FG000|Overall Study|Two or more reasons for discontinuation|17|||
33404773|NCT00545584|101369599|FG001|Overall Study|Two or more reasons for discontinuation|19|||
33404774|NCT00545584|101369600|FG002|Overall Study|Two or more reasons for discontinuation|8|||
33404775|NCT00787527|101369601|FG000|Overall Study|Toxicity|3|||
33404776|NCT00699582|101369611|FG000|Overall Study|Adverse Event|4|||
33404777|NCT00699582|101369612|FG001|Overall Study|Adverse Event|11|||
33612678|NCT03100058|102133646|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
33612679|NCT03100058|102133647|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
33612680|NCT03100058|102133648|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
33612681|NCT03100058|102133649|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
33205894|NCT03859323|100655869|FG009|Overall Study|Pregnancy|1|||
33205895|NCT03859323|100655870|FG010|Overall Study|Pregnancy|0|||
33337101|NCT00411554|101124727|FG000|Overall Study|Patient Moved|1|||
33337102|NCT00411554|101124728|FG001|Overall Study|Patient Moved|0|||
33337103|NCT00262873|101124729|FG000|Overall Study|Adverse Event|3|||
33337104|NCT00262873|101124729|FG000|Overall Study|Withdrawal by Subject|5|||
33337105|NCT01617460|101124730|FG000|Overall Study|Adverse Event|10|||
33337106|NCT01617460|101124730|FG000|Overall Study|Physician Decision|16|||
33337107|NCT01617460|101124730|FG000|Overall Study|Protocol Violation|5|||
33337108|NCT01617460|101124730|FG000|Overall Study|Withdrawal by Subject|9|||
33337109|NCT03451773|101124731|FG000|Overall Study|Death on study|1|||
33337110|NCT03451773|101124732|FG001|Overall Study|Death on study|5|||
33337111|NCT03451773|101124731|FG000|Overall Study|Death during follow-up period|0|||
33337112|NCT03451773|101124732|FG001|Overall Study|Death during follow-up period|1|||
33337113|NCT00179309|101124735|FG000|Treatment|Toxicity|2|||
33337114|NCT00179309|101124736|FG001|Treatment|Toxicity|3|||
33337115|NCT00179309|101124735|FG000|Treatment|Withdrawal by Subject|1|||
33337116|NCT00179309|101124736|FG001|Treatment|Withdrawal by Subject|2|||
33337117|NCT00179309|101124735|FG000|Treatment|Allergy|1|||
33337118|NCT00179309|101124736|FG001|Treatment|Allergy|0|||
33337119|NCT01137773|101124737|FG000|Overall Study|Death|3|||
33337120|NCT01137773|101124738|FG001|Overall Study|Death|3|||
33337121|NCT01137773|101124737|FG000|Overall Study|Lost to Follow-up|6|||
33337122|NCT01137773|101124738|FG001|Overall Study|Lost to Follow-up|0|||
33337123|NCT04899232|101124739|FG000|Screening Period|Physician Decision|1|||
33337124|NCT04899232|101124740|FG001|Screening Period|Physician Decision|0|||
33337125|NCT04899232|101124741|FG002|Screening Period|Physician Decision|0|||
33337126|NCT04899232|101124739|FG000|Screening Period|Withdrawal by Subject|1|||
33337127|NCT04899232|101124740|FG001|Screening Period|Withdrawal by Subject|0|||
33337128|NCT04899232|101124741|FG002|Screening Period|Withdrawal by Subject|0|||
33337129|NCT04899232|101124739|FG000|Screening Period|Participant discharged before receiving intervention|3|||
33404778|NCT00699582|101369613|FG002|Overall Study|Adverse Event|23|||
33404779|NCT00699582|101369611|FG000|Overall Study|Withdrawal by Subject|6|||
33612682|NCT03100058|102133650|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
33612683|NCT03100058|102133651|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
33612684|NCT03100058|102133652|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
33612685|NCT03100058|102133653|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
33612686|NCT03100058|102133654|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
33612687|NCT03100058|102133655|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
33612688|NCT03100058|102133656|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
33205896|NCT03859323|100655871|FG011|Overall Study|Pregnancy|0|||
33337130|NCT04899232|101124740|FG001|Screening Period|Participant discharged before receiving intervention|0|||
33337131|NCT04899232|101124741|FG002|Screening Period|Participant discharged before receiving intervention|0|||
33337132|NCT04041284|101124748|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
33337133|NCT04041284|101124749|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
33337134|NCT04041284|101124748|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
33337135|NCT04041284|101124749|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
33205897|NCT03859323|100655872|FG012|Overall Study|Pregnancy|0|||
33337136|NCT04041284|101124748|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
33612689|NCT03100058|102133657|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
33612690|NCT03100058|102133658|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
33612691|NCT03100058|102133646|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33612692|NCT03100058|102133647|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
33612693|NCT03100058|102133648|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
33612694|NCT03100058|102133649|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33612695|NCT03100058|102133650|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33612696|NCT03100058|102133651|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
33612697|NCT03100058|102133652|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
33612698|NCT03100058|102133653|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33612699|NCT03100058|102133654|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33612700|NCT03100058|102133655|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33612701|NCT03100058|102133656|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33612702|NCT03100058|102133657|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33612703|NCT03100058|102133658|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
33612704|NCT03100058|102133646|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33612705|NCT03100058|102133647|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
33612706|NCT03100058|102133648|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
33612707|NCT03100058|102133649|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33612708|NCT03100058|102133650|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33612709|NCT03100058|102133651|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33612710|NCT03100058|102133652|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
33612711|NCT03100058|102133653|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33612712|NCT03100058|102133654|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
33612713|NCT03100058|102133655|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33612714|NCT03100058|102133656|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33612715|NCT03100058|102133657|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33612716|NCT03100058|102133658|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
33612717|NCT03100058|102133646|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33612718|NCT03100058|102133647|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33612719|NCT03100058|102133648|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33612720|NCT03100058|102133649|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
33612721|NCT03100058|102133650|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33612722|NCT03100058|102133651|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33612723|NCT03100058|102133652|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33612724|NCT03100058|102133653|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
33612725|NCT03100058|102133654|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33612726|NCT03100058|102133655|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33612727|NCT03100058|102133656|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33612728|NCT03100058|102133657|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33612729|NCT03100058|102133658|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
33612730|NCT03100058|102133646|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33612731|NCT03100058|102133647|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33612732|NCT03100058|102133648|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33612733|NCT03100058|102133649|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
33612734|NCT03100058|102133650|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33612735|NCT03100058|102133651|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33612736|NCT03100058|102133652|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
33612737|NCT03100058|102133653|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33337137|NCT04041284|101124749|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
33337138|NCT04041284|101124748|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
33337139|NCT04041284|101124749|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
33337140|NCT04041284|101124748|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
33532254|NCT02829047|101849440|FG000|Overall Study|Withdrawal by Subject|1|||
33337141|NCT04041284|101124749|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
33337142|NCT04041284|101124748|FG000|DB Phase (12 Weeks)|Other than specified|1|||
33612738|NCT03100058|102133654|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33612739|NCT03100058|102133655|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33612740|NCT03100058|102133656|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33612741|NCT03100058|102133657|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33612742|NCT03100058|102133658|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
33612743|NCT03100058|102133646|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33612744|NCT03100058|102133647|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
33612745|NCT03100058|102133648|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33612746|NCT03100058|102133649|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33612747|NCT03100058|102133650|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33612748|NCT03100058|102133651|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33612749|NCT03100058|102133652|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33612750|NCT03100058|102133653|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33612751|NCT03100058|102133654|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33612752|NCT03100058|102133655|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33612753|NCT03100058|102133656|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33612754|NCT03100058|102133657|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33612755|NCT03100058|102133658|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
33612756|NCT03100058|102133646|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
33612757|NCT03100058|102133647|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33612758|NCT03100058|102133648|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33612759|NCT03100058|102133649|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33612760|NCT03100058|102133650|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33612761|NCT03100058|102133651|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33612762|NCT03100058|102133652|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33612763|NCT03100058|102133653|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33612764|NCT03100058|102133654|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33532255|NCT04613518|101849441|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
33532256|NCT04613518|101849442|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
33532257|NCT04613518|101849443|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
33532258|NCT04613518|101849441|FG000|Double-Blind Treatment Period|Adverse Event|2|||
33532259|NCT04613518|101849442|FG001|Double-Blind Treatment Period|Adverse Event|0|||
33532260|NCT04613518|101849443|FG002|Double-Blind Treatment Period|Adverse Event|1|||
33532261|NCT04613518|101849441|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
33532262|NCT04613518|101849442|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
33532263|NCT04613518|101849443|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
33532264|NCT04613518|101849441|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
33532265|NCT04613518|101849442|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
33532266|NCT04613518|101849443|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
33532267|NCT04613518|101849441|FG000|Double-Blind Treatment Period|Other Reasons|2|||
33532268|NCT04613518|101849442|FG001|Double-Blind Treatment Period|Other Reasons|0|||
33532269|NCT04613518|101849443|FG002|Double-Blind Treatment Period|Other Reasons|0|||
33532270|NCT04613518|101849441|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
33532271|NCT04613518|101849442|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
33612765|NCT03100058|102133655|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33612766|NCT03100058|102133656|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33612767|NCT03100058|102133657|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33612768|NCT03100058|102133658|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
33612769|NCT03100058|102133646|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33532272|NCT04613518|101849443|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
33532273|NCT04613518|101849441|FG000|Open-Label Treatment Period|Adverse Event|1|||
33532274|NCT04613518|101849442|FG001|Open-Label Treatment Period|Adverse Event|0|||
33532275|NCT04613518|101849443|FG002|Open-Label Treatment Period|Adverse Event|3|||
33532276|NCT04613518|101849441|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
33532277|NCT04613518|101849442|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
33532278|NCT04613518|101849443|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
33532279|NCT04613518|101849441|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
33532280|NCT04613518|101849442|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
33532281|NCT04613518|101849443|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
33532282|NCT04613518|101849441|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
33532283|NCT04613518|101849442|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
33532284|NCT04613518|101849443|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
33532285|NCT04613518|101849441|FG000|Open-Label Treatment Period|Other reasons|1|||
33532286|NCT04613518|101849442|FG001|Open-Label Treatment Period|Other reasons|0|||
33532287|NCT04613518|101849443|FG002|Open-Label Treatment Period|Other reasons|0|||
33532288|NCT00149396|101849455|FG000|Overall Study|Death|15|||
33532289|NCT00149396|101849455|FG000|Overall Study|Withdrawal by Subject|1|||
33532290|NCT00149396|101849455|FG000|Overall Study|Subject noncompliance|2|||
33532291|NCT00149396|101849455|FG000|Overall Study|other treatment|5|||
33532292|NCT01212094|101849456|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
33532293|NCT01212094|101849457|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
33532294|NCT01212094|101849458|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
33532295|NCT01212094|101849456|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
33532296|NCT01212094|101849457|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
33532297|NCT01212094|101849458|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
33532298|NCT01212094|101849456|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
33532299|NCT01212094|101849457|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
33612770|NCT03100058|102133647|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33532300|NCT01212094|101849458|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
33532301|NCT01212094|101849456|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
33532302|NCT01212094|101849457|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
33532303|NCT01212094|101849458|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
33532304|NCT01212094|101849456|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
33532305|NCT01212094|101849457|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
33532306|NCT01212094|101849458|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
33532307|NCT01212094|101849456|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
33532308|NCT01212094|101849457|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
33532309|NCT01212094|101849458|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
33532310|NCT02155699|101849460|FG000|Overall Study|Withdrawal by Subject|0|||
33532311|NCT02155699|101849461|FG001|Overall Study|Withdrawal by Subject|3|||
33532312|NCT02155699|101849462|FG002|Overall Study|Withdrawal by Subject|6|||
33532313|NCT02155699|101849463|FG003|Overall Study|Withdrawal by Subject|1|||
33532314|NCT02155699|101849460|FG000|Overall Study|Lost to Follow-up|0|||
33532315|NCT02155699|101849461|FG001|Overall Study|Lost to Follow-up|0|||
33532316|NCT02155699|101849462|FG002|Overall Study|Lost to Follow-up|0|||
33532317|NCT02155699|101849463|FG003|Overall Study|Lost to Follow-up|3|||
33532318|NCT02155699|101849460|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
33532319|NCT02155699|101849461|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
33532320|NCT02155699|101849462|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
33532321|NCT02155699|101849463|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
33532322|NCT04633226|101849467|FG000|Overall Study|Withdrawal by parent/guardian|4|||
33532323|NCT04633226|101849467|FG000|Overall Study|Randomized by mistake without study treatment|1|||
33532324|NCT01801111|101849471|FG000|Overall Study|Adverse Event|12|||
33532325|NCT01801111|101849471|FG000|Overall Study|Death|8|||
33532326|NCT01801111|101849471|FG000|Overall Study|Physician Decision|5|||
33532327|NCT01801111|101849471|FG000|Overall Study|Other|1|||
33532328|NCT01801111|101849471|FG000|Overall Study|Withdrawal by Subject|4|||
33532329|NCT01801111|101849471|FG000|Overall Study|Study Terminated by Sponsor|27|||
33532330|NCT01801111|101849471|FG000|Overall Study|Progressive Disease|81|||
33532331|NCT01367249|101849474|FG000|Overall Study|Withdrawal by Subject|6|||
33532332|NCT01367249|101849475|FG001|Overall Study|Withdrawal by Subject|6|||
33532333|NCT01367249|101849474|FG000|Overall Study|Other|3|||
33532334|NCT01367249|101849475|FG001|Overall Study|Other|10|||
33532335|NCT03839394|101849476|FG000|Overall Study|Lost to Follow-up|6|||
33532336|NCT03839394|101849477|FG001|Overall Study|Lost to Follow-up|8|||
33532337|NCT03839394|101849476|FG000|Overall Study|Withdrawal by Subject|0|||
33532338|NCT03839394|101849477|FG001|Overall Study|Withdrawal by Subject|2|||
33532339|NCT00003483|101849479|FG000|Overall Study|Not evaluable|1|||
33532340|NCT02256839|101849505|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
33532341|NCT02256839|101849506|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
33532342|NCT01845597|101849507|FG000|Overall Study|Death|8|||
33532343|NCT01845597|101849507|FG000|Overall Study|Lost to Follow-up|22|||
33532344|NCT00809445|101849511|FG000|1 Month Follow-up|Lost contact|1|||
33532345|NCT00809445|101849512|FG001|1 Month Follow-up|Lost contact|2|||
33532346|NCT00809445|101849513|FG002|1 Month Follow-up|Lost contact|1|||
33532347|NCT00809445|101849511|FG000|1 Month Follow-up|Withdrew consent|1|||
33532348|NCT00809445|101849512|FG001|1 Month Follow-up|Withdrew consent|1|||
33532349|NCT00809445|101849513|FG002|1 Month Follow-up|Withdrew consent|1|||
33532350|NCT00809445|101849511|FG000|1 Month Follow-up|Death|0|||
33532351|NCT00809445|101849512|FG001|1 Month Follow-up|Death|1|||
33205898|NCT03674177|100655874|FG000|Overall Study|Lost to Follow-up|2|||
33532352|NCT00809445|101849513|FG002|1 Month Follow-up|Death|1|||
33532353|NCT00809445|101849511|FG000|1 Month Follow-up|Incarcerated|0|||
33532354|NCT00809445|101849512|FG001|1 Month Follow-up|Incarcerated|0|||
33532355|NCT00809445|101849513|FG002|1 Month Follow-up|Incarcerated|1|||
33532356|NCT00809445|101849511|FG000|6 Month Follow-up|Lost contact|16|||
33205899|NCT03674177|100655875|FG001|Overall Study|Lost to Follow-up|1|||
33532357|NCT00809445|101849512|FG001|6 Month Follow-up|Lost contact|14|||
33532358|NCT00809445|101849513|FG002|6 Month Follow-up|Lost contact|14|||
33532359|NCT00809445|101849511|FG000|6 Month Follow-up|Death|2|||
33532360|NCT00809445|101849512|FG001|6 Month Follow-up|Death|1|||
33532361|NCT00809445|101849513|FG002|6 Month Follow-up|Death|1|||
33532362|NCT00809445|101849511|FG000|6 Month Follow-up|Incarcerated|6|||
33532363|NCT00809445|101849512|FG001|6 Month Follow-up|Incarcerated|8|||
33532364|NCT00809445|101849513|FG002|6 Month Follow-up|Incarcerated|8|||
33532365|NCT00809445|101849511|FG000|6 Month Follow-up|Withdrew consent|0|||
33532366|NCT00809445|101849512|FG001|6 Month Follow-up|Withdrew consent|0|||
33532367|NCT00809445|101849513|FG002|6 Month Follow-up|Withdrew consent|1|||
33532368|NCT04794751|101849514|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
33532369|NCT04794751|101849515|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
33532370|NCT04794751|101849514|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
33532371|NCT04794751|101849515|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
33532372|NCT04794751|101849514|FG000|Period 1|Protocol Violation|0|||
33532373|NCT04794751|101849515|FG001|Period 1|Protocol Violation|2|||
33532374|NCT04794751|101849514|FG000|Period 1|Withdrawal by Subject|0|||
33532375|NCT04794751|101849515|FG001|Period 1|Withdrawal by Subject|1|||
33532376|NCT04794751|101849514|FG000|Period 2|Withdrawal by Subject|0|||
33532377|NCT04794751|101849515|FG001|Period 2|Withdrawal by Subject|1|||
33532378|NCT04794751|101849514|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
33532379|NCT04794751|101849515|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
33532380|NCT04794751|101849514|FG000|Period 2|Protocol Violation|1|||
33532381|NCT04794751|101849515|FG001|Period 2|Protocol Violation|0|||
33532382|NCT00715299|101849516|FG000|Overall Study|Withdrawal by Subject|1|||
33532383|NCT00715299|101849516|FG000|Overall Study|Adverse Event|3|||
33532384|NCT00715299|101849516|FG000|Overall Study|failed the pre-screen exercise test|2|||
33532385|NCT01817075|101849526|FG000|Overall Study|Adverse Event|7|||
33532386|NCT01817075|101849527|FG001|Overall Study|Adverse Event|5|||
33532387|NCT01817075|101849526|FG000|Overall Study|Physician Decision|9|||
33532388|NCT01817075|101849527|FG001|Overall Study|Physician Decision|12|||
33532389|NCT01817075|101849526|FG000|Overall Study|Withdrawal by Subject|31|||
33532390|NCT01817075|101849527|FG001|Overall Study|Withdrawal by Subject|15|||
33532391|NCT01817075|101849526|FG000|Overall Study|Received Sorafenib after enrollment|0|||
33532392|NCT01817075|101849527|FG001|Overall Study|Received Sorafenib after enrollment|1|||
33532393|NCT01817075|101849526|FG000|Overall Study|Ineligible|0|||
33532394|NCT01817075|101849527|FG001|Overall Study|Ineligible|2|||
33532395|NCT02573259|101849528|FG000|Overall Study|Death|1|||
33532396|NCT02573259|101849529|FG001|Overall Study|Death|6|||
33532397|NCT02573259|101849530|FG002|Overall Study|Death|5|||
33532398|NCT02573259|101849531|FG003|Overall Study|Death|6|||
33532399|NCT02573259|101849532|FG004|Overall Study|Death|9|||
33532400|NCT02573259|101849533|FG005|Overall Study|Death|32|||
33532401|NCT02573259|101849534|FG006|Overall Study|Death|21|||
33532402|NCT02573259|101849528|FG000|Overall Study|Lost to Follow-up|0|||
33532403|NCT02573259|101849529|FG001|Overall Study|Lost to Follow-up|0|||
33532404|NCT02573259|101849530|FG002|Overall Study|Lost to Follow-up|0|||
33532405|NCT02573259|101849531|FG003|Overall Study|Lost to Follow-up|0|||
33532406|NCT02573259|101849532|FG004|Overall Study|Lost to Follow-up|0|||
33532407|NCT02573259|101849533|FG005|Overall Study|Lost to Follow-up|2|||
33532408|NCT02573259|101849534|FG006|Overall Study|Lost to Follow-up|1|||
33612771|NCT03100058|102133648|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33532409|NCT02573259|101849528|FG000|Overall Study|Participant refused further follow-up|0|||
33532410|NCT02573259|101849529|FG001|Overall Study|Participant refused further follow-up|2|||
33532411|NCT02573259|101849530|FG002|Overall Study|Participant refused further follow-up|1|||
33532412|NCT02573259|101849531|FG003|Overall Study|Participant refused further follow-up|0|||
33532413|NCT02573259|101849532|FG004|Overall Study|Participant refused further follow-up|3|||
33532414|NCT02573259|101849533|FG005|Overall Study|Participant refused further follow-up|20|||
33532415|NCT02573259|101849534|FG006|Overall Study|Participant refused further follow-up|7|||
33532416|NCT02573259|101849528|FG000|Overall Study|Other|0|||
33532417|NCT02573259|101849529|FG001|Overall Study|Other|0|||
33532418|NCT02573259|101849530|FG002|Overall Study|Other|0|||
33532419|NCT02573259|101849531|FG003|Overall Study|Other|0|||
33532420|NCT02573259|101849532|FG004|Overall Study|Other|1|||
33532421|NCT02573259|101849533|FG005|Overall Study|Other|4|||
33532422|NCT02573259|101849534|FG006|Overall Study|Other|5|||
33532423|NCT02302846|101849535|FG000|Overall Study|Withdrawal by Subject|1|||
33532424|NCT02003144|101849536|FG000|Open Label Maintenance Phase|Other than specified|2|||
33532425|NCT02003144|101849537|FG001|Open Label Maintenance Phase|Other than specified|4|||
33532426|NCT02003144|101849536|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
33532427|NCT02003144|101849537|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
33532428|NCT02003144|101849536|FG000|Open Label Maintenance Phase|Pregnancy|0|||
33532429|NCT02003144|101849537|FG001|Open Label Maintenance Phase|Pregnancy|2|||
33532430|NCT02003144|101849536|FG000|Open Label Maintenance Phase|Physician Decision|1|||
33532431|NCT02003144|101849537|FG001|Open Label Maintenance Phase|Physician Decision|1|||
33532432|NCT02003144|101849536|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
33532433|NCT02003144|101849537|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
33532434|NCT02003144|101849536|FG000|Open Label Maintenance Phase|Adverse Event|2|||
33532435|NCT02003144|101849537|FG001|Open Label Maintenance Phase|Adverse Event|1|||
33532436|NCT01249417|101849538|FG000|Randomised Population|Study treatment not received|0|||
33532437|NCT01249417|101849539|FG001|Randomised Population|Study treatment not received|0|||
33532438|NCT01249417|101849540|FG002|Randomised Population|Study treatment not received|2|||
33532439|NCT01249417|101849538|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
33532440|NCT01249417|101849539|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
33532441|NCT01249417|101849540|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
33532442|NCT01249417|101849538|FG000|Treatment Phase - ITT Population|Other|0|||
33532443|NCT01249417|101849539|FG001|Treatment Phase - ITT Population|Other|0|||
33532444|NCT01249417|101849540|FG002|Treatment Phase - ITT Population|Other|1|||
33532445|NCT01249417|101849538|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
33532446|NCT01249417|101849539|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
33532447|NCT01249417|101849540|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
33532448|NCT01249417|101849538|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
33532449|NCT01249417|101849539|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
33532450|NCT01249417|101849540|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
33532451|NCT01249417|101849538|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
33532452|NCT01249417|101849539|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
33532453|NCT01249417|101849540|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
33532454|NCT02171429|101849541|FG000|Overall Study|Other|0|||
33532455|NCT02171429|101849542|FG001|Overall Study|Other|1|||
33532456|NCT02171429|101849543|FG002|Overall Study|Other|1|||
33532457|NCT02171429|101849541|FG000|Overall Study|Non-Compliance|0|||
33532458|NCT02171429|101849542|FG001|Overall Study|Non-Compliance|0|||
33532459|NCT02171429|101849543|FG002|Overall Study|Non-Compliance|1|||
33532460|NCT02171429|101849541|FG000|Overall Study|Physician Decision|0|||
33532461|NCT02171429|101849542|FG001|Overall Study|Physician Decision|0|||
33532462|NCT02171429|101849543|FG002|Overall Study|Physician Decision|1|||
33532463|NCT02171429|101849541|FG000|Overall Study|Withdrawal by Subject|1|||
33532464|NCT02171429|101849542|FG001|Overall Study|Withdrawal by Subject|1|||
33532465|NCT02171429|101849543|FG002|Overall Study|Withdrawal by Subject|1|||
33532466|NCT02171429|101849541|FG000|Overall Study|Lost to Follow-up|0|||
33532467|NCT02171429|101849542|FG001|Overall Study|Lost to Follow-up|1|||
33532468|NCT02171429|101849543|FG002|Overall Study|Lost to Follow-up|0|||
33532469|NCT02171429|101849541|FG000|Overall Study|Death|0|||
33532470|NCT02171429|101849542|FG001|Overall Study|Death|0|||
33532471|NCT02171429|101849543|FG002|Overall Study|Death|1|||
33532472|NCT00970489|101849544|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
33532473|NCT00970489|101849545|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
33532474|NCT01178125|101849546|FG000|Overall Study|Lost to Follow-up|397|||
33532475|NCT01178125|101849546|FG000|Overall Study|Adverse Event|244|||
33532476|NCT01178125|101849546|FG000|Overall Study|Withdrawal by Subject|209|||
33532477|NCT01178125|101849546|FG000|Overall Study|Noncompliance|184|||
33532478|NCT01178125|101849546|FG000|Overall Study|Pregnancy|55|||
33532479|NCT01178125|101849546|FG000|Overall Study|Other Reason|39|||
33532480|NCT01178125|101849546|FG000|Overall Study|Sponsor Decision|28|||
33532481|NCT01178125|101849546|FG000|Overall Study|Protocol Violation|17|||
33532482|NCT01178125|101849546|FG000|Overall Study|Investigator Decision|5|||
33532483|NCT01566604|101849547|FG000|Overall Study|Patient's inability to use the device|1|||
33532484|NCT01566604|101849548|FG001|Overall Study|Patient's inability to use the device|0|||
33532485|NCT01566604|101849547|FG000|Overall Study|Administrative problems|1|||
33532486|NCT01566604|101849548|FG001|Overall Study|Administrative problems|0|||
33532487|NCT01566604|101849547|FG000|Overall Study|Lack of Efficacy|1|||
33532488|NCT01566604|101849548|FG001|Overall Study|Lack of Efficacy|2|||
33532489|NCT01566604|101849547|FG000|Overall Study|Protocol deviation|2|||
33532490|NCT01566604|101849548|FG001|Overall Study|Protocol deviation|0|||
33532491|NCT01566604|101849547|FG000|Overall Study|Abnormal laboratory value|2|||
33532492|NCT01566604|101849548|FG001|Overall Study|Abnormal laboratory value|0|||
33532493|NCT01566604|101849547|FG000|Overall Study|Death|4|||
33532494|NCT01566604|101849548|FG001|Overall Study|Death|1|||
33532495|NCT01566604|101849547|FG000|Overall Study|Adverse Event|4|||
33532496|NCT01566604|101849548|FG001|Overall Study|Adverse Event|2|||
33532497|NCT01566604|101849547|FG000|Overall Study|Withdrawal by Subject|9|||
33532498|NCT01566604|101849548|FG001|Overall Study|Withdrawal by Subject|6|||
33532499|NCT02824627|101849549|FG000|Overall Study|Adverse Event|1|||
33532500|NCT02824627|101849550|FG001|Overall Study|Adverse Event|2|||
33532501|NCT02824627|101849549|FG000|Overall Study|Lost to Follow-up|2|||
33532502|NCT02824627|101849550|FG001|Overall Study|Lost to Follow-up|1|||
33532503|NCT01932697|101849558|FG000|Overall Study|Received a different amount of tx|1|||
33532504|NCT01932697|101849559|FG001|Overall Study|Received a different amount of tx|0|||
33532505|NCT01932697|101849558|FG000|Overall Study|Ineligible|1|||
33532506|NCT01932697|101849559|FG001|Overall Study|Ineligible|0|||
33532507|NCT00919633|101849561|FG000|Overall Study|Adverse Event|1|||
33532508|NCT00919633|101849562|FG001|Overall Study|Adverse Event|9|||
33532509|NCT00919633|101849563|FG002|Overall Study|Adverse Event|12|||
33532510|NCT00919633|101849564|FG003|Overall Study|Adverse Event|10|||
33532511|NCT00919633|101849561|FG000|Overall Study|Death|0|||
33532512|NCT00919633|101849562|FG001|Overall Study|Death|0|||
33532513|NCT00919633|101849563|FG002|Overall Study|Death|2|||
33532514|NCT00919633|101849564|FG003|Overall Study|Death|0|||
33532515|NCT00919633|101849561|FG000|Overall Study|Lack of Efficacy|17|||
33532516|NCT00919633|101849562|FG001|Overall Study|Lack of Efficacy|3|||
33532517|NCT00919633|101849563|FG002|Overall Study|Lack of Efficacy|2|||
33532518|NCT00919633|101849564|FG003|Overall Study|Lack of Efficacy|3|||
33532519|NCT00919633|101849561|FG000|Overall Study|Withdrawal by Subject|1|||
33532520|NCT00919633|101849562|FG001|Overall Study|Withdrawal by Subject|2|||
33532521|NCT00919633|101849563|FG002|Overall Study|Withdrawal by Subject|4|||
33532522|NCT00919633|101849564|FG003|Overall Study|Withdrawal by Subject|3|||
33532523|NCT00919633|101849561|FG000|Overall Study|Lost to Follow-up|3|||
33532524|NCT00919633|101849562|FG001|Overall Study|Lost to Follow-up|1|||
33532525|NCT00919633|101849563|FG002|Overall Study|Lost to Follow-up|0|||
33532526|NCT00919633|101849564|FG003|Overall Study|Lost to Follow-up|2|||
33532527|NCT00919633|101849561|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
33532528|NCT00919633|101849562|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
33532529|NCT00919633|101849563|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
33532530|NCT00919633|101849564|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
33532531|NCT00919633|101849561|FG000|Overall Study|Protocol Violation|0|||
33532532|NCT00919633|101849562|FG001|Overall Study|Protocol Violation|0|||
33532533|NCT00919633|101849563|FG002|Overall Study|Protocol Violation|0|||
33532534|NCT00919633|101849564|FG003|Overall Study|Protocol Violation|1|||
33532535|NCT00919633|101849561|FG000|Overall Study|Physician Decision|0|||
33532536|NCT00919633|101849562|FG001|Overall Study|Physician Decision|0|||
33532537|NCT00919633|101849563|FG002|Overall Study|Physician Decision|0|||
33337143|NCT04041284|101124749|FG001|DB Phase (12 Weeks)|Other than specified|0|||
33337144|NCT04041284|101124748|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
33337145|NCT04041284|101124749|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
33532538|NCT00919633|101849564|FG003|Overall Study|Physician Decision|1|||
33337146|NCT04041284|101124748|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
33337147|NCT04041284|101124749|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
33337148|NCT04041284|101124748|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
33337149|NCT04041284|101124749|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
33337150|NCT04041284|101124748|FG000|OL Phase (12 Weeks)|Other than specified|6|||
33337151|NCT04041284|101124749|FG001|OL Phase (12 Weeks)|Other than specified|2|||
33532539|NCT00919633|101849561|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
33532540|NCT00919633|101849562|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
33532541|NCT00919633|101849563|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
33532542|NCT00919633|101849564|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
33532543|NCT00919633|101849561|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
33532544|NCT00919633|101849562|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
33532545|NCT00919633|101849563|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
33532546|NCT00919633|101849564|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
33404780|NCT00699582|101369612|FG001|Overall Study|Withdrawal by Subject|7|||
33404781|NCT00699582|101369613|FG002|Overall Study|Withdrawal by Subject|4|||
33404782|NCT00699582|101369611|FG000|Overall Study|Lack of Efficacy|1|||
33612772|NCT03100058|102133649|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33612773|NCT03100058|102133650|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33612774|NCT03100058|102133651|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33612775|NCT03100058|102133652|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
33612776|NCT03100058|102133653|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33612777|NCT03100058|102133654|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33612778|NCT03100058|102133655|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33612779|NCT03100058|102133656|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33612780|NCT03100058|102133657|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33612781|NCT03100058|102133658|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
33612782|NCT03100058|102133646|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33612783|NCT03100058|102133647|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33612784|NCT03100058|102133648|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33612785|NCT03100058|102133649|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33612786|NCT03100058|102133650|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33612787|NCT03100058|102133651|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33612788|NCT03100058|102133652|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33337152|NCT03344003|101124750|FG000|Overall Study|Switched to alternative treatment|1|||
33404783|NCT00699582|101369612|FG001|Overall Study|Lack of Efficacy|0|||
33612789|NCT03100058|102133653|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33612790|NCT03100058|102133654|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33612791|NCT03100058|102133655|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
33337153|NCT03344003|101124751|FG001|Overall Study|Switched to alternative treatment|0|||
33337154|NCT03344003|101124750|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
33337155|NCT03344003|101124751|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
33337156|NCT00606086|101124752|FG000|Overall Study|Adverse Event|1|||
33337157|NCT00606086|101124753|FG001|Overall Study|Adverse Event|1|||
33337158|NCT00606086|101124752|FG000|Overall Study|Lost to Follow-up|4|||
33337159|NCT00606086|101124753|FG001|Overall Study|Lost to Follow-up|8|||
33337160|NCT00606086|101124752|FG000|Overall Study|Protocol Violation|1|||
33337161|NCT00606086|101124753|FG001|Overall Study|Protocol Violation|0|||
33337162|NCT00606086|101124752|FG000|Overall Study|Withdrawal by Subject|5|||
33337163|NCT00606086|101124753|FG001|Overall Study|Withdrawal by Subject|3|||
33337164|NCT00606086|101124752|FG000|Overall Study|Non-compliance|0|||
33337165|NCT00606086|101124753|FG001|Overall Study|Non-compliance|1|||
33337166|NCT00606086|101124752|FG000|Overall Study|Randomized, not treated|1|||
33337167|NCT00606086|101124753|FG001|Overall Study|Randomized, not treated|2|||
33337168|NCT00159861|101124754|FG000|Core Study - 16 Weeks|Death|3|||
33337169|NCT00159861|101124755|FG001|Core Study - 16 Weeks|Death|0|||
33337170|NCT00159861|101124754|FG000|Core Study - 16 Weeks|Adverse Event|12|||
33337171|NCT00159861|101124755|FG001|Core Study - 16 Weeks|Adverse Event|6|||
33337172|NCT00159861|101124754|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
33337173|NCT00159861|101124755|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
33337174|NCT00159861|101124754|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
33337175|NCT00159861|101124755|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
33337176|NCT00159861|101124754|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
33337177|NCT00159861|101124755|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
33337178|NCT00159861|101124754|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
33337179|NCT00159861|101124755|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
33337180|NCT00159861|101124754|FG000|Extension Study - up to 3 Years|Death|24|||
33337181|NCT00159861|101124755|FG001|Extension Study - up to 3 Years|Death|28|||
33337182|NCT00159861|101124754|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
33337183|NCT00159861|101124755|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
33337184|NCT00159861|101124754|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
33337185|NCT00159861|101124755|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
33337186|NCT00159861|101124754|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
33337187|NCT00159861|101124755|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
33337188|NCT00159861|101124754|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
33337189|NCT00159861|101124755|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
33337190|NCT01462266|101124756|FG000|Overall Study|Adverse Event|7|||
33337191|NCT01462266|101124757|FG001|Overall Study|Adverse Event|6|||
33337192|NCT01462266|101124756|FG000|Overall Study|Death|2|||
33337193|NCT01462266|101124757|FG001|Overall Study|Death|1|||
33337194|NCT01462266|101124756|FG000|Overall Study|Lack of Efficacy|0|||
33337195|NCT01462266|101124757|FG001|Overall Study|Lack of Efficacy|2|||
33337196|NCT01462266|101124756|FG000|Overall Study|Lost to Follow-up|4|||
33337197|NCT01462266|101124757|FG001|Overall Study|Lost to Follow-up|3|||
33337198|NCT01462266|101124756|FG000|Overall Study|Non-compliance with study drug|3|||
33337199|NCT01462266|101124757|FG001|Overall Study|Non-compliance with study drug|0|||
33337200|NCT01462266|101124756|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
33337201|NCT01462266|101124757|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
33337202|NCT01462266|101124756|FG000|Overall Study|Physician Decision|2|||
33337203|NCT01462266|101124757|FG001|Overall Study|Physician Decision|5|||
33337204|NCT01462266|101124756|FG000|Overall Study|Protocol Violation|1|||
33337205|NCT01462266|101124757|FG001|Overall Study|Protocol Violation|3|||
33337206|NCT01462266|101124756|FG000|Overall Study|Withdrawal by Subject|7|||
33337207|NCT01462266|101124757|FG001|Overall Study|Withdrawal by Subject|2|||
33337208|NCT01462266|101124756|FG000|Overall Study|Screen failure|1|||
33337209|NCT01462266|101124757|FG001|Overall Study|Screen failure|1|||
33337210|NCT02161211|101124758|FG000|Overall Study|Lost to Follow-up|21|||
33337211|NCT02161211|101124759|FG001|Overall Study|Lost to Follow-up|27|||
33337212|NCT02161211|101124760|FG002|Overall Study|Lost to Follow-up|21|||
33337213|NCT02161211|101124758|FG000|Overall Study|Dropped|12|||
33337214|NCT02161211|101124759|FG001|Overall Study|Dropped|5|||
33337215|NCT02161211|101124760|FG002|Overall Study|Dropped|9|||
33337216|NCT03595553|101124762|FG000|Overall Study|Withdrawal by Subject|20|||
33337217|NCT03595553|101124763|FG001|Overall Study|Withdrawal by Subject|8|||
33337218|NCT03595553|101124762|FG000|Overall Study|Physician Decision|3|||
33337219|NCT03595553|101124763|FG001|Overall Study|Physician Decision|2|||
33337220|NCT03595553|101124762|FG000|Overall Study|Adverse Event|2|||
33337221|NCT03595553|101124763|FG001|Overall Study|Adverse Event|5|||
33337222|NCT03595553|101124762|FG000|Overall Study|Death|24|||
33337223|NCT03595553|101124763|FG001|Overall Study|Death|22|||
33337224|NCT03595553|101124762|FG000|Overall Study|Lost to Follow-up|6|||
33337225|NCT03595553|101124763|FG001|Overall Study|Lost to Follow-up|7|||
33337226|NCT03595553|101124762|FG000|Overall Study|Other as indicated in CSR|3|||
33337227|NCT03595553|101124763|FG001|Overall Study|Other as indicated in CSR|3|||
33337228|NCT03595553|101124762|FG000|Overall Study|Sponsor Decision|0|||
33337229|NCT03595553|101124763|FG001|Overall Study|Sponsor Decision|1|||
33337230|NCT00091832|101124765|FG000|Overall Study|Physician Decision|1|||
33337231|NCT00091832|101124766|FG001|Overall Study|Physician Decision|0|||
33337232|NCT00091832|101124767|FG002|Overall Study|Physician Decision|0|||
33337233|NCT00091832|101124768|FG003|Overall Study|Physician Decision|0|||
33337234|NCT00091832|101124769|FG004|Overall Study|Physician Decision|0|||
33337235|NCT00091832|101124770|FG005|Overall Study|Physician Decision|0|||
33337236|NCT00091832|101124765|FG000|Overall Study|Adverse Event|0|||
33337237|NCT00091832|101124766|FG001|Overall Study|Adverse Event|0|||
33337238|NCT00091832|101124767|FG002|Overall Study|Adverse Event|0|||
33337239|NCT00091832|101124768|FG003|Overall Study|Adverse Event|1|||
33337240|NCT00091832|101124769|FG004|Overall Study|Adverse Event|3|||
33337241|NCT00091832|101124770|FG005|Overall Study|Adverse Event|0|||
33337242|NCT00091832|101124765|FG000|Overall Study|Withdrawal by Subject|4|||
33337243|NCT00091832|101124766|FG001|Overall Study|Withdrawal by Subject|5|||
33337244|NCT00091832|101124767|FG002|Overall Study|Withdrawal by Subject|0|||
33337245|NCT00091832|101124768|FG003|Overall Study|Withdrawal by Subject|1|||
33337246|NCT00091832|101124769|FG004|Overall Study|Withdrawal by Subject|3|||
33337247|NCT00091832|101124770|FG005|Overall Study|Withdrawal by Subject|1|||
33337248|NCT00091832|101124765|FG000|Overall Study|Death|6|||
33337249|NCT00091832|101124766|FG001|Overall Study|Death|4|||
33337250|NCT00091832|101124767|FG002|Overall Study|Death|5|||
33337251|NCT00091832|101124768|FG003|Overall Study|Death|8|||
33337252|NCT00091832|101124769|FG004|Overall Study|Death|5|||
33337253|NCT00091832|101124770|FG005|Overall Study|Death|6|||
33337254|NCT00091832|101124765|FG000|Overall Study|Disease Progression|2|||
33337255|NCT00091832|101124766|FG001|Overall Study|Disease Progression|0|||
33404784|NCT00699582|101369613|FG002|Overall Study|Lack of Efficacy|1|||
33404785|NCT00699582|101369611|FG000|Overall Study|Progressive Disease|1|||
33404786|NCT00699582|101369612|FG001|Overall Study|Progressive Disease|0|||
33404787|NCT00699582|101369613|FG002|Overall Study|Progressive Disease|0|||
33404788|NCT00699582|101369611|FG000|Overall Study|Administrative/Other|4|||
33404789|NCT00699582|101369612|FG001|Overall Study|Administrative/Other|3|||
33404790|NCT00699582|101369613|FG002|Overall Study|Administrative/Other|0|||
33404791|NCT00699582|101369611|FG000|Overall Study|Randomized, Not Treated|2|||
33404792|NCT00699582|101369612|FG001|Overall Study|Randomized, Not Treated|1|||
33404793|NCT00699582|101369613|FG002|Overall Study|Randomized, Not Treated|0|||
33612792|NCT03100058|102133656|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
33337256|NCT00091832|101124767|FG002|Overall Study|Disease Progression|0|||
33337257|NCT00091832|101124768|FG003|Overall Study|Disease Progression|1|||
33337258|NCT00091832|101124769|FG004|Overall Study|Disease Progression|1|||
33337259|NCT00091832|101124770|FG005|Overall Study|Disease Progression|2|||
33337260|NCT00091832|101124765|FG000|Overall Study|Ineligibility Determined|0|||
33337261|NCT00091832|101124766|FG001|Overall Study|Ineligibility Determined|0|||
33337262|NCT00091832|101124767|FG002|Overall Study|Ineligibility Determined|1|||
33337263|NCT00091832|101124768|FG003|Overall Study|Ineligibility Determined|0|||
33337264|NCT00091832|101124769|FG004|Overall Study|Ineligibility Determined|1|||
33337265|NCT00091832|101124770|FG005|Overall Study|Ineligibility Determined|0|||
33337266|NCT00091832|101124765|FG000|Overall Study|Lost to Follow-up|1|||
33337267|NCT00091832|101124766|FG001|Overall Study|Lost to Follow-up|0|||
33337268|NCT00091832|101124767|FG002|Overall Study|Lost to Follow-up|3|||
33337269|NCT00091832|101124768|FG003|Overall Study|Lost to Follow-up|3|||
33337270|NCT00091832|101124769|FG004|Overall Study|Lost to Follow-up|2|||
33404794|NCT00660816|101369616|FG000|Overall Study|Adverse Event|1|||
33404795|NCT00660816|101369617|FG001|Overall Study|Adverse Event|2|||
33404796|NCT00660816|101369616|FG000|Overall Study|Withdrawal by Subject|1|||
33404797|NCT00660816|101369617|FG001|Overall Study|Withdrawal by Subject|0|||
33404798|NCT00660816|101369616|FG000|Overall Study|Death|0|||
33404799|NCT00660816|101369617|FG001|Overall Study|Death|2|||
33337271|NCT00091832|101124770|FG005|Overall Study|Lost to Follow-up|1|||
33337272|NCT00091832|101124765|FG000|Overall Study|Noncompliance|0|||
33337273|NCT00091832|101124766|FG001|Overall Study|Noncompliance|1|||
33337274|NCT00091832|101124767|FG002|Overall Study|Noncompliance|0|||
33404800|NCT00660816|101369616|FG000|Overall Study|Lack of Efficacy|1|||
33404801|NCT00660816|101369617|FG001|Overall Study|Lack of Efficacy|0|||
33404802|NCT00660816|101369616|FG000|Overall Study|Physician Decision|0|||
33404803|NCT00660816|101369617|FG001|Overall Study|Physician Decision|2|||
33337275|NCT00091832|101124768|FG003|Overall Study|Noncompliance|0|||
33337276|NCT00091832|101124769|FG004|Overall Study|Noncompliance|0|||
33337277|NCT00091832|101124770|FG005|Overall Study|Noncompliance|0|||
33337278|NCT00091832|101124765|FG000|Overall Study|Other|0|||
33337279|NCT00091832|101124766|FG001|Overall Study|Other|1|||
33337280|NCT00091832|101124767|FG002|Overall Study|Other|2|||
33337281|NCT00091832|101124768|FG003|Overall Study|Other|0|||
33337282|NCT00091832|101124769|FG004|Overall Study|Other|0|||
33337283|NCT00091832|101124770|FG005|Overall Study|Other|0|||
33337284|NCT00091832|101124765|FG000|Overall Study|Protocol Violation|0|||
33337285|NCT00091832|101124766|FG001|Overall Study|Protocol Violation|0|||
33337286|NCT00091832|101124767|FG002|Overall Study|Protocol Violation|1|||
33337287|NCT00091832|101124768|FG003|Overall Study|Protocol Violation|0|||
33337288|NCT00091832|101124769|FG004|Overall Study|Protocol Violation|0|||
33337289|NCT00091832|101124770|FG005|Overall Study|Protocol Violation|1|||
33337290|NCT04016311|101124771|FG000|Overall Study|Withdrawal by Subject|1|||
33337291|NCT04016311|101124772|FG001|Overall Study|Withdrawal by Subject|0|||
33337292|NCT03548558|101124773|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
33532547|NCT02848664|101849567|FG000|Overall Study|Withdrawal by Subject|2|||
33532548|NCT02848664|101849567|FG000|Overall Study|Adverse Event|1|||
33532549|NCT02848664|101849567|FG000|Overall Study|no assistance for device training|1|||
33532550|NCT01676701|101849577|FG000|Overall Study|Protocol Violation|1|||
33532551|NCT01676701|101849578|FG001|Overall Study|Protocol Violation|0|||
33532552|NCT01676701|101849577|FG000|Overall Study|Sponsor Decision|3|||
33532553|NCT01676701|101849578|FG001|Overall Study|Sponsor Decision|4|||
33532554|NCT04157088|101849579|FG000|Overall Study|Study terminated by sponsor|23|||
33532555|NCT04157088|101849579|FG000|Overall Study|Withdrawal by Subject|4|||
33532556|NCT04157088|101849579|FG000|Overall Study|Lost to Follow-up|2|||
33532557|NCT04157088|101849579|FG000|Overall Study|Death|1|||
33532558|NCT02735980|101849580|FG000|Overall Study|Adverse Event|0|||
33532559|NCT02735980|101849581|FG001|Overall Study|Adverse Event|4|||
33532560|NCT02735980|101849582|FG002|Overall Study|Adverse Event|1|||
33532561|NCT02735980|101849580|FG000|Overall Study|Death|5|||
33532562|NCT02735980|101849581|FG001|Overall Study|Death|4|||
33532563|NCT02735980|101849582|FG002|Overall Study|Death|0|||
33532564|NCT02735980|101849580|FG000|Overall Study|Physician Decision|3|||
33337293|NCT03548558|101124774|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
33337294|NCT03548558|101124775|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
33337295|NCT03548558|101124776|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
33532565|NCT02735980|101849581|FG001|Overall Study|Physician Decision|1|||
33532566|NCT02735980|101849582|FG002|Overall Study|Physician Decision|0|||
33337296|NCT03548558|101124777|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
33337297|NCT03548558|101124778|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
33337298|NCT03548558|101124779|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
33337299|NCT03548558|101124773|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
33337300|NCT03548558|101124774|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
33532567|NCT02735980|101849580|FG000|Overall Study|Screen failure|1|||
33532568|NCT02735980|101849581|FG001|Overall Study|Screen failure|0|||
33612793|NCT03100058|102133657|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
33337301|NCT03548558|101124775|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
33404804|NCT00660816|101369616|FG000|Overall Study|Protocol Violation|1|||
33532569|NCT02735980|101849582|FG002|Overall Study|Screen failure|0|||
33532570|NCT02735980|101849580|FG000|Overall Study|Withdrawal by Subject|1|||
33532571|NCT02735980|101849581|FG001|Overall Study|Withdrawal by Subject|2|||
33532572|NCT02735980|101849582|FG002|Overall Study|Withdrawal by Subject|0|||
33532573|NCT01255904|101849583|FG000|Overall Study|Physician Decision|1|||
33532574|NCT01255904|101849584|FG001|Overall Study|Physician Decision|4|||
33532575|NCT04202497|101849585|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
33532576|NCT04202497|101849586|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
33532577|NCT04202497|101849587|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
33532578|NCT04202497|101849588|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
33532579|NCT02949947|101849589|FG000|Overall Study|Non Compliance|0|||
33532580|NCT02949947|101849590|FG001|Overall Study|Non Compliance|1|||
33532581|NCT02949947|101849589|FG000|Overall Study|Insurance change|1|||
33532582|NCT02949947|101849590|FG001|Overall Study|Insurance change|0|||
33532583|NCT00490971|101849591|FG000|Acute/Continuation|Adverse Event|62|||
33532584|NCT00490971|101849592|FG001|Acute/Continuation|Adverse Event|13|||
33532585|NCT00490971|101849593|FG002|Acute/Continuation|Adverse Event|0|||
33532586|NCT00490971|101849594|FG003|Acute/Continuation|Adverse Event|0|||
33532587|NCT00490971|101849595|FG004|Acute/Continuation|Adverse Event|0|||
33532588|NCT00490971|101849591|FG000|Acute/Continuation|Death|2|||
33532589|NCT00490971|101849592|FG001|Acute/Continuation|Death|0|||
33532590|NCT00490971|101849593|FG002|Acute/Continuation|Death|0|||
33532591|NCT00490971|101849594|FG003|Acute/Continuation|Death|0|||
33337302|NCT03548558|101124776|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
33337303|NCT03548558|101124777|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
33337304|NCT03548558|101124778|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
33337305|NCT03548558|101124779|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
33337306|NCT03548558|101124773|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
33337307|NCT03548558|101124774|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
33337308|NCT03548558|101124775|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
33337309|NCT03548558|101124776|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
33337310|NCT03548558|101124777|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
33337311|NCT03548558|101124778|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
33337312|NCT03548558|101124779|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
33337313|NCT03548558|101124773|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
33337314|NCT03548558|101124774|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
33337315|NCT03548558|101124775|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
33337316|NCT03548558|101124776|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
33337317|NCT03548558|101124777|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
33337318|NCT03548558|101124778|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
33532592|NCT00490971|101849595|FG004|Acute/Continuation|Death|0|||
33532593|NCT00490971|101849591|FG000|Acute/Continuation|Lack of Efficacy|106|||
33532594|NCT00490971|101849592|FG001|Acute/Continuation|Lack of Efficacy|12|||
33532595|NCT00490971|101849593|FG002|Acute/Continuation|Lack of Efficacy|0|||
33532596|NCT00490971|101849594|FG003|Acute/Continuation|Lack of Efficacy|0|||
33532597|NCT00490971|101849595|FG004|Acute/Continuation|Lack of Efficacy|0|||
33532598|NCT00490971|101849591|FG000|Acute/Continuation|Lost to Follow-up|23|||
33532599|NCT00490971|101849592|FG001|Acute/Continuation|Lost to Follow-up|7|||
33532600|NCT00490971|101849593|FG002|Acute/Continuation|Lost to Follow-up|0|||
33532601|NCT00490971|101849594|FG003|Acute/Continuation|Lost to Follow-up|0|||
33532602|NCT00490971|101849595|FG004|Acute/Continuation|Lost to Follow-up|0|||
33337319|NCT03548558|101124779|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
33337320|NCT03548558|101124773|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
33337321|NCT03548558|101124774|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
33337322|NCT03548558|101124775|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
33337323|NCT03548558|101124776|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
33337324|NCT03548558|101124777|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
33337325|NCT03548558|101124778|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
33337326|NCT03548558|101124779|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
33337327|NCT03548558|101124773|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
33337328|NCT03548558|101124774|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
33337329|NCT03548558|101124775|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
33337330|NCT03548558|101124776|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
33337331|NCT03548558|101124777|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
33337332|NCT03548558|101124778|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
33337333|NCT03548558|101124779|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
33337334|NCT02556255|101128233|FG000|Overall Study|Lost to Follow-up|4|||
33337335|NCT01340209|101128235|FG000|Overall Study|Adverse Event|1|||
33337336|NCT01340209|101128236|FG001|Overall Study|Adverse Event|1|||
33337337|NCT01340209|101128237|FG002|Overall Study|Adverse Event|2|||
33337338|NCT01340209|101128235|FG000|Overall Study|Protocol Violation|1|||
33337339|NCT01340209|101128236|FG001|Overall Study|Protocol Violation|2|||
33337340|NCT01340209|101128237|FG002|Overall Study|Protocol Violation|1|||
33337341|NCT01340209|101128235|FG000|Overall Study|Withdrawal by Subject|0|||
33337342|NCT01340209|101128236|FG001|Overall Study|Withdrawal by Subject|0|||
33337343|NCT01340209|101128237|FG002|Overall Study|Withdrawal by Subject|1|||
33337344|NCT01340209|101128235|FG000|Overall Study|Other reason not defined above|3|||
33337345|NCT01340209|101128236|FG001|Overall Study|Other reason not defined above|5|||
33337346|NCT01340209|101128237|FG002|Overall Study|Other reason not defined above|4|||
33337347|NCT00429858|101128240|FG000|Overall Study|Withdrawal by Subject|1|||
33337348|NCT00429858|101128240|FG000|Overall Study|Study Termination|1|||
33337349|NCT00267748|101128244|FG000|Non-randomized Period|Progressive disease|10|||
33337350|NCT00267748|101128245|FG001|Non-randomized Period|Progressive disease|0|||
33337351|NCT00267748|101128246|FG002|Non-randomized Period|Progressive disease|0|||
33337352|NCT00267748|101128244|FG000|Non-randomized Period|Adverse Event|8|||
33337353|NCT00267748|101128245|FG001|Non-randomized Period|Adverse Event|0|||
33337354|NCT00267748|101128246|FG002|Non-randomized Period|Adverse Event|0|||
33337355|NCT00267748|101128244|FG000|Non-randomized Period|Death|1|||
33337356|NCT00267748|101128245|FG001|Non-randomized Period|Death|0|||
33337357|NCT00267748|101128246|FG002|Non-randomized Period|Death|0|||
33337358|NCT00267748|101128244|FG000|Non-randomized Period|Participant not willing to participate|1|||
33337359|NCT00267748|101128245|FG001|Non-randomized Period|Participant not willing to participate|0|||
33337360|NCT00267748|101128246|FG002|Non-randomized Period|Participant not willing to participate|0|||
33337361|NCT00267748|101128244|FG000|Non-randomized Period|Other|3|||
33337362|NCT00267748|101128245|FG001|Non-randomized Period|Other|0|||
33337363|NCT00267748|101128246|FG002|Non-randomized Period|Other|0|||
33337364|NCT00267748|101128244|FG000|Randomized Period|Death|0|||
33337365|NCT00267748|101128245|FG001|Randomized Period|Death|2|||
33337366|NCT00267748|101128246|FG002|Randomized Period|Death|3|||
33337367|NCT00267748|101128244|FG000|Randomized Period|Adverse Event|0|||
33337368|NCT00267748|101128245|FG001|Randomized Period|Adverse Event|23|||
33337369|NCT00267748|101128246|FG002|Randomized Period|Adverse Event|25|||
33337370|NCT00267748|101128244|FG000|Randomized Period|Global deterioration of health status|0|||
33337371|NCT00267748|101128245|FG001|Randomized Period|Global deterioration of health status|6|||
33337372|NCT00267748|101128246|FG002|Randomized Period|Global deterioration of health status|7|||
33337373|NCT00267748|101128244|FG000|Randomized Period|Lost to Follow-up|0|||
33337374|NCT00267748|101128245|FG001|Randomized Period|Lost to Follow-up|1|||
33337375|NCT00267748|101128246|FG002|Randomized Period|Lost to Follow-up|0|||
33337376|NCT00267748|101128244|FG000|Randomized Period|Objective progression or relapse|0|||
33337377|NCT00267748|101128245|FG001|Randomized Period|Objective progression or relapse|77|||
33337378|NCT00267748|101128246|FG002|Randomized Period|Objective progression or relapse|86|||
33337379|NCT00267748|101128244|FG000|Randomized Period|Withdrawal by Subject|0|||
33337380|NCT00267748|101128245|FG001|Randomized Period|Withdrawal by Subject|9|||
33337381|NCT00267748|101128246|FG002|Randomized Period|Withdrawal by Subject|2|||
33337382|NCT00267748|101128244|FG000|Randomized Period|Other|0|||
33532603|NCT00490971|101849591|FG000|Acute/Continuation|Protocol Violation|10|||
33532604|NCT00490971|101849592|FG001|Acute/Continuation|Protocol Violation|2|||
33532605|NCT00490971|101849593|FG002|Acute/Continuation|Protocol Violation|0|||
33532606|NCT00490971|101849594|FG003|Acute/Continuation|Protocol Violation|0|||
33532607|NCT00490971|101849595|FG004|Acute/Continuation|Protocol Violation|0|||
33532608|NCT00490971|101849591|FG000|Acute/Continuation|Withdrawal by Subject|92|||
33532609|NCT00490971|101849592|FG001|Acute/Continuation|Withdrawal by Subject|24|||
33532610|NCT00490971|101849593|FG002|Acute/Continuation|Withdrawal by Subject|0|||
33337383|NCT00267748|101128245|FG001|Randomized Period|Other|9|||
33337384|NCT00267748|101128246|FG002|Randomized Period|Other|6|||
33337385|NCT00267748|101128244|FG000|Randomized Period|randomized but not treated|0|||
33337386|NCT00267748|101128245|FG001|Randomized Period|randomized but not treated|0|||
33337387|NCT00267748|101128246|FG002|Randomized Period|randomized but not treated|3|||
33337388|NCT02706873|101128247|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
33404805|NCT00660816|101369617|FG001|Overall Study|Protocol Violation|0|||
33404806|NCT00660816|101369616|FG000|Overall Study|Disease Progression|16|||
33404807|NCT00660816|101369617|FG001|Overall Study|Disease Progression|12|||
33404808|NCT00660816|101369616|FG000|Overall Study|Complicating Disease|0|||
33532611|NCT00490971|101849594|FG003|Acute/Continuation|Withdrawal by Subject|0|||
33205900|NCT03674177|100655876|FG002|Overall Study|Lost to Follow-up|0|||
33337389|NCT02706873|101128248|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
33337390|NCT02706873|101128249|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
33337391|NCT02706873|101128250|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
33337392|NCT02706873|101128247|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
33337393|NCT02706873|101128248|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
33337394|NCT02706873|101128249|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
33337395|NCT02706873|101128250|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
33532612|NCT00490971|101849595|FG004|Acute/Continuation|Withdrawal by Subject|0|||
33532613|NCT00490971|101849591|FG000|Acute/Continuation|Other|11|||
33532614|NCT00490971|101849592|FG001|Acute/Continuation|Other|4|||
33532615|NCT00490971|101849593|FG002|Acute/Continuation|Other|0|||
33532616|NCT00490971|101849594|FG003|Acute/Continuation|Other|0|||
33532617|NCT00490971|101849595|FG004|Acute/Continuation|Other|0|||
33532618|NCT00490971|101849591|FG000|Maintenance|Adverse Event|0|||
33532619|NCT00490971|101849592|FG001|Maintenance|Adverse Event|0|||
33532620|NCT00490971|101849593|FG002|Maintenance|Adverse Event|4|||
33532621|NCT00490971|101849594|FG003|Maintenance|Adverse Event|5|||
33532622|NCT00490971|101849595|FG004|Maintenance|Adverse Event|7|||
33532623|NCT00490971|101849591|FG000|Maintenance|Death|0|||
33532624|NCT00490971|101849592|FG001|Maintenance|Death|0|||
33532625|NCT00490971|101849593|FG002|Maintenance|Death|0|||
33532626|NCT00490971|101849594|FG003|Maintenance|Death|2|||
33532627|NCT00490971|101849595|FG004|Maintenance|Death|0|||
33532628|NCT00490971|101849591|FG000|Maintenance|Lost to Follow-up|0|||
33532629|NCT00490971|101849592|FG001|Maintenance|Lost to Follow-up|0|||
33532630|NCT00490971|101849593|FG002|Maintenance|Lost to Follow-up|5|||
33532631|NCT00490971|101849594|FG003|Maintenance|Lost to Follow-up|8|||
33532632|NCT00490971|101849595|FG004|Maintenance|Lost to Follow-up|10|||
33532633|NCT00490971|101849591|FG000|Maintenance|Pregnancy|0|||
33532634|NCT00490971|101849592|FG001|Maintenance|Pregnancy|0|||
33532635|NCT00490971|101849593|FG002|Maintenance|Pregnancy|1|||
33532636|NCT00490971|101849594|FG003|Maintenance|Pregnancy|0|||
33532637|NCT00490971|101849595|FG004|Maintenance|Pregnancy|0|||
33532638|NCT00490971|101849591|FG000|Maintenance|Protocol Violation|0|||
33532639|NCT00490971|101849592|FG001|Maintenance|Protocol Violation|0|||
33532640|NCT00490971|101849593|FG002|Maintenance|Protocol Violation|4|||
33532641|NCT00490971|101849594|FG003|Maintenance|Protocol Violation|1|||
33532642|NCT00490971|101849595|FG004|Maintenance|Protocol Violation|1|||
33532643|NCT00490971|101849591|FG000|Maintenance|Withdrawal by Subject|0|||
33532644|NCT00490971|101849592|FG001|Maintenance|Withdrawal by Subject|0|||
33532645|NCT00490971|101849593|FG002|Maintenance|Withdrawal by Subject|26|||
33532646|NCT00490971|101849594|FG003|Maintenance|Withdrawal by Subject|28|||
33532647|NCT00490971|101849595|FG004|Maintenance|Withdrawal by Subject|18|||
33532648|NCT00490971|101849591|FG000|Maintenance|Other|0|||
33532649|NCT00490971|101849592|FG001|Maintenance|Other|0|||
33532650|NCT00490971|101849593|FG002|Maintenance|Other|11|||
33532651|NCT00490971|101849594|FG003|Maintenance|Other|9|||
33404809|NCT00660816|101369617|FG001|Overall Study|Complicating Disease|1|||
33532652|NCT00490971|101849595|FG004|Maintenance|Other|3|||
33532653|NCT02504320|101849596|FG000|Treatment Period 1|Positive Drug Screen|0|||
33532654|NCT02504320|101849597|FG001|Treatment Period 1|Positive Drug Screen|0|||
33532655|NCT02504320|101849598|FG002|Treatment Period 1|Positive Drug Screen|1|||
33532656|NCT02504320|101849599|FG003|Treatment Period 1|Positive Drug Screen|0|||
33532657|NCT02504320|101849596|FG000|Treatment Period 2|Positive Drug Screen|0|||
33532658|NCT02504320|101849597|FG001|Treatment Period 2|Positive Drug Screen|1|||
33532659|NCT02504320|101849598|FG002|Treatment Period 2|Positive Drug Screen|0|||
33532660|NCT02504320|101849599|FG003|Treatment Period 2|Positive Drug Screen|0|||
33532661|NCT02504320|101849596|FG000|Treatment Period 3|Positive Drug Screen|0|||
33532662|NCT02504320|101849597|FG001|Treatment Period 3|Positive Drug Screen|0|||
33532663|NCT02504320|101849598|FG002|Treatment Period 3|Positive Drug Screen|0|||
33205901|NCT03674177|100655877|FG003|Overall Study|Lost to Follow-up|2|||
33205902|NCT02460991|100655878|FG000|Overall Study|Withdrawal by Subject|0|||
33205903|NCT02460991|100655879|FG001|Overall Study|Withdrawal by Subject|2|||
33205904|NCT01343082|100655880|FG000|The run-in Period|Not meeting criteria|3|||
33205905|NCT01343082|100655881|FG001|The run-in Period|Not meeting criteria|4|||
33337396|NCT02706873|101128247|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
33205906|NCT01343082|100655882|FG002|The run-in Period|Not meeting criteria|5|||
33205907|NCT01343082|100655880|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
33337397|NCT02706873|101128248|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
33337398|NCT02706873|101128249|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
33337399|NCT02706873|101128250|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
33337400|NCT02706873|101128247|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
33337401|NCT02706873|101128248|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
33337402|NCT02706873|101128249|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
33337403|NCT02706873|101128250|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
33337404|NCT02706873|101128247|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
33532664|NCT02504320|101849599|FG003|Treatment Period 3|Positive Drug Screen|1|||
33532665|NCT02504320|101849596|FG000|Treatment Period 3|Adverse Event|0|||
33612794|NCT03100058|102133658|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
33205908|NCT01343082|100655881|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
33337405|NCT02706873|101128248|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
33205909|NCT01343082|100655882|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
33532666|NCT02504320|101849597|FG001|Treatment Period 3|Adverse Event|0|||
33404810|NCT02898662|101369621|FG000|Overall Study|Adverse Event|1|||
33532667|NCT02504320|101849598|FG002|Treatment Period 3|Adverse Event|1|||
33612795|NCT03100058|102133646|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33612796|NCT03100058|102133647|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33612797|NCT03100058|102133648|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33612798|NCT03100058|102133649|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33612799|NCT03100058|102133650|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33612800|NCT03100058|102133651|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33612801|NCT03100058|102133652|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33612802|NCT03100058|102133653|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33612803|NCT03100058|102133654|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33612804|NCT03100058|102133655|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33612805|NCT03100058|102133656|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
33612806|NCT03100058|102133657|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
33612807|NCT03100058|102133658|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
33612808|NCT03100058|102133646|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33612809|NCT03100058|102133647|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33612810|NCT03100058|102133648|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33404811|NCT02898662|101369622|FG001|Overall Study|Adverse Event|0|||
33532668|NCT02504320|101849599|FG003|Treatment Period 3|Adverse Event|0|||
33532669|NCT01683604|101849601|FG000|Overall Study|Adverse Event|2|||
33532670|NCT01683604|101849601|FG000|Overall Study|Lack of Efficacy|1|||
33532671|NCT01683604|101849601|FG000|Overall Study|Other|2|||
33532672|NCT01747499|101849602|FG000|Overall Study|Steroid refractory aGvHD|1|||
33532673|NCT01747499|101849603|FG001|Overall Study|Steroid refractory aGvHD|0|||
33532674|NCT01747499|101849604|FG002|Overall Study|Steroid refractory aGvHD|0|||
33532675|NCT01747499|101849605|FG003|Overall Study|Steroid refractory aGvHD|1|||
33532676|NCT01747499|101849606|FG004|Overall Study|Steroid refractory aGvHD|4|||
33532677|NCT01747499|101849602|FG000|Overall Study|Physician Decision|0|||
33532678|NCT01747499|101849603|FG001|Overall Study|Physician Decision|1|||
33532679|NCT01747499|101849604|FG002|Overall Study|Physician Decision|0|||
33612811|NCT03100058|102133649|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33404812|NCT02898662|101369621|FG000|Overall Study|Loss of asthma control|23|||
33532680|NCT01747499|101849605|FG003|Overall Study|Physician Decision|0|||
33404813|NCT02898662|101369622|FG001|Overall Study|Loss of asthma control|24|||
33532681|NCT01747499|101849606|FG004|Overall Study|Physician Decision|2|||
33532682|NCT01747499|101849602|FG000|Overall Study|Death|0|||
33612812|NCT03100058|102133650|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33612813|NCT03100058|102133651|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33612814|NCT03100058|102133652|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33612815|NCT03100058|102133653|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33532683|NCT01747499|101849603|FG001|Overall Study|Death|0|||
33532684|NCT01747499|101849604|FG002|Overall Study|Death|0|||
33532685|NCT01747499|101849605|FG003|Overall Study|Death|1|||
33532686|NCT01747499|101849606|FG004|Overall Study|Death|1|||
33532687|NCT01747499|101849602|FG000|Overall Study|Withdrawal by Subject|0|||
33532688|NCT01747499|101849603|FG001|Overall Study|Withdrawal by Subject|0|||
33532689|NCT01747499|101849604|FG002|Overall Study|Withdrawal by Subject|0|||
33532690|NCT01747499|101849605|FG003|Overall Study|Withdrawal by Subject|0|||
33532691|NCT01747499|101849606|FG004|Overall Study|Withdrawal by Subject|6|||
33532692|NCT01747499|101849602|FG000|Overall Study|Developed AML and death|0|||
33532693|NCT01747499|101849603|FG001|Overall Study|Developed AML and death|0|||
33532694|NCT01747499|101849604|FG002|Overall Study|Developed AML and death|0|||
33532695|NCT01747499|101849605|FG003|Overall Study|Developed AML and death|0|||
33532696|NCT01747499|101849606|FG004|Overall Study|Developed AML and death|1|||
33532697|NCT01747499|101849602|FG000|Overall Study|Determined not to be eligible|0|||
33532698|NCT01747499|101849603|FG001|Overall Study|Determined not to be eligible|0|||
33532699|NCT01747499|101849604|FG002|Overall Study|Determined not to be eligible|0|||
33532700|NCT01747499|101849605|FG003|Overall Study|Determined not to be eligible|0|||
33532701|NCT01747499|101849606|FG004|Overall Study|Determined not to be eligible|1|||
33532702|NCT03506438|101849607|FG000|Overall Study|Lost to Follow-up|8|||
33532703|NCT03506438|101849608|FG001|Overall Study|Lost to Follow-up|7|||
33532704|NCT03506438|101849609|FG002|Overall Study|Lost to Follow-up|8|||
33532705|NCT03506438|101849610|FG003|Overall Study|Lost to Follow-up|7|||
33532706|NCT03506438|101849611|FG004|Overall Study|Lost to Follow-up|0|||
33532707|NCT03506438|101849612|FG005|Overall Study|Lost to Follow-up|0|||
33532708|NCT03075267|101849616|FG000|Overall Study|Protocol Violation|1|||
33532709|NCT03075267|101849617|FG001|Overall Study|Protocol Violation|0|||
33532710|NCT03075267|101849618|FG002|Overall Study|Protocol Violation|0|||
33532711|NCT03146741|101849619|FG000|Overall Study|Txp with non-HCV+ heart|4|||
33532712|NCT03146741|101849619|FG000|Overall Study|Listeted for MOT|2|||
33532713|NCT03146741|101849619|FG000|Overall Study|Physician Decision|2|||
33532714|NCT03146741|101849619|FG000|Overall Study|Awaiting txp|2|||
33532715|NCT03498313|101849620|FG000|Experimental Period 1|Adverse Event|1|||
33532716|NCT03498313|101849621|FG001|Experimental Period 1|Adverse Event|0|||
33532717|NCT03498313|101849622|FG002|Experimental Period 1|Adverse Event|0|||
33532718|NCT03498313|101849623|FG003|Experimental Period 1|Adverse Event|1|||
33532719|NCT03498313|101849624|FG004|Experimental Period 1|Adverse Event|0|||
33532720|NCT03498313|101849625|FG005|Experimental Period 1|Adverse Event|0|||
33532721|NCT03498313|101849620|FG000|Experimental Period 1|Withdrawal by Subject|0|||
33532722|NCT03498313|101849621|FG001|Experimental Period 1|Withdrawal by Subject|1|||
33532723|NCT03498313|101849622|FG002|Experimental Period 1|Withdrawal by Subject|0|||
33532724|NCT03498313|101849623|FG003|Experimental Period 1|Withdrawal by Subject|0|||
33532725|NCT03498313|101849624|FG004|Experimental Period 1|Withdrawal by Subject|0|||
33532726|NCT03498313|101849625|FG005|Experimental Period 1|Withdrawal by Subject|0|||
33532727|NCT03498313|101849620|FG000|Washout Period 1|Anovulation|1|||
33532728|NCT03498313|101849621|FG001|Washout Period 1|Anovulation|0|||
33532729|NCT03498313|101849622|FG002|Washout Period 1|Anovulation|0|||
33532730|NCT03498313|101849623|FG003|Washout Period 1|Anovulation|0|||
33532731|NCT03498313|101849624|FG004|Washout Period 1|Anovulation|0|||
33532732|NCT03498313|101849625|FG005|Washout Period 1|Anovulation|0|||
33532733|NCT03498313|101849620|FG000|Washout Period 1|Withdrawal by Subject|0|||
33337406|NCT02706873|101128249|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
33532734|NCT03498313|101849621|FG001|Washout Period 1|Withdrawal by Subject|3|||
33532735|NCT03498313|101849622|FG002|Washout Period 1|Withdrawal by Subject|0|||
33532736|NCT03498313|101849623|FG003|Washout Period 1|Withdrawal by Subject|1|||
33532737|NCT03498313|101849624|FG004|Washout Period 1|Withdrawal by Subject|0|||
33532738|NCT03498313|101849625|FG005|Washout Period 1|Withdrawal by Subject|1|||
33612816|NCT03100058|102133654|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33612817|NCT03100058|102133655|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
33612818|NCT03100058|102133656|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
33612819|NCT03100058|102133657|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
33612820|NCT03100058|102133658|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
33612821|NCT03100058|102133646|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33612822|NCT03100058|102133647|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33532739|NCT03498313|101849620|FG000|Experimental Period 2|Adverse Event|0|||
33532740|NCT03498313|101849621|FG001|Experimental Period 2|Adverse Event|0|||
33532741|NCT03498313|101849622|FG002|Experimental Period 2|Adverse Event|0|||
33532742|NCT03498313|101849623|FG003|Experimental Period 2|Adverse Event|0|||
33532743|NCT03498313|101849624|FG004|Experimental Period 2|Adverse Event|1|||
33532744|NCT03498313|101849625|FG005|Experimental Period 2|Adverse Event|2|||
33532745|NCT03498313|101849620|FG000|Washout Period 2|Physician Decision|1|||
33532746|NCT03498313|101849621|FG001|Washout Period 2|Physician Decision|0|||
33532747|NCT03498313|101849622|FG002|Washout Period 2|Physician Decision|0|||
33532748|NCT03498313|101849623|FG003|Washout Period 2|Physician Decision|1|||
33532749|NCT03498313|101849624|FG004|Washout Period 2|Physician Decision|0|||
33612823|NCT03100058|102133648|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33612824|NCT03100058|102133649|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33612825|NCT03100058|102133650|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33404814|NCT02898662|101369621|FG000|Overall Study|Withdrawal by Subject|4|||
33404815|NCT02898662|101369622|FG001|Overall Study|Withdrawal by Subject|1|||
33404816|NCT02898662|101369621|FG000|Overall Study|Technical issue|0|||
33612826|NCT03100058|102133651|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33612827|NCT03100058|102133652|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33612828|NCT03100058|102133653|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33612829|NCT03100058|102133654|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33612830|NCT03100058|102133655|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33612831|NCT03100058|102133656|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
33612832|NCT03100058|102133657|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33612833|NCT03100058|102133658|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
33612834|NCT03100058|102133646|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33612835|NCT03100058|102133647|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33612836|NCT03100058|102133648|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33612837|NCT03100058|102133649|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33612838|NCT03100058|102133650|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33612839|NCT03100058|102133651|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33612840|NCT03100058|102133652|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33404817|NCT02898662|101369622|FG001|Overall Study|Technical issue|1|||
33404818|NCT02898662|101369621|FG000|Overall Study|Randomized in error|0|||
33404819|NCT02898662|101369622|FG001|Overall Study|Randomized in error|1|||
33404820|NCT02898662|101369621|FG000|Overall Study|Subject decision|1|||
33404821|NCT02898662|101369622|FG001|Overall Study|Subject decision|0|||
33404822|NCT02898662|101369621|FG000|Overall Study|Other|0|||
33404823|NCT02898662|101369622|FG001|Overall Study|Other|1|||
33404824|NCT00950755|101369623|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
33404825|NCT00950755|101369623|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
33404826|NCT00950755|101369623|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
33404827|NCT00950755|101369623|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
33404828|NCT00950755|101369623|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
33612841|NCT03100058|102133653|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33404829|NCT00950755|101369623|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
33404830|NCT00950755|101369623|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
33532750|NCT03498313|101849625|FG005|Washout Period 2|Physician Decision|1|||
33532751|NCT03498313|101849620|FG000|Washout Period 2|Withdrawal by Subject|3|||
33205910|NCT01343082|100655880|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
33205911|NCT01343082|100655881|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
33205912|NCT01343082|100655882|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
33205913|NCT01343082|100655880|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
33205914|NCT01343082|100655881|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
33205915|NCT01343082|100655882|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
33205916|NCT01343082|100655880|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
33205917|NCT01343082|100655881|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
33205918|NCT01343082|100655882|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
33404831|NCT00950755|101369623|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
33404832|NCT00950755|101369623|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
33404833|NCT00950755|101369623|FG000|Long-Term Follow-Up|Death|8|||
33404834|NCT02906644|101369626|FG000|First 2 Weeks|Withdrawal by Subject|0|||
33404835|NCT02906644|101369627|FG001|First 2 Weeks|Withdrawal by Subject|2|||
33404836|NCT02906644|101369626|FG000|First 2 Weeks|Physician Decision|1|||
33404837|NCT02906644|101369627|FG001|First 2 Weeks|Physician Decision|1|||
33404838|NCT02906644|101369626|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
33404839|NCT02906644|101369627|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
33404840|NCT02906644|101369626|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
33404841|NCT02906644|101369627|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
33404842|NCT01569568|101369628|FG000|Overall Study|Physician Decision|0|||
33404843|NCT01569568|101369629|FG001|Overall Study|Physician Decision|2|||
33404844|NCT02127931|101369630|FG000|Overall Study|Glitch in Game|1|||
33404845|NCT00302731|101369633|FG000|Overall Study|Lost to Follow-up|1|||
33404846|NCT00302731|101369634|FG001|Overall Study|Lost to Follow-up|2|||
33404847|NCT00302731|101369635|FG002|Overall Study|Lost to Follow-up|0|||
33404848|NCT00302731|101369636|FG003|Overall Study|Lost to Follow-up|0|||
33404849|NCT00302731|101369633|FG000|Overall Study|Adverse Event|0|||
33404850|NCT00302731|101369634|FG001|Overall Study|Adverse Event|2|||
33404851|NCT00302731|101369635|FG002|Overall Study|Adverse Event|2|||
33404852|NCT00302731|101369636|FG003|Overall Study|Adverse Event|0|||
33404853|NCT00302731|101369633|FG000|Overall Study|Withdrawal by Subject|1|||
33404854|NCT00302731|101369634|FG001|Overall Study|Withdrawal by Subject|1|||
33404855|NCT00302731|101369635|FG002|Overall Study|Withdrawal by Subject|0|||
33404856|NCT00302731|101369636|FG003|Overall Study|Withdrawal by Subject|0|||
33404857|NCT00302731|101369633|FG000|Overall Study|Protocol Violation|1|||
33612842|NCT03100058|102133654|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33612843|NCT03100058|102133655|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33612844|NCT03100058|102133656|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33612845|NCT03100058|102133657|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
33612846|NCT03100058|102133658|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
33205919|NCT00407537|100655883|FG000|Overall Study|Death|5|||
33205920|NCT00407537|100655884|FG001|Overall Study|Death|2|||
33612847|NCT03100058|102133646|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33612848|NCT03100058|102133647|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33205921|NCT00407537|100655883|FG000|Overall Study|Adverse Event|36|||
33205922|NCT00407537|100655884|FG001|Overall Study|Adverse Event|0|||
33205923|NCT00407537|100655883|FG000|Overall Study|Lost to Follow-up|12|||
33205924|NCT00407537|100655884|FG001|Overall Study|Lost to Follow-up|19|||
33404858|NCT00302731|101369634|FG001|Overall Study|Protocol Violation|0|||
33205925|NCT00407537|100655883|FG000|Overall Study|Other|6|||
33205926|NCT00407537|100655884|FG001|Overall Study|Other|7|||
33205927|NCT00407537|100655883|FG000|Overall Study|Withdrawal by Subject|34|||
33404859|NCT00302731|101369635|FG002|Overall Study|Protocol Violation|0|||
33404860|NCT00302731|101369636|FG003|Overall Study|Protocol Violation|0|||
33404861|NCT00302731|101369633|FG000|Overall Study|cancer unrelated to study discovered|1|||
33404862|NCT00302731|101369634|FG001|Overall Study|cancer unrelated to study discovered|0|||
33205928|NCT00407537|100655884|FG001|Overall Study|Withdrawal by Subject|16|||
33205929|NCT01218438|100655889|FG000|Epoch 1|Physician Decision|2|||
33205930|NCT01218438|100655889|FG000|Epoch 1|Adverse Event|1|||
33205931|NCT01218438|100655889|FG000|Epoch 3|Withdrawal by Subject|3|||
33205932|NCT01218438|100655889|FG000|Epoch 3|Adverse Event|1|||
33205933|NCT01218438|100655889|FG000|Epoch 4|Physician Decision|1|||
33205934|NCT01218438|100655889|FG000|Epoch 4|Withdrawal by Subject|2|||
33205935|NCT03387852|100655890|FG000|Overall Study|Adverse event (AE)|3|||
33205936|NCT03387852|100655891|FG001|Overall Study|Adverse event (AE)|0|||
33205937|NCT03387852|100655892|FG002|Overall Study|Adverse event (AE)|2|||
33205938|NCT03387852|100655893|FG003|Overall Study|Adverse event (AE)|0|||
33205939|NCT03387852|100655890|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
33205940|NCT03387852|100655891|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
33205941|NCT03387852|100655892|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
33205942|NCT03387852|100655893|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
33205943|NCT03387852|100655890|FG000|Overall Study|Withdrawal by participant|1|||
33337407|NCT02706873|101128250|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
33337408|NCT02706873|101128247|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
33337409|NCT02706873|101128248|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
33337410|NCT02706873|101128249|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
33337411|NCT02706873|101128250|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
33337412|NCT02706873|101128247|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
33337413|NCT02706873|101128248|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
33337414|NCT02706873|101128249|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
33337415|NCT02706873|101128250|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
33337416|NCT02706873|101128247|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
33337417|NCT02706873|101128248|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
33337418|NCT02706873|101128249|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
33337419|NCT02706873|101128250|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
33337420|NCT02706873|101128247|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
33337421|NCT02706873|101128248|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
33337422|NCT02706873|101128249|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
33337423|NCT02706873|101128250|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
33404863|NCT00302731|101369635|FG002|Overall Study|cancer unrelated to study discovered|1|||
33205944|NCT03387852|100655891|FG001|Overall Study|Withdrawal by participant|1|||
33205945|NCT03387852|100655892|FG002|Overall Study|Withdrawal by participant|3|||
33205946|NCT03387852|100655893|FG003|Overall Study|Withdrawal by participant|2|||
33205947|NCT03387852|100655890|FG000|Overall Study|Other- Unspecified|1|||
33337424|NCT02706873|101128247|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
33337425|NCT02706873|101128248|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
33337426|NCT02706873|101128249|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
33205948|NCT03387852|100655891|FG001|Overall Study|Other- Unspecified|1|||
33205949|NCT03387852|100655892|FG002|Overall Study|Other- Unspecified|2|||
33205950|NCT03387852|100655893|FG003|Overall Study|Other- Unspecified|1|||
33205951|NCT03387852|100655890|FG000|Overall Study|Poor compliance to protocol|0|||
33205952|NCT03387852|100655891|FG001|Overall Study|Poor compliance to protocol|0|||
33205953|NCT03387852|100655892|FG002|Overall Study|Poor compliance to protocol|0|||
33205954|NCT03387852|100655893|FG003|Overall Study|Poor compliance to protocol|1|||
33205955|NCT03387852|100655890|FG000|Overall Study|Randomized and not treated|0|||
33205956|NCT03387852|100655891|FG001|Overall Study|Randomized and not treated|0|||
33205957|NCT03387852|100655892|FG002|Overall Study|Randomized and not treated|0|||
33205958|NCT03387852|100655893|FG003|Overall Study|Randomized and not treated|1|||
33205959|NCT00413153|100655894|FG000|Overall Study|Withdrawal by Subject|1|||
33205960|NCT00413153|100655895|FG001|Overall Study|Withdrawal by Subject|1|||
33205961|NCT00413153|100655894|FG000|Overall Study|Adverse Event|1|||
33205962|NCT00413153|100655895|FG001|Overall Study|Adverse Event|0|||
33205963|NCT03447769|100655898|FG000|Overall Study|Progressive disease|138|||
33205964|NCT03447769|100655899|FG001|Overall Study|Progressive disease|148|||
33205965|NCT03447769|100655898|FG000|Overall Study|Study terminated by Sponsor|60|||
33205966|NCT03447769|100655899|FG001|Overall Study|Study terminated by Sponsor|44|||
33205967|NCT03447769|100655898|FG000|Overall Study|Adverse Event|34|||
33205968|NCT03447769|100655899|FG001|Overall Study|Adverse Event|31|||
33205969|NCT03447769|100655898|FG000|Overall Study|Patient decision|27|||
33532752|NCT03498313|101849621|FG001|Washout Period 2|Withdrawal by Subject|2|||
33532753|NCT03498313|101849622|FG002|Washout Period 2|Withdrawal by Subject|0|||
33532754|NCT03498313|101849623|FG003|Washout Period 2|Withdrawal by Subject|0|||
33532755|NCT03498313|101849624|FG004|Washout Period 2|Withdrawal by Subject|2|||
33532756|NCT03498313|101849625|FG005|Washout Period 2|Withdrawal by Subject|0|||
33532757|NCT03498313|101849620|FG000|Washout Period 2|Anovulation|0|||
33532758|NCT03498313|101849621|FG001|Washout Period 2|Anovulation|0|||
33532759|NCT03498313|101849622|FG002|Washout Period 2|Anovulation|0|||
33404864|NCT00302731|101369636|FG003|Overall Study|cancer unrelated to study discovered|0|||
33532760|NCT03498313|101849623|FG003|Washout Period 2|Anovulation|0|||
33532761|NCT03498313|101849624|FG004|Washout Period 2|Anovulation|0|||
33532762|NCT03498313|101849625|FG005|Washout Period 2|Anovulation|1|||
33532763|NCT03421379|101849628|FG000|Period 1|Withdrawal by Subject|0|||
33612849|NCT03100058|102133648|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33612850|NCT03100058|102133649|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33612851|NCT03100058|102133650|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33612852|NCT03100058|102133651|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33612853|NCT03100058|102133652|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33205970|NCT03447769|100655899|FG001|Overall Study|Patient decision|27|||
33205971|NCT03447769|100655898|FG000|Overall Study|Protocol deviation|4|||
33205972|NCT03447769|100655899|FG001|Overall Study|Protocol deviation|6|||
33205973|NCT03447769|100655898|FG000|Overall Study|Death|2|||
33205974|NCT03447769|100655899|FG001|Overall Study|Death|7|||
33205975|NCT03447769|100655898|FG000|Overall Study|Technical problems|1|||
33205976|NCT03447769|100655899|FG001|Overall Study|Technical problems|0|||
33205977|NCT03447769|100655898|FG000|Overall Study|Lost to Follow-up|0|||
33205978|NCT03447769|100655899|FG001|Overall Study|Lost to Follow-up|1|||
33205979|NCT03447769|100655898|FG000|Overall Study|Physician Decision|13|||
33205980|NCT03447769|100655899|FG001|Overall Study|Physician Decision|5|||
33205981|NCT02159482|100655904|FG000|Overall Study|Withdrawal by Subject|2|||
33205982|NCT02159482|100655904|FG000|Overall Study|Physician Decision|3|||
33532764|NCT03421379|101849629|FG001|Period 1|Withdrawal by Subject|1|||
33205983|NCT03879798|100655905|FG000|Overall Study|Adverse Event|0|||
33205984|NCT03879798|100655906|FG001|Overall Study|Adverse Event|0|||
33532765|NCT03421379|101849628|FG000|Period 1|Physician Decision|1|||
33532766|NCT03421379|101849629|FG001|Period 1|Physician Decision|1|||
33532767|NCT03421379|101849628|FG000|Period 1|Did not receive treatment|1|||
33532768|NCT03421379|101849629|FG001|Period 1|Did not receive treatment|2|||
33532769|NCT02750332|101849630|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33532770|NCT02750332|101849631|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33532771|NCT00828113|101849633|FG000|Overall Study|Withdrawal by Subject|27|||
33532772|NCT00828113|101849634|FG001|Overall Study|Withdrawal by Subject|26|||
33532773|NCT00828113|101849633|FG000|Overall Study|Lost to Follow-up|3|||
33532774|NCT00828113|101849634|FG001|Overall Study|Lost to Follow-up|5|||
33532775|NCT02895347|101849635|FG000|Overall Study|Withdrawal by Subject|3|||
33532776|NCT02895347|101849636|FG001|Overall Study|Withdrawal by Subject|1|||
33532777|NCT04010461|101849638|FG000|Overall Study|COVID based withdrawal|5|||
33532778|NCT04010461|101849638|FG000|Overall Study|Withdrawal by Subject|5|||
33532779|NCT04010461|101849638|FG000|Overall Study|Adverse Event|1|||
33532780|NCT04010461|101849638|FG000|Overall Study|No Motor Threshold obtainable|1|||
33205985|NCT03879798|100655907|FG002|Overall Study|Adverse Event|0|||
33205986|NCT03879798|100655908|FG003|Overall Study|Adverse Event|0|||
33205987|NCT03879798|100655909|FG004|Overall Study|Adverse Event|0|||
33205988|NCT03879798|100655910|FG005|Overall Study|Adverse Event|1|||
33205989|NCT03879798|100655905|FG000|Overall Study|Lack of Efficacy|0|||
33205990|NCT03879798|100655906|FG001|Overall Study|Lack of Efficacy|0|||
33404865|NCT00689299|101369639|FG000|Overall Study|Adverse Event|2|||
33532781|NCT04010461|101849638|FG000|Overall Study|Physician Decision|1|||
33532782|NCT00424593|101849639|FG000|Acute Double-Blind Period|Adverse Event|16|||
33532783|NCT00424593|101849640|FG001|Acute Double-Blind Period|Adverse Event|7|||
33532784|NCT00424593|101849639|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
33532785|NCT00424593|101849640|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
33532786|NCT00424593|101849639|FG000|Acute Double-Blind Period|Protocol Violation|2|||
33532787|NCT00424593|101849640|FG001|Acute Double-Blind Period|Protocol Violation|2|||
33532788|NCT00424593|101849639|FG000|Acute Double-Blind Period|Physician Decision|1|||
33532789|NCT00424593|101849640|FG001|Acute Double-Blind Period|Physician Decision|2|||
33532790|NCT00424593|101849639|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
33532791|NCT00424593|101849640|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
33532792|NCT00424593|101849639|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
33532793|NCT00424593|101849640|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
33532794|NCT00424593|101849639|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
33532795|NCT00424593|101849640|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
33532796|NCT00424593|101849639|FG000|Dose-Blind Extension Period|Adverse Event|18|||
33532797|NCT00424593|101849640|FG001|Dose-Blind Extension Period|Adverse Event|0|||
33532798|NCT00424593|101849639|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
33532799|NCT00424593|101849640|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
33532800|NCT00424593|101849639|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
33532801|NCT00424593|101849640|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
33532802|NCT00424593|101849639|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
33532803|NCT00424593|101849640|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
33532804|NCT00424593|101849639|FG000|Dose-Blind Extension Period|Physician Decision|3|||
33532805|NCT00424593|101849640|FG001|Dose-Blind Extension Period|Physician Decision|0|||
33532806|NCT01909804|101849641|FG000|Overall Study|Randomized but Never Treated|0|||
33532807|NCT01909804|101849642|FG001|Overall Study|Randomized but Never Treated|0|||
33532808|NCT01909804|101849643|FG002|Overall Study|Randomized but Never Treated|0|||
33532809|NCT01909804|101849644|FG003|Overall Study|Randomized but Never Treated|0|||
33532810|NCT01909804|101849645|FG004|Overall Study|Randomized but Never Treated|0|||
33532811|NCT01909804|101849646|FG005|Overall Study|Randomized but Never Treated|0|||
33612854|NCT03100058|102133653|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33612855|NCT03100058|102133654|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33612856|NCT03100058|102133655|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
33612857|NCT03100058|102133656|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33612858|NCT03100058|102133657|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33205991|NCT03879798|100655907|FG002|Overall Study|Lack of Efficacy|0|||
33205992|NCT03879798|100655908|FG003|Overall Study|Lack of Efficacy|0|||
33205993|NCT03879798|100655909|FG004|Overall Study|Lack of Efficacy|0|||
33205994|NCT03879798|100655910|FG005|Overall Study|Lack of Efficacy|1|||
33205995|NCT03879798|100655905|FG000|Overall Study|Withdrawal by Subject|0|||
33205996|NCT03879798|100655906|FG001|Overall Study|Withdrawal by Subject|0|||
33404866|NCT00689299|101369640|FG001|Overall Study|Adverse Event|1|||
33532812|NCT01909804|101849647|FG006|Overall Study|Randomized but Never Treated|1|||
33532813|NCT01909804|101849648|FG007|Overall Study|Randomized but Never Treated|0|||
33532814|NCT01909804|101849649|FG008|Overall Study|Randomized but Never Treated|0|||
33532815|NCT01909804|101849650|FG009|Overall Study|Randomized but Never Treated|0|||
33532816|NCT01909804|101849651|FG010|Overall Study|Randomized but Never Treated|0|||
33532817|NCT01909804|101849652|FG011|Overall Study|Randomized but Never Treated|1|||
33532818|NCT01909804|101849641|FG000|Overall Study|Death|0|||
33532819|NCT01909804|101849642|FG001|Overall Study|Death|0|||
33532820|NCT01909804|101849643|FG002|Overall Study|Death|0|||
33532821|NCT01909804|101849644|FG003|Overall Study|Death|0|||
33532822|NCT01909804|101849645|FG004|Overall Study|Death|0|||
33532823|NCT01909804|101849646|FG005|Overall Study|Death|0|||
33532824|NCT01909804|101849647|FG006|Overall Study|Death|0|||
33532825|NCT01909804|101849648|FG007|Overall Study|Death|0|||
33532826|NCT01909804|101849649|FG008|Overall Study|Death|0|||
33532827|NCT01909804|101849650|FG009|Overall Study|Death|0|||
33532828|NCT01909804|101849651|FG010|Overall Study|Death|1|||
33532829|NCT01909804|101849652|FG011|Overall Study|Death|0|||
33532830|NCT01909804|101849641|FG000|Overall Study|Lack of Efficacy|4|||
33532831|NCT01909804|101849642|FG001|Overall Study|Lack of Efficacy|1|||
33532832|NCT01909804|101849643|FG002|Overall Study|Lack of Efficacy|0|||
33532833|NCT01909804|101849644|FG003|Overall Study|Lack of Efficacy|0|||
33532834|NCT01909804|101849645|FG004|Overall Study|Lack of Efficacy|7|||
33532835|NCT01909804|101849646|FG005|Overall Study|Lack of Efficacy|3|||
33532836|NCT01909804|101849647|FG006|Overall Study|Lack of Efficacy|1|||
33532837|NCT01909804|101849648|FG007|Overall Study|Lack of Efficacy|1|||
33532838|NCT01909804|101849649|FG008|Overall Study|Lack of Efficacy|0|||
33532839|NCT01909804|101849650|FG009|Overall Study|Lack of Efficacy|1|||
33532840|NCT01909804|101849651|FG010|Overall Study|Lack of Efficacy|0|||
33532841|NCT01909804|101849652|FG011|Overall Study|Lack of Efficacy|1|||
33532842|NCT01909804|101849641|FG000|Overall Study|Withdrew Consent|0|||
33532843|NCT01909804|101849642|FG001|Overall Study|Withdrew Consent|0|||
33532844|NCT01909804|101849643|FG002|Overall Study|Withdrew Consent|0|||
33337427|NCT02706873|101128250|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
33532845|NCT01909804|101849644|FG003|Overall Study|Withdrew Consent|0|||
33532846|NCT01909804|101849645|FG004|Overall Study|Withdrew Consent|1|||
33532847|NCT01909804|101849646|FG005|Overall Study|Withdrew Consent|1|||
33532848|NCT01909804|101849647|FG006|Overall Study|Withdrew Consent|0|||
33532849|NCT01909804|101849648|FG007|Overall Study|Withdrew Consent|0|||
33532850|NCT01909804|101849649|FG008|Overall Study|Withdrew Consent|0|||
33532851|NCT01909804|101849650|FG009|Overall Study|Withdrew Consent|0|||
33205997|NCT03879798|100655907|FG002|Overall Study|Withdrawal by Subject|0|||
33205998|NCT03879798|100655908|FG003|Overall Study|Withdrawal by Subject|0|||
33205999|NCT03879798|100655909|FG004|Overall Study|Withdrawal by Subject|0|||
33206000|NCT03879798|100655910|FG005|Overall Study|Withdrawal by Subject|1|||
33206001|NCT00511004|100655911|FG000|Overall Study|Lost to Follow-up|0|||
33206002|NCT00511004|100655912|FG001|Overall Study|Lost to Follow-up|0|||
33206003|NCT00511004|100655913|FG002|Overall Study|Lost to Follow-up|4|||
33206004|NCT00744653|100655914|FG000|Overall Study|antineoplastic treatment|11|||
33206005|NCT00744653|100655914|FG000|Overall Study|Death|1|||
33206006|NCT00744653|100655914|FG000|Overall Study|Lost to Follow-up|1|||
33206007|NCT00744653|100655914|FG000|Overall Study|Physician Decision|3|||
33206008|NCT00360308|100655915|FG000|Overall Study|Adverse Event|15|||
33206009|NCT00360308|100655916|FG001|Overall Study|Adverse Event|14|||
33206010|NCT00360308|100655917|FG002|Overall Study|Adverse Event|25|||
33206011|NCT00360308|100655915|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
33206012|NCT00360308|100655916|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
33206013|NCT00360308|100655917|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
33404867|NCT00689299|101369641|FG002|Overall Study|Adverse Event|1|||
33404868|NCT00689299|101369639|FG000|Overall Study|Lost to Follow-up|0|||
33404869|NCT00689299|101369640|FG001|Overall Study|Lost to Follow-up|1|||
33404870|NCT00689299|101369641|FG002|Overall Study|Lost to Follow-up|1|||
33404871|NCT00689299|101369639|FG000|Overall Study|Withdrawal by Subject|4|||
33532852|NCT01909804|101849651|FG010|Overall Study|Withdrew Consent|0|||
33532853|NCT01909804|101849652|FG011|Overall Study|Withdrew Consent|0|||
33532854|NCT01909804|101849641|FG000|Overall Study|Protocol Violation|0|||
33532855|NCT01909804|101849642|FG001|Overall Study|Protocol Violation|0|||
33532856|NCT01909804|101849643|FG002|Overall Study|Protocol Violation|0|||
33532857|NCT01909804|101849644|FG003|Overall Study|Protocol Violation|0|||
33532858|NCT01909804|101849645|FG004|Overall Study|Protocol Violation|0|||
33532859|NCT01909804|101849646|FG005|Overall Study|Protocol Violation|0|||
33532860|NCT01909804|101849647|FG006|Overall Study|Protocol Violation|0|||
33532861|NCT01909804|101849648|FG007|Overall Study|Protocol Violation|0|||
33532862|NCT01909804|101849649|FG008|Overall Study|Protocol Violation|0|||
33532863|NCT01909804|101849650|FG009|Overall Study|Protocol Violation|0|||
33532864|NCT01909804|101849651|FG010|Overall Study|Protocol Violation|0|||
33532865|NCT01909804|101849652|FG011|Overall Study|Protocol Violation|1|||
33532866|NCT02595502|101849662|FG000|Period 1|Adverse Event|0|||
33532867|NCT02595502|101849663|FG001|Period 1|Adverse Event|1|||
33532868|NCT02595502|101849662|FG000|Period 1|Withdrawal by Subject|1|||
33532869|NCT02595502|101849663|FG001|Period 1|Withdrawal by Subject|0|||
33532870|NCT02595502|101849662|FG000|Period 1|Lost to Follow-up|0|||
33532871|NCT02595502|101849663|FG001|Period 1|Lost to Follow-up|1|||
33532872|NCT02595502|101849662|FG000|Period 2|Adverse Event|1|||
33532873|NCT02595502|101849663|FG001|Period 2|Adverse Event|1|||
33532874|NCT02595502|101849662|FG000|Period 2|Received incorrect lens at Period 1|0|||
33532875|NCT02595502|101849663|FG001|Period 2|Received incorrect lens at Period 1|1|||
33532876|NCT02595502|101849662|FG000|Period 3|Protocol Violation|0|||
33532877|NCT02595502|101849663|FG001|Period 3|Protocol Violation|1|||
33532878|NCT02595502|101849662|FG000|Period 3|Lost to Follow-up|1|||
33532879|NCT02595502|101849663|FG001|Period 3|Lost to Follow-up|0|||
33532880|NCT02595502|101849662|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
33532881|NCT02595502|101849663|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
33532882|NCT00485069|101849667|FG000|Overall Study|Adverse Event|10|||
33532883|NCT00485069|101849668|FG001|Overall Study|Adverse Event|4|||
33532884|NCT00485069|101849667|FG000|Overall Study|Lack of Efficacy|2|||
33532885|NCT00485069|101849668|FG001|Overall Study|Lack of Efficacy|1|||
33532886|NCT00485069|101849667|FG000|Overall Study|Protocol Violation|0|||
33532887|NCT00485069|101849668|FG001|Overall Study|Protocol Violation|1|||
33532888|NCT00485069|101849667|FG000|Overall Study|Withdrawal by Subject|6|||
33532889|NCT00485069|101849668|FG001|Overall Study|Withdrawal by Subject|6|||
33532890|NCT04131712|101849669|FG000|Overall Study|COVID related|0|||
33532891|NCT04131712|101849670|FG001|Overall Study|COVID related|0|||
33532892|NCT04131712|101849671|FG002|Overall Study|COVID related|2|||
33532893|NCT04131712|101849672|FG003|Overall Study|COVID related|0|||
33532894|NCT04131712|101849669|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
33206014|NCT00360308|100655915|FG000|Overall Study|Protocol Violation|2|||
33206015|NCT00360308|100655916|FG001|Overall Study|Protocol Violation|1|||
33206016|NCT00360308|100655917|FG002|Overall Study|Protocol Violation|2|||
33206017|NCT00360308|100655915|FG000|Overall Study|Withdrawal by Subject|11|||
33206018|NCT00360308|100655916|FG001|Overall Study|Withdrawal by Subject|7|||
33404872|NCT00689299|101369640|FG001|Overall Study|Withdrawal by Subject|1|||
33532895|NCT04131712|101849670|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
33532896|NCT04131712|101849671|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
33206019|NCT00360308|100655917|FG002|Overall Study|Withdrawal by Subject|14|||
33532897|NCT04131712|101849672|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
33532898|NCT00627497|101849673|FG000|Overall Study|Lost to Follow-up|1|||
33532899|NCT00627497|101849674|FG001|Overall Study|Lost to Follow-up|1|||
33532900|NCT00627497|101849675|FG002|Overall Study|Lost to Follow-up|0|||
33532901|NCT00627497|101849676|FG003|Overall Study|Lost to Follow-up|0|||
33532902|NCT05502302|101849677|FG000|Overall Study|Lost to Follow-up|6|||
33532903|NCT05502302|101849677|FG000|Overall Study|Death|2|||
33532904|NCT00305227|101849678|FG000|Overall Study|Lost to Follow-up|7|||
33532905|NCT00305227|101849679|FG001|Overall Study|Lost to Follow-up|6|||
33532906|NCT04435808|101849680|FG000|Overall Study|Study stopped by DSMB|0|||
33532907|NCT04435808|101849681|FG001|Overall Study|Study stopped by DSMB|1|||
33532908|NCT01081626|101849682|FG000|Overall Study|Dosing error|1|||
33532909|NCT01081626|101849683|FG001|Overall Study|Dosing error|1|||
33532910|NCT01081626|101849682|FG000|Overall Study|Missing Estradiol|25|||
33532911|NCT01081626|101849683|FG001|Overall Study|Missing Estradiol|28|||
33532912|NCT01081626|101849682|FG000|Overall Study|Low antral follicle count|1|||
33532913|NCT01081626|101849683|FG001|Overall Study|Low antral follicle count|0|||
33532914|NCT01081626|101849682|FG000|Overall Study|Overstimulation|0|||
33532915|NCT01081626|101849683|FG001|Overall Study|Overstimulation|1|||
33532916|NCT01081626|101849682|FG000|Overall Study|Lost to Follow-up|0|||
33532917|NCT01081626|101849683|FG001|Overall Study|Lost to Follow-up|1|||
33532918|NCT01081626|101849682|FG000|Overall Study|Other|33|||
33532919|NCT01081626|101849683|FG001|Overall Study|Other|30|||
33532920|NCT01029262|101849684|FG000|Overall Study|Adverse Event|9|||
33532921|NCT01029262|101849685|FG001|Overall Study|Adverse Event|52|||
33532922|NCT01029262|101849684|FG000|Overall Study|Lack of therapeutic effect|57|||
33532923|NCT01029262|101849685|FG001|Overall Study|Lack of therapeutic effect|76|||
33532924|NCT01029262|101849684|FG000|Overall Study|Withdrawal by Subject|10|||
33532925|NCT01029262|101849685|FG001|Overall Study|Withdrawal by Subject|17|||
33532926|NCT01029262|101849684|FG000|Overall Study|Protocol Violation|2|||
33532927|NCT01029262|101849685|FG001|Overall Study|Protocol Violation|3|||
33532928|NCT01029262|101849684|FG000|Overall Study|Miscellaneous|1|||
33532929|NCT01029262|101849685|FG001|Overall Study|Miscellaneous|9|||
33532930|NCT01029262|101849684|FG000|Overall Study|Death|0|||
33532931|NCT01029262|101849685|FG001|Overall Study|Death|3|||
33532932|NCT04378569|101849686|FG000|Overall Study|Adverse Event|0|||
33532933|NCT04378569|101849687|FG001|Overall Study|Adverse Event|0|||
33532934|NCT04378569|101849688|FG002|Overall Study|Adverse Event|2|||
33532935|NCT04378569|101849689|FG003|Overall Study|Adverse Event|0|||
33532936|NCT04378569|101849690|FG004|Overall Study|Adverse Event|3|||
33532937|NCT04378569|101849691|FG005|Overall Study|Adverse Event|3|||
33532938|NCT04378569|101849686|FG000|Overall Study|Lost to Follow-up|0|||
33532939|NCT04378569|101849687|FG001|Overall Study|Lost to Follow-up|3|||
33532940|NCT04378569|101849688|FG002|Overall Study|Lost to Follow-up|1|||
33532941|NCT04378569|101849689|FG003|Overall Study|Lost to Follow-up|0|||
33532942|NCT04378569|101849690|FG004|Overall Study|Lost to Follow-up|1|||
33532943|NCT04378569|101849691|FG005|Overall Study|Lost to Follow-up|1|||
33532944|NCT04378569|101849686|FG000|Overall Study|Protocol Violation|0|||
33532945|NCT04378569|101849687|FG001|Overall Study|Protocol Violation|0|||
33532946|NCT04378569|101849688|FG002|Overall Study|Protocol Violation|0|||
33532947|NCT04378569|101849689|FG003|Overall Study|Protocol Violation|0|||
33532948|NCT04378569|101849690|FG004|Overall Study|Protocol Violation|0|||
33532949|NCT04378569|101849691|FG005|Overall Study|Protocol Violation|1|||
33532950|NCT04378569|101849686|FG000|Overall Study|Withdrawal by Subject|0|||
33532951|NCT04378569|101849687|FG001|Overall Study|Withdrawal by Subject|6|||
33532952|NCT04378569|101849688|FG002|Overall Study|Withdrawal by Subject|7|||
33532953|NCT04378569|101849689|FG003|Overall Study|Withdrawal by Subject|4|||
33532954|NCT04378569|101849690|FG004|Overall Study|Withdrawal by Subject|5|||
33532955|NCT04378569|101849691|FG005|Overall Study|Withdrawal by Subject|4|||
33532956|NCT04378569|101849686|FG000|Overall Study|Lack of response|0|||
33532957|NCT04378569|101849687|FG001|Overall Study|Lack of response|0|||
33532958|NCT04378569|101849688|FG002|Overall Study|Lack of response|1|||
33532959|NCT04378569|101849689|FG003|Overall Study|Lack of response|0|||
33532960|NCT04378569|101849690|FG004|Overall Study|Lack of response|1|||
33532961|NCT04378569|101849691|FG005|Overall Study|Lack of response|1|||
33532962|NCT01806168|101849693|FG000|Overall Study|Adverse Event|1|||
33532963|NCT01806168|101849694|FG001|Overall Study|Adverse Event|0|||
33532964|NCT01806168|101849695|FG002|Overall Study|Adverse Event|0|||
33532965|NCT01806168|101849693|FG000|Overall Study|Withdrawal by Subject|0|||
33532966|NCT01806168|101849694|FG001|Overall Study|Withdrawal by Subject|1|||
33532967|NCT01806168|101849695|FG002|Overall Study|Withdrawal by Subject|2|||
33532968|NCT01806168|101849693|FG000|Overall Study|Protocol Violation|0|||
33532969|NCT01806168|101849694|FG001|Overall Study|Protocol Violation|0|||
33532970|NCT01806168|101849695|FG002|Overall Study|Protocol Violation|1|||
33532971|NCT03193047|101849696|FG000|Overall Study|Physician Decision|1|||
33532972|NCT03193047|101849697|FG001|Overall Study|Physician Decision|0|||
33532973|NCT03193047|101849696|FG000|Overall Study|Participant Left State|1|||
33532974|NCT03193047|101849697|FG001|Overall Study|Participant Left State|0|||
33532975|NCT01261390|101849706|FG000|Overall Study|Significant Concurrent Illness|1|||
33532976|NCT01261390|101849707|FG001|Overall Study|Significant Concurrent Illness|0|||
33532977|NCT01261390|101849708|FG002|Overall Study|Significant Concurrent Illness|1|||
33532978|NCT01261390|101849709|FG003|Overall Study|Significant Concurrent Illness|0|||
33612859|NCT03100058|102133658|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
33612860|NCT00448747|102133659|FG000|Overall Study|collapsed veins|1|||
33612861|NCT00448747|102133660|FG001|Overall Study|collapsed veins|0|||
33612862|NCT04440813|102133661|FG000|Overall Study|Lost to Follow-up|5|||
33612863|NCT04440813|102133662|FG001|Overall Study|Lost to Follow-up|5|||
33612864|NCT03781778|102133663|FG000|Overall Study|Withdrawal by Subject|2|||
33612865|NCT03781778|102133664|FG001|Overall Study|Withdrawal by Subject|2|||
33612866|NCT00416455|102133665|FG000|Overall Study|PET / CT not done|3|||
33612867|NCT00416455|102133666|FG001|Overall Study|PET / CT not done|5|||
33612868|NCT00416455|102133665|FG000|Overall Study|PET / CT poor quality|2|||
33612869|NCT00416455|102133666|FG001|Overall Study|PET / CT poor quality|1|||
33612870|NCT00416455|102133665|FG000|Overall Study|Inadequate pathology|11|||
33612871|NCT00416455|102133666|FG001|Overall Study|Inadequate pathology|2|||
33612872|NCT03214406|102133671|FG000|Overall Study|did not meet enrollment criteria|9|||
33404873|NCT00689299|101369641|FG002|Overall Study|Withdrawal by Subject|3|||
33404874|NCT00689299|101369639|FG000|Overall Study|Protocol Violation|1|||
33532979|NCT01261390|101849706|FG000|Overall Study|Dissatisfaction with Treatment|2|||
33532980|NCT01261390|101849707|FG001|Overall Study|Dissatisfaction with Treatment|1|||
33532981|NCT01261390|101849708|FG002|Overall Study|Dissatisfaction with Treatment|1|||
33532982|NCT01261390|101849709|FG003|Overall Study|Dissatisfaction with Treatment|2|||
33532983|NCT01261390|101849706|FG000|Overall Study|Relocation|0|||
33532984|NCT01261390|101849707|FG001|Overall Study|Relocation|1|||
33532985|NCT01261390|101849708|FG002|Overall Study|Relocation|0|||
33532986|NCT01261390|101849709|FG003|Overall Study|Relocation|0|||
33532987|NCT01261390|101849706|FG000|Overall Study|Loss of Interest in the Study|3|||
33532988|NCT01261390|101849707|FG001|Overall Study|Loss of Interest in the Study|1|||
33532989|NCT01261390|101849708|FG002|Overall Study|Loss of Interest in the Study|0|||
33532990|NCT01261390|101849709|FG003|Overall Study|Loss of Interest in the Study|0|||
33532991|NCT01261390|101849706|FG000|Overall Study|Lost to Follow-up|1|||
33532992|NCT01261390|101849707|FG001|Overall Study|Lost to Follow-up|6|||
33532993|NCT01261390|101849708|FG002|Overall Study|Lost to Follow-up|5|||
33532994|NCT01261390|101849709|FG003|Overall Study|Lost to Follow-up|6|||
33532995|NCT01468454|101849710|FG000|Overall Study|Did not have surgery after PET|9|||
33532996|NCT03654729|101849711|FG000|Overall Study|Death|9|||
33532997|NCT03654729|101849712|FG001|Overall Study|Death|9|||
33532998|NCT03654729|101849713|FG002|Overall Study|Death|16|||
33532999|NCT03654729|101849711|FG000|Overall Study|Withdrawal by Subject|8|||
33533000|NCT03654729|101849712|FG001|Overall Study|Withdrawal by Subject|6|||
33533001|NCT03654729|101849713|FG002|Overall Study|Withdrawal by Subject|4|||
33533002|NCT03654729|101849711|FG000|Overall Study|Study terminated by Sponsor|3|||
33533003|NCT03654729|101849712|FG001|Overall Study|Study terminated by Sponsor|5|||
33533004|NCT03654729|101849713|FG002|Overall Study|Study terminated by Sponsor|4|||
33533005|NCT03654729|101849711|FG000|Overall Study|Not reported|2|||
33533006|NCT03654729|101849712|FG001|Overall Study|Not reported|4|||
33533007|NCT03654729|101849713|FG002|Overall Study|Not reported|5|||
33533008|NCT03654729|101849711|FG000|Overall Study|Progressive disease|3|||
33533009|NCT03654729|101849712|FG001|Overall Study|Progressive disease|0|||
33533010|NCT03654729|101849713|FG002|Overall Study|Progressive disease|0|||
33533011|NCT03654729|101849711|FG000|Overall Study|Lost to Follow-up|2|||
33533012|NCT03654729|101849712|FG001|Overall Study|Lost to Follow-up|0|||
33533013|NCT03654729|101849713|FG002|Overall Study|Lost to Follow-up|0|||
33533014|NCT03654729|101849711|FG000|Overall Study|Physician Decision|2|||
33533015|NCT03654729|101849712|FG001|Overall Study|Physician Decision|0|||
33533016|NCT03654729|101849713|FG002|Overall Study|Physician Decision|0|||
33533017|NCT03654729|101849711|FG000|Overall Study|Protocol Violation|1|||
33533018|NCT03654729|101849712|FG001|Overall Study|Protocol Violation|1|||
33533019|NCT03654729|101849713|FG002|Overall Study|Protocol Violation|0|||
33533020|NCT03654729|101849711|FG000|Overall Study|Non-compliance with study drug|0|||
33533021|NCT03654729|101849712|FG001|Overall Study|Non-compliance with study drug|1|||
33533022|NCT03654729|101849713|FG002|Overall Study|Non-compliance with study drug|0|||
33533023|NCT03654729|101849711|FG000|Overall Study|Site terminated by Sponsor|1|||
33533024|NCT03654729|101849712|FG001|Overall Study|Site terminated by Sponsor|0|||
33612873|NCT03214406|102133672|FG001|Overall Study|did not meet enrollment criteria|13|||
33612874|NCT03214406|102133671|FG000|Overall Study|Withdrawal by Subject|1|||
33612875|NCT03214406|102133672|FG001|Overall Study|Withdrawal by Subject|0|||
33612876|NCT03214406|102133671|FG000|Overall Study|Lost to Follow-up|0|||
33612877|NCT03214406|102133672|FG001|Overall Study|Lost to Follow-up|2|||
33533025|NCT03654729|101849713|FG002|Overall Study|Site terminated by Sponsor|0|||
33612878|NCT01098305|102133673|FG000|Overall Study|Lost to Follow-up|31|||
33612879|NCT01098305|102133674|FG001|Overall Study|Lost to Follow-up|33|||
33612880|NCT00195663|102133675|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
33612881|NCT00195663|102133676|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
33612882|NCT00195663|102133677|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
33533026|NCT00493012|101849714|FG000|Overall Study|Lost to Follow-up|18|||
33533027|NCT00493012|101849715|FG001|Overall Study|Lost to Follow-up|17|||
33612883|NCT00195663|102133675|FG000|2-year Double-blind Treatment Period|Death|0|||
33533028|NCT01166750|101849720|FG000|Overall Study|Lost to Follow-up|1|||
33533029|NCT01166750|101849721|FG001|Overall Study|Lost to Follow-up|0|||
33533030|NCT00810199|101849722|FG000|Overall Study|Adverse Event|24|||
33533031|NCT00810199|101849723|FG001|Overall Study|Adverse Event|26|||
33533032|NCT00810199|101849722|FG000|Overall Study|Death|4|||
33533033|NCT00810199|101849723|FG001|Overall Study|Death|6|||
33533034|NCT00810199|101849722|FG000|Overall Study|Withdrew consent|9|||
33533035|NCT00810199|101849723|FG001|Overall Study|Withdrew consent|12|||
33533036|NCT00810199|101849722|FG000|Overall Study|Insufficient therapeutic response|5|||
33533037|NCT00810199|101849723|FG001|Overall Study|Insufficient therapeutic response|14|||
33533038|NCT00810199|101849722|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
33533039|NCT00810199|101849723|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
33533040|NCT00810199|101849722|FG000|Overall Study|Administrative/Other|5|||
33533041|NCT00810199|101849723|FG001|Overall Study|Administrative/Other|6|||
33533042|NCT00810199|101849722|FG000|Overall Study|Protocol Violation|2|||
33533043|NCT00810199|101849723|FG001|Overall Study|Protocol Violation|6|||
33533044|NCT00810199|101849722|FG000|Overall Study|Failure to return|1|||
33533045|NCT00810199|101849723|FG001|Overall Study|Failure to return|4|||
33533046|NCT00810199|101849722|FG000|Overall Study|Did not receive study drug|2|||
33533047|NCT00810199|101849723|FG001|Overall Study|Did not receive study drug|1|||
33533048|NCT00369915|101849726|FG000|Overall Study|expected side effects|2|||
33533049|NCT00369915|101849727|FG001|Overall Study|expected side effects|1|||
33533050|NCT00369915|101849726|FG000|Overall Study|Withdrawal by Subject|4|||
33533051|NCT00369915|101849727|FG001|Overall Study|Withdrawal by Subject|1|||
33533052|NCT00369915|101849726|FG000|Overall Study|W/drawl by investigators|0|||
33533053|NCT00369915|101849727|FG001|Overall Study|W/drawl by investigators|1|||
33533054|NCT01266824|101849728|FG000|Overall Study|Study terminated prior to completion|2|||
33533055|NCT01266824|101849729|FG001|Overall Study|Study terminated prior to completion|3|||
33533056|NCT01275144|101849730|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
33533057|NCT01275144|101849731|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
33533058|NCT01945944|101849735|FG000|Overall Study|Adverse Event|0|||
33533059|NCT01945944|101849736|FG001|Overall Study|Adverse Event|2|||
33533060|NCT01945944|101849735|FG000|Overall Study|Physician Decision|1|||
33533061|NCT01945944|101849736|FG001|Overall Study|Physician Decision|0|||
33533062|NCT01945944|101849735|FG000|Overall Study|Withdrawal by Subject|0|||
33533063|NCT01945944|101849736|FG001|Overall Study|Withdrawal by Subject|1|||
33533064|NCT00509899|101849752|FG000|Overall Study|Progressive disease|1|||
33533065|NCT00509899|101849753|FG001|Overall Study|Progressive disease|3|||
33533066|NCT00509899|101849754|FG002|Overall Study|Progressive disease|5|||
33533067|NCT00509899|101849755|FG003|Overall Study|Progressive disease|1|||
33533068|NCT00509899|101849756|FG004|Overall Study|Progressive disease|0|||
33533069|NCT00509899|101849757|FG005|Overall Study|Progressive disease|1|||
33533070|NCT00509899|101849758|FG006|Overall Study|Progressive disease|0|||
33533071|NCT00509899|101849759|FG007|Overall Study|Progressive disease|0|||
33533072|NCT00509899|101849752|FG000|Overall Study|Unacceptable Toxicity|1|||
33533073|NCT00509899|101849753|FG001|Overall Study|Unacceptable Toxicity|0|||
33533074|NCT00509899|101849754|FG002|Overall Study|Unacceptable Toxicity|0|||
33533075|NCT00509899|101849755|FG003|Overall Study|Unacceptable Toxicity|2|||
33533076|NCT00509899|101849756|FG004|Overall Study|Unacceptable Toxicity|0|||
33533077|NCT00509899|101849757|FG005|Overall Study|Unacceptable Toxicity|0|||
33533078|NCT00509899|101849758|FG006|Overall Study|Unacceptable Toxicity|0|||
33533079|NCT00509899|101849759|FG007|Overall Study|Unacceptable Toxicity|0|||
33533080|NCT00509899|101849752|FG000|Overall Study|Withdrawal by Subject|6|||
33533081|NCT00509899|101849753|FG001|Overall Study|Withdrawal by Subject|2|||
33533082|NCT00509899|101849754|FG002|Overall Study|Withdrawal by Subject|3|||
33533083|NCT00509899|101849755|FG003|Overall Study|Withdrawal by Subject|0|||
33533084|NCT00509899|101849756|FG004|Overall Study|Withdrawal by Subject|3|||
33533085|NCT00509899|101849757|FG005|Overall Study|Withdrawal by Subject|2|||
33533086|NCT00509899|101849758|FG006|Overall Study|Withdrawal by Subject|0|||
33533087|NCT00509899|101849759|FG007|Overall Study|Withdrawal by Subject|0|||
33533088|NCT00509899|101849752|FG000|Overall Study|Physician Decision|4|||
33533089|NCT00509899|101849753|FG001|Overall Study|Physician Decision|2|||
33533090|NCT00509899|101849754|FG002|Overall Study|Physician Decision|7|||
33533091|NCT00509899|101849755|FG003|Overall Study|Physician Decision|0|||
33533092|NCT00509899|101849756|FG004|Overall Study|Physician Decision|1|||
33533093|NCT00509899|101849757|FG005|Overall Study|Physician Decision|4|||
33533094|NCT00509899|101849758|FG006|Overall Study|Physician Decision|0|||
33533095|NCT00509899|101849759|FG007|Overall Study|Physician Decision|0|||
33533096|NCT00509899|101849752|FG000|Overall Study|Intercurrent Illness|1|||
33533097|NCT00509899|101849753|FG001|Overall Study|Intercurrent Illness|0|||
33533098|NCT00509899|101849754|FG002|Overall Study|Intercurrent Illness|0|||
33533099|NCT00509899|101849755|FG003|Overall Study|Intercurrent Illness|1|||
33533100|NCT00509899|101849756|FG004|Overall Study|Intercurrent Illness|0|||
33533101|NCT00509899|101849757|FG005|Overall Study|Intercurrent Illness|1|||
33533102|NCT00509899|101849758|FG006|Overall Study|Intercurrent Illness|0|||
33533103|NCT00509899|101849759|FG007|Overall Study|Intercurrent Illness|0|||
33533104|NCT00509899|101849752|FG000|Overall Study|Death|2|||
33533105|NCT00509899|101849753|FG001|Overall Study|Death|2|||
33533106|NCT00509899|101849754|FG002|Overall Study|Death|3|||
33533107|NCT00509899|101849755|FG003|Overall Study|Death|0|||
33533108|NCT00509899|101849756|FG004|Overall Study|Death|1|||
33533109|NCT00509899|101849757|FG005|Overall Study|Death|1|||
33533110|NCT00509899|101849758|FG006|Overall Study|Death|1|||
33533111|NCT00509899|101849759|FG007|Overall Study|Death|1|||
33533112|NCT00509899|101849752|FG000|Overall Study|Lack of Efficacy|1|||
33533113|NCT00509899|101849753|FG001|Overall Study|Lack of Efficacy|0|||
33612884|NCT00195663|102133676|FG001|2-year Double-blind Treatment Period|Death|2|||
33612885|NCT00195663|102133677|FG002|2-year Double-blind Treatment Period|Death|0|||
33612886|NCT00195663|102133675|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
33612887|NCT00195663|102133676|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
33612888|NCT00195663|102133677|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
33612889|NCT00195663|102133675|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
33612890|NCT00195663|102133676|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
33612891|NCT00195663|102133677|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
33612892|NCT00195663|102133675|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
33533114|NCT00509899|101849754|FG002|Overall Study|Lack of Efficacy|2|||
33533115|NCT00509899|101849755|FG003|Overall Study|Lack of Efficacy|0|||
33612893|NCT00195663|102133676|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
33612894|NCT00195663|102133677|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
33612895|NCT00195663|102133675|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
33612896|NCT00195663|102133676|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
33612897|NCT00195663|102133677|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
33612898|NCT00195663|102133675|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
33612899|NCT00195663|102133676|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
33612900|NCT00195663|102133677|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
33612901|NCT00195663|102133675|FG000|2-year Double-blind Treatment Period|Recovery|1|||
33612902|NCT00195663|102133676|FG001|2-year Double-blind Treatment Period|Recovery|0|||
33612903|NCT00195663|102133677|FG002|2-year Double-blind Treatment Period|Recovery|1|||
33612904|NCT00195663|102133675|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
33533116|NCT00509899|101849756|FG004|Overall Study|Lack of Efficacy|0|||
33533117|NCT00509899|101849757|FG005|Overall Study|Lack of Efficacy|1|||
33533118|NCT00509899|101849758|FG006|Overall Study|Lack of Efficacy|0|||
33533119|NCT00509899|101849759|FG007|Overall Study|Lack of Efficacy|0|||
33533120|NCT00929994|101849760|FG000|Overall Study|Withdrawal by Subject|1|||
33533121|NCT00929994|101849760|FG000|Overall Study|medical issue unrelated to intervention|4|||
33533122|NCT00929994|101849760|FG000|Overall Study|employment|1|||
33533123|NCT01724177|101849761|FG000|Overall Study|Adverse Event|8|||
33533124|NCT01724177|101849761|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
33533125|NCT01724177|101849761|FG000|Overall Study|Nervous participant|1|||
33533126|NCT01724177|101849761|FG000|Overall Study|Serious Adverse Event Related|1|||
33533127|NCT00613821|101852847|FG000|Overall Study|Withdrawal by Subject|1|||
33533128|NCT00613821|101852848|FG001|Overall Study|Withdrawal by Subject|0|||
33533129|NCT00613821|101852847|FG000|Overall Study|Physician Decision|1|||
33533130|NCT00613821|101852848|FG001|Overall Study|Physician Decision|1|||
33533131|NCT02485483|101852856|FG000|Overall Study|Depression at baseline|15|||
33533132|NCT02485483|101852857|FG001|Overall Study|Depression at baseline|0|||
33533133|NCT02485483|101852856|FG000|Overall Study|Discontinued after baseline|39|||
33533134|NCT02485483|101852857|FG001|Overall Study|Discontinued after baseline|0|||
33533135|NCT01607593|101852860|FG000|Overall Study|Adverse Event|15|||
33533136|NCT01607593|101852860|FG000|Overall Study|Lack of Efficacy|16|||
33206020|NCT00360308|100655915|FG000|Overall Study|Lack of Efficacy|3|||
33206021|NCT00360308|100655916|FG001|Overall Study|Lack of Efficacy|0|||
33206022|NCT00360308|100655917|FG002|Overall Study|Lack of Efficacy|2|||
33206023|NCT00360308|100655915|FG000|Overall Study|Other|2|||
33206024|NCT00360308|100655916|FG001|Overall Study|Other|1|||
33206025|NCT00360308|100655917|FG002|Overall Study|Other|1|||
33206026|NCT00360308|100655915|FG000|Overall Study|Study termination by sponsor|43|||
33533137|NCT01607593|101852860|FG000|Overall Study|Lost to Follow-up|25|||
33206027|NCT00360308|100655916|FG001|Overall Study|Study termination by sponsor|55|||
33533138|NCT01607593|101852860|FG000|Overall Study|Continuation|33|||
33533139|NCT01607593|101852860|FG000|Overall Study|Other|4|||
33404875|NCT00689299|101369640|FG001|Overall Study|Protocol Violation|0|||
33533140|NCT02915159|101852861|FG000|Overall Study|Participant no longer meets criteria|2|||
33533141|NCT02915159|101852862|FG001|Overall Study|Participant no longer meets criteria|0|||
33206028|NCT00360308|100655917|FG002|Overall Study|Study termination by sponsor|44|||
33533142|NCT02915159|101852861|FG000|Overall Study|poor/non-compliance|1|||
33533143|NCT02915159|101852862|FG001|Overall Study|poor/non-compliance|0|||
33533144|NCT02915159|101852861|FG000|Overall Study|Participant withdrew consent|5|||
33533145|NCT02915159|101852862|FG001|Overall Study|Participant withdrew consent|1|||
33533146|NCT02915159|101852861|FG000|Overall Study|Request to discontinue treatment|1|||
33533147|NCT02915159|101852862|FG001|Overall Study|Request to discontinue treatment|2|||
33533148|NCT02915159|101852861|FG000|Overall Study|Adverse Event|2|||
33533149|NCT02915159|101852862|FG001|Overall Study|Adverse Event|2|||
33533150|NCT02915159|101852861|FG000|Overall Study|Lack of Efficacy|0|||
33533151|NCT02915159|101852862|FG001|Overall Study|Lack of Efficacy|3|||
33533152|NCT00956839|101852869|FG000|Overall Study|Lost to Follow-up|3|||
33533153|NCT00956839|101852870|FG001|Overall Study|Lost to Follow-up|0|||
33533154|NCT00956839|101852871|FG002|Overall Study|Lost to Follow-up|3|||
33533155|NCT03225287|101852874|FG000|Overall Study|Adverse Event|0|||
33533156|NCT03225287|101852875|FG001|Overall Study|Adverse Event|0|||
33533157|NCT03225287|101852876|FG002|Overall Study|Adverse Event|1|||
33533158|NCT03225287|101852874|FG000|Overall Study|Protocol non-compliance|0|||
33533159|NCT03225287|101852875|FG001|Overall Study|Protocol non-compliance|0|||
33533160|NCT03225287|101852876|FG002|Overall Study|Protocol non-compliance|1|||
33533161|NCT03225287|101852874|FG000|Overall Study|Subject withdraws consent|3|||
33533162|NCT03225287|101852875|FG001|Overall Study|Subject withdraws consent|0|||
33533163|NCT03225287|101852876|FG002|Overall Study|Subject withdraws consent|0|||
33533164|NCT03225287|101852874|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
33533165|NCT03225287|101852875|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
33533166|NCT03225287|101852876|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
33533167|NCT03225287|101852874|FG000|Overall Study|Trial drug not effective|0|||
33533168|NCT03225287|101852875|FG001|Overall Study|Trial drug not effective|1|||
33533169|NCT03225287|101852876|FG002|Overall Study|Trial drug not effective|0|||
33533170|NCT03225287|101852874|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
33533171|NCT03225287|101852875|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
33533172|NCT03225287|101852876|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
33533173|NCT03225287|101852874|FG000|Overall Study|Stem cell transplantation|0|||
33533174|NCT03225287|101852875|FG001|Overall Study|Stem cell transplantation|1|||
33533175|NCT03225287|101852876|FG002|Overall Study|Stem cell transplantation|0|||
33533176|NCT01921517|101852877|FG000|Overall Study|Lost to Follow-up|5|||
33533177|NCT01921517|101852878|FG001|Overall Study|Lost to Follow-up|0|||
33612905|NCT00195663|102133676|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
33612906|NCT00195663|102133677|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
33612907|NCT00195663|102133675|FG000|Open-Label Extension Period|Adverse Event|21|||
33533178|NCT01921517|101852877|FG000|Overall Study|Newly diagnosed health concern|2|||
33533179|NCT01921517|101852878|FG001|Overall Study|Newly diagnosed health concern|0|||
33533180|NCT01921517|101852877|FG000|Overall Study|Physician Decision|0|||
33533181|NCT01921517|101852878|FG001|Overall Study|Physician Decision|2|||
33533182|NCT01921517|101852877|FG000|Overall Study|Withdrawal by Subject|7|||
33533183|NCT01921517|101852878|FG001|Overall Study|Withdrawal by Subject|3|||
33533184|NCT01921517|101852877|FG000|Overall Study|Subject missed final imaging|1|||
33533185|NCT01921517|101852878|FG001|Overall Study|Subject missed final imaging|4|||
33533186|NCT01419314|101852879|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
33533187|NCT01419314|101852880|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
33533188|NCT01419314|101852879|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
33533189|NCT01419314|101852880|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
33612908|NCT00195663|102133676|FG001|Open-Label Extension Period|Adverse Event|32|||
33612909|NCT00195663|102133677|FG002|Open-Label Extension Period|Adverse Event|36|||
33612910|NCT00195663|102133675|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
33612911|NCT00195663|102133676|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
33612912|NCT00195663|102133677|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
33612913|NCT00195663|102133675|FG000|Open-Label Extension Period|Recovery|0|||
33612914|NCT00195663|102133676|FG001|Open-Label Extension Period|Recovery|2|||
33612915|NCT00195663|102133677|FG002|Open-Label Extension Period|Recovery|2|||
33612916|NCT00195663|102133675|FG000|Open-Label Extension Period|Protocol Violation|3|||
33612917|NCT00195663|102133676|FG001|Open-Label Extension Period|Protocol Violation|4|||
33612918|NCT00195663|102133677|FG002|Open-Label Extension Period|Protocol Violation|4|||
33612919|NCT00195663|102133675|FG000|Open-Label Extension Period|Death|2|||
33612920|NCT00195663|102133676|FG001|Open-Label Extension Period|Death|2|||
33612921|NCT00195663|102133677|FG002|Open-Label Extension Period|Death|2|||
33612922|NCT00195663|102133675|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
33612923|NCT00195663|102133676|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
33612924|NCT00195663|102133677|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
33533190|NCT01419314|101852879|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
33612925|NCT00195663|102133675|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
33612926|NCT00195663|102133676|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
33612927|NCT00195663|102133677|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
33612928|NCT00195663|102133675|FG000|Open-Label Extension Period|Administrative reasons|11|||
33612929|NCT00195663|102133676|FG001|Open-Label Extension Period|Administrative reasons|11|||
33337428|NCT02706873|101128247|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
33533191|NCT01419314|101852880|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
33533192|NCT00411450|101852882|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
33533193|NCT01059773|101852883|FG000|Overall Study|Adverse Event|2|||
33533194|NCT01059773|101852884|FG001|Overall Study|Adverse Event|2|||
33533195|NCT01059773|101852883|FG000|Overall Study|Withdrawal by Subject|1|||
33533196|NCT01059773|101852884|FG001|Overall Study|Withdrawal by Subject|5|||
33533197|NCT01059773|101852883|FG000|Overall Study|Lost to Follow-up|1|||
33533198|NCT01059773|101852884|FG001|Overall Study|Lost to Follow-up|1|||
33533199|NCT01059773|101852883|FG000|Overall Study|Pregnancy|1|||
33533200|NCT01059773|101852884|FG001|Overall Study|Pregnancy|1|||
33533201|NCT01059773|101852883|FG000|Overall Study|Protocol Violation|6|||
33533202|NCT01059773|101852884|FG001|Overall Study|Protocol Violation|2|||
33533203|NCT01059773|101852883|FG000|Overall Study|Physician Decision|5|||
33533204|NCT01059773|101852884|FG001|Overall Study|Physician Decision|4|||
33612930|NCT00195663|102133677|FG002|Open-Label Extension Period|Administrative reasons|13|||
33337429|NCT02706873|101128248|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
33337430|NCT02706873|101128249|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
33337431|NCT02706873|101128250|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
33337432|NCT02706873|101128247|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
33337433|NCT02706873|101128248|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
33337434|NCT02706873|101128249|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
33337435|NCT02706873|101128250|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
33337436|NCT02706873|101128247|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
33337437|NCT02706873|101128248|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
33337438|NCT02706873|101128249|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
33337439|NCT02706873|101128250|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
33337440|NCT02239939|101128252|FG000|Overall Study|Adverse Event|1|||
33337441|NCT02239939|101128253|FG001|Overall Study|Adverse Event|0|||
33337442|NCT02239939|101128252|FG000|Overall Study|Withdrawal by Subject|1|||
33337443|NCT02239939|101128253|FG001|Overall Study|Withdrawal by Subject|1|||
33337444|NCT02239939|101128252|FG000|Overall Study|Lost to Follow-up|0|||
33337445|NCT02239939|101128253|FG001|Overall Study|Lost to Follow-up|1|||
33337446|NCT03920670|101128257|FG000|Overall Study|Protocol Violation|2|||
33337447|NCT03920670|101128258|FG001|Overall Study|Protocol Violation|2|||
33337448|NCT03920670|101128257|FG000|Overall Study|Adverse Event|1|||
33337449|NCT03920670|101128258|FG001|Overall Study|Adverse Event|0|||
33337450|NCT02415712|101128259|FG000|Overall Study|Protocol Violation|16|||
33337451|NCT01182428|101128270|FG000|Overall Study|Physician Decision|1|||
33337452|NCT01182428|101128271|FG001|Overall Study|Physician Decision|0|||
33337453|NCT01182428|101128270|FG000|Overall Study|Lost to Follow-up|9|||
33337454|NCT01182428|101128271|FG001|Overall Study|Lost to Follow-up|1|||
33337455|NCT01182428|101128270|FG000|Overall Study|Withdrawal by Subject|1|||
33337456|NCT01182428|101128271|FG001|Overall Study|Withdrawal by Subject|0|||
33337457|NCT02095535|101128275|FG000|Recruitment|Protocol Violation|2|||
33337458|NCT02573155|101128276|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
33337459|NCT02573155|101128277|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
33337460|NCT02573155|101128276|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
33533205|NCT01059773|101852883|FG000|Overall Study|Lack of Efficacy|3|||
33533206|NCT01059773|101852884|FG001|Overall Study|Lack of Efficacy|3|||
33612931|NCT03197376|102133678|FG000|Primary and Booster Phase|Adverse Event|0|||
33612932|NCT03197376|102133679|FG001|Primary and Booster Phase|Adverse Event|0|||
33612933|NCT03197376|102133680|FG002|Primary and Booster Phase|Adverse Event|0|||
33612934|NCT03197376|102133681|FG003|Primary and Booster Phase|Adverse Event|1|||
33612935|NCT03197376|102133678|FG000|Primary and Booster Phase|Death|1|||
33612936|NCT03197376|102133679|FG001|Primary and Booster Phase|Death|0|||
33404876|NCT00689299|101369641|FG002|Overall Study|Protocol Violation|0|||
33533207|NCT01059773|101852883|FG000|Overall Study|Death|0|||
33612937|NCT03197376|102133680|FG002|Primary and Booster Phase|Death|0|||
33612938|NCT03197376|102133681|FG003|Primary and Booster Phase|Death|2|||
33612939|NCT03197376|102133678|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
33612940|NCT03197376|102133679|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
33612941|NCT03197376|102133680|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
33612942|NCT03197376|102133681|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
33612943|NCT03197376|102133678|FG000|Primary and Booster Phase|Physician Decision|1|||
33612944|NCT03197376|102133679|FG001|Primary and Booster Phase|Physician Decision|0|||
33612945|NCT03197376|102133680|FG002|Primary and Booster Phase|Physician Decision|1|||
33612946|NCT03197376|102133681|FG003|Primary and Booster Phase|Physician Decision|3|||
33612947|NCT03197376|102133678|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
33612948|NCT03197376|102133679|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
33612949|NCT03197376|102133680|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
33612950|NCT03197376|102133681|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
33612951|NCT03197376|102133678|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
33612952|NCT03197376|102133679|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
33612953|NCT03197376|102133680|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
33612954|NCT03197376|102133681|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
33206029|NCT02103439|100655926|FG000|Overall Study|Adverse Event|0|||
33206030|NCT02103439|100655927|FG001|Overall Study|Adverse Event|2|||
33337461|NCT02573155|101128277|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
33206031|NCT02103439|100655926|FG000|Overall Study|Withdrawal by Subject|3|||
33206032|NCT02103439|100655927|FG001|Overall Study|Withdrawal by Subject|1|||
33337462|NCT02573155|101128276|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
33337463|NCT02573155|101128277|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
33337464|NCT02573155|101128276|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
33337465|NCT02573155|101128277|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
33337466|NCT02573155|101128276|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
33337467|NCT02573155|101128277|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
33337468|NCT02573155|101128276|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
33337469|NCT02573155|101128277|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
33337470|NCT02573155|101128276|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
33337471|NCT02573155|101128277|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
33337472|NCT02573155|101128276|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
33337473|NCT02573155|101128277|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
33337474|NCT00590590|101128278|FG000|Overall Study|Lack of Efficacy|1|||
33337475|NCT00590590|101128279|FG001|Overall Study|Lack of Efficacy|2|||
33337476|NCT00590590|101128280|FG002|Overall Study|Lack of Efficacy|0|||
33337477|NCT00590590|101128278|FG000|Overall Study|Adverse Event|1|||
33337478|NCT00590590|101128279|FG001|Overall Study|Adverse Event|0|||
33337479|NCT00590590|101128280|FG002|Overall Study|Adverse Event|0|||
33337480|NCT00590590|101128278|FG000|Overall Study|Protocol Violation|0|||
33337481|NCT00590590|101128279|FG001|Overall Study|Protocol Violation|0|||
33337482|NCT00590590|101128280|FG002|Overall Study|Protocol Violation|2|||
33337483|NCT00590590|101128278|FG000|Overall Study|Lost to Follow-up|4|||
33337484|NCT00590590|101128279|FG001|Overall Study|Lost to Follow-up|1|||
33337485|NCT00590590|101128280|FG002|Overall Study|Lost to Follow-up|2|||
33337486|NCT00590590|101128278|FG000|Overall Study|Withdrawal by Subject|0|||
33337487|NCT00590590|101128279|FG001|Overall Study|Withdrawal by Subject|1|||
33337488|NCT00590590|101128280|FG002|Overall Study|Withdrawal by Subject|1|||
33337489|NCT00590590|101128278|FG000|Overall Study|Did not complete due to study closure|1|||
33337490|NCT00590590|101128279|FG001|Overall Study|Did not complete due to study closure|1|||
33337491|NCT00590590|101128280|FG002|Overall Study|Did not complete due to study closure|1|||
33337492|NCT00590590|101128278|FG000|Overall Study|Did not complete study|0|||
33337493|NCT00590590|101128279|FG001|Overall Study|Did not complete study|1|||
33337494|NCT00590590|101128280|FG002|Overall Study|Did not complete study|0|||
33337495|NCT03298022|101128281|FG000|Overall Study|Lack of Efficacy|4|||
33337496|NCT03298022|101128281|FG000|Overall Study|Withdrawal by Subject|7|||
33404877|NCT00736840|101369656|FG000|Overall Study|Lost to Follow-up|13|||
33404878|NCT02926833|101369662|FG000|Overall Study|Death|1|||
33404879|NCT02926833|101369663|FG001|Overall Study|Death|1|||
33533208|NCT01059773|101852884|FG001|Overall Study|Death|1|||
33533209|NCT01059773|101852883|FG000|Overall Study|Malignancy including squamous cell skin|0|||
33533210|NCT01059773|101852884|FG001|Overall Study|Malignancy including squamous cell skin|1|||
33533211|NCT01059773|101852883|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
33404880|NCT02926833|101369664|FG002|Overall Study|Death|2|||
33404881|NCT02926833|101369665|FG003|Overall Study|Death|13|||
33404882|NCT02926833|101369662|FG000|Overall Study|Lost to Follow-up|1|||
33404883|NCT02926833|101369663|FG001|Overall Study|Lost to Follow-up|2|||
33404884|NCT02926833|101369664|FG002|Overall Study|Lost to Follow-up|0|||
33404885|NCT02926833|101369665|FG003|Overall Study|Lost to Follow-up|3|||
33404886|NCT02926833|101369662|FG000|Overall Study|Full Consent Withdrawal|0|||
33404887|NCT02926833|101369663|FG001|Overall Study|Full Consent Withdrawal|0|||
33404888|NCT02926833|101369664|FG002|Overall Study|Full Consent Withdrawal|0|||
33404889|NCT02926833|101369665|FG003|Overall Study|Full Consent Withdrawal|2|||
33404890|NCT02926833|101369662|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
33404891|NCT02926833|101369663|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
33404892|NCT02926833|101369664|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
33404893|NCT02926833|101369665|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
33404894|NCT02926833|101369662|FG000|Overall Study|Investigator Decision|0|||
33404895|NCT02926833|101369663|FG001|Overall Study|Investigator Decision|1|||
33404896|NCT02926833|101369664|FG002|Overall Study|Investigator Decision|0|||
33404897|NCT02926833|101369665|FG003|Overall Study|Investigator Decision|0|||
33404898|NCT02926833|101369662|FG000|Overall Study|Adverse Event|0|||
33404899|NCT02926833|101369663|FG001|Overall Study|Adverse Event|0|||
33404900|NCT02926833|101369664|FG002|Overall Study|Adverse Event|1|||
33404901|NCT02926833|101369665|FG003|Overall Study|Adverse Event|0|||
33404902|NCT02926833|101369662|FG000|Overall Study|Partial Withdrawal of Consent|0|||
33404903|NCT02926833|101369663|FG001|Overall Study|Partial Withdrawal of Consent|0|||
33404904|NCT02926833|101369664|FG002|Overall Study|Partial Withdrawal of Consent|0|||
33404905|NCT02926833|101369665|FG003|Overall Study|Partial Withdrawal of Consent|1|||
33404906|NCT00768040|101369666|FG000|Overall Study|Adverse Event|3|||
33404907|NCT00768040|101369667|FG001|Overall Study|Adverse Event|2|||
33404908|NCT00768040|101369666|FG000|Overall Study|Abnormal laboratory value|1|||
33533212|NCT01059773|101852884|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
33533213|NCT01059773|101852883|FG000|Overall Study|Other|1|||
33533214|NCT01059773|101852884|FG001|Overall Study|Other|3|||
33533215|NCT02021292|101852886|FG000|Overall Study|Physician Decision|0|||
33404909|NCT00768040|101369667|FG001|Overall Study|Abnormal laboratory value|1|||
33404910|NCT03288987|101369668|FG000|Overall Study|Protocol Violation|10|||
33404911|NCT03288987|101369669|FG001|Overall Study|Protocol Violation|4|||
33404912|NCT00247962|101369670|FG000|Overall Study|Adverse Event|15|||
33404913|NCT00247962|101369671|FG001|Overall Study|Adverse Event|12|||
33404914|NCT00247962|101369670|FG000|Overall Study|Lost to Follow-up|3|||
33404915|NCT00247962|101369671|FG001|Overall Study|Lost to Follow-up|1|||
33404916|NCT00247962|101369670|FG000|Overall Study|Physician Decision|0|||
33404917|NCT00247962|101369671|FG001|Overall Study|Physician Decision|1|||
33404918|NCT00247962|101369670|FG000|Overall Study|Protocol Violation|1|||
33404919|NCT00247962|101369671|FG001|Overall Study|Protocol Violation|1|||
33404920|NCT00247962|101369670|FG000|Overall Study|Withdrawal by Subject|3|||
33404921|NCT00247962|101369671|FG001|Overall Study|Withdrawal by Subject|2|||
33404922|NCT00247962|101369670|FG000|Overall Study|Lack of Efficacy|4|||
33404923|NCT00247962|101369671|FG001|Overall Study|Lack of Efficacy|2|||
33404924|NCT02711306|101369672|FG000|Overall Study|Withdrawal by Subject|2|||
33533216|NCT02021292|101852887|FG001|Overall Study|Physician Decision|1|||
33533217|NCT02021292|101852886|FG000|Overall Study|Lost to Follow-up|0|||
33533218|NCT02021292|101852887|FG001|Overall Study|Lost to Follow-up|1|||
33533219|NCT02021292|101852886|FG000|Overall Study|Death|0|||
33533220|NCT02021292|101852887|FG001|Overall Study|Death|1|||
33533221|NCT00715559|101852889|FG000|Overall Study|medication not tolerated - nausea|1|||
33533222|NCT01441973|101852890|FG000|Overall Study|Disease progression|8|||
33612955|NCT03197376|102133678|FG000|Primary and Booster Phase|Not vaccine related|1|||
33612956|NCT03197376|102133679|FG001|Primary and Booster Phase|Not vaccine related|2|||
33612957|NCT03197376|102133680|FG002|Primary and Booster Phase|Not vaccine related|0|||
33612958|NCT03197376|102133681|FG003|Primary and Booster Phase|Not vaccine related|6|||
33612959|NCT03197376|102133678|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
33533223|NCT01441973|101852891|FG001|Overall Study|Disease progression|6|||
33533224|NCT01441973|101852890|FG000|Overall Study|Adverse event unrelated to study drug|3|||
33533225|NCT01441973|101852891|FG001|Overall Study|Adverse event unrelated to study drug|2|||
33533226|NCT01441973|101852890|FG000|Overall Study|Participant request to discontinue|1|||
33533227|NCT01441973|101852891|FG001|Overall Study|Participant request to discontinue|1|||
33404925|NCT02711306|101369673|FG001|Overall Study|Withdrawal by Subject|2|||
33404926|NCT02390167|101369674|FG000|Overall Study|Lost to Follow-up|1|||
33404927|NCT04511533|101373221|FG000|Treatment|Other|2|||
33404928|NCT04511533|101373221|FG000|Treatment|Withdrawal by Subject|11|||
33404929|NCT04511533|101373221|FG000|Treatment|Death|5|||
33404930|NCT04511533|101373221|FG000|Treatment|Physician Decision|1|||
33404931|NCT04511533|101373221|FG000|Treatment|Progressive Disease|61|||
33404932|NCT04511533|101373221|FG000|Follow-Up|Other|7|||
33404933|NCT04511533|101373221|FG000|Follow-Up|Withdrawal by Subject|5|||
33404934|NCT04511533|101373221|FG000|Follow-Up|Lost to Follow-up|2|||
33404935|NCT04511533|101373221|FG000|Follow-Up|Death|4|||
33533228|NCT01441973|101852890|FG000|Overall Study|Poor compliance/noncompliance|0|||
33533229|NCT01441973|101852891|FG001|Overall Study|Poor compliance/noncompliance|1|||
33533230|NCT01441973|101852890|FG000|Overall Study|Administrative reason by sponsor|3|||
33533231|NCT01441973|101852891|FG001|Overall Study|Administrative reason by sponsor|5|||
33533232|NCT01441973|101852890|FG000|Overall Study|Participant withdrew consent|0|||
33533233|NCT01441973|101852891|FG001|Overall Study|Participant withdrew consent|1|||
33533234|NCT02329327|101852895|FG000|Overall Study|Death|78|||
33533235|NCT02329327|101852896|FG001|Overall Study|Death|0|||
33533236|NCT02329327|101852895|FG000|Overall Study|Withdrawal by Subject|3|||
33533237|NCT02329327|101852896|FG001|Overall Study|Withdrawal by Subject|0|||
33533238|NCT02329327|101852895|FG000|Overall Study|Lost to Follow-up|4|||
33533239|NCT02329327|101852896|FG001|Overall Study|Lost to Follow-up|0|||
33533240|NCT04194489|101852897|FG000|Overall Study|Withdrawal by Subject|5|||
33533241|NCT04194489|101852897|FG000|Overall Study|Lost to Follow-up|48|||
33533242|NCT02097823|101852898|FG000|Overall Study|Withdrawal by Subject|1|||
33533243|NCT02097823|101852899|FG001|Overall Study|Withdrawal by Subject|1|||
33533244|NCT02039778|101852902|FG000|Overall Study|Death|2|||
33533245|NCT02039778|101852902|FG000|Overall Study|Withdrawal by Subject|1|||
33533246|NCT02039778|101852902|FG000|Overall Study|Never started the protocol treatment|1|||
33533247|NCT00610168|101852907|FG000|Overall Study|Withdrawal by Subject|2|||
33337497|NCT03298022|101128281|FG000|Overall Study|Adverse Event|1|||
33337498|NCT03298022|101128281|FG000|Overall Study|disease relapse|1|||
33337499|NCT01965262|101128282|FG000|Second Intervention (7 Days)|Discontinued|0|||
33337500|NCT01965262|101128283|FG001|Second Intervention (7 Days)|Discontinued|1|||
33337501|NCT01965262|101128282|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
33337502|NCT01965262|101128283|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
33337503|NCT01965262|101128282|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
33337504|NCT01965262|101128283|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
33337505|NCT01618214|101128292|FG000|Overall Study|Adverse Event|3|||
33337506|NCT01618214|101128293|FG001|Overall Study|Adverse Event|1|||
33404936|NCT03382639|101373226|FG000|Overall Study|Adverse Event|2|||
33404937|NCT03382639|101373227|FG001|Overall Study|Adverse Event|0|||
33533248|NCT00610168|101852908|FG001|Overall Study|Withdrawal by Subject|0|||
33533249|NCT01839916|101852909|FG000|Overall Study|Death|9|||
33533250|NCT01839916|101852909|FG000|Overall Study|Physician Decision|17|||
33612960|NCT03197376|102133679|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
33612961|NCT03197376|102133680|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
33337507|NCT01618214|101128292|FG000|Overall Study|Lack of Efficacy|1|||
33404938|NCT03382639|101373228|FG002|Overall Study|Adverse Event|1|||
33404939|NCT03382639|101373229|FG003|Overall Study|Adverse Event|1|||
33404940|NCT03382639|101373226|FG000|Overall Study|Lost to Follow-up|1|||
33404941|NCT03382639|101373227|FG001|Overall Study|Lost to Follow-up|0|||
33404942|NCT03382639|101373228|FG002|Overall Study|Lost to Follow-up|0|||
33404943|NCT03382639|101373229|FG003|Overall Study|Lost to Follow-up|0|||
33404944|NCT03382639|101373226|FG000|Overall Study|Withdrawal by Subject|4|||
33404945|NCT03382639|101373227|FG001|Overall Study|Withdrawal by Subject|3|||
33404946|NCT03382639|101373228|FG002|Overall Study|Withdrawal by Subject|2|||
33404947|NCT03382639|101373229|FG003|Overall Study|Withdrawal by Subject|3|||
33404948|NCT03382639|101373226|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
33404949|NCT03382639|101373227|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
33404950|NCT03382639|101373228|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
33404951|NCT03382639|101373229|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
33404952|NCT03382639|101373226|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
33404953|NCT03382639|101373227|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
33404954|NCT03382639|101373228|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
33404955|NCT03382639|101373229|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
33404956|NCT03382639|101373226|FG000|Overall Study|Other|2|||
33404957|NCT03382639|101373227|FG001|Overall Study|Other|0|||
33404958|NCT03382639|101373228|FG002|Overall Study|Other|0|||
33404959|NCT03382639|101373229|FG003|Overall Study|Other|3|||
33404960|NCT02911285|101373234|FG000|Overall Study|Lost to Follow-up|8|||
33612962|NCT03197376|102133681|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
33337508|NCT01618214|101128293|FG001|Overall Study|Lack of Efficacy|1|||
33404961|NCT02911285|101373235|FG001|Overall Study|Lost to Follow-up|5|||
33533251|NCT01839916|101852909|FG000|Overall Study|Relapse|12|||
33533252|NCT01839916|101852909|FG000|Overall Study|GVHD|2|||
33533253|NCT01839916|101852909|FG000|Overall Study|Graft Failure|1|||
33533254|NCT00492726|101852915|FG000|Overall Study|Adverse Event|10|||
33612963|NCT03197376|102133678|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
33337509|NCT01618214|101128292|FG000|Overall Study|Protocol Violation|1|||
33404962|NCT02911285|101373234|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
33404963|NCT02911285|101373235|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
33404964|NCT02924129|101373236|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
33404965|NCT02924129|101373237|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
33404966|NCT02924129|101373236|FG000|Overall Study|Withdrawal by Subject|2|||
33404967|NCT02924129|101373237|FG001|Overall Study|Withdrawal by Subject|2|||
33404968|NCT02924129|101373236|FG000|Overall Study|Physician Decision|1|||
33404969|NCT02924129|101373237|FG001|Overall Study|Physician Decision|0|||
33404970|NCT02924129|101373236|FG000|Overall Study|Missed Visit|0|||
33404971|NCT02924129|101373237|FG001|Overall Study|Missed Visit|1|||
33404972|NCT02135848|101373238|FG000|Overall Study|Adverse Event|2|||
33404973|NCT02135848|101373239|FG001|Overall Study|Adverse Event|0|||
33404974|NCT02135848|101373238|FG000|Overall Study|Withdrawal by Subject|1|||
33404975|NCT02135848|101373239|FG001|Overall Study|Withdrawal by Subject|1|||
33404976|NCT01004861|101373240|FG000|Overall Study|Disease progression|3|||
33404977|NCT01004861|101373241|FG001|Overall Study|Disease progression|4|||
33404978|NCT01004861|101373242|FG002|Overall Study|Disease progression|5|||
33404979|NCT01004861|101373243|FG003|Overall Study|Disease progression|4|||
33612964|NCT03197376|102133679|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
33612965|NCT03197376|102133680|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
33612966|NCT03197376|102133681|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
33612967|NCT03197376|102133678|FG000|Immune Persistence Phase|Not vaccine related|1|||
33612968|NCT03197376|102133679|FG001|Immune Persistence Phase|Not vaccine related|0|||
33612969|NCT03197376|102133680|FG002|Immune Persistence Phase|Not vaccine related|1|||
33612970|NCT03197376|102133681|FG003|Immune Persistence Phase|Not vaccine related|1|||
33612971|NCT00842543|102133683|FG000|Overall Study|Withdrawal by Subject|2|||
33612972|NCT00842543|102133684|FG001|Overall Study|Withdrawal by Subject|0|||
33612973|NCT00842543|102133685|FG002|Overall Study|Withdrawal by Subject|3|||
33612974|NCT00842543|102133686|FG003|Overall Study|Withdrawal by Subject|4|||
33612975|NCT02669121|102133687|FG000|Overall Study|Adverse Event|4|||
33612976|NCT02669121|102133688|FG001|Overall Study|Adverse Event|5|||
33612977|NCT02669121|102133687|FG000|Overall Study|Lost to Follow-up|15|||
33612978|NCT02669121|102133688|FG001|Overall Study|Lost to Follow-up|27|||
33612979|NCT02669121|102133687|FG000|Overall Study|Withdrawal by Subject|132|||
33612980|NCT02669121|102133688|FG001|Overall Study|Withdrawal by Subject|140|||
33612981|NCT02669121|102133687|FG000|Overall Study|Pregnancy|0|||
33612982|NCT02669121|102133688|FG001|Overall Study|Pregnancy|1|||
33612983|NCT02669121|102133687|FG000|Overall Study|Discharged from US Military Active Service|117|||
33612984|NCT02669121|102133688|FG001|Overall Study|Discharged from US Military Active Service|91|||
33612985|NCT02669121|102133687|FG000|Overall Study|Reason not Specified|22|||
33612986|NCT02669121|102133688|FG001|Overall Study|Reason not Specified|18|||
33612987|NCT01611194|102133693|FG000|Overall Study|Lost to Follow-up|0|||
33612988|NCT01611194|102133694|FG001|Overall Study|Lost to Follow-up|1|||
33612989|NCT01611194|102133693|FG000|Overall Study|Withdrawal by Subject|0|||
33612990|NCT01611194|102133694|FG001|Overall Study|Withdrawal by Subject|1|||
33612991|NCT01611194|102133693|FG000|Overall Study|drug use|0|||
33612992|NCT01611194|102133694|FG001|Overall Study|drug use|1|||
33612993|NCT03517228|102133695|FG000|Overall Study|Withdrawal by Subject|2|||
33612994|NCT03517228|102133695|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
33612995|NCT03517228|102133695|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
33612996|NCT03517228|102133695|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
33612997|NCT03517228|102133695|FG000|Overall Study|Canceled due to device being updated|1|||
33612998|NCT03517228|102133695|FG000|Overall Study|No V Cares in stock|1|||
33612999|NCT03517228|102133695|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
33613000|NCT01240135|102133696|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
33613001|NCT01240135|102133697|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
33613002|NCT01240135|102133696|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
33613003|NCT01240135|102133697|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
33613004|NCT02560012|102133700|FG000|Overall Study|Study Terminated|2|||
33337510|NCT01618214|101128293|FG001|Overall Study|Protocol Violation|4|||
33404980|NCT01004861|101373244|FG004|Overall Study|Disease progression|4|||
33404981|NCT01004861|101373245|FG005|Overall Study|Disease progression|4|||
33404982|NCT01004861|101373246|FG006|Overall Study|Disease progression|5|||
33404983|NCT01004861|101373247|FG007|Overall Study|Disease progression|1|||
33613005|NCT02006979|102133701|FG000|Overall Study|Withdrawal by Subject|1|||
33613006|NCT02006979|102133702|FG001|Overall Study|Withdrawal by Subject|1|||
33613007|NCT02006979|102133701|FG000|Overall Study|Protocol Violation|0|||
33613008|NCT02006979|102133702|FG001|Overall Study|Protocol Violation|1|||
33404984|NCT01004861|101373248|FG008|Overall Study|Disease progression|4|||
33404985|NCT01004861|101373249|FG009|Overall Study|Disease progression|7|||
33404986|NCT01004861|101373250|FG010|Overall Study|Disease progression|6|||
33404987|NCT01004861|101373251|FG011|Overall Study|Disease progression|3|||
33404988|NCT01004861|101373252|FG012|Overall Study|Disease progression|8|||
33404989|NCT01004861|101373240|FG000|Overall Study|Physician Decision|0|||
33404990|NCT01004861|101373241|FG001|Overall Study|Physician Decision|2|||
33404991|NCT01004861|101373242|FG002|Overall Study|Physician Decision|1|||
33404992|NCT01004861|101373243|FG003|Overall Study|Physician Decision|1|||
33404993|NCT01004861|101373244|FG004|Overall Study|Physician Decision|1|||
33404994|NCT01004861|101373245|FG005|Overall Study|Physician Decision|0|||
33404995|NCT01004861|101373246|FG006|Overall Study|Physician Decision|0|||
33404996|NCT01004861|101373247|FG007|Overall Study|Physician Decision|1|||
33404997|NCT01004861|101373248|FG008|Overall Study|Physician Decision|0|||
33404998|NCT01004861|101373249|FG009|Overall Study|Physician Decision|0|||
33404999|NCT01004861|101373250|FG010|Overall Study|Physician Decision|0|||
33405000|NCT01004861|101373251|FG011|Overall Study|Physician Decision|0|||
33405001|NCT01004861|101373252|FG012|Overall Study|Physician Decision|3|||
33405002|NCT01004861|101373240|FG000|Overall Study|Adverse Event|0|||
33405003|NCT01004861|101373241|FG001|Overall Study|Adverse Event|0|||
33405004|NCT01004861|101373242|FG002|Overall Study|Adverse Event|0|||
33405005|NCT01004861|101373243|FG003|Overall Study|Adverse Event|1|||
33405006|NCT01004861|101373244|FG004|Overall Study|Adverse Event|0|||
33405007|NCT01004861|101373245|FG005|Overall Study|Adverse Event|2|||
33405008|NCT01004861|101373246|FG006|Overall Study|Adverse Event|1|||
33405009|NCT01004861|101373247|FG007|Overall Study|Adverse Event|1|||
33405010|NCT01004861|101373248|FG008|Overall Study|Adverse Event|13|||
33405011|NCT01004861|101373249|FG009|Overall Study|Adverse Event|1|||
33405012|NCT01004861|101373250|FG010|Overall Study|Adverse Event|1|||
33405013|NCT01004861|101373251|FG011|Overall Study|Adverse Event|0|||
33405014|NCT01004861|101373252|FG012|Overall Study|Adverse Event|2|||
33405015|NCT01004861|101373240|FG000|Overall Study|Protocol Violation|0|||
33405016|NCT01004861|101373241|FG001|Overall Study|Protocol Violation|0|||
33405017|NCT01004861|101373242|FG002|Overall Study|Protocol Violation|0|||
33405018|NCT01004861|101373243|FG003|Overall Study|Protocol Violation|0|||
33405019|NCT01004861|101373244|FG004|Overall Study|Protocol Violation|1|||
33405020|NCT01004861|101373245|FG005|Overall Study|Protocol Violation|0|||
33405021|NCT01004861|101373246|FG006|Overall Study|Protocol Violation|0|||
33405022|NCT01004861|101373247|FG007|Overall Study|Protocol Violation|0|||
33405023|NCT01004861|101373248|FG008|Overall Study|Protocol Violation|0|||
33405024|NCT01004861|101373249|FG009|Overall Study|Protocol Violation|0|||
33405025|NCT01004861|101373250|FG010|Overall Study|Protocol Violation|0|||
33405026|NCT01004861|101373251|FG011|Overall Study|Protocol Violation|0|||
33405027|NCT01004861|101373252|FG012|Overall Study|Protocol Violation|0|||
33405028|NCT01004861|101373240|FG000|Overall Study|Lost to Follow-up|0|||
33405029|NCT01004861|101373241|FG001|Overall Study|Lost to Follow-up|0|||
33405030|NCT01004861|101373242|FG002|Overall Study|Lost to Follow-up|0|||
33405031|NCT01004861|101373243|FG003|Overall Study|Lost to Follow-up|0|||
33405032|NCT01004861|101373244|FG004|Overall Study|Lost to Follow-up|0|||
33405033|NCT01004861|101373245|FG005|Overall Study|Lost to Follow-up|0|||
33405034|NCT01004861|101373246|FG006|Overall Study|Lost to Follow-up|0|||
33405035|NCT01004861|101373247|FG007|Overall Study|Lost to Follow-up|1|||
33405036|NCT01004861|101373248|FG008|Overall Study|Lost to Follow-up|3|||
33405037|NCT01004861|101373249|FG009|Overall Study|Lost to Follow-up|0|||
33405038|NCT01004861|101373250|FG010|Overall Study|Lost to Follow-up|0|||
33405039|NCT01004861|101373251|FG011|Overall Study|Lost to Follow-up|1|||
33405040|NCT01004861|101373252|FG012|Overall Study|Lost to Follow-up|0|||
33405041|NCT01004861|101373240|FG000|Overall Study|Non-compliance|0|||
33405042|NCT01004861|101373241|FG001|Overall Study|Non-compliance|0|||
33405043|NCT01004861|101373242|FG002|Overall Study|Non-compliance|0|||
33405044|NCT01004861|101373243|FG003|Overall Study|Non-compliance|0|||
33405045|NCT01004861|101373244|FG004|Overall Study|Non-compliance|0|||
33405046|NCT01004861|101373245|FG005|Overall Study|Non-compliance|0|||
33405047|NCT01004861|101373246|FG006|Overall Study|Non-compliance|0|||
33405048|NCT01004861|101373247|FG007|Overall Study|Non-compliance|0|||
33405049|NCT01004861|101373248|FG008|Overall Study|Non-compliance|5|||
33533255|NCT00492726|101852916|FG001|Overall Study|Adverse Event|6|||
33405050|NCT01004861|101373249|FG009|Overall Study|Non-compliance|0|||
33405051|NCT01004861|101373250|FG010|Overall Study|Non-compliance|0|||
33405052|NCT01004861|101373251|FG011|Overall Study|Non-compliance|0|||
33405053|NCT01004861|101373252|FG012|Overall Study|Non-compliance|1|||
33405054|NCT01004861|101373240|FG000|Overall Study|Other|0|||
33405055|NCT01004861|101373241|FG001|Overall Study|Other|0|||
33405056|NCT01004861|101373242|FG002|Overall Study|Other|0|||
33405057|NCT01004861|101373243|FG003|Overall Study|Other|0|||
33405058|NCT01004861|101373244|FG004|Overall Study|Other|0|||
33405059|NCT01004861|101373245|FG005|Overall Study|Other|0|||
33533256|NCT00492726|101852915|FG000|Overall Study|Death|7|||
33533257|NCT00492726|101852916|FG001|Overall Study|Death|2|||
33533258|NCT00492726|101852915|FG000|Overall Study|Lack of Efficacy|0|||
33533259|NCT00492726|101852916|FG001|Overall Study|Lack of Efficacy|2|||
33613009|NCT00555217|102133703|FG000|Overall Study|Withdrawal by Subject|35|||
33337511|NCT01618214|101128292|FG000|Overall Study|Withdrawal Criteria|1|||
33337512|NCT01618214|101128293|FG001|Overall Study|Withdrawal Criteria|2|||
33337513|NCT01618214|101128292|FG000|Overall Study|Unclassified|4|||
33337514|NCT01618214|101128293|FG001|Overall Study|Unclassified|5|||
33337515|NCT00516737|101128294|FG000|Overall Study|Lost to Follow-up|2|||
33337516|NCT00516737|101128295|FG001|Overall Study|Lost to Follow-up|0|||
33337517|NCT00516737|101128294|FG000|Overall Study|Physician Decision|0|||
33337518|NCT00516737|101128295|FG001|Overall Study|Physician Decision|1|||
33337519|NCT00516737|101128294|FG000|Overall Study|Withdrawal by Subject|0|||
33337520|NCT00516737|101128295|FG001|Overall Study|Withdrawal by Subject|1|||
33337521|NCT00516737|101128294|FG000|Overall Study|Lack of Qualifying Event|9|||
33337522|NCT00516737|101128295|FG001|Overall Study|Lack of Qualifying Event|6|||
33337523|NCT00749996|101128296|FG000|Overall Study|Lost to Follow-up|7|||
33337524|NCT00749996|101128297|FG001|Overall Study|Lost to Follow-up|4|||
33337525|NCT00749996|101128296|FG000|Overall Study|Withdrawal by Subject|5|||
33337526|NCT00749996|101128297|FG001|Overall Study|Withdrawal by Subject|4|||
33337527|NCT00749996|101128296|FG000|Overall Study|Protocol Violation|2|||
33337528|NCT00749996|101128297|FG001|Overall Study|Protocol Violation|3|||
33337529|NCT00749996|101128296|FG000|Overall Study|Physician Decision|2|||
33337530|NCT00749996|101128297|FG001|Overall Study|Physician Decision|0|||
33337531|NCT00749996|101128296|FG000|Overall Study|Pregnancy|0|||
33337532|NCT00749996|101128297|FG001|Overall Study|Pregnancy|2|||
33337533|NCT00749996|101128296|FG000|Overall Study|Adverse Event|1|||
33337534|NCT00749996|101128297|FG001|Overall Study|Adverse Event|0|||
33337535|NCT00749996|101128296|FG000|Overall Study|Death|1|||
33337536|NCT00749996|101128297|FG001|Overall Study|Death|0|||
33337537|NCT01780831|101128298|FG000|Overall Study|Withdrawal by Subject|0|||
33337538|NCT01780831|101128299|FG001|Overall Study|Withdrawal by Subject|0|||
33337539|NCT01780831|101128300|FG002|Overall Study|Withdrawal by Subject|4|||
33337540|NCT01780831|101128301|FG003|Overall Study|Withdrawal by Subject|0|||
33337541|NCT01780831|101128298|FG000|Overall Study|Lost to Follow-up|0|||
33533260|NCT00492726|101852915|FG000|Overall Study|Lost to Follow-up|27|||
33337542|NCT01780831|101128299|FG001|Overall Study|Lost to Follow-up|0|||
33337543|NCT01780831|101128300|FG002|Overall Study|Lost to Follow-up|0|||
33337544|NCT01780831|101128301|FG003|Overall Study|Lost to Follow-up|1|||
33337545|NCT03237065|101128303|FG000|Overall Study|Adverse Event|0|||
33337546|NCT03237065|101128304|FG001|Overall Study|Adverse Event|2|||
33337547|NCT03237065|101128303|FG000|Overall Study|Protocol Violation|0|||
33337548|NCT03237065|101128304|FG001|Overall Study|Protocol Violation|1|||
33337549|NCT03237065|101128303|FG000|Overall Study|Withdrawal by Subject|3|||
33337550|NCT03237065|101128304|FG001|Overall Study|Withdrawal by Subject|0|||
33337551|NCT03237065|101128303|FG000|Overall Study|Lost to Follow-up|1|||
33337552|NCT03237065|101128304|FG001|Overall Study|Lost to Follow-up|0|||
33337553|NCT03237065|101128303|FG000|Overall Study|Unable to obtain venous access|0|||
33337554|NCT03237065|101128304|FG001|Overall Study|Unable to obtain venous access|1|||
33337555|NCT00700271|101128312|FG000|Overall Study|Adverse Event|4|||
33533261|NCT00492726|101852916|FG001|Overall Study|Lost to Follow-up|19|||
33533262|NCT00492726|101852915|FG000|Overall Study|Physician Decision|0|||
33533263|NCT00492726|101852916|FG001|Overall Study|Physician Decision|1|||
33533264|NCT00492726|101852915|FG000|Overall Study|Withdrawal by Subject|6|||
33533265|NCT00492726|101852916|FG001|Overall Study|Withdrawal by Subject|3|||
33533266|NCT00492726|101852915|FG000|Overall Study|Non compliant with study medication|0|||
33533267|NCT00492726|101852916|FG001|Overall Study|Non compliant with study medication|3|||
33533268|NCT01687218|101852917|FG000|Overall Study|Withdrawal by Subject|2|||
33533269|NCT01687218|101852918|FG001|Overall Study|Withdrawal by Subject|3|||
33533270|NCT01687218|101852919|FG002|Overall Study|Withdrawal by Subject|0|||
33533271|NCT01687218|101852920|FG003|Overall Study|Withdrawal by Subject|1|||
33533272|NCT01687218|101852921|FG004|Overall Study|Withdrawal by Subject|1|||
33613010|NCT00555217|102133704|FG001|Overall Study|Withdrawal by Subject|31|||
33613011|NCT00555217|102133703|FG000|Overall Study|Lost to Follow-up|19|||
33613012|NCT00555217|102133704|FG001|Overall Study|Lost to Follow-up|20|||
33613013|NCT00555217|102133703|FG000|Overall Study|close out sites|21|||
33613014|NCT00555217|102133704|FG001|Overall Study|close out sites|17|||
33613015|NCT00793325|102133705|FG000|Overall Study|Protocol Violation|18|||
33613016|NCT00793325|102133705|FG000|Overall Study|Lost to Follow-up|1|||
33613017|NCT03722524|102133709|FG000|Overall Study|Protocol Violation|86|||
33613018|NCT03722524|102133709|FG000|Overall Study|Adverse Event|7|||
33613019|NCT03722524|102133709|FG000|Overall Study|Lost to Follow-up|1|||
33613020|NCT03722524|102133709|FG000|Overall Study|Reason is not stated|1|||
33613021|NCT03722524|102133709|FG000|Overall Study|Physician Decision|1|||
33613022|NCT03722524|102133709|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
33613023|NCT02473367|102133710|FG000|Wait 1|Withdrawal by Subject|1|||
33613024|NCT02473367|102133710|FG000|Period 4|Lost to Follow-up|1|||
33613025|NCT00245037|102133711|FG000|Overall Study|Death|17|||
33613026|NCT04039217|102133716|FG000|Overall Study|Lost to Follow-up|1|||
33613027|NCT02465203|102133717|FG000|Overall Study|Protocol Violation|1|||
33613028|NCT02465203|102133718|FG001|Overall Study|Protocol Violation|1|||
33613029|NCT02465203|102133719|FG002|Overall Study|Protocol Violation|1|||
33613030|NCT02465203|102133717|FG000|Overall Study|Study terminated by sponsor|50|||
33613031|NCT02465203|102133718|FG001|Overall Study|Study terminated by sponsor|34|||
33613032|NCT02465203|102133719|FG002|Overall Study|Study terminated by sponsor|11|||
33613033|NCT02465203|102133717|FG000|Overall Study|New therapy for study indication|4|||
33613034|NCT02465203|102133718|FG001|Overall Study|New therapy for study indication|0|||
33613035|NCT02465203|102133719|FG002|Overall Study|New therapy for study indication|0|||
33613036|NCT02465203|102133717|FG000|Overall Study|Patient/guardian decision|1|||
33613037|NCT02465203|102133718|FG001|Overall Study|Patient/guardian decision|1|||
33613038|NCT02465203|102133719|FG002|Overall Study|Patient/guardian decision|1|||
33613039|NCT02119663|102133721|FG000|Overall Study|Disease progression|26|||
33613040|NCT02119663|102133722|FG001|Overall Study|Disease progression|27|||
33613041|NCT02119663|102133721|FG000|Overall Study|Adverse Event|5|||
33613042|NCT02119663|102133722|FG001|Overall Study|Adverse Event|5|||
33613043|NCT02119663|102133721|FG000|Overall Study|Death|3|||
33206033|NCT03478891|100655928|FG000|Overall Study|Enrolled, but product never administered|0|||
33337556|NCT00700271|101128313|FG001|Overall Study|Adverse Event|6|||
33533273|NCT01687218|101852922|FG005|Overall Study|Withdrawal by Subject|0|||
33533274|NCT01687218|101852917|FG000|Overall Study|Relocated, no follow-up planned|1|||
33613044|NCT02119663|102133722|FG001|Overall Study|Death|2|||
33613045|NCT02119663|102133721|FG000|Overall Study|Physician Decision|1|||
33613046|NCT02119663|102133722|FG001|Overall Study|Physician Decision|2|||
33613047|NCT02119663|102133721|FG000|Overall Study|Other unspecified|2|||
33613048|NCT02119663|102133722|FG001|Overall Study|Other unspecified|0|||
33405060|NCT01004861|101373246|FG006|Overall Study|Other|0|||
33405061|NCT01004861|101373247|FG007|Overall Study|Other|0|||
33405062|NCT01004861|101373248|FG008|Overall Study|Other|0|||
33405063|NCT01004861|101373249|FG009|Overall Study|Other|2|||
33405064|NCT01004861|101373250|FG010|Overall Study|Other|1|||
33405065|NCT01004861|101373251|FG011|Overall Study|Other|2|||
33405066|NCT01004861|101373252|FG012|Overall Study|Other|3|||
33405067|NCT01004861|101373240|FG000|Overall Study|Patient decision|0|||
33405068|NCT01004861|101373241|FG001|Overall Study|Patient decision|0|||
33405069|NCT01004861|101373242|FG002|Overall Study|Patient decision|0|||
33405070|NCT01004861|101373243|FG003|Overall Study|Patient decision|0|||
33405071|NCT01004861|101373244|FG004|Overall Study|Patient decision|1|||
33405072|NCT01004861|101373245|FG005|Overall Study|Patient decision|0|||
33405073|NCT01004861|101373246|FG006|Overall Study|Patient decision|1|||
33405074|NCT01004861|101373247|FG007|Overall Study|Patient decision|0|||
33405075|NCT01004861|101373248|FG008|Overall Study|Patient decision|7|||
33405076|NCT01004861|101373249|FG009|Overall Study|Patient decision|1|||
33405077|NCT01004861|101373250|FG010|Overall Study|Patient decision|1|||
33405078|NCT01004861|101373251|FG011|Overall Study|Patient decision|2|||
33405079|NCT01004861|101373252|FG012|Overall Study|Patient decision|3|||
33405080|NCT01004861|101373240|FG000|Overall Study|Transitioned to Phase 4 study|0|||
33405081|NCT01004861|101373241|FG001|Overall Study|Transitioned to Phase 4 study|0|||
33405082|NCT01004861|101373242|FG002|Overall Study|Transitioned to Phase 4 study|0|||
33405083|NCT01004861|101373243|FG003|Overall Study|Transitioned to Phase 4 study|0|||
33405084|NCT01004861|101373244|FG004|Overall Study|Transitioned to Phase 4 study|0|||
33405085|NCT01004861|101373245|FG005|Overall Study|Transitioned to Phase 4 study|0|||
33405086|NCT01004861|101373246|FG006|Overall Study|Transitioned to Phase 4 study|0|||
33405087|NCT01004861|101373247|FG007|Overall Study|Transitioned to Phase 4 study|0|||
33405088|NCT01004861|101373248|FG008|Overall Study|Transitioned to Phase 4 study|2|||
33405089|NCT01004861|101373249|FG009|Overall Study|Transitioned to Phase 4 study|0|||
33405090|NCT01004861|101373250|FG010|Overall Study|Transitioned to Phase 4 study|0|||
33405091|NCT01004861|101373251|FG011|Overall Study|Transitioned to Phase 4 study|0|||
33405092|NCT01004861|101373252|FG012|Overall Study|Transitioned to Phase 4 study|0|||
33405093|NCT01004861|101373240|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33405094|NCT01004861|101373241|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33405095|NCT01004861|101373242|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33405096|NCT01004861|101373243|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33405097|NCT01004861|101373244|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33405098|NCT01004861|101373245|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33405099|NCT01004861|101373246|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33405100|NCT01004861|101373247|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33405101|NCT01004861|101373248|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
33405102|NCT01004861|101373249|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33405103|NCT01004861|101373250|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33405104|NCT01004861|101373251|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33405105|NCT01004861|101373252|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
33405106|NCT01004861|101373240|FG000|Overall Study|Patient withdrew|0|||
33405107|NCT01004861|101373241|FG001|Overall Study|Patient withdrew|0|||
33405108|NCT01004861|101373242|FG002|Overall Study|Patient withdrew|0|||
33405109|NCT01004861|101373243|FG003|Overall Study|Patient withdrew|0|||
33405110|NCT01004861|101373244|FG004|Overall Study|Patient withdrew|0|||
33405111|NCT01004861|101373245|FG005|Overall Study|Patient withdrew|0|||
33405112|NCT01004861|101373246|FG006|Overall Study|Patient withdrew|0|||
33405113|NCT01004861|101373247|FG007|Overall Study|Patient withdrew|0|||
33533275|NCT01687218|101852918|FG001|Overall Study|Relocated, no follow-up planned|0|||
33533276|NCT01687218|101852919|FG002|Overall Study|Relocated, no follow-up planned|1|||
33405114|NCT01004861|101373248|FG008|Overall Study|Patient withdrew|1|||
33405115|NCT01004861|101373249|FG009|Overall Study|Patient withdrew|0|||
33405116|NCT01004861|101373250|FG010|Overall Study|Patient withdrew|0|||
33405117|NCT01004861|101373251|FG011|Overall Study|Patient withdrew|0|||
33405118|NCT01004861|101373252|FG012|Overall Study|Patient withdrew|0|||
33405119|NCT01004861|101373240|FG000|Overall Study|Surgical resection|0|||
33405120|NCT01004861|101373241|FG001|Overall Study|Surgical resection|0|||
33405121|NCT01004861|101373242|FG002|Overall Study|Surgical resection|0|||
33405122|NCT01004861|101373243|FG003|Overall Study|Surgical resection|0|||
33405123|NCT01004861|101373244|FG004|Overall Study|Surgical resection|0|||
33405124|NCT01004861|101373245|FG005|Overall Study|Surgical resection|0|||
33405125|NCT01004861|101373246|FG006|Overall Study|Surgical resection|0|||
33405126|NCT01004861|101373247|FG007|Overall Study|Surgical resection|0|||
33533277|NCT01687218|101852920|FG003|Overall Study|Relocated, no follow-up planned|1|||
33533278|NCT01687218|101852921|FG004|Overall Study|Relocated, no follow-up planned|0|||
33405127|NCT01004861|101373248|FG008|Overall Study|Surgical resection|1|||
33405128|NCT01004861|101373249|FG009|Overall Study|Surgical resection|0|||
33405129|NCT01004861|101373250|FG010|Overall Study|Surgical resection|0|||
33405130|NCT01004861|101373251|FG011|Overall Study|Surgical resection|0|||
33405131|NCT01004861|101373252|FG012|Overall Study|Surgical resection|0|||
33405132|NCT01004861|101373240|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33405133|NCT01004861|101373241|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33405134|NCT01004861|101373242|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33405135|NCT01004861|101373243|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33405136|NCT01004861|101373244|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33405137|NCT01004861|101373245|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33405138|NCT01004861|101373246|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33405139|NCT01004861|101373247|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33405140|NCT01004861|101373248|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
33533279|NCT01687218|101852922|FG005|Overall Study|Relocated, no follow-up planned|0|||
33533280|NCT02667301|101852923|FG000|Overall Study|Adverse Event|1|||
33533281|NCT02667301|101852923|FG000|Overall Study|Lack of Efficacy|1|||
33533282|NCT01190813|101852930|FG000|Overall Study|Lost to Follow-up|1|||
33533283|NCT01190813|101852931|FG001|Overall Study|Lost to Follow-up|2|||
33533284|NCT01190813|101852930|FG000|Overall Study|Withdrawal by Subject|2|||
33533285|NCT01190813|101852931|FG001|Overall Study|Withdrawal by Subject|1|||
33533286|NCT01190813|101852930|FG000|Overall Study|Refused study treatment after randomized|1|||
33533287|NCT01190813|101852931|FG001|Overall Study|Refused study treatment after randomized|0|||
33533288|NCT01190813|101852930|FG000|Overall Study|Adverse Event|0|||
33533289|NCT01190813|101852931|FG001|Overall Study|Adverse Event|1|||
33533290|NCT03118518|101852932|FG000|Overall Study|Early Exit after treatment|2|||
33533291|NCT03118518|101852933|FG001|Overall Study|Early Exit after treatment|8|||
33533292|NCT03118518|101852932|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
33533293|NCT03118518|101852933|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
33533294|NCT03188055|101852934|FG000|Overall Study|Unavailable for training|0|||
33533295|NCT03188055|101852935|FG001|Overall Study|Unavailable for training|0|||
33533296|NCT03188055|101852936|FG002|Overall Study|Unavailable for training|19|||
33533297|NCT03188055|101852937|FG003|Overall Study|Unavailable for training|0|||
33533298|NCT03188055|101852938|FG004|Overall Study|Unavailable for training|0|||
33533299|NCT03188055|101852939|FG005|Overall Study|Unavailable for training|0|||
33337557|NCT00700271|101128312|FG000|Overall Study|Protocol Violation|1|||
33337558|NCT00700271|101128313|FG001|Overall Study|Protocol Violation|0|||
33337559|NCT00700271|101128312|FG000|Overall Study|Administrative Reasons|1|||
33337560|NCT00700271|101128313|FG001|Overall Study|Administrative Reasons|0|||
33337561|NCT00700271|101128312|FG000|Overall Study|Withdrawal by Subject|6|||
33337562|NCT00700271|101128313|FG001|Overall Study|Withdrawal by Subject|4|||
33337563|NCT00700271|101128312|FG000|Overall Study|Lost to Follow-up|2|||
33337564|NCT00700271|101128313|FG001|Overall Study|Lost to Follow-up|2|||
33337565|NCT00603915|101128316|FG000|Overall Study|Physician Decision|1|||
33337566|NCT00845728|101128317|FG000|Overall Study|Abnormal laboratory value (s)|2|||
33337567|NCT00845728|101128318|FG001|Overall Study|Abnormal laboratory value (s)|2|||
33337568|NCT00845728|101128317|FG000|Overall Study|Patient's inability to use the device|4|||
33337569|NCT00845728|101128318|FG001|Overall Study|Patient's inability to use the device|6|||
33337570|NCT00845728|101128317|FG000|Overall Study|Abnormal test procedure result (s)|7|||
33337571|NCT00845728|101128318|FG001|Overall Study|Abnormal test procedure result (s)|2|||
33533300|NCT03188055|101852934|FG000|Overall Study|Lost to Follow-up|0|||
33533301|NCT03188055|101852935|FG001|Overall Study|Lost to Follow-up|18|||
33533302|NCT03188055|101852936|FG002|Overall Study|Lost to Follow-up|0|||
33533303|NCT03188055|101852937|FG003|Overall Study|Lost to Follow-up|11|||
33533304|NCT03188055|101852938|FG004|Overall Study|Lost to Follow-up|0|||
33337572|NCT00845728|101128317|FG000|Overall Study|Lost to Follow-up|22|||
33337573|NCT00845728|101128318|FG001|Overall Study|Lost to Follow-up|13|||
33337574|NCT00845728|101128317|FG000|Overall Study|Death|24|||
33337575|NCT00845728|101128318|FG001|Overall Study|Death|26|||
33337576|NCT00845728|101128317|FG000|Overall Study|Administrative Problems|34|||
33337577|NCT00845728|101128318|FG001|Overall Study|Administrative Problems|26|||
33337578|NCT00845728|101128317|FG000|Overall Study|Protocol Violation|36|||
33337579|NCT00845728|101128318|FG001|Overall Study|Protocol Violation|24|||
33337580|NCT00845728|101128317|FG000|Overall Study|Lack of Efficacy|51|||
33337581|NCT00845728|101128318|FG001|Overall Study|Lack of Efficacy|39|||
33533305|NCT03188055|101852939|FG005|Overall Study|Lost to Follow-up|0|||
33533306|NCT03188055|101852934|FG000|Overall Study|Withdrawal by Subject|0|||
33533307|NCT03188055|101852935|FG001|Overall Study|Withdrawal by Subject|1|||
33533308|NCT03188055|101852936|FG002|Overall Study|Withdrawal by Subject|0|||
33533309|NCT03188055|101852937|FG003|Overall Study|Withdrawal by Subject|1|||
33533310|NCT03188055|101852938|FG004|Overall Study|Withdrawal by Subject|0|||
33533311|NCT03188055|101852939|FG005|Overall Study|Withdrawal by Subject|0|||
33533312|NCT04030598|101852944|FG000|Overall Study|Voluntary Withdrawal|0|||
33533313|NCT04030598|101852945|FG001|Overall Study|Voluntary Withdrawal|1|||
33533314|NCT04030598|101852946|FG002|Overall Study|Voluntary Withdrawal|0|||
33533315|NCT00115778|101852947|FG000|Overall Study|Withdrawal by Subject|0|||
33533316|NCT00115778|101852948|FG001|Overall Study|Withdrawal by Subject|1|||
33533317|NCT01096160|101852950|FG000|Overall Study|Adverse Event|0|||
33533318|NCT01096160|101852951|FG001|Overall Study|Adverse Event|0|||
33533319|NCT01096160|101852952|FG002|Overall Study|Adverse Event|1|||
33533320|NCT01096160|101852953|FG003|Overall Study|Adverse Event|0|||
33533321|NCT01096160|101852954|FG004|Overall Study|Adverse Event|0|||
33533322|NCT01096160|101852955|FG005|Overall Study|Adverse Event|0|||
33533323|NCT01096160|101852956|FG006|Overall Study|Adverse Event|0|||
33533324|NCT01096160|101852957|FG007|Overall Study|Adverse Event|0|||
33533325|NCT01096160|101852958|FG008|Overall Study|Adverse Event|0|||
33533326|NCT01096160|101852959|FG009|Overall Study|Adverse Event|1|||
33533327|NCT01096160|101852950|FG000|Overall Study|Met stopping criteria per protocol|0|||
33533328|NCT01096160|101852951|FG001|Overall Study|Met stopping criteria per protocol|0|||
33533329|NCT01096160|101852952|FG002|Overall Study|Met stopping criteria per protocol|0|||
33533330|NCT01096160|101852953|FG003|Overall Study|Met stopping criteria per protocol|0|||
33533331|NCT01096160|101852954|FG004|Overall Study|Met stopping criteria per protocol|1|||
33533332|NCT01096160|101852955|FG005|Overall Study|Met stopping criteria per protocol|0|||
33533333|NCT01096160|101852956|FG006|Overall Study|Met stopping criteria per protocol|2|||
33533334|NCT01096160|101852957|FG007|Overall Study|Met stopping criteria per protocol|0|||
33533335|NCT01096160|101852958|FG008|Overall Study|Met stopping criteria per protocol|2|||
33533336|NCT01096160|101852959|FG009|Overall Study|Met stopping criteria per protocol|0|||
33533337|NCT02219685|101852960|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
33533338|NCT02219685|101852961|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
33533339|NCT02219685|101852960|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
33533340|NCT02219685|101852961|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
33533341|NCT01841970|101852964|FG000|Overall Study|Withdrawal by Subject|1|||
33533342|NCT01841970|101852964|FG000|Overall Study|Physician Decision|2|||
33533343|NCT01841970|101852964|FG000|Overall Study|Lost to Follow-up|8|||
33533344|NCT00875563|101852965|FG000|Overall Study|Death|4|||
33533345|NCT00875563|101852965|FG000|Overall Study|Withdrawal by Subject|7|||
33206034|NCT03478891|100655929|FG001|Overall Study|Enrolled, but product never administered|0|||
33533346|NCT00875563|101852965|FG000|Overall Study|No long-term (3-5 year) consent|6|||
33533347|NCT00875563|101852965|FG000|Overall Study|Still be eligible for follow-up|7|||
33533348|NCT00922116|101852978|FG000|Overall Study|Adverse Event|4|||
33533349|NCT00922116|101852978|FG000|Overall Study|Death|1|||
33533350|NCT00922116|101852978|FG000|Overall Study|Lost to Follow-up|1|||
33533351|NCT00922116|101852978|FG000|Overall Study|Withdrawal by Subject|4|||
33533352|NCT00922116|101852978|FG000|Overall Study|Other|5|||
33533353|NCT00248651|101852979|FG000|Overall Study|Withdrawal by Subject|28|||
33533354|NCT00248651|101852980|FG001|Overall Study|Withdrawal by Subject|40|||
33533355|NCT00248651|101852981|FG002|Overall Study|Withdrawal by Subject|32|||
33533356|NCT01151345|101852982|FG000|First Intervention Period|Protocol Violation|0|||
33613049|NCT02119663|102133721|FG000|Overall Study|Subject decision|0|||
33337582|NCT00845728|101128317|FG000|Overall Study|Adverse Event|101|||
33337583|NCT00845728|101128318|FG001|Overall Study|Adverse Event|96|||
33337584|NCT00845728|101128317|FG000|Overall Study|Withdrawal by Subject|105|||
33337585|NCT00845728|101128318|FG001|Overall Study|Withdrawal by Subject|108|||
33337586|NCT02347176|101128327|FG000|Overall Study|Lost to Follow-up|2|||
33337587|NCT02347176|101128328|FG001|Overall Study|Lost to Follow-up|3|||
33337588|NCT02347176|101128329|FG002|Overall Study|Lost to Follow-up|1|||
33337589|NCT02347176|101128330|FG003|Overall Study|Lost to Follow-up|1|||
33337590|NCT02347176|101128327|FG000|Overall Study|Withdrawal by Subject|9|||
33337591|NCT02347176|101128328|FG001|Overall Study|Withdrawal by Subject|5|||
33337592|NCT02347176|101128329|FG002|Overall Study|Withdrawal by Subject|5|||
33337593|NCT02347176|101128330|FG003|Overall Study|Withdrawal by Subject|3|||
33337594|NCT02347176|101128327|FG000|Overall Study|Other|1|||
33337595|NCT02347176|101128328|FG001|Overall Study|Other|2|||
33337596|NCT02347176|101128329|FG002|Overall Study|Other|2|||
33337597|NCT02347176|101128330|FG003|Overall Study|Other|0|||
33337598|NCT01536860|101128331|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
33337599|NCT01536860|101128332|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
33337600|NCT01536860|101128333|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
33405141|NCT01004861|101373249|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33405142|NCT01004861|101373250|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33405143|NCT01004861|101373251|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33405144|NCT01004861|101373252|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
33405145|NCT01004861|101373240|FG000|Overall Study|Study termination by Sponsor|0|||
33405146|NCT01004861|101373241|FG001|Overall Study|Study termination by Sponsor|0|||
33405147|NCT01004861|101373242|FG002|Overall Study|Study termination by Sponsor|0|||
33405148|NCT01004861|101373243|FG003|Overall Study|Study termination by Sponsor|0|||
33405149|NCT01004861|101373244|FG004|Overall Study|Study termination by Sponsor|0|||
33405150|NCT01004861|101373245|FG005|Overall Study|Study termination by Sponsor|0|||
33405151|NCT01004861|101373246|FG006|Overall Study|Study termination by Sponsor|0|||
33405152|NCT01004861|101373247|FG007|Overall Study|Study termination by Sponsor|0|||
33405153|NCT01004861|101373248|FG008|Overall Study|Study termination by Sponsor|1|||
33405154|NCT01004861|101373249|FG009|Overall Study|Study termination by Sponsor|0|||
33533357|NCT01151345|101852983|FG001|First Intervention Period|Protocol Violation|1|||
33533358|NCT02718911|101852984|FG000|Overall Study|Adverse Event|0|||
33533359|NCT02718911|101852985|FG001|Overall Study|Adverse Event|0|||
33533360|NCT02718911|101852986|FG002|Overall Study|Adverse Event|0|||
33533361|NCT02718911|101852987|FG003|Overall Study|Adverse Event|0|||
33613050|NCT02119663|102133722|FG001|Overall Study|Subject decision|1|||
33613051|NCT02119663|102133721|FG000|Overall Study|Study Terminated by the Sponsor|3|||
33613052|NCT02119663|102133722|FG001|Overall Study|Study Terminated by the Sponsor|4|||
33613053|NCT00042991|102133723|FG000|Overall Study|Adverse Event|1|||
33613054|NCT00042991|102133724|FG001|Overall Study|Adverse Event|4|||
33613055|NCT00042991|102133725|FG002|Overall Study|Adverse Event|2|||
33613056|NCT00042991|102133726|FG003|Overall Study|Adverse Event|0|||
33613057|NCT00042991|102133727|FG004|Overall Study|Adverse Event|0|||
33337601|NCT03354663|101128334|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
33337602|NCT03354663|101128334|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
33337603|NCT03354663|101128334|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
33405155|NCT01004861|101373250|FG010|Overall Study|Study termination by Sponsor|0|||
33405156|NCT01004861|101373251|FG011|Overall Study|Study termination by Sponsor|0|||
33533362|NCT02718911|101852988|FG004|Overall Study|Adverse Event|0|||
33533363|NCT02718911|101852989|FG005|Overall Study|Adverse Event|0|||
33533364|NCT02718911|101852990|FG006|Overall Study|Adverse Event|0|||
33533365|NCT02718911|101852991|FG007|Overall Study|Adverse Event|0|||
33533366|NCT02718911|101852992|FG008|Overall Study|Adverse Event|0|||
33533367|NCT02718911|101852993|FG009|Overall Study|Adverse Event|2|||
33533368|NCT02718911|101852984|FG000|Overall Study|Death|2|||
33533369|NCT02718911|101852985|FG001|Overall Study|Death|3|||
33613058|NCT00042991|102133728|FG005|Overall Study|Adverse Event|1|||
33613059|NCT00042991|102133729|FG006|Overall Study|Adverse Event|0|||
33337604|NCT03354663|101128334|FG000|Completed 30-day Visit|Missed Visit|1|||
33337605|NCT02111993|101128338|FG000|Overall Study|Physician Decision|5|||
33533370|NCT02718911|101852986|FG002|Overall Study|Death|1|||
33337606|NCT02111993|101128339|FG001|Overall Study|Physician Decision|4|||
33337607|NCT02889796|101128340|FG000|Overall Study|Withdrew Consent|18|||
33337608|NCT02889796|101128341|FG001|Overall Study|Withdrew Consent|29|||
33337609|NCT02889796|101128342|FG002|Overall Study|Withdrew Consent|20|||
33533371|NCT02718911|101852987|FG003|Overall Study|Death|0|||
33337610|NCT02889796|101128343|FG003|Overall Study|Withdrew Consent|1|||
33337611|NCT02889796|101128344|FG004|Overall Study|Withdrew Consent|2|||
33337612|NCT02889796|101128345|FG005|Overall Study|Withdrew Consent|35|||
33533372|NCT02718911|101852988|FG004|Overall Study|Death|1|||
33613060|NCT00042991|102133723|FG000|Overall Study|Withdrawal by Subject|0|||
33613061|NCT00042991|102133724|FG001|Overall Study|Withdrawal by Subject|7|||
33533373|NCT02718911|101852989|FG005|Overall Study|Death|3|||
33533374|NCT02718911|101852990|FG006|Overall Study|Death|1|||
33533375|NCT02718911|101852991|FG007|Overall Study|Death|1|||
33337613|NCT02889796|101128340|FG000|Overall Study|Investigator's Discretion|10|||
33533376|NCT02718911|101852992|FG008|Overall Study|Death|4|||
33613062|NCT00042991|102133725|FG002|Overall Study|Withdrawal by Subject|2|||
33613063|NCT00042991|102133726|FG003|Overall Study|Withdrawal by Subject|0|||
33613064|NCT00042991|102133727|FG004|Overall Study|Withdrawal by Subject|1|||
33613065|NCT00042991|102133728|FG005|Overall Study|Withdrawal by Subject|0|||
33613066|NCT00042991|102133729|FG006|Overall Study|Withdrawal by Subject|0|||
33613067|NCT00042991|102133723|FG000|Overall Study|Disease Progression|5|||
33613068|NCT00042991|102133724|FG001|Overall Study|Disease Progression|29|||
33613069|NCT00042991|102133725|FG002|Overall Study|Disease Progression|2|||
33613070|NCT00042991|102133726|FG003|Overall Study|Disease Progression|2|||
33613071|NCT00042991|102133727|FG004|Overall Study|Disease Progression|1|||
33613072|NCT00042991|102133728|FG005|Overall Study|Disease Progression|4|||
33613073|NCT00042991|102133729|FG006|Overall Study|Disease Progression|2|||
33613074|NCT00042991|102133723|FG000|Overall Study|Alternative Therapy|0|||
33613075|NCT00042991|102133724|FG001|Overall Study|Alternative Therapy|0|||
33613076|NCT00042991|102133725|FG002|Overall Study|Alternative Therapy|0|||
33613077|NCT00042991|102133726|FG003|Overall Study|Alternative Therapy|0|||
33613078|NCT00042991|102133727|FG004|Overall Study|Alternative Therapy|1|||
33613079|NCT00042991|102133728|FG005|Overall Study|Alternative Therapy|0|||
33613080|NCT00042991|102133729|FG006|Overall Study|Alternative Therapy|0|||
33613081|NCT01835223|102133730|FG000|Overall Study|Adverse Event|1|||
33613082|NCT01835223|102133731|FG001|Overall Study|Adverse Event|0|||
33613083|NCT01835223|102133730|FG000|Overall Study|Withdrawal by Subject|2|||
33613084|NCT01835223|102133731|FG001|Overall Study|Withdrawal by Subject|0|||
33613085|NCT01835223|102133730|FG000|Overall Study|Disease progression|2|||
33613086|NCT01835223|102133731|FG001|Overall Study|Disease progression|1|||
33613087|NCT01835223|102133730|FG000|Overall Study|Became Inelligible|4|||
33613088|NCT01835223|102133731|FG001|Overall Study|Became Inelligible|0|||
33613089|NCT00650845|102133732|FG000|Overall Study|Withdrawal by Subject|5|||
33533377|NCT02718911|101852993|FG009|Overall Study|Death|3|||
33533378|NCT02718911|101852984|FG000|Overall Study|Lost to Follow-up|0|||
33533379|NCT02718911|101852985|FG001|Overall Study|Lost to Follow-up|0|||
33533380|NCT02718911|101852986|FG002|Overall Study|Lost to Follow-up|0|||
33533381|NCT02718911|101852987|FG003|Overall Study|Lost to Follow-up|0|||
33533382|NCT02718911|101852988|FG004|Overall Study|Lost to Follow-up|0|||
33533383|NCT02718911|101852989|FG005|Overall Study|Lost to Follow-up|0|||
33533384|NCT02718911|101852990|FG006|Overall Study|Lost to Follow-up|0|||
33533385|NCT02718911|101852991|FG007|Overall Study|Lost to Follow-up|0|||
33533386|NCT02718911|101852992|FG008|Overall Study|Lost to Follow-up|1|||
33533387|NCT02718911|101852993|FG009|Overall Study|Lost to Follow-up|0|||
33533388|NCT02718911|101852984|FG000|Overall Study|Physician Decision|2|||
33533389|NCT02718911|101852985|FG001|Overall Study|Physician Decision|0|||
33533390|NCT02718911|101852986|FG002|Overall Study|Physician Decision|1|||
33533391|NCT02718911|101852987|FG003|Overall Study|Physician Decision|1|||
33533392|NCT02718911|101852988|FG004|Overall Study|Physician Decision|0|||
33533393|NCT02718911|101852989|FG005|Overall Study|Physician Decision|0|||
33533394|NCT02718911|101852990|FG006|Overall Study|Physician Decision|0|||
33533395|NCT02718911|101852991|FG007|Overall Study|Physician Decision|1|||
33533396|NCT02718911|101852992|FG008|Overall Study|Physician Decision|2|||
33533397|NCT02718911|101852993|FG009|Overall Study|Physician Decision|1|||
33533398|NCT02718911|101852984|FG000|Overall Study|Withdrawal by Subject|0|||
33613090|NCT00650845|102133733|FG001|Overall Study|Withdrawal by Subject|0|||
33613091|NCT00650845|102133732|FG000|Overall Study|Protocol Violation|0|||
33337614|NCT02889796|101128341|FG001|Overall Study|Investigator's Discretion|9|||
33337615|NCT02889796|101128342|FG002|Overall Study|Investigator's Discretion|10|||
33337616|NCT02889796|101128343|FG003|Overall Study|Investigator's Discretion|3|||
33337617|NCT02889796|101128344|FG004|Overall Study|Investigator's Discretion|0|||
33337618|NCT02889796|101128345|FG005|Overall Study|Investigator's Discretion|15|||
33533399|NCT02718911|101852985|FG001|Overall Study|Withdrawal by Subject|0|||
33533400|NCT02718911|101852986|FG002|Overall Study|Withdrawal by Subject|0|||
33613092|NCT00650845|102133733|FG001|Overall Study|Protocol Violation|13|||
33613093|NCT02397057|102133734|FG000|Overall Study|Withdrawal by Subject|6|||
33613094|NCT02397057|102133735|FG001|Overall Study|Withdrawal by Subject|7|||
33613095|NCT02397057|102133734|FG000|Overall Study|Lost to Follow-up|4|||
33337619|NCT02889796|101128340|FG000|Overall Study|Adverse Event|17|||
33533401|NCT02718911|101852987|FG003|Overall Study|Withdrawal by Subject|0|||
33533402|NCT02718911|101852988|FG004|Overall Study|Withdrawal by Subject|1|||
33533403|NCT02718911|101852989|FG005|Overall Study|Withdrawal by Subject|0|||
33533404|NCT02718911|101852990|FG006|Overall Study|Withdrawal by Subject|0|||
33613096|NCT02397057|102133735|FG001|Overall Study|Lost to Follow-up|3|||
33613097|NCT02397057|102133734|FG000|Overall Study|Death|1|||
33613098|NCT02397057|102133735|FG001|Overall Study|Death|0|||
33613099|NCT02397057|102133734|FG000|Overall Study|Adverse Event|0|||
33613100|NCT02397057|102133735|FG001|Overall Study|Adverse Event|1|||
33613101|NCT02397057|102133734|FG000|Overall Study|Physician Decision|0|||
33613102|NCT02397057|102133735|FG001|Overall Study|Physician Decision|1|||
33613103|NCT02397057|102133734|FG000|Overall Study|Subject did not receive study drug|0|||
33613104|NCT02397057|102133735|FG001|Overall Study|Subject did not receive study drug|1|||
33613105|NCT00306527|102133736|FG000|Overall Study|Lost to Follow-up|3|||
33613106|NCT00306527|102133737|FG001|Overall Study|Lost to Follow-up|4|||
33533405|NCT02718911|101852991|FG007|Overall Study|Withdrawal by Subject|0|||
33533406|NCT02718911|101852992|FG008|Overall Study|Withdrawal by Subject|1|||
33337620|NCT02889796|101128341|FG001|Overall Study|Adverse Event|8|||
33337621|NCT02889796|101128342|FG002|Overall Study|Adverse Event|8|||
33337622|NCT02889796|101128343|FG003|Overall Study|Adverse Event|4|||
33337623|NCT02889796|101128344|FG004|Overall Study|Adverse Event|1|||
33337624|NCT02889796|101128345|FG005|Overall Study|Adverse Event|7|||
33337625|NCT02889796|101128340|FG000|Overall Study|Lost to Follow-up|5|||
33337626|NCT02889796|101128341|FG001|Overall Study|Lost to Follow-up|7|||
33533407|NCT02718911|101852993|FG009|Overall Study|Withdrawal by Subject|4|||
33613107|NCT00306527|102133738|FG002|Overall Study|Lost to Follow-up|3|||
33613108|NCT00306527|102133739|FG003|Overall Study|Lost to Follow-up|0|||
33533408|NCT02718911|101852984|FG000|Overall Study|Reason Not Collected|0|||
33405157|NCT01004861|101373252|FG012|Overall Study|Study termination by Sponsor|0|||
33533409|NCT02718911|101852985|FG001|Overall Study|Reason Not Collected|0|||
33533410|NCT02718911|101852986|FG002|Overall Study|Reason Not Collected|1|||
33533411|NCT02718911|101852987|FG003|Overall Study|Reason Not Collected|0|||
33533412|NCT02718911|101852988|FG004|Overall Study|Reason Not Collected|0|||
33533413|NCT02718911|101852989|FG005|Overall Study|Reason Not Collected|0|||
33533414|NCT02718911|101852990|FG006|Overall Study|Reason Not Collected|2|||
33533415|NCT02718911|101852991|FG007|Overall Study|Reason Not Collected|1|||
33613109|NCT00306527|102133736|FG000|Overall Study|Withdrawal by Subject|2|||
33613110|NCT00306527|102133737|FG001|Overall Study|Withdrawal by Subject|3|||
33613111|NCT00306527|102133738|FG002|Overall Study|Withdrawal by Subject|0|||
33337627|NCT02889796|101128342|FG002|Overall Study|Lost to Follow-up|2|||
33405158|NCT02569996|101373253|FG000|Overall Study|Adverse Event|6|||
33405159|NCT02569996|101373253|FG000|Overall Study|Physician Decision|3|||
33533416|NCT02718911|101852992|FG008|Overall Study|Reason Not Collected|4|||
33533417|NCT02718911|101852993|FG009|Overall Study|Reason Not Collected|9|||
33533418|NCT01450813|101852994|FG000|Overall Study|Physician Decision|1|||
33533419|NCT01450813|101852995|FG001|Overall Study|Physician Decision|1|||
33613112|NCT00306527|102133739|FG003|Overall Study|Withdrawal by Subject|3|||
33337628|NCT02889796|101128343|FG003|Overall Study|Lost to Follow-up|0|||
33337629|NCT02889796|101128344|FG004|Overall Study|Lost to Follow-up|2|||
33337630|NCT02889796|101128345|FG005|Overall Study|Lost to Follow-up|6|||
33337631|NCT02889796|101128340|FG000|Overall Study|Protocol Violation|0|||
33337632|NCT02889796|101128341|FG001|Overall Study|Protocol Violation|1|||
33337633|NCT02889796|101128342|FG002|Overall Study|Protocol Violation|3|||
33337634|NCT02889796|101128343|FG003|Overall Study|Protocol Violation|0|||
33337635|NCT02889796|101128344|FG004|Overall Study|Protocol Violation|0|||
33337636|NCT02889796|101128345|FG005|Overall Study|Protocol Violation|4|||
33337637|NCT02889796|101128340|FG000|Overall Study|Non-compliance With Study Drug|0|||
33337638|NCT02889796|101128341|FG001|Overall Study|Non-compliance With Study Drug|2|||
33337639|NCT02889796|101128342|FG002|Overall Study|Non-compliance With Study Drug|0|||
33337640|NCT02889796|101128343|FG003|Overall Study|Non-compliance With Study Drug|0|||
33337641|NCT02889796|101128344|FG004|Overall Study|Non-compliance With Study Drug|1|||
33337642|NCT02889796|101128345|FG005|Overall Study|Non-compliance With Study Drug|2|||
33337643|NCT02889796|101128340|FG000|Overall Study|Death|1|||
33337644|NCT02889796|101128341|FG001|Overall Study|Death|1|||
33337645|NCT02889796|101128342|FG002|Overall Study|Death|0|||
33337646|NCT02889796|101128343|FG003|Overall Study|Death|1|||
33337647|NCT02889796|101128344|FG004|Overall Study|Death|0|||
33337648|NCT02889796|101128345|FG005|Overall Study|Death|1|||
33337649|NCT02889796|101128340|FG000|Overall Study|Pregnancy|0|||
33337650|NCT02889796|101128341|FG001|Overall Study|Pregnancy|1|||
33337651|NCT02889796|101128342|FG002|Overall Study|Pregnancy|1|||
33337652|NCT02889796|101128343|FG003|Overall Study|Pregnancy|0|||
33337653|NCT02889796|101128344|FG004|Overall Study|Pregnancy|0|||
33337654|NCT02889796|101128345|FG005|Overall Study|Pregnancy|0|||
33337655|NCT02889796|101128340|FG000|Overall Study|Randomized but not Dosed|2|||
33337656|NCT02889796|101128341|FG001|Overall Study|Randomized but not Dosed|0|||
33337657|NCT02889796|101128342|FG002|Overall Study|Randomized but not Dosed|0|||
33337658|NCT02889796|101128343|FG003|Overall Study|Randomized but not Dosed|0|||
33533420|NCT01450813|101852996|FG002|Overall Study|Physician Decision|0|||
33533421|NCT01450813|101852997|FG003|Overall Study|Physician Decision|3|||
33337659|NCT02889796|101128344|FG004|Overall Study|Randomized but not Dosed|0|||
33337660|NCT02889796|101128345|FG005|Overall Study|Randomized but not Dosed|2|||
33337661|NCT00223496|101128348|FG000|Overall Study|screen failure|9|||
33533422|NCT00095979|101853001|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
33533423|NCT02899065|101853004|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
33337662|NCT00223496|101128348|FG000|Overall Study|Lost to Follow-up|4|||
33206035|NCT03478891|100655930|FG002|Overall Study|Enrolled, but product never administered|1|||
33206036|NCT03478891|100655928|FG000|Overall Study|Moved from area|0|||
33337663|NCT00223496|101128348|FG000|Overall Study|Lack of Efficacy|6|||
33337664|NCT00223496|101128348|FG000|Overall Study|Withdrawal by Subject|1|||
33337665|NCT00223496|101128348|FG000|Overall Study|Physician Decision|2|||
33613113|NCT00306527|102133736|FG000|Overall Study|Adverse Event|0|||
33405160|NCT02569996|101373253|FG000|Overall Study|Progression of the disease|18|||
33613114|NCT00306527|102133737|FG001|Overall Study|Adverse Event|0|||
33337666|NCT01568593|101128349|FG000|Overall Study|Lack of Efficacy|4|||
33337667|NCT01568593|101128350|FG001|Overall Study|Lack of Efficacy|1|||
33337668|NCT01568593|101128349|FG000|Overall Study|Adverse Event|3|||
33337669|NCT01568593|101128350|FG001|Overall Study|Adverse Event|2|||
33337670|NCT02229552|101128353|FG000|Baseline|Withdrawal by Subject|6|||
33337671|NCT02229552|101128353|FG000|1-year Follow up|Withdrawal by Subject|7|||
33337672|NCT02229552|101128353|FG000|1-year Follow up|Lost to Follow-up|18|||
33337673|NCT02229552|101128353|FG000|2-Year Follow up|Withdrawal by Subject|9|||
33337674|NCT02229552|101128353|FG000|2-Year Follow up|Lost to Follow-up|17|||
33337675|NCT01562548|101128354|FG000|Overall Study|Lost to Follow-up|0|||
33337676|NCT01562548|101128355|FG001|Overall Study|Lost to Follow-up|0|||
33337677|NCT01562548|101128356|FG002|Overall Study|Lost to Follow-up|1|||
33337678|NCT01562548|101128357|FG003|Overall Study|Lost to Follow-up|0|||
33337679|NCT02469090|101128358|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
33337680|NCT02469090|101128359|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
33337681|NCT02469090|101128360|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
33337682|NCT02469090|101128358|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
33337683|NCT02469090|101128359|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
33337684|NCT02469090|101128360|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
33337685|NCT02469090|101128358|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
33337686|NCT02469090|101128359|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
33337687|NCT02469090|101128360|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
33337688|NCT02469090|101128358|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
33337689|NCT02469090|101128359|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
33337690|NCT02469090|101128360|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
33337691|NCT02469090|101128358|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
33337692|NCT02469090|101128359|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
33337693|NCT02469090|101128360|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
33337694|NCT02469090|101128358|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
33337695|NCT02469090|101128359|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
33337696|NCT02469090|101128360|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
33337697|NCT02469090|101128358|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
33337698|NCT02469090|101128359|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
33337699|NCT02469090|101128360|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
33337700|NCT02469090|101128358|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
33337701|NCT02469090|101128359|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
33337702|NCT02469090|101128360|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
33337703|NCT00326898|101128363|FG000|Overall Study|Disease progression|52|||
33337704|NCT00326898|101128364|FG001|Overall Study|Disease progression|54|||
33337705|NCT00326898|101128365|FG002|Overall Study|Disease progression|102|||
33337706|NCT00326898|101128363|FG000|Overall Study|Adverse Event|124|||
33337707|NCT00326898|101128364|FG001|Overall Study|Adverse Event|128|||
33337708|NCT00326898|101128365|FG002|Overall Study|Adverse Event|33|||
33337709|NCT00326898|101128363|FG000|Overall Study|Death|2|||
33337710|NCT00326898|101128364|FG001|Overall Study|Death|0|||
33337711|NCT00326898|101128365|FG002|Overall Study|Death|0|||
33337712|NCT00326898|101128363|FG000|Overall Study|Withdrawal by Subject|134|||
33337713|NCT00326898|101128364|FG001|Overall Study|Withdrawal by Subject|128|||
33337714|NCT00326898|101128365|FG002|Overall Study|Withdrawal by Subject|32|||
33337715|NCT00326898|101128363|FG000|Overall Study|Alternative therapy|1|||
33337716|NCT00326898|101128364|FG001|Overall Study|Alternative therapy|0|||
33337717|NCT00326898|101128365|FG002|Overall Study|Alternative therapy|0|||
33337718|NCT00326898|101128363|FG000|Overall Study|Other complicating disease|5|||
33337719|NCT00326898|101128364|FG001|Overall Study|Other complicating disease|5|||
33337720|NCT00326898|101128365|FG002|Overall Study|Other complicating disease|4|||
33337721|NCT00326898|101128363|FG000|Overall Study|Other/Missing/Unknown|33|||
33337722|NCT00326898|101128364|FG001|Overall Study|Other/Missing/Unknown|28|||
33337723|NCT00326898|101128365|FG002|Overall Study|Other/Missing/Unknown|32|||
33337724|NCT00264875|101128366|FG000|Overall Study|Adverse Event|6|||
33337725|NCT00264875|101128366|FG000|Overall Study|Lost to Follow-up|6|||
33337726|NCT00264875|101128366|FG000|Overall Study|Protocol Violation|11|||
33337727|NCT00264875|101128366|FG000|Overall Study|Withdrawal by Subject|7|||
33337728|NCT01297270|101128367|FG000|Overall Study|Adverse Event|19|||
33337729|NCT01297270|101128368|FG001|Overall Study|Adverse Event|32|||
33337730|NCT01297270|101128369|FG002|Overall Study|Adverse Event|5|||
33337731|NCT01297270|101128367|FG000|Overall Study|Lack of Efficacy|15|||
33337732|NCT01297270|101128368|FG001|Overall Study|Lack of Efficacy|17|||
33337733|NCT01297270|101128369|FG002|Overall Study|Lack of Efficacy|15|||
33337734|NCT01297270|101128367|FG000|Overall Study|Lost to Follow-up|1|||
33337735|NCT01297270|101128368|FG001|Overall Study|Lost to Follow-up|2|||
33337736|NCT01297270|101128369|FG002|Overall Study|Lost to Follow-up|1|||
33337737|NCT01297270|101128367|FG000|Overall Study|Protocol Violation|0|||
33337738|NCT01297270|101128368|FG001|Overall Study|Protocol Violation|2|||
33337739|NCT01297270|101128369|FG002|Overall Study|Protocol Violation|0|||
33337740|NCT01297270|101128367|FG000|Overall Study|Withdrawal by Subject|7|||
33337741|NCT01297270|101128368|FG001|Overall Study|Withdrawal by Subject|15|||
33337742|NCT01297270|101128369|FG002|Overall Study|Withdrawal by Subject|7|||
33337743|NCT01297270|101128367|FG000|Overall Study|Other reason not defined above|3|||
33337744|NCT01297270|101128368|FG001|Overall Study|Other reason not defined above|3|||
33337745|NCT01297270|101128369|FG002|Overall Study|Other reason not defined above|1|||
33337746|NCT01297270|101128367|FG000|Overall Study|Not treated|0|||
33337747|NCT01297270|101128368|FG001|Overall Study|Not treated|1|||
33337748|NCT01297270|101128369|FG002|Overall Study|Not treated|0|||
33337749|NCT03847987|101128375|FG000|Overall Study|Lost to Follow-up|1|||
33337750|NCT03847987|101128376|FG001|Overall Study|Lost to Follow-up|0|||
33337751|NCT03847987|101128375|FG000|Overall Study|Adverse Event|2|||
33337752|NCT03847987|101128376|FG001|Overall Study|Adverse Event|0|||
33533424|NCT02899065|101853005|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
33533425|NCT02899065|101853004|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
33533426|NCT02899065|101853005|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
33533427|NCT02899065|101853004|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
33533428|NCT02899065|101853005|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
33533429|NCT04552132|101853006|FG000|Overall Study|Lost to Follow-up|4|||
33533430|NCT04552132|101853007|FG001|Overall Study|Lost to Follow-up|3|||
33533431|NCT04552132|101853006|FG000|Overall Study|Protocol Violation|1|||
33613115|NCT00306527|102133738|FG002|Overall Study|Adverse Event|1|||
33337753|NCT02002975|101128377|FG000|Overall Study|Case Report Forms Uncollected|135|||
33337754|NCT02002975|101128377|FG000|Overall Study|Protocol Deviation|437|||
33337755|NCT01692301|101128378|FG000|Overall Study|Adverse Event|15|||
33337756|NCT01692301|101128379|FG001|Overall Study|Adverse Event|12|||
33613116|NCT00306527|102133739|FG003|Overall Study|Adverse Event|1|||
33613117|NCT00306527|102133736|FG000|Overall Study|Death|1|||
33613118|NCT00306527|102133737|FG001|Overall Study|Death|0|||
33613119|NCT00306527|102133738|FG002|Overall Study|Death|1|||
33613120|NCT00306527|102133739|FG003|Overall Study|Death|2|||
33613121|NCT02942485|102133744|FG000|Overall Study|Lost to Follow-up|1|||
33613122|NCT02942485|102133745|FG001|Overall Study|Lost to Follow-up|0|||
33613123|NCT02106403|102133746|FG000|Follow-Up Visit 3|Other Reason|0|||
33613124|NCT02106403|102133747|FG001|Follow-Up Visit 3|Other Reason|0|||
33613125|NCT02106403|102133748|FG002|Follow-Up Visit 3|Other Reason|0|||
33613126|NCT02106403|102133749|FG003|Follow-Up Visit 3|Other Reason|0|||
33613127|NCT02106403|102133750|FG004|Follow-Up Visit 3|Other Reason|0|||
33337757|NCT01692301|101128378|FG000|Overall Study|Death|1|||
33533432|NCT04552132|101853007|FG001|Overall Study|Protocol Violation|0|||
33533433|NCT03372798|101853008|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
33613128|NCT02106403|102133751|FG005|Follow-Up Visit 3|Other Reason|1|||
33337758|NCT01692301|101128379|FG001|Overall Study|Death|2|||
33337759|NCT01692301|101128378|FG000|Overall Study|Lack of Efficacy|0|||
33337760|NCT01692301|101128379|FG001|Overall Study|Lack of Efficacy|5|||
33533434|NCT03372798|101853009|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
33533435|NCT03372798|101853008|FG000|Overall Study|Failure of imaging probe|0|||
33613129|NCT00555672|102133752|FG000|Overall Study|Death|0|||
33206037|NCT03478891|100655929|FG001|Overall Study|Moved from area|0|||
33206038|NCT03478891|100655930|FG002|Overall Study|Moved from area|1|||
33206039|NCT03478891|100655928|FG000|Overall Study|Lost to Follow-up|1|||
33206040|NCT03478891|100655929|FG001|Overall Study|Lost to Follow-up|0|||
33206041|NCT03478891|100655930|FG002|Overall Study|Lost to Follow-up|1|||
33206042|NCT01343368|100655931|FG000|Overall Study|Death|1|||
33206043|NCT01343368|100655932|FG001|Overall Study|Death|0|||
33206044|NCT01343368|100655931|FG000|Overall Study|Lost to Follow-up|1|||
33206045|NCT01343368|100655932|FG001|Overall Study|Lost to Follow-up|0|||
33206046|NCT01435577|100655933|FG000|Overall Study|Adverse Event|10|||
33206047|NCT01435577|100655934|FG001|Overall Study|Adverse Event|0|||
33206048|NCT01435577|100655933|FG000|Overall Study|Lack of Efficacy|7|||
33206049|NCT01435577|100655934|FG001|Overall Study|Lack of Efficacy|51|||
33206050|NCT01435577|100655933|FG000|Overall Study|Alternative treatment started|0|||
33206051|NCT01435577|100655934|FG001|Overall Study|Alternative treatment started|1|||
33206052|NCT04265755|100655935|FG000|Overall Study|Withdrawal by Subject|39|||
33206053|NCT04265755|100655935|FG000|Overall Study|Decision by sponsor|2|||
33206054|NCT04265755|100655935|FG000|Overall Study|Lost to Follow-up|11|||
33206055|NCT04265755|100655935|FG000|Overall Study|Death|1|||
33206056|NCT02244944|100655936|FG000|Overall Study|Withdrawal by Subject|1|||
33206057|NCT02244944|100655936|FG000|Overall Study|Study Terminated|1|||
33206058|NCT00096135|100655937|FG000|Overall Study|Physician Decision|20|||
33206059|NCT00096135|100655938|FG001|Overall Study|Physician Decision|4|||
33206060|NCT00096135|100655937|FG000|Overall Study|Refusal of further protocol therapy|4|||
33206061|NCT00096135|100655938|FG001|Overall Study|Refusal of further protocol therapy|1|||
33206062|NCT00096135|100655937|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
33206063|NCT00096135|100655938|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
33206064|NCT00096135|100655937|FG000|Overall Study|Other, specify|15|||
33206065|NCT00096135|100655938|FG001|Overall Study|Other, specify|3|||
33206066|NCT00096135|100655937|FG000|Overall Study|Ineligible|2|||
33206067|NCT00096135|100655938|FG001|Overall Study|Ineligible|0|||
33206068|NCT01660906|100655939|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
33206069|NCT02345512|100655940|FG000|Overall Study|Adverse Event|1|||
33206070|NCT02345512|100655940|FG000|Overall Study|Withdrawal by Subject|1|||
33206071|NCT02508311|100655941|FG000|Overall Study|Withdrawal by Subject|1|||
33206072|NCT02508311|100655942|FG001|Overall Study|Withdrawal by Subject|0|||
33206073|NCT00990652|100655944|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
33206074|NCT00990652|100655944|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
33206075|NCT02777593|100655945|FG000|Overall Study|Still in study|28|||
33206076|NCT02777593|100655946|FG001|Overall Study|Still in study|71|||
33206077|NCT02777593|100655947|FG002|Overall Study|Still in study|5|||
33206078|NCT02777593|100655948|FG003|Overall Study|Still in study|6|||
33206079|NCT02777593|100655949|FG004|Overall Study|Still in study|6|||
33206080|NCT02777593|100655945|FG000|Overall Study|Death|19|||
33206081|NCT02777593|100655946|FG001|Overall Study|Death|24|||
33206082|NCT02777593|100655947|FG002|Overall Study|Death|0|||
33206083|NCT02777593|100655948|FG003|Overall Study|Death|5|||
33206084|NCT02777593|100655949|FG004|Overall Study|Death|0|||
33206085|NCT02777593|100655945|FG000|Overall Study|Withdrawal by Subject|6|||
33206086|NCT02777593|100655946|FG001|Overall Study|Withdrawal by Subject|3|||
33206087|NCT02777593|100655947|FG002|Overall Study|Withdrawal by Subject|1|||
33206088|NCT02777593|100655948|FG003|Overall Study|Withdrawal by Subject|1|||
33206089|NCT02777593|100655949|FG004|Overall Study|Withdrawal by Subject|0|||
33206090|NCT02777593|100655945|FG000|Overall Study|Lost to Follow-up|4|||
33206091|NCT02777593|100655946|FG001|Overall Study|Lost to Follow-up|12|||
33206092|NCT02777593|100655947|FG002|Overall Study|Lost to Follow-up|4|||
33206093|NCT02777593|100655948|FG003|Overall Study|Lost to Follow-up|0|||
33206094|NCT02777593|100655949|FG004|Overall Study|Lost to Follow-up|0|||
33533436|NCT03372798|101853009|FG001|Overall Study|Failure of imaging probe|1|||
33533437|NCT01598610|101853010|FG000|Overall Study|Adverse Event|1|||
33533438|NCT00808067|101853011|FG000|Overall Study|Major/minor bleed|30|||
33533439|NCT00808067|101853012|FG001|Overall Study|Major/minor bleed|44|||
33533440|NCT00808067|101853011|FG000|Overall Study|Outcome event - other|33|||
33533441|NCT00808067|101853012|FG001|Overall Study|Outcome event - other|25|||
33533442|NCT00808067|101853011|FG000|Overall Study|Adverse Event|111|||
33533443|NCT00808067|101853012|FG001|Overall Study|Adverse Event|121|||
33206095|NCT02777593|100655945|FG000|Overall Study|Physician Decision|2|||
33206096|NCT02777593|100655946|FG001|Overall Study|Physician Decision|2|||
33206097|NCT02777593|100655947|FG002|Overall Study|Physician Decision|0|||
33206098|NCT02777593|100655948|FG003|Overall Study|Physician Decision|0|||
33206099|NCT02777593|100655949|FG004|Overall Study|Physician Decision|0|||
33533444|NCT00808067|101853011|FG000|Overall Study|Hospitalization (not including surgery)|18|||
33613130|NCT00555672|102133753|FG001|Overall Study|Death|2|||
33206100|NCT02777593|100655945|FG000|Overall Study|Discontinued due to Other|3|||
33206101|NCT02777593|100655946|FG001|Overall Study|Discontinued due to Other|0|||
33206102|NCT02777593|100655947|FG002|Overall Study|Discontinued due to Other|0|||
33206103|NCT02777593|100655948|FG003|Overall Study|Discontinued due to Other|0|||
33206104|NCT02777593|100655949|FG004|Overall Study|Discontinued due to Other|0|||
33613131|NCT00555672|102133752|FG000|Overall Study|Adverse Event|8|||
33206105|NCT02415400|100655950|FG000|Overall Study|Adverse Event|0|||
33206106|NCT02415400|100655951|FG001|Overall Study|Adverse Event|1|||
33206107|NCT02415400|100655952|FG002|Overall Study|Adverse Event|1|||
33206108|NCT02415400|100655953|FG003|Overall Study|Adverse Event|2|||
33206109|NCT02415400|100655950|FG000|Overall Study|Participant request to stop therapy|4|||
33206110|NCT02415400|100655951|FG001|Overall Study|Participant request to stop therapy|3|||
33206111|NCT02415400|100655952|FG002|Overall Study|Participant request to stop therapy|8|||
33206112|NCT02415400|100655953|FG003|Overall Study|Participant request to stop therapy|6|||
33206113|NCT02415400|100655950|FG000|Overall Study|Participant withdrew consent|14|||
33206114|NCT02415400|100655951|FG001|Overall Study|Participant withdrew consent|12|||
33206115|NCT02415400|100655952|FG002|Overall Study|Participant withdrew consent|30|||
33206116|NCT02415400|100655953|FG003|Overall Study|Participant withdrew consent|21|||
33206117|NCT02415400|100655950|FG000|Overall Study|Death|39|||
33206118|NCT02415400|100655951|FG001|Overall Study|Death|41|||
33206119|NCT02415400|100655952|FG002|Overall Study|Death|35|||
33206120|NCT02415400|100655953|FG003|Overall Study|Death|42|||
33206121|NCT02415400|100655950|FG000|Overall Study|Lost to Follow-up|3|||
33206122|NCT02415400|100655951|FG001|Overall Study|Lost to Follow-up|3|||
33206123|NCT02415400|100655952|FG002|Overall Study|Lost to Follow-up|2|||
33206124|NCT02415400|100655953|FG003|Overall Study|Lost to Follow-up|5|||
33206125|NCT02415400|100655950|FG000|Overall Study|Poor/Non-Compliance|0|||
33206126|NCT02415400|100655951|FG001|Overall Study|Poor/Non-Compliance|1|||
33206127|NCT02415400|100655952|FG002|Overall Study|Poor/Non-Compliance|3|||
33206128|NCT02415400|100655953|FG003|Overall Study|Poor/Non-Compliance|4|||
33206129|NCT02415400|100655950|FG000|Overall Study|Participant no longer meets criteria|2|||
33206130|NCT02415400|100655951|FG001|Overall Study|Participant no longer meets criteria|0|||
33206131|NCT02415400|100655952|FG002|Overall Study|Participant no longer meets criteria|0|||
33206132|NCT02415400|100655953|FG003|Overall Study|Participant no longer meets criteria|1|||
33206133|NCT02415400|100655950|FG000|Overall Study|Participant doesn't answer phone|1|||
33206134|NCT02415400|100655951|FG001|Overall Study|Participant doesn't answer phone|0|||
33206135|NCT02415400|100655952|FG002|Overall Study|Participant doesn't answer phone|0|||
33206136|NCT02415400|100655953|FG003|Overall Study|Participant doesn't answer phone|0|||
33206137|NCT02415400|100655950|FG000|Overall Study|Participant wanted home visits|1|||
33206138|NCT02415400|100655951|FG001|Overall Study|Participant wanted home visits|0|||
33206139|NCT02415400|100655952|FG002|Overall Study|Participant wanted home visits|0|||
33206140|NCT02415400|100655953|FG003|Overall Study|Participant wanted home visits|0|||
33206141|NCT02415400|100655950|FG000|Overall Study|Randomized in error|2|||
33206142|NCT02415400|100655951|FG001|Overall Study|Randomized in error|0|||
33206143|NCT02415400|100655952|FG002|Overall Study|Randomized in error|0|||
33206144|NCT02415400|100655953|FG003|Overall Study|Randomized in error|0|||
33206145|NCT02415400|100655950|FG000|Overall Study|No study drug on site|0|||
33206146|NCT02415400|100655951|FG001|Overall Study|No study drug on site|1|||
33206147|NCT02415400|100655952|FG002|Overall Study|No study drug on site|0|||
33206148|NCT02415400|100655953|FG003|Overall Study|No study drug on site|0|||
33206149|NCT02415400|100655950|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
33206150|NCT02415400|100655951|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
33206151|NCT02415400|100655952|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
33206152|NCT02415400|100655953|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
33206153|NCT02415400|100655950|FG000|Overall Study|Coagulation values cannot be set|0|||
33206154|NCT02415400|100655951|FG001|Overall Study|Coagulation values cannot be set|0|||
33405161|NCT02569996|101373253|FG000|Overall Study|New anti-lymphoma treatment|1|||
33206155|NCT02415400|100655952|FG002|Overall Study|Coagulation values cannot be set|1|||
33405162|NCT02569996|101373253|FG000|Overall Study|Non-compliance|9|||
33405163|NCT02569996|101373253|FG000|Overall Study|Withdrawal by Subject|5|||
33405164|NCT02569996|101373253|FG000|Overall Study|Lost to Follow-up|5|||
33206156|NCT02415400|100655953|FG003|Overall Study|Coagulation values cannot be set|0|||
33206157|NCT02415400|100655950|FG000|Overall Study|State regulations prevent participation|0|||
33206158|NCT02415400|100655951|FG001|Overall Study|State regulations prevent participation|0|||
33206159|NCT02415400|100655952|FG002|Overall Study|State regulations prevent participation|1|||
33206160|NCT02415400|100655953|FG003|Overall Study|State regulations prevent participation|0|||
33206161|NCT02415400|100655950|FG000|Overall Study|Poor treatment monitoring|0|||
33206162|NCT02415400|100655951|FG001|Overall Study|Poor treatment monitoring|0|||
33206163|NCT02415400|100655952|FG002|Overall Study|Poor treatment monitoring|1|||
33206164|NCT02415400|100655953|FG003|Overall Study|Poor treatment monitoring|0|||
33206165|NCT02415400|100655950|FG000|Overall Study|Participant in jail|0|||
33206166|NCT02415400|100655951|FG001|Overall Study|Participant in jail|0|||
33206167|NCT02415400|100655952|FG002|Overall Study|Participant in jail|1|||
33206168|NCT02415400|100655953|FG003|Overall Study|Participant in jail|0|||
33206169|NCT02415400|100655950|FG000|Overall Study|Investigator decision|0|||
33206170|NCT02415400|100655951|FG001|Overall Study|Investigator decision|0|||
33206171|NCT02415400|100655952|FG002|Overall Study|Investigator decision|1|||
33206172|NCT02415400|100655953|FG003|Overall Study|Investigator decision|1|||
33206173|NCT02415400|100655950|FG000|Overall Study|Site closure; participant won't transfer|0|||
33206174|NCT02415400|100655951|FG001|Overall Study|Site closure; participant won't transfer|0|||
33206175|NCT02415400|100655952|FG002|Overall Study|Site closure; participant won't transfer|0|||
33206176|NCT02415400|100655953|FG003|Overall Study|Site closure; participant won't transfer|1|||
33206177|NCT01458574|100655954|FG000|Overall Study|Adverse Event|5|||
33206178|NCT01458574|100655955|FG001|Overall Study|Adverse Event|9|||
33206179|NCT01458574|100655956|FG002|Overall Study|Adverse Event|7|||
33206180|NCT01458574|100655954|FG000|Overall Study|Lack of Efficacy|70|||
33206181|NCT01458574|100655955|FG001|Overall Study|Lack of Efficacy|53|||
33206182|NCT01458574|100655956|FG002|Overall Study|Lack of Efficacy|132|||
33206183|NCT01458574|100655954|FG000|Overall Study|Lost to Follow-up|3|||
33206184|NCT01458574|100655955|FG001|Overall Study|Lost to Follow-up|2|||
33206185|NCT01458574|100655956|FG002|Overall Study|Lost to Follow-up|1|||
33206186|NCT01458574|100655954|FG000|Overall Study|Pregnancy|1|||
33206187|NCT01458574|100655955|FG001|Overall Study|Pregnancy|1|||
33206188|NCT01458574|100655956|FG002|Overall Study|Pregnancy|0|||
33206189|NCT01458574|100655954|FG000|Overall Study|Protocol Violation|0|||
33206190|NCT01458574|100655955|FG001|Overall Study|Protocol Violation|1|||
33206191|NCT01458574|100655956|FG002|Overall Study|Protocol Violation|0|||
33206192|NCT01458574|100655954|FG000|Overall Study|Withdrawal by Subject|6|||
33206193|NCT01458574|100655955|FG001|Overall Study|Withdrawal by Subject|3|||
33206194|NCT01458574|100655956|FG002|Overall Study|Withdrawal by Subject|5|||
33206195|NCT01458574|100655954|FG000|Overall Study|Other|2|||
33206196|NCT01458574|100655955|FG001|Overall Study|Other|1|||
33206197|NCT01458574|100655956|FG002|Overall Study|Other|0|||
33206198|NCT01458574|100655954|FG000|Overall Study|Randomized but not treated|0|||
33206199|NCT01458574|100655955|FG001|Overall Study|Randomized but not treated|1|||
33206200|NCT01458574|100655956|FG002|Overall Study|Randomized but not treated|0|||
33206201|NCT03305016|100655959|FG000|Overall Study|Withdrawal by Subject|2|||
33206202|NCT03912259|100655960|FG000|Overall Study|Adverse Event (AE)|2|||
33206203|NCT03912259|100655961|FG001|Overall Study|Adverse Event (AE)|4|||
33206204|NCT03912259|100655960|FG000|Overall Study|Lack of Efficacy|4|||
33206205|NCT03912259|100655961|FG001|Overall Study|Lack of Efficacy|1|||
33206206|NCT03912259|100655960|FG000|Overall Study|Withdrawal by Subject|11|||
33206207|NCT03912259|100655961|FG001|Overall Study|Withdrawal by Subject|1|||
33206208|NCT03725982|100655962|FG000|First Intervention|Withdrawal by Subject|0|||
33206209|NCT03725982|100655963|FG001|First Intervention|Withdrawal by Subject|1|||
33206210|NCT03725982|100655962|FG000|First Intervention|Physician Decision|1|||
33206211|NCT03725982|100655963|FG001|First Intervention|Physician Decision|1|||
33206212|NCT01159691|100655964|FG000|Overall Study|Lost to Follow-up|2|||
33206213|NCT01159691|100655964|FG000|Overall Study|Unknown reasons|1|||
33206214|NCT01159691|100655964|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
33206215|NCT01159691|100655964|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
33206216|NCT01159691|100655964|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
33206217|NCT01159691|100655964|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
33206218|NCT01159691|100655964|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
33206219|NCT01159691|100655964|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
33206220|NCT01369342|100655965|FG000|Overall Study|Withdrawal by Subject|7|||
33613132|NCT00555672|102133753|FG001|Overall Study|Adverse Event|2|||
33206221|NCT01369342|100655966|FG001|Overall Study|Withdrawal by Subject|7|||
33206222|NCT01369342|100655967|FG002|Overall Study|Withdrawal by Subject|2|||
33206223|NCT01369342|100655965|FG000|Overall Study|Lost to Follow-up|5|||
33206224|NCT01369342|100655966|FG001|Overall Study|Lost to Follow-up|2|||
33337761|NCT01692301|101128378|FG000|Overall Study|Non-compliance with study treatment|1|||
33337762|NCT01692301|101128379|FG001|Overall Study|Non-compliance with study treatment|2|||
33337763|NCT01692301|101128378|FG000|Overall Study|Protocol deviation|9|||
33337764|NCT01692301|101128379|FG001|Overall Study|Protocol deviation|2|||
33206225|NCT01369342|100655967|FG002|Overall Study|Lost to Follow-up|1|||
33206226|NCT01369342|100655965|FG000|Overall Study|Not Treated|1|||
33206227|NCT01369342|100655966|FG001|Overall Study|Not Treated|0|||
33206228|NCT01369342|100655967|FG002|Overall Study|Not Treated|0|||
33206229|NCT01410448|100655972|FG000|Overall Study|No conversion to everolimus|0|||
33206230|NCT01410448|100655973|FG001|Overall Study|No conversion to everolimus|24|||
33206231|NCT01410448|100655972|FG000|Overall Study|Graft loss|4|||
33206232|NCT01410448|100655973|FG001|Overall Study|Graft loss|1|||
33206233|NCT01410448|100655972|FG000|Overall Study|Administrative issues|2|||
33533445|NCT00808067|101853012|FG001|Overall Study|Hospitalization (not including surgery)|17|||
33533446|NCT00808067|101853011|FG000|Overall Study|Hospitalization due to surgery|37|||
33533447|NCT00808067|101853012|FG001|Overall Study|Hospitalization due to surgery|40|||
33533448|NCT00808067|101853011|FG000|Overall Study|Reduced creatinine clearance|53|||
33533449|NCT00808067|101853012|FG001|Overall Study|Reduced creatinine clearance|55|||
33533450|NCT00808067|101853011|FG000|Overall Study|Elevated LFT results|7|||
33533451|NCT00808067|101853012|FG001|Overall Study|Elevated LFT results|3|||
33533452|NCT00808067|101853011|FG000|Overall Study|Patient refused to take study medication|65|||
33533453|NCT00808067|101853012|FG001|Overall Study|Patient refused to take study medication|76|||
33533454|NCT00808067|101853011|FG000|Overall Study|Missing|1|||
33206234|NCT01410448|100655973|FG001|Overall Study|Administrative issues|1|||
33206235|NCT01410448|100655972|FG000|Overall Study|Lost to Follow-up|1|||
33613133|NCT00555672|102133752|FG000|Overall Study|Objective progression or relapse|11|||
33613134|NCT00555672|102133753|FG001|Overall Study|Objective progression or relapse|5|||
33613135|NCT00555672|102133752|FG000|Overall Study|Other|3|||
33613136|NCT00555672|102133753|FG001|Overall Study|Other|1|||
33613137|NCT00555672|102133752|FG000|Overall Study|Participant refused|2|||
33613138|NCT00555672|102133753|FG001|Overall Study|Participant refused|0|||
33206236|NCT01410448|100655973|FG001|Overall Study|Lost to Follow-up|0|||
33533455|NCT00808067|101853012|FG001|Overall Study|Missing|0|||
33533456|NCT00808067|101853011|FG000|Overall Study|Death|1|||
33533457|NCT00808067|101853012|FG001|Overall Study|Death|1|||
33533458|NCT00808067|101853011|FG000|Overall Study|Procedure|6|||
33533459|NCT00808067|101853012|FG001|Overall Study|Procedure|7|||
33533460|NCT00808067|101853011|FG000|Overall Study|Withdrawal by Subject|21|||
33533461|NCT00808067|101853012|FG001|Overall Study|Withdrawal by Subject|25|||
33533462|NCT00808067|101853011|FG000|Overall Study|Site closed|4|||
33533463|NCT00808067|101853012|FG001|Overall Study|Site closed|3|||
33533464|NCT00808067|101853011|FG000|Overall Study|Physician Decision|47|||
33533465|NCT00808067|101853012|FG001|Overall Study|Physician Decision|38|||
33533466|NCT00808067|101853011|FG000|Overall Study|Protocol Violation|3|||
33533467|NCT00808067|101853012|FG001|Overall Study|Protocol Violation|11|||
33533468|NCT00808067|101853011|FG000|Overall Study|Patient elected|7|||
33533469|NCT00808067|101853012|FG001|Overall Study|Patient elected|9|||
33533470|NCT00808067|101853011|FG000|Overall Study|Site closed for cause|19|||
33533471|NCT00808067|101853012|FG001|Overall Study|Site closed for cause|19|||
33533472|NCT00808067|101853011|FG000|Overall Study|Other reason not defined above|5|||
33533473|NCT00808067|101853012|FG001|Overall Study|Other reason not defined above|5|||
33533474|NCT00808067|101853011|FG000|Overall Study|Excluded from analysis|13|||
33533475|NCT00808067|101853012|FG001|Overall Study|Excluded from analysis|19|||
33533476|NCT02340000|101853013|FG000|Time Period 1|Withdrawal by Subject|6|||
33533477|NCT02340000|101853014|FG001|Time Period 1|Withdrawal by Subject|8|||
33533478|NCT02340000|101853013|FG000|Time Period 1|Lost to Follow-up|6|||
33533479|NCT02340000|101853014|FG001|Time Period 1|Lost to Follow-up|7|||
33533480|NCT02340000|101853013|FG000|Time Period 2|Withdrawal by Subject|9|||
33533481|NCT02340000|101853014|FG001|Time Period 2|Withdrawal by Subject|7|||
33533482|NCT02340000|101853013|FG000|Time Period 2|Lost to Follow-up|10|||
33533483|NCT02340000|101853014|FG001|Time Period 2|Lost to Follow-up|8|||
33533484|NCT05137717|101853016|FG000|Overall Study|Death|2|||
33613139|NCT00892775|102133754|FG000|Overall Study|Protocol Violation|1|||
33613140|NCT00892775|102133755|FG001|Overall Study|Protocol Violation|0|||
33613141|NCT00892775|102133754|FG000|Overall Study|Subject difficulties with blood drawing|1|||
33613142|NCT00892775|102133755|FG001|Overall Study|Subject difficulties with blood drawing|0|||
33613143|NCT00892775|102133754|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
33613144|NCT00892775|102133755|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
33613145|NCT00892775|102133754|FG000|Overall Study|Migrated/ moved from study area|1|||
33613146|NCT00892775|102133755|FG001|Overall Study|Migrated/ moved from study area|0|||
33613147|NCT00892775|102133754|FG000|Overall Study|Withdrawal by Subject|0|||
33613148|NCT00892775|102133755|FG001|Overall Study|Withdrawal by Subject|1|||
33613149|NCT00892775|102133754|FG000|Overall Study|Lost to Follow-up|1|||
33405165|NCT02569996|101373253|FG000|Overall Study|Complete remission|7|||
33533485|NCT05137717|101853016|FG000|Overall Study|Withdrawal by Subject|6|||
33533486|NCT00419757|101853027|FG000|Overall Study|Adverse Event|1|||
33613150|NCT00892775|102133755|FG001|Overall Study|Lost to Follow-up|0|||
33613151|NCT00988091|102133756|FG000|Double-blind Period|Withdrawal by Subject|15|||
33613152|NCT00988091|102133757|FG001|Double-blind Period|Withdrawal by Subject|13|||
33613153|NCT00988091|102133756|FG000|Double-blind Period|Lost to Follow-up|12|||
33613154|NCT00988091|102133757|FG001|Double-blind Period|Lost to Follow-up|14|||
33533487|NCT00419757|101853028|FG001|Overall Study|Adverse Event|4|||
33533488|NCT00419757|101853027|FG000|Overall Study|Lost to Follow-up|1|||
33533489|NCT00419757|101853028|FG001|Overall Study|Lost to Follow-up|4|||
33206237|NCT01410448|100655972|FG000|Overall Study|Withdrawal by Subject|3|||
33533490|NCT00419757|101853027|FG000|Overall Study|Withdrawal by Subject|7|||
33533491|NCT00419757|101853028|FG001|Overall Study|Withdrawal by Subject|1|||
33533492|NCT00419757|101853027|FG000|Overall Study|Protocol Violation|2|||
33533493|NCT00419757|101853028|FG001|Overall Study|Protocol Violation|3|||
33613155|NCT00988091|102133756|FG000|Double-blind Period|Other|8|||
33337765|NCT01692301|101128378|FG000|Overall Study|Patient/guardian decision|16|||
33613156|NCT00988091|102133757|FG001|Double-blind Period|Other|8|||
33613157|NCT00988091|102133756|FG000|Double-blind Period|Adverse Event|6|||
33613158|NCT00988091|102133757|FG001|Double-blind Period|Adverse Event|9|||
33337766|NCT01692301|101128379|FG001|Overall Study|Patient/guardian decision|15|||
33337767|NCT01692301|101128378|FG000|Overall Study|Technical problems|0|||
33337768|NCT01692301|101128379|FG001|Overall Study|Technical problems|1|||
33337769|NCT01692301|101128378|FG000|Overall Study|Physician Decision|2|||
33337770|NCT01692301|101128379|FG001|Overall Study|Physician Decision|2|||
33337771|NCT01692301|101128378|FG000|Overall Study|Lost to Follow-up|1|||
33337772|NCT01692301|101128379|FG001|Overall Study|Lost to Follow-up|1|||
33337773|NCT03557281|101128380|FG000|Overall Study|Investigator discretion|0|||
33337774|NCT03557281|101128381|FG001|Overall Study|Investigator discretion|0|||
33337775|NCT03557281|101128382|FG002|Overall Study|Investigator discretion|1|||
33613159|NCT00988091|102133756|FG000|Double-blind Period|Use of exclusionary medication|2|||
33613160|NCT00988091|102133757|FG001|Double-blind Period|Use of exclusionary medication|3|||
33613161|NCT00988091|102133756|FG000|Open-label Period|Adverse Event|4|||
33613162|NCT00988091|102133757|FG001|Open-label Period|Adverse Event|7|||
33613163|NCT00988091|102133756|FG000|Open-label Period|Use of exclusionary medication|1|||
33613164|NCT00988091|102133757|FG001|Open-label Period|Use of exclusionary medication|1|||
33613165|NCT00988091|102133756|FG000|Open-label Period|Protocol Violation|1|||
33613166|NCT00988091|102133757|FG001|Open-label Period|Protocol Violation|1|||
33613167|NCT00988091|102133756|FG000|Open-label Period|Withdrawal by Subject|10|||
33613168|NCT00988091|102133757|FG001|Open-label Period|Withdrawal by Subject|16|||
33613169|NCT00988091|102133756|FG000|Open-label Period|Lost to Follow-up|3|||
33337776|NCT03557281|101128383|FG003|Overall Study|Investigator discretion|0|||
33337777|NCT03557281|101128384|FG004|Overall Study|Investigator discretion|0|||
33405166|NCT02569996|101373253|FG000|Overall Study|Unknown reason|1|||
33337778|NCT03557281|101128380|FG000|Overall Study|Withdrawal by Subject|0|||
33613170|NCT00988091|102133757|FG001|Open-label Period|Lost to Follow-up|5|||
33613171|NCT00988091|102133756|FG000|Open-label Period|Other|2|||
33613172|NCT00988091|102133757|FG001|Open-label Period|Other|3|||
33613173|NCT03268941|102133760|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
33613174|NCT03268941|102133761|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
33613175|NCT03268941|102133762|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
33613176|NCT03268941|102133763|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
33613177|NCT03268941|102133764|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
33613178|NCT03268941|102133765|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
33613179|NCT03268941|102133766|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
33613180|NCT03268941|102133760|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
33613181|NCT03268941|102133761|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
33613182|NCT03268941|102133762|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
33613183|NCT03268941|102133763|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
33613184|NCT03268941|102133764|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
33613185|NCT03268941|102133765|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
33613186|NCT03268941|102133766|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
33613187|NCT03268941|102133760|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
33613188|NCT03268941|102133761|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
33613189|NCT03268941|102133762|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
33613190|NCT03268941|102133763|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
33613191|NCT03268941|102133764|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
33613192|NCT03268941|102133765|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
33613193|NCT03268941|102133766|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
33613194|NCT03268941|102133760|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
33613195|NCT03268941|102133761|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
33613196|NCT03268941|102133762|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
33613197|NCT03268941|102133763|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
33613198|NCT03268941|102133764|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
33613199|NCT03268941|102133765|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
33613200|NCT03268941|102133766|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
33613201|NCT03268941|102133760|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
33613202|NCT03268941|102133761|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
33613203|NCT03268941|102133762|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
33613204|NCT03268941|102133763|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
33613205|NCT03268941|102133764|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
33613206|NCT03268941|102133765|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
33613207|NCT03268941|102133766|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
33613208|NCT00465647|102133770|FG000|Overall Study|Administrative|2|||
33613209|NCT00465647|102133771|FG001|Overall Study|Administrative|2|||
33613210|NCT00465647|102133772|FG002|Overall Study|Administrative|3|||
33613211|NCT00465647|102133773|FG003|Overall Study|Administrative|2|||
33613212|NCT00465647|102133770|FG000|Overall Study|Adverse Event|2|||
33613213|NCT00465647|102133771|FG001|Overall Study|Adverse Event|0|||
33613214|NCT00465647|102133772|FG002|Overall Study|Adverse Event|3|||
33613215|NCT00465647|102133773|FG003|Overall Study|Adverse Event|2|||
33613216|NCT00465647|102133770|FG000|Overall Study|Withdrawal by Subject|1|||
33533494|NCT00419757|101853027|FG000|Overall Study|Study specific discontinuation criteria|4|||
33533495|NCT00419757|101853028|FG001|Overall Study|Study specific discontinuation criteria|8|||
33613217|NCT00465647|102133771|FG001|Overall Study|Withdrawal by Subject|2|||
33613218|NCT00465647|102133772|FG002|Overall Study|Withdrawal by Subject|2|||
33613219|NCT00465647|102133773|FG003|Overall Study|Withdrawal by Subject|7|||
33613220|NCT00465647|102133770|FG000|Overall Study|"The other reasons included loss of IV"|8|||
33337779|NCT03557281|101128381|FG001|Overall Study|Withdrawal by Subject|1|||
33405167|NCT00808665|101373254|FG000|Overall Study|Withdrawal by Subject|1|||
33405168|NCT00808665|101373255|FG001|Overall Study|Withdrawal by Subject|0|||
33405169|NCT00808665|101373254|FG000|Overall Study|only required minimally invasive surgery|1|||
33405170|NCT00808665|101373255|FG001|Overall Study|only required minimally invasive surgery|0|||
33405171|NCT00808665|101373254|FG000|Overall Study|surgery cancelled|1|||
33405172|NCT00808665|101373255|FG001|Overall Study|surgery cancelled|0|||
33405173|NCT00808665|101373254|FG000|Overall Study|required an additional procedure|0|||
33405174|NCT00808665|101373255|FG001|Overall Study|required an additional procedure|1|||
33405175|NCT00808665|101373254|FG000|Overall Study|Physician Decision|3|||
33405176|NCT00808665|101373255|FG001|Overall Study|Physician Decision|1|||
33405177|NCT00808665|101373254|FG000|Overall Study|Medication stopped by resident|0|||
33405178|NCT00808665|101373255|FG001|Overall Study|Medication stopped by resident|1|||
33533496|NCT00419757|101853027|FG000|Overall Study|Multiple reasons|3|||
33533497|NCT00419757|101853028|FG001|Overall Study|Multiple reasons|1|||
33533498|NCT00227539|101853029|FG000|Overall Study|Protocol Violation|1|||
33613221|NCT00465647|102133771|FG001|Overall Study|"The other reasons included loss of IV"|4|||
33613222|NCT00465647|102133772|FG002|Overall Study|"The other reasons included loss of IV"|3|||
33613223|NCT00465647|102133773|FG003|Overall Study|"The other reasons included loss of IV"|2|||
33613224|NCT01045694|102133774|FG000|Overall Study|Withdrawal by Subject|2|||
33613225|NCT02504580|102133777|FG000|Overall Study|Other|1|||
33405179|NCT02718131|101373265|FG000|Overall Study|Withdrawal by Subject|1|||
33405180|NCT02718131|101373266|FG001|Overall Study|Withdrawal by Subject|0|||
33533499|NCT01519817|101853030|FG000|Overall Study|Withdrawal by Subject|1|||
33613226|NCT02504580|102133778|FG001|Overall Study|Other|0|||
33613227|NCT02504580|102133779|FG002|Overall Study|Other|0|||
33613228|NCT02504580|102133780|FG003|Overall Study|Other|2|||
33613229|NCT02504580|102133781|FG004|Overall Study|Other|1|||
33613230|NCT02504580|102133782|FG005|Overall Study|Other|1|||
33613231|NCT02504580|102133783|FG006|Overall Study|Other|1|||
33405181|NCT02718131|101373265|FG000|Overall Study|Adverse Event|1|||
33405182|NCT02718131|101373266|FG001|Overall Study|Adverse Event|0|||
33533500|NCT01519817|101853031|FG001|Overall Study|Withdrawal by Subject|0|||
33533501|NCT01519817|101853032|FG002|Overall Study|Withdrawal by Subject|0|||
33533502|NCT01519817|101853033|FG003|Overall Study|Withdrawal by Subject|0|||
33533503|NCT01519817|101853030|FG000|Overall Study|Off study due to infection|0|||
33533504|NCT01519817|101853031|FG001|Overall Study|Off study due to infection|0|||
33533505|NCT01519817|101853032|FG002|Overall Study|Off study due to infection|0|||
33533506|NCT01519817|101853033|FG003|Overall Study|Off study due to infection|1|||
33533507|NCT02168491|101853035|FG000|Overall Study|Withdrawal by Subject|1|||
33533508|NCT01657162|101853036|FG000|Overall Study|Adverse Event|26|||
33533509|NCT01657162|101853037|FG001|Overall Study|Adverse Event|36|||
33533510|NCT01657162|101853036|FG000|Overall Study|Withdrawal by Subject|13|||
33533511|NCT01657162|101853037|FG001|Overall Study|Withdrawal by Subject|13|||
33613232|NCT02504580|102133784|FG007|Overall Study|Other|2|||
33613233|NCT02504580|102133785|FG008|Overall Study|Other|0|||
33613234|NCT02504580|102133786|FG009|Overall Study|Other|0|||
33613235|NCT02504580|102133787|FG010|Overall Study|Other|0|||
33613236|NCT02504580|102133788|FG011|Overall Study|Other|2|||
33613237|NCT02504580|102133777|FG000|Overall Study|Subject refusal to continue|0|||
33533512|NCT01657162|101853036|FG000|Overall Study|Continuing Significant Deterioration|9|||
33533513|NCT01657162|101853037|FG001|Overall Study|Continuing Significant Deterioration|3|||
33533514|NCT01657162|101853036|FG000|Overall Study|Refusal of Treatment|4|||
33533515|NCT01657162|101853037|FG001|Overall Study|Refusal of Treatment|6|||
33613238|NCT02504580|102133778|FG001|Overall Study|Subject refusal to continue|1|||
33613239|NCT02504580|102133779|FG002|Overall Study|Subject refusal to continue|0|||
33337780|NCT03557281|101128382|FG002|Overall Study|Withdrawal by Subject|1|||
33337781|NCT03557281|101128383|FG003|Overall Study|Withdrawal by Subject|1|||
33337782|NCT03557281|101128384|FG004|Overall Study|Withdrawal by Subject|2|||
33337783|NCT03557281|101128380|FG000|Overall Study|Randomized, but did not receive treatment|0|||
33337784|NCT03557281|101128381|FG001|Overall Study|Randomized, but did not receive treatment|0|||
33337785|NCT03557281|101128382|FG002|Overall Study|Randomized, but did not receive treatment|0|||
33337786|NCT03557281|101128383|FG003|Overall Study|Randomized, but did not receive treatment|0|||
33337787|NCT03557281|101128384|FG004|Overall Study|Randomized, but did not receive treatment|1|||
33337788|NCT00852995|101128391|FG000|Overall Study|Adverse Event|1|||
33337789|NCT00852995|101128392|FG001|Overall Study|Adverse Event|0|||
33337790|NCT00852995|101128393|FG002|Overall Study|Adverse Event|4|||
33337791|NCT00852995|101128394|FG003|Overall Study|Adverse Event|0|||
33337792|NCT00852995|101128395|FG004|Overall Study|Adverse Event|0|||
33533516|NCT01657162|101853036|FG000|Overall Study|Lost to Follow-up|3|||
33533517|NCT01657162|101853037|FG001|Overall Study|Lost to Follow-up|4|||
33533518|NCT01657162|101853036|FG000|Overall Study|Death|2|||
33533519|NCT01657162|101853037|FG001|Overall Study|Death|3|||
33533520|NCT01657162|101853036|FG000|Overall Study|Inability to Complete Study Procedures|1|||
33533521|NCT01657162|101853037|FG001|Overall Study|Inability to Complete Study Procedures|7|||
33533522|NCT01657162|101853036|FG000|Overall Study|Protocol Violation|1|||
33533523|NCT01657162|101853037|FG001|Overall Study|Protocol Violation|0|||
33533524|NCT01657162|101853036|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
33533525|NCT01657162|101853037|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
33533526|NCT01657162|101853036|FG000|Overall Study|Other than Specified|0|||
33533527|NCT01657162|101853037|FG001|Overall Study|Other than Specified|2|||
33533528|NCT00994110|101853039|FG000|Overall Study|Withdrawal by Subject|9|||
33533529|NCT00994110|101853040|FG001|Overall Study|Withdrawal by Subject|9|||
33613240|NCT02504580|102133780|FG003|Overall Study|Subject refusal to continue|0|||
33613241|NCT02504580|102133781|FG004|Overall Study|Subject refusal to continue|0|||
33613242|NCT02504580|102133782|FG005|Overall Study|Subject refusal to continue|0|||
33337793|NCT00852995|101128391|FG000|Overall Study|Lost to Follow-up|0|||
33533530|NCT00994110|101853039|FG000|Overall Study|Not Treated|4|||
33533531|NCT00994110|101853040|FG001|Overall Study|Not Treated|8|||
33533532|NCT00994110|101853039|FG000|Overall Study|Adverse Event|1|||
33533533|NCT00994110|101853040|FG001|Overall Study|Adverse Event|0|||
33613243|NCT02504580|102133783|FG006|Overall Study|Subject refusal to continue|0|||
33613244|NCT02504580|102133784|FG007|Overall Study|Subject refusal to continue|0|||
33613245|NCT02504580|102133785|FG008|Overall Study|Subject refusal to continue|0|||
33613246|NCT02504580|102133786|FG009|Overall Study|Subject refusal to continue|0|||
33533534|NCT00994110|101853039|FG000|Overall Study|Patient not resected|41|||
33533535|NCT00994110|101853040|FG001|Overall Study|Patient not resected|52|||
33533536|NCT00994110|101853039|FG000|Overall Study|Pt not eligible|10|||
33533537|NCT00994110|101853040|FG001|Overall Study|Pt not eligible|5|||
33533538|NCT03225170|101853041|FG000|Overall Study|Lost to Follow-up|4|||
33533539|NCT03225170|101853042|FG001|Overall Study|Lost to Follow-up|4|||
33533540|NCT03225170|101853043|FG002|Overall Study|Lost to Follow-up|0|||
33533541|NCT03225170|101853041|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
33533542|NCT03225170|101853042|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
33533543|NCT03225170|101853043|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
33533544|NCT01076543|101853044|FG000|Overall Study|Withdrawal by Subject|2|||
33533545|NCT01076543|101853045|FG001|Overall Study|Withdrawal by Subject|0|||
33533546|NCT01076543|101853046|FG002|Overall Study|Withdrawal by Subject|0|||
33533547|NCT01076543|101853047|FG003|Overall Study|Withdrawal by Subject|0|||
33533548|NCT01076543|101853048|FG004|Overall Study|Withdrawal by Subject|0|||
33533549|NCT01076543|101853049|FG005|Overall Study|Withdrawal by Subject|0|||
33533550|NCT02616783|101853050|FG000|Overall Study|Randomized but Not Treated|1|||
33533551|NCT02616783|101853051|FG001|Overall Study|Randomized but Not Treated|0|||
33533552|NCT02616783|101853050|FG000|Overall Study|Adverse Event|1|||
33533553|NCT02616783|101853051|FG001|Overall Study|Adverse Event|0|||
33533554|NCT02616783|101853050|FG000|Overall Study|Death|1|||
33533555|NCT02616783|101853051|FG001|Overall Study|Death|0|||
33533556|NCT02616783|101853050|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33533557|NCT02616783|101853051|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33533558|NCT02616783|101853050|FG000|Overall Study|Protocol Violation|1|||
33533559|NCT02616783|101853051|FG001|Overall Study|Protocol Violation|1|||
33533560|NCT02616783|101853050|FG000|Overall Study|Withdrew Consent|1|||
33533561|NCT02616783|101853051|FG001|Overall Study|Withdrew Consent|1|||
33533562|NCT03489343|101853052|FG000|Overall Study|Documented progressive disease|1|||
33533563|NCT03489343|101853053|FG001|Overall Study|Documented progressive disease|0|||
33533564|NCT03489343|101853054|FG002|Overall Study|Documented progressive disease|3|||
33533565|NCT03489343|101853055|FG003|Overall Study|Documented progressive disease|1|||
33533566|NCT03489343|101853056|FG004|Overall Study|Documented progressive disease|3|||
33533567|NCT03489343|101853057|FG005|Overall Study|Documented progressive disease|5|||
33533568|NCT03489343|101853058|FG006|Overall Study|Documented progressive disease|4|||
33533569|NCT03489343|101853052|FG000|Overall Study|Adverse Event|0|||
33533570|NCT03489343|101853053|FG001|Overall Study|Adverse Event|1|||
33533571|NCT03489343|101853054|FG002|Overall Study|Adverse Event|0|||
33533572|NCT03489343|101853055|FG003|Overall Study|Adverse Event|0|||
33533573|NCT03489343|101853056|FG004|Overall Study|Adverse Event|0|||
33533574|NCT03489343|101853057|FG005|Overall Study|Adverse Event|1|||
33533575|NCT03489343|101853058|FG006|Overall Study|Adverse Event|0|||
33533576|NCT03489343|101853052|FG000|Overall Study|Withdrawal by Subject|0|||
33533577|NCT03489343|101853053|FG001|Overall Study|Withdrawal by Subject|0|||
33533578|NCT03489343|101853054|FG002|Overall Study|Withdrawal by Subject|0|||
33206238|NCT01410448|100655973|FG001|Overall Study|Withdrawal by Subject|2|||
33533579|NCT03489343|101853055|FG003|Overall Study|Withdrawal by Subject|1|||
33533580|NCT03489343|101853056|FG004|Overall Study|Withdrawal by Subject|0|||
33533581|NCT03489343|101853057|FG005|Overall Study|Withdrawal by Subject|1|||
33533582|NCT03489343|101853058|FG006|Overall Study|Withdrawal by Subject|1|||
33533583|NCT03489343|101853052|FG000|Overall Study|Clinical progression|0|||
33533584|NCT03489343|101853053|FG001|Overall Study|Clinical progression|0|||
33533585|NCT03489343|101853054|FG002|Overall Study|Clinical progression|0|||
33613247|NCT02504580|102133787|FG010|Overall Study|Subject refusal to continue|0|||
33613248|NCT02504580|102133788|FG011|Overall Study|Subject refusal to continue|0|||
33613249|NCT01792115|102133802|FG000|Overall Study|Lost to Follow-up|0|||
33613250|NCT01792115|102133803|FG001|Overall Study|Lost to Follow-up|1|||
33613251|NCT01792115|102133804|FG002|Overall Study|Lost to Follow-up|0|||
33613252|NCT01445080|102133805|FG000|Overall Study|Adverse Event|5|||
33613253|NCT01445080|102133806|FG001|Overall Study|Adverse Event|3|||
33613254|NCT01445080|102133807|FG002|Overall Study|Adverse Event|11|||
33613255|NCT01445080|102133808|FG003|Overall Study|Adverse Event|6|||
33613256|NCT01445080|102133809|FG004|Overall Study|Adverse Event|2|||
33613257|NCT01445080|102133810|FG005|Overall Study|Adverse Event|3|||
33613258|NCT01445080|102133811|FG006|Overall Study|Adverse Event|0|||
33613259|NCT01445080|102133812|FG007|Overall Study|Adverse Event|3|||
33613260|NCT01445080|102133813|FG008|Overall Study|Adverse Event|10|||
33613261|NCT01445080|102133805|FG000|Overall Study|Physician Decision|0|||
33613262|NCT01445080|102133806|FG001|Overall Study|Physician Decision|0|||
33206239|NCT01410448|100655972|FG000|Overall Study|Protocol Violation|0|||
33206240|NCT01410448|100655973|FG001|Overall Study|Protocol Violation|4|||
33206241|NCT01410448|100655972|FG000|Overall Study|Death|2|||
33337794|NCT00852995|101128392|FG001|Overall Study|Lost to Follow-up|1|||
33533586|NCT03489343|101853055|FG003|Overall Study|Clinical progression|1|||
33613263|NCT01445080|102133807|FG002|Overall Study|Physician Decision|1|||
33206242|NCT01410448|100655973|FG001|Overall Study|Death|3|||
33206243|NCT03538626|100655974|FG000|Overall Study|Withdrawal by Subject|0|||
33206244|NCT03538626|100655975|FG001|Overall Study|Withdrawal by Subject|1|||
33337795|NCT00852995|101128393|FG002|Overall Study|Lost to Follow-up|1|||
33533587|NCT03489343|101853056|FG004|Overall Study|Clinical progression|0|||
33533588|NCT03489343|101853057|FG005|Overall Study|Clinical progression|0|||
33613264|NCT01445080|102133808|FG003|Overall Study|Physician Decision|0|||
33613265|NCT01445080|102133809|FG004|Overall Study|Physician Decision|0|||
33613266|NCT01445080|102133810|FG005|Overall Study|Physician Decision|3|||
33613267|NCT01445080|102133811|FG006|Overall Study|Physician Decision|2|||
33533589|NCT03489343|101853058|FG006|Overall Study|Clinical progression|1|||
33533590|NCT02810418|101853059|FG000|Arm A Dose Escalation|Adverse Event|2|||
33533591|NCT02810418|101853060|FG001|Arm A Dose Escalation|Adverse Event|1|||
33533592|NCT02810418|101853061|FG002|Arm A Dose Escalation|Adverse Event|0|||
33533593|NCT02810418|101853062|FG003|Arm A Dose Escalation|Adverse Event|0|||
33533594|NCT02810418|101853063|FG004|Arm A Dose Escalation|Adverse Event|0|||
33533595|NCT02810418|101853064|FG005|Arm A Dose Escalation|Adverse Event|0|||
33533596|NCT02810418|101853065|FG006|Arm A Dose Escalation|Adverse Event|0|||
33533597|NCT02810418|101853059|FG000|Dose Expansion|Adverse Event|0|||
33533598|NCT02810418|101853060|FG001|Dose Expansion|Adverse Event|1|||
33533599|NCT02810418|101853061|FG002|Dose Expansion|Adverse Event|1|||
33533600|NCT02810418|101853062|FG003|Dose Expansion|Adverse Event|0|||
33533601|NCT02810418|101853063|FG004|Dose Expansion|Adverse Event|0|||
33533602|NCT02810418|101853064|FG005|Dose Expansion|Adverse Event|0|||
33533603|NCT02810418|101853065|FG006|Dose Expansion|Adverse Event|0|||
33533604|NCT02810418|101853059|FG000|Dose Expansion|Physician Decision|0|||
33533605|NCT02810418|101853060|FG001|Dose Expansion|Physician Decision|0|||
33533606|NCT02810418|101853061|FG002|Dose Expansion|Physician Decision|2|||
33337796|NCT00852995|101128394|FG003|Overall Study|Lost to Follow-up|0|||
33337797|NCT00852995|101128395|FG004|Overall Study|Lost to Follow-up|0|||
33337798|NCT00852995|101128391|FG000|Overall Study|Withdrawal by Subject|4|||
33533607|NCT02810418|101853062|FG003|Dose Expansion|Physician Decision|0|||
33533608|NCT02810418|101853063|FG004|Dose Expansion|Physician Decision|0|||
33533609|NCT02810418|101853064|FG005|Dose Expansion|Physician Decision|0|||
33337799|NCT00852995|101128392|FG001|Overall Study|Withdrawal by Subject|0|||
33337800|NCT00852995|101128393|FG002|Overall Study|Withdrawal by Subject|0|||
33337801|NCT00852995|101128394|FG003|Overall Study|Withdrawal by Subject|1|||
33337802|NCT00852995|101128395|FG004|Overall Study|Withdrawal by Subject|2|||
33337803|NCT00852995|101128391|FG000|Overall Study|Non-Compliance|0|||
33337804|NCT00852995|101128392|FG001|Overall Study|Non-Compliance|0|||
33337805|NCT00852995|101128393|FG002|Overall Study|Non-Compliance|0|||
33337806|NCT00852995|101128394|FG003|Overall Study|Non-Compliance|2|||
33337807|NCT00852995|101128395|FG004|Overall Study|Non-Compliance|0|||
33337808|NCT00852995|101128391|FG000|Overall Study|Progressive Disease|1|||
33337809|NCT00852995|101128392|FG001|Overall Study|Progressive Disease|0|||
33337810|NCT00852995|101128393|FG002|Overall Study|Progressive Disease|0|||
33337811|NCT00852995|101128394|FG003|Overall Study|Progressive Disease|2|||
33337812|NCT00852995|101128395|FG004|Overall Study|Progressive Disease|1|||
33337813|NCT00852995|101128391|FG000|Overall Study|Physician Decision|1|||
33337814|NCT00852995|101128392|FG001|Overall Study|Physician Decision|0|||
33337815|NCT00852995|101128393|FG002|Overall Study|Physician Decision|0|||
33337816|NCT00852995|101128394|FG003|Overall Study|Physician Decision|0|||
33337817|NCT00852995|101128395|FG004|Overall Study|Physician Decision|0|||
33337818|NCT00852995|101128391|FG000|Overall Study|Protocol Violation|0|||
33337819|NCT00852995|101128392|FG001|Overall Study|Protocol Violation|0|||
33337820|NCT00852995|101128393|FG002|Overall Study|Protocol Violation|0|||
33337821|NCT00852995|101128394|FG003|Overall Study|Protocol Violation|0|||
33337822|NCT00852995|101128395|FG004|Overall Study|Protocol Violation|1|||
33337823|NCT00852995|101128391|FG000|Overall Study|Moved Out of Area|1|||
33337824|NCT00852995|101128392|FG001|Overall Study|Moved Out of Area|0|||
33337825|NCT00852995|101128393|FG002|Overall Study|Moved Out of Area|0|||
33337826|NCT00852995|101128394|FG003|Overall Study|Moved Out of Area|0|||
33337827|NCT00852995|101128395|FG004|Overall Study|Moved Out of Area|0|||
33337828|NCT01564862|101128397|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
33337829|NCT01564862|101128398|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
33337830|NCT01564862|101128399|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
33337831|NCT01564862|101128397|FG000|Overall Study|Major Protocol Deviation|3|||
33337832|NCT01564862|101128398|FG001|Overall Study|Major Protocol Deviation|3|||
33533610|NCT02810418|101853065|FG006|Dose Expansion|Physician Decision|0|||
33533611|NCT02810418|101853059|FG000|Arm B Dose Escalation|Adverse Event|0|||
33533612|NCT02810418|101853060|FG001|Arm B Dose Escalation|Adverse Event|0|||
33533613|NCT02810418|101853061|FG002|Arm B Dose Escalation|Adverse Event|0|||
33533614|NCT02810418|101853062|FG003|Arm B Dose Escalation|Adverse Event|0|||
33533615|NCT02810418|101853063|FG004|Arm B Dose Escalation|Adverse Event|1|||
33533616|NCT02810418|101853064|FG005|Arm B Dose Escalation|Adverse Event|2|||
33533617|NCT02810418|101853065|FG006|Arm B Dose Escalation|Adverse Event|0|||
33533618|NCT01316575|101853071|FG000|Overall Study|Withdrawal by Subject|2|||
33533619|NCT01316575|101853072|FG001|Overall Study|Withdrawal by Subject|0|||
33533620|NCT01316575|101853071|FG000|Overall Study|Required alternate treatment|0|||
33533621|NCT01316575|101853072|FG001|Overall Study|Required alternate treatment|1|||
33533622|NCT02922153|101853075|FG000|Overall Study|Death|8|||
33206245|NCT03538626|100655976|FG002|Overall Study|Withdrawal by Subject|0|||
33337833|NCT01564862|101128399|FG002|Overall Study|Major Protocol Deviation|4|||
33337834|NCT01564862|101128397|FG000|Overall Study|Lost to Follow-up|10|||
33337835|NCT01564862|101128398|FG001|Overall Study|Lost to Follow-up|8|||
33337836|NCT01564862|101128399|FG002|Overall Study|Lost to Follow-up|6|||
33337837|NCT01564862|101128397|FG000|Overall Study|Voluntary Withdrawal|9|||
33337838|NCT01564862|101128398|FG001|Overall Study|Voluntary Withdrawal|6|||
33337839|NCT01564862|101128399|FG002|Overall Study|Voluntary Withdrawal|8|||
33337840|NCT01564862|101128397|FG000|Overall Study|Lack of Efficacy|1|||
33533623|NCT02922153|101853076|FG001|Overall Study|Death|1|||
33533624|NCT02922153|101853075|FG000|Overall Study|Lost to Follow-up|1|||
33337841|NCT01564862|101128398|FG001|Overall Study|Lack of Efficacy|5|||
33337842|NCT01564862|101128399|FG002|Overall Study|Lack of Efficacy|6|||
33337843|NCT01564862|101128397|FG000|Overall Study|Other reason(s)|1|||
33337844|NCT01564862|101128398|FG001|Overall Study|Other reason(s)|0|||
33337845|NCT01564862|101128399|FG002|Overall Study|Other reason(s)|0|||
33337846|NCT01580488|101128400|FG000|Overall Study|Withdrawal by Subject|1|||
33337847|NCT04428424|101128401|FG000|Overall Study|Does not meet entrance criteria|132|||
33337848|NCT04428424|101128401|FG000|Overall Study|Lost to Follow-up|115|||
33337849|NCT00424827|101128402|FG000|Overall Study|Adverse Event|1|||
33337850|NCT00512798|101128403|FG000|Overall Study|Death|0|||
33337851|NCT00512798|101128404|FG001|Overall Study|Death|3|||
33533625|NCT02922153|101853076|FG001|Overall Study|Lost to Follow-up|0|||
33337852|NCT00512798|101128403|FG000|Overall Study|Adverse Event|2|||
33337853|NCT00512798|101128404|FG001|Overall Study|Adverse Event|4|||
33533626|NCT02922153|101853075|FG000|Overall Study|Physician Decision|1|||
33337854|NCT00512798|101128403|FG000|Overall Study|Progression of disease|14|||
33337855|NCT00512798|101128404|FG001|Overall Study|Progression of disease|20|||
33533627|NCT02922153|101853076|FG001|Overall Study|Physician Decision|1|||
33337856|NCT00512798|101128403|FG000|Overall Study|Withdrawal by Subject|3|||
33337857|NCT00512798|101128404|FG001|Overall Study|Withdrawal by Subject|0|||
33337858|NCT02064387|101128405|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33337859|NCT02064387|101128406|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33337860|NCT02064387|101128407|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33337861|NCT02064387|101128408|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33337862|NCT02064387|101128409|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33337863|NCT02064387|101128410|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33337864|NCT02064387|101128411|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33337865|NCT02064387|101128412|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
33405183|NCT02718131|101373265|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
33533628|NCT00268983|101853077|FG000|Overall Study|Death|3|||
33533629|NCT00268983|101853078|FG001|Overall Study|Death|0|||
33533630|NCT00823264|101853079|FG000|Overall Study|Protocol Violation|2|||
33533631|NCT00823264|101853080|FG001|Overall Study|Protocol Violation|0|||
33533632|NCT03082729|101853082|FG000|Overall Study|Lost to Follow-up|7|||
33533633|NCT03082729|101853082|FG000|Overall Study|Physician Decision|2|||
33533634|NCT03082729|101853082|FG000|Overall Study|Withdrawal by Subject|1|||
33533635|NCT03082729|101853082|FG000|Overall Study|Lack of Efficacy|9|||
33533636|NCT03082729|101853082|FG000|Overall Study|Adverse Event|4|||
33533637|NCT03082729|101853082|FG000|Overall Study|Protocol Violation|6|||
33533638|NCT03082729|101853082|FG000|Overall Study|Fear of study procedure|1|||
33533639|NCT03082729|101853082|FG000|Overall Study|Scheduling conflict|1|||
33533640|NCT00752089|101853085|FG000|Overall Study|Adverse Event|1|||
33533641|NCT00752089|101853085|FG000|Overall Study|Protocol Deviation|2|||
33533642|NCT00752089|101853085|FG000|Overall Study|Could not attend visit 9|1|||
33533643|NCT00752089|101853085|FG000|Overall Study|Not capable of wearing partial denture|1|||
33533644|NCT00752089|101853085|FG000|Overall Study|Cannot continue the study|1|||
33533645|NCT03569098|101853086|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
33533646|NCT03569098|101853087|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
33533647|NCT03569098|101853088|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
33533648|NCT03569098|101853086|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
33533649|NCT03569098|101853087|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
33533650|NCT03569098|101853088|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
33533651|NCT03569098|101853086|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
33533652|NCT03569098|101853087|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
33533653|NCT03569098|101853088|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
33533654|NCT03569098|101853086|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
33533655|NCT03569098|101853087|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
33533656|NCT03569098|101853088|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
33533657|NCT03569098|101853086|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
33533658|NCT03569098|101853087|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
33533659|NCT03569098|101853088|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
33533660|NCT03569098|101853086|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
33533661|NCT03569098|101853087|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
33533662|NCT03569098|101853088|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
33533663|NCT03569098|101853086|FG000|Double-Blind Treatment Cycle 1|Other|1|||
33533664|NCT03569098|101853087|FG001|Double-Blind Treatment Cycle 1|Other|0|||
33533665|NCT03569098|101853088|FG002|Double-Blind Treatment Cycle 1|Other|1|||
33533666|NCT03569098|101853086|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
33533667|NCT03569098|101853087|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
33206246|NCT03538626|100655977|FG003|Overall Study|Withdrawal by Subject|0|||
33337866|NCT02064387|101128413|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33337867|NCT02064387|101128414|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
33337868|NCT02064387|101128415|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33337869|NCT02064387|101128416|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
33337870|NCT02064387|101128405|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33337871|NCT02064387|101128406|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33337872|NCT02064387|101128407|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33337873|NCT02064387|101128408|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33337874|NCT02064387|101128409|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33405184|NCT02718131|101373266|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
33405185|NCT04246996|101373269|FG000|Overall Study|Physician Decision|1|||
33533668|NCT03569098|101853088|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
33533669|NCT03569098|101853086|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
33533670|NCT03569098|101853087|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
33337875|NCT02064387|101128410|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33337876|NCT02064387|101128411|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33533671|NCT03569098|101853088|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
33206247|NCT03538626|100655978|FG004|Overall Study|Withdrawal by Subject|0|||
33206248|NCT03538626|100655979|FG005|Overall Study|Withdrawal by Subject|0|||
33206249|NCT03538626|100655980|FG006|Overall Study|Withdrawal by Subject|0|||
33206250|NCT03538626|100655981|FG007|Overall Study|Withdrawal by Subject|0|||
33206251|NCT03538626|100655974|FG000|Overall Study|Lost to Follow-up|0|||
33206252|NCT03538626|100655975|FG001|Overall Study|Lost to Follow-up|0|||
33206253|NCT03538626|100655976|FG002|Overall Study|Lost to Follow-up|0|||
33206254|NCT03538626|100655977|FG003|Overall Study|Lost to Follow-up|0|||
33206255|NCT03538626|100655978|FG004|Overall Study|Lost to Follow-up|0|||
33206256|NCT03538626|100655979|FG005|Overall Study|Lost to Follow-up|0|||
33206257|NCT03538626|100655980|FG006|Overall Study|Lost to Follow-up|1|||
33206258|NCT03538626|100655981|FG007|Overall Study|Lost to Follow-up|0|||
33206259|NCT00784043|100655984|FG000|Overall Study|Withdrawal by Subject|8|||
33206260|NCT00784043|100655985|FG001|Overall Study|Withdrawal by Subject|5|||
33206261|NCT00784043|100655984|FG000|Overall Study|Protocol Terminated|23|||
33405186|NCT04246996|101373270|FG001|Overall Study|Physician Decision|1|||
33405187|NCT04246996|101373269|FG000|Overall Study|Did not meet eligibility criteria|1|||
33533672|NCT03569098|101853086|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
33533673|NCT03569098|101853087|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
33533674|NCT03569098|101853088|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
33533675|NCT03569098|101853086|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
33533676|NCT03569098|101853087|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
33533677|NCT03569098|101853088|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
33533678|NCT03569098|101853086|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
33533679|NCT03569098|101853087|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
33533680|NCT03569098|101853088|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
33206262|NCT00784043|100655985|FG001|Overall Study|Protocol Terminated|1|||
33206263|NCT00936390|100655986|FG000|Overall Study|Protocol Violation|21|||
33206264|NCT00936390|100655987|FG001|Overall Study|Protocol Violation|25|||
33206265|NCT04667117|100655988|FG000|Investigational Period|Lost to Follow-up|0|||
33206266|NCT04667117|100655989|FG001|Investigational Period|Lost to Follow-up|0|||
33206267|NCT04667117|100655990|FG002|Investigational Period|Lost to Follow-up|1|||
33337877|NCT02064387|101128412|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
33337878|NCT02064387|101128413|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33337879|NCT02064387|101128414|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33337880|NCT02064387|101128415|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33337881|NCT02064387|101128416|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
33337882|NCT02064387|101128405|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33337883|NCT02064387|101128406|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33337884|NCT02064387|101128407|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33337885|NCT02064387|101128408|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33337886|NCT02064387|101128409|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33337887|NCT02064387|101128410|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33337888|NCT02064387|101128411|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33337889|NCT02064387|101128412|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33337890|NCT02064387|101128413|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
33337891|NCT02064387|101128414|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33337892|NCT02064387|101128415|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33337893|NCT02064387|101128416|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
33337894|NCT02064387|101128405|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
33337895|NCT02064387|101128406|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
33337896|NCT02064387|101128407|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
33337897|NCT02064387|101128408|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
33337898|NCT02064387|101128409|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
33337899|NCT02064387|101128410|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
33337900|NCT02064387|101128411|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
33337901|NCT02064387|101128412|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
33337902|NCT02064387|101128413|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
33337903|NCT02064387|101128414|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
33337904|NCT02064387|101128415|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
33337905|NCT02064387|101128416|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
33337906|NCT02064387|101128405|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33337907|NCT02064387|101128406|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33337908|NCT02064387|101128407|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33206268|NCT04667117|100655988|FG000|Investigational Period|Protocol Deviation|0|||
33206269|NCT04667117|100655989|FG001|Investigational Period|Protocol Deviation|1|||
33206270|NCT04667117|100655990|FG002|Investigational Period|Protocol Deviation|0|||
33206271|NCT04667117|100655988|FG000|Extension Period|Lost to Follow-up|1|||
33206272|NCT04667117|100655989|FG001|Extension Period|Lost to Follow-up|0|||
33206273|NCT04667117|100655990|FG002|Extension Period|Lost to Follow-up|0|||
33206274|NCT00380068|100655994|FG000|Overall Study|Adverse Event|40|||
33206275|NCT00380068|100655994|FG000|Overall Study|Withdrawal by Subject|10|||
33206276|NCT00380068|100655994|FG000|Overall Study|Not compliant|6|||
33206277|NCT00380068|100655994|FG000|Overall Study|Lost to Follow-up|1|||
33206278|NCT00380068|100655994|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
33206279|NCT00380068|100655994|FG000|Overall Study|Lung transplant|3|||
33206280|NCT00380068|100655994|FG000|Overall Study|Physician Decision|2|||
33206281|NCT00380068|100655994|FG000|Overall Study|Partipant moved away|1|||
33206282|NCT00380068|100655994|FG000|Overall Study|Lack of Efficacy|5|||
33206283|NCT02044510|100655997|FG000|Overall Study|Adverse Event|1|||
33206284|NCT02044510|100655998|FG001|Overall Study|Adverse Event|2|||
33206285|NCT01953926|100655999|FG000|Overall Study|Withdrawal by Subject|23|||
33206286|NCT01953926|100656000|FG001|Overall Study|Withdrawal by Subject|3|||
33206287|NCT01953926|100656001|FG002|Overall Study|Withdrawal by Subject|3|||
33206288|NCT01953926|100656002|FG003|Overall Study|Withdrawal by Subject|5|||
33206289|NCT01953926|100656003|FG004|Overall Study|Withdrawal by Subject|6|||
33206290|NCT01953926|100656004|FG005|Overall Study|Withdrawal by Subject|0|||
33206291|NCT01953926|100656005|FG006|Overall Study|Withdrawal by Subject|1|||
33533681|NCT03569098|101853086|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
33533682|NCT03569098|101853087|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
33533683|NCT03569098|101853088|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
33533684|NCT01819727|101853093|FG000|Overall Study|Adverse Event|8|||
33533685|NCT01819727|101853094|FG001|Overall Study|Adverse Event|9|||
33533686|NCT01819727|101853093|FG000|Overall Study|Death|1|||
33533687|NCT01819727|101853094|FG001|Overall Study|Death|0|||
33533688|NCT01819727|101853093|FG000|Overall Study|Lost to Follow-up|1|||
33533689|NCT01819727|101853094|FG001|Overall Study|Lost to Follow-up|1|||
33533690|NCT01819727|101853093|FG000|Overall Study|Physician Decision|3|||
33533691|NCT01819727|101853094|FG001|Overall Study|Physician Decision|2|||
33206292|NCT01953926|100655999|FG000|Overall Study|Physician Decision|1|||
33206293|NCT01953926|100656000|FG001|Overall Study|Physician Decision|0|||
33206294|NCT01953926|100656001|FG002|Overall Study|Physician Decision|0|||
33206295|NCT01953926|100656002|FG003|Overall Study|Physician Decision|0|||
33533692|NCT01819727|101853093|FG000|Overall Study|Pregnancy|1|||
33533693|NCT01819727|101853094|FG001|Overall Study|Pregnancy|0|||
33206296|NCT01953926|100656003|FG004|Overall Study|Physician Decision|2|||
33206297|NCT01953926|100656004|FG005|Overall Study|Physician Decision|0|||
33337909|NCT02064387|101128408|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33337910|NCT02064387|101128409|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33337911|NCT02064387|101128410|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33337912|NCT02064387|101128411|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33337913|NCT02064387|101128412|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33405188|NCT04246996|101373270|FG001|Overall Study|Did not meet eligibility criteria|4|||
33405189|NCT02207413|101373274|FG000|Overall Study|Withdrawal by Subject|1|||
33405190|NCT02207413|101373275|FG001|Overall Study|Withdrawal by Subject|0|||
33405191|NCT02207413|101373276|FG002|Overall Study|Withdrawal by Subject|0|||
33405192|NCT02207413|101373277|FG003|Overall Study|Withdrawal by Subject|0|||
33405193|NCT02207413|101373278|FG004|Overall Study|Withdrawal by Subject|3|||
33405194|NCT02207413|101373279|FG005|Overall Study|Withdrawal by Subject|7|||
33405195|NCT02207413|101373274|FG000|Overall Study|Lost to Follow-up|0|||
33405196|NCT02207413|101373275|FG001|Overall Study|Lost to Follow-up|0|||
33405197|NCT02207413|101373276|FG002|Overall Study|Lost to Follow-up|0|||
33405198|NCT02207413|101373277|FG003|Overall Study|Lost to Follow-up|1|||
33405199|NCT02207413|101373278|FG004|Overall Study|Lost to Follow-up|1|||
33405200|NCT02207413|101373279|FG005|Overall Study|Lost to Follow-up|5|||
33405201|NCT02207413|101373274|FG000|Overall Study|Adverse Event|0|||
33405202|NCT02207413|101373275|FG001|Overall Study|Adverse Event|0|||
33206298|NCT01953926|100656005|FG006|Overall Study|Physician Decision|0|||
33206299|NCT01953926|100655999|FG000|Overall Study|Lost to Follow-up|18|||
33206300|NCT01953926|100656000|FG001|Overall Study|Lost to Follow-up|3|||
33206301|NCT01953926|100656001|FG002|Overall Study|Lost to Follow-up|0|||
33206302|NCT01953926|100656002|FG003|Overall Study|Lost to Follow-up|5|||
33533694|NCT01819727|101853093|FG000|Overall Study|Protocol Violation|0|||
33533695|NCT01819727|101853094|FG001|Overall Study|Protocol Violation|2|||
33533696|NCT01819727|101853093|FG000|Overall Study|Study Terminated by Sponsor|0|||
33533697|NCT01819727|101853094|FG001|Overall Study|Study Terminated by Sponsor|1|||
33533698|NCT01819727|101853093|FG000|Overall Study|Withdrawal by Subject|6|||
33533699|NCT01819727|101853094|FG001|Overall Study|Withdrawal by Subject|11|||
33533700|NCT01819727|101853093|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
33533701|NCT01819727|101853094|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
33533702|NCT01819727|101853093|FG000|Overall Study|Quit due to lack of health benifits|0|||
33533703|NCT01819727|101853094|FG001|Overall Study|Quit due to lack of health benifits|1|||
33533704|NCT04771013|101853095|FG000|Overall Study|Withdrawal by Subject|2|||
33533705|NCT04771013|101853096|FG001|Overall Study|Withdrawal by Subject|0|||
33533706|NCT04771013|101853095|FG000|Overall Study|Death|0|||
33533707|NCT04771013|101853096|FG001|Overall Study|Death|5|||
33533708|NCT04771013|101853095|FG000|Overall Study|Referred to another hospital before day 20|0|||
33533709|NCT04771013|101853096|FG001|Overall Study|Referred to another hospital before day 20|1|||
33206303|NCT01953926|100656003|FG004|Overall Study|Lost to Follow-up|3|||
33533710|NCT03874013|101853101|FG000|Overall Study|Adverse Event|0|||
33533711|NCT03874013|101853102|FG001|Overall Study|Adverse Event|1|||
33533712|NCT01296412|101853103|FG000|Overall Study|Adverse Event|8|||
33206304|NCT01953926|100656004|FG005|Overall Study|Lost to Follow-up|0|||
33206305|NCT01953926|100656005|FG006|Overall Study|Lost to Follow-up|0|||
33206306|NCT01953926|100655999|FG000|Overall Study|Protocol Violation|1|||
33206307|NCT01953926|100656000|FG001|Overall Study|Protocol Violation|0|||
33206308|NCT01953926|100656001|FG002|Overall Study|Protocol Violation|0|||
33206309|NCT01953926|100656002|FG003|Overall Study|Protocol Violation|0|||
33206310|NCT01953926|100656003|FG004|Overall Study|Protocol Violation|0|||
33206311|NCT01953926|100656004|FG005|Overall Study|Protocol Violation|0|||
33206312|NCT01953926|100656005|FG006|Overall Study|Protocol Violation|0|||
33206313|NCT01953926|100655999|FG000|Overall Study|Other, Disease progression|2|||
33206314|NCT01953926|100656000|FG001|Overall Study|Other, Disease progression|1|||
33206315|NCT01953926|100656001|FG002|Overall Study|Other, Disease progression|0|||
33206316|NCT01953926|100656002|FG003|Overall Study|Other, Disease progression|0|||
33206317|NCT01953926|100656003|FG004|Overall Study|Other, Disease progression|1|||
33206318|NCT01953926|100656004|FG005|Overall Study|Other, Disease progression|0|||
33533713|NCT01296412|101853104|FG001|Overall Study|Adverse Event|29|||
33533714|NCT01296412|101853103|FG000|Overall Study|Lack of Efficacy|1|||
33533715|NCT01296412|101853104|FG001|Overall Study|Lack of Efficacy|0|||
33533716|NCT01296412|101853103|FG000|Overall Study|Lost to Follow-up|10|||
33533717|NCT01296412|101853104|FG001|Overall Study|Lost to Follow-up|7|||
33533718|NCT01296412|101853103|FG000|Overall Study|Non-compliance with study drug|1|||
33533719|NCT01296412|101853104|FG001|Overall Study|Non-compliance with study drug|2|||
33613268|NCT01445080|102133812|FG007|Overall Study|Physician Decision|2|||
33613269|NCT01445080|102133813|FG008|Overall Study|Physician Decision|0|||
33613270|NCT01445080|102133805|FG000|Overall Study|Withdrawal by Subject|1|||
33613271|NCT01445080|102133806|FG001|Overall Study|Withdrawal by Subject|0|||
33613272|NCT01445080|102133807|FG002|Overall Study|Withdrawal by Subject|0|||
33533720|NCT01296412|101853103|FG000|Overall Study|Other reason not specified|20|||
33533721|NCT01296412|101853104|FG001|Overall Study|Other reason not specified|15|||
33533722|NCT01296412|101853103|FG000|Overall Study|Physician Decision|1|||
33533723|NCT01296412|101853104|FG001|Overall Study|Physician Decision|3|||
33206319|NCT01953926|100656005|FG006|Overall Study|Other, Disease progression|0|||
33206320|NCT01953926|100655999|FG000|Overall Study|Discontinuation of study by sponsor|41|||
33405203|NCT02207413|101373276|FG002|Overall Study|Adverse Event|0|||
33613273|NCT01445080|102133808|FG003|Overall Study|Withdrawal by Subject|1|||
33533724|NCT01296412|101853103|FG000|Overall Study|Pregnancy|0|||
33533725|NCT01296412|101853104|FG001|Overall Study|Pregnancy|1|||
33533726|NCT01296412|101853103|FG000|Overall Study|Withdrawal by Subject|10|||
33533727|NCT01296412|101853104|FG001|Overall Study|Withdrawal by Subject|13|||
33533728|NCT03771963|101853105|FG000|Overall Study|Lost to Follow-up|22|||
33533729|NCT03771963|101853105|FG000|Overall Study|Withdrawal of Consent|10|||
33405204|NCT02207413|101373277|FG003|Overall Study|Adverse Event|0|||
33405205|NCT02207413|101373278|FG004|Overall Study|Adverse Event|2|||
33405206|NCT02207413|101373279|FG005|Overall Study|Adverse Event|1|||
33405207|NCT02207413|101373274|FG000|Overall Study|Migrated/moved from study area|0|||
33405208|NCT02207413|101373275|FG001|Overall Study|Migrated/moved from study area|0|||
33405209|NCT02207413|101373276|FG002|Overall Study|Migrated/moved from study area|0|||
33405210|NCT02207413|101373277|FG003|Overall Study|Migrated/moved from study area|0|||
33533730|NCT00588146|101853112|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
33533731|NCT00588146|101853113|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
33533732|NCT00249873|101853114|FG000|Overall Study|Not treated|7|||
33533733|NCT00249873|101853115|FG001|Overall Study|Not treated|8|||
33533734|NCT00249873|101853114|FG000|Overall Study|Significant thrombocytopenia|9|||
33533735|NCT00249873|101853115|FG001|Overall Study|Significant thrombocytopenia|8|||
33533736|NCT00249873|101853114|FG000|Overall Study|Severe allergic reaction|8|||
33613274|NCT01445080|102133809|FG004|Overall Study|Withdrawal by Subject|0|||
33613275|NCT01445080|102133810|FG005|Overall Study|Withdrawal by Subject|0|||
33613276|NCT01445080|102133811|FG006|Overall Study|Withdrawal by Subject|0|||
33613277|NCT01445080|102133812|FG007|Overall Study|Withdrawal by Subject|0|||
33613278|NCT01445080|102133813|FG008|Overall Study|Withdrawal by Subject|2|||
33613279|NCT01445080|102133805|FG000|Overall Study|Ineligible/Inevaluable|1|||
33613280|NCT01445080|102133806|FG001|Overall Study|Ineligible/Inevaluable|2|||
33613281|NCT01445080|102133807|FG002|Overall Study|Ineligible/Inevaluable|0|||
33613282|NCT01445080|102133808|FG003|Overall Study|Ineligible/Inevaluable|1|||
33613283|NCT01445080|102133809|FG004|Overall Study|Ineligible/Inevaluable|2|||
33613284|NCT01445080|102133810|FG005|Overall Study|Ineligible/Inevaluable|3|||
33613285|NCT01445080|102133811|FG006|Overall Study|Ineligible/Inevaluable|0|||
33613286|NCT01445080|102133812|FG007|Overall Study|Ineligible/Inevaluable|0|||
33613287|NCT01445080|102133813|FG008|Overall Study|Ineligible/Inevaluable|6|||
33613288|NCT00231413|102133814|FG000|Overall Study|Non-serious AE|0|||
33613289|NCT00231413|102133815|FG001|Overall Study|Non-serious AE|0|||
33613290|NCT00231413|102133816|FG002|Overall Study|Non-serious AE|1|||
33613291|NCT00231413|102133817|FG003|Overall Study|Non-serious AE|0|||
33613292|NCT00231413|102133818|FG004|Overall Study|Non-serious AE|0|||
33613293|NCT00231413|102133819|FG005|Overall Study|Non-serious AE|0|||
33613294|NCT00231413|102133820|FG006|Overall Study|Non-serious AE|1|||
33613295|NCT00231413|102133814|FG000|Overall Study|Withdrawal by Subject|3|||
33613296|NCT00231413|102133815|FG001|Overall Study|Withdrawal by Subject|1|||
33613297|NCT00231413|102133816|FG002|Overall Study|Withdrawal by Subject|4|||
33613298|NCT00231413|102133817|FG003|Overall Study|Withdrawal by Subject|2|||
33613299|NCT00231413|102133818|FG004|Overall Study|Withdrawal by Subject|2|||
33613300|NCT00231413|102133819|FG005|Overall Study|Withdrawal by Subject|0|||
33613301|NCT00231413|102133820|FG006|Overall Study|Withdrawal by Subject|3|||
33613302|NCT00231413|102133814|FG000|Overall Study|Migrated/moved from study area|0|||
33613303|NCT00231413|102133815|FG001|Overall Study|Migrated/moved from study area|0|||
33613304|NCT00231413|102133816|FG002|Overall Study|Migrated/moved from study area|1|||
33613305|NCT00231413|102133817|FG003|Overall Study|Migrated/moved from study area|0|||
33613306|NCT00231413|102133818|FG004|Overall Study|Migrated/moved from study area|0|||
33613307|NCT00231413|102133819|FG005|Overall Study|Migrated/moved from study area|1|||
33613308|NCT00231413|102133820|FG006|Overall Study|Migrated/moved from study area|0|||
33613309|NCT00231413|102133814|FG000|Overall Study|Lost to Follow-up|4|||
33206321|NCT01953926|100656000|FG001|Overall Study|Discontinuation of study by sponsor|7|||
33206322|NCT01953926|100656001|FG002|Overall Study|Discontinuation of study by sponsor|5|||
33206323|NCT01953926|100656002|FG003|Overall Study|Discontinuation of study by sponsor|12|||
33206324|NCT01953926|100656003|FG004|Overall Study|Discontinuation of study by sponsor|46|||
33206325|NCT01953926|100656004|FG005|Overall Study|Discontinuation of study by sponsor|5|||
33206326|NCT01953926|100656005|FG006|Overall Study|Discontinuation of study by sponsor|6|||
33405211|NCT02207413|101373278|FG004|Overall Study|Migrated/moved from study area|1|||
33405212|NCT02207413|101373279|FG005|Overall Study|Migrated/moved from study area|0|||
33405213|NCT00422942|101373280|FG000|Overall Study|Study terminated by Sponsor|3|||
33405214|NCT02438787|101373283|FG000|Overall Study|Adverse Event|1|||
33405215|NCT02438787|101373284|FG001|Overall Study|Adverse Event|0|||
33405216|NCT02438787|101373285|FG002|Overall Study|Adverse Event|2|||
33533737|NCT00249873|101853115|FG001|Overall Study|Severe allergic reaction|1|||
33613310|NCT00231413|102133815|FG001|Overall Study|Lost to Follow-up|4|||
33613311|NCT00231413|102133816|FG002|Overall Study|Lost to Follow-up|1|||
33613312|NCT00231413|102133817|FG003|Overall Study|Lost to Follow-up|1|||
33613313|NCT00231413|102133818|FG004|Overall Study|Lost to Follow-up|1|||
33613314|NCT00231413|102133819|FG005|Overall Study|Lost to Follow-up|4|||
33613315|NCT00231413|102133820|FG006|Overall Study|Lost to Follow-up|0|||
33613316|NCT00231413|102133814|FG000|Overall Study|Pregnancy|1|||
33533738|NCT00249873|101853114|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
33337914|NCT02064387|101128413|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33337915|NCT02064387|101128414|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33337916|NCT02064387|101128415|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
33337917|NCT02064387|101128416|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
33337918|NCT00253630|101128425|FG000|Overall Study|ineligible|2|||
33337919|NCT01411085|101128426|FG000|Overall Study|Physician Decision|1|||
33533739|NCT00249873|101853115|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
33613317|NCT00231413|102133815|FG001|Overall Study|Pregnancy|0|||
33613318|NCT00231413|102133816|FG002|Overall Study|Pregnancy|0|||
33613319|NCT00231413|102133817|FG003|Overall Study|Pregnancy|0|||
33613320|NCT00231413|102133818|FG004|Overall Study|Pregnancy|0|||
33613321|NCT00231413|102133819|FG005|Overall Study|Pregnancy|0|||
33613322|NCT00231413|102133820|FG006|Overall Study|Pregnancy|0|||
33613323|NCT05513053|102133821|FG000|Overall Study|Lost to Follow-up|9|||
33613324|NCT05513053|102133822|FG001|Overall Study|Lost to Follow-up|11|||
33613325|NCT05513053|102133821|FG000|Overall Study|Withdrawal by parent/guardian|2|||
33613326|NCT05513053|102133822|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33613327|NCT05513053|102133821|FG000|Overall Study|Withdrawal by Subject|2|||
33613328|NCT05513053|102133822|FG001|Overall Study|Withdrawal by Subject|9|||
33613329|NCT05513053|102133821|FG000|Overall Study|Protocol Violation|6|||
33613330|NCT05513053|102133822|FG001|Overall Study|Protocol Violation|3|||
33613331|NCT05513053|102133821|FG000|Overall Study|Adverse Event|0|||
33613332|NCT05513053|102133822|FG001|Overall Study|Adverse Event|2|||
33613333|NCT00874848|102133823|FG000|Overall Study|Adverse Event|13|||
33613334|NCT00874848|102133824|FG001|Overall Study|Adverse Event|2|||
33613335|NCT00874848|102133823|FG000|Overall Study|Progressive neoplastic disease|38|||
33337920|NCT01411085|101128426|FG000|Overall Study|Protocol Violation|1|||
33533740|NCT00249873|101853114|FG000|Overall Study|Other Serious Adverse Event|86|||
33533741|NCT00249873|101853115|FG001|Overall Study|Other Serious Adverse Event|97|||
33533742|NCT00249873|101853114|FG000|Overall Study|Qualifying condition not present|20|||
33533743|NCT00249873|101853115|FG001|Overall Study|Qualifying condition not present|23|||
33613336|NCT00874848|102133824|FG001|Overall Study|Progressive neoplastic disease|18|||
33613337|NCT00874848|102133823|FG000|Overall Study|Withdrawal by Subject|7|||
33613338|NCT00874848|102133824|FG001|Overall Study|Withdrawal by Subject|4|||
33613339|NCT00874848|102133823|FG000|Overall Study|Noncompliance|1|||
33613340|NCT00874848|102133824|FG001|Overall Study|Noncompliance|1|||
33613341|NCT00874848|102133823|FG000|Overall Study|Failure to comply with protocol|0|||
33613342|NCT00874848|102133824|FG001|Overall Study|Failure to comply with protocol|1|||
33613343|NCT00874848|102133823|FG000|Overall Study|Physician Decision|0|||
33613344|NCT00874848|102133824|FG001|Overall Study|Physician Decision|2|||
33613345|NCT00950248|102133825|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
33613346|NCT00950248|102133826|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
33613347|NCT00950248|102133827|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
33613348|NCT00950248|102133825|FG000|Year 1: Baseline|worsening of symptoms|2|||
33613349|NCT00950248|102133826|FG001|Year 1: Baseline|worsening of symptoms|0|||
33613350|NCT00950248|102133827|FG002|Year 1: Baseline|worsening of symptoms|0|||
33613351|NCT00950248|102133825|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
33613352|NCT00950248|102133826|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
33613353|NCT00950248|102133827|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
33613354|NCT00950248|102133825|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
33613355|NCT00950248|102133826|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
33613356|NCT00950248|102133827|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
33613357|NCT00950248|102133825|FG000|Year 2&3 Treatment Randomization|Death|0|||
33613358|NCT00950248|102133826|FG001|Year 2&3 Treatment Randomization|Death|0|||
33337921|NCT01411085|101128426|FG000|Overall Study|Adverse Event|1|||
33337922|NCT02797808|101128427|FG000|Overall Study|Withdrawal by Subject|1|||
33337923|NCT02797808|101128428|FG001|Overall Study|Withdrawal by Subject|1|||
33337924|NCT02797808|101128427|FG000|Overall Study|Physician Decision|6|||
33337925|NCT02797808|101128428|FG001|Overall Study|Physician Decision|2|||
33337926|NCT02482129|101128429|FG000|Overall Study|Adverse Event-prior to treatment|0|||
33533744|NCT00249873|101853114|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
33613359|NCT00950248|102133827|FG002|Year 2&3 Treatment Randomization|Death|1|||
33613360|NCT00950248|102133825|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
33613361|NCT00950248|102133826|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
33613362|NCT00950248|102133827|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
33533745|NCT00249873|101853115|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
33613363|NCT02485704|102133829|FG000|Overall Study|Lost to Follow-up|4|||
33613364|NCT02485704|102133830|FG001|Overall Study|Lost to Follow-up|5|||
33613365|NCT02485704|102133829|FG000|Overall Study|Withdrawal by Subject|0|||
33613366|NCT02485704|102133830|FG001|Overall Study|Withdrawal by Subject|3|||
33613367|NCT02485704|102133829|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
33613368|NCT02485704|102133830|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
33337927|NCT02482129|101128430|FG001|Overall Study|Adverse Event-prior to treatment|1|||
33337928|NCT02482129|101128429|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
33337929|NCT02482129|101128430|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
33337930|NCT02482129|101128429|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
33337931|NCT02482129|101128430|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
33337932|NCT02482129|101128429|FG000|Overall Study|Criteria not met-prior to treatment|1|||
33533746|NCT00249873|101853114|FG000|Overall Study|Withdrawal by Subject|504|||
33533747|NCT00249873|101853115|FG001|Overall Study|Withdrawal by Subject|466|||
33533748|NCT00249873|101853114|FG000|Overall Study|Lost to Follow-up|4|||
33533749|NCT00249873|101853115|FG001|Overall Study|Lost to Follow-up|7|||
33533750|NCT00249873|101853114|FG000|Overall Study|Minor bleeding|99|||
33533751|NCT00249873|101853115|FG001|Overall Study|Minor bleeding|37|||
33533752|NCT00249873|101853114|FG000|Overall Study|Non-compliance|41|||
33533753|NCT00249873|101853115|FG001|Overall Study|Non-compliance|46|||
33533754|NCT00249873|101853114|FG000|Overall Study|Other non serious Adverse Event|112|||
33533755|NCT00249873|101853115|FG001|Overall Study|Other non serious Adverse Event|108|||
33533756|NCT00249873|101853114|FG000|Overall Study|Other contraindicated medication|1|||
33533757|NCT00249873|101853115|FG001|Overall Study|Other contraindicated medication|0|||
33533758|NCT00249873|101853114|FG000|Overall Study|Patient not wish to continue after May08|3|||
33533759|NCT00249873|101853115|FG001|Overall Study|Patient not wish to continue after May08|4|||
33533760|NCT00249873|101853114|FG000|Overall Study|Physician withdrew consent|59|||
33533761|NCT00249873|101853115|FG001|Overall Study|Physician withdrew consent|60|||
33533762|NCT00249873|101853114|FG000|Overall Study|Open label clopidogrel required|31|||
33533763|NCT00249873|101853115|FG001|Overall Study|Open label clopidogrel required|42|||
33533764|NCT00249873|101853114|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
33613369|NCT00310817|102133834|FG000|Overall Study|AE or Death|3|||
33206327|NCT01953926|100655999|FG000|Overall Study|Not Treated|1|||
33206328|NCT01953926|100656000|FG001|Overall Study|Not Treated|0|||
33206329|NCT01953926|100656001|FG002|Overall Study|Not Treated|1|||
33206330|NCT01953926|100656002|FG003|Overall Study|Not Treated|0|||
33206331|NCT01953926|100656003|FG004|Overall Study|Not Treated|0|||
33206332|NCT01953926|100656004|FG005|Overall Study|Not Treated|0|||
33206333|NCT01953926|100656005|FG006|Overall Study|Not Treated|0|||
33206334|NCT02511431|100656007|FG000|Treatment|Lost to Follow-up|0|||
33206335|NCT02511431|100656008|FG001|Treatment|Lost to Follow-up|0|||
33613370|NCT00310817|102133835|FG001|Overall Study|AE or Death|1|||
33613371|NCT00310817|102133836|FG002|Overall Study|AE or Death|0|||
33613372|NCT00310817|102133837|FG003|Overall Study|AE or Death|0|||
33613373|NCT00310817|102133834|FG000|Overall Study|Withdrawal by Subject|1|||
33613374|NCT00310817|102133835|FG001|Overall Study|Withdrawal by Subject|4|||
33613375|NCT00310817|102133836|FG002|Overall Study|Withdrawal by Subject|6|||
33613376|NCT00310817|102133837|FG003|Overall Study|Withdrawal by Subject|7|||
33613377|NCT00310817|102133834|FG000|Overall Study|Lost to Follow-up|2|||
33337933|NCT02482129|101128430|FG001|Overall Study|Criteria not met-prior to treatment|0|||
33337934|NCT02482129|101128429|FG000|Overall Study|Adverse Event|1|||
33337935|NCT02482129|101128430|FG001|Overall Study|Adverse Event|0|||
33613378|NCT00310817|102133835|FG001|Overall Study|Lost to Follow-up|1|||
33613379|NCT00310817|102133836|FG002|Overall Study|Lost to Follow-up|0|||
33613380|NCT00310817|102133837|FG003|Overall Study|Lost to Follow-up|0|||
33613381|NCT00310817|102133834|FG000|Overall Study|Inappropriate Enrollment|1|||
33613382|NCT00310817|102133835|FG001|Overall Study|Inappropriate Enrollment|0|||
33613383|NCT00310817|102133836|FG002|Overall Study|Inappropriate Enrollment|1|||
33613384|NCT00310817|102133837|FG003|Overall Study|Inappropriate Enrollment|0|||
33613385|NCT00310817|102133834|FG000|Overall Study|Protocol Violation|1|||
33206336|NCT02511431|100656009|FG002|Treatment|Lost to Follow-up|1|||
33206337|NCT02511431|100656010|FG003|Treatment|Lost to Follow-up|0|||
33206338|NCT02511431|100656011|FG004|Treatment|Lost to Follow-up|0|||
33533765|NCT00249873|101853115|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
33206339|NCT02511431|100656012|FG005|Treatment|Lost to Follow-up|1|||
33206340|NCT01985126|100656017|FG000|Overall Study|Death|15|||
33206341|NCT01985126|100656018|FG001|Overall Study|Death|69|||
33533766|NCT00249873|101853114|FG000|Overall Study|Oral anticoagulant required|159|||
33533767|NCT00249873|101853115|FG001|Overall Study|Oral anticoagulant required|157|||
33613386|NCT00310817|102133835|FG001|Overall Study|Protocol Violation|1|||
33533768|NCT00249873|101853114|FG000|Overall Study|Study drug intolerance|5|||
33613387|NCT00310817|102133836|FG002|Overall Study|Protocol Violation|1|||
33613388|NCT00310817|102133837|FG003|Overall Study|Protocol Violation|1|||
33206342|NCT01985126|100656017|FG000|Overall Study|Lost to Follow-up|0|||
33206343|NCT01985126|100656018|FG001|Overall Study|Lost to Follow-up|8|||
33613389|NCT00310817|102133834|FG000|Overall Study|Unable to classify|3|||
33533769|NCT00249873|101853115|FG001|Overall Study|Study drug intolerance|0|||
33533770|NCT00249873|101853114|FG000|Overall Study|Surgery/ procedure|9|||
33533771|NCT00249873|101853115|FG001|Overall Study|Surgery/ procedure|9|||
33533772|NCT00249873|101853114|FG000|Overall Study|Event related to cardiac condition|12|||
33533773|NCT00249873|101853115|FG001|Overall Study|Event related to cardiac condition|21|||
33533774|NCT00249873|101853114|FG000|Overall Study|Thromboembolic/outcome event|82|||
33533775|NCT00249873|101853115|FG001|Overall Study|Thromboembolic/outcome event|122|||
33533776|NCT00325819|101853120|FG000|Overall Study|Study product lost in mail|2|||
33533777|NCT00325819|101853121|FG001|Overall Study|Study product lost in mail|1|||
33533778|NCT00325819|101853120|FG000|Overall Study|Did not take a dose of study product|4|||
33533779|NCT00325819|101853121|FG001|Overall Study|Did not take a dose of study product|9|||
33206344|NCT01985126|100656017|FG000|Overall Study|Study Terminated By Sponsor|1|||
33206345|NCT01985126|100656018|FG001|Overall Study|Study Terminated By Sponsor|22|||
33206346|NCT01985126|100656017|FG000|Overall Study|Withdrawal by Subject|2|||
33337936|NCT02482129|101128429|FG000|Overall Study|Withdrawal by Subject|2|||
33337937|NCT02482129|101128430|FG001|Overall Study|Withdrawal by Subject|0|||
33337938|NCT02482129|101128429|FG000|Overall Study|Criteria not met|1|||
33337939|NCT02482129|101128430|FG001|Overall Study|Criteria not met|0|||
33533780|NCT00325819|101853120|FG000|Overall Study|Lost to Follow-up|3|||
33533781|NCT00325819|101853121|FG001|Overall Study|Lost to Follow-up|3|||
33533782|NCT00113295|101853122|FG000|Overall Study|Adverse Event|4|||
33533783|NCT00113295|101853123|FG001|Overall Study|Adverse Event|1|||
33533784|NCT00113295|101853122|FG000|Overall Study|Unrelated Medical Illness|1|||
33533785|NCT00113295|101853123|FG001|Overall Study|Unrelated Medical Illness|0|||
33533786|NCT00281697|101853124|FG000|Overall Study|> 60 days since last dose of study drug|4|||
33533787|NCT00281697|101853125|FG001|Overall Study|> 60 days since last dose of study drug|4|||
33533788|NCT00281697|101853124|FG000|Overall Study|Adverse Event|54|||
33613390|NCT00310817|102133835|FG001|Overall Study|Unable to classify|1|||
33613391|NCT00310817|102133836|FG002|Overall Study|Unable to classify|0|||
33613392|NCT00310817|102133837|FG003|Overall Study|Unable to classify|0|||
33613393|NCT01153724|102133838|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33613394|NCT01153724|102133838|FG000|Treatment Period 2|Adverse Event|1|||
33613395|NCT01153724|102133838|FG000|Treatment Period 2|Other reason not defined above|1|||
33613396|NCT06359080|102133842|FG000|Overall Study|Withdrawal by Subject|3|||
33613397|NCT02069392|102133843|FG000|Overall Study|Withdrawal by Subject|4|||
33613398|NCT02069392|102133844|FG001|Overall Study|Withdrawal by Subject|2|||
33613399|NCT01657292|102133846|FG000|Overall Study|Adverse Event|6|||
33613400|NCT01657292|102133846|FG000|Overall Study|Withdrawal by Subject|2|||
33613401|NCT01657292|102133846|FG000|Overall Study|Violation of eligibility criteria|1|||
33613402|NCT01657292|102133846|FG000|Overall Study|Change of therapy|1|||
33613403|NCT00635882|102133852|FG000|Overall Study|Protocol Violation|1|||
33613404|NCT00635882|102133853|FG001|Overall Study|Protocol Violation|0|||
33613405|NCT00635882|102133854|FG002|Overall Study|Protocol Violation|0|||
33613406|NCT00635882|102133855|FG003|Overall Study|Protocol Violation|0|||
33613407|NCT00635882|102133856|FG004|Overall Study|Protocol Violation|0|||
33337940|NCT01060059|101128433|FG000|Overall Study|Adverse Event|1|||
33533789|NCT00281697|101853125|FG001|Overall Study|Adverse Event|15|||
33613408|NCT00635882|102133857|FG005|Overall Study|Protocol Violation|0|||
33613409|NCT00193180|102133866|FG000|Overall Study|Lack of Efficacy|1|||
33613410|NCT00193180|102133866|FG000|Overall Study|Adverse Event|8|||
33613411|NCT00193180|102133866|FG000|Overall Study|Protocol Violation|1|||
33206347|NCT01985126|100656018|FG001|Overall Study|Withdrawal by Subject|7|||
33206348|NCT02979535|100656019|FG000|Overall Study|Non compliance with the protocol|78|||
33206349|NCT02979535|100656020|FG001|Overall Study|Non compliance with the protocol|82|||
33206350|NCT02979535|100656019|FG000|Overall Study|Consent withdrawn by participant|11|||
33206351|NCT02979535|100656020|FG001|Overall Study|Consent withdrawn by participant|18|||
33206352|NCT02979535|100656019|FG000|Overall Study|Lost to Follow-up|6|||
33533790|NCT00281697|101853124|FG000|Overall Study|Death|8|||
33533791|NCT00281697|101853125|FG001|Overall Study|Death|3|||
33533792|NCT00281697|101853124|FG000|Overall Study|Disease progression|279|||
33533793|NCT00281697|101853125|FG001|Overall Study|Disease progression|149|||
33533794|NCT00281697|101853124|FG000|Overall Study|Other|5|||
33533795|NCT00281697|101853125|FG001|Overall Study|Other|6|||
33533796|NCT00281697|101853124|FG000|Overall Study|Physician's decision to withdraw|15|||
33533797|NCT00281697|101853125|FG001|Overall Study|Physician's decision to withdraw|12|||
33533798|NCT00281697|101853124|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
33533799|NCT00281697|101853125|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
33533800|NCT00281697|101853124|FG000|Overall Study|Did not receive study drug|3|||
33533801|NCT00281697|101853125|FG001|Overall Study|Did not receive study drug|2|||
33533802|NCT00698815|101853126|FG000|Overall Study|Death|1|||
33533803|NCT00698815|101853127|FG001|Overall Study|Death|2|||
33533804|NCT00698815|101853128|FG002|Overall Study|Death|4|||
33533805|NCT00698815|101853126|FG000|Overall Study|Withdrawal by Subject|6|||
33533806|NCT00698815|101853127|FG001|Overall Study|Withdrawal by Subject|3|||
33533807|NCT00698815|101853128|FG002|Overall Study|Withdrawal by Subject|2|||
33533808|NCT00698815|101853126|FG000|Overall Study|MD discretion|2|||
33533809|NCT00698815|101853127|FG001|Overall Study|MD discretion|7|||
33533810|NCT00698815|101853128|FG002|Overall Study|MD discretion|2|||
33533811|NCT00698815|101853126|FG000|Overall Study|Did not receive protocol treatment|1|||
33533812|NCT00698815|101853127|FG001|Overall Study|Did not receive protocol treatment|2|||
33533813|NCT00698815|101853128|FG002|Overall Study|Did not receive protocol treatment|2|||
33533814|NCT04158219|101853141|FG000|Overall Study|Lost to Follow-up|1|||
33533815|NCT01038687|101853142|FG000|Overall Study|Adverse Event|0|||
33533816|NCT01038687|101853143|FG001|Overall Study|Adverse Event|2|||
33533817|NCT01038687|101853144|FG002|Overall Study|Adverse Event|1|||
33533818|NCT04346199|101853149|FG000|Overall Study|Death|8|||
33533819|NCT04346199|101853150|FG001|Overall Study|Death|9|||
33533820|NCT04346199|101853149|FG000|Overall Study|Lost to Follow-up|0|||
33533821|NCT04346199|101853150|FG001|Overall Study|Lost to Follow-up|1|||
33533822|NCT04346199|101853149|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
33533823|NCT04346199|101853150|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
33533824|NCT04346199|101853149|FG000|Overall Study|Withdrawal by Subject|5|||
33533825|NCT04346199|101853150|FG001|Overall Study|Withdrawal by Subject|1|||
33533826|NCT03718429|101853156|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
33533827|NCT03718429|101853157|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
33533828|NCT03718429|101853158|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
33533829|NCT03718429|101853159|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
33533830|NCT01063855|101853160|FG000|Overall Study|Adverse Event|4|||
33533831|NCT01063855|101853161|FG001|Overall Study|Adverse Event|4|||
33533832|NCT01063855|101853160|FG000|Overall Study|Death|0|||
33533833|NCT01063855|101853161|FG001|Overall Study|Death|1|||
33533834|NCT01063855|101853160|FG000|Overall Study|Lost to Follow-up|8|||
33533835|NCT01063855|101853161|FG001|Overall Study|Lost to Follow-up|4|||
33533836|NCT01063855|101853160|FG000|Overall Study|Pregnancy|1|||
33533837|NCT01063855|101853161|FG001|Overall Study|Pregnancy|0|||
33533838|NCT01063855|101853160|FG000|Overall Study|Lack of Efficacy|0|||
33533839|NCT01063855|101853161|FG001|Overall Study|Lack of Efficacy|1|||
33533840|NCT01063855|101853160|FG000|Overall Study|Withdrawal by Subject|11|||
33533841|NCT01063855|101853161|FG001|Overall Study|Withdrawal by Subject|8|||
33533842|NCT01063855|101853160|FG000|Overall Study|Reason not specified|13|||
33533843|NCT01063855|101853161|FG001|Overall Study|Reason not specified|11|||
33206353|NCT02979535|100656020|FG001|Overall Study|Lost to Follow-up|1|||
33533844|NCT00689338|101853164|FG000|Overall Study|Death|65|||
33533845|NCT00689338|101853164|FG000|Overall Study|Adverse Event|13|||
33533846|NCT00689338|101853164|FG000|Overall Study|Insufficient Clinical Response|1|||
33533847|NCT00689338|101853164|FG000|Overall Study|Lack of Efficacy|6|||
33533848|NCT00689338|101853164|FG000|Overall Study|Other|8|||
33533849|NCT00689338|101853164|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
33533850|NCT00689338|101853164|FG000|Overall Study|Lost to Follow-up|5|||
33533851|NCT00689338|101853164|FG000|Overall Study|Withdrawal by Subject|3|||
33533852|NCT00689338|101853164|FG000|Overall Study|Protocol Violation|15|||
33533853|NCT03327324|101853165|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33206354|NCT02543346|100656021|FG000|Second Priming Visit|Withdrawal by Subject|0|||
33533854|NCT03327324|101853166|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
33533855|NCT03327324|101853167|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33337941|NCT01060059|101128434|FG001|Overall Study|Adverse Event|1|||
33337942|NCT01060059|101128433|FG000|Overall Study|Death|2|||
33337943|NCT01060059|101128434|FG001|Overall Study|Death|3|||
33337944|NCT01060059|101128433|FG000|Overall Study|Lost to Follow-up|18|||
33337945|NCT01060059|101128434|FG001|Overall Study|Lost to Follow-up|34|||
33337946|NCT01060059|101128433|FG000|Overall Study|entry criteria not met|4|||
33337947|NCT01060059|101128434|FG001|Overall Study|entry criteria not met|3|||
33337948|NCT01060059|101128433|FG000|Overall Study|Withdrawal by Subject|35|||
33337949|NCT01060059|101128434|FG001|Overall Study|Withdrawal by Subject|23|||
33337950|NCT01060059|101128433|FG000|Overall Study|lack of glycemic control|2|||
33337951|NCT01060059|101128434|FG001|Overall Study|lack of glycemic control|1|||
33337952|NCT01060059|101128433|FG000|Overall Study|lack of compliance|5|||
33337953|NCT01060059|101128434|FG001|Overall Study|lack of compliance|2|||
33337954|NCT00705783|101128435|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
33337955|NCT00705783|101128436|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
33337956|NCT00705783|101128437|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
33337957|NCT00705783|101128435|FG000|Conversion Phase|Lost to Follow-up|13|||
33337958|NCT00705783|101128436|FG001|Conversion Phase|Lost to Follow-up|0|||
33337959|NCT00705783|101128437|FG002|Conversion Phase|Lost to Follow-up|0|||
33337960|NCT00705783|101128435|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
33337961|NCT00705783|101128436|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
33337962|NCT00705783|101128437|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
33337963|NCT00705783|101128435|FG000|Conversion Phase|Withdrawn by Investigator|4|||
33337964|NCT00705783|101128436|FG001|Conversion Phase|Withdrawn by Investigator|0|||
33533856|NCT03327324|101853168|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
33533857|NCT03327324|101853169|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33533858|NCT03327324|101853170|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
33533859|NCT03327324|101853165|FG000|Baseline (Month 0-Month 3)|Refused|0|||
33533860|NCT03327324|101853166|FG001|Baseline (Month 0-Month 3)|Refused|0|||
33533861|NCT03327324|101853167|FG002|Baseline (Month 0-Month 3)|Refused|0|||
33533862|NCT03327324|101853168|FG003|Baseline (Month 0-Month 3)|Refused|0|||
33533863|NCT03327324|101853169|FG004|Baseline (Month 0-Month 3)|Refused|1|||
33533864|NCT03327324|101853170|FG005|Baseline (Month 0-Month 3)|Refused|0|||
33533865|NCT03327324|101853165|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
33533866|NCT03327324|101853166|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
33533867|NCT03327324|101853167|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
33533868|NCT03327324|101853168|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
33533869|NCT03327324|101853169|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
33533870|NCT03327324|101853170|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
33533871|NCT03327324|101853165|FG000|Baseline (Month 0-Month 3)|Death|0|||
33533872|NCT03327324|101853166|FG001|Baseline (Month 0-Month 3)|Death|0|||
33533873|NCT03327324|101853167|FG002|Baseline (Month 0-Month 3)|Death|0|||
33533874|NCT03327324|101853168|FG003|Baseline (Month 0-Month 3)|Death|0|||
33533875|NCT03327324|101853169|FG004|Baseline (Month 0-Month 3)|Death|1|||
33533876|NCT03327324|101853170|FG005|Baseline (Month 0-Month 3)|Death|0|||
33533877|NCT03327324|101853165|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33533878|NCT03327324|101853166|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33533879|NCT03327324|101853167|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33533880|NCT03327324|101853168|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33533881|NCT03327324|101853169|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33533882|NCT03327324|101853170|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
33533883|NCT03327324|101853165|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33533884|NCT03327324|101853166|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33533885|NCT03327324|101853167|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
33337965|NCT00705783|101128437|FG002|Conversion Phase|Withdrawn by Investigator|0|||
33405217|NCT02438787|101373283|FG000|Overall Study|Lack of Efficacy|1|||
33405218|NCT02438787|101373284|FG001|Overall Study|Lack of Efficacy|2|||
33405219|NCT02438787|101373285|FG002|Overall Study|Lack of Efficacy|0|||
33405220|NCT02438787|101373283|FG000|Overall Study|Lost to Follow-up|0|||
33337966|NCT00705783|101128435|FG000|Conversion Phase|Withdrew Consent|24|||
33337967|NCT00705783|101128436|FG001|Conversion Phase|Withdrew Consent|0|||
33337968|NCT00705783|101128437|FG002|Conversion Phase|Withdrew Consent|0|||
33405221|NCT02438787|101373284|FG001|Overall Study|Lost to Follow-up|1|||
33337969|NCT00705783|101128435|FG000|Conversion Phase|Protocol Deviation|2|||
33337970|NCT00705783|101128436|FG001|Conversion Phase|Protocol Deviation|0|||
33337971|NCT00705783|101128437|FG002|Conversion Phase|Protocol Deviation|0|||
33337972|NCT00705783|101128435|FG000|Conversion Phase|Adverse Event|11|||
33337973|NCT00705783|101128436|FG001|Conversion Phase|Adverse Event|0|||
33337974|NCT00705783|101128437|FG002|Conversion Phase|Adverse Event|0|||
33337975|NCT00705783|101128435|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
33337976|NCT00705783|101128436|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
33337977|NCT00705783|101128437|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
33337978|NCT00705783|101128435|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
33337979|NCT00705783|101128436|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
33337980|NCT00705783|101128437|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
33337981|NCT00705783|101128435|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
33337982|NCT00705783|101128436|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
33337983|NCT00705783|101128437|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
33337984|NCT00705783|101128435|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
33337985|NCT00705783|101128436|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
33337986|NCT00705783|101128437|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
33337987|NCT00705783|101128435|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
33337988|NCT00705783|101128436|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
33337989|NCT00705783|101128437|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
33337990|NCT00705783|101128435|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
33337991|NCT00705783|101128436|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
33337992|NCT00705783|101128437|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
33337993|NCT00705783|101128435|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
33337994|NCT00705783|101128436|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
33405222|NCT02438787|101373285|FG002|Overall Study|Lost to Follow-up|0|||
33405223|NCT02438787|101373283|FG000|Overall Study|Protocol Violation|0|||
33533886|NCT03327324|101853168|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33533887|NCT03327324|101853169|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33533888|NCT03327324|101853170|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33533889|NCT03327324|101853165|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
33533890|NCT03327324|101853166|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
33533891|NCT03327324|101853167|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
33533892|NCT03327324|101853168|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
33533893|NCT03327324|101853169|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
33533894|NCT03327324|101853170|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
33533895|NCT03327324|101853165|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
33533896|NCT03327324|101853166|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
33533897|NCT03327324|101853167|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
33533898|NCT03327324|101853168|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
33533899|NCT03327324|101853169|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
33533900|NCT03327324|101853170|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
33533901|NCT03327324|101853165|FG000|Intervention (Month 3-Month 6)|Death|1|||
33533902|NCT03327324|101853166|FG001|Intervention (Month 3-Month 6)|Death|0|||
33533903|NCT03327324|101853167|FG002|Intervention (Month 3-Month 6)|Death|1|||
33533904|NCT03327324|101853168|FG003|Intervention (Month 3-Month 6)|Death|1|||
33533905|NCT03327324|101853169|FG004|Intervention (Month 3-Month 6)|Death|1|||
33533906|NCT03327324|101853170|FG005|Intervention (Month 3-Month 6)|Death|0|||
33533907|NCT03327324|101853165|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33533908|NCT03327324|101853166|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33533909|NCT03327324|101853167|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33533910|NCT03327324|101853168|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33533911|NCT03327324|101853169|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33533912|NCT03327324|101853170|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
33613412|NCT00699660|102133867|FG000|Overall Study|Lost to Follow-up|4|||
33337995|NCT00705783|101128437|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
33613413|NCT00699660|102133868|FG001|Overall Study|Lost to Follow-up|2|||
33613414|NCT00699660|102133867|FG000|Overall Study|missing reports and recording failures|10|||
33613415|NCT00699660|102133868|FG001|Overall Study|missing reports and recording failures|6|||
33613416|NCT02649894|102133873|FG000|Overall Study|Adverse Event|1|||
33613417|NCT02649894|102133874|FG001|Overall Study|Adverse Event|0|||
33613418|NCT02649894|102133873|FG000|Overall Study|Physician Decision|0|||
33613419|NCT02649894|102133874|FG001|Overall Study|Physician Decision|1|||
33613420|NCT02649894|102133873|FG000|Overall Study|Withdrawal by Subject|5|||
33613421|NCT02649894|102133874|FG001|Overall Study|Withdrawal by Subject|2|||
33613422|NCT02649894|102133873|FG000|Overall Study|Lost to Follow-up|2|||
33613423|NCT02649894|102133874|FG001|Overall Study|Lost to Follow-up|1|||
33613424|NCT02649894|102133873|FG000|Overall Study|Death|30|||
33613425|NCT02649894|102133874|FG001|Overall Study|Death|7|||
33613426|NCT02649894|102133873|FG000|Overall Study|Other, not specified|6|||
33613427|NCT02649894|102133874|FG001|Overall Study|Other, not specified|0|||
33613428|NCT00947115|102133875|FG000|Overall Study|Missed reporting interval|3|||
33613429|NCT00947115|102133876|FG001|Overall Study|Missed reporting interval|4|||
33337996|NCT00705783|101128435|FG000|Oral Stabilization Phase|Adverse Event|14|||
33337997|NCT00705783|101128436|FG001|Oral Stabilization Phase|Adverse Event|0|||
33337998|NCT00705783|101128437|FG002|Oral Stabilization Phase|Adverse Event|0|||
33337999|NCT00705783|101128435|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
33338000|NCT00705783|101128436|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
33338001|NCT00705783|101128437|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
33338002|NCT00705783|101128435|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
33338003|NCT00705783|101128436|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
33338004|NCT00705783|101128437|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
33338005|NCT00705783|101128435|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
33338006|NCT00705783|101128436|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
33338007|NCT00705783|101128437|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
33338008|NCT00705783|101128435|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
33338009|NCT00705783|101128436|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
33338010|NCT00705783|101128437|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
33338011|NCT00705783|101128435|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
33338012|NCT00705783|101128436|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
33338013|NCT00705783|101128437|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
33338014|NCT00705783|101128435|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
33338015|NCT00705783|101128436|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
33338016|NCT00705783|101128437|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
33338017|NCT00705783|101128435|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
33338018|NCT00705783|101128436|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
33338019|NCT00705783|101128437|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
33338020|NCT00705783|101128435|FG000|Depot Stabilization Phase|Adverse Event|17|||
33338021|NCT00705783|101128436|FG001|Depot Stabilization Phase|Adverse Event|0|||
33338022|NCT00705783|101128437|FG002|Depot Stabilization Phase|Adverse Event|0|||
33338023|NCT00705783|101128435|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
33338024|NCT00705783|101128436|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
33338025|NCT00705783|101128437|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
33338026|NCT00705783|101128435|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
33338027|NCT00705783|101128436|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
33338028|NCT00705783|101128437|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
33338029|NCT00705783|101128435|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
33338030|NCT00705783|101128436|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
33338031|NCT00705783|101128437|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
33338032|NCT00705783|101128435|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
33613430|NCT00947115|102133877|FG002|Overall Study|Missed reporting interval|2|||
33613431|NCT00947115|102133875|FG000|Overall Study|Physician Decision|0|||
33338033|NCT00705783|101128436|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
33338034|NCT00705783|101128437|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
33613432|NCT00947115|102133876|FG001|Overall Study|Physician Decision|2|||
33613433|NCT00947115|102133877|FG002|Overall Study|Physician Decision|0|||
33613434|NCT00947115|102133875|FG000|Overall Study|Death|0|||
33613435|NCT00947115|102133876|FG001|Overall Study|Death|1|||
33613436|NCT00947115|102133877|FG002|Overall Study|Death|1|||
33613437|NCT00947115|102133875|FG000|Overall Study|Migrated from study area|2|||
33533913|NCT03327324|101853165|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
33533914|NCT03327324|101853166|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33533915|NCT03327324|101853167|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33533916|NCT03327324|101853168|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33533917|NCT03327324|101853169|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33533918|NCT03327324|101853170|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
33533919|NCT03327324|101853165|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
33533920|NCT03327324|101853166|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
33533921|NCT03327324|101853167|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
33533922|NCT03327324|101853168|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
33533923|NCT03327324|101853169|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
33533924|NCT03327324|101853170|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
33533925|NCT03327324|101853165|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
33533926|NCT03327324|101853166|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
33533927|NCT03327324|101853167|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
33533928|NCT03327324|101853168|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
33533929|NCT03327324|101853169|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
33533930|NCT03327324|101853170|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
33533931|NCT03327324|101853165|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33533932|NCT03327324|101853166|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33533933|NCT03327324|101853167|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33533934|NCT03327324|101853168|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
33533935|NCT03327324|101853169|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
33533936|NCT03327324|101853170|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
33533937|NCT03327324|101853165|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
33533938|NCT03327324|101853166|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
33533939|NCT03327324|101853167|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
33206355|NCT02543346|100656022|FG001|Second Priming Visit|Withdrawal by Subject|2|||
33206356|NCT02543346|100656023|FG002|Second Priming Visit|Withdrawal by Subject|2|||
33338035|NCT00705783|101128435|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
33338036|NCT00705783|101128436|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
33338037|NCT00705783|101128437|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
33338038|NCT00705783|101128435|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
33338039|NCT00705783|101128436|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
33338040|NCT00705783|101128437|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
33338041|NCT00705783|101128435|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
33338042|NCT00705783|101128436|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
33338043|NCT00705783|101128437|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
33338044|NCT00705783|101128435|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
33338045|NCT00705783|101128436|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
33338046|NCT00705783|101128437|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
33338047|NCT00705783|101128435|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
33338048|NCT00705783|101128436|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
33405224|NCT02438787|101373284|FG001|Overall Study|Protocol Violation|0|||
33405225|NCT02438787|101373285|FG002|Overall Study|Protocol Violation|1|||
33338049|NCT00705783|101128437|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
33338050|NCT00705783|101128435|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
33338051|NCT00705783|101128436|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
33338052|NCT00705783|101128437|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
33338053|NCT00705783|101128435|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
33338054|NCT00705783|101128436|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
33338055|NCT00705783|101128437|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
33338056|NCT03124784|101128438|FG000|Overall Study|Adverse Event|1|||
33338057|NCT03124784|101128438|FG000|Overall Study|Computer/Equip Malfunction|1|||
33338058|NCT01738971|101128441|FG000|Overall Study|Lost to Follow-up|19|||
33338059|NCT01738971|101128442|FG001|Overall Study|Lost to Follow-up|30|||
33338060|NCT01738971|101128443|FG002|Overall Study|Lost to Follow-up|17|||
33338061|NCT04849780|101128444|FG000|Period 1|Covid-19 Related|1|||
33338062|NCT04849780|101128445|FG001|Period 1|Covid-19 Related|0|||
33338063|NCT04849780|101128444|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
33338064|NCT04849780|101128445|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
33338065|NCT04849780|101128444|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
33338066|NCT04849780|101128445|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
33338067|NCT01908101|101128450|FG000|Overall Study|Physician Decision|1|||
33533940|NCT03327324|101853168|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
33533941|NCT03327324|101853169|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
33533942|NCT03327324|101853170|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
33533943|NCT03327324|101853165|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
33533944|NCT03327324|101853166|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
33533945|NCT03327324|101853167|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
33533946|NCT03327324|101853168|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
33533947|NCT03327324|101853169|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
33533948|NCT03327324|101853170|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
33533949|NCT03669549|101853175|FG000|Overall Study|Adverse Event|4|||
33533950|NCT03669549|101853175|FG000|Overall Study|Withdrawal by Subject|1|||
33533951|NCT03669549|101853175|FG000|Overall Study|Study terminated by the Sponsor|1|||
33533952|NCT00606307|101853176|FG000|Overall Study|Adverse Event|2|||
33533953|NCT00606307|101853176|FG000|Overall Study|Withdrawal by Subject|2|||
33533954|NCT00606307|101853176|FG000|Overall Study|Disease progression|6|||
33533955|NCT00606307|101853176|FG000|Overall Study|QTc prolongation|1|||
33533956|NCT02221648|101853177|FG000|Overall Study|Withdrawal by Subject|3|||
33533957|NCT02221648|101853178|FG001|Overall Study|Withdrawal by Subject|3|||
33533958|NCT01223404|101853179|FG000|First Intervention (1 Day)|Adverse Event|0|||
33533959|NCT01223404|101853180|FG001|First Intervention (1 Day)|Adverse Event|0|||
33533960|NCT01223404|101853181|FG002|First Intervention (1 Day)|Adverse Event|0|||
33533961|NCT01223404|101853182|FG003|First Intervention (1 Day)|Adverse Event|1|||
33533962|NCT01223404|101853183|FG004|First Intervention (1 Day)|Adverse Event|0|||
33533963|NCT01223404|101853184|FG005|First Intervention (1 Day)|Adverse Event|0|||
33533964|NCT01223404|101853179|FG000|Second Intervention (1 Day)|Adverse Event|1|||
33533965|NCT01223404|101853180|FG001|Second Intervention (1 Day)|Adverse Event|0|||
33533966|NCT01223404|101853181|FG002|Second Intervention (1 Day)|Adverse Event|0|||
33533967|NCT01223404|101853182|FG003|Second Intervention (1 Day)|Adverse Event|0|||
33533968|NCT01223404|101853183|FG004|Second Intervention (1 Day)|Adverse Event|0|||
33533969|NCT01223404|101853184|FG005|Second Intervention (1 Day)|Adverse Event|0|||
33533970|NCT01223404|101853179|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
33533971|NCT01223404|101853180|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
33533972|NCT01223404|101853181|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
33533973|NCT01223404|101853182|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
33533974|NCT01223404|101853183|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
33533975|NCT01223404|101853184|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
33533976|NCT02317991|101856282|FG000|Overall Study|Adverse Event|12|||
33533977|NCT02317991|101856282|FG000|Overall Study|Death|4|||
33533978|NCT02317991|101856282|FG000|Overall Study|Withdrawal by Subject|8|||
33533979|NCT02317991|101856282|FG000|Overall Study|Progressive Disease|41|||
33533980|NCT01316224|101856285|FG000|Overall Study|Protocol Violation|3|||
33533981|NCT01316224|101856285|FG000|Overall Study|Adverse Event|3|||
33533982|NCT01316224|101856285|FG000|Overall Study|Lack of Efficacy|1|||
33533983|NCT01316224|101856285|FG000|Overall Study|Withdrawal by Subject|1|||
33533984|NCT01316224|101856285|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
33533985|NCT01316224|101856285|FG000|Overall Study|Other|1|||
33533986|NCT01935089|101856288|FG000|Overall Study|Adverse Event|2|||
33206357|NCT02543346|100656024|FG003|Second Priming Visit|Withdrawal by Subject|2|||
33206358|NCT02543346|100656021|FG000|Second Priming Visit|Adverse Event|1|||
33206359|NCT02543346|100656022|FG001|Second Priming Visit|Adverse Event|0|||
33206360|NCT02543346|100656023|FG002|Second Priming Visit|Adverse Event|0|||
33206361|NCT02543346|100656024|FG003|Second Priming Visit|Adverse Event|0|||
33206362|NCT00288587|100656025|FG000|Overall Study|Death|4|||
33206363|NCT00288587|100656026|FG001|Overall Study|Death|4|||
33206364|NCT00288587|100656025|FG000|Overall Study|Transplant|0|||
33206365|NCT00288587|100656026|FG001|Overall Study|Transplant|3|||
33338068|NCT01908101|101128450|FG000|Overall Study|Withdrawal by Subject|1|||
33338069|NCT01908101|101128450|FG000|Overall Study|Incorrect Diagnosis|2|||
33338070|NCT01908101|101128450|FG000|Overall Study|Incorrect Starting Dose|1|||
33338071|NCT01908101|101128450|FG000|Overall Study|Did not complete the first cycle|4|||
33338072|NCT02104583|101128451|FG000|Overall Study|New ICD or CRT-D implanted|2|||
33338073|NCT02104583|101128452|FG001|Overall Study|New ICD or CRT-D implanted|0|||
33338074|NCT02104583|101128453|FG002|Overall Study|New ICD or CRT-D implanted|1|||
33338075|NCT02104583|101128454|FG003|Overall Study|New ICD or CRT-D implanted|0|||
33338076|NCT02104583|101128455|FG004|Overall Study|New ICD or CRT-D implanted|0|||
33338077|NCT02104583|101128451|FG000|Overall Study|Death|2|||
33338078|NCT02104583|101128452|FG001|Overall Study|Death|1|||
33338079|NCT02104583|101128453|FG002|Overall Study|Death|3|||
33338080|NCT02104583|101128454|FG003|Overall Study|Death|3|||
33338081|NCT02104583|101128455|FG004|Overall Study|Death|5|||
33338082|NCT02104583|101128451|FG000|Overall Study|Subject required cardiac ablation|6|||
33338083|NCT02104583|101128452|FG001|Overall Study|Subject required cardiac ablation|4|||
33338084|NCT02104583|101128453|FG002|Overall Study|Subject required cardiac ablation|4|||
33338085|NCT02104583|101128454|FG003|Overall Study|Subject required cardiac ablation|5|||
33338086|NCT02104583|101128455|FG004|Overall Study|Subject required cardiac ablation|4|||
33338087|NCT02104583|101128451|FG000|Overall Study|Subject required prohibited medication|0|||
33338088|NCT02104583|101128452|FG001|Overall Study|Subject required prohibited medication|1|||
33338089|NCT02104583|101128453|FG002|Overall Study|Subject required prohibited medication|1|||
33338090|NCT02104583|101128454|FG003|Overall Study|Subject required prohibited medication|0|||
33338091|NCT02104583|101128455|FG004|Overall Study|Subject required prohibited medication|1|||
33338092|NCT02104583|101128451|FG000|Overall Study|Withdrew Consent|3|||
33338093|NCT02104583|101128452|FG001|Overall Study|Withdrew Consent|2|||
33338094|NCT02104583|101128453|FG002|Overall Study|Withdrew Consent|0|||
33338095|NCT02104583|101128454|FG003|Overall Study|Withdrew Consent|2|||
33338096|NCT02104583|101128455|FG004|Overall Study|Withdrew Consent|1|||
33338097|NCT02104583|101128451|FG000|Overall Study|Investigator's Discretion|1|||
33338098|NCT02104583|101128452|FG001|Overall Study|Investigator's Discretion|0|||
33338099|NCT02104583|101128453|FG002|Overall Study|Investigator's Discretion|0|||
33338100|NCT02104583|101128454|FG003|Overall Study|Investigator's Discretion|0|||
33338101|NCT02104583|101128455|FG004|Overall Study|Investigator's Discretion|0|||
33338102|NCT02104583|101128451|FG000|Overall Study|Protocol Violation|0|||
33338103|NCT02104583|101128452|FG001|Overall Study|Protocol Violation|0|||
33533987|NCT01935089|101856288|FG000|Overall Study|Withdrawal by Subject|1|||
33533988|NCT00732069|101856289|FG000|Washout After First Study Drug|Adverse Event|1|||
33533989|NCT00732069|101856290|FG001|Washout After First Study Drug|Adverse Event|0|||
33533990|NCT00732069|101856291|FG002|Washout After First Study Drug|Adverse Event|0|||
33533991|NCT00732069|101856292|FG003|Washout After First Study Drug|Adverse Event|0|||
33533992|NCT00732069|101856293|FG004|Washout After First Study Drug|Adverse Event|0|||
33533993|NCT00732069|101856294|FG005|Washout After First Study Drug|Adverse Event|0|||
33533994|NCT01789047|101856295|FG000|Overall Study|Adverse Event|3|||
33533995|NCT01789047|101856296|FG001|Overall Study|Adverse Event|2|||
33533996|NCT01789047|101856295|FG000|Overall Study|Withdrawal by Subject|1|||
33533997|NCT01789047|101856296|FG001|Overall Study|Withdrawal by Subject|2|||
33533998|NCT02762084|101856298|FG000|Overall Study|Withdrawal by Subject|1|||
33533999|NCT02762084|101856299|FG001|Overall Study|Withdrawal by Subject|0|||
33534000|NCT02762084|101856300|FG002|Overall Study|Withdrawal by Subject|0|||
33534001|NCT02762084|101856298|FG000|Overall Study|Adverse Event|0|||
33534002|NCT02762084|101856299|FG001|Overall Study|Adverse Event|0|||
33534003|NCT02762084|101856300|FG002|Overall Study|Adverse Event|1|||
33534004|NCT01714544|101856301|FG000|Overall Study|Lost to Follow-up|1|||
33534005|NCT01714544|101856301|FG000|Overall Study|Physician Decision|1|||
33534006|NCT01714544|101856301|FG000|Overall Study|Withdrawal by Subject|1|||
33534007|NCT01348139|101856302|FG000|Period 1|Adverse Event|1|||
33534008|NCT01348139|101856303|FG001|Period 1|Adverse Event|0|||
33338104|NCT02104583|101128453|FG002|Overall Study|Protocol Violation|1|||
33338105|NCT02104583|101128454|FG003|Overall Study|Protocol Violation|0|||
33338106|NCT02104583|101128455|FG004|Overall Study|Protocol Violation|0|||
33534009|NCT01348139|101856304|FG002|Period 1|Adverse Event|0|||
33534010|NCT01348139|101856305|FG003|Period 1|Adverse Event|0|||
33534011|NCT01348139|101856306|FG004|Period 1|Adverse Event|0|||
33338107|NCT02104583|101128451|FG000|Overall Study|Adverse Event|3|||
33338108|NCT02104583|101128452|FG001|Overall Study|Adverse Event|3|||
33338109|NCT02104583|101128453|FG002|Overall Study|Adverse Event|6|||
33534012|NCT01348139|101856307|FG005|Period 1|Adverse Event|0|||
33613438|NCT00947115|102133876|FG001|Overall Study|Migrated from study area|0|||
33613439|NCT00947115|102133877|FG002|Overall Study|Migrated from study area|0|||
33613440|NCT00947115|102133875|FG000|Overall Study|Withdrawal by Subject|1|||
33613441|NCT00947115|102133876|FG001|Overall Study|Withdrawal by Subject|3|||
33534013|NCT02849743|101856308|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
33534014|NCT02849743|101856309|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
33534015|NCT02849743|101856308|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
33534016|NCT02849743|101856309|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
33534017|NCT02492165|101856310|FG000|Overall Study|Withdrawal by Subject|0|||
33534018|NCT02492165|101856311|FG001|Overall Study|Withdrawal by Subject|1|||
33338110|NCT02104583|101128454|FG003|Overall Study|Adverse Event|6|||
33405226|NCT02438787|101373283|FG000|Overall Study|Withdrawal by Subject|15|||
33534019|NCT02492165|101856312|FG002|Overall Study|Withdrawal by Subject|0|||
33534020|NCT02492165|101856313|FG003|Overall Study|Withdrawal by Subject|0|||
33534021|NCT02157519|101856314|FG000|Overall Study|Death|3|||
33534022|NCT02157519|101856315|FG001|Overall Study|Death|1|||
33534023|NCT02157519|101856314|FG000|Overall Study|Withdrawal by Subject|7|||
33338111|NCT02104583|101128455|FG004|Overall Study|Adverse Event|1|||
33534024|NCT02157519|101856315|FG001|Overall Study|Withdrawal by Subject|0|||
33534025|NCT02157519|101856314|FG000|Overall Study|Lost to Follow-up|1|||
33534026|NCT02157519|101856315|FG001|Overall Study|Lost to Follow-up|0|||
33534027|NCT02699996|101856316|FG000|Overall Study|Withdrawal by Subject|5|||
33534028|NCT02699996|101856317|FG001|Overall Study|Withdrawal by Subject|2|||
33534029|NCT05417412|101856326|FG000|Overall Study|Lost to Follow-up|2|||
33613442|NCT00947115|102133877|FG002|Overall Study|Withdrawal by Subject|4|||
33613443|NCT00947115|102133875|FG000|Overall Study|Lost to Follow-up|11|||
33613444|NCT00947115|102133876|FG001|Overall Study|Lost to Follow-up|12|||
33613445|NCT00947115|102133877|FG002|Overall Study|Lost to Follow-up|8|||
33613446|NCT03775512|102133878|FG000|Overall Study|Death|1|||
33613447|NCT03775512|102133879|FG001|Overall Study|Death|1|||
33613448|NCT03775512|102133878|FG000|Overall Study|Withdrawal by Subject|7|||
33613449|NCT03775512|102133879|FG001|Overall Study|Withdrawal by Subject|4|||
33613450|NCT03775512|102133878|FG000|Overall Study|Lost to Follow-up|5|||
33613451|NCT03775512|102133879|FG001|Overall Study|Lost to Follow-up|5|||
33613452|NCT03775512|102133878|FG000|Overall Study|Excluded before Catheter insertion|14|||
33613453|NCT03775512|102133879|FG001|Overall Study|Excluded before Catheter insertion|5|||
33613454|NCT03775512|102133878|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
33338112|NCT02104583|101128451|FG000|Overall Study|Lost to Follow-up|1|||
33338113|NCT02104583|101128452|FG001|Overall Study|Lost to Follow-up|0|||
33338114|NCT02104583|101128453|FG002|Overall Study|Lost to Follow-up|0|||
33338115|NCT02104583|101128454|FG003|Overall Study|Lost to Follow-up|0|||
33338116|NCT02104583|101128455|FG004|Overall Study|Lost to Follow-up|0|||
33534030|NCT01656395|101856329|FG000|Overall Study|Adverse Event|1|||
33534031|NCT01656395|101856330|FG001|Overall Study|Adverse Event|14|||
33338117|NCT02104583|101128451|FG000|Overall Study|Randomized but Never Treated|0|||
33338118|NCT02104583|101128452|FG001|Overall Study|Randomized but Never Treated|0|||
33338119|NCT02104583|101128453|FG002|Overall Study|Randomized but Never Treated|0|||
33338120|NCT02104583|101128454|FG003|Overall Study|Randomized but Never Treated|1|||
33338121|NCT02104583|101128455|FG004|Overall Study|Randomized but Never Treated|0|||
33338122|NCT01784965|101128457|FG000|Overall Study|Withdrawal by Subject|6|||
33338123|NCT01784965|101128458|FG001|Overall Study|Withdrawal by Subject|3|||
33338124|NCT01784965|101128457|FG000|Overall Study|Adverse Event|0|||
33338125|NCT01784965|101128458|FG001|Overall Study|Adverse Event|8|||
33338126|NCT00412750|101128461|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33405227|NCT02438787|101373284|FG001|Overall Study|Withdrawal by Subject|7|||
33405228|NCT02438787|101373285|FG002|Overall Study|Withdrawal by Subject|10|||
33405229|NCT02438787|101373283|FG000|Overall Study|Study discontinued by sponsor|64|||
33405230|NCT02438787|101373284|FG001|Overall Study|Study discontinued by sponsor|72|||
33534032|NCT01656395|101856331|FG002|Overall Study|Adverse Event|5|||
33534033|NCT01656395|101856332|FG003|Overall Study|Adverse Event|4|||
33534034|NCT01656395|101856333|FG004|Overall Study|Adverse Event|5|||
33534035|NCT01656395|101856334|FG005|Overall Study|Adverse Event|7|||
33534036|NCT01656395|101856335|FG006|Overall Study|Adverse Event|0|||
33534037|NCT01656395|101856336|FG007|Overall Study|Adverse Event|0|||
33613455|NCT03775512|102133879|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
33613456|NCT03775512|102133878|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
33534038|NCT01656395|101856329|FG000|Overall Study|Lack of Efficacy|1|||
33338127|NCT00412750|101128462|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33338128|NCT00412750|101128463|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33534039|NCT01656395|101856330|FG001|Overall Study|Lack of Efficacy|8|||
33338129|NCT00412750|101128461|FG000|Overall Study|Administrative problems|21|||
33405231|NCT02438787|101373285|FG002|Overall Study|Study discontinued by sponsor|69|||
33534040|NCT01656395|101856331|FG002|Overall Study|Lack of Efficacy|6|||
33405232|NCT02438787|101373283|FG000|Overall Study|Other|0|||
33613457|NCT03775512|102133879|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
33613458|NCT00766051|102133881|FG000|Overall Study|Withdrawal by Subject|2|||
33534041|NCT01656395|101856332|FG003|Overall Study|Lack of Efficacy|1|||
33534042|NCT01656395|101856333|FG004|Overall Study|Lack of Efficacy|1|||
33534043|NCT01656395|101856334|FG005|Overall Study|Lack of Efficacy|6|||
33534044|NCT01656395|101856335|FG006|Overall Study|Lack of Efficacy|0|||
33534045|NCT01656395|101856336|FG007|Overall Study|Lack of Efficacy|0|||
33534046|NCT01656395|101856329|FG000|Overall Study|Lost to Follow-up|1|||
33534047|NCT01656395|101856330|FG001|Overall Study|Lost to Follow-up|0|||
33534048|NCT01656395|101856331|FG002|Overall Study|Lost to Follow-up|0|||
33534049|NCT01656395|101856332|FG003|Overall Study|Lost to Follow-up|0|||
33534050|NCT01656395|101856333|FG004|Overall Study|Lost to Follow-up|0|||
33534051|NCT01656395|101856334|FG005|Overall Study|Lost to Follow-up|0|||
33534052|NCT01656395|101856335|FG006|Overall Study|Lost to Follow-up|0|||
33534053|NCT01656395|101856336|FG007|Overall Study|Lost to Follow-up|0|||
33534054|NCT01656395|101856329|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33534055|NCT01656395|101856330|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33534056|NCT01656395|101856331|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33534057|NCT01656395|101856332|FG003|Overall Study|Non-Compliance with Study Drug|0|||
33534058|NCT01656395|101856333|FG004|Overall Study|Non-Compliance with Study Drug|1|||
33534059|NCT01656395|101856334|FG005|Overall Study|Non-Compliance with Study Drug|1|||
33534060|NCT01656395|101856335|FG006|Overall Study|Non-Compliance with Study Drug|0|||
33534061|NCT01656395|101856336|FG007|Overall Study|Non-Compliance with Study Drug|0|||
33534062|NCT01656395|101856329|FG000|Overall Study|Other|0|||
33534063|NCT01656395|101856330|FG001|Overall Study|Other|0|||
33534064|NCT01656395|101856331|FG002|Overall Study|Other|1|||
33534065|NCT01656395|101856332|FG003|Overall Study|Other|0|||
33534066|NCT01656395|101856333|FG004|Overall Study|Other|0|||
33206366|NCT00288587|100656025|FG000|Overall Study|Adverse Event|0|||
33206367|NCT00288587|100656026|FG001|Overall Study|Adverse Event|1|||
33206368|NCT00288587|100656025|FG000|Overall Study|Physician Decision|0|||
33206369|NCT00288587|100656026|FG001|Overall Study|Physician Decision|2|||
33206370|NCT00288587|100656025|FG000|Overall Study|Severe Aortic Stenosis|1|||
33206371|NCT00288587|100656026|FG001|Overall Study|Severe Aortic Stenosis|0|||
33206372|NCT04053764|100656029|FG000|Overall Study|Withdrawal by Subject|6|||
33206373|NCT04053764|100656030|FG001|Overall Study|Withdrawal by Subject|2|||
33206374|NCT04053764|100656029|FG000|Overall Study|Physician Decision|2|||
33206375|NCT04053764|100656030|FG001|Overall Study|Physician Decision|1|||
33206376|NCT04053764|100656029|FG000|Overall Study|Adverse Event|1|||
33206377|NCT04053764|100656030|FG001|Overall Study|Adverse Event|0|||
33206378|NCT04053764|100656029|FG000|Overall Study|Pregnancy|1|||
33206379|NCT04053764|100656030|FG001|Overall Study|Pregnancy|0|||
33206380|NCT04304833|100656031|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
33206381|NCT04304833|100656032|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
33206382|NCT04139317|100656035|FG000|Overall Study|Adverse Event|10|||
33206383|NCT04139317|100656036|FG001|Overall Study|Adverse Event|2|||
33206384|NCT04139317|100656035|FG000|Overall Study|Death|6|||
33206385|NCT04139317|100656036|FG001|Overall Study|Death|4|||
33206386|NCT04139317|100656035|FG000|Overall Study|Lost to Follow-up|1|||
33206387|NCT04139317|100656036|FG001|Overall Study|Lost to Follow-up|0|||
33206388|NCT04139317|100656035|FG000|Overall Study|Physician Decision|3|||
33206389|NCT04139317|100656036|FG001|Overall Study|Physician Decision|1|||
33206390|NCT04139317|100656035|FG000|Overall Study|Progressive Disease|19|||
33338130|NCT00412750|101128462|FG001|Overall Study|Administrative problems|17|||
33338131|NCT00412750|101128463|FG002|Overall Study|Administrative problems|14|||
33338132|NCT00412750|101128461|FG000|Overall Study|Adverse Event|8|||
33338133|NCT00412750|101128462|FG001|Overall Study|Adverse Event|3|||
33338134|NCT00412750|101128463|FG002|Overall Study|Adverse Event|3|||
33338135|NCT00412750|101128461|FG000|Overall Study|Lost to Follow-up|1|||
33534067|NCT01656395|101856334|FG005|Overall Study|Other|1|||
33206391|NCT04139317|100656036|FG001|Overall Study|Progressive Disease|9|||
33206392|NCT04139317|100656035|FG000|Overall Study|Subject Decision|2|||
33206393|NCT04139317|100656036|FG001|Overall Study|Subject Decision|2|||
33338136|NCT00412750|101128462|FG001|Overall Study|Lost to Follow-up|0|||
33338137|NCT00412750|101128463|FG002|Overall Study|Lost to Follow-up|1|||
33534068|NCT01656395|101856335|FG006|Overall Study|Other|0|||
33206394|NCT04419493|100656037|FG000|Wash-out After Period 1|Adverse Event|1|||
33338138|NCT00412750|101128461|FG000|Overall Study|Withdrawal by Subject|0|||
33534069|NCT01656395|101856336|FG007|Overall Study|Other|0|||
33534070|NCT01656395|101856329|FG000|Overall Study|Physician Decision|2|||
33534071|NCT01656395|101856330|FG001|Overall Study|Physician Decision|3|||
33206395|NCT04419493|100656038|FG001|Wash-out After Period 1|Adverse Event|2|||
33206396|NCT04419493|100656039|FG002|Wash-out After Period 1|Adverse Event|1|||
33206397|NCT04419493|100656040|FG003|Wash-out After Period 1|Adverse Event|0|||
33206398|NCT03778294|100656041|FG000|Overall Study|Death|1|||
33206399|NCT03778294|100656041|FG000|Overall Study|Issues with insurance|1|||
33338139|NCT00412750|101128462|FG001|Overall Study|Withdrawal by Subject|1|||
33534072|NCT01656395|101856331|FG002|Overall Study|Physician Decision|3|||
33534073|NCT01656395|101856332|FG003|Overall Study|Physician Decision|2|||
33534074|NCT01656395|101856333|FG004|Overall Study|Physician Decision|3|||
33534075|NCT01656395|101856334|FG005|Overall Study|Physician Decision|3|||
33534076|NCT01656395|101856335|FG006|Overall Study|Physician Decision|0|||
33534077|NCT01656395|101856336|FG007|Overall Study|Physician Decision|0|||
33534078|NCT01656395|101856329|FG000|Overall Study|Pregnancy|0|||
33534079|NCT01656395|101856330|FG001|Overall Study|Pregnancy|0|||
33534080|NCT01656395|101856331|FG002|Overall Study|Pregnancy|1|||
33534081|NCT01656395|101856332|FG003|Overall Study|Pregnancy|0|||
33534082|NCT01656395|101856333|FG004|Overall Study|Pregnancy|0|||
33534083|NCT01656395|101856334|FG005|Overall Study|Pregnancy|0|||
33534084|NCT01656395|101856335|FG006|Overall Study|Pregnancy|0|||
33534085|NCT01656395|101856336|FG007|Overall Study|Pregnancy|0|||
33534086|NCT01656395|101856329|FG000|Overall Study|Progressive Disease|0|||
33534087|NCT01656395|101856330|FG001|Overall Study|Progressive Disease|0|||
33534088|NCT01656395|101856331|FG002|Overall Study|Progressive Disease|0|||
33534089|NCT01656395|101856332|FG003|Overall Study|Progressive Disease|0|||
33534090|NCT01656395|101856333|FG004|Overall Study|Progressive Disease|0|||
33534091|NCT01656395|101856334|FG005|Overall Study|Progressive Disease|1|||
33534092|NCT01656395|101856335|FG006|Overall Study|Progressive Disease|0|||
33534093|NCT01656395|101856336|FG007|Overall Study|Progressive Disease|0|||
33534094|NCT01656395|101856329|FG000|Overall Study|Protocol Violation|6|||
33534095|NCT01656395|101856330|FG001|Overall Study|Protocol Violation|6|||
33534096|NCT01656395|101856331|FG002|Overall Study|Protocol Violation|9|||
33534097|NCT01656395|101856332|FG003|Overall Study|Protocol Violation|2|||
33534098|NCT01656395|101856333|FG004|Overall Study|Protocol Violation|4|||
33534099|NCT01656395|101856334|FG005|Overall Study|Protocol Violation|10|||
33534100|NCT01656395|101856335|FG006|Overall Study|Protocol Violation|0|||
33534101|NCT01656395|101856336|FG007|Overall Study|Protocol Violation|0|||
33534102|NCT01656395|101856329|FG000|Overall Study|Screen Failure|2|||
33534103|NCT01656395|101856330|FG001|Overall Study|Screen Failure|1|||
33534104|NCT01656395|101856331|FG002|Overall Study|Screen Failure|7|||
33534105|NCT01656395|101856332|FG003|Overall Study|Screen Failure|1|||
33534106|NCT01656395|101856333|FG004|Overall Study|Screen Failure|0|||
33534107|NCT01656395|101856334|FG005|Overall Study|Screen Failure|8|||
33613459|NCT00766051|102133882|FG001|Overall Study|Withdrawal by Subject|0|||
33613460|NCT02578186|102133887|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
33613461|NCT02578186|102133888|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
33613462|NCT02578186|102133887|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
33613463|NCT02578186|102133888|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
33613464|NCT00940498|102133889|FG000|Overall Study|Death|2|||
33613465|NCT00940498|102133890|FG001|Overall Study|Death|0|||
33613466|NCT00940498|102133891|FG002|Overall Study|Death|0|||
33613467|NCT00940498|102133892|FG003|Overall Study|Death|1|||
33613468|NCT00940498|102133893|FG004|Overall Study|Death|5|||
33613469|NCT00940498|102133894|FG005|Overall Study|Death|0|||
33613470|NCT00940498|102133895|FG006|Overall Study|Death|1|||
33613471|NCT00940498|102133896|FG007|Overall Study|Death|0|||
33613472|NCT00940498|102133889|FG000|Overall Study|Lost to Follow-up|1|||
33534108|NCT01656395|101856335|FG006|Overall Study|Screen Failure|0|||
33534109|NCT01656395|101856336|FG007|Overall Study|Screen Failure|0|||
33613473|NCT00940498|102133890|FG001|Overall Study|Lost to Follow-up|1|||
33534110|NCT01656395|101856329|FG000|Overall Study|Withdrawal by Subject|3|||
33534111|NCT01656395|101856330|FG001|Overall Study|Withdrawal by Subject|1|||
33534112|NCT01656395|101856331|FG002|Overall Study|Withdrawal by Subject|4|||
33534113|NCT01656395|101856332|FG003|Overall Study|Withdrawal by Subject|2|||
33613474|NCT00940498|102133891|FG002|Overall Study|Lost to Follow-up|2|||
33613475|NCT00940498|102133892|FG003|Overall Study|Lost to Follow-up|0|||
33534114|NCT01656395|101856333|FG004|Overall Study|Withdrawal by Subject|0|||
33534115|NCT01656395|101856334|FG005|Overall Study|Withdrawal by Subject|3|||
33534116|NCT01656395|101856335|FG006|Overall Study|Withdrawal by Subject|0|||
33534117|NCT01656395|101856336|FG007|Overall Study|Withdrawal by Subject|0|||
33534118|NCT01298700|101856339|FG000|Overall Study|Adverse Event|50|||
33534119|NCT01298700|101856340|FG001|Overall Study|Adverse Event|51|||
33534120|NCT01298700|101856339|FG000|Overall Study|Lack of Efficacy|9|||
33534121|NCT01298700|101856340|FG001|Overall Study|Lack of Efficacy|14|||
33338140|NCT00412750|101128463|FG002|Overall Study|Withdrawal by Subject|2|||
33338141|NCT00412750|101128461|FG000|Overall Study|Lack of Efficacy|0|||
33338142|NCT00412750|101128462|FG001|Overall Study|Lack of Efficacy|0|||
33338143|NCT00412750|101128463|FG002|Overall Study|Lack of Efficacy|3|||
33338144|NCT01659320|101128464|FG000|Overall Study|Withdrawal by Subject|2|||
33338145|NCT01659320|101128464|FG000|Overall Study|Physician Decision|1|||
33338146|NCT01148537|101128465|FG000|Overall Study|Withdrawal by Subject|1|||
33338147|NCT01148537|101128466|FG001|Overall Study|Withdrawal by Subject|0|||
33338148|NCT01148537|101128467|FG002|Overall Study|Withdrawal by Subject|2|||
33338149|NCT01148537|101128465|FG000|Overall Study|Adverse Event|2|||
33206400|NCT03778294|100656041|FG000|Overall Study|disease progression before treatment|2|||
33206401|NCT00936858|100656042|FG000|Overall Study|Death|3|||
33206402|NCT00936858|100656042|FG000|Overall Study|Progression|29|||
33206403|NCT00936858|100656042|FG000|Overall Study|Withdrawal by Subject|5|||
33206404|NCT00936858|100656042|FG000|Overall Study|Adverse Event|1|||
33206405|NCT00936858|100656042|FG000|Overall Study|Physician Decision|7|||
33338150|NCT01148537|101128466|FG001|Overall Study|Adverse Event|0|||
33338151|NCT01148537|101128467|FG002|Overall Study|Adverse Event|1|||
33338152|NCT00452699|101128468|FG000|Overall Study|Adverse Event|10|||
33338153|NCT00452699|101128469|FG001|Overall Study|Adverse Event|3|||
33613476|NCT00940498|102133893|FG004|Overall Study|Lost to Follow-up|1|||
33338154|NCT00452699|101128468|FG000|Overall Study|Lack of Efficacy|6|||
33338155|NCT00452699|101128469|FG001|Overall Study|Lack of Efficacy|4|||
33613477|NCT00940498|102133894|FG005|Overall Study|Lost to Follow-up|0|||
33613478|NCT00940498|102133895|FG006|Overall Study|Lost to Follow-up|0|||
33613479|NCT00940498|102133896|FG007|Overall Study|Lost to Follow-up|1|||
33613480|NCT00940498|102133889|FG000|Overall Study|Disease Progression|0|||
33613481|NCT00940498|102133890|FG001|Overall Study|Disease Progression|0|||
33613482|NCT00940498|102133891|FG002|Overall Study|Disease Progression|1|||
33613483|NCT00940498|102133892|FG003|Overall Study|Disease Progression|1|||
33613484|NCT00940498|102133893|FG004|Overall Study|Disease Progression|0|||
33613485|NCT00940498|102133894|FG005|Overall Study|Disease Progression|1|||
33613486|NCT00940498|102133895|FG006|Overall Study|Disease Progression|0|||
33613487|NCT00940498|102133896|FG007|Overall Study|Disease Progression|0|||
33613488|NCT00940498|102133889|FG000|Overall Study|Physician Decision|0|||
33613489|NCT00940498|102133890|FG001|Overall Study|Physician Decision|0|||
33613490|NCT00940498|102133891|FG002|Overall Study|Physician Decision|0|||
33613491|NCT00940498|102133892|FG003|Overall Study|Physician Decision|0|||
33613492|NCT00940498|102133893|FG004|Overall Study|Physician Decision|2|||
33613493|NCT00940498|102133894|FG005|Overall Study|Physician Decision|0|||
33613494|NCT00940498|102133895|FG006|Overall Study|Physician Decision|0|||
33206406|NCT00936858|100656042|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
33206407|NCT00936858|100656042|FG000|Overall Study|Lost to Follow-up|1|||
33206408|NCT02079805|100656045|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33613495|NCT00940498|102133896|FG007|Overall Study|Physician Decision|0|||
33613496|NCT00940498|102133889|FG000|Overall Study|Not treated due to disease related pain|0|||
33206409|NCT02079805|100656046|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
33206410|NCT02079805|100656045|FG000|Overall Study|Voluntary Withdrawal|0|||
33206411|NCT02079805|100656046|FG001|Overall Study|Voluntary Withdrawal|1|||
33534122|NCT01298700|101856339|FG000|Overall Study|Lost to Follow-up|5|||
33534123|NCT01298700|101856340|FG001|Overall Study|Lost to Follow-up|2|||
33534124|NCT01298700|101856339|FG000|Overall Study|Withdrawal by Subject|12|||
33534125|NCT01298700|101856340|FG001|Overall Study|Withdrawal by Subject|9|||
33613497|NCT00940498|102133890|FG001|Overall Study|Not treated due to disease related pain|0|||
33613498|NCT00940498|102133891|FG002|Overall Study|Not treated due to disease related pain|0|||
33338156|NCT00452699|101128468|FG000|Overall Study|Lost to Follow-up|6|||
33534126|NCT01298700|101856339|FG000|Overall Study|Protocol Violation|6|||
33534127|NCT01298700|101856340|FG001|Overall Study|Protocol Violation|4|||
33534128|NCT01298700|101856339|FG000|Overall Study|Other Miscellaneous Reasons|16|||
33534129|NCT01298700|101856340|FG001|Overall Study|Other Miscellaneous Reasons|15|||
33206412|NCT00823719|100656049|FG000|Overall Study|Adverse Event|1|||
33206413|NCT00823719|100656050|FG001|Overall Study|Adverse Event|2|||
33534130|NCT01298700|101856339|FG000|Overall Study|Did not Receive Study Drug|3|||
33206414|NCT00823719|100656049|FG000|Overall Study|Physician Decision|1|||
33534131|NCT01298700|101856340|FG001|Overall Study|Did not Receive Study Drug|5|||
33534132|NCT00846053|101856345|FG000|Overall Study|Physician Decision|3|||
33534133|NCT00846053|101856346|FG001|Overall Study|Physician Decision|0|||
33534134|NCT00846586|101856356|FG000|Overall Study|Adverse Event|20|||
33534135|NCT00846586|101856357|FG001|Overall Study|Adverse Event|10|||
33534136|NCT00846586|101856356|FG000|Overall Study|Subject withdrew consent|8|||
33534137|NCT00846586|101856357|FG001|Overall Study|Subject withdrew consent|10|||
33206415|NCT00823719|100656050|FG001|Overall Study|Physician Decision|4|||
33534138|NCT00846586|101856356|FG000|Overall Study|Administrative problems|5|||
33534139|NCT00846586|101856357|FG001|Overall Study|Administrative problems|4|||
33534140|NCT00846586|101856356|FG000|Overall Study|Death|2|||
33338157|NCT00452699|101128469|FG001|Overall Study|Lost to Follow-up|9|||
33338158|NCT00452699|101128468|FG000|Overall Study|Protocol Violation|21|||
33338159|NCT00452699|101128469|FG001|Overall Study|Protocol Violation|25|||
33338160|NCT00452699|101128468|FG000|Overall Study|Withdrawal by Subject|26|||
33338161|NCT00452699|101128469|FG001|Overall Study|Withdrawal by Subject|25|||
33338162|NCT00452699|101128468|FG000|Overall Study|Other|12|||
33338163|NCT00452699|101128469|FG001|Overall Study|Other|7|||
33338164|NCT01870401|101128472|FG000|Overall Study|Death|48|||
33534141|NCT00846586|101856357|FG001|Overall Study|Death|0|||
33534142|NCT00846586|101856356|FG000|Overall Study|Protocol deviation|2|||
33534143|NCT00846586|101856357|FG001|Overall Study|Protocol deviation|6|||
33534144|NCT00846586|101856356|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33534145|NCT00846586|101856357|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33534146|NCT00846586|101856356|FG000|Overall Study|Lost to Follow-up|1|||
33534147|NCT00846586|101856357|FG001|Overall Study|Lost to Follow-up|4|||
33534148|NCT00846586|101856356|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33534149|NCT00846586|101856357|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33534150|NCT03528551|101856362|FG000|Overall Study|Lost to Follow-up|0|||
33534151|NCT03528551|101856363|FG001|Overall Study|Lost to Follow-up|1|||
33534152|NCT03528551|101856364|FG002|Overall Study|Lost to Follow-up|0|||
33534153|NCT03528551|101856362|FG000|Overall Study|Transferred to other arm/group|2|||
33534154|NCT03528551|101856363|FG001|Overall Study|Transferred to other arm/group|3|||
33534155|NCT03528551|101856364|FG002|Overall Study|Transferred to other arm/group|0|||
33534156|NCT03528551|101856362|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33534157|NCT03528551|101856363|FG001|Overall Study|Withdrawal by parent/guardian|5|||
33534158|NCT03528551|101856364|FG002|Overall Study|Withdrawal by parent/guardian|0|||
33534159|NCT03528551|101856362|FG000|Overall Study|Protocol Violation|0|||
33534160|NCT03528551|101856363|FG001|Overall Study|Protocol Violation|3|||
33534161|NCT03528551|101856364|FG002|Overall Study|Protocol Violation|0|||
33534162|NCT03528551|101856362|FG000|Overall Study|Withdrawal by Subject|0|||
33534163|NCT03528551|101856363|FG001|Overall Study|Withdrawal by Subject|7|||
33534164|NCT03528551|101856364|FG002|Overall Study|Withdrawal by Subject|0|||
33534165|NCT00676403|101856365|FG000|Overall Study|Adverse Event|1|||
33534166|NCT00676403|101856366|FG001|Overall Study|Adverse Event|2|||
33534167|NCT00676403|101856367|FG002|Overall Study|Adverse Event|0|||
33534168|NCT00676403|101856368|FG003|Overall Study|Adverse Event|5|||
33534169|NCT00676403|101856369|FG004|Overall Study|Adverse Event|1|||
33534170|NCT00676403|101856370|FG005|Overall Study|Adverse Event|2|||
33534171|NCT00676403|101856365|FG000|Overall Study|Lost to Follow-up|0|||
33534172|NCT00676403|101856366|FG001|Overall Study|Lost to Follow-up|0|||
33534173|NCT00676403|101856367|FG002|Overall Study|Lost to Follow-up|0|||
33534174|NCT00676403|101856368|FG003|Overall Study|Lost to Follow-up|0|||
33534175|NCT00676403|101856369|FG004|Overall Study|Lost to Follow-up|0|||
33534176|NCT00676403|101856370|FG005|Overall Study|Lost to Follow-up|1|||
33206416|NCT00823719|100656049|FG000|Overall Study|Withdrawal by Subject|0|||
33206417|NCT00823719|100656050|FG001|Overall Study|Withdrawal by Subject|1|||
33338165|NCT01870401|101128473|FG001|Overall Study|Death|24|||
33534177|NCT00676403|101856365|FG000|Overall Study|Reason Unspecified|1|||
33534178|NCT00676403|101856366|FG001|Overall Study|Reason Unspecified|0|||
33534179|NCT00676403|101856367|FG002|Overall Study|Reason Unspecified|1|||
33534180|NCT00676403|101856368|FG003|Overall Study|Reason Unspecified|0|||
33534181|NCT00676403|101856369|FG004|Overall Study|Reason Unspecified|0|||
33534182|NCT00676403|101856370|FG005|Overall Study|Reason Unspecified|1|||
33534183|NCT00676403|101856365|FG000|Overall Study|Withdrawal by Subject|0|||
33534184|NCT00676403|101856366|FG001|Overall Study|Withdrawal by Subject|0|||
33206418|NCT00823719|100656049|FG000|Overall Study|Disease Progression|4|||
33206419|NCT00823719|100656050|FG001|Overall Study|Disease Progression|4|||
33206420|NCT05132699|100656051|FG000|Overall Study|Withdrawal by Subject|3|||
33206421|NCT05132699|100656052|FG001|Overall Study|Withdrawal by Subject|0|||
33206422|NCT03152552|100656056|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
33206423|NCT03152552|100656057|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
33206424|NCT03152552|100656058|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
33206425|NCT03152552|100656059|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
33405233|NCT02438787|101373284|FG001|Overall Study|Other|1|||
33405234|NCT02438787|101373285|FG002|Overall Study|Other|0|||
33405235|NCT02438787|101373283|FG000|Overall Study|Site terminated by sponsor|0|||
33206426|NCT03152552|100656060|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
33206427|NCT03152552|100656056|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
33206428|NCT03152552|100656057|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
33206429|NCT03152552|100656058|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
33206430|NCT03152552|100656059|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
33206431|NCT03152552|100656060|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
33206432|NCT03152552|100656056|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
33206433|NCT03152552|100656057|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
33206434|NCT03152552|100656058|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
33206435|NCT03152552|100656059|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
33206436|NCT03152552|100656060|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
33206437|NCT03152552|100656056|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33206438|NCT03152552|100656057|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33206439|NCT03152552|100656058|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
33206440|NCT03152552|100656059|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33206441|NCT03152552|100656060|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33534185|NCT00676403|101856367|FG002|Overall Study|Withdrawal by Subject|0|||
33534186|NCT00676403|101856368|FG003|Overall Study|Withdrawal by Subject|0|||
33534187|NCT00676403|101856369|FG004|Overall Study|Withdrawal by Subject|0|||
33534188|NCT00676403|101856370|FG005|Overall Study|Withdrawal by Subject|1|||
33534189|NCT01825200|101856371|FG000|Overall Study|Lost to Follow-up|5|||
33534190|NCT01825200|101856372|FG001|Overall Study|Lost to Follow-up|6|||
33534191|NCT01825200|101856371|FG000|Overall Study|Withdrawal by Subject|0|||
33534192|NCT01825200|101856372|FG001|Overall Study|Withdrawal by Subject|1|||
33534193|NCT01001910|101856373|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
33534194|NCT02239640|101856375|FG000|Overall Study|Withdrawal by Subject|3|||
33534195|NCT02239640|101856375|FG000|Overall Study|Lost to Follow-up|72|||
33206442|NCT03152552|100656056|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
33206443|NCT03152552|100656057|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
33405236|NCT02438787|101373284|FG001|Overall Study|Site terminated by sponsor|0|||
33405237|NCT02438787|101373285|FG002|Overall Study|Site terminated by sponsor|1|||
33405238|NCT02033369|101373289|FG000|Overall Study|Physician Decision|1|||
33405239|NCT02033369|101373290|FG001|Overall Study|Physician Decision|2|||
33405240|NCT02033369|101373289|FG000|Overall Study|Not a good demographic match|0|||
33405241|NCT02033369|101373290|FG001|Overall Study|Not a good demographic match|2|||
33405242|NCT02033369|101373289|FG000|Overall Study|Withdrawal by Subject|1|||
33405243|NCT02033369|101373290|FG001|Overall Study|Withdrawal by Subject|1|||
33405244|NCT02033369|101373289|FG000|Overall Study|Lost to Follow-up|1|||
33206444|NCT03152552|100656058|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
33206445|NCT03152552|100656059|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
33206446|NCT03152552|100656060|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
33206447|NCT03152552|100656056|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
33206448|NCT03152552|100656057|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
33206449|NCT03152552|100656058|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
33206450|NCT03152552|100656059|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
33338166|NCT01870401|101128472|FG000|Overall Study|Withdrawal by Subject|39|||
33405245|NCT02033369|101373290|FG001|Overall Study|Lost to Follow-up|0|||
33405246|NCT02033369|101373289|FG000|Overall Study|Protocol Violation|2|||
33405247|NCT02033369|101373290|FG001|Overall Study|Protocol Violation|0|||
33405248|NCT01200758|101373291|FG000|Stage I|Death|0|||
33405249|NCT01200758|101373292|FG001|Stage I|Death|1|||
33534196|NCT02239640|101856375|FG000|Overall Study|Death|142|||
33534197|NCT02185417|101856376|FG000|Overall Study|Death|448|||
33534198|NCT02185417|101856377|FG001|Overall Study|Death|446|||
33534199|NCT02185417|101856378|FG002|Overall Study|Death|0|||
33534200|NCT02185417|101856376|FG000|Overall Study|Withdrawal by Subject|7|||
33206451|NCT03152552|100656060|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
33405250|NCT01200758|101373293|FG002|Stage I|Death|0|||
33405251|NCT01200758|101373294|FG003|Stage I|Death|0|||
33405252|NCT01200758|101373291|FG000|Stage I|Physician Decision|1|||
33405253|NCT01200758|101373292|FG001|Stage I|Physician Decision|1|||
33405254|NCT01200758|101373293|FG002|Stage I|Physician Decision|0|||
33534201|NCT02185417|101856377|FG001|Overall Study|Withdrawal by Subject|12|||
33534202|NCT02185417|101856378|FG002|Overall Study|Withdrawal by Subject|0|||
33206452|NCT03152552|100656056|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
33206453|NCT03152552|100656057|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
33338167|NCT01870401|101128473|FG001|Overall Study|Withdrawal by Subject|26|||
33405255|NCT01200758|101373294|FG003|Stage I|Physician Decision|0|||
33405256|NCT01200758|101373291|FG000|Stage I|Lack of Efficacy|2|||
33405257|NCT01200758|101373292|FG001|Stage I|Lack of Efficacy|1|||
33405258|NCT01200758|101373293|FG002|Stage I|Lack of Efficacy|0|||
33405259|NCT01200758|101373294|FG003|Stage I|Lack of Efficacy|0|||
33405260|NCT01200758|101373291|FG000|Stage I|Adverse Event|5|||
33405261|NCT01200758|101373292|FG001|Stage I|Adverse Event|5|||
33338168|NCT01870401|101128472|FG000|Overall Study|Lost to Follow-up|19|||
33338169|NCT01870401|101128473|FG001|Overall Study|Lost to Follow-up|14|||
33338170|NCT01870401|101128472|FG000|Overall Study|Other|9|||
33338171|NCT01870401|101128473|FG001|Overall Study|Other|7|||
33338172|NCT01870401|101128472|FG000|Overall Study|On-going in the Study|35|||
33338173|NCT01870401|101128473|FG001|Overall Study|On-going in the Study|25|||
33338174|NCT01453855|101128484|FG000|Overall Study|Adverse Event|3|||
33338175|NCT01453855|101128485|FG001|Overall Study|Adverse Event|4|||
33338176|NCT01453855|101128484|FG000|Overall Study|Lost to Follow-up|2|||
33338177|NCT01453855|101128485|FG001|Overall Study|Lost to Follow-up|1|||
33338178|NCT01453855|101128484|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
33338179|NCT01453855|101128485|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
33338180|NCT01453855|101128484|FG000|Overall Study|Noncompliance|1|||
33338181|NCT01453855|101128485|FG001|Overall Study|Noncompliance|0|||
33338182|NCT01453855|101128484|FG000|Overall Study|Inadequate Control of IOP|1|||
33338183|NCT01453855|101128485|FG001|Overall Study|Inadequate Control of IOP|5|||
33338184|NCT01453855|101128484|FG000|Overall Study|Other|0|||
33338185|NCT01453855|101128485|FG001|Overall Study|Other|1|||
33338186|NCT03110900|101128486|FG000|Overall Study|Sponsor withdrew|1|||
33338187|NCT03110900|101128487|FG001|Overall Study|Sponsor withdrew|1|||
33338188|NCT00623480|101128489|FG000|Overall Study|Lost to Follow-up|0|||
33338189|NCT00623480|101128490|FG001|Overall Study|Lost to Follow-up|1|||
33338190|NCT00623480|101128489|FG000|Overall Study|Withdrawal by Subject|2|||
33338191|NCT00623480|101128490|FG001|Overall Study|Withdrawal by Subject|4|||
33338192|NCT00623480|101128489|FG000|Overall Study|Lack of Efficacy|1|||
33338193|NCT00623480|101128490|FG001|Overall Study|Lack of Efficacy|0|||
33338194|NCT00623480|101128489|FG000|Overall Study|Non-compliant with study medication|4|||
33338195|NCT00623480|101128490|FG001|Overall Study|Non-compliant with study medication|0|||
33338196|NCT00623480|101128489|FG000|Overall Study|Protocol Violation|0|||
33338197|NCT00623480|101128490|FG001|Overall Study|Protocol Violation|1|||
33338198|NCT00623480|101128489|FG000|Overall Study|Site closed by sponsor|0|||
33338199|NCT00623480|101128490|FG001|Overall Study|Site closed by sponsor|1|||
33338200|NCT03048422|101128491|FG000|Overall Study|Death|1|||
33338201|NCT03048422|101128492|FG001|Overall Study|Death|0|||
33405262|NCT01200758|101373293|FG002|Stage I|Adverse Event|0|||
33405263|NCT01200758|101373294|FG003|Stage I|Adverse Event|0|||
33338202|NCT03048422|101128493|FG002|Overall Study|Death|0|||
33338203|NCT03048422|101128491|FG000|Overall Study|Lost to Follow-up|5|||
33338204|NCT03048422|101128492|FG001|Overall Study|Lost to Follow-up|0|||
33338205|NCT03048422|101128493|FG002|Overall Study|Lost to Follow-up|1|||
33338206|NCT03048422|101128491|FG000|Overall Study|Withdrawal by Subject|5|||
33338207|NCT03048422|101128492|FG001|Overall Study|Withdrawal by Subject|7|||
33338208|NCT03048422|101128493|FG002|Overall Study|Withdrawal by Subject|4|||
33338209|NCT03048422|101128491|FG000|Overall Study|Moved|3|||
33338210|NCT03048422|101128492|FG001|Overall Study|Moved|2|||
33338211|NCT03048422|101128493|FG002|Overall Study|Moved|2|||
33338212|NCT03048422|101128491|FG000|Overall Study|Noncompliant with Study Requirements|2|||
33534203|NCT02104895|101856379|FG000|Overall Study|Withdrawal by Subject|0|||
33206454|NCT03152552|100656058|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
33206455|NCT03152552|100656059|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
33338213|NCT03048422|101128492|FG001|Overall Study|Noncompliant with Study Requirements|1|||
33338214|NCT03048422|101128493|FG002|Overall Study|Noncompliant with Study Requirements|2|||
33338215|NCT03048422|101128491|FG000|Overall Study|Not Able to Get to Clinic|1|||
33338216|NCT03048422|101128492|FG001|Overall Study|Not Able to Get to Clinic|0|||
33338217|NCT03048422|101128493|FG002|Overall Study|Not Able to Get to Clinic|0|||
33338218|NCT02164981|101128494|FG000|Started|Withdrawal by Subject|2|||
33338219|NCT02164981|101128495|FG001|Started|Withdrawal by Subject|1|||
33338220|NCT02164981|101128496|FG002|Started|Withdrawal by Subject|0|||
33338221|NCT02164981|101128494|FG000|Started|Protocol Violation|2|||
33338222|NCT02164981|101128495|FG001|Started|Protocol Violation|0|||
33338223|NCT02164981|101128496|FG002|Started|Protocol Violation|0|||
33405264|NCT01200758|101373291|FG000|Stage I|Withdrawal by Subject|1|||
33613499|NCT00940498|102133892|FG003|Overall Study|Not treated due to disease related pain|0|||
33405265|NCT01200758|101373292|FG001|Stage I|Withdrawal by Subject|2|||
33338224|NCT02164981|101128494|FG000|Started|Adverse Event|1|||
33338225|NCT02164981|101128495|FG001|Started|Adverse Event|2|||
33405266|NCT01200758|101373293|FG002|Stage I|Withdrawal by Subject|0|||
33405267|NCT01200758|101373294|FG003|Stage I|Withdrawal by Subject|0|||
33405268|NCT01200758|101373291|FG000|Stage I|Disease Progression|9|||
33338226|NCT02164981|101128496|FG002|Started|Adverse Event|0|||
33338227|NCT02164981|101128494|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
33338228|NCT02164981|101128495|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
33338229|NCT02164981|101128496|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
33338230|NCT02164981|101128494|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
33338231|NCT02164981|101128495|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
33338232|NCT02164981|101128496|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
33405269|NCT01200758|101373292|FG001|Stage I|Disease Progression|7|||
33405270|NCT01200758|101373293|FG002|Stage I|Disease Progression|0|||
33405271|NCT01200758|101373294|FG003|Stage I|Disease Progression|0|||
33405272|NCT01200758|101373291|FG000|Stage 2|Disease Progression|0|||
33405273|NCT01200758|101373292|FG001|Stage 2|Disease Progression|0|||
33534204|NCT02104895|101856380|FG001|Overall Study|Withdrawal by Subject|14|||
33534205|NCT01783743|101856384|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
33534206|NCT01783743|101856385|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
33534207|NCT01783743|101856384|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
33534208|NCT01783743|101856385|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
33534209|NCT01783743|101856384|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
33338233|NCT02164981|101128494|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
33405274|NCT01200758|101373293|FG002|Stage 2|Disease Progression|16|||
33405275|NCT01200758|101373294|FG003|Stage 2|Disease Progression|21|||
33534210|NCT01783743|101856385|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
33534211|NCT01048541|101856386|FG000|Overall Study|Withdrawal by Subject|1|||
33534212|NCT01048541|101856387|FG001|Overall Study|Withdrawal by Subject|0|||
33534213|NCT03902613|101856390|FG000|Overall Study|Physician Decision|1|||
33534214|NCT00902577|101856393|FG000|Overall Study|Withdrawal by Subject|6|||
33534215|NCT00902577|101856393|FG000|Overall Study|FMISO production failure|2|||
33534216|NCT00338741|101856395|FG000|Overall Study|Lost to Follow-up|2|||
33534217|NCT00338741|101856396|FG001|Overall Study|Lost to Follow-up|0|||
33534218|NCT03478371|101856397|FG000|Overall Study|non-compliance|1|||
33534219|NCT03478371|101856397|FG000|Overall Study|Lost to Follow-up|4|||
33534220|NCT00103285|101856398|FG000|Induction|Adverse Event|14|||
33534221|NCT00103285|101856399|FG001|Induction|Adverse Event|0|||
33534222|NCT00103285|101856400|FG002|Induction|Adverse Event|0|||
33534223|NCT00103285|101856401|FG003|Induction|Adverse Event|0|||
33338234|NCT02164981|101128495|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
33534224|NCT00103285|101856402|FG004|Induction|Adverse Event|0|||
33534225|NCT00103285|101856403|FG005|Induction|Adverse Event|0|||
33534226|NCT00103285|101856404|FG006|Induction|Adverse Event|0|||
33534227|NCT00103285|101856405|FG007|Induction|Adverse Event|0|||
33534228|NCT00103285|101856398|FG000|Induction|Death|24|||
33534229|NCT00103285|101856399|FG001|Induction|Death|0|||
33534230|NCT00103285|101856400|FG002|Induction|Death|0|||
33405276|NCT01200758|101373291|FG000|Stage 2|Lack of Efficacy|0|||
33405277|NCT01200758|101373292|FG001|Stage 2|Lack of Efficacy|0|||
33405278|NCT01200758|101373293|FG002|Stage 2|Lack of Efficacy|4|||
33534231|NCT00103285|101856401|FG003|Induction|Death|0|||
33534232|NCT00103285|101856402|FG004|Induction|Death|0|||
33534233|NCT00103285|101856403|FG005|Induction|Death|0|||
33534234|NCT00103285|101856404|FG006|Induction|Death|0|||
33534235|NCT00103285|101856405|FG007|Induction|Death|0|||
33534236|NCT00103285|101856398|FG000|Induction|Physician Decision|103|||
33534237|NCT00103285|101856399|FG001|Induction|Physician Decision|0|||
33534238|NCT00103285|101856400|FG002|Induction|Physician Decision|0|||
33534239|NCT00103285|101856401|FG003|Induction|Physician Decision|0|||
33534240|NCT00103285|101856402|FG004|Induction|Physician Decision|0|||
33534241|NCT00103285|101856403|FG005|Induction|Physician Decision|0|||
33534242|NCT00103285|101856404|FG006|Induction|Physician Decision|0|||
33534243|NCT00103285|101856405|FG007|Induction|Physician Decision|0|||
33338235|NCT02164981|101128496|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
33338236|NCT04029519|101128497|FG000|Overall Study|Protocol Violation|1|||
33338237|NCT04029519|101128497|FG000|Overall Study|Withdrawal by Subject|3|||
33338238|NCT04029519|101128497|FG000|Overall Study|Lost to Follow-up|1|||
33338239|NCT00687362|101128500|FG000|Overall Study|Protocol Violation|2|||
33534244|NCT00103285|101856398|FG000|Induction|Withdrawal by Subject|1|||
33534245|NCT00103285|101856399|FG001|Induction|Withdrawal by Subject|0|||
33534246|NCT00103285|101856400|FG002|Induction|Withdrawal by Subject|0|||
33534247|NCT00103285|101856401|FG003|Induction|Withdrawal by Subject|0|||
33534248|NCT00103285|101856402|FG004|Induction|Withdrawal by Subject|0|||
33534249|NCT00103285|101856403|FG005|Induction|Withdrawal by Subject|0|||
33534250|NCT00103285|101856404|FG006|Induction|Withdrawal by Subject|0|||
33534251|NCT00103285|101856405|FG007|Induction|Withdrawal by Subject|0|||
33534252|NCT00103285|101856398|FG000|Induction|Ineligible|43|||
33534253|NCT00103285|101856399|FG001|Induction|Ineligible|0|||
33338240|NCT00687362|101128500|FG000|Overall Study|Withdrawal by Subject|1|||
33338241|NCT00488982|101128501|FG000|Course 1|Physician Decision|0|||
33338242|NCT00488982|101128502|FG001|Course 1|Physician Decision|2|||
33338243|NCT00488982|101128503|FG002|Course 1|Physician Decision|4|||
33338244|NCT00488982|101128501|FG000|Course 1|Withdrawal by Subject|0|||
33338245|NCT00488982|101128502|FG001|Course 1|Withdrawal by Subject|8|||
33338246|NCT00488982|101128503|FG002|Course 1|Withdrawal by Subject|2|||
33338247|NCT00488982|101128501|FG000|Course 1|nonprotocol therapy|0|||
33338248|NCT00488982|101128502|FG001|Course 1|nonprotocol therapy|2|||
33338249|NCT00488982|101128503|FG002|Course 1|nonprotocol therapy|2|||
33338250|NCT00488982|101128501|FG000|Course 1|Adverse Event|0|||
33338251|NCT00488982|101128502|FG001|Course 1|Adverse Event|0|||
33338252|NCT00488982|101128503|FG002|Course 1|Adverse Event|6|||
33338253|NCT01127165|101128504|FG000|Overall Study|Adverse Event|2|||
33338254|NCT01127165|101128505|FG001|Overall Study|Adverse Event|2|||
33338255|NCT01127165|101128504|FG000|Overall Study|Lack of Efficacy|10|||
33405279|NCT01200758|101373294|FG003|Stage 2|Lack of Efficacy|2|||
33338256|NCT01127165|101128505|FG001|Overall Study|Lack of Efficacy|8|||
33338257|NCT01127165|101128504|FG000|Overall Study|Lost to Follow-up|3|||
33338258|NCT01127165|101128505|FG001|Overall Study|Lost to Follow-up|5|||
33534254|NCT00103285|101856400|FG002|Induction|Ineligible|0|||
33534255|NCT00103285|101856401|FG003|Induction|Ineligible|0|||
33534256|NCT00103285|101856402|FG004|Induction|Ineligible|0|||
33534257|NCT00103285|101856403|FG005|Induction|Ineligible|0|||
33534258|NCT00103285|101856404|FG006|Induction|Ineligible|0|||
33534259|NCT00103285|101856405|FG007|Induction|Ineligible|0|||
33534260|NCT00103285|101856398|FG000|Induction|Refusal|906|||
33338259|NCT01127165|101128504|FG000|Overall Study|Withdrawal by Subject|1|||
33405280|NCT01200758|101373291|FG000|Stage 2|Physician Decision|0|||
33534261|NCT00103285|101856399|FG001|Induction|Refusal|0|||
33534262|NCT00103285|101856400|FG002|Induction|Refusal|0|||
33534263|NCT00103285|101856401|FG003|Induction|Refusal|0|||
33405281|NCT01200758|101373292|FG001|Stage 2|Physician Decision|0|||
33405282|NCT01200758|101373293|FG002|Stage 2|Physician Decision|5|||
33405283|NCT01200758|101373294|FG003|Stage 2|Physician Decision|7|||
33405284|NCT01200758|101373291|FG000|Stage 2|Adverse Event|0|||
33405285|NCT01200758|101373292|FG001|Stage 2|Adverse Event|0|||
33405286|NCT01200758|101373293|FG002|Stage 2|Adverse Event|5|||
33405287|NCT01200758|101373294|FG003|Stage 2|Adverse Event|9|||
33405288|NCT01200758|101373291|FG000|Stage 2|Withdrawal by Subject|0|||
33405289|NCT01200758|101373292|FG001|Stage 2|Withdrawal by Subject|0|||
33405290|NCT01200758|101373293|FG002|Stage 2|Withdrawal by Subject|4|||
33405291|NCT01200758|101373294|FG003|Stage 2|Withdrawal by Subject|1|||
33405292|NCT01200758|101373291|FG000|Stage 2|Lost to Follow-up|0|||
33405293|NCT01200758|101373292|FG001|Stage 2|Lost to Follow-up|0|||
33405294|NCT01200758|101373293|FG002|Stage 2|Lost to Follow-up|3|||
33405295|NCT01200758|101373294|FG003|Stage 2|Lost to Follow-up|1|||
33405296|NCT01200758|101373291|FG000|Stage 2|Protocol Violation|0|||
33405297|NCT01200758|101373292|FG001|Stage 2|Protocol Violation|0|||
33534264|NCT00103285|101856402|FG004|Induction|Refusal|0|||
33534265|NCT00103285|101856403|FG005|Induction|Refusal|0|||
33534266|NCT00103285|101856404|FG006|Induction|Refusal|0|||
33534267|NCT00103285|101856405|FG007|Induction|Refusal|0|||
33534268|NCT00103285|101856398|FG000|Induction|Other|258|||
33534269|NCT00103285|101856399|FG001|Induction|Other|0|||
33534270|NCT00103285|101856400|FG002|Induction|Other|0|||
33534271|NCT00103285|101856401|FG003|Induction|Other|0|||
33534272|NCT00103285|101856402|FG004|Induction|Other|0|||
33534273|NCT00103285|101856403|FG005|Induction|Other|0|||
33534274|NCT00103285|101856404|FG006|Induction|Other|0|||
33534275|NCT00103285|101856405|FG007|Induction|Other|0|||
33534276|NCT00103285|101856398|FG000|Response Assignment|Adverse Event|0|||
33534277|NCT00103285|101856399|FG001|Response Assignment|Adverse Event|8|||
33534278|NCT00103285|101856400|FG002|Response Assignment|Adverse Event|3|||
33534279|NCT00103285|101856401|FG003|Response Assignment|Adverse Event|2|||
33534280|NCT00103285|101856402|FG004|Response Assignment|Adverse Event|3|||
33534281|NCT00103285|101856403|FG005|Response Assignment|Adverse Event|1|||
33534282|NCT00103285|101856404|FG006|Response Assignment|Adverse Event|1|||
33534283|NCT00103285|101856405|FG007|Response Assignment|Adverse Event|2|||
33613500|NCT00940498|102133893|FG004|Overall Study|Not treated due to disease related pain|1|||
33613501|NCT00940498|102133894|FG005|Overall Study|Not treated due to disease related pain|0|||
33613502|NCT00940498|102133895|FG006|Overall Study|Not treated due to disease related pain|0|||
33613503|NCT00940498|102133896|FG007|Overall Study|Not treated due to disease related pain|0|||
33613504|NCT03364309|102133899|FG000|Induction Period|Adverse Event|4|||
33613505|NCT03364309|102133900|FG001|Induction Period|Adverse Event|0|||
33613506|NCT03364309|102133901|FG002|Induction Period|Adverse Event|1|||
33613507|NCT03364309|102133902|FG003|Induction Period|Adverse Event|0|||
33613508|NCT03364309|102133903|FG004|Induction Period|Adverse Event|0|||
33613509|NCT03364309|102133904|FG005|Induction Period|Adverse Event|0|||
33613510|NCT03364309|102133905|FG006|Induction Period|Adverse Event|0|||
33613511|NCT03364309|102133906|FG007|Induction Period|Adverse Event|0|||
33338260|NCT01127165|101128505|FG001|Overall Study|Withdrawal by Subject|3|||
33338261|NCT01127165|101128504|FG000|Overall Study|Protocol Violation|0|||
33405298|NCT01200758|101373293|FG002|Stage 2|Protocol Violation|1|||
33405299|NCT01200758|101373294|FG003|Stage 2|Protocol Violation|4|||
33405300|NCT01200758|101373291|FG000|Stage 2|Death|0|||
33405301|NCT01200758|101373292|FG001|Stage 2|Death|0|||
33405302|NCT01200758|101373293|FG002|Stage 2|Death|3|||
33534284|NCT00103285|101856398|FG000|Response Assignment|Death|0|||
33534285|NCT00103285|101856399|FG001|Response Assignment|Death|5|||
33534286|NCT00103285|101856400|FG002|Response Assignment|Death|2|||
33534287|NCT00103285|101856401|FG003|Response Assignment|Death|2|||
33405303|NCT01200758|101373294|FG003|Stage 2|Death|5|||
33405304|NCT01258738|101373296|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
33534288|NCT00103285|101856402|FG004|Response Assignment|Death|3|||
33534289|NCT00103285|101856403|FG005|Response Assignment|Death|1|||
33534290|NCT00103285|101856404|FG006|Response Assignment|Death|0|||
33534291|NCT00103285|101856405|FG007|Response Assignment|Death|8|||
33613512|NCT03364309|102133907|FG008|Induction Period|Adverse Event|0|||
33613513|NCT03364309|102133908|FG009|Induction Period|Adverse Event|0|||
33613514|NCT03364309|102133909|FG010|Induction Period|Adverse Event|0|||
33613515|NCT03364309|102133910|FG011|Induction Period|Adverse Event|0|||
33613516|NCT03364309|102133911|FG012|Induction Period|Adverse Event|0|||
33613517|NCT03364309|102133912|FG013|Induction Period|Adverse Event|0|||
33613518|NCT03364309|102133913|FG014|Induction Period|Adverse Event|0|||
33613519|NCT03364309|102133914|FG015|Induction Period|Adverse Event|0|||
33613520|NCT03364309|102133915|FG016|Induction Period|Adverse Event|0|||
33613521|NCT03364309|102133916|FG017|Induction Period|Adverse Event|0|||
33613522|NCT03364309|102133917|FG018|Induction Period|Adverse Event|0|||
33613523|NCT03364309|102133899|FG000|Induction Period|Withdrawal by Subject|1|||
33613524|NCT03364309|102133900|FG001|Induction Period|Withdrawal by Subject|3|||
33613525|NCT03364309|102133901|FG002|Induction Period|Withdrawal by Subject|0|||
33613526|NCT03364309|102133902|FG003|Induction Period|Withdrawal by Subject|0|||
33613527|NCT03364309|102133903|FG004|Induction Period|Withdrawal by Subject|0|||
33613528|NCT03364309|102133904|FG005|Induction Period|Withdrawal by Subject|0|||
33613529|NCT03364309|102133905|FG006|Induction Period|Withdrawal by Subject|0|||
33613530|NCT03364309|102133906|FG007|Induction Period|Withdrawal by Subject|0|||
33613531|NCT03364309|102133907|FG008|Induction Period|Withdrawal by Subject|0|||
33613532|NCT03364309|102133908|FG009|Induction Period|Withdrawal by Subject|0|||
33613533|NCT03364309|102133909|FG010|Induction Period|Withdrawal by Subject|0|||
33613534|NCT03364309|102133910|FG011|Induction Period|Withdrawal by Subject|0|||
33534292|NCT00103285|101856398|FG000|Response Assignment|Lost to Follow-up|0|||
33534293|NCT00103285|101856399|FG001|Response Assignment|Lost to Follow-up|9|||
33534294|NCT00103285|101856400|FG002|Response Assignment|Lost to Follow-up|5|||
33534295|NCT00103285|101856401|FG003|Response Assignment|Lost to Follow-up|5|||
33534296|NCT00103285|101856402|FG004|Response Assignment|Lost to Follow-up|1|||
33534297|NCT00103285|101856403|FG005|Response Assignment|Lost to Follow-up|2|||
33534298|NCT00103285|101856404|FG006|Response Assignment|Lost to Follow-up|2|||
33534299|NCT00103285|101856405|FG007|Response Assignment|Lost to Follow-up|5|||
33534300|NCT00103285|101856398|FG000|Response Assignment|Physician Decision|0|||
33534301|NCT00103285|101856399|FG001|Response Assignment|Physician Decision|13|||
33534302|NCT00103285|101856400|FG002|Response Assignment|Physician Decision|14|||
33534303|NCT00103285|101856401|FG003|Response Assignment|Physician Decision|9|||
33534304|NCT00103285|101856402|FG004|Response Assignment|Physician Decision|13|||
33534305|NCT00103285|101856403|FG005|Response Assignment|Physician Decision|7|||
33534306|NCT00103285|101856404|FG006|Response Assignment|Physician Decision|4|||
33534307|NCT00103285|101856405|FG007|Response Assignment|Physician Decision|35|||
33534308|NCT00103285|101856398|FG000|Response Assignment|Protocol Violation|0|||
33534309|NCT00103285|101856399|FG001|Response Assignment|Protocol Violation|2|||
33534310|NCT00103285|101856400|FG002|Response Assignment|Protocol Violation|0|||
33534311|NCT00103285|101856401|FG003|Response Assignment|Protocol Violation|0|||
33534312|NCT00103285|101856402|FG004|Response Assignment|Protocol Violation|0|||
33534313|NCT00103285|101856403|FG005|Response Assignment|Protocol Violation|0|||
33534314|NCT00103285|101856404|FG006|Response Assignment|Protocol Violation|0|||
33613535|NCT03364309|102133911|FG012|Induction Period|Withdrawal by Subject|0|||
33405305|NCT01258738|101373297|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
33405306|NCT01258738|101373296|FG000|Double-blind Period|Withdrawal by Subject|2|||
33534315|NCT00103285|101856405|FG007|Response Assignment|Protocol Violation|0|||
33534316|NCT00103285|101856398|FG000|Response Assignment|Withdrawal by Subject|0|||
33534317|NCT00103285|101856399|FG001|Response Assignment|Withdrawal by Subject|4|||
33534318|NCT00103285|101856400|FG002|Response Assignment|Withdrawal by Subject|1|||
33534319|NCT00103285|101856401|FG003|Response Assignment|Withdrawal by Subject|1|||
33613536|NCT03364309|102133912|FG013|Induction Period|Withdrawal by Subject|0|||
33613537|NCT03364309|102133913|FG014|Induction Period|Withdrawal by Subject|0|||
33613538|NCT03364309|102133914|FG015|Induction Period|Withdrawal by Subject|0|||
33613539|NCT03364309|102133915|FG016|Induction Period|Withdrawal by Subject|0|||
33534320|NCT00103285|101856402|FG004|Response Assignment|Withdrawal by Subject|2|||
33613540|NCT03364309|102133916|FG017|Induction Period|Withdrawal by Subject|0|||
33613541|NCT03364309|102133917|FG018|Induction Period|Withdrawal by Subject|0|||
33613542|NCT03364309|102133899|FG000|Induction Period|Lost to Follow-up|1|||
33613543|NCT03364309|102133900|FG001|Induction Period|Lost to Follow-up|0|||
33613544|NCT03364309|102133901|FG002|Induction Period|Lost to Follow-up|0|||
33613545|NCT03364309|102133902|FG003|Induction Period|Lost to Follow-up|0|||
33613546|NCT03364309|102133903|FG004|Induction Period|Lost to Follow-up|0|||
33534321|NCT00103285|101856403|FG005|Response Assignment|Withdrawal by Subject|2|||
33534322|NCT00103285|101856404|FG006|Response Assignment|Withdrawal by Subject|0|||
33534323|NCT00103285|101856405|FG007|Response Assignment|Withdrawal by Subject|2|||
33534324|NCT00103285|101856398|FG000|Response Assignment|Ineligible|0|||
33534325|NCT00103285|101856399|FG001|Response Assignment|Ineligible|8|||
33534326|NCT00103285|101856400|FG002|Response Assignment|Ineligible|6|||
33534327|NCT00103285|101856401|FG003|Response Assignment|Ineligible|2|||
33534328|NCT00103285|101856402|FG004|Response Assignment|Ineligible|0|||
33534329|NCT00103285|101856403|FG005|Response Assignment|Ineligible|3|||
33206456|NCT03152552|100656060|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
33206457|NCT00490646|100656061|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
33206458|NCT00490646|100656062|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
33206459|NCT00490646|100656061|FG000|Overall Study|Never Treated (had an adverse event)|1|||
33206460|NCT00490646|100656062|FG001|Overall Study|Never Treated (had an adverse event)|0|||
33206461|NCT00490646|100656061|FG000|Overall Study|Never Treated (withdrew consent)|0|||
33206462|NCT00490646|100656062|FG001|Overall Study|Never Treated (withdrew consent)|1|||
33206463|NCT04820673|100656063|FG000|Overall Study|Adverse Event|6|||
33534330|NCT00103285|101856404|FG006|Response Assignment|Ineligible|1|||
33534331|NCT00103285|101856405|FG007|Response Assignment|Ineligible|5|||
33534332|NCT00103285|101856398|FG000|Response Assignment|Refusal|0|||
33206464|NCT04820673|100656063|FG000|Overall Study|Due to Lack of Effectiveness|1|||
33534333|NCT00103285|101856399|FG001|Response Assignment|Refusal|53|||
33534334|NCT00103285|101856400|FG002|Response Assignment|Refusal|5|||
33534335|NCT00103285|101856401|FG003|Response Assignment|Refusal|3|||
33534336|NCT00103285|101856402|FG004|Response Assignment|Refusal|25|||
33206465|NCT04820673|100656063|FG000|Overall Study|Pregnancy|1|||
33206466|NCT04820673|100656063|FG000|Overall Study|Voluntary Withdrawal|20|||
33206467|NCT04820673|100656063|FG000|Overall Study|Lost to Follow-up|10|||
33206468|NCT01220557|100656064|FG000|Overall Study|Lost to Follow-up|5|||
33206469|NCT01220557|100656065|FG001|Overall Study|Lost to Follow-up|3|||
33206470|NCT01220557|100656064|FG000|Overall Study|attended less than 6 lessons|1|||
33206471|NCT01220557|100656065|FG001|Overall Study|attended less than 6 lessons|2|||
33206472|NCT03579563|100656071|FG000|Overall Study|Lost to Follow-up|0|||
33206473|NCT03579563|100656072|FG001|Overall Study|Lost to Follow-up|0|||
33206474|NCT03579563|100656073|FG002|Overall Study|Lost to Follow-up|0|||
33206475|NCT03579563|100656074|FG003|Overall Study|Lost to Follow-up|0|||
33206476|NCT03579563|100656075|FG004|Overall Study|Lost to Follow-up|1|||
33206477|NCT03579563|100656076|FG005|Overall Study|Lost to Follow-up|0|||
33206478|NCT03579563|100656071|FG000|Overall Study|Lack of Efficacy|1|||
33206479|NCT03579563|100656072|FG001|Overall Study|Lack of Efficacy|1|||
33206480|NCT03579563|100656073|FG002|Overall Study|Lack of Efficacy|4|||
33206481|NCT03579563|100656074|FG003|Overall Study|Lack of Efficacy|1|||
33206482|NCT03579563|100656075|FG004|Overall Study|Lack of Efficacy|2|||
33338262|NCT01127165|101128505|FG001|Overall Study|Protocol Violation|1|||
33534337|NCT00103285|101856403|FG005|Response Assignment|Refusal|15|||
33206483|NCT03579563|100656076|FG005|Overall Study|Lack of Efficacy|3|||
33206484|NCT03579563|100656071|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
33338263|NCT02926209|101131908|FG000|Study Cohort|Poor Bowel Preparation|1|||
33338264|NCT02926209|101131909|FG001|Study Cohort|Poor Bowel Preparation|0|||
33534338|NCT00103285|101856404|FG006|Response Assignment|Refusal|30|||
33534339|NCT00103285|101856405|FG007|Response Assignment|Refusal|10|||
33534340|NCT00103285|101856398|FG000|Response Assignment|Other|0|||
33534341|NCT00103285|101856399|FG001|Response Assignment|Other|30|||
33338265|NCT01687712|101131910|FG000|Cycle 1|Not Biochemically Pregnant|386|||
33534342|NCT00103285|101856400|FG002|Response Assignment|Other|48|||
33206485|NCT03579563|100656072|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
33206486|NCT03579563|100656073|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
33338266|NCT01687712|101131911|FG001|Cycle 1|Not Biochemically Pregnant|348|||
33534343|NCT00103285|101856401|FG003|Response Assignment|Other|38|||
33206487|NCT03579563|100656074|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
33206488|NCT03579563|100656075|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
33206489|NCT03579563|100656076|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
33206490|NCT03579563|100656071|FG000|Overall Study|Time/distance concern|0|||
33206491|NCT03579563|100656072|FG001|Overall Study|Time/distance concern|0|||
33206492|NCT03579563|100656073|FG002|Overall Study|Time/distance concern|1|||
33206493|NCT03579563|100656074|FG003|Overall Study|Time/distance concern|0|||
33206494|NCT03579563|100656075|FG004|Overall Study|Time/distance concern|0|||
33534344|NCT00103285|101856402|FG004|Response Assignment|Other|37|||
33206495|NCT03579563|100656076|FG005|Overall Study|Time/distance concern|1|||
33206496|NCT03579563|100656071|FG000|Overall Study|COVID shutdown|2|||
33206497|NCT03579563|100656072|FG001|Overall Study|COVID shutdown|3|||
33206498|NCT03579563|100656073|FG002|Overall Study|COVID shutdown|4|||
33206499|NCT03579563|100656074|FG003|Overall Study|COVID shutdown|3|||
33206500|NCT03579563|100656075|FG004|Overall Study|COVID shutdown|1|||
33206501|NCT03579563|100656076|FG005|Overall Study|COVID shutdown|2|||
33206502|NCT03579563|100656071|FG000|Overall Study|Protocol administration error|1|||
33206503|NCT03579563|100656072|FG001|Overall Study|Protocol administration error|0|||
33206504|NCT03579563|100656073|FG002|Overall Study|Protocol administration error|1|||
33206505|NCT03579563|100656074|FG003|Overall Study|Protocol administration error|0|||
33206506|NCT03579563|100656075|FG004|Overall Study|Protocol administration error|1|||
33206507|NCT03579563|100656076|FG005|Overall Study|Protocol administration error|5|||
33206508|NCT04495374|100656077|FG000|Overall Study|Protocol Violation|2|||
33206509|NCT04495374|100656078|FG001|Overall Study|Protocol Violation|1|||
33206510|NCT00562159|100656081|FG000|Overall Study|Adverse Event|11|||
33206511|NCT00562159|100656082|FG001|Overall Study|Adverse Event|8|||
33206512|NCT00562159|100656081|FG000|Overall Study|Lost to Follow-up|5|||
33206513|NCT00562159|100656082|FG001|Overall Study|Lost to Follow-up|4|||
33206514|NCT00562159|100656081|FG000|Overall Study|Withdrawal by Subject|9|||
33206515|NCT00562159|100656082|FG001|Overall Study|Withdrawal by Subject|8|||
33206516|NCT00562159|100656081|FG000|Overall Study|Protocol Violation|12|||
33206517|NCT00562159|100656082|FG001|Overall Study|Protocol Violation|12|||
33206518|NCT00562159|100656081|FG000|Overall Study|Did not meet protocol eligibility|1|||
33206519|NCT00562159|100656082|FG001|Overall Study|Did not meet protocol eligibility|1|||
33206520|NCT02828111|100656083|FG000|Overall Study|Withdrawal by Subject|0|||
33206521|NCT02828111|100656084|FG001|Overall Study|Withdrawal by Subject|0|||
33206522|NCT02828111|100656085|FG002|Overall Study|Withdrawal by Subject|2|||
33206523|NCT02828111|100656086|FG003|Overall Study|Withdrawal by Subject|0|||
33206524|NCT02828111|100656087|FG004|Overall Study|Withdrawal by Subject|0|||
33206525|NCT02828111|100656083|FG000|Overall Study|Lost to Follow-up|0|||
33206526|NCT02828111|100656084|FG001|Overall Study|Lost to Follow-up|0|||
33206527|NCT02828111|100656085|FG002|Overall Study|Lost to Follow-up|0|||
33206528|NCT02828111|100656086|FG003|Overall Study|Lost to Follow-up|1|||
33206529|NCT02828111|100656087|FG004|Overall Study|Lost to Follow-up|1|||
33206530|NCT04757753|100656092|FG000|Overall Study|Lost to Follow-up|7|||
33206531|NCT04757753|100656093|FG001|Overall Study|Lost to Follow-up|7|||
33206532|NCT04757753|100656092|FG000|Overall Study|Withdrawal by Subject|0|||
33206533|NCT04757753|100656093|FG001|Overall Study|Withdrawal by Subject|3|||
33206534|NCT04757753|100656092|FG000|Overall Study|Endodontic treatment failure|1|||
33206535|NCT04757753|100656093|FG001|Overall Study|Endodontic treatment failure|2|||
33206536|NCT04757753|100656092|FG000|Overall Study|Tooth fracture/extraction|3|||
33534345|NCT00103285|101856403|FG005|Response Assignment|Other|17|||
33534346|NCT00103285|101856404|FG006|Response Assignment|Other|11|||
33206537|NCT04757753|100656093|FG001|Overall Study|Tooth fracture/extraction|0|||
33206538|NCT02075593|100656097|FG000|Overall Study|Withdrawal by Subject|1|||
33206539|NCT03521635|100656098|FG000|Overall Study|Adverse Event|1|||
33206540|NCT03521635|100656099|FG001|Overall Study|Adverse Event|1|||
33338267|NCT01687712|101131910|FG000|Cycle 1|Early Pregnancy Loss|43|||
33338268|NCT01687712|101131911|FG001|Cycle 1|Early Pregnancy Loss|60|||
33338269|NCT01687712|101131910|FG000|Cycle 1|Ectopic Pregnancy|5|||
33338270|NCT01687712|101131911|FG001|Cycle 1|Ectopic Pregnancy|5|||
33534347|NCT00103285|101856405|FG007|Response Assignment|Other|53|||
33206541|NCT03521635|100656098|FG000|Overall Study|Refused to complete study visit|1|||
33206542|NCT03521635|100656099|FG001|Overall Study|Refused to complete study visit|0|||
33534348|NCT01716663|101856408|FG000|Overall Study|Withdrawn prior to procedure|4|||
33206543|NCT03521635|100656098|FG000|Overall Study|Refused to continue trial medication|2|||
33206544|NCT03521635|100656099|FG001|Overall Study|Refused to continue trial medication|2|||
33206545|NCT03521635|100656098|FG000|Overall Study|Lost to Follow-up|0|||
33206546|NCT03521635|100656099|FG001|Overall Study|Lost to Follow-up|1|||
33206547|NCT03521635|100656098|FG000|Overall Study|Meet exclusion criteria|0|||
33534349|NCT01716663|101856408|FG000|Overall Study|Treated with non-study catheter|2|||
33206548|NCT03521635|100656099|FG001|Overall Study|Meet exclusion criteria|1|||
33206549|NCT03521635|100656098|FG000|Overall Study|Patient not taken study medicine|0|||
33206550|NCT03521635|100656099|FG001|Overall Study|Patient not taken study medicine|1|||
33338271|NCT01687712|101131910|FG000|Cycle 1|Heterotropic Pregnancy|1|||
33338272|NCT01687712|101131911|FG001|Cycle 1|Heterotropic Pregnancy|0|||
33534350|NCT03286218|101856414|FG000|Qualification Phase Period 1|Adverse Event|1|||
33534351|NCT03286218|101856415|FG001|Qualification Phase Period 1|Adverse Event|0|||
33534352|NCT03286218|101856416|FG002|Qualification Phase Period 1|Adverse Event|0|||
33534353|NCT03286218|101856417|FG003|Qualification Phase Period 1|Adverse Event|0|||
33534354|NCT03286218|101856418|FG004|Qualification Phase Period 1|Adverse Event|0|||
33534355|NCT03286218|101856419|FG005|Qualification Phase Period 1|Adverse Event|0|||
33534356|NCT03286218|101856420|FG006|Qualification Phase Period 1|Adverse Event|0|||
33534357|NCT03286218|101856421|FG007|Qualification Phase Period 1|Adverse Event|0|||
33534358|NCT03286218|101856422|FG008|Qualification Phase Period 1|Adverse Event|0|||
33534359|NCT03286218|101856423|FG009|Qualification Phase Period 1|Adverse Event|0|||
33534360|NCT03286218|101856424|FG010|Qualification Phase Period 1|Adverse Event|0|||
33338273|NCT01687712|101131910|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
33338274|NCT01687712|101131911|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
33338275|NCT01687712|101131910|FG000|Cycle 1|Abortion|3|||
33534361|NCT03286218|101856425|FG011|Qualification Phase Period 1|Adverse Event|0|||
33534362|NCT03286218|101856414|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
33338276|NCT01687712|101131911|FG001|Cycle 1|Abortion|0|||
33338277|NCT01687712|101131910|FG000|Cycle 1|Intrauterine Fetal Death|0|||
33338278|NCT01687712|101131911|FG001|Cycle 1|Intrauterine Fetal Death|1|||
33338279|NCT01687712|101131910|FG000|Cycle 1|Lost to Follow-up|1|||
33534363|NCT03286218|101856415|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
33534364|NCT03286218|101856416|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
33534365|NCT03286218|101856417|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
33534366|NCT03286218|101856418|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
33534367|NCT03286218|101856419|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
33534368|NCT03286218|101856420|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
33534369|NCT03286218|101856421|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
33534370|NCT03286218|101856422|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
33534371|NCT03286218|101856423|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
33534372|NCT03286218|101856424|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
33534373|NCT03286218|101856425|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
33534374|NCT03286218|101856414|FG000|Qualification Phase Period 2|Adverse Event|0|||
33534375|NCT03286218|101856415|FG001|Qualification Phase Period 2|Adverse Event|1|||
33405307|NCT01258738|101373297|FG001|Double-blind Period|Withdrawal by Subject|2|||
33338280|NCT01687712|101131911|FG001|Cycle 1|Lost to Follow-up|1|||
33338281|NCT01687712|101131910|FG000|Cycle 2|Not Biochemically Pregnant|74|||
33338282|NCT01687712|101131911|FG001|Cycle 2|Not Biochemically Pregnant|77|||
33338283|NCT01687712|101131910|FG000|Cycle 2|Early Pregnancy Loss|18|||
33338284|NCT01687712|101131911|FG001|Cycle 2|Early Pregnancy Loss|16|||
33338285|NCT01687712|101131910|FG000|Cycle 2|Ectopic Pregnancy|0|||
33338286|NCT01687712|101131911|FG001|Cycle 2|Ectopic Pregnancy|1|||
33338287|NCT01687712|101131910|FG000|Cycle 2|Still Birth|1|||
33338288|NCT01687712|101131911|FG001|Cycle 2|Still Birth|0|||
33405308|NCT01258738|101373296|FG000|Double-blind Period|Protocol Violation|1|||
33405309|NCT01258738|101373297|FG001|Double-blind Period|Protocol Violation|1|||
33405310|NCT01258738|101373296|FG000|Double-blind Period|Adverse Event|3|||
33534376|NCT03286218|101856416|FG002|Qualification Phase Period 2|Adverse Event|0|||
33206551|NCT03727750|100656100|FG000|Overall Study|Death|45|||
33206552|NCT03727750|100656100|FG000|Overall Study|Withdrawal by Subject|2|||
33338289|NCT01687712|101131910|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
33338290|NCT01687712|101131911|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
33338291|NCT01687712|101131910|FG000|Cycle 3|Not Biochemically Pregnant|21|||
33338292|NCT01687712|101131911|FG001|Cycle 3|Not Biochemically Pregnant|22|||
33206553|NCT03727750|100656100|FG000|Overall Study|Lost to Follow-up|1|||
33338293|NCT01687712|101131910|FG000|Cycle 3|Early Pregnancy Loss|1|||
33206554|NCT03727750|100656100|FG000|Overall Study|Other|1|||
33338294|NCT01687712|101131911|FG001|Cycle 3|Early Pregnancy Loss|2|||
33405311|NCT01258738|101373297|FG001|Double-blind Period|Adverse Event|1|||
33338295|NCT01687712|101131910|FG000|Cycle 3|Ectopic Pregnancy|1|||
33338296|NCT01687712|101131911|FG001|Cycle 3|Ectopic Pregnancy|0|||
33338297|NCT01687712|101131910|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
33338298|NCT01687712|101131911|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
33206555|NCT02416791|100656101|FG000|6 Months|Lost to Follow-up|0|||
33206556|NCT02416791|100656102|FG001|6 Months|Lost to Follow-up|0|||
33206557|NCT02416791|100656103|FG002|6 Months|Lost to Follow-up|1|||
33206558|NCT00448539|100656104|FG000|Overall Study|Medication non-compliance|4|||
33534377|NCT03286218|101856417|FG003|Qualification Phase Period 2|Adverse Event|0|||
33534378|NCT03286218|101856418|FG004|Qualification Phase Period 2|Adverse Event|0|||
33534379|NCT03286218|101856419|FG005|Qualification Phase Period 2|Adverse Event|0|||
33534380|NCT03286218|101856420|FG006|Qualification Phase Period 2|Adverse Event|0|||
33534381|NCT03286218|101856421|FG007|Qualification Phase Period 2|Adverse Event|0|||
33206559|NCT00448539|100656105|FG001|Overall Study|Medication non-compliance|1|||
33338299|NCT02937350|101131912|FG000|Overall Study|Withdrawal by Subject|0|||
33338300|NCT02937350|101131913|FG001|Overall Study|Withdrawal by Subject|1|||
33338301|NCT02937350|101131914|FG002|Overall Study|Withdrawal by Subject|0|||
33338302|NCT01489527|101131915|FG000|Overall Study|Pregnancy|9|||
33206560|NCT00448539|100656104|FG000|Overall Study|Protocol Violation|1|||
33534382|NCT03286218|101856422|FG008|Qualification Phase Period 2|Adverse Event|0|||
33613547|NCT03364309|102133904|FG005|Induction Period|Lost to Follow-up|0|||
33613548|NCT03364309|102133905|FG006|Induction Period|Lost to Follow-up|0|||
33534383|NCT03286218|101856423|FG009|Qualification Phase Period 2|Adverse Event|0|||
33534384|NCT03286218|101856424|FG010|Qualification Phase Period 2|Adverse Event|0|||
33534385|NCT03286218|101856425|FG011|Qualification Phase Period 2|Adverse Event|0|||
33534386|NCT03286218|101856414|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
33206561|NCT00448539|100656105|FG001|Overall Study|Protocol Violation|0|||
33206562|NCT00448539|100656104|FG000|Overall Study|Request of the investigator or sponsor|67|||
33534387|NCT03286218|101856415|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
33534388|NCT03286218|101856416|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33338303|NCT01489527|101131916|FG001|Overall Study|Pregnancy|14|||
33338304|NCT01489527|101131915|FG000|Overall Study|Participant moved|6|||
33338305|NCT01489527|101131916|FG001|Overall Study|Participant moved|7|||
33338306|NCT01489527|101131915|FG000|Overall Study|Withdrawal by Subject|0|||
33338307|NCT01489527|101131916|FG001|Overall Study|Withdrawal by Subject|4|||
33338308|NCT01489527|101131915|FG000|Overall Study|Lost to Follow-up|5|||
33338309|NCT01489527|101131916|FG001|Overall Study|Lost to Follow-up|1|||
33534389|NCT03286218|101856417|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33613549|NCT03364309|102133906|FG007|Induction Period|Lost to Follow-up|0|||
33613550|NCT03364309|102133907|FG008|Induction Period|Lost to Follow-up|0|||
33206563|NCT00448539|100656105|FG001|Overall Study|Request of the investigator or sponsor|54|||
33206564|NCT00448539|100656104|FG000|Overall Study|Withdrawal by Subject|20|||
33338310|NCT01489527|101131915|FG000|Overall Study|Procedures|1|||
33338311|NCT01489527|101131916|FG001|Overall Study|Procedures|0|||
33338312|NCT01489527|101131915|FG000|Overall Study|Not compliant|1|||
33338313|NCT01489527|101131916|FG001|Overall Study|Not compliant|0|||
33206565|NCT00448539|100656105|FG001|Overall Study|Withdrawal by Subject|24|||
33534390|NCT03286218|101856418|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33534391|NCT03286218|101856419|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33534392|NCT03286218|101856420|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33534393|NCT03286218|101856421|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33534394|NCT03286218|101856422|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33534395|NCT03286218|101856423|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33534396|NCT03286218|101856424|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33534397|NCT03286218|101856425|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
33534398|NCT03286218|101856414|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
33534399|NCT03286218|101856415|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
33534400|NCT03286218|101856416|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
33534401|NCT03286218|101856417|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
33534402|NCT03286218|101856418|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
33534403|NCT03286218|101856419|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
33534404|NCT03286218|101856420|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
33534405|NCT03286218|101856421|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
33534406|NCT03286218|101856422|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
33534407|NCT03286218|101856423|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
33534408|NCT03286218|101856424|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
33534409|NCT03286218|101856425|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
33534410|NCT03286218|101856414|FG000|Qualification Phase Period 2|Protocol Violation|2|||
33534411|NCT03286218|101856415|FG001|Qualification Phase Period 2|Protocol Violation|0|||
33534412|NCT03286218|101856416|FG002|Qualification Phase Period 2|Protocol Violation|0|||
33206566|NCT00448539|100656104|FG000|Overall Study|Diary non-compliance|1|||
33206567|NCT00448539|100656105|FG001|Overall Study|Diary non-compliance|0|||
33206568|NCT00448539|100656104|FG000|Overall Study|Adverse Event|9|||
33206569|NCT00448539|100656105|FG001|Overall Study|Adverse Event|26|||
33206570|NCT00448539|100656104|FG000|Overall Study|Lack of Efficacy|27|||
33206571|NCT00448539|100656105|FG001|Overall Study|Lack of Efficacy|40|||
33206572|NCT00448539|100656104|FG000|Overall Study|Miscellaneous|2|||
33206573|NCT00448539|100656105|FG001|Overall Study|Miscellaneous|1|||
33206574|NCT00448539|100656104|FG000|Overall Study|Change of meds|2|||
33206575|NCT00448539|100656105|FG001|Overall Study|Change of meds|3|||
33206576|NCT00448539|100656104|FG000|Overall Study|Lost to Follow-up|1|||
33206577|NCT00448539|100656105|FG001|Overall Study|Lost to Follow-up|3|||
33206578|NCT02864082|100656107|FG000|Overall Study|Adverse Event|1|||
33206579|NCT02864082|100656108|FG001|Overall Study|Adverse Event|1|||
33206580|NCT02864082|100656107|FG000|Overall Study|Lost to Follow-up|0|||
33206581|NCT02864082|100656108|FG001|Overall Study|Lost to Follow-up|1|||
33206582|NCT02864082|100656107|FG000|Overall Study|Withdrawal by Subject|2|||
33206583|NCT02864082|100656108|FG001|Overall Study|Withdrawal by Subject|2|||
33206584|NCT00116805|100656109|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
33206585|NCT00116805|100656110|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
33206586|NCT00116805|100656109|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
33206587|NCT00116805|100656110|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
33206588|NCT00116805|100656109|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
33206589|NCT00116805|100656110|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
33206590|NCT00116805|100656109|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
33206591|NCT00116805|100656110|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
33206592|NCT00116805|100656109|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
33206593|NCT00116805|100656110|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
33206594|NCT00116805|100656109|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
33206595|NCT00116805|100656110|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
33206596|NCT00116805|100656109|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
33206597|NCT00116805|100656110|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
33206598|NCT00116805|100656109|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
33206599|NCT00116805|100656110|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
33206600|NCT00116805|100656109|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
33206601|NCT00116805|100656110|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
33206602|NCT00116805|100656109|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
33534413|NCT03286218|101856417|FG003|Qualification Phase Period 2|Protocol Violation|0|||
33534414|NCT03286218|101856418|FG004|Qualification Phase Period 2|Protocol Violation|0|||
33206603|NCT00116805|100656110|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
33206604|NCT00116805|100656109|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
33206605|NCT00116805|100656110|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
33206606|NCT00116805|100656109|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
33206607|NCT00116805|100656110|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
33206608|NCT00116805|100656109|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
33206609|NCT00116805|100656110|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
33206610|NCT00116805|100656109|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
33206611|NCT00116805|100656110|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
33534415|NCT03286218|101856419|FG005|Qualification Phase Period 2|Protocol Violation|0|||
33534416|NCT03286218|101856420|FG006|Qualification Phase Period 2|Protocol Violation|0|||
33534417|NCT03286218|101856421|FG007|Qualification Phase Period 2|Protocol Violation|0|||
33534418|NCT03286218|101856422|FG008|Qualification Phase Period 2|Protocol Violation|0|||
33534419|NCT03286218|101856423|FG009|Qualification Phase Period 2|Protocol Violation|0|||
33534420|NCT03286218|101856424|FG010|Qualification Phase Period 2|Protocol Violation|0|||
33534421|NCT03286218|101856425|FG011|Qualification Phase Period 2|Protocol Violation|0|||
33206612|NCT00116805|100656109|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
33206613|NCT00116805|100656110|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
33206614|NCT00116805|100656109|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
33206615|NCT00116805|100656110|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
33206616|NCT00116805|100656109|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
33206617|NCT00116805|100656110|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
33206618|NCT00116805|100656109|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
33206619|NCT00116805|100656110|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
33206620|NCT00116805|100656109|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
33206621|NCT00116805|100656110|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
33206622|NCT00116805|100656109|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
33206623|NCT00116805|100656110|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
33206624|NCT00116805|100656109|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
33206625|NCT00116805|100656110|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
33206626|NCT00116805|100656109|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
33206627|NCT00116805|100656110|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
33206628|NCT00116805|100656109|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
33206629|NCT00116805|100656110|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
33206630|NCT00116805|100656109|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
33206631|NCT00116805|100656110|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
33206632|NCT00116805|100656109|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
33206633|NCT00116805|100656110|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
33206634|NCT00116805|100656109|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
33206635|NCT00116805|100656110|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
33206636|NCT00116805|100656109|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
33206637|NCT00116805|100656110|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
33206638|NCT00116805|100656109|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
33206639|NCT00116805|100656110|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
33206640|NCT00116805|100656109|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
33206641|NCT00116805|100656110|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
33206642|NCT00116805|100656109|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
33206643|NCT00116805|100656110|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
33206644|NCT00116805|100656109|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
33206645|NCT00116805|100656110|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
33206646|NCT00116805|100656109|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
33206647|NCT00116805|100656110|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
33206648|NCT00116805|100656109|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
33206649|NCT00116805|100656110|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
33206650|NCT00116805|100656109|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
33206651|NCT00116805|100656110|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
33206652|NCT00116805|100656109|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
33206653|NCT00116805|100656110|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
33206654|NCT00116805|100656109|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
33206655|NCT00116805|100656110|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
33206656|NCT00116805|100656109|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
33206657|NCT00116805|100656110|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
33206658|NCT00116805|100656109|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
33206659|NCT00116805|100656110|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
33206660|NCT00116805|100656109|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
33405312|NCT01258738|101373296|FG000|Open-label Period|Did not meet inclusion criteria|0|||
33613551|NCT03364309|102133908|FG009|Induction Period|Lost to Follow-up|0|||
33613552|NCT03364309|102133909|FG010|Induction Period|Lost to Follow-up|0|||
33206661|NCT00116805|100656110|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
33206662|NCT00116805|100656109|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
33405313|NCT01258738|101373297|FG001|Open-label Period|Did not meet inclusion criteria|1|||
33405314|NCT01258738|101373296|FG000|Open-label Period|Insufficient clinical response|5|||
33206663|NCT00116805|100656110|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
33206664|NCT00116805|100656109|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
33206665|NCT00116805|100656110|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
33206666|NCT00116805|100656109|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
33206667|NCT00116805|100656110|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
33206668|NCT00116805|100656109|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
33206669|NCT00116805|100656110|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
33206670|NCT00116805|100656109|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
33206671|NCT00116805|100656110|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
33206672|NCT00116805|100656109|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
33206673|NCT00116805|100656110|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
33206674|NCT04818346|100656116|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
33206675|NCT04818346|100656117|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
33206676|NCT04818346|100656118|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
33206677|NCT04818346|100656119|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
33206678|NCT04818346|100656116|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
33206679|NCT04818346|100656117|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
33206680|NCT04818346|100656118|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
33206681|NCT04818346|100656119|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
33206682|NCT04818346|100656116|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
33206683|NCT04818346|100656117|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
33206684|NCT04818346|100656118|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
33206685|NCT04818346|100656119|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
33206686|NCT04818346|100656116|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
33206687|NCT04818346|100656117|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
33206688|NCT04818346|100656118|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
33206689|NCT04818346|100656119|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
33206690|NCT04818346|100656116|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
33206691|NCT04818346|100656117|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
33206692|NCT04818346|100656118|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
33206693|NCT04818346|100656119|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
33206694|NCT04818346|100656116|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
33206695|NCT04818346|100656117|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
33206696|NCT04818346|100656118|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
33206697|NCT04818346|100656119|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
33206698|NCT04818346|100656116|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
33338314|NCT03178487|101131917|FG000|Period 1|Adverse Event|1|||
33206699|NCT04818346|100656117|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
33206700|NCT04818346|100656118|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
33206701|NCT04818346|100656119|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
33206702|NCT04818346|100656116|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
33206703|NCT04818346|100656117|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
33206704|NCT04818346|100656118|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
33206705|NCT04818346|100656119|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
33206706|NCT04818346|100656116|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
33206707|NCT04818346|100656117|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
33206708|NCT04818346|100656118|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
33206709|NCT04818346|100656119|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
33206710|NCT04818346|100656116|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
33206711|NCT04818346|100656117|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
33206712|NCT04818346|100656118|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
33206713|NCT04818346|100656119|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
33338315|NCT03178487|101131918|FG001|Period 1|Adverse Event|2|||
33338316|NCT03178487|101131917|FG000|Period 1|Withdrawal by Subject|2|||
33338317|NCT03178487|101131918|FG001|Period 1|Withdrawal by Subject|1|||
33338318|NCT03178487|101131917|FG000|Period 1|Lost to Follow-up|1|||
33338319|NCT03178487|101131918|FG001|Period 1|Lost to Follow-up|0|||
33206714|NCT04818346|100656116|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
33206715|NCT04818346|100656117|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
33206716|NCT04818346|100656118|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
33206717|NCT04818346|100656119|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
33206718|NCT04818346|100656116|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
33206719|NCT04818346|100656117|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
33206720|NCT04818346|100656118|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
33206721|NCT04818346|100656119|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
33206722|NCT04818346|100656116|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
33206723|NCT04818346|100656117|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
33206724|NCT04818346|100656118|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
33206725|NCT04818346|100656119|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
33206726|NCT04818346|100656116|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
33206727|NCT04818346|100656117|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
33206728|NCT04818346|100656118|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
33206729|NCT04818346|100656119|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
33206730|NCT04818346|100656116|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
33206731|NCT04818346|100656117|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
33206732|NCT04818346|100656118|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
33206733|NCT04818346|100656119|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
33206734|NCT01432366|100656120|FG000|Overall Study|Non-Responder|7|||
33206735|NCT01432366|100656120|FG000|Overall Study|Adverse Event|8|||
33206736|NCT01432366|100656120|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
33206737|NCT01432366|100656120|FG000|Overall Study|Pregnancy|1|||
33206738|NCT01432366|100656120|FG000|Overall Study|Lost to Follow-up|13|||
33206739|NCT01432366|100656120|FG000|Overall Study|Lack of Efficacy|1|||
33206740|NCT01432366|100656120|FG000|Overall Study|Site Closed|20|||
33206741|NCT01432366|100656120|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
33206742|NCT01432366|100656120|FG000|Overall Study|Other|14|||
33206743|NCT03389802|100656121|FG000|Overall Study|Lack of Efficacy|3|||
33534422|NCT03286218|101856414|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
33534423|NCT03286218|101856415|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
33534424|NCT03286218|101856416|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
33534425|NCT03286218|101856417|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
33534426|NCT03286218|101856418|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
33534427|NCT03286218|101856419|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
33534428|NCT03286218|101856420|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
33534429|NCT03286218|101856421|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
33534430|NCT03286218|101856422|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
33534431|NCT03286218|101856423|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
33534432|NCT03286218|101856424|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
33534433|NCT03286218|101856425|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
33534434|NCT03286218|101856414|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
33534435|NCT03286218|101856415|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
33534436|NCT03286218|101856416|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
33534437|NCT03286218|101856417|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
33534438|NCT03286218|101856418|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
33534439|NCT03286218|101856419|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
33534440|NCT03286218|101856420|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
33534441|NCT03286218|101856421|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
33534442|NCT03286218|101856422|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
33534443|NCT03286218|101856423|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
33534444|NCT03286218|101856424|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
33534445|NCT03286218|101856425|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
33206744|NCT03389802|100656122|FG001|Overall Study|Lack of Efficacy|3|||
33206745|NCT03389802|100656123|FG002|Overall Study|Lack of Efficacy|13|||
33206746|NCT03389802|100656124|FG003|Overall Study|Lack of Efficacy|6|||
33206747|NCT03389802|100656125|FG004|Overall Study|Lack of Efficacy|1|||
33206748|NCT03389802|100656121|FG000|Overall Study|Adverse Event|0|||
33206749|NCT03389802|100656122|FG001|Overall Study|Adverse Event|0|||
33206750|NCT03389802|100656123|FG002|Overall Study|Adverse Event|1|||
33206751|NCT03389802|100656124|FG003|Overall Study|Adverse Event|0|||
33206752|NCT03389802|100656125|FG004|Overall Study|Adverse Event|4|||
33206753|NCT03389802|100656121|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
33206754|NCT03389802|100656122|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
33206755|NCT03389802|100656123|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
33206756|NCT03389802|100656124|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
33534446|NCT03286218|101856414|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
33534447|NCT03286218|101856415|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
33206757|NCT03389802|100656125|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
33206758|NCT04323436|100656126|FG000|Overall Study|Adverse Event|7|||
33206759|NCT04323436|100656127|FG001|Overall Study|Adverse Event|0|||
33206760|NCT04323436|100656128|FG002|Overall Study|Adverse Event|0|||
33206761|NCT04323436|100656126|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
33206762|NCT04323436|100656127|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
33206763|NCT04323436|100656128|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
33206764|NCT04323436|100656126|FG000|Overall Study|Death|1|||
33338320|NCT03178487|101131917|FG000|Period 1|Other|0|||
33206765|NCT04323436|100656127|FG001|Overall Study|Death|0|||
33206766|NCT04323436|100656128|FG002|Overall Study|Death|0|||
33206767|NCT04323436|100656126|FG000|Overall Study|Physician Decision|2|||
33206768|NCT04323436|100656127|FG001|Overall Study|Physician Decision|0|||
33206769|NCT04323436|100656128|FG002|Overall Study|Physician Decision|0|||
33206770|NCT04323436|100656126|FG000|Overall Study|Progressive disease|10|||
33206771|NCT04323436|100656127|FG001|Overall Study|Progressive disease|0|||
33206772|NCT04323436|100656128|FG002|Overall Study|Progressive disease|0|||
33206773|NCT04323436|100656126|FG000|Overall Study|Subject decision|3|||
33206774|NCT04323436|100656127|FG001|Overall Study|Subject decision|0|||
33206775|NCT04323436|100656128|FG002|Overall Study|Subject decision|0|||
33206776|NCT03972488|100656129|FG000|Overall Study|Progressive disease|42|||
33206777|NCT03972488|100656130|FG001|Overall Study|Progressive disease|44|||
33206778|NCT03972488|100656129|FG000|Overall Study|Physician Decision|13|||
33206779|NCT03972488|100656130|FG001|Overall Study|Physician Decision|7|||
33206780|NCT03972488|100656129|FG000|Overall Study|Adverse Event|8|||
33206781|NCT03972488|100656130|FG001|Overall Study|Adverse Event|1|||
33206782|NCT03972488|100656129|FG000|Overall Study|Death|4|||
33206783|NCT03972488|100656130|FG001|Overall Study|Death|4|||
33534448|NCT03286218|101856416|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
33534449|NCT03286218|101856417|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
33206784|NCT03972488|100656129|FG000|Overall Study|Withdrawal by Subject|3|||
33206785|NCT03972488|100656130|FG001|Overall Study|Withdrawal by Subject|4|||
33206786|NCT03972488|100656129|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
33206787|NCT03972488|100656130|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
33206788|NCT00599326|100656131|FG000|Overall Study|Lost to Follow-up|1|||
33206789|NCT00599326|100656131|FG000|Overall Study|Noncompliant|1|||
33206790|NCT04955639|100656132|FG000|Overall Study|Withdrawal by Subject|2|||
33206791|NCT04955639|100656133|FG001|Overall Study|Withdrawal by Subject|2|||
33206792|NCT04955639|100656132|FG000|Overall Study|Week 26 survey not completed|2|||
33206793|NCT04955639|100656133|FG001|Overall Study|Week 26 survey not completed|2|||
33206794|NCT00110617|100656134|FG000|Overall Study|Adverse Event|2|||
33206795|NCT00110617|100656135|FG001|Overall Study|Adverse Event|4|||
33206796|NCT00110617|100656134|FG000|Overall Study|Abnormal Laboratory Value|4|||
33206797|NCT00110617|100656135|FG001|Overall Study|Abnormal Laboratory Value|2|||
33206798|NCT00110617|100656134|FG000|Overall Study|Lack of Efficacy|1|||
33206799|NCT00110617|100656135|FG001|Overall Study|Lack of Efficacy|0|||
33206800|NCT00110617|100656134|FG000|Overall Study|Patient no longer requires study drug|1|||
33206801|NCT00110617|100656135|FG001|Overall Study|Patient no longer requires study drug|0|||
33206802|NCT00110617|100656134|FG000|Overall Study|Protocol Violation|5|||
33338321|NCT03178487|101131918|FG001|Period 1|Other|1|||
33338322|NCT03178487|101131917|FG000|Period 2|Adverse Event|4|||
33338323|NCT03178487|101131918|FG001|Period 2|Adverse Event|4|||
33338324|NCT03178487|101131917|FG000|Period 2|Withdrawal by Subject|6|||
33338325|NCT03178487|101131918|FG001|Period 2|Withdrawal by Subject|6|||
33338326|NCT03178487|101131917|FG000|Period 2|Lost to Follow-up|2|||
33338327|NCT03178487|101131918|FG001|Period 2|Lost to Follow-up|2|||
33338328|NCT03178487|101131917|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
33338329|NCT03178487|101131918|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
33338330|NCT03178487|101131917|FG000|Period 2|Other|8|||
33338331|NCT03178487|101131918|FG001|Period 2|Other|7|||
33338332|NCT02669017|101131919|FG000|Overall Study|Death|1|||
33338333|NCT02669017|101131920|FG001|Overall Study|Death|2|||
33338334|NCT02669017|101131921|FG002|Overall Study|Death|2|||
33338335|NCT02669017|101131922|FG003|Overall Study|Death|3|||
33338336|NCT02669017|101131923|FG004|Overall Study|Death|8|||
33338337|NCT02669017|101131924|FG005|Overall Study|Death|18|||
33338338|NCT02669017|101131925|FG006|Overall Study|Death|10|||
33338339|NCT02669017|101131926|FG007|Overall Study|Death|47|||
33338340|NCT02669017|101131927|FG008|Overall Study|Death|20|||
33338341|NCT02669017|101131919|FG000|Overall Study|Withdrawal by Subject|0|||
33338342|NCT02669017|101131920|FG001|Overall Study|Withdrawal by Subject|0|||
33338343|NCT02669017|101131921|FG002|Overall Study|Withdrawal by Subject|0|||
33338344|NCT02669017|101131922|FG003|Overall Study|Withdrawal by Subject|1|||
33338345|NCT02669017|101131923|FG004|Overall Study|Withdrawal by Subject|2|||
33613553|NCT03364309|102133910|FG011|Induction Period|Lost to Follow-up|0|||
33613554|NCT03364309|102133911|FG012|Induction Period|Lost to Follow-up|0|||
33206803|NCT00110617|100656135|FG001|Overall Study|Protocol Violation|0|||
33206804|NCT00110617|100656134|FG000|Overall Study|Withdrawal by Subject|10|||
33206805|NCT00110617|100656135|FG001|Overall Study|Withdrawal by Subject|4|||
33206806|NCT00110617|100656134|FG000|Overall Study|Lost to Follow-up|9|||
33206807|NCT00110617|100656135|FG001|Overall Study|Lost to Follow-up|1|||
33338346|NCT02669017|101131924|FG005|Overall Study|Withdrawal by Subject|0|||
33338347|NCT02669017|101131925|FG006|Overall Study|Withdrawal by Subject|0|||
33338348|NCT02669017|101131926|FG007|Overall Study|Withdrawal by Subject|2|||
33338349|NCT02669017|101131927|FG008|Overall Study|Withdrawal by Subject|2|||
33338350|NCT02669017|101131919|FG000|Overall Study|Lost to Follow-up|0|||
33338351|NCT02669017|101131920|FG001|Overall Study|Lost to Follow-up|0|||
33338352|NCT02669017|101131921|FG002|Overall Study|Lost to Follow-up|0|||
33338353|NCT02669017|101131922|FG003|Overall Study|Lost to Follow-up|0|||
33534450|NCT03286218|101856418|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
33534451|NCT03286218|101856419|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
33534452|NCT03286218|101856420|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
33534453|NCT03286218|101856421|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
33534454|NCT03286218|101856422|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
33338354|NCT02669017|101131923|FG004|Overall Study|Lost to Follow-up|0|||
33338355|NCT02669017|101131924|FG005|Overall Study|Lost to Follow-up|0|||
33338356|NCT02669017|101131925|FG006|Overall Study|Lost to Follow-up|0|||
33338357|NCT02669017|101131926|FG007|Overall Study|Lost to Follow-up|0|||
33338358|NCT02669017|101131927|FG008|Overall Study|Lost to Follow-up|1|||
33338359|NCT02669017|101131919|FG000|Overall Study|Miscellaneous|0|||
33338360|NCT02669017|101131920|FG001|Overall Study|Miscellaneous|0|||
33338361|NCT02669017|101131921|FG002|Overall Study|Miscellaneous|0|||
33338362|NCT02669017|101131922|FG003|Overall Study|Miscellaneous|0|||
33405315|NCT01258738|101373297|FG001|Open-label Period|Insufficient clinical response|3|||
33534455|NCT03286218|101856423|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
33534456|NCT03286218|101856424|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
33534457|NCT03286218|101856425|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
33534458|NCT04534517|101856429|FG000|Overall Study|Adverse Event|1|||
33534459|NCT04534517|101856429|FG000|Overall Study|Withdrawal by Subject|1|||
33534460|NCT04534517|101856429|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
33534461|NCT04534517|101856429|FG000|Overall Study|COVID-19 Related|1|||
33534462|NCT02948829|101856430|FG000|Overall Study|Lost to Follow-up|2|||
33534463|NCT02948829|101856430|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
33534464|NCT02948829|101856430|FG000|Overall Study|Pregnancy|1|||
33534465|NCT02948829|101856430|FG000|Overall Study|Other: Reason not Specified|8|||
33534466|NCT02260817|101856431|FG000|Overall Study|Lost to Follow-up|0|||
33534467|NCT02260817|101856432|FG001|Overall Study|Lost to Follow-up|14|||
33534468|NCT02260817|101856431|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
33534469|NCT02260817|101856432|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
33534470|NCT02260817|101856431|FG000|Overall Study|Observation, no biopsy|0|||
33534471|NCT02260817|101856432|FG001|Overall Study|Observation, no biopsy|1|||
33534472|NCT02260817|101856431|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
33534473|NCT02260817|101856432|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
33534474|NCT02260817|101856431|FG000|Overall Study|Protocol Violation|0|||
33534475|NCT02260817|101856432|FG001|Overall Study|Protocol Violation|14|||
33534476|NCT00102596|101856435|FG000|Part A|Screen failures|6|||
33534477|NCT00102596|101856436|FG001|Part A|Screen failures|0|||
33534478|NCT00102596|101856435|FG000|Part A|Adverse Event|1|||
33534479|NCT00102596|101856436|FG001|Part A|Adverse Event|0|||
33534480|NCT02053493|101856437|FG000|Overall Study|Withdrawal by Subject|1|||
33534481|NCT02053493|101856438|FG001|Overall Study|Withdrawal by Subject|1|||
33534482|NCT03234036|101856439|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
33534483|NCT03234036|101856440|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
33534484|NCT03234036|101856441|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
33534485|NCT03234036|101856442|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
33534486|NCT02782741|101856444|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
33534487|NCT02782741|101856445|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
33534488|NCT02782741|101856446|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
33534489|NCT02782741|101856444|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
33534490|NCT02782741|101856445|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
33534491|NCT02782741|101856446|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
33534492|NCT02782741|101856444|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
33534493|NCT02782741|101856445|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
33534494|NCT02782741|101856446|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
33534495|NCT02782741|101856444|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
33534496|NCT02782741|101856445|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
33534497|NCT02782741|101856446|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
33534498|NCT02782741|101856444|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
33338363|NCT02669017|101131923|FG004|Overall Study|Miscellaneous|2|||
33534499|NCT02782741|101856445|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
33534500|NCT02782741|101856446|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
33338364|NCT02669017|101131924|FG005|Overall Study|Miscellaneous|1|||
33534501|NCT01274351|101856447|FG000|Overall Study|Lost to Follow-up|1|||
33534502|NCT01274351|101856447|FG000|Overall Study|patient not compliant with the protocol|1|||
33534503|NCT01274351|101856447|FG000|Overall Study|Pregnancy|1|||
33206808|NCT00110617|100656134|FG000|Overall Study|Administrative problems|6|||
33206809|NCT00110617|100656135|FG001|Overall Study|Administrative problems|5|||
33206810|NCT00110617|100656134|FG000|Overall Study|Death|1|||
33206811|NCT00110617|100656135|FG001|Overall Study|Death|1|||
33206812|NCT00110617|100656134|FG000|Overall Study|Did not receive study drug|0|||
33206813|NCT00110617|100656135|FG001|Overall Study|Did not receive study drug|12|||
33206814|NCT04433767|100656136|FG000|Overall Study|Adverse Event|1|||
33206815|NCT04743908|100656141|FG000|Overall Study|Death|1|||
33206816|NCT04743908|100656142|FG001|Overall Study|Death|0|||
33206817|NCT04743908|100656141|FG000|Overall Study|Lost to Follow-up|181|||
33206818|NCT04743908|100656142|FG001|Overall Study|Lost to Follow-up|180|||
33206819|NCT04743908|100656141|FG000|Overall Study|Withdrawal by Subject|1|||
33206820|NCT04743908|100656142|FG001|Overall Study|Withdrawal by Subject|2|||
33206821|NCT02005471|100656143|FG000|Main Study|Adverse Event|0|||
33206822|NCT02005471|100656144|FG001|Main Study|Adverse Event|1|||
33206823|NCT02005471|100656145|FG002|Main Study|Adverse Event|0|||
33613555|NCT03364309|102133912|FG013|Induction Period|Lost to Follow-up|0|||
33613556|NCT03364309|102133913|FG014|Induction Period|Lost to Follow-up|0|||
33613557|NCT03364309|102133914|FG015|Induction Period|Lost to Follow-up|0|||
33613558|NCT03364309|102133915|FG016|Induction Period|Lost to Follow-up|0|||
33613559|NCT03364309|102133916|FG017|Induction Period|Lost to Follow-up|0|||
33613560|NCT03364309|102133917|FG018|Induction Period|Lost to Follow-up|0|||
33613561|NCT03364309|102133899|FG000|Induction Period|Physician Decision|0|||
33613562|NCT03364309|102133900|FG001|Induction Period|Physician Decision|1|||
33613563|NCT03364309|102133901|FG002|Induction Period|Physician Decision|0|||
33613564|NCT03364309|102133902|FG003|Induction Period|Physician Decision|0|||
33613565|NCT03364309|102133903|FG004|Induction Period|Physician Decision|0|||
33613566|NCT03364309|102133904|FG005|Induction Period|Physician Decision|0|||
33206824|NCT02005471|100656146|FG003|Main Study|Adverse Event|0|||
33206825|NCT02005471|100656143|FG000|Main Study|Death|83|||
33206826|NCT02005471|100656144|FG001|Main Study|Death|52|||
33206827|NCT02005471|100656145|FG002|Main Study|Death|0|||
33206828|NCT02005471|100656146|FG003|Main Study|Death|0|||
33206829|NCT02005471|100656143|FG000|Main Study|Lost to Follow-up|4|||
33206830|NCT02005471|100656144|FG001|Main Study|Lost to Follow-up|5|||
33206831|NCT02005471|100656145|FG002|Main Study|Lost to Follow-up|0|||
33206832|NCT02005471|100656146|FG003|Main Study|Lost to Follow-up|0|||
33206833|NCT02005471|100656143|FG000|Main Study|Physician Decision|3|||
33206834|NCT02005471|100656144|FG001|Main Study|Physician Decision|1|||
33206835|NCT02005471|100656145|FG002|Main Study|Physician Decision|0|||
33206836|NCT02005471|100656146|FG003|Main Study|Physician Decision|0|||
33206837|NCT02005471|100656143|FG000|Main Study|Withdrawal by Subject|26|||
33206838|NCT02005471|100656144|FG001|Main Study|Withdrawal by Subject|11|||
33613567|NCT03364309|102133905|FG006|Induction Period|Physician Decision|0|||
33613568|NCT03364309|102133906|FG007|Induction Period|Physician Decision|0|||
33613569|NCT03364309|102133907|FG008|Induction Period|Physician Decision|0|||
33613570|NCT03364309|102133908|FG009|Induction Period|Physician Decision|0|||
33206839|NCT02005471|100656145|FG002|Main Study|Withdrawal by Subject|0|||
33206840|NCT02005471|100656146|FG003|Main Study|Withdrawal by Subject|0|||
33534504|NCT01274351|101856447|FG000|Overall Study|Death|2|||
33534505|NCT01274351|101856447|FG000|Overall Study|Withdrawal by Subject|3|||
33534506|NCT01274351|101856447|FG000|Overall Study|Adverse Event|8|||
33534507|NCT01274351|101856447|FG000|Overall Study|progression of disease|3|||
33534508|NCT01274351|101856447|FG000|Overall Study|hospitalization|1|||
33534509|NCT00971867|101856448|FG000|Overall Study|Adverse Event|4|||
33534510|NCT00971867|101856448|FG000|Overall Study|Participant Withdrew Consent|1|||
33534511|NCT00971867|101856448|FG000|Overall Study|Disease Progression|6|||
33534512|NCT02700048|101856451|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
33613571|NCT03364309|102133909|FG010|Induction Period|Physician Decision|0|||
33613572|NCT03364309|102133910|FG011|Induction Period|Physician Decision|0|||
33206841|NCT02005471|100656143|FG000|Main Study|Reason not Specified|0|||
33206842|NCT02005471|100656144|FG001|Main Study|Reason not Specified|6|||
33206843|NCT02005471|100656145|FG002|Main Study|Reason not Specified|0|||
33534513|NCT02700048|101856452|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
33206844|NCT02005471|100656146|FG003|Main Study|Reason not Specified|0|||
33206845|NCT02005471|100656143|FG000|Main Study|Randomized but not Dosed|8|||
33206846|NCT02005471|100656144|FG001|Main Study|Randomized but not Dosed|0|||
33206847|NCT02005471|100656145|FG002|Main Study|Randomized but not Dosed|0|||
33206848|NCT02005471|100656146|FG003|Main Study|Randomized but not Dosed|0|||
33206849|NCT02005471|100656143|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
33534514|NCT02322749|101856457|FG000|Period 2|Adverse Event|0|||
33613573|NCT03364309|102133911|FG012|Induction Period|Physician Decision|0|||
33613574|NCT03364309|102133912|FG013|Induction Period|Physician Decision|0|||
33613575|NCT03364309|102133913|FG014|Induction Period|Physician Decision|0|||
33613576|NCT03364309|102133914|FG015|Induction Period|Physician Decision|0|||
33206850|NCT02005471|100656144|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
33206851|NCT02005471|100656145|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
33206852|NCT02005471|100656146|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
33206853|NCT02005471|100656143|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
33206854|NCT02005471|100656144|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
33206855|NCT02005471|100656145|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
33206856|NCT02005471|100656146|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
33206857|NCT02005471|100656143|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
33206858|NCT02005471|100656144|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
33534515|NCT02322749|101856458|FG001|Period 2|Adverse Event|0|||
33534516|NCT02322749|101856459|FG002|Period 2|Adverse Event|0|||
33206859|NCT02005471|100656145|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
33206860|NCT02005471|100656146|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
33206861|NCT03422003|100656149|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
33206862|NCT03422003|100656150|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
33206863|NCT03422003|100656149|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
33206864|NCT03422003|100656150|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
33206865|NCT01073618|100656151|FG000|Overall Study|Death|208|||
33206866|NCT01073618|100656151|FG000|Overall Study|Adverse Event|19|||
33206867|NCT01073618|100656151|FG000|Overall Study|Other|80|||
33206868|NCT03551938|100656152|FG000|3-Month Follow Up|Lost to Follow-up|39|||
33206869|NCT03551938|100656153|FG001|3-Month Follow Up|Lost to Follow-up|38|||
33206870|NCT03551938|100656152|FG000|6-Month Follow Up|Lost to Follow-up|46|||
33206871|NCT03551938|100656153|FG001|6-Month Follow Up|Lost to Follow-up|42|||
33206872|NCT03551938|100656152|FG000|9-Month Follow Up|Lost to Follow-up|44|||
33206873|NCT03551938|100656153|FG001|9-Month Follow Up|Lost to Follow-up|43|||
33206874|NCT02096900|100656158|FG000|Overall Study|Did not receive medication|3|||
33206875|NCT02096900|100656159|FG001|Overall Study|Did not receive medication|1|||
33206876|NCT02096900|100656158|FG000|Overall Study|Surgery cancelled- medication received|1|||
33206877|NCT02096900|100656159|FG001|Overall Study|Surgery cancelled- medication received|1|||
33206878|NCT01571362|100656160|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
33206879|NCT01571362|100656161|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
33206880|NCT01571362|100656162|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
33206881|NCT01571362|100656160|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
33534517|NCT02322749|101856460|FG003|Period 2|Adverse Event|1|||
33534518|NCT02322749|101856461|FG004|Period 2|Adverse Event|0|||
33534519|NCT02322749|101856462|FG005|Period 2|Adverse Event|0|||
33534520|NCT02322749|101856457|FG000|Period 2|Withdrawal by Subject|0|||
33534521|NCT02322749|101856458|FG001|Period 2|Withdrawal by Subject|0|||
33534522|NCT02322749|101856459|FG002|Period 2|Withdrawal by Subject|0|||
33534523|NCT02322749|101856460|FG003|Period 2|Withdrawal by Subject|1|||
33534524|NCT02322749|101856461|FG004|Period 2|Withdrawal by Subject|0|||
33534525|NCT02322749|101856462|FG005|Period 2|Withdrawal by Subject|0|||
33534526|NCT02322749|101856457|FG000|Period 3|Withdrawal by Subject|0|||
33534527|NCT02322749|101856458|FG001|Period 3|Withdrawal by Subject|0|||
33534528|NCT02322749|101856459|FG002|Period 3|Withdrawal by Subject|1|||
33534529|NCT02322749|101856460|FG003|Period 3|Withdrawal by Subject|0|||
33534530|NCT02322749|101856461|FG004|Period 3|Withdrawal by Subject|0|||
33534531|NCT02322749|101856462|FG005|Period 3|Withdrawal by Subject|0|||
33534532|NCT05133323|101856463|FG000|Overall Study|Lack of Efficacy|0|||
33206882|NCT01571362|100656161|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
33206883|NCT01571362|100656162|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
33206884|NCT01571362|100656160|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
33338365|NCT02669017|101131925|FG006|Overall Study|Miscellaneous|1|||
33338366|NCT02669017|101131926|FG007|Overall Study|Miscellaneous|13|||
33338367|NCT02669017|101131927|FG008|Overall Study|Miscellaneous|2|||
33338368|NCT03927105|101131928|FG000|Overall Study|Death|1|||
33338369|NCT03927105|101131928|FG000|Overall Study|In observation for potential re-treatment|2|||
33338370|NCT03927105|101131928|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
33338371|NCT01425203|101131929|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
33338372|NCT01425203|101131930|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
33338373|NCT01425203|101131931|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
33338374|NCT01425203|101131929|FG000|Treatment Phase|Failure at futility timepoint|8|||
33338375|NCT01425203|101131930|FG001|Treatment Phase|Failure at futility timepoint|27|||
33338376|NCT01425203|101131931|FG002|Treatment Phase|Failure at futility timepoint|0|||
33338377|NCT01425203|101131929|FG000|Treatment Phase|Other virologic failure criteria|5|||
33338378|NCT01425203|101131930|FG001|Treatment Phase|Other virologic failure criteria|3|||
33405316|NCT01258738|101373296|FG000|Open-label Period|Lost to Follow-up|0|||
33534533|NCT05133323|101856464|FG001|Overall Study|Lack of Efficacy|0|||
33534534|NCT05133323|101856465|FG002|Overall Study|Lack of Efficacy|1|||
33534535|NCT05133323|101856463|FG000|Overall Study|Withdrawal by Subject|2|||
33206885|NCT01571362|100656161|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
33206886|NCT01571362|100656162|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
33338379|NCT01425203|101131931|FG002|Treatment Phase|Other virologic failure criteria|0|||
33338380|NCT01425203|101131929|FG000|Treatment Phase|Unidentified reasons|11|||
33338381|NCT01425203|101131930|FG001|Treatment Phase|Unidentified reasons|5|||
33338382|NCT01425203|101131931|FG002|Treatment Phase|Unidentified reasons|0|||
33206887|NCT01571362|100656160|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
33206888|NCT01571362|100656161|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
33206889|NCT01571362|100656162|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
33206890|NCT01571362|100656160|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
33206891|NCT01571362|100656161|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
33206892|NCT01571362|100656162|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
33206893|NCT01571362|100656160|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
33206894|NCT01571362|100656161|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
33206895|NCT01571362|100656162|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
33338383|NCT01425203|101131929|FG000|Treatment Phase|Did not receive treatment|0|||
33338384|NCT01425203|101131930|FG001|Treatment Phase|Did not receive treatment|1|||
33338385|NCT01425203|101131931|FG002|Treatment Phase|Did not receive treatment|0|||
33338386|NCT01425203|101131929|FG000|Crossover Phase|Failure at futility timepoint|0|||
33338387|NCT01425203|101131930|FG001|Crossover Phase|Failure at futility timepoint|0|||
33338388|NCT01425203|101131931|FG002|Crossover Phase|Failure at futility timepoint|3|||
33338389|NCT01425203|101131929|FG000|Crossover Phase|Other virologic failure criteria|0|||
33405317|NCT01258738|101373297|FG001|Open-label Period|Lost to Follow-up|2|||
33405318|NCT01258738|101373296|FG000|Open-label Period|Withdrawal by Subject|5|||
33338390|NCT01425203|101131930|FG001|Crossover Phase|Other virologic failure criteria|0|||
33338391|NCT01425203|101131931|FG002|Crossover Phase|Other virologic failure criteria|3|||
33338392|NCT01736579|101131932|FG000|Overall Study|Termination of Study by Sponsor|2|||
33338393|NCT01736579|101131933|FG001|Overall Study|Termination of Study by Sponsor|2|||
33338394|NCT01834729|101131934|FG000|Overall Study|Did not return bowel diaries|0|||
33338395|NCT01834729|101131935|FG001|Overall Study|Did not return bowel diaries|0|||
33338396|NCT01834729|101131936|FG002|Overall Study|Did not return bowel diaries|3|||
33338397|NCT01834729|101131937|FG003|Overall Study|Did not return bowel diaries|0|||
33338398|NCT01834729|101131934|FG000|Overall Study|Withdrawal by Subject|1|||
33338399|NCT01834729|101131935|FG001|Overall Study|Withdrawal by Subject|1|||
33338400|NCT01834729|101131936|FG002|Overall Study|Withdrawal by Subject|0|||
33338401|NCT01834729|101131937|FG003|Overall Study|Withdrawal by Subject|0|||
33338402|NCT01834729|101131934|FG000|Overall Study|Adverse Event|0|||
33338403|NCT01834729|101131935|FG001|Overall Study|Adverse Event|0|||
33338404|NCT01834729|101131936|FG002|Overall Study|Adverse Event|0|||
33338405|NCT01834729|101131937|FG003|Overall Study|Adverse Event|2|||
33338406|NCT01356589|101131938|FG000|Overall Study|Enrolled, but not treated|3|||
33338407|NCT01356589|101131938|FG000|Overall Study|Dose data not recorded|2|||
33338408|NCT01285908|101131943|FG000|Baseline Measurement|unable to insert catheter|1|||
33405319|NCT01258738|101373297|FG001|Open-label Period|Withdrawal by Subject|6|||
33534536|NCT05133323|101856464|FG001|Overall Study|Withdrawal by Subject|1|||
33534537|NCT05133323|101856465|FG002|Overall Study|Withdrawal by Subject|0|||
33534538|NCT01239394|101856468|FG000|Overall Study|Adverse Event|1|||
33534539|NCT03492437|101856469|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33534540|NCT03492437|101856470|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33534541|NCT01026948|101856477|FG000|Overall Study|Physician Decision|8|||
33534542|NCT01573000|101856478|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
33534543|NCT01573000|101856479|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
33534544|NCT01573000|101856478|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
33534545|NCT01573000|101856479|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
33534546|NCT01573000|101856478|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
33534547|NCT01573000|101856479|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
33534548|NCT01573000|101856478|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
33534549|NCT01573000|101856479|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
33534550|NCT01573000|101856478|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
33534551|NCT01573000|101856479|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
33534552|NCT01573000|101856478|FG000|Crossover Phase|Lack of Efficacy|0|||
33534553|NCT01573000|101856479|FG001|Crossover Phase|Lack of Efficacy|13|||
33534554|NCT01573000|101856478|FG000|Crossover Phase|Lost to Follow-up|0|||
33534555|NCT01573000|101856479|FG001|Crossover Phase|Lost to Follow-up|2|||
33534556|NCT01573000|101856478|FG000|Crossover Phase|Death|0|||
33338409|NCT01285908|101131944|FG001|Baseline Measurement|unable to insert catheter|0|||
33338410|NCT01285908|101131945|FG002|Baseline Measurement|unable to insert catheter|0|||
33338411|NCT01285908|101131943|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
33338412|NCT01285908|101131944|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
33338413|NCT01285908|101131945|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
33338414|NCT01285908|101131943|FG000|Baseline Measurement|unable to tolerate procedure|1|||
33338415|NCT01285908|101131944|FG001|Baseline Measurement|unable to tolerate procedure|0|||
33338416|NCT01285908|101131945|FG002|Baseline Measurement|unable to tolerate procedure|0|||
33338417|NCT04673786|101131946|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
33338418|NCT04673786|101131947|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
33338419|NCT04673786|101131948|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
33338420|NCT04673786|101131946|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
33338421|NCT04673786|101131947|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
33338422|NCT04673786|101131948|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
33338423|NCT04673786|101131946|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
33534557|NCT01573000|101856479|FG001|Crossover Phase|Death|3|||
33534558|NCT01573000|101856478|FG000|Long-Term Follow-Up|Death|3|||
33534559|NCT01573000|101856479|FG001|Long-Term Follow-Up|Death|0|||
33534560|NCT01573000|101856478|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
33534561|NCT01573000|101856479|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
33534562|NCT04396626|101856480|FG000|Overall Study|Premature termination of study|975|||
33338424|NCT04673786|101131947|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
33338425|NCT04673786|101131948|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
33338426|NCT04673786|101131946|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
33338427|NCT04673786|101131947|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
33206896|NCT01571362|100656160|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33206897|NCT01571362|100656161|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
33206898|NCT01571362|100656162|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
33206899|NCT01571362|100656160|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
33206900|NCT01571362|100656161|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
33534563|NCT00917124|101856481|FG000|Overall Study|Protocol Violation|4|||
33534564|NCT00917124|101856482|FG001|Overall Study|Protocol Violation|6|||
33534565|NCT00577772|101856483|FG000|Overall Study|Lost to Follow-up|0|||
33534566|NCT00577772|101856484|FG001|Overall Study|Lost to Follow-up|1|||
33534567|NCT01705977|101856486|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
33534568|NCT01705977|101856487|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
33534569|NCT01705977|101856486|FG000|Treatment Period (Year 1)|Adverse Event|57|||
33534570|NCT01705977|101856487|FG001|Treatment Period (Year 1)|Adverse Event|49|||
33534571|NCT01705977|101856486|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
33534572|NCT01705977|101856487|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
33534573|NCT01705977|101856486|FG000|Treatment Period (Year 1)|Site closure|3|||
33613577|NCT03364309|102133915|FG016|Induction Period|Physician Decision|0|||
33338428|NCT04673786|101131948|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
33338429|NCT04673786|101131946|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
33338430|NCT04673786|101131947|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
33534574|NCT01705977|101856487|FG001|Treatment Period (Year 1)|Site closure|2|||
33534575|NCT01705977|101856486|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
33534576|NCT01705977|101856487|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
33206901|NCT01571362|100656162|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
33206902|NCT01571362|100656160|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33206903|NCT01571362|100656161|FG001|Double-Blind Treatment Period|Adverse Event|9|||
33206904|NCT01571362|100656162|FG002|Double-Blind Treatment Period|Adverse Event|14|||
33206905|NCT01571362|100656160|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33206906|NCT01571362|100656161|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
33206907|NCT01571362|100656162|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
33534577|NCT01705977|101856486|FG000|Treatment Period (Year 1)|Physician Decision|48|||
33534578|NCT01705977|101856487|FG001|Treatment Period (Year 1)|Physician Decision|38|||
33613578|NCT03364309|102133916|FG017|Induction Period|Physician Decision|0|||
33206908|NCT01571362|100656160|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
33613579|NCT03364309|102133917|FG018|Induction Period|Physician Decision|0|||
33613580|NCT03364309|102133899|FG000|Maintenance Period|Withdrawal by Subject|0|||
33613581|NCT03364309|102133900|FG001|Maintenance Period|Withdrawal by Subject|0|||
33613582|NCT03364309|102133901|FG002|Maintenance Period|Withdrawal by Subject|0|||
33613583|NCT03364309|102133902|FG003|Maintenance Period|Withdrawal by Subject|1|||
33613584|NCT03364309|102133903|FG004|Maintenance Period|Withdrawal by Subject|3|||
33613585|NCT03364309|102133904|FG005|Maintenance Period|Withdrawal by Subject|1|||
33613586|NCT03364309|102133905|FG006|Maintenance Period|Withdrawal by Subject|3|||
33613587|NCT03364309|102133906|FG007|Maintenance Period|Withdrawal by Subject|0|||
33613588|NCT03364309|102133907|FG008|Maintenance Period|Withdrawal by Subject|1|||
33613589|NCT03364309|102133908|FG009|Maintenance Period|Withdrawal by Subject|1|||
33206909|NCT01571362|100656161|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
33613590|NCT03364309|102133909|FG010|Maintenance Period|Withdrawal by Subject|2|||
33613591|NCT03364309|102133910|FG011|Maintenance Period|Withdrawal by Subject|0|||
33613592|NCT03364309|102133911|FG012|Maintenance Period|Withdrawal by Subject|0|||
33613593|NCT03364309|102133912|FG013|Maintenance Period|Withdrawal by Subject|0|||
33613594|NCT03364309|102133913|FG014|Maintenance Period|Withdrawal by Subject|0|||
33613595|NCT03364309|102133914|FG015|Maintenance Period|Withdrawal by Subject|0|||
33613596|NCT03364309|102133915|FG016|Maintenance Period|Withdrawal by Subject|0|||
33613597|NCT03364309|102133916|FG017|Maintenance Period|Withdrawal by Subject|0|||
33613598|NCT03364309|102133917|FG018|Maintenance Period|Withdrawal by Subject|0|||
33613599|NCT03364309|102133899|FG000|Maintenance Period|Adverse Event|0|||
33613600|NCT03364309|102133900|FG001|Maintenance Period|Adverse Event|0|||
33613601|NCT03364309|102133901|FG002|Maintenance Period|Adverse Event|0|||
33613602|NCT03364309|102133902|FG003|Maintenance Period|Adverse Event|0|||
33613603|NCT03364309|102133903|FG004|Maintenance Period|Adverse Event|2|||
33613604|NCT03364309|102133904|FG005|Maintenance Period|Adverse Event|0|||
33613605|NCT03364309|102133905|FG006|Maintenance Period|Adverse Event|3|||
33613606|NCT03364309|102133906|FG007|Maintenance Period|Adverse Event|0|||
33613607|NCT03364309|102133907|FG008|Maintenance Period|Adverse Event|1|||
33613608|NCT03364309|102133908|FG009|Maintenance Period|Adverse Event|0|||
33613609|NCT03364309|102133909|FG010|Maintenance Period|Adverse Event|2|||
33613610|NCT03364309|102133910|FG011|Maintenance Period|Adverse Event|0|||
33613611|NCT03364309|102133911|FG012|Maintenance Period|Adverse Event|0|||
33613612|NCT03364309|102133912|FG013|Maintenance Period|Adverse Event|0|||
33613613|NCT03364309|102133913|FG014|Maintenance Period|Adverse Event|0|||
33613614|NCT03364309|102133914|FG015|Maintenance Period|Adverse Event|0|||
33613615|NCT03364309|102133915|FG016|Maintenance Period|Adverse Event|0|||
33613616|NCT03364309|102133916|FG017|Maintenance Period|Adverse Event|0|||
33338431|NCT04673786|101131948|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
33613617|NCT03364309|102133917|FG018|Maintenance Period|Adverse Event|0|||
33613618|NCT03364309|102133899|FG000|Maintenance Period|Relapsed|0|||
33338432|NCT04673786|101131946|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
33613619|NCT03364309|102133900|FG001|Maintenance Period|Relapsed|0|||
33613620|NCT03364309|102133901|FG002|Maintenance Period|Relapsed|0|||
33613621|NCT03364309|102133902|FG003|Maintenance Period|Relapsed|43|||
33206910|NCT01571362|100656162|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
33206911|NCT01571362|100656160|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
33206912|NCT01571362|100656161|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
33206913|NCT01571362|100656162|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
33206914|NCT02132611|100656163|FG000|Overall Study|Death|2|||
33206915|NCT01627249|100656167|FG000|Overall Study|Death|3|||
33206916|NCT01627249|100656168|FG001|Overall Study|Death|5|||
33206917|NCT01627249|100656169|FG002|Overall Study|Death|3|||
33206918|NCT01627249|100656167|FG000|Overall Study|Withdrawal by Subject|12|||
33206919|NCT01627249|100656168|FG001|Overall Study|Withdrawal by Subject|6|||
33206920|NCT01627249|100656169|FG002|Overall Study|Withdrawal by Subject|9|||
33206921|NCT01627249|100656167|FG000|Overall Study|Missed Visit|1|||
33206922|NCT01627249|100656168|FG001|Overall Study|Missed Visit|1|||
33338433|NCT04673786|101131947|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
33206923|NCT01627249|100656169|FG002|Overall Study|Missed Visit|0|||
33206924|NCT04837482|100656170|FG000|Period 2|Withdrawal by Subject|0|||
33206925|NCT04837482|100656171|FG001|Period 2|Withdrawal by Subject|1|||
33206926|NCT01434602|100656180|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
33206927|NCT01434602|100656181|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
33206928|NCT01434602|100656182|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
33206929|NCT01434602|100656183|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
33206930|NCT01434602|100656184|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
33206931|NCT01434602|100656180|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
33206932|NCT01434602|100656181|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
33206933|NCT01434602|100656182|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
33206934|NCT01434602|100656183|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
33206935|NCT01434602|100656184|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
33206936|NCT01434602|100656180|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
33206937|NCT01434602|100656181|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
33206938|NCT01434602|100656182|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
33206939|NCT01434602|100656183|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
33206940|NCT01434602|100656184|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
33206941|NCT01434602|100656180|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
33338434|NCT04673786|101131948|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
33338435|NCT00713700|101131949|FG000|Overall Study|Lost to Follow-up|3|||
33534579|NCT01705977|101856486|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
33206942|NCT01434602|100656181|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
33206943|NCT01434602|100656182|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
33613622|NCT03364309|102133903|FG004|Maintenance Period|Relapsed|7|||
33613623|NCT03364309|102133904|FG005|Maintenance Period|Relapsed|45|||
33613624|NCT03364309|102133905|FG006|Maintenance Period|Relapsed|10|||
33613625|NCT03364309|102133906|FG007|Maintenance Period|Relapsed|2|||
33613626|NCT03364309|102133907|FG008|Maintenance Period|Relapsed|0|||
33338436|NCT00713700|101131949|FG000|Overall Study|Withdrawal by Subject|1|||
33338437|NCT03979274|101131950|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33338438|NCT03979274|101131951|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33338439|NCT02867761|101131952|FG000|Overall Study|Participant withdrawn by investigator|0|||
33338440|NCT02867761|101131953|FG001|Overall Study|Participant withdrawn by investigator|1|||
33338441|NCT02867761|101131952|FG000|Overall Study|Lost to Follow-up|25|||
33338442|NCT02867761|101131953|FG001|Overall Study|Lost to Follow-up|18|||
33338443|NCT02867761|101131952|FG000|Overall Study|Unable to complete protocol|3|||
33534580|NCT01705977|101856487|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
33534581|NCT01705977|101856486|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
33534582|NCT01705977|101856487|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
33534583|NCT01705977|101856486|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
33338444|NCT02867761|101131953|FG001|Overall Study|Unable to complete protocol|7|||
33534584|NCT01705977|101856487|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
33338445|NCT01844895|101131954|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
33338446|NCT01844895|101131954|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
33338447|NCT01844895|101131954|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
33338448|NCT01844895|101131954|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
33338449|NCT01844895|101131954|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
33338450|NCT01844895|101131954|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
33338451|NCT01844895|101131954|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
33338452|NCT01890421|101131955|FG000|Overall Study|Adverse Event|1|||
33338453|NCT01890421|101131955|FG000|Overall Study|Other reason|10|||
33338454|NCT01325428|101131958|FG000|Part A|Progressive disease according to RECIST|9|||
33338455|NCT01325428|101131958|FG000|Part A|Clinical signs, symptoms of progression|2|||
33613627|NCT03364309|102133908|FG009|Maintenance Period|Relapsed|0|||
33613628|NCT03364309|102133909|FG010|Maintenance Period|Relapsed|0|||
33613629|NCT03364309|102133910|FG011|Maintenance Period|Relapsed|0|||
33613630|NCT03364309|102133911|FG012|Maintenance Period|Relapsed|0|||
33613631|NCT03364309|102133912|FG013|Maintenance Period|Relapsed|0|||
33613632|NCT03364309|102133913|FG014|Maintenance Period|Relapsed|0|||
33613633|NCT03364309|102133914|FG015|Maintenance Period|Relapsed|0|||
33613634|NCT03364309|102133915|FG016|Maintenance Period|Relapsed|0|||
33613635|NCT03364309|102133916|FG017|Maintenance Period|Relapsed|0|||
33613636|NCT03364309|102133917|FG018|Maintenance Period|Relapsed|0|||
33613637|NCT03364309|102133899|FG000|Maintenance Period|Lack of Efficacy|0|||
33613638|NCT03364309|102133900|FG001|Maintenance Period|Lack of Efficacy|0|||
33613639|NCT03364309|102133901|FG002|Maintenance Period|Lack of Efficacy|0|||
33613640|NCT03364309|102133902|FG003|Maintenance Period|Lack of Efficacy|0|||
33613641|NCT03364309|102133903|FG004|Maintenance Period|Lack of Efficacy|0|||
33613642|NCT03364309|102133904|FG005|Maintenance Period|Lack of Efficacy|0|||
33613643|NCT03364309|102133905|FG006|Maintenance Period|Lack of Efficacy|0|||
33613644|NCT03364309|102133906|FG007|Maintenance Period|Lack of Efficacy|0|||
33613645|NCT03364309|102133907|FG008|Maintenance Period|Lack of Efficacy|1|||
33613646|NCT03364309|102133908|FG009|Maintenance Period|Lack of Efficacy|3|||
33613647|NCT03364309|102133909|FG010|Maintenance Period|Lack of Efficacy|2|||
33613648|NCT03364309|102133910|FG011|Maintenance Period|Lack of Efficacy|0|||
33613649|NCT03364309|102133911|FG012|Maintenance Period|Lack of Efficacy|0|||
33613650|NCT03364309|102133912|FG013|Maintenance Period|Lack of Efficacy|0|||
33613651|NCT03364309|102133913|FG014|Maintenance Period|Lack of Efficacy|0|||
33613652|NCT03364309|102133914|FG015|Maintenance Period|Lack of Efficacy|0|||
33613653|NCT03364309|102133915|FG016|Maintenance Period|Lack of Efficacy|0|||
33613654|NCT03364309|102133916|FG017|Maintenance Period|Lack of Efficacy|0|||
33613655|NCT03364309|102133917|FG018|Maintenance Period|Lack of Efficacy|0|||
33613656|NCT03364309|102133899|FG000|Maintenance Period|Death|0|||
33613657|NCT03364309|102133900|FG001|Maintenance Period|Death|0|||
33613658|NCT03364309|102133901|FG002|Maintenance Period|Death|0|||
33613659|NCT03364309|102133902|FG003|Maintenance Period|Death|0|||
33613660|NCT03364309|102133903|FG004|Maintenance Period|Death|0|||
33613661|NCT03364309|102133904|FG005|Maintenance Period|Death|0|||
33613662|NCT03364309|102133905|FG006|Maintenance Period|Death|0|||
33613663|NCT03364309|102133906|FG007|Maintenance Period|Death|0|||
33613664|NCT03364309|102133907|FG008|Maintenance Period|Death|1|||
33613665|NCT03364309|102133908|FG009|Maintenance Period|Death|0|||
33613666|NCT03364309|102133909|FG010|Maintenance Period|Death|0|||
33613667|NCT03364309|102133910|FG011|Maintenance Period|Death|0|||
33613668|NCT03364309|102133911|FG012|Maintenance Period|Death|0|||
33613669|NCT03364309|102133912|FG013|Maintenance Period|Death|0|||
33613670|NCT03364309|102133913|FG014|Maintenance Period|Death|0|||
33613671|NCT03364309|102133914|FG015|Maintenance Period|Death|0|||
33613672|NCT03364309|102133915|FG016|Maintenance Period|Death|0|||
33613673|NCT03364309|102133916|FG017|Maintenance Period|Death|0|||
33613674|NCT03364309|102133917|FG018|Maintenance Period|Death|0|||
33613675|NCT03364309|102133899|FG000|Maintenance Period|Lost to Follow-up|0|||
33613676|NCT03364309|102133900|FG001|Maintenance Period|Lost to Follow-up|0|||
33613677|NCT03364309|102133901|FG002|Maintenance Period|Lost to Follow-up|0|||
33613678|NCT03364309|102133902|FG003|Maintenance Period|Lost to Follow-up|0|||
33613679|NCT03364309|102133903|FG004|Maintenance Period|Lost to Follow-up|0|||
33613680|NCT03364309|102133904|FG005|Maintenance Period|Lost to Follow-up|0|||
33613681|NCT03364309|102133905|FG006|Maintenance Period|Lost to Follow-up|0|||
33613682|NCT03364309|102133906|FG007|Maintenance Period|Lost to Follow-up|0|||
33613683|NCT03364309|102133907|FG008|Maintenance Period|Lost to Follow-up|1|||
33613684|NCT03364309|102133908|FG009|Maintenance Period|Lost to Follow-up|0|||
33613685|NCT03364309|102133909|FG010|Maintenance Period|Lost to Follow-up|0|||
33613686|NCT03364309|102133910|FG011|Maintenance Period|Lost to Follow-up|0|||
33613687|NCT03364309|102133911|FG012|Maintenance Period|Lost to Follow-up|0|||
33613688|NCT03364309|102133912|FG013|Maintenance Period|Lost to Follow-up|0|||
33613689|NCT03364309|102133913|FG014|Maintenance Period|Lost to Follow-up|0|||
33613690|NCT03364309|102133914|FG015|Maintenance Period|Lost to Follow-up|0|||
33613691|NCT03364309|102133915|FG016|Maintenance Period|Lost to Follow-up|0|||
33613692|NCT03364309|102133916|FG017|Maintenance Period|Lost to Follow-up|0|||
33613693|NCT03364309|102133917|FG018|Maintenance Period|Lost to Follow-up|0|||
33613694|NCT03364309|102133899|FG000|Maintenance Period|Miscellaneous|0|||
33534585|NCT01705977|101856486|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
33534586|NCT01705977|101856487|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
33534587|NCT01705977|101856486|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
33534588|NCT01705977|101856487|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
33534589|NCT01705977|101856486|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
33534590|NCT01705977|101856487|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
33534591|NCT01973218|101856496|FG000|Overall Study|Adverse Event|1|||
33534592|NCT01973218|101856497|FG001|Overall Study|Adverse Event|0|||
33534593|NCT01973218|101856496|FG000|Overall Study|Withdrawal by Subject|1|||
33534594|NCT01973218|101856497|FG001|Overall Study|Withdrawal by Subject|0|||
33534595|NCT04386902|101856501|FG000|Overall Study|Withdrawal by Subject|5|||
33534596|NCT04386902|101856501|FG000|Overall Study|Technical problems in the recording|5|||
33534597|NCT00269152|101856502|FG000|Overall Study|Adverse Event|9|||
33534598|NCT00269152|101856503|FG001|Overall Study|Adverse Event|3|||
33534599|NCT00269152|101856502|FG000|Overall Study|Withdrawal by Subject|7|||
33534600|NCT00269152|101856503|FG001|Overall Study|Withdrawal by Subject|3|||
33534601|NCT00269152|101856502|FG000|Overall Study|Physician Decision|2|||
33534602|NCT00269152|101856503|FG001|Overall Study|Physician Decision|3|||
33534603|NCT00269152|101856502|FG000|Overall Study|Protocol Violation|0|||
33534604|NCT00269152|101856503|FG001|Overall Study|Protocol Violation|1|||
33534605|NCT03933449|101856505|FG000|Overall Study|Adverse Event|6|||
33534606|NCT03933449|101856506|FG001|Overall Study|Adverse Event|4|||
33534607|NCT03933449|101856505|FG000|Overall Study|Death|55|||
33534608|NCT03933449|101856506|FG001|Overall Study|Death|57|||
33534609|NCT03933449|101856505|FG000|Overall Study|Sponsor Decision|1|||
33534610|NCT03933449|101856506|FG001|Overall Study|Sponsor Decision|0|||
33534611|NCT00315445|101856507|FG000|Overall Study|Adverse Event|7|||
33534612|NCT00315445|101856508|FG001|Overall Study|Adverse Event|12|||
33534613|NCT00315445|101856509|FG002|Overall Study|Adverse Event|15|||
33613695|NCT03364309|102133900|FG001|Maintenance Period|Miscellaneous|0|||
33613696|NCT03364309|102133901|FG002|Maintenance Period|Miscellaneous|0|||
33534614|NCT00315445|101856507|FG000|Overall Study|Lack of Efficacy|16|||
33534615|NCT00315445|101856508|FG001|Overall Study|Lack of Efficacy|1|||
33534616|NCT00315445|101856509|FG002|Overall Study|Lack of Efficacy|7|||
33534617|NCT00315445|101856507|FG000|Overall Study|Lost to Follow-up|1|||
33613697|NCT03364309|102133902|FG003|Maintenance Period|Miscellaneous|0|||
33613698|NCT03364309|102133903|FG004|Maintenance Period|Miscellaneous|0|||
33534618|NCT00315445|101856508|FG001|Overall Study|Lost to Follow-up|0|||
33534619|NCT00315445|101856509|FG002|Overall Study|Lost to Follow-up|1|||
33206944|NCT01434602|100656183|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
33206945|NCT01434602|100656184|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
33405320|NCT01258738|101373296|FG000|Open-label Period|Protocol Violation|2|||
33405321|NCT01258738|101373297|FG001|Open-label Period|Protocol Violation|2|||
33405322|NCT01258738|101373296|FG000|Open-label Period|Adverse Event|4|||
33613699|NCT03364309|102133904|FG005|Maintenance Period|Miscellaneous|0|||
33206946|NCT01434602|100656180|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
33206947|NCT01434602|100656181|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
33206948|NCT01434602|100656182|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
33206949|NCT01434602|100656183|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
33206950|NCT01434602|100656184|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
33405323|NCT01258738|101373297|FG001|Open-label Period|Adverse Event|5|||
33405324|NCT01258738|101373296|FG000|Open-label Period|Other Reasons|0|||
33405325|NCT01258738|101373297|FG001|Open-label Period|Other Reasons|1|||
33405326|NCT01258738|101373296|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
33405327|NCT01258738|101373297|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
33405328|NCT02062385|101373300|FG000|Overall Study|Adverse Event|19|||
33405329|NCT02062385|101373301|FG001|Overall Study|Adverse Event|13|||
33405330|NCT02062385|101373302|FG002|Overall Study|Adverse Event|1|||
33405331|NCT02062385|101373303|FG003|Overall Study|Adverse Event|0|||
33405332|NCT02062385|101373300|FG000|Overall Study|Protocol Violation|1|||
33405333|NCT02062385|101373301|FG001|Overall Study|Protocol Violation|0|||
33534620|NCT00315445|101856507|FG000|Overall Study|Protocol Violation|2|||
33534621|NCT00315445|101856508|FG001|Overall Study|Protocol Violation|0|||
33534622|NCT00315445|101856509|FG002|Overall Study|Protocol Violation|1|||
33534623|NCT00315445|101856507|FG000|Overall Study|Other|1|||
33206951|NCT01434602|100656180|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
33206952|NCT01434602|100656181|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
33206953|NCT01434602|100656182|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
33206954|NCT01434602|100656183|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
33206955|NCT01434602|100656184|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
33206956|NCT01434602|100656180|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
33206957|NCT01434602|100656181|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
33206958|NCT01434602|100656182|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
33534624|NCT00315445|101856508|FG001|Overall Study|Other|3|||
33534625|NCT00315445|101856509|FG002|Overall Study|Other|0|||
33534626|NCT02346708|101856512|FG000|Overall Study|Adverse Event|2|||
33534627|NCT02346708|101856513|FG001|Overall Study|Adverse Event|0|||
33534628|NCT02346708|101856512|FG000|Overall Study|Protocol Violation|0|||
33534629|NCT02346708|101856513|FG001|Overall Study|Protocol Violation|1|||
33534630|NCT03589807|101856514|FG000|Overall Study|Lost to Follow-up|0|||
33534631|NCT03589807|101856515|FG001|Overall Study|Lost to Follow-up|2|||
33534632|NCT03589807|101856516|FG002|Overall Study|Lost to Follow-up|2|||
33534633|NCT03589807|101856517|FG003|Overall Study|Lost to Follow-up|3|||
33534634|NCT03589807|101856518|FG004|Overall Study|Lost to Follow-up|1|||
33534635|NCT03589807|101856519|FG005|Overall Study|Lost to Follow-up|1|||
33534636|NCT03589807|101856514|FG000|Overall Study|Withdrawal by Subject|0|||
33534637|NCT03589807|101856515|FG001|Overall Study|Withdrawal by Subject|5|||
33534638|NCT03589807|101856516|FG002|Overall Study|Withdrawal by Subject|0|||
33534639|NCT03589807|101856517|FG003|Overall Study|Withdrawal by Subject|0|||
33534640|NCT03589807|101856518|FG004|Overall Study|Withdrawal by Subject|0|||
33534641|NCT03589807|101856519|FG005|Overall Study|Withdrawal by Subject|0|||
33534642|NCT03589807|101856514|FG000|Overall Study|Protocol Violation|0|||
33534643|NCT03589807|101856515|FG001|Overall Study|Protocol Violation|0|||
33534644|NCT03589807|101856516|FG002|Overall Study|Protocol Violation|0|||
33534645|NCT03589807|101856517|FG003|Overall Study|Protocol Violation|1|||
33534646|NCT03589807|101856518|FG004|Overall Study|Protocol Violation|0|||
33534647|NCT03589807|101856519|FG005|Overall Study|Protocol Violation|0|||
33534648|NCT03589807|101856514|FG000|Overall Study|Enrolled but treatment not administered|0|||
33534649|NCT03589807|101856515|FG001|Overall Study|Enrolled but treatment not administered|0|||
33534650|NCT03589807|101856516|FG002|Overall Study|Enrolled but treatment not administered|0|||
33534651|NCT03589807|101856517|FG003|Overall Study|Enrolled but treatment not administered|0|||
33534652|NCT03589807|101856518|FG004|Overall Study|Enrolled but treatment not administered|1|||
33534653|NCT03589807|101856519|FG005|Overall Study|Enrolled but treatment not administered|0|||
33613700|NCT03364309|102133905|FG006|Maintenance Period|Miscellaneous|0|||
33206959|NCT01434602|100656183|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
33405334|NCT02062385|101373302|FG002|Overall Study|Protocol Violation|0|||
33405335|NCT02062385|101373303|FG003|Overall Study|Protocol Violation|0|||
33534654|NCT02557399|101856521|FG000|Overall Study|Adverse Event|6|||
33534655|NCT02557399|101856522|FG001|Overall Study|Adverse Event|5|||
33534656|NCT02557399|101856521|FG000|Overall Study|Protocol Violation|0|||
33534657|NCT02557399|101856522|FG001|Overall Study|Protocol Violation|1|||
33534658|NCT02557399|101856521|FG000|Overall Study|Protocol-defined stopping criteria|0|||
33534659|NCT02557399|101856522|FG001|Overall Study|Protocol-defined stopping criteria|1|||
33206960|NCT01434602|100656184|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
33206961|NCT01434602|100656180|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
33206962|NCT01434602|100656181|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
33206963|NCT01434602|100656182|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
33206964|NCT01434602|100656183|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
33534660|NCT02557399|101856521|FG000|Overall Study|Withdrawal by Subject|1|||
33613701|NCT03364309|102133906|FG007|Maintenance Period|Miscellaneous|0|||
33206965|NCT01434602|100656184|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
33206966|NCT01434602|100656180|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
33206967|NCT01434602|100656181|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
33206968|NCT01434602|100656182|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
33206969|NCT01434602|100656183|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
33206970|NCT01434602|100656184|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
33206971|NCT01434602|100656180|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
33206972|NCT01434602|100656181|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
33206973|NCT01434602|100656182|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
33206974|NCT01434602|100656183|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
33206975|NCT01434602|100656184|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
33206976|NCT01962493|100656185|FG000|Overall Study|Adverse Event|1|||
33206977|NCT01962493|100656186|FG001|Overall Study|Adverse Event|2|||
33206978|NCT01962493|100656185|FG000|Overall Study|Protocol Violation|0|||
33206979|NCT01962493|100656186|FG001|Overall Study|Protocol Violation|1|||
33206980|NCT01962493|100656185|FG000|Overall Study|Withdrawal by Subject|4|||
33206981|NCT01962493|100656186|FG001|Overall Study|Withdrawal by Subject|2|||
33206982|NCT00305058|100656187|FG000|Overall Study|Participant too young|1|||
33206983|NCT00305058|100656188|FG001|Overall Study|Participant too young|0|||
33206984|NCT00305058|100656187|FG000|Overall Study|Missing data collection instrument|3|||
33206985|NCT00305058|100656188|FG001|Overall Study|Missing data collection instrument|2|||
33206986|NCT00305058|100656187|FG000|Overall Study|Missing outcome data|3|||
33206987|NCT00305058|100656188|FG001|Overall Study|Missing outcome data|2|||
33206988|NCT00586105|100656189|FG000|Overall Study|Adverse Event|4|||
33206989|NCT00586105|100656189|FG000|Overall Study|Death|2|||
33206990|NCT00586105|100656189|FG000|Overall Study|Protocol Violation|1|||
33206991|NCT00586105|100656189|FG000|Overall Study|Withdrawal by Subject|3|||
33206992|NCT00586105|100656189|FG000|Overall Study|Disease progression|19|||
33206993|NCT00586105|100656189|FG000|Overall Study|Switched to commercial drug|9|||
33206994|NCT00586105|100656189|FG000|Overall Study|Reason not reported|1|||
33206995|NCT00144339|100656190|FG000|Overall Study|Adverse Event|746|||
33206996|NCT00144339|100656191|FG001|Overall Study|Adverse Event|627|||
33206997|NCT00144339|100656190|FG000|Overall Study|Protocol Violation|75|||
33206998|NCT00144339|100656191|FG001|Overall Study|Protocol Violation|48|||
33206999|NCT00144339|100656190|FG000|Overall Study|Withdrawal by Subject|403|||
33207000|NCT00144339|100656191|FG001|Overall Study|Withdrawal by Subject|300|||
33207001|NCT00144339|100656190|FG000|Overall Study|Lost to Follow-up|76|||
33207002|NCT00144339|100656191|FG001|Overall Study|Lost to Follow-up|64|||
33207003|NCT00144339|100656190|FG000|Overall Study|Other|58|||
33207004|NCT00144339|100656191|FG001|Overall Study|Other|60|||
33207005|NCT02462876|100656192|FG000|Overall Study|Death|3|||
33207006|NCT02462876|100656192|FG000|Overall Study|Lost to Follow-up|7|||
33207007|NCT02462876|100656192|FG000|Overall Study|Surgical Bypass|9|||
33207008|NCT02462876|100656192|FG000|Overall Study|Amputation Above the Metatarsals|1|||
33207009|NCT02462876|100656192|FG000|Overall Study|36 months follow-up visit missed|1|||
33207010|NCT02462876|100656192|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
33207011|NCT02462876|100656192|FG000|Overall Study|Patient did not come back to the vascular department|1|||
33207012|NCT02462876|100656192|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
33207013|NCT02462876|100656192|FG000|Overall Study|Patient refused to come back|1|||
33207014|NCT02462876|100656192|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
33207015|NCT02462876|100656192|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
33207016|NCT01949480|100656200|FG000|Overall Study|Physician Decision|5|||
33207017|NCT01949480|100656201|FG001|Overall Study|Physician Decision|8|||
33207018|NCT02053350|100656205|FG000|Overall Study|Withdrawal by Subject|1|||
33207019|NCT02053350|100656205|FG000|Overall Study|Adverse Event|4|||
33207020|NCT03077724|100661304|FG000|Overall Study|Lost to Follow-up|5|||
33207021|NCT03077724|100661305|FG001|Overall Study|Lost to Follow-up|1|||
33207022|NCT03077724|100661304|FG000|Overall Study|Withdrawal by Subject|3|||
33207023|NCT03077724|100661305|FG001|Overall Study|Withdrawal by Subject|1|||
33207024|NCT00971048|100661306|FG000|Overall Study|Protocol Violation|1|||
33207025|NCT00971048|100661307|FG001|Overall Study|Protocol Violation|2|||
33207026|NCT00971048|100661308|FG002|Overall Study|Protocol Violation|0|||
33207027|NCT00971048|100661309|FG003|Overall Study|Protocol Violation|1|||
33207028|NCT00971048|100661306|FG000|Overall Study|Adverse Event|0|||
33207029|NCT00971048|100661307|FG001|Overall Study|Adverse Event|0|||
33207030|NCT00971048|100661308|FG002|Overall Study|Adverse Event|1|||
33207031|NCT00971048|100661309|FG003|Overall Study|Adverse Event|0|||
33207032|NCT00971048|100661306|FG000|Overall Study|Physician Decision|0|||
33207033|NCT00971048|100661307|FG001|Overall Study|Physician Decision|0|||
33207034|NCT00971048|100661308|FG002|Overall Study|Physician Decision|0|||
33207035|NCT00971048|100661309|FG003|Overall Study|Physician Decision|1|||
33207036|NCT01917526|100661310|FG000|Overall Study|Protocol Violation|1|||
33338456|NCT01325428|101131958|FG000|Part A|Other adverse event|1|||
33338457|NCT01325428|101131958|FG000|Part A|Refused continue taking trial medication|2|||
33338458|NCT01325428|101131958|FG000|Part A|Other reason not defined above|2|||
33338459|NCT01325428|101131958|FG000|Part B|Refused continue taking trial medication|2|||
33338460|NCT01325428|101131958|FG000|Part B|Other reason not defined above|1|||
33338461|NCT02268058|101131959|FG000|Overall Study|Protocol Violation|1|||
33338462|NCT02268058|101131960|FG001|Overall Study|Protocol Violation|0|||
33338463|NCT02268058|101131961|FG002|Overall Study|Protocol Violation|0|||
33207037|NCT01917526|100661311|FG001|Overall Study|Protocol Violation|1|||
33338464|NCT02268058|101131962|FG003|Overall Study|Protocol Violation|0|||
33207038|NCT03712917|100661312|FG000|Overall Study|Pregnancy|0|||
33338465|NCT02971670|101131963|FG000|Overall Study|Withdrawal by Subject|4|||
33338466|NCT02971670|101131964|FG001|Overall Study|Withdrawal by Subject|1|||
33207039|NCT03712917|100661313|FG001|Overall Study|Pregnancy|0|||
33207040|NCT03712917|100661314|FG002|Overall Study|Pregnancy|1|||
33207041|NCT03712917|100661312|FG000|Overall Study|Adverse Event|0|||
33207042|NCT03712917|100661313|FG001|Overall Study|Adverse Event|4|||
33207043|NCT03712917|100661314|FG002|Overall Study|Adverse Event|3|||
33207044|NCT03712917|100661312|FG000|Overall Study|Lost to Follow-up|9|||
33338467|NCT02971670|101131965|FG002|Overall Study|Withdrawal by Subject|1|||
33207045|NCT03712917|100661313|FG001|Overall Study|Lost to Follow-up|4|||
33207046|NCT03712917|100661314|FG002|Overall Study|Lost to Follow-up|5|||
33207047|NCT01314118|100661317|FG000|Overall Study|Adverse Event|9|||
33207048|NCT01314118|100661317|FG000|Overall Study|Progressive disease|27|||
33207049|NCT01314118|100661317|FG000|Overall Study|Physician Decision|11|||
33207050|NCT01314118|100661317|FG000|Overall Study|Death|4|||
33207051|NCT01314118|100661317|FG000|Overall Study|Protocol Violation|5|||
33207052|NCT01314118|100661317|FG000|Overall Study|Withdrawal by Subject|11|||
33207053|NCT01314118|100661317|FG000|Overall Study|Other|2|||
33207054|NCT01314118|100661317|FG000|Overall Study|Ongoing|62|||
33207055|NCT00782340|100661320|FG000|Open Label Titration|Adverse Event|12|||
33207056|NCT00782340|100661321|FG001|Open Label Titration|Adverse Event|0|||
33207057|NCT00782340|100661322|FG002|Open Label Titration|Adverse Event|0|||
33207058|NCT00782340|100661320|FG000|Open Label Titration|Treatment failure|50|||
33207059|NCT00782340|100661321|FG001|Open Label Titration|Treatment failure|0|||
33207060|NCT00782340|100661322|FG002|Open Label Titration|Treatment failure|0|||
33207061|NCT00782340|100661320|FG000|Open Label Titration|Protocol Violation|5|||
33207062|NCT00782340|100661321|FG001|Open Label Titration|Protocol Violation|0|||
33207063|NCT00782340|100661322|FG002|Open Label Titration|Protocol Violation|0|||
33207064|NCT00782340|100661320|FG000|Open Label Titration|Withdrawal by Subject|5|||
33207065|NCT00782340|100661321|FG001|Open Label Titration|Withdrawal by Subject|0|||
33207066|NCT00782340|100661322|FG002|Open Label Titration|Withdrawal by Subject|0|||
33207067|NCT00782340|100661320|FG000|Open Label Titration|Enrollment capped|16|||
33207068|NCT00782340|100661321|FG001|Open Label Titration|Enrollment capped|0|||
33207069|NCT00782340|100661322|FG002|Open Label Titration|Enrollment capped|0|||
33207070|NCT00782340|100661320|FG000|Open Label Titration|Did not meet responder criteria|2|||
33207071|NCT00782340|100661321|FG001|Open Label Titration|Did not meet responder criteria|0|||
33207072|NCT00782340|100661322|FG002|Open Label Titration|Did not meet responder criteria|0|||
33207073|NCT00782340|100661320|FG000|Open Label Titration|Lost to Follow-up|5|||
33207074|NCT00782340|100661321|FG001|Open Label Titration|Lost to Follow-up|0|||
33338468|NCT02971670|101131966|FG003|Overall Study|Withdrawal by Subject|2|||
33338469|NCT02474082|101131967|FG000|Overall Study|Adverse Event|2|||
33338470|NCT02474082|101131968|FG001|Overall Study|Adverse Event|32|||
33338471|NCT02474082|101131967|FG000|Overall Study|Withdrawal of informed consent|1|||
33338472|NCT02474082|101131968|FG001|Overall Study|Withdrawal of informed consent|11|||
33338473|NCT02474082|101131967|FG000|Overall Study|Lost to Follow-up|2|||
33338474|NCT02474082|101131968|FG001|Overall Study|Lost to Follow-up|2|||
33338475|NCT02474082|101131967|FG000|Overall Study|Dose tapering not achieved|0|||
33534661|NCT02557399|101856522|FG001|Overall Study|Withdrawal by Subject|1|||
33534662|NCT01896193|101856523|FG000|Overall Study|Lack of Efficacy|20|||
33338476|NCT02474082|101131968|FG001|Overall Study|Dose tapering not achieved|4|||
33534663|NCT01896193|101856524|FG001|Overall Study|Lack of Efficacy|11|||
33207075|NCT00782340|100661322|FG002|Open Label Titration|Lost to Follow-up|0|||
33207076|NCT00782340|100661320|FG000|Open Label Titration|Randomized in error|6|||
33207077|NCT00782340|100661321|FG001|Open Label Titration|Randomized in error|0|||
33207078|NCT00782340|100661322|FG002|Open Label Titration|Randomized in error|0|||
33207079|NCT00321919|100661323|FG000|Overall Study|Adverse Event|17|||
33207080|NCT00321919|100661324|FG001|Overall Study|Adverse Event|10|||
33207081|NCT00321919|100661323|FG000|Overall Study|Death|21|||
33207082|NCT00321919|100661324|FG001|Overall Study|Death|17|||
33207083|NCT00321919|100661323|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33207084|NCT00321919|100661324|FG001|Overall Study|Insufficient Therapeutic Response|0|||
33207085|NCT00321919|100661323|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
33207086|NCT00321919|100661324|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
33207087|NCT00321919|100661323|FG000|Overall Study|Refused Treatment|23|||
33207088|NCT00321919|100661324|FG001|Overall Study|Refused Treatment|14|||
33207089|NCT00321919|100661323|FG000|Overall Study|Other Protocol Violation|2|||
33207090|NCT00321919|100661324|FG001|Overall Study|Other Protocol Violation|3|||
33207091|NCT00321919|100661323|FG000|Overall Study|Failure to Return|3|||
33207092|NCT00321919|100661324|FG001|Overall Study|Failure to Return|1|||
33207093|NCT00321919|100661323|FG000|Overall Study|Other withdrawal reason|7|||
33207094|NCT00321919|100661324|FG001|Overall Study|Other withdrawal reason|6|||
33207095|NCT01965834|100661327|FG000|Overall Study|Lack of Efficacy|4|||
33207096|NCT03034577|100661328|FG000|Overall Study|Withdrawal by Subject|6|||
33207097|NCT03034577|100661329|FG001|Overall Study|Withdrawal by Subject|9|||
33207098|NCT03034577|100661328|FG000|Overall Study|Lost to Follow-up|25|||
33207099|NCT03034577|100661329|FG001|Overall Study|Lost to Follow-up|26|||
33207100|NCT02365467|100661330|FG000|Overall Study|Death|3|||
33207101|NCT01659021|100661333|FG000|Main Study|Adverse Event|2|||
33207102|NCT01659021|100661334|FG001|Main Study|Adverse Event|3|||
33207103|NCT01659021|100661333|FG000|Main Study|Lost to Follow-up|1|||
33207104|NCT01659021|100661334|FG001|Main Study|Lost to Follow-up|0|||
33207105|NCT01659021|100661333|FG000|Main Study|Unknown Reasons|2|||
33207106|NCT01659021|100661334|FG001|Main Study|Unknown Reasons|1|||
33207107|NCT01659021|100661333|FG000|Main Study|Physician Decision|34|||
33338477|NCT02474082|101131967|FG000|Overall Study|Participant/guardian decision|1|||
33338478|NCT02474082|101131968|FG001|Overall Study|Participant/guardian decision|2|||
33338479|NCT02474082|101131967|FG000|Overall Study|Non-compliance with study treatment|0|||
33338480|NCT02474082|101131968|FG001|Overall Study|Non-compliance with study treatment|2|||
33338481|NCT02474082|101131967|FG000|Overall Study|Protocol deviation|0|||
33338482|NCT02474082|101131968|FG001|Overall Study|Protocol deviation|1|||
33338483|NCT01119248|101131969|FG000|Overall Study|Physician Decision|5|||
33338484|NCT02387580|101131970|FG000|Overall Study|Withdrawal by Subject|0|||
33338485|NCT02387580|101131971|FG001|Overall Study|Withdrawal by Subject|0|||
33338486|NCT02387580|101131972|FG002|Overall Study|Withdrawal by Subject|0|||
33534664|NCT01896193|101856523|FG000|Overall Study|Protocol Violation|0|||
33534665|NCT01896193|101856524|FG001|Overall Study|Protocol Violation|1|||
33534666|NCT01896193|101856523|FG000|Overall Study|Withdrew Consent|1|||
33534667|NCT01896193|101856524|FG001|Overall Study|Withdrew Consent|0|||
33534668|NCT02417753|101856525|FG000|Overall Study|Death|1|||
33534669|NCT03904420|101856526|FG000|Overall Study|Study terminated|2|||
33534670|NCT03904420|101856527|FG001|Overall Study|Study terminated|2|||
33534671|NCT02175225|101856532|FG000|Overall Study|Withdrawal by Subject|1|||
33534672|NCT02175225|101856533|FG001|Overall Study|Withdrawal by Subject|2|||
33534673|NCT02175225|101856532|FG000|Overall Study|Lost to Follow-up|6|||
33534674|NCT02175225|101856533|FG001|Overall Study|Lost to Follow-up|7|||
33534675|NCT02175225|101856532|FG000|Overall Study|Study drug not administered|1|||
33534676|NCT02175225|101856533|FG001|Overall Study|Study drug not administered|2|||
33534677|NCT02291029|101856534|FG000|Overall Study|Withdrawal by Subject|0|||
33534678|NCT02291029|101856535|FG001|Overall Study|Withdrawal by Subject|0|||
33534679|NCT02291029|101856536|FG002|Overall Study|Withdrawal by Subject|1|||
33534680|NCT02291029|101856537|FG003|Overall Study|Withdrawal by Subject|0|||
33613702|NCT03364309|102133907|FG008|Maintenance Period|Miscellaneous|1|||
33207108|NCT01659021|100661334|FG001|Main Study|Physician Decision|16|||
33338487|NCT02387580|101131973|FG003|Overall Study|Withdrawal by Subject|1|||
33534681|NCT02291029|101856538|FG004|Overall Study|Withdrawal by Subject|0|||
33207109|NCT01659021|100661333|FG000|Main Study|Withdrawal by Subject|19|||
33207110|NCT01659021|100661334|FG001|Main Study|Withdrawal by Subject|16|||
33207111|NCT01659021|100661333|FG000|Main Study|Study Terminated by Sponsor|16|||
33207112|NCT01659021|100661334|FG001|Main Study|Study Terminated by Sponsor|1|||
33207113|NCT01659021|100661333|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
33207114|NCT01659021|100661334|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
33534682|NCT02291029|101856539|FG005|Overall Study|Withdrawal by Subject|0|||
33534683|NCT02291029|101856534|FG000|Overall Study|Adverse Event|0|||
33534684|NCT02291029|101856535|FG001|Overall Study|Adverse Event|1|||
33534685|NCT02291029|101856536|FG002|Overall Study|Adverse Event|0|||
33534686|NCT02291029|101856537|FG003|Overall Study|Adverse Event|0|||
33534687|NCT02291029|101856538|FG004|Overall Study|Adverse Event|0|||
33534688|NCT02291029|101856539|FG005|Overall Study|Adverse Event|0|||
33534689|NCT02121795|101856540|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
33534690|NCT02121795|101856541|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
33534691|NCT02121795|101856540|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
33534692|NCT02121795|101856541|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
33534693|NCT02121795|101856540|FG000|Double-Blind Phase|Lost to Follow-up|7|||
33534694|NCT02121795|101856541|FG001|Double-Blind Phase|Lost to Follow-up|4|||
33613703|NCT03364309|102133908|FG009|Maintenance Period|Miscellaneous|0|||
33207115|NCT01659021|100661333|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
33207116|NCT01659021|100661334|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
33207117|NCT03667053|100661338|FG000|Overall Study|Withdrawal by Subject|1|||
33207118|NCT03667053|100661339|FG001|Overall Study|Withdrawal by Subject|0|||
33207119|NCT03667053|100661340|FG002|Overall Study|Withdrawal by Subject|0|||
33207120|NCT01910129|100661341|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
33207121|NCT01910129|100661342|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
33207122|NCT01910129|100661343|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
33207123|NCT01910129|100661341|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
33207124|NCT01910129|100661342|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
33207125|NCT01910129|100661343|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
33207126|NCT00655980|100661344|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
33207127|NCT00655980|100661345|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
33207128|NCT00655980|100661346|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
33207129|NCT00833989|100661347|FG000|Overall Study|Physician Decision|0|||
33207130|NCT00833989|100661348|FG001|Overall Study|Physician Decision|0|||
33207131|NCT00833989|100661349|FG002|Overall Study|Physician Decision|0|||
33207132|NCT00833989|100661350|FG003|Overall Study|Physician Decision|1|||
33207133|NCT00833989|100661347|FG000|Overall Study|Withdrawal by Subject|3|||
33207134|NCT00833989|100661348|FG001|Overall Study|Withdrawal by Subject|0|||
33207135|NCT00833989|100661349|FG002|Overall Study|Withdrawal by Subject|1|||
33207136|NCT00833989|100661350|FG003|Overall Study|Withdrawal by Subject|1|||
33207137|NCT00360529|100661356|FG000|Overall Study|Adverse Event|10|||
33207138|NCT00360529|100661357|FG001|Overall Study|Adverse Event|23|||
33207139|NCT00360529|100661358|FG002|Overall Study|Adverse Event|33|||
33207140|NCT00360529|100661356|FG000|Overall Study|Protocol Violation|3|||
33207141|NCT00360529|100661357|FG001|Overall Study|Protocol Violation|3|||
33207142|NCT00360529|100661358|FG002|Overall Study|Protocol Violation|11|||
33207143|NCT00360529|100661356|FG000|Overall Study|Lost to Follow-up|14|||
33207144|NCT00360529|100661357|FG001|Overall Study|Lost to Follow-up|10|||
33207145|NCT00360529|100661358|FG002|Overall Study|Lost to Follow-up|13|||
33207146|NCT00360529|100661356|FG000|Overall Study|Withdrawal by Subject|22|||
33207147|NCT00360529|100661357|FG001|Overall Study|Withdrawal by Subject|14|||
33207148|NCT00360529|100661358|FG002|Overall Study|Withdrawal by Subject|18|||
33338488|NCT02387580|101131974|FG004|Overall Study|Withdrawal by Subject|0|||
33534695|NCT02121795|101856540|FG000|Double-Blind Phase|Physician Decision|2|||
33534696|NCT02121795|101856541|FG001|Double-Blind Phase|Physician Decision|5|||
33207149|NCT00360529|100661356|FG000|Overall Study|Lack of Efficacy|8|||
33207150|NCT00360529|100661357|FG001|Overall Study|Lack of Efficacy|6|||
33207151|NCT00360529|100661358|FG002|Overall Study|Lack of Efficacy|5|||
33207152|NCT00360529|100661356|FG000|Overall Study|Reason discontinued not explained above|4|||
33207153|NCT00360529|100661357|FG001|Overall Study|Reason discontinued not explained above|9|||
33207154|NCT00360529|100661358|FG002|Overall Study|Reason discontinued not explained above|11|||
33207155|NCT03550313|100661363|FG000|Overall Study|Adverse Event|0|||
33207156|NCT03550313|100661364|FG001|Overall Study|Adverse Event|1|||
33207157|NCT03550313|100661365|FG002|Overall Study|Adverse Event|0|||
33207158|NCT03550313|100661363|FG000|Overall Study|Lost to Follow-up|5|||
33207159|NCT03550313|100661364|FG001|Overall Study|Lost to Follow-up|7|||
33207160|NCT03550313|100661365|FG002|Overall Study|Lost to Follow-up|12|||
33207161|NCT03550313|100661363|FG000|Overall Study|Study terminated by sponsor|44|||
33207162|NCT03550313|100661364|FG001|Overall Study|Study terminated by sponsor|37|||
33207163|NCT03550313|100661365|FG002|Overall Study|Study terminated by sponsor|48|||
33207164|NCT03550313|100661363|FG000|Overall Study|No longer met eligibility criteria|3|||
33207165|NCT03550313|100661364|FG001|Overall Study|No longer met eligibility criteria|5|||
33207166|NCT03550313|100661365|FG002|Overall Study|No longer met eligibility criteria|6|||
33207167|NCT03550313|100661363|FG000|Overall Study|Withdrawal by parent/guardian|20|||
33207168|NCT03550313|100661364|FG001|Overall Study|Withdrawal by parent/guardian|18|||
33207169|NCT03550313|100661365|FG002|Overall Study|Withdrawal by parent/guardian|26|||
33207170|NCT03550313|100661363|FG000|Overall Study|Other|4|||
33207171|NCT03550313|100661364|FG001|Overall Study|Other|2|||
33207172|NCT03550313|100661365|FG002|Overall Study|Other|2|||
33207173|NCT03550313|100661363|FG000|Overall Study|Randomized but not vaccinated|3|||
33207174|NCT03550313|100661364|FG001|Overall Study|Randomized but not vaccinated|23|||
33207175|NCT03550313|100661365|FG002|Overall Study|Randomized but not vaccinated|2|||
33207176|NCT03550313|100661363|FG000|Overall Study|Sites terminated due to quality issues|18|||
33207177|NCT03550313|100661364|FG001|Overall Study|Sites terminated due to quality issues|17|||
33207178|NCT03550313|100661365|FG002|Overall Study|Sites terminated due to quality issues|18|||
33338489|NCT02387580|101131975|FG005|Overall Study|Withdrawal by Subject|0|||
33338490|NCT01394939|101131976|FG000|Overall Study|Adverse Event|1|||
33338491|NCT01394939|101131977|FG001|Overall Study|Adverse Event|3|||
33338492|NCT01394939|101131978|FG002|Overall Study|Adverse Event|0|||
33338493|NCT01394939|101131979|FG003|Overall Study|Adverse Event|2|||
33338494|NCT01394939|101131976|FG000|Overall Study|Death|0|||
33338495|NCT01394939|101131977|FG001|Overall Study|Death|2|||
33338496|NCT01394939|101131978|FG002|Overall Study|Death|0|||
33338497|NCT01394939|101131979|FG003|Overall Study|Death|0|||
33338498|NCT01394939|101131976|FG000|Overall Study|Physician Decision|0|||
33338499|NCT01394939|101131977|FG001|Overall Study|Physician Decision|1|||
33338500|NCT01394939|101131978|FG002|Overall Study|Physician Decision|0|||
33338501|NCT01394939|101131979|FG003|Overall Study|Physician Decision|0|||
33338502|NCT01394939|101131976|FG000|Overall Study|Withdrawal by Subject|0|||
33338503|NCT01394939|101131977|FG001|Overall Study|Withdrawal by Subject|2|||
33338504|NCT01394939|101131978|FG002|Overall Study|Withdrawal by Subject|0|||
33338505|NCT01394939|101131979|FG003|Overall Study|Withdrawal by Subject|2|||
33338506|NCT01394939|101131976|FG000|Overall Study|Others|0|||
33338507|NCT01394939|101131977|FG001|Overall Study|Others|2|||
33338508|NCT01394939|101131978|FG002|Overall Study|Others|0|||
33338509|NCT01394939|101131979|FG003|Overall Study|Others|3|||
33338510|NCT01446419|101131980|FG000|Overall Study|Death|1|||
33338511|NCT01446419|101131981|FG001|Overall Study|Death|0|||
33405336|NCT02062385|101373300|FG000|Overall Study|Incomplete EPI by database lock|2|||
33405337|NCT02062385|101373301|FG001|Overall Study|Incomplete EPI by database lock|0|||
33613704|NCT03364309|102133909|FG010|Maintenance Period|Miscellaneous|0|||
33207179|NCT03230916|100661368|FG000|Overall Study|Withdrawal by Subject|0|||
33207180|NCT03230916|100661369|FG001|Overall Study|Withdrawal by Subject|0|||
33207181|NCT03230916|100661370|FG002|Overall Study|Withdrawal by Subject|0|||
33338512|NCT01446419|101131980|FG000|Overall Study|Withdrawal by Subject|1|||
33338513|NCT01446419|101131981|FG001|Overall Study|Withdrawal by Subject|1|||
33338514|NCT01446419|101131980|FG000|Overall Study|Terminated per protocol|3|||
33338515|NCT01446419|101131981|FG001|Overall Study|Terminated per protocol|0|||
33338516|NCT00511355|101131987|FG000|Overall Study|Adverse Event|4|||
33338517|NCT00511355|101131988|FG001|Overall Study|Adverse Event|4|||
33207182|NCT03230916|100661371|FG003|Overall Study|Withdrawal by Subject|0|||
33207183|NCT03230916|100661372|FG004|Overall Study|Withdrawal by Subject|0|||
33207184|NCT03230916|100661373|FG005|Overall Study|Withdrawal by Subject|1|||
33207185|NCT03230916|100661374|FG006|Overall Study|Withdrawal by Subject|0|||
33207186|NCT03230916|100661375|FG007|Overall Study|Withdrawal by Subject|0|||
33207187|NCT03230916|100661376|FG008|Overall Study|Withdrawal by Subject|0|||
33207188|NCT03230916|100661377|FG009|Overall Study|Withdrawal by Subject|0|||
33207189|NCT03230916|100661378|FG010|Overall Study|Withdrawal by Subject|0|||
33207190|NCT01781572|100661379|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
33207191|NCT01781572|100661380|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
33207192|NCT01781572|100661381|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
33207193|NCT01781572|100661379|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
33207194|NCT01781572|100661380|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
33207195|NCT01781572|100661381|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
33207196|NCT01781572|100661379|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
33207197|NCT01781572|100661380|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
33207198|NCT01781572|100661381|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
33207199|NCT01781572|100661379|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
33207200|NCT01781572|100661380|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
33338518|NCT00511355|101131987|FG000|Overall Study|Pregnancy Wish|1|||
33338519|NCT00511355|101131988|FG001|Overall Study|Pregnancy Wish|0|||
33338520|NCT00511355|101131987|FG000|Overall Study|Lost to Follow-up|2|||
33338521|NCT00511355|101131988|FG001|Overall Study|Lost to Follow-up|1|||
33338522|NCT00511355|101131987|FG000|Overall Study|Other Reason|0|||
33405338|NCT02062385|101373302|FG002|Overall Study|Incomplete EPI by database lock|0|||
33405339|NCT02062385|101373303|FG003|Overall Study|Incomplete EPI by database lock|0|||
33338523|NCT00511355|101131988|FG001|Overall Study|Other Reason|1|||
33338524|NCT00511355|101131987|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
33338525|NCT00511355|101131988|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
33338526|NCT00511355|101131987|FG000|Overall Study|Withdrawal of informed consent|0|||
33338527|NCT00511355|101131988|FG001|Overall Study|Withdrawal of informed consent|1|||
33338528|NCT00511355|101131987|FG000|Overall Study|Other reason pre-treatment|0|||
33338529|NCT00511355|101131988|FG001|Overall Study|Other reason pre-treatment|1|||
33338530|NCT01745146|101131989|FG000|Overall Study|Withdrawal by Subject|1|||
33338531|NCT01745146|101131990|FG001|Overall Study|Withdrawal by Subject|3|||
33338532|NCT01745146|101131989|FG000|Overall Study|Lost to Follow-up|2|||
33338533|NCT01745146|101131990|FG001|Overall Study|Lost to Follow-up|0|||
33338534|NCT00691483|101131993|FG000|Overall Study|Adverse Event|14|||
33338535|NCT00691483|101131994|FG001|Overall Study|Adverse Event|6|||
33338536|NCT00691483|101131993|FG000|Overall Study|Lost to Follow-up|17|||
33338537|NCT00691483|101131994|FG001|Overall Study|Lost to Follow-up|10|||
33338538|NCT00691483|101131993|FG000|Overall Study|Withdrawal by Subject|24|||
33338539|NCT00691483|101131994|FG001|Overall Study|Withdrawal by Subject|7|||
33338540|NCT00691483|101131993|FG000|Overall Study|Other known cause|6|||
33338541|NCT00691483|101131994|FG001|Overall Study|Other known cause|1|||
33338542|NCT00691483|101131993|FG000|Overall Study|Randomized by not treated|7|||
33338543|NCT00691483|101131994|FG001|Overall Study|Randomized by not treated|1|||
33338544|NCT00711100|101131998|FG000|Overall Study|Lack of Efficacy|5|||
33338545|NCT00711100|101131998|FG000|Overall Study|Withdrawal by Subject|8|||
33338546|NCT02447848|101131999|FG000|Overall Study|Patient discharged|3|||
33338547|NCT02447848|101131999|FG000|Overall Study|Lack of Efficacy|4|||
33338548|NCT02447848|101131999|FG000|Overall Study|Withdrawal by Subject|4|||
33338549|NCT01816243|101132004|FG000|Overall Study|Adverse Event|6|||
33338550|NCT01816243|101132004|FG000|Overall Study|Lost to Follow-up|1|||
33338551|NCT01816243|101132004|FG000|Overall Study|Lack of Efficacy|1|||
33338552|NCT01816243|101132004|FG000|Overall Study|Not eligible for the study|1|||
33405340|NCT02062385|101373300|FG000|Overall Study|Moved|10|||
33405341|NCT02062385|101373301|FG001|Overall Study|Moved|11|||
33207201|NCT01781572|100661381|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
33338553|NCT01816243|101132004|FG000|Overall Study|Amputation|3|||
33338554|NCT01097863|101132005|FG000|Overall Study|Discomfort|1|||
33338555|NCT01097863|101132006|FG001|Overall Study|Discomfort|0|||
33338556|NCT01097863|101132007|FG002|Overall Study|Discomfort|1|||
33338557|NCT01097863|101132005|FG000|Overall Study|Did not return for final visit|0|||
33338558|NCT01097863|101132006|FG001|Overall Study|Did not return for final visit|0|||
33338559|NCT01097863|101132007|FG002|Overall Study|Did not return for final visit|1|||
33405342|NCT02062385|101373302|FG002|Overall Study|Moved|1|||
33405343|NCT02062385|101373303|FG003|Overall Study|Moved|0|||
33338560|NCT00272038|101132009|FG000|Overall Study|withdrew before they received 2 cycles|7|||
33338561|NCT00848354|101132010|FG000|Phase 1|Adverse Event|5|||
33338562|NCT00848354|101132011|FG001|Phase 1|Adverse Event|4|||
33207202|NCT01781572|100661379|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
33207203|NCT01781572|100661380|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
33207204|NCT01781572|100661381|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
33338563|NCT00848354|101132010|FG000|Phase 1|Discontinuation of study by sponsor|2|||
33207205|NCT01781572|100661379|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
33207206|NCT01781572|100661380|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
33338564|NCT00848354|101132011|FG001|Phase 1|Discontinuation of study by sponsor|1|||
33338565|NCT00848354|101132010|FG000|Phase 1|Failed to return|0|||
33338566|NCT00848354|101132011|FG001|Phase 1|Failed to return|1|||
33338567|NCT00848354|101132010|FG000|Phase 1|Lost to Follow-up|1|||
33338568|NCT00848354|101132011|FG001|Phase 1|Lost to Follow-up|1|||
33338569|NCT00848354|101132010|FG000|Phase 1|Unspecified Reason|1|||
33338570|NCT00848354|101132011|FG001|Phase 1|Unspecified Reason|1|||
33338571|NCT00848354|101132010|FG000|Phase 1|Protocol Violation|1|||
33338572|NCT00848354|101132011|FG001|Phase 1|Protocol Violation|1|||
33338573|NCT00848354|101132010|FG000|Phase 1|Withdrawal by Subject|2|||
33338574|NCT00848354|101132011|FG001|Phase 1|Withdrawal by Subject|4|||
33613705|NCT03364309|102133910|FG011|Maintenance Period|Miscellaneous|0|||
33613706|NCT03364309|102133911|FG012|Maintenance Period|Miscellaneous|0|||
33613707|NCT03364309|102133912|FG013|Maintenance Period|Miscellaneous|0|||
33613708|NCT03364309|102133913|FG014|Maintenance Period|Miscellaneous|0|||
33613709|NCT03364309|102133914|FG015|Maintenance Period|Miscellaneous|0|||
33613710|NCT03364309|102133915|FG016|Maintenance Period|Miscellaneous|0|||
33613711|NCT03364309|102133916|FG017|Maintenance Period|Miscellaneous|0|||
33613712|NCT03364309|102133917|FG018|Maintenance Period|Miscellaneous|0|||
33613713|NCT03364309|102133899|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613714|NCT03364309|102133900|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613715|NCT03364309|102133901|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613716|NCT03364309|102133902|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613717|NCT03364309|102133903|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613718|NCT03364309|102133904|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613719|NCT03364309|102133905|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613720|NCT03364309|102133906|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613721|NCT03364309|102133907|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613722|NCT03364309|102133908|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613723|NCT03364309|102133909|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613724|NCT03364309|102133910|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613725|NCT03364309|102133911|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613726|NCT03364309|102133912|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
33613727|NCT03364309|102133913|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
33613728|NCT03364309|102133914|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
33613729|NCT03364309|102133915|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613730|NCT03364309|102133916|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613731|NCT03364309|102133917|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
33613732|NCT03364309|102133899|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613733|NCT03364309|102133900|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613734|NCT03364309|102133901|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613735|NCT03364309|102133902|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613736|NCT03364309|102133903|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613737|NCT03364309|102133904|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613738|NCT03364309|102133905|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613739|NCT03364309|102133906|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613740|NCT03364309|102133907|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613741|NCT03364309|102133908|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613742|NCT03364309|102133909|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613743|NCT03364309|102133910|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613744|NCT03364309|102133911|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613745|NCT03364309|102133912|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613746|NCT03364309|102133913|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
33613747|NCT03364309|102133914|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613748|NCT03364309|102133915|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
33207207|NCT01781572|100661381|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
33338575|NCT00848354|101132010|FG000|Phase 1|Lack of Efficacy|0|||
33338576|NCT00848354|101132011|FG001|Phase 1|Lack of Efficacy|1|||
33613749|NCT03364309|102133916|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
33338577|NCT00848354|101132010|FG000|Phase 2 Year 1|Adverse Event|7|||
33338578|NCT00848354|101132011|FG001|Phase 2 Year 1|Adverse Event|2|||
33338579|NCT00848354|101132010|FG000|Phase 2 Year 1|Death|1|||
33613750|NCT03364309|102133917|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
33613751|NCT03364309|102133899|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
33338580|NCT00848354|101132011|FG001|Phase 2 Year 1|Death|0|||
33534697|NCT02121795|101856540|FG000|Double-Blind Phase|Adverse Event|5|||
33534698|NCT02121795|101856541|FG001|Double-Blind Phase|Adverse Event|0|||
33534699|NCT02121795|101856540|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
33534700|NCT02121795|101856541|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
33534701|NCT02121795|101856540|FG000|Double-Blind Phase|Protocol Violation|0|||
33534702|NCT02121795|101856541|FG001|Double-Blind Phase|Protocol Violation|3|||
33534703|NCT02121795|101856540|FG000|Double-Blind Phase|Death|1|||
33534704|NCT02121795|101856541|FG001|Double-Blind Phase|Death|1|||
33534705|NCT02121795|101856540|FG000|Open-Label Phase|Physician Decision|8|||
33534706|NCT02121795|101856541|FG001|Open-Label Phase|Physician Decision|8|||
33534707|NCT02121795|101856540|FG000|Open-Label Phase|Withdrawal by Subject|3|||
33534708|NCT02121795|101856541|FG001|Open-Label Phase|Withdrawal by Subject|2|||
33534709|NCT02121795|101856540|FG000|Open-Label Phase|Lost to Follow-up|1|||
33534710|NCT02121795|101856541|FG001|Open-Label Phase|Lost to Follow-up|0|||
33534711|NCT00165503|101856542|FG000|Overall Study|Death|1|||
33534712|NCT00165503|101856542|FG000|Overall Study|Lost to Follow-up|12|||
33534713|NCT00165503|101856542|FG000|Overall Study|Unresectable|3|||
33534714|NCT00964028|101856546|FG000|Overall Study|Withdrawal by Subject|0|||
33534715|NCT00964028|101856547|FG001|Overall Study|Withdrawal by Subject|1|||
33534716|NCT03139552|101856551|FG000|Overall Study|unable to attend tasting due to schedule|3|||
33534717|NCT01149655|101856556|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
33534718|NCT01149655|101856557|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
33534719|NCT01149655|101856558|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
33534720|NCT01149655|101856559|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
33534721|NCT01149655|101856556|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
33534722|NCT01149655|101856557|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
33534723|NCT01149655|101856558|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
33534724|NCT01149655|101856559|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
33534725|NCT01149655|101856556|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
33534726|NCT01149655|101856557|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
33534727|NCT01149655|101856558|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
33534728|NCT01149655|101856559|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
33534729|NCT01149655|101856556|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
33534730|NCT01149655|101856557|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
33534731|NCT01149655|101856558|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
33534732|NCT01149655|101856559|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
33534733|NCT01149655|101856556|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
33534734|NCT01149655|101856557|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
33534735|NCT01149655|101856558|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
33534736|NCT01149655|101856559|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
33534737|NCT01149655|101856556|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
33534738|NCT01149655|101856557|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
33534739|NCT01149655|101856558|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
33534740|NCT01149655|101856559|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
33534741|NCT01149655|101856556|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
33534742|NCT01149655|101856557|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
33534743|NCT01149655|101856558|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
33534744|NCT01149655|101856559|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
33534745|NCT01149655|101856556|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
33534746|NCT01149655|101856557|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
33534747|NCT01149655|101856558|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
33534748|NCT01149655|101856559|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
33534749|NCT01149655|101856556|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
33534750|NCT01149655|101856557|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
33534751|NCT01149655|101856558|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
33534752|NCT01149655|101856559|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
33338581|NCT00848354|101132010|FG000|Phase 2 Year 1|Failed to Return|1|||
33338582|NCT00848354|101132011|FG001|Phase 2 Year 1|Failed to Return|1|||
33405344|NCT02062385|101373300|FG000|Overall Study|Withdrawn by parent/guardian|46|||
33405345|NCT02062385|101373301|FG001|Overall Study|Withdrawn by parent/guardian|41|||
33405346|NCT02062385|101373302|FG002|Overall Study|Withdrawn by parent/guardian|9|||
33405347|NCT02062385|101373303|FG003|Overall Study|Withdrawn by parent/guardian|8|||
33405348|NCT02062385|101373300|FG000|Overall Study|Death|0|||
33405349|NCT02062385|101373301|FG001|Overall Study|Death|0|||
33405350|NCT02062385|101373302|FG002|Overall Study|Death|0|||
33405351|NCT02062385|101373303|FG003|Overall Study|Death|1|||
33405352|NCT02062385|101373300|FG000|Overall Study|Lost to Follow-up|0|||
33405353|NCT02062385|101373301|FG001|Overall Study|Lost to Follow-up|0|||
33338583|NCT00848354|101132010|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
33338584|NCT00848354|101132011|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
33338585|NCT00848354|101132010|FG000|Phase 2 Year 1|Unspecified Reason|3|||
33338586|NCT00848354|101132011|FG001|Phase 2 Year 1|Unspecified Reason|0|||
33338587|NCT00848354|101132010|FG000|Phase 2 Year 1|Protocol Violation|4|||
33338588|NCT00848354|101132011|FG001|Phase 2 Year 1|Protocol Violation|1|||
33338589|NCT00848354|101132010|FG000|Phase 2 Year 1|Subject Request|1|||
33338590|NCT00848354|101132011|FG001|Phase 2 Year 1|Subject Request|2|||
33338591|NCT00848354|101132010|FG000|Phase 2 Year 2|Adverse Event|12|||
33338592|NCT00848354|101132011|FG001|Phase 2 Year 2|Adverse Event|2|||
33338593|NCT00848354|101132010|FG000|Phase 2 Year 2|Death|2|||
33338594|NCT00848354|101132011|FG001|Phase 2 Year 2|Death|0|||
33534753|NCT01149655|101856556|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
33338595|NCT00848354|101132010|FG000|Phase 2 Year 2|Failed to return|3|||
33338596|NCT00848354|101132011|FG001|Phase 2 Year 2|Failed to return|0|||
33338597|NCT00848354|101132010|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
33338598|NCT00848354|101132011|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
33338599|NCT00848354|101132010|FG000|Phase 2 Year 2|Unspecified Reason|1|||
33338600|NCT00848354|101132011|FG001|Phase 2 Year 2|Unspecified Reason|0|||
33338601|NCT00848354|101132010|FG000|Phase 2 Year 2|Protocol Violation|1|||
33338602|NCT00848354|101132011|FG001|Phase 2 Year 2|Protocol Violation|1|||
33338603|NCT00848354|101132010|FG000|Phase 2 Year 2|Subject Request|1|||
33338604|NCT00848354|101132011|FG001|Phase 2 Year 2|Subject Request|1|||
33338605|NCT00848354|101132010|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
33338606|NCT00848354|101132011|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
33338607|NCT00781456|101132012|FG000|Overall Study|Adverse Event|3|||
33338608|NCT00781456|101132013|FG001|Overall Study|Adverse Event|3|||
33534754|NCT01149655|101856557|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
33534755|NCT01149655|101856558|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
33534756|NCT01149655|101856559|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
33534757|NCT01149655|101856556|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
33534758|NCT01149655|101856557|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
33534759|NCT01149655|101856558|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
33534760|NCT01149655|101856559|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
33534761|NCT01149655|101856556|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
33534762|NCT01149655|101856557|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
33534763|NCT01149655|101856558|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
33534764|NCT01149655|101856559|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
33534765|NCT01149655|101856556|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
33534766|NCT01149655|101856557|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
33534767|NCT01149655|101856558|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
33534768|NCT01149655|101856559|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
33534769|NCT01149655|101856556|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
33534770|NCT01149655|101856557|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
33534771|NCT01149655|101856558|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
33534772|NCT01149655|101856559|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
33534773|NCT01149655|101856556|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
33534774|NCT01149655|101856557|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
33534775|NCT01149655|101856558|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
33338609|NCT00781456|101132012|FG000|Overall Study|Withdrawal by Subject|3|||
33338610|NCT00781456|101132013|FG001|Overall Study|Withdrawal by Subject|5|||
33338611|NCT00781456|101132012|FG000|Overall Study|Protocol Violation|4|||
33338612|NCT00781456|101132013|FG001|Overall Study|Protocol Violation|1|||
33338613|NCT00781456|101132012|FG000|Overall Study|Noncompliance With Protocol|1|||
33338614|NCT00781456|101132013|FG001|Overall Study|Noncompliance With Protocol|1|||
33405354|NCT02062385|101373302|FG002|Overall Study|Lost to Follow-up|1|||
33405355|NCT02062385|101373303|FG003|Overall Study|Lost to Follow-up|0|||
33405356|NCT00310440|101373304|FG000|Overall Study|Lost to Follow-up|17|||
33338615|NCT00781456|101132012|FG000|Overall Study|Lost to Follow-up|10|||
33338616|NCT00781456|101132013|FG001|Overall Study|Lost to Follow-up|5|||
33338617|NCT00781456|101132012|FG000|Overall Study|Other Reason, Unknown|0|||
33405357|NCT00310440|101373305|FG001|Overall Study|Lost to Follow-up|8|||
33405358|NCT00310440|101373304|FG000|Overall Study|Withdrawal by Subject|2|||
33338618|NCT00781456|101132013|FG001|Overall Study|Other Reason, Unknown|1|||
33207208|NCT01781572|100661379|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
33207209|NCT01781572|100661380|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
33338619|NCT02682901|101132017|FG000|Overall Study|Adverse Event|10|||
33338620|NCT02682901|101132018|FG001|Overall Study|Adverse Event|3|||
33338621|NCT02682901|101132017|FG000|Overall Study|Lack of Efficacy|0|||
33338622|NCT02682901|101132018|FG001|Overall Study|Lack of Efficacy|1|||
33338623|NCT01098071|101132021|FG000|Overall Study|Surgery (adenoidectomy)|2|||
33338624|NCT01098071|101132021|FG000|Overall Study|Lost to Follow-up|13|||
33338625|NCT01227902|101132024|FG000|Overall Study|Adverse Event|12|||
33338626|NCT01227902|101132025|FG001|Overall Study|Adverse Event|8|||
33338627|NCT01227902|101132026|FG002|Overall Study|Adverse Event|11|||
33338628|NCT01227902|101132027|FG003|Overall Study|Adverse Event|4|||
33338629|NCT01227902|101132024|FG000|Overall Study|Lack of Efficacy|1|||
33338630|NCT01227902|101132025|FG001|Overall Study|Lack of Efficacy|2|||
33338631|NCT01227902|101132026|FG002|Overall Study|Lack of Efficacy|2|||
33338632|NCT01227902|101132027|FG003|Overall Study|Lack of Efficacy|1|||
33338633|NCT01227902|101132024|FG000|Overall Study|Protocol Violation|1|||
33338634|NCT01227902|101132025|FG001|Overall Study|Protocol Violation|0|||
33338635|NCT01227902|101132026|FG002|Overall Study|Protocol Violation|0|||
33338636|NCT01227902|101132027|FG003|Overall Study|Protocol Violation|0|||
33338637|NCT01227902|101132024|FG000|Overall Study|Lost to Follow-up|0|||
33338638|NCT01227902|101132025|FG001|Overall Study|Lost to Follow-up|0|||
33338639|NCT01227902|101132026|FG002|Overall Study|Lost to Follow-up|1|||
33338640|NCT01227902|101132027|FG003|Overall Study|Lost to Follow-up|2|||
33338641|NCT01227902|101132024|FG000|Overall Study|Physician Decision|0|||
33338642|NCT01227902|101132025|FG001|Overall Study|Physician Decision|1|||
33338643|NCT01227902|101132026|FG002|Overall Study|Physician Decision|1|||
33338644|NCT01227902|101132027|FG003|Overall Study|Physician Decision|0|||
33338645|NCT01227902|101132024|FG000|Overall Study|Withdrawal by Subject|4|||
33338646|NCT01227902|101132025|FG001|Overall Study|Withdrawal by Subject|2|||
33534776|NCT01149655|101856559|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
33534777|NCT01149655|101856556|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
33534778|NCT01149655|101856557|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
33534779|NCT01149655|101856558|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
33534780|NCT01149655|101856559|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
33534781|NCT01610037|101856560|FG000|All Patients|Adverse Event|27|||
33534782|NCT01610037|101856561|FG001|All Patients|Adverse Event|22|||
33534783|NCT01610037|101856562|FG002|All Patients|Adverse Event|26|||
33534784|NCT01610037|101856560|FG000|All Patients|Withdrawal by Subject|12|||
33534785|NCT01610037|101856561|FG001|All Patients|Withdrawal by Subject|10|||
33534786|NCT01610037|101856562|FG002|All Patients|Withdrawal by Subject|20|||
33534787|NCT01610037|101856560|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
33534788|NCT01610037|101856561|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
33534789|NCT01610037|101856562|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
33534790|NCT01610037|101856560|FG000|All Patients|Death|4|||
33534791|NCT01610037|101856561|FG001|All Patients|Death|2|||
33534792|NCT01610037|101856562|FG002|All Patients|Death|1|||
33534793|NCT01610037|101856560|FG000|All Patients|Protocol deviation|4|||
33534794|NCT01610037|101856561|FG001|All Patients|Protocol deviation|3|||
33534795|NCT01610037|101856562|FG002|All Patients|Protocol deviation|3|||
33534796|NCT01610037|101856560|FG000|All Patients|Abnormal laboratory value|1|||
33534797|NCT01610037|101856561|FG001|All Patients|Abnormal laboratory value|1|||
33534798|NCT01610037|101856562|FG002|All Patients|Abnormal laboratory value|0|||
33534799|NCT01610037|101856560|FG000|All Patients|Administrative problems|1|||
33534800|NCT01610037|101856561|FG001|All Patients|Administrative problems|4|||
33534801|NCT01610037|101856562|FG002|All Patients|Administrative problems|4|||
33534802|NCT01610037|101856560|FG000|All Patients|Lost to Follow-up|1|||
33534803|NCT01610037|101856561|FG001|All Patients|Lost to Follow-up|0|||
33534804|NCT01610037|101856562|FG002|All Patients|Lost to Follow-up|0|||
33338647|NCT01227902|101132026|FG002|Overall Study|Withdrawal by Subject|4|||
33534805|NCT01610037|101856560|FG000|All Patients|Abnormal test procedure result(s)|0|||
33534806|NCT01610037|101856561|FG001|All Patients|Abnormal test procedure result(s)|1|||
33534807|NCT01610037|101856562|FG002|All Patients|Abnormal test procedure result(s)|3|||
33534808|NCT01610037|101856560|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
33338648|NCT01227902|101132027|FG003|Overall Study|Withdrawal by Subject|3|||
33338649|NCT01031446|101132035|FG000|Overall Study|Disease Progression|38|||
33338650|NCT01031446|101132035|FG000|Overall Study|Adverse Event|9|||
33338651|NCT01031446|101132035|FG000|Overall Study|Physician Decision|4|||
33338652|NCT01031446|101132035|FG000|Overall Study|Withdrawal by Subject|3|||
33338653|NCT01031446|101132035|FG000|Overall Study|Still on treatment|1|||
33338654|NCT03548051|101132036|FG000|Overall Study|Death|1|||
33534809|NCT01610037|101856561|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
33534810|NCT01610037|101856562|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
33534811|NCT01610037|101856560|FG000|Treatment and Follow up Period|Death|10|||
33534812|NCT01610037|101856561|FG001|Treatment and Follow up Period|Death|5|||
33405359|NCT00310440|101373305|FG001|Overall Study|Withdrawal by Subject|1|||
33207210|NCT01781572|100661381|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
33207211|NCT01781572|100661379|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
33338655|NCT03548051|101132037|FG001|Overall Study|Death|1|||
33338656|NCT03548051|101132036|FG000|Overall Study|Withdrawal by Subject|1|||
33338657|NCT03548051|101132037|FG001|Overall Study|Withdrawal by Subject|0|||
33338658|NCT03175549|101132042|FG000|Overall Study|Lost to Follow-up|2|||
33338659|NCT03175549|101132043|FG001|Overall Study|Lost to Follow-up|2|||
33338660|NCT03175549|101132042|FG000|Overall Study|Medication non-compliance|2|||
33338661|NCT03175549|101132043|FG001|Overall Study|Medication non-compliance|2|||
33338662|NCT02307370|101132044|FG000|Overall Study|Death|5|||
33338663|NCT02307370|101132044|FG000|Overall Study|Lost to Follow-up|1|||
33338664|NCT02307370|101132044|FG000|Overall Study|Withdrawal by Subject|1|||
33338665|NCT02307370|101132044|FG000|Overall Study|Declined Addendum ICF|6|||
33405360|NCT00310440|101373304|FG000|Overall Study|Missed 12 Month Visit|7|||
33405361|NCT00310440|101373305|FG001|Overall Study|Missed 12 Month Visit|4|||
33207212|NCT01781572|100661380|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
33338666|NCT02307370|101132044|FG000|Overall Study|No response during telephone contact|5|||
33338667|NCT02307370|101132044|FG000|Overall Study|Protocol Violation|1|||
33405362|NCT00489216|101373306|FG000|Overall Study|Adverse Event|1|||
33405363|NCT01874288|101373309|FG000|Overall Study|Withdrawal by Subject|1|||
33338668|NCT04093531|101132047|FG000|Overall Study|failed screening|4|||
33338669|NCT00584194|101132048|FG000|Overall Study|Other|135|||
33338670|NCT00640328|101132049|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
33534813|NCT01610037|101856562|FG002|Treatment and Follow up Period|Death|4|||
33534814|NCT01610037|101856560|FG000|Treatment and Follow up Period|Administrative problems|1|||
33207213|NCT01781572|100661381|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
33207214|NCT01781572|100661379|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
33207215|NCT01781572|100661380|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
33207216|NCT01781572|100661381|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
33534815|NCT01610037|101856561|FG001|Treatment and Follow up Period|Administrative problems|3|||
33534816|NCT01610037|101856562|FG002|Treatment and Follow up Period|Administrative problems|2|||
33534817|NCT01610037|101856560|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
33534818|NCT01610037|101856561|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
33534819|NCT01610037|101856562|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
33534820|NCT00737100|101856563|FG000|Overall Study|Adverse Event|6|||
33534821|NCT00737100|101856564|FG001|Overall Study|Adverse Event|5|||
33534822|NCT00737100|101856565|FG002|Overall Study|Adverse Event|3|||
33534823|NCT00737100|101856563|FG000|Overall Study|Lost to Follow-up|0|||
33613752|NCT03364309|102133900|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
33534824|NCT00737100|101856564|FG001|Overall Study|Lost to Follow-up|1|||
33534825|NCT00737100|101856565|FG002|Overall Study|Lost to Follow-up|0|||
33338671|NCT00640328|101132050|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
33338672|NCT00640328|101132051|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
33338673|NCT00640328|101132052|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
33534826|NCT00737100|101856563|FG000|Overall Study|Withdrawal by Subject|0|||
33534827|NCT00737100|101856564|FG001|Overall Study|Withdrawal by Subject|0|||
33338674|NCT00640328|101132053|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
33338675|NCT00640328|101132054|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
33338676|NCT00640328|101132049|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
33338677|NCT00640328|101132050|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
33338678|NCT00640328|101132051|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
33338679|NCT00640328|101132052|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
33338680|NCT00640328|101132053|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
33338681|NCT00640328|101132054|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
33338682|NCT00640328|101132049|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
33338683|NCT00640328|101132050|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
33338684|NCT00640328|101132051|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
33338685|NCT00640328|101132052|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
33338686|NCT00640328|101132053|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
33338687|NCT00640328|101132054|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
33338688|NCT00640328|101132049|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
33338689|NCT00640328|101132050|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
33338690|NCT00640328|101132051|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
33338691|NCT00640328|101132052|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
33338692|NCT00640328|101132053|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
33338693|NCT00640328|101132054|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
33338694|NCT04161131|101132055|FG000|Overall Study|Ineligible|2|||
33338695|NCT04161131|101132055|FG000|Overall Study|Lost to Follow-up|4|||
33534828|NCT00737100|101856565|FG002|Overall Study|Withdrawal by Subject|3|||
33534829|NCT00737100|101856563|FG000|Overall Study|Reason discontinued not explained above|1|||
33534830|NCT00737100|101856564|FG001|Overall Study|Reason discontinued not explained above|1|||
33534831|NCT00737100|101856565|FG002|Overall Study|Reason discontinued not explained above|1|||
33534832|NCT04980014|101856568|FG000|Overall Study|Participants who are Duplicated|1|||
33534833|NCT04980014|101856568|FG000|Overall Study|Follow-up Failure|13|||
33534834|NCT04980014|101856568|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
33534835|NCT04980014|101856568|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
33534836|NCT04980014|101856568|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
33534837|NCT02498678|101859659|FG000|Overall Study|interference from the surgical team|0|||
33534838|NCT02498678|101859660|FG001|Overall Study|interference from the surgical team|2|||
33534839|NCT03804268|101859661|FG000|Overall Study|Adverse Event|2|||
33534840|NCT03804268|101859662|FG001|Overall Study|Adverse Event|2|||
33534841|NCT03804268|101859661|FG000|Overall Study|Withdrawal by Subject|2|||
33534842|NCT03804268|101859662|FG001|Overall Study|Withdrawal by Subject|0|||
33534843|NCT03804268|101859661|FG000|Overall Study|Lost to Follow-up|1|||
33534844|NCT03804268|101859662|FG001|Overall Study|Lost to Follow-up|0|||
33534845|NCT03804268|101859661|FG000|Overall Study|Physician Decision|2|||
33534846|NCT03804268|101859662|FG001|Overall Study|Physician Decision|0|||
33534847|NCT02532374|101859665|FG000|Overall Study|Withdrawal by Subject|1|||
33534848|NCT02532374|101859665|FG000|Overall Study|Physician Decision|1|||
33613753|NCT03364309|102133901|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
33613754|NCT03364309|102133902|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
33613755|NCT03364309|102133903|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
33613756|NCT03364309|102133904|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
33613757|NCT03364309|102133905|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
33613758|NCT03364309|102133906|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
33613759|NCT03364309|102133907|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
33613760|NCT03364309|102133908|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
33613761|NCT03364309|102133909|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
33613762|NCT03364309|102133910|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
33613763|NCT03364309|102133911|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
33338696|NCT02799069|101132056|FG000|Overall Study|Adverse Event|0|||
33338697|NCT02799069|101132057|FG001|Overall Study|Adverse Event|2|||
33338698|NCT02799069|101132058|FG002|Overall Study|Adverse Event|2|||
33338699|NCT02799069|101132056|FG000|Overall Study|Lack of Efficacy|2|||
33534849|NCT02982863|101859666|FG000|Overall Study|Not eligible patients|809|||
33534850|NCT02982863|101859667|FG001|Overall Study|Not eligible patients|4261|||
33534851|NCT02982863|101859668|FG002|Overall Study|Not eligible patients|1852|||
33613764|NCT03364309|102133912|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
33613765|NCT03364309|102133913|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
33613766|NCT03364309|102133914|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
33613767|NCT03364309|102133915|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
33338700|NCT02799069|101132057|FG001|Overall Study|Lack of Efficacy|0|||
33338701|NCT02799069|101132058|FG002|Overall Study|Lack of Efficacy|0|||
33338702|NCT02799069|101132056|FG000|Overall Study|Lost to Follow-up|1|||
33338703|NCT02799069|101132057|FG001|Overall Study|Lost to Follow-up|1|||
33338704|NCT02799069|101132058|FG002|Overall Study|Lost to Follow-up|0|||
33338705|NCT02799069|101132056|FG000|Overall Study|Withdrawal by Subject|4|||
33338706|NCT02799069|101132057|FG001|Overall Study|Withdrawal by Subject|4|||
33338707|NCT02799069|101132058|FG002|Overall Study|Withdrawal by Subject|3|||
33338708|NCT02799069|101132056|FG000|Overall Study|Protocol Violation|1|||
33338709|NCT02799069|101132057|FG001|Overall Study|Protocol Violation|0|||
33338710|NCT02799069|101132058|FG002|Overall Study|Protocol Violation|2|||
33338711|NCT03686397|101132059|FG000|Overall Study|Lack of Efficacy|3|||
33338712|NCT03686397|101132060|FG001|Overall Study|Lack of Efficacy|5|||
33338713|NCT03686397|101132059|FG000|Overall Study|Adverse Event|0|||
33338714|NCT03686397|101132060|FG001|Overall Study|Adverse Event|1|||
33338715|NCT03686397|101132059|FG000|Overall Study|Protocol Violation|0|||
33338716|NCT03686397|101132060|FG001|Overall Study|Protocol Violation|1|||
33338717|NCT03686397|101132059|FG000|Overall Study|Withdrawal by Subject|0|||
33338718|NCT03686397|101132060|FG001|Overall Study|Withdrawal by Subject|1|||
33338719|NCT03686397|101132059|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
33338720|NCT03686397|101132060|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
33338721|NCT01929408|101132061|FG000|Overall Study|received HCT as initial treatment|8|||
33338722|NCT01212185|101132062|FG000|Overall Study|Protocol Violation|2|||
33338723|NCT01212185|101132063|FG001|Overall Study|Protocol Violation|1|||
33338724|NCT03047980|101132076|FG000|Overall Study|Adverse Event|1|||
33338725|NCT03605680|101132078|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
33338726|NCT03605680|101132079|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
33534852|NCT02982863|101859669|FG003|Overall Study|Not eligible patients|1400|||
33534853|NCT02982863|101859670|FG004|Overall Study|Not eligible patients|492|||
33534854|NCT00791999|101859672|FG000|Overall Study|Protocol planed withdrawal|14|||
33534855|NCT00791999|101859673|FG001|Overall Study|Protocol planed withdrawal|11|||
33534856|NCT00791999|101859674|FG002|Overall Study|Protocol planed withdrawal|11|||
33534857|NCT00791999|101859675|FG003|Overall Study|Protocol planed withdrawal|45|||
33534858|NCT00791999|101859672|FG000|Overall Study|Withdrawal by Subject|0|||
33534859|NCT00791999|101859673|FG001|Overall Study|Withdrawal by Subject|1|||
33534860|NCT00791999|101859674|FG002|Overall Study|Withdrawal by Subject|0|||
33534861|NCT00791999|101859675|FG003|Overall Study|Withdrawal by Subject|2|||
33534862|NCT00791999|101859672|FG000|Overall Study|Protocol Violation|3|||
33534863|NCT00791999|101859673|FG001|Overall Study|Protocol Violation|0|||
33534864|NCT00791999|101859674|FG002|Overall Study|Protocol Violation|1|||
33534865|NCT00791999|101859675|FG003|Overall Study|Protocol Violation|0|||
33534866|NCT00791999|101859672|FG000|Overall Study|Adverse Event|3|||
33534867|NCT00791999|101859673|FG001|Overall Study|Adverse Event|3|||
33534868|NCT00791999|101859674|FG002|Overall Study|Adverse Event|7|||
33534869|NCT00791999|101859675|FG003|Overall Study|Adverse Event|3|||
33534870|NCT00791999|101859672|FG000|Overall Study|Lack of Efficacy|0|||
33534871|NCT00791999|101859673|FG001|Overall Study|Lack of Efficacy|1|||
33534872|NCT00791999|101859674|FG002|Overall Study|Lack of Efficacy|0|||
33534873|NCT00791999|101859675|FG003|Overall Study|Lack of Efficacy|2|||
33534874|NCT00791999|101859672|FG000|Overall Study|Reason other than those above|1|||
33534875|NCT00791999|101859673|FG001|Overall Study|Reason other than those above|0|||
33534876|NCT00791999|101859674|FG002|Overall Study|Reason other than those above|1|||
33534877|NCT00791999|101859675|FG003|Overall Study|Reason other than those above|0|||
33534878|NCT01587885|101859676|FG000|Treatment Period 1|Failure to Return|0|||
33534879|NCT01587885|101859677|FG001|Treatment Period 1|Failure to Return|1|||
33534880|NCT01587885|101859676|FG000|Treatment Period 1|Protocol Violation|0|||
33534881|NCT01587885|101859677|FG001|Treatment Period 1|Protocol Violation|2|||
33534882|NCT00715403|101859681|FG000|Overall Study|Progressive disease|0|||
33534883|NCT00715403|101859682|FG001|Overall Study|Progressive disease|1|||
33534884|NCT00715403|101859683|FG002|Overall Study|Progressive disease|3|||
33534885|NCT00715403|101859684|FG003|Overall Study|Progressive disease|9|||
33534886|NCT00715403|101859685|FG004|Overall Study|Progressive disease|5|||
33338727|NCT03605680|101132080|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
33534887|NCT00715403|101859686|FG005|Overall Study|Progressive disease|14|||
33534888|NCT00715403|101859687|FG006|Overall Study|Progressive disease|1|||
33534889|NCT00715403|101859681|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
33613768|NCT03364309|102133916|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
33338728|NCT03605680|101132081|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
33338729|NCT03605680|101132078|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
33338730|NCT03605680|101132079|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
33338731|NCT03605680|101132080|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
33338732|NCT03605680|101132081|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
33405364|NCT01874288|101373310|FG001|Overall Study|Withdrawal by Subject|0|||
33534890|NCT00715403|101859682|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
33534891|NCT00715403|101859683|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
33534892|NCT00715403|101859684|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
33207217|NCT01781572|100661379|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
33613769|NCT03364309|102133917|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
33613770|NCT03364309|102133899|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33613771|NCT03364309|102133900|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33613772|NCT03364309|102133901|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33207218|NCT01781572|100661380|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
33338733|NCT03605680|101132078|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
33338734|NCT03605680|101132079|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
33338735|NCT03605680|101132080|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
33338736|NCT03605680|101132081|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
33338737|NCT03605680|101132078|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
33338738|NCT03605680|101132079|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
33338739|NCT03605680|101132080|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
33534893|NCT00715403|101859685|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
33534894|NCT00715403|101859686|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
33534895|NCT00715403|101859687|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
33534896|NCT00715403|101859681|FG000|Overall Study|Other Adverse Event than DLT|1|||
33338740|NCT03605680|101132081|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
33338741|NCT03605680|101132078|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
33338742|NCT03605680|101132079|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
33338743|NCT03605680|101132080|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
33338744|NCT03605680|101132081|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
33338745|NCT03605680|101132078|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
33338746|NCT03605680|101132079|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
33338747|NCT03605680|101132080|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
33338748|NCT03605680|101132081|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
33338749|NCT03605680|101132078|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
33338750|NCT03605680|101132079|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
33338751|NCT03605680|101132080|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
33338752|NCT03605680|101132081|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
33338753|NCT03605680|101132078|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
33338754|NCT03605680|101132079|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
33405365|NCT01874288|101373311|FG002|Overall Study|Withdrawal by Subject|2|||
33405366|NCT01874288|101373312|FG003|Overall Study|Withdrawal by Subject|1|||
33534897|NCT00715403|101859682|FG001|Overall Study|Other Adverse Event than DLT|0|||
33534898|NCT00715403|101859683|FG002|Overall Study|Other Adverse Event than DLT|0|||
33534899|NCT00715403|101859684|FG003|Overall Study|Other Adverse Event than DLT|0|||
33534900|NCT00715403|101859685|FG004|Overall Study|Other Adverse Event than DLT|0|||
33534901|NCT00715403|101859686|FG005|Overall Study|Other Adverse Event than DLT|2|||
33534902|NCT00715403|101859687|FG006|Overall Study|Other Adverse Event than DLT|0|||
33534903|NCT00715403|101859681|FG000|Overall Study|Protocol Violation|0|||
33534904|NCT00715403|101859682|FG001|Overall Study|Protocol Violation|0|||
33534905|NCT00715403|101859683|FG002|Overall Study|Protocol Violation|0|||
33534906|NCT00715403|101859684|FG003|Overall Study|Protocol Violation|0|||
33534907|NCT00715403|101859685|FG004|Overall Study|Protocol Violation|0|||
33534908|NCT00715403|101859686|FG005|Overall Study|Protocol Violation|1|||
33613773|NCT03364309|102133902|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33405367|NCT01874288|101373313|FG004|Overall Study|Withdrawal by Subject|1|||
33534909|NCT00715403|101859687|FG006|Overall Study|Protocol Violation|0|||
33613774|NCT03364309|102133903|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33613775|NCT03364309|102133904|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33338755|NCT03605680|101132080|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
33534910|NCT00715403|101859681|FG000|Overall Study|Other reason not defined above|0|||
33534911|NCT00715403|101859682|FG001|Overall Study|Other reason not defined above|0|||
33534912|NCT00715403|101859683|FG002|Overall Study|Other reason not defined above|1|||
33534913|NCT00715403|101859684|FG003|Overall Study|Other reason not defined above|0|||
33534914|NCT00715403|101859685|FG004|Overall Study|Other reason not defined above|1|||
33534915|NCT00715403|101859686|FG005|Overall Study|Other reason not defined above|1|||
33534916|NCT00715403|101859687|FG006|Overall Study|Other reason not defined above|0|||
33534917|NCT00327340|101859691|FG000|Overall Study|Withdrawal by Subject|1|||
33534918|NCT00327340|101859692|FG001|Overall Study|Withdrawal by Subject|5|||
33534919|NCT00327340|101859691|FG000|Overall Study|Physician Decision|1|||
33534920|NCT00327340|101859692|FG001|Overall Study|Physician Decision|1|||
33534921|NCT00327340|101859691|FG000|Overall Study|Disease Progression|10|||
33534922|NCT00327340|101859692|FG001|Overall Study|Disease Progression|19|||
33534923|NCT00327340|101859691|FG000|Overall Study|Symptomatic Disease|0|||
33534924|NCT00327340|101859692|FG001|Overall Study|Symptomatic Disease|2|||
33534925|NCT00327340|101859691|FG000|Overall Study|Adverse Event|3|||
33534926|NCT00327340|101859692|FG001|Overall Study|Adverse Event|3|||
33534927|NCT01089127|101859693|FG000|Overall Study|Adverse Event|5|||
33534928|NCT01089127|101859694|FG001|Overall Study|Adverse Event|1|||
33534929|NCT01089127|101859695|FG002|Overall Study|Adverse Event|1|||
33534930|NCT01089127|101859696|FG003|Overall Study|Adverse Event|0|||
33534931|NCT01089127|101859697|FG004|Overall Study|Adverse Event|0|||
33534932|NCT01089127|101859698|FG005|Overall Study|Adverse Event|1|||
33534933|NCT01089127|101859693|FG000|Overall Study|Subject withdrew consent|0|||
33534934|NCT01089127|101859694|FG001|Overall Study|Subject withdrew consent|1|||
33534935|NCT01089127|101859695|FG002|Overall Study|Subject withdrew consent|1|||
33534936|NCT01089127|101859696|FG003|Overall Study|Subject withdrew consent|1|||
33534937|NCT01089127|101859697|FG004|Overall Study|Subject withdrew consent|0|||
33534938|NCT01089127|101859698|FG005|Overall Study|Subject withdrew consent|2|||
33534939|NCT01089127|101859693|FG000|Overall Study|Abnormal test procedure result(s)|2|||
33534940|NCT01089127|101859694|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33534941|NCT01089127|101859695|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33534942|NCT01089127|101859696|FG003|Overall Study|Abnormal test procedure result(s)|0|||
33534943|NCT01089127|101859697|FG004|Overall Study|Abnormal test procedure result(s)|0|||
33534944|NCT01089127|101859698|FG005|Overall Study|Abnormal test procedure result(s)|0|||
33534945|NCT01089127|101859693|FG000|Overall Study|Lost to Follow-up|1|||
33534946|NCT01089127|101859694|FG001|Overall Study|Lost to Follow-up|1|||
33534947|NCT01089127|101859695|FG002|Overall Study|Lost to Follow-up|0|||
33534948|NCT01089127|101859696|FG003|Overall Study|Lost to Follow-up|0|||
33534949|NCT01089127|101859697|FG004|Overall Study|Lost to Follow-up|1|||
33534950|NCT01089127|101859698|FG005|Overall Study|Lost to Follow-up|0|||
33534951|NCT01089127|101859693|FG000|Overall Study|Protocol deviation|0|||
33534952|NCT01089127|101859694|FG001|Overall Study|Protocol deviation|1|||
33534953|NCT01089127|101859695|FG002|Overall Study|Protocol deviation|0|||
33534954|NCT01089127|101859696|FG003|Overall Study|Protocol deviation|0|||
33534955|NCT01089127|101859697|FG004|Overall Study|Protocol deviation|1|||
33534956|NCT01089127|101859698|FG005|Overall Study|Protocol deviation|0|||
33534957|NCT02619617|101859699|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
33534958|NCT02619617|101859700|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
33534959|NCT02619617|101859699|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
33534960|NCT02619617|101859700|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
33534961|NCT01324947|101859701|FG000|Overall Study|Adverse Event|7|||
33534962|NCT01324947|101859701|FG000|Overall Study|Death|10|||
33534963|NCT01324947|101859701|FG000|Overall Study|Other|3|||
33534964|NCT01324947|101859701|FG000|Overall Study|Progressive Disease|50|||
33534965|NCT01324947|101859701|FG000|Overall Study|Withdrawal by Subject|3|||
33534966|NCT01324947|101859701|FG000|Overall Study|1 discontinued before starting drug|1|||
33338756|NCT03605680|101132081|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
33534967|NCT01677741|101859705|FG000|Overall Study|Death|0|||
33534968|NCT01677741|101859706|FG001|Overall Study|Death|0|||
33534969|NCT01677741|101859707|FG002|Overall Study|Death|0|||
33534970|NCT01677741|101859708|FG003|Overall Study|Death|1|||
33534971|NCT01677741|101859709|FG004|Overall Study|Death|0|||
33534972|NCT01677741|101859710|FG005|Overall Study|Death|1|||
33534973|NCT01677741|101859711|FG006|Overall Study|Death|0|||
33534974|NCT01677741|101859712|FG007|Overall Study|Death|0|||
33534975|NCT01677741|101859705|FG000|Overall Study|Withdrawal by Subject|2|||
33534976|NCT01677741|101859706|FG001|Overall Study|Withdrawal by Subject|7|||
33534977|NCT01677741|101859707|FG002|Overall Study|Withdrawal by Subject|5|||
33534978|NCT01677741|101859708|FG003|Overall Study|Withdrawal by Subject|4|||
33534979|NCT01677741|101859709|FG004|Overall Study|Withdrawal by Subject|11|||
33534980|NCT01677741|101859710|FG005|Overall Study|Withdrawal by Subject|20|||
33534981|NCT01677741|101859711|FG006|Overall Study|Withdrawal by Subject|4|||
33534982|NCT01677741|101859712|FG007|Overall Study|Withdrawal by Subject|2|||
33338757|NCT03605680|101132078|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
33534983|NCT01677741|101859705|FG000|Overall Study|Enrolled in a rollover study|0|||
33534984|NCT01677741|101859706|FG001|Overall Study|Enrolled in a rollover study|3|||
33534985|NCT01677741|101859707|FG002|Overall Study|Enrolled in a rollover study|2|||
33534986|NCT01677741|101859708|FG003|Overall Study|Enrolled in a rollover study|1|||
33534987|NCT01677741|101859709|FG004|Overall Study|Enrolled in a rollover study|6|||
33534988|NCT01677741|101859710|FG005|Overall Study|Enrolled in a rollover study|6|||
33534989|NCT01677741|101859711|FG006|Overall Study|Enrolled in a rollover study|7|||
33534990|NCT01677741|101859712|FG007|Overall Study|Enrolled in a rollover study|0|||
33534991|NCT01677741|101859705|FG000|Overall Study|Progressive disease|1|||
33534992|NCT01677741|101859706|FG001|Overall Study|Progressive disease|0|||
33534993|NCT01677741|101859707|FG002|Overall Study|Progressive disease|1|||
33534994|NCT01677741|101859708|FG003|Overall Study|Progressive disease|0|||
33534995|NCT01677741|101859709|FG004|Overall Study|Progressive disease|0|||
33534996|NCT01677741|101859710|FG005|Overall Study|Progressive disease|1|||
33534997|NCT01677741|101859711|FG006|Overall Study|Progressive disease|0|||
33534998|NCT01677741|101859712|FG007|Overall Study|Progressive disease|0|||
33534999|NCT01691378|101859713|FG000|Overall Study|Withdrawal by Subject|2|||
33535000|NCT01691378|101859714|FG001|Overall Study|Withdrawal by Subject|0|||
33535001|NCT01691378|101859713|FG000|Overall Study|Lost to Follow-up|5|||
33535002|NCT01691378|101859714|FG001|Overall Study|Lost to Follow-up|2|||
33535003|NCT00577317|101859715|FG000|Overall Study|Study Terminated|0|||
33535004|NCT00577317|101859716|FG001|Overall Study|Study Terminated|2|||
33535005|NCT02364388|101859718|FG000|Overall Study|Protocol Violation|1|||
33535006|NCT02364388|101859718|FG000|Overall Study|Technical Failure|3|||
33535007|NCT02364388|101859718|FG000|Overall Study|No OA/US data|2|||
33535008|NCT02364388|101859718|FG000|Overall Study|No Biopsy|2|||
33535009|NCT03191552|101859719|FG000|Overall Study|Lost to Follow-up|1|||
33535010|NCT03191552|101859720|FG001|Overall Study|Lost to Follow-up|0|||
33535011|NCT03191552|101859721|FG002|Overall Study|Lost to Follow-up|0|||
33535012|NCT03191552|101859719|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
33535013|NCT03191552|101859720|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
33535014|NCT03191552|101859721|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
33535015|NCT01484951|101859726|FG000|Overall Study|Adverse Event|3|||
33535016|NCT01484951|101859726|FG000|Overall Study|Personal Reasons|1|||
33535017|NCT01484951|101859726|FG000|Overall Study|Non-Compliance|1|||
33535018|NCT00887484|101859727|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
33535019|NCT00887484|101859727|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
33535020|NCT00887484|101859727|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
33535021|NCT00465517|101859728|FG000|Overall Study|Adverse Event|7|||
33535022|NCT00465517|101859729|FG001|Overall Study|Adverse Event|3|||
33535023|NCT00465517|101859728|FG000|Overall Study|Lost to Follow-up|1|||
33535024|NCT00465517|101859729|FG001|Overall Study|Lost to Follow-up|0|||
33535025|NCT00465517|101859728|FG000|Overall Study|Withdrawal by Subject|4|||
33535026|NCT00465517|101859729|FG001|Overall Study|Withdrawal by Subject|1|||
33535027|NCT01534273|101859734|FG000|Period 1|Physician Decision|0|||
33535028|NCT01534273|101859735|FG001|Period 1|Physician Decision|0|||
33535029|NCT01534273|101859736|FG002|Period 1|Physician Decision|0|||
33535030|NCT01534273|101859737|FG003|Period 1|Physician Decision|1|||
33535031|NCT01534273|101859738|FG004|Period 1|Physician Decision|0|||
33535032|NCT01534273|101859739|FG005|Period 1|Physician Decision|0|||
33535033|NCT01534273|101859740|FG006|Period 1|Physician Decision|0|||
33535034|NCT00467519|101859748|FG000|Overall Study|Protocol Violation|8|||
33535035|NCT00467519|101859749|FG001|Overall Study|Protocol Violation|4|||
33535036|NCT00467519|101859748|FG000|Overall Study|Lost to Follow-up|2|||
33535037|NCT00467519|101859749|FG001|Overall Study|Lost to Follow-up|9|||
33535038|NCT00467519|101859748|FG000|Overall Study|Withdrawal by Subject|4|||
33535039|NCT00467519|101859749|FG001|Overall Study|Withdrawal by Subject|10|||
33535040|NCT05401565|101859750|FG000|Overall Study|Lost to Follow-up|1|||
33535041|NCT05401565|101859751|FG001|Overall Study|Lost to Follow-up|0|||
33535042|NCT05401565|101859750|FG000|Overall Study|Adverse Event|2|||
33535043|NCT05401565|101859751|FG001|Overall Study|Adverse Event|0|||
33535044|NCT03177148|101859757|FG000|Overall Study|Lost to Follow-up|50|||
33535045|NCT03177148|101859758|FG001|Overall Study|Lost to Follow-up|1|||
33613776|NCT03364309|102133905|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33613777|NCT03364309|102133906|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33535046|NCT03177148|101859757|FG000|Overall Study|Death|1|||
33535047|NCT03177148|101859758|FG001|Overall Study|Death|0|||
33613778|NCT03364309|102133907|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33613779|NCT03364309|102133908|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33613780|NCT03364309|102133909|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33535048|NCT02277028|101859759|FG000|Overall Study|Lost to Follow-up|1|||
33535049|NCT02277028|101859760|FG001|Overall Study|Lost to Follow-up|0|||
33535050|NCT02277028|101859759|FG000|Overall Study|Withdrawal by Subject|0|||
33535051|NCT02277028|101859760|FG001|Overall Study|Withdrawal by Subject|1|||
33535052|NCT00452439|101859762|FG000|Overall Study|Lost to Follow-up|1|||
33535053|NCT00452439|101859763|FG001|Overall Study|Lost to Follow-up|1|||
33535054|NCT00452439|101859762|FG000|Overall Study|Refused Treatment|4|||
33535055|NCT00452439|101859763|FG001|Overall Study|Refused Treatment|3|||
33535056|NCT00452439|101859762|FG000|Overall Study|Death|3|||
33535057|NCT00452439|101859763|FG001|Overall Study|Death|1|||
33535058|NCT00452439|101859762|FG000|Overall Study|Bone Marrow Transplant|0|||
33535059|NCT00452439|101859763|FG001|Overall Study|Bone Marrow Transplant|1|||
33535060|NCT00452439|101859762|FG000|Overall Study|Too Ill to Continue|0|||
33535061|NCT00452439|101859763|FG001|Overall Study|Too Ill to Continue|1|||
33535062|NCT00452439|101859762|FG000|Overall Study|Failed to achieve complete response|2|||
33535063|NCT00452439|101859763|FG001|Overall Study|Failed to achieve complete response|0|||
33535064|NCT00452439|101859762|FG000|Overall Study|Relapse|3|||
33535065|NCT00452439|101859763|FG001|Overall Study|Relapse|0|||
33535066|NCT00452439|101859762|FG000|Overall Study|Fracture|1|||
33535067|NCT00452439|101859763|FG001|Overall Study|Fracture|0|||
33535068|NCT00289276|101859765|FG000|Second Part of FAST Study (Expansion)|Death|0|||
33535069|NCT00289276|101859766|FG001|Second Part of FAST Study (Expansion)|Death|2|||
33535070|NCT00289276|101859765|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
33535071|NCT00289276|101859766|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
33535072|NCT01919164|101859768|FG000|Overall Study|Adverse Event|6|||
33535073|NCT01919164|101859769|FG001|Overall Study|Adverse Event|4|||
33535074|NCT01919164|101859770|FG002|Overall Study|Adverse Event|9|||
33535075|NCT01919164|101859771|FG003|Overall Study|Adverse Event|3|||
33535076|NCT01919164|101859772|FG004|Overall Study|Adverse Event|2|||
33535077|NCT01919164|101859768|FG000|Overall Study|Lost to Follow-up|2|||
33613781|NCT03364309|102133910|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33613782|NCT03364309|102133911|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33613783|NCT03364309|102133912|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33613784|NCT03364309|102133913|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33613785|NCT03364309|102133914|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
33613786|NCT03364309|102133915|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
33613787|NCT03364309|102133916|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
33613788|NCT03364309|102133917|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
33613789|NCT03364309|102133899|FG000|Post-Treatment Followup Period|Adverse Event|0|||
33613790|NCT03364309|102133900|FG001|Post-Treatment Followup Period|Adverse Event|0|||
33613791|NCT03364309|102133901|FG002|Post-Treatment Followup Period|Adverse Event|0|||
33613792|NCT03364309|102133902|FG003|Post-Treatment Followup Period|Adverse Event|0|||
33613793|NCT03364309|102133903|FG004|Post-Treatment Followup Period|Adverse Event|0|||
33613794|NCT03364309|102133904|FG005|Post-Treatment Followup Period|Adverse Event|0|||
33613795|NCT03364309|102133905|FG006|Post-Treatment Followup Period|Adverse Event|0|||
33613796|NCT03364309|102133906|FG007|Post-Treatment Followup Period|Adverse Event|0|||
33613797|NCT03364309|102133907|FG008|Post-Treatment Followup Period|Adverse Event|0|||
33613798|NCT03364309|102133908|FG009|Post-Treatment Followup Period|Adverse Event|0|||
33613799|NCT03364309|102133909|FG010|Post-Treatment Followup Period|Adverse Event|0|||
33613800|NCT03364309|102133910|FG011|Post-Treatment Followup Period|Adverse Event|0|||
33613801|NCT03364309|102133911|FG012|Post-Treatment Followup Period|Adverse Event|0|||
33613802|NCT03364309|102133912|FG013|Post-Treatment Followup Period|Adverse Event|0|||
33613803|NCT03364309|102133913|FG014|Post-Treatment Followup Period|Adverse Event|0|||
33613804|NCT03364309|102133914|FG015|Post-Treatment Followup Period|Adverse Event|0|||
33613805|NCT03364309|102133915|FG016|Post-Treatment Followup Period|Adverse Event|2|||
33613806|NCT03364309|102133916|FG017|Post-Treatment Followup Period|Adverse Event|6|||
33613807|NCT03364309|102133917|FG018|Post-Treatment Followup Period|Adverse Event|1|||
33613808|NCT03364309|102133899|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
33207219|NCT01781572|100661381|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
33207220|NCT01781572|100661379|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
33207221|NCT01781572|100661380|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
33207222|NCT01781572|100661381|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
33207223|NCT01781572|100661379|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
33207224|NCT01781572|100661380|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
33207225|NCT01781572|100661381|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
33207226|NCT01781572|100661379|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
33207227|NCT01781572|100661380|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
33207228|NCT01781572|100661381|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
33535078|NCT01919164|101859769|FG001|Overall Study|Lost to Follow-up|2|||
33535079|NCT01919164|101859770|FG002|Overall Study|Lost to Follow-up|2|||
33535080|NCT01919164|101859771|FG003|Overall Study|Lost to Follow-up|0|||
33613809|NCT03364309|102133900|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
33613810|NCT03364309|102133901|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
33535081|NCT01919164|101859772|FG004|Overall Study|Lost to Follow-up|4|||
33535082|NCT01919164|101859768|FG000|Overall Study|Death|1|||
33535083|NCT01919164|101859769|FG001|Overall Study|Death|0|||
33613811|NCT03364309|102133902|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
33613812|NCT03364309|102133903|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
33207229|NCT01781572|100661379|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
33535084|NCT01919164|101859770|FG002|Overall Study|Death|0|||
33535085|NCT01919164|101859771|FG003|Overall Study|Death|0|||
33535086|NCT01919164|101859772|FG004|Overall Study|Death|0|||
33535087|NCT01919164|101859768|FG000|Overall Study|Protocol Violation|6|||
33535088|NCT01919164|101859769|FG001|Overall Study|Protocol Violation|0|||
33535089|NCT01919164|101859770|FG002|Overall Study|Protocol Violation|3|||
33535090|NCT01919164|101859771|FG003|Overall Study|Protocol Violation|2|||
33535091|NCT01919164|101859772|FG004|Overall Study|Protocol Violation|2|||
33535092|NCT01919164|101859768|FG000|Overall Study|Disease progression|2|||
33535093|NCT01919164|101859769|FG001|Overall Study|Disease progression|2|||
33535094|NCT01919164|101859770|FG002|Overall Study|Disease progression|1|||
33535095|NCT01919164|101859771|FG003|Overall Study|Disease progression|2|||
33535096|NCT01919164|101859772|FG004|Overall Study|Disease progression|1|||
33535097|NCT01919164|101859768|FG000|Overall Study|Withdrew consent|13|||
33535098|NCT01919164|101859769|FG001|Overall Study|Withdrew consent|13|||
33535099|NCT01919164|101859770|FG002|Overall Study|Withdrew consent|14|||
33535100|NCT01919164|101859771|FG003|Overall Study|Withdrew consent|14|||
33535101|NCT01919164|101859772|FG004|Overall Study|Withdrew consent|9|||
33535102|NCT01919164|101859768|FG000|Overall Study|Other Un-specified|13|||
33535103|NCT01919164|101859769|FG001|Overall Study|Other Un-specified|9|||
33535104|NCT01919164|101859770|FG002|Overall Study|Other Un-specified|8|||
33535105|NCT01919164|101859771|FG003|Overall Study|Other Un-specified|7|||
33535106|NCT01919164|101859772|FG004|Overall Study|Other Un-specified|15|||
33535107|NCT02457195|101859773|FG000|Overall Study|Adverse Event|3|||
33535108|NCT02457195|101859773|FG000|Overall Study|Protocol Violation|2|||
33535109|NCT02457195|101859773|FG000|Overall Study|Withdrawal by Subject|4|||
33535110|NCT00969228|101859774|FG000|Overall Study|Adverse Event|1|||
33535111|NCT00969228|101859775|FG001|Overall Study|Adverse Event|0|||
33535112|NCT00969228|101859774|FG000|Overall Study|Withdrawal by Subject|4|||
33535113|NCT00969228|101859775|FG001|Overall Study|Withdrawal by Subject|0|||
33535114|NCT00969228|101859774|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
33535115|NCT00969228|101859775|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
33535116|NCT00780975|101859776|FG000|Overall Study|Progressive disease|3|||
33535117|NCT00780975|101859776|FG000|Overall Study|Toxicity|5|||
33535118|NCT01077323|101859780|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
33535119|NCT01077323|101859781|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
33535120|NCT01077323|101859782|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
33535121|NCT01077323|101859780|FG000|Overall Study|Dispensing of drug in baseline period|0|||
33535122|NCT01077323|101859781|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
33535123|NCT01077323|101859782|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
33535124|NCT01077323|101859780|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
33535125|NCT01077323|101859781|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
33535126|NCT01077323|101859782|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
33535127|NCT00377637|101859783|FG000|Induction Phase|Adverse Event|12|||
33535128|NCT00377637|101859784|FG001|Induction Phase|Adverse Event|21|||
33535129|NCT00377637|101859785|FG002|Induction Phase|Adverse Event|0|||
33535130|NCT00377637|101859786|FG003|Induction Phase|Adverse Event|0|||
33535131|NCT00377637|101859783|FG000|Induction Phase|Deterioration/serum creatinine|2|||
33535132|NCT00377637|101859784|FG001|Induction Phase|Deterioration/serum creatinine|0|||
33535133|NCT00377637|101859785|FG002|Induction Phase|Deterioration/serum creatinine|0|||
33535134|NCT00377637|101859786|FG003|Induction Phase|Deterioration/serum creatinine|0|||
33535135|NCT00377637|101859783|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
33535136|NCT00377637|101859784|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
33535137|NCT00377637|101859785|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
33535138|NCT00377637|101859786|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
33535139|NCT00377637|101859783|FG000|Induction Phase|Lost to Follow-up|2|||
33535140|NCT00377637|101859784|FG001|Induction Phase|Lost to Follow-up|1|||
33535141|NCT00377637|101859785|FG002|Induction Phase|Lost to Follow-up|0|||
33535142|NCT00377637|101859786|FG003|Induction Phase|Lost to Follow-up|0|||
33535143|NCT00377637|101859783|FG000|Induction Phase|Death|1|||
33535144|NCT00377637|101859784|FG001|Induction Phase|Death|3|||
33535145|NCT00377637|101859785|FG002|Induction Phase|Death|0|||
33535146|NCT00377637|101859786|FG003|Induction Phase|Death|0|||
33535147|NCT00377637|101859783|FG000|Induction Phase|Withdrawal by Subject|5|||
33535148|NCT00377637|101859784|FG001|Induction Phase|Withdrawal by Subject|6|||
33535149|NCT00377637|101859785|FG002|Induction Phase|Withdrawal by Subject|0|||
33535150|NCT00377637|101859786|FG003|Induction Phase|Withdrawal by Subject|0|||
33535151|NCT00377637|101859783|FG000|Induction Phase|Physician Decision|3|||
33535152|NCT00377637|101859784|FG001|Induction Phase|Physician Decision|1|||
33535153|NCT00377637|101859785|FG002|Induction Phase|Physician Decision|0|||
33535154|NCT00377637|101859786|FG003|Induction Phase|Physician Decision|0|||
33535155|NCT00377637|101859783|FG000|Induction Phase|Sponsor decision|1|||
33535156|NCT00377637|101859784|FG001|Induction Phase|Sponsor decision|2|||
33535157|NCT00377637|101859785|FG002|Induction Phase|Sponsor decision|0|||
33535158|NCT00377637|101859786|FG003|Induction Phase|Sponsor decision|0|||
33535159|NCT00377637|101859783|FG000|Induction Phase|Non-Compliance|1|||
33535160|NCT00377637|101859784|FG001|Induction Phase|Non-Compliance|0|||
33535161|NCT00377637|101859785|FG002|Induction Phase|Non-Compliance|0|||
33535162|NCT00377637|101859786|FG003|Induction Phase|Non-Compliance|0|||
33535163|NCT00377637|101859783|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
33535164|NCT00377637|101859784|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
33535165|NCT00377637|101859785|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
33535166|NCT00377637|101859786|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
33535167|NCT00377637|101859783|FG000|Maintenance Phase|Adverse Event|0|||
33535168|NCT00377637|101859784|FG001|Maintenance Phase|Adverse Event|0|||
33535169|NCT00377637|101859785|FG002|Maintenance Phase|Adverse Event|29|||
33535170|NCT00377637|101859786|FG003|Maintenance Phase|Adverse Event|43|||
33535171|NCT00377637|101859783|FG000|Maintenance Phase|Physician Decision|0|||
33535172|NCT00377637|101859784|FG001|Maintenance Phase|Physician Decision|0|||
33535173|NCT00377637|101859785|FG002|Maintenance Phase|Physician Decision|5|||
33535174|NCT00377637|101859786|FG003|Maintenance Phase|Physician Decision|4|||
33535175|NCT00377637|101859783|FG000|Maintenance Phase|Lost to Follow-up|0|||
33535176|NCT00377637|101859784|FG001|Maintenance Phase|Lost to Follow-up|0|||
33535177|NCT00377637|101859785|FG002|Maintenance Phase|Lost to Follow-up|3|||
33535178|NCT00377637|101859786|FG003|Maintenance Phase|Lost to Follow-up|1|||
33535179|NCT00377637|101859783|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33535180|NCT00377637|101859784|FG001|Maintenance Phase|Withdrawal by Subject|0|||
33535181|NCT00377637|101859785|FG002|Maintenance Phase|Withdrawal by Subject|3|||
33535182|NCT00377637|101859786|FG003|Maintenance Phase|Withdrawal by Subject|3|||
33535183|NCT00377637|101859783|FG000|Maintenance Phase|Sponsor decision|0|||
33535184|NCT00377637|101859784|FG001|Maintenance Phase|Sponsor decision|0|||
33535185|NCT00377637|101859785|FG002|Maintenance Phase|Sponsor decision|2|||
33535186|NCT00377637|101859786|FG003|Maintenance Phase|Sponsor decision|3|||
33535187|NCT00377637|101859783|FG000|Maintenance Phase|Non-compliance|0|||
33535188|NCT00377637|101859784|FG001|Maintenance Phase|Non-compliance|0|||
33207230|NCT01781572|100661380|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
33207231|NCT01781572|100661381|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
33207232|NCT01781572|100661379|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
33338758|NCT03605680|101132079|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
33338759|NCT03605680|101132080|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
33338760|NCT03605680|101132081|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
33338761|NCT03605680|101132078|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
33338762|NCT03605680|101132079|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
33207233|NCT01781572|100661380|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
33207234|NCT01781572|100661381|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
33207235|NCT01781572|100661379|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
33207236|NCT01781572|100661380|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
33207237|NCT01781572|100661381|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
33207238|NCT01781572|100661379|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
33207239|NCT01781572|100661380|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
33207240|NCT01781572|100661381|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
33207241|NCT01781572|100661379|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
33207242|NCT01781572|100661380|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
33207243|NCT01781572|100661381|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
33207244|NCT00321854|100661382|FG000|Overall Study|Adverse Event|41|||
33207245|NCT00321854|100661383|FG001|Overall Study|Adverse Event|43|||
33207246|NCT00321854|100661382|FG000|Overall Study|Lack of Efficacy|9|||
33207247|NCT00321854|100661383|FG001|Overall Study|Lack of Efficacy|14|||
33207248|NCT00321854|100661382|FG000|Overall Study|Protocol Violation|6|||
33207249|NCT00321854|100661383|FG001|Overall Study|Protocol Violation|5|||
33207250|NCT00321854|100661382|FG000|Overall Study|Lost to Follow-up|0|||
33207251|NCT00321854|100661383|FG001|Overall Study|Lost to Follow-up|2|||
33207252|NCT00321854|100661382|FG000|Overall Study|Withdrawal by Subject|6|||
33207253|NCT00321854|100661383|FG001|Overall Study|Withdrawal by Subject|17|||
33207254|NCT00321854|100661382|FG000|Overall Study|Other|1|||
33207255|NCT00321854|100661383|FG001|Overall Study|Other|1|||
33207256|NCT03690869|100661384|FG000|Overall Study|Adverse Event|0|||
33207257|NCT03690869|100661385|FG001|Overall Study|Adverse Event|0|||
33207258|NCT03690869|100661386|FG002|Overall Study|Adverse Event|0|||
33207259|NCT03690869|100661387|FG003|Overall Study|Adverse Event|1|||
33207260|NCT03690869|100661388|FG004|Overall Study|Adverse Event|0|||
33364968|NCT04760314|101223698|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
33405368|NCT01874288|101373309|FG000|Overall Study|Physician Decision|0|||
33535189|NCT00377637|101859785|FG002|Maintenance Phase|Non-compliance|1|||
33535190|NCT00377637|101859786|FG003|Maintenance Phase|Non-compliance|1|||
33535191|NCT00377637|101859783|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
33535192|NCT00377637|101859784|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
33207261|NCT03690869|100661389|FG005|Overall Study|Adverse Event|0|||
33207262|NCT03690869|100661390|FG006|Overall Study|Adverse Event|0|||
33207263|NCT03690869|100661391|FG007|Overall Study|Adverse Event|1|||
33207264|NCT03690869|100661392|FG008|Overall Study|Adverse Event|0|||
33207265|NCT03690869|100661393|FG009|Overall Study|Adverse Event|1|||
33207266|NCT03690869|100661384|FG000|Overall Study|Death|1|||
33535193|NCT00377637|101859785|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
33535194|NCT00377637|101859786|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
33535195|NCT00377637|101859783|FG000|Maintenance Phase|Death|0|||
33535196|NCT00377637|101859784|FG001|Maintenance Phase|Death|0|||
33535197|NCT00377637|101859785|FG002|Maintenance Phase|Death|0|||
33535198|NCT00377637|101859786|FG003|Maintenance Phase|Death|1|||
33535199|NCT05556148|101859789|FG000|Overall Study|Early Termination|29|||
33535200|NCT05556148|101859789|FG000|Overall Study|Baseline Tasks Expired|4|||
33535201|NCT05556148|101859789|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
33535202|NCT05556148|101859789|FG000|Overall Study|No Longer Wished to Participate|1|||
33535203|NCT05556148|101859789|FG000|Overall Study|Bacterial Conjunctivitis|1|||
33535204|NCT01061606|101859790|FG000|Overall Study|Adverse Event|1|||
33535205|NCT01061606|101859790|FG000|Overall Study|Death|1|||
33535206|NCT01061606|101859790|FG000|Overall Study|Disease Progression|4|||
33535207|NCT01061606|101859790|FG000|Overall Study|alternative therapy|2|||
33535208|NCT01159574|101859792|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
33535209|NCT01159574|101859792|FG000|Treatment Phase|Adverse Event|3|||
33535210|NCT01159574|101859792|FG000|Treatment Phase|Death|6|||
33535211|NCT01159574|101859792|FG000|Treatment Phase|Physician Decision|2|||
33535212|NCT01159574|101859792|FG000|Treatment Phase|Withdrawal by Subject|7|||
33535213|NCT01159574|101859792|FG000|Treatment Phase|still on treatment|2|||
33535214|NCT01159574|101859792|FG000|Follow Up Phase|Lost to Follow-up|2|||
33535215|NCT01159574|101859792|FG000|Follow Up Phase|still being followed for overall surviva|18|||
33535216|NCT03200548|101859793|FG000|Overall Study|Withdrawal by Subject|5|||
33535217|NCT03200548|101859794|FG001|Overall Study|Withdrawal by Subject|11|||
33535218|NCT03200548|101859795|FG002|Overall Study|Withdrawal by Subject|7|||
33535219|NCT03200548|101859796|FG003|Overall Study|Withdrawal by Subject|6|||
33535220|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
33535221|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
33535222|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
33535223|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
33535224|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
33535225|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
33535226|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
33535227|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
33535228|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
33338763|NCT03605680|101132080|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
33338764|NCT03605680|101132081|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
33535229|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
33535230|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
33535231|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
33207267|NCT03690869|100661385|FG001|Overall Study|Death|1|||
33207268|NCT03690869|100661386|FG002|Overall Study|Death|1|||
33207269|NCT03690869|100661387|FG003|Overall Study|Death|4|||
33207270|NCT03690869|100661388|FG004|Overall Study|Death|2|||
33207271|NCT03690869|100661389|FG005|Overall Study|Death|5|||
33207272|NCT03690869|100661390|FG006|Overall Study|Death|3|||
33207273|NCT03690869|100661391|FG007|Overall Study|Death|2|||
33207274|NCT03690869|100661392|FG008|Overall Study|Death|0|||
33207275|NCT03690869|100661393|FG009|Overall Study|Death|3|||
33207276|NCT03690869|100661384|FG000|Overall Study|Lost to Follow-up|0|||
33207277|NCT03690869|100661385|FG001|Overall Study|Lost to Follow-up|0|||
33207278|NCT03690869|100661386|FG002|Overall Study|Lost to Follow-up|1|||
33207279|NCT03690869|100661387|FG003|Overall Study|Lost to Follow-up|0|||
33207280|NCT03690869|100661388|FG004|Overall Study|Lost to Follow-up|0|||
33207281|NCT03690869|100661389|FG005|Overall Study|Lost to Follow-up|0|||
33207282|NCT03690869|100661390|FG006|Overall Study|Lost to Follow-up|0|||
33207283|NCT03690869|100661391|FG007|Overall Study|Lost to Follow-up|0|||
33207284|NCT03690869|100661392|FG008|Overall Study|Lost to Follow-up|0|||
33207285|NCT03690869|100661393|FG009|Overall Study|Lost to Follow-up|0|||
33207286|NCT03690869|100661384|FG000|Overall Study|Other Treatment|1|||
33207287|NCT03690869|100661385|FG001|Overall Study|Other Treatment|1|||
33207288|NCT03690869|100661386|FG002|Overall Study|Other Treatment|1|||
33207289|NCT03690869|100661387|FG003|Overall Study|Other Treatment|2|||
33207290|NCT03690869|100661388|FG004|Overall Study|Other Treatment|3|||
33207291|NCT03690869|100661389|FG005|Overall Study|Other Treatment|1|||
33207292|NCT03690869|100661390|FG006|Overall Study|Other Treatment|2|||
33207293|NCT03690869|100661391|FG007|Overall Study|Other Treatment|7|||
33207294|NCT03690869|100661392|FG008|Overall Study|Other Treatment|0|||
33207295|NCT03690869|100661393|FG009|Overall Study|Other Treatment|3|||
33207296|NCT03690869|100661384|FG000|Overall Study|Physician Decision|0|||
33207297|NCT03690869|100661385|FG001|Overall Study|Physician Decision|1|||
33207298|NCT03690869|100661386|FG002|Overall Study|Physician Decision|0|||
33207299|NCT03690869|100661387|FG003|Overall Study|Physician Decision|0|||
33207300|NCT03690869|100661388|FG004|Overall Study|Physician Decision|0|||
33207301|NCT03690869|100661389|FG005|Overall Study|Physician Decision|0|||
33207302|NCT03690869|100661390|FG006|Overall Study|Physician Decision|0|||
33207303|NCT03690869|100661391|FG007|Overall Study|Physician Decision|0|||
33207304|NCT03690869|100661392|FG008|Overall Study|Physician Decision|0|||
33207305|NCT03690869|100661393|FG009|Overall Study|Physician Decision|0|||
33207306|NCT03690869|100661384|FG000|Overall Study|Progressive Disease|1|||
33207307|NCT03690869|100661385|FG001|Overall Study|Progressive Disease|2|||
33207308|NCT03690869|100661386|FG002|Overall Study|Progressive Disease|0|||
33207309|NCT03690869|100661387|FG003|Overall Study|Progressive Disease|1|||
33207310|NCT03690869|100661388|FG004|Overall Study|Progressive Disease|0|||
33207311|NCT03690869|100661389|FG005|Overall Study|Progressive Disease|0|||
33207312|NCT03690869|100661390|FG006|Overall Study|Progressive Disease|0|||
33207313|NCT03690869|100661391|FG007|Overall Study|Progressive Disease|0|||
33207314|NCT03690869|100661392|FG008|Overall Study|Progressive Disease|1|||
33207315|NCT03690869|100661393|FG009|Overall Study|Progressive Disease|1|||
33207316|NCT03690869|100661384|FG000|Overall Study|Subject Decision|0|||
33207317|NCT03690869|100661385|FG001|Overall Study|Subject Decision|0|||
33207318|NCT03690869|100661386|FG002|Overall Study|Subject Decision|0|||
33207319|NCT03690869|100661387|FG003|Overall Study|Subject Decision|1|||
33207320|NCT03690869|100661388|FG004|Overall Study|Subject Decision|0|||
33207321|NCT03690869|100661389|FG005|Overall Study|Subject Decision|0|||
33207322|NCT03690869|100661390|FG006|Overall Study|Subject Decision|0|||
33207323|NCT03690869|100661391|FG007|Overall Study|Subject Decision|1|||
33207324|NCT03690869|100661392|FG008|Overall Study|Subject Decision|0|||
33207325|NCT03690869|100661393|FG009|Overall Study|Subject Decision|0|||
33207326|NCT02291614|100661394|FG000|Overall Study|Lost to Follow-up|0|||
33207327|NCT02291614|100661395|FG001|Overall Study|Lost to Follow-up|0|||
33207328|NCT02291614|100661396|FG002|Overall Study|Lost to Follow-up|0|||
33207329|NCT02291614|100661397|FG003|Overall Study|Lost to Follow-up|0|||
33207330|NCT02291614|100661398|FG004|Overall Study|Lost to Follow-up|0|||
33207331|NCT02291614|100661399|FG005|Overall Study|Lost to Follow-up|0|||
33207332|NCT02291614|100661400|FG006|Overall Study|Lost to Follow-up|0|||
33207333|NCT02291614|100661401|FG007|Overall Study|Lost to Follow-up|1|||
33207334|NCT02291614|100661402|FG008|Overall Study|Lost to Follow-up|0|||
33207335|NCT02291614|100661403|FG009|Overall Study|Lost to Follow-up|0|||
33207336|NCT02291614|100661404|FG010|Overall Study|Lost to Follow-up|0|||
33207337|NCT02291614|100661394|FG000|Overall Study|Withdrawal by Subject|0|||
33207338|NCT02291614|100661395|FG001|Overall Study|Withdrawal by Subject|1|||
33207339|NCT02291614|100661396|FG002|Overall Study|Withdrawal by Subject|0|||
33207340|NCT02291614|100661397|FG003|Overall Study|Withdrawal by Subject|0|||
33207341|NCT02291614|100661398|FG004|Overall Study|Withdrawal by Subject|0|||
33207342|NCT02291614|100661399|FG005|Overall Study|Withdrawal by Subject|0|||
33207343|NCT02291614|100661400|FG006|Overall Study|Withdrawal by Subject|0|||
33207344|NCT02291614|100661401|FG007|Overall Study|Withdrawal by Subject|0|||
33207345|NCT02291614|100661402|FG008|Overall Study|Withdrawal by Subject|0|||
33207346|NCT02291614|100661403|FG009|Overall Study|Withdrawal by Subject|2|||
33207347|NCT02291614|100661404|FG010|Overall Study|Withdrawal by Subject|2|||
33207348|NCT02291614|100661394|FG000|Overall Study|Decision by sponsor|0|||
33207349|NCT02291614|100661395|FG001|Overall Study|Decision by sponsor|0|||
33207350|NCT02291614|100661396|FG002|Overall Study|Decision by sponsor|0|||
33207351|NCT02291614|100661397|FG003|Overall Study|Decision by sponsor|1|||
33207352|NCT02291614|100661398|FG004|Overall Study|Decision by sponsor|0|||
33207353|NCT02291614|100661399|FG005|Overall Study|Decision by sponsor|0|||
33207354|NCT02291614|100661400|FG006|Overall Study|Decision by sponsor|0|||
33207355|NCT02291614|100661401|FG007|Overall Study|Decision by sponsor|0|||
33207356|NCT02291614|100661402|FG008|Overall Study|Decision by sponsor|0|||
33207357|NCT02291614|100661403|FG009|Overall Study|Decision by sponsor|0|||
33207358|NCT02291614|100661404|FG010|Overall Study|Decision by sponsor|0|||
33535232|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
33535233|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
33535234|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
33535235|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
33535236|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
33535237|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
33207359|NCT02291614|100661394|FG000|Overall Study|Death|0|||
33207360|NCT02291614|100661395|FG001|Overall Study|Death|0|||
33207361|NCT02291614|100661396|FG002|Overall Study|Death|1|||
33207362|NCT02291614|100661397|FG003|Overall Study|Death|0|||
33207363|NCT02291614|100661398|FG004|Overall Study|Death|1|||
33207364|NCT02291614|100661399|FG005|Overall Study|Death|1|||
33207365|NCT02291614|100661400|FG006|Overall Study|Death|1|||
33207366|NCT02291614|100661401|FG007|Overall Study|Death|0|||
33207367|NCT02291614|100661402|FG008|Overall Study|Death|0|||
33207368|NCT02291614|100661403|FG009|Overall Study|Death|0|||
33207369|NCT02291614|100661404|FG010|Overall Study|Death|0|||
33207370|NCT00838110|100661405|FG000|Overall Study|Death|0|||
33207371|NCT00838110|100661406|FG001|Overall Study|Death|0|||
33207372|NCT00838110|100661407|FG002|Overall Study|Death|1|||
33207373|NCT00838110|100661408|FG003|Overall Study|Death|2|||
33207374|NCT00838110|100661405|FG000|Overall Study|Adverse Event|11|||
33207375|NCT00838110|100661406|FG001|Overall Study|Adverse Event|10|||
33207376|NCT00838110|100661407|FG002|Overall Study|Adverse Event|8|||
33207377|NCT00838110|100661408|FG003|Overall Study|Adverse Event|7|||
33207378|NCT00838110|100661405|FG000|Overall Study|Withdrawal by Subject|5|||
33207379|NCT00838110|100661406|FG001|Overall Study|Withdrawal by Subject|6|||
33207380|NCT00838110|100661407|FG002|Overall Study|Withdrawal by Subject|3|||
33207381|NCT00838110|100661408|FG003|Overall Study|Withdrawal by Subject|4|||
33207382|NCT00838110|100661405|FG000|Overall Study|Other|3|||
33207383|NCT00838110|100661406|FG001|Overall Study|Other|3|||
33207384|NCT00838110|100661407|FG002|Overall Study|Other|3|||
33207385|NCT00838110|100661408|FG003|Overall Study|Other|2|||
33207386|NCT00838110|100661405|FG000|Overall Study|Protocol Violation|0|||
33207387|NCT00838110|100661406|FG001|Overall Study|Protocol Violation|2|||
33207388|NCT00838110|100661407|FG002|Overall Study|Protocol Violation|1|||
33207389|NCT00838110|100661408|FG003|Overall Study|Protocol Violation|1|||
33207390|NCT00838110|100661405|FG000|Overall Study|Lost to Follow-up|3|||
33207391|NCT00838110|100661406|FG001|Overall Study|Lost to Follow-up|0|||
33207392|NCT00838110|100661407|FG002|Overall Study|Lost to Follow-up|0|||
33207393|NCT00838110|100661408|FG003|Overall Study|Lost to Follow-up|0|||
33207394|NCT00838110|100661405|FG000|Overall Study|Did not meet eligibility criteria|0|||
33207395|NCT00838110|100661406|FG001|Overall Study|Did not meet eligibility criteria|0|||
33207396|NCT00838110|100661407|FG002|Overall Study|Did not meet eligibility criteria|1|||
33207397|NCT00838110|100661408|FG003|Overall Study|Did not meet eligibility criteria|2|||
33207398|NCT00838110|100661405|FG000|Overall Study|Randomized but not treated|0|||
33207399|NCT00838110|100661406|FG001|Overall Study|Randomized but not treated|1|||
33207400|NCT00838110|100661407|FG002|Overall Study|Randomized but not treated|0|||
33207401|NCT00838110|100661408|FG003|Overall Study|Randomized but not treated|0|||
33207402|NCT01308749|100661412|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
33207403|NCT01308749|100661413|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
33207404|NCT01308749|100661412|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
33535238|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
33613813|NCT03364309|102133904|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
33207405|NCT01308749|100661413|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
33207406|NCT01308749|100661412|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
33207407|NCT01308749|100661413|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
33207408|NCT01664078|100661414|FG000|Overall Study|Death|9|||
33207409|NCT01664078|100661414|FG000|Overall Study|Withdrawal by Subject|4|||
33207410|NCT01664078|100661414|FG000|Overall Study|Lost to Follow-up|2|||
33207411|NCT01664078|100661414|FG000|Overall Study|missed 5 year visit|1|||
33207412|NCT01664078|100661414|FG000|Overall Study|Other|53|||
33207413|NCT03776136|100661422|FG000|Overall Study|Death|85|||
33207414|NCT03776136|100661422|FG000|Overall Study|Withdrawal by Subject|3|||
33207415|NCT03776136|100661422|FG000|Overall Study|Sponsor Decision|15|||
33207416|NCT01026974|100661423|FG000|Overall Study|Withdrawal by Subject|0|||
33207417|NCT01026974|100661424|FG001|Overall Study|Withdrawal by Subject|1|||
33207418|NCT01026974|100661425|FG002|Overall Study|Withdrawal by Subject|7|||
33207419|NCT01026974|100661426|FG003|Overall Study|Withdrawal by Subject|2|||
33207420|NCT01026974|100661423|FG000|Overall Study|Lost to Follow-up|1|||
33207421|NCT01026974|100661424|FG001|Overall Study|Lost to Follow-up|1|||
33207422|NCT01026974|100661425|FG002|Overall Study|Lost to Follow-up|4|||
33207423|NCT01026974|100661426|FG003|Overall Study|Lost to Follow-up|0|||
33207424|NCT01026974|100661423|FG000|Overall Study|Adverse Event|0|||
33207425|NCT01026974|100661424|FG001|Overall Study|Adverse Event|0|||
33207426|NCT01026974|100661425|FG002|Overall Study|Adverse Event|0|||
33207427|NCT01026974|100661426|FG003|Overall Study|Adverse Event|1|||
33207428|NCT01026974|100661423|FG000|Overall Study|Inappropriate enrollment|0|||
33207429|NCT01026974|100661424|FG001|Overall Study|Inappropriate enrollment|0|||
33207430|NCT01026974|100661425|FG002|Overall Study|Inappropriate enrollment|1|||
33207431|NCT01026974|100661426|FG003|Overall Study|Inappropriate enrollment|0|||
33207432|NCT04479618|100661427|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
33207433|NCT04479618|100661428|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
33207434|NCT04479618|100661429|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
33207435|NCT04479618|100661427|FG000|Overall Study|Lack of Efficacy|1|||
33207436|NCT04479618|100661428|FG001|Overall Study|Lack of Efficacy|0|||
33207437|NCT04479618|100661429|FG002|Overall Study|Lack of Efficacy|0|||
33207438|NCT04479618|100661427|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
33207439|NCT04479618|100661428|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
33207440|NCT04479618|100661429|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
33207441|NCT04479618|100661427|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
33207442|NCT04479618|100661428|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
33535239|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
33535240|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
33207443|NCT04479618|100661429|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
33207444|NCT04479618|100661427|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
33207445|NCT04479618|100661428|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
33207446|NCT04479618|100661429|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
33207447|NCT04479618|100661427|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
33207448|NCT04479618|100661428|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
33535241|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
33535242|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
33535243|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
33535244|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
33535245|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
33535246|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
33535247|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
33535248|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
33535249|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
33535250|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
33535251|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
33535252|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
33535253|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
33535254|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
33535255|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
33535256|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
33535257|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
33535258|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
33535259|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
33535260|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
33535261|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
33535262|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
33613814|NCT03364309|102133905|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
33613815|NCT03364309|102133906|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
33207449|NCT04479618|100661429|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
33207450|NCT04831736|100661430|FG000|Overall Study|Withdrawal by Subject|0|||
33207451|NCT04831736|100661431|FG001|Overall Study|Withdrawal by Subject|1|||
33207452|NCT04348604|100661437|FG000|Week 8|Withdrawal by Subject|1|||
33207453|NCT04348604|100661438|FG001|Week 8|Withdrawal by Subject|1|||
33405369|NCT01874288|101373310|FG001|Overall Study|Physician Decision|0|||
33535263|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
33535264|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
33535265|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
33535266|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
33535267|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
33535268|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
33535269|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
33535270|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
33535271|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
33535272|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
33535273|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
33535274|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
33535275|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
33535276|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
33535277|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
33535278|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
33535279|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
33535280|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
33535281|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
33535282|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
33535283|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
33535284|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
33535285|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
33207454|NCT04348604|100661437|FG000|Week 8|Lost to Follow-up|1|||
33207455|NCT04348604|100661438|FG001|Week 8|Lost to Follow-up|2|||
33207456|NCT04348604|100661437|FG000|Week 8|Suspended|0|||
33207457|NCT04348604|100661438|FG001|Week 8|Suspended|1|||
33207458|NCT04348604|100661437|FG000|Week 12|Lost to Follow-up|1|||
33207459|NCT04348604|100661438|FG001|Week 12|Lost to Follow-up|2|||
33207460|NCT04348604|100661437|FG000|Week 12|Withdrawal by Subject|1|||
33207461|NCT04348604|100661438|FG001|Week 12|Withdrawal by Subject|0|||
33535286|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
33207462|NCT04348604|100661437|FG000|Week 24|Lost to Follow-up|2|||
33207463|NCT04348604|100661438|FG001|Week 24|Lost to Follow-up|1|||
33207464|NCT02352948|100661441|FG000|Overall Study|Death|47|||
33207465|NCT02352948|100661442|FG001|Overall Study|Death|48|||
33207466|NCT02352948|100661443|FG002|Overall Study|Death|114|||
33207467|NCT02352948|100661444|FG003|Overall Study|Death|74|||
33207468|NCT02352948|100661445|FG004|Overall Study|Death|77|||
33207469|NCT02352948|100661446|FG005|Overall Study|Death|44|||
33207470|NCT02352948|100661441|FG000|Overall Study|Lost to Follow-up|1|||
33207471|NCT02352948|100661442|FG001|Overall Study|Lost to Follow-up|0|||
33207472|NCT02352948|100661443|FG002|Overall Study|Lost to Follow-up|2|||
33207473|NCT02352948|100661444|FG003|Overall Study|Lost to Follow-up|1|||
33207474|NCT02352948|100661445|FG004|Overall Study|Lost to Follow-up|2|||
33535287|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
33535288|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
33535289|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
33535290|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
33535291|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
33535292|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
33535293|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
33535294|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
33613816|NCT03364309|102133907|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
33207475|NCT02352948|100661446|FG005|Overall Study|Lost to Follow-up|1|||
33207476|NCT02352948|100661441|FG000|Overall Study|Withdrawal by Subject|1|||
33207477|NCT02352948|100661442|FG001|Overall Study|Withdrawal by Subject|10|||
33207478|NCT02352948|100661443|FG002|Overall Study|Withdrawal by Subject|11|||
33207479|NCT02352948|100661444|FG003|Overall Study|Withdrawal by Subject|23|||
33207480|NCT02352948|100661445|FG004|Overall Study|Withdrawal by Subject|9|||
33207481|NCT02352948|100661446|FG005|Overall Study|Withdrawal by Subject|4|||
33207482|NCT02352948|100661441|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33207483|NCT02352948|100661442|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33405370|NCT01874288|101373311|FG002|Overall Study|Physician Decision|0|||
33207484|NCT02352948|100661443|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
33207485|NCT02352948|100661444|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
33207486|NCT02352948|100661445|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
33207487|NCT02352948|100661446|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
33207488|NCT02352948|100661441|FG000|Overall Study|Other|0|||
33207489|NCT02352948|100661442|FG001|Overall Study|Other|0|||
33207490|NCT02352948|100661443|FG002|Overall Study|Other|2|||
33535295|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
33535296|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
33535297|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
33535298|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
33535299|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
33535300|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
33535301|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
33535302|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
33535303|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
33535304|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
33535305|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
33535306|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
33535307|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
33535308|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
33535309|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
33535310|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
33535311|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
33535312|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
33535313|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
33535314|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
33535315|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
33535316|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
33535317|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
33535318|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
33535319|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
33613817|NCT03364309|102133908|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
33613818|NCT03364309|102133909|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
33207491|NCT02352948|100661444|FG003|Overall Study|Other|0|||
33207492|NCT02352948|100661445|FG004|Overall Study|Other|0|||
33207493|NCT02352948|100661446|FG005|Overall Study|Other|0|||
33207494|NCT00626522|100661447|FG000|Overall Study|Protocol Violation|0|||
33207495|NCT00626522|100661448|FG001|Overall Study|Protocol Violation|0|||
33207496|NCT00626522|100661449|FG002|Overall Study|Protocol Violation|0|||
33207497|NCT00626522|100661450|FG003|Overall Study|Protocol Violation|0|||
33338765|NCT03605680|101132078|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
33338766|NCT03605680|101132079|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
33338767|NCT03605680|101132080|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
33535320|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
33535321|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
33207498|NCT00626522|100661451|FG004|Overall Study|Protocol Violation|1|||
33207499|NCT00626522|100661452|FG005|Overall Study|Protocol Violation|0|||
33207500|NCT00626522|100661447|FG000|Overall Study|Adverse Event|2|||
33207501|NCT00626522|100661448|FG001|Overall Study|Adverse Event|1|||
33207502|NCT00626522|100661449|FG002|Overall Study|Adverse Event|2|||
33207503|NCT00626522|100661450|FG003|Overall Study|Adverse Event|0|||
33207504|NCT00626522|100661451|FG004|Overall Study|Adverse Event|1|||
33207505|NCT00626522|100661452|FG005|Overall Study|Adverse Event|1|||
33207506|NCT00626522|100661447|FG000|Overall Study|Withdrawal by Subject|2|||
33207507|NCT00626522|100661448|FG001|Overall Study|Withdrawal by Subject|5|||
33207508|NCT00626522|100661449|FG002|Overall Study|Withdrawal by Subject|5|||
33207509|NCT00626522|100661450|FG003|Overall Study|Withdrawal by Subject|0|||
33207510|NCT00626522|100661451|FG004|Overall Study|Withdrawal by Subject|4|||
33207511|NCT00626522|100661452|FG005|Overall Study|Withdrawal by Subject|1|||
33207512|NCT00626522|100661447|FG000|Overall Study|COPD exacerbation|0|||
33207513|NCT00626522|100661448|FG001|Overall Study|COPD exacerbation|0|||
33207514|NCT00626522|100661449|FG002|Overall Study|COPD exacerbation|0|||
33207515|NCT00626522|100661450|FG003|Overall Study|COPD exacerbation|1|||
33207516|NCT00626522|100661451|FG004|Overall Study|COPD exacerbation|1|||
33207517|NCT00626522|100661452|FG005|Overall Study|COPD exacerbation|0|||
33207518|NCT00626522|100661447|FG000|Overall Study|Lost to Follow-up|0|||
33207519|NCT00626522|100661448|FG001|Overall Study|Lost to Follow-up|1|||
33207520|NCT00626522|100661449|FG002|Overall Study|Lost to Follow-up|0|||
33207521|NCT00626522|100661450|FG003|Overall Study|Lost to Follow-up|0|||
33207522|NCT00626522|100661451|FG004|Overall Study|Lost to Follow-up|0|||
33207523|NCT00626522|100661452|FG005|Overall Study|Lost to Follow-up|0|||
33207524|NCT00626522|100661447|FG000|Overall Study|Inconsistent reason reported|1|||
33207525|NCT00626522|100661448|FG001|Overall Study|Inconsistent reason reported|0|||
33207526|NCT00626522|100661449|FG002|Overall Study|Inconsistent reason reported|0|||
33207527|NCT00626522|100661450|FG003|Overall Study|Inconsistent reason reported|0|||
33207528|NCT00626522|100661451|FG004|Overall Study|Inconsistent reason reported|0|||
33207529|NCT00626522|100661452|FG005|Overall Study|Inconsistent reason reported|0|||
33207530|NCT00626522|100661447|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
33207531|NCT00626522|100661448|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
33207532|NCT00626522|100661449|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
33207533|NCT00626522|100661450|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
33207534|NCT00626522|100661451|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
33207535|NCT00626522|100661452|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
33207536|NCT01310036|100661453|FG000|Overall Study|Administrative/other|10|||
33207537|NCT01310036|100661453|FG000|Overall Study|Withdrew Consent|11|||
33207538|NCT01310036|100661453|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
33207539|NCT01310036|100661453|FG000|Overall Study|Progression of Disease|164|||
33207540|NCT01310036|100661453|FG000|Overall Study|Death|1|||
33207541|NCT01310036|100661453|FG000|Overall Study|Adverse event or intercurrent illness|12|||
33207542|NCT02370602|100661456|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
33207543|NCT02370602|100661457|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
33207544|NCT02370602|100661458|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
33207545|NCT02370602|100661459|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
33207546|NCT02370602|100661460|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
33207547|NCT02370602|100661461|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
33207548|NCT00071487|100661462|FG000|52-Week Double-Blind Period|Adverse Event|5|||
33207549|NCT00071487|100661463|FG001|52-Week Double-Blind Period|Adverse Event|8|||
33207550|NCT00071487|100661464|FG002|52-Week Double-Blind Period|Adverse Event|4|||
33207551|NCT00071487|100661465|FG003|52-Week Double-Blind Period|Adverse Event|8|||
33207552|NCT00071487|100661462|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
33207553|NCT00071487|100661463|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
33207554|NCT00071487|100661464|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
33207555|NCT00071487|100661465|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
33207556|NCT00071487|100661462|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
33207557|NCT00071487|100661463|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
33207558|NCT00071487|100661464|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
33207559|NCT00071487|100661465|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
33207560|NCT00071487|100661462|FG000|52-Week Double-Blind Period|Physician Decision|1|||
33207561|NCT00071487|100661463|FG001|52-Week Double-Blind Period|Physician Decision|0|||
33207562|NCT00071487|100661464|FG002|52-Week Double-Blind Period|Physician Decision|0|||
33207563|NCT00071487|100661465|FG003|52-Week Double-Blind Period|Physician Decision|0|||
33207564|NCT00071487|100661462|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
33207565|NCT00071487|100661463|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
33207566|NCT00071487|100661464|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
33207567|NCT00071487|100661465|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
33207568|NCT00071487|100661462|FG000|52-Week Double-Blind Period|Pregnancy|0|||
33207569|NCT00071487|100661463|FG001|52-Week Double-Blind Period|Pregnancy|1|||
33207570|NCT00071487|100661464|FG002|52-Week Double-Blind Period|Pregnancy|0|||
33207571|NCT00071487|100661465|FG003|52-Week Double-Blind Period|Pregnancy|0|||
33207572|NCT00071487|100661462|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
33405371|NCT01874288|101373312|FG003|Overall Study|Physician Decision|1|||
33207573|NCT00071487|100661463|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
33207574|NCT00071487|100661464|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
33207575|NCT00071487|100661465|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
33207576|NCT00071487|100661462|FG000|52-Week Double-Blind Period|Death|0|||
33207577|NCT00071487|100661463|FG001|52-Week Double-Blind Period|Death|1|||
33207578|NCT00071487|100661464|FG002|52-Week Double-Blind Period|Death|0|||
33207579|NCT00071487|100661465|FG003|52-Week Double-Blind Period|Death|0|||
33207580|NCT00071487|100661462|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
33207581|NCT00071487|100661463|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
33207582|NCT00071487|100661464|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
33207583|NCT00071487|100661465|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
33207584|NCT00071487|100661462|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
33207585|NCT00071487|100661463|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
33207586|NCT00071487|100661464|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
33207587|NCT00071487|100661465|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
33207588|NCT00071487|100661462|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
33207589|NCT00071487|100661463|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
33207590|NCT00071487|100661464|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
33207591|NCT00071487|100661465|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
33207592|NCT00071487|100661462|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33207593|NCT00071487|100661463|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33207594|NCT00071487|100661464|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
33207595|NCT00071487|100661465|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
33207596|NCT00071487|100661462|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
33207597|NCT00071487|100661463|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
33207598|NCT00071487|100661464|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
33207599|NCT00071487|100661465|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
33207600|NCT00071487|100661462|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
33207601|NCT00071487|100661463|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
33207602|NCT00071487|100661464|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
33207603|NCT00071487|100661465|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
33207604|NCT00071487|100661462|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
33207605|NCT00071487|100661463|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
33207606|NCT00071487|100661464|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
33207607|NCT00071487|100661465|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
33207608|NCT00295750|100661466|FG000|Overall Study|Adverse Event|19|||
33207609|NCT00295750|100661467|FG001|Overall Study|Adverse Event|15|||
33207610|NCT00295750|100661468|FG002|Overall Study|Adverse Event|12|||
33207611|NCT00295750|100661466|FG000|Overall Study|Lack of Efficacy|1|||
33207612|NCT00295750|100661467|FG001|Overall Study|Lack of Efficacy|1|||
33207613|NCT00295750|100661468|FG002|Overall Study|Lack of Efficacy|0|||
33207614|NCT00295750|100661466|FG000|Overall Study|Lost to Follow-up|1|||
33207615|NCT00295750|100661467|FG001|Overall Study|Lost to Follow-up|4|||
33207616|NCT00295750|100661468|FG002|Overall Study|Lost to Follow-up|1|||
33207617|NCT00295750|100661466|FG000|Overall Study|Taking prohibited therapy|2|||
33207618|NCT00295750|100661467|FG001|Overall Study|Taking prohibited therapy|3|||
33207619|NCT00295750|100661468|FG002|Overall Study|Taking prohibited therapy|2|||
33207620|NCT00295750|100661466|FG000|Overall Study|Administrative errors|2|||
33207621|NCT00295750|100661467|FG001|Overall Study|Administrative errors|4|||
33207622|NCT00295750|100661468|FG002|Overall Study|Administrative errors|5|||
33207623|NCT00295750|100661466|FG000|Overall Study|Trial drug errors|1|||
33207624|NCT00295750|100661467|FG001|Overall Study|Trial drug errors|1|||
33207625|NCT00295750|100661468|FG002|Overall Study|Trial drug errors|0|||
33207626|NCT00295750|100661466|FG000|Overall Study|Disease progression|2|||
33207627|NCT00295750|100661467|FG001|Overall Study|Disease progression|1|||
33207628|NCT00295750|100661468|FG002|Overall Study|Disease progression|0|||
33207629|NCT00295750|100661466|FG000|Overall Study|Personal reasons|0|||
33207630|NCT00295750|100661467|FG001|Overall Study|Personal reasons|1|||
33207631|NCT00295750|100661468|FG002|Overall Study|Personal reasons|0|||
33207632|NCT00295750|100661466|FG000|Overall Study|Randomized but never received trial drug|4|||
33207633|NCT00295750|100661467|FG001|Overall Study|Randomized but never received trial drug|3|||
33405372|NCT01874288|101373313|FG004|Overall Study|Physician Decision|0|||
33405373|NCT01874288|101373309|FG000|Overall Study|Progressive disease|2|||
33535322|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
33613819|NCT03364309|102133910|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
33207634|NCT00295750|100661468|FG002|Overall Study|Randomized but never received trial drug|3|||
33207635|NCT00295750|100661466|FG000|Overall Study|Withdrawal by Subject|9|||
33207636|NCT00295750|100661467|FG001|Overall Study|Withdrawal by Subject|4|||
33207637|NCT00295750|100661468|FG002|Overall Study|Withdrawal by Subject|7|||
33207638|NCT00295750|100661466|FG000|Overall Study|Protocol Violation|2|||
33207639|NCT00295750|100661467|FG001|Overall Study|Protocol Violation|4|||
33207640|NCT00295750|100661468|FG002|Overall Study|Protocol Violation|2|||
33405374|NCT01874288|101373310|FG001|Overall Study|Progressive disease|0|||
33207641|NCT03105362|100661469|FG000|Overall Study|Withdrawal by Subject|1|||
33207642|NCT03105362|100661469|FG000|Overall Study|Lost to Follow-up|1|||
33207643|NCT01109992|100661470|FG000|Overall Study|Withdrawal by Subject|0|||
33207644|NCT01109992|100661471|FG001|Overall Study|Withdrawal by Subject|1|||
33207645|NCT01109992|100661470|FG000|Overall Study|Movement during rest scan.|0|||
33207646|NCT01109992|100661471|FG001|Overall Study|Movement during rest scan.|1|||
33207647|NCT03449030|100661472|FG000|Overall Study|Withdrawal by Subject|0|||
33207648|NCT03449030|100661473|FG001|Overall Study|Withdrawal by Subject|0|||
33207649|NCT03449030|100661474|FG002|Overall Study|Withdrawal by Subject|0|||
33207650|NCT03449030|100661475|FG003|Overall Study|Withdrawal by Subject|1|||
33207651|NCT03449030|100661476|FG004|Overall Study|Withdrawal by Subject|1|||
33207652|NCT03449030|100661477|FG005|Overall Study|Withdrawal by Subject|1|||
33207653|NCT03449030|100661478|FG006|Overall Study|Withdrawal by Subject|1|||
33207654|NCT03449030|100661479|FG007|Overall Study|Withdrawal by Subject|2|||
33207655|NCT03449030|100661480|FG008|Overall Study|Withdrawal by Subject|0|||
33207656|NCT03449030|100661481|FG009|Overall Study|Withdrawal by Subject|0|||
33207657|NCT03449030|100661472|FG000|Overall Study|Symptomatic Deterioration|0|||
33207658|NCT03449030|100661473|FG001|Overall Study|Symptomatic Deterioration|1|||
33207659|NCT03449030|100661474|FG002|Overall Study|Symptomatic Deterioration|0|||
33207660|NCT03449030|100661475|FG003|Overall Study|Symptomatic Deterioration|0|||
33207661|NCT03449030|100661476|FG004|Overall Study|Symptomatic Deterioration|0|||
33207662|NCT03449030|100661477|FG005|Overall Study|Symptomatic Deterioration|1|||
33207663|NCT03449030|100661478|FG006|Overall Study|Symptomatic Deterioration|1|||
33207664|NCT03449030|100661479|FG007|Overall Study|Symptomatic Deterioration|0|||
33207665|NCT03449030|100661480|FG008|Overall Study|Symptomatic Deterioration|2|||
33207666|NCT03449030|100661481|FG009|Overall Study|Symptomatic Deterioration|0|||
33207667|NCT03449030|100661472|FG000|Overall Study|Progressive Disease|1|||
33207668|NCT03449030|100661473|FG001|Overall Study|Progressive Disease|0|||
33207669|NCT03449030|100661474|FG002|Overall Study|Progressive Disease|1|||
33207670|NCT03449030|100661475|FG003|Overall Study|Progressive Disease|4|||
33207671|NCT03449030|100661476|FG004|Overall Study|Progressive Disease|5|||
33207672|NCT03449030|100661477|FG005|Overall Study|Progressive Disease|3|||
33207673|NCT03449030|100661478|FG006|Overall Study|Progressive Disease|0|||
33207674|NCT03449030|100661479|FG007|Overall Study|Progressive Disease|1|||
33207675|NCT03449030|100661480|FG008|Overall Study|Progressive Disease|1|||
33207676|NCT03449030|100661481|FG009|Overall Study|Progressive Disease|1|||
33207677|NCT03449030|100661472|FG000|Overall Study|Adverse Event|0|||
33207678|NCT03449030|100661473|FG001|Overall Study|Adverse Event|0|||
33207679|NCT03449030|100661474|FG002|Overall Study|Adverse Event|0|||
33207680|NCT03449030|100661475|FG003|Overall Study|Adverse Event|0|||
33207681|NCT03449030|100661476|FG004|Overall Study|Adverse Event|0|||
33207682|NCT03449030|100661477|FG005|Overall Study|Adverse Event|2|||
33535323|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
33535324|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
33535325|NCT02717195|101859797|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
33535326|NCT02717195|101859798|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
33535327|NCT02717195|101859799|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
33535328|NCT02717195|101859800|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
33535329|NCT02717195|101859801|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
33207683|NCT03449030|100661478|FG006|Overall Study|Adverse Event|0|||
33207684|NCT03449030|100661479|FG007|Overall Study|Adverse Event|0|||
33207685|NCT03449030|100661480|FG008|Overall Study|Adverse Event|0|||
33207686|NCT03449030|100661481|FG009|Overall Study|Adverse Event|0|||
33207687|NCT03449030|100661472|FG000|Overall Study|Death|0|||
33207688|NCT03449030|100661473|FG001|Overall Study|Death|0|||
33207689|NCT03449030|100661474|FG002|Overall Study|Death|0|||
33535330|NCT02717195|101859797|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
33535331|NCT02717195|101859798|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
33535332|NCT02717195|101859799|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
33535333|NCT02717195|101859800|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
33613820|NCT03364309|102133911|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
33613821|NCT03364309|102133912|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
33613822|NCT03364309|102133913|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
33613823|NCT03364309|102133914|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
33613824|NCT03364309|102133915|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
33207690|NCT03449030|100661475|FG003|Overall Study|Death|0|||
33207691|NCT03449030|100661476|FG004|Overall Study|Death|1|||
33207692|NCT03449030|100661477|FG005|Overall Study|Death|0|||
33207693|NCT03449030|100661478|FG006|Overall Study|Death|0|||
33207694|NCT03449030|100661479|FG007|Overall Study|Death|0|||
33207695|NCT03449030|100661480|FG008|Overall Study|Death|0|||
33207696|NCT03449030|100661481|FG009|Overall Study|Death|0|||
33207697|NCT03743038|100661486|FG000|Overall Study|Physician Decision|1|||
33207698|NCT00553267|100661487|FG000|Overall Study|Adverse Event|8|||
33207699|NCT00553267|100661488|FG001|Overall Study|Adverse Event|10|||
33207700|NCT00553267|100661489|FG002|Overall Study|Adverse Event|5|||
33207701|NCT00553267|100661487|FG000|Overall Study|Non compliant with protocol|3|||
33207702|NCT00553267|100661488|FG001|Overall Study|Non compliant with protocol|3|||
33207703|NCT00553267|100661489|FG002|Overall Study|Non compliant with protocol|2|||
33207704|NCT00553267|100661487|FG000|Overall Study|Lost to Follow-up|0|||
33207705|NCT00553267|100661488|FG001|Overall Study|Lost to Follow-up|0|||
33207706|NCT00553267|100661489|FG002|Overall Study|Lost to Follow-up|1|||
33207707|NCT00553267|100661487|FG000|Overall Study|Consent withdrawn|2|||
33207708|NCT00553267|100661488|FG001|Overall Study|Consent withdrawn|3|||
33207709|NCT00553267|100661489|FG002|Overall Study|Consent withdrawn|1|||
33207710|NCT00553267|100661487|FG000|Overall Study|Specified category|1|||
33207711|NCT00553267|100661488|FG001|Overall Study|Specified category|2|||
33207712|NCT00553267|100661489|FG002|Overall Study|Specified category|1|||
33207713|NCT03266588|100661492|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
33207714|NCT03266588|100661493|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
33207715|NCT03266588|100661494|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
33207716|NCT03266588|100661492|FG000|Observational Period|Withdrawal by Subject|44|||
33207717|NCT03266588|100661493|FG001|Observational Period|Withdrawal by Subject|22|||
33207718|NCT03266588|100661494|FG002|Observational Period|Withdrawal by Subject|13|||
33207719|NCT03266588|100661492|FG000|Observational Period|Non-compliance|18|||
33207720|NCT03266588|100661493|FG001|Observational Period|Non-compliance|12|||
33207721|NCT03266588|100661494|FG002|Observational Period|Non-compliance|10|||
33207722|NCT03266588|100661492|FG000|Observational Period|Lost to Follow-up|8|||
33207723|NCT03266588|100661493|FG001|Observational Period|Lost to Follow-up|12|||
33207724|NCT03266588|100661494|FG002|Observational Period|Lost to Follow-up|4|||
33207725|NCT03266588|100661492|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
33207726|NCT03266588|100661493|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
33207727|NCT03266588|100661494|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
33207728|NCT03266588|100661492|FG000|Observational Period|Protocol Deviation|1|||
33207729|NCT03266588|100661493|FG001|Observational Period|Protocol Deviation|0|||
33207730|NCT03266588|100661494|FG002|Observational Period|Protocol Deviation|0|||
33207731|NCT03266588|100661492|FG000|Observational Period|Other Reasons|3|||
33207732|NCT03266588|100661493|FG001|Observational Period|Other Reasons|0|||
33207733|NCT03266588|100661494|FG002|Observational Period|Other Reasons|1|||
33207734|NCT03266588|100661492|FG000|Long-term Treatment Period|Adverse Event|33|||
33207735|NCT03266588|100661493|FG001|Long-term Treatment Period|Adverse Event|17|||
33207736|NCT03266588|100661494|FG002|Long-term Treatment Period|Adverse Event|8|||
33207737|NCT03266588|100661492|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
33207738|NCT03266588|100661493|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
33207739|NCT03266588|100661494|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
33207740|NCT03266588|100661492|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
33207741|NCT03266588|100661493|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
33207742|NCT03266588|100661494|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
33207743|NCT03266588|100661492|FG000|Long-term Treatment Period|Non-Compliance|126|||
33207744|NCT03266588|100661493|FG001|Long-term Treatment Period|Non-Compliance|57|||
33207745|NCT03266588|100661494|FG002|Long-term Treatment Period|Non-Compliance|7|||
33613825|NCT03364309|102133916|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
33613826|NCT03364309|102133917|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
33613827|NCT03364309|102133899|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
33613828|NCT03364309|102133900|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
33613829|NCT03364309|102133901|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
33613830|NCT03364309|102133902|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
33613831|NCT03364309|102133903|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
33613832|NCT03364309|102133904|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
33613833|NCT03364309|102133905|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
33613834|NCT03364309|102133906|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
33613835|NCT03364309|102133907|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
33207746|NCT03266588|100661492|FG000|Long-term Treatment Period|Pregnancy|11|||
33207747|NCT03266588|100661493|FG001|Long-term Treatment Period|Pregnancy|5|||
33207748|NCT03266588|100661494|FG002|Long-term Treatment Period|Pregnancy|0|||
33207749|NCT03266588|100661492|FG000|Long-term Treatment Period|Protocol Deviation|17|||
33207750|NCT03266588|100661493|FG001|Long-term Treatment Period|Protocol Deviation|10|||
33613836|NCT03364309|102133908|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
33207751|NCT03266588|100661494|FG002|Long-term Treatment Period|Protocol Deviation|4|||
33207752|NCT03266588|100661492|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
33207753|NCT03266588|100661493|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
33207754|NCT03266588|100661494|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
33207755|NCT03266588|100661492|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
33207756|NCT03266588|100661493|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
33207757|NCT03266588|100661494|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
33613837|NCT03364309|102133909|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
33207758|NCT03266588|100661492|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
33613838|NCT03364309|102133910|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
33207759|NCT03266588|100661493|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
33207760|NCT03266588|100661494|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
33207761|NCT03266588|100661492|FG000|Long-term Treatment Period|Other Reasons|5|||
33207762|NCT03266588|100661493|FG001|Long-term Treatment Period|Other Reasons|0|||
33207763|NCT03266588|100661494|FG002|Long-term Treatment Period|Other Reasons|0|||
33207764|NCT03266588|100661492|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
33207765|NCT03266588|100661493|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
33207766|NCT03266588|100661494|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
33207767|NCT02007577|100661496|FG000|Overall Study|Adverse Event|1|||
33207768|NCT02007577|100661497|FG001|Overall Study|Adverse Event|0|||
33207769|NCT02007577|100661496|FG000|Overall Study|Withdrawal by Subject|0|||
33207770|NCT02007577|100661497|FG001|Overall Study|Withdrawal by Subject|1|||
33207771|NCT02367911|100661501|FG000|Overall Study|Withdrawal by Subject|3|||
33207772|NCT02367911|100661502|FG001|Overall Study|Withdrawal by Subject|2|||
33207773|NCT02367911|100661501|FG000|Overall Study|Lost to Follow-up|2|||
33338768|NCT03605680|101132081|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
33207774|NCT02367911|100661502|FG001|Overall Study|Lost to Follow-up|2|||
33207775|NCT01730937|100661503|FG000|Overall Study|Protocol Violation|5|||
33207776|NCT01730937|100661504|FG001|Overall Study|Protocol Violation|11|||
33207777|NCT03832010|100661505|FG000|Overall Study|Withdrawal by Subject|2|||
33207778|NCT03832010|100661506|FG001|Overall Study|Withdrawal by Subject|1|||
33207779|NCT03832010|100661507|FG002|Overall Study|Withdrawal by Subject|0|||
33207780|NCT03832010|100661505|FG000|Overall Study|Lost to Follow-up|2|||
33207781|NCT03832010|100661506|FG001|Overall Study|Lost to Follow-up|1|||
33207782|NCT03832010|100661507|FG002|Overall Study|Lost to Follow-up|1|||
33207783|NCT02091726|100661508|FG000|Overall Study|Lost to Follow-up|6|||
33207784|NCT02653482|100661509|FG000|Overall Study|Death|1|||
33207785|NCT02653482|100661510|FG001|Overall Study|Death|1|||
33207786|NCT02647658|100661515|FG000|Overall Study|Consent refusal|15|||
33207787|NCT02647658|100661516|FG001|Overall Study|Consent refusal|24|||
33207788|NCT04401579|100661517|FG000|Overall Study|Death|23|||
33207789|NCT04401579|100661518|FG001|Overall Study|Death|36|||
33207790|NCT04401579|100661517|FG000|Overall Study|Lost to Follow-up|40|||
33207791|NCT04401579|100661518|FG001|Overall Study|Lost to Follow-up|41|||
33207792|NCT04401579|100661517|FG000|Overall Study|Withdrawal by Subject|8|||
33207793|NCT04401579|100661518|FG001|Overall Study|Withdrawal by Subject|16|||
33207794|NCT04401579|100661517|FG000|Overall Study|Physician Decision|1|||
33338769|NCT03605680|101132078|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33338770|NCT03605680|101132079|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33338771|NCT03605680|101132080|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33338772|NCT03605680|101132081|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
33338773|NCT03605680|101132078|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
33338774|NCT03605680|101132079|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
33338775|NCT03605680|101132080|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
33338776|NCT03605680|101132081|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
33338777|NCT03605680|101132078|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
33207795|NCT04401579|100661518|FG001|Overall Study|Physician Decision|2|||
33207796|NCT04401579|100661517|FG000|Overall Study|Became ineligible after enrollment|1|||
33207797|NCT04401579|100661518|FG001|Overall Study|Became ineligible after enrollment|1|||
33207798|NCT04401579|100661517|FG000|Overall Study|Enrolled but treatment not administered|7|||
33207799|NCT04401579|100661518|FG001|Overall Study|Enrolled but treatment not administered|9|||
33207800|NCT04401579|100661517|FG000|Overall Study|Adverse Event|2|||
33207801|NCT04401579|100661518|FG001|Overall Study|Adverse Event|1|||
33207802|NCT04401579|100661517|FG000|Overall Study|Scheduling error|1|||
33207803|NCT04401579|100661518|FG001|Overall Study|Scheduling error|2|||
33207804|NCT04401579|100661517|FG000|Overall Study|Transferred to another hospital|1|||
33207805|NCT04401579|100661518|FG001|Overall Study|Transferred to another hospital|2|||
33207806|NCT03301051|100661519|FG000|Overall Study|Adverse Event|0|||
33535334|NCT02717195|101859801|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
33535335|NCT02717195|101859797|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
33613839|NCT03364309|102133911|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
33613840|NCT03364309|102133912|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
33613841|NCT03364309|102133913|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
33207807|NCT03301051|100661520|FG001|Overall Study|Adverse Event|4|||
33207808|NCT03301051|100661519|FG000|Overall Study|Withdrawal by Subject|59|||
33535336|NCT02717195|101859798|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
33535337|NCT02717195|101859799|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
33535338|NCT02717195|101859800|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
33535339|NCT02717195|101859801|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
33535340|NCT02717195|101859797|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
33535341|NCT02717195|101859798|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
33535342|NCT02717195|101859799|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
33535343|NCT02717195|101859800|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
33535344|NCT02717195|101859801|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
33535345|NCT02717195|101859797|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
33535346|NCT02717195|101859798|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
33535347|NCT02717195|101859799|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
33535348|NCT02717195|101859800|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
33535349|NCT02717195|101859801|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
33535350|NCT02717195|101859797|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
33535351|NCT02717195|101859798|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
33535352|NCT02717195|101859799|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
33535353|NCT02717195|101859800|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
33535354|NCT02717195|101859801|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
33535355|NCT02717195|101859797|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
33535356|NCT02717195|101859798|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
33535357|NCT02717195|101859799|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
33535358|NCT02717195|101859800|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
33535359|NCT02717195|101859801|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
33535360|NCT02717195|101859797|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
33535361|NCT02717195|101859798|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
33535362|NCT02717195|101859799|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
33535363|NCT02717195|101859800|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
33535364|NCT02717195|101859801|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
33535365|NCT02717195|101859797|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
33535366|NCT02717195|101859798|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
33535367|NCT02717195|101859799|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
33535368|NCT02717195|101859800|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
33535369|NCT02717195|101859801|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
33535370|NCT02717195|101859797|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
33535371|NCT02717195|101859798|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
33535372|NCT02717195|101859799|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
33535373|NCT02717195|101859800|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
33535374|NCT02717195|101859801|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
33535375|NCT02717195|101859797|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
33535376|NCT02717195|101859798|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
33207809|NCT03301051|100661520|FG001|Overall Study|Withdrawal by Subject|65|||
33207810|NCT03301051|100661519|FG000|Overall Study|Lost to Follow-up|263|||
33207811|NCT03301051|100661520|FG001|Overall Study|Lost to Follow-up|282|||
33207812|NCT03301051|100661519|FG000|Overall Study|Protocol Violation|1|||
33207813|NCT03301051|100661520|FG001|Overall Study|Protocol Violation|3|||
33207814|NCT03301051|100661519|FG000|Overall Study|Physician Decision|1|||
33207815|NCT03301051|100661520|FG001|Overall Study|Physician Decision|3|||
33207816|NCT03301051|100661519|FG000|Overall Study|Death|1|||
33207817|NCT03301051|100661520|FG001|Overall Study|Death|1|||
33207818|NCT03301051|100661519|FG000|Overall Study|Miscellaneous|8|||
33207819|NCT03301051|100661520|FG001|Overall Study|Miscellaneous|4|||
33207820|NCT03301051|100661519|FG000|Overall Study|Randomized, not vaccinated|13|||
33207821|NCT03301051|100661520|FG001|Overall Study|Randomized, not vaccinated|10|||
33207822|NCT01914926|100661521|FG000|Overall Study|Adverse Event|1|||
33535377|NCT02717195|101859799|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
33535378|NCT02717195|101859800|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
33535379|NCT02717195|101859801|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
33535380|NCT02717195|101859797|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
33535381|NCT02717195|101859798|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
33535382|NCT02717195|101859799|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
33535383|NCT02717195|101859800|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
33535384|NCT02717195|101859801|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
33535385|NCT02717195|101859797|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
33535386|NCT02717195|101859798|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
33535387|NCT02717195|101859799|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
33535388|NCT02717195|101859800|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
33535389|NCT02717195|101859801|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
33535390|NCT02717195|101859797|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
33535391|NCT02717195|101859798|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
33535392|NCT02717195|101859799|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
33535393|NCT02717195|101859800|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
33535394|NCT02717195|101859801|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
33535395|NCT02717195|101859797|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
33535396|NCT02717195|101859798|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
33535397|NCT02717195|101859799|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
33535398|NCT02717195|101859800|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
33535399|NCT02717195|101859801|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
33535400|NCT03110354|101859802|FG000|Overall Study|Death|1|||
33535401|NCT03110354|101859803|FG001|Overall Study|Death|0|||
33535402|NCT03110354|101859804|FG002|Overall Study|Death|0|||
33535403|NCT03110354|101859805|FG003|Overall Study|Death|1|||
33535404|NCT03110354|101859806|FG004|Overall Study|Death|0|||
33613842|NCT03364309|102133914|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
33613843|NCT03364309|102133915|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
33613844|NCT03364309|102133916|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
33613845|NCT03364309|102133917|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
33613846|NCT02058563|102133921|FG000|Overall Study|Lost to Follow-up|26|||
33613847|NCT02058563|102133922|FG001|Overall Study|Lost to Follow-up|22|||
33613848|NCT02058563|102133921|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
33613849|NCT02058563|102133922|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
33613850|NCT02058563|102133921|FG000|Overall Study|Consent Withdrawal|1|||
33613851|NCT02058563|102133922|FG001|Overall Study|Consent Withdrawal|1|||
33613852|NCT02058563|102133921|FG000|Overall Study|Other (patient incarcerated)|0|||
33613853|NCT02058563|102133922|FG001|Overall Study|Other (patient incarcerated)|1|||
33535405|NCT03110354|101859802|FG000|Overall Study|Start of new therapy|0|||
33535406|NCT03110354|101859803|FG001|Overall Study|Start of new therapy|0|||
33535407|NCT03110354|101859804|FG002|Overall Study|Start of new therapy|0|||
33535408|NCT03110354|101859805|FG003|Overall Study|Start of new therapy|0|||
33535409|NCT03110354|101859806|FG004|Overall Study|Start of new therapy|1|||
33535410|NCT03110354|101859802|FG000|Overall Study|Failure to achieve response|2|||
33207823|NCT01914926|100661522|FG001|Overall Study|Adverse Event|0|||
33207824|NCT01914926|100661521|FG000|Overall Study|uncooperative, agitated and removed|0|||
33338778|NCT03605680|101132079|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
33338779|NCT03605680|101132080|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
33338780|NCT03605680|101132081|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
33338781|NCT03605680|101132078|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
33405375|NCT01874288|101373311|FG002|Overall Study|Progressive disease|3|||
33535411|NCT03110354|101859803|FG001|Overall Study|Failure to achieve response|3|||
33535412|NCT03110354|101859804|FG002|Overall Study|Failure to achieve response|0|||
33535413|NCT03110354|101859805|FG003|Overall Study|Failure to achieve response|2|||
33535414|NCT03110354|101859806|FG004|Overall Study|Failure to achieve response|1|||
33535415|NCT03110354|101859802|FG000|Overall Study|Progressive disease|1|||
33535416|NCT03110354|101859803|FG001|Overall Study|Progressive disease|1|||
33535417|NCT03110354|101859804|FG002|Overall Study|Progressive disease|3|||
33535418|NCT03110354|101859805|FG003|Overall Study|Progressive disease|4|||
33535419|NCT03110354|101859806|FG004|Overall Study|Progressive disease|2|||
33535420|NCT03110354|101859802|FG000|Overall Study|Adverse Event|0|||
33535421|NCT03110354|101859803|FG001|Overall Study|Adverse Event|0|||
33535422|NCT03110354|101859804|FG002|Overall Study|Adverse Event|0|||
33535423|NCT03110354|101859805|FG003|Overall Study|Adverse Event|2|||
33535424|NCT03110354|101859806|FG004|Overall Study|Adverse Event|2|||
33535425|NCT03110354|101859802|FG000|Overall Study|Other|0|||
33535426|NCT03110354|101859803|FG001|Overall Study|Other|0|||
33535427|NCT03110354|101859804|FG002|Overall Study|Other|0|||
33535428|NCT03110354|101859805|FG003|Overall Study|Other|1|||
33535429|NCT03110354|101859806|FG004|Overall Study|Other|1|||
33535430|NCT02329847|101859807|FG000|Overall Study|Death|4|||
33535431|NCT02329847|101859808|FG001|Overall Study|Death|4|||
33535432|NCT02329847|101859809|FG002|Overall Study|Death|22|||
33535433|NCT02329847|101859810|FG003|Overall Study|Death|12|||
33535434|NCT02329847|101859811|FG004|Overall Study|Death|20|||
33535435|NCT02329847|101859812|FG005|Overall Study|Death|13|||
33535436|NCT02329847|101859807|FG000|Overall Study|Lost to Follow-up|0|||
33535437|NCT02329847|101859808|FG001|Overall Study|Lost to Follow-up|0|||
33535438|NCT02329847|101859809|FG002|Overall Study|Lost to Follow-up|2|||
33535439|NCT02329847|101859810|FG003|Overall Study|Lost to Follow-up|3|||
33535440|NCT02329847|101859811|FG004|Overall Study|Lost to Follow-up|0|||
33535441|NCT02329847|101859812|FG005|Overall Study|Lost to Follow-up|1|||
33535442|NCT02329847|101859807|FG000|Overall Study|Physician Decision|0|||
33535443|NCT02329847|101859808|FG001|Overall Study|Physician Decision|0|||
33535444|NCT02329847|101859809|FG002|Overall Study|Physician Decision|0|||
33535445|NCT02329847|101859810|FG003|Overall Study|Physician Decision|0|||
33535446|NCT02329847|101859811|FG004|Overall Study|Physician Decision|1|||
33535447|NCT02329847|101859812|FG005|Overall Study|Physician Decision|0|||
33535448|NCT02329847|101859807|FG000|Overall Study|Withdrawal by Subject|2|||
33535449|NCT02329847|101859808|FG001|Overall Study|Withdrawal by Subject|1|||
33535450|NCT02329847|101859809|FG002|Overall Study|Withdrawal by Subject|5|||
33535451|NCT02329847|101859810|FG003|Overall Study|Withdrawal by Subject|7|||
33535452|NCT02329847|101859811|FG004|Overall Study|Withdrawal by Subject|8|||
33535453|NCT02329847|101859812|FG005|Overall Study|Withdrawal by Subject|3|||
33207825|NCT01914926|100661522|FG001|Overall Study|uncooperative, agitated and removed|1|||
33405376|NCT01874288|101373312|FG003|Overall Study|Progressive disease|5|||
33535454|NCT02329847|101859807|FG000|Overall Study|Other|1|||
33535455|NCT02329847|101859808|FG001|Overall Study|Other|2|||
33535456|NCT02329847|101859809|FG002|Overall Study|Other|6|||
33535457|NCT02329847|101859810|FG003|Overall Study|Other|13|||
33535458|NCT02329847|101859811|FG004|Overall Study|Other|10|||
33535459|NCT02329847|101859812|FG005|Overall Study|Other|3|||
33535460|NCT00614874|101859813|FG000|Overall Study|Protocol Violation|1|||
33535461|NCT00614874|101859813|FG000|Overall Study|Withdrawal by Subject|1|||
33535462|NCT02723188|101859816|FG000|Overall Study|Withdrawal by Subject|1|||
33535463|NCT02723188|101859817|FG001|Overall Study|Withdrawal by Subject|0|||
33535464|NCT02723188|101859818|FG002|Overall Study|Withdrawal by Subject|0|||
33207826|NCT01178853|100661523|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
33207827|NCT01178853|100661524|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
33338782|NCT03605680|101132079|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
33338783|NCT03605680|101132080|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
33338784|NCT03605680|101132081|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
33338785|NCT03605680|101132078|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
33338786|NCT03605680|101132079|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
33338787|NCT03605680|101132080|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
33338788|NCT03605680|101132081|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
33338789|NCT03605680|101132078|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
33338790|NCT03605680|101132079|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
33338791|NCT03605680|101132080|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
33338792|NCT03605680|101132081|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
33338793|NCT03605680|101132078|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
33338794|NCT03605680|101132079|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
33338795|NCT03605680|101132080|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
33338796|NCT03605680|101132081|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
33338797|NCT03605680|101132078|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
33338798|NCT03605680|101132079|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
33338799|NCT03605680|101132080|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
33338800|NCT03605680|101132081|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
33338801|NCT00903929|101132082|FG000|Overall Study|Withdrawal by Subject|0|||
33338802|NCT00903929|101132083|FG001|Overall Study|Withdrawal by Subject|0|||
33338803|NCT00903929|101132084|FG002|Overall Study|Withdrawal by Subject|1|||
33338804|NCT00903929|101132085|FG003|Overall Study|Withdrawal by Subject|2|||
33338805|NCT00903929|101132082|FG000|Overall Study|Adverse Event|0|||
33338806|NCT00903929|101132083|FG001|Overall Study|Adverse Event|0|||
33338807|NCT00903929|101132084|FG002|Overall Study|Adverse Event|0|||
33338808|NCT00903929|101132085|FG003|Overall Study|Adverse Event|1|||
33338809|NCT01106846|101132088|FG000|Overall Study|Change in surgical procedure|0|||
33338810|NCT01106846|101132089|FG001|Overall Study|Change in surgical procedure|1|||
33338811|NCT01035905|101132094|FG000|Overall Study|Lack of Efficacy|1|||
33405377|NCT01874288|101373313|FG004|Overall Study|Progressive disease|1|||
33405378|NCT00265109|101373314|FG000|Overall Study|Withdrawal by Subject|5|||
33405379|NCT00265109|101373314|FG000|Overall Study|Adverse Event|1|||
33405380|NCT00689728|101373315|FG000|Double-Blind Treatment|Adverse Event|1|||
33405381|NCT00689728|101373316|FG001|Double-Blind Treatment|Adverse Event|0|||
33405382|NCT00689728|101373317|FG002|Double-Blind Treatment|Adverse Event|0|||
33405383|NCT00689728|101373315|FG000|Double-Blind Treatment|Protocol Violation|0|||
33535465|NCT01630135|101859819|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
33535466|NCT01630135|101859820|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
33535467|NCT02254772|101859822|FG000|Overall Study|Ineligible|1|||
33535468|NCT02254772|101859822|FG000|Overall Study|Withdrawal by Subject|1|||
33535469|NCT00230048|101859826|FG000|Overall Study|Lost to Follow-up|13|||
33535470|NCT00230048|101859827|FG001|Overall Study|Lost to Follow-up|18|||
33535471|NCT01228591|101859828|FG000|Baseline|Lack of Efficacy|1|||
33535472|NCT01228591|101859829|FG001|Baseline|Lack of Efficacy|2|||
33535473|NCT04155463|101859833|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
33535474|NCT04155463|101859834|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
33535475|NCT00274742|101859835|FG000|Overall Study|Adverse Event|0|||
33535476|NCT00274742|101859836|FG001|Overall Study|Adverse Event|4|||
33535477|NCT00274742|101859837|FG002|Overall Study|Adverse Event|1|||
33535478|NCT00274742|101859838|FG003|Overall Study|Adverse Event|4|||
33535479|NCT00274742|101859839|FG004|Overall Study|Adverse Event|12|||
33535480|NCT00274742|101859840|FG005|Overall Study|Adverse Event|3|||
33535481|NCT00274742|101859835|FG000|Overall Study|Lost to Follow-up|0|||
33535482|NCT00274742|101859836|FG001|Overall Study|Lost to Follow-up|0|||
33535483|NCT00274742|101859837|FG002|Overall Study|Lost to Follow-up|0|||
33535484|NCT00274742|101859838|FG003|Overall Study|Lost to Follow-up|0|||
33535485|NCT00274742|101859839|FG004|Overall Study|Lost to Follow-up|1|||
33535486|NCT00274742|101859840|FG005|Overall Study|Lost to Follow-up|0|||
33535487|NCT00274742|101859835|FG000|Overall Study|End of Study|0|||
33535488|NCT00274742|101859836|FG001|Overall Study|End of Study|0|||
33207828|NCT01178853|100661523|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
33207829|NCT01178853|100661524|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
33535489|NCT00274742|101859837|FG002|Overall Study|End of Study|0|||
33207830|NCT01178853|100661523|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
33535490|NCT00274742|101859838|FG003|Overall Study|End of Study|1|||
33535491|NCT00274742|101859839|FG004|Overall Study|End of Study|0|||
33535492|NCT00274742|101859840|FG005|Overall Study|End of Study|0|||
33535493|NCT00274742|101859835|FG000|Overall Study|Disease Progression|0|||
33207831|NCT01178853|100661524|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
33338812|NCT01035905|101132095|FG001|Overall Study|Lack of Efficacy|1|||
33405384|NCT00689728|101373316|FG001|Double-Blind Treatment|Protocol Violation|0|||
33405385|NCT00689728|101373317|FG002|Double-Blind Treatment|Protocol Violation|1|||
33405386|NCT00689728|101373315|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
33405387|NCT00689728|101373316|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
33405388|NCT00689728|101373317|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
33405389|NCT00689728|101373315|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
33405390|NCT00689728|101373316|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
33405391|NCT00689728|101373317|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
33405392|NCT00689728|101373315|FG000|Rescue|Adverse Event|0|||
33405393|NCT00689728|101373316|FG001|Rescue|Adverse Event|1|||
33405394|NCT00689728|101373317|FG002|Rescue|Adverse Event|0|||
33405395|NCT00689728|101373315|FG000|Rescue|Withdrawal by Subject|1|||
33405396|NCT00689728|101373316|FG001|Rescue|Withdrawal by Subject|1|||
33338813|NCT01902966|101132096|FG000|Overall Study|Death|1|||
33338814|NCT01902966|101132096|FG000|Overall Study|Physician Decision|1|||
33338815|NCT01902966|101132096|FG000|Overall Study|Withdrawal by Subject|1|||
33338816|NCT02531646|101132100|FG000|Overall Study|equip. image processing issue|5|||
33338817|NCT02531646|101132101|FG001|Overall Study|equip. image processing issue|1|||
33338818|NCT02531646|101132102|FG002|Overall Study|equip. image processing issue|0|||
33338819|NCT00705939|101132103|FG000|Overall Study|Protocol Violation|0|||
33338820|NCT00705939|101132104|FG001|Overall Study|Protocol Violation|0|||
33338821|NCT00705939|101132105|FG002|Overall Study|Protocol Violation|1|||
33338822|NCT00705939|101132103|FG000|Overall Study|Withdrawal by Subject|0|||
33338823|NCT00705939|101132104|FG001|Overall Study|Withdrawal by Subject|1|||
33338824|NCT00705939|101132105|FG002|Overall Study|Withdrawal by Subject|3|||
33338825|NCT00705939|101132103|FG000|Overall Study|Physician Decision|0|||
33338826|NCT00705939|101132104|FG001|Overall Study|Physician Decision|1|||
33338827|NCT00705939|101132105|FG002|Overall Study|Physician Decision|0|||
33338828|NCT02543528|101132106|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
33338829|NCT02543528|101132107|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
33338830|NCT02543528|101132108|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
33338831|NCT02543528|101132109|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
33338832|NCT02543528|101132110|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
33338833|NCT02543528|101132106|FG000|Adaptation Period|Lens Handling Difficultes|0|||
33338834|NCT02543528|101132107|FG001|Adaptation Period|Lens Handling Difficultes|0|||
33338835|NCT02543528|101132108|FG002|Adaptation Period|Lens Handling Difficultes|0|||
33338836|NCT02543528|101132109|FG003|Adaptation Period|Lens Handling Difficultes|0|||
33338837|NCT02543528|101132110|FG004|Adaptation Period|Lens Handling Difficultes|8|||
33338838|NCT02543528|101132106|FG000|Adaptation Period|Lost to Follow-up|0|||
33338839|NCT02543528|101132107|FG001|Adaptation Period|Lost to Follow-up|0|||
33338840|NCT02543528|101132108|FG002|Adaptation Period|Lost to Follow-up|0|||
33338841|NCT02543528|101132109|FG003|Adaptation Period|Lost to Follow-up|0|||
33338842|NCT02543528|101132110|FG004|Adaptation Period|Lost to Follow-up|14|||
33338843|NCT02543528|101132106|FG000|Adaptation Period|Adverse Event|0|||
33338844|NCT02543528|101132107|FG001|Adaptation Period|Adverse Event|0|||
33338845|NCT02543528|101132108|FG002|Adaptation Period|Adverse Event|0|||
33338846|NCT02543528|101132109|FG003|Adaptation Period|Adverse Event|0|||
33338847|NCT02543528|101132110|FG004|Adaptation Period|Adverse Event|2|||
33338848|NCT02543528|101132106|FG000|Extended Wear Period|Adverse Event|17|||
33338849|NCT02543528|101132107|FG001|Extended Wear Period|Adverse Event|11|||
33338850|NCT02543528|101132108|FG002|Extended Wear Period|Adverse Event|16|||
33338851|NCT02543528|101132109|FG003|Extended Wear Period|Adverse Event|3|||
33338852|NCT02543528|101132110|FG004|Extended Wear Period|Adverse Event|0|||
33338853|NCT02543528|101132106|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
33338854|NCT02543528|101132107|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
33338855|NCT02543528|101132108|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
33405397|NCT00689728|101373317|FG002|Rescue|Withdrawal by Subject|1|||
33405398|NCT00689728|101373315|FG000|Optional Follow-Up|Adverse Event|1|||
33338856|NCT02543528|101132109|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
33338857|NCT02543528|101132110|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
33338858|NCT02543528|101132106|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
33405399|NCT00689728|101373316|FG001|Optional Follow-Up|Adverse Event|0|||
33405400|NCT00689728|101373317|FG002|Optional Follow-Up|Adverse Event|0|||
33405401|NCT00689728|101373315|FG000|Optional Follow-Up|Lack of Efficacy|0|||
33405402|NCT00689728|101373316|FG001|Optional Follow-Up|Lack of Efficacy|1|||
33405403|NCT00689728|101373317|FG002|Optional Follow-Up|Lack of Efficacy|1|||
33405404|NCT00689728|101373315|FG000|Optional Follow-Up|Lost to Follow-up|0|||
33405405|NCT00689728|101373316|FG001|Optional Follow-Up|Lost to Follow-up|1|||
33405406|NCT00689728|101373317|FG002|Optional Follow-Up|Lost to Follow-up|1|||
33338859|NCT02543528|101132107|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
33338860|NCT02543528|101132108|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
33338861|NCT02543528|101132109|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
33338862|NCT02543528|101132110|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
33405407|NCT00689728|101373315|FG000|Optional Follow-Up|Protocol Violation|0|||
33405408|NCT00689728|101373316|FG001|Optional Follow-Up|Protocol Violation|0|||
33405409|NCT00689728|101373317|FG002|Optional Follow-Up|Protocol Violation|1|||
33613854|NCT03922620|102133923|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
33613855|NCT03922620|102133924|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
33338863|NCT02543528|101132106|FG000|Extended Wear Period|Lost to Follow-up|0|||
33338864|NCT02543528|101132107|FG001|Extended Wear Period|Lost to Follow-up|1|||
33535494|NCT00274742|101859836|FG001|Overall Study|Disease Progression|1|||
33535495|NCT00274742|101859837|FG002|Overall Study|Disease Progression|1|||
33535496|NCT00274742|101859838|FG003|Overall Study|Disease Progression|0|||
33405410|NCT00689728|101373315|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
33338865|NCT02543528|101132108|FG002|Extended Wear Period|Lost to Follow-up|2|||
33338866|NCT02543528|101132109|FG003|Extended Wear Period|Lost to Follow-up|1|||
33338867|NCT02543528|101132110|FG004|Extended Wear Period|Lost to Follow-up|0|||
33338868|NCT02543528|101132106|FG000|Extended Wear Period|Withdrawal by Subject|10|||
33338869|NCT02543528|101132107|FG001|Extended Wear Period|Withdrawal by Subject|9|||
33338870|NCT02543528|101132108|FG002|Extended Wear Period|Withdrawal by Subject|4|||
33338871|NCT02543528|101132109|FG003|Extended Wear Period|Withdrawal by Subject|5|||
33338872|NCT02543528|101132110|FG004|Extended Wear Period|Withdrawal by Subject|0|||
33338873|NCT03718143|101132111|FG000|Overall Study|Death|1|||
33338874|NCT03718143|101132112|FG001|Overall Study|Death|0|||
33338875|NCT03718143|101132113|FG002|Overall Study|Death|0|||
33338876|NCT03718143|101132111|FG000|Overall Study|Progression of Disease|1|||
33338877|NCT03718143|101132112|FG001|Overall Study|Progression of Disease|0|||
33338878|NCT03718143|101132113|FG002|Overall Study|Progression of Disease|0|||
33338879|NCT03718143|101132111|FG000|Overall Study|Withdrawal of Informed Consent|1|||
33338880|NCT03718143|101132112|FG001|Overall Study|Withdrawal of Informed Consent|2|||
33338881|NCT03718143|101132113|FG002|Overall Study|Withdrawal of Informed Consent|1|||
33405411|NCT00689728|101373316|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
33405412|NCT00689728|101373317|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
33405413|NCT01967134|101373320|FG000|Overall Study|Lost to Follow-up|0|||
33405414|NCT01967134|101373321|FG001|Overall Study|Lost to Follow-up|1|||
33405415|NCT01967134|101373322|FG002|Overall Study|Lost to Follow-up|0|||
33405416|NCT04794491|101373325|FG000|Overall Study|Adverse Event|1|||
33405417|NCT04794491|101373325|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
33405418|NCT04794491|101373325|FG000|Overall Study|Noncompliance With Study Intervention|1|||
33405419|NCT04794491|101373325|FG000|Overall Study|Withdrawal by Subject|2|||
33535497|NCT00274742|101859839|FG004|Overall Study|Disease Progression|1|||
33535498|NCT00274742|101859840|FG005|Overall Study|Disease Progression|0|||
33535499|NCT00274742|101859835|FG000|Overall Study|Other|0|||
33535500|NCT00274742|101859836|FG001|Overall Study|Other|3|||
33535501|NCT00274742|101859837|FG002|Overall Study|Other|0|||
33535502|NCT00274742|101859838|FG003|Overall Study|Other|0|||
33535503|NCT00274742|101859839|FG004|Overall Study|Other|2|||
33535504|NCT00274742|101859840|FG005|Overall Study|Other|0|||
33535505|NCT03118934|101859841|FG000|Overall Study|Adverse Event|0|||
33535506|NCT03118934|101859842|FG001|Overall Study|Adverse Event|0|||
33535507|NCT03118934|101859843|FG002|Overall Study|Adverse Event|0|||
33535508|NCT03118934|101859844|FG003|Overall Study|Adverse Event|0|||
33535509|NCT03118934|101859845|FG004|Overall Study|Adverse Event|0|||
33535510|NCT03118934|101859846|FG005|Overall Study|Adverse Event|1|||
33535511|NCT03118934|101859841|FG000|Overall Study|Physician Decision|0|||
33535512|NCT03118934|101859842|FG001|Overall Study|Physician Decision|0|||
33535513|NCT03118934|101859843|FG002|Overall Study|Physician Decision|0|||
33535514|NCT03118934|101859844|FG003|Overall Study|Physician Decision|0|||
33535515|NCT03118934|101859845|FG004|Overall Study|Physician Decision|0|||
33535516|NCT03118934|101859846|FG005|Overall Study|Physician Decision|1|||
33535517|NCT03118934|101859841|FG000|Overall Study|Discontinued prior to exposure|0|||
33535518|NCT03118934|101859842|FG001|Overall Study|Discontinued prior to exposure|1|||
33535519|NCT03118934|101859843|FG002|Overall Study|Discontinued prior to exposure|1|||
33535520|NCT03118934|101859844|FG003|Overall Study|Discontinued prior to exposure|1|||
33535521|NCT03118934|101859845|FG004|Overall Study|Discontinued prior to exposure|2|||
33535522|NCT03118934|101859846|FG005|Overall Study|Discontinued prior to exposure|0|||
33338882|NCT02435849|101132118|FG000|Overall Study|Death|23|||
33338883|NCT02435849|101132119|FG001|Overall Study|Death|0|||
33338884|NCT02435849|101132118|FG000|Overall Study|Lack of Efficacy|10|||
33535523|NCT03131167|101859847|FG000|Overall Study|Other (Unspecified)|0|||
33338885|NCT02435849|101132119|FG001|Overall Study|Lack of Efficacy|0|||
33338886|NCT02435849|101132118|FG000|Overall Study|New therapy for study indication|8|||
33338887|NCT02435849|101132119|FG001|Overall Study|New therapy for study indication|0|||
33405420|NCT05604781|101373326|FG000|Overall Study|Lost to Follow-up|3|||
33405421|NCT05604781|101373326|FG000|Overall Study|Adverse Event|1|||
33535524|NCT03131167|101859848|FG001|Overall Study|Other (Unspecified)|0|||
33613856|NCT01279616|102133925|FG000|Overall Study|donor could not be located|5|||
33338888|NCT02435849|101132118|FG000|Overall Study|Subject/guardian decision|5|||
33535525|NCT03131167|101859849|FG002|Overall Study|Other (Unspecified)|0|||
33535526|NCT03131167|101859850|FG003|Overall Study|Other (Unspecified)|0|||
33535527|NCT03131167|101859851|FG004|Overall Study|Other (Unspecified)|0|||
33535528|NCT03131167|101859852|FG005|Overall Study|Other (Unspecified)|1|||
33338889|NCT02435849|101132119|FG001|Overall Study|Subject/guardian decision|1|||
33338890|NCT02435849|101132118|FG000|Overall Study|Lost to Follow-up|1|||
33338891|NCT02435849|101132119|FG001|Overall Study|Lost to Follow-up|0|||
33338892|NCT02435849|101132118|FG000|Overall Study|Physician Decision|1|||
33338893|NCT02435849|101132119|FG001|Overall Study|Physician Decision|0|||
33338894|NCT03551743|101132120|FG000|Overall Study|Adverse Event|1|||
33338895|NCT03551743|101132121|FG001|Overall Study|Adverse Event|0|||
33338896|NCT03551743|101132122|FG002|Overall Study|Adverse Event|0|||
33338897|NCT03551743|101132123|FG003|Overall Study|Adverse Event|0|||
33338898|NCT03551743|101132120|FG000|Overall Study|Withdrawal by Subject|1|||
33338899|NCT03551743|101132121|FG001|Overall Study|Withdrawal by Subject|0|||
33338900|NCT03551743|101132122|FG002|Overall Study|Withdrawal by Subject|0|||
33338901|NCT03551743|101132123|FG003|Overall Study|Withdrawal by Subject|0|||
33338902|NCT00130832|101132124|FG000|Overall Study|Adverse Event|1|||
33338903|NCT00130832|101132125|FG001|Overall Study|Adverse Event|1|||
33338904|NCT00130832|101132124|FG000|Overall Study|Lost to Follow-up|1|||
33338905|NCT00130832|101132125|FG001|Overall Study|Lost to Follow-up|2|||
33338906|NCT00130832|101132124|FG000|Overall Study|Protocol Violation|6|||
33338907|NCT00130832|101132125|FG001|Overall Study|Protocol Violation|8|||
33338908|NCT00130832|101132124|FG000|Overall Study|Withdrawal by Subject|6|||
33338909|NCT00130832|101132125|FG001|Overall Study|Withdrawal by Subject|1|||
33338910|NCT00130832|101132124|FG000|Overall Study|Moved|2|||
33338911|NCT00130832|101132125|FG001|Overall Study|Moved|2|||
33338912|NCT00130832|101132124|FG000|Overall Study|Other|0|||
33338913|NCT00130832|101132125|FG001|Overall Study|Other|3|||
33338914|NCT01877083|101132128|FG000|Treatment Phase|Disease Progression|10|||
33338915|NCT01877083|101132128|FG000|Treatment Phase|Clinical Progression|1|||
33338916|NCT01877083|101132128|FG000|Treatment Phase|Adverse Event|6|||
33338917|NCT01877083|101132128|FG000|Treatment Phase|Withdrawal by Subject|2|||
33338918|NCT01877083|101132128|FG000|Treatment Phase|Lost to Follow-up|1|||
33405422|NCT03672006|101373328|FG000|Overall Study|exclusion criteria met|0|||
33405423|NCT03672006|101373329|FG001|Overall Study|exclusion criteria met|1|||
33405424|NCT02146274|101373330|FG000|Overall Study|Protocol Violation|73|||
33405425|NCT01224171|101373331|FG000|Overall Study|Adverse Event|8|||
33405426|NCT01224171|101373332|FG001|Overall Study|Adverse Event|4|||
33405427|NCT01224171|101373331|FG000|Overall Study|Protocol Violation|0|||
33405428|NCT01224171|101373332|FG001|Overall Study|Protocol Violation|1|||
33405429|NCT01224171|101373331|FG000|Overall Study|Lack of Efficacy|5|||
33405430|NCT01224171|101373332|FG001|Overall Study|Lack of Efficacy|1|||
33405431|NCT01224171|101373331|FG000|Overall Study|Withdrawal of Consent|2|||
33405432|NCT01224171|101373332|FG001|Overall Study|Withdrawal of Consent|4|||
33405433|NCT01224171|101373331|FG000|Overall Study|Lost to Follow-up|0|||
33405434|NCT01224171|101373332|FG001|Overall Study|Lost to Follow-up|3|||
33405435|NCT04557189|101373335|FG000|Overall Study|Adverse Event|0|||
33405436|NCT04557189|101373336|FG001|Overall Study|Adverse Event|1|||
33405437|NCT04557189|101373335|FG000|Overall Study|Lost to Follow-up|1|||
33405438|NCT04557189|101373336|FG001|Overall Study|Lost to Follow-up|1|||
33405439|NCT04557189|101373335|FG000|Overall Study|Withdrawal by Subject|2|||
33405440|NCT04557189|101373336|FG001|Overall Study|Withdrawal by Subject|1|||
33405441|NCT04557189|101373335|FG000|Overall Study|Reason not Specified|3|||
33405442|NCT04557189|101373336|FG001|Overall Study|Reason not Specified|6|||
33405443|NCT03650387|101373346|FG000|Overall Study|Withdrawal by Subject|13|||
33405444|NCT03650387|101373346|FG000|Overall Study|Lost to Follow-up|12|||
33613857|NCT01279616|102133925|FG000|Overall Study|no signs of sickle cell disease|2|||
33613858|NCT01371552|102133927|FG000|Part 1, First 3 Days|Inconvenience|0|||
33613859|NCT01371552|102133928|FG001|Part 1, First 3 Days|Inconvenience|0|||
33613860|NCT01371552|102133929|FG002|Part 1, First 3 Days|Inconvenience|1|||
33613861|NCT01371552|102133930|FG003|Part 1, First 3 Days|Inconvenience|0|||
33613862|NCT01371552|102133931|FG004|Part 1, First 3 Days|Inconvenience|0|||
33338919|NCT01877083|101132128|FG000|Extension Phase|Disease Progression|3|||
33338920|NCT01877083|101132128|FG000|Extension Phase|Adverse Event|2|||
33338921|NCT01110200|101132130|FG000|Overall Study|Adverse Event|28|||
33338922|NCT01110200|101132131|FG001|Overall Study|Adverse Event|28|||
33338923|NCT01110200|101132130|FG000|Overall Study|Withdrawal by Subject|25|||
33338924|NCT01110200|101132131|FG001|Overall Study|Withdrawal by Subject|32|||
33338925|NCT01110200|101132130|FG000|Overall Study|Lack of Efficacy|16|||
33405445|NCT03650387|101373346|FG000|Overall Study|Adverse Event (Not related)|1|||
33405446|NCT03650387|101373346|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
33613863|NCT01371552|102133932|FG005|Part 1, First 3 Days|Inconvenience|0|||
33613864|NCT03416127|102133937|FG000|Overall Study|Withdrawal by Subject|0|||
33613865|NCT03416127|102133938|FG001|Overall Study|Withdrawal by Subject|1|||
33338926|NCT01110200|101132131|FG001|Overall Study|Lack of Efficacy|25|||
33338927|NCT01110200|101132130|FG000|Overall Study|Protocol Violation|14|||
33338928|NCT01110200|101132131|FG001|Overall Study|Protocol Violation|12|||
33405447|NCT04034225|101373348|FG000|Overall Study|Death|3|||
33405448|NCT04034225|101373348|FG000|Overall Study|Withdrawal by Subject|2|||
33405449|NCT04034225|101373348|FG000|Overall Study|Study termination by Sponsor|18|||
33405450|NCT04034225|101373348|FG000|Overall Study|Physician Decision|1|||
33613866|NCT03416127|102133939|FG002|Overall Study|Withdrawal by Subject|1|||
33613867|NCT00599755|102133945|FG000|Overall Study|Adverse Event|11|||
33613868|NCT00599755|102133945|FG000|Overall Study|Withdrawal by Subject|2|||
33613869|NCT00599755|102133945|FG000|Overall Study|Progression of Disease|3|||
33613870|NCT00599755|102133945|FG000|Overall Study|Other Reason|2|||
33613871|NCT00599755|102133945|FG000|Overall Study|No data available|1|||
33613872|NCT01128946|102133946|FG000|Period I|Protocol Violation|0|||
33613873|NCT01128946|102133947|FG001|Period I|Protocol Violation|1|||
33613874|NCT01128946|102133948|FG002|Period I|Protocol Violation|0|||
33613875|NCT01128946|102133949|FG003|Period I|Protocol Violation|0|||
33613876|NCT01128946|102133946|FG000|Period I|Withdrawal by Subject|0|||
33613877|NCT01128946|102133947|FG001|Period I|Withdrawal by Subject|0|||
33613878|NCT01128946|102133948|FG002|Period I|Withdrawal by Subject|1|||
33613879|NCT01128946|102133949|FG003|Period I|Withdrawal by Subject|1|||
33613880|NCT01128946|102133946|FG000|Period II|Protocol Violation|0|||
33613881|NCT01128946|102133947|FG001|Period II|Protocol Violation|1|||
33613882|NCT01128946|102133948|FG002|Period II|Protocol Violation|0|||
33613883|NCT01128946|102133949|FG003|Period II|Protocol Violation|0|||
33613884|NCT01128946|102133946|FG000|Period II|Withdrawal by Subject|0|||
33613885|NCT01128946|102133947|FG001|Period II|Withdrawal by Subject|0|||
33613886|NCT01128946|102133948|FG002|Period II|Withdrawal by Subject|0|||
33613887|NCT01128946|102133949|FG003|Period II|Withdrawal by Subject|1|||
33613888|NCT01128946|102133946|FG000|Period III|Protocol Violation|1|||
33613889|NCT01128946|102133947|FG001|Period III|Protocol Violation|0|||
33613890|NCT01128946|102133948|FG002|Period III|Protocol Violation|0|||
33613891|NCT01128946|102133949|FG003|Period III|Protocol Violation|0|||
33613892|NCT03679624|102133950|FG000|Overall Study|Adverse Event|1|||
33613893|NCT03679624|102133951|FG001|Overall Study|Adverse Event|0|||
33613894|NCT03282097|102133954|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
33613895|NCT03282097|102133955|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
33613896|NCT03282097|102133954|FG000|Intervention Visit Complete|Patient Death|13|||
33613897|NCT03282097|102133955|FG001|Intervention Visit Complete|Patient Death|15|||
33613898|NCT03282097|102133954|FG000|Intervention Visit Complete|Caregiver Death|0|||
33613899|NCT03282097|102133955|FG001|Intervention Visit Complete|Caregiver Death|3|||
33613900|NCT03282097|102133954|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
33613901|NCT03282097|102133955|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
33613902|NCT03282097|102133954|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
33613903|NCT03282097|102133955|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
33613904|NCT03282097|102133954|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
33613905|NCT03282097|102133955|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
33613906|NCT03282097|102133954|FG000|Primary Outcome Data Collection Complete|Missing|2|||
33613907|NCT03282097|102133955|FG001|Primary Outcome Data Collection Complete|Missing|3|||
33613908|NCT03282097|102133954|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
33613909|NCT03282097|102133955|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
33613910|NCT03282097|102133954|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
33613911|NCT03282097|102133955|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
33613912|NCT03282097|102133954|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
33613913|NCT03282097|102133955|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
33613914|NCT02679287|102133956|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
33613915|NCT02679287|102133957|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
33613916|NCT02679287|102133956|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
33613917|NCT02679287|102133957|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
33613918|NCT02679287|102133956|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
33613919|NCT02679287|102133957|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
33613920|NCT02679287|102133956|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
33613921|NCT02679287|102133957|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
33613922|NCT02679287|102133956|FG000|Period 2|Work/Scheduling Conflict|1|||
33613923|NCT02679287|102133957|FG001|Period 2|Work/Scheduling Conflict|0|||
33613924|NCT02679287|102133956|FG000|Period 2|Disliked Mobile System|2|||
33613925|NCT02679287|102133957|FG001|Period 2|Disliked Mobile System|0|||
33613926|NCT02679287|102133956|FG000|Period 3|Work/Scheduling Conflict|0|||
33613927|NCT02679287|102133957|FG001|Period 3|Work/Scheduling Conflict|1|||
33613928|NCT03654885|102133958|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
33613929|NCT03654885|102133959|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
33613930|NCT03654885|102133958|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
33613931|NCT03654885|102133959|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
33613932|NCT03654885|102133958|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
33613933|NCT03654885|102133959|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
33631280|NCT03279081|102202900|FG001|Overall Study|Reason not Specified|4|||
33338929|NCT01110200|101132130|FG000|Overall Study|Physician Decision|13|||
33338930|NCT01110200|101132131|FG001|Overall Study|Physician Decision|17|||
33338931|NCT01110200|101132130|FG000|Overall Study|Lost to Follow-up|10|||
33338932|NCT01110200|101132131|FG001|Overall Study|Lost to Follow-up|7|||
33338933|NCT03529773|101132132|FG000|Overall Study|Adverse Event|0|||
33338934|NCT03529773|101132133|FG001|Overall Study|Adverse Event|0|||
33338935|NCT03529773|101132134|FG002|Overall Study|Adverse Event|0|||
33338936|NCT03529773|101132135|FG003|Overall Study|Adverse Event|0|||
33338937|NCT03529773|101132136|FG004|Overall Study|Adverse Event|0|||
33338938|NCT03529773|101132137|FG005|Overall Study|Adverse Event|0|||
33338939|NCT03529773|101132138|FG006|Overall Study|Adverse Event|0|||
33338940|NCT03529773|101132139|FG007|Overall Study|Adverse Event|0|||
33338941|NCT03529773|101132140|FG008|Overall Study|Adverse Event|0|||
33338942|NCT03529773|101132141|FG009|Overall Study|Adverse Event|0|||
33405451|NCT04034225|101373348|FG000|Overall Study|Lack of Efficacy|1|||
33405452|NCT04409262|101373349|FG000|Overall Study|Adverse Event|0|||
33535529|NCT03131167|101859853|FG006|Overall Study|Other (Unspecified)|0|||
33535530|NCT03131167|101859854|FG007|Overall Study|Other (Unspecified)|0|||
33535531|NCT03131167|101859855|FG008|Overall Study|Other (Unspecified)|0|||
33535532|NCT03131167|101859856|FG009|Overall Study|Other (Unspecified)|0|||
33535533|NCT03131167|101859857|FG010|Overall Study|Other (Unspecified)|0|||
33535534|NCT03131167|101859858|FG011|Overall Study|Other (Unspecified)|0|||
33535535|NCT03131167|101859859|FG012|Overall Study|Other (Unspecified)|0|||
33535536|NCT02438280|101859860|FG000|Overall Study|Physician Decision|1|||
33535537|NCT02438280|101859861|FG001|Overall Study|Physician Decision|0|||
33535538|NCT01093846|101859862|FG000|Overall Study|Adverse Event|0|||
33535539|NCT01093846|101859863|FG001|Overall Study|Adverse Event|0|||
33535540|NCT01093846|101859864|FG002|Overall Study|Adverse Event|1|||
33535541|NCT01093846|101859862|FG000|Overall Study|Lack of Efficacy|0|||
33535542|NCT01093846|101859863|FG001|Overall Study|Lack of Efficacy|0|||
33535543|NCT01093846|101859864|FG002|Overall Study|Lack of Efficacy|4|||
33535544|NCT01093846|101859862|FG000|Overall Study|Condition no longer required study drug|1|||
33535545|NCT01093846|101859863|FG001|Overall Study|Condition no longer required study drug|1|||
33535546|NCT01093846|101859864|FG002|Overall Study|Condition no longer required study drug|1|||
33535547|NCT01093846|101859862|FG000|Overall Study|Administrative Problems|18|||
33535548|NCT01093846|101859863|FG001|Overall Study|Administrative Problems|17|||
33535549|NCT01093846|101859864|FG002|Overall Study|Administrative Problems|15|||
33535550|NCT03769649|101859865|FG000|Overall Study|Lost to Follow-up|4|||
33535551|NCT01704755|101859866|FG000|Overall Study|Adverse Event|4|||
33535552|NCT01704755|101859867|FG001|Overall Study|Adverse Event|1|||
33535553|NCT01704755|101859866|FG000|Overall Study|Lost to Follow-up|3|||
33535554|NCT01704755|101859867|FG001|Overall Study|Lost to Follow-up|4|||
33535555|NCT01704755|101859866|FG000|Overall Study|Withdrew consent|1|||
33535556|NCT01704755|101859867|FG001|Overall Study|Withdrew consent|1|||
33535557|NCT01704755|101859866|FG000|Overall Study|Other (not specified)|3|||
33535558|NCT01704755|101859867|FG001|Overall Study|Other (not specified)|1|||
33535559|NCT01704755|101859866|FG000|Overall Study|Withdrew consent and personal issues|1|||
33535560|NCT01704755|101859867|FG001|Overall Study|Withdrew consent and personal issues|0|||
33535561|NCT03934216|101859871|FG000|Overall Study|Other Reasons|5|||
33535562|NCT03934216|101859872|FG001|Overall Study|Other Reasons|5|||
33535563|NCT03934216|101859871|FG000|Overall Study|Adverse Event|22|||
33535564|NCT03934216|101859872|FG001|Overall Study|Adverse Event|11|||
33535565|NCT03934216|101859871|FG000|Overall Study|Lack of Efficacy|8|||
33535566|NCT03934216|101859872|FG001|Overall Study|Lack of Efficacy|7|||
33535567|NCT03934216|101859871|FG000|Overall Study|Lost to Follow-up|2|||
33535568|NCT03934216|101859872|FG001|Overall Study|Lost to Follow-up|0|||
33535569|NCT03934216|101859871|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33535570|NCT03934216|101859872|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33535571|NCT03934216|101859871|FG000|Overall Study|Pregnancy|1|||
33535572|NCT03934216|101859872|FG001|Overall Study|Pregnancy|0|||
33535573|NCT03934216|101859871|FG000|Overall Study|Withdrawal by Subject|18|||
33535574|NCT03934216|101859872|FG001|Overall Study|Withdrawal by Subject|6|||
33535575|NCT03934216|101859871|FG000|Overall Study|Randomized but not treated|1|||
33338943|NCT03529773|101132142|FG010|Overall Study|Adverse Event|0|||
33338944|NCT03529773|101132143|FG011|Overall Study|Adverse Event|0|||
33405453|NCT04409262|101373350|FG001|Overall Study|Adverse Event|2|||
33405454|NCT04409262|101373349|FG000|Overall Study|Death|55|||
33535576|NCT03934216|101859872|FG001|Overall Study|Randomized but not treated|1|||
33535577|NCT02567188|101859874|FG000|Overall Study|Death|10|||
33535578|NCT02567188|101859874|FG000|Overall Study|Terminated Mircera Treatment|9|||
33535579|NCT02567188|101859874|FG000|Overall Study|Lost to Follow-up|5|||
33535580|NCT02567188|101859874|FG000|Overall Study|Adverse Event|1|||
33535581|NCT02567188|101859874|FG000|Overall Study|Withdrawal by Subject|1|||
33535582|NCT02567188|101859874|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
33535583|NCT02567188|101859874|FG000|Overall Study|Moved and Changed Clinic|1|||
33535584|NCT02567188|101859874|FG000|Overall Study|Started Hemodialysis|2|||
33535585|NCT02567188|101859874|FG000|Overall Study|Protocol Violation|5|||
33535586|NCT01305564|101859879|FG000|Overall Study|Death|21|||
33535587|NCT01305564|101859879|FG000|Overall Study|Lost to Follow-up|12|||
33535588|NCT01305564|101859879|FG000|Overall Study|Withdrawal by Subject|1|||
33535589|NCT01305564|101859879|FG000|Overall Study|Physician Decision|3|||
33535590|NCT00232557|101859882|FG000|Overall Study|Lost to Follow-up|3|||
33535591|NCT00232557|101859883|FG001|Overall Study|Lost to Follow-up|5|||
33535592|NCT00661089|101859884|FG000|Overall Study|1 subject withdrawal|0|||
33338945|NCT03529773|101132144|FG012|Overall Study|Adverse Event|0|||
33338946|NCT03529773|101132145|FG013|Overall Study|Adverse Event|0|||
33207832|NCT01178853|100661523|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
33338947|NCT03529773|101132146|FG014|Overall Study|Adverse Event|0|||
33338948|NCT03529773|101132147|FG015|Overall Study|Adverse Event|0|||
33338949|NCT03529773|101132148|FG016|Overall Study|Adverse Event|0|||
33338950|NCT03529773|101132149|FG017|Overall Study|Adverse Event|0|||
33535593|NCT00661089|101859885|FG001|Overall Study|1 subject withdrawal|1|||
33535594|NCT00661089|101859884|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
33535595|NCT00661089|101859885|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
33535596|NCT02033759|101859886|FG000|Overall Study|Withdrawal by Subject|2|||
33535597|NCT02033759|101859887|FG001|Overall Study|Withdrawal by Subject|1|||
33613934|NCT03654885|102133958|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
33613935|NCT03654885|102133959|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
33613936|NCT03654885|102133958|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
33613937|NCT03654885|102133959|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
33613938|NCT03654885|102133958|FG000|Overall Study|Adverse Event in Study Eye|3|||
33613939|NCT03654885|102133959|FG001|Overall Study|Adverse Event in Study Eye|0|||
33613940|NCT03654885|102133958|FG000|Overall Study|Consent Withdrawn|1|||
33613941|NCT03654885|102133959|FG001|Overall Study|Consent Withdrawn|0|||
33613942|NCT03654885|102133958|FG000|Overall Study|Death|3|||
33613943|NCT03654885|102133959|FG001|Overall Study|Death|1|||
33613944|NCT03654885|102133958|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
33613945|NCT03654885|102133959|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
33613946|NCT03654885|102133958|FG000|Overall Study|Lost to Follow-up|3|||
33613947|NCT03654885|102133959|FG001|Overall Study|Lost to Follow-up|3|||
33613948|NCT02863328|102133960|FG000|Overall Study|Lost to Follow-up|4|||
33613949|NCT02863328|102133961|FG001|Overall Study|Lost to Follow-up|10|||
33613950|NCT02863328|102133960|FG000|Overall Study|Withdrawal by Subject|7|||
33613951|NCT02863328|102133961|FG001|Overall Study|Withdrawal by Subject|12|||
33613952|NCT02863328|102133960|FG000|Overall Study|Died|0|||
33613953|NCT02863328|102133961|FG001|Overall Study|Died|1|||
33613954|NCT02218008|102133964|FG000|Stage 1 (S1)|Adverse Event|6|||
33613955|NCT02218008|102133965|FG001|Stage 1 (S1)|Adverse Event|5|||
33613956|NCT02218008|102133966|FG002|Stage 1 (S1)|Adverse Event|11|||
33613957|NCT02218008|102133967|FG003|Stage 1 (S1)|Adverse Event|0|||
33613958|NCT02218008|102133968|FG004|Stage 1 (S1)|Adverse Event|0|||
33613959|NCT02218008|102133969|FG005|Stage 1 (S1)|Adverse Event|0|||
33613960|NCT02218008|102133964|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
33613961|NCT02218008|102133965|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
33613962|NCT02218008|102133966|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
33613963|NCT02218008|102133967|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
33207833|NCT01178853|100661524|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
33207834|NCT01178853|100661523|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
33207835|NCT01178853|100661524|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
33338951|NCT03529773|101132150|FG018|Overall Study|Adverse Event|0|||
33338952|NCT03529773|101132151|FG019|Overall Study|Adverse Event|0|||
33338953|NCT03529773|101132152|FG020|Overall Study|Adverse Event|0|||
33338954|NCT03529773|101132153|FG021|Overall Study|Adverse Event|0|||
33338955|NCT03529773|101132154|FG022|Overall Study|Adverse Event|0|||
33338956|NCT03529773|101132155|FG023|Overall Study|Adverse Event|0|||
33338957|NCT03529773|101132156|FG024|Overall Study|Adverse Event|0|||
33338958|NCT03529773|101132157|FG025|Overall Study|Adverse Event|0|||
33338959|NCT03529773|101132158|FG026|Overall Study|Adverse Event|0|||
33338960|NCT03529773|101132159|FG027|Overall Study|Adverse Event|0|||
33338961|NCT03529773|101132160|FG028|Overall Study|Adverse Event|0|||
33613964|NCT02218008|102133968|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
33613965|NCT02218008|102133969|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
33613966|NCT02218008|102133964|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
33207836|NCT02105948|100661525|FG000|Overall Study|Adverse Event|10|||
33338962|NCT03529773|101132161|FG029|Overall Study|Adverse Event|0|||
33338963|NCT03529773|101132162|FG030|Overall Study|Adverse Event|1|||
33535598|NCT02033759|101859886|FG000|Overall Study|Protocol Violation|1|||
33535599|NCT02033759|101859887|FG001|Overall Study|Protocol Violation|1|||
33535600|NCT01619865|101859888|FG000|Overall Study|Adverse Event|1|||
33613967|NCT02218008|102133965|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
33613968|NCT02218008|102133966|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
33613969|NCT02218008|102133967|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
33613970|NCT02218008|102133968|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
33535601|NCT01619865|101859888|FG000|Overall Study|Death|2|||
33535602|NCT01619865|101859888|FG000|Overall Study|subject not able to comply|1|||
33535603|NCT00789321|101859889|FG000|Overall Study|Adverse Event|0|||
33535604|NCT00789321|101859890|FG001|Overall Study|Adverse Event|1|||
33535605|NCT00141518|101859895|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
33535606|NCT00141518|101859896|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
33535607|NCT00141518|101859897|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
33535608|NCT00141518|101859895|FG000|Overall Study|Adverse Event|7|||
33535609|NCT00141518|101859896|FG001|Overall Study|Adverse Event|5|||
33535610|NCT00141518|101859897|FG002|Overall Study|Adverse Event|2|||
33535611|NCT00141518|101859895|FG000|Overall Study|Withdrawal by Subject|2|||
33535612|NCT00141518|101859896|FG001|Overall Study|Withdrawal by Subject|0|||
33535613|NCT00141518|101859897|FG002|Overall Study|Withdrawal by Subject|2|||
33535614|NCT00141518|101859895|FG000|Overall Study|Protocol Violation|1|||
33535615|NCT00141518|101859896|FG001|Overall Study|Protocol Violation|1|||
33535616|NCT00141518|101859897|FG002|Overall Study|Protocol Violation|2|||
33535617|NCT00141518|101859895|FG000|Overall Study|Lack of Efficacy|5|||
33613971|NCT02218008|102133969|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
33613972|NCT02218008|102133964|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
33535618|NCT00141518|101859896|FG001|Overall Study|Lack of Efficacy|0|||
33535619|NCT00141518|101859897|FG002|Overall Study|Lack of Efficacy|0|||
33535620|NCT04350827|101859898|FG000|Overall Study|Lost to Follow-up|1|||
33535621|NCT04350827|101859899|FG001|Overall Study|Lost to Follow-up|2|||
33535622|NCT01914393|101859905|FG000|Overall Study|Protocol Violation|11|||
33535623|NCT01914393|101859906|FG001|Overall Study|Protocol Violation|3|||
33613973|NCT02218008|102133965|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
33613974|NCT02218008|102133966|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
33613975|NCT02218008|102133967|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
33613976|NCT02218008|102133968|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
33613977|NCT02218008|102133969|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
33613978|NCT02218008|102133964|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
33613979|NCT02218008|102133965|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
33613980|NCT02218008|102133966|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
33613981|NCT02218008|102133967|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
33613982|NCT02218008|102133968|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
33613983|NCT02218008|102133969|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
33338964|NCT03529773|101132163|FG031|Overall Study|Adverse Event|0|||
33405455|NCT04409262|101373350|FG001|Overall Study|Death|97|||
33405456|NCT04409262|101373349|FG000|Overall Study|Lost to Follow-up|12|||
33405457|NCT04409262|101373350|FG001|Overall Study|Lost to Follow-up|23|||
33405458|NCT04409262|101373349|FG000|Overall Study|Lack of Staff|0|||
33405459|NCT04409262|101373350|FG001|Overall Study|Lack of Staff|1|||
33405460|NCT04409262|101373349|FG000|Overall Study|Protocol Violation|3|||
33405461|NCT04409262|101373350|FG001|Overall Study|Protocol Violation|1|||
33405462|NCT04409262|101373349|FG000|Overall Study|Withdrawal by Subject|5|||
33405463|NCT04409262|101373350|FG001|Overall Study|Withdrawal by Subject|10|||
33405464|NCT01345162|101373351|FG000|Overall Study|Protocol Violation|2|||
33535624|NCT01914393|101859907|FG002|Overall Study|Protocol Violation|19|||
33613984|NCT02218008|102133964|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
33613985|NCT02218008|102133965|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
33613986|NCT02218008|102133966|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
33613987|NCT02218008|102133967|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
33338965|NCT03529773|101132164|FG032|Overall Study|Adverse Event|0|||
33338966|NCT03529773|101132165|FG033|Overall Study|Adverse Event|0|||
33338967|NCT03529773|101132166|FG034|Overall Study|Adverse Event|0|||
33338968|NCT03529773|101132167|FG035|Overall Study|Adverse Event|1|||
33338969|NCT03529773|101132168|FG036|Overall Study|Adverse Event|0|||
33338970|NCT03529773|101132169|FG037|Overall Study|Adverse Event|0|||
33338971|NCT03529773|101132170|FG038|Overall Study|Adverse Event|1|||
33338972|NCT03529773|101132171|FG039|Overall Study|Adverse Event|1|||
33613988|NCT02218008|102133968|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
33405465|NCT01345162|101373352|FG001|Overall Study|Protocol Violation|4|||
33613989|NCT02218008|102133969|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
33405466|NCT00724243|101373357|FG000|Overall Study|Lack of Efficacy|10|||
33405467|NCT00724243|101373357|FG000|Overall Study|Adverse Event|5|||
33613990|NCT02218008|102133964|FG000|Stage 1 (S1)|Pregnancy|0|||
33613991|NCT02218008|102133965|FG001|Stage 1 (S1)|Pregnancy|0|||
33613992|NCT02218008|102133966|FG002|Stage 1 (S1)|Pregnancy|1|||
33338973|NCT03529773|101132132|FG000|Overall Study|Death|0|||
33338974|NCT03529773|101132133|FG001|Overall Study|Death|0|||
33405468|NCT01354964|101373358|FG000|Overall Study|Lost to Follow-up|2|||
33535625|NCT01914393|101859905|FG000|Overall Study|Lack of Efficacy|11|||
33535626|NCT01914393|101859906|FG001|Overall Study|Lack of Efficacy|16|||
33535627|NCT01914393|101859907|FG002|Overall Study|Lack of Efficacy|5|||
33535628|NCT01914393|101859905|FG000|Overall Study|no reason given|14|||
33535629|NCT01914393|101859906|FG001|Overall Study|no reason given|8|||
33535630|NCT01914393|101859907|FG002|Overall Study|no reason given|16|||
33535631|NCT01914393|101859905|FG000|Overall Study|Adverse Event|29|||
33535632|NCT01914393|101859906|FG001|Overall Study|Adverse Event|18|||
33535633|NCT01914393|101859907|FG002|Overall Study|Adverse Event|31|||
33535634|NCT01914393|101859905|FG000|Overall Study|Withdrawal by Subject|38|||
33535635|NCT01914393|101859906|FG001|Overall Study|Withdrawal by Subject|20|||
33535636|NCT01914393|101859907|FG002|Overall Study|Withdrawal by Subject|47|||
33535637|NCT01914393|101859905|FG000|Overall Study|Lost to Follow-up|12|||
33535638|NCT01914393|101859906|FG001|Overall Study|Lost to Follow-up|6|||
33535639|NCT01914393|101859907|FG002|Overall Study|Lost to Follow-up|19|||
33535640|NCT01914393|101859905|FG000|Overall Study|subject never dosed|0|||
33535641|NCT01914393|101859906|FG001|Overall Study|subject never dosed|0|||
33535642|NCT01914393|101859907|FG002|Overall Study|subject never dosed|1|||
33535643|NCT00838097|101859911|FG000|Overall Study|Ineligibility determined|6|||
33535644|NCT00838097|101859911|FG000|Overall Study|Adverse Event|2|||
33535645|NCT00838097|101859911|FG000|Overall Study|Withdrawal by Subject|3|||
33535646|NCT00838097|101859911|FG000|Overall Study|Requirement for alternative therapy|2|||
33535647|NCT00838097|101859911|FG000|Overall Study|Physician Decision|4|||
33535648|NCT00838097|101859911|FG000|Overall Study|Lost to Follow-up|11|||
33535649|NCT00838097|101859911|FG000|Overall Study|Death|6|||
33535650|NCT00838097|101859911|FG000|Overall Study|Protocol-specified criteria|142|||
33338975|NCT03529773|101132134|FG002|Overall Study|Death|0|||
33338976|NCT03529773|101132135|FG003|Overall Study|Death|0|||
33338977|NCT03529773|101132136|FG004|Overall Study|Death|0|||
33338978|NCT03529773|101132137|FG005|Overall Study|Death|0|||
33338979|NCT03529773|101132138|FG006|Overall Study|Death|0|||
33338980|NCT03529773|101132139|FG007|Overall Study|Death|0|||
33338981|NCT03529773|101132140|FG008|Overall Study|Death|0|||
33338982|NCT03529773|101132141|FG009|Overall Study|Death|0|||
33338983|NCT03529773|101132142|FG010|Overall Study|Death|0|||
33338984|NCT03529773|101132143|FG011|Overall Study|Death|0|||
33338985|NCT03529773|101132144|FG012|Overall Study|Death|1|||
33338986|NCT03529773|101132145|FG013|Overall Study|Death|0|||
33338987|NCT03529773|101132146|FG014|Overall Study|Death|0|||
33338988|NCT03529773|101132147|FG015|Overall Study|Death|0|||
33338989|NCT03529773|101132148|FG016|Overall Study|Death|0|||
33338990|NCT03529773|101132149|FG017|Overall Study|Death|0|||
33338991|NCT03529773|101132150|FG018|Overall Study|Death|0|||
33338992|NCT03529773|101132151|FG019|Overall Study|Death|1|||
33338993|NCT03529773|101132152|FG020|Overall Study|Death|0|||
33338994|NCT03529773|101132153|FG021|Overall Study|Death|0|||
33405469|NCT01354964|101373359|FG001|Overall Study|Lost to Follow-up|0|||
33535651|NCT01705080|101859912|FG000|Overall Study|Missed visit|10|||
33535652|NCT01705080|101859913|FG001|Overall Study|Missed visit|4|||
33535653|NCT01705080|101859914|FG002|Overall Study|Missed visit|1|||
33207837|NCT02105948|100661526|FG001|Overall Study|Adverse Event|7|||
33338995|NCT03529773|101132154|FG022|Overall Study|Death|1|||
33338996|NCT03529773|101132155|FG023|Overall Study|Death|0|||
33338997|NCT03529773|101132156|FG024|Overall Study|Death|0|||
33535654|NCT01705080|101859912|FG000|Overall Study|Death|4|||
33535655|NCT01705080|101859913|FG001|Overall Study|Death|4|||
33535656|NCT01705080|101859914|FG002|Overall Study|Death|6|||
33535657|NCT01705080|101859912|FG000|Overall Study|Withdrawal by Subject|61|||
33207838|NCT02105948|100661527|FG002|Overall Study|Adverse Event|11|||
33207839|NCT02105948|100661528|FG003|Overall Study|Adverse Event|11|||
33207840|NCT02105948|100661525|FG000|Overall Study|Lack of Efficacy|0|||
33207841|NCT02105948|100661526|FG001|Overall Study|Lack of Efficacy|1|||
33207842|NCT02105948|100661527|FG002|Overall Study|Lack of Efficacy|3|||
33207843|NCT02105948|100661528|FG003|Overall Study|Lack of Efficacy|2|||
33207844|NCT02105948|100661525|FG000|Overall Study|Lost to Follow-up|0|||
33207845|NCT02105948|100661526|FG001|Overall Study|Lost to Follow-up|0|||
33207846|NCT02105948|100661527|FG002|Overall Study|Lost to Follow-up|2|||
33207847|NCT02105948|100661528|FG003|Overall Study|Lost to Follow-up|1|||
33207848|NCT02105948|100661525|FG000|Overall Study|Physician Decision|2|||
33207849|NCT02105948|100661526|FG001|Overall Study|Physician Decision|2|||
33207850|NCT02105948|100661527|FG002|Overall Study|Physician Decision|2|||
33207851|NCT02105948|100661528|FG003|Overall Study|Physician Decision|2|||
33207852|NCT02105948|100661525|FG000|Overall Study|Withdrawal by Subject|15|||
33207853|NCT02105948|100661526|FG001|Overall Study|Withdrawal by Subject|10|||
33207854|NCT02105948|100661527|FG002|Overall Study|Withdrawal by Subject|10|||
33207855|NCT02105948|100661528|FG003|Overall Study|Withdrawal by Subject|11|||
33207856|NCT02682264|100661529|FG000|Overall Study|Withdrawal by Subject|56|||
33207857|NCT02682264|100661530|FG001|Overall Study|Withdrawal by Subject|45|||
33207858|NCT02682264|100661529|FG000|Overall Study|Lost to Follow-up|49|||
33207859|NCT02682264|100661530|FG001|Overall Study|Lost to Follow-up|41|||
33207860|NCT02682264|100661529|FG000|Overall Study|Lack of Efficacy|14|||
33207861|NCT02682264|100661530|FG001|Overall Study|Lack of Efficacy|16|||
33207862|NCT02682264|100661529|FG000|Overall Study|Withdrawal by Parent|6|||
33207863|NCT02682264|100661530|FG001|Overall Study|Withdrawal by Parent|7|||
33207864|NCT02682264|100661529|FG000|Overall Study|Adverse Event|9|||
33207865|NCT02682264|100661530|FG001|Overall Study|Adverse Event|0|||
33207866|NCT02682264|100661529|FG000|Overall Study|Noncompliance with study drug|1|||
33207867|NCT02682264|100661530|FG001|Overall Study|Noncompliance with study drug|4|||
33207868|NCT02682264|100661529|FG000|Overall Study|Pregnancy|1|||
33207869|NCT02682264|100661530|FG001|Overall Study|Pregnancy|2|||
33207870|NCT02682264|100661529|FG000|Overall Study|Recovery|1|||
33207871|NCT02682264|100661530|FG001|Overall Study|Recovery|2|||
33207872|NCT02682264|100661529|FG000|Overall Study|Progressive Disease|1|||
33207873|NCT02682264|100661530|FG001|Overall Study|Progressive Disease|0|||
33207874|NCT02682264|100661529|FG000|Overall Study|Technical Problems|0|||
33207875|NCT02682264|100661530|FG001|Overall Study|Technical Problems|1|||
33207876|NCT02682264|100661529|FG000|Overall Study|Moved abroad and unable to continue|0|||
33207877|NCT02682264|100661530|FG001|Overall Study|Moved abroad and unable to continue|3|||
33207878|NCT02682264|100661529|FG000|Overall Study|Stopped test article application|0|||
33207879|NCT02682264|100661530|FG001|Overall Study|Stopped test article application|1|||
33207880|NCT02459574|100661532|FG000|Overall Study|Withdrawal by Subject|6|||
33207881|NCT02459574|100661533|FG001|Overall Study|Withdrawal by Subject|6|||
33207882|NCT02459574|100661534|FG002|Overall Study|Withdrawal by Subject|2|||
33207883|NCT02459574|100661532|FG000|Overall Study|Lost to Follow-up|1|||
33207884|NCT02459574|100661533|FG001|Overall Study|Lost to Follow-up|1|||
33207885|NCT02459574|100661534|FG002|Overall Study|Lost to Follow-up|0|||
33207886|NCT02459574|100661532|FG000|Overall Study|Death|0|||
33207887|NCT02459574|100661533|FG001|Overall Study|Death|1|||
33207888|NCT02459574|100661534|FG002|Overall Study|Death|0|||
33207889|NCT02012491|100661539|FG000|Overall Study|Lost to Follow-up|1|||
33207890|NCT02012491|100661540|FG001|Overall Study|Lost to Follow-up|0|||
33207891|NCT02012491|100661539|FG000|Overall Study|Protocol Violation|0|||
33207892|NCT02012491|100661540|FG001|Overall Study|Protocol Violation|1|||
33207893|NCT02012491|100661539|FG000|Overall Study|Withdrawal by Subject|1|||
33207894|NCT02012491|100661540|FG001|Overall Study|Withdrawal by Subject|0|||
33207895|NCT02252211|100661543|FG000|Overall Study|Adverse Event|0|||
33207896|NCT02252211|100661544|FG001|Overall Study|Adverse Event|1|||
33207897|NCT02252211|100661545|FG002|Overall Study|Adverse Event|0|||
33207898|NCT02252211|100661543|FG000|Overall Study|Progressive disease|3|||
33207899|NCT02252211|100661544|FG001|Overall Study|Progressive disease|2|||
33207900|NCT02252211|100661545|FG002|Overall Study|Progressive disease|0|||
33405470|NCT01354964|101373358|FG000|Overall Study|IV access issues|1|||
33613993|NCT02218008|102133967|FG003|Stage 1 (S1)|Pregnancy|0|||
33613994|NCT02218008|102133968|FG004|Stage 1 (S1)|Pregnancy|0|||
33613995|NCT02218008|102133969|FG005|Stage 1 (S1)|Pregnancy|0|||
33207901|NCT02252211|100661543|FG000|Overall Study|Withdrawal by Subject|1|||
33207902|NCT02252211|100661544|FG001|Overall Study|Withdrawal by Subject|0|||
33207903|NCT02252211|100661545|FG002|Overall Study|Withdrawal by Subject|0|||
33207904|NCT02252211|100661543|FG000|Overall Study|Serious Adverse Event During Screening|1|||
33207905|NCT02252211|100661544|FG001|Overall Study|Serious Adverse Event During Screening|0|||
33207906|NCT02252211|100661545|FG002|Overall Study|Serious Adverse Event During Screening|1|||
33207907|NCT00201006|100661548|FG000|Overall Study|Withdrawal by Subject|7|||
33207908|NCT00201006|100661549|FG001|Overall Study|Withdrawal by Subject|2|||
33207909|NCT00201006|100661550|FG002|Overall Study|Withdrawal by Subject|3|||
33207910|NCT00201006|100661548|FG000|Overall Study|Adverse Event|1|||
33207911|NCT00201006|100661549|FG001|Overall Study|Adverse Event|0|||
33613996|NCT02218008|102133964|FG000|Stage 1 (S1)|Protocol Violation|0|||
33207912|NCT00201006|100661550|FG002|Overall Study|Adverse Event|1|||
33207913|NCT00896168|100661551|FG000|Overall Study|Adverse Event|4|||
33207914|NCT00896168|100661552|FG001|Overall Study|Adverse Event|7|||
33207915|NCT00896168|100661551|FG000|Overall Study|Treatment failure|8|||
33207916|NCT00896168|100661552|FG001|Overall Study|Treatment failure|10|||
33207917|NCT00896168|100661551|FG000|Overall Study|Lost to Follow-up|1|||
33207918|NCT00896168|100661552|FG001|Overall Study|Lost to Follow-up|1|||
33207919|NCT00896168|100661551|FG000|Overall Study|Other|1|||
33207920|NCT00896168|100661552|FG001|Overall Study|Other|1|||
33207921|NCT03998618|100661553|FG000|Overall Study|Death|7|||
33207922|NCT03998618|100661554|FG001|Overall Study|Death|11|||
33338998|NCT03529773|101132157|FG025|Overall Study|Death|0|||
33338999|NCT03529773|101132158|FG026|Overall Study|Death|0|||
33207923|NCT03998618|100661553|FG000|Overall Study|hospice enrollment|3|||
33207924|NCT03998618|100661554|FG001|Overall Study|hospice enrollment|3|||
33207925|NCT03998618|100661553|FG000|Overall Study|Not feeling well/health problems|3|||
33207926|NCT03998618|100661554|FG001|Overall Study|Not feeling well/health problems|5|||
33207927|NCT03998618|100661553|FG000|Overall Study|Lost to Follow-up|6|||
33207928|NCT03998618|100661554|FG001|Overall Study|Lost to Follow-up|6|||
33207929|NCT03998618|100661553|FG000|Overall Study|Withdrawal by Subject|0|||
33207930|NCT03998618|100661554|FG001|Overall Study|Withdrawal by Subject|4|||
33207931|NCT00121238|100661555|FG000|Overall Study|disease progression before intervention|1|||
33207932|NCT00121238|100661555|FG000|Overall Study|Protocol Violation|2|||
33207933|NCT00987467|100661556|FG000|Overall Study|Lost to Follow-up|2|||
33207934|NCT01585103|100661557|FG000|Overall Study|Unable to swallow Cytosponge|6|||
33207935|NCT02504294|100661558|FG000|Overall Study|Adverse Event|15|||
33207936|NCT02504294|100661559|FG001|Overall Study|Adverse Event|12|||
33207937|NCT02504294|100661558|FG000|Overall Study|Withdrawal by Subject|7|||
33207938|NCT02504294|100661559|FG001|Overall Study|Withdrawal by Subject|1|||
33207939|NCT02504294|100661558|FG000|Overall Study|Protocol Violation|27|||
33207940|NCT02504294|100661559|FG001|Overall Study|Protocol Violation|26|||
33207941|NCT02504294|100661558|FG000|Overall Study|Physician Decision|1|||
33207942|NCT02504294|100661559|FG001|Overall Study|Physician Decision|2|||
33207943|NCT02504294|100661558|FG000|Overall Study|Lost to Follow-up|6|||
33207944|NCT02504294|100661559|FG001|Overall Study|Lost to Follow-up|7|||
33207945|NCT03019536|100661560|FG000|Overall Study|Withdrawal by Subject|1|||
33207946|NCT03019536|100661561|FG001|Overall Study|Withdrawal by Subject|1|||
33207947|NCT03019536|100661562|FG002|Overall Study|Withdrawal by Subject|0|||
33207948|NCT03019536|100661560|FG000|Overall Study|Adverse Event|0|||
33207949|NCT03019536|100661561|FG001|Overall Study|Adverse Event|0|||
33207950|NCT03019536|100661562|FG002|Overall Study|Adverse Event|2|||
33207951|NCT05553808|100661563|FG000|Overall Study|Death|25|||
33207952|NCT05553808|100661564|FG001|Overall Study|Death|62|||
33207953|NCT05553808|100661563|FG000|Overall Study|Site Closed|6|||
33207954|NCT05553808|100661564|FG001|Overall Study|Site Closed|6|||
33207955|NCT05553808|100661563|FG000|Overall Study|Lost to Follow-up|1|||
33207956|NCT05553808|100661564|FG001|Overall Study|Lost to Follow-up|0|||
33207957|NCT05553808|100661563|FG000|Overall Study|Withdrawal by Subject|3|||
33207958|NCT05553808|100661564|FG001|Overall Study|Withdrawal by Subject|2|||
33207959|NCT04969250|100661565|FG000|Overall Study|Protocol Violation|0|||
33207960|NCT04969250|100661566|FG001|Overall Study|Protocol Violation|2|||
33339000|NCT03529773|101132159|FG027|Overall Study|Death|0|||
33339001|NCT03529773|101132160|FG028|Overall Study|Death|0|||
33339002|NCT03529773|101132161|FG029|Overall Study|Death|0|||
33339003|NCT03529773|101132162|FG030|Overall Study|Death|0|||
33339004|NCT03529773|101132163|FG031|Overall Study|Death|0|||
33339005|NCT03529773|101132164|FG032|Overall Study|Death|0|||
33339006|NCT03529773|101132165|FG033|Overall Study|Death|1|||
33339007|NCT03529773|101132166|FG034|Overall Study|Death|1|||
33339008|NCT03529773|101132167|FG035|Overall Study|Death|0|||
33405471|NCT01354964|101373359|FG001|Overall Study|IV access issues|1|||
33207961|NCT04969250|100661567|FG002|Overall Study|Protocol Violation|3|||
33405472|NCT01354964|101373358|FG000|Overall Study|Physician Decision|1|||
33405473|NCT01354964|101373359|FG001|Overall Study|Physician Decision|0|||
33405474|NCT00660829|101373360|FG000|Overall Study|Adverse Event|3|||
33207962|NCT04969250|100661568|FG003|Overall Study|Protocol Violation|8|||
33207963|NCT04969250|100661565|FG000|Overall Study|Withdrawal by Subject|0|||
33207964|NCT04969250|100661566|FG001|Overall Study|Withdrawal by Subject|1|||
33207965|NCT04969250|100661567|FG002|Overall Study|Withdrawal by Subject|0|||
33207966|NCT04969250|100661568|FG003|Overall Study|Withdrawal by Subject|0|||
33207967|NCT01666002|100661573|FG000|Overall Study|Lost to Follow-up|5|||
33207968|NCT01666002|100661574|FG001|Overall Study|Lost to Follow-up|0|||
33207969|NCT01669122|100661578|FG000|Period I|Lost to Follow-up|1|||
33207970|NCT01669122|100661578|FG000|Washout Period II|Protocol Violation|2|||
33207971|NCT05608629|100661581|FG000|Overall Study|Lost to Follow-up|2|||
33339009|NCT03529773|101132168|FG036|Overall Study|Death|1|||
33339010|NCT03529773|101132169|FG037|Overall Study|Death|0|||
33207972|NCT00715429|100661582|FG000|Overall Study|Did not complete the study diary|0|||
33339011|NCT03529773|101132170|FG038|Overall Study|Death|0|||
33339012|NCT03529773|101132171|FG039|Overall Study|Death|0|||
33339013|NCT03529773|101132132|FG000|Overall Study|Lost to Follow-up|0|||
33207973|NCT00715429|100661583|FG001|Overall Study|Did not complete the study diary|1|||
33207974|NCT01054820|100661586|FG000|Overall Study|Withdrawal by Subject|2|||
33207975|NCT02937545|100661590|FG000|Overall Study|Withdrawal by Subject|1|||
33207976|NCT02937545|100661591|FG001|Overall Study|Withdrawal by Subject|2|||
33207977|NCT02937545|100661592|FG002|Overall Study|Withdrawal by Subject|6|||
33207978|NCT02937545|100661593|FG003|Overall Study|Withdrawal by Subject|7|||
33207979|NCT02937545|100661590|FG000|Overall Study|Lost to Follow-up|1|||
33207980|NCT02937545|100661591|FG001|Overall Study|Lost to Follow-up|0|||
33207981|NCT02937545|100661592|FG002|Overall Study|Lost to Follow-up|0|||
33207982|NCT02937545|100661593|FG003|Overall Study|Lost to Follow-up|0|||
33207983|NCT03166618|100661594|FG000|Overall Study|Study was Terminated|0|||
33207984|NCT03166618|100661595|FG001|Overall Study|Study was Terminated|1|||
33207985|NCT03643952|100661598|FG000|Overall Study|Lack of Efficacy|1|||
33207986|NCT05554237|100661599|FG000|Part 2 (7 Days)|Adverse Event|0|||
33207987|NCT05554237|100661600|FG001|Part 2 (7 Days)|Adverse Event|0|||
33207988|NCT05554237|100661601|FG002|Part 2 (7 Days)|Adverse Event|0|||
33207989|NCT05554237|100661602|FG003|Part 2 (7 Days)|Adverse Event|0|||
33207990|NCT05554237|100661603|FG004|Part 2 (7 Days)|Adverse Event|2|||
33207991|NCT05554237|100661604|FG005|Part 2 (7 Days)|Adverse Event|0|||
33613997|NCT02218008|102133965|FG001|Stage 1 (S1)|Protocol Violation|0|||
33613998|NCT02218008|102133966|FG002|Stage 1 (S1)|Protocol Violation|1|||
33207992|NCT05554237|100661605|FG006|Part 2 (7 Days)|Adverse Event|0|||
33207993|NCT05554237|100661606|FG007|Part 2 (7 Days)|Adverse Event|0|||
33207994|NCT05554237|100661607|FG008|Part 2 (7 Days)|Adverse Event|0|||
33207995|NCT05554237|100661608|FG009|Part 2 (7 Days)|Adverse Event|1|||
33207996|NCT05554237|100661609|FG010|Part 2 (7 Days)|Adverse Event|0|||
33207997|NCT05554237|100661610|FG011|Part 2 (7 Days)|Adverse Event|0|||
33207998|NCT05554237|100661611|FG012|Part 2 (7 Days)|Adverse Event|1|||
33207999|NCT05554237|100661612|FG013|Part 2 (7 Days)|Adverse Event|0|||
33208000|NCT02479412|100661614|FG000|Overall Study|Adverse Event|0|||
33208001|NCT02479412|100661615|FG001|Overall Study|Adverse Event|0|||
33208002|NCT02479412|100661616|FG002|Overall Study|Adverse Event|1|||
33208003|NCT02479412|100661617|FG003|Overall Study|Adverse Event|0|||
33208004|NCT02479412|100661618|FG004|Overall Study|Adverse Event|0|||
33208005|NCT02479412|100661619|FG005|Overall Study|Adverse Event|0|||
33208006|NCT02479412|100661620|FG006|Overall Study|Adverse Event|0|||
33208007|NCT02479412|100661621|FG007|Overall Study|Adverse Event|0|||
33208008|NCT02479412|100661622|FG008|Overall Study|Adverse Event|0|||
33208009|NCT02479412|100661614|FG000|Overall Study|Study-specific withdrawal criteria|0|||
33208010|NCT02479412|100661615|FG001|Overall Study|Study-specific withdrawal criteria|0|||
33208011|NCT02479412|100661616|FG002|Overall Study|Study-specific withdrawal criteria|1|||
33208012|NCT02479412|100661617|FG003|Overall Study|Study-specific withdrawal criteria|1|||
33208013|NCT02479412|100661618|FG004|Overall Study|Study-specific withdrawal criteria|0|||
33208014|NCT02479412|100661619|FG005|Overall Study|Study-specific withdrawal criteria|0|||
33208015|NCT02479412|100661620|FG006|Overall Study|Study-specific withdrawal criteria|0|||
33208016|NCT02479412|100661621|FG007|Overall Study|Study-specific withdrawal criteria|1|||
33208017|NCT02479412|100661622|FG008|Overall Study|Study-specific withdrawal criteria|1|||
33208018|NCT02479412|100661614|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
33208019|NCT02479412|100661615|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
33208020|NCT02479412|100661616|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
33208021|NCT02479412|100661617|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
33535658|NCT01705080|101859913|FG001|Overall Study|Withdrawal by Subject|44|||
33535659|NCT01705080|101859914|FG002|Overall Study|Withdrawal by Subject|9|||
33535660|NCT00372424|101859915|FG000|Overall Study|Adverse Event|2|||
33535661|NCT00372424|101859915|FG000|Overall Study|Withdrawal by Subject|1|||
33535662|NCT00372424|101859915|FG000|Overall Study|Death|1|||
33535663|NCT00372424|101859915|FG000|Overall Study|Objective Progression or Relapse|14|||
33535664|NCT00372424|101859915|FG000|Overall Study|Other|7|||
33535665|NCT00372424|101859915|FG000|Overall Study|Enrolled, Not Treated|1|||
33535666|NCT00928434|101859916|FG000|Overall Study|Adverse Event|14|||
33535667|NCT00928434|101859917|FG001|Overall Study|Adverse Event|5|||
33613999|NCT02218008|102133967|FG003|Stage 1 (S1)|Protocol Violation|0|||
33208022|NCT02479412|100661618|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
33208023|NCT02479412|100661619|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
33208024|NCT02479412|100661620|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
33208025|NCT02479412|100661621|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
33535668|NCT00928434|101859918|FG002|Overall Study|Adverse Event|18|||
33535669|NCT00928434|101859916|FG000|Overall Study|Protocol Violation|5|||
33535670|NCT00928434|101859917|FG001|Overall Study|Protocol Violation|0|||
33614000|NCT02218008|102133968|FG004|Stage 1 (S1)|Protocol Violation|0|||
33208026|NCT02479412|100661622|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
33208027|NCT04137380|100661632|FG000|Overall Study|Physician Decision|0|||
33208028|NCT04137380|100661633|FG001|Overall Study|Physician Decision|0|||
33208029|NCT04137380|100661634|FG002|Overall Study|Physician Decision|0|||
33208030|NCT04137380|100661635|FG003|Overall Study|Physician Decision|1|||
33339014|NCT03529773|101132133|FG001|Overall Study|Lost to Follow-up|0|||
33535671|NCT00928434|101859918|FG002|Overall Study|Protocol Violation|8|||
33535672|NCT00928434|101859916|FG000|Overall Study|Physician Decision|2|||
33535673|NCT00928434|101859917|FG001|Overall Study|Physician Decision|0|||
33535674|NCT00928434|101859918|FG002|Overall Study|Physician Decision|3|||
33535675|NCT00928434|101859916|FG000|Overall Study|Lost to Follow-up|1|||
33535676|NCT00928434|101859917|FG001|Overall Study|Lost to Follow-up|0|||
33535677|NCT00928434|101859918|FG002|Overall Study|Lost to Follow-up|3|||
33535678|NCT00928434|101859916|FG000|Overall Study|Withdrawal by Subject|5|||
33535679|NCT00928434|101859917|FG001|Overall Study|Withdrawal by Subject|3|||
33535680|NCT00928434|101859918|FG002|Overall Study|Withdrawal by Subject|2|||
33535681|NCT00928434|101859916|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
33535682|NCT00928434|101859917|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
33535683|NCT00928434|101859918|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
33535684|NCT00928434|101859916|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
33535685|NCT00928434|101859917|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
33535686|NCT00928434|101859918|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
33535687|NCT00928434|101859916|FG000|Overall Study|Other (not meeting above criteria)|5|||
33535688|NCT00928434|101859917|FG001|Overall Study|Other (not meeting above criteria)|1|||
33535689|NCT00928434|101859918|FG002|Overall Study|Other (not meeting above criteria)|2|||
33535690|NCT04460326|101859919|FG000|Completed at Least 4 Meals|Early discharge|5|||
33535691|NCT04460326|101859920|FG001|Completed at Least 4 Meals|Early discharge|5|||
33535692|NCT04460326|101859919|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
33535693|NCT04460326|101859920|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
33535694|NCT04460326|101859919|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
33535695|NCT04460326|101859920|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
33535696|NCT04460326|101859919|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
33535697|NCT04460326|101859920|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
33208031|NCT04137380|100661636|FG004|Overall Study|Physician Decision|0|||
33208032|NCT04137380|100661637|FG005|Overall Study|Physician Decision|0|||
33208033|NCT04137380|100661638|FG006|Overall Study|Physician Decision|0|||
33208034|NCT01939028|100661639|FG000|Overall Study|Withdrawal by Subject|5|||
33208035|NCT01939028|100661639|FG000|Overall Study|Physician Decision|7|||
33208036|NCT01613248|100661640|FG000|Overall Study|Adverse Event|0|||
33208037|NCT01613248|100661641|FG001|Overall Study|Adverse Event|0|||
33208038|NCT01613248|100661642|FG002|Overall Study|Adverse Event|0|||
33208039|NCT01613248|100661643|FG003|Overall Study|Adverse Event|1|||
33535698|NCT04460326|101859919|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
33535699|NCT04460326|101859920|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
33208040|NCT01613248|100661644|FG004|Overall Study|Adverse Event|0|||
33208041|NCT01613248|100661645|FG005|Overall Study|Adverse Event|0|||
33208042|NCT01613248|100661640|FG000|Overall Study|Withdrawal by Subject|3|||
33208043|NCT01613248|100661641|FG001|Overall Study|Withdrawal by Subject|2|||
33208044|NCT01613248|100661642|FG002|Overall Study|Withdrawal by Subject|2|||
33208045|NCT01613248|100661643|FG003|Overall Study|Withdrawal by Subject|5|||
33208046|NCT01613248|100661644|FG004|Overall Study|Withdrawal by Subject|0|||
33208047|NCT01613248|100661645|FG005|Overall Study|Withdrawal by Subject|1|||
33208048|NCT01613248|100661640|FG000|Overall Study|Lost to Follow-up|5|||
33208049|NCT01613248|100661641|FG001|Overall Study|Lost to Follow-up|7|||
33208050|NCT01613248|100661642|FG002|Overall Study|Lost to Follow-up|4|||
33208051|NCT01613248|100661643|FG003|Overall Study|Lost to Follow-up|8|||
33208052|NCT01613248|100661644|FG004|Overall Study|Lost to Follow-up|4|||
33208053|NCT01613248|100661645|FG005|Overall Study|Lost to Follow-up|2|||
33535700|NCT04460326|101859919|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
33535701|NCT04460326|101859920|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
33535702|NCT04817332|101859921|FG000|Overall Study|Lost to Follow-up|3|||
33535703|NCT04817332|101859922|FG001|Overall Study|Lost to Follow-up|3|||
33208054|NCT01613248|100661640|FG000|Overall Study|Study Terminated by Sponsor|4|||
33208055|NCT01613248|100661641|FG001|Overall Study|Study Terminated by Sponsor|6|||
33208056|NCT01613248|100661642|FG002|Overall Study|Study Terminated by Sponsor|8|||
33208057|NCT01613248|100661643|FG003|Overall Study|Study Terminated by Sponsor|8|||
33208058|NCT01613248|100661644|FG004|Overall Study|Study Terminated by Sponsor|9|||
33208059|NCT01613248|100661645|FG005|Overall Study|Study Terminated by Sponsor|11|||
33208060|NCT01613248|100661640|FG000|Overall Study|Physician Decision|8|||
33208061|NCT01613248|100661641|FG001|Overall Study|Physician Decision|8|||
33208062|NCT01613248|100661642|FG002|Overall Study|Physician Decision|9|||
33339015|NCT03529773|101132134|FG002|Overall Study|Lost to Follow-up|1|||
33339016|NCT03529773|101132135|FG003|Overall Study|Lost to Follow-up|0|||
33339017|NCT03529773|101132136|FG004|Overall Study|Lost to Follow-up|1|||
33339018|NCT03529773|101132137|FG005|Overall Study|Lost to Follow-up|1|||
33208063|NCT01613248|100661643|FG003|Overall Study|Physician Decision|4|||
33339019|NCT03529773|101132138|FG006|Overall Study|Lost to Follow-up|0|||
33339020|NCT03529773|101132139|FG007|Overall Study|Lost to Follow-up|0|||
33339021|NCT03529773|101132140|FG008|Overall Study|Lost to Follow-up|0|||
33208064|NCT01613248|100661644|FG004|Overall Study|Physician Decision|7|||
33208065|NCT01613248|100661645|FG005|Overall Study|Physician Decision|6|||
33208066|NCT01613248|100661640|FG000|Overall Study|Lack of Qualifying Event|9|||
33208067|NCT01613248|100661641|FG001|Overall Study|Lack of Qualifying Event|11|||
33208068|NCT01613248|100661642|FG002|Overall Study|Lack of Qualifying Event|10|||
33208069|NCT01613248|100661643|FG003|Overall Study|Lack of Qualifying Event|11|||
33208070|NCT01613248|100661644|FG004|Overall Study|Lack of Qualifying Event|15|||
33208071|NCT01613248|100661645|FG005|Overall Study|Lack of Qualifying Event|18|||
33208072|NCT01613248|100661640|FG000|Overall Study|Pregnancy|0|||
33208073|NCT01613248|100661641|FG001|Overall Study|Pregnancy|0|||
33208074|NCT01613248|100661642|FG002|Overall Study|Pregnancy|0|||
33208075|NCT01613248|100661643|FG003|Overall Study|Pregnancy|1|||
33208076|NCT01613248|100661644|FG004|Overall Study|Pregnancy|0|||
33208077|NCT01613248|100661645|FG005|Overall Study|Pregnancy|0|||
33208078|NCT02310750|100661649|FG000|HP Period 1|Lost to Follow-up|0|||
33208079|NCT02310750|100661650|FG001|HP Period 1|Lost to Follow-up|0|||
33208080|NCT02310750|100661651|FG002|HP Period 1|Lost to Follow-up|0|||
33208081|NCT02310750|100661652|FG003|HP Period 1|Lost to Follow-up|0|||
33208082|NCT02310750|100661653|FG004|HP Period 1|Lost to Follow-up|0|||
33208083|NCT02310750|100661654|FG005|HP Period 1|Lost to Follow-up|0|||
33208084|NCT02310750|100661655|FG006|HP Period 1|Lost to Follow-up|1|||
33208085|NCT02310750|100661656|FG007|HP Period 1|Lost to Follow-up|0|||
33208086|NCT02310750|100661657|FG008|HP Period 1|Lost to Follow-up|0|||
33208087|NCT02310750|100661658|FG009|HP Period 1|Lost to Follow-up|0|||
33208088|NCT02310750|100661659|FG010|HP Period 1|Lost to Follow-up|0|||
33208089|NCT02310750|100661660|FG011|HP Period 1|Lost to Follow-up|0|||
33208090|NCT02310750|100661661|FG012|HP Period 1|Lost to Follow-up|0|||
33208091|NCT02310750|100661662|FG013|HP Period 1|Lost to Follow-up|0|||
33208092|NCT02310750|100661663|FG014|HP Period 1|Lost to Follow-up|0|||
33208093|NCT02310750|100661664|FG015|HP Period 1|Lost to Follow-up|0|||
33208094|NCT02310750|100661649|FG000|HP Period 1|Withdrawal by Subject|1|||
33208095|NCT02310750|100661650|FG001|HP Period 1|Withdrawal by Subject|0|||
33208096|NCT02310750|100661651|FG002|HP Period 1|Withdrawal by Subject|0|||
33208097|NCT02310750|100661652|FG003|HP Period 1|Withdrawal by Subject|1|||
33208098|NCT02310750|100661653|FG004|HP Period 1|Withdrawal by Subject|0|||
33208099|NCT02310750|100661654|FG005|HP Period 1|Withdrawal by Subject|0|||
33208100|NCT02310750|100661655|FG006|HP Period 1|Withdrawal by Subject|0|||
33208101|NCT02310750|100661656|FG007|HP Period 1|Withdrawal by Subject|0|||
33208102|NCT02310750|100661657|FG008|HP Period 1|Withdrawal by Subject|0|||
33208103|NCT02310750|100661658|FG009|HP Period 1|Withdrawal by Subject|0|||
33208104|NCT02310750|100661659|FG010|HP Period 1|Withdrawal by Subject|0|||
33208105|NCT02310750|100661660|FG011|HP Period 1|Withdrawal by Subject|0|||
33208106|NCT02310750|100661661|FG012|HP Period 1|Withdrawal by Subject|0|||
33208107|NCT02310750|100661662|FG013|HP Period 1|Withdrawal by Subject|0|||
33208108|NCT02310750|100661663|FG014|HP Period 1|Withdrawal by Subject|0|||
33208109|NCT02310750|100661664|FG015|HP Period 1|Withdrawal by Subject|0|||
33208110|NCT02310750|100661649|FG000|HP Washout 1|Lost to Follow-up|0|||
33208111|NCT02310750|100661650|FG001|HP Washout 1|Lost to Follow-up|0|||
33208112|NCT02310750|100661651|FG002|HP Washout 1|Lost to Follow-up|1|||
33208113|NCT02310750|100661652|FG003|HP Washout 1|Lost to Follow-up|1|||
33208114|NCT02310750|100661653|FG004|HP Washout 1|Lost to Follow-up|2|||
33208115|NCT02310750|100661654|FG005|HP Washout 1|Lost to Follow-up|2|||
33208116|NCT02310750|100661655|FG006|HP Washout 1|Lost to Follow-up|3|||
33208117|NCT02310750|100661656|FG007|HP Washout 1|Lost to Follow-up|0|||
33208118|NCT02310750|100661657|FG008|HP Washout 1|Lost to Follow-up|0|||
33208119|NCT02310750|100661658|FG009|HP Washout 1|Lost to Follow-up|0|||
33208120|NCT02310750|100661659|FG010|HP Washout 1|Lost to Follow-up|0|||
33208121|NCT02310750|100661660|FG011|HP Washout 1|Lost to Follow-up|0|||
33208122|NCT02310750|100661661|FG012|HP Washout 1|Lost to Follow-up|0|||
33208123|NCT02310750|100661662|FG013|HP Washout 1|Lost to Follow-up|0|||
33208124|NCT02310750|100661663|FG014|HP Washout 1|Lost to Follow-up|0|||
33208125|NCT02310750|100661664|FG015|HP Washout 1|Lost to Follow-up|0|||
33208126|NCT02310750|100661649|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33208127|NCT02310750|100661650|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33208128|NCT02310750|100661651|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33208129|NCT02310750|100661652|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
33208130|NCT02310750|100661653|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33339022|NCT03529773|101132141|FG009|Overall Study|Lost to Follow-up|0|||
33208131|NCT02310750|100661654|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
33208132|NCT02310750|100661655|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33208133|NCT02310750|100661656|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33208134|NCT02310750|100661657|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
33208135|NCT02310750|100661658|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
33339023|NCT03529773|101132142|FG010|Overall Study|Lost to Follow-up|0|||
33339024|NCT03529773|101132143|FG011|Overall Study|Lost to Follow-up|0|||
33405475|NCT00660829|101373361|FG001|Overall Study|Adverse Event|4|||
33208136|NCT02310750|100661659|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33208137|NCT02310750|100661660|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33208138|NCT02310750|100661661|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33208139|NCT02310750|100661662|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33208140|NCT02310750|100661663|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33208141|NCT02310750|100661664|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
33208142|NCT02310750|100661649|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208143|NCT02310750|100661650|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208144|NCT02310750|100661651|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208145|NCT02310750|100661652|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208146|NCT02310750|100661653|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208147|NCT02310750|100661654|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208148|NCT02310750|100661655|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208149|NCT02310750|100661656|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208150|NCT02310750|100661657|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208151|NCT02310750|100661658|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
33208152|NCT02310750|100661659|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208153|NCT02310750|100661660|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208154|NCT02310750|100661661|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208155|NCT02310750|100661662|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208156|NCT02310750|100661663|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208157|NCT02310750|100661664|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
33208158|NCT02310750|100661649|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33208159|NCT02310750|100661650|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33208160|NCT02310750|100661651|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33208161|NCT02310750|100661652|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33208162|NCT02310750|100661653|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33208163|NCT02310750|100661654|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33208164|NCT02310750|100661655|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33208165|NCT02310750|100661656|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
33208166|NCT02310750|100661657|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
33208167|NCT02310750|100661658|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
33208168|NCT02310750|100661659|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33208169|NCT02310750|100661660|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33208170|NCT02310750|100661661|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33208171|NCT02310750|100661662|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33208172|NCT02310750|100661663|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33208173|NCT02310750|100661664|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
33208174|NCT02310750|100661649|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33208175|NCT02310750|100661650|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33208176|NCT02310750|100661651|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33208177|NCT02310750|100661652|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33208178|NCT02310750|100661653|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33208179|NCT02310750|100661654|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33208180|NCT02310750|100661655|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33208181|NCT02310750|100661656|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
33208182|NCT02310750|100661657|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
33208183|NCT02310750|100661658|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33208184|NCT02310750|100661659|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33208185|NCT02310750|100661660|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33208186|NCT02310750|100661661|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33208187|NCT02310750|100661662|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33208188|NCT02310750|100661663|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33208189|NCT02310750|100661664|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
33208190|NCT02310750|100661649|FG000|HP Washout 2|Lost to Follow-up|0|||
33405476|NCT00660829|101373360|FG000|Overall Study|Lack of Efficacy|2|||
33405477|NCT00660829|101373361|FG001|Overall Study|Lack of Efficacy|3|||
33535704|NCT04817332|101859921|FG000|Overall Study|Protocol Violation|2|||
33535705|NCT04817332|101859922|FG001|Overall Study|Protocol Violation|0|||
33535706|NCT02048722|101859923|FG000|2 Cycles of Treatment|Adverse Event|2|||
33535707|NCT02048722|101859923|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
33339025|NCT03529773|101132144|FG012|Overall Study|Lost to Follow-up|0|||
33339026|NCT03529773|101132145|FG013|Overall Study|Lost to Follow-up|1|||
33339027|NCT03529773|101132146|FG014|Overall Study|Lost to Follow-up|4|||
33339028|NCT03529773|101132147|FG015|Overall Study|Lost to Follow-up|1|||
33339029|NCT03529773|101132148|FG016|Overall Study|Lost to Follow-up|1|||
33339030|NCT03529773|101132149|FG017|Overall Study|Lost to Follow-up|0|||
33339031|NCT03529773|101132150|FG018|Overall Study|Lost to Follow-up|1|||
33339032|NCT03529773|101132151|FG019|Overall Study|Lost to Follow-up|1|||
33339033|NCT03529773|101132152|FG020|Overall Study|Lost to Follow-up|2|||
33339034|NCT03529773|101132153|FG021|Overall Study|Lost to Follow-up|4|||
33339035|NCT03529773|101132154|FG022|Overall Study|Lost to Follow-up|3|||
33339036|NCT03529773|101132155|FG023|Overall Study|Lost to Follow-up|4|||
33339037|NCT03529773|101132156|FG024|Overall Study|Lost to Follow-up|3|||
33535708|NCT02048722|101859923|FG000|2 Cycles of Treatment|Progressive Disease|2|||
33208191|NCT02310750|100661650|FG001|HP Washout 2|Lost to Follow-up|0|||
33208192|NCT02310750|100661651|FG002|HP Washout 2|Lost to Follow-up|0|||
33208193|NCT02310750|100661652|FG003|HP Washout 2|Lost to Follow-up|0|||
33208194|NCT02310750|100661653|FG004|HP Washout 2|Lost to Follow-up|1|||
33208195|NCT02310750|100661654|FG005|HP Washout 2|Lost to Follow-up|0|||
33208196|NCT02310750|100661655|FG006|HP Washout 2|Lost to Follow-up|7|||
33208197|NCT02310750|100661656|FG007|HP Washout 2|Lost to Follow-up|0|||
33208198|NCT02310750|100661657|FG008|HP Washout 2|Lost to Follow-up|0|||
33208199|NCT02310750|100661658|FG009|HP Washout 2|Lost to Follow-up|0|||
33208200|NCT02310750|100661659|FG010|HP Washout 2|Lost to Follow-up|0|||
33208201|NCT02310750|100661660|FG011|HP Washout 2|Lost to Follow-up|0|||
33208202|NCT02310750|100661661|FG012|HP Washout 2|Lost to Follow-up|0|||
33208203|NCT02310750|100661662|FG013|HP Washout 2|Lost to Follow-up|0|||
33208204|NCT02310750|100661663|FG014|HP Washout 2|Lost to Follow-up|0|||
33208205|NCT02310750|100661664|FG015|HP Washout 2|Lost to Follow-up|0|||
33208206|NCT04786444|100661665|FG000|Overall Study|Withdrawal by Subject|4|||
33208207|NCT04786444|100661666|FG001|Overall Study|Withdrawal by Subject|7|||
33208208|NCT04786444|100661667|FG002|Overall Study|Withdrawal by Subject|2|||
33208209|NCT04786444|100661665|FG000|Overall Study|Lost to Follow-up|11|||
33208210|NCT04786444|100661666|FG001|Overall Study|Lost to Follow-up|9|||
33208211|NCT04786444|100661667|FG002|Overall Study|Lost to Follow-up|10|||
33208212|NCT04786444|100661665|FG000|Overall Study|Subject would like to become pregnant|0|||
33208213|NCT04786444|100661666|FG001|Overall Study|Subject would like to become pregnant|1|||
33208214|NCT04786444|100661667|FG002|Overall Study|Subject would like to become pregnant|0|||
33208215|NCT01572727|100661668|FG000|Overall Study|Adverse Event|43|||
33208216|NCT01572727|100661669|FG001|Overall Study|Adverse Event|15|||
33208217|NCT01572727|100661668|FG000|Overall Study|Lost to Follow-up|1|||
33208218|NCT01572727|100661669|FG001|Overall Study|Lost to Follow-up|1|||
33208219|NCT01572727|100661668|FG000|Overall Study|Physician Decision|23|||
33208220|NCT01572727|100661669|FG001|Overall Study|Physician Decision|9|||
33208221|NCT01572727|100661668|FG000|Overall Study|Progressive disease|59|||
33208222|NCT01572727|100661669|FG001|Overall Study|Progressive disease|82|||
33208223|NCT01572727|100661668|FG000|Overall Study|Protocol Violation|0|||
33208224|NCT01572727|100661669|FG001|Overall Study|Protocol Violation|1|||
33208225|NCT01572727|100661668|FG000|Overall Study|Study terminated by sponsor|61|||
33208226|NCT01572727|100661669|FG001|Overall Study|Study terminated by sponsor|83|||
33208227|NCT01572727|100661668|FG000|Overall Study|Parent/guardian decision|14|||
33208228|NCT01572727|100661669|FG001|Overall Study|Parent/guardian decision|9|||
33208229|NCT01572727|100661668|FG000|Overall Study|Death|2|||
33208230|NCT01572727|100661669|FG001|Overall Study|Death|2|||
33208231|NCT01572727|100661668|FG000|Overall Study|Untreated|4|||
33208232|NCT01572727|100661669|FG001|Overall Study|Untreated|7|||
33208233|NCT02590354|100661670|FG000|Phase 1|Active hepatitis B or C infection|1|||
33208234|NCT02590354|100661670|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
33208235|NCT02590354|100661670|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
33208236|NCT02590354|100661670|FG000|Phase 1|Subject does not want to participate|20|||
33208237|NCT02590354|100661670|FG000|Phase 1|Lost to Follow-up|1|||
33208238|NCT02590354|100661670|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
33208239|NCT03759873|100661671|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
33208240|NCT03759873|100661672|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
33208241|NCT03759873|100661673|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
33208242|NCT03759873|100661674|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
33208243|NCT03759873|100661671|FG000|Overall Study|Moved outside eligible area|0|||
33208244|NCT03759873|100661672|FG001|Overall Study|Moved outside eligible area|2|||
33535709|NCT02048722|101859923|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
33535710|NCT02048722|101859923|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
33535711|NCT02048722|101859923|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
33535712|NCT01781962|101859933|FG000|Overall Study|Other Miscellaneous Reasons|5|||
33535713|NCT01232790|101859936|FG000|Randomization|Withdrawal by Subject|2|||
33535714|NCT01232790|101859937|FG001|Randomization|Withdrawal by Subject|0|||
33535715|NCT01232790|101859936|FG000|Randomization|Protocol Violation|0|||
33535716|NCT01232790|101859937|FG001|Randomization|Protocol Violation|1|||
33535717|NCT01232790|101859936|FG000|Randomization|Physician Decision|0|||
33535718|NCT01232790|101859937|FG001|Randomization|Physician Decision|1|||
33535719|NCT01232790|101859936|FG000|Initial Assessment|Withdrawal by Subject|0|||
33614001|NCT02218008|102133969|FG005|Stage 1 (S1)|Protocol Violation|0|||
33208245|NCT03759873|100661673|FG002|Overall Study|Moved outside eligible area|0|||
33208246|NCT03759873|100661674|FG003|Overall Study|Moved outside eligible area|0|||
33208247|NCT03759873|100661671|FG000|Overall Study|Withdrawal by Subject|0|||
33208248|NCT03759873|100661672|FG001|Overall Study|Withdrawal by Subject|0|||
33208249|NCT03759873|100661673|FG002|Overall Study|Withdrawal by Subject|1|||
33208250|NCT03759873|100661674|FG003|Overall Study|Withdrawal by Subject|0|||
33208251|NCT01764945|100661675|FG000|Overall Study|Adverse Event|0|||
33535720|NCT01232790|101859937|FG001|Initial Assessment|Withdrawal by Subject|1|||
33535721|NCT01232790|101859936|FG000|First Crossover|Withdrawal by Subject|1|||
33535722|NCT01232790|101859937|FG001|First Crossover|Withdrawal by Subject|0|||
33535723|NCT01232790|101859936|FG000|Second Crossover|Withdrawal by Subject|1|||
33535724|NCT01232790|101859937|FG001|Second Crossover|Withdrawal by Subject|2|||
33535725|NCT00667563|101859938|FG000|Overall Study|Protocol Violation|24|||
33535726|NCT00072410|101859939|FG000|Overall Study|Progressive disease|0|||
33535727|NCT00072410|101859940|FG001|Overall Study|Progressive disease|3|||
33535728|NCT01791595|101859941|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
33535729|NCT01791595|101859942|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
33208252|NCT01764945|100661676|FG001|Overall Study|Adverse Event|1|||
33208253|NCT01764945|100661677|FG002|Overall Study|Adverse Event|0|||
33208254|NCT01764945|100661678|FG003|Overall Study|Adverse Event|0|||
33208255|NCT01764945|100661679|FG004|Overall Study|Adverse Event|0|||
33208256|NCT01764945|100661680|FG005|Overall Study|Adverse Event|0|||
33208257|NCT01764945|100661681|FG006|Overall Study|Adverse Event|1|||
33208258|NCT01764945|100661682|FG007|Overall Study|Adverse Event|0|||
33208259|NCT00352365|100661683|FG000|Induction Therapy|Adverse Event|7|||
33208260|NCT00352365|100661683|FG000|Induction Therapy|Progression/Relapse|8|||
33208261|NCT00352365|100661683|FG000|Induction Therapy|Death|7|||
33208262|NCT00352365|100661683|FG000|Induction Therapy|Not protocol specified|1|||
33208263|NCT00352365|100661683|FG000|Induction Therapy|Not eligible|3|||
33208264|NCT00352365|100661683|FG000|Induction Therapy|Death before starting protocol therapy|1|||
33208265|NCT00352365|100661683|FG000|Maintenance Therapy|Progression/Relapse|3|||
33208266|NCT00352365|100661683|FG000|Maintenance Therapy|Death|2|||
33208267|NCT00352365|100661683|FG000|Maintenance Therapy|Not protocol specified|3|||
33208268|NCT00352365|100661683|FG000|Maintenance Therapy|Not eligible|4|||
33208269|NCT01221597|100661693|FG000|Overall Study|Adverse Event|4|||
33208270|NCT01221597|100661694|FG001|Overall Study|Adverse Event|1|||
33208271|NCT01221597|100661693|FG000|Overall Study|Withdrawal by Subject|20|||
33208272|NCT01221597|100661694|FG001|Overall Study|Withdrawal by Subject|6|||
33208273|NCT01221597|100661693|FG000|Overall Study|Lost to Follow-up|6|||
33208274|NCT01221597|100661694|FG001|Overall Study|Lost to Follow-up|5|||
33339038|NCT03529773|101132157|FG025|Overall Study|Lost to Follow-up|5|||
33339039|NCT03529773|101132158|FG026|Overall Study|Lost to Follow-up|5|||
33339040|NCT03529773|101132159|FG027|Overall Study|Lost to Follow-up|0|||
33339041|NCT03529773|101132160|FG028|Overall Study|Lost to Follow-up|0|||
33339042|NCT03529773|101132161|FG029|Overall Study|Lost to Follow-up|0|||
33339043|NCT03529773|101132162|FG030|Overall Study|Lost to Follow-up|1|||
33339044|NCT03529773|101132163|FG031|Overall Study|Lost to Follow-up|0|||
33535730|NCT01791595|101859943|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
33535731|NCT01791595|101859944|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
33535732|NCT01791595|101859945|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
33535733|NCT01791595|101859946|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
33535734|NCT01791595|101859947|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
33535735|NCT01791595|101859941|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
33535736|NCT01791595|101859942|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
33535737|NCT01791595|101859943|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
33535738|NCT01791595|101859944|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
33535739|NCT01791595|101859945|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
33535740|NCT01791595|101859946|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
33535741|NCT01791595|101859947|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
33535742|NCT01791595|101859941|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
33535743|NCT01791595|101859942|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
33535744|NCT01791595|101859943|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
33535745|NCT01791595|101859944|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
33535746|NCT01791595|101859945|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
33535747|NCT01791595|101859946|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
33535748|NCT01791595|101859947|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
33535749|NCT01791595|101859941|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
33208275|NCT01221597|100661693|FG000|Overall Study|Protocol Violation|1|||
33208276|NCT01221597|100661694|FG001|Overall Study|Protocol Violation|0|||
33208277|NCT01221597|100661693|FG000|Overall Study|Other|3|||
33208278|NCT01221597|100661694|FG001|Overall Study|Other|4|||
33208279|NCT01221597|100661693|FG000|Overall Study|Death|2|||
33208280|NCT01221597|100661694|FG001|Overall Study|Death|0|||
33208281|NCT03923959|100665442|FG000|Overall Study|Death|16|||
33208282|NCT03923959|100665443|FG001|Overall Study|Death|12|||
33339045|NCT03529773|101132164|FG032|Overall Study|Lost to Follow-up|0|||
33339046|NCT03529773|101132165|FG033|Overall Study|Lost to Follow-up|1|||
33208283|NCT03923959|100665442|FG000|Overall Study|Lost to Follow-up|56|||
33339047|NCT03529773|101132166|FG034|Overall Study|Lost to Follow-up|1|||
33208284|NCT03923959|100665443|FG001|Overall Study|Lost to Follow-up|56|||
33339048|NCT03529773|101132167|FG035|Overall Study|Lost to Follow-up|0|||
33339049|NCT03529773|101132168|FG036|Overall Study|Lost to Follow-up|0|||
33339050|NCT03529773|101132169|FG037|Overall Study|Lost to Follow-up|3|||
33339051|NCT03529773|101132170|FG038|Overall Study|Lost to Follow-up|1|||
33339052|NCT03529773|101132171|FG039|Overall Study|Lost to Follow-up|1|||
33339053|NCT03529773|101132132|FG000|Overall Study|No longer meets eligibility criteria|0|||
33339054|NCT03529773|101132133|FG001|Overall Study|No longer meets eligibility criteria|0|||
33339055|NCT03529773|101132134|FG002|Overall Study|No longer meets eligibility criteria|0|||
33339056|NCT03529773|101132135|FG003|Overall Study|No longer meets eligibility criteria|0|||
33339057|NCT03529773|101132136|FG004|Overall Study|No longer meets eligibility criteria|0|||
33339058|NCT03529773|101132137|FG005|Overall Study|No longer meets eligibility criteria|0|||
33405478|NCT00660829|101373360|FG000|Overall Study|Non-Compliance|0|||
33405479|NCT00660829|101373361|FG001|Overall Study|Non-Compliance|4|||
33405480|NCT00660829|101373360|FG000|Overall Study|Withdrawal by Subject|1|||
33405481|NCT00660829|101373361|FG001|Overall Study|Withdrawal by Subject|2|||
33405482|NCT00660829|101373360|FG000|Overall Study|Lost to Follow-up|3|||
33405483|NCT00660829|101373361|FG001|Overall Study|Lost to Follow-up|2|||
33405484|NCT00660829|101373360|FG000|Overall Study|Other|9|||
33405485|NCT00660829|101373361|FG001|Overall Study|Other|4|||
33405486|NCT02759939|101373365|FG000|Overall Study|Missing data on first outcome assessed|11|||
33405487|NCT02759939|101373366|FG001|Overall Study|Missing data on first outcome assessed|2|||
33405488|NCT02759939|101373367|FG002|Overall Study|Missing data on first outcome assessed|5|||
33405489|NCT02759939|101373368|FG003|Overall Study|Missing data on first outcome assessed|2|||
33405490|NCT02759939|101373365|FG000|Overall Study|Ineligible for T2 and T3|310|||
33405491|NCT02759939|101373366|FG001|Overall Study|Ineligible for T2 and T3|179|||
33405492|NCT02759939|101373367|FG002|Overall Study|Ineligible for T2 and T3|366|||
33405493|NCT02759939|101373368|FG003|Overall Study|Ineligible for T2 and T3|391|||
33405494|NCT02759939|101373365|FG000|Overall Study|Lost to Follow-up|735|||
33405495|NCT02759939|101373366|FG001|Overall Study|Lost to Follow-up|791|||
33405496|NCT02759939|101373367|FG002|Overall Study|Lost to Follow-up|783|||
33405497|NCT02759939|101373368|FG003|Overall Study|Lost to Follow-up|650|||
33405498|NCT01383317|101373369|FG000|Overall Study|Lost to Follow-up|2|||
33405499|NCT01383317|101373370|FG001|Overall Study|Lost to Follow-up|1|||
33405500|NCT01383317|101373369|FG000|Overall Study|Death|1|||
33405501|NCT01383317|101373370|FG001|Overall Study|Death|0|||
33405502|NCT01383317|101373369|FG000|Overall Study|Adverse Event|0|||
33405503|NCT01383317|101373370|FG001|Overall Study|Adverse Event|1|||
33405504|NCT02087085|101373371|FG000|Overall Study|Adverse Event|10|||
33405505|NCT02087085|101373372|FG001|Overall Study|Adverse Event|14|||
33405506|NCT02087085|101373371|FG000|Overall Study|Lack of Efficacy|4|||
33405507|NCT02087085|101373372|FG001|Overall Study|Lack of Efficacy|3|||
33405508|NCT02087085|101373371|FG000|Overall Study|Lost to Follow-up|6|||
33405509|NCT02087085|101373372|FG001|Overall Study|Lost to Follow-up|4|||
33405510|NCT02087085|101373371|FG000|Overall Study|Withdrawal by Subject|9|||
33405511|NCT02087085|101373372|FG001|Overall Study|Withdrawal by Subject|11|||
33405512|NCT02087085|101373371|FG000|Overall Study|Protocol Violation|1|||
33405513|NCT02087085|101373372|FG001|Overall Study|Protocol Violation|0|||
33405514|NCT02087085|101373371|FG000|Overall Study|Study Terminated by Sponsor|87|||
33405515|NCT02087085|101373372|FG001|Overall Study|Study Terminated by Sponsor|80|||
33405516|NCT02087085|101373371|FG000|Overall Study|Other Miscellaneous Reasons|3|||
33405517|NCT02087085|101373372|FG001|Overall Study|Other Miscellaneous Reasons|4|||
33405518|NCT04678557|101373379|FG000|Overall Study|Withdrawal by Subject|1|||
33405519|NCT04678557|101373380|FG001|Overall Study|Withdrawal by Subject|0|||
33405520|NCT04678557|101373379|FG000|Overall Study|Lack of Efficacy|0|||
33405521|NCT04678557|101373380|FG001|Overall Study|Lack of Efficacy|13|||
33405522|NCT04678557|101373379|FG000|Overall Study|Safety Evaluation|0|||
33405523|NCT04678557|101373380|FG001|Overall Study|Safety Evaluation|1|||
33405524|NCT00401726|101373383|FG000|Overall Study|Adverse Event|34|||
33405525|NCT00401726|101373384|FG001|Overall Study|Adverse Event|45|||
33405526|NCT00401726|101373383|FG000|Overall Study|Death|0|||
33405527|NCT00401726|101373384|FG001|Overall Study|Death|3|||
33535750|NCT01791595|101859942|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
33208285|NCT03923959|100665442|FG000|Overall Study|Withdrawal by Subject|1|||
33405528|NCT00401726|101373383|FG000|Overall Study|Sponsor Request|0|||
33405529|NCT00401726|101373384|FG001|Overall Study|Sponsor Request|1|||
33405530|NCT00401726|101373383|FG000|Overall Study|Physician Decision|3|||
33405531|NCT00401726|101373384|FG001|Overall Study|Physician Decision|6|||
33405532|NCT00401726|101373383|FG000|Overall Study|Lost to Follow-up|23|||
33405533|NCT00401726|101373384|FG001|Overall Study|Lost to Follow-up|20|||
33405534|NCT00401726|101373383|FG000|Overall Study|Protocol Violation|6|||
33405535|NCT00401726|101373384|FG001|Overall Study|Protocol Violation|3|||
33208286|NCT03923959|100665443|FG001|Overall Study|Withdrawal by Subject|1|||
33405536|NCT00401726|101373383|FG000|Overall Study|Withdrawal by Subject|18|||
33405537|NCT00401726|101373384|FG001|Overall Study|Withdrawal by Subject|24|||
33631281|NCT05106959|102202901|FG000|Overall Study|Lost to Follow-up|1|||
33405538|NCT00401726|101373383|FG000|Overall Study|Lack of Efficacy|4|||
33405539|NCT00401726|101373384|FG001|Overall Study|Lack of Efficacy|6|||
33405540|NCT00401726|101373383|FG000|Overall Study|Protocol Deviation|9|||
33405541|NCT00401726|101373384|FG001|Overall Study|Protocol Deviation|4|||
33405542|NCT00033514|101373388|FG000|Overall Study|Lost to Follow-up|1|||
33405543|NCT00033514|101373389|FG001|Overall Study|Lost to Follow-up|1|||
33405544|NCT00033514|101373388|FG000|Overall Study|Withdrawal by Subject|0|||
33405545|NCT00033514|101373389|FG001|Overall Study|Withdrawal by Subject|3|||
33405546|NCT00134563|101373392|FG000|Overall Study|Not treated due to protocol violation|0|||
33535751|NCT01791595|101859943|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
33535752|NCT01791595|101859944|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
33208287|NCT03923959|100665442|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
33208288|NCT03923959|100665443|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
33208289|NCT00377819|100665444|FG000|Overall Study|Adverse Event|2|||
33208290|NCT00377819|100665445|FG001|Overall Study|Adverse Event|3|||
33208291|NCT00377819|100665444|FG000|Overall Study|Withdrawal by Subject|10|||
33208292|NCT00377819|100665445|FG001|Overall Study|Withdrawal by Subject|4|||
33208293|NCT00377819|100665444|FG000|Overall Study|Death|0|||
33208294|NCT00377819|100665445|FG001|Overall Study|Death|1|||
33535753|NCT01791595|101859945|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
33614002|NCT02218008|102133964|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
33614003|NCT02218008|102133965|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
33614004|NCT02218008|102133966|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
33339059|NCT03529773|101132138|FG006|Overall Study|No longer meets eligibility criteria|0|||
33339060|NCT03529773|101132139|FG007|Overall Study|No longer meets eligibility criteria|0|||
33339061|NCT03529773|101132140|FG008|Overall Study|No longer meets eligibility criteria|0|||
33339062|NCT03529773|101132141|FG009|Overall Study|No longer meets eligibility criteria|0|||
33339063|NCT03529773|101132142|FG010|Overall Study|No longer meets eligibility criteria|0|||
33339064|NCT03529773|101132143|FG011|Overall Study|No longer meets eligibility criteria|0|||
33339065|NCT03529773|101132144|FG012|Overall Study|No longer meets eligibility criteria|0|||
33405547|NCT00134563|101373393|FG001|Overall Study|Not treated due to protocol violation|1|||
33405548|NCT00134563|101373394|FG002|Overall Study|Not treated due to protocol violation|1|||
33614005|NCT02218008|102133967|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
33535754|NCT01791595|101859946|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
33535755|NCT01791595|101859947|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
33535756|NCT01791595|101859941|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
33535757|NCT01791595|101859942|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
33535758|NCT01791595|101859943|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
33535759|NCT01791595|101859944|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
33535760|NCT01791595|101859945|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
33535761|NCT01791595|101859946|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
33535762|NCT01791595|101859947|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
33535763|NCT01791595|101859941|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
33535764|NCT01791595|101859942|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
33535765|NCT01791595|101859943|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
33535766|NCT01791595|101859944|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
33535767|NCT01791595|101859945|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
33535768|NCT01791595|101859946|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
33535769|NCT01791595|101859947|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
33535770|NCT01791595|101859941|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
33535771|NCT01791595|101859942|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
33535772|NCT01791595|101859943|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
33535773|NCT01791595|101859944|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
33535774|NCT01791595|101859945|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
33535775|NCT01791595|101859946|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
33535776|NCT01791595|101859947|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
33535777|NCT01791595|101859941|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
33614006|NCT02218008|102133968|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
33614007|NCT02218008|102133969|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
33614008|NCT02218008|102133964|FG000|Stage 2 (S2)|Adverse Event|0|||
33614009|NCT02218008|102133965|FG001|Stage 2 (S2)|Adverse Event|0|||
33208295|NCT00377819|100665444|FG000|Overall Study|Lost to Follow-up|0|||
33405549|NCT00134563|101373392|FG000|Overall Study|Adverse Event|29|||
33405550|NCT00134563|101373393|FG001|Overall Study|Adverse Event|37|||
33405551|NCT00134563|101373394|FG002|Overall Study|Adverse Event|38|||
33405552|NCT00134563|101373392|FG000|Overall Study|Lack of Efficacy|24|||
33405553|NCT00134563|101373393|FG001|Overall Study|Lack of Efficacy|14|||
33405554|NCT00134563|101373394|FG002|Overall Study|Lack of Efficacy|17|||
33567611|NCT02723955|101973209|FG040|Crossover/ Re-treatment Phase|Death|2|||
33614010|NCT02218008|102133966|FG002|Stage 2 (S2)|Adverse Event|0|||
33208296|NCT00377819|100665445|FG001|Overall Study|Lost to Follow-up|1|||
33614011|NCT02218008|102133967|FG003|Stage 2 (S2)|Adverse Event|2|||
33208297|NCT00377819|100665444|FG000|Overall Study|Protocol Violation|1|||
33535778|NCT01791595|101859942|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
33535779|NCT01791595|101859943|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
33535780|NCT01791595|101859944|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
33535781|NCT01791595|101859945|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
33535782|NCT01791595|101859946|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
33535783|NCT01791595|101859947|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
33535784|NCT01791595|101859941|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
33535785|NCT01791595|101859942|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
33535786|NCT01791595|101859943|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
33535787|NCT01791595|101859944|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
33535788|NCT01791595|101859945|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
33535789|NCT01791595|101859946|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
33535790|NCT01791595|101859947|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
33208298|NCT00377819|100665445|FG001|Overall Study|Protocol Violation|1|||
33208299|NCT01750268|100665446|FG000|Overall Study|Lost to Follow-up|0|||
33208300|NCT01750268|100665447|FG001|Overall Study|Lost to Follow-up|2|||
33208301|NCT01750268|100665446|FG000|Overall Study|Physician Decision|0|||
33339066|NCT03529773|101132145|FG013|Overall Study|No longer meets eligibility criteria|0|||
33339067|NCT03529773|101132146|FG014|Overall Study|No longer meets eligibility criteria|0|||
33339068|NCT03529773|101132147|FG015|Overall Study|No longer meets eligibility criteria|0|||
33339069|NCT03529773|101132148|FG016|Overall Study|No longer meets eligibility criteria|0|||
33339070|NCT03529773|101132149|FG017|Overall Study|No longer meets eligibility criteria|0|||
33339071|NCT03529773|101132150|FG018|Overall Study|No longer meets eligibility criteria|0|||
33339072|NCT03529773|101132151|FG019|Overall Study|No longer meets eligibility criteria|0|||
33339073|NCT03529773|101132152|FG020|Overall Study|No longer meets eligibility criteria|0|||
33339074|NCT03529773|101132153|FG021|Overall Study|No longer meets eligibility criteria|0|||
33339075|NCT03529773|101132154|FG022|Overall Study|No longer meets eligibility criteria|1|||
33339076|NCT03529773|101132155|FG023|Overall Study|No longer meets eligibility criteria|0|||
33339077|NCT03529773|101132156|FG024|Overall Study|No longer meets eligibility criteria|0|||
33339078|NCT03529773|101132157|FG025|Overall Study|No longer meets eligibility criteria|0|||
33339079|NCT03529773|101132158|FG026|Overall Study|No longer meets eligibility criteria|0|||
33339080|NCT03529773|101132159|FG027|Overall Study|No longer meets eligibility criteria|0|||
33339081|NCT03529773|101132160|FG028|Overall Study|No longer meets eligibility criteria|0|||
33339082|NCT03529773|101132161|FG029|Overall Study|No longer meets eligibility criteria|0|||
33339083|NCT03529773|101132162|FG030|Overall Study|No longer meets eligibility criteria|0|||
33339084|NCT03529773|101132163|FG031|Overall Study|No longer meets eligibility criteria|0|||
33339085|NCT03529773|101132164|FG032|Overall Study|No longer meets eligibility criteria|0|||
33339086|NCT03529773|101132165|FG033|Overall Study|No longer meets eligibility criteria|0|||
33339087|NCT03529773|101132166|FG034|Overall Study|No longer meets eligibility criteria|0|||
33339088|NCT03529773|101132167|FG035|Overall Study|No longer meets eligibility criteria|0|||
33339089|NCT03529773|101132168|FG036|Overall Study|No longer meets eligibility criteria|0|||
33339090|NCT03529773|101132169|FG037|Overall Study|No longer meets eligibility criteria|0|||
33339091|NCT03529773|101132170|FG038|Overall Study|No longer meets eligibility criteria|1|||
33339092|NCT03529773|101132171|FG039|Overall Study|No longer meets eligibility criteria|0|||
33339093|NCT03529773|101132132|FG000|Overall Study|Other|0|||
33339094|NCT03529773|101132133|FG001|Overall Study|Other|0|||
33339095|NCT03529773|101132134|FG002|Overall Study|Other|0|||
33339096|NCT03529773|101132135|FG003|Overall Study|Other|0|||
33339097|NCT03529773|101132136|FG004|Overall Study|Other|0|||
33339098|NCT03529773|101132137|FG005|Overall Study|Other|0|||
33339099|NCT03529773|101132138|FG006|Overall Study|Other|0|||
33339100|NCT03529773|101132139|FG007|Overall Study|Other|0|||
33339101|NCT03529773|101132140|FG008|Overall Study|Other|0|||
33339102|NCT03529773|101132141|FG009|Overall Study|Other|0|||
33405555|NCT00134563|101373392|FG000|Overall Study|Protocol Violation|3|||
33405556|NCT00134563|101373393|FG001|Overall Study|Protocol Violation|2|||
33535791|NCT01791595|101859941|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
33208302|NCT01750268|100665447|FG001|Overall Study|Physician Decision|3|||
33208303|NCT01750268|100665446|FG000|Overall Study|Withdrawal by Subject|2|||
33208304|NCT01750268|100665447|FG001|Overall Study|Withdrawal by Subject|0|||
33339103|NCT03529773|101132142|FG010|Overall Study|Other|0|||
33339104|NCT03529773|101132143|FG011|Overall Study|Other|0|||
33339105|NCT03529773|101132144|FG012|Overall Study|Other|1|||
33339106|NCT03529773|101132145|FG013|Overall Study|Other|0|||
33339107|NCT03529773|101132146|FG014|Overall Study|Other|2|||
33339108|NCT03529773|101132147|FG015|Overall Study|Other|0|||
33339109|NCT03529773|101132148|FG016|Overall Study|Other|0|||
33339110|NCT03529773|101132149|FG017|Overall Study|Other|3|||
33405557|NCT00134563|101373394|FG002|Overall Study|Protocol Violation|5|||
33614012|NCT02218008|102133968|FG004|Stage 2 (S2)|Adverse Event|3|||
33208305|NCT02363738|100665448|FG000|Overall Study|Adverse Event|5|||
33208306|NCT02363738|100665449|FG001|Overall Study|Adverse Event|2|||
33339111|NCT03529773|101132150|FG018|Overall Study|Other|0|||
33339112|NCT03529773|101132151|FG019|Overall Study|Other|0|||
33339113|NCT03529773|101132152|FG020|Overall Study|Other|1|||
33339114|NCT03529773|101132153|FG021|Overall Study|Other|0|||
33339115|NCT03529773|101132154|FG022|Overall Study|Other|1|||
33339116|NCT03529773|101132155|FG023|Overall Study|Other|0|||
33339117|NCT03529773|101132156|FG024|Overall Study|Other|3|||
33339118|NCT03529773|101132157|FG025|Overall Study|Other|2|||
33339119|NCT03529773|101132158|FG026|Overall Study|Other|2|||
33339120|NCT03529773|101132159|FG027|Overall Study|Other|0|||
33339121|NCT03529773|101132160|FG028|Overall Study|Other|0|||
33339122|NCT03529773|101132161|FG029|Overall Study|Other|0|||
33339123|NCT03529773|101132162|FG030|Overall Study|Other|0|||
33339124|NCT03529773|101132163|FG031|Overall Study|Other|0|||
33339125|NCT03529773|101132164|FG032|Overall Study|Other|0|||
33339126|NCT03529773|101132165|FG033|Overall Study|Other|0|||
33339127|NCT03529773|101132166|FG034|Overall Study|Other|1|||
33339128|NCT03529773|101132167|FG035|Overall Study|Other|1|||
33339129|NCT03529773|101132168|FG036|Overall Study|Other|0|||
33339130|NCT03529773|101132169|FG037|Overall Study|Other|0|||
33339131|NCT03529773|101132170|FG038|Overall Study|Other|0|||
33339132|NCT03529773|101132171|FG039|Overall Study|Other|0|||
33339133|NCT03529773|101132132|FG000|Overall Study|Physician Decision|0|||
33339134|NCT03529773|101132133|FG001|Overall Study|Physician Decision|0|||
33339135|NCT03529773|101132134|FG002|Overall Study|Physician Decision|0|||
33339136|NCT03529773|101132135|FG003|Overall Study|Physician Decision|0|||
33339137|NCT03529773|101132136|FG004|Overall Study|Physician Decision|0|||
33339138|NCT03529773|101132137|FG005|Overall Study|Physician Decision|0|||
33339139|NCT03529773|101132138|FG006|Overall Study|Physician Decision|0|||
33339140|NCT03529773|101132139|FG007|Overall Study|Physician Decision|0|||
33339141|NCT03529773|101132140|FG008|Overall Study|Physician Decision|0|||
33339142|NCT03529773|101132141|FG009|Overall Study|Physician Decision|0|||
33339143|NCT03529773|101132142|FG010|Overall Study|Physician Decision|0|||
33339144|NCT03529773|101132143|FG011|Overall Study|Physician Decision|0|||
33339145|NCT03529773|101132144|FG012|Overall Study|Physician Decision|0|||
33339146|NCT03529773|101132145|FG013|Overall Study|Physician Decision|0|||
33339147|NCT03529773|101132146|FG014|Overall Study|Physician Decision|0|||
33339148|NCT03529773|101132147|FG015|Overall Study|Physician Decision|0|||
33339149|NCT03529773|101132148|FG016|Overall Study|Physician Decision|0|||
33339150|NCT03529773|101132149|FG017|Overall Study|Physician Decision|0|||
33339151|NCT03529773|101132150|FG018|Overall Study|Physician Decision|0|||
33535792|NCT01791595|101859942|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
33535793|NCT01791595|101859943|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
33535794|NCT01791595|101859944|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
33535795|NCT01791595|101859945|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
33339152|NCT03529773|101132151|FG019|Overall Study|Physician Decision|1|||
33339153|NCT03529773|101132152|FG020|Overall Study|Physician Decision|1|||
33339154|NCT03529773|101132153|FG021|Overall Study|Physician Decision|0|||
33405558|NCT00134563|101373392|FG000|Overall Study|Lost to Follow-up|4|||
33208307|NCT02363738|100665448|FG000|Overall Study|Lack of Efficacy|1|||
33535796|NCT01791595|101859946|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
33535797|NCT01791595|101859947|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
33535798|NCT01791595|101859941|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
33535799|NCT01791595|101859942|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
33535800|NCT01791595|101859943|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
33535801|NCT01791595|101859944|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
33535802|NCT01791595|101859945|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
33535803|NCT01791595|101859946|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
33535804|NCT01791595|101859947|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
33535805|NCT01791595|101859941|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
33535806|NCT01791595|101859942|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
33535807|NCT01791595|101859943|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
33535808|NCT01791595|101859944|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
33614013|NCT02218008|102133969|FG005|Stage 2 (S2)|Adverse Event|3|||
33339155|NCT03529773|101132154|FG022|Overall Study|Physician Decision|0|||
33339156|NCT03529773|101132155|FG023|Overall Study|Physician Decision|0|||
33339157|NCT03529773|101132156|FG024|Overall Study|Physician Decision|0|||
33339158|NCT03529773|101132157|FG025|Overall Study|Physician Decision|0|||
33339159|NCT03529773|101132158|FG026|Overall Study|Physician Decision|0|||
33339160|NCT03529773|101132159|FG027|Overall Study|Physician Decision|0|||
33405559|NCT00134563|101373393|FG001|Overall Study|Lost to Follow-up|0|||
33208308|NCT02363738|100665449|FG001|Overall Study|Lack of Efficacy|2|||
33339161|NCT03529773|101132160|FG028|Overall Study|Physician Decision|0|||
33339162|NCT03529773|101132161|FG029|Overall Study|Physician Decision|0|||
33339163|NCT03529773|101132162|FG030|Overall Study|Physician Decision|0|||
33339164|NCT03529773|101132163|FG031|Overall Study|Physician Decision|0|||
33339165|NCT03529773|101132164|FG032|Overall Study|Physician Decision|0|||
33339166|NCT03529773|101132165|FG033|Overall Study|Physician Decision|0|||
33339167|NCT03529773|101132166|FG034|Overall Study|Physician Decision|0|||
33339168|NCT03529773|101132167|FG035|Overall Study|Physician Decision|0|||
33339169|NCT03529773|101132168|FG036|Overall Study|Physician Decision|0|||
33339170|NCT03529773|101132169|FG037|Overall Study|Physician Decision|0|||
33339171|NCT03529773|101132170|FG038|Overall Study|Physician Decision|0|||
33339172|NCT03529773|101132171|FG039|Overall Study|Physician Decision|0|||
33339173|NCT03529773|101132132|FG000|Overall Study|Protocol Violation|0|||
33339174|NCT03529773|101132133|FG001|Overall Study|Protocol Violation|0|||
33339175|NCT03529773|101132134|FG002|Overall Study|Protocol Violation|0|||
33339176|NCT03529773|101132135|FG003|Overall Study|Protocol Violation|0|||
33339177|NCT03529773|101132136|FG004|Overall Study|Protocol Violation|0|||
33339178|NCT03529773|101132137|FG005|Overall Study|Protocol Violation|0|||
33339179|NCT03529773|101132138|FG006|Overall Study|Protocol Violation|0|||
33339180|NCT03529773|101132139|FG007|Overall Study|Protocol Violation|0|||
33339181|NCT03529773|101132140|FG008|Overall Study|Protocol Violation|0|||
33339182|NCT03529773|101132141|FG009|Overall Study|Protocol Violation|0|||
33339183|NCT03529773|101132142|FG010|Overall Study|Protocol Violation|0|||
33339184|NCT03529773|101132143|FG011|Overall Study|Protocol Violation|0|||
33339185|NCT03529773|101132144|FG012|Overall Study|Protocol Violation|0|||
33339186|NCT03529773|101132145|FG013|Overall Study|Protocol Violation|0|||
33339187|NCT03529773|101132146|FG014|Overall Study|Protocol Violation|0|||
33339188|NCT03529773|101132147|FG015|Overall Study|Protocol Violation|0|||
33339189|NCT03529773|101132148|FG016|Overall Study|Protocol Violation|0|||
33339190|NCT03529773|101132149|FG017|Overall Study|Protocol Violation|0|||
33339191|NCT03529773|101132150|FG018|Overall Study|Protocol Violation|0|||
33339192|NCT03529773|101132151|FG019|Overall Study|Protocol Violation|0|||
33339193|NCT03529773|101132152|FG020|Overall Study|Protocol Violation|0|||
33339194|NCT03529773|101132153|FG021|Overall Study|Protocol Violation|0|||
33339195|NCT03529773|101132154|FG022|Overall Study|Protocol Violation|0|||
33339196|NCT03529773|101132155|FG023|Overall Study|Protocol Violation|0|||
33339197|NCT03529773|101132156|FG024|Overall Study|Protocol Violation|0|||
33339198|NCT03529773|101132157|FG025|Overall Study|Protocol Violation|0|||
33339199|NCT03529773|101132158|FG026|Overall Study|Protocol Violation|0|||
33339200|NCT03529773|101132159|FG027|Overall Study|Protocol Violation|0|||
33339201|NCT03529773|101132160|FG028|Overall Study|Protocol Violation|0|||
33339202|NCT03529773|101132161|FG029|Overall Study|Protocol Violation|0|||
33339203|NCT03529773|101132162|FG030|Overall Study|Protocol Violation|1|||
33339204|NCT03529773|101132163|FG031|Overall Study|Protocol Violation|0|||
33339205|NCT03529773|101132164|FG032|Overall Study|Protocol Violation|0|||
33339206|NCT03529773|101132165|FG033|Overall Study|Protocol Violation|0|||
33339207|NCT03529773|101132166|FG034|Overall Study|Protocol Violation|0|||
33339208|NCT03529773|101132167|FG035|Overall Study|Protocol Violation|0|||
33339209|NCT03529773|101132168|FG036|Overall Study|Protocol Violation|0|||
33339210|NCT03529773|101132169|FG037|Overall Study|Protocol Violation|0|||
33339211|NCT03529773|101132170|FG038|Overall Study|Protocol Violation|0|||
33339212|NCT03529773|101132171|FG039|Overall Study|Protocol Violation|0|||
33339213|NCT03529773|101132132|FG000|Overall Study|Withdrawal by Subject|0|||
33339214|NCT03529773|101132133|FG001|Overall Study|Withdrawal by Subject|0|||
33339215|NCT03529773|101132134|FG002|Overall Study|Withdrawal by Subject|0|||
33339216|NCT03529773|101132135|FG003|Overall Study|Withdrawal by Subject|0|||
33339217|NCT03529773|101132136|FG004|Overall Study|Withdrawal by Subject|0|||
33339218|NCT03529773|101132137|FG005|Overall Study|Withdrawal by Subject|0|||
33339219|NCT03529773|101132138|FG006|Overall Study|Withdrawal by Subject|0|||
33339220|NCT03529773|101132139|FG007|Overall Study|Withdrawal by Subject|1|||
33339221|NCT03529773|101132140|FG008|Overall Study|Withdrawal by Subject|0|||
33339222|NCT03529773|101132141|FG009|Overall Study|Withdrawal by Subject|1|||
33339223|NCT03529773|101132142|FG010|Overall Study|Withdrawal by Subject|1|||
33339224|NCT03529773|101132143|FG011|Overall Study|Withdrawal by Subject|0|||
33339225|NCT03529773|101132144|FG012|Overall Study|Withdrawal by Subject|0|||
33339226|NCT03529773|101132145|FG013|Overall Study|Withdrawal by Subject|0|||
33339227|NCT03529773|101132146|FG014|Overall Study|Withdrawal by Subject|0|||
33339228|NCT03529773|101132147|FG015|Overall Study|Withdrawal by Subject|3|||
33535809|NCT01791595|101859945|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
33535810|NCT01791595|101859946|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
33339229|NCT03529773|101132148|FG016|Overall Study|Withdrawal by Subject|0|||
33339230|NCT03529773|101132149|FG017|Overall Study|Withdrawal by Subject|2|||
33339231|NCT03529773|101132150|FG018|Overall Study|Withdrawal by Subject|3|||
33339232|NCT03529773|101132151|FG019|Overall Study|Withdrawal by Subject|1|||
33339233|NCT03529773|101132152|FG020|Overall Study|Withdrawal by Subject|3|||
33339234|NCT03529773|101132153|FG021|Overall Study|Withdrawal by Subject|1|||
33339235|NCT03529773|101132154|FG022|Overall Study|Withdrawal by Subject|1|||
33535811|NCT01791595|101859947|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
33339236|NCT03529773|101132155|FG023|Overall Study|Withdrawal by Subject|2|||
33339237|NCT03529773|101132156|FG024|Overall Study|Withdrawal by Subject|2|||
33339238|NCT03529773|101132157|FG025|Overall Study|Withdrawal by Subject|4|||
33339239|NCT03529773|101132158|FG026|Overall Study|Withdrawal by Subject|2|||
33405560|NCT00134563|101373394|FG002|Overall Study|Lost to Follow-up|2|||
33339240|NCT03529773|101132159|FG027|Overall Study|Withdrawal by Subject|1|||
33339241|NCT03529773|101132160|FG028|Overall Study|Withdrawal by Subject|1|||
33339242|NCT03529773|101132161|FG029|Overall Study|Withdrawal by Subject|0|||
33339243|NCT03529773|101132162|FG030|Overall Study|Withdrawal by Subject|0|||
33339244|NCT03529773|101132163|FG031|Overall Study|Withdrawal by Subject|0|||
33339245|NCT03529773|101132164|FG032|Overall Study|Withdrawal by Subject|0|||
33339246|NCT03529773|101132165|FG033|Overall Study|Withdrawal by Subject|0|||
33339247|NCT03529773|101132166|FG034|Overall Study|Withdrawal by Subject|1|||
33339248|NCT03529773|101132167|FG035|Overall Study|Withdrawal by Subject|2|||
33339249|NCT03529773|101132168|FG036|Overall Study|Withdrawal by Subject|0|||
33339250|NCT03529773|101132169|FG037|Overall Study|Withdrawal by Subject|2|||
33339251|NCT03529773|101132170|FG038|Overall Study|Withdrawal by Subject|1|||
33339252|NCT03529773|101132171|FG039|Overall Study|Withdrawal by Subject|1|||
33339253|NCT03529773|101132132|FG000|Overall Study|Screen Failure|0|||
33339254|NCT03529773|101132133|FG001|Overall Study|Screen Failure|0|||
33339255|NCT03529773|101132134|FG002|Overall Study|Screen Failure|0|||
33339256|NCT03529773|101132135|FG003|Overall Study|Screen Failure|0|||
33339257|NCT03529773|101132136|FG004|Overall Study|Screen Failure|0|||
33339258|NCT03529773|101132137|FG005|Overall Study|Screen Failure|0|||
33339259|NCT03529773|101132138|FG006|Overall Study|Screen Failure|0|||
33339260|NCT03529773|101132139|FG007|Overall Study|Screen Failure|0|||
33339261|NCT03529773|101132140|FG008|Overall Study|Screen Failure|0|||
33339262|NCT03529773|101132141|FG009|Overall Study|Screen Failure|0|||
33339263|NCT03529773|101132142|FG010|Overall Study|Screen Failure|0|||
33339264|NCT03529773|101132143|FG011|Overall Study|Screen Failure|0|||
33339265|NCT03529773|101132144|FG012|Overall Study|Screen Failure|0|||
33339266|NCT03529773|101132145|FG013|Overall Study|Screen Failure|0|||
33339267|NCT03529773|101132146|FG014|Overall Study|Screen Failure|0|||
33339268|NCT03529773|101132147|FG015|Overall Study|Screen Failure|0|||
33339269|NCT03529773|101132148|FG016|Overall Study|Screen Failure|0|||
33339270|NCT03529773|101132149|FG017|Overall Study|Screen Failure|0|||
33339271|NCT03529773|101132150|FG018|Overall Study|Screen Failure|0|||
33339272|NCT03529773|101132151|FG019|Overall Study|Screen Failure|0|||
33339273|NCT03529773|101132152|FG020|Overall Study|Screen Failure|0|||
33339274|NCT03529773|101132153|FG021|Overall Study|Screen Failure|0|||
33339275|NCT03529773|101132154|FG022|Overall Study|Screen Failure|0|||
33339276|NCT03529773|101132155|FG023|Overall Study|Screen Failure|0|||
33339277|NCT03529773|101132156|FG024|Overall Study|Screen Failure|0|||
33339278|NCT03529773|101132157|FG025|Overall Study|Screen Failure|0|||
33339279|NCT03529773|101132158|FG026|Overall Study|Screen Failure|0|||
33339280|NCT03529773|101132159|FG027|Overall Study|Screen Failure|0|||
33339281|NCT03529773|101132160|FG028|Overall Study|Screen Failure|0|||
33339282|NCT03529773|101132161|FG029|Overall Study|Screen Failure|0|||
33339283|NCT03529773|101132162|FG030|Overall Study|Screen Failure|0|||
33339284|NCT03529773|101132163|FG031|Overall Study|Screen Failure|0|||
33339285|NCT03529773|101132164|FG032|Overall Study|Screen Failure|0|||
33339286|NCT03529773|101132165|FG033|Overall Study|Screen Failure|0|||
33339287|NCT03529773|101132166|FG034|Overall Study|Screen Failure|0|||
33339288|NCT03529773|101132167|FG035|Overall Study|Screen Failure|0|||
33339289|NCT03529773|101132168|FG036|Overall Study|Screen Failure|1|||
33339290|NCT03529773|101132169|FG037|Overall Study|Screen Failure|1|||
33339291|NCT03529773|101132170|FG038|Overall Study|Screen Failure|0|||
33339292|NCT03529773|101132171|FG039|Overall Study|Screen Failure|1|||
33339293|NCT03529773|101132132|FG000|Overall Study|Randomized but not vaccinated|0|||
33339294|NCT03529773|101132133|FG001|Overall Study|Randomized but not vaccinated|0|||
33535812|NCT01791595|101859941|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
33535813|NCT01791595|101859942|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
33535814|NCT01791595|101859943|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
33535815|NCT01791595|101859944|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
33535816|NCT01791595|101859945|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
33535817|NCT01791595|101859946|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
33535818|NCT01791595|101859947|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
33535819|NCT01791595|101859941|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
33535820|NCT01791595|101859942|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
33535821|NCT01791595|101859943|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
33631282|NCT00886379|102202902|FG000|Overall Study|Transferred Schools|0|||
33339295|NCT03529773|101132134|FG002|Overall Study|Randomized but not vaccinated|0|||
33339296|NCT03529773|101132135|FG003|Overall Study|Randomized but not vaccinated|0|||
33339297|NCT03529773|101132136|FG004|Overall Study|Randomized but not vaccinated|0|||
33339298|NCT03529773|101132137|FG005|Overall Study|Randomized but not vaccinated|0|||
33339299|NCT03529773|101132138|FG006|Overall Study|Randomized but not vaccinated|0|||
33339300|NCT03529773|101132139|FG007|Overall Study|Randomized but not vaccinated|0|||
33339301|NCT03529773|101132140|FG008|Overall Study|Randomized but not vaccinated|0|||
33339302|NCT03529773|101132141|FG009|Overall Study|Randomized but not vaccinated|0|||
33339303|NCT03529773|101132142|FG010|Overall Study|Randomized but not vaccinated|0|||
33339304|NCT03529773|101132143|FG011|Overall Study|Randomized but not vaccinated|0|||
33535822|NCT01791595|101859944|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
33535823|NCT01791595|101859945|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
33535824|NCT01791595|101859946|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
33535825|NCT01791595|101859947|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
33535826|NCT01791595|101859941|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
33535827|NCT01791595|101859942|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
33535828|NCT01791595|101859943|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
33535829|NCT01791595|101859944|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
33535830|NCT01791595|101859945|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
33208309|NCT02363738|100665448|FG000|Overall Study|Lost to Follow-up|2|||
33339305|NCT03529773|101132144|FG012|Overall Study|Randomized but not vaccinated|0|||
33339306|NCT03529773|101132145|FG013|Overall Study|Randomized but not vaccinated|0|||
33339307|NCT03529773|101132146|FG014|Overall Study|Randomized but not vaccinated|0|||
33339308|NCT03529773|101132147|FG015|Overall Study|Randomized but not vaccinated|0|||
33339309|NCT03529773|101132148|FG016|Overall Study|Randomized but not vaccinated|0|||
33339310|NCT03529773|101132149|FG017|Overall Study|Randomized but not vaccinated|1|||
33339311|NCT03529773|101132150|FG018|Overall Study|Randomized but not vaccinated|0|||
33339312|NCT03529773|101132151|FG019|Overall Study|Randomized but not vaccinated|0|||
33339313|NCT03529773|101132152|FG020|Overall Study|Randomized but not vaccinated|0|||
33339314|NCT03529773|101132153|FG021|Overall Study|Randomized but not vaccinated|0|||
33339315|NCT03529773|101132154|FG022|Overall Study|Randomized but not vaccinated|0|||
33339316|NCT03529773|101132155|FG023|Overall Study|Randomized but not vaccinated|0|||
33339317|NCT03529773|101132156|FG024|Overall Study|Randomized but not vaccinated|0|||
33339318|NCT03529773|101132157|FG025|Overall Study|Randomized but not vaccinated|0|||
33339319|NCT03529773|101132158|FG026|Overall Study|Randomized but not vaccinated|0|||
33339320|NCT03529773|101132159|FG027|Overall Study|Randomized but not vaccinated|1|||
33339321|NCT03529773|101132160|FG028|Overall Study|Randomized but not vaccinated|0|||
33339322|NCT03529773|101132161|FG029|Overall Study|Randomized but not vaccinated|0|||
33339323|NCT03529773|101132162|FG030|Overall Study|Randomized but not vaccinated|0|||
33339324|NCT03529773|101132163|FG031|Overall Study|Randomized but not vaccinated|0|||
33339325|NCT03529773|101132164|FG032|Overall Study|Randomized but not vaccinated|0|||
33339326|NCT03529773|101132165|FG033|Overall Study|Randomized but not vaccinated|0|||
33339327|NCT03529773|101132166|FG034|Overall Study|Randomized but not vaccinated|0|||
33339328|NCT03529773|101132167|FG035|Overall Study|Randomized but not vaccinated|0|||
33339329|NCT03529773|101132168|FG036|Overall Study|Randomized but not vaccinated|0|||
33339330|NCT03529773|101132169|FG037|Overall Study|Randomized but not vaccinated|0|||
33339331|NCT03529773|101132170|FG038|Overall Study|Randomized but not vaccinated|0|||
33339332|NCT03529773|101132171|FG039|Overall Study|Randomized but not vaccinated|0|||
33339333|NCT04356183|101132176|FG000|Overall Study|Lost to Follow-up|1|||
33339334|NCT04356183|101132177|FG001|Overall Study|Lost to Follow-up|0|||
33339335|NCT04356183|101132176|FG000|Overall Study|Withdrawal by Subject|1|||
33339336|NCT04356183|101132177|FG001|Overall Study|Withdrawal by Subject|1|||
33339337|NCT01073566|101132178|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
33339338|NCT01073566|101132179|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
33339339|NCT00763139|101132180|FG000|Overall Study|Adverse Event|4|||
33339340|NCT00763139|101132181|FG001|Overall Study|Adverse Event|2|||
33339341|NCT00763139|101132180|FG000|Overall Study|Withdrawal by Subject|0|||
33339342|NCT00763139|101132181|FG001|Overall Study|Withdrawal by Subject|1|||
33339343|NCT00763139|101132180|FG000|Overall Study|med change not allowed by protocol|1|||
33339344|NCT00763139|101132181|FG001|Overall Study|med change not allowed by protocol|0|||
33339345|NCT02105454|101132197|FG000|Overall Study|Withdrawal by Subject|1|||
33339346|NCT01978093|101132198|FG000|Overall Study|Death|1|||
33339347|NCT01978093|101132199|FG001|Overall Study|Death|0|||
33339348|NCT01978093|101132198|FG000|Overall Study|Adverse Event|0|||
33339349|NCT01978093|101132199|FG001|Overall Study|Adverse Event|5|||
33339350|NCT01978093|101132198|FG000|Overall Study|Protocol Violation|8|||
33339351|NCT01978093|101132199|FG001|Overall Study|Protocol Violation|2|||
33339352|NCT01978093|101132198|FG000|Overall Study|Withdrawal by Subject|29|||
33339353|NCT01978093|101132199|FG001|Overall Study|Withdrawal by Subject|25|||
33339354|NCT01978093|101132198|FG000|Overall Study|Lost to Follow-up|11|||
33339355|NCT01978093|101132199|FG001|Overall Study|Lost to Follow-up|15|||
33339356|NCT01978093|101132198|FG000|Overall Study|Migrated/moved from study area|11|||
33339357|NCT01978093|101132199|FG001|Overall Study|Migrated/moved from study area|13|||
33339358|NCT01978093|101132198|FG000|Overall Study|Loss of kaiser coverage|4|||
33339359|NCT01978093|101132199|FG001|Overall Study|Loss of kaiser coverage|10|||
33339360|NCT01978093|101132198|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
33339361|NCT01978093|101132199|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
33405561|NCT00134563|101373392|FG000|Overall Study|progressive disease|11|||
33339362|NCT01978093|101132198|FG000|Overall Study|Mother lost custody of child|0|||
33405562|NCT00134563|101373393|FG001|Overall Study|progressive disease|4|||
33405563|NCT00134563|101373394|FG002|Overall Study|progressive disease|2|||
33405564|NCT00134563|101373392|FG000|Overall Study|did not wish to continue|33|||
33535831|NCT01791595|101859946|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
33535832|NCT01791595|101859947|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
33535833|NCT01791595|101859941|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
33535834|NCT01791595|101859942|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
33535835|NCT01791595|101859943|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
33535836|NCT01791595|101859944|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
33535837|NCT01791595|101859945|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
33535838|NCT01791595|101859946|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
33614014|NCT02218008|102133964|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
33614015|NCT02218008|102133965|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
33535839|NCT01791595|101859947|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
33535840|NCT01791595|101859941|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
33535841|NCT01791595|101859942|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
33535842|NCT01791595|101859943|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
33535843|NCT01791595|101859944|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
33535844|NCT01791595|101859945|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
33535845|NCT01791595|101859946|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
33535846|NCT01791595|101859947|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
33535847|NCT01791595|101859941|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
33535848|NCT01791595|101859942|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
33535849|NCT01791595|101859943|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
33535850|NCT01791595|101859944|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
33535851|NCT01791595|101859945|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
33535852|NCT01791595|101859946|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
33535853|NCT01791595|101859947|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
33535854|NCT01716806|101859948|FG000|Overall Study|Patient withdrawal of consent|4|||
33535855|NCT01716806|101859949|FG001|Overall Study|Patient withdrawal of consent|2|||
33535856|NCT01716806|101859950|FG002|Overall Study|Patient withdrawal of consent|4|||
33535857|NCT01716806|101859951|FG003|Overall Study|Patient withdrawal of consent|3|||
33535858|NCT01716806|101859952|FG004|Overall Study|Patient withdrawal of consent|2|||
33535859|NCT01716806|101859953|FG005|Overall Study|Patient withdrawal of consent|0|||
33535860|NCT01716806|101859948|FG000|Overall Study|Lost to Follow-up|3|||
33535861|NCT01716806|101859949|FG001|Overall Study|Lost to Follow-up|3|||
33535862|NCT01716806|101859950|FG002|Overall Study|Lost to Follow-up|0|||
33535863|NCT01716806|101859951|FG003|Overall Study|Lost to Follow-up|2|||
33535864|NCT01716806|101859952|FG004|Overall Study|Lost to Follow-up|1|||
33535865|NCT01716806|101859953|FG005|Overall Study|Lost to Follow-up|0|||
33535866|NCT01716806|101859948|FG000|Overall Study|Death|13|||
33535867|NCT01716806|101859949|FG001|Overall Study|Death|9|||
33535868|NCT01716806|101859950|FG002|Overall Study|Death|12|||
33535869|NCT01716806|101859951|FG003|Overall Study|Death|4|||
33535870|NCT01716806|101859952|FG004|Overall Study|Death|10|||
33535871|NCT01716806|101859953|FG005|Overall Study|Death|5|||
33535872|NCT01716806|101859948|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
33535873|NCT01716806|101859949|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
33535874|NCT01716806|101859950|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
33535875|NCT01716806|101859951|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
33535876|NCT01716806|101859952|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
33535877|NCT01716806|101859953|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
33535878|NCT01716806|101859948|FG000|Overall Study|PI decision|0|||
33535879|NCT01716806|101859949|FG001|Overall Study|PI decision|0|||
33535880|NCT01716806|101859950|FG002|Overall Study|PI decision|0|||
33535881|NCT01716806|101859951|FG003|Overall Study|PI decision|0|||
33535882|NCT01716806|101859952|FG004|Overall Study|PI decision|1|||
33535883|NCT01716806|101859953|FG005|Overall Study|PI decision|0|||
33614016|NCT02218008|102133966|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
33614017|NCT02218008|102133967|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
33614018|NCT02218008|102133968|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
33614019|NCT02218008|102133969|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
33614020|NCT02218008|102133964|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
33614021|NCT02218008|102133965|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
33614022|NCT02218008|102133966|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
33614023|NCT02218008|102133967|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
33614024|NCT02218008|102133968|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
33614025|NCT02218008|102133969|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
33405565|NCT00134563|101373393|FG001|Overall Study|did not wish to continue|32|||
33339363|NCT01978093|101132199|FG001|Overall Study|Mother lost custody of child|1|||
33339364|NCT01978093|101132198|FG000|Overall Study|Child was in care of grandmother|0|||
33339365|NCT01978093|101132199|FG001|Overall Study|Child was in care of grandmother|1|||
33339366|NCT01978093|101132198|FG000|Overall Study|N/A for vaccine administration|0|||
33339367|NCT01978093|101132199|FG001|Overall Study|N/A for vaccine administration|1|||
33339368|NCT03847610|101132200|FG000|Overall Study|Withdrawal by Subject|1|||
33339369|NCT01514682|101132203|FG000|Overall Study|Withdrawal by Subject|2|||
33339370|NCT01514682|101132204|FG001|Overall Study|Withdrawal by Subject|3|||
33339371|NCT01514682|101132203|FG000|Overall Study|Physician Decision|4|||
33339372|NCT01514682|101132204|FG001|Overall Study|Physician Decision|3|||
33339373|NCT01609842|101132207|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
33339374|NCT01609842|101132208|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
33339375|NCT00490568|101132209|FG000|Overall Study|Adverse Event|116|||
33339376|NCT00490568|101132209|FG000|Overall Study|Lost to Follow-up|13|||
33339377|NCT00490568|101132209|FG000|Overall Study|Protocol Violation|45|||
33339378|NCT00490568|101132209|FG000|Overall Study|Withdrawal by Subject|135|||
33339379|NCT00490568|101132209|FG000|Overall Study|Still in the study at termination|974|||
33339380|NCT00490568|101132209|FG000|Overall Study|Other|1|||
33339381|NCT00490568|101132209|FG000|Overall Study|Exclusion criteria met|1|||
33339382|NCT00490568|101132209|FG000|Overall Study|Caregiver related|20|||
33339383|NCT00490568|101132209|FG000|Overall Study|Abnormal ECG|25|||
33339384|NCT00490568|101132209|FG000|Overall Study|Participant refused follow-up|9|||
33339385|NCT00490568|101132209|FG000|Overall Study|Legal representative withdrew consent|1|||
33535884|NCT01716806|101859948|FG000|Overall Study|Change in performance status|1|||
33535885|NCT01716806|101859949|FG001|Overall Study|Change in performance status|0|||
33535886|NCT01716806|101859950|FG002|Overall Study|Change in performance status|0|||
33535887|NCT01716806|101859951|FG003|Overall Study|Change in performance status|0|||
33535888|NCT01716806|101859952|FG004|Overall Study|Change in performance status|0|||
33535889|NCT01716806|101859953|FG005|Overall Study|Change in performance status|0|||
33535890|NCT01716806|101859948|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
33535891|NCT01716806|101859949|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
33535892|NCT01716806|101859950|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
33535893|NCT01716806|101859951|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
33535894|NCT01716806|101859952|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
33535895|NCT01716806|101859953|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
33535896|NCT01716806|101859948|FG000|Overall Study|Sponsor direction|7|||
33535897|NCT01716806|101859949|FG001|Overall Study|Sponsor direction|8|||
33535898|NCT01716806|101859950|FG002|Overall Study|Sponsor direction|5|||
33535899|NCT01716806|101859951|FG003|Overall Study|Sponsor direction|12|||
33535900|NCT01716806|101859952|FG004|Overall Study|Sponsor direction|16|||
33535901|NCT01716806|101859953|FG005|Overall Study|Sponsor direction|1|||
33535902|NCT01462630|101859954|FG000|Overall Study|Did not initiate therapy|3|||
33535903|NCT01462630|101859954|FG000|Overall Study|Death|1|||
33535904|NCT01462630|101859954|FG000|Overall Study|Protocol Violation|2|||
33535905|NCT01462630|101859954|FG000|Overall Study|Adverse Event|1|||
33535906|NCT03498521|101859959|FG000|Overall Study|Death|191|||
33535907|NCT03498521|101859960|FG001|Overall Study|Death|64|||
33535908|NCT03498521|101859961|FG002|Overall Study|Death|72|||
33535909|NCT03498521|101859959|FG000|Overall Study|Exclusion criteria|1|||
33535910|NCT03498521|101859960|FG001|Overall Study|Exclusion criteria|0|||
33535911|NCT03498521|101859961|FG002|Overall Study|Exclusion criteria|0|||
33535912|NCT03498521|101859959|FG000|Overall Study|Lost to Follow-up|3|||
33535913|NCT03498521|101859960|FG001|Overall Study|Lost to Follow-up|3|||
33535914|NCT03498521|101859961|FG002|Overall Study|Lost to Follow-up|3|||
33535915|NCT03498521|101859959|FG000|Overall Study|No profile due to technical failure|1|||
33535916|NCT03498521|101859960|FG001|Overall Study|No profile due to technical failure|0|||
33535917|NCT03498521|101859961|FG002|Overall Study|No profile due to technical failure|0|||
33535918|NCT03498521|101859959|FG000|Overall Study|Physician Decision|0|||
33535919|NCT03498521|101859960|FG001|Overall Study|Physician Decision|1|||
33535920|NCT03498521|101859961|FG002|Overall Study|Physician Decision|0|||
33535921|NCT03498521|101859959|FG000|Overall Study|Withdrawal by Subject|9|||
33535922|NCT03498521|101859960|FG001|Overall Study|Withdrawal by Subject|6|||
33535923|NCT03498521|101859961|FG002|Overall Study|Withdrawal by Subject|2|||
33614026|NCT02218008|102133964|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
33535924|NCT03498521|101859959|FG000|Overall Study|Study ongoing|121|||
33535925|NCT03498521|101859960|FG001|Overall Study|Study ongoing|36|||
33535926|NCT03498521|101859961|FG002|Overall Study|Study ongoing|15|||
33535927|NCT01765296|101859967|FG000|Overall Study|Protocol Violation|0|||
33535928|NCT01765296|101859968|FG001|Overall Study|Protocol Violation|5|||
33339386|NCT00490568|101132209|FG000|Overall Study|Disease progression|4|||
33339387|NCT00490568|101132209|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
33339388|NCT00490568|101132209|FG000|Overall Study|Investigator decision|3|||
33339389|NCT00490568|101132209|FG000|Overall Study|Non-Compliance|7|||
33535929|NCT01765296|101859969|FG002|Overall Study|Protocol Violation|4|||
33535930|NCT01765296|101859967|FG000|Overall Study|Withdrawal by Subject|4|||
33535931|NCT01765296|101859968|FG001|Overall Study|Withdrawal by Subject|2|||
33535932|NCT01765296|101859969|FG002|Overall Study|Withdrawal by Subject|2|||
33535933|NCT01765296|101859967|FG000|Overall Study|Adverse Event|1|||
33535934|NCT01765296|101859968|FG001|Overall Study|Adverse Event|13|||
33535935|NCT01765296|101859969|FG002|Overall Study|Adverse Event|5|||
33535936|NCT01765296|101859967|FG000|Overall Study|Lack of Efficacy|0|||
33535937|NCT01765296|101859968|FG001|Overall Study|Lack of Efficacy|0|||
33535938|NCT01765296|101859969|FG002|Overall Study|Lack of Efficacy|2|||
33535939|NCT04210986|101859970|FG000|Overall Study|Lost to Follow-up|5|||
33535940|NCT04210986|101859971|FG001|Overall Study|Lost to Follow-up|2|||
33535941|NCT04210986|101859970|FG000|Overall Study|Withdrawal by Subject|3|||
33535942|NCT04210986|101859971|FG001|Overall Study|Withdrawal by Subject|1|||
33535943|NCT04210986|101859970|FG000|Overall Study|Protocol Violation|1|||
33535944|NCT04210986|101859971|FG001|Overall Study|Protocol Violation|1|||
33535945|NCT04210986|101859970|FG000|Overall Study|Physician Decision|0|||
33535946|NCT04210986|101859971|FG001|Overall Study|Physician Decision|1|||
33535947|NCT03028142|101859972|FG000|Overall Study|Adverse Event|1|||
33535948|NCT03028142|101859973|FG001|Overall Study|Adverse Event|1|||
33535949|NCT03028142|101859974|FG002|Overall Study|Adverse Event|0|||
33535950|NCT03028142|101859975|FG003|Overall Study|Adverse Event|0|||
33535951|NCT03028142|101859976|FG004|Overall Study|Adverse Event|0|||
33535952|NCT03028142|101859977|FG005|Overall Study|Adverse Event|1|||
33535953|NCT03028142|101859972|FG000|Overall Study|Withdrawal by Subject|0|||
33535954|NCT03028142|101859973|FG001|Overall Study|Withdrawal by Subject|0|||
33535955|NCT03028142|101859974|FG002|Overall Study|Withdrawal by Subject|0|||
33535956|NCT03028142|101859975|FG003|Overall Study|Withdrawal by Subject|0|||
33535957|NCT03028142|101859976|FG004|Overall Study|Withdrawal by Subject|1|||
33535958|NCT03028142|101859977|FG005|Overall Study|Withdrawal by Subject|0|||
33535959|NCT03160716|101859978|FG000|Overall Study|Lost to Follow-up|1|||
33535960|NCT01157845|101859989|FG000|Overall Study|Lost to Follow-up|5|||
33535961|NCT01157845|101859989|FG000|Overall Study|Withdrawal by Subject|12|||
33535962|NCT01157845|101859989|FG000|Overall Study|Physician Decision|3|||
33535963|NCT01157845|101859989|FG000|Overall Study|Protocol Violation|13|||
33535964|NCT01157845|101859989|FG000|Overall Study|Study was ended|1|||
33339390|NCT00490568|101132209|FG000|Overall Study|Efficacy related|3|||
33339391|NCT00490568|101132209|FG000|Overall Study|Participant died|1|||
33339392|NCT00490568|101132209|FG000|Overall Study|Participant withdrawal due to surgery|1|||
33339393|NCT03733392|101132210|FG000|Overall Study|Withdrawal by Subject|11|||
33339394|NCT03733392|101132211|FG001|Overall Study|Withdrawal by Subject|1|||
33339395|NCT03733392|101132210|FG000|Overall Study|Death|1|||
33339396|NCT03733392|101132211|FG001|Overall Study|Death|0|||
33339397|NCT03733392|101132210|FG000|Overall Study|Lost to Follow-up|5|||
33339398|NCT03733392|101132211|FG001|Overall Study|Lost to Follow-up|0|||
33339399|NCT03733392|101132210|FG000|Overall Study|Protocol Violation|0|||
33339400|NCT03733392|101132211|FG001|Overall Study|Protocol Violation|1|||
33339401|NCT03733392|101132210|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
33339402|NCT03733392|101132211|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
33339403|NCT03733392|101132210|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
33339404|NCT03733392|101132211|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
33339405|NCT03733392|101132210|FG000|Overall Study|Patient Non-Compliance|2|||
33339406|NCT03733392|101132211|FG001|Overall Study|Patient Non-Compliance|1|||
33339407|NCT03733392|101132210|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
33339408|NCT03733392|101132211|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
33339409|NCT03733392|101132210|FG000|Overall Study|Withdrawal prior to procedure|5|||
33339410|NCT03733392|101132211|FG001|Overall Study|Withdrawal prior to procedure|2|||
33339411|NCT00915343|101132212|FG000|Part B - Open Label Period|Treatment switch|0|||
33339412|NCT00915343|101132213|FG001|Part B - Open Label Period|Treatment switch|0|||
33339413|NCT00915343|101132214|FG002|Part B - Open Label Period|Treatment switch|1|||
33339414|NCT00915343|101132212|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
33339415|NCT00915343|101132213|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
33339416|NCT00915343|101132214|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
33535965|NCT01157845|101859989|FG000|Overall Study|Device malfunction|1|||
33535966|NCT00901342|101859990|FG000|Overall Study|Adverse Event|1|||
33535967|NCT00901342|101859990|FG000|Overall Study|Death|4|||
33535968|NCT00901342|101859990|FG000|Overall Study|Disease progression|1|||
33535969|NCT00901342|101859990|FG000|Overall Study|Withdrawal by Subject|9|||
33535970|NCT02849587|101859997|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
33535971|NCT02849587|101859998|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
33339417|NCT00487539|101132215|FG000|Overall Study|Adverse Event|3|||
33535972|NCT02849587|101859999|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
33339418|NCT00487539|101132216|FG001|Overall Study|Adverse Event|2|||
33339419|NCT00487539|101132217|FG002|Overall Study|Adverse Event|1|||
33339420|NCT00487539|101132218|FG003|Overall Study|Adverse Event|1|||
33339421|NCT00487539|101132215|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33339422|NCT00487539|101132216|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33339423|NCT00487539|101132217|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33339424|NCT00487539|101132218|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
33339425|NCT00487539|101132215|FG000|Overall Study|Other|3|||
33339426|NCT00487539|101132216|FG001|Overall Study|Other|1|||
33339427|NCT00487539|101132217|FG002|Overall Study|Other|2|||
33339428|NCT00487539|101132218|FG003|Overall Study|Other|2|||
33339429|NCT01926782|101132224|FG000|Overall Study|Participant moved|2|||
33339430|NCT01926782|101132225|FG001|Overall Study|Participant moved|0|||
33339431|NCT01926782|101132226|FG002|Overall Study|Participant moved|1|||
33339432|NCT01926782|101132227|FG003|Overall Study|Participant moved|1|||
33339433|NCT01926782|101132228|FG004|Overall Study|Participant moved|0|||
33339434|NCT01926782|101132229|FG005|Overall Study|Participant moved|3|||
33339435|NCT01926782|101132224|FG000|Overall Study|Physician Decision|0|||
33339436|NCT01926782|101132225|FG001|Overall Study|Physician Decision|2|||
33339437|NCT01926782|101132226|FG002|Overall Study|Physician Decision|1|||
33339438|NCT01926782|101132227|FG003|Overall Study|Physician Decision|1|||
33339439|NCT01926782|101132228|FG004|Overall Study|Physician Decision|0|||
33339440|NCT01926782|101132229|FG005|Overall Study|Physician Decision|0|||
33339441|NCT01926782|101132224|FG000|Overall Study|Other than specified|2|||
33339442|NCT01926782|101132225|FG001|Overall Study|Other than specified|3|||
33339443|NCT01926782|101132226|FG002|Overall Study|Other than specified|5|||
33339444|NCT01926782|101132227|FG003|Overall Study|Other than specified|12|||
33339445|NCT01926782|101132228|FG004|Overall Study|Other than specified|4|||
33339446|NCT01926782|101132229|FG005|Overall Study|Other than specified|11|||
33339447|NCT01926782|101132224|FG000|Overall Study|Adverse Event|13|||
33339448|NCT01926782|101132225|FG001|Overall Study|Adverse Event|4|||
33339449|NCT01926782|101132226|FG002|Overall Study|Adverse Event|17|||
33339450|NCT01926782|101132227|FG003|Overall Study|Adverse Event|4|||
33339451|NCT01926782|101132228|FG004|Overall Study|Adverse Event|3|||
33339452|NCT01926782|101132229|FG005|Overall Study|Adverse Event|14|||
33339453|NCT01926782|101132224|FG000|Overall Study|Poor compliance to protocol|5|||
33339454|NCT01926782|101132225|FG001|Overall Study|Poor compliance to protocol|3|||
33339455|NCT01926782|101132226|FG002|Overall Study|Poor compliance to protocol|8|||
33339456|NCT01926782|101132227|FG003|Overall Study|Poor compliance to protocol|0|||
33339457|NCT01926782|101132228|FG004|Overall Study|Poor compliance to protocol|1|||
33339458|NCT01926782|101132229|FG005|Overall Study|Poor compliance to protocol|6|||
33339459|NCT01926782|101132224|FG000|Overall Study|Randomized and not treated|0|||
33405566|NCT00134563|101373394|FG002|Overall Study|did not wish to continue|26|||
33535973|NCT02849587|101859997|FG000|Overall Study|Withdrawal by Subject|0|||
33535974|NCT02849587|101859998|FG001|Overall Study|Withdrawal by Subject|1|||
33535975|NCT02849587|101859999|FG002|Overall Study|Withdrawal by Subject|0|||
33535976|NCT01222104|101860000|FG000|Overall Study|Lost to Follow-up|37|||
33535977|NCT01222104|101860000|FG000|Overall Study|Death|10|||
33535978|NCT03016169|101863701|FG000|Overall Study|Lost to Follow-up|4|||
33535979|NCT03016169|101863701|FG000|Overall Study|Death|54|||
33535980|NCT03016169|101863701|FG000|Overall Study|Device Explant|11|||
33535981|NCT03016169|101863701|FG000|Overall Study|Withdrawal by Subject|19|||
33535982|NCT03016169|101863701|FG000|Overall Study|Other Reasons|1|||
33535983|NCT00458003|101863702|FG000|Overall Study|Non protocol spinal anesthesia|1|||
33535984|NCT00458003|101863703|FG001|Overall Study|Non protocol spinal anesthesia|1|||
33535985|NCT00739648|101863706|FG000|Overall Study|Adverse Event|3|||
33535986|NCT00739648|101863707|FG001|Overall Study|Adverse Event|15|||
33535987|NCT00739648|101863706|FG000|Overall Study|Withdrawal by Subject|13|||
33535988|NCT00739648|101863707|FG001|Overall Study|Withdrawal by Subject|25|||
33535989|NCT00739648|101863706|FG000|Overall Study|Lost to Follow-up|4|||
33535990|NCT00739648|101863707|FG001|Overall Study|Lost to Follow-up|7|||
33535991|NCT00739648|101863706|FG000|Overall Study|Death|2|||
33535992|NCT00739648|101863707|FG001|Overall Study|Death|0|||
33535993|NCT00739648|101863706|FG000|Overall Study|Do not know|4|||
33535994|NCT00739648|101863707|FG001|Overall Study|Do not know|6|||
33535995|NCT03533751|101863708|FG000|Overall Study|Withdrawal by Subject|12|||
33535996|NCT03533751|101863709|FG001|Overall Study|Withdrawal by Subject|6|||
33535997|NCT03533751|101863710|FG002|Overall Study|Withdrawal by Subject|11|||
33535998|NCT03533751|101863711|FG003|Overall Study|Withdrawal by Subject|9|||
33535999|NCT03533751|101863712|FG004|Overall Study|Withdrawal by Subject|10|||
33536000|NCT03533751|101863708|FG000|Overall Study|Adverse Event|4|||
33339460|NCT01926782|101132225|FG001|Overall Study|Randomized and not treated|0|||
33339461|NCT01926782|101132226|FG002|Overall Study|Randomized and not treated|0|||
33339462|NCT01926782|101132227|FG003|Overall Study|Randomized and not treated|1|||
33339463|NCT01926782|101132228|FG004|Overall Study|Randomized and not treated|0|||
33339464|NCT01926782|101132229|FG005|Overall Study|Randomized and not treated|0|||
33339465|NCT01926782|101132224|FG000|Overall Study|Withdrawal by Subject|6|||
33339466|NCT01926782|101132225|FG001|Overall Study|Withdrawal by Subject|1|||
33339467|NCT01926782|101132226|FG002|Overall Study|Withdrawal by Subject|8|||
33339468|NCT01926782|101132227|FG003|Overall Study|Withdrawal by Subject|1|||
33536001|NCT03533751|101863709|FG001|Overall Study|Adverse Event|7|||
33536002|NCT03533751|101863710|FG002|Overall Study|Adverse Event|2|||
33536003|NCT03533751|101863711|FG003|Overall Study|Adverse Event|4|||
33536004|NCT03533751|101863712|FG004|Overall Study|Adverse Event|5|||
33536005|NCT03533751|101863708|FG000|Overall Study|Physician Decision|0|||
33536006|NCT03533751|101863709|FG001|Overall Study|Physician Decision|2|||
33536007|NCT03533751|101863710|FG002|Overall Study|Physician Decision|1|||
33536008|NCT03533751|101863711|FG003|Overall Study|Physician Decision|2|||
33536009|NCT03533751|101863712|FG004|Overall Study|Physician Decision|1|||
33536010|NCT03533751|101863708|FG000|Overall Study|Sponsor Decision|0|||
33536011|NCT03533751|101863709|FG001|Overall Study|Sponsor Decision|0|||
33536012|NCT03533751|101863710|FG002|Overall Study|Sponsor Decision|1|||
33536013|NCT03533751|101863711|FG003|Overall Study|Sponsor Decision|1|||
33536014|NCT03533751|101863712|FG004|Overall Study|Sponsor Decision|0|||
33536015|NCT03533751|101863708|FG000|Overall Study|Lost to Follow-up|3|||
33536016|NCT03533751|101863709|FG001|Overall Study|Lost to Follow-up|7|||
33536017|NCT03533751|101863710|FG002|Overall Study|Lost to Follow-up|6|||
33536018|NCT03533751|101863711|FG003|Overall Study|Lost to Follow-up|4|||
33536019|NCT03533751|101863712|FG004|Overall Study|Lost to Follow-up|3|||
33536020|NCT03533751|101863708|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
33536021|NCT03533751|101863709|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
33536022|NCT03533751|101863710|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
33536023|NCT03533751|101863711|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
33536024|NCT03533751|101863712|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
33536025|NCT03533751|101863708|FG000|Overall Study|Other|0|||
33536026|NCT03533751|101863709|FG001|Overall Study|Other|2|||
33536027|NCT03533751|101863710|FG002|Overall Study|Other|1|||
33536028|NCT03533751|101863711|FG003|Overall Study|Other|0|||
33536029|NCT03533751|101863712|FG004|Overall Study|Other|3|||
33536030|NCT01526785|101863713|FG000|Overall Study|Study Terminated by Sponsor|8|||
33536031|NCT01526785|101863713|FG000|Overall Study|Death|2|||
33536032|NCT01526785|101863713|FG000|Overall Study|Physician Decision|1|||
33536033|NCT01526785|101863713|FG000|Overall Study|Withdrawal by Subject|2|||
33536034|NCT04805671|101863715|FG000|Overall Study|Death|2|||
33536035|NCT04805671|101863716|FG001|Overall Study|Death|7|||
33536036|NCT04805671|101863715|FG000|Overall Study|Lost to Follow-up|1|||
33536037|NCT04805671|101863716|FG001|Overall Study|Lost to Follow-up|0|||
33536038|NCT04805671|101863715|FG000|Overall Study|Withdrawal by Subject|9|||
33536039|NCT04805671|101863716|FG001|Overall Study|Withdrawal by Subject|7|||
33536040|NCT04805671|101863715|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
33536041|NCT04805671|101863716|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
33536042|NCT02144701|101863717|FG000|Overall Study|development of relapse, GVHD or death|9|||
33536043|NCT02144701|101863718|FG001|Overall Study|development of relapse, GVHD or death|3|||
33536044|NCT02314728|101863719|FG000|Overall Study|Protocol Violation|1|||
33536045|NCT02314728|101863720|FG001|Overall Study|Protocol Violation|0|||
33536046|NCT02314728|101863719|FG000|Overall Study|Lost to Follow-up|0|||
33536047|NCT02314728|101863720|FG001|Overall Study|Lost to Follow-up|1|||
33536048|NCT00297648|101863721|FG000|Overall Study|Adverse Event|13|||
33536049|NCT00297648|101863721|FG000|Overall Study|Lack of Efficacy|18|||
33536050|NCT00297648|101863721|FG000|Overall Study|Lost to Follow-up|1|||
33536051|NCT00297648|101863721|FG000|Overall Study|Withdrawal by Subject|3|||
33536052|NCT00297648|101863721|FG000|Overall Study|Other: Incompliance|1|||
33536053|NCT02823470|101863723|FG000|Overall Study|Adverse Event|1|||
33536054|NCT02823470|101863724|FG001|Overall Study|Adverse Event|0|||
33536055|NCT02823470|101863723|FG000|Overall Study|Study terminated by sponsor|8|||
33536056|NCT02823470|101863724|FG001|Overall Study|Study terminated by sponsor|15|||
33536057|NCT02486692|101863733|FG000|Overall Study|did not login for randomization|4|||
33536058|NCT02486692|101863734|FG001|Overall Study|did not login for randomization|7|||
33536059|NCT03154086|101863735|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33536060|NCT03154086|101863736|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33536061|NCT03154086|101863737|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33536062|NCT03154086|101863738|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
33536063|NCT03154086|101863739|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33536064|NCT03154086|101863740|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33536065|NCT03154086|101863741|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33536066|NCT03154086|101863742|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33536067|NCT03154086|101863743|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33536068|NCT03154086|101863744|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33536069|NCT03154086|101863745|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33536070|NCT03154086|101863746|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33536071|NCT03154086|101863747|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33536072|NCT03154086|101863748|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33536073|NCT03154086|101863749|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
33536074|NCT03154086|101863735|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33536075|NCT03154086|101863736|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
33536076|NCT03154086|101863737|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33536077|NCT03154086|101863738|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33536078|NCT03154086|101863739|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33536079|NCT03154086|101863740|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33536080|NCT03154086|101863741|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33536081|NCT03154086|101863742|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33536082|NCT03154086|101863743|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33536083|NCT03154086|101863744|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33536084|NCT03154086|101863745|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33405567|NCT00134563|101373392|FG000|Overall Study|Reason other than above|0|||
33405568|NCT00134563|101373393|FG001|Overall Study|Reason other than above|2|||
33405569|NCT00134563|101373394|FG002|Overall Study|Reason other than above|5|||
33405570|NCT01207427|101373409|FG000|Double-blind Treatment Period|Adverse Event|0|||
33405571|NCT01207427|101373410|FG001|Double-blind Treatment Period|Adverse Event|1|||
33405572|NCT01207427|101373411|FG002|Double-blind Treatment Period|Adverse Event|0|||
33405573|NCT01207427|101373409|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
33405574|NCT01207427|101373410|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
33405575|NCT01207427|101373411|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
33405576|NCT01207427|101373409|FG000|Double-blind Treatment Period|Protocol Violation|2|||
33405577|NCT01207427|101373410|FG001|Double-blind Treatment Period|Protocol Violation|1|||
33405578|NCT01207427|101373411|FG002|Double-blind Treatment Period|Protocol Violation|1|||
33405579|NCT01207427|101373409|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
33405580|NCT01207427|101373410|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
33405581|NCT01207427|101373411|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33405582|NCT00203294|101373413|FG000|Overall Study|Withdrawal by Subject|8|||
33405583|NCT00203294|101373414|FG001|Overall Study|Withdrawal by Subject|13|||
33405584|NCT02972658|101373417|FG000|Overall Study|Adverse Event|0|||
33405585|NCT02972658|101373418|FG001|Overall Study|Adverse Event|3|||
33405586|NCT02972658|101373419|FG002|Overall Study|Adverse Event|0|||
33405587|NCT02972658|101373420|FG003|Overall Study|Adverse Event|2|||
33405588|NCT02972658|101373417|FG000|Overall Study|Other-determined by Investigator|1|||
33405589|NCT02972658|101373418|FG001|Overall Study|Other-determined by Investigator|1|||
33405590|NCT02972658|101373419|FG002|Overall Study|Other-determined by Investigator|0|||
33405591|NCT02972658|101373420|FG003|Overall Study|Other-determined by Investigator|0|||
33405592|NCT02972658|101373417|FG000|Overall Study|Death|0|||
33405593|NCT02972658|101373418|FG001|Overall Study|Death|0|||
33405594|NCT02972658|101373419|FG002|Overall Study|Death|0|||
33405595|NCT02972658|101373420|FG003|Overall Study|Death|1|||
33405596|NCT02972658|101373417|FG000|Overall Study|Lost to Follow-up|0|||
33405597|NCT02972658|101373418|FG001|Overall Study|Lost to Follow-up|1|||
33405598|NCT02972658|101373419|FG002|Overall Study|Lost to Follow-up|1|||
33405599|NCT02972658|101373420|FG003|Overall Study|Lost to Follow-up|2|||
33405600|NCT02972658|101373417|FG000|Overall Study|Progressive Disease|0|||
33405601|NCT02972658|101373418|FG001|Overall Study|Progressive Disease|1|||
33405602|NCT02972658|101373419|FG002|Overall Study|Progressive Disease|0|||
33405603|NCT02972658|101373420|FG003|Overall Study|Progressive Disease|1|||
33405604|NCT02972658|101373417|FG000|Overall Study|Withdrawal by Subject|4|||
33405605|NCT02972658|101373418|FG001|Overall Study|Withdrawal by Subject|4|||
33405606|NCT02972658|101373419|FG002|Overall Study|Withdrawal by Subject|1|||
33405607|NCT02972658|101373420|FG003|Overall Study|Withdrawal by Subject|6|||
33405608|NCT02972658|101373417|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
33405609|NCT02972658|101373418|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
33405610|NCT02972658|101373419|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
33405611|NCT02972658|101373420|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
33405612|NCT02972658|101373417|FG000|Overall Study|Sponsor Decision|70|||
33405613|NCT02972658|101373418|FG001|Overall Study|Sponsor Decision|127|||
33405614|NCT02972658|101373419|FG002|Overall Study|Sponsor Decision|72|||
33405615|NCT02972658|101373420|FG003|Overall Study|Sponsor Decision|119|||
33405616|NCT03172026|101373421|FG000|Overall Study|Withdrawal by Subject|1|||
33405617|NCT03172026|101373422|FG001|Overall Study|Withdrawal by Subject|0|||
33405618|NCT03172026|101373421|FG000|Overall Study|COVID restrictions|1|||
33405619|NCT03172026|101373422|FG001|Overall Study|COVID restrictions|0|||
33405620|NCT01159665|101373423|FG000|Overall Study|Withdrawal by Subject|0|||
33405621|NCT01159665|101373424|FG001|Overall Study|Withdrawal by Subject|1|||
33405622|NCT01159665|101373425|FG002|Overall Study|Withdrawal by Subject|0|||
33405623|NCT01159665|101373426|FG003|Overall Study|Withdrawal by Subject|0|||
33536085|NCT03154086|101863746|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33405624|NCT01159665|101373427|FG004|Overall Study|Withdrawal by Subject|0|||
33405625|NCT01159665|101373428|FG005|Overall Study|Withdrawal by Subject|0|||
33405626|NCT02361307|101373430|FG000|Overall Study|Unstable medical condition.|0|||
33405627|NCT02361307|101373431|FG001|Overall Study|Unstable medical condition.|1|||
33536086|NCT03154086|101863747|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33536087|NCT03154086|101863748|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33536088|NCT03154086|101863749|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
33536089|NCT03154086|101863735|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33536090|NCT03154086|101863736|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33536091|NCT03154086|101863737|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
33536092|NCT03154086|101863738|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33536093|NCT03154086|101863739|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33536094|NCT03154086|101863740|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33536095|NCT03154086|101863741|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33536096|NCT03154086|101863742|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33536097|NCT03154086|101863743|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33536098|NCT03154086|101863744|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33536099|NCT03154086|101863745|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33536100|NCT03154086|101863746|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33536101|NCT03154086|101863747|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33536102|NCT03154086|101863748|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33536103|NCT03154086|101863749|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
33536104|NCT03154086|101863735|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
33536105|NCT03154086|101863736|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33536106|NCT03154086|101863737|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33536107|NCT03154086|101863738|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33536108|NCT03154086|101863739|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33536109|NCT03154086|101863740|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33536110|NCT03154086|101863741|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33536111|NCT03154086|101863742|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33536112|NCT03154086|101863743|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33536113|NCT03154086|101863744|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33536114|NCT03154086|101863745|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33536115|NCT03154086|101863746|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33536116|NCT03154086|101863747|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33536117|NCT03154086|101863748|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33536118|NCT03154086|101863749|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
33536119|NCT03154086|101863735|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33536120|NCT03154086|101863736|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33536121|NCT03154086|101863737|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33536122|NCT03154086|101863738|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33536123|NCT03154086|101863739|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33536124|NCT03154086|101863740|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33536125|NCT03154086|101863741|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33536126|NCT03154086|101863742|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33536127|NCT03154086|101863743|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
33536128|NCT03154086|101863744|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33536129|NCT03154086|101863745|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33536130|NCT03154086|101863746|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33536131|NCT03154086|101863747|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33536132|NCT03154086|101863748|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33536133|NCT03154086|101863749|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
33536134|NCT03154086|101863735|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33536135|NCT03154086|101863736|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33536136|NCT03154086|101863737|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33536137|NCT03154086|101863738|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33536138|NCT03154086|101863739|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33536139|NCT03154086|101863740|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33536140|NCT03154086|101863741|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33536141|NCT03154086|101863742|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
33536142|NCT03154086|101863743|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33536143|NCT03154086|101863744|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33536144|NCT03154086|101863745|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33536145|NCT03154086|101863746|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33536146|NCT03154086|101863747|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33536147|NCT03154086|101863748|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33536148|NCT03154086|101863749|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
33536149|NCT03154086|101863735|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
33536150|NCT03154086|101863736|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
33208310|NCT02363738|100665449|FG001|Overall Study|Lost to Follow-up|1|||
33208311|NCT01605617|100665452|FG000|First Intervention|Adverse Event|0|||
33208312|NCT01605617|100665453|FG001|First Intervention|Adverse Event|1|||
33208313|NCT01605617|100665452|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
33208314|NCT01605617|100665453|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
33208315|NCT04447404|100665454|FG000|Overall Study|Death|2|||
33208316|NCT04447404|100665455|FG001|Overall Study|Death|0|||
33208317|NCT04154787|100665456|FG000|Overall Study|Adverse Event|0|||
33208318|NCT04154787|100665457|FG001|Overall Study|Adverse Event|1|||
33339469|NCT01926782|101132228|FG004|Overall Study|Withdrawal by Subject|0|||
33405628|NCT02624713|101373435|FG000|Overall Study|Lost to Follow-up|14|||
33614027|NCT02218008|102133965|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
33614028|NCT02218008|102133966|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
33614029|NCT02218008|102133967|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
33614030|NCT02218008|102133968|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
33614031|NCT02218008|102133969|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
33614032|NCT02218008|102133964|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
33614033|NCT02218008|102133965|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
33614034|NCT02218008|102133966|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
33614035|NCT02218008|102133967|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
33614036|NCT02218008|102133968|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
33614037|NCT02218008|102133969|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
33614038|NCT01832155|102133971|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
33614039|NCT01832155|102133972|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
33614040|NCT01832155|102133971|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
33614041|NCT01832155|102133972|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
33614042|NCT01900652|102136943|FG000|Overall Study|Progressive Disease|1|||
33614043|NCT01900652|102136944|FG001|Overall Study|Progressive Disease|0|||
33614044|NCT01900652|102136943|FG000|Overall Study|Consent withdrawn by subject|1|||
33614045|NCT01900652|102136944|FG001|Overall Study|Consent withdrawn by subject|1|||
33614046|NCT01900652|102136943|FG000|Overall Study|Death|3|||
33614047|NCT01900652|102136944|FG001|Overall Study|Death|0|||
33208319|NCT04154787|100665458|FG002|Overall Study|Adverse Event|0|||
33208320|NCT04154787|100665456|FG000|Overall Study|Patient Requires Other Treatment|0|||
33614048|NCT01900652|102136943|FG000|Overall Study|Adverse Event|2|||
33208321|NCT04154787|100665457|FG001|Overall Study|Patient Requires Other Treatment|1|||
33208322|NCT04154787|100665458|FG002|Overall Study|Patient Requires Other Treatment|0|||
33208323|NCT04154787|100665456|FG000|Overall Study|Study Terminated By Sponsor|0|||
33208324|NCT04154787|100665457|FG001|Overall Study|Study Terminated By Sponsor|6|||
33208325|NCT04154787|100665458|FG002|Overall Study|Study Terminated By Sponsor|1|||
33208326|NCT04154787|100665456|FG000|Overall Study|Subject Decision|0|||
33208327|NCT04154787|100665457|FG001|Overall Study|Subject Decision|1|||
33208328|NCT04154787|100665458|FG002|Overall Study|Subject Decision|0|||
33208329|NCT04154787|100665456|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
33208330|NCT04154787|100665457|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
33536151|NCT03154086|101863737|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
33536152|NCT03154086|101863738|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
33536153|NCT03154086|101863739|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
33536154|NCT03154086|101863740|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
33536155|NCT03154086|101863741|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
33536156|NCT03154086|101863742|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
33208331|NCT04154787|100665458|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
33208332|NCT01715805|100665459|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
33208333|NCT01715805|100665460|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
33208334|NCT01715805|100665461|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
33208335|NCT01715805|100665462|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
33208336|NCT01715805|100665459|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
33208337|NCT01715805|100665460|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
33208338|NCT01715805|100665461|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
33208339|NCT01715805|100665462|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
33208340|NCT01715805|100665459|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
33208341|NCT01715805|100665460|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
33208342|NCT01715805|100665461|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
33208343|NCT01715805|100665462|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
33208344|NCT01715805|100665459|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
33208345|NCT01715805|100665460|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
33208346|NCT01715805|100665461|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
33405629|NCT02624713|101373436|FG001|Overall Study|Lost to Follow-up|0|||
33536157|NCT03154086|101863743|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
33536158|NCT03154086|101863744|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
33536159|NCT03154086|101863745|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
33536160|NCT03154086|101863746|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
33536161|NCT03154086|101863747|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
33536162|NCT03154086|101863748|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
33536163|NCT03154086|101863749|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
33536164|NCT05117060|101863762|FG000|Overall Study|Adverse Event|3|||
33536165|NCT05117060|101863763|FG001|Overall Study|Adverse Event|5|||
33536166|NCT05117060|101863764|FG002|Overall Study|Adverse Event|6|||
33536167|NCT05117060|101863765|FG003|Overall Study|Adverse Event|1|||
33536168|NCT05117060|101863762|FG000|Overall Study|Lost to Follow-up|0|||
33536169|NCT05117060|101863763|FG001|Overall Study|Lost to Follow-up|0|||
33536170|NCT05117060|101863764|FG002|Overall Study|Lost to Follow-up|0|||
33536171|NCT05117060|101863765|FG003|Overall Study|Lost to Follow-up|1|||
33208347|NCT01715805|100665462|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
33208348|NCT01715805|100665459|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
33405630|NCT01791543|101373437|FG000|Overall Study|Lost to Follow-up|1|||
33208349|NCT01715805|100665460|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
33208350|NCT01715805|100665461|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
33208351|NCT01715805|100665462|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
33208352|NCT01715805|100665459|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
33208353|NCT01715805|100665460|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
33208354|NCT01715805|100665461|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
33208355|NCT01715805|100665462|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
33208356|NCT01715805|100665459|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
33208357|NCT01715805|100665460|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
33208358|NCT01715805|100665461|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
33208359|NCT01715805|100665462|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
33208360|NCT01715805|100665459|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
33208361|NCT01715805|100665460|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
33208362|NCT01715805|100665461|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
33208363|NCT01715805|100665462|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
33208364|NCT01715805|100665459|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
33208365|NCT01715805|100665460|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
33208366|NCT01715805|100665461|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
33208367|NCT01715805|100665462|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
33208368|NCT01715805|100665459|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
33208369|NCT01715805|100665460|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
33339470|NCT01926782|101132229|FG005|Overall Study|Withdrawal by Subject|5|||
33405631|NCT01791543|101373437|FG000|Overall Study|Adverse Event|1|||
33536172|NCT05117060|101863762|FG000|Overall Study|Lack of Efficacy|4|||
33536173|NCT05117060|101863763|FG001|Overall Study|Lack of Efficacy|5|||
33536174|NCT05117060|101863764|FG002|Overall Study|Lack of Efficacy|2|||
33536175|NCT05117060|101863765|FG003|Overall Study|Lack of Efficacy|6|||
33536176|NCT05117060|101863762|FG000|Overall Study|Withdrawal by Subject|8|||
33536177|NCT05117060|101863763|FG001|Overall Study|Withdrawal by Subject|5|||
33536178|NCT05117060|101863764|FG002|Overall Study|Withdrawal by Subject|5|||
33536179|NCT05117060|101863765|FG003|Overall Study|Withdrawal by Subject|6|||
33536180|NCT05117060|101863762|FG000|Overall Study|Other|2|||
33536181|NCT05117060|101863763|FG001|Overall Study|Other|1|||
33536182|NCT05117060|101863764|FG002|Overall Study|Other|3|||
33536183|NCT05117060|101863765|FG003|Overall Study|Other|1|||
33536184|NCT04085601|101863766|FG000|Overall Study|Lost to Follow-up|1|||
33536185|NCT04085601|101863767|FG001|Overall Study|Lost to Follow-up|0|||
33536186|NCT04085601|101863766|FG000|Overall Study|Death|1|||
33536187|NCT04085601|101863767|FG001|Overall Study|Death|1|||
33536188|NCT01128296|101863770|FG000|Overall Study|Physician Decision|0|||
33536189|NCT01128296|101863771|FG001|Overall Study|Physician Decision|0|||
33536190|NCT01128296|101863772|FG002|Overall Study|Physician Decision|0|||
33536191|NCT01128296|101863773|FG003|Overall Study|Physician Decision|0|||
33536192|NCT01128296|101863774|FG004|Overall Study|Physician Decision|0|||
33536193|NCT01128296|101863775|FG005|Overall Study|Physician Decision|3|||
33536194|NCT01128296|101863770|FG000|Overall Study|Withdrawal by Subject|0|||
33536195|NCT01128296|101863771|FG001|Overall Study|Withdrawal by Subject|0|||
33536196|NCT01128296|101863772|FG002|Overall Study|Withdrawal by Subject|0|||
33536197|NCT01128296|101863773|FG003|Overall Study|Withdrawal by Subject|0|||
33536198|NCT01128296|101863774|FG004|Overall Study|Withdrawal by Subject|0|||
33536199|NCT01128296|101863775|FG005|Overall Study|Withdrawal by Subject|2|||
33536200|NCT01663402|101863776|FG000|Overall Study|Randomized but not treated|19|||
33339471|NCT01926782|101132224|FG000|Overall Study|Related to study drug administration|0|||
33339472|NCT01926782|101132225|FG001|Overall Study|Related to study drug administration|0|||
33339473|NCT01926782|101132226|FG002|Overall Study|Related to study drug administration|0|||
33339474|NCT01926782|101132227|FG003|Overall Study|Related to study drug administration|0|||
33339475|NCT01926782|101132228|FG004|Overall Study|Related to study drug administration|0|||
33536201|NCT01663402|101863777|FG001|Overall Study|Randomized but not treated|11|||
33536202|NCT01663402|101863776|FG000|Overall Study|Adverse Event|347|||
33536203|NCT01663402|101863777|FG001|Overall Study|Adverse Event|362|||
33536204|NCT01663402|101863776|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
33536205|NCT01663402|101863777|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
33536206|NCT01663402|101863776|FG000|Overall Study|Poor compliance to protocol|529|||
33536207|NCT01663402|101863777|FG001|Overall Study|Poor compliance to protocol|454|||
33536208|NCT01663402|101863776|FG000|Overall Study|Physician Decision|77|||
33536209|NCT01663402|101863777|FG001|Overall Study|Physician Decision|62|||
33536210|NCT01663402|101863776|FG000|Overall Study|Site terminated by sponsor|1|||
33536211|NCT01663402|101863777|FG001|Overall Study|Site terminated by sponsor|3|||
33536212|NCT01663402|101863776|FG000|Overall Study|Participant moved|139|||
33536213|NCT01663402|101863777|FG001|Overall Study|Participant moved|104|||
33536214|NCT01663402|101863776|FG000|Overall Study|Withdrawal by Subject|118|||
33614049|NCT01900652|102136944|FG001|Overall Study|Adverse Event|1|||
33614050|NCT01900652|102136943|FG000|Overall Study|Physician Decision|1|||
33614051|NCT01900652|102136944|FG001|Overall Study|Physician Decision|1|||
33614052|NCT00176462|102136945|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
33614053|NCT00176462|102136946|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
33614054|NCT00176462|102136945|FG000|Induction (4 Weeks)|Death|1|||
33614055|NCT00176462|102136946|FG001|Induction (4 Weeks)|Death|2|||
33614056|NCT00176462|102136945|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
33614057|NCT00176462|102136946|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
33339476|NCT01926782|101132229|FG005|Overall Study|Related to study drug administration|2|||
33536215|NCT01663402|101863777|FG001|Overall Study|Withdrawal by Subject|91|||
33536216|NCT01663402|101863776|FG000|Overall Study|Related to study drug administration|96|||
33536217|NCT01663402|101863777|FG001|Overall Study|Related to study drug administration|105|||
33339477|NCT00288080|101132231|FG000|Overall Study|Withdrawal by Subject|1|||
33405632|NCT01287403|101373438|FG000|1st Intervention (1 Day)|Adverse Event|1|||
33405633|NCT02039687|101373439|FG000|Overall Study|Adverse Event|0|||
33536218|NCT01663402|101863776|FG000|Overall Study|Lost to Follow-up|17|||
33536219|NCT01663402|101863777|FG001|Overall Study|Lost to Follow-up|15|||
33536220|NCT01663402|101863776|FG000|Overall Study|Other than specified above|172|||
33614058|NCT00176462|102136945|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
33614059|NCT00176462|102136946|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
33614060|NCT00176462|102136945|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
33339478|NCT00288080|101132232|FG001|Overall Study|Withdrawal by Subject|3|||
33339479|NCT00288080|101132231|FG000|Overall Study|Protocol Violation|25|||
33536221|NCT01663402|101863777|FG001|Overall Study|Other than specified above|147|||
33614061|NCT00176462|102136946|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
33614062|NCT00176462|102136945|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
33614063|NCT00176462|102136946|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
33536222|NCT02692586|101863779|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
33536223|NCT02692586|101863779|FG000|Overall Study|Received adjunctive thrombolytics|2|||
33536224|NCT00974311|101863786|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
33536225|NCT00974311|101863787|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
33208370|NCT01715805|100665461|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
33208371|NCT01715805|100665462|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
33208372|NCT01715805|100665459|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
33208373|NCT01715805|100665460|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
33208374|NCT01715805|100665461|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
33208375|NCT01715805|100665462|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
33208376|NCT01715805|100665459|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
33208377|NCT01715805|100665460|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
33208378|NCT01715805|100665461|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
33208379|NCT01715805|100665462|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
33208380|NCT01715805|100665459|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
33208381|NCT01715805|100665460|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
33208382|NCT01715805|100665461|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
33208383|NCT01715805|100665462|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
33208384|NCT01715805|100665459|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
33208385|NCT01715805|100665460|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
33208386|NCT01715805|100665461|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
33208387|NCT01715805|100665462|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
33208388|NCT02952924|100665463|FG000|Overall Study|Protocol Violation|0|||
33208389|NCT02952924|100665464|FG001|Overall Study|Protocol Violation|0|||
33208390|NCT02952924|100665465|FG002|Overall Study|Protocol Violation|0|||
33208391|NCT02952924|100665466|FG003|Overall Study|Protocol Violation|0|||
33208392|NCT02952924|100665467|FG004|Overall Study|Protocol Violation|0|||
33208393|NCT02952924|100665468|FG005|Overall Study|Protocol Violation|0|||
33208394|NCT02952924|100665469|FG006|Overall Study|Protocol Violation|0|||
33208395|NCT02952924|100665470|FG007|Overall Study|Protocol Violation|0|||
33208396|NCT02952924|100665471|FG008|Overall Study|Protocol Violation|0|||
33208397|NCT02952924|100665472|FG009|Overall Study|Protocol Violation|0|||
33536226|NCT00974311|101863786|FG000|DB Phase (up to 24 Months)|Death|561|||
33536227|NCT00974311|101863787|FG001|DB Phase (up to 24 Months)|Death|298|||
33536228|NCT00974311|101863786|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
33536229|NCT00974311|101863787|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
33536230|NCT00974311|101863786|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
33536231|NCT00974311|101863787|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
33536232|NCT00974311|101863786|FG000|DB Phase (up to 24 Months)|Other|1|||
33536233|NCT00974311|101863787|FG001|DB Phase (up to 24 Months)|Other|0|||
33536234|NCT00974311|101863786|FG000|OLE Phase (up to 77 Months)|Death|14|||
33536235|NCT00974311|101863787|FG001|OLE Phase (up to 77 Months)|Death|21|||
33536236|NCT00974311|101863786|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
33536237|NCT00974311|101863787|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
33536238|NCT00974311|101863786|FG000|OLE Phase (up to 77 Months)|Other|15|||
33536239|NCT00974311|101863787|FG001|OLE Phase (up to 77 Months)|Other|2|||
33536240|NCT00974311|101863786|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
33536241|NCT00974311|101863787|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
33536242|NCT01775670|101863788|FG000|Overall Study|Lost to Follow-up|1|||
33536243|NCT01775670|101863789|FG001|Overall Study|Lost to Follow-up|1|||
33536244|NCT02224625|101863790|FG000|Irritation|Adverse Event|6|||
33536245|NCT02224625|101863790|FG000|Sensitization|Adverse Event|55|||
33536246|NCT02230891|101863791|FG000|Baseline|Did not meet inclusion|0|||
33536247|NCT02230891|101863792|FG001|Baseline|Did not meet inclusion|1|||
33536248|NCT02230891|101863793|FG002|Baseline|Did not meet inclusion|1|||
33536249|NCT02230891|101863791|FG000|2 Week|Withdrawal by Subject|2|||
33536250|NCT02230891|101863792|FG001|2 Week|Withdrawal by Subject|2|||
33536251|NCT02230891|101863793|FG002|2 Week|Withdrawal by Subject|0|||
33536252|NCT02230891|101863791|FG000|2 Week|Consent withdrawn|1|||
33536253|NCT02230891|101863792|FG001|2 Week|Consent withdrawn|0|||
33536254|NCT02230891|101863793|FG002|2 Week|Consent withdrawn|0|||
33536255|NCT02230891|101863791|FG000|6 Month|Withdrawal by Subject|1|||
33536256|NCT02230891|101863792|FG001|6 Month|Withdrawal by Subject|1|||
33536257|NCT02230891|101863793|FG002|6 Month|Withdrawal by Subject|1|||
33536258|NCT02230891|101863791|FG000|6 Month|Physician Decision|0|||
33536259|NCT02230891|101863792|FG001|6 Month|Physician Decision|2|||
33208398|NCT02952924|100665473|FG010|Overall Study|Protocol Violation|0|||
33208399|NCT02952924|100665474|FG011|Overall Study|Protocol Violation|0|||
33536260|NCT02230891|101863793|FG002|6 Month|Physician Decision|0|||
33536261|NCT02230891|101863791|FG000|12 Month|Death|1|||
33536262|NCT02230891|101863792|FG001|12 Month|Death|0|||
33536263|NCT02230891|101863793|FG002|12 Month|Death|0|||
33536264|NCT02230891|101863791|FG000|12 Month|Lost to Follow-up|0|||
33536265|NCT02230891|101863792|FG001|12 Month|Lost to Follow-up|1|||
33536266|NCT02230891|101863793|FG002|12 Month|Lost to Follow-up|0|||
33536267|NCT02230891|101863791|FG000|12 Month|Withdrawal by Subject|0|||
33536268|NCT02230891|101863792|FG001|12 Month|Withdrawal by Subject|2|||
33536269|NCT02230891|101863793|FG002|12 Month|Withdrawal by Subject|0|||
33536270|NCT02230891|101863791|FG000|18 Month End of Study|Death|0|||
33536271|NCT02230891|101863792|FG001|18 Month End of Study|Death|0|||
33536272|NCT02230891|101863793|FG002|18 Month End of Study|Death|1|||
33536273|NCT02230891|101863791|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
33536274|NCT02230891|101863792|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
33536275|NCT02230891|101863793|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
33536276|NCT00128661|101863794|FG000|Overall Study|Adverse Event|14|||
33536277|NCT00128661|101863795|FG001|Overall Study|Adverse Event|11|||
33536278|NCT00128661|101863794|FG000|Overall Study|Lost to Follow-up|10|||
33536279|NCT00128661|101863795|FG001|Overall Study|Lost to Follow-up|7|||
33536280|NCT00128661|101863794|FG000|Overall Study|Withdrawal by Subject|243|||
33536281|NCT00128661|101863795|FG001|Overall Study|Withdrawal by Subject|232|||
33536282|NCT00128661|101863794|FG000|Overall Study|Other|7|||
33536283|NCT00128661|101863795|FG001|Overall Study|Other|8|||
33536284|NCT04249427|101863796|FG000|Overall Study|Adverse Event|3|||
33536285|NCT04249427|101863797|FG001|Overall Study|Adverse Event|1|||
33536286|NCT04249427|101863796|FG000|Overall Study|Lack of Efficacy|0|||
33536287|NCT04249427|101863797|FG001|Overall Study|Lack of Efficacy|1|||
33536288|NCT04249427|101863796|FG000|Overall Study|Withdrawal by Subject|1|||
33536289|NCT04249427|101863797|FG001|Overall Study|Withdrawal by Subject|2|||
33536290|NCT02974868|101863800|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
33536291|NCT02974868|101863801|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
33536292|NCT02974868|101863802|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
33536293|NCT02974868|101863803|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
33208400|NCT02952924|100665475|FG012|Overall Study|Protocol Violation|0|||
33339480|NCT00288080|101132232|FG001|Overall Study|Protocol Violation|20|||
33339481|NCT03665285|101132236|FG000|Overall Study|Started New Anticancer Treatment|1|||
33339482|NCT03665285|101132237|FG001|Overall Study|Started New Anticancer Treatment|1|||
33339483|NCT03665285|101132238|FG002|Overall Study|Started New Anticancer Treatment|2|||
33339484|NCT03665285|101132239|FG003|Overall Study|Started New Anticancer Treatment|4|||
33339485|NCT03665285|101132240|FG004|Overall Study|Started New Anticancer Treatment|1|||
33339486|NCT03665285|101132241|FG005|Overall Study|Started New Anticancer Treatment|1|||
33339487|NCT03665285|101132242|FG006|Overall Study|Started New Anticancer Treatment|2|||
33536294|NCT02974868|101863800|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
33536295|NCT02974868|101863801|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
33339488|NCT03665285|101132243|FG007|Overall Study|Started New Anticancer Treatment|15|||
33339489|NCT03665285|101132244|FG008|Overall Study|Started New Anticancer Treatment|1|||
33339490|NCT03665285|101132236|FG000|Overall Study|Disease Progression|0|||
33339491|NCT03665285|101132237|FG001|Overall Study|Disease Progression|0|||
33339492|NCT03665285|101132238|FG002|Overall Study|Disease Progression|3|||
33339493|NCT03665285|101132239|FG003|Overall Study|Disease Progression|1|||
33339494|NCT03665285|101132240|FG004|Overall Study|Disease Progression|0|||
33339495|NCT03665285|101132241|FG005|Overall Study|Disease Progression|0|||
33339496|NCT03665285|101132242|FG006|Overall Study|Disease Progression|0|||
33339497|NCT03665285|101132243|FG007|Overall Study|Disease Progression|7|||
33339498|NCT03665285|101132244|FG008|Overall Study|Disease Progression|1|||
33536296|NCT02974868|101863802|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
33536297|NCT02974868|101863803|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
33536298|NCT02974868|101863800|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
33536299|NCT02974868|101863801|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
33536300|NCT02974868|101863802|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
33536301|NCT02974868|101863803|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
33536302|NCT02974868|101863800|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
33536303|NCT02974868|101863801|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
33536304|NCT02974868|101863802|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
33536305|NCT02974868|101863803|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
33536306|NCT01396083|101863806|FG000|Overall Study|Adverse Event|2|||
33536307|NCT01396083|101863807|FG001|Overall Study|Adverse Event|28|||
33536308|NCT01396083|101863806|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33536309|NCT01396083|101863807|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
33536310|NCT01396083|101863806|FG000|Overall Study|Consent withdrawn|4|||
33536311|NCT01396083|101863807|FG001|Overall Study|Consent withdrawn|5|||
33614064|NCT00176462|102136945|FG000|Consolidation (12 Weeks)|Not documented|0|||
33208401|NCT02952924|100665476|FG013|Overall Study|Protocol Violation|0|||
33208402|NCT02952924|100665477|FG014|Overall Study|Protocol Violation|0|||
33339499|NCT03665285|101132236|FG000|Overall Study|Hospice|0|||
33339500|NCT03665285|101132237|FG001|Overall Study|Hospice|0|||
33339501|NCT03665285|101132238|FG002|Overall Study|Hospice|0|||
33339502|NCT03665285|101132239|FG003|Overall Study|Hospice|0|||
33339503|NCT03665285|101132240|FG004|Overall Study|Hospice|0|||
33339504|NCT03665285|101132241|FG005|Overall Study|Hospice|0|||
33339505|NCT03665285|101132242|FG006|Overall Study|Hospice|0|||
33536312|NCT01396083|101863806|FG000|Overall Study|Protocol deviation(s)|0|||
33536313|NCT01396083|101863807|FG001|Overall Study|Protocol deviation(s)|1|||
33614065|NCT00176462|102136946|FG001|Consolidation (12 Weeks)|Not documented|1|||
33614066|NCT00176462|102136945|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
33614067|NCT00176462|102136946|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
33614068|NCT00176462|102136945|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
33614069|NCT00176462|102136946|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
33614070|NCT01450098|102136947|FG000|Period 3|Protocol Violation|0|||
33339506|NCT03665285|101132243|FG007|Overall Study|Hospice|2|||
33339507|NCT03665285|101132244|FG008|Overall Study|Hospice|0|||
33614071|NCT01450098|102136948|FG001|Period 3|Protocol Violation|1|||
33614072|NCT01450098|102136947|FG000|Period 3|Withdrawal by Subject|0|||
33614073|NCT01450098|102136948|FG001|Period 3|Withdrawal by Subject|2|||
33614074|NCT01635855|102136955|FG000|Overall Study|Withdrawal by Subject|4|||
33614075|NCT01206582|102136962|FG000|Overall Study|Withdrew prior to study|1|||
33614076|NCT01206582|102136963|FG001|Overall Study|Withdrew prior to study|0|||
33614077|NCT01206582|102136962|FG000|Overall Study|Discontinued intervention before week 8|1|||
33614078|NCT01206582|102136963|FG001|Overall Study|Discontinued intervention before week 8|2|||
33614079|NCT00887926|102136966|FG000|Overall Study|Withdrawal by Subject|0|||
33614080|NCT00887926|102136967|FG001|Overall Study|Withdrawal by Subject|1|||
33614081|NCT00887926|102136968|FG002|Overall Study|Withdrawal by Subject|0|||
33614082|NCT00887926|102136969|FG003|Overall Study|Withdrawal by Subject|0|||
33614083|NCT00652951|102136975|FG000|Booster Phase|Adverse event, non-fatal|0|||
33614084|NCT00652951|102136976|FG001|Booster Phase|Adverse event, non-fatal|1|||
33614085|NCT00652951|102136977|FG002|Booster Phase|Adverse event, non-fatal|0|||
33614086|NCT00652951|102136975|FG000|Booster Phase|Other|1|||
33614087|NCT00652951|102136976|FG001|Booster Phase|Other|0|||
33614088|NCT00652951|102136977|FG002|Booster Phase|Other|0|||
33614089|NCT04177212|102136983|FG000|Overall Study|Withdrawal by Subject|9|||
33614090|NCT04177212|102136984|FG001|Overall Study|Withdrawal by Subject|7|||
33614091|NCT04177212|102136983|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
33208403|NCT02952924|100665478|FG015|Overall Study|Protocol Violation|0|||
33339508|NCT03665285|101132236|FG000|Overall Study|Withdrawal by Subject|0|||
33339509|NCT03665285|101132237|FG001|Overall Study|Withdrawal by Subject|0|||
33339510|NCT03665285|101132238|FG002|Overall Study|Withdrawal by Subject|0|||
33339511|NCT03665285|101132239|FG003|Overall Study|Withdrawal by Subject|0|||
33339512|NCT03665285|101132240|FG004|Overall Study|Withdrawal by Subject|1|||
33339513|NCT03665285|101132241|FG005|Overall Study|Withdrawal by Subject|0|||
33339514|NCT03665285|101132242|FG006|Overall Study|Withdrawal by Subject|0|||
33339515|NCT03665285|101132243|FG007|Overall Study|Withdrawal by Subject|2|||
33339516|NCT03665285|101132244|FG008|Overall Study|Withdrawal by Subject|0|||
33339517|NCT03665285|101132236|FG000|Overall Study|Physician Decision|0|||
33405634|NCT02039687|101373440|FG001|Overall Study|Adverse Event|0|||
33536314|NCT01396083|101863806|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33536315|NCT01396083|101863807|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33536316|NCT01396083|101863806|FG000|Overall Study|Administrative problems|1|||
33536317|NCT01396083|101863807|FG001|Overall Study|Administrative problems|0|||
33536318|NCT01396083|101863806|FG000|Overall Study|Lost to Follow-up|1|||
33536319|NCT01396083|101863807|FG001|Overall Study|Lost to Follow-up|0|||
33536320|NCT00960193|101863808|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
33536321|NCT00669318|101863809|FG000|Overall Study|Withdrawal by Subject|2|||
33536322|NCT02419807|101863810|FG000|Overall Study|Withdrawal by Subject|4|||
33536323|NCT02419807|101863810|FG000|Overall Study|Physician Decision|1|||
33536324|NCT02419807|101863810|FG000|Overall Study|Protocol Violation|5|||
33536325|NCT03101150|101863816|FG000|Overall Study|Lost to Follow-up|2|||
33536326|NCT03101150|101863817|FG001|Overall Study|Lost to Follow-up|4|||
33536327|NCT03101150|101863816|FG000|Overall Study|Miscarriage|3|||
33614092|NCT04177212|102136984|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
33614093|NCT04177212|102136983|FG000|Overall Study|Physician Decision|1|||
33339518|NCT03665285|101132237|FG001|Overall Study|Physician Decision|0|||
33614094|NCT04177212|102136984|FG001|Overall Study|Physician Decision|0|||
33339519|NCT03665285|101132238|FG002|Overall Study|Physician Decision|0|||
33339520|NCT03665285|101132239|FG003|Overall Study|Physician Decision|0|||
33536328|NCT03101150|101863817|FG001|Overall Study|Miscarriage|6|||
33536329|NCT01265498|101863818|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
33536330|NCT01265498|101863819|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
33536331|NCT02900352|101863822|FG000|Overall Study|Lost to Follow-up|28|||
33536332|NCT02900352|101863823|FG001|Overall Study|Lost to Follow-up|17|||
33536333|NCT01401322|101863826|FG000|Overall Study|Withdrawal by Subject|1|||
33536334|NCT01401322|101863826|FG000|Overall Study|Physician Decision|1|||
33536335|NCT01100853|101863827|FG000|Overall Study|Lost to Follow-up|11|||
33536336|NCT01100853|101863828|FG001|Overall Study|Lost to Follow-up|6|||
33536337|NCT01100853|101863827|FG000|Overall Study|Received <4 study injections|10|||
33536338|NCT01100853|101863828|FG001|Overall Study|Received <4 study injections|13|||
33536339|NCT01100853|101863827|FG000|Overall Study|Withdrawal by Subject|6|||
33536340|NCT01100853|101863828|FG001|Overall Study|Withdrawal by Subject|4|||
33536341|NCT03713684|101863830|FG000|Overall Study|Adverse Event|1|||
33536342|NCT03713684|101863831|FG001|Overall Study|Adverse Event|3|||
33536343|NCT03713684|101863832|FG002|Overall Study|Adverse Event|1|||
33536344|NCT03713684|101863833|FG003|Overall Study|Adverse Event|0|||
33536345|NCT03713684|101863830|FG000|Overall Study|Poor compliance to protocol|2|||
33536346|NCT03713684|101863831|FG001|Overall Study|Poor compliance to protocol|1|||
33614095|NCT04177212|102136983|FG000|Overall Study|Lost to Follow-up|0|||
33614096|NCT04177212|102136984|FG001|Overall Study|Lost to Follow-up|3|||
33614097|NCT04177212|102136983|FG000|Overall Study|Adverse Event|0|||
33614098|NCT04177212|102136984|FG001|Overall Study|Adverse Event|1|||
33614099|NCT04177212|102136983|FG000|Overall Study|Other|1|||
33614100|NCT04177212|102136984|FG001|Overall Study|Other|2|||
33614101|NCT03790917|102136985|FG000|Overall Study|Death|1|||
33614102|NCT01574651|102136986|FG000|Overall Study|Lost to Follow-up|2|||
33614103|NCT01574651|102136987|FG001|Overall Study|Lost to Follow-up|4|||
33614104|NCT01574651|102136986|FG000|Overall Study|Administrative problems|0|||
33208404|NCT02952924|100665479|FG016|Overall Study|Protocol Violation|0|||
33614105|NCT01574651|102136987|FG001|Overall Study|Administrative problems|1|||
33614106|NCT01574651|102136986|FG000|Overall Study|Death|3|||
33614107|NCT01574651|102136987|FG001|Overall Study|Death|3|||
33614108|NCT01574651|102136986|FG000|Overall Study|Patient's inability to use the device|0|||
33208405|NCT02952924|100665480|FG017|Overall Study|Protocol Violation|0|||
33208406|NCT02952924|100665481|FG018|Overall Study|Protocol Violation|0|||
33208407|NCT02952924|100665482|FG019|Overall Study|Protocol Violation|1|||
33208408|NCT02952924|100665483|FG020|Overall Study|Protocol Violation|0|||
33208409|NCT02952924|100665484|FG021|Overall Study|Protocol Violation|0|||
33208410|NCT02952924|100665463|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
33208411|NCT02952924|100665464|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
33208412|NCT02952924|100665465|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
33208413|NCT02952924|100665466|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
33208414|NCT02952924|100665467|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
33208415|NCT02952924|100665468|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
33339521|NCT03665285|101132240|FG004|Overall Study|Physician Decision|0|||
33339522|NCT03665285|101132241|FG005|Overall Study|Physician Decision|0|||
33339523|NCT03665285|101132242|FG006|Overall Study|Physician Decision|0|||
33339524|NCT03665285|101132243|FG007|Overall Study|Physician Decision|2|||
33614109|NCT01574651|102136987|FG001|Overall Study|Patient's inability to use the device|1|||
33614110|NCT01574651|102136986|FG000|Overall Study|Adverse Event|36|||
33614111|NCT01574651|102136987|FG001|Overall Study|Adverse Event|27|||
33614112|NCT01574651|102136986|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33614113|NCT01574651|102136987|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33614114|NCT01574651|102136986|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33614115|NCT01574651|102136987|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33614116|NCT01574651|102136986|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
33614117|NCT01574651|102136987|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33339525|NCT03665285|101132244|FG008|Overall Study|Physician Decision|0|||
33339526|NCT00191451|101132247|FG000|Overall Study|Withdrawal by Subject|2|||
33339527|NCT00191451|101132248|FG001|Overall Study|Withdrawal by Subject|3|||
33339528|NCT00191451|101132249|FG002|Overall Study|Withdrawal by Subject|5|||
33339529|NCT00191451|101132247|FG000|Overall Study|Physician Decision|2|||
33339530|NCT00191451|101132248|FG001|Overall Study|Physician Decision|9|||
33339531|NCT00191451|101132249|FG002|Overall Study|Physician Decision|6|||
33339532|NCT00191451|101132247|FG000|Overall Study|Sponsor Decision|1|||
33405635|NCT02039687|101373441|FG002|Overall Study|Adverse Event|1|||
33405636|NCT02039687|101373442|FG003|Overall Study|Adverse Event|0|||
33614118|NCT01574651|102136986|FG000|Overall Study|Protocol Violation|3|||
33614119|NCT01574651|102136987|FG001|Overall Study|Protocol Violation|5|||
33614120|NCT01574651|102136986|FG000|Overall Study|Withdrawal by Subject|9|||
33614121|NCT01574651|102136987|FG001|Overall Study|Withdrawal by Subject|10|||
33536347|NCT03713684|101863832|FG002|Overall Study|Poor compliance to protocol|0|||
33536348|NCT03713684|101863833|FG003|Overall Study|Poor compliance to protocol|1|||
33536349|NCT03713684|101863830|FG000|Overall Study|Withdrawal by Subject|14|||
33536350|NCT03713684|101863831|FG001|Overall Study|Withdrawal by Subject|6|||
33614122|NCT02652260|102136996|FG000|Overall Study|Pregnancy|0|||
33614123|NCT02652260|102136997|FG001|Overall Study|Pregnancy|1|||
33614124|NCT02652260|102136996|FG000|Overall Study|Withdrawal by Subject|0|||
33614125|NCT02652260|102136997|FG001|Overall Study|Withdrawal by Subject|1|||
33614126|NCT00774800|102136998|FG000|Intervention 4|Withdrawal by Subject|1|||
33614127|NCT01732770|102137007|FG000|Overall Study|Lost to Follow-up|2|||
33614128|NCT01732770|102137008|FG001|Overall Study|Lost to Follow-up|3|||
33614129|NCT01732770|102137007|FG000|Overall Study|Withdrawal by Subject|5|||
33614130|NCT01732770|102137008|FG001|Overall Study|Withdrawal by Subject|3|||
33614131|NCT01732770|102137007|FG000|Overall Study|Decision by Sponsor|2|||
33614132|NCT01732770|102137008|FG001|Overall Study|Decision by Sponsor|2|||
33614133|NCT01732770|102137007|FG000|Overall Study|Death|1|||
33614134|NCT01732770|102137008|FG001|Overall Study|Death|0|||
33614135|NCT00847886|102137011|FG000|Overall Study|Adverse Event|0|||
33614136|NCT00847886|102137012|FG001|Overall Study|Adverse Event|1|||
33614137|NCT02413489|102137015|FG000|Overall Study|Death|11|||
33614138|NCT02413489|102137016|FG001|Overall Study|Death|3|||
33614139|NCT02413489|102137017|FG002|Overall Study|Death|4|||
33614140|NCT02413489|102137015|FG000|Overall Study|Withdrawal by Subject|2|||
33614141|NCT02413489|102137016|FG001|Overall Study|Withdrawal by Subject|0|||
33614142|NCT02413489|102137017|FG002|Overall Study|Withdrawal by Subject|0|||
33208416|NCT02952924|100665469|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
33208417|NCT02952924|100665470|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
33208418|NCT02952924|100665471|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
33208419|NCT02952924|100665472|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
33536351|NCT03713684|101863832|FG002|Overall Study|Withdrawal by Subject|14|||
33208420|NCT02952924|100665473|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
33339533|NCT00191451|101132248|FG001|Overall Study|Sponsor Decision|0|||
33339534|NCT00191451|101132249|FG002|Overall Study|Sponsor Decision|0|||
33339535|NCT00191451|101132247|FG000|Overall Study|Ineligible|0|||
33339536|NCT00191451|101132248|FG001|Overall Study|Ineligible|1|||
33339537|NCT00191451|101132249|FG002|Overall Study|Ineligible|0|||
33339538|NCT00191451|101132247|FG000|Overall Study|Reason Not Specified|2|||
33339539|NCT00191451|101132248|FG001|Overall Study|Reason Not Specified|1|||
33339540|NCT00191451|101132249|FG002|Overall Study|Reason Not Specified|3|||
33339541|NCT00049673|101135789|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
33339542|NCT00049673|101135790|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
33339543|NCT01789970|101135794|FG000|Open-label Titration Period|Adverse Event|68|||
33339544|NCT01789970|101135795|FG001|Open-label Titration Period|Adverse Event|0|||
33339545|NCT01789970|101135796|FG002|Open-label Titration Period|Adverse Event|0|||
33339546|NCT01789970|101135794|FG000|Open-label Titration Period|Lack of Efficacy|31|||
33339547|NCT01789970|101135795|FG001|Open-label Titration Period|Lack of Efficacy|0|||
33339548|NCT01789970|101135796|FG002|Open-label Titration Period|Lack of Efficacy|0|||
33339549|NCT01789970|101135794|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
33536352|NCT03713684|101863833|FG003|Overall Study|Withdrawal by Subject|16|||
33536353|NCT03713684|101863830|FG000|Overall Study|Other than specified|69|||
33536354|NCT03713684|101863831|FG001|Overall Study|Other than specified|77|||
33536355|NCT03713684|101863832|FG002|Overall Study|Other than specified|73|||
33536356|NCT03713684|101863833|FG003|Overall Study|Other than specified|70|||
33536357|NCT03150082|101863834|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
33536358|NCT03150082|101863835|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
33536359|NCT02337491|101863838|FG000|Overall Study|Death|1|||
33536360|NCT02337491|101863839|FG001|Overall Study|Death|1|||
33536361|NCT02337491|101863838|FG000|Overall Study|Adverse Event|0|||
33536362|NCT02337491|101863839|FG001|Overall Study|Adverse Event|1|||
33536363|NCT02337491|101863838|FG000|Overall Study|Withdrawal by Subject|3|||
33536364|NCT02337491|101863839|FG001|Overall Study|Withdrawal by Subject|0|||
33536365|NCT02337491|101863838|FG000|Overall Study|Progressive Disease|44|||
33536366|NCT02337491|101863839|FG001|Overall Study|Progressive Disease|28|||
33536367|NCT02337491|101863838|FG000|Overall Study|On Treatment|2|||
33536368|NCT02337491|101863839|FG001|Overall Study|On Treatment|0|||
33208421|NCT02952924|100665474|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
33208422|NCT02952924|100665475|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
33208423|NCT02952924|100665476|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
33339550|NCT01789970|101135795|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
33339551|NCT01789970|101135796|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
33339552|NCT01789970|101135794|FG000|Open-label Titration Period|Protocol Violation|18|||
33339553|NCT01789970|101135795|FG001|Open-label Titration Period|Protocol Violation|0|||
33339554|NCT01789970|101135796|FG002|Open-label Titration Period|Protocol Violation|0|||
33536369|NCT00313846|101863845|FG000|Overall Study|Withdrawal by Subject|2|||
33614143|NCT02413489|102137015|FG000|Overall Study|Study Terminated By Sponsor|2|||
33614144|NCT02413489|102137016|FG001|Overall Study|Study Terminated By Sponsor|13|||
33614145|NCT02413489|102137017|FG002|Overall Study|Study Terminated By Sponsor|1|||
33614146|NCT02663622|102137018|FG000|Overall Study|Death|3|||
33614147|NCT02663622|102137019|FG001|Overall Study|Death|1|||
33614148|NCT02663622|102137020|FG002|Overall Study|Death|1|||
33614149|NCT02663622|102137021|FG003|Overall Study|Death|8|||
33536370|NCT00313846|101863846|FG001|Overall Study|Withdrawal by Subject|0|||
33536371|NCT00313846|101863845|FG000|Overall Study|Adverse Event|1|||
33536372|NCT00313846|101863846|FG001|Overall Study|Adverse Event|8|||
33536373|NCT00313846|101863845|FG000|Overall Study|Administrative|2|||
33536374|NCT00313846|101863846|FG001|Overall Study|Administrative|3|||
33536375|NCT02062437|101863847|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
33536376|NCT02062437|101863847|FG000|Overall Study|Patient not available for the 2y visit|18|||
33208424|NCT02952924|100665477|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
33208425|NCT02952924|100665478|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
33208426|NCT02952924|100665479|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
33208427|NCT02952924|100665480|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
33208428|NCT02952924|100665481|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
33208429|NCT02952924|100665482|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
33339555|NCT01789970|101135794|FG000|Open-label Titration Period|Lost to Follow-up|5|||
33339556|NCT01789970|101135795|FG001|Open-label Titration Period|Lost to Follow-up|0|||
33339557|NCT01789970|101135796|FG002|Open-label Titration Period|Lost to Follow-up|0|||
33536377|NCT02062437|101863847|FG000|Overall Study|Death|2|||
33339558|NCT01789970|101135794|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
33614150|NCT02663622|102137018|FG000|Overall Study|Protocol Violation|0|||
33614151|NCT02663622|102137019|FG001|Overall Study|Protocol Violation|0|||
33614152|NCT02663622|102137020|FG002|Overall Study|Protocol Violation|0|||
33614153|NCT02663622|102137021|FG003|Overall Study|Protocol Violation|1|||
33614154|NCT01357551|102137024|FG000|Overall Study|Withdrawal by Subject|6|||
33614155|NCT01357551|102137025|FG001|Overall Study|Withdrawal by Subject|4|||
33614156|NCT01357551|102137024|FG000|Overall Study|Death|0|||
33614157|NCT01357551|102137025|FG001|Overall Study|Death|1|||
33614158|NCT01357551|102137024|FG000|Overall Study|Lost to Follow-up|16|||
33339559|NCT01789970|101135795|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
33614159|NCT01357551|102137025|FG001|Overall Study|Lost to Follow-up|6|||
33614160|NCT00958165|102137026|FG000|Overall Study|Lost to Follow-up|5|||
33614161|NCT00958165|102137026|FG000|Overall Study|Not eligible|9|||
33614162|NCT04343755|102137027|FG000|Overall Study|Death|11|||
33614163|NCT04343755|102137027|FG000|Overall Study|Screen Failure|1|||
33614164|NCT01180296|102137034|FG000|Overall Study|Protocol Violation|1|||
33614165|NCT01180296|102137035|FG001|Overall Study|Protocol Violation|2|||
33614166|NCT00765063|102137036|FG000|Overall Study|Lack of Efficacy|5|||
33614167|NCT00765063|102137036|FG000|Overall Study|Withdrawal by Subject|1|||
33614168|NCT00765063|102137036|FG000|Overall Study|Other|16|||
33614169|NCT00765063|102137036|FG000|Overall Study|Protocol Violation|6|||
33614170|NCT00765063|102137036|FG000|Overall Study|Adverse Event|4|||
33614171|NCT02775916|102137037|FG000|Overall Study|Adverse Event|1|||
33614172|NCT02775916|102137038|FG001|Overall Study|Adverse Event|0|||
33614173|NCT02775916|102137037|FG000|Overall Study|Subject/Guardian Decision|2|||
33339560|NCT01789970|101135796|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
33339561|NCT01789970|101135794|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
33339562|NCT01789970|101135795|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
33339563|NCT01789970|101135796|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
33339564|NCT01789970|101135794|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
33536378|NCT02062437|101863847|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
33536379|NCT03322293|101863849|FG000|Overall Study|Lost to Follow-up|0|||
33339565|NCT01789970|101135795|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
33339566|NCT01789970|101135796|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
33339567|NCT01789970|101135794|FG000|Open-label Titration Period|Pregnancy|2|||
33405637|NCT02039687|101373439|FG000|Overall Study|Withdrawal by Subject|0|||
33405638|NCT02039687|101373440|FG001|Overall Study|Withdrawal by Subject|1|||
33536380|NCT03322293|101863850|FG001|Overall Study|Lost to Follow-up|0|||
33536381|NCT03322293|101863851|FG002|Overall Study|Lost to Follow-up|1|||
33536382|NCT00243919|101863852|FG000|Overall Study|Death|3|||
33536383|NCT00243919|101863853|FG001|Overall Study|Death|4|||
33614174|NCT02775916|102137038|FG001|Overall Study|Subject/Guardian Decision|0|||
33339568|NCT01789970|101135795|FG001|Open-label Titration Period|Pregnancy|0|||
33536384|NCT00243919|101863854|FG002|Overall Study|Death|6|||
33614175|NCT00787189|102137043|FG000|Overall Study|Lost to Follow-up|2|||
33614176|NCT00787189|102137044|FG001|Overall Study|Lost to Follow-up|2|||
33614177|NCT02881762|102137045|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
33614178|NCT02881762|102137046|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
33536385|NCT00243919|101863852|FG000|Overall Study|Withdrawal by Subject|6|||
33536386|NCT00243919|101863853|FG001|Overall Study|Withdrawal by Subject|6|||
33536387|NCT00243919|101863854|FG002|Overall Study|Withdrawal by Subject|2|||
33536388|NCT00243919|101863852|FG000|Overall Study|Lost to Follow-up|6|||
33536389|NCT00243919|101863853|FG001|Overall Study|Lost to Follow-up|7|||
33536390|NCT00243919|101863854|FG002|Overall Study|Lost to Follow-up|3|||
33536391|NCT00243919|101863852|FG000|Overall Study|Administrative Error|1|||
33536392|NCT00243919|101863853|FG001|Overall Study|Administrative Error|0|||
33536393|NCT00243919|101863854|FG002|Overall Study|Administrative Error|0|||
33536394|NCT00243919|101863852|FG000|Overall Study|Physician Decision|1|||
33614179|NCT00850538|102137047|FG000|Overall Study|unable/unwilling to complete MRI|13|||
33614180|NCT00850538|102137047|FG000|Overall Study|specimen missed due to scheduling error|14|||
33536395|NCT00243919|101863853|FG001|Overall Study|Physician Decision|1|||
33536396|NCT00243919|101863854|FG002|Overall Study|Physician Decision|0|||
33614181|NCT00850538|102137047|FG000|Overall Study|specimen unusable|7|||
33614182|NCT00850538|102137047|FG000|Overall Study|Withdrawal by Subject|3|||
33614183|NCT00850538|102137047|FG000|Overall Study|radiology error|2|||
33614184|NCT00850538|102137047|FG000|Overall Study|Protocol Violation|2|||
33536397|NCT00249834|101863856|FG000|Overall Study|Ovarian stimulation failed|1|||
33536398|NCT00249834|101863857|FG001|Overall Study|Ovarian stimulation failed|0|||
33536399|NCT00249834|101863858|FG002|Overall Study|Ovarian stimulation failed|0|||
33536400|NCT00249834|101863859|FG003|Overall Study|Ovarian stimulation failed|0|||
33614185|NCT00543387|102137048|FG000|Panel 1 + Panel 2|Adverse Event|0|||
33208430|NCT02952924|100665483|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
33208431|NCT02952924|100665484|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
33208432|NCT02952924|100665463|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208433|NCT02952924|100665464|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208434|NCT02952924|100665465|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208435|NCT02952924|100665466|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208436|NCT02952924|100665467|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208437|NCT02952924|100665468|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208438|NCT02952924|100665469|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208439|NCT02952924|100665470|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208440|NCT02952924|100665471|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208441|NCT02952924|100665472|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208442|NCT02952924|100665473|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208443|NCT02952924|100665474|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208444|NCT02952924|100665475|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208445|NCT02952924|100665476|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208446|NCT02952924|100665477|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208447|NCT02952924|100665478|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
33339569|NCT01789970|101135796|FG002|Open-label Titration Period|Pregnancy|0|||
33339570|NCT01789970|101135794|FG000|Open-label Titration Period|Other|76|||
33339571|NCT01789970|101135795|FG001|Open-label Titration Period|Other|0|||
33339572|NCT01789970|101135796|FG002|Open-label Titration Period|Other|0|||
33339573|NCT01789970|101135794|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
33339574|NCT01789970|101135795|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
33339575|NCT01789970|101135796|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
33339576|NCT01789970|101135794|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
33339577|NCT01789970|101135795|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
33339578|NCT01789970|101135796|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
33339579|NCT01789970|101135794|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
33339580|NCT01789970|101135795|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
33339581|NCT01789970|101135796|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
33339582|NCT01789970|101135794|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
33339583|NCT01789970|101135795|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
33339584|NCT01789970|101135796|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
33339585|NCT01789970|101135794|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
33339586|NCT01789970|101135795|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
33339587|NCT01789970|101135796|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
33339588|NCT01789970|101135794|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
33339589|NCT01789970|101135795|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
33339590|NCT01789970|101135796|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
33339591|NCT01789970|101135794|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
33339592|NCT01789970|101135795|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
33339593|NCT01789970|101135796|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
33339594|NCT01789970|101135794|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
33339595|NCT01789970|101135795|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
33339596|NCT01789970|101135796|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
33339597|NCT01789970|101135794|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
33339598|NCT01789970|101135795|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
33339599|NCT01789970|101135796|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
33339600|NCT01789970|101135794|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
33339601|NCT01789970|101135795|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
33339602|NCT01789970|101135796|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
33339603|NCT01789970|101135794|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
33339604|NCT01789970|101135795|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
33339605|NCT01789970|101135796|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
33339606|NCT00150592|101135797|FG000|Overall Study|Adverse Event|4|||
33339607|NCT00150592|101135798|FG001|Overall Study|Adverse Event|1|||
33339608|NCT00150592|101135797|FG000|Overall Study|Protocol Violation|1|||
33339609|NCT00150592|101135798|FG001|Overall Study|Protocol Violation|0|||
33339610|NCT00150592|101135797|FG000|Overall Study|Withdrawal by Subject|1|||
33339611|NCT00150592|101135798|FG001|Overall Study|Withdrawal by Subject|2|||
33339612|NCT00150592|101135797|FG000|Overall Study|Non-compliance|1|||
33224371|NCT05044325|100721812|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
33208448|NCT02952924|100665479|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208449|NCT02952924|100665480|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208450|NCT02952924|100665481|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208451|NCT02952924|100665482|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208452|NCT02952924|100665483|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
33208453|NCT02952924|100665484|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
33208454|NCT02952924|100665463|FG000|Overall Study|Noncompliance with study drug|0|||
33208455|NCT02952924|100665464|FG001|Overall Study|Noncompliance with study drug|0|||
33208456|NCT02952924|100665465|FG002|Overall Study|Noncompliance with study drug|0|||
33208457|NCT02952924|100665466|FG003|Overall Study|Noncompliance with study drug|0|||
33208458|NCT02952924|100665467|FG004|Overall Study|Noncompliance with study drug|0|||
33208459|NCT02952924|100665468|FG005|Overall Study|Noncompliance with study drug|0|||
33208460|NCT02952924|100665469|FG006|Overall Study|Noncompliance with study drug|0|||
33208461|NCT02952924|100665470|FG007|Overall Study|Noncompliance with study drug|0|||
33536401|NCT00249834|101863860|FG004|Overall Study|Ovarian stimulation failed|0|||
33536402|NCT00249834|101863861|FG005|Overall Study|Ovarian stimulation failed|0|||
33536403|NCT00249834|101863862|FG006|Overall Study|Ovarian stimulation failed|0|||
33536404|NCT00249834|101863863|FG007|Overall Study|Ovarian stimulation failed|0|||
33536405|NCT00249834|101863856|FG000|Overall Study|Failure of down-regulation|0|||
33536406|NCT00249834|101863857|FG001|Overall Study|Failure of down-regulation|0|||
33536407|NCT00249834|101863858|FG002|Overall Study|Failure of down-regulation|0|||
33536408|NCT00249834|101863859|FG003|Overall Study|Failure of down-regulation|0|||
33536409|NCT00249834|101863860|FG004|Overall Study|Failure of down-regulation|0|||
33536410|NCT00249834|101863861|FG005|Overall Study|Failure of down-regulation|0|||
33536411|NCT00249834|101863862|FG006|Overall Study|Failure of down-regulation|1|||
33536412|NCT00249834|101863863|FG007|Overall Study|Failure of down-regulation|0|||
33536413|NCT00249834|101863856|FG000|Overall Study|Protocol Violation|0|||
33536414|NCT00249834|101863857|FG001|Overall Study|Protocol Violation|19|||
33536415|NCT00249834|101863858|FG002|Overall Study|Protocol Violation|14|||
33536416|NCT00249834|101863859|FG003|Overall Study|Protocol Violation|8|||
33536417|NCT00249834|101863860|FG004|Overall Study|Protocol Violation|5|||
33536418|NCT00249834|101863861|FG005|Overall Study|Protocol Violation|2|||
33536419|NCT00249834|101863862|FG006|Overall Study|Protocol Violation|0|||
33536420|NCT00249834|101863863|FG007|Overall Study|Protocol Violation|0|||
33208462|NCT02952924|100665471|FG008|Overall Study|Noncompliance with study drug|0|||
33208463|NCT02952924|100665472|FG009|Overall Study|Noncompliance with study drug|0|||
33208464|NCT02952924|100665473|FG010|Overall Study|Noncompliance with study drug|0|||
33208465|NCT02952924|100665474|FG011|Overall Study|Noncompliance with study drug|0|||
33208466|NCT02952924|100665475|FG012|Overall Study|Noncompliance with study drug|0|||
33208467|NCT02952924|100665476|FG013|Overall Study|Noncompliance with study drug|0|||
33208468|NCT02952924|100665477|FG014|Overall Study|Noncompliance with study drug|0|||
33208469|NCT02952924|100665478|FG015|Overall Study|Noncompliance with study drug|0|||
33208470|NCT02952924|100665479|FG016|Overall Study|Noncompliance with study drug|0|||
33208471|NCT02952924|100665480|FG017|Overall Study|Noncompliance with study drug|0|||
33208472|NCT02952924|100665481|FG018|Overall Study|Noncompliance with study drug|0|||
33208473|NCT02952924|100665482|FG019|Overall Study|Noncompliance with study drug|0|||
33208474|NCT02952924|100665483|FG020|Overall Study|Noncompliance with study drug|0|||
33208475|NCT02952924|100665484|FG021|Overall Study|Noncompliance with study drug|1|||
33208476|NCT04066114|100665488|FG000|Overall Study|Adverse Event|1|||
33208477|NCT04066114|100665489|FG001|Overall Study|Adverse Event|0|||
33208478|NCT04066114|100665490|FG002|Overall Study|Adverse Event|0|||
33208479|NCT04066114|100665488|FG000|Overall Study|Withdrawal by Subject|1|||
33208480|NCT04066114|100665489|FG001|Overall Study|Withdrawal by Subject|0|||
33208481|NCT04066114|100665490|FG002|Overall Study|Withdrawal by Subject|0|||
33208482|NCT04066114|100665488|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
33208483|NCT04066114|100665489|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
33208484|NCT04066114|100665490|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
33208485|NCT02273141|100665493|FG000|Overall Study|Adverse Event|0|||
33208486|NCT02273141|100665494|FG001|Overall Study|Adverse Event|1|||
33208487|NCT02273141|100665493|FG000|Overall Study|Lost to Follow-up|1|||
33208488|NCT02273141|100665494|FG001|Overall Study|Lost to Follow-up|3|||
33208489|NCT02273141|100665493|FG000|Overall Study|Withdrawal by Subject|10|||
33339613|NCT00150592|101135798|FG001|Overall Study|Non-compliance|0|||
33208490|NCT02273141|100665494|FG001|Overall Study|Withdrawal by Subject|15|||
33208491|NCT02273141|100665493|FG000|Overall Study|Various|6|||
33208492|NCT02273141|100665494|FG001|Overall Study|Various|6|||
33208493|NCT05073133|100665497|FG000|Overall Study|Death|2|||
33208494|NCT02010060|100665498|FG000|Overall Study|Lost to Follow-up|1|||
33208495|NCT02010060|100665499|FG001|Overall Study|Lost to Follow-up|2|||
33339614|NCT00293579|101135799|FG000|Overall Study|Withdrawal by Subject|1|||
33536421|NCT02914834|101863865|FG000|Overall Study|Study halted due to COVID|1|||
33536422|NCT02914834|101863866|FG001|Overall Study|Study halted due to COVID|1|||
33536423|NCT02914834|101863865|FG000|Overall Study|1 subject withdrew|0|||
33614186|NCT00543387|102137049|FG001|Panel 1 + Panel 2|Adverse Event|1|||
33614187|NCT00543387|102137050|FG002|Panel 1 + Panel 2|Adverse Event|0|||
33614188|NCT00543387|102137051|FG003|Panel 1 + Panel 2|Adverse Event|0|||
33614189|NCT00543387|102137052|FG004|Panel 1 + Panel 2|Adverse Event|0|||
33614190|NCT00543387|102137053|FG005|Panel 1 + Panel 2|Adverse Event|0|||
33614191|NCT00543387|102137054|FG006|Panel 1 + Panel 2|Adverse Event|0|||
33614192|NCT00543387|102137055|FG007|Panel 1 + Panel 2|Adverse Event|1|||
33614193|NCT00543387|102137056|FG008|Panel 1 + Panel 2|Adverse Event|1|||
33614194|NCT00543387|102137057|FG009|Panel 1 + Panel 2|Adverse Event|0|||
33614195|NCT00543387|102137058|FG010|Panel 1 + Panel 2|Adverse Event|0|||
33614196|NCT00543387|102137048|FG000|Panel 1 + Panel 2|Physician Decision|0|||
33614197|NCT00543387|102137049|FG001|Panel 1 + Panel 2|Physician Decision|0|||
33614198|NCT00543387|102137050|FG002|Panel 1 + Panel 2|Physician Decision|1|||
33614199|NCT00543387|102137051|FG003|Panel 1 + Panel 2|Physician Decision|0|||
33614200|NCT00543387|102137052|FG004|Panel 1 + Panel 2|Physician Decision|0|||
33614201|NCT00543387|102137053|FG005|Panel 1 + Panel 2|Physician Decision|0|||
33614202|NCT00543387|102137054|FG006|Panel 1 + Panel 2|Physician Decision|0|||
33614203|NCT00543387|102137055|FG007|Panel 1 + Panel 2|Physician Decision|1|||
33614204|NCT00543387|102137056|FG008|Panel 1 + Panel 2|Physician Decision|0|||
33614205|NCT00543387|102137057|FG009|Panel 1 + Panel 2|Physician Decision|0|||
33614206|NCT00543387|102137058|FG010|Panel 1 + Panel 2|Physician Decision|0|||
33614207|NCT00543387|102137048|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
33614208|NCT00543387|102137049|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
33614209|NCT00543387|102137050|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
33614210|NCT00543387|102137051|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
33614211|NCT00543387|102137052|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
33614212|NCT00543387|102137053|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
33614213|NCT00543387|102137054|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
33614214|NCT00543387|102137055|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
33614215|NCT00543387|102137056|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
33614216|NCT00543387|102137057|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
33614217|NCT00543387|102137058|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
33614218|NCT00543387|102137048|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33614219|NCT00543387|102137049|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33614220|NCT00543387|102137050|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33614221|NCT00543387|102137051|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33614222|NCT00543387|102137052|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33614223|NCT00543387|102137053|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33614224|NCT00543387|102137054|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
33208496|NCT02010060|100665500|FG002|Overall Study|Lost to Follow-up|2|||
33208497|NCT02010060|100665498|FG000|Overall Study|Injury|0|||
33208498|NCT02010060|100665499|FG001|Overall Study|Injury|1|||
33208499|NCT02010060|100665500|FG002|Overall Study|Injury|0|||
33208500|NCT04717596|100665501|FG000|Overall Study|Withdrawal by Subject|4|||
33208501|NCT01328574|100665508|FG000|Overall Study|Refused further treatment|1|||
33208502|NCT00920426|100665517|FG000|ITZ111451|Adverse Event|1|||
33208503|NCT00920426|100665518|FG001|ITZ111451|Adverse Event|0|||
33208504|NCT00920426|100665519|FG002|ITZ111451|Adverse Event|0|||
33208505|NCT00920426|100665520|FG003|ITZ111451|Adverse Event|0|||
33208506|NCT02534909|100665521|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
33208507|NCT01380327|100665524|FG000|Overall Study|Lost to Follow-up|0|||
33208508|NCT01380327|100665525|FG001|Overall Study|Lost to Follow-up|1|||
33208509|NCT01380327|100665526|FG002|Overall Study|Lost to Follow-up|1|||
33208510|NCT01380327|100665524|FG000|Overall Study|Protocol Violation|3|||
33208511|NCT01380327|100665525|FG001|Overall Study|Protocol Violation|2|||
33208512|NCT01380327|100665526|FG002|Overall Study|Protocol Violation|3|||
33208513|NCT01380327|100665524|FG000|Overall Study|Withdrawal by Subject|0|||
33208514|NCT01380327|100665525|FG001|Overall Study|Withdrawal by Subject|0|||
33208515|NCT01380327|100665526|FG002|Overall Study|Withdrawal by Subject|1|||
33208516|NCT01380327|100665524|FG000|Overall Study|Housing situation precluded ability to k|0|||
33208517|NCT01380327|100665525|FG001|Overall Study|Housing situation precluded ability to k|0|||
33208518|NCT01380327|100665526|FG002|Overall Study|Housing situation precluded ability to k|1|||
33208519|NCT01380327|100665524|FG000|Overall Study|Questionable onset of epilepsy|0|||
33208520|NCT01380327|100665525|FG001|Overall Study|Questionable onset of epilepsy|0|||
33208521|NCT01380327|100665526|FG002|Overall Study|Questionable onset of epilepsy|1|||
33208522|NCT04482647|100665527|FG000|Overall Study|Time constraints|2|||
33208523|NCT04482647|100665527|FG000|Overall Study|Health issues|1|||
33208524|NCT04482647|100665527|FG000|Overall Study|Death in the family|1|||
33208525|NCT04482647|100665527|FG000|Overall Study|Disliked the intervention|1|||
33208526|NCT04482647|100665527|FG000|Overall Study|No reasons specified|7|||
33208527|NCT01650259|100665530|FG000|Overall Study|Improvement|105|||
33208528|NCT01650259|100665531|FG001|Overall Study|Improvement|0|||
33208529|NCT01650259|100665530|FG000|Overall Study|Adverse Event|127|||
33208530|NCT01650259|100665531|FG001|Overall Study|Adverse Event|0|||
33208531|NCT01650259|100665530|FG000|Overall Study|Lack of Efficacy|143|||
33208532|NCT01650259|100665531|FG001|Overall Study|Lack of Efficacy|0|||
33208533|NCT01650259|100665530|FG000|Overall Study|Lost to Follow-up|435|||
33208534|NCT01650259|100665531|FG001|Overall Study|Lost to Follow-up|0|||
33208535|NCT01650259|100665530|FG000|Overall Study|Patients had no visit after entry|70|||
33208536|NCT01650259|100665531|FG001|Overall Study|Patients had no visit after entry|0|||
33208537|NCT01650259|100665530|FG000|Overall Study|CRF not collected|98|||
33208538|NCT01650259|100665531|FG001|Overall Study|CRF not collected|82|||
33208539|NCT01650259|100665530|FG000|Overall Study|Not treated|1|||
33208540|NCT01650259|100665531|FG001|Overall Study|Not treated|7|||
33208541|NCT01650259|100665530|FG000|Overall Study|Other than listed|64|||
33208542|NCT01650259|100665531|FG001|Overall Study|Other than listed|146|||
33208543|NCT02625623|100665532|FG000|Overall Study|Participants randomized but not treated|9|||
33208544|NCT02625623|100665533|FG001|Overall Study|Participants randomized but not treated|1|||
33208545|NCT01517802|100665534|FG000|Overall Study|Death|1|||
33208546|NCT03336619|100665538|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
33208547|NCT03336619|100665539|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
33208548|NCT03336619|100665538|FG000|Overall Study|Withdrawal by Subject|17|||
33208549|NCT03336619|100665539|FG001|Overall Study|Withdrawal by Subject|16|||
33208550|NCT03336619|100665538|FG000|Overall Study|Adverse Event|2|||
33208551|NCT03336619|100665539|FG001|Overall Study|Adverse Event|5|||
33208552|NCT03336619|100665538|FG000|Overall Study|Physician Decision|3|||
33208553|NCT03336619|100665539|FG001|Overall Study|Physician Decision|0|||
33208554|NCT01556438|100665541|FG000|Overall Study|Adverse Event|4|||
33208555|NCT01556438|100665542|FG001|Overall Study|Adverse Event|2|||
33208556|NCT01556438|100665541|FG000|Overall Study|Sponsor Decision|0|||
33208557|NCT01556438|100665542|FG001|Overall Study|Sponsor Decision|2|||
33208558|NCT01556438|100665541|FG000|Overall Study|Progressive Disease|0|||
33208559|NCT01556438|100665542|FG001|Overall Study|Progressive Disease|6|||
33208560|NCT01556438|100665541|FG000|Overall Study|Death|0|||
33208561|NCT01556438|100665542|FG001|Overall Study|Death|1|||
33208562|NCT00263666|100665543|FG000|Overall Study|Adverse Event|6|||
33208563|NCT00263666|100665544|FG001|Overall Study|Adverse Event|8|||
33208564|NCT00263666|100665543|FG000|Overall Study|Lost to Follow-up|1|||
33208565|NCT00263666|100665544|FG001|Overall Study|Lost to Follow-up|2|||
33208566|NCT00263666|100665543|FG000|Overall Study|Withdrawal by Subject|0|||
33208567|NCT00263666|100665544|FG001|Overall Study|Withdrawal by Subject|1|||
33208568|NCT02384954|100665547|FG000|Phase 1|Progressive Disease|2|||
33208569|NCT02384954|100665548|FG001|Phase 1|Progressive Disease|0|||
33208570|NCT02384954|100665549|FG002|Phase 1|Progressive Disease|1|||
33208571|NCT02384954|100665550|FG003|Phase 1|Progressive Disease|1|||
33208572|NCT02384954|100665551|FG004|Phase 1|Progressive Disease|0|||
33208573|NCT02384954|100665552|FG005|Phase 1|Progressive Disease|0|||
33536424|NCT02914834|101863866|FG001|Overall Study|1 subject withdrew|1|||
33536425|NCT03428100|101863867|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
33536426|NCT03428100|101863868|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536427|NCT03428100|101863869|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
33536428|NCT03428100|101863870|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
33614225|NCT00543387|102137055|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33614226|NCT00543387|102137056|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33614227|NCT00543387|102137057|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33614228|NCT00543387|102137058|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
33614229|NCT00543387|102137048|FG000|Crossover Participants|Progressive Disease|0|||
33614230|NCT00543387|102137049|FG001|Crossover Participants|Progressive Disease|0|||
33614231|NCT00543387|102137050|FG002|Crossover Participants|Progressive Disease|0|||
33614232|NCT00543387|102137051|FG003|Crossover Participants|Progressive Disease|0|||
33614233|NCT00543387|102137052|FG004|Crossover Participants|Progressive Disease|0|||
33614234|NCT00543387|102137053|FG005|Crossover Participants|Progressive Disease|0|||
33614235|NCT00543387|102137054|FG006|Crossover Participants|Progressive Disease|0|||
33614236|NCT00543387|102137055|FG007|Crossover Participants|Progressive Disease|0|||
33536429|NCT03428100|101863871|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536430|NCT03428100|101863872|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536431|NCT03428100|101863873|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536432|NCT03428100|101863874|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536433|NCT03428100|101863875|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536434|NCT03428100|101863876|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536435|NCT03428100|101863877|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33208574|NCT02384954|100665553|FG006|Phase 1|Progressive Disease|0|||
33208575|NCT02384954|100665554|FG007|Phase 1|Progressive Disease|0|||
33208576|NCT02384954|100665555|FG008|Phase 1|Progressive Disease|0|||
33536436|NCT03428100|101863878|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536437|NCT03428100|101863879|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536438|NCT03428100|101863880|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536439|NCT03428100|101863881|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536440|NCT03428100|101863882|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536441|NCT03428100|101863883|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536442|NCT03428100|101863884|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536443|NCT03428100|101863885|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
33536444|NCT03428100|101863867|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
33536445|NCT03428100|101863868|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
33536446|NCT03428100|101863869|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
33614237|NCT00543387|102137056|FG008|Crossover Participants|Progressive Disease|0|||
33614238|NCT00543387|102137057|FG009|Crossover Participants|Progressive Disease|1|||
33208577|NCT02384954|100665547|FG000|Phase 1|Adverse Event|0|||
33208578|NCT02384954|100665548|FG001|Phase 1|Adverse Event|0|||
33208579|NCT02384954|100665549|FG002|Phase 1|Adverse Event|1|||
33536447|NCT03428100|101863870|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
33208580|NCT02384954|100665550|FG003|Phase 1|Adverse Event|0|||
33536448|NCT03428100|101863871|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33614239|NCT00543387|102137058|FG010|Crossover Participants|Progressive Disease|2|||
33614240|NCT00543387|102137048|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
33208581|NCT02384954|100665551|FG004|Phase 1|Adverse Event|0|||
33208582|NCT02384954|100665552|FG005|Phase 1|Adverse Event|0|||
33208583|NCT02384954|100665553|FG006|Phase 1|Adverse Event|0|||
33208584|NCT02384954|100665554|FG007|Phase 1|Adverse Event|0|||
33208585|NCT02384954|100665555|FG008|Phase 1|Adverse Event|0|||
33208586|NCT02384954|100665547|FG000|Phase 2|Progressive Disease|0|||
33208587|NCT02384954|100665548|FG001|Phase 2|Progressive Disease|0|||
33208588|NCT02384954|100665549|FG002|Phase 2|Progressive Disease|0|||
33208589|NCT02384954|100665550|FG003|Phase 2|Progressive Disease|0|||
33208590|NCT02384954|100665551|FG004|Phase 2|Progressive Disease|0|||
33536449|NCT03428100|101863872|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33536450|NCT03428100|101863873|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33536451|NCT03428100|101863874|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33536452|NCT03428100|101863875|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33536453|NCT03428100|101863876|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33536454|NCT03428100|101863877|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33536455|NCT03428100|101863878|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33536456|NCT03428100|101863879|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33536457|NCT03428100|101863880|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33208591|NCT02384954|100665552|FG005|Phase 2|Progressive Disease|0|||
33208592|NCT02384954|100665553|FG006|Phase 2|Progressive Disease|0|||
33208593|NCT02384954|100665554|FG007|Phase 2|Progressive Disease|1|||
33208594|NCT02384954|100665555|FG008|Phase 2|Progressive Disease|2|||
33208595|NCT02384954|100665547|FG000|Phase 2|Adverse Event|0|||
33208596|NCT02384954|100665548|FG001|Phase 2|Adverse Event|0|||
33208597|NCT02384954|100665549|FG002|Phase 2|Adverse Event|0|||
33208598|NCT02384954|100665550|FG003|Phase 2|Adverse Event|0|||
33208599|NCT02384954|100665551|FG004|Phase 2|Adverse Event|0|||
33208600|NCT02384954|100665552|FG005|Phase 2|Adverse Event|0|||
33208601|NCT02384954|100665553|FG006|Phase 2|Adverse Event|0|||
33208602|NCT02384954|100665554|FG007|Phase 2|Adverse Event|1|||
33208603|NCT02384954|100665555|FG008|Phase 2|Adverse Event|1|||
33208604|NCT02384954|100665547|FG000|Phase 2|Failure to meet continuation criteria|0|||
33208605|NCT02384954|100665548|FG001|Phase 2|Failure to meet continuation criteria|0|||
33208606|NCT02384954|100665549|FG002|Phase 2|Failure to meet continuation criteria|0|||
33208607|NCT02384954|100665550|FG003|Phase 2|Failure to meet continuation criteria|0|||
33208608|NCT02384954|100665551|FG004|Phase 2|Failure to meet continuation criteria|0|||
33208609|NCT02384954|100665552|FG005|Phase 2|Failure to meet continuation criteria|0|||
33208610|NCT02384954|100665553|FG006|Phase 2|Failure to meet continuation criteria|0|||
33208611|NCT02384954|100665554|FG007|Phase 2|Failure to meet continuation criteria|1|||
33208612|NCT02384954|100665555|FG008|Phase 2|Failure to meet continuation criteria|0|||
33208613|NCT03826667|100665556|FG000|Overall Study|Protocol deviation|21|||
33208614|NCT03713593|100665559|FG000|Overall Study|Participants Ongoing|140|||
33208615|NCT03713593|100665560|FG001|Overall Study|Participants Ongoing|114|||
33208616|NCT03713593|100665559|FG000|Overall Study|Withdrawal by Subject|3|||
33208617|NCT03713593|100665560|FG001|Overall Study|Withdrawal by Subject|6|||
33208618|NCT03713593|100665559|FG000|Overall Study|Death|252|||
33208619|NCT03713593|100665560|FG001|Overall Study|Death|279|||
33208620|NCT02959437|100665561|FG000|Overall Study|Death|33|||
33208621|NCT02959437|100665562|FG001|Overall Study|Death|3|||
33208622|NCT02959437|100665563|FG002|Overall Study|Death|0|||
33208623|NCT02959437|100665564|FG003|Overall Study|Death|0|||
33208624|NCT02959437|100665561|FG000|Overall Study|Lost to Follow-up|3|||
33208625|NCT02959437|100665562|FG001|Overall Study|Lost to Follow-up|1|||
33208626|NCT02959437|100665563|FG002|Overall Study|Lost to Follow-up|0|||
33208627|NCT02959437|100665564|FG003|Overall Study|Lost to Follow-up|0|||
33208628|NCT02959437|100665561|FG000|Overall Study|Withdrawal by Subject|11|||
33208629|NCT02959437|100665562|FG001|Overall Study|Withdrawal by Subject|3|||
33208630|NCT02959437|100665563|FG002|Overall Study|Withdrawal by Subject|0|||
33208631|NCT02959437|100665564|FG003|Overall Study|Withdrawal by Subject|0|||
33208632|NCT02959437|100665561|FG000|Overall Study|Progressive Disease|9|||
33208633|NCT02959437|100665562|FG001|Overall Study|Progressive Disease|1|||
33208634|NCT02959437|100665563|FG002|Overall Study|Progressive Disease|0|||
33405639|NCT02039687|101373441|FG002|Overall Study|Withdrawal by Subject|0|||
33536458|NCT03428100|101863881|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33536459|NCT03428100|101863882|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33208635|NCT02959437|100665564|FG003|Overall Study|Progressive Disease|0|||
33208636|NCT02959437|100665561|FG000|Overall Study|Study Terminated by Sponsor|4|||
33208637|NCT02959437|100665562|FG001|Overall Study|Study Terminated by Sponsor|0|||
33208638|NCT02959437|100665563|FG002|Overall Study|Study Terminated by Sponsor|0|||
33208639|NCT02959437|100665564|FG003|Overall Study|Study Terminated by Sponsor|0|||
33208640|NCT02959437|100665561|FG000|Overall Study|Other Unspecified|2|||
33208641|NCT02959437|100665562|FG001|Overall Study|Other Unspecified|0|||
33208642|NCT02959437|100665563|FG002|Overall Study|Other Unspecified|0|||
33208643|NCT02959437|100665564|FG003|Overall Study|Other Unspecified|0|||
33208644|NCT00688636|100665567|FG000|Overall Study|Adverse Event|2|||
33208645|NCT00688636|100665568|FG001|Overall Study|Adverse Event|1|||
33208646|NCT01064739|100665576|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
33208647|NCT03058679|100665582|FG000|Baseline to Week 6|Lost to Follow-up|3|||
33208648|NCT03058679|100665583|FG001|Baseline to Week 6|Lost to Follow-up|2|||
33208649|NCT03058679|100665582|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
33208650|NCT03058679|100665583|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
33614241|NCT00543387|102137049|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
33614242|NCT00543387|102137050|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
33614243|NCT00543387|102137051|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
33536460|NCT03428100|101863883|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33536461|NCT03428100|101863884|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33536462|NCT03428100|101863885|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
33536463|NCT03428100|101863867|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33536464|NCT03428100|101863868|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
33536465|NCT03428100|101863869|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
33536466|NCT03428100|101863870|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33536467|NCT03428100|101863871|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33536468|NCT03428100|101863872|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33536469|NCT03428100|101863873|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33536470|NCT03428100|101863874|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33536471|NCT03428100|101863875|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33339615|NCT00699907|101135800|FG000|Overall Study|Withdrawal by Subject|2|||
33614244|NCT00543387|102137052|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
33614245|NCT00543387|102137053|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
33614246|NCT00543387|102137054|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
33614247|NCT00543387|102137055|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
33614248|NCT00543387|102137056|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
33614249|NCT00543387|102137057|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
33614250|NCT00543387|102137058|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
33208651|NCT03058679|100665582|FG000|Baseline to Week 6|Adverse Event|6|||
33208652|NCT03058679|100665583|FG001|Baseline to Week 6|Adverse Event|6|||
33208653|NCT03058679|100665582|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
33208654|NCT03058679|100665583|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
33208655|NCT03058679|100665582|FG000|Baseline to Week 6|Difficulty following the diet|0|||
33208656|NCT03058679|100665583|FG001|Baseline to Week 6|Difficulty following the diet|2|||
33208657|NCT03058679|100665582|FG000|Baseline to Week 6|Physician Decision|1|||
33208658|NCT03058679|100665583|FG001|Baseline to Week 6|Physician Decision|0|||
33208659|NCT03058679|100665582|FG000|Week 6 to Week 12|Change in medication|5|||
33208660|NCT03058679|100665583|FG001|Week 6 to Week 12|Change in medication|7|||
33208661|NCT03058679|100665582|FG000|Week 6 to Week 12|Adverse Event|4|||
33208662|NCT03058679|100665583|FG001|Week 6 to Week 12|Adverse Event|3|||
33208663|NCT03058679|100665582|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
33208664|NCT03058679|100665583|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
33208665|NCT03058679|100665582|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
33208666|NCT03058679|100665583|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
33208667|NCT03150056|100665586|FG000|Overall Study|Withdrawal by Subject|0|||
33208668|NCT03150056|100665587|FG001|Overall Study|Withdrawal by Subject|0|||
33208669|NCT03150056|100665588|FG002|Overall Study|Withdrawal by Subject|0|||
33208670|NCT03150056|100665589|FG003|Overall Study|Withdrawal by Subject|0|||
33208671|NCT03150056|100665590|FG004|Overall Study|Withdrawal by Subject|0|||
33208672|NCT03150056|100665591|FG005|Overall Study|Withdrawal by Subject|2|||
33208673|NCT03150056|100665586|FG000|Overall Study|Study terminated by Sponsor|1|||
33614251|NCT00770601|102137061|FG000|Overall Study|Withdrawal by Subject|1|||
33614252|NCT03543137|102137062|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
33614253|NCT03543137|102137063|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
33614254|NCT03543137|102137062|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
33614255|NCT03543137|102137063|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
33614256|NCT03543137|102137062|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
33614257|NCT03543137|102137063|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
33614258|NCT00720343|102137064|FG000|Overall Study|Lost to Follow-up|1|||
33614259|NCT00720343|102137065|FG001|Overall Study|Lost to Follow-up|0|||
33614260|NCT00720343|102137064|FG000|Overall Study|Protocol Violation|0|||
33208674|NCT03150056|100665587|FG001|Overall Study|Study terminated by Sponsor|3|||
33208675|NCT03150056|100665588|FG002|Overall Study|Study terminated by Sponsor|1|||
33208676|NCT03150056|100665589|FG003|Overall Study|Study terminated by Sponsor|1|||
33208677|NCT03150056|100665590|FG004|Overall Study|Study terminated by Sponsor|5|||
33614261|NCT00720343|102137065|FG001|Overall Study|Protocol Violation|2|||
33614262|NCT00539305|102137066|FG000|Overall Study|Adverse Event|1|||
33208678|NCT03150056|100665591|FG005|Overall Study|Study terminated by Sponsor|6|||
33208679|NCT03150056|100665586|FG000|Overall Study|Death|9|||
33208680|NCT03150056|100665587|FG001|Overall Study|Death|2|||
33208681|NCT03150056|100665588|FG002|Overall Study|Death|2|||
33208682|NCT03150056|100665589|FG003|Overall Study|Death|7|||
33614263|NCT00539305|102137067|FG001|Overall Study|Adverse Event|0|||
33614264|NCT00539305|102137066|FG000|Overall Study|Substance Use|0|||
33614265|NCT00539305|102137067|FG001|Overall Study|Substance Use|1|||
33614266|NCT00539305|102137066|FG000|Overall Study|Withdrawal by Subject|0|||
33614267|NCT00539305|102137067|FG001|Overall Study|Withdrawal by Subject|1|||
33614268|NCT00826618|102137068|FG000|Overall Study|Withdrawal by Subject|1|||
33614269|NCT02100969|102137070|FG000|Overall Study|Did not pass screening phase|1|||
33614270|NCT02489942|102137075|FG000|Overall Study|Request by patient|602|||
33614271|NCT02489942|102137075|FG000|Overall Study|Improvement/remission|157|||
33614272|NCT02489942|102137075|FG000|Overall Study|No change/Progressive disease|263|||
33614273|NCT02489942|102137075|FG000|Overall Study|Adverse Event|522|||
33614274|NCT02489942|102137075|FG000|Overall Study|Other personal reasons|1218|||
33614275|NCT02489942|102137075|FG000|Overall Study|Lost to Follow-up|456|||
33614276|NCT02489942|102137075|FG000|Overall Study|Not continuously investigated|7|||
33614277|NCT02489942|102137075|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
33614278|NCT02489942|102137075|FG000|Overall Study|Multiple registration|1|||
33614279|NCT02489942|102137075|FG000|Overall Study|No patient visit after entry|100|||
33614280|NCT02489942|102137075|FG000|Overall Study|No treatment with Jardiance|2|||
33614281|NCT02489942|102137075|FG000|Overall Study|Patient received Jardiance before registration|1|||
33614282|NCT02489942|102137075|FG000|Overall Study|No CRF collected|86|||
33614283|NCT00549445|102137076|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
33614284|NCT00549445|102137077|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
33614285|NCT01339897|102137078|FG000|Overall Study|Adverse Event|1|||
33614286|NCT01339897|102137079|FG001|Overall Study|Adverse Event|0|||
33208683|NCT03150056|100665590|FG004|Overall Study|Death|8|||
33208684|NCT03150056|100665591|FG005|Overall Study|Death|10|||
33208685|NCT00868439|100665592|FG000|Overall Study|Adverse Event|4|||
33208686|NCT00868439|100665593|FG001|Overall Study|Adverse Event|3|||
33339616|NCT00699907|101135801|FG001|Overall Study|Withdrawal by Subject|1|||
33339617|NCT00699907|101135802|FG002|Overall Study|Withdrawal by Subject|0|||
33536472|NCT03428100|101863876|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33536473|NCT03428100|101863877|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33208687|NCT00868439|100665592|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
33208688|NCT00868439|100665593|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
33208689|NCT00868439|100665592|FG000|Overall Study|Death|0|||
33208690|NCT00868439|100665593|FG001|Overall Study|Death|1|||
33208691|NCT00868439|100665592|FG000|Overall Study|Protocol Violation|1|||
33208692|NCT00868439|100665593|FG001|Overall Study|Protocol Violation|1|||
33339618|NCT00699907|101135800|FG000|Overall Study|No usable sample|0|||
33339619|NCT00699907|101135801|FG001|Overall Study|No usable sample|9|||
33339620|NCT00699907|101135802|FG002|Overall Study|No usable sample|8|||
33339621|NCT01353703|101135803|FG000|Overall Study|Migrated/moved from study area|1|||
33339622|NCT01353703|101135804|FG001|Overall Study|Migrated/moved from study area|0|||
33536474|NCT03428100|101863878|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33536475|NCT03428100|101863879|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33614287|NCT01339897|102137080|FG002|Overall Study|Adverse Event|0|||
33614288|NCT01339897|102137081|FG003|Overall Study|Adverse Event|1|||
33614289|NCT01771250|102137082|FG000|Period 1|Met exclusion criteria|1|||
33614290|NCT01771250|102137083|FG001|Period 1|Met exclusion criteria|0|||
33614291|NCT00466921|102137090|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
33208693|NCT00868439|100665592|FG000|Overall Study|Physician Decision|1|||
33208694|NCT00868439|100665593|FG001|Overall Study|Physician Decision|0|||
33536476|NCT03428100|101863880|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33536477|NCT03428100|101863881|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33536478|NCT03428100|101863882|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33536479|NCT03428100|101863883|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33536480|NCT03428100|101863884|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33536481|NCT03428100|101863885|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
33614292|NCT00466921|102137090|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
33208695|NCT00868439|100665592|FG000|Overall Study|Withdrawal by Subject|0|||
33208696|NCT00868439|100665593|FG001|Overall Study|Withdrawal by Subject|1|||
33339623|NCT02979431|101135809|FG000|Overall Study|Parent/guardian withdrew consent|2|||
33339624|NCT02979431|101135810|FG001|Overall Study|Parent/guardian withdrew consent|1|||
33339625|NCT02979431|101135811|FG002|Overall Study|Parent/guardian withdrew consent|1|||
33339626|NCT02979431|101135812|FG003|Overall Study|Parent/guardian withdrew consent|1|||
33339627|NCT02979431|101135809|FG000|Overall Study|Randomized but received no study drug|1|||
33614293|NCT00466921|102137090|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
33614294|NCT00466921|102137090|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
33614295|NCT00466921|102137090|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
33208697|NCT01682460|100665597|FG000|Overall Study|Withdrawal by Subject|2|||
33208698|NCT01682460|100665597|FG000|Overall Study|Did not meet inclusion criteria|2|||
33339628|NCT02979431|101135810|FG001|Overall Study|Randomized but received no study drug|1|||
33614296|NCT00466921|102137090|FG000|Follow up for a Minimum of 1 Year|Death|6|||
33614297|NCT00858637|102137095|FG000|Active Comparison Phase|Adverse Event|14|||
33614298|NCT00858637|102137096|FG001|Active Comparison Phase|Adverse Event|0|||
33614299|NCT00858637|102137097|FG002|Active Comparison Phase|Adverse Event|0|||
33614300|NCT00858637|102137098|FG003|Active Comparison Phase|Adverse Event|9|||
33614301|NCT00858637|102137099|FG004|Active Comparison Phase|Adverse Event|0|||
33614302|NCT00858637|102137100|FG005|Active Comparison Phase|Adverse Event|0|||
33614303|NCT00858637|102137095|FG000|Active Comparison Phase|Death|1|||
33614304|NCT00858637|102137096|FG001|Active Comparison Phase|Death|0|||
33614305|NCT00858637|102137097|FG002|Active Comparison Phase|Death|0|||
33614306|NCT00858637|102137098|FG003|Active Comparison Phase|Death|1|||
33614307|NCT00858637|102137099|FG004|Active Comparison Phase|Death|0|||
33614308|NCT00858637|102137100|FG005|Active Comparison Phase|Death|0|||
33339629|NCT02979431|101135811|FG002|Overall Study|Randomized but received no study drug|0|||
33339630|NCT02979431|101135812|FG003|Overall Study|Randomized but received no study drug|0|||
33339631|NCT02979431|101135809|FG000|Overall Study|Adverse Event|0|||
33339632|NCT02979431|101135810|FG001|Overall Study|Adverse Event|0|||
33339633|NCT02979431|101135811|FG002|Overall Study|Adverse Event|1|||
33339634|NCT02979431|101135812|FG003|Overall Study|Adverse Event|0|||
33339635|NCT02979431|101135809|FG000|Overall Study|Subject left country after Day14|1|||
33339636|NCT02979431|101135810|FG001|Overall Study|Subject left country after Day14|0|||
33339637|NCT02979431|101135811|FG002|Overall Study|Subject left country after Day14|0|||
33339638|NCT02979431|101135812|FG003|Overall Study|Subject left country after Day14|0|||
33339639|NCT00911989|101135815|FG000|Overall Study|Adverse Event|1|||
33339640|NCT03839459|101135816|FG000|Overall Study|Withdrawal by Subject|2|||
33339641|NCT03839459|101135816|FG000|Overall Study|progression of disease|3|||
33339642|NCT01662895|101135829|FG000|Overall Study|Lost to Follow-up|0|||
33339643|NCT01662895|101135830|FG001|Overall Study|Lost to Follow-up|1|||
33339644|NCT00772668|101135831|FG000|Overall Study|Physician Decision|3|||
33339645|NCT02301403|101135832|FG000|Overall Study|Withdrawal by Subject|28|||
33339646|NCT02301403|101135833|FG001|Overall Study|Withdrawal by Subject|41|||
33339647|NCT00993031|101135837|FG000|Overall Study|Death|0|||
33339648|NCT00993031|101135838|FG001|Overall Study|Death|1|||
33339649|NCT00993031|101135837|FG000|Overall Study|Physician Decision|0|||
33339650|NCT00993031|101135838|FG001|Overall Study|Physician Decision|2|||
33339651|NCT00993031|101135837|FG000|Overall Study|Withdrawal by Subject|3|||
33339652|NCT00993031|101135838|FG001|Overall Study|Withdrawal by Subject|3|||
33339653|NCT00993031|101135837|FG000|Overall Study|Lost to Follow-up|19|||
33339654|NCT00993031|101135838|FG001|Overall Study|Lost to Follow-up|13|||
33339655|NCT00209339|101135839|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
33536482|NCT03428100|101863867|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
33536483|NCT03428100|101863868|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33614309|NCT00858637|102137095|FG000|Active Comparison Phase|Physician Decision|1|||
33614310|NCT00858637|102137096|FG001|Active Comparison Phase|Physician Decision|0|||
33614311|NCT00858637|102137097|FG002|Active Comparison Phase|Physician Decision|0|||
33536484|NCT03428100|101863869|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536485|NCT03428100|101863870|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536486|NCT03428100|101863871|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536487|NCT03428100|101863872|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536488|NCT03428100|101863873|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536489|NCT03428100|101863874|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536490|NCT03428100|101863875|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536491|NCT03428100|101863876|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536492|NCT03428100|101863877|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536493|NCT03428100|101863878|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33614312|NCT00858637|102137098|FG003|Active Comparison Phase|Physician Decision|1|||
33614313|NCT00858637|102137099|FG004|Active Comparison Phase|Physician Decision|0|||
33614314|NCT00858637|102137100|FG005|Active Comparison Phase|Physician Decision|0|||
33614315|NCT00858637|102137095|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
33614316|NCT00858637|102137096|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
33614317|NCT00858637|102137097|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
33614318|NCT00858637|102137098|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
33614319|NCT00858637|102137099|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
33614320|NCT00858637|102137100|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
33614321|NCT00858637|102137095|FG000|Active Comparison Phase|Other Reasons|1|||
33614322|NCT00858637|102137096|FG001|Active Comparison Phase|Other Reasons|0|||
33614323|NCT00858637|102137097|FG002|Active Comparison Phase|Other Reasons|0|||
33339656|NCT00209339|101135839|FG000|At 12 Months Follow-up|Death|1|||
33339657|NCT00209339|101135839|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
33339658|NCT00209339|101135839|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
33339659|NCT00209339|101135839|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
33339660|NCT00209339|101135839|FG000|At 24 Months Follow-up|Death|1|||
33614324|NCT00858637|102137098|FG003|Active Comparison Phase|Other Reasons|1|||
33614325|NCT00858637|102137099|FG004|Active Comparison Phase|Other Reasons|0|||
33208699|NCT03624504|100665598|FG000|Overall Study|Unsuccessful Implant|1|||
33208700|NCT00317772|100665599|FG000|Overall Study|Adverse Event|0|||
33208701|NCT00317772|100665600|FG001|Overall Study|Adverse Event|0|||
33208702|NCT00317772|100665601|FG002|Overall Study|Adverse Event|0|||
33208703|NCT00317772|100665602|FG003|Overall Study|Adverse Event|2|||
33208704|NCT00317772|100665599|FG000|Overall Study|Disease Progression|2|||
33614326|NCT00858637|102137100|FG005|Active Comparison Phase|Other Reasons|0|||
33614327|NCT00858637|102137095|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
33614328|NCT00858637|102137096|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
33614329|NCT00858637|102137097|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
33208705|NCT00317772|100665600|FG001|Overall Study|Disease Progression|2|||
33208706|NCT00317772|100665601|FG002|Overall Study|Disease Progression|1|||
33208707|NCT00317772|100665602|FG003|Overall Study|Disease Progression|7|||
33208708|NCT01672801|100665604|FG000|Overall Study|Screen Failure|0|||
33208709|NCT01672801|100665605|FG001|Overall Study|Screen Failure|1|||
33208710|NCT02395120|100665612|FG000|Overall Study|Missed follow-up dental exam|57|||
33208711|NCT02395120|100665613|FG001|Overall Study|Missed follow-up dental exam|62|||
33208712|NCT02395120|100665614|FG002|Overall Study|Missed follow-up dental exam|6|||
33208713|NCT02395120|100665615|FG003|Overall Study|Missed follow-up dental exam|6|||
33208714|NCT02395120|100665616|FG004|Overall Study|Missed follow-up dental exam|51|||
33208715|NCT02827877|100665617|FG000|Overall Study|Withdrawal by Subject|1|||
33208716|NCT02041195|100665620|FG000|Overall Study|Adverse Event|1|||
33208717|NCT02041195|100665621|FG001|Overall Study|Adverse Event|2|||
33208718|NCT02041195|100665622|FG002|Overall Study|Adverse Event|0|||
33208719|NCT02041195|100665623|FG003|Overall Study|Adverse Event|0|||
33208720|NCT02041195|100665624|FG004|Overall Study|Adverse Event|0|||
33208721|NCT02041195|100665625|FG005|Overall Study|Adverse Event|0|||
33208722|NCT02041195|100665626|FG006|Overall Study|Adverse Event|3|||
33208723|NCT02041195|100665627|FG007|Overall Study|Adverse Event|0|||
33208724|NCT02041195|100665620|FG000|Overall Study|Withdrawal by Subject|1|||
33208725|NCT02041195|100665621|FG001|Overall Study|Withdrawal by Subject|0|||
33208726|NCT02041195|100665622|FG002|Overall Study|Withdrawal by Subject|0|||
33208727|NCT02041195|100665623|FG003|Overall Study|Withdrawal by Subject|0|||
33208728|NCT02041195|100665624|FG004|Overall Study|Withdrawal by Subject|0|||
33208729|NCT02041195|100665625|FG005|Overall Study|Withdrawal by Subject|0|||
33208730|NCT02041195|100665626|FG006|Overall Study|Withdrawal by Subject|4|||
33536494|NCT03428100|101863879|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536495|NCT03428100|101863880|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536496|NCT03428100|101863881|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536497|NCT03428100|101863882|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536498|NCT03428100|101863883|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536499|NCT03428100|101863884|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536500|NCT03428100|101863885|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
33536501|NCT03428100|101863867|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536502|NCT03428100|101863868|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
33536503|NCT03428100|101863869|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536504|NCT03428100|101863870|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536505|NCT03428100|101863871|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536506|NCT03428100|101863872|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536507|NCT03428100|101863873|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536508|NCT03428100|101863874|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536509|NCT03428100|101863875|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536510|NCT03428100|101863876|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536511|NCT03428100|101863877|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536512|NCT03428100|101863878|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536513|NCT03428100|101863879|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536514|NCT03428100|101863880|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33614330|NCT00858637|102137098|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
33614331|NCT00858637|102137099|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
33614332|NCT00858637|102137100|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
33208731|NCT02041195|100665627|FG007|Overall Study|Withdrawal by Subject|3|||
33208732|NCT02041195|100665620|FG000|Overall Study|Unable to comply with study visits|0|||
33208733|NCT02041195|100665621|FG001|Overall Study|Unable to comply with study visits|1|||
33208734|NCT02041195|100665622|FG002|Overall Study|Unable to comply with study visits|0|||
33208735|NCT02041195|100665623|FG003|Overall Study|Unable to comply with study visits|0|||
33208736|NCT02041195|100665624|FG004|Overall Study|Unable to comply with study visits|1|||
33208737|NCT02041195|100665625|FG005|Overall Study|Unable to comply with study visits|0|||
33208738|NCT02041195|100665626|FG006|Overall Study|Unable to comply with study visits|0|||
33208739|NCT02041195|100665627|FG007|Overall Study|Unable to comply with study visits|0|||
33208740|NCT01349569|100665628|FG000|Overall Study|Lack of Efficacy|4|||
33208741|NCT00808808|100665638|FG000|Overall Study|Vaccinated; survey not completed|131|||
33208742|NCT00808808|100665639|FG001|Overall Study|Vaccinated; survey not completed|169|||
33208743|NCT00808808|100665640|FG002|Overall Study|Vaccinated; survey not completed|302|||
33208744|NCT00808808|100665638|FG000|Overall Study|Employee was not vaccinated.|2686|||
33208745|NCT00808808|100665639|FG001|Overall Study|Employee was not vaccinated.|2268|||
33208746|NCT00808808|100665640|FG002|Overall Study|Employee was not vaccinated.|2255|||
33208747|NCT00574080|100665641|FG000|Overall Study|Death|10|||
33339661|NCT00209339|101135839|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
33339662|NCT00209339|101135839|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
33405640|NCT02039687|101373442|FG003|Overall Study|Withdrawal by Subject|0|||
33405641|NCT02039687|101373439|FG000|Overall Study|treatment assignment could not be confir|0|||
33405642|NCT02039687|101373440|FG001|Overall Study|treatment assignment could not be confir|0|||
33405643|NCT02039687|101373441|FG002|Overall Study|treatment assignment could not be confir|2|||
33405644|NCT02039687|101373442|FG003|Overall Study|treatment assignment could not be confir|0|||
33339663|NCT00209339|101135839|FG000|At 4 Years Follow-up|Death|1|||
33339664|NCT00209339|101135839|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
33405645|NCT03077646|101373443|FG000|Overall Study|Lost to Follow-up|29|||
33536515|NCT03428100|101863881|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536516|NCT03428100|101863882|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536517|NCT03428100|101863883|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536518|NCT03428100|101863884|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33536519|NCT03428100|101863885|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
33339665|NCT00209339|101135839|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
33339666|NCT00209339|101135839|FG000|At 5 Years Follow-up|Death|1|||
33405646|NCT03077646|101373444|FG001|Overall Study|Lost to Follow-up|30|||
33536520|NCT03428100|101863867|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
33536521|NCT03428100|101863868|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
33536522|NCT03428100|101863869|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
33536523|NCT03428100|101863870|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
33536524|NCT03428100|101863871|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
33536525|NCT03428100|101863872|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
33536526|NCT03428100|101863873|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
33536527|NCT03428100|101863874|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
33536528|NCT03428100|101863875|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
33536529|NCT03428100|101863876|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
33536530|NCT03428100|101863877|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
33536531|NCT03428100|101863878|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
33536532|NCT03428100|101863879|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
33536533|NCT03428100|101863880|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
33536534|NCT03428100|101863881|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
33536535|NCT03428100|101863882|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
33208748|NCT00574080|100665642|FG001|Overall Study|Death|10|||
33339667|NCT02462473|101135841|FG000|Overall Study|Death|1|||
33405647|NCT03077646|101373445|FG002|Overall Study|Lost to Follow-up|31|||
33208749|NCT00843167|100665645|FG000|Treatment Period|Adverse Event|1|||
33339668|NCT02462473|101135841|FG000|Overall Study|Other|3|||
33339669|NCT01338415|101135844|FG000|Core + Extension|Adverse Event|8|||
33208750|NCT00843167|100665646|FG001|Treatment Period|Adverse Event|5|||
33339670|NCT01338415|101135845|FG001|Core + Extension|Adverse Event|6|||
33405648|NCT02554721|101373453|FG000|Overall Study|Adverse Event|1|||
33405649|NCT02554721|101373454|FG001|Overall Study|Adverse Event|0|||
33339671|NCT01338415|101135846|FG002|Core + Extension|Adverse Event|0|||
33339672|NCT01338415|101135844|FG000|Core + Extension|Withdrawal by Subject|1|||
33339673|NCT01338415|101135845|FG001|Core + Extension|Withdrawal by Subject|1|||
33339674|NCT01338415|101135846|FG002|Core + Extension|Withdrawal by Subject|0|||
33339675|NCT01338415|101135844|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
33339676|NCT01338415|101135845|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
33536536|NCT03428100|101863883|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
33536537|NCT03428100|101863884|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
33536538|NCT03428100|101863885|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
33536539|NCT03428100|101863867|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
33536540|NCT03428100|101863868|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
33536541|NCT03428100|101863869|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
33536542|NCT03428100|101863870|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
33536543|NCT03428100|101863871|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
33536544|NCT03428100|101863872|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
33536545|NCT03428100|101863873|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
33536546|NCT03428100|101863874|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
33536547|NCT03428100|101863875|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
33536548|NCT03428100|101863876|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
33536549|NCT03428100|101863877|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
33536550|NCT03428100|101863878|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
33536551|NCT03428100|101863879|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
33536552|NCT03428100|101863880|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
33536553|NCT03428100|101863881|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
33536554|NCT03428100|101863882|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
33536555|NCT03428100|101863883|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
33536556|NCT03428100|101863884|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
33536557|NCT03428100|101863885|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
33536558|NCT03428100|101863867|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
33536559|NCT03428100|101863868|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
33536560|NCT03428100|101863869|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
33536561|NCT03428100|101863870|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
33536562|NCT03428100|101863871|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
33536563|NCT03428100|101863872|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
33536564|NCT03428100|101863873|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
33536565|NCT03428100|101863874|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
33536566|NCT03428100|101863875|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
33536567|NCT03428100|101863876|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
33536568|NCT03428100|101863877|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
33536569|NCT03428100|101863878|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
33536570|NCT03428100|101863879|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
33536571|NCT03428100|101863880|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
33536572|NCT03428100|101863881|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
33536573|NCT03428100|101863882|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
33536574|NCT03428100|101863883|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
33536575|NCT03428100|101863884|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
33536576|NCT03428100|101863885|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
33536577|NCT03428100|101863867|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
33536578|NCT03428100|101863868|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
33536579|NCT03428100|101863869|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
33536580|NCT03428100|101863870|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
33536581|NCT03428100|101863871|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
33536582|NCT03428100|101863872|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
33536583|NCT03428100|101863873|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
33536584|NCT03428100|101863874|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
33536585|NCT03428100|101863875|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
33339677|NCT01338415|101135846|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
33339678|NCT01338415|101135844|FG000|Core + Extension|Other (administrative reason)|1|||
33339679|NCT01338415|101135845|FG001|Core + Extension|Other (administrative reason)|0|||
33536586|NCT03428100|101863876|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
33536587|NCT03428100|101863877|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
33536588|NCT03428100|101863878|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
33536589|NCT03428100|101863879|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
33536590|NCT03428100|101863880|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
33536591|NCT03428100|101863881|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
33339680|NCT01338415|101135846|FG002|Core + Extension|Other (administrative reason)|0|||
33339681|NCT01338415|101135844|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
33339682|NCT01338415|101135845|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
33339683|NCT01338415|101135846|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
33339684|NCT01338415|101135844|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
33339685|NCT01338415|101135845|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
33536592|NCT03428100|101863882|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
33536593|NCT03428100|101863883|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
33536594|NCT03428100|101863884|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
33536595|NCT03428100|101863885|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
33536596|NCT03428100|101863867|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
33536597|NCT03428100|101863868|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
33536598|NCT03428100|101863869|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
33536599|NCT03428100|101863870|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
33536600|NCT03428100|101863871|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
33536601|NCT03428100|101863872|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
33536602|NCT03428100|101863873|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
33536603|NCT03428100|101863874|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
33536604|NCT03428100|101863875|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
33536605|NCT03428100|101863876|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
33536606|NCT03428100|101863877|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
33536607|NCT03428100|101863878|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
33536608|NCT03428100|101863879|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
33536609|NCT03428100|101863880|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
33536610|NCT03428100|101863881|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
33536611|NCT03428100|101863882|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
33536612|NCT03428100|101863883|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
33536613|NCT03428100|101863884|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
33536614|NCT03428100|101863885|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
33536615|NCT03428100|101863867|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536616|NCT03428100|101863868|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536617|NCT03428100|101863869|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536618|NCT03428100|101863870|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536619|NCT03428100|101863871|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536620|NCT03428100|101863872|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536621|NCT03428100|101863873|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
33614333|NCT00858637|102137095|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
33631283|NCT00886379|102202903|FG001|Overall Study|Transferred Schools|0|||
33405650|NCT02554721|101373455|FG002|Overall Study|Adverse Event|0|||
33339686|NCT01338415|101135846|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
33631284|NCT00886379|102202904|FG002|Overall Study|Transferred Schools|2|||
33631285|NCT00886379|102202905|FG003|Overall Study|Transferred Schools|1|||
33631286|NCT00886379|102202906|FG004|Overall Study|Transferred Schools|1|||
33631287|NCT00886379|102202902|FG000|Overall Study|Final blood draw not obtained|3|||
33631288|NCT00886379|102202903|FG001|Overall Study|Final blood draw not obtained|3|||
33631289|NCT00886379|102202904|FG002|Overall Study|Final blood draw not obtained|4|||
33631290|NCT00886379|102202905|FG003|Overall Study|Final blood draw not obtained|2|||
33631291|NCT00886379|102202906|FG004|Overall Study|Final blood draw not obtained|2|||
33631292|NCT03486912|102202914|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
33631293|NCT03486912|102202915|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
33631294|NCT03486912|102202916|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
33631295|NCT03486912|102202917|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
33631296|NCT03486912|102202914|FG000|Treatment Period|Withdrawal by Subject|3|||
33614334|NCT00858637|102137096|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
33614335|NCT00858637|102137097|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
33614336|NCT00858637|102137098|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
33614337|NCT00858637|102137099|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
33614338|NCT00858637|102137100|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
33614339|NCT02478164|102137108|FG000|Overall Study|Lack of Efficacy|13|||
33614340|NCT02478164|102137108|FG000|Overall Study|Adverse Event|1|||
33614341|NCT02478164|102137108|FG000|Overall Study|Withdrawal by Subject|1|||
33614342|NCT02806960|102137109|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
33614343|NCT02806960|102137110|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
33614344|NCT02806960|102137111|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
33614345|NCT02806960|102137112|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
33614346|NCT00934128|102137115|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
33614347|NCT00934128|102137116|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
33208751|NCT00843167|100665645|FG000|Treatment Period|Withdrawal by Subject|2|||
33208752|NCT00843167|100665646|FG001|Treatment Period|Withdrawal by Subject|3|||
33208753|NCT03147248|100665647|FG000|Overall Study|Adverse Event|0|||
33208754|NCT03147248|100665648|FG001|Overall Study|Adverse Event|2|||
33208755|NCT03147248|100665649|FG002|Overall Study|Adverse Event|2|||
33208756|NCT03147248|100665650|FG003|Overall Study|Adverse Event|2|||
33339687|NCT01338415|101135844|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
33614348|NCT00934128|102137115|FG000|First Intervention (2 Hours)|Adverse Event|4|||
33208757|NCT03147248|100665651|FG004|Overall Study|Adverse Event|6|||
33208758|NCT03147248|100665652|FG005|Overall Study|Adverse Event|11|||
33208759|NCT03147248|100665647|FG000|Overall Study|Disease progression|1|||
33208760|NCT03147248|100665648|FG001|Overall Study|Disease progression|0|||
33208761|NCT03147248|100665649|FG002|Overall Study|Disease progression|0|||
33208762|NCT03147248|100665650|FG003|Overall Study|Disease progression|0|||
33208763|NCT03147248|100665651|FG004|Overall Study|Disease progression|0|||
33208764|NCT03147248|100665652|FG005|Overall Study|Disease progression|2|||
33208765|NCT03147248|100665647|FG000|Overall Study|Withdrawal by Subject|0|||
33208766|NCT03147248|100665648|FG001|Overall Study|Withdrawal by Subject|0|||
33208767|NCT03147248|100665649|FG002|Overall Study|Withdrawal by Subject|0|||
33208768|NCT03147248|100665650|FG003|Overall Study|Withdrawal by Subject|0|||
33208769|NCT03147248|100665651|FG004|Overall Study|Withdrawal by Subject|12|||
33208770|NCT03147248|100665652|FG005|Overall Study|Withdrawal by Subject|9|||
33208771|NCT03147248|100665647|FG000|Overall Study|Protocol Violation|0|||
33208772|NCT03147248|100665648|FG001|Overall Study|Protocol Violation|0|||
33208773|NCT03147248|100665649|FG002|Overall Study|Protocol Violation|0|||
33614349|NCT00934128|102137116|FG001|First Intervention (2 Hours)|Adverse Event|1|||
33208774|NCT03147248|100665650|FG003|Overall Study|Protocol Violation|0|||
33208775|NCT03147248|100665651|FG004|Overall Study|Protocol Violation|2|||
33208776|NCT03147248|100665652|FG005|Overall Study|Protocol Violation|0|||
33208777|NCT03147248|100665647|FG000|Overall Study|Lost to Follow-up|0|||
33208778|NCT03147248|100665648|FG001|Overall Study|Lost to Follow-up|0|||
33208779|NCT03147248|100665649|FG002|Overall Study|Lost to Follow-up|0|||
33208780|NCT03147248|100665650|FG003|Overall Study|Lost to Follow-up|0|||
33208781|NCT03147248|100665651|FG004|Overall Study|Lost to Follow-up|2|||
33208782|NCT03147248|100665652|FG005|Overall Study|Lost to Follow-up|0|||
33208783|NCT03147248|100665647|FG000|Overall Study|Pregnancy|0|||
33208784|NCT03147248|100665648|FG001|Overall Study|Pregnancy|0|||
33208785|NCT03147248|100665649|FG002|Overall Study|Pregnancy|0|||
33208786|NCT03147248|100665650|FG003|Overall Study|Pregnancy|0|||
33208787|NCT03147248|100665651|FG004|Overall Study|Pregnancy|1|||
33208788|NCT03147248|100665652|FG005|Overall Study|Pregnancy|0|||
33208789|NCT03147248|100665647|FG000|Overall Study|Death|0|||
33208790|NCT03147248|100665648|FG001|Overall Study|Death|0|||
33208791|NCT03147248|100665649|FG002|Overall Study|Death|0|||
33208792|NCT03147248|100665650|FG003|Overall Study|Death|0|||
33208793|NCT03147248|100665651|FG004|Overall Study|Death|0|||
33208794|NCT03147248|100665652|FG005|Overall Study|Death|4|||
33208795|NCT03147248|100665647|FG000|Overall Study|Physician Decision|0|||
33208796|NCT03147248|100665648|FG001|Overall Study|Physician Decision|0|||
33208797|NCT03147248|100665649|FG002|Overall Study|Physician Decision|0|||
33208798|NCT03147248|100665650|FG003|Overall Study|Physician Decision|0|||
33208799|NCT03147248|100665651|FG004|Overall Study|Physician Decision|2|||
33208800|NCT03147248|100665652|FG005|Overall Study|Physician Decision|4|||
33208801|NCT03147248|100665647|FG000|Overall Study|Prolonged Dosing Interval|0|||
33208802|NCT03147248|100665648|FG001|Overall Study|Prolonged Dosing Interval|0|||
33208803|NCT03147248|100665649|FG002|Overall Study|Prolonged Dosing Interval|0|||
33208804|NCT03147248|100665650|FG003|Overall Study|Prolonged Dosing Interval|0|||
33208805|NCT03147248|100665651|FG004|Overall Study|Prolonged Dosing Interval|1|||
33208806|NCT03147248|100665652|FG005|Overall Study|Prolonged Dosing Interval|1|||
33208807|NCT02605954|100665653|FG000|Overall Study|Adverse Event|5|||
33208808|NCT02605954|100665654|FG001|Overall Study|Adverse Event|1|||
33208809|NCT02605954|100665653|FG000|Overall Study|Investigator's Discretion|1|||
33208810|NCT02605954|100665654|FG001|Overall Study|Investigator's Discretion|0|||
33208811|NCT02605954|100665653|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33208812|NCT02605954|100665654|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33208813|NCT02605954|100665653|FG000|Overall Study|Withdrew Consent|2|||
33208814|NCT02605954|100665654|FG001|Overall Study|Withdrew Consent|2|||
33339688|NCT01338415|101135845|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
33339689|NCT01338415|101135846|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
33614350|NCT00934128|102137115|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
33614351|NCT00934128|102137116|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
33208815|NCT02605954|100665653|FG000|Overall Study|Lost to Follow-up|3|||
33208816|NCT02605954|100665654|FG001|Overall Study|Lost to Follow-up|0|||
33208817|NCT02605954|100665653|FG000|Overall Study|Randomized but not treated|0|||
33208818|NCT02605954|100665654|FG001|Overall Study|Randomized but not treated|1|||
33208819|NCT03069482|100665658|FG000|Overall Study|Lost to Follow-up|0|||
33208820|NCT03069482|100665659|FG001|Overall Study|Lost to Follow-up|1|||
33208821|NCT03069482|100665658|FG000|Overall Study|Physician Decision|1|||
33339690|NCT01338415|101135844|FG000|Exceptional Use Treatment Period|Death|0|||
33208822|NCT03069482|100665659|FG001|Overall Study|Physician Decision|0|||
33208823|NCT04899349|100665662|FG000|Overall Study|Study terminated by Sponsor|2|||
33208824|NCT04899349|100665663|FG001|Overall Study|Study terminated by Sponsor|0|||
33208825|NCT02576067|100665668|FG000|Overall Study|Death|0|||
33208826|NCT02576067|100665669|FG001|Overall Study|Death|1|||
33208827|NCT02576067|100665668|FG000|Overall Study|Lack of Efficacy|1|||
33208828|NCT02576067|100665669|FG001|Overall Study|Lack of Efficacy|0|||
33208829|NCT02576067|100665668|FG000|Overall Study|Lost to Follow-up|11|||
33208830|NCT02576067|100665669|FG001|Overall Study|Lost to Follow-up|0|||
33208831|NCT02576067|100665668|FG000|Overall Study|Withdrawal by Subject|11|||
33208832|NCT02576067|100665669|FG001|Overall Study|Withdrawal by Subject|2|||
33208833|NCT02576067|100665668|FG000|Overall Study|study closure of main CIRT trial)|0|||
33208834|NCT02576067|100665669|FG001|Overall Study|study closure of main CIRT trial)|8|||
33208835|NCT02576067|100665668|FG000|Overall Study|not randomized, failed run-in|7|||
33208836|NCT02576067|100665669|FG001|Overall Study|not randomized, failed run-in|0|||
33208837|NCT02576067|100665668|FG000|Overall Study|screen failure/ re-enrolled|0|||
33208838|NCT02576067|100665669|FG001|Overall Study|screen failure/ re-enrolled|25|||
33208839|NCT02576067|100665668|FG000|Overall Study|Physician Decision|4|||
33208840|NCT02576067|100665669|FG001|Overall Study|Physician Decision|0|||
33208841|NCT02734212|100665670|FG000|Overall Study|Lost to Follow-up|5|||
33208842|NCT02734212|100665671|FG001|Overall Study|Lost to Follow-up|10|||
33208843|NCT02477618|100665676|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
33208844|NCT02477618|100665677|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
33208845|NCT02477618|100665676|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
33208846|NCT02477618|100665677|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
33208847|NCT02477618|100665676|FG000|Overall Study|Adverse Event|1|||
33208848|NCT02477618|100665677|FG001|Overall Study|Adverse Event|1|||
33208849|NCT02477618|100665676|FG000|Overall Study|Transferred Away from Study Site|1|||
33208850|NCT02477618|100665677|FG001|Overall Study|Transferred Away from Study Site|0|||
33208851|NCT02477618|100665676|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
33208852|NCT02477618|100665677|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
33208853|NCT06281548|100665678|FG000|Overall Study|Lost to Follow-up|3|||
33208854|NCT00996996|100665679|FG000|Overall Study|Progressive Disease|10|||
33208855|NCT00996996|100665679|FG000|Overall Study|Non-compliance|8|||
33208856|NCT00996996|100665679|FG000|Overall Study|Lost to Follow-up|9|||
33208857|NCT00996996|100665679|FG000|Overall Study|Death|5|||
33208858|NCT00996996|100665679|FG000|Overall Study|Did Not Receive Study Medications|1|||
33208859|NCT03732209|100665683|FG000|Overall Study|Lost to Follow-up|4|||
33208860|NCT03732209|100665684|FG001|Overall Study|Lost to Follow-up|4|||
33208861|NCT03732209|100665683|FG000|Overall Study|Withdrawal by Subject|8|||
33208862|NCT03732209|100665684|FG001|Overall Study|Withdrawal by Subject|9|||
33208863|NCT01618838|100665687|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
33208864|NCT01292603|100665688|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
33208865|NCT01292603|100665689|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
33208866|NCT01292603|100665690|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
33208867|NCT01292603|100665691|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
33208868|NCT01292603|100665692|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
33208869|NCT01292603|100665693|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
33208870|NCT01292603|100665688|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
33208871|NCT01292603|100665689|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
33208872|NCT01292603|100665690|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
33208873|NCT01292603|100665691|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
33208874|NCT01292603|100665692|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
33208875|NCT01292603|100665693|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
33208876|NCT01292603|100665688|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
33208877|NCT01292603|100665689|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
33208878|NCT01292603|100665690|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
33208879|NCT01292603|100665691|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
33208880|NCT01292603|100665692|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
33339691|NCT01338415|101135845|FG001|Exceptional Use Treatment Period|Death|0|||
33339692|NCT01338415|101135846|FG002|Exceptional Use Treatment Period|Death|1|||
33339693|NCT03403205|101135847|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
33208881|NCT01292603|100665693|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
33208882|NCT01292603|100665688|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
33208883|NCT01292603|100665689|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
33208884|NCT01292603|100665690|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
33339694|NCT03403205|101135848|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
33208885|NCT01292603|100665691|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
33208886|NCT01292603|100665692|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
33208887|NCT01292603|100665693|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
33339695|NCT03403205|101135849|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
33405651|NCT02554721|101373456|FG003|Overall Study|Adverse Event|0|||
33536622|NCT03428100|101863874|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536623|NCT03428100|101863875|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536624|NCT03428100|101863876|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536625|NCT03428100|101863877|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536626|NCT03428100|101863878|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536627|NCT03428100|101863879|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536628|NCT03428100|101863880|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536629|NCT03428100|101863881|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536630|NCT03428100|101863882|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536631|NCT03428100|101863883|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536632|NCT03428100|101863884|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
33536633|NCT03428100|101863885|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
33536634|NCT03428100|101863867|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
33536635|NCT03428100|101863868|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
33536636|NCT03428100|101863869|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
33536637|NCT03428100|101863870|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
33536638|NCT03428100|101863871|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
33536639|NCT03428100|101863872|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
33536640|NCT03428100|101863873|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
33536641|NCT03428100|101863874|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
33536642|NCT03428100|101863875|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
33536643|NCT03428100|101863876|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
33536644|NCT03428100|101863877|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
33339696|NCT03403205|101135850|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
33339697|NCT03403205|101135851|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
33339698|NCT03403205|101135852|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
33339699|NCT03403205|101135847|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
33339700|NCT03403205|101135848|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
33339701|NCT03403205|101135849|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
33339702|NCT03403205|101135850|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
33339703|NCT03403205|101135851|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
33339704|NCT03403205|101135852|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
33536645|NCT03428100|101863878|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
33536646|NCT03428100|101863879|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
33536647|NCT03428100|101863880|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
33536648|NCT03428100|101863881|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
33536649|NCT03428100|101863882|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
33536650|NCT03428100|101863883|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
33536651|NCT03428100|101863884|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
33536652|NCT03428100|101863885|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
33536653|NCT03428100|101863867|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
33536654|NCT03428100|101863868|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
33614352|NCT00934128|102137115|FG000|Washout Period (1 Hour)|Patient preference|1|||
33614353|NCT00934128|102137116|FG001|Washout Period (1 Hour)|Patient preference|3|||
33614354|NCT00934128|102137115|FG000|Washout Period (1 Hour)|Pain|1|||
33614355|NCT00934128|102137116|FG001|Washout Period (1 Hour)|Pain|0|||
33614356|NCT00934128|102137115|FG000|Washout Period (1 Hour)|Too tired|1|||
33614357|NCT00934128|102137116|FG001|Washout Period (1 Hour)|Too tired|0|||
33614358|NCT00934128|102137115|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
33208888|NCT01292603|100665688|FG000|Part 1: Regular Follow-Up Period|Death|3|||
33339705|NCT03403205|101135847|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
33339706|NCT03403205|101135848|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
33339707|NCT03403205|101135849|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
33339708|NCT03403205|101135850|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
33339709|NCT03403205|101135851|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
33339710|NCT03403205|101135852|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
33339711|NCT03403205|101135847|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
33339712|NCT03403205|101135848|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
33339713|NCT03403205|101135849|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
33339714|NCT03403205|101135850|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
33339715|NCT03403205|101135851|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
33339716|NCT03403205|101135852|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
33339717|NCT03403205|101135847|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
33339718|NCT03403205|101135848|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
33339719|NCT03403205|101135849|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
33339720|NCT03403205|101135850|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
33339721|NCT03403205|101135851|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
33339722|NCT03403205|101135852|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
33339723|NCT03403205|101135847|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
33339724|NCT03403205|101135848|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
33339725|NCT03403205|101135849|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
33339726|NCT03403205|101135850|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
33339727|NCT03403205|101135851|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
33339728|NCT03403205|101135852|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
33339729|NCT03403205|101135847|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
33339730|NCT03403205|101135848|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
33339731|NCT03403205|101135849|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
33339732|NCT03403205|101135850|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
33339733|NCT03403205|101135851|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
33339734|NCT03403205|101135852|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
33339735|NCT03403205|101135847|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
33339736|NCT03403205|101135848|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
33339737|NCT03403205|101135849|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
33339738|NCT03403205|101135850|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
33339739|NCT03403205|101135851|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
33339740|NCT03403205|101135852|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
33339741|NCT03403205|101135847|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
33339742|NCT03403205|101135848|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
33339743|NCT03403205|101135849|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
33339744|NCT03403205|101135850|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
33339745|NCT03403205|101135851|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
33339746|NCT03403205|101135852|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
33339747|NCT03403205|101135847|FG000|Extension Period (Up to 60 Months)|Death|1|||
33536655|NCT03428100|101863869|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
33536656|NCT03428100|101863870|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
33536657|NCT03428100|101863871|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
33536658|NCT03428100|101863872|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
33536659|NCT03428100|101863873|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
33536660|NCT03428100|101863874|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
33536661|NCT03428100|101863875|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
33536662|NCT03428100|101863876|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
33614359|NCT00934128|102137116|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
33614360|NCT00934128|102137115|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
33614361|NCT00934128|102137116|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
33614362|NCT01769196|102137117|FG000|Overall Study|Adverse Event|24|||
33614363|NCT01769196|102137118|FG001|Overall Study|Adverse Event|20|||
33614364|NCT01769196|102137117|FG000|Overall Study|Death|21|||
33614365|NCT01769196|102137118|FG001|Overall Study|Death|26|||
33614366|NCT01769196|102137117|FG000|Overall Study|Investigator Discretion|7|||
33614367|NCT01769196|102137118|FG001|Overall Study|Investigator Discretion|3|||
33614368|NCT01769196|102137117|FG000|Overall Study|Lack of Efficacy|3|||
33614369|NCT01769196|102137118|FG001|Overall Study|Lack of Efficacy|2|||
33614370|NCT01769196|102137117|FG000|Overall Study|Progressive disease|11|||
33614371|NCT01769196|102137118|FG001|Overall Study|Progressive disease|6|||
33614372|NCT01769196|102137117|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
33614373|NCT01769196|102137118|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
33614374|NCT01769196|102137117|FG000|Overall Study|Protocol Violation|0|||
33614375|NCT01769196|102137118|FG001|Overall Study|Protocol Violation|3|||
33614376|NCT01769196|102137117|FG000|Overall Study|Study terminated by sponsor|160|||
33614377|NCT01769196|102137118|FG001|Overall Study|Study terminated by sponsor|161|||
33614378|NCT01769196|102137117|FG000|Overall Study|Participant never dosed with study drug|1|||
33614379|NCT01769196|102137118|FG001|Overall Study|Participant never dosed with study drug|0|||
33614380|NCT01769196|102137117|FG000|Overall Study|Withdrew consent|36|||
33614381|NCT01769196|102137118|FG001|Overall Study|Withdrew consent|40|||
33614382|NCT01393639|102137122|FG000|Overall Study|Protocol Violation|0|||
33614383|NCT01393639|102137123|FG001|Overall Study|Protocol Violation|0|||
33614384|NCT01393639|102137124|FG002|Overall Study|Protocol Violation|0|||
33614385|NCT01393639|102137125|FG003|Overall Study|Protocol Violation|1|||
33614386|NCT01393639|102137126|FG004|Overall Study|Protocol Violation|0|||
33614387|NCT01393639|102137127|FG005|Overall Study|Protocol Violation|0|||
33405652|NCT02554721|101373457|FG004|Overall Study|Adverse Event|1|||
33208889|NCT01292603|100665689|FG001|Part 1: Regular Follow-Up Period|Death|1|||
33208890|NCT01292603|100665690|FG002|Part 1: Regular Follow-Up Period|Death|3|||
33208891|NCT01292603|100665691|FG003|Part 1: Regular Follow-Up Period|Death|1|||
33208892|NCT01292603|100665692|FG004|Part 1: Regular Follow-Up Period|Death|0|||
33208893|NCT01292603|100665693|FG005|Part 1: Regular Follow-Up Period|Death|0|||
33208894|NCT01292603|100665688|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
33208895|NCT01292603|100665689|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
33208896|NCT01292603|100665690|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
33208897|NCT01292603|100665691|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
33208898|NCT01292603|100665692|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
33208899|NCT01292603|100665693|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
33208900|NCT01292603|100665688|FG000|Part 2: Dose Confirmation Period|Death|0|||
33208901|NCT01292603|100665689|FG001|Part 2: Dose Confirmation Period|Death|0|||
33208902|NCT01292603|100665690|FG002|Part 2: Dose Confirmation Period|Death|0|||
33208903|NCT01292603|100665691|FG003|Part 2: Dose Confirmation Period|Death|0|||
33208904|NCT01292603|100665692|FG004|Part 2: Dose Confirmation Period|Death|1|||
33208905|NCT01292603|100665693|FG005|Part 2: Dose Confirmation Period|Death|0|||
33208906|NCT01292603|100665688|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
33208907|NCT01292603|100665689|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
33208908|NCT01292603|100665690|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
33208909|NCT01292603|100665691|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
33208910|NCT01292603|100665692|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
33208911|NCT01292603|100665693|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
33208912|NCT01292603|100665688|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
33208913|NCT01292603|100665689|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
33208914|NCT01292603|100665690|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
33208915|NCT01292603|100665691|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
33208916|NCT01292603|100665692|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
33208917|NCT01292603|100665693|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
33208918|NCT01292603|100665688|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
33208919|NCT01292603|100665689|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
33208920|NCT01292603|100665690|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
33208921|NCT01292603|100665691|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
33208922|NCT01292603|100665692|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
33208923|NCT01292603|100665693|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
33208924|NCT01292603|100665688|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
33339748|NCT03403205|101135848|FG001|Extension Period (Up to 60 Months)|Death|0|||
33339749|NCT03403205|101135849|FG002|Extension Period (Up to 60 Months)|Death|0|||
33339750|NCT03403205|101135850|FG003|Extension Period (Up to 60 Months)|Death|0|||
33339751|NCT03403205|101135851|FG004|Extension Period (Up to 60 Months)|Death|0|||
33339752|NCT03403205|101135852|FG005|Extension Period (Up to 60 Months)|Death|0|||
33339753|NCT03403205|101135847|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
33339754|NCT03403205|101135848|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
33339755|NCT03403205|101135849|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
33208925|NCT01292603|100665689|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
33208926|NCT01292603|100665690|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
33208927|NCT01292603|100665691|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
33208928|NCT01292603|100665692|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
33208929|NCT01292603|100665693|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
33208930|NCT01292603|100665688|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
33208931|NCT01292603|100665689|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
33208932|NCT01292603|100665690|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
33208933|NCT01292603|100665691|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
33208934|NCT01292603|100665692|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
33208935|NCT01292603|100665693|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
33208936|NCT01292603|100665688|FG000|Part 2: Regular Follow-Up|Death|0|||
33208937|NCT01292603|100665689|FG001|Part 2: Regular Follow-Up|Death|0|||
33208938|NCT01292603|100665690|FG002|Part 2: Regular Follow-Up|Death|0|||
33208939|NCT01292603|100665691|FG003|Part 2: Regular Follow-Up|Death|0|||
33208940|NCT01292603|100665692|FG004|Part 2: Regular Follow-Up|Death|6|||
33208941|NCT01292603|100665693|FG005|Part 2: Regular Follow-Up|Death|3|||
33208942|NCT01292603|100665688|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
33339756|NCT03403205|101135850|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
33339757|NCT03403205|101135851|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
33339758|NCT03403205|101135852|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
33405653|NCT02554721|101373453|FG000|Overall Study|Noncompliance|0|||
33208943|NCT01292603|100665689|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
33208944|NCT01292603|100665690|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
33208945|NCT01292603|100665691|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
33208946|NCT01292603|100665692|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
33208947|NCT01292603|100665693|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
33208948|NCT01292603|100665688|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
33208949|NCT01292603|100665689|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
33208950|NCT01292603|100665690|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
33208951|NCT01292603|100665691|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
33208952|NCT01292603|100665692|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
33208953|NCT01292603|100665693|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
33208954|NCT01292603|100665688|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
33208955|NCT01292603|100665689|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
33208956|NCT01292603|100665690|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
33208957|NCT01292603|100665691|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
33208958|NCT01292603|100665692|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
33208959|NCT01292603|100665693|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
33208960|NCT01292603|100665688|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
33208961|NCT01292603|100665689|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
33208962|NCT01292603|100665690|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
33405654|NCT02554721|101373454|FG001|Overall Study|Noncompliance|0|||
33614388|NCT01393639|102137128|FG006|Overall Study|Protocol Violation|0|||
33208963|NCT01292603|100665691|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
33208964|NCT01292603|100665692|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
33208965|NCT01292603|100665693|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
33208966|NCT01292603|100665688|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
33208967|NCT01292603|100665689|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
33208968|NCT01292603|100665690|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
33208969|NCT01292603|100665691|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
33208970|NCT01292603|100665692|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
33208971|NCT01292603|100665693|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
33405655|NCT02554721|101373455|FG002|Overall Study|Noncompliance|0|||
33536663|NCT03428100|101863877|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
33536664|NCT03428100|101863878|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
33536665|NCT03428100|101863879|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
33536666|NCT03428100|101863880|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
33536667|NCT03428100|101863881|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
33536668|NCT03428100|101863882|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
33536669|NCT03428100|101863883|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
33536670|NCT03428100|101863884|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
33536671|NCT03428100|101863885|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
33536672|NCT00511810|101863886|FG000|Overall Study|Lost to Follow-up|1|||
33536673|NCT00511810|101863887|FG001|Overall Study|Lost to Follow-up|2|||
33536674|NCT00511810|101863886|FG000|Overall Study|Lack of Efficacy|0|||
33536675|NCT00511810|101863887|FG001|Overall Study|Lack of Efficacy|2|||
33536676|NCT00511810|101863886|FG000|Overall Study|Refused second scn|0|||
33536677|NCT00511810|101863887|FG001|Overall Study|Refused second scn|1|||
33536678|NCT03167242|101863889|FG000|Overall Study|Patient/Guardian Decision|0|||
33536679|NCT03167242|101863890|FG001|Overall Study|Patient/Guardian Decision|1|||
33536680|NCT03167242|101863891|FG002|Overall Study|Patient/Guardian Decision|2|||
33536681|NCT03167242|101863892|FG003|Overall Study|Patient/Guardian Decision|1|||
33536682|NCT03167242|101863893|FG004|Overall Study|Patient/Guardian Decision|1|||
33536683|NCT03167242|101863894|FG005|Overall Study|Patient/Guardian Decision|1|||
33536684|NCT03167242|101863895|FG006|Overall Study|Patient/Guardian Decision|0|||
33536685|NCT03167242|101863896|FG007|Overall Study|Patient/Guardian Decision|0|||
33536686|NCT03167242|101863897|FG008|Overall Study|Patient/Guardian Decision|0|||
33536687|NCT03167242|101863898|FG009|Overall Study|Patient/Guardian Decision|0|||
33536688|NCT03167242|101863899|FG010|Overall Study|Patient/Guardian Decision|1|||
33536689|NCT03167242|101863900|FG011|Overall Study|Patient/Guardian Decision|0|||
33536690|NCT03167242|101863889|FG000|Overall Study|Lost to Follow-up|0|||
33536691|NCT03167242|101863890|FG001|Overall Study|Lost to Follow-up|0|||
33536692|NCT03167242|101863891|FG002|Overall Study|Lost to Follow-up|1|||
33536693|NCT03167242|101863892|FG003|Overall Study|Lost to Follow-up|0|||
33536694|NCT03167242|101863893|FG004|Overall Study|Lost to Follow-up|0|||
33536695|NCT03167242|101863894|FG005|Overall Study|Lost to Follow-up|1|||
33536696|NCT03167242|101863895|FG006|Overall Study|Lost to Follow-up|2|||
33536697|NCT03167242|101863896|FG007|Overall Study|Lost to Follow-up|1|||
33536698|NCT03167242|101863897|FG008|Overall Study|Lost to Follow-up|0|||
33339759|NCT03403205|101135847|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
33536699|NCT03167242|101863898|FG009|Overall Study|Lost to Follow-up|0|||
33536700|NCT03167242|101863899|FG010|Overall Study|Lost to Follow-up|1|||
33536701|NCT03167242|101863900|FG011|Overall Study|Lost to Follow-up|1|||
33536702|NCT03167242|101863889|FG000|Overall Study|Reason not provided|0|||
33536703|NCT03167242|101863890|FG001|Overall Study|Reason not provided|0|||
33536704|NCT03167242|101863891|FG002|Overall Study|Reason not provided|0|||
33339760|NCT03403205|101135848|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
33339761|NCT03403205|101135849|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
33339762|NCT03403205|101135850|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
33339763|NCT03403205|101135851|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
33339764|NCT03403205|101135852|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
33339765|NCT03403205|101135847|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
33339766|NCT03403205|101135848|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
33339767|NCT03403205|101135849|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
33339768|NCT03403205|101135850|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
33339769|NCT03403205|101135851|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
33339770|NCT03403205|101135852|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
33339771|NCT03403205|101135847|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
33536705|NCT03167242|101863892|FG003|Overall Study|Reason not provided|0|||
33536706|NCT03167242|101863893|FG004|Overall Study|Reason not provided|0|||
33536707|NCT03167242|101863894|FG005|Overall Study|Reason not provided|0|||
33536708|NCT03167242|101863895|FG006|Overall Study|Reason not provided|0|||
33536709|NCT03167242|101863896|FG007|Overall Study|Reason not provided|0|||
33536710|NCT03167242|101863897|FG008|Overall Study|Reason not provided|1|||
33339772|NCT03403205|101135848|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
33339773|NCT03403205|101135849|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
33339774|NCT03403205|101135850|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
33536711|NCT03167242|101863898|FG009|Overall Study|Reason not provided|0|||
33536712|NCT03167242|101863899|FG010|Overall Study|Reason not provided|0|||
33536713|NCT03167242|101863900|FG011|Overall Study|Reason not provided|0|||
33614389|NCT01393639|102137122|FG000|Overall Study|Other|0|||
33614390|NCT01393639|102137123|FG001|Overall Study|Other|2|||
33339775|NCT03403205|101135851|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
33405656|NCT02554721|101373456|FG003|Overall Study|Noncompliance|0|||
33536714|NCT02592447|101863901|FG000|Overall Study|Lost to Follow-up|1|||
33536715|NCT02592447|101863902|FG001|Overall Study|Lost to Follow-up|0|||
33614391|NCT01393639|102137124|FG002|Overall Study|Other|0|||
33208972|NCT01292603|100665688|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
33208973|NCT01292603|100665689|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
33208974|NCT01292603|100665690|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
33339776|NCT03403205|101135852|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
33339777|NCT03403205|101135847|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
33339778|NCT03403205|101135848|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
33339779|NCT03403205|101135849|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
33339780|NCT03403205|101135850|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
33339781|NCT03403205|101135851|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
33339782|NCT03403205|101135852|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
33339783|NCT03403205|101135847|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
33339784|NCT03403205|101135848|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
33536716|NCT02592447|101863901|FG000|Overall Study|Ineligible after randomization|1|||
33536717|NCT02592447|101863902|FG001|Overall Study|Ineligible after randomization|0|||
33536718|NCT02592447|101863901|FG000|Overall Study|Withdrawal by Subject|0|||
33536719|NCT02592447|101863902|FG001|Overall Study|Withdrawal by Subject|1|||
33536720|NCT01447407|101863907|FG000|Overall Study|Withdrawal by Subject|2|||
33536721|NCT01447407|101863908|FG001|Overall Study|Withdrawal by Subject|0|||
33536722|NCT01447407|101863909|FG002|Overall Study|Withdrawal by Subject|0|||
33536723|NCT01447407|101863910|FG003|Overall Study|Withdrawal by Subject|1|||
33536724|NCT01447407|101863907|FG000|Overall Study|Physician Decision|0|||
33536725|NCT01447407|101863908|FG001|Overall Study|Physician Decision|0|||
33339785|NCT03403205|101135849|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
33339786|NCT03403205|101135850|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
33339787|NCT03403205|101135851|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
33339788|NCT03403205|101135852|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
33339789|NCT04327388|101135861|FG000|Overall Study|Adverse Event|17|||
33339790|NCT04327388|101135862|FG001|Overall Study|Adverse Event|18|||
33339791|NCT04327388|101135863|FG002|Overall Study|Adverse Event|9|||
33339792|NCT04327388|101135861|FG000|Overall Study|Other|1|||
33339793|NCT04327388|101135862|FG001|Overall Study|Other|2|||
33339794|NCT04327388|101135863|FG002|Overall Study|Other|0|||
33339795|NCT04327388|101135861|FG000|Overall Study|Randomized and not treated|2|||
33339796|NCT04327388|101135862|FG001|Overall Study|Randomized and not treated|0|||
33339797|NCT04327388|101135863|FG002|Overall Study|Randomized and not treated|2|||
33339798|NCT00132132|101135865|FG000|Overall Study|Lost to Follow-up|7|||
33339799|NCT00132132|101135866|FG001|Overall Study|Lost to Follow-up|2|||
33339800|NCT00243659|101135867|FG000|Overall Study|Withdrawal by Subject|1|||
33339801|NCT00243659|101135868|FG001|Overall Study|Withdrawal by Subject|1|||
33339802|NCT00243659|101135867|FG000|Overall Study|Protocol Violation|1|||
33339803|NCT00243659|101135868|FG001|Overall Study|Protocol Violation|2|||
33339804|NCT02921971|101135869|FG000|Overall Study|Adverse Event|1|||
33339805|NCT02921971|101135870|FG001|Overall Study|Adverse Event|2|||
33339806|NCT02921971|101135869|FG000|Overall Study|Lack of Efficacy|3|||
33536726|NCT01447407|101863909|FG002|Overall Study|Physician Decision|1|||
33536727|NCT01447407|101863910|FG003|Overall Study|Physician Decision|1|||
33536728|NCT03321721|101863911|FG000|Overall Study|Lost to Follow-up|4|||
33536729|NCT03321721|101863912|FG001|Overall Study|Lost to Follow-up|8|||
33536730|NCT03321721|101863913|FG002|Overall Study|Lost to Follow-up|11|||
33536731|NCT01619852|101863920|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
33536732|NCT01619852|101863921|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
33536733|NCT01619852|101863920|FG000|3 Month Follow up|Lost to Follow-up|31|||
33536734|NCT01619852|101863921|FG001|3 Month Follow up|Lost to Follow-up|34|||
33536735|NCT02427841|101863922|FG000|Overall Study|Lack of Efficacy|5|||
33536736|NCT02427841|101863922|FG000|Overall Study|Physician Decision|2|||
33536737|NCT02427841|101863922|FG000|Overall Study|Withdrawal by Subject|1|||
33536738|NCT00447772|101863923|FG000|Overall Study|Lack of Efficacy|3|||
33536739|NCT00447772|101863923|FG000|Overall Study|Insufficient compliance|6|||
33536740|NCT00447772|101863923|FG000|Overall Study|Discontinuation of drug therapy|1|||
33536741|NCT00447772|101863923|FG000|Overall Study|Lost to Follow-up|9|||
33614392|NCT01393639|102137125|FG003|Overall Study|Other|2|||
33614393|NCT01393639|102137126|FG004|Overall Study|Other|1|||
33614394|NCT01393639|102137127|FG005|Overall Study|Other|0|||
33614395|NCT01393639|102137128|FG006|Overall Study|Other|1|||
33208975|NCT01292603|100665691|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
33208976|NCT01292603|100665692|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
33339807|NCT02921971|101135870|FG001|Overall Study|Lack of Efficacy|1|||
33339808|NCT02921971|101135869|FG000|Overall Study|Other than specified above|2|||
33339809|NCT02921971|101135870|FG001|Overall Study|Other than specified above|1|||
33339810|NCT01375764|101135873|FG000|Overall Study|Lost to Follow-up|0|||
33536742|NCT00447772|101863923|FG000|Overall Study|Withdrawal by Subject|1|||
33536743|NCT00447772|101863923|FG000|Overall Study|Unable to attend all study visits|2|||
33536744|NCT00447772|101863923|FG000|Overall Study|Adverse Event|1|||
33536745|NCT00447772|101863923|FG000|Overall Study|Patient relocated|1|||
33536746|NCT00447772|101863923|FG000|Overall Study|Incomplete documentation at visit 1|1|||
33339811|NCT01375764|101135874|FG001|Overall Study|Lost to Follow-up|1|||
33339812|NCT01375764|101135875|FG002|Overall Study|Lost to Follow-up|0|||
33339813|NCT01375764|101135876|FG003|Overall Study|Lost to Follow-up|0|||
33339814|NCT01375764|101135877|FG004|Overall Study|Lost to Follow-up|0|||
33339815|NCT01375764|101135873|FG000|Overall Study|Withdrawal by Subject|2|||
33339816|NCT01375764|101135874|FG001|Overall Study|Withdrawal by Subject|0|||
33339817|NCT01375764|101135875|FG002|Overall Study|Withdrawal by Subject|0|||
33339818|NCT01375764|101135876|FG003|Overall Study|Withdrawal by Subject|0|||
33339819|NCT01375764|101135877|FG004|Overall Study|Withdrawal by Subject|1|||
33339820|NCT01375764|101135873|FG000|Overall Study|Other|0|||
33339821|NCT01375764|101135874|FG001|Overall Study|Other|0|||
33339822|NCT01375764|101135875|FG002|Overall Study|Other|0|||
33339823|NCT01375764|101135876|FG003|Overall Study|Other|1|||
33339824|NCT01375764|101135877|FG004|Overall Study|Other|0|||
33339825|NCT02474329|101135878|FG000|Overall Study|Withdraw or did not contribute data.|13|||
33339826|NCT03011333|101135883|FG000|Overall Study|Lost to Follow-up|0|||
33339827|NCT03011333|101135884|FG001|Overall Study|Lost to Follow-up|1|||
33339828|NCT03011333|101135885|FG002|Overall Study|Lost to Follow-up|0|||
33339829|NCT03011333|101135886|FG003|Overall Study|Lost to Follow-up|1|||
33339830|NCT03011333|101135887|FG004|Overall Study|Lost to Follow-up|4|||
33339831|NCT03011333|101135888|FG005|Overall Study|Lost to Follow-up|4|||
33339832|NCT03011333|101135889|FG006|Overall Study|Lost to Follow-up|5|||
33339833|NCT00725075|101135890|FG000|Overall Study|Use of Excluded Medication|0|||
33339834|NCT00725075|101135891|FG001|Overall Study|Use of Excluded Medication|1|||
33339835|NCT00725075|101135892|FG002|Overall Study|Use of Excluded Medication|0|||
33339836|NCT00725075|101135890|FG000|Overall Study|Protocol Violation|0|||
33339837|NCT00725075|101135891|FG001|Overall Study|Protocol Violation|0|||
33339838|NCT00725075|101135892|FG002|Overall Study|Protocol Violation|1|||
33339839|NCT00725075|101135890|FG000|Overall Study|Lost to Follow-up|1|||
33339840|NCT00725075|101135891|FG001|Overall Study|Lost to Follow-up|0|||
33339841|NCT00725075|101135892|FG002|Overall Study|Lost to Follow-up|0|||
33339842|NCT00725075|101135890|FG000|Overall Study|Withdrawal by Subject|4|||
33339843|NCT00725075|101135891|FG001|Overall Study|Withdrawal by Subject|5|||
33536747|NCT00447772|101863923|FG000|Overall Study|Chemotherapy for lung cancer|1|||
33536748|NCT00447772|101863923|FG000|Overall Study|Premature re-injection required|1|||
33536749|NCT03257436|101863928|FG000|Overall Study|Withdrawal by Subject|76|||
33536750|NCT03257436|101863928|FG000|Overall Study|Death|19|||
33536751|NCT01365130|101863929|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
33536752|NCT00570401|101863930|FG000|Overall Study|Adverse Event|2|||
33536753|NCT00643760|101863931|FG000|Overall Study|Adverse Event|11|||
33536754|NCT00643760|101863932|FG001|Overall Study|Adverse Event|5|||
33536755|NCT00643760|101863933|FG002|Overall Study|Adverse Event|12|||
33536756|NCT00643760|101863934|FG003|Overall Study|Adverse Event|21|||
33536757|NCT00643760|101863935|FG004|Overall Study|Adverse Event|6|||
33536758|NCT00643760|101863931|FG000|Overall Study|Lack of Efficacy|3|||
33536759|NCT00643760|101863932|FG001|Overall Study|Lack of Efficacy|1|||
33536760|NCT00643760|101863933|FG002|Overall Study|Lack of Efficacy|0|||
33536761|NCT00643760|101863934|FG003|Overall Study|Lack of Efficacy|4|||
33536762|NCT00643760|101863935|FG004|Overall Study|Lack of Efficacy|3|||
33536763|NCT00643760|101863931|FG000|Overall Study|Protocol Violation|7|||
33536764|NCT00643760|101863932|FG001|Overall Study|Protocol Violation|6|||
33536765|NCT00643760|101863933|FG002|Overall Study|Protocol Violation|4|||
33536766|NCT00643760|101863934|FG003|Overall Study|Protocol Violation|4|||
33536767|NCT00643760|101863935|FG004|Overall Study|Protocol Violation|6|||
33536768|NCT00643760|101863931|FG000|Overall Study|Lost to Follow-up|6|||
33536769|NCT00643760|101863932|FG001|Overall Study|Lost to Follow-up|2|||
33536770|NCT00643760|101863933|FG002|Overall Study|Lost to Follow-up|1|||
33536771|NCT00643760|101863934|FG003|Overall Study|Lost to Follow-up|3|||
33536772|NCT00643760|101863935|FG004|Overall Study|Lost to Follow-up|3|||
33536773|NCT00643760|101863931|FG000|Overall Study|Investigator Discretion|0|||
33536774|NCT00643760|101863932|FG001|Overall Study|Investigator Discretion|0|||
33536775|NCT00643760|101863933|FG002|Overall Study|Investigator Discretion|0|||
33536776|NCT00643760|101863934|FG003|Overall Study|Investigator Discretion|2|||
33536777|NCT00643760|101863935|FG004|Overall Study|Investigator Discretion|0|||
33339844|NCT00725075|101135892|FG002|Overall Study|Withdrawal by Subject|4|||
33339845|NCT00725075|101135890|FG000|Overall Study|Adverse Event|2|||
33339846|NCT00725075|101135891|FG001|Overall Study|Adverse Event|1|||
33405657|NCT02554721|101373457|FG004|Overall Study|Noncompliance|1|||
33339847|NCT00725075|101135892|FG002|Overall Study|Adverse Event|1|||
33339848|NCT00725075|101135890|FG000|Overall Study|Worsening of Disease|2|||
33339849|NCT00725075|101135891|FG001|Overall Study|Worsening of Disease|1|||
33339850|NCT00725075|101135892|FG002|Overall Study|Worsening of Disease|2|||
33339851|NCT00725075|101135890|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
33339852|NCT00725075|101135891|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
33339853|NCT00725075|101135892|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
33536778|NCT00643760|101863931|FG000|Overall Study|Withdrawal by Subject|3|||
33536779|NCT00643760|101863932|FG001|Overall Study|Withdrawal by Subject|1|||
33536780|NCT00643760|101863933|FG002|Overall Study|Withdrawal by Subject|2|||
33339854|NCT00725075|101135890|FG000|Overall Study|Other|1|||
33339855|NCT00725075|101135891|FG001|Overall Study|Other|0|||
33339856|NCT00725075|101135892|FG002|Overall Study|Other|0|||
33339857|NCT03115151|101135893|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
33339858|NCT03115151|101135894|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
33339859|NCT03115151|101135893|FG000|Overall Study|Epidural catheter removal|1|||
33339860|NCT03115151|101135894|FG001|Overall Study|Epidural catheter removal|0|||
33339861|NCT03115151|101135893|FG000|Overall Study|Withdrawal by Subject|0|||
33339862|NCT03115151|101135894|FG001|Overall Study|Withdrawal by Subject|1|||
33339863|NCT03115151|101135893|FG000|Overall Study|Intervention not received according to the protocol.|1|||
33339864|NCT03115151|101135894|FG001|Overall Study|Intervention not received according to the protocol.|1|||
33339865|NCT03115151|101135893|FG000|Overall Study|Physician Decision|1|||
33339866|NCT03115151|101135894|FG001|Overall Study|Physician Decision|0|||
33339867|NCT03115151|101135893|FG000|Overall Study|Randomization not applied|1|||
33339868|NCT03115151|101135894|FG001|Overall Study|Randomization not applied|1|||
33339869|NCT01903837|101135895|FG000|Part A|Withdrawal by Subject|4|||
33339870|NCT01903837|101135896|FG001|Part A|Withdrawal by Subject|9|||
33339871|NCT01903837|101135897|FG002|Part A|Withdrawal by Subject|8|||
33339872|NCT01903837|101135898|FG003|Part A|Withdrawal by Subject|5|||
33339873|NCT01903837|101135895|FG000|Part A|Adverse Event|3|||
33339874|NCT01903837|101135896|FG001|Part A|Adverse Event|6|||
33339875|NCT01903837|101135897|FG002|Part A|Adverse Event|9|||
33339876|NCT01903837|101135898|FG003|Part A|Adverse Event|6|||
33339877|NCT01903837|101135895|FG000|Part A|Lost to Follow-up|9|||
33339878|NCT01903837|101135896|FG001|Part A|Lost to Follow-up|7|||
33339879|NCT01903837|101135897|FG002|Part A|Lost to Follow-up|7|||
33339880|NCT01903837|101135898|FG003|Part A|Lost to Follow-up|2|||
33339881|NCT01903837|101135895|FG000|Part A|Non-compliance with study drug|1|||
33339882|NCT01903837|101135896|FG001|Part A|Non-compliance with study drug|4|||
33339883|NCT01903837|101135897|FG002|Part A|Non-compliance with study drug|4|||
33339884|NCT01903837|101135898|FG003|Part A|Non-compliance with study drug|0|||
33339885|NCT01903837|101135895|FG000|Part A|Physician Decision|1|||
33339886|NCT01903837|101135896|FG001|Part A|Physician Decision|1|||
33536781|NCT00643760|101863934|FG003|Overall Study|Withdrawal by Subject|4|||
33536782|NCT00643760|101863935|FG004|Overall Study|Withdrawal by Subject|1|||
33536783|NCT01065818|101863936|FG000|Overall Study|Withdrawal by Subject|1|||
33536784|NCT01065818|101863936|FG000|Overall Study|Not a candidate for surgery|1|||
33536785|NCT02515630|101863939|FG000|Overall Study|Withdrawal by Subject|5|||
33536786|NCT02515630|101863939|FG000|Overall Study|Adverse Event|4|||
33536787|NCT02515630|101863939|FG000|Overall Study|Physician Decision|4|||
33536788|NCT02515630|101863939|FG000|Overall Study|Death|2|||
33536789|NCT02515630|101863939|FG000|Overall Study|Disease Progression|1|||
33536790|NCT03205150|101863942|FG000|Overall Study|Protocol deviation|1|||
33536791|NCT03205150|101863943|FG001|Overall Study|Protocol deviation|3|||
33536792|NCT03205150|101863944|FG002|Overall Study|Protocol deviation|0|||
33536793|NCT03205150|101863942|FG000|Overall Study|Patient/guardian decision|0|||
33536794|NCT03205150|101863943|FG001|Overall Study|Patient/guardian decision|3|||
33536795|NCT03205150|101863944|FG002|Overall Study|Patient/guardian decision|0|||
33536796|NCT03205150|101863942|FG000|Overall Study|Adverse Event|1|||
33536797|NCT03205150|101863943|FG001|Overall Study|Adverse Event|1|||
33536798|NCT03205150|101863944|FG002|Overall Study|Adverse Event|1|||
33536799|NCT03205150|101863942|FG000|Overall Study|Lost to Follow-up|0|||
33536800|NCT03205150|101863943|FG001|Overall Study|Lost to Follow-up|0|||
33536801|NCT03205150|101863944|FG002|Overall Study|Lost to Follow-up|1|||
33536802|NCT01939314|101863945|FG000|Overall Study|Withdrawal by Subject|3|||
33536803|NCT01939314|101863946|FG001|Overall Study|Withdrawal by Subject|1|||
33536804|NCT01939314|101863945|FG000|Overall Study|Protocol Violation|1|||
33536805|NCT01939314|101863946|FG001|Overall Study|Protocol Violation|0|||
33536806|NCT01939314|101863945|FG000|Overall Study|Pregnancy|0|||
33536807|NCT01939314|101863946|FG001|Overall Study|Pregnancy|1|||
33536808|NCT01939314|101863945|FG000|Overall Study|Lost to Follow-up|5|||
33536809|NCT01939314|101863946|FG001|Overall Study|Lost to Follow-up|6|||
33536810|NCT01926028|101863948|FG000|Overall Study|Lost to Follow-up|7|||
33536811|NCT01926028|101863949|FG001|Overall Study|Lost to Follow-up|6|||
33614396|NCT01393639|102137122|FG000|Overall Study|Withdrawal by Subject|1|||
33339887|NCT01903837|101135897|FG002|Part A|Physician Decision|0|||
33339888|NCT01903837|101135898|FG003|Part A|Physician Decision|0|||
33339889|NCT01903837|101135895|FG000|Part A|Protocol Violation|1|||
33339890|NCT01903837|101135896|FG001|Part A|Protocol Violation|1|||
33339891|NCT01903837|101135897|FG002|Part A|Protocol Violation|0|||
33339892|NCT01903837|101135898|FG003|Part A|Protocol Violation|0|||
33339893|NCT01903837|101135895|FG000|Part B|Lost to Follow-up|0|||
33339894|NCT01903837|101135896|FG001|Part B|Lost to Follow-up|3|||
33339895|NCT01903837|101135897|FG002|Part B|Lost to Follow-up|3|||
33339896|NCT01903837|101135898|FG003|Part B|Lost to Follow-up|4|||
33339897|NCT01903837|101135895|FG000|Part B|Withdrawal by Subject|1|||
33536812|NCT01926028|101863950|FG002|Overall Study|Lost to Follow-up|0|||
33536813|NCT01926028|101863948|FG000|Overall Study|Physician Decision|1|||
33536814|NCT01926028|101863949|FG001|Overall Study|Physician Decision|5|||
33536815|NCT01926028|101863950|FG002|Overall Study|Physician Decision|0|||
33339898|NCT01903837|101135896|FG001|Part B|Withdrawal by Subject|2|||
33339899|NCT01903837|101135897|FG002|Part B|Withdrawal by Subject|0|||
33339900|NCT01903837|101135898|FG003|Part B|Withdrawal by Subject|3|||
33339901|NCT01903837|101135895|FG000|Part B|Adverse Event|3|||
33339902|NCT01903837|101135896|FG001|Part B|Adverse Event|0|||
33339903|NCT01903837|101135897|FG002|Part B|Adverse Event|2|||
33339904|NCT01903837|101135898|FG003|Part B|Adverse Event|0|||
33339905|NCT01903837|101135895|FG000|Part B|Non-compliance with study drug|2|||
33339906|NCT01903837|101135896|FG001|Part B|Non-compliance with study drug|0|||
33339907|NCT01903837|101135897|FG002|Part B|Non-compliance with study drug|0|||
33536816|NCT01926028|101863948|FG000|Overall Study|Withdrawal by Subject|9|||
33536817|NCT01926028|101863949|FG001|Overall Study|Withdrawal by Subject|9|||
33536818|NCT01926028|101863950|FG002|Overall Study|Withdrawal by Subject|2|||
33536819|NCT01926028|101863948|FG000|Overall Study|Non compliance or other reasons|4|||
33339908|NCT01903837|101135898|FG003|Part B|Non-compliance with study drug|1|||
33339909|NCT01903837|101135895|FG000|Part B|Incarceration|2|||
33536820|NCT01926028|101863949|FG001|Overall Study|Non compliance or other reasons|2|||
33536821|NCT01926028|101863950|FG002|Overall Study|Non compliance or other reasons|0|||
33536822|NCT00072384|101863954|FG000|Overall Study|Physician Decision|1|||
33536823|NCT00072384|101863954|FG000|Overall Study|Ineligible|8|||
33536824|NCT00471497|101863955|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
33536825|NCT00471497|101863956|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
33536826|NCT00471497|101863957|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
33536827|NCT00471497|101863955|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
33536828|NCT00471497|101863956|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
33536829|NCT00471497|101863957|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
33536830|NCT00471497|101863955|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
33536831|NCT00471497|101863956|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
33536832|NCT00471497|101863957|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
33536833|NCT00471497|101863955|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
33536834|NCT00471497|101863956|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
33536835|NCT00471497|101863957|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
33536836|NCT00471497|101863955|FG000|Core Treatment Phase|Lost to Follow-up|6|||
33536837|NCT00471497|101863956|FG001|Core Treatment Phase|Lost to Follow-up|6|||
33536838|NCT00471497|101863957|FG002|Core Treatment Phase|Lost to Follow-up|3|||
33536839|NCT00471497|101863955|FG000|Core Treatment Phase|Death|3|||
33536840|NCT00471497|101863956|FG001|Core Treatment Phase|Death|9|||
33536841|NCT00471497|101863957|FG002|Core Treatment Phase|Death|3|||
33536842|NCT00471497|101863955|FG000|Core Treatment Phase|Disease Progression|10|||
33536843|NCT00471497|101863956|FG001|Core Treatment Phase|Disease Progression|2|||
33536844|NCT00471497|101863957|FG002|Core Treatment Phase|Disease Progression|4|||
33536845|NCT00471497|101863955|FG000|Core Treatment Phase|Protocol Violation|6|||
33536846|NCT00471497|101863956|FG001|Core Treatment Phase|Protocol Violation|15|||
33536847|NCT00471497|101863957|FG002|Core Treatment Phase|Protocol Violation|11|||
33536848|NCT00471497|101863955|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
33536849|NCT00471497|101863956|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
33536850|NCT00471497|101863957|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
33536851|NCT00471497|101863955|FG000|Core Treatment Phase|Administrative problems|14|||
33536852|NCT00471497|101863956|FG001|Core Treatment Phase|Administrative problems|14|||
33536853|NCT00471497|101863957|FG002|Core Treatment Phase|Administrative problems|12|||
33536854|NCT00471497|101863955|FG000|Core Treatment Phase|Adverse Event|43|||
33536855|NCT00471497|101863956|FG001|Core Treatment Phase|Adverse Event|53|||
33536856|NCT00471497|101863957|FG002|Core Treatment Phase|Adverse Event|89|||
33536857|NCT00471497|101863955|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
33536858|NCT00471497|101863956|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
33339910|NCT01903837|101135896|FG001|Part B|Incarceration|0|||
33339911|NCT01903837|101135897|FG002|Part B|Incarceration|0|||
33339912|NCT01903837|101135898|FG003|Part B|Incarceration|1|||
33339913|NCT01903837|101135895|FG000|Part B|Physician Decision|1|||
33339914|NCT01903837|101135896|FG001|Part B|Physician Decision|0|||
33339915|NCT01903837|101135897|FG002|Part B|Physician Decision|0|||
33339916|NCT01903837|101135898|FG003|Part B|Physician Decision|2|||
33339917|NCT01903837|101135895|FG000|Part B|Lack of Efficacy|0|||
33339918|NCT01903837|101135896|FG001|Part B|Lack of Efficacy|1|||
33339919|NCT01903837|101135897|FG002|Part B|Lack of Efficacy|0|||
33339920|NCT01903837|101135898|FG003|Part B|Lack of Efficacy|0|||
33339921|NCT03891901|101135899|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
33339922|NCT03891901|101135900|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33536859|NCT00471497|101863957|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
33536860|NCT00471497|101863955|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
33536861|NCT00471497|101863956|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
33536862|NCT00471497|101863957|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
33536863|NCT00471497|101863955|FG000|Extension Phase|Adverse Event|9|||
33536864|NCT00471497|101863956|FG001|Extension Phase|Adverse Event|5|||
33339923|NCT03891901|101135901|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33339924|NCT03891901|101135902|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33339925|NCT03891901|101135903|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33339926|NCT03891901|101135904|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33339927|NCT03891901|101135905|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33339928|NCT03891901|101135906|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33339929|NCT03891901|101135907|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
33536865|NCT00471497|101863957|FG002|Extension Phase|Adverse Event|1|||
33536866|NCT00471497|101863955|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
33536867|NCT00471497|101863956|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
33536868|NCT00471497|101863957|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
33536869|NCT00471497|101863955|FG000|Extension Phase|Withdrawal by Subject|3|||
33536870|NCT00471497|101863956|FG001|Extension Phase|Withdrawal by Subject|1|||
33536871|NCT00471497|101863957|FG002|Extension Phase|Withdrawal by Subject|0|||
33339930|NCT03891901|101135899|FG000|Overall Study|Adverse Event|2|||
33536872|NCT00471497|101863955|FG000|Extension Phase|Lost to Follow-up|2|||
33536873|NCT00471497|101863956|FG001|Extension Phase|Lost to Follow-up|0|||
33536874|NCT00471497|101863957|FG002|Extension Phase|Lost to Follow-up|0|||
33536875|NCT00471497|101863955|FG000|Extension Phase|Death|1|||
33536876|NCT00471497|101863956|FG001|Extension Phase|Death|0|||
33536877|NCT00471497|101863957|FG002|Extension Phase|Death|0|||
33536878|NCT00471497|101863955|FG000|Extension Phase|Disease progression|2|||
33536879|NCT00471497|101863956|FG001|Extension Phase|Disease progression|0|||
33536880|NCT00471497|101863957|FG002|Extension Phase|Disease progression|0|||
33536881|NCT00471497|101863955|FG000|Extension Phase|Protocol Violation|2|||
33536882|NCT00471497|101863956|FG001|Extension Phase|Protocol Violation|2|||
33536883|NCT00471497|101863957|FG002|Extension Phase|Protocol Violation|0|||
33536884|NCT01241279|101863963|FG000|Overall Study|Lost to Follow-up|0|||
33536885|NCT01241279|101863964|FG001|Overall Study|Lost to Follow-up|1|||
33536886|NCT01883895|101863965|FG000|Overall Study|Lost to Follow-up|2|||
33536887|NCT01095835|101863966|FG000|Overall Study|Adverse Event|8|||
33536888|NCT01095835|101863967|FG001|Overall Study|Adverse Event|6|||
33536889|NCT01095835|101863968|FG002|Overall Study|Adverse Event|6|||
33536890|NCT01095835|101863966|FG000|Overall Study|Lack of Efficacy|0|||
33536891|NCT01095835|101863967|FG001|Overall Study|Lack of Efficacy|1|||
33536892|NCT01095835|101863968|FG002|Overall Study|Lack of Efficacy|0|||
33536893|NCT01095835|101863966|FG000|Overall Study|Physician Decision|0|||
33536894|NCT01095835|101863967|FG001|Overall Study|Physician Decision|0|||
33536895|NCT01095835|101863968|FG002|Overall Study|Physician Decision|1|||
33536896|NCT01095835|101863966|FG000|Overall Study|Withdrawal by Subject|1|||
33536897|NCT01095835|101863967|FG001|Overall Study|Withdrawal by Subject|3|||
33536898|NCT01095835|101863968|FG002|Overall Study|Withdrawal by Subject|0|||
33536899|NCT01095835|101863966|FG000|Overall Study|Non study compliance|0|||
33536900|NCT01095835|101863967|FG001|Overall Study|Non study compliance|0|||
33536901|NCT01095835|101863968|FG002|Overall Study|Non study compliance|1|||
33536902|NCT01095835|101863966|FG000|Overall Study|Protocol Violation|1|||
33536903|NCT01095835|101863967|FG001|Overall Study|Protocol Violation|2|||
33536904|NCT01095835|101863968|FG002|Overall Study|Protocol Violation|0|||
33536905|NCT01051921|101863969|FG000|Overall Study|Physician Decision|9|||
33536906|NCT01051921|101863969|FG000|Overall Study|Adverse Event|8|||
33536907|NCT01051921|101863969|FG000|Overall Study|Withdrawal by Subject|7|||
33536908|NCT01051921|101863969|FG000|Overall Study|Lost to Follow-up|4|||
33536909|NCT01051921|101863969|FG000|Overall Study|virological failure|1|||
33536910|NCT01051921|101863969|FG000|Overall Study|patient moved|1|||
33536911|NCT00735007|101863970|FG000|Overall Study|Adverse Event|4|||
33536912|NCT00735007|101863970|FG000|Overall Study|Protocol Violation|1|||
33536913|NCT03786380|101863971|FG000|Overall Study|Adverse Event|1|||
33536914|NCT03786380|101863972|FG001|Overall Study|Adverse Event|0|||
33536915|NCT03786380|101863973|FG002|Overall Study|Adverse Event|0|||
33536916|NCT03786380|101863974|FG003|Overall Study|Adverse Event|3|||
33536917|NCT03786380|101863975|FG004|Overall Study|Adverse Event|1|||
33536918|NCT03786380|101863971|FG000|Overall Study|Lack of Efficacy|0|||
33536919|NCT03786380|101863972|FG001|Overall Study|Lack of Efficacy|0|||
33536920|NCT03786380|101863973|FG002|Overall Study|Lack of Efficacy|0|||
33536921|NCT03786380|101863974|FG003|Overall Study|Lack of Efficacy|0|||
33536922|NCT03786380|101863975|FG004|Overall Study|Lack of Efficacy|1|||
33536923|NCT03786380|101863971|FG000|Overall Study|Withdrawal by Subject|1|||
33536924|NCT03786380|101863972|FG001|Overall Study|Withdrawal by Subject|2|||
33536925|NCT03786380|101863973|FG002|Overall Study|Withdrawal by Subject|2|||
33536926|NCT03786380|101863974|FG003|Overall Study|Withdrawal by Subject|1|||
33536927|NCT03786380|101863975|FG004|Overall Study|Withdrawal by Subject|2|||
33536928|NCT03786380|101863971|FG000|Overall Study|Lost to Follow-up|3|||
33536929|NCT03786380|101863972|FG001|Overall Study|Lost to Follow-up|0|||
33536930|NCT03786380|101863973|FG002|Overall Study|Lost to Follow-up|1|||
33208977|NCT01292603|100665693|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
33536931|NCT03786380|101863974|FG003|Overall Study|Lost to Follow-up|2|||
33536932|NCT03786380|101863975|FG004|Overall Study|Lost to Follow-up|0|||
33536933|NCT03786380|101863971|FG000|Overall Study|Physician Decision|0|||
33339931|NCT03891901|101135900|FG001|Overall Study|Adverse Event|2|||
33339932|NCT03891901|101135901|FG002|Overall Study|Adverse Event|0|||
33339933|NCT03891901|101135902|FG003|Overall Study|Adverse Event|0|||
33339934|NCT03891901|101135903|FG004|Overall Study|Adverse Event|0|||
33339935|NCT03891901|101135904|FG005|Overall Study|Adverse Event|0|||
33339936|NCT03891901|101135905|FG006|Overall Study|Adverse Event|0|||
33339937|NCT03891901|101135906|FG007|Overall Study|Adverse Event|0|||
33339938|NCT03891901|101135907|FG008|Overall Study|Adverse Event|0|||
33339939|NCT03891901|101135899|FG000|Overall Study|Poor venous access|1|||
33339940|NCT03891901|101135900|FG001|Overall Study|Poor venous access|0|||
33339941|NCT03891901|101135901|FG002|Overall Study|Poor venous access|0|||
33339942|NCT03891901|101135902|FG003|Overall Study|Poor venous access|0|||
33339943|NCT03891901|101135903|FG004|Overall Study|Poor venous access|0|||
33339944|NCT03891901|101135904|FG005|Overall Study|Poor venous access|0|||
33339945|NCT03891901|101135905|FG006|Overall Study|Poor venous access|0|||
33339946|NCT03891901|101135906|FG007|Overall Study|Poor venous access|0|||
33339947|NCT03891901|101135907|FG008|Overall Study|Poor venous access|0|||
33339948|NCT03891901|101135899|FG000|Overall Study|Withdrawal by Subject|0|||
33339949|NCT03891901|101135900|FG001|Overall Study|Withdrawal by Subject|2|||
33339950|NCT03891901|101135901|FG002|Overall Study|Withdrawal by Subject|0|||
33339951|NCT03891901|101135902|FG003|Overall Study|Withdrawal by Subject|0|||
33339952|NCT03891901|101135903|FG004|Overall Study|Withdrawal by Subject|0|||
33339953|NCT03891901|101135904|FG005|Overall Study|Withdrawal by Subject|0|||
33339954|NCT03891901|101135905|FG006|Overall Study|Withdrawal by Subject|0|||
33339955|NCT03891901|101135906|FG007|Overall Study|Withdrawal by Subject|0|||
33339956|NCT03891901|101135907|FG008|Overall Study|Withdrawal by Subject|0|||
33339957|NCT00695565|101135908|FG000|Overall Study|Lost to Follow-up|4|||
33339958|NCT00695565|101135909|FG001|Overall Study|Lost to Follow-up|4|||
33339959|NCT00695565|101135908|FG000|Overall Study|Adverse Event|3|||
33339960|NCT00695565|101135909|FG001|Overall Study|Adverse Event|1|||
33339961|NCT00695565|101135908|FG000|Overall Study|Protocol Violation|3|||
33339962|NCT00695565|101135909|FG001|Overall Study|Protocol Violation|1|||
33339963|NCT00695565|101135908|FG000|Overall Study|Withdrawal by Subject|1|||
33339964|NCT00695565|101135909|FG001|Overall Study|Withdrawal by Subject|1|||
33339965|NCT00695565|101135908|FG000|Overall Study|Lack of Efficacy|1|||
33339966|NCT00695565|101135909|FG001|Overall Study|Lack of Efficacy|1|||
33339967|NCT00695565|101135908|FG000|Overall Study|Subject did not follow instructions|1|||
33536934|NCT03786380|101863972|FG001|Overall Study|Physician Decision|0|||
33536935|NCT03786380|101863973|FG002|Overall Study|Physician Decision|1|||
33536936|NCT03786380|101863974|FG003|Overall Study|Physician Decision|0|||
33536937|NCT03786380|101863975|FG004|Overall Study|Physician Decision|0|||
33536938|NCT03786380|101863971|FG000|Overall Study|Study Terminated by the Sponsor|30|||
33536939|NCT03786380|101863972|FG001|Overall Study|Study Terminated by the Sponsor|20|||
33536940|NCT03786380|101863973|FG002|Overall Study|Study Terminated by the Sponsor|50|||
33536941|NCT03786380|101863974|FG003|Overall Study|Study Terminated by the Sponsor|57|||
33536942|NCT03786380|101863975|FG004|Overall Study|Study Terminated by the Sponsor|23|||
33536943|NCT03786380|101863971|FG000|Overall Study|Reason Not Specified|0|||
33536944|NCT03786380|101863972|FG001|Overall Study|Reason Not Specified|0|||
33536945|NCT03786380|101863973|FG002|Overall Study|Reason Not Specified|0|||
33536946|NCT03786380|101863974|FG003|Overall Study|Reason Not Specified|0|||
33536947|NCT03786380|101863975|FG004|Overall Study|Reason Not Specified|1|||
33536948|NCT00449163|101863976|FG000|Overall Study|Physician Decision|3|||
33536949|NCT04609514|101863977|FG000|Overall Study|Lost to Follow-up|5|||
33536950|NCT04609514|101863978|FG001|Overall Study|Lost to Follow-up|4|||
33536951|NCT04609514|101863977|FG000|Overall Study|Withdrawal by PI|0|||
33536952|NCT04609514|101863978|FG001|Overall Study|Withdrawal by PI|2|||
33536953|NCT01245101|101863979|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
33536954|NCT01245101|101863980|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
33536955|NCT01245101|101863979|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
33208978|NCT01292603|100665688|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
33339968|NCT00695565|101135909|FG001|Overall Study|Subject did not follow instructions|1|||
33339969|NCT01678144|101135910|FG000|Stage 1: MAR Classic|Adverse Event|1|||
33339970|NCT03984305|101135911|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
33339971|NCT03984305|101135912|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
33339972|NCT03984305|101135911|FG000|Overall Study|Withdrawal by Subject|3|||
33339973|NCT03984305|101135912|FG001|Overall Study|Withdrawal by Subject|3|||
33339974|NCT03984305|101135911|FG000|Overall Study|Lost to Follow-up|1|||
33536956|NCT01245101|101863980|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
33536957|NCT01245101|101863979|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
33339975|NCT03984305|101135912|FG001|Overall Study|Lost to Follow-up|0|||
33536958|NCT01245101|101863980|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
33339976|NCT01496885|101135915|FG000|Overall Study|Lost to Follow-up|13|||
33339977|NCT01496885|101135915|FG000|Overall Study|Withdrawal by Subject|7|||
33339978|NCT01496885|101135915|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
33339979|NCT01496885|101135915|FG000|Overall Study|Death|1|||
33339980|NCT03434977|101135916|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
33339981|NCT03434977|101135917|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
33536959|NCT04356937|101863983|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
33536960|NCT04356937|101863984|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
33339982|NCT05594173|101135918|FG000|Overall Study|Adverse Event|1|||
33339983|NCT05594173|101135918|FG000|Overall Study|COVID-19 Pandemic|2|||
33339984|NCT00874120|101135919|FG000|First Intervention|Adverse Event|0|||
33339985|NCT00874120|101135920|FG001|First Intervention|Adverse Event|1|||
33339986|NCT00874120|101135919|FG000|First Intervention|Withdrawal by Subject|2|||
33339987|NCT00874120|101135920|FG001|First Intervention|Withdrawal by Subject|0|||
33339988|NCT00874120|101135919|FG000|First Intervention|Lost to Follow-up|0|||
33339989|NCT00874120|101135920|FG001|First Intervention|Lost to Follow-up|1|||
33339990|NCT00874120|101135919|FG000|First Intervention|Protocol Violation|3|||
33339991|NCT00874120|101135920|FG001|First Intervention|Protocol Violation|0|||
33339992|NCT00874120|101135919|FG000|First Intervention|positive drug test|1|||
33536961|NCT03669588|101863985|FG000|Overall Study|Adverse Event|1|||
33536962|NCT03669588|101863986|FG001|Overall Study|Adverse Event|0|||
33536963|NCT03669588|101863985|FG000|Overall Study|Physician Decision|0|||
33536964|NCT03669588|101863986|FG001|Overall Study|Physician Decision|1|||
33536965|NCT03669588|101863985|FG000|Overall Study|Protocol Violation|1|||
33536966|NCT03669588|101863986|FG001|Overall Study|Protocol Violation|0|||
33536967|NCT03669588|101863985|FG000|Overall Study|Sponsor Decision|1|||
33536968|NCT03669588|101863986|FG001|Overall Study|Sponsor Decision|1|||
33536969|NCT03669588|101863985|FG000|Overall Study|Withdrawal by Subject|1|||
33536970|NCT03669588|101863986|FG001|Overall Study|Withdrawal by Subject|4|||
33536971|NCT03669588|101863985|FG000|Overall Study|Rescue Therapy Needed|0|||
33536972|NCT03669588|101863986|FG001|Overall Study|Rescue Therapy Needed|1|||
33536973|NCT01325350|101863987|FG000|Overall Study|Adverse Event|3|||
33536974|NCT01325350|101863988|FG001|Overall Study|Adverse Event|3|||
33536975|NCT01325350|101863989|FG002|Overall Study|Adverse Event|3|||
33536976|NCT01325350|101863990|FG003|Overall Study|Adverse Event|1|||
33536977|NCT01325350|101863991|FG004|Overall Study|Adverse Event|2|||
33536978|NCT01325350|101863987|FG000|Overall Study|Pregnancy|0|||
33536979|NCT01325350|101863988|FG001|Overall Study|Pregnancy|0|||
33536980|NCT01325350|101863989|FG002|Overall Study|Pregnancy|1|||
33536981|NCT01325350|101863990|FG003|Overall Study|Pregnancy|0|||
33536982|NCT01325350|101863991|FG004|Overall Study|Pregnancy|1|||
33536983|NCT01325350|101863987|FG000|Overall Study|Lost to Follow-up|1|||
33536984|NCT01325350|101863988|FG001|Overall Study|Lost to Follow-up|0|||
33536985|NCT01325350|101863989|FG002|Overall Study|Lost to Follow-up|5|||
33536986|NCT01325350|101863990|FG003|Overall Study|Lost to Follow-up|1|||
33536987|NCT01325350|101863991|FG004|Overall Study|Lost to Follow-up|5|||
33536988|NCT01325350|101863987|FG000|Overall Study|Personal Reasons|2|||
33536989|NCT01325350|101863988|FG001|Overall Study|Personal Reasons|1|||
33536990|NCT01325350|101863989|FG002|Overall Study|Personal Reasons|6|||
33536991|NCT01325350|101863990|FG003|Overall Study|Personal Reasons|5|||
33536992|NCT01325350|101863991|FG004|Overall Study|Personal Reasons|3|||
33536993|NCT01325350|101863987|FG000|Overall Study|Protocol Violation|0|||
33339993|NCT00874120|101135920|FG001|First Intervention|positive drug test|0|||
33339994|NCT00874120|101135919|FG000|Second Intervention|Withdrawal by Subject|1|||
33339995|NCT00874120|101135920|FG001|Second Intervention|Withdrawal by Subject|0|||
33339996|NCT00874120|101135919|FG000|Second Intervention|Protocol Violation|1|||
33339997|NCT00874120|101135920|FG001|Second Intervention|Protocol Violation|0|||
33339998|NCT01972074|101135921|FG000|Overall Study|Adverse Event|4|||
33339999|NCT01972074|101135922|FG001|Overall Study|Adverse Event|1|||
33340000|NCT01972074|101135923|FG002|Overall Study|Adverse Event|0|||
33340001|NCT01972074|101135921|FG000|Overall Study|Lack of Efficacy|1|||
33340002|NCT01972074|101135922|FG001|Overall Study|Lack of Efficacy|1|||
33340003|NCT01972074|101135923|FG002|Overall Study|Lack of Efficacy|0|||
33340004|NCT01972074|101135921|FG000|Overall Study|Lost to Follow-up|0|||
33340005|NCT01972074|101135922|FG001|Overall Study|Lost to Follow-up|1|||
33340006|NCT01972074|101135923|FG002|Overall Study|Lost to Follow-up|1|||
33340007|NCT01972074|101135921|FG000|Overall Study|Withdrawal by Subject|1|||
33340008|NCT01972074|101135922|FG001|Overall Study|Withdrawal by Subject|1|||
33340009|NCT01972074|101135923|FG002|Overall Study|Withdrawal by Subject|1|||
33340010|NCT01972074|101135921|FG000|Overall Study|Scanner Unavailable|0|||
33536994|NCT01325350|101863988|FG001|Overall Study|Protocol Violation|0|||
33536995|NCT01325350|101863989|FG002|Overall Study|Protocol Violation|0|||
33536996|NCT01325350|101863990|FG003|Overall Study|Protocol Violation|1|||
33536997|NCT01325350|101863991|FG004|Overall Study|Protocol Violation|0|||
33536998|NCT01325350|101863987|FG000|Overall Study|Withdrawal by Subject|0|||
33536999|NCT01325350|101863988|FG001|Overall Study|Withdrawal by Subject|0|||
33537000|NCT01325350|101863989|FG002|Overall Study|Withdrawal by Subject|1|||
33340011|NCT01972074|101135922|FG001|Overall Study|Scanner Unavailable|0|||
33208979|NCT01292603|100665689|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
33208980|NCT01292603|100665690|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
33208981|NCT01292603|100665691|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
33208982|NCT01292603|100665692|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
33208983|NCT01292603|100665693|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
33208984|NCT01292603|100665688|FG000|Overall Survival Status|Death|3|||
33208985|NCT01292603|100665689|FG001|Overall Survival Status|Death|1|||
33208986|NCT01292603|100665690|FG002|Overall Survival Status|Death|3|||
33208987|NCT01292603|100665691|FG003|Overall Survival Status|Death|1|||
33208988|NCT01292603|100665692|FG004|Overall Survival Status|Death|16|||
33208989|NCT01292603|100665693|FG005|Overall Survival Status|Death|10|||
33208990|NCT02097472|100665695|FG000|Received Vaccination 2|Adverse Event|0|||
33208991|NCT02097472|100665696|FG001|Received Vaccination 2|Adverse Event|0|||
33208992|NCT02097472|100665697|FG002|Received Vaccination 2|Adverse Event|0|||
33208993|NCT02097472|100665698|FG003|Received Vaccination 2|Adverse Event|0|||
33208994|NCT02097472|100665699|FG004|Received Vaccination 2|Adverse Event|0|||
33208995|NCT02097472|100665700|FG005|Received Vaccination 2|Adverse Event|0|||
33208996|NCT02097472|100665701|FG006|Received Vaccination 2|Adverse Event|1|||
33208997|NCT02097472|100665702|FG007|Received Vaccination 2|Adverse Event|0|||
33208998|NCT00622167|100665708|FG000|Overall Study|Did not meet angiographic criteria|20|||
33208999|NCT02566031|100665709|FG000|Overall Study|Patient/guardian decision|14|||
33209000|NCT02566031|100665710|FG001|Overall Study|Patient/guardian decision|7|||
33209001|NCT02566031|100665709|FG000|Overall Study|Protocol deviation|2|||
33209002|NCT02566031|100665710|FG001|Overall Study|Protocol deviation|3|||
33209003|NCT02566031|100665709|FG000|Overall Study|Adverse Event|3|||
33209004|NCT02566031|100665710|FG001|Overall Study|Adverse Event|1|||
33209005|NCT02566031|100665709|FG000|Overall Study|Lost to Follow-up|1|||
33209006|NCT02566031|100665710|FG001|Overall Study|Lost to Follow-up|1|||
33537001|NCT01325350|101863990|FG003|Overall Study|Withdrawal by Subject|1|||
33209007|NCT02911948|100665711|FG000|Overall Study|Protocol Violation|0|||
33209008|NCT02911948|100665712|FG001|Overall Study|Protocol Violation|1|||
33209009|NCT02911948|100665711|FG000|Overall Study|Withdrawal by Subject|0|||
33537002|NCT01325350|101863991|FG004|Overall Study|Withdrawal by Subject|0|||
33537003|NCT01325350|101863987|FG000|Overall Study|Did Not Receive Treatment|0|||
33537004|NCT01325350|101863988|FG001|Overall Study|Did Not Receive Treatment|1|||
33537005|NCT01325350|101863989|FG002|Overall Study|Did Not Receive Treatment|1|||
33537006|NCT01325350|101863990|FG003|Overall Study|Did Not Receive Treatment|0|||
33537007|NCT01325350|101863991|FG004|Overall Study|Did Not Receive Treatment|1|||
33537008|NCT05222880|101863996|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
33537009|NCT05222880|101863996|FG000|Overall Study|Withdrew Consent during Study|1|||
33537010|NCT05222880|101863996|FG000|Overall Study|COVID-19 Related|1|||
33537011|NCT01274533|101863997|FG000|Overall Study|Withdrawal by Subject|1|||
33537012|NCT01274533|101863997|FG000|Overall Study|Non-compliance|1|||
33537013|NCT01274533|101863997|FG000|Overall Study|Disease progression|2|||
33537014|NCT00617357|101864000|FG000|Overall Study|Lost to Follow-up|7|||
33537015|NCT00617357|101864000|FG000|Overall Study|Death|5|||
33537016|NCT00617357|101864000|FG000|Overall Study|insurance concerns|2|||
33537017|NCT00617357|101864000|FG000|Overall Study|Withdrawal by Subject|1|||
33537018|NCT00617357|101864000|FG000|Overall Study|Physician Decision|1|||
33340012|NCT01972074|101135923|FG002|Overall Study|Scanner Unavailable|1|||
33340013|NCT01294800|101135926|FG000|Overall Study|Adverse Event|7|||
33340014|NCT01294800|101135927|FG001|Overall Study|Adverse Event|6|||
33537019|NCT01545388|101864001|FG000|Overall Study|Adverse Event|2|||
33537020|NCT01545388|101864002|FG001|Overall Study|Adverse Event|4|||
33537021|NCT01545388|101864003|FG002|Overall Study|Adverse Event|1|||
33537022|NCT01545388|101864001|FG000|Overall Study|Lack of Efficacy|3|||
33537023|NCT01545388|101864002|FG001|Overall Study|Lack of Efficacy|2|||
33537024|NCT01545388|101864003|FG002|Overall Study|Lack of Efficacy|5|||
33537025|NCT01545388|101864001|FG000|Overall Study|Participant moved or relocated|1|||
33537026|NCT01545388|101864002|FG001|Overall Study|Participant moved or relocated|0|||
33537027|NCT01545388|101864003|FG002|Overall Study|Participant moved or relocated|0|||
33537028|NCT01545388|101864001|FG000|Overall Study|Withdrawal by Subject|1|||
33614397|NCT01393639|102137123|FG001|Overall Study|Withdrawal by Subject|1|||
33209010|NCT02911948|100665712|FG001|Overall Study|Withdrawal by Subject|2|||
33209011|NCT02911948|100665711|FG000|Overall Study|Lack of Efficacy|0|||
33209012|NCT02911948|100665712|FG001|Overall Study|Lack of Efficacy|1|||
33209013|NCT02911948|100665711|FG000|Overall Study|Unclassified|0|||
33209014|NCT02911948|100665712|FG001|Overall Study|Unclassified|3|||
33209015|NCT01972841|100665713|FG000|Overall Study|Randomized but Never Received Treatment|2|||
33209016|NCT01972841|100665714|FG001|Overall Study|Randomized but Never Received Treatment|5|||
33209017|NCT01972841|100665715|FG002|Overall Study|Randomized but Never Received Treatment|4|||
33209018|NCT01972841|100665716|FG003|Overall Study|Randomized but Never Received Treatment|2|||
33209019|NCT01972841|100665717|FG004|Overall Study|Randomized but Never Received Treatment|6|||
33209020|NCT01972841|100665718|FG005|Overall Study|Randomized but Never Received Treatment|13|||
33209021|NCT01972841|100665713|FG000|Overall Study|Adverse Event|13|||
33209022|NCT01972841|100665714|FG001|Overall Study|Adverse Event|8|||
33209023|NCT01972841|100665715|FG002|Overall Study|Adverse Event|12|||
33209024|NCT01972841|100665716|FG003|Overall Study|Adverse Event|9|||
33209025|NCT01972841|100665717|FG004|Overall Study|Adverse Event|21|||
33209026|NCT01972841|100665718|FG005|Overall Study|Adverse Event|26|||
33209027|NCT01972841|100665713|FG000|Overall Study|Lack of Efficacy|1|||
33209028|NCT01972841|100665714|FG001|Overall Study|Lack of Efficacy|0|||
33209029|NCT01972841|100665715|FG002|Overall Study|Lack of Efficacy|0|||
33209030|NCT01972841|100665716|FG003|Overall Study|Lack of Efficacy|2|||
33209031|NCT01972841|100665717|FG004|Overall Study|Lack of Efficacy|4|||
33340015|NCT01294800|101135928|FG002|Overall Study|Adverse Event|12|||
33340016|NCT01294800|101135929|FG003|Overall Study|Adverse Event|5|||
33340017|NCT01294800|101135926|FG000|Overall Study|Subject Withdrew Consent|2|||
33340018|NCT01294800|101135927|FG001|Overall Study|Subject Withdrew Consent|2|||
33405658|NCT01270139|101373459|FG000|Overall Study|Adverse Event|8|||
33405659|NCT01270139|101373460|FG001|Overall Study|Adverse Event|17|||
33405660|NCT01270139|101373461|FG002|Overall Study|Adverse Event|18|||
33209032|NCT01972841|100665718|FG005|Overall Study|Lack of Efficacy|1|||
33209033|NCT01972841|100665713|FG000|Overall Study|Lost to Follow-up|4|||
33209034|NCT01972841|100665714|FG001|Overall Study|Lost to Follow-up|2|||
33209035|NCT01972841|100665715|FG002|Overall Study|Lost to Follow-up|4|||
33537029|NCT01545388|101864002|FG001|Overall Study|Withdrawal by Subject|4|||
33537030|NCT01545388|101864003|FG002|Overall Study|Withdrawal by Subject|2|||
33537031|NCT01545388|101864001|FG000|Overall Study|Other|1|||
33537032|NCT01545388|101864002|FG001|Overall Study|Other|1|||
33537033|NCT01545388|101864003|FG002|Overall Study|Other|0|||
33537034|NCT01278342|101864004|FG000|Overall Study|Physician Decision|0|||
33537035|NCT01278342|101864005|FG001|Overall Study|Physician Decision|1|||
33209036|NCT01972841|100665716|FG003|Overall Study|Lost to Follow-up|2|||
33209037|NCT01972841|100665717|FG004|Overall Study|Lost to Follow-up|9|||
33209038|NCT01972841|100665718|FG005|Overall Study|Lost to Follow-up|3|||
33209039|NCT01972841|100665713|FG000|Overall Study|Protocol Violation|2|||
33405661|NCT01270139|101373459|FG000|Overall Study|Lost to Follow-up|10|||
33537036|NCT01278342|101864006|FG002|Overall Study|Physician Decision|0|||
33209040|NCT01972841|100665714|FG001|Overall Study|Protocol Violation|2|||
33209041|NCT01972841|100665715|FG002|Overall Study|Protocol Violation|3|||
33209042|NCT01972841|100665716|FG003|Overall Study|Protocol Violation|5|||
33209043|NCT01972841|100665717|FG004|Overall Study|Protocol Violation|9|||
33209044|NCT01972841|100665718|FG005|Overall Study|Protocol Violation|4|||
33209045|NCT01972841|100665713|FG000|Overall Study|Withdrawal by participants|21|||
33340019|NCT01294800|101135928|FG002|Overall Study|Subject Withdrew Consent|2|||
33340020|NCT01294800|101135929|FG003|Overall Study|Subject Withdrew Consent|11|||
33340021|NCT01294800|101135926|FG000|Overall Study|Lost to Follow-up|0|||
33340022|NCT01294800|101135927|FG001|Overall Study|Lost to Follow-up|0|||
33209046|NCT01972841|100665714|FG001|Overall Study|Withdrawal by participants|27|||
33209047|NCT01972841|100665715|FG002|Overall Study|Withdrawal by participants|23|||
33209048|NCT01972841|100665716|FG003|Overall Study|Withdrawal by participants|16|||
33209049|NCT01972841|100665717|FG004|Overall Study|Withdrawal by participants|33|||
33209050|NCT01972841|100665718|FG005|Overall Study|Withdrawal by participants|34|||
33209051|NCT01972841|100665713|FG000|Overall Study|Miscellaneous|0|||
33209052|NCT01972841|100665714|FG001|Overall Study|Miscellaneous|0|||
33209053|NCT01972841|100665715|FG002|Overall Study|Miscellaneous|4|||
33209054|NCT01972841|100665716|FG003|Overall Study|Miscellaneous|1|||
33209055|NCT01972841|100665717|FG004|Overall Study|Miscellaneous|0|||
33209056|NCT01972841|100665718|FG005|Overall Study|Miscellaneous|4|||
33209057|NCT01972841|100665713|FG000|Overall Study|Did not have end of treatment page|0|||
33209058|NCT01972841|100665714|FG001|Overall Study|Did not have end of treatment page|0|||
33209059|NCT01972841|100665715|FG002|Overall Study|Did not have end of treatment page|0|||
33209060|NCT01972841|100665716|FG003|Overall Study|Did not have end of treatment page|0|||
33209061|NCT01972841|100665717|FG004|Overall Study|Did not have end of treatment page|1|||
33209062|NCT01972841|100665718|FG005|Overall Study|Did not have end of treatment page|0|||
33209063|NCT02372409|100665721|FG000|Overall Study|Lost to Follow-up|1|||
33209064|NCT02372409|100665722|FG001|Overall Study|Lost to Follow-up|0|||
33340023|NCT01294800|101135928|FG002|Overall Study|Lost to Follow-up|1|||
33340024|NCT01294800|101135929|FG003|Overall Study|Lost to Follow-up|0|||
33340025|NCT01294800|101135926|FG000|Overall Study|Non-compliance With Protocol|0|||
33340026|NCT01294800|101135927|FG001|Overall Study|Non-compliance With Protocol|1|||
33340027|NCT01294800|101135928|FG002|Overall Study|Non-compliance With Protocol|1|||
33340028|NCT01294800|101135929|FG003|Overall Study|Non-compliance With Protocol|0|||
33537037|NCT01278342|101864004|FG000|Overall Study|Lost to Follow-up|1|||
33537038|NCT01278342|101864005|FG001|Overall Study|Lost to Follow-up|0|||
33537039|NCT01278342|101864006|FG002|Overall Study|Lost to Follow-up|0|||
33537040|NCT01278342|101864004|FG000|Overall Study|Administrative problems|2|||
33537041|NCT01278342|101864005|FG001|Overall Study|Administrative problems|0|||
33537042|NCT01278342|101864006|FG002|Overall Study|Administrative problems|0|||
33537043|NCT01278342|101864004|FG000|Overall Study|Other|1|||
33537044|NCT01278342|101864005|FG001|Overall Study|Other|0|||
33340029|NCT01294800|101135926|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
33340030|NCT01294800|101135927|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
33340031|NCT01294800|101135928|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
33340032|NCT01294800|101135929|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
33340033|NCT02432235|101135930|FG000|Overall Study|Death|1|||
33537045|NCT01278342|101864006|FG002|Overall Study|Other|0|||
33537046|NCT03044314|101864007|FG000|Overall Study|Physician Decision|2|||
33537047|NCT03044314|101864007|FG000|Overall Study|Withdrawal by Subject|1|||
33340034|NCT02432235|101135931|FG001|Overall Study|Death|1|||
33340035|NCT02432235|101135932|FG002|Overall Study|Death|2|||
33340036|NCT02432235|101135933|FG003|Overall Study|Death|2|||
33340037|NCT02432235|101135934|FG004|Overall Study|Death|1|||
33614398|NCT01393639|102137124|FG002|Overall Study|Withdrawal by Subject|0|||
33209065|NCT02372409|100665721|FG000|Overall Study|Disease progression|1|||
33209066|NCT02372409|100665722|FG001|Overall Study|Disease progression|1|||
33209067|NCT00476476|100665727|FG000|Overall Study|Adverse Event|2|||
33209068|NCT00476476|100665728|FG001|Overall Study|Adverse Event|7|||
33209069|NCT00476476|100665727|FG000|Overall Study|Progressive Disease|0|||
33209070|NCT00476476|100665728|FG001|Overall Study|Progressive Disease|17|||
33209071|NCT01343407|100665730|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
33209072|NCT01343407|100665731|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
33209073|NCT01343407|100665732|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
33340038|NCT02432235|101135935|FG005|Overall Study|Death|3|||
33340039|NCT02432235|101135936|FG006|Overall Study|Death|11|||
33340040|NCT02432235|101135937|FG007|Overall Study|Death|15|||
33340041|NCT02432235|101135938|FG008|Overall Study|Death|15|||
33209074|NCT01343407|100665733|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
33209075|NCT01343407|100665734|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
33209076|NCT01343407|100665735|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
33209077|NCT01343407|100665730|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
33209078|NCT01343407|100665731|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
33340042|NCT02432235|101135939|FG009|Overall Study|Death|3|||
33537048|NCT03044314|101864007|FG000|Overall Study|Connector tubing not available|1|||
33537049|NCT01251952|101864008|FG000|Overall Study|Adverse Event|1|||
33537050|NCT02563899|101864009|FG000|Overall Study|Protocol Violation|1|||
33209079|NCT01343407|100665732|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
33209080|NCT01343407|100665733|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
33209081|NCT01343407|100665734|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
33209082|NCT01343407|100665735|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
33209083|NCT01358968|100665741|FG000|Period 2|Adverse Event|0|||
33209084|NCT01358968|100665742|FG001|Period 2|Adverse Event|1|||
33209085|NCT01358968|100665743|FG002|Period 2|Adverse Event|0|||
33209086|NCT01358968|100665744|FG003|Period 2|Adverse Event|0|||
33209087|NCT01358968|100665741|FG000|Continued Access Phase|Progression of Disease|0|||
33209088|NCT01358968|100665742|FG001|Continued Access Phase|Progression of Disease|0|||
33209089|NCT01358968|100665743|FG002|Continued Access Phase|Progression of Disease|8|||
33209090|NCT01358968|100665744|FG003|Continued Access Phase|Progression of Disease|4|||
33537051|NCT02563899|101864010|FG001|Overall Study|Protocol Violation|0|||
33537052|NCT02563899|101864011|FG002|Overall Study|Protocol Violation|0|||
33537053|NCT02563899|101864012|FG003|Overall Study|Protocol Violation|0|||
33537054|NCT02563899|101864009|FG000|Overall Study|Withdrawal by Subject|0|||
33537055|NCT02563899|101864010|FG001|Overall Study|Withdrawal by Subject|0|||
33537056|NCT02563899|101864011|FG002|Overall Study|Withdrawal by Subject|1|||
33537057|NCT02563899|101864012|FG003|Overall Study|Withdrawal by Subject|0|||
33537058|NCT04069715|101864013|FG000|Overall Study|Lost to Follow-up|1|||
33537059|NCT04069715|101864014|FG001|Overall Study|Lost to Follow-up|1|||
33209091|NCT01358968|100665741|FG000|Continued Access Phase|Protocol Violation|0|||
33209092|NCT01358968|100665742|FG001|Continued Access Phase|Protocol Violation|0|||
33209093|NCT01358968|100665743|FG002|Continued Access Phase|Protocol Violation|0|||
33209094|NCT01358968|100665744|FG003|Continued Access Phase|Protocol Violation|2|||
33209095|NCT01358968|100665741|FG000|Continued Access Phase|Withdrawal by Subject|0|||
33209096|NCT01358968|100665742|FG001|Continued Access Phase|Withdrawal by Subject|0|||
33209097|NCT01358968|100665743|FG002|Continued Access Phase|Withdrawal by Subject|3|||
33209098|NCT01358968|100665744|FG003|Continued Access Phase|Withdrawal by Subject|0|||
33209099|NCT01358968|100665741|FG000|Continued Access Phase|Death|0|||
33405662|NCT01270139|101373460|FG001|Overall Study|Lost to Follow-up|9|||
33405663|NCT01270139|101373461|FG002|Overall Study|Lost to Follow-up|2|||
33405664|NCT02312934|101373462|FG000|Overall Study|Lost to Follow-up|1|||
33405665|NCT02312934|101373463|FG001|Overall Study|Lost to Follow-up|0|||
33537060|NCT04069715|101864013|FG000|Overall Study|Physician Decision|1|||
33209100|NCT01358968|100665742|FG001|Continued Access Phase|Death|0|||
33209101|NCT01358968|100665743|FG002|Continued Access Phase|Death|1|||
33209102|NCT01358968|100665744|FG003|Continued Access Phase|Death|1|||
33209103|NCT01302119|100665745|FG000|Overall Study|Withdrawal by Subject|30|||
33209104|NCT01302119|100665746|FG001|Overall Study|Withdrawal by Subject|20|||
33209105|NCT01302119|100665745|FG000|Overall Study|Lost to Follow-up|10|||
33209106|NCT01302119|100665746|FG001|Overall Study|Lost to Follow-up|4|||
33209107|NCT01302119|100665745|FG000|Overall Study|Adverse Event|2|||
33209108|NCT01302119|100665746|FG001|Overall Study|Adverse Event|1|||
33209109|NCT01302119|100665745|FG000|Overall Study|Non-compliance|4|||
33209110|NCT01302119|100665746|FG001|Overall Study|Non-compliance|2|||
33209111|NCT01302119|100665745|FG000|Overall Study|Non-specific|4|||
33537061|NCT04069715|101864014|FG001|Overall Study|Physician Decision|1|||
33537062|NCT04069715|101864013|FG000|Overall Study|Withdrawal by Subject|3|||
33209112|NCT01302119|100665746|FG001|Overall Study|Non-specific|1|||
33209113|NCT05239039|100665747|FG000|Overall Study|Withdrawal by Subject|0|||
33209114|NCT05239039|100665748|FG001|Overall Study|Withdrawal by Subject|1|||
33209115|NCT03586648|100665749|FG000|Period 1|Withdrawal by Subject|0|||
33209116|NCT03586648|100665750|FG001|Period 1|Withdrawal by Subject|1|||
33209117|NCT03586648|100665749|FG000|Period 1|Lost to Follow-up|1|||
33209118|NCT03586648|100665750|FG001|Period 1|Lost to Follow-up|1|||
33209119|NCT03586648|100665749|FG000|Period 1|Adverse Event|1|||
33209120|NCT03586648|100665750|FG001|Period 1|Adverse Event|0|||
33209121|NCT03586648|100665749|FG000|Period 1|Study related symptoms or complaints|2|||
33209122|NCT03586648|100665750|FG001|Period 1|Study related symptoms or complaints|1|||
33209123|NCT03586648|100665749|FG000|Period 1|Physician Decision|0|||
33209124|NCT03586648|100665750|FG001|Period 1|Physician Decision|1|||
33209125|NCT03586648|100665749|FG000|Period 2|Adverse Event|1|||
33209126|NCT03586648|100665750|FG001|Period 2|Adverse Event|0|||
33209127|NCT05046795|100670097|FG000|Overall Study|Adverse Event|13|||
33209128|NCT05046795|100670098|FG001|Overall Study|Adverse Event|15|||
33209129|NCT05046795|100670097|FG000|Overall Study|Withdrawal by Subject|4|||
33209130|NCT05046795|100670098|FG001|Overall Study|Withdrawal by Subject|7|||
33209131|NCT05046795|100670097|FG000|Overall Study|Physician Decision|1|||
33209132|NCT05046795|100670098|FG001|Overall Study|Physician Decision|2|||
33209133|NCT05046795|100670097|FG000|Overall Study|Protocol Violation|1|||
33209134|NCT05046795|100670098|FG001|Overall Study|Protocol Violation|2|||
33537063|NCT04069715|101864014|FG001|Overall Study|Withdrawal by Subject|3|||
33537064|NCT03299101|101864015|FG000|Overall Study|Lost to Follow-up|1|||
33537065|NCT03299101|101864015|FG000|Overall Study|Withdrawal by Subject|5|||
33209135|NCT05046795|100670097|FG000|Overall Study|Death|1|||
33209136|NCT05046795|100670098|FG001|Overall Study|Death|0|||
33340043|NCT02432235|101135940|FG010|Overall Study|Death|1|||
33209137|NCT05046795|100670097|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
33209138|NCT05046795|100670098|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
33209139|NCT01693120|100670100|FG000|Enrollment|Lost to Follow-up|1|||
33209140|NCT01693120|100670100|FG000|Enrollment|Withdrawal by Subject|10|||
33209141|NCT01693120|100670100|FG000|Enrollment|Protocol Violation|46|||
33209142|NCT01693120|100670100|FG000|Enrollment|Physician Decision|3|||
33209143|NCT01693120|100670100|FG000|Enrollment|Adverse Event|1|||
33209144|NCT01693120|100670100|FG000|Enrollment|Study closed|8|||
33209145|NCT01693120|100670100|FG000|Enrollment|Other|1|||
33209146|NCT01693120|100670100|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
33209147|NCT01693120|100670100|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
33209148|NCT01693120|100670100|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
33209149|NCT01693120|100670100|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
33209150|NCT01693120|100670100|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
33209151|NCT04302350|100670103|FG000|Overall Study|Physician Decision|1|||
33209152|NCT04302350|100670104|FG001|Overall Study|Physician Decision|1|||
33209153|NCT04302350|100670105|FG002|Overall Study|Physician Decision|2|||
33209154|NCT04302350|100670103|FG000|Overall Study|Lack of Efficacy|1|||
33209155|NCT04302350|100670104|FG001|Overall Study|Lack of Efficacy|1|||
33209156|NCT04302350|100670105|FG002|Overall Study|Lack of Efficacy|4|||
33209157|NCT04302350|100670103|FG000|Overall Study|Adverse Event|0|||
33209158|NCT04302350|100670104|FG001|Overall Study|Adverse Event|1|||
33209159|NCT04302350|100670105|FG002|Overall Study|Adverse Event|2|||
33209160|NCT00492284|100670106|FG000|Overall Study|Adverse Event|0|||
33209161|NCT00492284|100670107|FG001|Overall Study|Adverse Event|1|||
33209162|NCT00492284|100670108|FG002|Overall Study|Adverse Event|1|||
33209163|NCT00492284|100670109|FG003|Overall Study|Adverse Event|2|||
33209164|NCT00492284|100670106|FG000|Overall Study|Lost to Follow-up|0|||
33209165|NCT00492284|100670107|FG001|Overall Study|Lost to Follow-up|0|||
33209166|NCT00492284|100670108|FG002|Overall Study|Lost to Follow-up|3|||
33209167|NCT00492284|100670109|FG003|Overall Study|Lost to Follow-up|1|||
33209168|NCT00492284|100670106|FG000|Overall Study|Death|0|||
33209169|NCT00492284|100670107|FG001|Overall Study|Death|3|||
33209170|NCT00492284|100670108|FG002|Overall Study|Death|2|||
33209171|NCT00492284|100670109|FG003|Overall Study|Death|5|||
33209172|NCT00492284|100670106|FG000|Overall Study|Withdrawal by Subject|1|||
33209173|NCT00492284|100670107|FG001|Overall Study|Withdrawal by Subject|0|||
33209174|NCT00492284|100670108|FG002|Overall Study|Withdrawal by Subject|0|||
33209175|NCT00492284|100670109|FG003|Overall Study|Withdrawal by Subject|2|||
33209176|NCT01275625|100670110|FG000|Overall Study|Death|1|||
33209177|NCT01275625|100670110|FG000|Overall Study|Lack of Efficacy|2|||
33209178|NCT01275625|100670110|FG000|Overall Study|Lost to Follow-up|1|||
33209179|NCT01275625|100670110|FG000|Overall Study|Withdrawal by Subject|3|||
33209180|NCT01275625|100670110|FG000|Overall Study|Protocol Violation|1|||
33209181|NCT01275625|100670110|FG000|Overall Study|Adverse Event|4|||
33209182|NCT01275625|100670110|FG000|Overall Study|Other|1|||
33209183|NCT02062632|100670111|FG000|Overall Study|No treatment data|1|||
33209184|NCT05557942|100670122|FG000|Overall Study|Death|0|||
33209185|NCT05557942|100670123|FG001|Overall Study|Death|0|||
33209186|NCT05557942|100670124|FG002|Overall Study|Death|0|||
33209187|NCT05557942|100670125|FG003|Overall Study|Death|2|||
33209188|NCT05557942|100670126|FG004|Overall Study|Death|1|||
33209189|NCT05557942|100670127|FG005|Overall Study|Death|1|||
33209190|NCT05557942|100670122|FG000|Overall Study|Physician Decision|1|||
33209191|NCT05557942|100670123|FG001|Overall Study|Physician Decision|1|||
33209192|NCT05557942|100670124|FG002|Overall Study|Physician Decision|2|||
33209193|NCT05557942|100670125|FG003|Overall Study|Physician Decision|3|||
33340044|NCT02432235|101135941|FG011|Overall Study|Death|0|||
33340045|NCT02432235|101135930|FG000|Overall Study|Withdrawal by Subject|0|||
33340046|NCT02432235|101135931|FG001|Overall Study|Withdrawal by Subject|1|||
33209194|NCT05557942|100670126|FG004|Overall Study|Physician Decision|0|||
33209195|NCT05557942|100670127|FG005|Overall Study|Physician Decision|2|||
33340047|NCT02432235|101135932|FG002|Overall Study|Withdrawal by Subject|0|||
33209196|NCT05557942|100670122|FG000|Overall Study|Study terminated by sponsor|17|||
33209197|NCT05557942|100670123|FG001|Overall Study|Study terminated by sponsor|17|||
33209198|NCT05557942|100670124|FG002|Overall Study|Study terminated by sponsor|14|||
33209199|NCT05557942|100670125|FG003|Overall Study|Study terminated by sponsor|40|||
33340048|NCT02432235|101135933|FG003|Overall Study|Withdrawal by Subject|0|||
33209200|NCT05557942|100670126|FG004|Overall Study|Study terminated by sponsor|45|||
33209201|NCT05557942|100670127|FG005|Overall Study|Study terminated by sponsor|37|||
33209202|NCT05557942|100670122|FG000|Overall Study|Protocol Violation|0|||
33340049|NCT02432235|101135934|FG004|Overall Study|Withdrawal by Subject|0|||
33340050|NCT02432235|101135935|FG005|Overall Study|Withdrawal by Subject|2|||
33209203|NCT05557942|100670123|FG001|Overall Study|Protocol Violation|0|||
33209204|NCT05557942|100670124|FG002|Overall Study|Protocol Violation|0|||
33209205|NCT05557942|100670125|FG003|Overall Study|Protocol Violation|0|||
33209206|NCT05557942|100670126|FG004|Overall Study|Protocol Violation|0|||
33209207|NCT05557942|100670127|FG005|Overall Study|Protocol Violation|1|||
33340051|NCT02432235|101135936|FG006|Overall Study|Withdrawal by Subject|5|||
33537066|NCT03299101|101864015|FG000|Overall Study|Surgery was changed|3|||
33537067|NCT03299101|101864015|FG000|Overall Study|Not enough time to complete prehab|1|||
33537068|NCT01239797|101864021|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
33537069|NCT01239797|101864022|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
33537070|NCT01239797|101864021|FG000|Randomized Participants|Participant withdrew consent|1|||
33537071|NCT01239797|101864022|FG001|Randomized Participants|Participant withdrew consent|7|||
33537072|NCT01239797|101864021|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
33537073|NCT01239797|101864022|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
33537074|NCT01239797|101864021|FG000|Treated Participants|Disease progression|185|||
33209208|NCT05557942|100670122|FG000|Overall Study|Withdrawal by Subject|0|||
33209209|NCT05557942|100670123|FG001|Overall Study|Withdrawal by Subject|0|||
33209210|NCT05557942|100670124|FG002|Overall Study|Withdrawal by Subject|0|||
33209211|NCT05557942|100670125|FG003|Overall Study|Withdrawal by Subject|0|||
33209212|NCT05557942|100670126|FG004|Overall Study|Withdrawal by Subject|2|||
33209213|NCT05557942|100670127|FG005|Overall Study|Withdrawal by Subject|0|||
33209214|NCT02148250|100670128|FG000|Screening|Withdrawal by Subject|5|||
33209215|NCT02148250|100670129|FG001|Screening|Withdrawal by Subject|0|||
33209216|NCT02232893|100670130|FG000|Overall Study|Withdrawal by Subject|4|||
33209217|NCT02232893|100670131|FG001|Overall Study|Withdrawal by Subject|1|||
33209218|NCT02232893|100670130|FG000|Overall Study|Adverse Event|0|||
33209219|NCT02232893|100670131|FG001|Overall Study|Adverse Event|1|||
33209220|NCT02232893|100670130|FG000|Overall Study|Sponsor request early termination|0|||
33209221|NCT02232893|100670131|FG001|Overall Study|Sponsor request early termination|1|||
33209222|NCT02232893|100670130|FG000|Overall Study|Developed exclusion criteria|0|||
33209223|NCT02232893|100670131|FG001|Overall Study|Developed exclusion criteria|1|||
33209224|NCT02232893|100670130|FG000|Overall Study|Other|0|||
33209225|NCT02232893|100670131|FG001|Overall Study|Other|3|||
33209226|NCT04537923|100670132|FG000|Overall Study|Adverse Event|2|||
33209227|NCT04537923|100670133|FG001|Overall Study|Adverse Event|1|||
33209228|NCT04537923|100670134|FG002|Overall Study|Adverse Event|2|||
33209229|NCT04537923|100670135|FG003|Overall Study|Adverse Event|4|||
33209230|NCT04537923|100670132|FG000|Overall Study|Death|3|||
33537075|NCT01239797|101864022|FG001|Treated Participants|Disease progression|185|||
33537076|NCT01239797|101864021|FG000|Treated Participants|Study drug toxicity|39|||
33537077|NCT01239797|101864022|FG001|Treated Participants|Study drug toxicity|45|||
33537078|NCT01239797|101864021|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
33537079|NCT01239797|101864022|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
33537080|NCT01239797|101864021|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
33537081|NCT01239797|101864022|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
33537082|NCT01239797|101864021|FG000|Treated Participants|Administrative reason by sponsor|13|||
33537083|NCT01239797|101864022|FG001|Treated Participants|Administrative reason by sponsor|4|||
33537084|NCT01239797|101864021|FG000|Treated Participants|Other reasons|14|||
33537085|NCT01239797|101864022|FG001|Treated Participants|Other reasons|14|||
33537086|NCT01239797|101864021|FG000|Treated Participants|Participant withdrew consent|6|||
33209231|NCT04537923|100670133|FG001|Overall Study|Death|3|||
33209232|NCT04537923|100670134|FG002|Overall Study|Death|1|||
33209233|NCT04537923|100670135|FG003|Overall Study|Death|11|||
33209234|NCT04537923|100670132|FG000|Overall Study|Lost to Follow-up|1|||
33209235|NCT04537923|100670133|FG001|Overall Study|Lost to Follow-up|2|||
33209236|NCT04537923|100670134|FG002|Overall Study|Lost to Follow-up|1|||
33209237|NCT04537923|100670135|FG003|Overall Study|Lost to Follow-up|6|||
33209238|NCT04537923|100670132|FG000|Overall Study|Physician Decision|1|||
33209239|NCT04537923|100670133|FG001|Overall Study|Physician Decision|0|||
33209240|NCT04537923|100670134|FG002|Overall Study|Physician Decision|2|||
33209241|NCT04537923|100670135|FG003|Overall Study|Physician Decision|5|||
33209242|NCT04537923|100670132|FG000|Overall Study|Pregnancy|1|||
33209243|NCT04537923|100670133|FG001|Overall Study|Pregnancy|0|||
33209244|NCT04537923|100670134|FG002|Overall Study|Pregnancy|0|||
33209245|NCT04537923|100670135|FG003|Overall Study|Pregnancy|0|||
33209246|NCT04537923|100670132|FG000|Overall Study|Withdrawal by Subject|4|||
33209247|NCT04537923|100670133|FG001|Overall Study|Withdrawal by Subject|4|||
33209248|NCT04537923|100670134|FG002|Overall Study|Withdrawal by Subject|4|||
33209249|NCT04537923|100670135|FG003|Overall Study|Withdrawal by Subject|58|||
33209250|NCT04537923|100670132|FG000|Overall Study|Missed study visits|2|||
33209251|NCT04537923|100670133|FG001|Overall Study|Missed study visits|0|||
33209252|NCT04537923|100670134|FG002|Overall Study|Missed study visits|0|||
33209253|NCT04537923|100670135|FG003|Overall Study|Missed study visits|3|||
33209254|NCT04537923|100670132|FG000|Overall Study|Sponsor's decision|0|||
33209255|NCT04537923|100670133|FG001|Overall Study|Sponsor's decision|0|||
33209256|NCT04537923|100670134|FG002|Overall Study|Sponsor's decision|1|||
33209257|NCT04537923|100670135|FG003|Overall Study|Sponsor's decision|1|||
33537087|NCT01239797|101864022|FG001|Treated Participants|Participant withdrew consent|11|||
33537088|NCT01239797|101864021|FG000|Treated Participants|Death|1|||
33209258|NCT04537923|100670132|FG000|Overall Study|Safety reasons|1|||
33209259|NCT04537923|100670133|FG001|Overall Study|Safety reasons|0|||
33209260|NCT04537923|100670134|FG002|Overall Study|Safety reasons|0|||
33209261|NCT04537923|100670135|FG003|Overall Study|Safety reasons|0|||
33209262|NCT00725296|100670138|FG000|Overall Study|Adverse Event|11|||
33209263|NCT00725296|100670138|FG000|Overall Study|Lack of Efficacy|7|||
33209264|NCT00725296|100670138|FG000|Overall Study|Withdrawal by Subject|3|||
33209265|NCT00725296|100670138|FG000|Overall Study|Non-Compliance|2|||
33209266|NCT00725296|100670138|FG000|Overall Study|Lost to Follow-up|1|||
33209267|NCT00725296|100670138|FG000|Overall Study|Other|38|||
33209268|NCT00047879|100670139|FG000|Overall Study|Progressive disease|4|||
33209269|NCT00047879|100670140|FG001|Overall Study|Progressive disease|3|||
33209270|NCT02216123|100670141|FG000|Overall Study|Lost to Follow-up|4|||
33209271|NCT02216123|100670142|FG001|Overall Study|Lost to Follow-up|2|||
33209272|NCT02216123|100670141|FG000|Overall Study|Withdrawal by Subject|2|||
33209273|NCT02216123|100670142|FG001|Overall Study|Withdrawal by Subject|0|||
33209274|NCT02130193|100670145|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
33209275|NCT02130193|100670146|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
33209276|NCT02130193|100670147|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
33537089|NCT01239797|101864022|FG001|Treated Participants|Death|1|||
33537090|NCT01239797|101864021|FG000|Treated Participants|Participant no longer meets study criteria|1|||
33209277|NCT02130193|100670145|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
33209278|NCT02130193|100670146|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
33209279|NCT02130193|100670147|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
33209280|NCT02130193|100670145|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
33209281|NCT02130193|100670146|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
33209282|NCT02130193|100670147|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
33209283|NCT02130193|100670145|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
33209284|NCT02130193|100670146|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
33209285|NCT02130193|100670147|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
33209286|NCT02363946|100670153|FG000|Overall Study|Lost to Follow-up|0|||
33209287|NCT02363946|100670154|FG001|Overall Study|Lost to Follow-up|0|||
33209288|NCT02363946|100670155|FG002|Overall Study|Lost to Follow-up|0|||
33209289|NCT02363946|100670156|FG003|Overall Study|Lost to Follow-up|0|||
33209290|NCT02363946|100670157|FG004|Overall Study|Lost to Follow-up|0|||
33209291|NCT02363946|100670158|FG005|Overall Study|Lost to Follow-up|0|||
33209292|NCT02363946|100670159|FG006|Overall Study|Lost to Follow-up|0|||
33209293|NCT02363946|100670160|FG007|Overall Study|Lost to Follow-up|1|||
33209294|NCT02363946|100670161|FG008|Overall Study|Lost to Follow-up|0|||
33340052|NCT02432235|101135937|FG007|Overall Study|Withdrawal by Subject|3|||
33537091|NCT01239797|101864022|FG001|Treated Participants|Participant no longer meets study criteria|1|||
33537092|NCT01239797|101864021|FG000|Treated Participants|Poor/non-compliance|0|||
33537093|NCT01239797|101864022|FG001|Treated Participants|Poor/non-compliance|1|||
33537094|NCT02404545|101864023|FG000|Overall Study|Sponsor Termination|6|||
33537095|NCT02404545|101864024|FG001|Overall Study|Sponsor Termination|6|||
33537096|NCT01614470|101864027|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
33537097|NCT01614470|101864028|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
33537098|NCT01614470|101864029|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
33537099|NCT01614470|101864027|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
33537100|NCT01614470|101864028|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
33537101|NCT01614470|101864029|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
33537102|NCT01022203|101864030|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
33537103|NCT01022203|101864031|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
33537104|NCT01022203|101864030|FG000|Post Treatment Assessment|Physician Decision|2|||
33537105|NCT01022203|101864031|FG001|Post Treatment Assessment|Physician Decision|0|||
33537106|NCT01022203|101864030|FG000|Post Treatment Assessment|Adverse Event|0|||
33537107|NCT01022203|101864031|FG001|Post Treatment Assessment|Adverse Event|2|||
33537108|NCT01022203|101864030|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
33537109|NCT01022203|101864031|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
33537110|NCT00749398|101864032|FG000|Overall Study|Lack of Efficacy|7|||
33340053|NCT02432235|101135938|FG008|Overall Study|Withdrawal by Subject|1|||
33537111|NCT00749398|101864032|FG000|Overall Study|Adverse Event|4|||
33537112|NCT00749398|101864032|FG000|Overall Study|Serious adverse event|11|||
33537113|NCT00749398|101864032|FG000|Overall Study|Withdrawal by Subject|17|||
33537114|NCT00749398|101864032|FG000|Overall Study|Lost to Follow-up|11|||
33340054|NCT02432235|101135939|FG009|Overall Study|Withdrawal by Subject|0|||
33340055|NCT02432235|101135940|FG010|Overall Study|Withdrawal by Subject|0|||
33340056|NCT02432235|101135941|FG011|Overall Study|Withdrawal by Subject|0|||
33209295|NCT02363946|100670162|FG009|Overall Study|Lost to Follow-up|0|||
33340057|NCT02432235|101135930|FG000|Overall Study|Lost to Follow-up|0|||
33340058|NCT02432235|101135931|FG001|Overall Study|Lost to Follow-up|0|||
33340059|NCT02432235|101135932|FG002|Overall Study|Lost to Follow-up|0|||
33340060|NCT02432235|101135933|FG003|Overall Study|Lost to Follow-up|0|||
33340061|NCT02432235|101135934|FG004|Overall Study|Lost to Follow-up|0|||
33340062|NCT02432235|101135935|FG005|Overall Study|Lost to Follow-up|1|||
33340063|NCT02432235|101135936|FG006|Overall Study|Lost to Follow-up|0|||
33340064|NCT02432235|101135937|FG007|Overall Study|Lost to Follow-up|0|||
33340065|NCT02432235|101135938|FG008|Overall Study|Lost to Follow-up|1|||
33340066|NCT02432235|101135939|FG009|Overall Study|Lost to Follow-up|0|||
33340067|NCT02432235|101135940|FG010|Overall Study|Lost to Follow-up|0|||
33340068|NCT02432235|101135941|FG011|Overall Study|Lost to Follow-up|0|||
33340069|NCT02432235|101135930|FG000|Overall Study|Miscellaneous|0|||
33537115|NCT00749398|101864032|FG000|Overall Study|Reason not specified|2|||
33405666|NCT02312934|101373462|FG000|Overall Study|Physician Decision|1|||
33340070|NCT02432235|101135931|FG001|Overall Study|Miscellaneous|0|||
33209296|NCT02363946|100670163|FG010|Overall Study|Lost to Follow-up|0|||
33209297|NCT02363946|100670164|FG011|Overall Study|Lost to Follow-up|0|||
33209298|NCT02363946|100670165|FG012|Overall Study|Lost to Follow-up|0|||
33209299|NCT01983293|100670166|FG000|Overall Study|Withdrawal by Subject|29|||
33537116|NCT00749398|101864032|FG000|Overall Study|Unknown reason|1|||
33537117|NCT00264147|101864033|FG000|Treatment I Period|Adverse Event|3|||
33537118|NCT00264147|101864034|FG001|Treatment I Period|Adverse Event|6|||
33537119|NCT00264147|101864035|FG002|Treatment I Period|Adverse Event|3|||
33537120|NCT00264147|101864036|FG003|Treatment I Period|Adverse Event|5|||
33537121|NCT00264147|101864037|FG004|Treatment I Period|Adverse Event|7|||
33537122|NCT00264147|101864038|FG005|Treatment I Period|Adverse Event|0|||
33537123|NCT00264147|101864033|FG000|Treatment I Period|Laboratory Adverse Event|0|||
33537124|NCT00264147|101864034|FG001|Treatment I Period|Laboratory Adverse Event|0|||
33537125|NCT00264147|101864035|FG002|Treatment I Period|Laboratory Adverse Event|0|||
33537126|NCT00264147|101864036|FG003|Treatment I Period|Laboratory Adverse Event|1|||
33537127|NCT00264147|101864037|FG004|Treatment I Period|Laboratory Adverse Event|0|||
33537128|NCT00264147|101864038|FG005|Treatment I Period|Laboratory Adverse Event|0|||
33537129|NCT00264147|101864033|FG000|Treatment I Period|Lack of Efficacy|6|||
33537130|NCT00264147|101864034|FG001|Treatment I Period|Lack of Efficacy|2|||
33537131|NCT00264147|101864035|FG002|Treatment I Period|Lack of Efficacy|8|||
33537132|NCT00264147|101864036|FG003|Treatment I Period|Lack of Efficacy|0|||
33537133|NCT00264147|101864037|FG004|Treatment I Period|Lack of Efficacy|1|||
33537134|NCT00264147|101864038|FG005|Treatment I Period|Lack of Efficacy|0|||
33537135|NCT00264147|101864033|FG000|Treatment I Period|Lost to Follow-up|1|||
33537136|NCT00264147|101864034|FG001|Treatment I Period|Lost to Follow-up|0|||
33537137|NCT00264147|101864035|FG002|Treatment I Period|Lost to Follow-up|0|||
33537138|NCT00264147|101864036|FG003|Treatment I Period|Lost to Follow-up|1|||
33340071|NCT02432235|101135932|FG002|Overall Study|Miscellaneous|0|||
33340072|NCT02432235|101135933|FG003|Overall Study|Miscellaneous|0|||
33340073|NCT02432235|101135934|FG004|Overall Study|Miscellaneous|1|||
33340074|NCT02432235|101135935|FG005|Overall Study|Miscellaneous|6|||
33340075|NCT02432235|101135936|FG006|Overall Study|Miscellaneous|2|||
33340076|NCT02432235|101135937|FG007|Overall Study|Miscellaneous|2|||
33340077|NCT02432235|101135938|FG008|Overall Study|Miscellaneous|4|||
33340078|NCT02432235|101135939|FG009|Overall Study|Miscellaneous|0|||
33340079|NCT02432235|101135940|FG010|Overall Study|Miscellaneous|0|||
33340080|NCT02432235|101135941|FG011|Overall Study|Miscellaneous|1|||
33405667|NCT02312934|101373463|FG001|Overall Study|Physician Decision|0|||
33405668|NCT00125138|101373464|FG000|Overall Study|Adverse Event|1|||
33209300|NCT01983293|100670167|FG001|Overall Study|Withdrawal by Subject|15|||
33340081|NCT01913483|101135942|FG000|Overall Study|Withdrawal by Subject|1|||
33340082|NCT01913483|101135943|FG001|Overall Study|Withdrawal by Subject|2|||
33209301|NCT01983293|100670166|FG000|Overall Study|Missing 12-month visit|3|||
33209302|NCT01983293|100670167|FG001|Overall Study|Missing 12-month visit|3|||
33209303|NCT01983293|100670166|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
33209304|NCT01983293|100670167|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
33209305|NCT03585244|100670169|FG000|Overall Study|Withdrawal by Subject|15|||
33209306|NCT02412137|100670170|FG000|Overall Study|Withdrawal by Subject|2|||
33209307|NCT02412137|100670171|FG001|Overall Study|Withdrawal by Subject|0|||
33209308|NCT02412137|100670170|FG000|Overall Study|Lost to Follow-up|21|||
33209309|NCT02412137|100670171|FG001|Overall Study|Lost to Follow-up|14|||
33209310|NCT02412137|100670170|FG000|Overall Study|Physician Decision|28|||
33209311|NCT02412137|100670171|FG001|Overall Study|Physician Decision|9|||
33537139|NCT00264147|101864037|FG004|Treatment I Period|Lost to Follow-up|1|||
33537140|NCT00264147|101864038|FG005|Treatment I Period|Lost to Follow-up|0|||
33537141|NCT00264147|101864033|FG000|Treatment I Period|Protocol Violation|2|||
33537142|NCT00264147|101864034|FG001|Treatment I Period|Protocol Violation|2|||
33209312|NCT00489970|100670172|FG000|Persistence Year 9|Lost to Follow-up|2|||
33209313|NCT00489970|100670173|FG001|Persistence Year 9|Lost to Follow-up|2|||
33340083|NCT01913483|101135942|FG000|Overall Study|Lost to Follow-up|6|||
33405669|NCT00125138|101373465|FG001|Overall Study|Adverse Event|0|||
33537143|NCT00264147|101864035|FG002|Treatment I Period|Protocol Violation|0|||
33537144|NCT00264147|101864036|FG003|Treatment I Period|Protocol Violation|0|||
33537145|NCT00264147|101864037|FG004|Treatment I Period|Protocol Violation|0|||
33537146|NCT00264147|101864038|FG005|Treatment I Period|Protocol Violation|0|||
33537147|NCT00264147|101864033|FG000|Treatment I Period|Withdrawal by Subject|2|||
33537148|NCT00264147|101864034|FG001|Treatment I Period|Withdrawal by Subject|0|||
33537149|NCT00264147|101864035|FG002|Treatment I Period|Withdrawal by Subject|0|||
33537150|NCT00264147|101864036|FG003|Treatment I Period|Withdrawal by Subject|2|||
33537151|NCT00264147|101864037|FG004|Treatment I Period|Withdrawal by Subject|2|||
33537152|NCT00264147|101864038|FG005|Treatment I Period|Withdrawal by Subject|0|||
33537153|NCT00264147|101864033|FG000|Treatment I Period|Patient out of town for an extended time|0|||
33537154|NCT00264147|101864034|FG001|Treatment I Period|Patient out of town for an extended time|1|||
33537155|NCT00264147|101864035|FG002|Treatment I Period|Patient out of town for an extended time|0|||
33537156|NCT00264147|101864036|FG003|Treatment I Period|Patient out of town for an extended time|0|||
33537157|NCT00264147|101864037|FG004|Treatment I Period|Patient out of town for an extended time|0|||
33537158|NCT00264147|101864038|FG005|Treatment I Period|Patient out of town for an extended time|0|||
33537159|NCT00264147|101864033|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
33537160|NCT00264147|101864034|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
33537161|NCT00264147|101864035|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
33537162|NCT00264147|101864036|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
33537163|NCT00264147|101864037|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
33537164|NCT00264147|101864038|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
33537165|NCT00264147|101864033|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
33537166|NCT00264147|101864034|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
33537167|NCT00264147|101864035|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
33537168|NCT00264147|101864036|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
33537169|NCT00264147|101864037|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
33537170|NCT00264147|101864038|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
33537171|NCT00264147|101864033|FG000|Treatment II Period|Adverse Event|0|||
33537172|NCT00264147|101864034|FG001|Treatment II Period|Adverse Event|0|||
33537173|NCT00264147|101864035|FG002|Treatment II Period|Adverse Event|0|||
33537174|NCT00264147|101864036|FG003|Treatment II Period|Adverse Event|0|||
33537175|NCT00264147|101864037|FG004|Treatment II Period|Adverse Event|9|||
33537176|NCT00264147|101864038|FG005|Treatment II Period|Adverse Event|9|||
33537177|NCT00264147|101864033|FG000|Treatment II Period|Laboratory Adverse Event|0|||
33537178|NCT00264147|101864034|FG001|Treatment II Period|Laboratory Adverse Event|0|||
33537179|NCT00264147|101864035|FG002|Treatment II Period|Laboratory Adverse Event|0|||
33537180|NCT00264147|101864036|FG003|Treatment II Period|Laboratory Adverse Event|0|||
33537181|NCT00264147|101864037|FG004|Treatment II Period|Laboratory Adverse Event|0|||
33537182|NCT00264147|101864038|FG005|Treatment II Period|Laboratory Adverse Event|1|||
33537183|NCT00264147|101864033|FG000|Treatment II Period|Lack of Efficacy|0|||
33537184|NCT00264147|101864034|FG001|Treatment II Period|Lack of Efficacy|0|||
33537185|NCT00264147|101864035|FG002|Treatment II Period|Lack of Efficacy|0|||
33537186|NCT00264147|101864036|FG003|Treatment II Period|Lack of Efficacy|0|||
33537187|NCT00264147|101864037|FG004|Treatment II Period|Lack of Efficacy|20|||
33537188|NCT00264147|101864038|FG005|Treatment II Period|Lack of Efficacy|19|||
33537189|NCT00264147|101864033|FG000|Treatment II Period|Lost to Follow-up|0|||
33537190|NCT00264147|101864034|FG001|Treatment II Period|Lost to Follow-up|0|||
33537191|NCT00264147|101864035|FG002|Treatment II Period|Lost to Follow-up|0|||
33537192|NCT00264147|101864036|FG003|Treatment II Period|Lost to Follow-up|0|||
33537193|NCT00264147|101864037|FG004|Treatment II Period|Lost to Follow-up|1|||
33537194|NCT00264147|101864038|FG005|Treatment II Period|Lost to Follow-up|1|||
33537195|NCT00264147|101864033|FG000|Treatment II Period|Withdrawal by Subject|0|||
33537196|NCT00264147|101864034|FG001|Treatment II Period|Withdrawal by Subject|0|||
33537197|NCT00264147|101864035|FG002|Treatment II Period|Withdrawal by Subject|0|||
33537198|NCT00264147|101864036|FG003|Treatment II Period|Withdrawal by Subject|0|||
33537199|NCT00264147|101864037|FG004|Treatment II Period|Withdrawal by Subject|3|||
33537200|NCT00264147|101864038|FG005|Treatment II Period|Withdrawal by Subject|2|||
33537201|NCT00264147|101864033|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
33537202|NCT00264147|101864034|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
33537203|NCT00264147|101864035|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
33537204|NCT00264147|101864036|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
33340084|NCT01913483|101135943|FG001|Overall Study|Lost to Follow-up|3|||
33340085|NCT01913483|101135942|FG000|Overall Study|Death|14|||
33340086|NCT01913483|101135943|FG001|Overall Study|Death|17|||
33537205|NCT00264147|101864037|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
33537206|NCT00264147|101864038|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
33537207|NCT02460289|101864045|FG000|Overall Study|Adverse Event|1|||
33340087|NCT02926950|101135946|FG000|Overall Study|Adverse Event|4|||
33537208|NCT02460289|101864045|FG000|Overall Study|Withdrawal by Subject|8|||
33537209|NCT02460289|101864045|FG000|Overall Study|Lost to Follow-up|1|||
33537210|NCT01855958|101864046|FG000|Overall Study|Withdrawal by Subject|1|||
33209314|NCT00489970|100670174|FG002|Persistence Year 9|Lost to Follow-up|3|||
33209315|NCT00489970|100670172|FG000|Persistence Year 9|Other|1|||
33209316|NCT00489970|100670173|FG001|Persistence Year 9|Other|0|||
33209317|NCT00489970|100670174|FG002|Persistence Year 9|Other|2|||
33209318|NCT03252587|100670175|FG000|Overall Study|Adverse Event|3|||
33209319|NCT03252587|100670176|FG001|Overall Study|Adverse Event|8|||
33209320|NCT03252587|100670177|FG002|Overall Study|Adverse Event|6|||
33340088|NCT02926950|101135947|FG001|Overall Study|Adverse Event|6|||
33340089|NCT02926950|101135946|FG000|Overall Study|At the participant's own request|21|||
33340090|NCT02926950|101135947|FG001|Overall Study|At the participant's own request|25|||
33340091|NCT02926950|101135946|FG000|Overall Study|Reason not Specified|17|||
33340092|NCT02926950|101135947|FG001|Overall Study|Reason not Specified|9|||
33340093|NCT02926950|101135946|FG000|Overall Study|Lost to Follow-up|7|||
33340094|NCT02926950|101135947|FG001|Overall Study|Lost to Follow-up|8|||
33340095|NCT00608985|101135948|FG000|Overall Study|Adverse Event|2|||
33340096|NCT00608985|101135949|FG001|Overall Study|Adverse Event|7|||
33340097|NCT00608985|101135950|FG002|Overall Study|Adverse Event|4|||
33340098|NCT00608985|101135951|FG003|Overall Study|Adverse Event|6|||
33340099|NCT00608985|101135948|FG000|Overall Study|Administrative/Other|7|||
33340100|NCT00608985|101135949|FG001|Overall Study|Administrative/Other|4|||
33340101|NCT00608985|101135950|FG002|Overall Study|Administrative/Other|1|||
33340102|NCT00608985|101135951|FG003|Overall Study|Administrative/Other|2|||
33340103|NCT00608985|101135948|FG000|Overall Study|Withdrawal of Consent|5|||
33340104|NCT00608985|101135949|FG001|Overall Study|Withdrawal of Consent|1|||
33340105|NCT00608985|101135950|FG002|Overall Study|Withdrawal of Consent|1|||
33340106|NCT00608985|101135951|FG003|Overall Study|Withdrawal of Consent|1|||
33340107|NCT00608985|101135948|FG000|Overall Study|Lost to Follow-up|2|||
33340108|NCT00608985|101135949|FG001|Overall Study|Lost to Follow-up|1|||
33340109|NCT00608985|101135950|FG002|Overall Study|Lost to Follow-up|0|||
33340110|NCT00608985|101135951|FG003|Overall Study|Lost to Follow-up|0|||
33340111|NCT01430442|101135954|FG000|Overall Study|Subject Withdrew Consent|3|||
33537211|NCT01855958|101864047|FG001|Overall Study|Withdrawal by Subject|0|||
33537212|NCT00871234|101864048|FG000|Overall Study|Adverse Event|2|||
33537213|NCT00871234|101864048|FG000|Overall Study|Lost to Follow-up|3|||
33537214|NCT01405560|101864049|FG000|Overall Study|Physician Decision|1|||
33537215|NCT01064479|101864051|FG000|Overall Study|Death|10|||
33537216|NCT01064479|101864052|FG001|Overall Study|Death|11|||
33537217|NCT01064479|101864051|FG000|Overall Study|Withdrawal by Subject|2|||
33537218|NCT01064479|101864052|FG001|Overall Study|Withdrawal by Subject|2|||
33537219|NCT01064479|101864051|FG000|Overall Study|Disease progression|1|||
33537220|NCT01064479|101864052|FG001|Overall Study|Disease progression|1|||
33537221|NCT01064479|101864051|FG000|Overall Study|Toxicity|1|||
33537222|NCT01064479|101864052|FG001|Overall Study|Toxicity|1|||
33537223|NCT01064479|101864051|FG000|Overall Study|Other|1|||
33537224|NCT01064479|101864052|FG001|Overall Study|Other|2|||
33537225|NCT04494646|101864056|FG000|Overall Study|Adverse Event|0|||
33537226|NCT04494646|101864057|FG001|Overall Study|Adverse Event|1|||
33537227|NCT04494646|101864056|FG000|Overall Study|Withdrawal by Subject|0|||
33537228|NCT04494646|101864057|FG001|Overall Study|Withdrawal by Subject|1|||
33614399|NCT01393639|102137125|FG003|Overall Study|Withdrawal by Subject|0|||
33614400|NCT01393639|102137126|FG004|Overall Study|Withdrawal by Subject|0|||
33537229|NCT01719380|101867409|FG000|Overall Study|Adverse Event|0|||
33537230|NCT01719380|101867410|FG001|Overall Study|Adverse Event|0|||
33537231|NCT01719380|101867411|FG002|Overall Study|Adverse Event|1|||
33340112|NCT01430442|101135955|FG001|Overall Study|Subject Withdrew Consent|0|||
33340113|NCT01430442|101135956|FG002|Overall Study|Subject Withdrew Consent|1|||
33537232|NCT01719380|101867412|FG003|Overall Study|Adverse Event|2|||
33537233|NCT01719380|101867413|FG004|Overall Study|Adverse Event|0|||
33537234|NCT01719380|101867414|FG005|Overall Study|Adverse Event|1|||
33537235|NCT01719380|101867415|FG006|Overall Study|Adverse Event|0|||
33537236|NCT01719380|101867416|FG007|Overall Study|Adverse Event|1|||
33537237|NCT01719380|101867417|FG008|Overall Study|Adverse Event|4|||
33537238|NCT01719380|101867418|FG009|Overall Study|Adverse Event|3|||
33537239|NCT01719380|101867409|FG000|Overall Study|Death|0|||
33537240|NCT01719380|101867410|FG001|Overall Study|Death|1|||
33537241|NCT01719380|101867411|FG002|Overall Study|Death|0|||
33537242|NCT01719380|101867412|FG003|Overall Study|Death|0|||
33537243|NCT01719380|101867413|FG004|Overall Study|Death|0|||
33537244|NCT01719380|101867414|FG005|Overall Study|Death|0|||
33537245|NCT01719380|101867415|FG006|Overall Study|Death|0|||
33537246|NCT01719380|101867416|FG007|Overall Study|Death|0|||
33537247|NCT01719380|101867417|FG008|Overall Study|Death|3|||
33537248|NCT01719380|101867418|FG009|Overall Study|Death|3|||
33537249|NCT01719380|101867409|FG000|Overall Study|Participant/Guardian Decision|0|||
33537250|NCT01719380|101867410|FG001|Overall Study|Participant/Guardian Decision|0|||
33537251|NCT01719380|101867411|FG002|Overall Study|Participant/Guardian Decision|1|||
33537252|NCT01719380|101867412|FG003|Overall Study|Participant/Guardian Decision|0|||
33537253|NCT01719380|101867413|FG004|Overall Study|Participant/Guardian Decision|0|||
33537254|NCT01719380|101867414|FG005|Overall Study|Participant/Guardian Decision|0|||
33537255|NCT01719380|101867415|FG006|Overall Study|Participant/Guardian Decision|0|||
33537256|NCT01719380|101867416|FG007|Overall Study|Participant/Guardian Decision|0|||
33537257|NCT01719380|101867417|FG008|Overall Study|Participant/Guardian Decision|2|||
33537258|NCT01719380|101867418|FG009|Overall Study|Participant/Guardian Decision|2|||
33537259|NCT01719380|101867409|FG000|Overall Study|Physician Decision|0|||
33340114|NCT01430442|101135957|FG003|Overall Study|Subject Withdrew Consent|0|||
33340115|NCT01430442|101135958|FG004|Overall Study|Subject Withdrew Consent|2|||
33340116|NCT01430442|101135959|FG005|Overall Study|Subject Withdrew Consent|1|||
33340117|NCT01430442|101135960|FG006|Overall Study|Subject Withdrew Consent|5|||
33340118|NCT01430442|101135961|FG007|Overall Study|Subject Withdrew Consent|2|||
33340119|NCT01430442|101135954|FG000|Overall Study|Lost to Follow-up|2|||
33340120|NCT01430442|101135955|FG001|Overall Study|Lost to Follow-up|0|||
33340121|NCT01430442|101135956|FG002|Overall Study|Lost to Follow-up|1|||
33340122|NCT01430442|101135957|FG003|Overall Study|Lost to Follow-up|2|||
33340123|NCT01430442|101135958|FG004|Overall Study|Lost to Follow-up|2|||
33340124|NCT01430442|101135959|FG005|Overall Study|Lost to Follow-up|1|||
33340125|NCT01430442|101135960|FG006|Overall Study|Lost to Follow-up|5|||
33340126|NCT01430442|101135961|FG007|Overall Study|Lost to Follow-up|1|||
33340127|NCT01430442|101135954|FG000|Overall Study|Pregnancy|1|||
33340128|NCT01430442|101135955|FG001|Overall Study|Pregnancy|0|||
33340129|NCT01430442|101135956|FG002|Overall Study|Pregnancy|0|||
33340130|NCT01430442|101135957|FG003|Overall Study|Pregnancy|0|||
33340131|NCT01430442|101135958|FG004|Overall Study|Pregnancy|0|||
33340132|NCT01430442|101135959|FG005|Overall Study|Pregnancy|1|||
33340133|NCT01430442|101135960|FG006|Overall Study|Pregnancy|0|||
33340134|NCT01430442|101135961|FG007|Overall Study|Pregnancy|0|||
33340135|NCT01430442|101135954|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
33340136|NCT01430442|101135955|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
33340137|NCT01430442|101135956|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
33340138|NCT01430442|101135957|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
33340139|NCT01430442|101135958|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
33340140|NCT01430442|101135959|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
33340141|NCT01430442|101135960|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
33340142|NCT01430442|101135961|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
33340143|NCT02918019|101135962|FG000|Overall Study|Death|0|||
33537260|NCT01719380|101867410|FG001|Overall Study|Physician Decision|0|||
33537261|NCT01719380|101867411|FG002|Overall Study|Physician Decision|2|||
33340144|NCT02918019|101135963|FG001|Overall Study|Death|0|||
33340145|NCT02918019|101135964|FG002|Overall Study|Death|1|||
33340146|NCT02918019|101135965|FG003|Overall Study|Death|0|||
33340147|NCT02918019|101135962|FG000|Overall Study|Lost to Follow-up|1|||
33340148|NCT02918019|101135963|FG001|Overall Study|Lost to Follow-up|1|||
33340149|NCT02918019|101135964|FG002|Overall Study|Lost to Follow-up|0|||
33340150|NCT02918019|101135965|FG003|Overall Study|Lost to Follow-up|1|||
33340151|NCT02918019|101135962|FG000|Overall Study|Principal investigator request|0|||
33340152|NCT02918019|101135963|FG001|Overall Study|Principal investigator request|0|||
33340153|NCT02918019|101135964|FG002|Overall Study|Principal investigator request|0|||
33537262|NCT01719380|101867412|FG003|Overall Study|Physician Decision|0|||
33537263|NCT01719380|101867413|FG004|Overall Study|Physician Decision|0|||
33537264|NCT01719380|101867414|FG005|Overall Study|Physician Decision|0|||
33537265|NCT01719380|101867415|FG006|Overall Study|Physician Decision|0|||
33537266|NCT01719380|101867416|FG007|Overall Study|Physician Decision|0|||
33537267|NCT01719380|101867417|FG008|Overall Study|Physician Decision|1|||
33614401|NCT01393639|102137127|FG005|Overall Study|Withdrawal by Subject|0|||
33614402|NCT01393639|102137128|FG006|Overall Study|Withdrawal by Subject|1|||
33614403|NCT01393639|102137122|FG000|Overall Study|Medication error without associated AE|0|||
33614404|NCT01393639|102137123|FG001|Overall Study|Medication error without associated AE|0|||
33614405|NCT01393639|102137124|FG002|Overall Study|Medication error without associated AE|0|||
33614406|NCT01393639|102137125|FG003|Overall Study|Medication error without associated AE|0|||
33614407|NCT01393639|102137126|FG004|Overall Study|Medication error without associated AE|0|||
33614408|NCT01393639|102137127|FG005|Overall Study|Medication error without associated AE|0|||
33614409|NCT01393639|102137128|FG006|Overall Study|Medication error without associated AE|1|||
33614410|NCT01393639|102137122|FG000|Overall Study|Lost to Follow-up|0|||
33614411|NCT01393639|102137123|FG001|Overall Study|Lost to Follow-up|1|||
33614412|NCT01393639|102137124|FG002|Overall Study|Lost to Follow-up|0|||
33614413|NCT01393639|102137125|FG003|Overall Study|Lost to Follow-up|0|||
33614414|NCT01393639|102137126|FG004|Overall Study|Lost to Follow-up|0|||
33614415|NCT01393639|102137127|FG005|Overall Study|Lost to Follow-up|0|||
33614416|NCT01393639|102137128|FG006|Overall Study|Lost to Follow-up|1|||
33614417|NCT01393639|102137122|FG000|Overall Study|Lack of Efficacy|0|||
33614418|NCT01393639|102137123|FG001|Overall Study|Lack of Efficacy|0|||
33614419|NCT01393639|102137124|FG002|Overall Study|Lack of Efficacy|0|||
33614420|NCT01393639|102137125|FG003|Overall Study|Lack of Efficacy|0|||
33614421|NCT01393639|102137126|FG004|Overall Study|Lack of Efficacy|0|||
33614422|NCT01393639|102137127|FG005|Overall Study|Lack of Efficacy|0|||
33614423|NCT01393639|102137128|FG006|Overall Study|Lack of Efficacy|1|||
33614424|NCT01393639|102137122|FG000|Overall Study|Adverse Event|2|||
33614425|NCT01393639|102137123|FG001|Overall Study|Adverse Event|3|||
33614426|NCT01393639|102137124|FG002|Overall Study|Adverse Event|1|||
33614427|NCT01393639|102137125|FG003|Overall Study|Adverse Event|2|||
33614428|NCT01393639|102137126|FG004|Overall Study|Adverse Event|0|||
33614429|NCT01393639|102137127|FG005|Overall Study|Adverse Event|2|||
33614430|NCT01393639|102137128|FG006|Overall Study|Adverse Event|3|||
33614431|NCT00851786|102137134|FG000|Overall Study|Withdrawal by Subject|0|||
33614432|NCT00851786|102137135|FG001|Overall Study|Withdrawal by Subject|1|||
33614433|NCT00851786|102137134|FG000|Overall Study|Protocol Violation|0|||
33614434|NCT00851786|102137135|FG001|Overall Study|Protocol Violation|1|||
33614435|NCT00851786|102137134|FG000|Overall Study|Lost to Follow-up|1|||
33614436|NCT00851786|102137135|FG001|Overall Study|Lost to Follow-up|0|||
33614437|NCT00851786|102137134|FG000|Overall Study|Incarceration|1|||
33614438|NCT00851786|102137135|FG001|Overall Study|Incarceration|0|||
33614439|NCT00851786|102137134|FG000|Overall Study|Site Closure|1|||
33614440|NCT00851786|102137135|FG001|Overall Study|Site Closure|0|||
33614441|NCT00851786|102137134|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
33614442|NCT00851786|102137135|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
33614443|NCT01740401|102137136|FG000|Overall Study|Progression of disease|6|||
33614444|NCT01740401|102137136|FG000|Overall Study|Adverse Event|2|||
33614445|NCT01740401|102137136|FG000|Overall Study|Did not reach primary endpoint|2|||
33614446|NCT02703324|102137153|FG000|Period Two|Withdrawal by Subject|0|||
33614447|NCT02703324|102137154|FG001|Period Two|Withdrawal by Subject|0|||
33614448|NCT02703324|102137155|FG002|Period Two|Withdrawal by Subject|1|||
33614449|NCT02703324|102137156|FG003|Period Two|Withdrawal by Subject|0|||
33614450|NCT02703324|102137157|FG004|Period Two|Withdrawal by Subject|0|||
33614451|NCT02703324|102137158|FG005|Period Two|Withdrawal by Subject|0|||
33614452|NCT01301833|102137159|FG000|Overall Study|Adverse Event|7|||
33614453|NCT01301833|102137160|FG001|Overall Study|Adverse Event|5|||
33614454|NCT01301833|102137161|FG002|Overall Study|Adverse Event|5|||
33614455|NCT01301833|102137162|FG003|Overall Study|Adverse Event|5|||
33614456|NCT01301833|102137159|FG000|Overall Study|Lack of Efficacy|1|||
33614457|NCT01301833|102137160|FG001|Overall Study|Lack of Efficacy|1|||
33614458|NCT01301833|102137161|FG002|Overall Study|Lack of Efficacy|0|||
33614459|NCT01301833|102137162|FG003|Overall Study|Lack of Efficacy|0|||
33614460|NCT01301833|102137159|FG000|Overall Study|Physician Decision|3|||
33614461|NCT01301833|102137160|FG001|Overall Study|Physician Decision|1|||
33614462|NCT01301833|102137161|FG002|Overall Study|Physician Decision|1|||
33614463|NCT01301833|102137162|FG003|Overall Study|Physician Decision|0|||
33614464|NCT01301833|102137159|FG000|Overall Study|Withdrawal by Subject|3|||
33614465|NCT01301833|102137160|FG001|Overall Study|Withdrawal by Subject|1|||
33614466|NCT01301833|102137161|FG002|Overall Study|Withdrawal by Subject|1|||
33614467|NCT01301833|102137162|FG003|Overall Study|Withdrawal by Subject|2|||
33614468|NCT01301833|102137159|FG000|Overall Study|Personal matter|1|||
33614469|NCT01301833|102137160|FG001|Overall Study|Personal matter|0|||
33614470|NCT01301833|102137161|FG002|Overall Study|Personal matter|0|||
33614471|NCT01301833|102137162|FG003|Overall Study|Personal matter|0|||
33614472|NCT01858740|102137171|FG000|Overall Study|Death|4|||
33614473|NCT01856582|102137173|FG000|Overall Study|Died prior to Boost infusion|1|||
33614474|NCT00711971|102137174|FG000|Overall Study|Lost to Follow-up|3|||
33614475|NCT00711971|102137175|FG001|Overall Study|Lost to Follow-up|4|||
33614476|NCT00711971|102137176|FG002|Overall Study|Lost to Follow-up|1|||
33614477|NCT00753454|102137177|FG000|Overall Study|Adverse Event|4|||
33614478|NCT00753454|102137177|FG000|Overall Study|Lack of Efficacy|1|||
33340154|NCT02918019|101135965|FG003|Overall Study|Principal investigator request|1|||
33340155|NCT02918019|101135962|FG000|Overall Study|Physician Decision|1|||
33340156|NCT02918019|101135963|FG001|Overall Study|Physician Decision|3|||
33340157|NCT02918019|101135964|FG002|Overall Study|Physician Decision|2|||
33340158|NCT02918019|101135965|FG003|Overall Study|Physician Decision|0|||
33340159|NCT02918019|101135962|FG000|Overall Study|Protocol deviation|1|||
33340160|NCT02918019|101135963|FG001|Overall Study|Protocol deviation|1|||
33340161|NCT02918019|101135964|FG002|Overall Study|Protocol deviation|0|||
33340162|NCT02918019|101135965|FG003|Overall Study|Protocol deviation|2|||
33340163|NCT02918019|101135962|FG000|Overall Study|Withdrawal by Subject|3|||
33340164|NCT02918019|101135963|FG001|Overall Study|Withdrawal by Subject|4|||
33340165|NCT02918019|101135964|FG002|Overall Study|Withdrawal by Subject|6|||
33340166|NCT02918019|101135965|FG003|Overall Study|Withdrawal by Subject|4|||
33340167|NCT02918019|101135962|FG000|Overall Study|Adverse Event|0|||
33340168|NCT02918019|101135963|FG001|Overall Study|Adverse Event|1|||
33340169|NCT02918019|101135964|FG002|Overall Study|Adverse Event|0|||
33340170|NCT02918019|101135965|FG003|Overall Study|Adverse Event|1|||
33340171|NCT04316585|101135970|FG000|Overall Study|Adverse Event|2|||
33340172|NCT04316585|101135971|FG001|Overall Study|Adverse Event|1|||
33340173|NCT04316585|101135970|FG000|Overall Study|Lost to Follow-up|1|||
33340174|NCT04316585|101135971|FG001|Overall Study|Lost to Follow-up|0|||
33340175|NCT04316585|101135970|FG000|Overall Study|Withdrawal by Subject|2|||
33340176|NCT04316585|101135971|FG001|Overall Study|Withdrawal by Subject|3|||
33340177|NCT04316585|101135970|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
33340178|NCT04316585|101135971|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
33340179|NCT04316585|101135970|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
33340180|NCT04316585|101135971|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
33340181|NCT01445678|101135972|FG000|Overall Study|Adverse Event|12|||
33340182|NCT01445678|101135973|FG001|Overall Study|Adverse Event|8|||
33340183|NCT01445678|101135972|FG000|Overall Study|Lack of Efficacy|0|||
33340184|NCT01445678|101135973|FG001|Overall Study|Lack of Efficacy|2|||
33340185|NCT01445678|101135972|FG000|Overall Study|Lost to Follow-up|8|||
33340186|NCT01445678|101135973|FG001|Overall Study|Lost to Follow-up|5|||
33340187|NCT01445678|101135972|FG000|Overall Study|Protocol Violation|1|||
33340188|NCT01445678|101135973|FG001|Overall Study|Protocol Violation|1|||
33340189|NCT01445678|101135972|FG000|Overall Study|Withdrawal by Subject|9|||
33340190|NCT01445678|101135973|FG001|Overall Study|Withdrawal by Subject|5|||
33340191|NCT01463098|101135974|FG000|Part A (11 Days)|Participant Choice|2|||
33340192|NCT01463098|101135975|FG001|Part A (11 Days)|Participant Choice|0|||
33340193|NCT01463098|101135976|FG002|Part A (11 Days)|Participant Choice|0|||
33340194|NCT01463098|101135977|FG003|Part A (11 Days)|Participant Choice|0|||
33340195|NCT01463098|101135978|FG004|Part A (11 Days)|Participant Choice|0|||
33340196|NCT01463098|101135979|FG005|Part A (11 Days)|Participant Choice|0|||
33340197|NCT01463098|101135980|FG006|Part A (11 Days)|Participant Choice|0|||
33340198|NCT01463098|101135981|FG007|Part A (11 Days)|Participant Choice|0|||
33340199|NCT01463098|101135982|FG008|Part A (11 Days)|Participant Choice|1|||
33340200|NCT01463098|101135983|FG009|Part A (11 Days)|Participant Choice|0|||
33340201|NCT01463098|101135984|FG010|Part A (11 Days)|Participant Choice|0|||
33340202|NCT01463098|101135985|FG011|Part A (11 Days)|Participant Choice|0|||
33340203|NCT01463098|101135986|FG012|Part A (11 Days)|Participant Choice|0|||
33340204|NCT01463098|101135987|FG013|Part A (11 Days)|Participant Choice|0|||
33340205|NCT01463098|101135974|FG000|Part A (11 Days)|Lost to Follow-up|0|||
33537268|NCT01719380|101867418|FG009|Overall Study|Physician Decision|1|||
33537269|NCT01719380|101867409|FG000|Overall Study|Lack of Efficacy|2|||
33537270|NCT01719380|101867410|FG001|Overall Study|Lack of Efficacy|6|||
33537271|NCT01719380|101867411|FG002|Overall Study|Lack of Efficacy|5|||
33537272|NCT01719380|101867412|FG003|Overall Study|Lack of Efficacy|6|||
33537273|NCT01719380|101867413|FG004|Overall Study|Lack of Efficacy|3|||
33537274|NCT01719380|101867414|FG005|Overall Study|Lack of Efficacy|7|||
33537275|NCT01719380|101867415|FG006|Overall Study|Lack of Efficacy|10|||
33537276|NCT01719380|101867416|FG007|Overall Study|Lack of Efficacy|6|||
33209321|NCT03252587|100670178|FG003|Overall Study|Adverse Event|12|||
33340206|NCT01463098|101135975|FG001|Part A (11 Days)|Lost to Follow-up|0|||
33340207|NCT01463098|101135976|FG002|Part A (11 Days)|Lost to Follow-up|0|||
33340208|NCT01463098|101135977|FG003|Part A (11 Days)|Lost to Follow-up|0|||
33340209|NCT01463098|101135978|FG004|Part A (11 Days)|Lost to Follow-up|1|||
33340210|NCT01463098|101135979|FG005|Part A (11 Days)|Lost to Follow-up|0|||
33340211|NCT01463098|101135980|FG006|Part A (11 Days)|Lost to Follow-up|0|||
33340212|NCT01463098|101135981|FG007|Part A (11 Days)|Lost to Follow-up|0|||
33340213|NCT01463098|101135982|FG008|Part A (11 Days)|Lost to Follow-up|0|||
33340214|NCT01463098|101135983|FG009|Part A (11 Days)|Lost to Follow-up|0|||
33340215|NCT01463098|101135984|FG010|Part A (11 Days)|Lost to Follow-up|0|||
33340216|NCT01463098|101135985|FG011|Part A (11 Days)|Lost to Follow-up|0|||
33340217|NCT01463098|101135986|FG012|Part A (11 Days)|Lost to Follow-up|0|||
33537277|NCT01719380|101867417|FG008|Overall Study|Lack of Efficacy|39|||
33537278|NCT01719380|101867418|FG009|Overall Study|Lack of Efficacy|42|||
33209322|NCT03252587|100670175|FG000|Overall Study|Lack of Efficacy|7|||
33340218|NCT01463098|101135987|FG013|Part A (11 Days)|Lost to Follow-up|0|||
33340219|NCT01463098|101135974|FG000|Part B (11 Days)|Participant Choice|0|||
33340220|NCT01463098|101135975|FG001|Part B (11 Days)|Participant Choice|0|||
33340221|NCT01463098|101135976|FG002|Part B (11 Days)|Participant Choice|0|||
33537279|NCT01719380|101867409|FG000|Overall Study|Progressive Disease|0|||
33340222|NCT01463098|101135977|FG003|Part B (11 Days)|Participant Choice|0|||
33340223|NCT01463098|101135978|FG004|Part B (11 Days)|Participant Choice|0|||
33340224|NCT01463098|101135979|FG005|Part B (11 Days)|Participant Choice|0|||
33340225|NCT01463098|101135980|FG006|Part B (11 Days)|Participant Choice|0|||
33537280|NCT01719380|101867410|FG001|Overall Study|Progressive Disease|0|||
33537281|NCT01719380|101867411|FG002|Overall Study|Progressive Disease|0|||
33537282|NCT01719380|101867412|FG003|Overall Study|Progressive Disease|0|||
33537283|NCT01719380|101867413|FG004|Overall Study|Progressive Disease|0|||
33537284|NCT01719380|101867414|FG005|Overall Study|Progressive Disease|0|||
33537285|NCT01719380|101867415|FG006|Overall Study|Progressive Disease|0|||
33537286|NCT01719380|101867416|FG007|Overall Study|Progressive Disease|0|||
33537287|NCT01719380|101867417|FG008|Overall Study|Progressive Disease|1|||
33537288|NCT01719380|101867418|FG009|Overall Study|Progressive Disease|0|||
33537289|NCT00723229|101867419|FG000|First Intervention|Lost to Follow-up|7|||
33537290|NCT00723229|101867420|FG001|First Intervention|Lost to Follow-up|3|||
33537291|NCT01710020|101867421|FG000|Period 1|Protocol Violation|1|||
33537292|NCT02287038|101867422|FG000|Overall Study|Stopped attending appointments|3|||
33537293|NCT02287038|101867423|FG001|Overall Study|Stopped attending appointments|2|||
33537294|NCT02287038|101867422|FG000|Overall Study|Anxiety after starting medication|0|||
33537295|NCT02287038|101867423|FG001|Overall Study|Anxiety after starting medication|1|||
33537296|NCT02287038|101867422|FG000|Overall Study|Nausea after starting medication|1|||
33537297|NCT02287038|101867423|FG001|Overall Study|Nausea after starting medication|0|||
33537298|NCT02287038|101867422|FG000|Overall Study|Abnormal ECG after starting medication|1|||
33537299|NCT02287038|101867423|FG001|Overall Study|Abnormal ECG after starting medication|0|||
33537300|NCT01100502|101867429|FG000|Overall Study|Withdrawal by Subject|18|||
33537301|NCT01100502|101867430|FG001|Overall Study|Withdrawal by Subject|25|||
33537302|NCT01100502|101867429|FG000|Overall Study|Lost to Follow-up|13|||
33537303|NCT01100502|101867430|FG001|Overall Study|Lost to Follow-up|28|||
33537304|NCT01100502|101867429|FG000|Overall Study|Site request to end participation in study|0|||
33537305|NCT01100502|101867430|FG001|Overall Study|Site request to end participation in study|1|||
33537306|NCT01100502|101867429|FG000|Overall Study|Death|45|||
33537307|NCT01100502|101867430|FG001|Overall Study|Death|40|||
33537308|NCT01418339|101867431|FG000|Overall Study|Adverse Event|5|||
33537309|NCT01418339|101867432|FG001|Overall Study|Adverse Event|2|||
33537310|NCT01418339|101867431|FG000|Overall Study|Subject Withdrew Consent|1|||
33537311|NCT01418339|101867432|FG001|Overall Study|Subject Withdrew Consent|2|||
33537312|NCT01418339|101867431|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
33537313|NCT01418339|101867432|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
33537314|NCT03092752|101867450|FG000|Overall Study|Aged <40 years|14209|||
33537315|NCT03092752|101867450|FG000|Overall Study|At least one claim with T2DM|61299|||
33537316|NCT03092752|101867450|FG000|Overall Study|Having no claim of study drugs|29282|||
33340226|NCT01463098|101135981|FG007|Part B (11 Days)|Participant Choice|0|||
33340227|NCT01463098|101135982|FG008|Part B (11 Days)|Participant Choice|0|||
33340228|NCT01463098|101135983|FG009|Part B (11 Days)|Participant Choice|0|||
33537317|NCT03092752|101867450|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
33537318|NCT03092752|101867450|FG000|Overall Study|<6 month history|245900|||
33537319|NCT02976519|101867451|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
33537320|NCT02976519|101867452|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
33537321|NCT02976519|101867453|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
33537322|NCT02976519|101867454|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
33537323|NCT02976519|101867455|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
33537324|NCT02976519|101867456|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
33537325|NCT02976519|101867457|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
33537326|NCT02976519|101867451|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
33209323|NCT03252587|100670176|FG001|Overall Study|Lack of Efficacy|2|||
33209324|NCT03252587|100670177|FG002|Overall Study|Lack of Efficacy|2|||
33537327|NCT02976519|101867452|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
33537328|NCT02976519|101867453|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
33209325|NCT03252587|100670178|FG003|Overall Study|Lack of Efficacy|4|||
33340229|NCT01463098|101135984|FG010|Part B (11 Days)|Participant Choice|0|||
33405670|NCT00125138|101373466|FG002|Overall Study|Adverse Event|3|||
33537329|NCT02976519|101867454|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
33537330|NCT02976519|101867455|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
33537331|NCT02976519|101867456|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
33537332|NCT02976519|101867457|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
33537333|NCT02976519|101867451|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
33537334|NCT02976519|101867452|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
33614479|NCT00753454|102137177|FG000|Overall Study|Lost to Follow-up|3|||
33614480|NCT00753454|102137177|FG000|Overall Study|Withdrawal by Subject|5|||
33614481|NCT00753454|102137177|FG000|Overall Study|Investigator Decision|1|||
33614482|NCT03932760|102137178|FG000|Overall Study|Became Ineligible|2|||
33614483|NCT03932760|102137179|FG001|Overall Study|Became Ineligible|5|||
33614484|NCT03932760|102137178|FG000|Overall Study|Withdrawal by Subject|6|||
33614485|NCT03932760|102137179|FG001|Overall Study|Withdrawal by Subject|6|||
33614486|NCT01934010|102137180|FG000|Overall Study|Adverse Event|1|||
33614487|NCT01934010|102137181|FG001|Overall Study|Adverse Event|1|||
33614488|NCT01934010|102137182|FG002|Overall Study|Adverse Event|0|||
33614489|NCT01934010|102137180|FG000|Overall Study|Withdrawal by Subject|15|||
33614490|NCT01934010|102137181|FG001|Overall Study|Withdrawal by Subject|6|||
33614491|NCT01934010|102137182|FG002|Overall Study|Withdrawal by Subject|2|||
33614492|NCT01934010|102137180|FG000|Overall Study|Lost to Follow-up|7|||
33614493|NCT01934010|102137181|FG001|Overall Study|Lost to Follow-up|4|||
33614494|NCT01934010|102137182|FG002|Overall Study|Lost to Follow-up|0|||
33614495|NCT02206035|102137183|FG000|Overall Study|Physician Decision|10|||
33614496|NCT02206035|102137184|FG001|Overall Study|Physician Decision|0|||
33614497|NCT02206035|102137185|FG002|Overall Study|Physician Decision|175|||
33614498|NCT02702180|102137186|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
33614499|NCT02702180|102137187|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
33614500|NCT02702180|102137188|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33614501|NCT02702180|102137186|FG000|Double-blind Treatment Period|Adverse Event|0|||
33614502|NCT02702180|102137187|FG001|Double-blind Treatment Period|Adverse Event|0|||
33614503|NCT02702180|102137188|FG002|Double-blind Treatment Period|Adverse Event|1|||
33614504|NCT02702180|102137186|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
33340230|NCT01463098|101135985|FG011|Part B (11 Days)|Participant Choice|1|||
33340231|NCT01463098|101135986|FG012|Part B (11 Days)|Participant Choice|0|||
33340232|NCT01463098|101135987|FG013|Part B (11 Days)|Participant Choice|0|||
33340233|NCT01100944|101135988|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
33340234|NCT01100944|101135989|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
33340235|NCT01100944|101135990|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
33340236|NCT01100944|101135988|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
33340237|NCT01100944|101135989|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
33340238|NCT01100944|101135990|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
33340239|NCT01100944|101135988|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
33340240|NCT01100944|101135989|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
33340241|NCT01100944|101135990|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
33340242|NCT01100944|101135988|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
33340243|NCT01100944|101135989|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
33340244|NCT01100944|101135990|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
33340245|NCT02361216|101135991|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
33340246|NCT02361216|101135992|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
33340247|NCT02361216|101135991|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
33340248|NCT02361216|101135992|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
33340249|NCT02361216|101135991|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
33340250|NCT02361216|101135992|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
33340251|NCT02361216|101135991|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
33340252|NCT02361216|101135992|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
33340253|NCT02361216|101135991|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
33340254|NCT02361216|101135992|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
33340255|NCT02361216|101135991|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
33340256|NCT02361216|101135992|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
33340257|NCT00428597|101135996|FG000|Overall Study|Randomized but not treated|3|||
33340258|NCT00428597|101135997|FG001|Overall Study|Randomized but not treated|3|||
33340259|NCT00428597|101135996|FG000|Overall Study|Objective Progression or Relapse|19|||
33537335|NCT02976519|101867453|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
33537336|NCT02976519|101867454|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
33537337|NCT02976519|101867455|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
33537338|NCT02976519|101867456|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
33537339|NCT02976519|101867457|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
33537340|NCT02976519|101867451|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
33537341|NCT02976519|101867452|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
33537342|NCT02976519|101867453|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
33537343|NCT02976519|101867454|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
33537344|NCT02976519|101867455|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
33537345|NCT02976519|101867456|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
33614505|NCT02702180|102137187|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
33614506|NCT02702180|102137188|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
33405671|NCT00125138|101373467|FG003|Overall Study|Adverse Event|2|||
33405672|NCT00125138|101373464|FG000|Overall Study|Withdrawal by Subject|2|||
33405673|NCT00125138|101373465|FG001|Overall Study|Withdrawal by Subject|3|||
33405674|NCT00125138|101373466|FG002|Overall Study|Withdrawal by Subject|1|||
33405675|NCT00125138|101373467|FG003|Overall Study|Withdrawal by Subject|1|||
33405676|NCT00125138|101373464|FG000|Overall Study|Lack of Efficacy|0|||
33405677|NCT00125138|101373465|FG001|Overall Study|Lack of Efficacy|0|||
33405678|NCT00125138|101373466|FG002|Overall Study|Lack of Efficacy|0|||
33405679|NCT00125138|101373467|FG003|Overall Study|Lack of Efficacy|1|||
33405680|NCT00125138|101373464|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
33405681|NCT00125138|101373465|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
33405682|NCT00125138|101373466|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
33405683|NCT00125138|101373467|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
33405684|NCT02441517|101373468|FG000|Overall Study|Lost to Follow-up|1|||
33405685|NCT02441517|101373468|FG000|Overall Study|Withdrawal by Subject|2|||
33405686|NCT02441517|101373468|FG000|Overall Study|Study Terminated by Sponsor|1|||
33405687|NCT02477215|101373470|FG000|Dose Escalation Phase|Physician Decision|1|||
33405688|NCT02477215|101373471|FG001|Dose Escalation Phase|Physician Decision|2|||
33405689|NCT02477215|101373472|FG002|Dose Escalation Phase|Physician Decision|0|||
33405690|NCT02477215|101373470|FG000|Fixed Dose Phase|Physician Decision|0|||
33405691|NCT02477215|101373471|FG001|Fixed Dose Phase|Physician Decision|7|||
33405692|NCT02477215|101373472|FG002|Fixed Dose Phase|Physician Decision|0|||
33405693|NCT00656136|101373475|FG000|Overall Study|Progressive disease|177|||
33405694|NCT00656136|101373476|FG001|Overall Study|Progressive disease|322|||
33405695|NCT00656136|101373475|FG000|Overall Study|Other Adverse Event|5|||
33340260|NCT00428597|101135997|FG001|Overall Study|Objective Progression or Relapse|47|||
33340261|NCT00428597|101135996|FG000|Overall Study|Study Terminated by Sponsor|41|||
33340262|NCT00428597|101135997|FG001|Overall Study|Study Terminated by Sponsor|16|||
33340263|NCT00428597|101135996|FG000|Overall Study|Adverse Event|15|||
33340264|NCT00428597|101135997|FG001|Overall Study|Adverse Event|7|||
33340265|NCT00428597|101135996|FG000|Overall Study|Global Deterioration of Health Status|1|||
33405696|NCT00656136|101373476|FG001|Overall Study|Other Adverse Event|51|||
33405697|NCT00656136|101373475|FG000|Overall Study|Protocol Violation|2|||
33537346|NCT02976519|101867457|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
33537347|NCT02976519|101867451|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
33537348|NCT02976519|101867452|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
33537349|NCT02976519|101867453|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
33537350|NCT02976519|101867454|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
33537351|NCT02976519|101867455|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
33537352|NCT02976519|101867456|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
33537353|NCT02976519|101867457|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
33537354|NCT01618968|101867458|FG000|Overall Study|Adverse Event|1|||
33537355|NCT01618968|101867459|FG001|Overall Study|Adverse Event|0|||
33537356|NCT01618968|101867460|FG002|Overall Study|Adverse Event|0|||
33537357|NCT01618968|101867461|FG003|Overall Study|Adverse Event|0|||
33537358|NCT01618968|101867458|FG000|Overall Study|Death|0|||
33340266|NCT00428597|101135997|FG001|Overall Study|Global Deterioration of Health Status|5|||
33405698|NCT00656136|101373476|FG001|Overall Study|Protocol Violation|3|||
33405699|NCT00656136|101373475|FG000|Overall Study|Patient refused to take study medication|7|||
33405700|NCT00656136|101373476|FG001|Overall Study|Patient refused to take study medication|10|||
33537359|NCT01618968|101867459|FG001|Overall Study|Death|0|||
33537360|NCT01618968|101867460|FG002|Overall Study|Death|0|||
33537361|NCT01618968|101867461|FG003|Overall Study|Death|1|||
33537362|NCT00828711|101867462|FG000|Overall Study|Lost to Follow-up|1|||
33537363|NCT00828711|101867463|FG001|Overall Study|Lost to Follow-up|0|||
33537364|NCT00828711|101867464|FG002|Overall Study|Lost to Follow-up|0|||
33340267|NCT00428597|101135996|FG000|Overall Study|Protocol Violation|2|||
33340268|NCT00428597|101135997|FG001|Overall Study|Protocol Violation|1|||
33340269|NCT00428597|101135996|FG000|Overall Study|Withdrawal by Subject|2|||
33340270|NCT00428597|101135997|FG001|Overall Study|Withdrawal by Subject|1|||
33340271|NCT00428597|101135996|FG000|Overall Study|Other|1|||
33340272|NCT00428597|101135997|FG001|Overall Study|Other|1|||
33340273|NCT00428597|101135996|FG000|Overall Study|Lost to Follow-up|0|||
33405701|NCT00656136|101373475|FG000|Overall Study|Unknown and others|4|||
33405702|NCT00656136|101373476|FG001|Overall Study|Unknown and others|4|||
33405703|NCT01640353|101373477|FG000|Overall Study|Withdrew prior to treatment|10|||
33405704|NCT01640353|101373477|FG000|Overall Study|Withdrawn from analysis at term site|12|||
33405705|NCT01640353|101373477|FG000|Overall Study|Withdrawal by Subject|5|||
33405706|NCT01640353|101373477|FG000|Overall Study|Death|2|||
33405707|NCT01640353|101373477|FG000|Overall Study|Early site termination|3|||
33405708|NCT01640353|101373477|FG000|Overall Study|Lost to Follow-up|12|||
33405709|NCT01640353|101373477|FG000|Overall Study|Physician Decision|1|||
33537365|NCT03638128|101867467|FG000|Overall Study|Withdrawal by Subject|1|||
33537366|NCT03638128|101867468|FG001|Overall Study|Withdrawal by Subject|7|||
33537367|NCT03638128|101867469|FG002|Overall Study|Withdrawal by Subject|6|||
33614507|NCT02702180|102137186|FG000|Double-blind Treatment Period|Protocol Violation|0|||
33340274|NCT00428597|101135997|FG001|Overall Study|Lost to Follow-up|1|||
33340275|NCT00428597|101135996|FG000|Overall Study|Pregnancy|1|||
33340276|NCT00428597|101135997|FG001|Overall Study|Pregnancy|0|||
33340277|NCT00428597|101135996|FG000|Overall Study|Death|1|||
33340278|NCT00428597|101135997|FG001|Overall Study|Death|3|||
33340279|NCT04823949|101135998|FG000|Overall Study|Withdrawal by Subject|0|||
33340280|NCT04823949|101135999|FG001|Overall Study|Withdrawal by Subject|4|||
33340281|NCT04823949|101135998|FG000|Overall Study|Physician Decision|0|||
33340282|NCT04823949|101135999|FG001|Overall Study|Physician Decision|1|||
33340283|NCT00666458|101136000|FG000|Overall Study|Adverse Event|8|||
33340284|NCT00666458|101136001|FG001|Overall Study|Adverse Event|7|||
33340285|NCT00666458|101136000|FG000|Overall Study|Withdrawal by Subject|5|||
33340286|NCT00666458|101136001|FG001|Overall Study|Withdrawal by Subject|4|||
33340287|NCT00666458|101136000|FG000|Overall Study|Lost to Follow-up|0|||
33340288|NCT00666458|101136001|FG001|Overall Study|Lost to Follow-up|3|||
33340289|NCT00666458|101136000|FG000|Overall Study|Administrative reason by sponsor|1|||
33340290|NCT00666458|101136001|FG001|Overall Study|Administrative reason by sponsor|1|||
33340291|NCT00666458|101136000|FG000|Overall Study|Incorrect enrollment|7|||
33340292|NCT00666458|101136001|FG001|Overall Study|Incorrect enrollment|1|||
33340293|NCT00666458|101136000|FG000|Overall Study|Study specific discontinuation criteria|14|||
33405710|NCT01003691|101373478|FG000|Overall Study|Adverse Event|0|||
33405711|NCT01003691|101373479|FG001|Overall Study|Adverse Event|0|||
33537368|NCT03638128|101867467|FG000|Overall Study|Sponsor Decision|15|||
33537369|NCT03638128|101867468|FG001|Overall Study|Sponsor Decision|12|||
33537370|NCT03638128|101867469|FG002|Overall Study|Sponsor Decision|19|||
33537371|NCT03638128|101867467|FG000|Overall Study|Lost to Follow-up|0|||
33537372|NCT03638128|101867468|FG001|Overall Study|Lost to Follow-up|0|||
33537373|NCT03638128|101867469|FG002|Overall Study|Lost to Follow-up|1|||
33537374|NCT01307787|101867471|FG000|Overall Study|Withdrawal by Subject|2|||
33537375|NCT01307787|101867472|FG001|Overall Study|Withdrawal by Subject|0|||
33537376|NCT00126594|101867473|FG000|Overall Study|Ineligible|2|||
33537377|NCT00126594|101867474|FG001|Overall Study|Ineligible|0|||
33537378|NCT00126594|101867473|FG000|Overall Study|Withdrawal by Subject|0|||
33537379|NCT00126594|101867474|FG001|Overall Study|Withdrawal by Subject|4|||
33537380|NCT00126594|101867473|FG000|Overall Study|Physician Decision|1|||
33537381|NCT00126594|101867474|FG001|Overall Study|Physician Decision|3|||
33405712|NCT01003691|101373480|FG002|Overall Study|Adverse Event|0|||
33537382|NCT00126594|101867473|FG000|Overall Study|Adverse Event|7|||
33537383|NCT00126594|101867474|FG001|Overall Study|Adverse Event|5|||
33537384|NCT00126594|101867473|FG000|Overall Study|Non-compliance|0|||
33537385|NCT00126594|101867474|FG001|Overall Study|Non-compliance|1|||
33614508|NCT02702180|102137187|FG001|Double-blind Treatment Period|Protocol Violation|0|||
33405713|NCT01003691|101373481|FG003|Overall Study|Adverse Event|1|||
33405714|NCT02451137|101373482|FG000|Overall Study|Randomized but not treated|19|||
33405715|NCT02451137|101373483|FG001|Overall Study|Randomized but not treated|27|||
33405716|NCT02451137|101373482|FG000|Overall Study|Adverse Event|43|||
33405717|NCT02451137|101373483|FG001|Overall Study|Adverse Event|42|||
33405718|NCT02451137|101373482|FG000|Overall Study|Lack of Efficacy|4|||
33405719|NCT02451137|101373483|FG001|Overall Study|Lack of Efficacy|9|||
33405720|NCT02451137|101373482|FG000|Overall Study|Participant decision:discontinue insulin|41|||
33405721|NCT02451137|101373483|FG001|Overall Study|Participant decision:discontinue insulin|43|||
33405722|NCT02451137|101373482|FG000|Overall Study|Hypoglycemia|2|||
33405723|NCT02451137|101373483|FG001|Overall Study|Hypoglycemia|1|||
33405724|NCT02451137|101373482|FG000|Overall Study|Investigator's decision|23|||
33405725|NCT02451137|101373483|FG001|Overall Study|Investigator's decision|19|||
33405726|NCT02451137|101373482|FG000|Overall Study|Lost to Follow-up|53|||
33405727|NCT02451137|101373483|FG001|Overall Study|Lost to Follow-up|61|||
33405728|NCT02451137|101373482|FG000|Overall Study|Physician Decision|6|||
33405729|NCT02451137|101373483|FG001|Overall Study|Physician Decision|5|||
33405730|NCT02451137|101373482|FG000|Overall Study|Sponsor decision|13|||
33405731|NCT02451137|101373483|FG001|Overall Study|Sponsor decision|25|||
33405732|NCT02451137|101373482|FG000|Overall Study|Withdrawal by Subject|40|||
33405733|NCT02451137|101373483|FG001|Overall Study|Withdrawal by Subject|63|||
33405734|NCT02451137|101373482|FG000|Overall Study|Other than specified above|2|||
33405735|NCT02451137|101373483|FG001|Overall Study|Other than specified above|3|||
33405736|NCT04235959|101373484|FG000|Overall Study|Protocol Violation|0|||
33405737|NCT04235959|101373485|FG001|Overall Study|Protocol Violation|1|||
33405738|NCT04235959|101373486|FG002|Overall Study|Protocol Violation|0|||
33405739|NCT04235959|101373484|FG000|Overall Study|Adverse Event|1|||
33340294|NCT00666458|101136001|FG001|Overall Study|Study specific discontinuation criteria|7|||
33405740|NCT04235959|101373485|FG001|Overall Study|Adverse Event|0|||
33405741|NCT04235959|101373486|FG002|Overall Study|Adverse Event|0|||
33340295|NCT00666458|101136000|FG000|Overall Study|Severe non-compliance to the protocol|1|||
33340296|NCT00666458|101136001|FG001|Overall Study|Severe non-compliance to the protocol|1|||
33340297|NCT00666458|101136000|FG000|Overall Study|Safety reasons|1|||
33340298|NCT00666458|101136001|FG001|Overall Study|Safety reasons|0|||
33340299|NCT00666458|101136000|FG000|Overall Study|Medical history of anemia|1|||
33340300|NCT00666458|101136001|FG001|Overall Study|Medical history of anemia|0|||
33340301|NCT00356278|101136005|FG000|Overall Study|Withdrawal by Subject|25|||
33340302|NCT00356278|101136006|FG001|Overall Study|Withdrawal by Subject|15|||
33340303|NCT00356278|101136007|FG002|Overall Study|Withdrawal by Subject|19|||
33340304|NCT00464178|101136012|FG000|Overall Study|Protocol Violation|1|||
33340305|NCT00464178|101136012|FG000|Overall Study|Withdrawal by Subject|1|||
33340306|NCT01964352|101136013|FG000|Overall Study|Adverse Event|13|||
33340307|NCT01964352|101136014|FG001|Overall Study|Adverse Event|3|||
33340308|NCT01964352|101136015|FG002|Overall Study|Adverse Event|4|||
33340309|NCT01964352|101136016|FG003|Overall Study|Adverse Event|3|||
33340310|NCT01964352|101136013|FG000|Overall Study|Lack of Efficacy|6|||
33340311|NCT01964352|101136014|FG001|Overall Study|Lack of Efficacy|0|||
33340312|NCT01964352|101136015|FG002|Overall Study|Lack of Efficacy|0|||
33340313|NCT01964352|101136016|FG003|Overall Study|Lack of Efficacy|0|||
33340314|NCT01964352|101136013|FG000|Overall Study|Protocol Violation|2|||
33340315|NCT01964352|101136014|FG001|Overall Study|Protocol Violation|4|||
33340316|NCT01964352|101136015|FG002|Overall Study|Protocol Violation|0|||
33340317|NCT01964352|101136016|FG003|Overall Study|Protocol Violation|2|||
33340318|NCT01964352|101136013|FG000|Overall Study|Lost to Follow-up|1|||
33340319|NCT01964352|101136014|FG001|Overall Study|Lost to Follow-up|0|||
33340320|NCT01964352|101136015|FG002|Overall Study|Lost to Follow-up|0|||
33340321|NCT01964352|101136016|FG003|Overall Study|Lost to Follow-up|1|||
33340322|NCT01964352|101136013|FG000|Overall Study|Withdrawal by Subject|4|||
33405742|NCT01365182|101373489|FG000|Overall Study|Withdrawal by Subject|10|||
33405743|NCT01365182|101373490|FG001|Overall Study|Withdrawal by Subject|13|||
33405744|NCT01365182|101373491|FG002|Overall Study|Withdrawal by Subject|12|||
33405745|NCT01377194|101373492|FG000|Overall Study|Adverse Event|3|||
33405746|NCT01377194|101373493|FG001|Overall Study|Adverse Event|12|||
33405747|NCT01377194|101373494|FG002|Overall Study|Adverse Event|19|||
33405748|NCT01377194|101373492|FG000|Overall Study|Lack of Efficacy|3|||
33405749|NCT01377194|101373493|FG001|Overall Study|Lack of Efficacy|3|||
33405750|NCT01377194|101373494|FG002|Overall Study|Lack of Efficacy|3|||
33405751|NCT01377194|101373492|FG000|Overall Study|Protocol Violation|4|||
33405752|NCT01377194|101373493|FG001|Overall Study|Protocol Violation|10|||
33340323|NCT01964352|101136014|FG001|Overall Study|Withdrawal by Subject|2|||
33340324|NCT01964352|101136015|FG002|Overall Study|Withdrawal by Subject|1|||
33340325|NCT01964352|101136016|FG003|Overall Study|Withdrawal by Subject|0|||
33340326|NCT01964352|101136013|FG000|Overall Study|Other than stated above|0|||
33340327|NCT01964352|101136014|FG001|Overall Study|Other than stated above|2|||
33405753|NCT01377194|101373494|FG002|Overall Study|Protocol Violation|6|||
33405754|NCT01377194|101373492|FG000|Overall Study|Withdrawal by Subject|8|||
33537386|NCT00126594|101867473|FG000|Overall Study|Disease Progression|29|||
33537387|NCT00126594|101867474|FG001|Overall Study|Disease Progression|24|||
33537388|NCT01774591|101867477|FG000|Overall Study|Physician Decision|1|||
33537389|NCT01774591|101867478|FG001|Overall Study|Physician Decision|1|||
33537390|NCT01774591|101867477|FG000|Overall Study|Withdrawal by Subject|0|||
33537391|NCT01774591|101867478|FG001|Overall Study|Withdrawal by Subject|1|||
33537392|NCT01774591|101867477|FG000|Overall Study|Adverse Event|0|||
33537393|NCT01774591|101867478|FG001|Overall Study|Adverse Event|2|||
33537394|NCT02187783|101867480|FG000|Overall Study|Adverse Event|8|||
33537395|NCT02187783|101867480|FG000|Overall Study|Death|3|||
33537396|NCT02187783|101867480|FG000|Overall Study|Progressive disease|80|||
33537397|NCT02187783|101867480|FG000|Overall Study|Protocol Violation|3|||
33537398|NCT02187783|101867480|FG000|Overall Study|Physician Decision|2|||
33537399|NCT02187783|101867480|FG000|Overall Study|Withdrawal by Subject|9|||
33537400|NCT02187783|101867480|FG000|Overall Study|Study terminated by sponsor|1|||
33537401|NCT02783170|101867481|FG000|Overall Study|Randomized but not Vaccinated|1|||
33537402|NCT02783170|101867482|FG001|Overall Study|Randomized but not Vaccinated|0|||
33537403|NCT00528424|101867483|FG000|Overall Study|Lost to Follow-up|13|||
33537404|NCT00528424|101867483|FG000|Overall Study|Withdrew consent|2|||
33537405|NCT00528424|101867483|FG000|Overall Study|Administrative reason|2|||
33537406|NCT00528424|101867483|FG000|Overall Study|Other|12|||
33537407|NCT02456727|101867484|FG000|Overall Study|Lost to Follow-up|63|||
33537408|NCT02456727|101867485|FG001|Overall Study|Lost to Follow-up|65|||
33537409|NCT02456727|101867484|FG000|Overall Study|Death|2|||
33537410|NCT02456727|101867485|FG001|Overall Study|Death|1|||
33537411|NCT02456727|101867484|FG000|Overall Study|Withdrawal by Subject|1|||
33537412|NCT02456727|101867485|FG001|Overall Study|Withdrawal by Subject|10|||
33537413|NCT02456727|101867484|FG000|Overall Study|Never Initiated Treatment|43|||
33537414|NCT02456727|101867485|FG001|Overall Study|Never Initiated Treatment|30|||
33537415|NCT03080935|101867486|FG000|Overall Study|Death|34|||
33537416|NCT03080935|101867487|FG001|Overall Study|Death|50|||
33537417|NCT03080935|101867486|FG000|Overall Study|Lost to Follow-up|5|||
33537418|NCT03080935|101867487|FG001|Overall Study|Lost to Follow-up|4|||
33537419|NCT03080935|101867486|FG000|Overall Study|Withdrawal by Subject|11|||
33537420|NCT03080935|101867487|FG001|Overall Study|Withdrawal by Subject|15|||
33537421|NCT00671788|101867488|FG000|Overall Study|Adverse Event|8|||
33537422|NCT00671788|101867488|FG000|Overall Study|Refused further treatment|3|||
33537423|NCT00671788|101867488|FG000|Overall Study|Ineligible|1|||
33537424|NCT00671788|101867488|FG000|Overall Study|MD Decision|1|||
33537425|NCT00671788|101867488|FG000|Overall Study|Other|1|||
33537426|NCT01053741|101867490|FG000|2nd Study Intervention|Physician Decision|0|||
33537427|NCT01053741|101867491|FG001|2nd Study Intervention|Physician Decision|1|||
33537428|NCT01499810|101867493|FG000|Overall Study|Lost to Follow-up|10|||
33537429|NCT01499810|101867493|FG000|Overall Study|Protocol Violation|1|||
33537430|NCT01499810|101867493|FG000|Overall Study|Withdrawal by Subject|1|||
33537431|NCT02175121|101867494|FG000|Overall Study|Lack of Efficacy|1|||
33537432|NCT02175121|101867495|FG001|Overall Study|Lack of Efficacy|0|||
33537433|NCT02175121|101867496|FG002|Overall Study|Lack of Efficacy|0|||
33537434|NCT02175121|101867497|FG003|Overall Study|Lack of Efficacy|0|||
33537435|NCT02175121|101867498|FG004|Overall Study|Lack of Efficacy|0|||
33209326|NCT03252587|100670175|FG000|Overall Study|Lost to Follow-up|2|||
33340328|NCT01964352|101136015|FG002|Overall Study|Other than stated above|1|||
33340329|NCT01964352|101136016|FG003|Overall Study|Other than stated above|2|||
33340330|NCT01282229|101136024|FG000|Overall Study|Protocol Violation|2|||
33340331|NCT03804684|101136026|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
33340332|NCT03804684|101136027|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
33340333|NCT02062658|101136028|FG000|Overall Study|Withdrawal by Subject|1|||
33340334|NCT02062658|101136028|FG000|Overall Study|Lack of Efficacy|1|||
33340335|NCT01777152|101136030|FG000|Overall Study|Withdrawal by Subject|22|||
33340336|NCT01777152|101136031|FG001|Overall Study|Withdrawal by Subject|16|||
33405755|NCT01377194|101373493|FG001|Overall Study|Withdrawal by Subject|10|||
33405756|NCT01377194|101373494|FG002|Overall Study|Withdrawal by Subject|7|||
33405757|NCT01377194|101373492|FG000|Overall Study|Lost to Follow-up|14|||
33405758|NCT01377194|101373493|FG001|Overall Study|Lost to Follow-up|8|||
33537436|NCT02175121|101867494|FG000|Overall Study|Lost to Follow-up|0|||
33537437|NCT02175121|101867495|FG001|Overall Study|Lost to Follow-up|1|||
33537438|NCT02175121|101867496|FG002|Overall Study|Lost to Follow-up|0|||
33537439|NCT02175121|101867497|FG003|Overall Study|Lost to Follow-up|1|||
33537440|NCT02175121|101867498|FG004|Overall Study|Lost to Follow-up|0|||
33537441|NCT02175121|101867494|FG000|Overall Study|Personal emergency|0|||
33537442|NCT02175121|101867495|FG001|Overall Study|Personal emergency|0|||
33537443|NCT02175121|101867496|FG002|Overall Study|Personal emergency|0|||
33537444|NCT02175121|101867497|FG003|Overall Study|Personal emergency|0|||
33537445|NCT02175121|101867498|FG004|Overall Study|Personal emergency|1|||
33614509|NCT02702180|102137188|FG002|Double-blind Treatment Period|Protocol Violation|2|||
33537446|NCT02175121|101867494|FG000|Overall Study|Schedule conflict|0|||
33340337|NCT01777152|101136030|FG000|Overall Study|Lost to Follow-up|3|||
33340338|NCT01777152|101136031|FG001|Overall Study|Lost to Follow-up|5|||
33340339|NCT01777152|101136030|FG000|Overall Study|Death|68|||
33340340|NCT01777152|101136031|FG001|Overall Study|Death|89|||
33340341|NCT01777152|101136030|FG000|Overall Study|Not eligible, no study drug received|1|||
33340342|NCT01777152|101136031|FG001|Overall Study|Not eligible, no study drug received|0|||
33340343|NCT01777152|101136030|FG000|Overall Study|Change of diagnosis|1|||
33340344|NCT01777152|101136031|FG001|Overall Study|Change of diagnosis|0|||
33340345|NCT03509350|101136032|FG000|Overall Study|Withdrawal by Subject|0|||
33340346|NCT03509350|101136033|FG001|Overall Study|Withdrawal by Subject|2|||
33340347|NCT02302963|101136034|FG000|Overall Study|Withdrawal by Subject|2|||
33340348|NCT02302963|101136035|FG001|Overall Study|Withdrawal by Subject|1|||
33340349|NCT02302963|101136034|FG000|Overall Study|Steroid injection|0|||
33340350|NCT02302963|101136035|FG001|Overall Study|Steroid injection|1|||
33340351|NCT02302963|101136034|FG000|Overall Study|Physician Decision|1|||
33340352|NCT02302963|101136035|FG001|Overall Study|Physician Decision|0|||
33340353|NCT01731678|101136036|FG000|Overall Study|Withdrawal by Subject|3|||
33340354|NCT01731678|101136036|FG000|Overall Study|Did not meet inclusion criteria|1|||
33340355|NCT01731678|101136036|FG000|Overall Study|RMT too high, making TMS difficult|3|||
33340356|NCT00803179|101136037|FG000|Overall Study|Lost to Follow-up|3|||
33340357|NCT00268242|101136039|FG000|Overall Study|Death|1|||
33340358|NCT03310970|101136040|FG000|Overall Study|Withdrawal by Subject|0|||
33340359|NCT03310970|101136041|FG001|Overall Study|Withdrawal by Subject|1|||
33340360|NCT02175680|101136044|FG000|Overall Study|non-compliance|1|||
33340361|NCT02175680|101136044|FG000|Overall Study|other non-medical reason|1|||
33340362|NCT00430508|101136047|FG000|Overall Study|Adverse Event|2|||
33340363|NCT00430508|101136048|FG001|Overall Study|Adverse Event|3|||
33340364|NCT00430508|101136049|FG002|Overall Study|Adverse Event|5|||
33340365|NCT00430508|101136050|FG003|Overall Study|Adverse Event|3|||
33340366|NCT00430508|101136047|FG000|Overall Study|Withdrawal by Subject|0|||
33340367|NCT00430508|101136048|FG001|Overall Study|Withdrawal by Subject|1|||
33340368|NCT00430508|101136049|FG002|Overall Study|Withdrawal by Subject|1|||
33340369|NCT00430508|101136050|FG003|Overall Study|Withdrawal by Subject|1|||
33340370|NCT00430508|101136047|FG000|Overall Study|responder at visit 4|0|||
33340371|NCT00430508|101136048|FG001|Overall Study|responder at visit 4|0|||
33340372|NCT00430508|101136049|FG002|Overall Study|responder at visit 4|2|||
33340373|NCT00430508|101136050|FG003|Overall Study|responder at visit 4|0|||
33340374|NCT00430508|101136047|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
33340375|NCT00430508|101136048|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
33340376|NCT00430508|101136049|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
33340377|NCT00430508|101136050|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
33340378|NCT00430508|101136047|FG000|Overall Study|Other|1|||
33340379|NCT00430508|101136048|FG001|Overall Study|Other|1|||
33340380|NCT00430508|101136049|FG002|Overall Study|Other|3|||
33340381|NCT00430508|101136050|FG003|Overall Study|Other|0|||
33209327|NCT03252587|100670176|FG001|Overall Study|Lost to Follow-up|0|||
33340382|NCT03273166|101136053|FG000|Overall Study|Withdrawn prior to Completion|31|||
33340383|NCT00796315|101136062|FG000|Overall Study|Protocol Violation|0|||
33340384|NCT00796315|101136063|FG001|Overall Study|Protocol Violation|1|||
33340385|NCT00796315|101136064|FG002|Overall Study|Protocol Violation|0|||
33340386|NCT05019131|101136065|FG000|Overall Study|Lost to Follow-up|0|||
33340387|NCT05019131|101136066|FG001|Overall Study|Lost to Follow-up|3|||
33537447|NCT02175121|101867495|FG001|Overall Study|Schedule conflict|0|||
33340388|NCT01408147|101136067|FG000|Overall Study|Withdrawal by Subject|0|||
33340389|NCT01408147|101136068|FG001|Overall Study|Withdrawal by Subject|1|||
33340390|NCT00704964|101136069|FG000|Overall Study|Not completed on time|328|||
33340391|NCT03742037|101136070|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
33340392|NCT03742037|101136071|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
33209328|NCT03252587|100670177|FG002|Overall Study|Lost to Follow-up|0|||
33405759|NCT01377194|101373494|FG002|Overall Study|Lost to Follow-up|11|||
33405760|NCT01616173|101373495|FG000|Overall Study|Lost to Follow-up|0|||
33405761|NCT01616173|101373496|FG001|Overall Study|Lost to Follow-up|2|||
33405762|NCT01616173|101373497|FG002|Overall Study|Lost to Follow-up|0|||
33405763|NCT00280059|101373502|FG000|Efficacy Assessment Phase|Death|2|||
33340393|NCT03742037|101136072|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
33340394|NCT03742037|101136073|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
33340395|NCT03742037|101136074|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
33340396|NCT03742037|101136075|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
33340397|NCT03742037|101136076|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
33340398|NCT03742037|101136070|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
33340399|NCT03742037|101136071|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
33340400|NCT03742037|101136072|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
33340401|NCT03742037|101136073|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
33340402|NCT03742037|101136074|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
33340403|NCT03742037|101136075|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
33340404|NCT03742037|101136076|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
33340405|NCT03742037|101136070|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
33340406|NCT03742037|101136071|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
33340407|NCT03742037|101136072|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
33340408|NCT03742037|101136073|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
33340409|NCT03742037|101136074|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
33340410|NCT03742037|101136075|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
33340411|NCT03742037|101136076|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
33340412|NCT03742037|101136070|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
33340413|NCT03742037|101136071|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
33405764|NCT00280059|101373503|FG001|Efficacy Assessment Phase|Death|0|||
33405765|NCT00280059|101373502|FG000|Efficacy Assessment Phase|Adverse Event|33|||
33405766|NCT00280059|101373503|FG001|Efficacy Assessment Phase|Adverse Event|31|||
33405767|NCT00280059|101373502|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
33405768|NCT00280059|101373503|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
33405769|NCT00280059|101373502|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
33405770|NCT00280059|101373503|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
33405771|NCT00280059|101373502|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
33405772|NCT00280059|101373503|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
33405773|NCT00280059|101373502|FG000|Efficacy Assessment Phase|Other|7|||
33405774|NCT00280059|101373503|FG001|Efficacy Assessment Phase|Other|8|||
33405775|NCT00280059|101373502|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
33405776|NCT00280059|101373503|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
33405777|NCT02418000|101373505|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
33537448|NCT02175121|101867496|FG002|Overall Study|Schedule conflict|1|||
33537449|NCT02175121|101867497|FG003|Overall Study|Schedule conflict|0|||
33537450|NCT02175121|101867498|FG004|Overall Study|Schedule conflict|0|||
33537451|NCT02175121|101867494|FG000|Overall Study|Time issues|0|||
33537452|NCT02175121|101867495|FG001|Overall Study|Time issues|0|||
33537453|NCT02175121|101867496|FG002|Overall Study|Time issues|1|||
33537454|NCT02175121|101867497|FG003|Overall Study|Time issues|0|||
33209329|NCT03252587|100670178|FG003|Overall Study|Lost to Follow-up|2|||
33209330|NCT03252587|100670175|FG000|Overall Study|Pregnancy|2|||
33209331|NCT03252587|100670176|FG001|Overall Study|Pregnancy|1|||
33209332|NCT03252587|100670177|FG002|Overall Study|Pregnancy|0|||
33340414|NCT03742037|101136072|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
33405778|NCT02418000|101373506|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
33405779|NCT02418000|101373507|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
33209333|NCT03252587|100670178|FG003|Overall Study|Pregnancy|1|||
33209334|NCT03252587|100670175|FG000|Overall Study|Withdrawal by Subject|8|||
33340415|NCT03742037|101136073|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
33340416|NCT03742037|101136074|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
33340417|NCT03742037|101136075|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
33340418|NCT03742037|101136076|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
33405780|NCT02418000|101373508|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
33405781|NCT02418000|101373509|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
33405782|NCT02418000|101373505|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
33405783|NCT02418000|101373506|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
33537455|NCT02175121|101867498|FG004|Overall Study|Time issues|0|||
33340419|NCT03742037|101136070|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
33340420|NCT03742037|101136071|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
33340421|NCT03742037|101136072|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
33537456|NCT00823134|101867499|FG000|Overall Study|Invalid measurement|1|||
33209335|NCT03252587|100670176|FG001|Overall Study|Withdrawal by Subject|4|||
33537457|NCT03217591|101867502|FG000|Overall Study|Adverse Event|1|||
33537458|NCT03217591|101867503|FG001|Overall Study|Adverse Event|2|||
33537459|NCT03217591|101867504|FG002|Overall Study|Adverse Event|6|||
33537460|NCT03217591|101867502|FG000|Overall Study|Withdrawal by Subject|0|||
33537461|NCT03217591|101867503|FG001|Overall Study|Withdrawal by Subject|1|||
33537462|NCT03217591|101867504|FG002|Overall Study|Withdrawal by Subject|3|||
33537463|NCT03217591|101867502|FG000|Overall Study|Lost to Follow-up|1|||
33537464|NCT03217591|101867503|FG001|Overall Study|Lost to Follow-up|0|||
33537465|NCT03217591|101867504|FG002|Overall Study|Lost to Follow-up|0|||
33209336|NCT03252587|100670177|FG002|Overall Study|Withdrawal by Subject|4|||
33340422|NCT03742037|101136073|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
33340423|NCT03742037|101136074|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
33340424|NCT03742037|101136075|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
33340425|NCT03742037|101136076|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
33340426|NCT03742037|101136070|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
33340427|NCT03742037|101136071|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
33364969|NCT04760314|101223699|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
33537466|NCT03217591|101867502|FG000|Overall Study|Protocol Violation|1|||
33537467|NCT03217591|101867503|FG001|Overall Study|Protocol Violation|0|||
33537468|NCT03217591|101867504|FG002|Overall Study|Protocol Violation|1|||
33537469|NCT02163395|101867505|FG000|Overall Study|Withdrawal by Subject|1|||
33537470|NCT02163395|101867505|FG000|Overall Study|Lost to Follow-up|3|||
33537471|NCT02163395|101867505|FG000|Overall Study|Adverse Event|1|||
33209337|NCT03252587|100670178|FG003|Overall Study|Withdrawal by Subject|4|||
33614510|NCT02702180|102137186|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
33209338|NCT03252587|100670175|FG000|Overall Study|Other Reasons|2|||
33209339|NCT03252587|100670176|FG001|Overall Study|Other Reasons|5|||
33209340|NCT03252587|100670177|FG002|Overall Study|Other Reasons|5|||
33340428|NCT03742037|101136072|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
33340429|NCT03742037|101136073|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
33340430|NCT03742037|101136074|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
33340431|NCT03742037|101136075|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
33340432|NCT03742037|101136076|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
33340433|NCT03742037|101136070|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
33340434|NCT03742037|101136071|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
33340435|NCT03742037|101136072|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
33340436|NCT03742037|101136073|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
33340437|NCT03742037|101136074|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
33340438|NCT03742037|101136075|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
33340439|NCT03742037|101136076|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
33340440|NCT03742037|101136070|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
33340441|NCT03742037|101136071|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
33340442|NCT03742037|101136072|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
33340443|NCT03742037|101136073|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
33340444|NCT03742037|101136074|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
33340445|NCT03742037|101136075|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
33340446|NCT03742037|101136076|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
33340447|NCT03742037|101136070|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
33340448|NCT03742037|101136071|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
33340449|NCT03742037|101136072|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
33340450|NCT03742037|101136073|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
33405784|NCT02418000|101373507|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
33405785|NCT02418000|101373508|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
33537472|NCT01494818|101867507|FG000|Overall Study|Relocation|1|||
33537473|NCT01494818|101867508|FG001|Overall Study|Relocation|2|||
33537474|NCT01494818|101867507|FG000|Overall Study|Lost to Follow-up|1|||
33537475|NCT01494818|101867508|FG001|Overall Study|Lost to Follow-up|0|||
33537476|NCT01198002|101867511|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
33537477|NCT01198002|101867512|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
33537478|NCT01198002|101867513|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
33537479|NCT01198002|101867511|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
33537480|NCT01198002|101867512|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
33537481|NCT01198002|101867513|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
33537482|NCT01198002|101867511|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
33537483|NCT01198002|101867512|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
33537484|NCT01198002|101867513|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
33537485|NCT01198002|101867511|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
33537486|NCT01198002|101867512|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
33537487|NCT01198002|101867513|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
33537488|NCT01198002|101867511|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
33537489|NCT01198002|101867512|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
33537490|NCT01198002|101867513|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
33537491|NCT01198002|101867511|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
33537492|NCT01198002|101867512|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
33537493|NCT01198002|101867513|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
33537494|NCT01198002|101867511|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
33537495|NCT01198002|101867512|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
33537496|NCT01198002|101867513|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
33537497|NCT01198002|101867511|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
33537498|NCT01198002|101867512|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
33537499|NCT01198002|101867513|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
33537500|NCT01198002|101867511|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
33537501|NCT01198002|101867512|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
33537502|NCT01198002|101867513|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
33537503|NCT01198002|101867511|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
33614511|NCT02702180|102137187|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
33209341|NCT03252587|100670178|FG003|Overall Study|Other Reasons|4|||
33537504|NCT01198002|101867512|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
33537505|NCT01198002|101867513|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
33614512|NCT02702180|102137188|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
33614513|NCT02702180|102137186|FG000|Open-label Treatment Period|Withdrawn in error|0|||
33209342|NCT02671435|100670180|FG000|Overall Study|Death|1|||
33537506|NCT01198002|101867511|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
33537507|NCT01198002|101867512|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
33537508|NCT01198002|101867513|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
33537509|NCT01198002|101867511|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
33537510|NCT01198002|101867512|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
33537511|NCT01198002|101867513|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
33537512|NCT01198002|101867511|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
33537513|NCT01198002|101867512|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
33537514|NCT01198002|101867513|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
33537515|NCT01198002|101867511|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
33537516|NCT01198002|101867512|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
33537517|NCT01198002|101867513|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
33537518|NCT01198002|101867511|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
33614514|NCT02702180|102137187|FG001|Open-label Treatment Period|Withdrawn in error|0|||
33614515|NCT02702180|102137188|FG002|Open-label Treatment Period|Withdrawn in error|1|||
33614516|NCT04599465|102137189|FG000|Overall Study|Physician Decision|1|||
33614517|NCT04599465|102137189|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
33537519|NCT01198002|101867512|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
33537520|NCT01198002|101867513|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
33537521|NCT01064414|101867517|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
33537522|NCT01064414|101867518|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
33537523|NCT01064414|101867519|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
33537524|NCT01064414|101867517|FG000|Core Period: Baseline to Week 26|Death|0|||
33537525|NCT01064414|101867518|FG001|Core Period: Baseline to Week 26|Death|1|||
33537526|NCT01064414|101867519|FG002|Core Period: Baseline to Week 26|Death|0|||
33537527|NCT01064414|101867517|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
33537528|NCT01064414|101867518|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
33537529|NCT01064414|101867519|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
33537530|NCT01064414|101867517|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
33537531|NCT01064414|101867518|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
33537532|NCT01064414|101867519|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
33614518|NCT01059318|102137193|FG000|Core Study (26 Week)|Adverse Event|3|||
33614519|NCT01059318|102137193|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
33614520|NCT01059318|102137193|FG000|Extension (36 Week)|Adverse Event|3|||
33209343|NCT02671435|100670181|FG001|Overall Study|Death|3|||
33209344|NCT02671435|100670182|FG002|Overall Study|Death|0|||
33209345|NCT02671435|100670183|FG003|Overall Study|Death|16|||
33537533|NCT01064414|101867517|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33537534|NCT01064414|101867518|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
33537535|NCT01064414|101867519|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33537536|NCT01064414|101867517|FG000|Core Period: Baseline to Week 26|Other|4|||
33537537|NCT01064414|101867518|FG001|Core Period: Baseline to Week 26|Other|7|||
33537538|NCT01064414|101867519|FG002|Core Period: Baseline to Week 26|Other|2|||
33537539|NCT01064414|101867517|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
33537540|NCT01064414|101867518|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
33537541|NCT01064414|101867519|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
33537542|NCT01064414|101867517|FG000|Extension Period: Week 26 to Week 52|Death|0|||
33537543|NCT01064414|101867518|FG001|Extension Period: Week 26 to Week 52|Death|1|||
33537544|NCT01064414|101867519|FG002|Extension Period: Week 26 to Week 52|Death|0|||
33340451|NCT03742037|101136074|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
33340452|NCT03742037|101136075|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
33340453|NCT03742037|101136076|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
33340454|NCT03742037|101136070|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
33340455|NCT03742037|101136071|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
33340456|NCT03742037|101136072|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
33340457|NCT03742037|101136073|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
33340458|NCT03742037|101136074|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
33340459|NCT03742037|101136075|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
33340460|NCT03742037|101136076|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
33340461|NCT03742037|101136070|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
33340462|NCT03742037|101136071|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
33537545|NCT01064414|101867517|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
33537546|NCT01064414|101867518|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33537547|NCT01064414|101867519|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33614521|NCT01610336|102137196|FG000|Overall Study|Progressive Disease|4|||
33614522|NCT01610336|102137197|FG001|Overall Study|Progressive Disease|6|||
33209346|NCT02671435|100670184|FG004|Overall Study|Death|14|||
33209347|NCT02671435|100670185|FG005|Overall Study|Death|29|||
33209348|NCT02671435|100670186|FG006|Overall Study|Death|34|||
33209349|NCT02671435|100670187|FG007|Overall Study|Death|28|||
33209350|NCT02671435|100670188|FG008|Overall Study|Death|19|||
33537548|NCT01064414|101867517|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
33537549|NCT01064414|101867518|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33537550|NCT01064414|101867519|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33405786|NCT02418000|101373509|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
33209351|NCT02671435|100670189|FG009|Overall Study|Death|10|||
33209352|NCT02671435|100670190|FG010|Overall Study|Death|8|||
33537551|NCT01064414|101867517|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33537552|NCT01064414|101867518|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
33537553|NCT01064414|101867519|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33405787|NCT02418000|101373505|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
33537554|NCT01064414|101867517|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
33537555|NCT01064414|101867518|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
33537556|NCT01064414|101867519|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
33537557|NCT01064414|101867517|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
33537558|NCT01064414|101867518|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
33537559|NCT01064414|101867519|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
33537560|NCT01064414|101867517|FG000|Extension Period: Week 26 to Week 52|Other|5|||
33537561|NCT01064414|101867518|FG001|Extension Period: Week 26 to Week 52|Other|2|||
33537562|NCT01064414|101867519|FG002|Extension Period: Week 26 to Week 52|Other|1|||
33537563|NCT05081388|101867520|FG000|Overall Study|Adverse Event|1|||
33537564|NCT05081388|101867521|FG001|Overall Study|Adverse Event|0|||
33537565|NCT05081388|101867522|FG002|Overall Study|Adverse Event|0|||
33537566|NCT05081388|101867523|FG003|Overall Study|Adverse Event|0|||
33537567|NCT05081388|101867524|FG004|Overall Study|Adverse Event|0|||
33537568|NCT05081388|101867520|FG000|Overall Study|Lost to Follow-up|0|||
33537569|NCT05081388|101867521|FG001|Overall Study|Lost to Follow-up|1|||
33340463|NCT03742037|101136072|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
33340464|NCT03742037|101136073|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
33340465|NCT03742037|101136074|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
33340466|NCT03742037|101136075|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
33340467|NCT03742037|101136076|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
33340468|NCT03742037|101136070|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
33340469|NCT03742037|101136071|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
33340470|NCT03742037|101136072|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
33340471|NCT03742037|101136073|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
33340472|NCT03742037|101136074|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
33340473|NCT03742037|101136075|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
33340474|NCT03742037|101136076|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
33340475|NCT03742037|101136070|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
33340476|NCT03742037|101136071|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
33340477|NCT03742037|101136072|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
33340478|NCT03742037|101136073|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
33537570|NCT05081388|101867522|FG002|Overall Study|Lost to Follow-up|0|||
33537571|NCT05081388|101867523|FG003|Overall Study|Lost to Follow-up|0|||
33537572|NCT05081388|101867524|FG004|Overall Study|Lost to Follow-up|0|||
33537573|NCT05081388|101867520|FG000|Overall Study|Subject decision|0|||
33537574|NCT05081388|101867521|FG001|Overall Study|Subject decision|0|||
33537575|NCT05081388|101867522|FG002|Overall Study|Subject decision|0|||
33537576|NCT05081388|101867523|FG003|Overall Study|Subject decision|1|||
33537577|NCT05081388|101867524|FG004|Overall Study|Subject decision|0|||
33537578|NCT00726609|101867525|FG000|Overall Study|Adverse Event|10|||
33537579|NCT00726609|101867525|FG000|Overall Study|Withdrawal by Subject|2|||
33537580|NCT00726609|101867525|FG000|Overall Study|Lack of Efficacy|25|||
33537581|NCT00726609|101867525|FG000|Overall Study|Other|16|||
33340479|NCT03742037|101136074|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
33340480|NCT03742037|101136075|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
33340481|NCT03742037|101136076|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
33340482|NCT03742037|101136070|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
33340483|NCT03742037|101136071|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
33537582|NCT00726609|101867525|FG000|Overall Study|Missing|42|||
33537583|NCT00726609|101867525|FG000|Overall Study|Other|3|||
33537584|NCT01791985|101867526|FG000|Overall Study|Adverse Event|7|||
33537585|NCT01791985|101867526|FG000|Overall Study|Withdrawal by Subject|1|||
33537586|NCT03102762|101867529|FG000|Overall Study|Lost to Follow-up|1|||
33537587|NCT03102762|101867530|FG001|Overall Study|Lost to Follow-up|0|||
33537588|NCT00863707|101867531|FG000|Overall Study|Randomized, but drug not received|4|||
33537589|NCT00863707|101867532|FG001|Overall Study|Randomized, but drug not received|3|||
33537590|NCT00735709|101867539|FG000|Overall Study|Adverse Event|2|||
33537591|NCT00735709|101867540|FG001|Overall Study|Adverse Event|3|||
33537592|NCT00735709|101867541|FG002|Overall Study|Adverse Event|1|||
33614523|NCT01610336|102137198|FG002|Overall Study|Progressive Disease|6|||
33209353|NCT02671435|100670191|FG011|Overall Study|Death|29|||
33340484|NCT03742037|101136072|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
33340485|NCT03742037|101136073|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
33209354|NCT02671435|100670192|FG012|Overall Study|Death|29|||
33537593|NCT00735709|101867542|FG003|Overall Study|Adverse Event|5|||
33537594|NCT00735709|101867539|FG000|Overall Study|Lack of Efficacy|8|||
33537595|NCT00735709|101867540|FG001|Overall Study|Lack of Efficacy|4|||
33537596|NCT00735709|101867541|FG002|Overall Study|Lack of Efficacy|2|||
33537597|NCT00735709|101867542|FG003|Overall Study|Lack of Efficacy|3|||
33537598|NCT00735709|101867539|FG000|Overall Study|Noncompliance|0|||
33537599|NCT00735709|101867540|FG001|Overall Study|Noncompliance|0|||
33537600|NCT00735709|101867541|FG002|Overall Study|Noncompliance|1|||
33614524|NCT01610336|102137199|FG003|Overall Study|Progressive Disease|5|||
33614525|NCT01610336|102137200|FG004|Overall Study|Progressive Disease|3|||
33614526|NCT01610336|102137201|FG005|Overall Study|Progressive Disease|10|||
33614527|NCT01610336|102137202|FG006|Overall Study|Progressive Disease|1|||
33614528|NCT01610336|102137203|FG007|Overall Study|Progressive Disease|6|||
33614529|NCT01610336|102137204|FG008|Overall Study|Progressive Disease|6|||
33614530|NCT01610336|102137205|FG009|Overall Study|Progressive Disease|40|||
33614531|NCT01610336|102137206|FG010|Overall Study|Progressive Disease|36|||
33614532|NCT01610336|102137196|FG000|Overall Study|Adverse Event|0|||
33614533|NCT01610336|102137197|FG001|Overall Study|Adverse Event|0|||
33614534|NCT01610336|102137198|FG002|Overall Study|Adverse Event|0|||
33614535|NCT01610336|102137199|FG003|Overall Study|Adverse Event|1|||
33614536|NCT01610336|102137200|FG004|Overall Study|Adverse Event|1|||
33614537|NCT01610336|102137201|FG005|Overall Study|Adverse Event|1|||
33614538|NCT01610336|102137202|FG006|Overall Study|Adverse Event|0|||
33614539|NCT01610336|102137203|FG007|Overall Study|Adverse Event|0|||
33614540|NCT01610336|102137204|FG008|Overall Study|Adverse Event|2|||
33614541|NCT01610336|102137205|FG009|Overall Study|Adverse Event|8|||
33614542|NCT01610336|102137206|FG010|Overall Study|Adverse Event|6|||
33614543|NCT01610336|102137196|FG000|Overall Study|Subject/Guardian decision|1|||
33614544|NCT01610336|102137197|FG001|Overall Study|Subject/Guardian decision|1|||
33614545|NCT01610336|102137198|FG002|Overall Study|Subject/Guardian decision|0|||
33614546|NCT01610336|102137199|FG003|Overall Study|Subject/Guardian decision|1|||
33614547|NCT01610336|102137200|FG004|Overall Study|Subject/Guardian decision|0|||
33614548|NCT01610336|102137201|FG005|Overall Study|Subject/Guardian decision|0|||
33614549|NCT01610336|102137202|FG006|Overall Study|Subject/Guardian decision|0|||
33614550|NCT01610336|102137203|FG007|Overall Study|Subject/Guardian decision|1|||
33614551|NCT01610336|102137204|FG008|Overall Study|Subject/Guardian decision|0|||
33614552|NCT01610336|102137205|FG009|Overall Study|Subject/Guardian decision|2|||
33614553|NCT01610336|102137206|FG010|Overall Study|Subject/Guardian decision|2|||
33614554|NCT01610336|102137196|FG000|Overall Study|Death|0|||
33614555|NCT01610336|102137197|FG001|Overall Study|Death|0|||
33614556|NCT01610336|102137198|FG002|Overall Study|Death|0|||
33614557|NCT01610336|102137199|FG003|Overall Study|Death|0|||
33614558|NCT01610336|102137200|FG004|Overall Study|Death|0|||
33614559|NCT01610336|102137201|FG005|Overall Study|Death|1|||
33340486|NCT03742037|101136074|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
33340487|NCT03742037|101136075|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
33340488|NCT03742037|101136076|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
33340489|NCT03742037|101136070|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
33340490|NCT03742037|101136071|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
33340491|NCT03742037|101136072|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
33340492|NCT03742037|101136073|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
33537601|NCT00735709|101867542|FG003|Overall Study|Noncompliance|0|||
33537602|NCT00735709|101867539|FG000|Overall Study|Protocol deviations|1|||
33537603|NCT00735709|101867540|FG001|Overall Study|Protocol deviations|2|||
33537604|NCT00735709|101867541|FG002|Overall Study|Protocol deviations|1|||
33537605|NCT00735709|101867542|FG003|Overall Study|Protocol deviations|1|||
33537606|NCT00735709|101867539|FG000|Overall Study|Voluntary Withdrawal|1|||
33537607|NCT00735709|101867540|FG001|Overall Study|Voluntary Withdrawal|3|||
33537608|NCT00735709|101867541|FG002|Overall Study|Voluntary Withdrawal|5|||
33537609|NCT00735709|101867542|FG003|Overall Study|Voluntary Withdrawal|7|||
33537610|NCT00735709|101867539|FG000|Overall Study|Lost to Follow-up|0|||
33537611|NCT00735709|101867540|FG001|Overall Study|Lost to Follow-up|1|||
33537612|NCT00735709|101867541|FG002|Overall Study|Lost to Follow-up|1|||
33537613|NCT00735709|101867542|FG003|Overall Study|Lost to Follow-up|1|||
33537614|NCT00735709|101867539|FG000|Overall Study|Excluded medication|1|||
33537615|NCT00735709|101867540|FG001|Overall Study|Excluded medication|0|||
33537616|NCT00735709|101867541|FG002|Overall Study|Excluded medication|0|||
33537617|NCT00735709|101867542|FG003|Overall Study|Excluded medication|1|||
33537618|NCT02781324|101867543|FG000|Overall Study|Withdrawal by Subject|1|||
33537619|NCT02781324|101867544|FG001|Overall Study|Withdrawal by Subject|0|||
33537620|NCT02781324|101867543|FG000|Overall Study|Physician Decision|1|||
33537621|NCT02781324|101867544|FG001|Overall Study|Physician Decision|2|||
33537622|NCT00746551|101867545|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
33614560|NCT01610336|102137202|FG006|Overall Study|Death|3|||
33614561|NCT01610336|102137203|FG007|Overall Study|Death|0|||
33614562|NCT01610336|102137204|FG008|Overall Study|Death|0|||
33614563|NCT01610336|102137205|FG009|Overall Study|Death|1|||
33614564|NCT01610336|102137206|FG010|Overall Study|Death|2|||
33537623|NCT00746551|101867546|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
33537624|NCT00746551|101867545|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
33614565|NCT01610336|102137196|FG000|Overall Study|Non-Compliance with study treatment|0|||
33614566|NCT01610336|102137197|FG001|Overall Study|Non-Compliance with study treatment|0|||
33614567|NCT01610336|102137198|FG002|Overall Study|Non-Compliance with study treatment|0|||
33614568|NCT01610336|102137199|FG003|Overall Study|Non-Compliance with study treatment|0|||
33614569|NCT01610336|102137200|FG004|Overall Study|Non-Compliance with study treatment|0|||
33614570|NCT01610336|102137201|FG005|Overall Study|Non-Compliance with study treatment|0|||
33614571|NCT01610336|102137202|FG006|Overall Study|Non-Compliance with study treatment|0|||
33614572|NCT01610336|102137203|FG007|Overall Study|Non-Compliance with study treatment|0|||
33614573|NCT01610336|102137204|FG008|Overall Study|Non-Compliance with study treatment|0|||
33614574|NCT01610336|102137205|FG009|Overall Study|Non-Compliance with study treatment|1|||
33537625|NCT00746551|101867546|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
33537626|NCT00746551|101867545|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
33537627|NCT00746551|101867546|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
33537628|NCT01204671|101867547|FG000|Overall Study|Adverse Event|4|||
33537629|NCT01204671|101867548|FG001|Overall Study|Adverse Event|3|||
33537630|NCT01204671|101867549|FG002|Overall Study|Adverse Event|3|||
33537631|NCT01204671|101867550|FG003|Overall Study|Adverse Event|3|||
33537632|NCT01204671|101867551|FG004|Overall Study|Adverse Event|1|||
33537633|NCT01204671|101867547|FG000|Overall Study|Withdrawal by Subject|2|||
33537634|NCT01204671|101867548|FG001|Overall Study|Withdrawal by Subject|3|||
33537635|NCT01204671|101867549|FG002|Overall Study|Withdrawal by Subject|4|||
33537636|NCT01204671|101867550|FG003|Overall Study|Withdrawal by Subject|5|||
33537637|NCT01204671|101867551|FG004|Overall Study|Withdrawal by Subject|3|||
33537638|NCT01204671|101867547|FG000|Overall Study|Lost to Follow-up|7|||
33537639|NCT01204671|101867548|FG001|Overall Study|Lost to Follow-up|8|||
33537640|NCT01204671|101867549|FG002|Overall Study|Lost to Follow-up|6|||
33537641|NCT01204671|101867550|FG003|Overall Study|Lost to Follow-up|4|||
33537642|NCT01204671|101867551|FG004|Overall Study|Lost to Follow-up|0|||
33537643|NCT01204671|101867547|FG000|Overall Study|Unknown Completion Status|1|||
33537644|NCT01204671|101867548|FG001|Overall Study|Unknown Completion Status|1|||
33537645|NCT01204671|101867549|FG002|Overall Study|Unknown Completion Status|0|||
33537646|NCT01204671|101867550|FG003|Overall Study|Unknown Completion Status|0|||
33537647|NCT01204671|101867551|FG004|Overall Study|Unknown Completion Status|0|||
33537648|NCT01204671|101867547|FG000|Overall Study|Physician Decision|0|||
33537649|NCT01204671|101867548|FG001|Overall Study|Physician Decision|0|||
33537650|NCT01204671|101867549|FG002|Overall Study|Physician Decision|0|||
33537651|NCT01204671|101867550|FG003|Overall Study|Physician Decision|1|||
33537652|NCT01204671|101867551|FG004|Overall Study|Physician Decision|0|||
33614575|NCT01610336|102137206|FG010|Overall Study|Non-Compliance with study treatment|0|||
33614576|NCT01610336|102137196|FG000|Overall Study|Physician Decision|0|||
33614577|NCT01610336|102137197|FG001|Overall Study|Physician Decision|0|||
33614578|NCT01610336|102137198|FG002|Overall Study|Physician Decision|0|||
33614579|NCT01610336|102137199|FG003|Overall Study|Physician Decision|0|||
33614580|NCT01610336|102137200|FG004|Overall Study|Physician Decision|0|||
33614581|NCT01610336|102137201|FG005|Overall Study|Physician Decision|0|||
33614582|NCT01610336|102137202|FG006|Overall Study|Physician Decision|1|||
33614583|NCT01610336|102137203|FG007|Overall Study|Physician Decision|0|||
33614584|NCT01610336|102137204|FG008|Overall Study|Physician Decision|0|||
33614585|NCT01610336|102137205|FG009|Overall Study|Physician Decision|0|||
33614586|NCT01610336|102137206|FG010|Overall Study|Physician Decision|0|||
33614587|NCT01610336|102137196|FG000|Overall Study|Protocol Deviation|0|||
33614588|NCT01610336|102137197|FG001|Overall Study|Protocol Deviation|0|||
33209355|NCT02671435|100670193|FG013|Overall Study|Death|29|||
33209356|NCT02671435|100670194|FG014|Overall Study|Death|27|||
33209357|NCT02671435|100670180|FG000|Overall Study|Lost to Follow-up|0|||
33209358|NCT02671435|100670181|FG001|Overall Study|Lost to Follow-up|0|||
33209359|NCT02671435|100670182|FG002|Overall Study|Lost to Follow-up|1|||
33209360|NCT02671435|100670183|FG003|Overall Study|Lost to Follow-up|0|||
33209361|NCT02671435|100670184|FG004|Overall Study|Lost to Follow-up|1|||
33209362|NCT02671435|100670185|FG005|Overall Study|Lost to Follow-up|1|||
33209363|NCT02671435|100670186|FG006|Overall Study|Lost to Follow-up|2|||
33209364|NCT02671435|100670187|FG007|Overall Study|Lost to Follow-up|2|||
33209365|NCT02671435|100670188|FG008|Overall Study|Lost to Follow-up|0|||
33340493|NCT03742037|101136074|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
33340494|NCT03742037|101136075|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
33537653|NCT02247466|101867560|FG000|Overall Study|Procedure changed to open surgery|0|||
33537654|NCT02247466|101867561|FG001|Overall Study|Procedure changed to open surgery|3|||
33614589|NCT01610336|102137198|FG002|Overall Study|Protocol Deviation|0|||
33614590|NCT01610336|102137199|FG003|Overall Study|Protocol Deviation|0|||
33614591|NCT01610336|102137200|FG004|Overall Study|Protocol Deviation|0|||
33614592|NCT01610336|102137201|FG005|Overall Study|Protocol Deviation|0|||
33614593|NCT01610336|102137202|FG006|Overall Study|Protocol Deviation|0|||
33537655|NCT03585270|101867562|FG000|Overall Study|Withdrawal by Subject|2|||
33537656|NCT03585270|101867563|FG001|Overall Study|Withdrawal by Subject|6|||
33537657|NCT03585270|101867562|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
33614594|NCT01610336|102137203|FG007|Overall Study|Protocol Deviation|0|||
33614595|NCT01610336|102137204|FG008|Overall Study|Protocol Deviation|0|||
33614596|NCT01610336|102137205|FG009|Overall Study|Protocol Deviation|1|||
33209366|NCT02671435|100670189|FG009|Overall Study|Lost to Follow-up|2|||
33614597|NCT01610336|102137206|FG010|Overall Study|Protocol Deviation|0|||
33614598|NCT01610336|102137196|FG000|Overall Study|Transfer to another trial|0|||
33614599|NCT01610336|102137197|FG001|Overall Study|Transfer to another trial|0|||
33340495|NCT03742037|101136076|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
33537658|NCT03585270|101867563|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
33614600|NCT01610336|102137198|FG002|Overall Study|Transfer to another trial|0|||
33614601|NCT01610336|102137199|FG003|Overall Study|Transfer to another trial|0|||
33537659|NCT03585270|101867562|FG000|Overall Study|Adverse Event|5|||
33537660|NCT03585270|101867563|FG001|Overall Study|Adverse Event|2|||
33537661|NCT03585270|101867562|FG000|Overall Study|Lost to Follow-up|1|||
33537662|NCT03585270|101867563|FG001|Overall Study|Lost to Follow-up|4|||
33537663|NCT03585270|101867562|FG000|Overall Study|Death|5|||
33537664|NCT03585270|101867563|FG001|Overall Study|Death|3|||
33537665|NCT03585270|101867562|FG000|Overall Study|Other reasons|2|||
33537666|NCT03585270|101867563|FG001|Overall Study|Other reasons|2|||
33537667|NCT02087774|101867576|FG000|Overall Study|Were absent day of data collection|8|||
33537668|NCT02087774|101867577|FG001|Overall Study|Were absent day of data collection|20|||
33537669|NCT01200329|101867579|FG000|Overall Study|Lack of financial coverage|2|||
33537670|NCT01200329|101867579|FG000|Overall Study|Progressive disease|1|||
33537671|NCT03368807|101867580|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
33537672|NCT03368807|101867580|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
33614602|NCT01610336|102137200|FG004|Overall Study|Transfer to another trial|0|||
33614603|NCT01610336|102137201|FG005|Overall Study|Transfer to another trial|0|||
33340496|NCT01042600|101136077|FG000|Overall Study|Ineligible|1|||
33340497|NCT01042600|101136078|FG001|Overall Study|Ineligible|0|||
33340498|NCT01400451|101136081|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
33340499|NCT01400451|101136082|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
33340500|NCT01400451|101136083|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
33340501|NCT01400451|101136081|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
33340502|NCT01400451|101136082|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
33340503|NCT01400451|101136083|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
33340504|NCT01400451|101136081|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
33340505|NCT01400451|101136082|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
33340506|NCT01400451|101136083|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
33340507|NCT01400451|101136081|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
33340508|NCT01400451|101136082|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
33340509|NCT01400451|101136083|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
33340510|NCT01400451|101136081|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
33340511|NCT01400451|101136082|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
33340512|NCT01400451|101136083|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
33340513|NCT01512264|101136084|FG000|Overall Study|Lost to Follow-up|0|||
33340514|NCT01512264|101136085|FG001|Overall Study|Lost to Follow-up|0|||
33340515|NCT01512264|101136086|FG002|Overall Study|Lost to Follow-up|0|||
33340516|NCT01512264|101136087|FG003|Overall Study|Lost to Follow-up|1|||
33340517|NCT04372927|101136093|FG000|Overall Study|Death|1|||
33340518|NCT03870555|101136098|FG000|Period 3 (2 Days)|Adverse Event|1|||
33340519|NCT03870555|101136099|FG001|Period 3 (2 Days)|Adverse Event|0|||
33340520|NCT03870555|101136100|FG002|Period 3 (2 Days)|Adverse Event|0|||
33340521|NCT01857869|101136102|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
33340522|NCT01857869|101136103|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
33340523|NCT01857869|101136104|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
33340524|NCT01857869|101136105|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
33340525|NCT01857869|101136106|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
33340526|NCT01857869|101136107|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
33340527|NCT01857869|101136108|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
33340528|NCT01857869|101136109|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
33340529|NCT01857869|101136110|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
33340530|NCT01857869|101136111|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
33340531|NCT01857869|101136102|FG000|Primary/Challenge Phase|Pregnancy|1|||
33340532|NCT01857869|101136103|FG001|Primary/Challenge Phase|Pregnancy|0|||
33405788|NCT02418000|101373506|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
33405789|NCT02418000|101373507|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
33405790|NCT02418000|101373508|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
33537673|NCT03368807|101867580|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
33614604|NCT01610336|102137202|FG006|Overall Study|Transfer to another trial|0|||
33340533|NCT01857869|101136104|FG002|Primary/Challenge Phase|Pregnancy|0|||
33340534|NCT01857869|101136105|FG003|Primary/Challenge Phase|Pregnancy|0|||
33340535|NCT01857869|101136106|FG004|Primary/Challenge Phase|Pregnancy|0|||
33340536|NCT01857869|101136107|FG005|Primary/Challenge Phase|Pregnancy|0|||
33537674|NCT03368807|101867580|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
33537675|NCT02812186|101867582|FG000|Period 1|Post randomization screen failure|5|||
33537676|NCT02812186|101867583|FG001|Period 1|Post randomization screen failure|9|||
33614605|NCT01610336|102137203|FG007|Overall Study|Transfer to another trial|0|||
33340537|NCT01857869|101136108|FG006|Primary/Challenge Phase|Pregnancy|0|||
33209367|NCT02671435|100670190|FG010|Overall Study|Lost to Follow-up|0|||
33209368|NCT02671435|100670191|FG011|Overall Study|Lost to Follow-up|3|||
33209369|NCT02671435|100670192|FG012|Overall Study|Lost to Follow-up|3|||
33209370|NCT02671435|100670193|FG013|Overall Study|Lost to Follow-up|2|||
33209371|NCT02671435|100670194|FG014|Overall Study|Lost to Follow-up|0|||
33537677|NCT02812186|101867582|FG000|Period 1|nonevaluable data sets|6|||
33537678|NCT02812186|101867583|FG001|Period 1|nonevaluable data sets|6|||
33340538|NCT01857869|101136109|FG007|Primary/Challenge Phase|Pregnancy|0|||
33340539|NCT01857869|101136110|FG008|Primary/Challenge Phase|Pregnancy|0|||
33209372|NCT02671435|100670180|FG000|Overall Study|Withdrawal by Subject|2|||
33209373|NCT02671435|100670181|FG001|Overall Study|Withdrawal by Subject|0|||
33209374|NCT02671435|100670182|FG002|Overall Study|Withdrawal by Subject|2|||
33209375|NCT02671435|100670183|FG003|Overall Study|Withdrawal by Subject|2|||
33209376|NCT02671435|100670184|FG004|Overall Study|Withdrawal by Subject|2|||
33209377|NCT02671435|100670185|FG005|Overall Study|Withdrawal by Subject|7|||
33209378|NCT02671435|100670186|FG006|Overall Study|Withdrawal by Subject|2|||
33209379|NCT02671435|100670187|FG007|Overall Study|Withdrawal by Subject|7|||
33209380|NCT02671435|100670188|FG008|Overall Study|Withdrawal by Subject|1|||
33340540|NCT01857869|101136111|FG009|Primary/Challenge Phase|Pregnancy|0|||
33340541|NCT01857869|101136102|FG000|Primary/Challenge Phase|Protocol Violation|1|||
33340542|NCT01857869|101136103|FG001|Primary/Challenge Phase|Protocol Violation|0|||
33340543|NCT01857869|101136104|FG002|Primary/Challenge Phase|Protocol Violation|0|||
33209381|NCT02671435|100670189|FG009|Overall Study|Withdrawal by Subject|1|||
33209382|NCT02671435|100670190|FG010|Overall Study|Withdrawal by Subject|2|||
33209383|NCT02671435|100670191|FG011|Overall Study|Withdrawal by Subject|4|||
33209384|NCT02671435|100670192|FG012|Overall Study|Withdrawal by Subject|4|||
33209385|NCT02671435|100670193|FG013|Overall Study|Withdrawal by Subject|4|||
33209386|NCT02671435|100670194|FG014|Overall Study|Withdrawal by Subject|2|||
33209387|NCT02671435|100670180|FG000|Overall Study|Un-specified|0|||
33209388|NCT02671435|100670181|FG001|Overall Study|Un-specified|0|||
33209389|NCT02671435|100670182|FG002|Overall Study|Un-specified|0|||
33209390|NCT02671435|100670183|FG003|Overall Study|Un-specified|0|||
33209391|NCT02671435|100670184|FG004|Overall Study|Un-specified|1|||
33340544|NCT01857869|101136105|FG003|Primary/Challenge Phase|Protocol Violation|0|||
33340545|NCT01857869|101136106|FG004|Primary/Challenge Phase|Protocol Violation|0|||
33340546|NCT01857869|101136107|FG005|Primary/Challenge Phase|Protocol Violation|0|||
33340547|NCT01857869|101136108|FG006|Primary/Challenge Phase|Protocol Violation|0|||
33340548|NCT01857869|101136109|FG007|Primary/Challenge Phase|Protocol Violation|0|||
33340549|NCT01857869|101136110|FG008|Primary/Challenge Phase|Protocol Violation|0|||
33340550|NCT01857869|101136111|FG009|Primary/Challenge Phase|Protocol Violation|0|||
33340551|NCT01857869|101136102|FG000|Primary/Challenge Phase|Other|1|||
33340552|NCT01857869|101136103|FG001|Primary/Challenge Phase|Other|1|||
33340553|NCT01857869|101136104|FG002|Primary/Challenge Phase|Other|0|||
33340554|NCT01857869|101136105|FG003|Primary/Challenge Phase|Other|0|||
33340555|NCT01857869|101136106|FG004|Primary/Challenge Phase|Other|0|||
33340556|NCT01857869|101136107|FG005|Primary/Challenge Phase|Other|0|||
33537679|NCT02806713|101867585|FG000|Overall Study|Urethral injury during procedure|1|||
33537680|NCT02806713|101867586|FG001|Overall Study|Urethral injury during procedure|0|||
33537681|NCT02806713|101867585|FG000|Overall Study|cancelled surgery|1|||
33537682|NCT02806713|101867586|FG001|Overall Study|cancelled surgery|2|||
33537683|NCT00468585|101867588|FG000|Overall Study|Patient not treated|1|||
33537684|NCT00468585|101867589|FG001|Overall Study|Patient not treated|0|||
33209392|NCT02671435|100670185|FG005|Overall Study|Un-specified|3|||
33209393|NCT02671435|100670186|FG006|Overall Study|Un-specified|2|||
33209394|NCT02671435|100670187|FG007|Overall Study|Un-specified|3|||
33209395|NCT02671435|100670188|FG008|Overall Study|Un-specified|0|||
33209396|NCT02671435|100670189|FG009|Overall Study|Un-specified|5|||
33209397|NCT02671435|100670190|FG010|Overall Study|Un-specified|8|||
33209398|NCT02671435|100670191|FG011|Overall Study|Un-specified|4|||
33209399|NCT02671435|100670192|FG012|Overall Study|Un-specified|5|||
33209400|NCT02671435|100670193|FG013|Overall Study|Un-specified|9|||
33209401|NCT02671435|100670194|FG014|Overall Study|Un-specified|8|||
33209402|NCT00700401|100670206|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
33209403|NCT00700401|100670206|FG000|Overall Study|Adverse Event|5|||
33209404|NCT00700401|100670206|FG000|Overall Study|Refused Treatment|2|||
33340557|NCT01857869|101136108|FG006|Primary/Challenge Phase|Other|0|||
33340558|NCT01857869|101136109|FG007|Primary/Challenge Phase|Other|0|||
33340559|NCT01857869|101136110|FG008|Primary/Challenge Phase|Other|0|||
33209405|NCT00700401|100670206|FG000|Overall Study|Lost to Follow-up|1|||
33209406|NCT00700401|100670206|FG000|Overall Study|Treatment never started|1|||
33537685|NCT00468585|101867590|FG002|Overall Study|Patient not treated|1|||
33537686|NCT00468585|101867591|FG003|Overall Study|Patient not treated|0|||
33209407|NCT00700401|100670206|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
33340560|NCT01857869|101136111|FG009|Primary/Challenge Phase|Other|0|||
33537687|NCT00468585|101867588|FG000|Overall Study|Patient found to be ineligible|0|||
33537688|NCT00468585|101867589|FG001|Overall Study|Patient found to be ineligible|0|||
33614606|NCT01610336|102137204|FG008|Overall Study|Transfer to another trial|0|||
33209408|NCT00700401|100670206|FG000|Overall Study|Withdrawal by Subject|2|||
33209409|NCT00113568|100670207|FG000|Overall Study|Adverse Event|97|||
33209410|NCT00113568|100670207|FG000|Overall Study|Death|1|||
33209411|NCT00113568|100670207|FG000|Overall Study|Lack of Efficacy|30|||
33405791|NCT02418000|101373509|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
33405792|NCT02418000|101373505|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
33209412|NCT00113568|100670207|FG000|Overall Study|Lost to Follow-up|156|||
33209413|NCT00113568|100670207|FG000|Overall Study|Protocol Violation|32|||
33209414|NCT00113568|100670207|FG000|Overall Study|Withdrawal by Subject|117|||
33537689|NCT00468585|101867590|FG002|Overall Study|Patient found to be ineligible|1|||
33537690|NCT00468585|101867591|FG003|Overall Study|Patient found to be ineligible|0|||
33537691|NCT00468585|101867588|FG000|Overall Study|Adverse Event|0|||
33537692|NCT00468585|101867589|FG001|Overall Study|Adverse Event|0|||
33537693|NCT00468585|101867590|FG002|Overall Study|Adverse Event|1|||
33537694|NCT00468585|101867591|FG003|Overall Study|Adverse Event|0|||
33537695|NCT00468585|101867588|FG000|Overall Study|Withdrawal by Subject|0|||
33537696|NCT00468585|101867589|FG001|Overall Study|Withdrawal by Subject|0|||
33537697|NCT00468585|101867590|FG002|Overall Study|Withdrawal by Subject|2|||
33537698|NCT00468585|101867591|FG003|Overall Study|Withdrawal by Subject|1|||
33537699|NCT03641508|101867596|FG000|First Injection|Lost to Follow-up|2|||
33537700|NCT03641508|101867597|FG001|First Injection|Lost to Follow-up|0|||
33537701|NCT01443858|101867599|FG000|Overall Study|Withdrawal by Subject|9|||
33537702|NCT01443858|101867600|FG001|Overall Study|Withdrawal by Subject|8|||
33537703|NCT01443858|101867601|FG002|Overall Study|Withdrawal by Subject|5|||
33537704|NCT01443858|101867599|FG000|Overall Study|Lack of Efficacy|1|||
33537705|NCT01443858|101867600|FG001|Overall Study|Lack of Efficacy|0|||
33537706|NCT01443858|101867601|FG002|Overall Study|Lack of Efficacy|0|||
33537707|NCT01443858|101867599|FG000|Overall Study|Lost to Follow-up|5|||
33537708|NCT01443858|101867600|FG001|Overall Study|Lost to Follow-up|5|||
33209415|NCT00113568|100670207|FG000|Overall Study|Other|112|||
33209416|NCT02239679|100670208|FG000|Overall Study|Lost to Follow-up|1|||
33209417|NCT02239679|100670209|FG001|Overall Study|Lost to Follow-up|0|||
33405793|NCT02418000|101373506|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
33405794|NCT02418000|101373507|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
33405795|NCT02418000|101373508|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
33405796|NCT02418000|101373509|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
33405797|NCT02418000|101373505|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
33405798|NCT02418000|101373506|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
33405799|NCT02418000|101373507|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
33405800|NCT02418000|101373508|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
33405801|NCT02418000|101373509|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
33405802|NCT02418000|101373505|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33405803|NCT02418000|101373506|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33405804|NCT02418000|101373507|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
33537709|NCT01443858|101867601|FG002|Overall Study|Lost to Follow-up|2|||
33209418|NCT02239679|100670210|FG002|Overall Study|Lost to Follow-up|0|||
33209419|NCT02239679|100670208|FG000|Overall Study|Withdrawal by Subject|2|||
33209420|NCT02239679|100670209|FG001|Overall Study|Withdrawal by Subject|3|||
33209421|NCT02239679|100670210|FG002|Overall Study|Withdrawal by Subject|1|||
33537710|NCT00496769|101867603|FG000|Double Blind|>=1 reason assigned per patient|558|||
33537711|NCT00496769|101867604|FG001|Double Blind|>=1 reason assigned per patient|649|||
33537712|NCT00496769|101867605|FG002|Double Blind|>=1 reason assigned per patient|0|||
33537713|NCT00496769|101867603|FG000|Open Label|>=1 reason assigned per patient|0|||
33537714|NCT00496769|101867604|FG001|Open Label|>=1 reason assigned per patient|0|||
33537715|NCT00496769|101867605|FG002|Open Label|>=1 reason assigned per patient|1011|||
33209422|NCT01128413|100670212|FG000|Overall Study|Withdrawal by Subject|1|||
33209423|NCT01128413|100670213|FG001|Overall Study|Withdrawal by Subject|0|||
33209424|NCT01128413|100670212|FG000|Overall Study|NICOM Monitor Problems|2|||
33209425|NCT01128413|100670213|FG001|Overall Study|NICOM Monitor Problems|1|||
33209426|NCT01128413|100670212|FG000|Overall Study|Pt made DNR|1|||
33209427|NCT01128413|100670213|FG001|Overall Study|Pt made DNR|0|||
33209428|NCT03555396|100670217|FG000|Overall Study|Death|3|||
33209429|NCT03555396|100670218|FG001|Overall Study|Death|1|||
33209430|NCT03555396|100670217|FG000|Overall Study|Lost to Follow-up|0|||
33209431|NCT03555396|100670218|FG001|Overall Study|Lost to Follow-up|2|||
33209432|NCT02300220|100670219|FG000|Overall Study|Lost to Follow-up|1|||
33209433|NCT02300220|100670220|FG001|Overall Study|Lost to Follow-up|2|||
33209434|NCT02300220|100670219|FG000|Overall Study|Death|1|||
33209435|NCT02300220|100670220|FG001|Overall Study|Death|1|||
33209436|NCT02300220|100670219|FG000|Overall Study|Adverse Event|1|||
33209437|NCT02300220|100670220|FG001|Overall Study|Adverse Event|1|||
33209438|NCT02300220|100670219|FG000|Overall Study|Protocol Violation|1|||
33209439|NCT02300220|100670220|FG001|Overall Study|Protocol Violation|0|||
33209440|NCT02300220|100670219|FG000|Overall Study|Withdrawal by Subject|0|||
33209441|NCT02300220|100670220|FG001|Overall Study|Withdrawal by Subject|2|||
33209442|NCT02300220|100670219|FG000|Overall Study|Did not tolerate IMP|0|||
33209443|NCT02300220|100670220|FG001|Overall Study|Did not tolerate IMP|1|||
33209444|NCT03282227|100670221|FG000|Overall Study|Exposure Goals Achieved|60|||
33209445|NCT03282227|100670221|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
33209446|NCT03282227|100670221|FG000|Overall Study|Adverse Event|15|||
33209447|NCT03282227|100670221|FG000|Overall Study|Lost to Follow-up|21|||
33209448|NCT03282227|100670221|FG000|Overall Study|Withdrawal by Subject|20|||
33209449|NCT03282227|100670221|FG000|Overall Study|Lack of Efficacy|12|||
33209450|NCT03282227|100670221|FG000|Overall Study|Sponsor decision|3|||
33209451|NCT03282227|100670221|FG000|Overall Study|Physician Decision|2|||
33209452|NCT03282227|100670221|FG000|Overall Study|Pregnancy|2|||
33209453|NCT03282227|100670221|FG000|Overall Study|Other|1|||
33209454|NCT05224050|100670223|FG000|Overall Study|Withdrawal by Subject|9|||
33209455|NCT05224050|100670223|FG000|Overall Study|Lost to Follow-up|3|||
33209456|NCT01217073|100670226|FG000|Base Period|Adverse Event|1|||
33209457|NCT01217073|100670227|FG001|Base Period|Adverse Event|0|||
33209458|NCT01217073|100670228|FG002|Base Period|Adverse Event|1|||
33209459|NCT01217073|100670229|FG003|Base Period|Adverse Event|0|||
33209460|NCT01217073|100670230|FG004|Base Period|Adverse Event|4|||
33209461|NCT01217073|100670231|FG005|Base Period|Adverse Event|1|||
33209462|NCT01217073|100670232|FG006|Base Period|Adverse Event|0|||
33209463|NCT01217073|100670233|FG007|Base Period|Adverse Event|0|||
33209464|NCT01217073|100670226|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
33209465|NCT01217073|100670227|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
33209466|NCT01217073|100670228|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
33209467|NCT01217073|100670229|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
33209468|NCT01217073|100670230|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
33209469|NCT01217073|100670231|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
33209470|NCT01217073|100670232|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
33209471|NCT01217073|100670233|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
33209472|NCT01217073|100670226|FG000|Base Period|Excluded medication|0|||
33209473|NCT01217073|100670227|FG001|Base Period|Excluded medication|0|||
33209474|NCT01217073|100670228|FG002|Base Period|Excluded medication|0|||
33209475|NCT01217073|100670229|FG003|Base Period|Excluded medication|0|||
33209476|NCT01217073|100670230|FG004|Base Period|Excluded medication|1|||
33209477|NCT01217073|100670231|FG005|Base Period|Excluded medication|0|||
33209478|NCT01217073|100670232|FG006|Base Period|Excluded medication|0|||
33209479|NCT01217073|100670233|FG007|Base Period|Excluded medication|0|||
33209480|NCT01217073|100670226|FG000|Base Period|Lack of Efficacy|0|||
33209481|NCT01217073|100670227|FG001|Base Period|Lack of Efficacy|0|||
33209482|NCT01217073|100670228|FG002|Base Period|Lack of Efficacy|0|||
33209483|NCT01217073|100670229|FG003|Base Period|Lack of Efficacy|0|||
33209484|NCT01217073|100670230|FG004|Base Period|Lack of Efficacy|0|||
33209485|NCT01217073|100670231|FG005|Base Period|Lack of Efficacy|1|||
33209486|NCT01217073|100670232|FG006|Base Period|Lack of Efficacy|0|||
33209487|NCT01217073|100670233|FG007|Base Period|Lack of Efficacy|0|||
33209488|NCT01217073|100670226|FG000|Base Period|Lost to Follow-up|0|||
33209489|NCT01217073|100670227|FG001|Base Period|Lost to Follow-up|0|||
33209490|NCT01217073|100670228|FG002|Base Period|Lost to Follow-up|1|||
33209491|NCT01217073|100670229|FG003|Base Period|Lost to Follow-up|1|||
33209492|NCT01217073|100670230|FG004|Base Period|Lost to Follow-up|3|||
33209493|NCT01217073|100670231|FG005|Base Period|Lost to Follow-up|0|||
33209494|NCT01217073|100670232|FG006|Base Period|Lost to Follow-up|0|||
33340561|NCT01857869|101136102|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33209495|NCT01217073|100670233|FG007|Base Period|Lost to Follow-up|0|||
33209496|NCT01217073|100670226|FG000|Base Period|Physician Decision|0|||
33209497|NCT01217073|100670227|FG001|Base Period|Physician Decision|0|||
33209498|NCT01217073|100670228|FG002|Base Period|Physician Decision|0|||
33209499|NCT01217073|100670229|FG003|Base Period|Physician Decision|0|||
33209500|NCT01217073|100670230|FG004|Base Period|Physician Decision|1|||
33209501|NCT01217073|100670231|FG005|Base Period|Physician Decision|0|||
33209502|NCT01217073|100670232|FG006|Base Period|Physician Decision|0|||
33209503|NCT01217073|100670233|FG007|Base Period|Physician Decision|0|||
33209504|NCT01217073|100670226|FG000|Base Period|Protocol Violation|1|||
33209505|NCT01217073|100670227|FG001|Base Period|Protocol Violation|0|||
33209506|NCT01217073|100670228|FG002|Base Period|Protocol Violation|0|||
33209507|NCT01217073|100670229|FG003|Base Period|Protocol Violation|0|||
33209508|NCT01217073|100670230|FG004|Base Period|Protocol Violation|1|||
33209509|NCT01217073|100670231|FG005|Base Period|Protocol Violation|2|||
33209510|NCT01217073|100670232|FG006|Base Period|Protocol Violation|0|||
33209511|NCT01217073|100670233|FG007|Base Period|Protocol Violation|0|||
33209512|NCT01217073|100670226|FG000|Base Period|Withdrawal by Subject|4|||
33209513|NCT01217073|100670227|FG001|Base Period|Withdrawal by Subject|5|||
33209514|NCT01217073|100670228|FG002|Base Period|Withdrawal by Subject|5|||
33209515|NCT01217073|100670229|FG003|Base Period|Withdrawal by Subject|1|||
33209516|NCT01217073|100670230|FG004|Base Period|Withdrawal by Subject|5|||
33209517|NCT01217073|100670231|FG005|Base Period|Withdrawal by Subject|5|||
33209518|NCT01217073|100670232|FG006|Base Period|Withdrawal by Subject|0|||
33209519|NCT01217073|100670233|FG007|Base Period|Withdrawal by Subject|0|||
33209520|NCT01217073|100670226|FG000|Extension Period|Adverse Event|0|||
33209521|NCT01217073|100670227|FG001|Extension Period|Adverse Event|0|||
33209522|NCT01217073|100670228|FG002|Extension Period|Adverse Event|0|||
33209523|NCT01217073|100670229|FG003|Extension Period|Adverse Event|0|||
33209524|NCT01217073|100670230|FG004|Extension Period|Adverse Event|0|||
33209525|NCT01217073|100670231|FG005|Extension Period|Adverse Event|0|||
33209526|NCT01217073|100670232|FG006|Extension Period|Adverse Event|19|||
33209527|NCT01217073|100670233|FG007|Extension Period|Adverse Event|5|||
33209528|NCT01217073|100670226|FG000|Extension Period|ALT/AST|0|||
33209529|NCT01217073|100670227|FG001|Extension Period|ALT/AST|0|||
33209530|NCT01217073|100670228|FG002|Extension Period|ALT/AST|0|||
33209531|NCT01217073|100670229|FG003|Extension Period|ALT/AST|0|||
33209532|NCT01217073|100670230|FG004|Extension Period|ALT/AST|0|||
33209533|NCT01217073|100670231|FG005|Extension Period|ALT/AST|0|||
33209534|NCT01217073|100670232|FG006|Extension Period|ALT/AST|2|||
33209535|NCT01217073|100670233|FG007|Extension Period|ALT/AST|0|||
33209536|NCT01217073|100670226|FG000|Extension Period|Contraindication to study medication|0|||
33209537|NCT01217073|100670227|FG001|Extension Period|Contraindication to study medication|0|||
33209538|NCT01217073|100670228|FG002|Extension Period|Contraindication to study medication|0|||
33209539|NCT01217073|100670229|FG003|Extension Period|Contraindication to study medication|0|||
33209540|NCT01217073|100670230|FG004|Extension Period|Contraindication to study medication|0|||
33209541|NCT01217073|100670231|FG005|Extension Period|Contraindication to study medication|0|||
33209542|NCT01217073|100670232|FG006|Extension Period|Contraindication to study medication|1|||
33209543|NCT01217073|100670233|FG007|Extension Period|Contraindication to study medication|0|||
33209544|NCT01217073|100670226|FG000|Extension Period|Creatinine/eGFR|0|||
33209545|NCT01217073|100670227|FG001|Extension Period|Creatinine/eGFR|0|||
33209546|NCT01217073|100670228|FG002|Extension Period|Creatinine/eGFR|0|||
33209547|NCT01217073|100670229|FG003|Extension Period|Creatinine/eGFR|0|||
33209548|NCT01217073|100670230|FG004|Extension Period|Creatinine/eGFR|0|||
33209549|NCT01217073|100670231|FG005|Extension Period|Creatinine/eGFR|0|||
33340562|NCT01857869|101136103|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33405805|NCT02418000|101373508|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33209550|NCT01217073|100670232|FG006|Extension Period|Creatinine/eGFR|11|||
33209551|NCT01217073|100670233|FG007|Extension Period|Creatinine/eGFR|1|||
33209552|NCT01217073|100670226|FG000|Extension Period|Death|0|||
33209553|NCT01217073|100670227|FG001|Extension Period|Death|0|||
33209554|NCT01217073|100670228|FG002|Extension Period|Death|0|||
33209555|NCT01217073|100670229|FG003|Extension Period|Death|0|||
33405806|NCT02418000|101373509|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33405807|NCT02418000|101373505|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33405808|NCT02418000|101373506|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33405809|NCT02418000|101373507|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33405810|NCT02418000|101373508|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
33405811|NCT02418000|101373509|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33405812|NCT02418000|101373505|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
33405813|NCT02418000|101373506|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
33405814|NCT02418000|101373507|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
33405815|NCT02418000|101373508|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
33405816|NCT02418000|101373509|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
33405817|NCT02418000|101373505|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33405818|NCT02418000|101373506|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33405819|NCT02418000|101373507|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33405820|NCT02418000|101373508|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
33405821|NCT02418000|101373509|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
33405822|NCT01219959|101373513|FG000|Overall Study|Adverse Event|6|||
33405823|NCT01219959|101373514|FG001|Overall Study|Adverse Event|14|||
33405824|NCT01219959|101373513|FG000|Overall Study|Physician Decision|0|||
33537716|NCT03368664|101867615|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
33537717|NCT03368664|101867615|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
33537718|NCT03368664|101867615|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
33537719|NCT03368664|101867615|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
33537720|NCT00368251|101867618|FG000|Overall Study|SAE, non-fatal|1|||
33537721|NCT00368251|101867619|FG001|Overall Study|SAE, non-fatal|0|||
33537722|NCT00368251|101867620|FG002|Overall Study|SAE, non-fatal|0|||
33537723|NCT00368251|101867618|FG000|Overall Study|AE, non-serious non-fatal|0|||
33537724|NCT00368251|101867619|FG001|Overall Study|AE, non-serious non-fatal|0|||
33537725|NCT00368251|101867620|FG002|Overall Study|AE, non-serious non-fatal|1|||
33537726|NCT01776554|101867621|FG000|Overall Study|Adverse Event|1|||
33537727|NCT01776554|101867622|FG001|Overall Study|Adverse Event|0|||
33537728|NCT01776554|101867621|FG000|Overall Study|Withdrawal by Subject|3|||
33614607|NCT01610336|102137205|FG009|Overall Study|Transfer to another trial|0|||
33405825|NCT01219959|101373514|FG001|Overall Study|Physician Decision|4|||
33209556|NCT01217073|100670230|FG004|Extension Period|Death|0|||
33537729|NCT01776554|101867622|FG001|Overall Study|Withdrawal by Subject|8|||
33537730|NCT01776554|101867621|FG000|Overall Study|Lost to Follow-up|6|||
33209557|NCT01217073|100670231|FG005|Extension Period|Death|0|||
33537731|NCT01776554|101867622|FG001|Overall Study|Lost to Follow-up|9|||
33537732|NCT01776554|101867621|FG000|Overall Study|Administrative Reason|2|||
33537733|NCT01776554|101867622|FG001|Overall Study|Administrative Reason|5|||
33537734|NCT01776554|101867621|FG000|Overall Study|Protocol Violation|1|||
33537735|NCT01776554|101867622|FG001|Overall Study|Protocol Violation|0|||
33537736|NCT01776554|101867621|FG000|Overall Study|Unclassified|4|||
33537737|NCT01776554|101867622|FG001|Overall Study|Unclassified|1|||
33537738|NCT01814007|101867625|FG000|Overall Study|Withdrawal by Subject|1|||
33537739|NCT00728494|101867626|FG000|Overall Study|Adverse Event|7|||
33537740|NCT00728494|101867627|FG001|Overall Study|Adverse Event|0|||
33537741|NCT00728494|101867626|FG000|Overall Study|Withdrawal by Subject|0|||
33537742|NCT00728494|101867627|FG001|Overall Study|Withdrawal by Subject|2|||
33537743|NCT00728494|101867626|FG000|Overall Study|Lack of Efficacy|2|||
33537744|NCT00728494|101867627|FG001|Overall Study|Lack of Efficacy|4|||
33537745|NCT00728494|101867626|FG000|Overall Study|No data available|0|||
33537746|NCT00728494|101867627|FG001|Overall Study|No data available|1|||
33537747|NCT00716456|101867628|FG000|Overall Study|Adverse Event|0|||
33537748|NCT00716456|101867629|FG001|Overall Study|Adverse Event|2|||
33537749|NCT00716456|101867630|FG002|Overall Study|Adverse Event|0|||
33537750|NCT05021640|101867631|FG000|Overall Study|Lost to Follow-up|0|||
33537751|NCT05021640|101867632|FG001|Overall Study|Lost to Follow-up|0|||
33537752|NCT05021640|101867633|FG002|Overall Study|Lost to Follow-up|0|||
33537753|NCT05021640|101867634|FG003|Overall Study|Lost to Follow-up|0|||
33537754|NCT05021640|101867635|FG004|Overall Study|Lost to Follow-up|1|||
33537755|NCT01811732|101867639|FG000|Overall Study|Lost to Follow-up|24|||
33537756|NCT01811732|101867640|FG001|Overall Study|Lost to Follow-up|30|||
33537757|NCT01811732|101867639|FG000|Overall Study|Withdrawal by Subject|16|||
33537758|NCT01811732|101867640|FG001|Overall Study|Withdrawal by Subject|10|||
33537759|NCT01811732|101867639|FG000|Overall Study|Adverse Event|3|||
33537760|NCT01811732|101867640|FG001|Overall Study|Adverse Event|9|||
33537761|NCT01811732|101867639|FG000|Overall Study|Lack of Efficacy|3|||
33537762|NCT01811732|101867640|FG001|Overall Study|Lack of Efficacy|1|||
33537763|NCT01811732|101867639|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
33537764|NCT01811732|101867640|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
33537765|NCT01811732|101867639|FG000|Overall Study|Physician Decision|2|||
33537766|NCT01811732|101867640|FG001|Overall Study|Physician Decision|0|||
33537767|NCT01811732|101867639|FG000|Overall Study|Death|1|||
33537768|NCT01811732|101867640|FG001|Overall Study|Death|1|||
33614608|NCT01610336|102137206|FG010|Overall Study|Transfer to another trial|1|||
33614609|NCT01463306|102137207|FG000|Overall Study|Adverse Event|6|||
33614610|NCT01463306|102137208|FG001|Overall Study|Adverse Event|9|||
33614611|NCT01463306|102137209|FG002|Overall Study|Adverse Event|3|||
33614612|NCT01463306|102137207|FG000|Overall Study|Death|3|||
33614613|NCT01463306|102137208|FG001|Overall Study|Death|3|||
33614614|NCT01463306|102137209|FG002|Overall Study|Death|0|||
33614615|NCT01463306|102137207|FG000|Overall Study|Lack of Efficacy|22|||
33614616|NCT01463306|102137208|FG001|Overall Study|Lack of Efficacy|16|||
33340563|NCT01857869|101136104|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33340564|NCT01857869|101136105|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
33340565|NCT01857869|101136106|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33340566|NCT01857869|101136107|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33340567|NCT01857869|101136108|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33209558|NCT01217073|100670232|FG006|Extension Period|Death|1|||
33537769|NCT01811732|101867639|FG000|Overall Study|Insufficient venous access|0|||
33537770|NCT01811732|101867640|FG001|Overall Study|Insufficient venous access|1|||
33537771|NCT01811732|101867639|FG000|Overall Study|Protocol Violation|0|||
33537772|NCT01811732|101867640|FG001|Overall Study|Protocol Violation|1|||
33537773|NCT01811732|101867639|FG000|Overall Study|Subject incarcerated|1|||
33537774|NCT01811732|101867640|FG001|Overall Study|Subject incarcerated|2|||
33537775|NCT01811732|101867639|FG000|Overall Study|Admitted to another facility|1|||
33537776|NCT01811732|101867640|FG001|Overall Study|Admitted to another facility|0|||
33537777|NCT01811732|101867639|FG000|Overall Study|Correct study drug not available on site|1|||
33614617|NCT01463306|102137209|FG002|Overall Study|Lack of Efficacy|1|||
33614618|NCT01463306|102137207|FG000|Overall Study|Lost to Follow-up|5|||
33614619|NCT01463306|102137208|FG001|Overall Study|Lost to Follow-up|2|||
33209559|NCT01217073|100670233|FG007|Extension Period|Death|0|||
33209560|NCT01217073|100670226|FG000|Extension Period|Excluded medication|0|||
33209561|NCT01217073|100670227|FG001|Extension Period|Excluded medication|0|||
33209562|NCT01217073|100670228|FG002|Extension Period|Excluded medication|0|||
33209563|NCT01217073|100670229|FG003|Extension Period|Excluded medication|0|||
33209564|NCT01217073|100670230|FG004|Extension Period|Excluded medication|0|||
33209565|NCT01217073|100670231|FG005|Extension Period|Excluded medication|0|||
33209566|NCT01217073|100670232|FG006|Extension Period|Excluded medication|2|||
33537778|NCT01811732|101867640|FG001|Overall Study|Correct study drug not available on site|0|||
33537779|NCT03885908|101867643|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
33209567|NCT01217073|100670233|FG007|Extension Period|Excluded medication|0|||
33209568|NCT01217073|100670226|FG000|Extension Period|Lack of Efficacy|0|||
33209569|NCT01217073|100670227|FG001|Extension Period|Lack of Efficacy|0|||
33209570|NCT01217073|100670228|FG002|Extension Period|Lack of Efficacy|0|||
33209571|NCT01217073|100670229|FG003|Extension Period|Lack of Efficacy|0|||
33537780|NCT03885908|101867644|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
33209572|NCT01217073|100670230|FG004|Extension Period|Lack of Efficacy|0|||
33209573|NCT01217073|100670231|FG005|Extension Period|Lack of Efficacy|0|||
33209574|NCT01217073|100670232|FG006|Extension Period|Lack of Efficacy|3|||
33614620|NCT01463306|102137209|FG002|Overall Study|Lost to Follow-up|0|||
33614621|NCT01463306|102137207|FG000|Overall Study|Protocol Violation|4|||
33614622|NCT01463306|102137208|FG001|Overall Study|Protocol Violation|0|||
33614623|NCT01463306|102137209|FG002|Overall Study|Protocol Violation|0|||
33614624|NCT01463306|102137207|FG000|Overall Study|Withdrawal by Subject|19|||
33614625|NCT01463306|102137208|FG001|Overall Study|Withdrawal by Subject|9|||
33614626|NCT01463306|102137209|FG002|Overall Study|Withdrawal by Subject|1|||
33614627|NCT01463306|102137207|FG000|Overall Study|Other|26|||
33614628|NCT01463306|102137208|FG001|Overall Study|Other|13|||
33209575|NCT01217073|100670233|FG007|Extension Period|Lack of Efficacy|0|||
33209576|NCT01217073|100670226|FG000|Extension Period|Lost to Follow-up|0|||
33209577|NCT01217073|100670227|FG001|Extension Period|Lost to Follow-up|0|||
33209578|NCT01217073|100670228|FG002|Extension Period|Lost to Follow-up|0|||
33209579|NCT01217073|100670229|FG003|Extension Period|Lost to Follow-up|0|||
33209580|NCT01217073|100670230|FG004|Extension Period|Lost to Follow-up|0|||
33209581|NCT01217073|100670231|FG005|Extension Period|Lost to Follow-up|0|||
33537781|NCT03885908|101867643|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
33537782|NCT03885908|101867644|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
33537783|NCT03885908|101867643|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
33537784|NCT03885908|101867644|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
33537785|NCT03885908|101867643|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
33537786|NCT03885908|101867644|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
33537787|NCT00764790|101867646|FG000|Overall Study|Protocol Violation|0|||
33537788|NCT00764790|101867647|FG001|Overall Study|Protocol Violation|0|||
33614629|NCT01463306|102137209|FG002|Overall Study|Other|0|||
33614630|NCT01463306|102137207|FG000|Overall Study|Approval expiry at site|1|||
33614631|NCT01463306|102137208|FG001|Overall Study|Approval expiry at site|0|||
33614632|NCT01463306|102137209|FG002|Overall Study|Approval expiry at site|0|||
33614633|NCT00779025|102137222|FG000|Overall Study|Withdrawal by Subject|1|||
33209582|NCT01217073|100670232|FG006|Extension Period|Lost to Follow-up|9|||
33209583|NCT01217073|100670233|FG007|Extension Period|Lost to Follow-up|1|||
33209584|NCT01217073|100670226|FG000|Extension Period|Non-compliance with study drug|0|||
33209585|NCT01217073|100670227|FG001|Extension Period|Non-compliance with study drug|0|||
33537789|NCT00764790|101867648|FG002|Overall Study|Protocol Violation|1|||
33537790|NCT00764790|101867646|FG000|Overall Study|Withdrawal by Subject|10|||
33537791|NCT00764790|101867647|FG001|Overall Study|Withdrawal by Subject|12|||
33537792|NCT00764790|101867648|FG002|Overall Study|Withdrawal by Subject|6|||
33537793|NCT00764790|101867646|FG000|Overall Study|Lost to Follow-up|28|||
33537794|NCT00764790|101867647|FG001|Overall Study|Lost to Follow-up|29|||
33537795|NCT00764790|101867648|FG002|Overall Study|Lost to Follow-up|23|||
33537796|NCT02154139|101867651|FG000|Overall Study|Injection not administered|2|||
33537797|NCT02154139|101867651|FG000|Overall Study|Other|2|||
33537798|NCT02154139|101867651|FG000|Overall Study|Investigator transferred|3|||
33537799|NCT02100839|101867656|FG000|Multiple Ascending Dose|Adverse Event|2|||
33537800|NCT02100839|101867657|FG001|Multiple Ascending Dose|Adverse Event|0|||
33537801|NCT02100839|101867656|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
33537802|NCT02100839|101867657|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
33537803|NCT00830765|101867658|FG000|Overall Study|Protocol Violation|3|||
33537804|NCT00830765|101867659|FG001|Overall Study|Protocol Violation|2|||
33537805|NCT00104052|101867668|FG000|Overall Study|Adverse Event|1|||
33537806|NCT00104052|101867668|FG000|Overall Study|Lack of Efficacy|26|||
33537807|NCT00104052|101867668|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
33537808|NCT01190891|101867671|FG000|Overall Study|Protocol Violation|1|||
33537809|NCT01190891|101867672|FG001|Overall Study|Protocol Violation|0|||
33537810|NCT01190891|101867671|FG000|Overall Study|Withdrawal by Subject|5|||
33537811|NCT01190891|101867672|FG001|Overall Study|Withdrawal by Subject|0|||
33537812|NCT01041859|101867673|FG000|Open-Label Titration|Adverse Event|69|||
33537813|NCT01041859|101867674|FG001|Open-Label Titration|Adverse Event|0|||
33537814|NCT01041859|101867675|FG002|Open-Label Titration|Adverse Event|0|||
33537815|NCT01041859|101867673|FG000|Open-Label Titration|Lack of Efficacy|3|||
33537816|NCT01041859|101867674|FG001|Open-Label Titration|Lack of Efficacy|0|||
33537817|NCT01041859|101867675|FG002|Open-Label Titration|Lack of Efficacy|0|||
33537818|NCT01041859|101867673|FG000|Open-Label Titration|Lost to Follow-up|1|||
33537819|NCT01041859|101867674|FG001|Open-Label Titration|Lost to Follow-up|0|||
33537820|NCT01041859|101867675|FG002|Open-Label Titration|Lost to Follow-up|0|||
33537821|NCT01041859|101867673|FG000|Open-Label Titration|Physician Decision|1|||
33537822|NCT01041859|101867674|FG001|Open-Label Titration|Physician Decision|0|||
33537823|NCT01041859|101867675|FG002|Open-Label Titration|Physician Decision|0|||
33537824|NCT01041859|101867673|FG000|Open-Label Titration|Protocol Violation|1|||
33537825|NCT01041859|101867674|FG001|Open-Label Titration|Protocol Violation|0|||
33537826|NCT01041859|101867675|FG002|Open-Label Titration|Protocol Violation|0|||
33537827|NCT01041859|101867673|FG000|Open-Label Titration|Other|7|||
33537828|NCT01041859|101867674|FG001|Open-Label Titration|Other|0|||
33537829|NCT01041859|101867675|FG002|Open-Label Titration|Other|0|||
33537830|NCT01041859|101867673|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
33537831|NCT01041859|101867674|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
33537832|NCT01041859|101867675|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
33537833|NCT01041859|101867673|FG000|Open-Label Titration|Withdrawal by Subject|11|||
33537834|NCT01041859|101867674|FG001|Open-Label Titration|Withdrawal by Subject|0|||
33537835|NCT01041859|101867675|FG002|Open-Label Titration|Withdrawal by Subject|0|||
33537836|NCT01041859|101867673|FG000|Double-Blind Maintenance|Adverse Event|0|||
33537837|NCT01041859|101867674|FG001|Double-Blind Maintenance|Adverse Event|23|||
33537838|NCT01041859|101867675|FG002|Double-Blind Maintenance|Adverse Event|13|||
33537839|NCT01041859|101867673|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
33537840|NCT01041859|101867674|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
33537841|NCT01041859|101867675|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
33537842|NCT01041859|101867673|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
33537843|NCT01041859|101867674|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
33537844|NCT01041859|101867675|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
33537845|NCT01041859|101867673|FG000|Double-Blind Maintenance|Physician Decision|0|||
33537846|NCT01041859|101867674|FG001|Double-Blind Maintenance|Physician Decision|2|||
33537847|NCT01041859|101867675|FG002|Double-Blind Maintenance|Physician Decision|1|||
33537848|NCT01041859|101867673|FG000|Double-Blind Maintenance|Protocol Violation|0|||
33537849|NCT01041859|101867674|FG001|Double-Blind Maintenance|Protocol Violation|1|||
33537850|NCT01041859|101867675|FG002|Double-Blind Maintenance|Protocol Violation|3|||
33537851|NCT01041859|101867673|FG000|Double-Blind Maintenance|Other|0|||
33537852|NCT01041859|101867674|FG001|Double-Blind Maintenance|Other|6|||
33537853|NCT01041859|101867675|FG002|Double-Blind Maintenance|Other|2|||
33537854|NCT01041859|101867673|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
33537855|NCT01041859|101867674|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
33537856|NCT01041859|101867675|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
33614634|NCT00379912|102137223|FG000|Overall Study|Lack of Efficacy|1|||
33209586|NCT01217073|100670228|FG002|Extension Period|Non-compliance with study drug|0|||
33340568|NCT01857869|101136109|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33537857|NCT01041859|101867673|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
33537858|NCT01041859|101867674|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
33614635|NCT00379912|102137224|FG001|Overall Study|Lack of Efficacy|0|||
33537859|NCT01041859|101867675|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
33537860|NCT02446691|101867676|FG000|Overall Study|Withdrawal by Subject|2|||
33537861|NCT02446691|101867676|FG000|Overall Study|Lost to Follow-up|8|||
33537862|NCT02446691|101867676|FG000|Overall Study|Protocol Violation|1|||
33537863|NCT02611882|101867677|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
33537864|NCT02611882|101867678|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
33537865|NCT02611882|101867679|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
33537866|NCT01309386|101867680|FG000|Overall Study|Other|2|||
33537867|NCT01309386|101867681|FG001|Overall Study|Other|0|||
33537868|NCT01309386|101867680|FG000|Overall Study|Withdrawal by Subject|2|||
33537869|NCT01309386|101867681|FG001|Overall Study|Withdrawal by Subject|0|||
33537870|NCT01309386|101867680|FG000|Overall Study|Progressive disease|9|||
33537871|NCT01309386|101867681|FG001|Overall Study|Progressive disease|11|||
33537872|NCT01309386|101867680|FG000|Overall Study|Physician Decision|1|||
33537873|NCT01309386|101867681|FG001|Overall Study|Physician Decision|1|||
33537874|NCT01309386|101867680|FG000|Overall Study|Lack of Efficacy|3|||
33537875|NCT01309386|101867681|FG001|Overall Study|Lack of Efficacy|1|||
33537876|NCT01309386|101867680|FG000|Overall Study|Adverse Event|5|||
33537877|NCT01309386|101867681|FG001|Overall Study|Adverse Event|8|||
33537878|NCT00010257|101867682|FG000|Overall Study|Withdrawal by Subject|1|||
33537879|NCT00010257|101867683|FG001|Overall Study|Withdrawal by Subject|0|||
33537880|NCT02999789|101867685|FG000|Overall Study|Withdrawal by Subject|0|||
33537881|NCT02999789|101867686|FG001|Overall Study|Withdrawal by Subject|1|||
33537882|NCT02999789|101867685|FG000|Overall Study|Became ineligible|1|||
33537883|NCT02999789|101867686|FG001|Overall Study|Became ineligible|2|||
33537884|NCT03555149|101867687|FG000|Overall Study|Death|18|||
33537885|NCT03555149|101867688|FG001|Overall Study|Death|15|||
33537886|NCT03555149|101867689|FG002|Overall Study|Death|15|||
33537887|NCT03555149|101867690|FG003|Overall Study|Death|4|||
33537888|NCT03555149|101867691|FG004|Overall Study|Death|4|||
33537889|NCT03555149|101867692|FG005|Overall Study|Death|11|||
33537890|NCT03555149|101867693|FG006|Overall Study|Death|12|||
33537891|NCT03555149|101867694|FG007|Overall Study|Death|1|||
33537892|NCT03555149|101867687|FG000|Overall Study|Lost to Follow-up|1|||
33537893|NCT03555149|101867688|FG001|Overall Study|Lost to Follow-up|0|||
33537894|NCT03555149|101867689|FG002|Overall Study|Lost to Follow-up|0|||
33537895|NCT03555149|101867690|FG003|Overall Study|Lost to Follow-up|0|||
33405826|NCT01219959|101373513|FG000|Overall Study|Withdrawal by Subject|0|||
33405827|NCT01219959|101373514|FG001|Overall Study|Withdrawal by Subject|2|||
33405828|NCT01219959|101373513|FG000|Overall Study|Renal Transplantation|0|||
33405829|NCT01219959|101373514|FG001|Overall Study|Renal Transplantation|3|||
33405830|NCT01219959|101373513|FG000|Overall Study|Other|1|||
33405831|NCT01219959|101373514|FG001|Overall Study|Other|0|||
33405832|NCT02569398|101373518|FG000|Overall Study|Adverse Event|0|||
33405833|NCT02569398|101373519|FG001|Overall Study|Adverse Event|1|||
33405834|NCT02569398|101373520|FG002|Overall Study|Adverse Event|6|||
33405835|NCT02569398|101373518|FG000|Overall Study|Withdrawal by Subject|43|||
33405836|NCT02569398|101373519|FG001|Overall Study|Withdrawal by Subject|43|||
33405837|NCT02569398|101373520|FG002|Overall Study|Withdrawal by Subject|30|||
33405838|NCT02569398|101373518|FG000|Overall Study|Study terminated by sponsor|130|||
33405839|NCT02569398|101373519|FG001|Overall Study|Study terminated by sponsor|131|||
33405840|NCT02569398|101373520|FG002|Overall Study|Study terminated by sponsor|134|||
33405841|NCT02569398|101373518|FG000|Overall Study|Other|12|||
33537896|NCT03555149|101867691|FG004|Overall Study|Lost to Follow-up|0|||
33537897|NCT03555149|101867692|FG005|Overall Study|Lost to Follow-up|1|||
33537898|NCT03555149|101867693|FG006|Overall Study|Lost to Follow-up|0|||
33537899|NCT03555149|101867694|FG007|Overall Study|Lost to Follow-up|0|||
33537900|NCT03555149|101867687|FG000|Overall Study|Physician Decision|1|||
33537901|NCT03555149|101867688|FG001|Overall Study|Physician Decision|0|||
33537902|NCT03555149|101867689|FG002|Overall Study|Physician Decision|0|||
33340569|NCT01857869|101136110|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33340570|NCT01857869|101136111|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
33340571|NCT01857869|101136102|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33340572|NCT01857869|101136103|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33340573|NCT01857869|101136104|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33340574|NCT01857869|101136105|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
33340575|NCT01857869|101136106|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33340576|NCT01857869|101136107|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33340577|NCT01857869|101136108|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33340578|NCT01857869|101136109|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33340579|NCT01857869|101136110|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33340580|NCT01857869|101136111|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
33340581|NCT02740478|101136112|FG000|Overall Study|Withdrawal by Subject|1|||
33340582|NCT02068547|101136117|FG000|Overall Study|Lost to Follow-up|3|||
33340583|NCT02068547|101136118|FG001|Overall Study|Lost to Follow-up|3|||
33537903|NCT03555149|101867690|FG003|Overall Study|Physician Decision|0|||
33537904|NCT03555149|101867691|FG004|Overall Study|Physician Decision|0|||
33537905|NCT03555149|101867692|FG005|Overall Study|Physician Decision|0|||
33537906|NCT03555149|101867693|FG006|Overall Study|Physician Decision|0|||
33537907|NCT03555149|101867694|FG007|Overall Study|Physician Decision|0|||
33405842|NCT02569398|101373519|FG001|Overall Study|Other|14|||
33405843|NCT02569398|101373520|FG002|Overall Study|Other|13|||
33405844|NCT03982069|101373521|FG000|Overall Study|Lost to Follow-up|5|||
33405845|NCT03982069|101373522|FG001|Overall Study|Lost to Follow-up|5|||
33405846|NCT03982069|101373523|FG002|Overall Study|Lost to Follow-up|3|||
33537908|NCT03555149|101867687|FG000|Overall Study|Study Terminated By Sponsor|1|||
33537909|NCT03555149|101867688|FG001|Overall Study|Study Terminated By Sponsor|0|||
33537910|NCT03555149|101867689|FG002|Overall Study|Study Terminated By Sponsor|0|||
33537911|NCT03555149|101867690|FG003|Overall Study|Study Terminated By Sponsor|0|||
33537912|NCT03555149|101867691|FG004|Overall Study|Study Terminated By Sponsor|0|||
33537913|NCT03555149|101867692|FG005|Overall Study|Study Terminated By Sponsor|2|||
33537914|NCT03555149|101867693|FG006|Overall Study|Study Terminated By Sponsor|3|||
33537915|NCT03555149|101867694|FG007|Overall Study|Study Terminated By Sponsor|1|||
33537916|NCT03555149|101867687|FG000|Overall Study|Withdrawal by Subject|3|||
33537917|NCT03555149|101867688|FG001|Overall Study|Withdrawal by Subject|0|||
33537918|NCT03555149|101867689|FG002|Overall Study|Withdrawal by Subject|0|||
33537919|NCT03555149|101867690|FG003|Overall Study|Withdrawal by Subject|2|||
33537920|NCT03555149|101867691|FG004|Overall Study|Withdrawal by Subject|0|||
33537921|NCT03555149|101867692|FG005|Overall Study|Withdrawal by Subject|1|||
33537922|NCT03555149|101867693|FG006|Overall Study|Withdrawal by Subject|0|||
33537923|NCT03555149|101867694|FG007|Overall Study|Withdrawal by Subject|0|||
33537924|NCT00521365|101867695|FG000|Overall Study|Adverse Event|3|||
33537925|NCT00521365|101867695|FG000|Overall Study|Lost to Follow-up|6|||
33537926|NCT00521365|101867695|FG000|Overall Study|Protocol deviation|2|||
33537927|NCT00521365|101867695|FG000|Overall Study|Drug compliance|3|||
33537928|NCT00521365|101867695|FG000|Overall Study|Usage of not allowed drugs|6|||
33537929|NCT03575702|101867696|FG000|Overall Study|Withdrawal by Subject|1|||
33537930|NCT03575702|101867697|FG001|Overall Study|Withdrawal by Subject|1|||
33537931|NCT03575702|101867696|FG000|Overall Study|Lost to Follow-up|1|||
33537932|NCT03575702|101867697|FG001|Overall Study|Lost to Follow-up|2|||
33537933|NCT03575702|101867696|FG000|Overall Study|Protocol Violation|0|||
33537934|NCT03575702|101867697|FG001|Overall Study|Protocol Violation|1|||
33537935|NCT03575702|101867696|FG000|Overall Study|Patient non compliance|4|||
33537936|NCT03575702|101867697|FG001|Overall Study|Patient non compliance|0|||
33537937|NCT01172873|101867698|FG000|Overall Study|Withdrawal by Subject|3|||
33537938|NCT01172873|101867699|FG001|Overall Study|Withdrawal by Subject|2|||
33537939|NCT01576575|101867701|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
33537940|NCT01576575|101867701|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
33537941|NCT01576575|101867701|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
33537942|NCT00073918|101870816|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
33340584|NCT02068547|101136117|FG000|Overall Study|Physician Decision|1|||
33340585|NCT02068547|101136118|FG001|Overall Study|Physician Decision|0|||
33340586|NCT02792842|101136120|FG000|Overall Study|Adverse Event|4|||
33340587|NCT02792842|101136121|FG001|Overall Study|Adverse Event|2|||
33340588|NCT02792842|101136122|FG002|Overall Study|Adverse Event|3|||
33340589|NCT02792842|101136120|FG000|Overall Study|Withdrawal by Subject|0|||
33340590|NCT02792842|101136121|FG001|Overall Study|Withdrawal by Subject|1|||
33340591|NCT02792842|101136122|FG002|Overall Study|Withdrawal by Subject|2|||
33340592|NCT02792842|101136120|FG000|Overall Study|Lost to Follow-up|0|||
33340593|NCT02792842|101136121|FG001|Overall Study|Lost to Follow-up|0|||
33340594|NCT02792842|101136122|FG002|Overall Study|Lost to Follow-up|1|||
33340595|NCT02792842|101136120|FG000|Overall Study|Schedule delay|0|||
33340596|NCT02792842|101136121|FG001|Overall Study|Schedule delay|1|||
33340597|NCT02792842|101136122|FG002|Overall Study|Schedule delay|1|||
33340598|NCT03064841|101136125|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
33340599|NCT03064841|101136125|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
33340600|NCT03064841|101136125|FG000|Overall Study|Screen failure|2|||
33340601|NCT01414257|101136129|FG000|Overall Study|No Visit After First Day of Treatment|12|||
33340602|NCT01414257|101136129|FG000|Overall Study|Protocol Violation|10|||
33340603|NCT00789529|101136130|FG000|Overall Study|Withdrawal by Subject|0|||
33340604|NCT00789529|101136131|FG001|Overall Study|Withdrawal by Subject|1|||
33340605|NCT00789529|101136130|FG000|Overall Study|Other Reason|1|||
33340606|NCT00789529|101136131|FG001|Overall Study|Other Reason|0|||
33340607|NCT00883337|101136132|FG000|Core Treatment Period|Adverse Event|9|||
33340608|NCT00883337|101136133|FG001|Core Treatment Period|Adverse Event|12|||
33340609|NCT00883337|101136134|FG002|Core Treatment Period|Adverse Event|22|||
33340610|NCT00883337|101136132|FG000|Core Treatment Period|Lack of Efficacy|7|||
33340611|NCT00883337|101136133|FG001|Core Treatment Period|Lack of Efficacy|4|||
33340612|NCT00883337|101136134|FG002|Core Treatment Period|Lack of Efficacy|2|||
33340613|NCT00883337|101136132|FG000|Core Treatment Period|Lost to Follow-up|1|||
33340614|NCT00883337|101136133|FG001|Core Treatment Period|Lost to Follow-up|1|||
33340615|NCT00883337|101136134|FG002|Core Treatment Period|Lost to Follow-up|0|||
33537943|NCT00073918|101870816|FG000|Overall Study|Rapid disease progression|2|||
33537944|NCT00073918|101870816|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
33537945|NCT01746862|101870817|FG000|Overall Study|Withdrawal by Subject|1|||
33537946|NCT01746862|101870818|FG001|Overall Study|Withdrawal by Subject|1|||
33537947|NCT01746862|101870817|FG000|Overall Study|Protocol Violation|1|||
33537948|NCT01746862|101870818|FG001|Overall Study|Protocol Violation|0|||
33537949|NCT01746862|101870817|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
33537950|NCT01746862|101870818|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
33537951|NCT01746862|101870817|FG000|Overall Study|Entered puberty during the study|1|||
33537952|NCT01746862|101870818|FG001|Overall Study|Entered puberty during the study|0|||
33537953|NCT02869789|101870819|FG000|Overall Study|Disease progression|184|||
33537954|NCT02869789|101870820|FG001|Overall Study|Disease progression|109|||
33537955|NCT02869789|101870821|FG002|Overall Study|Disease progression|260|||
33537956|NCT02869789|101870822|FG003|Overall Study|Disease progression|19|||
33537957|NCT02869789|101870819|FG000|Overall Study|Study drug toxicity|90|||
33537958|NCT02869789|101870820|FG001|Overall Study|Study drug toxicity|32|||
33537959|NCT02869789|101870821|FG002|Overall Study|Study drug toxicity|55|||
33537960|NCT02869789|101870822|FG003|Overall Study|Study drug toxicity|14|||
33537961|NCT02869789|101870819|FG000|Overall Study|Death|7|||
33537962|NCT02869789|101870820|FG001|Overall Study|Death|3|||
33537963|NCT02869789|101870821|FG002|Overall Study|Death|5|||
33537964|NCT02869789|101870822|FG003|Overall Study|Death|1|||
33537965|NCT02869789|101870819|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
33537966|NCT02869789|101870820|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
33537967|NCT02869789|101870821|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
33537968|NCT02869789|101870822|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
33537969|NCT02869789|101870819|FG000|Overall Study|Participant request to discontinue study treatment|10|||
33537970|NCT02869789|101870820|FG001|Overall Study|Participant request to discontinue study treatment|5|||
33537971|NCT02869789|101870821|FG002|Overall Study|Participant request to discontinue study treatment|5|||
33537972|NCT02869789|101870822|FG003|Overall Study|Participant request to discontinue study treatment|3|||
33614636|NCT03477838|102137225|FG000|Overall Study|Lost to Follow-up|14|||
33614637|NCT03539601|102137226|FG000|Overall Study|Withdraw by parent/guardian|1|||
33614638|NCT03539601|102137227|FG001|Overall Study|Withdraw by parent/guardian|0|||
33614639|NCT03539601|102137228|FG002|Overall Study|Withdraw by parent/guardian|1|||
33614640|NCT03539601|102137229|FG003|Overall Study|Withdraw by parent/guardian|0|||
33614641|NCT03539601|102137226|FG000|Overall Study|Adverse Event|0|||
33614642|NCT03539601|102137227|FG001|Overall Study|Adverse Event|2|||
33209587|NCT01217073|100670229|FG003|Extension Period|Non-compliance with study drug|0|||
33340616|NCT00883337|101136132|FG000|Core Treatment Period|Withdrawal by Subject|2|||
33340617|NCT00883337|101136133|FG001|Core Treatment Period|Withdrawal by Subject|2|||
33340618|NCT00883337|101136134|FG002|Core Treatment Period|Withdrawal by Subject|6|||
33340619|NCT00883337|101136132|FG000|Core Treatment Period|Wish to be pregnant|1|||
33340620|NCT00883337|101136133|FG001|Core Treatment Period|Wish to be pregnant|2|||
33340621|NCT00883337|101136134|FG002|Core Treatment Period|Wish to be pregnant|1|||
33340622|NCT00883337|101136132|FG000|Core Treatment Period|Poor compliance to protocol|0|||
33340623|NCT00883337|101136133|FG001|Core Treatment Period|Poor compliance to protocol|0|||
33340624|NCT00883337|101136134|FG002|Core Treatment Period|Poor compliance to protocol|1|||
33340625|NCT00883337|101136132|FG000|Core Treatment Period|Other than above|0|||
33340626|NCT00883337|101136133|FG001|Core Treatment Period|Other than above|1|||
33340627|NCT00883337|101136134|FG002|Core Treatment Period|Other than above|1|||
33340628|NCT00883337|101136132|FG000|Extension Treatment Period|Adverse Event|8|||
33340629|NCT00883337|101136133|FG001|Extension Treatment Period|Adverse Event|5|||
33340630|NCT00883337|101136134|FG002|Extension Treatment Period|Adverse Event|5|||
33340631|NCT00883337|101136132|FG000|Extension Treatment Period|Lack of Efficacy|8|||
33340632|NCT00883337|101136133|FG001|Extension Treatment Period|Lack of Efficacy|8|||
33340633|NCT00883337|101136134|FG002|Extension Treatment Period|Lack of Efficacy|8|||
33340634|NCT00883337|101136132|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
33340635|NCT00883337|101136133|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
33340636|NCT00883337|101136134|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
33340637|NCT00883337|101136132|FG000|Extension Treatment Period|Lost to Follow-up|1|||
33537973|NCT02869789|101870819|FG000|Overall Study|Withdrawal by Subject|5|||
33537974|NCT02869789|101870820|FG001|Overall Study|Withdrawal by Subject|2|||
33537975|NCT02869789|101870821|FG002|Overall Study|Withdrawal by Subject|7|||
33537976|NCT02869789|101870822|FG003|Overall Study|Withdrawal by Subject|2|||
33537977|NCT02869789|101870819|FG000|Overall Study|Lost to Follow-up|0|||
33614643|NCT03539601|102137228|FG002|Overall Study|Adverse Event|0|||
33614644|NCT03539601|102137229|FG003|Overall Study|Adverse Event|0|||
33614645|NCT03539601|102137226|FG000|Overall Study|Lost to Follow-up|2|||
33614646|NCT03539601|102137227|FG001|Overall Study|Lost to Follow-up|4|||
33537978|NCT02869789|101870820|FG001|Overall Study|Lost to Follow-up|0|||
33537979|NCT02869789|101870821|FG002|Overall Study|Lost to Follow-up|2|||
33537980|NCT02869789|101870822|FG003|Overall Study|Lost to Follow-up|0|||
33614647|NCT03539601|102137228|FG002|Overall Study|Lost to Follow-up|5|||
33614648|NCT03539601|102137229|FG003|Overall Study|Lost to Follow-up|0|||
33537981|NCT02869789|101870819|FG000|Overall Study|Maximum clinical benefit|5|||
33537982|NCT02869789|101870820|FG001|Overall Study|Maximum clinical benefit|2|||
33537983|NCT02869789|101870821|FG002|Overall Study|Maximum clinical benefit|1|||
33537984|NCT02869789|101870822|FG003|Overall Study|Maximum clinical benefit|0|||
33537985|NCT02869789|101870819|FG000|Overall Study|Poor/Non-compliance|0|||
33537986|NCT02869789|101870820|FG001|Overall Study|Poor/Non-compliance|2|||
33537987|NCT02869789|101870821|FG002|Overall Study|Poor/Non-compliance|1|||
33340638|NCT00883337|101136133|FG001|Extension Treatment Period|Lost to Follow-up|0|||
33537988|NCT02869789|101870822|FG003|Overall Study|Poor/Non-compliance|0|||
33537989|NCT02869789|101870819|FG000|Overall Study|Participant no longer meets study criteria|0|||
33537990|NCT02869789|101870820|FG001|Overall Study|Participant no longer meets study criteria|1|||
33537991|NCT02869789|101870821|FG002|Overall Study|Participant no longer meets study criteria|1|||
33537992|NCT02869789|101870822|FG003|Overall Study|Participant no longer meets study criteria|0|||
33537993|NCT02869789|101870819|FG000|Overall Study|Administrative reason by sponsor|0|||
33537994|NCT02869789|101870820|FG001|Overall Study|Administrative reason by sponsor|0|||
33537995|NCT02869789|101870821|FG002|Overall Study|Administrative reason by sponsor|1|||
33537996|NCT02869789|101870822|FG003|Overall Study|Administrative reason by sponsor|0|||
33537997|NCT02869789|101870819|FG000|Overall Study|Other reasons|4|||
33537998|NCT02869789|101870820|FG001|Overall Study|Other reasons|8|||
33340639|NCT00883337|101136134|FG002|Extension Treatment Period|Lost to Follow-up|0|||
33340640|NCT00883337|101136132|FG000|Extension Treatment Period|Other than above|10|||
33340641|NCT00883337|101136133|FG001|Extension Treatment Period|Other than above|9|||
33340642|NCT00883337|101136134|FG002|Extension Treatment Period|Other than above|5|||
33340643|NCT01823679|101136139|FG000|Overall Study|Death|1|||
33340644|NCT01665807|101136140|FG000|Overall Study|Withdrawal by Subject|2|||
33340645|NCT01665807|101136141|FG001|Overall Study|Withdrawal by Subject|0|||
33340646|NCT01665807|101136142|FG002|Overall Study|Withdrawal by Subject|1|||
33340647|NCT02568046|101136143|FG000|Overall Study|Adverse Event|0|||
33340648|NCT02568046|101136144|FG001|Overall Study|Adverse Event|1|||
33340649|NCT02568046|101136143|FG000|Overall Study|Death|2|||
33340650|NCT02568046|101136144|FG001|Overall Study|Death|0|||
33340651|NCT02568046|101136143|FG000|Overall Study|Progressive Disease|1|||
33340652|NCT02568046|101136144|FG001|Overall Study|Progressive Disease|0|||
33340653|NCT02568046|101136143|FG000|Overall Study|Withdrawal by Subject|2|||
33340654|NCT02568046|101136144|FG001|Overall Study|Withdrawal by Subject|1|||
33340655|NCT02568046|101136143|FG000|Overall Study|Other Events|0|||
33340656|NCT02568046|101136144|FG001|Overall Study|Other Events|1|||
33340657|NCT01765673|101136145|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
33340658|NCT03694925|101136146|FG000|Overall Study|Inadequate laboratory testing|0|||
33340659|NCT03694925|101136147|FG001|Overall Study|Inadequate laboratory testing|3|||
33537999|NCT02869789|101870821|FG002|Overall Study|Other reasons|6|||
33538000|NCT02869789|101870822|FG003|Overall Study|Other reasons|0|||
33340660|NCT03694925|101136148|FG002|Overall Study|Inadequate laboratory testing|0|||
33340661|NCT03107793|101136149|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
33538001|NCT01290718|101870823|FG000|Overall Study|Early termination of the study|4|||
33538002|NCT02121210|101870824|FG000|Overall Study|Adverse Event|5|||
33538003|NCT02121210|101870825|FG001|Overall Study|Adverse Event|7|||
33405847|NCT03982069|101373524|FG003|Overall Study|Lost to Follow-up|5|||
33405848|NCT03982069|101373521|FG000|Overall Study|Physician Decision|0|||
33405849|NCT03982069|101373522|FG001|Overall Study|Physician Decision|1|||
33405850|NCT03982069|101373523|FG002|Overall Study|Physician Decision|0|||
33405851|NCT03982069|101373524|FG003|Overall Study|Physician Decision|0|||
33405852|NCT03982069|101373521|FG000|Overall Study|Withdrawal by Subject|2|||
33405853|NCT03982069|101373522|FG001|Overall Study|Withdrawal by Subject|1|||
33405854|NCT03982069|101373523|FG002|Overall Study|Withdrawal by Subject|5|||
33405855|NCT03982069|101373524|FG003|Overall Study|Withdrawal by Subject|2|||
33405856|NCT03982069|101373521|FG000|Overall Study|Specimen loss|3|||
33340662|NCT03107793|101136150|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
33405857|NCT03982069|101373522|FG001|Overall Study|Specimen loss|3|||
33405858|NCT03982069|101373523|FG002|Overall Study|Specimen loss|1|||
33405859|NCT03982069|101373524|FG003|Overall Study|Specimen loss|1|||
33405860|NCT00121485|101373526|FG000|Overall Study|Not implanted|1|||
33405861|NCT00121485|101373527|FG001|Overall Study|Not implanted|5|||
33405862|NCT00121485|101373526|FG000|Overall Study|Crossover|0|||
33405863|NCT00121485|101373527|FG001|Overall Study|Crossover|2|||
33405864|NCT01757821|101373528|FG000|Overall Study|Adverse Event|1|||
33405865|NCT00486720|101373529|FG000|Overall Study|Adverse Event|1|||
33340663|NCT03107793|101136151|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
33340664|NCT03107793|101136152|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
33340665|NCT03107793|101136153|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
33340666|NCT03107793|101136149|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
33340667|NCT03107793|101136150|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
33340668|NCT03107793|101136151|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
33340669|NCT03107793|101136152|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
33405866|NCT00486720|101373530|FG001|Overall Study|Adverse Event|2|||
33405867|NCT00486720|101373529|FG000|Overall Study|Lack of Efficacy|4|||
33405868|NCT00486720|101373530|FG001|Overall Study|Lack of Efficacy|6|||
33405869|NCT00486720|101373529|FG000|Overall Study|Physician Decision|1|||
33405870|NCT00486720|101373530|FG001|Overall Study|Physician Decision|2|||
33405871|NCT00486720|101373529|FG000|Overall Study|Protocol Violation|1|||
33405872|NCT00486720|101373530|FG001|Overall Study|Protocol Violation|0|||
33405873|NCT00486720|101373529|FG000|Overall Study|Withdrawal by Subject|3|||
33405874|NCT00486720|101373530|FG001|Overall Study|Withdrawal by Subject|1|||
33405875|NCT00486720|101373529|FG000|Overall Study|Progressive Disease|0|||
33405876|NCT00486720|101373530|FG001|Overall Study|Progressive Disease|1|||
33405877|NCT02173158|101373532|FG000|Efficacy Phase|Adverse Event|1|||
33405878|NCT01681004|101373535|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
33405879|NCT01681004|101373536|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
33405880|NCT01681004|101373535|FG000|Study Completion|Lost to Follow-up|8|||
33405881|NCT01681004|101373536|FG001|Study Completion|Lost to Follow-up|3|||
33405882|NCT01681004|101373535|FG000|Study Completion|Physician Decision|1|||
33405883|NCT01681004|101373536|FG001|Study Completion|Physician Decision|3|||
33405884|NCT01681004|101373535|FG000|Study Completion|Site Termination|2|||
33405885|NCT01681004|101373536|FG001|Study Completion|Site Termination|1|||
33405886|NCT01681004|101373535|FG000|Study Completion|Death|1|||
33405887|NCT01681004|101373536|FG001|Study Completion|Death|1|||
33405888|NCT00174460|101373537|FG000|Overall Study|Withdrawal by Subject|0|||
33405889|NCT00174460|101373538|FG001|Overall Study|Withdrawal by Subject|1|||
33405890|NCT02079077|101377507|FG000|Overall Study|Lost to Follow-up|5|||
33405891|NCT02079077|101377508|FG001|Overall Study|Lost to Follow-up|7|||
33405892|NCT02079077|101377507|FG000|Overall Study|Became STIs Positive|1|||
33405893|NCT02079077|101377508|FG001|Overall Study|Became STIs Positive|2|||
33405894|NCT00960323|101377509|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
33538004|NCT02121210|101870824|FG000|Overall Study|Lack of Efficacy|2|||
33538005|NCT02121210|101870825|FG001|Overall Study|Lack of Efficacy|0|||
33538006|NCT02121210|101870824|FG000|Overall Study|Other than specified above|0|||
33538007|NCT02121210|101870825|FG001|Overall Study|Other than specified above|2|||
33538008|NCT02668640|101870826|FG000|Overall Study|Lost to Follow-up|13|||
33538009|NCT02668640|101870826|FG000|Overall Study|Other, not specified|1|||
33405895|NCT00948896|101377519|FG000|Randomization to 24 Months of Age|Death|1|||
33405896|NCT00948896|101377520|FG001|Randomization to 24 Months of Age|Death|0|||
33405897|NCT00948896|101377521|FG002|Randomization to 24 Months of Age|Death|0|||
33405898|NCT00948896|101377522|FG003|Randomization to 24 Months of Age|Death|0|||
33405899|NCT00948896|101377523|FG004|Randomization to 24 Months of Age|Death|2|||
33405900|NCT00948896|101377524|FG005|Randomization to 24 Months of Age|Death|1|||
33405901|NCT00948896|101377525|FG006|Randomization to 24 Months of Age|Death|2|||
33405902|NCT00948896|101377526|FG007|Randomization to 24 Months of Age|Death|1|||
33405903|NCT00948896|101377519|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
33538010|NCT02351934|101870827|FG000|Allocation|POD weight<pre-op weight|3|||
33340670|NCT03107793|101136153|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
33538011|NCT02351934|101870828|FG001|Allocation|POD weight<pre-op weight|0|||
33405904|NCT00948896|101377520|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
33405905|NCT00948896|101377521|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
33538012|NCT02351934|101870827|FG000|Allocation|Hypotension preventing administration|2|||
33209588|NCT01217073|100670230|FG004|Extension Period|Non-compliance with study drug|0|||
33209589|NCT01217073|100670231|FG005|Extension Period|Non-compliance with study drug|0|||
33405906|NCT00948896|101377522|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
33405907|NCT00948896|101377523|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
33405908|NCT00948896|101377524|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
33405909|NCT00948896|101377525|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
33405910|NCT00948896|101377526|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
33405911|NCT00948896|101377519|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
33405912|NCT00948896|101377520|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
33405913|NCT00948896|101377521|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
33405914|NCT00948896|101377522|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
33405915|NCT00948896|101377523|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
33405916|NCT00948896|101377524|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
33405917|NCT00948896|101377525|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
33405918|NCT00948896|101377526|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
33405919|NCT00948896|101377519|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
33405920|NCT00948896|101377520|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
33405921|NCT00948896|101377521|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
33405922|NCT00948896|101377522|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
33405923|NCT00948896|101377523|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
33405924|NCT00948896|101377524|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
33405925|NCT00948896|101377525|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
33405926|NCT00948896|101377526|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
33405927|NCT00948896|101377519|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
33405928|NCT00948896|101377520|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
33405929|NCT00948896|101377521|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
33405930|NCT00948896|101377522|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
33405931|NCT00948896|101377523|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
33405932|NCT00948896|101377524|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
33405933|NCT00948896|101377525|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
33405934|NCT00948896|101377526|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
33405935|NCT00948896|101377519|FG000|24 Months of Age to 36 Months of Age|Death|0|||
33538013|NCT02351934|101870828|FG001|Allocation|Hypotension preventing administration|0|||
33538014|NCT02351934|101870827|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
33538015|NCT02351934|101870828|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
33538016|NCT02351934|101870827|FG000|Follow-Up|POD weight<pre-op weight|3|||
33538017|NCT02351934|101870828|FG001|Follow-Up|POD weight<pre-op weight|0|||
33538018|NCT02351934|101870827|FG000|Follow-Up|Acute Kidney Injury|1|||
33538019|NCT02351934|101870828|FG001|Follow-Up|Acute Kidney Injury|0|||
33538020|NCT02351934|101870827|FG000|Follow-Up|Early dismissal|3|||
33538021|NCT02351934|101870828|FG001|Follow-Up|Early dismissal|0|||
33538022|NCT02351934|101870827|FG000|Follow-Up|Hypotension|3|||
33538023|NCT02351934|101870828|FG001|Follow-Up|Hypotension|0|||
33405936|NCT00948896|101377520|FG001|24 Months of Age to 36 Months of Age|Death|2|||
33538024|NCT02351934|101870827|FG000|Follow-Up|No documentation|2|||
33538025|NCT02351934|101870828|FG001|Follow-Up|No documentation|0|||
33538026|NCT02351934|101870827|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
33538027|NCT02351934|101870828|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
33209590|NCT01217073|100670232|FG006|Extension Period|Non-compliance with study drug|0|||
33209591|NCT01217073|100670233|FG007|Extension Period|Non-compliance with study drug|1|||
33209592|NCT01217073|100670226|FG000|Extension Period|Physician Decision|0|||
33614649|NCT03539601|102137226|FG000|Overall Study|Withdrawal by Subject|2|||
33614650|NCT03539601|102137227|FG001|Overall Study|Withdrawal by Subject|0|||
33614651|NCT03539601|102137228|FG002|Overall Study|Withdrawal by Subject|0|||
33614652|NCT03539601|102137229|FG003|Overall Study|Withdrawal by Subject|1|||
33614653|NCT03539601|102137226|FG000|Overall Study|Randomized but not treated|1|||
33538028|NCT02351934|101870827|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
33538029|NCT02351934|101870828|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
33538030|NCT02051296|101870829|FG000|Overall Study|Lost to Follow-up|1|||
33538031|NCT02051296|101870830|FG001|Overall Study|Lost to Follow-up|2|||
33538032|NCT02051296|101870829|FG000|Overall Study|withdraw prior to treatment|7|||
33538033|NCT02051296|101870830|FG001|Overall Study|withdraw prior to treatment|7|||
33538034|NCT01111565|101870833|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
33538035|NCT01111565|101870834|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
33538036|NCT01111565|101870835|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
33538037|NCT01111565|101870836|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
33538038|NCT01111565|101870837|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
33538039|NCT01111565|101870833|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
33538040|NCT01111565|101870834|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
33538041|NCT01111565|101870835|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
33538042|NCT01111565|101870836|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
33538043|NCT01111565|101870837|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
33538044|NCT01111565|101870833|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
33538045|NCT01111565|101870834|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
33538046|NCT01111565|101870835|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
33538047|NCT01111565|101870836|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
33538048|NCT01111565|101870837|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
33538049|NCT01111565|101870833|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
33538050|NCT01111565|101870834|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
33538051|NCT01111565|101870835|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
33538052|NCT01111565|101870836|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
33538053|NCT01111565|101870837|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
33538054|NCT01111565|101870833|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
33538055|NCT01111565|101870834|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
33538056|NCT01111565|101870835|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
33538057|NCT01111565|101870836|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
33538058|NCT01111565|101870837|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
33538059|NCT01111565|101870833|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
33538060|NCT01111565|101870834|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
33538061|NCT01111565|101870835|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
33538062|NCT01111565|101870836|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
33538063|NCT01111565|101870837|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
33340671|NCT03107793|101136149|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
33340672|NCT03107793|101136150|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
33340673|NCT03107793|101136151|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
33340674|NCT03107793|101136152|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
33340675|NCT03107793|101136153|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
33340676|NCT03107793|101136149|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
33340677|NCT03107793|101136150|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33340678|NCT03107793|101136151|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33340679|NCT03107793|101136152|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33538064|NCT01111565|101870833|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
33538065|NCT01111565|101870834|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
33538066|NCT01111565|101870835|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
33538067|NCT01111565|101870836|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
33538068|NCT01111565|101870837|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
33538069|NCT01111565|101870833|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
33538070|NCT01111565|101870834|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
33538071|NCT01111565|101870835|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
33538072|NCT01111565|101870836|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
33538073|NCT01111565|101870837|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
33538074|NCT01111565|101870833|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33538075|NCT01111565|101870834|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33538076|NCT01111565|101870835|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
33538077|NCT01111565|101870836|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33538078|NCT01111565|101870837|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33538079|NCT01111565|101870833|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
33538080|NCT01111565|101870834|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
33538081|NCT01111565|101870835|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
33340680|NCT03107793|101136153|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33340681|NCT03107793|101136149|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
33340682|NCT03107793|101136150|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
33340683|NCT03107793|101136151|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
33340684|NCT03107793|101136152|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
33340685|NCT03107793|101136153|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
33340686|NCT03107793|101136149|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
33340687|NCT03107793|101136150|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
33340688|NCT03107793|101136151|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
33340689|NCT03107793|101136152|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
33340690|NCT03107793|101136153|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
33405937|NCT00948896|101377521|FG002|24 Months of Age to 36 Months of Age|Death|2|||
33405938|NCT00948896|101377522|FG003|24 Months of Age to 36 Months of Age|Death|0|||
33405939|NCT00948896|101377523|FG004|24 Months of Age to 36 Months of Age|Death|0|||
33405940|NCT00948896|101377524|FG005|24 Months of Age to 36 Months of Age|Death|1|||
33405941|NCT00948896|101377525|FG006|24 Months of Age to 36 Months of Age|Death|0|||
33405942|NCT00948896|101377526|FG007|24 Months of Age to 36 Months of Age|Death|0|||
33405943|NCT00948896|101377519|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
33405944|NCT00948896|101377520|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
33405945|NCT00948896|101377521|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
33405946|NCT00948896|101377522|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
33405947|NCT00948896|101377523|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
33405948|NCT00948896|101377524|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
33405949|NCT00948896|101377525|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
33538082|NCT01111565|101870836|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
33538083|NCT01111565|101870837|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
33405950|NCT00948896|101377526|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
33405951|NCT00948896|101377519|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
33405952|NCT00948896|101377520|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
33405953|NCT00948896|101377521|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
33405954|NCT00948896|101377522|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
33405955|NCT00948896|101377523|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
33405956|NCT00948896|101377524|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
33405957|NCT00948896|101377525|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
33405958|NCT00948896|101377526|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
33405959|NCT00948896|101377519|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
33405960|NCT00948896|101377520|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
33405961|NCT00948896|101377521|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
33405962|NCT00948896|101377522|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
33405963|NCT00948896|101377523|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
33405964|NCT00948896|101377524|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
33405965|NCT00948896|101377525|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
33405966|NCT00948896|101377526|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
33405967|NCT00948896|101377519|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
33538084|NCT01111565|101870833|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
33538085|NCT01111565|101870834|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
33538086|NCT01111565|101870835|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
33538087|NCT01111565|101870836|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
33538088|NCT01111565|101870837|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
33538089|NCT01111565|101870833|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
33538090|NCT01111565|101870834|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
33538091|NCT01111565|101870835|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
33538092|NCT01111565|101870836|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
33538093|NCT01111565|101870837|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
33538094|NCT02792504|101870838|FG000|Overall Study|Lost to Follow-up|24|||
33538095|NCT02792504|101870838|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
33538096|NCT00483652|101870839|FG000|Double-blind Treatment Period|Protocol Violation|2|||
33538097|NCT00483652|101870840|FG001|Double-blind Treatment Period|Protocol Violation|1|||
33538098|NCT00483652|101870839|FG000|Double-blind Treatment Period|Adverse Event|3|||
33538099|NCT00483652|101870840|FG001|Double-blind Treatment Period|Adverse Event|4|||
33538100|NCT00483652|101870839|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
33538101|NCT00483652|101870840|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
33340691|NCT03107793|101136149|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
33340692|NCT03107793|101136150|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
33340693|NCT03107793|101136151|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
33340694|NCT03107793|101136152|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
33340695|NCT03107793|101136153|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
33340696|NCT03107793|101136149|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
33340697|NCT03107793|101136150|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
33538102|NCT00483652|101870839|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
33538103|NCT00483652|101870840|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
33538104|NCT00643201|101870841|FG000|Randomized, Completed 6 Months of Study|Death|20|||
33538105|NCT00643201|101870842|FG001|Randomized, Completed 6 Months of Study|Death|26|||
33538106|NCT00643201|101870841|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
33538107|NCT00643201|101870842|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
33538108|NCT00643201|101870841|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
33538109|NCT00643201|101870842|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
33538110|NCT00643201|101870841|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
33538111|NCT00643201|101870842|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
33538112|NCT00643201|101870841|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
33538113|NCT00643201|101870842|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
33538114|NCT00643201|101870841|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
33538115|NCT00643201|101870842|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
33538116|NCT00643201|101870841|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
33538117|NCT00643201|101870842|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
33538118|NCT00643201|101870841|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
33538119|NCT00643201|101870842|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
33538120|NCT00643201|101870841|FG000|Randomized, Completed 6 Months of Study|Other|107|||
33538121|NCT00643201|101870842|FG001|Randomized, Completed 6 Months of Study|Other|107|||
33538122|NCT00643201|101870841|FG000|Completed Study Follow Up|Death|28|||
33538123|NCT00643201|101870842|FG001|Completed Study Follow Up|Death|34|||
33538124|NCT00643201|101870841|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
33538125|NCT00643201|101870842|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
33538126|NCT00643201|101870841|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
33538127|NCT00643201|101870842|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
33538128|NCT00643201|101870841|FG000|Completed Study Follow Up|non-specified|1|||
33538129|NCT00643201|101870842|FG001|Completed Study Follow Up|non-specified|0|||
33538130|NCT00731822|101870847|FG000|Overall Study|Adverse Event|2|||
33538131|NCT00731822|101870848|FG001|Overall Study|Adverse Event|1|||
33538132|NCT00731822|101870847|FG000|Overall Study|Protocol Violation|1|||
33538133|NCT00731822|101870848|FG001|Overall Study|Protocol Violation|0|||
33538134|NCT00731822|101870847|FG000|Overall Study|Lost to Follow-up|1|||
33538135|NCT00731822|101870848|FG001|Overall Study|Lost to Follow-up|0|||
33538136|NCT00983372|101870852|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
33538137|NCT00983372|101870852|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
33538138|NCT00983372|101870852|FG000|Diltiazem ER Alone|Adverse Event|1|||
33538139|NCT03006562|101870853|FG000|Overall Study|Lost to Follow-up|0|||
33538140|NCT03006562|101870854|FG001|Overall Study|Lost to Follow-up|1|||
33538141|NCT02662569|101870855|FG000|Overall Study|Withdrawal by Subject|6|||
33538142|NCT02662569|101870856|FG001|Overall Study|Withdrawal by Subject|1|||
33538143|NCT02662569|101870857|FG002|Overall Study|Withdrawal by Subject|6|||
33538144|NCT02662569|101870858|FG003|Overall Study|Withdrawal by Subject|4|||
33538145|NCT02662569|101870855|FG000|Overall Study|Lost to Follow-up|1|||
33538146|NCT02662569|101870856|FG001|Overall Study|Lost to Follow-up|0|||
33538147|NCT02662569|101870857|FG002|Overall Study|Lost to Follow-up|0|||
33538148|NCT02662569|101870858|FG003|Overall Study|Lost to Follow-up|0|||
33538149|NCT02089347|101870860|FG000|Overall Study|Protocol Violation|1|||
33538150|NCT02089347|101870861|FG001|Overall Study|Protocol Violation|0|||
33538151|NCT01178294|101870862|FG000|Overall Study|Adverse Event|4|||
33538152|NCT01178294|101870862|FG000|Overall Study|Lost to Follow-up|2|||
33538153|NCT01178294|101870862|FG000|Overall Study|Lack of Efficacy|1|||
33538154|NCT01178294|101870862|FG000|Overall Study|Death|1|||
33538155|NCT01178294|101870862|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
33340698|NCT03107793|101136151|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
33340699|NCT03107793|101136152|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
33538156|NCT01178294|101870862|FG000|Overall Study|Subject status is terminal|1|||
33538157|NCT01178294|101870862|FG000|Overall Study|Completion status could not be verified|1|||
33538158|NCT02659943|101870865|FG000|Overall Study|Switched to alternative treatment|1|||
33538159|NCT02659943|101870866|FG001|Overall Study|Switched to alternative treatment|1|||
33538160|NCT02659943|101870867|FG002|Overall Study|Switched to alternative treatment|0|||
33538161|NCT02659943|101870868|FG003|Overall Study|Switched to alternative treatment|2|||
33538162|NCT02659943|101870869|FG004|Overall Study|Switched to alternative treatment|1|||
33340700|NCT03107793|101136153|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
33340701|NCT03107793|101136149|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
33340702|NCT03107793|101136150|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
33209593|NCT01217073|100670227|FG001|Extension Period|Physician Decision|0|||
33209594|NCT01217073|100670228|FG002|Extension Period|Physician Decision|0|||
33340703|NCT03107793|101136151|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
33340704|NCT03107793|101136152|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
33340705|NCT03107793|101136153|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
33340706|NCT03107793|101136149|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
33340707|NCT03107793|101136150|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
33340708|NCT03107793|101136151|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
33340709|NCT03107793|101136152|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
33340710|NCT03107793|101136153|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
33340711|NCT03107793|101136149|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33340712|NCT03107793|101136150|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
33340713|NCT03107793|101136151|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33340714|NCT03107793|101136152|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33340715|NCT03107793|101136153|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33340716|NCT03107793|101136149|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
33340717|NCT03107793|101136150|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
33340718|NCT03107793|101136151|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
33340719|NCT03107793|101136152|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
33340720|NCT03107793|101136153|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
33340721|NCT03107793|101136149|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
33340722|NCT03107793|101136150|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
33340723|NCT03107793|101136151|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
33340724|NCT03107793|101136152|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
33340725|NCT03107793|101136153|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
33340726|NCT03107793|101136149|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
33340727|NCT03107793|101136150|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
33340728|NCT03107793|101136151|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
33340729|NCT03107793|101136152|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
33340730|NCT03107793|101136153|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
33340731|NCT03107793|101136149|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
33340732|NCT03107793|101136150|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
33340733|NCT03107793|101136151|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
33340734|NCT03107793|101136152|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
33340735|NCT03107793|101136153|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
33340736|NCT03107793|101136149|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
33340737|NCT03107793|101136150|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
33340738|NCT03107793|101136151|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
33340739|NCT03107793|101136152|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
33340740|NCT03107793|101136153|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
33340741|NCT03107793|101136149|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
33340742|NCT03107793|101136150|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
33340743|NCT03107793|101136151|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
33340744|NCT03107793|101136152|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
33340745|NCT03107793|101136153|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
33340746|NCT03107793|101136149|FG000|Extension Period (Week 48- Week 104)|Death|0|||
33340747|NCT03107793|101136150|FG001|Extension Period (Week 48- Week 104)|Death|0|||
33340748|NCT03107793|101136151|FG002|Extension Period (Week 48- Week 104)|Death|0|||
33340749|NCT03107793|101136152|FG003|Extension Period (Week 48- Week 104)|Death|0|||
33340750|NCT03107793|101136153|FG004|Extension Period (Week 48- Week 104)|Death|1|||
33340751|NCT03107793|101136149|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
33340752|NCT03107793|101136150|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
33340753|NCT03107793|101136151|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
33340754|NCT03107793|101136152|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
33340755|NCT03107793|101136153|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
33340756|NCT03107793|101136149|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
33340757|NCT03107793|101136150|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
33340758|NCT03107793|101136151|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
33405968|NCT00948896|101377520|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
33405969|NCT00948896|101377521|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
33405970|NCT00948896|101377522|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
33405971|NCT00948896|101377523|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
33209595|NCT01217073|100670229|FG003|Extension Period|Physician Decision|0|||
33538163|NCT02659943|101870870|FG005|Overall Study|Switched to alternative treatment|0|||
33538164|NCT02659943|101870871|FG006|Overall Study|Switched to alternative treatment|1|||
33538165|NCT02659943|101870865|FG000|Overall Study|Disease progression on study|0|||
33538166|NCT02659943|101870866|FG001|Overall Study|Disease progression on study|1|||
33538167|NCT02659943|101870867|FG002|Overall Study|Disease progression on study|1|||
33538168|NCT02659943|101870868|FG003|Overall Study|Disease progression on study|1|||
33340759|NCT03107793|101136152|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
33340760|NCT03107793|101136153|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
33340761|NCT03107793|101136149|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
33340762|NCT03107793|101136150|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
33340763|NCT03107793|101136151|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
33340764|NCT03107793|101136152|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
33340765|NCT03107793|101136153|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
33340766|NCT03107793|101136149|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
33340767|NCT03107793|101136150|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
33340768|NCT03107793|101136151|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
33340769|NCT03107793|101136152|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
33340770|NCT03107793|101136153|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
33340771|NCT03107793|101136149|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
33340772|NCT03107793|101136150|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
33340773|NCT03107793|101136151|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
33340774|NCT03107793|101136152|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
33340775|NCT03107793|101136153|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
33340776|NCT03107793|101136149|FG000|Extension Period (Week 48- Week 104)|Other|0|||
33340777|NCT03107793|101136150|FG001|Extension Period (Week 48- Week 104)|Other|0|||
33340778|NCT03107793|101136151|FG002|Extension Period (Week 48- Week 104)|Other|0|||
33340779|NCT03107793|101136152|FG003|Extension Period (Week 48- Week 104)|Other|1|||
33340780|NCT03107793|101136153|FG004|Extension Period (Week 48- Week 104)|Other|3|||
33538169|NCT02659943|101870869|FG004|Overall Study|Disease progression on study|1|||
33538170|NCT02659943|101870870|FG005|Overall Study|Disease progression on study|4|||
33538171|NCT02659943|101870871|FG006|Overall Study|Disease progression on study|0|||
33538172|NCT02659943|101870865|FG000|Overall Study|Patient's condition per principal investigator|0|||
33538173|NCT02659943|101870866|FG001|Overall Study|Patient's condition per principal investigator|0|||
33538174|NCT02659943|101870867|FG002|Overall Study|Patient's condition per principal investigator|0|||
33538175|NCT02659943|101870868|FG003|Overall Study|Patient's condition per principal investigator|0|||
33538176|NCT02659943|101870869|FG004|Overall Study|Patient's condition per principal investigator|0|||
33538177|NCT02659943|101870870|FG005|Overall Study|Patient's condition per principal investigator|1|||
33538178|NCT02659943|101870871|FG006|Overall Study|Patient's condition per principal investigator|0|||
33538179|NCT02659943|101870865|FG000|Overall Study|Ineligible|0|||
33538180|NCT02659943|101870866|FG001|Overall Study|Ineligible|0|||
33538181|NCT02659943|101870867|FG002|Overall Study|Ineligible|0|||
33538182|NCT02659943|101870868|FG003|Overall Study|Ineligible|0|||
33538183|NCT02659943|101870869|FG004|Overall Study|Ineligible|0|||
33538184|NCT02659943|101870870|FG005|Overall Study|Ineligible|0|||
33538185|NCT02659943|101870871|FG006|Overall Study|Ineligible|1|||
33538186|NCT02659943|101870865|FG000|Overall Study|No longer meets eligibility|0|||
33538187|NCT02659943|101870866|FG001|Overall Study|No longer meets eligibility|0|||
33538188|NCT02659943|101870867|FG002|Overall Study|No longer meets eligibility|0|||
33538189|NCT02659943|101870868|FG003|Overall Study|No longer meets eligibility|0|||
33538190|NCT02659943|101870869|FG004|Overall Study|No longer meets eligibility|0|||
33538191|NCT02659943|101870870|FG005|Overall Study|No longer meets eligibility|0|||
33538192|NCT02659943|101870871|FG006|Overall Study|No longer meets eligibility|1|||
33538193|NCT02659943|101870865|FG000|Overall Study|No treatment, per protocol|0|||
33538194|NCT02659943|101870866|FG001|Overall Study|No treatment, per protocol|0|||
33538195|NCT02659943|101870867|FG002|Overall Study|No treatment, per protocol|0|||
33538196|NCT02659943|101870868|FG003|Overall Study|No treatment, per protocol|0|||
33538197|NCT02659943|101870869|FG004|Overall Study|No treatment, per protocol|0|||
33538198|NCT02659943|101870870|FG005|Overall Study|No treatment, per protocol|0|||
33340781|NCT03107793|101136149|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
33340782|NCT03107793|101136150|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
33340783|NCT03107793|101136151|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
33340784|NCT03107793|101136152|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
33340785|NCT03107793|101136153|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
33340786|NCT00797732|101136154|FG000|Overall Study|Withdrawal by Subject|3|||
33340787|NCT00797732|101136155|FG001|Overall Study|Withdrawal by Subject|3|||
33538199|NCT02659943|101870871|FG006|Overall Study|No treatment, per protocol|3|||
33538200|NCT01692119|101870874|FG000|Overall Study|Protocol Violation|3|||
33538201|NCT01692119|101870875|FG001|Overall Study|Protocol Violation|1|||
33340788|NCT00797732|101136156|FG002|Overall Study|Withdrawal by Subject|0|||
33340789|NCT00797732|101136154|FG000|Overall Study|Lost to Follow-up|1|||
33340790|NCT00797732|101136155|FG001|Overall Study|Lost to Follow-up|0|||
33340791|NCT00797732|101136156|FG002|Overall Study|Lost to Follow-up|0|||
33340792|NCT00797732|101136154|FG000|Overall Study|Death|1|||
33340793|NCT00797732|101136155|FG001|Overall Study|Death|0|||
33340794|NCT00797732|101136156|FG002|Overall Study|Death|0|||
33340795|NCT00797732|101136154|FG000|Overall Study|Not meet inclusion criteria|0|||
33340796|NCT00797732|101136155|FG001|Overall Study|Not meet inclusion criteria|0|||
33340797|NCT00797732|101136156|FG002|Overall Study|Not meet inclusion criteria|7|||
33340798|NCT00797732|101136154|FG000|Overall Study|Excluded due to time constraints|0|||
33340799|NCT00797732|101136155|FG001|Overall Study|Excluded due to time constraints|0|||
33340800|NCT00797732|101136156|FG002|Overall Study|Excluded due to time constraints|24|||
33340801|NCT00797732|101136154|FG000|Overall Study|Refused to Participate|0|||
33340802|NCT00797732|101136155|FG001|Overall Study|Refused to Participate|0|||
33340803|NCT00797732|101136156|FG002|Overall Study|Refused to Participate|123|||
33340804|NCT02450578|101136159|FG000|Overall Study|ECG abnormality so not treated|1|||
33340805|NCT02450578|101136160|FG001|Overall Study|ECG abnormality so not treated|0|||
33340806|NCT02450578|101136161|FG002|Overall Study|ECG abnormality so not treated|0|||
33340807|NCT02450578|101136162|FG003|Overall Study|ECG abnormality so not treated|0|||
33340808|NCT00493870|101136163|FG000|Overall Study|Lost to Follow-up|12|||
33340809|NCT00493870|101136164|FG001|Overall Study|Lost to Follow-up|15|||
33340810|NCT01157078|101141609|FG000|Overall Study|Withdrawal by Subject|12|||
33340811|NCT01157078|101141610|FG001|Overall Study|Withdrawal by Subject|14|||
33340812|NCT01157078|101141609|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33340813|NCT01157078|101141610|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33340814|NCT01157078|101141609|FG000|Overall Study|Adverse Event|6|||
33340815|NCT01157078|101141610|FG001|Overall Study|Adverse Event|6|||
33340816|NCT01157078|101141609|FG000|Overall Study|Severe non-compliance to protocol|2|||
33340817|NCT01157078|101141610|FG001|Overall Study|Severe non-compliance to protocol|4|||
33340818|NCT01157078|101141609|FG000|Overall Study|Condition under investigation worsened|0|||
33340819|NCT01157078|101141610|FG001|Overall Study|Condition under investigation worsened|1|||
33340820|NCT01157078|101141609|FG000|Overall Study|Lack of Efficacy|2|||
33340821|NCT01157078|101141610|FG001|Overall Study|Lack of Efficacy|0|||
33340822|NCT01157078|101141609|FG000|Overall Study|Study-specific withdrawal criteria|2|||
33614654|NCT03539601|102137227|FG001|Overall Study|Randomized but not treated|1|||
33614655|NCT03539601|102137228|FG002|Overall Study|Randomized but not treated|0|||
33340823|NCT01157078|101141610|FG001|Overall Study|Study-specific withdrawal criteria|2|||
33340824|NCT01157078|101141609|FG000|Overall Study|Lost to Follow-up|7|||
33340825|NCT01157078|101141610|FG001|Overall Study|Lost to Follow-up|5|||
33340826|NCT01157078|101141609|FG000|Overall Study|Other|2|||
33340827|NCT01157078|101141610|FG001|Overall Study|Other|4|||
33340828|NCT01587079|101141614|FG000|Overall Study|Protocol-specified criteria|9|||
33340829|NCT01587079|101141614|FG000|Overall Study|Protocol Violation|5|||
33340830|NCT01587079|101141614|FG000|Overall Study|Lost to Follow-up|2|||
33340831|NCT01587079|101141614|FG000|Overall Study|Physician Decision|2|||
33340832|NCT01587079|101141614|FG000|Overall Study|Withdrawal by Subject|7|||
33340833|NCT01587079|101141614|FG000|Overall Study|Adverse Event|14|||
33340834|NCT01049035|101141615|FG000|Overall Study|Serious adverse event|0|||
33340835|NCT01049035|101141616|FG001|Overall Study|Serious adverse event|1|||
33340836|NCT01049035|101141617|FG002|Overall Study|Serious adverse event|1|||
33614656|NCT03539601|102137229|FG003|Overall Study|Randomized but not treated|0|||
33614657|NCT04178720|102137230|FG000|Overall Study|Withdrawal by Subject|2|||
33614658|NCT04178720|102137231|FG001|Overall Study|Withdrawal by Subject|0|||
33614659|NCT04178720|102137230|FG000|Overall Study|Relocation|0|||
33614660|NCT04178720|102137231|FG001|Overall Study|Relocation|1|||
33614661|NCT02519595|102137236|FG000|Overall Study|Protocol Violation|8|||
33614662|NCT02519595|102137237|FG001|Overall Study|Protocol Violation|22|||
33614663|NCT02519595|102137238|FG002|Overall Study|Protocol Violation|16|||
33340837|NCT01049035|101141618|FG003|Overall Study|Serious adverse event|2|||
33340838|NCT01049035|101141619|FG004|Overall Study|Serious adverse event|0|||
33340839|NCT01049035|101141620|FG005|Overall Study|Serious adverse event|0|||
33340840|NCT01049035|101141621|FG006|Overall Study|Serious adverse event|0|||
33614664|NCT01529034|102137239|FG000|Overall Study|Discontinued prior to study treatment|14|||
33614665|NCT01529034|102137239|FG000|Overall Study|Site closure|62|||
33614666|NCT01529034|102137239|FG000|Overall Study|Study termination|29|||
33614667|NCT01529034|102137239|FG000|Overall Study|Withdrawal by Subject|25|||
33340841|NCT01049035|101141615|FG000|Overall Study|Other adverse event (AE)|0|||
33340842|NCT01049035|101141616|FG001|Overall Study|Other adverse event (AE)|0|||
33340843|NCT01049035|101141617|FG002|Overall Study|Other adverse event (AE)|0|||
33340844|NCT01049035|101141618|FG003|Overall Study|Other adverse event (AE)|1|||
33340845|NCT01049035|101141619|FG004|Overall Study|Other adverse event (AE)|0|||
33340846|NCT01049035|101141620|FG005|Overall Study|Other adverse event (AE)|0|||
33340847|NCT01049035|101141621|FG006|Overall Study|Other adverse event (AE)|0|||
33340848|NCT01049035|101141615|FG000|Overall Study|Non-compliance with the protocol|12|||
33340849|NCT01049035|101141616|FG001|Overall Study|Non-compliance with the protocol|6|||
33340850|NCT01049035|101141617|FG002|Overall Study|Non-compliance with the protocol|14|||
33340851|NCT01049035|101141618|FG003|Overall Study|Non-compliance with the protocol|5|||
33340852|NCT01049035|101141619|FG004|Overall Study|Non-compliance with the protocol|3|||
33340853|NCT01049035|101141620|FG005|Overall Study|Non-compliance with the protocol|4|||
33340854|NCT01049035|101141621|FG006|Overall Study|Non-compliance with the protocol|10|||
33340855|NCT01049035|101141615|FG000|Overall Study|Lost to Follow-up|5|||
33340856|NCT01049035|101141616|FG001|Overall Study|Lost to Follow-up|4|||
33340857|NCT01049035|101141617|FG002|Overall Study|Lost to Follow-up|4|||
33340858|NCT01049035|101141618|FG003|Overall Study|Lost to Follow-up|1|||
33340859|NCT01049035|101141619|FG004|Overall Study|Lost to Follow-up|0|||
33340860|NCT01049035|101141620|FG005|Overall Study|Lost to Follow-up|3|||
33340861|NCT01049035|101141621|FG006|Overall Study|Lost to Follow-up|3|||
33340862|NCT01049035|101141615|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
33340863|NCT01049035|101141616|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
33340864|NCT01049035|101141617|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
33340865|NCT01049035|101141618|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
33340866|NCT01049035|101141619|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
33340867|NCT01049035|101141620|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
33340868|NCT01049035|101141621|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
33340869|NCT02239263|101141622|FG000|Overall Study|Protocol Violation|6|||
33340870|NCT04506294|101141623|FG000|Overall Study|Lost to Follow-up|70|||
33340871|NCT04506294|101141624|FG001|Overall Study|Lost to Follow-up|20|||
33340872|NCT04506294|101141623|FG000|Overall Study|Withdrawal by Subject|16|||
33340873|NCT04506294|101141624|FG001|Overall Study|Withdrawal by Subject|2|||
33340874|NCT00676715|101141629|FG000|Overall Study|Withdrawal by Subject|7|||
33340875|NCT00676715|101141630|FG001|Overall Study|Withdrawal by Subject|9|||
33340876|NCT00676715|101141631|FG002|Overall Study|Withdrawal by Subject|10|||
33340877|NCT00676715|101141632|FG003|Overall Study|Withdrawal by Subject|10|||
33340878|NCT00676715|101141629|FG000|Overall Study|Other|2|||
33340879|NCT00676715|101141630|FG001|Overall Study|Other|6|||
33340880|NCT00676715|101141631|FG002|Overall Study|Other|4|||
33340881|NCT00676715|101141632|FG003|Overall Study|Other|3|||
33340882|NCT00676715|101141629|FG000|Overall Study|Lost to Follow-up|1|||
33340883|NCT00676715|101141630|FG001|Overall Study|Lost to Follow-up|1|||
33340884|NCT00676715|101141631|FG002|Overall Study|Lost to Follow-up|7|||
33340885|NCT00676715|101141632|FG003|Overall Study|Lost to Follow-up|3|||
33340886|NCT00676715|101141629|FG000|Overall Study|Death|1|||
33340887|NCT00676715|101141630|FG001|Overall Study|Death|1|||
33340888|NCT00676715|101141631|FG002|Overall Study|Death|1|||
33340889|NCT00676715|101141632|FG003|Overall Study|Death|0|||
33340890|NCT00676715|101141629|FG000|Overall Study|Adverse Event|0|||
33340891|NCT00676715|101141630|FG001|Overall Study|Adverse Event|1|||
33538202|NCT01692119|101870874|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
33538203|NCT01692119|101870875|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
33538204|NCT01165307|101870876|FG000|Overall Study|Lost to Follow-up|11|||
33538205|NCT01165307|101870877|FG001|Overall Study|Lost to Follow-up|3|||
33538206|NCT01165307|101870876|FG000|Overall Study|Withdrawal by Subject|2|||
33538207|NCT01165307|101870877|FG001|Overall Study|Withdrawal by Subject|0|||
33538208|NCT01165307|101870876|FG000|Overall Study|Subject not available for contact|1|||
33538209|NCT01165307|101870877|FG001|Overall Study|Subject not available for contact|0|||
33538210|NCT00885118|101870878|FG000|Overall Study|Adverse Event|1|||
33538211|NCT00885118|101870879|FG001|Overall Study|Adverse Event|0|||
33538212|NCT00885118|101870880|FG002|Overall Study|Adverse Event|0|||
33538213|NCT00885118|101870881|FG003|Overall Study|Adverse Event|0|||
33538214|NCT00885118|101870882|FG004|Overall Study|Adverse Event|0|||
33538215|NCT00885118|101870878|FG000|Overall Study|Withdrawal by Subject|0|||
33538216|NCT00885118|101870879|FG001|Overall Study|Withdrawal by Subject|0|||
33538217|NCT00885118|101870880|FG002|Overall Study|Withdrawal by Subject|0|||
33538218|NCT00885118|101870881|FG003|Overall Study|Withdrawal by Subject|0|||
33538219|NCT00885118|101870882|FG004|Overall Study|Withdrawal by Subject|1|||
33340892|NCT00676715|101141631|FG002|Overall Study|Adverse Event|2|||
33340893|NCT00676715|101141632|FG003|Overall Study|Adverse Event|0|||
33340894|NCT00676715|101141629|FG000|Overall Study|Participants Ongoing|29|||
33340895|NCT00676715|101141630|FG001|Overall Study|Participants Ongoing|29|||
33340896|NCT00676715|101141631|FG002|Overall Study|Participants Ongoing|17|||
33340897|NCT00676715|101141632|FG003|Overall Study|Participants Ongoing|24|||
33340898|NCT00527605|101141633|FG000|Overall Study|Adverse Event|3|||
33340899|NCT00527605|101141634|FG001|Overall Study|Adverse Event|0|||
33538220|NCT00885118|101870878|FG000|Overall Study|Other reason not defined above|0|||
33340900|NCT00527605|101141633|FG000|Overall Study|Withdrawal by Subject|3|||
33340901|NCT00527605|101141634|FG001|Overall Study|Withdrawal by Subject|7|||
33340902|NCT00527605|101141633|FG000|Overall Study|Lost to Follow-up|6|||
33340903|NCT00527605|101141634|FG001|Overall Study|Lost to Follow-up|2|||
33340904|NCT00527605|101141633|FG000|Overall Study|Protocol Violation|1|||
33340905|NCT00527605|101141634|FG001|Overall Study|Protocol Violation|2|||
33340906|NCT00774345|101141635|FG000|Pre-treatment|Other reasons|2|||
33340907|NCT00774345|101141636|FG001|Pre-treatment|Other reasons|0|||
33340908|NCT00774345|101141635|FG000|Treatment|Adverse Event|61|||
33340909|NCT00774345|101141636|FG001|Treatment|Adverse Event|15|||
33340910|NCT00774345|101141635|FG000|Treatment|Progressive Disease without histologic transformation|51|||
33340911|NCT00774345|101141636|FG001|Treatment|Progressive Disease without histologic transformation|111|||
33340912|NCT00774345|101141635|FG000|Treatment|Progressive Disease with histologic transformation|4|||
33340913|NCT00774345|101141636|FG001|Treatment|Progressive Disease with histologic transformation|2|||
33340914|NCT00774345|101141635|FG000|Treatment|Withdrawal by Subject|5|||
33340915|NCT00774345|101141636|FG001|Treatment|Withdrawal by Subject|2|||
33340916|NCT00774345|101141635|FG000|Treatment|Lost to Follow-up|1|||
33340917|NCT00774345|101141636|FG001|Treatment|Lost to Follow-up|1|||
33340918|NCT00774345|101141635|FG000|Treatment|Death|4|||
33340919|NCT00774345|101141636|FG001|Treatment|Death|0|||
33340920|NCT00774345|101141635|FG000|Treatment|Other Reasons|32|||
33340921|NCT00774345|101141636|FG001|Treatment|Other Reasons|26|||
33614668|NCT01529034|102137239|FG000|Overall Study|No treated SCs within protocol window|13|||
33614669|NCT01529034|102137239|FG000|Overall Study|Noncompliance|8|||
33340922|NCT05099640|101141637|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
33340923|NCT05099640|101141638|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
33340924|NCT05099640|101141639|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
33340925|NCT05099640|101141637|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
33340926|NCT05099640|101141638|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
33340927|NCT05099640|101141639|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
33340928|NCT05099640|101141637|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
33340929|NCT05099640|101141638|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
33340930|NCT05099640|101141639|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
33538221|NCT00885118|101870879|FG001|Overall Study|Other reason not defined above|0|||
33538222|NCT00885118|101870880|FG002|Overall Study|Other reason not defined above|1|||
33538223|NCT00885118|101870881|FG003|Overall Study|Other reason not defined above|0|||
33538224|NCT00885118|101870882|FG004|Overall Study|Other reason not defined above|0|||
33538225|NCT00875810|101870883|FG000|Overall Study|Withdrawal by Subject|1|||
33538226|NCT00875810|101870883|FG000|Overall Study|Physician Decision|3|||
33538227|NCT00875810|101870883|FG000|Overall Study|Lost to Follow-up|39|||
33538228|NCT00875810|101870883|FG000|Overall Study|Patient enroled but not implanted|2|||
33538229|NCT00875810|101870883|FG000|Overall Study|Device explanted|1|||
33538230|NCT05002972|101870884|FG000|Overall Study|Withdrawal by Subject|2|||
33538231|NCT00975416|101870885|FG000|Overall Study|early discharge from tx|3|||
33538232|NCT00975416|101870886|FG001|Overall Study|early discharge from tx|5|||
33538233|NCT01118052|101870887|FG000|Overall Study|Never treated|2|||
33538234|NCT04644029|101870888|FG000|Overall Study|Death|1|||
33538235|NCT04644029|101870889|FG001|Overall Study|Death|0|||
33538236|NCT04644029|101870888|FG000|Overall Study|Physician Decision|1|||
33538237|NCT04644029|101870889|FG001|Overall Study|Physician Decision|2|||
33538238|NCT04644029|101870888|FG000|Overall Study|Withdrawal by Subject|21|||
33538239|NCT04644029|101870889|FG001|Overall Study|Withdrawal by Subject|19|||
33538240|NCT04644029|101870888|FG000|Overall Study|Lost to Follow-up|31|||
33538241|NCT04644029|101870889|FG001|Overall Study|Lost to Follow-up|34|||
33538242|NCT04644029|101870888|FG000|Overall Study|Study Terminated by Sponsor|305|||
33538243|NCT04644029|101870889|FG001|Overall Study|Study Terminated by Sponsor|301|||
33538244|NCT04644029|101870888|FG000|Overall Study|Status Not Recorded|3|||
33538245|NCT04644029|101870889|FG001|Overall Study|Status Not Recorded|8|||
33538246|NCT04644029|101870888|FG000|Overall Study|Randomized in Error|2|||
33538247|NCT04644029|101870889|FG001|Overall Study|Randomized in Error|1|||
33538248|NCT04644029|101870888|FG000|Overall Study|Other|0|||
33538249|NCT04644029|101870889|FG001|Overall Study|Other|1|||
33538250|NCT03342001|101870896|FG000|Overall Study|Adverse Event|1|||
33538251|NCT03342001|101870896|FG000|Overall Study|Lost to Follow-up|1|||
33538252|NCT00379834|101870901|FG000|Overall Study|Time constraints|2|||
33538253|NCT02736617|101870902|FG000|Treatment|Adverse Event|1|||
33538254|NCT02736617|101870902|FG000|Treatment|Lack of Efficacy|1|||
33538255|NCT02736617|101870902|FG000|Treatment|Withdrawal by Subject|1|||
33538256|NCT02736617|101870902|FG000|Maintenance|Lack of Efficacy|4|||
33538257|NCT02736617|101870902|FG000|Maintenance|Physician Decision|1|||
33538258|NCT00617279|101870903|FG000|Overall Study|Study terminated by Sponsor|10|||
33538259|NCT00617279|101870904|FG001|Overall Study|Study terminated by Sponsor|15|||
33538260|NCT00617279|101870903|FG000|Overall Study|Graft abandonment|2|||
33538261|NCT00617279|101870904|FG001|Overall Study|Graft abandonment|0|||
33538262|NCT00617279|101870903|FG000|Overall Study|Lost to Follow-up|1|||
33538263|NCT00617279|101870904|FG001|Overall Study|Lost to Follow-up|0|||
33538264|NCT00617279|101870903|FG000|Overall Study|Death|1|||
33538265|NCT00617279|101870904|FG001|Overall Study|Death|2|||
33538266|NCT01764841|101870905|FG000|Overall Study|Logistical Difficulties|0|||
33538267|NCT01764841|101870906|FG001|Overall Study|Logistical Difficulties|1|||
33538268|NCT01764841|101870907|FG002|Overall Study|Logistical Difficulties|0|||
33538269|NCT01764841|101870908|FG003|Overall Study|Logistical Difficulties|0|||
33538270|NCT01764841|101870905|FG000|Overall Study|Death|3|||
33538271|NCT01764841|101870906|FG001|Overall Study|Death|0|||
33538272|NCT01764841|101870907|FG002|Overall Study|Death|1|||
33405972|NCT00948896|101377524|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
33538273|NCT01764841|101870908|FG003|Overall Study|Death|4|||
33538274|NCT01764841|101870905|FG000|Overall Study|No Follow Up|1|||
33538275|NCT01764841|101870906|FG001|Overall Study|No Follow Up|0|||
33538276|NCT01764841|101870907|FG002|Overall Study|No Follow Up|1|||
33538277|NCT01764841|101870908|FG003|Overall Study|No Follow Up|0|||
33538278|NCT01764841|101870905|FG000|Overall Study|Protocol Violation|0|||
33538279|NCT01764841|101870906|FG001|Overall Study|Protocol Violation|1|||
33538280|NCT01764841|101870907|FG002|Overall Study|Protocol Violation|0|||
33538281|NCT01764841|101870908|FG003|Overall Study|Protocol Violation|0|||
33538282|NCT01764841|101870905|FG000|Overall Study|Withdrawal by Subject|16|||
33538283|NCT01764841|101870906|FG001|Overall Study|Withdrawal by Subject|24|||
33538284|NCT01764841|101870907|FG002|Overall Study|Withdrawal by Subject|11|||
33538285|NCT01764841|101870908|FG003|Overall Study|Withdrawal by Subject|15|||
33538286|NCT01764841|101870905|FG000|Overall Study|Lost to Follow-up|3|||
33538287|NCT01764841|101870906|FG001|Overall Study|Lost to Follow-up|0|||
33538288|NCT01764841|101870907|FG002|Overall Study|Lost to Follow-up|1|||
33209596|NCT01217073|100670230|FG004|Extension Period|Physician Decision|0|||
33340931|NCT05099640|101141637|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
33340932|NCT05099640|101141638|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
33340933|NCT05099640|101141639|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
33340934|NCT05099640|101141637|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
33340935|NCT05099640|101141638|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
33340936|NCT05099640|101141639|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
33340937|NCT05099640|101141637|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
33340938|NCT05099640|101141638|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
33340939|NCT05099640|101141639|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
33538289|NCT01764841|101870908|FG003|Overall Study|Lost to Follow-up|0|||
33538290|NCT01286129|101870912|FG000|Overall Study|Withdrawal by Subject|4|||
33614670|NCT01529034|102137239|FG000|Overall Study|Caregiver no longer available|7|||
33614671|NCT01529034|102137239|FG000|Overall Study|Adverse Event|4|||
33614672|NCT01529034|102137239|FG000|Overall Study|Protocol Violation|4|||
33614673|NCT01529034|102137239|FG000|Overall Study|Lack of Efficacy|4|||
33614674|NCT01529034|102137239|FG000|Overall Study|Investigator no longer available|2|||
33614675|NCT01529034|102137239|FG000|Overall Study|Study drug not available|2|||
33614676|NCT01712204|102137240|FG000|Overall Study|Adverse Event|3|||
33614677|NCT01712204|102137241|FG001|Overall Study|Adverse Event|1|||
33614678|NCT01712204|102137240|FG000|Overall Study|Withdrawal by Subject|3|||
33614679|NCT01712204|102137241|FG001|Overall Study|Withdrawal by Subject|3|||
33614680|NCT01712204|102137240|FG000|Overall Study|Lost to Follow-up|1|||
33614681|NCT01712204|102137241|FG001|Overall Study|Lost to Follow-up|0|||
33614682|NCT01712204|102137240|FG000|Overall Study|Protocol Violation|1|||
33614683|NCT01712204|102137241|FG001|Overall Study|Protocol Violation|1|||
33614684|NCT04207060|102137244|FG000|Overall Study|Lost to Follow-up|2|||
33340940|NCT01537211|101141640|FG000|Overall Study|Lost to Follow-up|0|||
33340941|NCT01537211|101141641|FG001|Overall Study|Lost to Follow-up|1|||
33538291|NCT01286129|101870913|FG001|Overall Study|Withdrawal by Subject|1|||
33538292|NCT01286129|101870912|FG000|Overall Study|Could not comply with study requirements|4|||
33538293|NCT01286129|101870913|FG001|Overall Study|Could not comply with study requirements|4|||
33538294|NCT01408706|101870914|FG000|Overall Study|Physician Decision|1|||
33538295|NCT01408706|101870915|FG001|Overall Study|Physician Decision|0|||
33538296|NCT00111761|101870916|FG000|Part 1|Physician Decision|0|||
33538297|NCT00111761|101870917|FG001|Part 1|Physician Decision|1|||
33538298|NCT00111761|101870916|FG000|Part 1|Death|0|||
33538299|NCT00111761|101870917|FG001|Part 1|Death|2|||
33538300|NCT00111761|101870916|FG000|Part 1|Other|0|||
33538301|NCT00111761|101870917|FG001|Part 1|Other|1|||
33538302|NCT00111761|101870916|FG000|Part 1|Withdrawal by Subject|0|||
33538303|NCT00111761|101870917|FG001|Part 1|Withdrawal by Subject|1|||
33538304|NCT00111761|101870916|FG000|Part 2|Adverse Event|1|||
33538305|NCT00111761|101870917|FG001|Part 2|Adverse Event|0|||
33538306|NCT00111761|101870916|FG000|Part 2|Physician Decision|1|||
33538307|NCT00111761|101870917|FG001|Part 2|Physician Decision|0|||
33538308|NCT00111761|101870916|FG000|Part 2|Death|1|||
33538309|NCT00111761|101870917|FG001|Part 2|Death|0|||
33538310|NCT00111761|101870916|FG000|Part 2|Disease progression|3|||
33538311|NCT00111761|101870917|FG001|Part 2|Disease progression|0|||
33538312|NCT00111761|101870916|FG000|Part 2|Protocol-specified criteria|1|||
33538313|NCT00111761|101870917|FG001|Part 2|Protocol-specified criteria|0|||
33538314|NCT00111761|101870916|FG000|Part 2|Other|1|||
33538315|NCT00111761|101870917|FG001|Part 2|Other|0|||
33538316|NCT02481050|101870920|FG000|Overall Study|Adverse Event|1|||
33538317|NCT02481050|101870920|FG000|Overall Study|Disease Progression|47|||
33538318|NCT02481050|101870920|FG000|Overall Study|Withdrawal by Subject|7|||
33538319|NCT02481050|101870920|FG000|Overall Study|Other|3|||
33538320|NCT00706004|101870921|FG000|Overall Study|Did not meet eligibility criteria|2|||
33538321|NCT03122171|101870922|FG000|Overall Study|Withdrawal by Subject|1|||
33538322|NCT01802385|101870923|FG000|Overall Study|Death|106|||
33538323|NCT01802385|101870924|FG001|Overall Study|Death|120|||
33538324|NCT02127658|101870925|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
33538325|NCT02127658|101870926|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
33538326|NCT02127658|101870925|FG000|Overall Study|Withdrawal by Subject|0|||
33538327|NCT02127658|101870926|FG001|Overall Study|Withdrawal by Subject|2|||
33614685|NCT04207060|102137245|FG001|Overall Study|Lost to Follow-up|0|||
33614686|NCT00794950|102137246|FG000|BCG Induction|Withdrawal by Subject|2|||
33614687|NCT00794950|102137246|FG000|BCG Induction|ineligible|3|||
33614688|NCT00794950|102137246|FG000|BCG Induction|noncompliant w. BCG|1|||
33614689|NCT00794950|102137246|FG000|BCG Induction|Adverse Event|1|||
33340942|NCT02275338|101141642|FG000|Overall Study|Adverse Event|15|||
33340943|NCT02275338|101141642|FG000|Overall Study|Lack of Efficacy|3|||
33340944|NCT02275338|101141642|FG000|Overall Study|Withdrawal by Subject|4|||
33340945|NCT02275338|101141642|FG000|Overall Study|Disease progression (death)|1|||
33340946|NCT02275338|101141642|FG000|Overall Study|Ineligible to start Phase 2|4|||
33340947|NCT02275338|101141642|FG000|Overall Study|Reason not specified|5|||
33340948|NCT02275338|101141642|FG000|Overall Study|Does not meet entry criteria|1|||
33340949|NCT00323557|101141643|FG000|Overall Study|Physician Decision|1|||
33340950|NCT00323557|101141644|FG001|Overall Study|Physician Decision|0|||
33340951|NCT02684981|101141647|FG000|Overall Study|Permanently discontinued the treatment|157|||
33340952|NCT02684981|101141648|FG001|Overall Study|Permanently discontinued the treatment|161|||
33340953|NCT02684981|101141649|FG002|Overall Study|Permanently discontinued the treatment|110|||
33340954|NCT02684981|101141647|FG000|Overall Study|Other|83|||
33340955|NCT02684981|101141648|FG001|Overall Study|Other|49|||
33340956|NCT02684981|101141649|FG002|Overall Study|Other|17|||
33340957|NCT02665286|101141650|FG000|Overall Study|Lost to Follow-up|3|||
33340958|NCT02665286|101141651|FG001|Overall Study|Lost to Follow-up|2|||
33340959|NCT02665286|101141652|FG002|Overall Study|Lost to Follow-up|1|||
33340960|NCT01707693|101141655|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
33340961|NCT01707693|101141656|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
33538328|NCT02127658|101870925|FG000|Overall Study|Physician Decision|0|||
33538329|NCT02127658|101870926|FG001|Overall Study|Physician Decision|1|||
33538330|NCT00368108|101870927|FG000|Overall Study|Adverse Event|38|||
33538331|NCT00368108|101870928|FG001|Overall Study|Adverse Event|26|||
33538332|NCT00368108|101870929|FG002|Overall Study|Adverse Event|44|||
33538333|NCT00368108|101870927|FG000|Overall Study|Abnormal Laboratory Value|0|||
33538334|NCT00368108|101870928|FG001|Overall Study|Abnormal Laboratory Value|0|||
33538335|NCT00368108|101870929|FG002|Overall Study|Abnormal Laboratory Value|3|||
33538336|NCT00368108|101870927|FG000|Overall Study|Protocol Violation|5|||
33538337|NCT00368108|101870928|FG001|Overall Study|Protocol Violation|9|||
33538338|NCT00368108|101870929|FG002|Overall Study|Protocol Violation|9|||
33538339|NCT00368108|101870927|FG000|Overall Study|Withdrawal by Subject|9|||
33538340|NCT00368108|101870928|FG001|Overall Study|Withdrawal by Subject|3|||
33538341|NCT00368108|101870929|FG002|Overall Study|Withdrawal by Subject|5|||
33538342|NCT00368108|101870927|FG000|Overall Study|Lack of Efficacy|7|||
33538343|NCT00368108|101870928|FG001|Overall Study|Lack of Efficacy|8|||
33538344|NCT00368108|101870929|FG002|Overall Study|Lack of Efficacy|5|||
33538345|NCT00368108|101870927|FG000|Overall Study|Physician Decision|2|||
33538346|NCT00368108|101870928|FG001|Overall Study|Physician Decision|0|||
33538347|NCT00368108|101870929|FG002|Overall Study|Physician Decision|1|||
33614690|NCT00794950|102137246|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
33614691|NCT00794950|102137246|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
33614692|NCT00794950|102137246|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
33614693|NCT00794950|102137246|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
33614694|NCT02688985|102137251|FG000|Overall Study|Adverse Event|1|||
33614695|NCT02688985|102137252|FG001|Overall Study|Adverse Event|2|||
33614696|NCT02688985|102137253|FG002|Overall Study|Adverse Event|2|||
33614697|NCT02688985|102137254|FG003|Overall Study|Adverse Event|0|||
33614698|NCT02688985|102137255|FG004|Overall Study|Adverse Event|0|||
33614699|NCT02688985|102137251|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
33614700|NCT02688985|102137252|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
33614701|NCT02688985|102137253|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
33614702|NCT02688985|102137254|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
33614703|NCT02688985|102137255|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
33614704|NCT02688985|102137251|FG000|Overall Study|Death|0|||
33340962|NCT01707693|101141655|FG000|Overall Study Allocation|Protocol Violation|4|||
33340963|NCT01707693|101141656|FG001|Overall Study Allocation|Protocol Violation|3|||
33340964|NCT01707693|101141655|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
33340965|NCT01707693|101141656|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
33538348|NCT00368108|101870927|FG000|Overall Study|Other|3|||
33538349|NCT00368108|101870928|FG001|Overall Study|Other|7|||
33538350|NCT00368108|101870929|FG002|Overall Study|Other|1|||
33340966|NCT01707693|101141655|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
33538351|NCT01723072|101870931|FG000|Overall Study|Withdrawal by Subject|7|||
33538352|NCT01723072|101870932|FG001|Overall Study|Withdrawal by Subject|13|||
33538353|NCT01723072|101870931|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
33538354|NCT01723072|101870932|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
33340967|NCT01707693|101141656|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
33538355|NCT01723072|101870931|FG000|Overall Study|Other|4|||
33538356|NCT01723072|101870932|FG001|Overall Study|Other|3|||
33538357|NCT00171249|101870933|FG000|Overall Study|Withdrawal by Subject|2|||
33340968|NCT03657043|101141660|FG000|Overall Study|Withdrawal by Subject|1|||
33614705|NCT02688985|102137252|FG001|Overall Study|Death|0|||
33614706|NCT02688985|102137253|FG002|Overall Study|Death|0|||
33614707|NCT02688985|102137254|FG003|Overall Study|Death|0|||
33614708|NCT02688985|102137255|FG004|Overall Study|Death|1|||
33538358|NCT00171249|101870934|FG001|Overall Study|Withdrawal by Subject|0|||
33538359|NCT00171249|101870935|FG002|Overall Study|Withdrawal by Subject|0|||
33538360|NCT00171249|101870936|FG003|Overall Study|Withdrawal by Subject|6|||
33538361|NCT00171249|101870937|FG004|Overall Study|Withdrawal by Subject|0|||
33538362|NCT00171249|101870938|FG005|Overall Study|Withdrawal by Subject|0|||
33538363|NCT00171249|101870939|FG006|Overall Study|Withdrawal by Subject|0|||
33538364|NCT00171249|101870933|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
33538365|NCT00171249|101870934|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
33538366|NCT00171249|101870935|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
33614709|NCT02688985|102137251|FG000|Overall Study|Lack of Efficacy|0|||
33538367|NCT00171249|101870936|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
33538368|NCT00171249|101870937|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
33614710|NCT02688985|102137252|FG001|Overall Study|Lack of Efficacy|0|||
33614711|NCT02688985|102137253|FG002|Overall Study|Lack of Efficacy|0|||
33614712|NCT02688985|102137254|FG003|Overall Study|Lack of Efficacy|0|||
33614713|NCT02688985|102137255|FG004|Overall Study|Lack of Efficacy|1|||
33614714|NCT02688985|102137251|FG000|Overall Study|Lost to Follow-up|2|||
33209597|NCT01217073|100670231|FG005|Extension Period|Physician Decision|0|||
33340969|NCT03657043|101141661|FG001|Overall Study|Withdrawal by Subject|1|||
33538369|NCT00171249|101870938|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
33538370|NCT00171249|101870939|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
33538371|NCT00171249|101870933|FG000|Overall Study|Death|7|||
33538372|NCT00171249|101870934|FG001|Overall Study|Death|1|||
33614715|NCT02688985|102137252|FG001|Overall Study|Lost to Follow-up|0|||
33340970|NCT03657043|101141662|FG002|Overall Study|Withdrawal by Subject|0|||
33614716|NCT02688985|102137253|FG002|Overall Study|Lost to Follow-up|1|||
33538373|NCT00171249|101870935|FG002|Overall Study|Death|0|||
33538374|NCT00171249|101870936|FG003|Overall Study|Death|4|||
33538375|NCT00171249|101870937|FG004|Overall Study|Death|0|||
33538376|NCT00171249|101870938|FG005|Overall Study|Death|3|||
33538377|NCT00171249|101870939|FG006|Overall Study|Death|1|||
33538378|NCT00171249|101870933|FG000|Overall Study|Other|10|||
33538379|NCT00171249|101870934|FG001|Overall Study|Other|0|||
33538380|NCT00171249|101870935|FG002|Overall Study|Other|0|||
33538381|NCT00171249|101870936|FG003|Overall Study|Other|43|||
33538382|NCT00171249|101870937|FG004|Overall Study|Other|0|||
33538383|NCT00171249|101870938|FG005|Overall Study|Other|2|||
33538384|NCT00171249|101870939|FG006|Overall Study|Other|0|||
33538385|NCT00171249|101870933|FG000|Overall Study|No Longer Requires Study Drug|4|||
33538386|NCT00171249|101870934|FG001|Overall Study|No Longer Requires Study Drug|0|||
33538387|NCT00171249|101870935|FG002|Overall Study|No Longer Requires Study Drug|0|||
33538388|NCT00171249|101870936|FG003|Overall Study|No Longer Requires Study Drug|3|||
33538389|NCT00171249|101870937|FG004|Overall Study|No Longer Requires Study Drug|0|||
33538390|NCT00171249|101870938|FG005|Overall Study|No Longer Requires Study Drug|5|||
33538391|NCT00171249|101870939|FG006|Overall Study|No Longer Requires Study Drug|0|||
33538392|NCT00171249|101870933|FG000|Overall Study|Administrative Problems|1|||
33614717|NCT02688985|102137254|FG003|Overall Study|Lost to Follow-up|1|||
33614718|NCT02688985|102137255|FG004|Overall Study|Lost to Follow-up|1|||
33614719|NCT02688985|102137251|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33614720|NCT02688985|102137252|FG001|Overall Study|Non-Compliance With Study Drug|3|||
33614721|NCT02688985|102137253|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33614722|NCT02688985|102137254|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33614723|NCT02688985|102137255|FG004|Overall Study|Non-Compliance With Study Drug|1|||
33614724|NCT02688985|102137251|FG000|Overall Study|Other|3|||
33614725|NCT02688985|102137252|FG001|Overall Study|Other|4|||
33614726|NCT02688985|102137253|FG002|Overall Study|Other|1|||
33614727|NCT02688985|102137254|FG003|Overall Study|Other|0|||
33614728|NCT02688985|102137255|FG004|Overall Study|Other|0|||
33614729|NCT02688985|102137251|FG000|Overall Study|Physician Decision|2|||
33614730|NCT02688985|102137252|FG001|Overall Study|Physician Decision|2|||
33614731|NCT02688985|102137253|FG002|Overall Study|Physician Decision|0|||
33614732|NCT02688985|102137254|FG003|Overall Study|Physician Decision|0|||
33614733|NCT02688985|102137255|FG004|Overall Study|Physician Decision|1|||
33614734|NCT02688985|102137251|FG000|Overall Study|Pregnancy|0|||
33614735|NCT02688985|102137252|FG001|Overall Study|Pregnancy|0|||
33614736|NCT02688985|102137253|FG002|Overall Study|Pregnancy|2|||
33614737|NCT02688985|102137254|FG003|Overall Study|Pregnancy|1|||
33614738|NCT02688985|102137255|FG004|Overall Study|Pregnancy|0|||
33614739|NCT02688985|102137251|FG000|Overall Study|Study Terminated By Sponsor|0|||
33614740|NCT02688985|102137252|FG001|Overall Study|Study Terminated By Sponsor|0|||
33614741|NCT02688985|102137253|FG002|Overall Study|Study Terminated By Sponsor|0|||
33614742|NCT02688985|102137254|FG003|Overall Study|Study Terminated By Sponsor|1|||
33614743|NCT02688985|102137255|FG004|Overall Study|Study Terminated By Sponsor|0|||
33614744|NCT02688985|102137251|FG000|Overall Study|Withdrawal by Subject|2|||
33614745|NCT02688985|102137252|FG001|Overall Study|Withdrawal by Subject|8|||
33614746|NCT02688985|102137253|FG002|Overall Study|Withdrawal by Subject|7|||
33614747|NCT02688985|102137254|FG003|Overall Study|Withdrawal by Subject|1|||
33614748|NCT02688985|102137255|FG004|Overall Study|Withdrawal by Subject|4|||
33614749|NCT01361178|102140087|FG000|Overall Study|Death|13|||
33538393|NCT00171249|101870934|FG001|Overall Study|Administrative Problems|0|||
33538394|NCT00171249|101870935|FG002|Overall Study|Administrative Problems|0|||
33538395|NCT00171249|101870936|FG003|Overall Study|Administrative Problems|2|||
33538396|NCT00171249|101870937|FG004|Overall Study|Administrative Problems|0|||
33538397|NCT00171249|101870938|FG005|Overall Study|Administrative Problems|0|||
33538398|NCT00171249|101870939|FG006|Overall Study|Administrative Problems|0|||
33614750|NCT01361178|102140088|FG001|Overall Study|Death|0|||
33614751|NCT03688074|102140089|FG000|Overall Study|Adverse Event|0|||
33538399|NCT00171249|101870933|FG000|Overall Study|Adverse Event|3|||
33538400|NCT00171249|101870934|FG001|Overall Study|Adverse Event|1|||
33614752|NCT03688074|102140090|FG001|Overall Study|Adverse Event|1|||
33614753|NCT03688074|102140089|FG000|Overall Study|Other|1|||
33614754|NCT03688074|102140090|FG001|Overall Study|Other|0|||
33614755|NCT03521141|102140091|FG000|Overall Study|Death|1|||
33614756|NCT03521141|102140092|FG001|Overall Study|Death|0|||
33614757|NCT03521141|102140093|FG002|Overall Study|Death|1|||
33614758|NCT00767819|102140097|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
33614759|NCT00767819|102140098|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
33614760|NCT00767819|102140099|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33614761|NCT00767819|102140097|FG000|Overall Study|Withdrawal by Subject|1|||
33614762|NCT00767819|102140098|FG001|Overall Study|Withdrawal by Subject|1|||
33538401|NCT00171249|101870935|FG002|Overall Study|Adverse Event|0|||
33538402|NCT00171249|101870936|FG003|Overall Study|Adverse Event|15|||
33538403|NCT00171249|101870937|FG004|Overall Study|Adverse Event|0|||
33614763|NCT00767819|102140099|FG002|Overall Study|Withdrawal by Subject|0|||
33614764|NCT00767819|102140097|FG000|Overall Study|Administrative problems|0|||
33538404|NCT00171249|101870938|FG005|Overall Study|Adverse Event|2|||
33538405|NCT00171249|101870939|FG006|Overall Study|Adverse Event|0|||
33538406|NCT00171249|101870933|FG000|Overall Study|Lost to Follow-up|5|||
33538407|NCT00171249|101870934|FG001|Overall Study|Lost to Follow-up|0|||
33538408|NCT00171249|101870935|FG002|Overall Study|Lost to Follow-up|0|||
33538409|NCT00171249|101870936|FG003|Overall Study|Lost to Follow-up|9|||
33538410|NCT00171249|101870937|FG004|Overall Study|Lost to Follow-up|0|||
33538411|NCT00171249|101870938|FG005|Overall Study|Lost to Follow-up|0|||
33538412|NCT00171249|101870939|FG006|Overall Study|Lost to Follow-up|0|||
33538413|NCT02966834|101870951|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
33538414|NCT02966834|101870952|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
33538415|NCT02966834|101870953|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
33538416|NCT02966834|101870954|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
33538417|NCT02966834|101870955|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
33340971|NCT03657043|101141663|FG003|Overall Study|Withdrawal by Subject|0|||
33340972|NCT03657043|101141664|FG004|Overall Study|Withdrawal by Subject|4|||
33538418|NCT02966834|101870956|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
33538419|NCT02966834|101870951|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
33538420|NCT02966834|101870952|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33538421|NCT02966834|101870953|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33538422|NCT02966834|101870954|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33538423|NCT02966834|101870955|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33538424|NCT02966834|101870956|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33538425|NCT02966834|101870951|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
33538426|NCT02966834|101870952|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
33538427|NCT02966834|101870953|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
33538428|NCT02966834|101870954|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
33538429|NCT02966834|101870955|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
33538430|NCT02966834|101870956|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
33538431|NCT02966834|101870951|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
33538432|NCT02966834|101870952|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
33538433|NCT02966834|101870953|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
33538434|NCT02966834|101870954|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
33538435|NCT02966834|101870955|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
33538436|NCT02966834|101870956|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
33538437|NCT02966834|101870951|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
33538438|NCT02966834|101870952|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
33538439|NCT02966834|101870953|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
33538440|NCT02966834|101870954|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
33538441|NCT02966834|101870955|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
33538442|NCT02966834|101870956|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
33538443|NCT02966834|101870951|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
33538444|NCT02966834|101870952|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
33538445|NCT02966834|101870953|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
33538446|NCT02966834|101870954|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
33538447|NCT02966834|101870955|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
33538448|NCT02966834|101870956|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
33538449|NCT00785356|101870957|FG000|Overall Study|Study prematurely terminated|8|||
33538450|NCT03627832|101870958|FG000|Overall Study|Withdrawal by Subject|10|||
33538451|NCT03627832|101870959|FG001|Overall Study|Withdrawal by Subject|1|||
33538452|NCT04556760|101870960|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
33538453|NCT04556760|101870961|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
33538454|NCT04556760|101870962|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
33538455|NCT04556760|101870963|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
33340973|NCT03657043|101141660|FG000|Overall Study|Study closure by Sponsor|0|||
33340974|NCT03657043|101141661|FG001|Overall Study|Study closure by Sponsor|2|||
33340975|NCT03657043|101141662|FG002|Overall Study|Study closure by Sponsor|0|||
33340976|NCT03657043|101141663|FG003|Overall Study|Study closure by Sponsor|0|||
33340977|NCT03657043|101141664|FG004|Overall Study|Study closure by Sponsor|17|||
33340978|NCT03657043|101141660|FG000|Overall Study|Lost to Follow-up|0|||
33340979|NCT03657043|101141661|FG001|Overall Study|Lost to Follow-up|0|||
33405973|NCT00948896|101377525|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
33405974|NCT00948896|101377526|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
33538456|NCT04556760|101870964|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
33538457|NCT04556760|101870965|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
33538458|NCT04556760|101870960|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
33405975|NCT01005966|101377527|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
33340980|NCT03657043|101141662|FG002|Overall Study|Lost to Follow-up|0|||
33340981|NCT03657043|101141663|FG003|Overall Study|Lost to Follow-up|0|||
33538459|NCT04556760|101870961|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
33340982|NCT03657043|101141664|FG004|Overall Study|Lost to Follow-up|4|||
33340983|NCT03657043|101141660|FG000|Overall Study|Death|6|||
33340984|NCT03657043|101141661|FG001|Overall Study|Death|5|||
33340985|NCT03657043|101141662|FG002|Overall Study|Death|0|||
33340986|NCT03657043|101141663|FG003|Overall Study|Death|0|||
33340987|NCT03657043|101141664|FG004|Overall Study|Death|53|||
33340988|NCT03657043|101141660|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
33340989|NCT03657043|101141661|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
33340990|NCT03657043|101141662|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
33340991|NCT03657043|101141663|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
33340992|NCT03657043|101141664|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
33340993|NCT03657043|101141660|FG000|Overall Study|Adverse Event|0|||
33340994|NCT03657043|101141661|FG001|Overall Study|Adverse Event|0|||
33340995|NCT03657043|101141662|FG002|Overall Study|Adverse Event|0|||
33538460|NCT04556760|101870962|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
33538461|NCT04556760|101870963|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
33538462|NCT04556760|101870964|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
33538463|NCT04556760|101870965|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
33538464|NCT01811238|101870966|FG000|Overall Study|Withdrawal by Subject|42|||
33538465|NCT01811238|101870966|FG000|Overall Study|Adverse Event|25|||
33538466|NCT01811238|101870966|FG000|Overall Study|Protocol Violation|4|||
33538467|NCT01811238|101870966|FG000|Overall Study|Lack of Efficacy|4|||
33538468|NCT01811238|101870966|FG000|Overall Study|subject refused study medication|6|||
33538469|NCT00830128|101870967|FG000|Overall Study|Adverse Event|5|||
33538470|NCT00830128|101870967|FG000|Overall Study|Lack of Efficacy|7|||
33538471|NCT00830128|101870967|FG000|Overall Study|Protocol Violation|1|||
33538472|NCT00830128|101870967|FG000|Overall Study|Withdrawal by Subject|2|||
33538473|NCT00830128|101870967|FG000|Overall Study|Family obligation|1|||
33538474|NCT00830128|101870967|FG000|Overall Study|Relocation|1|||
33538475|NCT00830128|101870967|FG000|Overall Study|Work obligation|1|||
33538476|NCT00830128|101870967|FG000|Overall Study|Operating a vehicle|1|||
33538477|NCT03644017|101870970|FG000|Overall Study|Access Abandonment|5|||
33538478|NCT03644017|101870970|FG000|Overall Study|Kidney Transplant|2|||
33538479|NCT00239720|101870971|FG000|Overall Study|Adverse Event|1|||
33538480|NCT00239720|101870972|FG001|Overall Study|Adverse Event|0|||
33538481|NCT00239720|101870971|FG000|Overall Study|Lost to Follow-up|0|||
33538482|NCT00239720|101870972|FG001|Overall Study|Lost to Follow-up|1|||
33538483|NCT02513550|101870977|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
33538484|NCT02513550|101870978|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
33538485|NCT02513550|101870979|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
33538486|NCT02513550|101870980|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
33538487|NCT02513550|101870981|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
33538488|NCT02513550|101870982|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
33538489|NCT02513550|101870977|FG000|Double Blind Treatment Period|Adverse Event|5|||
33538490|NCT02513550|101870978|FG001|Double Blind Treatment Period|Adverse Event|13|||
33538491|NCT02513550|101870979|FG002|Double Blind Treatment Period|Adverse Event|17|||
33538492|NCT02513550|101870980|FG003|Double Blind Treatment Period|Adverse Event|0|||
33538493|NCT02513550|101870981|FG004|Double Blind Treatment Period|Adverse Event|1|||
33538494|NCT02513550|101870982|FG005|Double Blind Treatment Period|Adverse Event|0|||
33538495|NCT02513550|101870977|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
33538496|NCT02513550|101870978|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
33538497|NCT02513550|101870979|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
33538498|NCT02513550|101870980|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
33538499|NCT02513550|101870981|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
33538500|NCT02513550|101870982|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
33538501|NCT02513550|101870977|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
33538502|NCT02513550|101870978|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
33538503|NCT02513550|101870979|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
33538504|NCT02513550|101870980|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
33340996|NCT03657043|101141663|FG003|Overall Study|Adverse Event|0|||
33340997|NCT03657043|101141664|FG004|Overall Study|Adverse Event|2|||
33340998|NCT03657043|101141660|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
33538505|NCT02513550|101870981|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
33538506|NCT02513550|101870982|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
33538507|NCT02513550|101870977|FG000|Double Blind Treatment Period|Protocol Violation|1|||
33538508|NCT02513550|101870978|FG001|Double Blind Treatment Period|Protocol Violation|1|||
33538509|NCT02513550|101870979|FG002|Double Blind Treatment Period|Protocol Violation|4|||
33340999|NCT03657043|101141661|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
33341000|NCT03657043|101141662|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
33341001|NCT03657043|101141663|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
33341002|NCT03657043|101141664|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
33538510|NCT02513550|101870980|FG003|Double Blind Treatment Period|Protocol Violation|0|||
33538511|NCT02513550|101870981|FG004|Double Blind Treatment Period|Protocol Violation|0|||
33538512|NCT02513550|101870982|FG005|Double Blind Treatment Period|Protocol Violation|0|||
33538513|NCT02513550|101870977|FG000|Double Blind Treatment Period|Physician Decision|2|||
33538514|NCT02513550|101870978|FG001|Double Blind Treatment Period|Physician Decision|0|||
33538515|NCT02513550|101870979|FG002|Double Blind Treatment Period|Physician Decision|4|||
33538516|NCT02513550|101870980|FG003|Double Blind Treatment Period|Physician Decision|0|||
33538517|NCT02513550|101870981|FG004|Double Blind Treatment Period|Physician Decision|0|||
33538518|NCT02513550|101870982|FG005|Double Blind Treatment Period|Physician Decision|0|||
33538519|NCT02513550|101870977|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
33538520|NCT02513550|101870978|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
33538521|NCT02513550|101870979|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
33538522|NCT02513550|101870980|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
33538523|NCT02513550|101870981|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
33538524|NCT02513550|101870982|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
33538525|NCT02513550|101870977|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
33538526|NCT02513550|101870978|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
33538527|NCT02513550|101870979|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
33538528|NCT02513550|101870980|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
33538529|NCT02513550|101870981|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
33538530|NCT02513550|101870982|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
33538531|NCT02513550|101870977|FG000|Double Blind Treatment Period|Due to personal business|2|||
33209598|NCT01217073|100670232|FG006|Extension Period|Physician Decision|4|||
33209599|NCT01217073|100670233|FG007|Extension Period|Physician Decision|1|||
33209600|NCT01217073|100670226|FG000|Extension Period|Protocol Violation|0|||
33209601|NCT01217073|100670227|FG001|Extension Period|Protocol Violation|0|||
33209602|NCT01217073|100670228|FG002|Extension Period|Protocol Violation|0|||
33209603|NCT01217073|100670229|FG003|Extension Period|Protocol Violation|0|||
33209604|NCT01217073|100670230|FG004|Extension Period|Protocol Violation|0|||
33209605|NCT01217073|100670231|FG005|Extension Period|Protocol Violation|0|||
33209606|NCT01217073|100670232|FG006|Extension Period|Protocol Violation|2|||
33209607|NCT01217073|100670233|FG007|Extension Period|Protocol Violation|1|||
33209608|NCT01217073|100670226|FG000|Extension Period|Site discontinued study participation|0|||
33209609|NCT01217073|100670227|FG001|Extension Period|Site discontinued study participation|0|||
33209610|NCT01217073|100670228|FG002|Extension Period|Site discontinued study participation|0|||
33209611|NCT01217073|100670229|FG003|Extension Period|Site discontinued study participation|0|||
33209612|NCT01217073|100670230|FG004|Extension Period|Site discontinued study participation|0|||
33209613|NCT01217073|100670231|FG005|Extension Period|Site discontinued study participation|0|||
33209614|NCT01217073|100670232|FG006|Extension Period|Site discontinued study participation|7|||
33209615|NCT01217073|100670233|FG007|Extension Period|Site discontinued study participation|2|||
33538532|NCT02513550|101870978|FG001|Double Blind Treatment Period|Due to personal business|0|||
33538533|NCT02513550|101870979|FG002|Double Blind Treatment Period|Due to personal business|1|||
33209616|NCT01217073|100670226|FG000|Extension Period|Withdrawal by Subject|0|||
33209617|NCT01217073|100670227|FG001|Extension Period|Withdrawal by Subject|0|||
33209618|NCT01217073|100670228|FG002|Extension Period|Withdrawal by Subject|0|||
33209619|NCT01217073|100670229|FG003|Extension Period|Withdrawal by Subject|0|||
33209620|NCT01217073|100670230|FG004|Extension Period|Withdrawal by Subject|0|||
33341003|NCT03657043|101141660|FG000|Overall Study|Withdrawal - declined follow-up|0|||
33341004|NCT03657043|101141661|FG001|Overall Study|Withdrawal - declined follow-up|0|||
33341005|NCT03657043|101141662|FG002|Overall Study|Withdrawal - declined follow-up|0|||
33341006|NCT03657043|101141663|FG003|Overall Study|Withdrawal - declined follow-up|0|||
33341007|NCT03657043|101141664|FG004|Overall Study|Withdrawal - declined follow-up|1|||
33341008|NCT02437162|101141679|FG000|Overall Study|Protocol Violation|0|||
33341009|NCT02437162|101141680|FG001|Overall Study|Protocol Violation|1|||
33341010|NCT02437162|101141681|FG002|Overall Study|Protocol Violation|0|||
33341011|NCT02437162|101141679|FG000|Overall Study|Randomized but not treated|0|||
33341012|NCT02437162|101141680|FG001|Overall Study|Randomized but not treated|0|||
33341013|NCT02437162|101141681|FG002|Overall Study|Randomized but not treated|1|||
33341014|NCT02437162|101141679|FG000|Overall Study|Study discontinued by Sponsor|93|||
33341015|NCT02437162|101141680|FG001|Overall Study|Study discontinued by Sponsor|98|||
33341016|NCT02437162|101141681|FG002|Overall Study|Study discontinued by Sponsor|97|||
33341017|NCT02437162|101141679|FG000|Overall Study|Withdrawal by Subject|13|||
33538534|NCT02513550|101870980|FG003|Double Blind Treatment Period|Due to personal business|0|||
33209621|NCT01217073|100670231|FG005|Extension Period|Withdrawal by Subject|0|||
33209622|NCT01217073|100670232|FG006|Extension Period|Withdrawal by Subject|30|||
33209623|NCT01217073|100670233|FG007|Extension Period|Withdrawal by Subject|8|||
33209624|NCT00695903|100670234|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
33341018|NCT02437162|101141680|FG001|Overall Study|Withdrawal by Subject|7|||
33341019|NCT02437162|101141681|FG002|Overall Study|Withdrawal by Subject|9|||
33341020|NCT02437162|101141679|FG000|Overall Study|Adverse Event|0|||
33341021|NCT02437162|101141680|FG001|Overall Study|Adverse Event|1|||
33341022|NCT02437162|101141681|FG002|Overall Study|Adverse Event|0|||
33341023|NCT02437162|101141679|FG000|Overall Study|Lost to Follow-up|1|||
33341024|NCT02437162|101141680|FG001|Overall Study|Lost to Follow-up|0|||
33341025|NCT02437162|101141681|FG002|Overall Study|Lost to Follow-up|1|||
33341026|NCT02437162|101141679|FG000|Overall Study|Death|0|||
33341027|NCT02437162|101141680|FG001|Overall Study|Death|1|||
33341028|NCT02437162|101141681|FG002|Overall Study|Death|0|||
33341029|NCT02437162|101141679|FG000|Overall Study|Other|0|||
33341030|NCT02437162|101141680|FG001|Overall Study|Other|0|||
33341031|NCT02437162|101141681|FG002|Overall Study|Other|1|||
33341032|NCT00662792|101141683|FG000|Period 1|Personal Reasons|0|||
33341033|NCT00662792|101141684|FG001|Period 1|Personal Reasons|0|||
33341034|NCT00662792|101141685|FG002|Period 1|Personal Reasons|1|||
33341035|NCT00662792|101141686|FG003|Period 1|Personal Reasons|0|||
33341036|NCT00662792|101141683|FG000|Period 1|Refused continuing medication|0|||
33341037|NCT00662792|101141684|FG001|Period 1|Refused continuing medication|1|||
33405976|NCT01005966|101377528|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
33405977|NCT01005966|101377529|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
33405978|NCT01005966|101377530|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
33405979|NCT01005966|101377531|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
33405980|NCT01005966|101377527|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
33405981|NCT01005966|101377528|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
33405982|NCT01005966|101377529|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
33538535|NCT02513550|101870981|FG004|Double Blind Treatment Period|Due to personal business|0|||
33538536|NCT02513550|101870982|FG005|Double Blind Treatment Period|Due to personal business|0|||
33538537|NCT02513550|101870977|FG000|Double Blind Treatment Period|Death|1|||
33538538|NCT02513550|101870978|FG001|Double Blind Treatment Period|Death|0|||
33538539|NCT02513550|101870979|FG002|Double Blind Treatment Period|Death|2|||
33538540|NCT02513550|101870980|FG003|Double Blind Treatment Period|Death|0|||
33538541|NCT02513550|101870981|FG004|Double Blind Treatment Period|Death|0|||
33538542|NCT02513550|101870982|FG005|Double Blind Treatment Period|Death|0|||
33538543|NCT02513550|101870977|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
33538544|NCT02513550|101870978|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
33538545|NCT02513550|101870979|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
33538546|NCT02513550|101870980|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33538547|NCT02513550|101870981|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33538548|NCT02513550|101870982|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
33538549|NCT02513550|101870977|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
33538550|NCT02513550|101870978|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
33538551|NCT02513550|101870979|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
33538552|NCT02513550|101870980|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
33538553|NCT02513550|101870981|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
33538554|NCT02513550|101870982|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
33538555|NCT02513550|101870977|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
33538556|NCT02513550|101870978|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
33538557|NCT02513550|101870979|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
33538558|NCT02513550|101870980|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33538559|NCT02513550|101870981|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33538560|NCT02513550|101870982|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
33538561|NCT02513550|101870977|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
33538562|NCT02513550|101870978|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
33538563|NCT02513550|101870979|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
33341038|NCT00662792|101141685|FG002|Period 1|Refused continuing medication|1|||
33341039|NCT00662792|101141686|FG003|Period 1|Refused continuing medication|0|||
33341040|NCT00662792|101141683|FG000|Period 1|Lost to Follow-up|1|||
33341041|NCT00662792|101141684|FG001|Period 1|Lost to Follow-up|0|||
33341042|NCT00662792|101141685|FG002|Period 1|Lost to Follow-up|0|||
33341043|NCT00662792|101141686|FG003|Period 1|Lost to Follow-up|0|||
33341044|NCT00662792|101141683|FG000|Period 1|Other adverse event (AE)|0|||
33405983|NCT01005966|101377530|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
33538564|NCT02513550|101870980|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
33538565|NCT02513550|101870981|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
33341045|NCT00662792|101141684|FG001|Period 1|Other adverse event (AE)|2|||
33341046|NCT00662792|101141685|FG002|Period 1|Other adverse event (AE)|0|||
33341047|NCT00662792|101141686|FG003|Period 1|Other adverse event (AE)|0|||
33341048|NCT00662792|101141683|FG000|Period 1|Worsening of disease under study (AE)|1|||
33405984|NCT01005966|101377531|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
33341049|NCT00662792|101141684|FG001|Period 1|Worsening of disease under study (AE)|3|||
33341050|NCT00662792|101141685|FG002|Period 1|Worsening of disease under study (AE)|2|||
33341051|NCT00662792|101141686|FG003|Period 1|Worsening of disease under study (AE)|0|||
33341052|NCT00662792|101141683|FG000|Period 1|Not treated|0|||
33209625|NCT00695903|100670235|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
33538566|NCT02513550|101870982|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
33538567|NCT02513550|101870977|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
33538568|NCT02513550|101870978|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
33538569|NCT02513550|101870979|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
33209626|NCT00695903|100670234|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
33209627|NCT00695903|100670235|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
33209628|NCT00695903|100670234|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
33209629|NCT00695903|100670235|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
33209630|NCT00695903|100670234|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
33209631|NCT00695903|100670235|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
33209632|NCT00695903|100670234|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
33209633|NCT00695903|100670235|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
33209634|NCT00695903|100670234|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
33209635|NCT00695903|100670235|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
33209636|NCT00695903|100670234|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
33209637|NCT00695903|100670235|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
33209638|NCT00695903|100670234|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
33209639|NCT00695903|100670235|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
33209640|NCT00695903|100670234|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
33209641|NCT00695903|100670235|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
33209642|NCT00784810|100670246|FG000|Overall Study|Adverse Event|32|||
33209643|NCT00784810|100670247|FG001|Overall Study|Adverse Event|20|||
33209644|NCT00784810|100670246|FG000|Overall Study|Lack of Efficacy|14|||
33209645|NCT00784810|100670247|FG001|Overall Study|Lack of Efficacy|11|||
33209646|NCT00784810|100670246|FG000|Overall Study|Withdrawal by Subject|11|||
33209647|NCT00784810|100670247|FG001|Overall Study|Withdrawal by Subject|9|||
33538570|NCT02513550|101870980|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
33538571|NCT02513550|101870981|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
33538572|NCT02513550|101870982|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
33538573|NCT02513550|101870977|FG000|Post-Treatment Follow-up Period|Death|0|||
33209648|NCT00784810|100670246|FG000|Overall Study|Administrative|5|||
33209649|NCT00784810|100670247|FG001|Overall Study|Administrative|8|||
33209650|NCT00784810|100670246|FG000|Overall Study|Lost to Follow-up|1|||
33209651|NCT00784810|100670247|FG001|Overall Study|Lost to Follow-up|1|||
33341053|NCT00662792|101141684|FG001|Period 1|Not treated|1|||
33341054|NCT00662792|101141685|FG002|Period 1|Not treated|0|||
33341055|NCT00662792|101141686|FG003|Period 1|Not treated|0|||
33341056|NCT00662792|101141683|FG000|Period 2|Worsening of disease under study|1|||
33341057|NCT00662792|101141684|FG001|Period 2|Worsening of disease under study|0|||
33341058|NCT00662792|101141685|FG002|Period 2|Worsening of disease under study|0|||
33341059|NCT00662792|101141686|FG003|Period 2|Worsening of disease under study|3|||
33538574|NCT02513550|101870978|FG001|Post-Treatment Follow-up Period|Death|0|||
33538575|NCT02513550|101870979|FG002|Post-Treatment Follow-up Period|Death|1|||
33341060|NCT00662792|101141683|FG000|Period 3|Refused continuing medication|1|||
33341061|NCT00662792|101141684|FG001|Period 3|Refused continuing medication|0|||
33341062|NCT00662792|101141685|FG002|Period 3|Refused continuing medication|1|||
33341063|NCT00662792|101141686|FG003|Period 3|Refused continuing medication|0|||
33341064|NCT00662792|101141683|FG000|Period 3|Other adverse event (AE)|0|||
33341065|NCT00662792|101141684|FG001|Period 3|Other adverse event (AE)|0|||
33341066|NCT00662792|101141685|FG002|Period 3|Other adverse event (AE)|1|||
33538576|NCT02513550|101870980|FG003|Post-Treatment Follow-up Period|Death|0|||
33538577|NCT02513550|101870981|FG004|Post-Treatment Follow-up Period|Death|0|||
33538578|NCT02513550|101870982|FG005|Post-Treatment Follow-up Period|Death|0|||
33538579|NCT02513550|101870977|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
33538580|NCT02513550|101870978|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
33538581|NCT02513550|101870979|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
33538582|NCT02513550|101870980|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
33538583|NCT02513550|101870981|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
33538584|NCT02513550|101870982|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
33538585|NCT02513550|101870977|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
33209652|NCT02097108|100670248|FG000|Overall Study|Adverse Event|1|||
33341067|NCT00662792|101141686|FG003|Period 3|Other adverse event (AE)|1|||
33341068|NCT00662792|101141683|FG000|Period 4|Refused continuing medication|0|||
33538586|NCT02513550|101870978|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
33209653|NCT02097108|100670248|FG000|Overall Study|patient was abroad for 6 months|1|||
33209654|NCT00679939|100670249|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
33209655|NCT00679939|100670250|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
33209656|NCT00679939|100670249|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
33341069|NCT00662792|101141684|FG001|Period 4|Refused continuing medication|1|||
33341070|NCT00662792|101141685|FG002|Period 4|Refused continuing medication|0|||
33341071|NCT00662792|101141686|FG003|Period 4|Refused continuing medication|0|||
33341072|NCT00662792|101141683|FG000|Period 4|Other adverse event (AE)|1|||
33341073|NCT00662792|101141684|FG001|Period 4|Other adverse event (AE)|0|||
33341074|NCT00662792|101141685|FG002|Period 4|Other adverse event (AE)|0|||
33341075|NCT00662792|101141686|FG003|Period 4|Other adverse event (AE)|0|||
33341076|NCT00662792|101141683|FG000|Period 4|Worsening of disease under study (AE)|0|||
33538587|NCT02513550|101870979|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
33538588|NCT02513550|101870980|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
33614765|NCT00767819|102140098|FG001|Overall Study|Administrative problems|1|||
33614766|NCT00767819|102140099|FG002|Overall Study|Administrative problems|0|||
33614767|NCT00767819|102140097|FG000|Overall Study|Death|2|||
33614768|NCT00767819|102140098|FG001|Overall Study|Death|3|||
33614769|NCT00767819|102140099|FG002|Overall Study|Death|0|||
33614770|NCT00767819|102140097|FG000|Overall Study|Adverse Event|2|||
33614771|NCT00767819|102140098|FG001|Overall Study|Adverse Event|0|||
33614772|NCT00767819|102140099|FG002|Overall Study|Adverse Event|0|||
33614773|NCT00767819|102140097|FG000|Overall Study|Abnormal lab values|1|||
33614774|NCT00767819|102140098|FG001|Overall Study|Abnormal lab values|0|||
33614775|NCT00767819|102140099|FG002|Overall Study|Abnormal lab values|0|||
33614776|NCT00767819|102140097|FG000|Overall Study|Lost to Follow-up|1|||
33614777|NCT00767819|102140098|FG001|Overall Study|Lost to Follow-up|0|||
33614778|NCT00767819|102140099|FG002|Overall Study|Lost to Follow-up|0|||
33614779|NCT01957202|102140100|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33614780|NCT01957202|102140101|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
33614781|NCT01957202|102140102|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33614782|NCT01957202|102140103|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33614783|NCT01957202|102140104|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33614784|NCT01957202|102140105|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33614785|NCT01957202|102140106|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33538589|NCT02513550|101870981|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
33538590|NCT02513550|101870982|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
33538591|NCT02513550|101870977|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
33538592|NCT02513550|101870978|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
33538593|NCT02513550|101870979|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
33538594|NCT02513550|101870980|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
33538595|NCT02513550|101870981|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
33538596|NCT02513550|101870982|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
33538597|NCT00086190|101870983|FG000|Overall Study|Adverse Event|6|||
33614786|NCT01957202|102140107|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33341077|NCT00662792|101141684|FG001|Period 4|Worsening of disease under study (AE)|0|||
33614787|NCT01957202|102140108|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33341078|NCT00662792|101141685|FG002|Period 4|Worsening of disease under study (AE)|0|||
33614788|NCT01957202|102140109|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33614789|NCT01957202|102140110|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33341079|NCT00662792|101141686|FG003|Period 4|Worsening of disease under study (AE)|1|||
33614790|NCT01957202|102140111|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33614791|NCT01957202|102140112|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33614792|NCT01957202|102140113|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33614793|NCT01957202|102140114|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33614794|NCT01957202|102140115|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33614795|NCT01957202|102140116|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
33341080|NCT00493038|101141687|FG000|Treatment|Adverse Event|8|||
33614796|NCT01957202|102140117|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
33538598|NCT00086190|101870984|FG001|Overall Study|Adverse Event|2|||
33538599|NCT00086190|101870985|FG002|Overall Study|Adverse Event|2|||
33405985|NCT01005966|101377527|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
33538600|NCT00086190|101870983|FG000|Overall Study|Withdrawal by Subject|0|||
33538601|NCT00086190|101870984|FG001|Overall Study|Withdrawal by Subject|2|||
33538602|NCT00086190|101870985|FG002|Overall Study|Withdrawal by Subject|2|||
33538603|NCT00086190|101870983|FG000|Overall Study|Protocol Violation|1|||
33538604|NCT00086190|101870984|FG001|Overall Study|Protocol Violation|0|||
33538605|NCT00086190|101870985|FG002|Overall Study|Protocol Violation|0|||
33538606|NCT00086190|101870983|FG000|Overall Study|Moved|1|||
33538607|NCT00086190|101870984|FG001|Overall Study|Moved|0|||
33538608|NCT00086190|101870985|FG002|Overall Study|Moved|0|||
33538609|NCT00086190|101870983|FG000|Overall Study|Worsening depression|0|||
33538610|NCT00086190|101870984|FG001|Overall Study|Worsening depression|0|||
33538611|NCT00086190|101870985|FG002|Overall Study|Worsening depression|2|||
33538612|NCT00402831|101870986|FG000|Overall Study|Lost to Follow-up|1|||
33538613|NCT00402831|101870987|FG001|Overall Study|Lost to Follow-up|2|||
33341081|NCT00493038|101141688|FG001|Treatment|Adverse Event|4|||
33341082|NCT00493038|101141687|FG000|Treatment|Lost to Follow-up|5|||
33341083|NCT00493038|101141688|FG001|Treatment|Lost to Follow-up|3|||
33341084|NCT00493038|101141687|FG000|Treatment|Withdrawal by Subject|11|||
33538614|NCT00402831|101870986|FG000|Overall Study|Non-compliance with protocol|0|||
33538615|NCT00402831|101870987|FG001|Overall Study|Non-compliance with protocol|1|||
33538616|NCT01525589|101870988|FG000|Overall Study|Non-treatment-related AE|1|||
33538617|NCT01525589|101870989|FG001|Overall Study|Non-treatment-related AE|0|||
33538618|NCT01525589|101870990|FG002|Overall Study|Non-treatment-related AE|0|||
33538619|NCT01525589|101870988|FG000|Overall Study|Progressive disease|48|||
33538620|NCT01525589|101870989|FG001|Overall Study|Progressive disease|15|||
33538621|NCT01525589|101870990|FG002|Overall Study|Progressive disease|29|||
33538622|NCT01525589|101870988|FG000|Overall Study|Never treated|2|||
33538623|NCT01525589|101870989|FG001|Overall Study|Never treated|0|||
33538624|NCT01525589|101870990|FG002|Overall Study|Never treated|0|||
33538625|NCT01525589|101870988|FG000|Overall Study|Physician Decision|4|||
33538626|NCT01525589|101870989|FG001|Overall Study|Physician Decision|2|||
33538627|NCT01525589|101870990|FG002|Overall Study|Physician Decision|2|||
33538628|NCT01525589|101870988|FG000|Overall Study|Death|0|||
33538629|NCT01525589|101870989|FG001|Overall Study|Death|0|||
33538630|NCT01525589|101870990|FG002|Overall Study|Death|2|||
33538631|NCT01525589|101870988|FG000|Overall Study|Treatment-related AE|1|||
33538632|NCT01525589|101870989|FG001|Overall Study|Treatment-related AE|1|||
33538633|NCT01525589|101870990|FG002|Overall Study|Treatment-related AE|2|||
33538634|NCT01525589|101870988|FG000|Overall Study|Other reasons|0|||
33538635|NCT01525589|101870989|FG001|Overall Study|Other reasons|1|||
33538636|NCT01525589|101870990|FG002|Overall Study|Other reasons|0|||
33538637|NCT01525589|101870988|FG000|Overall Study|Withdrawal by Subject|0|||
33538638|NCT01525589|101870989|FG001|Overall Study|Withdrawal by Subject|1|||
33538639|NCT01525589|101870990|FG002|Overall Study|Withdrawal by Subject|0|||
33341085|NCT00493038|101141688|FG001|Treatment|Withdrawal by Subject|12|||
33341086|NCT00493038|101141687|FG000|Treatment|Other|0|||
33341087|NCT00493038|101141688|FG001|Treatment|Other|1|||
33341088|NCT00493038|101141687|FG000|Follow-up|Lost to Follow-up|1|||
33538640|NCT02027025|101870993|FG000|Overall Study|Adverse Event|0|||
33538641|NCT02027025|101870994|FG001|Overall Study|Adverse Event|1|||
33538642|NCT02027025|101870995|FG002|Overall Study|Adverse Event|1|||
33538643|NCT02027025|101870993|FG000|Overall Study|Protocol Violation|1|||
33341089|NCT00493038|101141688|FG001|Follow-up|Lost to Follow-up|0|||
33341090|NCT02831673|101141689|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
33341091|NCT02831673|101141690|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
33341092|NCT02831673|101141691|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
33538644|NCT02027025|101870994|FG001|Overall Study|Protocol Violation|0|||
33538645|NCT02027025|101870995|FG002|Overall Study|Protocol Violation|0|||
33538646|NCT02027025|101870993|FG000|Overall Study|Lost to Follow-up|0|||
33538647|NCT02027025|101870994|FG001|Overall Study|Lost to Follow-up|2|||
33538648|NCT02027025|101870995|FG002|Overall Study|Lost to Follow-up|0|||
33538649|NCT02027025|101870993|FG000|Overall Study|Withdrawal by Subject|0|||
33538650|NCT02027025|101870994|FG001|Overall Study|Withdrawal by Subject|1|||
33538651|NCT02027025|101870995|FG002|Overall Study|Withdrawal by Subject|0|||
33538652|NCT02027025|101870993|FG000|Overall Study|Sponsor's decision|0|||
33538653|NCT02027025|101870994|FG001|Overall Study|Sponsor's decision|1|||
33538654|NCT02027025|101870995|FG002|Overall Study|Sponsor's decision|0|||
33538655|NCT03292016|101871007|FG000|Second Washout|Adverse Event|0|||
33538656|NCT03292016|101871008|FG001|Second Washout|Adverse Event|1|||
33538657|NCT03292016|101871009|FG002|Second Washout|Adverse Event|0|||
33538658|NCT03292016|101871010|FG003|Second Washout|Adverse Event|0|||
33538659|NCT03292016|101871011|FG004|Second Washout|Adverse Event|0|||
33538660|NCT03292016|101871012|FG005|Second Washout|Adverse Event|0|||
33538661|NCT02683109|101871014|FG000|Overall Study|Adverse Event|1|||
33538662|NCT02683109|101871015|FG001|Overall Study|Adverse Event|0|||
33538663|NCT03704064|101871016|FG000|Overall Study|Lost to Follow-up|8|||
33538664|NCT03704064|101871017|FG001|Overall Study|Lost to Follow-up|4|||
33538665|NCT03704064|101871016|FG000|Overall Study|Withdrawal by Subject|1|||
33538666|NCT03704064|101871017|FG001|Overall Study|Withdrawal by Subject|1|||
33614797|NCT01957202|102140100|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
33614798|NCT01957202|102140101|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
33614799|NCT01957202|102140102|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
33209657|NCT00679939|100670250|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
33209658|NCT00679939|100670249|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
33341093|NCT02831673|101141692|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
33341094|NCT02831673|101141693|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
33341095|NCT02831673|101141689|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
33341096|NCT02831673|101141690|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
33341097|NCT02831673|101141691|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
33341098|NCT02831673|101141692|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
33538667|NCT03704064|101871016|FG000|Overall Study|No longer available for study visits|0|||
33538668|NCT03704064|101871017|FG001|Overall Study|No longer available for study visits|1|||
33538669|NCT03704064|101871016|FG000|Overall Study|Censoring event|1|||
33538670|NCT03704064|101871017|FG001|Overall Study|Censoring event|0|||
33538671|NCT00094445|101871020|FG000|Overall Study|Withdrawal by Subject|3|||
33538672|NCT00094445|101871020|FG000|Overall Study|Lost to Follow-up|1|||
33538673|NCT00094445|101871020|FG000|Overall Study|Progressive Disease|2|||
33538674|NCT02204917|101871021|FG000|Overall Study|Protocol Violation|1|||
33538675|NCT00869960|101871025|FG000|Overall Study|Lost to Follow-up|2|||
33538676|NCT02801331|101871026|FG000|Overall Study|Transferred to another hospital|8|||
33538677|NCT02801331|101871027|FG001|Overall Study|Transferred to another hospital|7|||
33538678|NCT02801331|101871026|FG000|Overall Study|Withdrawal by Subject|0|||
33341099|NCT02831673|101141693|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
33538679|NCT02801331|101871027|FG001|Overall Study|Withdrawal by Subject|4|||
33538680|NCT02801331|101871026|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
33538681|NCT02801331|101871027|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
33538682|NCT01326871|101871028|FG000|Overall Study|Major surgery|0|||
33538683|NCT01326871|101871029|FG001|Overall Study|Major surgery|1|||
33538684|NCT01326871|101871030|FG002|Overall Study|Major surgery|0|||
33538685|NCT01326871|101871028|FG000|Overall Study|SAE and death|0|||
33538686|NCT01326871|101871029|FG001|Overall Study|SAE and death|2|||
33538687|NCT01326871|101871030|FG002|Overall Study|SAE and death|0|||
33538688|NCT01326871|101871028|FG000|Overall Study|Physician decision and decreased performance status|0|||
33538689|NCT01326871|101871029|FG001|Overall Study|Physician decision and decreased performance status|1|||
33538690|NCT01326871|101871030|FG002|Overall Study|Physician decision and decreased performance status|0|||
33538691|NCT01326871|101871028|FG000|Overall Study|Disease progression|0|||
33538692|NCT01326871|101871029|FG001|Overall Study|Disease progression|11|||
33614800|NCT01957202|102140103|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
33538693|NCT01326871|101871030|FG002|Overall Study|Disease progression|5|||
33538694|NCT01326871|101871028|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
33538695|NCT01326871|101871029|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
33538696|NCT01326871|101871030|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
33538697|NCT01326871|101871028|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
33538698|NCT01326871|101871029|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
33538699|NCT01326871|101871030|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
33538700|NCT01326871|101871028|FG000|Overall Study|Withdrawal by Subject|0|||
33538701|NCT01326871|101871029|FG001|Overall Study|Withdrawal by Subject|1|||
33538702|NCT01326871|101871030|FG002|Overall Study|Withdrawal by Subject|0|||
33538703|NCT01326871|101871028|FG000|Overall Study|DLT|0|||
33538704|NCT01326871|101871029|FG001|Overall Study|DLT|2|||
33538705|NCT01326871|101871030|FG002|Overall Study|DLT|0|||
33538706|NCT01326871|101871028|FG000|Overall Study|SAE, disease progression and subject decision|0|||
33538707|NCT01326871|101871029|FG001|Overall Study|SAE, disease progression and subject decision|1|||
33538708|NCT01326871|101871030|FG002|Overall Study|SAE, disease progression and subject decision|0|||
33538709|NCT01326871|101871028|FG000|Overall Study|Death|0|||
33538710|NCT01326871|101871029|FG001|Overall Study|Death|1|||
33538711|NCT01326871|101871030|FG002|Overall Study|Death|0|||
33538712|NCT01326871|101871028|FG000|Overall Study|Other|0|||
33538713|NCT01326871|101871029|FG001|Overall Study|Other|3|||
33538714|NCT01326871|101871030|FG002|Overall Study|Other|0|||
33538715|NCT01326871|101871028|FG000|Overall Study|SAE and disease progression|0|||
33538716|NCT01326871|101871029|FG001|Overall Study|SAE and disease progression|0|||
33538717|NCT01326871|101871030|FG002|Overall Study|SAE and disease progression|1|||
33538718|NCT01326871|101871028|FG000|Overall Study|SAE and physician decision|0|||
33538719|NCT01326871|101871029|FG001|Overall Study|SAE and physician decision|0|||
33538720|NCT01326871|101871030|FG002|Overall Study|SAE and physician decision|1|||
33538721|NCT01326871|101871028|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
33538722|NCT01326871|101871029|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
33538723|NCT01326871|101871030|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
33538724|NCT01326871|101871028|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
33209659|NCT00679939|100670250|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
33209660|NCT00679939|100670249|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
33209661|NCT00679939|100670250|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
33209662|NCT00679939|100670249|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
33209663|NCT00679939|100670250|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
33209664|NCT00679939|100670249|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
33209665|NCT00679939|100670250|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
33209666|NCT00679939|100670249|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
33209667|NCT00679939|100670250|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
33209668|NCT00679939|100670249|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
33209669|NCT00679939|100670250|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
33209670|NCT00679939|100670249|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
33209671|NCT00679939|100670250|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
33538725|NCT01326871|101871029|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
33538726|NCT01326871|101871030|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
33209672|NCT00679939|100670249|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
33209673|NCT00679939|100670250|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
33538727|NCT01326871|101871028|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
33209674|NCT01381692|100670251|FG000|Overall Study|Adverse Event|1|||
33209675|NCT01381692|100670252|FG001|Overall Study|Adverse Event|0|||
33209676|NCT01381692|100670253|FG002|Overall Study|Adverse Event|0|||
33209677|NCT01381692|100670254|FG003|Overall Study|Adverse Event|0|||
33209678|NCT01381692|100670255|FG004|Overall Study|Adverse Event|0|||
33209679|NCT01381692|100670256|FG005|Overall Study|Adverse Event|0|||
33209680|NCT02564523|100670257|FG000|Overall Study|Withdrawal by Subject|3|||
33209681|NCT02564523|100670258|FG001|Overall Study|Withdrawal by Subject|0|||
33209682|NCT02564523|100670259|FG002|Overall Study|Withdrawal by Subject|1|||
33341100|NCT02831673|101141689|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
33341101|NCT02831673|101141690|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
33341102|NCT02831673|101141691|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
33538728|NCT01326871|101871029|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
33538729|NCT01326871|101871030|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
33538730|NCT01326871|101871028|FG000|Overall Study|Physician Decision|0|||
33209683|NCT02564523|100670260|FG003|Overall Study|Withdrawal by Subject|0|||
33209684|NCT02564523|100670261|FG004|Overall Study|Withdrawal by Subject|1|||
33209685|NCT02564523|100670262|FG005|Overall Study|Withdrawal by Subject|0|||
33209686|NCT02564523|100670263|FG006|Overall Study|Withdrawal by Subject|1|||
33209687|NCT02564523|100670264|FG007|Overall Study|Withdrawal by Subject|0|||
33209688|NCT02564523|100670265|FG008|Overall Study|Withdrawal by Subject|0|||
33209689|NCT02564523|100670266|FG009|Overall Study|Withdrawal by Subject|0|||
33209690|NCT02564523|100670267|FG010|Overall Study|Withdrawal by Subject|1|||
33614801|NCT01957202|102140104|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
33614802|NCT01957202|102140105|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
33209691|NCT02564523|100670268|FG011|Overall Study|Withdrawal by Subject|0|||
33209692|NCT02564523|100670269|FG012|Overall Study|Withdrawal by Subject|1|||
33209693|NCT02564523|100670270|FG013|Overall Study|Withdrawal by Subject|0|||
33209694|NCT02564523|100670271|FG014|Overall Study|Withdrawal by Subject|0|||
33209695|NCT02564523|100670272|FG015|Overall Study|Withdrawal by Subject|0|||
33341103|NCT02831673|101141692|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
33341104|NCT02831673|101141693|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
33341105|NCT02831673|101141689|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
33341106|NCT02831673|101141690|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
33341107|NCT02831673|101141691|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
33341108|NCT02831673|101141692|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
33341109|NCT02831673|101141693|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
33341110|NCT02831673|101141689|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
33341111|NCT02831673|101141690|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
33341112|NCT02831673|101141691|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
33341113|NCT02831673|101141692|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
33341114|NCT02831673|101141693|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
33405986|NCT01005966|101377528|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
33405987|NCT01005966|101377529|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
33614803|NCT01957202|102140106|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
33614804|NCT01957202|102140107|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
33614805|NCT01957202|102140108|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
33614806|NCT01957202|102140109|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
33614807|NCT01957202|102140110|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
33614808|NCT01957202|102140111|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
33614809|NCT01957202|102140112|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
33614810|NCT01957202|102140113|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
33614811|NCT01957202|102140114|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
33614812|NCT01957202|102140115|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
33614813|NCT01957202|102140116|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
33614814|NCT01957202|102140117|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
33614815|NCT02586727|102140118|FG000|Overall Study|Lost to Follow-up|1|||
33614816|NCT02586727|102140119|FG001|Overall Study|Lost to Follow-up|0|||
33614817|NCT02669212|102140125|FG000|Overall Study|Lost to Follow-up|1|||
33614818|NCT02669212|102140126|FG001|Overall Study|Lost to Follow-up|0|||
33614819|NCT02669212|102140125|FG000|Overall Study|Medical Condition|3|||
33614820|NCT02669212|102140126|FG001|Overall Study|Medical Condition|4|||
33614821|NCT02669212|102140125|FG000|Overall Study|Withdrawal by Subject|0|||
33614822|NCT02669212|102140126|FG001|Overall Study|Withdrawal by Subject|2|||
33614823|NCT02669212|102140125|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
33614824|NCT02669212|102140126|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
33614825|NCT00994422|102140127|FG000|Overall Study|Lost to Follow-up|7|||
33614826|NCT00994422|102140128|FG001|Overall Study|Lost to Follow-up|1|||
33614827|NCT00344500|102140129|FG000|Overall Study|Adverse Event|6|||
33614828|NCT00344500|102140130|FG001|Overall Study|Adverse Event|2|||
33614829|NCT00344500|102140131|FG002|Overall Study|Adverse Event|0|||
33614830|NCT00344500|102140129|FG000|Overall Study|Lost to Follow-up|5|||
33614831|NCT00344500|102140130|FG001|Overall Study|Lost to Follow-up|13|||
33614832|NCT00344500|102140131|FG002|Overall Study|Lost to Follow-up|1|||
33614833|NCT00344500|102140129|FG000|Overall Study|Withdrawal by Subject|7|||
33614834|NCT00344500|102140130|FG001|Overall Study|Withdrawal by Subject|10|||
33614835|NCT00344500|102140131|FG002|Overall Study|Withdrawal by Subject|0|||
33209696|NCT02564523|100670273|FG016|Overall Study|Withdrawal by Subject|0|||
33209697|NCT02564523|100670274|FG017|Overall Study|Withdrawal by Subject|0|||
33209698|NCT02564523|100670257|FG000|Overall Study|Adverse Event|0|||
33341115|NCT02831673|101141689|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
33341116|NCT02831673|101141690|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
33341117|NCT02831673|101141691|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
33341118|NCT02831673|101141692|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
33341119|NCT02831673|101141693|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
33341120|NCT02831673|101141689|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
33341121|NCT02831673|101141690|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
33341122|NCT02831673|101141691|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
33341123|NCT02831673|101141692|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
33341124|NCT02831673|101141693|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
33405988|NCT01005966|101377530|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
33538731|NCT01326871|101871029|FG001|Overall Study|Physician Decision|0|||
33538732|NCT01326871|101871030|FG002|Overall Study|Physician Decision|1|||
33341125|NCT02831673|101141689|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
33341126|NCT02831673|101141690|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
33405989|NCT01005966|101377531|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
33405990|NCT01005966|101377527|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
33405991|NCT01005966|101377528|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
33405992|NCT01005966|101377529|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
33538733|NCT01326871|101871028|FG000|Overall Study|SAE|0|||
33538734|NCT01326871|101871029|FG001|Overall Study|SAE|0|||
33538735|NCT01326871|101871030|FG002|Overall Study|SAE|1|||
33538736|NCT01326871|101871028|FG000|Overall Study|Disease progression and death|0|||
33538737|NCT01326871|101871029|FG001|Overall Study|Disease progression and death|0|||
33538738|NCT01326871|101871030|FG002|Overall Study|Disease progression and death|1|||
33538739|NCT01326871|101871028|FG000|Overall Study|Subject decision|0|||
33538740|NCT01326871|101871029|FG001|Overall Study|Subject decision|0|||
33538741|NCT01326871|101871030|FG002|Overall Study|Subject decision|1|||
33209699|NCT02564523|100670258|FG001|Overall Study|Adverse Event|0|||
33209700|NCT02564523|100670259|FG002|Overall Study|Adverse Event|0|||
33341127|NCT02831673|101141691|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
33341128|NCT02831673|101141692|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
33341129|NCT02831673|101141693|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
33341130|NCT02831673|101141689|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
33341131|NCT02831673|101141690|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
33341132|NCT02831673|101141691|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
33341133|NCT02831673|101141692|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
33341134|NCT02831673|101141693|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
33341135|NCT02831673|101141689|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
33341136|NCT02831673|101141690|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
33341137|NCT02831673|101141691|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
33341138|NCT02831673|101141692|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
33341139|NCT02831673|101141693|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
33341140|NCT02831673|101141689|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
33341141|NCT02831673|101141690|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
33341142|NCT02831673|101141691|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
33341143|NCT02831673|101141692|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
33341144|NCT02831673|101141693|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
33341145|NCT02831673|101141689|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
33341146|NCT02831673|101141690|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
33341147|NCT02831673|101141691|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
33341148|NCT02831673|101141692|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
33341149|NCT02831673|101141693|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
33341150|NCT02831673|101141689|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
33341151|NCT02831673|101141690|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
33341152|NCT02831673|101141691|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
33341153|NCT02831673|101141692|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
33341154|NCT02831673|101141693|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
33341155|NCT02831673|101141689|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
33341156|NCT02831673|101141690|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
33341157|NCT02831673|101141691|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
33341158|NCT02831673|101141692|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
33341159|NCT02831673|101141693|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
33341160|NCT02831673|101141689|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
33341161|NCT02831673|101141690|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
33341162|NCT02831673|101141691|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
33405993|NCT01005966|101377530|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
33538742|NCT00721799|101871031|FG000|Overall Study|Withdrawal by Subject|7|||
33538743|NCT00721799|101871031|FG000|Overall Study|withdraw by subject after scan 1|1|||
33209701|NCT02564523|100670260|FG003|Overall Study|Adverse Event|0|||
33209702|NCT02564523|100670261|FG004|Overall Study|Adverse Event|0|||
33341163|NCT02831673|101141692|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
33341164|NCT02831673|101141693|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
33341165|NCT02831673|101141689|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
33341166|NCT02831673|101141690|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
33341167|NCT02831673|101141691|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
33341168|NCT02831673|101141692|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
33341169|NCT02831673|101141693|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
33341170|NCT02831673|101141689|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33341171|NCT02831673|101141690|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33341172|NCT02831673|101141691|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33341173|NCT02831673|101141692|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33341174|NCT02831673|101141693|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
33341175|NCT02831673|101141689|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33341176|NCT02831673|101141690|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33341177|NCT02831673|101141691|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33341178|NCT02831673|101141692|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33341179|NCT02831673|101141693|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
33341180|NCT02831673|101141689|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33341181|NCT02831673|101141690|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33341182|NCT02831673|101141691|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33405994|NCT01005966|101377531|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
33405995|NCT01005966|101377527|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33405996|NCT01005966|101377528|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33405997|NCT01005966|101377529|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33405998|NCT01005966|101377530|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
33405999|NCT01005966|101377531|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
33406000|NCT01005966|101377527|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33406001|NCT01005966|101377528|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33406002|NCT01005966|101377529|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
33406003|NCT01005966|101377530|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33406004|NCT01005966|101377531|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
33406005|NCT01005966|101377527|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
33406006|NCT01005966|101377528|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
33406007|NCT01005966|101377529|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
33406008|NCT01005966|101377530|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
33406009|NCT01005966|101377531|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
33406010|NCT01005966|101377527|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
33406011|NCT01005966|101377528|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
33406012|NCT01005966|101377529|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
33538744|NCT02791269|101871035|FG000|Overall Study|Lost to Follow-up|0|||
33341183|NCT02831673|101141692|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33341184|NCT02831673|101141693|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
33341185|NCT02831673|101141689|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33341186|NCT02831673|101141690|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33341187|NCT02831673|101141691|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33341188|NCT02831673|101141692|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33538745|NCT02791269|101871036|FG001|Overall Study|Lost to Follow-up|1|||
33341189|NCT02831673|101141693|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
33341190|NCT01422239|101141694|FG000|Overall Study|Lost to Follow-up|4|||
33341191|NCT01422239|101141695|FG001|Overall Study|Lost to Follow-up|3|||
33341192|NCT03988907|101141696|FG000|Overall Study|Unable to complete visit|0|||
33341193|NCT03988907|101141697|FG001|Overall Study|Unable to complete visit|1|||
33341194|NCT01142726|101141698|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
33406013|NCT01005966|101377530|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
33538746|NCT00909844|101871037|FG000|Overall Study|Adverse Event|1|||
33209703|NCT02564523|100670262|FG005|Overall Study|Adverse Event|0|||
33209704|NCT02564523|100670263|FG006|Overall Study|Adverse Event|0|||
33209705|NCT02564523|100670264|FG007|Overall Study|Adverse Event|0|||
33209706|NCT02564523|100670265|FG008|Overall Study|Adverse Event|0|||
33341195|NCT01142726|101141699|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
33341196|NCT01142726|101141700|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
33341197|NCT01142726|101141698|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
33341198|NCT01142726|101141699|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
33406014|NCT01005966|101377531|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
33538747|NCT00909844|101871037|FG000|Overall Study|Withdrawal by Subject|1|||
33209707|NCT02564523|100670266|FG009|Overall Study|Adverse Event|0|||
33341199|NCT01142726|101141700|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
33341200|NCT01142726|101141698|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
33341201|NCT01142726|101141699|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
33341202|NCT01142726|101141700|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
33341203|NCT01142726|101141698|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
33341204|NCT01142726|101141699|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
33341205|NCT01142726|101141700|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
33341206|NCT01142726|101141698|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
33341207|NCT01142726|101141699|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
33341208|NCT01142726|101141700|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
33341209|NCT01142726|101141698|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
33341210|NCT01142726|101141699|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
33341211|NCT01142726|101141700|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
33341212|NCT01142726|101141698|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
33341213|NCT01142726|101141699|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
33341214|NCT01142726|101141700|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
33341215|NCT01142726|101141698|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
33341216|NCT01142726|101141699|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
33341217|NCT01142726|101141700|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
33341218|NCT01142726|101141698|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
33341219|NCT01142726|101141699|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
33341220|NCT01142726|101141700|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
33341221|NCT01142726|101141698|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
33341222|NCT01142726|101141699|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
33341223|NCT01142726|101141700|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
33341224|NCT01142726|101141698|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
33341225|NCT01142726|101141699|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
33341226|NCT01142726|101141700|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
33341227|NCT01142726|101141698|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
33406015|NCT01005966|101377527|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
33406016|NCT01005966|101377528|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
33406017|NCT01005966|101377529|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
33406018|NCT01005966|101377530|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
33406019|NCT01005966|101377531|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
33406020|NCT00911508|101377538|FG000|Overall Study|Lost to Follow-up|27|||
33406021|NCT00911508|101377539|FG001|Overall Study|Lost to Follow-up|18|||
33406022|NCT00911508|101377538|FG000|Overall Study|Withdrawal by Subject|79|||
33406023|NCT00911508|101377539|FG001|Overall Study|Withdrawal by Subject|112|||
33406024|NCT01072175|101377543|FG000|Part A (Drug-Drug Interaction)|Death|1|||
33406025|NCT01072175|101377544|FG001|Part A (Drug-Drug Interaction)|Death|0|||
33406026|NCT01072175|101377545|FG002|Part A (Drug-Drug Interaction)|Death|0|||
33406027|NCT01072175|101377546|FG003|Part A (Drug-Drug Interaction)|Death|0|||
33406028|NCT01072175|101377547|FG004|Part A (Drug-Drug Interaction)|Death|0|||
33406029|NCT01072175|101377548|FG005|Part A (Drug-Drug Interaction)|Death|0|||
33406030|NCT01072175|101377549|FG006|Part A (Drug-Drug Interaction)|Death|0|||
33406031|NCT01072175|101377550|FG007|Part A (Drug-Drug Interaction)|Death|0|||
33406032|NCT01072175|101377551|FG008|Part A (Drug-Drug Interaction)|Death|0|||
33406033|NCT01072175|101377552|FG009|Part A (Drug-Drug Interaction)|Death|0|||
33406034|NCT01072175|101377553|FG010|Part A (Drug-Drug Interaction)|Death|0|||
33406035|NCT01072175|101377554|FG011|Part A (Drug-Drug Interaction)|Death|0|||
33406036|NCT01072175|101377555|FG012|Part A (Drug-Drug Interaction)|Death|0|||
33406037|NCT01072175|101377543|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
33406038|NCT01072175|101377544|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33406039|NCT01072175|101377545|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33406040|NCT01072175|101377546|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33406041|NCT01072175|101377547|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33538748|NCT00909844|101871037|FG000|Overall Study|Lost to Follow-up|2|||
33406042|NCT01072175|101377548|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33538749|NCT01386606|101871038|FG000|Overall Study|Adverse Event|0|||
33538750|NCT01386606|101871039|FG001|Overall Study|Adverse Event|1|||
33209708|NCT02564523|100670267|FG010|Overall Study|Adverse Event|0|||
33406043|NCT01072175|101377549|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33538751|NCT01386606|101871040|FG002|Overall Study|Adverse Event|0|||
33538752|NCT01386606|101871041|FG003|Overall Study|Adverse Event|0|||
33209709|NCT02564523|100670268|FG011|Overall Study|Adverse Event|0|||
33341228|NCT01142726|101141699|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
33341229|NCT01142726|101141700|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
33341230|NCT01142726|101141698|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
33341231|NCT01142726|101141699|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
33341232|NCT01142726|101141700|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
33341233|NCT01142726|101141698|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
33341234|NCT01142726|101141699|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
33341235|NCT01142726|101141700|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
33341236|NCT01142726|101141698|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
33341237|NCT01142726|101141699|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
33341238|NCT01142726|101141700|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
33341239|NCT01142726|101141698|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
33341240|NCT01142726|101141699|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
33341241|NCT01142726|101141700|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
33341242|NCT00686647|101141701|FG000|Overall Study|Lost to Follow-up|1|||
33341243|NCT00686647|101141701|FG000|Overall Study|Death|1|||
33341244|NCT00865020|101141702|FG000|Overall Study|Withdrawal by Subject|22|||
33341245|NCT00865020|101141703|FG001|Overall Study|Withdrawal by Subject|16|||
33341246|NCT00865020|101141702|FG000|Overall Study|Adverse Event|9|||
33341247|NCT00865020|101141703|FG001|Overall Study|Adverse Event|14|||
33538753|NCT01386606|101871038|FG000|Overall Study|Withdrawal by Subject|0|||
33341248|NCT00865020|101141702|FG000|Overall Study|Abnormal test procedure result(s)|6|||
33538754|NCT01386606|101871039|FG001|Overall Study|Withdrawal by Subject|1|||
33209710|NCT02564523|100670269|FG012|Overall Study|Adverse Event|0|||
33341249|NCT00865020|101141703|FG001|Overall Study|Abnormal test procedure result(s)|8|||
33406044|NCT01072175|101377550|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33406045|NCT01072175|101377551|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33406046|NCT01072175|101377552|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33406047|NCT01072175|101377553|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33406048|NCT01072175|101377554|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33406049|NCT01072175|101377555|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
33406050|NCT01072175|101377543|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
33406051|NCT01072175|101377544|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33406052|NCT01072175|101377545|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33341250|NCT00865020|101141702|FG000|Overall Study|Lost to Follow-up|6|||
33341251|NCT00865020|101141703|FG001|Overall Study|Lost to Follow-up|4|||
33341252|NCT00865020|101141702|FG000|Overall Study|Protocol deviation|4|||
33341253|NCT00865020|101141703|FG001|Overall Study|Protocol deviation|1|||
33341254|NCT00865020|101141702|FG000|Overall Study|Administrative problems|0|||
33341255|NCT00865020|101141703|FG001|Overall Study|Administrative problems|2|||
33341256|NCT00865020|101141702|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33341257|NCT00865020|101141703|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33341258|NCT00865020|101141702|FG000|Overall Study|Death|0|||
33406053|NCT01072175|101377546|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33406054|NCT01072175|101377547|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33406055|NCT01072175|101377548|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33341259|NCT00865020|101141703|FG001|Overall Study|Death|1|||
33341260|NCT00865020|101141702|FG000|Overall Study|Randomized but discontinued|2|||
33341261|NCT00865020|101141703|FG001|Overall Study|Randomized but discontinued|4|||
33341262|NCT01017952|101141704|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
33406056|NCT01072175|101377549|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33406057|NCT01072175|101377550|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33538755|NCT01386606|101871040|FG002|Overall Study|Withdrawal by Subject|1|||
33538756|NCT01386606|101871041|FG003|Overall Study|Withdrawal by Subject|0|||
33341263|NCT01017952|101141705|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33341264|NCT01017952|101141706|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33341265|NCT01017952|101141707|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33341266|NCT01017952|101141708|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33341267|NCT01017952|101141704|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
33341268|NCT01017952|101141705|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
33341269|NCT01017952|101141706|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
33341270|NCT01017952|101141707|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
33341271|NCT01017952|101141708|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
33341272|NCT01017952|101141704|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
33341273|NCT01017952|101141705|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
33341274|NCT01017952|101141706|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
33341275|NCT01017952|101141707|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
33341276|NCT01017952|101141708|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
33341277|NCT01017952|101141704|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
33341278|NCT01017952|101141705|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33341279|NCT01017952|101141706|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33341280|NCT01017952|101141707|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33341281|NCT01017952|101141708|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33341282|NCT01017952|101141704|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
33341283|NCT01017952|101141705|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
33341284|NCT01017952|101141706|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
33341285|NCT01017952|101141707|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
33341286|NCT01017952|101141708|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
33341287|NCT01017952|101141704|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
33341288|NCT01017952|101141705|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33341289|NCT01017952|101141706|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33341290|NCT01017952|101141707|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33341291|NCT01017952|101141708|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33341292|NCT01017952|101141704|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
33341293|NCT01017952|101141705|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
33341294|NCT01017952|101141706|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
33341295|NCT01017952|101141707|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
33341296|NCT01017952|101141708|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
33341297|NCT01017952|101141704|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
33341298|NCT01017952|101141705|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
33341299|NCT01017952|101141706|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
33341300|NCT01017952|101141707|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
33341301|NCT01017952|101141708|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
33341302|NCT01017952|101141704|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
33341303|NCT01017952|101141705|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
33341304|NCT01017952|101141706|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
33341305|NCT01017952|101141707|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
33341306|NCT01017952|101141708|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
33341307|NCT01017952|101141704|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
33341308|NCT01017952|101141705|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
33538757|NCT01386606|101871038|FG000|Overall Study|Protocol Violation|1|||
33538758|NCT01386606|101871039|FG001|Overall Study|Protocol Violation|0|||
33341309|NCT01017952|101141706|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
33341310|NCT01017952|101141707|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
33538759|NCT01386606|101871040|FG002|Overall Study|Protocol Violation|1|||
33538760|NCT01386606|101871041|FG003|Overall Study|Protocol Violation|1|||
33538761|NCT01386606|101871038|FG000|Overall Study|Lost to Follow-up|2|||
33538762|NCT01386606|101871039|FG001|Overall Study|Lost to Follow-up|0|||
33406058|NCT01072175|101377551|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33538763|NCT01386606|101871040|FG002|Overall Study|Lost to Follow-up|0|||
33538764|NCT01386606|101871041|FG003|Overall Study|Lost to Follow-up|0|||
33341311|NCT01017952|101141708|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
33341312|NCT01017952|101141704|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
33341313|NCT01017952|101141705|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
33341314|NCT01017952|101141706|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
33341315|NCT01017952|101141707|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
33341316|NCT01017952|101141708|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
33341317|NCT01017952|101141704|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
33341318|NCT01017952|101141705|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
33406059|NCT01072175|101377552|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33406060|NCT01072175|101377553|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33406061|NCT01072175|101377554|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33406062|NCT01072175|101377555|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
33406063|NCT01072175|101377543|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
33614836|NCT00344500|102140129|FG000|Overall Study|Protocol Violation|4|||
33406064|NCT01072175|101377544|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
33406065|NCT01072175|101377545|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
33406066|NCT01072175|101377546|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
33406067|NCT01072175|101377547|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
33406068|NCT01072175|101377548|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
33406069|NCT01072175|101377549|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
33406070|NCT01072175|101377550|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
33406071|NCT01072175|101377551|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
33406072|NCT01072175|101377552|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
33406073|NCT01072175|101377553|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
33406074|NCT01072175|101377554|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
33406075|NCT01072175|101377555|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
33406076|NCT01072175|101377543|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33406077|NCT01072175|101377544|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33614837|NCT00344500|102140130|FG001|Overall Study|Protocol Violation|7|||
33614838|NCT00344500|102140131|FG002|Overall Study|Protocol Violation|1|||
33614839|NCT00344500|102140129|FG000|Overall Study|Not Noted|1|||
33614840|NCT00344500|102140130|FG001|Overall Study|Not Noted|3|||
33614841|NCT00344500|102140131|FG002|Overall Study|Not Noted|0|||
33614842|NCT00704288|102140132|FG000|Overall Treatment Period|Adverse Event|11|||
33614843|NCT00704288|102140133|FG001|Overall Treatment Period|Adverse Event|8|||
33614844|NCT00704288|102140134|FG002|Overall Treatment Period|Adverse Event|22|||
33614845|NCT00704288|102140132|FG000|Overall Treatment Period|Death|0|||
33614846|NCT00704288|102140133|FG001|Overall Treatment Period|Death|0|||
33614847|NCT00704288|102140134|FG002|Overall Treatment Period|Death|1|||
33614848|NCT00704288|102140132|FG000|Overall Treatment Period|Physician Decision|0|||
33614849|NCT00704288|102140133|FG001|Overall Treatment Period|Physician Decision|2|||
33614850|NCT00704288|102140134|FG002|Overall Treatment Period|Physician Decision|0|||
33614851|NCT00704288|102140132|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
33538765|NCT01386606|101871038|FG000|Overall Study|Subject incarcerated|0|||
33538766|NCT01386606|101871039|FG001|Overall Study|Subject incarcerated|1|||
33538767|NCT01386606|101871040|FG002|Overall Study|Subject incarcerated|0|||
33538768|NCT01386606|101871041|FG003|Overall Study|Subject incarcerated|0|||
33538769|NCT01386606|101871038|FG000|Overall Study|Unable to draw PK|1|||
33538770|NCT01386606|101871039|FG001|Overall Study|Unable to draw PK|0|||
33538771|NCT01386606|101871040|FG002|Overall Study|Unable to draw PK|0|||
33538772|NCT01386606|101871041|FG003|Overall Study|Unable to draw PK|0|||
33538773|NCT01386606|101871038|FG000|Overall Study|T levels too high|0|||
33538774|NCT01386606|101871039|FG001|Overall Study|T levels too high|1|||
33538775|NCT01386606|101871040|FG002|Overall Study|T levels too high|1|||
33538776|NCT01386606|101871041|FG003|Overall Study|T levels too high|0|||
33614852|NCT00704288|102140133|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
33614853|NCT00704288|102140134|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
33614854|NCT00704288|102140132|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
33614855|NCT00704288|102140133|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
33614856|NCT00704288|102140134|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
33614857|NCT00704288|102140132|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
33614858|NCT00704288|102140133|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
33614859|NCT00704288|102140134|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
33614860|NCT00704288|102140132|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
33538777|NCT03712280|101871044|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
33538778|NCT03712280|101871045|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
33538779|NCT03712280|101871046|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
33538780|NCT03712280|101871047|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
33538781|NCT03712280|101871044|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
33538782|NCT03712280|101871045|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
33406078|NCT01072175|101377545|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
33406079|NCT01072175|101377546|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33406080|NCT01072175|101377547|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
33406081|NCT01072175|101377548|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33406082|NCT01072175|101377549|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33406083|NCT01072175|101377550|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33406084|NCT01072175|101377551|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33406085|NCT01072175|101377552|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33341319|NCT01017952|101141706|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
33341320|NCT01017952|101141707|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
33341321|NCT01017952|101141708|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
33341322|NCT01017952|101141704|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33341323|NCT01017952|101141705|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
33341324|NCT01017952|101141706|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
33341325|NCT01017952|101141707|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
33341326|NCT01017952|101141708|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
33341327|NCT01017952|101141704|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
33341328|NCT01017952|101141705|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
33341329|NCT01017952|101141706|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
33341330|NCT01017952|101141707|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
33341331|NCT01017952|101141708|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
33341332|NCT02217566|101141709|FG000|Overall Study|Lost to Follow-up|2|||
33341333|NCT02217566|101141709|FG000|Overall Study|Death|3|||
33341334|NCT02217566|101141709|FG000|Overall Study|Early study termination|6|||
33341335|NCT02317562|101141710|FG000|Overall Study|Physician Decision|1|||
33341336|NCT02317562|101141710|FG000|Overall Study|early termination of the study|8|||
33341337|NCT02317562|101141710|FG000|Overall Study|Lack of Efficacy|4|||
33341338|NCT02317562|101141710|FG000|Overall Study|Withdrawal by Subject|1|||
33341339|NCT01582308|101141711|FG000|Period 1|Withdrawal by Subject|0|||
33341340|NCT01582308|101141712|FG001|Period 1|Withdrawal by Subject|0|||
33341341|NCT01582308|101141713|FG002|Period 1|Withdrawal by Subject|0|||
33341342|NCT01582308|101141714|FG003|Period 1|Withdrawal by Subject|0|||
33406086|NCT01072175|101377553|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33406087|NCT01072175|101377554|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33406088|NCT01072175|101377555|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
33406089|NCT01072175|101377543|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33406090|NCT01072175|101377544|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
33538783|NCT03712280|101871046|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
33538784|NCT03712280|101871047|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
33538785|NCT03712280|101871044|FG000|Overall Study|Adverse Event|0|||
33538786|NCT03712280|101871045|FG001|Overall Study|Adverse Event|0|||
33538787|NCT03712280|101871046|FG002|Overall Study|Adverse Event|1|||
33538788|NCT03712280|101871047|FG003|Overall Study|Adverse Event|0|||
33538789|NCT02666222|101871048|FG000|Overall Study|Death|2|||
33538790|NCT04161391|101871049|FG000|Overall Study|Adverse Event|0|||
33538791|NCT04161391|101871050|FG001|Overall Study|Adverse Event|1|||
33538792|NCT04161391|101871051|FG002|Overall Study|Adverse Event|0|||
33538793|NCT04161391|101871052|FG003|Overall Study|Adverse Event|1|||
33538794|NCT04161391|101871053|FG004|Overall Study|Adverse Event|0|||
33614861|NCT00704288|102140133|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
33614862|NCT00704288|102140134|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
33538795|NCT04161391|101871054|FG005|Overall Study|Adverse Event|0|||
33538796|NCT04161391|101871055|FG006|Overall Study|Adverse Event|0|||
33538797|NCT04161391|101871056|FG007|Overall Study|Adverse Event|3|||
33538798|NCT04161391|101871057|FG008|Overall Study|Adverse Event|0|||
33614863|NCT00704288|102140132|FG000|Overall Treatment Period|Roll-over to another study|1|||
33341343|NCT01582308|101141715|FG004|Period 1|Withdrawal by Subject|0|||
33341344|NCT01582308|101141716|FG005|Period 1|Withdrawal by Subject|0|||
33341345|NCT01582308|101141717|FG006|Period 1|Withdrawal by Subject|1|||
33341346|NCT01582308|101141718|FG007|Period 1|Withdrawal by Subject|0|||
33341347|NCT01582308|101141719|FG008|Period 1|Withdrawal by Subject|0|||
33341348|NCT01582308|101141720|FG009|Period 1|Withdrawal by Subject|0|||
33406091|NCT01072175|101377545|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33538799|NCT04161391|101871049|FG000|Overall Study|Death|0|||
33538800|NCT04161391|101871050|FG001|Overall Study|Death|0|||
33538801|NCT04161391|101871051|FG002|Overall Study|Death|0|||
33538802|NCT04161391|101871052|FG003|Overall Study|Death|0|||
33538803|NCT04161391|101871053|FG004|Overall Study|Death|0|||
33538804|NCT04161391|101871054|FG005|Overall Study|Death|0|||
33538805|NCT04161391|101871055|FG006|Overall Study|Death|0|||
33406092|NCT01072175|101377546|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
33406093|NCT01072175|101377547|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
33406094|NCT01072175|101377548|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33406095|NCT01072175|101377549|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33406096|NCT01072175|101377550|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33406097|NCT01072175|101377551|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33406098|NCT01072175|101377552|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33406099|NCT01072175|101377553|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33406100|NCT01072175|101377554|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33406101|NCT01072175|101377555|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
33406102|NCT01072175|101377543|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33406103|NCT01072175|101377544|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33406104|NCT01072175|101377545|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
33341349|NCT01582308|101141711|FG000|10-day Washout Following Period 1|Physician Decision|0|||
33341350|NCT01582308|101141712|FG001|10-day Washout Following Period 1|Physician Decision|0|||
33341351|NCT01582308|101141713|FG002|10-day Washout Following Period 1|Physician Decision|0|||
33341352|NCT01582308|101141714|FG003|10-day Washout Following Period 1|Physician Decision|0|||
33406105|NCT01072175|101377546|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
33406106|NCT01072175|101377547|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
33406107|NCT01072175|101377548|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33406108|NCT01072175|101377549|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33406109|NCT01072175|101377550|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33406110|NCT01072175|101377551|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33406111|NCT01072175|101377552|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33538806|NCT04161391|101871056|FG007|Overall Study|Death|1|||
33538807|NCT04161391|101871057|FG008|Overall Study|Death|0|||
33538808|NCT04161391|101871049|FG000|Overall Study|Physician Decision|0|||
33538809|NCT04161391|101871050|FG001|Overall Study|Physician Decision|0|||
33538810|NCT04161391|101871051|FG002|Overall Study|Physician Decision|1|||
33538811|NCT04161391|101871052|FG003|Overall Study|Physician Decision|2|||
33538812|NCT04161391|101871053|FG004|Overall Study|Physician Decision|0|||
33538813|NCT04161391|101871054|FG005|Overall Study|Physician Decision|0|||
33538814|NCT04161391|101871055|FG006|Overall Study|Physician Decision|2|||
33538815|NCT04161391|101871056|FG007|Overall Study|Physician Decision|0|||
33538816|NCT04161391|101871057|FG008|Overall Study|Physician Decision|0|||
33538817|NCT04161391|101871049|FG000|Overall Study|Progressive Disease|4|||
33538818|NCT04161391|101871050|FG001|Overall Study|Progressive Disease|3|||
33341353|NCT01582308|101141715|FG004|10-day Washout Following Period 1|Physician Decision|1|||
33341354|NCT01582308|101141716|FG005|10-day Washout Following Period 1|Physician Decision|0|||
33341355|NCT01582308|101141717|FG006|10-day Washout Following Period 1|Physician Decision|0|||
33341356|NCT01582308|101141718|FG007|10-day Washout Following Period 1|Physician Decision|0|||
33341357|NCT01582308|101141719|FG008|10-day Washout Following Period 1|Physician Decision|0|||
33341358|NCT01582308|101141720|FG009|10-day Washout Following Period 1|Physician Decision|0|||
33341359|NCT01582308|101141711|FG000|Period 4|Physician Decision|1|||
33341360|NCT01582308|101141712|FG001|Period 4|Physician Decision|0|||
33341361|NCT01582308|101141713|FG002|Period 4|Physician Decision|0|||
33341362|NCT01582308|101141714|FG003|Period 4|Physician Decision|0|||
33341363|NCT01582308|101141715|FG004|Period 4|Physician Decision|0|||
33341364|NCT01582308|101141716|FG005|Period 4|Physician Decision|1|||
33341365|NCT01582308|101141717|FG006|Period 4|Physician Decision|0|||
33341366|NCT01582308|101141718|FG007|Period 4|Physician Decision|0|||
33341367|NCT01582308|101141719|FG008|Period 4|Physician Decision|0|||
33341368|NCT01582308|101141720|FG009|Period 4|Physician Decision|1|||
33341369|NCT01999582|101141721|FG000|Overall Study|Withdrawal by Subject|0|||
33341370|NCT01999582|101141722|FG001|Overall Study|Withdrawal by Subject|0|||
33341371|NCT01999582|101141723|FG002|Overall Study|Withdrawal by Subject|0|||
33406112|NCT01072175|101377553|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33538819|NCT04161391|101871051|FG002|Overall Study|Progressive Disease|3|||
33538820|NCT04161391|101871052|FG003|Overall Study|Progressive Disease|5|||
33538821|NCT04161391|101871053|FG004|Overall Study|Progressive Disease|3|||
33341372|NCT01999582|101141724|FG003|Overall Study|Withdrawal by Subject|1|||
33341373|NCT01999582|101141725|FG004|Overall Study|Withdrawal by Subject|0|||
33538822|NCT04161391|101871054|FG005|Overall Study|Progressive Disease|3|||
33538823|NCT04161391|101871055|FG006|Overall Study|Progressive Disease|5|||
33538824|NCT04161391|101871056|FG007|Overall Study|Progressive Disease|2|||
33538825|NCT04161391|101871057|FG008|Overall Study|Progressive Disease|2|||
33538826|NCT00492297|101871058|FG000|Treatment|Death|2|||
33341374|NCT01999582|101141726|FG005|Overall Study|Withdrawal by Subject|0|||
33341375|NCT01999582|101141721|FG000|Overall Study|Adverse Event|0|||
33341376|NCT01999582|101141722|FG001|Overall Study|Adverse Event|0|||
33341377|NCT01999582|101141723|FG002|Overall Study|Adverse Event|3|||
33538827|NCT00492297|101871058|FG000|Treatment|Study terminated by sponsor|3|||
33538828|NCT00492297|101871058|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
33538829|NCT00492297|101871058|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
33538830|NCT00492297|101871058|FG000|Survival Only Follow-up|Death|46|||
33538831|NCT00492297|101871058|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
33538832|NCT00492297|101871058|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
33538833|NCT01483118|101871059|FG000|Overall Study|Lost to Follow-up|12|||
33538834|NCT01483118|101871060|FG001|Overall Study|Lost to Follow-up|16|||
33538835|NCT02984982|101871061|FG000|Overall Study|Adverse Event|2|||
33538836|NCT02984982|101871062|FG001|Overall Study|Adverse Event|5|||
33538837|NCT02984982|101871061|FG000|Overall Study|Poor Compliance to Protocol|4|||
33538838|NCT02984982|101871062|FG001|Overall Study|Poor Compliance to Protocol|4|||
33538839|NCT02984982|101871061|FG000|Overall Study|Withdrawal by Subject|2|||
33538840|NCT02984982|101871062|FG001|Overall Study|Withdrawal by Subject|0|||
33538841|NCT02984982|101871061|FG000|Overall Study|Randomized but not treated|0|||
33538842|NCT02984982|101871062|FG001|Overall Study|Randomized but not treated|1|||
33538843|NCT01674725|101871063|FG000|Overall Study|Adverse Event|1|||
33538844|NCT01674725|101871064|FG001|Overall Study|Adverse Event|0|||
33538845|NCT01674725|101871063|FG000|Overall Study|Did not receive study drug|1|||
33538846|NCT01674725|101871064|FG001|Overall Study|Did not receive study drug|0|||
33538847|NCT01674725|101871063|FG000|Overall Study|Withdrawal by Subject|1|||
33538848|NCT01674725|101871064|FG001|Overall Study|Withdrawal by Subject|0|||
33538849|NCT01674725|101871063|FG000|Overall Study|Lost to Follow-up|0|||
33538850|NCT01674725|101871064|FG001|Overall Study|Lost to Follow-up|1|||
33538851|NCT01867008|101871065|FG000|Overall Study|Withdrawal by Subject|1|||
33538852|NCT03652818|101871066|FG000|Overall Study|Adverse Event|1|||
33538853|NCT03652818|101871067|FG001|Overall Study|Adverse Event|0|||
33538854|NCT03652818|101871068|FG002|Overall Study|Adverse Event|0|||
33538855|NCT03652818|101871069|FG003|Overall Study|Adverse Event|0|||
33538856|NCT03652818|101871070|FG004|Overall Study|Adverse Event|0|||
33538857|NCT03652818|101871066|FG000|Overall Study|Physician Decision|1|||
33538858|NCT03652818|101871067|FG001|Overall Study|Physician Decision|0|||
33538859|NCT03652818|101871068|FG002|Overall Study|Physician Decision|0|||
33538860|NCT03652818|101871069|FG003|Overall Study|Physician Decision|0|||
33538861|NCT03652818|101871070|FG004|Overall Study|Physician Decision|0|||
33538862|NCT03652818|101871066|FG000|Overall Study|Lost to Follow-up|0|||
33538863|NCT03652818|101871067|FG001|Overall Study|Lost to Follow-up|1|||
33538864|NCT03652818|101871068|FG002|Overall Study|Lost to Follow-up|2|||
33538865|NCT03652818|101871069|FG003|Overall Study|Lost to Follow-up|1|||
33538866|NCT03652818|101871070|FG004|Overall Study|Lost to Follow-up|1|||
33538867|NCT01928771|101871071|FG000|Overall Study|Adverse Event|6|||
33538868|NCT01928771|101871072|FG001|Overall Study|Adverse Event|5|||
33538869|NCT01928771|101871073|FG002|Overall Study|Adverse Event|1|||
33538870|NCT01928771|101871071|FG000|Overall Study|Death|2|||
33538871|NCT01928771|101871072|FG001|Overall Study|Death|2|||
33406113|NCT01072175|101377554|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33406114|NCT01072175|101377555|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
33406115|NCT01072175|101377543|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33406116|NCT01072175|101377544|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
33406117|NCT01072175|101377545|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33406118|NCT01072175|101377546|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
33406119|NCT01072175|101377547|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
33406120|NCT01072175|101377548|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33406121|NCT01072175|101377549|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33406122|NCT01072175|101377550|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33538872|NCT01928771|101871073|FG002|Overall Study|Death|2|||
33538873|NCT01928771|101871071|FG000|Overall Study|Lost to Follow-up|5|||
33538874|NCT01928771|101871072|FG001|Overall Study|Lost to Follow-up|6|||
33538875|NCT01928771|101871073|FG002|Overall Study|Lost to Follow-up|3|||
33538876|NCT01928771|101871071|FG000|Overall Study|Withdrawal by Subject|20|||
33538877|NCT01928771|101871072|FG001|Overall Study|Withdrawal by Subject|15|||
33538878|NCT01928771|101871073|FG002|Overall Study|Withdrawal by Subject|17|||
33538879|NCT01928771|101871071|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
33538880|NCT01928771|101871072|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
33538881|NCT01928771|101871073|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
33538882|NCT01928771|101871071|FG000|Overall Study|Other Reasons|9|||
33538883|NCT01928771|101871072|FG001|Overall Study|Other Reasons|9|||
33538884|NCT01928771|101871073|FG002|Overall Study|Other Reasons|14|||
33538885|NCT01928771|101871071|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
33538886|NCT01928771|101871072|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
33538887|NCT01928771|101871073|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
33341378|NCT01999582|101141724|FG003|Overall Study|Adverse Event|0|||
33341379|NCT01999582|101141725|FG004|Overall Study|Adverse Event|1|||
33341380|NCT01999582|101141726|FG005|Overall Study|Adverse Event|0|||
33341381|NCT01999582|101141721|FG000|Overall Study|Other Reasons|1|||
33341382|NCT01999582|101141722|FG001|Overall Study|Other Reasons|0|||
33341383|NCT01999582|101141723|FG002|Overall Study|Other Reasons|3|||
33341384|NCT01999582|101141724|FG003|Overall Study|Other Reasons|1|||
33341385|NCT01999582|101141725|FG004|Overall Study|Other Reasons|1|||
33341386|NCT01999582|101141726|FG005|Overall Study|Other Reasons|2|||
33341387|NCT01999582|101141721|FG000|Overall Study|Protocol Violation|1|||
33341388|NCT01999582|101141722|FG001|Overall Study|Protocol Violation|0|||
33341389|NCT01999582|101141723|FG002|Overall Study|Protocol Violation|0|||
33341390|NCT01999582|101141724|FG003|Overall Study|Protocol Violation|0|||
33341391|NCT01999582|101141725|FG004|Overall Study|Protocol Violation|0|||
33538888|NCT01232283|101871074|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
33538889|NCT01232283|101871075|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
33538890|NCT01232283|101871076|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33538891|NCT01232283|101871077|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33341392|NCT01999582|101141726|FG005|Overall Study|Protocol Violation|1|||
33341393|NCT01999582|101141721|FG000|Overall Study|Lack of Efficacy|1|||
33341394|NCT01999582|101141722|FG001|Overall Study|Lack of Efficacy|3|||
33341395|NCT01999582|101141723|FG002|Overall Study|Lack of Efficacy|0|||
33341396|NCT01999582|101141724|FG003|Overall Study|Lack of Efficacy|1|||
33341397|NCT01999582|101141725|FG004|Overall Study|Lack of Efficacy|0|||
33341398|NCT01999582|101141726|FG005|Overall Study|Lack of Efficacy|0|||
33341399|NCT01133171|101141732|FG000|Overall Study|Withdrawal by Subject|1|||
33341400|NCT01133171|101141733|FG001|Overall Study|Withdrawal by Subject|2|||
33341401|NCT01133171|101141734|FG002|Overall Study|Withdrawal by Subject|0|||
33341402|NCT00880893|101141740|FG000|Overall Study|Protocol Violation|13|||
33341403|NCT00880893|101141741|FG001|Overall Study|Protocol Violation|1|||
33341404|NCT00880893|101141740|FG000|Overall Study|Withdrawal by Subject|15|||
33341405|NCT00880893|101141741|FG001|Overall Study|Withdrawal by Subject|11|||
33341406|NCT00880893|101141740|FG000|Overall Study|Lost to Follow-up|76|||
33341407|NCT00880893|101141741|FG001|Overall Study|Lost to Follow-up|33|||
33341408|NCT00880893|101141740|FG000|Overall Study|Serious adverse event|3|||
33341409|NCT00880893|101141741|FG001|Overall Study|Serious adverse event|0|||
33341410|NCT05048719|101141745|FG000|Overall Study|Withdrawal by Subject|2|||
33341411|NCT05048719|101141746|FG001|Overall Study|Withdrawal by Subject|1|||
33341412|NCT05048719|101141747|FG002|Overall Study|Withdrawal by Subject|3|||
33341413|NCT05048719|101141748|FG003|Overall Study|Withdrawal by Subject|1|||
33341414|NCT05048719|101141749|FG004|Overall Study|Withdrawal by Subject|0|||
33341415|NCT05048719|101141750|FG005|Overall Study|Withdrawal by Subject|2|||
33341416|NCT05048719|101141751|FG006|Overall Study|Withdrawal by Subject|1|||
33341417|NCT05048719|101141752|FG007|Overall Study|Withdrawal by Subject|1|||
33341418|NCT05048719|101141753|FG008|Overall Study|Withdrawal by Subject|0|||
33341419|NCT05048719|101141745|FG000|Overall Study|Death|1|||
33341420|NCT05048719|101141746|FG001|Overall Study|Death|0|||
33341421|NCT05048719|101141747|FG002|Overall Study|Death|0|||
33341422|NCT05048719|101141748|FG003|Overall Study|Death|0|||
33341423|NCT05048719|101141749|FG004|Overall Study|Death|0|||
33341424|NCT05048719|101141750|FG005|Overall Study|Death|0|||
33341425|NCT05048719|101141751|FG006|Overall Study|Death|0|||
33538892|NCT01232283|101871078|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33614864|NCT00704288|102140133|FG001|Overall Treatment Period|Roll-over to another study|0|||
33614865|NCT00704288|102140134|FG002|Overall Treatment Period|Roll-over to another study|4|||
33341426|NCT05048719|101141752|FG007|Overall Study|Death|0|||
33341427|NCT05048719|101141753|FG008|Overall Study|Death|0|||
33341428|NCT05048719|101141745|FG000|Overall Study|Adverse Event|0|||
33341429|NCT05048719|101141746|FG001|Overall Study|Adverse Event|1|||
33341430|NCT05048719|101141747|FG002|Overall Study|Adverse Event|2|||
33341431|NCT05048719|101141748|FG003|Overall Study|Adverse Event|0|||
33341432|NCT05048719|101141749|FG004|Overall Study|Adverse Event|1|||
33341433|NCT05048719|101141750|FG005|Overall Study|Adverse Event|0|||
33341434|NCT05048719|101141751|FG006|Overall Study|Adverse Event|0|||
33341435|NCT05048719|101141752|FG007|Overall Study|Adverse Event|0|||
33341436|NCT05048719|101141753|FG008|Overall Study|Adverse Event|0|||
33341437|NCT05048719|101141745|FG000|Overall Study|Lost to Follow-up|0|||
33341438|NCT05048719|101141746|FG001|Overall Study|Lost to Follow-up|0|||
33341439|NCT05048719|101141747|FG002|Overall Study|Lost to Follow-up|1|||
33341440|NCT05048719|101141748|FG003|Overall Study|Lost to Follow-up|3|||
33341441|NCT05048719|101141749|FG004|Overall Study|Lost to Follow-up|1|||
33341442|NCT05048719|101141750|FG005|Overall Study|Lost to Follow-up|1|||
33538893|NCT01232283|101871079|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33538894|NCT01232283|101871080|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33341443|NCT05048719|101141751|FG006|Overall Study|Lost to Follow-up|1|||
33341444|NCT05048719|101141752|FG007|Overall Study|Lost to Follow-up|1|||
33341445|NCT05048719|101141753|FG008|Overall Study|Lost to Follow-up|0|||
33341446|NCT05048719|101141745|FG000|Overall Study|Physician Decision|0|||
33341447|NCT05048719|101141746|FG001|Overall Study|Physician Decision|0|||
33341448|NCT05048719|101141747|FG002|Overall Study|Physician Decision|0|||
33341449|NCT05048719|101141748|FG003|Overall Study|Physician Decision|0|||
33341450|NCT05048719|101141749|FG004|Overall Study|Physician Decision|0|||
33341451|NCT05048719|101141750|FG005|Overall Study|Physician Decision|0|||
33341452|NCT05048719|101141751|FG006|Overall Study|Physician Decision|0|||
33341453|NCT05048719|101141752|FG007|Overall Study|Physician Decision|1|||
33341454|NCT05048719|101141753|FG008|Overall Study|Physician Decision|1|||
33341455|NCT05048719|101141745|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
33341456|NCT05048719|101141746|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
33341457|NCT05048719|101141747|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
33341458|NCT05048719|101141748|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
33341459|NCT05048719|101141749|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
33341460|NCT05048719|101141750|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
33341461|NCT05048719|101141751|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
33341462|NCT05048719|101141752|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
33341463|NCT05048719|101141753|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
33341464|NCT05048719|101141745|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
33341465|NCT05048719|101141746|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
33341466|NCT05048719|101141747|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
33341467|NCT05048719|101141748|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
33341468|NCT05048719|101141749|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
33341469|NCT05048719|101141750|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
33341470|NCT05048719|101141751|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
33341471|NCT05048719|101141752|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
33341472|NCT05048719|101141753|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
33341473|NCT05048719|101141745|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
33341474|NCT05048719|101141746|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
33341475|NCT05048719|101141747|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
33341476|NCT05048719|101141748|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
33341477|NCT05048719|101141749|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
33341478|NCT05048719|101141750|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
33341479|NCT05048719|101141751|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
33341480|NCT05048719|101141752|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
33341481|NCT05048719|101141753|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
33341482|NCT05048719|101141745|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
33341483|NCT05048719|101141746|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
33538895|NCT01232283|101871081|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33538896|NCT01232283|101871082|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33538897|NCT01232283|101871083|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
33538898|NCT01232283|101871074|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
33538899|NCT01232283|101871075|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
33538900|NCT01232283|101871076|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33538901|NCT01232283|101871077|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33341484|NCT05048719|101141747|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
33538902|NCT01232283|101871078|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33538903|NCT01232283|101871079|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33538904|NCT01232283|101871080|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33538905|NCT01232283|101871081|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33538906|NCT01232283|101871082|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33538907|NCT01232283|101871083|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
33538908|NCT01232283|101871074|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
33538909|NCT01232283|101871075|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33341485|NCT05048719|101141748|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
33341486|NCT05048719|101141749|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
33341487|NCT05048719|101141750|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
33341488|NCT05048719|101141751|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
33341489|NCT05048719|101141752|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
33341490|NCT05048719|101141753|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
33341491|NCT05048719|101141745|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
33341492|NCT05048719|101141746|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
33341493|NCT05048719|101141747|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
33341494|NCT05048719|101141748|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
33341495|NCT05048719|101141749|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
33341496|NCT05048719|101141750|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
33341497|NCT05048719|101141751|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
33341498|NCT05048719|101141752|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
33341499|NCT05048719|101141753|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
33341500|NCT01580397|101141754|FG000|Overall Study|Lack of Efficacy|14|||
33341501|NCT01292057|101141755|FG000|Overall Study|Protocol Violation|1|||
33341502|NCT01292057|101141756|FG001|Overall Study|Protocol Violation|1|||
33341503|NCT01292057|101141755|FG000|Overall Study|Lost to Follow-up|1|||
33341504|NCT01292057|101141756|FG001|Overall Study|Lost to Follow-up|1|||
33341505|NCT01405053|101141757|FG000|Overall Study|Adverse Event|3|||
33341506|NCT01405053|101141758|FG001|Overall Study|Adverse Event|0|||
33341507|NCT01405053|101141757|FG000|Overall Study|Lost to Follow-up|0|||
33341508|NCT01405053|101141758|FG001|Overall Study|Lost to Follow-up|1|||
33341509|NCT01405053|101141757|FG000|Overall Study|Participant choice|2|||
33341510|NCT01405053|101141758|FG001|Overall Study|Participant choice|1|||
33341511|NCT01405053|101141757|FG000|Overall Study|Inadequate therapeutic effect|2|||
33341512|NCT01405053|101141758|FG001|Overall Study|Inadequate therapeutic effect|1|||
33341513|NCT01405053|101141757|FG000|Overall Study|Withdrawal by Subject|3|||
33341514|NCT01405053|101141758|FG001|Overall Study|Withdrawal by Subject|4|||
33341515|NCT01405053|101141757|FG000|Overall Study|Other|0|||
33341516|NCT01405053|101141758|FG001|Overall Study|Other|1|||
33538910|NCT01232283|101871076|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33538911|NCT01232283|101871077|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33538912|NCT01232283|101871078|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33538913|NCT01232283|101871079|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33538914|NCT01232283|101871080|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33538915|NCT01232283|101871081|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33538916|NCT01232283|101871082|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33538917|NCT01232283|101871083|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
33538918|NCT01232283|101871074|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
33538919|NCT01232283|101871075|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
33538920|NCT01232283|101871076|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33538921|NCT01232283|101871077|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33538922|NCT01232283|101871078|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33209711|NCT02564523|100670270|FG013|Overall Study|Adverse Event|0|||
33341517|NCT00429585|101141759|FG000|Overall Study|Death|1|||
33341518|NCT00429585|101141760|FG001|Overall Study|Death|0|||
33341519|NCT00429585|101141759|FG000|Overall Study|Lost to Follow-up|27|||
33538923|NCT01232283|101871079|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33538924|NCT01232283|101871080|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33538925|NCT01232283|101871081|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33341520|NCT00429585|101141760|FG001|Overall Study|Lost to Follow-up|20|||
33341521|NCT00429585|101141759|FG000|Overall Study|Physician Decision|2|||
33341522|NCT00429585|101141760|FG001|Overall Study|Physician Decision|0|||
33209712|NCT02564523|100670271|FG014|Overall Study|Adverse Event|0|||
33209713|NCT02564523|100670272|FG015|Overall Study|Adverse Event|0|||
33341523|NCT02559687|101141763|FG000|Overall Study|Death|112|||
33341524|NCT02559687|101141763|FG000|Overall Study|Sponsor Decision|5|||
33341525|NCT02559687|101141763|FG000|Overall Study|Withdrawal by Subject|4|||
33341526|NCT03948178|101141764|FG000|Overall Study|Protocol Violation|1|||
33341527|NCT03948178|101141764|FG000|Overall Study|Lost to Follow-up|2|||
33341528|NCT03948178|101141764|FG000|Overall Study|Withdrawal by Subject|2|||
33341529|NCT03948178|101141764|FG000|Overall Study|Reason not known|2|||
33341530|NCT03948178|101141764|FG000|Overall Study|Personal reason|14|||
33341531|NCT03948178|101141764|FG000|Overall Study|Disease progression|30|||
33341532|NCT03948178|101141764|FG000|Overall Study|Adverse Event|12|||
33341533|NCT03948178|101141764|FG000|Overall Study|Sponsor terminated study|164|||
33341534|NCT04682405|101141765|FG000|Overall Study|Adverse Event|0|||
33341535|NCT04682405|101141766|FG001|Overall Study|Adverse Event|1|||
33341536|NCT01783678|101141768|FG000|Overall Study|Randomized but Not Treated|0|||
33538926|NCT01232283|101871082|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33538927|NCT01232283|101871083|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
33538928|NCT01232283|101871074|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
33538929|NCT01232283|101871075|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
33538930|NCT01232283|101871076|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33538931|NCT01232283|101871077|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33538932|NCT01232283|101871078|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33538933|NCT01232283|101871079|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33538934|NCT01232283|101871080|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33538935|NCT01232283|101871081|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33538936|NCT01232283|101871082|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33538937|NCT01232283|101871083|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
33538938|NCT01232283|101871074|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
33538939|NCT01232283|101871075|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
33538940|NCT01232283|101871076|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33538941|NCT01232283|101871077|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33538942|NCT01232283|101871078|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33538943|NCT01232283|101871079|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33538944|NCT01232283|101871080|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33538945|NCT01232283|101871081|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33538946|NCT01232283|101871082|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33538947|NCT01232283|101871083|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
33341537|NCT01783678|101141769|FG001|Overall Study|Randomized but Not Treated|0|||
33341538|NCT01783678|101141770|FG002|Overall Study|Randomized but Not Treated|0|||
33341539|NCT01783678|101141771|FG003|Overall Study|Randomized but Not Treated|1|||
33341540|NCT01783678|101141772|FG004|Overall Study|Randomized but Not Treated|0|||
33538948|NCT01232283|101871074|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
33538949|NCT01232283|101871075|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
33538950|NCT01232283|101871076|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33538951|NCT01232283|101871077|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33538952|NCT01232283|101871078|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33538953|NCT01232283|101871079|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33538954|NCT01232283|101871080|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33538955|NCT01232283|101871081|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33614866|NCT00704288|102140132|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
33341541|NCT01783678|101141773|FG005|Overall Study|Randomized but Not Treated|0|||
33341542|NCT01783678|101141768|FG000|Overall Study|Lack of Efficacy|1|||
33341543|NCT01783678|101141769|FG001|Overall Study|Lack of Efficacy|13|||
33341544|NCT01783678|101141770|FG002|Overall Study|Lack of Efficacy|1|||
33341545|NCT01783678|101141771|FG003|Overall Study|Lack of Efficacy|3|||
33341546|NCT01783678|101141772|FG004|Overall Study|Lack of Efficacy|6|||
33341547|NCT01783678|101141773|FG005|Overall Study|Lack of Efficacy|5|||
33341548|NCT01783678|101141768|FG000|Overall Study|Lost to Follow-up|0|||
33341549|NCT01783678|101141769|FG001|Overall Study|Lost to Follow-up|4|||
33341550|NCT01783678|101141770|FG002|Overall Study|Lost to Follow-up|0|||
33538956|NCT01232283|101871082|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33631297|NCT03486912|102202915|FG001|Treatment Period|Withdrawal by Subject|3|||
33538957|NCT01232283|101871083|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
33341551|NCT01783678|101141771|FG003|Overall Study|Lost to Follow-up|2|||
33341552|NCT01783678|101141772|FG004|Overall Study|Lost to Follow-up|1|||
33341553|NCT01783678|101141773|FG005|Overall Study|Lost to Follow-up|0|||
33341554|NCT01783678|101141768|FG000|Overall Study|Withdrew Consent|1|||
33538958|NCT01232283|101871074|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33341555|NCT01783678|101141769|FG001|Overall Study|Withdrew Consent|1|||
33341556|NCT01783678|101141770|FG002|Overall Study|Withdrew Consent|0|||
33341557|NCT01783678|101141771|FG003|Overall Study|Withdrew Consent|2|||
33538959|NCT01232283|101871075|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33341558|NCT01783678|101141772|FG004|Overall Study|Withdrew Consent|0|||
33341559|NCT01783678|101141773|FG005|Overall Study|Withdrew Consent|0|||
33341560|NCT03434379|101141774|FG000|Global Period|Lost to Follow-up|3|||
33341561|NCT03434379|101141775|FG001|Global Period|Lost to Follow-up|6|||
33341562|NCT03434379|101141776|FG002|Global Period|Lost to Follow-up|0|||
33341563|NCT03434379|101141777|FG003|Global Period|Lost to Follow-up|0|||
33341564|NCT03434379|101141774|FG000|Global Period|Death|115|||
33341565|NCT03434379|101141775|FG001|Global Period|Death|228|||
33341566|NCT03434379|101141776|FG002|Global Period|Death|0|||
33341567|NCT03434379|101141777|FG003|Global Period|Death|0|||
33341568|NCT03434379|101141774|FG000|Global Period|Withdrawal by Subject|20|||
33341569|NCT03434379|101141775|FG001|Global Period|Withdrawal by Subject|21|||
33341570|NCT03434379|101141776|FG002|Global Period|Withdrawal by Subject|0|||
33341571|NCT03434379|101141777|FG003|Global Period|Withdrawal by Subject|0|||
33341572|NCT03434379|101141774|FG000|Global Period|Reason Unspecified|0|||
33341573|NCT03434379|101141775|FG001|Global Period|Reason Unspecified|1|||
33341574|NCT03434379|101141776|FG002|Global Period|Reason Unspecified|0|||
33341575|NCT03434379|101141777|FG003|Global Period|Reason Unspecified|0|||
33341576|NCT03434379|101141774|FG000|Global Period|Study Ended by Sponsor|26|||
33341577|NCT03434379|101141775|FG001|Global Period|Study Ended by Sponsor|80|||
33341578|NCT03434379|101141776|FG002|Global Period|Study Ended by Sponsor|0|||
33341579|NCT03434379|101141777|FG003|Global Period|Study Ended by Sponsor|0|||
33341580|NCT03434379|101141774|FG000|Global Period|Physician Decision|1|||
33341581|NCT03434379|101141775|FG001|Global Period|Physician Decision|0|||
33341582|NCT03434379|101141776|FG002|Global Period|Physician Decision|0|||
33538960|NCT01232283|101871076|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
33614867|NCT00704288|102140133|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
33614868|NCT00704288|102140134|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
33614869|NCT00704288|102140132|FG000|Extended Post Treatment Follow Up Period|Death|41|||
33614870|NCT00704288|102140133|FG001|Extended Post Treatment Follow Up Period|Death|50|||
33614871|NCT00704288|102140134|FG002|Extended Post Treatment Follow Up Period|Death|93|||
33209714|NCT02564523|100670273|FG016|Overall Study|Adverse Event|0|||
33538961|NCT01232283|101871077|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
33538962|NCT01232283|101871078|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33538963|NCT01232283|101871079|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33538964|NCT01232283|101871080|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33538965|NCT01232283|101871081|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33538966|NCT01232283|101871082|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33538967|NCT01232283|101871083|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
33538968|NCT01232283|101871074|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33538969|NCT01232283|101871075|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33538970|NCT01232283|101871076|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
33538971|NCT01232283|101871077|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
33538972|NCT01232283|101871078|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33538973|NCT01232283|101871079|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33538974|NCT01232283|101871080|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33538975|NCT01232283|101871081|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33538976|NCT01232283|101871082|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33538977|NCT01232283|101871083|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
33538978|NCT01232283|101871074|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33538979|NCT01232283|101871075|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33209715|NCT02564523|100670274|FG017|Overall Study|Adverse Event|1|||
33209716|NCT02564523|100670257|FG000|Overall Study|Death|0|||
33209717|NCT02564523|100670258|FG001|Overall Study|Death|0|||
33209718|NCT02564523|100670259|FG002|Overall Study|Death|0|||
33209719|NCT02564523|100670260|FG003|Overall Study|Death|0|||
33209720|NCT02564523|100670261|FG004|Overall Study|Death|0|||
33209721|NCT02564523|100670262|FG005|Overall Study|Death|0|||
33209722|NCT02564523|100670263|FG006|Overall Study|Death|1|||
33209723|NCT02564523|100670264|FG007|Overall Study|Death|0|||
33341583|NCT03434379|101141777|FG003|Global Period|Physician Decision|0|||
33341584|NCT03434379|101141774|FG000|China Extension Period|Lost to Follow-up|0|||
33538980|NCT01232283|101871076|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
33341585|NCT03434379|101141775|FG001|China Extension Period|Lost to Follow-up|0|||
33341586|NCT03434379|101141776|FG002|China Extension Period|Lost to Follow-up|2|||
33538981|NCT01232283|101871077|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33209724|NCT02564523|100670265|FG008|Overall Study|Death|0|||
33209725|NCT02564523|100670266|FG009|Overall Study|Death|0|||
33209726|NCT02564523|100670267|FG010|Overall Study|Death|1|||
33209727|NCT02564523|100670268|FG011|Overall Study|Death|0|||
33209728|NCT02564523|100670269|FG012|Overall Study|Death|0|||
33341587|NCT03434379|101141777|FG003|China Extension Period|Lost to Follow-up|3|||
33341588|NCT03434379|101141774|FG000|China Extension Period|Death|0|||
33341589|NCT03434379|101141775|FG001|China Extension Period|Death|0|||
33209729|NCT02564523|100670270|FG013|Overall Study|Death|0|||
33209730|NCT02564523|100670271|FG014|Overall Study|Death|0|||
33209731|NCT02564523|100670272|FG015|Overall Study|Death|0|||
33209732|NCT02564523|100670273|FG016|Overall Study|Death|0|||
33406123|NCT01072175|101377551|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33406124|NCT01072175|101377552|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33406125|NCT01072175|101377553|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33406126|NCT01072175|101377554|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33406127|NCT01072175|101377555|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
33406128|NCT01072175|101377543|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
33406129|NCT01072175|101377544|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
33406130|NCT01072175|101377545|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
33406131|NCT01072175|101377546|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
33406132|NCT01072175|101377547|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
33406133|NCT01072175|101377548|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
33406134|NCT01072175|101377549|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
33406135|NCT01072175|101377550|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
33406136|NCT01072175|101377551|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
33406137|NCT01072175|101377552|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
33406138|NCT01072175|101377553|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
33406139|NCT01072175|101377554|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
33406140|NCT01072175|101377555|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
33406141|NCT01072175|101377543|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33538982|NCT01232283|101871078|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33538983|NCT01232283|101871079|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33538984|NCT01232283|101871080|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33538985|NCT01232283|101871081|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33538986|NCT01232283|101871082|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33538987|NCT01232283|101871083|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
33538988|NCT01232283|101871074|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33538989|NCT01232283|101871075|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33538990|NCT01232283|101871076|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
33538991|NCT01232283|101871077|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
33538992|NCT01232283|101871078|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33209733|NCT02564523|100670274|FG017|Overall Study|Death|0|||
33209734|NCT02564523|100670257|FG000|Overall Study|Lost to Follow-up|2|||
33209735|NCT02564523|100670258|FG001|Overall Study|Lost to Follow-up|1|||
33341590|NCT03434379|101141776|FG002|China Extension Period|Death|46|||
33341591|NCT03434379|101141777|FG003|China Extension Period|Death|88|||
33341592|NCT03434379|101141774|FG000|China Extension Period|Withdrawal by Subject|0|||
33341593|NCT03434379|101141775|FG001|China Extension Period|Withdrawal by Subject|0|||
33341594|NCT03434379|101141776|FG002|China Extension Period|Withdrawal by Subject|8|||
33341595|NCT03434379|101141777|FG003|China Extension Period|Withdrawal by Subject|6|||
33341596|NCT03434379|101141774|FG000|China Extension Period|Study Ended by Sponsor|0|||
33341597|NCT03434379|101141775|FG001|China Extension Period|Study Ended by Sponsor|0|||
33341598|NCT03434379|101141776|FG002|China Extension Period|Study Ended by Sponsor|5|||
33341599|NCT03434379|101141777|FG003|China Extension Period|Study Ended by Sponsor|36|||
33341600|NCT01534676|101141780|FG000|Overall Study|Study closed due to poor enrollment|2|||
33341601|NCT01534676|101141781|FG001|Overall Study|Study closed due to poor enrollment|1|||
33341602|NCT01920711|101141782|FG000|Overall Study|Death|347|||
33341603|NCT01920711|101141783|FG001|Overall Study|Death|356|||
33341604|NCT01920711|101141782|FG000|Overall Study|Lost to Follow-up|13|||
33341605|NCT01920711|101141783|FG001|Overall Study|Lost to Follow-up|14|||
33341606|NCT01920711|101141782|FG000|Overall Study|Withdrawal by Subject|4|||
33341607|NCT01920711|101141783|FG001|Overall Study|Withdrawal by Subject|3|||
33341608|NCT02863809|101141790|FG000|Overall Study|Adverse Event|8|||
33341609|NCT02863809|101141791|FG001|Overall Study|Adverse Event|8|||
33341610|NCT02863809|101141790|FG000|Overall Study|Withdrawal by Subject|0|||
33341611|NCT02863809|101141791|FG001|Overall Study|Withdrawal by Subject|1|||
33341612|NCT02863809|101141790|FG000|Overall Study|Lost to Follow-up|1|||
33341613|NCT02863809|101141791|FG001|Overall Study|Lost to Follow-up|1|||
33341614|NCT02863809|101141790|FG000|Overall Study|Death|1|||
33341615|NCT02863809|101141791|FG001|Overall Study|Death|0|||
33341616|NCT01298492|101141793|FG000|Overall Study|Death|2|||
33341617|NCT01298492|101141793|FG000|Overall Study|Insufficient Clinical Response|22|||
33209736|NCT02564523|100670259|FG002|Overall Study|Lost to Follow-up|4|||
33209737|NCT02564523|100670260|FG003|Overall Study|Lost to Follow-up|0|||
33209738|NCT02564523|100670261|FG004|Overall Study|Lost to Follow-up|1|||
33341618|NCT01298492|101141793|FG000|Overall Study|Lost to Follow-up|12|||
33406142|NCT01072175|101377544|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33406143|NCT01072175|101377545|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33209739|NCT02564523|100670262|FG005|Overall Study|Lost to Follow-up|0|||
33341619|NCT01298492|101141793|FG000|Overall Study|Withdrawal by Subject|47|||
33614872|NCT00704288|102140132|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
33614873|NCT00704288|102140133|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
33614874|NCT00704288|102140134|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
33614875|NCT00704288|102140132|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
33614876|NCT00704288|102140133|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
33614877|NCT00704288|102140134|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
33614878|NCT00704288|102140132|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
33614879|NCT00704288|102140133|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
33614880|NCT00704288|102140134|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
33614881|NCT01807299|102140135|FG000|Overall Study|Protocol Violation|3|||
33614882|NCT01807299|102140136|FG001|Overall Study|Protocol Violation|1|||
33614883|NCT01807299|102140137|FG002|Overall Study|Protocol Violation|0|||
33614884|NCT01807299|102140138|FG003|Overall Study|Protocol Violation|2|||
33614885|NCT01711645|102140140|FG000|Overall Study|Withdrawal by Subject|8|||
33614886|NCT01711645|102140140|FG000|Overall Study|Lost to Follow-up|6|||
33614887|NCT01711645|102140140|FG000|Overall Study|Physician Decision|5|||
33614888|NCT01843062|102140141|FG000|Overall Study|Protocol Violation|1|||
33614889|NCT01843062|102140142|FG001|Overall Study|Protocol Violation|0|||
33614890|NCT01843062|102140141|FG000|Overall Study|New treatment following progression|2|||
33614891|NCT01843062|102140142|FG001|Overall Study|New treatment following progression|0|||
33614892|NCT01843062|102140141|FG000|Overall Study|Pregnancy|1|||
33614893|NCT01843062|102140142|FG001|Overall Study|Pregnancy|0|||
33614894|NCT01843062|102140141|FG000|Overall Study|Adverse Event|2|||
33614895|NCT01843062|102140142|FG001|Overall Study|Adverse Event|0|||
33614896|NCT01843062|102140141|FG000|Overall Study|Incorrect randomisation|1|||
33614897|NCT01843062|102140142|FG001|Overall Study|Incorrect randomisation|0|||
33614898|NCT01843062|102140141|FG000|Overall Study|Withdrawal by Subject|12|||
33614899|NCT01843062|102140142|FG001|Overall Study|Withdrawal by Subject|3|||
33614900|NCT01843062|102140141|FG000|Overall Study|Death|1|||
33614901|NCT01843062|102140142|FG001|Overall Study|Death|2|||
33614902|NCT01843062|102140141|FG000|Overall Study|Lost to Follow-up|2|||
33406144|NCT01072175|101377546|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33406145|NCT01072175|101377547|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33406146|NCT01072175|101377548|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
33406147|NCT01072175|101377549|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
33406148|NCT01072175|101377550|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
33614903|NCT01843062|102140142|FG001|Overall Study|Lost to Follow-up|4|||
33614904|NCT04522141|102140143|FG000|Overall Study|Withdrawal by Subject|1|||
33614905|NCT04522141|102140144|FG001|Overall Study|Withdrawal by Subject|0|||
33614906|NCT01415401|102140151|FG000|Overall Study|Adverse Event|5|||
33614907|NCT01415401|102140151|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
33614908|NCT01415401|102140151|FG000|Overall Study|Terminated by Sponsor|1|||
33614909|NCT00423449|102140152|FG000|Overall Study|Clinical Adverse Event|1|||
33614910|NCT00423449|102140153|FG001|Overall Study|Clinical Adverse Event|0|||
33614911|NCT00423449|102140154|FG002|Overall Study|Clinical Adverse Event|1|||
33209740|NCT02564523|100670263|FG006|Overall Study|Lost to Follow-up|1|||
33209741|NCT02564523|100670264|FG007|Overall Study|Lost to Follow-up|0|||
33209742|NCT02564523|100670265|FG008|Overall Study|Lost to Follow-up|0|||
33209743|NCT02564523|100670266|FG009|Overall Study|Lost to Follow-up|0|||
33209744|NCT02564523|100670267|FG010|Overall Study|Lost to Follow-up|0|||
33209745|NCT02564523|100670268|FG011|Overall Study|Lost to Follow-up|1|||
33209746|NCT02564523|100670269|FG012|Overall Study|Lost to Follow-up|1|||
33209747|NCT02564523|100670270|FG013|Overall Study|Lost to Follow-up|0|||
33209748|NCT02564523|100670271|FG014|Overall Study|Lost to Follow-up|0|||
33209749|NCT02564523|100670272|FG015|Overall Study|Lost to Follow-up|0|||
33209750|NCT02564523|100670273|FG016|Overall Study|Lost to Follow-up|0|||
33209751|NCT02564523|100670274|FG017|Overall Study|Lost to Follow-up|0|||
33209752|NCT02564523|100670257|FG000|Overall Study|Physician Decision|0|||
33209753|NCT02564523|100670258|FG001|Overall Study|Physician Decision|0|||
33406149|NCT01072175|101377551|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33406150|NCT01072175|101377552|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33209754|NCT02564523|100670259|FG002|Overall Study|Physician Decision|0|||
33209755|NCT02564523|100670260|FG003|Overall Study|Physician Decision|0|||
33209756|NCT02564523|100670261|FG004|Overall Study|Physician Decision|1|||
33209757|NCT02564523|100670262|FG005|Overall Study|Physician Decision|0|||
33209758|NCT02564523|100670263|FG006|Overall Study|Physician Decision|0|||
33406151|NCT01072175|101377553|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33614912|NCT00423449|102140155|FG003|Overall Study|Clinical Adverse Event|8|||
33209759|NCT02564523|100670264|FG007|Overall Study|Physician Decision|0|||
33209760|NCT02564523|100670265|FG008|Overall Study|Physician Decision|0|||
33209761|NCT02564523|100670266|FG009|Overall Study|Physician Decision|0|||
33614913|NCT00423449|102140156|FG004|Overall Study|Clinical Adverse Event|2|||
33614914|NCT00423449|102140152|FG000|Overall Study|Death|1|||
33614915|NCT00423449|102140153|FG001|Overall Study|Death|0|||
33614916|NCT00423449|102140154|FG002|Overall Study|Death|2|||
33209762|NCT02564523|100670267|FG010|Overall Study|Physician Decision|1|||
33614917|NCT00423449|102140155|FG003|Overall Study|Death|1|||
33614918|NCT00423449|102140156|FG004|Overall Study|Death|1|||
33614919|NCT00423449|102140152|FG000|Overall Study|Progressive Disease|1|||
33614920|NCT00423449|102140153|FG001|Overall Study|Progressive Disease|3|||
33341620|NCT01298492|101141793|FG000|Overall Study|Other (Unspecified)|7|||
33341621|NCT01298492|101141793|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
33341622|NCT01298492|101141793|FG000|Overall Study|Protocol Violation|2|||
33341623|NCT01298492|101141793|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
33341624|NCT01298492|101141793|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
33341625|NCT01543087|101141797|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
33341626|NCT01543087|101141798|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
33341627|NCT01543087|101141799|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
33341628|NCT01543087|101141800|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
33341629|NCT01543087|101141801|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
33341630|NCT01543087|101141802|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
33341631|NCT01543087|101141797|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
33341632|NCT01543087|101141798|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
33341633|NCT01543087|101141799|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
33341634|NCT01543087|101141800|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
33341635|NCT01543087|101141801|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
33341636|NCT01543087|101141802|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
33341637|NCT01543087|101141797|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
33341638|NCT01543087|101141798|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
33341639|NCT01543087|101141799|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
33341640|NCT01543087|101141800|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
33341641|NCT01543087|101141801|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
33341642|NCT01543087|101141802|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
33341643|NCT01543087|101141797|FG000|Stage 1 (48 Months)|Other than specified|5|||
33341644|NCT01543087|101141798|FG001|Stage 1 (48 Months)|Other than specified|0|||
33341645|NCT01543087|101141799|FG002|Stage 1 (48 Months)|Other than specified|9|||
33341646|NCT01543087|101141800|FG003|Stage 1 (48 Months)|Other than specified|0|||
33341647|NCT01543087|101141801|FG004|Stage 1 (48 Months)|Other than specified|0|||
33341648|NCT01543087|101141802|FG005|Stage 1 (48 Months)|Other than specified|0|||
33341649|NCT01543087|101141797|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
33614921|NCT00423449|102140154|FG002|Overall Study|Progressive Disease|8|||
33614922|NCT00423449|102140155|FG003|Overall Study|Progressive Disease|11|||
33341650|NCT01543087|101141798|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
33341651|NCT01543087|101141799|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
33341652|NCT01543087|101141800|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
33341653|NCT01543087|101141801|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
33341654|NCT01543087|101141802|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
33341655|NCT01543087|101141797|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
33341656|NCT01543087|101141798|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
33341657|NCT01543087|101141799|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
33341658|NCT01543087|101141800|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
33341659|NCT01543087|101141801|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
33341660|NCT01543087|101141802|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
33341661|NCT01543087|101141797|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
33341662|NCT01543087|101141798|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
33341663|NCT01543087|101141799|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
33341664|NCT01543087|101141800|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
33341665|NCT01543087|101141801|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
33341666|NCT01543087|101141802|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
33341667|NCT02450487|101141803|FG000|Overall Study|Lost to Follow-up|3|||
33341668|NCT00523991|101141804|FG000|Overall Study|Adverse Event|6|||
33341669|NCT00523991|101141805|FG001|Overall Study|Adverse Event|5|||
33341670|NCT00523991|101141804|FG000|Overall Study|Protocol Violation|1|||
33341671|NCT00523991|101141805|FG001|Overall Study|Protocol Violation|4|||
33341672|NCT00523991|101141804|FG000|Overall Study|Lost to Follow-up|4|||
33341673|NCT00523991|101141805|FG001|Overall Study|Lost to Follow-up|1|||
33341674|NCT00523991|101141804|FG000|Overall Study|Withdrawal by Subject|7|||
33614923|NCT00423449|102140156|FG004|Overall Study|Progressive Disease|4|||
33614924|NCT00423449|102140152|FG000|Overall Study|Laboratory Adverse Event|0|||
33614925|NCT00423449|102140153|FG001|Overall Study|Laboratory Adverse Event|1|||
33614926|NCT00423449|102140154|FG002|Overall Study|Laboratory Adverse Event|2|||
33341675|NCT00523991|101141805|FG001|Overall Study|Withdrawal by Subject|17|||
33341676|NCT00523991|101141804|FG000|Overall Study|Other reason (not specified)|3|||
33341677|NCT00523991|101141805|FG001|Overall Study|Other reason (not specified)|0|||
33614927|NCT00423449|102140155|FG003|Overall Study|Laboratory Adverse Event|0|||
33614928|NCT00423449|102140156|FG004|Overall Study|Laboratory Adverse Event|0|||
33614929|NCT00423449|102140152|FG000|Overall Study|Other|0|||
33614930|NCT00423449|102140153|FG001|Overall Study|Other|0|||
33614931|NCT00423449|102140154|FG002|Overall Study|Other|0|||
33538993|NCT01232283|101871079|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33538994|NCT01232283|101871080|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33538995|NCT01232283|101871081|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33538996|NCT01232283|101871082|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33538997|NCT01232283|101871083|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
33538998|NCT01232283|101871074|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33538999|NCT01232283|101871075|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33614932|NCT00423449|102140155|FG003|Overall Study|Other|1|||
33614933|NCT00423449|102140156|FG004|Overall Study|Other|0|||
33614934|NCT00423449|102140152|FG000|Overall Study|Protocol Violation|0|||
33614935|NCT00423449|102140153|FG001|Overall Study|Protocol Violation|0|||
33614936|NCT00423449|102140154|FG002|Overall Study|Protocol Violation|2|||
33614937|NCT00423449|102140155|FG003|Overall Study|Protocol Violation|1|||
33209763|NCT02564523|100670268|FG011|Overall Study|Physician Decision|0|||
33209764|NCT02564523|100670269|FG012|Overall Study|Physician Decision|0|||
33209765|NCT02564523|100670270|FG013|Overall Study|Physician Decision|0|||
33209766|NCT02564523|100670271|FG014|Overall Study|Physician Decision|0|||
33209767|NCT02564523|100670272|FG015|Overall Study|Physician Decision|0|||
33209768|NCT02564523|100670273|FG016|Overall Study|Physician Decision|0|||
33209769|NCT02564523|100670274|FG017|Overall Study|Physician Decision|0|||
33209770|NCT02564523|100670257|FG000|Overall Study|Protocol Violation|2|||
33209771|NCT02564523|100670258|FG001|Overall Study|Protocol Violation|2|||
33209772|NCT02564523|100670259|FG002|Overall Study|Protocol Violation|5|||
33341678|NCT03245450|101141806|FG000|Overall Study|Radiological disease progression|3|||
33341679|NCT03245450|101141807|FG001|Overall Study|Radiological disease progression|3|||
33341680|NCT03245450|101141808|FG002|Overall Study|Radiological disease progression|2|||
33341681|NCT03245450|101141809|FG003|Overall Study|Radiological disease progression|2|||
33341682|NCT03245450|101141810|FG004|Overall Study|Radiological disease progression|7|||
33341683|NCT03245450|101141811|FG005|Overall Study|Radiological disease progression|6|||
33341684|NCT03245450|101141812|FG006|Overall Study|Radiological disease progression|6|||
33341685|NCT03245450|101141806|FG000|Overall Study|Clinical disease progression|0|||
33341686|NCT03245450|101141807|FG001|Overall Study|Clinical disease progression|0|||
33341687|NCT03245450|101141808|FG002|Overall Study|Clinical disease progression|1|||
33539000|NCT01232283|101871076|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
33539001|NCT01232283|101871077|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
33539002|NCT01232283|101871078|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33539003|NCT01232283|101871079|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33539004|NCT01232283|101871080|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33539005|NCT01232283|101871081|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33539006|NCT01232283|101871082|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33539007|NCT01232283|101871083|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
33539008|NCT01232283|101871074|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
33539009|NCT01232283|101871075|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
33539010|NCT01232283|101871076|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
33539011|NCT01232283|101871077|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
33539012|NCT01232283|101871078|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
33539013|NCT01232283|101871079|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
33539014|NCT01232283|101871080|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
33539015|NCT01232283|101871081|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
33539016|NCT01232283|101871082|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
33539017|NCT01232283|101871083|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
33539018|NCT01232283|101871074|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
33539019|NCT01232283|101871075|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
33539020|NCT01232283|101871076|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
33539021|NCT01232283|101871077|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
33539022|NCT01232283|101871078|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
33539023|NCT01232283|101871079|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
33539024|NCT01232283|101871080|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
33539025|NCT01232283|101871081|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
33539026|NCT01232283|101871082|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
33539027|NCT01232283|101871083|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
33539028|NCT01232283|101871074|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
33539029|NCT01232283|101871075|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
33539030|NCT01232283|101871076|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
33539031|NCT01232283|101871077|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
33614938|NCT00423449|102140156|FG004|Overall Study|Protocol Violation|0|||
33209773|NCT02564523|100670260|FG003|Overall Study|Protocol Violation|0|||
33209774|NCT02564523|100670261|FG004|Overall Study|Protocol Violation|1|||
33209775|NCT02564523|100670262|FG005|Overall Study|Protocol Violation|0|||
33209776|NCT02564523|100670263|FG006|Overall Study|Protocol Violation|0|||
33209777|NCT02564523|100670264|FG007|Overall Study|Protocol Violation|0|||
33341688|NCT03245450|101141809|FG003|Overall Study|Clinical disease progression|0|||
33341689|NCT03245450|101141810|FG004|Overall Study|Clinical disease progression|0|||
33341690|NCT03245450|101141811|FG005|Overall Study|Clinical disease progression|2|||
33341691|NCT03245450|101141812|FG006|Overall Study|Clinical disease progression|0|||
33341692|NCT03245450|101141806|FG000|Overall Study|Other|0|||
33341693|NCT03245450|101141807|FG001|Overall Study|Other|0|||
33341694|NCT03245450|101141808|FG002|Overall Study|Other|0|||
33341695|NCT03245450|101141809|FG003|Overall Study|Other|1|||
33341696|NCT03245450|101141810|FG004|Overall Study|Other|1|||
33341697|NCT03245450|101141811|FG005|Overall Study|Other|1|||
33341698|NCT03245450|101141812|FG006|Overall Study|Other|1|||
33341699|NCT03245450|101141806|FG000|Overall Study|Withdrawal by Subject|0|||
33341700|NCT03245450|101141807|FG001|Overall Study|Withdrawal by Subject|1|||
33341701|NCT03245450|101141808|FG002|Overall Study|Withdrawal by Subject|0|||
33341702|NCT03245450|101141809|FG003|Overall Study|Withdrawal by Subject|0|||
33341703|NCT03245450|101141810|FG004|Overall Study|Withdrawal by Subject|0|||
33341704|NCT03245450|101141811|FG005|Overall Study|Withdrawal by Subject|0|||
33341705|NCT03245450|101141812|FG006|Overall Study|Withdrawal by Subject|0|||
33341706|NCT03245450|101141806|FG000|Overall Study|Adverse Event|0|||
33341707|NCT03245450|101141807|FG001|Overall Study|Adverse Event|0|||
33209778|NCT02564523|100670265|FG008|Overall Study|Protocol Violation|0|||
33341708|NCT03245450|101141808|FG002|Overall Study|Adverse Event|0|||
33341709|NCT03245450|101141809|FG003|Overall Study|Adverse Event|0|||
33341710|NCT03245450|101141810|FG004|Overall Study|Adverse Event|1|||
33341711|NCT03245450|101141811|FG005|Overall Study|Adverse Event|0|||
33341712|NCT03245450|101141812|FG006|Overall Study|Adverse Event|2|||
33341713|NCT01995071|101141813|FG000|Overall Study|Adverse Event|0|||
33341714|NCT01995071|101141814|FG001|Overall Study|Adverse Event|0|||
33341715|NCT01995071|101141815|FG002|Overall Study|Adverse Event|0|||
33341716|NCT01995071|101141816|FG003|Overall Study|Adverse Event|0|||
33341717|NCT01995071|101141817|FG004|Overall Study|Adverse Event|0|||
33341718|NCT01995071|101141818|FG005|Overall Study|Adverse Event|0|||
33341719|NCT01995071|101141819|FG006|Overall Study|Adverse Event|1|||
33341720|NCT01995071|101141820|FG007|Overall Study|Adverse Event|0|||
33341721|NCT01995071|101141821|FG008|Overall Study|Adverse Event|0|||
33341722|NCT01995071|101141822|FG009|Overall Study|Adverse Event|0|||
33341723|NCT01995071|101141823|FG010|Overall Study|Adverse Event|0|||
33341724|NCT01995071|101141824|FG011|Overall Study|Adverse Event|0|||
33341725|NCT01995071|101141813|FG000|Overall Study|Moved|0|||
33341726|NCT01995071|101141814|FG001|Overall Study|Moved|0|||
33341727|NCT01995071|101141815|FG002|Overall Study|Moved|1|||
33341728|NCT01995071|101141816|FG003|Overall Study|Moved|0|||
33341729|NCT01995071|101141817|FG004|Overall Study|Moved|1|||
33341730|NCT01995071|101141818|FG005|Overall Study|Moved|0|||
33341731|NCT01995071|101141819|FG006|Overall Study|Moved|0|||
33341732|NCT01995071|101141820|FG007|Overall Study|Moved|0|||
33341733|NCT01995071|101141821|FG008|Overall Study|Moved|0|||
33341734|NCT01995071|101141822|FG009|Overall Study|Moved|0|||
33341735|NCT01995071|101141823|FG010|Overall Study|Moved|1|||
33341736|NCT01995071|101141824|FG011|Overall Study|Moved|0|||
33341737|NCT01995071|101141813|FG000|Overall Study|Lost to Follow-up|1|||
33341738|NCT01995071|101141814|FG001|Overall Study|Lost to Follow-up|0|||
33341739|NCT01995071|101141815|FG002|Overall Study|Lost to Follow-up|0|||
33341740|NCT01995071|101141816|FG003|Overall Study|Lost to Follow-up|0|||
33341741|NCT01995071|101141817|FG004|Overall Study|Lost to Follow-up|0|||
33341742|NCT01995071|101141818|FG005|Overall Study|Lost to Follow-up|0|||
33341743|NCT01995071|101141819|FG006|Overall Study|Lost to Follow-up|0|||
33341744|NCT01995071|101141820|FG007|Overall Study|Lost to Follow-up|1|||
33341745|NCT01995071|101141821|FG008|Overall Study|Lost to Follow-up|1|||
33341746|NCT01995071|101141822|FG009|Overall Study|Lost to Follow-up|0|||
33341747|NCT01995071|101141823|FG010|Overall Study|Lost to Follow-up|0|||
33341748|NCT01995071|101141824|FG011|Overall Study|Lost to Follow-up|0|||
33341749|NCT01995071|101141813|FG000|Overall Study|Incarcerated|0|||
33341750|NCT01995071|101141814|FG001|Overall Study|Incarcerated|0|||
33341751|NCT01995071|101141815|FG002|Overall Study|Incarcerated|0|||
33341752|NCT01995071|101141816|FG003|Overall Study|Incarcerated|0|||
33341753|NCT01995071|101141817|FG004|Overall Study|Incarcerated|0|||
33341754|NCT01995071|101141818|FG005|Overall Study|Incarcerated|0|||
33341755|NCT01995071|101141819|FG006|Overall Study|Incarcerated|0|||
33341756|NCT01995071|101141820|FG007|Overall Study|Incarcerated|1|||
33341757|NCT01995071|101141821|FG008|Overall Study|Incarcerated|0|||
33341758|NCT01995071|101141822|FG009|Overall Study|Incarcerated|0|||
33341759|NCT01995071|101141823|FG010|Overall Study|Incarcerated|0|||
33341760|NCT01995071|101141824|FG011|Overall Study|Incarcerated|0|||
33341761|NCT00391222|101141825|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
33341762|NCT00391222|101141826|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
33341763|NCT00391222|101141827|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
33341764|NCT00391222|101141828|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
33341765|NCT00391222|101141825|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
33539032|NCT01232283|101871078|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
33539033|NCT01232283|101871079|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
33539034|NCT01232283|101871080|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
33539035|NCT01232283|101871081|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
33539036|NCT01232283|101871082|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
33539037|NCT01232283|101871083|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
33539038|NCT01232283|101871074|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
33539039|NCT01232283|101871075|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
33539040|NCT01232283|101871076|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
33539041|NCT01232283|101871077|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
33539042|NCT01232283|101871078|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
33539043|NCT01232283|101871079|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
33341766|NCT00391222|101141826|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
33341767|NCT00391222|101141827|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
33341768|NCT00391222|101141828|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
33341769|NCT00391222|101141825|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
33341770|NCT00391222|101141826|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
33341771|NCT00391222|101141827|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
33341772|NCT00391222|101141828|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
33341773|NCT00391222|101141825|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
33341774|NCT00391222|101141826|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
33341775|NCT00391222|101141827|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
33341776|NCT00391222|101141828|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
33341777|NCT00391222|101141825|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
33341778|NCT00391222|101141826|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
33341779|NCT00391222|101141827|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
33341780|NCT00391222|101141828|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
33341781|NCT00391222|101141825|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
33406152|NCT01072175|101377554|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33341782|NCT00391222|101141826|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
33341783|NCT00391222|101141827|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
33341784|NCT00391222|101141828|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
33341785|NCT00391222|101141825|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
33341786|NCT00391222|101141826|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
33341787|NCT00391222|101141827|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
33341788|NCT00391222|101141828|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
33341789|NCT00391222|101141825|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
33341790|NCT00391222|101141826|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
33341791|NCT00391222|101141827|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
33341792|NCT00391222|101141828|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
33341793|NCT00391222|101141825|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
33341794|NCT00391222|101141826|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
33341795|NCT00391222|101141827|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
33341796|NCT00391222|101141828|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
33341797|NCT00391222|101141825|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
33341798|NCT00391222|101141826|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
33341799|NCT00391222|101141827|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
33406153|NCT01072175|101377555|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
33406154|NCT01072175|101377543|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33406155|NCT01072175|101377544|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33406156|NCT01072175|101377545|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33406157|NCT01072175|101377546|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33341800|NCT00391222|101141828|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
33539044|NCT01232283|101871080|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
33539045|NCT01232283|101871081|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
33539046|NCT01232283|101871082|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
33539047|NCT01232283|101871083|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
33539048|NCT01232283|101871074|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33539049|NCT01232283|101871075|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33539050|NCT01232283|101871076|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33539051|NCT01232283|101871077|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33539052|NCT01232283|101871078|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
33539053|NCT01232283|101871079|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33539054|NCT01232283|101871080|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33539055|NCT01232283|101871081|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33539056|NCT01232283|101871082|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33539057|NCT01232283|101871083|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
33539058|NCT01232283|101871074|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
33539059|NCT01232283|101871075|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
33539060|NCT01232283|101871076|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
33539061|NCT01232283|101871077|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
33539062|NCT01232283|101871078|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
33539063|NCT01232283|101871079|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
33539064|NCT01232283|101871080|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
33539065|NCT01232283|101871081|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
33539066|NCT01232283|101871082|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
33539067|NCT01232283|101871083|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
33539068|NCT01232283|101871074|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33539069|NCT01232283|101871075|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33539070|NCT01232283|101871076|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33539071|NCT01232283|101871077|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33539072|NCT01232283|101871078|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33539073|NCT01232283|101871079|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33539074|NCT01232283|101871080|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33539075|NCT01232283|101871081|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
33539076|NCT01232283|101871082|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33539077|NCT01232283|101871083|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
33341801|NCT00391222|101141825|FG000|Period III (Double-Blind Treatment)|Other|6|||
33341802|NCT00391222|101141826|FG001|Period III (Double-Blind Treatment)|Other|1|||
33341803|NCT00391222|101141827|FG002|Period III (Double-Blind Treatment)|Other|6|||
33341804|NCT00391222|101141828|FG003|Period III (Double-Blind Treatment)|Other|0|||
33341805|NCT01162421|101141829|FG000|Overall Study|Did not receive study drug|2|||
33341806|NCT01162421|101141830|FG001|Overall Study|Did not receive study drug|1|||
33341807|NCT01162421|101141829|FG000|Overall Study|Adverse Event|2|||
33341808|NCT01162421|101141830|FG001|Overall Study|Adverse Event|5|||
33341809|NCT01162421|101141829|FG000|Overall Study|Lost to Follow-up|0|||
33341810|NCT01162421|101141830|FG001|Overall Study|Lost to Follow-up|2|||
33341811|NCT01162421|101141829|FG000|Overall Study|Lack of Efficacy|2|||
33341812|NCT01162421|101141830|FG001|Overall Study|Lack of Efficacy|2|||
33341813|NCT01162421|101141829|FG000|Overall Study|Other|2|||
33341814|NCT01162421|101141830|FG001|Overall Study|Other|3|||
33341815|NCT02154087|101141833|FG000|Overall Study|Study Termination|1|||
33341816|NCT01046877|101141834|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
33341817|NCT01046877|101141834|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
33341818|NCT01847885|101141835|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
33341819|NCT01847885|101141836|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
33341820|NCT01847885|101141837|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
33341821|NCT01847885|101141835|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
33341822|NCT01847885|101141836|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
33341823|NCT01847885|101141837|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
33341824|NCT01847885|101141835|FG000|Initial Enrollment (Consented)|Screen failure|39|||
33341825|NCT01847885|101141836|FG001|Initial Enrollment (Consented)|Screen failure|0|||
33341826|NCT01847885|101141837|FG002|Initial Enrollment (Consented)|Screen failure|0|||
33341827|NCT01847885|101141835|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
33341828|NCT01847885|101141836|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
33406158|NCT01072175|101377547|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33539078|NCT01232283|101871074|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33539079|NCT01232283|101871075|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33539080|NCT01232283|101871076|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33539081|NCT01232283|101871077|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33539082|NCT01232283|101871078|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33539083|NCT01232283|101871079|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
33539084|NCT01232283|101871080|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33539085|NCT01232283|101871081|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33539086|NCT01232283|101871082|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33539087|NCT01232283|101871083|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
33539088|NCT01232283|101871074|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33539089|NCT01232283|101871075|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33539090|NCT01232283|101871076|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33539091|NCT01232283|101871077|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33539092|NCT01232283|101871078|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33539093|NCT01232283|101871079|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33539094|NCT01232283|101871080|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33539095|NCT01232283|101871081|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
33539096|NCT01232283|101871082|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
33539097|NCT01232283|101871083|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
33539098|NCT01232283|101871074|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33539099|NCT01232283|101871075|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33539100|NCT01232283|101871076|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33539101|NCT01232283|101871077|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33539102|NCT01232283|101871078|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33539103|NCT01232283|101871079|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33539104|NCT01232283|101871080|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33539105|NCT01232283|101871081|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
33539106|NCT01232283|101871082|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
33539107|NCT01232283|101871083|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
33341829|NCT01847885|101141837|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
33341830|NCT01847885|101141835|FG000|Randomization|Protocol Violation|0|||
33341831|NCT01847885|101141836|FG001|Randomization|Protocol Violation|1|||
33341832|NCT01847885|101141837|FG002|Randomization|Protocol Violation|0|||
33341833|NCT01847885|101141835|FG000|Randomization|Withdrawal by Subject|0|||
33341834|NCT01847885|101141836|FG001|Randomization|Withdrawal by Subject|0|||
33341835|NCT01847885|101141837|FG002|Randomization|Withdrawal by Subject|2|||
33341836|NCT01847885|101141835|FG000|Randomization|Screen Failure|0|||
33341837|NCT01847885|101141836|FG001|Randomization|Screen Failure|3|||
33341838|NCT01847885|101141837|FG002|Randomization|Screen Failure|0|||
33341839|NCT02867995|101141838|FG000|Overall Study|Withdrawal by Subject|0|||
33341840|NCT02867995|101141839|FG001|Overall Study|Withdrawal by Subject|1|||
33341841|NCT02867995|101141838|FG000|Overall Study|Lost to Follow-up|0|||
33341842|NCT02867995|101141839|FG001|Overall Study|Lost to Follow-up|2|||
33341843|NCT02526550|101141840|FG000|Overall Study|Lost to Follow-up|1|||
33341844|NCT01465659|101141841|FG000|Completed 1 Cycle of Treatment|Death|0|||
33341845|NCT01465659|101141842|FG001|Completed 1 Cycle of Treatment|Death|1|||
33341846|NCT01465659|101141843|FG002|Completed 1 Cycle of Treatment|Death|0|||
33341847|NCT01465659|101141844|FG003|Completed 1 Cycle of Treatment|Death|0|||
33341848|NCT01465659|101141841|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
33341849|NCT01465659|101141842|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
33341850|NCT01465659|101141843|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
33341851|NCT01465659|101141844|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
33341852|NCT01465659|101141841|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
33341853|NCT01465659|101141842|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
33341854|NCT01465659|101141843|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
33539108|NCT01232283|101871074|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33539109|NCT01232283|101871075|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33539110|NCT01232283|101871076|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33341855|NCT01465659|101141844|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
33341856|NCT01465659|101141841|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
33341857|NCT01465659|101141842|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
33341858|NCT01465659|101141843|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
33341859|NCT01465659|101141844|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
33341860|NCT01465659|101141841|FG000|Completed Follow for 1 Year|Death|6|||
33341861|NCT01465659|101141842|FG001|Completed Follow for 1 Year|Death|3|||
33341862|NCT01465659|101141843|FG002|Completed Follow for 1 Year|Death|2|||
33341863|NCT01465659|101141844|FG003|Completed Follow for 1 Year|Death|4|||
33341864|NCT00684957|101141845|FG000|Overall Study|Withdrawal by Subject|1|||
33341865|NCT00684957|101141846|FG001|Overall Study|Withdrawal by Subject|1|||
33341866|NCT00684957|101141845|FG000|Overall Study|Lost to Follow-up|1|||
33341867|NCT00684957|101141846|FG001|Overall Study|Lost to Follow-up|0|||
33341868|NCT01583374|101141847|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
33341869|NCT01583374|101141848|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
33341870|NCT01583374|101141849|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
33341871|NCT01583374|101141850|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33341872|NCT01583374|101141851|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33341873|NCT01583374|101141852|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33341874|NCT01583374|101141853|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33341875|NCT01583374|101141854|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33341876|NCT01583374|101141855|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
33341877|NCT01583374|101141847|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
33341878|NCT01583374|101141848|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
33341879|NCT01583374|101141849|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
33341880|NCT01583374|101141850|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33341881|NCT01583374|101141851|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33341882|NCT01583374|101141852|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33341883|NCT01583374|101141853|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33341884|NCT01583374|101141854|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33341885|NCT01583374|101141855|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
33341886|NCT01583374|101141847|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
33341887|NCT01583374|101141848|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
33341888|NCT01583374|101141849|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33341889|NCT01583374|101141850|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33341890|NCT01583374|101141851|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33341891|NCT01583374|101141852|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33341892|NCT01583374|101141853|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33341893|NCT01583374|101141854|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33341894|NCT01583374|101141855|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
33341895|NCT01583374|101141847|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
33341896|NCT01583374|101141848|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
33341897|NCT01583374|101141849|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
33406159|NCT01072175|101377548|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33406160|NCT01072175|101377549|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
33406161|NCT01072175|101377550|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
33406162|NCT01072175|101377551|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33406163|NCT01072175|101377552|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33406164|NCT01072175|101377553|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33406165|NCT01072175|101377554|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33539111|NCT01232283|101871077|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33539112|NCT01232283|101871078|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33539113|NCT01232283|101871079|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33539114|NCT01232283|101871080|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33539115|NCT01232283|101871081|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
33539116|NCT01232283|101871082|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
33539117|NCT01232283|101871083|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
33539118|NCT01232283|101871074|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33539119|NCT01232283|101871075|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33539120|NCT01232283|101871076|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33614939|NCT00303485|102140157|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
33614940|NCT00303485|102140158|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
33614941|NCT00303485|102140157|FG000|Overall Study|Failure to return|0|||
33614942|NCT00303485|102140158|FG001|Overall Study|Failure to return|1|||
33614943|NCT00303485|102140157|FG000|Overall Study|Withdrawal by Subject|1|||
33614944|NCT00303485|102140158|FG001|Overall Study|Withdrawal by Subject|0|||
33614945|NCT00319254|102140162|FG000|Overall Study|Withdrawal by Subject|4|||
33614946|NCT00319254|102140162|FG000|Overall Study|Death|46|||
33614947|NCT00319254|102140162|FG000|Overall Study|Lost to Follow-up|2|||
33614948|NCT00319254|102140162|FG000|Overall Study|Enrolled, Not Treated|2|||
33341898|NCT01583374|101141850|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33341899|NCT01583374|101141851|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33341900|NCT01583374|101141852|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33341901|NCT01583374|101141853|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33341902|NCT01583374|101141854|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33341903|NCT01583374|101141855|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
33341904|NCT01583374|101141847|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
33341905|NCT01583374|101141848|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
33341906|NCT01583374|101141849|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
33341907|NCT01583374|101141850|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
33341908|NCT01583374|101141851|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
33341909|NCT01583374|101141852|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
33341910|NCT01583374|101141853|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
33614949|NCT00705367|102140163|FG000|Long-term Extension Period|Adverse Event|2|||
33341911|NCT01583374|101141854|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
33341912|NCT01583374|101141855|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
33341913|NCT01583374|101141847|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33341914|NCT01583374|101141848|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33341915|NCT01583374|101141849|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
33341916|NCT01583374|101141850|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33341917|NCT01583374|101141851|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33341918|NCT01583374|101141852|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33341919|NCT01583374|101141853|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33614950|NCT00705367|102140164|FG001|Long-term Extension Period|Adverse Event|0|||
33614951|NCT00705367|102140163|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
33614952|NCT00705367|102140164|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
33614953|NCT00705367|102140163|FG000|Long-term Extension Period|Lack of Efficacy|1|||
33614954|NCT00705367|102140164|FG001|Long-term Extension Period|Lack of Efficacy|0|||
33614955|NCT00705367|102140163|FG000|Long-term Extension Period|No longer met study criteria|1|||
33614956|NCT00705367|102140164|FG001|Long-term Extension Period|No longer met study criteria|0|||
33614957|NCT00705367|102140163|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
33614958|NCT00705367|102140164|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
33614959|NCT02279095|102140167|FG000|Overall Study|Non-Compliance|1|||
33614960|NCT02279095|102140167|FG000|Overall Study|Withdrawal by Subject|8|||
33614961|NCT02279095|102140167|FG000|Overall Study|Adverse Event|2|||
33614962|NCT02279095|102140167|FG000|Overall Study|Other|7|||
33614963|NCT02279095|102140167|FG000|Overall Study|Lost to Follow-up|1|||
33614964|NCT00709618|102140168|FG000|Overall Study|Withdrawal by Subject|4|||
33614965|NCT00709618|102140168|FG000|Overall Study|Lost to Follow-up|1|||
33614966|NCT00709618|102140168|FG000|Overall Study|Study Closed/Terminated|25|||
33614967|NCT02978833|102140169|FG000|Overall Study|Study terminated|1|||
33614968|NCT02978833|102140170|FG001|Overall Study|Study terminated|1|||
33614969|NCT00595478|102140171|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
33614970|NCT00595478|102140172|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
33614971|NCT00595478|102140171|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
33614972|NCT00595478|102140172|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
33614973|NCT02451124|102140173|FG000|Overall Study|Withdrawal by Subject|1|||
33614974|NCT01378325|102140174|FG000|Overall Study|Protocol Violation|0|||
33614975|NCT01378325|102140175|FG001|Overall Study|Protocol Violation|1|||
33614976|NCT00358436|102140180|FG000|Overall Study|Adverse Event|29|||
33614977|NCT00358436|102140181|FG001|Overall Study|Adverse Event|13|||
33614978|NCT00358436|102140180|FG000|Overall Study|Lack of Efficacy|34|||
33614979|NCT00358436|102140181|FG001|Overall Study|Lack of Efficacy|36|||
33614980|NCT00358436|102140180|FG000|Overall Study|Lost to Follow-up|11|||
33614981|NCT00358436|102140181|FG001|Overall Study|Lost to Follow-up|6|||
33614982|NCT00358436|102140180|FG000|Overall Study|Protocol Violation|8|||
33341920|NCT01583374|101141854|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33341921|NCT01583374|101141855|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
33341922|NCT01583374|101141847|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
33341923|NCT01583374|101141848|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
33341924|NCT01583374|101141849|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
33341925|NCT01583374|101141850|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
33341926|NCT01583374|101141851|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
33341927|NCT01583374|101141852|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
33341928|NCT01583374|101141853|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
33341929|NCT01583374|101141854|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
33341930|NCT01583374|101141855|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
33341931|NCT01583374|101141847|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33341932|NCT01583374|101141848|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33341933|NCT01583374|101141849|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33341934|NCT01583374|101141850|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33341935|NCT01583374|101141851|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33341936|NCT01583374|101141852|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33341937|NCT01583374|101141853|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33341938|NCT01583374|101141854|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
33341939|NCT01583374|101141855|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33341940|NCT01583374|101141847|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
33341941|NCT01583374|101141848|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
33341942|NCT01583374|101141849|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
33341943|NCT01583374|101141850|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
33341944|NCT01583374|101141851|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
33341945|NCT01583374|101141852|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
33341946|NCT01583374|101141853|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
33341947|NCT01583374|101141854|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
33341948|NCT01583374|101141855|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
33341949|NCT01583374|101141847|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
33406166|NCT01072175|101377555|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
33406167|NCT01072175|101377543|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33614983|NCT00358436|102140181|FG001|Overall Study|Protocol Violation|3|||
33614984|NCT00358436|102140180|FG000|Overall Study|Withdrawal by Subject|40|||
33614985|NCT00358436|102140181|FG001|Overall Study|Withdrawal by Subject|17|||
33614986|NCT00358436|102140180|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
33614987|NCT00358436|102140181|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
33614988|NCT00358436|102140180|FG000|Overall Study|COPD exacerbation|22|||
33614989|NCT00358436|102140181|FG001|Overall Study|COPD exacerbation|10|||
33614990|NCT00358436|102140180|FG000|Overall Study|Other|6|||
33614991|NCT00358436|102140181|FG001|Overall Study|Other|1|||
33614992|NCT00320515|102140189|FG000|Overall Study|Death|33|||
33614993|NCT00320515|102140189|FG000|Overall Study|Lost to Follow-up|6|||
33614994|NCT00320515|102140189|FG000|Overall Study|Physician Decision|2|||
33614995|NCT00320515|102140189|FG000|Overall Study|Withdrawal by Subject|8|||
33614996|NCT01067144|102140190|FG000|Treatment|Did not receive allocated intervention|4|||
33614997|NCT01067144|102140191|FG001|Treatment|Did not receive allocated intervention|7|||
33614998|NCT01067144|102140190|FG000|Follow-up|Lost to Follow-up|22|||
33614999|NCT01067144|102140191|FG001|Follow-up|Lost to Follow-up|12|||
33615000|NCT01067144|102140190|FG000|Follow-up|Censored owing to second surgery|19|||
33615001|NCT01067144|102140191|FG001|Follow-up|Censored owing to second surgery|28|||
33615002|NCT01067144|102140190|FG000|Follow-up|Withdrawal by Subject|18|||
33615003|NCT01067144|102140191|FG001|Follow-up|Withdrawal by Subject|14|||
33615004|NCT01067144|102140190|FG000|Follow-up|Surgery cancelled|0|||
33615005|NCT01067144|102140191|FG001|Follow-up|Surgery cancelled|1|||
33615006|NCT01067144|102140190|FG000|Follow-up|Death|0|||
33615007|NCT01067144|102140191|FG001|Follow-up|Death|1|||
33615008|NCT02008227|102140192|FG000|Overall Study|Lost to Follow-up|7|||
33615009|NCT02008227|102140193|FG001|Overall Study|Lost to Follow-up|9|||
33615010|NCT02008227|102140192|FG000|Overall Study|Death|494|||
33615011|NCT02008227|102140193|FG001|Overall Study|Death|485|||
33615012|NCT02008227|102140192|FG000|Overall Study|Withdrawal by Subject|67|||
33615013|NCT02008227|102140193|FG001|Overall Study|Withdrawal by Subject|36|||
33615014|NCT02008227|102140192|FG000|Overall Study|Study Terminated By Sponsor|44|||
33615015|NCT02008227|102140193|FG001|Overall Study|Study Terminated By Sponsor|83|||
33341950|NCT01583374|101141848|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
33341951|NCT01583374|101141849|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
33615016|NCT01625000|102140194|FG000|Overall Study|Physician Decision|15|||
33615017|NCT01625000|102140195|FG001|Overall Study|Physician Decision|7|||
33615018|NCT01625000|102140196|FG002|Overall Study|Physician Decision|7|||
33615019|NCT01625000|102140197|FG003|Overall Study|Physician Decision|2|||
33615020|NCT01625000|102140198|FG004|Overall Study|Physician Decision|15|||
33615021|NCT01625000|102140194|FG000|Overall Study|Protocol Violation|3|||
33615022|NCT01625000|102140195|FG001|Overall Study|Protocol Violation|10|||
33615023|NCT01625000|102140196|FG002|Overall Study|Protocol Violation|4|||
33615024|NCT01625000|102140197|FG003|Overall Study|Protocol Violation|1|||
33615025|NCT01625000|102140198|FG004|Overall Study|Protocol Violation|2|||
33615026|NCT01625000|102140194|FG000|Overall Study|Withdrawal by Subject|19|||
33615027|NCT01625000|102140195|FG001|Overall Study|Withdrawal by Subject|16|||
33615028|NCT01625000|102140196|FG002|Overall Study|Withdrawal by Subject|11|||
33615029|NCT01625000|102140197|FG003|Overall Study|Withdrawal by Subject|9|||
33615030|NCT01625000|102140198|FG004|Overall Study|Withdrawal by Subject|17|||
33615031|NCT01625000|102140194|FG000|Overall Study|Adverse Event (including Death)|15|||
33615032|NCT01625000|102140195|FG001|Overall Study|Adverse Event (including Death)|19|||
33615033|NCT01625000|102140196|FG002|Overall Study|Adverse Event (including Death)|11|||
33615034|NCT01625000|102140197|FG003|Overall Study|Adverse Event (including Death)|7|||
33615035|NCT01625000|102140198|FG004|Overall Study|Adverse Event (including Death)|21|||
33615036|NCT00741013|102140200|FG000|Overall Study|Adverse Event|1|||
33341952|NCT01583374|101141850|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
33615037|NCT00741013|102140201|FG001|Overall Study|Adverse Event|0|||
33615038|NCT00741013|102140202|FG002|Overall Study|Adverse Event|0|||
33539121|NCT01232283|101871077|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33539122|NCT01232283|101871078|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33539123|NCT01232283|101871079|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33539124|NCT01232283|101871080|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33539125|NCT01232283|101871081|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
33539126|NCT01232283|101871082|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
33539127|NCT01232283|101871083|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
33539128|NCT01232283|101871074|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33539129|NCT01232283|101871075|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33539130|NCT01232283|101871076|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33539131|NCT01232283|101871077|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33539132|NCT01232283|101871078|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33539133|NCT01232283|101871079|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33539134|NCT01232283|101871080|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33539135|NCT01232283|101871081|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
33539136|NCT01232283|101871082|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
33539137|NCT01232283|101871083|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
33539138|NCT01232283|101871074|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33539139|NCT01232283|101871075|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33539140|NCT01232283|101871076|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33539141|NCT01232283|101871077|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33539142|NCT01232283|101871078|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33539143|NCT01232283|101871079|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33539144|NCT01232283|101871080|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33539145|NCT01232283|101871081|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33539146|NCT01232283|101871082|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
33539147|NCT01232283|101871083|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
33539148|NCT01232283|101871074|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33539149|NCT01232283|101871075|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33539150|NCT01232283|101871076|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33539151|NCT01232283|101871077|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33539152|NCT01232283|101871078|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33615039|NCT00741013|102140200|FG000|Overall Study|Withdrawal by Subject|0|||
33341953|NCT01583374|101141851|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
33341954|NCT01583374|101141852|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
33341955|NCT01583374|101141853|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
33341956|NCT01583374|101141854|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
33341957|NCT01583374|101141855|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
33341958|NCT01583374|101141847|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
33341959|NCT01583374|101141848|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
33341960|NCT01583374|101141849|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
33341961|NCT01583374|101141850|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
33341962|NCT01583374|101141851|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
33341963|NCT01583374|101141852|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
33341964|NCT01583374|101141853|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
33341965|NCT01583374|101141854|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
33341966|NCT01583374|101141855|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
33341967|NCT01583374|101141847|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
33341968|NCT01583374|101141848|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
33341969|NCT01583374|101141849|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
33341970|NCT01583374|101141850|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
33341971|NCT01583374|101141851|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
33341972|NCT01583374|101141852|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
33341973|NCT01583374|101141853|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
33341974|NCT01583374|101141854|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
33341975|NCT01583374|101141855|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
33341976|NCT01583374|101141847|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
33341977|NCT01583374|101141848|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
33341978|NCT01583374|101141849|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
33341979|NCT01583374|101141850|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
33341980|NCT01583374|101141851|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
33341981|NCT01583374|101141852|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
33341982|NCT01583374|101141853|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
33341983|NCT01583374|101141854|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
33615040|NCT00741013|102140201|FG001|Overall Study|Withdrawal by Subject|0|||
33341984|NCT01583374|101141855|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
33341985|NCT01583374|101141847|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
33341986|NCT01583374|101141848|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
33341987|NCT01583374|101141849|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
33341988|NCT01583374|101141850|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
33341989|NCT01583374|101141851|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
33341990|NCT01583374|101141852|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
33341991|NCT01583374|101141853|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
33341992|NCT01583374|101141854|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
33341993|NCT01583374|101141855|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
33341994|NCT01583374|101141847|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
33341995|NCT01583374|101141848|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
33341996|NCT01583374|101141849|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
33539153|NCT01232283|101871079|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33539154|NCT01232283|101871080|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33539155|NCT01232283|101871081|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33539156|NCT01232283|101871082|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
33615041|NCT00741013|102140202|FG002|Overall Study|Withdrawal by Subject|1|||
33615042|NCT00741013|102140200|FG000|Overall Study|Discovered failed screen after enrolled|0|||
33615043|NCT00741013|102140201|FG001|Overall Study|Discovered failed screen after enrolled|2|||
33615044|NCT00741013|102140202|FG002|Overall Study|Discovered failed screen after enrolled|0|||
33615045|NCT03302247|102140207|FG000|Overall Study|the study has closed prematurely|2|||
33615046|NCT03302247|102140207|FG000|Overall Study|Death|1|||
33615047|NCT01746225|102140211|FG000|Overall Study|Death|1|||
33615048|NCT01746225|102140212|FG001|Overall Study|Death|0|||
33615049|NCT01746225|102140213|FG002|Overall Study|Death|1|||
33615050|NCT01746225|102140211|FG000|Overall Study|Withdrawal by Subject|5|||
33539157|NCT01232283|101871083|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
33539158|NCT01232283|101871074|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33539159|NCT01232283|101871075|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33539160|NCT01232283|101871076|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33539161|NCT01232283|101871077|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33539162|NCT01232283|101871078|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33341997|NCT01583374|101141850|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
33615051|NCT01746225|102140212|FG001|Overall Study|Withdrawal by Subject|15|||
33341998|NCT01583374|101141851|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
33341999|NCT01583374|101141852|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
33342000|NCT01583374|101141853|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
33342001|NCT01583374|101141854|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
33539163|NCT01232283|101871079|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33539164|NCT01232283|101871080|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33539165|NCT01232283|101871081|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
33539166|NCT01232283|101871082|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
33539167|NCT01232283|101871083|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
33539168|NCT01123655|101871084|FG000|Overall Study|Medication for RA had to be changed|1|||
33539169|NCT01123655|101871085|FG001|Overall Study|Medication for RA had to be changed|0|||
33539170|NCT01123655|101871086|FG002|Overall Study|Medication for RA had to be changed|0|||
33539171|NCT01123655|101871084|FG000|Overall Study|new illness|0|||
33615052|NCT01746225|102140213|FG002|Overall Study|Withdrawal by Subject|19|||
33615053|NCT01746225|102140211|FG000|Overall Study|Physician Decision|14|||
33615054|NCT01746225|102140212|FG001|Overall Study|Physician Decision|11|||
33342002|NCT01583374|101141855|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
33342003|NCT01583374|101141847|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
33342004|NCT01583374|101141848|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
33342005|NCT01583374|101141849|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
33615055|NCT01746225|102140213|FG002|Overall Study|Physician Decision|3|||
33615056|NCT01746225|102140211|FG000|Overall Study|Adverse Event|15|||
33342006|NCT01583374|101141850|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
33342007|NCT01583374|101141851|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
33342008|NCT01583374|101141852|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
33539172|NCT01123655|101871085|FG001|Overall Study|new illness|1|||
33539173|NCT01123655|101871086|FG002|Overall Study|new illness|0|||
33615057|NCT01746225|102140212|FG001|Overall Study|Adverse Event|12|||
33615058|NCT01746225|102140213|FG002|Overall Study|Adverse Event|17|||
33615059|NCT01746225|102140211|FG000|Overall Study|Continuing Treatment|5|||
33615060|NCT01746225|102140212|FG001|Overall Study|Continuing Treatment|8|||
33342009|NCT01583374|101141853|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
33615061|NCT01746225|102140213|FG002|Overall Study|Continuing Treatment|3|||
33539174|NCT01123655|101871084|FG000|Overall Study|began prohibitive drug|0|||
33209779|NCT02564523|100670266|FG009|Overall Study|Protocol Violation|0|||
33209780|NCT02564523|100670267|FG010|Overall Study|Protocol Violation|0|||
33209781|NCT02564523|100670268|FG011|Overall Study|Protocol Violation|0|||
33209782|NCT02564523|100670269|FG012|Overall Study|Protocol Violation|0|||
33209783|NCT02564523|100670270|FG013|Overall Study|Protocol Violation|0|||
33209784|NCT02564523|100670271|FG014|Overall Study|Protocol Violation|0|||
33209785|NCT02564523|100670272|FG015|Overall Study|Protocol Violation|0|||
33209786|NCT02564523|100670273|FG016|Overall Study|Protocol Violation|0|||
33209787|NCT02564523|100670274|FG017|Overall Study|Protocol Violation|0|||
33209788|NCT02564523|100670257|FG000|Overall Study|Other|3|||
33209789|NCT02564523|100670258|FG001|Overall Study|Other|0|||
33209790|NCT02564523|100670259|FG002|Overall Study|Other|0|||
33209791|NCT02564523|100670260|FG003|Overall Study|Other|1|||
33342010|NCT01583374|101141854|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
33342011|NCT01583374|101141855|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
33342012|NCT01583374|101141847|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
33342013|NCT01583374|101141848|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
33342014|NCT01583374|101141849|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
33342015|NCT01583374|101141850|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
33342016|NCT01583374|101141851|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
33539175|NCT01123655|101871085|FG001|Overall Study|began prohibitive drug|0|||
33539176|NCT01123655|101871086|FG002|Overall Study|began prohibitive drug|1|||
33539177|NCT03307174|101871088|FG000|Overall Study|Unplanned ICU Administrion|5|||
33539178|NCT03307174|101871089|FG001|Overall Study|Unplanned ICU Administrion|3|||
33539179|NCT03307174|101871088|FG000|Overall Study|Aborted Surgery|1|||
33539180|NCT03307174|101871089|FG001|Overall Study|Aborted Surgery|2|||
33539181|NCT03307174|101871088|FG000|Overall Study|Hypotension|6|||
33539182|NCT03307174|101871089|FG001|Overall Study|Hypotension|0|||
33539183|NCT03307174|101871088|FG000|Overall Study|Nonfunctional epidural|1|||
33539184|NCT03307174|101871089|FG001|Overall Study|Nonfunctional epidural|1|||
33539185|NCT03307174|101871088|FG000|Overall Study|Planned epidural removal|1|||
33539186|NCT03307174|101871089|FG001|Overall Study|Planned epidural removal|0|||
33539187|NCT03307174|101871088|FG000|Overall Study|Intrathecal catheter placement|0|||
33539188|NCT03307174|101871089|FG001|Overall Study|Intrathecal catheter placement|1|||
33539189|NCT03353792|101871090|FG000|Overall Study|Lost to Follow-up|1|||
33539190|NCT03353792|101871091|FG001|Overall Study|Lost to Follow-up|0|||
33539191|NCT03353792|101871090|FG000|Overall Study|Participant Unable to Manage Device|1|||
33539192|NCT03353792|101871091|FG001|Overall Study|Participant Unable to Manage Device|0|||
33539193|NCT00846365|101871094|FG000|Overall Study|Adverse Event|20|||
33539194|NCT00846365|101871095|FG001|Overall Study|Adverse Event|30|||
33539195|NCT00846365|101871096|FG002|Overall Study|Adverse Event|11|||
33539196|NCT00846365|101871094|FG000|Overall Study|Protocol Violation|5|||
33539197|NCT00846365|101871095|FG001|Overall Study|Protocol Violation|4|||
33539198|NCT00846365|101871096|FG002|Overall Study|Protocol Violation|0|||
33539199|NCT00846365|101871094|FG000|Overall Study|Lost to Follow-up|8|||
33539200|NCT00846365|101871095|FG001|Overall Study|Lost to Follow-up|2|||
33209792|NCT02564523|100670261|FG004|Overall Study|Other|0|||
33209793|NCT02564523|100670262|FG005|Overall Study|Other|0|||
33209794|NCT02564523|100670263|FG006|Overall Study|Other|0|||
33209795|NCT02564523|100670264|FG007|Overall Study|Other|0|||
33209796|NCT02564523|100670265|FG008|Overall Study|Other|0|||
33209797|NCT02564523|100670266|FG009|Overall Study|Other|0|||
33209798|NCT02564523|100670267|FG010|Overall Study|Other|0|||
33209799|NCT02564523|100670268|FG011|Overall Study|Other|0|||
33342017|NCT01583374|101141852|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
33342018|NCT01583374|101141853|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
33342019|NCT01583374|101141854|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
33342020|NCT01583374|101141855|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
33342021|NCT01583374|101141847|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
33342022|NCT01583374|101141848|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
33342023|NCT01583374|101141849|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
33342024|NCT01583374|101141850|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
33342025|NCT01583374|101141851|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
33615062|NCT00571038|102140217|FG000|Overall Study|Lost to Follow-up|1|||
33209800|NCT02564523|100670269|FG012|Overall Study|Other|0|||
33209801|NCT02564523|100670270|FG013|Overall Study|Other|0|||
33209802|NCT02564523|100670271|FG014|Overall Study|Other|0|||
33209803|NCT02564523|100670272|FG015|Overall Study|Other|0|||
33209804|NCT02564523|100670273|FG016|Overall Study|Other|0|||
33209805|NCT02564523|100670274|FG017|Overall Study|Other|0|||
33342026|NCT01583374|101141852|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
33539201|NCT00846365|101871096|FG002|Overall Study|Lost to Follow-up|5|||
33539202|NCT00846365|101871094|FG000|Overall Study|Withdrawal by Subject|11|||
33539203|NCT00846365|101871095|FG001|Overall Study|Withdrawal by Subject|11|||
33539204|NCT00846365|101871096|FG002|Overall Study|Withdrawal by Subject|9|||
33539205|NCT00846365|101871094|FG000|Overall Study|Pregnancy|1|||
33539206|NCT00846365|101871095|FG001|Overall Study|Pregnancy|0|||
33209806|NCT03568318|100670275|FG000|Overall Study|Adverse Event|3|||
33209807|NCT03568318|100670276|FG001|Overall Study|Adverse Event|1|||
33209808|NCT03568318|100670277|FG002|Overall Study|Adverse Event|1|||
33209809|NCT03568318|100670278|FG003|Overall Study|Adverse Event|0|||
33539207|NCT00846365|101871096|FG002|Overall Study|Pregnancy|0|||
33539208|NCT00846365|101871094|FG000|Overall Study|Lack of Efficacy|1|||
33539209|NCT00846365|101871095|FG001|Overall Study|Lack of Efficacy|1|||
33539210|NCT00846365|101871096|FG002|Overall Study|Lack of Efficacy|2|||
33539211|NCT00846365|101871094|FG000|Overall Study|Other|9|||
33539212|NCT00846365|101871095|FG001|Overall Study|Other|1|||
33539213|NCT00846365|101871096|FG002|Overall Study|Other|6|||
33539214|NCT01832766|101871097|FG000|Washout|Lost to Follow-up|0|||
33209810|NCT03568318|100670279|FG004|Overall Study|Adverse Event|1|||
33209811|NCT03568318|100670280|FG005|Overall Study|Adverse Event|0|||
33209812|NCT03568318|100670275|FG000|Overall Study|Withdrawal by Subject|6|||
33209813|NCT03568318|100670276|FG001|Overall Study|Withdrawal by Subject|5|||
33209814|NCT03568318|100670277|FG002|Overall Study|Withdrawal by Subject|2|||
33209815|NCT03568318|100670278|FG003|Overall Study|Withdrawal by Subject|1|||
33209816|NCT03568318|100670279|FG004|Overall Study|Withdrawal by Subject|0|||
33209817|NCT03568318|100670280|FG005|Overall Study|Withdrawal by Subject|0|||
33539215|NCT01832766|101871098|FG001|Washout|Lost to Follow-up|1|||
33539216|NCT01850641|101871099|FG000|Overall Study|Physician Decision|1|||
33539217|NCT01850641|101871099|FG000|Overall Study|Decrease in serum phosphorus|1|||
33539218|NCT01850641|101871099|FG000|Overall Study|Decrease in serum calcium|2|||
33539219|NCT01850641|101871099|FG000|Overall Study|Increase in serum ferritin|1|||
33539220|NCT01079780|101871100|FG000|Overall Study|Disease progression|43|||
33539221|NCT01079780|101871101|FG001|Overall Study|Disease progression|7|||
33539222|NCT01079780|101871102|FG002|Overall Study|Disease progression|31|||
33539223|NCT01079780|101871100|FG000|Overall Study|Adverse Event|13|||
33539224|NCT01079780|101871101|FG001|Overall Study|Adverse Event|5|||
33539225|NCT01079780|101871102|FG002|Overall Study|Adverse Event|7|||
33539226|NCT01079780|101871100|FG000|Overall Study|Death|2|||
33539227|NCT01079780|101871101|FG001|Overall Study|Death|0|||
33539228|NCT01079780|101871102|FG002|Overall Study|Death|2|||
33539229|NCT01079780|101871100|FG000|Overall Study|Withdrawal by Subject|6|||
33539230|NCT01079780|101871101|FG001|Overall Study|Withdrawal by Subject|4|||
33539231|NCT01079780|101871102|FG002|Overall Study|Withdrawal by Subject|4|||
33539232|NCT01079780|101871100|FG000|Overall Study|Alternative therapy|2|||
33209818|NCT03568318|100670275|FG000|Overall Study|Lost to Follow-up|3|||
33209819|NCT03568318|100670276|FG001|Overall Study|Lost to Follow-up|2|||
33209820|NCT03568318|100670277|FG002|Overall Study|Lost to Follow-up|2|||
33209821|NCT03568318|100670278|FG003|Overall Study|Lost to Follow-up|2|||
33209822|NCT03568318|100670279|FG004|Overall Study|Lost to Follow-up|1|||
33209823|NCT03568318|100670280|FG005|Overall Study|Lost to Follow-up|0|||
33209824|NCT03568318|100670275|FG000|Overall Study|Other|3|||
33209825|NCT03568318|100670276|FG001|Overall Study|Other|1|||
33209826|NCT03568318|100670277|FG002|Overall Study|Other|3|||
33209827|NCT03568318|100670278|FG003|Overall Study|Other|0|||
33209828|NCT03568318|100670279|FG004|Overall Study|Other|0|||
33209829|NCT03568318|100670280|FG005|Overall Study|Other|0|||
33209830|NCT03568318|100670275|FG000|Overall Study|Ongoing at Time of Analysis|5|||
33209831|NCT03568318|100670276|FG001|Overall Study|Ongoing at Time of Analysis|3|||
33209832|NCT03568318|100670277|FG002|Overall Study|Ongoing at Time of Analysis|2|||
33209833|NCT03568318|100670278|FG003|Overall Study|Ongoing at Time of Analysis|1|||
33209834|NCT03568318|100670279|FG004|Overall Study|Ongoing at Time of Analysis|0|||
33209835|NCT03568318|100670280|FG005|Overall Study|Ongoing at Time of Analysis|0|||
33209836|NCT01864564|100670281|FG000|Overall Study|Lost to Follow-up|17|||
33209837|NCT01864564|100670282|FG001|Overall Study|Lost to Follow-up|23|||
33209838|NCT01864564|100670281|FG000|Overall Study|Withdrawal by Subject|20|||
33209839|NCT01864564|100670282|FG001|Overall Study|Withdrawal by Subject|11|||
33209840|NCT01864564|100670281|FG000|Overall Study|Protocol Violation|0|||
33209841|NCT01864564|100670282|FG001|Overall Study|Protocol Violation|27|||
33209842|NCT01864564|100670281|FG000|Overall Study|not reported|0|||
33539233|NCT01079780|101871101|FG001|Overall Study|Alternative therapy|0|||
33539234|NCT01079780|101871102|FG002|Overall Study|Alternative therapy|2|||
33209843|NCT01864564|100670282|FG001|Overall Study|not reported|34|||
33209844|NCT03053050|100670283|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
33209845|NCT03053050|100670284|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
33209846|NCT03053050|100670285|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
33615063|NCT00571038|102140218|FG001|Overall Study|Lost to Follow-up|4|||
33209847|NCT03053050|100670286|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
33209848|NCT03053050|100670283|FG000|Randomized Phase|Withdrew Consent|16|||
33209849|NCT03053050|100670284|FG001|Randomized Phase|Withdrew Consent|8|||
33209850|NCT03053050|100670285|FG002|Randomized Phase|Withdrew Consent|9|||
33209851|NCT03053050|100670286|FG003|Randomized Phase|Withdrew Consent|0|||
33209852|NCT03053050|100670283|FG000|Randomized Phase|Investigator's Discretion|6|||
33539235|NCT01079780|101871100|FG000|Overall Study|Physician Decision|1|||
33539236|NCT01079780|101871101|FG001|Overall Study|Physician Decision|0|||
33539237|NCT01079780|101871102|FG002|Overall Study|Physician Decision|1|||
33539238|NCT01079780|101871100|FG000|Overall Study|Error made in lesion measurement|1|||
33539239|NCT01079780|101871101|FG001|Overall Study|Error made in lesion measurement|0|||
33209853|NCT03053050|100670284|FG001|Randomized Phase|Investigator's Discretion|6|||
33209854|NCT03053050|100670285|FG002|Randomized Phase|Investigator's Discretion|3|||
33209855|NCT03053050|100670286|FG003|Randomized Phase|Investigator's Discretion|0|||
33209856|NCT03053050|100670283|FG000|Randomized Phase|Lost to Follow-up|5|||
33209857|NCT03053050|100670284|FG001|Randomized Phase|Lost to Follow-up|1|||
33209858|NCT03053050|100670285|FG002|Randomized Phase|Lost to Follow-up|1|||
33209859|NCT03053050|100670286|FG003|Randomized Phase|Lost to Follow-up|0|||
33209860|NCT03053050|100670283|FG000|Randomized Phase|Adverse Event|0|||
33209861|NCT03053050|100670284|FG001|Randomized Phase|Adverse Event|1|||
33209862|NCT03053050|100670285|FG002|Randomized Phase|Adverse Event|0|||
33209863|NCT03053050|100670286|FG003|Randomized Phase|Adverse Event|0|||
33209864|NCT03053050|100670283|FG000|Randomized Phase|Randomized but Never Treated|2|||
33209865|NCT03053050|100670284|FG001|Randomized Phase|Randomized but Never Treated|2|||
33209866|NCT03053050|100670285|FG002|Randomized Phase|Randomized but Never Treated|2|||
33209867|NCT03053050|100670286|FG003|Randomized Phase|Randomized but Never Treated|0|||
33209868|NCT03053050|100670283|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
33209869|NCT03053050|100670284|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
33209870|NCT03053050|100670285|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
33209871|NCT03053050|100670286|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
33209872|NCT03053050|100670283|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
33209873|NCT03053050|100670284|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
33209874|NCT03053050|100670285|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
33209875|NCT03053050|100670286|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
33209876|NCT03053050|100670283|FG000|Open-label Phase|Withdrew Consent|0|||
33209877|NCT03053050|100670284|FG001|Open-label Phase|Withdrew Consent|0|||
33209878|NCT03053050|100670285|FG002|Open-label Phase|Withdrew Consent|0|||
33209879|NCT03053050|100670286|FG003|Open-label Phase|Withdrew Consent|6|||
33209880|NCT03053050|100670283|FG000|Open-label Phase|Investigator's Discretion|0|||
33209881|NCT03053050|100670284|FG001|Open-label Phase|Investigator's Discretion|0|||
33209882|NCT03053050|100670285|FG002|Open-label Phase|Investigator's Discretion|0|||
33209883|NCT03053050|100670286|FG003|Open-label Phase|Investigator's Discretion|4|||
33209884|NCT01880424|100670287|FG000|Overall Study|Adverse Event|7|||
33209885|NCT01880424|100670288|FG001|Overall Study|Adverse Event|6|||
33209886|NCT01880424|100670287|FG000|Overall Study|Lack of Efficacy|1|||
33209887|NCT01880424|100670288|FG001|Overall Study|Lack of Efficacy|4|||
33209888|NCT01880424|100670287|FG000|Overall Study|Lost to Follow-up|3|||
33209889|NCT01880424|100670288|FG001|Overall Study|Lost to Follow-up|2|||
33209890|NCT01880424|100670287|FG000|Overall Study|Protocol Violation|11|||
33209891|NCT01880424|100670288|FG001|Overall Study|Protocol Violation|13|||
33342027|NCT01583374|101141853|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
33342028|NCT01583374|101141854|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
33342029|NCT01583374|101141855|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
33342030|NCT01583374|101141847|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
33342031|NCT01583374|101141848|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
33342032|NCT01583374|101141849|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
33342033|NCT01583374|101141850|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
33539240|NCT01079780|101871102|FG002|Overall Study|Error made in lesion measurement|0|||
33539241|NCT01079780|101871100|FG000|Overall Study|Patient had surgery|1|||
33539242|NCT01079780|101871101|FG001|Overall Study|Patient had surgery|0|||
33539243|NCT01079780|101871102|FG002|Overall Study|Patient had surgery|0|||
33342034|NCT01583374|101141851|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
33342035|NCT01583374|101141852|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
33342036|NCT01583374|101141853|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
33342037|NCT01583374|101141854|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
33342038|NCT01583374|101141855|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
33342039|NCT01145066|101141860|FG000|Overall Study|To resume NSAIDs|2|||
33342040|NCT01145066|101141861|FG001|Overall Study|To resume NSAIDs|2|||
33342041|NCT01145066|101141862|FG002|Overall Study|To resume NSAIDs|1|||
33342042|NCT01145066|101141860|FG000|Overall Study|Non-related surgery|0|||
33342043|NCT01145066|101141861|FG001|Overall Study|Non-related surgery|0|||
33342044|NCT01145066|101141862|FG002|Overall Study|Non-related surgery|1|||
33342045|NCT01145066|101141860|FG000|Overall Study|Withdrawal by Subject|0|||
33539244|NCT01079780|101871100|FG000|Overall Study|Treatment cycle delay|0|||
33539245|NCT01079780|101871101|FG001|Overall Study|Treatment cycle delay|0|||
33539246|NCT01079780|101871102|FG002|Overall Study|Treatment cycle delay|1|||
33209892|NCT01880424|100670287|FG000|Overall Study|Withdrawal by Subject|10|||
33209893|NCT01880424|100670288|FG001|Overall Study|Withdrawal by Subject|30|||
33209894|NCT01880424|100670287|FG000|Overall Study|Other|1|||
33209895|NCT01880424|100670288|FG001|Overall Study|Other|0|||
33209896|NCT00325468|100670289|FG000|Overall Study|Adverse Event|1|||
33209897|NCT00325468|100670290|FG001|Overall Study|Adverse Event|1|||
33209898|NCT00325468|100670291|FG002|Overall Study|Adverse Event|0|||
33342046|NCT01145066|101141861|FG001|Overall Study|Withdrawal by Subject|0|||
33209899|NCT00325468|100670292|FG003|Overall Study|Adverse Event|5|||
33209900|NCT00325468|100670293|FG004|Overall Study|Adverse Event|1|||
33209901|NCT00325468|100670289|FG000|Overall Study|Death|2|||
33209902|NCT00325468|100670290|FG001|Overall Study|Death|0|||
33209903|NCT00325468|100670291|FG002|Overall Study|Death|2|||
33209904|NCT00325468|100670292|FG003|Overall Study|Death|4|||
33209905|NCT00325468|100670293|FG004|Overall Study|Death|0|||
33406168|NCT01072175|101377544|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33406169|NCT01072175|101377545|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33406170|NCT01072175|101377546|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33406171|NCT01072175|101377547|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33406172|NCT01072175|101377548|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
33406173|NCT01072175|101377549|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
33406174|NCT01072175|101377550|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
33406175|NCT01072175|101377551|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33406176|NCT01072175|101377552|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33406177|NCT01072175|101377553|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33406178|NCT01072175|101377554|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33406179|NCT01072175|101377555|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
33406180|NCT01072175|101377543|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33406181|NCT01072175|101377544|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33406182|NCT01072175|101377545|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33406183|NCT01072175|101377546|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33406184|NCT01072175|101377547|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33406185|NCT01072175|101377548|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
33406186|NCT01072175|101377549|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
33406187|NCT01072175|101377550|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33406188|NCT01072175|101377551|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33406189|NCT01072175|101377552|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33209906|NCT00325468|100670289|FG000|Overall Study|Lost to Follow-up|0|||
33209907|NCT00325468|100670290|FG001|Overall Study|Lost to Follow-up|0|||
33209908|NCT00325468|100670291|FG002|Overall Study|Lost to Follow-up|1|||
33209909|NCT00325468|100670292|FG003|Overall Study|Lost to Follow-up|2|||
33209910|NCT00325468|100670293|FG004|Overall Study|Lost to Follow-up|2|||
33209911|NCT00325468|100670289|FG000|Overall Study|Physician Decision|1|||
33209912|NCT00325468|100670290|FG001|Overall Study|Physician Decision|1|||
33209913|NCT00325468|100670291|FG002|Overall Study|Physician Decision|0|||
33209914|NCT00325468|100670292|FG003|Overall Study|Physician Decision|1|||
33209915|NCT00325468|100670293|FG004|Overall Study|Physician Decision|0|||
33406190|NCT01072175|101377553|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33406191|NCT01072175|101377554|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33406192|NCT01072175|101377555|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
33209916|NCT00325468|100670289|FG000|Overall Study|Withdrawal by Subject|3|||
33209917|NCT00325468|100670290|FG001|Overall Study|Withdrawal by Subject|1|||
33209918|NCT00325468|100670291|FG002|Overall Study|Withdrawal by Subject|0|||
33342047|NCT01145066|101141862|FG002|Overall Study|Withdrawal by Subject|2|||
33342048|NCT01145066|101141860|FG000|Overall Study|To start new med|1|||
33342049|NCT01145066|101141861|FG001|Overall Study|To start new med|0|||
33342050|NCT01145066|101141862|FG002|Overall Study|To start new med|0|||
33342051|NCT01145066|101141860|FG000|Overall Study|problems swallowing capsule|1|||
33342052|NCT01145066|101141861|FG001|Overall Study|problems swallowing capsule|0|||
33342053|NCT01145066|101141862|FG002|Overall Study|problems swallowing capsule|0|||
33342054|NCT01145066|101141860|FG000|Overall Study|Abdominal discomfort|0|||
33342055|NCT01145066|101141861|FG001|Overall Study|Abdominal discomfort|1|||
33342056|NCT01145066|101141862|FG002|Overall Study|Abdominal discomfort|0|||
33342057|NCT01145066|101141860|FG000|Overall Study|Low platelet count|0|||
33342058|NCT01145066|101141861|FG001|Overall Study|Low platelet count|1|||
33406193|NCT01072175|101377543|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33539247|NCT01079780|101871100|FG000|Overall Study|Never started treatment|1|||
33342059|NCT01145066|101141862|FG002|Overall Study|Low platelet count|0|||
33342060|NCT02362503|101141891|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
33539248|NCT01079780|101871101|FG001|Overall Study|Never started treatment|0|||
33539249|NCT01079780|101871102|FG002|Overall Study|Never started treatment|2|||
33539250|NCT00116688|101871104|FG000|Overall Study|Protocol deviation|1|||
33539251|NCT00116688|101871105|FG001|Overall Study|Protocol deviation|0|||
33539252|NCT00116688|101871104|FG000|Overall Study|Noncompliance|3|||
33539253|NCT00116688|101871105|FG001|Overall Study|Noncompliance|1|||
33539254|NCT00116688|101871104|FG000|Overall Study|Adverse Event|11|||
33209919|NCT00325468|100670292|FG003|Overall Study|Withdrawal by Subject|14|||
33209920|NCT00325468|100670293|FG004|Overall Study|Withdrawal by Subject|4|||
33209921|NCT00325468|100670289|FG000|Overall Study|site closure etc|4|||
33342061|NCT02362503|101141892|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
33342062|NCT02362503|101141893|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
33209922|NCT00325468|100670290|FG001|Overall Study|site closure etc|2|||
33209923|NCT00325468|100670291|FG002|Overall Study|site closure etc|1|||
33209924|NCT00325468|100670292|FG003|Overall Study|site closure etc|8|||
33209925|NCT00325468|100670293|FG004|Overall Study|site closure etc|1|||
33342063|NCT02362503|101141891|FG000|Double-blind Period-Up to 8 Days|Death|1|||
33342064|NCT02362503|101141892|FG001|Double-blind Period-Up to 8 Days|Death|0|||
33342065|NCT02362503|101141893|FG002|Double-blind Period-Up to 8 Days|Death|0|||
33342066|NCT02362503|101141891|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
33342067|NCT02362503|101141892|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
33342068|NCT02362503|101141893|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
33342069|NCT02362503|101141891|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
33342070|NCT02362503|101141892|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
33342071|NCT02362503|101141893|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
33342072|NCT02362503|101141891|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
33342073|NCT02362503|101141892|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
33342074|NCT02362503|101141893|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
33342075|NCT02362503|101141891|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
33342076|NCT02362503|101141892|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
33342077|NCT02362503|101141893|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
33342078|NCT02362503|101141891|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
33342079|NCT02362503|101141892|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
33342080|NCT02362503|101141893|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
33539255|NCT00116688|101871105|FG001|Overall Study|Adverse Event|0|||
33539256|NCT00116688|101871104|FG000|Overall Study|Withdrawal by Subject|26|||
33539257|NCT00116688|101871105|FG001|Overall Study|Withdrawal by Subject|2|||
33539258|NCT00116688|101871104|FG000|Overall Study|Requirement for alternative therapy|11|||
33539259|NCT00116688|101871105|FG001|Overall Study|Requirement for alternative therapy|1|||
33539260|NCT00116688|101871104|FG000|Overall Study|Physician Decision|7|||
33539261|NCT00116688|101871105|FG001|Overall Study|Physician Decision|0|||
33615064|NCT00571038|102140217|FG000|Overall Study|Death|7|||
33615065|NCT00571038|102140218|FG001|Overall Study|Death|5|||
33209926|NCT02081846|100670300|FG000|Overall Study|Withdrawal by Subject|1|||
33209927|NCT02081846|100670301|FG001|Overall Study|Withdrawal by Subject|0|||
33342081|NCT02362503|101141891|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
33342082|NCT02362503|101141892|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
33342083|NCT02362503|101141893|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
33342084|NCT02362503|101141891|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
33615066|NCT00571038|102140217|FG000|Overall Study|Withdrawal by Subject|1|||
33615067|NCT00571038|102140218|FG001|Overall Study|Withdrawal by Subject|3|||
33615068|NCT00571038|102140217|FG000|Overall Study|Moved out of state|2|||
33615069|NCT00571038|102140218|FG001|Overall Study|Moved out of state|2|||
33615070|NCT01248949|102140219|FG000|Overall Study|Lost to Follow-up|2|||
33615071|NCT01248949|102140220|FG001|Overall Study|Lost to Follow-up|2|||
33615072|NCT01248949|102140221|FG002|Overall Study|Lost to Follow-up|2|||
33615073|NCT01248949|102140222|FG003|Overall Study|Lost to Follow-up|1|||
33615074|NCT01248949|102140223|FG004|Overall Study|Lost to Follow-up|0|||
33615075|NCT01248949|102140219|FG000|Overall Study|Withdrawal by Subject|5|||
33615076|NCT01248949|102140220|FG001|Overall Study|Withdrawal by Subject|3|||
33615077|NCT01248949|102140221|FG002|Overall Study|Withdrawal by Subject|11|||
33615078|NCT01248949|102140222|FG003|Overall Study|Withdrawal by Subject|3|||
33615079|NCT01248949|102140223|FG004|Overall Study|Withdrawal by Subject|1|||
33342085|NCT02362503|101141892|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
33342086|NCT02362503|101141893|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
33342087|NCT02362503|101141891|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
33342088|NCT02362503|101141892|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
33342089|NCT02362503|101141893|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
33342090|NCT02362503|101141891|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
33342091|NCT02362503|101141892|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
33615080|NCT01248949|102140219|FG000|Overall Study|Death|22|||
33342092|NCT02362503|101141893|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
33342093|NCT02362503|101141891|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
33342094|NCT02362503|101141892|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
33342095|NCT02362503|101141893|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
33342096|NCT02362503|101141891|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
33406194|NCT01072175|101377544|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33406195|NCT01072175|101377545|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33615081|NCT01248949|102140220|FG001|Overall Study|Death|7|||
33615082|NCT01248949|102140221|FG002|Overall Study|Death|21|||
33209928|NCT02081846|100670300|FG000|Overall Study|invalid consent|1|||
33406196|NCT01072175|101377546|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33615083|NCT01248949|102140222|FG003|Overall Study|Death|6|||
33615084|NCT01248949|102140223|FG004|Overall Study|Death|2|||
33209929|NCT02081846|100670301|FG001|Overall Study|invalid consent|0|||
33209930|NCT01808690|100670304|FG000|Overall Study|Withdrawal by Subject|1|||
33209931|NCT01808690|100670305|FG001|Overall Study|Withdrawal by Subject|2|||
33209932|NCT00727272|100670306|FG000|Washout Period A|Adverse Event|0|||
33209933|NCT00727272|100670307|FG001|Washout Period A|Adverse Event|0|||
33209934|NCT00727272|100670308|FG002|Washout Period A|Adverse Event|1|||
33209935|NCT00727272|100670306|FG000|Washout Period B|Withdrawal by Subject|0|||
33209936|NCT00727272|100670307|FG001|Washout Period B|Withdrawal by Subject|0|||
33209937|NCT00727272|100670308|FG002|Washout Period B|Withdrawal by Subject|1|||
33406197|NCT01072175|101377547|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33406198|NCT01072175|101377548|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33342097|NCT02362503|101141892|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
33342098|NCT02362503|101141893|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
33406199|NCT01072175|101377549|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33406200|NCT01072175|101377550|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33406201|NCT01072175|101377551|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
33406202|NCT01072175|101377552|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33406203|NCT01072175|101377553|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33406204|NCT01072175|101377554|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33406205|NCT01072175|101377555|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
33406206|NCT01072175|101377543|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33406207|NCT01072175|101377544|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33406208|NCT01072175|101377545|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33406209|NCT01072175|101377546|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33406210|NCT01072175|101377547|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33406211|NCT01072175|101377548|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33342099|NCT02362503|101141891|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
33342100|NCT02362503|101141892|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
33342101|NCT02362503|101141893|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
33342102|NCT04429061|101141895|FG000|Overall Study|Lost to Follow-up|62|||
33342103|NCT04429061|101141896|FG001|Overall Study|Lost to Follow-up|87|||
33342104|NCT04429061|101141895|FG000|Overall Study|Withdrawal by Subject|3|||
33342105|NCT04429061|101141896|FG001|Overall Study|Withdrawal by Subject|4|||
33342106|NCT00352105|101141897|FG000|Overall Study|Death|5|||
33342107|NCT00352105|101141897|FG000|Overall Study|Withdrawal by Subject|5|||
33342108|NCT00352105|101141897|FG000|Overall Study|Lack of Efficacy|9|||
33342109|NCT00352105|101141897|FG000|Overall Study|Adverse Event|19|||
33342110|NCT00352105|101141897|FG000|Overall Study|Protocol Violation|2|||
33342111|NCT01114529|101141898|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
33342112|NCT01114529|101141899|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
33342113|NCT01114529|101141900|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
33342114|NCT01114529|101141898|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
33342115|NCT01114529|101141899|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
33342116|NCT01114529|101141900|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
33342117|NCT01114529|101141898|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
33342118|NCT01114529|101141899|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
33342119|NCT01114529|101141900|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
33342120|NCT01114529|101141898|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
33342121|NCT01114529|101141899|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
33342122|NCT01114529|101141900|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
33342123|NCT01114529|101141898|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
33342124|NCT01114529|101141899|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
33342125|NCT01114529|101141900|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
33342126|NCT01114529|101141898|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
33342127|NCT01114529|101141899|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
33342128|NCT01114529|101141900|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
33342129|NCT01114529|101141898|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
33342130|NCT01114529|101141899|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
33342131|NCT01114529|101141900|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
33342132|NCT01114529|101141898|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
33342133|NCT01114529|101141899|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
33342134|NCT01114529|101141900|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
33342135|NCT01114529|101141898|FG000|Completed Study Medication at Month 24|Death|2|||
33342136|NCT01114529|101141899|FG001|Completed Study Medication at Month 24|Death|1|||
33406212|NCT01072175|101377549|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33539262|NCT00116688|101871104|FG000|Overall Study|Lost to Follow-up|3|||
33209938|NCT02105116|100670316|FG000|Overall Study|not eligible for step 2 of trial|5|||
33209939|NCT02105116|100670316|FG000|Overall Study|Death|1|||
33209940|NCT00722761|100670317|FG000|Overall Study|Lost to Follow-up|1|||
33342137|NCT01114529|101141900|FG002|Completed Study Medication at Month 24|Death|2|||
33342138|NCT01114529|101141898|FG000|Completed Study Medication at Month 24|Graft loss|0|||
33342139|NCT01114529|101141899|FG001|Completed Study Medication at Month 24|Graft loss|2|||
33342140|NCT01114529|101141900|FG002|Completed Study Medication at Month 24|Graft loss|0|||
33342141|NCT01114529|101141898|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
33342142|NCT01114529|101141899|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
33342143|NCT01114529|101141900|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
33342144|NCT01114529|101141898|FG000|Completed Study Medication at Month 24|Missing|2|||
33342145|NCT01114529|101141899|FG001|Completed Study Medication at Month 24|Missing|0|||
33342146|NCT01114529|101141900|FG002|Completed Study Medication at Month 24|Missing|0|||
33342147|NCT01114529|101141898|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
33342148|NCT01114529|101141899|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
33342149|NCT01114529|101141900|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
33342150|NCT01114529|101141898|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
33342151|NCT01114529|101141899|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
33342152|NCT01114529|101141900|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
33342153|NCT01114529|101141898|FG000|Completed Study Phase at Month 24|Death|8|||
33539263|NCT00116688|101871105|FG001|Overall Study|Lost to Follow-up|0|||
33539264|NCT00116688|101871104|FG000|Overall Study|Death|15|||
33539265|NCT00116688|101871105|FG001|Overall Study|Death|0|||
33539266|NCT00116688|101871104|FG000|Overall Study|Protocol-specified criteria|3|||
33539267|NCT00116688|101871105|FG001|Overall Study|Protocol-specified criteria|0|||
33539268|NCT00116688|101871104|FG000|Overall Study|Pregnancy|1|||
33539269|NCT00116688|101871105|FG001|Overall Study|Pregnancy|0|||
33539270|NCT00116688|101871104|FG000|Overall Study|Other|11|||
33539271|NCT00116688|101871105|FG001|Overall Study|Other|0|||
33539272|NCT00087178|101871110|FG000|Overall Study|No follow up data|5|||
33539273|NCT00087178|101871111|FG001|Overall Study|No follow up data|15|||
33539274|NCT00087178|101871110|FG000|Overall Study|No clinical assessment|1|||
33539275|NCT00087178|101871111|FG001|Overall Study|No clinical assessment|2|||
33539276|NCT00087178|101871110|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
33539277|NCT00087178|101871111|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
33539278|NCT03191799|101871112|FG000|Overall Study|Withdrawal by Subject|4|||
33539279|NCT03191799|101871112|FG000|Overall Study|Physician Decision|2|||
33539280|NCT03191799|101871112|FG000|Overall Study|Lost to Follow-up|1|||
33539281|NCT03191799|101871112|FG000|Overall Study|Death|2|||
33539282|NCT01107925|101871113|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
33539283|NCT01107925|101871114|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
33539284|NCT01107925|101871115|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
33539285|NCT01107925|101871116|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
33539286|NCT01107925|101871117|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
33539287|NCT01107925|101871118|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
33539288|NCT01107925|101871113|FG000|Period 2|Withdrawal by Subject|0|||
33539289|NCT01107925|101871114|FG001|Period 2|Withdrawal by Subject|1|||
33539290|NCT01107925|101871115|FG002|Period 2|Withdrawal by Subject|0|||
33539291|NCT01107925|101871116|FG003|Period 2|Withdrawal by Subject|0|||
33539292|NCT01107925|101871117|FG004|Period 2|Withdrawal by Subject|0|||
33539293|NCT01107925|101871118|FG005|Period 2|Withdrawal by Subject|1|||
33539294|NCT02732639|101871119|FG000|Overall Study|Lost to Follow-up|1|||
33539295|NCT01981616|101871120|FG000|Overall Study|Adverse Event|0|||
33539296|NCT01981616|101871121|FG001|Overall Study|Adverse Event|1|||
33539297|NCT01981616|101871120|FG000|Overall Study|Protocol Violation|1|||
33615085|NCT01248949|102140219|FG000|Overall Study|Alternative Therapy|1|||
33615086|NCT01248949|102140220|FG001|Overall Study|Alternative Therapy|0|||
33615087|NCT01248949|102140221|FG002|Overall Study|Alternative Therapy|0|||
33615088|NCT01248949|102140222|FG003|Overall Study|Alternative Therapy|0|||
33615089|NCT01248949|102140223|FG004|Overall Study|Alternative Therapy|0|||
33615090|NCT01248949|102140219|FG000|Overall Study|Alternative Therapy.|1|||
33342154|NCT01114529|101141899|FG001|Completed Study Phase at Month 24|Death|5|||
33406213|NCT01072175|101377550|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33539298|NCT01981616|101871121|FG001|Overall Study|Protocol Violation|0|||
33539299|NCT03499795|101871122|FG000|Overall Study|Adverse Event|1|||
33539300|NCT03499795|101871122|FG000|Overall Study|Lost to Follow-up|1|||
33539301|NCT00161213|101874296|FG000|Overall Study|Withdrawal by Subject|1|||
33539302|NCT00161213|101874296|FG000|Overall Study|Evaluable for toxicity but not response|1|||
33615091|NCT01248949|102140220|FG001|Overall Study|Alternative Therapy.|0|||
33342155|NCT01114529|101141900|FG002|Completed Study Phase at Month 24|Death|4|||
33342156|NCT01114529|101141898|FG000|Completed Study Phase at Month 24|Other|2|||
33539303|NCT03106077|101874307|FG000|Overall Study|Screen Failure|94|||
33539304|NCT03106077|101874308|FG001|Overall Study|Screen Failure|0|||
33539305|NCT03316586|101874309|FG000|Overall Study|Adverse Event|2|||
33539306|NCT03316586|101874309|FG000|Overall Study|Physician Decision|3|||
33539307|NCT03316586|101874309|FG000|Overall Study|Lack of Efficacy|10|||
33615092|NCT01248949|102140221|FG002|Overall Study|Alternative Therapy.|0|||
33539308|NCT03316586|101874309|FG000|Overall Study|still on treatment|1|||
33539309|NCT03316586|101874309|FG000|Overall Study|Patient needed radiation therapy|1|||
33539310|NCT03316586|101874309|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
33539311|NCT03234465|101874310|FG000|Overall Study|Adverse Event|4|||
33539312|NCT03234465|101874311|FG001|Overall Study|Adverse Event|2|||
33539313|NCT03234465|101874310|FG000|Overall Study|Death|0|||
33539314|NCT03234465|101874311|FG001|Overall Study|Death|1|||
33539315|NCT03234465|101874310|FG000|Overall Study|Lost to Follow-up|1|||
33539316|NCT03234465|101874311|FG001|Overall Study|Lost to Follow-up|1|||
33539317|NCT03234465|101874310|FG000|Overall Study|Withdrawal by Subject|12|||
33539318|NCT03234465|101874311|FG001|Overall Study|Withdrawal by Subject|27|||
33342157|NCT01114529|101141899|FG001|Completed Study Phase at Month 24|Other|0|||
33342158|NCT01114529|101141900|FG002|Completed Study Phase at Month 24|Other|0|||
33342159|NCT01114529|101141898|FG000|Completed Study Phase at Month 24|Missing|2|||
33209941|NCT00722761|100670318|FG001|Overall Study|Lost to Follow-up|4|||
33209942|NCT00722761|100670317|FG000|Overall Study|Withdrawal by Subject|5|||
33209943|NCT00722761|100670318|FG001|Overall Study|Withdrawal by Subject|2|||
33209944|NCT01587651|100670326|FG000|Overall Study|Adverse Event|0|||
33209945|NCT01587651|100670327|FG001|Overall Study|Adverse Event|1|||
33209946|NCT01587651|100670328|FG002|Overall Study|Adverse Event|0|||
33209947|NCT01587651|100670326|FG000|Overall Study|Protocol Violation|0|||
33209948|NCT01587651|100670327|FG001|Overall Study|Protocol Violation|1|||
33209949|NCT01587651|100670328|FG002|Overall Study|Protocol Violation|1|||
33209950|NCT01587651|100670326|FG000|Overall Study|Withdrawal by Subject|0|||
33209951|NCT01587651|100670327|FG001|Overall Study|Withdrawal by Subject|1|||
33342160|NCT01114529|101141899|FG001|Completed Study Phase at Month 24|Missing|0|||
33342161|NCT01114529|101141900|FG002|Completed Study Phase at Month 24|Missing|0|||
33342162|NCT00328627|101141903|FG000|Overall Study|Hyperglycemic Rescue|41|||
33342163|NCT00328627|101141904|FG001|Overall Study|Hyperglycemic Rescue|18|||
33342164|NCT00328627|101141905|FG002|Overall Study|Hyperglycemic Rescue|16|||
33342165|NCT00328627|101141906|FG003|Overall Study|Hyperglycemic Rescue|13|||
33615093|NCT01248949|102140222|FG003|Overall Study|Alternative Therapy.|0|||
33342166|NCT00328627|101141907|FG004|Overall Study|Hyperglycemic Rescue|6|||
33615094|NCT01248949|102140223|FG004|Overall Study|Alternative Therapy.|0|||
33615095|NCT01248949|102140219|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
33615096|NCT01248949|102140220|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
33615097|NCT01248949|102140221|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
33615098|NCT01248949|102140222|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
33342167|NCT00328627|101141908|FG005|Overall Study|Hyperglycemic Rescue|5|||
33539319|NCT03234465|101874310|FG000|Overall Study|Symptomatic deterioration|0|||
33539320|NCT03234465|101874311|FG001|Overall Study|Symptomatic deterioration|1|||
33209952|NCT01587651|100670328|FG002|Overall Study|Withdrawal by Subject|0|||
33342168|NCT00328627|101141909|FG006|Overall Study|Hyperglycemic Rescue|19|||
33615099|NCT01248949|102140223|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
33209953|NCT02277106|100670329|FG000|Stage 2|Adverse Event|0|||
33209954|NCT02277106|100670330|FG001|Stage 2|Adverse Event|0|||
33342169|NCT00328627|101141910|FG007|Overall Study|Hyperglycemic Rescue|6|||
33342170|NCT00328627|101141911|FG008|Overall Study|Hyperglycemic Rescue|6|||
33342171|NCT00328627|101141912|FG009|Overall Study|Hyperglycemic Rescue|11|||
33209955|NCT02277106|100670331|FG002|Stage 2|Adverse Event|1|||
33209956|NCT01854827|100670332|FG000|Overall Study|Death|1|||
33209957|NCT00518115|100670333|FG000|Overall Study|Adverse Event|6|||
33342172|NCT00328627|101141913|FG010|Overall Study|Hyperglycemic Rescue|3|||
33342173|NCT00328627|101141914|FG011|Overall Study|Hyperglycemic Rescue|2|||
33342174|NCT00328627|101141903|FG000|Overall Study|Adverse Event|3|||
33342175|NCT00328627|101141904|FG001|Overall Study|Adverse Event|1|||
33406214|NCT01072175|101377551|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
33342176|NCT00328627|101141905|FG002|Overall Study|Adverse Event|2|||
33342177|NCT00328627|101141906|FG003|Overall Study|Adverse Event|3|||
33342178|NCT00328627|101141907|FG004|Overall Study|Adverse Event|1|||
33342179|NCT00328627|101141908|FG005|Overall Study|Adverse Event|2|||
33342180|NCT00328627|101141909|FG006|Overall Study|Adverse Event|1|||
33342181|NCT00328627|101141910|FG007|Overall Study|Adverse Event|2|||
33342182|NCT00328627|101141911|FG008|Overall Study|Adverse Event|0|||
33342183|NCT00328627|101141912|FG009|Overall Study|Adverse Event|7|||
33342184|NCT00328627|101141913|FG010|Overall Study|Adverse Event|5|||
33342185|NCT00328627|101141914|FG011|Overall Study|Adverse Event|4|||
33342186|NCT00328627|101141903|FG000|Overall Study|Protocol Violation|2|||
33406215|NCT01072175|101377552|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33406216|NCT01072175|101377553|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33406217|NCT01072175|101377554|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33406218|NCT01072175|101377555|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
33406219|NCT01072175|101377543|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33406220|NCT01072175|101377544|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33406221|NCT01072175|101377545|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33406222|NCT01072175|101377546|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33406223|NCT01072175|101377547|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33406224|NCT01072175|101377548|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33406225|NCT01072175|101377549|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33406226|NCT01072175|101377550|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33406227|NCT01072175|101377551|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
33406228|NCT01072175|101377552|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33406229|NCT01072175|101377553|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33406230|NCT01072175|101377554|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33406231|NCT01072175|101377555|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
33406232|NCT01072175|101377543|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33406233|NCT01072175|101377544|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33539321|NCT03234465|101874310|FG000|Overall Study|Non-compliance|2|||
33209958|NCT00518115|100670334|FG001|Overall Study|Adverse Event|1|||
33342187|NCT00328627|101141904|FG001|Overall Study|Protocol Violation|2|||
33342188|NCT00328627|101141905|FG002|Overall Study|Protocol Violation|2|||
33342189|NCT00328627|101141906|FG003|Overall Study|Protocol Violation|8|||
33342190|NCT00328627|101141907|FG004|Overall Study|Protocol Violation|5|||
33342191|NCT00328627|101141908|FG005|Overall Study|Protocol Violation|5|||
33209959|NCT00518115|100670335|FG002|Overall Study|Adverse Event|5|||
33342192|NCT00328627|101141909|FG006|Overall Study|Protocol Violation|6|||
33342193|NCT00328627|101141910|FG007|Overall Study|Protocol Violation|2|||
33342194|NCT00328627|101141911|FG008|Overall Study|Protocol Violation|1|||
33342195|NCT00328627|101141912|FG009|Overall Study|Protocol Violation|4|||
33342196|NCT00328627|101141913|FG010|Overall Study|Protocol Violation|6|||
33342197|NCT00328627|101141914|FG011|Overall Study|Protocol Violation|2|||
33342198|NCT00328627|101141903|FG000|Overall Study|Lost to Follow-up|4|||
33342199|NCT00328627|101141904|FG001|Overall Study|Lost to Follow-up|2|||
33342200|NCT00328627|101141905|FG002|Overall Study|Lost to Follow-up|2|||
33342201|NCT00328627|101141906|FG003|Overall Study|Lost to Follow-up|4|||
33342202|NCT00328627|101141907|FG004|Overall Study|Lost to Follow-up|0|||
33539322|NCT03234465|101874311|FG001|Overall Study|Non-compliance|0|||
33209960|NCT00518115|100670336|FG003|Overall Study|Adverse Event|6|||
33209961|NCT00518115|100670337|FG004|Overall Study|Adverse Event|5|||
33209962|NCT00518115|100670338|FG005|Overall Study|Adverse Event|5|||
33342203|NCT00328627|101141908|FG005|Overall Study|Lost to Follow-up|2|||
33342204|NCT00328627|101141909|FG006|Overall Study|Lost to Follow-up|3|||
33342205|NCT00328627|101141910|FG007|Overall Study|Lost to Follow-up|0|||
33342206|NCT00328627|101141911|FG008|Overall Study|Lost to Follow-up|3|||
33342207|NCT00328627|101141912|FG009|Overall Study|Lost to Follow-up|2|||
33342208|NCT00328627|101141913|FG010|Overall Study|Lost to Follow-up|0|||
33539323|NCT03234465|101874310|FG000|Overall Study|Other|14|||
33539324|NCT03234465|101874311|FG001|Overall Study|Other|8|||
33539325|NCT00896493|101874314|FG000|Overall Study|Early disease relapse|3|||
33539326|NCT01317940|101874315|FG000|Overall Study|Death|1|||
33539327|NCT01317940|101874316|FG001|Overall Study|Death|0|||
33539328|NCT01317940|101874317|FG002|Overall Study|Death|1|||
33539329|NCT01317940|101874318|FG003|Overall Study|Death|0|||
33539330|NCT01317940|101874319|FG004|Overall Study|Death|0|||
33539331|NCT01317940|101874320|FG005|Overall Study|Death|0|||
33539332|NCT01317940|101874315|FG000|Overall Study|Lost to Follow-up|0|||
33539333|NCT01317940|101874316|FG001|Overall Study|Lost to Follow-up|0|||
33539334|NCT01317940|101874317|FG002|Overall Study|Lost to Follow-up|1|||
33539335|NCT01317940|101874318|FG003|Overall Study|Lost to Follow-up|1|||
33539336|NCT01317940|101874319|FG004|Overall Study|Lost to Follow-up|1|||
33539337|NCT01317940|101874320|FG005|Overall Study|Lost to Follow-up|0|||
33539338|NCT01317940|101874315|FG000|Overall Study|Change in therapy plan|0|||
33539339|NCT01317940|101874316|FG001|Overall Study|Change in therapy plan|0|||
33539340|NCT01317940|101874317|FG002|Overall Study|Change in therapy plan|3|||
33539341|NCT01317940|101874318|FG003|Overall Study|Change in therapy plan|0|||
33539342|NCT01317940|101874319|FG004|Overall Study|Change in therapy plan|0|||
33615100|NCT01248949|102140219|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
33539343|NCT01317940|101874320|FG005|Overall Study|Change in therapy plan|0|||
33209963|NCT00518115|100670339|FG006|Overall Study|Adverse Event|5|||
33539344|NCT01001429|101874321|FG000|Overall Study|surgery cancelled|0|||
33539345|NCT01001429|101874322|FG001|Overall Study|surgery cancelled|1|||
33539346|NCT01103323|101874323|FG000|Without/Before Drug Switch|Adverse Event|50|||
33539347|NCT01103323|101874324|FG001|Without/Before Drug Switch|Adverse Event|7|||
33539348|NCT01103323|101874323|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
33406234|NCT01072175|101377545|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33406235|NCT01072175|101377546|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33406236|NCT01072175|101377547|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33406237|NCT01072175|101377548|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33406238|NCT01072175|101377549|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33406239|NCT01072175|101377550|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33406240|NCT01072175|101377551|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
33406241|NCT01072175|101377552|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33406242|NCT01072175|101377553|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33406243|NCT01072175|101377554|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33406244|NCT01072175|101377555|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
33406245|NCT01072175|101377543|FG000|Part D (HPMC Capsules)|Death|0|||
33406246|NCT01072175|101377544|FG001|Part D (HPMC Capsules)|Death|0|||
33406247|NCT01072175|101377545|FG002|Part D (HPMC Capsules)|Death|0|||
33406248|NCT01072175|101377546|FG003|Part D (HPMC Capsules)|Death|0|||
33406249|NCT01072175|101377547|FG004|Part D (HPMC Capsules)|Death|0|||
33539349|NCT01103323|101874324|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
33342209|NCT00328627|101141914|FG011|Overall Study|Lost to Follow-up|1|||
33342210|NCT00328627|101141903|FG000|Overall Study|Withdrawal by Subject|5|||
33342211|NCT00328627|101141904|FG001|Overall Study|Withdrawal by Subject|4|||
33342212|NCT00328627|101141905|FG002|Overall Study|Withdrawal by Subject|5|||
33342213|NCT00328627|101141906|FG003|Overall Study|Withdrawal by Subject|6|||
33342214|NCT00328627|101141907|FG004|Overall Study|Withdrawal by Subject|2|||
33342215|NCT00328627|101141908|FG005|Overall Study|Withdrawal by Subject|5|||
33342216|NCT00328627|101141909|FG006|Overall Study|Withdrawal by Subject|4|||
33342217|NCT00328627|101141910|FG007|Overall Study|Withdrawal by Subject|4|||
33406250|NCT01072175|101377548|FG005|Part D (HPMC Capsules)|Death|0|||
33539350|NCT01103323|101874323|FG000|Without/Before Drug Switch|Protocol Violation|2|||
33539351|NCT01103323|101874324|FG001|Without/Before Drug Switch|Protocol Violation|0|||
33342218|NCT00328627|101141911|FG008|Overall Study|Withdrawal by Subject|4|||
33342219|NCT00328627|101141912|FG009|Overall Study|Withdrawal by Subject|5|||
33539352|NCT01103323|101874323|FG000|Without/Before Drug Switch|Physician Decision|2|||
33539353|NCT01103323|101874324|FG001|Without/Before Drug Switch|Physician Decision|0|||
33539354|NCT01103323|101874323|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
33539355|NCT01103323|101874324|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
33539356|NCT01103323|101874323|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
33539357|NCT01103323|101874324|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
33539358|NCT01103323|101874323|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
33539359|NCT01103323|101874324|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
33539360|NCT01884597|101874325|FG000|Overall Study|Adverse Event|0|||
33539361|NCT01884597|101874326|FG001|Overall Study|Adverse Event|0|||
33539362|NCT01884597|101874327|FG002|Overall Study|Adverse Event|1|||
33539363|NCT01884597|101874325|FG000|Overall Study|Lack of Efficacy|1|||
33539364|NCT01884597|101874326|FG001|Overall Study|Lack of Efficacy|0|||
33539365|NCT01884597|101874327|FG002|Overall Study|Lack of Efficacy|0|||
33539366|NCT01884597|101874325|FG000|Overall Study|Death|0|||
33539367|NCT01884597|101874326|FG001|Overall Study|Death|1|||
33539368|NCT01884597|101874327|FG002|Overall Study|Death|0|||
33539369|NCT02771275|101874328|FG000|Overall Study|Reoperation|3|||
33539370|NCT02771275|101874328|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
33539371|NCT02737722|101874329|FG000|Overall Study|Physician Decision|0|||
33539372|NCT02737722|101874330|FG001|Overall Study|Physician Decision|0|||
33539373|NCT02737722|101874331|FG002|Overall Study|Physician Decision|1|||
33539374|NCT02737722|101874332|FG003|Overall Study|Physician Decision|0|||
33539375|NCT03608826|101874337|FG000|Overall Study|Death|3|||
33539376|NCT03608826|101874337|FG000|Overall Study|Heart Transplant|3|||
33539377|NCT03608826|101874337|FG000|Overall Study|Physician Decision|4|||
33539378|NCT03163446|101874346|FG000|Overall Study|Unable to return for Day 180 visit|2|||
33539379|NCT03163446|101874347|FG001|Overall Study|Unable to return for Day 180 visit|0|||
33539380|NCT03163446|101874346|FG000|Overall Study|Withdrawal by Subject|2|||
33539381|NCT03163446|101874347|FG001|Overall Study|Withdrawal by Subject|6|||
33539382|NCT03163446|101874346|FG000|Overall Study|Death|16|||
33539383|NCT03163446|101874347|FG001|Overall Study|Death|5|||
33539384|NCT03163446|101874346|FG000|Overall Study|Lost to Follow-up|6|||
33539385|NCT03163446|101874347|FG001|Overall Study|Lost to Follow-up|5|||
33539386|NCT03163446|101874346|FG000|Overall Study|Physician Decision|1|||
33539387|NCT03163446|101874347|FG001|Overall Study|Physician Decision|1|||
33539388|NCT03163446|101874346|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
33539389|NCT03163446|101874347|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
33539390|NCT01701245|101874348|FG000|Overall Study|Protocol Violation|1|||
33539391|NCT01701245|101874349|FG001|Overall Study|Protocol Violation|3|||
33539392|NCT01701245|101874348|FG000|Overall Study|Did not complete the open label period|11|||
33539393|NCT01701245|101874349|FG001|Overall Study|Did not complete the open label period|12|||
33539394|NCT01548404|101874350|FG000|Overall Study|Adverse Event|3|||
33539395|NCT01548404|101874351|FG001|Overall Study|Adverse Event|1|||
33539396|NCT01548404|101874350|FG000|Overall Study|Physician Decision|2|||
33342220|NCT00328627|101141913|FG010|Overall Study|Withdrawal by Subject|2|||
33342221|NCT00328627|101141914|FG011|Overall Study|Withdrawal by Subject|7|||
33342222|NCT00328627|101141903|FG000|Overall Study|Pregnancy|0|||
33342223|NCT00328627|101141904|FG001|Overall Study|Pregnancy|1|||
33342224|NCT00328627|101141905|FG002|Overall Study|Pregnancy|0|||
33342225|NCT00328627|101141906|FG003|Overall Study|Pregnancy|0|||
33342226|NCT00328627|101141907|FG004|Overall Study|Pregnancy|0|||
33342227|NCT00328627|101141908|FG005|Overall Study|Pregnancy|0|||
33342228|NCT00328627|101141909|FG006|Overall Study|Pregnancy|0|||
33342229|NCT00328627|101141910|FG007|Overall Study|Pregnancy|0|||
33342230|NCT00328627|101141911|FG008|Overall Study|Pregnancy|0|||
33615101|NCT01248949|102140220|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
33342231|NCT00328627|101141912|FG009|Overall Study|Pregnancy|0|||
33342232|NCT00328627|101141913|FG010|Overall Study|Pregnancy|0|||
33342233|NCT00328627|101141914|FG011|Overall Study|Pregnancy|0|||
33539397|NCT01548404|101874351|FG001|Overall Study|Physician Decision|1|||
33539398|NCT01548404|101874350|FG000|Overall Study|Inadequate response to study treatment|23|||
33539399|NCT01548404|101874351|FG001|Overall Study|Inadequate response to study treatment|7|||
33539400|NCT01548404|101874350|FG000|Overall Study|Lost to Follow-up|2|||
33539401|NCT01548404|101874351|FG001|Overall Study|Lost to Follow-up|0|||
33342234|NCT00328627|101141903|FG000|Overall Study|Physician Decision|4|||
33342235|NCT00328627|101141904|FG001|Overall Study|Physician Decision|3|||
33342236|NCT00328627|101141905|FG002|Overall Study|Physician Decision|1|||
33342237|NCT00328627|101141906|FG003|Overall Study|Physician Decision|2|||
33342238|NCT00328627|101141907|FG004|Overall Study|Physician Decision|1|||
33342239|NCT00328627|101141908|FG005|Overall Study|Physician Decision|1|||
33342240|NCT00328627|101141909|FG006|Overall Study|Physician Decision|1|||
33342241|NCT00328627|101141910|FG007|Overall Study|Physician Decision|0|||
33342242|NCT00328627|101141911|FG008|Overall Study|Physician Decision|3|||
33342243|NCT00328627|101141912|FG009|Overall Study|Physician Decision|2|||
33342244|NCT00328627|101141913|FG010|Overall Study|Physician Decision|1|||
33342245|NCT00328627|101141914|FG011|Overall Study|Physician Decision|0|||
33406251|NCT01072175|101377549|FG006|Part D (HPMC Capsules)|Death|0|||
33406252|NCT01072175|101377550|FG007|Part D (HPMC Capsules)|Death|0|||
33406253|NCT01072175|101377551|FG008|Part D (HPMC Capsules)|Death|0|||
33406254|NCT01072175|101377552|FG009|Part D (HPMC Capsules)|Death|10|||
33406255|NCT01072175|101377553|FG010|Part D (HPMC Capsules)|Death|12|||
33406256|NCT01072175|101377554|FG011|Part D (HPMC Capsules)|Death|28|||
33406257|NCT01072175|101377555|FG012|Part D (HPMC Capsules)|Death|26|||
33406258|NCT01072175|101377543|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
33406259|NCT01072175|101377544|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
33406260|NCT01072175|101377545|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
33406261|NCT01072175|101377546|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
33406262|NCT01072175|101377547|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
33406263|NCT01072175|101377548|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
33406264|NCT01072175|101377549|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
33406265|NCT01072175|101377550|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
33406266|NCT01072175|101377551|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
33406267|NCT01072175|101377552|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
33406268|NCT01072175|101377553|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
33406269|NCT01072175|101377554|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
33406270|NCT01072175|101377555|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
33406271|NCT01072175|101377543|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33406272|NCT01072175|101377544|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33406273|NCT01072175|101377545|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33406274|NCT01072175|101377546|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33406275|NCT01072175|101377547|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33406276|NCT01072175|101377548|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33406277|NCT01072175|101377549|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33406278|NCT01072175|101377550|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33406279|NCT01072175|101377551|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33406280|NCT01072175|101377552|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
33406281|NCT01072175|101377553|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
33406282|NCT01072175|101377554|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
33342246|NCT00328627|101141903|FG000|Overall Study|Other|0|||
33342247|NCT00328627|101141904|FG001|Overall Study|Other|0|||
33342248|NCT00328627|101141905|FG002|Overall Study|Other|0|||
33406283|NCT01072175|101377555|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
33406284|NCT01072175|101377543|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
33406285|NCT01072175|101377544|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
33406286|NCT01072175|101377545|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
33406287|NCT01072175|101377546|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
33342249|NCT00328627|101141906|FG003|Overall Study|Other|1|||
33342250|NCT00328627|101141907|FG004|Overall Study|Other|0|||
33342251|NCT00328627|101141908|FG005|Overall Study|Other|0|||
33342252|NCT00328627|101141909|FG006|Overall Study|Other|1|||
33342253|NCT00328627|101141910|FG007|Overall Study|Other|0|||
33342254|NCT00328627|101141911|FG008|Overall Study|Other|0|||
33342255|NCT00328627|101141912|FG009|Overall Study|Other|1|||
33342256|NCT00328627|101141913|FG010|Overall Study|Other|1|||
33342257|NCT00328627|101141914|FG011|Overall Study|Other|0|||
33342258|NCT01614093|101141915|FG000|Overall Study|Withdrawal by Subject|1|||
33342259|NCT03604445|101141916|FG000|Overall Study|Death|0|||
33342260|NCT03604445|101141917|FG001|Overall Study|Death|0|||
33342261|NCT03604445|101141918|FG002|Overall Study|Death|0|||
33406288|NCT01072175|101377547|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
33406289|NCT01072175|101377548|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
33406290|NCT01072175|101377549|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
33406291|NCT01072175|101377550|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
33406292|NCT01072175|101377551|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
33406293|NCT01072175|101377552|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
33406294|NCT01072175|101377553|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
33406295|NCT01072175|101377554|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
33406296|NCT01072175|101377555|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
33342262|NCT03604445|101141919|FG003|Overall Study|Death|0|||
33342263|NCT03604445|101141920|FG004|Overall Study|Death|0|||
33342264|NCT03604445|101141921|FG005|Overall Study|Death|0|||
33342265|NCT03604445|101141922|FG006|Overall Study|Death|0|||
33406297|NCT01072175|101377543|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33342266|NCT03604445|101141923|FG007|Overall Study|Death|0|||
33342267|NCT03604445|101141924|FG008|Overall Study|Death|1|||
33342268|NCT03604445|101141916|FG000|Overall Study|Withdrawal by Subject|0|||
33539402|NCT01548404|101874350|FG000|Overall Study|Withdrawal by Subject|0|||
33539403|NCT01548404|101874351|FG001|Overall Study|Withdrawal by Subject|3|||
33539404|NCT01548404|101874350|FG000|Overall Study|Other than specified above|0|||
33539405|NCT01548404|101874351|FG001|Overall Study|Other than specified above|2|||
33539406|NCT03054428|101874352|FG000|Overall Study|Physician Decision|0|||
33539407|NCT03054428|101874353|FG001|Overall Study|Physician Decision|1|||
33539408|NCT03054428|101874354|FG002|Overall Study|Physician Decision|1|||
33539409|NCT03054428|101874352|FG000|Overall Study|Lack of Efficacy|3|||
33539410|NCT03054428|101874353|FG001|Overall Study|Lack of Efficacy|1|||
33539411|NCT03054428|101874354|FG002|Overall Study|Lack of Efficacy|0|||
33539412|NCT03054428|101874352|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
33539413|NCT03054428|101874353|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
33539414|NCT03054428|101874354|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
33539415|NCT03054428|101874352|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
33539416|NCT03054428|101874353|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
33539417|NCT03054428|101874354|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
33539418|NCT03054428|101874352|FG000|Overall Study|Transitioned to OLE study|76|||
33539419|NCT03054428|101874353|FG001|Overall Study|Transitioned to OLE study|76|||
33539420|NCT03054428|101874354|FG002|Overall Study|Transitioned to OLE study|73|||
33539421|NCT03054428|101874352|FG000|Overall Study|Withdrawal by Subject|3|||
33539422|NCT03054428|101874353|FG001|Overall Study|Withdrawal by Subject|2|||
33539423|NCT03054428|101874354|FG002|Overall Study|Withdrawal by Subject|3|||
33539424|NCT03054428|101874352|FG000|Overall Study|Lost to Follow-up|0|||
33539425|NCT03054428|101874353|FG001|Overall Study|Lost to Follow-up|0|||
33539426|NCT03054428|101874354|FG002|Overall Study|Lost to Follow-up|1|||
33539427|NCT00427934|101874360|FG000|Overall Study|Adverse Event|1|||
33539428|NCT00427934|101874361|FG001|Overall Study|Adverse Event|0|||
33539429|NCT00427934|101874362|FG002|Overall Study|Adverse Event|5|||
33539430|NCT00427934|101874363|FG003|Overall Study|Adverse Event|4|||
33539431|NCT00427934|101874360|FG000|Overall Study|Lack of Efficacy|0|||
33539432|NCT00427934|101874361|FG001|Overall Study|Lack of Efficacy|0|||
33539433|NCT00427934|101874362|FG002|Overall Study|Lack of Efficacy|5|||
33539434|NCT00427934|101874363|FG003|Overall Study|Lack of Efficacy|2|||
33539435|NCT00427934|101874360|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
33539436|NCT00427934|101874361|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
33539437|NCT00427934|101874362|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
33539438|NCT00427934|101874363|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
33539439|NCT00427934|101874360|FG000|Overall Study|Other|0|||
33539440|NCT00427934|101874361|FG001|Overall Study|Other|0|||
33539441|NCT00427934|101874362|FG002|Overall Study|Other|11|||
33539442|NCT00427934|101874363|FG003|Overall Study|Other|5|||
33539443|NCT00427934|101874360|FG000|Overall Study|Withdrawal by Subject|0|||
33539444|NCT00427934|101874361|FG001|Overall Study|Withdrawal by Subject|0|||
33539445|NCT00427934|101874362|FG002|Overall Study|Withdrawal by Subject|1|||
33539446|NCT00427934|101874363|FG003|Overall Study|Withdrawal by Subject|3|||
33539447|NCT03642990|101874368|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
33539448|NCT03642990|101874368|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
33539449|NCT01294423|101874369|FG000|Overall Study|Adverse Event|1|||
33539450|NCT01294423|101874370|FG001|Overall Study|Adverse Event|2|||
33539451|NCT01294423|101874371|FG002|Overall Study|Adverse Event|3|||
33539452|NCT01294423|101874369|FG000|Overall Study|Withdrawal by Subject|1|||
33539453|NCT01294423|101874370|FG001|Overall Study|Withdrawal by Subject|2|||
33539454|NCT01294423|101874371|FG002|Overall Study|Withdrawal by Subject|2|||
33539455|NCT01294423|101874369|FG000|Overall Study|subject no longer meets study criteria|2|||
33539456|NCT01294423|101874370|FG001|Overall Study|subject no longer meets study criteria|5|||
33539457|NCT01294423|101874371|FG002|Overall Study|subject no longer meets study criteria|2|||
33539458|NCT01294423|101874369|FG000|Overall Study|poor/non-compliance|1|||
33539459|NCT01294423|101874370|FG001|Overall Study|poor/non-compliance|0|||
33539460|NCT01294423|101874371|FG002|Overall Study|poor/non-compliance|1|||
33539461|NCT01604785|101874372|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
33539462|NCT01604785|101874373|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
33539463|NCT00192114|101874376|FG000|Overall Study|Objective Tumor Progression|19|||
33539464|NCT00192114|101874376|FG000|Overall Study|Adverse Event|2|||
33539465|NCT00192114|101874376|FG000|Overall Study|Clinical Progression|2|||
33539466|NCT00192114|101874376|FG000|Overall Study|Death|1|||
33539467|NCT00848497|101874385|FG000|Overall Study|Screen failure|2|||
33539468|NCT00848497|101874386|FG001|Overall Study|Screen failure|0|||
33539469|NCT00848497|101874385|FG000|Overall Study|Withdrawal by Subject|0|||
33539470|NCT00848497|101874386|FG001|Overall Study|Withdrawal by Subject|1|||
33539471|NCT02063672|101874387|FG000|Overall Study|Ongoing Follow-up|27|||
33539472|NCT02063672|101874388|FG001|Overall Study|Ongoing Follow-up|14|||
33539473|NCT02063672|101874387|FG000|Overall Study|Death|5|||
33539474|NCT02063672|101874388|FG001|Overall Study|Death|3|||
33539475|NCT02063672|101874387|FG000|Overall Study|Lost to Follow-up|1|||
33539476|NCT02063672|101874388|FG001|Overall Study|Lost to Follow-up|3|||
33539477|NCT02063672|101874387|FG000|Overall Study|Withdrawal by Subject|2|||
33539478|NCT02063672|101874388|FG001|Overall Study|Withdrawal by Subject|2|||
33539479|NCT01302899|101874389|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
33539480|NCT01302899|101874390|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
33539481|NCT01302899|101874389|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
33539482|NCT01302899|101874390|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
33539483|NCT03964207|101874391|FG000|First Treatment|Withdrawal by Subject|1|||
33539484|NCT03964207|101874392|FG001|First Treatment|Withdrawal by Subject|2|||
33539485|NCT03964207|101874391|FG000|First Treatment|Protocol Violation|1|||
33539486|NCT03964207|101874392|FG001|First Treatment|Protocol Violation|0|||
33539487|NCT03964207|101874391|FG000|First Treatment|Lost to Follow-up|1|||
33539488|NCT03964207|101874392|FG001|First Treatment|Lost to Follow-up|0|||
33539489|NCT03964207|101874391|FG000|Second Treatment|Lost to Follow-up|0|||
33539490|NCT03964207|101874392|FG001|Second Treatment|Lost to Follow-up|1|||
33539491|NCT03964207|101874391|FG000|Second Treatment|Adverse Event|1|||
33539492|NCT03964207|101874392|FG001|Second Treatment|Adverse Event|2|||
33539493|NCT01715831|101874394|FG000|Overall Study|Adverse Event|1|||
33539494|NCT03074500|101874395|FG000|Overall Study|Lost to Follow-up|1|||
33539495|NCT03074500|101874396|FG001|Overall Study|Lost to Follow-up|0|||
33539496|NCT03074500|101874397|FG002|Overall Study|Lost to Follow-up|0|||
33539497|NCT03074500|101874395|FG000|Overall Study|Lack of Efficacy|0|||
33539498|NCT03074500|101874396|FG001|Overall Study|Lack of Efficacy|1|||
33539499|NCT03074500|101874397|FG002|Overall Study|Lack of Efficacy|0|||
33539500|NCT03074500|101874395|FG000|Overall Study|Adverse Event|0|||
33539501|NCT03074500|101874396|FG001|Overall Study|Adverse Event|0|||
33539502|NCT03074500|101874397|FG002|Overall Study|Adverse Event|1|||
33539503|NCT01863771|101874398|FG000|Induction Phase|Adverse Event|9|||
33539504|NCT01863771|101874399|FG001|Induction Phase|Adverse Event|0|||
33539505|NCT01863771|101874400|FG002|Induction Phase|Adverse Event|0|||
33539506|NCT01863771|101874401|FG003|Induction Phase|Adverse Event|0|||
33539507|NCT01863771|101874398|FG000|Induction Phase|Lack of Efficacy|10|||
33539508|NCT01863771|101874399|FG001|Induction Phase|Lack of Efficacy|0|||
33539509|NCT01863771|101874400|FG002|Induction Phase|Lack of Efficacy|0|||
33539510|NCT01863771|101874401|FG003|Induction Phase|Lack of Efficacy|0|||
33539511|NCT01863771|101874398|FG000|Induction Phase|Withdrawal by Subject|2|||
33539512|NCT01863771|101874399|FG001|Induction Phase|Withdrawal by Subject|0|||
33539513|NCT01863771|101874400|FG002|Induction Phase|Withdrawal by Subject|0|||
33539514|NCT01863771|101874401|FG003|Induction Phase|Withdrawal by Subject|0|||
33539515|NCT01863771|101874398|FG000|Maintenance Phase|Adverse Event|0|||
33539516|NCT01863771|101874399|FG001|Maintenance Phase|Adverse Event|0|||
33539517|NCT01863771|101874400|FG002|Maintenance Phase|Adverse Event|1|||
33539518|NCT01863771|101874401|FG003|Maintenance Phase|Adverse Event|1|||
33539519|NCT01863771|101874398|FG000|Maintenance Phase|Lack of Efficacy|0|||
33539520|NCT01863771|101874399|FG001|Maintenance Phase|Lack of Efficacy|3|||
33539521|NCT01863771|101874400|FG002|Maintenance Phase|Lack of Efficacy|7|||
33342269|NCT03604445|101141917|FG001|Overall Study|Withdrawal by Subject|0|||
33539522|NCT01863771|101874401|FG003|Maintenance Phase|Lack of Efficacy|38|||
33539523|NCT01863771|101874398|FG000|Maintenance Phase|Physician Decision|0|||
33539524|NCT01863771|101874399|FG001|Maintenance Phase|Physician Decision|0|||
33539525|NCT01863771|101874400|FG002|Maintenance Phase|Physician Decision|2|||
33539526|NCT01863771|101874401|FG003|Maintenance Phase|Physician Decision|1|||
33539527|NCT01863771|101874398|FG000|Maintenance Phase|Pregnancy|0|||
33539528|NCT01863771|101874399|FG001|Maintenance Phase|Pregnancy|1|||
33539529|NCT01863771|101874400|FG002|Maintenance Phase|Pregnancy|0|||
33539530|NCT01863771|101874401|FG003|Maintenance Phase|Pregnancy|0|||
33539531|NCT01863771|101874398|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33539532|NCT01863771|101874399|FG001|Maintenance Phase|Withdrawal by Subject|1|||
33539533|NCT01863771|101874400|FG002|Maintenance Phase|Withdrawal by Subject|2|||
33539534|NCT01863771|101874401|FG003|Maintenance Phase|Withdrawal by Subject|3|||
33539535|NCT00666237|101874405|FG000|Overall Study|Death|5|||
33342270|NCT03604445|101141918|FG002|Overall Study|Withdrawal by Subject|0|||
33342271|NCT03604445|101141919|FG003|Overall Study|Withdrawal by Subject|0|||
33539536|NCT00666237|101874406|FG001|Overall Study|Death|5|||
33539537|NCT00666237|101874405|FG000|Overall Study|Lost to Follow-up|29|||
33539538|NCT00666237|101874406|FG001|Overall Study|Lost to Follow-up|25|||
33539539|NCT03248037|101874407|FG000|Overall Study|Withdrawal by Subject|6|||
33342272|NCT03604445|101141920|FG004|Overall Study|Withdrawal by Subject|0|||
33539540|NCT03248037|101874408|FG001|Overall Study|Withdrawal by Subject|9|||
33342273|NCT03604445|101141921|FG005|Overall Study|Withdrawal by Subject|0|||
33539541|NCT03248037|101874407|FG000|Overall Study|Adverse Event|15|||
33539542|NCT03248037|101874408|FG001|Overall Study|Adverse Event|0|||
33539543|NCT03074695|101874409|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
33539544|NCT03074695|101874410|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
33342274|NCT03604445|101141922|FG006|Overall Study|Withdrawal by Subject|1|||
33342275|NCT03604445|101141923|FG007|Overall Study|Withdrawal by Subject|0|||
33342276|NCT03604445|101141924|FG008|Overall Study|Withdrawal by Subject|0|||
33342277|NCT03604445|101141916|FG000|Overall Study|Missing visit|0|||
33342278|NCT03604445|101141917|FG001|Overall Study|Missing visit|0|||
33342279|NCT03604445|101141918|FG002|Overall Study|Missing visit|0|||
33342280|NCT03604445|101141919|FG003|Overall Study|Missing visit|0|||
33342281|NCT03604445|101141920|FG004|Overall Study|Missing visit|0|||
33342282|NCT03604445|101141921|FG005|Overall Study|Missing visit|1|||
33342283|NCT03604445|101141922|FG006|Overall Study|Missing visit|0|||
33342284|NCT03604445|101141923|FG007|Overall Study|Missing visit|1|||
33342285|NCT03604445|101141924|FG008|Overall Study|Missing visit|0|||
33342286|NCT03604445|101141916|FG000|Overall Study|Adverse Event|0|||
33342287|NCT03604445|101141917|FG001|Overall Study|Adverse Event|0|||
33342288|NCT03604445|101141918|FG002|Overall Study|Adverse Event|0|||
33342289|NCT03604445|101141919|FG003|Overall Study|Adverse Event|1|||
33342290|NCT03604445|101141920|FG004|Overall Study|Adverse Event|0|||
33342291|NCT03604445|101141921|FG005|Overall Study|Adverse Event|0|||
33342292|NCT03604445|101141922|FG006|Overall Study|Adverse Event|0|||
33342293|NCT03604445|101141923|FG007|Overall Study|Adverse Event|0|||
33342294|NCT03604445|101141924|FG008|Overall Study|Adverse Event|1|||
33342295|NCT02627495|101141925|FG000|Overall Study|Withdrawal by Subject|4|||
33342296|NCT02445586|101141926|FG000|Overall Study|Death|14|||
33342297|NCT02445586|101141926|FG000|Overall Study|Withdrawal by Subject|13|||
33342298|NCT02445586|101141926|FG000|Overall Study|Disease Progression|10|||
33342299|NCT02445586|101141926|FG000|Overall Study|Protocol Violation|1|||
33342300|NCT02445586|101141926|FG000|Overall Study|Medical Condition|1|||
33342301|NCT01459614|101141927|FG000|Overall Study|Adverse Event|1|||
33406298|NCT01072175|101377544|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33406299|NCT01072175|101377545|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33406300|NCT01072175|101377546|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33406301|NCT01072175|101377547|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33406302|NCT01072175|101377548|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33406303|NCT01072175|101377549|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33406304|NCT01072175|101377550|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33406305|NCT01072175|101377551|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33406306|NCT01072175|101377552|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33406307|NCT01072175|101377553|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
33406308|NCT01072175|101377554|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
33406309|NCT01072175|101377555|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
33406310|NCT01928758|101377556|FG000|Overall Study|Lost to Follow-up|14|||
33406311|NCT01928758|101377557|FG001|Overall Study|Lost to Follow-up|9|||
33406312|NCT01928758|101377556|FG000|Overall Study|Withdrawal by Subject|5|||
33406313|NCT01928758|101377557|FG001|Overall Study|Withdrawal by Subject|2|||
33406314|NCT01928758|101377556|FG000|Overall Study|Adverse Event|3|||
33406315|NCT01928758|101377557|FG001|Overall Study|Adverse Event|5|||
33406316|NCT01928758|101377556|FG000|Overall Study|Protocol Violation|3|||
33406317|NCT01928758|101377557|FG001|Overall Study|Protocol Violation|4|||
33406318|NCT00883896|101377558|FG000|Overall Study|Lost to Follow-up|0|||
33406319|NCT00883896|101377559|FG001|Overall Study|Lost to Follow-up|0|||
33406320|NCT00883896|101377560|FG002|Overall Study|Lost to Follow-up|0|||
33406321|NCT00883896|101377561|FG003|Overall Study|Lost to Follow-up|2|||
33406322|NCT00883896|101377558|FG000|Overall Study|Withdrawal by Subject|5|||
33406323|NCT00883896|101377559|FG001|Overall Study|Withdrawal by Subject|0|||
33406324|NCT00883896|101377560|FG002|Overall Study|Withdrawal by Subject|1|||
33406325|NCT00883896|101377561|FG003|Overall Study|Withdrawal by Subject|3|||
33406326|NCT00883896|101377558|FG000|Overall Study|Lack of Efficacy|0|||
33539545|NCT03074695|101874409|FG000|Overall Study|Research staff not available|1|||
33539546|NCT03074695|101874410|FG001|Overall Study|Research staff not available|2|||
33406327|NCT00883896|101377559|FG001|Overall Study|Lack of Efficacy|0|||
33406328|NCT00883896|101377560|FG002|Overall Study|Lack of Efficacy|0|||
33539547|NCT03074695|101874409|FG000|Overall Study|Did not receive neuraxial block|2|||
33539548|NCT03074695|101874410|FG001|Overall Study|Did not receive neuraxial block|2|||
33342302|NCT01459614|101141928|FG001|Overall Study|Adverse Event|0|||
33342303|NCT01699087|101141929|FG000|Overall Study|Lost to Follow-up|7|||
33342304|NCT01699087|101141929|FG000|Overall Study|Screen failure (prior to treatment)|15|||
33342305|NCT01699087|101141929|FG000|Overall Study|Unable to make future visits|2|||
33342306|NCT02793232|101141936|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
33406329|NCT00883896|101377561|FG003|Overall Study|Lack of Efficacy|2|||
33342307|NCT02793232|101141937|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
33342308|NCT02793232|101141938|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
33342309|NCT02793232|101141939|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
33342310|NCT02793232|101141940|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
33406330|NCT00883896|101377558|FG000|Overall Study|Other|1|||
33406331|NCT00883896|101377559|FG001|Overall Study|Other|0|||
33406332|NCT00883896|101377560|FG002|Overall Study|Other|0|||
33406333|NCT00883896|101377561|FG003|Overall Study|Other|0|||
33539549|NCT03504917|101874416|FG000|Blinded Treatment Period|Protocol Violation|1|||
33539550|NCT03504917|101874417|FG001|Blinded Treatment Period|Protocol Violation|0|||
33539551|NCT03504917|101874416|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
33539552|NCT03504917|101874417|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
33539553|NCT03504917|101874416|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
33539554|NCT03504917|101874417|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
33539555|NCT03504917|101874416|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
33539556|NCT03504917|101874417|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
33539557|NCT03504917|101874416|FG000|Blinded Treatment Period|Adverse Event|4|||
33539558|NCT03504917|101874417|FG001|Blinded Treatment Period|Adverse Event|4|||
33539559|NCT03504917|101874416|FG000|Blinded Treatment Period|Physician Decision|1|||
33539560|NCT03504917|101874417|FG001|Blinded Treatment Period|Physician Decision|0|||
33539561|NCT03504917|101874416|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
33539562|NCT03504917|101874417|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
33539563|NCT03504917|101874416|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
33539564|NCT03504917|101874417|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
33209964|NCT00518115|100670340|FG007|Overall Study|Adverse Event|10|||
33209965|NCT00518115|100670341|FG008|Overall Study|Adverse Event|2|||
33615102|NCT01248949|102140221|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
33209966|NCT00518115|100670342|FG009|Overall Study|Adverse Event|9|||
33406334|NCT00711009|101377562|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
33209967|NCT00518115|100670333|FG000|Overall Study|Lost to Follow-up|0|||
33406335|NCT00711009|101377563|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
33406336|NCT00711009|101377562|FG000|Overall Study|Withdrawal by Subject|4|||
33406337|NCT00711009|101377563|FG001|Overall Study|Withdrawal by Subject|2|||
33406338|NCT00711009|101377562|FG000|Overall Study|Lost to Follow-up|3|||
33406339|NCT00711009|101377563|FG001|Overall Study|Lost to Follow-up|9|||
33406340|NCT00711009|101377562|FG000|Overall Study|Participant Noncompliant|0|||
33406341|NCT00711009|101377563|FG001|Overall Study|Participant Noncompliant|1|||
33406342|NCT00711009|101377562|FG000|Overall Study|Virologic Failure|2|||
33342311|NCT02793232|101141941|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
33342312|NCT02793232|101141942|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
33342313|NCT02793232|101141943|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
33342314|NCT02793232|101141944|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
33342315|NCT00105443|101141946|FG000|Double-Blind Treatment|Adverse Event|1|||
33342316|NCT00105443|101141947|FG001|Double-Blind Treatment|Adverse Event|0|||
33342317|NCT00105443|101141948|FG002|Double-Blind Treatment|Adverse Event|0|||
33342318|NCT00105443|101141949|FG003|Double-Blind Treatment|Adverse Event|0|||
33342319|NCT00105443|101141946|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
33342320|NCT00105443|101141947|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
33342321|NCT00105443|101141948|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
33342322|NCT00105443|101141949|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
33342323|NCT00105443|101141946|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
33342324|NCT00105443|101141947|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
33342325|NCT00105443|101141948|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
33342326|NCT00105443|101141949|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
33342327|NCT00105443|101141946|FG000|Double-Blind Treatment|Physician Decision|1|||
33342328|NCT00105443|101141947|FG001|Double-Blind Treatment|Physician Decision|0|||
33342329|NCT00105443|101141948|FG002|Double-Blind Treatment|Physician Decision|2|||
33342330|NCT00105443|101141949|FG003|Double-Blind Treatment|Physician Decision|0|||
33342331|NCT00105443|101141946|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
33342332|NCT00105443|101141947|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
33342333|NCT00105443|101141948|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
33342334|NCT00105443|101141949|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
33342335|NCT00105443|101141946|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
33342336|NCT00105443|101141947|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
33342337|NCT00105443|101141948|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
33342338|NCT00105443|101141949|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
33342339|NCT00105443|101141946|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
33342340|NCT00105443|101141947|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
33342341|NCT00105443|101141948|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
33342342|NCT00105443|101141949|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
33342343|NCT00105443|101141946|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
33342344|NCT00105443|101141947|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
33342345|NCT00105443|101141948|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
33342346|NCT00105443|101141949|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
33342347|NCT00105443|101141946|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
33342348|NCT00105443|101141947|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
33342349|NCT00105443|101141948|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
33342350|NCT00105443|101141949|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
33406343|NCT00711009|101377563|FG001|Overall Study|Virologic Failure|1|||
33406344|NCT00711009|101377562|FG000|Overall Study|Pregnancy|1|||
33406345|NCT00711009|101377563|FG001|Overall Study|Pregnancy|0|||
33406346|NCT00711009|101377562|FG000|Overall Study|Site closing|0|||
33406347|NCT00711009|101377563|FG001|Overall Study|Site closing|1|||
33342351|NCT00105443|101141946|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
33342352|NCT00105443|101141947|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
33342353|NCT00105443|101141948|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
33342354|NCT00105443|101141949|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
33342355|NCT00105443|101141946|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
33342356|NCT00105443|101141947|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
33342357|NCT00105443|101141948|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
33342358|NCT00105443|101141949|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
33342359|NCT00105443|101141946|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
33342360|NCT00105443|101141947|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
33342361|NCT00105443|101141948|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
33406348|NCT00711009|101377562|FG000|Overall Study|Dose adjustment|1|||
33406349|NCT00711009|101377563|FG001|Overall Study|Dose adjustment|0|||
33342362|NCT00105443|101141949|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
33539565|NCT03504917|101874416|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
33539566|NCT03504917|101874417|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
33539567|NCT03504917|101874416|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
33539568|NCT03504917|101874417|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
33539569|NCT03504917|101874416|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
33539570|NCT03504917|101874417|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
33539571|NCT03504917|101874416|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
33539572|NCT03504917|101874417|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
33539573|NCT03504917|101874416|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
33539574|NCT03504917|101874417|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
33539575|NCT03504917|101874416|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
33539576|NCT03504917|101874417|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
33539577|NCT03504917|101874416|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
33539578|NCT03504917|101874417|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
33539579|NCT03504917|101874416|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
33539580|NCT03504917|101874417|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
33539581|NCT01155570|101874418|FG000|Overall Study|Adverse Event|39|||
33539582|NCT01155570|101874418|FG000|Overall Study|Lack of Efficacy|46|||
33539583|NCT01155570|101874418|FG000|Overall Study|Participant's Economic Reasons|17|||
33539584|NCT01155570|101874418|FG000|Overall Study|No Hospital Visits|7|||
33539585|NCT01155570|101874418|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
33539586|NCT01155570|101874418|FG000|Overall Study|Adverse Event + Other Reasons|7|||
33539587|NCT01155570|101874418|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
33539588|NCT01155570|101874418|FG000|Overall Study|Other Reasons|23|||
33539589|NCT02814526|101874419|FG000|Overall Study|Adverse Event|4|||
33539590|NCT02814526|101874420|FG001|Overall Study|Adverse Event|3|||
33539591|NCT02814526|101874419|FG000|Overall Study|Death|1|||
33539592|NCT02814526|101874420|FG001|Overall Study|Death|1|||
33539593|NCT02814526|101874419|FG000|Overall Study|Lost to Follow-up|3|||
33539594|NCT02814526|101874420|FG001|Overall Study|Lost to Follow-up|4|||
33539595|NCT02814526|101874419|FG000|Overall Study|non site physician decision|1|||
33539596|NCT02814526|101874420|FG001|Overall Study|non site physician decision|0|||
33539597|NCT02814526|101874419|FG000|Overall Study|participant noncompliance|1|||
33539598|NCT02814526|101874420|FG001|Overall Study|participant noncompliance|1|||
33539599|NCT02814526|101874419|FG000|Overall Study|Withdrawal by Subject|20|||
33342363|NCT00105443|101141946|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
33342364|NCT00105443|101141947|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
33539600|NCT02814526|101874420|FG001|Overall Study|Withdrawal by Subject|14|||
33539601|NCT02814526|101874419|FG000|Overall Study|safety risk|2|||
33539602|NCT02814526|101874420|FG001|Overall Study|safety risk|1|||
33539603|NCT02814526|101874419|FG000|Overall Study|early termination-study terminated|1|||
33539604|NCT02814526|101874420|FG001|Overall Study|early termination-study terminated|2|||
33539605|NCT02814526|101874419|FG000|Overall Study|Other|0|||
33539606|NCT02814526|101874420|FG001|Overall Study|Other|4|||
33539607|NCT00997334|101874421|FG000|Overall Study|still on therapy|12|||
33539608|NCT00997334|101874421|FG000|Overall Study|Adverse Event|3|||
33539609|NCT00997334|101874421|FG000|Overall Study|Patient non-compliance|1|||
33539610|NCT00997334|101874421|FG000|Overall Study|Withdrawal by Subject|3|||
33539611|NCT00997334|101874421|FG000|Overall Study|Death|2|||
33539612|NCT00997334|101874421|FG000|Overall Study|Urgent Palliative Care|2|||
33539613|NCT00997334|101874421|FG000|Overall Study|No lesion amenable|1|||
33539614|NCT00997334|101874421|FG000|Overall Study|Ineligible|1|||
33209968|NCT00518115|100670334|FG001|Overall Study|Lost to Follow-up|0|||
33209969|NCT00518115|100670335|FG002|Overall Study|Lost to Follow-up|2|||
33342365|NCT00105443|101141948|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
33406350|NCT01233284|101377564|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
33406351|NCT01233284|101377565|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33406352|NCT01233284|101377566|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33406353|NCT01233284|101377567|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33406354|NCT01233284|101377568|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33406355|NCT01233284|101377564|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
33406356|NCT01233284|101377565|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
33406357|NCT01233284|101377566|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
33406358|NCT01233284|101377567|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
33406359|NCT01233284|101377568|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
33406360|NCT01233284|101377564|FG000|Period 1 (4 Weeks)|Other|0|||
33406361|NCT01233284|101377565|FG001|Period 1 (4 Weeks)|Other|0|||
33406362|NCT01233284|101377566|FG002|Period 1 (4 Weeks)|Other|1|||
33406363|NCT01233284|101377567|FG003|Period 1 (4 Weeks)|Other|0|||
33406364|NCT01233284|101377568|FG004|Period 1 (4 Weeks)|Other|0|||
33406365|NCT01233284|101377564|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33406366|NCT01233284|101377565|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33406367|NCT01233284|101377566|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
33406368|NCT01233284|101377567|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33406369|NCT01233284|101377568|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33539615|NCT01411852|101874429|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
33539616|NCT01411852|101874430|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
33539617|NCT01411852|101874429|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
33539618|NCT01411852|101874430|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
33539619|NCT01411852|101874429|FG000|Prehospital Intervention Phase|Found to be under age|0|||
33539620|NCT01411852|101874430|FG001|Prehospital Intervention Phase|Found to be under age|1|||
33539621|NCT01411852|101874429|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
33539622|NCT01411852|101874430|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
33342366|NCT00105443|101141949|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
33342367|NCT00105443|101141946|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
33342368|NCT00105443|101141947|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
33342369|NCT00105443|101141948|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
33342370|NCT00105443|101141949|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
33342371|NCT00105443|101141946|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
33342372|NCT00105443|101141947|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
33342373|NCT00105443|101141948|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
33342374|NCT00105443|101141949|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
33342375|NCT00105443|101141946|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
33342376|NCT00105443|101141947|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
33342377|NCT00105443|101141948|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
33342378|NCT00105443|101141949|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
33342379|NCT00105443|101141946|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
33342380|NCT00105443|101141947|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
33342381|NCT00105443|101141948|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
33342382|NCT00105443|101141949|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
33342383|NCT00105443|101141946|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
33342384|NCT00105443|101141947|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
33342385|NCT00105443|101141948|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
33342386|NCT00105443|101141949|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
33342387|NCT00105443|101141946|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
33342388|NCT00105443|101141947|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
33342389|NCT00105443|101141948|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
33342390|NCT00105443|101141949|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
33342391|NCT01396005|101141954|FG000|Overall Study|Withdrawal by Subject|0|||
33342392|NCT01396005|101141955|FG001|Overall Study|Withdrawal by Subject|1|||
33342393|NCT01396005|101141954|FG000|Overall Study|Non-compliance with protocol|0|||
33342394|NCT01396005|101141955|FG001|Overall Study|Non-compliance with protocol|1|||
33342395|NCT02083380|101141956|FG000|Overall Study|Lack of Efficacy|68|||
33342396|NCT02083380|101141957|FG001|Overall Study|Lack of Efficacy|79|||
33342397|NCT02083380|101141958|FG002|Overall Study|Lack of Efficacy|64|||
33342398|NCT02083380|101141956|FG000|Overall Study|Withdrawal by Subject|9|||
33539623|NCT01411852|101874429|FG000|Hospital Intervention Phase|Severe head injury|5|||
33539624|NCT01411852|101874430|FG001|Hospital Intervention Phase|Severe head injury|4|||
33406370|NCT01233284|101377564|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
33406371|NCT01233284|101377565|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
33342399|NCT02083380|101141957|FG001|Overall Study|Withdrawal by Subject|3|||
33342400|NCT02083380|101141958|FG002|Overall Study|Withdrawal by Subject|7|||
33539625|NCT01411852|101874429|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
33539626|NCT01411852|101874430|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
33539627|NCT01411852|101874429|FG000|Hospital Intervention Phase|Miscommunication error|1|||
33539628|NCT01411852|101874430|FG001|Hospital Intervention Phase|Miscommunication error|2|||
33539629|NCT01411852|101874429|FG000|Hospital Intervention Phase|CPR administered|3|||
33539630|NCT01411852|101874430|FG001|Hospital Intervention Phase|CPR administered|1|||
33539631|NCT01411852|101874429|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
33342401|NCT02083380|101141956|FG000|Overall Study|Physician Decision|1|||
33342402|NCT02083380|101141957|FG001|Overall Study|Physician Decision|6|||
33342403|NCT02083380|101141958|FG002|Overall Study|Physician Decision|3|||
33342404|NCT02083380|101141956|FG000|Overall Study|Adverse Event|0|||
33342405|NCT02083380|101141957|FG001|Overall Study|Adverse Event|0|||
33342406|NCT02083380|101141958|FG002|Overall Study|Adverse Event|1|||
33342407|NCT02083380|101141956|FG000|Overall Study|Lost to Follow-up|5|||
33539632|NCT01411852|101874430|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
33539633|NCT01411852|101874429|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
33539634|NCT01411852|101874430|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
33539635|NCT01411852|101874429|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
33539636|NCT01411852|101874430|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
33539637|NCT01411852|101874429|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
33539638|NCT01411852|101874430|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
33539639|NCT01411852|101874429|FG000|Hospital Intervention Phase|Other ineligible|2|||
33539640|NCT01411852|101874430|FG001|Hospital Intervention Phase|Other ineligible|2|||
33539641|NCT01411852|101874429|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
33539642|NCT01411852|101874430|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
33539643|NCT01411852|101874429|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
33539644|NCT01411852|101874430|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
33539645|NCT01411852|101874429|FG000|Hospital Intervention Phase|Vascular access failed|1|||
33539646|NCT01411852|101874430|FG001|Hospital Intervention Phase|Vascular access failed|0|||
33539647|NCT03311555|101874431|FG000|Overall Study|Adverse Event|1|||
33539648|NCT01787552|101874432|FG000|Overall Study|Withdrawal by Subject|2|||
33539649|NCT01787552|101874433|FG001|Overall Study|Withdrawal by Subject|0|||
33539650|NCT01787552|101874434|FG002|Overall Study|Withdrawal by Subject|0|||
33539651|NCT01787552|101874435|FG003|Overall Study|Withdrawal by Subject|4|||
33539652|NCT01787552|101874432|FG000|Overall Study|Physician Decision|2|||
33539653|NCT01787552|101874433|FG001|Overall Study|Physician Decision|2|||
33539654|NCT01787552|101874434|FG002|Overall Study|Physician Decision|1|||
33615103|NCT01248949|102140222|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
33615104|NCT01248949|102140223|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
33615105|NCT01248949|102140219|FG000|Overall Study|Participant Went To Hospice|0|||
33615106|NCT01248949|102140220|FG001|Overall Study|Participant Went To Hospice|0|||
33539655|NCT01787552|101874435|FG003|Overall Study|Physician Decision|2|||
33615107|NCT01248949|102140221|FG002|Overall Study|Participant Went To Hospice|1|||
33342408|NCT02083380|101141957|FG001|Overall Study|Lost to Follow-up|3|||
33342409|NCT02083380|101141958|FG002|Overall Study|Lost to Follow-up|3|||
33539656|NCT01787552|101874432|FG000|Overall Study|Death|0|||
33539657|NCT01787552|101874433|FG001|Overall Study|Death|0|||
33539658|NCT01787552|101874434|FG002|Overall Study|Death|0|||
33539659|NCT01787552|101874435|FG003|Overall Study|Death|1|||
33539660|NCT01787552|101874432|FG000|Overall Study|Adverse Event|2|||
33539661|NCT01787552|101874433|FG001|Overall Study|Adverse Event|5|||
33539662|NCT01787552|101874434|FG002|Overall Study|Adverse Event|2|||
33539663|NCT01787552|101874435|FG003|Overall Study|Adverse Event|16|||
33539664|NCT01787552|101874432|FG000|Overall Study|Study terminated by Sponsor|0|||
33539665|NCT01787552|101874433|FG001|Overall Study|Study terminated by Sponsor|0|||
33539666|NCT01787552|101874434|FG002|Overall Study|Study terminated by Sponsor|1|||
33539667|NCT01787552|101874435|FG003|Overall Study|Study terminated by Sponsor|3|||
33539668|NCT01787552|101874432|FG000|Overall Study|Progressive Disease|2|||
33539669|NCT01787552|101874433|FG001|Overall Study|Progressive Disease|2|||
33539670|NCT01787552|101874434|FG002|Overall Study|Progressive Disease|1|||
33539671|NCT01787552|101874435|FG003|Overall Study|Progressive Disease|1|||
33539672|NCT02785939|101874436|FG000|Overall Study|Progression|25|||
33539673|NCT02785939|101874437|FG001|Overall Study|Progression|8|||
33539674|NCT02785939|101874436|FG000|Overall Study|Adverse Event|3|||
33539675|NCT02785939|101874437|FG001|Overall Study|Adverse Event|1|||
33539676|NCT02785939|101874436|FG000|Overall Study|Death|1|||
33539677|NCT02785939|101874437|FG001|Overall Study|Death|0|||
33539678|NCT02785939|101874436|FG000|Overall Study|Refusal|1|||
33539679|NCT02785939|101874437|FG001|Overall Study|Refusal|0|||
33539680|NCT02785939|101874436|FG000|Overall Study|Deteriorating health|1|||
33539681|NCT02785939|101874437|FG001|Overall Study|Deteriorating health|0|||
33539682|NCT02785939|101874436|FG000|Overall Study|Not protocol specified|0|||
33539683|NCT02785939|101874437|FG001|Overall Study|Not protocol specified|1|||
33539684|NCT02391337|101874439|FG000|6 Months Follow-up|Death|5|||
33539685|NCT02391337|101874440|FG001|6 Months Follow-up|Death|4|||
33539686|NCT02391337|101874439|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
33539687|NCT02391337|101874440|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
33539688|NCT02391337|101874439|FG000|12 Months Follow-up|Death|2|||
33539689|NCT02391337|101874440|FG001|12 Months Follow-up|Death|0|||
33539690|NCT02391337|101874439|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
33539691|NCT02391337|101874440|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
33539692|NCT02391337|101874439|FG000|12 Months Follow-up|Lost to Follow-up|0|||
33539693|NCT02391337|101874440|FG001|12 Months Follow-up|Lost to Follow-up|2|||
33539694|NCT00744939|101874441|FG000|Overall Study|Withdrawal by Subject|9|||
33539695|NCT00744939|101874441|FG000|Overall Study|Protocol Violation|13|||
33539696|NCT00744939|101874441|FG000|Overall Study|Death|24|||
33539697|NCT00744939|101874441|FG000|Overall Study|distance|4|||
33539698|NCT00744939|101874441|FG000|Overall Study|Lost to Follow-up|12|||
33539699|NCT00744939|101874441|FG000|Overall Study|Medical history exclusionary|1|||
33539700|NCT00744939|101874441|FG000|Overall Study|Did not receive Magnevist|7|||
33539701|NCT00744939|101874441|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
33539702|NCT00744939|101874441|FG000|Overall Study|coma|1|||
33539703|NCT00744939|101874441|FG000|Overall Study|incorrect race|1|||
33539704|NCT01965327|101874442|FG000|Overall Study|Physician Decision|2|||
33539705|NCT00069264|101874443|FG000|Overall Study|Adverse Event|3|||
33539706|NCT00069264|101874443|FG000|Overall Study|Progressive Disease|23|||
33539707|NCT00069264|101874443|FG000|Overall Study|Withdrawal by Subject|3|||
33539708|NCT00069264|101874443|FG000|Overall Study|Discon Therapy|3|||
33539709|NCT01529606|101874446|FG000|Overall Study|Lost to Follow-up|21|||
33539710|NCT01529606|101874447|FG001|Overall Study|Lost to Follow-up|18|||
33539711|NCT03435055|101874448|FG000|Screening|Physician Decision|2|||
33539712|NCT03435055|101874448|FG000|Received Intervention|Did not complete nitrous administration|3|||
33539713|NCT00266708|101874449|FG000|Overall Study|No renal function|1|||
33539714|NCT00266708|101874450|FG001|Overall Study|No renal function|1|||
33539715|NCT00266708|101874449|FG000|Overall Study|Refused biopsy|3|||
33539716|NCT00266708|101874450|FG001|Overall Study|Refused biopsy|6|||
33539717|NCT00266708|101874449|FG000|Overall Study|Asthma|0|||
33539718|NCT00266708|101874450|FG001|Overall Study|Asthma|2|||
33539719|NCT01287936|101874464|FG000|Overall Study|Lost to Follow-up|0|||
33539720|NCT01287936|101874465|FG001|Overall Study|Lost to Follow-up|1|||
33539721|NCT01287936|101874466|FG002|Overall Study|Lost to Follow-up|1|||
33539722|NCT02643693|101874467|FG000|Overall Study|Physician Decision|0|||
33539723|NCT02643693|101874468|FG001|Overall Study|Physician Decision|1|||
33539724|NCT02643693|101874469|FG002|Overall Study|Physician Decision|0|||
33539725|NCT02643693|101874470|FG003|Overall Study|Physician Decision|0|||
33539726|NCT02643693|101874471|FG004|Overall Study|Physician Decision|0|||
33539727|NCT02643693|101874472|FG005|Overall Study|Physician Decision|0|||
33539728|NCT02643693|101874467|FG000|Overall Study|Withdrawal by Subject|0|||
33539729|NCT02643693|101874468|FG001|Overall Study|Withdrawal by Subject|1|||
33539730|NCT02643693|101874469|FG002|Overall Study|Withdrawal by Subject|0|||
33539731|NCT02643693|101874470|FG003|Overall Study|Withdrawal by Subject|0|||
33539732|NCT02643693|101874471|FG004|Overall Study|Withdrawal by Subject|0|||
33539733|NCT02643693|101874472|FG005|Overall Study|Withdrawal by Subject|0|||
33539734|NCT02643693|101874467|FG000|Overall Study|Protocol Adherence Issues|2|||
33539735|NCT02643693|101874468|FG001|Overall Study|Protocol Adherence Issues|0|||
33539736|NCT02643693|101874469|FG002|Overall Study|Protocol Adherence Issues|1|||
33539737|NCT02643693|101874470|FG003|Overall Study|Protocol Adherence Issues|0|||
33539738|NCT02643693|101874471|FG004|Overall Study|Protocol Adherence Issues|0|||
33342410|NCT02083380|101141956|FG000|Overall Study|Other|8|||
33342411|NCT02083380|101141957|FG001|Overall Study|Other|4|||
33342412|NCT02083380|101141958|FG002|Overall Study|Other|6|||
33406372|NCT01233284|101377566|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
33406373|NCT01233284|101377567|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
33406374|NCT01233284|101377568|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
33406375|NCT01233284|101377564|FG000|Period 3 (4 Weeks)|Other|0|||
33406376|NCT01233284|101377565|FG001|Period 3 (4 Weeks)|Other|0|||
33406377|NCT01233284|101377566|FG002|Period 3 (4 Weeks)|Other|0|||
33406378|NCT01233284|101377567|FG003|Period 3 (4 Weeks)|Other|1|||
33406379|NCT01233284|101377568|FG004|Period 3 (4 Weeks)|Other|0|||
33406380|NCT01233284|101377564|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
33406381|NCT01233284|101377565|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
33406382|NCT01233284|101377566|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
33406383|NCT01233284|101377567|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
33406384|NCT01233284|101377568|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
33406385|NCT01233284|101377564|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
33406386|NCT01233284|101377565|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
33406387|NCT01233284|101377566|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
33406388|NCT01233284|101377567|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
33406389|NCT01233284|101377568|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
33406390|NCT01087944|101377571|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
33406391|NCT01087944|101377572|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
33406392|NCT01087944|101377571|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
33539739|NCT02643693|101874472|FG005|Overall Study|Protocol Adherence Issues|1|||
33539740|NCT00003537|101874473|FG000|Overall Study|Not evalauable|1|||
33539741|NCT03810183|101874476|FG000|Overall Study|Study terminated by Sponsor|2|||
33539742|NCT03810183|101874477|FG001|Overall Study|Study terminated by Sponsor|1|||
33539743|NCT01035138|101874478|FG000|Overall Study|Adverse Event|4|||
33539744|NCT01035138|101874479|FG001|Overall Study|Adverse Event|0|||
33539745|NCT01035138|101874480|FG002|Overall Study|Adverse Event|2|||
33342413|NCT01623271|101141959|FG000|Overall Study|Withdrawal by Subject|2|||
33342414|NCT01777581|101141964|FG000|Overall Study|Lost to Follow-up|1|||
33342415|NCT01777581|101141965|FG001|Overall Study|Lost to Follow-up|1|||
33342416|NCT01777581|101141964|FG000|Overall Study|Adverse Event|2|||
33342417|NCT01777581|101141965|FG001|Overall Study|Adverse Event|0|||
33342418|NCT01777581|101141964|FG000|Overall Study|Lack of Efficacy|0|||
33342419|NCT01777581|101141965|FG001|Overall Study|Lack of Efficacy|1|||
33342420|NCT02004873|101141966|FG000|Overall Study|Implant unsuccessful|6|||
33342421|NCT02004873|101141966|FG000|Overall Study|Awaiting 6-month visit|390|||
33342422|NCT02004873|101141966|FG000|Overall Study|Missed 6-month visit|4|||
33342423|NCT02004873|101141966|FG000|Overall Study|Death|23|||
33342424|NCT02004873|101141966|FG000|Overall Study|Withdrawal by Subject|1|||
33342425|NCT01482910|101145432|FG000|Overall Study|Adverse Event|6|||
33342426|NCT01482910|101145433|FG001|Overall Study|Adverse Event|5|||
33342427|NCT01482910|101145432|FG000|Overall Study|Lost to Follow-up|0|||
33539746|NCT01035138|101874478|FG000|Overall Study|Caregiver Decision|2|||
33539747|NCT01035138|101874479|FG001|Overall Study|Caregiver Decision|0|||
33539748|NCT01035138|101874480|FG002|Overall Study|Caregiver Decision|1|||
33539749|NCT01035138|101874478|FG000|Overall Study|Withdrawal by Subject|1|||
33342428|NCT01482910|101145433|FG001|Overall Study|Lost to Follow-up|1|||
33342429|NCT01482910|101145432|FG000|Overall Study|Protocol Violation|1|||
33342430|NCT01482910|101145433|FG001|Overall Study|Protocol Violation|1|||
33342431|NCT01482910|101145432|FG000|Overall Study|Withdrawal by Subject|7|||
33539750|NCT01035138|101874479|FG001|Overall Study|Withdrawal by Subject|0|||
33342432|NCT01482910|101145433|FG001|Overall Study|Withdrawal by Subject|2|||
33342433|NCT01482910|101145432|FG000|Overall Study|Death|1|||
33406393|NCT01087944|101377572|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
33406394|NCT01883362|101377573|FG000|Treatment|Adverse Event|1|||
33406395|NCT01883362|101377574|FG001|Treatment|Adverse Event|8|||
33406396|NCT01883362|101377573|FG000|Treatment|Withdrawal by Subject|6|||
33406397|NCT01883362|101377574|FG001|Treatment|Withdrawal by Subject|2|||
33406398|NCT01883362|101377573|FG000|Treatment|Administrative problems|4|||
33342434|NCT01482910|101145433|FG001|Overall Study|Death|0|||
33342435|NCT04607733|101145438|FG000|Overall Study|Lost to Follow-up|1|||
33342436|NCT04607733|101145439|FG001|Overall Study|Lost to Follow-up|0|||
33342437|NCT04607733|101145440|FG002|Overall Study|Lost to Follow-up|0|||
33342438|NCT04607733|101145441|FG003|Overall Study|Lost to Follow-up|1|||
33342439|NCT04607733|101145442|FG004|Overall Study|Lost to Follow-up|1|||
33342440|NCT04607733|101145443|FG005|Overall Study|Lost to Follow-up|0|||
33342441|NCT04607733|101145438|FG000|Overall Study|Withdrawal by Subject|0|||
33342442|NCT04607733|101145439|FG001|Overall Study|Withdrawal by Subject|0|||
33342443|NCT04607733|101145440|FG002|Overall Study|Withdrawal by Subject|0|||
33342444|NCT04607733|101145441|FG003|Overall Study|Withdrawal by Subject|0|||
33342445|NCT04607733|101145442|FG004|Overall Study|Withdrawal by Subject|1|||
33342446|NCT04607733|101145443|FG005|Overall Study|Withdrawal by Subject|0|||
33342447|NCT02508194|101145444|FG000|Overall Study|Death|5|||
33342448|NCT02508194|101145445|FG001|Overall Study|Death|3|||
33342449|NCT02508194|101145444|FG000|Overall Study|Lost to Follow-up|25|||
33342450|NCT02508194|101145445|FG001|Overall Study|Lost to Follow-up|18|||
33342451|NCT02508194|101145444|FG000|Overall Study|Withdrawal by Subject|20|||
33342452|NCT02508194|101145445|FG001|Overall Study|Withdrawal by Subject|18|||
33342453|NCT02508194|101145444|FG000|Overall Study|Error in Randomization|1|||
33342454|NCT02508194|101145445|FG001|Overall Study|Error in Randomization|3|||
33342455|NCT02508194|101145444|FG000|Overall Study|Principal Investigator Decision|1|||
33342456|NCT02508194|101145445|FG001|Overall Study|Principal Investigator Decision|2|||
33342457|NCT02634580|101145449|FG000|Double-blind Treatment Period|Subject Request|1|||
33342458|NCT02634580|101145450|FG001|Double-blind Treatment Period|Subject Request|0|||
33342459|NCT02634580|101145451|FG002|Double-blind Treatment Period|Subject Request|1|||
33342460|NCT02634580|101145452|FG003|Double-blind Treatment Period|Subject Request|1|||
33342461|NCT02634580|101145449|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
33342462|NCT02634580|101145450|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
33342463|NCT02634580|101145451|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
33342464|NCT02634580|101145452|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
33342465|NCT02658812|101145454|FG000|Overall Study|Disease Progression|7|||
33342466|NCT02658812|101145454|FG000|Overall Study|Unrelated to study treatment|1|||
33342467|NCT02658812|101145454|FG000|Overall Study|Adverse Event|1|||
33342468|NCT00577993|101145455|FG000|Overall Study|Adverse Event|1|||
33342469|NCT00577993|101145456|FG001|Overall Study|Adverse Event|0|||
33342470|NCT00577993|101145457|FG002|Overall Study|Adverse Event|0|||
33342471|NCT00577993|101145455|FG000|Overall Study|Death|0|||
33342472|NCT00577993|101145456|FG001|Overall Study|Death|1|||
33342473|NCT00577993|101145457|FG002|Overall Study|Death|1|||
33342474|NCT00577993|101145455|FG000|Overall Study|Lack of Efficacy|0|||
33342475|NCT00577993|101145456|FG001|Overall Study|Lack of Efficacy|1|||
33342476|NCT00577993|101145457|FG002|Overall Study|Lack of Efficacy|0|||
33342477|NCT00577993|101145455|FG000|Overall Study|Protocol Violation|2|||
33342478|NCT00577993|101145456|FG001|Overall Study|Protocol Violation|3|||
33342479|NCT00577993|101145457|FG002|Overall Study|Protocol Violation|0|||
33342480|NCT00577993|101145455|FG000|Overall Study|Withdrawal by Subject|1|||
33342481|NCT00577993|101145456|FG001|Overall Study|Withdrawal by Subject|0|||
33342482|NCT00577993|101145457|FG002|Overall Study|Withdrawal by Subject|2|||
33342483|NCT00577993|101145455|FG000|Overall Study|Conversion|2|||
33342484|NCT00577993|101145456|FG001|Overall Study|Conversion|5|||
33342485|NCT00577993|101145457|FG002|Overall Study|Conversion|0|||
33342486|NCT00577993|101145455|FG000|Overall Study|Uninsured|1|||
33342487|NCT00577993|101145456|FG001|Overall Study|Uninsured|0|||
33406399|NCT01883362|101377574|FG001|Treatment|Administrative problems|1|||
33539751|NCT01035138|101874480|FG002|Overall Study|Withdrawal by Subject|0|||
33539752|NCT01035138|101874478|FG000|Overall Study|Physician Decision|0|||
33539753|NCT01035138|101874479|FG001|Overall Study|Physician Decision|0|||
33539754|NCT01035138|101874480|FG002|Overall Study|Physician Decision|1|||
33539755|NCT01035138|101874478|FG000|Overall Study|Sponsor Decision|66|||
33539756|NCT01035138|101874479|FG001|Overall Study|Sponsor Decision|60|||
33539757|NCT01035138|101874480|FG002|Overall Study|Sponsor Decision|42|||
33342488|NCT00577993|101145457|FG002|Overall Study|Uninsured|0|||
33342489|NCT01986062|101145459|FG000|Overall Study|Lost to Follow-up|1|||
33342490|NCT01986062|101145460|FG001|Overall Study|Lost to Follow-up|0|||
33342491|NCT01986062|101145459|FG000|Overall Study|Withdrawal by Subject|0|||
33342492|NCT01986062|101145460|FG001|Overall Study|Withdrawal by Subject|1|||
33342493|NCT04002310|101145461|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
33342494|NCT04002310|101145462|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
33342495|NCT04002310|101145463|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
33539758|NCT01035138|101874478|FG000|Overall Study|Lost to Follow-up|0|||
33539759|NCT01035138|101874479|FG001|Overall Study|Lost to Follow-up|0|||
33342496|NCT04002310|101145464|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
33342497|NCT04002310|101145465|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
33342498|NCT01486199|101145466|FG000|Two Year Period Between Study Days|Physician Decision|1|||
33342499|NCT01486199|101145467|FG001|Two Year Period Between Study Days|Physician Decision|0|||
33342500|NCT00854828|101145468|FG000|Overall Study|Death|1|||
33342501|NCT00854828|101145469|FG001|Overall Study|Death|0|||
33342502|NCT00854828|101145470|FG002|Overall Study|Death|0|||
33342503|NCT00854828|101145471|FG003|Overall Study|Death|0|||
33342504|NCT00854828|101145468|FG000|Overall Study|Withdrawal by Subject|1|||
33342505|NCT00854828|101145469|FG001|Overall Study|Withdrawal by Subject|1|||
33342506|NCT00854828|101145470|FG002|Overall Study|Withdrawal by Subject|0|||
33342507|NCT00854828|101145471|FG003|Overall Study|Withdrawal by Subject|9|||
33342508|NCT00854828|101145468|FG000|Overall Study|Missed 24mo visit|1|||
33342509|NCT00854828|101145469|FG001|Overall Study|Missed 24mo visit|1|||
33539760|NCT01035138|101874480|FG002|Overall Study|Lost to Follow-up|1|||
33539761|NCT00843492|101874488|FG000|Overall Study|Adverse Event|0|||
33539762|NCT00843492|101874489|FG001|Overall Study|Adverse Event|3|||
33539763|NCT00843492|101874488|FG000|Overall Study|Lost to Follow-up|4|||
33539764|NCT00843492|101874489|FG001|Overall Study|Lost to Follow-up|4|||
33539765|NCT00843492|101874488|FG000|Overall Study|Withdrawal by Subject|0|||
33539766|NCT00843492|101874489|FG001|Overall Study|Withdrawal by Subject|4|||
33539767|NCT00843492|101874488|FG000|Overall Study|Immobilization Stopped|1|||
33539768|NCT00843492|101874489|FG001|Overall Study|Immobilization Stopped|0|||
33539769|NCT00843492|101874488|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
33539770|NCT00843492|101874489|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
33539771|NCT00843492|101874488|FG000|Overall Study|Orthopedic Surgery|0|||
33539772|NCT00843492|101874489|FG001|Overall Study|Orthopedic Surgery|2|||
33539773|NCT00843492|101874488|FG000|Overall Study|Visit Not Performed|1|||
33539774|NCT00843492|101874489|FG001|Overall Study|Visit Not Performed|0|||
33539775|NCT00843492|101874488|FG000|Overall Study|Deep-vein Thrombosis|1|||
33539776|NCT00843492|101874489|FG001|Overall Study|Deep-vein Thrombosis|0|||
33539777|NCT02988661|101874492|FG000|Overall Study|Death|2|||
33539778|NCT02988661|101874493|FG001|Overall Study|Death|18|||
33539779|NCT02988661|101874492|FG000|Overall Study|Lost to Follow-up|0|||
33539780|NCT02988661|101874493|FG001|Overall Study|Lost to Follow-up|33|||
33539781|NCT02988661|101874492|FG000|Overall Study|Withdrawal by Subject|0|||
33539782|NCT02988661|101874493|FG001|Overall Study|Withdrawal by Subject|6|||
33539783|NCT02988661|101874492|FG000|Overall Study|Unable to complete the 18-month survey|1|||
33539784|NCT02988661|101874493|FG001|Overall Study|Unable to complete the 18-month survey|27|||
33539785|NCT01474486|101874494|FG000|Overall Study|Death|2|||
33539786|NCT01474486|101874494|FG000|Overall Study|Withdrawal by Subject|4|||
33539787|NCT01474486|101874494|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
33615108|NCT01248949|102140222|FG003|Overall Study|Participant Went To Hospice|0|||
33209970|NCT00518115|100670336|FG003|Overall Study|Lost to Follow-up|3|||
33209971|NCT00518115|100670337|FG004|Overall Study|Lost to Follow-up|1|||
33209972|NCT00518115|100670338|FG005|Overall Study|Lost to Follow-up|3|||
33209973|NCT00518115|100670339|FG006|Overall Study|Lost to Follow-up|0|||
33209974|NCT00518115|100670340|FG007|Overall Study|Lost to Follow-up|1|||
33209975|NCT00518115|100670341|FG008|Overall Study|Lost to Follow-up|1|||
33209976|NCT00518115|100670342|FG009|Overall Study|Lost to Follow-up|1|||
33209977|NCT00518115|100670333|FG000|Overall Study|Protocol Violation|1|||
33342510|NCT00854828|101145470|FG002|Overall Study|Missed 24mo visit|8|||
33342511|NCT00854828|101145471|FG003|Overall Study|Missed 24mo visit|8|||
33539788|NCT00686972|101874495|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
33539789|NCT01387269|101874496|FG000|Overall Study|Death|38|||
33539790|NCT01387269|101874497|FG001|Overall Study|Death|20|||
33539791|NCT01387269|101874496|FG000|Overall Study|Other|8|||
33539792|NCT01387269|101874497|FG001|Overall Study|Other|7|||
33539793|NCT01387269|101874496|FG000|Overall Study|Unrelated AE|12|||
33209978|NCT00518115|100670334|FG001|Overall Study|Protocol Violation|3|||
33539794|NCT01387269|101874497|FG001|Overall Study|Unrelated AE|3|||
33539795|NCT01387269|101874496|FG000|Overall Study|Withdrawal by patient|32|||
33615109|NCT01248949|102140223|FG004|Overall Study|Participant Went To Hospice|0|||
33615110|NCT01248949|102140219|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
33615111|NCT01248949|102140220|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
33615112|NCT01248949|102140221|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
33615113|NCT01248949|102140222|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
33615114|NCT01248949|102140223|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
33615115|NCT01248949|102140219|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
33615116|NCT01248949|102140220|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
33615117|NCT01248949|102140221|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
33615118|NCT01248949|102140222|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
33539796|NCT01387269|101874497|FG001|Overall Study|Withdrawal by patient|10|||
33209979|NCT00518115|100670335|FG002|Overall Study|Protocol Violation|1|||
33209980|NCT00518115|100670336|FG003|Overall Study|Protocol Violation|0|||
33539797|NCT01387269|101874496|FG000|Overall Study|Study drug-related AE|1|||
33539798|NCT01387269|101874497|FG001|Overall Study|Study drug-related AE|0|||
33539799|NCT01387269|101874496|FG000|Overall Study|Lost to Follow-up|1|||
33539800|NCT01387269|101874497|FG001|Overall Study|Lost to Follow-up|0|||
33539801|NCT02078817|101874500|FG000|Overall Study|Withdrawal by Subject|1|||
33539802|NCT03238417|101874501|FG000|Overall|non-response|955|||
33539803|NCT03238417|101874502|FG001|Overall|non-response|1920|||
33539804|NCT03238417|101874501|FG000|Overall|partial completion|48|||
33539805|NCT03238417|101874502|FG001|Overall|partial completion|68|||
33539806|NCT03238417|101874501|FG000|Baseline|Partial completion|17|||
33539807|NCT03238417|101874502|FG001|Baseline|Partial completion|48|||
33539808|NCT03238417|101874501|FG000|Baseline|non-response|372|||
33539809|NCT03238417|101874502|FG001|Baseline|non-response|669|||
33539810|NCT03238417|101874501|FG000|12-month|non-response|296|||
33539811|NCT03238417|101874502|FG001|12-month|non-response|669|||
33539812|NCT03238417|101874501|FG000|12-month|partial completion|23|||
33539813|NCT03238417|101874502|FG001|12-month|partial completion|37|||
33539814|NCT03238417|101874501|FG000|24-month|non-response|287|||
33539815|NCT03238417|101874502|FG001|24-month|non-response|594|||
33539816|NCT03238417|101874501|FG000|24-month|partial completion|8|||
33539817|NCT03238417|101874502|FG001|24-month|partial completion|31|||
33539818|NCT02674516|101874503|FG000|Overall Study|Lost to Follow-up|3|||
33539819|NCT02674516|101874504|FG001|Overall Study|Lost to Follow-up|0|||
33209981|NCT00518115|100670337|FG004|Overall Study|Protocol Violation|0|||
33209982|NCT00518115|100670338|FG005|Overall Study|Protocol Violation|0|||
33539820|NCT02674516|101874503|FG000|Overall Study|Protocol Violation|0|||
33539821|NCT02674516|101874504|FG001|Overall Study|Protocol Violation|4|||
33539822|NCT02674516|101874503|FG000|Overall Study|Knowledge of study hypothesis|1|||
33539823|NCT02674516|101874504|FG001|Overall Study|Knowledge of study hypothesis|0|||
33342512|NCT00379795|101145472|FG000|Overall Study|Death|31|||
33539824|NCT03103503|101874508|FG000|Overall Study|Death|64|||
33539825|NCT03103503|101874508|FG000|Overall Study|Physician Decision|57|||
33539826|NCT03103503|101874508|FG000|Overall Study|Withdrawal by Subject|10|||
33539827|NCT03103503|101874508|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
33539828|NCT03103503|101874508|FG000|Overall Study|Lost to Follow-up|3|||
33539829|NCT03103503|101874508|FG000|Overall Study|Study Closure|757|||
33615119|NCT01248949|102140223|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
33615120|NCT01248949|102140219|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
33615121|NCT01248949|102140220|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
33615122|NCT01248949|102140221|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
33615123|NCT01248949|102140222|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
33615124|NCT01248949|102140223|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
33209983|NCT00518115|100670339|FG006|Overall Study|Protocol Violation|0|||
33209984|NCT00518115|100670340|FG007|Overall Study|Protocol Violation|0|||
33342513|NCT00379795|101145473|FG001|Overall Study|Death|8|||
33539830|NCT00794664|101874509|FG000|Treatment Period|Withdrawal by Subject|0|||
33539831|NCT00794664|101874510|FG001|Treatment Period|Withdrawal by Subject|2|||
33539832|NCT00794664|101874509|FG000|Treatment Period|Protocol non-compliance|0|||
33539833|NCT00794664|101874510|FG001|Treatment Period|Protocol non-compliance|1|||
33539834|NCT00794664|101874509|FG000|Treatment Period|Other|0|||
33539835|NCT00794664|101874510|FG001|Treatment Period|Other|1|||
33539836|NCT00794664|101874509|FG000|Treatment Period|Adverse Event|1|||
33342514|NCT00379795|101145474|FG002|Overall Study|Death|6|||
33406400|NCT01883362|101377573|FG000|Treatment|Relapse|4|||
33406401|NCT01883362|101377574|FG001|Treatment|Relapse|2|||
33406402|NCT01883362|101377573|FG000|Treatment|Randomized, not treated|1|||
33406403|NCT01883362|101377574|FG001|Treatment|Randomized, not treated|1|||
33406404|NCT01883362|101377573|FG000|Post Treatment Follow-up|Protocol Violation|0|||
33406405|NCT01883362|101377574|FG001|Post Treatment Follow-up|Protocol Violation|1|||
33406406|NCT01883362|101377573|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
33406407|NCT01883362|101377574|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
33406408|NCT01883362|101377573|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
33406409|NCT01883362|101377574|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
33539837|NCT00794664|101874510|FG001|Treatment Period|Adverse Event|8|||
33539838|NCT00794664|101874509|FG000|Follow-up Period|Other|1|||
33539839|NCT00794664|101874510|FG001|Follow-up Period|Other|2|||
33342515|NCT00379795|101145475|FG003|Overall Study|Death|4|||
33342516|NCT00379795|101145476|FG004|Overall Study|Death|7|||
33342517|NCT00379795|101145472|FG000|Overall Study|Adverse Event|17|||
33342518|NCT00379795|101145473|FG001|Overall Study|Adverse Event|3|||
33342519|NCT00379795|101145474|FG002|Overall Study|Adverse Event|3|||
33342520|NCT00379795|101145475|FG003|Overall Study|Adverse Event|1|||
33342521|NCT00379795|101145476|FG004|Overall Study|Adverse Event|4|||
33342522|NCT00379795|101145472|FG000|Overall Study|Lost to Follow-up|8|||
33342523|NCT00379795|101145473|FG001|Overall Study|Lost to Follow-up|1|||
33342524|NCT00379795|101145474|FG002|Overall Study|Lost to Follow-up|2|||
33342525|NCT00379795|101145475|FG003|Overall Study|Lost to Follow-up|1|||
33342526|NCT00379795|101145476|FG004|Overall Study|Lost to Follow-up|4|||
33342527|NCT00379795|101145472|FG000|Overall Study|Physician Decision|25|||
33342528|NCT00379795|101145473|FG001|Overall Study|Physician Decision|0|||
33342529|NCT00379795|101145474|FG002|Overall Study|Physician Decision|2|||
33342530|NCT00379795|101145475|FG003|Overall Study|Physician Decision|2|||
33342531|NCT00379795|101145476|FG004|Overall Study|Physician Decision|2|||
33342532|NCT00379795|101145472|FG000|Overall Study|Withdrawal by Subject|94|||
33342533|NCT00379795|101145473|FG001|Overall Study|Withdrawal by Subject|11|||
33406410|NCT01883362|101377573|FG000|Post Treatment Follow-up|Administrative problems|2|||
33406411|NCT01883362|101377574|FG001|Post Treatment Follow-up|Administrative problems|0|||
33406412|NCT01883362|101377573|FG000|Post Treatment Follow-up|Death|8|||
33406413|NCT01883362|101377574|FG001|Post Treatment Follow-up|Death|4|||
33406414|NCT01883362|101377573|FG000|Post Treatment Follow-up|Relapse|1|||
33406415|NCT01883362|101377574|FG001|Post Treatment Follow-up|Relapse|2|||
33406416|NCT04382066|101377581|FG000|Overall Study|Adverse Event|1|||
33406417|NCT04382066|101377582|FG001|Overall Study|Adverse Event|0|||
33406418|NCT04382066|101377583|FG002|Overall Study|Adverse Event|0|||
33406419|NCT04382066|101377581|FG000|Overall Study|Death|1|||
33406420|NCT04382066|101377582|FG001|Overall Study|Death|0|||
33406421|NCT04382066|101377583|FG002|Overall Study|Death|1|||
33406422|NCT04491591|101377586|FG000|Overall Study|Accidently randomized|3|||
33406423|NCT04491591|101377587|FG001|Overall Study|Accidently randomized|1|||
33406424|NCT04491591|101377588|FG002|Overall Study|Accidently randomized|0|||
33406425|NCT04491591|101377586|FG000|Overall Study|Did not complete survey|28|||
33406426|NCT04491591|101377587|FG001|Overall Study|Did not complete survey|20|||
33406427|NCT04491591|101377588|FG002|Overall Study|Did not complete survey|3|||
33406428|NCT01756846|101377589|FG000|Overall Study|Lost to Follow-up|5|||
33406429|NCT01756846|101377590|FG001|Overall Study|Lost to Follow-up|10|||
33406430|NCT01756846|101377589|FG000|Overall Study|Withdrawal by Subject|1|||
33406431|NCT01756846|101377590|FG001|Overall Study|Withdrawal by Subject|2|||
33406432|NCT02505945|101377591|FG000|Overall Study|Withdrawal by Subject|13|||
33406433|NCT02505945|101377592|FG001|Overall Study|Withdrawal by Subject|2|||
33406434|NCT02505945|101377591|FG000|Overall Study|Adverse Event|1|||
33406435|NCT02505945|101377592|FG001|Overall Study|Adverse Event|0|||
33406436|NCT02505945|101377591|FG000|Overall Study|Physician Decision|2|||
33406437|NCT02505945|101377592|FG001|Overall Study|Physician Decision|1|||
33406438|NCT02505945|101377591|FG000|Overall Study|Lost to Follow-up|6|||
33342534|NCT00379795|101145474|FG002|Overall Study|Withdrawal by Subject|19|||
33342535|NCT00379795|101145475|FG003|Overall Study|Withdrawal by Subject|7|||
33406439|NCT02505945|101377592|FG001|Overall Study|Lost to Follow-up|1|||
33539840|NCT00794664|101874509|FG000|Follow-up Period|Withdrawal by Subject|0|||
33342536|NCT00379795|101145476|FG004|Overall Study|Withdrawal by Subject|14|||
33342537|NCT00379795|101145472|FG000|Overall Study|Subject non-compliance|7|||
33342538|NCT00379795|101145473|FG001|Overall Study|Subject non-compliance|2|||
33342539|NCT00379795|101145474|FG002|Overall Study|Subject non-compliance|0|||
33406440|NCT00579059|101377593|FG000|Overall Study|Study Canceled at 1 Year|21|||
33539841|NCT00794664|101874510|FG001|Follow-up Period|Withdrawal by Subject|2|||
33342540|NCT00379795|101145475|FG003|Overall Study|Subject non-compliance|0|||
33342541|NCT00379795|101145476|FG004|Overall Study|Subject non-compliance|1|||
33406441|NCT00579059|101377594|FG001|Overall Study|Study Canceled at 1 Year|10|||
33406442|NCT04391894|101377595|FG000|Overall Study|Adverse Event|1|||
33406443|NCT04391894|101377596|FG001|Overall Study|Adverse Event|1|||
33406444|NCT04391894|101377597|FG002|Overall Study|Adverse Event|1|||
33406445|NCT04391894|101377598|FG003|Overall Study|Adverse Event|1|||
33406446|NCT04391894|101377599|FG004|Overall Study|Adverse Event|1|||
33406447|NCT04391894|101377595|FG000|Overall Study|Lost to Follow-up|1|||
33406448|NCT04391894|101377596|FG001|Overall Study|Lost to Follow-up|0|||
33406449|NCT04391894|101377597|FG002|Overall Study|Lost to Follow-up|0|||
33406450|NCT04391894|101377598|FG003|Overall Study|Lost to Follow-up|0|||
33406451|NCT04391894|101377599|FG004|Overall Study|Lost to Follow-up|0|||
33615125|NCT01248949|102140219|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
33615126|NCT01248949|102140220|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
33615127|NCT01248949|102140221|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
33615128|NCT01248949|102140222|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
33615129|NCT01248949|102140223|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
33615130|NCT01777776|102140224|FG000|Overall Study|Adverse Event|2|||
33615131|NCT01777776|102140225|FG001|Overall Study|Adverse Event|4|||
33615132|NCT01777776|102140226|FG002|Overall Study|Adverse Event|0|||
33615133|NCT01777776|102140227|FG003|Overall Study|Adverse Event|0|||
33615134|NCT01777776|102140224|FG000|Overall Study|Disease Progression|4|||
33615135|NCT01777776|102140225|FG001|Overall Study|Disease Progression|8|||
33615136|NCT01777776|102140226|FG002|Overall Study|Disease Progression|6|||
33615137|NCT01777776|102140227|FG003|Overall Study|Disease Progression|3|||
33615138|NCT01777776|102140224|FG000|Overall Study|Withdrawal by Subject|0|||
33615139|NCT01777776|102140225|FG001|Overall Study|Withdrawal by Subject|0|||
33615140|NCT01777776|102140226|FG002|Overall Study|Withdrawal by Subject|0|||
33615141|NCT01777776|102140227|FG003|Overall Study|Withdrawal by Subject|1|||
33342542|NCT00379795|101145472|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
33342543|NCT00379795|101145473|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
33342544|NCT00379795|101145474|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
33342545|NCT00379795|101145475|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
33342546|NCT00379795|101145476|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
33342547|NCT00379795|101145472|FG000|Overall Study|Subjects condition mandated intervention|34|||
33342548|NCT00379795|101145473|FG001|Overall Study|Subjects condition mandated intervention|9|||
33342549|NCT00379795|101145474|FG002|Overall Study|Subjects condition mandated intervention|7|||
33342550|NCT00379795|101145475|FG003|Overall Study|Subjects condition mandated intervention|5|||
33342551|NCT00379795|101145476|FG004|Overall Study|Subjects condition mandated intervention|7|||
33342552|NCT00379795|101145472|FG000|Overall Study|Sponsor's decision|257|||
33342553|NCT00379795|101145473|FG001|Overall Study|Sponsor's decision|17|||
33342554|NCT00379795|101145474|FG002|Overall Study|Sponsor's decision|54|||
33342555|NCT00379795|101145475|FG003|Overall Study|Sponsor's decision|47|||
33342556|NCT00379795|101145476|FG004|Overall Study|Sponsor's decision|10|||
33342557|NCT02902120|101145477|FG000|Overall Study|Lack of Efficacy|1|||
33342558|NCT00573794|101145480|FG000|Overall Study|Adverse Event|81|||
33342559|NCT00573794|101145480|FG000|Overall Study|Withdrew Consent|90|||
33342560|NCT00573794|101145480|FG000|Overall Study|Lost to Follow-up|13|||
33342561|NCT00573794|101145480|FG000|Overall Study|Protocol Violation|6|||
33406452|NCT04391894|101377595|FG000|Overall Study|Protocol Violation|0|||
33406453|NCT04391894|101377596|FG001|Overall Study|Protocol Violation|0|||
33406454|NCT04391894|101377597|FG002|Overall Study|Protocol Violation|0|||
33406455|NCT04391894|101377598|FG003|Overall Study|Protocol Violation|1|||
33406456|NCT04391894|101377599|FG004|Overall Study|Protocol Violation|0|||
33615142|NCT02564978|102140228|FG000|Overall Study|Adverse Event|8|||
33615143|NCT02564978|102140228|FG000|Overall Study|Death|1|||
33615144|NCT02564978|102140228|FG000|Overall Study|Lost to Follow-up|1|||
33615145|NCT02564978|102140228|FG000|Overall Study|Withdrawal by Subject|15|||
33615146|NCT02564978|102140228|FG000|Overall Study|Early Study Closure|2|||
33209985|NCT00518115|100670341|FG008|Overall Study|Protocol Violation|0|||
33209986|NCT00518115|100670342|FG009|Overall Study|Protocol Violation|0|||
33209987|NCT00518115|100670333|FG000|Overall Study|Withdrawal by Subject|1|||
33209988|NCT00518115|100670334|FG001|Overall Study|Withdrawal by Subject|1|||
33209989|NCT00518115|100670335|FG002|Overall Study|Withdrawal by Subject|5|||
33342562|NCT00573794|101145480|FG000|Overall Study|Lack of Efficacy|94|||
33406457|NCT04391894|101377595|FG000|Overall Study|Withdrawal by Subject|2|||
33342563|NCT00573794|101145480|FG000|Overall Study|Other|46|||
33342564|NCT02615990|101145481|FG000|Overall Study|study terminated|1|||
33406458|NCT04391894|101377596|FG001|Overall Study|Withdrawal by Subject|0|||
33406459|NCT04391894|101377597|FG002|Overall Study|Withdrawal by Subject|3|||
33406460|NCT04391894|101377598|FG003|Overall Study|Withdrawal by Subject|0|||
33209990|NCT00518115|100670336|FG003|Overall Study|Withdrawal by Subject|0|||
33615147|NCT02564978|102140228|FG000|Overall Study|Other Reason|5|||
33615148|NCT01286077|102140230|FG000|Overall Study|Adverse Event|2|||
33615149|NCT01286077|102140231|FG001|Overall Study|Adverse Event|0|||
33615150|NCT01286077|102140230|FG000|Overall Study|Death|1|||
33615151|NCT01286077|102140231|FG001|Overall Study|Death|0|||
33615152|NCT01286077|102140230|FG000|Overall Study|Protocol Violation|1|||
33615153|NCT01286077|102140231|FG001|Overall Study|Protocol Violation|1|||
33539842|NCT00794664|101874509|FG000|Follow-up Period|Protocol non-compliance|0|||
33539843|NCT00794664|101874510|FG001|Follow-up Period|Protocol non-compliance|1|||
33539844|NCT02119299|101874511|FG000|Overall Study|Withdrawal by Subject|7|||
33539845|NCT02119299|101874511|FG000|Overall Study|Lack of Efficacy|1|||
33539846|NCT02119299|101874511|FG000|Overall Study|Pregnancy|1|||
33539847|NCT01255163|101874514|FG000|Overall Study|Withdrawal by Subject|1|||
33539848|NCT01255163|101874515|FG001|Overall Study|Withdrawal by Subject|0|||
33539849|NCT01255163|101874514|FG000|Overall Study|Lost to Follow-up|2|||
33539850|NCT01255163|101874515|FG001|Overall Study|Lost to Follow-up|0|||
33539851|NCT01255163|101874514|FG000|Overall Study|Adverse Event|0|||
33539852|NCT01255163|101874515|FG001|Overall Study|Adverse Event|2|||
33342565|NCT02615990|101145482|FG001|Overall Study|study terminated|1|||
33539853|NCT01255163|101874514|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
33539854|NCT01255163|101874515|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
33539855|NCT02295644|101874516|FG000|Overall Study|Did not meet inclusion criterion|0|||
33209991|NCT00518115|100670337|FG004|Overall Study|Withdrawal by Subject|2|||
33209992|NCT00518115|100670338|FG005|Overall Study|Withdrawal by Subject|1|||
33209993|NCT00518115|100670339|FG006|Overall Study|Withdrawal by Subject|0|||
33209994|NCT00518115|100670340|FG007|Overall Study|Withdrawal by Subject|2|||
33209995|NCT00518115|100670341|FG008|Overall Study|Withdrawal by Subject|1|||
33209996|NCT00518115|100670342|FG009|Overall Study|Withdrawal by Subject|3|||
33209997|NCT00518115|100670333|FG000|Overall Study|Lack of Efficacy|1|||
33209998|NCT00518115|100670334|FG001|Overall Study|Lack of Efficacy|0|||
33209999|NCT00518115|100670335|FG002|Overall Study|Lack of Efficacy|1|||
33210000|NCT00518115|100670336|FG003|Overall Study|Lack of Efficacy|1|||
33210001|NCT00518115|100670337|FG004|Overall Study|Lack of Efficacy|0|||
33210002|NCT00518115|100670338|FG005|Overall Study|Lack of Efficacy|0|||
33210003|NCT00518115|100670339|FG006|Overall Study|Lack of Efficacy|0|||
33210004|NCT00518115|100670340|FG007|Overall Study|Lack of Efficacy|1|||
33210005|NCT00518115|100670341|FG008|Overall Study|Lack of Efficacy|0|||
33210006|NCT00518115|100670342|FG009|Overall Study|Lack of Efficacy|0|||
33210007|NCT00518115|100670333|FG000|Overall Study|Non-Compliance|1|||
33210008|NCT00518115|100670334|FG001|Overall Study|Non-Compliance|0|||
33210009|NCT00518115|100670335|FG002|Overall Study|Non-Compliance|1|||
33210010|NCT00518115|100670336|FG003|Overall Study|Non-Compliance|0|||
33210011|NCT00518115|100670337|FG004|Overall Study|Non-Compliance|1|||
33210012|NCT00518115|100670338|FG005|Overall Study|Non-Compliance|1|||
33210013|NCT00518115|100670339|FG006|Overall Study|Non-Compliance|1|||
33210014|NCT00518115|100670340|FG007|Overall Study|Non-Compliance|1|||
33210015|NCT00518115|100670341|FG008|Overall Study|Non-Compliance|0|||
33210016|NCT00518115|100670342|FG009|Overall Study|Non-Compliance|1|||
33210017|NCT00518115|100670333|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
33210018|NCT00518115|100670334|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
33210019|NCT00518115|100670335|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33210020|NCT00518115|100670336|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33210021|NCT00518115|100670337|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33210022|NCT00518115|100670338|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
33342566|NCT01500057|101145485|FG000|Overall Study|Lost to Follow-up|6|||
33406461|NCT04391894|101377599|FG004|Overall Study|Withdrawal by Subject|1|||
33539856|NCT02295644|101874517|FG001|Overall Study|Did not meet inclusion criterion|0|||
33539857|NCT02295644|101874518|FG002|Overall Study|Did not meet inclusion criterion|1|||
33539858|NCT02295644|101874519|FG003|Overall Study|Did not meet inclusion criterion|2|||
33539859|NCT02273167|101874523|FG000|Overall Study|Adverse Event|1|||
33210023|NCT00518115|100670339|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33210024|NCT00518115|100670340|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33210025|NCT00518115|100670341|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33539860|NCT02273167|101874524|FG001|Overall Study|Adverse Event|0|||
33210026|NCT00518115|100670342|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33210027|NCT00518115|100670333|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
33210028|NCT00518115|100670334|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33210029|NCT00518115|100670335|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33210030|NCT00518115|100670336|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33210031|NCT00518115|100670337|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33210032|NCT00518115|100670338|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33210033|NCT00518115|100670339|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33210034|NCT00518115|100670340|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33210035|NCT00518115|100670341|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33539861|NCT02273167|101874525|FG002|Overall Study|Adverse Event|0|||
33539862|NCT02273167|101874523|FG000|Overall Study|Protocol Violation|3|||
33539863|NCT02273167|101874524|FG001|Overall Study|Protocol Violation|1|||
33539864|NCT02273167|101874525|FG002|Overall Study|Protocol Violation|1|||
33539865|NCT02273167|101874523|FG000|Overall Study|Lost to Follow-up|0|||
33539866|NCT02273167|101874524|FG001|Overall Study|Lost to Follow-up|1|||
33539867|NCT02273167|101874525|FG002|Overall Study|Lost to Follow-up|1|||
33539868|NCT02273167|101874523|FG000|Overall Study|Withdrawal by Subject|10|||
33539869|NCT02273167|101874524|FG001|Overall Study|Withdrawal by Subject|12|||
33539870|NCT02273167|101874525|FG002|Overall Study|Withdrawal by Subject|11|||
33539871|NCT02273167|101874523|FG000|Overall Study|Various|10|||
33539872|NCT02273167|101874524|FG001|Overall Study|Various|9|||
33539873|NCT02273167|101874525|FG002|Overall Study|Various|8|||
33539874|NCT01433159|101874526|FG000|Overall Study|Adverse Event|1|||
33539875|NCT01433159|101874527|FG001|Overall Study|Adverse Event|0|||
33539876|NCT01433159|101874526|FG000|Overall Study|Physician Decision|1|||
33539877|NCT01433159|101874527|FG001|Overall Study|Physician Decision|0|||
33539878|NCT01433159|101874526|FG000|Overall Study|Protocol Violation|0|||
33539879|NCT01433159|101874527|FG001|Overall Study|Protocol Violation|1|||
33539880|NCT00473655|101874530|FG000|Overall Study|Lost to Follow-up|9|||
33539881|NCT00473655|101874531|FG001|Overall Study|Lost to Follow-up|5|||
33539882|NCT00473655|101874532|FG002|Overall Study|Lost to Follow-up|8|||
33539883|NCT03538041|101874533|FG000|12-Week Treatment Period|Adverse Event|1|||
33539884|NCT03538041|101874534|FG001|12-Week Treatment Period|Adverse Event|1|||
33539885|NCT03538041|101874533|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
33539886|NCT03538041|101874534|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
33539887|NCT03538041|101874533|FG000|Treatment Extension Period|Adverse Event|4|||
33539888|NCT03538041|101874534|FG001|Treatment Extension Period|Adverse Event|0|||
33539889|NCT03538041|101874533|FG000|Treatment Extension Period|Physician Decision|1|||
33539890|NCT03538041|101874534|FG001|Treatment Extension Period|Physician Decision|0|||
33539891|NCT03538041|101874533|FG000|Treatment Extension Period|Lack of Efficacy|1|||
33539892|NCT03538041|101874534|FG001|Treatment Extension Period|Lack of Efficacy|3|||
33539893|NCT03538041|101874533|FG000|Treatment Extension Period|Ongoing; Still Receiving Treatment|1|||
33539894|NCT03538041|101874534|FG001|Treatment Extension Period|Ongoing; Still Receiving Treatment|7|||
33539895|NCT02669849|101874537|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
33539896|NCT02669849|101874538|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
33539897|NCT02669849|101874539|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
33539898|NCT02669849|101874537|FG000|Overall Study|Lost to Follow-up|1|||
33539899|NCT02669849|101874538|FG001|Overall Study|Lost to Follow-up|0|||
33539900|NCT02669849|101874539|FG002|Overall Study|Lost to Follow-up|3|||
33539901|NCT02669849|101874537|FG000|Overall Study|Death|1|||
33539902|NCT02669849|101874538|FG001|Overall Study|Death|1|||
33539903|NCT02669849|101874539|FG002|Overall Study|Death|2|||
33539904|NCT02669849|101874537|FG000|Overall Study|Study terminated by sponsor|16|||
33539905|NCT02669849|101874538|FG001|Overall Study|Study terminated by sponsor|1|||
33539906|NCT02669849|101874539|FG002|Overall Study|Study terminated by sponsor|14|||
33539907|NCT02669849|101874537|FG000|Overall Study|Other|0|||
33539908|NCT02669849|101874538|FG001|Overall Study|Other|0|||
33539909|NCT02669849|101874539|FG002|Overall Study|Other|2|||
33539910|NCT00113607|101874540|FG000|Overall Study|Adverse Event|40|||
33539911|NCT00113607|101874541|FG001|Overall Study|Adverse Event|71|||
33539912|NCT00113607|101874540|FG000|Overall Study|Death|8|||
33539913|NCT00113607|101874541|FG001|Overall Study|Death|8|||
33210036|NCT00518115|100670342|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
33210037|NCT00518115|100670333|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
33210038|NCT00518115|100670334|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
33539914|NCT00113607|101874540|FG000|Overall Study|Withdrawal by Subject|50|||
33539915|NCT00113607|101874541|FG001|Overall Study|Withdrawal by Subject|58|||
33539916|NCT00113607|101874540|FG000|Overall Study|Lost to Follow-up|0|||
33539917|NCT00113607|101874541|FG001|Overall Study|Lost to Follow-up|2|||
33539918|NCT00113607|101874540|FG000|Overall Study|Disease Progression|180|||
33539919|NCT00113607|101874541|FG001|Overall Study|Disease Progression|142|||
33539920|NCT00113607|101874540|FG000|Overall Study|Complete Response (Confirmed)|14|||
33539921|NCT00113607|101874541|FG001|Overall Study|Complete Response (Confirmed)|24|||
33539922|NCT00113607|101874540|FG000|Overall Study|Other|43|||
33539923|NCT00113607|101874541|FG001|Overall Study|Other|32|||
33539924|NCT03439137|101874544|FG000|Overall Study|Adverse Event|16|||
33210039|NCT00518115|100670335|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
33210040|NCT00518115|100670336|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
33539925|NCT03439137|101874545|FG001|Overall Study|Adverse Event|12|||
33539926|NCT03439137|101874544|FG000|Overall Study|Physician Decision|0|||
33539927|NCT03439137|101874545|FG001|Overall Study|Physician Decision|5|||
33210041|NCT00518115|100670337|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
33210042|NCT00518115|100670338|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
33539928|NCT03439137|101874544|FG000|Overall Study|Withdrawal by Subject|14|||
33539929|NCT03439137|101874545|FG001|Overall Study|Withdrawal by Subject|4|||
33539930|NCT03439137|101874544|FG000|Overall Study|Conducting rescue therapy|2|||
33539931|NCT03439137|101874545|FG001|Overall Study|Conducting rescue therapy|1|||
33539932|NCT03439137|101874544|FG000|Overall Study|Difficult to control Hb|10|||
33539933|NCT03439137|101874545|FG001|Overall Study|Difficult to control Hb|2|||
33539934|NCT03439137|101874544|FG000|Overall Study|Initiation of a renal transplant|0|||
33539935|NCT03439137|101874545|FG001|Overall Study|Initiation of a renal transplant|2|||
33539936|NCT00856180|101874546|FG000|Overall Study|Adverse Event|4|||
33539937|NCT00856180|101874546|FG000|Overall Study|Progressive Disease|16|||
33539938|NCT01652690|101874552|FG000|Overall Study|Withdrawal by Subject|16|||
33539939|NCT01652690|101874553|FG001|Overall Study|Withdrawal by Subject|4|||
33539940|NCT01652690|101874552|FG000|Overall Study|Other|8|||
33539941|NCT01652690|101874553|FG001|Overall Study|Other|9|||
33539942|NCT01652690|101874552|FG000|Overall Study|Lost to Follow-up|6|||
33539943|NCT01652690|101874553|FG001|Overall Study|Lost to Follow-up|6|||
33539944|NCT01652690|101874552|FG000|Overall Study|Death|5|||
33539945|NCT01652690|101874553|FG001|Overall Study|Death|2|||
33539946|NCT00427908|101874554|FG000|Primary Phase|Lost to Follow-up|4|||
33539947|NCT00427908|101874555|FG001|Primary Phase|Lost to Follow-up|0|||
33539948|NCT00427908|101874556|FG002|Primary Phase|Lost to Follow-up|2|||
33539949|NCT00427908|101874557|FG003|Primary Phase|Lost to Follow-up|0|||
33539950|NCT00427908|101874554|FG000|Primary Phase|Withdrawal by Subject|1|||
33539951|NCT00427908|101874555|FG001|Primary Phase|Withdrawal by Subject|2|||
33539952|NCT00427908|101874556|FG002|Primary Phase|Withdrawal by Subject|1|||
33539953|NCT00427908|101874557|FG003|Primary Phase|Withdrawal by Subject|0|||
33539954|NCT00427908|101874554|FG000|Primary Phase|Adverse Event|0|||
33539955|NCT00427908|101874555|FG001|Primary Phase|Adverse Event|1|||
33539956|NCT00427908|101874556|FG002|Primary Phase|Adverse Event|0|||
33539957|NCT00427908|101874557|FG003|Primary Phase|Adverse Event|0|||
33539958|NCT01774981|101874559|FG000|Overall Study|Adverse Event|0|||
33342567|NCT01500057|101145486|FG001|Overall Study|Lost to Follow-up|4|||
33539959|NCT01774981|101874560|FG001|Overall Study|Adverse Event|0|||
33539960|NCT01774981|101874561|FG002|Overall Study|Adverse Event|0|||
33539961|NCT01774981|101874562|FG003|Overall Study|Adverse Event|0|||
33539962|NCT01774981|101874563|FG004|Overall Study|Adverse Event|0|||
33539963|NCT01774981|101874564|FG005|Overall Study|Adverse Event|1|||
33539964|NCT01774981|101874565|FG006|Overall Study|Adverse Event|0|||
33539965|NCT01774981|101874566|FG007|Overall Study|Adverse Event|0|||
33539966|NCT01774981|101874559|FG000|Overall Study|Withdrawal by Subject|0|||
33539967|NCT01774981|101874560|FG001|Overall Study|Withdrawal by Subject|0|||
33539968|NCT01774981|101874561|FG002|Overall Study|Withdrawal by Subject|0|||
33539969|NCT01774981|101874562|FG003|Overall Study|Withdrawal by Subject|0|||
33539970|NCT01774981|101874563|FG004|Overall Study|Withdrawal by Subject|0|||
33539971|NCT01774981|101874564|FG005|Overall Study|Withdrawal by Subject|0|||
33539972|NCT01774981|101874565|FG006|Overall Study|Withdrawal by Subject|0|||
33539973|NCT01774981|101874566|FG007|Overall Study|Withdrawal by Subject|1|||
33539974|NCT01774981|101874559|FG000|Overall Study|Death|0|||
33342568|NCT01870739|101145487|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
33539975|NCT01774981|101874560|FG001|Overall Study|Death|0|||
33539976|NCT01774981|101874561|FG002|Overall Study|Death|0|||
33539977|NCT01774981|101874562|FG003|Overall Study|Death|0|||
33539978|NCT01774981|101874563|FG004|Overall Study|Death|1|||
33539979|NCT01774981|101874564|FG005|Overall Study|Death|0|||
33210043|NCT00518115|100670339|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
33210044|NCT00518115|100670340|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
33210045|NCT00518115|100670341|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
33342569|NCT01870739|101145488|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
33342570|NCT01870739|101145487|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
33342571|NCT01870739|101145488|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
33210046|NCT00518115|100670342|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
33210047|NCT00518115|100670333|FG000|Overall Study|Wrong Monotherapy Administered|0|||
33210048|NCT00518115|100670334|FG001|Overall Study|Wrong Monotherapy Administered|0|||
33210049|NCT00518115|100670335|FG002|Overall Study|Wrong Monotherapy Administered|1|||
33210050|NCT00518115|100670336|FG003|Overall Study|Wrong Monotherapy Administered|0|||
33210051|NCT00518115|100670337|FG004|Overall Study|Wrong Monotherapy Administered|0|||
33210052|NCT00518115|100670338|FG005|Overall Study|Wrong Monotherapy Administered|0|||
33210053|NCT00518115|100670339|FG006|Overall Study|Wrong Monotherapy Administered|1|||
33210054|NCT00518115|100670340|FG007|Overall Study|Wrong Monotherapy Administered|0|||
33342572|NCT01870739|101145487|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
33342573|NCT01870739|101145488|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
33342574|NCT01870739|101145487|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
33342575|NCT01870739|101145488|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
33342576|NCT01870739|101145487|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
33342577|NCT01870739|101145488|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
33539980|NCT01774981|101874565|FG006|Overall Study|Death|0|||
33539981|NCT01774981|101874566|FG007|Overall Study|Death|0|||
33539982|NCT00141817|101874567|FG000|Overall Study|Protocol Violation|0|||
33539983|NCT00141817|101874568|FG001|Overall Study|Protocol Violation|0|||
33539984|NCT00141817|101874569|FG002|Overall Study|Protocol Violation|1|||
33539985|NCT00141817|101874570|FG003|Overall Study|Protocol Violation|0|||
33539986|NCT00141817|101874567|FG000|Overall Study|Parent request|1|||
33539987|NCT00141817|101874568|FG001|Overall Study|Parent request|0|||
33539988|NCT00141817|101874569|FG002|Overall Study|Parent request|0|||
33539989|NCT00141817|101874570|FG003|Overall Study|Parent request|0|||
33539990|NCT02834975|101874571|FG000|Overall Study|Physician Decision|2|||
33539991|NCT02834975|101874571|FG000|Overall Study|Adverse Event|1|||
33615154|NCT01286077|102140230|FG000|Overall Study|Withdrawal by Subject|0|||
33210055|NCT00518115|100670341|FG008|Overall Study|Wrong Monotherapy Administered|0|||
33210056|NCT00518115|100670342|FG009|Overall Study|Wrong Monotherapy Administered|0|||
33210057|NCT00518115|100670333|FG000|Overall Study|Violation of Exclusion Criteria|0|||
33210058|NCT00518115|100670334|FG001|Overall Study|Violation of Exclusion Criteria|0|||
33539992|NCT02834975|101874571|FG000|Overall Study|Withdrawal by Subject|1|||
33539993|NCT02834975|101874571|FG000|Overall Study|Lack of Efficacy|1|||
33539994|NCT00262119|101874576|FG000|Overall Study|Lost to Follow-up|38|||
33539995|NCT00262119|101874577|FG001|Overall Study|Lost to Follow-up|51|||
33539996|NCT00262119|101874578|FG002|Overall Study|Lost to Follow-up|42|||
33539997|NCT00262119|101874576|FG000|Overall Study|Death|20|||
33539998|NCT00262119|101874577|FG001|Overall Study|Death|19|||
33539999|NCT00262119|101874578|FG002|Overall Study|Death|16|||
33615155|NCT01286077|102140231|FG001|Overall Study|Withdrawal by Subject|2|||
33615156|NCT01286077|102140230|FG000|Overall Study|Intercurrent illness|1|||
33615157|NCT01286077|102140231|FG001|Overall Study|Intercurrent illness|0|||
33615158|NCT01286077|102140230|FG000|Overall Study|Non-compliance|1|||
33615159|NCT01286077|102140231|FG001|Overall Study|Non-compliance|0|||
33615160|NCT01286077|102140230|FG000|Overall Study|The subject starts with alternative MMY|0|||
33615161|NCT01286077|102140231|FG001|Overall Study|The subject starts with alternative MMY|3|||
33615162|NCT01286077|102140230|FG000|Overall Study|Patient's decision to stop treatment|3|||
33615163|NCT01286077|102140231|FG001|Overall Study|Patient's decision to stop treatment|0|||
33615164|NCT01286077|102140230|FG000|Overall Study|Progression of disease|0|||
33615165|NCT01286077|102140231|FG001|Overall Study|Progression of disease|1|||
33540000|NCT01924533|101874579|FG000|Overall Study|Death|181|||
33540001|NCT01924533|101874580|FG001|Overall Study|Death|200|||
33540002|NCT01924533|101874579|FG000|Overall Study|Lost to Follow-up|0|||
33540003|NCT01924533|101874580|FG001|Overall Study|Lost to Follow-up|1|||
33540004|NCT01924533|101874579|FG000|Overall Study|Withdrawal by Subject|7|||
33540005|NCT01924533|101874580|FG001|Overall Study|Withdrawal by Subject|3|||
33540006|NCT01924533|101874579|FG000|Overall Study|Other Eligibility criteria|1|||
33540007|NCT01924533|101874580|FG001|Overall Study|Other Eligibility criteria|1|||
33540008|NCT01186770|101874586|FG000|Overall Study|Ineligibility|0|||
33540009|NCT01186770|101874587|FG001|Overall Study|Ineligibility|0|||
33540010|NCT01186770|101874588|FG002|Overall Study|Ineligibility|2|||
33540011|NCT01186770|101874589|FG003|Overall Study|Ineligibility|0|||
33540012|NCT01186770|101874586|FG000|Overall Study|Protocol Violation|7|||
33540013|NCT01186770|101874587|FG001|Overall Study|Protocol Violation|9|||
33540014|NCT01186770|101874588|FG002|Overall Study|Protocol Violation|12|||
33540015|NCT01186770|101874589|FG003|Overall Study|Protocol Violation|14|||
33540016|NCT01186770|101874586|FG000|Overall Study|Adverse Event|2|||
33540017|NCT01186770|101874587|FG001|Overall Study|Adverse Event|9|||
33540018|NCT01186770|101874588|FG002|Overall Study|Adverse Event|7|||
33540019|NCT01186770|101874589|FG003|Overall Study|Adverse Event|9|||
33540020|NCT01186770|101874586|FG000|Overall Study|Withdrawal by Subject|15|||
33540021|NCT01186770|101874587|FG001|Overall Study|Withdrawal by Subject|13|||
33540022|NCT01186770|101874588|FG002|Overall Study|Withdrawal by Subject|11|||
33540023|NCT01186770|101874589|FG003|Overall Study|Withdrawal by Subject|17|||
33540024|NCT01186770|101874586|FG000|Overall Study|Lost to Follow-up|10|||
33540025|NCT01186770|101874587|FG001|Overall Study|Lost to Follow-up|6|||
33540026|NCT01186770|101874588|FG002|Overall Study|Lost to Follow-up|14|||
33540027|NCT01186770|101874589|FG003|Overall Study|Lost to Follow-up|9|||
33540028|NCT01186770|101874586|FG000|Overall Study|Insufficient response to treatment|7|||
33540029|NCT01186770|101874587|FG001|Overall Study|Insufficient response to treatment|8|||
33540030|NCT01186770|101874588|FG002|Overall Study|Insufficient response to treatment|5|||
33540031|NCT01186770|101874589|FG003|Overall Study|Insufficient response to treatment|7|||
33540032|NCT01186770|101874586|FG000|Overall Study|Other than specified|0|||
33615166|NCT01286077|102140230|FG000|Overall Study|refill medication not received in time|1|||
33615167|NCT01286077|102140231|FG001|Overall Study|refill medication not received in time|0|||
33540033|NCT01186770|101874587|FG001|Overall Study|Other than specified|1|||
33540034|NCT01186770|101874588|FG002|Overall Study|Other than specified|1|||
33540035|NCT01186770|101874589|FG003|Overall Study|Other than specified|2|||
33540036|NCT01420536|101874590|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
33540037|NCT01420536|101874591|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
33540038|NCT00855218|101874592|FG000|Overall Study|Adverse Event|43|||
33540039|NCT00855218|101874593|FG001|Overall Study|Adverse Event|27|||
33615168|NCT01055314|102140232|FG000|Overall Study|Adverse Event|7|||
33615169|NCT01055314|102140233|FG001|Overall Study|Adverse Event|4|||
33210059|NCT00518115|100670335|FG002|Overall Study|Violation of Exclusion Criteria|0|||
33210060|NCT00518115|100670336|FG003|Overall Study|Violation of Exclusion Criteria|1|||
33210061|NCT00518115|100670337|FG004|Overall Study|Violation of Exclusion Criteria|0|||
33210062|NCT00518115|100670338|FG005|Overall Study|Violation of Exclusion Criteria|0|||
33210063|NCT00518115|100670339|FG006|Overall Study|Violation of Exclusion Criteria|1|||
33210064|NCT00518115|100670340|FG007|Overall Study|Violation of Exclusion Criteria|0|||
33210065|NCT00518115|100670341|FG008|Overall Study|Violation of Exclusion Criteria|0|||
33210066|NCT00518115|100670342|FG009|Overall Study|Violation of Exclusion Criteria|0|||
33210067|NCT00518115|100670333|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
33210068|NCT00518115|100670334|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
33540040|NCT00855218|101874592|FG000|Overall Study|Withdrawal by Subject|10|||
33540041|NCT00855218|101874593|FG001|Overall Study|Withdrawal by Subject|6|||
33540042|NCT00855218|101874592|FG000|Overall Study|Physician Decision|18|||
33540043|NCT00855218|101874593|FG001|Overall Study|Physician Decision|11|||
33540044|NCT00855218|101874592|FG000|Overall Study|Lost to Follow-up|0|||
33540045|NCT00855218|101874593|FG001|Overall Study|Lost to Follow-up|1|||
33210069|NCT00518115|100670335|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
33210070|NCT00518115|100670336|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
33540046|NCT00855218|101874592|FG000|Overall Study|Protocol Violation|5|||
33540047|NCT00855218|101874593|FG001|Overall Study|Protocol Violation|9|||
33540048|NCT00855218|101874592|FG000|Overall Study|non-compliant with study drug|3|||
33540049|NCT00855218|101874593|FG001|Overall Study|non-compliant with study drug|1|||
33540050|NCT00855218|101874592|FG000|Overall Study|patient convenience|2|||
33540051|NCT00855218|101874593|FG001|Overall Study|patient convenience|0|||
33540052|NCT00855218|101874592|FG000|Overall Study|technical problems|2|||
33540053|NCT00855218|101874593|FG001|Overall Study|technical problems|1|||
33540054|NCT00855218|101874592|FG000|Overall Study|Still treated with study medication|0|||
33540055|NCT00855218|101874593|FG001|Overall Study|Still treated with study medication|1|||
33540056|NCT00855218|101874592|FG000|Overall Study|Untreatable disease progression|54|||
33615170|NCT01055314|102140232|FG000|Overall Study|Death|2|||
33615171|NCT01055314|102140233|FG001|Overall Study|Death|1|||
33615172|NCT01055314|102140232|FG000|Overall Study|Lack of Efficacy|11|||
33615173|NCT01055314|102140233|FG001|Overall Study|Lack of Efficacy|19|||
33615174|NCT01055314|102140232|FG000|Overall Study|Physician Decision|10|||
33615175|NCT01055314|102140233|FG001|Overall Study|Physician Decision|5|||
33615176|NCT01055314|102140232|FG000|Overall Study|Withdrawal by Subject|1|||
33615177|NCT01055314|102140233|FG001|Overall Study|Withdrawal by Subject|0|||
33615178|NCT01055314|102140232|FG000|Overall Study|Ineligible|3|||
33615179|NCT01055314|102140233|FG001|Overall Study|Ineligible|5|||
33615180|NCT01055314|102140232|FG000|Overall Study|Refusal of further protocol therapy|10|||
33615181|NCT01055314|102140233|FG001|Overall Study|Refusal of further protocol therapy|4|||
33615182|NCT01055314|102140232|FG000|Overall Study|No treatment|1|||
33615183|NCT01055314|102140233|FG001|Overall Study|No treatment|0|||
33615184|NCT00853151|102140234|FG000|Overall Study|Adverse Event|1|||
33615185|NCT00853151|102140235|FG001|Overall Study|Adverse Event|4|||
33615186|NCT00853151|102140236|FG002|Overall Study|Adverse Event|2|||
33615187|NCT00853151|102140237|FG003|Overall Study|Adverse Event|0|||
33615188|NCT00853151|102140234|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
33615189|NCT00853151|102140235|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33615190|NCT00853151|102140236|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33615191|NCT00853151|102140237|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33615192|NCT00853151|102140234|FG000|Overall Study|Lost to Follow-up|2|||
33210071|NCT00518115|100670337|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
33210072|NCT00518115|100670338|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
33540057|NCT00855218|101874593|FG001|Overall Study|Untreatable disease progression|67|||
33540058|NCT00855218|101874592|FG000|Overall Study|Second malignancy|0|||
33540059|NCT00855218|101874593|FG001|Overall Study|Second malignancy|1|||
33540060|NCT00855218|101874592|FG000|Overall Study|Progression measurement proven|7|||
33615193|NCT00853151|102140235|FG001|Overall Study|Lost to Follow-up|0|||
33615194|NCT00853151|102140236|FG002|Overall Study|Lost to Follow-up|3|||
33615195|NCT00853151|102140237|FG003|Overall Study|Lost to Follow-up|0|||
33615196|NCT00853151|102140234|FG000|Overall Study|Death|1|||
33615197|NCT00853151|102140235|FG001|Overall Study|Death|0|||
33615198|NCT00853151|102140236|FG002|Overall Study|Death|0|||
33615199|NCT00853151|102140237|FG003|Overall Study|Death|1|||
33615200|NCT00853151|102140234|FG000|Overall Study|Protocol Violation|0|||
33210073|NCT00518115|100670339|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
33210074|NCT00518115|100670340|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
33210075|NCT00518115|100670341|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
33210076|NCT00518115|100670342|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
33342578|NCT01870739|101145487|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
33615201|NCT00853151|102140235|FG001|Overall Study|Protocol Violation|0|||
33615202|NCT00853151|102140236|FG002|Overall Study|Protocol Violation|0|||
33342579|NCT01870739|101145488|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
33342580|NCT01870739|101145487|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
33342581|NCT01870739|101145488|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
33342582|NCT02721355|101145502|FG000|Overall Study|Lost to Follow-up|6|||
33342583|NCT02721355|101145503|FG001|Overall Study|Lost to Follow-up|1|||
33615203|NCT00853151|102140237|FG003|Overall Study|Protocol Violation|1|||
33615204|NCT00853151|102140234|FG000|Overall Study|Withdrawal by Subject|5|||
33615205|NCT00853151|102140235|FG001|Overall Study|Withdrawal by Subject|4|||
33615206|NCT00853151|102140236|FG002|Overall Study|Withdrawal by Subject|2|||
33615207|NCT00853151|102140237|FG003|Overall Study|Withdrawal by Subject|1|||
33615208|NCT00853151|102140234|FG000|Overall Study|Physician Decision|0|||
33615209|NCT00853151|102140235|FG001|Overall Study|Physician Decision|2|||
33615210|NCT00853151|102140236|FG002|Overall Study|Physician Decision|1|||
33615211|NCT00853151|102140237|FG003|Overall Study|Physician Decision|0|||
33615212|NCT00853151|102140234|FG000|Overall Study|Sponsor Decision|0|||
33615213|NCT00853151|102140235|FG001|Overall Study|Sponsor Decision|3|||
33615214|NCT00853151|102140236|FG002|Overall Study|Sponsor Decision|0|||
33615215|NCT00853151|102140237|FG003|Overall Study|Sponsor Decision|0|||
33615216|NCT01461707|102140240|FG000|Overall Study|Withdrawal by Subject|1|||
33615217|NCT01461707|102140241|FG001|Overall Study|Withdrawal by Subject|0|||
33615218|NCT00163020|102140242|FG000|Overall Study|Lost to Follow-up|0|||
33615219|NCT00163020|102140243|FG001|Overall Study|Lost to Follow-up|2|||
33210077|NCT00518115|100670333|FG000|Overall Study|Withdrew Consent|0|||
33615220|NCT00166439|102140244|FG000|Overall Study|Ineligible|5|||
33615221|NCT00348673|102140245|FG000|Stage 1|Randomized but not Treated|0|||
33615222|NCT00348673|102140246|FG001|Stage 1|Randomized but not Treated|0|||
33615223|NCT00348673|102140247|FG002|Stage 1|Randomized but not Treated|1|||
33210078|NCT00518115|100670334|FG001|Overall Study|Withdrew Consent|0|||
33210079|NCT00518115|100670335|FG002|Overall Study|Withdrew Consent|0|||
33210080|NCT00518115|100670336|FG003|Overall Study|Withdrew Consent|0|||
33210081|NCT00518115|100670337|FG004|Overall Study|Withdrew Consent|0|||
33210082|NCT00518115|100670338|FG005|Overall Study|Withdrew Consent|1|||
33210083|NCT00518115|100670339|FG006|Overall Study|Withdrew Consent|0|||
33210084|NCT00518115|100670340|FG007|Overall Study|Withdrew Consent|0|||
33210085|NCT00518115|100670341|FG008|Overall Study|Withdrew Consent|0|||
33210086|NCT00518115|100670342|FG009|Overall Study|Withdrew Consent|0|||
33210087|NCT00518115|100670333|FG000|Overall Study|Moved Out of State|0|||
33406462|NCT04391894|101377595|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
33406463|NCT04391894|101377596|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
33406464|NCT04391894|101377597|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
33406465|NCT04391894|101377598|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
33406466|NCT04391894|101377599|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
33210088|NCT00518115|100670334|FG001|Overall Study|Moved Out of State|0|||
33210089|NCT00518115|100670335|FG002|Overall Study|Moved Out of State|0|||
33210090|NCT00518115|100670336|FG003|Overall Study|Moved Out of State|0|||
33210091|NCT00518115|100670337|FG004|Overall Study|Moved Out of State|0|||
33210092|NCT00518115|100670338|FG005|Overall Study|Moved Out of State|0|||
33210093|NCT00518115|100670339|FG006|Overall Study|Moved Out of State|0|||
33210094|NCT00518115|100670340|FG007|Overall Study|Moved Out of State|0|||
33210095|NCT00518115|100670341|FG008|Overall Study|Moved Out of State|0|||
33210096|NCT00518115|100670342|FG009|Overall Study|Moved Out of State|1|||
33210097|NCT00729833|100670344|FG000|Overall Study|Death|5|||
33210098|NCT00729833|100670345|FG001|Overall Study|Death|1|||
33210099|NCT00729833|100670346|FG002|Overall Study|Death|3|||
33210100|NCT00729833|100670347|FG003|Overall Study|Death|5|||
33210101|NCT00729833|100670344|FG000|Overall Study|Study Terminated by Sponsor|0|||
33210102|NCT00729833|100670345|FG001|Overall Study|Study Terminated by Sponsor|0|||
33210103|NCT00729833|100670346|FG002|Overall Study|Study Terminated by Sponsor|1|||
33210104|NCT00729833|100670347|FG003|Overall Study|Study Terminated by Sponsor|0|||
33210105|NCT00729833|100670344|FG000|Overall Study|Lost to Follow-up|1|||
33210106|NCT00729833|100670345|FG001|Overall Study|Lost to Follow-up|0|||
33210107|NCT00729833|100670346|FG002|Overall Study|Lost to Follow-up|0|||
33210108|NCT00729833|100670347|FG003|Overall Study|Lost to Follow-up|0|||
33210109|NCT00729833|100670344|FG000|Overall Study|Withdrawal by Subject|3|||
33210110|NCT00729833|100670345|FG001|Overall Study|Withdrawal by Subject|1|||
33210111|NCT00729833|100670346|FG002|Overall Study|Withdrawal by Subject|3|||
33210112|NCT00729833|100670347|FG003|Overall Study|Withdrawal by Subject|0|||
33210113|NCT00729833|100670344|FG000|Overall Study|Unspecified Reasons|11|||
33210114|NCT00729833|100670345|FG001|Overall Study|Unspecified Reasons|5|||
33210115|NCT00729833|100670346|FG002|Overall Study|Unspecified Reasons|5|||
33210116|NCT00729833|100670347|FG003|Overall Study|Unspecified Reasons|1|||
33540061|NCT00855218|101874593|FG001|Overall Study|Progression measurement proven|15|||
33540062|NCT00855218|101874592|FG000|Overall Study|Clinical endpoint reached|10|||
33540063|NCT00855218|101874593|FG001|Overall Study|Clinical endpoint reached|13|||
33540064|NCT02008526|101874601|FG000|Overall Study|Death|0|||
33540065|NCT02008526|101874602|FG001|Overall Study|Death|2|||
33540066|NCT02008526|101874603|FG002|Overall Study|Death|1|||
33540067|NCT02008526|101874601|FG000|Overall Study|Withdrawal by Subject|3|||
33406467|NCT01189201|101377600|FG000|Overall Study|Adverse Event|1|||
33406468|NCT00972309|101377605|FG000|Overall Study|Switched to alternative treatment|0|||
33406469|NCT00972309|101377606|FG001|Overall Study|Switched to alternative treatment|2|||
33406470|NCT00972309|101377605|FG000|Overall Study|Refused further treatment|0|||
33406471|NCT00972309|101377606|FG001|Overall Study|Refused further treatment|1|||
33406472|NCT00972309|101377605|FG000|Overall Study|Late determination of ineligibility|0|||
33406473|NCT00972309|101377606|FG001|Overall Study|Late determination of ineligibility|1|||
33406474|NCT00972309|101377605|FG000|Overall Study|Second malignancy|1|||
33406475|NCT00972309|101377606|FG001|Overall Study|Second malignancy|1|||
33406476|NCT00972309|101377605|FG000|Overall Study|Visa issues|0|||
33406477|NCT00972309|101377606|FG001|Overall Study|Visa issues|1|||
33406478|NCT00972309|101377605|FG000|Overall Study|Secondary cancer (SCC)|0|||
33406479|NCT00972309|101377606|FG001|Overall Study|Secondary cancer (SCC)|1|||
33210117|NCT00522275|100670350|FG000|Overall Study|Adverse Event|35|||
33406480|NCT00972309|101377605|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
33540068|NCT02008526|101874602|FG001|Overall Study|Withdrawal by Subject|3|||
33210118|NCT00522275|100670350|FG000|Overall Study|Lack of Efficacy|80|||
33210119|NCT00522275|100670350|FG000|Overall Study|Subject withdrew consent|16|||
33210120|NCT00522275|100670350|FG000|Overall Study|Protocol deviation|1|||
33210121|NCT00522275|100670350|FG000|Overall Study|Unsatisfactory compliance|11|||
33210122|NCT00522275|100670350|FG000|Overall Study|Lost to Follow-up|8|||
33210123|NCT00522275|100670350|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
33210124|NCT00522275|100670350|FG000|Overall Study|Other: Subject is pregnant|2|||
33406481|NCT00972309|101377606|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
33406482|NCT00972309|101377605|FG000|Overall Study|Lost to Follow-up|1|||
33406483|NCT00972309|101377606|FG001|Overall Study|Lost to Follow-up|1|||
33406484|NCT00972309|101377605|FG000|Overall Study|Disease progression on study|10|||
33210125|NCT00522275|100670350|FG000|Overall Study|Other: Subject relocated|2|||
33210126|NCT00522275|100670350|FG000|Overall Study|Other: Subject arrested|1|||
33406485|NCT00972309|101377606|FG001|Overall Study|Disease progression on study|4|||
33406486|NCT04563845|101377607|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
33406487|NCT04563845|101377608|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
33406488|NCT04563845|101377609|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
33406489|NCT04563845|101377610|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
33406490|NCT04563845|101377611|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
33210127|NCT00522275|100670350|FG000|Overall Study|Other: Site / clinic closed|4|||
33210128|NCT00522275|100670350|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
33210129|NCT00522275|100670350|FG000|Overall Study|Other: Sponsor request|2|||
33210130|NCT00522275|100670350|FG000|Overall Study|Other: Subject ran out of medication|1|||
33210131|NCT00522275|100670350|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
33210132|NCT00833638|100670354|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
33210133|NCT00833638|100670355|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
33210134|NCT00833638|100670356|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
33406491|NCT04563845|101377612|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
33406492|NCT04563845|101377613|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
33406493|NCT04563845|101377614|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
33406494|NCT04563845|101377615|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
33210135|NCT00833638|100670354|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
33210136|NCT00833638|100670355|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
33210137|NCT00833638|100670356|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
33210138|NCT00833638|100670354|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
33210139|NCT00833638|100670355|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
33210140|NCT00833638|100670356|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
33210141|NCT00833638|100670354|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
33210142|NCT00833638|100670355|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
33210143|NCT00833638|100670356|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
33210144|NCT00833638|100670354|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
33210145|NCT00833638|100670355|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
33210146|NCT00833638|100670356|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
33210147|NCT00833638|100670354|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
33210148|NCT00833638|100670355|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
33210149|NCT00833638|100670356|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
33210150|NCT00833638|100670354|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
33210151|NCT00833638|100670355|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
33210152|NCT00833638|100670356|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
33210153|NCT00833638|100670354|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
33210154|NCT00833638|100670355|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
33210155|NCT00833638|100670356|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
33210156|NCT00833638|100670354|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
33210157|NCT00833638|100670355|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
33210158|NCT00833638|100670356|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
33210159|NCT00487162|100670357|FG000|Overall Study|Adverse Event|0|||
33210160|NCT00487162|100670358|FG001|Overall Study|Adverse Event|1|||
33210161|NCT00487162|100670357|FG000|Overall Study|Physician Decision|0|||
33210162|NCT00487162|100670358|FG001|Overall Study|Physician Decision|1|||
33210163|NCT00487162|100670357|FG000|Overall Study|Withdrawal by Subject|2|||
33210164|NCT00487162|100670358|FG001|Overall Study|Withdrawal by Subject|3|||
33210165|NCT03581305|100670360|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
33210166|NCT03581305|100670361|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
33210167|NCT03581305|100670360|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
33406495|NCT04563845|101377616|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
33406496|NCT04563845|101377617|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
33406497|NCT04563845|101377618|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
33406498|NCT04563845|101377619|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
33406499|NCT04563845|101377620|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
33406500|NCT04563845|101377607|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
33406501|NCT04563845|101377608|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
33406502|NCT04563845|101377609|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
33210168|NCT03581305|100670361|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
33210169|NCT03581305|100670360|FG000|Serotonergic Study|Withdrawal by Subject|5|||
33210170|NCT03581305|100670361|FG001|Serotonergic Study|Withdrawal by Subject|1|||
33210171|NCT01260350|100670362|FG000|Overall Study|Lack of Efficacy|0|||
33210172|NCT01260350|100670363|FG001|Overall Study|Lack of Efficacy|0|||
33210173|NCT01260350|100670364|FG002|Overall Study|Lack of Efficacy|0|||
33210174|NCT01260350|100670365|FG003|Overall Study|Lack of Efficacy|0|||
33210175|NCT01260350|100670366|FG004|Overall Study|Lack of Efficacy|0|||
33210176|NCT01260350|100670367|FG005|Overall Study|Lack of Efficacy|0|||
33210177|NCT01260350|100670368|FG006|Overall Study|Lack of Efficacy|0|||
33210178|NCT01260350|100670369|FG007|Overall Study|Lack of Efficacy|0|||
33210179|NCT01260350|100670370|FG008|Overall Study|Lack of Efficacy|0|||
33210180|NCT01260350|100670371|FG009|Overall Study|Lack of Efficacy|0|||
33210181|NCT01260350|100670372|FG010|Overall Study|Lack of Efficacy|0|||
33210182|NCT01260350|100670373|FG011|Overall Study|Lack of Efficacy|0|||
33210183|NCT01260350|100670374|FG012|Overall Study|Lack of Efficacy|0|||
33210184|NCT01260350|100670375|FG013|Overall Study|Lack of Efficacy|0|||
33210185|NCT01260350|100670376|FG014|Overall Study|Lack of Efficacy|0|||
33210186|NCT01260350|100670377|FG015|Overall Study|Lack of Efficacy|0|||
33210187|NCT01260350|100670378|FG016|Overall Study|Lack of Efficacy|0|||
33210188|NCT01260350|100670379|FG017|Overall Study|Lack of Efficacy|1|||
33210189|NCT01260350|100670380|FG018|Overall Study|Lack of Efficacy|0|||
33210190|NCT01260350|100670381|FG019|Overall Study|Lack of Efficacy|0|||
33406503|NCT04563845|101377610|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
33406504|NCT04563845|101377611|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
33406505|NCT04563845|101377612|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
33210191|NCT01260350|100670382|FG020|Overall Study|Lack of Efficacy|3|||
33210192|NCT01260350|100670383|FG021|Overall Study|Lack of Efficacy|0|||
33210193|NCT01260350|100670362|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210194|NCT01260350|100670363|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210195|NCT01260350|100670364|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210196|NCT01260350|100670365|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210197|NCT01260350|100670366|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210198|NCT01260350|100670367|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210199|NCT01260350|100670368|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210200|NCT01260350|100670369|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210201|NCT01260350|100670370|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
33210202|NCT01260350|100670371|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210203|NCT01260350|100670372|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33406506|NCT04563845|101377613|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
33406507|NCT04563845|101377614|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
33210204|NCT01260350|100670373|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210205|NCT01260350|100670374|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210206|NCT01260350|100670375|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210207|NCT01260350|100670376|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210208|NCT01260350|100670377|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210209|NCT01260350|100670378|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210210|NCT01260350|100670379|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210211|NCT01260350|100670380|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210212|NCT01260350|100670381|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33406508|NCT04563845|101377615|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
33406509|NCT04563845|101377616|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
33406510|NCT04563845|101377617|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
33406511|NCT04563845|101377618|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
33406512|NCT04563845|101377619|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
33406513|NCT04563845|101377620|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
33406514|NCT01610752|101377622|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
33406515|NCT01610752|101377623|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
33406516|NCT01610752|101377624|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
33406517|NCT01425268|101377625|FG000|Overall Study|Withdrawal by Subject|2|||
33406518|NCT01425268|101377626|FG001|Overall Study|Withdrawal by Subject|0|||
33406519|NCT01425268|101377625|FG000|Overall Study|Sponsor Decision|5|||
33406520|NCT01425268|101377626|FG001|Overall Study|Sponsor Decision|0|||
33406521|NCT01425268|101377625|FG000|Overall Study|Physician Decision|1|||
33406522|NCT01425268|101377626|FG001|Overall Study|Physician Decision|0|||
33406523|NCT02756182|101377632|FG000|Overall Study|StudyTechnical Difficulties|4|||
33406524|NCT01265719|101377638|FG000|Overall Study|Does not meet entrance criteria|0|||
33406525|NCT01265719|101377639|FG001|Overall Study|Does not meet entrance criteria|3|||
33406526|NCT01265719|101377638|FG000|Overall Study|Other reasons|2|||
33406527|NCT01265719|101377639|FG001|Overall Study|Other reasons|0|||
33406528|NCT01265719|101377638|FG000|Overall Study|Withdrawal by Subject|8|||
33406529|NCT01265719|101377639|FG001|Overall Study|Withdrawal by Subject|3|||
33406530|NCT01265719|101377638|FG000|Overall Study|Lost to Follow-up|2|||
33406531|NCT01265719|101377639|FG001|Overall Study|Lost to Follow-up|7|||
33406532|NCT01265719|101377638|FG000|Overall Study|Adverse Event|2|||
33406533|NCT01265719|101377639|FG001|Overall Study|Adverse Event|0|||
33406534|NCT00553319|101377640|FG000|Overall Study|Lost to Follow-up|10|||
33406535|NCT00553319|101377641|FG001|Overall Study|Lost to Follow-up|9|||
33210213|NCT01260350|100670382|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210214|NCT01260350|100670383|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
33210215|NCT03182868|100670391|FG000|Overall Study|Protocol Violation|3|||
33210216|NCT03182868|100670392|FG001|Overall Study|Protocol Violation|0|||
33406536|NCT00553319|101377642|FG002|Overall Study|Lost to Follow-up|5|||
33406537|NCT00553319|101377640|FG000|Overall Study|wanted treatment elsewhere|2|||
33406538|NCT00553319|101377641|FG001|Overall Study|wanted treatment elsewhere|1|||
33406539|NCT00553319|101377642|FG002|Overall Study|wanted treatment elsewhere|1|||
33406540|NCT00553319|101377640|FG000|Overall Study|non-compliance|0|||
33406541|NCT00553319|101377641|FG001|Overall Study|non-compliance|0|||
33406542|NCT00553319|101377642|FG002|Overall Study|non-compliance|2|||
33540069|NCT02008526|101874603|FG002|Overall Study|Withdrawal by Subject|2|||
33540070|NCT02008526|101874601|FG000|Overall Study|Lost to Follow-up|5|||
33540071|NCT02008526|101874602|FG001|Overall Study|Lost to Follow-up|9|||
33540072|NCT02008526|101874603|FG002|Overall Study|Lost to Follow-up|6|||
33540073|NCT05379920|101874604|FG000|Overall Study|Lost to Follow-up|0|||
33540074|NCT05379920|101874605|FG001|Overall Study|Lost to Follow-up|5|||
33540075|NCT05379920|101874606|FG002|Overall Study|Lost to Follow-up|0|||
33540076|NCT05379920|101874607|FG003|Overall Study|Lost to Follow-up|0|||
33540077|NCT01020123|101874608|FG000|Main Period|Withdrawal by Subject|6|||
33540078|NCT01020123|101874609|FG001|Main Period|Withdrawal by Subject|5|||
33540079|NCT01020123|101874610|FG002|Main Period|Withdrawal by Subject|3|||
33540080|NCT01020123|101874611|FG003|Main Period|Withdrawal by Subject|1|||
33540081|NCT01020123|101874612|FG004|Main Period|Withdrawal by Subject|6|||
33540082|NCT01020123|101874613|FG005|Main Period|Withdrawal by Subject|3|||
33540083|NCT01020123|101874614|FG006|Main Period|Withdrawal by Subject|2|||
33540084|NCT01020123|101874608|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
33540085|NCT01020123|101874609|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
33540086|NCT01020123|101874610|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
33540087|NCT01020123|101874611|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
33540088|NCT01020123|101874612|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
33540089|NCT01020123|101874613|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
33540090|NCT01020123|101874614|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
33540091|NCT01020123|101874608|FG000|Main Period|Adverse Event|5|||
33540092|NCT01020123|101874609|FG001|Main Period|Adverse Event|2|||
33540093|NCT01020123|101874610|FG002|Main Period|Adverse Event|2|||
33540094|NCT01020123|101874611|FG003|Main Period|Adverse Event|1|||
33540095|NCT01020123|101874612|FG004|Main Period|Adverse Event|1|||
33540096|NCT01020123|101874613|FG005|Main Period|Adverse Event|2|||
33540097|NCT01020123|101874614|FG006|Main Period|Adverse Event|1|||
33540098|NCT01020123|101874608|FG000|Main Period|Protocol Violation|4|||
33540099|NCT01020123|101874609|FG001|Main Period|Protocol Violation|4|||
33540100|NCT01020123|101874610|FG002|Main Period|Protocol Violation|2|||
33540101|NCT01020123|101874611|FG003|Main Period|Protocol Violation|5|||
33540102|NCT01020123|101874612|FG004|Main Period|Protocol Violation|2|||
33540103|NCT01020123|101874613|FG005|Main Period|Protocol Violation|3|||
33615224|NCT00348673|102140248|FG003|Stage 1|Randomized but not Treated|0|||
33615225|NCT00348673|102140249|FG004|Stage 1|Randomized but not Treated|0|||
33615226|NCT00348673|102140250|FG005|Stage 1|Randomized but not Treated|0|||
33615227|NCT00348673|102140251|FG006|Stage 1|Randomized but not Treated|0|||
33615228|NCT00348673|102140252|FG007|Stage 1|Randomized but not Treated|0|||
33615229|NCT00348673|102140253|FG008|Stage 1|Randomized but not Treated|0|||
33615230|NCT00532298|102140254|FG000|Overall Study|Adverse Event|1|||
33615231|NCT00532298|102140255|FG001|Overall Study|Adverse Event|0|||
33615232|NCT00532298|102140256|FG002|Overall Study|Adverse Event|0|||
33615233|NCT00532298|102140257|FG003|Overall Study|Adverse Event|0|||
33615234|NCT00532298|102140258|FG004|Overall Study|Adverse Event|1|||
33615235|NCT00532298|102140259|FG005|Overall Study|Adverse Event|1|||
33615236|NCT00532298|102140254|FG000|Overall Study|Lost to Follow-up|1|||
33615237|NCT00532298|102140255|FG001|Overall Study|Lost to Follow-up|1|||
33615238|NCT00532298|102140256|FG002|Overall Study|Lost to Follow-up|1|||
33615239|NCT00532298|102140257|FG003|Overall Study|Lost to Follow-up|0|||
33615240|NCT00532298|102140258|FG004|Overall Study|Lost to Follow-up|0|||
33615241|NCT00532298|102140259|FG005|Overall Study|Lost to Follow-up|1|||
33615242|NCT02828436|102140260|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
33615243|NCT02828436|102140261|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
33615244|NCT02828436|102140260|FG000|Period 1|Lost to Follow-up|0|||
33615245|NCT02828436|102140261|FG001|Period 1|Lost to Follow-up|1|||
33615246|NCT02828436|102140260|FG000|Period 2|Withdrawal by Subject|4|||
33615247|NCT02828436|102140261|FG001|Period 2|Withdrawal by Subject|0|||
33615248|NCT02828436|102140260|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
33615249|NCT02828436|102140261|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
33615250|NCT02828436|102140260|FG000|Period 2|Lost to Follow-up|1|||
33615251|NCT02828436|102140261|FG001|Period 2|Lost to Follow-up|0|||
33615252|NCT01618695|102140264|FG000|Core Phase|Adverse Event|4|||
33615253|NCT01618695|102140265|FG001|Core Phase|Adverse Event|5|||
33615254|NCT01618695|102140266|FG002|Core Phase|Adverse Event|15|||
33540104|NCT01020123|101874614|FG006|Main Period|Protocol Violation|2|||
33540105|NCT01020123|101874608|FG000|Main Period|Lost to Follow-up|0|||
33540106|NCT01020123|101874609|FG001|Main Period|Lost to Follow-up|2|||
33540107|NCT01020123|101874610|FG002|Main Period|Lost to Follow-up|0|||
33615255|NCT01618695|102140267|FG003|Core Phase|Adverse Event|20|||
33615256|NCT01618695|102140264|FG000|Core Phase|Lost to Follow-up|0|||
33540108|NCT01020123|101874611|FG003|Main Period|Lost to Follow-up|0|||
33615257|NCT01618695|102140265|FG001|Core Phase|Lost to Follow-up|0|||
33615258|NCT01618695|102140266|FG002|Core Phase|Lost to Follow-up|1|||
33615259|NCT01618695|102140267|FG003|Core Phase|Lost to Follow-up|0|||
33615260|NCT01618695|102140264|FG000|Core Phase|Withdrawal by Subject|16|||
33615261|NCT01618695|102140265|FG001|Core Phase|Withdrawal by Subject|11|||
33540109|NCT01020123|101874612|FG004|Main Period|Lost to Follow-up|0|||
33540110|NCT01020123|101874613|FG005|Main Period|Lost to Follow-up|0|||
33615262|NCT01618695|102140266|FG002|Core Phase|Withdrawal by Subject|9|||
33540111|NCT01020123|101874614|FG006|Main Period|Lost to Follow-up|0|||
33540112|NCT01020123|101874608|FG000|Main Period|Unclasified|2|||
33540113|NCT01020123|101874609|FG001|Main Period|Unclasified|0|||
33540114|NCT01020123|101874610|FG002|Main Period|Unclasified|1|||
33540115|NCT01020123|101874611|FG003|Main Period|Unclasified|0|||
33540116|NCT01020123|101874612|FG004|Main Period|Unclasified|1|||
33540117|NCT01020123|101874613|FG005|Main Period|Unclasified|3|||
33540118|NCT01020123|101874614|FG006|Main Period|Unclasified|6|||
33540119|NCT01020123|101874608|FG000|Extention Period|Withdrawal by Subject|2|||
33540120|NCT01020123|101874609|FG001|Extention Period|Withdrawal by Subject|1|||
33540121|NCT01020123|101874610|FG002|Extention Period|Withdrawal by Subject|1|||
33540122|NCT01020123|101874611|FG003|Extention Period|Withdrawal by Subject|0|||
33540123|NCT01020123|101874612|FG004|Extention Period|Withdrawal by Subject|0|||
33540124|NCT01020123|101874613|FG005|Extention Period|Withdrawal by Subject|0|||
33540125|NCT01020123|101874614|FG006|Extention Period|Withdrawal by Subject|0|||
33540126|NCT01020123|101874608|FG000|Extention Period|Adverse Event|0|||
33615263|NCT01618695|102140267|FG003|Core Phase|Withdrawal by Subject|13|||
33540127|NCT01020123|101874609|FG001|Extention Period|Adverse Event|0|||
33540128|NCT01020123|101874610|FG002|Extention Period|Adverse Event|0|||
33540129|NCT01020123|101874611|FG003|Extention Period|Adverse Event|1|||
33540130|NCT01020123|101874612|FG004|Extention Period|Adverse Event|0|||
33540131|NCT01020123|101874613|FG005|Extention Period|Adverse Event|0|||
33540132|NCT01020123|101874614|FG006|Extention Period|Adverse Event|0|||
33540133|NCT01020123|101874608|FG000|Extention Period|Protocol Violation|1|||
33540134|NCT01020123|101874609|FG001|Extention Period|Protocol Violation|1|||
33540135|NCT01020123|101874610|FG002|Extention Period|Protocol Violation|1|||
33540136|NCT01020123|101874611|FG003|Extention Period|Protocol Violation|0|||
33540137|NCT01020123|101874612|FG004|Extention Period|Protocol Violation|0|||
33540138|NCT01020123|101874613|FG005|Extention Period|Protocol Violation|0|||
33540139|NCT01020123|101874614|FG006|Extention Period|Protocol Violation|1|||
33540140|NCT01020123|101874608|FG000|Extention Period|Lost to Follow-up|0|||
33615264|NCT01618695|102140264|FG000|Core Phase|Pregnancy|2|||
33615265|NCT01618695|102140265|FG001|Core Phase|Pregnancy|0|||
33615266|NCT01618695|102140266|FG002|Core Phase|Pregnancy|0|||
33615267|NCT01618695|102140267|FG003|Core Phase|Pregnancy|0|||
33615268|NCT01618695|102140264|FG000|Core Phase|Lack of Efficacy|1|||
33615269|NCT01618695|102140265|FG001|Core Phase|Lack of Efficacy|2|||
33615270|NCT01618695|102140266|FG002|Core Phase|Lack of Efficacy|1|||
33615271|NCT01618695|102140267|FG003|Core Phase|Lack of Efficacy|1|||
33615272|NCT01618695|102140264|FG000|Core Phase|Other than specified|1|||
33615273|NCT01618695|102140265|FG001|Core Phase|Other than specified|2|||
33615274|NCT01618695|102140266|FG002|Core Phase|Other than specified|2|||
33615275|NCT01618695|102140267|FG003|Core Phase|Other than specified|2|||
33615276|NCT01618695|102140264|FG000|Core Phase|Not treated|1|||
33615277|NCT01618695|102140265|FG001|Core Phase|Not treated|0|||
33615278|NCT01618695|102140266|FG002|Core Phase|Not treated|2|||
33615279|NCT01618695|102140267|FG003|Core Phase|Not treated|0|||
33615280|NCT01618695|102140264|FG000|Extension Phase|Lack of Efficacy|17|||
33615281|NCT01618695|102140265|FG001|Extension Phase|Lack of Efficacy|33|||
33615282|NCT01618695|102140266|FG002|Extension Phase|Lack of Efficacy|26|||
33615283|NCT01618695|102140267|FG003|Extension Phase|Lack of Efficacy|24|||
33615284|NCT01618695|102140264|FG000|Extension Phase|Pregnancy|2|||
33615285|NCT01618695|102140265|FG001|Extension Phase|Pregnancy|0|||
33615286|NCT01618695|102140266|FG002|Extension Phase|Pregnancy|1|||
33615287|NCT01618695|102140267|FG003|Extension Phase|Pregnancy|1|||
33615288|NCT01618695|102140264|FG000|Extension Phase|Withdrawal by Subject|43|||
33615289|NCT01618695|102140265|FG001|Extension Phase|Withdrawal by Subject|48|||
33615290|NCT01618695|102140266|FG002|Extension Phase|Withdrawal by Subject|42|||
33615291|NCT01618695|102140267|FG003|Extension Phase|Withdrawal by Subject|33|||
33615292|NCT01618695|102140264|FG000|Extension Phase|Adverse Event|18|||
33615293|NCT01618695|102140265|FG001|Extension Phase|Adverse Event|16|||
33540141|NCT01020123|101874609|FG001|Extention Period|Lost to Follow-up|0|||
33540142|NCT01020123|101874610|FG002|Extention Period|Lost to Follow-up|0|||
33615294|NCT01618695|102140266|FG002|Extension Phase|Adverse Event|9|||
33615295|NCT01618695|102140267|FG003|Extension Phase|Adverse Event|20|||
33540143|NCT01020123|101874611|FG003|Extention Period|Lost to Follow-up|0|||
33615296|NCT01618695|102140264|FG000|Extension Phase|Lost to Follow-up|2|||
33615297|NCT01618695|102140265|FG001|Extension Phase|Lost to Follow-up|1|||
33540144|NCT01020123|101874612|FG004|Extention Period|Lost to Follow-up|0|||
33540145|NCT01020123|101874613|FG005|Extention Period|Lost to Follow-up|2|||
33540146|NCT01020123|101874614|FG006|Extention Period|Lost to Follow-up|0|||
33540147|NCT03087058|101874615|FG000|Overall Study|Withdrawal by Subject|2|||
33540148|NCT03087058|101874616|FG001|Overall Study|Withdrawal by Subject|0|||
33540149|NCT03087058|101874617|FG002|Overall Study|Withdrawal by Subject|0|||
33615298|NCT01618695|102140266|FG002|Extension Phase|Lost to Follow-up|1|||
33615299|NCT01618695|102140267|FG003|Extension Phase|Lost to Follow-up|1|||
33615300|NCT01618695|102140264|FG000|Extension Phase|Other than specified|13|||
33615301|NCT01618695|102140265|FG001|Extension Phase|Other than specified|18|||
33615302|NCT01618695|102140266|FG002|Extension Phase|Other than specified|13|||
33540150|NCT04539275|101878405|FG000|Overall Study|Death|2|||
33540151|NCT04539275|101878406|FG001|Overall Study|Death|4|||
33540152|NCT04539275|101878405|FG000|Overall Study|Lost to Follow-up|1|||
33540153|NCT04539275|101878406|FG001|Overall Study|Lost to Follow-up|1|||
33540154|NCT04539275|101878405|FG000|Overall Study|Withdrawal by Subject|3|||
33540155|NCT04539275|101878406|FG001|Overall Study|Withdrawal by Subject|0|||
33540156|NCT01075048|101878411|FG000|Overall Study|Death|4|||
33540157|NCT01075048|101878412|FG001|Overall Study|Death|17|||
33540158|NCT01075048|101878413|FG002|Overall Study|Death|12|||
33540159|NCT01075048|101878411|FG000|Overall Study|Start of other or new therapy|4|||
33540160|NCT01075048|101878412|FG001|Overall Study|Start of other or new therapy|36|||
33540161|NCT01075048|101878413|FG002|Overall Study|Start of other or new therapy|46|||
33540162|NCT01075048|101878411|FG000|Overall Study|Withdrawal by Subject|1|||
33540163|NCT01075048|101878412|FG001|Overall Study|Withdrawal by Subject|6|||
33540164|NCT01075048|101878413|FG002|Overall Study|Withdrawal by Subject|3|||
33540165|NCT01075048|101878411|FG000|Overall Study|Lost to Follow-up|0|||
33210217|NCT03182868|100670393|FG002|Overall Study|Protocol Violation|4|||
33210218|NCT03182868|100670394|FG003|Overall Study|Protocol Violation|1|||
33210219|NCT03182868|100670395|FG004|Overall Study|Protocol Violation|8|||
33210220|NCT01475136|100670396|FG000|Overall Study|Sponsor Decision|0|||
33615303|NCT01618695|102140267|FG003|Extension Phase|Other than specified|18|||
33540166|NCT01075048|101878412|FG001|Overall Study|Lost to Follow-up|1|||
33342584|NCT00772629|101145504|FG000|Overall Study|Subject was not vaccinated|1|||
33342585|NCT00772629|101145505|FG001|Overall Study|Subject was not vaccinated|0|||
33342586|NCT00477165|101145506|FG000|Overall Study|Adverse Event|7|||
33342587|NCT00477165|101145507|FG001|Overall Study|Adverse Event|2|||
33342588|NCT02486757|101145508|FG000|Overall Study|Lost to Follow-up|1|||
33342589|NCT00559507|101145509|FG000|Overall Study|Not treated, patient ineligible|3|||
33342590|NCT02810964|101145510|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
33342591|NCT02810964|101145511|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
33342592|NCT02810964|101145510|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
33342593|NCT02810964|101145511|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
33342594|NCT02810964|101145510|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
33540167|NCT01075048|101878413|FG002|Overall Study|Lost to Follow-up|1|||
33540168|NCT04919317|101878414|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
33540169|NCT04919317|101878415|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
33540170|NCT04919317|101878414|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
33540171|NCT04919317|101878415|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
33540172|NCT04006145|101878416|FG000|Overall Study|Lost to Follow-up|0|||
33540173|NCT04006145|101878417|FG001|Overall Study|Lost to Follow-up|1|||
33540174|NCT04006145|101878416|FG000|Overall Study|Other|1|||
33342595|NCT02810964|101145511|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
33342596|NCT02810964|101145510|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
33210221|NCT01475136|100670397|FG001|Overall Study|Sponsor Decision|1|||
33210222|NCT01475136|100670398|FG002|Overall Study|Sponsor Decision|0|||
33540175|NCT04006145|101878417|FG001|Overall Study|Other|2|||
33540176|NCT00001566|101878418|FG000|Overall Study|patients' choice to discontinue protocol|3|||
33210223|NCT01475136|100670399|FG003|Overall Study|Sponsor Decision|0|||
33210224|NCT01475136|100670396|FG000|Overall Study|Entry Criteria Not Met|0|||
33210225|NCT01475136|100670397|FG001|Overall Study|Entry Criteria Not Met|2|||
33210226|NCT01475136|100670398|FG002|Overall Study|Entry Criteria Not Met|3|||
33210227|NCT01475136|100670399|FG003|Overall Study|Entry Criteria Not Met|1|||
33210228|NCT01475136|100670396|FG000|Overall Study|Withdrawal by Subject|0|||
33210229|NCT01475136|100670397|FG001|Overall Study|Withdrawal by Subject|0|||
33210230|NCT01475136|100670398|FG002|Overall Study|Withdrawal by Subject|0|||
33210231|NCT01475136|100670399|FG003|Overall Study|Withdrawal by Subject|2|||
33210232|NCT01475136|100670396|FG000|Overall Study|Adverse Event|1|||
33406543|NCT00553319|101377640|FG000|Overall Study|incarceration|1|||
33406544|NCT00553319|101377641|FG001|Overall Study|incarceration|0|||
33406545|NCT00553319|101377642|FG002|Overall Study|incarceration|0|||
33406546|NCT00553319|101377640|FG000|Overall Study|moved|1|||
33540177|NCT00001566|101878418|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
33540178|NCT00001566|101878418|FG000|Overall Study|Death|13|||
33540179|NCT00001566|101878418|FG000|Overall Study|Lost to Follow-up|1|||
33540180|NCT00001566|101878418|FG000|Overall Study|unable to complete initial apheresis|1|||
33540181|NCT00297167|101878419|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
33540182|NCT00297167|101878420|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
33540183|NCT00297167|101878421|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
33540184|NCT00297167|101878419|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
33540185|NCT00297167|101878420|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
33540186|NCT00297167|101878421|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
33540187|NCT02378662|101878422|FG000|Overall Study|Early Discontinuation|2|||
33615304|NCT00103740|102140268|FG000|Period 1 - Core|Adverse Event|1|||
33615305|NCT00103740|102140269|FG001|Period 1 - Core|Adverse Event|0|||
33615306|NCT00103740|102140268|FG000|Period 1 - Core|Protocol Violation|3|||
33615307|NCT00103740|102140269|FG001|Period 1 - Core|Protocol Violation|2|||
33615308|NCT00103740|102140268|FG000|Period 1 - Core|Patient withdrew consent|3|||
33615309|NCT00103740|102140269|FG001|Period 1 - Core|Patient withdrew consent|2|||
33615310|NCT00103740|102140268|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
33615311|NCT00103740|102140269|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
33615312|NCT00103740|102140268|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
33615313|NCT00103740|102140269|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
33615314|NCT00103740|102140268|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
33615315|NCT00103740|102140269|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
33615316|NCT00103740|102140268|FG000|Period 2 - Extended Observation Period|Death|6|||
33615317|NCT00103740|102140269|FG001|Period 2 - Extended Observation Period|Death|2|||
33210233|NCT01475136|100670397|FG001|Overall Study|Adverse Event|0|||
33210234|NCT01475136|100670398|FG002|Overall Study|Adverse Event|0|||
33210235|NCT01475136|100670399|FG003|Overall Study|Adverse Event|1|||
33210236|NCT01475136|100670396|FG000|Overall Study|Death|0|||
33210237|NCT01475136|100670397|FG001|Overall Study|Death|0|||
33210238|NCT01475136|100670398|FG002|Overall Study|Death|0|||
33210239|NCT01475136|100670399|FG003|Overall Study|Death|1|||
33210240|NCT02270450|100670404|FG000|Overall Study|Refusal unrelated to adverse event|3|||
33210241|NCT02270450|100670405|FG001|Overall Study|Refusal unrelated to adverse event|1|||
33210242|NCT02270450|100670406|FG002|Overall Study|Refusal unrelated to adverse event|5|||
33210243|NCT02270450|100670407|FG003|Overall Study|Refusal unrelated to adverse event|14|||
33540188|NCT02378662|101878423|FG001|Overall Study|Early Discontinuation|0|||
33540189|NCT03886272|101878425|FG000|Period 1|Withdrawal by Subject|0|||
33210244|NCT02270450|100670404|FG000|Overall Study|Progression/relapse|1|||
33210245|NCT02270450|100670405|FG001|Overall Study|Progression/relapse|2|||
33210246|NCT02270450|100670406|FG002|Overall Study|Progression/relapse|4|||
33406547|NCT00553319|101377641|FG001|Overall Study|moved|0|||
33406548|NCT00553319|101377642|FG002|Overall Study|moved|1|||
33406549|NCT03938857|101377643|FG000|Overall Study|Physician Decision|1|||
33342597|NCT02810964|101145511|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
33342598|NCT02574637|101145518|FG000|Double-blind Period|Adverse Event|1|||
33342599|NCT02574637|101145519|FG001|Double-blind Period|Adverse Event|0|||
33540190|NCT03886272|101878426|FG001|Period 1|Withdrawal by Subject|0|||
33540191|NCT03886272|101878427|FG002|Period 1|Withdrawal by Subject|0|||
33540192|NCT03886272|101878428|FG003|Period 1|Withdrawal by Subject|0|||
33540193|NCT03886272|101878429|FG004|Period 1|Withdrawal by Subject|0|||
33540194|NCT03886272|101878430|FG005|Period 1|Withdrawal by Subject|1|||
33540195|NCT03886272|101878431|FG006|Period 1|Withdrawal by Subject|0|||
33540196|NCT00296244|101878432|FG000|Overall Study|Underwent retransplant|0|||
33540197|NCT00296244|101878433|FG001|Overall Study|Underwent retransplant|1|||
33540198|NCT00879658|101878446|FG000|Overall Study|Abnormal laboratory value(s)|3|||
33540199|NCT00879658|101878447|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33540200|NCT00879658|101878448|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33540201|NCT00879658|101878449|FG003|Overall Study|Abnormal laboratory value(s)|1|||
33540202|NCT00879658|101878450|FG004|Overall Study|Abnormal laboratory value(s)|0|||
33540203|NCT00879658|101878451|FG005|Overall Study|Abnormal laboratory value(s)|0|||
33342600|NCT02574637|101145520|FG002|Double-blind Period|Adverse Event|0|||
33615318|NCT00103740|102140268|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
33615319|NCT00103740|102140269|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
33615320|NCT01272635|102140272|FG000|Overall Study|Lost to Follow-up|31|||
33615321|NCT01272635|102140273|FG001|Overall Study|Lost to Follow-up|20|||
33615322|NCT01272635|102140274|FG002|Overall Study|Lost to Follow-up|31|||
33615323|NCT01272635|102140275|FG003|Overall Study|Lost to Follow-up|23|||
33210247|NCT02270450|100670407|FG003|Overall Study|Progression/relapse|9|||
33540204|NCT00879658|101878452|FG006|Overall Study|Abnormal laboratory value(s)|0|||
33540205|NCT00879658|101878446|FG000|Overall Study|Administrative problems|2|||
33342601|NCT02574637|101145521|FG003|Double-blind Period|Adverse Event|0|||
33342602|NCT02574637|101145522|FG004|Double-blind Period|Adverse Event|0|||
33342603|NCT02574637|101145523|FG005|Double-blind Period|Adverse Event|0|||
33342604|NCT02574637|101145524|FG006|Double-blind Period|Adverse Event|0|||
33342605|NCT02574637|101145525|FG007|Double-blind Period|Adverse Event|0|||
33342606|NCT02574637|101145526|FG008|Double-blind Period|Adverse Event|0|||
33342607|NCT02574637|101145527|FG009|Double-blind Period|Adverse Event|0|||
33342608|NCT02574637|101145518|FG000|Double-blind Period|Lack of Efficacy|0|||
33342609|NCT02574637|101145519|FG001|Double-blind Period|Lack of Efficacy|0|||
33342610|NCT02574637|101145520|FG002|Double-blind Period|Lack of Efficacy|2|||
33342611|NCT02574637|101145521|FG003|Double-blind Period|Lack of Efficacy|0|||
33540206|NCT00879658|101878447|FG001|Overall Study|Administrative problems|1|||
33540207|NCT00879658|101878448|FG002|Overall Study|Administrative problems|0|||
33540208|NCT00879658|101878449|FG003|Overall Study|Administrative problems|1|||
33540209|NCT00879658|101878450|FG004|Overall Study|Administrative problems|0|||
33540210|NCT00879658|101878451|FG005|Overall Study|Administrative problems|0|||
33540211|NCT00879658|101878452|FG006|Overall Study|Administrative problems|0|||
33342612|NCT02574637|101145522|FG004|Double-blind Period|Lack of Efficacy|0|||
33342613|NCT02574637|101145523|FG005|Double-blind Period|Lack of Efficacy|0|||
33342614|NCT02574637|101145524|FG006|Double-blind Period|Lack of Efficacy|0|||
33342615|NCT02574637|101145525|FG007|Double-blind Period|Lack of Efficacy|0|||
33342616|NCT02574637|101145526|FG008|Double-blind Period|Lack of Efficacy|0|||
33342617|NCT02574637|101145527|FG009|Double-blind Period|Lack of Efficacy|0|||
33342618|NCT02574637|101145518|FG000|Double-blind Period|Protocol Deviation|1|||
33342619|NCT02574637|101145519|FG001|Double-blind Period|Protocol Deviation|0|||
33342620|NCT02574637|101145520|FG002|Double-blind Period|Protocol Deviation|0|||
33342621|NCT02574637|101145521|FG003|Double-blind Period|Protocol Deviation|0|||
33342622|NCT02574637|101145522|FG004|Double-blind Period|Protocol Deviation|0|||
33342623|NCT02574637|101145523|FG005|Double-blind Period|Protocol Deviation|0|||
33342624|NCT02574637|101145524|FG006|Double-blind Period|Protocol Deviation|0|||
33342625|NCT02574637|101145525|FG007|Double-blind Period|Protocol Deviation|0|||
33342626|NCT02574637|101145526|FG008|Double-blind Period|Protocol Deviation|0|||
33406550|NCT03938857|101377644|FG001|Overall Study|Physician Decision|0|||
33342627|NCT02574637|101145527|FG009|Double-blind Period|Protocol Deviation|0|||
33342628|NCT02574637|101145518|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
33342629|NCT02574637|101145519|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
33615324|NCT01031979|102140276|FG000|Overall Study|Lost to Follow-up|5|||
33210248|NCT02270450|100670404|FG000|Overall Study|Death|19|||
33540212|NCT00879658|101878446|FG000|Overall Study|Adverse Event|6|||
33540213|NCT00879658|101878447|FG001|Overall Study|Adverse Event|4|||
33540214|NCT00879658|101878448|FG002|Overall Study|Adverse Event|3|||
33540215|NCT00879658|101878449|FG003|Overall Study|Adverse Event|1|||
33540216|NCT00879658|101878450|FG004|Overall Study|Adverse Event|2|||
33540217|NCT00879658|101878451|FG005|Overall Study|Adverse Event|0|||
33540218|NCT00879658|101878452|FG006|Overall Study|Adverse Event|0|||
33540219|NCT00879658|101878446|FG000|Overall Study|Protocol Violation|1|||
33540220|NCT00879658|101878447|FG001|Overall Study|Protocol Violation|0|||
33540221|NCT00879658|101878448|FG002|Overall Study|Protocol Violation|0|||
33540222|NCT00879658|101878449|FG003|Overall Study|Protocol Violation|0|||
33540223|NCT00879658|101878450|FG004|Overall Study|Protocol Violation|0|||
33540224|NCT00879658|101878451|FG005|Overall Study|Protocol Violation|0|||
33540225|NCT00879658|101878452|FG006|Overall Study|Protocol Violation|0|||
33210249|NCT02270450|100670405|FG001|Overall Study|Death|19|||
33210250|NCT02270450|100670406|FG002|Overall Study|Death|31|||
33210251|NCT02270450|100670407|FG003|Overall Study|Death|59|||
33210252|NCT02137369|100670408|FG000|Overall Study|Withdrawal by Subject|3|||
33210253|NCT02137369|100670409|FG001|Overall Study|Withdrawal by Subject|2|||
33210254|NCT02137369|100670408|FG000|Overall Study|Adverse Event|2|||
33210255|NCT02137369|100670409|FG001|Overall Study|Adverse Event|0|||
33210256|NCT02137369|100670408|FG000|Overall Study|Lost to Follow-up|1|||
33210257|NCT02137369|100670409|FG001|Overall Study|Lost to Follow-up|0|||
33210258|NCT02137369|100670408|FG000|Overall Study|Moved away|2|||
33210259|NCT02137369|100670409|FG001|Overall Study|Moved away|0|||
33342630|NCT02574637|101145520|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
33342631|NCT02574637|101145521|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
33342632|NCT02574637|101145522|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
33342633|NCT02574637|101145523|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
33342634|NCT02574637|101145524|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
33342635|NCT02574637|101145525|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
33342636|NCT02574637|101145526|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
33342637|NCT02574637|101145527|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
33342638|NCT02574637|101145518|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
33540226|NCT00879658|101878446|FG000|Overall Study|Withdrawal by Subject|3|||
33342639|NCT02574637|101145519|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
33342640|NCT02574637|101145520|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
33540227|NCT00879658|101878447|FG001|Overall Study|Withdrawal by Subject|0|||
33540228|NCT00879658|101878448|FG002|Overall Study|Withdrawal by Subject|2|||
33540229|NCT00879658|101878449|FG003|Overall Study|Withdrawal by Subject|0|||
33540230|NCT00879658|101878450|FG004|Overall Study|Withdrawal by Subject|0|||
33540231|NCT00879658|101878451|FG005|Overall Study|Withdrawal by Subject|1|||
33540232|NCT00879658|101878452|FG006|Overall Study|Withdrawal by Subject|0|||
33540233|NCT00879658|101878446|FG000|Overall Study|Lack of Efficacy|0|||
33540234|NCT00879658|101878447|FG001|Overall Study|Lack of Efficacy|0|||
33540235|NCT00879658|101878448|FG002|Overall Study|Lack of Efficacy|2|||
33540236|NCT00879658|101878449|FG003|Overall Study|Lack of Efficacy|0|||
33540237|NCT00879658|101878450|FG004|Overall Study|Lack of Efficacy|0|||
33540238|NCT00879658|101878451|FG005|Overall Study|Lack of Efficacy|0|||
33540239|NCT00879658|101878452|FG006|Overall Study|Lack of Efficacy|0|||
33540240|NCT00879658|101878446|FG000|Overall Study|misrandomized (never received study med)|0|||
33540241|NCT00879658|101878447|FG001|Overall Study|misrandomized (never received study med)|0|||
33540242|NCT00879658|101878448|FG002|Overall Study|misrandomized (never received study med)|0|||
33540243|NCT00879658|101878449|FG003|Overall Study|misrandomized (never received study med)|1|||
33540244|NCT00879658|101878450|FG004|Overall Study|misrandomized (never received study med)|0|||
33540245|NCT00879658|101878451|FG005|Overall Study|misrandomized (never received study med)|0|||
33540246|NCT00879658|101878452|FG006|Overall Study|misrandomized (never received study med)|0|||
33540247|NCT01316614|101878455|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
33540248|NCT01316614|101878455|FG000|Overall Study|Cytology slides not available for review|4|||
33540249|NCT01316614|101878455|FG000|Overall Study|Cystic lesion|5|||
33540250|NCT01316614|101878455|FG000|Overall Study|Inadequate number of passes|2|||
33615325|NCT01031979|102140277|FG001|Overall Study|Lost to Follow-up|4|||
33615326|NCT00132808|102140278|FG000|Stratum I|Adverse Event|2|||
33540251|NCT01316614|101878455|FG000|Overall Study|Medically unstable|1|||
33540252|NCT02100124|101878458|FG000|Overall Study|Lost to Follow-up|5|||
33540253|NCT02100124|101878459|FG001|Overall Study|Lost to Follow-up|11|||
33540254|NCT02100124|101878460|FG002|Overall Study|Lost to Follow-up|3|||
33540255|NCT02100124|101878458|FG000|Overall Study|Withdrawal by Subject|1|||
33540256|NCT02100124|101878459|FG001|Overall Study|Withdrawal by Subject|0|||
33615327|NCT00132808|102140279|FG001|Stratum I|Adverse Event|1|||
33615328|NCT00132808|102140280|FG002|Stratum I|Adverse Event|0|||
33540257|NCT02100124|101878460|FG002|Overall Study|Withdrawal by Subject|0|||
33342641|NCT02574637|101145521|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
33540258|NCT00830219|101878461|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
33540259|NCT00830219|101878462|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
33540260|NCT02709746|101878469|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
33540261|NCT02709746|101878470|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
33540262|NCT02709746|101878471|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
33540263|NCT02709746|101878472|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
33540264|NCT02709746|101878473|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
33540265|NCT02709746|101878469|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
33540266|NCT02709746|101878470|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
33540267|NCT02709746|101878471|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
33615329|NCT00132808|102140278|FG000|Stratum I|Lost to Follow-up|3|||
33615330|NCT00132808|102140279|FG001|Stratum I|Lost to Follow-up|4|||
33615331|NCT00132808|102140280|FG002|Stratum I|Lost to Follow-up|1|||
33615332|NCT00132808|102140278|FG000|Stratum I|Withdrawal by Subject|4|||
33615333|NCT00132808|102140279|FG001|Stratum I|Withdrawal by Subject|7|||
33615334|NCT00132808|102140280|FG002|Stratum I|Withdrawal by Subject|3|||
33615335|NCT00132808|102140278|FG000|Stratum I|Abnormal test procedure result (s)|0|||
33615336|NCT00132808|102140279|FG001|Stratum I|Abnormal test procedure result (s)|0|||
33540268|NCT02709746|101878472|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
33540269|NCT02709746|101878473|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
33540270|NCT02709746|101878469|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
33540271|NCT02709746|101878470|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
33540272|NCT02709746|101878471|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
33615337|NCT00132808|102140280|FG002|Stratum I|Abnormal test procedure result (s)|1|||
33615338|NCT00132808|102140278|FG000|Stratum II|Adverse Event|1|||
33210260|NCT01297062|100670410|FG000|Overall Study|Adverse Event|2|||
33210261|NCT01297062|100670411|FG001|Overall Study|Adverse Event|0|||
33210262|NCT01297062|100670412|FG002|Overall Study|Adverse Event|1|||
33210263|NCT01297062|100670413|FG003|Overall Study|Adverse Event|0|||
33210264|NCT01297062|100670414|FG004|Overall Study|Adverse Event|0|||
33210265|NCT01297062|100670415|FG005|Overall Study|Adverse Event|0|||
33210266|NCT01297062|100670416|FG006|Overall Study|Adverse Event|0|||
33210267|NCT01297062|100670410|FG000|Overall Study|Physician Decision|1|||
33210268|NCT01297062|100670411|FG001|Overall Study|Physician Decision|0|||
33210269|NCT01297062|100670412|FG002|Overall Study|Physician Decision|1|||
33210270|NCT01297062|100670413|FG003|Overall Study|Physician Decision|0|||
33210271|NCT01297062|100670414|FG004|Overall Study|Physician Decision|0|||
33210272|NCT01297062|100670415|FG005|Overall Study|Physician Decision|0|||
33210273|NCT01297062|100670416|FG006|Overall Study|Physician Decision|6|||
33210274|NCT01297062|100670410|FG000|Overall Study|Protocol Violation|0|||
33210275|NCT01297062|100670411|FG001|Overall Study|Protocol Violation|0|||
33210276|NCT01297062|100670412|FG002|Overall Study|Protocol Violation|0|||
33210277|NCT01297062|100670413|FG003|Overall Study|Protocol Violation|0|||
33210278|NCT01297062|100670414|FG004|Overall Study|Protocol Violation|1|||
33210279|NCT01297062|100670415|FG005|Overall Study|Protocol Violation|0|||
33210280|NCT01297062|100670416|FG006|Overall Study|Protocol Violation|0|||
33210281|NCT01297062|100670410|FG000|Overall Study|Subject Decision|1|||
33210282|NCT01297062|100670411|FG001|Overall Study|Subject Decision|1|||
33210283|NCT01297062|100670412|FG002|Overall Study|Subject Decision|0|||
33210284|NCT01297062|100670413|FG003|Overall Study|Subject Decision|1|||
33342642|NCT02574637|101145522|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
33342643|NCT02574637|101145523|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
33342644|NCT02574637|101145524|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
33342645|NCT02574637|101145525|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
33342646|NCT02574637|101145526|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
33342647|NCT02574637|101145527|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
33342648|NCT02574637|101145518|FG000|Double-blind Period|Reason Not Specified|0|||
33615339|NCT00132808|102140279|FG001|Stratum II|Adverse Event|2|||
33615340|NCT00132808|102140280|FG002|Stratum II|Adverse Event|1|||
33615341|NCT00132808|102140278|FG000|Stratum II|Death|1|||
33615342|NCT00132808|102140279|FG001|Stratum II|Death|0|||
33615343|NCT00132808|102140280|FG002|Stratum II|Death|0|||
33210285|NCT01297062|100670414|FG004|Overall Study|Subject Decision|1|||
33210286|NCT01297062|100670415|FG005|Overall Study|Subject Decision|1|||
33342649|NCT02574637|101145519|FG001|Double-blind Period|Reason Not Specified|0|||
33615344|NCT00132808|102140278|FG000|Stratum II|Lost to Follow-up|2|||
33210287|NCT01297062|100670416|FG006|Overall Study|Subject Decision|2|||
33406551|NCT03938857|101377645|FG002|Overall Study|Physician Decision|0|||
33406552|NCT03938857|101377646|FG003|Overall Study|Physician Decision|0|||
33615345|NCT00132808|102140279|FG001|Stratum II|Lost to Follow-up|2|||
33615346|NCT00132808|102140280|FG002|Stratum II|Lost to Follow-up|1|||
33615347|NCT00132808|102140278|FG000|Stratum II|Protocol Violation|0|||
33210288|NCT04764396|100670417|FG000|Overall Study|Physician Decision|1|||
33210289|NCT04764396|100670418|FG001|Overall Study|Physician Decision|0|||
33210290|NCT01454583|100670419|FG000|1st Year|Lost to Follow-up|1057|||
33210291|NCT01454583|100670420|FG001|1st Year|Lost to Follow-up|318|||
33210292|NCT01454583|100670421|FG002|1st Year|Lost to Follow-up|180|||
33210293|NCT01454583|100670419|FG000|2nd Year|Lost to Follow-up|3965|||
33210294|NCT01454583|100670420|FG001|2nd Year|Lost to Follow-up|1049|||
33210295|NCT01454583|100670421|FG002|2nd Year|Lost to Follow-up|737|||
33210296|NCT01454583|100670419|FG000|3rd Year|Lost to Follow-up|1959|||
33210297|NCT01454583|100670420|FG001|3rd Year|Lost to Follow-up|512|||
33210298|NCT01454583|100670421|FG002|3rd Year|Lost to Follow-up|297|||
33210299|NCT03526250|100670429|FG000|Overall Study|Adverse Event|4|||
33210300|NCT03526250|100670429|FG000|Overall Study|Progressive Disease|16|||
33210301|NCT03526250|100670429|FG000|Overall Study|No Treatment|3|||
33210302|NCT02341417|100670435|FG000|Overall Study|Withdrawal by Subject|0|||
33210303|NCT02341417|100670436|FG001|Overall Study|Withdrawal by Subject|2|||
33210304|NCT02341417|100670437|FG002|Overall Study|Withdrawal by Subject|0|||
33210305|NCT02341417|100670435|FG000|Overall Study|Decision by sponsor|2|||
33210306|NCT02341417|100670436|FG001|Overall Study|Decision by sponsor|0|||
33210307|NCT02341417|100670437|FG002|Overall Study|Decision by sponsor|0|||
33210308|NCT02341417|100670435|FG000|Overall Study|Death|0|||
33210309|NCT02341417|100670436|FG001|Overall Study|Death|0|||
33210310|NCT02341417|100670437|FG002|Overall Study|Death|1|||
33210311|NCT00058123|100670438|FG000|Overall Study|Wrong histology|9|||
33210312|NCT00058123|100670438|FG000|Overall Study|Received >3 prior treatments|1|||
33210313|NCT03695172|100670439|FG000|Overall Study|Withdrawal by Subject|1|||
33210314|NCT03695172|100670440|FG001|Overall Study|Withdrawal by Subject|1|||
33210315|NCT03695172|100670441|FG002|Overall Study|Withdrawal by Subject|0|||
33210316|NCT03137303|100670442|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
33210317|NCT03137303|100670443|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
33210318|NCT03137303|100670442|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
33210319|NCT03137303|100670443|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
33210320|NCT03137303|100670442|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
33210321|NCT03137303|100670443|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
33210322|NCT03137303|100670442|FG000|T3: 9-month Follow-up|Death|1|||
33210323|NCT03137303|100670443|FG001|T3: 9-month Follow-up|Death|0|||
33210324|NCT03137303|100670442|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
33210325|NCT03137303|100670443|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
33210326|NCT03137303|100670442|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
33210327|NCT03137303|100670443|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
33210328|NCT03137303|100670442|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
33210329|NCT03137303|100670443|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
33210330|NCT02298192|100670444|FG000|Overall Study|Unclassified|3|||
33210331|NCT02298192|100670445|FG001|Overall Study|Unclassified|2|||
33210332|NCT02298192|100670444|FG000|Overall Study|Withdrawal criteria|2|||
33210333|NCT02298192|100670445|FG001|Overall Study|Withdrawal criteria|0|||
33210334|NCT02298192|100670444|FG000|Overall Study|Withdrawal by Subject|6|||
33210335|NCT02298192|100670445|FG001|Overall Study|Withdrawal by Subject|1|||
33210336|NCT02298192|100670444|FG000|Overall Study|Lost to Follow-up|2|||
33210337|NCT02298192|100670445|FG001|Overall Study|Lost to Follow-up|1|||
33210338|NCT02298192|100670444|FG000|Overall Study|Adverse Event|6|||
33210339|NCT02298192|100670445|FG001|Overall Study|Adverse Event|2|||
33210340|NCT01178086|100670447|FG000|Overall Study|Participant refusal|7|||
33210341|NCT01178086|100670447|FG000|Overall Study|Physician Decision|44|||
33210342|NCT01178086|100670447|FG000|Overall Study|Switch to other CLL therapy|113|||
33210343|NCT01178086|100670447|FG000|Overall Study|Death|59|||
33540273|NCT02709746|101878472|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
33540274|NCT02709746|101878473|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
33540275|NCT02709746|101878469|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
33540276|NCT02709746|101878470|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
33540277|NCT02709746|101878471|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
33210344|NCT01178086|100670447|FG000|Overall Study|Other unspecified|89|||
33210345|NCT01178086|100670447|FG000|Overall Study|Excluded from EAS|20|||
33210346|NCT03273946|100670450|FG000|Overall Study|Withdrawal by Subject|5|||
33210347|NCT03273946|100670450|FG000|Overall Study|Unwillingness of the guardian|1|||
33210348|NCT03273946|100670450|FG000|Overall Study|Participant refused to use the drug|2|||
33210349|NCT03273946|100670450|FG000|Overall Study|Participant relative refused to use drug|1|||
33210350|NCT00726752|100670451|FG000|Overall Study|Lack of Efficacy|6|||
33210351|NCT04656847|100670452|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
33210352|NCT01565707|100670453|FG000|Overall Study|Adverse Event|1|||
33210353|NCT01565707|100670454|FG001|Overall Study|Adverse Event|6|||
33210354|NCT01565707|100670455|FG002|Overall Study|Adverse Event|2|||
33210355|NCT01565707|100670456|FG003|Overall Study|Adverse Event|1|||
33210356|NCT01565707|100670453|FG000|Overall Study|Lost to Follow-up|1|||
33210357|NCT01565707|100670454|FG001|Overall Study|Lost to Follow-up|0|||
33210358|NCT01565707|100670455|FG002|Overall Study|Lost to Follow-up|0|||
33210359|NCT01565707|100670456|FG003|Overall Study|Lost to Follow-up|0|||
33210360|NCT01565707|100670453|FG000|Overall Study|Protocol Violation|1|||
33210361|NCT01565707|100670454|FG001|Overall Study|Protocol Violation|0|||
33210362|NCT01565707|100670455|FG002|Overall Study|Protocol Violation|0|||
33210363|NCT01565707|100670456|FG003|Overall Study|Protocol Violation|1|||
33210364|NCT01565707|100670453|FG000|Overall Study|Withdrawal by Subject|3|||
33210365|NCT01565707|100670454|FG001|Overall Study|Withdrawal by Subject|1|||
33210366|NCT01565707|100670455|FG002|Overall Study|Withdrawal by Subject|1|||
33210367|NCT01565707|100670456|FG003|Overall Study|Withdrawal by Subject|1|||
33210368|NCT01565707|100670453|FG000|Overall Study|Randomized but not evaluable|2|||
33210369|NCT01565707|100670454|FG001|Overall Study|Randomized but not evaluable|0|||
33210370|NCT01565707|100670455|FG002|Overall Study|Randomized but not evaluable|0|||
33210371|NCT01565707|100670456|FG003|Overall Study|Randomized but not evaluable|0|||
33210372|NCT01565707|100670453|FG000|Overall Study|Miscellaneous|1|||
33210373|NCT01565707|100670454|FG001|Overall Study|Miscellaneous|1|||
33210374|NCT01565707|100670455|FG002|Overall Study|Miscellaneous|0|||
33210375|NCT01565707|100670456|FG003|Overall Study|Miscellaneous|2|||
33210376|NCT02491671|100670457|FG000|Overall Study|Adverse Event|6|||
33210377|NCT02491671|100670458|FG001|Overall Study|Adverse Event|8|||
33210378|NCT02491671|100670457|FG000|Overall Study|Death|0|||
33210379|NCT02491671|100670458|FG001|Overall Study|Death|2|||
33210380|NCT02491671|100670457|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
33210381|NCT02491671|100670458|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
33210382|NCT02099838|100670459|FG000|Overall Study|Death|1|||
33210383|NCT02099838|100670460|FG001|Overall Study|Death|0|||
33210384|NCT02099838|100670459|FG000|Overall Study|Lost to Follow-up|3|||
33210385|NCT02099838|100670460|FG001|Overall Study|Lost to Follow-up|1|||
33210386|NCT02099838|100670459|FG000|Overall Study|Withdrawal by Subject|0|||
33210387|NCT02099838|100670460|FG001|Overall Study|Withdrawal by Subject|1|||
33210388|NCT04827212|100670462|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
33210389|NCT04827212|100670463|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
33210390|NCT04827212|100670462|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
33210391|NCT04827212|100670463|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
33210392|NCT01814371|100670464|FG000|Overall Study|Lost to Follow-up|30|||
33210393|NCT01814371|100670465|FG001|Overall Study|Lost to Follow-up|27|||
33210394|NCT02347761|100670467|FG000|All Collected|Death|1|||
33210395|NCT02347761|100670468|FG001|All Collected|Death|0|||
33210396|NCT02347761|100670469|FG002|All Collected|Death|0|||
33210397|NCT02347761|100670467|FG000|All Collected|Lost to Follow-up|3|||
33210398|NCT02347761|100670468|FG001|All Collected|Lost to Follow-up|2|||
33210399|NCT02347761|100670469|FG002|All Collected|Lost to Follow-up|3|||
33210400|NCT02347761|100670467|FG000|All Collected|Withdrawal by Subject|11|||
33210401|NCT02347761|100670468|FG001|All Collected|Withdrawal by Subject|11|||
33210402|NCT02347761|100670469|FG002|All Collected|Withdrawal by Subject|22|||
33210403|NCT02347761|100670467|FG000|All Collected|invetigator disretion|2|||
33210404|NCT02347761|100670468|FG001|All Collected|invetigator disretion|0|||
33615348|NCT00132808|102140279|FG001|Stratum II|Protocol Violation|2|||
33540278|NCT02709746|101878472|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
33540279|NCT02709746|101878473|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
33540280|NCT02709746|101878469|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
33540281|NCT02709746|101878470|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
33540282|NCT02709746|101878471|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
33540283|NCT02709746|101878472|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
33615349|NCT00132808|102140280|FG002|Stratum II|Protocol Violation|1|||
33210405|NCT02347761|100670469|FG002|All Collected|invetigator disretion|0|||
33342650|NCT02574637|101145520|FG002|Double-blind Period|Reason Not Specified|0|||
33342651|NCT02574637|101145521|FG003|Double-blind Period|Reason Not Specified|1|||
33615350|NCT00132808|102140278|FG000|Stratum II|Withdrawal by Subject|4|||
33615351|NCT00132808|102140279|FG001|Stratum II|Withdrawal by Subject|9|||
33615352|NCT00132808|102140280|FG002|Stratum II|Withdrawal by Subject|6|||
33210406|NCT02347761|100670467|FG000|All Collected|instillation site pain|0|||
33210407|NCT02347761|100670468|FG001|All Collected|instillation site pain|0|||
33210408|NCT02347761|100670469|FG002|All Collected|instillation site pain|1|||
33210409|NCT02347761|100670467|FG000|All Collected|exacerbation of COPD|0|||
33210410|NCT02347761|100670468|FG001|All Collected|exacerbation of COPD|0|||
33210411|NCT02347761|100670469|FG002|All Collected|exacerbation of COPD|1|||
33210412|NCT02347761|100670467|FG000|All Collected|moved/travel|0|||
33210413|NCT02347761|100670468|FG001|All Collected|moved/travel|1|||
33210414|NCT02347761|100670469|FG002|All Collected|moved/travel|0|||
33210415|NCT02347761|100670467|FG000|On Study Treatment|Lack of Efficacy|2|||
33210416|NCT02347761|100670468|FG001|On Study Treatment|Lack of Efficacy|3|||
33210417|NCT02347761|100670469|FG002|On Study Treatment|Lack of Efficacy|4|||
33210418|NCT02347761|100670467|FG000|On Study Treatment|non-compliance with study medication|0|||
33210419|NCT02347761|100670468|FG001|On Study Treatment|non-compliance with study medication|0|||
33210420|NCT02347761|100670469|FG002|On Study Treatment|non-compliance with study medication|2|||
33210421|NCT02347761|100670467|FG000|On Study Treatment|Withdrawal by Subject|7|||
33210422|NCT02347761|100670468|FG001|On Study Treatment|Withdrawal by Subject|3|||
33210423|NCT02347761|100670469|FG002|On Study Treatment|Withdrawal by Subject|5|||
33210424|NCT02347761|100670467|FG000|On Study Treatment|move/travel|2|||
33210425|NCT02347761|100670468|FG001|On Study Treatment|move/travel|6|||
33210426|NCT02347761|100670469|FG002|On Study Treatment|move/travel|5|||
33210427|NCT02347761|100670467|FG000|On Study Treatment|dissastisfaction with device|2|||
33210428|NCT02347761|100670468|FG001|On Study Treatment|dissastisfaction with device|1|||
33540284|NCT02709746|101878473|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
33210429|NCT02347761|100670469|FG002|On Study Treatment|dissastisfaction with device|4|||
33210430|NCT02347761|100670467|FG000|On Study Treatment|Lost to Follow-up|2|||
33210431|NCT02347761|100670468|FG001|On Study Treatment|Lost to Follow-up|1|||
33210432|NCT02347761|100670469|FG002|On Study Treatment|Lost to Follow-up|1|||
33210433|NCT02347761|100670467|FG000|On Study Treatment|investigator discretion|2|||
33210434|NCT02347761|100670468|FG001|On Study Treatment|investigator discretion|0|||
33210435|NCT02347761|100670469|FG002|On Study Treatment|investigator discretion|0|||
33210436|NCT02347761|100670467|FG000|On Study Treatment|durg not working|0|||
33210437|NCT02347761|100670468|FG001|On Study Treatment|durg not working|1|||
33210438|NCT02347761|100670469|FG002|On Study Treatment|durg not working|1|||
33210439|NCT02347761|100670467|FG000|On Study Treatment|Adverse Event|10|||
33210440|NCT02347761|100670468|FG001|On Study Treatment|Adverse Event|8|||
33210441|NCT02347761|100670469|FG002|On Study Treatment|Adverse Event|20|||
33342652|NCT02574637|101145522|FG004|Double-blind Period|Reason Not Specified|0|||
33342653|NCT02574637|101145523|FG005|Double-blind Period|Reason Not Specified|0|||
33342654|NCT02574637|101145524|FG006|Double-blind Period|Reason Not Specified|0|||
33342655|NCT02574637|101145525|FG007|Double-blind Period|Reason Not Specified|0|||
33342656|NCT02574637|101145526|FG008|Double-blind Period|Reason Not Specified|0|||
33342657|NCT02574637|101145527|FG009|Double-blind Period|Reason Not Specified|0|||
33342658|NCT02574637|101145518|FG000|Open-label (OL) Period|Adverse Event|0|||
33342659|NCT02574637|101145519|FG001|Open-label (OL) Period|Adverse Event|0|||
33342660|NCT02574637|101145520|FG002|Open-label (OL) Period|Adverse Event|0|||
33342661|NCT02574637|101145521|FG003|Open-label (OL) Period|Adverse Event|0|||
33342662|NCT02574637|101145522|FG004|Open-label (OL) Period|Adverse Event|0|||
33342663|NCT02574637|101145523|FG005|Open-label (OL) Period|Adverse Event|0|||
33342664|NCT02574637|101145524|FG006|Open-label (OL) Period|Adverse Event|0|||
33342665|NCT02574637|101145525|FG007|Open-label (OL) Period|Adverse Event|0|||
33342666|NCT02574637|101145526|FG008|Open-label (OL) Period|Adverse Event|1|||
33342667|NCT02574637|101145527|FG009|Open-label (OL) Period|Adverse Event|0|||
33342668|NCT02574637|101145518|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
33342669|NCT02574637|101145519|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
33342670|NCT02574637|101145520|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
33342671|NCT02574637|101145521|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
33342672|NCT02574637|101145522|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
33342673|NCT02574637|101145523|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
33342674|NCT02574637|101145524|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
33342675|NCT02574637|101145525|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
33342676|NCT02574637|101145526|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
33342677|NCT02574637|101145527|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
33342678|NCT02574637|101145518|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
33342679|NCT02574637|101145519|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
33342680|NCT02574637|101145520|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
33342681|NCT02574637|101145521|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
33342682|NCT02574637|101145522|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
33540285|NCT02709746|101878469|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
33210442|NCT04177758|100670471|FG000|Overall Study|Lost to Follow-up|19|||
33210443|NCT04177758|100670472|FG001|Overall Study|Lost to Follow-up|11|||
33210444|NCT01816594|100670476|FG000|Overall Study|Local Progress|0|||
33342683|NCT02574637|101145523|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
33342684|NCT02574637|101145524|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
33342685|NCT02574637|101145525|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
33342686|NCT02574637|101145526|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
33406553|NCT00764465|101377647|FG000|Overall Study|Adverse Event|2|||
33210445|NCT01816594|100670477|FG001|Overall Study|Local Progress|2|||
33210446|NCT01816594|100670476|FG000|Overall Study|Adverse Event|9|||
33406554|NCT00764465|101377648|FG001|Overall Study|Adverse Event|0|||
33406555|NCT00764465|101377649|FG002|Overall Study|Adverse Event|0|||
33406556|NCT00764465|101377650|FG003|Overall Study|Adverse Event|1|||
33406557|NCT00764465|101377651|FG004|Overall Study|Adverse Event|1|||
33406558|NCT00764465|101377652|FG005|Overall Study|Adverse Event|1|||
33406559|NCT00764465|101377647|FG000|Overall Study|Withdrawal by Subject|0|||
33406560|NCT00764465|101377648|FG001|Overall Study|Withdrawal by Subject|1|||
33406561|NCT00764465|101377649|FG002|Overall Study|Withdrawal by Subject|1|||
33406562|NCT00764465|101377650|FG003|Overall Study|Withdrawal by Subject|0|||
33406563|NCT00764465|101377651|FG004|Overall Study|Withdrawal by Subject|0|||
33406564|NCT00764465|101377652|FG005|Overall Study|Withdrawal by Subject|0|||
33406565|NCT03039699|101377653|FG000|Overall Study|Incorrect inclusion|5|||
33406566|NCT03039699|101377654|FG001|Overall Study|Incorrect inclusion|4|||
33406567|NCT03039699|101377653|FG000|Overall Study|Lack of data to assess study endpoint|5|||
33406568|NCT03039699|101377654|FG001|Overall Study|Lack of data to assess study endpoint|3|||
33406569|NCT03039699|101377653|FG000|Overall Study|Bacterial infection|12|||
33406570|NCT03039699|101377654|FG001|Overall Study|Bacterial infection|28|||
33540286|NCT02709746|101878470|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
33342687|NCT02574637|101145527|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
33342688|NCT01116544|101145528|FG000|Overall Study|Protocol Violation|1|||
33342689|NCT01116544|101145529|FG001|Overall Study|Protocol Violation|0|||
33342690|NCT01116544|101145528|FG000|Overall Study|Withdrawal by Subject|1|||
33342691|NCT01116544|101145529|FG001|Overall Study|Withdrawal by Subject|1|||
33342692|NCT02475655|101145530|FG000|Overall Study|Lost to Follow-up|0|||
33342693|NCT02475655|101145531|FG001|Overall Study|Lost to Follow-up|1|||
33342694|NCT00648167|101145532|FG000|Overall Study|Adverse Event|6|||
33342695|NCT00648167|101145532|FG000|Overall Study|unable to swallow tablets|1|||
33342696|NCT02600507|101145534|FG000|Overall Study|Adverse Event|3|||
33342697|NCT02600507|101145535|FG001|Overall Study|Adverse Event|15|||
33342698|NCT02600507|101145536|FG002|Overall Study|Adverse Event|5|||
33342699|NCT02600507|101145534|FG000|Overall Study|Lack of Efficacy|3|||
33342700|NCT02600507|101145535|FG001|Overall Study|Lack of Efficacy|8|||
33342701|NCT02600507|101145536|FG002|Overall Study|Lack of Efficacy|5|||
33342702|NCT02600507|101145534|FG000|Overall Study|Lost to Follow-up|3|||
33342703|NCT02600507|101145535|FG001|Overall Study|Lost to Follow-up|5|||
33342704|NCT02600507|101145536|FG002|Overall Study|Lost to Follow-up|2|||
33342705|NCT02600507|101145534|FG000|Overall Study|Protocol Violation|12|||
33342706|NCT02600507|101145535|FG001|Overall Study|Protocol Violation|4|||
33342707|NCT02600507|101145536|FG002|Overall Study|Protocol Violation|4|||
33342708|NCT02600507|101145534|FG000|Overall Study|Physician Decision|1|||
33342709|NCT02600507|101145535|FG001|Overall Study|Physician Decision|0|||
33342710|NCT02600507|101145536|FG002|Overall Study|Physician Decision|1|||
33342711|NCT02600507|101145534|FG000|Overall Study|Withdrawal by Subject|7|||
33342712|NCT02600507|101145535|FG001|Overall Study|Withdrawal by Subject|11|||
33342713|NCT02600507|101145536|FG002|Overall Study|Withdrawal by Subject|7|||
33342714|NCT02600507|101145534|FG000|Overall Study|Other|0|||
33342715|NCT02600507|101145535|FG001|Overall Study|Other|1|||
33342716|NCT02600507|101145536|FG002|Overall Study|Other|1|||
33342717|NCT00700180|101145542|FG000|Overall Study|Death|99|||
33342718|NCT00700180|101145543|FG001|Overall Study|Death|114|||
33210447|NCT01816594|100670477|FG001|Overall Study|Adverse Event|0|||
33342719|NCT00700180|101145542|FG000|Overall Study|Alive on treatment|5|||
33342720|NCT00700180|101145543|FG001|Overall Study|Alive on treatment|3|||
33342721|NCT00700180|101145542|FG000|Overall Study|Alive in follow-up|46|||
33342722|NCT00700180|101145543|FG001|Overall Study|Alive in follow-up|27|||
33342723|NCT00700180|101145542|FG000|Overall Study|Lost to Follow-up|4|||
33342724|NCT00700180|101145543|FG001|Overall Study|Lost to Follow-up|5|||
33342725|NCT00044512|101145544|FG000|Follow Up|Lost to Follow-up|2|||
33406571|NCT02383966|101377658|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
33406572|NCT02383966|101377659|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
33406573|NCT02383966|101377658|FG000|Overall Study|Randomized, but not treated|1|||
33406574|NCT02383966|101377659|FG001|Overall Study|Randomized, but not treated|3|||
33406575|NCT00490815|101377660|FG000|Overall Study|Adverse Event|2|||
33406576|NCT00490815|101377661|FG001|Overall Study|Adverse Event|3|||
33406577|NCT00490815|101377660|FG000|Overall Study|Withdrawal by Subject|4|||
33342726|NCT01761266|101145545|FG000|Overall Study|Death|415|||
33342727|NCT01761266|101145546|FG001|Overall Study|Death|402|||
33342728|NCT01761266|101145545|FG000|Overall Study|Lost to Follow-up|8|||
33342729|NCT01761266|101145546|FG001|Overall Study|Lost to Follow-up|12|||
33342730|NCT01761266|101145545|FG000|Overall Study|Withdrawal by Subject|14|||
33342731|NCT01761266|101145546|FG001|Overall Study|Withdrawal by Subject|10|||
33342732|NCT01761266|101145545|FG000|Overall Study|Sponsor Decision|41|||
33342733|NCT01761266|101145546|FG001|Overall Study|Sponsor Decision|52|||
33342734|NCT01164722|101145547|FG000|Overall Study|Adverse Event|0|||
33342735|NCT01164722|101145548|FG001|Overall Study|Adverse Event|1|||
33342736|NCT01164722|101145547|FG000|Overall Study|Withdrawal by Subject|3|||
33342737|NCT01164722|101145548|FG001|Overall Study|Withdrawal by Subject|4|||
33342738|NCT01164722|101145547|FG000|Overall Study|Lost to Follow-up|3|||
33342739|NCT01164722|101145548|FG001|Overall Study|Lost to Follow-up|6|||
33342740|NCT01164722|101145547|FG000|Overall Study|met protocol criteria for non-treatment|11|||
33342741|NCT01164722|101145548|FG001|Overall Study|met protocol criteria for non-treatment|1|||
33342742|NCT01164722|101145547|FG000|Overall Study|enrolled on other study, concomitant med|1|||
33342743|NCT01164722|101145548|FG001|Overall Study|enrolled on other study, concomitant med|3|||
33342744|NCT02599961|101145549|FG000|Overall Study|Withdrawal by Subject|1|||
33342745|NCT02599961|101145549|FG000|Overall Study|Subject Non-Compliance|2|||
33342746|NCT02599961|101145549|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
33342747|NCT02599961|101145549|FG000|Overall Study|Other, Not Specified|3|||
33342748|NCT01557166|101145550|FG000|Overall Study|Adverse Event|20|||
33342749|NCT01557166|101145551|FG001|Overall Study|Adverse Event|6|||
33342750|NCT01557166|101145550|FG000|Overall Study|Lack of Efficacy|2|||
33342751|NCT01557166|101145551|FG001|Overall Study|Lack of Efficacy|1|||
33342752|NCT01557166|101145550|FG000|Overall Study|Protocol Violation|8|||
33342753|NCT01557166|101145551|FG001|Overall Study|Protocol Violation|5|||
33342754|NCT01557166|101145550|FG000|Overall Study|Withdrawn consent|12|||
33342755|NCT01557166|101145551|FG001|Overall Study|Withdrawn consent|20|||
33342756|NCT01557166|101145550|FG000|Overall Study|Target dose not tolerated|1|||
33406578|NCT00490815|101377661|FG001|Overall Study|Withdrawal by Subject|0|||
33406579|NCT00490815|101377660|FG000|Overall Study|Lost to Follow-up|1|||
33406580|NCT00490815|101377661|FG001|Overall Study|Lost to Follow-up|3|||
33406581|NCT00490815|101377660|FG000|Overall Study|Death|1|||
33342757|NCT01557166|101145551|FG001|Overall Study|Target dose not tolerated|0|||
33342758|NCT01557166|101145550|FG000|Overall Study|Psychiatric disorder|1|||
33342759|NCT01557166|101145551|FG001|Overall Study|Psychiatric disorder|0|||
33342760|NCT01557166|101145550|FG000|Overall Study|Unclassified|2|||
33342761|NCT01557166|101145551|FG001|Overall Study|Unclassified|5|||
33342762|NCT00684515|101145552|FG000|Overall Study|Adverse Event|3|||
33342763|NCT00684515|101145553|FG001|Overall Study|Adverse Event|3|||
33342764|NCT00684515|101145554|FG002|Overall Study|Adverse Event|1|||
33342765|NCT00684515|101145552|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
33342766|NCT00684515|101145553|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
33342767|NCT00684515|101145554|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
33342768|NCT01827384|101145555|FG000|Overall Study|Switched to alternative treatment|0|||
33342769|NCT01827384|101145556|FG001|Overall Study|Switched to alternative treatment|0|||
33342770|NCT01827384|101145557|FG002|Overall Study|Switched to alternative treatment|0|||
33342771|NCT01827384|101145558|FG003|Overall Study|Switched to alternative treatment|0|||
33342772|NCT01827384|101145559|FG004|Overall Study|Switched to alternative treatment|0|||
33342773|NCT01827384|101145560|FG005|Overall Study|Switched to alternative treatment|0|||
33342774|NCT01827384|101145561|FG006|Overall Study|Switched to alternative treatment|0|||
33342775|NCT01827384|101145562|FG007|Overall Study|Switched to alternative treatment|0|||
33342776|NCT01827384|101145563|FG008|Overall Study|Switched to alternative treatment|0|||
33342777|NCT01827384|101145564|FG009|Overall Study|Switched to alternative treatment|0|||
33342778|NCT01827384|101145565|FG010|Overall Study|Switched to alternative treatment|0|||
33342779|NCT01827384|101145566|FG011|Overall Study|Switched to alternative treatment|0|||
33342780|NCT01827384|101145567|FG012|Overall Study|Switched to alternative treatment|0|||
33342781|NCT01827384|101145568|FG013|Overall Study|Switched to alternative treatment|2|||
33342782|NCT01827384|101145555|FG000|Overall Study|Disease progression before treatment|0|||
33342783|NCT01827384|101145556|FG001|Overall Study|Disease progression before treatment|0|||
33342784|NCT01827384|101145557|FG002|Overall Study|Disease progression before treatment|0|||
33406582|NCT00490815|101377661|FG001|Overall Study|Death|3|||
33406583|NCT01012765|101377664|FG000|Treatment Period 1|Adverse Event|1|||
33540287|NCT02709746|101878471|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
33342785|NCT01827384|101145558|FG003|Overall Study|Disease progression before treatment|0|||
33406584|NCT01012765|101377665|FG001|Treatment Period 1|Adverse Event|0|||
33342786|NCT01827384|101145559|FG004|Overall Study|Disease progression before treatment|0|||
33342787|NCT01827384|101145560|FG005|Overall Study|Disease progression before treatment|0|||
33342788|NCT01827384|101145561|FG006|Overall Study|Disease progression before treatment|0|||
33406585|NCT01012765|101377666|FG002|Treatment Period 1|Adverse Event|1|||
33406586|NCT01012765|101377667|FG003|Treatment Period 1|Adverse Event|0|||
33406587|NCT01012765|101377668|FG004|Treatment Period 1|Adverse Event|0|||
33540288|NCT02709746|101878472|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
33540289|NCT02709746|101878473|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
33540290|NCT02709746|101878469|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
33540291|NCT02709746|101878470|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
33540292|NCT02709746|101878471|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
33540293|NCT02709746|101878472|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
33540294|NCT02709746|101878473|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
33540295|NCT02709746|101878469|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
33540296|NCT02709746|101878470|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
33540297|NCT02709746|101878471|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
33540298|NCT02709746|101878472|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
33540299|NCT02709746|101878473|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
33540300|NCT02709746|101878469|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
33540301|NCT02709746|101878470|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
33540302|NCT02709746|101878471|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
33540303|NCT02709746|101878472|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
33540304|NCT02709746|101878473|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
33540305|NCT02709746|101878469|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
33540306|NCT02709746|101878470|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
33540307|NCT02709746|101878471|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
33540308|NCT02709746|101878472|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
33540309|NCT02709746|101878473|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
33540310|NCT02709746|101878469|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
33540311|NCT02709746|101878470|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
33540312|NCT02709746|101878471|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
33540313|NCT02709746|101878472|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
33540314|NCT02709746|101878473|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
33540315|NCT02709746|101878469|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
33540316|NCT02709746|101878470|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
33540317|NCT02709746|101878471|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
33540318|NCT02709746|101878472|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
33540319|NCT02709746|101878473|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
33540320|NCT02709746|101878469|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
33540321|NCT02709746|101878470|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
33540322|NCT02709746|101878471|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
33540323|NCT02709746|101878472|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
33540324|NCT02709746|101878473|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
33540325|NCT02709746|101878469|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
33540326|NCT02709746|101878470|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
33540327|NCT02709746|101878471|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
33540328|NCT02709746|101878472|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
33540329|NCT02709746|101878473|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
33615353|NCT00434642|102140282|FG000|Blinded Treatment Phase|Adverse Event|12|||
33615354|NCT00434642|102140283|FG001|Blinded Treatment Phase|Adverse Event|58|||
33342789|NCT01827384|101145562|FG007|Overall Study|Disease progression before treatment|0|||
33342790|NCT01827384|101145563|FG008|Overall Study|Disease progression before treatment|0|||
33342791|NCT01827384|101145564|FG009|Overall Study|Disease progression before treatment|0|||
33342792|NCT01827384|101145565|FG010|Overall Study|Disease progression before treatment|0|||
33342793|NCT01827384|101145566|FG011|Overall Study|Disease progression before treatment|0|||
33342794|NCT01827384|101145567|FG012|Overall Study|Disease progression before treatment|0|||
33342795|NCT01827384|101145568|FG013|Overall Study|Disease progression before treatment|4|||
33342796|NCT01827384|101145555|FG000|Overall Study|Ineligible|0|||
33342797|NCT01827384|101145556|FG001|Overall Study|Ineligible|0|||
33342798|NCT01827384|101145557|FG002|Overall Study|Ineligible|0|||
33342799|NCT01827384|101145558|FG003|Overall Study|Ineligible|0|||
33342800|NCT01827384|101145559|FG004|Overall Study|Ineligible|0|||
33342801|NCT01827384|101145560|FG005|Overall Study|Ineligible|0|||
33342802|NCT01827384|101145561|FG006|Overall Study|Ineligible|0|||
33342803|NCT01827384|101145562|FG007|Overall Study|Ineligible|0|||
33342804|NCT01827384|101145563|FG008|Overall Study|Ineligible|0|||
33342805|NCT01827384|101145564|FG009|Overall Study|Ineligible|0|||
33342806|NCT01827384|101145565|FG010|Overall Study|Ineligible|0|||
33406588|NCT01012765|101377669|FG005|Treatment Period 1|Adverse Event|0|||
33406589|NCT01012765|101377664|FG000|Treatment Period 1|Withdrawal by Subject|2|||
33406590|NCT01012765|101377665|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33406591|NCT01012765|101377666|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33406592|NCT01012765|101377667|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33406593|NCT01012765|101377668|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33406594|NCT01012765|101377669|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33406595|NCT01012765|101377664|FG000|Treatment Period 1|Administrative problems|0|||
33406596|NCT01012765|101377665|FG001|Treatment Period 1|Administrative problems|0|||
33342807|NCT01827384|101145566|FG011|Overall Study|Ineligible|0|||
33342808|NCT01827384|101145567|FG012|Overall Study|Ineligible|0|||
33342809|NCT01827384|101145568|FG013|Overall Study|Ineligible|19|||
33342810|NCT01827384|101145555|FG000|Overall Study|Participant died before treatment|0|||
33342811|NCT01827384|101145556|FG001|Overall Study|Participant died before treatment|0|||
33342812|NCT01827384|101145557|FG002|Overall Study|Participant died before treatment|0|||
33406597|NCT01012765|101377666|FG002|Treatment Period 1|Administrative problems|1|||
33406598|NCT01012765|101377667|FG003|Treatment Period 1|Administrative problems|1|||
33406599|NCT01012765|101377668|FG004|Treatment Period 1|Administrative problems|1|||
33406600|NCT01012765|101377669|FG005|Treatment Period 1|Administrative problems|0|||
33406601|NCT01012765|101377664|FG000|Treatment Period 1|Protocol Violation|0|||
33406602|NCT01012765|101377665|FG001|Treatment Period 1|Protocol Violation|0|||
33406603|NCT01012765|101377666|FG002|Treatment Period 1|Protocol Violation|0|||
33406604|NCT01012765|101377667|FG003|Treatment Period 1|Protocol Violation|2|||
33406605|NCT01012765|101377668|FG004|Treatment Period 1|Protocol Violation|1|||
33406606|NCT01012765|101377669|FG005|Treatment Period 1|Protocol Violation|0|||
33406607|NCT01012765|101377664|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
33406608|NCT01012765|101377665|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
33540330|NCT02709746|101878469|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
33406609|NCT01012765|101377666|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
33406610|NCT01012765|101377667|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
33406611|NCT01012765|101377668|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
33406612|NCT01012765|101377669|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
33540331|NCT02709746|101878470|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
33540332|NCT02709746|101878471|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
33540333|NCT02709746|101878472|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
33540334|NCT02709746|101878473|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
33540335|NCT02709746|101878469|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
33540336|NCT02709746|101878470|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
33540337|NCT02709746|101878471|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
33540338|NCT02709746|101878472|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
33540339|NCT02709746|101878473|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
33540340|NCT02709746|101878469|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
33540341|NCT02709746|101878470|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
33540342|NCT02709746|101878471|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
33540343|NCT02709746|101878472|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
33540344|NCT02709746|101878473|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
33540345|NCT02592824|101878474|FG000|Overall Study|Protocol Violation|5|||
33342813|NCT01827384|101145558|FG003|Overall Study|Participant died before treatment|0|||
33342814|NCT01827384|101145559|FG004|Overall Study|Participant died before treatment|0|||
33406613|NCT01012765|101377664|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33406614|NCT01012765|101377665|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33406615|NCT01012765|101377666|FG002|Treatment Period 2|Withdrawal by Subject|1|||
33540346|NCT02592824|101878475|FG001|Overall Study|Protocol Violation|3|||
33540347|NCT02592824|101878474|FG000|Overall Study|Lost to Follow-up|2|||
33210448|NCT01816594|100670476|FG000|Overall Study|Withdrawal by Subject|1|||
33342815|NCT01827384|101145560|FG005|Overall Study|Participant died before treatment|0|||
33406616|NCT01012765|101377667|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33342816|NCT01827384|101145561|FG006|Overall Study|Participant died before treatment|0|||
33342817|NCT01827384|101145562|FG007|Overall Study|Participant died before treatment|0|||
33342818|NCT01827384|101145563|FG008|Overall Study|Participant died before treatment|0|||
33342819|NCT01827384|101145564|FG009|Overall Study|Participant died before treatment|0|||
33342820|NCT01827384|101145565|FG010|Overall Study|Participant died before treatment|0|||
33342821|NCT01827384|101145566|FG011|Overall Study|Participant died before treatment|0|||
33342822|NCT01827384|101145567|FG012|Overall Study|Participant died before treatment|0|||
33342823|NCT01827384|101145568|FG013|Overall Study|Participant died before treatment|5|||
33342824|NCT01827384|101145555|FG000|Overall Study|Insufficient tumor cells|0|||
33342825|NCT01827384|101145556|FG001|Overall Study|Insufficient tumor cells|0|||
33342826|NCT01827384|101145557|FG002|Overall Study|Insufficient tumor cells|0|||
33342827|NCT01827384|101145558|FG003|Overall Study|Insufficient tumor cells|0|||
33342828|NCT01827384|101145559|FG004|Overall Study|Insufficient tumor cells|0|||
33342829|NCT01827384|101145560|FG005|Overall Study|Insufficient tumor cells|0|||
33342830|NCT01827384|101145561|FG006|Overall Study|Insufficient tumor cells|0|||
33342831|NCT01827384|101145562|FG007|Overall Study|Insufficient tumor cells|0|||
33406617|NCT01012765|101377668|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33406618|NCT01012765|101377669|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33406619|NCT01012765|101377664|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
33406620|NCT01012765|101377665|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
33406621|NCT01012765|101377666|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
33406622|NCT01012765|101377667|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
33406623|NCT01012765|101377668|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
33406624|NCT01012765|101377669|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
33406625|NCT01012765|101377664|FG000|Treatment Period 2|Adverse Event|0|||
33406626|NCT01012765|101377665|FG001|Treatment Period 2|Adverse Event|1|||
33406627|NCT01012765|101377666|FG002|Treatment Period 2|Adverse Event|1|||
33406628|NCT01012765|101377667|FG003|Treatment Period 2|Adverse Event|0|||
33406629|NCT01012765|101377668|FG004|Treatment Period 2|Adverse Event|0|||
33406630|NCT01012765|101377669|FG005|Treatment Period 2|Adverse Event|0|||
33406631|NCT01012765|101377664|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
33406632|NCT01012765|101377665|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
33406633|NCT01012765|101377666|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
33406634|NCT01012765|101377667|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
33406635|NCT01012765|101377668|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
33406636|NCT01012765|101377669|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
33406637|NCT02195531|101377670|FG000|Overall Study|Withdrawal by Subject|1|||
33406638|NCT02195531|101377671|FG001|Overall Study|Withdrawal by Subject|1|||
33406639|NCT02195531|101377672|FG002|Overall Study|Withdrawal by Subject|1|||
33406640|NCT03691831|101377682|FG000|Overall Study|Lost to Follow-up|16|||
33406641|NCT03691831|101377683|FG001|Overall Study|Lost to Follow-up|12|||
33406642|NCT03691831|101377682|FG000|Overall Study|Withdrawal by Subject|9|||
33406643|NCT03691831|101377683|FG001|Overall Study|Withdrawal by Subject|17|||
33540348|NCT02592824|101878475|FG001|Overall Study|Lost to Follow-up|1|||
33540349|NCT03558516|101878476|FG000|Overall Study|Protocol Violation|2|||
33540350|NCT03558516|101878477|FG001|Overall Study|Protocol Violation|2|||
33540351|NCT01922934|101878481|FG000|Eligible Patients|Death|0|||
33406644|NCT03691831|101377682|FG000|Overall Study|Investigator Decision|2|||
33406645|NCT03691831|101377683|FG001|Overall Study|Investigator Decision|2|||
33406646|NCT02577107|101377686|FG000|Overall Study|Protocol deviation|0|||
33406647|NCT02577107|101377687|FG001|Overall Study|Protocol deviation|1|||
33406648|NCT04335929|101377689|FG000|Overall Study|Lost to Follow-up|10|||
33406649|NCT05102734|101377693|FG000|Overall Study|Did not require vasopressors|1|||
33406650|NCT05102734|101377694|FG001|Overall Study|Did not require vasopressors|0|||
33406651|NCT05102734|101377693|FG000|Overall Study|Did not have functioning PA catheter|1|||
33406652|NCT05102734|101377694|FG001|Overall Study|Did not have functioning PA catheter|0|||
33406653|NCT05102734|101377693|FG000|Overall Study|Inadequate video quality|2|||
33406654|NCT05102734|101377694|FG001|Overall Study|Inadequate video quality|0|||
33406655|NCT00303602|101377697|FG000|Overall Study|Adverse Event|2|||
33406656|NCT00303602|101377698|FG001|Overall Study|Adverse Event|2|||
33406657|NCT00303602|101377697|FG000|Overall Study|Withdrawal by Subject|5|||
33406658|NCT00303602|101377698|FG001|Overall Study|Withdrawal by Subject|6|||
33406659|NCT00303602|101377697|FG000|Overall Study|Lost to Follow-up|5|||
33406660|NCT00303602|101377698|FG001|Overall Study|Lost to Follow-up|2|||
33406661|NCT00303602|101377697|FG000|Overall Study|Protocol entry criteria not met|2|||
33406662|NCT00303602|101377698|FG001|Overall Study|Protocol entry criteria not met|2|||
33406663|NCT00303602|101377697|FG000|Overall Study|Physician Decision|2|||
33406664|NCT00303602|101377698|FG001|Overall Study|Physician Decision|1|||
33406665|NCT00303602|101377697|FG000|Overall Study|Noncompliance|2|||
33406666|NCT00303602|101377698|FG001|Overall Study|Noncompliance|2|||
33406667|NCT00303602|101377697|FG000|Overall Study|Protocol Violation|1|||
33406668|NCT00303602|101377698|FG001|Overall Study|Protocol Violation|0|||
33406669|NCT02493712|101377699|FG000|Overall Study|Withdrawal by Subject|1|||
33406670|NCT02493712|101377700|FG001|Overall Study|Withdrawal by Subject|0|||
33406671|NCT02493712|101377701|FG002|Overall Study|Withdrawal by Subject|2|||
33342832|NCT01827384|101145563|FG008|Overall Study|Insufficient tumor cells|0|||
33342833|NCT01827384|101145564|FG009|Overall Study|Insufficient tumor cells|0|||
33342834|NCT01827384|101145565|FG010|Overall Study|Insufficient tumor cells|0|||
33342835|NCT01827384|101145566|FG011|Overall Study|Insufficient tumor cells|0|||
33342836|NCT01827384|101145567|FG012|Overall Study|Insufficient tumor cells|0|||
33342837|NCT01827384|101145568|FG013|Overall Study|Insufficient tumor cells|13|||
33342838|NCT01827384|101145555|FG000|Overall Study|No actionable mutation|0|||
33342839|NCT01827384|101145556|FG001|Overall Study|No actionable mutation|0|||
33342840|NCT01827384|101145557|FG002|Overall Study|No actionable mutation|0|||
33342841|NCT01827384|101145558|FG003|Overall Study|No actionable mutation|0|||
33342842|NCT01827384|101145559|FG004|Overall Study|No actionable mutation|0|||
33342843|NCT01827384|101145560|FG005|Overall Study|No actionable mutation|0|||
33342844|NCT01827384|101145561|FG006|Overall Study|No actionable mutation|0|||
33342845|NCT01827384|101145562|FG007|Overall Study|No actionable mutation|0|||
33406672|NCT02493712|101377699|FG000|Overall Study|Protocol Violation|0|||
33406673|NCT02493712|101377700|FG001|Overall Study|Protocol Violation|0|||
33406674|NCT02493712|101377701|FG002|Overall Study|Protocol Violation|1|||
33406675|NCT02493712|101377699|FG000|Overall Study|Lost to Follow-up|1|||
33406676|NCT02493712|101377700|FG001|Overall Study|Lost to Follow-up|0|||
33342846|NCT01827384|101145563|FG008|Overall Study|No actionable mutation|0|||
33342847|NCT01827384|101145564|FG009|Overall Study|No actionable mutation|0|||
33342848|NCT01827384|101145565|FG010|Overall Study|No actionable mutation|0|||
33342849|NCT01827384|101145566|FG011|Overall Study|No actionable mutation|0|||
33342850|NCT01827384|101145567|FG012|Overall Study|No actionable mutation|0|||
33342851|NCT01827384|101145568|FG013|Overall Study|No actionable mutation|73|||
33342852|NCT01827384|101145555|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
33342853|NCT01827384|101145556|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
33342854|NCT01827384|101145557|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
33342855|NCT01827384|101145558|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
33342856|NCT01827384|101145559|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
33342857|NCT01827384|101145560|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
33342858|NCT01827384|101145561|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
33342859|NCT01827384|101145562|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
33342860|NCT01827384|101145563|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
33342861|NCT01827384|101145564|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
33342862|NCT01827384|101145565|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
33406677|NCT02493712|101377701|FG002|Overall Study|Lost to Follow-up|0|||
33406678|NCT02493712|101377699|FG000|Overall Study|Physician Decision|0|||
33406679|NCT02493712|101377700|FG001|Overall Study|Physician Decision|1|||
33406680|NCT02493712|101377701|FG002|Overall Study|Physician Decision|0|||
33406681|NCT02493712|101377699|FG000|Overall Study|Lack of Efficacy|0|||
33406682|NCT02493712|101377700|FG001|Overall Study|Lack of Efficacy|5|||
33406683|NCT02493712|101377701|FG002|Overall Study|Lack of Efficacy|3|||
33540352|NCT01922934|101878482|FG001|Eligible Patients|Death|7|||
33540353|NCT01922934|101878481|FG000|Eligible Patients|Physician Decision|17|||
33342863|NCT01827384|101145566|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
33540354|NCT01922934|101878482|FG001|Eligible Patients|Physician Decision|0|||
33540355|NCT01922934|101878481|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
33540356|NCT01922934|101878482|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
33540357|NCT01922934|101878481|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
33540358|NCT01922934|101878482|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
33540359|NCT01922934|101878481|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
33540360|NCT01922934|101878482|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
33540361|NCT01922934|101878481|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
33540362|NCT01922934|101878482|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
33540363|NCT02074514|101878483|FG000|Overall Study|Lack of Efficacy|3|||
33540364|NCT02074514|101878484|FG001|Overall Study|Lack of Efficacy|2|||
33540365|NCT02074514|101878483|FG000|Overall Study|Lost to Follow-up|0|||
33540366|NCT02074514|101878484|FG001|Overall Study|Lost to Follow-up|1|||
33540367|NCT02074514|101878483|FG000|Overall Study|Withdrew Consent|0|||
33540368|NCT02074514|101878484|FG001|Overall Study|Withdrew Consent|1|||
33540369|NCT01670292|101878485|FG000|Overall Study|Lost to Follow-up|14|||
33540370|NCT01603277|101878486|FG000|Overall Study|Adverse Event|1|||
33342864|NCT01827384|101145567|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
33342865|NCT01827384|101145568|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
33342866|NCT03472560|101145569|FG000|Overall Study|Subject transfer to continuation protocol|0|||
33342867|NCT03472560|101145570|FG001|Overall Study|Subject transfer to continuation protocol|1|||
33342868|NCT03472560|101145569|FG000|Overall Study|Withdrawal by Subject|4|||
33342869|NCT03472560|101145570|FG001|Overall Study|Withdrawal by Subject|0|||
33342870|NCT03472560|101145569|FG000|Overall Study|Progressive disease|24|||
33342871|NCT03472560|101145570|FG001|Overall Study|Progressive disease|8|||
33342872|NCT03472560|101145569|FG000|Overall Study|Physician Decision|1|||
33342873|NCT03472560|101145570|FG001|Overall Study|Physician Decision|0|||
33342874|NCT03472560|101145569|FG000|Overall Study|Death|7|||
33342875|NCT03472560|101145570|FG001|Overall Study|Death|4|||
33342876|NCT03472560|101145569|FG000|Overall Study|Adverse Event|5|||
33342877|NCT03472560|101145570|FG001|Overall Study|Adverse Event|3|||
33342878|NCT03472560|101145569|FG000|Overall Study|Global deterioration of health status|0|||
33342879|NCT03472560|101145570|FG001|Overall Study|Global deterioration of health status|4|||
33342880|NCT01407926|101145571|FG000|Overall Study|Lost to Follow-up|55|||
33342881|NCT01014585|101145572|FG000|Overall Study|Adverse Event|0|||
33342882|NCT01014585|101145573|FG001|Overall Study|Adverse Event|2|||
33342883|NCT01014585|101145574|FG002|Overall Study|Adverse Event|0|||
33342884|NCT01014585|101145575|FG003|Overall Study|Adverse Event|3|||
33342885|NCT01014585|101145572|FG000|Overall Study|Withdrawal by Subject|2|||
33342886|NCT01014585|101145573|FG001|Overall Study|Withdrawal by Subject|0|||
33342887|NCT01014585|101145574|FG002|Overall Study|Withdrawal by Subject|1|||
33342888|NCT01014585|101145575|FG003|Overall Study|Withdrawal by Subject|3|||
33342889|NCT01014585|101145572|FG000|Overall Study|Lost to Follow-up|0|||
33342890|NCT01014585|101145573|FG001|Overall Study|Lost to Follow-up|0|||
33342891|NCT01014585|101145574|FG002|Overall Study|Lost to Follow-up|0|||
33342892|NCT01014585|101145575|FG003|Overall Study|Lost to Follow-up|2|||
33342893|NCT01014585|101145572|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
33342894|NCT01014585|101145573|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
33342895|NCT01014585|101145574|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
33342896|NCT01014585|101145575|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
33342897|NCT01363986|101145576|FG000|Overall Study|Disease progression|1|||
33342898|NCT02356562|101145577|FG000|Overall Study|Withdrawal by Subject|0|||
33342899|NCT02356562|101145578|FG001|Overall Study|Withdrawal by Subject|1|||
33342900|NCT02356562|101145577|FG000|Overall Study|Re-entered treatment in a previous study|1|||
33342901|NCT02356562|101145578|FG001|Overall Study|Re-entered treatment in a previous study|0|||
33540371|NCT01603277|101878487|FG001|Overall Study|Adverse Event|2|||
33540372|NCT01603277|101878486|FG000|Overall Study|Physician Decision|0|||
33540373|NCT01603277|101878487|FG001|Overall Study|Physician Decision|1|||
33210449|NCT01816594|100670477|FG001|Overall Study|Withdrawal by Subject|0|||
33342902|NCT02356562|101145577|FG000|Overall Study|site closure|1|||
33342903|NCT02356562|101145578|FG001|Overall Study|site closure|0|||
33342904|NCT02623335|101145581|FG000|Overall Study|Death|8|||
33342905|NCT02623335|101145582|FG001|Overall Study|Death|7|||
33342906|NCT02623335|101145581|FG000|Overall Study|Lost to Follow-up|15|||
33342907|NCT02623335|101145582|FG001|Overall Study|Lost to Follow-up|23|||
33406684|NCT02643420|101377705|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
33210450|NCT01816594|100670476|FG000|Overall Study|Physician Decision|1|||
33210451|NCT01816594|100670477|FG001|Overall Study|Physician Decision|0|||
33210452|NCT01540851|100670478|FG000|Overall Study|Lost to Follow-up|14|||
33210453|NCT01540851|100670479|FG001|Overall Study|Lost to Follow-up|15|||
33342908|NCT02623335|101145581|FG000|Overall Study|Withdrawal by Subject|2|||
33342909|NCT02623335|101145582|FG001|Overall Study|Withdrawal by Subject|5|||
33342910|NCT02623335|101145581|FG000|Overall Study|Protocol Violation|2|||
33342911|NCT02623335|101145582|FG001|Overall Study|Protocol Violation|1|||
33406685|NCT02643420|101377706|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
33540374|NCT01603277|101878486|FG000|Overall Study|Protocol Violation|6|||
33540375|NCT01603277|101878487|FG001|Overall Study|Protocol Violation|10|||
33540376|NCT01603277|101878486|FG000|Overall Study|Withdrawal by Subject|5|||
33342912|NCT00486278|101145583|FG000|Overall Study|Adverse Event|5|||
33342913|NCT00486278|101145583|FG000|Overall Study|Withdrawal by Subject|2|||
33342914|NCT00486278|101145583|FG000|Overall Study|Physician Decision|2|||
33342915|NCT00197054|101145584|FG000|Overall Study|Withdrawal by Subject|9|||
33342916|NCT00197054|101145585|FG001|Overall Study|Withdrawal by Subject|3|||
33342917|NCT00197054|101145586|FG002|Overall Study|Withdrawal by Subject|3|||
33342918|NCT00197054|101145584|FG000|Overall Study|Moved from area|7|||
33342919|NCT00197054|101145585|FG001|Overall Study|Moved from area|14|||
33342920|NCT00197054|101145586|FG002|Overall Study|Moved from area|9|||
33342921|NCT00197054|101145584|FG000|Overall Study|Lost to Follow-up|1|||
33342922|NCT00197054|101145585|FG001|Overall Study|Lost to Follow-up|4|||
33342923|NCT00197054|101145586|FG002|Overall Study|Lost to Follow-up|0|||
33342924|NCT00343512|101145587|FG000|Overall Study|Withdrawal by Subject|2|||
33342925|NCT00500682|101145589|FG000|Overall Study|Adverse Event|37|||
33342926|NCT00500682|101145590|FG001|Overall Study|Adverse Event|29|||
33342927|NCT00500682|101145589|FG000|Overall Study|Death|25|||
33342928|NCT00500682|101145590|FG001|Overall Study|Death|16|||
33342929|NCT00500682|101145589|FG000|Overall Study|Lost to Follow-up|11|||
33342930|NCT00500682|101145590|FG001|Overall Study|Lost to Follow-up|11|||
33342931|NCT00500682|101145589|FG000|Overall Study|Physician Decision|6|||
33342932|NCT00500682|101145590|FG001|Overall Study|Physician Decision|10|||
33342933|NCT00500682|101145589|FG000|Overall Study|Pregnancy|2|||
33342934|NCT00500682|101145590|FG001|Overall Study|Pregnancy|0|||
33342935|NCT00500682|101145589|FG000|Overall Study|Protocol Violation|1|||
33342936|NCT00500682|101145590|FG001|Overall Study|Protocol Violation|3|||
33342937|NCT00500682|101145589|FG000|Overall Study|Withdrawal by Subject|80|||
33342938|NCT00500682|101145590|FG001|Overall Study|Withdrawal by Subject|74|||
33342939|NCT00500682|101145589|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
33342940|NCT00500682|101145590|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
33342941|NCT00482014|101145593|FG000|Overall Study|Withdrawal by Subject|1|||
33342942|NCT00482014|101145594|FG001|Overall Study|Withdrawal by Subject|2|||
33342943|NCT00482014|101145595|FG002|Overall Study|Withdrawal by Subject|3|||
33406686|NCT02643420|101377705|FG000|Overall Study|Withdrawal by Subject|25|||
33540377|NCT01603277|101878487|FG001|Overall Study|Withdrawal by Subject|4|||
33540378|NCT01603277|101878486|FG000|Overall Study|Non-Compliance|2|||
33540379|NCT01603277|101878487|FG001|Overall Study|Non-Compliance|1|||
33540380|NCT02000921|101878488|FG000|Overall Study|Withdrawal by Subject|3|||
33540381|NCT02000921|101878489|FG001|Overall Study|Withdrawal by Subject|10|||
33210454|NCT01540851|100670478|FG000|Overall Study|Withdrawal by Subject|7|||
33210455|NCT01540851|100670479|FG001|Overall Study|Withdrawal by Subject|3|||
33210456|NCT00251745|100670480|FG000|Overall Study|Adverse Event|7|||
33342944|NCT00482014|101145596|FG003|Overall Study|Withdrawal by Subject|4|||
33342945|NCT00482014|101145593|FG000|Overall Study|Adverse Event|3|||
33540382|NCT02000921|101878490|FG002|Overall Study|Withdrawal by Subject|5|||
33210457|NCT00251745|100670481|FG001|Overall Study|Adverse Event|9|||
33210458|NCT00251745|100670482|FG002|Overall Study|Adverse Event|11|||
33210459|NCT00251745|100670480|FG000|Overall Study|Lost to Follow-up|4|||
33342946|NCT00482014|101145594|FG001|Overall Study|Adverse Event|0|||
33342947|NCT00482014|101145595|FG002|Overall Study|Adverse Event|2|||
33342948|NCT00482014|101145596|FG003|Overall Study|Adverse Event|8|||
33342949|NCT00482014|101145593|FG000|Overall Study|Death|1|||
33342950|NCT00482014|101145594|FG001|Overall Study|Death|2|||
33342951|NCT00482014|101145595|FG002|Overall Study|Death|1|||
33342952|NCT00482014|101145596|FG003|Overall Study|Death|4|||
33342953|NCT00482014|101145593|FG000|Overall Study|Lack of Efficacy|1|||
33540383|NCT02000921|101878488|FG000|Overall Study|Lost to Follow-up|2|||
33342954|NCT00482014|101145594|FG001|Overall Study|Lack of Efficacy|0|||
33342955|NCT00482014|101145595|FG002|Overall Study|Lack of Efficacy|4|||
33342956|NCT00482014|101145596|FG003|Overall Study|Lack of Efficacy|6|||
33342957|NCT00482014|101145593|FG000|Overall Study|Sponsor Decision|1|||
33342958|NCT00482014|101145594|FG001|Overall Study|Sponsor Decision|2|||
33342959|NCT00482014|101145595|FG002|Overall Study|Sponsor Decision|1|||
33342960|NCT00482014|101145596|FG003|Overall Study|Sponsor Decision|1|||
33342961|NCT00217087|101145599|FG000|Overall Study|decided to have esophagectomy|1|||
33342962|NCT00217087|101145600|FG001|Overall Study|decided to have esophagectomy|2|||
33342963|NCT00217087|101145599|FG000|Overall Study|completed less than 12 months return|10|||
33342964|NCT00217087|101145600|FG001|Overall Study|completed less than 12 months return|18|||
33342965|NCT01988090|101145601|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
33342966|NCT01988090|101145602|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
33342967|NCT01988090|101145601|FG000|Start Treament After Randomization|Protocol Violation|0|||
33342968|NCT01988090|101145602|FG001|Start Treament After Randomization|Protocol Violation|1|||
33342969|NCT01988090|101145601|FG000|Complete Study After Start|Withdrawal by Subject|2|||
33342970|NCT01988090|101145602|FG001|Complete Study After Start|Withdrawal by Subject|0|||
33342971|NCT01988090|101145601|FG000|Complete Study After Start|Protocol Violation|1|||
33342972|NCT01988090|101145602|FG001|Complete Study After Start|Protocol Violation|1|||
33342973|NCT00626093|101145603|FG000|Overall Study|Lost to Follow-up|5|||
33342974|NCT00626093|101145603|FG000|Overall Study|Death|1|||
33342975|NCT00626093|101145603|FG000|Overall Study|Physician Decision|4|||
33342976|NCT00626093|101145603|FG000|Overall Study|Withdrawal by Subject|6|||
33342977|NCT00626093|101145603|FG000|Overall Study|Protocol Violation|1|||
33342978|NCT00626093|101145603|FG000|Overall Study|One of the required devices not implante|6|||
33342979|NCT00820755|101145605|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
33342980|NCT00820755|101145606|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
33342981|NCT00820755|101145607|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
33342982|NCT00820755|101145605|FG000|Period 1: Combination Therapy Phase|Death|28|||
33342983|NCT00820755|101145606|FG001|Period 1: Combination Therapy Phase|Death|0|||
33342984|NCT00820755|101145607|FG002|Period 1: Combination Therapy Phase|Death|0|||
33342985|NCT00820755|101145605|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
33342986|NCT00820755|101145606|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
33342987|NCT00820755|101145607|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
33342988|NCT00820755|101145605|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
33342989|NCT00820755|101145606|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
33342990|NCT00820755|101145607|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
33342991|NCT00820755|101145605|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
33342992|NCT00820755|101145606|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
33342993|NCT00820755|101145607|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
33342994|NCT00820755|101145605|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
33342995|NCT00820755|101145606|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
33342996|NCT00820755|101145607|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
33342997|NCT00820755|101145605|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
33342998|NCT00820755|101145606|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
33342999|NCT00820755|101145607|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
33343000|NCT00820755|101145605|FG000|Period 1: Combination Therapy Phase|Other|11|||
33343001|NCT00820755|101145606|FG001|Period 1: Combination Therapy Phase|Other|0|||
33343002|NCT00820755|101145607|FG002|Period 1: Combination Therapy Phase|Other|0|||
33343003|NCT00820755|101145605|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
33343004|NCT00820755|101145606|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
33343005|NCT00820755|101145607|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
33343006|NCT00168831|101145609|FG000|Overall Study|Adverse Event|36|||
33343007|NCT00168831|101145610|FG001|Overall Study|Adverse Event|47|||
33343008|NCT00168831|101145611|FG002|Overall Study|Adverse Event|74|||
33540384|NCT02000921|101878489|FG001|Overall Study|Lost to Follow-up|4|||
33540385|NCT02000921|101878490|FG002|Overall Study|Lost to Follow-up|5|||
33343009|NCT00168831|101145609|FG000|Overall Study|Lost to Follow-up|5|||
33343010|NCT00168831|101145610|FG001|Overall Study|Lost to Follow-up|6|||
33343011|NCT00168831|101145611|FG002|Overall Study|Lost to Follow-up|4|||
33343012|NCT00168831|101145609|FG000|Overall Study|Withdrawal by Subject|7|||
33343013|NCT00168831|101145610|FG001|Overall Study|Withdrawal by Subject|14|||
33343014|NCT00168831|101145611|FG002|Overall Study|Withdrawal by Subject|19|||
33343015|NCT00168831|101145609|FG000|Overall Study|Protocol Violation|6|||
33343016|NCT00168831|101145610|FG001|Overall Study|Protocol Violation|11|||
33343017|NCT00168831|101145611|FG002|Overall Study|Protocol Violation|11|||
33343018|NCT00168831|101145609|FG000|Overall Study|Other|6|||
33343019|NCT00168831|101145610|FG001|Overall Study|Other|3|||
33343020|NCT00168831|101145611|FG002|Overall Study|Other|6|||
33406687|NCT02643420|101377706|FG001|Overall Study|Withdrawal by Subject|19|||
33540386|NCT02000921|101878488|FG000|Overall Study|Physician Decision|0|||
33343021|NCT02340663|101145612|FG000|Overall Study|Lost to Follow-up|1|||
33343022|NCT02340663|101145613|FG001|Overall Study|Lost to Follow-up|0|||
33343023|NCT02340663|101145612|FG000|Overall Study|Protocol Violation|1|||
33343024|NCT02340663|101145613|FG001|Overall Study|Protocol Violation|0|||
33343025|NCT02340663|101145612|FG000|Overall Study|Withdrawal by Subject|3|||
33343026|NCT02340663|101145613|FG001|Overall Study|Withdrawal by Subject|1|||
33540387|NCT02000921|101878489|FG001|Overall Study|Physician Decision|2|||
33540388|NCT02000921|101878490|FG002|Overall Study|Physician Decision|0|||
33540389|NCT01285518|101878491|FG000|Overall Study|Lost to Follow-up|0|||
33540390|NCT01285518|101878492|FG001|Overall Study|Lost to Follow-up|0|||
33540391|NCT01285518|101878493|FG002|Overall Study|Lost to Follow-up|0|||
33540392|NCT01285518|101878494|FG003|Overall Study|Lost to Follow-up|0|||
33540393|NCT01285518|101878495|FG004|Overall Study|Lost to Follow-up|0|||
33540394|NCT01285518|101878496|FG005|Overall Study|Lost to Follow-up|1|||
33540395|NCT01285518|101878497|FG006|Overall Study|Lost to Follow-up|0|||
33540396|NCT01285518|101878498|FG007|Overall Study|Lost to Follow-up|0|||
33540397|NCT01249131|101878499|FG000|Washout Period of 10 Days|Adverse Event|0|||
33540398|NCT01249131|101878500|FG001|Washout Period of 10 Days|Adverse Event|0|||
33540399|NCT01249131|101878501|FG002|Washout Period of 10 Days|Adverse Event|0|||
33540400|NCT01249131|101878502|FG003|Washout Period of 10 Days|Adverse Event|0|||
33540401|NCT01249131|101878503|FG004|Washout Period of 10 Days|Adverse Event|1|||
33540402|NCT01249131|101878504|FG005|Washout Period of 10 Days|Adverse Event|0|||
33540403|NCT03903172|101878505|FG000|Overall Study|screen fail|4|||
33540404|NCT03903172|101878506|FG001|Overall Study|screen fail|1|||
33540405|NCT01268267|101878507|FG000|Overall Study|Protocol Violation|1|||
33540406|NCT00977197|101878508|FG000|Overall Study|Withdrawal by Subject|3|||
33540407|NCT00977197|101878509|FG001|Overall Study|Withdrawal by Subject|4|||
33540408|NCT00977197|101878508|FG000|Overall Study|Adverse Event|3|||
33540409|NCT00977197|101878509|FG001|Overall Study|Adverse Event|1|||
33540410|NCT00977197|101878508|FG000|Overall Study|Lack of Efficacy|1|||
33540411|NCT00977197|101878509|FG001|Overall Study|Lack of Efficacy|0|||
33540412|NCT00977197|101878508|FG000|Overall Study|Lost to Follow-up|1|||
33540413|NCT00977197|101878509|FG001|Overall Study|Lost to Follow-up|3|||
33540414|NCT00977197|101878508|FG000|Overall Study|Nonadherence|1|||
33540415|NCT00977197|101878509|FG001|Overall Study|Nonadherence|1|||
33540416|NCT01699750|101878538|FG000|Overall Study|Withdrew Consent|0|||
33540417|NCT01699750|101878539|FG001|Overall Study|Withdrew Consent|1|||
33540418|NCT01699750|101878538|FG000|Overall Study|Other|0|||
33540419|NCT01699750|101878539|FG001|Overall Study|Other|2|||
33540420|NCT00611806|101878540|FG000|Overall Study|Withdrawal by Subject|8|||
33540421|NCT00611806|101878541|FG001|Overall Study|Withdrawal by Subject|2|||
33540422|NCT00611806|101878540|FG000|Overall Study|Adverse Event|2|||
33540423|NCT00611806|101878541|FG001|Overall Study|Adverse Event|1|||
33540424|NCT00611806|101878540|FG000|Overall Study|Lost to Follow-up|6|||
33540425|NCT00611806|101878541|FG001|Overall Study|Lost to Follow-up|0|||
33540426|NCT04584788|101878542|FG000|Overall Study|Physician Decision|8|||
33540427|NCT04584788|101878542|FG000|Overall Study|Withdrawal by Subject|1|||
33343027|NCT03683394|101145614|FG000|Overall Study|Withdrawal by Subject|4|||
33343028|NCT03683394|101145615|FG001|Overall Study|Withdrawal by Subject|8|||
33343029|NCT03683394|101145614|FG000|Overall Study|Lost to Follow-up|7|||
33343030|NCT03683394|101145615|FG001|Overall Study|Lost to Follow-up|0|||
33343031|NCT03683394|101145614|FG000|Overall Study|Death|3|||
33343032|NCT03683394|101145615|FG001|Overall Study|Death|1|||
33343033|NCT00841763|101145618|FG000|Overall Study|Withdrawal by Subject|60|||
33343034|NCT00841763|101145619|FG001|Overall Study|Withdrawal by Subject|17|||
33343035|NCT00841763|101145620|FG002|Overall Study|Withdrawal by Subject|4|||
33343036|NCT00841763|101145621|FG003|Overall Study|Withdrawal by Subject|1|||
33540428|NCT04584788|101878542|FG000|Overall Study|Adverse Event|3|||
33540429|NCT02452047|101878543|FG000|Overall Study|Adverse Event|0|||
33540430|NCT02452047|101878544|FG001|Overall Study|Adverse Event|1|||
33540431|NCT02452047|101878545|FG002|Overall Study|Adverse Event|1|||
33540432|NCT02452047|101878543|FG000|Overall Study|Death|1|||
33540433|NCT02452047|101878544|FG001|Overall Study|Death|3|||
33343037|NCT00841763|101145618|FG000|Overall Study|Adverse Event|9|||
33540434|NCT02452047|101878545|FG002|Overall Study|Death|1|||
33540435|NCT02452047|101878543|FG000|Overall Study|Physician Decision|1|||
33540436|NCT02452047|101878544|FG001|Overall Study|Physician Decision|0|||
33540437|NCT02452047|101878545|FG002|Overall Study|Physician Decision|0|||
33343038|NCT00841763|101145619|FG001|Overall Study|Adverse Event|10|||
33540438|NCT02452047|101878543|FG000|Overall Study|Lost to Follow-up|1|||
33540439|NCT02452047|101878544|FG001|Overall Study|Lost to Follow-up|1|||
33540440|NCT02452047|101878545|FG002|Overall Study|Lost to Follow-up|0|||
33540441|NCT02452047|101878543|FG000|Overall Study|Withdrawal by Subject|1|||
33540442|NCT02452047|101878544|FG001|Overall Study|Withdrawal by Subject|0|||
33540443|NCT02452047|101878545|FG002|Overall Study|Withdrawal by Subject|0|||
33540444|NCT02133508|101878546|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
33540445|NCT02133508|101878546|FG000|Overall Study|Death|12|||
33540446|NCT02133508|101878546|FG000|Overall Study|Lost to Follow-up|2|||
33343039|NCT00841763|101145620|FG002|Overall Study|Adverse Event|3|||
33343040|NCT00841763|101145621|FG003|Overall Study|Adverse Event|2|||
33343041|NCT00841763|101145618|FG000|Overall Study|Lost to Follow-up|63|||
33343042|NCT00841763|101145619|FG001|Overall Study|Lost to Follow-up|25|||
33343043|NCT00841763|101145620|FG002|Overall Study|Lost to Follow-up|0|||
33343044|NCT00841763|101145621|FG003|Overall Study|Lost to Follow-up|0|||
33343045|NCT00841763|101145618|FG000|Overall Study|Protocol Violation|20|||
33343046|NCT00841763|101145619|FG001|Overall Study|Protocol Violation|3|||
33343047|NCT00841763|101145620|FG002|Overall Study|Protocol Violation|1|||
33343048|NCT00841763|101145621|FG003|Overall Study|Protocol Violation|0|||
33343049|NCT00841763|101145618|FG000|Overall Study|Administrative Reasons|3|||
33343050|NCT00841763|101145619|FG001|Overall Study|Administrative Reasons|1|||
33343051|NCT00841763|101145620|FG002|Overall Study|Administrative Reasons|0|||
33343052|NCT00841763|101145621|FG003|Overall Study|Administrative Reasons|0|||
33343053|NCT00841763|101145618|FG000|Overall Study|Unable to Classify|7|||
33343054|NCT00841763|101145619|FG001|Overall Study|Unable to Classify|1|||
33343055|NCT00841763|101145620|FG002|Overall Study|Unable to Classify|0|||
33343056|NCT00841763|101145621|FG003|Overall Study|Unable to Classify|0|||
33343057|NCT01656434|101145625|FG000|Overall Study|Adverse Event|199|||
33343058|NCT01656434|101145626|FG001|Overall Study|Adverse Event|63|||
33343059|NCT01656434|101145625|FG000|Overall Study|Enrollment terminated at trial site|2|||
33343060|NCT01656434|101145626|FG001|Overall Study|Enrollment terminated at trial site|0|||
33343061|NCT01656434|101145625|FG000|Overall Study|Lost to Follow-up|309|||
33343062|NCT01656434|101145626|FG001|Overall Study|Lost to Follow-up|76|||
33343063|NCT01656434|101145625|FG000|Overall Study|Site discontinued study participation|24|||
33343064|NCT01656434|101145626|FG001|Overall Study|Site discontinued study participation|9|||
33343065|NCT01656434|101145625|FG000|Overall Study|Screen failure|2|||
33343066|NCT01656434|101145626|FG001|Overall Study|Screen failure|0|||
33343067|NCT01656434|101145625|FG000|Overall Study|Protocol Violation|7|||
33343068|NCT01656434|101145626|FG001|Overall Study|Protocol Violation|0|||
33343069|NCT01656434|101145625|FG000|Overall Study|Pregnancy wish|18|||
33343070|NCT01656434|101145626|FG001|Overall Study|Pregnancy wish|6|||
33343071|NCT01656434|101145625|FG000|Overall Study|Pregnancy|45|||
33343072|NCT01656434|101145626|FG001|Overall Study|Pregnancy|10|||
33343073|NCT01656434|101145625|FG000|Overall Study|Physician Decision|7|||
33343074|NCT01656434|101145626|FG001|Overall Study|Physician Decision|2|||
33343075|NCT01656434|101145625|FG000|Overall Study|Non-compliance with study drug|48|||
33343076|NCT01656434|101145626|FG001|Overall Study|Non-compliance with study drug|9|||
33343077|NCT01656434|101145625|FG000|Overall Study|Study terminated by sponsor|1501|||
33343078|NCT01656434|101145626|FG001|Overall Study|Study terminated by sponsor|348|||
33343079|NCT01656434|101145625|FG000|Overall Study|Participant discontinued; drug related|13|||
33343080|NCT01656434|101145626|FG001|Overall Study|Participant discontinued; drug related|4|||
33343081|NCT01656434|101145625|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
33343082|NCT01656434|101145626|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
33343083|NCT01656434|101145625|FG000|Overall Study|Non-compliance with protocol|39|||
33343084|NCT01656434|101145626|FG001|Overall Study|Non-compliance with protocol|15|||
33343085|NCT01656434|101145625|FG000|Overall Study|Participant moved|40|||
33343086|NCT01656434|101145626|FG001|Overall Study|Participant moved|12|||
33343087|NCT01656434|101145625|FG000|Overall Study|Participant withdrew consent|28|||
33343088|NCT01656434|101145626|FG001|Overall Study|Participant withdrew consent|9|||
33343089|NCT01656434|101145625|FG000|Overall Study|Withdrawal by Subject|64|||
33343090|NCT01656434|101145626|FG001|Overall Study|Withdrawal by Subject|7|||
33343091|NCT02513329|101145627|FG000|Overall Study|Lost to Follow-up|5|||
33343092|NCT02513329|101145628|FG001|Overall Study|Lost to Follow-up|2|||
33343093|NCT05162066|101145633|FG000|Overall Study|Adverse Event|1|||
33540447|NCT00834041|101878547|FG000|Overall Study|Withdrawal by Subject|1|||
33540448|NCT00834041|101878548|FG001|Overall Study|Withdrawal by Subject|0|||
33540449|NCT00834041|101878547|FG000|Overall Study|Lost to Follow-up|0|||
33540450|NCT00834041|101878548|FG001|Overall Study|Lost to Follow-up|1|||
33343094|NCT05162066|101145634|FG001|Overall Study|Adverse Event|0|||
33343095|NCT05162066|101145635|FG002|Overall Study|Adverse Event|0|||
33343096|NCT05162066|101145633|FG000|Overall Study|Perceived lack of efficacy|1|||
33343097|NCT05162066|101145634|FG001|Overall Study|Perceived lack of efficacy|0|||
33343098|NCT05162066|101145635|FG002|Overall Study|Perceived lack of efficacy|0|||
33540451|NCT00288912|101878549|FG000|Overall Study|Developed exclusion criterion|4|||
33540452|NCT00288912|101878550|FG001|Overall Study|Developed exclusion criterion|6|||
33343099|NCT03213366|101145636|FG000|Overall Study|Lost to Follow-up|9|||
33343100|NCT03213366|101145637|FG001|Overall Study|Lost to Follow-up|4|||
33343101|NCT01064167|101145638|FG000|Overall Study|Protocol Violation|14|||
33343102|NCT01064167|101145639|FG001|Overall Study|Protocol Violation|15|||
33343103|NCT03094195|101145644|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
33343104|NCT03094195|101145645|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
33343105|NCT03094195|101145646|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
33343106|NCT03094195|101145647|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33343107|NCT03094195|101145648|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33343108|NCT03094195|101145649|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33343109|NCT03094195|101145650|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33343110|NCT03094195|101145651|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33343111|NCT03094195|101145644|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
33343112|NCT03094195|101145645|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
33343113|NCT03094195|101145646|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
33343114|NCT03094195|101145647|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33343115|NCT03094195|101145648|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33343116|NCT03094195|101145649|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33343117|NCT03094195|101145650|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33343118|NCT03094195|101145651|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33343119|NCT03094195|101145644|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33343120|NCT03094195|101145645|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33343121|NCT03094195|101145646|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
33343122|NCT03094195|101145647|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33343123|NCT03094195|101145648|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33343124|NCT03094195|101145649|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33343125|NCT03094195|101145650|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33343126|NCT03094195|101145651|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33343127|NCT03094195|101145644|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33343128|NCT03094195|101145645|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
33343129|NCT03094195|101145646|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
33343130|NCT03094195|101145647|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33343131|NCT03094195|101145648|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33343132|NCT03094195|101145649|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33343133|NCT03094195|101145650|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33343134|NCT03094195|101145651|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33343135|NCT03056573|101145652|FG000|Overall Study|Death|2|||
33406688|NCT02643420|101377705|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
33406689|NCT02643420|101377706|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
33343136|NCT03056573|101145653|FG001|Overall Study|Death|4|||
33210460|NCT00251745|100670481|FG001|Overall Study|Lost to Follow-up|2|||
33615355|NCT00434642|102140282|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
33615356|NCT00434642|102140283|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
33615357|NCT00434642|102140282|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
33343137|NCT03056573|101145652|FG000|Overall Study|Withdrawal by Subject|2|||
33343138|NCT03056573|101145653|FG001|Overall Study|Withdrawal by Subject|0|||
33343139|NCT03056573|101145652|FG000|Overall Study|Lost to Follow-up|1|||
33343140|NCT03056573|101145653|FG001|Overall Study|Lost to Follow-up|1|||
33343141|NCT00654498|101145654|FG000|Overall Study|Not Treated|1|||
33343142|NCT00654498|101145655|FG001|Overall Study|Not Treated|0|||
33343143|NCT00654498|101145654|FG000|Overall Study|Adverse Event|6|||
33343144|NCT00654498|101145655|FG001|Overall Study|Adverse Event|1|||
33343145|NCT00654498|101145654|FG000|Overall Study|Protocol Violation|1|||
33343146|NCT00654498|101145655|FG001|Overall Study|Protocol Violation|1|||
33343147|NCT00654498|101145654|FG000|Overall Study|Lost to Follow-up|1|||
33343148|NCT00654498|101145655|FG001|Overall Study|Lost to Follow-up|5|||
33343149|NCT00654498|101145654|FG000|Overall Study|Withdrawal by Subject|1|||
33343150|NCT00654498|101145655|FG001|Overall Study|Withdrawal by Subject|0|||
33343151|NCT00654498|101145654|FG000|Overall Study|Other reason not defined above|4|||
33343152|NCT00654498|101145655|FG001|Overall Study|Other reason not defined above|5|||
33343153|NCT00880256|101145659|FG000|Overall Study|Lost to Follow-up|28|||
33343154|NCT01627860|101145662|FG000|Overall Study|Adverse Event|9|||
33343155|NCT01627860|101145663|FG001|Overall Study|Adverse Event|4|||
33343156|NCT01627860|101145662|FG000|Overall Study|Withdrawal by Subject|2|||
33343157|NCT01627860|101145663|FG001|Overall Study|Withdrawal by Subject|1|||
33343158|NCT01627860|101145662|FG000|Overall Study|Seizure frequency doubled|0|||
33343159|NCT01627860|101145663|FG001|Overall Study|Seizure frequency doubled|1|||
33343160|NCT01627860|101145662|FG000|Overall Study|Protocol Violation|1|||
33540453|NCT00288912|101878551|FG002|Overall Study|Developed exclusion criterion|7|||
33540454|NCT00288912|101878549|FG000|Overall Study|Lost to Follow-up|9|||
33540455|NCT00288912|101878550|FG001|Overall Study|Lost to Follow-up|6|||
33540456|NCT00288912|101878551|FG002|Overall Study|Lost to Follow-up|9|||
33540457|NCT00288912|101878549|FG000|Overall Study|Withdrawal by Subject|4|||
33540458|NCT00288912|101878550|FG001|Overall Study|Withdrawal by Subject|5|||
33540459|NCT00288912|101878551|FG002|Overall Study|Withdrawal by Subject|12|||
33540460|NCT00572832|101878554|FG000|Overall Study|Lost to Follow-up|0|||
33540461|NCT00572832|101878555|FG001|Overall Study|Lost to Follow-up|11|||
33540462|NCT00572832|101878554|FG000|Overall Study|Pregnancy|0|||
33540463|NCT00572832|101878555|FG001|Overall Study|Pregnancy|1|||
33343161|NCT01627860|101145663|FG001|Overall Study|Protocol Violation|0|||
33343162|NCT04418765|101145664|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
33343163|NCT04418765|101145665|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
33343164|NCT04418765|101145666|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
33406690|NCT02643420|101377705|FG000|Overall Study|Lost to Follow-up|6|||
33540464|NCT03183908|101878562|FG000|Overall Study|Missing Symptom Diary Data|0|||
33540465|NCT03183908|101878563|FG001|Overall Study|Missing Symptom Diary Data|2|||
33540466|NCT01663623|101878564|FG000|Overall Study|Adverse Event|3|||
33540467|NCT01663623|101878565|FG001|Overall Study|Adverse Event|7|||
33540468|NCT01663623|101878564|FG000|Overall Study|Lack of Efficacy|5|||
33540469|NCT01663623|101878565|FG001|Overall Study|Lack of Efficacy|6|||
33540470|NCT01663623|101878564|FG000|Overall Study|Protocol Violation|0|||
33540471|NCT01663623|101878565|FG001|Overall Study|Protocol Violation|1|||
33540472|NCT01663623|101878564|FG000|Overall Study|Other-Study closed/terminated|1|||
33540473|NCT01663623|101878565|FG001|Overall Study|Other-Study closed/terminated|1|||
33540474|NCT01663623|101878564|FG000|Overall Study|Physician Decision|1|||
33540475|NCT01663623|101878565|FG001|Overall Study|Physician Decision|4|||
33540476|NCT01663623|101878564|FG000|Overall Study|Withdrawal by Subject|2|||
33540477|NCT01663623|101878565|FG001|Overall Study|Withdrawal by Subject|1|||
33540478|NCT04889040|101878566|FG000|Overall Study|Withdrawal by Subject|3|||
33540479|NCT04889040|101878567|FG001|Overall Study|Withdrawal by Subject|3|||
33540480|NCT04889040|101878566|FG000|Overall Study|Lost to Follow-up|0|||
33540481|NCT04889040|101878567|FG001|Overall Study|Lost to Follow-up|1|||
33540482|NCT04889040|101878566|FG000|Overall Study|Adverse Event|2|||
33540483|NCT04889040|101878567|FG001|Overall Study|Adverse Event|1|||
33540484|NCT04275336|101878568|FG000|Overall Study|First venipuncture failed|4|||
33540485|NCT04275336|101878569|FG001|Overall Study|First venipuncture failed|6|||
33540486|NCT04275336|101878570|FG002|Overall Study|First venipuncture failed|5|||
33210461|NCT00251745|100670482|FG002|Overall Study|Lost to Follow-up|5|||
33210462|NCT00251745|100670480|FG000|Overall Study|Withdrawal by Subject|13|||
33210463|NCT00251745|100670481|FG001|Overall Study|Withdrawal by Subject|7|||
33210464|NCT00251745|100670482|FG002|Overall Study|Withdrawal by Subject|3|||
33343165|NCT04418765|101145664|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
33343166|NCT04418765|101145665|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
33343167|NCT04418765|101145666|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
33343168|NCT04418765|101145664|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
33343169|NCT04418765|101145665|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
33343170|NCT04418765|101145666|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
33343171|NCT04418765|101145664|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
33343172|NCT04418765|101145665|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
33343173|NCT04418765|101145666|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
33343174|NCT04418765|101145664|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
33343175|NCT04418765|101145665|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
33343176|NCT04418765|101145666|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
33343177|NCT04418765|101145664|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
33343178|NCT04418765|101145665|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
33343179|NCT04418765|101145666|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
33343180|NCT04418765|101145664|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
33343181|NCT04418765|101145665|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
33343182|NCT04418765|101145666|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
33210465|NCT00251745|100670480|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
33343183|NCT04418765|101145664|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
33343184|NCT04418765|101145665|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
33343185|NCT04418765|101145666|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
33343186|NCT04418765|101145664|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
33343187|NCT04418765|101145665|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
33343188|NCT04418765|101145666|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
33343189|NCT04418765|101145664|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
33343190|NCT04418765|101145665|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
33343191|NCT04418765|101145666|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
33406691|NCT02643420|101377706|FG001|Overall Study|Lost to Follow-up|10|||
33406692|NCT02643420|101377705|FG000|Overall Study|Investigator Decision|2|||
33406693|NCT02643420|101377706|FG001|Overall Study|Investigator Decision|4|||
33406694|NCT02643420|101377705|FG000|Overall Study|Sponsor decision|1|||
33406695|NCT02643420|101377706|FG001|Overall Study|Sponsor decision|1|||
33406696|NCT02643420|101377705|FG000|Overall Study|Death|0|||
33540487|NCT04275336|101878568|FG000|Overall Study|Unscheduled venipuncture|9|||
33540488|NCT04275336|101878569|FG001|Overall Study|Unscheduled venipuncture|13|||
33540489|NCT04275336|101878570|FG002|Overall Study|Unscheduled venipuncture|7|||
33540490|NCT04275336|101878568|FG000|Overall Study|Failed specimen of saliva|4|||
33540491|NCT04275336|101878569|FG001|Overall Study|Failed specimen of saliva|3|||
33540492|NCT04275336|101878570|FG002|Overall Study|Failed specimen of saliva|4|||
33540493|NCT00251758|101878571|FG000|Overall Study|Adverse Event|7|||
33540494|NCT00251758|101878572|FG001|Overall Study|Adverse Event|9|||
33540495|NCT00251758|101878573|FG002|Overall Study|Adverse Event|11|||
33540496|NCT00251758|101878571|FG000|Overall Study|Lost to Follow-up|4|||
33540497|NCT00251758|101878572|FG001|Overall Study|Lost to Follow-up|2|||
33540498|NCT00251758|101878573|FG002|Overall Study|Lost to Follow-up|5|||
33540499|NCT00251758|101878571|FG000|Overall Study|Withdrawal by Subject|13|||
33540500|NCT00251758|101878572|FG001|Overall Study|Withdrawal by Subject|7|||
33540501|NCT00251758|101878573|FG002|Overall Study|Withdrawal by Subject|3|||
33210466|NCT00251745|100670481|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
33540502|NCT00251758|101878571|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
33615358|NCT00434642|102140283|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
33343192|NCT04418765|101145664|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
33343193|NCT04418765|101145665|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
33406697|NCT02643420|101377706|FG001|Overall Study|Death|2|||
33406698|NCT02643420|101377705|FG000|Overall Study|Reason not Specified|8|||
33210467|NCT00251745|100670482|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
33210468|NCT00251745|100670480|FG000|Overall Study|Lack of Efficacy|3|||
33210469|NCT00251745|100670481|FG001|Overall Study|Lack of Efficacy|0|||
33210470|NCT00251745|100670482|FG002|Overall Study|Lack of Efficacy|0|||
33210471|NCT00251745|100670480|FG000|Overall Study|Noncompliant|0|||
33210472|NCT00251745|100670481|FG001|Overall Study|Noncompliant|2|||
33210473|NCT00251745|100670482|FG002|Overall Study|Noncompliant|2|||
33210474|NCT00251745|100670480|FG000|Overall Study|Pregnancy|0|||
33210475|NCT00251745|100670481|FG001|Overall Study|Pregnancy|1|||
33210476|NCT00251745|100670482|FG002|Overall Study|Pregnancy|0|||
33210477|NCT00251745|100670480|FG000|Overall Study|Per Subject Request|0|||
33210478|NCT00251745|100670481|FG001|Overall Study|Per Subject Request|0|||
33210479|NCT00251745|100670482|FG002|Overall Study|Per Subject Request|1|||
33210480|NCT00251745|100670480|FG000|Overall Study|Per Investigator Request|1|||
33210481|NCT00251745|100670481|FG001|Overall Study|Per Investigator Request|0|||
33210482|NCT00251745|100670482|FG002|Overall Study|Per Investigator Request|0|||
33210483|NCT05374421|100670483|FG000|Overall Study|Withdrawal by Subject|3|||
33210484|NCT05374421|100670484|FG001|Overall Study|Withdrawal by Subject|4|||
33210485|NCT03595904|100673389|FG000|Overall Study|Protocol Violation|3|||
33210486|NCT03595904|100673390|FG001|Overall Study|Protocol Violation|1|||
33210487|NCT03595904|100673389|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
33210488|NCT03595904|100673390|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
33210489|NCT03595904|100673389|FG000|Overall Study|Insurance complications|1|||
33210490|NCT03595904|100673390|FG001|Overall Study|Insurance complications|0|||
33210491|NCT03595904|100673389|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
33210492|NCT03595904|100673390|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
33210493|NCT02526693|100673391|FG000|Overall Study|Physician Decision|3|||
33210494|NCT02526693|100673392|FG001|Overall Study|Physician Decision|1|||
33210495|NCT00989287|100673393|FG000|Overall Study|Adverse Event|1|||
33210496|NCT00989287|100673394|FG001|Overall Study|Adverse Event|0|||
33210497|NCT00989287|100673393|FG000|Overall Study|Lost to Follow-up|0|||
33210498|NCT00989287|100673394|FG001|Overall Study|Lost to Follow-up|1|||
33210499|NCT00983073|100673395|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
33210500|NCT00983073|100673395|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
33210501|NCT00983073|100673395|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
33210502|NCT00983073|100673395|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
33210503|NCT00983073|100673395|FG000|Titration and Optimal Dose Period|Other reason|4|||
33210504|NCT00983073|100673395|FG000|Maintenance Period|Adverse Event|5|||
33210505|NCT00983073|100673395|FG000|Maintenance Period|Withdrawal by Subject|2|||
33210506|NCT00983073|100673395|FG000|Maintenance Period|Lack of Efficacy|2|||
33210507|NCT00983073|100673395|FG000|Maintenance Period|Other Reason|7|||
33615359|NCT00434642|102140282|FG000|Blinded Treatment Phase|Physician Decision|19|||
33210508|NCT02891187|100673406|FG000|Overall Study|Lost to Follow-up|1|||
33210509|NCT02891187|100673407|FG001|Overall Study|Lost to Follow-up|2|||
33210510|NCT03996473|100673408|FG000|Treatment Assignment|Withdrawal by Subject|1|||
33406699|NCT02643420|101377706|FG001|Overall Study|Reason not Specified|7|||
33406700|NCT00337935|101377707|FG000|Overall Study|Adverse Event|2|||
33406701|NCT00337935|101377708|FG001|Overall Study|Adverse Event|5|||
33406702|NCT00337935|101377707|FG000|Overall Study|Death|2|||
33406703|NCT00337935|101377708|FG001|Overall Study|Death|8|||
33406704|NCT00337935|101377707|FG000|Overall Study|Physician Decision|1|||
33406705|NCT00337935|101377708|FG001|Overall Study|Physician Decision|1|||
33406706|NCT00337935|101377707|FG000|Overall Study|Lost to Follow-up|0|||
33406707|NCT00337935|101377708|FG001|Overall Study|Lost to Follow-up|1|||
33406708|NCT00337935|101377707|FG000|Overall Study|Protocol Violation|4|||
33406709|NCT00337935|101377708|FG001|Overall Study|Protocol Violation|3|||
33406710|NCT00337935|101377707|FG000|Overall Study|Withdrawal by Subject|1|||
33406711|NCT00337935|101377708|FG001|Overall Study|Withdrawal by Subject|7|||
33406712|NCT00337935|101377707|FG000|Overall Study|Other|0|||
33406713|NCT00337935|101377708|FG001|Overall Study|Other|1|||
33406714|NCT00337935|101377707|FG000|Overall Study|Lack of Efficacy|0|||
33210511|NCT03996473|100673408|FG000|Treatment Assignment|Progressive disease|6|||
33406715|NCT00337935|101377708|FG001|Overall Study|Lack of Efficacy|1|||
33406716|NCT00933543|101377709|FG000|Overall Study|Adverse Event|2|||
33406717|NCT00933543|101377710|FG001|Overall Study|Adverse Event|1|||
33406718|NCT00933543|101377709|FG000|Overall Study|Lost to Follow-up|0|||
33406719|NCT00933543|101377710|FG001|Overall Study|Lost to Follow-up|1|||
33406720|NCT00933543|101377709|FG000|Overall Study|Withdrawal by Subject|0|||
33210512|NCT03996473|100673408|FG000|Treatment Assignment|Study drug never administered|1|||
33210513|NCT03996473|100673408|FG000|Active Follow-up|Death|1|||
33210514|NCT03996473|100673408|FG000|Long-term Follow-up|Death|5|||
33210515|NCT04575467|100673409|FG000|Overall Study|Adverse Event|0|||
33210516|NCT04575467|100673410|FG001|Overall Study|Adverse Event|1|||
33210517|NCT04575467|100673411|FG002|Overall Study|Adverse Event|0|||
33210518|NCT04575467|100673412|FG003|Overall Study|Adverse Event|0|||
33210519|NCT03117738|100673413|FG000|Overall Study|Withdrawal by Subject|3|||
33210520|NCT03117738|100673414|FG001|Overall Study|Withdrawal by Subject|1|||
33210521|NCT03117738|100673413|FG000|Overall Study|Lost to Follow-up|1|||
33210522|NCT03117738|100673414|FG001|Overall Study|Lost to Follow-up|4|||
33210523|NCT04988308|100673418|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
33210524|NCT04988308|100673419|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
33210525|NCT04988308|100673420|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
33210526|NCT04988308|100673421|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
33210527|NCT04988308|100673422|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
33210528|NCT04988308|100673423|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
33210529|NCT04988308|100673418|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
33210530|NCT04988308|100673419|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
33210531|NCT04988308|100673420|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
33210532|NCT04988308|100673421|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
33210533|NCT04988308|100673422|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
33210534|NCT04988308|100673423|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
33210535|NCT04988308|100673418|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
33210536|NCT04988308|100673419|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
33210537|NCT04988308|100673420|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
33210538|NCT04988308|100673421|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
33210539|NCT04988308|100673422|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
33210540|NCT04988308|100673423|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
33210541|NCT04988308|100673418|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
33210542|NCT04988308|100673419|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
33210543|NCT04988308|100673420|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
33210544|NCT04988308|100673421|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
33540503|NCT00251758|101878572|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
33540504|NCT00251758|101878573|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
33540505|NCT00251758|101878571|FG000|Overall Study|Lack of Efficacy|3|||
33540506|NCT00251758|101878572|FG001|Overall Study|Lack of Efficacy|0|||
33540507|NCT00251758|101878573|FG002|Overall Study|Lack of Efficacy|0|||
33615360|NCT00434642|102140283|FG001|Blinded Treatment Phase|Physician Decision|27|||
33615361|NCT00434642|102140282|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
33615362|NCT00434642|102140283|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
33210545|NCT04988308|100673422|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
33210546|NCT04988308|100673423|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
33210547|NCT04988308|100673418|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
33210548|NCT04988308|100673419|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
33210549|NCT04988308|100673420|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
33210550|NCT04988308|100673421|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
33210551|NCT04988308|100673422|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
33210552|NCT04988308|100673423|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
33210553|NCT04988308|100673418|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
33406721|NCT00933543|101377710|FG001|Overall Study|Withdrawal by Subject|1|||
33406722|NCT00933543|101377709|FG000|Overall Study|Lack of Efficacy|0|||
33406723|NCT00933543|101377710|FG001|Overall Study|Lack of Efficacy|3|||
33406724|NCT00933543|101377709|FG000|Overall Study|Other|1|||
33406725|NCT00933543|101377710|FG001|Overall Study|Other|1|||
33406726|NCT03922945|101377712|FG000|Overall Study|Adverse Event|1|||
33406727|NCT03922945|101377713|FG001|Overall Study|Adverse Event|1|||
33210554|NCT04988308|100673419|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
33406728|NCT03922945|101377714|FG002|Overall Study|Adverse Event|2|||
33406729|NCT03922945|101377712|FG000|Overall Study|Lost to Follow-up|13|||
33406730|NCT03922945|101377713|FG001|Overall Study|Lost to Follow-up|9|||
33540508|NCT00251758|101878571|FG000|Overall Study|Noncompliant|0|||
33540509|NCT00251758|101878572|FG001|Overall Study|Noncompliant|2|||
33540510|NCT00251758|101878573|FG002|Overall Study|Noncompliant|2|||
33210555|NCT04988308|100673420|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
33210556|NCT04988308|100673421|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
33210557|NCT04988308|100673422|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
33210558|NCT04988308|100673423|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
33210559|NCT04988308|100673418|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
33210560|NCT04988308|100673419|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
33210561|NCT04988308|100673420|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
33210562|NCT04988308|100673421|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
33210563|NCT04988308|100673422|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
33210564|NCT04988308|100673423|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
33210565|NCT04988308|100673418|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
33210566|NCT04988308|100673419|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
33210567|NCT04988308|100673420|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
33210568|NCT04988308|100673421|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
33210569|NCT04988308|100673422|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
33210570|NCT04988308|100673423|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
33210571|NCT04988308|100673418|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
33210572|NCT04988308|100673419|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
33210573|NCT04988308|100673420|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
33210574|NCT04988308|100673421|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
33210575|NCT04988308|100673422|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
33210576|NCT04988308|100673423|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
33210577|NCT02862106|100673424|FG000|Overall Study|Adverse Event|4|||
33210578|NCT02862106|100673425|FG001|Overall Study|Adverse Event|0|||
33210579|NCT02862106|100673424|FG000|Overall Study|Protocol Violation|16|||
33210580|NCT02862106|100673425|FG001|Overall Study|Protocol Violation|1|||
33210581|NCT02862106|100673424|FG000|Overall Study|Lost to Follow-up|15|||
33210582|NCT02862106|100673425|FG001|Overall Study|Lost to Follow-up|5|||
33210583|NCT02862106|100673424|FG000|Overall Study|Withdrawal by Subject|2|||
33210584|NCT02862106|100673425|FG001|Overall Study|Withdrawal by Subject|0|||
33210585|NCT02862106|100673424|FG000|Overall Study|Subjects moved to other city|1|||
33210586|NCT02862106|100673425|FG001|Overall Study|Subjects moved to other city|0|||
33210587|NCT01392560|100673432|FG000|Overall Study|Adverse Event|2|||
33210588|NCT01392560|100673432|FG000|Overall Study|not entered|8|||
33210589|NCT01392560|100673432|FG000|Overall Study|discontinued during placebo run-in|2|||
33210590|NCT01775904|100673433|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
33210591|NCT01775904|100673433|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
33210592|NCT03342638|100673435|FG000|Overall Study|Withdrawal by Subject|1|||
33210593|NCT03342638|100673436|FG001|Overall Study|Withdrawal by Subject|0|||
33210594|NCT03342638|100673435|FG000|Overall Study|Physician Decision|0|||
33210595|NCT03342638|100673436|FG001|Overall Study|Physician Decision|1|||
33210596|NCT01581281|100673438|FG000|Overall Study|Early Study Closure|15|||
33210597|NCT01581281|100673439|FG001|Overall Study|Early Study Closure|6|||
33210598|NCT01581281|100673440|FG002|Overall Study|Early Study Closure|12|||
33406731|NCT03922945|101377714|FG002|Overall Study|Lost to Follow-up|20|||
33406732|NCT03922945|101377712|FG000|Overall Study|Lack of Efficacy|2|||
33406733|NCT03922945|101377713|FG001|Overall Study|Lack of Efficacy|0|||
33406734|NCT03922945|101377714|FG002|Overall Study|Lack of Efficacy|1|||
33406735|NCT03922945|101377712|FG000|Overall Study|Protocol Non-Compliance|0|||
33406736|NCT03922945|101377713|FG001|Overall Study|Protocol Non-Compliance|0|||
33406737|NCT03922945|101377714|FG002|Overall Study|Protocol Non-Compliance|1|||
33210599|NCT02388724|100673441|FG000|Overall Study|Reason not Specified|0|||
33210600|NCT02388724|100673442|FG001|Overall Study|Reason not Specified|1|||
33210601|NCT02388724|100673441|FG000|Overall Study|Major Protocol Deviation|3|||
33210602|NCT02388724|100673442|FG001|Overall Study|Major Protocol Deviation|3|||
33210603|NCT02388724|100673441|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
33210604|NCT02388724|100673442|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
33210605|NCT02388724|100673441|FG000|Overall Study|Voluntary Withdrawal|6|||
33210606|NCT02388724|100673442|FG001|Overall Study|Voluntary Withdrawal|5|||
33210607|NCT02388724|100673441|FG000|Overall Study|Randomized but not Treated|0|||
33210608|NCT02388724|100673442|FG001|Overall Study|Randomized but not Treated|2|||
33210609|NCT01747772|100673443|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
33210610|NCT02119416|100673444|FG000|Overall Study|Protocol Violation|1|||
33210611|NCT02119416|100673445|FG001|Overall Study|Protocol Violation|1|||
33406738|NCT03922945|101377712|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
33406739|NCT03922945|101377713|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
33210612|NCT02119416|100673446|FG002|Overall Study|Protocol Violation|1|||
33210613|NCT02119416|100673444|FG000|Overall Study|wrong pubertal stage|1|||
33406740|NCT03922945|101377714|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
33406741|NCT03922945|101377712|FG000|Overall Study|All Other Personal Reasons|1|||
33406742|NCT03922945|101377713|FG001|Overall Study|All Other Personal Reasons|1|||
33406743|NCT03922945|101377714|FG002|Overall Study|All Other Personal Reasons|2|||
33406744|NCT00157157|101377715|FG000|Overall Study|Withdrawal by Subject|6|||
33406745|NCT00157157|101377715|FG000|Overall Study|Physician Decision|1|||
33406746|NCT00157157|101377715|FG000|Overall Study|Lost to Follow-up|1|||
33406747|NCT00157157|101377715|FG000|Overall Study|Enrolled in another study|1|||
33210614|NCT02119416|100673445|FG001|Overall Study|wrong pubertal stage|0|||
33210615|NCT02119416|100673446|FG002|Overall Study|wrong pubertal stage|1|||
33210616|NCT01300546|100673447|FG000|Overall Study|Withdrawal by Subject|1|||
33343194|NCT04418765|101145666|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
33406748|NCT00157157|101377715|FG000|Overall Study|Met exclusion criteria|1|||
33406749|NCT00157157|101377715|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
33406750|NCT00643006|101377716|FG000|Overall Study|Lost to Follow-up|5|||
33406751|NCT00643006|101377717|FG001|Overall Study|Lost to Follow-up|4|||
33406752|NCT01370499|101377718|FG000|Overall Study|Adverse Event|38|||
33406753|NCT01370499|101377719|FG001|Overall Study|Adverse Event|12|||
33343195|NCT04418765|101145664|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
33343196|NCT04418765|101145665|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
33343197|NCT04418765|101145666|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
33343198|NCT04418765|101145664|FG000|Extension Period (48 Weeks)|Other than specified|0|||
33343199|NCT04418765|101145665|FG001|Extension Period (48 Weeks)|Other than specified|5|||
33343200|NCT04418765|101145666|FG002|Extension Period (48 Weeks)|Other than specified|2|||
33343201|NCT03099707|101145667|FG000|Overall Study|Withdrawal by Subject|0|||
33343202|NCT03099707|101145668|FG001|Overall Study|Withdrawal by Subject|3|||
33343203|NCT03099707|101145667|FG000|Overall Study|Lost to Follow-up|0|||
33343204|NCT03099707|101145668|FG001|Overall Study|Lost to Follow-up|1|||
33343205|NCT03167073|101145670|FG000|Overall Study|Stillbirth|1|||
33343206|NCT03167073|101145671|FG001|Overall Study|Stillbirth|0|||
33343207|NCT00291551|101145672|FG000|Overall Study|Death|7|||
33343208|NCT00291551|101145672|FG000|Overall Study|Withdrawal by Subject|6|||
33343209|NCT04541004|101145682|FG000|Overall Study|Adverse Event|2|||
33343210|NCT00331409|101145683|FG000|Overall Study|Lack of Efficacy|4|||
33343211|NCT02944448|101145686|FG000|Overall Study|Adverse Event|37|||
33343212|NCT02944448|101145687|FG001|Overall Study|Adverse Event|6|||
33343213|NCT02944448|101145686|FG000|Overall Study|Lack of Efficacy|8|||
33343214|NCT02944448|101145687|FG001|Overall Study|Lack of Efficacy|5|||
33343215|NCT02944448|101145686|FG000|Overall Study|Lost to Follow-up|3|||
33343216|NCT02944448|101145687|FG001|Overall Study|Lost to Follow-up|1|||
33343217|NCT02944448|101145686|FG000|Overall Study|Protocol Violation|25|||
33343218|NCT02944448|101145687|FG001|Overall Study|Protocol Violation|7|||
33343219|NCT02944448|101145686|FG000|Overall Study|Withdrawal by Subject|14|||
33343220|NCT02944448|101145687|FG001|Overall Study|Withdrawal by Subject|4|||
33343221|NCT02944448|101145686|FG000|Overall Study|Sponsor did not supply drug in time|0|||
33343222|NCT02944448|101145687|FG001|Overall Study|Sponsor did not supply drug in time|1|||
33343223|NCT02944448|101145686|FG000|Overall Study|Noncompliant with dosing|1|||
33343224|NCT02944448|101145687|FG001|Overall Study|Noncompliant with dosing|0|||
33343225|NCT02944448|101145686|FG000|Overall Study|Abnormal laboratory values|1|||
33343226|NCT02944448|101145687|FG001|Overall Study|Abnormal laboratory values|0|||
33343227|NCT04142983|101145688|FG000|Overall Study|Lost to Follow-up|73|||
33343228|NCT04142983|101145688|FG000|Overall Study|Withdrawal by Subject|10|||
33343229|NCT04142983|101145688|FG000|Overall Study|Physician Decision|1|||
33343230|NCT04142983|101145688|FG000|Overall Study|Adverse Event|1|||
33343231|NCT04142983|101145688|FG000|Overall Study|No longer eligible|4|||
33343232|NCT04142983|101145688|FG000|Overall Study|Screen Failure|10|||
33343233|NCT00330187|101145689|FG000|Overall Study|Lost to Follow-up|12|||
33343234|NCT00330187|101145690|FG001|Overall Study|Lost to Follow-up|13|||
33343235|NCT00330187|101145691|FG002|Overall Study|Lost to Follow-up|14|||
33343236|NCT00330187|101145692|FG003|Overall Study|Lost to Follow-up|10|||
33343237|NCT00330187|101145689|FG000|Overall Study|Withdrawal by Subject|8|||
33343238|NCT00330187|101145690|FG001|Overall Study|Withdrawal by Subject|5|||
33406754|NCT01370499|101377718|FG000|Overall Study|Lack of Efficacy|4|||
33406755|NCT01370499|101377719|FG001|Overall Study|Lack of Efficacy|2|||
33406756|NCT01370499|101377718|FG000|Overall Study|Lost to Follow-up|2|||
33406757|NCT01370499|101377719|FG001|Overall Study|Lost to Follow-up|1|||
33343239|NCT00330187|101145691|FG002|Overall Study|Withdrawal by Subject|4|||
33343240|NCT00330187|101145692|FG003|Overall Study|Withdrawal by Subject|4|||
33343241|NCT01925209|101145693|FG000|Treatment Epoch|Physician Decision|1|||
33343242|NCT01925209|101145694|FG001|Treatment Epoch|Physician Decision|0|||
33343243|NCT01925209|101145695|FG002|Treatment Epoch|Physician Decision|0|||
33343244|NCT01925209|101145696|FG003|Treatment Epoch|Physician Decision|0|||
33343245|NCT01925209|101145693|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
33406758|NCT01370499|101377718|FG000|Overall Study|Physician Decision|3|||
33406759|NCT01370499|101377719|FG001|Overall Study|Physician Decision|3|||
33406760|NCT01370499|101377718|FG000|Overall Study|Protocol Violation|5|||
33406761|NCT01370499|101377719|FG001|Overall Study|Protocol Violation|4|||
33343246|NCT01925209|101145694|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
33343247|NCT01925209|101145695|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
33540511|NCT00251758|101878571|FG000|Overall Study|Pregnancy|0|||
33343248|NCT01925209|101145696|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
33343249|NCT01925209|101145693|FG000|Treatment Epoch|Death|1|||
33343250|NCT01925209|101145694|FG001|Treatment Epoch|Death|0|||
33343251|NCT01925209|101145695|FG002|Treatment Epoch|Death|0|||
33343252|NCT01925209|101145696|FG003|Treatment Epoch|Death|0|||
33343253|NCT01925209|101145693|FG000|Treatment Epoch|Protocol deviation|0|||
33343254|NCT01925209|101145694|FG001|Treatment Epoch|Protocol deviation|0|||
33343255|NCT01925209|101145695|FG002|Treatment Epoch|Protocol deviation|1|||
33343256|NCT01925209|101145696|FG003|Treatment Epoch|Protocol deviation|1|||
33343257|NCT01925209|101145693|FG000|Treatment Epoch|Withdrawal by Subject|4|||
33343258|NCT01925209|101145694|FG001|Treatment Epoch|Withdrawal by Subject|3|||
33406762|NCT01370499|101377718|FG000|Overall Study|Withdrawal by Subject|18|||
33540512|NCT00251758|101878572|FG001|Overall Study|Pregnancy|1|||
33540513|NCT00251758|101878573|FG002|Overall Study|Pregnancy|0|||
33540514|NCT00251758|101878571|FG000|Overall Study|Per Subject Request|0|||
33540515|NCT00251758|101878572|FG001|Overall Study|Per Subject Request|0|||
33540516|NCT00251758|101878573|FG002|Overall Study|Per Subject Request|1|||
33540517|NCT00251758|101878571|FG000|Overall Study|Per Investigator Request|1|||
33540518|NCT00251758|101878572|FG001|Overall Study|Per Investigator Request|0|||
33540519|NCT00251758|101878573|FG002|Overall Study|Per Investigator Request|0|||
33540520|NCT00853762|101878574|FG000|Overall Study|Premature Termination|16|||
33540521|NCT00853762|101878575|FG001|Overall Study|Premature Termination|15|||
33540522|NCT00853762|101878576|FG002|Overall Study|Premature Termination|14|||
33540523|NCT00853762|101878577|FG003|Overall Study|Premature Termination|21|||
33540524|NCT00853762|101878574|FG000|Overall Study|Protocol Violation|0|||
33540525|NCT00853762|101878575|FG001|Overall Study|Protocol Violation|0|||
33540526|NCT00853762|101878576|FG002|Overall Study|Protocol Violation|0|||
33540527|NCT00853762|101878577|FG003|Overall Study|Protocol Violation|1|||
33540528|NCT00853762|101878574|FG000|Overall Study|Withdrawal by Subject|0|||
33540529|NCT00853762|101878575|FG001|Overall Study|Withdrawal by Subject|0|||
33540530|NCT00853762|101878576|FG002|Overall Study|Withdrawal by Subject|1|||
33540531|NCT00853762|101878577|FG003|Overall Study|Withdrawal by Subject|0|||
33210617|NCT01300546|100673448|FG001|Overall Study|Withdrawal by Subject|0|||
33210618|NCT01300546|100673447|FG000|Overall Study|Lost to Follow-up|0|||
33210619|NCT01300546|100673448|FG001|Overall Study|Lost to Follow-up|2|||
33210620|NCT01300546|100673447|FG000|Overall Study|Lack of Efficacy|0|||
33210621|NCT01300546|100673448|FG001|Overall Study|Lack of Efficacy|3|||
33210622|NCT01300546|100673447|FG000|Overall Study|Adverse Event|0|||
33210623|NCT01300546|100673448|FG001|Overall Study|Adverse Event|1|||
33210624|NCT04393441|100673449|FG000|Overall Study|Adverse Event|0|||
33210625|NCT04393441|100673450|FG001|Overall Study|Adverse Event|3|||
33210626|NCT04393441|100673449|FG000|Overall Study|Withdrawal by Subject|5|||
33210627|NCT04393441|100673450|FG001|Overall Study|Withdrawal by Subject|7|||
33210628|NCT04393441|100673449|FG000|Overall Study|Lost to Follow-up|0|||
33210629|NCT04393441|100673450|FG001|Overall Study|Lost to Follow-up|2|||
33210630|NCT04393441|100673449|FG000|Overall Study|Protocol Deviation|2|||
33210631|NCT04393441|100673450|FG001|Overall Study|Protocol Deviation|1|||
33210632|NCT04393441|100673449|FG000|Overall Study|Reason not Specified|1|||
33210633|NCT04393441|100673450|FG001|Overall Study|Reason not Specified|1|||
33210634|NCT00657618|100673451|FG000|Overall Study|Adverse Event|32|||
33210635|NCT00657618|100673451|FG000|Overall Study|Withdrawal by Subject|8|||
33210636|NCT00657618|100673451|FG000|Overall Study|negative for leishmaniasis|2|||
33210637|NCT00657618|100673451|FG000|Overall Study|didn't start due to schedule conflicts|1|||
33210638|NCT01262651|100673452|FG000|Overall Study|Adverse Event|40|||
33210639|NCT01262651|100673453|FG001|Overall Study|Adverse Event|35|||
33210640|NCT01262651|100673452|FG000|Overall Study|Withdrawal by Subject|15|||
33210641|NCT01262651|100673453|FG001|Overall Study|Withdrawal by Subject|11|||
33210642|NCT01262651|100673452|FG000|Overall Study|Withdrawal by Investigator|2|||
33540532|NCT00853762|101878574|FG000|Overall Study|Other|0|||
33210643|NCT01262651|100673453|FG001|Overall Study|Withdrawal by Investigator|2|||
33343259|NCT01925209|101145695|FG002|Treatment Epoch|Withdrawal by Subject|3|||
33343260|NCT01925209|101145696|FG003|Treatment Epoch|Withdrawal by Subject|2|||
33343261|NCT01925209|101145693|FG000|Treatment Epoch|Adverse Event|3|||
33540533|NCT00853762|101878575|FG001|Overall Study|Other|2|||
33540534|NCT00853762|101878576|FG002|Overall Study|Other|0|||
33540535|NCT00853762|101878577|FG003|Overall Study|Other|0|||
33540536|NCT00853762|101878574|FG000|Overall Study|Randomised but not Treated|0|||
33540537|NCT00853762|101878575|FG001|Overall Study|Randomised but not Treated|2|||
33540538|NCT00853762|101878576|FG002|Overall Study|Randomised but not Treated|2|||
33540539|NCT00853762|101878577|FG003|Overall Study|Randomised but not Treated|0|||
33540540|NCT01718483|101878578|FG000|Overall Study|Withdrawal by Subject|14|||
33540541|NCT01718483|101878579|FG001|Overall Study|Withdrawal by Subject|12|||
33540542|NCT01718483|101878578|FG000|Overall Study|Adverse Event|5|||
33540543|NCT01718483|101878579|FG001|Overall Study|Adverse Event|12|||
33540544|NCT01718483|101878578|FG000|Overall Study|Lost to Follow-up|8|||
33540545|NCT01718483|101878579|FG001|Overall Study|Lost to Follow-up|3|||
33540546|NCT01718483|101878578|FG000|Overall Study|Protocol Violation|4|||
33210644|NCT01262651|100673452|FG000|Overall Study|Met Withdrawal Criteria|1|||
33540547|NCT01718483|101878579|FG001|Overall Study|Protocol Violation|2|||
33540548|NCT01718483|101878578|FG000|Overall Study|Other|1|||
33540549|NCT01718483|101878579|FG001|Overall Study|Other|4|||
33343262|NCT01925209|101145694|FG001|Treatment Epoch|Adverse Event|5|||
33343263|NCT01925209|101145695|FG002|Treatment Epoch|Adverse Event|3|||
33343264|NCT01925209|101145696|FG003|Treatment Epoch|Adverse Event|1|||
33540550|NCT01718483|101878578|FG000|Overall Study|Pregnancy|1|||
33343265|NCT01925209|101145693|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
33343266|NCT01925209|101145694|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
33343267|NCT01925209|101145695|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
33343268|NCT01925209|101145696|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
33343269|NCT01925209|101145693|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
33343270|NCT01925209|101145694|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
33343271|NCT01925209|101145695|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
33343272|NCT01925209|101145696|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
33343273|NCT01925209|101145693|FG000|Follow-up|Adverse Event|1|||
33343274|NCT01925209|101145694|FG001|Follow-up|Adverse Event|4|||
33343275|NCT01925209|101145695|FG002|Follow-up|Adverse Event|0|||
33343276|NCT01925209|101145696|FG003|Follow-up|Adverse Event|1|||
33343277|NCT01925209|101145693|FG000|Follow-up|Physician Decision|0|||
33343278|NCT01925209|101145694|FG001|Follow-up|Physician Decision|0|||
33343279|NCT01925209|101145695|FG002|Follow-up|Physician Decision|1|||
33343280|NCT01925209|101145696|FG003|Follow-up|Physician Decision|0|||
33343281|NCT01925209|101145693|FG000|Follow-up|Non-compliance with study treatment|0|||
33343282|NCT01925209|101145694|FG001|Follow-up|Non-compliance with study treatment|0|||
33343283|NCT01925209|101145695|FG002|Follow-up|Non-compliance with study treatment|0|||
33343284|NCT01925209|101145696|FG003|Follow-up|Non-compliance with study treatment|1|||
33343285|NCT01925209|101145693|FG000|Follow-up|Withdrawal by Subject|0|||
33343286|NCT01925209|101145694|FG001|Follow-up|Withdrawal by Subject|2|||
33343287|NCT01925209|101145695|FG002|Follow-up|Withdrawal by Subject|0|||
33343288|NCT01925209|101145696|FG003|Follow-up|Withdrawal by Subject|2|||
33343289|NCT00272987|101145697|FG000|Overall Study|Adverse Event|1|||
33343290|NCT00272987|101145698|FG001|Overall Study|Adverse Event|0|||
33343291|NCT00272987|101145699|FG002|Overall Study|Adverse Event|0|||
33343292|NCT00272987|101145697|FG000|Overall Study|Lost to Follow-up|3|||
33343293|NCT00272987|101145698|FG001|Overall Study|Lost to Follow-up|1|||
33343294|NCT00272987|101145699|FG002|Overall Study|Lost to Follow-up|1|||
33343295|NCT00272987|101145697|FG000|Overall Study|Withdrawal by Subject|1|||
33343296|NCT00272987|101145698|FG001|Overall Study|Withdrawal by Subject|0|||
33343297|NCT00272987|101145699|FG002|Overall Study|Withdrawal by Subject|3|||
33343298|NCT00272987|101145697|FG000|Overall Study|Sponsor Terminated study|0|||
33343299|NCT00272987|101145698|FG001|Overall Study|Sponsor Terminated study|1|||
33343300|NCT00272987|101145699|FG002|Overall Study|Sponsor Terminated study|1|||
33343301|NCT00272987|101145697|FG000|Overall Study|Disease progression|1|||
33343302|NCT00272987|101145698|FG001|Overall Study|Disease progression|1|||
33343303|NCT00272987|101145699|FG002|Overall Study|Disease progression|2|||
33343304|NCT00272987|101145697|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
33343305|NCT00272987|101145698|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
33343306|NCT00272987|101145699|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
33343307|NCT00272987|101145697|FG000|Overall Study|Death|1|||
33343308|NCT00272987|101145698|FG001|Overall Study|Death|0|||
33343309|NCT00272987|101145699|FG002|Overall Study|Death|0|||
33343310|NCT04660643|101145700|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
33343311|NCT04660643|101145701|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
33343312|NCT04660643|101145702|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
33343313|NCT04660643|101145700|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
33343314|NCT04660643|101145701|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
33343315|NCT04660643|101145702|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
33343316|NCT04660643|101145700|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
33540551|NCT01718483|101878579|FG001|Overall Study|Pregnancy|1|||
33540552|NCT01718483|101878578|FG000|Overall Study|Lack of Efficacy|1|||
33540553|NCT01718483|101878579|FG001|Overall Study|Lack of Efficacy|0|||
33540554|NCT00323063|101878586|FG000|Overall Study|Adverse Event|1|||
33540555|NCT00323063|101878587|FG001|Overall Study|Adverse Event|0|||
33540556|NCT00323063|101878586|FG000|Overall Study|brain mets discovered prior to treatment|1|||
33540557|NCT00323063|101878587|FG001|Overall Study|brain mets discovered prior to treatment|0|||
33540558|NCT01317641|101878588|FG000|Overall Study|Not treated|0|||
33540559|NCT01317641|101878589|FG001|Overall Study|Not treated|0|||
33540560|NCT01317641|101878590|FG002|Overall Study|Not treated|0|||
33540561|NCT01317641|101878591|FG003|Overall Study|Not treated|0|||
33540562|NCT01317641|101878592|FG004|Overall Study|Not treated|0|||
33343317|NCT04660643|101145701|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
33343318|NCT04660643|101145702|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
33343319|NCT04660643|101145700|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
33540563|NCT01317641|101878593|FG005|Overall Study|Not treated|0|||
33343320|NCT04660643|101145701|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
33343321|NCT04660643|101145702|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
33343322|NCT04660643|101145700|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
33343323|NCT04660643|101145701|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
33540564|NCT01317641|101878594|FG006|Overall Study|Not treated|0|||
33540565|NCT01317641|101878595|FG007|Overall Study|Not treated|1|||
33540566|NCT01317641|101878596|FG008|Overall Study|Not treated|1|||
33540567|NCT01317641|101878588|FG000|Overall Study|Adverse Event|0|||
33406763|NCT01370499|101377719|FG001|Overall Study|Withdrawal by Subject|7|||
33406764|NCT01370499|101377718|FG000|Overall Study|Sponsor Decision|41|||
33406765|NCT01370499|101377719|FG001|Overall Study|Sponsor Decision|15|||
33406766|NCT02030067|101377721|FG000|Overall Study|Disease Progression|1|||
33406767|NCT02030067|101377722|FG001|Overall Study|Disease Progression|1|||
33406768|NCT02030067|101377723|FG002|Overall Study|Disease Progression|2|||
33406769|NCT02030067|101377724|FG003|Overall Study|Disease Progression|2|||
33406770|NCT02030067|101377725|FG004|Overall Study|Disease Progression|3|||
33406771|NCT02030067|101377726|FG005|Overall Study|Disease Progression|2|||
33406772|NCT02030067|101377727|FG006|Overall Study|Disease Progression|3|||
33406773|NCT02030067|101377728|FG007|Overall Study|Disease Progression|3|||
33406774|NCT02030067|101377729|FG008|Overall Study|Disease Progression|4|||
33615363|NCT00434642|102140282|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
33615364|NCT00434642|102140283|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
33615365|NCT00434642|102140282|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
33615366|NCT00434642|102140283|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
33615367|NCT00434642|102140282|FG000|Open-label Treatment Phase|Adverse Event|0|||
33615368|NCT00434642|102140283|FG001|Open-label Treatment Phase|Adverse Event|5|||
33615369|NCT00434642|102140282|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
33615370|NCT00434642|102140283|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
33615371|NCT00992459|102140284|FG000|Overall Study|Withdrawal by Subject|0|||
33615372|NCT00992459|102140285|FG001|Overall Study|Withdrawal by Subject|1|||
33615373|NCT00992459|102140284|FG000|Overall Study|Adverse Event|1|||
33615374|NCT00992459|102140285|FG001|Overall Study|Adverse Event|0|||
33615375|NCT01702246|102140286|FG000|Overall Study|Lost to Follow-up|2|||
33615376|NCT01702246|102140286|FG000|Overall Study|Withdrawal by Subject|2|||
33615377|NCT01702246|102140286|FG000|Overall Study|Physician Decision|1|||
33615378|NCT03250182|102140289|FG000|Overall Study|Withdrawal by Subject|1|||
33615379|NCT01178099|102140292|FG000|Overall Study|Physician Decision|0|||
33615380|NCT01178099|102140293|FG001|Overall Study|Physician Decision|1|||
33615381|NCT01858766|102140296|FG000|Overall Study|Randomized but Never Treated|0|||
33615382|NCT01858766|102140297|FG001|Overall Study|Randomized but Never Treated|0|||
33615383|NCT01858766|102140298|FG002|Overall Study|Randomized but Never Treated|0|||
33540568|NCT01317641|101878589|FG001|Overall Study|Adverse Event|1|||
33615384|NCT01858766|102140299|FG003|Overall Study|Randomized but Never Treated|0|||
33615385|NCT01858766|102140300|FG004|Overall Study|Randomized but Never Treated|0|||
33615386|NCT01858766|102140301|FG005|Overall Study|Randomized but Never Treated|1|||
33615387|NCT01858766|102140302|FG006|Overall Study|Randomized but Never Treated|0|||
33210645|NCT01262651|100673453|FG001|Overall Study|Met Withdrawal Criteria|0|||
33343324|NCT04660643|101145702|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
33343325|NCT04660643|101145700|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
33343326|NCT04660643|101145701|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
33343327|NCT04660643|101145702|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
33343328|NCT04660643|101145700|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
33343329|NCT04660643|101145701|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
33343330|NCT04660643|101145702|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
33343331|NCT04660643|101145700|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
33343332|NCT04660643|101145701|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
33343333|NCT04660643|101145702|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
33343334|NCT04660643|101145700|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
33343335|NCT04660643|101145701|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
33343336|NCT04660643|101145702|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
33343337|NCT04660643|101145700|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
33343338|NCT04660643|101145701|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
33343339|NCT04660643|101145702|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
33343340|NCT04660643|101145700|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
33343341|NCT04660643|101145701|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
33343342|NCT04660643|101145702|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
33343343|NCT04660643|101145700|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
33343344|NCT04660643|101145701|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
33343345|NCT04660643|101145702|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
33343346|NCT04660643|101145700|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
33343347|NCT04660643|101145701|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
33540569|NCT01317641|101878590|FG002|Overall Study|Adverse Event|0|||
33540570|NCT01317641|101878591|FG003|Overall Study|Adverse Event|1|||
33343348|NCT04660643|101145702|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
33343349|NCT04660643|101145700|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
33343350|NCT04660643|101145701|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
33343351|NCT04660643|101145702|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
33343352|NCT04660643|101145700|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
33343353|NCT04660643|101145701|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
33343354|NCT04660643|101145702|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
33343355|NCT04660643|101145700|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
33343356|NCT04660643|101145701|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
33343357|NCT04660643|101145702|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
33343358|NCT01882907|101145703|FG000|Overall Study|Adverse Event|3|||
33343359|NCT01882907|101145704|FG001|Overall Study|Adverse Event|1|||
33343360|NCT01882907|101145703|FG000|Overall Study|Lack of Efficacy|0|||
33343361|NCT01882907|101145704|FG001|Overall Study|Lack of Efficacy|3|||
33343362|NCT01882907|101145703|FG000|Overall Study|Lost to Follow-up|1|||
33343363|NCT01882907|101145704|FG001|Overall Study|Lost to Follow-up|4|||
33540571|NCT01317641|101878592|FG004|Overall Study|Adverse Event|0|||
33540572|NCT01317641|101878593|FG005|Overall Study|Adverse Event|0|||
33540573|NCT01317641|101878594|FG006|Overall Study|Adverse Event|2|||
33540574|NCT01317641|101878595|FG007|Overall Study|Adverse Event|1|||
33540575|NCT01317641|101878596|FG008|Overall Study|Adverse Event|0|||
33540576|NCT01317641|101878588|FG000|Overall Study|Protocol Violation|1|||
33540577|NCT01317641|101878589|FG001|Overall Study|Protocol Violation|0|||
33540578|NCT01317641|101878590|FG002|Overall Study|Protocol Violation|0|||
33540579|NCT01317641|101878591|FG003|Overall Study|Protocol Violation|0|||
33210646|NCT00234065|100673454|FG000|Overall Study|Adverse Event|268|||
33343364|NCT01882907|101145703|FG000|Overall Study|Protocol Violation|10|||
33343365|NCT01882907|101145704|FG001|Overall Study|Protocol Violation|14|||
33343366|NCT01882907|101145703|FG000|Overall Study|Withdrawal by Subject|0|||
33343367|NCT01882907|101145704|FG001|Overall Study|Withdrawal by Subject|6|||
33343368|NCT02499029|101145710|FG000|Overall Study|Lost to Follow-up|2|||
33343369|NCT02499029|101145711|FG001|Overall Study|Lost to Follow-up|2|||
33343370|NCT02499029|101145710|FG000|Overall Study|Physician Decision|2|||
33343371|NCT02499029|101145711|FG001|Overall Study|Physician Decision|1|||
33343372|NCT02499029|101145710|FG000|Overall Study|Death|1|||
33210647|NCT00234065|100673455|FG001|Overall Study|Adverse Event|166|||
33343373|NCT02499029|101145711|FG001|Overall Study|Death|0|||
33343374|NCT00763321|101145716|FG000|Open-label Period|Adverse Event|24|||
33540580|NCT01317641|101878592|FG004|Overall Study|Protocol Violation|0|||
33540581|NCT01317641|101878593|FG005|Overall Study|Protocol Violation|0|||
33540582|NCT01317641|101878594|FG006|Overall Study|Protocol Violation|0|||
33540583|NCT01317641|101878595|FG007|Overall Study|Protocol Violation|0|||
33615388|NCT01858766|102140303|FG007|Overall Study|Randomized but Never Treated|0|||
33615389|NCT01858766|102140304|FG008|Overall Study|Randomized but Never Treated|0|||
33615390|NCT01858766|102140305|FG009|Overall Study|Randomized but Never Treated|0|||
33615391|NCT01858766|102140306|FG010|Overall Study|Randomized but Never Treated|0|||
33615392|NCT01858766|102140307|FG011|Overall Study|Randomized but Never Treated|0|||
33615393|NCT01858766|102140308|FG012|Overall Study|Randomized but Never Treated|0|||
33615394|NCT01858766|102140309|FG013|Overall Study|Randomized but Never Treated|0|||
33615395|NCT01858766|102140310|FG014|Overall Study|Randomized but Never Treated|0|||
33615396|NCT01858766|102140311|FG015|Overall Study|Randomized but Never Treated|0|||
33615397|NCT01858766|102140312|FG016|Overall Study|Randomized but Never Treated|0|||
33615398|NCT01858766|102140313|FG017|Overall Study|Randomized but Never Treated|1|||
33210648|NCT00234065|100673454|FG000|Overall Study|Withdrawal by Subject|73|||
33210649|NCT00234065|100673455|FG001|Overall Study|Withdrawal by Subject|56|||
33210650|NCT00234065|100673454|FG000|Overall Study|Physician Decision|23|||
33210651|NCT00234065|100673455|FG001|Overall Study|Physician Decision|22|||
33343375|NCT00763321|101145717|FG001|Open-label Period|Adverse Event|0|||
33343376|NCT00763321|101145718|FG002|Open-label Period|Adverse Event|0|||
33343377|NCT00763321|101145716|FG000|Open-label Period|Lost to Follow-up|14|||
33343378|NCT00763321|101145717|FG001|Open-label Period|Lost to Follow-up|0|||
33343379|NCT00763321|101145718|FG002|Open-label Period|Lost to Follow-up|0|||
33343380|NCT00763321|101145716|FG000|Open-label Period|Withdrawal by Subject|7|||
33343381|NCT00763321|101145717|FG001|Open-label Period|Withdrawal by Subject|0|||
33343382|NCT00763321|101145718|FG002|Open-label Period|Withdrawal by Subject|0|||
33343383|NCT00763321|101145716|FG000|Open-label Period|Subject noncompliant|7|||
33343384|NCT00763321|101145717|FG001|Open-label Period|Subject noncompliant|0|||
33343385|NCT00763321|101145718|FG002|Open-label Period|Subject noncompliant|0|||
33540584|NCT01317641|101878596|FG008|Overall Study|Protocol Violation|0|||
33540585|NCT01317641|101878588|FG000|Overall Study|Disease progression|0|||
33540586|NCT01317641|101878589|FG001|Overall Study|Disease progression|0|||
33540587|NCT01317641|101878590|FG002|Overall Study|Disease progression|0|||
33540588|NCT01317641|101878591|FG003|Overall Study|Disease progression|0|||
33540589|NCT01317641|101878592|FG004|Overall Study|Disease progression|0|||
33540590|NCT01317641|101878593|FG005|Overall Study|Disease progression|0|||
33540591|NCT01317641|101878594|FG006|Overall Study|Disease progression|0|||
33540592|NCT01317641|101878595|FG007|Overall Study|Disease progression|3|||
33540593|NCT01317641|101878596|FG008|Overall Study|Disease progression|4|||
33540594|NCT01317641|101878588|FG000|Overall Study|Withdrawal by Subject|0|||
33540595|NCT01317641|101878589|FG001|Overall Study|Withdrawal by Subject|0|||
33540596|NCT01317641|101878590|FG002|Overall Study|Withdrawal by Subject|0|||
33540597|NCT01317641|101878591|FG003|Overall Study|Withdrawal by Subject|0|||
33540598|NCT01317641|101878592|FG004|Overall Study|Withdrawal by Subject|0|||
33540599|NCT01317641|101878593|FG005|Overall Study|Withdrawal by Subject|0|||
33540600|NCT01317641|101878594|FG006|Overall Study|Withdrawal by Subject|1|||
33540601|NCT01317641|101878595|FG007|Overall Study|Withdrawal by Subject|0|||
33540602|NCT01317641|101878596|FG008|Overall Study|Withdrawal by Subject|0|||
33540603|NCT01586195|101878597|FG000|Overall Study|Death|11|||
33615399|NCT01858766|102140314|FG018|Overall Study|Randomized but Never Treated|0|||
33615400|NCT01858766|102140296|FG000|Overall Study|Death|0|||
33615401|NCT01858766|102140297|FG001|Overall Study|Death|0|||
33615402|NCT01858766|102140298|FG002|Overall Study|Death|1|||
33210652|NCT00234065|100673454|FG000|Overall Study|Not Classified|111|||
33210653|NCT00234065|100673455|FG001|Overall Study|Not Classified|112|||
33210654|NCT03969719|100673456|FG000|Overall Study|Other reasons not specified|1|||
33210655|NCT03969719|100673457|FG001|Overall Study|Other reasons not specified|1|||
33210656|NCT03969719|100673458|FG002|Overall Study|Other reasons not specified|3|||
33210657|NCT03969719|100673456|FG000|Overall Study|Withdrawal by Subject|2|||
33210658|NCT03969719|100673457|FG001|Overall Study|Withdrawal by Subject|3|||
33343386|NCT00763321|101145716|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
33343387|NCT00763321|101145717|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
33343388|NCT00763321|101145718|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
33343389|NCT00763321|101145716|FG000|Open-label Period|Lack of Efficacy|2|||
33615403|NCT01858766|102140299|FG003|Overall Study|Death|0|||
33615404|NCT01858766|102140300|FG004|Overall Study|Death|0|||
33343390|NCT00763321|101145717|FG001|Open-label Period|Lack of Efficacy|0|||
33343391|NCT00763321|101145718|FG002|Open-label Period|Lack of Efficacy|0|||
33540604|NCT01586195|101878597|FG000|Overall Study|Withdrawal of Consent|5|||
33615405|NCT01858766|102140301|FG005|Overall Study|Death|0|||
33210659|NCT03969719|100673458|FG002|Overall Study|Withdrawal by Subject|2|||
33540605|NCT01586195|101878597|FG000|Overall Study|Started new anti-melanoma therapy|1|||
33540606|NCT01586195|101878597|FG000|Overall Study|Reason not specified|9|||
33540607|NCT00947544|101878602|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
33540608|NCT00947544|101878603|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
33615406|NCT01858766|102140302|FG006|Overall Study|Death|0|||
33615407|NCT01858766|102140303|FG007|Overall Study|Death|0|||
33615408|NCT01858766|102140304|FG008|Overall Study|Death|0|||
33210660|NCT03969719|100673456|FG000|Overall Study|Protocol Violation|1|||
33210661|NCT03969719|100673457|FG001|Overall Study|Protocol Violation|2|||
33210662|NCT03969719|100673458|FG002|Overall Study|Protocol Violation|0|||
33210663|NCT03969719|100673456|FG000|Overall Study|Adverse Event|0|||
33210664|NCT03969719|100673457|FG001|Overall Study|Adverse Event|2|||
33210665|NCT03969719|100673458|FG002|Overall Study|Adverse Event|0|||
33210666|NCT03969719|100673456|FG000|Overall Study|Lost to Follow-up|0|||
33210667|NCT03969719|100673457|FG001|Overall Study|Lost to Follow-up|1|||
33210668|NCT03969719|100673458|FG002|Overall Study|Lost to Follow-up|0|||
33210669|NCT02015676|100673459|FG000|Overall Study|Adverse Event|2|||
33210670|NCT02015676|100673460|FG001|Overall Study|Adverse Event|18|||
33210671|NCT02015676|100673461|FG002|Overall Study|Adverse Event|0|||
33210672|NCT02015676|100673459|FG000|Overall Study|Lack of Efficacy|2|||
33210673|NCT02015676|100673460|FG001|Overall Study|Lack of Efficacy|4|||
33210674|NCT02015676|100673461|FG002|Overall Study|Lack of Efficacy|0|||
33210675|NCT02015676|100673459|FG000|Overall Study|Protocol Violation|1|||
33210676|NCT02015676|100673460|FG001|Overall Study|Protocol Violation|0|||
33210677|NCT02015676|100673461|FG002|Overall Study|Protocol Violation|0|||
33210678|NCT02015676|100673459|FG000|Overall Study|Withdrawal by Subject|1|||
33210679|NCT02015676|100673460|FG001|Overall Study|Withdrawal by Subject|7|||
33210680|NCT02015676|100673461|FG002|Overall Study|Withdrawal by Subject|1|||
33210681|NCT02015676|100673459|FG000|Overall Study|Administrative reasons|0|||
33210682|NCT02015676|100673460|FG001|Overall Study|Administrative reasons|3|||
33210683|NCT02015676|100673461|FG002|Overall Study|Administrative reasons|1|||
33210684|NCT02015676|100673459|FG000|Overall Study|Death|0|||
33210685|NCT02015676|100673460|FG001|Overall Study|Death|1|||
33210686|NCT02015676|100673461|FG002|Overall Study|Death|0|||
33210687|NCT02015676|100673459|FG000|Overall Study|Disease progression|3|||
33210688|NCT02015676|100673460|FG001|Overall Study|Disease progression|1|||
33210689|NCT02015676|100673461|FG002|Overall Study|Disease progression|1|||
33210690|NCT00092131|100673464|FG000|Treatment Period I|Adverse Event|1|||
33210691|NCT00092131|100673465|FG001|Treatment Period I|Adverse Event|0|||
33210692|NCT00092131|100673464|FG000|Treatment Period II|Adverse Event|0|||
33210693|NCT00092131|100673465|FG001|Treatment Period II|Adverse Event|1|||
33210694|NCT04391023|100673470|FG000|Overall Study|Withdrawal by Subject|2|||
33343392|NCT00763321|101145716|FG000|Open-label Period|Other|4|||
33343393|NCT00763321|101145717|FG001|Open-label Period|Other|0|||
33343394|NCT00763321|101145718|FG002|Open-label Period|Other|0|||
33343395|NCT00763321|101145716|FG000|Double-blind Period|Lack of Efficacy|0|||
33540609|NCT04076917|101878604|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
33540610|NCT04076917|101878604|FG000|Overall Study|Study closure|13|||
33540611|NCT04076917|101878604|FG000|Overall Study|Physician Decision|3|||
33540612|NCT04076917|101878604|FG000|Overall Study|Death|1|||
33540613|NCT04076917|101878604|FG000|Overall Study|Lost to Follow-up|1|||
33540614|NCT04076917|101878604|FG000|Overall Study|Withdrawal by Subject|1|||
33540615|NCT04076917|101878604|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
33540616|NCT00296517|101878607|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
33540617|NCT00296517|101878608|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
33540618|NCT00296517|101878607|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
33540619|NCT00296517|101878608|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
33540620|NCT00296517|101878607|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
33540621|NCT00296517|101878608|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
33540622|NCT00296517|101878607|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
33540623|NCT00296517|101878608|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
33210695|NCT04391023|100673471|FG001|Overall Study|Withdrawal by Subject|2|||
33210696|NCT00937924|100673474|FG000|Overall Study|Lost to Follow-up|44|||
33343396|NCT00763321|101145717|FG001|Double-blind Period|Lack of Efficacy|9|||
33540624|NCT00296517|101878607|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
33343397|NCT00763321|101145718|FG002|Double-blind Period|Lack of Efficacy|17|||
33343398|NCT00763321|101145716|FG000|Double-blind Period|Adverse Event|0|||
33343399|NCT00763321|101145717|FG001|Double-blind Period|Adverse Event|4|||
33343400|NCT00763321|101145718|FG002|Double-blind Period|Adverse Event|4|||
33343401|NCT00763321|101145716|FG000|Double-blind Period|Lost to Follow-up|0|||
33343402|NCT00763321|101145717|FG001|Double-blind Period|Lost to Follow-up|4|||
33210697|NCT00937924|100673475|FG001|Overall Study|Lost to Follow-up|44|||
33210698|NCT00937924|100673476|FG002|Overall Study|Lost to Follow-up|41|||
33210699|NCT03325712|100673481|FG000|Overall Study|Protocol Violation|0|||
33210700|NCT03325712|100673482|FG001|Overall Study|Protocol Violation|0|||
33343403|NCT00763321|101145718|FG002|Double-blind Period|Lost to Follow-up|2|||
33343404|NCT00763321|101145716|FG000|Double-blind Period|Withdrawal by Subject|0|||
33343405|NCT00763321|101145717|FG001|Double-blind Period|Withdrawal by Subject|2|||
33343406|NCT00763321|101145718|FG002|Double-blind Period|Withdrawal by Subject|3|||
33343407|NCT00763321|101145716|FG000|Double-blind Period|Other|0|||
33343408|NCT00763321|101145717|FG001|Double-blind Period|Other|2|||
33343409|NCT00763321|101145718|FG002|Double-blind Period|Other|3|||
33343410|NCT00624520|101145719|FG000|Overall Study|Withdrawal by Subject|12|||
33343411|NCT00624520|101145720|FG001|Overall Study|Withdrawal by Subject|7|||
33343412|NCT00624520|101145719|FG000|Overall Study|Death|0|||
33343413|NCT00624520|101145720|FG001|Overall Study|Death|1|||
33343414|NCT01791855|101145721|FG000|Overall Study|Adverse Event|0|||
33343415|NCT01791855|101145722|FG001|Overall Study|Adverse Event|0|||
33343416|NCT01791855|101145723|FG002|Overall Study|Adverse Event|0|||
33343417|NCT01791855|101145724|FG003|Overall Study|Adverse Event|1|||
33343418|NCT01791855|101145721|FG000|Overall Study|Randomized, not treated|0|||
33210701|NCT03325712|100673483|FG002|Overall Study|Protocol Violation|0|||
33210702|NCT03325712|100673484|FG003|Overall Study|Protocol Violation|0|||
33210703|NCT03325712|100673485|FG004|Overall Study|Protocol Violation|1|||
33210704|NCT03325712|100673486|FG005|Overall Study|Protocol Violation|0|||
33210705|NCT03325712|100673487|FG006|Overall Study|Protocol Violation|0|||
33210706|NCT03325712|100673488|FG007|Overall Study|Protocol Violation|0|||
33210707|NCT03325712|100673481|FG000|Overall Study|Adverse Event|0|||
33210708|NCT03325712|100673482|FG001|Overall Study|Adverse Event|0|||
33210709|NCT03325712|100673483|FG002|Overall Study|Adverse Event|0|||
33210710|NCT03325712|100673484|FG003|Overall Study|Adverse Event|0|||
33210711|NCT03325712|100673485|FG004|Overall Study|Adverse Event|1|||
33210712|NCT03325712|100673486|FG005|Overall Study|Adverse Event|0|||
33210713|NCT03325712|100673487|FG006|Overall Study|Adverse Event|0|||
33210714|NCT03325712|100673488|FG007|Overall Study|Adverse Event|0|||
33210715|NCT01453595|100673489|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
33210716|NCT01453595|100673490|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
33210717|NCT01453595|100673491|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
33210718|NCT02269670|100673492|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
33210719|NCT01371851|100673493|FG000|Overall Study|Lost to Follow-up|5|||
33210720|NCT01371851|100673494|FG001|Overall Study|Lost to Follow-up|8|||
33210721|NCT01371851|100673493|FG000|Overall Study|was arrested and put in jail|0|||
33210722|NCT01371851|100673494|FG001|Overall Study|was arrested and put in jail|1|||
33210723|NCT01371851|100673493|FG000|Overall Study|non study related adverse event|1|||
33210724|NCT01371851|100673494|FG001|Overall Study|non study related adverse event|0|||
33210725|NCT01371851|100673493|FG000|Overall Study|Blood Pressure outside study parameters|2|||
33210726|NCT01371851|100673494|FG001|Overall Study|Blood Pressure outside study parameters|0|||
33343419|NCT01791855|101145722|FG001|Overall Study|Randomized, not treated|1|||
33343420|NCT01791855|101145723|FG002|Overall Study|Randomized, not treated|0|||
33210727|NCT01388816|100673495|FG000|Overall Study|Adverse Event|0|||
33343421|NCT01791855|101145724|FG003|Overall Study|Randomized, not treated|0|||
33540625|NCT00296517|101878608|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
33343422|NCT02605642|101145727|FG000|Overall Study|Other|11|||
33343423|NCT02605642|101145728|FG001|Overall Study|Other|1|||
33210728|NCT01388816|100673496|FG001|Overall Study|Adverse Event|2|||
33210729|NCT01388816|100673497|FG002|Overall Study|Adverse Event|0|||
33210730|NCT01388816|100673498|FG003|Overall Study|Adverse Event|0|||
33343424|NCT02605642|101145727|FG000|Overall Study|Participant non-compliance|2|||
33343425|NCT02605642|101145728|FG001|Overall Study|Participant non-compliance|4|||
33210731|NCT01388816|100673495|FG000|Overall Study|Lost to Follow-up|0|||
33210732|NCT01388816|100673496|FG001|Overall Study|Lost to Follow-up|1|||
33210733|NCT01388816|100673497|FG002|Overall Study|Lost to Follow-up|0|||
33210734|NCT01388816|100673498|FG003|Overall Study|Lost to Follow-up|0|||
33210735|NCT01388816|100673495|FG000|Overall Study|Withdrawal by Subject|2|||
33210736|NCT01388816|100673496|FG001|Overall Study|Withdrawal by Subject|1|||
33210737|NCT01388816|100673497|FG002|Overall Study|Withdrawal by Subject|1|||
33210738|NCT01388816|100673498|FG003|Overall Study|Withdrawal by Subject|0|||
33210739|NCT01388816|100673495|FG000|Overall Study|Protocol Violation|0|||
33210740|NCT01388816|100673496|FG001|Overall Study|Protocol Violation|0|||
33210741|NCT01388816|100673497|FG002|Overall Study|Protocol Violation|2|||
33210742|NCT01388816|100673498|FG003|Overall Study|Protocol Violation|0|||
33210743|NCT01786512|100673499|FG000|Overall Study|Lost to Follow-up|0|||
33210744|NCT01786512|100673500|FG001|Overall Study|Lost to Follow-up|0|||
33210745|NCT01786512|100673501|FG002|Overall Study|Lost to Follow-up|0|||
33210746|NCT01786512|100673502|FG003|Overall Study|Lost to Follow-up|0|||
33210747|NCT01786512|100673503|FG004|Overall Study|Lost to Follow-up|0|||
33210748|NCT01786512|100673504|FG005|Overall Study|Lost to Follow-up|0|||
33210749|NCT01786512|100673505|FG006|Overall Study|Lost to Follow-up|0|||
33210750|NCT01786512|100673506|FG007|Overall Study|Lost to Follow-up|0|||
33210751|NCT01786512|100673507|FG008|Overall Study|Lost to Follow-up|0|||
33210752|NCT01786512|100673508|FG009|Overall Study|Lost to Follow-up|1|||
33210753|NCT01786512|100673509|FG010|Overall Study|Lost to Follow-up|0|||
33210754|NCT01786512|100673499|FG000|Overall Study|Decision by sponsor|0|||
33210755|NCT01786512|100673500|FG001|Overall Study|Decision by sponsor|0|||
33210756|NCT01786512|100673501|FG002|Overall Study|Decision by sponsor|0|||
33210757|NCT01786512|100673502|FG003|Overall Study|Decision by sponsor|0|||
33210758|NCT01786512|100673503|FG004|Overall Study|Decision by sponsor|0|||
33210759|NCT01786512|100673504|FG005|Overall Study|Decision by sponsor|0|||
33210760|NCT01786512|100673505|FG006|Overall Study|Decision by sponsor|0|||
33210761|NCT01786512|100673506|FG007|Overall Study|Decision by sponsor|0|||
33210762|NCT01786512|100673507|FG008|Overall Study|Decision by sponsor|0|||
33210763|NCT01786512|100673508|FG009|Overall Study|Decision by sponsor|0|||
33210764|NCT01786512|100673509|FG010|Overall Study|Decision by sponsor|2|||
33210765|NCT01786512|100673499|FG000|Overall Study|Withdrawal by Subject|0|||
33615409|NCT01858766|102140305|FG009|Overall Study|Death|0|||
33615410|NCT01858766|102140306|FG010|Overall Study|Death|0|||
33210766|NCT01786512|100673500|FG001|Overall Study|Withdrawal by Subject|1|||
33210767|NCT01786512|100673501|FG002|Overall Study|Withdrawal by Subject|0|||
33210768|NCT01786512|100673502|FG003|Overall Study|Withdrawal by Subject|0|||
33210769|NCT01786512|100673503|FG004|Overall Study|Withdrawal by Subject|0|||
33210770|NCT01786512|100673504|FG005|Overall Study|Withdrawal by Subject|0|||
33343426|NCT02605642|101145727|FG000|Overall Study|Physician Decision|10|||
33210771|NCT01786512|100673505|FG006|Overall Study|Withdrawal by Subject|1|||
33210772|NCT01786512|100673506|FG007|Overall Study|Withdrawal by Subject|0|||
33210773|NCT01786512|100673507|FG008|Overall Study|Withdrawal by Subject|0|||
33210774|NCT01786512|100673508|FG009|Overall Study|Withdrawal by Subject|3|||
33210775|NCT01786512|100673509|FG010|Overall Study|Withdrawal by Subject|7|||
33210776|NCT01786512|100673499|FG000|Overall Study|Death|0|||
33210777|NCT01786512|100673500|FG001|Overall Study|Death|0|||
33615411|NCT01858766|102140307|FG011|Overall Study|Death|0|||
33615412|NCT01858766|102140308|FG012|Overall Study|Death|0|||
33615413|NCT01858766|102140309|FG013|Overall Study|Death|0|||
33615414|NCT01858766|102140310|FG014|Overall Study|Death|0|||
33615415|NCT01858766|102140311|FG015|Overall Study|Death|0|||
33615416|NCT01858766|102140312|FG016|Overall Study|Death|0|||
33210778|NCT01786512|100673501|FG002|Overall Study|Death|0|||
33210779|NCT01786512|100673502|FG003|Overall Study|Death|0|||
33210780|NCT01786512|100673503|FG004|Overall Study|Death|0|||
33343427|NCT02605642|101145728|FG001|Overall Study|Physician Decision|0|||
33343428|NCT02605642|101145727|FG000|Overall Study|Lost to Follow-up|12|||
33343429|NCT02605642|101145728|FG001|Overall Study|Lost to Follow-up|1|||
33343430|NCT02605642|101145727|FG000|Overall Study|Adverse Event|14|||
33210781|NCT01786512|100673504|FG005|Overall Study|Death|0|||
33210782|NCT01786512|100673505|FG006|Overall Study|Death|0|||
33210783|NCT01786512|100673506|FG007|Overall Study|Death|0|||
33210784|NCT01786512|100673507|FG008|Overall Study|Death|4|||
33210785|NCT01786512|100673508|FG009|Overall Study|Death|1|||
33210786|NCT01786512|100673509|FG010|Overall Study|Death|3|||
33210787|NCT01662310|100673510|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
33210788|NCT01662310|100673511|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
33210789|NCT01662310|100673512|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
33210790|NCT01662310|100673513|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
33210791|NCT01662310|100673514|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
33210792|NCT01662310|100673510|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
33210793|NCT01662310|100673511|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
33210794|NCT01662310|100673512|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
33210795|NCT01662310|100673513|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
33210796|NCT01662310|100673514|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
33210797|NCT01662310|100673510|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
33210798|NCT01662310|100673511|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
33210799|NCT01662310|100673512|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
33210800|NCT01662310|100673513|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
33210801|NCT01662310|100673514|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
33210802|NCT01662310|100673510|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
33210803|NCT01662310|100673511|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
33210804|NCT01662310|100673512|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
33210805|NCT01662310|100673513|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
33210806|NCT01662310|100673514|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
33210807|NCT01662310|100673510|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
33343431|NCT02605642|101145728|FG001|Overall Study|Adverse Event|2|||
33343432|NCT02605642|101145727|FG000|Overall Study|Withdrawal by Subject|23|||
33343433|NCT02605642|101145728|FG001|Overall Study|Withdrawal by Subject|2|||
33343434|NCT02605642|101145727|FG000|Overall Study|Lack of response|24|||
33343435|NCT02605642|101145728|FG001|Overall Study|Lack of response|11|||
33343436|NCT01700192|101145729|FG000|Overall Study|Adverse Event|73|||
33343437|NCT01700192|101145730|FG001|Overall Study|Adverse Event|18|||
33343438|NCT01700192|101145729|FG000|Overall Study|Lack of Efficacy|1|||
33343439|NCT01700192|101145730|FG001|Overall Study|Lack of Efficacy|0|||
33343440|NCT01700192|101145729|FG000|Overall Study|Lost to Follow-up|42|||
33343441|NCT01700192|101145730|FG001|Overall Study|Lost to Follow-up|29|||
33343442|NCT01700192|101145729|FG000|Overall Study|Noncompliance with study drug|0|||
33343443|NCT01700192|101145730|FG001|Overall Study|Noncompliance with study drug|5|||
33343444|NCT01700192|101145729|FG000|Overall Study|Physician Decision|2|||
33343445|NCT01700192|101145730|FG001|Overall Study|Physician Decision|3|||
33343446|NCT01700192|101145729|FG000|Overall Study|Pregnancy|1|||
33540626|NCT00296517|101878607|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
33615417|NCT01858766|102140313|FG017|Overall Study|Death|0|||
33615418|NCT01858766|102140314|FG018|Overall Study|Death|0|||
33210808|NCT01662310|100673511|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
33210809|NCT01662310|100673512|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
33210810|NCT01662310|100673513|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
33210811|NCT01662310|100673514|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
33210812|NCT01662310|100673510|FG000|Run-In or Stabilization Phase|Other|1|||
33343447|NCT01700192|101145730|FG001|Overall Study|Pregnancy|4|||
33343448|NCT01700192|101145729|FG000|Overall Study|Progressive disease|1|||
33343449|NCT01700192|101145730|FG001|Overall Study|Progressive disease|0|||
33343450|NCT01700192|101145729|FG000|Overall Study|Protocol Violation|3|||
33343451|NCT01700192|101145730|FG001|Overall Study|Protocol Violation|4|||
33615419|NCT01858766|102140296|FG000|Overall Study|Lack of Efficacy|1|||
33210813|NCT01662310|100673511|FG001|Run-In or Stabilization Phase|Other|0|||
33210814|NCT01662310|100673512|FG002|Run-In or Stabilization Phase|Other|0|||
33210815|NCT01662310|100673513|FG003|Run-In or Stabilization Phase|Other|0|||
33210816|NCT01662310|100673514|FG004|Run-In or Stabilization Phase|Other|0|||
33210817|NCT01662310|100673510|FG000|Double-Blind Phase|Adverse Event|0|||
33210818|NCT01662310|100673511|FG001|Double-Blind Phase|Adverse Event|0|||
33210819|NCT01662310|100673512|FG002|Double-Blind Phase|Adverse Event|1|||
33210820|NCT01662310|100673513|FG003|Double-Blind Phase|Adverse Event|0|||
33210821|NCT01662310|100673514|FG004|Double-Blind Phase|Adverse Event|0|||
33210822|NCT01662310|100673510|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33210823|NCT01662310|100673511|FG001|Double-Blind Phase|Lost to Follow-up|3|||
33210824|NCT01662310|100673512|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33210825|NCT01662310|100673513|FG003|Double-Blind Phase|Lost to Follow-up|0|||
33210826|NCT01662310|100673514|FG004|Double-Blind Phase|Lost to Follow-up|0|||
33210827|NCT01662310|100673510|FG000|Double-Blind Phase|Pregnancy|0|||
33615420|NCT01858766|102140297|FG001|Overall Study|Lack of Efficacy|0|||
33615421|NCT01858766|102140298|FG002|Overall Study|Lack of Efficacy|0|||
33615422|NCT01858766|102140299|FG003|Overall Study|Lack of Efficacy|0|||
33615423|NCT01858766|102140300|FG004|Overall Study|Lack of Efficacy|1|||
33615424|NCT01858766|102140301|FG005|Overall Study|Lack of Efficacy|2|||
33615425|NCT01858766|102140302|FG006|Overall Study|Lack of Efficacy|0|||
33615426|NCT01858766|102140303|FG007|Overall Study|Lack of Efficacy|0|||
33540627|NCT00296517|101878608|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
33540628|NCT00296517|101878607|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
33540629|NCT00296517|101878608|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
33540630|NCT00296517|101878607|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
33540631|NCT00296517|101878608|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
33615427|NCT01858766|102140304|FG008|Overall Study|Lack of Efficacy|0|||
33615428|NCT01858766|102140305|FG009|Overall Study|Lack of Efficacy|0|||
33210828|NCT01662310|100673511|FG001|Double-Blind Phase|Pregnancy|2|||
33210829|NCT01662310|100673512|FG002|Double-Blind Phase|Pregnancy|0|||
33210830|NCT01662310|100673513|FG003|Double-Blind Phase|Pregnancy|0|||
33210831|NCT01662310|100673514|FG004|Double-Blind Phase|Pregnancy|0|||
33210832|NCT01662310|100673510|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
33210833|NCT01662310|100673511|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
33210834|NCT01662310|100673512|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
33210835|NCT01662310|100673513|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
33210836|NCT01662310|100673514|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
33210837|NCT01662310|100673510|FG000|Double-Blind Phase|Other|0|||
33210838|NCT01662310|100673511|FG001|Double-Blind Phase|Other|0|||
33210839|NCT01662310|100673512|FG002|Double-Blind Phase|Other|1|||
33210840|NCT01662310|100673513|FG003|Double-Blind Phase|Other|0|||
33210841|NCT01662310|100673514|FG004|Double-Blind Phase|Other|0|||
33210842|NCT01662310|100673510|FG000|Double-Blind Phase|Randomized but not treated|0|||
33210843|NCT01662310|100673511|FG001|Double-Blind Phase|Randomized but not treated|1|||
33210844|NCT01662310|100673512|FG002|Double-Blind Phase|Randomized but not treated|0|||
33210845|NCT01662310|100673513|FG003|Double-Blind Phase|Randomized but not treated|0|||
33210846|NCT01662310|100673514|FG004|Double-Blind Phase|Randomized but not treated|0|||
33210847|NCT01662310|100673510|FG000|Open-Label Extension Phase|Adverse Event|0|||
33210848|NCT01662310|100673511|FG001|Open-Label Extension Phase|Adverse Event|0|||
33210849|NCT01662310|100673512|FG002|Open-Label Extension Phase|Adverse Event|0|||
33210850|NCT01662310|100673513|FG003|Open-Label Extension Phase|Adverse Event|3|||
33210851|NCT01662310|100673514|FG004|Open-Label Extension Phase|Adverse Event|0|||
33210852|NCT01662310|100673510|FG000|Open-Label Extension Phase|Death|0|||
33210853|NCT01662310|100673511|FG001|Open-Label Extension Phase|Death|0|||
33210854|NCT01662310|100673512|FG002|Open-Label Extension Phase|Death|0|||
33210855|NCT01662310|100673513|FG003|Open-Label Extension Phase|Death|1|||
33210856|NCT01662310|100673514|FG004|Open-Label Extension Phase|Death|0|||
33210857|NCT01662310|100673510|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
33210858|NCT01662310|100673511|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
33210859|NCT01662310|100673512|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
33210860|NCT01662310|100673513|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
33210861|NCT01662310|100673514|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
33210862|NCT01662310|100673510|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
33210863|NCT01662310|100673511|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
33210864|NCT01662310|100673512|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
33210865|NCT01662310|100673513|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
33210866|NCT01662310|100673514|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
33210867|NCT01662310|100673510|FG000|Open-Label Extension Phase|Pregnancy|0|||
33210868|NCT01662310|100673511|FG001|Open-Label Extension Phase|Pregnancy|0|||
33210869|NCT01662310|100673512|FG002|Open-Label Extension Phase|Pregnancy|0|||
33210870|NCT01662310|100673513|FG003|Open-Label Extension Phase|Pregnancy|1|||
33210871|NCT01662310|100673514|FG004|Open-Label Extension Phase|Pregnancy|0|||
33210872|NCT01662310|100673510|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
33210873|NCT01662310|100673511|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
33210874|NCT01662310|100673512|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
33210875|NCT01662310|100673513|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
33210876|NCT01662310|100673514|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
33210877|NCT00074282|100673515|FG000|Step 1|Adverse Event|32|||
33210878|NCT00074282|100673516|FG001|Step 1|Adverse Event|0|||
33210879|NCT00074282|100673517|FG002|Step 1|Adverse Event|0|||
33210880|NCT00074282|100673515|FG000|Step 1|Death|6|||
33210881|NCT00074282|100673516|FG001|Step 1|Death|0|||
33210882|NCT00074282|100673517|FG002|Step 1|Death|0|||
33210883|NCT00074282|100673515|FG000|Step 1|Withdrawal by Subject|7|||
33210884|NCT00074282|100673516|FG001|Step 1|Withdrawal by Subject|0|||
33210885|NCT00074282|100673517|FG002|Step 1|Withdrawal by Subject|0|||
33210886|NCT00074282|100673515|FG000|Step 1|Disease progression|2|||
33210887|NCT00074282|100673516|FG001|Step 1|Disease progression|0|||
33210888|NCT00074282|100673517|FG002|Step 1|Disease progression|0|||
33210889|NCT00074282|100673515|FG000|Step 1|Alternative therapy|2|||
33210890|NCT00074282|100673516|FG001|Step 1|Alternative therapy|0|||
33210891|NCT00074282|100673517|FG002|Step 1|Alternative therapy|0|||
33210892|NCT00074282|100673515|FG000|Step 1|Other complicating disease|2|||
33210893|NCT00074282|100673516|FG001|Step 1|Other complicating disease|0|||
33210894|NCT00074282|100673517|FG002|Step 1|Other complicating disease|0|||
33210895|NCT00074282|100673515|FG000|Step 1|Physician Decision|1|||
33210896|NCT00074282|100673516|FG001|Step 1|Physician Decision|0|||
33540632|NCT00296517|101878607|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
33210897|NCT00074282|100673517|FG002|Step 1|Physician Decision|0|||
33210898|NCT00074282|100673515|FG000|Step 1|Ineligible|4|||
33210899|NCT00074282|100673516|FG001|Step 1|Ineligible|0|||
33210900|NCT00074282|100673517|FG002|Step 1|Ineligible|0|||
33210901|NCT00074282|100673515|FG000|Step 1|Never started treatment|2|||
33210902|NCT00074282|100673516|FG001|Step 1|Never started treatment|0|||
33210903|NCT00074282|100673517|FG002|Step 1|Never started treatment|0|||
33210904|NCT00074282|100673515|FG000|Step 2|Adverse Event|0|||
33210905|NCT00074282|100673516|FG001|Step 2|Adverse Event|2|||
33210906|NCT00074282|100673517|FG002|Step 2|Adverse Event|12|||
33210907|NCT00074282|100673515|FG000|Step 2|Disease progression|0|||
33210908|NCT00074282|100673516|FG001|Step 2|Disease progression|0|||
33210909|NCT00074282|100673517|FG002|Step 2|Disease progression|5|||
33210910|NCT00074282|100673515|FG000|Step 2|Death|0|||
33210911|NCT00074282|100673516|FG001|Step 2|Death|0|||
33210912|NCT00074282|100673517|FG002|Step 2|Death|3|||
33210913|NCT00074282|100673515|FG000|Step 2|Withdrawal by Subject|0|||
33210914|NCT00074282|100673516|FG001|Step 2|Withdrawal by Subject|0|||
33210915|NCT00074282|100673517|FG002|Step 2|Withdrawal by Subject|2|||
33210916|NCT00074282|100673515|FG000|Step 2|Physician Decision|0|||
33210917|NCT00074282|100673516|FG001|Step 2|Physician Decision|0|||
33210918|NCT00074282|100673517|FG002|Step 2|Physician Decision|1|||
33210919|NCT00074282|100673515|FG000|Step 2|Ineligible|0|||
33210920|NCT00074282|100673516|FG001|Step 2|Ineligible|0|||
33210921|NCT00074282|100673517|FG002|Step 2|Ineligible|1|||
33343452|NCT01700192|101145729|FG000|Overall Study|Technical problems|0|||
33343453|NCT01700192|101145730|FG001|Overall Study|Technical problems|1|||
33406775|NCT02030067|101377730|FG009|Overall Study|Disease Progression|3|||
33540633|NCT00296517|101878608|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
33540634|NCT03736967|101878616|FG000|Overall Study|Withdrawal by Subject|26|||
33540635|NCT03736967|101878617|FG001|Overall Study|Withdrawal by Subject|25|||
33540636|NCT03736967|101878618|FG002|Overall Study|Withdrawal by Subject|23|||
33540637|NCT03736967|101878619|FG003|Overall Study|Withdrawal by Subject|26|||
33615429|NCT01858766|102140306|FG010|Overall Study|Lack of Efficacy|0|||
33615430|NCT01858766|102140307|FG011|Overall Study|Lack of Efficacy|3|||
33210922|NCT01227889|100673520|FG000|Randomized Phase (RP)|Adverse Event|13|||
33210923|NCT01227889|100673521|FG001|Randomized Phase (RP)|Adverse Event|0|||
33210924|NCT01227889|100673520|FG000|Randomized Phase (RP)|Physician Decision|13|||
33210925|NCT01227889|100673521|FG001|Randomized Phase (RP)|Physician Decision|5|||
33343454|NCT01700192|101145729|FG000|Overall Study|Withdrawal by Subject|56|||
33343455|NCT01700192|101145730|FG001|Overall Study|Withdrawal by Subject|64|||
33343456|NCT01700192|101145729|FG000|Overall Study|Never received study drug|1|||
33343457|NCT01700192|101145730|FG001|Overall Study|Never received study drug|0|||
33343458|NCT02532855|101145733|FG000|Overall Study|Lost to Follow-up|4|||
33343459|NCT02532855|101145734|FG001|Overall Study|Lost to Follow-up|3|||
33343460|NCT02532855|101145733|FG000|Overall Study|Withdrawal by Subject|4|||
33343461|NCT02532855|101145734|FG001|Overall Study|Withdrawal by Subject|8|||
33343462|NCT01192347|101145735|FG000|Overall Study|Death|3|||
33343463|NCT01192347|101145735|FG000|Overall Study|Lost to Follow-up|3|||
33343464|NCT01192347|101145735|FG000|Overall Study|Withdrawal by Subject|1|||
33343465|NCT01192347|101145735|FG000|Overall Study|Adverse Event|1|||
33343466|NCT01192347|101145735|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
33343467|NCT01192347|101145735|FG000|Overall Study|Patient seen in different hospital|1|||
33343468|NCT01192347|101145735|FG000|Overall Study|Patient not visiting hospital regularly|1|||
33343469|NCT01192347|101145735|FG000|Overall Study|Patient did not show up for visits|1|||
33343470|NCT00769119|101145736|FG000|Overall Study|Voluntary discontinuation|0|||
33343471|NCT00769119|101145737|FG001|Overall Study|Voluntary discontinuation|2|||
33343472|NCT00769119|101145736|FG000|Overall Study|Adverse Event|1|||
33343473|NCT00769119|101145737|FG001|Overall Study|Adverse Event|1|||
33343474|NCT00769119|101145736|FG000|Overall Study|Disallowed medication|1|||
33343475|NCT00769119|101145737|FG001|Overall Study|Disallowed medication|0|||
33343476|NCT03345472|101145738|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
33343477|NCT03345472|101145738|FG000|Implant to 3 Months|Physician Decision|1|||
33343478|NCT03345472|101145738|FG000|Implant to 3 Months|Adverse Event|1|||
33343479|NCT03345472|101145738|FG000|3 Months to 12 Months|Physician Decision|3|||
33343480|NCT03345472|101145738|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
33343481|NCT03345472|101145738|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
33343482|NCT03345472|101145738|FG000|3 Months to 12 Months|Adverse Event|1|||
33343483|NCT03345472|101145738|FG000|3 Months to 12 Months|Death|1|||
33343484|NCT02787850|101145739|FG000|Overall Study|Withdrawal by Subject|0|||
33343485|NCT02787850|101145740|FG001|Overall Study|Withdrawal by Subject|1|||
33343486|NCT02161562|101148182|FG000|Overall Study|Withdrawal by Subject|5|||
33343487|NCT02161562|101148183|FG001|Overall Study|Withdrawal by Subject|8|||
33343488|NCT02161562|101148182|FG000|Overall Study|Protocol Violation|9|||
33343489|NCT02161562|101148183|FG001|Overall Study|Protocol Violation|4|||
33343490|NCT02161562|101148182|FG000|Overall Study|Pregnancy|1|||
33343491|NCT02161562|101148183|FG001|Overall Study|Pregnancy|2|||
33343492|NCT02161562|101148182|FG000|Overall Study|Lost to Follow-up|3|||
33343493|NCT02161562|101148183|FG001|Overall Study|Lost to Follow-up|1|||
33343494|NCT02161562|101148182|FG000|Overall Study|Lack of Efficacy|4|||
33343495|NCT02161562|101148183|FG001|Overall Study|Lack of Efficacy|1|||
33343496|NCT02161562|101148182|FG000|Overall Study|Adverse Event|1|||
33343497|NCT02161562|101148183|FG001|Overall Study|Adverse Event|1|||
33343498|NCT02161562|101148182|FG000|Overall Study|Participant moved back to home country|1|||
33343499|NCT02161562|101148183|FG001|Overall Study|Participant moved back to home country|0|||
33343500|NCT02161562|101148182|FG000|Overall Study|Withdrew due to being out of the country|1|||
33343501|NCT02161562|101148183|FG001|Overall Study|Withdrew due to being out of the country|0|||
33343502|NCT02161562|101148182|FG000|Overall Study|Participant moved out of province|1|||
33343503|NCT02161562|101148183|FG001|Overall Study|Participant moved out of province|0|||
33343504|NCT01469000|101148185|FG000|Overall Study|Withdrawal by Subject|16|||
33343505|NCT01469000|101148186|FG001|Overall Study|Withdrawal by Subject|3|||
33615431|NCT01858766|102140308|FG012|Overall Study|Lack of Efficacy|5|||
33210926|NCT01227889|100673520|FG000|Randomized Phase (RP)|Progressive Disease|135|||
33210927|NCT01227889|100673521|FG001|Randomized Phase (RP)|Progressive Disease|52|||
33343506|NCT01469000|101148185|FG000|Overall Study|Sponsor Decision|4|||
33343507|NCT01469000|101148186|FG001|Overall Study|Sponsor Decision|1|||
33343508|NCT01652287|101148192|FG000|Overall Study|Withdrawal by Subject|2|||
33343509|NCT01652287|101148193|FG001|Overall Study|Withdrawal by Subject|0|||
33343510|NCT00112905|101148196|FG000|Overall Study|Adverse Event|4|||
33343511|NCT00112905|101148196|FG000|Overall Study|Death|1|||
33343512|NCT00112905|101148196|FG000|Overall Study|Ineligibility|5|||
33343513|NCT00112905|101148196|FG000|Overall Study|Alternative treatment|1|||
33615432|NCT01858766|102140309|FG013|Overall Study|Lack of Efficacy|3|||
33210928|NCT01227889|100673520|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
33210929|NCT01227889|100673521|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
33210930|NCT01227889|100673520|FG000|Randomized Phase (RP)|Missing|1|||
33210931|NCT01227889|100673521|FG001|Randomized Phase (RP)|Missing|3|||
33210932|NCT01227889|100673520|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
33210933|NCT01227889|100673521|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
33210934|NCT01227889|100673520|FG000|Crossover Phase|Adverse Event|0|||
33210935|NCT01227889|100673521|FG001|Crossover Phase|Adverse Event|1|||
33210936|NCT01227889|100673520|FG000|Crossover Phase|Physician Decision|0|||
33210937|NCT01227889|100673521|FG001|Crossover Phase|Physician Decision|3|||
33210938|NCT01227889|100673520|FG000|Crossover Phase|Progressive Disease|0|||
33210939|NCT01227889|100673521|FG001|Crossover Phase|Progressive Disease|31|||
33210940|NCT01227889|100673520|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
33210941|NCT01227889|100673521|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
33210942|NCT01227889|100673520|FG000|Crossover Phase|Withdrawal by Subject|0|||
33210943|NCT01227889|100673521|FG001|Crossover Phase|Withdrawal by Subject|1|||
33210944|NCT02313428|100673525|FG000|Overall Study|Lost to Follow-up|1|||
33343514|NCT00112905|101148196|FG000|Overall Study|performance status was deteiorating|1|||
33343515|NCT00090545|101148197|FG000|Overall Study|Disease progression on study|21|||
33343516|NCT00090545|101148198|FG001|Overall Study|Disease progression on study|17|||
33343517|NCT00090545|101148197|FG000|Overall Study|Refused further treatment|1|||
33343518|NCT00090545|101148198|FG001|Overall Study|Refused further treatment|4|||
33343519|NCT00090545|101148197|FG000|Overall Study|Death|0|||
33343520|NCT00090545|101148198|FG001|Overall Study|Death|1|||
33210945|NCT02313428|100673526|FG001|Overall Study|Lost to Follow-up|1|||
33210946|NCT00374322|100673527|FG000|Overall Study|Lost to Follow-up|92|||
33210947|NCT00374322|100673528|FG001|Overall Study|Lost to Follow-up|90|||
33210948|NCT00374322|100673527|FG000|Overall Study|Protocol Violation|8|||
33210949|NCT00374322|100673528|FG001|Overall Study|Protocol Violation|3|||
33210950|NCT00374322|100673527|FG000|Overall Study|Withdrawal by Subject|235|||
33210951|NCT00374322|100673528|FG001|Overall Study|Withdrawal by Subject|167|||
33210952|NCT00374322|100673527|FG000|Overall Study|Sponsor Terminated Study|866|||
33210953|NCT00374322|100673528|FG001|Overall Study|Sponsor Terminated Study|990|||
33210954|NCT00374322|100673527|FG000|Overall Study|Physician Decision|36|||
33210955|NCT00374322|100673528|FG001|Overall Study|Physician Decision|32|||
33210956|NCT00374322|100673527|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
33343521|NCT00090545|101148197|FG000|Overall Study|Adverse Event|0|||
33540638|NCT03736967|101878616|FG000|Overall Study|Lost to Follow-up|3|||
33540639|NCT03736967|101878617|FG001|Overall Study|Lost to Follow-up|2|||
33343522|NCT00090545|101148198|FG001|Overall Study|Adverse Event|2|||
33343523|NCT02049944|101148199|FG000|Overall Study|Protocol Violation|2|||
33343524|NCT01639833|101148200|FG000|Overall Study|Death|4|||
33343525|NCT01639833|101148201|FG001|Overall Study|Death|2|||
33210957|NCT00374322|100673528|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
33210958|NCT00374322|100673527|FG000|Overall Study|Sponsor Decision|2|||
33210959|NCT00374322|100673528|FG001|Overall Study|Sponsor Decision|3|||
33343526|NCT01639833|101148200|FG000|Overall Study|Withdrawal by Subject|2|||
33343527|NCT01639833|101148201|FG001|Overall Study|Withdrawal by Subject|2|||
33343528|NCT01813890|101148202|FG000|Overall Study|Adverse Event|0|||
33343529|NCT01813890|101148203|FG001|Overall Study|Adverse Event|3|||
33343530|NCT01813890|101148204|FG002|Overall Study|Adverse Event|4|||
33343531|NCT01813890|101148202|FG000|Overall Study|Lack of Efficacy|9|||
33343532|NCT01813890|101148203|FG001|Overall Study|Lack of Efficacy|1|||
33540640|NCT03736967|101878618|FG002|Overall Study|Lost to Follow-up|1|||
33540641|NCT03736967|101878619|FG003|Overall Study|Lost to Follow-up|1|||
33540642|NCT03736967|101878616|FG000|Overall Study|Physician Decision|1|||
33210960|NCT00374322|100673527|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
33540643|NCT03736967|101878617|FG001|Overall Study|Physician Decision|0|||
33540644|NCT03736967|101878618|FG002|Overall Study|Physician Decision|0|||
33615433|NCT01858766|102140310|FG014|Overall Study|Lack of Efficacy|5|||
33615434|NCT01858766|102140311|FG015|Overall Study|Lack of Efficacy|5|||
33615435|NCT01858766|102140312|FG016|Overall Study|Lack of Efficacy|2|||
33615436|NCT01858766|102140313|FG017|Overall Study|Lack of Efficacy|3|||
33615437|NCT01858766|102140314|FG018|Overall Study|Lack of Efficacy|3|||
33615438|NCT01858766|102140296|FG000|Overall Study|Lost to Follow-up|0|||
33615439|NCT01858766|102140297|FG001|Overall Study|Lost to Follow-up|0|||
33615440|NCT01858766|102140298|FG002|Overall Study|Lost to Follow-up|0|||
33615441|NCT01858766|102140299|FG003|Overall Study|Lost to Follow-up|0|||
33615442|NCT01858766|102140300|FG004|Overall Study|Lost to Follow-up|0|||
33615443|NCT01858766|102140301|FG005|Overall Study|Lost to Follow-up|1|||
33615444|NCT01858766|102140302|FG006|Overall Study|Lost to Follow-up|0|||
33615445|NCT01858766|102140303|FG007|Overall Study|Lost to Follow-up|2|||
33615446|NCT01858766|102140304|FG008|Overall Study|Lost to Follow-up|0|||
33615447|NCT01858766|102140305|FG009|Overall Study|Lost to Follow-up|0|||
33615448|NCT01858766|102140306|FG010|Overall Study|Lost to Follow-up|0|||
33615449|NCT01858766|102140307|FG011|Overall Study|Lost to Follow-up|1|||
33615450|NCT01858766|102140308|FG012|Overall Study|Lost to Follow-up|0|||
33615451|NCT01858766|102140309|FG013|Overall Study|Lost to Follow-up|0|||
33615452|NCT01858766|102140310|FG014|Overall Study|Lost to Follow-up|3|||
33615453|NCT01858766|102140311|FG015|Overall Study|Lost to Follow-up|1|||
33615454|NCT01858766|102140312|FG016|Overall Study|Lost to Follow-up|1|||
33615455|NCT01858766|102140313|FG017|Overall Study|Lost to Follow-up|0|||
33615456|NCT01858766|102140314|FG018|Overall Study|Lost to Follow-up|1|||
33615457|NCT01858766|102140296|FG000|Overall Study|Withdrew Consent|0|||
33615458|NCT01858766|102140297|FG001|Overall Study|Withdrew Consent|0|||
33615459|NCT01858766|102140298|FG002|Overall Study|Withdrew Consent|0|||
33615460|NCT01858766|102140299|FG003|Overall Study|Withdrew Consent|0|||
33615461|NCT01858766|102140300|FG004|Overall Study|Withdrew Consent|0|||
33615462|NCT01858766|102140301|FG005|Overall Study|Withdrew Consent|0|||
33615463|NCT01858766|102140302|FG006|Overall Study|Withdrew Consent|0|||
33615464|NCT01858766|102140303|FG007|Overall Study|Withdrew Consent|0|||
33615465|NCT01858766|102140304|FG008|Overall Study|Withdrew Consent|0|||
33615466|NCT01858766|102140305|FG009|Overall Study|Withdrew Consent|0|||
33615467|NCT01858766|102140306|FG010|Overall Study|Withdrew Consent|0|||
33615468|NCT01858766|102140307|FG011|Overall Study|Withdrew Consent|1|||
33615469|NCT01858766|102140308|FG012|Overall Study|Withdrew Consent|0|||
33615470|NCT01858766|102140309|FG013|Overall Study|Withdrew Consent|0|||
33615471|NCT01858766|102140310|FG014|Overall Study|Withdrew Consent|0|||
33615472|NCT01858766|102140311|FG015|Overall Study|Withdrew Consent|0|||
33615473|NCT01858766|102140312|FG016|Overall Study|Withdrew Consent|0|||
33615474|NCT01858766|102140313|FG017|Overall Study|Withdrew Consent|0|||
33615475|NCT01858766|102140314|FG018|Overall Study|Withdrew Consent|0|||
33615476|NCT00003199|102140317|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
33615477|NCT00003199|102140317|FG000|Overall Study|Lack of insurance clearance|2|||
33615478|NCT00003199|102140317|FG000|Overall Study|Screen fail|15|||
33615479|NCT01685697|102140320|FG000|Overall Study|Protocol Violation|3|||
33615480|NCT01685697|102140321|FG001|Overall Study|Protocol Violation|3|||
33615481|NCT04124705|102140326|FG000|Titration Period|Adverse Event|9|||
33615482|NCT04124705|102140327|FG001|Titration Period|Adverse Event|5|||
33615483|NCT04124705|102140326|FG000|Titration Period|Withdrawal by Subject|6|||
33615484|NCT04124705|102140327|FG001|Titration Period|Withdrawal by Subject|3|||
33615485|NCT04124705|102140326|FG000|Titration Period|Lost to Follow-up|0|||
33615486|NCT04124705|102140327|FG001|Titration Period|Lost to Follow-up|1|||
33615487|NCT04124705|102140326|FG000|Titration Period|Death|1|||
33615488|NCT04124705|102140327|FG001|Titration Period|Death|1|||
33615489|NCT04124705|102140326|FG000|Titration Period|Lack of Efficacy|2|||
33615490|NCT04124705|102140327|FG001|Titration Period|Lack of Efficacy|0|||
33615491|NCT04124705|102140326|FG000|Titration Period|Physician Decision|2|||
33615492|NCT04124705|102140327|FG001|Titration Period|Physician Decision|0|||
33615493|NCT04124705|102140326|FG000|Titration Period|Non-compliance with Study Drug|2|||
33343533|NCT01813890|101148204|FG002|Overall Study|Lack of Efficacy|2|||
33343534|NCT01688050|101148205|FG000|Overall Study|Death|7|||
33343535|NCT01688050|101148205|FG000|Overall Study|Conversion to open repair|1|||
33343536|NCT01688050|101148205|FG000|Overall Study|Lost to Follow-up|13|||
33343537|NCT01688050|101148205|FG000|Overall Study|Withdrawal by Subject|10|||
33615494|NCT04124705|102140327|FG001|Titration Period|Non-compliance with Study Drug|0|||
33343538|NCT01239160|101148206|FG000|Overall Study|Lost to Follow-up|3|||
33615495|NCT04124705|102140326|FG000|Titration Period|Other|4|||
33615496|NCT04124705|102140327|FG001|Titration Period|Other|9|||
33615497|NCT04124705|102140326|FG000|Stabilization Period|Adverse Event|4|||
33615498|NCT04124705|102140327|FG001|Stabilization Period|Adverse Event|2|||
33615499|NCT04124705|102140326|FG000|Stabilization Period|Withdrawal by Subject|1|||
33615500|NCT04124705|102140327|FG001|Stabilization Period|Withdrawal by Subject|1|||
33540645|NCT03736967|101878619|FG003|Overall Study|Physician Decision|1|||
33540646|NCT03736967|101878616|FG000|Overall Study|Adverse Event|0|||
33540647|NCT03736967|101878617|FG001|Overall Study|Adverse Event|1|||
33540648|NCT03736967|101878618|FG002|Overall Study|Adverse Event|0|||
33540649|NCT03736967|101878619|FG003|Overall Study|Adverse Event|1|||
33540650|NCT03736967|101878616|FG000|Overall Study|Death|0|||
33540651|NCT03736967|101878617|FG001|Overall Study|Death|0|||
33540652|NCT03736967|101878618|FG002|Overall Study|Death|0|||
33540653|NCT03736967|101878619|FG003|Overall Study|Death|1|||
33540654|NCT03736967|101878616|FG000|Overall Study|Randomized but never treated|1|||
33540655|NCT03736967|101878617|FG001|Overall Study|Randomized but never treated|0|||
33540656|NCT03736967|101878618|FG002|Overall Study|Randomized but never treated|0|||
33540657|NCT03736967|101878619|FG003|Overall Study|Randomized but never treated|0|||
33540658|NCT03363906|101878622|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
33540659|NCT03363906|101878623|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
33540660|NCT03363906|101878622|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
33540661|NCT03363906|101878623|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
33540662|NCT03363906|101878622|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
33540663|NCT03363906|101878623|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
33540664|NCT03363906|101878622|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
33540665|NCT03363906|101878623|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
33540666|NCT03805841|101878626|FG000|Overall Study|Clinical Progression|2|||
33540667|NCT03805841|101878627|FG001|Overall Study|Clinical Progression|0|||
33540668|NCT03805841|101878628|FG002|Overall Study|Clinical Progression|0|||
33540669|NCT03805841|101878626|FG000|Overall Study|Death|0|||
33540670|NCT03805841|101878627|FG001|Overall Study|Death|3|||
33540671|NCT03805841|101878628|FG002|Overall Study|Death|1|||
33540672|NCT03805841|101878626|FG000|Overall Study|Lost to Follow-up|0|||
33540673|NCT03805841|101878627|FG001|Overall Study|Lost to Follow-up|0|||
33540674|NCT03805841|101878628|FG002|Overall Study|Lost to Follow-up|1|||
33540675|NCT03805841|101878626|FG000|Overall Study|Withdrawal by Subject|2|||
33540676|NCT03805841|101878627|FG001|Overall Study|Withdrawal by Subject|3|||
33540677|NCT03805841|101878628|FG002|Overall Study|Withdrawal by Subject|0|||
33540678|NCT03805841|101878626|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
33540679|NCT03805841|101878627|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
33540680|NCT03805841|101878628|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
33540681|NCT00386334|101878631|FG000|Double Blind Period|Adverse Event|9|||
33540682|NCT00386334|101878632|FG001|Double Blind Period|Adverse Event|14|||
33540683|NCT00386334|101878631|FG000|Double Blind Period|Protocol Violation|1|||
33540684|NCT00386334|101878632|FG001|Double Blind Period|Protocol Violation|1|||
33540685|NCT00386334|101878631|FG000|Double Blind Period|Withdrawal by Subject|9|||
33540686|NCT00386334|101878632|FG001|Double Blind Period|Withdrawal by Subject|13|||
33540687|NCT00386334|101878631|FG000|Double Blind Period|Lack of Efficacy|20|||
33540688|NCT00386334|101878632|FG001|Double Blind Period|Lack of Efficacy|11|||
33540689|NCT00386334|101878631|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
33540690|NCT00386334|101878632|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
33540691|NCT00386334|101878631|FG000|Double Blind Period|Other|3|||
33540692|NCT00386334|101878632|FG001|Double Blind Period|Other|3|||
33540693|NCT00386334|101878631|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
33540694|NCT00386334|101878632|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
33540695|NCT02858401|101878637|FG000|Overall Study|Withdrew Consent|0|||
33540696|NCT02858401|101878638|FG001|Overall Study|Withdrew Consent|0|||
33540697|NCT02858401|101878639|FG002|Overall Study|Withdrew Consent|0|||
33540698|NCT02858401|101878640|FG003|Overall Study|Withdrew Consent|0|||
33540699|NCT02858401|101878641|FG004|Overall Study|Withdrew Consent|0|||
33540700|NCT02858401|101878642|FG005|Overall Study|Withdrew Consent|1|||
33540701|NCT02858401|101878643|FG006|Overall Study|Withdrew Consent|0|||
33540702|NCT02858401|101878637|FG000|Overall Study|Lost to Follow-up|0|||
33540703|NCT02858401|101878638|FG001|Overall Study|Lost to Follow-up|1|||
33540704|NCT02858401|101878639|FG002|Overall Study|Lost to Follow-up|0|||
33540705|NCT02858401|101878640|FG003|Overall Study|Lost to Follow-up|0|||
33540706|NCT02858401|101878641|FG004|Overall Study|Lost to Follow-up|0|||
33615501|NCT04124705|102140326|FG000|Stabilization Period|Lost to Follow-up|0|||
33343539|NCT01239160|101148207|FG001|Overall Study|Lost to Follow-up|5|||
33343540|NCT01239160|101148208|FG002|Overall Study|Lost to Follow-up|0|||
33343541|NCT01239160|101148206|FG000|Overall Study|Withdrawal by Subject|17|||
33343542|NCT01239160|101148207|FG001|Overall Study|Withdrawal by Subject|6|||
33540707|NCT02858401|101878642|FG005|Overall Study|Lost to Follow-up|0|||
33540708|NCT02858401|101878643|FG006|Overall Study|Lost to Follow-up|0|||
33540709|NCT00626639|101878645|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
33540710|NCT00626639|101878646|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
33540711|NCT01225549|101878647|FG000|Period 4 - Washout|Disallowed medication|0|||
33540712|NCT01225549|101878648|FG001|Period 4 - Washout|Disallowed medication|1|||
33615502|NCT04124705|102140327|FG001|Stabilization Period|Lost to Follow-up|1|||
33343543|NCT01239160|101148208|FG002|Overall Study|Withdrawal by Subject|2|||
33540713|NCT01225549|101878649|FG002|Period 4 - Washout|Disallowed medication|0|||
33540714|NCT01225549|101878650|FG003|Period 4 - Washout|Disallowed medication|0|||
33540715|NCT01225549|101878651|FG004|Period 4 - Washout|Disallowed medication|0|||
33540716|NCT01225549|101878652|FG005|Period 4 - Washout|Disallowed medication|0|||
33540717|NCT01225549|101878653|FG006|Period 4 - Washout|Disallowed medication|0|||
33540718|NCT01225549|101878654|FG007|Period 4 - Washout|Disallowed medication|0|||
33540719|NCT01225549|101878655|FG008|Period 4 - Washout|Disallowed medication|0|||
33540720|NCT01225549|101878656|FG009|Period 4 - Washout|Disallowed medication|0|||
33540721|NCT01225549|101878647|FG000|Period 6 - Washout|Disallowed medication|0|||
33540722|NCT01225549|101878648|FG001|Period 6 - Washout|Disallowed medication|0|||
33540723|NCT01225549|101878649|FG002|Period 6 - Washout|Disallowed medication|0|||
33540724|NCT01225549|101878650|FG003|Period 6 - Washout|Disallowed medication|1|||
33540725|NCT01225549|101878651|FG004|Period 6 - Washout|Disallowed medication|0|||
33540726|NCT01225549|101878652|FG005|Period 6 - Washout|Disallowed medication|0|||
33540727|NCT01225549|101878653|FG006|Period 6 - Washout|Disallowed medication|0|||
33540728|NCT01225549|101878654|FG007|Period 6 - Washout|Disallowed medication|0|||
33540729|NCT01225549|101878655|FG008|Period 6 - Washout|Disallowed medication|0|||
33540730|NCT01225549|101878656|FG009|Period 6 - Washout|Disallowed medication|0|||
33540731|NCT01930539|101878660|FG000|Overall Study|Withdrawal by Subject|2|||
33540732|NCT01930539|101878661|FG001|Overall Study|Withdrawal by Subject|2|||
33540733|NCT00284856|101878668|FG000|Overall Study|Adverse Event|3|||
33540734|NCT00284856|101878669|FG001|Overall Study|Adverse Event|3|||
33540735|NCT00284856|101878670|FG002|Overall Study|Adverse Event|3|||
33540736|NCT00284856|101878668|FG000|Overall Study|Lack of Efficacy|2|||
33540737|NCT00284856|101878669|FG001|Overall Study|Lack of Efficacy|1|||
33540738|NCT00284856|101878670|FG002|Overall Study|Lack of Efficacy|8|||
33540739|NCT00284856|101878668|FG000|Overall Study|Lost to Follow-up|25|||
33540740|NCT00284856|101878669|FG001|Overall Study|Lost to Follow-up|21|||
33540741|NCT00284856|101878670|FG002|Overall Study|Lost to Follow-up|22|||
33540742|NCT00284856|101878668|FG000|Overall Study|Protocol Violation|5|||
33540743|NCT00284856|101878669|FG001|Overall Study|Protocol Violation|4|||
33540744|NCT00284856|101878670|FG002|Overall Study|Protocol Violation|5|||
33540745|NCT00284856|101878668|FG000|Overall Study|Withdrawal by Subject|12|||
33540746|NCT00284856|101878669|FG001|Overall Study|Withdrawal by Subject|16|||
33540747|NCT00284856|101878670|FG002|Overall Study|Withdrawal by Subject|18|||
33540748|NCT00284856|101878668|FG000|Overall Study|Other|4|||
33540749|NCT00284856|101878669|FG001|Overall Study|Other|5|||
33540750|NCT00284856|101878670|FG002|Overall Study|Other|4|||
33540751|NCT01181167|101878674|FG000|Overall Study|Adverse Event|11|||
33540752|NCT01181167|101878675|FG001|Overall Study|Adverse Event|21|||
33540753|NCT01181167|101878674|FG000|Overall Study|Lost to Follow-up|1|||
33540754|NCT01181167|101878675|FG001|Overall Study|Lost to Follow-up|0|||
33540755|NCT01181167|101878674|FG000|Overall Study|Physician Decision|2|||
33540756|NCT01181167|101878675|FG001|Overall Study|Physician Decision|3|||
33540757|NCT01181167|101878674|FG000|Overall Study|Protocol Violation|3|||
33540758|NCT01181167|101878675|FG001|Overall Study|Protocol Violation|0|||
33540759|NCT01181167|101878674|FG000|Overall Study|Withdrawal by Subject|6|||
33540760|NCT01181167|101878675|FG001|Overall Study|Withdrawal by Subject|8|||
33540761|NCT02014272|101878678|FG000|Intervention Period 1|Withdrawal by Subject|1|||
33540762|NCT02014272|101878679|FG001|Intervention Period 1|Withdrawal by Subject|0|||
33540763|NCT02014272|101878678|FG000|Intervention Period 1|Adverse Event|0|||
33540764|NCT02014272|101878679|FG001|Intervention Period 1|Adverse Event|1|||
33615503|NCT04124705|102140326|FG000|Stabilization Period|Lack of Efficacy|4|||
33540765|NCT02153918|101878680|FG000|Overall Study|Refused further treatment|1|||
33540766|NCT01901185|101878681|FG000|Overall Study|Withdrawal by Subject|2|||
33540767|NCT00472420|101878685|FG000|Induction Treatment Period|Physician Decision|9|||
33540768|NCT00472420|101878685|FG000|Induction Treatment Period|Adverse Event|3|||
33540769|NCT00472420|101878685|FG000|Induction Treatment Period|Non-compliance|1|||
33540770|NCT00472420|101878685|FG000|Induction Treatment Period|Death|3|||
33540771|NCT00472420|101878685|FG000|Follow-up Period|Death|5|||
33406776|NCT02030067|101377731|FG010|Overall Study|Disease Progression|7|||
33406777|NCT02030067|101377732|FG011|Overall Study|Disease Progression|2|||
33406778|NCT02030067|101377733|FG012|Overall Study|Disease Progression|59|||
33406779|NCT02030067|101377721|FG000|Overall Study|Withdrawal by Subject|0|||
33406780|NCT02030067|101377722|FG001|Overall Study|Withdrawal by Subject|0|||
33406781|NCT02030067|101377723|FG002|Overall Study|Withdrawal by Subject|0|||
33406782|NCT02030067|101377724|FG003|Overall Study|Withdrawal by Subject|1|||
33406783|NCT02030067|101377725|FG004|Overall Study|Withdrawal by Subject|0|||
33406784|NCT02030067|101377726|FG005|Overall Study|Withdrawal by Subject|0|||
33406785|NCT02030067|101377727|FG006|Overall Study|Withdrawal by Subject|0|||
33406786|NCT02030067|101377728|FG007|Overall Study|Withdrawal by Subject|1|||
33406787|NCT02030067|101377729|FG008|Overall Study|Withdrawal by Subject|0|||
33406788|NCT02030067|101377730|FG009|Overall Study|Withdrawal by Subject|0|||
33406789|NCT02030067|101377731|FG010|Overall Study|Withdrawal by Subject|3|||
33406790|NCT02030067|101377732|FG011|Overall Study|Withdrawal by Subject|0|||
33406791|NCT02030067|101377733|FG012|Overall Study|Withdrawal by Subject|6|||
33406792|NCT02030067|101377721|FG000|Overall Study|Physician Decision|0|||
33406793|NCT02030067|101377722|FG001|Overall Study|Physician Decision|0|||
33406794|NCT02030067|101377723|FG002|Overall Study|Physician Decision|0|||
33406795|NCT02030067|101377724|FG003|Overall Study|Physician Decision|0|||
33406796|NCT02030067|101377725|FG004|Overall Study|Physician Decision|0|||
33406797|NCT02030067|101377726|FG005|Overall Study|Physician Decision|0|||
33406798|NCT02030067|101377727|FG006|Overall Study|Physician Decision|0|||
33406799|NCT02030067|101377728|FG007|Overall Study|Physician Decision|0|||
33406800|NCT02030067|101377729|FG008|Overall Study|Physician Decision|0|||
33406801|NCT02030067|101377730|FG009|Overall Study|Physician Decision|0|||
33406802|NCT02030067|101377731|FG010|Overall Study|Physician Decision|1|||
33406803|NCT02030067|101377732|FG011|Overall Study|Physician Decision|0|||
33406804|NCT02030067|101377733|FG012|Overall Study|Physician Decision|3|||
33406805|NCT02030067|101377721|FG000|Overall Study|other reasons|0|||
33406806|NCT02030067|101377722|FG001|Overall Study|other reasons|0|||
33406807|NCT02030067|101377723|FG002|Overall Study|other reasons|0|||
33406808|NCT02030067|101377724|FG003|Overall Study|other reasons|0|||
33406809|NCT02030067|101377725|FG004|Overall Study|other reasons|0|||
33406810|NCT02030067|101377726|FG005|Overall Study|other reasons|1|||
33406811|NCT02030067|101377727|FG006|Overall Study|other reasons|0|||
33406812|NCT02030067|101377728|FG007|Overall Study|other reasons|0|||
33406813|NCT02030067|101377729|FG008|Overall Study|other reasons|2|||
33406814|NCT02030067|101377730|FG009|Overall Study|other reasons|0|||
33406815|NCT02030067|101377731|FG010|Overall Study|other reasons|0|||
33406816|NCT02030067|101377732|FG011|Overall Study|other reasons|0|||
33406817|NCT02030067|101377733|FG012|Overall Study|other reasons|4|||
33406818|NCT02030067|101377721|FG000|Overall Study|Adverse Event|0|||
33406819|NCT02030067|101377722|FG001|Overall Study|Adverse Event|0|||
33406820|NCT02030067|101377723|FG002|Overall Study|Adverse Event|0|||
33406821|NCT02030067|101377724|FG003|Overall Study|Adverse Event|0|||
33406822|NCT02030067|101377725|FG004|Overall Study|Adverse Event|0|||
33406823|NCT02030067|101377726|FG005|Overall Study|Adverse Event|0|||
33406824|NCT02030067|101377727|FG006|Overall Study|Adverse Event|0|||
33406825|NCT02030067|101377728|FG007|Overall Study|Adverse Event|0|||
33406826|NCT02030067|101377729|FG008|Overall Study|Adverse Event|0|||
33406827|NCT02030067|101377730|FG009|Overall Study|Adverse Event|0|||
33406828|NCT02030067|101377731|FG010|Overall Study|Adverse Event|0|||
33406829|NCT02030067|101377732|FG011|Overall Study|Adverse Event|1|||
33406830|NCT02030067|101377733|FG012|Overall Study|Adverse Event|8|||
33406831|NCT04576702|101377734|FG000|Overall Study|Death|1|||
33406832|NCT04576702|101377735|FG001|Overall Study|Death|0|||
33406833|NCT04576702|101377736|FG002|Overall Study|Death|0|||
33406834|NCT04576702|101377737|FG003|Overall Study|Death|0|||
33406835|NCT04576702|101377734|FG000|Overall Study|Withdrawal by Subject|0|||
33406836|NCT04576702|101377735|FG001|Overall Study|Withdrawal by Subject|2|||
33406837|NCT04576702|101377736|FG002|Overall Study|Withdrawal by Subject|1|||
33406838|NCT04576702|101377737|FG003|Overall Study|Withdrawal by Subject|0|||
33406839|NCT04576702|101377734|FG000|Overall Study|Lost to Follow-up|3|||
33406840|NCT04576702|101377735|FG001|Overall Study|Lost to Follow-up|3|||
33406841|NCT04576702|101377736|FG002|Overall Study|Lost to Follow-up|3|||
33406842|NCT04576702|101377737|FG003|Overall Study|Lost to Follow-up|4|||
33406843|NCT01220024|101377738|FG000|Overall Study|Lost to Follow-up|1|||
33406844|NCT01220024|101377739|FG001|Overall Study|Lost to Follow-up|1|||
33406845|NCT00565721|101377740|FG000|Overall Study|Screen Failure|2|||
33406846|NCT00565721|101377740|FG000|Overall Study|Lost to Follow-up|6|||
33406847|NCT00565721|101377740|FG000|Overall Study|Technical Problems|1|||
33406848|NCT00565721|101377740|FG000|Overall Study|Physician Decision|2|||
33406849|NCT00565721|101377740|FG000|Overall Study|Other reasons|6|||
33406850|NCT00285857|101377742|FG000|Overall Study|Withdrawal by Subject|2|||
33406851|NCT00285857|101377742|FG000|Overall Study|Inadequate initial breast cytology|1|||
33540772|NCT00472420|101878685|FG000|Follow-up Period|Physician Decision|9|||
33540773|NCT00472420|101878685|FG000|Follow-up Period|Lost to Follow-up|2|||
33540774|NCT00472420|101878685|FG000|Follow-up Period|Protocol Violation|1|||
33540775|NCT00465179|101878692|FG000|Overall Study|Adverse Event|4|||
33540776|NCT00465179|101878692|FG000|Overall Study|Withdrawal by Subject|2|||
33540777|NCT00465179|101878692|FG000|Overall Study|Progression of Disease|47|||
33540778|NCT01933594|101878696|FG000|Overall Study|Lost to Follow-up|1|||
33540779|NCT01933594|101878697|FG001|Overall Study|Lost to Follow-up|0|||
33540780|NCT01933594|101878698|FG002|Overall Study|Lost to Follow-up|0|||
33540781|NCT01933594|101878699|FG003|Overall Study|Lost to Follow-up|0|||
33540782|NCT01933594|101878700|FG004|Overall Study|Lost to Follow-up|1|||
33540783|NCT01933594|101878701|FG005|Overall Study|Lost to Follow-up|0|||
33540784|NCT01933594|101878696|FG000|Overall Study|Ineligible for subsequent study step|0|||
33540785|NCT01933594|101878697|FG001|Overall Study|Ineligible for subsequent study step|0|||
33540786|NCT01933594|101878698|FG002|Overall Study|Ineligible for subsequent study step|0|||
33540787|NCT01933594|101878699|FG003|Overall Study|Ineligible for subsequent study step|0|||
33540788|NCT01933594|101878700|FG004|Overall Study|Ineligible for subsequent study step|1|||
33615504|NCT04124705|102140327|FG001|Stabilization Period|Lack of Efficacy|2|||
33615505|NCT04124705|102140326|FG000|Stabilization Period|Protocol Deviation|0|||
33615506|NCT04124705|102140327|FG001|Stabilization Period|Protocol Deviation|2|||
33615507|NCT04124705|102140326|FG000|Stabilization Period|Other|2|||
33615508|NCT04124705|102140327|FG001|Stabilization Period|Other|2|||
33615509|NCT01286740|102140329|FG000|Overall Study|Enrolled but not treated|1|||
33615510|NCT01286740|102140329|FG000|Overall Study|Protocol Violation|1|||
33615511|NCT00719355|102140332|FG000|Overall Study|Death|0|||
33615512|NCT00719355|102140333|FG001|Overall Study|Death|1|||
33615513|NCT00719355|102140332|FG000|Overall Study|Medical|14|||
33615514|NCT00719355|102140333|FG001|Overall Study|Medical|5|||
33615515|NCT00719355|102140332|FG000|Overall Study|Compliance|4|||
33615516|NCT00719355|102140333|FG001|Overall Study|Compliance|6|||
33615517|NCT00719355|102140332|FG000|Overall Study|Moved|0|||
33615518|NCT00719355|102140333|FG001|Overall Study|Moved|1|||
33615519|NCT02720692|102140334|FG000|Overall Study|Withdrawal by Subject|3|||
33615520|NCT02720692|102140335|FG001|Overall Study|Withdrawal by Subject|0|||
33615521|NCT02720692|102140334|FG000|Overall Study|Physician Decision|1|||
33615522|NCT02720692|102140335|FG001|Overall Study|Physician Decision|0|||
33615523|NCT02720692|102140334|FG000|Overall Study|Lost to Follow-up|8|||
33615524|NCT02720692|102140335|FG001|Overall Study|Lost to Follow-up|3|||
33615525|NCT02720692|102140334|FG000|Overall Study|Subject unable to return for visit|1|||
33343544|NCT01239160|101148206|FG000|Overall Study|Physician Decision|5|||
33343545|NCT01239160|101148207|FG001|Overall Study|Physician Decision|7|||
33343546|NCT01239160|101148208|FG002|Overall Study|Physician Decision|2|||
33343547|NCT01239160|101148206|FG000|Overall Study|Early Termination Due to Study Closure|0|||
33343548|NCT01239160|101148207|FG001|Overall Study|Early Termination Due to Study Closure|1|||
33343549|NCT01239160|101148208|FG002|Overall Study|Early Termination Due to Study Closure|6|||
33343550|NCT01641939|101148210|FG000|Overall Study|Death|90|||
33343551|NCT01641939|101148211|FG001|Overall Study|Death|187|||
33343552|NCT01641939|101148212|FG002|Overall Study|Death|61|||
33343553|NCT01641939|101148210|FG000|Overall Study|Lost to Follow-up|3|||
33343554|NCT01641939|101148211|FG001|Overall Study|Lost to Follow-up|2|||
33343555|NCT01641939|101148212|FG002|Overall Study|Lost to Follow-up|1|||
33343556|NCT01641939|101148210|FG000|Overall Study|Withdrawal by Subject|14|||
33343557|NCT01641939|101148211|FG001|Overall Study|Withdrawal by Subject|11|||
33343558|NCT01641939|101148212|FG002|Overall Study|Withdrawal by Subject|5|||
33343559|NCT01641939|101148210|FG000|Overall Study|Study Terminated by Sponsor|10|||
33343560|NCT01641939|101148211|FG001|Overall Study|Study Terminated by Sponsor|28|||
33343561|NCT01641939|101148212|FG002|Overall Study|Study Terminated by Sponsor|3|||
33343562|NCT03969888|101148213|FG000|Overall Study|Never Received Study Drug|0|||
33343563|NCT03969888|101148214|FG001|Overall Study|Never Received Study Drug|0|||
33343564|NCT03969888|101148215|FG002|Overall Study|Never Received Study Drug|1|||
33343565|NCT03969888|101148216|FG003|Overall Study|Never Received Study Drug|0|||
33343566|NCT03969888|101148217|FG004|Overall Study|Never Received Study Drug|0|||
33406852|NCT00285857|101377742|FG000|Overall Study|Adverse Event|1|||
33540789|NCT01933594|101878701|FG005|Overall Study|Ineligible for subsequent study step|0|||
33540790|NCT03176771|101878706|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
33540791|NCT03176771|101878707|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
33540792|NCT03176771|101878708|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
33615526|NCT02720692|102140335|FG001|Overall Study|Subject unable to return for visit|0|||
33615527|NCT04071158|102140336|FG000|Overall Study|Lost to Follow-up|1|||
33615528|NCT04071158|102140337|FG001|Overall Study|Lost to Follow-up|2|||
33343567|NCT03969888|101148218|FG005|Overall Study|Never Received Study Drug|0|||
33343568|NCT03969888|101148219|FG006|Overall Study|Never Received Study Drug|1|||
33343569|NCT03969888|101148220|FG007|Overall Study|Never Received Study Drug|0|||
33343570|NCT03969888|101148213|FG000|Overall Study|Reason Not Specified|0|||
33343571|NCT03969888|101148214|FG001|Overall Study|Reason Not Specified|0|||
33343572|NCT03969888|101148215|FG002|Overall Study|Reason Not Specified|0|||
33343573|NCT03969888|101148216|FG003|Overall Study|Reason Not Specified|0|||
33343574|NCT03969888|101148217|FG004|Overall Study|Reason Not Specified|0|||
33343575|NCT03969888|101148218|FG005|Overall Study|Reason Not Specified|0|||
33343576|NCT03969888|101148219|FG006|Overall Study|Reason Not Specified|0|||
33343577|NCT03969888|101148220|FG007|Overall Study|Reason Not Specified|1|||
33343578|NCT01235962|101148221|FG000|Overall Study|Withdrawal by Subject|20|||
33343579|NCT01235962|101148222|FG001|Overall Study|Withdrawal by Subject|19|||
33343580|NCT01235962|101148223|FG002|Overall Study|Withdrawal by Subject|62|||
33343581|NCT01235962|101148224|FG003|Overall Study|Withdrawal by Subject|49|||
33343582|NCT01235962|101148221|FG000|Overall Study|Lost to Follow-up|21|||
33343583|NCT01235962|101148222|FG001|Overall Study|Lost to Follow-up|16|||
33343584|NCT01235962|101148223|FG002|Overall Study|Lost to Follow-up|47|||
33343585|NCT01235962|101148224|FG003|Overall Study|Lost to Follow-up|32|||
33343586|NCT01235962|101148221|FG000|Overall Study|Physician Decision|5|||
33343587|NCT01235962|101148222|FG001|Overall Study|Physician Decision|0|||
33343588|NCT01235962|101148223|FG002|Overall Study|Physician Decision|9|||
33343589|NCT01235962|101148224|FG003|Overall Study|Physician Decision|5|||
33343590|NCT02319044|101148225|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
33343591|NCT02319044|101148226|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
33343592|NCT02319044|101148227|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
33343593|NCT02319044|101148225|FG000|Overall Study|Withdrawal by Subject|3|||
33343594|NCT02319044|101148226|FG001|Overall Study|Withdrawal by Subject|3|||
33343595|NCT02319044|101148227|FG002|Overall Study|Withdrawal by Subject|6|||
33343596|NCT02319044|101148225|FG000|Overall Study|Condition under investigation worsened|100|||
33343597|NCT02319044|101148226|FG001|Overall Study|Condition under investigation worsened|50|||
33343598|NCT02319044|101148227|FG002|Overall Study|Condition under investigation worsened|46|||
33343599|NCT02319044|101148225|FG000|Overall Study|Adverse Event|17|||
33343600|NCT02319044|101148226|FG001|Overall Study|Adverse Event|2|||
33343601|NCT02319044|101148227|FG002|Overall Study|Adverse Event|8|||
33343602|NCT02319044|101148225|FG000|Overall Study|Study specific discontinuation criteria|2|||
33343603|NCT02319044|101148226|FG001|Overall Study|Study specific discontinuation criteria|2|||
33343604|NCT02319044|101148227|FG002|Overall Study|Study specific discontinuation criteria|1|||
33343605|NCT02319044|101148225|FG000|Overall Study|Not treated|0|||
33343606|NCT02319044|101148226|FG001|Overall Study|Not treated|2|||
33343607|NCT02319044|101148227|FG002|Overall Study|Not treated|2|||
33343608|NCT04957290|101148234|FG000|Overall Study|Progressive disease|3|||
33343609|NCT04957290|101148235|FG001|Overall Study|Progressive disease|3|||
33343610|NCT04957290|101148236|FG002|Overall Study|Progressive disease|2|||
33343611|NCT04957290|101148237|FG003|Overall Study|Progressive disease|0|||
33343612|NCT04957290|101148238|FG004|Overall Study|Progressive disease|0|||
33343613|NCT04957290|101148239|FG005|Overall Study|Progressive disease|0|||
33343614|NCT04957290|101148234|FG000|Overall Study|Withdrawal by Subject|1|||
33343615|NCT04957290|101148235|FG001|Overall Study|Withdrawal by Subject|0|||
33343616|NCT04957290|101148236|FG002|Overall Study|Withdrawal by Subject|1|||
33343617|NCT04957290|101148237|FG003|Overall Study|Withdrawal by Subject|0|||
33343618|NCT04957290|101148238|FG004|Overall Study|Withdrawal by Subject|0|||
33343619|NCT04957290|101148239|FG005|Overall Study|Withdrawal by Subject|0|||
33343620|NCT04957290|101148234|FG000|Overall Study|Death|0|||
33343621|NCT04957290|101148235|FG001|Overall Study|Death|2|||
33343622|NCT04957290|101148236|FG002|Overall Study|Death|1|||
33343623|NCT04957290|101148237|FG003|Overall Study|Death|0|||
33343624|NCT04957290|101148238|FG004|Overall Study|Death|0|||
33343625|NCT04957290|101148239|FG005|Overall Study|Death|0|||
33343626|NCT04957290|101148234|FG000|Overall Study|non compliance with study drug|0|||
33343627|NCT04957290|101148235|FG001|Overall Study|non compliance with study drug|1|||
33343628|NCT04957290|101148236|FG002|Overall Study|non compliance with study drug|0|||
33343629|NCT04957290|101148237|FG003|Overall Study|non compliance with study drug|0|||
33343630|NCT04957290|101148238|FG004|Overall Study|non compliance with study drug|0|||
33343631|NCT04957290|101148239|FG005|Overall Study|non compliance with study drug|0|||
33343632|NCT04957290|101148234|FG000|Overall Study|none specified.|0|||
33343633|NCT04957290|101148235|FG001|Overall Study|none specified.|1|||
33343634|NCT04957290|101148236|FG002|Overall Study|none specified.|2|||
33343635|NCT04957290|101148237|FG003|Overall Study|none specified.|0|||
33343636|NCT04957290|101148238|FG004|Overall Study|none specified.|0|||
33343637|NCT04957290|101148239|FG005|Overall Study|none specified.|0|||
33343638|NCT04957290|101148234|FG000|Overall Study|unacceptable toxicity|0|||
33343639|NCT04957290|101148235|FG001|Overall Study|unacceptable toxicity|0|||
33343640|NCT04957290|101148236|FG002|Overall Study|unacceptable toxicity|1|||
33343641|NCT04957290|101148237|FG003|Overall Study|unacceptable toxicity|0|||
33343642|NCT04957290|101148238|FG004|Overall Study|unacceptable toxicity|0|||
33343643|NCT04957290|101148239|FG005|Overall Study|unacceptable toxicity|0|||
33540793|NCT03176771|101878709|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
33540794|NCT03176771|101878710|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
33540795|NCT03176771|101878706|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
33540796|NCT03176771|101878707|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
33540797|NCT03176771|101878708|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
33540798|NCT03176771|101878709|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
33540799|NCT03176771|101878710|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
33615529|NCT04071158|102140338|FG002|Overall Study|Lost to Follow-up|3|||
33615530|NCT04071158|102140339|FG003|Overall Study|Lost to Follow-up|3|||
33615531|NCT04071158|102140340|FG004|Overall Study|Lost to Follow-up|5|||
33615532|NCT04071158|102140336|FG000|Overall Study|Randomized but not treated|2|||
33615533|NCT04071158|102140337|FG001|Overall Study|Randomized but not treated|2|||
33343644|NCT04957290|101148234|FG000|Overall Study|Adverse Event|0|||
33343645|NCT04957290|101148235|FG001|Overall Study|Adverse Event|0|||
33343646|NCT04957290|101148236|FG002|Overall Study|Adverse Event|1|||
33343647|NCT04957290|101148237|FG003|Overall Study|Adverse Event|0|||
33343648|NCT04957290|101148238|FG004|Overall Study|Adverse Event|0|||
33615534|NCT04071158|102140338|FG002|Overall Study|Randomized but not treated|0|||
33615535|NCT04071158|102140339|FG003|Overall Study|Randomized but not treated|0|||
33615536|NCT04071158|102140340|FG004|Overall Study|Randomized but not treated|0|||
33615537|NCT02462720|102140343|FG000|Part 2|Withdrawal by Subject|1|||
33343649|NCT04957290|101148239|FG005|Overall Study|Adverse Event|0|||
33343650|NCT04957290|101148234|FG000|Overall Study|study terminated by sponsor|0|||
33343651|NCT04957290|101148235|FG001|Overall Study|study terminated by sponsor|0|||
33343652|NCT04957290|101148236|FG002|Overall Study|study terminated by sponsor|2|||
33343653|NCT04957290|101148237|FG003|Overall Study|study terminated by sponsor|0|||
33343654|NCT04957290|101148238|FG004|Overall Study|study terminated by sponsor|0|||
33343655|NCT04957290|101148239|FG005|Overall Study|study terminated by sponsor|0|||
33406853|NCT02985996|101377743|FG000|Overall Study|Withdrawal by Subject|0|||
33615538|NCT02462720|102140344|FG001|Part 2|Withdrawal by Subject|0|||
33615539|NCT02462720|102140343|FG000|Part 2|Protocol Violation|0|||
33615540|NCT02462720|102140344|FG001|Part 2|Protocol Violation|1|||
33615541|NCT01331109|102140345|FG000|Overall Study|Adverse Event|6|||
33615542|NCT01331109|102140345|FG000|Overall Study|Lack of Efficacy|2|||
33615543|NCT01331109|102140345|FG000|Overall Study|Protocol Violation|3|||
33615544|NCT01331109|102140345|FG000|Overall Study|Withdrawal by Subject|7|||
33615545|NCT01331109|102140345|FG000|Overall Study|Lost to Follow-up|1|||
33615546|NCT01331109|102140345|FG000|Overall Study|Study Terminated by Sponsor|38|||
33615547|NCT01865448|102140350|FG000|Overall Study|Adverse Event|1|||
33615548|NCT01865448|102140351|FG001|Overall Study|Adverse Event|1|||
33615549|NCT01865448|102140350|FG000|Overall Study|Pregnancy|0|||
33615550|NCT01865448|102140351|FG001|Overall Study|Pregnancy|1|||
33615551|NCT01865448|102140350|FG000|Overall Study|dropout unrelated to study|1|||
33615552|NCT01865448|102140351|FG001|Overall Study|dropout unrelated to study|1|||
33615553|NCT02363959|102140352|FG000|Overall Study|Medical instability|1|||
33406854|NCT02985996|101377744|FG001|Overall Study|Withdrawal by Subject|0|||
33615554|NCT02363959|102140353|FG001|Overall Study|Medical instability|0|||
33615555|NCT00630344|102140354|FG000|Overall Study|Adverse Event|5|||
33615556|NCT00630344|102140354|FG000|Overall Study|Progressive Disease|19|||
33615557|NCT00630344|102140354|FG000|Overall Study|Physician Decision|9|||
33615558|NCT00630344|102140354|FG000|Overall Study|Withdrawal by Subject|1|||
33615559|NCT00630344|102140354|FG000|Overall Study|Intercurrent Illness|1|||
33615560|NCT00630344|102140354|FG000|Overall Study|Other|1|||
33615561|NCT03221842|102140355|FG000|Period 1 (Open-label)|Adverse Event|4|||
33615562|NCT03221842|102140356|FG001|Period 1 (Open-label)|Adverse Event|0|||
33615563|NCT03221842|102140355|FG000|Period 1 (Open-label)|Physician Decision|2|||
33615564|NCT03221842|102140356|FG001|Period 1 (Open-label)|Physician Decision|0|||
33615565|NCT03221842|102140355|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
33615566|NCT03221842|102140356|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
33615567|NCT03221842|102140355|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
33615568|NCT03221842|102140356|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
33343656|NCT00448708|101148240|FG000|Overall Study|Death|21|||
33210961|NCT00374322|100673528|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
33210962|NCT00374322|100673527|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
33210963|NCT00374322|100673528|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
33210964|NCT00374322|100673527|FG000|Overall Study|Severe Toxicity|1|||
33210965|NCT00374322|100673528|FG001|Overall Study|Severe Toxicity|0|||
33210966|NCT00374322|100673527|FG000|Overall Study|Site Closed|2|||
33210967|NCT00374322|100673528|FG001|Overall Study|Site Closed|2|||
33210968|NCT00374322|100673527|FG000|Overall Study|Participant Changed Physician|1|||
33210969|NCT00374322|100673528|FG001|Overall Study|Participant Changed Physician|0|||
33210970|NCT00374322|100673527|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
33210971|NCT00374322|100673528|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
33210972|NCT00374322|100673527|FG000|Overall Study|Noncompliance with Study Requirements|0|||
33210973|NCT00374322|100673528|FG001|Overall Study|Noncompliance with Study Requirements|1|||
33210974|NCT00374322|100673527|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
33210975|NCT00374322|100673528|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
33210976|NCT00374322|100673527|FG000|Overall Study|Did Not Receive Study Medication|8|||
33210977|NCT00374322|100673528|FG001|Overall Study|Did Not Receive Study Medication|6|||
33210978|NCT02962908|100673529|FG000|Overall Study|Lost to Follow-up|0|||
33210979|NCT02962908|100673530|FG001|Overall Study|Lost to Follow-up|3|||
33210980|NCT02962908|100673531|FG002|Overall Study|Lost to Follow-up|0|||
33210981|NCT02962908|100673532|FG003|Overall Study|Lost to Follow-up|1|||
33210982|NCT02962908|100673529|FG000|Overall Study|Withdrawal by Subject|0|||
33210983|NCT02962908|100673530|FG001|Overall Study|Withdrawal by Subject|3|||
33210984|NCT02962908|100673531|FG002|Overall Study|Withdrawal by Subject|0|||
33210985|NCT02962908|100673532|FG003|Overall Study|Withdrawal by Subject|2|||
33210986|NCT02962908|100673529|FG000|Overall Study|Protocol Violation|0|||
33210987|NCT02962908|100673530|FG001|Overall Study|Protocol Violation|1|||
33210988|NCT02962908|100673531|FG002|Overall Study|Protocol Violation|0|||
33210989|NCT02962908|100673532|FG003|Overall Study|Protocol Violation|0|||
33210990|NCT02962908|100673529|FG000|Overall Study|Physician Decision|0|||
33210991|NCT02962908|100673530|FG001|Overall Study|Physician Decision|1|||
33210992|NCT02962908|100673531|FG002|Overall Study|Physician Decision|0|||
33210993|NCT02962908|100673532|FG003|Overall Study|Physician Decision|0|||
33210994|NCT01777854|100673533|FG000|Overall Study|Physician Decision|3|||
33210995|NCT01777854|100673534|FG001|Overall Study|Physician Decision|3|||
33210996|NCT01549613|100673535|FG000|Overall Study|Lost to Follow-up|11|||
33210997|NCT01549613|100673536|FG001|Overall Study|Lost to Follow-up|11|||
33210998|NCT03966157|100673537|FG000|Overall Study|Physician Decision|1|||
33210999|NCT03966157|100673538|FG001|Overall Study|Physician Decision|0|||
33211000|NCT03835533|100673546|FG000|Overall Study|Death|5|||
33211001|NCT03835533|100673547|FG001|Overall Study|Death|10|||
33211002|NCT03835533|100673548|FG002|Overall Study|Death|9|||
33211003|NCT03835533|100673546|FG000|Overall Study|Withdrawal by Subject|2|||
33211004|NCT03835533|100673547|FG001|Overall Study|Withdrawal by Subject|2|||
33211005|NCT03835533|100673548|FG002|Overall Study|Withdrawal by Subject|2|||
33211006|NCT03835533|100673546|FG000|Overall Study|Lost to Follow-up|1|||
33211007|NCT03835533|100673547|FG001|Overall Study|Lost to Follow-up|0|||
33211008|NCT03835533|100673548|FG002|Overall Study|Lost to Follow-up|0|||
33211009|NCT00594854|100673551|FG000|Overall Study|Study terminated|7|||
33343657|NCT00448708|101148241|FG001|Overall Study|Death|17|||
33343658|NCT00448708|101148240|FG000|Overall Study|Withdrawal by Subject|8|||
33343659|NCT00448708|101148241|FG001|Overall Study|Withdrawal by Subject|4|||
33343660|NCT00448708|101148240|FG000|Overall Study|Lost to Follow-up|6|||
33343661|NCT00448708|101148241|FG001|Overall Study|Lost to Follow-up|8|||
33343662|NCT00448708|101148240|FG000|Overall Study|not listed|0|||
33343663|NCT00448708|101148241|FG001|Overall Study|not listed|2|||
33343664|NCT04599062|101148242|FG000|Overall Study|Physician Decision|1|||
33343665|NCT04599062|101148243|FG001|Overall Study|Physician Decision|0|||
33343666|NCT00433329|101148244|FG000|Overall Study|Adverse Event|9|||
33343667|NCT00433329|101148244|FG000|Overall Study|Death|4|||
33540800|NCT03176771|101878706|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
33540801|NCT03176771|101878707|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
33540802|NCT03176771|101878708|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
33343668|NCT00433329|101148244|FG000|Overall Study|Withdrew consent|3|||
33343669|NCT00433329|101148244|FG000|Overall Study|Discontinued sildenafil|2|||
33211010|NCT00594854|100673552|FG001|Overall Study|Study terminated|10|||
33211011|NCT03762473|100673553|FG000|Overall Study|Death|1|||
33211012|NCT03762473|100673554|FG001|Overall Study|Death|0|||
33211013|NCT01474681|100673555|FG000|Overall Study|Death|0|||
33211014|NCT01474681|100673556|FG001|Overall Study|Death|3|||
33211015|NCT01474681|100673557|FG002|Overall Study|Death|2|||
33343670|NCT00433329|101148244|FG000|Overall Study|Moved out of state|1|||
33211016|NCT01474681|100673558|FG003|Overall Study|Death|6|||
33211017|NCT00377234|100673559|FG000|Overall Study|Adverse Event|14|||
33211018|NCT00377234|100673560|FG001|Overall Study|Adverse Event|17|||
33211019|NCT00377234|100673559|FG000|Overall Study|Withdrawal by Subject|11|||
33211020|NCT00377234|100673560|FG001|Overall Study|Withdrawal by Subject|9|||
33211021|NCT00377234|100673559|FG000|Overall Study|Lost to Follow-up|4|||
33211022|NCT00377234|100673560|FG001|Overall Study|Lost to Follow-up|2|||
33211023|NCT00377234|100673559|FG000|Overall Study|Administrative|2|||
33211024|NCT00377234|100673560|FG001|Overall Study|Administrative|1|||
33211025|NCT00377234|100673559|FG000|Overall Study|Not assigned|3|||
33211026|NCT00377234|100673560|FG001|Overall Study|Not assigned|2|||
33211027|NCT00829387|100673570|FG000|Overall Study|Withdrawal by Subject|2|||
33211028|NCT00829387|100673571|FG001|Overall Study|Withdrawal by Subject|3|||
33211029|NCT00829387|100673570|FG000|Overall Study|Disqualified by PI|1|||
33211030|NCT00829387|100673571|FG001|Overall Study|Disqualified by PI|0|||
33211031|NCT01754467|100673572|FG000|Overall Study|Lost to Follow-up|1|||
33211032|NCT00126438|100673573|FG000|Overall Study|Withdrawal due to adverse event|1|||
33211033|NCT00126438|100673574|FG001|Overall Study|Withdrawal due to adverse event|0|||
33211034|NCT00126438|100673573|FG000|Overall Study|Lost to Follow-up|22|||
33211035|NCT00126438|100673574|FG001|Overall Study|Lost to Follow-up|0|||
33211036|NCT00126438|100673573|FG000|Overall Study|Protocol Violation|8|||
33211037|NCT00126438|100673574|FG001|Overall Study|Protocol Violation|8|||
33211038|NCT00126438|100673573|FG000|Overall Study|Withdrawal by Subject|3|||
33211039|NCT00126438|100673574|FG001|Overall Study|Withdrawal by Subject|2|||
33211040|NCT02301143|100673575|FG000|Induction Period|Enrolled But Not Treated|1|||
33211041|NCT02301143|100673576|FG001|Induction Period|Enrolled But Not Treated|0|||
33211042|NCT02301143|100673575|FG000|Induction Period|Death|1|||
33211043|NCT02301143|100673576|FG001|Induction Period|Death|0|||
33211044|NCT02301143|100673575|FG000|Induction Period|Adverse Event|22|||
33211045|NCT02301143|100673576|FG001|Induction Period|Adverse Event|0|||
33211046|NCT02301143|100673575|FG000|Induction Period|Progressive Disease|8|||
33211047|NCT02301143|100673576|FG001|Induction Period|Progressive Disease|0|||
33211048|NCT02301143|100673575|FG000|Induction Period|Withdrawal by Subject|3|||
33211049|NCT02301143|100673576|FG001|Induction Period|Withdrawal by Subject|0|||
33211050|NCT02301143|100673575|FG000|Induction Period|Noncompliance with Study Drug|1|||
33211051|NCT02301143|100673576|FG001|Induction Period|Noncompliance with Study Drug|0|||
33211052|NCT02301143|100673575|FG000|Induction Period|Physician Decision|4|||
33211053|NCT02301143|100673576|FG001|Induction Period|Physician Decision|0|||
33211054|NCT02301143|100673575|FG000|Induction Period|Symptomatic Deterioration|2|||
33211055|NCT02301143|100673576|FG001|Induction Period|Symptomatic Deterioration|0|||
33211056|NCT02301143|100673575|FG000|Induction Period|Protocol Violation|2|||
33211057|NCT02301143|100673576|FG001|Induction Period|Protocol Violation|0|||
33211058|NCT02301143|100673575|FG000|Induction Period|Other|1|||
33211059|NCT02301143|100673576|FG001|Induction Period|Other|0|||
33211060|NCT02301143|100673575|FG000|Investigator's Choice|Adverse Event|0|||
33211061|NCT02301143|100673576|FG001|Investigator's Choice|Adverse Event|3|||
33211062|NCT02301143|100673575|FG000|Investigator's Choice|Progressive Disease|0|||
33343671|NCT00433329|101148244|FG000|Overall Study|Lost to Follow-up|1|||
33343672|NCT00433329|101148244|FG000|Overall Study|Physician Decision|1|||
33343673|NCT02908880|101148247|FG000|Overall Study|Lost to Follow-up|4|||
33343674|NCT02908880|101148247|FG000|Overall Study|Explantation of the device|1|||
33343675|NCT02908880|101148247|FG000|Overall Study|Withdrawal by Subject|17|||
33343676|NCT02908880|101148247|FG000|Overall Study|Death|5|||
33343677|NCT03705793|101148248|FG000|Overall Study|Lost to Follow-up|3|||
33343678|NCT03705793|101148249|FG001|Overall Study|Lost to Follow-up|4|||
33343679|NCT03705793|101148248|FG000|Overall Study|Withdrawal by Subject|2|||
33343680|NCT03705793|101148249|FG001|Overall Study|Withdrawal by Subject|1|||
33343681|NCT02631538|101148251|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
33343682|NCT02631538|101148252|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
33343683|NCT02631538|101148253|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
33343684|NCT02631538|101148254|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
33343685|NCT02631538|101148251|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
33343686|NCT02631538|101148252|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
33343687|NCT02631538|101148253|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
33343688|NCT02631538|101148254|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
33343689|NCT02631538|101148251|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
33343690|NCT02631538|101148252|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
33343691|NCT02631538|101148253|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
33343692|NCT02631538|101148254|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
33343693|NCT02631538|101148251|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
33343694|NCT02631538|101148252|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
33540803|NCT03176771|101878709|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
33615569|NCT03221842|102140355|FG000|Period 1 (Open-label)|Other|2|||
33211063|NCT02301143|100673576|FG001|Investigator's Choice|Progressive Disease|3|||
33211064|NCT02301143|100673575|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
33211065|NCT02301143|100673576|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
33211066|NCT02301143|100673575|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
33211067|NCT02301143|100673576|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
33211068|NCT02301143|100673575|FG000|Investigator's Choice|Other|0|||
33211069|NCT02301143|100673576|FG001|Investigator's Choice|Other|1|||
33211070|NCT02301143|100673575|FG000|Investigator's Choice|Unresectable Surgery|0|||
33211071|NCT02301143|100673576|FG001|Investigator's Choice|Unresectable Surgery|1|||
33211072|NCT03834779|100673577|FG000|Overall Study|Death|1|||
33211073|NCT03834779|100673578|FG001|Overall Study|Death|2|||
33211074|NCT03834779|100673577|FG000|Overall Study|Lost to Follow-up|6|||
33211075|NCT03834779|100673578|FG001|Overall Study|Lost to Follow-up|4|||
33615570|NCT03221842|102140356|FG001|Period 1 (Open-label)|Other|0|||
33615571|NCT03221842|102140355|FG000|Period 2 (Randomized, Blinded)|Death|0|||
33211076|NCT03593655|100673579|FG000|First Product Use Period|Withdrawal by Subject|1|||
33211077|NCT03593655|100673580|FG001|First Product Use Period|Withdrawal by Subject|1|||
33211078|NCT03593655|100673579|FG000|First Product Use Period|Lost to Follow-up|1|||
33211079|NCT03593655|100673580|FG001|First Product Use Period|Lost to Follow-up|3|||
33211080|NCT03593655|100673579|FG000|Second Product Use Period|Withdrawal by Subject|1|||
33211081|NCT03593655|100673580|FG001|Second Product Use Period|Withdrawal by Subject|1|||
33615572|NCT03221842|102140356|FG001|Period 2 (Randomized, Blinded)|Death|1|||
33211082|NCT03593655|100673579|FG000|Second Product Use Period|Lost to Follow-up|1|||
33211083|NCT03593655|100673580|FG001|Second Product Use Period|Lost to Follow-up|0|||
33211084|NCT03593655|100673579|FG000|Third Product Use Period|Lost to Follow-up|1|||
33211085|NCT03593655|100673580|FG001|Third Product Use Period|Lost to Follow-up|2|||
33343695|NCT02631538|101148253|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
33343696|NCT02631538|101148254|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
33343697|NCT02631538|101148251|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
33343698|NCT02631538|101148252|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
33343699|NCT02631538|101148253|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
33343700|NCT02631538|101148254|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
33211086|NCT03593655|100673579|FG000|Third Product Use Period|Physician Decision|0|||
33211087|NCT03593655|100673580|FG001|Third Product Use Period|Physician Decision|1|||
33211088|NCT03593655|100673579|FG000|Third Product Use Period|Withdrawal by Subject|0|||
33211089|NCT03593655|100673580|FG001|Third Product Use Period|Withdrawal by Subject|1|||
33211090|NCT04313881|100673587|FG000|Overall Study|Death|138|||
33211091|NCT04313881|100673588|FG001|Overall Study|Death|126|||
33211092|NCT04313881|100673587|FG000|Overall Study|Study terminated by sponsor|108|||
33211093|NCT04313881|100673588|FG001|Overall Study|Study terminated by sponsor|129|||
33211094|NCT04313881|100673587|FG000|Overall Study|Consent withdrawn|19|||
33211095|NCT04313881|100673588|FG001|Overall Study|Consent withdrawn|15|||
33211096|NCT04313881|100673587|FG000|Overall Study|Reason not Specified|3|||
33211097|NCT04313881|100673588|FG001|Overall Study|Reason not Specified|1|||
33211098|NCT00791765|100673591|FG000|Weeks 1 to 12|Adverse Event|0|||
33211099|NCT00791765|100673592|FG001|Weeks 1 to 12|Adverse Event|1|||
33211100|NCT00791765|100673591|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
33211101|NCT00791765|100673592|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
33211102|NCT00791765|100673591|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
33211103|NCT00791765|100673592|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
33211104|NCT00791765|100673591|FG000|Weeks 1 to 12|Physician Decision|1|||
33540804|NCT03176771|101878710|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
33540805|NCT03176771|101878706|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
33540806|NCT03176771|101878707|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
33540807|NCT03176771|101878708|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
33540808|NCT03176771|101878709|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
33540809|NCT03176771|101878710|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
33211105|NCT00791765|100673592|FG001|Weeks 1 to 12|Physician Decision|0|||
33211106|NCT00791765|100673591|FG000|Weeks 1 to 12|Disease progression|3|||
33211107|NCT00791765|100673592|FG001|Weeks 1 to 12|Disease progression|0|||
33211108|NCT00791765|100673591|FG000|Weeks 1 to 12|Ineligibility determined|0|||
33211109|NCT00791765|100673592|FG001|Weeks 1 to 12|Ineligibility determined|3|||
33211110|NCT00791765|100673591|FG000|Weeks 13 to 24|Protocol deviation|2|||
33211111|NCT00791765|100673592|FG001|Weeks 13 to 24|Protocol deviation|0|||
33211112|NCT00791765|100673591|FG000|Weeks 13 to 24|Adverse Event|0|||
33211113|NCT00791765|100673592|FG001|Weeks 13 to 24|Adverse Event|3|||
33211114|NCT00791765|100673591|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
33211115|NCT00791765|100673592|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
33211116|NCT00791765|100673591|FG000|Weeks 13 to 24|Disease progression|0|||
33211117|NCT00791765|100673592|FG001|Weeks 13 to 24|Disease progression|1|||
33211118|NCT00791765|100673591|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
33211119|NCT00791765|100673592|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
33211120|NCT00791765|100673591|FG000|Weeks 13 to 24|Other|0|||
33211121|NCT00791765|100673592|FG001|Weeks 13 to 24|Other|1|||
33211122|NCT00907153|100673593|FG000|Overall Study|Lost to Follow-up|1|||
33211123|NCT00907153|100673594|FG001|Overall Study|Lost to Follow-up|1|||
33211124|NCT00907153|100673593|FG000|Overall Study|Withdrawal by Subject|1|||
33211125|NCT00907153|100673594|FG001|Overall Study|Withdrawal by Subject|3|||
33211126|NCT00417079|100673595|FG000|Overall Study|Disease progression|267|||
33211127|NCT00417079|100673596|FG001|Overall Study|Disease progression|180|||
33211128|NCT00417079|100673595|FG000|Overall Study|Adverse Event|32|||
33211129|NCT00417079|100673596|FG001|Overall Study|Adverse Event|67|||
33211130|NCT00417079|100673595|FG000|Overall Study|Non-compliance to protocol|0|||
33211131|NCT00417079|100673596|FG001|Overall Study|Non-compliance to protocol|1|||
33211132|NCT00417079|100673595|FG000|Overall Study|Lost to Follow-up|2|||
33343701|NCT02631538|101148251|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
33343702|NCT02631538|101148252|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
33343703|NCT02631538|101148253|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
33343704|NCT02631538|101148254|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
33343705|NCT00494091|101148255|FG000|Overall Study|Death|5|||
33343706|NCT00494091|101148256|FG001|Overall Study|Death|54|||
33343707|NCT00494091|101148255|FG000|Overall Study|Lost to Follow-up|0|||
33343708|NCT00494091|101148256|FG001|Overall Study|Lost to Follow-up|4|||
33343709|NCT00494091|101148255|FG000|Overall Study|Other|1|||
33343710|NCT00494091|101148256|FG001|Overall Study|Other|11|||
33343711|NCT00494091|101148255|FG000|Overall Study|Withdrawal by Subject|0|||
33343712|NCT00494091|101148256|FG001|Overall Study|Withdrawal by Subject|7|||
33343713|NCT01637142|101148259|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
33343714|NCT00999908|101148260|FG000|Treatment Period 1|Subject withdrew consent|2|||
33343715|NCT00999908|101148261|FG001|Treatment Period 1|Subject withdrew consent|0|||
33343716|NCT00999908|101148262|FG002|Treatment Period 1|Subject withdrew consent|0|||
33343717|NCT00999908|101148260|FG000|Treatment Period 2|Protocol Violation|1|||
33343718|NCT00999908|101148261|FG001|Treatment Period 2|Protocol Violation|0|||
33343719|NCT00999908|101148262|FG002|Treatment Period 2|Protocol Violation|0|||
33343720|NCT02549339|101148263|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
33343721|NCT02549339|101148264|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
33343722|NCT02549339|101148263|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
33343723|NCT02549339|101148264|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
33343724|NCT02549339|101148263|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
33343725|NCT02549339|101148264|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
33343726|NCT02549339|101148263|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
33343727|NCT02549339|101148264|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
33343728|NCT02549339|101148263|FG000|12-month Follow-up|Lack of Efficacy|0|||
33343729|NCT02549339|101148264|FG001|12-month Follow-up|Lack of Efficacy|2|||
33343730|NCT02549339|101148263|FG000|12-month Follow-up|Withdrawal by Subject|8|||
33343731|NCT02549339|101148264|FG001|12-month Follow-up|Withdrawal by Subject|3|||
33343732|NCT02549339|101148263|FG000|12-month Follow-up|Lost to Follow-up|1|||
33343733|NCT02549339|101148264|FG001|12-month Follow-up|Lost to Follow-up|3|||
33343734|NCT02549339|101148263|FG000|12-month Follow-up|Other|0|||
33343735|NCT02549339|101148264|FG001|12-month Follow-up|Other|3|||
33343736|NCT03468309|101148265|FG000|Overall Study|Lost to Follow-up|4|||
33343737|NCT03468309|101148265|FG000|Overall Study|Withdrawal by Subject|2|||
33343738|NCT01724528|101148266|FG000|Overall Study|Death|3|||
33343739|NCT01724528|101148267|FG001|Overall Study|Death|0|||
33343740|NCT01724528|101148266|FG000|Overall Study|Withdrawal by Subject|0|||
33211133|NCT00417079|100673596|FG001|Overall Study|Lost to Follow-up|0|||
33211134|NCT00417079|100673595|FG000|Overall Study|Withdrawal by Subject|17|||
33211135|NCT00417079|100673596|FG001|Overall Study|Withdrawal by Subject|8|||
33211136|NCT00417079|100673595|FG000|Overall Study|Not treated|6|||
33211137|NCT00417079|100673596|FG001|Overall Study|Not treated|7|||
33211138|NCT00417079|100673595|FG000|Overall Study|Screened failure|2|||
33211139|NCT00417079|100673596|FG001|Overall Study|Screened failure|1|||
33343741|NCT01724528|101148267|FG001|Overall Study|Withdrawal by Subject|2|||
33343742|NCT01724528|101148266|FG000|Overall Study|Protocol Violation|0|||
33343743|NCT01724528|101148267|FG001|Overall Study|Protocol Violation|1|||
33343744|NCT01724528|101148266|FG000|Overall Study|Patient refused to attend last visit|1|||
33343745|NCT01724528|101148267|FG001|Overall Study|Patient refused to attend last visit|0|||
33343746|NCT02419508|101148270|FG000|Overall Study|Adverse Event|9|||
33343747|NCT02419508|101148271|FG001|Overall Study|Adverse Event|3|||
33343748|NCT02419508|101148270|FG000|Overall Study|Withdrawal by Subject|1|||
33343749|NCT02419508|101148271|FG001|Overall Study|Withdrawal by Subject|0|||
33343750|NCT02419508|101148270|FG000|Overall Study|Other - Reason not specified|0|||
33343751|NCT02419508|101148271|FG001|Overall Study|Other - Reason not specified|1|||
33343752|NCT00661271|101148273|FG000|Overall Study|Lost to Follow-up|28|||
33343753|NCT00661271|101148274|FG001|Overall Study|Lost to Follow-up|25|||
33343754|NCT03474679|101148275|FG000|Overall Study|Death|7|||
33343755|NCT03474679|101148275|FG000|Overall Study|Withdrawal by Subject|1|||
33343756|NCT02769624|101148276|FG000|Overall Study|Lost to Follow-up|0|||
33343757|NCT02769624|101148277|FG001|Overall Study|Lost to Follow-up|1|||
33343758|NCT02026063|101148278|FG000|Overall Study|Physician Decision|0|||
33343759|NCT02026063|101148279|FG001|Overall Study|Physician Decision|10|||
33343760|NCT02026063|101148278|FG000|Overall Study|Noncompliance with Study Drug|1|||
33343761|NCT02026063|101148279|FG001|Overall Study|Noncompliance with Study Drug|1|||
33343762|NCT02026063|101148278|FG000|Overall Study|Withdrawal of Consent|1|||
33343763|NCT02026063|101148279|FG001|Overall Study|Withdrawal of Consent|6|||
33343764|NCT02026063|101148278|FG000|Overall Study|Adverse Event|5|||
33343765|NCT02026063|101148279|FG001|Overall Study|Adverse Event|20|||
33343766|NCT02026063|101148278|FG000|Overall Study|Lack of Efficacy|0|||
33343767|NCT02026063|101148279|FG001|Overall Study|Lack of Efficacy|4|||
33343768|NCT02026063|101148278|FG000|Overall Study|Lost to Follow-up|0|||
33343769|NCT02026063|101148279|FG001|Overall Study|Lost to Follow-up|1|||
33343770|NCT02026063|101148278|FG000|Overall Study|Reason not Specified|2|||
33343771|NCT02026063|101148279|FG001|Overall Study|Reason not Specified|7|||
33343772|NCT01613326|101148280|FG000|Overall Study|Adverse Event|7|||
33343773|NCT01613326|101148281|FG001|Overall Study|Adverse Event|5|||
33343774|NCT01613326|101148280|FG000|Overall Study|Withdrawal by Subject|3|||
33343775|NCT01613326|101148281|FG001|Overall Study|Withdrawal by Subject|4|||
33343776|NCT01613326|101148280|FG000|Overall Study|Abnormal test procedure result(s)|2|||
33343777|NCT01613326|101148281|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33343778|NCT01613326|101148280|FG000|Overall Study|inability to use device|1|||
33343779|NCT01613326|101148281|FG001|Overall Study|inability to use device|0|||
33343780|NCT01613326|101148280|FG000|Overall Study|Lack of Efficacy|0|||
33343781|NCT01613326|101148281|FG001|Overall Study|Lack of Efficacy|1|||
33343782|NCT01613326|101148280|FG000|Overall Study|Lost to Follow-up|0|||
33343783|NCT01613326|101148281|FG001|Overall Study|Lost to Follow-up|1|||
33343784|NCT01613326|101148280|FG000|Overall Study|Administrative|0|||
33343785|NCT01613326|101148281|FG001|Overall Study|Administrative|2|||
33343786|NCT01613326|101148280|FG000|Overall Study|Protocol Violation|0|||
33343787|NCT01613326|101148281|FG001|Overall Study|Protocol Violation|1|||
33343788|NCT00584870|101148282|FG000|Overall Study|Adverse Event|4|||
33343789|NCT00584870|101148283|FG001|Overall Study|Adverse Event|3|||
33343790|NCT00584870|101148284|FG002|Overall Study|Adverse Event|2|||
33343791|NCT00584870|101148282|FG000|Overall Study|Lost to Follow-up|4|||
33343792|NCT00584870|101148283|FG001|Overall Study|Lost to Follow-up|1|||
33343793|NCT00584870|101148284|FG002|Overall Study|Lost to Follow-up|1|||
33343794|NCT00584870|101148282|FG000|Overall Study|Lack of Efficacy|7|||
33343795|NCT00584870|101148283|FG001|Overall Study|Lack of Efficacy|14|||
33343796|NCT00584870|101148284|FG002|Overall Study|Lack of Efficacy|8|||
33343797|NCT00584870|101148282|FG000|Overall Study|Withdrawal by Subject|10|||
33343798|NCT00584870|101148283|FG001|Overall Study|Withdrawal by Subject|5|||
33343799|NCT00584870|101148284|FG002|Overall Study|Withdrawal by Subject|3|||
33343800|NCT00584870|101148282|FG000|Overall Study|Protocol Violation|1|||
33343801|NCT00584870|101148283|FG001|Overall Study|Protocol Violation|1|||
33343802|NCT00584870|101148284|FG002|Overall Study|Protocol Violation|2|||
33343803|NCT00584870|101148282|FG000|Overall Study|Did not met entrance criteria|1|||
33343804|NCT00584870|101148283|FG001|Overall Study|Did not met entrance criteria|0|||
33343805|NCT00584870|101148284|FG002|Overall Study|Did not met entrance criteria|0|||
33343806|NCT00584870|101148282|FG000|Overall Study|Other|2|||
33343807|NCT00584870|101148283|FG001|Overall Study|Other|0|||
33343808|NCT00584870|101148284|FG002|Overall Study|Other|0|||
33343809|NCT00584870|101148282|FG000|Overall Study|Randomized but not treated|0|||
33343810|NCT00584870|101148283|FG001|Overall Study|Randomized but not treated|1|||
33343811|NCT00584870|101148284|FG002|Overall Study|Randomized but not treated|2|||
33343812|NCT02322710|101148285|FG000|Overall Study|No efficacy assessment post-baseline|0|||
33343813|NCT02322710|101148286|FG001|Overall Study|No efficacy assessment post-baseline|1|||
33343814|NCT02322710|101148285|FG000|Overall Study|Protocol Violation|20|||
33343815|NCT02322710|101148286|FG001|Overall Study|Protocol Violation|25|||
33343816|NCT00621504|101148287|FG000|Overall Study|Adverse Event|1|||
33343817|NCT00621504|101148288|FG001|Overall Study|Adverse Event|3|||
33343818|NCT00621504|101148287|FG000|Overall Study|At the request of sponsor/investigator|1|||
33343819|NCT00621504|101148288|FG001|Overall Study|At the request of sponsor/investigator|0|||
33343820|NCT00621504|101148287|FG000|Overall Study|Withdrew consent|9|||
33343821|NCT00621504|101148288|FG001|Overall Study|Withdrew consent|6|||
33343822|NCT00621504|101148287|FG000|Overall Study|Lost to Follow-up|8|||
33343823|NCT00621504|101148288|FG001|Overall Study|Lost to Follow-up|10|||
33343824|NCT00621504|101148287|FG000|Overall Study|Other|1|||
33343825|NCT00621504|101148288|FG001|Overall Study|Other|0|||
33343826|NCT00621504|101148287|FG000|Overall Study|Death|6|||
33343827|NCT00621504|101148288|FG001|Overall Study|Death|6|||
33343828|NCT02631200|101148291|FG000|First Period|Death|1|||
33343829|NCT02631200|101148292|FG001|First Period|Death|2|||
33343830|NCT02631200|101148291|FG000|First Period|Patient ill-health|2|||
33343831|NCT02631200|101148292|FG001|First Period|Patient ill-health|4|||
33343832|NCT02631200|101148291|FG000|First Period|Withdrawal by Subject|4|||
33343833|NCT02631200|101148292|FG001|First Period|Withdrawal by Subject|1|||
33343834|NCT02631200|101148291|FG000|Deferred Period|Death|0|||
33343835|NCT02631200|101148292|FG001|Deferred Period|Death|1|||
33343836|NCT02631200|101148291|FG000|Deferred Period|Received kidney transplant|0|||
33343837|NCT02631200|101148292|FG001|Deferred Period|Received kidney transplant|1|||
33343838|NCT02631200|101148291|FG000|Deferred Period|Withdrawal by Subject|0|||
33343839|NCT02631200|101148292|FG001|Deferred Period|Withdrawal by Subject|2|||
33343840|NCT02631200|101148291|FG000|Deferred Period|Lost to Follow-up|0|||
33343841|NCT02631200|101148292|FG001|Deferred Period|Lost to Follow-up|1|||
33211140|NCT00417079|100673595|FG000|Overall Study|Investigator's decision|1|||
33211141|NCT00417079|100673596|FG001|Overall Study|Investigator's decision|4|||
33343842|NCT00634569|101148298|FG000|Overall Study|Withdrawal by Subject|0|||
33343843|NCT00634569|101148299|FG001|Overall Study|Withdrawal by Subject|4|||
33343844|NCT00634569|101148298|FG000|Overall Study|Physician Decision|0|||
33343845|NCT00634569|101148299|FG001|Overall Study|Physician Decision|1|||
33343846|NCT02479802|101148303|FG000|Overall Study|Lost to Follow-up|1|||
33343847|NCT02479802|101148303|FG000|Overall Study|Adverse Event|1|||
33343848|NCT03887130|101148304|FG000|Overall Study|Progressive disease|23|||
33343849|NCT03887130|101148305|FG001|Overall Study|Progressive disease|14|||
33343850|NCT03887130|101148306|FG002|Overall Study|Progressive disease|7|||
33343851|NCT03887130|101148304|FG000|Overall Study|Protocol Violation|3|||
33343852|NCT03887130|101148305|FG001|Overall Study|Protocol Violation|1|||
33343853|NCT03887130|101148306|FG002|Overall Study|Protocol Violation|2|||
33343854|NCT03887130|101148304|FG000|Overall Study|Drug related toxicity|7|||
33343855|NCT03887130|101148305|FG001|Overall Study|Drug related toxicity|7|||
33343856|NCT03887130|101148306|FG002|Overall Study|Drug related toxicity|13|||
33343857|NCT03887130|101148304|FG000|Overall Study|Non drug related toxicity|3|||
33343858|NCT03887130|101148305|FG001|Overall Study|Non drug related toxicity|0|||
33343859|NCT03887130|101148306|FG002|Overall Study|Non drug related toxicity|0|||
33343860|NCT03887130|101148304|FG000|Overall Study|Death|2|||
33343861|NCT03887130|101148305|FG001|Overall Study|Death|2|||
33343862|NCT03887130|101148306|FG002|Overall Study|Death|1|||
33343863|NCT03887130|101148304|FG000|Overall Study|Withdrawal by Subject|7|||
33343864|NCT03887130|101148305|FG001|Overall Study|Withdrawal by Subject|6|||
33343865|NCT03887130|101148306|FG002|Overall Study|Withdrawal by Subject|11|||
33343866|NCT03887130|101148304|FG000|Overall Study|other reason|6|||
33343867|NCT03887130|101148305|FG001|Overall Study|other reason|20|||
33343868|NCT03887130|101148306|FG002|Overall Study|other reason|17|||
33343869|NCT05098041|101148307|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
33343870|NCT00087646|101148309|FG000|Overall Study|Adverse Event|37|||
33343871|NCT00087646|101148310|FG001|Overall Study|Adverse Event|6|||
33343872|NCT00087646|101148311|FG002|Overall Study|Adverse Event|18|||
33343873|NCT00087646|101148312|FG003|Overall Study|Adverse Event|20|||
33343874|NCT00087646|101148309|FG000|Overall Study|Death|0|||
33615573|NCT03221842|102140355|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
33615574|NCT03221842|102140356|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
33615575|NCT00548145|102140357|FG000|Overall Study|Death|0|||
33615576|NCT00548145|102140358|FG001|Overall Study|Death|1|||
33615577|NCT00548145|102140357|FG000|Overall Study|Withdrawal by Subject|0|||
33343875|NCT00087646|101148310|FG001|Overall Study|Death|1|||
33343876|NCT00087646|101148311|FG002|Overall Study|Death|0|||
33615578|NCT00548145|102140358|FG001|Overall Study|Withdrawal by Subject|2|||
33615579|NCT00548145|102140357|FG000|Overall Study|Physician Decision|1|||
33343877|NCT00087646|101148312|FG003|Overall Study|Death|0|||
33343878|NCT00087646|101148309|FG000|Overall Study|Withdrawal by Subject|6|||
33343879|NCT00087646|101148310|FG001|Overall Study|Withdrawal by Subject|1|||
33343880|NCT00087646|101148311|FG002|Overall Study|Withdrawal by Subject|2|||
33211142|NCT00417079|100673595|FG000|Overall Study|Non-confirmed Disease progression|1|||
33211143|NCT00417079|100673596|FG001|Overall Study|Non-confirmed Disease progression|1|||
33211144|NCT00417079|100673595|FG000|Overall Study|Clinical deterioration|1|||
33211145|NCT00417079|100673596|FG001|Overall Study|Clinical deterioration|0|||
33211146|NCT00417079|100673595|FG000|Overall Study|Screening error|2|||
33211147|NCT00417079|100673596|FG001|Overall Study|Screening error|1|||
33211148|NCT00417079|100673595|FG000|Overall Study|Withdrawal by subject's family|0|||
33211149|NCT00417079|100673596|FG001|Overall Study|Withdrawal by subject's family|1|||
33211150|NCT00417079|100673595|FG000|Overall Study|Patient unable to come to the clinic|0|||
33211151|NCT00417079|100673596|FG001|Overall Study|Patient unable to come to the clinic|1|||
33211152|NCT00417079|100673595|FG000|Overall Study|abnormal liver function tests|0|||
33211153|NCT00417079|100673596|FG001|Overall Study|abnormal liver function tests|1|||
33211154|NCT03543254|100673604|FG000|Overall Study|Lost to Follow-up|1|||
33211155|NCT02834780|100673605|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
33211156|NCT02834780|100673606|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
33211157|NCT02834780|100673607|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
33211158|NCT02834780|100673608|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
33211159|NCT02834780|100673609|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
33211160|NCT02834780|100673610|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
33211161|NCT02834780|100673611|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
33211162|NCT02834780|100673612|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
33211163|NCT02834780|100673613|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
33211164|NCT02834780|100673614|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
33211165|NCT02834780|100673615|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
33343881|NCT00087646|101148312|FG003|Overall Study|Withdrawal by Subject|2|||
33343882|NCT00087646|101148309|FG000|Overall Study|Insufficient therapeutic response|64|||
33343883|NCT00087646|101148310|FG001|Overall Study|Insufficient therapeutic response|24|||
33615580|NCT00548145|102140358|FG001|Overall Study|Physician Decision|1|||
33615581|NCT00381693|102140364|FG000|Overall Study|Death|1|||
33615582|NCT00381693|102140364|FG000|Overall Study|Adverse Event|4|||
33615583|NCT00381693|102140364|FG000|Overall Study|Patient Choice|1|||
33615584|NCT00381693|102140364|FG000|Overall Study|Progression|2|||
33343884|NCT00087646|101148311|FG002|Overall Study|Insufficient therapeutic response|38|||
33343885|NCT00087646|101148312|FG003|Overall Study|Insufficient therapeutic response|51|||
33343886|NCT00087646|101148309|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
33343887|NCT00087646|101148310|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
33343888|NCT00087646|101148311|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
33343889|NCT00087646|101148312|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
33343890|NCT00087646|101148309|FG000|Overall Study|Failure to Return|5|||
33343891|NCT00087646|101148310|FG001|Overall Study|Failure to Return|2|||
33343892|NCT00087646|101148311|FG002|Overall Study|Failure to Return|2|||
33343893|NCT00087646|101148312|FG003|Overall Study|Failure to Return|3|||
33343894|NCT00087646|101148309|FG000|Overall Study|Administrative/Other|6|||
33343895|NCT00087646|101148310|FG001|Overall Study|Administrative/Other|1|||
33343896|NCT00087646|101148311|FG002|Overall Study|Administrative/Other|1|||
33343897|NCT00087646|101148312|FG003|Overall Study|Administrative/Other|2|||
33343898|NCT00087646|101148309|FG000|Overall Study|Other Protocol Violation|3|||
33343899|NCT00087646|101148310|FG001|Overall Study|Other Protocol Violation|1|||
33343900|NCT00087646|101148311|FG002|Overall Study|Other Protocol Violation|0|||
33343901|NCT00087646|101148312|FG003|Overall Study|Other Protocol Violation|0|||
33343902|NCT00087646|101148309|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
33343903|NCT00087646|101148310|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
33343904|NCT00087646|101148311|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
33343905|NCT00087646|101148312|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
33343906|NCT02814565|101148316|FG000|Overall Study|Lack of Efficacy|0|||
33343907|NCT02814565|101148317|FG001|Overall Study|Lack of Efficacy|1|||
33343908|NCT02814565|101148316|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
33343909|NCT02814565|101148317|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
33343910|NCT00647556|101148318|FG000|Overall Study|Adverse Event|0|||
33343911|NCT00647556|101148319|FG001|Overall Study|Adverse Event|1|||
33343912|NCT00647556|101148318|FG000|Overall Study|Lost to Follow-up|1|||
33540810|NCT03176771|101878706|FG000|Double-Blind Extension Period|Adverse Event|0|||
33540811|NCT03176771|101878707|FG001|Double-Blind Extension Period|Adverse Event|0|||
33540812|NCT03176771|101878708|FG002|Double-Blind Extension Period|Adverse Event|0|||
33540813|NCT03176771|101878709|FG003|Double-Blind Extension Period|Adverse Event|15|||
33540814|NCT03176771|101878710|FG004|Double-Blind Extension Period|Adverse Event|18|||
33540815|NCT03176771|101878706|FG000|Double-Blind Extension Period|Death|0|||
33343913|NCT00647556|101148319|FG001|Overall Study|Lost to Follow-up|0|||
33343914|NCT00647556|101148318|FG000|Overall Study|Protocol Violation|0|||
33343915|NCT00647556|101148319|FG001|Overall Study|Protocol Violation|1|||
33343916|NCT00647556|101148318|FG000|Overall Study|Withdrawal by Subject|1|||
33343917|NCT00647556|101148319|FG001|Overall Study|Withdrawal by Subject|0|||
33343918|NCT00647556|101148318|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
33343919|NCT00647556|101148319|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
33343920|NCT01602341|101148320|FG000|Overall Study|Adverse Event|0|||
33343921|NCT01602341|101148321|FG001|Overall Study|Adverse Event|1|||
33343922|NCT03208231|101148322|FG000|Overall Study|Death|1|||
33343923|NCT03208231|101148323|FG001|Overall Study|Death|2|||
33343924|NCT03208231|101148322|FG000|Overall Study|Moved and unable to get to clinic|1|||
33343925|NCT03208231|101148323|FG001|Overall Study|Moved and unable to get to clinic|0|||
33343926|NCT03208231|101148322|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
33343927|NCT03208231|101148323|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
33343928|NCT01078805|101148326|FG000|Overall Study|Clinically significant abnormal lab|5|||
33343929|NCT01078805|101148326|FG000|Overall Study|Death|134|||
33343930|NCT01078805|101148326|FG000|Overall Study|Lost to Follow-up|676|||
33343931|NCT01078805|101148326|FG000|Overall Study|Physician Decision|169|||
33343932|NCT01078805|101148326|FG000|Overall Study|Serious adverse event|26|||
33615585|NCT04829916|102140367|FG000|Overall Study|Withdrawal by Subject|1|||
33615586|NCT04829916|102140368|FG001|Overall Study|Withdrawal by Subject|0|||
33343933|NCT01078805|101148326|FG000|Overall Study|Sponsor decision|46|||
33343934|NCT01078805|101148326|FG000|Overall Study|Withdrawal by Subject|739|||
33540816|NCT03176771|101878707|FG001|Double-Blind Extension Period|Death|0|||
33540817|NCT03176771|101878708|FG002|Double-Blind Extension Period|Death|0|||
33540818|NCT03176771|101878709|FG003|Double-Blind Extension Period|Death|3|||
33540819|NCT03176771|101878710|FG004|Double-Blind Extension Period|Death|4|||
33540820|NCT03176771|101878706|FG000|Double-Blind Extension Period|Physician Decision|0|||
33540821|NCT03176771|101878707|FG001|Double-Blind Extension Period|Physician Decision|0|||
33540822|NCT03176771|101878708|FG002|Double-Blind Extension Period|Physician Decision|0|||
33540823|NCT03176771|101878709|FG003|Double-Blind Extension Period|Physician Decision|3|||
33540824|NCT03176771|101878710|FG004|Double-Blind Extension Period|Physician Decision|1|||
33540825|NCT03176771|101878706|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
33540826|NCT03176771|101878707|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
33540827|NCT03176771|101878708|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
33540828|NCT03176771|101878709|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
33540829|NCT03176771|101878710|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
33540830|NCT02029417|101878711|FG000|Overall Study|Death|1|||
33540831|NCT02029417|101878711|FG000|Overall Study|Adverse Event|1|||
33540832|NCT02147626|101878715|FG000|Overall Study|Lost to Follow-up|4|||
33540833|NCT02147626|101878716|FG001|Overall Study|Lost to Follow-up|4|||
33540834|NCT02147626|101878715|FG000|Overall Study|Pregnancy|1|||
33540835|NCT02147626|101878716|FG001|Overall Study|Pregnancy|2|||
33540836|NCT02147626|101878715|FG000|Overall Study|Withdrawal by Subject|0|||
33540837|NCT02147626|101878716|FG001|Overall Study|Withdrawal by Subject|1|||
33540838|NCT02111083|101878717|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
33540839|NCT02111083|101878718|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
33540840|NCT00076570|101878724|FG000|Overall Study|Drug intolerance|8|||
33540841|NCT00076570|101878725|FG001|Overall Study|Drug intolerance|8|||
33540842|NCT00321763|101878726|FG000|Overall Study|Adverse Event|1|||
33540843|NCT00321763|101878727|FG001|Overall Study|Adverse Event|1|||
33540844|NCT00321763|101878728|FG002|Overall Study|Adverse Event|0|||
33615587|NCT00637416|102140369|FG000|Overall Study|Lost to Follow-up|1|||
33615588|NCT00637416|102140370|FG001|Overall Study|Lost to Follow-up|1|||
33615589|NCT00637416|102140369|FG000|Overall Study|Unable to take study drug|0|||
33615590|NCT00637416|102140370|FG001|Overall Study|Unable to take study drug|1|||
33343935|NCT01078805|101148326|FG000|Overall Study|Other|173|||
33343936|NCT01078805|101148326|FG000|Overall Study|Didn't take study drug|82|||
33343937|NCT05425563|101148327|FG000|Overall Study|Withdrawal by Subject|17|||
33343938|NCT02771522|101148328|FG000|Overall Study|Lost to Follow-up|3|||
33615591|NCT03614325|102140371|FG000|Overall Study|Withdrawal by Subject|0|||
33615592|NCT03614325|102140372|FG001|Overall Study|Withdrawal by Subject|2|||
33615593|NCT03614325|102140371|FG000|Overall Study|Surgery Cancelled|2|||
33343939|NCT02771522|101148328|FG000|Overall Study|Withdrawal by Subject|2|||
33343940|NCT02771522|101148328|FG000|Overall Study|No white spot lesions|3|||
33343941|NCT02354703|101148346|FG000|Overall Study|Withdrawal by Subject|1|||
33343942|NCT02354703|101148347|FG001|Overall Study|Withdrawal by Subject|1|||
33343943|NCT02354703|101148348|FG002|Overall Study|Withdrawal by Subject|1|||
33343944|NCT02354703|101148349|FG003|Overall Study|Withdrawal by Subject|1|||
33343945|NCT02354703|101148346|FG000|Overall Study|Lost to Follow-up|2|||
33615594|NCT03614325|102140372|FG001|Overall Study|Surgery Cancelled|1|||
33615595|NCT03614325|102140371|FG000|Overall Study|Lost to Follow-up|2|||
33615596|NCT03614325|102140372|FG001|Overall Study|Lost to Follow-up|1|||
33615597|NCT03614325|102140371|FG000|Overall Study|Surgery never scheduled|1|||
33615598|NCT03614325|102140372|FG001|Overall Study|Surgery never scheduled|0|||
33615599|NCT02596230|102140377|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
33343946|NCT02354703|101148347|FG001|Overall Study|Lost to Follow-up|7|||
33540845|NCT00321763|101878729|FG003|Overall Study|Adverse Event|1|||
33540846|NCT00321763|101878726|FG000|Overall Study|Withdrawal by Subject|2|||
33540847|NCT00321763|101878727|FG001|Overall Study|Withdrawal by Subject|0|||
33343947|NCT02354703|101148348|FG002|Overall Study|Lost to Follow-up|9|||
33343948|NCT02354703|101148349|FG003|Overall Study|Lost to Follow-up|2|||
33343949|NCT02354703|101148346|FG000|Overall Study|Adverse Event|0|||
33540848|NCT00321763|101878728|FG002|Overall Study|Withdrawal by Subject|1|||
33540849|NCT00321763|101878729|FG003|Overall Study|Withdrawal by Subject|0|||
33540850|NCT00321763|101878726|FG000|Overall Study|Lost to Follow-up|3|||
33540851|NCT00321763|101878727|FG001|Overall Study|Lost to Follow-up|1|||
33540852|NCT00321763|101878728|FG002|Overall Study|Lost to Follow-up|5|||
33540853|NCT00321763|101878729|FG003|Overall Study|Lost to Follow-up|4|||
33540854|NCT01218308|101878730|FG000|Overall Study|Adverse Event|1|||
33540855|NCT01218308|101878731|FG001|Overall Study|Adverse Event|2|||
33540856|NCT01218308|101878730|FG000|Overall Study|Protocol Violation|0|||
33540857|NCT01218308|101878731|FG001|Overall Study|Protocol Violation|2|||
33540858|NCT01218308|101878730|FG000|Overall Study|Withdrawal by Subject|61|||
33540859|NCT01218308|101878731|FG001|Overall Study|Withdrawal by Subject|64|||
33540860|NCT01218308|101878730|FG000|Overall Study|Lost to Follow-up|27|||
33540861|NCT01218308|101878731|FG001|Overall Study|Lost to Follow-up|31|||
33540862|NCT01218308|101878730|FG000|Overall Study|Other|14|||
33540863|NCT01218308|101878731|FG001|Overall Study|Other|21|||
33540864|NCT02701634|101881470|FG000|Overall Study|Adverse Event|2|||
33540865|NCT02701634|101881471|FG001|Overall Study|Adverse Event|3|||
33540866|NCT02701634|101881470|FG000|Overall Study|Death|1|||
33540867|NCT02701634|101881471|FG001|Overall Study|Death|0|||
33343950|NCT02354703|101148347|FG001|Overall Study|Adverse Event|0|||
33343951|NCT02354703|101148348|FG002|Overall Study|Adverse Event|1|||
33343952|NCT02354703|101148349|FG003|Overall Study|Adverse Event|0|||
33343953|NCT03624946|101148351|FG000|Overall Study|Lost to Follow-up|0|||
33343954|NCT03624946|101148352|FG001|Overall Study|Lost to Follow-up|1|||
33343955|NCT01337973|101148353|FG000|Overall Study|Lost to Follow-up|2|||
33343956|NCT01337973|101148354|FG001|Overall Study|Lost to Follow-up|4|||
33343957|NCT01337973|101148355|FG002|Overall Study|Lost to Follow-up|3|||
33343958|NCT01337973|101148353|FG000|Overall Study|Death|1|||
33343959|NCT01337973|101148354|FG001|Overall Study|Death|2|||
33343960|NCT01337973|101148355|FG002|Overall Study|Death|1|||
33343961|NCT01337973|101148353|FG000|Overall Study|Withdrawal by Subject|10|||
33343962|NCT01337973|101148354|FG001|Overall Study|Withdrawal by Subject|8|||
33343963|NCT01337973|101148355|FG002|Overall Study|Withdrawal by Subject|4|||
33343964|NCT01337973|101148353|FG000|Overall Study|missing data on primary outcome|3|||
33343965|NCT01337973|101148354|FG001|Overall Study|missing data on primary outcome|1|||
33343966|NCT01337973|101148355|FG002|Overall Study|missing data on primary outcome|3|||
33343967|NCT04269395|101148356|FG000|Overall Study|Lost to Follow-up|1|||
33343968|NCT04269395|101148357|FG001|Overall Study|Lost to Follow-up|0|||
33343969|NCT04269395|101148356|FG000|Overall Study|Study terminated by Sponsor|13|||
33343970|NCT04269395|101148357|FG001|Overall Study|Study terminated by Sponsor|10|||
33343971|NCT02471716|101148366|FG000|Overall Study|Withdrawal by Subject|0|||
33343972|NCT02471716|101148367|FG001|Overall Study|Withdrawal by Subject|1|||
33343973|NCT02471716|101148368|FG002|Overall Study|Withdrawal by Subject|0|||
33343974|NCT02471716|101148369|FG003|Overall Study|Withdrawal by Subject|2|||
33343975|NCT02471716|101148370|FG004|Overall Study|Withdrawal by Subject|5|||
33343976|NCT02471716|101148366|FG000|Overall Study|Study Terminiated by sponsor|0|||
33343977|NCT02471716|101148367|FG001|Overall Study|Study Terminiated by sponsor|0|||
33343978|NCT02471716|101148368|FG002|Overall Study|Study Terminiated by sponsor|0|||
33343979|NCT02471716|101148369|FG003|Overall Study|Study Terminiated by sponsor|1|||
33343980|NCT02471716|101148370|FG004|Overall Study|Study Terminiated by sponsor|0|||
33343981|NCT02471716|101148366|FG000|Overall Study|Lost to Follow-up|0|||
33343982|NCT02471716|101148367|FG001|Overall Study|Lost to Follow-up|0|||
33343983|NCT02471716|101148368|FG002|Overall Study|Lost to Follow-up|0|||
33343984|NCT02471716|101148369|FG003|Overall Study|Lost to Follow-up|3|||
33343985|NCT02471716|101148370|FG004|Overall Study|Lost to Follow-up|2|||
33343986|NCT02471716|101148366|FG000|Overall Study|Death|0|||
33343987|NCT02471716|101148367|FG001|Overall Study|Death|0|||
33343988|NCT02471716|101148368|FG002|Overall Study|Death|0|||
33343989|NCT02471716|101148369|FG003|Overall Study|Death|1|||
33343990|NCT02471716|101148370|FG004|Overall Study|Death|0|||
33343991|NCT02471716|101148366|FG000|Overall Study|Other|0|||
33343992|NCT02471716|101148367|FG001|Overall Study|Other|0|||
33343993|NCT02471716|101148368|FG002|Overall Study|Other|0|||
33540868|NCT02701634|101881470|FG000|Overall Study|Investigator's Discretion|7|||
33540869|NCT02701634|101881471|FG001|Overall Study|Investigator's Discretion|4|||
33540870|NCT02701634|101881470|FG000|Overall Study|Study terminated by Sponsor|15|||
33540871|NCT02701634|101881471|FG001|Overall Study|Study terminated by Sponsor|17|||
33540872|NCT02701634|101881470|FG000|Overall Study|Withdrew Consent|6|||
33540873|NCT02701634|101881471|FG001|Overall Study|Withdrew Consent|7|||
33343994|NCT02471716|101148369|FG003|Overall Study|Other|8|||
33343995|NCT02471716|101148370|FG004|Overall Study|Other|9|||
33540874|NCT02701634|101881470|FG000|Overall Study|Randomized but not treated|1|||
33540875|NCT02701634|101881471|FG001|Overall Study|Randomized but not treated|0|||
33540876|NCT00748241|101881473|FG000|Overall Study|Implant failure|1|||
33540877|NCT00748241|101881473|FG000|Overall Study|Lost to Follow-up|5|||
33540878|NCT00748241|101881473|FG000|Overall Study|Death|2|||
33343996|NCT02629159|101148375|FG000|Overall Study|Adverse Event|17|||
33343997|NCT02629159|101148376|FG001|Overall Study|Adverse Event|20|||
33343998|NCT02629159|101148377|FG002|Overall Study|Adverse Event|22|||
33343999|NCT02629159|101148375|FG000|Overall Study|Withdrawal by Subject|22|||
33344000|NCT02629159|101148376|FG001|Overall Study|Withdrawal by Subject|11|||
33540879|NCT01033136|101881474|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
33540880|NCT01033136|101881475|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
33540881|NCT00505921|101881477|FG000|Overall Study|Ineligible|1|||
33540882|NCT00505921|101881477|FG000|Overall Study|Failed to Mobilize|8|||
33540883|NCT01900444|101881478|FG000|Overall Study|Protocol Violation|2|||
33540884|NCT01900444|101881478|FG000|Overall Study|Lost to Follow-up|1|||
33540885|NCT02765035|101881481|FG000|First Intervention (90 Days)|Adverse Event|1|||
33540886|NCT02765035|101881482|FG001|First Intervention (90 Days)|Adverse Event|1|||
33540887|NCT02765035|101881481|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
33540888|NCT02765035|101881482|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
33540889|NCT00827567|101881483|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
33540890|NCT00921024|101881484|FG000|Overall Study|Lost to Follow-up|2|||
33540891|NCT00921024|101881485|FG001|Overall Study|Lost to Follow-up|0|||
33540892|NCT00921024|101881484|FG000|Overall Study|Received concomittant therapy|2|||
33540893|NCT00921024|101881485|FG001|Overall Study|Received concomittant therapy|0|||
33540894|NCT00921024|101881484|FG000|Overall Study|Withdrawal by Subject|0|||
33540895|NCT00921024|101881485|FG001|Overall Study|Withdrawal by Subject|3|||
33540896|NCT01712178|101881490|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
33540897|NCT01712178|101881491|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
33540898|NCT01712178|101881490|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
33540899|NCT01712178|101881491|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
33540900|NCT01712178|101881490|FG000|Overall Study|Lost to Follow-up|0|||
33540901|NCT01712178|101881491|FG001|Overall Study|Lost to Follow-up|1|||
33540902|NCT00336544|101881492|FG000|Overall Study|Lack of Efficacy|8|||
33540903|NCT00336544|101881493|FG001|Overall Study|Lack of Efficacy|5|||
33540904|NCT00336544|101881492|FG000|Overall Study|Adverse Event|4|||
33540905|NCT00336544|101881493|FG001|Overall Study|Adverse Event|9|||
33540906|NCT00336544|101881492|FG000|Overall Study|Withdrawal by Subject|4|||
33540907|NCT00336544|101881493|FG001|Overall Study|Withdrawal by Subject|3|||
33540908|NCT00336544|101881492|FG000|Overall Study|Other|3|||
33540909|NCT00336544|101881493|FG001|Overall Study|Other|5|||
33540910|NCT01240746|101881494|FG000|Overall Study|Adverse Event|2|||
33540911|NCT01240746|101881495|FG001|Overall Study|Adverse Event|0|||
33344001|NCT02629159|101148377|FG002|Overall Study|Withdrawal by Subject|15|||
33344002|NCT02629159|101148375|FG000|Overall Study|Lost to Follow-up|7|||
33344003|NCT02629159|101148376|FG001|Overall Study|Lost to Follow-up|4|||
33344004|NCT02629159|101148377|FG002|Overall Study|Lost to Follow-up|5|||
33540912|NCT01240746|101881496|FG002|Overall Study|Adverse Event|10|||
33540913|NCT01240746|101881494|FG000|Overall Study|Lost to Follow-up|23|||
33540914|NCT01240746|101881495|FG001|Overall Study|Lost to Follow-up|20|||
33540915|NCT01240746|101881496|FG002|Overall Study|Lost to Follow-up|102|||
33540916|NCT01240746|101881494|FG000|Overall Study|Protocol Violation|24|||
33540917|NCT01240746|101881495|FG001|Overall Study|Protocol Violation|15|||
33540918|NCT01240746|101881496|FG002|Overall Study|Protocol Violation|72|||
33540919|NCT01240746|101881494|FG000|Overall Study|Withdrawal by Subject|10|||
33540920|NCT01240746|101881495|FG001|Overall Study|Withdrawal by Subject|13|||
33540921|NCT01240746|101881496|FG002|Overall Study|Withdrawal by Subject|59|||
33540922|NCT00641056|101881498|FG000|Overall Study|Adverse Event|12|||
33540923|NCT00641056|101881499|FG001|Overall Study|Adverse Event|2|||
33540924|NCT00641056|101881498|FG000|Overall Study|Lost to Follow-up|2|||
33540925|NCT00641056|101881499|FG001|Overall Study|Lost to Follow-up|1|||
33540926|NCT00641056|101881498|FG000|Overall Study|Physician Decision|3|||
33540927|NCT00641056|101881499|FG001|Overall Study|Physician Decision|1|||
33540928|NCT00641056|101881498|FG000|Overall Study|Protocol Violation|2|||
33540929|NCT00641056|101881499|FG001|Overall Study|Protocol Violation|0|||
33540930|NCT00641056|101881498|FG000|Overall Study|Entry Criteria Not Met|3|||
33540931|NCT00641056|101881499|FG001|Overall Study|Entry Criteria Not Met|0|||
33344005|NCT02629159|101148375|FG000|Overall Study|Lack of Efficacy|4|||
33344006|NCT02629159|101148376|FG001|Overall Study|Lack of Efficacy|0|||
33344007|NCT02629159|101148377|FG002|Overall Study|Lack of Efficacy|1|||
33344008|NCT02629159|101148375|FG000|Overall Study|Other|6|||
33344009|NCT02629159|101148376|FG001|Overall Study|Other|4|||
33344010|NCT02629159|101148377|FG002|Overall Study|Other|8|||
33344011|NCT03898063|101148378|FG000|Overall Study|Withdrawal by Subject|10|||
33344012|NCT03898063|101148379|FG001|Overall Study|Withdrawal by Subject|8|||
33540932|NCT00641056|101881498|FG000|Overall Study|Subject Decision|6|||
33540933|NCT00641056|101881499|FG001|Overall Study|Subject Decision|19|||
33540934|NCT00641056|101881498|FG000|Overall Study|Sponsor Decision|1|||
33540935|NCT00641056|101881499|FG001|Overall Study|Sponsor Decision|2|||
33540936|NCT01004614|101881500|FG000|Washout|Withdrawal by Subject|0|||
33540937|NCT01004614|101881501|FG001|Washout|Withdrawal by Subject|1|||
33540938|NCT01004614|101881502|FG002|Washout|Withdrawal by Subject|0|||
33540939|NCT01004614|101881503|FG003|Washout|Withdrawal by Subject|0|||
33540940|NCT01192178|101881504|FG000|Overall Study|Withdrawal by Subject|6|||
33540941|NCT01192178|101881505|FG001|Overall Study|Withdrawal by Subject|10|||
33540942|NCT01192178|101881504|FG000|Overall Study|Protocol Violation|10|||
33344013|NCT02614079|101148380|FG000|Overall Study|Withdrawal by Subject|1|||
33344014|NCT00469612|101148391|FG000|Overall Study|Study terminated before data collected|2|||
33540943|NCT01192178|101881505|FG001|Overall Study|Protocol Violation|3|||
33344015|NCT00469612|101148392|FG001|Overall Study|Study terminated before data collected|0|||
33344016|NCT03222349|101148393|FG000|Overall Study|Treatment B not done|5|||
33344017|NCT03222349|101148394|FG001|Overall Study|Treatment B not done|0|||
33344018|NCT03222349|101148393|FG000|Overall Study|Lost to Follow-up|1|||
33344019|NCT03222349|101148394|FG001|Overall Study|Lost to Follow-up|2|||
33344020|NCT03222349|101148393|FG000|Overall Study|Withdrawal by Subject|1|||
33540944|NCT01192178|101881504|FG000|Overall Study|Physician Decision|2|||
33406855|NCT02985996|101377745|FG002|Overall Study|Withdrawal by Subject|1|||
33406856|NCT02985996|101377746|FG003|Overall Study|Withdrawal by Subject|0|||
33406857|NCT02985996|101377747|FG004|Overall Study|Withdrawal by Subject|0|||
33406858|NCT02985996|101377743|FG000|Overall Study|Protocol Violation|0|||
33406859|NCT02985996|101377744|FG001|Overall Study|Protocol Violation|1|||
33540945|NCT01192178|101881505|FG001|Overall Study|Physician Decision|4|||
33540946|NCT01192178|101881504|FG000|Overall Study|Lost to Follow-up|3|||
33540947|NCT01192178|101881505|FG001|Overall Study|Lost to Follow-up|3|||
33211166|NCT02834780|100673616|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
33211167|NCT02834780|100673617|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
33211168|NCT02834780|100673605|FG000|Overall Study|Withdrawal by Subject|0|||
33211169|NCT02834780|100673606|FG001|Overall Study|Withdrawal by Subject|0|||
33211170|NCT02834780|100673607|FG002|Overall Study|Withdrawal by Subject|1|||
33211171|NCT02834780|100673608|FG003|Overall Study|Withdrawal by Subject|0|||
33211172|NCT02834780|100673609|FG004|Overall Study|Withdrawal by Subject|0|||
33211173|NCT02834780|100673610|FG005|Overall Study|Withdrawal by Subject|0|||
33211174|NCT02834780|100673611|FG006|Overall Study|Withdrawal by Subject|0|||
33211175|NCT02834780|100673612|FG007|Overall Study|Withdrawal by Subject|0|||
33211176|NCT02834780|100673613|FG008|Overall Study|Withdrawal by Subject|0|||
33540948|NCT01192178|101881504|FG000|Overall Study|Adverse Event|2|||
33540949|NCT01192178|101881505|FG001|Overall Study|Adverse Event|1|||
33211177|NCT02834780|100673614|FG009|Overall Study|Withdrawal by Subject|0|||
33211178|NCT02834780|100673615|FG010|Overall Study|Withdrawal by Subject|1|||
33211179|NCT02834780|100673616|FG011|Overall Study|Withdrawal by Subject|0|||
33211180|NCT02834780|100673617|FG012|Overall Study|Withdrawal by Subject|0|||
33211181|NCT02834780|100673605|FG000|Overall Study|Adverse Event|0|||
33211182|NCT02834780|100673606|FG001|Overall Study|Adverse Event|0|||
33211183|NCT02834780|100673607|FG002|Overall Study|Adverse Event|0|||
33211184|NCT02834780|100673608|FG003|Overall Study|Adverse Event|0|||
33211185|NCT02834780|100673609|FG004|Overall Study|Adverse Event|1|||
33211186|NCT02834780|100673610|FG005|Overall Study|Adverse Event|0|||
33211187|NCT02834780|100673611|FG006|Overall Study|Adverse Event|1|||
33211188|NCT02834780|100673612|FG007|Overall Study|Adverse Event|1|||
33211189|NCT02834780|100673613|FG008|Overall Study|Adverse Event|0|||
33211190|NCT02834780|100673614|FG009|Overall Study|Adverse Event|2|||
33211191|NCT02834780|100673615|FG010|Overall Study|Adverse Event|0|||
33211192|NCT02834780|100673616|FG011|Overall Study|Adverse Event|3|||
33211193|NCT02834780|100673617|FG012|Overall Study|Adverse Event|2|||
33211194|NCT02834780|100673605|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
33211195|NCT02834780|100673606|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
33344021|NCT03222349|101148394|FG001|Overall Study|Withdrawal by Subject|0|||
33344022|NCT03222349|101148393|FG000|Overall Study|Treatment A not done|0|||
33406860|NCT02985996|101377745|FG002|Overall Study|Protocol Violation|0|||
33540950|NCT01192178|101881504|FG000|Overall Study|Lack of Efficacy|1|||
33540951|NCT01192178|101881505|FG001|Overall Study|Lack of Efficacy|2|||
33211196|NCT02834780|100673607|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
33211197|NCT02834780|100673608|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
33211198|NCT02834780|100673609|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
33211199|NCT02834780|100673610|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
33344023|NCT03222349|101148394|FG001|Overall Study|Treatment A not done|5|||
33406861|NCT02985996|101377746|FG003|Overall Study|Protocol Violation|0|||
33406862|NCT02985996|101377747|FG004|Overall Study|Protocol Violation|0|||
33540952|NCT00720499|101881506|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
33540953|NCT00720499|101881507|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
33211200|NCT02834780|100673611|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
33211201|NCT02834780|100673612|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
33211202|NCT02834780|100673613|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
33211203|NCT02834780|100673614|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
33211204|NCT02834780|100673615|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
33344024|NCT03222349|101148393|FG000|Overall Study|Study terminated by sponsor|1|||
33344025|NCT03222349|101148394|FG001|Overall Study|Study terminated by sponsor|0|||
33344026|NCT01445769|101148406|FG000|Overall Study|Consent Withdrawn|2|||
33344027|NCT01445769|101148406|FG000|Overall Study|Disease Progression|1|||
33344028|NCT01445769|101148406|FG000|Overall Study|Lost to Follow-up|5|||
33344029|NCT03118297|101148414|FG000|Overall Study|Lost to Follow-up|0|||
33344030|NCT03118297|101148415|FG001|Overall Study|Lost to Follow-up|2|||
33344031|NCT01327651|101148420|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
33344032|NCT01327651|101148421|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
33344033|NCT01327651|101148422|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
33344034|NCT01327651|101148423|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
33344035|NCT01327651|101148424|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
33344036|NCT01327651|101148425|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
33344037|NCT01327651|101148426|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
33344038|NCT01327651|101148427|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
33344039|NCT01327651|101148428|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
33344040|NCT01327651|101148420|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
33344041|NCT01327651|101148421|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33344042|NCT01327651|101148422|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33344043|NCT01327651|101148423|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33344044|NCT01327651|101148424|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33344045|NCT01327651|101148425|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33540954|NCT00720499|101881506|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
33540955|NCT00720499|101881507|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
33540956|NCT00720499|101881506|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
33540957|NCT00720499|101881507|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
33344046|NCT01327651|101148426|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33344047|NCT01327651|101148427|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33344048|NCT01327651|101148428|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
33344049|NCT01327651|101148420|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
33344050|NCT01327651|101148421|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
33344051|NCT01327651|101148422|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
33344052|NCT01327651|101148423|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
33344053|NCT01327651|101148424|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
33344054|NCT01327651|101148425|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
33344055|NCT01327651|101148426|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
33344056|NCT01327651|101148427|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
33540958|NCT03353220|101881510|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
33540959|NCT03353220|101881511|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
33540960|NCT00888654|101881514|FG000|Overall Study|Problems swallowing oral meds.|1|||
33540961|NCT00888654|101881514|FG000|Overall Study|Not enough oral meds before surgery|3|||
33211205|NCT02834780|100673616|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
33211206|NCT02834780|100673617|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
33211207|NCT02834780|100673605|FG000|Overall Study|Other|1|||
33211208|NCT02834780|100673606|FG001|Overall Study|Other|0|||
33211209|NCT02834780|100673607|FG002|Overall Study|Other|1|||
33211210|NCT02834780|100673608|FG003|Overall Study|Other|2|||
33211211|NCT02834780|100673609|FG004|Overall Study|Other|0|||
33211212|NCT02834780|100673610|FG005|Overall Study|Other|0|||
33211213|NCT02834780|100673611|FG006|Overall Study|Other|0|||
33211214|NCT02834780|100673612|FG007|Overall Study|Other|0|||
33211215|NCT02834780|100673613|FG008|Overall Study|Other|0|||
33211216|NCT02834780|100673614|FG009|Overall Study|Other|0|||
33211217|NCT02834780|100673615|FG010|Overall Study|Other|0|||
33211218|NCT02834780|100673616|FG011|Overall Study|Other|0|||
33344057|NCT01327651|101148428|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
33540962|NCT00888654|101881514|FG000|Overall Study|Surgery aborted|2|||
33540963|NCT00888654|101881514|FG000|Overall Study|Withdrawal by Subject|1|||
33540964|NCT00888654|101881514|FG000|Overall Study|Inelig. due to contraindication of med|1|||
33540965|NCT00888654|101881514|FG000|Overall Study|Change in surg date|1|||
33540966|NCT00888654|101881514|FG000|Overall Study|Stopped meds due to headaches|1|||
33540967|NCT02495389|101881517|FG000|Overall Study|Withdrawal by Subject|40|||
33211219|NCT02834780|100673617|FG012|Overall Study|Other|1|||
33211220|NCT02820623|100673618|FG000|Overall Study|Withdrawal by Subject|1|||
33344058|NCT01327651|101148420|FG000|Post Study Follow-up|Lost to Follow-up|0|||
33344059|NCT01327651|101148421|FG001|Post Study Follow-up|Lost to Follow-up|1|||
33344060|NCT01327651|101148422|FG002|Post Study Follow-up|Lost to Follow-up|1|||
33344061|NCT01327651|101148423|FG003|Post Study Follow-up|Lost to Follow-up|0|||
33344062|NCT01327651|101148424|FG004|Post Study Follow-up|Lost to Follow-up|0|||
33344063|NCT01327651|101148425|FG005|Post Study Follow-up|Lost to Follow-up|0|||
33344064|NCT01327651|101148426|FG006|Post Study Follow-up|Lost to Follow-up|4|||
33344065|NCT01327651|101148427|FG007|Post Study Follow-up|Lost to Follow-up|1|||
33344066|NCT01327651|101148428|FG008|Post Study Follow-up|Lost to Follow-up|2|||
33344067|NCT01289015|101148429|FG000|Overall Study|Protocol Violation|12|||
33344068|NCT01289015|101148430|FG001|Overall Study|Protocol Violation|9|||
33344069|NCT01289015|101148429|FG000|Overall Study|Adverse Event|3|||
33211221|NCT02820623|100673619|FG001|Overall Study|Withdrawal by Subject|3|||
33211222|NCT02820623|100673620|FG002|Overall Study|Withdrawal by Subject|3|||
33211223|NCT02820623|100673618|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
33211224|NCT02820623|100673619|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
33211225|NCT02820623|100673620|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
33211226|NCT02820623|100673618|FG000|Overall Study|Therapist unable to enroll clients|1|||
33211227|NCT02820623|100673619|FG001|Overall Study|Therapist unable to enroll clients|1|||
33211228|NCT02820623|100673620|FG002|Overall Study|Therapist unable to enroll clients|3|||
33344070|NCT01289015|101148430|FG001|Overall Study|Adverse Event|0|||
33344071|NCT01289015|101148429|FG000|Overall Study|Lost to Follow-up|33|||
33344072|NCT01289015|101148430|FG001|Overall Study|Lost to Follow-up|17|||
33344073|NCT01289015|101148429|FG000|Overall Study|Withdrawal by Subject|17|||
33344074|NCT01289015|101148430|FG001|Overall Study|Withdrawal by Subject|8|||
33344075|NCT01289015|101148429|FG000|Overall Study|Disease progression|1|||
33344076|NCT01289015|101148430|FG001|Overall Study|Disease progression|0|||
33344077|NCT01289015|101148429|FG000|Overall Study|Negative baseline culture and others|33|||
33211229|NCT02820623|100673618|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
33211230|NCT02820623|100673619|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
33211231|NCT02820623|100673620|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
33211232|NCT01090453|100673623|FG000|Overall Study|Withdrawal by Subject|1|||
33211233|NCT01090453|100673624|FG001|Overall Study|Withdrawal by Subject|2|||
33344078|NCT01289015|101148430|FG001|Overall Study|Negative baseline culture and others|20|||
33344079|NCT03261531|101148432|FG000|Overall Study|Withdrawal by Subject|4|||
33344080|NCT01015833|101148433|FG000|Overall Study|Death|1|||
33344081|NCT01015833|101148434|FG001|Overall Study|Death|0|||
33344082|NCT01015833|101148433|FG000|Overall Study|Withdrawal by Subject|3|||
33344083|NCT01015833|101148434|FG001|Overall Study|Withdrawal by Subject|2|||
33344084|NCT01015833|101148433|FG000|Overall Study|Adverse Event|0|||
33344085|NCT01015833|101148434|FG001|Overall Study|Adverse Event|1|||
33344086|NCT01015833|101148433|FG000|Overall Study|Physician Decision|2|||
33406863|NCT02815670|101377750|FG000|Overall Study|Prematurely discontinued of the trial|1|||
33540968|NCT03863353|101881520|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
33344087|NCT01015833|101148434|FG001|Overall Study|Physician Decision|0|||
33344088|NCT01015833|101148433|FG000|Overall Study|Symptomatic deterioration|0|||
33344089|NCT01015833|101148434|FG001|Overall Study|Symptomatic deterioration|1|||
33344090|NCT01015833|101148433|FG000|Overall Study|Other|5|||
33344091|NCT01015833|101148434|FG001|Overall Study|Other|1|||
33567612|NCT02723955|101973210|FG041|Crossover/ Re-treatment Phase|Death|1|||
33211234|NCT01090453|100673623|FG000|Overall Study|Lost to Follow-up|7|||
33211235|NCT01090453|100673624|FG001|Overall Study|Lost to Follow-up|7|||
33211236|NCT01090453|100673623|FG000|Overall Study|Non serious AEs|1|||
33344092|NCT01015833|101148433|FG000|Overall Study|Motor Vehicle Accidents|1|||
33344093|NCT01015833|101148434|FG001|Overall Study|Motor Vehicle Accidents|0|||
33344094|NCT01015833|101148433|FG000|Overall Study|Did not start treatment|1|||
33344095|NCT01015833|101148434|FG001|Overall Study|Did not start treatment|0|||
33344096|NCT01276236|101148441|FG000|Overall Study|Lack of Efficacy|2|||
33344097|NCT01276236|101148441|FG000|Overall Study|Withdrawal by Subject|4|||
33344098|NCT00699348|101148442|FG000|Overall Study|Death|6|||
33344099|NCT00699348|101148442|FG000|Overall Study|Adverse Event|15|||
33344100|NCT00699348|101148442|FG000|Overall Study|Withdrawal by Subject|11|||
33344101|NCT00699348|101148442|FG000|Overall Study|Protocol Violation|10|||
33344102|NCT00699348|101148442|FG000|Overall Study|Lack of Efficacy|8|||
33344103|NCT00699348|101148442|FG000|Overall Study|Failure to return|1|||
33344104|NCT00699348|101148442|FG000|Overall Study|Blood transfusion|24|||
33344105|NCT00699348|101148442|FG000|Overall Study|Renal transplantation|10|||
33344106|NCT00699348|101148442|FG000|Overall Study|Other|5|||
33344107|NCT00264004|101148445|FG000|Overall Study|Adverse Event|2|||
33344108|NCT00264004|101148446|FG001|Overall Study|Adverse Event|3|||
33344109|NCT00264004|101148447|FG002|Overall Study|Adverse Event|6|||
33344110|NCT00264004|101148448|FG003|Overall Study|Adverse Event|4|||
33344111|NCT00264004|101148445|FG000|Overall Study|Withdrawal by Subject|0|||
33344112|NCT00264004|101148446|FG001|Overall Study|Withdrawal by Subject|1|||
33344113|NCT00264004|101148447|FG002|Overall Study|Withdrawal by Subject|2|||
33344114|NCT00264004|101148448|FG003|Overall Study|Withdrawal by Subject|2|||
33344115|NCT00264004|101148445|FG000|Overall Study|Other|2|||
33344116|NCT00264004|101148446|FG001|Overall Study|Other|2|||
33344117|NCT00264004|101148447|FG002|Overall Study|Other|0|||
33344118|NCT00264004|101148448|FG003|Overall Study|Other|3|||
33344119|NCT00264004|101148445|FG000|Overall Study|Development study specific disc. crit.|1|||
33344120|NCT00264004|101148446|FG001|Overall Study|Development study specific disc. crit.|0|||
33344121|NCT00264004|101148447|FG002|Overall Study|Development study specific disc. crit.|1|||
33344122|NCT00264004|101148448|FG003|Overall Study|Development study specific disc. crit.|0|||
33344123|NCT00264004|101148445|FG000|Overall Study|Cond. under inv. worsened|9|||
33344124|NCT00264004|101148446|FG001|Overall Study|Cond. under inv. worsened|5|||
33344125|NCT00264004|101148447|FG002|Overall Study|Cond. under inv. worsened|3|||
33344126|NCT00264004|101148448|FG003|Overall Study|Cond. under inv. worsened|4|||
33344127|NCT00264004|101148445|FG000|Overall Study|Not treated|3|||
33344128|NCT00264004|101148446|FG001|Overall Study|Not treated|0|||
33344129|NCT00264004|101148447|FG002|Overall Study|Not treated|2|||
33344130|NCT00264004|101148448|FG003|Overall Study|Not treated|2|||
33344131|NCT02307682|101148451|FG000|Overall Study|Adverse Event|9|||
33344132|NCT02307682|101148452|FG001|Overall Study|Adverse Event|8|||
33344133|NCT02307682|101148453|FG002|Overall Study|Adverse Event|12|||
33344134|NCT02307682|101148451|FG000|Overall Study|Lack of Efficacy|1|||
33344135|NCT02307682|101148452|FG001|Overall Study|Lack of Efficacy|0|||
33344136|NCT02307682|101148453|FG002|Overall Study|Lack of Efficacy|1|||
33344137|NCT02307682|101148451|FG000|Overall Study|Physician Decision|2|||
33344138|NCT02307682|101148452|FG001|Overall Study|Physician Decision|2|||
33344139|NCT02307682|101148453|FG002|Overall Study|Physician Decision|8|||
33344140|NCT02307682|101148451|FG000|Overall Study|Progressive Disease|1|||
33344141|NCT02307682|101148452|FG001|Overall Study|Progressive Disease|0|||
33344142|NCT02307682|101148453|FG002|Overall Study|Progressive Disease|0|||
33211237|NCT01090453|100673624|FG001|Overall Study|Non serious AEs|0|||
33211238|NCT01090453|100673623|FG000|Overall Study|Protocol Violation|2|||
33211239|NCT01090453|100673624|FG001|Overall Study|Protocol Violation|0|||
33211240|NCT01090453|100673623|FG000|Overall Study|Other|2|||
33211241|NCT01090453|100673624|FG001|Overall Study|Other|4|||
33211242|NCT01090453|100673623|FG000|Overall Study|Eligibility Criteria|0|||
33211243|NCT01090453|100673624|FG001|Overall Study|Eligibility Criteria|1|||
33344143|NCT02307682|101148451|FG000|Overall Study|Withdrawal by Subject|26|||
33344144|NCT02307682|101148452|FG001|Overall Study|Withdrawal by Subject|34|||
33344145|NCT02307682|101148453|FG002|Overall Study|Withdrawal by Subject|23|||
33344146|NCT02307682|101148451|FG000|Overall Study|Death|9|||
33344147|NCT02307682|101148452|FG001|Overall Study|Death|7|||
33344148|NCT02307682|101148453|FG002|Overall Study|Death|12|||
33344149|NCT02307682|101148451|FG000|Overall Study|Lost to Follow-up|1|||
33344150|NCT02307682|101148452|FG001|Overall Study|Lost to Follow-up|5|||
33344151|NCT02307682|101148453|FG002|Overall Study|Lost to Follow-up|6|||
33344152|NCT02307682|101148451|FG000|Overall Study|Protocol Deviation|0|||
33344153|NCT02307682|101148452|FG001|Overall Study|Protocol Deviation|0|||
33344154|NCT02307682|101148453|FG002|Overall Study|Protocol Deviation|2|||
33344155|NCT02307682|101148451|FG000|Overall Study|Other|1|||
33344156|NCT02307682|101148452|FG001|Overall Study|Other|1|||
33344157|NCT02307682|101148453|FG002|Overall Study|Other|0|||
33344158|NCT00454805|101148456|FG000|Overall Study|Withdrawal by Subject|9|||
33344159|NCT00454805|101148457|FG001|Overall Study|Withdrawal by Subject|2|||
33211244|NCT03320070|100673625|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
33211245|NCT03320070|100673626|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
33211246|NCT03320070|100673625|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
33344160|NCT00454805|101148456|FG000|Overall Study|Death|0|||
33344161|NCT00454805|101148457|FG001|Overall Study|Death|2|||
33344162|NCT00454805|101148456|FG000|Overall Study|Disease progression|16|||
33344163|NCT00454805|101148457|FG001|Overall Study|Disease progression|19|||
33344164|NCT00454805|101148456|FG000|Overall Study|In order to begin radiotherapy|1|||
33344165|NCT00454805|101148457|FG001|Overall Study|In order to begin radiotherapy|0|||
33344166|NCT00382993|101148458|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
33344167|NCT00382993|101148459|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
33344168|NCT00382993|101148458|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
33344169|NCT00382993|101148459|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
33344170|NCT00382993|101148458|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
33344171|NCT00382993|101148459|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
33344172|NCT00382993|101148458|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
33344173|NCT00382993|101148459|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
33344174|NCT00382993|101148458|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
33344175|NCT00382993|101148459|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
33344176|NCT00382993|101148458|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
33540969|NCT03863353|101881521|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
33540970|NCT01324102|101881522|FG000|Overall Study|illness|1|||
33540971|NCT01324102|101881523|FG001|Overall Study|illness|6|||
33540972|NCT00385840|101881524|FG000|Overall Study|Adverse Event|1|||
33540973|NCT00385840|101881525|FG001|Overall Study|Adverse Event|1|||
33211247|NCT03320070|100673626|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
33211248|NCT03320070|100673625|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
33211249|NCT03320070|100673626|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
33211250|NCT03320070|100673625|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
33211251|NCT03320070|100673626|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
33211252|NCT03320070|100673625|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
33211253|NCT03320070|100673626|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
33344177|NCT00382993|101148459|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
33344178|NCT00382993|101148458|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
33344179|NCT00382993|101148459|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
33344180|NCT00382993|101148458|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
33344181|NCT00382993|101148459|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
33344182|NCT00382993|101148458|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
33344183|NCT00382993|101148459|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
33344184|NCT00382993|101148458|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
33344185|NCT00382993|101148459|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
33344186|NCT02425098|101148464|FG000|Overall Study|Lost to Follow-up|7|||
33344187|NCT02425098|101148465|FG001|Overall Study|Lost to Follow-up|7|||
33344188|NCT02425098|101148464|FG000|Overall Study|Withdrawal by Subject|4|||
33344189|NCT02425098|101148465|FG001|Overall Study|Withdrawal by Subject|8|||
33344190|NCT02425098|101148464|FG000|Overall Study|Pregnancy|2|||
33344191|NCT02425098|101148465|FG001|Overall Study|Pregnancy|0|||
33344192|NCT02425098|101148464|FG000|Overall Study|Reason not Specified|0|||
33344193|NCT02425098|101148465|FG001|Overall Study|Reason not Specified|1|||
33344194|NCT01818297|101148470|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
33344195|NCT01818297|101148471|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
33344196|NCT01818297|101148470|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
33344197|NCT01818297|101148471|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
33344198|NCT01818297|101148470|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
33344199|NCT01818297|101148471|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
33344200|NCT00939692|101151856|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
33344201|NCT00939692|101151857|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
33344202|NCT00939692|101151856|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
33344203|NCT00939692|101151857|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
33344204|NCT02847598|101151858|FG000|Overall Study|Adverse Event|0|||
33344205|NCT02847598|101151859|FG001|Overall Study|Adverse Event|0|||
33344206|NCT02847598|101151860|FG002|Overall Study|Adverse Event|0|||
33344207|NCT02847598|101151861|FG003|Overall Study|Adverse Event|0|||
33344208|NCT02847598|101151862|FG004|Overall Study|Adverse Event|0|||
33344209|NCT02847598|101151863|FG005|Overall Study|Adverse Event|0|||
33344210|NCT02847598|101151864|FG006|Overall Study|Adverse Event|0|||
33344211|NCT02847598|101151865|FG007|Overall Study|Adverse Event|1|||
33344212|NCT02847598|101151858|FG000|Overall Study|Consent withdrawn|2|||
33406864|NCT00039377|101377751|FG000|Initial Registration|Adverse Event|2|||
33615600|NCT02596230|102140378|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
33344213|NCT02847598|101151859|FG001|Overall Study|Consent withdrawn|0|||
33344214|NCT02847598|101151860|FG002|Overall Study|Consent withdrawn|0|||
33406865|NCT00039377|101377752|FG001|Initial Registration|Adverse Event|0|||
33406866|NCT00039377|101377753|FG002|Initial Registration|Adverse Event|0|||
33540974|NCT00385840|101881524|FG000|Overall Study|Lost to Follow-up|3|||
33344215|NCT02847598|101151861|FG003|Overall Study|Consent withdrawn|4|||
33344216|NCT02847598|101151862|FG004|Overall Study|Consent withdrawn|3|||
33344217|NCT02847598|101151863|FG005|Overall Study|Consent withdrawn|2|||
33344218|NCT02847598|101151864|FG006|Overall Study|Consent withdrawn|1|||
33344219|NCT02847598|101151865|FG007|Overall Study|Consent withdrawn|3|||
33344220|NCT02847598|101151858|FG000|Overall Study|Death|3|||
33344221|NCT02847598|101151859|FG001|Overall Study|Death|0|||
33211254|NCT03320070|100673625|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
33344222|NCT02847598|101151860|FG002|Overall Study|Death|0|||
33344223|NCT02847598|101151861|FG003|Overall Study|Death|0|||
33344224|NCT02847598|101151862|FG004|Overall Study|Death|0|||
33344225|NCT02847598|101151863|FG005|Overall Study|Death|0|||
33344226|NCT02847598|101151864|FG006|Overall Study|Death|0|||
33344227|NCT02847598|101151865|FG007|Overall Study|Death|0|||
33344228|NCT02847598|101151858|FG000|Overall Study|Lost to Follow-up|0|||
33344229|NCT02847598|101151859|FG001|Overall Study|Lost to Follow-up|0|||
33344230|NCT02847598|101151860|FG002|Overall Study|Lost to Follow-up|0|||
33344231|NCT02847598|101151861|FG003|Overall Study|Lost to Follow-up|0|||
33344232|NCT02847598|101151862|FG004|Overall Study|Lost to Follow-up|0|||
33344233|NCT02847598|101151863|FG005|Overall Study|Lost to Follow-up|1|||
33344234|NCT02847598|101151864|FG006|Overall Study|Lost to Follow-up|1|||
33211255|NCT03320070|100673626|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
33211256|NCT01003899|100673627|FG000|Overall Study|Other Adverse Event|8|||
33211257|NCT01003899|100673627|FG000|Overall Study|Not entered|4|||
33211258|NCT01003899|100673627|FG000|Overall Study|Not treated|1|||
33211259|NCT01003899|100673627|FG000|Overall Study|Progressive disease|34|||
33211260|NCT01667432|100673629|FG000|Overall Study|Premature Study Termination|26|||
33211261|NCT01667432|100673629|FG000|Overall Study|Failure to Return|10|||
33211262|NCT01667432|100673629|FG000|Overall Study|Moved to Another Center|3|||
33211263|NCT01667432|100673629|FG000|Overall Study|Lost to Follow-up|3|||
33211264|NCT01667432|100673629|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
33211265|NCT01667432|100673629|FG000|Overall Study|Insufficient Therapeutic Response|4|||
33211266|NCT01667432|100673629|FG000|Overall Study|Adverse Event|1|||
33211267|NCT01667432|100673629|FG000|Overall Study|Protocol Deviation|2|||
33211268|NCT01667432|100673629|FG000|Overall Study|Principal Investigator Decision|1|||
33211269|NCT01667432|100673629|FG000|Overall Study|Reason Not Specified|2|||
33211270|NCT01667432|100673629|FG000|Overall Study|Missing Information|4|||
33211271|NCT01990950|100673630|FG000|Overall Study|Death|3|||
33211272|NCT01990950|100673630|FG000|Overall Study|Lost to Follow-up|2|||
33211273|NCT01990950|100673630|FG000|Overall Study|Withdrawal by Subject|6|||
33211274|NCT02372396|100673633|FG000|Overall Study|Lost to Follow-up|7|||
33211275|NCT02372396|100673634|FG001|Overall Study|Lost to Follow-up|9|||
33211276|NCT00423176|100673637|FG000|Overall Study|Adverse Event|4|||
33211277|NCT00423176|100673638|FG001|Overall Study|Adverse Event|6|||
33211278|NCT00423176|100673637|FG000|Overall Study|Treatment Failure|1|||
33211279|NCT00423176|100673638|FG001|Overall Study|Treatment Failure|6|||
33211280|NCT00423176|100673637|FG000|Overall Study|Lost to Follow-up|4|||
33211281|NCT00423176|100673638|FG001|Overall Study|Lost to Follow-up|7|||
33211282|NCT00423176|100673637|FG000|Overall Study|Withdrawal by Subject|4|||
33211283|NCT00423176|100673638|FG001|Overall Study|Withdrawal by Subject|3|||
33211284|NCT00423176|100673637|FG000|Overall Study|Protocol Violation|1|||
33211285|NCT00423176|100673638|FG001|Overall Study|Protocol Violation|3|||
33211286|NCT00423176|100673637|FG000|Overall Study|Did not meet protocol eligibility|2|||
33211287|NCT00423176|100673638|FG001|Overall Study|Did not meet protocol eligibility|4|||
33211288|NCT00674986|100673642|FG000|Overall Study|Adverse Event|2|||
33211289|NCT00674986|100673643|FG001|Overall Study|Adverse Event|1|||
33211290|NCT00674986|100673642|FG000|Overall Study|Subject withdrew consent|12|||
33211291|NCT00674986|100673643|FG001|Overall Study|Subject withdrew consent|19|||
33211292|NCT00674986|100673642|FG000|Overall Study|Lost to Follow-up|25|||
33344235|NCT02847598|101151865|FG007|Overall Study|Lost to Follow-up|0|||
33211293|NCT00674986|100673643|FG001|Overall Study|Lost to Follow-up|53|||
33211294|NCT00674986|100673642|FG000|Overall Study|Other reasons|4|||
33344236|NCT03687502|101151866|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
33211295|NCT00674986|100673643|FG001|Overall Study|Other reasons|8|||
33344237|NCT03687502|101151866|FG000|Overall Study|Lumason not available|1|||
33344238|NCT00413959|101151870|FG000|Overall Study|Pt had only one cycle.|1|||
33344239|NCT02154425|101151871|FG000|Screening Period|Adverse Event|1|||
33344240|NCT04178772|101151875|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
33344241|NCT04178772|101151875|FG000|Overall Study|study terminated early due to COVID-19|7|||
33344242|NCT02167945|101151877|FG000|Overall Study|Adverse Event|16|||
33211296|NCT02576678|100673644|FG000|Overall Study|Adverse Event|0|||
33211297|NCT02576678|100673645|FG001|Overall Study|Adverse Event|0|||
33211298|NCT02576678|100673646|FG002|Overall Study|Adverse Event|2|||
33211299|NCT02576678|100673644|FG000|Overall Study|Withdrawal by Subject|3|||
33344243|NCT02167945|101151877|FG000|Overall Study|Withdrew Consent|42|||
33344244|NCT02167945|101151877|FG000|Overall Study|Lost to Follow-up|122|||
33344245|NCT02167945|101151877|FG000|Overall Study|COVID-19 logistical restrictions|6|||
33344246|NCT02167945|101151877|FG000|Overall Study|Other, not specified|63|||
33344247|NCT00070941|101151881|FG000|Overall Study|Adverse Event|10|||
33344248|NCT00070941|101151882|FG001|Overall Study|Adverse Event|8|||
33211300|NCT02576678|100673645|FG001|Overall Study|Withdrawal by Subject|1|||
33211301|NCT02576678|100673646|FG002|Overall Study|Withdrawal by Subject|2|||
33211302|NCT02576678|100673644|FG000|Overall Study|Lost to Follow-up|0|||
33211303|NCT02576678|100673645|FG001|Overall Study|Lost to Follow-up|0|||
33211304|NCT02576678|100673646|FG002|Overall Study|Lost to Follow-up|1|||
33211305|NCT02576678|100673644|FG000|Overall Study|Miscellaneous|2|||
33211306|NCT02576678|100673645|FG001|Overall Study|Miscellaneous|0|||
33211307|NCT02576678|100673646|FG002|Overall Study|Miscellaneous|0|||
33211308|NCT01640808|100673648|FG000|Overall Study|Unable to continue dynamic CT|14|||
33211309|NCT01640808|100673649|FG001|Overall Study|Unable to continue dynamic CT|4|||
33211310|NCT01640808|100673648|FG000|Overall Study|Withdrawal by Subject|12|||
33211311|NCT01640808|100673649|FG001|Overall Study|Withdrawal by Subject|4|||
33211312|NCT01640808|100673648|FG000|Overall Study|Lost to Follow-up|4|||
33211313|NCT01640808|100673649|FG001|Overall Study|Lost to Follow-up|0|||
33211314|NCT01640808|100673648|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
33344249|NCT00070941|101151883|FG002|Overall Study|Adverse Event|4|||
33344250|NCT01871090|101151884|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
33344251|NCT01871090|101151885|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
33344252|NCT01871090|101151884|FG000|Overall Study|Interrogation not completed correctly|1|||
33344253|NCT01871090|101151885|FG001|Overall Study|Interrogation not completed correctly|0|||
33344254|NCT01871090|101151884|FG000|Overall Study|Subject Non-Compliance|0|||
33344255|NCT01871090|101151885|FG001|Overall Study|Subject Non-Compliance|1|||
33344256|NCT03575104|101151886|FG000|Overall Study|Adverse Event|4|||
33344257|NCT03575104|101151887|FG001|Overall Study|Adverse Event|3|||
33344258|NCT03575104|101151888|FG002|Overall Study|Adverse Event|4|||
33344259|NCT03575104|101151886|FG000|Overall Study|Withdrawal by Subject|13|||
33344260|NCT03575104|101151887|FG001|Overall Study|Withdrawal by Subject|16|||
33344261|NCT03575104|101151888|FG002|Overall Study|Withdrawal by Subject|11|||
33344262|NCT03575104|101151886|FG000|Overall Study|Other reasons|6|||
33344263|NCT03575104|101151887|FG001|Overall Study|Other reasons|8|||
33344264|NCT03575104|101151888|FG002|Overall Study|Other reasons|6|||
33344265|NCT03575104|101151886|FG000|Overall Study|Lost to Follow-up|1|||
33344266|NCT03575104|101151887|FG001|Overall Study|Lost to Follow-up|2|||
33344267|NCT03575104|101151888|FG002|Overall Study|Lost to Follow-up|1|||
33344268|NCT01703858|101151889|FG000|Overall Study|Withdrawal by Subject|0|||
33344269|NCT01703858|101151890|FG001|Overall Study|Withdrawal by Subject|1|||
33344270|NCT01703858|101151891|FG002|Overall Study|Withdrawal by Subject|0|||
33344271|NCT03980938|101151893|FG000|Treatment Period 1|Study Terminated|1|||
33344272|NCT03980938|101151894|FG001|Treatment Period 1|Study Terminated|1|||
33344273|NCT03980938|101151893|FG000|Treatment Period 2|Study Terminated|2|||
33344274|NCT03980938|101151894|FG001|Treatment Period 2|Study Terminated|2|||
33344275|NCT02296242|101151895|FG000|Overall Study|Death|1|||
33344276|NCT02296242|101151896|FG001|Overall Study|Death|1|||
33344277|NCT02296242|101151897|FG002|Overall Study|Death|1|||
33344278|NCT02296242|101151898|FG003|Overall Study|Death|1|||
33344279|NCT02296242|101151899|FG004|Overall Study|Death|1|||
33344280|NCT02296242|101151895|FG000|Overall Study|Withdrawal by Subject|0|||
33344281|NCT02296242|101151896|FG001|Overall Study|Withdrawal by Subject|0|||
33344282|NCT02296242|101151897|FG002|Overall Study|Withdrawal by Subject|1|||
33344283|NCT02296242|101151898|FG003|Overall Study|Withdrawal by Subject|1|||
33540975|NCT00385840|101881525|FG001|Overall Study|Lost to Follow-up|13|||
33540976|NCT02631941|101881526|FG000|Overall Study|Physician Decision|0|||
33540977|NCT02631941|101881527|FG001|Overall Study|Physician Decision|1|||
33540978|NCT02631941|101881528|FG002|Overall Study|Physician Decision|0|||
33540979|NCT02631941|101881529|FG003|Overall Study|Physician Decision|0|||
33540980|NCT02631941|101881530|FG004|Overall Study|Physician Decision|0|||
33540981|NCT02631941|101881531|FG005|Overall Study|Physician Decision|0|||
33540982|NCT02631941|101881532|FG006|Overall Study|Physician Decision|0|||
33540983|NCT02631941|101881533|FG007|Overall Study|Physician Decision|0|||
33540984|NCT02631941|101881534|FG008|Overall Study|Physician Decision|0|||
33211315|NCT01640808|100673649|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
33211316|NCT01640808|100673648|FG000|Overall Study|Administration of anticancer drugs|2|||
33211317|NCT01640808|100673649|FG001|Overall Study|Administration of anticancer drugs|1|||
33344284|NCT02296242|101151899|FG004|Overall Study|Withdrawal by Subject|3|||
33344285|NCT02296242|101151895|FG000|Overall Study|Disease Progression|1|||
33211318|NCT01640808|100673648|FG000|Overall Study|Physician Decision|19|||
33211319|NCT01640808|100673649|FG001|Overall Study|Physician Decision|5|||
33211320|NCT01640808|100673648|FG000|Overall Study|Randomized but not treated|4|||
33344286|NCT02296242|101151896|FG001|Overall Study|Disease Progression|3|||
33344287|NCT02296242|101151897|FG002|Overall Study|Disease Progression|2|||
33344288|NCT02296242|101151898|FG003|Overall Study|Disease Progression|8|||
33344289|NCT02296242|101151899|FG004|Overall Study|Disease Progression|11|||
33344290|NCT02296242|101151895|FG000|Overall Study|Unacceptable Toxicity|0|||
33344291|NCT02296242|101151896|FG001|Overall Study|Unacceptable Toxicity|0|||
33540985|NCT02631941|101881535|FG009|Overall Study|Physician Decision|0|||
33540986|NCT02631941|101881526|FG000|Overall Study|Adverse Event|0|||
33344292|NCT02296242|101151897|FG002|Overall Study|Unacceptable Toxicity|0|||
33344293|NCT02296242|101151898|FG003|Overall Study|Unacceptable Toxicity|0|||
33344294|NCT02296242|101151899|FG004|Overall Study|Unacceptable Toxicity|1|||
33344295|NCT02296242|101151895|FG000|Overall Study|Patient Condition Changed|0|||
33344296|NCT02296242|101151896|FG001|Overall Study|Patient Condition Changed|0|||
33540987|NCT02631941|101881527|FG001|Overall Study|Adverse Event|1|||
33540988|NCT02631941|101881528|FG002|Overall Study|Adverse Event|0|||
33540989|NCT02631941|101881529|FG003|Overall Study|Adverse Event|0|||
33540990|NCT02631941|101881530|FG004|Overall Study|Adverse Event|0|||
33540991|NCT02631941|101881531|FG005|Overall Study|Adverse Event|0|||
33540992|NCT02631941|101881532|FG006|Overall Study|Adverse Event|0|||
33540993|NCT02631941|101881533|FG007|Overall Study|Adverse Event|0|||
33540994|NCT02631941|101881534|FG008|Overall Study|Adverse Event|0|||
33540995|NCT02631941|101881535|FG009|Overall Study|Adverse Event|0|||
33540996|NCT02631941|101881526|FG000|Overall Study|Withdrawal by Subject|0|||
33540997|NCT02631941|101881527|FG001|Overall Study|Withdrawal by Subject|0|||
33540998|NCT02631941|101881528|FG002|Overall Study|Withdrawal by Subject|0|||
33540999|NCT02631941|101881529|FG003|Overall Study|Withdrawal by Subject|0|||
33541000|NCT02631941|101881530|FG004|Overall Study|Withdrawal by Subject|1|||
33541001|NCT02631941|101881531|FG005|Overall Study|Withdrawal by Subject|0|||
33541002|NCT02631941|101881532|FG006|Overall Study|Withdrawal by Subject|0|||
33541003|NCT02631941|101881533|FG007|Overall Study|Withdrawal by Subject|1|||
33541004|NCT02631941|101881534|FG008|Overall Study|Withdrawal by Subject|0|||
33541005|NCT02631941|101881535|FG009|Overall Study|Withdrawal by Subject|0|||
33541006|NCT02631941|101881526|FG000|Overall Study|Lost to Follow-up|0|||
33541007|NCT02631941|101881527|FG001|Overall Study|Lost to Follow-up|0|||
33541008|NCT02631941|101881528|FG002|Overall Study|Lost to Follow-up|0|||
33541009|NCT02631941|101881529|FG003|Overall Study|Lost to Follow-up|0|||
33541010|NCT02631941|101881530|FG004|Overall Study|Lost to Follow-up|0|||
33541011|NCT02631941|101881531|FG005|Overall Study|Lost to Follow-up|0|||
33615601|NCT02596230|102140379|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
33615602|NCT02596230|102140380|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
33211321|NCT01640808|100673649|FG001|Overall Study|Randomized but not treated|2|||
33211322|NCT03905655|100673650|FG000|Overall Study|Adverse Event|1|||
33211323|NCT03905655|100673651|FG001|Overall Study|Adverse Event|0|||
33211324|NCT03905655|100673652|FG002|Overall Study|Adverse Event|1|||
33211325|NCT03905655|100673653|FG003|Overall Study|Adverse Event|1|||
33211326|NCT01212770|100673660|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
33211327|NCT01212770|100673661|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
33211328|NCT01212770|100673662|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
33211329|NCT01212770|100673663|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33211330|NCT01212770|100673664|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33211331|NCT01212770|100673665|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33211332|NCT01212770|100673666|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33211333|NCT01212770|100673667|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33211334|NCT01212770|100673668|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33211335|NCT01212770|100673660|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
33211336|NCT01212770|100673661|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
33211337|NCT01212770|100673662|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
33211338|NCT01212770|100673663|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33211339|NCT01212770|100673664|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33211340|NCT01212770|100673665|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33211341|NCT01212770|100673666|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33211342|NCT01212770|100673667|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33211343|NCT01212770|100673668|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33211344|NCT01212770|100673660|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
33211345|NCT01212770|100673661|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
33211346|NCT01212770|100673662|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
33344297|NCT02296242|101151897|FG002|Overall Study|Patient Condition Changed|2|||
33344298|NCT02296242|101151898|FG003|Overall Study|Patient Condition Changed|0|||
33344299|NCT02296242|101151899|FG004|Overall Study|Patient Condition Changed|1|||
33344300|NCT02296242|101151895|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
33344301|NCT02296242|101151896|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
33615603|NCT02596230|102140381|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
33211347|NCT01212770|100673663|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33344302|NCT02296242|101151897|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
33211348|NCT01212770|100673664|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33541012|NCT02631941|101881532|FG006|Overall Study|Lost to Follow-up|0|||
33541013|NCT02631941|101881533|FG007|Overall Study|Lost to Follow-up|0|||
33541014|NCT02631941|101881534|FG008|Overall Study|Lost to Follow-up|1|||
33541015|NCT02631941|101881535|FG009|Overall Study|Lost to Follow-up|0|||
33541016|NCT01868646|101881536|FG000|Overall Study|Do not meet inclusion criteria|3|||
33344303|NCT02296242|101151898|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
33344304|NCT02296242|101151899|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
33344305|NCT02296242|101151895|FG000|Overall Study|Lost to Follow-up|1|||
33344306|NCT02296242|101151896|FG001|Overall Study|Lost to Follow-up|0|||
33344307|NCT02296242|101151897|FG002|Overall Study|Lost to Follow-up|0|||
33344308|NCT02296242|101151898|FG003|Overall Study|Lost to Follow-up|0|||
33344309|NCT02296242|101151899|FG004|Overall Study|Lost to Follow-up|0|||
33211349|NCT01212770|100673665|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33211350|NCT01212770|100673666|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33211351|NCT01212770|100673667|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33211352|NCT01212770|100673668|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33211353|NCT01212770|100673660|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
33211354|NCT01212770|100673661|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33344310|NCT02296242|101151895|FG000|Overall Study|Need for Hydroxyurea|2|||
33344311|NCT02296242|101151896|FG001|Overall Study|Need for Hydroxyurea|0|||
33344312|NCT02296242|101151897|FG002|Overall Study|Need for Hydroxyurea|0|||
33344313|NCT02296242|101151898|FG003|Overall Study|Need for Hydroxyurea|0|||
33344314|NCT02296242|101151899|FG004|Overall Study|Need for Hydroxyurea|0|||
33344315|NCT02296242|101151895|FG000|Overall Study|Screened for Other Protocol|0|||
33344316|NCT02296242|101151896|FG001|Overall Study|Screened for Other Protocol|1|||
33344317|NCT02296242|101151897|FG002|Overall Study|Screened for Other Protocol|0|||
33344318|NCT02296242|101151898|FG003|Overall Study|Screened for Other Protocol|0|||
33344319|NCT02296242|101151899|FG004|Overall Study|Screened for Other Protocol|0|||
33344320|NCT02296242|101151895|FG000|Overall Study|Physician Decision|0|||
33344321|NCT02296242|101151896|FG001|Overall Study|Physician Decision|1|||
33344322|NCT02296242|101151897|FG002|Overall Study|Physician Decision|0|||
33344323|NCT02296242|101151898|FG003|Overall Study|Physician Decision|1|||
33344324|NCT02296242|101151899|FG004|Overall Study|Physician Decision|0|||
33211355|NCT01212770|100673662|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
33211356|NCT01212770|100673663|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33211357|NCT01212770|100673664|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33211358|NCT01212770|100673665|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33211359|NCT01212770|100673666|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33344325|NCT02296242|101151895|FG000|Overall Study|Alternative Treatment|0|||
33344326|NCT02296242|101151896|FG001|Overall Study|Alternative Treatment|0|||
33344327|NCT02296242|101151897|FG002|Overall Study|Alternative Treatment|0|||
33344328|NCT02296242|101151898|FG003|Overall Study|Alternative Treatment|1|||
33344329|NCT02296242|101151899|FG004|Overall Study|Alternative Treatment|0|||
33344330|NCT02296242|101151895|FG000|Overall Study|Adverse Event|0|||
33344331|NCT02296242|101151896|FG001|Overall Study|Adverse Event|0|||
33541017|NCT01868646|101881537|FG001|Overall Study|Do not meet inclusion criteria|5|||
33541018|NCT02579629|101881540|FG000|Overall Study|Withdrawal by Subject|0|||
33211360|NCT01212770|100673667|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33211361|NCT01212770|100673668|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33211362|NCT01212770|100673660|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33211363|NCT01212770|100673661|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33211364|NCT01212770|100673662|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
33211365|NCT01212770|100673663|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33211366|NCT01212770|100673664|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33211367|NCT01212770|100673665|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33211368|NCT01212770|100673666|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33211369|NCT01212770|100673667|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33211370|NCT01212770|100673668|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33211371|NCT01212770|100673660|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
33211372|NCT01212770|100673661|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
33211373|NCT01212770|100673662|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
33211374|NCT01212770|100673663|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
33211375|NCT01212770|100673664|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
33211376|NCT01212770|100673665|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
33344332|NCT02296242|101151897|FG002|Overall Study|Adverse Event|0|||
33344333|NCT02296242|101151898|FG003|Overall Study|Adverse Event|1|||
33344334|NCT02296242|101151899|FG004|Overall Study|Adverse Event|0|||
33541019|NCT02579629|101881541|FG001|Overall Study|Withdrawal by Subject|1|||
33541020|NCT02579629|101881542|FG002|Overall Study|Withdrawal by Subject|0|||
33211377|NCT01212770|100673666|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
33211378|NCT01212770|100673667|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
33344335|NCT02296242|101151895|FG000|Overall Study|Lack of Efficacy|0|||
33344336|NCT02296242|101151896|FG001|Overall Study|Lack of Efficacy|0|||
33344337|NCT02296242|101151897|FG002|Overall Study|Lack of Efficacy|0|||
33344338|NCT02296242|101151898|FG003|Overall Study|Lack of Efficacy|0|||
33344339|NCT02296242|101151899|FG004|Overall Study|Lack of Efficacy|3|||
33211379|NCT01212770|100673668|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
33211380|NCT01212770|100673660|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
33211381|NCT01212770|100673661|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
33211382|NCT01212770|100673662|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
33344340|NCT00605085|101151900|FG000|Overall Study|Withdrawal by Subject|8|||
33344341|NCT00605085|101151901|FG001|Overall Study|Withdrawal by Subject|5|||
33344342|NCT00605085|101151900|FG000|Overall Study|Adverse Event|9|||
33344343|NCT00605085|101151901|FG001|Overall Study|Adverse Event|5|||
33344344|NCT00605085|101151900|FG000|Overall Study|Pregnancy|2|||
33344345|NCT00605085|101151901|FG001|Overall Study|Pregnancy|0|||
33344346|NCT00605085|101151900|FG000|Overall Study|Protocol Violation|3|||
33344347|NCT00605085|101151901|FG001|Overall Study|Protocol Violation|2|||
33344348|NCT00605085|101151900|FG000|Overall Study|Lost to Follow-up|10|||
33344349|NCT00605085|101151901|FG001|Overall Study|Lost to Follow-up|5|||
33344350|NCT00605085|101151900|FG000|Overall Study|administrative reasons|18|||
33344351|NCT00605085|101151901|FG001|Overall Study|administrative reasons|8|||
33344352|NCT00821678|101151902|FG000|Overall Study|Withdrawal by Subject|8|||
33344353|NCT00821678|101151903|FG001|Overall Study|Withdrawal by Subject|0|||
33344354|NCT00821678|101151902|FG000|Overall Study|Lost to Follow-up|13|||
33344355|NCT00821678|101151903|FG001|Overall Study|Lost to Follow-up|12|||
33344356|NCT00821678|101151902|FG000|Overall Study|Death|0|||
33344357|NCT00821678|101151903|FG001|Overall Study|Death|2|||
33344358|NCT00110019|101151904|FG000|Overall Study|Lack of Efficacy|253|||
33344359|NCT00110019|101151905|FG001|Overall Study|Lack of Efficacy|285|||
33344360|NCT00110019|101151904|FG000|Overall Study|Adverse Event|61|||
33344361|NCT00110019|101151905|FG001|Overall Study|Adverse Event|40|||
33344362|NCT00110019|101151904|FG000|Overall Study|Death|13|||
33344363|NCT00110019|101151905|FG001|Overall Study|Death|15|||
33344364|NCT00110019|101151904|FG000|Overall Study|Withdrawal by Subject|21|||
33344365|NCT00110019|101151905|FG001|Overall Study|Withdrawal by Subject|9|||
33344366|NCT00110019|101151904|FG000|Overall Study|alternative therapy|5|||
33344367|NCT00110019|101151905|FG001|Overall Study|alternative therapy|1|||
33344368|NCT00110019|101151904|FG000|Overall Study|complicating disease|1|||
33344369|NCT00110019|101151905|FG001|Overall Study|complicating disease|1|||
33344370|NCT00110019|101151904|FG000|Overall Study|symptom deterioration|13|||
33344371|NCT00110019|101151905|FG001|Overall Study|symptom deterioration|16|||
33344372|NCT00110019|101151904|FG000|Overall Study|Not start protocol therapy|17|||
33344373|NCT00110019|101151905|FG001|Overall Study|Not start protocol therapy|16|||
33344374|NCT00110019|101151904|FG000|Overall Study|other reasons|22|||
33344375|NCT00110019|101151905|FG001|Overall Study|other reasons|30|||
33344376|NCT01554579|101151908|FG000|Overall Study|Adverse Event|6|||
33344377|NCT01554579|101151909|FG001|Overall Study|Adverse Event|25|||
33344378|NCT01554579|101151908|FG000|Overall Study|Lack of Efficacy|2|||
33344379|NCT01554579|101151909|FG001|Overall Study|Lack of Efficacy|1|||
33344380|NCT01554579|101151908|FG000|Overall Study|Withdrawal by Subject|2|||
33344381|NCT01554579|101151909|FG001|Overall Study|Withdrawal by Subject|1|||
33344382|NCT02546986|101151910|FG000|Treatment Period|Progressive Disease|20|||
33344383|NCT02546986|101151911|FG001|Treatment Period|Progressive Disease|22|||
33344384|NCT02546986|101151910|FG000|Treatment Period|Adverse Event|14|||
33344385|NCT02546986|101151911|FG001|Treatment Period|Adverse Event|6|||
33344386|NCT02546986|101151910|FG000|Treatment Period|Symptomatic Deterioration|4|||
33344387|NCT02546986|101151911|FG001|Treatment Period|Symptomatic Deterioration|3|||
33344388|NCT02546986|101151910|FG000|Treatment Period|Death|3|||
33344389|NCT02546986|101151911|FG001|Treatment Period|Death|4|||
33344390|NCT02546986|101151910|FG000|Treatment Period|Physician Decision|1|||
33344391|NCT02546986|101151911|FG001|Treatment Period|Physician Decision|2|||
33344392|NCT02546986|101151910|FG000|Treatment Period|Protocol Violation|1|||
33344393|NCT02546986|101151911|FG001|Treatment Period|Protocol Violation|0|||
33344394|NCT02546986|101151910|FG000|Treatment Period|Withdrawal by Subject|1|||
33344395|NCT02546986|101151911|FG001|Treatment Period|Withdrawal by Subject|1|||
33344396|NCT02546986|101151910|FG000|Treatment Period|Non-compliance with Study Drug|0|||
33344397|NCT02546986|101151911|FG001|Treatment Period|Non-compliance with Study Drug|1|||
33344398|NCT02546986|101151910|FG000|Treatment Period|Study Terminated by Sponsor|0|||
33344399|NCT02546986|101151911|FG001|Treatment Period|Study Terminated by Sponsor|1|||
33344400|NCT02546986|101151910|FG000|Treatment Period|Miscellaneous|7|||
33344401|NCT02546986|101151911|FG001|Treatment Period|Miscellaneous|9|||
33344402|NCT02546986|101151910|FG000|Survival Follow-Up Phase|Missing Status|3|||
33211383|NCT01212770|100673663|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
33211384|NCT01212770|100673664|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
33211385|NCT01212770|100673665|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
33211386|NCT01212770|100673666|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
33211387|NCT01212770|100673667|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
33344403|NCT02546986|101151911|FG001|Survival Follow-Up Phase|Missing Status|5|||
33344404|NCT02546986|101151910|FG000|Survival Follow-Up Phase|Death|18|||
33344405|NCT02546986|101151911|FG001|Survival Follow-Up Phase|Death|12|||
33344406|NCT02546986|101151910|FG000|Survival Follow-Up Phase|Alive|13|||
33344407|NCT02546986|101151911|FG001|Survival Follow-Up Phase|Alive|16|||
33344408|NCT02546986|101151910|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
33344409|NCT02546986|101151911|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
33344410|NCT01318122|101151912|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33344411|NCT01318122|101151913|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33344412|NCT01318122|101151914|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
33344413|NCT01318122|101151915|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
33344414|NCT01318122|101151912|FG000|Enrolled - Long-Term Extension Study|Other|1|||
33344415|NCT01318122|101151913|FG001|Enrolled - Long-Term Extension Study|Other|0|||
33344416|NCT01318122|101151914|FG002|Enrolled - Long-Term Extension Study|Other|0|||
33344417|NCT01318122|101151915|FG003|Enrolled - Long-Term Extension Study|Other|0|||
33344418|NCT01318122|101151912|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
33344419|NCT01318122|101151913|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
33344420|NCT01318122|101151914|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
33211388|NCT01212770|100673668|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
33211389|NCT01212770|100673660|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
33211390|NCT01212770|100673661|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
33211391|NCT01212770|100673662|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
33344421|NCT01318122|101151915|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
33344422|NCT01318122|101151912|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
33344423|NCT01318122|101151913|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33344424|NCT01318122|101151914|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33344425|NCT01318122|101151915|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33344426|NCT01318122|101151912|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33344427|NCT01318122|101151913|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
33541021|NCT02579629|101881540|FG000|Overall Study|Screen Failure|2|||
33211392|NCT01212770|100673663|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
33211393|NCT01212770|100673664|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
33541022|NCT02579629|101881541|FG001|Overall Study|Screen Failure|0|||
33211394|NCT01212770|100673665|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
33211395|NCT01212770|100673666|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
33211396|NCT01212770|100673667|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
33211397|NCT01212770|100673668|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
33211398|NCT01212770|100673660|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
33211399|NCT01212770|100673661|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
33211400|NCT01212770|100673662|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
33211401|NCT01212770|100673663|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
33211402|NCT01212770|100673664|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
33211403|NCT01212770|100673665|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
33211404|NCT01212770|100673666|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
33344428|NCT01318122|101151914|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33344429|NCT01318122|101151915|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
33344430|NCT01318122|101151912|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
33344431|NCT01318122|101151913|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
33615604|NCT02596230|102140377|FG000|Objective 2, One Year|Lost to Follow-up|0|||
33541023|NCT02579629|101881542|FG002|Overall Study|Screen Failure|2|||
33615605|NCT02596230|102140378|FG001|Objective 2, One Year|Lost to Follow-up|41|||
33211405|NCT01212770|100673667|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
33211406|NCT01212770|100673668|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
33211407|NCT01212770|100673660|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33211408|NCT01212770|100673661|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33211409|NCT01212770|100673662|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
33211410|NCT01212770|100673663|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33211411|NCT01212770|100673664|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33211412|NCT01212770|100673665|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33211413|NCT01212770|100673666|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33211414|NCT01212770|100673667|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33211415|NCT01212770|100673668|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
33211416|NCT01212770|100673660|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33211417|NCT01212770|100673661|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33211418|NCT01212770|100673662|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33211419|NCT01212770|100673663|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
33211420|NCT01212770|100673664|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33211421|NCT01212770|100673665|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33211422|NCT01212770|100673666|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33211423|NCT01212770|100673667|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33211424|NCT01212770|100673668|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
33211425|NCT01212770|100673660|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
33211426|NCT01212770|100673661|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
33344432|NCT01318122|101151914|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
33344433|NCT01318122|101151915|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
33344434|NCT03595280|101151916|FG000|Overall Study|Lost to Follow-up|6|||
33344435|NCT03595280|101151917|FG001|Overall Study|Lost to Follow-up|9|||
33344436|NCT03595280|101151918|FG002|Overall Study|Lost to Follow-up|15|||
33344437|NCT03686969|101151920|FG000|Overall Study|Study terminated|1|||
33344438|NCT03686969|101151921|FG001|Overall Study|Study terminated|0|||
33344439|NCT00944034|101151924|FG000|Overall Study|Inappropriate enrollment|0|||
33344440|NCT00944034|101151925|FG001|Overall Study|Inappropriate enrollment|1|||
33344441|NCT00944034|101151926|FG002|Overall Study|Inappropriate enrollment|0|||
33344442|NCT00944034|101151927|FG003|Overall Study|Inappropriate enrollment|1|||
33344443|NCT00944034|101151928|FG004|Overall Study|Inappropriate enrollment|2|||
33344444|NCT00944034|101151929|FG005|Overall Study|Inappropriate enrollment|1|||
33344445|NCT00944034|101151930|FG006|Overall Study|Inappropriate enrollment|0|||
33344446|NCT00944034|101151931|FG007|Overall Study|Inappropriate enrollment|0|||
33344447|NCT00944034|101151932|FG008|Overall Study|Inappropriate enrollment|1|||
33344448|NCT00944034|101151933|FG009|Overall Study|Inappropriate enrollment|1|||
33344449|NCT00944034|101151934|FG010|Overall Study|Inappropriate enrollment|0|||
33344450|NCT00944034|101151935|FG011|Overall Study|Inappropriate enrollment|0|||
33344451|NCT00944034|101151924|FG000|Overall Study|Withdrawal by Subject|3|||
33344452|NCT00944034|101151925|FG001|Overall Study|Withdrawal by Subject|2|||
33541024|NCT01548599|101881543|FG000|Overall Study|Lost to Follow-up|0|||
33541025|NCT01548599|101881544|FG001|Overall Study|Lost to Follow-up|1|||
33541026|NCT01548599|101881543|FG000|Overall Study|Withdrawal by Subject|4|||
33541027|NCT01548599|101881544|FG001|Overall Study|Withdrawal by Subject|0|||
33541028|NCT01548599|101881543|FG000|Overall Study|Death|2|||
33541029|NCT01548599|101881544|FG001|Overall Study|Death|1|||
33541030|NCT01349595|101881546|FG000|Overall Study|Lack of funding|2|||
33541031|NCT01349595|101881547|FG001|Overall Study|Lack of funding|2|||
33541032|NCT01496456|101881553|FG000|Overall Study|Protocol Violation|1|||
33541033|NCT01496456|101881553|FG000|Overall Study|Lost to Follow-up|7|||
33541034|NCT02897349|101881554|FG000|Overall Study|Lost to Follow-up|2|||
33541035|NCT02897349|101881555|FG001|Overall Study|Lost to Follow-up|2|||
33541036|NCT02897349|101881554|FG000|Overall Study|Adverse Event|3|||
33541037|NCT02897349|101881555|FG001|Overall Study|Adverse Event|3|||
33541038|NCT02897349|101881554|FG000|Overall Study|Other than listed above|0|||
33541039|NCT02897349|101881555|FG001|Overall Study|Other than listed above|1|||
33541040|NCT00499122|101881558|FG000|Overall Study|Withdrawal by Subject|2|||
33344453|NCT00944034|101151926|FG002|Overall Study|Withdrawal by Subject|6|||
33344454|NCT00944034|101151927|FG003|Overall Study|Withdrawal by Subject|2|||
33344455|NCT00944034|101151928|FG004|Overall Study|Withdrawal by Subject|5|||
33344456|NCT00944034|101151929|FG005|Overall Study|Withdrawal by Subject|8|||
33541041|NCT03506477|101881559|FG000|Overall Study|Withdrawal by Subject|1|||
33541042|NCT03506477|101881560|FG001|Overall Study|Withdrawal by Subject|0|||
33541043|NCT00922636|101881568|FG000|Overall Study|Adverse Event|3|||
33541044|NCT00922636|101881569|FG001|Overall Study|Adverse Event|3|||
33344457|NCT00944034|101151930|FG006|Overall Study|Withdrawal by Subject|2|||
33541045|NCT00922636|101881570|FG002|Overall Study|Adverse Event|2|||
33541046|NCT00922636|101881571|FG003|Overall Study|Adverse Event|3|||
33541047|NCT00922636|101881572|FG004|Overall Study|Adverse Event|2|||
33615606|NCT02596230|102140379|FG002|Objective 2, One Year|Lost to Follow-up|41|||
33211427|NCT01212770|100673662|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
33211428|NCT01212770|100673663|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
33211429|NCT01212770|100673664|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
33211430|NCT01212770|100673665|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
33211431|NCT01212770|100673666|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
33211432|NCT01212770|100673667|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
33211433|NCT01212770|100673668|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
33211434|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33211435|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
33211436|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
33211437|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33211438|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33211439|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33406867|NCT00039377|101377754|FG003|Initial Registration|Adverse Event|0|||
33406868|NCT00039377|101377751|FG000|Initial Registration|Relapsed|6|||
33406869|NCT00039377|101377752|FG001|Initial Registration|Relapsed|0|||
33406870|NCT00039377|101377753|FG002|Initial Registration|Relapsed|0|||
33406871|NCT00039377|101377754|FG003|Initial Registration|Relapsed|0|||
33406872|NCT00039377|101377751|FG000|Initial Registration|Received non-protocol therapy|11|||
33406873|NCT00039377|101377752|FG001|Initial Registration|Received non-protocol therapy|0|||
33406874|NCT00039377|101377753|FG002|Initial Registration|Received non-protocol therapy|0|||
33406875|NCT00039377|101377754|FG003|Initial Registration|Received non-protocol therapy|0|||
33406876|NCT00039377|101377751|FG000|Initial Registration|Withdrawal by Subject|3|||
33406877|NCT00039377|101377752|FG001|Initial Registration|Withdrawal by Subject|0|||
33406878|NCT00039377|101377753|FG002|Initial Registration|Withdrawal by Subject|0|||
33406879|NCT00039377|101377754|FG003|Initial Registration|Withdrawal by Subject|0|||
33406880|NCT00505765|101377759|FG000|Overall Study|Withdrawal by Subject|1|||
33406881|NCT00505765|101377760|FG001|Overall Study|Withdrawal by Subject|0|||
33406882|NCT00505765|101377761|FG002|Overall Study|Withdrawal by Subject|0|||
33406883|NCT00505765|101377759|FG000|Overall Study|Adverse Event|1|||
33541048|NCT00922636|101881568|FG000|Overall Study|Lack of Efficacy|1|||
33541049|NCT00922636|101881569|FG001|Overall Study|Lack of Efficacy|7|||
33541050|NCT00922636|101881570|FG002|Overall Study|Lack of Efficacy|3|||
33541051|NCT00922636|101881571|FG003|Overall Study|Lack of Efficacy|2|||
33541052|NCT00922636|101881572|FG004|Overall Study|Lack of Efficacy|4|||
33541053|NCT00922636|101881568|FG000|Overall Study|Sponsor Decision|0|||
33541054|NCT00922636|101881569|FG001|Overall Study|Sponsor Decision|0|||
33541055|NCT00922636|101881570|FG002|Overall Study|Sponsor Decision|2|||
33541056|NCT00922636|101881571|FG003|Overall Study|Sponsor Decision|0|||
33541057|NCT00922636|101881572|FG004|Overall Study|Sponsor Decision|0|||
33541058|NCT00922636|101881568|FG000|Overall Study|Withdrawal by Subject|0|||
33541059|NCT00922636|101881569|FG001|Overall Study|Withdrawal by Subject|0|||
33541060|NCT00922636|101881570|FG002|Overall Study|Withdrawal by Subject|5|||
33541061|NCT00922636|101881571|FG003|Overall Study|Withdrawal by Subject|2|||
33541062|NCT00922636|101881572|FG004|Overall Study|Withdrawal by Subject|4|||
33541063|NCT00922636|101881568|FG000|Overall Study|Protocol Violation|0|||
33541064|NCT00922636|101881569|FG001|Overall Study|Protocol Violation|0|||
33541065|NCT00922636|101881570|FG002|Overall Study|Protocol Violation|2|||
33211440|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33406884|NCT00505765|101377760|FG001|Overall Study|Adverse Event|2|||
33406885|NCT00505765|101377761|FG002|Overall Study|Adverse Event|0|||
33406886|NCT00505765|101377759|FG000|Overall Study|Noncompliance|0|||
33344458|NCT00944034|101151931|FG007|Overall Study|Withdrawal by Subject|2|||
33344459|NCT00944034|101151932|FG008|Overall Study|Withdrawal by Subject|3|||
33344460|NCT00944034|101151933|FG009|Overall Study|Withdrawal by Subject|4|||
33344461|NCT00944034|101151934|FG010|Overall Study|Withdrawal by Subject|0|||
33344462|NCT00944034|101151935|FG011|Overall Study|Withdrawal by Subject|4|||
33344463|NCT00944034|101151924|FG000|Overall Study|Lost to Follow-up|0|||
33344464|NCT00944034|101151925|FG001|Overall Study|Lost to Follow-up|4|||
33344465|NCT00944034|101151926|FG002|Overall Study|Lost to Follow-up|2|||
33344466|NCT00944034|101151927|FG003|Overall Study|Lost to Follow-up|0|||
33344467|NCT00944034|101151928|FG004|Overall Study|Lost to Follow-up|5|||
33344468|NCT00944034|101151929|FG005|Overall Study|Lost to Follow-up|7|||
33344469|NCT00944034|101151930|FG006|Overall Study|Lost to Follow-up|0|||
33541066|NCT00922636|101881571|FG003|Overall Study|Protocol Violation|2|||
33541067|NCT00922636|101881572|FG004|Overall Study|Protocol Violation|0|||
33541068|NCT00922636|101881568|FG000|Overall Study|Entry Criteria Not Met|0|||
33541069|NCT00922636|101881569|FG001|Overall Study|Entry Criteria Not Met|0|||
33541070|NCT00922636|101881570|FG002|Overall Study|Entry Criteria Not Met|1|||
33541071|NCT00922636|101881571|FG003|Overall Study|Entry Criteria Not Met|1|||
33541072|NCT00922636|101881572|FG004|Overall Study|Entry Criteria Not Met|0|||
33541073|NCT00922636|101881568|FG000|Overall Study|Parent/Caregiver Decision|2|||
33541074|NCT00922636|101881569|FG001|Overall Study|Parent/Caregiver Decision|4|||
33344470|NCT00944034|101151931|FG007|Overall Study|Lost to Follow-up|1|||
33344471|NCT00944034|101151932|FG008|Overall Study|Lost to Follow-up|5|||
33344472|NCT00944034|101151933|FG009|Overall Study|Lost to Follow-up|1|||
33344473|NCT00944034|101151934|FG010|Overall Study|Lost to Follow-up|1|||
33344474|NCT00944034|101151935|FG011|Overall Study|Lost to Follow-up|0|||
33344475|NCT00944034|101151924|FG000|Overall Study|Death|0|||
33344476|NCT00944034|101151925|FG001|Overall Study|Death|0|||
33344477|NCT00944034|101151926|FG002|Overall Study|Death|1|||
33344478|NCT00944034|101151927|FG003|Overall Study|Death|0|||
33344479|NCT00944034|101151928|FG004|Overall Study|Death|0|||
33344480|NCT00944034|101151929|FG005|Overall Study|Death|0|||
33344481|NCT00944034|101151930|FG006|Overall Study|Death|0|||
33344482|NCT00944034|101151931|FG007|Overall Study|Death|0|||
33344483|NCT00944034|101151932|FG008|Overall Study|Death|0|||
33344484|NCT00944034|101151933|FG009|Overall Study|Death|0|||
33344485|NCT00944034|101151934|FG010|Overall Study|Death|0|||
33344486|NCT00944034|101151935|FG011|Overall Study|Death|0|||
33344487|NCT00944034|101151924|FG000|Overall Study|Protocol Violation|2|||
33344488|NCT00944034|101151925|FG001|Overall Study|Protocol Violation|0|||
33344489|NCT00944034|101151926|FG002|Overall Study|Protocol Violation|0|||
33344490|NCT00944034|101151927|FG003|Overall Study|Protocol Violation|1|||
33344491|NCT00944034|101151928|FG004|Overall Study|Protocol Violation|2|||
33344492|NCT00944034|101151929|FG005|Overall Study|Protocol Violation|3|||
33344493|NCT00944034|101151930|FG006|Overall Study|Protocol Violation|0|||
33344494|NCT00944034|101151931|FG007|Overall Study|Protocol Violation|1|||
33344495|NCT00944034|101151932|FG008|Overall Study|Protocol Violation|1|||
33344496|NCT00944034|101151933|FG009|Overall Study|Protocol Violation|4|||
33344497|NCT00944034|101151934|FG010|Overall Study|Protocol Violation|0|||
33344498|NCT00944034|101151935|FG011|Overall Study|Protocol Violation|0|||
33344499|NCT00944034|101151924|FG000|Overall Study|Unable to classify|0|||
33344500|NCT00944034|101151925|FG001|Overall Study|Unable to classify|0|||
33344501|NCT00944034|101151926|FG002|Overall Study|Unable to classify|0|||
33406887|NCT00505765|101377760|FG001|Overall Study|Noncompliance|1|||
33541075|NCT00922636|101881570|FG002|Overall Study|Parent/Caregiver Decision|3|||
33344502|NCT00944034|101151927|FG003|Overall Study|Unable to classify|0|||
33344503|NCT00944034|101151928|FG004|Overall Study|Unable to classify|0|||
33344504|NCT00944034|101151929|FG005|Overall Study|Unable to classify|1|||
33344505|NCT00944034|101151930|FG006|Overall Study|Unable to classify|1|||
33406888|NCT00505765|101377761|FG002|Overall Study|Noncompliance|3|||
33406889|NCT03633461|101377762|FG000|Overall Study|Lost to Follow-up|0|||
33344506|NCT00944034|101151931|FG007|Overall Study|Unable to classify|1|||
33344507|NCT00944034|101151932|FG008|Overall Study|Unable to classify|0|||
33344508|NCT00944034|101151933|FG009|Overall Study|Unable to classify|0|||
33344509|NCT00944034|101151934|FG010|Overall Study|Unable to classify|0|||
33344510|NCT00944034|101151935|FG011|Overall Study|Unable to classify|0|||
33344511|NCT00944034|101151924|FG000|Overall Study|Administrative reason|0|||
33344512|NCT00944034|101151925|FG001|Overall Study|Administrative reason|0|||
33344513|NCT00944034|101151926|FG002|Overall Study|Administrative reason|0|||
33344514|NCT00944034|101151927|FG003|Overall Study|Administrative reason|0|||
33406890|NCT03633461|101377763|FG001|Overall Study|Lost to Follow-up|1|||
33541076|NCT00922636|101881571|FG003|Overall Study|Parent/Caregiver Decision|5|||
33541077|NCT00922636|101881572|FG004|Overall Study|Parent/Caregiver Decision|2|||
33406891|NCT02534324|101377766|FG000|Overall Study|Protocol Violation|4|||
33406892|NCT02534324|101377767|FG001|Overall Study|Protocol Violation|1|||
33406893|NCT02534324|101377766|FG000|Overall Study|Lost to Follow-up|20|||
33406894|NCT02534324|101377767|FG001|Overall Study|Lost to Follow-up|7|||
33406895|NCT02534324|101377766|FG000|Overall Study|Adverse Event|1|||
33406896|NCT02534324|101377767|FG001|Overall Study|Adverse Event|0|||
33541078|NCT00922636|101881568|FG000|Overall Study|Lost to Follow-up|1|||
33541079|NCT00922636|101881569|FG001|Overall Study|Lost to Follow-up|2|||
33211441|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33406897|NCT00450814|101377770|FG000|Overall Study|Failed to complete the initial therapy|0|||
33541080|NCT00922636|101881570|FG002|Overall Study|Lost to Follow-up|2|||
33541081|NCT00922636|101881571|FG003|Overall Study|Lost to Follow-up|2|||
33541082|NCT00922636|101881572|FG004|Overall Study|Lost to Follow-up|4|||
33541083|NCT00062166|101881573|FG000|Overall Study|Withdrawal by Subject|6|||
33541084|NCT02426684|101881574|FG000|Overall Study|Physician Decision|1|||
33541085|NCT01218802|101881577|FG000|Overall Study|Lost to Follow-up|5|||
33541086|NCT01218802|101881578|FG001|Overall Study|Lost to Follow-up|6|||
33541087|NCT01218802|101881577|FG000|Overall Study|Withdrawal by Subject|3|||
33541088|NCT01218802|101881578|FG001|Overall Study|Withdrawal by Subject|10|||
33541089|NCT01218802|101881577|FG000|Overall Study|Adverse Event|0|||
33541090|NCT01218802|101881578|FG001|Overall Study|Adverse Event|2|||
33541091|NCT01218802|101881577|FG000|Overall Study|Incarcerated|2|||
33541092|NCT01218802|101881578|FG001|Overall Study|Incarcerated|0|||
33541093|NCT03040726|101881579|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
33541094|NCT03040726|101881580|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
33541095|NCT03040726|101881579|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
33541096|NCT03040726|101881580|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
33541097|NCT03040726|101881579|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
33541098|NCT03040726|101881580|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
33541099|NCT03040726|101881579|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
33541100|NCT03040726|101881580|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
33541101|NCT03040726|101881579|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
33541102|NCT03040726|101881580|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
33541103|NCT02466399|101881581|FG000|Overall Study|Adverse Event|1|||
33541104|NCT02466399|101881582|FG001|Overall Study|Adverse Event|0|||
33541105|NCT02466399|101881581|FG000|Overall Study|Early exit due to family emergency|1|||
33541106|NCT02466399|101881582|FG001|Overall Study|Early exit due to family emergency|0|||
33541107|NCT00551369|101881596|FG000|Overall Study|Protocol Violation|5|||
33541108|NCT00551369|101881596|FG000|Overall Study|Withdrawal by Subject|1|||
33615607|NCT02596230|102140380|FG003|Objective 2, One Year|Lost to Follow-up|32|||
33541109|NCT00551369|101881596|FG000|Overall Study|Not treated per protocol and re|1|||
33541110|NCT01977846|101881605|FG000|Total Study - Prospective|Death|0|||
33541111|NCT01977846|101881606|FG001|Total Study - Prospective|Death|1|||
33541112|NCT01977846|101881605|FG000|Total Study - Prospective|Lost to Follow-up|0|||
33541113|NCT01977846|101881606|FG001|Total Study - Prospective|Lost to Follow-up|8|||
33541114|NCT01977846|101881605|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
33541115|NCT01977846|101881606|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
33541116|NCT01977846|101881605|FG000|Total Study - Prospective|Not available at time of visit|0|||
33541117|NCT01977846|101881606|FG001|Total Study - Prospective|Not available at time of visit|5|||
33541118|NCT01977846|101881605|FG000|Total Study - Prospective|No show|0|||
33541119|NCT01977846|101881606|FG001|Total Study - Prospective|No show|1|||
33541120|NCT01977846|101881605|FG000|Total Study - Prospective|Protocol Violation|0|||
33541121|NCT01977846|101881606|FG001|Total Study - Prospective|Protocol Violation|1|||
33541122|NCT00106002|101881607|FG000|Overall Study|Did not take any study drug|1|||
33541123|NCT00106002|101881607|FG000|Overall Study|Ineligible after Registration|1|||
33541124|NCT01162343|101881608|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
33541125|NCT01162343|101881608|FG000|Overall Study|Refused psychiatrist assessment|12|||
33541126|NCT04018066|101881609|FG000|Overall Study|participants started taking medications during the study period|3|||
33541127|NCT04018066|101881609|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
33541128|NCT03409744|101881611|FG000|Overall Study|Death|2|||
33541129|NCT03409744|101881611|FG000|Overall Study|Physician Decision|5|||
33541130|NCT03409744|101881611|FG000|Overall Study|Pregnancy|1|||
33541131|NCT03409744|101881611|FG000|Overall Study|Lost to Follow-up|1|||
33541132|NCT03409744|101881611|FG000|Overall Study|Protocol Violation|1|||
33541133|NCT03250273|101881614|FG000|Overall Study|Disease Progression|2|||
33541134|NCT03250273|101881615|FG001|Overall Study|Disease Progression|11|||
33541135|NCT03250273|101881614|FG000|Overall Study|Death|0|||
33541136|NCT03250273|101881615|FG001|Overall Study|Death|1|||
33541137|NCT02737358|101881616|FG000|Overall Study|Withdrawal by Subject|7|||
33541138|NCT02737358|101881617|FG001|Overall Study|Withdrawal by Subject|12|||
33541139|NCT02737358|101881616|FG000|Overall Study|Lost to Follow-up|2|||
33541140|NCT02737358|101881617|FG001|Overall Study|Lost to Follow-up|3|||
33541141|NCT05412134|101881618|FG000|Overall Study|Lost to Follow-up|2|||
33541142|NCT05412134|101881619|FG001|Overall Study|Lost to Follow-up|0|||
33541143|NCT03817528|101881621|FG000|Overall Study|Withdrawal by Subject|1|||
33541144|NCT03817528|101881621|FG000|Overall Study|Adverse Event|2|||
33541145|NCT02020941|101881623|FG000|Overall Study|Adverse Event|1|||
33541146|NCT02020941|101881623|FG000|Overall Study|Physician Decision|2|||
33541147|NCT02020941|101881623|FG000|Overall Study|Withdrawal by Subject|1|||
33541148|NCT02020941|101881623|FG000|Overall Study|Disease Progression|4|||
33541149|NCT00606008|101881637|FG000|Overall Study|Adverse Event|1|||
33541150|NCT00606008|101881637|FG000|Overall Study|Withdrawal by Subject|4|||
33541151|NCT01664091|101881640|FG000|Overall Study|Death|1|||
33541152|NCT01664091|101881640|FG000|Overall Study|Disease Progression|2|||
33541153|NCT01664091|101881640|FG000|Overall Study|Lost to Follow-up|2|||
33541154|NCT01664091|101881640|FG000|Overall Study|Withdrawal by Subject|1|||
33541155|NCT02364557|101881645|FG000|Overall Study|Protocol Violation|3|||
33541156|NCT02364557|101881646|FG001|Overall Study|Protocol Violation|1|||
33541157|NCT05630196|101881647|FG000|Overall Study|Adverse Event|2|||
33541158|NCT05630196|101881648|FG001|Overall Study|Adverse Event|1|||
33541159|NCT05630196|101881647|FG000|Overall Study|Lost to Follow-up|1|||
33541160|NCT05630196|101881648|FG001|Overall Study|Lost to Follow-up|1|||
33541161|NCT05630196|101881647|FG000|Overall Study|Protocol Violation|2|||
33541162|NCT05630196|101881648|FG001|Overall Study|Protocol Violation|3|||
33541163|NCT05630196|101881647|FG000|Overall Study|Physician Decision|1|||
33541164|NCT05630196|101881648|FG001|Overall Study|Physician Decision|0|||
33541165|NCT05630196|101881647|FG000|Overall Study|Withdrawal by Subject|3|||
33541166|NCT05630196|101881648|FG001|Overall Study|Withdrawal by Subject|4|||
33541167|NCT00619827|101881649|FG000|Overall Study|Adverse Event|1|||
33344515|NCT00944034|101151928|FG004|Overall Study|Administrative reason|0|||
33541168|NCT00619827|101881650|FG001|Overall Study|Adverse Event|2|||
33541169|NCT00619827|101881649|FG000|Overall Study|Withdrawal by Subject|2|||
33541170|NCT00619827|101881650|FG001|Overall Study|Withdrawal by Subject|2|||
33541171|NCT04796415|101881651|FG000|Overall Study|not interested|12|||
33541172|NCT04796415|101881651|FG000|Overall Study|health issue|8|||
33541173|NCT04796415|101881651|FG000|Overall Study|Other|4|||
33541174|NCT04796415|101881651|FG000|Overall Study|discharged from home health service|3|||
33541175|NCT04796415|101881651|FG000|Overall Study|re-hospitalization|2|||
33541176|NCT04796415|101881651|FG000|Overall Study|moving to nursing home|1|||
33541177|NCT04796415|101881651|FG000|Overall Study|lost contact|1|||
33541178|NCT00490035|101881652|FG000|Overall Study|AE, non-serious non-fatal|3|||
33541179|NCT00490035|101881653|FG001|Overall Study|AE, non-serious non-fatal|4|||
33541180|NCT00490035|101881654|FG002|Overall Study|AE, non-serious non-fatal|4|||
33344516|NCT00944034|101151929|FG005|Overall Study|Administrative reason|0|||
33344517|NCT00944034|101151930|FG006|Overall Study|Administrative reason|1|||
33615608|NCT02596230|102140381|FG004|Objective 2, One Year|Lost to Follow-up|46|||
33541181|NCT00490035|101881655|FG003|Overall Study|AE, non-serious non-fatal|5|||
33541182|NCT00490035|101881652|FG000|Overall Study|Lost to Follow-up|2|||
33541183|NCT00490035|101881653|FG001|Overall Study|Lost to Follow-up|0|||
33541184|NCT00490035|101881654|FG002|Overall Study|Lost to Follow-up|1|||
33541185|NCT00490035|101881655|FG003|Overall Study|Lost to Follow-up|0|||
33541186|NCT00490035|101881652|FG000|Overall Study|Withdrawal by Subject|2|||
33541187|NCT00490035|101881653|FG001|Overall Study|Withdrawal by Subject|1|||
33541188|NCT00490035|101881654|FG002|Overall Study|Withdrawal by Subject|1|||
33541189|NCT00490035|101881655|FG003|Overall Study|Withdrawal by Subject|0|||
33541190|NCT00490035|101881652|FG000|Overall Study|Other reason|0|||
33541191|NCT00490035|101881653|FG001|Overall Study|Other reason|1|||
33541192|NCT00490035|101881654|FG002|Overall Study|Other reason|3|||
33541193|NCT00490035|101881655|FG003|Overall Study|Other reason|1|||
33541194|NCT00490035|101881652|FG000|Overall Study|AE, serious fatal|1|||
33541195|NCT00490035|101881653|FG001|Overall Study|AE, serious fatal|0|||
33541196|NCT00490035|101881654|FG002|Overall Study|AE, serious fatal|0|||
33541197|NCT00490035|101881655|FG003|Overall Study|AE, serious fatal|0|||
33541198|NCT00490035|101881652|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
33541199|NCT00490035|101881653|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
33541200|NCT00490035|101881654|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
33541201|NCT00490035|101881655|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
33541202|NCT00490035|101881652|FG000|Overall Study|AE of unknown type|0|||
33541203|NCT00490035|101881653|FG001|Overall Study|AE of unknown type|0|||
33541204|NCT00490035|101881654|FG002|Overall Study|AE of unknown type|2|||
33541205|NCT00490035|101881655|FG003|Overall Study|AE of unknown type|0|||
33541206|NCT02152007|101881656|FG000|Overall Study|Withdrawal by Subject|1|||
33541207|NCT00329108|101881657|FG000|Overall Study|Adverse Event|2|||
33541208|NCT00329108|101881658|FG001|Overall Study|Adverse Event|2|||
33541209|NCT00329108|101881657|FG000|Overall Study|Lack of Efficacy|3|||
33541210|NCT00329108|101881658|FG001|Overall Study|Lack of Efficacy|3|||
33541211|NCT00329108|101881657|FG000|Overall Study|Withdrawal by Subject|0|||
33541212|NCT00329108|101881658|FG001|Overall Study|Withdrawal by Subject|2|||
33541213|NCT00329108|101881657|FG000|Overall Study|symptomatic deterioration|1|||
33541214|NCT00329108|101881658|FG001|Overall Study|symptomatic deterioration|1|||
33541215|NCT00329108|101881657|FG000|Overall Study|Subject no longer willing to participate|2|||
33541216|NCT00329108|101881658|FG001|Overall Study|Subject no longer willing to participate|2|||
33541217|NCT00329108|101881657|FG000|Overall Study|study terminated by sponsor|1|||
33211442|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
33541218|NCT00329108|101881658|FG001|Overall Study|study terminated by sponsor|0|||
33541219|NCT00329108|101881657|FG000|Overall Study|withdrew patient after SAE resolved|1|||
33541220|NCT00329108|101881658|FG001|Overall Study|withdrew patient after SAE resolved|0|||
33541221|NCT00329108|101881657|FG000|Overall Study|Protocol Violation|0|||
33541222|NCT00329108|101881658|FG001|Overall Study|Protocol Violation|2|||
33541223|NCT00630916|101881665|FG000|Overall Study|Death|110|||
33541224|NCT00630916|101881665|FG000|Overall Study|Explant|8|||
33541225|NCT00630916|101881665|FG000|Overall Study|Lost to Follow-up|5|||
33541226|NCT00630916|101881665|FG000|Overall Study|Withdrawal by Subject|30|||
33541227|NCT00630916|101881665|FG000|Overall Study|Protocol Violation|7|||
33541228|NCT00630916|101881665|FG000|Overall Study|Physician Decision|47|||
33541229|NCT00630916|101881665|FG000|Overall Study|Lack of Efficacy|3|||
33211443|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33211444|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
33211445|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
33541230|NCT01145482|101881666|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
33541231|NCT01145482|101881667|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
33541232|NCT02696798|101881676|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
33541233|NCT02696798|101881677|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
33541234|NCT02696798|101881678|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
33541235|NCT02696798|101881676|FG000|Blinded Treatment Dosing Period|Death|0|||
33541236|NCT02696798|101881677|FG001|Blinded Treatment Dosing Period|Death|0|||
33541237|NCT02696798|101881678|FG002|Blinded Treatment Dosing Period|Death|1|||
33541238|NCT02696798|101881676|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
33541239|NCT02696798|101881677|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
33541240|NCT02696798|101881678|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
33541241|NCT02696798|101881676|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
33541242|NCT02696798|101881677|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
33541243|NCT02696798|101881678|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
33541244|NCT02696798|101881676|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
33541245|NCT02696798|101881677|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
33541246|NCT02696798|101881678|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
33541247|NCT02696798|101881676|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
33541248|NCT02696798|101881677|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
33541249|NCT02696798|101881678|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
33541250|NCT02696798|101881676|FG000|Extended Treatment Period|Adverse Event|1|||
33541251|NCT02696798|101881677|FG001|Extended Treatment Period|Adverse Event|4|||
33541252|NCT02696798|101881678|FG002|Extended Treatment Period|Adverse Event|5|||
33541253|NCT02696798|101881676|FG000|Extended Treatment Period|Lack of Efficacy|7|||
33541254|NCT02696798|101881677|FG001|Extended Treatment Period|Lack of Efficacy|2|||
33211446|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33541255|NCT02696798|101881678|FG002|Extended Treatment Period|Lack of Efficacy|2|||
33211447|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33344518|NCT00944034|101151931|FG007|Overall Study|Administrative reason|0|||
33541256|NCT02696798|101881676|FG000|Extended Treatment Period|Lost to Follow-up|1|||
33541257|NCT02696798|101881677|FG001|Extended Treatment Period|Lost to Follow-up|0|||
33541258|NCT02696798|101881678|FG002|Extended Treatment Period|Lost to Follow-up|0|||
33541259|NCT02696798|101881676|FG000|Extended Treatment Period|Physician Decision|0|||
33541260|NCT02696798|101881677|FG001|Extended Treatment Period|Physician Decision|1|||
33541261|NCT02696798|101881678|FG002|Extended Treatment Period|Physician Decision|0|||
33541262|NCT02696798|101881676|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
33541263|NCT02696798|101881677|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
33211448|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33344519|NCT00944034|101151932|FG008|Overall Study|Administrative reason|0|||
33344520|NCT00944034|101151933|FG009|Overall Study|Administrative reason|0|||
33344521|NCT00944034|101151934|FG010|Overall Study|Administrative reason|0|||
33344522|NCT00944034|101151935|FG011|Overall Study|Administrative reason|0|||
33344523|NCT02024971|101151939|FG000|Overall Study|Data Not Available|30|||
33344524|NCT02024971|101151939|FG000|Overall Study|Lost to Follow-up|6|||
33344525|NCT03786432|101151941|FG000|Overall Study|Screen Failure after consent|1|||
33344526|NCT03786432|101151941|FG000|Overall Study|Lost to Follow-up|4|||
33344527|NCT03786432|101151941|FG000|Overall Study|did not complete 12 month CT scan|1|||
33344528|NCT00568555|101151944|FG000|Overall Study|Withdrawal by Subject|1|||
33344529|NCT00568555|101151945|FG001|Overall Study|Withdrawal by Subject|1|||
33344530|NCT01441063|101151955|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
33344531|NCT01441063|101151955|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
33344532|NCT00996203|101151956|FG000|Overall Study|Adverse Event|3|||
33344533|NCT00996203|101151956|FG000|Overall Study|Lost to Follow-up|1|||
33344534|NCT00996203|101151956|FG000|Overall Study|Lack of Efficacy|1|||
33344535|NCT00996203|101151956|FG000|Overall Study|Protocol Violation|2|||
33344536|NCT04428411|101151962|FG000|Overall Study|Lost to Follow-up|114|||
33344537|NCT01565980|101151963|FG000|Overall Study|Death|1|||
33344538|NCT01565980|101151964|FG001|Overall Study|Death|0|||
33344539|NCT01565980|101151963|FG000|Overall Study|Lost to Follow-up|1|||
33344540|NCT01565980|101151964|FG001|Overall Study|Lost to Follow-up|0|||
33344541|NCT01565980|101151963|FG000|Overall Study|health complications|1|||
33344542|NCT01565980|101151964|FG001|Overall Study|health complications|1|||
33344543|NCT01565980|101151963|FG000|Overall Study|stopped medical treatment|1|||
33344544|NCT01565980|101151964|FG001|Overall Study|stopped medical treatment|0|||
33344545|NCT01565980|101151963|FG000|Overall Study|Withdrawal by Subject|0|||
33344546|NCT01565980|101151964|FG001|Overall Study|Withdrawal by Subject|3|||
33344547|NCT04270760|101151965|FG000|Overall Study|Withdrawal by Subject|0|||
33344548|NCT04270760|101151966|FG001|Overall Study|Withdrawal by Subject|1|||
33344549|NCT04270760|101151967|FG002|Overall Study|Withdrawal by Subject|3|||
33344550|NCT04270760|101151968|FG003|Overall Study|Withdrawal by Subject|0|||
33344551|NCT04270760|101151969|FG004|Overall Study|Withdrawal by Subject|0|||
33344552|NCT04270760|101151965|FG000|Overall Study|Lost to Follow-up|1|||
33344553|NCT04270760|101151966|FG001|Overall Study|Lost to Follow-up|2|||
33344554|NCT04270760|101151967|FG002|Overall Study|Lost to Follow-up|1|||
33344555|NCT04270760|101151968|FG003|Overall Study|Lost to Follow-up|0|||
33344556|NCT04270760|101151969|FG004|Overall Study|Lost to Follow-up|0|||
33344557|NCT04270760|101151965|FG000|Overall Study|Death|0|||
33344558|NCT04270760|101151966|FG001|Overall Study|Death|0|||
33344559|NCT04270760|101151967|FG002|Overall Study|Death|0|||
33344560|NCT04270760|101151968|FG003|Overall Study|Death|0|||
33344561|NCT04270760|101151969|FG004|Overall Study|Death|1|||
33344562|NCT01592760|101151970|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
33344563|NCT01592760|101151971|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
33344564|NCT01592760|101151972|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
33344565|NCT00364689|101151976|FG000|Overall Study|Lost to Follow-up|1|||
33344566|NCT02404103|101151977|FG000|Overall Study|Adverse Event|1|||
33344567|NCT02404103|101151978|FG001|Overall Study|Adverse Event|0|||
33406898|NCT00450814|101377771|FG001|Overall Study|Failed to complete the initial therapy|0|||
33406899|NCT00450814|101377772|FG002|Overall Study|Failed to complete the initial therapy|0|||
33406900|NCT00450814|101377773|FG003|Overall Study|Failed to complete the initial therapy|1|||
33344568|NCT02404103|101151977|FG000|Overall Study|Lost to Follow-up|3|||
33406901|NCT00450814|101377774|FG004|Overall Study|Failed to complete the initial therapy|1|||
33406902|NCT00450814|101377775|FG005|Overall Study|Failed to complete the initial therapy|1|||
33615609|NCT02596230|102140377|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
33615610|NCT02596230|102140378|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
33344569|NCT02404103|101151978|FG001|Overall Study|Lost to Follow-up|3|||
33344570|NCT00556426|101151986|FG000|Overall Study|Withdrawal by Subject|3|||
33344571|NCT00556426|101151986|FG000|Overall Study|Death|6|||
33406903|NCT00450814|101377776|FG006|Overall Study|Failed to complete the initial therapy|0|||
33344572|NCT01622569|101151992|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
33344573|NCT01622569|101151993|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
33344574|NCT01622569|101151994|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
33344575|NCT01622569|101151995|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
33541264|NCT02696798|101881678|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
33541265|NCT02696798|101881676|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
33541266|NCT02696798|101881677|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
33541267|NCT02696798|101881678|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
33541268|NCT02696798|101881676|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
33541269|NCT02696798|101881677|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
33541270|NCT02696798|101881678|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
33541271|NCT02696798|101881676|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
33541272|NCT02696798|101881677|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
33541273|NCT02696798|101881678|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
33541274|NCT02696798|101881676|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
33541275|NCT02696798|101881677|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
33541276|NCT02696798|101881678|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
33541277|NCT02696798|101881676|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
33541278|NCT02696798|101881677|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
33541279|NCT02696798|101881678|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
33541280|NCT02696798|101881676|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
33541281|NCT02696798|101881677|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
33541282|NCT02696798|101881678|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
33541283|NCT03573297|101881679|FG000|Open Label Treatment Period|Adverse Event|67|||
33541284|NCT03573297|101881680|FG001|Open Label Treatment Period|Adverse Event|0|||
33541285|NCT03573297|101881681|FG002|Open Label Treatment Period|Adverse Event|0|||
33541286|NCT03573297|101881682|FG003|Open Label Treatment Period|Adverse Event|0|||
33541287|NCT03573297|101881679|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
33541288|NCT03573297|101881680|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
33541289|NCT03573297|101881681|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
33541290|NCT03573297|101881682|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
33541291|NCT03573297|101881679|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
33541292|NCT03573297|101881680|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
33541293|NCT03573297|101881681|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
33541294|NCT03573297|101881682|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
33541295|NCT03573297|101881679|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
33541296|NCT03573297|101881680|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
33541297|NCT03573297|101881681|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
33541298|NCT03573297|101881682|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
33541299|NCT03573297|101881679|FG000|Open Label Treatment Period|Pregnancy|1|||
33541300|NCT03573297|101881680|FG001|Open Label Treatment Period|Pregnancy|0|||
33541301|NCT03573297|101881681|FG002|Open Label Treatment Period|Pregnancy|0|||
33541302|NCT03573297|101881682|FG003|Open Label Treatment Period|Pregnancy|0|||
33541303|NCT03573297|101881679|FG000|Open Label Treatment Period|Protocol Violation|17|||
33541304|NCT03573297|101881680|FG001|Open Label Treatment Period|Protocol Violation|0|||
33541305|NCT03573297|101881681|FG002|Open Label Treatment Period|Protocol Violation|0|||
33541306|NCT03573297|101881682|FG003|Open Label Treatment Period|Protocol Violation|0|||
33541307|NCT03573297|101881679|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
33541308|NCT03573297|101881680|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
33541309|NCT03573297|101881681|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
33541310|NCT03573297|101881682|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
33541311|NCT03573297|101881679|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
33541312|NCT03573297|101881680|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
33541313|NCT03573297|101881681|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
33541314|NCT03573297|101881682|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
33541315|NCT03573297|101881679|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
33541316|NCT03573297|101881680|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
33541317|NCT03573297|101881681|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
33541318|NCT03573297|101881682|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
33541319|NCT03573297|101881679|FG000|Open Label Treatment Period|Other, Not Specified|7|||
33541320|NCT03573297|101881680|FG001|Open Label Treatment Period|Other, Not Specified|0|||
33541321|NCT03573297|101881681|FG002|Open Label Treatment Period|Other, Not Specified|0|||
33541322|NCT03573297|101881682|FG003|Open Label Treatment Period|Other, Not Specified|0|||
33344576|NCT01622569|101151992|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
33344577|NCT01622569|101151993|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
33344578|NCT01622569|101151994|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
33344579|NCT01622569|101151995|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
33344580|NCT01622569|101151992|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
33541323|NCT03573297|101881679|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
33541324|NCT03573297|101881680|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
33541325|NCT03573297|101881681|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
33541326|NCT03573297|101881682|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
33541327|NCT03573297|101881679|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33541328|NCT03573297|101881680|FG001|Double-Blind Treatment Period|Adverse Event|1|||
33541329|NCT03573297|101881681|FG002|Double-Blind Treatment Period|Adverse Event|5|||
33541330|NCT03573297|101881682|FG003|Double-Blind Treatment Period|Adverse Event|1|||
33541331|NCT03573297|101881679|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
33541332|NCT03573297|101881680|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
33541333|NCT03573297|101881681|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
33541334|NCT03573297|101881682|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
33541335|NCT03573297|101881679|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33541336|NCT03573297|101881680|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
33541337|NCT03573297|101881681|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
33541338|NCT03573297|101881682|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
33541339|NCT03573297|101881679|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33541340|NCT03573297|101881680|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
33541341|NCT03573297|101881681|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
33541342|NCT03573297|101881682|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
33541343|NCT03573297|101881679|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
33541344|NCT03573297|101881680|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
33541345|NCT03573297|101881681|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
33541346|NCT03573297|101881682|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
33541347|NCT03573297|101881679|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
33541348|NCT03573297|101881680|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
33541349|NCT03573297|101881681|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
33541350|NCT03573297|101881682|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
33541351|NCT03573297|101881679|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
33541352|NCT03573297|101881680|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
33541353|NCT03573297|101881681|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
33541354|NCT03573297|101881682|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
33541355|NCT01026493|101881684|FG000|Overall Study|Protocol Violation|0|||
33541356|NCT01026493|101881685|FG001|Overall Study|Protocol Violation|1|||
33541357|NCT01026493|101881686|FG002|Overall Study|Protocol Violation|0|||
33541358|NCT01026493|101881687|FG003|Overall Study|Protocol Violation|0|||
33541359|NCT01026493|101881688|FG004|Overall Study|Protocol Violation|2|||
33541360|NCT01026493|101881689|FG005|Overall Study|Protocol Violation|3|||
33541361|NCT01026493|101881690|FG006|Overall Study|Protocol Violation|4|||
33541362|NCT01026493|101881691|FG007|Overall Study|Protocol Violation|1|||
33541363|NCT02577029|101881692|FG000|Overall Study|Adverse Event|1|||
33541364|NCT02577029|101881693|FG001|Overall Study|Adverse Event|0|||
33344581|NCT01622569|101151993|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
33344582|NCT01622569|101151994|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
33344583|NCT01622569|101151995|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
33344584|NCT01622569|101151992|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
33541365|NCT02577029|101881694|FG002|Overall Study|Adverse Event|2|||
33541366|NCT02577029|101881695|FG003|Overall Study|Adverse Event|0|||
33541367|NCT02577029|101881696|FG004|Overall Study|Adverse Event|1|||
33541368|NCT02577029|101881697|FG005|Overall Study|Adverse Event|0|||
33541369|NCT02577029|101881698|FG006|Overall Study|Adverse Event|0|||
33541370|NCT02577029|101881699|FG007|Overall Study|Adverse Event|0|||
33541371|NCT02577029|101881692|FG000|Overall Study|Withdrawal by Subject|0|||
33541372|NCT02577029|101881693|FG001|Overall Study|Withdrawal by Subject|0|||
33541373|NCT02577029|101881694|FG002|Overall Study|Withdrawal by Subject|0|||
33541374|NCT02577029|101881695|FG003|Overall Study|Withdrawal by Subject|0|||
33541375|NCT02577029|101881696|FG004|Overall Study|Withdrawal by Subject|0|||
33615611|NCT02596230|102140379|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
33615612|NCT02596230|102140380|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
33615613|NCT02596230|102140381|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
33615614|NCT02596230|102140377|FG000|Objective 2, One Year|Adverse drug reaction|0|||
33344585|NCT01622569|101151993|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
33344586|NCT01622569|101151994|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
33344587|NCT01622569|101151995|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
33344588|NCT01622569|101151992|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
33344589|NCT01622569|101151993|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
33344590|NCT01622569|101151994|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
33541376|NCT02577029|101881697|FG005|Overall Study|Withdrawal by Subject|1|||
33541377|NCT02577029|101881698|FG006|Overall Study|Withdrawal by Subject|0|||
33615615|NCT02596230|102140378|FG001|Objective 2, One Year|Adverse drug reaction|1|||
33615616|NCT02596230|102140379|FG002|Objective 2, One Year|Adverse drug reaction|0|||
33541378|NCT02577029|101881699|FG007|Overall Study|Withdrawal by Subject|0|||
33541379|NCT02577029|101881692|FG000|Overall Study|Sponsor Termination of the Study|9|||
33541380|NCT02577029|101881693|FG001|Overall Study|Sponsor Termination of the Study|2|||
33541381|NCT02577029|101881694|FG002|Overall Study|Sponsor Termination of the Study|5|||
33541382|NCT02577029|101881695|FG003|Overall Study|Sponsor Termination of the Study|12|||
33541383|NCT02577029|101881696|FG004|Overall Study|Sponsor Termination of the Study|10|||
33541384|NCT02577029|101881697|FG005|Overall Study|Sponsor Termination of the Study|12|||
33541385|NCT02577029|101881698|FG006|Overall Study|Sponsor Termination of the Study|12|||
33541386|NCT02577029|101881699|FG007|Overall Study|Sponsor Termination of the Study|12|||
33541387|NCT00423046|101881700|FG000|Overall Study|Other|340|||
33541388|NCT00423046|101881701|FG001|Overall Study|Other|345|||
33541389|NCT04079790|101881702|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
33541390|NCT04079790|101881703|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
33541391|NCT04079790|101881704|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
33541392|NCT04079790|101881705|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
33541393|NCT04079790|101881702|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
33541394|NCT04079790|101881703|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
33541395|NCT04079790|101881704|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
33541396|NCT04079790|101881705|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
33541397|NCT04079790|101881702|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
33541398|NCT04079790|101881703|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
33541399|NCT04079790|101881704|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
33541400|NCT04079790|101881705|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
33541401|NCT02164916|101881706|FG000|Overall Study|Adverse Event|3|||
33541402|NCT02164916|101881707|FG001|Overall Study|Adverse Event|8|||
33541403|NCT02164916|101881706|FG000|Overall Study|Death|1|||
33541404|NCT02164916|101881707|FG001|Overall Study|Death|1|||
33541405|NCT02164916|101881706|FG000|Overall Study|Refusal unrelated to adverse event|3|||
33541406|NCT02164916|101881707|FG001|Overall Study|Refusal unrelated to adverse event|7|||
33541407|NCT02164916|101881706|FG000|Overall Study|Progression|37|||
33541408|NCT02164916|101881707|FG001|Overall Study|Progression|26|||
33541409|NCT02164916|101881706|FG000|Overall Study|Not protocol specified|5|||
33541410|NCT02164916|101881707|FG001|Overall Study|Not protocol specified|1|||
33541411|NCT02164916|101881706|FG000|Overall Study|Reason under review|1|||
33541412|NCT02164916|101881707|FG001|Overall Study|Reason under review|6|||
33541413|NCT02164916|101881706|FG000|Overall Study|Not eligible|2|||
33541414|NCT02164916|101881707|FG001|Overall Study|Not eligible|5|||
33541415|NCT03470922|101881710|FG000|Overall Study|Death|107|||
33541416|NCT03470922|101881711|FG001|Overall Study|Death|118|||
33541417|NCT03470922|101881710|FG000|Overall Study|Lost to Follow-up|5|||
33541418|NCT03470922|101881711|FG001|Overall Study|Lost to Follow-up|5|||
33541419|NCT03470922|101881710|FG000|Overall Study|Participant Withdrew Consent|4|||
33541420|NCT03470922|101881711|FG001|Overall Study|Participant Withdrew Consent|9|||
33541421|NCT03470922|101881710|FG000|Overall Study|Other reasons|1|||
33541422|NCT03470922|101881711|FG001|Overall Study|Other reasons|0|||
33541423|NCT03470922|101881710|FG000|Overall Study|Not reported|1|||
33541424|NCT03470922|101881711|FG001|Overall Study|Not reported|0|||
33541425|NCT02410629|101881714|FG000|Overall Study|Family cannot commit to the study|2|||
33615617|NCT02596230|102140380|FG003|Objective 2, One Year|Adverse drug reaction|0|||
33615618|NCT02596230|102140381|FG004|Objective 2, One Year|Adverse drug reaction|0|||
33344591|NCT01622569|101151995|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
33615619|NCT02596230|102140377|FG000|Objective 2, One Year|Death|0|||
33541426|NCT02410629|101881715|FG001|Overall Study|Family cannot commit to the study|1|||
33541427|NCT02410629|101881714|FG000|Overall Study|Subject returned to work|1|||
33541428|NCT02410629|101881715|FG001|Overall Study|Subject returned to work|0|||
33541429|NCT02410629|101881714|FG000|Overall Study|Subject moved back to home country|0|||
33541430|NCT02410629|101881715|FG001|Overall Study|Subject moved back to home country|1|||
33541431|NCT02410629|101881714|FG000|Overall Study|Subject underwent heart surgery|0|||
33541432|NCT02410629|101881715|FG001|Overall Study|Subject underwent heart surgery|1|||
33541433|NCT01299584|101881718|FG000|Overall Study|Protocol Violation|9|||
33541434|NCT02308046|101881719|FG000|Overall Study|Negative yeast culture at Baseline|32|||
33541435|NCT02308046|101881720|FG001|Overall Study|Negative yeast culture at Baseline|33|||
33541436|NCT02308046|101881719|FG000|Overall Study|Positive for STD at Baseline|1|||
33541437|NCT02308046|101881720|FG001|Overall Study|Positive for STD at Baseline|2|||
33541438|NCT02308046|101881719|FG000|Overall Study|Lost to Follow-up|1|||
33541439|NCT02308046|101881720|FG001|Overall Study|Lost to Follow-up|3|||
33615620|NCT02596230|102140378|FG001|Objective 2, One Year|Death|12|||
33615621|NCT02596230|102140379|FG002|Objective 2, One Year|Death|41|||
33615622|NCT02596230|102140380|FG003|Objective 2, One Year|Death|21|||
33211449|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33211450|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
33211451|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
33211452|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33211453|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
33211454|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33211455|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33211456|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33211457|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33211458|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33211459|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33211460|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
33211461|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33211462|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
33211463|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
33211464|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33211465|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33211466|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33211467|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33211468|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
33211469|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
33211470|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
33211471|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
33211472|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
33211473|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
33615623|NCT02596230|102140381|FG004|Objective 2, One Year|Death|30|||
33615624|NCT02596230|102140377|FG000|Objective 2, One Year|Other|0|||
33615625|NCT02596230|102140378|FG001|Objective 2, One Year|Other|3|||
33615626|NCT02596230|102140379|FG002|Objective 2, One Year|Other|2|||
33615627|NCT02596230|102140380|FG003|Objective 2, One Year|Other|0|||
33615628|NCT02596230|102140381|FG004|Objective 2, One Year|Other|0|||
33615629|NCT00479856|102140386|FG000|Overall Study|Adverse Event|1|||
33615630|NCT00479856|102140386|FG000|Overall Study|Withdrawal by Subject|1|||
33211474|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
33211475|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
33211476|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
33211477|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
33211478|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
33211479|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33211480|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
33211481|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
33211482|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33211483|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33211484|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33344592|NCT01622569|101151992|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
33344593|NCT01622569|101151993|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
33344594|NCT01622569|101151994|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
33344595|NCT01622569|101151995|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
33344596|NCT01622569|101151992|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
33344597|NCT01622569|101151993|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
33344598|NCT01622569|101151994|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
33615631|NCT00479856|102140386|FG000|Overall Study|Physician Decision|1|||
33211485|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33211486|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33211487|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
33541440|NCT03451071|101881721|FG000|First Vaccine|Withdrawal by Subject|1|||
33615632|NCT02524158|102140387|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
33615633|NCT02524158|102140388|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
33615634|NCT02524158|102140387|FG000|12-weeks Assessment|Lost to Follow-up|18|||
33211488|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33211489|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
33211490|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
33211491|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33211492|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33211493|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33211494|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33211495|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
33211496|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
33211497|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33211498|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
33211499|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
33211500|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33211501|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33211502|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33211503|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33211504|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
33211505|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
33211506|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33211507|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
33211508|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
33211509|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33211510|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33406904|NCT00450814|101377777|FG007|Overall Study|Failed to complete the initial therapy|0|||
33406905|NCT00450814|101377778|FG008|Overall Study|Failed to complete the initial therapy|0|||
33406906|NCT00450814|101377779|FG009|Overall Study|Failed to complete the initial therapy|0|||
33344599|NCT01622569|101151995|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
33344600|NCT01622569|101151992|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
33211511|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33211512|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33211513|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
33211514|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
33211515|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33211516|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
33211517|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33211518|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33211519|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33211520|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33211521|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33211522|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33211523|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33211524|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33211525|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33211526|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33211527|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33211528|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33211529|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33211530|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33211531|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
33211532|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
33615635|NCT02524158|102140388|FG001|12-weeks Assessment|Lost to Follow-up|12|||
33615636|NCT02524158|102140387|FG000|6-month Assessment|Withdrawal by Subject|1|||
33615637|NCT02524158|102140388|FG001|6-month Assessment|Withdrawal by Subject|1|||
33211533|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33211534|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
33406907|NCT00450814|101377780|FG010|Overall Study|Failed to complete the initial therapy|0|||
33406908|NCT00450814|101377770|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
33541441|NCT03451071|101881721|FG000|Second Vaccine|Lost to Follow-up|19|||
33541442|NCT03451071|101881721|FG000|Third Vaccine|Lost to Follow-up|22|||
33211535|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
33344601|NCT01622569|101151993|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
33344602|NCT01622569|101151994|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
33541443|NCT03451071|101881721|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
33541444|NCT01799889|101885180|FG000|Overall Study|Adverse Event|4|||
33541445|NCT01799889|101885181|FG001|Overall Study|Adverse Event|4|||
33541446|NCT01799889|101885182|FG002|Overall Study|Adverse Event|5|||
33541447|NCT01799889|101885183|FG003|Overall Study|Adverse Event|1|||
33541448|NCT01799889|101885184|FG004|Overall Study|Adverse Event|11|||
33344603|NCT01622569|101151995|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
33344604|NCT03269344|101151996|FG000|Overall Study|Protocol Violation|4|||
33344605|NCT03269344|101151997|FG001|Overall Study|Protocol Violation|3|||
33344606|NCT02901431|101152004|FG000|PK Part|Adverse Event|0|||
33344607|NCT02901431|101152005|FG001|PK Part|Adverse Event|1|||
33344608|NCT02901431|101152006|FG002|PK Part|Adverse Event|0|||
33344609|NCT02901431|101152007|FG003|PK Part|Adverse Event|0|||
33541449|NCT01799889|101885185|FG005|Overall Study|Adverse Event|1|||
33541450|NCT01799889|101885186|FG006|Overall Study|Adverse Event|5|||
33541451|NCT01799889|101885187|FG007|Overall Study|Adverse Event|2|||
33615638|NCT02524158|102140387|FG000|6-month Assessment|Lost to Follow-up|21|||
33211536|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33211537|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33344610|NCT02901431|101152008|FG004|PK Part|Adverse Event|0|||
33344611|NCT02901431|101152009|FG005|PK Part|Adverse Event|0|||
33344612|NCT02901431|101152010|FG006|PK Part|Adverse Event|0|||
33344613|NCT02901431|101152011|FG007|PK Part|Adverse Event|0|||
33344614|NCT02901431|101152012|FG008|PK Part|Adverse Event|0|||
33344615|NCT02901431|101152013|FG009|PK Part|Adverse Event|0|||
33344616|NCT02901431|101152014|FG010|PK Part|Adverse Event|0|||
33344617|NCT02901431|101152015|FG011|PK Part|Adverse Event|0|||
33344618|NCT02901431|101152016|FG012|PK Part|Adverse Event|0|||
33344619|NCT02901431|101152004|FG000|PK Part|Lost to Follow-up|0|||
33344620|NCT02901431|101152005|FG001|PK Part|Lost to Follow-up|0|||
33344621|NCT02901431|101152006|FG002|PK Part|Lost to Follow-up|1|||
33344622|NCT02901431|101152007|FG003|PK Part|Lost to Follow-up|0|||
33344623|NCT02901431|101152008|FG004|PK Part|Lost to Follow-up|0|||
33344624|NCT02901431|101152009|FG005|PK Part|Lost to Follow-up|0|||
33541452|NCT01799889|101885188|FG008|Overall Study|Adverse Event|3|||
33541453|NCT01799889|101885189|FG009|Overall Study|Adverse Event|1|||
33541454|NCT01799889|101885190|FG010|Overall Study|Adverse Event|1|||
33615639|NCT02524158|102140388|FG001|6-month Assessment|Lost to Follow-up|20|||
33541455|NCT01799889|101885191|FG011|Overall Study|Adverse Event|0|||
33541456|NCT01799889|101885180|FG000|Overall Study|Death|1|||
33211538|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33211539|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33211540|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
33211541|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
33211542|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33211543|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
33211544|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
33211545|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33211546|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33211547|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33211548|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33211549|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33211550|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
33211551|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33211552|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
33211553|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
33211554|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33211555|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33211556|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33211557|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33211558|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
33211559|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33211560|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
33211561|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
33211562|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
33541457|NCT01799889|101885181|FG001|Overall Study|Death|0|||
33211563|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
33211564|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
33211565|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
33211566|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
33211567|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
33211568|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
33211569|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33211570|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
33211571|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
33211572|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33211573|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33211574|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33211575|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33211576|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33211577|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33211578|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33211579|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33211580|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
33541458|NCT01799889|101885182|FG002|Overall Study|Death|5|||
33541459|NCT01799889|101885183|FG003|Overall Study|Death|3|||
33541460|NCT01799889|101885184|FG004|Overall Study|Death|1|||
33541461|NCT01799889|101885185|FG005|Overall Study|Death|0|||
33541462|NCT01799889|101885186|FG006|Overall Study|Death|0|||
33541463|NCT01799889|101885187|FG007|Overall Study|Death|0|||
33541464|NCT01799889|101885188|FG008|Overall Study|Death|1|||
33541465|NCT01799889|101885189|FG009|Overall Study|Death|0|||
33541466|NCT01799889|101885190|FG010|Overall Study|Death|1|||
33541467|NCT01799889|101885191|FG011|Overall Study|Death|0|||
33541468|NCT01799889|101885180|FG000|Overall Study|Lack of Efficacy|1|||
33211581|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33211582|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33211583|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33406909|NCT00450814|101377771|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
33406910|NCT00450814|101377772|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
33541469|NCT01799889|101885181|FG001|Overall Study|Lack of Efficacy|1|||
33615640|NCT01359943|102140389|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
33211584|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33541470|NCT01799889|101885182|FG002|Overall Study|Lack of Efficacy|0|||
33541471|NCT01799889|101885183|FG003|Overall Study|Lack of Efficacy|1|||
33541472|NCT01799889|101885184|FG004|Overall Study|Lack of Efficacy|2|||
33541473|NCT01799889|101885185|FG005|Overall Study|Lack of Efficacy|2|||
33541474|NCT01799889|101885186|FG006|Overall Study|Lack of Efficacy|0|||
33615641|NCT01359943|102140390|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
33211585|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33211586|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33211587|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33211588|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
33211589|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33211590|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33211591|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33211592|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33211593|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33211594|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33211595|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
33211596|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
33211597|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
33211598|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
33211599|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
33211600|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
33211601|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
33211602|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
33211603|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
33211604|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
33211605|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33211606|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33211607|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
33211608|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33211609|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33211610|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33211611|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33211612|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33211613|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33211614|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33211615|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33211616|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
33211617|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33211618|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33211619|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33211620|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33211621|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33211622|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
33211623|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33211624|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33211625|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
33211626|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33211627|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33211628|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33211629|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33211630|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33211631|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33211632|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33211633|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
33211634|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
33344625|NCT02901431|101152010|FG006|PK Part|Lost to Follow-up|0|||
33344626|NCT02901431|101152011|FG007|PK Part|Lost to Follow-up|0|||
33211635|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33211636|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33211637|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33211638|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33211639|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
33211640|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33211641|NCT01212770|100673660|FG000|Long-term Safety Phase (Year 5)|Death|0|||
33211642|NCT01212770|100673661|FG001|Long-term Safety Phase (Year 5)|Death|0|||
33211643|NCT01212770|100673662|FG002|Long-term Safety Phase (Year 5)|Death|0|||
33344627|NCT02901431|101152012|FG008|PK Part|Lost to Follow-up|0|||
33211644|NCT01212770|100673663|FG003|Long-term Safety Phase (Year 5)|Death|0|||
33344628|NCT02901431|101152013|FG009|PK Part|Lost to Follow-up|0|||
33211645|NCT01212770|100673664|FG004|Long-term Safety Phase (Year 5)|Death|0|||
33211646|NCT01212770|100673665|FG005|Long-term Safety Phase (Year 5)|Death|0|||
33211647|NCT01212770|100673666|FG006|Long-term Safety Phase (Year 5)|Death|0|||
33211648|NCT01212770|100673667|FG007|Long-term Safety Phase (Year 5)|Death|1|||
33211649|NCT01212770|100673668|FG008|Long-term Safety Phase (Year 5)|Death|0|||
33344629|NCT02901431|101152014|FG010|PK Part|Lost to Follow-up|0|||
33211650|NCT02489500|100673669|FG000|Overall Study|Death|1|||
33211651|NCT02489500|100673670|FG001|Overall Study|Death|1|||
33211652|NCT01353313|100673678|FG000|Overall Study|Lost to Follow-up|22|||
33211653|NCT01353313|100673679|FG001|Overall Study|Lost to Follow-up|23|||
33211654|NCT01353313|100673678|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
33211655|NCT01353313|100673679|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
33211656|NCT03240692|100673687|FG000|Overall Study|Physician Decision|1|||
33211657|NCT03240692|100673687|FG000|Overall Study|Withdrawal by Subject|1|||
33211658|NCT02293538|100673688|FG000|Overall Study|Adverse Event|0|||
33211659|NCT02293538|100673689|FG001|Overall Study|Adverse Event|1|||
33211660|NCT02293538|100673688|FG000|Overall Study|Lost to Follow-up|1|||
33211661|NCT02293538|100673689|FG001|Overall Study|Lost to Follow-up|0|||
33211662|NCT02293538|100673688|FG000|Overall Study|Withdrawal by Subject|0|||
33211663|NCT02293538|100673689|FG001|Overall Study|Withdrawal by Subject|1|||
33211664|NCT00955357|100673693|FG000|Titration Phase|Adverse Event|9|||
33211665|NCT00955357|100673694|FG001|Titration Phase|Adverse Event|46|||
33211666|NCT00955357|100673693|FG000|Titration Phase|Lack of Efficacy|0|||
33211667|NCT00955357|100673694|FG001|Titration Phase|Lack of Efficacy|2|||
33211668|NCT00955357|100673693|FG000|Titration Phase|Protocol Violation|3|||
33211669|NCT00955357|100673694|FG001|Titration Phase|Protocol Violation|7|||
33211670|NCT00955357|100673693|FG000|Titration Phase|Lost to Follow-up|1|||
33211671|NCT00955357|100673694|FG001|Titration Phase|Lost to Follow-up|3|||
33211672|NCT00955357|100673693|FG000|Titration Phase|Withdrawal by Subject|3|||
33211673|NCT00955357|100673694|FG001|Titration Phase|Withdrawal by Subject|5|||
33344630|NCT02901431|101152015|FG011|PK Part|Lost to Follow-up|0|||
33344631|NCT02901431|101152016|FG012|PK Part|Lost to Follow-up|0|||
33344632|NCT02901431|101152004|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
33344633|NCT02901431|101152005|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33344634|NCT02901431|101152006|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33344635|NCT02901431|101152007|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33541475|NCT01799889|101885187|FG007|Overall Study|Lack of Efficacy|0|||
33344636|NCT02901431|101152008|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33344637|NCT02901431|101152009|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33344638|NCT02901431|101152010|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33344639|NCT02901431|101152011|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33344640|NCT02901431|101152012|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33344641|NCT02901431|101152013|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33344642|NCT02901431|101152014|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33344643|NCT02901431|101152015|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33344644|NCT02901431|101152016|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
33344645|NCT02901431|101152004|FG000|PK Part|Pending dose confirmation|0|||
33344646|NCT02901431|101152005|FG001|PK Part|Pending dose confirmation|1|||
33344647|NCT02901431|101152006|FG002|PK Part|Pending dose confirmation|0|||
33344648|NCT02901431|101152007|FG003|PK Part|Pending dose confirmation|0|||
33344649|NCT02901431|101152008|FG004|PK Part|Pending dose confirmation|0|||
33344650|NCT02901431|101152009|FG005|PK Part|Pending dose confirmation|0|||
33344651|NCT02901431|101152010|FG006|PK Part|Pending dose confirmation|0|||
33344652|NCT02901431|101152011|FG007|PK Part|Pending dose confirmation|0|||
33344653|NCT02901431|101152012|FG008|PK Part|Pending dose confirmation|0|||
33344654|NCT02901431|101152013|FG009|PK Part|Pending dose confirmation|0|||
33344655|NCT02901431|101152014|FG010|PK Part|Pending dose confirmation|0|||
33344656|NCT02901431|101152015|FG011|PK Part|Pending dose confirmation|0|||
33344657|NCT02901431|101152016|FG012|PK Part|Pending dose confirmation|0|||
33344658|NCT02901431|101152004|FG000|PK Part|8 weeks of treatment ran out|2|||
33344659|NCT02901431|101152005|FG001|PK Part|8 weeks of treatment ran out|0|||
33344660|NCT02901431|101152006|FG002|PK Part|8 weeks of treatment ran out|0|||
33344661|NCT02901431|101152007|FG003|PK Part|8 weeks of treatment ran out|0|||
33344662|NCT02901431|101152008|FG004|PK Part|8 weeks of treatment ran out|0|||
33344663|NCT02901431|101152009|FG005|PK Part|8 weeks of treatment ran out|0|||
33344664|NCT02901431|101152010|FG006|PK Part|8 weeks of treatment ran out|0|||
33344665|NCT02901431|101152011|FG007|PK Part|8 weeks of treatment ran out|0|||
33344666|NCT02901431|101152012|FG008|PK Part|8 weeks of treatment ran out|0|||
33541476|NCT01799889|101885188|FG008|Overall Study|Lack of Efficacy|2|||
33344667|NCT02901431|101152013|FG009|PK Part|8 weeks of treatment ran out|0|||
33406911|NCT00450814|101377773|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
33541477|NCT01799889|101885189|FG009|Overall Study|Lack of Efficacy|0|||
33344668|NCT02901431|101152014|FG010|PK Part|8 weeks of treatment ran out|0|||
33344669|NCT02901431|101152015|FG011|PK Part|8 weeks of treatment ran out|0|||
33344670|NCT02901431|101152016|FG012|PK Part|8 weeks of treatment ran out|0|||
33211674|NCT00955357|100673693|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
33211675|NCT00955357|100673694|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
33344671|NCT02901431|101152004|FG000|PK Part|Stopped treatment after 8 weeks|1|||
33344672|NCT02901431|101152005|FG001|PK Part|Stopped treatment after 8 weeks|0|||
33541478|NCT01799889|101885190|FG010|Overall Study|Lack of Efficacy|1|||
33541479|NCT01799889|101885191|FG011|Overall Study|Lack of Efficacy|0|||
33541480|NCT01799889|101885180|FG000|Overall Study|Lost to Follow-up|0|||
33211676|NCT00955357|100673693|FG000|Titration Phase|Study medication not tolerated|0|||
33211677|NCT00955357|100673694|FG001|Titration Phase|Study medication not tolerated|1|||
33211678|NCT00955357|100673693|FG000|Titration Phase|Non compliance to study procedures|0|||
33344673|NCT02901431|101152006|FG002|PK Part|Stopped treatment after 8 weeks|1|||
33344674|NCT02901431|101152007|FG003|PK Part|Stopped treatment after 8 weeks|0|||
33344675|NCT02901431|101152008|FG004|PK Part|Stopped treatment after 8 weeks|0|||
33344676|NCT02901431|101152009|FG005|PK Part|Stopped treatment after 8 weeks|0|||
33344677|NCT02901431|101152010|FG006|PK Part|Stopped treatment after 8 weeks|0|||
33344678|NCT02901431|101152011|FG007|PK Part|Stopped treatment after 8 weeks|0|||
33344679|NCT02901431|101152012|FG008|PK Part|Stopped treatment after 8 weeks|0|||
33344680|NCT02901431|101152013|FG009|PK Part|Stopped treatment after 8 weeks|0|||
33344681|NCT02901431|101152014|FG010|PK Part|Stopped treatment after 8 weeks|0|||
33344682|NCT02901431|101152015|FG011|PK Part|Stopped treatment after 8 weeks|0|||
33344683|NCT02901431|101152016|FG012|PK Part|Stopped treatment after 8 weeks|0|||
33344684|NCT02901431|101152004|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
33344685|NCT02901431|101152005|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33344686|NCT02901431|101152006|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
33344687|NCT02901431|101152007|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33344688|NCT02901431|101152008|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33344689|NCT02901431|101152009|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33344690|NCT02901431|101152010|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33344691|NCT02901431|101152011|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33344692|NCT02901431|101152012|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33344693|NCT02901431|101152013|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33344694|NCT02901431|101152014|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33344695|NCT02901431|101152015|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33344696|NCT02901431|101152016|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
33344697|NCT02901431|101152004|FG000|PK Part|Discontinued per Sponsor|0|||
33344698|NCT02901431|101152005|FG001|PK Part|Discontinued per Sponsor|3|||
33344699|NCT02901431|101152006|FG002|PK Part|Discontinued per Sponsor|0|||
33344700|NCT02901431|101152007|FG003|PK Part|Discontinued per Sponsor|0|||
33344701|NCT02901431|101152008|FG004|PK Part|Discontinued per Sponsor|0|||
33344702|NCT02901431|101152009|FG005|PK Part|Discontinued per Sponsor|0|||
33344703|NCT02901431|101152010|FG006|PK Part|Discontinued per Sponsor|0|||
33344704|NCT02901431|101152011|FG007|PK Part|Discontinued per Sponsor|0|||
33344705|NCT02901431|101152012|FG008|PK Part|Discontinued per Sponsor|0|||
33344706|NCT02901431|101152013|FG009|PK Part|Discontinued per Sponsor|0|||
33344707|NCT02901431|101152014|FG010|PK Part|Discontinued per Sponsor|0|||
33344708|NCT02901431|101152015|FG011|PK Part|Discontinued per Sponsor|0|||
33344709|NCT02901431|101152016|FG012|PK Part|Discontinued per Sponsor|0|||
33344710|NCT02901431|101152004|FG000|PK Part|Withdrawal by Subject|1|||
33344711|NCT02901431|101152005|FG001|PK Part|Withdrawal by Subject|1|||
33344712|NCT02901431|101152006|FG002|PK Part|Withdrawal by Subject|3|||
33615642|NCT01359943|102140391|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
33344713|NCT02901431|101152007|FG003|PK Part|Withdrawal by Subject|0|||
33344714|NCT02901431|101152008|FG004|PK Part|Withdrawal by Subject|0|||
33344715|NCT02901431|101152009|FG005|PK Part|Withdrawal by Subject|0|||
33344716|NCT02901431|101152010|FG006|PK Part|Withdrawal by Subject|0|||
33344717|NCT02901431|101152011|FG007|PK Part|Withdrawal by Subject|0|||
33344718|NCT02901431|101152012|FG008|PK Part|Withdrawal by Subject|0|||
33344719|NCT02901431|101152013|FG009|PK Part|Withdrawal by Subject|0|||
33344720|NCT02901431|101152014|FG010|PK Part|Withdrawal by Subject|0|||
33344721|NCT02901431|101152015|FG011|PK Part|Withdrawal by Subject|0|||
33344722|NCT02901431|101152016|FG012|PK Part|Withdrawal by Subject|0|||
33344723|NCT02901431|101152004|FG000|Main Treatment Part|Adverse Event|0|||
33406912|NCT00450814|101377774|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
33406913|NCT00450814|101377775|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
33406914|NCT00450814|101377776|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
33406915|NCT00450814|101377777|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
33406916|NCT00450814|101377778|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
33406917|NCT00450814|101377779|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
33406918|NCT00450814|101377780|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
33406919|NCT04533204|101377782|FG000|Overall Study|Unable to understand training instructions|1|||
33406920|NCT04533204|101377783|FG001|Overall Study|Unable to understand training instructions|1|||
33406921|NCT00422227|101377784|FG000|Overall Study|Adverse Event|3|||
33406922|NCT00422227|101377785|FG001|Overall Study|Adverse Event|8|||
33406923|NCT00422227|101377784|FG000|Overall Study|Lost to Follow-up|1|||
33406924|NCT00422227|101377785|FG001|Overall Study|Lost to Follow-up|3|||
33541481|NCT01799889|101885181|FG001|Overall Study|Lost to Follow-up|1|||
33541482|NCT01799889|101885182|FG002|Overall Study|Lost to Follow-up|0|||
33541483|NCT01799889|101885183|FG003|Overall Study|Lost to Follow-up|0|||
33541484|NCT01799889|101885184|FG004|Overall Study|Lost to Follow-up|0|||
33541485|NCT01799889|101885185|FG005|Overall Study|Lost to Follow-up|0|||
33541486|NCT01799889|101885186|FG006|Overall Study|Lost to Follow-up|0|||
33541487|NCT01799889|101885187|FG007|Overall Study|Lost to Follow-up|0|||
33541488|NCT01799889|101885188|FG008|Overall Study|Lost to Follow-up|0|||
33541489|NCT01799889|101885189|FG009|Overall Study|Lost to Follow-up|0|||
33541490|NCT01799889|101885190|FG010|Overall Study|Lost to Follow-up|0|||
33541491|NCT01799889|101885191|FG011|Overall Study|Lost to Follow-up|0|||
33541492|NCT01799889|101885180|FG000|Overall Study|Physician Decision|3|||
33541493|NCT01799889|101885181|FG001|Overall Study|Physician Decision|2|||
33541494|NCT01799889|101885182|FG002|Overall Study|Physician Decision|4|||
33541495|NCT01799889|101885183|FG003|Overall Study|Physician Decision|4|||
33541496|NCT01799889|101885184|FG004|Overall Study|Physician Decision|5|||
33541497|NCT01799889|101885185|FG005|Overall Study|Physician Decision|5|||
33541498|NCT01799889|101885186|FG006|Overall Study|Physician Decision|5|||
33344724|NCT02901431|101152005|FG001|Main Treatment Part|Adverse Event|0|||
33344725|NCT02901431|101152006|FG002|Main Treatment Part|Adverse Event|0|||
33344726|NCT02901431|101152007|FG003|Main Treatment Part|Adverse Event|3|||
33344727|NCT02901431|101152008|FG004|Main Treatment Part|Adverse Event|3|||
33406925|NCT00422227|101377784|FG000|Overall Study|Withdrawal by Subject|0|||
33406926|NCT00422227|101377785|FG001|Overall Study|Withdrawal by Subject|4|||
33406927|NCT00532441|101377786|FG000|Overall Study|Death|1|||
33344728|NCT02901431|101152009|FG005|Main Treatment Part|Adverse Event|4|||
33344729|NCT02901431|101152010|FG006|Main Treatment Part|Adverse Event|1|||
33541499|NCT01799889|101885187|FG007|Overall Study|Physician Decision|2|||
33541500|NCT01799889|101885188|FG008|Overall Study|Physician Decision|6|||
33541501|NCT01799889|101885189|FG009|Overall Study|Physician Decision|0|||
33541502|NCT01799889|101885190|FG010|Overall Study|Physician Decision|0|||
33541503|NCT01799889|101885191|FG011|Overall Study|Physician Decision|1|||
33541504|NCT01799889|101885180|FG000|Overall Study|Progressive Disease|30|||
33541505|NCT01799889|101885181|FG001|Overall Study|Progressive Disease|26|||
33541506|NCT01799889|101885182|FG002|Overall Study|Progressive Disease|25|||
33541507|NCT01799889|101885183|FG003|Overall Study|Progressive Disease|30|||
33344730|NCT02901431|101152011|FG007|Main Treatment Part|Adverse Event|0|||
33344731|NCT02901431|101152012|FG008|Main Treatment Part|Adverse Event|0|||
33344732|NCT02901431|101152013|FG009|Main Treatment Part|Adverse Event|0|||
33344733|NCT02901431|101152014|FG010|Main Treatment Part|Adverse Event|0|||
33344734|NCT02901431|101152015|FG011|Main Treatment Part|Adverse Event|0|||
33344735|NCT02901431|101152016|FG012|Main Treatment Part|Adverse Event|0|||
33344736|NCT02901431|101152004|FG000|Main Treatment Part|Lack of Efficacy|0|||
33344737|NCT02901431|101152005|FG001|Main Treatment Part|Lack of Efficacy|0|||
33344738|NCT02901431|101152006|FG002|Main Treatment Part|Lack of Efficacy|0|||
33541508|NCT01799889|101885184|FG004|Overall Study|Progressive Disease|23|||
33541509|NCT01799889|101885185|FG005|Overall Study|Progressive Disease|9|||
33541510|NCT01799889|101885186|FG006|Overall Study|Progressive Disease|8|||
33541511|NCT01799889|101885187|FG007|Overall Study|Progressive Disease|13|||
33541512|NCT01799889|101885188|FG008|Overall Study|Progressive Disease|18|||
33541513|NCT01799889|101885189|FG009|Overall Study|Progressive Disease|5|||
33541514|NCT01799889|101885190|FG010|Overall Study|Progressive Disease|3|||
33541515|NCT01799889|101885191|FG011|Overall Study|Progressive Disease|1|||
33541516|NCT01799889|101885180|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
33541517|NCT01799889|101885181|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
33541518|NCT01799889|101885182|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
33541519|NCT01799889|101885183|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
33541520|NCT01799889|101885184|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
33541521|NCT01799889|101885185|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
33541522|NCT01799889|101885186|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
33541523|NCT01799889|101885187|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
33541524|NCT01799889|101885188|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
33541525|NCT01799889|101885189|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
33541526|NCT01799889|101885190|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
33541527|NCT01799889|101885191|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
33541528|NCT01799889|101885180|FG000|Overall Study|Study Terminated By Sponsor|1|||
33541529|NCT01799889|101885181|FG001|Overall Study|Study Terminated By Sponsor|0|||
33541530|NCT01799889|101885182|FG002|Overall Study|Study Terminated By Sponsor|0|||
33541531|NCT01799889|101885183|FG003|Overall Study|Study Terminated By Sponsor|0|||
33541532|NCT01799889|101885184|FG004|Overall Study|Study Terminated By Sponsor|2|||
33541533|NCT01799889|101885185|FG005|Overall Study|Study Terminated By Sponsor|1|||
33541534|NCT01799889|101885186|FG006|Overall Study|Study Terminated By Sponsor|0|||
33541535|NCT01799889|101885187|FG007|Overall Study|Study Terminated By Sponsor|2|||
33541536|NCT01799889|101885188|FG008|Overall Study|Study Terminated By Sponsor|1|||
33541537|NCT01799889|101885189|FG009|Overall Study|Study Terminated By Sponsor|1|||
33541538|NCT01799889|101885190|FG010|Overall Study|Study Terminated By Sponsor|0|||
33541539|NCT01799889|101885191|FG011|Overall Study|Study Terminated By Sponsor|0|||
33541540|NCT01799889|101885180|FG000|Overall Study|Withdrawal by Subject|1|||
33541541|NCT01799889|101885181|FG001|Overall Study|Withdrawal by Subject|6|||
33541542|NCT01799889|101885182|FG002|Overall Study|Withdrawal by Subject|4|||
33541543|NCT01799889|101885183|FG003|Overall Study|Withdrawal by Subject|0|||
33615643|NCT01359943|102140389|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
33211679|NCT00955357|100673694|FG001|Titration Phase|Non compliance to study procedures|1|||
33406928|NCT00532441|101377787|FG001|Overall Study|Death|0|||
33406929|NCT02283411|101377788|FG000|Overall Study|Withdrawal by Subject|3|||
33406930|NCT02283411|101377788|FG000|Overall Study|Screen Failed|28|||
33406931|NCT00887822|101377789|FG000|Overall Study|Insufficient therapeutic response|53|||
33406932|NCT00887822|101377790|FG001|Overall Study|Insufficient therapeutic response|55|||
33406933|NCT00887822|101377789|FG000|Overall Study|Adverse Event|14|||
33406934|NCT00887822|101377790|FG001|Overall Study|Adverse Event|17|||
33406935|NCT00887822|101377789|FG000|Overall Study|Failure to return|11|||
33406936|NCT00887822|101377790|FG001|Overall Study|Failure to return|11|||
33406937|NCT00887822|101377789|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
33406938|NCT00887822|101377790|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
33541544|NCT01799889|101885184|FG004|Overall Study|Withdrawal by Subject|5|||
33541545|NCT01799889|101885185|FG005|Overall Study|Withdrawal by Subject|1|||
33541546|NCT01799889|101885186|FG006|Overall Study|Withdrawal by Subject|3|||
33615644|NCT01359943|102140390|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
33344739|NCT02901431|101152007|FG003|Main Treatment Part|Lack of Efficacy|1|||
33406939|NCT00887822|101377789|FG000|Overall Study|Administrative/Other than specified|5|||
33615645|NCT01359943|102140391|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
33344740|NCT02901431|101152008|FG004|Main Treatment Part|Lack of Efficacy|0|||
33406940|NCT00887822|101377790|FG001|Overall Study|Administrative/Other than specified|4|||
33541547|NCT01799889|101885187|FG007|Overall Study|Withdrawal by Subject|1|||
33541548|NCT01799889|101885188|FG008|Overall Study|Withdrawal by Subject|2|||
33541549|NCT01799889|101885189|FG009|Overall Study|Withdrawal by Subject|1|||
33541550|NCT01799889|101885190|FG010|Overall Study|Withdrawal by Subject|1|||
33541551|NCT01799889|101885191|FG011|Overall Study|Withdrawal by Subject|1|||
33541552|NCT01799889|101885180|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33541553|NCT01799889|101885181|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33541554|NCT01799889|101885182|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33211680|NCT00955357|100673693|FG000|Maintenance Phase|Adverse Event|3|||
33211681|NCT00955357|100673694|FG001|Maintenance Phase|Adverse Event|23|||
33211682|NCT00955357|100673693|FG000|Maintenance Phase|Lack of Efficacy|0|||
33211683|NCT00955357|100673694|FG001|Maintenance Phase|Lack of Efficacy|4|||
33211684|NCT00955357|100673693|FG000|Maintenance Phase|Protocol Violation|2|||
33211685|NCT00955357|100673694|FG001|Maintenance Phase|Protocol Violation|6|||
33211686|NCT00955357|100673693|FG000|Maintenance Phase|Lost to Follow-up|2|||
33211687|NCT00955357|100673694|FG001|Maintenance Phase|Lost to Follow-up|7|||
33211688|NCT00955357|100673693|FG000|Maintenance Phase|Withdrawal by Subject|4|||
33211689|NCT00955357|100673694|FG001|Maintenance Phase|Withdrawal by Subject|4|||
33211690|NCT00955357|100673693|FG000|Maintenance Phase|Patient moving out of area|0|||
33211691|NCT00955357|100673694|FG001|Maintenance Phase|Patient moving out of area|1|||
33211692|NCT00955357|100673693|FG000|Maintenance Phase|Non compliance to study procedures|1|||
33211693|NCT00955357|100673694|FG001|Maintenance Phase|Non compliance to study procedures|0|||
33211694|NCT00941330|100673695|FG000|Overall Study|Other|1|||
33211695|NCT00941330|100673696|FG001|Overall Study|Other|0|||
33211696|NCT00941330|100673695|FG000|Overall Study|Physician Decision|0|||
33211697|NCT00941330|100673696|FG001|Overall Study|Physician Decision|2|||
33211698|NCT00818753|100673697|FG000|Overall Study|Protocol Violation|1|||
33211699|NCT00818753|100673698|FG001|Overall Study|Protocol Violation|0|||
33211700|NCT00818753|100673699|FG002|Overall Study|Protocol Violation|0|||
33211701|NCT00818753|100673697|FG000|Overall Study|Other reason (not specified)|0|||
33211702|NCT00818753|100673698|FG001|Overall Study|Other reason (not specified)|0|||
33211703|NCT00818753|100673699|FG002|Overall Study|Other reason (not specified)|1|||
33211704|NCT00818753|100673697|FG000|Overall Study|Randomised and not treated|2|||
33211705|NCT00818753|100673698|FG001|Overall Study|Randomised and not treated|0|||
33211706|NCT00818753|100673699|FG002|Overall Study|Randomised and not treated|0|||
33211707|NCT02085252|100673700|FG000|Overall Study|Withdrawal of Consent|1|||
33211708|NCT02085252|100673701|FG001|Overall Study|Withdrawal of Consent|0|||
33211709|NCT02085252|100673700|FG000|Overall Study|Adverse Event|0|||
33211710|NCT02085252|100673701|FG001|Overall Study|Adverse Event|1|||
33211711|NCT02085252|100673700|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
33211712|NCT02085252|100673701|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
33211713|NCT02085252|100673700|FG000|Overall Study|Reason Not Specified|0|||
33211714|NCT02085252|100673701|FG001|Overall Study|Reason Not Specified|1|||
33211715|NCT02085252|100673700|FG000|Overall Study|Reason Unknown|0|||
33211716|NCT02085252|100673701|FG001|Overall Study|Reason Unknown|1|||
33211717|NCT02844946|100673702|FG000|Overall Study|Lost to Follow-up|7|||
33211718|NCT02844946|100673703|FG001|Overall Study|Lost to Follow-up|0|||
33211719|NCT01798927|100676493|FG000|Overall Study|Withdrawal by Subject|1|||
33211720|NCT04154956|100676494|FG000|Overall Study|Death|109|||
33211721|NCT04154956|100676495|FG001|Overall Study|Death|110|||
33211722|NCT04154956|100676494|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
33211723|NCT04154956|100676495|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
33211724|NCT04154956|100676494|FG000|Overall Study|Withdrawal by Subject|1|||
33211725|NCT04154956|100676495|FG001|Overall Study|Withdrawal by Subject|7|||
33211726|NCT04154956|100676494|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
33211727|NCT04154956|100676495|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
33211728|NCT01857531|100676496|FG000|Overall Study|Withdrawal by Subject|4|||
33211729|NCT00802074|100676502|FG000|Overall Study|Adverse Event|1|||
33211730|NCT00802074|100676503|FG001|Overall Study|Adverse Event|1|||
33211731|NCT00802074|100676504|FG002|Overall Study|Adverse Event|1|||
33211732|NCT00802074|100676505|FG003|Overall Study|Adverse Event|0|||
33211733|NCT00802074|100676506|FG004|Overall Study|Adverse Event|0|||
33211734|NCT00802074|100676507|FG005|Overall Study|Adverse Event|0|||
33211735|NCT00802074|100676502|FG000|Overall Study|Withdrawal by Subject|1|||
33211736|NCT00802074|100676503|FG001|Overall Study|Withdrawal by Subject|0|||
33211737|NCT00802074|100676504|FG002|Overall Study|Withdrawal by Subject|0|||
33211738|NCT00802074|100676505|FG003|Overall Study|Withdrawal by Subject|0|||
33211739|NCT00802074|100676506|FG004|Overall Study|Withdrawal by Subject|0|||
33211740|NCT00802074|100676507|FG005|Overall Study|Withdrawal by Subject|0|||
33211741|NCT02811861|100676508|FG000|Overall Study|Radiological Disease Progression|123|||
33211742|NCT02811861|100676509|FG001|Overall Study|Radiological Disease Progression|97|||
33541555|NCT01799889|101885183|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33615646|NCT01359943|102140389|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
33211743|NCT02811861|100676510|FG002|Overall Study|Radiological Disease Progression|174|||
33211744|NCT02811861|100676508|FG000|Overall Study|Clinical Disease Progression|20|||
33211745|NCT02811861|100676509|FG001|Overall Study|Clinical Disease Progression|19|||
33211746|NCT02811861|100676510|FG002|Overall Study|Clinical Disease Progression|22|||
33211747|NCT02811861|100676508|FG000|Overall Study|Adverse Event|63|||
33211748|NCT02811861|100676509|FG001|Overall Study|Adverse Event|60|||
33211749|NCT02811861|100676510|FG002|Overall Study|Adverse Event|41|||
33211750|NCT02811861|100676508|FG000|Overall Study|Lost to Follow-up|0|||
33211751|NCT02811861|100676509|FG001|Overall Study|Lost to Follow-up|0|||
33211752|NCT02811861|100676510|FG002|Overall Study|Lost to Follow-up|1|||
33344741|NCT02901431|101152009|FG005|Main Treatment Part|Lack of Efficacy|0|||
33344742|NCT02901431|101152010|FG006|Main Treatment Part|Lack of Efficacy|0|||
33344743|NCT02901431|101152011|FG007|Main Treatment Part|Lack of Efficacy|0|||
33344744|NCT02901431|101152012|FG008|Main Treatment Part|Lack of Efficacy|0|||
33344745|NCT02901431|101152013|FG009|Main Treatment Part|Lack of Efficacy|0|||
33344746|NCT02901431|101152014|FG010|Main Treatment Part|Lack of Efficacy|0|||
33344747|NCT02901431|101152015|FG011|Main Treatment Part|Lack of Efficacy|0|||
33344748|NCT02901431|101152016|FG012|Main Treatment Part|Lack of Efficacy|0|||
33211753|NCT02811861|100676508|FG000|Overall Study|Subject Choice|29|||
33211754|NCT02811861|100676509|FG001|Overall Study|Subject Choice|17|||
33211755|NCT02811861|100676510|FG002|Overall Study|Subject Choice|23|||
33211756|NCT02811861|100676508|FG000|Overall Study|Withdrawal by Subject|4|||
33211757|NCT02811861|100676509|FG001|Overall Study|Withdrawal by Subject|4|||
33211758|NCT02811861|100676510|FG002|Overall Study|Withdrawal by Subject|9|||
33211759|NCT02811861|100676508|FG000|Overall Study|Other|4|||
33211760|NCT02811861|100676509|FG001|Overall Study|Other|13|||
33211761|NCT02811861|100676510|FG002|Overall Study|Other|3|||
33211762|NCT02811861|100676508|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
33211763|NCT02811861|100676509|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
33211764|NCT02811861|100676510|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
33211765|NCT02811861|100676508|FG000|Overall Study|Randomized but not treated|2|||
33211766|NCT02811861|100676509|FG001|Overall Study|Randomized but not treated|3|||
33211767|NCT02811861|100676510|FG002|Overall Study|Randomized but not treated|17|||
33211768|NCT02527798|100676515|FG000|Overall Study|Physician Decision|1|||
33211769|NCT02527798|100676516|FG001|Overall Study|Physician Decision|0|||
33211770|NCT02527798|100676517|FG002|Overall Study|Physician Decision|1|||
33211771|NCT02527798|100676518|FG003|Overall Study|Physician Decision|1|||
33211772|NCT02527798|100676519|FG004|Overall Study|Physician Decision|0|||
33211773|NCT02527798|100676520|FG005|Overall Study|Physician Decision|0|||
33211774|NCT02527798|100676515|FG000|Overall Study|Death|0|||
33211775|NCT02527798|100676516|FG001|Overall Study|Death|0|||
33211776|NCT02527798|100676517|FG002|Overall Study|Death|1|||
33211777|NCT02527798|100676518|FG003|Overall Study|Death|0|||
33211778|NCT02527798|100676519|FG004|Overall Study|Death|0|||
33211779|NCT02527798|100676520|FG005|Overall Study|Death|0|||
33211780|NCT02527798|100676515|FG000|Overall Study|Withdrawal by Subject|0|||
33211781|NCT02527798|100676516|FG001|Overall Study|Withdrawal by Subject|1|||
33211782|NCT02527798|100676517|FG002|Overall Study|Withdrawal by Subject|2|||
33211783|NCT02527798|100676518|FG003|Overall Study|Withdrawal by Subject|0|||
33211784|NCT02527798|100676519|FG004|Overall Study|Withdrawal by Subject|0|||
33211785|NCT02527798|100676520|FG005|Overall Study|Withdrawal by Subject|0|||
33211786|NCT02527798|100676515|FG000|Overall Study|Reason undisclosed|1|||
33211787|NCT02527798|100676516|FG001|Overall Study|Reason undisclosed|0|||
33211788|NCT02527798|100676517|FG002|Overall Study|Reason undisclosed|1|||
33211789|NCT02527798|100676518|FG003|Overall Study|Reason undisclosed|0|||
33211790|NCT02527798|100676519|FG004|Overall Study|Reason undisclosed|0|||
33211791|NCT02527798|100676520|FG005|Overall Study|Reason undisclosed|0|||
33211792|NCT02527798|100676515|FG000|Overall Study|Did not receive intervention|1|||
33211793|NCT02527798|100676516|FG001|Overall Study|Did not receive intervention|1|||
33211794|NCT02527798|100676517|FG002|Overall Study|Did not receive intervention|0|||
33211795|NCT02527798|100676518|FG003|Overall Study|Did not receive intervention|0|||
33211796|NCT02527798|100676519|FG004|Overall Study|Did not receive intervention|0|||
33211797|NCT02527798|100676520|FG005|Overall Study|Did not receive intervention|0|||
33211798|NCT01140880|100676521|FG000|Overall Study|Death|0|||
33211799|NCT01140880|100676522|FG001|Overall Study|Death|1|||
33211800|NCT01140880|100676521|FG000|Overall Study|Withdrawal by Subject|6|||
33211801|NCT01140880|100676522|FG001|Overall Study|Withdrawal by Subject|3|||
33211802|NCT01140880|100676521|FG000|Overall Study|Lost to Follow-up|8|||
33211803|NCT01140880|100676522|FG001|Overall Study|Lost to Follow-up|10|||
33211804|NCT01140880|100676521|FG000|Overall Study|Protocol Violation|0|||
33211805|NCT01140880|100676522|FG001|Overall Study|Protocol Violation|30|||
33344749|NCT02901431|101152004|FG000|Main Treatment Part|Lost to Follow-up|0|||
33344750|NCT02901431|101152005|FG001|Main Treatment Part|Lost to Follow-up|0|||
33344751|NCT02901431|101152006|FG002|Main Treatment Part|Lost to Follow-up|0|||
33541556|NCT01799889|101885184|FG004|Overall Study|Non-Compliance With Study Drug|0|||
33541557|NCT01799889|101885185|FG005|Overall Study|Non-Compliance With Study Drug|1|||
33541558|NCT01799889|101885186|FG006|Overall Study|Non-Compliance With Study Drug|0|||
33541559|NCT01799889|101885187|FG007|Overall Study|Non-Compliance With Study Drug|0|||
33541560|NCT01799889|101885188|FG008|Overall Study|Non-Compliance With Study Drug|0|||
33541561|NCT01799889|101885189|FG009|Overall Study|Non-Compliance With Study Drug|0|||
33541562|NCT01799889|101885190|FG010|Overall Study|Non-Compliance With Study Drug|0|||
33541563|NCT01799889|101885191|FG011|Overall Study|Non-Compliance With Study Drug|0|||
33211806|NCT04794803|100676525|FG000|Overall Study|Death|1|||
33211807|NCT04794803|100676526|FG001|Overall Study|Death|3|||
33211808|NCT04794803|100676525|FG000|Overall Study|Lost to Follow-up|2|||
33211809|NCT04794803|100676526|FG001|Overall Study|Lost to Follow-up|2|||
33344752|NCT02901431|101152007|FG003|Main Treatment Part|Lost to Follow-up|3|||
33344753|NCT02901431|101152008|FG004|Main Treatment Part|Lost to Follow-up|1|||
33211810|NCT04794803|100676525|FG000|Overall Study|Withdrawal by Subject|1|||
33211811|NCT04794803|100676526|FG001|Overall Study|Withdrawal by Subject|0|||
33211812|NCT04794803|100676525|FG000|Overall Study|Physician Decision|1|||
33211813|NCT04794803|100676526|FG001|Overall Study|Physician Decision|1|||
33211814|NCT04794803|100676525|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
33211815|NCT04794803|100676526|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
33541564|NCT00644059|101885192|FG000|Overall Study|Lost to Follow-up|37|||
33344754|NCT02901431|101152009|FG005|Main Treatment Part|Lost to Follow-up|2|||
33344755|NCT02901431|101152010|FG006|Main Treatment Part|Lost to Follow-up|3|||
33344756|NCT02901431|101152011|FG007|Main Treatment Part|Lost to Follow-up|0|||
33344757|NCT02901431|101152012|FG008|Main Treatment Part|Lost to Follow-up|0|||
33344758|NCT02901431|101152013|FG009|Main Treatment Part|Lost to Follow-up|0|||
33344759|NCT02901431|101152014|FG010|Main Treatment Part|Lost to Follow-up|0|||
33344760|NCT02901431|101152015|FG011|Main Treatment Part|Lost to Follow-up|0|||
33344761|NCT02901431|101152016|FG012|Main Treatment Part|Lost to Follow-up|0|||
33344762|NCT02901431|101152004|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
33344763|NCT02901431|101152005|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
33344764|NCT02901431|101152006|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
33344765|NCT02901431|101152007|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
33344766|NCT02901431|101152008|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
33344767|NCT02901431|101152009|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
33344768|NCT02901431|101152010|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
33344769|NCT02901431|101152011|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
33344770|NCT02901431|101152012|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
33344771|NCT02901431|101152013|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
33344772|NCT02901431|101152014|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
33406941|NCT00887822|101377789|FG000|Overall Study|Death|2|||
33406942|NCT00887822|101377790|FG001|Overall Study|Death|3|||
33406943|NCT00887822|101377789|FG000|Overall Study|Protocol Violation|0|||
33406944|NCT00887822|101377790|FG001|Overall Study|Protocol Violation|1|||
33406945|NCT00887822|101377789|FG000|Overall Study|Randomized but not treated|0|||
33406946|NCT00887822|101377790|FG001|Overall Study|Randomized but not treated|1|||
33406947|NCT01474291|101377792|FG000|Overall Study|Not Evaluable for Efficacy|26|||
33406948|NCT01474291|101377792|FG000|Overall Study|Lack of Treatment Efficacy|88|||
33406949|NCT01474291|101377792|FG000|Overall Study|Adverse Event|53|||
33406950|NCT01474291|101377792|FG000|Overall Study|Lost to Follow-up|29|||
33406951|NCT01474291|101377792|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
33406952|NCT01474291|101377792|FG000|Overall Study|No Reason Reported|10|||
33541565|NCT00644059|101885193|FG001|Overall Study|Lost to Follow-up|34|||
33541566|NCT00644059|101885194|FG002|Overall Study|Lost to Follow-up|16|||
33344773|NCT02901431|101152015|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
33344774|NCT02901431|101152016|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
33541567|NCT00644059|101885192|FG000|Overall Study|Withdrawal by Subject|52|||
33344775|NCT02901431|101152004|FG000|Main Treatment Part|Physician Decision|0|||
33344776|NCT02901431|101152005|FG001|Main Treatment Part|Physician Decision|0|||
33344777|NCT02901431|101152006|FG002|Main Treatment Part|Physician Decision|0|||
33406953|NCT01474291|101377792|FG000|Overall Study|Death|2|||
33406954|NCT01349816|101377804|FG000|Overall Study|Withdrawal by Subject|4|||
33406955|NCT01349816|101377804|FG000|Overall Study|Physician Decision|1|||
33406956|NCT01349816|101377804|FG000|Overall Study|Adverse Event|14|||
33541568|NCT00644059|101885193|FG001|Overall Study|Withdrawal by Subject|60|||
33406957|NCT01349816|101377804|FG000|Overall Study|Lost to Follow-up|2|||
33406958|NCT01349816|101377804|FG000|Overall Study|Protocol Violation|1|||
33406959|NCT01349816|101377804|FG000|Overall Study|Protocol-specified criteria|8|||
33406960|NCT03726320|101377809|FG000|Overall Study|Lost to Follow-up|2|||
33406961|NCT03726320|101377810|FG001|Overall Study|Lost to Follow-up|4|||
33406962|NCT03726320|101377811|FG002|Overall Study|Lost to Follow-up|0|||
33406963|NCT03726320|101377809|FG000|Overall Study|Time Constraints|4|||
33406964|NCT03726320|101377810|FG001|Overall Study|Time Constraints|1|||
33406965|NCT03726320|101377811|FG002|Overall Study|Time Constraints|0|||
33406966|NCT03726320|101377809|FG000|Overall Study|Ineligible after enrollment|3|||
33406967|NCT03726320|101377810|FG001|Overall Study|Ineligible after enrollment|3|||
33406968|NCT03726320|101377811|FG002|Overall Study|Ineligible after enrollment|0|||
33406969|NCT03726320|101377809|FG000|Overall Study|Clinic / insurance issue|2|||
33406970|NCT03726320|101377810|FG001|Overall Study|Clinic / insurance issue|0|||
33406971|NCT03726320|101377811|FG002|Overall Study|Clinic / insurance issue|0|||
33406972|NCT03726320|101377809|FG000|Overall Study|Language barrier|1|||
33406973|NCT03726320|101377810|FG001|Overall Study|Language barrier|0|||
33211816|NCT04794803|100676525|FG000|Overall Study|Refused to continue the treatment|1|||
33211817|NCT04794803|100676526|FG001|Overall Study|Refused to continue the treatment|0|||
33211818|NCT04794803|100676525|FG000|Overall Study|Patient admitted to ICU|0|||
33211819|NCT04794803|100676526|FG001|Overall Study|Patient admitted to ICU|1|||
33211820|NCT02638948|100676527|FG000|Overall Study|Withdrawal by Subject|4|||
33211821|NCT02638948|100676528|FG001|Overall Study|Withdrawal by Subject|5|||
33211822|NCT02638948|100676529|FG002|Overall Study|Withdrawal by Subject|3|||
33211823|NCT02638948|100676530|FG003|Overall Study|Withdrawal by Subject|1|||
33211824|NCT02638948|100676527|FG000|Overall Study|Administrative Reason by Sponsor|0|||
33211825|NCT02638948|100676528|FG001|Overall Study|Administrative Reason by Sponsor|1|||
33344778|NCT02901431|101152007|FG003|Main Treatment Part|Physician Decision|1|||
33344779|NCT02901431|101152008|FG004|Main Treatment Part|Physician Decision|0|||
33344780|NCT02901431|101152009|FG005|Main Treatment Part|Physician Decision|0|||
33344781|NCT02901431|101152010|FG006|Main Treatment Part|Physician Decision|1|||
33344782|NCT02901431|101152011|FG007|Main Treatment Part|Physician Decision|0|||
33344783|NCT02901431|101152012|FG008|Main Treatment Part|Physician Decision|0|||
33344784|NCT02901431|101152013|FG009|Main Treatment Part|Physician Decision|0|||
33344785|NCT02901431|101152014|FG010|Main Treatment Part|Physician Decision|0|||
33344786|NCT02901431|101152015|FG011|Main Treatment Part|Physician Decision|0|||
33344787|NCT02901431|101152016|FG012|Main Treatment Part|Physician Decision|0|||
33344788|NCT02901431|101152004|FG000|Main Treatment Part|Withdrawal by Subject|0|||
33344789|NCT02901431|101152005|FG001|Main Treatment Part|Withdrawal by Subject|0|||
33406974|NCT03726320|101377811|FG002|Overall Study|Language barrier|0|||
33406975|NCT03726320|101377809|FG000|Overall Study|Provider left the clinic|0|||
33406976|NCT03726320|101377810|FG001|Overall Study|Provider left the clinic|0|||
33406977|NCT03726320|101377811|FG002|Overall Study|Provider left the clinic|1|||
33406978|NCT01855919|101377812|FG000|Overall Study|Adverse Event|16|||
33406979|NCT01855919|101377813|FG001|Overall Study|Adverse Event|8|||
33406980|NCT01855919|101377812|FG000|Overall Study|Lack of Efficacy|1|||
33406981|NCT01855919|101377813|FG001|Overall Study|Lack of Efficacy|3|||
33541569|NCT00644059|101885194|FG002|Overall Study|Withdrawal by Subject|30|||
33541570|NCT00644059|101885192|FG000|Overall Study|Adverse Event|8|||
33541571|NCT00644059|101885193|FG001|Overall Study|Adverse Event|5|||
33541572|NCT00644059|101885194|FG002|Overall Study|Adverse Event|1|||
33541573|NCT00644059|101885192|FG000|Overall Study|Inappropriate Enrollment|1|||
33541574|NCT00644059|101885193|FG001|Overall Study|Inappropriate Enrollment|3|||
33541575|NCT00644059|101885194|FG002|Overall Study|Inappropriate Enrollment|0|||
33541576|NCT00644059|101885192|FG000|Overall Study|Protocol Deviation/violation|20|||
33541577|NCT00644059|101885193|FG001|Overall Study|Protocol Deviation/violation|19|||
33541578|NCT00644059|101885194|FG002|Overall Study|Protocol Deviation/violation|15|||
33541579|NCT00644059|101885192|FG000|Overall Study|Unable to classify|6|||
33541580|NCT00644059|101885193|FG001|Overall Study|Unable to classify|2|||
33541581|NCT00644059|101885194|FG002|Overall Study|Unable to classify|3|||
33541582|NCT01553851|101885195|FG000|Overall Study|Adverse Event|2|||
33541583|NCT01553851|101885195|FG000|Overall Study|constipation|1|||
33541584|NCT02997163|101885197|FG000|Overall Study|Adverse Event|1|||
33541585|NCT02997163|101885198|FG001|Overall Study|Adverse Event|0|||
33541586|NCT02997163|101885199|FG002|Overall Study|Adverse Event|0|||
33541587|NCT02997163|101885200|FG003|Overall Study|Adverse Event|1|||
33541588|NCT02870868|101885201|FG000|Overall Study|Withdrawal by Subject|2|||
33541589|NCT02870868|101885202|FG001|Overall Study|Withdrawal by Subject|1|||
33541590|NCT00109343|101885203|FG000|Overall Study|Adverse Event|1|||
33541591|NCT00109343|101885204|FG001|Overall Study|Adverse Event|0|||
33541592|NCT00109343|101885205|FG002|Overall Study|Adverse Event|2|||
33344790|NCT02901431|101152006|FG002|Main Treatment Part|Withdrawal by Subject|0|||
33406982|NCT01855919|101377812|FG000|Overall Study|Withdrawal by Subject|4|||
33406983|NCT01855919|101377813|FG001|Overall Study|Withdrawal by Subject|10|||
33406984|NCT01855919|101377812|FG000|Overall Study|Entry Criteria Not Met|1|||
33541593|NCT00109343|101885203|FG000|Overall Study|Lack of Efficacy|1|||
33406985|NCT01855919|101377813|FG001|Overall Study|Entry Criteria Not Met|1|||
33211826|NCT02638948|100676529|FG002|Overall Study|Administrative Reason by Sponsor|0|||
33406986|NCT01855919|101377812|FG000|Overall Study|Protocol Violation|1|||
33406987|NCT01855919|101377813|FG001|Overall Study|Protocol Violation|4|||
33406988|NCT00135694|101377814|FG000|Overall Study|Adverse Event|17|||
33406989|NCT00135694|101377815|FG001|Overall Study|Adverse Event|4|||
33406990|NCT00135694|101377816|FG002|Overall Study|Adverse Event|0|||
33406991|NCT00135694|101377814|FG000|Overall Study|Death|14|||
33406992|NCT00135694|101377815|FG001|Overall Study|Death|1|||
33406993|NCT00135694|101377816|FG002|Overall Study|Death|2|||
33406994|NCT00135694|101377814|FG000|Overall Study|Lost to Follow-up|8|||
33406995|NCT00135694|101377815|FG001|Overall Study|Lost to Follow-up|7|||
33406996|NCT00135694|101377816|FG002|Overall Study|Lost to Follow-up|1|||
33406997|NCT00135694|101377814|FG000|Overall Study|Withdrawal by Subject|41|||
33406998|NCT00135694|101377815|FG001|Overall Study|Withdrawal by Subject|7|||
33406999|NCT00135694|101377816|FG002|Overall Study|Withdrawal by Subject|4|||
33407000|NCT00135694|101377814|FG000|Overall Study|Protocol Violation|19|||
33407001|NCT00135694|101377815|FG001|Overall Study|Protocol Violation|1|||
33407002|NCT00135694|101377816|FG002|Overall Study|Protocol Violation|0|||
33407003|NCT00135694|101377814|FG000|Overall Study|Hepatitis C related reasons|39|||
33407004|NCT00135694|101377815|FG001|Overall Study|Hepatitis C related reasons|1|||
33407005|NCT00135694|101377816|FG002|Overall Study|Hepatitis C related reasons|0|||
33407006|NCT00135694|101377814|FG000|Overall Study|Ineligible for Random assignment|42|||
33407007|NCT00135694|101377815|FG001|Overall Study|Ineligible for Random assignment|0|||
33407008|NCT00135694|101377816|FG002|Overall Study|Ineligible for Random assignment|0|||
33407009|NCT01396434|101377817|FG000|Overall Study|Lost to Follow-up|1|||
33407010|NCT01396434|101377818|FG001|Overall Study|Lost to Follow-up|0|||
33407011|NCT01396434|101377819|FG002|Overall Study|Lost to Follow-up|0|||
33407012|NCT01396434|101377817|FG000|Overall Study|Other|10|||
33407013|NCT01396434|101377818|FG001|Overall Study|Other|0|||
33407014|NCT01396434|101377819|FG002|Overall Study|Other|0|||
33407015|NCT02516605|101377820|FG000|Overall Study|Protocol Violation|0|||
33407016|NCT02516605|101377821|FG001|Overall Study|Protocol Violation|0|||
33407017|NCT02516605|101377822|FG002|Overall Study|Protocol Violation|0|||
33407018|NCT02516605|101377823|FG003|Overall Study|Protocol Violation|0|||
33407019|NCT02516605|101377824|FG004|Overall Study|Protocol Violation|1|||
33407020|NCT02516605|101377820|FG000|Overall Study|Withdrawal by Subject|0|||
33407021|NCT02516605|101377821|FG001|Overall Study|Withdrawal by Subject|0|||
33407022|NCT02516605|101377822|FG002|Overall Study|Withdrawal by Subject|0|||
33407023|NCT02516605|101377823|FG003|Overall Study|Withdrawal by Subject|1|||
33407024|NCT02516605|101377824|FG004|Overall Study|Withdrawal by Subject|0|||
33541594|NCT00109343|101885204|FG001|Overall Study|Lack of Efficacy|0|||
33541595|NCT00109343|101885205|FG002|Overall Study|Lack of Efficacy|0|||
33211827|NCT02638948|100676530|FG003|Overall Study|Administrative Reason by Sponsor|4|||
33211828|NCT02638948|100676527|FG000|Overall Study|Adverse Event|0|||
33211829|NCT02638948|100676528|FG001|Overall Study|Adverse Event|0|||
33211830|NCT02638948|100676529|FG002|Overall Study|Adverse Event|1|||
33211831|NCT02638948|100676530|FG003|Overall Study|Adverse Event|1|||
33211832|NCT02638948|100676527|FG000|Overall Study|Lack of Efficacy|1|||
33211833|NCT02638948|100676528|FG001|Overall Study|Lack of Efficacy|1|||
33211834|NCT02638948|100676529|FG002|Overall Study|Lack of Efficacy|0|||
33211835|NCT02638948|100676530|FG003|Overall Study|Lack of Efficacy|0|||
33211836|NCT02638948|100676527|FG000|Overall Study|Lost to Follow-up|0|||
33211837|NCT02638948|100676528|FG001|Overall Study|Lost to Follow-up|0|||
33211838|NCT02638948|100676529|FG002|Overall Study|Lost to Follow-up|1|||
33211839|NCT02638948|100676530|FG003|Overall Study|Lost to Follow-up|1|||
33211840|NCT02638948|100676527|FG000|Overall Study|Poor/Non-Compliance|0|||
33211841|NCT02638948|100676528|FG001|Overall Study|Poor/Non-Compliance|2|||
33211842|NCT02638948|100676529|FG002|Overall Study|Poor/Non-Compliance|1|||
33211843|NCT02638948|100676530|FG003|Overall Study|Poor/Non-Compliance|0|||
33211844|NCT02638948|100676527|FG000|Overall Study|Participant no longer met study criteria|0|||
33211845|NCT02638948|100676528|FG001|Overall Study|Participant no longer met study criteria|1|||
33211846|NCT02638948|100676529|FG002|Overall Study|Participant no longer met study criteria|0|||
33211847|NCT02638948|100676530|FG003|Overall Study|Participant no longer met study criteria|0|||
33211848|NCT02638948|100676527|FG000|Overall Study|Other than specified above|4|||
33407025|NCT00561795|101377825|FG000|Overall Study|Adverse Event|3|||
33407026|NCT00561795|101377826|FG001|Overall Study|Adverse Event|3|||
33407027|NCT00561795|101377827|FG002|Overall Study|Adverse Event|0|||
33407028|NCT00561795|101377828|FG003|Overall Study|Adverse Event|0|||
33407029|NCT00561795|101377825|FG000|Overall Study|Study Closed/Terminated|0|||
33407030|NCT00561795|101377826|FG001|Overall Study|Study Closed/Terminated|3|||
33407031|NCT00561795|101377827|FG002|Overall Study|Study Closed/Terminated|0|||
33407032|NCT00561795|101377828|FG003|Overall Study|Study Closed/Terminated|0|||
33407033|NCT00561795|101377825|FG000|Overall Study|Physician Decision|1|||
33541596|NCT00109343|101885203|FG000|Overall Study|Lost to Follow-up|35|||
33211849|NCT02638948|100676528|FG001|Overall Study|Other than specified above|1|||
33211850|NCT02638948|100676529|FG002|Overall Study|Other than specified above|1|||
33211851|NCT02638948|100676530|FG003|Overall Study|Other than specified above|1|||
33211852|NCT02278328|100676532|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
33211853|NCT02278328|100676533|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
33407034|NCT00561795|101377826|FG001|Overall Study|Physician Decision|0|||
33407035|NCT00561795|101377827|FG002|Overall Study|Physician Decision|0|||
33344791|NCT02901431|101152007|FG003|Main Treatment Part|Withdrawal by Subject|18|||
33344792|NCT02901431|101152008|FG004|Main Treatment Part|Withdrawal by Subject|3|||
33344793|NCT02901431|101152009|FG005|Main Treatment Part|Withdrawal by Subject|5|||
33344794|NCT02901431|101152010|FG006|Main Treatment Part|Withdrawal by Subject|6|||
33344795|NCT02901431|101152011|FG007|Main Treatment Part|Withdrawal by Subject|0|||
33344796|NCT02901431|101152012|FG008|Main Treatment Part|Withdrawal by Subject|0|||
33344797|NCT02901431|101152013|FG009|Main Treatment Part|Withdrawal by Subject|0|||
33344798|NCT02901431|101152014|FG010|Main Treatment Part|Withdrawal by Subject|0|||
33344799|NCT02901431|101152015|FG011|Main Treatment Part|Withdrawal by Subject|0|||
33344800|NCT02901431|101152016|FG012|Main Treatment Part|Withdrawal by Subject|0|||
33344801|NCT02901431|101152004|FG000|Open Label Part|Adverse Event|0|||
33344802|NCT02901431|101152005|FG001|Open Label Part|Adverse Event|0|||
33344803|NCT02901431|101152006|FG002|Open Label Part|Adverse Event|0|||
33344804|NCT02901431|101152007|FG003|Open Label Part|Adverse Event|0|||
33344805|NCT02901431|101152008|FG004|Open Label Part|Adverse Event|0|||
33344806|NCT02901431|101152009|FG005|Open Label Part|Adverse Event|0|||
33344807|NCT02901431|101152010|FG006|Open Label Part|Adverse Event|0|||
33344808|NCT02901431|101152011|FG007|Open Label Part|Adverse Event|0|||
33344809|NCT02901431|101152012|FG008|Open Label Part|Adverse Event|4|||
33344810|NCT02901431|101152013|FG009|Open Label Part|Adverse Event|4|||
33344811|NCT02901431|101152014|FG010|Open Label Part|Adverse Event|0|||
33344812|NCT02901431|101152015|FG011|Open Label Part|Adverse Event|4|||
33344813|NCT02901431|101152016|FG012|Open Label Part|Adverse Event|1|||
33344814|NCT02901431|101152004|FG000|Open Label Part|Lost to Follow-up|0|||
33407036|NCT00561795|101377828|FG003|Overall Study|Physician Decision|0|||
33407037|NCT03359811|101377829|FG000|Overall Study|Protocol Violation|2|||
33407038|NCT03359811|101377830|FG001|Overall Study|Protocol Violation|0|||
33407039|NCT01233076|101377831|FG000|Period 2, One Week|Lost to Follow-up|1|||
33407040|NCT01233076|101377832|FG001|Period 2, One Week|Lost to Follow-up|0|||
33407041|NCT03053180|101377833|FG000|Overall Study|Failure to Return|1|||
33541597|NCT00109343|101885204|FG001|Overall Study|Lost to Follow-up|20|||
33541598|NCT00109343|101885205|FG002|Overall Study|Lost to Follow-up|14|||
33541599|NCT00109343|101885203|FG000|Overall Study|Protocol Violation|1|||
33541600|NCT00109343|101885204|FG001|Overall Study|Protocol Violation|2|||
33541601|NCT00109343|101885205|FG002|Overall Study|Protocol Violation|2|||
33541602|NCT00109343|101885203|FG000|Overall Study|Withdrawal by Subject|15|||
33541603|NCT00109343|101885204|FG001|Overall Study|Withdrawal by Subject|11|||
33541604|NCT00109343|101885205|FG002|Overall Study|Withdrawal by Subject|10|||
33541605|NCT00109343|101885203|FG000|Overall Study|Subject Moved|6|||
33541606|NCT00109343|101885204|FG001|Overall Study|Subject Moved|2|||
33541607|NCT00109343|101885205|FG002|Overall Study|Subject Moved|1|||
33541608|NCT00109343|101885203|FG000|Overall Study|Other|5|||
33541609|NCT00109343|101885204|FG001|Overall Study|Other|2|||
33541610|NCT00109343|101885205|FG002|Overall Study|Other|1|||
33541611|NCT00945243|101885206|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
33541612|NCT02371616|101885207|FG000|Overall Study|Protocol Violation|2|||
33541613|NCT02371616|101885208|FG001|Overall Study|Protocol Violation|1|||
33541614|NCT02371616|101885207|FG000|Overall Study|Adverse Event|0|||
33541615|NCT02371616|101885208|FG001|Overall Study|Adverse Event|1|||
33541616|NCT02371616|101885207|FG000|Overall Study|Withdrawal of Consent|1|||
33541617|NCT02371616|101885208|FG001|Overall Study|Withdrawal of Consent|0|||
33541618|NCT02371616|101885207|FG000|Overall Study|Other (Not specified)|1|||
33541619|NCT02371616|101885208|FG001|Overall Study|Other (Not specified)|5|||
33541620|NCT01094288|101885209|FG000|Overall Study|Adverse Event|0|||
33541621|NCT01094288|101885210|FG001|Overall Study|Adverse Event|3|||
33541622|NCT01094288|101885211|FG002|Overall Study|Adverse Event|1|||
33541623|NCT01094288|101885212|FG003|Overall Study|Adverse Event|1|||
33541624|NCT01094288|101885213|FG004|Overall Study|Adverse Event|0|||
33541625|NCT01094288|101885214|FG005|Overall Study|Adverse Event|0|||
33541626|NCT01094288|101885215|FG006|Overall Study|Adverse Event|0|||
33615647|NCT01359943|102140390|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
33344815|NCT02901431|101152005|FG001|Open Label Part|Lost to Follow-up|0|||
33344816|NCT02901431|101152006|FG002|Open Label Part|Lost to Follow-up|0|||
33344817|NCT02901431|101152007|FG003|Open Label Part|Lost to Follow-up|0|||
33344818|NCT02901431|101152008|FG004|Open Label Part|Lost to Follow-up|0|||
33344819|NCT02901431|101152009|FG005|Open Label Part|Lost to Follow-up|0|||
33344820|NCT02901431|101152010|FG006|Open Label Part|Lost to Follow-up|0|||
33344821|NCT02901431|101152011|FG007|Open Label Part|Lost to Follow-up|0|||
33407042|NCT01277757|101377834|FG000|Overall Study|Disease Progression|1|||
33407043|NCT01277757|101377834|FG000|Overall Study|Withdrawal by Subject|1|||
33541627|NCT01094288|101885216|FG007|Overall Study|Adverse Event|0|||
33541628|NCT01094288|101885209|FG000|Overall Study|Withdrawal by Subject|0|||
33541629|NCT01094288|101885210|FG001|Overall Study|Withdrawal by Subject|1|||
33541630|NCT01094288|101885211|FG002|Overall Study|Withdrawal by Subject|2|||
33541631|NCT01094288|101885212|FG003|Overall Study|Withdrawal by Subject|0|||
33541632|NCT01094288|101885213|FG004|Overall Study|Withdrawal by Subject|0|||
33344822|NCT02901431|101152012|FG008|Open Label Part|Lost to Follow-up|2|||
33344823|NCT02901431|101152013|FG009|Open Label Part|Lost to Follow-up|2|||
33344824|NCT02901431|101152014|FG010|Open Label Part|Lost to Follow-up|1|||
33344825|NCT02901431|101152015|FG011|Open Label Part|Lost to Follow-up|1|||
33344826|NCT02901431|101152016|FG012|Open Label Part|Lost to Follow-up|1|||
33344827|NCT02901431|101152004|FG000|Open Label Part|Physician Decision|0|||
33344828|NCT02901431|101152005|FG001|Open Label Part|Physician Decision|0|||
33344829|NCT02901431|101152006|FG002|Open Label Part|Physician Decision|0|||
33344830|NCT02901431|101152007|FG003|Open Label Part|Physician Decision|0|||
33344831|NCT02901431|101152008|FG004|Open Label Part|Physician Decision|0|||
33344832|NCT02901431|101152009|FG005|Open Label Part|Physician Decision|0|||
33344833|NCT02901431|101152010|FG006|Open Label Part|Physician Decision|0|||
33344834|NCT02901431|101152011|FG007|Open Label Part|Physician Decision|0|||
33344835|NCT02901431|101152012|FG008|Open Label Part|Physician Decision|1|||
33344836|NCT02901431|101152013|FG009|Open Label Part|Physician Decision|1|||
33344837|NCT02901431|101152014|FG010|Open Label Part|Physician Decision|0|||
33344838|NCT02901431|101152015|FG011|Open Label Part|Physician Decision|0|||
33344839|NCT02901431|101152016|FG012|Open Label Part|Physician Decision|0|||
33344840|NCT02901431|101152004|FG000|Open Label Part|Study Terminated By Sponsor|0|||
33344841|NCT02901431|101152005|FG001|Open Label Part|Study Terminated By Sponsor|0|||
33407044|NCT02260804|101377836|FG000|Induction Study Period|Protocol Violation|2|||
33407045|NCT02260804|101377837|FG001|Induction Study Period|Protocol Violation|0|||
33407046|NCT02260804|101377836|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
33407047|NCT02260804|101377837|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
33407048|NCT02260804|101377836|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
33407049|NCT02260804|101377837|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
33407050|NCT02260804|101377836|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
33407051|NCT02260804|101377837|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
33407052|NCT02260804|101377836|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
33407053|NCT02260804|101377837|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
33407054|NCT02260804|101377836|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
33407055|NCT02260804|101377837|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
33407056|NCT02260804|101377836|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
33407057|NCT02260804|101377837|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
33407058|NCT02260804|101377836|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
33407059|NCT02260804|101377837|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
33407060|NCT02260804|101377836|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
33407061|NCT02260804|101377837|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
33407062|NCT02260804|101377836|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
33407063|NCT02260804|101377837|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
33407064|NCT02260804|101377836|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
33407065|NCT02260804|101377837|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
33407066|NCT00542321|101377848|FG000|Overall Study|Death|0|||
33407067|NCT00542321|101377849|FG001|Overall Study|Death|1|||
33407068|NCT02406586|101377850|FG000|Overall Study|Lost to Follow-up|0|||
33407069|NCT02406586|101377851|FG001|Overall Study|Lost to Follow-up|4|||
33407070|NCT02406586|101377852|FG002|Overall Study|Lost to Follow-up|2|||
33407071|NCT02406586|101377850|FG000|Overall Study|Withdrawal by Subject|1|||
33407072|NCT02406586|101377851|FG001|Overall Study|Withdrawal by Subject|0|||
33407073|NCT02406586|101377852|FG002|Overall Study|Withdrawal by Subject|0|||
33407074|NCT01016912|101377857|FG000|End of Treatment Period|Lack of Efficacy|0|||
33407075|NCT01016912|101377858|FG001|End of Treatment Period|Lack of Efficacy|1|||
33407076|NCT01016912|101377859|FG002|End of Treatment Period|Lack of Efficacy|0|||
33407077|NCT01016912|101377860|FG003|End of Treatment Period|Lack of Efficacy|4|||
33407078|NCT01016912|101377861|FG004|End of Treatment Period|Lack of Efficacy|4|||
33407079|NCT01016912|101377857|FG000|End of Treatment Period|Adverse Event|0|||
33407080|NCT01016912|101377858|FG001|End of Treatment Period|Adverse Event|1|||
33407081|NCT01016912|101377859|FG002|End of Treatment Period|Adverse Event|1|||
33407082|NCT01016912|101377860|FG003|End of Treatment Period|Adverse Event|0|||
33407083|NCT01016912|101377861|FG004|End of Treatment Period|Adverse Event|0|||
33407084|NCT01016912|101377857|FG000|End of Treatment Period|Completed double-blind period only|0|||
33407085|NCT01016912|101377858|FG001|End of Treatment Period|Completed double-blind period only|1|||
33344842|NCT02901431|101152006|FG002|Open Label Part|Study Terminated By Sponsor|0|||
33344843|NCT02901431|101152007|FG003|Open Label Part|Study Terminated By Sponsor|0|||
33344844|NCT02901431|101152008|FG004|Open Label Part|Study Terminated By Sponsor|0|||
33344845|NCT02901431|101152009|FG005|Open Label Part|Study Terminated By Sponsor|0|||
33344846|NCT02901431|101152010|FG006|Open Label Part|Study Terminated By Sponsor|0|||
33344847|NCT02901431|101152011|FG007|Open Label Part|Study Terminated By Sponsor|0|||
33407086|NCT01016912|101377859|FG002|End of Treatment Period|Completed double-blind period only|0|||
33407087|NCT01016912|101377860|FG003|End of Treatment Period|Completed double-blind period only|0|||
33407088|NCT01016912|101377861|FG004|End of Treatment Period|Completed double-blind period only|0|||
33407089|NCT01016912|101377857|FG000|Follow-up Period|Other reason|0|||
33541633|NCT01094288|101885214|FG005|Overall Study|Withdrawal by Subject|0|||
33541634|NCT01094288|101885215|FG006|Overall Study|Withdrawal by Subject|0|||
33541635|NCT01094288|101885216|FG007|Overall Study|Withdrawal by Subject|2|||
33615648|NCT01359943|102140391|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
33211854|NCT02278328|100676534|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
33211855|NCT02278328|100676532|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
33211856|NCT02278328|100676533|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
33211857|NCT02278328|100676534|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
33211858|NCT02278328|100676532|FG000|Neuropsych Screening|incomplete consent|0|||
33211859|NCT02278328|100676533|FG001|Neuropsych Screening|incomplete consent|0|||
33211860|NCT02278328|100676534|FG002|Neuropsych Screening|incomplete consent|2|||
33211861|NCT03031938|100676535|FG000|Overall Study|Death|1|||
33211862|NCT03031938|100676536|FG001|Overall Study|Death|0|||
33211863|NCT00675766|100676537|FG000|Overall Study|Lost to Follow-up|6|||
33211864|NCT00675766|100676538|FG001|Overall Study|Lost to Follow-up|5|||
33211865|NCT00675766|100676539|FG002|Overall Study|Lost to Follow-up|21|||
33211866|NCT00675766|100676540|FG003|Overall Study|Lost to Follow-up|26|||
33211867|NCT02349295|100676541|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
33211868|NCT02349295|100676542|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
33211869|NCT02349295|100676543|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
33211870|NCT02349295|100676544|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33211871|NCT02349295|100676545|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33211872|NCT02349295|100676546|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33211873|NCT02349295|100676547|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33211874|NCT02349295|100676548|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33211875|NCT02349295|100676549|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33211876|NCT02349295|100676550|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33211877|NCT02349295|100676551|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33211878|NCT02349295|100676552|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33211879|NCT02349295|100676553|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33211880|NCT02349295|100676554|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
33211881|NCT02349295|100676541|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
33211882|NCT02349295|100676542|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
33211883|NCT02349295|100676543|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
33211884|NCT02349295|100676544|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33211885|NCT02349295|100676545|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33211886|NCT02349295|100676546|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33211887|NCT02349295|100676547|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33211888|NCT02349295|100676548|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33211889|NCT02349295|100676549|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33211890|NCT02349295|100676550|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33211891|NCT02349295|100676551|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33211892|NCT02349295|100676552|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33211893|NCT02349295|100676553|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33211894|NCT02349295|100676554|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
33211895|NCT02349295|100676541|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
33211896|NCT02349295|100676542|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
33211897|NCT02349295|100676543|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
33344848|NCT02901431|101152012|FG008|Open Label Part|Study Terminated By Sponsor|35|||
33344849|NCT02901431|101152013|FG009|Open Label Part|Study Terminated By Sponsor|12|||
33211898|NCT02349295|100676544|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33211899|NCT02349295|100676545|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33211900|NCT02349295|100676546|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33211901|NCT02349295|100676547|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33211902|NCT02349295|100676548|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33211903|NCT02349295|100676549|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33211904|NCT02349295|100676550|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33211905|NCT02349295|100676551|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33211906|NCT02349295|100676552|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33344850|NCT02901431|101152014|FG010|Open Label Part|Study Terminated By Sponsor|21|||
33344851|NCT02901431|101152015|FG011|Open Label Part|Study Terminated By Sponsor|31|||
33541636|NCT01094288|101885209|FG000|Overall Study|Initiation of Alternative Therapy|0|||
33541637|NCT01094288|101885210|FG001|Overall Study|Initiation of Alternative Therapy|0|||
33211907|NCT02349295|100676553|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33615649|NCT01359943|102140389|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
33344852|NCT02901431|101152016|FG012|Open Label Part|Study Terminated By Sponsor|0|||
33407090|NCT01016912|101377858|FG001|Follow-up Period|Other reason|0|||
33407091|NCT01016912|101377859|FG002|Follow-up Period|Other reason|1|||
33541638|NCT01094288|101885211|FG002|Overall Study|Initiation of Alternative Therapy|1|||
33541639|NCT01094288|101885212|FG003|Overall Study|Initiation of Alternative Therapy|0|||
33541640|NCT01094288|101885213|FG004|Overall Study|Initiation of Alternative Therapy|0|||
33541641|NCT01094288|101885214|FG005|Overall Study|Initiation of Alternative Therapy|0|||
33541642|NCT01094288|101885215|FG006|Overall Study|Initiation of Alternative Therapy|0|||
33615650|NCT01359943|102140390|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
33615651|NCT01359943|102140391|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
33541643|NCT01094288|101885216|FG007|Overall Study|Initiation of Alternative Therapy|0|||
33541644|NCT01094288|101885209|FG000|Overall Study|Reason not Specified|2|||
33541645|NCT01094288|101885210|FG001|Overall Study|Reason not Specified|3|||
33541646|NCT01094288|101885211|FG002|Overall Study|Reason not Specified|0|||
33541647|NCT01094288|101885212|FG003|Overall Study|Reason not Specified|1|||
33541648|NCT01094288|101885213|FG004|Overall Study|Reason not Specified|0|||
33541649|NCT01094288|101885214|FG005|Overall Study|Reason not Specified|0|||
33541650|NCT01094288|101885215|FG006|Overall Study|Reason not Specified|0|||
33541651|NCT01094288|101885216|FG007|Overall Study|Reason not Specified|0|||
33541652|NCT01094288|101885209|FG000|Overall Study|Ongoing Participants|0|||
33541653|NCT01094288|101885210|FG001|Overall Study|Ongoing Participants|3|||
33541654|NCT01094288|101885211|FG002|Overall Study|Ongoing Participants|0|||
33541655|NCT01094288|101885212|FG003|Overall Study|Ongoing Participants|0|||
33541656|NCT01094288|101885213|FG004|Overall Study|Ongoing Participants|0|||
33541657|NCT01094288|101885214|FG005|Overall Study|Ongoing Participants|0|||
33541658|NCT01094288|101885215|FG006|Overall Study|Ongoing Participants|0|||
33541659|NCT01094288|101885216|FG007|Overall Study|Ongoing Participants|0|||
33541660|NCT01673386|101885217|FG000|Overall Study|Study terminated by sponsor|16|||
33541661|NCT01673386|101885218|FG001|Overall Study|Study terminated by sponsor|22|||
33541662|NCT01673386|101885217|FG000|Overall Study|Adverse Event|5|||
33541663|NCT01673386|101885218|FG001|Overall Study|Adverse Event|2|||
33541664|NCT01673386|101885217|FG000|Overall Study|Progressive disease|4|||
33541665|NCT01673386|101885218|FG001|Overall Study|Progressive disease|1|||
33615652|NCT01359943|102140389|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
33615653|NCT01359943|102140390|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
33615654|NCT01359943|102140391|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
33615655|NCT01359943|102140389|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
33615656|NCT01359943|102140390|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
33615657|NCT01359943|102140391|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
33615658|NCT01359943|102140389|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
33615659|NCT01359943|102140390|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
33615660|NCT01359943|102140391|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
33615661|NCT01359943|102140389|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
33615662|NCT01359943|102140390|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
33615663|NCT01359943|102140391|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
33615664|NCT01359943|102140389|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
33615665|NCT01359943|102140390|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
33615666|NCT01359943|102140391|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
33615667|NCT01359943|102140389|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
33541666|NCT01673386|101885217|FG000|Overall Study|Withdrawal by Subject|0|||
33344853|NCT02901431|101152004|FG000|Open Label Part|Withdrawal by Subject|0|||
33541667|NCT01673386|101885218|FG001|Overall Study|Withdrawal by Subject|2|||
33541668|NCT05001620|101885219|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
33407092|NCT01016912|101377860|FG003|Follow-up Period|Other reason|1|||
33407093|NCT01016912|101377861|FG004|Follow-up Period|Other reason|0|||
33541669|NCT05001620|101885220|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
33541670|NCT03034967|101885221|FG000|Overall Study|Withdrawal by Subject|9|||
33541671|NCT03034967|101885222|FG001|Overall Study|Withdrawal by Subject|2|||
33541672|NCT03034967|101885223|FG002|Overall Study|Withdrawal by Subject|6|||
33541673|NCT03034967|101885224|FG003|Overall Study|Withdrawal by Subject|6|||
33541674|NCT03034967|101885225|FG004|Overall Study|Withdrawal by Subject|9|||
33541675|NCT03034967|101885226|FG005|Overall Study|Withdrawal by Subject|2|||
33541676|NCT03034967|101885221|FG000|Overall Study|Physician Decision|1|||
33541677|NCT03034967|101885222|FG001|Overall Study|Physician Decision|0|||
33541678|NCT03034967|101885223|FG002|Overall Study|Physician Decision|1|||
33541679|NCT03034967|101885224|FG003|Overall Study|Physician Decision|1|||
33541680|NCT03034967|101885225|FG004|Overall Study|Physician Decision|1|||
33541681|NCT03034967|101885226|FG005|Overall Study|Physician Decision|0|||
33541682|NCT03034967|101885221|FG000|Overall Study|Lost to Follow-up|0|||
33541683|NCT03034967|101885222|FG001|Overall Study|Lost to Follow-up|0|||
33541684|NCT03034967|101885223|FG002|Overall Study|Lost to Follow-up|0|||
33541685|NCT03034967|101885224|FG003|Overall Study|Lost to Follow-up|1|||
33541686|NCT03034967|101885225|FG004|Overall Study|Lost to Follow-up|0|||
33541687|NCT03034967|101885226|FG005|Overall Study|Lost to Follow-up|2|||
33541688|NCT03034967|101885221|FG000|Overall Study|Liver function test abnormality|0|||
33541689|NCT03034967|101885222|FG001|Overall Study|Liver function test abnormality|0|||
33541690|NCT03034967|101885223|FG002|Overall Study|Liver function test abnormality|1|||
33541691|NCT03034967|101885224|FG003|Overall Study|Liver function test abnormality|0|||
33541692|NCT03034967|101885225|FG004|Overall Study|Liver function test abnormality|0|||
33541693|NCT03034967|101885226|FG005|Overall Study|Liver function test abnormality|0|||
33541694|NCT03034967|101885221|FG000|Overall Study|Protocol Violation|1|||
33541695|NCT03034967|101885222|FG001|Overall Study|Protocol Violation|0|||
33541696|NCT03034967|101885223|FG002|Overall Study|Protocol Violation|0|||
33541697|NCT03034967|101885224|FG003|Overall Study|Protocol Violation|0|||
33541698|NCT03034967|101885225|FG004|Overall Study|Protocol Violation|0|||
33541699|NCT03034967|101885226|FG005|Overall Study|Protocol Violation|2|||
33541700|NCT03034967|101885221|FG000|Overall Study|Lack of Efficacy|0|||
33541701|NCT03034967|101885222|FG001|Overall Study|Lack of Efficacy|1|||
33541702|NCT03034967|101885223|FG002|Overall Study|Lack of Efficacy|2|||
33541703|NCT03034967|101885224|FG003|Overall Study|Lack of Efficacy|1|||
33541704|NCT03034967|101885225|FG004|Overall Study|Lack of Efficacy|1|||
33615668|NCT01359943|102140390|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
33615669|NCT01359943|102140391|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
33615670|NCT01359943|102140389|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
33615671|NCT01359943|102140390|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
33615672|NCT01359943|102140391|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
33615673|NCT01359943|102140389|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
33615674|NCT01359943|102140390|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
33615675|NCT01359943|102140391|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
33541705|NCT03034967|101885226|FG005|Overall Study|Lack of Efficacy|0|||
33541706|NCT03034967|101885221|FG000|Overall Study|Adverse Event, non-fatal|3|||
33541707|NCT03034967|101885222|FG001|Overall Study|Adverse Event, non-fatal|1|||
33541708|NCT03034967|101885223|FG002|Overall Study|Adverse Event, non-fatal|2|||
33541709|NCT03034967|101885224|FG003|Overall Study|Adverse Event, non-fatal|0|||
33541710|NCT03034967|101885225|FG004|Overall Study|Adverse Event, non-fatal|2|||
33541711|NCT03034967|101885226|FG005|Overall Study|Adverse Event, non-fatal|8|||
33541712|NCT03034967|101885221|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
33541713|NCT03034967|101885222|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
33541714|NCT03034967|101885223|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
33615676|NCT01359943|102140389|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
33615677|NCT01359943|102140390|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
33615678|NCT01359943|102140391|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
33615679|NCT01359943|102140389|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
33615680|NCT01359943|102140390|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
33615681|NCT01359943|102140391|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
33615682|NCT01359943|102140389|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
33615683|NCT01359943|102140390|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
33615684|NCT01359943|102140391|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
33615685|NCT02287467|102140392|FG000|Overall Study|Protocol Violation|12|||
33615686|NCT02287467|102140393|FG001|Overall Study|Protocol Violation|9|||
33615687|NCT01949090|102140396|FG000|Overall Study|Serious Adverse Event|0|||
33615688|NCT01949090|102140397|FG001|Overall Study|Serious Adverse Event|1|||
33615689|NCT01949090|102140398|FG002|Overall Study|Serious Adverse Event|2|||
33615690|NCT01949090|102140399|FG003|Overall Study|Serious Adverse Event|0|||
33615691|NCT01949090|102140400|FG004|Overall Study|Serious Adverse Event|1|||
33615692|NCT01949090|102140396|FG000|Overall Study|Withdrawal by Subject|2|||
33615693|NCT01949090|102140397|FG001|Overall Study|Withdrawal by Subject|0|||
33615694|NCT01949090|102140398|FG002|Overall Study|Withdrawal by Subject|0|||
33615695|NCT01949090|102140399|FG003|Overall Study|Withdrawal by Subject|0|||
33615696|NCT01949090|102140400|FG004|Overall Study|Withdrawal by Subject|1|||
33615697|NCT01949090|102140396|FG000|Overall Study|Protocol non-compliance|0|||
33615698|NCT01949090|102140397|FG001|Overall Study|Protocol non-compliance|0|||
33615699|NCT01949090|102140398|FG002|Overall Study|Protocol non-compliance|0|||
33615700|NCT01949090|102140399|FG003|Overall Study|Protocol non-compliance|0|||
33615701|NCT01949090|102140400|FG004|Overall Study|Protocol non-compliance|1|||
33615702|NCT01949090|102140396|FG000|Overall Study|Lost to Follow-up|2|||
33615703|NCT01949090|102140397|FG001|Overall Study|Lost to Follow-up|1|||
33615704|NCT01949090|102140398|FG002|Overall Study|Lost to Follow-up|0|||
33615705|NCT01949090|102140399|FG003|Overall Study|Lost to Follow-up|1|||
33615706|NCT01949090|102140400|FG004|Overall Study|Lost to Follow-up|1|||
33615707|NCT01824355|102140402|FG000|Overall Study|Adverse Event|2|||
33615708|NCT01824355|102140402|FG000|Overall Study|unevaluable reference method results per|1|||
33615709|NCT00546000|102140407|FG000|Overall Study|Adverse Event|1|||
33615710|NCT00546000|102140407|FG000|Overall Study|Lost to Follow-up|1|||
33615711|NCT00546000|102140407|FG000|Overall Study|Baseline HPA Axis Supression|2|||
33541715|NCT03034967|101885224|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
33541716|NCT03034967|101885225|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
33541717|NCT03034967|101885226|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
33541718|NCT01118299|101885227|FG000|Overall Study|Death|7|||
33541719|NCT01118299|101885228|FG001|Overall Study|Death|5|||
33541720|NCT01118299|101885227|FG000|Overall Study|Withdrawal by Subject|8|||
33541721|NCT01118299|101885228|FG001|Overall Study|Withdrawal by Subject|8|||
33541722|NCT01118299|101885227|FG000|Overall Study|Lost to Follow-up|2|||
33541723|NCT01118299|101885228|FG001|Overall Study|Lost to Follow-up|1|||
33541724|NCT01118299|101885227|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
33541725|NCT01118299|101885228|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
33615712|NCT00048347|102140408|FG000|Overall Study|Screen failure|2|||
33615713|NCT02454478|102144165|FG000|Overall Study|Incomplete DLT Evaluation|1|||
33615714|NCT01670721|102144166|FG000|Overall Study|Participant's decision|15|||
33211908|NCT02349295|100676554|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
33407094|NCT02927990|101377862|FG000|Overall Study|Protocol Violation|4|||
33407095|NCT02927990|101377862|FG000|Overall Study|Physician Decision|9|||
33407096|NCT02927990|101377862|FG000|Overall Study|Room switched and therefore no study device available|15|||
33407097|NCT02927990|101377862|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
33407098|NCT00985114|101377863|FG000|Overall Study|Adverse Event|1|||
33407099|NCT00985114|101377864|FG001|Overall Study|Adverse Event|0|||
33407100|NCT00985114|101377863|FG000|Overall Study|Withdrawal by Subject|0|||
33407101|NCT00985114|101377864|FG001|Overall Study|Withdrawal by Subject|2|||
33541726|NCT02915835|101885229|FG000|Overall Study|Physician Decision|1|||
33541727|NCT02915835|101885230|FG001|Overall Study|Physician Decision|0|||
33541728|NCT02915835|101885229|FG000|Overall Study|Withdrawal by Subject|0|||
33541729|NCT02915835|101885230|FG001|Overall Study|Withdrawal by Subject|1|||
33615715|NCT01670721|102144166|FG000|Overall Study|Other than specified above|38|||
33615716|NCT04395690|102144171|FG000|Overall Study|Lost to Follow-up|1|||
33615717|NCT04395690|102144172|FG001|Overall Study|Lost to Follow-up|1|||
33541730|NCT01685437|101885231|FG000|Overall Study|Withdrawal by Subject|22|||
33541731|NCT01685437|101885231|FG000|Overall Study|Lost to Follow-up|3|||
33615718|NCT01687101|102144173|FG000|Overall Study|Lost to Follow-up|7|||
33615719|NCT00567359|102144174|FG000|Overall Study|Withdrawal by Subject|1|||
33615720|NCT04079816|102144175|FG000|Overall Study|Request of Subject|2|||
33407102|NCT01083121|101377865|FG000|Overall Study|Use of Humira outside the approved label|81|||
33615721|NCT04079816|102144175|FG000|Overall Study|Unable to draw samples|1|||
33211909|NCT02349295|100676541|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
33211910|NCT02349295|100676542|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
33211911|NCT02349295|100676543|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
33211912|NCT02349295|100676544|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33211913|NCT02349295|100676545|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33211914|NCT02349295|100676546|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33211915|NCT02349295|100676547|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33211916|NCT02349295|100676548|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33211917|NCT02349295|100676549|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33211918|NCT02349295|100676550|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33211919|NCT02349295|100676551|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33211920|NCT02349295|100676552|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33211921|NCT02349295|100676553|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33211922|NCT02349295|100676554|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
33211923|NCT02349295|100676541|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33211924|NCT02349295|100676542|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
33211925|NCT02349295|100676543|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
33211926|NCT02349295|100676544|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33211927|NCT02349295|100676545|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33211928|NCT02349295|100676546|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33211929|NCT02349295|100676547|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33211930|NCT02349295|100676548|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33211931|NCT02349295|100676549|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33211932|NCT02349295|100676550|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33211933|NCT02349295|100676551|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33211934|NCT02349295|100676552|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33211935|NCT02349295|100676553|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33211936|NCT02349295|100676554|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
33211937|NCT02349295|100676541|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
33211938|NCT02349295|100676542|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
33211939|NCT02349295|100676543|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
33211940|NCT02349295|100676544|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
33211941|NCT02349295|100676545|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
33211942|NCT02349295|100676546|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
33211943|NCT02349295|100676547|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
33211944|NCT02349295|100676548|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
33211945|NCT02349295|100676549|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
33211946|NCT02349295|100676550|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
33211947|NCT02349295|100676551|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
33211948|NCT02349295|100676552|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
33211949|NCT02349295|100676553|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
33211950|NCT02349295|100676554|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
33211951|NCT02349295|100676541|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33211952|NCT02349295|100676542|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33211953|NCT02349295|100676543|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33211954|NCT02349295|100676544|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33211955|NCT02349295|100676545|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33211956|NCT02349295|100676546|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33211957|NCT02349295|100676547|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33211958|NCT02349295|100676548|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
33211959|NCT02349295|100676549|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
33211960|NCT02349295|100676550|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
33407103|NCT02988115|101380534|FG000|Overall Study|Adverse Event|6|||
33407104|NCT02988115|101380535|FG001|Overall Study|Adverse Event|1|||
33407105|NCT02988115|101380534|FG000|Overall Study|Sponsor Decision|5|||
33211961|NCT02349295|100676551|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
33407106|NCT02988115|101380535|FG001|Overall Study|Sponsor Decision|2|||
33407107|NCT02988115|101380534|FG000|Overall Study|Withdrawal by Subject|1|||
33407108|NCT02988115|101380535|FG001|Overall Study|Withdrawal by Subject|1|||
33407109|NCT02988115|101380534|FG000|Overall Study|Withdrawn by Mistake|1|||
33344854|NCT02901431|101152005|FG001|Open Label Part|Withdrawal by Subject|0|||
33344855|NCT02901431|101152006|FG002|Open Label Part|Withdrawal by Subject|0|||
33344856|NCT02901431|101152007|FG003|Open Label Part|Withdrawal by Subject|0|||
33344857|NCT02901431|101152008|FG004|Open Label Part|Withdrawal by Subject|0|||
33344858|NCT02901431|101152009|FG005|Open Label Part|Withdrawal by Subject|0|||
33344859|NCT02901431|101152010|FG006|Open Label Part|Withdrawal by Subject|0|||
33344860|NCT02901431|101152011|FG007|Open Label Part|Withdrawal by Subject|0|||
33344861|NCT02901431|101152012|FG008|Open Label Part|Withdrawal by Subject|6|||
33344862|NCT02901431|101152013|FG009|Open Label Part|Withdrawal by Subject|5|||
33344863|NCT02901431|101152014|FG010|Open Label Part|Withdrawal by Subject|7|||
33344864|NCT02901431|101152015|FG011|Open Label Part|Withdrawal by Subject|3|||
33344865|NCT02901431|101152016|FG012|Open Label Part|Withdrawal by Subject|1|||
33344866|NCT03183128|101152019|FG000|Overall Study|Adverse Event|1|||
33344867|NCT03183128|101152020|FG001|Overall Study|Adverse Event|2|||
33344868|NCT03183128|101152019|FG000|Overall Study|Withdrawal by Subject|1|||
33344869|NCT03183128|101152020|FG001|Overall Study|Withdrawal by Subject|8|||
33344870|NCT03183128|101152019|FG000|Overall Study|Protocol Violation|2|||
33344871|NCT03183128|101152020|FG001|Overall Study|Protocol Violation|0|||
33344872|NCT03183128|101152019|FG000|Overall Study|Lack of Efficacy|4|||
33344873|NCT03183128|101152020|FG001|Overall Study|Lack of Efficacy|27|||
33344874|NCT03183128|101152019|FG000|Overall Study|Lost to Follow-up|1|||
33344875|NCT03183128|101152020|FG001|Overall Study|Lost to Follow-up|0|||
33344876|NCT03183128|101152019|FG000|Overall Study|Death|2|||
33344877|NCT03183128|101152020|FG001|Overall Study|Death|0|||
33344878|NCT03183128|101152019|FG000|Overall Study|Physician Decision|1|||
33344879|NCT03183128|101152020|FG001|Overall Study|Physician Decision|0|||
33344880|NCT01934140|101152021|FG000|Persistence Phase (Year 6-10)|Other|24|||
33344881|NCT01934140|101152022|FG001|Persistence Phase (Year 6-10)|Other|6|||
33344882|NCT01934140|101152021|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
33344883|NCT01934140|101152022|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
33541732|NCT01685437|101885231|FG000|Overall Study|Adverse Event|1|||
33541733|NCT01685437|101885231|FG000|Overall Study|Protocol Violation|4|||
33541734|NCT01685437|101885231|FG000|Overall Study|Unable to make visits due to work|1|||
33541735|NCT03426345|101885240|FG000|Overall Study|Adverse Event|4|||
33541736|NCT03426345|101885241|FG001|Overall Study|Adverse Event|4|||
33344884|NCT01934140|101152021|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
33344885|NCT01934140|101152022|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
33344886|NCT01934140|101152021|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
33344887|NCT01934140|101152022|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
33344888|NCT01934140|101152021|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
33344889|NCT01934140|101152022|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
33344890|NCT01934140|101152021|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
33344891|NCT01934140|101152022|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
33344892|NCT01934140|101152021|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
33407110|NCT02988115|101380535|FG001|Overall Study|Withdrawn by Mistake|0|||
33407111|NCT02988115|101380534|FG000|Overall Study|Lost to Follow-up|1|||
33407112|NCT02988115|101380535|FG001|Overall Study|Lost to Follow-up|0|||
33407113|NCT00348348|101380540|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
33407114|NCT00348348|101380541|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
33407115|NCT00348348|101380540|FG000|Overall Study|Lack of Efficacy|1|||
33407116|NCT00348348|101380541|FG001|Overall Study|Lack of Efficacy|1|||
33407117|NCT00348348|101380540|FG000|Overall Study|Lost to Follow-up|8|||
33407118|NCT00348348|101380541|FG001|Overall Study|Lost to Follow-up|10|||
33344893|NCT01934140|101152022|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
33344894|NCT01934140|101152021|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
33344895|NCT01934140|101152022|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
33344896|NCT00159432|101152025|FG000|Overall Study|Adverse Event|1|||
33344897|NCT00159432|101152025|FG000|Overall Study|Death|1|||
33344898|NCT00159432|101152025|FG000|Overall Study|Lack of Efficacy|8|||
33344899|NCT01439945|101152027|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
33344900|NCT01439945|101152028|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
33344901|NCT01439945|101152029|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
33407119|NCT00348348|101380540|FG000|Overall Study|Withdrawal by Subject|4|||
33407120|NCT00348348|101380541|FG001|Overall Study|Withdrawal by Subject|1|||
33615722|NCT02728089|102144176|FG000|Overall Study|Physician Decision|2|||
33344902|NCT01439945|101152030|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
33344903|NCT01439945|101152027|FG000|Double-Blind Treatment Phase|Ineligible|1|||
33344904|NCT01439945|101152028|FG001|Double-Blind Treatment Phase|Ineligible|2|||
33344905|NCT01439945|101152029|FG002|Double-Blind Treatment Phase|Ineligible|0|||
33407121|NCT00348348|101380540|FG000|Overall Study|Other|7|||
33407122|NCT00348348|101380541|FG001|Overall Study|Other|4|||
33407123|NCT00348348|101380540|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
33407124|NCT00348348|101380541|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
33344906|NCT01439945|101152030|FG003|Double-Blind Treatment Phase|Ineligible|1|||
33344907|NCT00481065|101152031|FG000|Overall Study|Adverse event or death|1|||
33344908|NCT00481065|101152032|FG001|Overall Study|Adverse event or death|1|||
33344909|NCT00481065|101152033|FG002|Overall Study|Adverse event or death|3|||
33344910|NCT00481065|101152034|FG003|Overall Study|Adverse event or death|0|||
33344911|NCT00481065|101152035|FG004|Overall Study|Adverse event or death|2|||
33344912|NCT00481065|101152036|FG005|Overall Study|Adverse event or death|0|||
33541737|NCT03426345|101885240|FG000|Overall Study|Lack of Efficacy|1|||
33541738|NCT03426345|101885241|FG001|Overall Study|Lack of Efficacy|0|||
33541739|NCT03426345|101885240|FG000|Overall Study|Withdrawal by Subject|5|||
33541740|NCT03426345|101885241|FG001|Overall Study|Withdrawal by Subject|6|||
33344913|NCT00481065|101152037|FG006|Overall Study|Adverse event or death|1|||
33344914|NCT00481065|101152038|FG007|Overall Study|Adverse event or death|1|||
33344915|NCT00481065|101152031|FG000|Overall Study|Withdrawal by Subject|11|||
33344916|NCT00481065|101152032|FG001|Overall Study|Withdrawal by Subject|12|||
33344917|NCT00481065|101152033|FG002|Overall Study|Withdrawal by Subject|7|||
33344918|NCT00481065|101152034|FG003|Overall Study|Withdrawal by Subject|11|||
33344919|NCT00481065|101152035|FG004|Overall Study|Withdrawal by Subject|13|||
33344920|NCT00481065|101152036|FG005|Overall Study|Withdrawal by Subject|12|||
33344921|NCT00481065|101152037|FG006|Overall Study|Withdrawal by Subject|9|||
33344922|NCT00481065|101152038|FG007|Overall Study|Withdrawal by Subject|10|||
33344923|NCT00481065|101152031|FG000|Overall Study|Lost to Follow-up|4|||
33344924|NCT00481065|101152032|FG001|Overall Study|Lost to Follow-up|2|||
33344925|NCT00481065|101152033|FG002|Overall Study|Lost to Follow-up|4|||
33344926|NCT00481065|101152034|FG003|Overall Study|Lost to Follow-up|3|||
33344927|NCT00481065|101152035|FG004|Overall Study|Lost to Follow-up|3|||
33344928|NCT00481065|101152036|FG005|Overall Study|Lost to Follow-up|3|||
33344929|NCT00481065|101152037|FG006|Overall Study|Lost to Follow-up|2|||
33344930|NCT00481065|101152038|FG007|Overall Study|Lost to Follow-up|5|||
33344931|NCT00481065|101152031|FG000|Overall Study|Inappropriate enrollment|4|||
33344932|NCT00481065|101152032|FG001|Overall Study|Inappropriate enrollment|0|||
33344933|NCT00481065|101152033|FG002|Overall Study|Inappropriate enrollment|2|||
33344934|NCT00481065|101152034|FG003|Overall Study|Inappropriate enrollment|0|||
33344935|NCT00481065|101152035|FG004|Overall Study|Inappropriate enrollment|2|||
33344936|NCT00481065|101152036|FG005|Overall Study|Inappropriate enrollment|1|||
33344937|NCT00481065|101152037|FG006|Overall Study|Inappropriate enrollment|0|||
33344938|NCT00481065|101152038|FG007|Overall Study|Inappropriate enrollment|1|||
33344939|NCT00481065|101152031|FG000|Overall Study|Administrative reason|0|||
33344940|NCT00481065|101152032|FG001|Overall Study|Administrative reason|0|||
33344941|NCT00481065|101152033|FG002|Overall Study|Administrative reason|0|||
33344942|NCT00481065|101152034|FG003|Overall Study|Administrative reason|0|||
33344943|NCT00481065|101152035|FG004|Overall Study|Administrative reason|0|||
33344944|NCT00481065|101152036|FG005|Overall Study|Administrative reason|2|||
33344945|NCT00481065|101152037|FG006|Overall Study|Administrative reason|1|||
33344946|NCT00481065|101152038|FG007|Overall Study|Administrative reason|0|||
33541741|NCT03426345|101885240|FG000|Overall Study|Lost to Follow-up|3|||
33541742|NCT03426345|101885241|FG001|Overall Study|Lost to Follow-up|1|||
33541743|NCT03426345|101885240|FG000|Overall Study|Protocol Deviation|3|||
33541744|NCT03426345|101885241|FG001|Overall Study|Protocol Deviation|4|||
33541745|NCT03426345|101885240|FG000|Overall Study|Reason Not Specified|1|||
33541746|NCT03426345|101885241|FG001|Overall Study|Reason Not Specified|2|||
33541747|NCT03426345|101885240|FG000|Overall Study|Missing Completion Status|1|||
33541748|NCT03426345|101885241|FG001|Overall Study|Missing Completion Status|0|||
33541749|NCT03444584|101885246|FG000|Overall Study|Withdrawal by Subject|0|||
33541750|NCT03444584|101885247|FG001|Overall Study|Withdrawal by Subject|1|||
33541751|NCT03444584|101885246|FG000|Overall Study|Other|0|||
33541752|NCT03444584|101885247|FG001|Overall Study|Other|1|||
33541753|NCT00909870|101885248|FG000|Overall Study|Adverse Event|13|||
33541754|NCT00909870|101885249|FG001|Overall Study|Adverse Event|7|||
33541755|NCT00909870|101885248|FG000|Overall Study|Protocol Violation|1|||
33541756|NCT00909870|101885249|FG001|Overall Study|Protocol Violation|2|||
33541757|NCT00909870|101885248|FG000|Overall Study|Withdrawal by Subject|5|||
33541758|NCT00909870|101885249|FG001|Overall Study|Withdrawal by Subject|8|||
33541759|NCT00909870|101885248|FG000|Overall Study|Lost to Follow-up|3|||
33344947|NCT00481065|101152031|FG000|Overall Study|Protocol Violation|2|||
33344948|NCT00481065|101152032|FG001|Overall Study|Protocol Violation|1|||
33344949|NCT00481065|101152033|FG002|Overall Study|Protocol Violation|1|||
33541760|NCT00909870|101885249|FG001|Overall Study|Lost to Follow-up|3|||
33541761|NCT00909870|101885248|FG000|Overall Study|Physician Decision|0|||
33541762|NCT00909870|101885249|FG001|Overall Study|Physician Decision|2|||
33541763|NCT00909870|101885248|FG000|Overall Study|Other|1|||
33344950|NCT00481065|101152034|FG003|Overall Study|Protocol Violation|1|||
33344951|NCT00481065|101152035|FG004|Overall Study|Protocol Violation|2|||
33344952|NCT00481065|101152036|FG005|Overall Study|Protocol Violation|6|||
33344953|NCT00481065|101152037|FG006|Overall Study|Protocol Violation|3|||
33344954|NCT00481065|101152038|FG007|Overall Study|Protocol Violation|2|||
33541764|NCT00909870|101885249|FG001|Overall Study|Other|5|||
33407125|NCT00348348|101380540|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
33407126|NCT00348348|101380541|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
33407127|NCT00348348|101380540|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
33407128|NCT00348348|101380541|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
33407129|NCT00348348|101380540|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
33407130|NCT00348348|101380541|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
33407131|NCT00348348|101380540|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
33407132|NCT00348348|101380541|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
33407133|NCT00348348|101380540|FG000|Overall Study|Adverse event probably related to study|1|||
33407134|NCT00348348|101380541|FG001|Overall Study|Adverse event probably related to study|0|||
33407135|NCT04225026|101380542|FG000|Overall Study|Withdrawal by Subject|4|||
33407136|NCT04225026|101380542|FG000|Overall Study|Adverse Event|1|||
33407137|NCT04225026|101380542|FG000|Overall Study|Other|1|||
33407138|NCT04225026|101380542|FG000|Overall Study|Death|11|||
33407139|NCT04225026|101380542|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
33407140|NCT00779506|101380548|FG000|Overall Study|Screening Failed|2|||
33407141|NCT00779506|101380548|FG000|Overall Study|Adverse Event|4|||
33407142|NCT00779506|101380548|FG000|Overall Study|Lack of Efficacy|11|||
33407143|NCT00779506|101380548|FG000|Overall Study|Protocol Violation|5|||
33407144|NCT00779506|101380548|FG000|Overall Study|Withdrawal by Subject|6|||
33407145|NCT00779506|101380548|FG000|Overall Study|Lost to Follow-up|1|||
33407146|NCT01014442|101380549|FG000|Overall Study|Adverse Event|0|||
33407147|NCT01014442|101380550|FG001|Overall Study|Adverse Event|8|||
33407148|NCT01014442|101380549|FG000|Overall Study|Withdrawal by Subject|4|||
33407149|NCT01014442|101380550|FG001|Overall Study|Withdrawal by Subject|4|||
33407150|NCT01014442|101380549|FG000|Overall Study|Protocol Violation|2|||
33407151|NCT01014442|101380550|FG001|Overall Study|Protocol Violation|5|||
33407152|NCT01014442|101380549|FG000|Overall Study|Lack of Compliance|0|||
33407153|NCT01014442|101380550|FG001|Overall Study|Lack of Compliance|1|||
33407154|NCT01014442|101380549|FG000|Overall Study|Unspecified Reason|1|||
33407155|NCT01014442|101380550|FG001|Overall Study|Unspecified Reason|1|||
33407156|NCT02506101|101380551|FG000|Overall Study|Transportation issues|1|||
33407157|NCT02506101|101380552|FG001|Overall Study|Transportation issues|0|||
33407158|NCT02506101|101380551|FG000|Overall Study|No enrollment and staff unavailability|1|||
33407159|NCT02506101|101380552|FG001|Overall Study|No enrollment and staff unavailability|0|||
33407160|NCT03287960|101380553|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
33407161|NCT03287960|101380553|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
33407162|NCT01858701|101380555|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
33407163|NCT01858701|101380556|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
33407164|NCT01858701|101380555|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
33407165|NCT01858701|101380556|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
33407166|NCT01858701|101380555|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
33407167|NCT01858701|101380556|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
33407168|NCT01858701|101380555|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
33407169|NCT01858701|101380556|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
33541765|NCT02337764|101885250|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
33541766|NCT02337764|101885250|FG000|Overall Study|Voluntary Withdrawal|12|||
33541767|NCT02337764|101885250|FG000|Overall Study|Lack of Efficacy|2|||
33541768|NCT03257267|101885255|FG000|Overall Study|Adverse Event|17|||
33541769|NCT03257267|101885256|FG001|Overall Study|Adverse Event|7|||
33541770|NCT03257267|101885255|FG000|Overall Study|Death|96|||
33541771|NCT03257267|101885256|FG001|Overall Study|Death|98|||
33541772|NCT03257267|101885255|FG000|Overall Study|Lost to Follow-up|2|||
33541773|NCT03257267|101885256|FG001|Overall Study|Lost to Follow-up|2|||
33541774|NCT03257267|101885255|FG000|Overall Study|Non-compliance with Study Drug|0|||
33541775|NCT03257267|101885256|FG001|Overall Study|Non-compliance with Study Drug|2|||
33541776|NCT03257267|101885255|FG000|Overall Study|Participant Decision|35|||
33407170|NCT00423137|101380557|FG000|Overall Study|Lost to Follow-up|0|||
33407171|NCT00423137|101380558|FG001|Overall Study|Lost to Follow-up|0|||
33407172|NCT00423137|101380559|FG002|Overall Study|Lost to Follow-up|1|||
33407173|NCT00423137|101380560|FG003|Overall Study|Lost to Follow-up|0|||
33407174|NCT00423137|101380557|FG000|Overall Study|Protocol Violation|0|||
33407175|NCT00423137|101380558|FG001|Overall Study|Protocol Violation|0|||
33407176|NCT00423137|101380559|FG002|Overall Study|Protocol Violation|0|||
33407177|NCT00423137|101380560|FG003|Overall Study|Protocol Violation|1|||
33407178|NCT00423137|101380557|FG000|Overall Study|Adverse Event Study disease worse|1|||
33407179|NCT00423137|101380558|FG001|Overall Study|Adverse Event Study disease worse|0|||
33541777|NCT03257267|101885256|FG001|Overall Study|Participant Decision|43|||
33541778|NCT03257267|101885255|FG000|Overall Study|Sponsor Decision|1|||
33541779|NCT03257267|101885256|FG001|Overall Study|Sponsor Decision|0|||
33407180|NCT00423137|101380559|FG002|Overall Study|Adverse Event Study disease worse|3|||
33407181|NCT00423137|101380560|FG003|Overall Study|Adverse Event Study disease worse|1|||
33541780|NCT03257267|101885255|FG000|Overall Study|Physician Decision|1|||
33541781|NCT03257267|101885256|FG001|Overall Study|Physician Decision|3|||
33541782|NCT03257267|101885255|FG000|Overall Study|Disease Progression|109|||
33407182|NCT00423137|101380557|FG000|Overall Study|Adverse Event Other|0|||
33407183|NCT00423137|101380558|FG001|Overall Study|Adverse Event Other|0|||
33407184|NCT00423137|101380559|FG002|Overall Study|Adverse Event Other|2|||
33407185|NCT00423137|101380560|FG003|Overall Study|Adverse Event Other|0|||
33407186|NCT01684930|101380565|FG000|Overall Study|Withdrawal by Subject|3|||
33407187|NCT01684930|101380566|FG001|Overall Study|Withdrawal by Subject|1|||
33407188|NCT00772031|101380567|FG000|Overall Study|Early termination of trial|12|||
33344955|NCT00481065|101152031|FG000|Overall Study|Unable to classify|0|||
33344956|NCT00481065|101152032|FG001|Overall Study|Unable to classify|1|||
33344957|NCT00481065|101152033|FG002|Overall Study|Unable to classify|2|||
33344958|NCT00481065|101152034|FG003|Overall Study|Unable to classify|0|||
33344959|NCT00481065|101152035|FG004|Overall Study|Unable to classify|1|||
33344960|NCT00481065|101152036|FG005|Overall Study|Unable to classify|0|||
33344961|NCT00481065|101152037|FG006|Overall Study|Unable to classify|0|||
33344962|NCT00481065|101152038|FG007|Overall Study|Unable to classify|0|||
33344963|NCT00598975|101152039|FG000|Overall Study|Adverse Event|1|||
33344964|NCT00598975|101152040|FG001|Overall Study|Adverse Event|1|||
33344965|NCT00598975|101152039|FG000|Overall Study|Brain metastases|1|||
33344966|NCT00598975|101152040|FG001|Overall Study|Brain metastases|0|||
33344967|NCT00598975|101152039|FG000|Overall Study|Withdrawal by Subject|1|||
33344968|NCT00598975|101152040|FG001|Overall Study|Withdrawal by Subject|1|||
33344969|NCT00598975|101152039|FG000|Overall Study|Withdrawal of consent|0|||
33344970|NCT00598975|101152040|FG001|Overall Study|Withdrawal of consent|1|||
33344971|NCT00598975|101152039|FG000|Overall Study|Disease progression|8|||
33344972|NCT00598975|101152040|FG001|Overall Study|Disease progression|3|||
33344973|NCT00598975|101152039|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
33344974|NCT00598975|101152040|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
33344975|NCT02817087|101152041|FG000|Overall Study|Withdrawal by Subject|2|||
33344976|NCT02817087|101152042|FG001|Overall Study|Withdrawal by Subject|0|||
33344977|NCT00860158|101152043|FG000|Overall Study|Study Terminated|1|||
33344978|NCT01178138|101152045|FG000|Overall Study|Lost to Follow-up|8|||
33344979|NCT01178138|101152045|FG000|Overall Study|Withdrawal by Subject|7|||
33344980|NCT01178138|101152045|FG000|Overall Study|Physician Decision|8|||
33344981|NCT01194440|101152046|FG000|Baseline (First Dose)|Reason not specified|4|||
33344982|NCT01194440|101152046|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
33344983|NCT01194440|101152046|FG000|Baseline (First Dose)|Change in therapy|1|||
33344984|NCT01194440|101152046|FG000|Baseline (First Dose)|Adverse Event|1|||
33344985|NCT01194440|101152046|FG000|6-months (2nd Dose)|Change in therapy|4|||
33344986|NCT00441545|101152061|FG000|First Intervention|Adverse Event|6|||
33344987|NCT00441545|101152062|FG001|First Intervention|Adverse Event|5|||
33344988|NCT00441545|101152061|FG000|First Intervention|Protocol Violation|2|||
33344989|NCT00441545|101152062|FG001|First Intervention|Protocol Violation|2|||
33344990|NCT00441545|101152061|FG000|First Intervention|Withdrawal by Subject|3|||
33407189|NCT00772031|101380568|FG001|Overall Study|Early termination of trial|10|||
33407190|NCT00772031|101380567|FG000|Overall Study|Lost to Follow-up|20|||
33541783|NCT03257267|101885256|FG001|Overall Study|Disease Progression|121|||
33541784|NCT03257267|101885255|FG000|Overall Study|Withdrawal by Subject|8|||
33541785|NCT03257267|101885256|FG001|Overall Study|Withdrawal by Subject|26|||
33541786|NCT03257267|101885255|FG000|Overall Study|Other|0|||
33541787|NCT03257267|101885256|FG001|Overall Study|Other|2|||
33541788|NCT02160626|101885261|FG000|Overall Study|Adverse Event|1|||
33541789|NCT02160626|101885262|FG001|Overall Study|Adverse Event|0|||
33541790|NCT02160626|101885263|FG002|Overall Study|Adverse Event|0|||
33541791|NCT02160626|101885261|FG000|Overall Study|Schedule not conducive to study visits|0|||
33541792|NCT02160626|101885262|FG001|Overall Study|Schedule not conducive to study visits|0|||
33541793|NCT02160626|101885263|FG002|Overall Study|Schedule not conducive to study visits|1|||
33541794|NCT02160626|101885261|FG000|Overall Study|Withdrawal by Subject|0|||
33541795|NCT02160626|101885262|FG001|Overall Study|Withdrawal by Subject|1|||
33541796|NCT02160626|101885263|FG002|Overall Study|Withdrawal by Subject|0|||
33541797|NCT02765165|101885264|FG000|Treatment Period|Progressive disease|3|||
33541798|NCT02765165|101885265|FG001|Treatment Period|Progressive disease|2|||
33541799|NCT02765165|101885266|FG002|Treatment Period|Progressive disease|3|||
33541800|NCT02765165|101885267|FG003|Treatment Period|Progressive disease|3|||
33541801|NCT02765165|101885268|FG004|Treatment Period|Progressive disease|4|||
33541802|NCT02765165|101885269|FG005|Treatment Period|Progressive disease|2|||
33541803|NCT02765165|101885270|FG006|Treatment Period|Progressive disease|2|||
33541804|NCT02765165|101885264|FG000|Treatment Period|Physician Decision|0|||
33541805|NCT02765165|101885265|FG001|Treatment Period|Physician Decision|1|||
33541806|NCT02765165|101885266|FG002|Treatment Period|Physician Decision|0|||
33541807|NCT02765165|101885267|FG003|Treatment Period|Physician Decision|0|||
33541808|NCT02765165|101885268|FG004|Treatment Period|Physician Decision|0|||
33541809|NCT02765165|101885269|FG005|Treatment Period|Physician Decision|0|||
33541810|NCT02765165|101885270|FG006|Treatment Period|Physician Decision|0|||
33541811|NCT02765165|101885264|FG000|Treatment Period|Adverse Event|0|||
33541812|NCT02765165|101885265|FG001|Treatment Period|Adverse Event|1|||
33541813|NCT02765165|101885266|FG002|Treatment Period|Adverse Event|0|||
33541814|NCT02765165|101885267|FG003|Treatment Period|Adverse Event|0|||
33541815|NCT02765165|101885268|FG004|Treatment Period|Adverse Event|0|||
33541816|NCT02765165|101885269|FG005|Treatment Period|Adverse Event|0|||
33541817|NCT02765165|101885270|FG006|Treatment Period|Adverse Event|0|||
33541818|NCT02765165|101885264|FG000|Treatment Period|Withdrawal by Subject|0|||
33541819|NCT02765165|101885265|FG001|Treatment Period|Withdrawal by Subject|0|||
33541820|NCT02765165|101885266|FG002|Treatment Period|Withdrawal by Subject|0|||
33541821|NCT02765165|101885267|FG003|Treatment Period|Withdrawal by Subject|0|||
33541822|NCT02765165|101885268|FG004|Treatment Period|Withdrawal by Subject|2|||
33407191|NCT00772031|101380568|FG001|Overall Study|Lost to Follow-up|33|||
33407192|NCT02304484|101380569|FG000|Overall Study|Death|9|||
33407193|NCT02304484|101380569|FG000|Overall Study|Withdrawal by Subject|14|||
33344991|NCT00441545|101152062|FG001|First Intervention|Withdrawal by Subject|3|||
33344992|NCT00441545|101152061|FG000|First Intervention|Kidney transplant|1|||
33344993|NCT00441545|101152062|FG001|First Intervention|Kidney transplant|1|||
33344994|NCT00441545|101152061|FG000|First Intervention|Lack of Efficacy|2|||
33344995|NCT00441545|101152062|FG001|First Intervention|Lack of Efficacy|0|||
33344996|NCT00441545|101152061|FG000|First Intervention|Subject exceeded safety criteria|0|||
33344997|NCT00441545|101152062|FG001|First Intervention|Subject exceeded safety criteria|1|||
33344998|NCT00441545|101152061|FG000|First Intervention|Subject met an exclusionary criteria|1|||
33407194|NCT02304484|101380569|FG000|Overall Study|Lost to Follow-up|2|||
33407195|NCT00438815|101380570|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
33407196|NCT00438815|101380570|FG000|Overall Study|3-month follow-up no longer required|12|||
33407197|NCT00438815|101380570|FG000|Overall Study|Noncompliance with protocol requirements|9|||
33407198|NCT00438815|101380570|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
33407199|NCT00438815|101380570|FG000|Overall Study|Lost to Follow-up|6|||
33407200|NCT00438815|101380570|FG000|Overall Study|Withdrawal by Subject|6|||
33407201|NCT00438815|101380570|FG000|Overall Study|Death|1|||
33407202|NCT03099096|101380572|FG000|Overall Study|Adverse Event|1|||
33407203|NCT03099096|101380572|FG000|Overall Study|Physician Decision|1|||
33407204|NCT01101321|101380573|FG000|Period 1|Withdrawal by Subject|1|||
33407205|NCT01101321|101380574|FG001|Period 1|Withdrawal by Subject|1|||
33407206|NCT01101321|101380573|FG000|Period 1|Adverse Event|3|||
33541823|NCT02765165|101885269|FG005|Treatment Period|Withdrawal by Subject|0|||
33541824|NCT02765165|101885270|FG006|Treatment Period|Withdrawal by Subject|0|||
33541825|NCT02765165|101885264|FG000|Treatment Period|Study terminated|0|||
33344999|NCT00441545|101152062|FG001|First Intervention|Subject met an exclusionary criteria|0|||
33345000|NCT00441545|101152061|FG000|First Intervention|Extended hospitalization|1|||
33345001|NCT00441545|101152062|FG001|First Intervention|Extended hospitalization|0|||
33345002|NCT00441545|101152061|FG000|First Intervention|Site error|1|||
33345003|NCT00441545|101152062|FG001|First Intervention|Site error|0|||
33345004|NCT00441545|101152061|FG000|First Intervention|Sponsor's request|1|||
33345005|NCT00441545|101152062|FG001|First Intervention|Sponsor's request|0|||
33345006|NCT00441545|101152061|FG000|Second Intervention|Adverse Event|5|||
33345007|NCT00441545|101152062|FG001|Second Intervention|Adverse Event|2|||
33345008|NCT00441545|101152061|FG000|Second Intervention|Protocol Violation|4|||
33345009|NCT00441545|101152062|FG001|Second Intervention|Protocol Violation|1|||
33345010|NCT00441545|101152061|FG000|Second Intervention|Withdrawal by Subject|1|||
33345011|NCT00441545|101152062|FG001|Second Intervention|Withdrawal by Subject|1|||
33345012|NCT00441545|101152061|FG000|Second Intervention|Kidney Transplant|1|||
33345013|NCT00441545|101152062|FG001|Second Intervention|Kidney Transplant|1|||
33345014|NCT00441545|101152061|FG000|Second Intervention|Lack of Efficacy|0|||
33345015|NCT00441545|101152062|FG001|Second Intervention|Lack of Efficacy|1|||
33345016|NCT00441545|101152061|FG000|Second Intervention|Subject exceeded safety criteria|1|||
33345017|NCT00441545|101152062|FG001|Second Intervention|Subject exceeded safety criteria|0|||
33345018|NCT00441545|101152061|FG000|Second Intervention|Subject moved|0|||
33345019|NCT00441545|101152062|FG001|Second Intervention|Subject moved|1|||
33345020|NCT01461044|101152064|FG000|Overall Study|Death|58|||
33345021|NCT01461044|101152065|FG001|Overall Study|Death|35|||
33345022|NCT01461044|101152064|FG000|Overall Study|Lost to Follow-up|12|||
33345023|NCT01461044|101152065|FG001|Overall Study|Lost to Follow-up|5|||
33345024|NCT00122135|101152066|FG000|Overall Study|Withdrawal by Subject|3|||
33345025|NCT00122135|101152067|FG001|Overall Study|Withdrawal by Subject|0|||
33345026|NCT01957137|101152068|FG000|Randomized Portion|Adverse Event|1|||
33345027|NCT01957137|101152068|FG000|Randomized Portion|Withdrawal by Subject|1|||
33345028|NCT01001702|101152069|FG000|Overall Study|Lost to Follow-up|7|||
33345029|NCT01001702|101152069|FG000|Overall Study|Adverse Event|7|||
33407207|NCT01101321|101380574|FG001|Period 1|Adverse Event|3|||
33407208|NCT01430559|101380575|FG000|Overall Study|Adverse Event|7|||
33407209|NCT01430559|101380576|FG001|Overall Study|Adverse Event|3|||
33407210|NCT01430559|101380575|FG000|Overall Study|Entry criteria not met|1|||
33407211|NCT01430559|101380576|FG001|Overall Study|Entry criteria not met|1|||
33407212|NCT01430559|101380575|FG000|Overall Study|Lost to Follow-up|1|||
33541826|NCT02765165|101885265|FG001|Treatment Period|Study terminated|0|||
33541827|NCT02765165|101885266|FG002|Treatment Period|Study terminated|0|||
33345030|NCT01001702|101152069|FG000|Overall Study|Sponsor Discontinued Study|4|||
33345031|NCT01001702|101152069|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
33345032|NCT01001702|101152069|FG000|Overall Study|Investigator withdrew Subject|10|||
33345033|NCT01001702|101152069|FG000|Overall Study|Withdrawal by Subject|19|||
33345034|NCT01001702|101152069|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
33345035|NCT03336502|101152070|FG000|Overall Study|Physician Decision|0|||
33407213|NCT01430559|101380576|FG001|Overall Study|Lost to Follow-up|0|||
33407214|NCT01430559|101380575|FG000|Overall Study|Medication error|1|||
33407215|NCT01430559|101380576|FG001|Overall Study|Medication error|0|||
33407216|NCT01430559|101380575|FG000|Overall Study|Withdrawal by Subject|3|||
33407217|NCT01430559|101380576|FG001|Overall Study|Withdrawal by Subject|2|||
33407218|NCT01430559|101380575|FG000|Overall Study|Protocol Violation|1|||
33407219|NCT01430559|101380576|FG001|Overall Study|Protocol Violation|0|||
33407220|NCT01430559|101380575|FG000|Overall Study|Other|3|||
33407221|NCT01430559|101380576|FG001|Overall Study|Other|3|||
33407222|NCT01430559|101380575|FG000|Overall Study|Randomized, Not Treated|3|||
33407223|NCT01430559|101380576|FG001|Overall Study|Randomized, Not Treated|3|||
33407224|NCT00561912|101380577|FG000|Overall Study|ineligible|1|||
33407225|NCT01710709|101380578|FG000|Overall Study|Lost to Follow-up|29|||
33407226|NCT01710709|101380578|FG000|Overall Study|Adverse Event|48|||
33407227|NCT01710709|101380578|FG000|Overall Study|Participant met withdrawal criteria|33|||
33407228|NCT01710709|101380578|FG000|Overall Study|Participant withdrawn by investigator|2|||
33407229|NCT01710709|101380578|FG000|Overall Study|Withdrawal by Subject|53|||
33407230|NCT01710709|101380578|FG000|Overall Study|Protocol Violation|5|||
33407231|NCT01710709|101380578|FG000|Overall Study|Lack of Efficacy|3|||
33407232|NCT03795233|101380579|FG000|Overall Study|Withdrawal by Subject|2|||
33407233|NCT03795233|101380580|FG001|Overall Study|Withdrawal by Subject|1|||
33407234|NCT03795233|101380579|FG000|Overall Study|Lost to Follow-up|1|||
33407235|NCT03795233|101380580|FG001|Overall Study|Lost to Follow-up|0|||
33407236|NCT03795233|101380579|FG000|Overall Study|Death|1|||
33407237|NCT03795233|101380580|FG001|Overall Study|Death|0|||
33407238|NCT01503229|101380584|FG000|Overall Study|Withdrew consent|1|||
33407239|NCT03814499|101380585|FG000|Overall Study|Lost to Follow-up|3|||
33407240|NCT02539160|101380592|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
33615723|NCT02728089|102144176|FG000|Overall Study|Withdrawal by Subject|1|||
33615724|NCT03671304|102144177|FG000|Overall Study|study terminated|7|||
33615725|NCT01427933|102144182|FG000|Overall Study|Withdrawal by Subject|5|||
33615726|NCT01427933|102144183|FG001|Overall Study|Withdrawal by Subject|8|||
33615727|NCT01427933|102144182|FG000|Overall Study|Lost to Follow-up|1|||
33615728|NCT01427933|102144183|FG001|Overall Study|Lost to Follow-up|5|||
33407241|NCT02539160|101380593|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
33407242|NCT02539160|101380594|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
33615729|NCT01427933|102144182|FG000|Overall Study|Other|1|||
33615730|NCT01427933|102144183|FG001|Overall Study|Other|0|||
33407243|NCT02539160|101380595|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
33407244|NCT02539160|101380592|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
33615731|NCT01427933|102144182|FG000|Overall Study|Investigator's Decision|1|||
33407245|NCT02539160|101380593|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
33407246|NCT02539160|101380594|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
33407247|NCT02539160|101380595|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
33615732|NCT01427933|102144183|FG001|Overall Study|Investigator's Decision|0|||
33407248|NCT02539160|101380592|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
33615733|NCT02391363|102144184|FG000|Overall Study|Lost to Follow-up|5|||
33615734|NCT02391363|102144185|FG001|Overall Study|Lost to Follow-up|5|||
33615735|NCT02391363|102144184|FG000|Overall Study|Withdrawal by Subject|6|||
33615736|NCT02391363|102144185|FG001|Overall Study|Withdrawal by Subject|3|||
33615737|NCT01487265|102144187|FG000|Overall Study|Adverse Event|8|||
33615738|NCT01487265|102144187|FG000|Overall Study|Withdrawal by Subject|5|||
33615739|NCT01487265|102144187|FG000|Overall Study|Disease Progression|21|||
33615740|NCT01487265|102144187|FG000|Overall Study|Death|2|||
33615741|NCT01487265|102144187|FG000|Overall Study|Still on Treatment|1|||
33615742|NCT01504412|102144188|FG000|Overall Study|Adverse Event|1|||
33615743|NCT01504412|102144189|FG001|Overall Study|Adverse Event|8|||
33615744|NCT01504412|102144190|FG002|Overall Study|Adverse Event|1|||
33615745|NCT01504412|102144191|FG003|Overall Study|Adverse Event|7|||
33615746|NCT01504412|102144192|FG004|Overall Study|Adverse Event|10|||
33345036|NCT03336502|101152071|FG001|Overall Study|Physician Decision|1|||
33345037|NCT03336502|101152070|FG000|Overall Study|Prohibited Drugs|1|||
33541828|NCT02765165|101885267|FG003|Treatment Period|Study terminated|0|||
33345038|NCT03336502|101152071|FG001|Overall Study|Prohibited Drugs|1|||
33345039|NCT03336502|101152070|FG000|Overall Study|Death|1|||
33345040|NCT03336502|101152071|FG001|Overall Study|Death|2|||
33345041|NCT03336502|101152070|FG000|Overall Study|Adverse Event|2|||
33345042|NCT03336502|101152071|FG001|Overall Study|Adverse Event|5|||
33345043|NCT01046695|101152072|FG000|Overall Study|Subject had a pacemaker|0|||
33345044|NCT01046695|101152073|FG001|Overall Study|Subject had a pacemaker|1|||
33345045|NCT01046695|101152072|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
33345046|NCT01046695|101152073|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
33345047|NCT02654002|101152074|FG000|Overall Study|Adverse Event|0|||
33345048|NCT02654002|101152075|FG001|Overall Study|Adverse Event|0|||
33541829|NCT02765165|101885268|FG004|Treatment Period|Study terminated|0|||
33541830|NCT02765165|101885269|FG005|Treatment Period|Study terminated|1|||
33541831|NCT02765165|101885270|FG006|Treatment Period|Study terminated|2|||
33541832|NCT02765165|101885264|FG000|Post-treatment Follow-up|Death|1|||
33345049|NCT02654002|101152076|FG002|Overall Study|Adverse Event|0|||
33345050|NCT02654002|101152077|FG003|Overall Study|Adverse Event|0|||
33345051|NCT02654002|101152078|FG004|Overall Study|Adverse Event|0|||
33345052|NCT02654002|101152079|FG005|Overall Study|Adverse Event|0|||
33345053|NCT02654002|101152080|FG006|Overall Study|Adverse Event|1|||
33541833|NCT02765165|101885265|FG001|Post-treatment Follow-up|Death|2|||
33541834|NCT02765165|101885266|FG002|Post-treatment Follow-up|Death|1|||
33541835|NCT02765165|101885267|FG003|Post-treatment Follow-up|Death|1|||
33541836|NCT02765165|101885268|FG004|Post-treatment Follow-up|Death|1|||
33541837|NCT02765165|101885269|FG005|Post-treatment Follow-up|Death|1|||
33541838|NCT02765165|101885270|FG006|Post-treatment Follow-up|Death|0|||
33615747|NCT01504412|102144188|FG000|Overall Study|Withdrawal by Subject|2|||
33615748|NCT01504412|102144189|FG001|Overall Study|Withdrawal by Subject|1|||
33615749|NCT01504412|102144190|FG002|Overall Study|Withdrawal by Subject|1|||
33615750|NCT01504412|102144191|FG003|Overall Study|Withdrawal by Subject|5|||
33541839|NCT02765165|101885264|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
33541840|NCT02765165|101885265|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
33345054|NCT02654002|101152081|FG007|Overall Study|Adverse Event|0|||
33345055|NCT02654002|101152082|FG008|Overall Study|Adverse Event|0|||
33345056|NCT02654002|101152074|FG000|Overall Study|Withdrew Consent|0|||
33345057|NCT02654002|101152075|FG001|Overall Study|Withdrew Consent|0|||
33345058|NCT02654002|101152076|FG002|Overall Study|Withdrew Consent|0|||
33541841|NCT02765165|101885266|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
33345059|NCT02654002|101152077|FG003|Overall Study|Withdrew Consent|0|||
33615751|NCT01504412|102144192|FG004|Overall Study|Withdrawal by Subject|1|||
33615752|NCT01504412|102144188|FG000|Overall Study|Other|2|||
33615753|NCT01504412|102144189|FG001|Overall Study|Other|1|||
33345060|NCT02654002|101152078|FG004|Overall Study|Withdrew Consent|0|||
33345061|NCT02654002|101152079|FG005|Overall Study|Withdrew Consent|1|||
33345062|NCT02654002|101152080|FG006|Overall Study|Withdrew Consent|0|||
33345063|NCT02654002|101152081|FG007|Overall Study|Withdrew Consent|1|||
33345064|NCT02654002|101152082|FG008|Overall Study|Withdrew Consent|0|||
33345065|NCT00560755|101152085|FG000|Overall Study|Protocol Violation|15|||
33345066|NCT00560755|101152085|FG000|Overall Study|Withdrawal by Subject|26|||
33345067|NCT00560755|101152085|FG000|Overall Study|Lost to Follow-up|9|||
33345068|NCT00560755|101152085|FG000|Overall Study|Adverse Event|8|||
33345069|NCT00560755|101152085|FG000|Overall Study|Physician Decision|2|||
33345070|NCT02183519|101152086|FG000|Overall Study|computer error|3|||
33345071|NCT02183519|101152087|FG001|Overall Study|computer error|0|||
33345072|NCT02183519|101152086|FG000|Overall Study|Did not respond to cough inducter|0|||
33345073|NCT02183519|101152087|FG001|Overall Study|Did not respond to cough inducter|3|||
33345074|NCT00805740|101152089|FG000|Overall Study|Death|7|||
33345075|NCT00805740|101152090|FG001|Overall Study|Death|4|||
33345076|NCT00805740|101152089|FG000|Overall Study|Withdrawal by Subject|1|||
33407249|NCT02539160|101380593|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
33407250|NCT02539160|101380594|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
33407251|NCT02539160|101380595|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
33541842|NCT02765165|101885267|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
33541843|NCT02765165|101885268|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
33541844|NCT02765165|101885269|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
33541845|NCT02765165|101885270|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
33541846|NCT02765165|101885264|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
33541847|NCT02765165|101885265|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
33541848|NCT02765165|101885266|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
33541849|NCT02765165|101885267|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
33615754|NCT01504412|102144190|FG002|Overall Study|Other|1|||
33615755|NCT01504412|102144191|FG003|Overall Study|Other|6|||
33615756|NCT01504412|102144192|FG004|Overall Study|Other|1|||
33615757|NCT01504412|102144188|FG000|Overall Study|Lost to Follow-up|0|||
33615758|NCT01504412|102144189|FG001|Overall Study|Lost to Follow-up|2|||
33615759|NCT01504412|102144190|FG002|Overall Study|Lost to Follow-up|0|||
33615760|NCT01504412|102144191|FG003|Overall Study|Lost to Follow-up|0|||
33615761|NCT01504412|102144192|FG004|Overall Study|Lost to Follow-up|0|||
33615762|NCT01504412|102144188|FG000|Overall Study|Lack of Efficacy|0|||
33615763|NCT01504412|102144189|FG001|Overall Study|Lack of Efficacy|0|||
33615764|NCT01504412|102144190|FG002|Overall Study|Lack of Efficacy|1|||
33615765|NCT01504412|102144191|FG003|Overall Study|Lack of Efficacy|0|||
33345077|NCT00805740|101152090|FG001|Overall Study|Withdrawal by Subject|0|||
33345078|NCT00805740|101152089|FG000|Overall Study|Lost to Follow-up|1|||
33345079|NCT00805740|101152090|FG001|Overall Study|Lost to Follow-up|0|||
33345080|NCT00805740|101152089|FG000|Overall Study|Randomized, but not treated|2|||
33407252|NCT03418727|101380602|FG000|Overall Study|Adverse Event|1|||
33407253|NCT03418727|101380603|FG001|Overall Study|Adverse Event|2|||
33407254|NCT03418727|101380604|FG002|Overall Study|Adverse Event|0|||
33407255|NCT03418727|101380602|FG000|Overall Study|Withdrawal by Subject|0|||
33407256|NCT03418727|101380603|FG001|Overall Study|Withdrawal by Subject|0|||
33407257|NCT03418727|101380604|FG002|Overall Study|Withdrawal by Subject|2|||
33407258|NCT03258710|101380609|FG000|Overall Study|Adverse Event|1|||
33407259|NCT03258710|101380609|FG000|Overall Study|Protocol-defined stopping criteria|1|||
33407260|NCT03258710|101380609|FG000|Overall Study|Physician Decision|1|||
33541850|NCT02765165|101885268|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
33541851|NCT02765165|101885269|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
33541852|NCT02765165|101885270|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
33615766|NCT01504412|102144192|FG004|Overall Study|Lack of Efficacy|1|||
33615767|NCT01504412|102144188|FG000|Overall Study|Death|0|||
33615768|NCT01504412|102144189|FG001|Overall Study|Death|0|||
33615769|NCT01504412|102144190|FG002|Overall Study|Death|0|||
33345081|NCT00805740|101152090|FG001|Overall Study|Randomized, but not treated|0|||
33345082|NCT00440726|101152091|FG000|Phase 1|Dose-Limiting Toxicity|0|||
33345083|NCT00440726|101152092|FG001|Phase 1|Dose-Limiting Toxicity|1|||
33345084|NCT00440726|101152093|FG002|Phase 1|Dose-Limiting Toxicity|0|||
33407261|NCT01398176|101380620|FG000|Overall Study|Lost to Follow-up|1|||
33407262|NCT01398176|101380621|FG001|Overall Study|Lost to Follow-up|3|||
33407263|NCT01398176|101380620|FG000|Overall Study|Physician Decision|2|||
33407264|NCT01398176|101380621|FG001|Overall Study|Physician Decision|3|||
33541853|NCT02765165|101885264|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
33345085|NCT00440726|101152091|FG000|Phase 1|Physician Decision|1|||
33345086|NCT00440726|101152092|FG001|Phase 1|Physician Decision|0|||
33407265|NCT01190839|101380622|FG000|Overall Study|Adverse Event|32|||
33615770|NCT01504412|102144191|FG003|Overall Study|Death|1|||
33615771|NCT01504412|102144192|FG004|Overall Study|Death|0|||
33615772|NCT01063153|102144195|FG000|Overall Study|Found Ineligible During Screening|2|||
33407266|NCT01190839|101380623|FG001|Overall Study|Adverse Event|41|||
33407267|NCT01190839|101380622|FG000|Overall Study|Protocol Violation|2|||
33407268|NCT01190839|101380623|FG001|Overall Study|Protocol Violation|2|||
33407269|NCT01190839|101380622|FG000|Overall Study|Lost to Follow-up|7|||
33407270|NCT01190839|101380623|FG001|Overall Study|Lost to Follow-up|1|||
33407271|NCT01190839|101380622|FG000|Overall Study|Death|1|||
33407272|NCT01190839|101380623|FG001|Overall Study|Death|0|||
33407273|NCT01190839|101380622|FG000|Overall Study|Trial stopped by Sponsor|71|||
33407274|NCT01190839|101380623|FG001|Overall Study|Trial stopped by Sponsor|68|||
33407275|NCT01190839|101380622|FG000|Overall Study|Undefined|35|||
33407276|NCT01190839|101380623|FG001|Overall Study|Undefined|31|||
33407277|NCT01190839|101380622|FG000|Overall Study|Randomized but not treated|2|||
33407278|NCT01190839|101380623|FG001|Overall Study|Randomized but not treated|4|||
33407279|NCT03031327|101380624|FG000|Overall Study|Withdrawal by Subject|0|||
33407280|NCT03031327|101380625|FG001|Overall Study|Withdrawal by Subject|1|||
33407281|NCT03031327|101380626|FG002|Overall Study|Withdrawal by Subject|1|||
33407282|NCT04594213|101380627|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
33407283|NCT04594213|101380628|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
33407284|NCT04594213|101380629|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
33407285|NCT04594213|101380630|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
33407286|NCT04594213|101380631|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
33407287|NCT04594213|101380632|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
33615773|NCT01063153|102144196|FG001|Overall Study|Found Ineligible During Screening|0|||
33211962|NCT02349295|100676552|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33407288|NCT04594213|101380627|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
33407289|NCT04594213|101380628|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
33407290|NCT04594213|101380629|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
33407291|NCT04594213|101380630|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
33615774|NCT01063153|102144195|FG000|Overall Study|Lost to Follow-up|0|||
33541854|NCT02765165|101885265|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
33541855|NCT02765165|101885266|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
33541856|NCT02765165|101885267|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
33541857|NCT02765165|101885268|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
33541858|NCT02765165|101885269|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
33541859|NCT02765165|101885270|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
33541860|NCT02765165|101885264|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
33541861|NCT02765165|101885265|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
33541862|NCT02765165|101885266|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
33541863|NCT02765165|101885267|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
33541864|NCT02765165|101885268|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
33541865|NCT02765165|101885269|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
33541866|NCT02765165|101885270|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
33541867|NCT02765165|101885264|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
33541868|NCT02765165|101885265|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
33541869|NCT02765165|101885266|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
33541870|NCT02765165|101885267|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
33541871|NCT02765165|101885268|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
33541872|NCT02765165|101885269|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
33541873|NCT02765165|101885270|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
33541874|NCT00486044|101885273|FG000|Overall Study|Withdrawal by Subject|2|||
33541875|NCT00486044|101885274|FG001|Overall Study|Withdrawal by Subject|1|||
33541876|NCT00486044|101885273|FG000|Overall Study|Adverse Event|0|||
33541877|NCT00486044|101885274|FG001|Overall Study|Adverse Event|1|||
33541878|NCT00486044|101885273|FG000|Overall Study|Lost to Follow-up|0|||
33541879|NCT00486044|101885274|FG001|Overall Study|Lost to Follow-up|1|||
33541880|NCT02382939|101885275|FG000|Overall Study|Adverse Event|1|||
33541881|NCT02382939|101885276|FG001|Overall Study|Adverse Event|1|||
33541882|NCT02382939|101885275|FG000|Overall Study|Withdrawal by Subject|2|||
33541883|NCT02382939|101885276|FG001|Overall Study|Withdrawal by Subject|2|||
33541884|NCT01147822|101885277|FG000|Overall Study|Death|66|||
33541885|NCT01147822|101885278|FG001|Overall Study|Death|59|||
33541886|NCT01147822|101885277|FG000|Overall Study|Protocol Violation|0|||
33541887|NCT01147822|101885278|FG001|Overall Study|Protocol Violation|1|||
33541888|NCT01147822|101885277|FG000|Overall Study|Lost to Follow-up|3|||
33541889|NCT01147822|101885278|FG001|Overall Study|Lost to Follow-up|2|||
33541890|NCT01147822|101885277|FG000|Overall Study|Physician Decision|0|||
33541891|NCT01147822|101885278|FG001|Overall Study|Physician Decision|2|||
33541892|NCT01147822|101885277|FG000|Overall Study|Withdrawal by Subject|8|||
33541893|NCT01147822|101885278|FG001|Overall Study|Withdrawal by Subject|13|||
33541894|NCT01147822|101885277|FG000|Overall Study|Not Completed/Ongoing|111|||
33541895|NCT01147822|101885278|FG001|Overall Study|Not Completed/Ongoing|102|||
33541896|NCT00717886|101885279|FG000|Overall Study|Withdrawal by Subject|3|||
33541897|NCT00717886|101885279|FG000|Overall Study|Treatment Failure|1|||
33541898|NCT03334175|101885280|FG000|Overall Study|Lost to Follow-up|0|||
33541899|NCT03334175|101885281|FG001|Overall Study|Lost to Follow-up|1|||
33541900|NCT04239924|101885282|FG000|Overall Study|Lost to Follow-up|2|||
33541901|NCT02251275|101885285|FG000|Overall Study|Adverse Event|23|||
33541902|NCT02251275|101885286|FG001|Overall Study|Adverse Event|60|||
33541903|NCT02251275|101885287|FG002|Overall Study|Adverse Event|28|||
33541904|NCT02251275|101885288|FG003|Overall Study|Adverse Event|0|||
33541905|NCT02251275|101885289|FG004|Overall Study|Adverse Event|0|||
33541906|NCT02251275|101885285|FG000|Overall Study|Lost to Follow-up|5|||
33541907|NCT02251275|101885286|FG001|Overall Study|Lost to Follow-up|6|||
33541908|NCT02251275|101885287|FG002|Overall Study|Lost to Follow-up|4|||
33541909|NCT02251275|101885288|FG003|Overall Study|Lost to Follow-up|0|||
33345087|NCT00440726|101152093|FG002|Phase 1|Physician Decision|0|||
33345088|NCT00440726|101152091|FG000|Phase 2|Death|0|||
33345089|NCT00440726|101152092|FG001|Phase 2|Death|0|||
33345090|NCT00440726|101152093|FG002|Phase 2|Death|1|||
33345091|NCT00440726|101152091|FG000|Phase 2|Adverse Event|0|||
33345092|NCT00440726|101152092|FG001|Phase 2|Adverse Event|0|||
33345093|NCT00440726|101152093|FG002|Phase 2|Adverse Event|1|||
33345094|NCT04640766|101152103|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
33345095|NCT02320487|101152104|FG000|Overall Study|Reason not Specified|1|||
33345096|NCT02320487|101152104|FG000|Overall Study|Physician Decision|5|||
33541910|NCT02251275|101885289|FG004|Overall Study|Lost to Follow-up|0|||
33541911|NCT02251275|101885285|FG000|Overall Study|Physician Decision|19|||
33541912|NCT02251275|101885286|FG001|Overall Study|Physician Decision|30|||
33541913|NCT02251275|101885287|FG002|Overall Study|Physician Decision|26|||
33541914|NCT02251275|101885288|FG003|Overall Study|Physician Decision|0|||
33345097|NCT02320487|101152104|FG000|Overall Study|Withdrawal by Subject|1|||
33345098|NCT02320487|101152104|FG000|Overall Study|Death|3|||
33345099|NCT02320487|101152104|FG000|Overall Study|Adverse Event|11|||
33345100|NCT03555266|101152107|FG000|Overall Study|Protocol Violation|6|||
33345101|NCT03555266|101152108|FG001|Overall Study|Protocol Violation|4|||
33345102|NCT00666926|101152114|FG000|Overall Study|Adverse Event|0|||
33345103|NCT00666926|101152115|FG001|Overall Study|Adverse Event|0|||
33345104|NCT00666926|101152116|FG002|Overall Study|Adverse Event|0|||
33345105|NCT00666926|101152117|FG003|Overall Study|Adverse Event|0|||
33345106|NCT00666926|101152118|FG004|Overall Study|Adverse Event|0|||
33345107|NCT00666926|101152119|FG005|Overall Study|Adverse Event|0|||
33345108|NCT00666926|101152120|FG006|Overall Study|Adverse Event|0|||
33345109|NCT00666926|101152121|FG007|Overall Study|Adverse Event|0|||
33345110|NCT00666926|101152122|FG008|Overall Study|Adverse Event|0|||
33345111|NCT00666926|101152123|FG009|Overall Study|Adverse Event|2|||
33345112|NCT00666926|101152124|FG010|Overall Study|Adverse Event|2|||
33345113|NCT00666926|101152125|FG011|Overall Study|Adverse Event|2|||
33345114|NCT00666926|101152126|FG012|Overall Study|Adverse Event|0|||
33345115|NCT00666926|101152127|FG013|Overall Study|Adverse Event|1|||
33345116|NCT00666926|101152128|FG014|Overall Study|Adverse Event|0|||
33345117|NCT00666926|101152129|FG015|Overall Study|Adverse Event|0|||
33345118|NCT00666926|101152114|FG000|Overall Study|Laboratory abnormality|0|||
33345119|NCT00666926|101152115|FG001|Overall Study|Laboratory abnormality|0|||
33345120|NCT00666926|101152116|FG002|Overall Study|Laboratory abnormality|0|||
33345121|NCT00666926|101152117|FG003|Overall Study|Laboratory abnormality|0|||
33345122|NCT00666926|101152118|FG004|Overall Study|Laboratory abnormality|0|||
33345123|NCT00666926|101152119|FG005|Overall Study|Laboratory abnormality|0|||
33345124|NCT00666926|101152120|FG006|Overall Study|Laboratory abnormality|0|||
33345125|NCT00666926|101152121|FG007|Overall Study|Laboratory abnormality|0|||
33345126|NCT00666926|101152122|FG008|Overall Study|Laboratory abnormality|0|||
33345127|NCT00666926|101152123|FG009|Overall Study|Laboratory abnormality|0|||
33345128|NCT00666926|101152124|FG010|Overall Study|Laboratory abnormality|1|||
33345129|NCT00666926|101152125|FG011|Overall Study|Laboratory abnormality|0|||
33345130|NCT00666926|101152126|FG012|Overall Study|Laboratory abnormality|0|||
33345131|NCT00666926|101152127|FG013|Overall Study|Laboratory abnormality|0|||
33345132|NCT00666926|101152128|FG014|Overall Study|Laboratory abnormality|0|||
33345133|NCT00666926|101152129|FG015|Overall Study|Laboratory abnormality|1|||
33211963|NCT02349295|100676553|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33211964|NCT02349295|100676554|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
33211965|NCT02349295|100676541|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33211966|NCT02349295|100676542|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33211967|NCT02349295|100676543|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33211968|NCT02349295|100676544|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33211969|NCT02349295|100676545|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33211970|NCT02349295|100676546|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33211971|NCT02349295|100676547|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33211972|NCT02349295|100676548|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
33211973|NCT02349295|100676549|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
33211974|NCT02349295|100676550|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
33211975|NCT02349295|100676551|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
33211976|NCT02349295|100676552|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33211977|NCT02349295|100676553|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33211978|NCT02349295|100676554|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
33345134|NCT00666926|101152114|FG000|Overall Study|Lack of Efficacy|0|||
33345135|NCT00666926|101152115|FG001|Overall Study|Lack of Efficacy|0|||
33345136|NCT00666926|101152116|FG002|Overall Study|Lack of Efficacy|0|||
33345137|NCT00666926|101152117|FG003|Overall Study|Lack of Efficacy|0|||
33345138|NCT00666926|101152118|FG004|Overall Study|Lack of Efficacy|0|||
33345139|NCT00666926|101152119|FG005|Overall Study|Lack of Efficacy|1|||
33345140|NCT00666926|101152120|FG006|Overall Study|Lack of Efficacy|0|||
33345141|NCT00666926|101152121|FG007|Overall Study|Lack of Efficacy|0|||
33345142|NCT00666926|101152122|FG008|Overall Study|Lack of Efficacy|0|||
33345143|NCT00666926|101152123|FG009|Overall Study|Lack of Efficacy|0|||
33345144|NCT00666926|101152124|FG010|Overall Study|Lack of Efficacy|0|||
33345145|NCT00666926|101152125|FG011|Overall Study|Lack of Efficacy|1|||
33345146|NCT00666926|101152126|FG012|Overall Study|Lack of Efficacy|0|||
33345147|NCT00666926|101152127|FG013|Overall Study|Lack of Efficacy|0|||
33345148|NCT00666926|101152128|FG014|Overall Study|Lack of Efficacy|0|||
33345149|NCT00666926|101152129|FG015|Overall Study|Lack of Efficacy|0|||
33345150|NCT00666926|101152114|FG000|Overall Study|Lost to Follow-up|0|||
33345151|NCT00666926|101152115|FG001|Overall Study|Lost to Follow-up|0|||
33345152|NCT00666926|101152116|FG002|Overall Study|Lost to Follow-up|0|||
33345153|NCT00666926|101152117|FG003|Overall Study|Lost to Follow-up|1|||
33345154|NCT00666926|101152118|FG004|Overall Study|Lost to Follow-up|0|||
33345155|NCT00666926|101152119|FG005|Overall Study|Lost to Follow-up|0|||
33345156|NCT00666926|101152120|FG006|Overall Study|Lost to Follow-up|0|||
33345157|NCT00666926|101152121|FG007|Overall Study|Lost to Follow-up|0|||
33345158|NCT00666926|101152122|FG008|Overall Study|Lost to Follow-up|0|||
33345159|NCT00666926|101152123|FG009|Overall Study|Lost to Follow-up|0|||
33345160|NCT00666926|101152124|FG010|Overall Study|Lost to Follow-up|0|||
33345161|NCT00666926|101152125|FG011|Overall Study|Lost to Follow-up|0|||
33345162|NCT00666926|101152126|FG012|Overall Study|Lost to Follow-up|0|||
33345163|NCT00666926|101152127|FG013|Overall Study|Lost to Follow-up|0|||
33345164|NCT00666926|101152128|FG014|Overall Study|Lost to Follow-up|0|||
33345165|NCT00666926|101152129|FG015|Overall Study|Lost to Follow-up|0|||
33345166|NCT00666926|101152114|FG000|Overall Study|Other|2|||
33345167|NCT00666926|101152115|FG001|Overall Study|Other|4|||
33345168|NCT00666926|101152116|FG002|Overall Study|Other|3|||
33345169|NCT00666926|101152117|FG003|Overall Study|Other|3|||
33345170|NCT00666926|101152118|FG004|Overall Study|Other|3|||
33345171|NCT00666926|101152119|FG005|Overall Study|Other|3|||
33345172|NCT00666926|101152120|FG006|Overall Study|Other|4|||
33345173|NCT00666926|101152121|FG007|Overall Study|Other|0|||
33345174|NCT00666926|101152122|FG008|Overall Study|Other|3|||
33345175|NCT00666926|101152123|FG009|Overall Study|Other|5|||
33345176|NCT00666926|101152124|FG010|Overall Study|Other|3|||
33345177|NCT00666926|101152125|FG011|Overall Study|Other|26|||
33345178|NCT00666926|101152126|FG012|Overall Study|Other|3|||
33345179|NCT00666926|101152127|FG013|Overall Study|Other|2|||
33345180|NCT00666926|101152128|FG014|Overall Study|Other|4|||
33345181|NCT00666926|101152129|FG015|Overall Study|Other|4|||
33345182|NCT00666926|101152114|FG000|Overall Study|Withdrawal by Subject|0|||
33345183|NCT00666926|101152115|FG001|Overall Study|Withdrawal by Subject|0|||
33345184|NCT00666926|101152116|FG002|Overall Study|Withdrawal by Subject|0|||
33345185|NCT00666926|101152117|FG003|Overall Study|Withdrawal by Subject|0|||
33345186|NCT00666926|101152118|FG004|Overall Study|Withdrawal by Subject|0|||
33345187|NCT00666926|101152119|FG005|Overall Study|Withdrawal by Subject|0|||
33345188|NCT00666926|101152120|FG006|Overall Study|Withdrawal by Subject|0|||
33345189|NCT00666926|101152121|FG007|Overall Study|Withdrawal by Subject|1|||
33345190|NCT00666926|101152122|FG008|Overall Study|Withdrawal by Subject|0|||
33345191|NCT00666926|101152123|FG009|Overall Study|Withdrawal by Subject|3|||
33345192|NCT00666926|101152124|FG010|Overall Study|Withdrawal by Subject|0|||
33345193|NCT00666926|101152125|FG011|Overall Study|Withdrawal by Subject|3|||
33345194|NCT00666926|101152126|FG012|Overall Study|Withdrawal by Subject|0|||
33345195|NCT00666926|101152127|FG013|Overall Study|Withdrawal by Subject|1|||
33345196|NCT00666926|101152128|FG014|Overall Study|Withdrawal by Subject|3|||
33345197|NCT00666926|101152129|FG015|Overall Study|Withdrawal by Subject|3|||
33345198|NCT00666926|101152114|FG000|Overall Study|Death|0|||
33345199|NCT00666926|101152115|FG001|Overall Study|Death|0|||
33345200|NCT00666926|101152116|FG002|Overall Study|Death|0|||
33345201|NCT00666926|101152117|FG003|Overall Study|Death|0|||
33345202|NCT00666926|101152118|FG004|Overall Study|Death|0|||
33345203|NCT00666926|101152119|FG005|Overall Study|Death|0|||
33345204|NCT00666926|101152120|FG006|Overall Study|Death|0|||
33345205|NCT00666926|101152121|FG007|Overall Study|Death|0|||
33345206|NCT00666926|101152122|FG008|Overall Study|Death|0|||
33345207|NCT00666926|101152123|FG009|Overall Study|Death|0|||
33345208|NCT00666926|101152124|FG010|Overall Study|Death|0|||
33345209|NCT00666926|101152125|FG011|Overall Study|Death|1|||
33345210|NCT00666926|101152126|FG012|Overall Study|Death|0|||
33345211|NCT00666926|101152127|FG013|Overall Study|Death|0|||
33345212|NCT00666926|101152128|FG014|Overall Study|Death|0|||
33541915|NCT02251275|101885289|FG004|Overall Study|Physician Decision|1|||
33541916|NCT02251275|101885285|FG000|Overall Study|Protocol Deviation|0|||
33541917|NCT02251275|101885286|FG001|Overall Study|Protocol Deviation|0|||
33345213|NCT00666926|101152129|FG015|Overall Study|Death|0|||
33345214|NCT02883244|101152130|FG000|Overall Study|Lost to Follow-up|0|||
33345215|NCT02883244|101152131|FG001|Overall Study|Lost to Follow-up|1|||
33345216|NCT04082663|101152132|FG000|Overall Study|Adverse Event|6|||
33345217|NCT04082663|101152132|FG000|Overall Study|Lost to Follow-up|1|||
33541918|NCT02251275|101885287|FG002|Overall Study|Protocol Deviation|1|||
33345218|NCT00132730|101152133|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
33345219|NCT00132730|101152134|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
33345220|NCT00132730|101152135|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
33345221|NCT00132730|101152136|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
33345222|NCT00132730|101152137|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
33541919|NCT02251275|101885288|FG003|Overall Study|Protocol Deviation|0|||
33345223|NCT00132730|101152138|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
33345224|NCT00132730|101152133|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
33345225|NCT00132730|101152134|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
33345226|NCT00132730|101152135|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
33345227|NCT00132730|101152136|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
33345228|NCT00132730|101152137|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
33345229|NCT00132730|101152138|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
33345230|NCT00132730|101152133|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
33345231|NCT00132730|101152134|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
33345232|NCT00132730|101152135|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
33345233|NCT00132730|101152136|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
33345234|NCT00132730|101152137|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
33345235|NCT00132730|101152138|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
33345236|NCT00132730|101152133|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
33345237|NCT00132730|101152134|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
33345238|NCT00132730|101152135|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
33345239|NCT00132730|101152136|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
33345240|NCT00132730|101152137|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
33345241|NCT00132730|101152138|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
33345242|NCT00132730|101152133|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
33345243|NCT00132730|101152134|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
33345244|NCT00132730|101152135|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
33345245|NCT00132730|101152136|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
33345246|NCT00132730|101152137|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
33345247|NCT00132730|101152138|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
33345248|NCT00132730|101152133|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
33345249|NCT00132730|101152134|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
33345250|NCT00132730|101152135|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
33345251|NCT00132730|101152136|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
33345252|NCT00132730|101152137|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
33345253|NCT00132730|101152138|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
33345254|NCT00132730|101152133|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
33345255|NCT00132730|101152134|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
33345256|NCT00132730|101152135|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
33345257|NCT00132730|101152136|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
33345258|NCT00132730|101152137|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
33345259|NCT00132730|101152138|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
33345260|NCT00132730|101152133|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
33345261|NCT00132730|101152134|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
33345262|NCT00132730|101152135|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
33345263|NCT00132730|101152136|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
33345264|NCT00132730|101152137|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
33345265|NCT00132730|101152138|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
33407292|NCT04594213|101380631|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
33407293|NCT04594213|101380632|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
33407294|NCT04594213|101380627|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
33407295|NCT04594213|101380628|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
33407296|NCT04594213|101380629|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
33407297|NCT04594213|101380630|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
33345266|NCT00132730|101152133|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
33345267|NCT00132730|101152134|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
33345268|NCT00132730|101152135|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
33345269|NCT00132730|101152136|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
33345270|NCT00132730|101152137|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
33345271|NCT00132730|101152138|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
33345272|NCT00132730|101152133|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
33345273|NCT00132730|101152134|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
33345274|NCT00132730|101152135|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
33345275|NCT00132730|101152136|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
33345276|NCT00132730|101152137|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
33345277|NCT00132730|101152138|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
33345278|NCT00132730|101152133|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
33345279|NCT00132730|101152134|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
33345280|NCT00132730|101152135|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
33345281|NCT00132730|101152136|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
33345282|NCT00132730|101152137|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
33345283|NCT00132730|101152138|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
33345284|NCT00132730|101152133|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
33345285|NCT00132730|101152134|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
33345286|NCT00132730|101152135|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
33345287|NCT00132730|101152136|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
33345288|NCT00132730|101152137|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
33345289|NCT00132730|101152138|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
33345290|NCT03064490|101152141|FG000|Overall Study|Physician Decision|5|||
33345291|NCT01790048|101152144|FG000|Overall Study|Incorrect Age|9|||
33345292|NCT01790048|101152145|FG001|Overall Study|Incorrect Age|14|||
33345293|NCT01790048|101152144|FG000|Overall Study|data entry error|0|||
33345294|NCT01790048|101152145|FG001|Overall Study|data entry error|1|||
33345295|NCT01790048|101152144|FG000|Overall Study|Other|0|||
33345296|NCT01790048|101152145|FG001|Overall Study|Other|2|||
33345297|NCT01790048|101152144|FG000|Overall Study|SAM at Enrollment|2|||
33345298|NCT01790048|101152145|FG001|Overall Study|SAM at Enrollment|0|||
33407298|NCT04594213|101380631|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
33407299|NCT04594213|101380632|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
33211979|NCT02349295|100676541|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33211980|NCT02349295|100676542|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33211981|NCT02349295|100676543|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33211982|NCT02349295|100676544|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33211983|NCT02349295|100676545|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33211984|NCT02349295|100676546|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33211985|NCT02349295|100676547|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33407300|NCT04594213|101380627|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
33211986|NCT02349295|100676548|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
33211987|NCT02349295|100676549|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33211988|NCT02349295|100676550|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
33211989|NCT02349295|100676551|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33211990|NCT02349295|100676552|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33211991|NCT02349295|100676553|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33211992|NCT02349295|100676554|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
33211993|NCT02349295|100676541|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
33211994|NCT02349295|100676542|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
33211995|NCT02349295|100676543|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
33211996|NCT02349295|100676544|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
33211997|NCT02349295|100676545|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
33211998|NCT02349295|100676546|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
33211999|NCT02349295|100676547|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
33212000|NCT02349295|100676548|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
33212001|NCT02349295|100676549|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
33345299|NCT01790048|101152144|FG000|Overall Study|Measurement error|1|||
33345300|NCT01790048|101152145|FG001|Overall Study|Measurement error|0|||
33345301|NCT01931059|101152146|FG000|Day 1|Pregnancy|0|||
33345302|NCT01931059|101152147|FG001|Day 1|Pregnancy|1|||
33345303|NCT01931059|101152146|FG000|Day3|Lost to Follow-up|1|||
33345304|NCT01931059|101152147|FG001|Day3|Lost to Follow-up|0|||
33212002|NCT02349295|100676550|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
33212003|NCT02349295|100676551|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
33212004|NCT02349295|100676552|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
33212005|NCT02349295|100676553|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
33212006|NCT02349295|100676554|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
33212007|NCT02349295|100676541|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33212008|NCT02349295|100676542|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33212009|NCT02349295|100676543|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33212010|NCT02349295|100676544|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33212011|NCT02349295|100676545|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33212012|NCT02349295|100676546|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33212013|NCT02349295|100676547|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33212014|NCT02349295|100676548|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
33212015|NCT02349295|100676549|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
33212016|NCT02349295|100676550|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
33212017|NCT02349295|100676551|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
33212018|NCT02349295|100676552|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33212019|NCT02349295|100676553|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33212020|NCT02349295|100676554|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
33212021|NCT02349295|100676541|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33212022|NCT02349295|100676542|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33212023|NCT02349295|100676543|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33212024|NCT02349295|100676544|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33212025|NCT02349295|100676545|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33212026|NCT02349295|100676546|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33212027|NCT02349295|100676547|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33212028|NCT02349295|100676548|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
33212029|NCT02349295|100676549|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
33212030|NCT02349295|100676550|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33212031|NCT02349295|100676551|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33212032|NCT02349295|100676552|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33212033|NCT02349295|100676553|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33212034|NCT02349295|100676554|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
33212035|NCT02349295|100676541|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33212036|NCT02349295|100676542|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33212037|NCT02349295|100676543|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33212038|NCT02349295|100676544|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33212039|NCT02349295|100676545|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33212040|NCT02349295|100676546|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33212041|NCT02349295|100676547|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33212042|NCT02349295|100676548|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
33212043|NCT02349295|100676549|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
33212044|NCT02349295|100676550|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33212045|NCT02349295|100676551|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33212046|NCT02349295|100676552|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33212047|NCT02349295|100676553|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33212048|NCT02349295|100676554|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
33212049|NCT02349295|100676541|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33345305|NCT02624492|101152151|FG000|Overall Study|Adverse Event|2|||
33212050|NCT02349295|100676542|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33212051|NCT02349295|100676543|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33212052|NCT02349295|100676544|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33212053|NCT02349295|100676545|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33212054|NCT02349295|100676546|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33212055|NCT02349295|100676547|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33212056|NCT02349295|100676548|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33212057|NCT02349295|100676549|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33212058|NCT02349295|100676550|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33212059|NCT02349295|100676551|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
33212060|NCT02349295|100676552|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
33212061|NCT02349295|100676553|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
33212062|NCT02349295|100676554|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
33212063|NCT02349295|100676541|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33212064|NCT02349295|100676542|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33212065|NCT02349295|100676543|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33212066|NCT02349295|100676544|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33212067|NCT02349295|100676545|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33212068|NCT02349295|100676546|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33212069|NCT02349295|100676547|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33212070|NCT02349295|100676548|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33212071|NCT02349295|100676549|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33212072|NCT02349295|100676550|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33212073|NCT02349295|100676551|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33212074|NCT02349295|100676552|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
33212075|NCT02349295|100676553|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
33212076|NCT02349295|100676554|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
33212077|NCT02349295|100676541|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33212078|NCT02349295|100676542|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33212079|NCT02349295|100676543|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33212080|NCT02349295|100676544|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33212081|NCT02349295|100676545|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33212082|NCT02349295|100676546|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33212083|NCT02349295|100676547|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33212084|NCT02349295|100676548|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33212085|NCT02349295|100676549|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33212086|NCT02349295|100676550|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33212087|NCT02349295|100676551|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33212088|NCT02349295|100676552|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
33212089|NCT02349295|100676553|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
33212090|NCT02349295|100676554|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
33212091|NCT02349295|100676541|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33212092|NCT02349295|100676542|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33345306|NCT02624492|101152152|FG001|Overall Study|Adverse Event|2|||
33345307|NCT02624492|101152153|FG002|Overall Study|Adverse Event|2|||
33345308|NCT02624492|101152151|FG000|Overall Study|Progressive disease|0|||
33345309|NCT02624492|101152152|FG001|Overall Study|Progressive disease|2|||
33345310|NCT02624492|101152153|FG002|Overall Study|Progressive disease|3|||
33345311|NCT03905863|101152154|FG000|Overall Study|Adverse Event|2|||
33345312|NCT03905863|101152155|FG001|Overall Study|Adverse Event|4|||
33212093|NCT02349295|100676543|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33212094|NCT02349295|100676544|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33212095|NCT02349295|100676545|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33541920|NCT02251275|101885289|FG004|Overall Study|Protocol Deviation|0|||
33541921|NCT02251275|101885285|FG000|Overall Study|Withdrawal by Subject|25|||
33212096|NCT02349295|100676546|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33212097|NCT02349295|100676547|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33212098|NCT02349295|100676548|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33212099|NCT02349295|100676549|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33212100|NCT02349295|100676550|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33212101|NCT02349295|100676551|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33212102|NCT02349295|100676552|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
33345313|NCT03905863|101152154|FG000|Overall Study|Withdrawal by Subject|2|||
33345314|NCT03905863|101152155|FG001|Overall Study|Withdrawal by Subject|2|||
33345315|NCT03905863|101152154|FG000|Overall Study|Physician Decision|0|||
33345316|NCT03905863|101152155|FG001|Overall Study|Physician Decision|3|||
33345317|NCT03905863|101152154|FG000|Overall Study|Lost to Follow-up|1|||
33345318|NCT03905863|101152155|FG001|Overall Study|Lost to Follow-up|0|||
33345319|NCT03905863|101152154|FG000|Overall Study|Protocol Violation|0|||
33345320|NCT03905863|101152155|FG001|Overall Study|Protocol Violation|2|||
33345321|NCT03905863|101152154|FG000|Overall Study|Death|0|||
33345322|NCT03905863|101152155|FG001|Overall Study|Death|1|||
33345323|NCT01360645|101152156|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
33345324|NCT01360645|101152157|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
33345325|NCT01360645|101152158|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
33345326|NCT01360645|101152159|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
33345327|NCT01360645|101152156|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
33345328|NCT01360645|101152157|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
33345329|NCT01360645|101152158|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
33345330|NCT01360645|101152159|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
33345331|NCT01360645|101152156|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
33345332|NCT01360645|101152157|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
33345333|NCT01360645|101152158|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
33345334|NCT01360645|101152159|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
33345335|NCT01360645|101152156|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
33345336|NCT01360645|101152157|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
33345337|NCT01360645|101152158|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
33345338|NCT01360645|101152159|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
33345339|NCT01360645|101152156|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
33345340|NCT01360645|101152157|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
33345341|NCT01360645|101152158|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
33345342|NCT01360645|101152159|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
33345343|NCT01360645|101152156|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
33345344|NCT01360645|101152157|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
33345345|NCT01360645|101152158|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
33345346|NCT01360645|101152159|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
33345347|NCT01360645|101152156|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
33345348|NCT01360645|101152157|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
33345349|NCT01360645|101152158|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
33345350|NCT01360645|101152159|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
33345351|NCT01360645|101152156|FG000|Phase B (6 Weeks)|Adverse Event|0|||
33345352|NCT01360645|101152157|FG001|Phase B (6 Weeks)|Adverse Event|6|||
33345353|NCT01360645|101152158|FG002|Phase B (6 Weeks)|Adverse Event|0|||
33345354|NCT01360645|101152159|FG003|Phase B (6 Weeks)|Adverse Event|0|||
33345355|NCT01360645|101152156|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
33407301|NCT04594213|101380628|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
33345356|NCT01360645|101152157|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
33541922|NCT02251275|101885286|FG001|Overall Study|Withdrawal by Subject|51|||
33541923|NCT02251275|101885287|FG002|Overall Study|Withdrawal by Subject|35|||
33541924|NCT02251275|101885288|FG003|Overall Study|Withdrawal by Subject|1|||
33541925|NCT02251275|101885289|FG004|Overall Study|Withdrawal by Subject|0|||
33541926|NCT03722576|101885292|FG000|Overall Study|Withdrawal by Subject|3|||
33541927|NCT03722576|101885292|FG000|Overall Study|Adverse Event|2|||
33541928|NCT03722576|101885292|FG000|Overall Study|Physician Decision|1|||
33541929|NCT03722576|101885292|FG000|Overall Study|Lost to Follow-up|1|||
33541930|NCT02696616|101885298|FG000|Overall Study|Adverse Event|0|||
33541931|NCT02696616|101885299|FG001|Overall Study|Adverse Event|1|||
33541932|NCT02696616|101885300|FG002|Overall Study|Adverse Event|0|||
33541933|NCT02696616|101885301|FG003|Overall Study|Adverse Event|0|||
33541934|NCT02696616|101885302|FG004|Overall Study|Adverse Event|0|||
33541935|NCT02696616|101885303|FG005|Overall Study|Adverse Event|0|||
33541936|NCT02696616|101885304|FG006|Overall Study|Adverse Event|0|||
33541937|NCT00407511|101885307|FG000|Overall Study|Adverse Event|9|||
33541938|NCT00407511|101885307|FG000|Overall Study|Lost to Follow-up|4|||
33541939|NCT00407511|101885307|FG000|Overall Study|Other|5|||
33541940|NCT00407511|101885307|FG000|Overall Study|Withdrawal by Subject|4|||
33541941|NCT03093181|101885312|FG000|Overall Study|Withdrawal by Subject|2|||
33541942|NCT03093181|101885313|FG001|Overall Study|Withdrawal by Subject|1|||
33541943|NCT03093181|101885314|FG002|Overall Study|Withdrawal by Subject|2|||
33541944|NCT03093181|101885312|FG000|Overall Study|Other (Not specified)|1|||
33541945|NCT03093181|101885313|FG001|Overall Study|Other (Not specified)|0|||
33541946|NCT03093181|101885314|FG002|Overall Study|Other (Not specified)|0|||
33541947|NCT03093181|101885312|FG000|Overall Study|Adverse Event|0|||
33541948|NCT03093181|101885313|FG001|Overall Study|Adverse Event|1|||
33541949|NCT03093181|101885314|FG002|Overall Study|Adverse Event|0|||
33541950|NCT03093181|101885312|FG000|Overall Study|Other (Protocol violation)|0|||
33541951|NCT03093181|101885313|FG001|Overall Study|Other (Protocol violation)|0|||
33541952|NCT03093181|101885314|FG002|Overall Study|Other (Protocol violation)|1|||
33541953|NCT00924898|101885315|FG000|Overall Study|Withdrawal by Subject|2|||
33541954|NCT01047319|101885316|FG000|Overall Study|Teva requested participant withdrawal|3|||
33541955|NCT01047319|101885317|FG001|Overall Study|Teva requested participant withdrawal|0|||
33541956|NCT01047319|101885318|FG002|Overall Study|Teva requested participant withdrawal|1|||
33541957|NCT01047319|101885316|FG000|Overall Study|Protocol Violation|3|||
33541958|NCT01047319|101885317|FG001|Overall Study|Protocol Violation|2|||
33541959|NCT01047319|101885318|FG002|Overall Study|Protocol Violation|4|||
33541960|NCT01047319|101885316|FG000|Overall Study|Lack of Efficacy|4|||
33541961|NCT01047319|101885317|FG001|Overall Study|Lack of Efficacy|3|||
33541962|NCT01047319|101885318|FG002|Overall Study|Lack of Efficacy|3|||
33541963|NCT01047319|101885316|FG000|Overall Study|Death|5|||
33541964|NCT01047319|101885317|FG001|Overall Study|Death|1|||
33541965|NCT01047319|101885318|FG002|Overall Study|Death|5|||
33541966|NCT01047319|101885316|FG000|Overall Study|Pregnancy|13|||
33541967|NCT01047319|101885317|FG001|Overall Study|Pregnancy|8|||
33541968|NCT01047319|101885318|FG002|Overall Study|Pregnancy|8|||
33541969|NCT01047319|101885316|FG000|Overall Study|Physician Decision|12|||
33541970|NCT01047319|101885317|FG001|Overall Study|Physician Decision|9|||
33541971|NCT01047319|101885318|FG002|Overall Study|Physician Decision|10|||
33541972|NCT01047319|101885316|FG000|Overall Study|Lost to Follow-up|14|||
33541973|NCT01047319|101885317|FG001|Overall Study|Lost to Follow-up|10|||
33541974|NCT01047319|101885318|FG002|Overall Study|Lost to Follow-up|10|||
33541975|NCT01047319|101885316|FG000|Overall Study|Adverse Event|16|||
33541976|NCT01047319|101885317|FG001|Overall Study|Adverse Event|27|||
33541977|NCT01047319|101885318|FG002|Overall Study|Adverse Event|21|||
33541978|NCT01047319|101885316|FG000|Overall Study|Withdrawal by Subject|77|||
33541979|NCT01047319|101885317|FG001|Overall Study|Withdrawal by Subject|75|||
33541980|NCT01047319|101885318|FG002|Overall Study|Withdrawal by Subject|87|||
33541981|NCT01047319|101885316|FG000|Overall Study|Study terminated by Sponsor|198|||
33541982|NCT01047319|101885317|FG001|Overall Study|Study terminated by Sponsor|215|||
33541983|NCT01047319|101885318|FG002|Overall Study|Study terminated by Sponsor|203|||
33541984|NCT02783066|101885321|FG000|Overall Study|Withdrawal by Subject|13|||
33541985|NCT00433836|101885322|FG000|Overall Study|Adverse Event|7|||
33541986|NCT00433836|101885323|FG001|Overall Study|Adverse Event|0|||
33541987|NCT00433836|101885322|FG000|Overall Study|Lost to Follow-up|3|||
33541988|NCT00433836|101885323|FG001|Overall Study|Lost to Follow-up|0|||
33541989|NCT00433836|101885322|FG000|Overall Study|Withdrawal by Subject|2|||
33541990|NCT00433836|101885323|FG001|Overall Study|Withdrawal by Subject|1|||
33541991|NCT00433836|101885322|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33541992|NCT00433836|101885323|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33541993|NCT00433836|101885322|FG000|Overall Study|Protocol Violation|0|||
33541994|NCT00433836|101885323|FG001|Overall Study|Protocol Violation|2|||
33541995|NCT00433836|101885322|FG000|Overall Study|Condition no longer requires study drug|0|||
33541996|NCT00433836|101885323|FG001|Overall Study|Condition no longer requires study drug|1|||
33541997|NCT00433836|101885322|FG000|Overall Study|Abnormal laboratory values|0|||
33541998|NCT00433836|101885323|FG001|Overall Study|Abnormal laboratory values|1|||
33541999|NCT03620162|101885327|FG000|Overall Study|Physician Decision|4|||
33407302|NCT04594213|101380629|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
33407303|NCT04594213|101380630|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
33407304|NCT04594213|101380631|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
33407305|NCT04594213|101380632|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
33407306|NCT04594213|101380627|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
33407307|NCT04594213|101380628|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
33407308|NCT04594213|101380629|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
33407309|NCT04594213|101380630|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
33407310|NCT04594213|101380631|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
33542000|NCT03620162|101885328|FG001|Overall Study|Physician Decision|0|||
33542001|NCT03620162|101885329|FG002|Overall Study|Physician Decision|1|||
33212103|NCT02349295|100676553|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33212104|NCT02349295|100676554|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
33345357|NCT01360645|101152158|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
33345358|NCT01360645|101152159|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
33345359|NCT01360645|101152156|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
33345360|NCT01360645|101152157|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
33345361|NCT01360645|101152158|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
33345362|NCT01360645|101152159|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
33345363|NCT01360645|101152156|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
33345364|NCT01360645|101152157|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
33345365|NCT01360645|101152158|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
33345366|NCT01360645|101152159|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
33345367|NCT01360645|101152156|FG000|Phase A+|Lost to Follow-up|0|||
33345368|NCT01360645|101152157|FG001|Phase A+|Lost to Follow-up|0|||
33345369|NCT01360645|101152158|FG002|Phase A+|Lost to Follow-up|0|||
33345370|NCT01360645|101152159|FG003|Phase A+|Lost to Follow-up|7|||
33345371|NCT01360645|101152156|FG000|Phase A+|Adverse Event|0|||
33345372|NCT01360645|101152157|FG001|Phase A+|Adverse Event|0|||
33345373|NCT01360645|101152158|FG002|Phase A+|Adverse Event|0|||
33345374|NCT01360645|101152159|FG003|Phase A+|Adverse Event|2|||
33345375|NCT01360645|101152156|FG000|Phase A+|Met Withdrawal Criteria|0|||
33345376|NCT01360645|101152157|FG001|Phase A+|Met Withdrawal Criteria|0|||
33345377|NCT01360645|101152158|FG002|Phase A+|Met Withdrawal Criteria|0|||
33345378|NCT01360645|101152159|FG003|Phase A+|Met Withdrawal Criteria|4|||
33345379|NCT01360645|101152156|FG000|Phase A+|Physician Decision|0|||
33345380|NCT01360645|101152157|FG001|Phase A+|Physician Decision|0|||
33345381|NCT01360645|101152158|FG002|Phase A+|Physician Decision|0|||
33345382|NCT01360645|101152159|FG003|Phase A+|Physician Decision|2|||
33345383|NCT01360645|101152156|FG000|Phase A+|Withdrawal by Subject|0|||
33345384|NCT01360645|101152157|FG001|Phase A+|Withdrawal by Subject|0|||
33345385|NCT01360645|101152158|FG002|Phase A+|Withdrawal by Subject|0|||
33345386|NCT01360645|101152159|FG003|Phase A+|Withdrawal by Subject|5|||
33345387|NCT01360645|101152156|FG000|Phase A+|Protocol Deviation|0|||
33345388|NCT01360645|101152157|FG001|Phase A+|Protocol Deviation|0|||
33345389|NCT01360645|101152158|FG002|Phase A+|Protocol Deviation|0|||
33345390|NCT01360645|101152159|FG003|Phase A+|Protocol Deviation|4|||
33345391|NCT02452762|101152163|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
33345392|NCT02452762|101152164|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
33345393|NCT02452762|101152163|FG000|Overall Study|Withdrawal by Subject|1|||
33345394|NCT02452762|101152164|FG001|Overall Study|Withdrawal by Subject|0|||
33345395|NCT05655377|101152167|FG000|Overall Study|Withdrawal by Subject|2|||
33407311|NCT04594213|101380632|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
33407312|NCT04594213|101380627|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
33407313|NCT04594213|101380628|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
33407314|NCT04594213|101380629|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
33407315|NCT04594213|101380630|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
33345396|NCT01668654|101152168|FG000|Overall Study|Study Closed/Terminated|3|||
33345397|NCT01668654|101152168|FG000|Overall Study|Withdrawal by Subject|1|||
33345398|NCT00772447|101152169|FG000|Overall Study|Withdrawal by Subject|9|||
33345399|NCT00772447|101152170|FG001|Overall Study|Withdrawal by Subject|5|||
33345400|NCT00772447|101152169|FG000|Overall Study|Physician Decision|4|||
33345401|NCT00772447|101152170|FG001|Overall Study|Physician Decision|8|||
33345402|NCT00772447|101152169|FG000|Overall Study|Lost to Follow-up|2|||
33345403|NCT00772447|101152170|FG001|Overall Study|Lost to Follow-up|4|||
33345404|NCT00772447|101152169|FG000|Overall Study|incorrect enrolment|3|||
33407316|NCT04594213|101380631|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
33407317|NCT04594213|101380632|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
33407318|NCT04594213|101380627|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
33407319|NCT04594213|101380628|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
33407320|NCT04594213|101380629|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
33407321|NCT04594213|101380630|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
33407322|NCT04594213|101380631|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
33407323|NCT04594213|101380632|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
33407324|NCT04594213|101380627|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
33407325|NCT04594213|101380628|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
33407326|NCT04594213|101380629|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
33407327|NCT04594213|101380630|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
33407328|NCT04594213|101380631|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
33407329|NCT04594213|101380632|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
33407330|NCT04594213|101380627|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
33407331|NCT04594213|101380628|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
33407332|NCT04594213|101380629|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
33407333|NCT04594213|101380630|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
33407334|NCT04594213|101380631|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
33407335|NCT04594213|101380632|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
33407336|NCT04594213|101380627|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
33407337|NCT04594213|101380628|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
33407338|NCT04594213|101380629|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
33407339|NCT04594213|101380630|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
33407340|NCT04594213|101380631|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
33542002|NCT03620162|101885330|FG003|Overall Study|Physician Decision|0|||
33542003|NCT03620162|101885331|FG004|Overall Study|Physician Decision|2|||
33542004|NCT03620162|101885327|FG000|Overall Study|Lost to Follow-up|2|||
33542005|NCT03620162|101885328|FG001|Overall Study|Lost to Follow-up|6|||
33542006|NCT03620162|101885329|FG002|Overall Study|Lost to Follow-up|7|||
33542007|NCT03620162|101885330|FG003|Overall Study|Lost to Follow-up|3|||
33407341|NCT04594213|101380632|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
33407342|NCT04594213|101380627|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
33407343|NCT04594213|101380628|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
33407344|NCT04594213|101380629|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
33407345|NCT04594213|101380630|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
33407346|NCT04594213|101380631|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
33407347|NCT04594213|101380632|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
33407348|NCT03219372|101380633|FG000|Overall Study|Withdrawal by Subject|1|||
33407349|NCT03219372|101380634|FG001|Overall Study|Withdrawal by Subject|0|||
33542008|NCT03620162|101885331|FG004|Overall Study|Lost to Follow-up|2|||
33345405|NCT00772447|101152170|FG001|Overall Study|incorrect enrolment|4|||
33345406|NCT00772447|101152169|FG000|Overall Study|Protocol Violation|0|||
33345407|NCT00772447|101152170|FG001|Overall Study|Protocol Violation|1|||
33345408|NCT00772447|101152169|FG000|Overall Study|all others|2|||
33345409|NCT00772447|101152170|FG001|Overall Study|all others|2|||
33345410|NCT01481896|101152171|FG000|Overall Study|Lost to Follow-up|12|||
33345411|NCT00200850|101152172|FG000|Overall Study|relocation|1|||
33345412|NCT00200850|101152173|FG001|Overall Study|relocation|0|||
33345413|NCT00200850|101152174|FG002|Overall Study|relocation|1|||
33345414|NCT00200850|101152172|FG000|Overall Study|too busy|1|||
33345415|NCT00200850|101152173|FG001|Overall Study|too busy|0|||
33345416|NCT00200850|101152174|FG002|Overall Study|too busy|0|||
33345417|NCT00200850|101152172|FG000|Overall Study|Pregnancy|0|||
33345418|NCT00200850|101152173|FG001|Overall Study|Pregnancy|0|||
33345419|NCT00200850|101152174|FG002|Overall Study|Pregnancy|1|||
33345420|NCT00200850|101152172|FG000|Overall Study|Poor adherence|0|||
33345421|NCT00200850|101152173|FG001|Overall Study|Poor adherence|0|||
33345422|NCT00200850|101152174|FG002|Overall Study|Poor adherence|1|||
33542009|NCT03620162|101885327|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
33542010|NCT03620162|101885328|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
33345423|NCT00200850|101152172|FG000|Overall Study|optic neuritis|0|||
33345424|NCT00200850|101152173|FG001|Overall Study|optic neuritis|0|||
33345425|NCT00200850|101152174|FG002|Overall Study|optic neuritis|1|||
33345426|NCT00200850|101152172|FG000|Overall Study|Adverse Event|1|||
33345427|NCT00200850|101152173|FG001|Overall Study|Adverse Event|1|||
33345428|NCT00200850|101152174|FG002|Overall Study|Adverse Event|2|||
33345429|NCT00888238|101152180|FG000|Washout Period After Period 2|Adverse Event|0|||
33345430|NCT00888238|101152181|FG001|Washout Period After Period 2|Adverse Event|0|||
33345431|NCT00888238|101152182|FG002|Washout Period After Period 2|Adverse Event|1|||
33345432|NCT04173741|101152185|FG000|Overall Study|IVC measurement cannot be done|1|||
33345433|NCT04173741|101152186|FG001|Overall Study|IVC measurement cannot be done|1|||
33542011|NCT03620162|101885329|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
33542012|NCT03620162|101885330|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
33542013|NCT03620162|101885331|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
33345434|NCT01284114|101152187|FG000|Overall Study|viral infection|1|||
33345435|NCT01284114|101152187|FG000|Overall Study|From the results of ALLTITUDE study|1|||
33345436|NCT01284114|101152187|FG000|Overall Study|Symptomatic hypotension|1|||
33542014|NCT02690727|101885337|FG000|Overall Study|Adverse Event|2|||
33542015|NCT02690727|101885338|FG001|Overall Study|Adverse Event|2|||
33542016|NCT03587636|101885341|FG000|Overall Study|Lost to Follow-up|2|||
33542017|NCT03587636|101885342|FG001|Overall Study|Lost to Follow-up|5|||
33542018|NCT02394756|101885343|FG000|Period 1|Lens Discomfort|0|||
33542019|NCT02394756|101885344|FG001|Period 1|Lens Discomfort|0|||
33542020|NCT02394756|101885345|FG002|Period 1|Lens Discomfort|0|||
33542021|NCT02394756|101885346|FG003|Period 1|Lens Discomfort|0|||
33542022|NCT02394756|101885347|FG004|Period 1|Lens Discomfort|0|||
33542023|NCT02394756|101885348|FG005|Period 1|Lens Discomfort|1|||
33542024|NCT02394756|101885343|FG000|Period 1|Withdrawal by Subject|0|||
33542025|NCT02394756|101885344|FG001|Period 1|Withdrawal by Subject|1|||
33542026|NCT02394756|101885345|FG002|Period 1|Withdrawal by Subject|1|||
33542027|NCT02394756|101885346|FG003|Period 1|Withdrawal by Subject|1|||
33542028|NCT02394756|101885347|FG004|Period 1|Withdrawal by Subject|0|||
33542029|NCT02394756|101885348|FG005|Period 1|Withdrawal by Subject|0|||
33542030|NCT02394756|101885343|FG000|Period 2|Unsatisfactory Visual Response|0|||
33542031|NCT02394756|101885344|FG001|Period 2|Unsatisfactory Visual Response|0|||
33542032|NCT02394756|101885345|FG002|Period 2|Unsatisfactory Visual Response|0|||
33542033|NCT02394756|101885346|FG003|Period 2|Unsatisfactory Visual Response|0|||
33542034|NCT02394756|101885347|FG004|Period 2|Unsatisfactory Visual Response|1|||
33542035|NCT02394756|101885348|FG005|Period 2|Unsatisfactory Visual Response|0|||
33542036|NCT04219189|101885349|FG000|Overall Study|Withdrawal by Subject|1|||
33542037|NCT04219189|101885350|FG001|Overall Study|Withdrawal by Subject|2|||
33345437|NCT01284114|101152187|FG000|Overall Study|dizziness|1|||
33542038|NCT04219189|101885349|FG000|Overall Study|Protocol Violation|0|||
33542039|NCT04219189|101885350|FG001|Overall Study|Protocol Violation|1|||
33542040|NCT04219189|101885349|FG000|Overall Study|Lost to Follow-up|0|||
33542041|NCT04219189|101885350|FG001|Overall Study|Lost to Follow-up|1|||
33542042|NCT04219189|101885349|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
33615775|NCT01063153|102144196|FG001|Overall Study|Lost to Follow-up|7|||
33345438|NCT00400400|101152191|FG000|Overall Study|Adverse Event|9|||
33345439|NCT00400400|101152192|FG001|Overall Study|Adverse Event|8|||
33345440|NCT00400400|101152191|FG000|Overall Study|Protocol Violation|2|||
33345441|NCT00400400|101152192|FG001|Overall Study|Protocol Violation|0|||
33345442|NCT00400400|101152191|FG000|Overall Study|Withdrawal by Subject|1|||
33345443|NCT00400400|101152192|FG001|Overall Study|Withdrawal by Subject|3|||
33345444|NCT00400400|101152191|FG000|Overall Study|Administrative Problem|1|||
33345445|NCT00400400|101152192|FG001|Overall Study|Administrative Problem|0|||
33345446|NCT00400400|101152191|FG000|Overall Study|Lost to Follow-up|0|||
33345447|NCT00400400|101152192|FG001|Overall Study|Lost to Follow-up|1|||
33345448|NCT00400400|101152191|FG000|Overall Study|Did not receive study drug|1|||
33542043|NCT04219189|101885350|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
33345449|NCT00400400|101152192|FG001|Overall Study|Did not receive study drug|3|||
33345450|NCT03806127|101152193|FG000|Overall Study|Withdrawal by Subject|4|||
33345451|NCT03806127|101152194|FG001|Overall Study|Withdrawal by Subject|5|||
33345452|NCT03806127|101152193|FG000|Overall Study|Protocol Violation|3|||
33345453|NCT03806127|101152194|FG001|Overall Study|Protocol Violation|1|||
33345454|NCT03806127|101152193|FG000|Overall Study|Adverse Event|3|||
33345455|NCT03806127|101152194|FG001|Overall Study|Adverse Event|0|||
33345456|NCT03806127|101152193|FG000|Overall Study|Unable to Complete Procedures|0|||
33345457|NCT03806127|101152194|FG001|Overall Study|Unable to Complete Procedures|1|||
33345458|NCT03806127|101152193|FG000|Overall Study|Pregnancy|0|||
33345459|NCT03806127|101152194|FG001|Overall Study|Pregnancy|1|||
33345460|NCT03806127|101152193|FG000|Overall Study|Lost to Follow-up|5|||
33345461|NCT03806127|101152194|FG001|Overall Study|Lost to Follow-up|1|||
33345462|NCT03806127|101152193|FG000|Overall Study|Physician Decision|1|||
33345463|NCT03806127|101152194|FG001|Overall Study|Physician Decision|1|||
33345464|NCT03806127|101152193|FG000|Overall Study|Could Not Come Due to Covid|1|||
33542044|NCT01706328|101885351|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
33542045|NCT01706328|101885352|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33542046|NCT01706328|101885353|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33542047|NCT01706328|101885351|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
33542048|NCT01706328|101885352|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
33542049|NCT01706328|101885353|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
33542050|NCT01706328|101885351|FG000|2-week Run-in Period|Physician Decision|4|||
33542051|NCT01706328|101885352|FG001|2-week Run-in Period|Physician Decision|0|||
33542052|NCT01706328|101885353|FG002|2-week Run-in Period|Physician Decision|0|||
33542053|NCT01706328|101885351|FG000|2-week Run-in Period|Adverse Event|4|||
33542054|NCT01706328|101885352|FG001|2-week Run-in Period|Adverse Event|0|||
33542055|NCT01706328|101885353|FG002|2-week Run-in Period|Adverse Event|0|||
33345465|NCT03806127|101152194|FG001|Overall Study|Could Not Come Due to Covid|0|||
33345466|NCT03806127|101152193|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
33345467|NCT03806127|101152194|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
33345468|NCT03806127|101152193|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
33345469|NCT03806127|101152194|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
33345470|NCT03806127|101152193|FG000|Overall Study|Covid 19 Restrictions|2|||
33345471|NCT03806127|101152194|FG001|Overall Study|Covid 19 Restrictions|0|||
33345472|NCT03806127|101152193|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
33345473|NCT03806127|101152194|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
33345474|NCT03806127|101152193|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
33345475|NCT03806127|101152194|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
33345476|NCT01412957|101152195|FG000|Overall Study|Withdrawal by Subject|6|||
33345477|NCT01412957|101152196|FG001|Overall Study|Withdrawal by Subject|22|||
33345478|NCT01412957|101152195|FG000|Overall Study|Lost to Follow-up|7|||
33345479|NCT01412957|101152196|FG001|Overall Study|Lost to Follow-up|2|||
33345480|NCT01412957|101152195|FG000|Overall Study|Death|136|||
33345481|NCT01412957|101152196|FG001|Overall Study|Death|133|||
33345482|NCT01764633|101152202|FG000|Overall Study|Withdrawal by Subject|105|||
33345483|NCT01764633|101152203|FG001|Overall Study|Withdrawal by Subject|88|||
33345484|NCT01764633|101152202|FG000|Overall Study|Lost to Follow-up|13|||
33345485|NCT01764633|101152203|FG001|Overall Study|Lost to Follow-up|5|||
33345486|NCT01662440|101156371|FG000|Overall Study|Adverse Event|1|||
33345487|NCT01662440|101156372|FG001|Overall Study|Adverse Event|0|||
33345488|NCT01662440|101156373|FG002|Overall Study|Adverse Event|0|||
33345489|NCT01662440|101156374|FG003|Overall Study|Adverse Event|1|||
33345490|NCT01662440|101156371|FG000|Overall Study|Death|0|||
33345491|NCT01662440|101156372|FG001|Overall Study|Death|1|||
33345492|NCT01662440|101156373|FG002|Overall Study|Death|0|||
33345493|NCT01662440|101156374|FG003|Overall Study|Death|0|||
33345494|NCT01662440|101156371|FG000|Overall Study|Lost to Follow-up|2|||
33345495|NCT01662440|101156372|FG001|Overall Study|Lost to Follow-up|2|||
33345496|NCT01662440|101156373|FG002|Overall Study|Lost to Follow-up|4|||
33345497|NCT01662440|101156374|FG003|Overall Study|Lost to Follow-up|1|||
33542056|NCT01706328|101885351|FG000|2-week Run-in Period|Lost to Follow-up|2|||
33542057|NCT01706328|101885352|FG001|2-week Run-in Period|Lost to Follow-up|0|||
33542058|NCT01706328|101885353|FG002|2-week Run-in Period|Lost to Follow-up|0|||
33345498|NCT01662440|101156371|FG000|Overall Study|Subject moved to another country.|0|||
33615776|NCT01063153|102144195|FG000|Overall Study|Withdrawal by Subject|0|||
33345499|NCT01662440|101156372|FG001|Overall Study|Subject moved to another country.|1|||
33345500|NCT01662440|101156373|FG002|Overall Study|Subject moved to another country.|0|||
33345501|NCT01662440|101156374|FG003|Overall Study|Subject moved to another country.|0|||
33345502|NCT01662440|101156371|FG000|Overall Study|Protocol Violation|1|||
33345503|NCT01662440|101156372|FG001|Overall Study|Protocol Violation|0|||
33345504|NCT01662440|101156373|FG002|Overall Study|Protocol Violation|0|||
33345505|NCT01662440|101156374|FG003|Overall Study|Protocol Violation|0|||
33345506|NCT01662440|101156371|FG000|Overall Study|Withdrawal by Subject|5|||
33345507|NCT01662440|101156372|FG001|Overall Study|Withdrawal by Subject|2|||
33345508|NCT01662440|101156373|FG002|Overall Study|Withdrawal by Subject|2|||
33345509|NCT01662440|101156374|FG003|Overall Study|Withdrawal by Subject|2|||
33345510|NCT01885000|101156375|FG000|Overall Study|Adverse Event|1|||
33345511|NCT01885000|101156376|FG001|Overall Study|Adverse Event|0|||
33345512|NCT01885000|101156375|FG000|Overall Study|Withdrawal by Subject|1|||
33345513|NCT01885000|101156376|FG001|Overall Study|Withdrawal by Subject|1|||
33345514|NCT01885000|101156375|FG000|Overall Study|Protocol Violation|0|||
33345515|NCT01885000|101156376|FG001|Overall Study|Protocol Violation|1|||
33345516|NCT01291017|101156381|FG000|Overall Study|Lost to Follow-up|2|||
33345517|NCT01291017|101156381|FG000|Overall Study|Withdrawal by Subject|3|||
33345518|NCT03430986|101156387|FG000|24-week Control Period|Adverse Event|1|||
33345519|NCT03430986|101156388|FG001|24-week Control Period|Adverse Event|0|||
33345520|NCT03430986|101156387|FG000|24-week Control Period|Lost to Follow-up|2|||
33345521|NCT03430986|101156388|FG001|24-week Control Period|Lost to Follow-up|2|||
33345522|NCT03430986|101156387|FG000|24-week Control Period|Withdrawal by Participant|5|||
33345523|NCT03430986|101156388|FG001|24-week Control Period|Withdrawal by Participant|0|||
33345524|NCT03430986|101156387|FG000|24-week Control Period|Protocol Deviation|0|||
33345525|NCT03430986|101156388|FG001|24-week Control Period|Protocol Deviation|2|||
33345526|NCT03430986|101156387|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
33542059|NCT01706328|101885351|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
33542060|NCT01706328|101885352|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
33542061|NCT01706328|101885353|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
33542062|NCT01706328|101885351|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
33542063|NCT01706328|101885352|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
33542064|NCT01706328|101885353|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
33542065|NCT01706328|101885351|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
33542066|NCT01706328|101885352|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
33542067|NCT01706328|101885353|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
33542068|NCT01706328|101885351|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
33542069|NCT01706328|101885352|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
33542070|NCT01706328|101885353|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
33542071|NCT01706328|101885351|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
33542072|NCT01706328|101885352|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
33542073|NCT01706328|101885353|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
33542074|NCT01706328|101885351|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
33542075|NCT01706328|101885352|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
33542076|NCT01706328|101885353|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
33542077|NCT01706328|101885351|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33542078|NCT01706328|101885352|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
33542079|NCT01706328|101885353|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
33542080|NCT03312738|101885356|FG000|Overall Study|Progressive disease|58|||
33542081|NCT03312738|101885357|FG001|Overall Study|Progressive disease|67|||
33542082|NCT03312738|101885356|FG000|Overall Study|Patient/guardian decision|13|||
33542083|NCT03312738|101885357|FG001|Overall Study|Patient/guardian decision|5|||
33542084|NCT03312738|101885356|FG000|Overall Study|Adverse Event|5|||
33542085|NCT03312738|101885357|FG001|Overall Study|Adverse Event|3|||
33542086|NCT03312738|101885356|FG000|Overall Study|Protocol deviation|2|||
33542087|NCT03312738|101885357|FG001|Overall Study|Protocol deviation|0|||
33542088|NCT03312738|101885356|FG000|Overall Study|Technical problems|0|||
33542089|NCT03312738|101885357|FG001|Overall Study|Technical problems|1|||
33345527|NCT03430986|101156388|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
33345528|NCT03430986|101156387|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
33542090|NCT03312738|101885356|FG000|Overall Study|Physician Decision|2|||
33542091|NCT03312738|101885357|FG001|Overall Study|Physician Decision|3|||
33542092|NCT02471339|101885358|FG000|Overall Study|Did not provide follow-up data|2|||
33542093|NCT02471339|101885359|FG001|Overall Study|Did not provide follow-up data|0|||
33542094|NCT00183430|101885360|FG000|Overall Study|Adverse Event|1|||
33542095|NCT00183430|101885361|FG001|Overall Study|Adverse Event|0|||
33345529|NCT03430986|101156388|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
33345530|NCT03682120|101156391|FG000|Overall Study|Lost to Follow-up|11|||
33542096|NCT00183430|101885360|FG000|Overall Study|Lost to Follow-up|3|||
33542097|NCT00183430|101885361|FG001|Overall Study|Lost to Follow-up|0|||
33542098|NCT00183430|101885360|FG000|Overall Study|did not meet inclusion criteria|1|||
33345531|NCT03682120|101156392|FG001|Overall Study|Lost to Follow-up|4|||
33345532|NCT03682120|101156393|FG002|Overall Study|Lost to Follow-up|5|||
33345533|NCT03682120|101156394|FG003|Overall Study|Lost to Follow-up|2|||
33345534|NCT03682120|101156391|FG000|Overall Study|Physician Decision|1|||
33345535|NCT03682120|101156392|FG001|Overall Study|Physician Decision|0|||
33542099|NCT00183430|101885361|FG001|Overall Study|did not meet inclusion criteria|0|||
33542100|NCT00183430|101885360|FG000|Overall Study|Withdrawal by Subject|1|||
33345536|NCT03682120|101156393|FG002|Overall Study|Physician Decision|0|||
33407350|NCT01856920|101380637|FG000|Overall Study|Disease Progression On Study|3|||
33407351|NCT01856920|101380638|FG001|Overall Study|Disease Progression On Study|4|||
33407352|NCT01856920|101380637|FG000|Overall Study|Disease Progression before Treatment|1|||
33407353|NCT01856920|101380638|FG001|Overall Study|Disease Progression before Treatment|0|||
33407354|NCT01856920|101380637|FG000|Overall Study|Ineligible|0|||
33407355|NCT01856920|101380638|FG001|Overall Study|Ineligible|1|||
33407356|NCT01856920|101380637|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
33407357|NCT01856920|101380638|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
33407358|NCT01856920|101380637|FG000|Overall Study|Refused further Treatment|5|||
33407359|NCT01856920|101380638|FG001|Overall Study|Refused further Treatment|1|||
33407360|NCT01856920|101380637|FG000|Overall Study|Other Reasons|0|||
33407361|NCT01856920|101380638|FG001|Overall Study|Other Reasons|1|||
33407362|NCT01856920|101380637|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
33407363|NCT01856920|101380638|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
33407364|NCT00267202|101380639|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
33407365|NCT00267202|101380640|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
33407366|NCT00267202|101380639|FG000|Overall Study|Withdrawal by Subject|12|||
33615777|NCT01063153|102144196|FG001|Overall Study|Withdrawal by Subject|1|||
33615778|NCT01063153|102144195|FG000|Overall Study|Physician Decision|0|||
33615779|NCT01063153|102144196|FG001|Overall Study|Physician Decision|4|||
33615780|NCT00350844|102144197|FG000|Overall Study|Lost to Follow-up|1|||
33615781|NCT02352753|102144200|FG000|6-Month Dosing Period|Decision by sponsor|2|||
33615782|NCT02352753|102144200|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
33615783|NCT02352753|102144200|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
33615784|NCT02352753|102144200|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
33615785|NCT02352753|102144200|FG000|3-Month Dosing Period|Decision by sponsor|14|||
33615786|NCT02352753|102144200|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
33615787|NCT01919801|102144201|FG000|Overall Study|Withdrawal by Subject|1|||
33615788|NCT01919801|102144202|FG001|Overall Study|Withdrawal by Subject|0|||
33615789|NCT01919801|102144201|FG000|Overall Study|Physician Decision|0|||
33615790|NCT01919801|102144202|FG001|Overall Study|Physician Decision|1|||
33615791|NCT01919801|102144201|FG000|Overall Study|Lost to Follow-up|0|||
33615792|NCT01919801|102144202|FG001|Overall Study|Lost to Follow-up|1|||
33615793|NCT01919801|102144201|FG000|Overall Study|Other|0|||
33407367|NCT00267202|101380640|FG001|Overall Study|Withdrawal by Subject|15|||
33407368|NCT00267202|101380639|FG000|Overall Study|Adverse Event|13|||
33407369|NCT00267202|101380640|FG001|Overall Study|Adverse Event|7|||
33542101|NCT00183430|101885361|FG001|Overall Study|Withdrawal by Subject|0|||
33542102|NCT02783911|101885362|FG000|Overall Study|Lost to Follow-up|3|||
33542103|NCT02783911|101885363|FG001|Overall Study|Lost to Follow-up|32|||
33542104|NCT01654276|101885370|FG000|Overall Study|Lack of Efficacy|1|||
33542105|NCT01654276|101885370|FG000|Overall Study|Lost to Follow-up|4|||
33542106|NCT01654276|101885370|FG000|Overall Study|Withdrawal by Subject|1|||
33542107|NCT00997893|101885371|FG000|Overall Study|Adverse Event|1|||
33542108|NCT00997893|101885372|FG001|Overall Study|Adverse Event|0|||
33542109|NCT00997893|101885373|FG002|Overall Study|Adverse Event|0|||
33542110|NCT00997893|101885371|FG000|Overall Study|Unable to meet study timelines|1|||
33542111|NCT00997893|101885372|FG001|Overall Study|Unable to meet study timelines|0|||
33542112|NCT00997893|101885373|FG002|Overall Study|Unable to meet study timelines|0|||
33542113|NCT00997893|101885371|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
33542114|NCT00997893|101885372|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
33542115|NCT00997893|101885373|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
33542116|NCT02265510|101885374|FG000|Overall Study|Withdrawal by Subject|1|||
33542117|NCT02265510|101885375|FG001|Overall Study|Withdrawal by Subject|1|||
33615794|NCT01919801|102144202|FG001|Overall Study|Other|1|||
33615795|NCT03056339|102144205|FG000|Overall Study|Failed Requirements|0|||
33407370|NCT00267202|101380639|FG000|Overall Study|Protocol Violation|2|||
33542118|NCT02265510|101885376|FG002|Overall Study|Withdrawal by Subject|2|||
33542119|NCT02265510|101885377|FG003|Overall Study|Withdrawal by Subject|1|||
33542120|NCT02265510|101885378|FG004|Overall Study|Withdrawal by Subject|0|||
33407371|NCT00267202|101380640|FG001|Overall Study|Protocol Violation|3|||
33407372|NCT00267202|101380639|FG000|Overall Study|Administrative problems|2|||
33542121|NCT02265510|101885379|FG005|Overall Study|Withdrawal by Subject|2|||
33615796|NCT03056339|102144206|FG001|Overall Study|Failed Requirements|2|||
33615797|NCT03056339|102144207|FG002|Overall Study|Failed Requirements|7|||
33212105|NCT02349295|100676541|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33212106|NCT02349295|100676542|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33212107|NCT02349295|100676543|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33212108|NCT02349295|100676544|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33212109|NCT02349295|100676545|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33212110|NCT02349295|100676546|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33345537|NCT03682120|101156394|FG003|Overall Study|Physician Decision|0|||
33345538|NCT03682120|101156391|FG000|Overall Study|Withdrawal by Subject|1|||
33345539|NCT03682120|101156392|FG001|Overall Study|Withdrawal by Subject|2|||
33345540|NCT03682120|101156393|FG002|Overall Study|Withdrawal by Subject|3|||
33345541|NCT03682120|101156394|FG003|Overall Study|Withdrawal by Subject|0|||
33345542|NCT03682120|101156391|FG000|Overall Study|Death|0|||
33345543|NCT03682120|101156392|FG001|Overall Study|Death|1|||
33345544|NCT03682120|101156393|FG002|Overall Study|Death|0|||
33542122|NCT02265510|101885380|FG006|Overall Study|Withdrawal by Subject|0|||
33542123|NCT02265510|101885381|FG007|Overall Study|Withdrawal by Subject|2|||
33212111|NCT02349295|100676547|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33212112|NCT02349295|100676548|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33212113|NCT02349295|100676549|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33212114|NCT02349295|100676550|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33212115|NCT02349295|100676551|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33212116|NCT02349295|100676552|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
33212117|NCT02349295|100676553|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33212118|NCT02349295|100676554|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
33212119|NCT03561090|100676555|FG000|Overall Study|Adverse Event|11|||
33212120|NCT03561090|100676556|FG001|Overall Study|Adverse Event|7|||
33212121|NCT03561090|100676555|FG000|Overall Study|Non-Compliance With Study Drug|2|||
33212122|NCT03561090|100676556|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33212123|NCT03561090|100676555|FG000|Overall Study|Protocol Violation|2|||
33212124|NCT03561090|100676556|FG001|Overall Study|Protocol Violation|2|||
33212125|NCT03561090|100676555|FG000|Overall Study|Withdrawal by Subject|7|||
33212126|NCT03561090|100676556|FG001|Overall Study|Withdrawal by Subject|7|||
33212127|NCT03561090|100676555|FG000|Overall Study|Lost to Follow-up|7|||
33212128|NCT03561090|100676556|FG001|Overall Study|Lost to Follow-up|2|||
33212129|NCT03561090|100676555|FG000|Overall Study|Study Terminated by Sponsor|10|||
33212130|NCT03561090|100676556|FG001|Overall Study|Study Terminated by Sponsor|15|||
33212131|NCT03561090|100676555|FG000|Overall Study|Randomized by Mistake|1|||
33212132|NCT03561090|100676556|FG001|Overall Study|Randomized by Mistake|1|||
33212133|NCT03561090|100676555|FG000|Overall Study|Other Not Specified|0|||
33212134|NCT03561090|100676556|FG001|Overall Study|Other Not Specified|2|||
33212135|NCT01491854|100676566|FG000|Overall Study|mainly due to premature termination|93|||
33212136|NCT01491854|100676566|FG000|Overall Study|Death|1|||
33212137|NCT01491854|100676566|FG000|Overall Study|Withdrawal by Subject|3|||
33212138|NCT01491854|100676566|FG000|Overall Study|Lost to Follow-up|33|||
33212139|NCT05054374|100676567|FG000|Overall Study|Withdrawal by Subject|1|||
33212140|NCT05054374|100676568|FG001|Overall Study|Withdrawal by Subject|0|||
33212141|NCT05054374|100676569|FG002|Overall Study|Withdrawal by Subject|0|||
33212142|NCT05054374|100676570|FG003|Overall Study|Withdrawal by Subject|0|||
33542124|NCT02265510|101885382|FG008|Overall Study|Withdrawal by Subject|0|||
33212143|NCT05054374|100676567|FG000|Overall Study|Progressive Disease|5|||
33345545|NCT03682120|101156394|FG003|Overall Study|Death|0|||
33345546|NCT03682120|101156391|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
33345547|NCT03682120|101156392|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
33345548|NCT03682120|101156393|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
33542125|NCT02265510|101885383|FG009|Overall Study|Withdrawal by Subject|0|||
33542126|NCT02265510|101885384|FG010|Overall Study|Withdrawal by Subject|0|||
33542127|NCT02265510|101885385|FG011|Overall Study|Withdrawal by Subject|0|||
33542128|NCT02265510|101885386|FG012|Overall Study|Withdrawal by Subject|1|||
33542129|NCT02265510|101885387|FG013|Overall Study|Withdrawal by Subject|0|||
33542130|NCT02265510|101885374|FG000|Overall Study|Disease Progression|0|||
33542131|NCT02265510|101885375|FG001|Overall Study|Disease Progression|1|||
33542132|NCT02265510|101885376|FG002|Overall Study|Disease Progression|2|||
33542133|NCT02265510|101885377|FG003|Overall Study|Disease Progression|1|||
33542134|NCT02265510|101885378|FG004|Overall Study|Disease Progression|1|||
33542135|NCT02265510|101885379|FG005|Overall Study|Disease Progression|0|||
33345549|NCT03682120|101156394|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
33212144|NCT05054374|100676568|FG001|Overall Study|Progressive Disease|0|||
33212145|NCT05054374|100676569|FG002|Overall Study|Progressive Disease|0|||
33212146|NCT05054374|100676570|FG003|Overall Study|Progressive Disease|0|||
33212147|NCT02492100|100676571|FG000|Overall Study|Death|1|||
33212148|NCT00902304|100676572|FG000|Overall Study|Adverse Event|4|||
33212149|NCT00902304|100676573|FG001|Overall Study|Adverse Event|10|||
33345550|NCT00167245|101156402|FG000|Overall Study|Lost to Follow-up|20|||
33542136|NCT02265510|101885380|FG006|Overall Study|Disease Progression|0|||
33542137|NCT02265510|101885381|FG007|Overall Study|Disease Progression|0|||
33615798|NCT03056339|102144208|FG003|Overall Study|Failed Requirements|1|||
33615799|NCT03566082|102144209|FG000|Overall Study|Death|7|||
33615800|NCT03566082|102144209|FG000|Overall Study|Failures (revision required)|2|||
33345551|NCT00167245|101156403|FG001|Overall Study|Lost to Follow-up|31|||
33542138|NCT02265510|101885382|FG008|Overall Study|Disease Progression|0|||
33542139|NCT02265510|101885383|FG009|Overall Study|Disease Progression|0|||
33542140|NCT02265510|101885384|FG010|Overall Study|Disease Progression|0|||
33542141|NCT02265510|101885385|FG011|Overall Study|Disease Progression|0|||
33542142|NCT02265510|101885386|FG012|Overall Study|Disease Progression|0|||
33542143|NCT02265510|101885387|FG013|Overall Study|Disease Progression|0|||
33542144|NCT02265510|101885374|FG000|Overall Study|Death|2|||
33542145|NCT02265510|101885375|FG001|Overall Study|Death|0|||
33542146|NCT02265510|101885376|FG002|Overall Study|Death|2|||
33542147|NCT02265510|101885377|FG003|Overall Study|Death|2|||
33542148|NCT02265510|101885378|FG004|Overall Study|Death|1|||
33542149|NCT02265510|101885379|FG005|Overall Study|Death|3|||
33542150|NCT02265510|101885380|FG006|Overall Study|Death|2|||
33542151|NCT02265510|101885381|FG007|Overall Study|Death|1|||
33542152|NCT02265510|101885382|FG008|Overall Study|Death|3|||
33542153|NCT02265510|101885383|FG009|Overall Study|Death|3|||
33542154|NCT02265510|101885384|FG010|Overall Study|Death|4|||
33542155|NCT02265510|101885385|FG011|Overall Study|Death|12|||
33542156|NCT02265510|101885386|FG012|Overall Study|Death|7|||
33542157|NCT02265510|101885387|FG013|Overall Study|Death|6|||
33542158|NCT02265510|101885374|FG000|Overall Study|Lost to Follow-up|0|||
33542159|NCT02265510|101885375|FG001|Overall Study|Lost to Follow-up|0|||
33542160|NCT02265510|101885376|FG002|Overall Study|Lost to Follow-up|0|||
33542161|NCT02265510|101885377|FG003|Overall Study|Lost to Follow-up|0|||
33542162|NCT02265510|101885378|FG004|Overall Study|Lost to Follow-up|1|||
33542163|NCT02265510|101885379|FG005|Overall Study|Lost to Follow-up|0|||
33542164|NCT02265510|101885380|FG006|Overall Study|Lost to Follow-up|0|||
33542165|NCT02265510|101885381|FG007|Overall Study|Lost to Follow-up|0|||
33542166|NCT02265510|101885382|FG008|Overall Study|Lost to Follow-up|0|||
33345552|NCT00167245|101156402|FG000|Overall Study|Withdrawal by Subject|5|||
33345553|NCT00167245|101156403|FG001|Overall Study|Withdrawal by Subject|8|||
33345554|NCT00167245|101156402|FG000|Overall Study|Incarcerated|3|||
33345555|NCT00167245|101156403|FG001|Overall Study|Incarcerated|2|||
33345556|NCT00167245|101156402|FG000|Overall Study|Drowsy|1|||
33345557|NCT00167245|101156403|FG001|Overall Study|Drowsy|0|||
33345558|NCT00132041|101156407|FG000|Baseline|Ineligible|6|||
33345559|NCT00132041|101156407|FG000|3 Months Post Ablation|Transplant|1|||
33345560|NCT00132041|101156407|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
33345561|NCT00132041|101156407|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
33542167|NCT02265510|101885383|FG009|Overall Study|Lost to Follow-up|2|||
33542168|NCT02265510|101885384|FG010|Overall Study|Lost to Follow-up|0|||
33542169|NCT02265510|101885385|FG011|Overall Study|Lost to Follow-up|0|||
33542170|NCT02265510|101885386|FG012|Overall Study|Lost to Follow-up|0|||
33542171|NCT02265510|101885387|FG013|Overall Study|Lost to Follow-up|2|||
33542172|NCT02265510|101885374|FG000|Overall Study|Other|0|||
33542173|NCT02265510|101885375|FG001|Overall Study|Other|1|||
33542174|NCT02265510|101885376|FG002|Overall Study|Other|0|||
33615801|NCT03566082|102144209|FG000|Overall Study|Lost to Follow-up|8|||
33615802|NCT02152761|102144210|FG000|Epoch: Treatment Epoch|Technical problems|0|||
33345562|NCT00132041|101156407|FG000|6 Months Post Ablation|Death|2|||
33345563|NCT00132041|101156407|FG000|6 Months Post Ablation|Transplant|6|||
33542175|NCT02265510|101885377|FG003|Overall Study|Other|0|||
33542176|NCT02265510|101885378|FG004|Overall Study|Other|0|||
33542177|NCT02265510|101885379|FG005|Overall Study|Other|0|||
33615803|NCT02152761|102144211|FG001|Epoch: Treatment Epoch|Technical problems|0|||
33345564|NCT00132041|101156407|FG000|9 Months Post Ablation|Death|1|||
33345565|NCT00132041|101156407|FG000|9 Months Post Ablation|Transplant|1|||
33345566|NCT00132041|101156407|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
33345567|NCT00132041|101156407|FG000|12 Months Post Ablation|Death|1|||
33345568|NCT00132041|101156407|FG000|12 Months Post Ablation|Transplant|1|||
33407373|NCT00267202|101380640|FG001|Overall Study|Administrative problems|1|||
33542178|NCT02265510|101885380|FG006|Overall Study|Other|0|||
33542179|NCT02265510|101885381|FG007|Overall Study|Other|0|||
33542180|NCT02265510|101885382|FG008|Overall Study|Other|0|||
33542181|NCT02265510|101885383|FG009|Overall Study|Other|0|||
33542182|NCT02265510|101885384|FG010|Overall Study|Other|0|||
33542183|NCT02265510|101885385|FG011|Overall Study|Other|0|||
33615804|NCT02152761|102144212|FG002|Epoch: Treatment Epoch|Technical problems|0|||
33212150|NCT00902304|100676574|FG002|Overall Study|Adverse Event|25|||
33407374|NCT00267202|101380639|FG000|Overall Study|Lost to Follow-up|3|||
33542184|NCT02265510|101885386|FG012|Overall Study|Other|0|||
33542185|NCT02265510|101885387|FG013|Overall Study|Other|0|||
33542186|NCT02265510|101885374|FG000|Overall Study|Study Terminated by Sponsor|0|||
33615805|NCT02152761|102144213|FG003|Epoch: Treatment Epoch|Technical problems|1|||
33542187|NCT02265510|101885375|FG001|Overall Study|Study Terminated by Sponsor|0|||
33542188|NCT02265510|101885376|FG002|Overall Study|Study Terminated by Sponsor|0|||
33542189|NCT02265510|101885377|FG003|Overall Study|Study Terminated by Sponsor|0|||
33542190|NCT02265510|101885378|FG004|Overall Study|Study Terminated by Sponsor|0|||
33542191|NCT02265510|101885379|FG005|Overall Study|Study Terminated by Sponsor|1|||
33542192|NCT02265510|101885380|FG006|Overall Study|Study Terminated by Sponsor|1|||
33542193|NCT02265510|101885381|FG007|Overall Study|Study Terminated by Sponsor|1|||
33542194|NCT02265510|101885382|FG008|Overall Study|Study Terminated by Sponsor|1|||
33542195|NCT02265510|101885383|FG009|Overall Study|Study Terminated by Sponsor|2|||
33542196|NCT02265510|101885384|FG010|Overall Study|Study Terminated by Sponsor|1|||
33542197|NCT02265510|101885385|FG011|Overall Study|Study Terminated by Sponsor|4|||
33542198|NCT02265510|101885386|FG012|Overall Study|Study Terminated by Sponsor|1|||
33542199|NCT02265510|101885387|FG013|Overall Study|Study Terminated by Sponsor|2|||
33212151|NCT00902304|100676572|FG000|Overall Study|Investigator discretion|3|||
33212152|NCT00902304|100676573|FG001|Overall Study|Investigator discretion|5|||
33407375|NCT00267202|101380640|FG001|Overall Study|Lost to Follow-up|0|||
33542200|NCT03427411|101885389|FG000|Overall Study|Screen failure - platelets too low|0|||
33615806|NCT02152761|102144210|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
33345569|NCT00132041|101156407|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
33345570|NCT00132041|101156407|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
33542201|NCT03427411|101885390|FG001|Overall Study|Screen failure - platelets too low|1|||
33542202|NCT03834350|101885391|FG000|Overall Study|Withdrawal by Subject|1|||
33542203|NCT00964782|101885392|FG000|Overall Study|Lost to Follow-up|1|||
33542204|NCT00964782|101885393|FG001|Overall Study|Lost to Follow-up|0|||
33542205|NCT00374868|101885394|FG000|Overall Study|Adverse Event|12|||
33542206|NCT00374868|101885394|FG000|Overall Study|Progressive Disease|7|||
33542207|NCT00374868|101885394|FG000|Overall Study|Physician Decision|13|||
33542208|NCT00374868|101885394|FG000|Overall Study|Lost to Follow-up|1|||
33542209|NCT00374868|101885394|FG000|Overall Study|Death|2|||
33542210|NCT00374868|101885394|FG000|Overall Study|Other - Not Specified|1|||
33542211|NCT00473083|101885395|FG000|Overall Study|Adverse Event|1|||
33542212|NCT00473083|101885396|FG001|Overall Study|Adverse Event|0|||
33542213|NCT00473083|101885397|FG002|Overall Study|Adverse Event|0|||
33542214|NCT01569022|101885407|FG000|First Intervention|Lost to Follow-up|2|||
33212153|NCT00902304|100676574|FG002|Overall Study|Investigator discretion|13|||
33212154|NCT00902304|100676572|FG000|Overall Study|Lost to Follow-up|7|||
33345571|NCT00132041|101156407|FG000|15 Months Post Ablation|Death|1|||
33345572|NCT00132041|101156407|FG000|15 Months Post Ablation|Transplant|5|||
33212155|NCT00902304|100676573|FG001|Overall Study|Lost to Follow-up|7|||
33542215|NCT01569022|101885408|FG001|First Intervention|Lost to Follow-up|1|||
33542216|NCT01569022|101885407|FG000|Second Intervention|Lost to Follow-up|2|||
33542217|NCT01569022|101885408|FG001|Second Intervention|Lost to Follow-up|2|||
33542218|NCT03415178|101885412|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
33542219|NCT03415178|101885413|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
33542220|NCT03415178|101885412|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
33542221|NCT03415178|101885413|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
33542222|NCT01130272|101885416|FG000|Overall Study|Adverse Event|2|||
33542223|NCT01130272|101885417|FG001|Overall Study|Adverse Event|5|||
33542224|NCT01130272|101885418|FG002|Overall Study|Adverse Event|6|||
33542225|NCT01130272|101885419|FG003|Overall Study|Adverse Event|22|||
33542226|NCT01130272|101885420|FG004|Overall Study|Adverse Event|7|||
33542227|NCT01130272|101885416|FG000|Overall Study|IVRS-confirmed constipation|0|||
33542228|NCT01130272|101885417|FG001|Overall Study|IVRS-confirmed constipation|1|||
33542229|NCT01130272|101885418|FG002|Overall Study|IVRS-confirmed constipation|1|||
33542230|NCT01130272|101885419|FG003|Overall Study|IVRS-confirmed constipation|2|||
33542231|NCT01130272|101885420|FG004|Overall Study|IVRS-confirmed constipation|0|||
33542232|NCT01130272|101885416|FG000|Overall Study|Rescue medications due to diarrhea|3|||
33542233|NCT01130272|101885417|FG001|Overall Study|Rescue medications due to diarrhea|5|||
33542234|NCT01130272|101885418|FG002|Overall Study|Rescue medications due to diarrhea|8|||
33542235|NCT01130272|101885419|FG003|Overall Study|Rescue medications due to diarrhea|8|||
33542236|NCT01130272|101885420|FG004|Overall Study|Rescue medications due to diarrhea|6|||
33542237|NCT01130272|101885416|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
33542238|NCT01130272|101885417|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
33542239|NCT01130272|101885418|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
33542240|NCT01130272|101885419|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
33542241|NCT01130272|101885420|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
33542242|NCT01130272|101885416|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
33542243|NCT01130272|101885417|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
33542244|NCT01130272|101885418|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
33542245|NCT01130272|101885419|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
33542246|NCT01130272|101885420|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
33542247|NCT01130272|101885416|FG000|Overall Study|Protocol Violation|0|||
33542248|NCT01130272|101885417|FG001|Overall Study|Protocol Violation|0|||
33542249|NCT01130272|101885418|FG002|Overall Study|Protocol Violation|3|||
33542250|NCT01130272|101885419|FG003|Overall Study|Protocol Violation|5|||
33212156|NCT00902304|100676574|FG002|Overall Study|Lost to Follow-up|7|||
33407376|NCT04676022|101380645|FG000|Overall Study|Screen Failure/|1|||
33212157|NCT00902304|100676572|FG000|Overall Study|Protocol Violation|9|||
33212158|NCT00902304|100676573|FG001|Overall Study|Protocol Violation|18|||
33212159|NCT00902304|100676574|FG002|Overall Study|Protocol Violation|20|||
33212160|NCT00902304|100676572|FG000|Overall Study|Withdrawal by Subject|32|||
33212161|NCT00902304|100676573|FG001|Overall Study|Withdrawal by Subject|22|||
33212162|NCT00902304|100676574|FG002|Overall Study|Withdrawal by Subject|43|||
33212163|NCT00902304|100676572|FG000|Overall Study|includes pregnancy|3|||
33212164|NCT00902304|100676573|FG001|Overall Study|includes pregnancy|9|||
33212165|NCT00902304|100676574|FG002|Overall Study|includes pregnancy|2|||
33212166|NCT00529399|100676575|FG000|Overall Study|Lost to Follow-up|1|||
33212167|NCT00529399|100676576|FG001|Overall Study|Lost to Follow-up|0|||
33212168|NCT00529399|100676577|FG002|Overall Study|Lost to Follow-up|1|||
33212169|NCT00529399|100676575|FG000|Overall Study|Withdrawal by Subject|1|||
33212170|NCT00529399|100676576|FG001|Overall Study|Withdrawal by Subject|0|||
33212171|NCT00529399|100676577|FG002|Overall Study|Withdrawal by Subject|1|||
33212172|NCT00529399|100676575|FG000|Overall Study|Non-compliant|0|||
33212173|NCT00529399|100676576|FG001|Overall Study|Non-compliant|1|||
33212174|NCT00529399|100676577|FG002|Overall Study|Non-compliant|0|||
33212175|NCT00951483|100676578|FG000|Overall Study|Physician Decision|4|||
33212176|NCT00951483|100676579|FG001|Overall Study|Physician Decision|0|||
33212177|NCT00951483|100676578|FG000|Overall Study|Withdrawal by Subject|15|||
33212178|NCT00951483|100676579|FG001|Overall Study|Withdrawal by Subject|0|||
33212179|NCT03950739|100676580|FG000|Treatment Phase|Adverse Event|2|||
33212180|NCT03950739|100676580|FG000|Optional Extension Phase|Death|1|||
33212181|NCT03950739|100676580|FG000|Optional Extension Phase|Progressive Disease|5|||
33212182|NCT03950739|100676580|FG000|Optional Extension Phase|Adverse Event|7|||
33212183|NCT03950739|100676580|FG000|Optional Extension Phase|Lost to Follow-up|2|||
33212184|NCT03950739|100676580|FG000|Optional Extension Phase|Site Closure|2|||
33212185|NCT03950739|100676580|FG000|Optional Extension Phase|Pregnancy|1|||
33212186|NCT00686166|100676586|FG000|Overall Study|Adverse Event|7|||
33212187|NCT00686166|100676586|FG000|Overall Study|Withdrawal by Subject|1|||
33212188|NCT00686166|100676586|FG000|Overall Study|Progression/Relapse|1|||
33212189|NCT00686166|100676586|FG000|Overall Study|Death|1|||
33212190|NCT00686166|100676586|FG000|Overall Study|Not Protocol Specified|1|||
33212191|NCT00686166|100676586|FG000|Overall Study|Ineligible|5|||
33212192|NCT00686166|100676586|FG000|Overall Study|Did not begin protocol therapy|4|||
33212193|NCT02925455|100676587|FG000|Overall Study|Withdrawal by Subject|2|||
33212194|NCT02925455|100676588|FG001|Overall Study|Withdrawal by Subject|0|||
33212195|NCT05338333|100676589|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
33212196|NCT05338333|100676590|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
33212197|NCT03896035|100676593|FG000|Overall Study|Lost to Follow-up|2|||
33212198|NCT03896035|100676594|FG001|Overall Study|Lost to Follow-up|6|||
33345573|NCT00132041|101156407|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
33345574|NCT00132041|101156407|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
33345575|NCT00132041|101156407|FG000|18 Months Post Ablation|Transplant|1|||
33345576|NCT00132041|101156407|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
33407377|NCT04676022|101380646|FG001|Overall Study|Screen Failure/|1|||
33212199|NCT03896035|100676593|FG000|Overall Study|Withdrawal by Subject|0|||
33212200|NCT03896035|100676594|FG001|Overall Study|Withdrawal by Subject|1|||
33212201|NCT03896035|100676593|FG000|Overall Study|Health/family health issues during COVID|0|||
33212202|NCT03896035|100676594|FG001|Overall Study|Health/family health issues during COVID|4|||
33212203|NCT00045110|100676595|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
33212204|NCT00045110|100676596|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
33212205|NCT00045110|100676597|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
33212206|NCT00045110|100676595|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
33212207|NCT00045110|100676596|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
33345577|NCT00132041|101156407|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
33345578|NCT02809833|101156408|FG000|Overall Study|Death|3|||
33345579|NCT02809833|101156408|FG000|Overall Study|Intolerance|54|||
33345580|NCT02809833|101156408|FG000|Overall Study|Lack of Efficacy|89|||
33345581|NCT02809833|101156408|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
33345582|NCT02809833|101156408|FG000|Overall Study|Noncompliance|1|||
33345583|NCT02809833|101156408|FG000|Overall Study|Withdrawal by Subject|34|||
33345584|NCT02809833|101156408|FG000|Overall Study|Lost to Follow-up|35|||
33345585|NCT02809833|101156408|FG000|Overall Study|Adverse Event (AE)|24|||
33345586|NCT02809833|101156408|FG000|Overall Study|Other|5|||
33345587|NCT02809833|101156408|FG000|Overall Study|Missing Information|52|||
33345588|NCT04557384|101156409|FG000|Overall Study|Study Terminated by Sponsor|1|||
33345589|NCT04557384|101156409|FG000|Overall Study|Death|1|||
33345590|NCT02111564|101156410|FG000|Overall Study|Death|109|||
33345591|NCT02111564|101156411|FG001|Overall Study|Death|120|||
33345592|NCT02111564|101156410|FG000|Overall Study|Lost to Follow-up|2|||
33345593|NCT02111564|101156411|FG001|Overall Study|Lost to Follow-up|3|||
33345594|NCT02111564|101156410|FG000|Overall Study|Withdrawal by Subject|20|||
33345595|NCT02111564|101156411|FG001|Overall Study|Withdrawal by Subject|20|||
33345596|NCT00741819|101156412|FG000|Overall Study|Adverse Event|3|||
33345597|NCT00741819|101156412|FG000|Overall Study|Withdrawal by Subject|3|||
33345598|NCT00741819|101156412|FG000|Overall Study|Death|1|||
33345599|NCT00741819|101156412|FG000|Overall Study|Disease progression|1|||
33345600|NCT02688647|101156413|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
33345601|NCT02688647|101156414|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
33345602|NCT02688647|101156413|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
33345603|NCT02688647|101156414|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
33345604|NCT02688647|101156413|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
33345605|NCT02688647|101156414|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
33345606|NCT02688647|101156413|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
33345607|NCT02688647|101156414|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
33345608|NCT02688647|101156413|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
33345609|NCT02688647|101156414|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
33345610|NCT02688647|101156413|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
33542251|NCT01130272|101885420|FG004|Overall Study|Protocol Violation|5|||
33542252|NCT01130272|101885416|FG000|Overall Study|Lost to Follow-up|4|||
33542253|NCT01130272|101885417|FG001|Overall Study|Lost to Follow-up|3|||
33542254|NCT01130272|101885418|FG002|Overall Study|Lost to Follow-up|4|||
33542255|NCT01130272|101885419|FG003|Overall Study|Lost to Follow-up|7|||
33542256|NCT01130272|101885420|FG004|Overall Study|Lost to Follow-up|6|||
33542257|NCT01130272|101885416|FG000|Overall Study|Withdrawal by Subject|4|||
33345611|NCT02688647|101156414|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
33345612|NCT02688647|101156413|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
33345613|NCT02688647|101156414|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
33345614|NCT02363478|101156415|FG000|Overall Study|Lost to Follow-up|4|||
33345615|NCT02363478|101156415|FG000|Overall Study|Adverse Event|4|||
33345616|NCT00709956|101156416|FG000|Overall Study|Withdrawal by Subject|1|||
33542258|NCT01130272|101885417|FG001|Overall Study|Withdrawal by Subject|11|||
33345617|NCT00709956|101156417|FG001|Overall Study|Withdrawal by Subject|1|||
33542259|NCT01130272|101885418|FG002|Overall Study|Withdrawal by Subject|10|||
33542260|NCT01130272|101885419|FG003|Overall Study|Withdrawal by Subject|9|||
33345618|NCT00709956|101156416|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
33542261|NCT01130272|101885420|FG004|Overall Study|Withdrawal by Subject|8|||
33542262|NCT01130272|101885416|FG000|Overall Study|Physician Decision|1|||
33542263|NCT01130272|101885417|FG001|Overall Study|Physician Decision|1|||
33542264|NCT01130272|101885418|FG002|Overall Study|Physician Decision|0|||
33542265|NCT01130272|101885419|FG003|Overall Study|Physician Decision|1|||
33542266|NCT01130272|101885420|FG004|Overall Study|Physician Decision|2|||
33542267|NCT01130272|101885416|FG000|Overall Study|Sponsor decision|6|||
33542268|NCT01130272|101885417|FG001|Overall Study|Sponsor decision|15|||
33542269|NCT01130272|101885418|FG002|Overall Study|Sponsor decision|16|||
33542270|NCT01130272|101885419|FG003|Overall Study|Sponsor decision|13|||
33542271|NCT01130272|101885420|FG004|Overall Study|Sponsor decision|16|||
33542272|NCT01130272|101885416|FG000|Overall Study|Study arm discontinued|38|||
33542273|NCT01130272|101885417|FG001|Overall Study|Study arm discontinued|0|||
33542274|NCT01130272|101885418|FG002|Overall Study|Study arm discontinued|0|||
33542275|NCT01130272|101885419|FG003|Overall Study|Study arm discontinued|0|||
33542276|NCT01130272|101885420|FG004|Overall Study|Study arm discontinued|0|||
33542277|NCT03329885|101885422|FG000|Overall Study|Sponsor discontinued the study early|0|||
33345619|NCT00709956|101156417|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
33345620|NCT02292771|101156418|FG000|Overall Study|Withdrawal by Subject|2|||
33345621|NCT02292771|101156419|FG001|Overall Study|Withdrawal by Subject|1|||
33212208|NCT00045110|100676597|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
33212209|NCT00045110|100676595|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
33212210|NCT00045110|100676596|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
33212211|NCT00045110|100676597|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
33212212|NCT01152580|100676599|FG000|Overall Study|Withdrawal by Subject|0|||
33212213|NCT01152580|100676600|FG001|Overall Study|Withdrawal by Subject|1|||
33212214|NCT00092534|100676601|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
33212215|NCT00092534|100676602|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
33212216|NCT00092534|100676603|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
33212217|NCT00092534|100676604|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
33212218|NCT00092534|100676605|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
33212219|NCT00092534|100676601|FG000|Base Study Vaccination Period|Adverse Event|3|||
33212220|NCT00092534|100676602|FG001|Base Study Vaccination Period|Adverse Event|1|||
33212221|NCT00092534|100676603|FG002|Base Study Vaccination Period|Adverse Event|0|||
33212222|NCT00092534|100676604|FG003|Base Study Vaccination Period|Adverse Event|0|||
33212223|NCT00092534|100676605|FG004|Base Study Vaccination Period|Adverse Event|0|||
33212224|NCT00092534|100676601|FG000|Base Study Vaccination Period|Death|5|||
33212225|NCT00092534|100676602|FG001|Base Study Vaccination Period|Death|4|||
33212226|NCT00092534|100676603|FG002|Base Study Vaccination Period|Death|0|||
33212227|NCT00092534|100676604|FG003|Base Study Vaccination Period|Death|0|||
33212228|NCT00092534|100676605|FG004|Base Study Vaccination Period|Death|0|||
33212229|NCT00092534|100676601|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
33212230|NCT00092534|100676602|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
33212231|NCT00092534|100676603|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
33212232|NCT00092534|100676604|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
33212233|NCT00092534|100676605|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
33212234|NCT00092534|100676601|FG000|Base Study Vaccination Period|Physician Decision|1|||
33212235|NCT00092534|100676602|FG001|Base Study Vaccination Period|Physician Decision|0|||
33212236|NCT00092534|100676603|FG002|Base Study Vaccination Period|Physician Decision|0|||
33212237|NCT00092534|100676604|FG003|Base Study Vaccination Period|Physician Decision|0|||
33212238|NCT00092534|100676605|FG004|Base Study Vaccination Period|Physician Decision|0|||
33212239|NCT00092534|100676601|FG000|Base Study Vaccination Period|Pregnancy|9|||
33212240|NCT00092534|100676602|FG001|Base Study Vaccination Period|Pregnancy|7|||
33212241|NCT00092534|100676603|FG002|Base Study Vaccination Period|Pregnancy|0|||
33212242|NCT00092534|100676604|FG003|Base Study Vaccination Period|Pregnancy|0|||
33212243|NCT00092534|100676605|FG004|Base Study Vaccination Period|Pregnancy|0|||
33212244|NCT00092534|100676601|FG000|Base Study Vaccination Period|Protocol Violation|2|||
33212245|NCT00092534|100676602|FG001|Base Study Vaccination Period|Protocol Violation|1|||
33212246|NCT00092534|100676603|FG002|Base Study Vaccination Period|Protocol Violation|0|||
33212247|NCT00092534|100676604|FG003|Base Study Vaccination Period|Protocol Violation|0|||
33212248|NCT00092534|100676605|FG004|Base Study Vaccination Period|Protocol Violation|0|||
33212249|NCT00092534|100676601|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
33212250|NCT00092534|100676602|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
33212251|NCT00092534|100676603|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
33212252|NCT00092534|100676604|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
33212253|NCT00092534|100676605|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
33615807|NCT02152761|102144211|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
33212254|NCT00092534|100676601|FG000|Base Study Vaccination Period|Moved|14|||
33407378|NCT04676022|101380647|FG002|Overall Study|Screen Failure/|85|||
33542278|NCT03329885|101885423|FG001|Overall Study|Sponsor discontinued the study early|0|||
33542279|NCT03329885|101885424|FG002|Overall Study|Sponsor discontinued the study early|0|||
33615808|NCT02152761|102144212|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
33212255|NCT00092534|100676602|FG001|Base Study Vaccination Period|Moved|12|||
33212256|NCT00092534|100676603|FG002|Base Study Vaccination Period|Moved|0|||
33212257|NCT00092534|100676604|FG003|Base Study Vaccination Period|Moved|0|||
33542280|NCT03329885|101885425|FG003|Overall Study|Sponsor discontinued the study early|0|||
33407379|NCT04676022|101380645|FG000|Overall Study|Lost to Follow-up|1|||
33407380|NCT04676022|101380646|FG001|Overall Study|Lost to Follow-up|1|||
33407381|NCT04676022|101380647|FG002|Overall Study|Lost to Follow-up|0|||
33407382|NCT04676022|101380645|FG000|Overall Study|Adverse Event|2|||
33407383|NCT04676022|101380646|FG001|Overall Study|Adverse Event|0|||
33407384|NCT04676022|101380647|FG002|Overall Study|Adverse Event|1|||
33407385|NCT04676022|101380645|FG000|Overall Study|Physician Decision|2|||
33407386|NCT04676022|101380646|FG001|Overall Study|Physician Decision|0|||
33407387|NCT04676022|101380647|FG002|Overall Study|Physician Decision|1|||
33407388|NCT04676022|101380645|FG000|Overall Study|Withdrawal by Subject|3|||
33407389|NCT04676022|101380646|FG001|Overall Study|Withdrawal by Subject|1|||
33407390|NCT04676022|101380647|FG002|Overall Study|Withdrawal by Subject|6|||
33407391|NCT04676022|101380645|FG000|Overall Study|Will not move forward with permanent implant|6|||
33407392|NCT04676022|101380646|FG001|Overall Study|Will not move forward with permanent implant|0|||
33407393|NCT04676022|101380647|FG002|Overall Study|Will not move forward with permanent implant|0|||
33407394|NCT04676022|101380645|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
33407395|NCT04676022|101380646|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
33407396|NCT04676022|101380647|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
33407397|NCT01084096|101380648|FG000|Overall Study|Lost to Follow-up|1501|||
33407398|NCT01084096|101380649|FG001|Overall Study|Lost to Follow-up|1833|||
33407399|NCT01084096|101380648|FG000|Overall Study|Withdrawal by Subject|3|||
33407400|NCT01084096|101380649|FG001|Overall Study|Withdrawal by Subject|0|||
33407401|NCT01084096|101380648|FG000|Overall Study|Woman had a miscarriage|21|||
33407402|NCT01084096|101380649|FG001|Overall Study|Woman had a miscarriage|17|||
33407403|NCT04001790|101380650|FG000|Overall Study|Withdrawal by Subject|1|||
33407404|NCT04001790|101380651|FG001|Overall Study|Withdrawal by Subject|2|||
33407405|NCT01054443|101380652|FG000|Overall Study|Withdrawal by Subject|0|||
33407406|NCT01054443|101380653|FG001|Overall Study|Withdrawal by Subject|0|||
33407407|NCT01054443|101380654|FG002|Overall Study|Withdrawal by Subject|0|||
33407408|NCT01054443|101380655|FG003|Overall Study|Withdrawal by Subject|1|||
33407409|NCT05602818|101380656|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
33407410|NCT05602818|101380657|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
33407411|NCT05602818|101380658|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
33542281|NCT03329885|101885426|FG004|Overall Study|Sponsor discontinued the study early|0|||
33542282|NCT03329885|101885427|FG005|Overall Study|Sponsor discontinued the study early|0|||
33542283|NCT03329885|101885428|FG006|Overall Study|Sponsor discontinued the study early|1|||
33542284|NCT03329885|101885429|FG007|Overall Study|Sponsor discontinued the study early|1|||
33542285|NCT03329885|101885430|FG008|Overall Study|Sponsor discontinued the study early|0|||
33542286|NCT02497469|101885431|FG000|Overall Study|Randomized but not Treated|0|||
33542287|NCT02497469|101885432|FG001|Overall Study|Randomized but not Treated|2|||
33542288|NCT02497469|101885431|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
33542289|NCT02497469|101885432|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
33542290|NCT02497469|101885431|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
33542291|NCT02497469|101885432|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
33542292|NCT02497469|101885431|FG000|Overall Study|Significant Protocol Deviation|4|||
33542293|NCT02497469|101885432|FG001|Overall Study|Significant Protocol Deviation|5|||
33542294|NCT02497469|101885431|FG000|Overall Study|Lost to Follow-up|14|||
33542295|NCT02497469|101885432|FG001|Overall Study|Lost to Follow-up|4|||
33542296|NCT02497469|101885431|FG000|Overall Study|Voluntary Withdrawal|39|||
33542297|NCT02497469|101885432|FG001|Overall Study|Voluntary Withdrawal|41|||
33542298|NCT02497469|101885431|FG000|Overall Study|Pregnancy|1|||
33542299|NCT02497469|101885432|FG001|Overall Study|Pregnancy|1|||
33542300|NCT02497469|101885431|FG000|Overall Study|Lack of Efficacy|86|||
33542301|NCT02497469|101885432|FG001|Overall Study|Lack of Efficacy|40|||
33542302|NCT02497469|101885431|FG000|Overall Study|Reason not Specified|6|||
33542303|NCT02497469|101885432|FG001|Overall Study|Reason not Specified|6|||
33542304|NCT01516216|101885433|FG000|Overall Study|Adverse Event|2|||
33542305|NCT01516216|101885434|FG001|Overall Study|Adverse Event|4|||
33542306|NCT01516216|101885433|FG000|Overall Study|Disease Progression|38|||
33542307|NCT01516216|101885434|FG001|Overall Study|Disease Progression|34|||
33542308|NCT01516216|101885433|FG000|Overall Study|Withdrawal by Subject|9|||
33542309|NCT01516216|101885434|FG001|Overall Study|Withdrawal by Subject|11|||
33542310|NCT01516216|101885433|FG000|Overall Study|Potentially Curative Resection|6|||
33542311|NCT01516216|101885434|FG001|Overall Study|Potentially Curative Resection|12|||
33542312|NCT01516216|101885433|FG000|Overall Study|Nonadherence|2|||
33542313|NCT01516216|101885434|FG001|Overall Study|Nonadherence|3|||
33542314|NCT01516216|101885433|FG000|Overall Study|Physician Decision|6|||
33407412|NCT05602818|101380659|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
33407413|NCT05602818|101380660|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
33407414|NCT05602818|101380661|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
33407415|NCT05602818|101380662|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
33407416|NCT05602818|101380663|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
33407417|NCT05602818|101380664|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
33407418|NCT05602818|101380665|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
33407419|NCT05602818|101380666|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
33407420|NCT05602818|101380667|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
33407421|NCT05602818|101380656|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
33407422|NCT05602818|101380657|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
33407423|NCT05602818|101380658|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
33407424|NCT05602818|101380659|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
33407425|NCT05602818|101380660|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
33407426|NCT05602818|101380661|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
33407427|NCT05602818|101380662|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
33407428|NCT05602818|101380663|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
33407429|NCT05602818|101380664|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
33407430|NCT05602818|101380665|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
33407431|NCT05602818|101380666|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
33407432|NCT05602818|101380667|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
33407433|NCT05602818|101380656|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
33407434|NCT05602818|101380657|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
33407435|NCT05602818|101380658|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
33407436|NCT05602818|101380659|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
33407437|NCT05602818|101380660|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
33407438|NCT05602818|101380661|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
33407439|NCT05602818|101380662|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
33407440|NCT05602818|101380663|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
33407441|NCT05602818|101380664|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
33407442|NCT05602818|101380665|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
33407443|NCT05602818|101380666|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
33407444|NCT05602818|101380667|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
33407445|NCT05602818|101380656|FG000|Qualification Phase (3 Days)|Other|1|||
33407446|NCT05602818|101380657|FG001|Qualification Phase (3 Days)|Other|0|||
33407447|NCT05602818|101380658|FG002|Qualification Phase (3 Days)|Other|0|||
33407448|NCT05602818|101380659|FG003|Qualification Phase (3 Days)|Other|0|||
33407449|NCT05602818|101380660|FG004|Qualification Phase (3 Days)|Other|0|||
33407450|NCT05602818|101380661|FG005|Qualification Phase (3 Days)|Other|0|||
33407451|NCT05602818|101380662|FG006|Qualification Phase (3 Days)|Other|0|||
33407452|NCT05602818|101380663|FG007|Qualification Phase (3 Days)|Other|0|||
33407453|NCT05602818|101380664|FG008|Qualification Phase (3 Days)|Other|0|||
33407454|NCT05602818|101380665|FG009|Qualification Phase (3 Days)|Other|0|||
33407455|NCT05602818|101380666|FG010|Qualification Phase (3 Days)|Other|0|||
33407456|NCT05602818|101380667|FG011|Qualification Phase (3 Days)|Other|0|||
33407457|NCT05602818|101380656|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
33407458|NCT05602818|101380657|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
33407459|NCT05602818|101380658|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
33407460|NCT05602818|101380659|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
33407461|NCT05602818|101380660|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
33407462|NCT05602818|101380661|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
33407463|NCT05602818|101380662|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
33407464|NCT05602818|101380663|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
33407465|NCT05602818|101380664|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
33407466|NCT05602818|101380665|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
33407467|NCT05602818|101380666|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
33407468|NCT05602818|101380667|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
33407469|NCT05602818|101380656|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
33407470|NCT05602818|101380657|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
33407471|NCT05602818|101380658|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
33407472|NCT05602818|101380659|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
33542315|NCT01516216|101885434|FG001|Overall Study|Physician Decision|3|||
33542316|NCT01516216|101885433|FG000|Overall Study|Prolonged Treatment Delay|5|||
33212258|NCT00092534|100676605|FG004|Base Study Vaccination Period|Moved|0|||
33212259|NCT00092534|100676601|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
33542317|NCT01516216|101885434|FG001|Overall Study|Prolonged Treatment Delay|1|||
33212260|NCT00092534|100676602|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
33212261|NCT00092534|100676603|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
33212262|NCT00092534|100676604|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
33407473|NCT05602818|101380660|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
33615809|NCT02152761|102144213|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
33615810|NCT02152761|102144210|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
33615811|NCT02152761|102144211|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
33615812|NCT02152761|102144212|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
33615813|NCT02152761|102144213|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
33615814|NCT02152761|102144210|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
33615815|NCT02152761|102144211|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
33615816|NCT02152761|102144212|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
33615817|NCT02152761|102144213|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
33615818|NCT02152761|102144210|FG000|Epoch: Treatment Epoch|Death|0|||
33615819|NCT02152761|102144211|FG001|Epoch: Treatment Epoch|Death|3|||
33615820|NCT02152761|102144212|FG002|Epoch: Treatment Epoch|Death|1|||
33615821|NCT02152761|102144213|FG003|Epoch: Treatment Epoch|Death|0|||
33615822|NCT02152761|102144210|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
33615823|NCT02152761|102144211|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
33615824|NCT02152761|102144212|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
33615825|NCT02152761|102144213|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
33615826|NCT02152761|102144210|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
33615827|NCT02152761|102144211|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
33615828|NCT02152761|102144212|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
33615829|NCT02152761|102144213|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
33615830|NCT02152761|102144210|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
33615831|NCT02152761|102144211|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
33615832|NCT02152761|102144212|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
33615833|NCT02152761|102144213|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
33615834|NCT02152761|102144210|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
33407474|NCT05602818|101380661|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
33407475|NCT05602818|101380662|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
33407476|NCT05602818|101380663|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
33407477|NCT05602818|101380664|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
33407478|NCT05602818|101380665|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
33407479|NCT05602818|101380666|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
33407480|NCT05602818|101380667|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
33407481|NCT05602818|101380656|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
33407482|NCT05602818|101380657|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
33615835|NCT02152761|102144211|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
33615836|NCT02152761|102144212|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
33615837|NCT02152761|102144213|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
33615838|NCT02152761|102144210|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
33615839|NCT02152761|102144211|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
33615840|NCT02152761|102144212|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
33615841|NCT02152761|102144213|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
33615842|NCT00660179|102144214|FG000|Overall Study|Death|44|||
33615843|NCT00660179|102144215|FG001|Overall Study|Death|47|||
33615844|NCT00660179|102144216|FG002|Overall Study|Death|34|||
33615845|NCT00660179|102144214|FG000|Overall Study|Withdrawal of consent|4|||
33407483|NCT05602818|101380658|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
33407484|NCT05602818|101380659|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
33407485|NCT05602818|101380660|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
33407486|NCT05602818|101380661|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
33407487|NCT05602818|101380662|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
33407488|NCT05602818|101380663|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
33407489|NCT05602818|101380664|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
33407490|NCT05602818|101380665|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
33407491|NCT05602818|101380666|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
33615846|NCT00660179|102144215|FG001|Overall Study|Withdrawal of consent|6|||
33615847|NCT00660179|102144216|FG002|Overall Study|Withdrawal of consent|4|||
33407492|NCT05602818|101380667|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
33407493|NCT05602818|101380656|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
33407494|NCT05602818|101380657|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
33542318|NCT01516216|101885433|FG000|Overall Study|Intercurrent Illness|1|||
33542319|NCT01516216|101885434|FG001|Overall Study|Intercurrent Illness|0|||
33542320|NCT01516216|101885433|FG000|Overall Study|Death|1|||
33542321|NCT01516216|101885434|FG001|Overall Study|Death|1|||
33542322|NCT01248455|101885447|FG000|Overall Study|switched to alternate treatment|1|||
33542323|NCT00833755|101885451|FG000|Overall Study|Physician Decision|4|||
33542324|NCT00833755|101885452|FG001|Overall Study|Physician Decision|4|||
33542325|NCT00833755|101885453|FG002|Overall Study|Physician Decision|2|||
33542326|NCT00833755|101885454|FG003|Overall Study|Physician Decision|6|||
33542327|NCT00833755|101885451|FG000|Overall Study|Subject had scheduling issues|0|||
33542328|NCT00833755|101885452|FG001|Overall Study|Subject had scheduling issues|1|||
33542329|NCT00833755|101885453|FG002|Overall Study|Subject had scheduling issues|0|||
33542330|NCT00833755|101885454|FG003|Overall Study|Subject had scheduling issues|0|||
33542331|NCT01721798|101885455|FG000|Overall Study|Death|0|||
33542332|NCT01721798|101885456|FG001|Overall Study|Death|0|||
33542333|NCT01721798|101885457|FG002|Overall Study|Death|1|||
33542334|NCT01721798|101885458|FG003|Overall Study|Death|1|||
33542335|NCT01721798|101885455|FG000|Overall Study|Lost to Follow-up|2|||
33542336|NCT01721798|101885456|FG001|Overall Study|Lost to Follow-up|2|||
33212263|NCT00092534|100676605|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
33212264|NCT00092534|100676601|FG000|Base Study Vaccination Period|Travel|1|||
33212265|NCT00092534|100676602|FG001|Base Study Vaccination Period|Travel|0|||
33212266|NCT00092534|100676603|FG002|Base Study Vaccination Period|Travel|0|||
33345622|NCT02292771|101156418|FG000|Overall Study|Lost to Follow-up|2|||
33345623|NCT02292771|101156419|FG001|Overall Study|Lost to Follow-up|1|||
33345624|NCT03609619|101156420|FG000|Overall Study|Adverse Event|1|||
33345625|NCT03609619|101156421|FG001|Overall Study|Adverse Event|0|||
33345626|NCT03609619|101156420|FG000|Overall Study|Lack of Efficacy|1|||
33345627|NCT03609619|101156421|FG001|Overall Study|Lack of Efficacy|2|||
33345628|NCT03609619|101156420|FG000|Overall Study|Protocol Violation|5|||
33345629|NCT03609619|101156421|FG001|Overall Study|Protocol Violation|0|||
33345630|NCT03609619|101156420|FG000|Overall Study|Withdrawal by Subject|2|||
33345631|NCT03609619|101156421|FG001|Overall Study|Withdrawal by Subject|3|||
33345632|NCT03609619|101156420|FG000|Overall Study|Lost to Follow-up|1|||
33345633|NCT03609619|101156421|FG001|Overall Study|Lost to Follow-up|1|||
33345634|NCT02597855|101156424|FG000|Overall Study|Lost to Follow-up|2|||
33345635|NCT02597855|101156425|FG001|Overall Study|Lost to Follow-up|1|||
33345636|NCT00257010|101156428|FG000|Overall Study|Lack of Efficacy|11|||
33345637|NCT00257010|101156428|FG000|Overall Study|Lost to Follow-up|53|||
33345638|NCT00257010|101156428|FG000|Overall Study|Withdrawal by Subject|34|||
33345639|NCT00257010|101156428|FG000|Overall Study|Adverse Event|10|||
33345640|NCT00257010|101156428|FG000|Overall Study|various|11|||
33345641|NCT00257010|101156428|FG000|Overall Study|no headache reported|9|||
33345642|NCT03538743|101156429|FG000|Overall Study|Adverse Event|0|||
33345643|NCT03538743|101156430|FG001|Overall Study|Adverse Event|0|||
33345644|NCT03538743|101156431|FG002|Overall Study|Adverse Event|1|||
33345645|NCT03538743|101156432|FG003|Overall Study|Adverse Event|1|||
33345646|NCT03538743|101156433|FG004|Overall Study|Adverse Event|0|||
33345647|NCT03538743|101156434|FG005|Overall Study|Adverse Event|0|||
33542337|NCT01721798|101885457|FG002|Overall Study|Lost to Follow-up|9|||
33345648|NCT03538743|101156435|FG006|Overall Study|Adverse Event|0|||
33542338|NCT01721798|101885458|FG003|Overall Study|Lost to Follow-up|9|||
33345649|NCT03538743|101156436|FG007|Overall Study|Adverse Event|0|||
33345650|NCT03538743|101156437|FG008|Overall Study|Adverse Event|0|||
33542339|NCT01721798|101885455|FG000|Overall Study|Pregnancy|0|||
33542340|NCT01721798|101885456|FG001|Overall Study|Pregnancy|0|||
33542341|NCT01721798|101885457|FG002|Overall Study|Pregnancy|1|||
33542342|NCT01721798|101885458|FG003|Overall Study|Pregnancy|1|||
33542343|NCT01721798|101885455|FG000|Overall Study|Withdrawal by Subject|1|||
33542344|NCT01721798|101885456|FG001|Overall Study|Withdrawal by Subject|0|||
33542345|NCT01721798|101885457|FG002|Overall Study|Withdrawal by Subject|2|||
33542346|NCT01721798|101885458|FG003|Overall Study|Withdrawal by Subject|1|||
33542347|NCT01721798|101885455|FG000|Overall Study|Not eligible for 24 month visit|1|||
33542348|NCT01721798|101885456|FG001|Overall Study|Not eligible for 24 month visit|0|||
33542349|NCT01721798|101885457|FG002|Overall Study|Not eligible for 24 month visit|8|||
33542350|NCT01721798|101885458|FG003|Overall Study|Not eligible for 24 month visit|7|||
33542351|NCT00314145|101885462|FG000|Overall Study|Withdrawal by Subject|8|||
33345651|NCT03538743|101156429|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
33345652|NCT03538743|101156430|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
33345653|NCT03538743|101156431|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
33542352|NCT00314145|101885463|FG001|Overall Study|Withdrawal by Subject|10|||
33542353|NCT00314145|101885462|FG000|Overall Study|Lost to Follow-up|5|||
33542354|NCT00314145|101885463|FG001|Overall Study|Lost to Follow-up|12|||
33542355|NCT00314145|101885462|FG000|Overall Study|Physician Decision|3|||
33542356|NCT00314145|101885463|FG001|Overall Study|Physician Decision|4|||
33542357|NCT00314145|101885462|FG000|Overall Study|Adverse Event|0|||
33542358|NCT00314145|101885463|FG001|Overall Study|Adverse Event|3|||
33542359|NCT00314145|101885462|FG000|Overall Study|Protocol Violation|3|||
33542360|NCT00314145|101885463|FG001|Overall Study|Protocol Violation|0|||
33542361|NCT00314145|101885462|FG000|Overall Study|Sponsor Decision|2|||
33542362|NCT00314145|101885463|FG001|Overall Study|Sponsor Decision|0|||
33542363|NCT01631214|101885464|FG000|Overall Study|Withdrawal by Subject|276|||
33542364|NCT01631214|101885465|FG001|Overall Study|Withdrawal by Subject|290|||
33542365|NCT01631214|101885464|FG000|Overall Study|Death|113|||
33542366|NCT01631214|101885465|FG001|Overall Study|Death|106|||
33542367|NCT01631214|101885464|FG000|Overall Study|Lost to Follow-up|54|||
33542368|NCT01631214|101885465|FG001|Overall Study|Lost to Follow-up|40|||
33542369|NCT01631214|101885464|FG000|Overall Study|Adverse Event|45|||
33542370|NCT01631214|101885465|FG001|Overall Study|Adverse Event|45|||
33542371|NCT01631214|101885464|FG000|Overall Study|Other|22|||
33542372|NCT01631214|101885465|FG001|Overall Study|Other|19|||
33542373|NCT01631214|101885464|FG000|Overall Study|Noncompliance|16|||
33542374|NCT01631214|101885465|FG001|Overall Study|Noncompliance|15|||
33542375|NCT01631214|101885464|FG000|Overall Study|Requirement for Alternative Therapy|8|||
33542376|NCT01631214|101885465|FG001|Overall Study|Requirement for Alternative Therapy|3|||
33542377|NCT01631214|101885464|FG000|Overall Study|Protocol Deviation|4|||
33542378|NCT01631214|101885465|FG001|Overall Study|Protocol Deviation|3|||
33542379|NCT01631214|101885464|FG000|Overall Study|Ineligibility determined|5|||
33542380|NCT01631214|101885465|FG001|Overall Study|Ineligibility determined|2|||
33542381|NCT01631214|101885464|FG000|Overall Study|Administrative Decision|1|||
33542382|NCT01631214|101885465|FG001|Overall Study|Administrative Decision|0|||
33542383|NCT02030600|101885466|FG000|Treatment Period 1|Adverse Event|5|||
33542384|NCT02030600|101885467|FG001|Treatment Period 1|Adverse Event|7|||
33542385|NCT02030600|101885466|FG000|Treatment Period 1|Lack of Efficacy|0|||
33542386|NCT02030600|101885467|FG001|Treatment Period 1|Lack of Efficacy|1|||
33542387|NCT02030600|101885466|FG000|Treatment Period 1|Lost to Follow-up|11|||
33542388|NCT02030600|101885467|FG001|Treatment Period 1|Lost to Follow-up|3|||
33542389|NCT02030600|101885466|FG000|Treatment Period 1|Protocol Violation|22|||
33542390|NCT02030600|101885467|FG001|Treatment Period 1|Protocol Violation|17|||
33542391|NCT02030600|101885466|FG000|Treatment Period 1|Withdrawal by Subject|13|||
33542392|NCT02030600|101885467|FG001|Treatment Period 1|Withdrawal by Subject|17|||
33542393|NCT02030600|101885466|FG000|Treatment Period 1|Casebook Unsigned|1|||
33542394|NCT02030600|101885467|FG001|Treatment Period 1|Casebook Unsigned|0|||
33542395|NCT02030600|101885466|FG000|Treatment Period 1|Unclassified|1|||
33345654|NCT03538743|101156432|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
33542396|NCT02030600|101885467|FG001|Treatment Period 1|Unclassified|0|||
33542397|NCT02030600|101885466|FG000|Treatment Period 2|Adverse Event|4|||
33542398|NCT02030600|101885467|FG001|Treatment Period 2|Adverse Event|4|||
33542399|NCT02030600|101885466|FG000|Treatment Period 2|Lack of Efficacy|2|||
33542400|NCT02030600|101885467|FG001|Treatment Period 2|Lack of Efficacy|1|||
33542401|NCT02030600|101885466|FG000|Treatment Period 2|Lost to Follow-up|4|||
33542402|NCT02030600|101885467|FG001|Treatment Period 2|Lost to Follow-up|2|||
33542403|NCT02030600|101885466|FG000|Treatment Period 2|Protocol Violation|1|||
33542404|NCT02030600|101885467|FG001|Treatment Period 2|Protocol Violation|2|||
33345655|NCT03538743|101156433|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
33542405|NCT02030600|101885466|FG000|Treatment Period 2|Withdrawal by Subject|13|||
33542406|NCT02030600|101885467|FG001|Treatment Period 2|Withdrawal by Subject|9|||
33542407|NCT02030600|101885466|FG000|Treatment Period 2|Unclassified|1|||
33542408|NCT02030600|101885467|FG001|Treatment Period 2|Unclassified|0|||
33542409|NCT01299909|101885468|FG000|Overall Study|Lost to Follow-up|22|||
33542410|NCT01299909|101885469|FG001|Overall Study|Lost to Follow-up|18|||
33542411|NCT01299909|101885470|FG002|Overall Study|Lost to Follow-up|17|||
33615848|NCT00660179|102144214|FG000|Overall Study|Lost to Follow-up|7|||
33542412|NCT01277861|101885477|FG000|Overall Study|Physician Decision|2|||
33542413|NCT01277861|101885478|FG001|Overall Study|Physician Decision|2|||
33542414|NCT01125930|101885479|FG000|Overall Study|Adverse Event|0|||
33542415|NCT01125930|101885480|FG001|Overall Study|Adverse Event|1|||
33542416|NCT01125930|101885479|FG000|Overall Study|Withdrawal by Subject|1|||
33542417|NCT01125930|101885480|FG001|Overall Study|Withdrawal by Subject|6|||
33542418|NCT01125930|101885479|FG000|Overall Study|Protocol Violation|0|||
33542419|NCT01125930|101885480|FG001|Overall Study|Protocol Violation|1|||
33542420|NCT01125930|101885479|FG000|Overall Study|Lost to Follow-up|0|||
33542421|NCT01125930|101885480|FG001|Overall Study|Lost to Follow-up|2|||
33542422|NCT01253161|101885482|FG000|Overall Study|Adverse Event|1|||
33542423|NCT03630393|101885483|FG000|Overall Study|Death|1|||
33542424|NCT03630393|101885484|FG001|Overall Study|Death|0|||
33542425|NCT01704261|101885485|FG000|Overall Study|Withdrawal by Subject|12|||
33542426|NCT01704261|101885486|FG001|Overall Study|Withdrawal by Subject|15|||
33542427|NCT01704261|101885485|FG000|Overall Study|Lost to Follow-up|1|||
33542428|NCT01704261|101885486|FG001|Overall Study|Lost to Follow-up|0|||
33542429|NCT01259245|101885487|FG000|Overall Study|Withdrawal by Subject|27|||
33542430|NCT01259245|101885488|FG001|Overall Study|Withdrawal by Subject|24|||
33542431|NCT01259245|101885487|FG000|Overall Study|Death|1|||
33542432|NCT01259245|101885488|FG001|Overall Study|Death|2|||
33542433|NCT02472353|101885489|FG000|Overall Study|Lost to Follow-up|1|||
33542434|NCT02472353|101885490|FG001|Overall Study|Lost to Follow-up|1|||
33212267|NCT00092534|100676604|FG003|Base Study Vaccination Period|Travel|0|||
33212268|NCT00092534|100676605|FG004|Base Study Vaccination Period|Travel|0|||
33542435|NCT02472353|101885489|FG000|Overall Study|Withdrawal by Subject|2|||
33542436|NCT02472353|101885490|FG001|Overall Study|Withdrawal by Subject|1|||
33542437|NCT02472353|101885489|FG000|Overall Study|Study Termination|1|||
33212269|NCT00092534|100676601|FG000|Base Study Vaccination Period|Site Closed|0|||
33212270|NCT00092534|100676602|FG001|Base Study Vaccination Period|Site Closed|1|||
33212271|NCT00092534|100676603|FG002|Base Study Vaccination Period|Site Closed|0|||
33542438|NCT02472353|101885490|FG001|Overall Study|Study Termination|4|||
33542439|NCT00487188|101885493|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
33542440|NCT00487188|101885494|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
33542441|NCT00487188|101885495|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
33542442|NCT00487188|101885493|FG000|Induction Phase|Adverse Event|5|||
33542443|NCT00487188|101885494|FG001|Induction Phase|Adverse Event|0|||
33212272|NCT00092534|100676604|FG003|Base Study Vaccination Period|Site Closed|0|||
33212273|NCT00092534|100676605|FG004|Base Study Vaccination Period|Site Closed|0|||
33212274|NCT00092534|100676601|FG000|Base Study Follow-Up Period|Adverse Event|2|||
33212275|NCT00092534|100676602|FG001|Base Study Follow-Up Period|Adverse Event|4|||
33212276|NCT00092534|100676603|FG002|Base Study Follow-Up Period|Adverse Event|0|||
33212277|NCT00092534|100676604|FG003|Base Study Follow-Up Period|Adverse Event|0|||
33212278|NCT00092534|100676605|FG004|Base Study Follow-Up Period|Adverse Event|0|||
33212279|NCT00092534|100676601|FG000|Base Study Follow-Up Period|Death|2|||
33212280|NCT00092534|100676602|FG001|Base Study Follow-Up Period|Death|1|||
33212281|NCT00092534|100676603|FG002|Base Study Follow-Up Period|Death|0|||
33542444|NCT00487188|101885495|FG002|Induction Phase|Adverse Event|0|||
33542445|NCT00487188|101885493|FG000|Induction Phase|Lack of Efficacy|0|||
33542446|NCT00487188|101885494|FG001|Induction Phase|Lack of Efficacy|1|||
33542447|NCT00487188|101885495|FG002|Induction Phase|Lack of Efficacy|0|||
33542448|NCT00487188|101885493|FG000|Induction Phase|Protocol Violation|1|||
33542449|NCT00487188|101885494|FG001|Induction Phase|Protocol Violation|0|||
33542450|NCT00487188|101885495|FG002|Induction Phase|Protocol Violation|0|||
33542451|NCT00487188|101885493|FG000|Induction Phase|Refused Treatment|1|||
33542452|NCT00487188|101885494|FG001|Induction Phase|Refused Treatment|2|||
33542453|NCT00487188|101885495|FG002|Induction Phase|Refused Treatment|0|||
33542454|NCT00487188|101885493|FG000|Induction Phase|Lost to Follow-up|2|||
33542455|NCT00487188|101885494|FG001|Induction Phase|Lost to Follow-up|2|||
33542456|NCT00487188|101885495|FG002|Induction Phase|Lost to Follow-up|0|||
33542457|NCT00487188|101885493|FG000|Induction Phase|Administrative|0|||
33542458|NCT00487188|101885494|FG001|Induction Phase|Administrative|1|||
33542459|NCT00487188|101885495|FG002|Induction Phase|Administrative|0|||
33542460|NCT00487188|101885493|FG000|Maintenance Phase|Adverse Event|1|||
33345656|NCT03538743|101156434|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
33345657|NCT03538743|101156435|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
33345658|NCT03538743|101156436|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
33345659|NCT03538743|101156437|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
33542461|NCT00487188|101885494|FG001|Maintenance Phase|Adverse Event|0|||
33542462|NCT00487188|101885495|FG002|Maintenance Phase|Adverse Event|0|||
33542463|NCT00487188|101885493|FG000|Maintenance Phase|Death|1|||
33542464|NCT00487188|101885494|FG001|Maintenance Phase|Death|0|||
33542465|NCT00487188|101885495|FG002|Maintenance Phase|Death|0|||
33542466|NCT00487188|101885493|FG000|Maintenance Phase|Lost to Follow-up|1|||
33542467|NCT00487188|101885494|FG001|Maintenance Phase|Lost to Follow-up|0|||
33542468|NCT00487188|101885495|FG002|Maintenance Phase|Lost to Follow-up|0|||
33542469|NCT00487188|101885493|FG000|Maintenance Phase|Administrative|0|||
33542470|NCT00487188|101885494|FG001|Maintenance Phase|Administrative|0|||
33542471|NCT00487188|101885495|FG002|Maintenance Phase|Administrative|1|||
33542472|NCT00350545|101885496|FG000|Overall Study|Withdrawal by Subject|2|||
33542473|NCT03427892|101885498|FG000|Overall Study|Lost to Follow-up|2|||
33542474|NCT00726453|101885499|FG000|Primary Enrollment Group|Death|18|||
33542475|NCT00726453|101885500|FG001|Primary Enrollment Group|Death|0|||
33542476|NCT00726453|101885499|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
33542477|NCT00726453|101885500|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
33542478|NCT00726453|101885499|FG000|38 mm Length Group|Death|0|||
33542479|NCT00726453|101885500|FG001|38 mm Length Group|Death|3|||
33542480|NCT02349386|101885501|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
33542481|NCT02349386|101885502|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
33542482|NCT02349386|101885503|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
33542483|NCT02349386|101885504|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
33542484|NCT02349386|101885501|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
33345660|NCT03538743|101156429|FG000|Overall Study|Withdrawal by Subject|0|||
33542485|NCT02349386|101885502|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
33542486|NCT02349386|101885503|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
33542487|NCT02349386|101885504|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
33542488|NCT02349386|101885501|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
33542489|NCT02349386|101885502|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
33542490|NCT02349386|101885503|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
33542491|NCT02349386|101885504|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
33567613|NCT02723955|101973211|FG042|Crossover/ Re-treatment Phase|Death|0|||
33345661|NCT03538743|101156430|FG001|Overall Study|Withdrawal by Subject|0|||
33345662|NCT03538743|101156431|FG002|Overall Study|Withdrawal by Subject|0|||
33345663|NCT03538743|101156432|FG003|Overall Study|Withdrawal by Subject|1|||
33345664|NCT03538743|101156433|FG004|Overall Study|Withdrawal by Subject|0|||
33345665|NCT03538743|101156434|FG005|Overall Study|Withdrawal by Subject|0|||
33542492|NCT02349386|101885501|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
33542493|NCT02349386|101885502|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
33542494|NCT02349386|101885503|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
33542495|NCT02349386|101885504|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
33542496|NCT02349386|101885501|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
33542497|NCT02349386|101885502|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
33542498|NCT02349386|101885503|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
33542499|NCT02349386|101885504|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
33542500|NCT02349386|101885501|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
33542501|NCT02349386|101885502|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
33542502|NCT02349386|101885503|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
33542503|NCT02349386|101885504|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
33542504|NCT03101020|101885505|FG000|Overall Study|Lack of time to participate|1|||
33542505|NCT03101020|101885506|FG001|Overall Study|Lack of time to participate|0|||
33542506|NCT03101020|101885505|FG000|Overall Study|Ran over by a car|0|||
33542507|NCT03101020|101885506|FG001|Overall Study|Ran over by a car|1|||
33542508|NCT03101020|101885505|FG000|Overall Study|Withdrawal by Subject|0|||
33542509|NCT03101020|101885506|FG001|Overall Study|Withdrawal by Subject|2|||
33542510|NCT03055936|101885507|FG000|Overall Study|Adverse Event|0|||
33542511|NCT03055936|101885508|FG001|Overall Study|Adverse Event|1|||
33542512|NCT03055936|101885509|FG002|Overall Study|Adverse Event|1|||
33542513|NCT03055936|101885510|FG003|Overall Study|Adverse Event|1|||
33542514|NCT03055936|101885507|FG000|Overall Study|Personal reason|2|||
33542515|NCT03055936|101885508|FG001|Overall Study|Personal reason|0|||
33542516|NCT03055936|101885509|FG002|Overall Study|Personal reason|1|||
33542517|NCT03055936|101885510|FG003|Overall Study|Personal reason|0|||
33542518|NCT03408899|101885514|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
33542519|NCT04040439|101885516|FG000|Overall Study|Invalid registration|11|||
33542520|NCT04040439|101885516|FG000|Overall Study|No IC* on publication of study results|2|||
33542521|NCT00701363|101888722|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
33542522|NCT00701363|101888723|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
33542523|NCT00701363|101888724|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
33542524|NCT00701363|101888725|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
33542525|NCT00701363|101888722|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
33542526|NCT00701363|101888723|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
33542527|NCT00701363|101888724|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
33542528|NCT00701363|101888725|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
33542529|NCT00701363|101888722|FG000|Treatment Phase 1|Adverse Event|7|||
33345666|NCT03538743|101156435|FG006|Overall Study|Withdrawal by Subject|0|||
33542530|NCT00701363|101888723|FG001|Treatment Phase 1|Adverse Event|0|||
33542531|NCT00701363|101888724|FG002|Treatment Phase 1|Adverse Event|0|||
33542532|NCT00701363|101888725|FG003|Treatment Phase 1|Adverse Event|0|||
33542533|NCT00701363|101888722|FG000|Treatment Phase 1|Protocol Violation|1|||
33542534|NCT00701363|101888723|FG001|Treatment Phase 1|Protocol Violation|0|||
33542535|NCT00701363|101888724|FG002|Treatment Phase 1|Protocol Violation|0|||
33542536|NCT00701363|101888725|FG003|Treatment Phase 1|Protocol Violation|0|||
33542537|NCT00701363|101888722|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
33212282|NCT00092534|100676604|FG003|Base Study Follow-Up Period|Death|0|||
33345667|NCT03538743|101156436|FG007|Overall Study|Withdrawal by Subject|0|||
33345668|NCT03538743|101156437|FG008|Overall Study|Withdrawal by Subject|0|||
33345669|NCT03446885|101156438|FG000|Overall Study|Lost to Follow-up|1|||
33407495|NCT05602818|101380658|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
33407496|NCT05602818|101380659|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
33542538|NCT00701363|101888723|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
33542539|NCT00701363|101888724|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
33542540|NCT00701363|101888725|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
33542541|NCT00701363|101888722|FG000|Treatment Phase 1|Lack of Efficacy|1|||
33542542|NCT00701363|101888723|FG001|Treatment Phase 1|Lack of Efficacy|0|||
33542543|NCT00701363|101888724|FG002|Treatment Phase 1|Lack of Efficacy|0|||
33542544|NCT00701363|101888725|FG003|Treatment Phase 1|Lack of Efficacy|0|||
33542545|NCT00701363|101888722|FG000|Treatment Phase 2|Adverse Event|0|||
33542546|NCT00701363|101888723|FG001|Treatment Phase 2|Adverse Event|0|||
33542547|NCT00701363|101888724|FG002|Treatment Phase 2|Adverse Event|1|||
33345670|NCT03446885|101156439|FG001|Overall Study|Lost to Follow-up|0|||
33542548|NCT00701363|101888725|FG003|Treatment Phase 2|Adverse Event|0|||
33542549|NCT00701363|101888722|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
33542550|NCT00701363|101888723|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
33542551|NCT00701363|101888724|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
33542552|NCT00701363|101888725|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
33542553|NCT02550795|101888726|FG000|Overall Study|Physician Decision|0|||
33542554|NCT02550795|101888727|FG001|Overall Study|Physician Decision|1|||
33542555|NCT02550795|101888728|FG002|Overall Study|Physician Decision|0|||
33615849|NCT00660179|102144215|FG001|Overall Study|Lost to Follow-up|5|||
33615850|NCT00660179|102144216|FG002|Overall Study|Lost to Follow-up|2|||
33615851|NCT00660179|102144214|FG000|Overall Study|Administrative reason|0|||
33345671|NCT03446885|101156438|FG000|Overall Study|Did not complete entire visit|1|||
33345672|NCT03446885|101156439|FG001|Overall Study|Did not complete entire visit|0|||
33345673|NCT02894840|101156440|FG000|Overall Study|Lost to Follow-up|1|||
33345674|NCT02894840|101156441|FG001|Overall Study|Lost to Follow-up|0|||
33345675|NCT02894840|101156442|FG002|Overall Study|Lost to Follow-up|3|||
33345676|NCT02894840|101156443|FG003|Overall Study|Lost to Follow-up|0|||
33345677|NCT04684420|101156444|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33345678|NCT04684420|101156445|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33345679|NCT04684420|101156446|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
33345680|NCT04684420|101156447|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
33345681|NCT04684420|101156444|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
33345682|NCT04684420|101156445|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
33345683|NCT04684420|101156446|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
33345684|NCT04684420|101156447|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
33345685|NCT03093155|101156449|FG000|Overall Study|Not Eligible|1|||
33345686|NCT03093155|101156450|FG001|Overall Study|Not Eligible|0|||
33615852|NCT00660179|102144215|FG001|Overall Study|Administrative reason|0|||
33615853|NCT00660179|102144216|FG002|Overall Study|Administrative reason|1|||
33615854|NCT00660179|102144214|FG000|Overall Study|Incorrect randomization|1|||
33212283|NCT00092534|100676605|FG004|Base Study Follow-Up Period|Death|0|||
33212284|NCT00092534|100676601|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
33212285|NCT00092534|100676602|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
33212286|NCT00092534|100676603|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
33212287|NCT00092534|100676604|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
33212288|NCT00092534|100676605|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
33212289|NCT00092534|100676601|FG000|Base Study Follow-Up Period|Pregnancy|6|||
33212290|NCT00092534|100676602|FG001|Base Study Follow-Up Period|Pregnancy|10|||
33212291|NCT00092534|100676603|FG002|Base Study Follow-Up Period|Pregnancy|0|||
33212292|NCT00092534|100676604|FG003|Base Study Follow-Up Period|Pregnancy|0|||
33212293|NCT00092534|100676605|FG004|Base Study Follow-Up Period|Pregnancy|0|||
33212294|NCT00092534|100676601|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
33212295|NCT00092534|100676602|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
33212296|NCT00092534|100676603|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
33212297|NCT00092534|100676604|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
33212298|NCT00092534|100676605|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
33345687|NCT03093155|101156449|FG000|Overall Study|Withdrawal by Subject|0|||
33542556|NCT05259917|101888729|FG000|Overall Study|Protocol Violation|0|||
33542557|NCT05259917|101888730|FG001|Overall Study|Protocol Violation|0|||
33542558|NCT05259917|101888731|FG002|Overall Study|Protocol Violation|1|||
33542559|NCT05259917|101888732|FG003|Overall Study|Protocol Violation|0|||
33212299|NCT00092534|100676601|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
33212300|NCT00092534|100676602|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
33212301|NCT00092534|100676603|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
33212302|NCT00092534|100676604|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
33212303|NCT00092534|100676605|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
33212304|NCT00092534|100676601|FG000|Base Study Follow-Up Period|Moved|62|||
33212305|NCT00092534|100676602|FG001|Base Study Follow-Up Period|Moved|58|||
33212306|NCT00092534|100676603|FG002|Base Study Follow-Up Period|Moved|0|||
33212307|NCT00092534|100676604|FG003|Base Study Follow-Up Period|Moved|0|||
33212308|NCT00092534|100676605|FG004|Base Study Follow-Up Period|Moved|0|||
33212309|NCT00092534|100676601|FG000|Base Study Follow-Up Period|Travel|10|||
33212310|NCT00092534|100676602|FG001|Base Study Follow-Up Period|Travel|7|||
33212311|NCT00092534|100676603|FG002|Base Study Follow-Up Period|Travel|0|||
33212312|NCT00092534|100676604|FG003|Base Study Follow-Up Period|Travel|0|||
33212313|NCT00092534|100676605|FG004|Base Study Follow-Up Period|Travel|0|||
33212314|NCT00092534|100676601|FG000|Base Study Follow-Up Period|Site Closed|0|||
33212315|NCT00092534|100676602|FG001|Base Study Follow-Up Period|Site Closed|2|||
33212316|NCT00092534|100676603|FG002|Base Study Follow-Up Period|Site Closed|0|||
33212317|NCT00092534|100676604|FG003|Base Study Follow-Up Period|Site Closed|0|||
33212318|NCT00092534|100676605|FG004|Base Study Follow-Up Period|Site Closed|0|||
33212319|NCT00092534|100676601|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
33212320|NCT00092534|100676602|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
33212321|NCT00092534|100676603|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
33212322|NCT00092534|100676604|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
33212323|NCT00092534|100676605|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
33212324|NCT00092534|100676601|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
33212325|NCT00092534|100676602|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
33212326|NCT00092534|100676603|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
33212327|NCT00092534|100676604|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
33212328|NCT00092534|100676605|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
33212329|NCT00092534|100676601|FG000|Base Study EXT|Lost to Follow-up|0|||
33212330|NCT00092534|100676602|FG001|Base Study EXT|Lost to Follow-up|0|||
33212331|NCT00092534|100676603|FG002|Base Study EXT|Lost to Follow-up|41|||
33212332|NCT00092534|100676604|FG003|Base Study EXT|Lost to Follow-up|0|||
33212333|NCT00092534|100676605|FG004|Base Study EXT|Lost to Follow-up|0|||
33212334|NCT00092534|100676601|FG000|Base Study EXT|Physician Decision|0|||
33212335|NCT00092534|100676602|FG001|Base Study EXT|Physician Decision|0|||
33212336|NCT00092534|100676603|FG002|Base Study EXT|Physician Decision|1|||
33212337|NCT00092534|100676604|FG003|Base Study EXT|Physician Decision|0|||
33345688|NCT03093155|101156450|FG001|Overall Study|Withdrawal by Subject|1|||
33345689|NCT03634800|101156451|FG000|Overall Study|Adverse Event|1|||
33212338|NCT00092534|100676605|FG004|Base Study EXT|Physician Decision|0|||
33212339|NCT00092534|100676601|FG000|Base Study EXT|Pregnancy|0|||
33212340|NCT00092534|100676602|FG001|Base Study EXT|Pregnancy|0|||
33212341|NCT00092534|100676603|FG002|Base Study EXT|Pregnancy|12|||
33212342|NCT00092534|100676604|FG003|Base Study EXT|Pregnancy|0|||
33212343|NCT00092534|100676605|FG004|Base Study EXT|Pregnancy|0|||
33212344|NCT00092534|100676601|FG000|Base Study EXT|Withdrawal by Subject|0|||
33212345|NCT00092534|100676602|FG001|Base Study EXT|Withdrawal by Subject|0|||
33212346|NCT00092534|100676603|FG002|Base Study EXT|Withdrawal by Subject|18|||
33212347|NCT00092534|100676604|FG003|Base Study EXT|Withdrawal by Subject|0|||
33212348|NCT00092534|100676605|FG004|Base Study EXT|Withdrawal by Subject|0|||
33212349|NCT00092534|100676601|FG000|Base Study EXT|Participant moved|0|||
33212350|NCT00092534|100676602|FG001|Base Study EXT|Participant moved|0|||
33212351|NCT00092534|100676603|FG002|Base Study EXT|Participant moved|6|||
33212352|NCT00092534|100676604|FG003|Base Study EXT|Participant moved|0|||
33212353|NCT00092534|100676605|FG004|Base Study EXT|Participant moved|0|||
33212354|NCT00092534|100676601|FG000|Base Study EXT|Travel|0|||
33212355|NCT00092534|100676602|FG001|Base Study EXT|Travel|0|||
33345690|NCT03634800|101156451|FG000|Overall Study|Disease Progression|4|||
33345691|NCT03634800|101156451|FG000|Overall Study|Withdrawal by Subject|1|||
33345692|NCT02058147|101156452|FG000|Overall Study|Randomized but not treated|0|||
33345693|NCT02058147|101156453|FG001|Overall Study|Randomized but not treated|0|||
33345694|NCT02058147|101156454|FG002|Overall Study|Randomized but not treated|1|||
33345695|NCT02058147|101156452|FG000|Overall Study|Adverse Event|12|||
33345696|NCT02058147|101156453|FG001|Overall Study|Adverse Event|9|||
33345697|NCT02058147|101156454|FG002|Overall Study|Adverse Event|21|||
33345698|NCT02058147|101156452|FG000|Overall Study|Lack of Efficacy|1|||
33345699|NCT02058147|101156453|FG001|Overall Study|Lack of Efficacy|0|||
33212356|NCT00092534|100676603|FG002|Base Study EXT|Travel|2|||
33212357|NCT00092534|100676604|FG003|Base Study EXT|Travel|0|||
33212358|NCT00092534|100676605|FG004|Base Study EXT|Travel|0|||
33212359|NCT00092534|100676601|FG000|Base Study EXT|Site closed|0|||
33212360|NCT00092534|100676602|FG001|Base Study EXT|Site closed|0|||
33212361|NCT00092534|100676603|FG002|Base Study EXT|Site closed|21|||
33212362|NCT00092534|100676604|FG003|Base Study EXT|Site closed|0|||
33345700|NCT02058147|101156454|FG002|Overall Study|Lack of Efficacy|3|||
33212363|NCT00092534|100676605|FG004|Base Study EXT|Site closed|0|||
33212364|NCT00092534|100676601|FG000|Base Study EXT|Study ended|0|||
33212365|NCT00092534|100676602|FG001|Base Study EXT|Study ended|0|||
33212366|NCT00092534|100676603|FG002|Base Study EXT|Study ended|29|||
33212367|NCT00092534|100676604|FG003|Base Study EXT|Study ended|0|||
33212368|NCT00092534|100676605|FG004|Base Study EXT|Study ended|0|||
33212369|NCT00092534|100676601|FG000|Base Study EXT|Protocol Violation|0|||
33212370|NCT00092534|100676602|FG001|Base Study EXT|Protocol Violation|0|||
33212371|NCT00092534|100676603|FG002|Base Study EXT|Protocol Violation|15|||
33212372|NCT00092534|100676604|FG003|Base Study EXT|Protocol Violation|0|||
33212373|NCT00092534|100676605|FG004|Base Study EXT|Protocol Violation|0|||
33212374|NCT00092534|100676601|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
33212375|NCT00092534|100676602|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
33212376|NCT00092534|100676603|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
33212377|NCT00092534|100676604|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
33212378|NCT00092534|100676605|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
33212379|NCT01362140|100676606|FG000|Overall Study|Noncompliance|1|||
33212380|NCT01362140|100676607|FG001|Overall Study|Noncompliance|0|||
33212381|NCT01362140|100676606|FG000|Overall Study|Adverse Event|2|||
33212382|NCT01362140|100676607|FG001|Overall Study|Adverse Event|2|||
33212383|NCT01362140|100676606|FG000|Overall Study|Withdrawal by Subject|3|||
33212384|NCT01362140|100676607|FG001|Overall Study|Withdrawal by Subject|3|||
33212385|NCT01362140|100676606|FG000|Overall Study|Administrative Decision|0|||
33345701|NCT02058147|101156452|FG000|Overall Study|Poor compliance to protocol|8|||
33345702|NCT02058147|101156453|FG001|Overall Study|Poor compliance to protocol|9|||
33345703|NCT02058147|101156454|FG002|Overall Study|Poor compliance to protocol|4|||
33345704|NCT02058147|101156452|FG000|Overall Study|Other than specified|8|||
33615855|NCT00660179|102144215|FG001|Overall Study|Incorrect randomization|0|||
33615856|NCT00660179|102144216|FG002|Overall Study|Incorrect randomization|0|||
33615857|NCT05274269|102144217|FG000|Overall Study|Adverse Event|0|||
33345705|NCT02058147|101156453|FG001|Overall Study|Other than specified|9|||
33345706|NCT02058147|101156454|FG002|Overall Study|Other than specified|0|||
33345707|NCT00643994|101156455|FG000|Overall Study|Death|24|||
33542560|NCT05259917|101888733|FG004|Overall Study|Protocol Violation|0|||
33542561|NCT05259917|101888734|FG005|Overall Study|Protocol Violation|0|||
33542562|NCT05259917|101888729|FG000|Overall Study|Lost to Follow-up|0|||
33542563|NCT05259917|101888730|FG001|Overall Study|Lost to Follow-up|0|||
33542564|NCT05259917|101888731|FG002|Overall Study|Lost to Follow-up|1|||
33542565|NCT05259917|101888732|FG003|Overall Study|Lost to Follow-up|0|||
33542566|NCT05259917|101888733|FG004|Overall Study|Lost to Follow-up|0|||
33542567|NCT05259917|101888734|FG005|Overall Study|Lost to Follow-up|1|||
33542568|NCT05259917|101888729|FG000|Overall Study|Physician Decision|0|||
33542569|NCT05259917|101888730|FG001|Overall Study|Physician Decision|1|||
33542570|NCT05259917|101888731|FG002|Overall Study|Physician Decision|0|||
33542571|NCT05259917|101888732|FG003|Overall Study|Physician Decision|0|||
33542572|NCT05259917|101888733|FG004|Overall Study|Physician Decision|0|||
33542573|NCT05259917|101888734|FG005|Overall Study|Physician Decision|0|||
33345708|NCT00643994|101156455|FG000|Overall Study|Lost to Follow-up|72|||
33345709|NCT03543410|101156456|FG000|Overall Study|Adverse Event|10|||
33345710|NCT03543410|101156457|FG001|Overall Study|Adverse Event|8|||
33345711|NCT03543410|101156458|FG002|Overall Study|Adverse Event|2|||
33345712|NCT03543410|101156456|FG000|Overall Study|Lack of Efficacy|0|||
33345713|NCT03543410|101156457|FG001|Overall Study|Lack of Efficacy|1|||
33345714|NCT03543410|101156458|FG002|Overall Study|Lack of Efficacy|0|||
33345715|NCT03543410|101156456|FG000|Overall Study|Lost to Follow-up|0|||
33345716|NCT03543410|101156457|FG001|Overall Study|Lost to Follow-up|1|||
33345717|NCT03543410|101156458|FG002|Overall Study|Lost to Follow-up|0|||
33345718|NCT03543410|101156456|FG000|Overall Study|Withdrawal by Subject|5|||
33345719|NCT03543410|101156457|FG001|Overall Study|Withdrawal by Subject|2|||
33345720|NCT03543410|101156458|FG002|Overall Study|Withdrawal by Subject|8|||
33345721|NCT03543410|101156456|FG000|Overall Study|Protocol Violation|0|||
33345722|NCT03543410|101156457|FG001|Overall Study|Protocol Violation|1|||
33345723|NCT03543410|101156458|FG002|Overall Study|Protocol Violation|0|||
33345724|NCT03543410|101156456|FG000|Overall Study|Due to COVID-19|4|||
33345725|NCT03543410|101156457|FG001|Overall Study|Due to COVID-19|0|||
33345726|NCT03543410|101156458|FG002|Overall Study|Due to COVID-19|2|||
33345727|NCT03543410|101156456|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
33345728|NCT03543410|101156457|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
33542574|NCT05259917|101888729|FG000|Overall Study|Withdrawal by Subject|0|||
33212386|NCT01362140|100676607|FG001|Overall Study|Administrative Decision|1|||
33212387|NCT01362140|100676606|FG000|Overall Study|Death|2|||
33542575|NCT05259917|101888730|FG001|Overall Study|Withdrawal by Subject|1|||
33212388|NCT01362140|100676607|FG001|Overall Study|Death|1|||
33407497|NCT05602818|101380660|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
33407498|NCT05602818|101380661|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
33407499|NCT05602818|101380662|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
33407500|NCT05602818|101380663|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
33407501|NCT05602818|101380664|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
33407502|NCT05602818|101380665|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
33407503|NCT05602818|101380666|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
33407504|NCT05602818|101380667|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
33407505|NCT01411917|101380670|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
33407506|NCT01411917|101380671|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
33407507|NCT02198040|101380680|FG000|Overall Study|Work reasons|0|||
33407508|NCT02198040|101380681|FG001|Overall Study|Work reasons|1|||
33345729|NCT03543410|101156458|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
33345730|NCT03543410|101156456|FG000|Overall Study|Not Due to COVID-19|2|||
33345731|NCT03543410|101156457|FG001|Overall Study|Not Due to COVID-19|0|||
33345732|NCT03543410|101156458|FG002|Overall Study|Not Due to COVID-19|1|||
33345733|NCT01725750|101156459|FG000|Overall Study|Adverse Event|1|||
33542576|NCT05259917|101888731|FG002|Overall Study|Withdrawal by Subject|0|||
33542577|NCT05259917|101888732|FG003|Overall Study|Withdrawal by Subject|0|||
33542578|NCT05259917|101888733|FG004|Overall Study|Withdrawal by Subject|1|||
33542579|NCT05259917|101888734|FG005|Overall Study|Withdrawal by Subject|1|||
33542580|NCT05259917|101888729|FG000|Overall Study|Trial Termination by Sponsor|7|||
33542581|NCT05259917|101888730|FG001|Overall Study|Trial Termination by Sponsor|2|||
33542582|NCT05259917|101888731|FG002|Overall Study|Trial Termination by Sponsor|3|||
33542583|NCT05259917|101888732|FG003|Overall Study|Trial Termination by Sponsor|5|||
33542584|NCT05259917|101888733|FG004|Overall Study|Trial Termination by Sponsor|11|||
33542585|NCT05259917|101888734|FG005|Overall Study|Trial Termination by Sponsor|4|||
33542586|NCT05259917|101888729|FG000|Overall Study|Other|1|||
33542587|NCT05259917|101888730|FG001|Overall Study|Other|0|||
33542588|NCT05259917|101888731|FG002|Overall Study|Other|2|||
33542589|NCT05259917|101888732|FG003|Overall Study|Other|0|||
33542590|NCT05259917|101888733|FG004|Overall Study|Other|0|||
33542591|NCT05259917|101888734|FG005|Overall Study|Other|0|||
33542592|NCT03937778|101888735|FG000|Overall Study|Withdrawal by Subject|1|||
33542593|NCT03937778|101888735|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
33542594|NCT03256578|101888736|FG000|Overall Study|Excluded Post Randomization|66|||
33542595|NCT03256578|101888737|FG001|Overall Study|Excluded Post Randomization|56|||
33542596|NCT01739335|101888739|FG000|Overall Study|Lost to Follow-up|7|||
33542597|NCT01739335|101888740|FG001|Overall Study|Lost to Follow-up|4|||
33542598|NCT01739335|101888739|FG000|Overall Study|Ineligible patient randomized|0|||
33542599|NCT01739335|101888740|FG001|Overall Study|Ineligible patient randomized|1|||
33542600|NCT02349412|101888742|FG000|Overall Study|Withdrawal by Subject|7|||
33542601|NCT02349412|101888743|FG001|Overall Study|Withdrawal by Subject|7|||
33542602|NCT02530385|101888744|FG000|Overall Study|Withdrawal by Subject|0|||
33542603|NCT02530385|101888745|FG001|Overall Study|Withdrawal by Subject|1|||
33542604|NCT04635839|101888752|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
33542605|NCT04635839|101888753|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
33542606|NCT01294046|101888754|FG000|Overall Study|Infection and surgical explant|1|||
33542607|NCT01294046|101888754|FG000|Overall Study|Eligibility criteria expanded|1|||
33542608|NCT01294046|101888754|FG000|Overall Study|Stimulation response inadqequate|1|||
33542609|NCT02774889|101888755|FG000|Overall Study|Lost to Follow-up|2|||
33542610|NCT02774889|101888756|FG001|Overall Study|Lost to Follow-up|1|||
33542611|NCT01142336|101888757|FG000|Overall Study|Adverse Event|1|||
33542612|NCT01142336|101888758|FG001|Overall Study|Adverse Event|1|||
33542613|NCT01142336|101888757|FG000|Overall Study|Lost to Follow-up|0|||
33542614|NCT01142336|101888758|FG001|Overall Study|Lost to Follow-up|1|||
33542615|NCT02832037|101888759|FG000|Overall Study|Administrative reasons|0|||
33542616|NCT02832037|101888760|FG001|Overall Study|Administrative reasons|0|||
33542617|NCT02832037|101888761|FG002|Overall Study|Administrative reasons|1|||
33542618|NCT02832037|101888762|FG003|Overall Study|Administrative reasons|0|||
33542619|NCT02832037|101888763|FG004|Overall Study|Administrative reasons|0|||
33542620|NCT02832037|101888759|FG000|Overall Study|Protocol Violation|3|||
33542621|NCT02832037|101888760|FG001|Overall Study|Protocol Violation|0|||
33542622|NCT02832037|101888761|FG002|Overall Study|Protocol Violation|4|||
33542623|NCT02832037|101888762|FG003|Overall Study|Protocol Violation|1|||
33345734|NCT01725750|101156460|FG001|Overall Study|Adverse Event|0|||
33542624|NCT02832037|101888763|FG004|Overall Study|Protocol Violation|2|||
33542625|NCT02832037|101888759|FG000|Overall Study|Lost to Follow-up|2|||
33345735|NCT01725750|101156459|FG000|Overall Study|Lost to Follow-up|1|||
33345736|NCT01725750|101156460|FG001|Overall Study|Lost to Follow-up|1|||
33345737|NCT01725750|101156459|FG000|Overall Study|Withdrawal by Subject|0|||
33345738|NCT01725750|101156460|FG001|Overall Study|Withdrawal by Subject|9|||
33407509|NCT02198040|101380682|FG002|Overall Study|Work reasons|0|||
33542626|NCT02832037|101888760|FG001|Overall Study|Lost to Follow-up|0|||
33542627|NCT02832037|101888761|FG002|Overall Study|Lost to Follow-up|3|||
33542628|NCT02832037|101888762|FG003|Overall Study|Lost to Follow-up|0|||
33542629|NCT02832037|101888763|FG004|Overall Study|Lost to Follow-up|5|||
33542630|NCT02832037|101888759|FG000|Overall Study|Withdrawal by Subject|9|||
33542631|NCT02832037|101888760|FG001|Overall Study|Withdrawal by Subject|8|||
33542632|NCT02832037|101888761|FG002|Overall Study|Withdrawal by Subject|0|||
33542633|NCT02832037|101888762|FG003|Overall Study|Withdrawal by Subject|4|||
33542634|NCT02832037|101888763|FG004|Overall Study|Withdrawal by Subject|8|||
33542635|NCT02832037|101888759|FG000|Overall Study|Adverse Event|5|||
33542636|NCT02832037|101888760|FG001|Overall Study|Adverse Event|4|||
33542637|NCT02832037|101888761|FG002|Overall Study|Adverse Event|0|||
33542638|NCT02832037|101888762|FG003|Overall Study|Adverse Event|2|||
33542639|NCT02832037|101888763|FG004|Overall Study|Adverse Event|4|||
33542640|NCT01838876|101888765|FG000|Overall Study|Adverse Event|49|||
33542641|NCT01838876|101888765|FG000|Overall Study|Insufficient Therapeutic Response|10|||
33542642|NCT01838876|101888765|FG000|Overall Study|Protocol Violation|34|||
33542643|NCT01838876|101888765|FG000|Overall Study|Withdrawal of Consent|33|||
33542644|NCT01838876|101888765|FG000|Overall Study|Lost to Follow-up|21|||
33542645|NCT01838876|101888765|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
33542646|NCT01838876|101888765|FG000|Overall Study|Reason not Specified|7|||
33542647|NCT01838876|101888765|FG000|Overall Study|Did not meet eligibility criteria|78|||
33542648|NCT01963611|101888768|FG000|Overall Study|Adverse Event|1|||
33542649|NCT01963611|101888769|FG001|Overall Study|Adverse Event|1|||
33542650|NCT01963611|101888770|FG002|Overall Study|Adverse Event|3|||
33542651|NCT01963611|101888771|FG003|Overall Study|Adverse Event|4|||
33542652|NCT01963611|101888772|FG004|Overall Study|Adverse Event|3|||
33542653|NCT01963611|101888768|FG000|Overall Study|Protocol Violation|0|||
33345739|NCT02796755|101156461|FG000|Overall Study|Adverse Event|2|||
33345740|NCT02796755|101156462|FG001|Overall Study|Adverse Event|0|||
33345741|NCT01671345|101156463|FG000|Overall Study|Lost to Follow-up|10|||
33345742|NCT01671345|101156464|FG001|Overall Study|Lost to Follow-up|6|||
33542654|NCT01963611|101888769|FG001|Overall Study|Protocol Violation|0|||
33542655|NCT01963611|101888770|FG002|Overall Study|Protocol Violation|0|||
33542656|NCT01963611|101888771|FG003|Overall Study|Protocol Violation|1|||
33345743|NCT01671345|101156463|FG000|Overall Study|visit with non-participating physician|3|||
33345744|NCT01671345|101156464|FG001|Overall Study|visit with non-participating physician|3|||
33345745|NCT01651780|101156465|FG000|Overall Study|Physician decision: No 30-day visit|2|||
33345746|NCT01651780|101156466|FG001|Overall Study|Physician decision: No 30-day visit|1|||
33345747|NCT01651780|101156465|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
33345748|NCT01651780|101156466|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
33345749|NCT01651780|101156465|FG000|Overall Study|Withdrawal by Subject|2|||
33345750|NCT01651780|101156466|FG001|Overall Study|Withdrawal by Subject|0|||
33345751|NCT01651780|101156465|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
33345752|NCT01651780|101156466|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33345753|NCT01651780|101156465|FG000|Overall Study|Lost to Follow-up|1|||
33345754|NCT01651780|101156466|FG001|Overall Study|Lost to Follow-up|2|||
33345755|NCT01651780|101156465|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
33345756|NCT01651780|101156466|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
33345757|NCT00809328|101156467|FG000|Overall Study|Lack of Efficacy|18|||
33345758|NCT00809328|101156467|FG000|Overall Study|Adverse Event|6|||
33345759|NCT00809328|101156467|FG000|Overall Study|Protocol Violation|3|||
33345760|NCT00809328|101156467|FG000|Overall Study|Withdrawal by Subject|2|||
33345761|NCT03902080|101156468|FG000|Overall Study|Adverse Event|17|||
33345762|NCT03902080|101156469|FG001|Overall Study|Adverse Event|15|||
33345763|NCT03902080|101156468|FG000|Overall Study|Withdrawal by Subject|28|||
33345764|NCT03902080|101156469|FG001|Overall Study|Withdrawal by Subject|35|||
33345765|NCT03902080|101156468|FG000|Overall Study|Lost to Follow-up|6|||
33345766|NCT03902080|101156469|FG001|Overall Study|Lost to Follow-up|7|||
33345767|NCT03902080|101156468|FG000|Overall Study|Other|3|||
33345768|NCT03902080|101156469|FG001|Overall Study|Other|5|||
33345769|NCT03902080|101156468|FG000|Overall Study|Non compliance|4|||
33345770|NCT03902080|101156469|FG001|Overall Study|Non compliance|3|||
33542657|NCT01963611|101888772|FG004|Overall Study|Protocol Violation|0|||
33542658|NCT01963611|101888768|FG000|Overall Study|Lack of Efficacy|0|||
33542659|NCT01963611|101888769|FG001|Overall Study|Lack of Efficacy|0|||
33542660|NCT01963611|101888770|FG002|Overall Study|Lack of Efficacy|0|||
33542661|NCT01963611|101888771|FG003|Overall Study|Lack of Efficacy|1|||
33542662|NCT01963611|101888772|FG004|Overall Study|Lack of Efficacy|0|||
33542663|NCT01963611|101888768|FG000|Overall Study|Withdrawal by Subject|3|||
33542664|NCT01963611|101888769|FG001|Overall Study|Withdrawal by Subject|2|||
33542665|NCT01963611|101888770|FG002|Overall Study|Withdrawal by Subject|1|||
33542666|NCT01963611|101888771|FG003|Overall Study|Withdrawal by Subject|1|||
33542667|NCT01963611|101888772|FG004|Overall Study|Withdrawal by Subject|3|||
33542668|NCT01963611|101888768|FG000|Overall Study|Other|47|||
33345771|NCT03902080|101156468|FG000|Overall Study|Physician Decision|5|||
33345772|NCT03902080|101156469|FG001|Overall Study|Physician Decision|1|||
33542669|NCT01963611|101888769|FG001|Overall Study|Other|46|||
33542670|NCT01963611|101888770|FG002|Overall Study|Other|48|||
33542671|NCT01963611|101888771|FG003|Overall Study|Other|45|||
33615858|NCT05274269|102144218|FG001|Overall Study|Adverse Event|3|||
33615859|NCT05274269|102144217|FG000|Overall Study|Death|0|||
33615860|NCT05274269|102144218|FG001|Overall Study|Death|1|||
33615861|NCT05274269|102144217|FG000|Overall Study|Other|0|||
33615862|NCT05274269|102144218|FG001|Overall Study|Other|2|||
33615863|NCT05274269|102144217|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
33615864|NCT05274269|102144218|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
33615865|NCT04090242|102144222|FG000|Overall Study|Withdrawal by Subject|1|||
33615866|NCT04090242|102144223|FG001|Overall Study|Withdrawal by Subject|0|||
33615867|NCT00104650|102144224|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
33615868|NCT00104650|102144225|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
33615869|NCT00104650|102144226|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
33615870|NCT00104650|102144224|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
33615871|NCT00104650|102144225|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
33615872|NCT00104650|102144226|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
33615873|NCT00104650|102144224|FG000|Treatment Period (25 Weeks)|Death|7|||
33615874|NCT00104650|102144225|FG001|Treatment Period (25 Weeks)|Death|5|||
33615875|NCT00104650|102144226|FG002|Treatment Period (25 Weeks)|Death|6|||
33615876|NCT00104650|102144224|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
33615877|NCT00104650|102144225|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
33615878|NCT00104650|102144226|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
33615879|NCT00104650|102144224|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
33615880|NCT00104650|102144225|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
33615881|NCT00104650|102144226|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
33615882|NCT00104650|102144224|FG000|Treatment Period (25 Weeks)|Other|1|||
33615883|NCT00104650|102144225|FG001|Treatment Period (25 Weeks)|Other|0|||
33615884|NCT00104650|102144226|FG002|Treatment Period (25 Weeks)|Other|0|||
33615885|NCT00104650|102144224|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
33615886|NCT00104650|102144225|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
33615887|NCT00104650|102144226|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
33615888|NCT00104650|102144224|FG000|Follow-up Period|Physician Decision|1|||
33615889|NCT00104650|102144225|FG001|Follow-up Period|Physician Decision|1|||
33615890|NCT00104650|102144226|FG002|Follow-up Period|Physician Decision|0|||
33615891|NCT00104650|102144224|FG000|Follow-up Period|Adverse Event|1|||
33615892|NCT00104650|102144225|FG001|Follow-up Period|Adverse Event|0|||
33615893|NCT00104650|102144226|FG002|Follow-up Period|Adverse Event|1|||
33615894|NCT00104650|102144224|FG000|Follow-up Period|Withdrawal by Subject|0|||
33615895|NCT00104650|102144225|FG001|Follow-up Period|Withdrawal by Subject|3|||
33615896|NCT00104650|102144226|FG002|Follow-up Period|Withdrawal by Subject|3|||
33615897|NCT00104650|102144224|FG000|Follow-up Period|Death|6|||
33407510|NCT02198040|101380680|FG000|Overall Study|Withdrawal by Subject|0|||
33407511|NCT02198040|101380681|FG001|Overall Study|Withdrawal by Subject|0|||
33407512|NCT02198040|101380682|FG002|Overall Study|Withdrawal by Subject|1|||
33407513|NCT00405756|101380683|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
33407514|NCT00405756|101380684|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
33407515|NCT00405756|101380685|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
33407516|NCT00405756|101380683|FG000|Double-blind Treatment|Adverse Event|31|||
33407517|NCT00405756|101380684|FG001|Double-blind Treatment|Adverse Event|27|||
33407518|NCT00405756|101380685|FG002|Double-blind Treatment|Adverse Event|12|||
33407519|NCT00405756|101380683|FG000|Double-blind Treatment|Disease Progression|47|||
33542672|NCT01963611|101888772|FG004|Overall Study|Other|45|||
33542673|NCT01117870|101888774|FG000|Overall Study|Inability to place needle|1|||
33542674|NCT01117870|101888775|FG001|Overall Study|Inability to place needle|0|||
33542675|NCT04009837|101888784|FG000|Overall Study|Withdrawal by Subject|5|||
33542676|NCT04009837|101888785|FG001|Overall Study|Withdrawal by Subject|4|||
33542677|NCT04009837|101888784|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
33542678|NCT04009837|101888785|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
33542679|NCT00325416|101888789|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
33542680|NCT00325416|101888790|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
33542681|NCT00325416|101888789|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
33542682|NCT00325416|101888790|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
33542683|NCT00325416|101888789|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
33542684|NCT00325416|101888790|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
33615898|NCT00104650|102144225|FG001|Follow-up Period|Death|6|||
33615899|NCT00104650|102144226|FG002|Follow-up Period|Death|4|||
33615900|NCT00104650|102144224|FG000|Follow-up Period|Disease progression|3|||
33615901|NCT00104650|102144225|FG001|Follow-up Period|Disease progression|1|||
33407520|NCT00405756|101380684|FG001|Double-blind Treatment|Disease Progression|81|||
33542685|NCT00325416|101888789|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
33615902|NCT00104650|102144226|FG002|Follow-up Period|Disease progression|0|||
33615903|NCT00104650|102144224|FG000|Follow-up Period|Lost to Follow-up|0|||
33615904|NCT00104650|102144225|FG001|Follow-up Period|Lost to Follow-up|1|||
33615905|NCT00104650|102144226|FG002|Follow-up Period|Lost to Follow-up|2|||
33615906|NCT00104650|102144224|FG000|Follow-up Period|Other|0|||
33407521|NCT00405756|101380685|FG002|Double-blind Treatment|Disease Progression|102|||
33407522|NCT00405756|101380683|FG000|Double-blind Treatment|Lack of Efficacy|1|||
33407523|NCT00405756|101380684|FG001|Double-blind Treatment|Lack of Efficacy|4|||
33407524|NCT00405756|101380685|FG002|Double-blind Treatment|Lack of Efficacy|2|||
33407525|NCT00405756|101380683|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
33407526|NCT00405756|101380684|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
33407527|NCT00405756|101380685|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
33407528|NCT00405756|101380683|FG000|Double-blind Treatment|Lost to Follow-up|1|||
33407529|NCT00405756|101380684|FG001|Double-blind Treatment|Lost to Follow-up|0|||
33407530|NCT00405756|101380685|FG002|Double-blind Treatment|Lost to Follow-up|0|||
33407531|NCT00405756|101380683|FG000|Double-blind Treatment|Death|4|||
33407532|NCT00405756|101380684|FG001|Double-blind Treatment|Death|4|||
33407533|NCT00405756|101380685|FG002|Double-blind Treatment|Death|4|||
33407534|NCT00405756|101380683|FG000|Double-blind Treatment|Protocol Violation|1|||
33407535|NCT00405756|101380684|FG001|Double-blind Treatment|Protocol Violation|0|||
33407536|NCT00405756|101380685|FG002|Double-blind Treatment|Protocol Violation|2|||
33407537|NCT00405756|101380683|FG000|Double-blind Treatment|Other|7|||
33407538|NCT00405756|101380684|FG001|Double-blind Treatment|Other|4|||
33407539|NCT00405756|101380685|FG002|Double-blind Treatment|Other|4|||
33407540|NCT00405756|101380683|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
33407541|NCT00405756|101380684|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
33407542|NCT00405756|101380685|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
33407543|NCT00405756|101380683|FG000|Open-label Extension|Adverse Event|1|||
33407544|NCT00405756|101380684|FG001|Open-label Extension|Adverse Event|3|||
33407545|NCT00405756|101380685|FG002|Open-label Extension|Adverse Event|7|||
33407546|NCT00405756|101380683|FG000|Open-label Extension|Disease Progression|8|||
33407547|NCT00405756|101380684|FG001|Open-label Extension|Disease Progression|23|||
33407548|NCT00405756|101380685|FG002|Open-label Extension|Disease Progression|26|||
33407549|NCT00405756|101380683|FG000|Open-label Extension|Withdrawal by Subject|2|||
33407550|NCT00405756|101380684|FG001|Open-label Extension|Withdrawal by Subject|3|||
33407551|NCT00405756|101380685|FG002|Open-label Extension|Withdrawal by Subject|3|||
33407552|NCT00405756|101380683|FG000|Open-label Extension|Death|1|||
33407553|NCT00405756|101380684|FG001|Open-label Extension|Death|2|||
33407554|NCT00405756|101380685|FG002|Open-label Extension|Death|4|||
33407555|NCT00405756|101380683|FG000|Open-label Extension|Other|0|||
33407556|NCT00405756|101380684|FG001|Open-label Extension|Other|1|||
33407557|NCT00405756|101380685|FG002|Open-label Extension|Other|7|||
33407558|NCT00405756|101380683|FG000|Follow-up|Ongoing in Follow-up Period|52|||
33407559|NCT00405756|101380684|FG001|Follow-up|Ongoing in Follow-up Period|51|||
33407560|NCT00405756|101380685|FG002|Follow-up|Ongoing in Follow-up Period|60|||
33407561|NCT00405756|101380683|FG000|Follow-up|Death|21|||
33407562|NCT00405756|101380684|FG001|Follow-up|Death|31|||
33407563|NCT00405756|101380685|FG002|Follow-up|Death|24|||
33407564|NCT00405756|101380683|FG000|Follow-up|Lost to Follow-up|2|||
33407565|NCT00405756|101380684|FG001|Follow-up|Lost to Follow-up|8|||
33407566|NCT00405756|101380685|FG002|Follow-up|Lost to Follow-up|4|||
33407567|NCT02985541|101380686|FG000|Overall Study|Withdrawal by Subject|33|||
33407568|NCT02985541|101380686|FG000|Overall Study|Lost to Follow-up|26|||
33407569|NCT02985541|101380686|FG000|Overall Study|Adverse Event|27|||
33407570|NCT02985541|101380686|FG000|Overall Study|Physician Decision|2|||
33407571|NCT02985541|101380686|FG000|Overall Study|Pregnancy|2|||
33407572|NCT02985541|101380686|FG000|Overall Study|Wish for pregnancy|44|||
33407573|NCT02985541|101380686|FG000|Overall Study|Other reason|5|||
33407574|NCT02985541|101380686|FG000|Overall Study|Not valid for analysis|2|||
33407575|NCT02442284|101380688|FG000|Overall Study|Adverse Event|1|||
33407576|NCT02442284|101380688|FG000|Overall Study|Withdrew Consent|2|||
33407577|NCT02442284|101380688|FG000|Overall Study|Lost to Follow-up|3|||
33542686|NCT00325416|101888790|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
33542687|NCT00325416|101888789|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
33542688|NCT00325416|101888790|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
33542689|NCT00325416|101888789|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
33542690|NCT00325416|101888790|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
33407578|NCT02442284|101380688|FG000|Overall Study|Other|1|||
33407579|NCT01471197|101380689|FG000|Overall Study|Disease Progression|4|||
33407580|NCT01471197|101380690|FG001|Overall Study|Disease Progression|2|||
33407581|NCT01471197|101380689|FG000|Overall Study|Death|1|||
33407582|NCT01471197|101380690|FG001|Overall Study|Death|0|||
33407583|NCT01471197|101380689|FG000|Overall Study|Study Drug Toxicity|1|||
33407584|NCT01471197|101380690|FG001|Overall Study|Study Drug Toxicity|0|||
33407585|NCT00761891|101380691|FG000|Overall Study|Withdrawal by Subject|10|||
33542691|NCT03069989|101888793|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
33407586|NCT03205605|101380692|FG000|Overall Study|Withdrawal by Subject|1|||
33407587|NCT02713490|101380695|FG000|Overall Study|Withdrawal by Subject|2|||
33407588|NCT02713490|101380696|FG001|Overall Study|Withdrawal by Subject|1|||
33407589|NCT02713490|101380695|FG000|Overall Study|Did not receive study drug|1|||
33407590|NCT02713490|101380696|FG001|Overall Study|Did not receive study drug|0|||
33407591|NCT02713490|101380695|FG000|Overall Study|Met exclusion criteria|0|||
33615907|NCT00104650|102144225|FG001|Follow-up Period|Other|1|||
33615908|NCT00104650|102144226|FG002|Follow-up Period|Other|0|||
33615909|NCT00206440|102144230|FG000|Overall Study|Protocol Violation|1|||
33615910|NCT00206440|102144231|FG001|Overall Study|Protocol Violation|2|||
33615911|NCT00206440|102144230|FG000|Overall Study|Adverse Event|4|||
33615912|NCT00206440|102144231|FG001|Overall Study|Adverse Event|2|||
33615913|NCT00126776|102144232|FG000|Overall Study|follow up complete on all patients|0|||
33615914|NCT00126776|102144233|FG001|Overall Study|follow up complete on all patients|0|||
33345773|NCT03902080|101156468|FG000|Overall Study|Protocol Violation|3|||
33345774|NCT03902080|101156469|FG001|Overall Study|Protocol Violation|3|||
33345775|NCT03902080|101156468|FG000|Overall Study|Lack of Efficacy|1|||
33345776|NCT03902080|101156469|FG001|Overall Study|Lack of Efficacy|3|||
33345777|NCT03902080|101156468|FG000|Overall Study|Withdrawn prior to dosing|0|||
33345778|NCT03902080|101156469|FG001|Overall Study|Withdrawn prior to dosing|1|||
33345779|NCT04167345|101156470|FG000|Overall Study|Other|1|||
33345780|NCT04167345|101156471|FG001|Overall Study|Other|1|||
33345781|NCT04167345|101156472|FG002|Overall Study|Other|0|||
33345782|NCT04167345|101156473|FG003|Overall Study|Other|0|||
33542692|NCT03069989|101888794|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
33542693|NCT03255187|101888798|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
33542694|NCT03255187|101888799|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
33615915|NCT00434109|102144234|FG000|Overall Study|Physician Decision|9|||
33615916|NCT00434109|102144234|FG000|Overall Study|Adverse Event|5|||
33615917|NCT00434109|102144234|FG000|Overall Study|Protocol Violation|1|||
33407592|NCT02713490|101380696|FG001|Overall Study|Met exclusion criteria|1|||
33407593|NCT01786707|101380702|FG000|Overall Study|Lost to Follow-up|1|||
33407594|NCT01786707|101380703|FG001|Overall Study|Lost to Follow-up|1|||
33407595|NCT01955005|101380704|FG000|Overall Study|Withdrawal by Subject|3|||
33407596|NCT01955005|101380705|FG001|Overall Study|Withdrawal by Subject|5|||
33407597|NCT00792467|101380706|FG000|Overall Study|progression of disease|17|||
33407598|NCT00792467|101380706|FG000|Overall Study|Adverse Event|1|||
33407599|NCT00792467|101380706|FG000|Overall Study|patient request|1|||
33407600|NCT00792467|101380706|FG000|Overall Study|Lost to Follow-up|1|||
33407601|NCT00792467|101380706|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
33407602|NCT00792467|101380706|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
33407603|NCT02463097|101380707|FG000|Overall Study|Withdrawal by Subject|1|||
33407604|NCT00672490|101380708|FG000|Overall Study|Withdrawal by Subject|8|||
33407605|NCT00672490|101380709|FG001|Overall Study|Withdrawal by Subject|8|||
33407606|NCT00672490|101380708|FG000|Overall Study|Lack of Compliance|2|||
33407607|NCT00672490|101380709|FG001|Overall Study|Lack of Compliance|7|||
33407608|NCT00672490|101380708|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
33407609|NCT00672490|101380709|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
33407610|NCT00672490|101380708|FG000|Overall Study|Adverse Event|5|||
33407611|NCT00672490|101380709|FG001|Overall Study|Adverse Event|8|||
33407612|NCT00672490|101380708|FG000|Overall Study|Violation of Concomitant Medicine|1|||
33407613|NCT00672490|101380709|FG001|Overall Study|Violation of Concomitant Medicine|0|||
33407614|NCT00672490|101380708|FG000|Overall Study|Intolerance|0|||
33407615|NCT00672490|101380709|FG001|Overall Study|Intolerance|2|||
33407616|NCT00672490|101380708|FG000|Overall Study|Lost to Follow-up|1|||
33345783|NCT04167345|101156474|FG004|Overall Study|Other|0|||
33345784|NCT00630331|101156475|FG000|Overall Study|Death|2|||
33345785|NCT00630331|101156476|FG001|Overall Study|Death|1|||
33345786|NCT00630331|101156477|FG002|Overall Study|Death|1|||
33345787|NCT00630331|101156475|FG000|Overall Study|Adverse Event|1|||
33345788|NCT00630331|101156476|FG001|Overall Study|Adverse Event|0|||
33345789|NCT00630331|101156477|FG002|Overall Study|Adverse Event|0|||
33345790|NCT00630331|101156475|FG000|Overall Study|Withdrawal by Subject|12|||
33345791|NCT00630331|101156476|FG001|Overall Study|Withdrawal by Subject|7|||
33345792|NCT00630331|101156477|FG002|Overall Study|Withdrawal by Subject|5|||
33345793|NCT00630331|101156475|FG000|Overall Study|Lost to Follow-up|175|||
33345794|NCT00630331|101156476|FG001|Overall Study|Lost to Follow-up|143|||
33345795|NCT00630331|101156477|FG002|Overall Study|Lost to Follow-up|170|||
33345796|NCT00630331|101156475|FG000|Overall Study|Inappropriate enrollment|3|||
33345797|NCT00630331|101156476|FG001|Overall Study|Inappropriate enrollment|6|||
33345798|NCT00630331|101156477|FG002|Overall Study|Inappropriate enrollment|3|||
33345799|NCT00630331|101156475|FG000|Overall Study|Unable to classify|9|||
33407617|NCT00672490|101380709|FG001|Overall Study|Lost to Follow-up|5|||
33407618|NCT00672490|101380708|FG000|Overall Study|No reason was provided|6|||
33345800|NCT00630331|101156476|FG001|Overall Study|Unable to classify|4|||
33345801|NCT00630331|101156477|FG002|Overall Study|Unable to classify|3|||
33345802|NCT00630331|101156475|FG000|Overall Study|Protocol Violation|4|||
33407619|NCT00672490|101380709|FG001|Overall Study|No reason was provided|2|||
33345803|NCT00630331|101156476|FG001|Overall Study|Protocol Violation|5|||
33345804|NCT00630331|101156477|FG002|Overall Study|Protocol Violation|6|||
33345805|NCT03828487|101156478|FG000|Overall Study|Physician Decision|1|||
33407620|NCT04298229|101380710|FG000|Overall Study|Physician Decision|1|||
33407621|NCT04298229|101380711|FG001|Overall Study|Physician Decision|1|||
33407622|NCT04298229|101380710|FG000|Overall Study|Withdrawal by Subject|1|||
33407623|NCT04298229|101380711|FG001|Overall Study|Withdrawal by Subject|1|||
33407624|NCT04298229|101380710|FG000|Overall Study|Did not receive IV loop diuretics|2|||
33407625|NCT04298229|101380711|FG001|Overall Study|Did not receive IV loop diuretics|0|||
33407626|NCT02557308|101380718|FG000|Overall Study|Withdrawal by Subject|11|||
33407627|NCT02557308|101380719|FG001|Overall Study|Withdrawal by Subject|3|||
33407628|NCT02557308|101380720|FG002|Overall Study|Withdrawal by Subject|2|||
33407629|NCT02557308|101380721|FG003|Overall Study|Withdrawal by Subject|0|||
33407630|NCT02557308|101380722|FG004|Overall Study|Withdrawal by Subject|1|||
33407631|NCT02557308|101380723|FG005|Overall Study|Withdrawal by Subject|0|||
33407632|NCT02557308|101380724|FG006|Overall Study|Withdrawal by Subject|10|||
33407633|NCT02557308|101380725|FG007|Overall Study|Withdrawal by Subject|1|||
33407634|NCT02557308|101380718|FG000|Overall Study|Disease Progression|0|||
33407635|NCT02557308|101380719|FG001|Overall Study|Disease Progression|1|||
33407636|NCT02557308|101380720|FG002|Overall Study|Disease Progression|0|||
33407637|NCT02557308|101380721|FG003|Overall Study|Disease Progression|0|||
33407638|NCT02557308|101380722|FG004|Overall Study|Disease Progression|0|||
33407639|NCT02557308|101380723|FG005|Overall Study|Disease Progression|0|||
33345806|NCT02554929|101156479|FG000|Overall Study|Lost to Follow-up|4|||
33407640|NCT02557308|101380724|FG006|Overall Study|Disease Progression|0|||
33407641|NCT02557308|101380725|FG007|Overall Study|Disease Progression|0|||
33407642|NCT02557308|101380718|FG000|Overall Study|Lack of Efficacy|3|||
33407643|NCT02557308|101380719|FG001|Overall Study|Lack of Efficacy|0|||
33407644|NCT02557308|101380720|FG002|Overall Study|Lack of Efficacy|0|||
33407645|NCT02557308|101380721|FG003|Overall Study|Lack of Efficacy|0|||
33407646|NCT02557308|101380722|FG004|Overall Study|Lack of Efficacy|0|||
33407647|NCT02557308|101380723|FG005|Overall Study|Lack of Efficacy|0|||
33407648|NCT02557308|101380724|FG006|Overall Study|Lack of Efficacy|1|||
33407649|NCT02557308|101380725|FG007|Overall Study|Lack of Efficacy|0|||
33407650|NCT02557308|101380718|FG000|Overall Study|Adverse Event|4|||
33407651|NCT02557308|101380719|FG001|Overall Study|Adverse Event|1|||
33407652|NCT02557308|101380720|FG002|Overall Study|Adverse Event|2|||
33407653|NCT02557308|101380721|FG003|Overall Study|Adverse Event|0|||
33407654|NCT02557308|101380722|FG004|Overall Study|Adverse Event|0|||
33407655|NCT02557308|101380723|FG005|Overall Study|Adverse Event|0|||
33407656|NCT02557308|101380724|FG006|Overall Study|Adverse Event|4|||
33407657|NCT02557308|101380725|FG007|Overall Study|Adverse Event|1|||
33407658|NCT02557308|101380718|FG000|Overall Study|Lost to Follow-up|2|||
33407659|NCT02557308|101380719|FG001|Overall Study|Lost to Follow-up|0|||
33345807|NCT02554929|101156480|FG001|Overall Study|Lost to Follow-up|4|||
33345808|NCT02554929|101156479|FG000|Overall Study|Withdrawal by Subject|2|||
33345809|NCT02554929|101156480|FG001|Overall Study|Withdrawal by Subject|8|||
33345810|NCT03313050|101156481|FG000|Stage 2: 12 Months|Adverse Event|0|||
33345811|NCT03313050|101156482|FG001|Stage 2: 12 Months|Adverse Event|0|||
33345812|NCT03313050|101156483|FG002|Stage 2: 12 Months|Adverse Event|0|||
33345813|NCT03313050|101156484|FG003|Stage 2: 12 Months|Adverse Event|1|||
33407660|NCT02557308|101380720|FG002|Overall Study|Lost to Follow-up|1|||
33407661|NCT02557308|101380721|FG003|Overall Study|Lost to Follow-up|0|||
33407662|NCT02557308|101380722|FG004|Overall Study|Lost to Follow-up|0|||
33407663|NCT02557308|101380723|FG005|Overall Study|Lost to Follow-up|0|||
33407664|NCT02557308|101380724|FG006|Overall Study|Lost to Follow-up|2|||
33407665|NCT02557308|101380725|FG007|Overall Study|Lost to Follow-up|0|||
33407666|NCT02557308|101380718|FG000|Overall Study|Death|1|||
33407667|NCT02557308|101380719|FG001|Overall Study|Death|0|||
33345814|NCT03313050|101156481|FG000|Stage 2: 12 Months|Death|0|||
33345815|NCT03313050|101156482|FG001|Stage 2: 12 Months|Death|0|||
33407668|NCT02557308|101380720|FG002|Overall Study|Death|0|||
33407669|NCT02557308|101380721|FG003|Overall Study|Death|0|||
33407670|NCT02557308|101380722|FG004|Overall Study|Death|0|||
33407671|NCT02557308|101380723|FG005|Overall Study|Death|0|||
33407672|NCT02557308|101380724|FG006|Overall Study|Death|0|||
33407673|NCT02557308|101380725|FG007|Overall Study|Death|0|||
33407674|NCT02557308|101380718|FG000|Overall Study|Study Close|98|||
33407675|NCT02557308|101380719|FG001|Overall Study|Study Close|18|||
33407676|NCT02557308|101380720|FG002|Overall Study|Study Close|5|||
33615918|NCT00434109|102144234|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
33615919|NCT01843023|102144235|FG000|Overall Study|Death|1|||
33615920|NCT01843023|102144236|FG001|Overall Study|Death|0|||
33345816|NCT03313050|101156483|FG002|Stage 2: 12 Months|Death|3|||
33345817|NCT03313050|101156484|FG003|Stage 2: 12 Months|Death|0|||
33407677|NCT02557308|101380721|FG003|Overall Study|Study Close|3|||
33407678|NCT02557308|101380722|FG004|Overall Study|Study Close|1|||
33407679|NCT02557308|101380723|FG005|Overall Study|Study Close|0|||
33407680|NCT02557308|101380724|FG006|Overall Study|Study Close|123|||
33407681|NCT02557308|101380725|FG007|Overall Study|Study Close|5|||
33407682|NCT02557308|101380718|FG000|Overall Study|Except for study close|5|||
33407683|NCT02557308|101380719|FG001|Overall Study|Except for study close|0|||
33407684|NCT02557308|101380720|FG002|Overall Study|Except for study close|0|||
33407685|NCT02557308|101380721|FG003|Overall Study|Except for study close|0|||
33407686|NCT02557308|101380722|FG004|Overall Study|Except for study close|3|||
33407687|NCT02557308|101380723|FG005|Overall Study|Except for study close|0|||
33407688|NCT02557308|101380724|FG006|Overall Study|Except for study close|6|||
33407689|NCT02557308|101380725|FG007|Overall Study|Except for study close|10|||
33407690|NCT05261126|101380730|FG000|Overall Study|Death|0|||
33407691|NCT05261126|101380731|FG001|Overall Study|Death|0|||
33542695|NCT03255187|101888798|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
33542696|NCT03255187|101888799|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
33542697|NCT01114724|101888800|FG000|Overall Study|Death|8|||
33542698|NCT01114724|101888800|FG000|Overall Study|Lost to Follow-up|1|||
33542699|NCT01114724|101888800|FG000|Overall Study|Withdrawal by Subject|1|||
33542700|NCT00300053|101888801|FG000|Overall Study|Patient/Caregiver Preference|2|||
33542701|NCT00300053|101888802|FG001|Overall Study|Patient/Caregiver Preference|2|||
33542702|NCT00300053|101888803|FG002|Overall Study|Patient/Caregiver Preference|3|||
33542703|NCT00300053|101888801|FG000|Overall Study|Death|0|||
33542704|NCT00300053|101888802|FG001|Overall Study|Death|0|||
33542705|NCT00300053|101888803|FG002|Overall Study|Death|3|||
33542706|NCT00300053|101888801|FG000|Overall Study|Lost to Follow-up|0|||
33542707|NCT00300053|101888802|FG001|Overall Study|Lost to Follow-up|1|||
33542708|NCT00300053|101888803|FG002|Overall Study|Lost to Follow-up|0|||
33542709|NCT00301834|101888809|FG000|Overall Study|Death|1|||
33542710|NCT01697579|101888812|FG000|Base Study-Cycle 1|Adverse Event|1|||
33345818|NCT03313050|101156481|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
33345819|NCT03313050|101156482|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
33345820|NCT03313050|101156483|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
33345821|NCT03313050|101156484|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
33345822|NCT03313050|101156481|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
33345823|NCT03313050|101156482|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
33345824|NCT03313050|101156483|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
33407692|NCT05261126|101380732|FG002|Overall Study|Death|1|||
33407693|NCT05261126|101380733|FG003|Overall Study|Death|0|||
33407694|NCT05261126|101380734|FG004|Overall Study|Death|0|||
33407695|NCT05261126|101380730|FG000|Overall Study|Lost to Follow-up|0|||
33407696|NCT05261126|101380731|FG001|Overall Study|Lost to Follow-up|0|||
33407697|NCT05261126|101380732|FG002|Overall Study|Lost to Follow-up|0|||
33542711|NCT01697579|101888813|FG001|Base Study-Cycle 1|Adverse Event|0|||
33407698|NCT05261126|101380733|FG003|Overall Study|Lost to Follow-up|0|||
33407699|NCT05261126|101380734|FG004|Overall Study|Lost to Follow-up|1|||
33542712|NCT01697579|101888814|FG002|Base Study-Cycle 1|Adverse Event|0|||
33542713|NCT01697579|101888815|FG003|Base Study-Cycle 1|Adverse Event|0|||
33542714|NCT01697579|101888816|FG004|Base Study-Cycle 1|Adverse Event|0|||
33542715|NCT01697579|101888817|FG005|Base Study-Cycle 1|Adverse Event|0|||
33407700|NCT05261126|101380730|FG000|Overall Study|Physician Decision|1|||
33407701|NCT05261126|101380731|FG001|Overall Study|Physician Decision|0|||
33407702|NCT05261126|101380732|FG002|Overall Study|Physician Decision|0|||
33615921|NCT01843023|102144235|FG000|Overall Study|Lost to Follow-up|24|||
33542716|NCT01697579|101888818|FG006|Base Study-Cycle 1|Adverse Event|0|||
33542717|NCT01697579|101888812|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
33542718|NCT01697579|101888813|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
33542719|NCT01697579|101888814|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
33542720|NCT01697579|101888815|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
33542721|NCT01697579|101888816|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
33542722|NCT01697579|101888817|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
33542723|NCT01697579|101888818|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
33542724|NCT01697579|101888812|FG000|Base Study-Cycle 1|Protocol Violation|0|||
33542725|NCT01697579|101888813|FG001|Base Study-Cycle 1|Protocol Violation|0|||
33345825|NCT03313050|101156484|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
33345826|NCT03313050|101156481|FG000|Stage 2: 12 Months|Protocol deviation|0|||
33345827|NCT03313050|101156482|FG001|Stage 2: 12 Months|Protocol deviation|0|||
33345828|NCT03313050|101156483|FG002|Stage 2: 12 Months|Protocol deviation|7|||
33345829|NCT03313050|101156484|FG003|Stage 2: 12 Months|Protocol deviation|7|||
33345830|NCT03313050|101156481|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
33345831|NCT03313050|101156482|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
33542726|NCT01697579|101888814|FG002|Base Study-Cycle 1|Protocol Violation|0|||
33542727|NCT01697579|101888815|FG003|Base Study-Cycle 1|Protocol Violation|0|||
33345832|NCT03313050|101156483|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
33345833|NCT03313050|101156484|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
33542728|NCT01697579|101888816|FG004|Base Study-Cycle 1|Protocol Violation|3|||
33212389|NCT01362140|100676606|FG000|Overall Study|Other|1|||
33212390|NCT01362140|100676607|FG001|Overall Study|Other|1|||
33212391|NCT01362140|100676606|FG000|Overall Study|Protocol-specified Criteria|1|||
33212392|NCT01362140|100676607|FG001|Overall Study|Protocol-specified Criteria|2|||
33212393|NCT01362140|100676606|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
33212394|NCT01362140|100676607|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
33212395|NCT00608582|100676612|FG000|Overall Study|Lost to Follow-up|2|||
33212396|NCT00608582|100676613|FG001|Overall Study|Lost to Follow-up|0|||
33212397|NCT00608582|100676612|FG000|Overall Study|No Best Response in Phase 1 located|1|||
33212398|NCT00608582|100676613|FG001|Overall Study|No Best Response in Phase 1 located|1|||
33212399|NCT00608582|100676612|FG000|Overall Study|Illicit Drug Use|1|||
33212400|NCT00608582|100676613|FG001|Overall Study|Illicit Drug Use|0|||
33212401|NCT00608582|100676612|FG000|Overall Study|Early stage Design Change|0|||
33212402|NCT00608582|100676613|FG001|Overall Study|Early stage Design Change|3|||
33212403|NCT03822533|100676620|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
33212404|NCT03822533|100676621|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
33212405|NCT03822533|100676620|FG000|3 Month Follow-up|Lost to Follow-up|2|||
33212406|NCT03822533|100676621|FG001|3 Month Follow-up|Lost to Follow-up|2|||
33212407|NCT03822533|100676620|FG000|6 Month Follow-up|Lost to Follow-up|3|||
33212408|NCT03822533|100676621|FG001|6 Month Follow-up|Lost to Follow-up|0|||
33212409|NCT03822533|100676620|FG000|12 Month Follow-up|Lost to Follow-up|2|||
33212410|NCT03822533|100676621|FG001|12 Month Follow-up|Lost to Follow-up|3|||
33542729|NCT01697579|101888817|FG005|Base Study-Cycle 1|Protocol Violation|0|||
33212411|NCT03822533|100676620|FG000|12 Month Follow-up|Pregnancy|0|||
33212412|NCT03822533|100676621|FG001|12 Month Follow-up|Pregnancy|1|||
33212413|NCT03822533|100676620|FG000|12 Month Follow-up|Surgery|2|||
33345834|NCT03313050|101156481|FG000|Stage 2: 12 Months|Other|0|||
33345835|NCT03313050|101156482|FG001|Stage 2: 12 Months|Other|0|||
33345836|NCT03313050|101156483|FG002|Stage 2: 12 Months|Other|0|||
33345837|NCT03313050|101156484|FG003|Stage 2: 12 Months|Other|1|||
33345838|NCT02690194|101156485|FG000|Overall Study|Withdrawal by Subject|1|||
33345839|NCT02690194|101156486|FG001|Overall Study|Withdrawal by Subject|4|||
33345840|NCT02690194|101156487|FG002|Overall Study|Withdrawal by Subject|0|||
33345841|NCT04276207|101156488|FG000|Period 1|Withdrawal by Subject|0|||
33345842|NCT04276207|101156489|FG001|Period 1|Withdrawal by Subject|1|||
33345843|NCT00706030|101156492|FG000|Overall Study|Disease Progression|4|||
33345844|NCT00706030|101156493|FG001|Overall Study|Disease Progression|6|||
33345845|NCT00706030|101156494|FG002|Overall Study|Disease Progression|46|||
33345846|NCT00706030|101156495|FG003|Overall Study|Disease Progression|12|||
33345847|NCT00706030|101156492|FG000|Overall Study|Adverse Event|1|||
33345848|NCT00706030|101156493|FG001|Overall Study|Adverse Event|0|||
33345849|NCT00706030|101156494|FG002|Overall Study|Adverse Event|4|||
33345850|NCT00706030|101156495|FG003|Overall Study|Adverse Event|2|||
33345851|NCT00706030|101156492|FG000|Overall Study|Withdrawal by Subject|1|||
33407703|NCT05261126|101380733|FG003|Overall Study|Physician Decision|0|||
33407704|NCT05261126|101380734|FG004|Overall Study|Physician Decision|0|||
33407705|NCT05261126|101380730|FG000|Overall Study|Screen Failure|0|||
33212414|NCT03822533|100676621|FG001|12 Month Follow-up|Surgery|0|||
33212415|NCT03822533|100676620|FG000|12 Month Follow-up|Wrong address|1|||
33407706|NCT05261126|101380731|FG001|Overall Study|Screen Failure|0|||
33212416|NCT03822533|100676621|FG001|12 Month Follow-up|Wrong address|0|||
33345852|NCT00706030|101156493|FG001|Overall Study|Withdrawal by Subject|0|||
33345853|NCT00706030|101156494|FG002|Overall Study|Withdrawal by Subject|2|||
33345854|NCT00706030|101156495|FG003|Overall Study|Withdrawal by Subject|0|||
33345855|NCT00706030|101156492|FG000|Overall Study|Physician Decision|0|||
33345856|NCT00706030|101156493|FG001|Overall Study|Physician Decision|0|||
33407707|NCT05261126|101380732|FG002|Overall Study|Screen Failure|0|||
33407708|NCT05261126|101380733|FG003|Overall Study|Screen Failure|0|||
33407709|NCT05261126|101380734|FG004|Overall Study|Screen Failure|1|||
33407710|NCT05261126|101380730|FG000|Overall Study|Withdrawal by Subject|1|||
33407711|NCT05261126|101380731|FG001|Overall Study|Withdrawal by Subject|0|||
33407712|NCT05261126|101380732|FG002|Overall Study|Withdrawal by Subject|1|||
33407713|NCT05261126|101380733|FG003|Overall Study|Withdrawal by Subject|1|||
33542730|NCT01697579|101888818|FG006|Base Study-Cycle 1|Protocol Violation|0|||
33345857|NCT00706030|101156494|FG002|Overall Study|Physician Decision|2|||
33407714|NCT05261126|101380734|FG004|Overall Study|Withdrawal by Subject|0|||
33407715|NCT05261126|101380730|FG000|Overall Study|Not Recorded|0|||
33542731|NCT01697579|101888812|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
33615922|NCT01843023|102144236|FG001|Overall Study|Lost to Follow-up|29|||
33212417|NCT03822533|100676620|FG000|12 Month Follow-up|No symptoms|1|||
33212418|NCT03822533|100676621|FG001|12 Month Follow-up|No symptoms|0|||
33212419|NCT03822533|100676620|FG000|12 Month Follow-up|Changed primary care center|0|||
33345858|NCT00706030|101156495|FG003|Overall Study|Physician Decision|0|||
33345859|NCT00706030|101156492|FG000|Overall Study|Not recorded|0|||
33345860|NCT00706030|101156493|FG001|Overall Study|Not recorded|0|||
33345861|NCT00706030|101156494|FG002|Overall Study|Not recorded|2|||
33345862|NCT00706030|101156495|FG003|Overall Study|Not recorded|0|||
33345863|NCT00706030|101156492|FG000|Overall Study|Protocol Violation|0|||
33212420|NCT03822533|100676621|FG001|12 Month Follow-up|Changed primary care center|1|||
33212421|NCT04403698|100676622|FG000|Overall Study|Adverse Event|1|||
33212422|NCT04403698|100676623|FG001|Overall Study|Adverse Event|1|||
33212423|NCT04403698|100676622|FG000|Overall Study|Lost to Follow-up|1|||
33212424|NCT04403698|100676623|FG001|Overall Study|Lost to Follow-up|0|||
33212425|NCT04403698|100676622|FG000|Overall Study|Protocol Violation|0|||
33212426|NCT04403698|100676623|FG001|Overall Study|Protocol Violation|1|||
33212427|NCT05349617|100676624|FG000|Overall Study|Death|1|||
33212428|NCT05349617|100676625|FG001|Overall Study|Death|1|||
33212429|NCT05349617|100676624|FG000|Overall Study|Lost to Follow-up|3|||
33212430|NCT05349617|100676625|FG001|Overall Study|Lost to Follow-up|8|||
33212431|NCT05349617|100676624|FG000|Overall Study|Withdrawal by Subject|2|||
33212432|NCT05349617|100676625|FG001|Overall Study|Withdrawal by Subject|10|||
33212433|NCT01654549|100676626|FG000|Overall Study|H.pylori eradication not successful|0|||
33212434|NCT01654549|100676627|FG001|Overall Study|H.pylori eradication not successful|1|||
33212435|NCT02522494|100676632|FG000|Overall Study|Lost to Follow-up|6|||
33212436|NCT02522494|100676633|FG001|Overall Study|Lost to Follow-up|2|||
33212437|NCT02522494|100676632|FG000|Overall Study|Withdrawal by Subject|1|||
33212438|NCT02522494|100676633|FG001|Overall Study|Withdrawal by Subject|0|||
33212439|NCT02522494|100676632|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
33212440|NCT02522494|100676633|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
33212441|NCT02522494|100676632|FG000|Overall Study|Participant did not watch the video|1|||
33212442|NCT02522494|100676633|FG001|Overall Study|Participant did not watch the video|0|||
33212443|NCT02522494|100676632|FG000|Overall Study|Death|0|||
33212444|NCT02522494|100676633|FG001|Overall Study|Death|1|||
33212445|NCT00651664|100676635|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
33212446|NCT00651664|100676636|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
33212447|NCT00651664|100676637|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
33345864|NCT00706030|101156493|FG001|Overall Study|Protocol Violation|0|||
33345865|NCT00706030|101156494|FG002|Overall Study|Protocol Violation|1|||
33345866|NCT00706030|101156495|FG003|Overall Study|Protocol Violation|1|||
33345867|NCT00706030|101156492|FG000|Overall Study|Failed to return|0|||
33345868|NCT00706030|101156493|FG001|Overall Study|Failed to return|0|||
33345869|NCT00706030|101156494|FG002|Overall Study|Failed to return|1|||
33345870|NCT00706030|101156495|FG003|Overall Study|Failed to return|0|||
33345871|NCT00706030|101156492|FG000|Overall Study|Symptomatic Deterioration|0|||
33345872|NCT00706030|101156493|FG001|Overall Study|Symptomatic Deterioration|0|||
33345873|NCT00706030|101156494|FG002|Overall Study|Symptomatic Deterioration|1|||
33345874|NCT00706030|101156495|FG003|Overall Study|Symptomatic Deterioration|0|||
33345875|NCT00706030|101156492|FG000|Overall Study|No treatment received|0|||
33345876|NCT00706030|101156493|FG001|Overall Study|No treatment received|0|||
33345877|NCT00706030|101156494|FG002|Overall Study|No treatment received|0|||
33345878|NCT00706030|101156495|FG003|Overall Study|No treatment received|1|||
33345879|NCT00706030|101156492|FG000|Overall Study|Death|0|||
33345880|NCT00706030|101156493|FG001|Overall Study|Death|0|||
33345881|NCT00706030|101156494|FG002|Overall Study|Death|1|||
33345882|NCT00706030|101156495|FG003|Overall Study|Death|0|||
33345883|NCT01275222|101156496|FG000|Phase l by Treatment|Adverse Event|1|||
33345884|NCT01275222|101156497|FG001|Phase l by Treatment|Adverse Event|4|||
33345885|NCT01275222|101156498|FG002|Phase l by Treatment|Adverse Event|2|||
33212448|NCT00651664|100676638|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
33212449|NCT00651664|100676639|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
33212450|NCT00651664|100676640|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
33212451|NCT00651664|100676641|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
33212452|NCT00651664|100676642|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
33345886|NCT01275222|101156499|FG003|Phase l by Treatment|Adverse Event|3|||
33345887|NCT01275222|101156500|FG004|Phase l by Treatment|Adverse Event|0|||
33345888|NCT01275222|101156501|FG005|Phase l by Treatment|Adverse Event|0|||
33345889|NCT01275222|101156496|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
33345890|NCT01275222|101156497|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
33345891|NCT01275222|101156498|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
33345892|NCT01275222|101156499|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
33345893|NCT01275222|101156500|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
33345894|NCT01275222|101156501|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
33345895|NCT01275222|101156496|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
33345896|NCT01275222|101156497|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
33345897|NCT01275222|101156498|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
33345898|NCT01275222|101156499|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
33345899|NCT01275222|101156500|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
33345900|NCT01275222|101156501|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
33345901|NCT01275222|101156496|FG000|Phase l by Treatment|Disease progression|12|||
33345902|NCT01275222|101156497|FG001|Phase l by Treatment|Disease progression|8|||
33345903|NCT01275222|101156498|FG002|Phase l by Treatment|Disease progression|2|||
33345904|NCT01275222|101156499|FG003|Phase l by Treatment|Disease progression|5|||
33345905|NCT01275222|101156500|FG004|Phase l by Treatment|Disease progression|0|||
33345906|NCT01275222|101156501|FG005|Phase l by Treatment|Disease progression|0|||
33345907|NCT01275222|101156496|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
33345908|NCT01275222|101156497|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
33407716|NCT05261126|101380731|FG001|Overall Study|Not Recorded|0|||
33407717|NCT05261126|101380732|FG002|Overall Study|Not Recorded|0|||
33407718|NCT05261126|101380733|FG003|Overall Study|Not Recorded|1|||
33407719|NCT05261126|101380734|FG004|Overall Study|Not Recorded|0|||
33407720|NCT03287089|101380735|FG000|Overall Study|Lost to Follow-up|0|||
33407721|NCT03287089|101380736|FG001|Overall Study|Lost to Follow-up|2|||
33345909|NCT01275222|101156498|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
33345910|NCT01275222|101156499|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
33345911|NCT01275222|101156500|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
33407722|NCT03287089|101380735|FG000|Overall Study|Physician Decision|0|||
33542732|NCT01697579|101888813|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
33542733|NCT01697579|101888814|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
33212453|NCT00651664|100676643|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
33345912|NCT01275222|101156501|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
33345913|NCT01275222|101156496|FG000|Phase l by Treatment|Death|0|||
33345914|NCT01275222|101156497|FG001|Phase l by Treatment|Death|1|||
33345915|NCT01275222|101156498|FG002|Phase l by Treatment|Death|0|||
33345916|NCT01275222|101156499|FG003|Phase l by Treatment|Death|1|||
33407723|NCT03287089|101380736|FG001|Overall Study|Physician Decision|2|||
33345917|NCT01275222|101156500|FG004|Phase l by Treatment|Death|0|||
33345918|NCT01275222|101156501|FG005|Phase l by Treatment|Death|0|||
33345919|NCT01275222|101156496|FG000|Phase ll by Stratum|Adverse Event|0|||
33615923|NCT01843023|102144235|FG000|Overall Study|Withdrawal by Subject|8|||
33615924|NCT01843023|102144236|FG001|Overall Study|Withdrawal by Subject|6|||
33615925|NCT03464019|102144242|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
33615926|NCT03464019|102144243|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
33615927|NCT03464019|102144244|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
33345920|NCT01275222|101156497|FG001|Phase ll by Stratum|Adverse Event|0|||
33345921|NCT01275222|101156498|FG002|Phase ll by Stratum|Adverse Event|0|||
33615928|NCT03464019|102144242|FG000|NODE-301 Part 1|Ablation|0|||
33615929|NCT03464019|102144243|FG001|NODE-301 Part 1|Ablation|0|||
33615930|NCT03464019|102144244|FG002|NODE-301 Part 1|Ablation|16|||
33407724|NCT03287089|101380735|FG000|Overall Study|Withdrawal by Subject|0|||
33407725|NCT03287089|101380736|FG001|Overall Study|Withdrawal by Subject|2|||
33407726|NCT04524663|101380737|FG000|Overall Study|Withdrawal by Subject|0|||
33407727|NCT04524663|101380738|FG001|Overall Study|Withdrawal by Subject|2|||
33407728|NCT00223990|101380739|FG000|Overall Study|Moved from area|2|||
33615931|NCT03464019|102144242|FG000|NODE-301 Part 1|Test Dose Failure|0|||
33615932|NCT03464019|102144243|FG001|NODE-301 Part 1|Test Dose Failure|0|||
33345922|NCT01275222|101156499|FG003|Phase ll by Stratum|Adverse Event|0|||
33345923|NCT01275222|101156500|FG004|Phase ll by Stratum|Adverse Event|2|||
33345924|NCT01275222|101156501|FG005|Phase ll by Stratum|Adverse Event|10|||
33345925|NCT01275222|101156496|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
33345926|NCT01275222|101156497|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
33345927|NCT01275222|101156498|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
33345928|NCT01275222|101156499|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
33345929|NCT01275222|101156500|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
33345930|NCT01275222|101156501|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
33345931|NCT01275222|101156496|FG000|Phase ll by Stratum|Disease progression|0|||
33345932|NCT01275222|101156497|FG001|Phase ll by Stratum|Disease progression|0|||
33345933|NCT01275222|101156498|FG002|Phase ll by Stratum|Disease progression|0|||
33345934|NCT01275222|101156499|FG003|Phase ll by Stratum|Disease progression|0|||
33345935|NCT01275222|101156500|FG004|Phase ll by Stratum|Disease progression|23|||
33345936|NCT01275222|101156501|FG005|Phase ll by Stratum|Disease progression|31|||
33345937|NCT01275222|101156496|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
33345938|NCT01275222|101156497|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
33345939|NCT01275222|101156498|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
33345940|NCT01275222|101156499|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
33345941|NCT01275222|101156500|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
33345942|NCT01275222|101156501|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
33345943|NCT01275222|101156496|FG000|Phase ll by Stratum|Death|0|||
33345944|NCT01275222|101156497|FG001|Phase ll by Stratum|Death|0|||
33345945|NCT01275222|101156498|FG002|Phase ll by Stratum|Death|0|||
33345946|NCT01275222|101156499|FG003|Phase ll by Stratum|Death|0|||
33407729|NCT00223990|101380740|FG001|Overall Study|Moved from area|1|||
33345947|NCT01275222|101156500|FG004|Phase ll by Stratum|Death|1|||
33615933|NCT03464019|102144244|FG002|NODE-301 Part 1|Test Dose Failure|8|||
33615934|NCT03464019|102144242|FG000|NODE-301 Part 1|Adverse Event|0|||
33407730|NCT00223990|101380739|FG000|Overall Study|Withdrawal by Subject|4|||
33615935|NCT03464019|102144243|FG001|NODE-301 Part 1|Adverse Event|0|||
33615936|NCT03464019|102144244|FG002|NODE-301 Part 1|Adverse Event|5|||
33345948|NCT01275222|101156501|FG005|Phase ll by Stratum|Death|1|||
33345949|NCT00578643|101156502|FG000|Overall Study|Death|1|||
33345950|NCT00578643|101156502|FG000|Overall Study|Lost to Follow-up|1|||
33345951|NCT03603652|101156504|FG000|Overall Study|Death|2|||
33345952|NCT00331006|101156505|FG000|Screening Phase|Withdrawal by Subject|1|||
33345953|NCT00331006|101156505|FG000|Screening Phase|enrollment halted|1|||
33345954|NCT00331006|101156505|FG000|Screening Phase|Lost to Follow-up|1|||
33345955|NCT00331006|101156505|FG000|Screening Phase|Ineligible for treatment phase|4|||
33345956|NCT00331006|101156505|FG000|Treatment Phase|Withdrawal by Subject|1|||
33345957|NCT00331006|101156505|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
33345958|NCT00331006|101156505|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
33345959|NCT04162210|101156508|FG000|Overall Study|Lost to Follow-up|4|||
33345960|NCT04162210|101156509|FG001|Overall Study|Lost to Follow-up|1|||
33407731|NCT00223990|101380740|FG001|Overall Study|Withdrawal by Subject|8|||
33407732|NCT00223990|101380739|FG000|Overall Study|Lost to Follow-up|1|||
33407733|NCT00223990|101380740|FG001|Overall Study|Lost to Follow-up|0|||
33407734|NCT00383292|101380745|FG000|Overall Study|Adverse Event|4|||
33407735|NCT00383292|101380746|FG001|Overall Study|Adverse Event|1|||
33407736|NCT00383292|101380747|FG002|Overall Study|Adverse Event|2|||
33407737|NCT00383292|101380745|FG000|Overall Study|Death|3|||
33407738|NCT00383292|101380746|FG001|Overall Study|Death|3|||
33542734|NCT01697579|101888815|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
33542735|NCT01697579|101888816|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
33542736|NCT01697579|101888817|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
33542737|NCT01697579|101888818|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
33542738|NCT01697579|101888812|FG000|Base Study-Cycle 1|Technical Problems|0|||
33542739|NCT01697579|101888813|FG001|Base Study-Cycle 1|Technical Problems|0|||
33542740|NCT01697579|101888814|FG002|Base Study-Cycle 1|Technical Problems|1|||
33345961|NCT04162210|101156508|FG000|Overall Study|Withdrawal by Subject|17|||
33407739|NCT00383292|101380747|FG002|Overall Study|Death|3|||
33542741|NCT01697579|101888815|FG003|Base Study-Cycle 1|Technical Problems|1|||
33542742|NCT01697579|101888816|FG004|Base Study-Cycle 1|Technical Problems|0|||
33542743|NCT01697579|101888817|FG005|Base Study-Cycle 1|Technical Problems|0|||
33615937|NCT03464019|102144242|FG000|NODE-301 Part 1|Physician Decision|0|||
33345962|NCT04162210|101156509|FG001|Overall Study|Withdrawal by Subject|9|||
33407740|NCT00383292|101380745|FG000|Overall Study|Physician Decision|4|||
33407741|NCT00383292|101380746|FG001|Overall Study|Physician Decision|0|||
33542744|NCT01697579|101888818|FG006|Base Study-Cycle 1|Technical Problems|0|||
33345963|NCT04162210|101156508|FG000|Overall Study|Ongoing|113|||
33345964|NCT04162210|101156509|FG001|Overall Study|Ongoing|59|||
33407742|NCT00383292|101380747|FG002|Overall Study|Physician Decision|1|||
33345965|NCT00946309|101156510|FG000|Overall Study|Protocol Violation|1|||
33345966|NCT00946309|101156511|FG001|Overall Study|Protocol Violation|0|||
33345967|NCT00946309|101156510|FG000|Overall Study|Lost to Follow-up|0|||
33542745|NCT01697579|101888812|FG000|Optional Extension-Cycles 2-6|Death|0|||
33542746|NCT01697579|101888813|FG001|Optional Extension-Cycles 2-6|Death|0|||
33542747|NCT01697579|101888814|FG002|Optional Extension-Cycles 2-6|Death|0|||
33542748|NCT01697579|101888815|FG003|Optional Extension-Cycles 2-6|Death|0|||
33542749|NCT01697579|101888816|FG004|Optional Extension-Cycles 2-6|Death|0|||
33542750|NCT01697579|101888817|FG005|Optional Extension-Cycles 2-6|Death|0|||
33615938|NCT03464019|102144243|FG001|NODE-301 Part 1|Physician Decision|0|||
33615939|NCT03464019|102144244|FG002|NODE-301 Part 1|Physician Decision|4|||
33345968|NCT00946309|101156511|FG001|Overall Study|Lost to Follow-up|1|||
33345969|NCT00946309|101156510|FG000|Overall Study|Procedure cancelled/discontinued|0|||
33345970|NCT00946309|101156511|FG001|Overall Study|Procedure cancelled/discontinued|3|||
33345971|NCT02720757|101156512|FG000|Overall Study|Other reason|5|||
33345972|NCT02720757|101156512|FG000|Overall Study|Loss of contact|4|||
33407743|NCT00383292|101380745|FG000|Overall Study|Withdrawal by Subject|3|||
33407744|NCT00383292|101380746|FG001|Overall Study|Withdrawal by Subject|2|||
33407745|NCT00383292|101380747|FG002|Overall Study|Withdrawal by Subject|2|||
33407746|NCT00383292|101380745|FG000|Overall Study|Other|1|||
33615940|NCT03464019|102144242|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
33615941|NCT03464019|102144243|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
33542751|NCT01697579|101888818|FG006|Optional Extension-Cycles 2-6|Death|2|||
33542752|NCT01697579|101888812|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
33542753|NCT01697579|101888813|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
33542754|NCT01697579|101888814|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
33542755|NCT01697579|101888815|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
33542756|NCT01697579|101888816|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
33542757|NCT01697579|101888817|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
33542758|NCT01697579|101888818|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
33542759|NCT01697579|101888812|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
33407747|NCT00383292|101380746|FG001|Overall Study|Other|0|||
33407748|NCT00383292|101380747|FG002|Overall Study|Other|0|||
33407749|NCT03758612|101380748|FG000|Washout Period|Withdrawal by Subject|0|||
33407750|NCT03758612|101380749|FG001|Washout Period|Withdrawal by Subject|0|||
33542760|NCT01697579|101888813|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
33542761|NCT01697579|101888814|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
33542762|NCT01697579|101888815|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
33542763|NCT01697579|101888816|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
33542764|NCT01697579|101888817|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
33542765|NCT01697579|101888818|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
33542766|NCT01697579|101888812|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
33542767|NCT01697579|101888813|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
33615942|NCT03464019|102144244|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
33615943|NCT03464019|102144242|FG000|NODE-301 Part 1|Protocol Violation|0|||
33407751|NCT03758612|101380750|FG002|Washout Period|Withdrawal by Subject|2|||
33407752|NCT03758612|101380751|FG003|Washout Period|Withdrawal by Subject|0|||
33407753|NCT03758612|101380752|FG004|Washout Period|Withdrawal by Subject|0|||
33407754|NCT03758612|101380753|FG005|Washout Period|Withdrawal by Subject|0|||
33407755|NCT03758612|101380754|FG006|Washout Period|Withdrawal by Subject|0|||
33407756|NCT03758612|101380755|FG007|Washout Period|Withdrawal by Subject|0|||
33407757|NCT03758612|101380756|FG008|Washout Period|Withdrawal by Subject|0|||
33407758|NCT03758612|101380757|FG009|Washout Period|Withdrawal by Subject|0|||
33407759|NCT03758612|101380758|FG010|Washout Period|Withdrawal by Subject|0|||
33407760|NCT03758612|101380759|FG011|Washout Period|Withdrawal by Subject|0|||
33407761|NCT03758612|101380748|FG000|Period 2|Protocol Violation|0|||
33542768|NCT01697579|101888814|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
33542769|NCT01697579|101888815|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
33542770|NCT01697579|101888816|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
33615944|NCT03464019|102144243|FG001|NODE-301 Part 1|Protocol Violation|0|||
33615945|NCT03464019|102144244|FG002|NODE-301 Part 1|Protocol Violation|2|||
33345973|NCT02720757|101156512|FG000|Overall Study|Informed consent withdrawal|1|||
33345974|NCT02720757|101156512|FG000|Overall Study|Patients wish to withdraw|2|||
33345975|NCT02720757|101156512|FG000|Overall Study|Missing|3|||
33345976|NCT02720757|101156512|FG000|Overall Study|General exclusion|3|||
33407762|NCT03758612|101380749|FG001|Period 2|Protocol Violation|0|||
33407763|NCT03758612|101380750|FG002|Period 2|Protocol Violation|0|||
33407764|NCT03758612|101380751|FG003|Period 2|Protocol Violation|0|||
33542771|NCT01697579|101888817|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
33615946|NCT03464019|102144242|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
33407765|NCT03758612|101380752|FG004|Period 2|Protocol Violation|1|||
33407766|NCT03758612|101380753|FG005|Period 2|Protocol Violation|0|||
33407767|NCT03758612|101380754|FG006|Period 2|Protocol Violation|0|||
33407768|NCT03758612|101380755|FG007|Period 2|Protocol Violation|0|||
33542772|NCT01697579|101888818|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
33542773|NCT01697579|101888812|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
33542774|NCT01697579|101888813|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
33542775|NCT01697579|101888814|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
33542776|NCT01697579|101888815|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
33542777|NCT01697579|101888816|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
33542778|NCT01697579|101888817|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
33542779|NCT01697579|101888818|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
33542780|NCT01697579|101888812|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
33542781|NCT01697579|101888813|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
33542782|NCT01697579|101888814|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
33542783|NCT01697579|101888815|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
33542784|NCT01697579|101888816|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
33542785|NCT01697579|101888817|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
33542786|NCT01697579|101888818|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
33542787|NCT01697579|101888812|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
33542788|NCT01697579|101888813|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
33542789|NCT01697579|101888814|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
33542790|NCT01697579|101888815|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
33542791|NCT01697579|101888816|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
33542792|NCT01697579|101888817|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
33542793|NCT01697579|101888818|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
33542794|NCT01697579|101888812|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
33542795|NCT01697579|101888813|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
33542796|NCT01697579|101888814|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
33212454|NCT00651664|100676644|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
33212455|NCT00651664|100676635|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
33212456|NCT00651664|100676636|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
33212457|NCT00651664|100676637|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
33212458|NCT00651664|100676638|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
33212459|NCT00651664|100676639|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
33212460|NCT00651664|100676640|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
33212461|NCT00651664|100676641|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
33212462|NCT00651664|100676642|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
33212463|NCT00651664|100676643|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
33212464|NCT00651664|100676644|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
33212465|NCT00651664|100676635|FG000|Overall Study|Progressive Disease|3|||
33212466|NCT00651664|100676636|FG001|Overall Study|Progressive Disease|3|||
33212467|NCT00651664|100676637|FG002|Overall Study|Progressive Disease|3|||
33212468|NCT00651664|100676638|FG003|Overall Study|Progressive Disease|12|||
33212469|NCT00651664|100676639|FG004|Overall Study|Progressive Disease|4|||
33212470|NCT00651664|100676640|FG005|Overall Study|Progressive Disease|1|||
33212471|NCT00651664|100676641|FG006|Overall Study|Progressive Disease|3|||
33212472|NCT00651664|100676642|FG007|Overall Study|Progressive Disease|6|||
33212473|NCT00651664|100676643|FG008|Overall Study|Progressive Disease|5|||
33212474|NCT00651664|100676644|FG009|Overall Study|Progressive Disease|5|||
33212475|NCT00651664|100676635|FG000|Overall Study|Patient Declined Further Treatment|0|||
33212476|NCT00651664|100676636|FG001|Overall Study|Patient Declined Further Treatment|0|||
33212477|NCT00651664|100676637|FG002|Overall Study|Patient Declined Further Treatment|0|||
33212478|NCT00651664|100676638|FG003|Overall Study|Patient Declined Further Treatment|1|||
33542797|NCT01697579|101888815|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
33542798|NCT01697579|101888816|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
33542799|NCT01697579|101888817|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
33542800|NCT01697579|101888818|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
33542801|NCT01697579|101888812|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
33542802|NCT01697579|101888813|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
33542803|NCT01697579|101888814|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
33542804|NCT01697579|101888815|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
33542805|NCT01697579|101888816|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
33212479|NCT00651664|100676639|FG004|Overall Study|Patient Declined Further Treatment|1|||
33212480|NCT00651664|100676640|FG005|Overall Study|Patient Declined Further Treatment|1|||
33212481|NCT00651664|100676641|FG006|Overall Study|Patient Declined Further Treatment|0|||
33212482|NCT00651664|100676642|FG007|Overall Study|Patient Declined Further Treatment|0|||
33212483|NCT00651664|100676643|FG008|Overall Study|Patient Declined Further Treatment|0|||
33212484|NCT00651664|100676644|FG009|Overall Study|Patient Declined Further Treatment|1|||
33212485|NCT00651664|100676635|FG000|Overall Study|Symptomatic Deterioration|0|||
33212486|NCT00651664|100676636|FG001|Overall Study|Symptomatic Deterioration|0|||
33345977|NCT01214044|101156515|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
33345978|NCT01214044|101156515|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
33345979|NCT01214044|101156515|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
33345980|NCT01214044|101156515|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
33345981|NCT01214044|101156515|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
33345982|NCT01214044|101156515|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
33345983|NCT00713219|101156516|FG000|Overall Study|Death|1|||
33345984|NCT00713219|101156516|FG000|Overall Study|Protocol Violation|1|||
33345985|NCT00705263|101156523|FG000|Overall Study|Withdrawal by Subject|2|||
33345986|NCT00332709|101156524|FG000|Overall Study|Adverse Event|11|||
33345987|NCT00332709|101156525|FG001|Overall Study|Adverse Event|14|||
33345988|NCT00332709|101156524|FG000|Overall Study|Withdrawal by Subject|2|||
33345989|NCT00332709|101156525|FG001|Overall Study|Withdrawal by Subject|3|||
33345990|NCT00332709|101156524|FG000|Overall Study|Lost to Follow-up|2|||
33345991|NCT00332709|101156525|FG001|Overall Study|Lost to Follow-up|0|||
33345992|NCT00332709|101156524|FG000|Overall Study|Administrative Problems|0|||
33345993|NCT00332709|101156525|FG001|Overall Study|Administrative Problems|3|||
33345994|NCT00332709|101156524|FG000|Overall Study|Abnormal test procedure result|1|||
33345995|NCT00332709|101156525|FG001|Overall Study|Abnormal test procedure result|0|||
33345996|NCT02382133|101156526|FG000|Overall Study|Death|22|||
33345997|NCT02382133|101156526|FG000|Overall Study|transfer out of ICU|4|||
33542806|NCT01697579|101888817|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
33542807|NCT01697579|101888818|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
33542808|NCT01697579|101888812|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
33542809|NCT01697579|101888813|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
33542810|NCT01697579|101888814|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
33542811|NCT01697579|101888815|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
33542812|NCT01697579|101888816|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
33542813|NCT01697579|101888817|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
33542814|NCT01697579|101888818|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
33542815|NCT01697579|101888812|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
33542816|NCT01697579|101888813|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
33542817|NCT01697579|101888814|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
33542818|NCT01697579|101888815|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
33542819|NCT01697579|101888816|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
33542820|NCT01697579|101888817|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
33542821|NCT01697579|101888818|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
33542822|NCT01697579|101888812|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
33542823|NCT01697579|101888813|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
33542824|NCT01697579|101888814|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
33542825|NCT01697579|101888815|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
33542826|NCT01697579|101888816|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
33542827|NCT01697579|101888817|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
33542828|NCT01697579|101888818|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
33542829|NCT01697579|101888812|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
33542830|NCT01697579|101888813|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
33542831|NCT01697579|101888814|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
33615947|NCT03464019|102144243|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
33615948|NCT03464019|102144244|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
33345998|NCT02382133|101156526|FG000|Overall Study|Physician Decision|2|||
33345999|NCT02382133|101156526|FG000|Overall Study|arterial catheter loss|4|||
33407769|NCT03758612|101380756|FG008|Period 2|Protocol Violation|0|||
33407770|NCT03758612|101380757|FG009|Period 2|Protocol Violation|0|||
33346000|NCT02382133|101156526|FG000|Overall Study|pressure injury both sites|1|||
33346001|NCT02468648|101156527|FG000|Overall Study|Death|1|||
33346002|NCT04373460|101156528|FG000|Overall Study|Did not receive tranfusion|18|||
33212487|NCT00651664|100676637|FG002|Overall Study|Symptomatic Deterioration|0|||
33212488|NCT00651664|100676638|FG003|Overall Study|Symptomatic Deterioration|1|||
33212489|NCT00651664|100676639|FG004|Overall Study|Symptomatic Deterioration|0|||
33212490|NCT00651664|100676640|FG005|Overall Study|Symptomatic Deterioration|0|||
33212491|NCT00651664|100676641|FG006|Overall Study|Symptomatic Deterioration|1|||
33212492|NCT00651664|100676642|FG007|Overall Study|Symptomatic Deterioration|0|||
33212493|NCT00651664|100676643|FG008|Overall Study|Symptomatic Deterioration|1|||
33212494|NCT00651664|100676644|FG009|Overall Study|Symptomatic Deterioration|0|||
33212495|NCT00651664|100676635|FG000|Overall Study|Reason not Specified|0|||
33212496|NCT00651664|100676636|FG001|Overall Study|Reason not Specified|0|||
33212497|NCT00651664|100676637|FG002|Overall Study|Reason not Specified|0|||
33212498|NCT00651664|100676638|FG003|Overall Study|Reason not Specified|0|||
33346003|NCT04373460|101156529|FG001|Overall Study|Did not receive tranfusion|26|||
33346004|NCT01497262|101156533|FG000|Overall Study|Abnormal Lab Values|4|||
33346005|NCT01497262|101156533|FG000|Overall Study|Abnormal Test Procedure Result|1|||
33346006|NCT01497262|101156533|FG000|Overall Study|Physician Decision|1|||
33346007|NCT01497262|101156533|FG000|Overall Study|Withdrawal by Subject|2|||
33346008|NCT01497262|101156533|FG000|Overall Study|Adverse Event|2|||
33346009|NCT01497262|101156533|FG000|Overall Study|Protocol Violation|1|||
33346010|NCT01171820|101156534|FG000|Overall Study|Death|3|||
33346011|NCT01171820|101156535|FG001|Overall Study|Death|3|||
33346012|NCT01171820|101156534|FG000|Overall Study|Lost to Follow-up|0|||
33346013|NCT01171820|101156535|FG001|Overall Study|Lost to Follow-up|1|||
33346014|NCT01171820|101156534|FG000|Overall Study|Withdrawal by Subject|2|||
33346015|NCT01171820|101156535|FG001|Overall Study|Withdrawal by Subject|0|||
33346016|NCT01171820|101156534|FG000|Overall Study|Physician Decision|0|||
33346017|NCT01171820|101156535|FG001|Overall Study|Physician Decision|1|||
33346018|NCT01171820|101156534|FG000|Overall Study|1-Year Missed Visit|1|||
33212499|NCT00651664|100676639|FG004|Overall Study|Reason not Specified|0|||
33212500|NCT00651664|100676640|FG005|Overall Study|Reason not Specified|0|||
33212501|NCT00651664|100676641|FG006|Overall Study|Reason not Specified|1|||
33346019|NCT01171820|101156535|FG001|Overall Study|1-Year Missed Visit|1|||
33346020|NCT03757988|101156536|FG000|Overall Study|Withdrawal by Subject|1|||
33346021|NCT02848833|101156544|FG000|Overall Study|subject who are duplicated|1|||
33346022|NCT02848833|101156544|FG000|Overall Study|have not taken the study drug|11|||
33212502|NCT00651664|100676642|FG007|Overall Study|Reason not Specified|0|||
33212503|NCT00651664|100676643|FG008|Overall Study|Reason not Specified|0|||
33212504|NCT00651664|100676644|FG009|Overall Study|Reason not Specified|0|||
33212505|NCT01597050|100676645|FG000|Overall Study|Withdrawal by Subject|1|||
33212506|NCT01597050|100676646|FG001|Overall Study|Withdrawal by Subject|0|||
33212507|NCT03492281|100676649|FG000|Overall Study|Withdrawal by Subject|21|||
33212508|NCT03492281|100676650|FG001|Overall Study|Withdrawal by Subject|14|||
33212509|NCT03492281|100676651|FG002|Overall Study|Withdrawal by Subject|13|||
33212510|NCT03492281|100676649|FG000|Overall Study|Lost to Follow-up|14|||
33212511|NCT03492281|100676650|FG001|Overall Study|Lost to Follow-up|15|||
33212512|NCT03492281|100676651|FG002|Overall Study|Lost to Follow-up|10|||
33212513|NCT03492281|100676649|FG000|Overall Study|Adverse Event|6|||
33212514|NCT03492281|100676650|FG001|Overall Study|Adverse Event|8|||
33212515|NCT03492281|100676651|FG002|Overall Study|Adverse Event|13|||
33212516|NCT03492281|100676649|FG000|Overall Study|Lack of Efficacy|3|||
33212517|NCT03492281|100676650|FG001|Overall Study|Lack of Efficacy|0|||
33212518|NCT03492281|100676651|FG002|Overall Study|Lack of Efficacy|1|||
33212519|NCT03492281|100676649|FG000|Overall Study|Physician Decision|1|||
33212520|NCT03492281|100676650|FG001|Overall Study|Physician Decision|0|||
33212521|NCT03492281|100676651|FG002|Overall Study|Physician Decision|3|||
33212522|NCT03492281|100676649|FG000|Overall Study|Protocol Violation|0|||
33212523|NCT03492281|100676650|FG001|Overall Study|Protocol Violation|2|||
33212524|NCT03492281|100676651|FG002|Overall Study|Protocol Violation|1|||
33212525|NCT03492281|100676649|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
33212526|NCT03492281|100676650|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
33212527|NCT03492281|100676651|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
33212528|NCT03492281|100676649|FG000|Overall Study|Death|0|||
33212529|NCT03492281|100676650|FG001|Overall Study|Death|0|||
33212530|NCT03492281|100676651|FG002|Overall Study|Death|1|||
33212531|NCT03492281|100676649|FG000|Overall Study|Captured as Other in Database|8|||
33212532|NCT03492281|100676650|FG001|Overall Study|Captured as Other in Database|6|||
33212533|NCT03492281|100676651|FG002|Overall Study|Captured as Other in Database|3|||
33212534|NCT02280044|100676655|FG000|Overall Study|Planned alternate|0|||
33212535|NCT02280044|100676656|FG001|Overall Study|Planned alternate|2|||
33542832|NCT01697579|101888815|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
33542833|NCT01697579|101888816|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
33542834|NCT01697579|101888817|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
33542835|NCT01697579|101888818|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
33542836|NCT01369433|101888824|FG000|Overall Study|Adverse Event|31|||
33542837|NCT01369433|101888825|FG001|Overall Study|Adverse Event|1|||
33542838|NCT01369433|101888824|FG000|Overall Study|Required significant surgical procedure|1|||
33542839|NCT01369433|101888825|FG001|Overall Study|Required significant surgical procedure|0|||
33542840|NCT01369433|101888824|FG000|Overall Study|Non-compliance|1|||
33542841|NCT01369433|101888825|FG001|Overall Study|Non-compliance|0|||
33542842|NCT01369433|101888824|FG000|Overall Study|Withdrawal by Subject|5|||
33542843|NCT01369433|101888825|FG001|Overall Study|Withdrawal by Subject|2|||
33542844|NCT01369433|101888824|FG000|Overall Study|Study terminated by Sponsor|67|||
33542845|NCT01369433|101888825|FG001|Overall Study|Study terminated by Sponsor|0|||
33542846|NCT01369433|101888824|FG000|Overall Study|Lost to Follow-up|1|||
33542847|NCT01369433|101888825|FG001|Overall Study|Lost to Follow-up|0|||
33542848|NCT01369433|101888824|FG000|Overall Study|Death|5|||
33542849|NCT01369433|101888825|FG001|Overall Study|Death|0|||
33542850|NCT01369433|101888824|FG000|Overall Study|Investigator discretion|6|||
33542851|NCT01369433|101888825|FG001|Overall Study|Investigator discretion|1|||
33542852|NCT01369433|101888824|FG000|Overall Study|Progressive Disease|92|||
33542853|NCT01369433|101888825|FG001|Overall Study|Progressive Disease|12|||
33542854|NCT02990000|101888826|FG000|Overall Study|Failed to provide data beyond baseline|36|||
33542855|NCT02990000|101888827|FG001|Overall Study|Failed to provide data beyond baseline|34|||
33542856|NCT04113694|101888828|FG000|Overall Study|Adverse Event|2|||
33542857|NCT04113694|101888828|FG000|Overall Study|Lost to Follow-up|2|||
33542858|NCT04113694|101888828|FG000|Overall Study|Withdrawal by Subject|6|||
33542859|NCT04113694|101888828|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
33542860|NCT04456686|101888829|FG000|Overall Study|Adverse Event|2|||
33542861|NCT04456686|101888830|FG001|Overall Study|Adverse Event|1|||
33542862|NCT04456686|101888829|FG000|Overall Study|Lack of Efficacy|3|||
33212536|NCT04546581|100676657|FG000|Overall Study|Adverse Event|9|||
33212537|NCT04546581|100676658|FG001|Overall Study|Adverse Event|3|||
33212538|NCT04546581|100676657|FG000|Overall Study|Physician Decision|0|||
33212539|NCT04546581|100676658|FG001|Overall Study|Physician Decision|1|||
33212540|NCT04546581|100676657|FG000|Overall Study|Protocol Violation|1|||
33212541|NCT04546581|100676658|FG001|Overall Study|Protocol Violation|2|||
33212542|NCT04546581|100676657|FG000|Overall Study|Withdrawal by Subject|3|||
33212543|NCT04546581|100676658|FG001|Overall Study|Withdrawal by Subject|7|||
33212544|NCT01625897|100676659|FG000|Overall Study|Adverse Event|27|||
33212545|NCT01625897|100676660|FG001|Overall Study|Adverse Event|10|||
33212546|NCT01625897|100676659|FG000|Overall Study|Physician Decision|0|||
33212547|NCT01625897|100676660|FG001|Overall Study|Physician Decision|1|||
33212548|NCT01625897|100676659|FG000|Overall Study|Withdrawal by Subject|25|||
33212549|NCT01625897|100676660|FG001|Overall Study|Withdrawal by Subject|3|||
33212550|NCT02477696|100676661|FG000|Overall Study|Death|89|||
33615949|NCT03464019|102144242|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
33212551|NCT02477696|100676662|FG001|Overall Study|Death|106|||
33212552|NCT02477696|100676661|FG000|Overall Study|Lost to Follow-up|7|||
33212553|NCT02477696|100676662|FG001|Overall Study|Lost to Follow-up|5|||
33212554|NCT02477696|100676661|FG000|Overall Study|Withdrawal by Subject|37|||
33212555|NCT02477696|100676662|FG001|Overall Study|Withdrawal by Subject|34|||
33212556|NCT02477696|100676661|FG000|Overall Study|Physician Decision|7|||
33212557|NCT02477696|100676662|FG001|Overall Study|Physician Decision|9|||
33212558|NCT02477696|100676661|FG000|Overall Study|Study terminated by sponsor|103|||
33212559|NCT02477696|100676662|FG001|Overall Study|Study terminated by sponsor|99|||
33212560|NCT02477696|100676661|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
33212561|NCT02477696|100676662|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
33212562|NCT02477696|100676661|FG000|Overall Study|Missing/Unknown|2|||
33212563|NCT02477696|100676662|FG001|Overall Study|Missing/Unknown|0|||
33212564|NCT01669629|100676665|FG000|Period 1|protocol deviation|1|||
33212565|NCT01669629|100676666|FG001|Period 1|protocol deviation|2|||
33212566|NCT01995461|100676667|FG000|Overall Study|Death|1|||
33212567|NCT01995461|100676667|FG000|Overall Study|Lost to Follow-up|2|||
33212568|NCT01995461|100676667|FG000|Overall Study|Withdrawal by Subject|2|||
33212569|NCT00707031|100676671|FG000|Overall Study|Adverse Event|45|||
33212570|NCT00707031|100676672|FG001|Overall Study|Adverse Event|45|||
33212571|NCT00707031|100676671|FG000|Overall Study|Lack of Efficacy|19|||
33212572|NCT00707031|100676672|FG001|Overall Study|Lack of Efficacy|6|||
33212573|NCT00707031|100676671|FG000|Overall Study|Lost to Follow-up|2|||
33212574|NCT00707031|100676672|FG001|Overall Study|Lost to Follow-up|1|||
33212575|NCT00707031|100676671|FG000|Overall Study|Protocol Violation|1|||
33212576|NCT00707031|100676672|FG001|Overall Study|Protocol Violation|0|||
33212577|NCT00707031|100676671|FG000|Overall Study|Withdrawal by Subject|7|||
33212578|NCT00707031|100676672|FG001|Overall Study|Withdrawal by Subject|8|||
33212579|NCT00707031|100676671|FG000|Overall Study|Poor Compliance to Protocol|7|||
33212580|NCT00707031|100676672|FG001|Overall Study|Poor Compliance to Protocol|13|||
33212581|NCT00707031|100676671|FG000|Overall Study|Familial or Personal Reasons|12|||
33212582|NCT00707031|100676672|FG001|Overall Study|Familial or Personal Reasons|15|||
33212583|NCT00707031|100676671|FG000|Overall Study|Serious Noncompliance|2|||
33212584|NCT00707031|100676672|FG001|Overall Study|Serious Noncompliance|3|||
33212585|NCT00707031|100676671|FG000|Overall Study|Sponsor Decision|9|||
33346023|NCT02848833|101156544|FG000|Overall Study|follow-up failure|6|||
33346024|NCT02848833|101156544|FG000|Overall Study|Protocol Violation|119|||
33346025|NCT01824979|101156545|FG000|Overall Study|Withdrawal by Subject|5|||
33346026|NCT01824979|101156546|FG001|Overall Study|Withdrawal by Subject|0|||
33346027|NCT01824979|101156545|FG000|Overall Study|Physician Decision|2|||
33346028|NCT01824979|101156546|FG001|Overall Study|Physician Decision|0|||
33346029|NCT01824979|101156545|FG000|Overall Study|Protocol Violation|6|||
33346030|NCT01824979|101156546|FG001|Overall Study|Protocol Violation|13|||
33346031|NCT02078219|101156547|FG000|Overall Study|Other|2|||
33346032|NCT02078219|101156548|FG001|Overall Study|Other|2|||
33346033|NCT02078219|101156549|FG002|Overall Study|Other|3|||
33346034|NCT02078219|101156550|FG003|Overall Study|Other|0|||
33346035|NCT02078219|101156551|FG004|Overall Study|Other|1|||
33212586|NCT00707031|100676672|FG001|Overall Study|Sponsor Decision|8|||
33212587|NCT02863926|100676673|FG000|Overall Study|Physician Decision|1|||
33212588|NCT02863926|100676674|FG001|Overall Study|Physician Decision|0|||
33212589|NCT02863926|100676673|FG000|Overall Study|Lost to Follow-up|1|||
33212590|NCT02863926|100676674|FG001|Overall Study|Lost to Follow-up|1|||
33212591|NCT03625570|100676676|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
33212592|NCT03625570|100676677|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
33212593|NCT03625570|100676676|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
33346036|NCT02078219|101156547|FG000|Overall Study|Withdrawal by Subject|0|||
33346037|NCT02078219|101156548|FG001|Overall Study|Withdrawal by Subject|1|||
33346038|NCT02078219|101156549|FG002|Overall Study|Withdrawal by Subject|0|||
33346039|NCT02078219|101156550|FG003|Overall Study|Withdrawal by Subject|1|||
33346040|NCT02078219|101156551|FG004|Overall Study|Withdrawal by Subject|1|||
33346041|NCT02078219|101156547|FG000|Overall Study|Protocol Violation|0|||
33346042|NCT02078219|101156548|FG001|Overall Study|Protocol Violation|0|||
33346043|NCT02078219|101156549|FG002|Overall Study|Protocol Violation|0|||
33346044|NCT02078219|101156550|FG003|Overall Study|Protocol Violation|1|||
33346045|NCT02078219|101156551|FG004|Overall Study|Protocol Violation|0|||
33346046|NCT02078219|101156547|FG000|Overall Study|Death|0|||
33346047|NCT02078219|101156548|FG001|Overall Study|Death|0|||
33346048|NCT02078219|101156549|FG002|Overall Study|Death|0|||
33346049|NCT02078219|101156550|FG003|Overall Study|Death|1|||
33346050|NCT02078219|101156551|FG004|Overall Study|Death|0|||
33346051|NCT02078219|101156547|FG000|Overall Study|Adverse Event|1|||
33346052|NCT02078219|101156548|FG001|Overall Study|Adverse Event|1|||
33346053|NCT02078219|101156549|FG002|Overall Study|Adverse Event|3|||
33346054|NCT02078219|101156550|FG003|Overall Study|Adverse Event|1|||
33346055|NCT02078219|101156551|FG004|Overall Study|Adverse Event|0|||
33346056|NCT01570244|101156552|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
33346057|NCT01790503|101156561|FG000|Overall Study|Adverse Event|1|||
33346058|NCT01790503|101156562|FG001|Overall Study|Adverse Event|0|||
33346059|NCT01790503|101156563|FG002|Overall Study|Adverse Event|0|||
33346060|NCT01790503|101156564|FG003|Overall Study|Adverse Event|0|||
33346061|NCT01790503|101156565|FG004|Overall Study|Adverse Event|0|||
33346062|NCT01790503|101156566|FG005|Overall Study|Adverse Event|2|||
33346063|NCT01790503|101156567|FG006|Overall Study|Adverse Event|0|||
33346064|NCT01790503|101156568|FG007|Overall Study|Adverse Event|0|||
33346065|NCT01790503|101156569|FG008|Overall Study|Adverse Event|2|||
33346066|NCT01790503|101156570|FG009|Overall Study|Adverse Event|4|||
33346067|NCT01790503|101156571|FG010|Overall Study|Adverse Event|7|||
33346068|NCT01790503|101156561|FG000|Overall Study|Withdrawal by Subject|0|||
33346069|NCT01790503|101156562|FG001|Overall Study|Withdrawal by Subject|0|||
33346070|NCT01790503|101156563|FG002|Overall Study|Withdrawal by Subject|1|||
33346071|NCT01790503|101156564|FG003|Overall Study|Withdrawal by Subject|1|||
33346072|NCT01790503|101156565|FG004|Overall Study|Withdrawal by Subject|1|||
33346073|NCT01790503|101156566|FG005|Overall Study|Withdrawal by Subject|2|||
33346074|NCT01790503|101156567|FG006|Overall Study|Withdrawal by Subject|1|||
33346075|NCT01790503|101156568|FG007|Overall Study|Withdrawal by Subject|0|||
33346076|NCT01790503|101156569|FG008|Overall Study|Withdrawal by Subject|0|||
33346077|NCT01790503|101156570|FG009|Overall Study|Withdrawal by Subject|0|||
33346078|NCT01790503|101156571|FG010|Overall Study|Withdrawal by Subject|1|||
33346079|NCT01790503|101156561|FG000|Overall Study|Disease progression|2|||
33346080|NCT01790503|101156562|FG001|Overall Study|Disease progression|1|||
33346081|NCT01790503|101156563|FG002|Overall Study|Disease progression|0|||
33346082|NCT01790503|101156564|FG003|Overall Study|Disease progression|1|||
33346083|NCT01790503|101156565|FG004|Overall Study|Disease progression|2|||
33346084|NCT01790503|101156566|FG005|Overall Study|Disease progression|1|||
33346085|NCT01790503|101156567|FG006|Overall Study|Disease progression|0|||
33346086|NCT01790503|101156568|FG007|Overall Study|Disease progression|1|||
33346087|NCT01790503|101156569|FG008|Overall Study|Disease progression|0|||
33346088|NCT01790503|101156570|FG009|Overall Study|Disease progression|17|||
33346089|NCT01790503|101156571|FG010|Overall Study|Disease progression|7|||
33346090|NCT01790503|101156561|FG000|Overall Study|Protocol Violation|0|||
33346091|NCT01790503|101156562|FG001|Overall Study|Protocol Violation|0|||
33346092|NCT01790503|101156563|FG002|Overall Study|Protocol Violation|0|||
33346093|NCT01790503|101156564|FG003|Overall Study|Protocol Violation|0|||
33407771|NCT03758612|101380758|FG010|Period 2|Protocol Violation|0|||
33615950|NCT03464019|102144243|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
33615951|NCT03464019|102144244|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
33615952|NCT03464019|102144242|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
33615953|NCT03464019|102144243|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
33615954|NCT03464019|102144244|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
33615955|NCT03464019|102144242|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
33615956|NCT03464019|102144243|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
33615957|NCT03464019|102144244|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
33615958|NCT03464019|102144242|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
33615959|NCT03464019|102144243|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
33212594|NCT03625570|100676677|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
33212595|NCT03625570|100676676|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
33615960|NCT03464019|102144244|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
33346094|NCT01790503|101156565|FG004|Overall Study|Protocol Violation|0|||
33346095|NCT01790503|101156566|FG005|Overall Study|Protocol Violation|0|||
33346096|NCT01790503|101156567|FG006|Overall Study|Protocol Violation|0|||
33346097|NCT01790503|101156568|FG007|Overall Study|Protocol Violation|0|||
33346098|NCT01790503|101156569|FG008|Overall Study|Protocol Violation|0|||
33346099|NCT01790503|101156570|FG009|Overall Study|Protocol Violation|1|||
33346100|NCT01790503|101156571|FG010|Overall Study|Protocol Violation|0|||
33346101|NCT01790503|101156561|FG000|Overall Study|Physician Decision|0|||
33346102|NCT01790503|101156562|FG001|Overall Study|Physician Decision|0|||
33346103|NCT01790503|101156563|FG002|Overall Study|Physician Decision|0|||
33407772|NCT03758612|101380759|FG011|Period 2|Protocol Violation|0|||
33407773|NCT04152200|101380760|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
33407774|NCT04152200|101380761|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
33407775|NCT04067310|101380762|FG000|Overall Study|Physician Decision|2|||
33407776|NCT04067310|101380763|FG001|Overall Study|Physician Decision|6|||
33407777|NCT04067310|101380762|FG000|Overall Study|Lost to Follow-up|0|||
33407778|NCT04067310|101380763|FG001|Overall Study|Lost to Follow-up|1|||
33407779|NCT04067310|101380762|FG000|Overall Study|Withdrawal by Subject|3|||
33407780|NCT04067310|101380763|FG001|Overall Study|Withdrawal by Subject|0|||
33407781|NCT02950831|101380768|FG000|Overall Study|Lost to Follow-up|1|||
33407782|NCT02950831|101380768|FG000|Overall Study|Withdrawal by Subject|3|||
33407783|NCT02950831|101380768|FG000|Overall Study|stimulation trail failure|5|||
33407784|NCT05807464|101380769|FG000|Overall Study|Adverse Event|1|||
33407785|NCT04047472|101380776|FG000|Overall Study|Adverse Event|3|||
33407786|NCT04047472|101380777|FG001|Overall Study|Adverse Event|3|||
33407787|NCT04047472|101380776|FG000|Overall Study|Death|0|||
33407788|NCT04047472|101380777|FG001|Overall Study|Death|1|||
33407789|NCT04047472|101380776|FG000|Overall Study|Lost to Follow-up|1|||
33407790|NCT04047472|101380777|FG001|Overall Study|Lost to Follow-up|0|||
33407791|NCT04047472|101380776|FG000|Overall Study|Physician Decision|1|||
33407792|NCT04047472|101380777|FG001|Overall Study|Physician Decision|2|||
33407793|NCT04047472|101380776|FG000|Overall Study|Protocol Violation|1|||
33407794|NCT04047472|101380777|FG001|Overall Study|Protocol Violation|0|||
33407795|NCT04047472|101380776|FG000|Overall Study|Withdrawal by Subject|10|||
33407796|NCT04047472|101380777|FG001|Overall Study|Withdrawal by Subject|10|||
33407797|NCT01000311|101380780|FG000|Overall Study|Adverse Event|2|||
33407798|NCT01000311|101380781|FG001|Overall Study|Adverse Event|5|||
33407799|NCT01000311|101380780|FG000|Overall Study|Withdrawal by Subject|16|||
33407800|NCT01000311|101380781|FG001|Overall Study|Withdrawal by Subject|24|||
33407801|NCT01000311|101380780|FG000|Overall Study|Lost to Follow-up|15|||
33407802|NCT01000311|101380781|FG001|Overall Study|Lost to Follow-up|24|||
33407803|NCT01000311|101380780|FG000|Overall Study|Protocol Violation|1|||
33407804|NCT01000311|101380781|FG001|Overall Study|Protocol Violation|2|||
33212596|NCT03625570|100676677|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
33542863|NCT04456686|101888830|FG001|Overall Study|Lack of Efficacy|1|||
33542864|NCT04456686|101888829|FG000|Overall Study|Withdrew consent|3|||
33542865|NCT04456686|101888830|FG001|Overall Study|Withdrew consent|1|||
33542866|NCT04456686|101888829|FG000|Overall Study|Physician Decision|2|||
33542867|NCT04456686|101888830|FG001|Overall Study|Physician Decision|2|||
33407805|NCT01000311|101380780|FG000|Overall Study|Inappropriate enrollment|2|||
33212597|NCT01261611|100676678|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
33212598|NCT01261611|100676679|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
33212599|NCT01261611|100676680|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
33407806|NCT01000311|101380781|FG001|Overall Study|Inappropriate enrollment|0|||
33407807|NCT01000311|101380780|FG000|Overall Study|Administrative reason|9|||
33407808|NCT01000311|101380781|FG001|Overall Study|Administrative reason|15|||
33407809|NCT00608426|101380784|FG000|Overall Study|Death|32|||
33542868|NCT04456686|101888829|FG000|Overall Study|Withdrawal by Subject|5|||
33542869|NCT04456686|101888830|FG001|Overall Study|Withdrawal by Subject|1|||
33542870|NCT04456686|101888829|FG000|Overall Study|Protocol Violation|0|||
33542871|NCT04456686|101888830|FG001|Overall Study|Protocol Violation|1|||
33542872|NCT00719901|101888831|FG000|Overall Study|Adverse Event|5|||
33615961|NCT03464019|102144242|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
33407810|NCT00608426|101380785|FG001|Overall Study|Death|36|||
33407811|NCT00608426|101380784|FG000|Overall Study|Lost to Follow-up|485|||
33407812|NCT00608426|101380785|FG001|Overall Study|Lost to Follow-up|521|||
33407813|NCT00608426|101380784|FG000|Overall Study|refused, health issues, wrong address|319|||
33407814|NCT00608426|101380785|FG001|Overall Study|refused, health issues, wrong address|348|||
33407815|NCT04052425|101380788|FG000|24-Week Double-blind Period|Adverse Event|0|||
33407816|NCT04052425|101380789|FG001|24-Week Double-blind Period|Adverse Event|1|||
33407817|NCT04052425|101380790|FG002|24-Week Double-blind Period|Adverse Event|0|||
33407818|NCT04052425|101380791|FG003|24-Week Double-blind Period|Adverse Event|0|||
33407819|NCT04052425|101380788|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
33407820|NCT04052425|101380789|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
33407821|NCT04052425|101380790|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
33407822|NCT04052425|101380791|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
33346104|NCT01790503|101156564|FG003|Overall Study|Physician Decision|0|||
33346105|NCT01790503|101156565|FG004|Overall Study|Physician Decision|0|||
33346106|NCT01790503|101156566|FG005|Overall Study|Physician Decision|0|||
33346107|NCT01790503|101156567|FG006|Overall Study|Physician Decision|0|||
33346108|NCT01790503|101156568|FG007|Overall Study|Physician Decision|0|||
33346109|NCT01790503|101156569|FG008|Overall Study|Physician Decision|0|||
33346110|NCT01790503|101156570|FG009|Overall Study|Physician Decision|1|||
33346111|NCT01790503|101156571|FG010|Overall Study|Physician Decision|1|||
33346112|NCT01790503|101156561|FG000|Overall Study|Death|0|||
33346113|NCT01790503|101156562|FG001|Overall Study|Death|0|||
33346114|NCT01790503|101156563|FG002|Overall Study|Death|0|||
33346115|NCT01790503|101156564|FG003|Overall Study|Death|0|||
33346116|NCT01790503|101156565|FG004|Overall Study|Death|0|||
33346117|NCT01790503|101156566|FG005|Overall Study|Death|0|||
33346118|NCT01790503|101156567|FG006|Overall Study|Death|0|||
33346119|NCT01790503|101156568|FG007|Overall Study|Death|0|||
33346120|NCT01790503|101156569|FG008|Overall Study|Death|0|||
33407823|NCT04052425|101380788|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
33407824|NCT04052425|101380789|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
33407825|NCT04052425|101380790|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
33407826|NCT04052425|101380791|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
33542873|NCT00719901|101888831|FG000|Overall Study|Withdrawal by Subject|1|||
33346121|NCT01790503|101156570|FG009|Overall Study|Death|1|||
33346122|NCT01790503|101156571|FG010|Overall Study|Death|0|||
33346123|NCT01790503|101156561|FG000|Overall Study|Non Compliance|0|||
33346124|NCT01790503|101156562|FG001|Overall Study|Non Compliance|0|||
33407827|NCT04052425|101380788|FG000|24-Week Double-blind Period|Physician Decision|1|||
33407828|NCT04052425|101380789|FG001|24-Week Double-blind Period|Physician Decision|0|||
33407829|NCT04052425|101380790|FG002|24-Week Double-blind Period|Physician Decision|0|||
33407830|NCT04052425|101380791|FG003|24-Week Double-blind Period|Physician Decision|0|||
33407831|NCT04052425|101380788|FG000|24-Week Double-blind Period|Protocol Violation|1|||
33407832|NCT04052425|101380789|FG001|24-Week Double-blind Period|Protocol Violation|0|||
33407833|NCT04052425|101380790|FG002|24-Week Double-blind Period|Protocol Violation|0|||
33407834|NCT04052425|101380791|FG003|24-Week Double-blind Period|Protocol Violation|0|||
33407835|NCT04052425|101380788|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
33407836|NCT04052425|101380789|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
33407837|NCT04052425|101380790|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
33407838|NCT04052425|101380791|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
33407839|NCT04052425|101380788|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
33407840|NCT04052425|101380789|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
33407841|NCT04052425|101380790|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
33407842|NCT04052425|101380791|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
33407843|NCT04052425|101380788|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
33407844|NCT04052425|101380789|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
33407845|NCT04052425|101380790|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
33407846|NCT04052425|101380791|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
33407847|NCT04052425|101380788|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
33407848|NCT04052425|101380789|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
33346125|NCT01790503|101156563|FG002|Overall Study|Non Compliance|0|||
33346126|NCT01790503|101156564|FG003|Overall Study|Non Compliance|0|||
33346127|NCT01790503|101156565|FG004|Overall Study|Non Compliance|1|||
33346128|NCT01790503|101156566|FG005|Overall Study|Non Compliance|0|||
33346129|NCT01790503|101156567|FG006|Overall Study|Non Compliance|0|||
33346130|NCT01790503|101156568|FG007|Overall Study|Non Compliance|0|||
33346131|NCT01790503|101156569|FG008|Overall Study|Non Compliance|0|||
33346132|NCT01790503|101156570|FG009|Overall Study|Non Compliance|0|||
33346133|NCT01790503|101156571|FG010|Overall Study|Non Compliance|0|||
33346134|NCT01790503|101156561|FG000|Overall Study|Other|0|||
33346135|NCT01790503|101156562|FG001|Overall Study|Other|0|||
33346136|NCT01790503|101156563|FG002|Overall Study|Other|0|||
33346137|NCT01790503|101156564|FG003|Overall Study|Other|0|||
33346138|NCT01790503|101156565|FG004|Overall Study|Other|1|||
33346139|NCT01790503|101156566|FG005|Overall Study|Other|0|||
33346140|NCT01790503|101156567|FG006|Overall Study|Other|0|||
33346141|NCT01790503|101156568|FG007|Overall Study|Other|0|||
33346142|NCT01790503|101156569|FG008|Overall Study|Other|1|||
33346143|NCT01790503|101156570|FG009|Overall Study|Other|2|||
33346144|NCT01790503|101156571|FG010|Overall Study|Other|0|||
33346145|NCT01467492|101156572|FG000|Overall Study|Withdrawal by Subject|6|||
33346146|NCT01467492|101156573|FG001|Overall Study|Withdrawal by Subject|4|||
33346147|NCT01467492|101156572|FG000|Overall Study|Study Terminated by Sponsor|6|||
33346148|NCT01467492|101156573|FG001|Overall Study|Study Terminated by Sponsor|4|||
33346149|NCT01467492|101156572|FG000|Overall Study|Adverse Event|4|||
33346150|NCT01467492|101156573|FG001|Overall Study|Adverse Event|3|||
33346151|NCT01467492|101156572|FG000|Overall Study|Lost to Follow-up|3|||
33346152|NCT01467492|101156573|FG001|Overall Study|Lost to Follow-up|2|||
33346153|NCT01467492|101156572|FG000|Overall Study|Undefined|2|||
33346154|NCT01467492|101156573|FG001|Overall Study|Undefined|0|||
33346155|NCT01467492|101156572|FG000|Overall Study|Enrolled But Not Treated|1|||
33346156|NCT01467492|101156573|FG001|Overall Study|Enrolled But Not Treated|0|||
33346157|NCT02266433|101156574|FG000|Overall Study|Lost to Follow-up|54|||
33346158|NCT02266433|101156575|FG001|Overall Study|Lost to Follow-up|46|||
33346159|NCT02266433|101156574|FG000|Overall Study|Withdrawal by Subject|5|||
33346160|NCT02266433|101156575|FG001|Overall Study|Withdrawal by Subject|7|||
33346161|NCT01262976|101156580|FG000|Up to Month 2|Serious Adverse Event|0|||
33346162|NCT01262976|101156581|FG001|Up to Month 2|Serious Adverse Event|0|||
33346163|NCT01262976|101156582|FG002|Up to Month 2|Serious Adverse Event|1|||
33346164|NCT01262976|101156583|FG003|Up to Month 2|Serious Adverse Event|0|||
33346165|NCT01262976|101156584|FG004|Up to Month 2|Serious Adverse Event|0|||
33346166|NCT01262976|101156585|FG005|Up to Month 2|Serious Adverse Event|0|||
33346167|NCT01262976|101156580|FG000|Up to Month 2|Withdrawal by Subject|1|||
33346168|NCT01262976|101156581|FG001|Up to Month 2|Withdrawal by Subject|0|||
33346169|NCT01262976|101156582|FG002|Up to Month 2|Withdrawal by Subject|0|||
33346170|NCT01262976|101156583|FG003|Up to Month 2|Withdrawal by Subject|0|||
33346171|NCT01262976|101156584|FG004|Up to Month 2|Withdrawal by Subject|0|||
33346172|NCT01262976|101156585|FG005|Up to Month 2|Withdrawal by Subject|0|||
33346173|NCT01262976|101156580|FG000|Up to Month 2|Migrated/moved from study area|0|||
33346174|NCT01262976|101156581|FG001|Up to Month 2|Migrated/moved from study area|1|||
33346175|NCT01262976|101156582|FG002|Up to Month 2|Migrated/moved from study area|0|||
33346176|NCT01262976|101156583|FG003|Up to Month 2|Migrated/moved from study area|0|||
33346177|NCT01262976|101156584|FG004|Up to Month 2|Migrated/moved from study area|1|||
33346178|NCT01262976|101156585|FG005|Up to Month 2|Migrated/moved from study area|1|||
33346179|NCT01262976|101156580|FG000|Up to Month 2|Lost to Follow-up|1|||
33407849|NCT04052425|101380790|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
33407850|NCT04052425|101380791|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
33407851|NCT04052425|101380788|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
33407852|NCT04052425|101380789|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
33407853|NCT04052425|101380790|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
33407854|NCT04052425|101380791|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
33542874|NCT00719901|101888831|FG000|Overall Study|Alternate Treatment|1|||
33346180|NCT01262976|101156581|FG001|Up to Month 2|Lost to Follow-up|0|||
33346181|NCT01262976|101156582|FG002|Up to Month 2|Lost to Follow-up|0|||
33346182|NCT01262976|101156583|FG003|Up to Month 2|Lost to Follow-up|1|||
33346183|NCT01262976|101156584|FG004|Up to Month 2|Lost to Follow-up|1|||
33346184|NCT01262976|101156585|FG005|Up to Month 2|Lost to Follow-up|1|||
33346185|NCT01262976|101156580|FG000|Up to Month 2|Other|1|||
33346186|NCT01262976|101156581|FG001|Up to Month 2|Other|0|||
33346187|NCT01262976|101156582|FG002|Up to Month 2|Other|0|||
33346188|NCT01262976|101156583|FG003|Up to Month 2|Other|1|||
33346189|NCT01262976|101156584|FG004|Up to Month 2|Other|0|||
33346190|NCT01262976|101156585|FG005|Up to Month 2|Other|2|||
33346191|NCT01262976|101156580|FG000|Up to Month 7|Serious Adverse Event|0|||
33346192|NCT01262976|101156581|FG001|Up to Month 7|Serious Adverse Event|0|||
33346193|NCT01262976|101156582|FG002|Up to Month 7|Serious Adverse Event|2|||
33346194|NCT01262976|101156583|FG003|Up to Month 7|Serious Adverse Event|0|||
33346195|NCT01262976|101156584|FG004|Up to Month 7|Serious Adverse Event|0|||
33346196|NCT01262976|101156585|FG005|Up to Month 7|Serious Adverse Event|0|||
33346197|NCT01262976|101156580|FG000|Up to Month 7|Withdrawal by Subject|1|||
33346198|NCT01262976|101156581|FG001|Up to Month 7|Withdrawal by Subject|0|||
33346199|NCT01262976|101156582|FG002|Up to Month 7|Withdrawal by Subject|0|||
33346200|NCT01262976|101156583|FG003|Up to Month 7|Withdrawal by Subject|0|||
33346201|NCT01262976|101156584|FG004|Up to Month 7|Withdrawal by Subject|0|||
33346202|NCT01262976|101156585|FG005|Up to Month 7|Withdrawal by Subject|0|||
33346203|NCT01262976|101156580|FG000|Up to Month 7|Migrated/moved from study area|0|||
33346204|NCT01262976|101156581|FG001|Up to Month 7|Migrated/moved from study area|0|||
33346205|NCT01262976|101156582|FG002|Up to Month 7|Migrated/moved from study area|1|||
33346206|NCT01262976|101156583|FG003|Up to Month 7|Migrated/moved from study area|3|||
33346207|NCT01262976|101156584|FG004|Up to Month 7|Migrated/moved from study area|1|||
33346208|NCT01262976|101156585|FG005|Up to Month 7|Migrated/moved from study area|1|||
33346209|NCT01262976|101156580|FG000|Up to Month 7|Lost to Follow-up|1|||
33346210|NCT01262976|101156581|FG001|Up to Month 7|Lost to Follow-up|0|||
33346211|NCT01262976|101156582|FG002|Up to Month 7|Lost to Follow-up|1|||
33346212|NCT01262976|101156583|FG003|Up to Month 7|Lost to Follow-up|3|||
33346213|NCT01262976|101156584|FG004|Up to Month 7|Lost to Follow-up|1|||
33346214|NCT01262976|101156585|FG005|Up to Month 7|Lost to Follow-up|3|||
33346215|NCT01262976|101156580|FG000|Up to Month 7|Other|3|||
33346216|NCT01262976|101156581|FG001|Up to Month 7|Other|0|||
33346217|NCT01262976|101156582|FG002|Up to Month 7|Other|2|||
33346218|NCT01262976|101156583|FG003|Up to Month 7|Other|0|||
33346219|NCT01262976|101156584|FG004|Up to Month 7|Other|0|||
33346220|NCT01262976|101156585|FG005|Up to Month 7|Other|0|||
33346221|NCT01262976|101156580|FG000|Up to Year 1|Serious Adverse Event|0|||
33346222|NCT01262976|101156581|FG001|Up to Year 1|Serious Adverse Event|0|||
33346223|NCT01262976|101156582|FG002|Up to Year 1|Serious Adverse Event|2|||
33346224|NCT01262976|101156583|FG003|Up to Year 1|Serious Adverse Event|0|||
33346225|NCT01262976|101156584|FG004|Up to Year 1|Serious Adverse Event|0|||
33346226|NCT01262976|101156585|FG005|Up to Year 1|Serious Adverse Event|0|||
33346227|NCT01262976|101156580|FG000|Up to Year 1|Withdrawal by Subject|1|||
33346228|NCT01262976|101156581|FG001|Up to Year 1|Withdrawal by Subject|0|||
33346229|NCT01262976|101156582|FG002|Up to Year 1|Withdrawal by Subject|0|||
33346230|NCT01262976|101156583|FG003|Up to Year 1|Withdrawal by Subject|0|||
33346231|NCT01262976|101156584|FG004|Up to Year 1|Withdrawal by Subject|0|||
33346232|NCT01262976|101156585|FG005|Up to Year 1|Withdrawal by Subject|0|||
33346233|NCT01262976|101156580|FG000|Up to Year 1|Migrated/moved from study area|1|||
33346234|NCT01262976|101156581|FG001|Up to Year 1|Migrated/moved from study area|0|||
33346235|NCT01262976|101156582|FG002|Up to Year 1|Migrated/moved from study area|0|||
33346236|NCT01262976|101156583|FG003|Up to Year 1|Migrated/moved from study area|3|||
33407855|NCT04052425|101380788|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
33346237|NCT01262976|101156584|FG004|Up to Year 1|Migrated/moved from study area|3|||
33346238|NCT01262976|101156585|FG005|Up to Year 1|Migrated/moved from study area|2|||
33346239|NCT01262976|101156580|FG000|Up to Year 1|Lost to Follow-up|4|||
33346240|NCT01262976|101156581|FG001|Up to Year 1|Lost to Follow-up|0|||
33346241|NCT01262976|101156582|FG002|Up to Year 1|Lost to Follow-up|0|||
33346242|NCT01262976|101156583|FG003|Up to Year 1|Lost to Follow-up|1|||
33615962|NCT03464019|102144243|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
33615963|NCT03464019|102144244|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
33615964|NCT03464019|102144242|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
33615965|NCT03464019|102144243|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
33615966|NCT03464019|102144244|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
33615967|NCT03464019|102144242|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
33615968|NCT03464019|102144243|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
33615969|NCT03464019|102144244|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
33615970|NCT03464019|102144242|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
33615971|NCT03464019|102144243|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
33615972|NCT03464019|102144244|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
33615973|NCT03464019|102144242|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
33615974|NCT03464019|102144243|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
33615975|NCT03464019|102144244|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
33615976|NCT03464019|102144242|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
33615977|NCT03464019|102144243|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
33615978|NCT03464019|102144244|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
33615979|NCT03464019|102144242|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
33615980|NCT03464019|102144243|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
33615981|NCT03464019|102144244|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
33615982|NCT03464019|102144242|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
33615983|NCT03464019|102144243|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
33615984|NCT03464019|102144244|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
33615985|NCT03464019|102144242|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
33615986|NCT03464019|102144243|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
33615987|NCT03464019|102144244|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
33615988|NCT03068754|102144258|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
33615989|NCT03068754|102144259|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
33615990|NCT03068754|102144260|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
33615991|NCT03068754|102144261|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
33615992|NCT03068754|102144258|FG000|Randomized Treatment Period (RTP)|Death|2|||
33615993|NCT03068754|102144259|FG001|Randomized Treatment Period (RTP)|Death|2|||
33615994|NCT03068754|102144260|FG002|Randomized Treatment Period (RTP)|Death|0|||
33615995|NCT03068754|102144261|FG003|Randomized Treatment Period (RTP)|Death|0|||
33615996|NCT03068754|102144258|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
33615997|NCT03068754|102144259|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
33615998|NCT03068754|102144260|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
33346243|NCT01262976|101156584|FG004|Up to Year 1|Lost to Follow-up|6|||
33346244|NCT01262976|101156585|FG005|Up to Year 1|Lost to Follow-up|5|||
33346245|NCT01262976|101156580|FG000|Up to Year 1|Other|3|||
33346246|NCT01262976|101156581|FG001|Up to Year 1|Other|1|||
33346247|NCT01262976|101156582|FG002|Up to Year 1|Other|0|||
33346248|NCT01262976|101156583|FG003|Up to Year 1|Other|0|||
33346249|NCT01262976|101156584|FG004|Up to Year 1|Other|2|||
33346250|NCT01262976|101156585|FG005|Up to Year 1|Other|1|||
33346251|NCT01262976|101156580|FG000|Up to Year 1|Subjects with unknown completion status|0|||
33346252|NCT01262976|101156581|FG001|Up to Year 1|Subjects with unknown completion status|0|||
33346253|NCT01262976|101156582|FG002|Up to Year 1|Subjects with unknown completion status|1|||
33346254|NCT01262976|101156583|FG003|Up to Year 1|Subjects with unknown completion status|0|||
33346255|NCT01262976|101156584|FG004|Up to Year 1|Subjects with unknown completion status|0|||
33346256|NCT01262976|101156585|FG005|Up to Year 1|Subjects with unknown completion status|1|||
33346257|NCT01262976|101156580|FG000|Up to Year 2|Serious Adverse Event|0|||
33346258|NCT01262976|101156581|FG001|Up to Year 2|Serious Adverse Event|0|||
33346259|NCT01262976|101156582|FG002|Up to Year 2|Serious Adverse Event|2|||
33615999|NCT03068754|102144261|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
33616000|NCT03068754|102144258|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
33616001|NCT03068754|102144259|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
33616002|NCT03068754|102144260|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
33616003|NCT03068754|102144261|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
33616004|NCT03068754|102144258|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
33616005|NCT03068754|102144259|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
33616006|NCT03068754|102144260|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
33616007|NCT03068754|102144261|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
33616008|NCT03068754|102144258|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
33616009|NCT03068754|102144259|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
33616010|NCT03068754|102144260|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
33616011|NCT03068754|102144261|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
33346260|NCT01262976|101156583|FG003|Up to Year 2|Serious Adverse Event|0|||
33346261|NCT01262976|101156584|FG004|Up to Year 2|Serious Adverse Event|0|||
33346262|NCT01262976|101156585|FG005|Up to Year 2|Serious Adverse Event|0|||
33212600|NCT01261611|100676678|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
33212601|NCT01261611|100676679|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
33407856|NCT04052425|101380789|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
33407857|NCT04052425|101380790|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
33407858|NCT04052425|101380791|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
33407859|NCT04052425|101380788|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
33407860|NCT04052425|101380789|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
33407861|NCT04052425|101380790|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
33407862|NCT04052425|101380791|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
33407863|NCT04052425|101380788|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
33407864|NCT04052425|101380789|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
33407865|NCT04052425|101380790|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
33407866|NCT04052425|101380791|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
33407867|NCT04052425|101380788|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
33407868|NCT04052425|101380789|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
33407869|NCT04052425|101380790|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
33407870|NCT04052425|101380791|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
33407871|NCT01288911|101380792|FG000|Double-blind Period|Death|11|||
33407872|NCT01288911|101380793|FG001|Double-blind Period|Death|7|||
33407873|NCT01288911|101380792|FG000|Double-blind Period|Lost to Follow-up|0|||
33407874|NCT01288911|101380793|FG001|Double-blind Period|Lost to Follow-up|2|||
33407875|NCT01288911|101380792|FG000|Double-blind Period|Progressive Disease|75|||
33407876|NCT01288911|101380793|FG001|Double-blind Period|Progressive Disease|103|||
33407877|NCT01288911|101380792|FG000|Double-blind Period|Protocol Violation|1|||
33407878|NCT01288911|101380793|FG001|Double-blind Period|Protocol Violation|0|||
33407879|NCT01288911|101380792|FG000|Double-blind Period|Withdrawal by Subject|25|||
33407880|NCT01288911|101380793|FG001|Double-blind Period|Withdrawal by Subject|26|||
33407881|NCT01288911|101380792|FG000|Double-blind Period|Miscellaneous Reason|29|||
33407882|NCT01288911|101380793|FG001|Double-blind Period|Miscellaneous Reason|42|||
33407883|NCT01288911|101380792|FG000|Double-blind Period|Randomized but never received study drug|1|||
33407884|NCT01288911|101380793|FG001|Double-blind Period|Randomized but never received study drug|2|||
33407885|NCT01288911|101380792|FG000|Open-label Period (All Enzalutamide)|Death|0|||
33407886|NCT01288911|101380793|FG001|Open-label Period (All Enzalutamide)|Death|1|||
33407887|NCT01288911|101380792|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
33407888|NCT01288911|101380793|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
33407889|NCT01288911|101380792|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
33407890|NCT01288911|101380793|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
33407891|NCT01288911|101380792|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
33407892|NCT01288911|101380793|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
33407893|NCT01288911|101380792|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
33407894|NCT01288911|101380793|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
33407895|NCT01288911|101380792|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
33407896|NCT01288911|101380793|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
33542875|NCT00719901|101888831|FG000|Overall Study|Disease Progression|3|||
33542876|NCT00719901|101888831|FG000|Overall Study|Availability of Study Drug|1|||
33542877|NCT03636256|101888838|FG000|Overall Study|Lost to Follow-up|3|||
33542878|NCT03636256|101888839|FG001|Overall Study|Lost to Follow-up|0|||
33542879|NCT03636256|101888840|FG002|Overall Study|Lost to Follow-up|2|||
33542880|NCT03636256|101888841|FG003|Overall Study|Lost to Follow-up|1|||
33542881|NCT03636256|101888842|FG004|Overall Study|Lost to Follow-up|0|||
33542882|NCT03636256|101888843|FG005|Overall Study|Lost to Follow-up|4|||
33542883|NCT03636256|101888844|FG006|Overall Study|Lost to Follow-up|2|||
33346263|NCT01262976|101156580|FG000|Up to Year 2|Withdrawal by Subject|1|||
33346264|NCT01262976|101156581|FG001|Up to Year 2|Withdrawal by Subject|0|||
33542884|NCT03636256|101888845|FG007|Overall Study|Lost to Follow-up|0|||
33346265|NCT01262976|101156582|FG002|Up to Year 2|Withdrawal by Subject|0|||
33346266|NCT01262976|101156583|FG003|Up to Year 2|Withdrawal by Subject|0|||
33346267|NCT01262976|101156584|FG004|Up to Year 2|Withdrawal by Subject|0|||
33542885|NCT03636256|101888846|FG008|Overall Study|Lost to Follow-up|4|||
33346268|NCT01262976|101156585|FG005|Up to Year 2|Withdrawal by Subject|0|||
33616012|NCT03068754|102144258|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
33616013|NCT03068754|102144259|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
33616014|NCT03068754|102144260|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
33616015|NCT03068754|102144261|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
33616016|NCT03068754|102144258|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
33616017|NCT03068754|102144259|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
33616018|NCT03068754|102144260|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
33616019|NCT03068754|102144261|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
33407897|NCT01654666|101380794|FG000|Overall Study|Protocol Violation|7|||
33407898|NCT01654666|101380795|FG001|Overall Study|Protocol Violation|4|||
33407899|NCT01654666|101380796|FG002|Overall Study|Protocol Violation|8|||
33407900|NCT01654666|101380794|FG000|Overall Study|Lost to Follow-up|4|||
33407901|NCT01654666|101380795|FG001|Overall Study|Lost to Follow-up|5|||
33407902|NCT01654666|101380796|FG002|Overall Study|Lost to Follow-up|5|||
33407903|NCT01654666|101380794|FG000|Overall Study|Withdrawal by Subject|4|||
33407904|NCT01654666|101380795|FG001|Overall Study|Withdrawal by Subject|4|||
33407905|NCT01654666|101380796|FG002|Overall Study|Withdrawal by Subject|1|||
33407906|NCT03759340|101380797|FG000|Overall Study|Adverse Event|2|||
33407907|NCT03759340|101380797|FG000|Overall Study|Lost to Follow-up|1|||
33407908|NCT03759340|101380797|FG000|Overall Study|Withdrawal by Subject|15|||
33407909|NCT03759340|101380797|FG000|Overall Study|Study Terminated by Sponsor|38|||
33407910|NCT04668157|101380798|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
33542886|NCT03636256|101888838|FG000|Overall Study|Withdrawal by Subject|0|||
33542887|NCT03636256|101888839|FG001|Overall Study|Withdrawal by Subject|0|||
33542888|NCT03636256|101888840|FG002|Overall Study|Withdrawal by Subject|0|||
33542889|NCT03636256|101888841|FG003|Overall Study|Withdrawal by Subject|0|||
33542890|NCT03636256|101888842|FG004|Overall Study|Withdrawal by Subject|0|||
33542891|NCT03636256|101888843|FG005|Overall Study|Withdrawal by Subject|0|||
33542892|NCT03636256|101888844|FG006|Overall Study|Withdrawal by Subject|0|||
33542893|NCT03636256|101888845|FG007|Overall Study|Withdrawal by Subject|0|||
33542894|NCT03636256|101888846|FG008|Overall Study|Withdrawal by Subject|1|||
33542895|NCT01715298|101888855|FG000|Overall Study|Lost to Follow-up|0|||
33542896|NCT01715298|101888856|FG001|Overall Study|Lost to Follow-up|2|||
33542897|NCT01715298|101888855|FG000|Overall Study|Patient/guardian decision|7|||
33542898|NCT01715298|101888856|FG001|Overall Study|Patient/guardian decision|9|||
33542899|NCT03502798|101888857|FG000|Overall Study|equipment failure|0|||
33542900|NCT03502798|101888858|FG001|Overall Study|equipment failure|7|||
33542901|NCT03479905|101888859|FG000|Overall Study|Other airway method used|4|||
33542902|NCT03479905|101888860|FG001|Overall Study|Other airway method used|5|||
33542903|NCT03479905|101888861|FG002|Overall Study|Other airway method used|5|||
33542904|NCT00769561|101888862|FG000|Overall Study|Withdrawal by Subject|2|||
33616020|NCT03068754|102144258|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
33616021|NCT03068754|102144259|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
33616022|NCT03068754|102144260|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
33616023|NCT03068754|102144261|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
33542905|NCT00769561|101888863|FG001|Overall Study|Withdrawal by Subject|2|||
33542906|NCT00769561|101888862|FG000|Overall Study|Lost to Follow-up|1|||
33542907|NCT00769561|101888863|FG001|Overall Study|Lost to Follow-up|3|||
33542908|NCT00819039|101888864|FG000|Overall Study|Physician Decision|1|||
33542909|NCT00819039|101888865|FG001|Overall Study|Physician Decision|0|||
33542910|NCT00819039|101888866|FG002|Overall Study|Physician Decision|1|||
33542911|NCT00819039|101888864|FG000|Overall Study|Protocol Violation|1|||
33542912|NCT00819039|101888865|FG001|Overall Study|Protocol Violation|0|||
33616024|NCT03068754|102144258|FG000|Open Label Extension Period (OLE)|Death|0|||
33407911|NCT04668157|101380799|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
33407912|NCT04668157|101380798|FG000|Treatment Period (52 Weeks)|Other|0|||
33407913|NCT04668157|101380799|FG001|Treatment Period (52 Weeks)|Other|2|||
33407914|NCT04738123|101380802|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
33542913|NCT00819039|101888866|FG002|Overall Study|Protocol Violation|0|||
33542914|NCT02873689|101888867|FG000|Overall Study|Lack of Efficacy|1|||
33542915|NCT02873689|101888868|FG001|Overall Study|Lack of Efficacy|0|||
33542916|NCT02873689|101888867|FG000|Overall Study|Withdrawal by Subject|2|||
33542917|NCT02873689|101888868|FG001|Overall Study|Withdrawal by Subject|2|||
33542918|NCT02873689|101888867|FG000|Overall Study|Protocol Violation|1|||
33542919|NCT02873689|101888868|FG001|Overall Study|Protocol Violation|0|||
33542920|NCT02873689|101888867|FG000|Overall Study|Adverse Event|2|||
33542921|NCT02873689|101888868|FG001|Overall Study|Adverse Event|2|||
33542922|NCT02873689|101888867|FG000|Overall Study|Randomized but not Treated|1|||
33616025|NCT03068754|102144259|FG001|Open Label Extension Period (OLE)|Death|0|||
33616026|NCT03068754|102144260|FG002|Open Label Extension Period (OLE)|Death|0|||
33616027|NCT03068754|102144261|FG003|Open Label Extension Period (OLE)|Death|1|||
33616028|NCT03068754|102144258|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
33616029|NCT03068754|102144259|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
33616030|NCT03068754|102144260|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
33616031|NCT03068754|102144261|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
33616032|NCT03068754|102144258|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
33616033|NCT03068754|102144259|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
33616034|NCT03068754|102144260|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
33542923|NCT02873689|101888868|FG001|Overall Study|Randomized but not Treated|1|||
33542924|NCT03462680|101888869|FG000|Overall Study|Withdrawal by Subject|3|||
33542925|NCT03462680|101888870|FG001|Overall Study|Withdrawal by Subject|5|||
33542926|NCT01030900|101888871|FG000|Overall Study|Not treated due to congestive heart failure|1|||
33542927|NCT01030900|101888871|FG000|Overall Study|Not treated due to rapid disease|1|||
33542928|NCT02340949|101888872|FG000|Overall Study|Adverse Event|4|||
33542929|NCT02340949|101888873|FG001|Overall Study|Adverse Event|2|||
33542930|NCT02340949|101888872|FG000|Overall Study|Withdrawal by Subject|2|||
33542931|NCT02340949|101888873|FG001|Overall Study|Withdrawal by Subject|0|||
33542932|NCT02340949|101888872|FG000|Overall Study|Progression disease|6|||
33542933|NCT02340949|101888873|FG001|Overall Study|Progression disease|2|||
33542934|NCT02340949|101888872|FG000|Overall Study|Death|3|||
33542935|NCT02340949|101888873|FG001|Overall Study|Death|0|||
33542936|NCT02340949|101888872|FG000|Overall Study|Physician Decision|1|||
33542937|NCT02340949|101888873|FG001|Overall Study|Physician Decision|0|||
33542938|NCT02225587|101888874|FG000|Overall Study|Adverse Event|5|||
33542939|NCT02225587|101888875|FG001|Overall Study|Adverse Event|5|||
33542940|NCT02225587|101888874|FG000|Overall Study|Lost to Follow-up|5|||
33542941|NCT02225587|101888875|FG001|Overall Study|Lost to Follow-up|5|||
33542942|NCT02225587|101888874|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33542943|NCT02225587|101888875|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33542944|NCT02225587|101888874|FG000|Overall Study|Physician Decision|2|||
33542945|NCT02225587|101888875|FG001|Overall Study|Physician Decision|0|||
33542946|NCT02225587|101888874|FG000|Overall Study|Protocol Violation|1|||
33542947|NCT02225587|101888875|FG001|Overall Study|Protocol Violation|0|||
33542948|NCT02225587|101888874|FG000|Overall Study|Participant Moved|1|||
33542949|NCT02225587|101888875|FG001|Overall Study|Participant Moved|0|||
33542950|NCT02225587|101888874|FG000|Overall Study|Withdrawal by Subject|13|||
33542951|NCT02225587|101888875|FG001|Overall Study|Withdrawal by Subject|28|||
33542952|NCT00984867|101888877|FG000|Overall Study|Adverse Event|3|||
33542953|NCT00984867|101888878|FG001|Overall Study|Adverse Event|7|||
33542954|NCT00984867|101888877|FG000|Overall Study|Death|1|||
33542955|NCT00984867|101888878|FG001|Overall Study|Death|0|||
33542956|NCT00984867|101888877|FG000|Overall Study|Withdrawal by Subject|13|||
33542957|NCT00984867|101888878|FG001|Overall Study|Withdrawal by Subject|4|||
33542958|NCT00984867|101888877|FG000|Overall Study|Lost to Follow-up|3|||
33542959|NCT00984867|101888878|FG001|Overall Study|Lost to Follow-up|4|||
33542960|NCT00984867|101888877|FG000|Overall Study|Poor/non-compliance|0|||
33542961|NCT00984867|101888878|FG001|Overall Study|Poor/non-compliance|1|||
33542962|NCT00984867|101888877|FG000|Overall Study|Subject no longer meets study criteria|1|||
33542963|NCT00984867|101888878|FG001|Overall Study|Subject no longer meets study criteria|1|||
33542964|NCT00984867|101888877|FG000|Overall Study|site closing|1|||
33542965|NCT00984867|101888878|FG001|Overall Study|site closing|0|||
33542966|NCT00984867|101888877|FG000|Overall Study|lack of efficacy and subject compliance|1|||
33346269|NCT01262976|101156580|FG000|Up to Year 2|Migrated/moved from study area|0|||
33346270|NCT01262976|101156581|FG001|Up to Year 2|Migrated/moved from study area|0|||
33346271|NCT01262976|101156582|FG002|Up to Year 2|Migrated/moved from study area|0|||
33542967|NCT00984867|101888878|FG001|Overall Study|lack of efficacy and subject compliance|0|||
33616035|NCT03068754|102144261|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
33616036|NCT03068754|102144258|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
33616037|NCT03068754|102144259|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
33346272|NCT01262976|101156583|FG003|Up to Year 2|Migrated/moved from study area|2|||
33346273|NCT01262976|101156584|FG004|Up to Year 2|Migrated/moved from study area|1|||
33542968|NCT00754741|101888879|FG000|Overall Study|Died or disenrolled|57|||
33542969|NCT00754741|101888880|FG001|Overall Study|Died or disenrolled|69|||
33542970|NCT00754741|101888881|FG002|Overall Study|Died or disenrolled|54|||
33542971|NCT03188822|101888882|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
33542972|NCT03188822|101888882|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
33542973|NCT01206764|101888885|FG000|Overall Study|Adverse Event|20|||
33542974|NCT01206764|101888885|FG000|Overall Study|Abnormal laboratory value|2|||
33212602|NCT01261611|100676680|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
33212603|NCT01261611|100676678|FG000|Treatment Cycle 1|Adverse Event|0|||
33212604|NCT01261611|100676679|FG001|Treatment Cycle 1|Adverse Event|1|||
33212605|NCT01261611|100676680|FG002|Treatment Cycle 1|Adverse Event|0|||
33212606|NCT01261611|100676678|FG000|Treatment Cycle 1|Protocol Violation|0|||
33212607|NCT01261611|100676679|FG001|Treatment Cycle 1|Protocol Violation|0|||
33212608|NCT01261611|100676680|FG002|Treatment Cycle 1|Protocol Violation|2|||
33212609|NCT01261611|100676678|FG000|Treatment Cycle 2|Completed study|4|||
33212610|NCT01261611|100676679|FG001|Treatment Cycle 2|Completed study|0|||
33212611|NCT01261611|100676680|FG002|Treatment Cycle 2|Completed study|0|||
33212612|NCT01261611|100676678|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
33616038|NCT03068754|102144260|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
33616039|NCT03068754|102144261|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
33212613|NCT01261611|100676679|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
33212614|NCT01261611|100676680|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
33212615|NCT01261611|100676678|FG000|Treatment Cycle 2|Adverse Event|1|||
33616040|NCT03068754|102144258|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
33616041|NCT03068754|102144259|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
33616042|NCT03068754|102144260|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
33616043|NCT03068754|102144261|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
33212616|NCT01261611|100676679|FG001|Treatment Cycle 2|Adverse Event|0|||
33212617|NCT01261611|100676680|FG002|Treatment Cycle 2|Adverse Event|0|||
33212618|NCT01261611|100676678|FG000|Treatment Cycle 2|Protocol Violation|2|||
33212619|NCT01261611|100676679|FG001|Treatment Cycle 2|Protocol Violation|0|||
33212620|NCT01261611|100676680|FG002|Treatment Cycle 2|Protocol Violation|0|||
33212621|NCT01261611|100676678|FG000|Treatment Cycle 2|Not otherwise specified|2|||
33212622|NCT01261611|100676679|FG001|Treatment Cycle 2|Not otherwise specified|0|||
33212623|NCT01261611|100676680|FG002|Treatment Cycle 2|Not otherwise specified|0|||
33212624|NCT01261611|100676678|FG000|Treatment Cycle 3|Completed study|24|||
33212625|NCT01261611|100676679|FG001|Treatment Cycle 3|Completed study|0|||
33212626|NCT01261611|100676680|FG002|Treatment Cycle 3|Completed study|0|||
33212627|NCT01261611|100676678|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
33212628|NCT01261611|100676679|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
33542975|NCT01206764|101888885|FG000|Overall Study|Abnormal test procedure result|1|||
33542976|NCT01206764|101888885|FG000|Overall Study|Patient withdrew consent|5|||
33542977|NCT01206764|101888885|FG000|Overall Study|Lost to Follow-up|6|||
33542978|NCT01206764|101888885|FG000|Overall Study|Death|11|||
33542979|NCT01206764|101888885|FG000|Overall Study|New cancer therapy|2|||
33542980|NCT01206764|101888885|FG000|Overall Study|Disease progression|88|||
33542981|NCT01206764|101888885|FG000|Overall Study|Protocol deviation|3|||
33542982|NCT00410163|101888886|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
33542983|NCT00410163|101888887|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
33542984|NCT00410163|101888886|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
33542985|NCT00410163|101888887|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
33542986|NCT00410163|101888886|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
33542987|NCT00410163|101888887|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
33542988|NCT00410163|101888886|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
33542989|NCT00410163|101888887|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
33542990|NCT00410163|101888886|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
33542991|NCT00410163|101888887|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
33542992|NCT00410163|101888886|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
33616044|NCT00291486|102144262|FG000|Overall Study|Adverse Event|0|||
33212629|NCT01261611|100676680|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
33616045|NCT00291486|102144263|FG001|Overall Study|Adverse Event|3|||
33212630|NCT01261611|100676678|FG000|Treatment Cycle 3|Adverse Event|1|||
33212631|NCT01261611|100676679|FG001|Treatment Cycle 3|Adverse Event|0|||
33212632|NCT01261611|100676680|FG002|Treatment Cycle 3|Adverse Event|0|||
33212633|NCT01261611|100676678|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
33212634|NCT01261611|100676679|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
33212635|NCT01261611|100676680|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
33212636|NCT01261611|100676678|FG000|Treatment Cycle 4|Completed study|87|||
33212637|NCT01261611|100676679|FG001|Treatment Cycle 4|Completed study|0|||
33346274|NCT01262976|101156585|FG005|Up to Year 2|Migrated/moved from study area|2|||
33407915|NCT04738123|101380803|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
33616046|NCT00291486|102144264|FG002|Overall Study|Adverse Event|0|||
33616047|NCT00291486|102144265|FG003|Overall Study|Adverse Event|1|||
33616048|NCT00291486|102144266|FG004|Overall Study|Adverse Event|0|||
33616049|NCT00291486|102144262|FG000|Overall Study|Withdrawal by Subject|0|||
33616050|NCT00291486|102144263|FG001|Overall Study|Withdrawal by Subject|0|||
33616051|NCT00291486|102144264|FG002|Overall Study|Withdrawal by Subject|0|||
33616052|NCT00291486|102144265|FG003|Overall Study|Withdrawal by Subject|0|||
33616053|NCT00291486|102144266|FG004|Overall Study|Withdrawal by Subject|1|||
33616054|NCT00291486|102144262|FG000|Overall Study|Disease progression|1|||
33616055|NCT00291486|102144263|FG001|Overall Study|Disease progression|0|||
33616056|NCT00291486|102144264|FG002|Overall Study|Disease progression|1|||
33616057|NCT00291486|102144265|FG003|Overall Study|Disease progression|0|||
33616058|NCT00291486|102144266|FG004|Overall Study|Disease progression|0|||
33616059|NCT01363908|102144267|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
33616060|NCT01363908|102144268|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
33616061|NCT01363908|102144267|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
33616062|NCT01363908|102144268|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
33616063|NCT01363908|102144267|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
33616064|NCT01363908|102144268|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
33616065|NCT01363908|102144267|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
33212638|NCT01261611|100676680|FG002|Treatment Cycle 4|Completed study|0|||
33346275|NCT01262976|101156580|FG000|Up to Year 2|Lost to Follow-up|1|||
33407916|NCT04738123|101380802|FG000|Overall Study|Progressive Disease|0|||
33616066|NCT01363908|102144268|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
33616067|NCT01221350|102144273|FG000|Overall Study|Discontinued intervention (GERD)|1|||
33616068|NCT01221350|102144274|FG001|Overall Study|Discontinued intervention (GERD)|0|||
33616069|NCT01221350|102144273|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
33616070|NCT01221350|102144274|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
33616071|NCT01221350|102144273|FG000|Overall Study|Withdrawal by Subject|4|||
33616072|NCT01221350|102144274|FG001|Overall Study|Withdrawal by Subject|2|||
33212639|NCT01261611|100676678|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
33346276|NCT01262976|101156581|FG001|Up to Year 2|Lost to Follow-up|1|||
33346277|NCT01262976|101156582|FG002|Up to Year 2|Lost to Follow-up|2|||
33346278|NCT01262976|101156583|FG003|Up to Year 2|Lost to Follow-up|2|||
33346279|NCT01262976|101156584|FG004|Up to Year 2|Lost to Follow-up|3|||
33346280|NCT01262976|101156585|FG005|Up to Year 2|Lost to Follow-up|3|||
33407917|NCT04738123|101380803|FG001|Overall Study|Progressive Disease|4|||
33407918|NCT04738123|101380802|FG000|Overall Study|Adverse Event|8|||
33542993|NCT00410163|101888887|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
33616073|NCT01807598|102144275|FG000|Overall Study|Withdrawal by Subject|4|||
33616074|NCT01807598|102144275|FG000|Overall Study|Adverse Event|1|||
33616075|NCT01807598|102144275|FG000|Overall Study|Other Physician Decision|1|||
33616076|NCT00825812|102144276|FG000|Overall Study|Never entered follow up|0|||
33616077|NCT00825812|102144277|FG001|Overall Study|Never entered follow up|0|||
33616078|NCT00825812|102144278|FG002|Overall Study|Never entered follow up|0|||
33616079|NCT00825812|102144279|FG003|Overall Study|Never entered follow up|1|||
33616080|NCT00825812|102144276|FG000|Overall Study|Adverse Event|0|||
33212640|NCT01261611|100676679|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
33212641|NCT01261611|100676680|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
33212642|NCT01261611|100676678|FG000|Treatment Cycle 4|Adverse Event|1|||
33212643|NCT01261611|100676679|FG001|Treatment Cycle 4|Adverse Event|0|||
33616081|NCT00825812|102144277|FG001|Overall Study|Adverse Event|0|||
33346281|NCT01262976|101156580|FG000|Up to Year 2|Subjects with unknown completion status|0|||
33346282|NCT01262976|101156581|FG001|Up to Year 2|Subjects with unknown completion status|0|||
33346283|NCT01262976|101156582|FG002|Up to Year 2|Subjects with unknown completion status|1|||
33346284|NCT01262976|101156583|FG003|Up to Year 2|Subjects with unknown completion status|0|||
33346285|NCT01262976|101156584|FG004|Up to Year 2|Subjects with unknown completion status|0|||
33346286|NCT01262976|101156585|FG005|Up to Year 2|Subjects with unknown completion status|0|||
33346287|NCT01262976|101156580|FG000|Up to Year 2|Other|3|||
33346288|NCT01262976|101156581|FG001|Up to Year 2|Other|0|||
33346289|NCT01262976|101156582|FG002|Up to Year 2|Other|0|||
33346290|NCT01262976|101156583|FG003|Up to Year 2|Other|0|||
33346291|NCT01262976|101156584|FG004|Up to Year 2|Other|0|||
33346292|NCT01262976|101156585|FG005|Up to Year 2|Other|0|||
33346293|NCT01262976|101156580|FG000|Up to Year 3|Serious Adverse Event|0|||
33346294|NCT01262976|101156581|FG001|Up to Year 3|Serious Adverse Event|0|||
33346295|NCT01262976|101156582|FG002|Up to Year 3|Serious Adverse Event|2|||
33346296|NCT01262976|101156583|FG003|Up to Year 3|Serious Adverse Event|0|||
33346297|NCT01262976|101156584|FG004|Up to Year 3|Serious Adverse Event|0|||
33346298|NCT01262976|101156585|FG005|Up to Year 3|Serious Adverse Event|0|||
33346299|NCT01262976|101156580|FG000|Up to Year 3|Withdrawal by Subject|1|||
33346300|NCT01262976|101156581|FG001|Up to Year 3|Withdrawal by Subject|0|||
33346301|NCT01262976|101156582|FG002|Up to Year 3|Withdrawal by Subject|0|||
33346302|NCT01262976|101156583|FG003|Up to Year 3|Withdrawal by Subject|0|||
33346303|NCT01262976|101156584|FG004|Up to Year 3|Withdrawal by Subject|0|||
33407919|NCT04738123|101380803|FG001|Overall Study|Adverse Event|7|||
33407920|NCT04738123|101380802|FG000|Overall Study|Other Reasons|0|||
33346304|NCT01262976|101156585|FG005|Up to Year 3|Withdrawal by Subject|0|||
33346305|NCT01262976|101156580|FG000|Up to Year 3|Migrated/moved from study area|0|||
33346306|NCT01262976|101156581|FG001|Up to Year 3|Migrated/moved from study area|0|||
33346307|NCT01262976|101156582|FG002|Up to Year 3|Migrated/moved from study area|0|||
33346308|NCT01262976|101156583|FG003|Up to Year 3|Migrated/moved from study area|2|||
33346309|NCT01262976|101156584|FG004|Up to Year 3|Migrated/moved from study area|1|||
33346310|NCT01262976|101156585|FG005|Up to Year 3|Migrated/moved from study area|1|||
33346311|NCT01262976|101156580|FG000|Up to Year 3|Lost to Follow-up|2|||
33346312|NCT01262976|101156581|FG001|Up to Year 3|Lost to Follow-up|2|||
33346313|NCT01262976|101156582|FG002|Up to Year 3|Lost to Follow-up|4|||
33346314|NCT01262976|101156583|FG003|Up to Year 3|Lost to Follow-up|3|||
33346315|NCT01262976|101156584|FG004|Up to Year 3|Lost to Follow-up|1|||
33346316|NCT01262976|101156585|FG005|Up to Year 3|Lost to Follow-up|3|||
33346317|NCT01262976|101156580|FG000|Up to Year 3|Subjects with unknown completion status|0|||
33346318|NCT01262976|101156581|FG001|Up to Year 3|Subjects with unknown completion status|0|||
33346319|NCT01262976|101156582|FG002|Up to Year 3|Subjects with unknown completion status|1|||
33346320|NCT01262976|101156583|FG003|Up to Year 3|Subjects with unknown completion status|0|||
33346321|NCT01262976|101156584|FG004|Up to Year 3|Subjects with unknown completion status|0|||
33346322|NCT01262976|101156585|FG005|Up to Year 3|Subjects with unknown completion status|0|||
33346323|NCT01262976|101156580|FG000|Up to Year 3|Other|3|||
33346324|NCT01262976|101156581|FG001|Up to Year 3|Other|0|||
33346325|NCT01262976|101156582|FG002|Up to Year 3|Other|0|||
33346326|NCT01262976|101156583|FG003|Up to Year 3|Other|0|||
33346327|NCT01262976|101156584|FG004|Up to Year 3|Other|0|||
33346328|NCT01262976|101156585|FG005|Up to Year 3|Other|0|||
33346329|NCT01163786|101156598|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
33346330|NCT01163786|101156598|FG000|Treatment With Bortezomib|Adverse Event|2|||
33346331|NCT01163786|101156598|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
33346332|NCT00214461|101156599|FG000|Overall Study|Adverse Event|0|||
33346333|NCT00214461|101156600|FG001|Overall Study|Adverse Event|0|||
33346334|NCT00214461|101156601|FG002|Overall Study|Adverse Event|1|||
33346335|NCT00214461|101156602|FG003|Overall Study|Adverse Event|1|||
33346336|NCT00214461|101156599|FG000|Overall Study|Withdrawal by Subject|0|||
33346337|NCT00214461|101156600|FG001|Overall Study|Withdrawal by Subject|0|||
33346338|NCT00214461|101156601|FG002|Overall Study|Withdrawal by Subject|1|||
33346339|NCT00214461|101156602|FG003|Overall Study|Withdrawal by Subject|0|||
33346340|NCT03075163|101156603|FG000|Overall Study|not eligible for treatment limb|138|||
33346341|NCT03075163|101156604|FG001|Overall Study|not eligible for treatment limb|138|||
33346342|NCT01916980|101156605|FG000|Overall Study|Adverse Event|4|||
33346343|NCT01916980|101156606|FG001|Overall Study|Adverse Event|2|||
33346344|NCT01916980|101156605|FG000|Overall Study|Lack of Efficacy|2|||
33346345|NCT01916980|101156606|FG001|Overall Study|Lack of Efficacy|2|||
33346346|NCT01916980|101156605|FG000|Overall Study|Withdrawal by Subject|1|||
33346347|NCT01916980|101156606|FG001|Overall Study|Withdrawal by Subject|0|||
33346348|NCT03136107|101156607|FG000|Overall Study|Other (Not specified)|1|||
33346349|NCT03033745|101156613|FG000|Overall Study|Protocol Violation|0|||
33346350|NCT03033745|101156614|FG001|Overall Study|Protocol Violation|0|||
33346351|NCT03033745|101156615|FG002|Overall Study|Protocol Violation|1|||
33346352|NCT03033745|101156613|FG000|Overall Study|Adverse Event|1|||
33346353|NCT03033745|101156614|FG001|Overall Study|Adverse Event|0|||
33346354|NCT03033745|101156615|FG002|Overall Study|Adverse Event|1|||
33346355|NCT03033745|101156613|FG000|Overall Study|Withdrawal by Subject|0|||
33346356|NCT03033745|101156614|FG001|Overall Study|Withdrawal by Subject|1|||
33346357|NCT03033745|101156615|FG002|Overall Study|Withdrawal by Subject|0|||
33346358|NCT01808612|101156621|FG000|Treatment Period|Adverse Event|8|||
33346359|NCT01808612|101156622|FG001|Treatment Period|Adverse Event|4|||
33346360|NCT01808612|101156623|FG002|Treatment Period|Adverse Event|3|||
33346361|NCT01808612|101156621|FG000|Treatment Period|Lost to Follow-up|2|||
33346362|NCT01808612|101156622|FG001|Treatment Period|Lost to Follow-up|2|||
33346363|NCT01808612|101156623|FG002|Treatment Period|Lost to Follow-up|1|||
33346364|NCT01808612|101156621|FG000|Treatment Period|Protocol Violation|1|||
33346365|NCT01808612|101156622|FG001|Treatment Period|Protocol Violation|0|||
33346366|NCT01808612|101156623|FG002|Treatment Period|Protocol Violation|0|||
33346367|NCT01808612|101156621|FG000|Treatment Period|Withdrawal by Subject|1|||
33346368|NCT01808612|101156622|FG001|Treatment Period|Withdrawal by Subject|0|||
33346369|NCT01808612|101156623|FG002|Treatment Period|Withdrawal by Subject|4|||
33346370|NCT01808612|101156621|FG000|Treatment Period|Physician Decision|1|||
33346371|NCT01808612|101156622|FG001|Treatment Period|Physician Decision|0|||
33346372|NCT01808612|101156623|FG002|Treatment Period|Physician Decision|4|||
33346373|NCT01808612|101156621|FG000|Treatment Period|Sponsor Decision|1|||
33346374|NCT01808612|101156622|FG001|Treatment Period|Sponsor Decision|0|||
33346375|NCT01808612|101156623|FG002|Treatment Period|Sponsor Decision|0|||
33346376|NCT01808612|101156621|FG000|Treatment Period|Lack of Efficacy|1|||
33346377|NCT01808612|101156622|FG001|Treatment Period|Lack of Efficacy|1|||
33346378|NCT01808612|101156623|FG002|Treatment Period|Lack of Efficacy|2|||
33346379|NCT01808612|101156621|FG000|Discontinuation Period|Adverse Event|1|||
33346380|NCT01808612|101156622|FG001|Discontinuation Period|Adverse Event|0|||
33346381|NCT01808612|101156623|FG002|Discontinuation Period|Adverse Event|0|||
33346382|NCT01808612|101156621|FG000|Discontinuation Period|Physician Decision|1|||
33346383|NCT01808612|101156622|FG001|Discontinuation Period|Physician Decision|0|||
33346384|NCT01808612|101156623|FG002|Discontinuation Period|Physician Decision|0|||
33542994|NCT00410163|101888886|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
33407921|NCT04738123|101380803|FG001|Overall Study|Other Reasons|1|||
33407922|NCT04738123|101380802|FG000|Overall Study|Suicidal or assaultive behavior|0|||
33407923|NCT04738123|101380803|FG001|Overall Study|Suicidal or assaultive behavior|2|||
33407924|NCT04738123|101380802|FG000|Overall Study|Protocol Violation|2|||
33407925|NCT04738123|101380803|FG001|Overall Study|Protocol Violation|2|||
33407926|NCT04738123|101380802|FG000|Overall Study|Consent Withdrawn|35|||
33407927|NCT04738123|101380803|FG001|Overall Study|Consent Withdrawn|22|||
33407928|NCT04882072|101380804|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
33407929|NCT04882072|101380805|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
33407930|NCT04882072|101380804|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
33407931|NCT04882072|101380805|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
33407932|NCT04882072|101380804|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
33407933|NCT04882072|101380805|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
33407934|NCT05403502|101380806|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
33407935|NCT05403502|101380806|FG000|Humalog Lead-In Period|Physician Decision|2|||
33407936|NCT05403502|101380806|FG000|Humalog Lead-In Period|Protocol Violation|1|||
33346385|NCT01808612|101156621|FG000|Discontinuation Period|Lost to Follow-up|0|||
33346386|NCT01808612|101156622|FG001|Discontinuation Period|Lost to Follow-up|1|||
33346387|NCT01808612|101156623|FG002|Discontinuation Period|Lost to Follow-up|0|||
33346388|NCT01528787|101156624|FG000|Overall Study|Withdrawal by Subject|0|||
33346389|NCT01528787|101156625|FG001|Overall Study|Withdrawal by Subject|0|||
33346390|NCT01528787|101156626|FG002|Overall Study|Withdrawal by Subject|0|||
33346391|NCT01528787|101156627|FG003|Overall Study|Withdrawal by Subject|1|||
33346392|NCT01528787|101156624|FG000|Overall Study|Family Emergency|0|||
33346393|NCT01528787|101156625|FG001|Overall Study|Family Emergency|0|||
33346394|NCT01528787|101156626|FG002|Overall Study|Family Emergency|1|||
33346395|NCT01528787|101156627|FG003|Overall Study|Family Emergency|0|||
33407937|NCT05403502|101380806|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
33407938|NCT05403502|101380806|FG000|Lyumjev Treatment Period|Physician Decision|2|||
33407939|NCT01694849|101382999|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
33407940|NCT01694849|101383000|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
33407941|NCT01694849|101383001|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
33542995|NCT00410163|101888887|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
33542996|NCT00410163|101888886|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
33542997|NCT00410163|101888887|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
33542998|NCT00410163|101888886|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
33542999|NCT00410163|101888887|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
33543000|NCT00410163|101888886|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
33543001|NCT00410163|101888887|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
33346396|NCT02542072|101156628|FG000|First Intervention (1 Month)|Adverse Event|1|||
33346397|NCT02542072|101156629|FG001|First Intervention (1 Month)|Adverse Event|1|||
33346398|NCT02542072|101156628|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
33346399|NCT02542072|101156629|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
33346400|NCT02542072|101156628|FG000|First Intervention (1 Month)|Lens discomfort|1|||
33346401|NCT02542072|101156629|FG001|First Intervention (1 Month)|Lens discomfort|2|||
33407942|NCT01694849|101382999|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
33407943|NCT01694849|101383000|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
33543002|NCT00410163|101888886|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
33543003|NCT00410163|101888887|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
33543004|NCT00410163|101888886|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
33543005|NCT00410163|101888887|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
33543006|NCT00410163|101888886|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
33543007|NCT00410163|101888887|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
33543008|NCT00410163|101888886|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
33543009|NCT00410163|101888887|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
33543010|NCT00426270|101888888|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
33543011|NCT00426270|101888888|FG000|Overall Study|Adverse Event|5|||
33543012|NCT00547339|101888895|FG000|Overall Study|Physician Decision|0|||
33543013|NCT00547339|101888896|FG001|Overall Study|Physician Decision|0|||
33543014|NCT00547339|101888897|FG002|Overall Study|Physician Decision|1|||
33543015|NCT00547339|101888898|FG003|Overall Study|Physician Decision|0|||
33543016|NCT00703534|101888899|FG000|Overall Study|Adverse Event|14|||
33407944|NCT01694849|101383001|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
33407945|NCT01694849|101382999|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
33543017|NCT00703534|101888900|FG001|Overall Study|Adverse Event|3|||
33346402|NCT02542072|101156628|FG000|First Intervention (1 Month)|Protocol Violation|1|||
33346403|NCT02542072|101156629|FG001|First Intervention (1 Month)|Protocol Violation|0|||
33346404|NCT02542072|101156628|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
33212644|NCT01261611|100676680|FG002|Treatment Cycle 4|Adverse Event|0|||
33346405|NCT02542072|101156629|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
33346406|NCT02542072|101156628|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
33346407|NCT02542072|101156629|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
33346408|NCT01273064|101156630|FG000|Overall Study|Adverse Event|5|||
33346409|NCT01273064|101156631|FG001|Overall Study|Adverse Event|1|||
33543018|NCT00703534|101888899|FG000|Overall Study|Withdrawal by Subject|8|||
33543019|NCT00703534|101888900|FG001|Overall Study|Withdrawal by Subject|7|||
33543020|NCT00703534|101888899|FG000|Overall Study|Incorrect Enrollment|6|||
33543021|NCT00703534|101888900|FG001|Overall Study|Incorrect Enrollment|6|||
33543022|NCT00703534|101888899|FG000|Overall Study|Lost to Follow-up|1|||
33543023|NCT00703534|101888900|FG001|Overall Study|Lost to Follow-up|4|||
33543024|NCT00703534|101888899|FG000|Overall Study|Severe Non Compliance|1|||
33543025|NCT00703534|101888900|FG001|Overall Study|Severe Non Compliance|5|||
33543026|NCT00408499|101888901|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
33212645|NCT01261611|100676678|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
33346410|NCT01273064|101156632|FG002|Overall Study|Adverse Event|3|||
33346411|NCT01273064|101156633|FG003|Overall Study|Adverse Event|2|||
33346412|NCT01273064|101156634|FG004|Overall Study|Adverse Event|1|||
33346413|NCT01273064|101156630|FG000|Overall Study|Withdrawal by Subject|4|||
33346414|NCT01273064|101156631|FG001|Overall Study|Withdrawal by Subject|2|||
33346415|NCT01273064|101156632|FG002|Overall Study|Withdrawal by Subject|2|||
33346416|NCT01273064|101156633|FG003|Overall Study|Withdrawal by Subject|2|||
33346417|NCT01273064|101156634|FG004|Overall Study|Withdrawal by Subject|0|||
33346418|NCT01273064|101156630|FG000|Overall Study|Study Termination|13|||
33346419|NCT01273064|101156631|FG001|Overall Study|Study Termination|27|||
33346420|NCT01273064|101156632|FG002|Overall Study|Study Termination|26|||
33346421|NCT01273064|101156633|FG003|Overall Study|Study Termination|16|||
33346422|NCT01273064|101156634|FG004|Overall Study|Study Termination|8|||
33346423|NCT01273064|101156630|FG000|Overall Study|Lost to Follow-up|1|||
33346424|NCT01273064|101156631|FG001|Overall Study|Lost to Follow-up|0|||
33346425|NCT01273064|101156632|FG002|Overall Study|Lost to Follow-up|0|||
33346426|NCT01273064|101156633|FG003|Overall Study|Lost to Follow-up|0|||
33346427|NCT01273064|101156634|FG004|Overall Study|Lost to Follow-up|0|||
33346428|NCT01273064|101156630|FG000|Overall Study|Physician Decision|0|||
33346429|NCT01273064|101156631|FG001|Overall Study|Physician Decision|0|||
33346430|NCT01273064|101156632|FG002|Overall Study|Physician Decision|0|||
33346431|NCT01273064|101156633|FG003|Overall Study|Physician Decision|0|||
33346432|NCT01273064|101156634|FG004|Overall Study|Physician Decision|1|||
33346433|NCT03739528|101156635|FG000|Overall Study|Not treated|8|||
33346434|NCT03739528|101156636|FG001|Overall Study|Not treated|12|||
33346435|NCT03739528|101156635|FG000|Overall Study|Treatment and study discontinued|6|||
33346436|NCT03739528|101156636|FG001|Overall Study|Treatment and study discontinued|2|||
33346437|NCT03739528|101156635|FG000|Overall Study|Treatment discontinued + study completed|1|||
33346438|NCT03739528|101156636|FG001|Overall Study|Treatment discontinued + study completed|3|||
33346439|NCT01354028|101156643|FG000|Overall Study|Physician Decision|0|||
33346440|NCT01354028|101156644|FG001|Overall Study|Physician Decision|2|||
33543027|NCT00408499|101888902|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
33543028|NCT00408499|101888903|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
33543029|NCT00408499|101888904|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
33543030|NCT00408499|101888905|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
33212646|NCT01261611|100676679|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
33543031|NCT00408499|101888901|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
33543032|NCT00408499|101888902|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
33212647|NCT01261611|100676680|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
33346441|NCT01354028|101156643|FG000|Overall Study|Discharged before study start|2|||
33346442|NCT01354028|101156644|FG001|Overall Study|Discharged before study start|2|||
33346443|NCT01354028|101156643|FG000|Overall Study|No quiet alert state|0|||
33346444|NCT01354028|101156644|FG001|Overall Study|No quiet alert state|1|||
33346445|NCT00510276|101156645|FG000|Acute Double-Blind Phase|Adverse Event|21|||
33346446|NCT00510276|101156646|FG001|Acute Double-Blind Phase|Adverse Event|6|||
33346447|NCT00510276|101156645|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
33346448|NCT00510276|101156646|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
33346449|NCT00510276|101156645|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
33346450|NCT00510276|101156646|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
33346451|NCT00510276|101156645|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
33346452|NCT00510276|101156646|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
33346453|NCT00510276|101156645|FG000|Acute Double-Blind Phase|Physician Decision|0|||
33346454|NCT00510276|101156646|FG001|Acute Double-Blind Phase|Physician Decision|3|||
33346455|NCT00510276|101156645|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
33346456|NCT00510276|101156646|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
33346457|NCT00510276|101156645|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
33346458|NCT00510276|101156646|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
33346459|NCT00510276|101156645|FG000|Acute Double-Blind Phase|Subject Decision|26|||
33346460|NCT00510276|101156646|FG001|Acute Double-Blind Phase|Subject Decision|28|||
33346461|NCT00510276|101156645|FG000|Extension Open-Label Phase|Adverse Event|9|||
33346462|NCT00510276|101156646|FG001|Extension Open-Label Phase|Adverse Event|18|||
33346463|NCT00510276|101156645|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
33346464|NCT00510276|101156646|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
33346465|NCT00510276|101156645|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
33346466|NCT00510276|101156646|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
33346467|NCT00510276|101156645|FG000|Extension Open-Label Phase|Physician Decision|2|||
33346468|NCT00510276|101156646|FG001|Extension Open-Label Phase|Physician Decision|3|||
33346469|NCT00510276|101156645|FG000|Extension Open-Label Phase|Protocol Violation|0|||
33346470|NCT00510276|101156646|FG001|Extension Open-Label Phase|Protocol Violation|1|||
33346471|NCT00510276|101156645|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
33346472|NCT00510276|101156646|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
33346473|NCT00510276|101156645|FG000|Extension Open-Label Phase|Subject Decision|7|||
33346474|NCT00510276|101156646|FG001|Extension Open-Label Phase|Subject Decision|9|||
33346475|NCT02435914|101156657|FG000|Overall Study|Ocular Adverse Event|1|||
33346476|NCT02435914|101156658|FG001|Overall Study|Ocular Adverse Event|0|||
33346477|NCT02435914|101156659|FG002|Overall Study|Ocular Adverse Event|0|||
33346478|NCT02435914|101156660|FG003|Overall Study|Ocular Adverse Event|0|||
33346479|NCT02435914|101156657|FG000|Overall Study|Withdrawal by Subject|0|||
33346480|NCT02435914|101156658|FG001|Overall Study|Withdrawal by Subject|1|||
33346481|NCT02435914|101156659|FG002|Overall Study|Withdrawal by Subject|0|||
33346482|NCT02435914|101156660|FG003|Overall Study|Withdrawal by Subject|0|||
33346483|NCT02435914|101156657|FG000|Overall Study|Other Miscellaneous Reason|0|||
33346484|NCT02435914|101156658|FG001|Overall Study|Other Miscellaneous Reason|0|||
33346485|NCT02435914|101156659|FG002|Overall Study|Other Miscellaneous Reason|1|||
33346486|NCT02435914|101156660|FG003|Overall Study|Other Miscellaneous Reason|0|||
33346487|NCT00364182|101156664|FG000|First Intervention|Secondary prophylaxis|1|||
33346488|NCT00364182|101156665|FG001|First Intervention|Secondary prophylaxis|0|||
33346489|NCT00364182|101156666|FG002|First Intervention|Secondary prophylaxis|0|||
33346490|NCT00364182|101156664|FG000|First Intervention|Withdrawal by Subject|2|||
33346491|NCT00364182|101156665|FG001|First Intervention|Withdrawal by Subject|0|||
33346492|NCT00364182|101156666|FG002|First Intervention|Withdrawal by Subject|0|||
33346493|NCT00364182|101156664|FG000|Second Intervention|non-compliance|0|||
33346494|NCT00364182|101156665|FG001|Second Intervention|non-compliance|1|||
33346495|NCT00364182|101156666|FG002|Second Intervention|non-compliance|1|||
33346496|NCT00364182|101156664|FG000|Second Intervention|Protocol Violation|0|||
33346497|NCT00364182|101156665|FG001|Second Intervention|Protocol Violation|1|||
33346498|NCT00364182|101156666|FG002|Second Intervention|Protocol Violation|0|||
33346499|NCT00364182|101156664|FG000|Second Intervention|Adverse Event|0|||
33212648|NCT01261611|100676678|FG000|Treatment Cycle 4|Not otherwise specified|3|||
33212649|NCT01261611|100676679|FG001|Treatment Cycle 4|Not otherwise specified|0|||
33212650|NCT01261611|100676680|FG002|Treatment Cycle 4|Not otherwise specified|0|||
33212651|NCT01261611|100676678|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
33212652|NCT01261611|100676679|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
33346500|NCT00364182|101156665|FG001|Second Intervention|Adverse Event|0|||
33346501|NCT00364182|101156666|FG002|Second Intervention|Adverse Event|1|||
33346502|NCT00364182|101156664|FG000|Third Intervention|non-compliance|0|||
33346503|NCT00364182|101156665|FG001|Third Intervention|non-compliance|1|||
33212653|NCT01261611|100676680|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
33212654|NCT01261611|100676678|FG000|Treatment Cycle 5|Adverse Event|1|||
33212655|NCT01261611|100676679|FG001|Treatment Cycle 5|Adverse Event|0|||
33346504|NCT00364182|101156666|FG002|Third Intervention|non-compliance|0|||
33346505|NCT00364182|101156664|FG000|Third Intervention|Lost to Follow-up|0|||
33346506|NCT00364182|101156665|FG001|Third Intervention|Lost to Follow-up|0|||
33346507|NCT00364182|101156666|FG002|Third Intervention|Lost to Follow-up|1|||
33346508|NCT02211261|101156667|FG000|Overall Study|Withdrawal by Subject|0|||
33346509|NCT02211261|101156668|FG001|Overall Study|Withdrawal by Subject|0|||
33543033|NCT00408499|101888903|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
33543034|NCT00408499|101888904|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
33543035|NCT00408499|101888905|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
33543036|NCT00408499|101888901|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
33543037|NCT00408499|101888902|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
33543038|NCT00408499|101888903|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
33543039|NCT00408499|101888904|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
33543040|NCT00408499|101888905|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
33543041|NCT00408499|101888901|FG000|Phase II- MTD Expansion|Adverse Event|0|||
33543042|NCT00408499|101888902|FG001|Phase II- MTD Expansion|Adverse Event|0|||
33543043|NCT00408499|101888903|FG002|Phase II- MTD Expansion|Adverse Event|0|||
33543044|NCT00408499|101888904|FG003|Phase II- MTD Expansion|Adverse Event|0|||
33543045|NCT00408499|101888905|FG004|Phase II- MTD Expansion|Adverse Event|9|||
33212656|NCT01261611|100676680|FG002|Treatment Cycle 5|Adverse Event|0|||
33212657|NCT01261611|100676678|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
33212658|NCT01261611|100676679|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
33212659|NCT01261611|100676680|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
33212660|NCT00450411|100676682|FG000|Overall Study|Protocol Violation|6|||
33212661|NCT00450411|100676682|FG000|Overall Study|No protocol treatment|2|||
33212662|NCT00862134|100676683|FG000|Overall Study|Death|1|||
33212663|NCT00862134|100676684|FG001|Overall Study|Death|0|||
33346510|NCT02211261|101156669|FG002|Overall Study|Withdrawal by Subject|1|||
33346511|NCT02211261|101156670|FG003|Overall Study|Withdrawal by Subject|0|||
33346512|NCT02211261|101156671|FG004|Overall Study|Withdrawal by Subject|2|||
33346513|NCT02211261|101156672|FG005|Overall Study|Withdrawal by Subject|0|||
33346514|NCT02211261|101156673|FG006|Overall Study|Withdrawal by Subject|0|||
33346515|NCT02211261|101156674|FG007|Overall Study|Withdrawal by Subject|0|||
33346516|NCT02211261|101156675|FG008|Overall Study|Withdrawal by Subject|0|||
33346517|NCT02211261|101156676|FG009|Overall Study|Withdrawal by Subject|0|||
33346518|NCT02211261|101156677|FG010|Overall Study|Withdrawal by Subject|0|||
33346519|NCT02211261|101156667|FG000|Overall Study|Other|0|||
33346520|NCT02211261|101156668|FG001|Overall Study|Other|0|||
33346521|NCT02211261|101156669|FG002|Overall Study|Other|0|||
33346522|NCT02211261|101156670|FG003|Overall Study|Other|0|||
33346523|NCT02211261|101156671|FG004|Overall Study|Other|0|||
33346524|NCT02211261|101156672|FG005|Overall Study|Other|1|||
33346525|NCT02211261|101156673|FG006|Overall Study|Other|0|||
33346526|NCT02211261|101156674|FG007|Overall Study|Other|0|||
33346527|NCT02211261|101156675|FG008|Overall Study|Other|0|||
33346528|NCT02211261|101156676|FG009|Overall Study|Other|2|||
33346529|NCT02211261|101156677|FG010|Overall Study|Other|0|||
33346530|NCT02211261|101156667|FG000|Overall Study|Lost to Follow-up|0|||
33346531|NCT02211261|101156668|FG001|Overall Study|Lost to Follow-up|0|||
33346532|NCT02211261|101156669|FG002|Overall Study|Lost to Follow-up|0|||
33346533|NCT02211261|101156670|FG003|Overall Study|Lost to Follow-up|0|||
33346534|NCT02211261|101156671|FG004|Overall Study|Lost to Follow-up|0|||
33346535|NCT02211261|101156672|FG005|Overall Study|Lost to Follow-up|0|||
33346536|NCT02211261|101156673|FG006|Overall Study|Lost to Follow-up|0|||
33346537|NCT02211261|101156674|FG007|Overall Study|Lost to Follow-up|1|||
33346538|NCT02211261|101156675|FG008|Overall Study|Lost to Follow-up|0|||
33346539|NCT02211261|101156676|FG009|Overall Study|Lost to Follow-up|0|||
33346540|NCT02211261|101156677|FG010|Overall Study|Lost to Follow-up|0|||
33346541|NCT01323478|101156678|FG000|Overall Study|Adverse Event|7|||
33346542|NCT01323478|101156678|FG000|Overall Study|Lack of Efficacy|4|||
33407946|NCT01694849|101383000|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
33407947|NCT01694849|101383001|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
33407948|NCT01694849|101382999|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
33543046|NCT00408499|101888901|FG000|Phase II- MTD Expansion|Death|0|||
33543047|NCT00408499|101888902|FG001|Phase II- MTD Expansion|Death|0|||
33212664|NCT00862134|100676683|FG000|Overall Study|Physician Decision|0|||
33212665|NCT00862134|100676684|FG001|Overall Study|Physician Decision|1|||
33212666|NCT00862134|100676683|FG000|Overall Study|Withdrawal by Subject|1|||
33346543|NCT01323478|101156678|FG000|Overall Study|Non-compliance With Study Product|3|||
33346544|NCT01323478|101156678|FG000|Overall Study|Protocol Violation|1|||
33346545|NCT01323478|101156678|FG000|Overall Study|Withdrawal of Consent|1|||
33346546|NCT01323478|101156678|FG000|Overall Study|Administrative or Other Reasons|8|||
33346547|NCT03446456|101156679|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
33346548|NCT03446456|101156680|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
33346549|NCT03446456|101156679|FG000|Overall Study|Lost to Follow-up|1|||
33212667|NCT00862134|100676684|FG001|Overall Study|Withdrawal by Subject|2|||
33212668|NCT00862134|100676683|FG000|Overall Study|Sponsor terminated study|5|||
33212669|NCT00862134|100676684|FG001|Overall Study|Sponsor terminated study|7|||
33212670|NCT00862134|100676683|FG000|Overall Study|Adverse Event|2|||
33212671|NCT00862134|100676684|FG001|Overall Study|Adverse Event|2|||
33212672|NCT00862134|100676683|FG000|Overall Study|Withdrew prior to dosing|2|||
33212673|NCT00862134|100676684|FG001|Overall Study|Withdrew prior to dosing|0|||
33212674|NCT00003298|100676687|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
33212675|NCT00003298|100676687|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
33212676|NCT00003298|100676687|FG000|Surgery|Unresectable at surgery|3|||
33212677|NCT00003298|100676687|FG000|Surgery|Progression before surgery|2|||
33212678|NCT00003298|100676687|FG000|Surgery|Unevaluable and off study|2|||
33212679|NCT00003298|100676687|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
33212680|NCT00003298|100676687|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
33212681|NCT00003298|100676687|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
33212682|NCT00003298|100676687|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
33212683|NCT00003298|100676687|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
33212684|NCT00003298|100676687|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
33212685|NCT00003298|100676687|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
33212686|NCT00003298|100676687|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
33212687|NCT00003298|100676687|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
33212688|NCT00003298|100676687|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
33212689|NCT00605280|100676688|FG000|Year 1|Protocol Violation|0|||
33212690|NCT00605280|100676689|FG001|Year 1|Protocol Violation|0|||
33212691|NCT00605280|100676690|FG002|Year 1|Protocol Violation|0|||
33212692|NCT00605280|100676691|FG003|Year 1|Protocol Violation|1|||
33212693|NCT00605280|100676688|FG000|Year 1|Adverse Event|3|||
33212694|NCT00605280|100676689|FG001|Year 1|Adverse Event|1|||
33212695|NCT00605280|100676690|FG002|Year 1|Adverse Event|1|||
33212696|NCT00605280|100676691|FG003|Year 1|Adverse Event|5|||
33212697|NCT00605280|100676688|FG000|Year 1|Physician Decision|7|||
33212698|NCT00605280|100676689|FG001|Year 1|Physician Decision|4|||
33212699|NCT00605280|100676690|FG002|Year 1|Physician Decision|0|||
33212700|NCT00605280|100676691|FG003|Year 1|Physician Decision|6|||
33212701|NCT00605280|100676688|FG000|Year 1|Withdrawal by Subject|2|||
33212702|NCT00605280|100676689|FG001|Year 1|Withdrawal by Subject|4|||
33212703|NCT00605280|100676690|FG002|Year 1|Withdrawal by Subject|0|||
33212704|NCT00605280|100676691|FG003|Year 1|Withdrawal by Subject|4|||
33212705|NCT00605280|100676688|FG000|Year 1|Other|2|||
33212706|NCT00605280|100676689|FG001|Year 1|Other|1|||
33212707|NCT00605280|100676690|FG002|Year 1|Other|0|||
33212708|NCT00605280|100676691|FG003|Year 1|Other|1|||
33212709|NCT00605280|100676688|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
33212710|NCT00605280|100676689|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
33212711|NCT00605280|100676690|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
33212712|NCT00605280|100676691|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
33212713|NCT00605280|100676688|FG000|Year 2|Adverse Event|4|||
33212714|NCT00605280|100676689|FG001|Year 2|Adverse Event|0|||
33212715|NCT00605280|100676690|FG002|Year 2|Adverse Event|2|||
33212716|NCT00605280|100676691|FG003|Year 2|Adverse Event|4|||
33212717|NCT00605280|100676688|FG000|Year 2|Physician Decision|11|||
33212718|NCT00605280|100676689|FG001|Year 2|Physician Decision|6|||
33212719|NCT00605280|100676690|FG002|Year 2|Physician Decision|4|||
33212720|NCT00605280|100676691|FG003|Year 2|Physician Decision|11|||
33212721|NCT00605280|100676688|FG000|Year 2|Withdrawal by Subject|4|||
33212722|NCT00605280|100676689|FG001|Year 2|Withdrawal by Subject|0|||
33212723|NCT00605280|100676690|FG002|Year 2|Withdrawal by Subject|0|||
33212724|NCT00605280|100676691|FG003|Year 2|Withdrawal by Subject|4|||
33212725|NCT00605280|100676688|FG000|Year 2|Other|1|||
33212726|NCT00605280|100676689|FG001|Year 2|Other|0|||
33346550|NCT03446456|101156680|FG001|Overall Study|Lost to Follow-up|3|||
33346551|NCT03446456|101156679|FG000|Overall Study|Participant failed the toxicology test|1|||
33407949|NCT01694849|101383000|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
33212727|NCT00605280|100676690|FG002|Year 2|Other|0|||
33212728|NCT00605280|100676691|FG003|Year 2|Other|1|||
33212729|NCT00605280|100676688|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
33212730|NCT00605280|100676689|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
33212731|NCT00605280|100676690|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
33212732|NCT00605280|100676691|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
33212733|NCT00605280|100676688|FG000|Year 3 Extension|Adverse Event|2|||
33212734|NCT00605280|100676689|FG001|Year 3 Extension|Adverse Event|0|||
33212735|NCT00605280|100676690|FG002|Year 3 Extension|Adverse Event|0|||
33212736|NCT00605280|100676691|FG003|Year 3 Extension|Adverse Event|2|||
33212737|NCT00605280|100676688|FG000|Year 3 Extension|Physician Decision|0|||
33212738|NCT00605280|100676689|FG001|Year 3 Extension|Physician Decision|0|||
33212739|NCT00605280|100676690|FG002|Year 3 Extension|Physician Decision|0|||
33212740|NCT00605280|100676691|FG003|Year 3 Extension|Physician Decision|2|||
33212741|NCT00605280|100676688|FG000|Year 3 Extension|Withdrawal by Subject|2|||
33212742|NCT00605280|100676689|FG001|Year 3 Extension|Withdrawal by Subject|0|||
33212743|NCT00605280|100676690|FG002|Year 3 Extension|Withdrawal by Subject|0|||
33212744|NCT00605280|100676691|FG003|Year 3 Extension|Withdrawal by Subject|5|||
33212745|NCT00605280|100676688|FG000|Year 3 Extension|Other|2|||
33212746|NCT00605280|100676689|FG001|Year 3 Extension|Other|0|||
33212747|NCT00605280|100676690|FG002|Year 3 Extension|Other|0|||
33212748|NCT00605280|100676691|FG003|Year 3 Extension|Other|0|||
33212749|NCT00605280|100676688|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
33212750|NCT00605280|100676689|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
33212751|NCT00605280|100676690|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
33212752|NCT00605280|100676691|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
33212753|NCT04368429|100676692|FG000|Overall Study|Adverse Event|1|||
33212754|NCT04368429|100676693|FG001|Overall Study|Adverse Event|0|||
33212755|NCT03221387|100676697|FG000|Overall Study|Lost to Follow-up|1|||
33212756|NCT03221387|100676697|FG000|Overall Study|Lung transplant|1|||
33212757|NCT00617344|100676699|FG000|Overall Study|Serious adverse event|1|||
33212758|NCT00617344|100676700|FG001|Overall Study|Serious adverse event|0|||
33212759|NCT00617344|100676701|FG002|Overall Study|Serious adverse event|0|||
33212760|NCT00617344|100676699|FG000|Overall Study|Other Adverse Event|1|||
33212761|NCT00617344|100676700|FG001|Overall Study|Other Adverse Event|1|||
33212762|NCT00617344|100676701|FG002|Overall Study|Other Adverse Event|0|||
33212763|NCT00617344|100676699|FG000|Overall Study|Protocol Violation|10|||
33212764|NCT00617344|100676700|FG001|Overall Study|Protocol Violation|8|||
33212765|NCT00617344|100676701|FG002|Overall Study|Protocol Violation|5|||
33212766|NCT00617344|100676699|FG000|Overall Study|Lost to Follow-up|5|||
33212767|NCT00617344|100676700|FG001|Overall Study|Lost to Follow-up|4|||
33212768|NCT00617344|100676701|FG002|Overall Study|Lost to Follow-up|1|||
33212769|NCT00617344|100676699|FG000|Overall Study|Withdrawal by Subject|8|||
33212770|NCT00617344|100676700|FG001|Overall Study|Withdrawal by Subject|9|||
33212771|NCT00617344|100676701|FG002|Overall Study|Withdrawal by Subject|2|||
33212772|NCT01830127|100676707|FG000|Overall Study|Adverse Event|1|||
33212773|NCT01830127|100676708|FG001|Overall Study|Adverse Event|6|||
33212774|NCT01830127|100676707|FG000|Overall Study|Lack of Efficacy|3|||
33212775|NCT01830127|100676708|FG001|Overall Study|Lack of Efficacy|0|||
33212776|NCT01830127|100676707|FG000|Overall Study|Withdrawal by Subject|1|||
33212777|NCT01830127|100676708|FG001|Overall Study|Withdrawal by Subject|1|||
33212778|NCT01830127|100676707|FG000|Overall Study|Other reason not defined above|0|||
33212779|NCT01830127|100676708|FG001|Overall Study|Other reason not defined above|2|||
33212780|NCT02085408|100676709|FG000|Step 1: Induction|Disease Progression|19|||
33212781|NCT02085408|100676710|FG001|Step 1: Induction|Disease Progression|19|||
33212782|NCT02085408|100676709|FG000|Step 1: Induction|Adverse Event|18|||
33212783|NCT02085408|100676710|FG001|Step 1: Induction|Adverse Event|17|||
33212784|NCT02085408|100676709|FG000|Step 1: Induction|Death|33|||
33212785|NCT02085408|100676710|FG001|Step 1: Induction|Death|30|||
33212786|NCT02085408|100676709|FG000|Step 1: Induction|Withdrawal by Subject|16|||
33212787|NCT02085408|100676710|FG001|Step 1: Induction|Withdrawal by Subject|8|||
33212788|NCT02085408|100676709|FG000|Step 1: Induction|Alternative Therapy|15|||
33212789|NCT02085408|100676710|FG001|Step 1: Induction|Alternative Therapy|19|||
33212790|NCT02085408|100676709|FG000|Step 1: Induction|Complicating Disease|2|||
33212791|NCT02085408|100676710|FG001|Step 1: Induction|Complicating Disease|3|||
33212792|NCT02085408|100676709|FG000|Step 1: Induction|Other|27|||
33212793|NCT02085408|100676710|FG001|Step 1: Induction|Other|39|||
33212794|NCT02085408|100676709|FG000|Step 1: Induction|Never started treatment|6|||
33212795|NCT02085408|100676710|FG001|Step 1: Induction|Never started treatment|4|||
33212796|NCT02085408|100676709|FG000|Step 2: Consolidation|Disease Progression|5|||
33212797|NCT02085408|100676710|FG001|Step 2: Consolidation|Disease Progression|20|||
33212798|NCT02085408|100676709|FG000|Step 2: Consolidation|Adverse Event|9|||
33212799|NCT02085408|100676710|FG001|Step 2: Consolidation|Adverse Event|8|||
33212800|NCT02085408|100676709|FG000|Step 2: Consolidation|Death|4|||
33346552|NCT03446456|101156680|FG001|Overall Study|Participant failed the toxicology test|0|||
33346553|NCT03446456|101156679|FG000|Overall Study|Break down of the experimental equipment|1|||
33346554|NCT03446456|101156680|FG001|Overall Study|Break down of the experimental equipment|0|||
33346555|NCT04258579|101156683|FG000|Overall Study|Withdrawal by Subject|7|||
33346556|NCT04258579|101156683|FG000|Overall Study|Lost to Follow-up|3|||
33346557|NCT04258579|101156683|FG000|Overall Study|Protocol Violation|2|||
33346558|NCT04258579|101156683|FG000|Overall Study|Adverse Event|1|||
33212801|NCT02085408|100676710|FG001|Step 2: Consolidation|Death|3|||
33212802|NCT02085408|100676709|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
33212803|NCT02085408|100676710|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
33212804|NCT02085408|100676709|FG000|Step 2: Consolidation|Alternative Therapy|9|||
33212805|NCT02085408|100676710|FG001|Step 2: Consolidation|Alternative Therapy|3|||
33212806|NCT02085408|100676709|FG000|Step 2: Consolidation|Complicating Disease|0|||
33212807|NCT02085408|100676710|FG001|Step 2: Consolidation|Complicating Disease|2|||
33212808|NCT02085408|100676709|FG000|Step 2: Consolidation|Other|6|||
33212809|NCT02085408|100676710|FG001|Step 2: Consolidation|Other|6|||
33212810|NCT02085408|100676709|FG000|Step 2: Consolidation|Never started treatment|4|||
33212811|NCT02085408|100676710|FG001|Step 2: Consolidation|Never started treatment|3|||
33212812|NCT02085408|100676709|FG000|Step 3: Maintenance|Disease Progression|13|||
33212813|NCT02085408|100676710|FG001|Step 3: Maintenance|Disease Progression|11|||
33212814|NCT02085408|100676709|FG000|Step 3: Maintenance|Adverse Event|2|||
33212815|NCT02085408|100676710|FG001|Step 3: Maintenance|Adverse Event|4|||
33212816|NCT02085408|100676709|FG000|Step 3: Maintenance|Death|1|||
33212817|NCT02085408|100676710|FG001|Step 3: Maintenance|Death|2|||
33212818|NCT02085408|100676709|FG000|Step 3: Maintenance|Alternative Therapy|1|||
33212819|NCT02085408|100676710|FG001|Step 3: Maintenance|Alternative Therapy|1|||
33212820|NCT02085408|100676709|FG000|Step 3: Maintenance|Complicating Disease|0|||
33212821|NCT02085408|100676710|FG001|Step 3: Maintenance|Complicating Disease|1|||
33212822|NCT02085408|100676709|FG000|Step 3: Maintenance|Other|3|||
33212823|NCT02085408|100676710|FG001|Step 3: Maintenance|Other|2|||
33543048|NCT00408499|101888903|FG002|Phase II- MTD Expansion|Death|0|||
33543049|NCT00408499|101888904|FG003|Phase II- MTD Expansion|Death|0|||
33543050|NCT00408499|101888905|FG004|Phase II- MTD Expansion|Death|2|||
33543051|NCT00408499|101888901|FG000|Phase II- MTD Expansion|Physician Decision|0|||
33543052|NCT00408499|101888902|FG001|Phase II- MTD Expansion|Physician Decision|0|||
33543053|NCT00408499|101888903|FG002|Phase II- MTD Expansion|Physician Decision|0|||
33543054|NCT00408499|101888904|FG003|Phase II- MTD Expansion|Physician Decision|0|||
33543055|NCT00408499|101888905|FG004|Phase II- MTD Expansion|Physician Decision|1|||
33543056|NCT00408499|101888901|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
33543057|NCT00408499|101888902|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
33543058|NCT00408499|101888903|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
33543059|NCT00408499|101888904|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
33543060|NCT00408499|101888905|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
33543061|NCT00408499|101888901|FG000|Phase II- MTD Expansion|treatment delay|0|||
33543062|NCT00408499|101888902|FG001|Phase II- MTD Expansion|treatment delay|0|||
33543063|NCT00408499|101888903|FG002|Phase II- MTD Expansion|treatment delay|0|||
33543064|NCT00408499|101888904|FG003|Phase II- MTD Expansion|treatment delay|0|||
33543065|NCT00408499|101888905|FG004|Phase II- MTD Expansion|treatment delay|3|||
33543066|NCT03883386|101888906|FG000|First Assignment|Lost to Follow-up|1|||
33543067|NCT03883386|101888907|FG001|First Assignment|Lost to Follow-up|0|||
33543068|NCT03883386|101888906|FG000|First Assignment|Withdrawal by Subject|1|||
33543069|NCT03883386|101888907|FG001|First Assignment|Withdrawal by Subject|1|||
33543070|NCT00142415|101888911|FG000|Overall Study|Physician Decision|0|||
33543071|NCT00142415|101888912|FG001|Overall Study|Physician Decision|0|||
33543072|NCT00142415|101888913|FG002|Overall Study|Physician Decision|0|||
33543073|NCT00142415|101888914|FG003|Overall Study|Physician Decision|0|||
33543074|NCT00142415|101888915|FG004|Overall Study|Physician Decision|1|||
33543075|NCT00142415|101888916|FG005|Overall Study|Physician Decision|2|||
33543076|NCT02188160|101888917|FG000|Overall Study|Adverse Event|1|||
33616082|NCT00825812|102144278|FG002|Overall Study|Adverse Event|0|||
33616083|NCT00825812|102144279|FG003|Overall Study|Adverse Event|1|||
33616084|NCT00825812|102144276|FG000|Overall Study|Subject withdrew consent|0|||
33616085|NCT00825812|102144277|FG001|Overall Study|Subject withdrew consent|0|||
33616086|NCT00825812|102144278|FG002|Overall Study|Subject withdrew consent|3|||
33616087|NCT00825812|102144279|FG003|Overall Study|Subject withdrew consent|2|||
33616088|NCT00825812|102144276|FG000|Overall Study|Non-compliance with protocol|0|||
33212824|NCT02085408|100676709|FG000|Step 3: Maintenance|Never started treatment|5|||
33212825|NCT02085408|100676710|FG001|Step 3: Maintenance|Never started treatment|1|||
33212826|NCT00636610|100676711|FG000|Overall Study|Adverse Event|4|||
33212827|NCT00636610|100676712|FG001|Overall Study|Adverse Event|4|||
33212828|NCT00636610|100676711|FG000|Overall Study|Death|6|||
33212829|NCT00636610|100676712|FG001|Overall Study|Death|3|||
33212830|NCT00636610|100676711|FG000|Overall Study|Physician decision to withdraw patient|15|||
33212831|NCT00636610|100676712|FG001|Overall Study|Physician decision to withdraw patient|9|||
33212832|NCT00636610|100676711|FG000|Overall Study|Subject decision to withdraw|15|||
33212833|NCT00636610|100676712|FG001|Overall Study|Subject decision to withdraw|11|||
33212834|NCT00636610|100676711|FG000|Overall Study|Disease progression - radiographic|41|||
33212835|NCT00636610|100676712|FG001|Overall Study|Disease progression - radiographic|51|||
33212836|NCT00636610|100676711|FG000|Overall Study|Disease progression - clinical|8|||
33212837|NCT00636610|100676712|FG001|Overall Study|Disease progression - clinical|3|||
33212838|NCT00636610|100676711|FG000|Overall Study|Reason for discontinuation not available|3|||
33212839|NCT00636610|100676712|FG001|Overall Study|Reason for discontinuation not available|2|||
33212840|NCT03461003|100676713|FG000|Overall Study|Lost to Follow-up|2|||
33543077|NCT02188160|101888918|FG001|Overall Study|Adverse Event|0|||
33543078|NCT02188160|101888917|FG000|Overall Study|Use of an excluded medication|0|||
33543079|NCT02188160|101888918|FG001|Overall Study|Use of an excluded medication|1|||
33543080|NCT01799941|101888920|FG000|Overall Study|Adverse Event|34|||
33543081|NCT01799941|101888920|FG000|Overall Study|Withdrawal by Subject|21|||
33543082|NCT01799941|101888920|FG000|Overall Study|Death|2|||
33212841|NCT03461003|100676714|FG001|Overall Study|Lost to Follow-up|2|||
33212842|NCT03461003|100676713|FG000|Overall Study|Withdrawal by Subject|3|||
33543083|NCT01799941|101888920|FG000|Overall Study|Investigator Decision|4|||
33212843|NCT03461003|100676714|FG001|Overall Study|Withdrawal by Subject|1|||
33616089|NCT00825812|102144277|FG001|Overall Study|Non-compliance with protocol|0|||
33407950|NCT01694849|101383001|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
33407951|NCT01694849|101382999|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
33407952|NCT01694849|101383000|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
33407953|NCT01694849|101383001|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
33407954|NCT01694849|101382999|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
33407955|NCT01694849|101383000|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
33407956|NCT01694849|101383001|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
33407957|NCT01694849|101382999|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
33407958|NCT01694849|101383000|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
33543084|NCT01799941|101888920|FG000|Overall Study|Lack of Efficacy|3|||
33543085|NCT01799941|101888920|FG000|Overall Study|Lost to Follow-up|17|||
33543086|NCT01799941|101888920|FG000|Overall Study|Other|15|||
33543087|NCT04969289|101888923|FG000|Overall Study|Lost to Follow-up|13|||
33543088|NCT04969289|101888924|FG001|Overall Study|Lost to Follow-up|9|||
33543089|NCT00900562|101888925|FG000|Overall Study|Progressive disease|9|||
33543090|NCT00900562|101888926|FG001|Overall Study|Progressive disease|5|||
33543091|NCT00900562|101888925|FG000|Overall Study|Toxicity|1|||
33543092|NCT00900562|101888926|FG001|Overall Study|Toxicity|0|||
33543093|NCT00900562|101888925|FG000|Overall Study|Death|1|||
33543094|NCT00900562|101888926|FG001|Overall Study|Death|1|||
33543095|NCT00900562|101888925|FG000|Overall Study|Withdrawal by Subject|0|||
33543096|NCT00900562|101888926|FG001|Overall Study|Withdrawal by Subject|1|||
33543097|NCT00900562|101888925|FG000|Overall Study|Unrelated adverse event|1|||
33543098|NCT00900562|101888926|FG001|Overall Study|Unrelated adverse event|0|||
33543099|NCT00695019|101888927|FG000|Overall Study|Withdrawal by Subject|8|||
33543100|NCT00695019|101888928|FG001|Overall Study|Withdrawal by Subject|6|||
33543101|NCT00695019|101888929|FG002|Overall Study|Withdrawal by Subject|4|||
33543102|NCT00695019|101888927|FG000|Overall Study|Protocol Violation|1|||
33543103|NCT00695019|101888928|FG001|Overall Study|Protocol Violation|3|||
33543104|NCT00695019|101888929|FG002|Overall Study|Protocol Violation|1|||
33543105|NCT00695019|101888927|FG000|Overall Study|Lack of Efficacy|0|||
33543106|NCT00695019|101888928|FG001|Overall Study|Lack of Efficacy|0|||
33543107|NCT00695019|101888929|FG002|Overall Study|Lack of Efficacy|1|||
33543108|NCT00695019|101888927|FG000|Overall Study|Various|4|||
33543109|NCT00695019|101888928|FG001|Overall Study|Various|5|||
33543110|NCT00695019|101888929|FG002|Overall Study|Various|4|||
33543111|NCT03451045|101888930|FG000|Overall Study|Lack of Efficacy|3|||
33543112|NCT03451045|101888931|FG001|Overall Study|Lack of Efficacy|2|||
33543113|NCT03451045|101888932|FG002|Overall Study|Lack of Efficacy|2|||
33543114|NCT03451045|101888930|FG000|Overall Study|Physician Decision|1|||
33543115|NCT03451045|101888931|FG001|Overall Study|Physician Decision|1|||
33543116|NCT03451045|101888932|FG002|Overall Study|Physician Decision|1|||
33543117|NCT03451045|101888930|FG000|Overall Study|Withdrawal by Subject|4|||
33543118|NCT03451045|101888931|FG001|Overall Study|Withdrawal by Subject|0|||
33543119|NCT03451045|101888932|FG002|Overall Study|Withdrawal by Subject|5|||
33543120|NCT03451045|101888930|FG000|Overall Study|Pregnancy|0|||
33543121|NCT03451045|101888931|FG001|Overall Study|Pregnancy|0|||
33543122|NCT03451045|101888932|FG002|Overall Study|Pregnancy|2|||
33543123|NCT03451045|101888930|FG000|Overall Study|Adverse Event|7|||
33543124|NCT03451045|101888931|FG001|Overall Study|Adverse Event|1|||
33543125|NCT03451045|101888932|FG002|Overall Study|Adverse Event|3|||
33543126|NCT03451045|101888930|FG000|Overall Study|Non-compliance with study|2|||
33543127|NCT03451045|101888931|FG001|Overall Study|Non-compliance with study|0|||
33543128|NCT03451045|101888932|FG002|Overall Study|Non-compliance with study|1|||
33543129|NCT03451045|101888930|FG000|Overall Study|any other reason|10|||
33543130|NCT03451045|101888931|FG001|Overall Study|any other reason|2|||
33543131|NCT03451045|101888932|FG002|Overall Study|any other reason|13|||
33543132|NCT04400318|101888935|FG000|Overall Study|Adverse Event|1|||
33543133|NCT04400318|101888936|FG001|Overall Study|Adverse Event|0|||
33543134|NCT04400318|101888935|FG000|Overall Study|Withdrawal by Subject|1|||
33543135|NCT04400318|101888936|FG001|Overall Study|Withdrawal by Subject|1|||
33543136|NCT04400318|101888935|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
33543137|NCT04400318|101888936|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
33407959|NCT01694849|101383001|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
33407960|NCT01694849|101382999|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
33543138|NCT01668797|101888937|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
33543139|NCT01668797|101888938|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
33543140|NCT01668797|101888939|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
33543141|NCT01668797|101888940|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
33543142|NCT01668797|101888937|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
33543143|NCT01668797|101888938|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
33543144|NCT01668797|101888939|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
33543145|NCT01668797|101888940|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
33543146|NCT01668797|101888937|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
33543147|NCT01668797|101888938|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
33407961|NCT01694849|101383000|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
33407962|NCT01694849|101383001|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
33407963|NCT04652245|101383003|FG000|Wash-Out Period|Adverse Event|0|||
33407964|NCT04652245|101383004|FG001|Wash-Out Period|Adverse Event|2|||
33407965|NCT04652245|101383003|FG000|Wash-Out Period|Withdrawal by Subject|0|||
33407966|NCT04652245|101383004|FG001|Wash-Out Period|Withdrawal by Subject|2|||
33407967|NCT02918968|101383005|FG000|1st Line AAT|Progressive disease|9|||
33407968|NCT02918968|101383006|FG001|1st Line AAT|Progressive disease|4|||
33407969|NCT02918968|101383005|FG000|1st Line AAT|Adverse Event|12|||
33407970|NCT02918968|101383006|FG001|1st Line AAT|Adverse Event|3|||
33407971|NCT02918968|101383005|FG000|1st Line AAT|Physician Decision|4|||
33407972|NCT02918968|101383006|FG001|1st Line AAT|Physician Decision|2|||
33407973|NCT02918968|101383005|FG000|1st Line AAT|Withdrawal by Subject|2|||
33407974|NCT02918968|101383006|FG001|1st Line AAT|Withdrawal by Subject|1|||
33407975|NCT02918968|101383005|FG000|1st Line AAT|Lost to Follow-up|0|||
33407976|NCT02918968|101383006|FG001|1st Line AAT|Lost to Follow-up|1|||
33407977|NCT02918968|101383005|FG000|1st Line AAT|Death|1|||
33407978|NCT02918968|101383006|FG001|1st Line AAT|Death|0|||
33407979|NCT02918968|101383005|FG000|1st Line AAT|Miscellaneous|1|||
33407980|NCT02918968|101383006|FG001|1st Line AAT|Miscellaneous|0|||
33407981|NCT02918968|101383005|FG000|2nd Line AAT|Progressive disease|21|||
33407982|NCT02918968|101383006|FG001|2nd Line AAT|Progressive disease|3|||
33616090|NCT00825812|102144278|FG002|Overall Study|Non-compliance with protocol|0|||
33616091|NCT00825812|102144279|FG003|Overall Study|Non-compliance with protocol|1|||
33616092|NCT00825812|102144276|FG000|Overall Study|Administrative|0|||
33616093|NCT00825812|102144277|FG001|Overall Study|Administrative|1|||
33616094|NCT00825812|102144278|FG002|Overall Study|Administrative|3|||
33616095|NCT00825812|102144279|FG003|Overall Study|Administrative|5|||
33616096|NCT00145574|102144280|FG000|Double Blind|Adverse Event|0|||
33616097|NCT00145574|102144281|FG001|Double Blind|Adverse Event|3|||
33616098|NCT00145574|102144282|FG002|Double Blind|Adverse Event|1|||
33616099|NCT00145574|102144280|FG000|Double Blind|Withdrawal by Subject|1|||
33616100|NCT00145574|102144281|FG001|Double Blind|Withdrawal by Subject|1|||
33616101|NCT00145574|102144282|FG002|Double Blind|Withdrawal by Subject|1|||
33616102|NCT00145574|102144280|FG000|Double Blind|required restricted medicine|0|||
33616103|NCT00145574|102144281|FG001|Double Blind|required restricted medicine|1|||
33616104|NCT00145574|102144282|FG002|Double Blind|required restricted medicine|0|||
33616105|NCT00145574|102144280|FG000|Open Label Long-term Extension|Adverse Event|0|||
33616106|NCT00145574|102144281|FG001|Open Label Long-term Extension|Adverse Event|0|||
33616107|NCT00145574|102144282|FG002|Open Label Long-term Extension|Adverse Event|5|||
33616108|NCT00145574|102144280|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
33616109|NCT00145574|102144281|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
33616110|NCT00145574|102144282|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
33616111|NCT00145574|102144280|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
33616112|NCT00145574|102144281|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
33616113|NCT00145574|102144282|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
33616114|NCT00145574|102144280|FG000|Open Label Long-term Extension|required restricted medicine|0|||
33616115|NCT00145574|102144281|FG001|Open Label Long-term Extension|required restricted medicine|0|||
33616116|NCT00145574|102144282|FG002|Open Label Long-term Extension|required restricted medicine|1|||
33616117|NCT03992846|102144285|FG000|Overall Study|Adverse Event|8|||
33616118|NCT03992846|102144286|FG001|Overall Study|Adverse Event|6|||
33616119|NCT03992846|102144287|FG002|Overall Study|Adverse Event|3|||
33616120|NCT03992846|102144285|FG000|Overall Study|Lost to Follow-up|0|||
33407983|NCT02918968|101383005|FG000|2nd Line AAT|Adverse Event|2|||
33407984|NCT02918968|101383006|FG001|2nd Line AAT|Adverse Event|5|||
33407985|NCT02918968|101383005|FG000|2nd Line AAT|Physician Decision|0|||
33407986|NCT02918968|101383006|FG001|2nd Line AAT|Physician Decision|1|||
33407987|NCT02918968|101383005|FG000|2nd Line AAT|Withdrawal by Subject|2|||
33407988|NCT02918968|101383006|FG001|2nd Line AAT|Withdrawal by Subject|2|||
33543148|NCT01668797|101888939|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
33543149|NCT01668797|101888940|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
33543150|NCT01668797|101888937|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
33543151|NCT01668797|101888938|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
33543152|NCT01668797|101888939|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
33543153|NCT01668797|101888940|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
33543154|NCT01668797|101888937|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
33543155|NCT01668797|101888938|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
33543156|NCT01668797|101888939|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
33543157|NCT01668797|101888940|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
33616121|NCT03992846|102144286|FG001|Overall Study|Lost to Follow-up|1|||
33616122|NCT03992846|102144287|FG002|Overall Study|Lost to Follow-up|1|||
33616123|NCT03992846|102144285|FG000|Overall Study|Pregnancy|2|||
33616124|NCT03992846|102144286|FG001|Overall Study|Pregnancy|0|||
33616125|NCT03992846|102144287|FG002|Overall Study|Pregnancy|1|||
33616126|NCT03992846|102144285|FG000|Overall Study|Protocol Violation|1|||
33616127|NCT03992846|102144286|FG001|Overall Study|Protocol Violation|2|||
33616128|NCT03992846|102144287|FG002|Overall Study|Protocol Violation|0|||
33616129|NCT03992846|102144285|FG000|Overall Study|Withdrawal by Subject|8|||
33616130|NCT03992846|102144286|FG001|Overall Study|Withdrawal by Subject|10|||
33616131|NCT03992846|102144287|FG002|Overall Study|Withdrawal by Subject|20|||
33616132|NCT03992846|102144285|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
33616133|NCT03992846|102144286|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
33616134|NCT03992846|102144287|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
33616135|NCT02073682|102144288|FG000|Overall Study|Low Creatinine Clearance|1|||
33616136|NCT02073682|102144289|FG001|Overall Study|Low Creatinine Clearance|2|||
33616137|NCT02073682|102144288|FG000|Overall Study|Death|86|||
33616138|NCT02073682|102144289|FG001|Overall Study|Death|100|||
33616139|NCT02073682|102144288|FG000|Overall Study|Cancer Cured|10|||
33616140|NCT02073682|102144289|FG001|Overall Study|Cancer Cured|15|||
33616141|NCT02073682|102144288|FG000|Overall Study|ID: Patient Noncompliance|1|||
33616142|NCT02073682|102144289|FG001|Overall Study|ID: Patient Noncompliance|2|||
33616143|NCT02073682|102144288|FG000|Overall Study|ID: Palliative Treatment Only|10|||
33616144|NCT02073682|102144289|FG001|Overall Study|ID: Palliative Treatment Only|7|||
33616145|NCT02073682|102144288|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
33616146|NCT02073682|102144289|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
33616147|NCT02073682|102144288|FG000|Overall Study|Platelet Count <50,000/mL|1|||
33543158|NCT01668797|101888937|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
33346559|NCT00631137|101156684|FG000|Overall Study|Withdrawal by Subject|1|||
33346560|NCT00631137|101156685|FG001|Overall Study|Withdrawal by Subject|0|||
33346561|NCT01795547|101156686|FG000|Overall Study|Adverse Event|16|||
33346562|NCT01795547|101156687|FG001|Overall Study|Adverse Event|27|||
33346563|NCT01795547|101156686|FG000|Overall Study|Lack of Efficacy|8|||
33346564|NCT01795547|101156687|FG001|Overall Study|Lack of Efficacy|3|||
33346565|NCT01795547|101156686|FG000|Overall Study|Protocol Violation|6|||
33346566|NCT01795547|101156687|FG001|Overall Study|Protocol Violation|4|||
33346567|NCT01795547|101156686|FG000|Overall Study|Lost to Follow-up|2|||
33346568|NCT01795547|101156687|FG001|Overall Study|Lost to Follow-up|5|||
33346569|NCT01795547|101156686|FG000|Overall Study|Withdrawal of consent|7|||
33543159|NCT01668797|101888938|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
33543160|NCT01668797|101888939|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
33407989|NCT02918968|101383005|FG000|2nd Line AAT|Death|0|||
33543161|NCT01668797|101888940|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
33543162|NCT01668797|101888937|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
33543163|NCT01668797|101888938|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
33543164|NCT01668797|101888939|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
33543165|NCT01668797|101888940|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
33543166|NCT01668797|101888937|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
33543167|NCT01668797|101888938|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
33543168|NCT01668797|101888939|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
33543169|NCT01668797|101888940|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
33543170|NCT01668797|101888937|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
33543171|NCT01668797|101888938|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
33543172|NCT01668797|101888939|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
33543173|NCT01668797|101888940|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
33543174|NCT01668797|101888937|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
33543175|NCT01668797|101888938|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
33616148|NCT02073682|102144289|FG001|Overall Study|Platelet Count <50,000/mL|2|||
33346570|NCT01795547|101156687|FG001|Overall Study|Withdrawal of consent|12|||
33346571|NCT01795547|101156686|FG000|Overall Study|Not Treated|4|||
33407990|NCT02918968|101383006|FG001|2nd Line AAT|Death|1|||
33543176|NCT01668797|101888939|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
33616149|NCT02073682|102144288|FG000|Overall Study|Surgery/Medical Procedure|3|||
33407991|NCT03799198|101383008|FG000|Overall Study|Lost to Follow-up|4|||
33543177|NCT01668797|101888940|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
33543178|NCT01668797|101888937|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
33543179|NCT01668797|101888938|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
33543180|NCT01668797|101888939|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
33543181|NCT01668797|101888940|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
33543182|NCT01668797|101888937|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
33543183|NCT01668797|101888938|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
33543184|NCT01668797|101888939|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
33543185|NCT01668797|101888940|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
33543186|NCT01668797|101888937|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
33543187|NCT01668797|101888938|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
33543188|NCT01668797|101888939|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
33543189|NCT01668797|101888940|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
33543190|NCT01668797|101888937|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
33543191|NCT01668797|101888938|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
33543192|NCT01668797|101888939|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
33616150|NCT02073682|102144289|FG001|Overall Study|Surgery/Medical Procedure|1|||
33616151|NCT02073682|102144288|FG000|Overall Study|Withdrawal by Subject|6|||
33616152|NCT02073682|102144289|FG001|Overall Study|Withdrawal by Subject|8|||
33616153|NCT02073682|102144288|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
33616154|NCT02073682|102144289|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
33616155|NCT02073682|102144288|FG000|Overall Study|Cancer Progression|53|||
33543193|NCT01668797|101888940|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
33543194|NCT01668797|101888937|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
33543195|NCT01668797|101888938|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
33543196|NCT01668797|101888939|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
33616156|NCT02073682|102144289|FG001|Overall Study|Cancer Progression|33|||
33616157|NCT02073682|102144288|FG000|Overall Study|Protocol Violation|1|||
33616158|NCT02073682|102144289|FG001|Overall Study|Protocol Violation|0|||
33616159|NCT02073682|102144288|FG000|Overall Study|Adverse Event|79|||
33346572|NCT01795547|101156687|FG001|Overall Study|Not Treated|10|||
33407992|NCT03799198|101383009|FG001|Overall Study|Lost to Follow-up|8|||
33407993|NCT03799198|101383008|FG000|Overall Study|Death|0|||
33407994|NCT03799198|101383009|FG001|Overall Study|Death|1|||
33407995|NCT02452320|101383010|FG000|Overall Study|Adverse Event|0|||
33543197|NCT01668797|101888940|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
33616160|NCT02073682|102144289|FG001|Overall Study|Adverse Event|62|||
33616161|NCT02073682|102144288|FG000|Overall Study|No reason provided|11|||
33616162|NCT02073682|102144289|FG001|Overall Study|No reason provided|9|||
33616163|NCT02073682|102144288|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
33346573|NCT01795547|101156686|FG000|Overall Study|Non-compliance with IMP|1|||
33346574|NCT01795547|101156687|FG001|Overall Study|Non-compliance with IMP|1|||
33346575|NCT01795547|101156686|FG000|Overall Study|Others|4|||
33346576|NCT01795547|101156687|FG001|Overall Study|Others|1|||
33346577|NCT01795547|101156686|FG000|Overall Study|Not stated|0|||
33346578|NCT01795547|101156687|FG001|Overall Study|Not stated|1|||
33346579|NCT02400255|101156691|FG000|Overall Study|Relapse|4|||
33346580|NCT02400255|101156692|FG001|Overall Study|Relapse|1|||
33346581|NCT02400255|101156693|FG002|Overall Study|Relapse|1|||
33346582|NCT02400255|101156694|FG003|Overall Study|Relapse|2|||
33346583|NCT02400255|101156691|FG000|Overall Study|Adverse Event|6|||
33346584|NCT02400255|101156692|FG001|Overall Study|Adverse Event|3|||
33346585|NCT02400255|101156693|FG002|Overall Study|Adverse Event|0|||
33346586|NCT02400255|101156694|FG003|Overall Study|Adverse Event|0|||
33346587|NCT02400255|101156691|FG000|Overall Study|Physician Decision|6|||
33346588|NCT02400255|101156692|FG001|Overall Study|Physician Decision|0|||
33346589|NCT02400255|101156693|FG002|Overall Study|Physician Decision|0|||
33346590|NCT02400255|101156694|FG003|Overall Study|Physician Decision|0|||
33346591|NCT02400255|101156691|FG000|Overall Study|Loss of insurance|1|||
33346592|NCT02400255|101156692|FG001|Overall Study|Loss of insurance|0|||
33346593|NCT02400255|101156693|FG002|Overall Study|Loss of insurance|0|||
33346594|NCT02400255|101156694|FG003|Overall Study|Loss of insurance|0|||
33346595|NCT04451330|101156695|FG000|Overall Study|Adverse Event|1|||
33346596|NCT04451330|101156696|FG001|Overall Study|Adverse Event|2|||
33346597|NCT04451330|101156695|FG000|Overall Study|Lost to Follow-up|5|||
33346598|NCT04451330|101156696|FG001|Overall Study|Lost to Follow-up|0|||
33346599|NCT04451330|101156695|FG000|Overall Study|Withdrawal by Subject|3|||
33346600|NCT04451330|101156696|FG001|Overall Study|Withdrawal by Subject|1|||
33346601|NCT04451330|101156695|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33346602|NCT04451330|101156696|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33346603|NCT04451330|101156695|FG000|Overall Study|Other than specified|0|||
33346604|NCT04451330|101156696|FG001|Overall Study|Other than specified|1|||
33346605|NCT00584233|101156699|FG000|Overall Study|Withdrawal by Subject|5|||
33346606|NCT00584233|101156699|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
33407996|NCT02452320|101383011|FG001|Overall Study|Adverse Event|1|||
33407997|NCT03737812|101383012|FG000|Overall Study|Withdrawal by Subject|1|||
33407998|NCT03737812|101383013|FG001|Overall Study|Withdrawal by Subject|2|||
33407999|NCT03737812|101383014|FG002|Overall Study|Withdrawal by Subject|1|||
33408000|NCT03737812|101383012|FG000|Overall Study|Sponsor Discontinued the Study|4|||
33408001|NCT03737812|101383013|FG001|Overall Study|Sponsor Discontinued the Study|3|||
33408002|NCT03737812|101383014|FG002|Overall Study|Sponsor Discontinued the Study|2|||
33408003|NCT03737812|101383012|FG000|Overall Study|Adverse Event|0|||
33408004|NCT03737812|101383013|FG001|Overall Study|Adverse Event|1|||
33408005|NCT03737812|101383014|FG002|Overall Study|Adverse Event|0|||
33408006|NCT03737812|101383012|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
33408007|NCT03737812|101383013|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
33543198|NCT01668797|101888937|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
33543199|NCT01668797|101888938|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
33543200|NCT01668797|101888939|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
33346607|NCT02118792|101156700|FG000|Overall Study|Withdrawal by Subject|6|||
33346608|NCT02118792|101156701|FG001|Overall Study|Withdrawal by Subject|3|||
33346609|NCT02118792|101156700|FG000|Overall Study|Lost to Follow-up|4|||
33346610|NCT02118792|101156701|FG001|Overall Study|Lost to Follow-up|4|||
33346611|NCT02118792|101156700|FG000|Overall Study|Adverse Event|5|||
33346612|NCT02118792|101156701|FG001|Overall Study|Adverse Event|4|||
33346613|NCT02118792|101156700|FG000|Overall Study|Withdrawal by parent/guardian|14|||
33346614|NCT02118792|101156701|FG001|Overall Study|Withdrawal by parent/guardian|20|||
33346615|NCT02118792|101156700|FG000|Overall Study|Other|1|||
33346616|NCT02118792|101156701|FG001|Overall Study|Other|6|||
33346617|NCT02118792|101156700|FG000|Overall Study|Randomised but not treated|1|||
33346618|NCT02118792|101156701|FG001|Overall Study|Randomised but not treated|0|||
33346619|NCT00756938|101156704|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
33346620|NCT00756938|101156705|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
33346621|NCT00756938|101156706|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
33346622|NCT00756938|101156707|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
33346623|NCT00756938|101156704|FG000|12-week Base Study|Protocol Violation|0|||
33346624|NCT00756938|101156705|FG001|12-week Base Study|Protocol Violation|0|||
33346625|NCT00756938|101156706|FG002|12-week Base Study|Protocol Violation|1|||
33346626|NCT00756938|101156707|FG003|12-week Base Study|Protocol Violation|0|||
33346627|NCT00756938|101156704|FG000|12-week Base Study|Lost to Follow-up|1|||
33346628|NCT00756938|101156705|FG001|12-week Base Study|Lost to Follow-up|0|||
33346629|NCT00756938|101156706|FG002|12-week Base Study|Lost to Follow-up|0|||
33346630|NCT00756938|101156707|FG003|12-week Base Study|Lost to Follow-up|0|||
33346631|NCT00756938|101156704|FG000|Optional Extension|Lack of Efficacy|0|||
33346632|NCT00756938|101156705|FG001|Optional Extension|Lack of Efficacy|0|||
33346633|NCT00756938|101156706|FG002|Optional Extension|Lack of Efficacy|0|||
33346634|NCT00756938|101156707|FG003|Optional Extension|Lack of Efficacy|1|||
33346635|NCT00756938|101156704|FG000|Optional Extension|End of Study|0|||
33346636|NCT00756938|101156705|FG001|Optional Extension|End of Study|0|||
33346637|NCT00756938|101156706|FG002|Optional Extension|End of Study|0|||
33346638|NCT00756938|101156707|FG003|Optional Extension|End of Study|11|||
33346639|NCT00756938|101156704|FG000|Optional Extension|Protocol-specific criteria met|0|||
33346640|NCT00756938|101156705|FG001|Optional Extension|Protocol-specific criteria met|0|||
33543201|NCT01668797|101888940|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
33543202|NCT01668797|101888937|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
33543203|NCT01668797|101888938|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
33543204|NCT01668797|101888939|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
33543205|NCT01668797|101888940|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
33543206|NCT01668797|101888937|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
33543207|NCT01668797|101888938|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
33543208|NCT01668797|101888939|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
33543209|NCT01668797|101888940|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
33543210|NCT01668797|101888937|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
33543211|NCT01668797|101888938|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
33346641|NCT00756938|101156706|FG002|Optional Extension|Protocol-specific criteria met|0|||
33346642|NCT00756938|101156707|FG003|Optional Extension|Protocol-specific criteria met|9|||
33346643|NCT00756938|101156704|FG000|Optional Extension|Physician Decision|0|||
33346644|NCT00756938|101156705|FG001|Optional Extension|Physician Decision|0|||
33346645|NCT00756938|101156706|FG002|Optional Extension|Physician Decision|0|||
33408008|NCT03737812|101383014|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
33408009|NCT05784129|101383015|FG000|Overall Study|Study terminated by sponsor|2|||
33346646|NCT00756938|101156707|FG003|Optional Extension|Physician Decision|3|||
33346647|NCT00756938|101156704|FG000|Optional Extension|Lost to Follow-up|0|||
33346648|NCT00756938|101156705|FG001|Optional Extension|Lost to Follow-up|0|||
33346649|NCT00756938|101156706|FG002|Optional Extension|Lost to Follow-up|0|||
33346650|NCT00756938|101156707|FG003|Optional Extension|Lost to Follow-up|1|||
33346651|NCT00756938|101156704|FG000|Optional Extension|Protocol Violation|0|||
33346652|NCT00756938|101156705|FG001|Optional Extension|Protocol Violation|0|||
33346653|NCT00756938|101156706|FG002|Optional Extension|Protocol Violation|0|||
33346654|NCT00756938|101156707|FG003|Optional Extension|Protocol Violation|1|||
33346655|NCT00756938|101156704|FG000|Optional Extension|Withdrawal by Subject|0|||
33346656|NCT00756938|101156705|FG001|Optional Extension|Withdrawal by Subject|0|||
33346657|NCT00756938|101156706|FG002|Optional Extension|Withdrawal by Subject|0|||
33346658|NCT00756938|101156707|FG003|Optional Extension|Withdrawal by Subject|10|||
33346659|NCT00756938|101156704|FG000|Optional Extension|Adverse Event|0|||
33346660|NCT00756938|101156705|FG001|Optional Extension|Adverse Event|0|||
33346661|NCT00756938|101156706|FG002|Optional Extension|Adverse Event|0|||
33346662|NCT00756938|101156707|FG003|Optional Extension|Adverse Event|1|||
33346663|NCT00848120|101156711|FG000|Overall Study|Adverse Event|1|||
33346664|NCT02324270|101156715|FG000|Overall Study|Withdrawal by Subject|0|||
33346665|NCT02324270|101156716|FG001|Overall Study|Withdrawal by Subject|1|||
33346666|NCT02324270|101156717|FG002|Overall Study|Withdrawal by Subject|0|||
33346667|NCT02324270|101156715|FG000|Overall Study|Lost to Follow-up|4|||
33346668|NCT02324270|101156716|FG001|Overall Study|Lost to Follow-up|3|||
33346669|NCT02324270|101156717|FG002|Overall Study|Lost to Follow-up|4|||
33346670|NCT02324270|101156715|FG000|Overall Study|Protocol Violation|0|||
33346671|NCT02324270|101156716|FG001|Overall Study|Protocol Violation|1|||
33346672|NCT02324270|101156717|FG002|Overall Study|Protocol Violation|1|||
33346673|NCT02324270|101156715|FG000|Overall Study|Non Compliance with Study Drug|1|||
33346674|NCT02324270|101156716|FG001|Overall Study|Non Compliance with Study Drug|2|||
33346675|NCT02324270|101156717|FG002|Overall Study|Non Compliance with Study Drug|0|||
33346676|NCT04436276|101156718|FG000|Overall Study|Adverse Event|0|||
33346677|NCT04436276|101156719|FG001|Overall Study|Adverse Event|0|||
33346678|NCT04436276|101156720|FG002|Overall Study|Adverse Event|0|||
33346679|NCT04436276|101156721|FG003|Overall Study|Adverse Event|0|||
33346680|NCT04436276|101156722|FG004|Overall Study|Adverse Event|0|||
33346681|NCT04436276|101156723|FG005|Overall Study|Adverse Event|0|||
33346682|NCT04436276|101156724|FG006|Overall Study|Adverse Event|0|||
33346683|NCT04436276|101156725|FG007|Overall Study|Adverse Event|0|||
33346684|NCT04436276|101156726|FG008|Overall Study|Adverse Event|0|||
33346685|NCT04436276|101156727|FG009|Overall Study|Adverse Event|0|||
33346686|NCT04436276|101156728|FG010|Overall Study|Adverse Event|0|||
33346687|NCT04436276|101156729|FG011|Overall Study|Adverse Event|0|||
33346688|NCT04436276|101156730|FG012|Overall Study|Adverse Event|0|||
33346689|NCT04436276|101156731|FG013|Overall Study|Adverse Event|0|||
33346690|NCT04436276|101156732|FG014|Overall Study|Adverse Event|0|||
33346691|NCT04436276|101156733|FG015|Overall Study|Adverse Event|0|||
33346692|NCT04436276|101156734|FG016|Overall Study|Adverse Event|1|||
33346693|NCT04436276|101156735|FG017|Overall Study|Adverse Event|0|||
33346694|NCT04436276|101156736|FG018|Overall Study|Adverse Event|0|||
33346695|NCT04436276|101156737|FG019|Overall Study|Adverse Event|0|||
33346696|NCT04436276|101156738|FG020|Overall Study|Adverse Event|0|||
33346697|NCT04436276|101156739|FG021|Overall Study|Adverse Event|0|||
33346698|NCT04436276|101156740|FG022|Overall Study|Adverse Event|0|||
33346699|NCT04436276|101156718|FG000|Overall Study|Death|0|||
33346700|NCT04436276|101156719|FG001|Overall Study|Death|0|||
33346701|NCT04436276|101156720|FG002|Overall Study|Death|0|||
33346702|NCT04436276|101156721|FG003|Overall Study|Death|0|||
33346703|NCT04436276|101156722|FG004|Overall Study|Death|0|||
33346704|NCT04436276|101156723|FG005|Overall Study|Death|0|||
33346705|NCT04436276|101156724|FG006|Overall Study|Death|0|||
33346706|NCT04436276|101156725|FG007|Overall Study|Death|0|||
33346707|NCT04436276|101156726|FG008|Overall Study|Death|0|||
33346708|NCT04436276|101156727|FG009|Overall Study|Death|0|||
33543212|NCT01668797|101888939|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
33543213|NCT01668797|101888940|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
33543214|NCT01668797|101888937|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
33346709|NCT04436276|101156728|FG010|Overall Study|Death|0|||
33543215|NCT01668797|101888938|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
33346710|NCT04436276|101156729|FG011|Overall Study|Death|0|||
33346711|NCT04436276|101156730|FG012|Overall Study|Death|1|||
33346712|NCT04436276|101156731|FG013|Overall Study|Death|0|||
33408010|NCT05784129|101383016|FG001|Overall Study|Study terminated by sponsor|2|||
33408011|NCT02335411|101383017|FG000|Overall Study|Death|223|||
33346713|NCT04436276|101156732|FG014|Overall Study|Death|1|||
33346714|NCT04436276|101156733|FG015|Overall Study|Death|0|||
33346715|NCT04436276|101156734|FG016|Overall Study|Death|0|||
33346716|NCT04436276|101156735|FG017|Overall Study|Death|0|||
33346717|NCT04436276|101156736|FG018|Overall Study|Death|0|||
33346718|NCT04436276|101156737|FG019|Overall Study|Death|2|||
33346719|NCT04436276|101156738|FG020|Overall Study|Death|0|||
33346720|NCT04436276|101156739|FG021|Overall Study|Death|1|||
33346721|NCT04436276|101156740|FG022|Overall Study|Death|0|||
33346722|NCT04436276|101156718|FG000|Overall Study|Lost to Follow-up|0|||
33346723|NCT04436276|101156719|FG001|Overall Study|Lost to Follow-up|2|||
33346724|NCT04436276|101156720|FG002|Overall Study|Lost to Follow-up|2|||
33346725|NCT04436276|101156721|FG003|Overall Study|Lost to Follow-up|1|||
33346726|NCT04436276|101156722|FG004|Overall Study|Lost to Follow-up|4|||
33346727|NCT04436276|101156723|FG005|Overall Study|Lost to Follow-up|1|||
33616164|NCT02073682|102144289|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
33616165|NCT02073682|102144288|FG000|Overall Study|Lost to Follow-up|1|||
33616166|NCT02073682|102144289|FG001|Overall Study|Lost to Follow-up|1|||
33616167|NCT02073682|102144288|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
33616168|NCT02073682|102144289|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
33616169|NCT00894361|102144292|FG000|Overall Study|deaths and less than 2 years followup|24|||
33616170|NCT00894361|102144293|FG001|Overall Study|deaths and less than 2 years followup|64|||
33616171|NCT00302211|102144294|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
33616172|NCT00302211|102144295|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
33616173|NCT00302211|102144296|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
33616174|NCT00302211|102144297|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
33616175|NCT00302211|102144298|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
33346728|NCT04436276|101156724|FG006|Overall Study|Lost to Follow-up|0|||
33346729|NCT04436276|101156725|FG007|Overall Study|Lost to Follow-up|0|||
33346730|NCT04436276|101156726|FG008|Overall Study|Lost to Follow-up|1|||
33408012|NCT02335411|101383018|FG001|Overall Study|Death|22|||
33408013|NCT02335411|101383019|FG002|Overall Study|Death|26|||
33408014|NCT02335411|101383017|FG000|Overall Study|Physician Decision|3|||
33408015|NCT02335411|101383018|FG001|Overall Study|Physician Decision|0|||
33408016|NCT02335411|101383019|FG002|Overall Study|Physician Decision|0|||
33408017|NCT02335411|101383017|FG000|Overall Study|Protocol Violation|1|||
33408018|NCT02335411|101383018|FG001|Overall Study|Protocol Violation|0|||
33408019|NCT02335411|101383019|FG002|Overall Study|Protocol Violation|0|||
33408020|NCT02335411|101383017|FG000|Overall Study|Withdrawal by Subject|11|||
33408021|NCT02335411|101383018|FG001|Overall Study|Withdrawal by Subject|0|||
33408022|NCT02335411|101383019|FG002|Overall Study|Withdrawal by Subject|3|||
33408023|NCT02335411|101383017|FG000|Overall Study|Sponsor Decision|12|||
33408024|NCT02335411|101383018|FG001|Overall Study|Sponsor Decision|3|||
33408025|NCT02335411|101383019|FG002|Overall Study|Sponsor Decision|2|||
33408026|NCT02335411|101383017|FG000|Overall Study|Adverse Event|9|||
33408027|NCT02335411|101383018|FG001|Overall Study|Adverse Event|0|||
33408028|NCT02335411|101383019|FG002|Overall Study|Adverse Event|0|||
33408029|NCT00499694|101383020|FG000|Overall Study|Patient never received treatment.|1|||
33408030|NCT01151085|101383021|FG000|Overall Study|Lost to Follow-up|31|||
33408031|NCT01151085|101383021|FG000|Overall Study|Protocol Violation|25|||
33408032|NCT05643573|101383022|FG000|Overall Study|Adverse Event|117|||
33408033|NCT05643573|101383023|FG001|Overall Study|Adverse Event|90|||
33408034|NCT05643573|101383022|FG000|Overall Study|Death|53|||
33346731|NCT04436276|101156727|FG009|Overall Study|Lost to Follow-up|0|||
33346732|NCT04436276|101156728|FG010|Overall Study|Lost to Follow-up|5|||
33408035|NCT05643573|101383023|FG001|Overall Study|Death|57|||
33408036|NCT05643573|101383022|FG000|Overall Study|Lost to Follow-up|6|||
33408037|NCT05643573|101383023|FG001|Overall Study|Lost to Follow-up|3|||
33408038|NCT05643573|101383022|FG000|Overall Study|Other|18|||
33408039|NCT05643573|101383023|FG001|Overall Study|Other|15|||
33408040|NCT05643573|101383022|FG000|Overall Study|Outcome event|64|||
33408041|NCT05643573|101383023|FG001|Overall Study|Outcome event|36|||
33408042|NCT05643573|101383022|FG000|Overall Study|Physician Decision|33|||
33408043|NCT05643573|101383023|FG001|Overall Study|Physician Decision|19|||
33408044|NCT05643573|101383022|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
33408045|NCT05643573|101383023|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
33408046|NCT05643573|101383022|FG000|Overall Study|Site terminated by sponsor|10|||
33408047|NCT05643573|101383023|FG001|Overall Study|Site terminated by sponsor|10|||
33408048|NCT05643573|101383022|FG000|Overall Study|Study terminated by sponsor|1|||
33408049|NCT05643573|101383023|FG001|Overall Study|Study terminated by sponsor|0|||
33408050|NCT05643573|101383022|FG000|Overall Study|Withdrawal by Subject|178|||
33408051|NCT05643573|101383023|FG001|Overall Study|Withdrawal by Subject|130|||
33408052|NCT00508872|101383024|FG000|Overall Study|Lost to Follow-up|1|||
33408053|NCT00508872|101383024|FG000|Overall Study|Physician Decision|1|||
33616176|NCT00302211|102144294|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
33408054|NCT04535544|101383035|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
33408055|NCT04535544|101383036|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
33408056|NCT04535544|101383037|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
33408057|NCT04535544|101383038|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
33408058|NCT04535544|101383035|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
33616177|NCT00302211|102144295|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
33616178|NCT00302211|102144296|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
33616179|NCT00302211|102144297|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
33346733|NCT04436276|101156729|FG011|Overall Study|Lost to Follow-up|5|||
33346734|NCT04436276|101156730|FG012|Overall Study|Lost to Follow-up|4|||
33346735|NCT04436276|101156731|FG013|Overall Study|Lost to Follow-up|1|||
33408059|NCT04535544|101383036|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
33408060|NCT04535544|101383037|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
33346736|NCT04436276|101156732|FG014|Overall Study|Lost to Follow-up|7|||
33408061|NCT04535544|101383038|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
33408062|NCT04535544|101383035|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
33408063|NCT04535544|101383036|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
33408064|NCT04535544|101383037|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
33408065|NCT04535544|101383038|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
33408066|NCT04535544|101383035|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
33346737|NCT04436276|101156733|FG015|Overall Study|Lost to Follow-up|7|||
33346738|NCT04436276|101156734|FG016|Overall Study|Lost to Follow-up|1|||
33346739|NCT04436276|101156735|FG017|Overall Study|Lost to Follow-up|0|||
33346740|NCT04436276|101156736|FG018|Overall Study|Lost to Follow-up|1|||
33346741|NCT04436276|101156737|FG019|Overall Study|Lost to Follow-up|1|||
33346742|NCT04436276|101156738|FG020|Overall Study|Lost to Follow-up|2|||
33346743|NCT04436276|101156739|FG021|Overall Study|Lost to Follow-up|1|||
33346744|NCT04436276|101156740|FG022|Overall Study|Lost to Follow-up|1|||
33346745|NCT04436276|101156718|FG000|Overall Study|Physician Decision|1|||
33346746|NCT04436276|101156719|FG001|Overall Study|Physician Decision|0|||
33346747|NCT04436276|101156720|FG002|Overall Study|Physician Decision|2|||
33346748|NCT04436276|101156721|FG003|Overall Study|Physician Decision|1|||
33346749|NCT04436276|101156722|FG004|Overall Study|Physician Decision|0|||
33346750|NCT04436276|101156723|FG005|Overall Study|Physician Decision|0|||
33346751|NCT04436276|101156724|FG006|Overall Study|Physician Decision|0|||
33346752|NCT04436276|101156725|FG007|Overall Study|Physician Decision|0|||
33346753|NCT04436276|101156726|FG008|Overall Study|Physician Decision|0|||
33346754|NCT04436276|101156727|FG009|Overall Study|Physician Decision|0|||
33346755|NCT04436276|101156728|FG010|Overall Study|Physician Decision|0|||
33346756|NCT04436276|101156729|FG011|Overall Study|Physician Decision|1|||
33346757|NCT04436276|101156730|FG012|Overall Study|Physician Decision|2|||
33346758|NCT04436276|101156731|FG013|Overall Study|Physician Decision|0|||
33346759|NCT04436276|101156732|FG014|Overall Study|Physician Decision|0|||
33346760|NCT04436276|101156733|FG015|Overall Study|Physician Decision|0|||
33346761|NCT04436276|101156734|FG016|Overall Study|Physician Decision|0|||
33346762|NCT04436276|101156735|FG017|Overall Study|Physician Decision|0|||
33346763|NCT04436276|101156736|FG018|Overall Study|Physician Decision|0|||
33346764|NCT04436276|101156737|FG019|Overall Study|Physician Decision|0|||
33346765|NCT04436276|101156738|FG020|Overall Study|Physician Decision|1|||
33346766|NCT04436276|101156739|FG021|Overall Study|Physician Decision|2|||
33346767|NCT04436276|101156740|FG022|Overall Study|Physician Decision|0|||
33408067|NCT04535544|101383036|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
33408068|NCT04535544|101383037|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
33408069|NCT04535544|101383038|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
33408070|NCT04535544|101383035|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
33408071|NCT04535544|101383036|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
33408072|NCT04535544|101383037|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
33408073|NCT04535544|101383038|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
33408074|NCT04535544|101383035|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
33408075|NCT04535544|101383036|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
33408076|NCT04535544|101383037|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
33408077|NCT04535544|101383038|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
33408078|NCT04535544|101383035|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
33408079|NCT04535544|101383036|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
33408080|NCT04535544|101383037|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
33408081|NCT04535544|101383038|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
33408082|NCT04535544|101383035|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
33408083|NCT04535544|101383036|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
33408084|NCT04535544|101383037|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
33408085|NCT04535544|101383038|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
33543216|NCT01668797|101888939|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
33543217|NCT01668797|101888940|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
33543218|NCT01668797|101888937|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
33543219|NCT01668797|101888938|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
33543220|NCT01668797|101888939|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
33543221|NCT01668797|101888940|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
33408086|NCT03159455|101383043|FG000|Overall Study|Adverse Event|0|||
33543222|NCT01668797|101888937|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
33408087|NCT03159455|101383044|FG001|Overall Study|Adverse Event|0|||
33346768|NCT04436276|101156718|FG000|Overall Study|Protocol Violation|0|||
33346769|NCT04436276|101156719|FG001|Overall Study|Protocol Violation|0|||
33346770|NCT04436276|101156720|FG002|Overall Study|Protocol Violation|0|||
33346771|NCT04436276|101156721|FG003|Overall Study|Protocol Violation|0|||
33346772|NCT04436276|101156722|FG004|Overall Study|Protocol Violation|0|||
33346773|NCT04436276|101156723|FG005|Overall Study|Protocol Violation|0|||
33346774|NCT04436276|101156724|FG006|Overall Study|Protocol Violation|0|||
33346775|NCT04436276|101156725|FG007|Overall Study|Protocol Violation|0|||
33346776|NCT04436276|101156726|FG008|Overall Study|Protocol Violation|0|||
33408088|NCT03159455|101383045|FG002|Overall Study|Adverse Event|0|||
33408089|NCT03159455|101383046|FG003|Overall Study|Adverse Event|0|||
33408090|NCT03159455|101383047|FG004|Overall Study|Adverse Event|0|||
33408091|NCT03159455|101383048|FG005|Overall Study|Adverse Event|1|||
33408092|NCT01393444|101383049|FG000|Overall Study|Withdrawal by Subject|1|||
33408093|NCT01393444|101383049|FG000|Overall Study|Determined ineligible during screening.|2|||
33408094|NCT02058849|101383050|FG000|Overall Study|Hospitalization|1|||
33408095|NCT02058849|101383051|FG001|Overall Study|Hospitalization|1|||
33408096|NCT02058849|101383050|FG000|Overall Study|Death|1|||
33408097|NCT02058849|101383051|FG001|Overall Study|Death|0|||
33408098|NCT02058849|101383050|FG000|Overall Study|Lost to Follow-up|1|||
33408099|NCT02058849|101383051|FG001|Overall Study|Lost to Follow-up|0|||
33408100|NCT02058849|101383050|FG000|Overall Study|Withdrawal by Subject|4|||
33408101|NCT02058849|101383051|FG001|Overall Study|Withdrawal by Subject|0|||
33408102|NCT01977651|101383052|FG000|4 Month Treatment Period|Adverse Event|34|||
33408103|NCT01977651|101383052|FG000|4 Month Treatment Period|Death|3|||
33408104|NCT01977651|101383052|FG000|4 Month Treatment Period|Progressive Disease|43|||
33408105|NCT01977651|101383052|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
33408106|NCT01977651|101383052|FG000|4 Month Treatment Period|Physician Decision|4|||
33408107|NCT01977651|101383052|FG000|1 Year Extension Period|Adverse Event|14|||
33408108|NCT01977651|101383052|FG000|1 Year Extension Period|Death|10|||
33408109|NCT01977651|101383052|FG000|1 Year Extension Period|Lost to Follow-up|2|||
33408110|NCT01977651|101383052|FG000|1 Year Extension Period|Progressive Disease|86|||
33408111|NCT01977651|101383052|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
33408112|NCT01977651|101383052|FG000|1 Year Extension Period|Physician Decision|6|||
33408113|NCT01977651|101383052|FG000|1 Year Extension Period|Miscellaneous|1|||
33408114|NCT01977651|101383052|FG000|Post 1 Year Extension Period|Adverse Event|5|||
33408115|NCT01977651|101383052|FG000|Post 1 Year Extension Period|Death|13|||
33408116|NCT01977651|101383052|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
33408117|NCT01977651|101383052|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
33408118|NCT01977651|101383052|FG000|Post 1 Year Extension Period|Physician Decision|4|||
33408119|NCT01977651|101383052|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
33408120|NCT00596466|101383053|FG000|Overall Study|Lack of Efficacy|5|||
33408121|NCT00596466|101383053|FG000|Overall Study|Adverse Event|4|||
33408122|NCT00596466|101383053|FG000|Overall Study|Withdrawal by Subject|2|||
33408123|NCT00596466|101383053|FG000|Overall Study|Protocol Violation|2|||
33408124|NCT00596466|101383053|FG000|Overall Study|Unpecified|2|||
33408125|NCT00596466|101383053|FG000|Overall Study|Enrolled, not treated|2|||
33408126|NCT02708524|101383054|FG000|Overall Study|Adverse Event|0|||
33408127|NCT02708524|101383055|FG001|Overall Study|Adverse Event|1|||
33408128|NCT02708524|101383056|FG002|Overall Study|Adverse Event|0|||
33408129|NCT02708524|101383057|FG003|Overall Study|Adverse Event|0|||
33408130|NCT02708524|101383054|FG000|Overall Study|Lens Discomfort|1|||
33408131|NCT02708524|101383055|FG001|Overall Study|Lens Discomfort|0|||
33408132|NCT02708524|101383056|FG002|Overall Study|Lens Discomfort|1|||
33408133|NCT02708524|101383057|FG003|Overall Study|Lens Discomfort|0|||
33408134|NCT02708524|101383054|FG000|Overall Study|Lost to Follow-up|1|||
33408135|NCT02708524|101383055|FG001|Overall Study|Lost to Follow-up|1|||
33408136|NCT02708524|101383056|FG002|Overall Study|Lost to Follow-up|1|||
33408137|NCT02708524|101383057|FG003|Overall Study|Lost to Follow-up|0|||
33408138|NCT02708524|101383054|FG000|Overall Study|Protocol Violation|0|||
33408139|NCT02708524|101383055|FG001|Overall Study|Protocol Violation|1|||
33408140|NCT02708524|101383056|FG002|Overall Study|Protocol Violation|0|||
33408141|NCT02708524|101383057|FG003|Overall Study|Protocol Violation|0|||
33408142|NCT02708524|101383054|FG000|Overall Study|Withdrawal by Subject|1|||
33408143|NCT02708524|101383055|FG001|Overall Study|Withdrawal by Subject|1|||
33408144|NCT02708524|101383056|FG002|Overall Study|Withdrawal by Subject|0|||
33408145|NCT02708524|101383057|FG003|Overall Study|Withdrawal by Subject|0|||
33408146|NCT02708524|101383054|FG000|Overall Study|Dispensed incorrect study lens|0|||
33408147|NCT02708524|101383055|FG001|Overall Study|Dispensed incorrect study lens|1|||
33408148|NCT02708524|101383056|FG002|Overall Study|Dispensed incorrect study lens|1|||
33408149|NCT02708524|101383057|FG003|Overall Study|Dispensed incorrect study lens|0|||
33408150|NCT02708524|101383054|FG000|Overall Study|Did not wear lens at final visit|0|||
33408151|NCT02708524|101383055|FG001|Overall Study|Did not wear lens at final visit|1|||
33408152|NCT02708524|101383056|FG002|Overall Study|Did not wear lens at final visit|0|||
33408153|NCT02708524|101383057|FG003|Overall Study|Did not wear lens at final visit|0|||
33408154|NCT02708524|101383054|FG000|Overall Study|Subject lost study lens|1|||
33543223|NCT01668797|101888938|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
33346777|NCT04436276|101156727|FG009|Overall Study|Protocol Violation|0|||
33346778|NCT04436276|101156728|FG010|Overall Study|Protocol Violation|0|||
33346779|NCT04436276|101156729|FG011|Overall Study|Protocol Violation|0|||
33346780|NCT04436276|101156730|FG012|Overall Study|Protocol Violation|0|||
33346781|NCT04436276|101156731|FG013|Overall Study|Protocol Violation|1|||
33346782|NCT04436276|101156732|FG014|Overall Study|Protocol Violation|0|||
33346783|NCT04436276|101156733|FG015|Overall Study|Protocol Violation|1|||
33346784|NCT04436276|101156734|FG016|Overall Study|Protocol Violation|0|||
33346785|NCT04436276|101156735|FG017|Overall Study|Protocol Violation|0|||
33346786|NCT04436276|101156736|FG018|Overall Study|Protocol Violation|0|||
33346787|NCT04436276|101156737|FG019|Overall Study|Protocol Violation|0|||
33346788|NCT04436276|101156738|FG020|Overall Study|Protocol Violation|0|||
33346789|NCT04436276|101156739|FG021|Overall Study|Protocol Violation|0|||
33346790|NCT04436276|101156740|FG022|Overall Study|Protocol Violation|0|||
33346791|NCT04436276|101156718|FG000|Overall Study|Withdrawal by Subject|25|||
33346792|NCT04436276|101156719|FG001|Overall Study|Withdrawal by Subject|22|||
33408155|NCT02708524|101383055|FG001|Overall Study|Subject lost study lens|0|||
33408156|NCT02708524|101383056|FG002|Overall Study|Subject lost study lens|0|||
33543224|NCT01668797|101888939|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
33543225|NCT01668797|101888940|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
33543226|NCT01668797|101888937|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
33543227|NCT01668797|101888938|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
33543228|NCT01668797|101888939|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
33543229|NCT01668797|101888940|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
33543230|NCT01668797|101888937|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
33543231|NCT01668797|101888938|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
33543232|NCT01668797|101888939|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
33543233|NCT01668797|101888940|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
33543234|NCT01668797|101888937|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
33543235|NCT01668797|101888938|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
33543236|NCT01668797|101888939|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
33543237|NCT01668797|101888940|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
33543238|NCT01458587|101888941|FG000|Overall Study|Withdrawal by Subject|1|||
33543239|NCT01458587|101888942|FG001|Overall Study|Withdrawal by Subject|0|||
33543240|NCT00737048|101888943|FG000|Overall Study|Physician Decision|0|||
33543241|NCT00737048|101888944|FG001|Overall Study|Physician Decision|0|||
33543242|NCT00737048|101888945|FG002|Overall Study|Physician Decision|1|||
33543243|NCT00737048|101888943|FG000|Overall Study|Adverse Event|0|||
33543244|NCT00737048|101888944|FG001|Overall Study|Adverse Event|1|||
33543245|NCT00737048|101888945|FG002|Overall Study|Adverse Event|0|||
33543246|NCT00737048|101888943|FG000|Overall Study|Worsening of the symptoms|3|||
33543247|NCT00737048|101888944|FG001|Overall Study|Worsening of the symptoms|5|||
33543248|NCT00737048|101888945|FG002|Overall Study|Worsening of the symptoms|3|||
33543249|NCT01122173|101888946|FG000|Overall Study|Lost to Follow-up|3|||
33543250|NCT01122173|101888946|FG000|Overall Study|Withdrawal by Subject|3|||
33543251|NCT01122173|101888946|FG000|Overall Study|Left study for other reasons|3|||
33543252|NCT00207740|101888947|FG000|Overall Study|Adverse Event|4|||
33543253|NCT00207740|101888948|FG001|Overall Study|Adverse Event|14|||
33543254|NCT00207740|101888949|FG002|Overall Study|Adverse Event|14|||
33543255|NCT00207740|101888950|FG003|Overall Study|Adverse Event|11|||
33346793|NCT04436276|101156720|FG002|Overall Study|Withdrawal by Subject|24|||
33408157|NCT02708524|101383057|FG003|Overall Study|Subject lost study lens|0|||
33408158|NCT01590628|101383063|FG000|Overall Study|Death|2|||
33408159|NCT01590628|101383064|FG001|Overall Study|Death|0|||
33543256|NCT00207740|101888947|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33543257|NCT00207740|101888948|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33408160|NCT03772574|101383065|FG000|Overall Study|Protocol Violation|2|||
33543258|NCT00207740|101888949|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
33616180|NCT00302211|102144298|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
33346794|NCT04436276|101156721|FG003|Overall Study|Withdrawal by Subject|23|||
33346795|NCT04436276|101156722|FG004|Overall Study|Withdrawal by Subject|14|||
33346796|NCT04436276|101156723|FG005|Overall Study|Withdrawal by Subject|0|||
33408161|NCT03772574|101383066|FG001|Overall Study|Protocol Violation|0|||
33543259|NCT00207740|101888950|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
33543260|NCT00207740|101888947|FG000|Overall Study|Lost to Follow-up|0|||
33543261|NCT00207740|101888948|FG001|Overall Study|Lost to Follow-up|2|||
33346797|NCT04436276|101156724|FG006|Overall Study|Withdrawal by Subject|0|||
33346798|NCT04436276|101156725|FG007|Overall Study|Withdrawal by Subject|1|||
33346799|NCT04436276|101156726|FG008|Overall Study|Withdrawal by Subject|0|||
33346800|NCT04436276|101156727|FG009|Overall Study|Withdrawal by Subject|1|||
33346801|NCT04436276|101156728|FG010|Overall Study|Withdrawal by Subject|17|||
33346802|NCT04436276|101156729|FG011|Overall Study|Withdrawal by Subject|7|||
33346803|NCT04436276|101156730|FG012|Overall Study|Withdrawal by Subject|10|||
33346804|NCT04436276|101156731|FG013|Overall Study|Withdrawal by Subject|6|||
33346805|NCT04436276|101156732|FG014|Overall Study|Withdrawal by Subject|20|||
33346806|NCT04436276|101156733|FG015|Overall Study|Withdrawal by Subject|6|||
33346807|NCT04436276|101156734|FG016|Overall Study|Withdrawal by Subject|11|||
33346808|NCT04436276|101156735|FG017|Overall Study|Withdrawal by Subject|4|||
33346809|NCT04436276|101156736|FG018|Overall Study|Withdrawal by Subject|14|||
33346810|NCT04436276|101156737|FG019|Overall Study|Withdrawal by Subject|24|||
33346811|NCT04436276|101156738|FG020|Overall Study|Withdrawal by Subject|24|||
33408162|NCT03772574|101383067|FG002|Overall Study|Protocol Violation|0|||
33408163|NCT03772574|101383065|FG000|Overall Study|Discomfort|0|||
33408164|NCT03772574|101383066|FG001|Overall Study|Discomfort|5|||
33408165|NCT03772574|101383067|FG002|Overall Study|Discomfort|4|||
33408166|NCT03007472|101383068|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
33408167|NCT03007472|101383068|FG000|Overall Study|Death|2|||
33408168|NCT03007472|101383068|FG000|Overall Study|Loss to Follow Up|1|||
33408169|NCT01479777|101383069|FG000|Overall Study|Physician Decision|2|||
33408170|NCT03457701|101383070|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
33408171|NCT03457701|101383071|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
33408172|NCT03457701|101383070|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
33408173|NCT03457701|101383071|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
33408174|NCT00848965|101383072|FG000|Overall Study|Adverse Event|1|||
33408175|NCT00848965|101383072|FG000|Overall Study|Withdrawal by Subject|1|||
33408176|NCT02370173|101383073|FG000|Overall Study|Protocol Violation|1|||
33408177|NCT02370173|101383074|FG001|Overall Study|Protocol Violation|1|||
33408178|NCT02370173|101383073|FG000|Overall Study|Withdrawal by Subject|2|||
33408179|NCT02370173|101383074|FG001|Overall Study|Withdrawal by Subject|2|||
33408180|NCT00421928|101383078|FG000|Overall Study|Adverse Event|61|||
33408181|NCT00421928|101383079|FG001|Overall Study|Adverse Event|140|||
33408182|NCT00421928|101383080|FG002|Overall Study|Adverse Event|22|||
33408183|NCT00421928|101383078|FG000|Overall Study|Lost to Follow-up|5|||
33408184|NCT00421928|101383079|FG001|Overall Study|Lost to Follow-up|0|||
33408185|NCT00421928|101383080|FG002|Overall Study|Lost to Follow-up|3|||
33408186|NCT00421928|101383078|FG000|Overall Study|Withdrawal by Subject|50|||
33543262|NCT00207740|101888949|FG002|Overall Study|Lost to Follow-up|1|||
33543263|NCT00207740|101888950|FG003|Overall Study|Lost to Follow-up|1|||
33543264|NCT00207740|101888947|FG000|Overall Study|Death|0|||
33543265|NCT00207740|101888948|FG001|Overall Study|Death|0|||
33543266|NCT00207740|101888949|FG002|Overall Study|Death|0|||
33543267|NCT00207740|101888950|FG003|Overall Study|Death|1|||
33543268|NCT00207740|101888947|FG000|Overall Study|Sponsor Directive|22|||
33543269|NCT00207740|101888948|FG001|Overall Study|Sponsor Directive|15|||
33543270|NCT00207740|101888949|FG002|Overall Study|Sponsor Directive|16|||
33543271|NCT00207740|101888950|FG003|Overall Study|Sponsor Directive|21|||
33543272|NCT00207740|101888947|FG000|Overall Study|Other|2|||
33543273|NCT00207740|101888948|FG001|Overall Study|Other|10|||
33543274|NCT00207740|101888949|FG002|Overall Study|Other|7|||
33543275|NCT00207740|101888950|FG003|Overall Study|Other|5|||
33543276|NCT04748718|101888956|FG000|Overall Study|Lost to Follow-up|50|||
33543277|NCT00720759|101888962|FG000|Overall Study|Lost to Follow-up|0|||
33543278|NCT00720759|101888963|FG001|Overall Study|Lost to Follow-up|1|||
33346812|NCT04436276|101156739|FG021|Overall Study|Withdrawal by Subject|16|||
33408187|NCT00421928|101383079|FG001|Overall Study|Withdrawal by Subject|48|||
33408188|NCT00421928|101383080|FG002|Overall Study|Withdrawal by Subject|43|||
33408189|NCT00421928|101383078|FG000|Overall Study|Lack of Efficacy|15|||
33543279|NCT00720759|101888964|FG002|Overall Study|Lost to Follow-up|1|||
33543280|NCT00720759|101888965|FG003|Overall Study|Lost to Follow-up|0|||
33543281|NCT03530293|101888966|FG000|Pre-randomization|Adverse Event|12|||
33543282|NCT03530293|101888967|FG001|Pre-randomization|Adverse Event|0|||
33543283|NCT03530293|101888968|FG002|Pre-randomization|Adverse Event|0|||
33346813|NCT04436276|101156740|FG022|Overall Study|Withdrawal by Subject|14|||
33346814|NCT04436276|101156718|FG000|Overall Study|Other|3|||
33346815|NCT04436276|101156719|FG001|Overall Study|Other|2|||
33346816|NCT04436276|101156720|FG002|Overall Study|Other|5|||
33346817|NCT04436276|101156721|FG003|Overall Study|Other|9|||
33543284|NCT03530293|101888966|FG000|Pre-randomization|Protocol Violation|2|||
33408190|NCT00421928|101383079|FG001|Overall Study|Lack of Efficacy|7|||
33543285|NCT03530293|101888967|FG001|Pre-randomization|Protocol Violation|0|||
33543286|NCT03530293|101888968|FG002|Pre-randomization|Protocol Violation|0|||
33543287|NCT03530293|101888966|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
33543288|NCT03530293|101888967|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
33346818|NCT04436276|101156722|FG004|Overall Study|Other|23|||
33346819|NCT04436276|101156723|FG005|Overall Study|Other|1|||
33543289|NCT03530293|101888968|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
33543290|NCT03530293|101888966|FG000|Pre-randomization|Withdrawal by Subject|5|||
33543291|NCT03530293|101888967|FG001|Pre-randomization|Withdrawal by Subject|0|||
33543292|NCT03530293|101888968|FG002|Pre-randomization|Withdrawal by Subject|0|||
33543293|NCT03530293|101888966|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
33543294|NCT03530293|101888967|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
33543295|NCT03530293|101888968|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
33543296|NCT03530293|101888966|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
33543297|NCT03530293|101888967|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
33543298|NCT03530293|101888968|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
33543299|NCT03530293|101888966|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
33543300|NCT03530293|101888967|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
33543301|NCT03530293|101888968|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
33543302|NCT03530293|101888966|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
33543303|NCT03530293|101888967|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
33543304|NCT03530293|101888968|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
33346820|NCT04436276|101156724|FG006|Overall Study|Other|0|||
33346821|NCT04436276|101156725|FG007|Overall Study|Other|0|||
33346822|NCT04436276|101156726|FG008|Overall Study|Other|0|||
33346823|NCT04436276|101156727|FG009|Overall Study|Other|0|||
33543305|NCT03530293|101888966|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
33543306|NCT03530293|101888967|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
33543307|NCT03530293|101888968|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
33543308|NCT03095287|101888981|FG000|Overall Study|Treatment Failure|1|||
33543309|NCT03095287|101888981|FG000|Overall Study|Adverse Event|1|||
33543310|NCT01655901|101888982|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
33543311|NCT01655901|101888983|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
33543312|NCT01655901|101888984|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
33543313|NCT01655901|101888985|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
33543314|NCT01655901|101888986|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
33543315|NCT01655901|101888987|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
33543316|NCT04711005|101888992|FG000|Overall Study|Withdrawal by Subject|0|||
33543317|NCT04711005|101888993|FG001|Overall Study|Withdrawal by Subject|0|||
33543318|NCT04711005|101888994|FG002|Overall Study|Withdrawal by Subject|0|||
33543319|NCT04711005|101888995|FG003|Overall Study|Withdrawal by Subject|0|||
33543320|NCT04711005|101888996|FG004|Overall Study|Withdrawal by Subject|0|||
33543321|NCT04711005|101888997|FG005|Overall Study|Withdrawal by Subject|0|||
33543322|NCT04711005|101888998|FG006|Overall Study|Withdrawal by Subject|0|||
33543323|NCT04711005|101888999|FG007|Overall Study|Withdrawal by Subject|1|||
33543324|NCT04711005|101889000|FG008|Overall Study|Withdrawal by Subject|0|||
33543325|NCT04711005|101889001|FG009|Overall Study|Withdrawal by Subject|0|||
33543326|NCT04711005|101888992|FG000|Overall Study|Physician Decision|0|||
33543327|NCT04711005|101888993|FG001|Overall Study|Physician Decision|0|||
33543328|NCT04711005|101888994|FG002|Overall Study|Physician Decision|0|||
33543329|NCT04711005|101888995|FG003|Overall Study|Physician Decision|0|||
33543330|NCT04711005|101888996|FG004|Overall Study|Physician Decision|0|||
33543331|NCT04711005|101888997|FG005|Overall Study|Physician Decision|0|||
33543332|NCT04711005|101888998|FG006|Overall Study|Physician Decision|0|||
33543333|NCT04711005|101888999|FG007|Overall Study|Physician Decision|2|||
33543334|NCT04711005|101889000|FG008|Overall Study|Physician Decision|1|||
33543335|NCT04711005|101889001|FG009|Overall Study|Physician Decision|0|||
33543336|NCT03482024|101889009|FG000|Overall Study|Physician Decision|1|||
33543337|NCT03482024|101889010|FG001|Overall Study|Physician Decision|0|||
33212844|NCT03204279|100676719|FG000|Overall Study|Withdrawal by Subject|0|||
33346824|NCT04436276|101156728|FG010|Overall Study|Other|3|||
33543338|NCT03482024|101889011|FG002|Overall Study|Physician Decision|0|||
33543339|NCT03482024|101889012|FG003|Overall Study|Physician Decision|0|||
33543340|NCT03482024|101889013|FG004|Overall Study|Physician Decision|0|||
33543341|NCT00656617|101889017|FG000|Overall Study|Adverse Event|1|||
33543342|NCT00656617|101889017|FG000|Overall Study|Death|2|||
33543343|NCT00656617|101889017|FG000|Overall Study|Insurance Issues|2|||
33543344|NCT00656617|101889017|FG000|Overall Study|Move to different clinical trial|2|||
33543345|NCT00658528|101889018|FG000|Overall Study|Adverse Event|5|||
33543346|NCT00658528|101889019|FG001|Overall Study|Adverse Event|7|||
33346825|NCT04436276|101156729|FG011|Overall Study|Other|1|||
33212845|NCT03204279|100676720|FG001|Overall Study|Withdrawal by Subject|1|||
33346826|NCT04436276|101156730|FG012|Overall Study|Other|1|||
33543347|NCT00658528|101889018|FG000|Overall Study|Lost to Follow-up|14|||
33543348|NCT00658528|101889019|FG001|Overall Study|Lost to Follow-up|22|||
33543349|NCT00658528|101889018|FG000|Overall Study|Withdrawal by Subject|8|||
33543350|NCT00658528|101889019|FG001|Overall Study|Withdrawal by Subject|6|||
33543351|NCT00658528|101889018|FG000|Overall Study|Withdrawal of consent|5|||
33543352|NCT00658528|101889019|FG001|Overall Study|Withdrawal of consent|6|||
33543353|NCT00658528|101889018|FG000|Overall Study|Other|8|||
33543354|NCT00658528|101889019|FG001|Overall Study|Other|4|||
33543355|NCT03329989|101889023|FG000|Overall Study|Withdrawal by Subject|9|||
33543356|NCT03329989|101889023|FG000|Overall Study|Lost to Follow-up|8|||
33543357|NCT03329989|101889023|FG000|Overall Study|Adverse Event|5|||
33543358|NCT03329989|101889023|FG000|Overall Study|Protocol Violation|1|||
33616181|NCT00302211|102144294|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
33616182|NCT00302211|102144295|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
33616183|NCT00302211|102144296|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
33616184|NCT00302211|102144297|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
33212846|NCT02660827|100676723|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
33212847|NCT02660827|100676723|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
33212848|NCT02660827|100676723|FG000|From Study to End of Continued Access|Adverse Event|3|||
33212849|NCT02660827|100676723|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
33616185|NCT00302211|102144298|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
33616186|NCT00302211|102144294|FG000|Double Blind Period (New Patients)|Disease progression|0|||
33616187|NCT00302211|102144295|FG001|Double Blind Period (New Patients)|Disease progression|1|||
33616188|NCT00302211|102144296|FG002|Double Blind Period (New Patients)|Disease progression|1|||
33616189|NCT00302211|102144297|FG003|Double Blind Period (New Patients)|Disease progression|0|||
33616190|NCT00302211|102144298|FG004|Double Blind Period (New Patients)|Disease progression|0|||
33212850|NCT02660827|100676723|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
33212851|NCT02660827|100676723|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
33212852|NCT02660827|100676723|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
33212853|NCT02660827|100676723|FG000|Period 2: Continued Access Period|Adverse Event|3|||
33212854|NCT01018394|100676724|FG000|Overall Study|Withdrawal by Subject|5|||
33212855|NCT01018394|100676725|FG001|Overall Study|Withdrawal by Subject|5|||
33212856|NCT01018394|100676724|FG000|Overall Study|Lost to Follow-up|4|||
33212857|NCT01018394|100676725|FG001|Overall Study|Lost to Follow-up|3|||
33212858|NCT02187991|100676730|FG000|Overall Study|Adverse Event|13|||
33212859|NCT02187991|100676731|FG001|Overall Study|Adverse Event|14|||
33212860|NCT02187991|100676732|FG002|Overall Study|Adverse Event|3|||
33212861|NCT02187991|100676733|FG003|Overall Study|Adverse Event|2|||
33212862|NCT02187991|100676730|FG000|Overall Study|Withdrawal by Subject|9|||
33212863|NCT02187991|100676731|FG001|Overall Study|Withdrawal by Subject|6|||
33212864|NCT02187991|100676732|FG002|Overall Study|Withdrawal by Subject|3|||
33212865|NCT02187991|100676733|FG003|Overall Study|Withdrawal by Subject|2|||
33346827|NCT04436276|101156731|FG013|Overall Study|Other|2|||
33346828|NCT04436276|101156732|FG014|Overall Study|Other|3|||
33346829|NCT04436276|101156733|FG015|Overall Study|Other|0|||
33346830|NCT04436276|101156734|FG016|Overall Study|Other|0|||
33346831|NCT04436276|101156735|FG017|Overall Study|Other|6|||
33346832|NCT04436276|101156736|FG018|Overall Study|Other|1|||
33346833|NCT04436276|101156737|FG019|Overall Study|Other|0|||
33346834|NCT04436276|101156738|FG020|Overall Study|Other|2|||
33346835|NCT04436276|101156739|FG021|Overall Study|Other|2|||
33346836|NCT04436276|101156740|FG022|Overall Study|Other|60|||
33346837|NCT00792298|101156742|FG000|Treatment Period 1|Adverse Event|0|||
33346838|NCT00792298|101156743|FG001|Treatment Period 1|Adverse Event|1|||
33346839|NCT00792298|101156744|FG002|Treatment Period 1|Adverse Event|0|||
33346840|NCT00792298|101156745|FG003|Treatment Period 1|Adverse Event|1|||
33346841|NCT00792298|101156746|FG004|Treatment Period 1|Adverse Event|0|||
33346842|NCT00792298|101156747|FG005|Treatment Period 1|Adverse Event|1|||
33346843|NCT00792298|101156748|FG006|Treatment Period 1|Adverse Event|1|||
33346844|NCT00792298|101156749|FG007|Treatment Period 1|Adverse Event|0|||
33346845|NCT00792298|101156742|FG000|Treatment Period 1|Lack of Efficacy|0|||
33346846|NCT00792298|101156743|FG001|Treatment Period 1|Lack of Efficacy|0|||
33346847|NCT00792298|101156744|FG002|Treatment Period 1|Lack of Efficacy|1|||
33346848|NCT00792298|101156745|FG003|Treatment Period 1|Lack of Efficacy|0|||
33346849|NCT00792298|101156746|FG004|Treatment Period 1|Lack of Efficacy|0|||
33543359|NCT01101178|101889024|FG000|Period 1|Withdrawal by Subject|1|||
33543360|NCT01101178|101889025|FG001|Period 1|Withdrawal by Subject|2|||
33543361|NCT01101178|101889024|FG000|Period 1|Positive drug screen|1|||
33212866|NCT02187991|100676730|FG000|Overall Study|Physician Decision|4|||
33346850|NCT00792298|101156747|FG005|Treatment Period 1|Lack of Efficacy|0|||
33346851|NCT00792298|101156748|FG006|Treatment Period 1|Lack of Efficacy|0|||
33346852|NCT00792298|101156749|FG007|Treatment Period 1|Lack of Efficacy|0|||
33543362|NCT01101178|101889025|FG001|Period 1|Positive drug screen|1|||
33543363|NCT01101178|101889024|FG000|Period 1|Adverse Event|2|||
33543364|NCT01101178|101889025|FG001|Period 1|Adverse Event|1|||
33408191|NCT00421928|101383080|FG002|Overall Study|Lack of Efficacy|35|||
33408192|NCT00421928|101383078|FG000|Overall Study|Study drug non-compliant|6|||
33408193|NCT00421928|101383079|FG001|Overall Study|Study drug non-compliant|7|||
33346853|NCT00792298|101156742|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33346854|NCT00792298|101156743|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33346855|NCT00792298|101156744|FG002|Treatment Period 1|Withdrawal by Subject|1|||
33346856|NCT00792298|101156745|FG003|Treatment Period 1|Withdrawal by Subject|2|||
33346857|NCT00792298|101156746|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33346858|NCT00792298|101156747|FG005|Treatment Period 1|Withdrawal by Subject|2|||
33408194|NCT00421928|101383080|FG002|Overall Study|Study drug non-compliant|4|||
33408195|NCT00421928|101383078|FG000|Overall Study|All other|26|||
33408196|NCT00421928|101383079|FG001|Overall Study|All other|21|||
33408197|NCT00421928|101383080|FG002|Overall Study|All other|27|||
33408198|NCT00421928|101383078|FG000|Overall Study|Death|0|||
33408199|NCT00421928|101383079|FG001|Overall Study|Death|1|||
33408200|NCT00421928|101383080|FG002|Overall Study|Death|0|||
33408201|NCT04502862|101383081|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
33408202|NCT04502862|101383082|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
33408203|NCT04502862|101383081|FG000|Overall Study|Withdrawal by Subject|1|||
33408204|NCT04502862|101383082|FG001|Overall Study|Withdrawal by Subject|0|||
33408205|NCT04502862|101383081|FG000|Overall Study|Adverse Event|1|||
33408206|NCT04502862|101383082|FG001|Overall Study|Adverse Event|1|||
33408207|NCT04236986|101383083|FG000|Overall Study|Withdrawal by Subject|3|||
33408208|NCT04236986|101383084|FG001|Overall Study|Withdrawal by Subject|1|||
33408209|NCT00649220|101383091|FG000|Overall Study|Adverse Event|2|||
33408210|NCT00649220|101383091|FG000|Overall Study|Withdrawal by Subject|1|||
33408211|NCT04338685|101383092|FG000|Overall Study|Death|3|||
33408212|NCT04338685|101383093|FG001|Overall Study|Death|4|||
33408213|NCT04338685|101383094|FG002|Overall Study|Death|2|||
33408214|NCT04338685|101383095|FG003|Overall Study|Death|4|||
33408215|NCT04338685|101383096|FG004|Overall Study|Death|4|||
33408216|NCT04338685|101383097|FG005|Overall Study|Death|8|||
33408217|NCT04338685|101383098|FG006|Overall Study|Death|1|||
33408218|NCT04338685|101383099|FG007|Overall Study|Death|0|||
33408219|NCT04338685|101383100|FG008|Overall Study|Death|0|||
33408220|NCT04338685|101383092|FG000|Overall Study|Study terminated by Sponsor|0|||
33543365|NCT01101178|101889024|FG000|Period 2|Withdrawal by Subject|0|||
33543366|NCT01101178|101889025|FG001|Period 2|Withdrawal by Subject|1|||
33346859|NCT00792298|101156748|FG006|Treatment Period 1|Withdrawal by Subject|1|||
33346860|NCT00792298|101156749|FG007|Treatment Period 1|Withdrawal by Subject|0|||
33346861|NCT00792298|101156742|FG000|Treatment Period 1|Lost to Follow-up|0|||
33346862|NCT00792298|101156743|FG001|Treatment Period 1|Lost to Follow-up|0|||
33346863|NCT00792298|101156744|FG002|Treatment Period 1|Lost to Follow-up|0|||
33408221|NCT04338685|101383093|FG001|Overall Study|Study terminated by Sponsor|0|||
33408222|NCT04338685|101383094|FG002|Overall Study|Study terminated by Sponsor|1|||
33408223|NCT04338685|101383095|FG003|Overall Study|Study terminated by Sponsor|4|||
33543367|NCT00362232|101889026|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
33543368|NCT00362232|101889027|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
33543369|NCT00362232|101889026|FG000|Treatment (12 +/- 2 Days)|Death|1|||
33543370|NCT00362232|101889027|FG001|Treatment (12 +/- 2 Days)|Death|3|||
33543371|NCT00362232|101889026|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
33543372|NCT00362232|101889027|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
33543373|NCT00362232|101889026|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
33543374|NCT00362232|101889027|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
33543375|NCT00362232|101889026|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
33543376|NCT00362232|101889027|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
33543377|NCT00362232|101889026|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
33543378|NCT00362232|101889027|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
33543379|NCT00362232|101889026|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
33543380|NCT00362232|101889027|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
33543381|NCT00362232|101889026|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
33543382|NCT00362232|101889027|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
33543383|NCT00362232|101889026|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
33346864|NCT00792298|101156745|FG003|Treatment Period 1|Lost to Follow-up|0|||
33543384|NCT00362232|101889027|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
33346865|NCT00792298|101156746|FG004|Treatment Period 1|Lost to Follow-up|0|||
33346866|NCT00792298|101156747|FG005|Treatment Period 1|Lost to Follow-up|0|||
33543385|NCT00362232|101889026|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
33543386|NCT00362232|101889027|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
33543387|NCT00362232|101889026|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
33543388|NCT00362232|101889027|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
33408224|NCT04338685|101383096|FG004|Overall Study|Study terminated by Sponsor|0|||
33408225|NCT04338685|101383097|FG005|Overall Study|Study terminated by Sponsor|5|||
33408226|NCT04338685|101383098|FG006|Overall Study|Study terminated by Sponsor|2|||
33408227|NCT04338685|101383099|FG007|Overall Study|Study terminated by Sponsor|4|||
33408228|NCT04338685|101383100|FG008|Overall Study|Study terminated by Sponsor|1|||
33616191|NCT00302211|102144294|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
33616192|NCT00302211|102144295|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
33616193|NCT00302211|102144296|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
33616194|NCT00302211|102144297|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
33616195|NCT00302211|102144298|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
33616196|NCT00302211|102144294|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
33616197|NCT00302211|102144295|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
33616198|NCT00302211|102144296|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
33616199|NCT00302211|102144297|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
33616200|NCT00302211|102144298|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
33616201|NCT00302211|102144294|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
33616202|NCT00302211|102144295|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
33616203|NCT00302211|102144296|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
33616204|NCT00302211|102144297|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
33616205|NCT00302211|102144298|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
33346867|NCT00792298|101156748|FG006|Treatment Period 1|Lost to Follow-up|1|||
33543389|NCT00362232|101889026|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
33543390|NCT00362232|101889027|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
33543391|NCT00362232|101889026|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
33543392|NCT00362232|101889027|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
33543393|NCT02145390|101889030|FG000|Overall Study|Withdrawal by Subject|1|||
33543394|NCT01192815|101889032|FG000|Overall Study|Withdrawal by Subject|1|||
33543395|NCT01192815|101889032|FG000|Overall Study|Lack of Efficacy|1|||
33543396|NCT00537277|101889035|FG000|Overall Study|Adverse Event|1|||
33543397|NCT00537277|101889035|FG000|Overall Study|Lack of Efficacy|2|||
33543398|NCT00537277|101889035|FG000|Overall Study|Lost to Follow-up|12|||
33543399|NCT00537277|101889035|FG000|Overall Study|Protocol Violation|11|||
33543400|NCT00537277|101889035|FG000|Overall Study|Unclassified|4|||
33543401|NCT00537277|101889035|FG000|Overall Study|Inability to tolerate trial medication|4|||
33543402|NCT00537277|101889035|FG000|Overall Study|Non-compliance with trial procedures|15|||
33543403|NCT02475369|101889038|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
33543404|NCT02475369|101889039|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
33543405|NCT02324153|101889042|FG000|Overall Study|Withdrawal by Subject|4|||
33543406|NCT02324153|101889043|FG001|Overall Study|Withdrawal by Subject|1|||
33543407|NCT02324153|101889042|FG000|Overall Study|Surgery postponed after randomization|3|||
33543408|NCT02324153|101889043|FG001|Overall Study|Surgery postponed after randomization|0|||
33543409|NCT02324153|101889042|FG000|Overall Study|Developed delirium preoperatively|1|||
33543410|NCT02324153|101889043|FG001|Overall Study|Developed delirium preoperatively|0|||
33543411|NCT01240382|101889044|FG000|Overall Study|Adverse Event|2|||
33543412|NCT01240382|101889045|FG001|Overall Study|Adverse Event|1|||
33543413|NCT01240382|101889044|FG000|Overall Study|Lack of Efficacy|0|||
33543414|NCT01240382|101889045|FG001|Overall Study|Lack of Efficacy|2|||
33543415|NCT01240382|101889044|FG000|Overall Study|Fear of adverse events|0|||
33543416|NCT01240382|101889045|FG001|Overall Study|Fear of adverse events|1|||
33543417|NCT00671060|101889046|FG000|Overall Study|Protocol Violation|1|||
33543418|NCT00671060|101889047|FG001|Overall Study|Protocol Violation|0|||
33543419|NCT00671060|101889046|FG000|Overall Study|Physician Decision|0|||
33543420|NCT00671060|101889047|FG001|Overall Study|Physician Decision|1|||
33543421|NCT00375752|101891701|FG000|Overall Study|Lack of Efficacy|4|||
33543422|NCT00375752|101891702|FG001|Overall Study|Lack of Efficacy|4|||
33543423|NCT00375752|101891701|FG000|Overall Study|Adverse Event|1|||
33543424|NCT00375752|101891702|FG001|Overall Study|Adverse Event|6|||
33543425|NCT00375752|101891701|FG000|Overall Study|Withdrawal by Subject|6|||
33543426|NCT00375752|101891702|FG001|Overall Study|Withdrawal by Subject|1|||
33543427|NCT00375752|101891701|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
33543428|NCT00375752|101891702|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
33543429|NCT00375752|101891701|FG000|Overall Study|Protocol Violation|0|||
33543430|NCT00375752|101891702|FG001|Overall Study|Protocol Violation|2|||
33543431|NCT00375752|101891701|FG000|Overall Study|Administrative Problems|0|||
33543432|NCT00375752|101891702|FG001|Overall Study|Administrative Problems|1|||
33543433|NCT03979313|101891708|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
33543434|NCT03979313|101891709|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
33543435|NCT03979313|101891708|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
33543436|NCT03979313|101891709|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
33543437|NCT03979313|101891708|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
33543438|NCT03979313|101891709|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
33616206|NCT00302211|102144294|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
33543439|NCT03979313|101891708|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
33543440|NCT03979313|101891709|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
33616207|NCT00302211|102144295|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
33616208|NCT00302211|102144296|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
33616209|NCT00302211|102144297|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
33616210|NCT00302211|102144298|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
33212867|NCT02187991|100676731|FG001|Overall Study|Physician Decision|4|||
33212868|NCT02187991|100676732|FG002|Overall Study|Physician Decision|0|||
33346868|NCT00792298|101156749|FG007|Treatment Period 1|Lost to Follow-up|0|||
33346869|NCT00792298|101156742|FG000|Treatment Period 1|Physician Decision|0|||
33346870|NCT00792298|101156743|FG001|Treatment Period 1|Physician Decision|0|||
33346871|NCT00792298|101156744|FG002|Treatment Period 1|Physician Decision|0|||
33346872|NCT00792298|101156745|FG003|Treatment Period 1|Physician Decision|1|||
33346873|NCT00792298|101156746|FG004|Treatment Period 1|Physician Decision|0|||
33346874|NCT00792298|101156747|FG005|Treatment Period 1|Physician Decision|0|||
33346875|NCT00792298|101156748|FG006|Treatment Period 1|Physician Decision|1|||
33543441|NCT03979313|101891708|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
33543442|NCT03979313|101891709|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
33543443|NCT03979313|101891708|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
33346876|NCT00792298|101156749|FG007|Treatment Period 1|Physician Decision|0|||
33346877|NCT00792298|101156742|FG000|Treatment Period 1|Protocol Violation|0|||
33408229|NCT04338685|101383092|FG000|Overall Study|Withdrawal by Subject|1|||
33408230|NCT04338685|101383093|FG001|Overall Study|Withdrawal by Subject|2|||
33408231|NCT04338685|101383094|FG002|Overall Study|Withdrawal by Subject|0|||
33408232|NCT04338685|101383095|FG003|Overall Study|Withdrawal by Subject|2|||
33408233|NCT04338685|101383096|FG004|Overall Study|Withdrawal by Subject|0|||
33408234|NCT04338685|101383097|FG005|Overall Study|Withdrawal by Subject|5|||
33408235|NCT04338685|101383098|FG006|Overall Study|Withdrawal by Subject|1|||
33408236|NCT04338685|101383099|FG007|Overall Study|Withdrawal by Subject|1|||
33408237|NCT04338685|101383100|FG008|Overall Study|Withdrawal by Subject|0|||
33408238|NCT02889861|101383102|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
33408239|NCT02028182|101383103|FG000|Overall Study|Protocol Violation|2|||
33408240|NCT01451203|101383104|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
33408241|NCT01451203|101383105|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
33408242|NCT01451203|101383104|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
33408243|NCT01451203|101383105|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
33408244|NCT01451203|101383104|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
33408245|NCT01451203|101383105|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
33408246|NCT01451203|101383104|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
33408247|NCT01451203|101383105|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
33408248|NCT01451203|101383104|FG000|Double-blind Treatment Period|Adverse Event|6|||
33408249|NCT01451203|101383105|FG001|Double-blind Treatment Period|Adverse Event|9|||
33408250|NCT01451203|101383104|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
33408251|NCT01451203|101383105|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
33408252|NCT01451203|101383104|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
33408253|NCT01451203|101383105|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
33408254|NCT01451203|101383104|FG000|Double-blind Treatment Period|Investigator decision|2|||
33408255|NCT01451203|101383105|FG001|Double-blind Treatment Period|Investigator decision|0|||
33408256|NCT01451203|101383104|FG000|Post-treatment Period|Consent withdrawn|2|||
33408257|NCT01451203|101383105|FG001|Post-treatment Period|Consent withdrawn|4|||
33408258|NCT01451203|101383104|FG000|Post-treatment Period|Lack of Efficacy|12|||
33408259|NCT01451203|101383105|FG001|Post-treatment Period|Lack of Efficacy|28|||
33346878|NCT00792298|101156743|FG001|Treatment Period 1|Protocol Violation|0|||
33346879|NCT00792298|101156744|FG002|Treatment Period 1|Protocol Violation|0|||
33408260|NCT01451203|101383104|FG000|Post-treatment Period|Adverse Event|0|||
33408261|NCT01451203|101383105|FG001|Post-treatment Period|Adverse Event|1|||
33408262|NCT01451203|101383104|FG000|Post-treatment Period|Investigator decision|0|||
33543444|NCT03979313|101891709|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
33543445|NCT03979313|101891708|FG000|All Subjects|Any Other Reason|16|||
33543446|NCT03979313|101891709|FG001|All Subjects|Any Other Reason|23|||
33543447|NCT03979313|101891708|FG000|All Subjects|Covid-19|1|||
33543448|NCT03979313|101891709|FG001|All Subjects|Covid-19|3|||
33543449|NCT03979313|101891708|FG000|All Subjects|Withdrawal by Subject|35|||
33543450|NCT03979313|101891709|FG001|All Subjects|Withdrawal by Subject|44|||
33543451|NCT03979313|101891708|FG000|All Subjects|Death|0|||
33543452|NCT03979313|101891709|FG001|All Subjects|Death|5|||
33543453|NCT03979313|101891708|FG000|All Subjects|Lost to Follow-up|28|||
33543454|NCT03979313|101891709|FG001|All Subjects|Lost to Follow-up|61|||
33543455|NCT00392223|101891710|FG000|Overall Study|Adverse Event|5|||
33346880|NCT00792298|101156745|FG003|Treatment Period 1|Protocol Violation|0|||
33543456|NCT00392223|101891711|FG001|Overall Study|Adverse Event|4|||
33543457|NCT00392223|101891710|FG000|Overall Study|Lost to Follow-up|1|||
33543458|NCT00392223|101891711|FG001|Overall Study|Lost to Follow-up|4|||
33408263|NCT01451203|101383105|FG001|Post-treatment Period|Investigator decision|1|||
33408264|NCT02546193|101383108|FG000|Overall Study|Withdrawal by Subject|2|||
33408265|NCT02546193|101383109|FG001|Overall Study|Withdrawal by Subject|0|||
33408266|NCT02546193|101383110|FG002|Overall Study|Withdrawal by Subject|1|||
33408267|NCT02546193|101383111|FG003|Overall Study|Withdrawal by Subject|0|||
33408268|NCT02546193|101383108|FG000|Overall Study|Not eligible at time of induction|4|||
33408269|NCT02546193|101383109|FG001|Overall Study|Not eligible at time of induction|6|||
33408270|NCT02546193|101383110|FG002|Overall Study|Not eligible at time of induction|1|||
33408271|NCT02546193|101383111|FG003|Overall Study|Not eligible at time of induction|0|||
33408272|NCT03911401|101383117|FG000|Overall Study|Adverse Event|1|||
33408273|NCT03911401|101383118|FG001|Overall Study|Adverse Event|2|||
33408274|NCT03911401|101383119|FG002|Overall Study|Adverse Event|5|||
33408275|NCT03911401|101383117|FG000|Overall Study|Lack of Efficacy|1|||
33408276|NCT03911401|101383118|FG001|Overall Study|Lack of Efficacy|1|||
33408277|NCT03911401|101383119|FG002|Overall Study|Lack of Efficacy|8|||
33408278|NCT03911401|101383117|FG000|Overall Study|Physician Decision|0|||
33408279|NCT03911401|101383118|FG001|Overall Study|Physician Decision|0|||
33408280|NCT03911401|101383119|FG002|Overall Study|Physician Decision|1|||
33408281|NCT03911401|101383117|FG000|Overall Study|Withdrawal by Subject|1|||
33408282|NCT03911401|101383118|FG001|Overall Study|Withdrawal by Subject|2|||
33408283|NCT03911401|101383119|FG002|Overall Study|Withdrawal by Subject|0|||
33408284|NCT03911401|101383117|FG000|Overall Study|Withdrawal by parent/guardian|4|||
33346881|NCT00792298|101156746|FG004|Treatment Period 1|Protocol Violation|0|||
33346882|NCT00792298|101156747|FG005|Treatment Period 1|Protocol Violation|0|||
33346883|NCT00792298|101156748|FG006|Treatment Period 1|Protocol Violation|0|||
33346884|NCT00792298|101156749|FG007|Treatment Period 1|Protocol Violation|1|||
33346885|NCT00792298|101156742|FG000|Washout|Adverse Event|0|||
33543459|NCT00392223|101891710|FG000|Overall Study|Protocol Violation|0|||
33543460|NCT00392223|101891711|FG001|Overall Study|Protocol Violation|3|||
33543461|NCT00392223|101891710|FG000|Overall Study|Withdrawal by Subject|3|||
33543462|NCT00392223|101891711|FG001|Overall Study|Withdrawal by Subject|2|||
33543463|NCT00761319|101891713|FG000|Overall Study|Protocol Violation|21|||
33543464|NCT00761319|101891714|FG001|Overall Study|Protocol Violation|14|||
33543465|NCT00761319|101891713|FG000|Overall Study|Adverse Event|11|||
33543466|NCT00761319|101891714|FG001|Overall Study|Adverse Event|7|||
33543467|NCT00761319|101891713|FG000|Overall Study|Withdrawal by Subject|8|||
33616211|NCT00302211|102144294|FG000|Open Label-Patients From Double-Blind|Death|0|||
33616212|NCT00302211|102144295|FG001|Open Label-Patients From Double-Blind|Death|0|||
33616213|NCT00302211|102144296|FG002|Open Label-Patients From Double-Blind|Death|0|||
33616214|NCT00302211|102144297|FG003|Open Label-Patients From Double-Blind|Death|1|||
33616215|NCT00302211|102144298|FG004|Open Label-Patients From Double-Blind|Death|1|||
33616216|NCT00302211|102144294|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
33616217|NCT00302211|102144295|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
33616218|NCT00302211|102144296|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
33616219|NCT00302211|102144297|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
33346886|NCT00792298|101156743|FG001|Washout|Adverse Event|0|||
33346887|NCT00792298|101156744|FG002|Washout|Adverse Event|0|||
33346888|NCT00792298|101156745|FG003|Washout|Adverse Event|0|||
33346889|NCT00792298|101156746|FG004|Washout|Adverse Event|0|||
33346890|NCT00792298|101156747|FG005|Washout|Adverse Event|1|||
33346891|NCT00792298|101156748|FG006|Washout|Adverse Event|0|||
33346892|NCT00792298|101156749|FG007|Washout|Adverse Event|0|||
33346893|NCT00792298|101156742|FG000|Washout|Withdrawal by Subject|0|||
33346894|NCT00792298|101156743|FG001|Washout|Withdrawal by Subject|0|||
33346895|NCT00792298|101156744|FG002|Washout|Withdrawal by Subject|1|||
33346896|NCT00792298|101156745|FG003|Washout|Withdrawal by Subject|0|||
33408285|NCT03911401|101383118|FG001|Overall Study|Withdrawal by parent/guardian|4|||
33408286|NCT03911401|101383119|FG002|Overall Study|Withdrawal by parent/guardian|11|||
33408287|NCT01020812|101383123|FG000|Overall Study|Physician Decision|1|||
33543468|NCT00761319|101891714|FG001|Overall Study|Withdrawal by Subject|7|||
33616220|NCT00302211|102144298|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
33346897|NCT00792298|101156746|FG004|Washout|Withdrawal by Subject|0|||
33408288|NCT01020812|101383123|FG000|Overall Study|Withdrawal by Subject|1|||
33346898|NCT00792298|101156747|FG005|Washout|Withdrawal by Subject|1|||
33346899|NCT00792298|101156748|FG006|Washout|Withdrawal by Subject|0|||
33346900|NCT00792298|101156749|FG007|Washout|Withdrawal by Subject|0|||
33408289|NCT01020812|101383123|FG000|Overall Study|Protocol Violation|1|||
33408290|NCT03198559|101383125|FG000|Overall Study|Adverse Event|2|||
33543469|NCT00761319|101891713|FG000|Overall Study|Noncompliance|4|||
33543470|NCT00761319|101891714|FG001|Overall Study|Noncompliance|3|||
33543471|NCT00761319|101891713|FG000|Overall Study|Lost to Follow-up|1|||
33543472|NCT00761319|101891714|FG001|Overall Study|Lost to Follow-up|1|||
33543473|NCT00761319|101891713|FG000|Overall Study|Nonspecified|2|||
33543474|NCT00761319|101891714|FG001|Overall Study|Nonspecified|2|||
33543475|NCT00761319|101891713|FG000|Overall Study|Missing|1|||
33543476|NCT00761319|101891714|FG001|Overall Study|Missing|0|||
33543477|NCT01027949|101891715|FG000|Overall Study|Death|174|||
33616221|NCT00302211|102144294|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
33616222|NCT00302211|102144295|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
33616223|NCT00302211|102144296|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
33616224|NCT00302211|102144297|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
33616225|NCT00302211|102144298|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
33616226|NCT00302211|102144294|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
33616227|NCT00302211|102144295|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
33408291|NCT00489411|101383128|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
33408292|NCT00489411|101383129|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
33408293|NCT00489411|101383128|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
33408294|NCT00489411|101383129|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
33346901|NCT00792298|101156742|FG000|Treatment Period 2|Lack of Efficacy|0|||
33346902|NCT00792298|101156743|FG001|Treatment Period 2|Lack of Efficacy|0|||
33346903|NCT00792298|101156744|FG002|Treatment Period 2|Lack of Efficacy|0|||
33346904|NCT00792298|101156745|FG003|Treatment Period 2|Lack of Efficacy|0|||
33346905|NCT00792298|101156746|FG004|Treatment Period 2|Lack of Efficacy|1|||
33346906|NCT00792298|101156747|FG005|Treatment Period 2|Lack of Efficacy|0|||
33346907|NCT00792298|101156748|FG006|Treatment Period 2|Lack of Efficacy|0|||
33346908|NCT00792298|101156749|FG007|Treatment Period 2|Lack of Efficacy|0|||
33346909|NCT00792298|101156742|FG000|Treatment Period 2|Physician Decision|0|||
33346910|NCT00792298|101156743|FG001|Treatment Period 2|Physician Decision|0|||
33346911|NCT00792298|101156744|FG002|Treatment Period 2|Physician Decision|0|||
33346912|NCT00792298|101156745|FG003|Treatment Period 2|Physician Decision|0|||
33346913|NCT00792298|101156746|FG004|Treatment Period 2|Physician Decision|0|||
33346914|NCT00792298|101156747|FG005|Treatment Period 2|Physician Decision|0|||
33543478|NCT01027949|101891715|FG000|Overall Study|Progressive Disease|163|||
33543479|NCT01027949|101891715|FG000|Overall Study|Adverse Event|172|||
33543480|NCT01027949|101891715|FG000|Overall Study|Withdrawal by Subject|113|||
33543481|NCT01027949|101891715|FG000|Overall Study|Lost to Follow-up|17|||
33543482|NCT01027949|101891715|FG000|Overall Study|Protocol Violation|13|||
33543483|NCT01027949|101891715|FG000|Overall Study|PI Decision|8|||
33346915|NCT00792298|101156748|FG006|Treatment Period 2|Physician Decision|1|||
33616228|NCT00302211|102144296|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
33616229|NCT00302211|102144297|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
33616230|NCT00302211|102144298|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
33616231|NCT01196026|102144300|FG000|Overall Study|Withdrawal by Subject|1|||
33616232|NCT01196026|102144301|FG001|Overall Study|Withdrawal by Subject|4|||
33616233|NCT01196026|102144302|FG002|Overall Study|Withdrawal by Subject|0|||
33212869|NCT02187991|100676733|FG003|Overall Study|Physician Decision|2|||
33346916|NCT00792298|101156749|FG007|Treatment Period 2|Physician Decision|0|||
33346917|NCT00792298|101156742|FG000|Treatment Period 2|Pregnancy|0|||
33346918|NCT00792298|101156743|FG001|Treatment Period 2|Pregnancy|0|||
33346919|NCT00792298|101156744|FG002|Treatment Period 2|Pregnancy|1|||
33346920|NCT00792298|101156745|FG003|Treatment Period 2|Pregnancy|0|||
33346921|NCT00792298|101156746|FG004|Treatment Period 2|Pregnancy|0|||
33346922|NCT00792298|101156747|FG005|Treatment Period 2|Pregnancy|0|||
33346923|NCT00792298|101156748|FG006|Treatment Period 2|Pregnancy|0|||
33346924|NCT00792298|101156749|FG007|Treatment Period 2|Pregnancy|0|||
33346925|NCT00792298|101156742|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33346926|NCT00792298|101156743|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33346927|NCT00792298|101156744|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33346928|NCT00792298|101156745|FG003|Treatment Period 2|Withdrawal by Subject|2|||
33346929|NCT00792298|101156746|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33346930|NCT00792298|101156747|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33543484|NCT01027949|101891715|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
33543485|NCT01027949|101891715|FG000|Overall Study|Non-compliance with Study Procedures|7|||
33543486|NCT01027949|101891715|FG000|Overall Study|Lung Transplant|5|||
33543487|NCT01027949|101891715|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
33543488|NCT01027949|101891715|FG000|Overall Study|Use of Excluded Medication|2|||
33543489|NCT01027949|101891715|FG000|Overall Study|Patient Self-discontinuation|1|||
33543490|NCT01027949|101891715|FG000|Overall Study|Pregnancy|1|||
33543491|NCT01027949|101891715|FG000|Overall Study|Surgery|1|||
33543492|NCT03980223|101891716|FG000|Overall Study|Lost to Follow-up|3|||
33543493|NCT03980223|101891717|FG001|Overall Study|Lost to Follow-up|7|||
33543494|NCT03980223|101891718|FG002|Overall Study|Lost to Follow-up|10|||
33543495|NCT03980223|101891719|FG003|Overall Study|Lost to Follow-up|8|||
33543496|NCT03980223|101891716|FG000|Overall Study|Withdrawal by Subject|0|||
33543497|NCT03980223|101891717|FG001|Overall Study|Withdrawal by Subject|0|||
33543498|NCT03980223|101891718|FG002|Overall Study|Withdrawal by Subject|1|||
33543499|NCT03980223|101891719|FG003|Overall Study|Withdrawal by Subject|2|||
33543500|NCT03980223|101891716|FG000|Overall Study|Physician Decision|0|||
33543501|NCT03980223|101891717|FG001|Overall Study|Physician Decision|0|||
33543502|NCT03980223|101891718|FG002|Overall Study|Physician Decision|1|||
33543503|NCT03980223|101891719|FG003|Overall Study|Physician Decision|0|||
33543504|NCT03980223|101891716|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
33543505|NCT03980223|101891717|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
33543506|NCT03980223|101891718|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
33543507|NCT03980223|101891719|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
33543508|NCT04745351|101891720|FG000|Overall Study|Death|51|||
33543509|NCT04745351|101891721|FG001|Overall Study|Death|25|||
33543510|NCT04745351|101891720|FG000|Overall Study|Lost to Follow-up|9|||
33543511|NCT04745351|101891721|FG001|Overall Study|Lost to Follow-up|3|||
33543512|NCT04745351|101891720|FG000|Overall Study|Randomized but Never Treated|3|||
33543513|NCT04745351|101891721|FG001|Overall Study|Randomized but Never Treated|3|||
33543514|NCT04745351|101891720|FG000|Overall Study|Adverse Event|4|||
33543515|NCT04745351|101891721|FG001|Overall Study|Adverse Event|0|||
33346931|NCT00792298|101156748|FG006|Treatment Period 2|Withdrawal by Subject|0|||
33543516|NCT04745351|101891720|FG000|Overall Study|Withdrew Consent|1|||
33543517|NCT04745351|101891721|FG001|Overall Study|Withdrew Consent|2|||
33543518|NCT04745351|101891720|FG000|Overall Study|Investigator's Discretion|2|||
33543519|NCT04745351|101891721|FG001|Overall Study|Investigator's Discretion|0|||
33346932|NCT00792298|101156749|FG007|Treatment Period 2|Withdrawal by Subject|2|||
33543520|NCT04745351|101891720|FG000|Overall Study|Protocol Violation|1|||
33543521|NCT04745351|101891721|FG001|Overall Study|Protocol Violation|0|||
33543522|NCT00712920|101891722|FG000|Overall Study|Adverse Event|3|||
33543523|NCT00712920|101891723|FG001|Overall Study|Adverse Event|4|||
33543524|NCT00712920|101891724|FG002|Overall Study|Adverse Event|7|||
33543525|NCT00712920|101891722|FG000|Overall Study|Withdrawal by Subject|4|||
33543526|NCT00712920|101891723|FG001|Overall Study|Withdrawal by Subject|2|||
33543527|NCT00712920|101891724|FG002|Overall Study|Withdrawal by Subject|1|||
33616234|NCT01196026|102144303|FG003|Overall Study|Withdrawal by Subject|0|||
33616235|NCT01196026|102144304|FG004|Overall Study|Withdrawal by Subject|0|||
33616236|NCT01196026|102144305|FG005|Overall Study|Withdrawal by Subject|0|||
33616237|NCT01196026|102144300|FG000|Overall Study|Lost to Follow-up|0|||
33616238|NCT01196026|102144301|FG001|Overall Study|Lost to Follow-up|3|||
33212870|NCT02187991|100676730|FG000|Overall Study|Other, unrelated complication|7|||
33212871|NCT02187991|100676731|FG001|Overall Study|Other, unrelated complication|1|||
33212872|NCT02187991|100676732|FG002|Overall Study|Other, unrelated complication|1|||
33408295|NCT00489411|101383128|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
33616239|NCT01196026|102144302|FG002|Overall Study|Lost to Follow-up|0|||
33616240|NCT01196026|102144303|FG003|Overall Study|Lost to Follow-up|0|||
33616241|NCT01196026|102144304|FG004|Overall Study|Lost to Follow-up|1|||
33543528|NCT00712920|101891722|FG000|Overall Study|Lost to Follow-up|1|||
33543529|NCT00712920|101891723|FG001|Overall Study|Lost to Follow-up|4|||
33616242|NCT01196026|102144305|FG005|Overall Study|Lost to Follow-up|0|||
33408296|NCT00489411|101383129|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
33408297|NCT00489411|101383128|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
33408298|NCT00489411|101383129|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
33408299|NCT00489411|101383128|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
33408300|NCT00489411|101383129|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
33408301|NCT01491802|101383130|FG000|Overall Study|Adverse Event|1|||
33408302|NCT01491802|101383131|FG001|Overall Study|Adverse Event|1|||
33408303|NCT01491802|101383130|FG000|Overall Study|Withdrawal by Subject|0|||
33212873|NCT02187991|100676733|FG003|Overall Study|Other, unrelated complication|2|||
33346933|NCT02149810|101159915|FG000|Overall Study|Physician Decision|1|||
33346934|NCT02149810|101159916|FG001|Overall Study|Physician Decision|2|||
33346935|NCT02149810|101159915|FG000|Overall Study|Lost to Follow-up|2|||
33346936|NCT02149810|101159916|FG001|Overall Study|Lost to Follow-up|1|||
33346937|NCT02149810|101159915|FG000|Overall Study|Withdrawal by Subject|5|||
33346938|NCT02149810|101159916|FG001|Overall Study|Withdrawal by Subject|1|||
33346939|NCT00074958|101159917|FG000|Overall Study|Adverse Event|1|||
33346940|NCT02675075|101159918|FG000|Overall Study|Lost to Follow-up|3|||
33346941|NCT02675075|101159919|FG001|Overall Study|Lost to Follow-up|0|||
33346942|NCT00508391|101159920|FG000|First Treatment|Withdrawal by Subject|6|||
33346943|NCT00508391|101159921|FG001|First Treatment|Withdrawal by Subject|3|||
33346944|NCT00508391|101159920|FG000|Second Treatment|Withdrawal by Subject|2|||
33346945|NCT00508391|101159921|FG001|Second Treatment|Withdrawal by Subject|0|||
33346946|NCT00849667|101159927|FG000|Overall Study|Withdrawal by Subject|16|||
33346947|NCT00849667|101159928|FG001|Overall Study|Withdrawal by Subject|33|||
33346948|NCT00849667|101159929|FG002|Overall Study|Withdrawal by Subject|35|||
33346949|NCT00849667|101159927|FG000|Overall Study|Lost to Follow-up|8|||
33346950|NCT00849667|101159928|FG001|Overall Study|Lost to Follow-up|8|||
33346951|NCT00849667|101159929|FG002|Overall Study|Lost to Follow-up|8|||
33346952|NCT00849667|101159927|FG000|Overall Study|Adverse Event|1|||
33346953|NCT00849667|101159928|FG001|Overall Study|Adverse Event|2|||
33408304|NCT01491802|101383131|FG001|Overall Study|Withdrawal by Subject|1|||
33408305|NCT02500732|101383134|FG000|Overall Study|Physician Decision|0|||
33408306|NCT02500732|101383135|FG001|Overall Study|Physician Decision|1|||
33408307|NCT01348828|101383148|FG000|Overall Study|Death|20|||
33346954|NCT00849667|101159929|FG002|Overall Study|Adverse Event|0|||
33346955|NCT00849667|101159927|FG000|Overall Study|Other|18|||
33346956|NCT00849667|101159928|FG001|Overall Study|Other|19|||
33346957|NCT00849667|101159929|FG002|Overall Study|Other|18|||
33408308|NCT01348828|101383148|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
33212874|NCT02187991|100676730|FG000|Overall Study|Death|1|||
33346958|NCT00849667|101159927|FG000|Overall Study|Progressive disease|119|||
33346959|NCT00849667|101159928|FG001|Overall Study|Progressive disease|100|||
33543530|NCT00712920|101891724|FG002|Overall Study|Lost to Follow-up|0|||
33616243|NCT01196026|102144300|FG000|Overall Study|Other|0|||
33616244|NCT01196026|102144301|FG001|Overall Study|Other|1|||
33616245|NCT01196026|102144302|FG002|Overall Study|Other|0|||
33346960|NCT00849667|101159929|FG002|Overall Study|Progressive disease|112|||
33346961|NCT00849667|101159927|FG000|Overall Study|Sponsor decision|208|||
33346962|NCT00849667|101159928|FG001|Overall Study|Sponsor decision|204|||
33346963|NCT00849667|101159929|FG002|Overall Study|Sponsor decision|190|||
33346964|NCT00849667|101159927|FG000|Overall Study|Investigator discretion|0|||
33346965|NCT00849667|101159928|FG001|Overall Study|Investigator discretion|0|||
33543531|NCT00712920|101891722|FG000|Overall Study|Lack of Efficacy|1|||
33543532|NCT00712920|101891723|FG001|Overall Study|Lack of Efficacy|0|||
33543533|NCT00712920|101891724|FG002|Overall Study|Lack of Efficacy|1|||
33543534|NCT00712920|101891722|FG000|Overall Study|Other|5|||
33543535|NCT00712920|101891723|FG001|Overall Study|Other|7|||
33543536|NCT00712920|101891724|FG002|Overall Study|Other|3|||
33543537|NCT00712920|101891722|FG000|Overall Study|Non-compliance|3|||
33543538|NCT00712920|101891723|FG001|Overall Study|Non-compliance|0|||
33543539|NCT00712920|101891724|FG002|Overall Study|Non-compliance|0|||
33543540|NCT01140906|101891725|FG000|Overall Study|Adverse Event|7|||
33543541|NCT01140906|101891726|FG001|Overall Study|Adverse Event|10|||
33543542|NCT01140906|101891727|FG002|Overall Study|Adverse Event|17|||
33543543|NCT01140906|101891728|FG003|Overall Study|Adverse Event|7|||
33543544|NCT01140906|101891725|FG000|Overall Study|Lack of Efficacy|6|||
33543545|NCT01140906|101891726|FG001|Overall Study|Lack of Efficacy|8|||
33543546|NCT01140906|101891727|FG002|Overall Study|Lack of Efficacy|2|||
33543547|NCT01140906|101891728|FG003|Overall Study|Lack of Efficacy|1|||
33543548|NCT01140906|101891725|FG000|Overall Study|Non-compliance|0|||
33543549|NCT01140906|101891726|FG001|Overall Study|Non-compliance|1|||
33543550|NCT01140906|101891727|FG002|Overall Study|Non-compliance|0|||
33543551|NCT01140906|101891728|FG003|Overall Study|Non-compliance|1|||
33543552|NCT01140906|101891725|FG000|Overall Study|Protocol Violation|5|||
33543553|NCT01140906|101891726|FG001|Overall Study|Protocol Violation|3|||
33543554|NCT01140906|101891727|FG002|Overall Study|Protocol Violation|2|||
33543555|NCT01140906|101891728|FG003|Overall Study|Protocol Violation|1|||
33543556|NCT01140906|101891725|FG000|Overall Study|Withdrawal of consent|6|||
33543557|NCT01140906|101891726|FG001|Overall Study|Withdrawal of consent|6|||
33543558|NCT01140906|101891727|FG002|Overall Study|Withdrawal of consent|2|||
33543559|NCT01140906|101891728|FG003|Overall Study|Withdrawal of consent|2|||
33543560|NCT01140906|101891725|FG000|Overall Study|Lost to Follow-up|1|||
33543561|NCT01140906|101891726|FG001|Overall Study|Lost to Follow-up|1|||
33543562|NCT01140906|101891727|FG002|Overall Study|Lost to Follow-up|0|||
33543563|NCT01140906|101891728|FG003|Overall Study|Lost to Follow-up|2|||
33543564|NCT01140906|101891725|FG000|Overall Study|Administrative or other reason|0|||
33543565|NCT01140906|101891726|FG001|Overall Study|Administrative or other reason|5|||
33543566|NCT01140906|101891727|FG002|Overall Study|Administrative or other reason|3|||
33543567|NCT01140906|101891728|FG003|Overall Study|Administrative or other reason|2|||
33543568|NCT02948400|101891729|FG000|Overall Study|Withdrawal by Subject|17|||
33543569|NCT02948400|101891730|FG001|Overall Study|Withdrawal by Subject|10|||
33543570|NCT02948400|101891729|FG000|Overall Study|failed to attend appointments|47|||
33616246|NCT01196026|102144303|FG003|Overall Study|Other|0|||
33616247|NCT01196026|102144304|FG004|Overall Study|Other|0|||
33616248|NCT01196026|102144305|FG005|Overall Study|Other|0|||
33616249|NCT01440816|102144306|FG000|Overall Study|Disease Progression|0|||
33616250|NCT01440816|102144307|FG001|Overall Study|Disease Progression|9|||
33616251|NCT01440816|102144306|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
33346966|NCT00849667|101159929|FG002|Overall Study|Investigator discretion|1|||
33346967|NCT00787787|101159930|FG000|Overall Study|Lack of Efficacy|4|||
33346968|NCT00787787|101159930|FG000|Overall Study|Adverse Event|3|||
33346969|NCT00763009|101159931|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
33408309|NCT01348828|101383148|FG000|Overall Study|Conversion|2|||
33543571|NCT02948400|101891730|FG001|Overall Study|failed to attend appointments|34|||
33543572|NCT02948400|101891729|FG000|Overall Study|COVID-related closure|6|||
33543573|NCT02948400|101891730|FG001|Overall Study|COVID-related closure|2|||
33543574|NCT02948400|101891729|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
33616252|NCT01440816|102144307|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
33212875|NCT02187991|100676731|FG001|Overall Study|Death|3|||
33408310|NCT01348828|101383148|FG000|Overall Study|missed visit|1|||
33543575|NCT02948400|101891730|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
33543576|NCT02948400|101891729|FG000|Overall Study|motion sickness in virtual reality|2|||
33543577|NCT02948400|101891730|FG001|Overall Study|motion sickness in virtual reality|0|||
33543578|NCT00916578|101891733|FG000|Overall Study|Physician Decision|2|||
33543579|NCT00916578|101891733|FG000|Overall Study|Withdrawal by Subject|3|||
33543580|NCT00916578|101891733|FG000|Overall Study|Insurance Denial|2|||
33616253|NCT00666224|102144316|FG000|Double-Blind|Adverse Event|15|||
33616254|NCT00666224|102144317|FG001|Double-Blind|Adverse Event|5|||
33616255|NCT00666224|102144316|FG000|Double-Blind|Lost to Follow-up|2|||
33543581|NCT00961064|101891734|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
33543582|NCT00961064|101891734|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
33543583|NCT00961064|101891734|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
33543584|NCT00961064|101891734|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
33543585|NCT00961064|101891734|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
33543586|NCT00961064|101891734|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
33543587|NCT00961064|101891734|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
33543588|NCT00961064|101891734|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
33543589|NCT01384877|101891742|FG000|Treatment 2|Lost to Follow-up|2|||
33543590|NCT01384877|101891743|FG001|Treatment 2|Lost to Follow-up|2|||
33543591|NCT03738696|101891744|FG000|Overall Study|Withdrawal by Subject|0|||
33543592|NCT03738696|101891745|FG001|Overall Study|Withdrawal by Subject|1|||
33543593|NCT03738696|101891744|FG000|Overall Study|Lost to Follow-up|8|||
33543594|NCT03738696|101891745|FG001|Overall Study|Lost to Follow-up|14|||
33543595|NCT00700635|101891746|FG000|Overall Study|Adverse Event|1|||
33543596|NCT00700635|101891747|FG001|Overall Study|Adverse Event|0|||
33543597|NCT00700635|101891748|FG002|Overall Study|Adverse Event|0|||
33543598|NCT00700635|101891746|FG000|Overall Study|Lost to Follow-up|1|||
33543599|NCT00700635|101891747|FG001|Overall Study|Lost to Follow-up|3|||
33543600|NCT00700635|101891748|FG002|Overall Study|Lost to Follow-up|0|||
33543601|NCT00700635|101891746|FG000|Overall Study|Protocol Violation|2|||
33543602|NCT00700635|101891747|FG001|Overall Study|Protocol Violation|2|||
33543603|NCT00700635|101891748|FG002|Overall Study|Protocol Violation|0|||
33543604|NCT00700635|101891746|FG000|Overall Study|Withdrawal by Subject|7|||
33543605|NCT00700635|101891747|FG001|Overall Study|Withdrawal by Subject|3|||
33543606|NCT00700635|101891748|FG002|Overall Study|Withdrawal by Subject|1|||
33543607|NCT00390689|101891761|FG000|Overall Study|Adverse Event|2|||
33543608|NCT00390689|101891762|FG001|Overall Study|Adverse Event|5|||
33543609|NCT00390689|101891763|FG002|Overall Study|Adverse Event|2|||
33543610|NCT00390689|101891761|FG000|Overall Study|Lack of Efficacy|0|||
33543611|NCT00390689|101891762|FG001|Overall Study|Lack of Efficacy|0|||
33543612|NCT00390689|101891763|FG002|Overall Study|Lack of Efficacy|1|||
33543613|NCT00390689|101891761|FG000|Overall Study|Protocol Violation|1|||
33543614|NCT00390689|101891762|FG001|Overall Study|Protocol Violation|0|||
33543615|NCT00390689|101891763|FG002|Overall Study|Protocol Violation|0|||
33543616|NCT00390689|101891761|FG000|Overall Study|Investigator's judgement|2|||
33543617|NCT00390689|101891762|FG001|Overall Study|Investigator's judgement|0|||
33543618|NCT00390689|101891763|FG002|Overall Study|Investigator's judgement|0|||
33543619|NCT00420745|101891764|FG000|Overall Study|Adverse Event|2|||
33543620|NCT00420745|101891765|FG001|Overall Study|Adverse Event|2|||
33543621|NCT00420745|101891764|FG000|Overall Study|Lost to Follow-up|10|||
33543622|NCT00420745|101891765|FG001|Overall Study|Lost to Follow-up|2|||
33543623|NCT00420745|101891764|FG000|Overall Study|Protocol Violation|1|||
33543624|NCT00420745|101891765|FG001|Overall Study|Protocol Violation|0|||
33543625|NCT00420745|101891764|FG000|Overall Study|Physician Decision|1|||
33543626|NCT00420745|101891765|FG001|Overall Study|Physician Decision|1|||
33543627|NCT00420745|101891764|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
33543628|NCT00420745|101891765|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
33543629|NCT00420745|101891764|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
33212876|NCT02187991|100676732|FG002|Overall Study|Death|0|||
33543630|NCT00420745|101891765|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
33543631|NCT02357459|101891768|FG000|Overall Study|Adverse Event|0|||
33543632|NCT02357459|101891769|FG001|Overall Study|Adverse Event|1|||
33616256|NCT00666224|102144317|FG001|Double-Blind|Lost to Follow-up|2|||
33212877|NCT02187991|100676733|FG003|Overall Study|Death|0|||
33543633|NCT02357459|101891770|FG002|Overall Study|Adverse Event|1|||
33543634|NCT02357459|101891768|FG000|Overall Study|Withdrawal by Subject|5|||
33543635|NCT02357459|101891769|FG001|Overall Study|Withdrawal by Subject|3|||
33543636|NCT02357459|101891770|FG002|Overall Study|Withdrawal by Subject|3|||
33543637|NCT02357459|101891768|FG000|Overall Study|Physician Decision|0|||
33212878|NCT00558428|100676737|FG000|Overall Study|Adverse Event|6|||
33543638|NCT02357459|101891769|FG001|Overall Study|Physician Decision|2|||
33543639|NCT02357459|101891770|FG002|Overall Study|Physician Decision|0|||
33543640|NCT02357459|101891768|FG000|Overall Study|Protocol Violation|1|||
33616257|NCT00666224|102144316|FG000|Double-Blind|Withdrawal by Subject|18|||
33543641|NCT02357459|101891769|FG001|Overall Study|Protocol Violation|1|||
33543642|NCT02357459|101891770|FG002|Overall Study|Protocol Violation|0|||
33543643|NCT02357459|101891768|FG000|Overall Study|Lost to Follow-up|1|||
33543644|NCT02357459|101891769|FG001|Overall Study|Lost to Follow-up|3|||
33543645|NCT02357459|101891770|FG002|Overall Study|Lost to Follow-up|0|||
33543646|NCT02357459|101891768|FG000|Overall Study|Lack of Efficacy|7|||
33543647|NCT02357459|101891769|FG001|Overall Study|Lack of Efficacy|4|||
33543648|NCT02357459|101891770|FG002|Overall Study|Lack of Efficacy|4|||
33543649|NCT02357459|101891768|FG000|Overall Study|Patient Relocated|2|||
33543650|NCT02357459|101891769|FG001|Overall Study|Patient Relocated|0|||
33543651|NCT02357459|101891770|FG002|Overall Study|Patient Relocated|0|||
33543652|NCT02357459|101891768|FG000|Overall Study|Instruction from PCP|1|||
33543653|NCT02357459|101891769|FG001|Overall Study|Instruction from PCP|0|||
33543654|NCT02357459|101891770|FG002|Overall Study|Instruction from PCP|0|||
33543655|NCT02357459|101891768|FG000|Overall Study|Incarceration|0|||
33543656|NCT02357459|101891769|FG001|Overall Study|Incarceration|0|||
33543657|NCT02357459|101891770|FG002|Overall Study|Incarceration|1|||
33543658|NCT02357459|101891768|FG000|Overall Study|Pre-planned Knee surgery|0|||
33543659|NCT02357459|101891769|FG001|Overall Study|Pre-planned Knee surgery|0|||
33543660|NCT02357459|101891770|FG002|Overall Study|Pre-planned Knee surgery|2|||
33543661|NCT02357459|101891768|FG000|Overall Study|Job Commitments|0|||
33543662|NCT02357459|101891769|FG001|Overall Study|Job Commitments|0|||
33543663|NCT02357459|101891770|FG002|Overall Study|Job Commitments|1|||
33543664|NCT00753519|101891771|FG000|Overall Study|Withdrawal by Subject|0|||
33543665|NCT00753519|101891772|FG001|Overall Study|Withdrawal by Subject|2|||
33212879|NCT00558428|100676738|FG001|Overall Study|Adverse Event|22|||
33212880|NCT00558428|100676739|FG002|Overall Study|Adverse Event|3|||
33212881|NCT00558428|100676740|FG003|Overall Study|Adverse Event|4|||
33543666|NCT02369653|101891773|FG000|Overall Study|Lost to Follow-up|0|||
33543667|NCT02369653|101891774|FG001|Overall Study|Lost to Follow-up|1|||
33543668|NCT02369653|101891773|FG000|Overall Study|Administrative reason by sponsor|0|||
33543669|NCT02369653|101891774|FG001|Overall Study|Administrative reason by sponsor|1|||
33543670|NCT02369653|101891773|FG000|Overall Study|Death|1|||
33543671|NCT02369653|101891774|FG001|Overall Study|Death|2|||
33212882|NCT00558428|100676737|FG000|Overall Study|Lost to Follow-up|0|||
33212883|NCT00558428|100676738|FG001|Overall Study|Lost to Follow-up|1|||
33212884|NCT00558428|100676739|FG002|Overall Study|Lost to Follow-up|0|||
33212885|NCT00558428|100676740|FG003|Overall Study|Lost to Follow-up|0|||
33212886|NCT00558428|100676737|FG000|Overall Study|Lack of Efficacy|0|||
33212887|NCT00558428|100676738|FG001|Overall Study|Lack of Efficacy|0|||
33212888|NCT00558428|100676739|FG002|Overall Study|Lack of Efficacy|1|||
33212889|NCT00558428|100676740|FG003|Overall Study|Lack of Efficacy|2|||
33212890|NCT00558428|100676737|FG000|Overall Study|Non compliant with protocol|1|||
33212891|NCT00558428|100676738|FG001|Overall Study|Non compliant with protocol|0|||
33212892|NCT00558428|100676739|FG002|Overall Study|Non compliant with protocol|0|||
33212893|NCT00558428|100676740|FG003|Overall Study|Non compliant with protocol|3|||
33212894|NCT00558428|100676737|FG000|Overall Study|Consent withdrawn|2|||
33212895|NCT00558428|100676738|FG001|Overall Study|Consent withdrawn|1|||
33212896|NCT00558428|100676739|FG002|Overall Study|Consent withdrawn|0|||
33212897|NCT00558428|100676740|FG003|Overall Study|Consent withdrawn|1|||
33543672|NCT02369653|101891773|FG000|Overall Study|Participant withdrew consent|13|||
33616258|NCT00666224|102144317|FG001|Double-Blind|Withdrawal by Subject|14|||
33212898|NCT00558428|100676737|FG000|Overall Study|Other|3|||
33212899|NCT00558428|100676738|FG001|Overall Study|Other|0|||
33212900|NCT00558428|100676739|FG002|Overall Study|Other|0|||
33543673|NCT02369653|101891774|FG001|Overall Study|Participant withdrew consent|3|||
33543674|NCT01787838|101891777|FG000|Overall Study|refused|1413|||
33543675|NCT01189266|101891778|FG000|Overall Study|Adverse Event|1|||
33212901|NCT00558428|100676740|FG003|Overall Study|Other|1|||
33543676|NCT01189266|101891779|FG001|Overall Study|Adverse Event|0|||
33616259|NCT00666224|102144316|FG000|Double-Blind|Physician Decision|0|||
33616260|NCT00666224|102144317|FG001|Double-Blind|Physician Decision|3|||
33212902|NCT02858895|100676741|FG000|Overall Study|Disease progression|31|||
33212903|NCT02858895|100676741|FG000|Overall Study|Death|2|||
33346970|NCT01506882|101159934|FG000|Overall Study|Lack of Efficacy|4|||
33212904|NCT02858895|100676741|FG000|Overall Study|Adverse Event|1|||
33543677|NCT01189266|101891780|FG002|Overall Study|Adverse Event|5|||
33543678|NCT01189266|101891778|FG000|Overall Study|Death|0|||
33543679|NCT01189266|101891779|FG001|Overall Study|Death|0|||
33543680|NCT01189266|101891780|FG002|Overall Study|Death|5|||
33543681|NCT01189266|101891778|FG000|Overall Study|Lack of Efficacy|4|||
33543682|NCT01189266|101891779|FG001|Overall Study|Lack of Efficacy|5|||
33543683|NCT01189266|101891780|FG002|Overall Study|Lack of Efficacy|44|||
33543684|NCT01189266|101891778|FG000|Overall Study|Physician Decision|0|||
33543685|NCT01189266|101891779|FG001|Overall Study|Physician Decision|0|||
33543686|NCT01189266|101891780|FG002|Overall Study|Physician Decision|1|||
33543687|NCT01189266|101891778|FG000|Overall Study|Protocol Violation|0|||
33543688|NCT01189266|101891779|FG001|Overall Study|Protocol Violation|1|||
33543689|NCT01189266|101891780|FG002|Overall Study|Protocol Violation|1|||
33543690|NCT01189266|101891778|FG000|Overall Study|Withdrawal by Subject|0|||
33212905|NCT02858895|100676741|FG000|Overall Study|Withdrawal by Subject|3|||
33212906|NCT02858895|100676741|FG000|Overall Study|hospice,|1|||
33212907|NCT02858895|100676741|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
33212908|NCT00535730|100676749|FG000|Overall Study|Adverse Event|1|||
33212909|NCT00535730|100676750|FG001|Overall Study|Adverse Event|1|||
33212910|NCT00535730|100676749|FG000|Overall Study|Lost to Follow-up|0|||
33212911|NCT00535730|100676750|FG001|Overall Study|Lost to Follow-up|1|||
33212912|NCT00535730|100676749|FG000|Overall Study|Physician Decision|0|||
33212913|NCT00535730|100676750|FG001|Overall Study|Physician Decision|1|||
33212914|NCT00535730|100676749|FG000|Overall Study|Protocol Violation|1|||
33543691|NCT01189266|101891779|FG001|Overall Study|Withdrawal by Subject|0|||
33543692|NCT01189266|101891780|FG002|Overall Study|Withdrawal by Subject|1|||
33212915|NCT00535730|100676750|FG001|Overall Study|Protocol Violation|0|||
33212916|NCT00535730|100676749|FG000|Overall Study|Withdrawal by Subject|0|||
33212917|NCT00535730|100676750|FG001|Overall Study|Withdrawal by Subject|4|||
33212918|NCT00454051|100676751|FG000|Overall Study|Adverse Event|1|||
33212919|NCT00454051|100676752|FG001|Overall Study|Adverse Event|2|||
33212920|NCT00454051|100676751|FG000|Overall Study|Withdrawal by Subject|1|||
33212921|NCT00454051|100676752|FG001|Overall Study|Withdrawal by Subject|0|||
33212922|NCT00454051|100676751|FG000|Overall Study|Protocol Violation|1|||
33212923|NCT00454051|100676752|FG001|Overall Study|Protocol Violation|1|||
33212924|NCT03519854|100676753|FG000|Overall Study|Technical Error|0|||
33212925|NCT03519854|100676754|FG001|Overall Study|Technical Error|0|||
33212926|NCT03519854|100676755|FG002|Overall Study|Technical Error|1|||
33212927|NCT03519854|100676756|FG003|Overall Study|Technical Error|0|||
33212928|NCT03519854|100676757|FG004|Overall Study|Technical Error|0|||
33212929|NCT03519854|100676758|FG005|Overall Study|Technical Error|0|||
33212930|NCT03519854|100676759|FG006|Overall Study|Technical Error|0|||
33212931|NCT03519854|100676760|FG007|Overall Study|Technical Error|0|||
33212932|NCT03519854|100676761|FG008|Overall Study|Technical Error|0|||
33212933|NCT03519854|100676762|FG009|Overall Study|Technical Error|0|||
33212934|NCT03519854|100676763|FG010|Overall Study|Technical Error|0|||
33212935|NCT03519854|100676764|FG011|Overall Study|Technical Error|0|||
33212936|NCT03519854|100676765|FG012|Overall Study|Technical Error|0|||
33212937|NCT03519854|100676766|FG013|Overall Study|Technical Error|0|||
33212938|NCT03519854|100676767|FG014|Overall Study|Technical Error|0|||
33212939|NCT03519854|100676768|FG015|Overall Study|Technical Error|0|||
33212940|NCT03519854|100676769|FG016|Overall Study|Technical Error|0|||
33212941|NCT03519854|100676770|FG017|Overall Study|Technical Error|0|||
33212942|NCT02693743|100676775|FG000|Overall Study|Physician Decision|1|||
33212943|NCT02693743|100676776|FG001|Overall Study|Physician Decision|0|||
33212944|NCT03707977|100676777|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
33212945|NCT03707977|100676778|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
33212946|NCT03707977|100676779|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
33212947|NCT03707977|100676777|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
33346971|NCT01506882|101159935|FG001|Overall Study|Lack of Efficacy|3|||
33543693|NCT01189266|101891778|FG000|Overall Study|Patient refuses further therapy|1|||
33212948|NCT03707977|100676778|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
33212949|NCT03707977|100676779|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
33212950|NCT00760929|100676783|FG000|Overall Study|Adverse Event|2|||
33212951|NCT00760929|100676784|FG001|Overall Study|Adverse Event|0|||
33346972|NCT01506882|101159934|FG000|Overall Study|Lost to Follow-up|1|||
33212952|NCT00760929|100676785|FG002|Overall Study|Adverse Event|6|||
33212953|NCT00760929|100676786|FG003|Overall Study|Adverse Event|10|||
33212954|NCT00760929|100676783|FG000|Overall Study|Lack of Efficacy|0|||
33212955|NCT00760929|100676784|FG001|Overall Study|Lack of Efficacy|2|||
33543694|NCT01189266|101891779|FG001|Overall Study|Patient refuses further therapy|0|||
33212956|NCT00760929|100676785|FG002|Overall Study|Lack of Efficacy|1|||
33212957|NCT00760929|100676786|FG003|Overall Study|Lack of Efficacy|0|||
33212958|NCT00760929|100676783|FG000|Overall Study|Withdrawal by Subject|1|||
33212959|NCT00760929|100676784|FG001|Overall Study|Withdrawal by Subject|0|||
33212960|NCT00760929|100676785|FG002|Overall Study|Withdrawal by Subject|9|||
33346973|NCT01506882|101159935|FG001|Overall Study|Lost to Follow-up|0|||
33346974|NCT01506882|101159934|FG000|Overall Study|Withdrawal by Subject|9|||
33543695|NCT01189266|101891780|FG002|Overall Study|Patient refuses further therapy|7|||
33212961|NCT00760929|100676786|FG003|Overall Study|Withdrawal by Subject|1|||
33212962|NCT00760929|100676783|FG000|Overall Study|Lost to Follow-up|0|||
33212963|NCT00760929|100676784|FG001|Overall Study|Lost to Follow-up|0|||
33212964|NCT00760929|100676785|FG002|Overall Study|Lost to Follow-up|1|||
33212965|NCT00760929|100676786|FG003|Overall Study|Lost to Follow-up|0|||
33212966|NCT00760929|100676783|FG000|Overall Study|Progression of Disease|21|||
33212967|NCT00760929|100676784|FG001|Overall Study|Progression of Disease|26|||
33212968|NCT00760929|100676785|FG002|Overall Study|Progression of Disease|38|||
33212969|NCT00760929|100676786|FG003|Overall Study|Progression of Disease|42|||
33212970|NCT00760929|100676783|FG000|Overall Study|Other|2|||
33212971|NCT00760929|100676784|FG001|Overall Study|Other|0|||
33212972|NCT00760929|100676785|FG002|Overall Study|Other|2|||
33212973|NCT00760929|100676786|FG003|Overall Study|Other|1|||
33212974|NCT00760929|100676783|FG000|Overall Study|Death|0|||
33212975|NCT00760929|100676784|FG001|Overall Study|Death|0|||
33212976|NCT00760929|100676785|FG002|Overall Study|Death|1|||
33543696|NCT01189266|101891778|FG000|Overall Study|No treatment|0|||
33543697|NCT01189266|101891779|FG001|Overall Study|No treatment|0|||
33543698|NCT01189266|101891780|FG002|Overall Study|No treatment|1|||
33543699|NCT03839641|101891781|FG000|Overall Study|Withdrawal by Subject|1|||
33543700|NCT03839641|101891782|FG001|Overall Study|Withdrawal by Subject|1|||
33543701|NCT01937299|101891783|FG000|Overall Study|Adverse Event|13|||
33543702|NCT01937299|101891784|FG001|Overall Study|Adverse Event|0|||
33346975|NCT01506882|101159935|FG001|Overall Study|Withdrawal by Subject|3|||
33543703|NCT01937299|101891783|FG000|Overall Study|Lack of Efficacy|0|||
33543704|NCT01937299|101891784|FG001|Overall Study|Lack of Efficacy|4|||
33543705|NCT01937299|101891783|FG000|Overall Study|Withdrawal by Subject|1|||
33543706|NCT01937299|101891784|FG001|Overall Study|Withdrawal by Subject|0|||
33543707|NCT01163617|101891785|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
33543708|NCT01163617|101891786|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
33543709|NCT01163617|101891787|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
33543710|NCT01163617|101891788|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
33543711|NCT01163617|101891789|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
33543712|NCT01163617|101891790|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
33346976|NCT01506882|101159934|FG000|Overall Study|SAE, non-fatal|2|||
33346977|NCT01506882|101159935|FG001|Overall Study|SAE, non-fatal|0|||
33543713|NCT01163617|101891791|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
33543714|NCT01163617|101891792|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
33212977|NCT00760929|100676786|FG003|Overall Study|Death|0|||
33543715|NCT01163617|101891785|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
33567614|NCT02723955|101973169|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33212978|NCT00760929|100676783|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
33212979|NCT00760929|100676784|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
33212980|NCT00760929|100676785|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
33212981|NCT00760929|100676786|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
33212982|NCT01773070|100676787|FG000|Overall Study|Withdrawal by Subject|24|||
33212983|NCT01773070|100676787|FG000|Overall Study|Lost to Follow-up|39|||
33212984|NCT01773070|100676787|FG000|Overall Study|Other|15|||
33212985|NCT01773070|100676787|FG000|Overall Study|Death (unrelated to study procedures)|3|||
33212986|NCT00127101|100676788|FG000|Base Protocol|Adverse Event|0|||
33212987|NCT00127101|100676789|FG001|Base Protocol|Adverse Event|2|||
33212988|NCT00127101|100676790|FG002|Base Protocol|Adverse Event|1|||
33212989|NCT00127101|100676791|FG003|Base Protocol|Adverse Event|0|||
33212990|NCT00127101|100676792|FG004|Base Protocol|Adverse Event|0|||
33212991|NCT00127101|100676793|FG005|Base Protocol|Adverse Event|0|||
33212992|NCT00127101|100676788|FG000|Base Protocol|Lack of Efficacy|1|||
33212993|NCT00127101|100676789|FG001|Base Protocol|Lack of Efficacy|0|||
33212994|NCT00127101|100676790|FG002|Base Protocol|Lack of Efficacy|0|||
33212995|NCT00127101|100676791|FG003|Base Protocol|Lack of Efficacy|0|||
33212996|NCT00127101|100676792|FG004|Base Protocol|Lack of Efficacy|2|||
33212997|NCT00127101|100676793|FG005|Base Protocol|Lack of Efficacy|0|||
33212998|NCT00127101|100676788|FG000|Base Protocol|Withdrawal by Subject|1|||
33212999|NCT00127101|100676789|FG001|Base Protocol|Withdrawal by Subject|2|||
33213000|NCT00127101|100676790|FG002|Base Protocol|Withdrawal by Subject|1|||
33213001|NCT00127101|100676791|FG003|Base Protocol|Withdrawal by Subject|0|||
33213002|NCT00127101|100676792|FG004|Base Protocol|Withdrawal by Subject|0|||
33213003|NCT00127101|100676793|FG005|Base Protocol|Withdrawal by Subject|1|||
33213004|NCT00127101|100676788|FG000|Continuation Phase|Adverse Event|0|||
33213005|NCT00127101|100676789|FG001|Continuation Phase|Adverse Event|0|||
33213006|NCT00127101|100676790|FG002|Continuation Phase|Adverse Event|0|||
33213007|NCT00127101|100676791|FG003|Continuation Phase|Adverse Event|0|||
33213008|NCT00127101|100676792|FG004|Continuation Phase|Adverse Event|1|||
33213009|NCT00127101|100676793|FG005|Continuation Phase|Adverse Event|1|||
33213010|NCT00127101|100676788|FG000|Continuation Phase|Lack of Efficacy|0|||
33213011|NCT00127101|100676789|FG001|Continuation Phase|Lack of Efficacy|0|||
33213012|NCT00127101|100676790|FG002|Continuation Phase|Lack of Efficacy|0|||
33213013|NCT00127101|100676791|FG003|Continuation Phase|Lack of Efficacy|0|||
33213014|NCT00127101|100676792|FG004|Continuation Phase|Lack of Efficacy|0|||
33213015|NCT00127101|100676793|FG005|Continuation Phase|Lack of Efficacy|1|||
33213016|NCT00127101|100676788|FG000|Continuation Phase|Withdrawal by Subject|0|||
33213017|NCT00127101|100676789|FG001|Continuation Phase|Withdrawal by Subject|0|||
33213018|NCT00127101|100676790|FG002|Continuation Phase|Withdrawal by Subject|1|||
33213019|NCT00127101|100676791|FG003|Continuation Phase|Withdrawal by Subject|0|||
33213020|NCT00127101|100676792|FG004|Continuation Phase|Withdrawal by Subject|2|||
33213021|NCT00127101|100676793|FG005|Continuation Phase|Withdrawal by Subject|1|||
33213022|NCT03422250|100676794|FG000|Intervention|Adverse Event|0|||
33213023|NCT03422250|100676795|FG001|Intervention|Adverse Event|1|||
33543716|NCT01163617|101891786|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
33543717|NCT01163617|101891787|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
33543718|NCT01163617|101891788|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
33543719|NCT01163617|101891789|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
33543720|NCT01163617|101891790|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
33543721|NCT01163617|101891791|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
33616261|NCT00666224|102144316|FG000|Double-Blind|Sponsor decision|1|||
33213024|NCT03422250|100676796|FG002|Intervention|Adverse Event|0|||
33213025|NCT03422250|100676797|FG003|Intervention|Adverse Event|1|||
33213026|NCT03422250|100676794|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
33213027|NCT03422250|100676795|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
33213028|NCT03422250|100676796|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
33213029|NCT03422250|100676797|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
33213030|NCT03422250|100676794|FG000|Follow-up|Withdrawal by Subject|0|||
33213031|NCT03422250|100676795|FG001|Follow-up|Withdrawal by Subject|0|||
33213032|NCT03422250|100676796|FG002|Follow-up|Withdrawal by Subject|0|||
33213033|NCT03422250|100676797|FG003|Follow-up|Withdrawal by Subject|1|||
33213034|NCT03422250|100676794|FG000|Follow-up|Adverse Event|0|||
33616262|NCT00666224|102144317|FG001|Double-Blind|Sponsor decision|0|||
33616263|NCT00666224|102144316|FG000|Double-Blind|Pregnancy|3|||
33616264|NCT00666224|102144317|FG001|Double-Blind|Pregnancy|2|||
33616265|NCT00666224|102144316|FG000|Double-Blind|Noncompliance|1|||
33616266|NCT00666224|102144317|FG001|Double-Blind|Noncompliance|0|||
33616267|NCT00666224|102144316|FG000|Double-Blind|Death|1|||
33616268|NCT00666224|102144317|FG001|Double-Blind|Death|0|||
33616269|NCT00666224|102144316|FG000|Double-Blind|Undefined/Unknown|4|||
33616270|NCT00666224|102144317|FG001|Double-Blind|Undefined/Unknown|1|||
33616271|NCT00666224|102144316|FG000|Open-Label|Adverse Event|8|||
33616272|NCT00666224|102144317|FG001|Open-Label|Adverse Event|43|||
33616273|NCT00666224|102144316|FG000|Open-Label|Lost to Follow-up|4|||
33213035|NCT03422250|100676795|FG001|Follow-up|Adverse Event|0|||
33213036|NCT03422250|100676796|FG002|Follow-up|Adverse Event|0|||
33213037|NCT03422250|100676797|FG003|Follow-up|Adverse Event|1|||
33213038|NCT01692782|100676800|FG000|Overall Study|Adverse Event|12|||
33213039|NCT01692782|100676801|FG001|Overall Study|Adverse Event|32|||
33213040|NCT01692782|100676802|FG002|Overall Study|Adverse Event|2|||
33213041|NCT01692782|100676800|FG000|Overall Study|Lack of Efficacy|1|||
33213042|NCT01692782|100676801|FG001|Overall Study|Lack of Efficacy|2|||
33213043|NCT01692782|100676802|FG002|Overall Study|Lack of Efficacy|0|||
33213044|NCT01692782|100676800|FG000|Overall Study|Lost to Follow-up|2|||
33213045|NCT01692782|100676801|FG001|Overall Study|Lost to Follow-up|7|||
33213046|NCT01692782|100676802|FG002|Overall Study|Lost to Follow-up|1|||
33213047|NCT01692782|100676800|FG000|Overall Study|Pregnancy|1|||
33213048|NCT01692782|100676801|FG001|Overall Study|Pregnancy|0|||
33213049|NCT01692782|100676802|FG002|Overall Study|Pregnancy|0|||
33213050|NCT01692782|100676800|FG000|Overall Study|Protocol Violation|1|||
33213051|NCT01692782|100676801|FG001|Overall Study|Protocol Violation|0|||
33213052|NCT01692782|100676802|FG002|Overall Study|Protocol Violation|2|||
33213053|NCT01692782|100676800|FG000|Overall Study|Non-complance with study drug|0|||
33213054|NCT01692782|100676801|FG001|Overall Study|Non-complance with study drug|4|||
33213055|NCT01692782|100676802|FG002|Overall Study|Non-complance with study drug|1|||
33213056|NCT01692782|100676800|FG000|Overall Study|Non-compliant with study visits|0|||
33213057|NCT01692782|100676801|FG001|Overall Study|Non-compliant with study visits|0|||
33213058|NCT01692782|100676802|FG002|Overall Study|Non-compliant with study visits|1|||
33213059|NCT01692782|100676800|FG000|Overall Study|SAE not related to study drug|0|||
33213060|NCT01692782|100676801|FG001|Overall Study|SAE not related to study drug|1|||
33213061|NCT01692782|100676802|FG002|Overall Study|SAE not related to study drug|0|||
33213062|NCT01692782|100676800|FG000|Overall Study|Withdrawal by Subject|3|||
33213063|NCT01692782|100676801|FG001|Overall Study|Withdrawal by Subject|10|||
33213064|NCT01692782|100676802|FG002|Overall Study|Withdrawal by Subject|3|||
33213065|NCT02261493|100676803|FG000|Overall Study|Noncompliance|0|||
33213066|NCT02261493|100676804|FG001|Overall Study|Noncompliance|0|||
33213067|NCT02261493|100676805|FG002|Overall Study|Noncompliance|2|||
33213068|NCT02261493|100676803|FG000|Overall Study|Physician Decision|0|||
33213069|NCT02261493|100676804|FG001|Overall Study|Physician Decision|1|||
33213070|NCT02261493|100676805|FG002|Overall Study|Physician Decision|0|||
33213071|NCT02261493|100676803|FG000|Overall Study|Undisclosed alcohol abuse|0|||
33213072|NCT02261493|100676804|FG001|Overall Study|Undisclosed alcohol abuse|1|||
33213073|NCT02261493|100676805|FG002|Overall Study|Undisclosed alcohol abuse|0|||
33616274|NCT00666224|102144317|FG001|Open-Label|Lost to Follow-up|5|||
33213074|NCT02261493|100676803|FG000|Overall Study|Protocol Violation|1|||
33213075|NCT02261493|100676804|FG001|Overall Study|Protocol Violation|0|||
33213076|NCT02261493|100676805|FG002|Overall Study|Protocol Violation|0|||
33213077|NCT02261493|100676803|FG000|Overall Study|Personal Reasons|14|||
33213078|NCT02261493|100676804|FG001|Overall Study|Personal Reasons|14|||
33213079|NCT02261493|100676805|FG002|Overall Study|Personal Reasons|16|||
33213080|NCT02261493|100676803|FG000|Overall Study|Lost to Follow-up|14|||
33213081|NCT02261493|100676804|FG001|Overall Study|Lost to Follow-up|27|||
33213082|NCT02261493|100676805|FG002|Overall Study|Lost to Follow-up|8|||
33213083|NCT02261493|100676803|FG000|Overall Study|Pregnancy|1|||
33213084|NCT02261493|100676804|FG001|Overall Study|Pregnancy|2|||
33213085|NCT02261493|100676805|FG002|Overall Study|Pregnancy|0|||
33616275|NCT00666224|102144316|FG000|Open-Label|Withdrawal by Subject|12|||
33213086|NCT02261493|100676803|FG000|Overall Study|Lack of Efficacy|0|||
33213087|NCT02261493|100676804|FG001|Overall Study|Lack of Efficacy|1|||
33213088|NCT02261493|100676805|FG002|Overall Study|Lack of Efficacy|0|||
33213089|NCT02261493|100676803|FG000|Overall Study|Adverse Event|0|||
33213090|NCT02261493|100676804|FG001|Overall Study|Adverse Event|1|||
33213091|NCT02261493|100676805|FG002|Overall Study|Adverse Event|0|||
33213092|NCT02519348|100679558|FG000|Overall Study|Death|31|||
33213093|NCT02519348|100679559|FG001|Overall Study|Death|74|||
33213094|NCT02519348|100679560|FG002|Overall Study|Death|47|||
33213095|NCT02519348|100679561|FG003|Overall Study|Death|54|||
33213096|NCT02519348|100679562|FG004|Overall Study|Death|63|||
33213097|NCT02519348|100679563|FG005|Overall Study|Death|18|||
33616276|NCT00666224|102144317|FG001|Open-Label|Withdrawal by Subject|25|||
33616277|NCT00666224|102144316|FG000|Open-Label|Physician Decision|7|||
33616278|NCT00666224|102144317|FG001|Open-Label|Physician Decision|5|||
33616279|NCT00666224|102144316|FG000|Open-Label|Pregnancy|1|||
33213098|NCT02519348|100679564|FG006|Overall Study|Death|2|||
33213099|NCT02519348|100679565|FG007|Overall Study|Death|5|||
33213100|NCT02519348|100679566|FG008|Overall Study|Death|5|||
33213101|NCT02519348|100679558|FG000|Overall Study|Withdrawal by Subject|4|||
33213102|NCT02519348|100679559|FG001|Overall Study|Withdrawal by Subject|7|||
33213103|NCT02519348|100679560|FG002|Overall Study|Withdrawal by Subject|4|||
33213104|NCT02519348|100679561|FG003|Overall Study|Withdrawal by Subject|3|||
33213105|NCT02519348|100679562|FG004|Overall Study|Withdrawal by Subject|3|||
33213106|NCT02519348|100679563|FG005|Overall Study|Withdrawal by Subject|2|||
33213107|NCT02519348|100679564|FG006|Overall Study|Withdrawal by Subject|0|||
33213108|NCT02519348|100679565|FG007|Overall Study|Withdrawal by Subject|0|||
33213109|NCT02519348|100679566|FG008|Overall Study|Withdrawal by Subject|1|||
33213110|NCT02519348|100679558|FG000|Overall Study|Lost to Follow-up|0|||
33213111|NCT02519348|100679559|FG001|Overall Study|Lost to Follow-up|0|||
33213112|NCT02519348|100679560|FG002|Overall Study|Lost to Follow-up|1|||
33213113|NCT02519348|100679561|FG003|Overall Study|Lost to Follow-up|0|||
33213114|NCT02519348|100679562|FG004|Overall Study|Lost to Follow-up|2|||
33213115|NCT02519348|100679563|FG005|Overall Study|Lost to Follow-up|1|||
33213116|NCT02519348|100679564|FG006|Overall Study|Lost to Follow-up|1|||
33213117|NCT02519348|100679565|FG007|Overall Study|Lost to Follow-up|0|||
33213118|NCT02519348|100679566|FG008|Overall Study|Lost to Follow-up|0|||
33213119|NCT02519348|100679558|FG000|Overall Study|Other|0|||
33408311|NCT01319422|101383149|FG000|Overall Study|Withdrawal by Subject|1|||
33408312|NCT01319422|101383150|FG001|Overall Study|Withdrawal by Subject|0|||
33408313|NCT02491463|101383153|FG000|Overall Study|Withdrawal by Subject|1|||
33408314|NCT02491463|101383154|FG001|Overall Study|Withdrawal by Subject|2|||
33408315|NCT02491463|101383155|FG002|Overall Study|Withdrawal by Subject|0|||
33408316|NCT02491463|101383156|FG003|Overall Study|Withdrawal by Subject|0|||
33408317|NCT02491463|101383153|FG000|Overall Study|Migrated/moved from study area|1|||
33543722|NCT01163617|101891792|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
33543723|NCT01163617|101891785|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
33543724|NCT01163617|101891786|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
33543725|NCT01163617|101891787|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
33543726|NCT01163617|101891788|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
33543727|NCT01163617|101891789|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
33543728|NCT01163617|101891790|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
33543729|NCT01163617|101891791|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
33543730|NCT01163617|101891792|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
33408318|NCT02491463|101383154|FG001|Overall Study|Migrated/moved from study area|5|||
33408319|NCT02491463|101383155|FG002|Overall Study|Migrated/moved from study area|1|||
33543731|NCT01925417|101891793|FG000|Overall Study|Withdrawal by Subject|2|||
33543732|NCT01925417|101891793|FG000|Overall Study|Death|1|||
33616280|NCT00666224|102144317|FG001|Open-Label|Pregnancy|5|||
33616281|NCT00666224|102144316|FG000|Open-Label|Noncompliance|2|||
33213120|NCT02519348|100679559|FG001|Overall Study|Other|3|||
33213121|NCT02519348|100679560|FG002|Overall Study|Other|0|||
33408320|NCT02491463|101383156|FG003|Overall Study|Migrated/moved from study area|1|||
33408321|NCT02491463|101383153|FG000|Overall Study|Lost to Follow-up|0|||
33616282|NCT00666224|102144317|FG001|Open-Label|Noncompliance|1|||
33213122|NCT02519348|100679561|FG003|Overall Study|Other|0|||
33213123|NCT02519348|100679562|FG004|Overall Study|Other|1|||
33213124|NCT02519348|100679563|FG005|Overall Study|Other|0|||
33213125|NCT02519348|100679564|FG006|Overall Study|Other|0|||
33213126|NCT02519348|100679565|FG007|Overall Study|Other|0|||
33408322|NCT02491463|101383154|FG001|Overall Study|Lost to Follow-up|3|||
33408323|NCT02491463|101383155|FG002|Overall Study|Lost to Follow-up|3|||
33408324|NCT02491463|101383156|FG003|Overall Study|Lost to Follow-up|0|||
33408325|NCT00462501|101383159|FG000|Overall Study|Not treated|3|||
33408326|NCT00462501|101383159|FG000|Overall Study|Adverse Event|2|||
33408327|NCT00934661|101383160|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
33408328|NCT00934661|101383161|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
33408329|NCT02452892|101383164|FG000|Week 1 Initial Randommization|Adverse Event|1|||
33408330|NCT02452892|101383165|FG001|Week 1 Initial Randommization|Adverse Event|0|||
33543733|NCT00634504|101891794|FG000|Overall Study|Protocol Violation|1|||
33543734|NCT00634504|101891795|FG001|Overall Study|Protocol Violation|0|||
33543735|NCT00317369|101891796|FG000|Overall Study|Adverse Event|2|||
33543736|NCT00317369|101891797|FG001|Overall Study|Adverse Event|1|||
33543737|NCT00317369|101891798|FG002|Overall Study|Adverse Event|0|||
33543738|NCT00317369|101891796|FG000|Overall Study|Lack of Efficacy|0|||
33543739|NCT00317369|101891797|FG001|Overall Study|Lack of Efficacy|1|||
33543740|NCT00317369|101891798|FG002|Overall Study|Lack of Efficacy|1|||
33543741|NCT00317369|101891796|FG000|Overall Study|Withdrawal by Subject|0|||
33543742|NCT00317369|101891797|FG001|Overall Study|Withdrawal by Subject|0|||
33616283|NCT00666224|102144316|FG000|Open-Label|Undefined/Unknown|1|||
33616284|NCT00666224|102144317|FG001|Open-Label|Undefined/Unknown|1|||
33616285|NCT05236257|102144318|FG000|Overall Study|Ongoing with study treatment|29|||
33616286|NCT05236257|102144319|FG001|Overall Study|Ongoing with study treatment|1|||
33616287|NCT05236257|102144318|FG000|Overall Study|Discontinued study treatment|22|||
33616288|NCT05236257|102144319|FG001|Overall Study|Discontinued study treatment|41|||
33616289|NCT00596830|102144320|FG000|Overall Study|Death|258|||
33616290|NCT00596830|102144321|FG001|Overall Study|Death|247|||
33616291|NCT00596830|102144320|FG000|Overall Study|Lost to Follow-up|7|||
33616292|NCT00596830|102144321|FG001|Overall Study|Lost to Follow-up|11|||
33213127|NCT02519348|100679566|FG008|Overall Study|Other|0|||
33408331|NCT02452892|101383166|FG002|Week 1 Initial Randommization|Adverse Event|0|||
33408332|NCT02452892|101383167|FG003|Week 1 Initial Randommization|Adverse Event|0|||
33408333|NCT02452892|101383164|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
33543743|NCT00317369|101891798|FG002|Overall Study|Withdrawal by Subject|1|||
33616293|NCT00596830|102144320|FG000|Overall Study|Withdrawal by Subject|22|||
33543744|NCT00797563|101891799|FG000|Overall Study|Adverse Event|1|||
33543745|NCT04465422|101891800|FG000|Overall Study|Lost to Follow-up|0|||
33543746|NCT04465422|101891801|FG001|Overall Study|Lost to Follow-up|2|||
33543747|NCT01582451|101891802|FG000|Overall Study|Adverse Event|1|||
33616294|NCT00596830|102144321|FG001|Overall Study|Withdrawal by Subject|12|||
33543748|NCT01582451|101891803|FG001|Overall Study|Adverse Event|3|||
33213128|NCT02519348|100679558|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
33213129|NCT02519348|100679559|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
33213130|NCT02519348|100679560|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
33213131|NCT02519348|100679561|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
33213132|NCT02519348|100679562|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
33213133|NCT02519348|100679563|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
33213134|NCT02519348|100679564|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
33213135|NCT02519348|100679565|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
33213136|NCT02519348|100679566|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
33346978|NCT01506882|101159934|FG000|Overall Study|AE, non-serious non-fatal|3|||
33346979|NCT01506882|101159935|FG001|Overall Study|AE, non-serious non-fatal|1|||
33346980|NCT01506882|101159934|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
33408334|NCT02452892|101383165|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
33408335|NCT02452892|101383166|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
33408336|NCT02452892|101383167|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
33408337|NCT02452892|101383164|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
33408338|NCT02452892|101383165|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
33408339|NCT02452892|101383166|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
33346981|NCT01506882|101159935|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
33346982|NCT01506882|101159934|FG000|Overall Study|Other Reason|2|||
33346983|NCT01506882|101159935|FG001|Overall Study|Other Reason|0|||
33346984|NCT00700804|101159938|FG000|Overall Study|Withdrawal by Subject|1|||
33346985|NCT00700804|101159939|FG001|Overall Study|Withdrawal by Subject|2|||
33346986|NCT00700804|101159938|FG000|Overall Study|Protocol Violation|1|||
33346987|NCT00700804|101159939|FG001|Overall Study|Protocol Violation|1|||
33346988|NCT00700804|101159938|FG000|Overall Study|Loose Stools|1|||
33408340|NCT02452892|101383167|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
33408341|NCT02452892|101383164|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
33408342|NCT02452892|101383165|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
33408343|NCT02452892|101383166|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
33408344|NCT02452892|101383167|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
33408345|NCT02452892|101383164|FG000|Follow-up|Withdrawal by Subject|0|||
33543749|NCT01582451|101891802|FG000|Overall Study|Death|3|||
33543750|NCT01582451|101891803|FG001|Overall Study|Death|3|||
33346989|NCT00700804|101159939|FG001|Overall Study|Loose Stools|1|||
33408346|NCT02452892|101383165|FG001|Follow-up|Withdrawal by Subject|0|||
33543751|NCT01582451|101891802|FG000|Overall Study|Lost to Follow-up|0|||
33346990|NCT01256177|101159940|FG000|Overall Study|Withdrawal by Subject|23|||
33346991|NCT01256177|101159941|FG001|Overall Study|Withdrawal by Subject|22|||
33408347|NCT02452892|101383166|FG002|Follow-up|Withdrawal by Subject|0|||
33408348|NCT02452892|101383167|FG003|Follow-up|Withdrawal by Subject|1|||
33408349|NCT02452892|101383164|FG000|Follow-up|Subject left town on Day 42|1|||
33408350|NCT02452892|101383165|FG001|Follow-up|Subject left town on Day 42|0|||
33408351|NCT02452892|101383166|FG002|Follow-up|Subject left town on Day 42|0|||
33408352|NCT02452892|101383167|FG003|Follow-up|Subject left town on Day 42|0|||
33408353|NCT01021423|101383177|FG000|Overall Study|Study terminated|4|||
33408354|NCT01021423|101383178|FG001|Overall Study|Study terminated|5|||
33408355|NCT00148109|101383179|FG000|Overall Study|Lack of Efficacy|10|||
33408356|NCT00148109|101383180|FG001|Overall Study|Lack of Efficacy|18|||
33408357|NCT00148109|101383179|FG000|Overall Study|Adverse Event|0|||
33408358|NCT00148109|101383180|FG001|Overall Study|Adverse Event|2|||
33408359|NCT00148109|101383179|FG000|Overall Study|Withdrawal by Subject|2|||
33408360|NCT00148109|101383180|FG001|Overall Study|Withdrawal by Subject|0|||
33408361|NCT02613910|101383187|FG000|Overall Study|Termination of study|1|||
33408362|NCT02788981|101383188|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
33408363|NCT02788981|101383189|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
33408364|NCT02763566|101383190|FG000|Overall Study|Lost to Follow-up|1|||
33408365|NCT02763566|101383191|FG001|Overall Study|Lost to Follow-up|4|||
33408366|NCT02763566|101383192|FG002|Overall Study|Lost to Follow-up|0|||
33408367|NCT02763566|101383193|FG003|Overall Study|Lost to Follow-up|1|||
33408368|NCT02763566|101383190|FG000|Overall Study|On study treatment at study conclusion|114|||
33408369|NCT02763566|101383191|FG001|Overall Study|On study treatment at study conclusion|34|||
33408370|NCT02763566|101383192|FG002|Overall Study|On study treatment at study conclusion|54|||
33408371|NCT02763566|101383193|FG003|Overall Study|On study treatment at study conclusion|13|||
33408372|NCT02763566|101383190|FG000|Overall Study|Withdrawal by Subject|3|||
33408373|NCT02763566|101383191|FG001|Overall Study|Withdrawal by Subject|1|||
33408374|NCT02763566|101383192|FG002|Overall Study|Withdrawal by Subject|0|||
33408375|NCT02763566|101383193|FG003|Overall Study|Withdrawal by Subject|0|||
33408376|NCT00496782|101383196|FG000|Overall Study|Protocol Violation|1|||
33408377|NCT00496782|101383197|FG001|Overall Study|Protocol Violation|2|||
33408378|NCT03319160|101383198|FG000|Overall Study|Data not available.|7|||
33408379|NCT00945815|101383199|FG000|Overall Study|Death|3|||
33408380|NCT00945815|101383199|FG000|Overall Study|Not protocol specified|1|||
33408381|NCT00945815|101383199|FG000|Overall Study|Ineligible|3|||
33408382|NCT00945815|101383199|FG000|Overall Study|Did not begin protocol therapy|1|||
33408383|NCT02221882|101383200|FG000|Overall Study|Withdrawal by Subject|0|||
33408384|NCT02221882|101383201|FG001|Overall Study|Withdrawal by Subject|0|||
33408385|NCT02221882|101383202|FG002|Overall Study|Withdrawal by Subject|4|||
33408386|NCT02221882|101383203|FG003|Overall Study|Withdrawal by Subject|2|||
33408387|NCT02221882|101383204|FG004|Overall Study|Withdrawal by Subject|2|||
33408388|NCT02221882|101383205|FG005|Overall Study|Withdrawal by Subject|2|||
33408389|NCT02221882|101383200|FG000|Overall Study|Death|0|||
33408390|NCT02221882|101383201|FG001|Overall Study|Death|1|||
33408391|NCT02221882|101383202|FG002|Overall Study|Death|0|||
33408392|NCT02221882|101383203|FG003|Overall Study|Death|0|||
33408393|NCT02221882|101383204|FG004|Overall Study|Death|0|||
33408394|NCT02221882|101383205|FG005|Overall Study|Death|0|||
33408395|NCT01539512|101383206|FG000|Overall Study|Adverse Event|9|||
33408396|NCT01539512|101383207|FG001|Overall Study|Adverse Event|7|||
33408397|NCT01539512|101383206|FG000|Overall Study|Physician Decision|1|||
33408398|NCT01539512|101383207|FG001|Overall Study|Physician Decision|1|||
33408399|NCT01539512|101383206|FG000|Overall Study|Withdrawal by Subject|12|||
33408400|NCT01539512|101383207|FG001|Overall Study|Withdrawal by Subject|5|||
33408401|NCT01539512|101383206|FG000|Overall Study|Richter's Transformation|1|||
33408402|NCT01539512|101383207|FG001|Overall Study|Richter's Transformation|0|||
33543752|NCT01582451|101891803|FG001|Overall Study|Lost to Follow-up|2|||
33616295|NCT00596830|102144320|FG000|Overall Study|Study terminated by sponsor|51|||
33616296|NCT00596830|102144321|FG001|Overall Study|Study terminated by sponsor|62|||
33616297|NCT00596830|102144320|FG000|Overall Study|Follow-up was discontinued|1|||
33408403|NCT03319368|101383208|FG000|Overall Study|Discharge swabs not collected from resident|57|||
33408404|NCT03319368|101383209|FG001|Overall Study|Discharge swabs not collected from resident|46|||
33408405|NCT01641952|101383210|FG000|Overall Study|Lost to Follow-up|28|||
33408406|NCT01641952|101383210|FG000|Overall Study|Adverse Event|6|||
33408407|NCT02369874|101383213|FG000|Overall Study|Lost to Follow-up|2|||
33408408|NCT02369874|101383214|FG001|Overall Study|Lost to Follow-up|2|||
33408409|NCT02369874|101383215|FG002|Overall Study|Lost to Follow-up|2|||
33408410|NCT02369874|101383213|FG000|Overall Study|Withdrawal by Subject|7|||
33408411|NCT02369874|101383214|FG001|Overall Study|Withdrawal by Subject|9|||
33408412|NCT02369874|101383215|FG002|Overall Study|Withdrawal by Subject|27|||
33543753|NCT01582451|101891802|FG000|Overall Study|Protocol Violation|11|||
33543754|NCT01582451|101891803|FG001|Overall Study|Protocol Violation|3|||
33543755|NCT01582451|101891802|FG000|Overall Study|Withdrawal by Subject|13|||
33543756|NCT01582451|101891803|FG001|Overall Study|Withdrawal by Subject|9|||
33543757|NCT01582451|101891802|FG000|Overall Study|Physician Decision|3|||
33543758|NCT01582451|101891803|FG001|Overall Study|Physician Decision|0|||
33543759|NCT01582451|101891802|FG000|Overall Study|Sponsor Decision|1|||
33543760|NCT01582451|101891803|FG001|Overall Study|Sponsor Decision|0|||
33543761|NCT02787304|101891804|FG000|Overall Study|Adverse Event|9|||
33543762|NCT02787304|101891805|FG001|Overall Study|Adverse Event|3|||
33543763|NCT02787304|101891806|FG002|Overall Study|Adverse Event|8|||
33543764|NCT02787304|101891807|FG003|Overall Study|Adverse Event|1|||
33543765|NCT02787304|101891804|FG000|Overall Study|Withdrawal by Subject|1|||
33616298|NCT00596830|102144321|FG001|Overall Study|Follow-up was discontinued|0|||
33616299|NCT00596830|102144320|FG000|Overall Study|Randomized but not treated|3|||
33616300|NCT00596830|102144321|FG001|Overall Study|Randomized but not treated|7|||
33616301|NCT01363661|102144326|FG000|Overall Study|Adverse Event|9|||
33616302|NCT01363661|102144327|FG001|Overall Study|Adverse Event|2|||
33616303|NCT01363661|102144326|FG000|Overall Study|Withdrawal by Subject|1|||
33346992|NCT01256177|101159940|FG000|Overall Study|Lost to Follow-up|2|||
33346993|NCT01256177|101159941|FG001|Overall Study|Lost to Follow-up|2|||
33346994|NCT01256177|101159940|FG000|Overall Study|Adverse Event|8|||
33346995|NCT01256177|101159941|FG001|Overall Study|Adverse Event|9|||
33346996|NCT01256177|101159940|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
33346997|NCT01256177|101159941|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
33346998|NCT01256177|101159940|FG000|Overall Study|Condition under Investigation Worsened|1|||
33346999|NCT01256177|101159941|FG001|Overall Study|Condition under Investigation Worsened|0|||
33347000|NCT01256177|101159940|FG000|Overall Study|Lack of Efficacy|11|||
33347001|NCT01256177|101159941|FG001|Overall Study|Lack of Efficacy|2|||
33347002|NCT01256177|101159940|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
33347003|NCT01256177|101159941|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
33347004|NCT01959165|101159942|FG000|Overall Study|Adverse Event|0|||
33347005|NCT01959165|101159943|FG001|Overall Study|Adverse Event|0|||
33347006|NCT01959165|101159944|FG002|Overall Study|Adverse Event|0|||
33347007|NCT01959165|101159945|FG003|Overall Study|Adverse Event|1|||
33347008|NCT01959165|101159942|FG000|Overall Study|Lack of Efficacy|1|||
33347009|NCT01959165|101159943|FG001|Overall Study|Lack of Efficacy|0|||
33347010|NCT01959165|101159944|FG002|Overall Study|Lack of Efficacy|0|||
33347011|NCT01959165|101159945|FG003|Overall Study|Lack of Efficacy|0|||
33347012|NCT01959165|101159942|FG000|Overall Study|overdose|0|||
33347013|NCT01959165|101159943|FG001|Overall Study|overdose|0|||
33347014|NCT01959165|101159944|FG002|Overall Study|overdose|0|||
33347015|NCT01959165|101159945|FG003|Overall Study|overdose|1|||
33347016|NCT01959165|101159942|FG000|Overall Study|Welfare recipient|0|||
33347017|NCT01959165|101159943|FG001|Overall Study|Welfare recipient|1|||
33347018|NCT01959165|101159944|FG002|Overall Study|Welfare recipient|0|||
33347019|NCT01959165|101159945|FG003|Overall Study|Welfare recipient|0|||
33347020|NCT02723201|101159948|FG000|Second Intervention Period|Protocol Violation|1|||
33347021|NCT02723201|101159949|FG001|Second Intervention Period|Protocol Violation|0|||
33347022|NCT02723201|101159950|FG002|Second Intervention Period|Protocol Violation|0|||
33347023|NCT02723201|101159948|FG000|Second Intervention Period|Adverse Event|1|||
33347024|NCT02723201|101159949|FG001|Second Intervention Period|Adverse Event|0|||
33347025|NCT02723201|101159950|FG002|Second Intervention Period|Adverse Event|0|||
33347026|NCT01671280|101159953|FG000|Overall Study|Withdrawal by Subject|2|||
33347027|NCT01848145|101159954|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
33347028|NCT01848145|101159954|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
33347029|NCT01848145|101159954|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
33347030|NCT01848145|101159954|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
33347031|NCT01848145|101159954|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
33616304|NCT01363661|102144327|FG001|Overall Study|Withdrawal by Subject|1|||
33616305|NCT01363661|102144326|FG000|Overall Study|Protocol Violation|1|||
33616306|NCT01363661|102144327|FG001|Overall Study|Protocol Violation|0|||
33347032|NCT01848145|101159954|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
33347033|NCT01848145|101159954|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
33347034|NCT00463476|101159955|FG000|Overall Study|Withdrawal by Subject|1|||
33347035|NCT00463476|101159956|FG001|Overall Study|Withdrawal by Subject|2|||
33347036|NCT00463476|101159955|FG000|Overall Study|Lost to Follow-up|1|||
33347037|NCT00463476|101159956|FG001|Overall Study|Lost to Follow-up|1|||
33408413|NCT02369874|101383213|FG000|Overall Study|Miscellaneous|1|||
33543766|NCT02787304|101891805|FG001|Overall Study|Withdrawal by Subject|4|||
33543767|NCT02787304|101891806|FG002|Overall Study|Withdrawal by Subject|0|||
33543768|NCT02787304|101891807|FG003|Overall Study|Withdrawal by Subject|0|||
33408414|NCT02369874|101383214|FG001|Overall Study|Miscellaneous|1|||
33408415|NCT02369874|101383215|FG002|Overall Study|Miscellaneous|0|||
33408416|NCT02369874|101383213|FG000|Overall Study|On Treatment/Off Study|34|||
33408417|NCT02369874|101383214|FG001|Overall Study|On Treatment/Off Study|45|||
33408418|NCT02369874|101383215|FG002|Overall Study|On Treatment/Off Study|32|||
33408419|NCT00682539|101383216|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
33408420|NCT00682539|101383217|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
33408421|NCT00682539|101383218|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
33408422|NCT00682539|101383216|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
33408423|NCT00682539|101383217|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
33408424|NCT00682539|101383218|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
33408425|NCT01161173|101383220|FG000|Overall Study|Protocol Violation|13|||
33408426|NCT01161173|101383220|FG000|Overall Study|Lost to Follow-up|7|||
33408427|NCT01161173|101383220|FG000|Overall Study|Progressive Disease|82|||
33408428|NCT01161173|101383220|FG000|Overall Study|Withdrawal of Consent|5|||
33408429|NCT01161173|101383220|FG000|Overall Study|Unacceptable Toxicity|21|||
33408430|NCT01161173|101383220|FG000|Overall Study|Death|194|||
33408431|NCT01161173|101383220|FG000|Overall Study|End of Study|2|||
33408432|NCT01161173|101383220|FG000|Overall Study|Reasons Not Specified|23|||
33408433|NCT00706901|101386004|FG000|Overall Study|Lost to Follow-up|2|||
33408434|NCT00706901|101386005|FG001|Overall Study|Lost to Follow-up|3|||
33408435|NCT00706901|101386006|FG002|Overall Study|Lost to Follow-up|2|||
33408436|NCT00706901|101386004|FG000|Overall Study|Withdrawal by Subject|4|||
33408437|NCT00706901|101386005|FG001|Overall Study|Withdrawal by Subject|2|||
33408438|NCT00706901|101386006|FG002|Overall Study|Withdrawal by Subject|5|||
33408439|NCT00706901|101386004|FG000|Overall Study|In Jail|1|||
33408440|NCT00706901|101386005|FG001|Overall Study|In Jail|0|||
33408441|NCT00706901|101386006|FG002|Overall Study|In Jail|1|||
33408442|NCT00706901|101386004|FG000|Overall Study|Death|1|||
33408443|NCT00706901|101386005|FG001|Overall Study|Death|0|||
33408444|NCT00706901|101386006|FG002|Overall Study|Death|0|||
33408445|NCT03785782|101386007|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
33408446|NCT03785782|101386008|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
33408447|NCT03785782|101386007|FG000|Overall Study|Withdrawal by Subject|1|||
33408448|NCT03785782|101386008|FG001|Overall Study|Withdrawal by Subject|1|||
33408449|NCT03785782|101386007|FG000|Overall Study|insufficient image quality.|3|||
33408450|NCT03785782|101386008|FG001|Overall Study|insufficient image quality.|0|||
33408451|NCT02180659|101386012|FG000|Overall Study|Adverse Event|1|||
33408452|NCT02180659|101386013|FG001|Overall Study|Adverse Event|0|||
33408453|NCT02180659|101386012|FG000|Overall Study|Lost to Follow-up|4|||
33408454|NCT02180659|101386013|FG001|Overall Study|Lost to Follow-up|2|||
33408455|NCT02180659|101386012|FG000|Overall Study|Subject incarcerated during conduct|1|||
33408456|NCT02180659|101386013|FG001|Overall Study|Subject incarcerated during conduct|0|||
33408457|NCT02180659|101386012|FG000|Overall Study|Withdrawal by Subject|0|||
33408458|NCT02180659|101386013|FG001|Overall Study|Withdrawal by Subject|2|||
33408459|NCT02180659|101386012|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
33408460|NCT02180659|101386013|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
33408461|NCT03380091|101386014|FG000|Overall Study|Withdrawal by Subject|2|||
33408462|NCT03380091|101386015|FG001|Overall Study|Withdrawal by Subject|1|||
33408463|NCT02839330|101386022|FG000|Overall Study|Adverse Event|0|||
33408464|NCT02839330|101386023|FG001|Overall Study|Adverse Event|1|||
33408465|NCT02839330|101386024|FG002|Overall Study|Adverse Event|2|||
33213137|NCT03750552|100679567|FG000|Overall Study|Adverse Event|5|||
33408466|NCT02839330|101386025|FG003|Overall Study|Adverse Event|2|||
33408467|NCT02839330|101386022|FG000|Overall Study|Death|4|||
33543769|NCT02787304|101891804|FG000|Overall Study|Lost to Follow-up|1|||
33543770|NCT02787304|101891805|FG001|Overall Study|Lost to Follow-up|0|||
33543771|NCT02787304|101891806|FG002|Overall Study|Lost to Follow-up|0|||
33543772|NCT02787304|101891807|FG003|Overall Study|Lost to Follow-up|1|||
33543773|NCT02787304|101891804|FG000|Overall Study|Noncompliance with study drug|0|||
33543774|NCT02787304|101891805|FG001|Overall Study|Noncompliance with study drug|0|||
33543775|NCT02787304|101891806|FG002|Overall Study|Noncompliance with study drug|1|||
33543776|NCT02787304|101891807|FG003|Overall Study|Noncompliance with study drug|0|||
33543777|NCT02787304|101891804|FG000|Overall Study|Physician Decision|0|||
33543778|NCT02787304|101891805|FG001|Overall Study|Physician Decision|0|||
33543779|NCT02787304|101891806|FG002|Overall Study|Physician Decision|1|||
33543780|NCT02787304|101891807|FG003|Overall Study|Physician Decision|0|||
33347038|NCT01777763|101159959|FG000|Overall Study|Adverse Event|2|||
33347039|NCT01777763|101159960|FG001|Overall Study|Adverse Event|32|||
33347040|NCT01777763|101159959|FG000|Overall Study|Protocol Violation|1|||
33347041|NCT01777763|101159960|FG001|Overall Study|Protocol Violation|7|||
33347042|NCT01777763|101159959|FG000|Overall Study|Withdrawal by Subject|0|||
33347043|NCT01777763|101159960|FG001|Overall Study|Withdrawal by Subject|2|||
33347044|NCT01777763|101159959|FG000|Overall Study|Treatment Failure|1|||
33347045|NCT01777763|101159960|FG001|Overall Study|Treatment Failure|6|||
33347046|NCT03372941|101159961|FG000|Overall Study|Lost to Follow-up|2|||
33347047|NCT03372941|101159962|FG001|Overall Study|Lost to Follow-up|4|||
33543781|NCT02787304|101891804|FG000|Overall Study|Study terminated by sponsor|25|||
33543782|NCT02787304|101891805|FG001|Overall Study|Study terminated by sponsor|31|||
33543783|NCT02787304|101891806|FG002|Overall Study|Study terminated by sponsor|31|||
33543784|NCT02787304|101891807|FG003|Overall Study|Study terminated by sponsor|32|||
33543785|NCT02747927|101891810|FG000|Overall Study|Adverse Event|5|||
33543786|NCT02747927|101891811|FG001|Overall Study|Adverse Event|14|||
33543787|NCT02747927|101891810|FG000|Overall Study|Lost to Follow-up|22|||
33543788|NCT02747927|101891811|FG001|Overall Study|Lost to Follow-up|43|||
33543789|NCT02747927|101891810|FG000|Overall Study|Pregnancy|34|||
33543790|NCT02747927|101891811|FG001|Overall Study|Pregnancy|66|||
33543791|NCT02747927|101891810|FG000|Overall Study|Protocol Violation|2|||
33543792|NCT02747927|101891811|FG001|Overall Study|Protocol Violation|4|||
33347048|NCT02899156|101159963|FG000|Overall Study|Death|1|||
33347049|NCT02899156|101159964|FG001|Overall Study|Death|0|||
33543793|NCT02747927|101891810|FG000|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|147|||
33347050|NCT02899156|101159963|FG000|Overall Study|Physician Decision|0|||
33347051|NCT02899156|101159964|FG001|Overall Study|Physician Decision|1|||
33616307|NCT01363661|102144326|FG000|Overall Study|Lost to Follow-up|3|||
33616308|NCT01363661|102144327|FG001|Overall Study|Lost to Follow-up|1|||
33616309|NCT02452424|102144328|FG000|Overall Study|Death|2|||
33616310|NCT02452424|102144329|FG001|Overall Study|Death|2|||
33616311|NCT02452424|102144330|FG002|Overall Study|Death|2|||
33616312|NCT02452424|102144331|FG003|Overall Study|Death|6|||
33616313|NCT02452424|102144332|FG004|Overall Study|Death|2|||
33616314|NCT02452424|102144333|FG005|Overall Study|Death|0|||
33543794|NCT02747927|101891811|FG001|Overall Study|Withdrawal by Participant and/or Participants Parent/Guardian|304|||
33543795|NCT02747927|101891810|FG000|Overall Study|Reason not Specified|11|||
33543796|NCT02747927|101891811|FG001|Overall Study|Reason not Specified|27|||
33543797|NCT01202591|101891818|FG000|Overall Study|Adverse Event|2|||
33616315|NCT02452424|102144334|FG006|Overall Study|Death|5|||
33616316|NCT02452424|102144335|FG007|Overall Study|Death|1|||
33616317|NCT02452424|102144336|FG008|Overall Study|Death|3|||
33543798|NCT01202591|101891819|FG001|Overall Study|Adverse Event|1|||
33543799|NCT01202591|101891820|FG002|Overall Study|Adverse Event|4|||
33543800|NCT01202591|101891821|FG003|Overall Study|Adverse Event|4|||
33616318|NCT02452424|102144337|FG009|Overall Study|Death|1|||
33616319|NCT02452424|102144338|FG010|Overall Study|Death|0|||
33616320|NCT02452424|102144328|FG000|Overall Study|Lost to Follow-up|0|||
33616321|NCT02452424|102144329|FG001|Overall Study|Lost to Follow-up|1|||
33616322|NCT02452424|102144330|FG002|Overall Study|Lost to Follow-up|1|||
33616323|NCT02452424|102144331|FG003|Overall Study|Lost to Follow-up|0|||
33616324|NCT02452424|102144332|FG004|Overall Study|Lost to Follow-up|0|||
33616325|NCT02452424|102144333|FG005|Overall Study|Lost to Follow-up|0|||
33616326|NCT02452424|102144334|FG006|Overall Study|Lost to Follow-up|0|||
33616327|NCT02452424|102144335|FG007|Overall Study|Lost to Follow-up|0|||
33616328|NCT02452424|102144336|FG008|Overall Study|Lost to Follow-up|0|||
33616329|NCT02452424|102144337|FG009|Overall Study|Lost to Follow-up|0|||
33543801|NCT01202591|101891822|FG004|Overall Study|Adverse Event|0|||
33543802|NCT01202591|101891823|FG005|Overall Study|Adverse Event|0|||
33543803|NCT01202591|101891818|FG000|Overall Study|Other reason as per investigator|3|||
33543804|NCT01202591|101891819|FG001|Overall Study|Other reason as per investigator|4|||
33543805|NCT01202591|101891820|FG002|Overall Study|Other reason as per investigator|7|||
33543806|NCT01202591|101891821|FG003|Overall Study|Other reason as per investigator|3|||
33616330|NCT02452424|102144338|FG010|Overall Study|Lost to Follow-up|0|||
33616331|NCT02452424|102144328|FG000|Overall Study|Withdrawal by Subject|0|||
33616332|NCT02452424|102144329|FG001|Overall Study|Withdrawal by Subject|0|||
33616333|NCT02452424|102144330|FG002|Overall Study|Withdrawal by Subject|3|||
33616334|NCT02452424|102144331|FG003|Overall Study|Withdrawal by Subject|2|||
33347052|NCT02911688|101159965|FG000|Washout|Lost to Follow-up|1|||
33347053|NCT02911688|101159966|FG001|Washout|Lost to Follow-up|1|||
33543807|NCT01202591|101891822|FG004|Overall Study|Other reason as per investigator|1|||
33543808|NCT01202591|101891823|FG005|Overall Study|Other reason as per investigator|3|||
33543809|NCT01202591|101891818|FG000|Overall Study|Withdrawal by Subject|0|||
33543810|NCT01202591|101891819|FG001|Overall Study|Withdrawal by Subject|0|||
33543811|NCT01202591|101891820|FG002|Overall Study|Withdrawal by Subject|0|||
33543812|NCT01202591|101891821|FG003|Overall Study|Withdrawal by Subject|0|||
33543813|NCT01202591|101891822|FG004|Overall Study|Withdrawal by Subject|2|||
33543814|NCT01202591|101891823|FG005|Overall Study|Withdrawal by Subject|1|||
33543815|NCT01202591|101891818|FG000|Overall Study|Objective Disease Progression|0|||
33543816|NCT01202591|101891819|FG001|Overall Study|Objective Disease Progression|0|||
33543817|NCT01202591|101891820|FG002|Overall Study|Objective Disease Progression|0|||
33543818|NCT01202591|101891821|FG003|Overall Study|Objective Disease Progression|0|||
33543819|NCT01202591|101891822|FG004|Overall Study|Objective Disease Progression|2|||
33543820|NCT01202591|101891823|FG005|Overall Study|Objective Disease Progression|0|||
33543821|NCT00765076|101891824|FG000|Overall Study|Adverse Event|1|||
33543822|NCT00765076|101891825|FG001|Overall Study|Adverse Event|0|||
33616335|NCT02452424|102144332|FG004|Overall Study|Withdrawal by Subject|0|||
33347054|NCT02911688|101159965|FG000|Washout|Withdrawal by Subject|0|||
33347055|NCT02911688|101159966|FG001|Washout|Withdrawal by Subject|1|||
33347056|NCT00559273|101159967|FG000|Correction Period (20 Weeks)|Death|3|||
33543823|NCT00765076|101891826|FG002|Overall Study|Adverse Event|0|||
33543824|NCT00765076|101891824|FG000|Overall Study|Withdrawal by Subject|0|||
33543825|NCT00765076|101891825|FG001|Overall Study|Withdrawal by Subject|0|||
33543826|NCT00765076|101891826|FG002|Overall Study|Withdrawal by Subject|1|||
33616336|NCT02452424|102144333|FG005|Overall Study|Withdrawal by Subject|0|||
33616337|NCT02452424|102144334|FG006|Overall Study|Withdrawal by Subject|1|||
33616338|NCT02452424|102144335|FG007|Overall Study|Withdrawal by Subject|0|||
33347057|NCT00559273|101159968|FG001|Correction Period (20 Weeks)|Death|4|||
33543827|NCT03550209|101891827|FG000|Overall Study|Lost to Follow-up|1|||
33543828|NCT03550209|101891828|FG001|Overall Study|Lost to Follow-up|0|||
33543829|NCT03550209|101891829|FG002|Overall Study|Lost to Follow-up|1|||
33543830|NCT03550209|101891830|FG003|Overall Study|Lost to Follow-up|0|||
33616339|NCT02452424|102144336|FG008|Overall Study|Withdrawal by Subject|1|||
33543831|NCT03550209|101891827|FG000|Overall Study|Withdrawal by Subject|0|||
33543832|NCT03550209|101891828|FG001|Overall Study|Withdrawal by Subject|3|||
33543833|NCT03550209|101891829|FG002|Overall Study|Withdrawal by Subject|1|||
33543834|NCT03550209|101891830|FG003|Overall Study|Withdrawal by Subject|2|||
33543835|NCT03550209|101891827|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
33543836|NCT03550209|101891828|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
33543837|NCT03550209|101891829|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
33543838|NCT03550209|101891830|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
33543839|NCT00903201|101891831|FG000|Overall Study|Adverse Event|1|||
33543840|NCT00903201|101891832|FG001|Overall Study|Adverse Event|4|||
33543841|NCT00903201|101891833|FG002|Overall Study|Adverse Event|0|||
33543842|NCT00903201|101891831|FG000|Overall Study|Protocol Violation|2|||
33543843|NCT00903201|101891832|FG001|Overall Study|Protocol Violation|1|||
33543844|NCT00903201|101891833|FG002|Overall Study|Protocol Violation|0|||
33543845|NCT00903201|101891831|FG000|Overall Study|Lost to Follow-up|0|||
33543846|NCT00903201|101891832|FG001|Overall Study|Lost to Follow-up|1|||
33543847|NCT00903201|101891833|FG002|Overall Study|Lost to Follow-up|0|||
33543848|NCT00903201|101891831|FG000|Overall Study|Physician Decision|1|||
33543849|NCT00903201|101891832|FG001|Overall Study|Physician Decision|0|||
33543850|NCT00903201|101891833|FG002|Overall Study|Physician Decision|1|||
33543851|NCT00903201|101891831|FG000|Overall Study|Withdrawal by Subject|1|||
33543852|NCT00903201|101891832|FG001|Overall Study|Withdrawal by Subject|0|||
33543853|NCT00903201|101891833|FG002|Overall Study|Withdrawal by Subject|1|||
33543854|NCT01416571|101891834|FG000|Overall Study|Lost to Follow-up|2|||
33543855|NCT02908347|101891845|FG000|Overall Study|Adverse Event|0|||
33543856|NCT02908347|101891846|FG001|Overall Study|Adverse Event|1|||
33543857|NCT02908347|101891845|FG000|Overall Study|Lost to Follow-up|1|||
33543858|NCT02908347|101891846|FG001|Overall Study|Lost to Follow-up|0|||
33543859|NCT02802228|101891847|FG000|Overall Study|Withdrawal by Subject|2|||
33543860|NCT02802228|101891848|FG001|Overall Study|Withdrawal by Subject|0|||
33543861|NCT02802228|101891847|FG000|Overall Study|Lost to Follow-up|1|||
33543862|NCT02802228|101891848|FG001|Overall Study|Lost to Follow-up|0|||
33543863|NCT02802228|101891847|FG000|Overall Study|Adverse Event|1|||
33543864|NCT02802228|101891848|FG001|Overall Study|Adverse Event|0|||
33543865|NCT02802228|101891847|FG000|Overall Study|Physician Decision|1|||
33543866|NCT02802228|101891848|FG001|Overall Study|Physician Decision|0|||
33543867|NCT00294658|101891849|FG000|Overall Study|Death|0|||
33543868|NCT00294658|101891850|FG001|Overall Study|Death|1|||
33543869|NCT00294658|101891849|FG000|Overall Study|Lost to Follow-up|4|||
33543870|NCT00294658|101891850|FG001|Overall Study|Lost to Follow-up|0|||
33543871|NCT00294658|101891849|FG000|Overall Study|Physician Decision|1|||
33543872|NCT00294658|101891850|FG001|Overall Study|Physician Decision|2|||
33543873|NCT00294658|101891849|FG000|Overall Study|Pregnancy|0|||
33543874|NCT00294658|101891850|FG001|Overall Study|Pregnancy|1|||
33543875|NCT00294658|101891849|FG000|Overall Study|Withdrawal by Subject|0|||
33543876|NCT00294658|101891850|FG001|Overall Study|Withdrawal by Subject|4|||
33543877|NCT00294658|101891849|FG000|Overall Study|Found to have invasive thymoma|1|||
33543878|NCT00294658|101891850|FG001|Overall Study|Found to have invasive thymoma|0|||
33543879|NCT00294658|101891849|FG000|Overall Study|Patient and family were not satisfied|0|||
33213138|NCT03750552|100679568|FG001|Overall Study|Adverse Event|1|||
33213139|NCT03750552|100679567|FG000|Overall Study|Withdrawal by Subject|1|||
33213140|NCT03750552|100679568|FG001|Overall Study|Withdrawal by Subject|1|||
33213141|NCT03750552|100679567|FG000|Overall Study|Other|2|||
33213142|NCT03750552|100679568|FG001|Overall Study|Other|0|||
33347058|NCT00559273|101159967|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
33347059|NCT00559273|101159968|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
33543880|NCT00294658|101891850|FG001|Overall Study|Patient and family were not satisfied|1|||
33543881|NCT04459338|101891851|FG000|Overall Study|Loss of IV during study|1|||
33543882|NCT04459338|101891852|FG001|Overall Study|Loss of IV during study|0|||
33543883|NCT00352118|101891853|FG000|Overall Study|Physician Decision|4|||
33543884|NCT00630292|101891854|FG000|Overall Study|Withdrawal by Subject|1|||
33543885|NCT03091439|101891858|FG000|Overall Study|Study Terminated by the Sponsor|1|||
33543886|NCT03091439|101891859|FG001|Overall Study|Study Terminated by the Sponsor|0|||
33543887|NCT02059239|101891860|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
33543888|NCT02059239|101891861|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
33543889|NCT02059239|101891860|FG000|Overall Study|Physician Decision|1|||
33543890|NCT02059239|101891861|FG001|Overall Study|Physician Decision|0|||
33543891|NCT01294514|101891862|FG000|Overall Study|Excluded due to Arrhythmia|1|||
33543892|NCT03098979|101891863|FG000|Overall Study|Adverse Event|1|||
33543893|NCT03098979|101891864|FG001|Overall Study|Adverse Event|0|||
33543894|NCT03098979|101891865|FG002|Overall Study|Adverse Event|1|||
33543895|NCT03098979|101891866|FG003|Overall Study|Adverse Event|4|||
33543896|NCT03098979|101891867|FG004|Overall Study|Adverse Event|6|||
33543897|NCT03098979|101891868|FG005|Overall Study|Adverse Event|1|||
33543898|NCT03098979|101891863|FG000|Overall Study|Withdrawal by Subject|2|||
33213143|NCT00605293|100679571|FG000|Overall Study|Death|2|||
33213144|NCT00605293|100679572|FG001|Overall Study|Death|1|||
33543899|NCT03098979|101891864|FG001|Overall Study|Withdrawal by Subject|1|||
33543900|NCT03098979|101891865|FG002|Overall Study|Withdrawal by Subject|1|||
33543901|NCT03098979|101891866|FG003|Overall Study|Withdrawal by Subject|1|||
33543902|NCT03098979|101891867|FG004|Overall Study|Withdrawal by Subject|2|||
33543903|NCT03098979|101891868|FG005|Overall Study|Withdrawal by Subject|1|||
33543904|NCT03098979|101891863|FG000|Overall Study|Death|1|||
33543905|NCT03098979|101891864|FG001|Overall Study|Death|0|||
33543906|NCT03098979|101891865|FG002|Overall Study|Death|2|||
33543907|NCT03098979|101891866|FG003|Overall Study|Death|0|||
33543908|NCT03098979|101891867|FG004|Overall Study|Death|1|||
33543909|NCT03098979|101891868|FG005|Overall Study|Death|0|||
33543910|NCT03098979|101891863|FG000|Overall Study|Physician Decision|2|||
33543911|NCT03098979|101891864|FG001|Overall Study|Physician Decision|1|||
33543912|NCT03098979|101891865|FG002|Overall Study|Physician Decision|0|||
33543913|NCT03098979|101891866|FG003|Overall Study|Physician Decision|0|||
33543914|NCT03098979|101891867|FG004|Overall Study|Physician Decision|0|||
33543915|NCT03098979|101891868|FG005|Overall Study|Physician Decision|0|||
33543916|NCT03098979|101891863|FG000|Overall Study|Non-compliance|0|||
33543917|NCT03098979|101891864|FG001|Overall Study|Non-compliance|0|||
33543918|NCT03098979|101891865|FG002|Overall Study|Non-compliance|0|||
33543919|NCT03098979|101891866|FG003|Overall Study|Non-compliance|0|||
33543920|NCT03098979|101891867|FG004|Overall Study|Non-compliance|0|||
33543921|NCT03098979|101891868|FG005|Overall Study|Non-compliance|1|||
33543922|NCT03098979|101891863|FG000|Overall Study|Protocol Violation|0|||
33543923|NCT03098979|101891864|FG001|Overall Study|Protocol Violation|0|||
33543924|NCT03098979|101891865|FG002|Overall Study|Protocol Violation|0|||
33543925|NCT03098979|101891866|FG003|Overall Study|Protocol Violation|0|||
33543926|NCT03098979|101891867|FG004|Overall Study|Protocol Violation|0|||
33543927|NCT03098979|101891868|FG005|Overall Study|Protocol Violation|1|||
33543928|NCT00091819|101891873|FG000|Overall Study|Adverse Event|1|||
33543929|NCT00091819|101891874|FG001|Overall Study|Adverse Event|1|||
33543930|NCT00091819|101891873|FG000|Overall Study|Death|4|||
33543931|NCT00091819|101891874|FG001|Overall Study|Death|5|||
33543932|NCT00091819|101891873|FG000|Overall Study|Lost to Follow-up|26|||
33543933|NCT00091819|101891874|FG001|Overall Study|Lost to Follow-up|23|||
33543934|NCT00091819|101891873|FG000|Overall Study|Withdrawal by Subject|5|||
33543935|NCT00091819|101891874|FG001|Overall Study|Withdrawal by Subject|8|||
33543936|NCT00091819|101891873|FG000|Overall Study|Protocol Violation|1|||
33543937|NCT00091819|101891874|FG001|Overall Study|Protocol Violation|2|||
33543938|NCT00091819|101891873|FG000|Overall Study|Other|2|||
33543939|NCT00091819|101891874|FG001|Overall Study|Other|3|||
33543940|NCT00091819|101891873|FG000|Overall Study|Never received study treatment|3|||
33543941|NCT00091819|101891874|FG001|Overall Study|Never received study treatment|4|||
33543942|NCT02722967|101891877|FG000|Overall Study|Adverse Event|1|||
33543943|NCT02722967|101891878|FG001|Overall Study|Adverse Event|0|||
33543944|NCT02722967|101891879|FG002|Overall Study|Adverse Event|0|||
33543945|NCT02722967|101891877|FG000|Overall Study|Lost to Follow-up|0|||
33543946|NCT02722967|101891878|FG001|Overall Study|Lost to Follow-up|1|||
33543947|NCT02722967|101891879|FG002|Overall Study|Lost to Follow-up|0|||
33543948|NCT02722967|101891877|FG000|Overall Study|Non-compliance with patch wearing|2|||
33543949|NCT02722967|101891878|FG001|Overall Study|Non-compliance with patch wearing|1|||
33543950|NCT02722967|101891879|FG002|Overall Study|Non-compliance with patch wearing|1|||
33543951|NCT02722967|101891877|FG000|Overall Study|Withdrawal by Subject|1|||
33543952|NCT02722967|101891878|FG001|Overall Study|Withdrawal by Subject|0|||
33543953|NCT02722967|101891879|FG002|Overall Study|Withdrawal by Subject|1|||
33543954|NCT02722967|101891877|FG000|Overall Study|Physician Decision|1|||
33543955|NCT02722967|101891878|FG001|Overall Study|Physician Decision|0|||
33543956|NCT02722967|101891879|FG002|Overall Study|Physician Decision|0|||
33543957|NCT02722967|101891877|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
33543958|NCT02722967|101891878|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
33543959|NCT02722967|101891879|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
33213145|NCT00605293|100679571|FG000|Overall Study|Insufficient Therapeutic Response|2|||
33543960|NCT02335944|101891883|FG000|Treatment Phase|Progressive Disease|2|||
33543961|NCT02335944|101891884|FG001|Treatment Phase|Progressive Disease|5|||
33543962|NCT02335944|101891885|FG002|Treatment Phase|Progressive Disease|2|||
33543963|NCT02335944|101891886|FG003|Treatment Phase|Progressive Disease|11|||
33543964|NCT02335944|101891887|FG004|Treatment Phase|Progressive Disease|4|||
33543965|NCT02335944|101891888|FG005|Treatment Phase|Progressive Disease|25|||
33543966|NCT02335944|101891889|FG006|Treatment Phase|Progressive Disease|2|||
33543967|NCT02335944|101891890|FG007|Treatment Phase|Progressive Disease|30|||
33543968|NCT02335944|101891891|FG008|Treatment Phase|Progressive Disease|27|||
33543969|NCT02335944|101891892|FG009|Treatment Phase|Progressive Disease|0|||
33543970|NCT02335944|101891883|FG000|Treatment Phase|Adverse Event|2|||
33543971|NCT02335944|101891884|FG001|Treatment Phase|Adverse Event|0|||
33543972|NCT02335944|101891885|FG002|Treatment Phase|Adverse Event|0|||
33543973|NCT02335944|101891886|FG003|Treatment Phase|Adverse Event|2|||
33543974|NCT02335944|101891887|FG004|Treatment Phase|Adverse Event|1|||
33543975|NCT02335944|101891888|FG005|Treatment Phase|Adverse Event|15|||
33543976|NCT02335944|101891889|FG006|Treatment Phase|Adverse Event|0|||
33543977|NCT02335944|101891890|FG007|Treatment Phase|Adverse Event|5|||
33543978|NCT02335944|101891891|FG008|Treatment Phase|Adverse Event|7|||
33543979|NCT02335944|101891892|FG009|Treatment Phase|Adverse Event|0|||
33543980|NCT02335944|101891883|FG000|Treatment Phase|Physician Decision|0|||
33543981|NCT02335944|101891884|FG001|Treatment Phase|Physician Decision|0|||
33543982|NCT02335944|101891885|FG002|Treatment Phase|Physician Decision|0|||
33543983|NCT02335944|101891886|FG003|Treatment Phase|Physician Decision|1|||
33543984|NCT02335944|101891887|FG004|Treatment Phase|Physician Decision|0|||
33543985|NCT02335944|101891888|FG005|Treatment Phase|Physician Decision|6|||
33543986|NCT02335944|101891889|FG006|Treatment Phase|Physician Decision|1|||
33543987|NCT02335944|101891890|FG007|Treatment Phase|Physician Decision|2|||
33543988|NCT02335944|101891891|FG008|Treatment Phase|Physician Decision|1|||
33543989|NCT02335944|101891892|FG009|Treatment Phase|Physician Decision|0|||
33543990|NCT02335944|101891883|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
33543991|NCT02335944|101891884|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
33543992|NCT02335944|101891885|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
33543993|NCT02335944|101891886|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
33543994|NCT02335944|101891887|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
33543995|NCT02335944|101891888|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
33543996|NCT02335944|101891889|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
33543997|NCT02335944|101891890|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
33543998|NCT02335944|101891891|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
33543999|NCT02335944|101891892|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
33544000|NCT02335944|101891883|FG000|Treatment Phase|Subject/Guardian Decision|0|||
33544001|NCT02335944|101891884|FG001|Treatment Phase|Subject/Guardian Decision|0|||
33544002|NCT02335944|101891885|FG002|Treatment Phase|Subject/Guardian Decision|1|||
33544003|NCT02335944|101891886|FG003|Treatment Phase|Subject/Guardian Decision|0|||
33544004|NCT02335944|101891887|FG004|Treatment Phase|Subject/Guardian Decision|0|||
33544005|NCT02335944|101891888|FG005|Treatment Phase|Subject/Guardian Decision|1|||
33544006|NCT02335944|101891889|FG006|Treatment Phase|Subject/Guardian Decision|0|||
33544007|NCT02335944|101891890|FG007|Treatment Phase|Subject/Guardian Decision|4|||
33544008|NCT02335944|101891891|FG008|Treatment Phase|Subject/Guardian Decision|0|||
33544009|NCT02335944|101891892|FG009|Treatment Phase|Subject/Guardian Decision|0|||
33544010|NCT02335944|101891883|FG000|Post-treatment Follow-up|Progressive Disease|0|||
33544011|NCT02335944|101891884|FG001|Post-treatment Follow-up|Progressive Disease|0|||
33544012|NCT02335944|101891885|FG002|Post-treatment Follow-up|Progressive Disease|0|||
33544013|NCT02335944|101891886|FG003|Post-treatment Follow-up|Progressive Disease|1|||
33544014|NCT02335944|101891887|FG004|Post-treatment Follow-up|Progressive Disease|0|||
33544015|NCT02335944|101891888|FG005|Post-treatment Follow-up|Progressive Disease|9|||
33544016|NCT02335944|101891889|FG006|Post-treatment Follow-up|Progressive Disease|0|||
33544017|NCT02335944|101891890|FG007|Post-treatment Follow-up|Progressive Disease|2|||
33544018|NCT02335944|101891891|FG008|Post-treatment Follow-up|Progressive Disease|3|||
33544019|NCT02335944|101891892|FG009|Post-treatment Follow-up|Progressive Disease|0|||
33544020|NCT02335944|101891883|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33544021|NCT02335944|101891884|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33544022|NCT02335944|101891885|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33544023|NCT02335944|101891886|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33544024|NCT02335944|101891887|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33544025|NCT02335944|101891888|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
33544026|NCT02335944|101891889|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33544027|NCT02335944|101891890|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33544028|NCT02335944|101891891|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33544029|NCT02335944|101891892|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
33347060|NCT00559273|101159967|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
33544030|NCT02335944|101891883|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
33544031|NCT02335944|101891884|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
33544032|NCT02335944|101891885|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
33544033|NCT02335944|101891886|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
33544034|NCT02335944|101891887|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
33544035|NCT02335944|101891888|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
33544036|NCT02335944|101891889|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
33544037|NCT02335944|101891890|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
33544038|NCT02335944|101891891|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
33544039|NCT02335944|101891892|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
33544040|NCT02335944|101891883|FG000|Post-treatment Follow-up|Adverse Event|0|||
33544041|NCT02335944|101891884|FG001|Post-treatment Follow-up|Adverse Event|0|||
33544042|NCT02335944|101891885|FG002|Post-treatment Follow-up|Adverse Event|0|||
33544043|NCT02335944|101891886|FG003|Post-treatment Follow-up|Adverse Event|0|||
33544044|NCT02335944|101891887|FG004|Post-treatment Follow-up|Adverse Event|0|||
33544045|NCT02335944|101891888|FG005|Post-treatment Follow-up|Adverse Event|1|||
33544046|NCT02335944|101891889|FG006|Post-treatment Follow-up|Adverse Event|0|||
33544047|NCT02335944|101891890|FG007|Post-treatment Follow-up|Adverse Event|0|||
33544048|NCT02335944|101891891|FG008|Post-treatment Follow-up|Adverse Event|0|||
33544049|NCT02335944|101891892|FG009|Post-treatment Follow-up|Adverse Event|0|||
33544050|NCT02335944|101891883|FG000|Post-treatment Follow-up|Death|0|||
33544051|NCT02335944|101891884|FG001|Post-treatment Follow-up|Death|0|||
33544052|NCT02335944|101891885|FG002|Post-treatment Follow-up|Death|0|||
33544053|NCT02335944|101891886|FG003|Post-treatment Follow-up|Death|1|||
33544054|NCT02335944|101891887|FG004|Post-treatment Follow-up|Death|0|||
33544055|NCT02335944|101891888|FG005|Post-treatment Follow-up|Death|1|||
33544056|NCT02335944|101891889|FG006|Post-treatment Follow-up|Death|0|||
33544057|NCT02335944|101891890|FG007|Post-treatment Follow-up|Death|0|||
33544058|NCT02335944|101891891|FG008|Post-treatment Follow-up|Death|0|||
33544059|NCT02335944|101891892|FG009|Post-treatment Follow-up|Death|0|||
33544060|NCT02335944|101891883|FG000|Post-treatment Follow-up|Physician Decision|1|||
33544061|NCT02335944|101891884|FG001|Post-treatment Follow-up|Physician Decision|0|||
33544062|NCT02335944|101891885|FG002|Post-treatment Follow-up|Physician Decision|0|||
33544063|NCT02335944|101891886|FG003|Post-treatment Follow-up|Physician Decision|0|||
33544064|NCT02335944|101891887|FG004|Post-treatment Follow-up|Physician Decision|0|||
33544065|NCT02335944|101891888|FG005|Post-treatment Follow-up|Physician Decision|0|||
33544066|NCT02335944|101891889|FG006|Post-treatment Follow-up|Physician Decision|0|||
33544067|NCT02335944|101891890|FG007|Post-treatment Follow-up|Physician Decision|1|||
33544068|NCT02335944|101891891|FG008|Post-treatment Follow-up|Physician Decision|0|||
33544069|NCT02335944|101891892|FG009|Post-treatment Follow-up|Physician Decision|0|||
33544070|NCT01513590|101891893|FG000|Overall Study|Adverse Event|2|||
33544071|NCT01513590|101891894|FG001|Overall Study|Adverse Event|3|||
33544072|NCT01513590|101891893|FG000|Overall Study|Withdrawal Criteria|3|||
33544073|NCT01513590|101891894|FG001|Overall Study|Withdrawal Criteria|0|||
33544074|NCT01513590|101891893|FG000|Overall Study|Unclassified|5|||
33616340|NCT02452424|102144337|FG009|Overall Study|Withdrawal by Subject|1|||
33616341|NCT02452424|102144338|FG010|Overall Study|Withdrawal by Subject|0|||
33616342|NCT02452424|102144328|FG000|Overall Study|Other|0|||
33616343|NCT02452424|102144329|FG001|Overall Study|Other|0|||
33544075|NCT01513590|101891894|FG001|Overall Study|Unclassified|10|||
33544076|NCT00862992|101891895|FG000|Overall Study|Adverse Event|2|||
33544077|NCT00862992|101891896|FG001|Overall Study|Adverse Event|1|||
33544078|NCT00862992|101891897|FG002|Overall Study|Adverse Event|1|||
33544079|NCT00862992|101891895|FG000|Overall Study|Physician Decision|1|||
33544080|NCT00862992|101891896|FG001|Overall Study|Physician Decision|0|||
33544081|NCT00862992|101891897|FG002|Overall Study|Physician Decision|0|||
33544082|NCT00862992|101891895|FG000|Overall Study|Withdrawal by Subject|0|||
33544083|NCT00862992|101891896|FG001|Overall Study|Withdrawal by Subject|0|||
33544084|NCT00862992|101891897|FG002|Overall Study|Withdrawal by Subject|2|||
33544085|NCT02026141|101891898|FG000|Overall Study|Protocol Violation|0|||
33408468|NCT02839330|101386023|FG001|Overall Study|Death|6|||
33408469|NCT02839330|101386024|FG002|Overall Study|Death|1|||
33408470|NCT02839330|101386025|FG003|Overall Study|Death|1|||
33544086|NCT02026141|101891899|FG001|Overall Study|Protocol Violation|1|||
33544087|NCT02453048|101891900|FG000|Overall Study|Only part of initial 6 mo. study|0|||
33544088|NCT02453048|101891901|FG001|Overall Study|Only part of initial 6 mo. study|0|||
33544089|NCT02453048|101891902|FG002|Overall Study|Only part of initial 6 mo. study|0|||
33544090|NCT02453048|101891903|FG003|Overall Study|Only part of initial 6 mo. study|0|||
33544091|NCT02453048|101891904|FG004|Overall Study|Only part of initial 6 mo. study|6|||
33544092|NCT02453048|101891900|FG000|Overall Study|Lost to Follow-up|0|||
33544093|NCT02453048|101891901|FG001|Overall Study|Lost to Follow-up|1|||
33544094|NCT02453048|101891902|FG002|Overall Study|Lost to Follow-up|2|||
33544095|NCT02453048|101891903|FG003|Overall Study|Lost to Follow-up|0|||
33408471|NCT02839330|101386022|FG000|Overall Study|Withdrawal by Subject|27|||
33213146|NCT00605293|100679572|FG001|Overall Study|Insufficient Therapeutic Response|0|||
33213147|NCT00605293|100679571|FG000|Overall Study|Adverse Event|1|||
33213148|NCT00605293|100679572|FG001|Overall Study|Adverse Event|0|||
33213149|NCT00605293|100679571|FG000|Overall Study|Holidays Dialysis Out|1|||
33213150|NCT00605293|100679572|FG001|Overall Study|Holidays Dialysis Out|0|||
33213151|NCT00605293|100679571|FG000|Overall Study|Blood Transfusion|7|||
33213152|NCT00605293|100679572|FG001|Overall Study|Blood Transfusion|1|||
33213153|NCT00605293|100679571|FG000|Overall Study|Renal Transplantation|3|||
33213154|NCT00605293|100679572|FG001|Overall Study|Renal Transplantation|1|||
33213155|NCT00605293|100679571|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
33213156|NCT00605293|100679572|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
33213157|NCT00605293|100679571|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
33213158|NCT00605293|100679572|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
33544096|NCT02453048|101891904|FG004|Overall Study|Lost to Follow-up|0|||
33544097|NCT01184872|101891920|FG000|Overall Study|Adverse Event|3|||
33544098|NCT01184872|101891921|FG001|Overall Study|Adverse Event|4|||
33544099|NCT01184872|101891920|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
33544100|NCT01184872|101891921|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33544101|NCT01184872|101891920|FG000|Overall Study|Withdrawal by Subject|2|||
33544102|NCT01184872|101891921|FG001|Overall Study|Withdrawal by Subject|0|||
33544103|NCT01184872|101891920|FG000|Overall Study|Lost to Follow-up|0|||
33544104|NCT01184872|101891921|FG001|Overall Study|Lost to Follow-up|1|||
33544105|NCT01184872|101891920|FG000|Overall Study|Administrative problems|1|||
33544106|NCT01184872|101891921|FG001|Overall Study|Administrative problems|1|||
33544107|NCT01184872|101891920|FG000|Overall Study|Protocol deviation|1|||
33544108|NCT01184872|101891921|FG001|Overall Study|Protocol deviation|0|||
33544109|NCT03530696|101891925|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
33544110|NCT03530696|101891926|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
33544111|NCT03861039|101891927|FG000|Overall Study|Adverse Event|2|||
33544112|NCT03861039|101891928|FG001|Overall Study|Adverse Event|5|||
33544113|NCT03861039|101891929|FG002|Overall Study|Adverse Event|11|||
33544114|NCT03861039|101891927|FG000|Overall Study|Withdrawal by Subject|1|||
33544115|NCT03861039|101891928|FG001|Overall Study|Withdrawal by Subject|3|||
33544116|NCT03861039|101891929|FG002|Overall Study|Withdrawal by Subject|4|||
33544117|NCT00832975|101891930|FG000|Overall Study|Lost to Follow-up|7|||
33544118|NCT00832975|101891930|FG000|Overall Study|Protocol Violation|6|||
33544119|NCT00832975|101891930|FG000|Overall Study|Death|5|||
33544120|NCT00832975|101891930|FG000|Overall Study|Physician Decision|4|||
33544121|NCT00832975|101891930|FG000|Overall Study|Withdrawal by Subject|3|||
33544122|NCT00832975|101891930|FG000|Overall Study|Other reasons|14|||
33544123|NCT00959751|101891931|FG000|Overall Study|Lost to Follow-up|2|||
33544124|NCT00959751|101891932|FG001|Overall Study|Lost to Follow-up|3|||
33544125|NCT00959751|101891931|FG000|Overall Study|Consent Withdrawn|0|||
33544126|NCT00959751|101891932|FG001|Overall Study|Consent Withdrawn|1|||
33544127|NCT00959751|101891931|FG000|Overall Study|Non-compliance to Study Procedures|0|||
33616344|NCT02452424|102144330|FG002|Overall Study|Other|1|||
33616345|NCT02452424|102144331|FG003|Overall Study|Other|0|||
33616346|NCT02452424|102144332|FG004|Overall Study|Other|0|||
33616347|NCT02452424|102144333|FG005|Overall Study|Other|1|||
33616348|NCT02452424|102144334|FG006|Overall Study|Other|4|||
33213159|NCT00605293|100679571|FG000|Overall Study|Principal Investigator Decision|0|||
33213160|NCT00605293|100679572|FG001|Overall Study|Principal Investigator Decision|1|||
33213161|NCT01483924|100679573|FG000|Overall Study|Withdrawal by Subject|2|||
33213162|NCT01483924|100679574|FG001|Overall Study|Withdrawal by Subject|0|||
33213163|NCT01483924|100679575|FG002|Overall Study|Withdrawal by Subject|0|||
33213164|NCT01483924|100679576|FG003|Overall Study|Withdrawal by Subject|1|||
33213165|NCT01483924|100679577|FG004|Overall Study|Withdrawal by Subject|1|||
33213166|NCT01483924|100679573|FG000|Overall Study|Adverse Event|0|||
33213167|NCT01483924|100679574|FG001|Overall Study|Adverse Event|0|||
33213168|NCT01483924|100679575|FG002|Overall Study|Adverse Event|1|||
33213169|NCT01483924|100679576|FG003|Overall Study|Adverse Event|1|||
33213170|NCT01483924|100679577|FG004|Overall Study|Adverse Event|0|||
33213171|NCT01483924|100679573|FG000|Overall Study|Non-compliance|0|||
33213172|NCT01483924|100679574|FG001|Overall Study|Non-compliance|0|||
33213173|NCT01483924|100679575|FG002|Overall Study|Non-compliance|0|||
33213174|NCT01483924|100679576|FG003|Overall Study|Non-compliance|1|||
33213175|NCT01483924|100679577|FG004|Overall Study|Non-compliance|1|||
33213176|NCT01483924|100679573|FG000|Overall Study|Sponsor concern over ECG result|0|||
33213177|NCT01483924|100679574|FG001|Overall Study|Sponsor concern over ECG result|0|||
33213178|NCT01483924|100679575|FG002|Overall Study|Sponsor concern over ECG result|0|||
33213179|NCT01483924|100679576|FG003|Overall Study|Sponsor concern over ECG result|1|||
33213180|NCT01483924|100679577|FG004|Overall Study|Sponsor concern over ECG result|0|||
33213181|NCT03015402|100679578|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
33544128|NCT00959751|101891932|FG001|Overall Study|Non-compliance to Study Procedures|1|||
33544129|NCT00959751|101891931|FG000|Overall Study|No migraine headache without aura|7|||
33544130|NCT00959751|101891932|FG001|Overall Study|No migraine headache without aura|7|||
33544131|NCT00083915|101891938|FG000|Overall Study|Death|6|||
33616349|NCT02452424|102144335|FG007|Overall Study|Other|3|||
33616350|NCT02452424|102144336|FG008|Overall Study|Other|0|||
33616351|NCT02452424|102144337|FG009|Overall Study|Other|0|||
33544132|NCT00083915|101891939|FG001|Overall Study|Death|3|||
33544133|NCT00083915|101891938|FG000|Overall Study|Physician Decision|11|||
33213182|NCT03015402|100679579|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
33213183|NCT03015402|100679578|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
33213184|NCT03015402|100679579|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
33213185|NCT00262821|100679580|FG000|Overall Study|Ineligible - wrong stage|0|||
33213186|NCT00262821|100679581|FG001|Overall Study|Ineligible - wrong stage|3|||
33544134|NCT00083915|101891939|FG001|Overall Study|Physician Decision|6|||
33213187|NCT00262821|100679580|FG000|Overall Study|Ineligible - wrong cell type|2|||
33616352|NCT02452424|102144338|FG010|Overall Study|Other|1|||
33616353|NCT02452424|102144328|FG000|Overall Study|Progressive disease (per RECIST)|0|||
33616354|NCT02452424|102144329|FG001|Overall Study|Progressive disease (per RECIST)|0|||
33616355|NCT02452424|102144330|FG002|Overall Study|Progressive disease (per RECIST)|0|||
33616356|NCT02452424|102144331|FG003|Overall Study|Progressive disease (per RECIST)|0|||
33616357|NCT02452424|102144332|FG004|Overall Study|Progressive disease (per RECIST)|0|||
33616358|NCT02452424|102144333|FG005|Overall Study|Progressive disease (per RECIST)|0|||
33616359|NCT02452424|102144334|FG006|Overall Study|Progressive disease (per RECIST)|0|||
33616360|NCT02452424|102144335|FG007|Overall Study|Progressive disease (per RECIST)|0|||
33616361|NCT02452424|102144336|FG008|Overall Study|Progressive disease (per RECIST)|2|||
33616362|NCT02452424|102144337|FG009|Overall Study|Progressive disease (per RECIST)|0|||
33616363|NCT02452424|102144338|FG010|Overall Study|Progressive disease (per RECIST)|0|||
33616364|NCT02452424|102144328|FG000|Overall Study|Adverse Event|0|||
33616365|NCT02452424|102144329|FG001|Overall Study|Adverse Event|0|||
33616366|NCT02452424|102144330|FG002|Overall Study|Adverse Event|0|||
33616367|NCT02452424|102144331|FG003|Overall Study|Adverse Event|0|||
33616368|NCT02452424|102144332|FG004|Overall Study|Adverse Event|0|||
33616369|NCT02452424|102144333|FG005|Overall Study|Adverse Event|0|||
33616370|NCT02452424|102144334|FG006|Overall Study|Adverse Event|0|||
33616371|NCT02452424|102144335|FG007|Overall Study|Adverse Event|0|||
33616372|NCT02452424|102144336|FG008|Overall Study|Adverse Event|0|||
33616373|NCT02452424|102144337|FG009|Overall Study|Adverse Event|0|||
33616374|NCT02452424|102144338|FG010|Overall Study|Adverse Event|1|||
33616375|NCT01514201|102144342|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
33616376|NCT01514201|102144343|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
33616377|NCT01514201|102144344|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
33616378|NCT01514201|102144345|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
33616379|NCT01514201|102144342|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
33616380|NCT01514201|102144343|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
33616381|NCT01514201|102144344|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
33616382|NCT01514201|102144345|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
33616383|NCT01514201|102144342|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
33616384|NCT01514201|102144343|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
33616385|NCT01514201|102144344|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
33616386|NCT01514201|102144345|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
33616387|NCT01514201|102144342|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
33616388|NCT01514201|102144343|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
33616389|NCT01514201|102144344|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
33616390|NCT01514201|102144345|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
33408472|NCT02839330|101386023|FG001|Overall Study|Withdrawal by Subject|19|||
33408473|NCT02839330|101386024|FG002|Overall Study|Withdrawal by Subject|11|||
33408474|NCT02839330|101386025|FG003|Overall Study|Withdrawal by Subject|13|||
33408475|NCT02839330|101386022|FG000|Overall Study|Lost to Follow-up|22|||
33408476|NCT02839330|101386023|FG001|Overall Study|Lost to Follow-up|27|||
33408477|NCT02839330|101386024|FG002|Overall Study|Lost to Follow-up|29|||
33408478|NCT02839330|101386025|FG003|Overall Study|Lost to Follow-up|25|||
33408479|NCT02839330|101386022|FG000|Overall Study|Administrative Reason|0|||
33408480|NCT02839330|101386023|FG001|Overall Study|Administrative Reason|0|||
33408481|NCT02839330|101386024|FG002|Overall Study|Administrative Reason|0|||
33408482|NCT02839330|101386025|FG003|Overall Study|Administrative Reason|1|||
33408483|NCT02839330|101386022|FG000|Overall Study|Protocol Violation|1|||
33408484|NCT02839330|101386023|FG001|Overall Study|Protocol Violation|2|||
33408485|NCT02839330|101386024|FG002|Overall Study|Protocol Violation|2|||
33616391|NCT01514201|102144342|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
33616392|NCT01514201|102144343|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
33616393|NCT01514201|102144344|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
33616394|NCT01514201|102144345|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
33616395|NCT01514201|102144342|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
33616396|NCT01514201|102144343|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
33616397|NCT01514201|102144344|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
33616398|NCT01514201|102144345|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
33616399|NCT01514201|102144342|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
33616400|NCT01514201|102144343|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
33616401|NCT01514201|102144344|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
33616402|NCT01514201|102144345|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
33408486|NCT02839330|101386025|FG003|Overall Study|Protocol Violation|3|||
33408487|NCT02839330|101386022|FG000|Overall Study|Other reason, not specified|4|||
33408488|NCT02839330|101386023|FG001|Overall Study|Other reason, not specified|3|||
33408489|NCT02839330|101386024|FG002|Overall Study|Other reason, not specified|3|||
33213188|NCT00262821|100679581|FG001|Overall Study|Ineligible - wrong cell type|2|||
33213189|NCT00262821|100679580|FG000|Overall Study|Ineligible - wrong primary|0|||
33408490|NCT02839330|101386025|FG003|Overall Study|Other reason, not specified|6|||
33408491|NCT00976989|101386028|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
33616403|NCT01514201|102144342|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
33616404|NCT01514201|102144343|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
33616405|NCT01514201|102144344|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
33616406|NCT01514201|102144345|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
33616407|NCT01514201|102144342|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
33616408|NCT01514201|102144343|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
33616409|NCT01514201|102144344|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
33616410|NCT01514201|102144345|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
33616411|NCT01514201|102144342|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
33616412|NCT01514201|102144343|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
33616413|NCT01514201|102144344|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
33616414|NCT01514201|102144345|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
33616415|NCT01514201|102144342|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
33616416|NCT01514201|102144343|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
33616417|NCT01514201|102144344|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
33616418|NCT01514201|102144345|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
33616419|NCT01514201|102144342|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
33616420|NCT01514201|102144343|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
33616421|NCT01514201|102144344|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
33616422|NCT01514201|102144345|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
33213190|NCT00262821|100679581|FG001|Overall Study|Ineligible - wrong primary|1|||
33213191|NCT00262821|100679580|FG000|Overall Study|Ineligible - inadequate pathology|1|||
33213192|NCT00262821|100679581|FG001|Overall Study|Ineligible - inadequate pathology|3|||
33616423|NCT03495102|102144346|FG000|Overall Study|Adverse Event|5|||
33616424|NCT03495102|102144347|FG001|Overall Study|Adverse Event|7|||
33616425|NCT03495102|102144348|FG002|Overall Study|Adverse Event|10|||
33616426|NCT03495102|102144346|FG000|Overall Study|Death|3|||
33616427|NCT03495102|102144347|FG001|Overall Study|Death|4|||
33616428|NCT03495102|102144348|FG002|Overall Study|Death|4|||
33616429|NCT03495102|102144346|FG000|Overall Study|Lost to Follow-up|15|||
33616430|NCT03495102|102144347|FG001|Overall Study|Lost to Follow-up|16|||
33616431|NCT03495102|102144348|FG002|Overall Study|Lost to Follow-up|17|||
33616432|NCT03495102|102144346|FG000|Overall Study|Physician Decision|2|||
33616433|NCT03495102|102144347|FG001|Overall Study|Physician Decision|0|||
33616434|NCT03495102|102144348|FG002|Overall Study|Physician Decision|2|||
33616435|NCT03495102|102144346|FG000|Overall Study|Withdrawal by Subject|25|||
33616436|NCT03495102|102144347|FG001|Overall Study|Withdrawal by Subject|36|||
33616437|NCT03495102|102144348|FG002|Overall Study|Withdrawal by Subject|18|||
33616438|NCT03495102|102144346|FG000|Overall Study|Protocol Violation|1|||
33616439|NCT03495102|102144347|FG001|Overall Study|Protocol Violation|1|||
33616440|NCT03495102|102144348|FG002|Overall Study|Protocol Violation|0|||
33616441|NCT03495102|102144346|FG000|Overall Study|Site Closure|3|||
33616442|NCT03495102|102144347|FG001|Overall Study|Site Closure|1|||
33616443|NCT03495102|102144348|FG002|Overall Study|Site Closure|2|||
33616444|NCT03495102|102144346|FG000|Overall Study|Non-compliance|1|||
33616445|NCT03495102|102144347|FG001|Overall Study|Non-compliance|0|||
33616446|NCT03495102|102144348|FG002|Overall Study|Non-compliance|0|||
33616447|NCT03495102|102144346|FG000|Overall Study|Participant Duplicated at Another Site|0|||
33616448|NCT03495102|102144347|FG001|Overall Study|Participant Duplicated at Another Site|0|||
33616449|NCT03495102|102144348|FG002|Overall Study|Participant Duplicated at Another Site|1|||
33616450|NCT03495102|102144346|FG000|Overall Study|Primary Care Physician Recommendation|0|||
33616451|NCT03495102|102144347|FG001|Overall Study|Primary Care Physician Recommendation|1|||
33616452|NCT03495102|102144348|FG002|Overall Study|Primary Care Physician Recommendation|0|||
33616453|NCT03495102|102144346|FG000|Overall Study|Relocated to Another Country|0|||
33616454|NCT03495102|102144347|FG001|Overall Study|Relocated to Another Country|1|||
33616455|NCT03495102|102144348|FG002|Overall Study|Relocated to Another Country|0|||
33616456|NCT03495102|102144346|FG000|Overall Study|Participant was in Rehabilitation|1|||
33616457|NCT03495102|102144347|FG001|Overall Study|Participant was in Rehabilitation|0|||
33616458|NCT03495102|102144348|FG002|Overall Study|Participant was in Rehabilitation|0|||
33616459|NCT00566852|102144352|FG000|Overall Study|Protocol Violation|22|||
33616460|NCT00566852|102144353|FG001|Overall Study|Protocol Violation|24|||
33616461|NCT00566852|102144352|FG000|Overall Study|Death|95|||
33347061|NCT00559273|101159968|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
33347062|NCT00559273|101159967|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
33347063|NCT00559273|101159968|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
33347064|NCT00559273|101159967|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
33347065|NCT00559273|101159968|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
33347066|NCT00559273|101159967|FG000|Evaluation Period (8 Weeks)|Death|1|||
33347067|NCT00559273|101159968|FG001|Evaluation Period (8 Weeks)|Death|3|||
33347068|NCT00559273|101159967|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
33347069|NCT00559273|101159968|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
33408492|NCT00976989|101386029|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
33408493|NCT00976989|101386030|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
33408494|NCT00976989|101386028|FG000|Overall Study|Death|5|||
33408495|NCT00976989|101386029|FG001|Overall Study|Death|7|||
33408496|NCT00976989|101386030|FG002|Overall Study|Death|10|||
33408497|NCT00976989|101386028|FG000|Overall Study|Refused Treatment|4|||
33408498|NCT00976989|101386029|FG001|Overall Study|Refused Treatment|3|||
33616462|NCT00566852|102144353|FG001|Overall Study|Death|78|||
33616463|NCT00566852|102144352|FG000|Overall Study|Withdrawal by Subject|30|||
33616464|NCT00566852|102144353|FG001|Overall Study|Withdrawal by Subject|25|||
33616465|NCT00566852|102144352|FG000|Overall Study|Patient refusal|37|||
33616466|NCT00566852|102144353|FG001|Overall Study|Patient refusal|37|||
33616467|NCT00566852|102144352|FG000|Overall Study|Not tested due to disability|6|||
33616468|NCT00566852|102144353|FG001|Overall Study|Not tested due to disability|12|||
33616469|NCT00566852|102144352|FG000|Overall Study|Missing reason not specified|1|||
33616470|NCT00566852|102144353|FG001|Overall Study|Missing reason not specified|2|||
33616471|NCT00566852|102144352|FG000|Overall Study|Missing reason not reported|16|||
33616472|NCT00566852|102144353|FG001|Overall Study|Missing reason not reported|20|||
33616473|NCT01076036|102144355|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
33616474|NCT00858208|102144356|FG000|Overall Study|Adverse Event|3|||
33616475|NCT00858208|102144356|FG000|Overall Study|Lost to Follow-up|26|||
33616476|NCT00858208|102144356|FG000|Overall Study|Participant refused|40|||
33544135|NCT00083915|101891938|FG000|Overall Study|Withdrawal by Subject|8|||
33544136|NCT00083915|101891939|FG001|Overall Study|Withdrawal by Subject|3|||
33544137|NCT00083915|101891938|FG000|Overall Study|disease progression|18|||
33544138|NCT00083915|101891939|FG001|Overall Study|disease progression|23|||
33544139|NCT00083915|101891938|FG000|Overall Study|Failure to collect|3|||
33544140|NCT00083915|101891939|FG001|Overall Study|Failure to collect|0|||
33544141|NCT00083915|101891938|FG000|Overall Study|No response|3|||
33544142|NCT00083915|101891939|FG001|Overall Study|No response|1|||
33544143|NCT00083915|101891938|FG000|Overall Study|Insurance issues|1|||
33544144|NCT00083915|101891939|FG001|Overall Study|Insurance issues|1|||
33544145|NCT00706797|101891942|FG000|Overall Study|Lack of Efficacy|3|||
33544146|NCT00706797|101891943|FG001|Overall Study|Lack of Efficacy|0|||
33544147|NCT00706797|101891942|FG000|Overall Study|Adverse Event|0|||
33544148|NCT00706797|101891943|FG001|Overall Study|Adverse Event|3|||
33544149|NCT00706797|101891942|FG000|Overall Study|Withdrawal by Subject|8|||
33544150|NCT00706797|101891943|FG001|Overall Study|Withdrawal by Subject|1|||
33544151|NCT00706797|101891942|FG000|Overall Study|Death|1|||
33544152|NCT00706797|101891943|FG001|Overall Study|Death|0|||
33544153|NCT00706797|101891942|FG000|Overall Study|Discontinuation of study by sponsor|52|||
33544154|NCT00706797|101891943|FG001|Overall Study|Discontinuation of study by sponsor|63|||
33544155|NCT00706797|101891942|FG000|Overall Study|Protocol Violation|3|||
33544156|NCT00706797|101891943|FG001|Overall Study|Protocol Violation|2|||
33616477|NCT00858208|102144356|FG000|Overall Study|Other|10|||
33616478|NCT01147055|102144357|FG000|First Intervention Period|Lost to Follow-up|1|||
33616479|NCT01147055|102144358|FG001|First Intervention Period|Lost to Follow-up|0|||
33408499|NCT00976989|101386030|FG002|Overall Study|Refused Treatment|5|||
33616480|NCT05249569|102144359|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
33616481|NCT00286429|102144360|FG000|Overall Study|Adverse Event|4|||
33616482|NCT00286429|102144361|FG001|Overall Study|Adverse Event|1|||
33616483|NCT00286429|102144362|FG002|Overall Study|Adverse Event|6|||
33616484|NCT00286429|102144360|FG000|Overall Study|Lack of Efficacy|52|||
33616485|NCT00286429|102144361|FG001|Overall Study|Lack of Efficacy|27|||
33616486|NCT00286429|102144362|FG002|Overall Study|Lack of Efficacy|25|||
33616487|NCT00286429|102144360|FG000|Overall Study|Lost to Follow-up|2|||
33408500|NCT00976989|101386028|FG000|Overall Study|Failure to Return|2|||
33408501|NCT00976989|101386029|FG001|Overall Study|Failure to Return|1|||
33408502|NCT00976989|101386030|FG002|Overall Study|Failure to Return|0|||
33544157|NCT00706797|101891942|FG000|Overall Study|Lost to Follow-up|1|||
33616488|NCT00286429|102144361|FG001|Overall Study|Lost to Follow-up|4|||
33616489|NCT00286429|102144362|FG002|Overall Study|Lost to Follow-up|3|||
33616490|NCT00286429|102144360|FG000|Overall Study|Physician Decision|10|||
33616491|NCT00286429|102144361|FG001|Overall Study|Physician Decision|7|||
33213193|NCT00262821|100679580|FG000|Overall Study|Ineligible - elevated creatinine|0|||
33408503|NCT00976989|101386028|FG000|Overall Study|Recurrence of Disease|0|||
33408504|NCT00976989|101386029|FG001|Overall Study|Recurrence of Disease|1|||
33616492|NCT00286429|102144362|FG002|Overall Study|Physician Decision|7|||
33408505|NCT00976989|101386030|FG002|Overall Study|Recurrence of Disease|0|||
33408506|NCT00976989|101386028|FG000|Overall Study|Other|1|||
33544158|NCT00706797|101891943|FG001|Overall Study|Lost to Follow-up|2|||
33544159|NCT00706797|101891942|FG000|Overall Study|Other|1|||
33544160|NCT00706797|101891943|FG001|Overall Study|Other|0|||
33544161|NCT00851591|101891953|FG000|Overall Study|Withdrawal by Subject|2|||
33544162|NCT00851591|101891954|FG001|Overall Study|Withdrawal by Subject|0|||
33544163|NCT00639509|101891957|FG000|Overall Study|Death|1|||
33544164|NCT01018979|101891958|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
33544165|NCT01018979|101891959|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
33544166|NCT01018979|101891958|FG000|Overall Study|Not received at least one dose|0|||
33544167|NCT01018979|101891959|FG001|Overall Study|Not received at least one dose|1|||
33544168|NCT02246777|101891960|FG000|Overall Study|Adverse Event|2|||
33544169|NCT02246777|101891960|FG000|Overall Study|Change of residence|1|||
33544170|NCT00557466|101891966|FG000|Overall Study|Adverse Event|3|||
33544171|NCT00557466|101891967|FG001|Overall Study|Adverse Event|1|||
33544172|NCT00557466|101891968|FG002|Overall Study|Adverse Event|4|||
33544173|NCT00557466|101891969|FG003|Overall Study|Adverse Event|1|||
33544174|NCT00557466|101891970|FG004|Overall Study|Adverse Event|2|||
33544175|NCT00557466|101891971|FG005|Overall Study|Adverse Event|4|||
33544176|NCT00557466|101891966|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33544177|NCT00557466|101891967|FG001|Overall Study|Abnormal laboratory value(s)|2|||
33544178|NCT00557466|101891968|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33544179|NCT00557466|101891969|FG003|Overall Study|Abnormal laboratory value(s)|0|||
33213194|NCT00262821|100679581|FG001|Overall Study|Ineligible - elevated creatinine|2|||
33213195|NCT00262821|100679580|FG000|Overall Study|Ineligible - required test not done|1|||
33213196|NCT00262821|100679581|FG001|Overall Study|Ineligible - required test not done|4|||
33213197|NCT00262821|100679580|FG000|Overall Study|Inevaluable - inadequate data|0|||
33213198|NCT00262821|100679581|FG001|Overall Study|Inevaluable - inadequate data|4|||
33213199|NCT02332590|100679585|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
33544180|NCT00557466|101891970|FG004|Overall Study|Abnormal laboratory value(s)|0|||
33544181|NCT00557466|101891971|FG005|Overall Study|Abnormal laboratory value(s)|0|||
33544182|NCT00557466|101891966|FG000|Overall Study|Protocol deviation|0|||
33544183|NCT00557466|101891967|FG001|Overall Study|Protocol deviation|1|||
33544184|NCT00557466|101891968|FG002|Overall Study|Protocol deviation|0|||
33544185|NCT00557466|101891969|FG003|Overall Study|Protocol deviation|2|||
33544186|NCT00557466|101891970|FG004|Overall Study|Protocol deviation|0|||
33544187|NCT00557466|101891971|FG005|Overall Study|Protocol deviation|0|||
33544188|NCT00557466|101891966|FG000|Overall Study|Subject withdrew consent|0|||
33544189|NCT00557466|101891967|FG001|Overall Study|Subject withdrew consent|0|||
33544190|NCT00557466|101891968|FG002|Overall Study|Subject withdrew consent|0|||
33544191|NCT00557466|101891969|FG003|Overall Study|Subject withdrew consent|0|||
33544192|NCT00557466|101891970|FG004|Overall Study|Subject withdrew consent|1|||
33544193|NCT00557466|101891971|FG005|Overall Study|Subject withdrew consent|2|||
33544194|NCT00557466|101891966|FG000|Overall Study|Administrative problems|0|||
33544195|NCT00557466|101891967|FG001|Overall Study|Administrative problems|1|||
33544196|NCT00557466|101891968|FG002|Overall Study|Administrative problems|1|||
33544197|NCT00557466|101891969|FG003|Overall Study|Administrative problems|0|||
33544198|NCT00557466|101891970|FG004|Overall Study|Administrative problems|0|||
33544199|NCT00557466|101891971|FG005|Overall Study|Administrative problems|0|||
33544200|NCT00557466|101891966|FG000|Overall Study|Abnormal test procedure results|0|||
33544201|NCT00557466|101891967|FG001|Overall Study|Abnormal test procedure results|0|||
33544202|NCT00557466|101891968|FG002|Overall Study|Abnormal test procedure results|1|||
33544203|NCT00557466|101891969|FG003|Overall Study|Abnormal test procedure results|0|||
33544204|NCT00557466|101891970|FG004|Overall Study|Abnormal test procedure results|0|||
33544205|NCT00557466|101891971|FG005|Overall Study|Abnormal test procedure results|0|||
33544206|NCT00557466|101891966|FG000|Overall Study|Lost to Follow-up|0|||
33544207|NCT00557466|101891967|FG001|Overall Study|Lost to Follow-up|0|||
33544208|NCT00557466|101891968|FG002|Overall Study|Lost to Follow-up|0|||
33544209|NCT00557466|101891969|FG003|Overall Study|Lost to Follow-up|1|||
33544210|NCT00557466|101891970|FG004|Overall Study|Lost to Follow-up|0|||
33544211|NCT00557466|101891971|FG005|Overall Study|Lost to Follow-up|0|||
33544212|NCT00891813|101891972|FG000|Overall Study|Adverse Event|3|||
33544213|NCT00891813|101891972|FG000|Overall Study|Withdrawal by Subject|1|||
33544214|NCT00891813|101891972|FG000|Overall Study|Patient Noncompliance|6|||
33213200|NCT02332590|100679586|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
33213201|NCT02332590|100679585|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
33347070|NCT00559273|101159967|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
33347071|NCT00559273|101159968|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
33347072|NCT00559273|101159967|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
33347073|NCT00559273|101159968|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
33544215|NCT00891813|101891972|FG000|Overall Study|Protocol Violation|2|||
33544216|NCT00640289|101891973|FG000|Overall Study|Death|3|||
33544217|NCT00640289|101891973|FG000|Overall Study|Withdrawal by Subject|1|||
33544218|NCT00640289|101891973|FG000|Overall Study|Lost to Follow-up|1|||
33544219|NCT00640289|101891973|FG000|Overall Study|Data collected under different amendment|2|||
33544220|NCT00640289|101891973|FG000|Overall Study|Transferred to another center|1|||
33544221|NCT00640289|101891973|FG000|Overall Study|Missing status|5|||
33213202|NCT02332590|100679586|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
33544222|NCT00750269|101891974|FG000|Overall Study|Protocol Violation|0|||
33544223|NCT00750269|101891975|FG001|Overall Study|Protocol Violation|1|||
33544224|NCT00750269|101891976|FG002|Overall Study|Protocol Violation|1|||
33408507|NCT00976989|101386029|FG001|Overall Study|Other|0|||
33408508|NCT00976989|101386030|FG002|Overall Study|Other|1|||
33408509|NCT03326323|101386031|FG000|Overall Study|Unable to receive ANH protocol|3|||
33408510|NCT01050998|101386032|FG000|Overall Study|Adverse Event|1|||
33408511|NCT01050998|101386033|FG001|Overall Study|Adverse Event|0|||
33408512|NCT01050998|101386034|FG002|Overall Study|Adverse Event|1|||
33408513|NCT01050998|101386035|FG003|Overall Study|Adverse Event|0|||
33408514|NCT01050998|101386036|FG004|Overall Study|Adverse Event|2|||
33408515|NCT01050998|101386032|FG000|Overall Study|Withdrawal by Subject|0|||
33408516|NCT01050998|101386033|FG001|Overall Study|Withdrawal by Subject|0|||
33408517|NCT01050998|101386034|FG002|Overall Study|Withdrawal by Subject|0|||
33408518|NCT01050998|101386035|FG003|Overall Study|Withdrawal by Subject|1|||
33408519|NCT01050998|101386036|FG004|Overall Study|Withdrawal by Subject|3|||
33408520|NCT01050998|101386032|FG000|Overall Study|Other|3|||
33408521|NCT01050998|101386033|FG001|Overall Study|Other|2|||
33408522|NCT01050998|101386034|FG002|Overall Study|Other|1|||
33408523|NCT01050998|101386035|FG003|Overall Study|Other|1|||
33408524|NCT01050998|101386036|FG004|Overall Study|Other|5|||
33408525|NCT01050998|101386032|FG000|Overall Study|Data integrity issues|0|||
33408526|NCT01050998|101386033|FG001|Overall Study|Data integrity issues|0|||
33408527|NCT01050998|101386034|FG002|Overall Study|Data integrity issues|1|||
33408528|NCT01050998|101386035|FG003|Overall Study|Data integrity issues|1|||
33408529|NCT01050998|101386036|FG004|Overall Study|Data integrity issues|4|||
33408530|NCT00003526|101386040|FG000|Overall Study|Not evaluable|6|||
33408531|NCT00750061|101386041|FG000|Overall Study|Adverse Event|2|||
33408532|NCT00750061|101386042|FG001|Overall Study|Adverse Event|0|||
33408533|NCT00750061|101386041|FG000|Overall Study|Withdrawal by Subject|0|||
33408534|NCT00750061|101386042|FG001|Overall Study|Withdrawal by Subject|1|||
33408535|NCT00750061|101386041|FG000|Overall Study|Physician Decision|0|||
33408536|NCT00750061|101386042|FG001|Overall Study|Physician Decision|1|||
33408537|NCT02930889|101386045|FG000|Overall Study|Lost to Follow-up|2|||
33408538|NCT02930889|101386045|FG000|Overall Study|Withdrawal by Subject|6|||
33408539|NCT02930889|101386045|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
33408540|NCT01336647|101386049|FG000|Overall Study|Lost to Follow-up|4|||
33408541|NCT01336647|101386050|FG001|Overall Study|Lost to Follow-up|1|||
33408542|NCT01336647|101386051|FG002|Overall Study|Lost to Follow-up|3|||
33408543|NCT01266967|101386052|FG000|Overall Study|Death|69|||
33408544|NCT01266967|101386053|FG001|Overall Study|Death|61|||
33544225|NCT00750269|101891977|FG003|Overall Study|Protocol Violation|2|||
33544226|NCT00750269|101891978|FG004|Overall Study|Protocol Violation|4|||
33544227|NCT00750269|101891974|FG000|Overall Study|Withdrawal by Subject|0|||
33544228|NCT00750269|101891975|FG001|Overall Study|Withdrawal by Subject|0|||
33544229|NCT00750269|101891976|FG002|Overall Study|Withdrawal by Subject|2|||
33544230|NCT00750269|101891977|FG003|Overall Study|Withdrawal by Subject|2|||
33544231|NCT00750269|101891978|FG004|Overall Study|Withdrawal by Subject|2|||
33544232|NCT00750269|101891974|FG000|Overall Study|Physician Decision|0|||
33544233|NCT00750269|101891975|FG001|Overall Study|Physician Decision|0|||
33544234|NCT00750269|101891976|FG002|Overall Study|Physician Decision|0|||
33544235|NCT00750269|101891977|FG003|Overall Study|Physician Decision|0|||
33544236|NCT00750269|101891978|FG004|Overall Study|Physician Decision|2|||
33544237|NCT00750269|101891974|FG000|Overall Study|Patient too large for positioning|0|||
33544238|NCT00750269|101891975|FG001|Overall Study|Patient too large for positioning|0|||
33544239|NCT00750269|101891976|FG002|Overall Study|Patient too large for positioning|1|||
33408545|NCT01266967|101386052|FG000|Overall Study|Study Closed/Terminated|15|||
33408546|NCT01266967|101386053|FG001|Overall Study|Study Closed/Terminated|17|||
33408547|NCT01266967|101386052|FG000|Overall Study|Lost to Follow-up|2|||
33408548|NCT01266967|101386053|FG001|Overall Study|Lost to Follow-up|1|||
33408549|NCT01266967|101386052|FG000|Overall Study|Physician Decision|0|||
33408550|NCT01266967|101386053|FG001|Overall Study|Physician Decision|1|||
33408551|NCT01266967|101386052|FG000|Overall Study|Withdrawal by Subject|3|||
33408552|NCT01266967|101386053|FG001|Overall Study|Withdrawal by Subject|3|||
33408553|NCT03841331|101386054|FG000|Overall Study|Withdrawal by Subject|4|||
33408554|NCT03841331|101386055|FG001|Overall Study|Withdrawal by Subject|9|||
33544240|NCT00750269|101891977|FG003|Overall Study|Patient too large for positioning|0|||
33544241|NCT00750269|101891978|FG004|Overall Study|Patient too large for positioning|0|||
33544242|NCT00750269|101891974|FG000|Overall Study|Site error|0|||
33408555|NCT03841331|101386054|FG000|Overall Study|Lost to Follow-up|5|||
33408556|NCT03841331|101386055|FG001|Overall Study|Lost to Follow-up|1|||
33408557|NCT03764813|101386056|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
33408558|NCT03764813|101386057|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
33408559|NCT03764813|101386058|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
33408560|NCT03764813|101386059|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
33408561|NCT02600559|101386062|FG000|Overall Study|Withdrawal by Subject|3|||
33408562|NCT02600559|101386062|FG000|Overall Study|Lost to Follow-up|20|||
33408563|NCT02528643|101386063|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
33408564|NCT02528643|101386064|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
33408565|NCT02528643|101386063|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
33408566|NCT02528643|101386064|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
33408567|NCT02528643|101386063|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
33408568|NCT02528643|101386064|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
33408569|NCT02528643|101386063|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
33408570|NCT02528643|101386064|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
33408571|NCT02528643|101386063|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
33408572|NCT02528643|101386064|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
33408573|NCT02528643|101386063|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
33408574|NCT02528643|101386064|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
33408575|NCT02528643|101386063|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
33408576|NCT02528643|101386064|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
33408577|NCT02146365|101386071|FG000|Overall Study|Lost to Follow-up|2|||
33408578|NCT02146365|101386072|FG001|Overall Study|Lost to Follow-up|1|||
33408579|NCT02146365|101386073|FG002|Overall Study|Lost to Follow-up|3|||
33408580|NCT02146365|101386074|FG003|Overall Study|Lost to Follow-up|3|||
33408581|NCT02146365|101386075|FG004|Overall Study|Lost to Follow-up|1|||
33408582|NCT02146365|101386076|FG005|Overall Study|Lost to Follow-up|1|||
33408583|NCT02146365|101386077|FG006|Overall Study|Lost to Follow-up|0|||
33408584|NCT02146365|101386078|FG007|Overall Study|Lost to Follow-up|1|||
33408585|NCT02146365|101386071|FG000|Overall Study|Withdrawal by Subject|1|||
33408586|NCT02146365|101386072|FG001|Overall Study|Withdrawal by Subject|2|||
33408587|NCT02146365|101386073|FG002|Overall Study|Withdrawal by Subject|1|||
33408588|NCT02146365|101386074|FG003|Overall Study|Withdrawal by Subject|5|||
33408589|NCT02146365|101386075|FG004|Overall Study|Withdrawal by Subject|1|||
33408590|NCT02146365|101386076|FG005|Overall Study|Withdrawal by Subject|0|||
33408591|NCT02146365|101386077|FG006|Overall Study|Withdrawal by Subject|0|||
33408592|NCT02146365|101386078|FG007|Overall Study|Withdrawal by Subject|0|||
33408593|NCT02146365|101386071|FG000|Overall Study|Unable to Comply with Protocol|0|||
33408594|NCT02146365|101386072|FG001|Overall Study|Unable to Comply with Protocol|1|||
33408595|NCT02146365|101386073|FG002|Overall Study|Unable to Comply with Protocol|1|||
33408596|NCT02146365|101386074|FG003|Overall Study|Unable to Comply with Protocol|0|||
33544243|NCT00750269|101891975|FG001|Overall Study|Site error|0|||
33544244|NCT00750269|101891976|FG002|Overall Study|Site error|0|||
33544245|NCT00750269|101891977|FG003|Overall Study|Site error|1|||
33544246|NCT00750269|101891978|FG004|Overall Study|Site error|0|||
33544247|NCT00750269|101891974|FG000|Overall Study|SBRT plan could not be drawn|0|||
33544248|NCT00750269|101891975|FG001|Overall Study|SBRT plan could not be drawn|0|||
33544249|NCT00750269|101891976|FG002|Overall Study|SBRT plan could not be drawn|0|||
33544250|NCT00750269|101891977|FG003|Overall Study|SBRT plan could not be drawn|0|||
33544251|NCT00750269|101891978|FG004|Overall Study|SBRT plan could not be drawn|1|||
33544252|NCT00750269|101891974|FG000|Overall Study|Fiducials could not be placed|0|||
33544253|NCT00750269|101891975|FG001|Overall Study|Fiducials could not be placed|0|||
33544254|NCT00750269|101891976|FG002|Overall Study|Fiducials could not be placed|0|||
33544255|NCT00750269|101891977|FG003|Overall Study|Fiducials could not be placed|0|||
33544256|NCT00750269|101891978|FG004|Overall Study|Fiducials could not be placed|1|||
33544257|NCT00607893|101891979|FG000|Overall Study|Lost to Follow-up|4|||
33544258|NCT00607893|101891980|FG001|Overall Study|Lost to Follow-up|0|||
33544259|NCT00607893|101891979|FG000|Overall Study|withdrew due to loss of interest|0|||
33544260|NCT00607893|101891980|FG001|Overall Study|withdrew due to loss of interest|1|||
33544261|NCT00607893|101891979|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
33544262|NCT00607893|101891980|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
33544263|NCT00607893|101891979|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
33544264|NCT00607893|101891980|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
33544265|NCT00607893|101891979|FG000|Overall Study|Declined to be treated|1|||
33544266|NCT00607893|101891980|FG001|Overall Study|Declined to be treated|0|||
33544267|NCT00607893|101891979|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
33544268|NCT00607893|101891980|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
33544269|NCT03157089|101891981|FG000|Overall Study|Treated only with pembrolizumab|1|||
33544270|NCT03157089|101891982|FG001|Overall Study|Treated only with pembrolizumab|0|||
33544271|NCT03157089|101891981|FG000|Overall Study|Adverse Event|5|||
33544272|NCT03157089|101891982|FG001|Overall Study|Adverse Event|4|||
33544273|NCT03157089|101891981|FG000|Overall Study|Progressive disease|6|||
33544274|NCT03157089|101891982|FG001|Overall Study|Progressive disease|8|||
33544275|NCT00963235|101891983|FG000|Overall Study|Withdrawal by Subject|22|||
33544276|NCT00963235|101891983|FG000|Overall Study|Lost to Follow-up|14|||
33347074|NCT01449708|101159969|FG000|Overall Study|Protocol Violation|0|||
33408597|NCT02146365|101386075|FG004|Overall Study|Unable to Comply with Protocol|0|||
33408598|NCT02146365|101386076|FG005|Overall Study|Unable to Comply with Protocol|0|||
33408599|NCT02146365|101386077|FG006|Overall Study|Unable to Comply with Protocol|0|||
33408600|NCT02146365|101386078|FG007|Overall Study|Unable to Comply with Protocol|0|||
33408601|NCT02146365|101386071|FG000|Overall Study|Other|1|||
33544277|NCT00963235|101891983|FG000|Overall Study|Failed to return|9|||
33544278|NCT00963235|101891983|FG000|Overall Study|Protocol Violation|7|||
33408602|NCT02146365|101386072|FG001|Overall Study|Other|0|||
33408603|NCT02146365|101386073|FG002|Overall Study|Other|2|||
33408604|NCT02146365|101386074|FG003|Overall Study|Other|1|||
33408605|NCT02146365|101386075|FG004|Overall Study|Other|0|||
33408606|NCT02146365|101386076|FG005|Overall Study|Other|0|||
33408607|NCT02146365|101386077|FG006|Overall Study|Other|0|||
33408608|NCT02146365|101386078|FG007|Overall Study|Other|0|||
33408609|NCT02195479|101386079|FG000|Overall Study|Lost to Follow-up|3|||
33408610|NCT02195479|101386080|FG001|Overall Study|Lost to Follow-up|0|||
33408611|NCT02195479|101386079|FG000|Overall Study|Death|48|||
33408612|NCT02195479|101386080|FG001|Overall Study|Death|45|||
33408613|NCT02195479|101386079|FG000|Overall Study|Physician Decision|1|||
33408614|NCT02195479|101386080|FG001|Overall Study|Physician Decision|0|||
33408615|NCT02195479|101386079|FG000|Overall Study|Withdrawal by Subject|11|||
33408616|NCT02195479|101386080|FG001|Overall Study|Withdrawal by Subject|6|||
33616493|NCT00286429|102144360|FG000|Overall Study|Protocol Violation|3|||
33616494|NCT00286429|102144361|FG001|Overall Study|Protocol Violation|5|||
33616495|NCT00286429|102144362|FG002|Overall Study|Protocol Violation|4|||
33616496|NCT00286429|102144360|FG000|Overall Study|Withdrawal by Subject|3|||
33616497|NCT00286429|102144361|FG001|Overall Study|Withdrawal by Subject|2|||
33408617|NCT02195479|101386079|FG000|Overall Study|Other|2|||
33408618|NCT02195479|101386080|FG001|Overall Study|Other|2|||
33408619|NCT02195479|101386079|FG000|Overall Study|Ongoing|291|||
33408620|NCT02195479|101386080|FG001|Overall Study|Ongoing|297|||
33408621|NCT01886105|101386081|FG000|Overall Study|Lack of Efficacy|3|||
33408622|NCT00368069|101386082|FG000|Overall Study|Adverse Event|5|||
33408623|NCT00368069|101386083|FG001|Overall Study|Adverse Event|2|||
33408624|NCT00368069|101386082|FG000|Overall Study|Lack of Efficacy|0|||
33408625|NCT00368069|101386083|FG001|Overall Study|Lack of Efficacy|1|||
33408626|NCT00368069|101386082|FG000|Overall Study|Lost to Follow-up|1|||
33408627|NCT00368069|101386083|FG001|Overall Study|Lost to Follow-up|0|||
33408628|NCT00368069|101386082|FG000|Overall Study|Protocol Violation|0|||
33408629|NCT00368069|101386083|FG001|Overall Study|Protocol Violation|2|||
33408630|NCT00368069|101386082|FG000|Overall Study|Withdrawal of Consent|2|||
33408631|NCT00368069|101386083|FG001|Overall Study|Withdrawal of Consent|1|||
33408632|NCT00368069|101386082|FG000|Overall Study|no blood sampling possible|0|||
33408633|NCT00368069|101386083|FG001|Overall Study|no blood sampling possible|1|||
33408634|NCT03814746|101386084|FG000|Overall Study|Participant decision|9|||
33408635|NCT03814746|101386085|FG001|Overall Study|Participant decision|6|||
33408636|NCT03814746|101386086|FG002|Overall Study|Participant decision|15|||
33408637|NCT03814746|101386084|FG000|Overall Study|Physician Decision|2|||
33408638|NCT03814746|101386085|FG001|Overall Study|Physician Decision|2|||
33408639|NCT03814746|101386086|FG002|Overall Study|Physician Decision|4|||
33408640|NCT03814746|101386084|FG000|Overall Study|Death|2|||
33408641|NCT03814746|101386085|FG001|Overall Study|Death|2|||
33408642|NCT03814746|101386086|FG002|Overall Study|Death|2|||
33408643|NCT03814746|101386084|FG000|Overall Study|Adverse Event|2|||
33408644|NCT03814746|101386085|FG001|Overall Study|Adverse Event|2|||
33408645|NCT03814746|101386086|FG002|Overall Study|Adverse Event|1|||
33408646|NCT03814746|101386084|FG000|Overall Study|Lost to Follow-up|2|||
33408647|NCT03814746|101386085|FG001|Overall Study|Lost to Follow-up|1|||
33408648|NCT03814746|101386086|FG002|Overall Study|Lost to Follow-up|2|||
33408649|NCT03814746|101386084|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33408650|NCT03814746|101386085|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33544279|NCT00963235|101891983|FG000|Overall Study|Adverse Event|5|||
33213203|NCT02332590|100679585|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
33213204|NCT02332590|100679586|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
33213205|NCT02332590|100679585|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
33408651|NCT03814746|101386086|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
33408652|NCT03814746|101386084|FG000|Overall Study|Pregnancy|0|||
33408653|NCT03814746|101386085|FG001|Overall Study|Pregnancy|1|||
33408654|NCT03814746|101386086|FG002|Overall Study|Pregnancy|1|||
33544280|NCT00963235|101891983|FG000|Overall Study|Physician Decision|2|||
33408655|NCT03814746|101386084|FG000|Overall Study|Protocol Violation|1|||
33408656|NCT03814746|101386085|FG001|Overall Study|Protocol Violation|0|||
33408657|NCT03814746|101386086|FG002|Overall Study|Protocol Violation|0|||
33408658|NCT01428882|101386087|FG000|Overall Study|Lack of Efficacy|2|||
33408659|NCT01428882|101386088|FG001|Overall Study|Lack of Efficacy|7|||
33408660|NCT01428882|101386087|FG000|Overall Study|Protocol Violation|4|||
33408661|NCT01428882|101386088|FG001|Overall Study|Protocol Violation|3|||
33408662|NCT04823494|101386090|FG000|Overall Study|Programming software malfunction.|1|||
33347075|NCT01449708|101159970|FG001|Overall Study|Protocol Violation|1|||
33347076|NCT01449708|101159969|FG000|Overall Study|surgical complication|1|||
33347077|NCT01449708|101159970|FG001|Overall Study|surgical complication|2|||
33347078|NCT01449708|101159969|FG000|Overall Study|respiratory failure|1|||
33408663|NCT04823494|101386091|FG001|Overall Study|Programming software malfunction.|0|||
33408664|NCT04823494|101386090|FG000|Overall Study|Withdrawal by Subject|1|||
33408665|NCT04823494|101386091|FG001|Overall Study|Withdrawal by Subject|0|||
33408666|NCT04823494|101386090|FG000|Overall Study|Devices lost|0|||
33408667|NCT04823494|101386091|FG001|Overall Study|Devices lost|1|||
33408668|NCT05664672|101386092|FG000|Overall Study|Adverse Event|0|||
33408669|NCT05664672|101386093|FG001|Overall Study|Adverse Event|0|||
33408670|NCT05664672|101386094|FG002|Overall Study|Adverse Event|0|||
33408671|NCT05664672|101386095|FG003|Overall Study|Adverse Event|0|||
33408672|NCT05664672|101386096|FG004|Overall Study|Adverse Event|0|||
33544281|NCT00963235|101891983|FG000|Overall Study|Other|1|||
33544282|NCT02034006|101891984|FG000|Overall Study|Withdrawal by Subject|7|||
33544283|NCT02034006|101891984|FG000|Overall Study|Lost to Follow-up|5|||
33544284|NCT02034006|101891984|FG000|Overall Study|Death|1|||
33544285|NCT02034006|101891984|FG000|Overall Study|Pregnancy|1|||
33544286|NCT02472405|101891985|FG000|Overall Study|Lost to Follow-up|9|||
33347079|NCT01449708|101159970|FG001|Overall Study|respiratory failure|0|||
33347080|NCT02117687|101159971|FG000|Overall Study|Lost to Follow-up|0|||
33347081|NCT02117687|101159972|FG001|Overall Study|Lost to Follow-up|1|||
33347082|NCT02117687|101159971|FG000|Overall Study|Adverse Event|0|||
33347083|NCT02117687|101159972|FG001|Overall Study|Adverse Event|2|||
33347084|NCT02117687|101159971|FG000|Overall Study|Other Reasons|1|||
33347085|NCT02117687|101159972|FG001|Overall Study|Other Reasons|1|||
33347086|NCT03653390|101159973|FG000|Overall Study|Lost to Follow-up|12|||
33347087|NCT03653390|101159974|FG001|Overall Study|Lost to Follow-up|8|||
33347088|NCT03653390|101159975|FG002|Overall Study|Lost to Follow-up|7|||
33347089|NCT03653390|101159973|FG000|Overall Study|Withdrawal by Subject|6|||
33347090|NCT03653390|101159974|FG001|Overall Study|Withdrawal by Subject|1|||
33347091|NCT03653390|101159975|FG002|Overall Study|Withdrawal by Subject|1|||
33347092|NCT03653390|101159973|FG000|Overall Study|Death|1|||
33347093|NCT03653390|101159974|FG001|Overall Study|Death|0|||
33347094|NCT03653390|101159975|FG002|Overall Study|Death|0|||
33347095|NCT03653390|101159973|FG000|Overall Study|Paper Survey Lost|1|||
33544287|NCT02472405|101891985|FG000|Overall Study|Adverse Event|1|||
33544288|NCT01160614|101891993|FG000|Overall Study|Withdrawal by Subject|0|||
33544289|NCT01160614|101891994|FG001|Overall Study|Withdrawal by Subject|2|||
33544290|NCT01860989|101891997|FG000|Overall Study|Unsatisfactory therapeutic|5|||
33544291|NCT00720278|101891998|FG000|Overall Study|Adverse Event|5|||
33544292|NCT00720278|101891999|FG001|Overall Study|Adverse Event|3|||
33544293|NCT00720278|101892000|FG002|Overall Study|Adverse Event|4|||
33544294|NCT00720278|101891998|FG000|Overall Study|Withdrawal by Subject|0|||
33544295|NCT00720278|101891999|FG001|Overall Study|Withdrawal by Subject|1|||
33544296|NCT00720278|101892000|FG002|Overall Study|Withdrawal by Subject|0|||
33544297|NCT00720278|101891998|FG000|Overall Study|Lost to Follow-up|0|||
33544298|NCT00720278|101891999|FG001|Overall Study|Lost to Follow-up|0|||
33544299|NCT00720278|101892000|FG002|Overall Study|Lost to Follow-up|1|||
33544300|NCT00720278|101891998|FG000|Overall Study|Non-compliance|1|||
33544301|NCT00720278|101891999|FG001|Overall Study|Non-compliance|0|||
33544302|NCT00720278|101892000|FG002|Overall Study|Non-compliance|0|||
33544303|NCT00720278|101891998|FG000|Overall Study|eligibility criteria violation|1|||
33544304|NCT00720278|101891999|FG001|Overall Study|eligibility criteria violation|0|||
33544305|NCT00720278|101892000|FG002|Overall Study|eligibility criteria violation|1|||
33544306|NCT02875080|101894488|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
33544307|NCT02875080|101894489|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
33347096|NCT03653390|101159974|FG001|Overall Study|Paper Survey Lost|0|||
33347097|NCT03653390|101159975|FG002|Overall Study|Paper Survey Lost|0|||
33347098|NCT00236080|101159976|FG000|Overall Study|Adverse Event|0|||
33347099|NCT00236080|101159977|FG001|Overall Study|Adverse Event|0|||
33347100|NCT00236080|101159978|FG002|Overall Study|Adverse Event|3|||
33408673|NCT05664672|101386097|FG005|Overall Study|Adverse Event|1|||
33408674|NCT05664672|101386092|FG000|Overall Study|Withdrawal by Subject|0|||
33408675|NCT05664672|101386093|FG001|Overall Study|Withdrawal by Subject|1|||
33544308|NCT02875080|101894490|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
33544309|NCT01303419|101894493|FG000|Overall Study|Discontinuation of study|60|||
33544310|NCT01303419|101894493|FG000|Overall Study|Did not complete both imaging methods|5|||
33408676|NCT05664672|101386094|FG002|Overall Study|Withdrawal by Subject|3|||
33408677|NCT05664672|101386095|FG003|Overall Study|Withdrawal by Subject|0|||
33544311|NCT01303419|101894493|FG000|Overall Study|Did not meet all I/E after screening|31|||
33544312|NCT01452347|101894498|FG000|Overall Study|Adverse Event|2|||
33347101|NCT00236080|101159979|FG003|Overall Study|Adverse Event|1|||
33347102|NCT00236080|101159980|FG004|Overall Study|Adverse Event|0|||
33408678|NCT05664672|101386096|FG004|Overall Study|Withdrawal by Subject|5|||
33347103|NCT00236080|101159976|FG000|Overall Study|Lost to Follow-up|0|||
33347104|NCT00236080|101159977|FG001|Overall Study|Lost to Follow-up|1|||
33616498|NCT00286429|102144362|FG002|Overall Study|Withdrawal by Subject|6|||
33616499|NCT00286429|102144360|FG000|Overall Study|Administrative Error|1|||
33616500|NCT00286429|102144361|FG001|Overall Study|Administrative Error|1|||
33616501|NCT00286429|102144362|FG002|Overall Study|Administrative Error|1|||
33616502|NCT00286429|102144360|FG000|Overall Study|Administrative Decision|0|||
33616503|NCT00286429|102144361|FG001|Overall Study|Administrative Decision|1|||
33616504|NCT00286429|102144362|FG002|Overall Study|Administrative Decision|0|||
33616505|NCT03387020|102144364|FG000|Overall Study|Adverse Event|0|||
33616506|NCT03387020|102144365|FG001|Overall Study|Adverse Event|2|||
33616507|NCT03387020|102144366|FG002|Overall Study|Adverse Event|0|||
33616508|NCT03387020|102144364|FG000|Overall Study|Withdrawal by Subject|2|||
33616509|NCT03387020|102144365|FG001|Overall Study|Withdrawal by Subject|0|||
33616510|NCT03387020|102144366|FG002|Overall Study|Withdrawal by Subject|0|||
33616511|NCT00650767|102144367|FG000|Overall Study|Adverse Event|0|||
33616512|NCT00650767|102144368|FG001|Overall Study|Adverse Event|3|||
33347105|NCT00236080|101159978|FG002|Overall Study|Lost to Follow-up|0|||
33347106|NCT00236080|101159979|FG003|Overall Study|Lost to Follow-up|0|||
33616513|NCT00650767|102144369|FG002|Overall Study|Adverse Event|10|||
33616514|NCT00650767|102144370|FG003|Overall Study|Adverse Event|8|||
33616515|NCT00650767|102144367|FG000|Overall Study|Death|1|||
33347107|NCT00236080|101159980|FG004|Overall Study|Lost to Follow-up|0|||
33347108|NCT00236080|101159976|FG000|Overall Study|Physician Decision|1|||
33347109|NCT00236080|101159977|FG001|Overall Study|Physician Decision|0|||
33347110|NCT00236080|101159978|FG002|Overall Study|Physician Decision|1|||
33347111|NCT00236080|101159979|FG003|Overall Study|Physician Decision|1|||
33347112|NCT00236080|101159980|FG004|Overall Study|Physician Decision|1|||
33347113|NCT00236080|101159976|FG000|Overall Study|Withdrawal by Subject|1|||
33347114|NCT00236080|101159977|FG001|Overall Study|Withdrawal by Subject|0|||
33544313|NCT01452347|101894499|FG001|Overall Study|Adverse Event|1|||
33544314|NCT01452347|101894498|FG000|Overall Study|Non compliance protocol|2|||
33544315|NCT01452347|101894499|FG001|Overall Study|Non compliance protocol|0|||
33544316|NCT01452347|101894498|FG000|Overall Study|Lost to Follow-up|2|||
33544317|NCT01452347|101894499|FG001|Overall Study|Lost to Follow-up|0|||
33544318|NCT01452347|101894498|FG000|Overall Study|Withdrawal by Subject|3|||
33544319|NCT01452347|101894499|FG001|Overall Study|Withdrawal by Subject|3|||
33544320|NCT01452347|101894498|FG000|Overall Study|Not treated|6|||
33544321|NCT01452347|101894499|FG001|Overall Study|Not treated|3|||
33544322|NCT01452347|101894498|FG000|Overall Study|Other reason not defined above|2|||
33544323|NCT01452347|101894499|FG001|Overall Study|Other reason not defined above|0|||
33544324|NCT00116142|101894500|FG000|Overall Study|Adverse Event|8|||
33544325|NCT00116142|101894501|FG001|Overall Study|Adverse Event|7|||
33616516|NCT00650767|102144368|FG001|Overall Study|Death|0|||
33616517|NCT00650767|102144369|FG002|Overall Study|Death|0|||
33616518|NCT00650767|102144370|FG003|Overall Study|Death|0|||
33616519|NCT00650767|102144367|FG000|Overall Study|Withdrawal by Subject|2|||
33616520|NCT00650767|102144368|FG001|Overall Study|Withdrawal by Subject|4|||
33616521|NCT00650767|102144369|FG002|Overall Study|Withdrawal by Subject|3|||
33616522|NCT00650767|102144370|FG003|Overall Study|Withdrawal by Subject|3|||
33616523|NCT00650767|102144367|FG000|Overall Study|Lost to Follow-up|1|||
33616524|NCT00650767|102144368|FG001|Overall Study|Lost to Follow-up|1|||
33616525|NCT00650767|102144369|FG002|Overall Study|Lost to Follow-up|1|||
33616526|NCT00650767|102144370|FG003|Overall Study|Lost to Follow-up|0|||
33616527|NCT00650767|102144367|FG000|Overall Study|Other|1|||
33616528|NCT00650767|102144368|FG001|Overall Study|Other|1|||
33616529|NCT00650767|102144369|FG002|Overall Study|Other|0|||
33616530|NCT00650767|102144370|FG003|Overall Study|Other|0|||
33616531|NCT00391027|102144371|FG000|Overall Study|Adverse Event|8|||
33616532|NCT00391027|102144372|FG001|Overall Study|Adverse Event|8|||
33616533|NCT00391027|102144371|FG000|Overall Study|Lack of Efficacy|3|||
33347115|NCT00236080|101159978|FG002|Overall Study|Withdrawal by Subject|0|||
33347116|NCT00236080|101159979|FG003|Overall Study|Withdrawal by Subject|0|||
33347117|NCT00236080|101159980|FG004|Overall Study|Withdrawal by Subject|0|||
33347118|NCT00236080|101159976|FG000|Overall Study|Miscellaneous|0|||
33347119|NCT00236080|101159977|FG001|Overall Study|Miscellaneous|0|||
33347120|NCT00236080|101159978|FG002|Overall Study|Miscellaneous|1|||
33347121|NCT00236080|101159979|FG003|Overall Study|Miscellaneous|0|||
33616534|NCT00391027|102144372|FG001|Overall Study|Lack of Efficacy|0|||
33616535|NCT00391027|102144371|FG000|Overall Study|Withdrawal by Subject|10|||
33616536|NCT00391027|102144372|FG001|Overall Study|Withdrawal by Subject|1|||
33616537|NCT00391027|102144371|FG000|Overall Study|Other|4|||
33616538|NCT00391027|102144372|FG001|Overall Study|Other|3|||
33544326|NCT00116142|101894500|FG000|Overall Study|Protocol Violation|2|||
33544327|NCT00116142|101894501|FG001|Overall Study|Protocol Violation|1|||
33616539|NCT02629822|102144376|FG000|Base Study|Lost to Follow-up|2|||
33616540|NCT02629822|102144376|FG000|Base Study|Non-Compliance With Study Drug|1|||
33616541|NCT02629822|102144376|FG000|Extension Study|Adverse Event|1|||
33616542|NCT02629822|102144376|FG000|Extension Study|Lost to Follow-up|1|||
33347122|NCT00236080|101159980|FG004|Overall Study|Miscellaneous|0|||
33544328|NCT00116142|101894500|FG000|Overall Study|Withdrawal by Subject|5|||
33616543|NCT03210961|102144377|FG000|Overall Study|Adverse Event|0|||
33616544|NCT03210961|102144378|FG001|Overall Study|Adverse Event|0|||
33616545|NCT03210961|102144379|FG002|Overall Study|Adverse Event|0|||
33616546|NCT03210961|102144380|FG003|Overall Study|Adverse Event|0|||
33616547|NCT03210961|102144381|FG004|Overall Study|Adverse Event|0|||
33347123|NCT01773421|101159981|FG000|Treatment Phase|Other|0|||
33347124|NCT01773421|101159982|FG001|Treatment Phase|Other|0|||
33347125|NCT01773421|101159983|FG002|Treatment Phase|Other|2|||
33347126|NCT01773421|101159984|FG003|Treatment Phase|Other|0|||
33347127|NCT01773421|101159985|FG004|Treatment Phase|Other|0|||
33347128|NCT01773421|101159986|FG005|Treatment Phase|Other|0|||
33347129|NCT01773421|101159987|FG006|Treatment Phase|Other|0|||
33347130|NCT01773421|101159981|FG000|Treatment Phase|Adverse Event|0|||
33347131|NCT01773421|101159982|FG001|Treatment Phase|Adverse Event|0|||
33347132|NCT01773421|101159983|FG002|Treatment Phase|Adverse Event|3|||
33347133|NCT01773421|101159984|FG003|Treatment Phase|Adverse Event|1|||
33347134|NCT01773421|101159985|FG004|Treatment Phase|Adverse Event|0|||
33347135|NCT01773421|101159986|FG005|Treatment Phase|Adverse Event|0|||
33347136|NCT01773421|101159987|FG006|Treatment Phase|Adverse Event|0|||
33347137|NCT01773421|101159981|FG000|Treatment Phase|Withdrawal by Subject|0|||
33347138|NCT01773421|101159982|FG001|Treatment Phase|Withdrawal by Subject|0|||
33347139|NCT01773421|101159983|FG002|Treatment Phase|Withdrawal by Subject|1|||
33347140|NCT01773421|101159984|FG003|Treatment Phase|Withdrawal by Subject|1|||
33347141|NCT01773421|101159985|FG004|Treatment Phase|Withdrawal by Subject|0|||
33347142|NCT01773421|101159986|FG005|Treatment Phase|Withdrawal by Subject|0|||
33347143|NCT01773421|101159987|FG006|Treatment Phase|Withdrawal by Subject|0|||
33347144|NCT01773421|101159981|FG000|Extension Phase|Other|0|||
33347145|NCT01773421|101159982|FG001|Extension Phase|Other|0|||
33347146|NCT01773421|101159983|FG002|Extension Phase|Other|0|||
33347147|NCT01773421|101159984|FG003|Extension Phase|Other|0|||
33347148|NCT01773421|101159985|FG004|Extension Phase|Other|1|||
33347149|NCT01773421|101159986|FG005|Extension Phase|Other|2|||
33347150|NCT01773421|101159987|FG006|Extension Phase|Other|0|||
33347151|NCT01773421|101159981|FG000|Extension Phase|Adverse Event|0|||
33347152|NCT01773421|101159982|FG001|Extension Phase|Adverse Event|0|||
33347153|NCT01773421|101159983|FG002|Extension Phase|Adverse Event|0|||
33347154|NCT01773421|101159984|FG003|Extension Phase|Adverse Event|0|||
33544329|NCT00116142|101894501|FG001|Overall Study|Withdrawal by Subject|5|||
33544330|NCT00116142|101894500|FG000|Overall Study|Physician Decision|3|||
33544331|NCT00116142|101894501|FG001|Overall Study|Physician Decision|1|||
33544332|NCT00116142|101894500|FG000|Overall Study|Delayed Radiation Therapy|1|||
33544333|NCT00116142|101894501|FG001|Overall Study|Delayed Radiation Therapy|0|||
33544334|NCT00116142|101894500|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
33544335|NCT00116142|101894501|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
33544336|NCT00116142|101894500|FG000|Overall Study|Patient stopped due to depression|0|||
33616548|NCT03210961|102144382|FG005|Overall Study|Adverse Event|0|||
33616549|NCT03210961|102144383|FG006|Overall Study|Adverse Event|0|||
33616550|NCT03210961|102144384|FG007|Overall Study|Adverse Event|0|||
33616551|NCT03210961|102144385|FG008|Overall Study|Adverse Event|0|||
33616552|NCT03210961|102144386|FG009|Overall Study|Adverse Event|0|||
33616553|NCT03210961|102144387|FG010|Overall Study|Adverse Event|0|||
33616554|NCT03210961|102144388|FG011|Overall Study|Adverse Event|0|||
33616555|NCT03210961|102144389|FG012|Overall Study|Adverse Event|0|||
33347155|NCT01773421|101159985|FG004|Extension Phase|Adverse Event|2|||
33347156|NCT01773421|101159986|FG005|Extension Phase|Adverse Event|0|||
33347157|NCT01773421|101159987|FG006|Extension Phase|Adverse Event|0|||
33347158|NCT02971202|101159988|FG000|Overall Study|Pregnancy|1|||
33347159|NCT02971202|101159989|FG001|Overall Study|Pregnancy|0|||
33347160|NCT02971202|101159990|FG002|Overall Study|Pregnancy|0|||
33347161|NCT02971202|101159988|FG000|Overall Study|screen fail after consent|1|||
33347162|NCT02971202|101159989|FG001|Overall Study|screen fail after consent|0|||
33347163|NCT02971202|101159990|FG002|Overall Study|screen fail after consent|1|||
33616556|NCT03210961|102144390|FG013|Overall Study|Adverse Event|1|||
33616557|NCT03210961|102144391|FG014|Overall Study|Adverse Event|0|||
33616558|NCT03210961|102144377|FG000|Overall Study|Lost to Follow-up|0|||
33616559|NCT03210961|102144378|FG001|Overall Study|Lost to Follow-up|0|||
33616560|NCT03210961|102144379|FG002|Overall Study|Lost to Follow-up|0|||
33616561|NCT03210961|102144380|FG003|Overall Study|Lost to Follow-up|0|||
33616562|NCT03210961|102144381|FG004|Overall Study|Lost to Follow-up|0|||
33616563|NCT03210961|102144382|FG005|Overall Study|Lost to Follow-up|0|||
33616564|NCT03210961|102144383|FG006|Overall Study|Lost to Follow-up|0|||
33616565|NCT03210961|102144384|FG007|Overall Study|Lost to Follow-up|0|||
33616566|NCT03210961|102144385|FG008|Overall Study|Lost to Follow-up|0|||
33616567|NCT03210961|102144386|FG009|Overall Study|Lost to Follow-up|0|||
33616568|NCT03210961|102144387|FG010|Overall Study|Lost to Follow-up|0|||
33616569|NCT03210961|102144388|FG011|Overall Study|Lost to Follow-up|0|||
33616570|NCT03210961|102144389|FG012|Overall Study|Lost to Follow-up|0|||
33616571|NCT03210961|102144390|FG013|Overall Study|Lost to Follow-up|0|||
33616572|NCT03210961|102144391|FG014|Overall Study|Lost to Follow-up|1|||
33616573|NCT03210961|102144377|FG000|Overall Study|Withdrawal by Subject|0|||
33616574|NCT03210961|102144378|FG001|Overall Study|Withdrawal by Subject|0|||
33616575|NCT03210961|102144379|FG002|Overall Study|Withdrawal by Subject|0|||
33616576|NCT03210961|102144380|FG003|Overall Study|Withdrawal by Subject|0|||
33616577|NCT03210961|102144381|FG004|Overall Study|Withdrawal by Subject|0|||
33616578|NCT03210961|102144382|FG005|Overall Study|Withdrawal by Subject|0|||
33616579|NCT03210961|102144383|FG006|Overall Study|Withdrawal by Subject|0|||
33616580|NCT03210961|102144384|FG007|Overall Study|Withdrawal by Subject|0|||
33616581|NCT03210961|102144385|FG008|Overall Study|Withdrawal by Subject|0|||
33616582|NCT03210961|102144386|FG009|Overall Study|Withdrawal by Subject|0|||
33616583|NCT03210961|102144387|FG010|Overall Study|Withdrawal by Subject|0|||
33347164|NCT01084551|101159992|FG000|Overall Study|Adverse Event|2|||
33347165|NCT01084551|101159993|FG001|Overall Study|Adverse Event|9|||
33347166|NCT01084551|101159994|FG002|Overall Study|Adverse Event|4|||
33347167|NCT01084551|101159992|FG000|Overall Study|Lack of Efficacy|2|||
33347168|NCT01084551|101159993|FG001|Overall Study|Lack of Efficacy|0|||
33347169|NCT01084551|101159994|FG002|Overall Study|Lack of Efficacy|1|||
33347170|NCT01084551|101159992|FG000|Overall Study|Withdrawal by Subject|2|||
33347171|NCT01084551|101159993|FG001|Overall Study|Withdrawal by Subject|1|||
33347172|NCT01084551|101159994|FG002|Overall Study|Withdrawal by Subject|0|||
33347173|NCT01084551|101159992|FG000|Overall Study|Protocol Violation|2|||
33347174|NCT01084551|101159993|FG001|Overall Study|Protocol Violation|4|||
33408679|NCT05664672|101386097|FG005|Overall Study|Withdrawal by Subject|6|||
33544337|NCT00116142|101894501|FG001|Overall Study|Patient stopped due to depression|1|||
33544338|NCT00116142|101894500|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
33544339|NCT00116142|101894501|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
33544340|NCT00116142|101894500|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
33544341|NCT00116142|101894501|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
33544342|NCT00116142|101894500|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
33544343|NCT00116142|101894501|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
33544344|NCT01572792|101894502|FG000|Lead-in Study|Lost to Follow-up|5|||
33544345|NCT01572792|101894503|FG001|Lead-in Study|Lost to Follow-up|9|||
33544346|NCT01572792|101894504|FG002|Lead-in Study|Lost to Follow-up|4|||
33544347|NCT01572792|101894505|FG003|Lead-in Study|Lost to Follow-up|2|||
33544348|NCT01572792|101894506|FG004|Lead-in Study|Lost to Follow-up|4|||
33544349|NCT01572792|101894502|FG000|Lead-in Study|Withdrawal by Subject|22|||
33544350|NCT01572792|101894503|FG001|Lead-in Study|Withdrawal by Subject|11|||
33544351|NCT01572792|101894504|FG002|Lead-in Study|Withdrawal by Subject|12|||
33544352|NCT01572792|101894505|FG003|Lead-in Study|Withdrawal by Subject|24|||
33544353|NCT01572792|101894506|FG004|Lead-in Study|Withdrawal by Subject|11|||
33544354|NCT01572792|101894502|FG000|Lead-in Study|Protocol Violation|19|||
33544355|NCT01572792|101894503|FG001|Lead-in Study|Protocol Violation|10|||
33544356|NCT01572792|101894504|FG002|Lead-in Study|Protocol Violation|12|||
33544357|NCT01572792|101894505|FG003|Lead-in Study|Protocol Violation|13|||
33544358|NCT01572792|101894506|FG004|Lead-in Study|Protocol Violation|21|||
33616584|NCT03210961|102144388|FG011|Overall Study|Withdrawal by Subject|0|||
33616585|NCT03210961|102144389|FG012|Overall Study|Withdrawal by Subject|0|||
33616586|NCT03210961|102144390|FG013|Overall Study|Withdrawal by Subject|0|||
33616587|NCT03210961|102144391|FG014|Overall Study|Withdrawal by Subject|1|||
33213206|NCT02332590|100679586|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
33616588|NCT03210961|102144377|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33347175|NCT01084551|101159994|FG002|Overall Study|Protocol Violation|0|||
33347176|NCT01084551|101159992|FG000|Overall Study|Lost to Follow-up|0|||
33347177|NCT01084551|101159993|FG001|Overall Study|Lost to Follow-up|0|||
33408680|NCT05664672|101386092|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
33408681|NCT05664672|101386093|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
33408682|NCT05664672|101386094|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
33616589|NCT03210961|102144378|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33616590|NCT03210961|102144379|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
33616591|NCT03210961|102144380|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
33616592|NCT03210961|102144381|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
33616593|NCT03210961|102144382|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
33616594|NCT03210961|102144383|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
33616595|NCT03210961|102144384|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
33616596|NCT03210961|102144385|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
33616597|NCT03210961|102144386|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
33616598|NCT03210961|102144387|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
33616599|NCT03210961|102144388|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
33616600|NCT03210961|102144389|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
33616601|NCT03210961|102144390|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
33616602|NCT03210961|102144391|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
33616603|NCT03210961|102144377|FG000|Overall Study|Other|0|||
33616604|NCT03210961|102144378|FG001|Overall Study|Other|0|||
33616605|NCT03210961|102144379|FG002|Overall Study|Other|0|||
33616606|NCT03210961|102144380|FG003|Overall Study|Other|1|||
33616607|NCT03210961|102144381|FG004|Overall Study|Other|0|||
33616608|NCT03210961|102144382|FG005|Overall Study|Other|0|||
33616609|NCT03210961|102144383|FG006|Overall Study|Other|1|||
33616610|NCT03210961|102144384|FG007|Overall Study|Other|0|||
33616611|NCT03210961|102144385|FG008|Overall Study|Other|0|||
33408683|NCT05664672|101386095|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
33408684|NCT05664672|101386096|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
33544359|NCT01572792|101894502|FG000|Lead-in Study|Lack of Efficacy|20|||
33544360|NCT01572792|101894503|FG001|Lead-in Study|Lack of Efficacy|5|||
33544361|NCT01572792|101894504|FG002|Lead-in Study|Lack of Efficacy|4|||
33544362|NCT01572792|101894505|FG003|Lead-in Study|Lack of Efficacy|8|||
33544363|NCT01572792|101894506|FG004|Lead-in Study|Lack of Efficacy|10|||
33544364|NCT01572792|101894502|FG000|Lead-in Study|Adverse Event|21|||
33544365|NCT01572792|101894503|FG001|Lead-in Study|Adverse Event|21|||
33544366|NCT01572792|101894504|FG002|Lead-in Study|Adverse Event|22|||
33544367|NCT01572792|101894505|FG003|Lead-in Study|Adverse Event|16|||
33544368|NCT01572792|101894506|FG004|Lead-in Study|Adverse Event|14|||
33544369|NCT01572792|101894502|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
33544370|NCT01572792|101894503|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
33544371|NCT01572792|101894504|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
33544372|NCT01572792|101894505|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
33544373|NCT01572792|101894506|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
33544374|NCT01572792|101894502|FG000|Extension Study|Lost to Follow-up|6|||
33544375|NCT01572792|101894503|FG001|Extension Study|Lost to Follow-up|2|||
33544376|NCT01572792|101894504|FG002|Extension Study|Lost to Follow-up|0|||
33544377|NCT01572792|101894505|FG003|Extension Study|Lost to Follow-up|3|||
33544378|NCT01572792|101894506|FG004|Extension Study|Lost to Follow-up|3|||
33544379|NCT01572792|101894502|FG000|Extension Study|Withdrawal by Subject|7|||
33544380|NCT01572792|101894503|FG001|Extension Study|Withdrawal by Subject|6|||
33544381|NCT01572792|101894504|FG002|Extension Study|Withdrawal by Subject|11|||
33544382|NCT01572792|101894505|FG003|Extension Study|Withdrawal by Subject|8|||
33544383|NCT01572792|101894506|FG004|Extension Study|Withdrawal by Subject|14|||
33544384|NCT01572792|101894502|FG000|Extension Study|Protocol Violation|0|||
33544385|NCT01572792|101894503|FG001|Extension Study|Protocol Violation|4|||
33544386|NCT01572792|101894504|FG002|Extension Study|Protocol Violation|3|||
33544387|NCT01572792|101894505|FG003|Extension Study|Protocol Violation|4|||
33544388|NCT01572792|101894506|FG004|Extension Study|Protocol Violation|3|||
33544389|NCT01572792|101894502|FG000|Extension Study|Lack of Efficacy|2|||
33544390|NCT01572792|101894503|FG001|Extension Study|Lack of Efficacy|3|||
33544391|NCT01572792|101894504|FG002|Extension Study|Lack of Efficacy|3|||
33544392|NCT01572792|101894505|FG003|Extension Study|Lack of Efficacy|2|||
33544393|NCT01572792|101894506|FG004|Extension Study|Lack of Efficacy|2|||
33544394|NCT01572792|101894502|FG000|Extension Study|Adverse Event|7|||
33544395|NCT01572792|101894503|FG001|Extension Study|Adverse Event|6|||
33544396|NCT01572792|101894504|FG002|Extension Study|Adverse Event|5|||
33544397|NCT01572792|101894505|FG003|Extension Study|Adverse Event|6|||
33544398|NCT01572792|101894506|FG004|Extension Study|Adverse Event|4|||
33544399|NCT01572792|101894502|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
33544400|NCT01572792|101894503|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
33544401|NCT01572792|101894504|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
33544402|NCT01572792|101894505|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
33544403|NCT01572792|101894506|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
33544404|NCT02469857|101894509|FG000|Overall Study|Death|24|||
33544405|NCT02469857|101894510|FG001|Overall Study|Death|29|||
33544406|NCT02469857|101894509|FG000|Overall Study|Discontinuation|1|||
33544407|NCT02469857|101894510|FG001|Overall Study|Discontinuation|3|||
33544408|NCT01603602|101894511|FG000|Overall Study|Adverse Event|1|||
33544409|NCT01603602|101894512|FG001|Overall Study|Adverse Event|0|||
33544410|NCT01603602|101894513|FG002|Overall Study|Adverse Event|0|||
33544411|NCT01603602|101894511|FG000|Overall Study|Personal Reasons|1|||
33544412|NCT01603602|101894512|FG001|Overall Study|Personal Reasons|0|||
33544413|NCT01603602|101894513|FG002|Overall Study|Personal Reasons|1|||
33544414|NCT01991314|101894520|FG000|Overall Study|Adverse Event|5|||
33544415|NCT01991314|101894521|FG001|Overall Study|Adverse Event|1|||
33544416|NCT01991314|101894520|FG000|Overall Study|Lost to Follow-up|6|||
33544417|NCT01991314|101894521|FG001|Overall Study|Lost to Follow-up|10|||
33616612|NCT03210961|102144386|FG009|Overall Study|Other|0|||
33347178|NCT01084551|101159994|FG002|Overall Study|Lost to Follow-up|3|||
33544418|NCT00845182|101894522|FG000|Overall Study|Lost to Follow-up|3|||
33544419|NCT00845182|101894523|FG001|Overall Study|Lost to Follow-up|3|||
33616613|NCT03210961|102144387|FG010|Overall Study|Other|1|||
33544420|NCT00845182|101894524|FG002|Overall Study|Lost to Follow-up|4|||
33544421|NCT00845182|101894522|FG000|Overall Study|Adverse Event|0|||
33544422|NCT00845182|101894523|FG001|Overall Study|Adverse Event|1|||
33544423|NCT00845182|101894524|FG002|Overall Study|Adverse Event|1|||
33544424|NCT00845182|101894522|FG000|Overall Study|Physician Decision|0|||
33544425|NCT00845182|101894523|FG001|Overall Study|Physician Decision|0|||
33544426|NCT00845182|101894524|FG002|Overall Study|Physician Decision|1|||
33616614|NCT03210961|102144388|FG011|Overall Study|Other|0|||
33544427|NCT00903968|101894529|FG000|Overall Study|Adverse Event|0|||
33544428|NCT00903968|101894530|FG001|Overall Study|Adverse Event|0|||
33544429|NCT00903968|101894531|FG002|Overall Study|Adverse Event|0|||
33544430|NCT00903968|101894532|FG003|Overall Study|Adverse Event|0|||
33544431|NCT00903968|101894533|FG004|Overall Study|Adverse Event|0|||
33544432|NCT00903968|101894534|FG005|Overall Study|Adverse Event|0|||
33544433|NCT00903968|101894535|FG006|Overall Study|Adverse Event|1|||
33544434|NCT00903968|101894536|FG007|Overall Study|Adverse Event|8|||
33544435|NCT00903968|101894529|FG000|Overall Study|DLT|0|||
33544436|NCT00903968|101894530|FG001|Overall Study|DLT|0|||
33544437|NCT00903968|101894531|FG002|Overall Study|DLT|0|||
33544438|NCT00903968|101894532|FG003|Overall Study|DLT|0|||
33544439|NCT00903968|101894533|FG004|Overall Study|DLT|0|||
33544440|NCT00903968|101894534|FG005|Overall Study|DLT|0|||
33544441|NCT00903968|101894535|FG006|Overall Study|DLT|2|||
33544442|NCT00903968|101894536|FG007|Overall Study|DLT|0|||
33544443|NCT00903968|101894529|FG000|Overall Study|Withdrawal by Subject|1|||
33544444|NCT00903968|101894530|FG001|Overall Study|Withdrawal by Subject|0|||
33544445|NCT00903968|101894531|FG002|Overall Study|Withdrawal by Subject|1|||
33544446|NCT00903968|101894532|FG003|Overall Study|Withdrawal by Subject|0|||
33544447|NCT00903968|101894533|FG004|Overall Study|Withdrawal by Subject|1|||
33544448|NCT00903968|101894534|FG005|Overall Study|Withdrawal by Subject|1|||
33544449|NCT00903968|101894535|FG006|Overall Study|Withdrawal by Subject|0|||
33408685|NCT05664672|101386097|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
33544450|NCT00903968|101894536|FG007|Overall Study|Withdrawal by Subject|4|||
33544451|NCT00903968|101894529|FG000|Overall Study|Non-Compliance|0|||
33544452|NCT00903968|101894530|FG001|Overall Study|Non-Compliance|0|||
33544453|NCT00903968|101894531|FG002|Overall Study|Non-Compliance|0|||
33544454|NCT00903968|101894532|FG003|Overall Study|Non-Compliance|0|||
33544455|NCT00903968|101894533|FG004|Overall Study|Non-Compliance|0|||
33544456|NCT00903968|101894534|FG005|Overall Study|Non-Compliance|1|||
33544457|NCT00903968|101894535|FG006|Overall Study|Non-Compliance|0|||
33544458|NCT00903968|101894536|FG007|Overall Study|Non-Compliance|0|||
33213207|NCT02332590|100679585|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
33213208|NCT02332590|100679586|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
33213209|NCT02332590|100679585|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
33213210|NCT02332590|100679586|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
33213211|NCT02332590|100679585|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
33213212|NCT02332590|100679586|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
33213213|NCT02332590|100679585|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
33213214|NCT02332590|100679586|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
33213215|NCT02332590|100679585|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
33213216|NCT02332590|100679586|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
33616615|NCT03210961|102144389|FG012|Overall Study|Other|2|||
33616616|NCT03210961|102144390|FG013|Overall Study|Other|2|||
33213217|NCT01618162|100679587|FG000|Overall Study|Protocol Violation|13|||
33213218|NCT01618162|100679588|FG001|Overall Study|Protocol Violation|10|||
33213219|NCT01618162|100679587|FG000|Overall Study|Adverse Event|9|||
33213220|NCT01618162|100679588|FG001|Overall Study|Adverse Event|2|||
33213221|NCT01618162|100679587|FG000|Overall Study|Withdrawal Criteria|2|||
33213222|NCT01618162|100679588|FG001|Overall Study|Withdrawal Criteria|10|||
33213223|NCT01618162|100679587|FG000|Overall Study|Unclassified|14|||
33213224|NCT01618162|100679588|FG001|Overall Study|Unclassified|13|||
33213225|NCT03265600|100679589|FG000|Overall Study|Lost to Follow-up|17|||
33213226|NCT03265600|100679590|FG001|Overall Study|Lost to Follow-up|5|||
33213227|NCT03265600|100679589|FG000|Overall Study|Withdrawal by Subject|4|||
33213228|NCT03265600|100679590|FG001|Overall Study|Withdrawal by Subject|2|||
33213229|NCT03265600|100679589|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
33213230|NCT03265600|100679590|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
33213231|NCT00381940|100679591|FG000|Overall Study|Lack of Efficacy|3|||
33213232|NCT00381940|100679591|FG000|Overall Study|Protocol Violation|1|||
33408686|NCT05664672|101386092|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
33408687|NCT05664672|101386093|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
33544459|NCT00903968|101894529|FG000|Overall Study|Physician Decision|0|||
33544460|NCT00903968|101894530|FG001|Overall Study|Physician Decision|0|||
33616617|NCT03210961|102144391|FG014|Overall Study|Other|0|||
33616618|NCT02360228|102144392|FG000|Overall Study|Withdrawal by Subject|1|||
33616619|NCT02360228|102144393|FG001|Overall Study|Withdrawal by Subject|0|||
33616620|NCT02360228|102144394|FG002|Overall Study|Withdrawal by Subject|0|||
33616621|NCT02360228|102144392|FG000|Overall Study|Self-discontinued medication|0|||
33544461|NCT00903968|101894531|FG002|Overall Study|Physician Decision|0|||
33408688|NCT05664672|101386094|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
33544462|NCT00903968|101894532|FG003|Overall Study|Physician Decision|0|||
33544463|NCT00903968|101894533|FG004|Overall Study|Physician Decision|0|||
33544464|NCT00903968|101894534|FG005|Overall Study|Physician Decision|1|||
33544465|NCT00903968|101894535|FG006|Overall Study|Physician Decision|0|||
33544466|NCT00903968|101894536|FG007|Overall Study|Physician Decision|0|||
33544467|NCT00903968|101894529|FG000|Overall Study|Progressive Disease|2|||
33544468|NCT00903968|101894530|FG001|Overall Study|Progressive Disease|3|||
33544469|NCT00903968|101894531|FG002|Overall Study|Progressive Disease|2|||
33544470|NCT00903968|101894532|FG003|Overall Study|Progressive Disease|3|||
33544471|NCT00903968|101894533|FG004|Overall Study|Progressive Disease|3|||
33544472|NCT00903968|101894534|FG005|Overall Study|Progressive Disease|3|||
33544473|NCT00903968|101894535|FG006|Overall Study|Progressive Disease|0|||
33544474|NCT00903968|101894536|FG007|Overall Study|Progressive Disease|18|||
33544475|NCT00903968|101894529|FG000|Overall Study|Lack of Efficacy|0|||
33544476|NCT00903968|101894530|FG001|Overall Study|Lack of Efficacy|0|||
33616622|NCT02360228|102144393|FG001|Overall Study|Self-discontinued medication|1|||
33616623|NCT02360228|102144394|FG002|Overall Study|Self-discontinued medication|0|||
33347179|NCT01084551|101159992|FG000|Overall Study|Physician Decision|1|||
33347180|NCT01084551|101159993|FG001|Overall Study|Physician Decision|0|||
33347181|NCT01084551|101159994|FG002|Overall Study|Physician Decision|0|||
33347182|NCT02495948|101159995|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
33347183|NCT02495948|101159996|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
33347184|NCT02495948|101159995|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
33347185|NCT02495948|101159996|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
33347186|NCT00618748|101159997|FG000|Overall Study|Adverse Event|4|||
33347187|NCT00618748|101159998|FG001|Overall Study|Adverse Event|3|||
33347188|NCT00618748|101159999|FG002|Overall Study|Adverse Event|8|||
33347189|NCT00618748|101159997|FG000|Overall Study|Physician Decision|3|||
33347190|NCT00618748|101159998|FG001|Overall Study|Physician Decision|1|||
33408689|NCT05664672|101386095|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
33408690|NCT05664672|101386096|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
33408691|NCT05664672|101386097|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
33408692|NCT04308668|101386098|FG000|Overall Study|Lost to Follow-up|32|||
33408693|NCT04308668|101386099|FG001|Overall Study|Lost to Follow-up|38|||
33408694|NCT04308668|101386098|FG000|Overall Study|Withdrawal by Subject|4|||
33408695|NCT04308668|101386099|FG001|Overall Study|Withdrawal by Subject|4|||
33347191|NCT00618748|101159999|FG002|Overall Study|Physician Decision|1|||
33347192|NCT00618748|101159997|FG000|Overall Study|Withdrawal by Subject|4|||
33347193|NCT00618748|101159998|FG001|Overall Study|Withdrawal by Subject|1|||
33408696|NCT01119118|101386100|FG000|Overall Study|Adverse Event|1|||
33544477|NCT00903968|101894531|FG002|Overall Study|Lack of Efficacy|0|||
33544478|NCT00903968|101894532|FG003|Overall Study|Lack of Efficacy|0|||
33347194|NCT00618748|101159999|FG002|Overall Study|Withdrawal by Subject|5|||
33347195|NCT01817790|101160000|FG000|Overall Study|Adverse Event|0|||
33347196|NCT01817790|101160001|FG001|Overall Study|Adverse Event|2|||
33408697|NCT02061293|101386101|FG000|Overall Study|Elevated Blood Pressure|1|||
33347197|NCT01817790|101160000|FG000|Overall Study|Lost to Follow-up|0|||
33347198|NCT01817790|101160001|FG001|Overall Study|Lost to Follow-up|1|||
33347199|NCT01817790|101160000|FG000|Overall Study|Protocol Violation|2|||
33347200|NCT01817790|101160001|FG001|Overall Study|Protocol Violation|1|||
33347201|NCT01817790|101160000|FG000|Overall Study|Withdrawal by Subject|1|||
33347202|NCT01817790|101160001|FG001|Overall Study|Withdrawal by Subject|3|||
33544479|NCT00903968|101894533|FG004|Overall Study|Lack of Efficacy|0|||
33544480|NCT00903968|101894534|FG005|Overall Study|Lack of Efficacy|0|||
33544481|NCT00903968|101894535|FG006|Overall Study|Lack of Efficacy|0|||
33347203|NCT01817790|101160000|FG000|Overall Study|Other: Could not attend appointment|1|||
33347204|NCT01817790|101160001|FG001|Overall Study|Other: Could not attend appointment|1|||
33347205|NCT00094757|101160002|FG000|Overall Study|Adverse Event|11|||
33347206|NCT00094757|101160003|FG001|Overall Study|Adverse Event|9|||
33347207|NCT00094757|101160004|FG002|Overall Study|Adverse Event|6|||
33213233|NCT00381940|100679591|FG000|Overall Study|Ineligible|1|||
33213234|NCT00162370|100679592|FG000|Efficacy Population|Lost to Follow-up|51|||
33213235|NCT02621931|100679593|FG000|Overall Study|Death|0|||
33213236|NCT02621931|100679594|FG001|Overall Study|Death|1|||
33213237|NCT02621931|100679595|FG002|Overall Study|Death|0|||
33213238|NCT02621931|100679593|FG000|Overall Study|Adverse Event|8|||
33213239|NCT02621931|100679594|FG001|Overall Study|Adverse Event|5|||
33213240|NCT02621931|100679595|FG002|Overall Study|Adverse Event|7|||
33213241|NCT02621931|100679593|FG000|Overall Study|Withdrawal by Subject|12|||
33213242|NCT02621931|100679594|FG001|Overall Study|Withdrawal by Subject|10|||
33213243|NCT02621931|100679595|FG002|Overall Study|Withdrawal by Subject|11|||
33213244|NCT02621931|100679593|FG000|Overall Study|Protocol Violation|2|||
33213245|NCT02621931|100679594|FG001|Overall Study|Protocol Violation|2|||
33213246|NCT02621931|100679595|FG002|Overall Study|Protocol Violation|2|||
33213247|NCT02621931|100679593|FG000|Overall Study|Pregnancy|2|||
33213248|NCT02621931|100679594|FG001|Overall Study|Pregnancy|0|||
33213249|NCT02621931|100679595|FG002|Overall Study|Pregnancy|0|||
33213250|NCT02621931|100679593|FG000|Overall Study|Noncompliance to study procedures|0|||
33347208|NCT00094757|101160002|FG000|Overall Study|Lack of Efficacy|11|||
33347209|NCT00094757|101160003|FG001|Overall Study|Lack of Efficacy|15|||
33347210|NCT00094757|101160004|FG002|Overall Study|Lack of Efficacy|8|||
33347211|NCT00094757|101160002|FG000|Overall Study|Lost to Follow-up|3|||
33347212|NCT00094757|101160003|FG001|Overall Study|Lost to Follow-up|5|||
33347213|NCT00094757|101160004|FG002|Overall Study|Lost to Follow-up|6|||
33347214|NCT00094757|101160002|FG000|Overall Study|Patient Moved|2|||
33408698|NCT02061293|101386102|FG001|Overall Study|Elevated Blood Pressure|1|||
33544482|NCT00903968|101894536|FG007|Overall Study|Lack of Efficacy|3|||
33544483|NCT03197129|101894542|FG000|Overall Study|did not answer the VPT: shyness|4|||
33544484|NCT03197129|101894543|FG001|Overall Study|did not answer the VPT: shyness|5|||
33544485|NCT00127803|101894545|FG000|Overall Study|Adverse Event|2|||
33544486|NCT00127803|101894546|FG001|Overall Study|Adverse Event|0|||
33544487|NCT00127803|101894547|FG002|Overall Study|Adverse Event|0|||
33544488|NCT00127803|101894548|FG003|Overall Study|Adverse Event|0|||
33544489|NCT00127803|101894545|FG000|Overall Study|Withdrawal by Subject|1|||
33544490|NCT00127803|101894546|FG001|Overall Study|Withdrawal by Subject|0|||
33544491|NCT00127803|101894547|FG002|Overall Study|Withdrawal by Subject|0|||
33544492|NCT00127803|101894548|FG003|Overall Study|Withdrawal by Subject|0|||
33544493|NCT00127803|101894545|FG000|Overall Study|Lost to Follow-up|0|||
33544494|NCT00127803|101894546|FG001|Overall Study|Lost to Follow-up|0|||
33544495|NCT00127803|101894547|FG002|Overall Study|Lost to Follow-up|0|||
33544496|NCT00127803|101894548|FG003|Overall Study|Lost to Follow-up|1|||
33544497|NCT02058095|101894557|FG000|Overall Study|Adverse Event|1|||
33544498|NCT02058095|101894558|FG001|Overall Study|Adverse Event|0|||
33544499|NCT02101294|101894571|FG000|Overall Study|Withdrawal by Subject|5|||
33544500|NCT02101294|101894571|FG000|Overall Study|Lost to Follow-up|6|||
33544501|NCT05172570|101894576|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
33544502|NCT05172570|101894577|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
33544503|NCT05172570|101894578|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
33544504|NCT05172570|101894576|FG000|Overall Study|PI Decision due to equipment shortages|0|||
33544505|NCT05172570|101894577|FG001|Overall Study|PI Decision due to equipment shortages|0|||
33213251|NCT02621931|100679594|FG001|Overall Study|Noncompliance to study procedures|1|||
33213252|NCT02621931|100679595|FG002|Overall Study|Noncompliance to study procedures|2|||
33213253|NCT02621931|100679593|FG000|Overall Study|Lost to Follow-up|8|||
33213254|NCT02621931|100679594|FG001|Overall Study|Lost to Follow-up|7|||
33408699|NCT01249404|101386103|FG000|Overall Study|Study treatment not received|0|||
33544506|NCT05172570|101894578|FG002|Overall Study|PI Decision due to equipment shortages|1|||
33544507|NCT01179516|101894579|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
33544508|NCT01179516|101894580|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
33544509|NCT01179516|101894581|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
33544510|NCT01179516|101894579|FG000|Overall Study|Lack of Efficacy|4|||
33544511|NCT01179516|101894580|FG001|Overall Study|Lack of Efficacy|2|||
33213255|NCT02621931|100679595|FG002|Overall Study|Lost to Follow-up|10|||
33544512|NCT01179516|101894581|FG002|Overall Study|Lack of Efficacy|0|||
33213256|NCT02621931|100679593|FG000|Overall Study|Lack of Efficacy|0|||
33213257|NCT02621931|100679594|FG001|Overall Study|Lack of Efficacy|0|||
33347215|NCT00094757|101160003|FG001|Overall Study|Patient Moved|1|||
33347216|NCT00094757|101160004|FG002|Overall Study|Patient Moved|1|||
33347217|NCT00094757|101160002|FG000|Overall Study|Protocol Violation|8|||
33347218|NCT00094757|101160003|FG001|Overall Study|Protocol Violation|5|||
33213258|NCT02621931|100679595|FG002|Overall Study|Lack of Efficacy|1|||
33544513|NCT01179516|101894579|FG000|Overall Study|Noncompliance with Study Drug|2|||
33544514|NCT01179516|101894580|FG001|Overall Study|Noncompliance with Study Drug|0|||
33544515|NCT01179516|101894581|FG002|Overall Study|Noncompliance with Study Drug|1|||
33544516|NCT01179516|101894579|FG000|Overall Study|Protocol Deviations|4|||
33544517|NCT01179516|101894580|FG001|Overall Study|Protocol Deviations|3|||
33544518|NCT01179516|101894581|FG002|Overall Study|Protocol Deviations|3|||
33544519|NCT01179516|101894579|FG000|Overall Study|Withdrawal of Consent|2|||
33544520|NCT01179516|101894580|FG001|Overall Study|Withdrawal of Consent|6|||
33544521|NCT01179516|101894581|FG002|Overall Study|Withdrawal of Consent|10|||
33544522|NCT01179516|101894579|FG000|Overall Study|Lost to Follow-up|7|||
33544523|NCT01179516|101894580|FG001|Overall Study|Lost to Follow-up|7|||
33544524|NCT01179516|101894581|FG002|Overall Study|Lost to Follow-up|3|||
33544525|NCT01179516|101894579|FG000|Overall Study|Other|2|||
33544526|NCT01179516|101894580|FG001|Overall Study|Other|0|||
33544527|NCT01179516|101894581|FG002|Overall Study|Other|2|||
33544528|NCT00655889|101894582|FG000|Overall Study|Inadequate cell growth|1|||
33544529|NCT00655889|101894582|FG000|Overall Study|Protocol Violation|1|||
33544530|NCT00715208|101894586|FG000|Overall Study|Withdrawal by Subject|1|||
33544531|NCT00715208|101894587|FG001|Overall Study|Withdrawal by Subject|1|||
33544532|NCT00715208|101894586|FG000|Overall Study|Adverse Event|0|||
33544533|NCT00715208|101894587|FG001|Overall Study|Adverse Event|6|||
33544534|NCT00715208|101894586|FG000|Overall Study|Lack of Efficacy|0|||
33544535|NCT00715208|101894587|FG001|Overall Study|Lack of Efficacy|2|||
33544536|NCT00529035|101894588|FG000|Overall Study|Withdrawal by Subject|1|||
33544537|NCT01408641|101894589|FG000|Overall Study|Physician Decision|1|||
33544538|NCT01408641|101894590|FG001|Overall Study|Physician Decision|0|||
33544539|NCT01260948|101894600|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
33544540|NCT01260948|101894601|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
33544541|NCT01260948|101894600|FG000|Second Intervention|Emesis|0|||
33544542|NCT01260948|101894601|FG001|Second Intervention|Emesis|1|||
33544543|NCT00817063|101894603|FG000|Overall Study|Adverse Event|32|||
33544544|NCT00817063|101894604|FG001|Overall Study|Adverse Event|13|||
33544545|NCT00817063|101894603|FG000|Overall Study|Death|1|||
33544546|NCT00817063|101894604|FG001|Overall Study|Death|1|||
33544547|NCT00817063|101894603|FG000|Overall Study|Lack of Efficacy|33|||
33544548|NCT00817063|101894604|FG001|Overall Study|Lack of Efficacy|86|||
33544549|NCT00817063|101894603|FG000|Overall Study|Failure to Return|13|||
33544550|NCT00817063|101894604|FG001|Overall Study|Failure to Return|12|||
33544551|NCT00817063|101894603|FG000|Overall Study|Violation of Selection at Entry|7|||
33544552|NCT00817063|101894604|FG001|Overall Study|Violation of Selection at Entry|4|||
33544553|NCT00817063|101894603|FG000|Overall Study|Protocol Violation|3|||
33544554|NCT00817063|101894604|FG001|Overall Study|Protocol Violation|8|||
33544555|NCT00817063|101894603|FG000|Overall Study|Withdrawal by Subject|17|||
33544556|NCT00817063|101894604|FG001|Overall Study|Withdrawal by Subject|37|||
33544557|NCT00817063|101894603|FG000|Overall Study|Early Improvement|19|||
33544558|NCT00817063|101894604|FG001|Overall Study|Early Improvement|4|||
33544559|NCT00817063|101894603|FG000|Overall Study|Administrative|10|||
33544560|NCT00817063|101894604|FG001|Overall Study|Administrative|4|||
33544561|NCT00817063|101894603|FG000|Overall Study|Abnormality of Laboratory Test|2|||
33544562|NCT00817063|101894604|FG001|Overall Study|Abnormality of Laboratory Test|1|||
33544563|NCT01682031|101894605|FG000|Overall Study|Withdrawal by Subject|0|||
33544564|NCT01682031|101894606|FG001|Overall Study|Withdrawal by Subject|1|||
33544565|NCT01682031|101894605|FG000|Overall Study|Adverse Event|0|||
33544566|NCT01682031|101894606|FG001|Overall Study|Adverse Event|2|||
33544567|NCT01682031|101894605|FG000|Overall Study|MRI results indicate increased nodul|0|||
33544568|NCT01682031|101894606|FG001|Overall Study|MRI results indicate increased nodul|1|||
33544569|NCT01682031|101894605|FG000|Overall Study|Patient could not swallow tablets|1|||
33544570|NCT01682031|101894606|FG001|Overall Study|Patient could not swallow tablets|0|||
33544571|NCT01682031|101894605|FG000|Overall Study|Patient stopped selenium on his own|0|||
33544572|NCT01682031|101894606|FG001|Overall Study|Patient stopped selenium on his own|1|||
33544573|NCT00929669|101894607|FG000|Overall Study|elevated glucose levels|1|||
33544574|NCT00831844|101894608|FG000|Overall Study|Adverse Event|2|||
33544575|NCT00831844|101894609|FG001|Overall Study|Adverse Event|0|||
33544576|NCT00831844|101894610|FG002|Overall Study|Adverse Event|0|||
33347219|NCT00094757|101160004|FG002|Overall Study|Protocol Violation|3|||
33347220|NCT00094757|101160002|FG000|Overall Study|Withdrawal by Subject|14|||
33347221|NCT00094757|101160003|FG001|Overall Study|Withdrawal by Subject|21|||
33347222|NCT00094757|101160004|FG002|Overall Study|Withdrawal by Subject|5|||
33347223|NCT00094757|101160002|FG000|Overall Study|Other|3|||
33347224|NCT00094757|101160003|FG001|Overall Study|Other|3|||
33544577|NCT00831844|101894611|FG003|Overall Study|Adverse Event|0|||
33544578|NCT00831844|101894612|FG004|Overall Study|Adverse Event|1|||
33544579|NCT00831844|101894613|FG005|Overall Study|Adverse Event|1|||
33544580|NCT00831844|101894614|FG006|Overall Study|Adverse Event|2|||
33544581|NCT00831844|101894615|FG007|Overall Study|Adverse Event|0|||
33544582|NCT00831844|101894616|FG008|Overall Study|Adverse Event|0|||
33544583|NCT00831844|101894617|FG009|Overall Study|Adverse Event|0|||
33544584|NCT00831844|101894608|FG000|Overall Study|Death|0|||
33347225|NCT00094757|101160004|FG002|Overall Study|Other|1|||
33347226|NCT00094757|101160002|FG000|Overall Study|Protocol specified discontinuation|1|||
33347227|NCT00094757|101160003|FG001|Overall Study|Protocol specified discontinuation|3|||
33347228|NCT00094757|101160004|FG002|Overall Study|Protocol specified discontinuation|0|||
33544585|NCT00831844|101894609|FG001|Overall Study|Death|0|||
33544586|NCT00831844|101894610|FG002|Overall Study|Death|0|||
33544587|NCT00831844|101894611|FG003|Overall Study|Death|1|||
33544588|NCT00831844|101894612|FG004|Overall Study|Death|0|||
33544589|NCT00831844|101894613|FG005|Overall Study|Death|0|||
33544590|NCT00831844|101894614|FG006|Overall Study|Death|0|||
33544591|NCT00831844|101894615|FG007|Overall Study|Death|0|||
33544592|NCT00831844|101894616|FG008|Overall Study|Death|0|||
33544593|NCT00831844|101894617|FG009|Overall Study|Death|0|||
33544594|NCT00831844|101894608|FG000|Overall Study|Lack of Efficacy|8|||
33544595|NCT00831844|101894609|FG001|Overall Study|Lack of Efficacy|10|||
33544596|NCT00831844|101894610|FG002|Overall Study|Lack of Efficacy|15|||
33544597|NCT00831844|101894611|FG003|Overall Study|Lack of Efficacy|8|||
33544598|NCT00831844|101894612|FG004|Overall Study|Lack of Efficacy|11|||
33544599|NCT00831844|101894613|FG005|Overall Study|Lack of Efficacy|17|||
33544600|NCT00831844|101894614|FG006|Overall Study|Lack of Efficacy|8|||
33544601|NCT00831844|101894615|FG007|Overall Study|Lack of Efficacy|9|||
33347229|NCT01926626|101160009|FG000|Overall Study|Withdrawal by Subject|15|||
33347230|NCT01926626|101160009|FG000|Overall Study|Lost to Follow-up|7|||
33347231|NCT00544869|101160010|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
33347232|NCT00544869|101160011|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
33347233|NCT00544869|101160012|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
33347234|NCT00544869|101160010|FG000|Overall Study|Adverse Event|6|||
33347235|NCT00544869|101160011|FG001|Overall Study|Adverse Event|1|||
33347236|NCT00544869|101160012|FG002|Overall Study|Adverse Event|0|||
33347237|NCT00544869|101160010|FG000|Overall Study|Lack of Efficacy|1|||
33347238|NCT00544869|101160011|FG001|Overall Study|Lack of Efficacy|1|||
33347239|NCT00544869|101160012|FG002|Overall Study|Lack of Efficacy|0|||
33347240|NCT00544869|101160010|FG000|Overall Study|Physician Decision|2|||
33347241|NCT00544869|101160011|FG001|Overall Study|Physician Decision|0|||
33347242|NCT00544869|101160012|FG002|Overall Study|Physician Decision|0|||
33347243|NCT02411747|101160013|FG000|Overall Study|Withdrawal by Subject|1|||
33347244|NCT02411747|101160014|FG001|Overall Study|Withdrawal by Subject|0|||
33347245|NCT02411747|101160013|FG000|Overall Study|Protocol Violation|2|||
33347246|NCT02411747|101160014|FG001|Overall Study|Protocol Violation|4|||
33347247|NCT01707030|101160017|FG000|Overall Study|Death|1|||
33347248|NCT01707030|101160018|FG001|Overall Study|Death|1|||
33347249|NCT01707030|101160017|FG000|Overall Study|Withdrawal by Subject|2|||
33347250|NCT01707030|101160018|FG001|Overall Study|Withdrawal by Subject|3|||
33347251|NCT01707030|101160017|FG000|Overall Study|Lost to Follow-up|8|||
33347252|NCT01707030|101160018|FG001|Overall Study|Lost to Follow-up|13|||
33347253|NCT00605267|101160019|FG000|Overall Study|Adverse Event|0|||
33347254|NCT00605267|101160020|FG001|Overall Study|Adverse Event|1|||
33347255|NCT00605267|101160019|FG000|Overall Study|Lack of Efficacy|1|||
33347256|NCT00605267|101160020|FG001|Overall Study|Lack of Efficacy|5|||
33347257|NCT00605267|101160019|FG000|Overall Study|Withdrawal by Subject|2|||
33347258|NCT00605267|101160020|FG001|Overall Study|Withdrawal by Subject|3|||
33347259|NCT01262625|101160021|FG000|Overall Study|Administrative Error|1|||
33347260|NCT01262625|101160022|FG001|Overall Study|Administrative Error|1|||
33347261|NCT01262625|101160021|FG000|Overall Study|Site Closed|1|||
33347262|NCT01262625|101160022|FG001|Overall Study|Site Closed|0|||
33347263|NCT00804687|101160023|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
33347264|NCT00804687|101160024|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
33347265|NCT00804687|101160025|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
33347266|NCT00804687|101160026|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
33347267|NCT00804687|101160027|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
33347268|NCT00804687|101160028|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
33347269|NCT00804687|101160023|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
33544602|NCT00831844|101894616|FG008|Overall Study|Lack of Efficacy|7|||
33347270|NCT00804687|101160024|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
33347271|NCT00804687|101160025|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
33347272|NCT00804687|101160026|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
33347273|NCT00804687|101160027|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
33347274|NCT00804687|101160028|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
33347275|NCT00804687|101160023|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
33347276|NCT00804687|101160024|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
33347277|NCT00804687|101160025|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
33544603|NCT00831844|101894617|FG009|Overall Study|Lack of Efficacy|0|||
33544604|NCT00831844|101894608|FG000|Overall Study|Physician Decision|0|||
33544605|NCT00831844|101894609|FG001|Overall Study|Physician Decision|1|||
33213259|NCT02621931|100679593|FG000|Overall Study|Other|1|||
33544606|NCT00831844|101894610|FG002|Overall Study|Physician Decision|3|||
33544607|NCT00831844|101894611|FG003|Overall Study|Physician Decision|1|||
33213260|NCT02621931|100679594|FG001|Overall Study|Other|1|||
33544608|NCT00831844|101894612|FG004|Overall Study|Physician Decision|1|||
33544609|NCT00831844|101894613|FG005|Overall Study|Physician Decision|1|||
33544610|NCT00831844|101894614|FG006|Overall Study|Physician Decision|0|||
33544611|NCT00831844|101894615|FG007|Overall Study|Physician Decision|0|||
33544612|NCT00831844|101894616|FG008|Overall Study|Physician Decision|1|||
33544613|NCT00831844|101894617|FG009|Overall Study|Physician Decision|0|||
33544614|NCT00831844|101894608|FG000|Overall Study|Withdrawal by Subject|0|||
33544615|NCT00831844|101894609|FG001|Overall Study|Withdrawal by Subject|0|||
33544616|NCT00831844|101894610|FG002|Overall Study|Withdrawal by Subject|1|||
33544617|NCT00831844|101894611|FG003|Overall Study|Withdrawal by Subject|0|||
33544618|NCT00831844|101894612|FG004|Overall Study|Withdrawal by Subject|0|||
33544619|NCT00831844|101894613|FG005|Overall Study|Withdrawal by Subject|0|||
33544620|NCT00831844|101894614|FG006|Overall Study|Withdrawal by Subject|0|||
33544621|NCT00831844|101894615|FG007|Overall Study|Withdrawal by Subject|1|||
33544622|NCT00831844|101894616|FG008|Overall Study|Withdrawal by Subject|1|||
33544623|NCT00831844|101894617|FG009|Overall Study|Withdrawal by Subject|0|||
33544624|NCT00831844|101894608|FG000|Overall Study|Ineligible|0|||
33544625|NCT00831844|101894609|FG001|Overall Study|Ineligible|1|||
33544626|NCT00831844|101894610|FG002|Overall Study|Ineligible|1|||
33544627|NCT00831844|101894611|FG003|Overall Study|Ineligible|0|||
33544628|NCT00831844|101894612|FG004|Overall Study|Ineligible|1|||
33544629|NCT00831844|101894613|FG005|Overall Study|Ineligible|0|||
33544630|NCT00831844|101894614|FG006|Overall Study|Ineligible|0|||
33544631|NCT00831844|101894615|FG007|Overall Study|Ineligible|0|||
33544632|NCT00831844|101894616|FG008|Overall Study|Ineligible|0|||
33544633|NCT00831844|101894617|FG009|Overall Study|Ineligible|0|||
33544634|NCT01649765|101894619|FG000|Overall Study|Adverse Event|5|||
33544635|NCT01649765|101894620|FG001|Overall Study|Adverse Event|3|||
33544636|NCT01649765|101894619|FG000|Overall Study|Lack of Efficacy|1|||
33544637|NCT01649765|101894620|FG001|Overall Study|Lack of Efficacy|1|||
33544638|NCT01649765|101894619|FG000|Overall Study|Physician Decision|0|||
33544639|NCT01649765|101894620|FG001|Overall Study|Physician Decision|3|||
33544640|NCT01649765|101894619|FG000|Overall Study|Protocol Violation|1|||
33544641|NCT01649765|101894620|FG001|Overall Study|Protocol Violation|0|||
33544642|NCT01649765|101894619|FG000|Overall Study|Withdrawal by Subject|2|||
33544643|NCT01649765|101894620|FG001|Overall Study|Withdrawal by Subject|1|||
33544644|NCT01056276|101894621|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
33544645|NCT01056276|101894622|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
33544646|NCT01056276|101894621|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
33544647|NCT01056276|101894622|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
33544648|NCT01056276|101894621|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
33544649|NCT01056276|101894622|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
33544650|NCT01056276|101894621|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
33544651|NCT01056276|101894622|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
33544652|NCT01056276|101894621|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
33544653|NCT01056276|101894622|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
33544654|NCT01056276|101894621|FG000|Treatment Period-Cycles 1-8|Death|3|||
33544655|NCT01056276|101894622|FG001|Treatment Period-Cycles 1-8|Death|1|||
33544656|NCT01056276|101894621|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
33544657|NCT01056276|101894622|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
33544658|NCT01056276|101894621|FG000|Maintenance Therapy|Toxicity|0|||
33544659|NCT01056276|101894622|FG001|Maintenance Therapy|Toxicity|2|||
33544660|NCT01056276|101894621|FG000|Maintenance Therapy|Progressive Disease|0|||
33544661|NCT01056276|101894622|FG001|Maintenance Therapy|Progressive Disease|9|||
33544662|NCT01056276|101894621|FG000|Maintenance Therapy|Physician Decision|0|||
33544663|NCT01056276|101894622|FG001|Maintenance Therapy|Physician Decision|1|||
33544664|NCT01056276|101894621|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
33544665|NCT01056276|101894622|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
33544666|NCT01056276|101894621|FG000|Maintenance Therapy|Intercurrent Illness|0|||
33213261|NCT02621931|100679595|FG002|Overall Study|Other|3|||
33213262|NCT01967732|100679596|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
33544667|NCT01056276|101894622|FG001|Maintenance Therapy|Intercurrent Illness|1|||
33544668|NCT01056276|101894621|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
33213263|NCT01967732|100679597|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
33408700|NCT01249404|101386104|FG001|Overall Study|Study treatment not received|1|||
33544669|NCT01056276|101894622|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
33544670|NCT04682301|101894627|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
33544671|NCT04682301|101894627|FG000|Overall Study|Death|2|||
33544672|NCT00593814|101894628|FG000|Overall Study|Death|7|||
33544673|NCT00593814|101894629|FG001|Overall Study|Death|0|||
33544674|NCT00593814|101894628|FG000|Overall Study|Withdrawal by Subject|7|||
33544675|NCT00593814|101894629|FG001|Overall Study|Withdrawal by Subject|0|||
33544676|NCT00593814|101894628|FG000|Overall Study|Lost to Follow-up|7|||
33544677|NCT00593814|101894629|FG001|Overall Study|Lost to Follow-up|0|||
33544678|NCT00593814|101894628|FG000|Overall Study|Physician Decision|3|||
33544679|NCT00593814|101894629|FG001|Overall Study|Physician Decision|0|||
33544680|NCT03261401|101894630|FG000|Overall Study|Withdrawal by Subject|0|||
33213264|NCT01967732|100679598|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
33213265|NCT01967732|100679599|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
33213266|NCT01967732|100679596|FG000|First Intervention (Day 1)|Poor venous access|0|||
33213267|NCT01967732|100679597|FG001|First Intervention (Day 1)|Poor venous access|1|||
33213268|NCT01967732|100679598|FG002|First Intervention (Day 1)|Poor venous access|0|||
33213269|NCT01967732|100679599|FG003|First Intervention (Day 1)|Poor venous access|0|||
33213270|NCT03832595|100679600|FG000|Overall Study|Death|142|||
33213271|NCT03832595|100679601|FG001|Overall Study|Death|130|||
33213272|NCT03832595|100679600|FG000|Overall Study|Medical management without dialysis|37|||
33213273|NCT03832595|100679601|FG001|Overall Study|Medical management without dialysis|1|||
33347278|NCT00804687|101160026|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
33347279|NCT00804687|101160027|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
33347280|NCT00804687|101160028|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
33347281|NCT00804687|101160023|FG000|Period 5: Treatment Period|Positive drug test|1|||
33347282|NCT00804687|101160024|FG001|Period 5: Treatment Period|Positive drug test|0|||
33347283|NCT00804687|101160025|FG002|Period 5: Treatment Period|Positive drug test|0|||
33347284|NCT00804687|101160026|FG003|Period 5: Treatment Period|Positive drug test|0|||
33347285|NCT00804687|101160027|FG004|Period 5: Treatment Period|Positive drug test|0|||
33347286|NCT00804687|101160028|FG005|Period 5: Treatment Period|Positive drug test|0|||
33347287|NCT02804763|101160029|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
33347288|NCT02804763|101160030|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
33347289|NCT02804763|101160031|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
33347290|NCT02804763|101160032|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
33347291|NCT02804763|101160029|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
33347292|NCT02804763|101160030|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
33347293|NCT02804763|101160031|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
33347294|NCT02804763|101160032|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
33347295|NCT02804763|101160029|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
33347296|NCT02804763|101160030|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
33347297|NCT02804763|101160031|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
33347298|NCT02804763|101160032|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
33347299|NCT02804763|101160029|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
33347300|NCT02804763|101160030|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
33347301|NCT02804763|101160031|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
33408701|NCT01249404|101386105|FG002|Overall Study|Study treatment not received|2|||
33408702|NCT01249404|101386103|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
33408703|NCT01249404|101386104|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
33408704|NCT01249404|101386105|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
33347302|NCT02804763|101160032|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
33347303|NCT02804763|101160029|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
33347304|NCT02804763|101160030|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
33347305|NCT02804763|101160031|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
33347306|NCT02804763|101160032|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
33347307|NCT02804763|101160029|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
33347308|NCT02804763|101160030|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
33347309|NCT02804763|101160031|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
33347310|NCT02804763|101160032|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
33616624|NCT02360228|102144392|FG000|Overall Study|Unstable symptoms during screening|0|||
33616625|NCT02360228|102144393|FG001|Overall Study|Unstable symptoms during screening|0|||
33616626|NCT02360228|102144394|FG002|Overall Study|Unstable symptoms during screening|1|||
33213274|NCT03792126|100679604|FG000|Overall Study|Adverse Event|1|||
33213275|NCT03792126|100679605|FG001|Overall Study|Adverse Event|2|||
33213276|NCT03792126|100679604|FG000|Overall Study|Death|0|||
33347311|NCT00483327|101160037|FG000|Overall Study|Adverse Event|1|||
33616627|NCT02735343|102144395|FG000|Overall Study|screen fail|0|||
33616628|NCT02735343|102144396|FG001|Overall Study|screen fail|2|||
33616629|NCT00577824|102144397|FG000|Overall Study|Adverse Event|6|||
33616630|NCT00577824|102144398|FG001|Overall Study|Adverse Event|18|||
33213277|NCT03792126|100679605|FG001|Overall Study|Death|1|||
33213278|NCT03792126|100679604|FG000|Overall Study|Lost to Follow-up|1|||
33347312|NCT00483327|101160037|FG000|Overall Study|Withdrawal by Subject|3|||
33347313|NCT00483327|101160037|FG000|Overall Study|Lost to Follow-up|4|||
33347314|NCT00483327|101160037|FG000|Overall Study|Patient Non Compliance|2|||
33347315|NCT03158220|101160038|FG000|Overall Study|Screen Failure|0|||
33347316|NCT03158220|101160039|FG001|Overall Study|Screen Failure|1|||
33616631|NCT00577824|102144399|FG002|Overall Study|Adverse Event|1|||
33616632|NCT00577824|102144397|FG000|Overall Study|Patient decision|0|||
33616633|NCT00577824|102144398|FG001|Overall Study|Patient decision|1|||
33616634|NCT00577824|102144399|FG002|Overall Study|Patient decision|1|||
33616635|NCT00577824|102144397|FG000|Overall Study|Protocol Violation|1|||
33616636|NCT00577824|102144398|FG001|Overall Study|Protocol Violation|1|||
33616637|NCT00577824|102144399|FG002|Overall Study|Protocol Violation|0|||
33616638|NCT03852719|102144400|FG000|Overall Study|Still on study after Week 192|37|||
33616639|NCT03852719|102144401|FG001|Overall Study|Still on study after Week 192|35|||
33616640|NCT03852719|102144402|FG002|Overall Study|Still on study after Week 192|35|||
33616641|NCT03852719|102144400|FG000|Overall Study|Withdrawal of consent|5|||
33616642|NCT03852719|102144401|FG001|Overall Study|Withdrawal of consent|8|||
33616643|NCT03852719|102144402|FG002|Overall Study|Withdrawal of consent|7|||
33616644|NCT03852719|102144400|FG000|Overall Study|Physician Decision|0|||
33616645|NCT03852719|102144401|FG001|Overall Study|Physician Decision|1|||
33616646|NCT03852719|102144402|FG002|Overall Study|Physician Decision|1|||
33616647|NCT03852719|102144400|FG000|Overall Study|Pregnancy|2|||
33616648|NCT03852719|102144401|FG001|Overall Study|Pregnancy|1|||
33616649|NCT03852719|102144402|FG002|Overall Study|Pregnancy|0|||
33616650|NCT03852719|102144400|FG000|Overall Study|Death|1|||
33616651|NCT03852719|102144401|FG001|Overall Study|Death|0|||
33616652|NCT03852719|102144402|FG002|Overall Study|Death|0|||
33616653|NCT03852719|102144400|FG000|Overall Study|Reason not Specified|3|||
33616654|NCT03852719|102144401|FG001|Overall Study|Reason not Specified|2|||
33616655|NCT03852719|102144402|FG002|Overall Study|Reason not Specified|2|||
33616656|NCT03852719|102144400|FG000|Overall Study|Adverse Event|1|||
33616657|NCT03852719|102144401|FG001|Overall Study|Adverse Event|0|||
33616658|NCT03852719|102144402|FG002|Overall Study|Adverse Event|4|||
33616659|NCT03852719|102144400|FG000|Overall Study|Progressive disease|1|||
33616660|NCT03852719|102144401|FG001|Overall Study|Progressive disease|2|||
33616661|NCT03852719|102144402|FG002|Overall Study|Progressive disease|1|||
33616662|NCT03852719|102144400|FG000|Overall Study|Lost to Follow-up|1|||
33616663|NCT03852719|102144401|FG001|Overall Study|Lost to Follow-up|0|||
33347317|NCT03158220|101160038|FG000|Overall Study|Withdrawal by Subject|8|||
33347318|NCT03158220|101160039|FG001|Overall Study|Withdrawal by Subject|9|||
33213279|NCT03792126|100679605|FG001|Overall Study|Lost to Follow-up|0|||
33616664|NCT03852719|102144402|FG002|Overall Study|Lost to Follow-up|0|||
33616665|NCT01959139|102144405|FG000|Phase II|Disease progression|0|||
33616666|NCT01959139|102144406|FG001|Phase II|Disease progression|0|||
33616667|NCT01959139|102144407|FG002|Phase II|Disease progression|26|||
33616668|NCT01959139|102144408|FG003|Phase II|Disease progression|34|||
33616669|NCT01959139|102144405|FG000|Phase II|Adverse Event|0|||
33616670|NCT01959139|102144406|FG001|Phase II|Adverse Event|0|||
33616671|NCT01959139|102144407|FG002|Phase II|Adverse Event|10|||
33213280|NCT03792126|100679604|FG000|Overall Study|Withdrawal by Subject|0|||
33213281|NCT03792126|100679605|FG001|Overall Study|Withdrawal by Subject|1|||
33213282|NCT03792126|100679604|FG000|Overall Study|COVID-19 Restrictions|1|||
33213283|NCT03792126|100679605|FG001|Overall Study|COVID-19 Restrictions|3|||
33544681|NCT03261401|101894631|FG001|Overall Study|Withdrawal by Subject|0|||
33544682|NCT03261401|101894632|FG002|Overall Study|Withdrawal by Subject|0|||
33544683|NCT03261401|101894633|FG003|Overall Study|Withdrawal by Subject|0|||
33544684|NCT03261401|101894634|FG004|Overall Study|Withdrawal by Subject|0|||
33544685|NCT03261401|101894635|FG005|Overall Study|Withdrawal by Subject|1|||
33544686|NCT03261401|101894636|FG006|Overall Study|Withdrawal by Subject|0|||
33544687|NCT03261401|101894637|FG007|Overall Study|Withdrawal by Subject|0|||
33544688|NCT03261401|101894638|FG008|Overall Study|Withdrawal by Subject|0|||
33544689|NCT03261401|101894639|FG009|Overall Study|Withdrawal by Subject|0|||
33544690|NCT03261401|101894640|FG010|Overall Study|Withdrawal by Subject|0|||
33544691|NCT03261401|101894641|FG011|Overall Study|Withdrawal by Subject|0|||
33544692|NCT03261401|101894642|FG012|Overall Study|Withdrawal by Subject|0|||
33544693|NCT03261401|101894630|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
33544694|NCT03261401|101894631|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
33544695|NCT03261401|101894632|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
33544696|NCT03261401|101894633|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
33544697|NCT03261401|101894634|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
33544698|NCT03261401|101894635|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
33544699|NCT03261401|101894636|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
33544700|NCT03261401|101894637|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
33544701|NCT03261401|101894638|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
33544702|NCT03261401|101894639|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
33544703|NCT03261401|101894640|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
33544704|NCT03261401|101894641|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
33347319|NCT03158220|101160038|FG000|Overall Study|Status unknown|0|||
33347320|NCT03158220|101160039|FG001|Overall Study|Status unknown|1|||
33347321|NCT03158220|101160038|FG000|Overall Study|Lost to Follow-up|8|||
33544705|NCT03261401|101894642|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
33544706|NCT01240694|101894644|FG000|Overall Study|Adverse Event|9|||
33544707|NCT01240694|101894644|FG000|Overall Study|Lack of Efficacy|6|||
33544708|NCT01240694|101894644|FG000|Overall Study|Withdrawal by Subject|6|||
33544709|NCT01240694|101894644|FG000|Overall Study|Protocol Violation|2|||
33544710|NCT01240694|101894644|FG000|Overall Study|Lost to Follow-up|2|||
33544711|NCT01240694|101894644|FG000|Overall Study|Other than specified|3|||
33544712|NCT01240694|101894644|FG000|Overall Study|Withdrawn due to early study termination|107|||
33544713|NCT01126424|101894645|FG000|Overall Study|Adverse Event|0|||
33544714|NCT01126424|101894646|FG001|Overall Study|Adverse Event|0|||
33544715|NCT01126424|101894647|FG002|Overall Study|Adverse Event|0|||
33544716|NCT01126424|101894648|FG003|Overall Study|Adverse Event|0|||
33544717|NCT01126424|101894649|FG004|Overall Study|Adverse Event|1|||
33544718|NCT01126424|101894650|FG005|Overall Study|Adverse Event|0|||
33544719|NCT01126424|101894645|FG000|Overall Study|Withdrawal by Subject|0|||
33544720|NCT01126424|101894646|FG001|Overall Study|Withdrawal by Subject|0|||
33544721|NCT01126424|101894647|FG002|Overall Study|Withdrawal by Subject|1|||
33544722|NCT01126424|101894648|FG003|Overall Study|Withdrawal by Subject|3|||
33544723|NCT01126424|101894649|FG004|Overall Study|Withdrawal by Subject|1|||
33213284|NCT03792126|100679604|FG000|Overall Study|Symptoms resolved|0|||
33213285|NCT03792126|100679605|FG001|Overall Study|Symptoms resolved|3|||
33213286|NCT01022762|100679606|FG000|Overall Study|Adverse Event|3|||
33213287|NCT01022762|100679607|FG001|Overall Study|Adverse Event|1|||
33213288|NCT01022762|100679606|FG000|Overall Study|Lack of Efficacy|0|||
33213289|NCT01022762|100679607|FG001|Overall Study|Lack of Efficacy|1|||
33347322|NCT03158220|101160039|FG001|Overall Study|Lost to Follow-up|5|||
33544724|NCT01126424|101894650|FG005|Overall Study|Withdrawal by Subject|0|||
33544725|NCT00262925|101894659|FG000|Overall Study|Lack of Efficacy|3|||
33544726|NCT00262925|101894659|FG000|Overall Study|Adverse Event|4|||
33544727|NCT00262925|101894659|FG000|Overall Study|Death|2|||
33544728|NCT00262925|101894659|FG000|Overall Study|alternative therapy|1|||
33544729|NCT00262925|101894659|FG000|Overall Study|Other|1|||
33616672|NCT01959139|102144408|FG003|Phase II|Adverse Event|11|||
33616673|NCT01959139|102144405|FG000|Phase II|Patient Refusal|0|||
33544730|NCT02515227|101894660|FG000|Overall Study|Adverse Event|0|||
33213290|NCT01022762|100679606|FG000|Overall Study|Protocol Violation|7|||
33213291|NCT01022762|100679607|FG001|Overall Study|Protocol Violation|6|||
33544731|NCT02515227|101894661|FG001|Overall Study|Adverse Event|2|||
33544732|NCT02515227|101894660|FG000|Overall Study|Progressive disease|2|||
33616674|NCT01959139|102144406|FG001|Phase II|Patient Refusal|0|||
33213292|NCT01022762|100679606|FG000|Overall Study|Unclassified|12|||
33213293|NCT01022762|100679607|FG001|Overall Study|Unclassified|20|||
33213294|NCT04435665|100679612|FG000|Overall Study|Lost to Follow-up|0|||
33213295|NCT04435665|100679613|FG001|Overall Study|Lost to Follow-up|0|||
33213296|NCT04435665|100679614|FG002|Overall Study|Lost to Follow-up|0|||
33213297|NCT04435665|100679615|FG003|Overall Study|Lost to Follow-up|1|||
33213298|NCT00771810|100679617|FG000|Overall Study|Adverse Event|3|||
33213299|NCT00771810|100679618|FG001|Overall Study|Adverse Event|0|||
33213300|NCT00771810|100679619|FG002|Overall Study|Adverse Event|2|||
33213301|NCT00771810|100679617|FG000|Overall Study|Lost to Follow-up|0|||
33213302|NCT00771810|100679618|FG001|Overall Study|Lost to Follow-up|0|||
33213303|NCT00771810|100679619|FG002|Overall Study|Lost to Follow-up|1|||
33213304|NCT00771810|100679617|FG000|Overall Study|Physician Decision|1|||
33213305|NCT00771810|100679618|FG001|Overall Study|Physician Decision|2|||
33213306|NCT00771810|100679619|FG002|Overall Study|Physician Decision|2|||
33213307|NCT00771810|100679617|FG000|Overall Study|Protocol Violation|0|||
33213308|NCT00771810|100679618|FG001|Overall Study|Protocol Violation|1|||
33213309|NCT00771810|100679619|FG002|Overall Study|Protocol Violation|1|||
33213310|NCT00771810|100679617|FG000|Overall Study|Withdrawal by Subject|1|||
33213311|NCT00771810|100679618|FG001|Overall Study|Withdrawal by Subject|2|||
33213312|NCT00771810|100679619|FG002|Overall Study|Withdrawal by Subject|0|||
33213313|NCT00771810|100679617|FG000|Overall Study|Other|0|||
33213314|NCT00771810|100679618|FG001|Overall Study|Other|0|||
33213315|NCT00771810|100679619|FG002|Overall Study|Other|1|||
33213316|NCT00322348|100679620|FG000|Overall Study|Adverse Event|0|||
33213317|NCT00322348|100679621|FG001|Overall Study|Adverse Event|1|||
33213318|NCT00322348|100679620|FG000|Overall Study|Withdrawal by Subject|1|||
33213319|NCT00322348|100679621|FG001|Overall Study|Withdrawal by Subject|4|||
33213320|NCT00322348|100679620|FG000|Overall Study|Lost to Follow-up|1|||
33213321|NCT00322348|100679621|FG001|Overall Study|Lost to Follow-up|0|||
33213322|NCT00322348|100679620|FG000|Overall Study|Death|0|||
33213323|NCT00322348|100679621|FG001|Overall Study|Death|2|||
33213324|NCT00322348|100679620|FG000|Overall Study|Disease Progression|30|||
33213325|NCT00322348|100679621|FG001|Overall Study|Disease Progression|25|||
33213326|NCT00322348|100679620|FG000|Overall Study|Reasons not specified|5|||
33213327|NCT00322348|100679621|FG001|Overall Study|Reasons not specified|1|||
33213328|NCT01261338|100679622|FG000|Overall Study|Withdrawal by Subject|3|||
33213329|NCT01261338|100679623|FG001|Overall Study|Withdrawal by Subject|2|||
33213330|NCT01928719|100679624|FG000|Overall Study|Lost to Follow-up|26|||
33213331|NCT01928719|100679625|FG001|Overall Study|Lost to Follow-up|11|||
33213332|NCT01928719|100679624|FG000|Overall Study|Withdrawal by Subject|22|||
33213333|NCT01928719|100679625|FG001|Overall Study|Withdrawal by Subject|7|||
33213334|NCT01928719|100679624|FG000|Overall Study|Protocol Violation|3|||
33213335|NCT01928719|100679625|FG001|Overall Study|Protocol Violation|1|||
33213336|NCT01928719|100679624|FG000|Overall Study|Adverse Event|1|||
33213337|NCT01928719|100679625|FG001|Overall Study|Adverse Event|0|||
33213338|NCT03152526|100679627|FG000|Overall Study|Withdrawal by Subject|0|||
33544733|NCT02515227|101894661|FG001|Overall Study|Progressive disease|9|||
33213339|NCT03152526|100679628|FG001|Overall Study|Withdrawal by Subject|1|||
33213340|NCT00265889|100679629|FG000|Overall Study|Physician Decision|1|||
33213341|NCT00265889|100679629|FG000|Overall Study|Protocol Violation|1|||
33213342|NCT00265889|100679629|FG000|Overall Study|Insurance denied the request|3|||
33213343|NCT00695669|100679634|FG000|Overall Study|Adverse Event|0|||
33213344|NCT00695669|100679635|FG001|Overall Study|Adverse Event|0|||
33213345|NCT00695669|100679636|FG002|Overall Study|Adverse Event|2|||
33213346|NCT00695669|100679637|FG003|Overall Study|Adverse Event|0|||
33544734|NCT00587457|101894662|FG000|Overall Study|Adverse Event|1|||
33544735|NCT00587457|101894663|FG001|Overall Study|Adverse Event|2|||
33544736|NCT00587457|101894664|FG002|Overall Study|Adverse Event|1|||
33544737|NCT00587457|101894662|FG000|Overall Study|Disease progression|2|||
33544738|NCT00587457|101894663|FG001|Overall Study|Disease progression|0|||
33544739|NCT00587457|101894664|FG002|Overall Study|Disease progression|2|||
33544740|NCT00587457|101894662|FG000|Overall Study|Initiation of alternative therapy|0|||
33544741|NCT00587457|101894663|FG001|Overall Study|Initiation of alternative therapy|1|||
33544742|NCT00587457|101894664|FG002|Overall Study|Initiation of alternative therapy|0|||
33544743|NCT00587457|101894662|FG000|Overall Study|Undefined|0|||
33544744|NCT00587457|101894663|FG001|Overall Study|Undefined|0|||
33544745|NCT00587457|101894664|FG002|Overall Study|Undefined|1|||
33213347|NCT00695669|100679634|FG000|Overall Study|Lost to Follow-up|4|||
33213348|NCT00695669|100679635|FG001|Overall Study|Lost to Follow-up|4|||
33213349|NCT00695669|100679636|FG002|Overall Study|Lost to Follow-up|1|||
33213350|NCT00695669|100679637|FG003|Overall Study|Lost to Follow-up|4|||
33213351|NCT04575051|100679638|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
33213352|NCT04575051|100679639|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
33213353|NCT04575051|100679640|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
33213354|NCT04575051|100679641|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
33213355|NCT04575051|100679642|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
33213356|NCT04575051|100679638|FG000|Time Period 1|Missing follow up|1|||
33544746|NCT00587457|101894662|FG000|Overall Study|Development of neutralizing Abs|0|||
33544747|NCT00587457|101894663|FG001|Overall Study|Development of neutralizing Abs|0|||
33213357|NCT04575051|100679639|FG001|Time Period 1|Missing follow up|3|||
33213358|NCT04575051|100679640|FG002|Time Period 1|Missing follow up|1|||
33213359|NCT04575051|100679641|FG003|Time Period 1|Missing follow up|3|||
33213360|NCT04575051|100679642|FG004|Time Period 1|Missing follow up|2|||
33213361|NCT04575051|100679638|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
33213362|NCT04575051|100679639|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
33213363|NCT04575051|100679640|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
33213364|NCT04575051|100679641|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
33213365|NCT04575051|100679642|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
33213366|NCT04575051|100679638|FG000|Time Period 2|Missing follow up|1|||
33213367|NCT04575051|100679639|FG001|Time Period 2|Missing follow up|8|||
33213368|NCT04575051|100679640|FG002|Time Period 2|Missing follow up|7|||
33213369|NCT04575051|100679641|FG003|Time Period 2|Missing follow up|0|||
33213370|NCT04575051|100679642|FG004|Time Period 2|Missing follow up|1|||
33213371|NCT04575051|100679638|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
33213372|NCT04575051|100679639|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
33213373|NCT04575051|100679640|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
33213374|NCT04575051|100679641|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
33213375|NCT04575051|100679642|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
33213376|NCT04575051|100679638|FG000|Time Period 3|Missing follow up|8|||
33213377|NCT04575051|100679639|FG001|Time Period 3|Missing follow up|6|||
33213378|NCT04575051|100679640|FG002|Time Period 3|Missing follow up|4|||
33213379|NCT04575051|100679641|FG003|Time Period 3|Missing follow up|3|||
33213380|NCT04575051|100679642|FG004|Time Period 3|Missing follow up|0|||
33213381|NCT04575051|100679638|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
33213382|NCT04575051|100679639|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
33213383|NCT04575051|100679640|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
33213384|NCT04575051|100679641|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
33408705|NCT01249404|101386103|FG000|Overall Study|Adverse Event|2|||
33408706|NCT01249404|101386104|FG001|Overall Study|Adverse Event|2|||
33408707|NCT01249404|101386105|FG002|Overall Study|Adverse Event|2|||
33408708|NCT01249404|101386103|FG000|Overall Study|Withdrawal by Subject|2|||
33408709|NCT01249404|101386104|FG001|Overall Study|Withdrawal by Subject|2|||
33408710|NCT01249404|101386105|FG002|Overall Study|Withdrawal by Subject|0|||
33408711|NCT01249404|101386103|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
33616675|NCT01959139|102144407|FG002|Phase II|Patient Refusal|5|||
33408712|NCT01249404|101386104|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
33408713|NCT01249404|101386105|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
33408714|NCT01249404|101386103|FG000|Overall Study|Non compliance to visit schedule|0|||
33408715|NCT01249404|101386104|FG001|Overall Study|Non compliance to visit schedule|1|||
33408716|NCT01249404|101386105|FG002|Overall Study|Non compliance to visit schedule|0|||
33408717|NCT00577382|101386106|FG000|Overall Study|Adverse Event|0|||
33408718|NCT00577382|101386107|FG001|Overall Study|Adverse Event|6|||
33408719|NCT00577382|101386106|FG000|Overall Study|Withdrawal by Subject|0|||
33408720|NCT00577382|101386107|FG001|Overall Study|Withdrawal by Subject|1|||
33544748|NCT00587457|101894664|FG002|Overall Study|Development of neutralizing Abs|1|||
33544749|NCT00770367|101894667|FG000|First Intervention|Withdrawal by Subject|0|||
33544750|NCT00770367|101894668|FG001|First Intervention|Withdrawal by Subject|2|||
33544751|NCT00770367|101894667|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
33544752|NCT00770367|101894668|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
33544753|NCT00770367|101894667|FG000|Second Intervention|Lost to Follow-up|2|||
33616676|NCT01959139|102144408|FG003|Phase II|Patient Refusal|4|||
33408721|NCT00577382|101386106|FG000|Overall Study|Progressive Disease|17|||
33408722|NCT00577382|101386107|FG001|Overall Study|Progressive Disease|19|||
33213385|NCT04575051|100679642|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
33213386|NCT04575051|100679638|FG000|Time Period 4|Missing follow up|17|||
33213387|NCT04575051|100679639|FG001|Time Period 4|Missing follow up|3|||
33213388|NCT04575051|100679640|FG002|Time Period 4|Missing follow up|4|||
33213389|NCT04575051|100679641|FG003|Time Period 4|Missing follow up|2|||
33213390|NCT04575051|100679642|FG004|Time Period 4|Missing follow up|1|||
33213391|NCT04575051|100679638|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
33213392|NCT04575051|100679639|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
33213393|NCT04575051|100679640|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
33213394|NCT04575051|100679641|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
33213395|NCT04575051|100679642|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
33213396|NCT04575051|100679638|FG000|Time Period 5|Missing follow up|11|||
33213397|NCT04575051|100679639|FG001|Time Period 5|Missing follow up|8|||
33213398|NCT04575051|100679640|FG002|Time Period 5|Missing follow up|12|||
33213399|NCT04575051|100679641|FG003|Time Period 5|Missing follow up|3|||
33213400|NCT04575051|100679642|FG004|Time Period 5|Missing follow up|11|||
33213401|NCT01270347|100679643|FG000|Core Phase|Adverse Event|1|||
33213402|NCT01270347|100679644|FG001|Core Phase|Adverse Event|6|||
33408723|NCT00577382|101386106|FG000|Overall Study|Intercurrent Illness|1|||
33408724|NCT00577382|101386107|FG001|Overall Study|Intercurrent Illness|2|||
33408725|NCT00577382|101386106|FG000|Overall Study|Death|1|||
33408726|NCT00577382|101386107|FG001|Overall Study|Death|1|||
33408727|NCT00577382|101386106|FG000|Overall Study|Lost to Follow-up|2|||
33408728|NCT00577382|101386107|FG001|Overall Study|Lost to Follow-up|2|||
33544754|NCT00770367|101894668|FG001|Second Intervention|Lost to Follow-up|0|||
33544755|NCT00434252|101894669|FG000|Overall Study|Lack of Efficacy|50|||
33544756|NCT00434252|101894670|FG001|Overall Study|Lack of Efficacy|100|||
33544757|NCT00434252|101894669|FG000|Overall Study|Adverse Event|6|||
33544758|NCT00434252|101894670|FG001|Overall Study|Adverse Event|13|||
33544759|NCT00434252|101894669|FG000|Overall Study|Death|1|||
33544760|NCT00434252|101894670|FG001|Overall Study|Death|2|||
33544761|NCT00434252|101894669|FG000|Overall Study|Lost to Follow-up|0|||
33544762|NCT00434252|101894670|FG001|Overall Study|Lost to Follow-up|1|||
33544763|NCT00434252|101894669|FG000|Overall Study|Physician Decision|4|||
33544764|NCT00434252|101894670|FG001|Overall Study|Physician Decision|8|||
33544765|NCT00434252|101894669|FG000|Overall Study|Withdrawal by Subject|3|||
33544766|NCT00434252|101894670|FG001|Overall Study|Withdrawal by Subject|7|||
33544767|NCT00157755|101894671|FG000|Overall Study|Death|2|||
33544768|NCT00157755|101894672|FG001|Overall Study|Death|3|||
33544769|NCT00157755|101894673|FG002|Overall Study|Death|3|||
33544770|NCT00157755|101894674|FG003|Overall Study|Death|2|||
33544771|NCT00157755|101894675|FG004|Overall Study|Death|0|||
33544772|NCT00157755|101894676|FG005|Overall Study|Death|0|||
33544773|NCT00157755|101894671|FG000|Overall Study|Lost to Follow-up|0|||
33544774|NCT00157755|101894672|FG001|Overall Study|Lost to Follow-up|0|||
33544775|NCT00157755|101894673|FG002|Overall Study|Lost to Follow-up|1|||
33347323|NCT03158220|101160038|FG000|Overall Study|Physician Decision|1|||
33347324|NCT03158220|101160039|FG001|Overall Study|Physician Decision|0|||
33347325|NCT03529409|101160040|FG000|Randomized|Lost to Follow-up|0|||
33347326|NCT03529409|101160041|FG001|Randomized|Lost to Follow-up|0|||
33347327|NCT03529409|101160042|FG002|Randomized|Lost to Follow-up|4|||
33347328|NCT03529409|101160040|FG000|Randomized|Excluded|0|||
33347329|NCT03529409|101160041|FG001|Randomized|Excluded|0|||
33347330|NCT03529409|101160042|FG002|Randomized|Excluded|1|||
33347331|NCT03529409|101160040|FG000|Post-treatment Assessment|Death|1|||
33347332|NCT03529409|101160041|FG001|Post-treatment Assessment|Death|0|||
33347333|NCT03529409|101160042|FG002|Post-treatment Assessment|Death|0|||
33347334|NCT03529409|101160040|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
33347335|NCT03529409|101160041|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
33347336|NCT03529409|101160042|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
33347337|NCT03529409|101160040|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
33364970|NCT04760314|101223689|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33544776|NCT00157755|101894674|FG003|Overall Study|Lost to Follow-up|0|||
33544777|NCT00157755|101894675|FG004|Overall Study|Lost to Follow-up|0|||
33544778|NCT00157755|101894676|FG005|Overall Study|Lost to Follow-up|0|||
33544779|NCT00157755|101894671|FG000|Overall Study|Withdrawal by Subject|0|||
33213403|NCT01270347|100679643|FG000|Core Phase|Withdrawal by Subject|1|||
33213404|NCT01270347|100679644|FG001|Core Phase|Withdrawal by Subject|2|||
33213405|NCT01270347|100679643|FG000|Core Phase|Lost to Follow-up|0|||
33213406|NCT01270347|100679644|FG001|Core Phase|Lost to Follow-up|1|||
33213407|NCT01270347|100679643|FG000|Core Phase|Miscellaneous|8|||
33408729|NCT03471507|101386108|FG000|Overall Study|Lost to Follow-up|1|||
33544780|NCT00157755|101894672|FG001|Overall Study|Withdrawal by Subject|0|||
33544781|NCT00157755|101894673|FG002|Overall Study|Withdrawal by Subject|1|||
33408730|NCT03471507|101386109|FG001|Overall Study|Lost to Follow-up|3|||
33544782|NCT00157755|101894674|FG003|Overall Study|Withdrawal by Subject|1|||
33544783|NCT00157755|101894675|FG004|Overall Study|Withdrawal by Subject|1|||
33544784|NCT00157755|101894676|FG005|Overall Study|Withdrawal by Subject|2|||
33544785|NCT00157755|101894671|FG000|Overall Study|Explant due to infection|0|||
33544786|NCT00157755|101894672|FG001|Overall Study|Explant due to infection|0|||
33544787|NCT00157755|101894673|FG002|Overall Study|Explant due to infection|1|||
33544788|NCT00157755|101894674|FG003|Overall Study|Explant due to infection|0|||
33544789|NCT00157755|101894675|FG004|Overall Study|Explant due to infection|0|||
33544790|NCT00157755|101894676|FG005|Overall Study|Explant due to infection|0|||
33544791|NCT00157755|101894671|FG000|Overall Study|Medical reason|0|||
33544792|NCT00157755|101894672|FG001|Overall Study|Medical reason|0|||
33544793|NCT00157755|101894673|FG002|Overall Study|Medical reason|1|||
33616677|NCT01959139|102144405|FG000|Phase II|Death|0|||
33616678|NCT01959139|102144406|FG001|Phase II|Death|0|||
33616679|NCT01959139|102144407|FG002|Phase II|Death|3|||
33616680|NCT01959139|102144408|FG003|Phase II|Death|1|||
33616681|NCT01959139|102144405|FG000|Phase II|Other/Unknown|0|||
33616682|NCT01959139|102144406|FG001|Phase II|Other/Unknown|0|||
33616683|NCT01959139|102144407|FG002|Phase II|Other/Unknown|8|||
33616684|NCT01959139|102144408|FG003|Phase II|Other/Unknown|5|||
33213408|NCT01270347|100679644|FG001|Core Phase|Miscellaneous|14|||
33213409|NCT01270347|100679643|FG000|Extension Phase|Adverse Event|1|||
33213410|NCT01270347|100679644|FG001|Extension Phase|Adverse Event|3|||
33213411|NCT01270347|100679643|FG000|Extension Phase|Withdrawal by Subject|3|||
33213412|NCT01270347|100679644|FG001|Extension Phase|Withdrawal by Subject|4|||
33213413|NCT01270347|100679643|FG000|Extension Phase|Miscellaneous|2|||
33213414|NCT01270347|100679644|FG001|Extension Phase|Miscellaneous|2|||
33213415|NCT02570126|100679645|FG000|Overall Study|Lost to Follow-up|2|||
33213416|NCT02570126|100679646|FG001|Overall Study|Lost to Follow-up|0|||
33213417|NCT02570126|100679645|FG000|Overall Study|Unable To Arrange Visit 3|1|||
33213418|NCT02570126|100679646|FG001|Overall Study|Unable To Arrange Visit 3|0|||
33213419|NCT02570126|100679645|FG000|Overall Study|Violation Of Procedures GSK|0|||
33213420|NCT02570126|100679646|FG001|Overall Study|Violation Of Procedures GSK|1|||
33213421|NCT02570126|100679645|FG000|Overall Study|Protocol Violation|0|||
33616685|NCT01959139|102144405|FG000|Phase II|On treatment|0|||
33616686|NCT01959139|102144406|FG001|Phase II|On treatment|0|||
33616687|NCT01959139|102144407|FG002|Phase II|On treatment|4|||
33347338|NCT03529409|101160041|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
33544794|NCT00157755|101894674|FG003|Overall Study|Medical reason|1|||
33544795|NCT00157755|101894675|FG004|Overall Study|Medical reason|0|||
33213422|NCT02570126|100679646|FG001|Overall Study|Protocol Violation|1|||
33213423|NCT02570126|100679645|FG000|Overall Study|Withdrawal by Subject|3|||
33544796|NCT00157755|101894676|FG005|Overall Study|Medical reason|0|||
33544797|NCT00157755|101894671|FG000|Overall Study|Study site closure|0|||
33616688|NCT01959139|102144408|FG003|Phase II|On treatment|0|||
33616689|NCT00726232|102144409|FG000|Initial Phase (Dose-finding)|Death|0|||
33213424|NCT02570126|100679646|FG001|Overall Study|Withdrawal by Subject|7|||
33213425|NCT02192502|100679649|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
33213426|NCT02192502|100679650|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
33213427|NCT02192502|100679649|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
33213428|NCT02192502|100679650|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
33213429|NCT02192502|100679649|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
33213430|NCT02192502|100679650|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
33213431|NCT01302847|100679651|FG000|Overall Study|Death|0|||
33213432|NCT01302847|100679652|FG001|Overall Study|Death|1|||
33213433|NCT01302847|100679653|FG002|Overall Study|Death|0|||
33213434|NCT01302847|100679654|FG003|Overall Study|Death|0|||
33213435|NCT01302847|100679655|FG004|Overall Study|Death|0|||
33213436|NCT01302847|100679656|FG005|Overall Study|Death|1|||
33616690|NCT00726232|102144410|FG001|Initial Phase (Dose-finding)|Death|0|||
33616691|NCT00726232|102144411|FG002|Initial Phase (Dose-finding)|Death|0|||
33616692|NCT00726232|102144412|FG003|Initial Phase (Dose-finding)|Death|0|||
33616693|NCT00726232|102144413|FG004|Initial Phase (Dose-finding)|Death|1|||
33616694|NCT00726232|102144414|FG005|Initial Phase (Dose-finding)|Death|0|||
33616695|NCT00726232|102144415|FG006|Initial Phase (Dose-finding)|Death|0|||
33616696|NCT00726232|102144416|FG007|Initial Phase (Dose-finding)|Death|0|||
33616697|NCT00726232|102144409|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
33616698|NCT00726232|102144410|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
33616699|NCT00726232|102144411|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
33616700|NCT00726232|102144412|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
33616701|NCT00726232|102144413|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
33616702|NCT00726232|102144414|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
33616703|NCT00726232|102144415|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
33616704|NCT00726232|102144416|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
33616705|NCT00726232|102144409|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
33616706|NCT00726232|102144410|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
33616707|NCT00726232|102144411|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
33616708|NCT00726232|102144412|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
33616709|NCT00726232|102144413|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
33616710|NCT00726232|102144414|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
33616711|NCT00726232|102144415|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
33213437|NCT01302847|100679657|FG006|Overall Study|Death|1|||
33213438|NCT01302847|100679658|FG007|Overall Study|Death|0|||
33213439|NCT01302847|100679651|FG000|Overall Study|Pregnancy|2|||
33213440|NCT01302847|100679652|FG001|Overall Study|Pregnancy|0|||
33544798|NCT00157755|101894672|FG001|Overall Study|Study site closure|1|||
33544799|NCT00157755|101894673|FG002|Overall Study|Study site closure|0|||
33544800|NCT00157755|101894674|FG003|Overall Study|Study site closure|0|||
33544801|NCT00157755|101894675|FG004|Overall Study|Study site closure|0|||
33544802|NCT00157755|101894676|FG005|Overall Study|Study site closure|0|||
33544803|NCT00157755|101894671|FG000|Overall Study|Subject non-compliance|0|||
33544804|NCT00157755|101894672|FG001|Overall Study|Subject non-compliance|0|||
33544805|NCT00157755|101894673|FG002|Overall Study|Subject non-compliance|0|||
33544806|NCT00157755|101894674|FG003|Overall Study|Subject non-compliance|0|||
33544807|NCT00157755|101894675|FG004|Overall Study|Subject non-compliance|0|||
33544808|NCT00157755|101894676|FG005|Overall Study|Subject non-compliance|1|||
33544809|NCT00157755|101894671|FG000|Overall Study|Study completion|0|||
33544810|NCT00157755|101894672|FG001|Overall Study|Study completion|0|||
33544811|NCT00157755|101894673|FG002|Overall Study|Study completion|0|||
33544812|NCT00157755|101894674|FG003|Overall Study|Study completion|0|||
33544813|NCT00157755|101894675|FG004|Overall Study|Study completion|1|||
33544814|NCT00157755|101894676|FG005|Overall Study|Study completion|2|||
33616712|NCT00726232|102144416|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
33544815|NCT04181788|101894677|FG000|TREATMENT|Adverse Event|0|||
33213441|NCT01302847|100679653|FG002|Overall Study|Pregnancy|0|||
33213442|NCT01302847|100679654|FG003|Overall Study|Pregnancy|0|||
33544816|NCT04181788|101894678|FG001|TREATMENT|Adverse Event|2|||
33213443|NCT01302847|100679655|FG004|Overall Study|Pregnancy|0|||
33408731|NCT03471507|101386108|FG000|Overall Study|Physician Decision|0|||
33408732|NCT03471507|101386109|FG001|Overall Study|Physician Decision|1|||
33408733|NCT03471507|101386108|FG000|Overall Study|Withdrawal by Subject|2|||
33408734|NCT03471507|101386109|FG001|Overall Study|Withdrawal by Subject|1|||
33408735|NCT03451630|101386111|FG000|Overall Study|Death|15|||
33408736|NCT03451630|101386112|FG001|Overall Study|Death|16|||
33408737|NCT03451630|101386113|FG002|Overall Study|Death|11|||
33408738|NCT03451630|101386111|FG000|Overall Study|Lost to Follow-up|9|||
33408739|NCT03451630|101386112|FG001|Overall Study|Lost to Follow-up|0|||
33408740|NCT03451630|101386113|FG002|Overall Study|Lost to Follow-up|4|||
33408741|NCT03451630|101386111|FG000|Overall Study|Withdrawal by Subject|0|||
33408742|NCT03451630|101386112|FG001|Overall Study|Withdrawal by Subject|3|||
33408743|NCT03451630|101386113|FG002|Overall Study|Withdrawal by Subject|0|||
33408744|NCT03451630|101386111|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
33408745|NCT03451630|101386112|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
33408746|NCT03451630|101386113|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
33408747|NCT02210559|101386114|FG000|Overall Study|Progressive Disease|3|||
33408748|NCT02210559|101386115|FG001|Overall Study|Progressive Disease|2|||
33408749|NCT02210559|101386114|FG000|Overall Study|Adverse Event|2|||
33408750|NCT02210559|101386115|FG001|Overall Study|Adverse Event|2|||
33408751|NCT02210559|101386114|FG000|Overall Study|Physician Decision|1|||
33408752|NCT02210559|101386115|FG001|Overall Study|Physician Decision|0|||
33408753|NCT02210559|101386114|FG000|Overall Study|Withdrawal by Subject|0|||
33408754|NCT02210559|101386115|FG001|Overall Study|Withdrawal by Subject|1|||
33408755|NCT02210559|101386114|FG000|Overall Study|Other than specified|0|||
33408756|NCT02210559|101386115|FG001|Overall Study|Other than specified|1|||
33408757|NCT01707667|101386122|FG000|Period 1|expulsion of colonic sensor catheter|1|||
33408758|NCT01707667|101386123|FG001|Period 1|expulsion of colonic sensor catheter|0|||
33408759|NCT01733758|101386124|FG000|Overall Study|Adverse Event|5|||
33408760|NCT01733758|101386125|FG001|Overall Study|Adverse Event|7|||
33544817|NCT04181788|101894679|FG002|TREATMENT|Adverse Event|1|||
33544818|NCT04181788|101894680|FG003|TREATMENT|Adverse Event|0|||
33544819|NCT04181788|101894681|FG004|TREATMENT|Adverse Event|1|||
33544820|NCT04181788|101894682|FG005|TREATMENT|Adverse Event|3|||
33544821|NCT04181788|101894677|FG000|TREATMENT|Death|0|||
33544822|NCT04181788|101894678|FG001|TREATMENT|Death|0|||
33544823|NCT04181788|101894679|FG002|TREATMENT|Death|0|||
33544824|NCT04181788|101894680|FG003|TREATMENT|Death|0|||
33544825|NCT04181788|101894681|FG004|TREATMENT|Death|8|||
33544826|NCT04181788|101894682|FG005|TREATMENT|Death|8|||
33544827|NCT04181788|101894677|FG000|TREATMENT|Physician Decision|0|||
33544828|NCT04181788|101894678|FG001|TREATMENT|Physician Decision|0|||
33544829|NCT04181788|101894679|FG002|TREATMENT|Physician Decision|0|||
33544830|NCT04181788|101894680|FG003|TREATMENT|Physician Decision|0|||
33544831|NCT04181788|101894681|FG004|TREATMENT|Physician Decision|0|||
33544832|NCT04181788|101894682|FG005|TREATMENT|Physician Decision|1|||
33544833|NCT04181788|101894677|FG000|TREATMENT|Progressive disease|3|||
33544834|NCT04181788|101894678|FG001|TREATMENT|Progressive disease|3|||
33544835|NCT04181788|101894679|FG002|TREATMENT|Progressive disease|5|||
33544836|NCT04181788|101894680|FG003|TREATMENT|Progressive disease|7|||
33544837|NCT04181788|101894681|FG004|TREATMENT|Progressive disease|20|||
33544838|NCT04181788|101894682|FG005|TREATMENT|Progressive disease|38|||
33544839|NCT04181788|101894677|FG000|TREATMENT|Global deterioration of health status|0|||
33544840|NCT04181788|101894678|FG001|TREATMENT|Global deterioration of health status|2|||
33544841|NCT04181788|101894679|FG002|TREATMENT|Global deterioration of health status|0|||
33544842|NCT04181788|101894680|FG003|TREATMENT|Global deterioration of health status|0|||
33213444|NCT01302847|100679656|FG005|Overall Study|Pregnancy|0|||
33408761|NCT01733758|101386126|FG002|Overall Study|Adverse Event|8|||
33408762|NCT01733758|101386127|FG003|Overall Study|Adverse Event|1|||
33408763|NCT01733758|101386124|FG000|Overall Study|Withdrawal by Subject|1|||
33408764|NCT01733758|101386125|FG001|Overall Study|Withdrawal by Subject|1|||
33408765|NCT01733758|101386126|FG002|Overall Study|Withdrawal by Subject|5|||
33408766|NCT01733758|101386127|FG003|Overall Study|Withdrawal by Subject|3|||
33408767|NCT01733758|101386124|FG000|Overall Study|Persistent Hyperglycemia|3|||
33544843|NCT04181788|101894681|FG004|TREATMENT|Global deterioration of health status|2|||
33544844|NCT04181788|101894682|FG005|TREATMENT|Global deterioration of health status|8|||
33544845|NCT04181788|101894677|FG000|TREATMENT|Withdrawal by Subject|1|||
33408768|NCT01733758|101386125|FG001|Overall Study|Persistent Hyperglycemia|2|||
33408769|NCT01733758|101386126|FG002|Overall Study|Persistent Hyperglycemia|0|||
33544846|NCT04181788|101894678|FG001|TREATMENT|Withdrawal by Subject|2|||
33544847|NCT04181788|101894679|FG002|TREATMENT|Withdrawal by Subject|0|||
33544848|NCT04181788|101894680|FG003|TREATMENT|Withdrawal by Subject|0|||
33544849|NCT04181788|101894681|FG004|TREATMENT|Withdrawal by Subject|3|||
33213445|NCT01302847|100679657|FG006|Overall Study|Pregnancy|0|||
33408770|NCT01733758|101386127|FG003|Overall Study|Persistent Hyperglycemia|0|||
33408771|NCT01733758|101386124|FG000|Overall Study|Protocol Violation|0|||
33544850|NCT04181788|101894682|FG005|TREATMENT|Withdrawal by Subject|5|||
33544851|NCT04181788|101894677|FG000|TREATMENT|Other unspecified|0|||
33544852|NCT04181788|101894678|FG001|TREATMENT|Other unspecified|0|||
33213446|NCT01302847|100679658|FG007|Overall Study|Pregnancy|0|||
33213447|NCT01302847|100679651|FG000|Overall Study|Virologic failure|0|||
33213448|NCT01302847|100679652|FG001|Overall Study|Virologic failure|2|||
33213449|NCT01302847|100679653|FG002|Overall Study|Virologic failure|0|||
33213450|NCT01302847|100679654|FG003|Overall Study|Virologic failure|2|||
33213451|NCT01302847|100679655|FG004|Overall Study|Virologic failure|1|||
33213452|NCT01302847|100679656|FG005|Overall Study|Virologic failure|3|||
33213453|NCT01302847|100679657|FG006|Overall Study|Virologic failure|1|||
33213454|NCT01302847|100679658|FG007|Overall Study|Virologic failure|2|||
33213455|NCT01302847|100679651|FG000|Overall Study|Severe debilitation, unable to continue|0|||
33213456|NCT01302847|100679652|FG001|Overall Study|Severe debilitation, unable to continue|0|||
33213457|NCT01302847|100679653|FG002|Overall Study|Severe debilitation, unable to continue|0|||
33213458|NCT01302847|100679654|FG003|Overall Study|Severe debilitation, unable to continue|0|||
33213459|NCT01302847|100679655|FG004|Overall Study|Severe debilitation, unable to continue|0|||
33213460|NCT01302847|100679656|FG005|Overall Study|Severe debilitation, unable to continue|1|||
33213461|NCT01302847|100679657|FG006|Overall Study|Severe debilitation, unable to continue|1|||
33213462|NCT01302847|100679658|FG007|Overall Study|Severe debilitation, unable to continue|0|||
33213463|NCT01302847|100679651|FG000|Overall Study|Not able to get to clinic|1|||
33213464|NCT01302847|100679652|FG001|Overall Study|Not able to get to clinic|1|||
33213465|NCT01302847|100679653|FG002|Overall Study|Not able to get to clinic|0|||
33213466|NCT01302847|100679654|FG003|Overall Study|Not able to get to clinic|0|||
33544853|NCT04181788|101894679|FG002|TREATMENT|Other unspecified|0|||
33544854|NCT04181788|101894680|FG003|TREATMENT|Other unspecified|0|||
33544855|NCT04181788|101894681|FG004|TREATMENT|Other unspecified|0|||
33544856|NCT04181788|101894682|FG005|TREATMENT|Other unspecified|2|||
33544857|NCT04181788|101894677|FG000|TREATMENT|Ongoing|0|||
33544858|NCT04181788|101894678|FG001|TREATMENT|Ongoing|3|||
33544859|NCT04181788|101894679|FG002|TREATMENT|Ongoing|0|||
33544860|NCT04181788|101894680|FG003|TREATMENT|Ongoing|5|||
33544861|NCT04181788|101894681|FG004|TREATMENT|Ongoing|7|||
33544862|NCT04181788|101894682|FG005|TREATMENT|Ongoing|15|||
33544863|NCT04181788|101894677|FG000|FOLLOW-UP|Death|0|||
33544864|NCT04181788|101894678|FG001|FOLLOW-UP|Death|0|||
33544865|NCT04181788|101894679|FG002|FOLLOW-UP|Death|1|||
33544866|NCT04181788|101894680|FG003|FOLLOW-UP|Death|2|||
33544867|NCT04181788|101894681|FG004|FOLLOW-UP|Death|8|||
33544868|NCT04181788|101894682|FG005|FOLLOW-UP|Death|20|||
33544869|NCT04181788|101894677|FG000|FOLLOW-UP|Lost to Follow-up|0|||
33544870|NCT04181788|101894678|FG001|FOLLOW-UP|Lost to Follow-up|0|||
33616713|NCT00726232|102144409|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
33616714|NCT00726232|102144410|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
33616715|NCT00726232|102144411|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
33544871|NCT04181788|101894679|FG002|FOLLOW-UP|Lost to Follow-up|0|||
33544872|NCT04181788|101894680|FG003|FOLLOW-UP|Lost to Follow-up|0|||
33544873|NCT04181788|101894681|FG004|FOLLOW-UP|Lost to Follow-up|0|||
33544874|NCT04181788|101894682|FG005|FOLLOW-UP|Lost to Follow-up|2|||
33213467|NCT01302847|100679655|FG004|Overall Study|Not able to get to clinic|0|||
33213468|NCT01302847|100679656|FG005|Overall Study|Not able to get to clinic|0|||
33213469|NCT01302847|100679657|FG006|Overall Study|Not able to get to clinic|0|||
33213470|NCT01302847|100679658|FG007|Overall Study|Not able to get to clinic|0|||
33213471|NCT01302847|100679651|FG000|Overall Study|Site closing|2|||
33213472|NCT01302847|100679652|FG001|Overall Study|Site closing|2|||
33544875|NCT04181788|101894677|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
33544876|NCT04181788|101894678|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
33544877|NCT04181788|101894679|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
33213473|NCT01302847|100679653|FG002|Overall Study|Site closing|0|||
33544878|NCT04181788|101894680|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
33616716|NCT00726232|102144412|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
33213474|NCT01302847|100679654|FG003|Overall Study|Site closing|0|||
33544879|NCT04181788|101894681|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
33544880|NCT04181788|101894682|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
33544881|NCT04181788|101894677|FG000|FOLLOW-UP|Other unspecified|0|||
33544882|NCT04181788|101894678|FG001|FOLLOW-UP|Other unspecified|1|||
33213475|NCT01302847|100679655|FG004|Overall Study|Site closing|0|||
33213476|NCT01302847|100679656|FG005|Overall Study|Site closing|0|||
33213477|NCT01302847|100679657|FG006|Overall Study|Site closing|0|||
33213478|NCT01302847|100679658|FG007|Overall Study|Site closing|0|||
33213479|NCT01302847|100679651|FG000|Overall Study|Withdrawal by Subject|1|||
33213480|NCT01302847|100679652|FG001|Overall Study|Withdrawal by Subject|0|||
33213481|NCT01302847|100679653|FG002|Overall Study|Withdrawal by Subject|0|||
33347339|NCT03529409|101160042|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
33347340|NCT03529409|101160040|FG000|Follow-up Assessment|Death|1|||
33347341|NCT03529409|101160041|FG001|Follow-up Assessment|Death|0|||
33347342|NCT03529409|101160042|FG002|Follow-up Assessment|Death|0|||
33347343|NCT03529409|101160040|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
33347344|NCT03529409|101160041|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
33347345|NCT03529409|101160042|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
33347346|NCT01551693|101160043|FG000|Overall Study|Disease Progression|1|||
33347347|NCT01551693|101160044|FG001|Overall Study|Disease Progression|0|||
33347348|NCT01551693|101160043|FG000|Overall Study|Adverse Event|0|||
33347349|NCT01551693|101160044|FG001|Overall Study|Adverse Event|1|||
33347350|NCT01551693|101160043|FG000|Overall Study|Withdrawal by Subject|0|||
33347351|NCT01551693|101160044|FG001|Overall Study|Withdrawal by Subject|1|||
33347352|NCT00818259|101160045|FG000|Part I|Withdrawal by Subject|1|||
33347353|NCT00818259|101160046|FG001|Part I|Withdrawal by Subject|0|||
33347354|NCT00818259|101160047|FG002|Part I|Withdrawal by Subject|0|||
33347355|NCT00818259|101160048|FG003|Part I|Withdrawal by Subject|0|||
33347356|NCT00818259|101160049|FG004|Part I|Withdrawal by Subject|0|||
33347357|NCT00818259|101160050|FG005|Part I|Withdrawal by Subject|0|||
33347358|NCT00818259|101160051|FG006|Part I|Withdrawal by Subject|0|||
33347359|NCT00818259|101160052|FG007|Part I|Withdrawal by Subject|0|||
33347360|NCT00818259|101160053|FG008|Part I|Withdrawal by Subject|0|||
33347361|NCT00818259|101160045|FG000|Part II|Physician Decision|0|||
33347362|NCT00818259|101160046|FG001|Part II|Physician Decision|0|||
33347363|NCT00818259|101160047|FG002|Part II|Physician Decision|1|||
33347364|NCT00818259|101160048|FG003|Part II|Physician Decision|0|||
33544883|NCT04181788|101894679|FG002|FOLLOW-UP|Other unspecified|0|||
33347365|NCT00818259|101160049|FG004|Part II|Physician Decision|0|||
33347366|NCT00818259|101160050|FG005|Part II|Physician Decision|0|||
33347367|NCT00818259|101160051|FG006|Part II|Physician Decision|0|||
33347368|NCT00818259|101160052|FG007|Part II|Physician Decision|0|||
33347369|NCT00818259|101160053|FG008|Part II|Physician Decision|0|||
33347370|NCT00818259|101160045|FG000|Part II|Lack of Efficacy|0|||
33347371|NCT00818259|101160046|FG001|Part II|Lack of Efficacy|0|||
33347372|NCT00818259|101160047|FG002|Part II|Lack of Efficacy|0|||
33347373|NCT00818259|101160048|FG003|Part II|Lack of Efficacy|1|||
33347374|NCT00818259|101160049|FG004|Part II|Lack of Efficacy|0|||
33347375|NCT00818259|101160050|FG005|Part II|Lack of Efficacy|0|||
33347376|NCT00818259|101160051|FG006|Part II|Lack of Efficacy|0|||
33347377|NCT00818259|101160052|FG007|Part II|Lack of Efficacy|0|||
33347378|NCT00818259|101160053|FG008|Part II|Lack of Efficacy|0|||
33347379|NCT00818259|101160045|FG000|Part II|Not Treated|0|||
33347380|NCT00818259|101160046|FG001|Part II|Not Treated|0|||
33347381|NCT00818259|101160047|FG002|Part II|Not Treated|0|||
33347382|NCT00818259|101160048|FG003|Part II|Not Treated|1|||
33347383|NCT00818259|101160049|FG004|Part II|Not Treated|0|||
33347384|NCT00818259|101160050|FG005|Part II|Not Treated|0|||
33347385|NCT00818259|101160051|FG006|Part II|Not Treated|0|||
33347386|NCT00818259|101160052|FG007|Part II|Not Treated|0|||
33347387|NCT00818259|101160053|FG008|Part II|Not Treated|0|||
33347388|NCT00818259|101160045|FG000|Part IV|Physician Decision|0|||
33347389|NCT00818259|101160046|FG001|Part IV|Physician Decision|0|||
33347390|NCT00818259|101160047|FG002|Part IV|Physician Decision|0|||
33347391|NCT00818259|101160048|FG003|Part IV|Physician Decision|0|||
33408772|NCT01733758|101386125|FG001|Overall Study|Protocol Violation|1|||
33408773|NCT01733758|101386126|FG002|Overall Study|Protocol Violation|2|||
33213482|NCT01302847|100679654|FG003|Overall Study|Withdrawal by Subject|0|||
33213483|NCT01302847|100679655|FG004|Overall Study|Withdrawal by Subject|1|||
33213484|NCT01302847|100679656|FG005|Overall Study|Withdrawal by Subject|0|||
33213485|NCT01302847|100679657|FG006|Overall Study|Withdrawal by Subject|0|||
33347392|NCT00818259|101160049|FG004|Part IV|Physician Decision|0|||
33347393|NCT00818259|101160050|FG005|Part IV|Physician Decision|1|||
33347394|NCT00818259|101160051|FG006|Part IV|Physician Decision|0|||
33408774|NCT01733758|101386127|FG003|Overall Study|Protocol Violation|2|||
33347395|NCT00818259|101160052|FG007|Part IV|Physician Decision|0|||
33347396|NCT00818259|101160053|FG008|Part IV|Physician Decision|0|||
33347397|NCT00818259|101160045|FG000|Part V|Adverse Event|0|||
33347398|NCT00818259|101160046|FG001|Part V|Adverse Event|0|||
33347399|NCT00818259|101160047|FG002|Part V|Adverse Event|0|||
33347400|NCT00818259|101160048|FG003|Part V|Adverse Event|0|||
33347401|NCT00818259|101160049|FG004|Part V|Adverse Event|0|||
33347402|NCT00818259|101160050|FG005|Part V|Adverse Event|0|||
33347403|NCT00818259|101160051|FG006|Part V|Adverse Event|0|||
33408775|NCT01733758|101386124|FG000|Overall Study|Non-compliance|1|||
33408776|NCT01733758|101386125|FG001|Overall Study|Non-compliance|0|||
33408777|NCT01733758|101386126|FG002|Overall Study|Non-compliance|0|||
33408778|NCT01733758|101386127|FG003|Overall Study|Non-compliance|0|||
33408779|NCT01733758|101386124|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
33408780|NCT01733758|101386125|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
33408781|NCT01733758|101386126|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
33408782|NCT01733758|101386127|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
33408783|NCT01733758|101386124|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
33408784|NCT01733758|101386125|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
33408785|NCT01733758|101386126|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
33408786|NCT01733758|101386127|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
33408787|NCT00727246|101386128|FG000|Overall Study|could not complete MRI|0|||
33408788|NCT00727246|101386129|FG001|Overall Study|could not complete MRI|1|||
33408789|NCT00727246|101386130|FG002|Overall Study|could not complete MRI|0|||
33408790|NCT00727246|101386131|FG003|Overall Study|could not complete MRI|1|||
33408791|NCT00727246|101386128|FG000|Overall Study|incidental finding|0|||
33408792|NCT00727246|101386129|FG001|Overall Study|incidental finding|0|||
33408793|NCT00727246|101386130|FG002|Overall Study|incidental finding|0|||
33408794|NCT00727246|101386131|FG003|Overall Study|incidental finding|1|||
33408795|NCT00727246|101386128|FG000|Overall Study|withdrawn|0|||
33408796|NCT00727246|101386129|FG001|Overall Study|withdrawn|0|||
33408797|NCT00727246|101386130|FG002|Overall Study|withdrawn|1|||
33408798|NCT00727246|101386131|FG003|Overall Study|withdrawn|0|||
33408799|NCT03237325|101386132|FG000|Overall Study|Lost to Follow-up|3|||
33408800|NCT03237325|101386133|FG001|Overall Study|Lost to Follow-up|5|||
33408801|NCT03237325|101386132|FG000|Overall Study|Physician Decision|2|||
33408802|NCT03237325|101386133|FG001|Overall Study|Physician Decision|4|||
33408803|NCT03237325|101386132|FG000|Overall Study|Withdrawal by Subject|9|||
33408804|NCT03237325|101386133|FG001|Overall Study|Withdrawal by Subject|12|||
33408805|NCT03237325|101386132|FG000|Overall Study|Noncompliance with Study Procedures|1|||
33408806|NCT03237325|101386133|FG001|Overall Study|Noncompliance with Study Procedures|1|||
33408807|NCT03237325|101386132|FG000|Overall Study|Termination by Sponsor|0|||
33408808|NCT03237325|101386133|FG001|Overall Study|Termination by Sponsor|1|||
33347404|NCT00818259|101160052|FG007|Part V|Adverse Event|1|||
33347405|NCT00818259|101160053|FG008|Part V|Adverse Event|0|||
33347406|NCT01290887|101160054|FG000|Overall Study|Adverse Event|6|||
33347407|NCT01290887|101160055|FG001|Overall Study|Adverse Event|11|||
33347408|NCT01290887|101160054|FG000|Overall Study|Lack of Efficacy|4|||
33347409|NCT01290887|101160055|FG001|Overall Study|Lack of Efficacy|5|||
33347410|NCT01290887|101160054|FG000|Overall Study|Withdrawal by Subject|26|||
33347411|NCT01290887|101160055|FG001|Overall Study|Withdrawal by Subject|32|||
33347412|NCT01290887|101160054|FG000|Overall Study|Protocol Violation|2|||
33347413|NCT01290887|101160055|FG001|Overall Study|Protocol Violation|1|||
33347414|NCT01290887|101160054|FG000|Overall Study|Lost to Follow-up|4|||
33347415|NCT01290887|101160055|FG001|Overall Study|Lost to Follow-up|4|||
33347416|NCT01290887|101160054|FG000|Overall Study|Non-compliance to study procedures|0|||
33347417|NCT01290887|101160055|FG001|Overall Study|Non-compliance to study procedures|1|||
33347418|NCT01290887|101160054|FG000|Overall Study|Non-compliance to study medications|1|||
33347419|NCT01290887|101160055|FG001|Overall Study|Non-compliance to study medications|0|||
33408809|NCT03237325|101386132|FG000|Overall Study|Reason other than described|0|||
33408810|NCT03237325|101386133|FG001|Overall Study|Reason other than described|2|||
33408811|NCT04668066|101386135|FG000|Part 1: Treatment Phase|Adverse Event|0|||
33408812|NCT04668066|101386136|FG001|Part 1: Treatment Phase|Adverse Event|0|||
33408813|NCT04668066|101386137|FG002|Part 1: Treatment Phase|Adverse Event|0|||
33408814|NCT04668066|101386138|FG003|Part 1: Treatment Phase|Adverse Event|0|||
33408815|NCT04668066|101386139|FG004|Part 1: Treatment Phase|Adverse Event|0|||
33408816|NCT04668066|101386140|FG005|Part 1: Treatment Phase|Adverse Event|0|||
33408817|NCT04668066|101386141|FG006|Part 1: Treatment Phase|Adverse Event|0|||
33408818|NCT04668066|101386142|FG007|Part 1: Treatment Phase|Adverse Event|0|||
33408819|NCT04668066|101386143|FG008|Part 1: Treatment Phase|Adverse Event|0|||
33408820|NCT04668066|101386144|FG009|Part 1: Treatment Phase|Adverse Event|0|||
33408821|NCT04668066|101386145|FG010|Part 1: Treatment Phase|Adverse Event|0|||
33408822|NCT04668066|101386146|FG011|Part 1: Treatment Phase|Adverse Event|1|||
33408823|NCT04668066|101386147|FG012|Part 1: Treatment Phase|Adverse Event|1|||
33408824|NCT04668066|101386148|FG013|Part 1: Treatment Phase|Adverse Event|0|||
33544884|NCT04181788|101894680|FG003|FOLLOW-UP|Other unspecified|0|||
33347420|NCT01290887|101160054|FG000|Overall Study|Sponsor closure of study|420|||
33408825|NCT04668066|101386149|FG014|Part 1: Treatment Phase|Adverse Event|0|||
33408826|NCT04668066|101386150|FG015|Part 1: Treatment Phase|Adverse Event|0|||
33408827|NCT04668066|101386151|FG016|Part 1: Treatment Phase|Adverse Event|0|||
33408828|NCT04668066|101386152|FG017|Part 1: Treatment Phase|Adverse Event|0|||
33408829|NCT04668066|101386153|FG018|Part 1: Treatment Phase|Adverse Event|0|||
33408830|NCT04668066|101386135|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
33544885|NCT04181788|101894681|FG004|FOLLOW-UP|Other unspecified|0|||
33544886|NCT04181788|101894682|FG005|FOLLOW-UP|Other unspecified|3|||
33213486|NCT01302847|100679658|FG007|Overall Study|Withdrawal by Subject|1|||
33213487|NCT01302847|100679651|FG000|Overall Study|Not willing to adhere to requirements|5|||
33213488|NCT01302847|100679652|FG001|Overall Study|Not willing to adhere to requirements|0|||
33213489|NCT01302847|100679653|FG002|Overall Study|Not willing to adhere to requirements|1|||
33213490|NCT01302847|100679654|FG003|Overall Study|Not willing to adhere to requirements|0|||
33213491|NCT01302847|100679655|FG004|Overall Study|Not willing to adhere to requirements|0|||
33347421|NCT01290887|101160055|FG001|Overall Study|Sponsor closure of study|476|||
33347422|NCT01290887|101160054|FG000|Overall Study|Other|3|||
33544887|NCT04181788|101894677|FG000|FOLLOW-UP|Ongoing|0|||
33544888|NCT04181788|101894678|FG001|FOLLOW-UP|Ongoing|0|||
33544889|NCT04181788|101894679|FG002|FOLLOW-UP|Ongoing|1|||
33544890|NCT04181788|101894680|FG003|FOLLOW-UP|Ongoing|3|||
33544891|NCT04181788|101894681|FG004|FOLLOW-UP|Ongoing|2|||
33544892|NCT04181788|101894682|FG005|FOLLOW-UP|Ongoing|2|||
33544893|NCT01541748|101894683|FG000|Overall Study|Lost to Follow-up|17|||
33544894|NCT01541748|101894683|FG000|Overall Study|Moved out of state|1|||
33544895|NCT01541748|101894683|FG000|Overall Study|Withdrawal by Subject|7|||
33544896|NCT01541748|101894683|FG000|Overall Study|Screen failure|5|||
33544897|NCT01541748|101894683|FG000|Overall Study|Did not receive study device|1|||
33544898|NCT00484159|101894693|FG000|Overall Study|Lost to Follow-up|1|||
33544899|NCT00484159|101894694|FG001|Overall Study|Lost to Follow-up|1|||
33544900|NCT00484159|101894695|FG002|Overall Study|Lost to Follow-up|0|||
33544901|NCT02300610|101894698|FG000|Overall Study|Withdrawal by Subject|1|||
33544902|NCT02300610|101894699|FG001|Overall Study|Withdrawal by Subject|0|||
33544903|NCT02300610|101894700|FG002|Overall Study|Withdrawal by Subject|1|||
33544904|NCT04470427|101894703|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
33544905|NCT04470427|101894704|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
33544906|NCT04470427|101894705|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
33544907|NCT04470427|101894706|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
33544908|NCT04470427|101894707|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
33544909|NCT04470427|101894708|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
33544910|NCT04470427|101894703|FG000|Part B :Open-label|Other than specified|0|||
33544911|NCT04470427|101894704|FG001|Part B :Open-label|Other than specified|0|||
33544912|NCT04470427|101894705|FG002|Part B :Open-label|Other than specified|788|||
33544913|NCT04470427|101894706|FG003|Part B :Open-label|Other than specified|0|||
33544914|NCT04470427|101894707|FG004|Part B :Open-label|Other than specified|523|||
33616717|NCT00726232|102144413|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
33616718|NCT00726232|102144414|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
33213492|NCT01302847|100679656|FG005|Overall Study|Not willing to adhere to requirements|0|||
33213493|NCT01302847|100679657|FG006|Overall Study|Not willing to adhere to requirements|0|||
33347423|NCT01290887|101160055|FG001|Overall Study|Other|6|||
33347424|NCT00045032|101160058|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
33347425|NCT00045032|101160059|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
33347426|NCT00045032|101160060|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
33347427|NCT00045032|101160058|FG000|Overall Study|Death|22|||
33347428|NCT00045032|101160059|FG001|Overall Study|Death|24|||
33347429|NCT00045032|101160060|FG002|Overall Study|Death|17|||
33347430|NCT00045032|101160058|FG000|Overall Study|Insufficient Therapeutic Response|542|||
33347431|NCT00045032|101160059|FG001|Overall Study|Insufficient Therapeutic Response|437|||
33347432|NCT00045032|101160060|FG002|Overall Study|Insufficient Therapeutic Response|445|||
33347433|NCT00045032|101160058|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
33408831|NCT04668066|101386136|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
33544915|NCT04470427|101894708|FG005|Part B :Open-label|Other than specified|0|||
33544916|NCT04470427|101894703|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
33544917|NCT04470427|101894704|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
33544918|NCT04470427|101894705|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
33544919|NCT04470427|101894706|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
33544920|NCT04470427|101894707|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
33544921|NCT04470427|101894708|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
33544922|NCT04470427|101894703|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
33408832|NCT04668066|101386137|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
33408833|NCT04668066|101386138|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
33408834|NCT04668066|101386139|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
33408835|NCT04668066|101386140|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
33408836|NCT04668066|101386141|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
33408837|NCT04668066|101386142|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
33408838|NCT04668066|101386143|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
33408839|NCT04668066|101386144|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
33408840|NCT04668066|101386145|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
33408841|NCT04668066|101386146|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
33408842|NCT04668066|101386147|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
33616719|NCT00726232|102144415|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
33616720|NCT00726232|102144416|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
33616721|NCT00726232|102144409|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
33213494|NCT01302847|100679658|FG007|Overall Study|Not willing to adhere to requirements|2|||
33213495|NCT01302847|100679651|FG000|Overall Study|Site unable to contact participant|2|||
33213496|NCT01302847|100679652|FG001|Overall Study|Site unable to contact participant|1|||
33213497|NCT01302847|100679653|FG002|Overall Study|Site unable to contact participant|0|||
33213498|NCT01302847|100679654|FG003|Overall Study|Site unable to contact participant|0|||
33213499|NCT01302847|100679655|FG004|Overall Study|Site unable to contact participant|0|||
33213500|NCT01302847|100679656|FG005|Overall Study|Site unable to contact participant|0|||
33213501|NCT01302847|100679657|FG006|Overall Study|Site unable to contact participant|2|||
33213502|NCT01302847|100679658|FG007|Overall Study|Site unable to contact participant|0|||
33213503|NCT00686881|100679660|FG000|Overall Study|Withdrawal by Subject|11|||
33213504|NCT00686881|100679661|FG001|Overall Study|Withdrawal by Subject|18|||
33213505|NCT00686881|100679660|FG000|Overall Study|Lost to Follow-up|0|||
33213506|NCT00686881|100679661|FG001|Overall Study|Lost to Follow-up|1|||
33213507|NCT00686881|100679660|FG000|Overall Study|Treatment-related adverse event|10|||
33213508|NCT00686881|100679661|FG001|Overall Study|Treatment-related adverse event|9|||
33213509|NCT00686881|100679660|FG000|Overall Study|Met discontinuation criteria|5|||
33213510|NCT00686881|100679661|FG001|Overall Study|Met discontinuation criteria|0|||
33213511|NCT00686881|100679660|FG000|Overall Study|Onset of malignant tumor|11|||
33213512|NCT00686881|100679661|FG001|Overall Study|Onset of malignant tumor|11|||
33213513|NCT00686881|100679660|FG000|Overall Study|Lack of Efficacy|4|||
33213514|NCT00686881|100679661|FG001|Overall Study|Lack of Efficacy|3|||
33213515|NCT00686881|100679660|FG000|Overall Study|Physician Decision|1|||
33408843|NCT04668066|101386148|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
33408844|NCT04668066|101386149|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
33408845|NCT04668066|101386150|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
33408846|NCT04668066|101386151|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
33408847|NCT04668066|101386152|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
33544923|NCT04470427|101894704|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
33544924|NCT04470427|101894705|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
33544925|NCT04470427|101894706|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
33544926|NCT04470427|101894707|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
33544927|NCT04470427|101894708|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
33544928|NCT02318940|101894709|FG000|Overall Study|lost the record|1|||
33544929|NCT02318940|101894710|FG001|Overall Study|lost the record|0|||
33544930|NCT00849056|101894711|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
33544931|NCT00849056|101894712|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
33544932|NCT00849056|101894711|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
33544933|NCT00849056|101894712|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
33544934|NCT00849056|101894711|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
33544935|NCT00849056|101894712|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
33544936|NCT00849056|101894711|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
33544937|NCT00849056|101894712|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
33544938|NCT00849056|101894711|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
33544939|NCT00849056|101894712|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
33544940|NCT00849056|101894711|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
33544941|NCT00849056|101894712|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
33544942|NCT00849056|101894711|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
33544943|NCT00849056|101894712|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
33544944|NCT00849056|101894711|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
33544945|NCT00849056|101894712|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
33544946|NCT00849056|101894711|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
33544947|NCT00849056|101894712|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
33544948|NCT00849056|101894711|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
33544949|NCT00849056|101894712|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
33544950|NCT00849056|101894711|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
33544951|NCT00849056|101894712|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
33544952|NCT00849056|101894711|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
33544953|NCT00849056|101894712|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
33213516|NCT00686881|100679661|FG001|Overall Study|Physician Decision|0|||
33213517|NCT00686881|100679660|FG000|Overall Study|Circumstances of site|1|||
33213518|NCT00686881|100679661|FG001|Overall Study|Circumstances of site|1|||
33213519|NCT00686881|100679660|FG000|Overall Study|Did not meet protocol eligibility|1|||
33213520|NCT00686881|100679661|FG001|Overall Study|Did not meet protocol eligibility|0|||
33213521|NCT00686881|100679660|FG000|Overall Study|Irregular visits|1|||
33213522|NCT00686881|100679661|FG001|Overall Study|Irregular visits|0|||
33213523|NCT00686881|100679660|FG000|Overall Study|Study discontinuation|35|||
33213524|NCT00686881|100679661|FG001|Overall Study|Study discontinuation|32|||
33213525|NCT00686881|100679660|FG000|Overall Study|Never received study drug|2|||
33213526|NCT00686881|100679661|FG001|Overall Study|Never received study drug|6|||
33213527|NCT00447057|100679662|FG000|Overall Study|Adverse Event|4|||
33213528|NCT00447057|100679663|FG001|Overall Study|Adverse Event|10|||
33408848|NCT04668066|101386153|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
33213529|NCT00447057|100679664|FG002|Overall Study|Adverse Event|0|||
33213530|NCT00447057|100679665|FG003|Overall Study|Adverse Event|3|||
33213531|NCT00447057|100679662|FG000|Overall Study|Death due to study disease|6|||
33213532|NCT00447057|100679663|FG001|Overall Study|Death due to study disease|4|||
33213533|NCT00447057|100679664|FG002|Overall Study|Death due to study disease|1|||
33213534|NCT00447057|100679665|FG003|Overall Study|Death due to study disease|1|||
33213535|NCT00447057|100679662|FG000|Overall Study|Lost to Follow-up|0|||
33213536|NCT00447057|100679663|FG001|Overall Study|Lost to Follow-up|1|||
33213537|NCT00447057|100679664|FG002|Overall Study|Lost to Follow-up|0|||
33213538|NCT00447057|100679665|FG003|Overall Study|Lost to Follow-up|0|||
33213539|NCT00447057|100679662|FG000|Overall Study|Entry criteria not met|1|||
33408849|NCT04668066|101386135|FG000|Part 1: Treatment Phase|Other|0|||
33408850|NCT04668066|101386136|FG001|Part 1: Treatment Phase|Other|0|||
33408851|NCT04668066|101386137|FG002|Part 1: Treatment Phase|Other|0|||
33408852|NCT04668066|101386138|FG003|Part 1: Treatment Phase|Other|0|||
33408853|NCT04668066|101386139|FG004|Part 1: Treatment Phase|Other|0|||
33408854|NCT04668066|101386140|FG005|Part 1: Treatment Phase|Other|0|||
33408855|NCT04668066|101386141|FG006|Part 1: Treatment Phase|Other|0|||
33408856|NCT04668066|101386142|FG007|Part 1: Treatment Phase|Other|0|||
33408857|NCT04668066|101386143|FG008|Part 1: Treatment Phase|Other|0|||
33408858|NCT04668066|101386144|FG009|Part 1: Treatment Phase|Other|0|||
33408859|NCT04668066|101386145|FG010|Part 1: Treatment Phase|Other|0|||
33408860|NCT04668066|101386146|FG011|Part 1: Treatment Phase|Other|1|||
33408861|NCT04668066|101386147|FG012|Part 1: Treatment Phase|Other|0|||
33408862|NCT04668066|101386148|FG013|Part 1: Treatment Phase|Other|0|||
33408863|NCT04668066|101386149|FG014|Part 1: Treatment Phase|Other|0|||
33408864|NCT04668066|101386150|FG015|Part 1: Treatment Phase|Other|0|||
33544954|NCT00849056|101894711|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
33544955|NCT00849056|101894712|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
33544956|NCT00849056|101894711|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
33544957|NCT00849056|101894712|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
33544958|NCT00849056|101894711|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
33544959|NCT00849056|101894712|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
33544960|NCT00849056|101894711|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
33544961|NCT00849056|101894712|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
33544962|NCT00596635|101894713|FG000|Overall Study|Lost to Follow-up|0|||
33544963|NCT00596635|101894714|FG001|Overall Study|Lost to Follow-up|2|||
33544964|NCT00596635|101894715|FG002|Overall Study|Lost to Follow-up|0|||
33544965|NCT00596635|101894713|FG000|Overall Study|Treatment for symptomatic UTI|4|||
33544966|NCT00596635|101894714|FG001|Overall Study|Treatment for symptomatic UTI|6|||
33213540|NCT00447057|100679663|FG001|Overall Study|Entry criteria not met|1|||
33213541|NCT00447057|100679664|FG002|Overall Study|Entry criteria not met|0|||
33213542|NCT00447057|100679665|FG003|Overall Study|Entry criteria not met|0|||
33408865|NCT04668066|101386151|FG016|Part 1: Treatment Phase|Other|0|||
33408866|NCT04668066|101386152|FG017|Part 1: Treatment Phase|Other|0|||
33408867|NCT04668066|101386153|FG018|Part 1: Treatment Phase|Other|0|||
33213543|NCT00447057|100679662|FG000|Overall Study|Protocol Violation|0|||
33213544|NCT00447057|100679663|FG001|Overall Study|Protocol Violation|1|||
33213545|NCT00447057|100679664|FG002|Overall Study|Protocol Violation|0|||
33408868|NCT04668066|101386135|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408869|NCT04668066|101386136|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408870|NCT04668066|101386137|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408871|NCT04668066|101386138|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408872|NCT04668066|101386139|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408873|NCT04668066|101386140|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408874|NCT04668066|101386141|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408875|NCT04668066|101386142|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408876|NCT04668066|101386143|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408877|NCT04668066|101386144|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408878|NCT04668066|101386145|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408879|NCT04668066|101386146|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408880|NCT04668066|101386147|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
33408881|NCT04668066|101386148|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408882|NCT04668066|101386149|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408883|NCT04668066|101386150|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
33408884|NCT04668066|101386151|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408885|NCT04668066|101386152|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408886|NCT04668066|101386153|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
33408887|NCT04668066|101386135|FG000|Part 1: Follow-Up|Adverse Event|0|||
33408888|NCT04668066|101386136|FG001|Part 1: Follow-Up|Adverse Event|0|||
33408889|NCT04668066|101386137|FG002|Part 1: Follow-Up|Adverse Event|0|||
33544967|NCT00596635|101894715|FG002|Overall Study|Treatment for symptomatic UTI|3|||
33544968|NCT00596635|101894713|FG000|Overall Study|Hip fracture|2|||
33544969|NCT00596635|101894714|FG001|Overall Study|Hip fracture|3|||
33544970|NCT00596635|101894715|FG002|Overall Study|Hip fracture|3|||
33544971|NCT00596635|101894713|FG000|Overall Study|Could not provide urine specimen|1|||
33544972|NCT00596635|101894714|FG001|Overall Study|Could not provide urine specimen|2|||
33544973|NCT00596635|101894715|FG002|Overall Study|Could not provide urine specimen|2|||
33616722|NCT00726232|102144410|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
33616723|NCT00726232|102144411|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
33616724|NCT00726232|102144412|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
33616725|NCT00726232|102144413|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
33616726|NCT00726232|102144414|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
33616727|NCT00726232|102144415|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
33544974|NCT00941928|101894718|FG000|Overall Study|Withdrawal by Subject|1|||
33544975|NCT00941928|101894718|FG000|Overall Study|Disease Progression|1|||
33544976|NCT01631188|101894722|FG000|Overall Study|Physician Decision|75|||
33544977|NCT00937950|101894725|FG000|Overall Study|Withdrawal by Subject|23|||
33544978|NCT00937950|101894725|FG000|Overall Study|Migrated/moved from study area|27|||
33544979|NCT00937950|101894725|FG000|Overall Study|Lost to Follow-up|144|||
33347434|NCT00045032|101160059|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
33347435|NCT00045032|101160060|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
33347436|NCT00045032|101160058|FG000|Overall Study|Other Protocol Violation|2|||
33347437|NCT00045032|101160059|FG001|Overall Study|Other Protocol Violation|0|||
33616728|NCT00726232|102144416|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
33616729|NCT00726232|102144409|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
33616730|NCT00726232|102144410|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
33347438|NCT00045032|101160060|FG002|Overall Study|Other Protocol Violation|1|||
33347439|NCT00045032|101160058|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
33347440|NCT00045032|101160059|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
33544980|NCT00937950|101894725|FG000|Overall Study|Missing confirmed|4|||
33347441|NCT00045032|101160060|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
33544981|NCT00937950|101894725|FG000|Overall Study|Other|18|||
33544982|NCT00858988|101894731|FG000|Analysis|Lactulose unable to be detected in urine|2|||
33544983|NCT00858988|101894732|FG001|Analysis|Lactulose unable to be detected in urine|1|||
33544984|NCT00741611|101894733|FG000|Overall Study|Death|0|||
33544985|NCT00741611|101894734|FG001|Overall Study|Death|0|||
33544986|NCT00741611|101894735|FG002|Overall Study|Death|1|||
33544987|NCT00741611|101894733|FG000|Overall Study|Withdrawal by Subject|0|||
33544988|NCT00741611|101894734|FG001|Overall Study|Withdrawal by Subject|2|||
33544989|NCT00741611|101894735|FG002|Overall Study|Withdrawal by Subject|2|||
33544990|NCT02566005|101894740|FG000|Overall Study|vaginal bleeding|0|||
33544991|NCT02566005|101894741|FG001|Overall Study|vaginal bleeding|1|||
33544992|NCT02566005|101894740|FG000|Overall Study|received foley|8|||
33544993|NCT02566005|101894741|FG001|Overall Study|received foley|0|||
33544994|NCT02566005|101894740|FG000|Overall Study|did not receive foley|0|||
33544995|NCT02566005|101894741|FG001|Overall Study|did not receive foley|1|||
33544996|NCT02566005|101894740|FG000|Overall Study|labor after randomization|0|||
33544997|NCT02566005|101894741|FG001|Overall Study|labor after randomization|4|||
33544998|NCT00423605|101894742|FG000|Overall Study|Adverse Event|129|||
33544999|NCT00423605|101894742|FG000|Overall Study|Withdrawal by Subject|36|||
33545000|NCT00423605|101894742|FG000|Overall Study|Lost to Follow-up|15|||
33545001|NCT00423605|101894742|FG000|Overall Study|Lack of Efficacy|38|||
33545002|NCT00423605|101894742|FG000|Overall Study|Sponsor Decision|3|||
33545003|NCT00423605|101894742|FG000|Overall Study|Physician Decision|8|||
33545004|NCT00423605|101894742|FG000|Overall Study|Protocol Violation|7|||
33545005|NCT00423605|101894742|FG000|Overall Study|Not one of the pre-specified options|5|||
33545006|NCT00089648|101894743|FG000|Overall Study|Adverse Event|7|||
33545007|NCT00089648|101894743|FG000|Overall Study|Withdrawal by Subject|1|||
33545008|NCT00089648|101894743|FG000|Overall Study|Lack of Efficacy|33|||
33545009|NCT03440320|101894750|FG000|Overall Study|Withdrawal by Subject|0|||
33545010|NCT03440320|101894751|FG001|Overall Study|Withdrawal by Subject|1|||
33545011|NCT02572167|101894752|FG000|Overall Study|Withdrawal by Subject|0|||
33545012|NCT02572167|101894753|FG001|Overall Study|Withdrawal by Subject|3|||
33545013|NCT02572167|101894754|FG002|Overall Study|Withdrawal by Subject|0|||
33545014|NCT02572167|101894752|FG000|Overall Study|Lost to Follow-up|2|||
33545015|NCT02572167|101894753|FG001|Overall Study|Lost to Follow-up|5|||
33545016|NCT02572167|101894754|FG002|Overall Study|Lost to Follow-up|3|||
33545017|NCT02572167|101894752|FG000|Overall Study|Death|0|||
33545018|NCT02572167|101894753|FG001|Overall Study|Death|8|||
33545019|NCT02572167|101894754|FG002|Overall Study|Death|3|||
33545020|NCT02572167|101894752|FG000|Overall Study|Did not meet inclusion criteria|0|||
33545021|NCT02572167|101894753|FG001|Overall Study|Did not meet inclusion criteria|0|||
33545022|NCT02572167|101894754|FG002|Overall Study|Did not meet inclusion criteria|1|||
33545023|NCT02572167|101894752|FG000|Overall Study|Study closure by Sponsor|4|||
33545024|NCT02572167|101894753|FG001|Overall Study|Study closure by Sponsor|40|||
33545025|NCT02572167|101894754|FG002|Overall Study|Study closure by Sponsor|24|||
33545026|NCT00424008|101894755|FG000|Overall Study|Adverse Event|8|||
33545027|NCT00424008|101894756|FG001|Overall Study|Adverse Event|6|||
33545028|NCT00424008|101894755|FG000|Overall Study|Lack of Efficacy|40|||
33545029|NCT00424008|101894756|FG001|Overall Study|Lack of Efficacy|34|||
33545030|NCT00424008|101894755|FG000|Overall Study|Lost to Follow-up|1|||
33545031|NCT00424008|101894756|FG001|Overall Study|Lost to Follow-up|2|||
33545032|NCT00424008|101894755|FG000|Overall Study|Withdrawal by Subject|5|||
33545033|NCT00424008|101894756|FG001|Overall Study|Withdrawal by Subject|8|||
33545034|NCT00424008|101894755|FG000|Overall Study|Noncompliance with protocol|13|||
33545035|NCT00424008|101894756|FG001|Overall Study|Noncompliance with protocol|7|||
33545036|NCT00424008|101894755|FG000|Overall Study|Did not meet protocol eligibility|16|||
33545037|NCT00424008|101894756|FG001|Overall Study|Did not meet protocol eligibility|21|||
33616731|NCT00726232|102144411|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
33616732|NCT00726232|102144412|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
33616733|NCT00726232|102144413|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
33616734|NCT00726232|102144414|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
33616735|NCT00726232|102144415|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
33616736|NCT00726232|102144416|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
33616737|NCT00726232|102144409|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
33545038|NCT00424008|101894755|FG000|Overall Study|Administrative|266|||
33545039|NCT00424008|101894756|FG001|Overall Study|Administrative|257|||
33545040|NCT02934178|101894757|FG000|Received Vaccination 2|Death|0|||
33545041|NCT02934178|101894758|FG001|Received Vaccination 2|Death|1|||
33545042|NCT02934178|101894757|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
33545043|NCT02934178|101894758|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
33545044|NCT00549055|101894761|FG000|Overall Study|Adverse Event|4|||
33545045|NCT00549055|101894761|FG000|Overall Study|Lack of Efficacy|18|||
33545046|NCT00549055|101894761|FG000|Overall Study|Stabilization|5|||
33545047|NCT00549055|101894761|FG000|Overall Study|Progression to fibrosis|2|||
33616738|NCT00726232|102144410|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
33616739|NCT00726232|102144411|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
33616740|NCT00726232|102144412|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
33616741|NCT00726232|102144413|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
33616742|NCT00726232|102144414|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
33616743|NCT00726232|102144415|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
33616744|NCT00726232|102144416|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
33616745|NCT00726232|102144409|FG000|Expansion Phase|Death|0|||
33616746|NCT00726232|102144410|FG001|Expansion Phase|Death|0|||
33616747|NCT00726232|102144411|FG002|Expansion Phase|Death|0|||
33616748|NCT00726232|102144412|FG003|Expansion Phase|Death|0|||
33616749|NCT00726232|102144413|FG004|Expansion Phase|Death|0|||
33616750|NCT00726232|102144414|FG005|Expansion Phase|Death|0|||
33616751|NCT00726232|102144415|FG006|Expansion Phase|Death|0|||
33616752|NCT00726232|102144416|FG007|Expansion Phase|Death|1|||
33616753|NCT00726232|102144409|FG000|Expansion Phase|Adverse Event|0|||
33616754|NCT00726232|102144410|FG001|Expansion Phase|Adverse Event|0|||
33545048|NCT00549055|101894761|FG000|Overall Study|Decrease of size|1|||
33213546|NCT00447057|100679665|FG003|Overall Study|Protocol Violation|0|||
33213547|NCT00447057|100679662|FG000|Overall Study|Withdrawal by Subject|4|||
33545049|NCT00549055|101894761|FG000|Overall Study|Active choroidal neovascula increased|1|||
33545050|NCT00549055|101894761|FG000|Overall Study|Vitreous hemorrhage|1|||
33545051|NCT00549055|101894761|FG000|Overall Study|Growth choroidal neovascularisation|1|||
33545052|NCT00549055|101894761|FG000|Overall Study|Choroidal neovascularization|1|||
33545053|NCT00549055|101894761|FG000|Overall Study|Very low visual acuity (VA)|1|||
33545054|NCT02309359|101894762|FG000|Overall Study|Adverse Event|4|||
33545055|NCT02309359|101894763|FG001|Overall Study|Adverse Event|5|||
33545056|NCT02309359|101894764|FG002|Overall Study|Adverse Event|5|||
33545057|NCT02309359|101894765|FG003|Overall Study|Adverse Event|4|||
33545058|NCT02309359|101894766|FG004|Overall Study|Adverse Event|4|||
33545059|NCT02309359|101894762|FG000|Overall Study|Death|1|||
33545060|NCT02309359|101894763|FG001|Overall Study|Death|0|||
33545061|NCT02309359|101894764|FG002|Overall Study|Death|0|||
33545062|NCT02309359|101894765|FG003|Overall Study|Death|0|||
33545063|NCT02309359|101894766|FG004|Overall Study|Death|0|||
33545064|NCT02309359|101894762|FG000|Overall Study|Withdrawal by Subject|2|||
33545065|NCT02309359|101894763|FG001|Overall Study|Withdrawal by Subject|2|||
33545066|NCT02309359|101894764|FG002|Overall Study|Withdrawal by Subject|4|||
33545067|NCT02309359|101894765|FG003|Overall Study|Withdrawal by Subject|4|||
33545068|NCT02309359|101894766|FG004|Overall Study|Withdrawal by Subject|0|||
33545069|NCT02309359|101894762|FG000|Overall Study|Lack of Efficacy|3|||
33545070|NCT02309359|101894763|FG001|Overall Study|Lack of Efficacy|1|||
33545071|NCT02309359|101894764|FG002|Overall Study|Lack of Efficacy|0|||
33545072|NCT02309359|101894765|FG003|Overall Study|Lack of Efficacy|0|||
33545073|NCT02309359|101894766|FG004|Overall Study|Lack of Efficacy|3|||
33545074|NCT02309359|101894762|FG000|Overall Study|Lost to Follow-up|0|||
33545075|NCT02309359|101894763|FG001|Overall Study|Lost to Follow-up|0|||
33545076|NCT02309359|101894764|FG002|Overall Study|Lost to Follow-up|0|||
33545077|NCT02309359|101894765|FG003|Overall Study|Lost to Follow-up|1|||
33545078|NCT02309359|101894766|FG004|Overall Study|Lost to Follow-up|0|||
33545079|NCT02309359|101894762|FG000|Overall Study|Other|2|||
33545080|NCT02309359|101894763|FG001|Overall Study|Other|0|||
33545081|NCT02309359|101894764|FG002|Overall Study|Other|2|||
33545082|NCT02309359|101894765|FG003|Overall Study|Other|3|||
33545083|NCT02309359|101894766|FG004|Overall Study|Other|2|||
33545084|NCT00324155|101894769|FG000|Enrolled and Randomized|No longer met study criteria|3|||
33545085|NCT00324155|101894770|FG001|Enrolled and Randomized|No longer met study criteria|0|||
33545086|NCT00324155|101894769|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
33545087|NCT00324155|101894770|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
33545088|NCT00324155|101894769|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
33545089|NCT00324155|101894770|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
33545090|NCT00324155|101894769|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
33545091|NCT00324155|101894770|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
33545092|NCT00324155|101894769|FG000|Received Treatment in Induction Phase|Death|8|||
33616755|NCT00726232|102144411|FG002|Expansion Phase|Adverse Event|0|||
33545093|NCT00324155|101894770|FG001|Received Treatment in Induction Phase|Death|15|||
33616756|NCT00726232|102144412|FG003|Expansion Phase|Adverse Event|0|||
33616757|NCT00726232|102144413|FG004|Expansion Phase|Adverse Event|0|||
33545094|NCT00324155|101894769|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
33545095|NCT00324155|101894770|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
33616758|NCT00726232|102144414|FG005|Expansion Phase|Adverse Event|0|||
33616759|NCT00726232|102144415|FG006|Expansion Phase|Adverse Event|6|||
33616760|NCT00726232|102144416|FG007|Expansion Phase|Adverse Event|11|||
33616761|NCT00726232|102144409|FG000|Expansion Phase|Withdrawal by Subject|0|||
33616762|NCT00726232|102144410|FG001|Expansion Phase|Withdrawal by Subject|0|||
33616763|NCT00726232|102144411|FG002|Expansion Phase|Withdrawal by Subject|0|||
33213548|NCT00447057|100679663|FG001|Overall Study|Withdrawal by Subject|5|||
33545096|NCT00324155|101894769|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
33545097|NCT00324155|101894770|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
33545098|NCT00324155|101894769|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
33545099|NCT00324155|101894770|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
33545100|NCT00324155|101894769|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
33545101|NCT00324155|101894770|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
33545102|NCT00324155|101894769|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
33545103|NCT00324155|101894770|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
33545104|NCT00324155|101894769|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
33545105|NCT00324155|101894770|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
33545106|NCT00324155|101894769|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
33545107|NCT00324155|101894770|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
33545108|NCT00324155|101894769|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
33545109|NCT00324155|101894770|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
33545110|NCT00324155|101894769|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
33545111|NCT00324155|101894770|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
33545112|NCT00324155|101894769|FG000|Follow-up Phase|On-going participants still on drug|11|||
33545113|NCT00324155|101894770|FG001|Follow-up Phase|On-going participants still on drug|6|||
33545114|NCT01829347|101894771|FG000|VTI-210|Death|5|||
33545115|NCT01829347|101894772|FG001|VTI-210|Death|3|||
33545116|NCT01829347|101894771|FG000|VTI-210|Withdrawal by Subject|1|||
33545117|NCT01829347|101894772|FG001|VTI-210|Withdrawal by Subject|0|||
33545118|NCT01829347|101894771|FG000|VTI-210E|Death|2|||
33545119|NCT01829347|101894772|FG001|VTI-210E|Death|1|||
33545120|NCT01829347|101894771|FG000|VTI-210E|Study terminated prematurely|1|||
33545121|NCT01829347|101894772|FG001|VTI-210E|Study terminated prematurely|5|||
33545122|NCT00481676|101894775|FG000|Overall Study|Adverse Event|0|||
33545123|NCT00481676|101894776|FG001|Overall Study|Adverse Event|1|||
33545124|NCT00481676|101894775|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33545125|NCT00481676|101894776|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
33545126|NCT00481676|101894775|FG000|Overall Study|Administrative problem|1|||
33545127|NCT00481676|101894776|FG001|Overall Study|Administrative problem|0|||
33545128|NCT02811159|101894781|FG000|Treatment Course 1|Lost to Follow-up|1|||
33545129|NCT03407482|101894782|FG000|Overall Study|Adverse Event|12|||
33545130|NCT03407482|101894782|FG000|Overall Study|Disease Relapse|1|||
33545131|NCT03407482|101894782|FG000|Overall Study|Lost to Follow-up|1|||
33545132|NCT03407482|101894782|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33545133|NCT03407482|101894782|FG000|Overall Study|Pregnancy|2|||
33545134|NCT03407482|101894782|FG000|Overall Study|Protocol Violation|1|||
33545135|NCT03407482|101894782|FG000|Overall Study|Study Terminated By Sponsor|106|||
33545136|NCT03407482|101894782|FG000|Overall Study|Withdrawal by Subject|6|||
33545137|NCT03407482|101894782|FG000|Overall Study|Data Entry Error|1|||
33545138|NCT00548327|101898488|FG000|Overall Study|Adverse Event|0|||
33213549|NCT00447057|100679664|FG002|Overall Study|Withdrawal by Subject|1|||
33347442|NCT00045032|101160058|FG000|Overall Study|Failure to Return|57|||
33347443|NCT00045032|101160059|FG001|Overall Study|Failure to Return|62|||
33347444|NCT00045032|101160060|FG002|Overall Study|Failure to Return|61|||
33347445|NCT00045032|101160058|FG000|Overall Study|Other|93|||
33347446|NCT00045032|101160059|FG001|Overall Study|Other|84|||
33545139|NCT00548327|101898489|FG001|Overall Study|Adverse Event|1|||
33545140|NCT00998946|101898490|FG000|Overall Study|Lost to Follow-up|1|||
33545141|NCT00998946|101898490|FG000|Overall Study|Withdrawal by Subject|1|||
33545142|NCT00998946|101898490|FG000|Overall Study|Death|2|||
33213550|NCT00447057|100679665|FG003|Overall Study|Withdrawal by Subject|1|||
33347447|NCT00045032|101160060|FG002|Overall Study|Other|105|||
33213551|NCT00447057|100679662|FG000|Overall Study|Physician Decision|9|||
33213552|NCT00447057|100679663|FG001|Overall Study|Physician Decision|6|||
33213553|NCT00447057|100679664|FG002|Overall Study|Physician Decision|3|||
33213554|NCT00447057|100679665|FG003|Overall Study|Physician Decision|1|||
33213555|NCT00447057|100679662|FG000|Overall Study|Sponsor decision|1|||
33213556|NCT00447057|100679663|FG001|Overall Study|Sponsor decision|1|||
33213557|NCT00447057|100679664|FG002|Overall Study|Sponsor decision|0|||
33213558|NCT00447057|100679665|FG003|Overall Study|Sponsor decision|0|||
33213559|NCT00447057|100679662|FG000|Overall Study|Progressive disease|58|||
33213560|NCT00447057|100679663|FG001|Overall Study|Progressive disease|43|||
33213561|NCT00447057|100679664|FG002|Overall Study|Progressive disease|13|||
33213562|NCT00447057|100679665|FG003|Overall Study|Progressive disease|18|||
33213563|NCT00447057|100679662|FG000|Overall Study|Death due to adverse event|0|||
33213564|NCT00447057|100679663|FG001|Overall Study|Death due to adverse event|0|||
33213565|NCT00447057|100679664|FG002|Overall Study|Death due to adverse event|1|||
33213566|NCT00447057|100679665|FG003|Overall Study|Death due to adverse event|2|||
33213567|NCT00447057|100679662|FG000|Overall Study|Death, study drug related|0|||
33213568|NCT00447057|100679663|FG001|Overall Study|Death, study drug related|1|||
33213569|NCT00447057|100679664|FG002|Overall Study|Death, study drug related|0|||
33213570|NCT00447057|100679665|FG003|Overall Study|Death, study drug related|0|||
33213571|NCT03213158|100679668|FG000|Overall Study|Withdrawal by Subject|1|||
33213572|NCT03213158|100679668|FG000|Overall Study|Physician Decision|2|||
33213573|NCT05045625|100679669|FG000|Overall Study|Lost to Follow-up|3|||
33213574|NCT03178266|100679670|FG000|Overall Study|Death|0|||
33213575|NCT03178266|100679671|FG001|Overall Study|Death|1|||
33213576|NCT03178266|100679670|FG000|Overall Study|Disont. Early|0|||
33545143|NCT00998946|101898490|FG000|Overall Study|Reason Unspecified|3|||
33545144|NCT00998946|101898490|FG000|Overall Study|Enrolled but not Dosed|2|||
33545145|NCT00303186|101898493|FG000|Overall Study|Other|52|||
33347448|NCT00927563|101160061|FG000|Overall Study|Lost to Follow-up|1|||
33347449|NCT00927563|101160061|FG000|Overall Study|Withdrawal by Subject|1|||
33347450|NCT02009878|101160062|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
33213577|NCT03178266|100679671|FG001|Overall Study|Disont. Early|1|||
33213578|NCT03178266|100679670|FG000|Overall Study|Withdrawal by Subject|0|||
33213579|NCT03178266|100679671|FG001|Overall Study|Withdrawal by Subject|2|||
33213580|NCT03141359|100679672|FG000|Overall Study|Death|32|||
33213581|NCT03141359|100679672|FG000|Overall Study|Still On Study (in follow up)|29|||
33213582|NCT04085328|100679673|FG000|Overall Study|Witihdrew Consent|16|||
33213583|NCT04085328|100679674|FG001|Overall Study|Witihdrew Consent|16|||
33213584|NCT04085328|100679673|FG000|Overall Study|Adverse Event|8|||
33213585|NCT04085328|100679674|FG001|Overall Study|Adverse Event|7|||
33213586|NCT04085328|100679673|FG000|Overall Study|Lost to Follow-up|7|||
33213587|NCT04085328|100679674|FG001|Overall Study|Lost to Follow-up|2|||
33213588|NCT04085328|100679673|FG000|Overall Study|Physician Decision|0|||
33213589|NCT04085328|100679674|FG001|Overall Study|Physician Decision|1|||
33213590|NCT04085328|100679673|FG000|Overall Study|Pregnancy|0|||
33213591|NCT04085328|100679674|FG001|Overall Study|Pregnancy|1|||
33213592|NCT04085328|100679673|FG000|Overall Study|Reasons Related to COVID-19|5|||
33213593|NCT04085328|100679674|FG001|Overall Study|Reasons Related to COVID-19|8|||
33213594|NCT04085328|100679673|FG000|Overall Study|Did not meet inclusion criteria|1|||
33213595|NCT04085328|100679674|FG001|Overall Study|Did not meet inclusion criteria|1|||
33213596|NCT04085328|100679673|FG000|Overall Study|Early termination|1|||
33213597|NCT04085328|100679674|FG001|Overall Study|Early termination|0|||
33213598|NCT03597568|100679681|FG000|Overall Study|Withdrawal by Subject|1|||
33213599|NCT03597568|100679682|FG001|Overall Study|Withdrawal by Subject|1|||
33213600|NCT03597568|100679681|FG000|Overall Study|Unable to analyze vascular data|1|||
33213601|NCT03597568|100679682|FG001|Overall Study|Unable to analyze vascular data|1|||
33213602|NCT01881126|100679687|FG000|Overall Study|Non-compliance|1|||
33213603|NCT01881126|100679688|FG001|Overall Study|Non-compliance|1|||
33213604|NCT01881126|100679687|FG000|Overall Study|Adverse Event|0|||
33213605|NCT01881126|100679688|FG001|Overall Study|Adverse Event|1|||
33347451|NCT02009878|101160063|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
33347452|NCT02009878|101160064|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
33347453|NCT01703000|101160065|FG000|Overall Study|Death|1|||
33408890|NCT04668066|101386138|FG003|Part 1: Follow-Up|Adverse Event|0|||
33408891|NCT04668066|101386139|FG004|Part 1: Follow-Up|Adverse Event|0|||
33347454|NCT01176916|101160074|FG000|Overall Study|Adverse Event|61|||
33347455|NCT01176916|101160074|FG000|Overall Study|Death|1|||
33213606|NCT03923933|100679695|FG000|Overall Study|Lost to Follow-up|1|||
33408892|NCT04668066|101386140|FG005|Part 1: Follow-Up|Adverse Event|0|||
33213607|NCT03923933|100679696|FG001|Overall Study|Lost to Follow-up|0|||
33213608|NCT03923933|100679695|FG000|Overall Study|Withdrawal by Subject|0|||
33213609|NCT03923933|100679696|FG001|Overall Study|Withdrawal by Subject|1|||
33213610|NCT02207816|100679698|FG000|Overall Study|Serious Adverse Event|0|||
33213611|NCT02207816|100679699|FG001|Overall Study|Serious Adverse Event|5|||
33213612|NCT02207816|100679700|FG002|Overall Study|Serious Adverse Event|2|||
33213613|NCT02207816|100679698|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
33213614|NCT02207816|100679699|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
33213615|NCT02207816|100679700|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
33213616|NCT02207816|100679698|FG000|Overall Study|Withdrawal by Subject|4|||
33213617|NCT02207816|100679699|FG001|Overall Study|Withdrawal by Subject|9|||
33213618|NCT02207816|100679700|FG002|Overall Study|Withdrawal by Subject|7|||
33213619|NCT02207816|100679698|FG000|Overall Study|Migrated/Moved From Study Area|41|||
33213620|NCT02207816|100679699|FG001|Overall Study|Migrated/Moved From Study Area|60|||
33616764|NCT00726232|102144412|FG003|Expansion Phase|Withdrawal by Subject|0|||
33616765|NCT00726232|102144413|FG004|Expansion Phase|Withdrawal by Subject|0|||
33616766|NCT00726232|102144414|FG005|Expansion Phase|Withdrawal by Subject|0|||
33616767|NCT00726232|102144415|FG006|Expansion Phase|Withdrawal by Subject|2|||
33616768|NCT00726232|102144416|FG007|Expansion Phase|Withdrawal by Subject|3|||
33616769|NCT00726232|102144409|FG000|Expansion Phase|Disease progression|0|||
33616770|NCT00726232|102144410|FG001|Expansion Phase|Disease progression|0|||
33616771|NCT00726232|102144411|FG002|Expansion Phase|Disease progression|0|||
33616772|NCT00726232|102144412|FG003|Expansion Phase|Disease progression|0|||
33616773|NCT00726232|102144413|FG004|Expansion Phase|Disease progression|0|||
33616774|NCT00726232|102144414|FG005|Expansion Phase|Disease progression|0|||
33616775|NCT00726232|102144415|FG006|Expansion Phase|Disease progression|4|||
33616776|NCT00726232|102144416|FG007|Expansion Phase|Disease progression|0|||
33616777|NCT00726232|102144409|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
33616778|NCT00726232|102144410|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
33616779|NCT00726232|102144411|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
33213621|NCT02207816|100679700|FG002|Overall Study|Migrated/Moved From Study Area|51|||
33213622|NCT02207816|100679698|FG000|Overall Study|Lost to Follow-up|3|||
33213623|NCT02207816|100679699|FG001|Overall Study|Lost to Follow-up|9|||
33213624|NCT02207816|100679700|FG002|Overall Study|Lost to Follow-up|1|||
33213625|NCT02207816|100679698|FG000|Overall Study|Other|1|||
33347456|NCT01176916|101160074|FG000|Overall Study|Lost to Follow-up|15|||
33347457|NCT01176916|101160074|FG000|Overall Study|Objective progression or relapse|17|||
33347458|NCT01176916|101160074|FG000|Overall Study|Protocol Violation|24|||
33347459|NCT01176916|101160074|FG000|Overall Study|Withdrawal by Subject|37|||
33347460|NCT01176916|101160074|FG000|Overall Study|Other|6|||
33347461|NCT01176916|101160074|FG000|Overall Study|Withdrawal prior to Treatment|6|||
33347462|NCT01307033|101160075|FG000|8-week Double-blind Period|Adverse Event|2|||
33347463|NCT01307033|101160076|FG001|8-week Double-blind Period|Adverse Event|0|||
33545146|NCT00283959|101898494|FG000|Extension Period|Low Compliance|1|||
33545147|NCT01179399|101898495|FG000|Overall Study|Adverse Event|1|||
33545148|NCT01179399|101898495|FG000|Overall Study|Lack of Efficacy|30|||
33545149|NCT01179399|101898495|FG000|Overall Study|Withdrawal by Subject|1|||
33545150|NCT00250588|101898496|FG000|Overall Study|Withdrawal by Subject|3|||
33545151|NCT00250588|101898497|FG001|Overall Study|Withdrawal by Subject|6|||
33545152|NCT00250588|101898498|FG002|Overall Study|Withdrawal by Subject|0|||
33545153|NCT00250588|101898496|FG000|Overall Study|Lost to Follow-up|6|||
33545154|NCT00250588|101898497|FG001|Overall Study|Lost to Follow-up|13|||
33545155|NCT00250588|101898498|FG002|Overall Study|Lost to Follow-up|13|||
33545156|NCT01562444|101898499|FG000|Overall Study|Did not meet entry criteria|2|||
33545157|NCT01562444|101898500|FG001|Overall Study|Did not meet entry criteria|0|||
33545158|NCT01562444|101898501|FG002|Overall Study|Did not meet entry criteria|3|||
33545159|NCT01562444|101898499|FG000|Overall Study|Did not comply with blood draw schedule|1|||
33545160|NCT01562444|101898500|FG001|Overall Study|Did not comply with blood draw schedule|0|||
33545161|NCT01562444|101898501|FG002|Overall Study|Did not comply with blood draw schedule|1|||
33545162|NCT01562444|101898499|FG000|Overall Study|Unavailable serological results|0|||
33545163|NCT01562444|101898500|FG001|Overall Study|Unavailable serological results|2|||
33545164|NCT01562444|101898501|FG002|Overall Study|Unavailable serological results|2|||
33545165|NCT01562444|101898499|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
33545166|NCT01562444|101898500|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
33545167|NCT01562444|101898501|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
33616780|NCT00726232|102144412|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
33616781|NCT00726232|102144413|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
33616782|NCT00726232|102144414|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
33213626|NCT02207816|100679699|FG001|Overall Study|Other|2|||
33347464|NCT01307033|101160077|FG002|8-week Double-blind Period|Adverse Event|0|||
33408893|NCT04668066|101386141|FG006|Part 1: Follow-Up|Adverse Event|0|||
33616783|NCT00726232|102144415|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
33616784|NCT00726232|102144416|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
33616785|NCT00726232|102144409|FG000|Expansion Phase|Per Investigator: lack of response|0|||
33616786|NCT00726232|102144410|FG001|Expansion Phase|Per Investigator: lack of response|0|||
33616787|NCT00726232|102144411|FG002|Expansion Phase|Per Investigator: lack of response|0|||
33616788|NCT00726232|102144412|FG003|Expansion Phase|Per Investigator: lack of response|0|||
33616789|NCT00726232|102144413|FG004|Expansion Phase|Per Investigator: lack of response|0|||
33616790|NCT00726232|102144414|FG005|Expansion Phase|Per Investigator: lack of response|0|||
33616791|NCT00726232|102144415|FG006|Expansion Phase|Per Investigator: lack of response|1|||
33616792|NCT00726232|102144416|FG007|Expansion Phase|Per Investigator: lack of response|7|||
33616793|NCT00726232|102144409|FG000|Expansion Phase|Unspecified reason|0|||
33616794|NCT00726232|102144410|FG001|Expansion Phase|Unspecified reason|0|||
33347465|NCT01307033|101160078|FG003|8-week Double-blind Period|Adverse Event|0|||
33347466|NCT01307033|101160075|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
33347467|NCT01307033|101160076|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
33347468|NCT01307033|101160077|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
33347469|NCT01307033|101160078|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
33347470|NCT01307033|101160075|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
33347471|NCT01307033|101160076|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
33347472|NCT01307033|101160077|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
33347473|NCT01307033|101160078|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
33347474|NCT01307033|101160075|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
33347475|NCT01307033|101160076|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
33347476|NCT01307033|101160077|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
33347477|NCT01307033|101160078|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
33347478|NCT01307033|101160075|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
33347479|NCT01307033|101160076|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
33347480|NCT01307033|101160077|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
33347481|NCT01307033|101160078|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
33347482|NCT01307033|101160075|FG000|44-week Open-label Extension|Adverse Event|0|||
33347483|NCT01307033|101160076|FG001|44-week Open-label Extension|Adverse Event|0|||
33347484|NCT01307033|101160077|FG002|44-week Open-label Extension|Adverse Event|2|||
33347485|NCT01307033|101160078|FG003|44-week Open-label Extension|Adverse Event|1|||
33347486|NCT01307033|101160075|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
33347487|NCT01307033|101160076|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
33347488|NCT01307033|101160077|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
33347489|NCT01307033|101160078|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
33347490|NCT01307033|101160075|FG000|44-week Open-label Extension|Physician Decision|0|||
33347491|NCT01307033|101160076|FG001|44-week Open-label Extension|Physician Decision|0|||
33347492|NCT01307033|101160077|FG002|44-week Open-label Extension|Physician Decision|1|||
33347493|NCT01307033|101160078|FG003|44-week Open-label Extension|Physician Decision|0|||
33347494|NCT01307033|101160075|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
33347495|NCT01307033|101160076|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
33347496|NCT01307033|101160077|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
33347497|NCT01307033|101160078|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
33347498|NCT01307033|101160075|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
33347499|NCT01307033|101160076|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
33347500|NCT01307033|101160077|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
33347501|NCT01307033|101160078|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
33347502|NCT01307033|101160075|FG000|44-week Open-label Extension|Death|0|||
33347503|NCT01307033|101160076|FG001|44-week Open-label Extension|Death|0|||
33347504|NCT01307033|101160077|FG002|44-week Open-label Extension|Death|0|||
33347505|NCT01307033|101160078|FG003|44-week Open-label Extension|Death|1|||
33347506|NCT00491179|101160079|FG000|Overall Study|Adverse Event|5|||
33347507|NCT00491179|101160080|FG001|Overall Study|Adverse Event|1|||
33347508|NCT00491179|101160079|FG000|Overall Study|Withdrawal by Subject|2|||
33347509|NCT00491179|101160080|FG001|Overall Study|Withdrawal by Subject|1|||
33347510|NCT01072344|101160083|FG000|Overall Study|Relasped-reached end point|7|||
33347511|NCT01072344|101160084|FG001|Overall Study|Relasped-reached end point|12|||
33347512|NCT01072344|101160083|FG000|Overall Study|Protocol Violation|1|||
33347513|NCT01072344|101160084|FG001|Overall Study|Protocol Violation|2|||
33347514|NCT01072344|101160083|FG000|Overall Study|Lost to Follow-up|3|||
33347515|NCT01072344|101160084|FG001|Overall Study|Lost to Follow-up|4|||
33347516|NCT01728779|101160085|FG000|Overall Study|Withdrawal by Subject|1|||
33616795|NCT00726232|102144411|FG002|Expansion Phase|Unspecified reason|0|||
33616796|NCT00726232|102144412|FG003|Expansion Phase|Unspecified reason|0|||
33347517|NCT00930059|101160086|FG000|Overall Study|Death|1|||
33408894|NCT04668066|101386142|FG007|Part 1: Follow-Up|Adverse Event|0|||
33616797|NCT00726232|102144413|FG004|Expansion Phase|Unspecified reason|0|||
33545168|NCT01562444|101898499|FG000|Overall Study|Protocol forbidden medication|1|||
33545169|NCT01562444|101898500|FG001|Overall Study|Protocol forbidden medication|0|||
33545170|NCT01562444|101898501|FG002|Overall Study|Protocol forbidden medication|0|||
33545171|NCT02969018|101898504|FG000|Overall Study|Adverse Event|2|||
33545172|NCT02969018|101898505|FG001|Overall Study|Adverse Event|4|||
33213627|NCT02207816|100679700|FG002|Overall Study|Other|4|||
33213628|NCT04495179|100679703|FG000|Overall Study|Lost to Follow-up|0|||
33213629|NCT04495179|100679704|FG001|Overall Study|Lost to Follow-up|1|||
33213630|NCT04495179|100679703|FG000|Overall Study|Withdrawal by Subject|2|||
33213631|NCT04495179|100679704|FG001|Overall Study|Withdrawal by Subject|4|||
33213632|NCT04495179|100679703|FG000|Overall Study|Study terminated by sponsor|0|||
33213633|NCT04495179|100679704|FG001|Overall Study|Study terminated by sponsor|18|||
33545173|NCT02969018|101898506|FG002|Overall Study|Adverse Event|1|||
33545174|NCT02969018|101898507|FG003|Overall Study|Adverse Event|2|||
33545175|NCT02969018|101898508|FG004|Overall Study|Adverse Event|0|||
33213634|NCT04495179|100679703|FG000|Overall Study|Death|0|||
33213635|NCT04495179|100679704|FG001|Overall Study|Death|4|||
33213636|NCT04495179|100679703|FG000|Overall Study|Adverse Event|0|||
33213637|NCT04495179|100679704|FG001|Overall Study|Adverse Event|1|||
33213638|NCT01041638|100679705|FG000|Overall Study|Adverse Event|4|||
33213639|NCT01041638|100679705|FG000|Overall Study|Death|1|||
33213640|NCT01041638|100679705|FG000|Overall Study|Lack of Efficacy|7|||
33213641|NCT01041638|100679705|FG000|Overall Study|Physician Decision|4|||
33213642|NCT01041638|100679705|FG000|Overall Study|Withdrawal by Subject|11|||
33213643|NCT02862457|100679706|FG000|Overall Study|Death|1|||
33213644|NCT02862457|100679707|FG001|Overall Study|Death|3|||
33213645|NCT02862457|100679708|FG002|Overall Study|Death|2|||
33213646|NCT02862457|100679709|FG003|Overall Study|Death|3|||
33213647|NCT02862457|100679710|FG004|Overall Study|Death|0|||
33213648|NCT02862457|100679711|FG005|Overall Study|Death|2|||
33213649|NCT02862457|100679712|FG006|Overall Study|Death|1|||
33213650|NCT02862457|100679706|FG000|Overall Study|Lost to Follow-up|1|||
33213651|NCT02862457|100679707|FG001|Overall Study|Lost to Follow-up|0|||
33213652|NCT02862457|100679708|FG002|Overall Study|Lost to Follow-up|0|||
33213653|NCT02862457|100679709|FG003|Overall Study|Lost to Follow-up|1|||
33213654|NCT02862457|100679710|FG004|Overall Study|Lost to Follow-up|0|||
33213655|NCT02862457|100679711|FG005|Overall Study|Lost to Follow-up|0|||
33213656|NCT02862457|100679712|FG006|Overall Study|Lost to Follow-up|0|||
33213657|NCT02862457|100679706|FG000|Overall Study|Withdrawal by Subject|0|||
33213658|NCT02862457|100679707|FG001|Overall Study|Withdrawal by Subject|0|||
33213659|NCT02862457|100679708|FG002|Overall Study|Withdrawal by Subject|1|||
33213660|NCT02862457|100679709|FG003|Overall Study|Withdrawal by Subject|0|||
33213661|NCT02862457|100679710|FG004|Overall Study|Withdrawal by Subject|0|||
33213662|NCT02862457|100679711|FG005|Overall Study|Withdrawal by Subject|1|||
33347518|NCT00930059|101160087|FG001|Overall Study|Death|0|||
33347519|NCT00930059|101160086|FG000|Overall Study|Did not meet entrance criteria|1|||
33347520|NCT00930059|101160087|FG001|Overall Study|Did not meet entrance criteria|1|||
33347521|NCT00930059|101160086|FG000|Overall Study|Withdrawal by Subject|3|||
33347522|NCT00930059|101160087|FG001|Overall Study|Withdrawal by Subject|4|||
33347523|NCT00930059|101160086|FG000|Overall Study|Other|1|||
33347524|NCT00930059|101160087|FG001|Overall Study|Other|0|||
33347525|NCT00930059|101160086|FG000|Overall Study|1 site terminated by sponsor|1|||
33347526|NCT00930059|101160087|FG001|Overall Study|1 site terminated by sponsor|1|||
33347527|NCT00930059|101160086|FG000|Overall Study|Adverse Event|1|||
33347528|NCT00930059|101160087|FG001|Overall Study|Adverse Event|6|||
33347529|NCT03480802|101160088|FG000|Overall Study|Lost to Follow-up|5|||
33347530|NCT03480802|101160089|FG001|Overall Study|Lost to Follow-up|1|||
33347531|NCT03480802|101160088|FG000|Overall Study|Withdrawal by Subject|2|||
33347532|NCT03480802|101160089|FG001|Overall Study|Withdrawal by Subject|1|||
33347533|NCT03480802|101160088|FG000|Overall Study|Relocated|0|||
33545176|NCT02969018|101898509|FG005|Overall Study|Adverse Event|1|||
33545177|NCT02969018|101898510|FG006|Overall Study|Adverse Event|2|||
33545178|NCT02969018|101898511|FG007|Overall Study|Adverse Event|0|||
33213663|NCT02862457|100679712|FG006|Overall Study|Withdrawal by Subject|0|||
33213664|NCT04088409|100679713|FG000|Part A|Withdrawal by Subject|2|||
33213665|NCT04088409|100679714|FG001|Part A|Withdrawal by Subject|1|||
33213666|NCT04088409|100679713|FG000|Part A|Did Not Meet Randomization Criteria|2|||
33213667|NCT04088409|100679714|FG001|Part A|Did Not Meet Randomization Criteria|0|||
33213668|NCT04088409|100679713|FG000|Part A|Lack of Efficacy|9|||
33213669|NCT04088409|100679714|FG001|Part A|Lack of Efficacy|0|||
33213670|NCT04088409|100679713|FG000|Part A|Lost to Follow-up|1|||
33213671|NCT04088409|100679714|FG001|Part A|Lost to Follow-up|0|||
33213672|NCT04088409|100679713|FG000|Part A|Adverse Event|1|||
33213673|NCT04088409|100679714|FG001|Part A|Adverse Event|0|||
33213674|NCT04088409|100679713|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
33347534|NCT03480802|101160089|FG001|Overall Study|Relocated|1|||
33347535|NCT02522767|101160091|FG000|Double-blind|Withdrawal by Subject|8|||
33347536|NCT02522767|101160092|FG001|Double-blind|Withdrawal by Subject|11|||
33545179|NCT02969018|101898504|FG000|Overall Study|Lack of Efficacy|0|||
33408895|NCT04668066|101386143|FG008|Part 1: Follow-Up|Adverse Event|0|||
33408896|NCT04668066|101386144|FG009|Part 1: Follow-Up|Adverse Event|0|||
33408897|NCT04668066|101386145|FG010|Part 1: Follow-Up|Adverse Event|0|||
33408898|NCT04668066|101386146|FG011|Part 1: Follow-Up|Adverse Event|1|||
33408899|NCT04668066|101386147|FG012|Part 1: Follow-Up|Adverse Event|0|||
33408900|NCT04668066|101386148|FG013|Part 1: Follow-Up|Adverse Event|0|||
33408901|NCT04668066|101386149|FG014|Part 1: Follow-Up|Adverse Event|0|||
33408902|NCT04668066|101386150|FG015|Part 1: Follow-Up|Adverse Event|0|||
33408903|NCT04668066|101386151|FG016|Part 1: Follow-Up|Adverse Event|0|||
33408904|NCT04668066|101386152|FG017|Part 1: Follow-Up|Adverse Event|0|||
33408905|NCT04668066|101386153|FG018|Part 1: Follow-Up|Adverse Event|0|||
33408906|NCT04668066|101386135|FG000|Part 1: Follow-Up|Other|0|||
33408907|NCT04668066|101386136|FG001|Part 1: Follow-Up|Other|0|||
33408908|NCT04668066|101386137|FG002|Part 1: Follow-Up|Other|0|||
33408909|NCT04668066|101386138|FG003|Part 1: Follow-Up|Other|0|||
33408910|NCT04668066|101386139|FG004|Part 1: Follow-Up|Other|0|||
33408911|NCT04668066|101386140|FG005|Part 1: Follow-Up|Other|0|||
33408912|NCT04668066|101386141|FG006|Part 1: Follow-Up|Other|0|||
33408913|NCT04668066|101386142|FG007|Part 1: Follow-Up|Other|0|||
33408914|NCT04668066|101386143|FG008|Part 1: Follow-Up|Other|0|||
33408915|NCT04668066|101386144|FG009|Part 1: Follow-Up|Other|0|||
33408916|NCT04668066|101386145|FG010|Part 1: Follow-Up|Other|0|||
33408917|NCT04668066|101386146|FG011|Part 1: Follow-Up|Other|1|||
33408918|NCT04668066|101386147|FG012|Part 1: Follow-Up|Other|1|||
33408919|NCT04668066|101386148|FG013|Part 1: Follow-Up|Other|0|||
33408920|NCT04668066|101386149|FG014|Part 1: Follow-Up|Other|0|||
33408921|NCT04668066|101386150|FG015|Part 1: Follow-Up|Other|0|||
33408922|NCT04668066|101386151|FG016|Part 1: Follow-Up|Other|0|||
33408923|NCT04668066|101386152|FG017|Part 1: Follow-Up|Other|0|||
33408924|NCT04668066|101386153|FG018|Part 1: Follow-Up|Other|0|||
33408925|NCT04668066|101386135|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408926|NCT04668066|101386136|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408927|NCT04668066|101386137|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408928|NCT04668066|101386138|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408929|NCT04668066|101386139|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408930|NCT04668066|101386140|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408931|NCT04668066|101386141|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408932|NCT04668066|101386142|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408933|NCT04668066|101386143|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408934|NCT04668066|101386144|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408935|NCT04668066|101386145|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408936|NCT04668066|101386146|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408937|NCT04668066|101386147|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
33408938|NCT04668066|101386148|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408939|NCT04668066|101386149|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408940|NCT04668066|101386150|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
33408941|NCT04668066|101386151|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408942|NCT04668066|101386152|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408943|NCT04668066|101386153|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
33408944|NCT04668066|101386135|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33408945|NCT04668066|101386136|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33408946|NCT04668066|101386137|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33408947|NCT04668066|101386138|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33408948|NCT04668066|101386139|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33408949|NCT04668066|101386140|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33408950|NCT04668066|101386141|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33545180|NCT02969018|101898505|FG001|Overall Study|Lack of Efficacy|1|||
33545181|NCT02969018|101898506|FG002|Overall Study|Lack of Efficacy|0|||
33545182|NCT02969018|101898507|FG003|Overall Study|Lack of Efficacy|0|||
33545183|NCT02969018|101898508|FG004|Overall Study|Lack of Efficacy|1|||
33545184|NCT02969018|101898509|FG005|Overall Study|Lack of Efficacy|1|||
33545185|NCT02969018|101898510|FG006|Overall Study|Lack of Efficacy|1|||
33545186|NCT02969018|101898511|FG007|Overall Study|Lack of Efficacy|1|||
33545187|NCT02969018|101898504|FG000|Overall Study|Lost to Follow-up|1|||
33545188|NCT02969018|101898505|FG001|Overall Study|Lost to Follow-up|2|||
33545189|NCT02969018|101898506|FG002|Overall Study|Lost to Follow-up|2|||
33545190|NCT02969018|101898507|FG003|Overall Study|Lost to Follow-up|0|||
33408951|NCT04668066|101386142|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33408952|NCT04668066|101386143|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33408953|NCT04668066|101386144|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33408954|NCT04668066|101386145|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33408955|NCT04668066|101386146|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33408956|NCT04668066|101386147|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33408957|NCT04668066|101386148|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33408958|NCT04668066|101386149|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33545191|NCT02969018|101898508|FG004|Overall Study|Lost to Follow-up|1|||
33545192|NCT02969018|101898509|FG005|Overall Study|Lost to Follow-up|1|||
33545193|NCT02969018|101898510|FG006|Overall Study|Lost to Follow-up|0|||
33408959|NCT04668066|101386150|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33545194|NCT02969018|101898511|FG007|Overall Study|Lost to Follow-up|1|||
33545195|NCT02969018|101898504|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33545196|NCT02969018|101898505|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33545197|NCT02969018|101898506|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
33545198|NCT02969018|101898507|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
33545199|NCT02969018|101898508|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
33545200|NCT02969018|101898509|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
33545201|NCT02969018|101898510|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
33545202|NCT02969018|101898511|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
33545203|NCT02969018|101898504|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33545204|NCT02969018|101898505|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33545205|NCT02969018|101898506|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33545206|NCT02969018|101898507|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33545207|NCT02969018|101898508|FG004|Overall Study|Non-Compliance With Study Drug|0|||
33545208|NCT02969018|101898509|FG005|Overall Study|Non-Compliance With Study Drug|0|||
33545209|NCT02969018|101898510|FG006|Overall Study|Non-Compliance With Study Drug|0|||
33545210|NCT02969018|101898511|FG007|Overall Study|Non-Compliance With Study Drug|0|||
33616798|NCT00726232|102144414|FG005|Expansion Phase|Unspecified reason|0|||
33616799|NCT00726232|102144415|FG006|Expansion Phase|Unspecified reason|1|||
33408960|NCT04668066|101386151|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33408961|NCT04668066|101386152|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
33545211|NCT02969018|101898504|FG000|Overall Study|Other|0|||
33545212|NCT02969018|101898505|FG001|Overall Study|Other|0|||
33616800|NCT00726232|102144416|FG007|Expansion Phase|Unspecified reason|0|||
33616801|NCT00475709|102144417|FG000|Overall Study|Did not meet eligibility criteria|8|||
33616802|NCT00475709|102144417|FG000|Overall Study|Death|41|||
33616803|NCT00475709|102144417|FG000|Overall Study|Device Explant|6|||
33616804|NCT00475709|102144417|FG000|Overall Study|Lost to Follow-up|21|||
33616805|NCT02652156|102144424|FG000|Overall Study|Physician Decision|1|||
33616806|NCT02652156|102144425|FG001|Overall Study|Physician Decision|0|||
33616807|NCT02652156|102144426|FG002|Overall Study|Physician Decision|0|||
33616808|NCT00264537|102144427|FG000|Overall Study|Death|0|||
33616809|NCT00264537|102144428|FG001|Overall Study|Death|3|||
33616810|NCT00264537|102144429|FG002|Overall Study|Death|3|||
33616811|NCT00264537|102144430|FG003|Overall Study|Death|2|||
33616812|NCT00264537|102144427|FG000|Overall Study|Lost to Follow-up|3|||
33347537|NCT02522767|101160091|FG000|Double-blind|Lost to Follow-up|1|||
33347538|NCT02522767|101160092|FG001|Double-blind|Lost to Follow-up|0|||
33347539|NCT02522767|101160091|FG000|Double-blind|Adverse Event|1|||
33347540|NCT02522767|101160092|FG001|Double-blind|Adverse Event|10|||
33347541|NCT02522767|101160091|FG000|Double-blind|Protocol Violation|0|||
33347542|NCT02522767|101160092|FG001|Double-blind|Protocol Violation|1|||
33347543|NCT02522767|101160091|FG000|Double-blind|Lack of Efficacy|0|||
33347544|NCT02522767|101160092|FG001|Double-blind|Lack of Efficacy|2|||
33347545|NCT02522767|101160091|FG000|Double-blind|Protocol Deviation|1|||
33347546|NCT02522767|101160092|FG001|Double-blind|Protocol Deviation|0|||
33347547|NCT02522767|101160091|FG000|Open-label|Withdrawal by Subject|2|||
33347548|NCT02522767|101160092|FG001|Open-label|Withdrawal by Subject|3|||
33347549|NCT02522767|101160091|FG000|Open-label|Lost to Follow-up|0|||
33347550|NCT02522767|101160092|FG001|Open-label|Lost to Follow-up|1|||
33347551|NCT02522767|101160091|FG000|Open-label|Adverse Event|2|||
33347552|NCT02522767|101160092|FG001|Open-label|Adverse Event|1|||
33347553|NCT02522767|101160091|FG000|Open-label|Lack of Efficacy|1|||
33347554|NCT02522767|101160092|FG001|Open-label|Lack of Efficacy|1|||
33347555|NCT02522767|101160091|FG000|Open-label|Protocol Violation|0|||
33347556|NCT02522767|101160092|FG001|Open-label|Protocol Violation|1|||
33347557|NCT02542267|101160102|FG000|Overall Study|Withdrawal by Subject|10|||
33347558|NCT02542267|101160102|FG000|Overall Study|Physician Decision|6|||
33347559|NCT02542267|101160102|FG000|Overall Study|Lost to Follow-up|4|||
33347560|NCT02542267|101160102|FG000|Overall Study|Death|13|||
33347561|NCT02542267|101160102|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
33347562|NCT02542267|101160102|FG000|Overall Study|Other|9|||
33347563|NCT01583179|101160105|FG000|Overall Study|Screen failure|1|||
33347564|NCT01583179|101160106|FG001|Overall Study|Screen failure|2|||
33347565|NCT00988247|101160110|FG000|Overall Study|Adverse Event|17|||
33347566|NCT00988247|101160111|FG001|Overall Study|Adverse Event|3|||
33347567|NCT00988247|101160110|FG000|Overall Study|Withdrawal by Subject|44|||
33347568|NCT00988247|101160111|FG001|Overall Study|Withdrawal by Subject|13|||
33347569|NCT00988247|101160110|FG000|Overall Study|Pregnancy|1|||
33347570|NCT00988247|101160111|FG001|Overall Study|Pregnancy|2|||
33347571|NCT00988247|101160110|FG000|Overall Study|Lost to Follow-up|11|||
33347572|NCT00988247|101160111|FG001|Overall Study|Lost to Follow-up|2|||
33347573|NCT00988247|101160110|FG000|Overall Study|Protocol Violation|4|||
33347574|NCT00988247|101160111|FG001|Overall Study|Protocol Violation|5|||
33347575|NCT00988247|101160110|FG000|Overall Study|Sponsor requested withdrawal|3|||
33347576|NCT00988247|101160111|FG001|Overall Study|Sponsor requested withdrawal|1|||
33347577|NCT00988247|101160110|FG000|Overall Study|Other|3|||
33545213|NCT02969018|101898506|FG002|Overall Study|Other|0|||
33347578|NCT00988247|101160111|FG001|Overall Study|Other|0|||
33347579|NCT00552110|101160115|FG000|Overall Study|Serious or Life-Threatening AE|0|||
33347580|NCT00552110|101160116|FG001|Overall Study|Serious or Life-Threatening AE|0|||
33347581|NCT00552110|101160117|FG002|Overall Study|Serious or Life-Threatening AE|1|||
33347582|NCT00552110|101160118|FG003|Overall Study|Serious or Life-Threatening AE|0|||
33347583|NCT00552110|101160119|FG004|Overall Study|Serious or Life-Threatening AE|0|||
33347584|NCT00552110|101160115|FG000|Overall Study|Lack of Efficacy|1|||
33347585|NCT00552110|101160116|FG001|Overall Study|Lack of Efficacy|0|||
33347586|NCT00552110|101160117|FG002|Overall Study|Lack of Efficacy|0|||
33347587|NCT00552110|101160118|FG003|Overall Study|Lack of Efficacy|1|||
33347588|NCT00552110|101160119|FG004|Overall Study|Lack of Efficacy|4|||
33347589|NCT00552110|101160115|FG000|Overall Study|Withdrawal by Subject|0|||
33347590|NCT00552110|101160116|FG001|Overall Study|Withdrawal by Subject|2|||
33347591|NCT00552110|101160117|FG002|Overall Study|Withdrawal by Subject|0|||
33347592|NCT00552110|101160118|FG003|Overall Study|Withdrawal by Subject|3|||
33347593|NCT00552110|101160119|FG004|Overall Study|Withdrawal by Subject|2|||
33347594|NCT00552110|101160115|FG000|Overall Study|Lost to Follow-up|0|||
33347595|NCT00552110|101160116|FG001|Overall Study|Lost to Follow-up|0|||
33347596|NCT00552110|101160117|FG002|Overall Study|Lost to Follow-up|0|||
33347597|NCT00552110|101160118|FG003|Overall Study|Lost to Follow-up|1|||
33347598|NCT00552110|101160119|FG004|Overall Study|Lost to Follow-up|1|||
33347599|NCT00552110|101160115|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
33347600|NCT00552110|101160116|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
33347601|NCT00552110|101160117|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
33347602|NCT00552110|101160118|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
33347603|NCT00552110|101160119|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
33347604|NCT00552110|101160115|FG000|Overall Study|Withdrawn per Sponsor|0|||
33347605|NCT00552110|101160116|FG001|Overall Study|Withdrawn per Sponsor|1|||
33347606|NCT00552110|101160117|FG002|Overall Study|Withdrawn per Sponsor|0|||
33347607|NCT00552110|101160118|FG003|Overall Study|Withdrawn per Sponsor|0|||
33347608|NCT00552110|101160119|FG004|Overall Study|Withdrawn per Sponsor|1|||
33347609|NCT00552110|101160115|FG000|Overall Study|Use of Prohibited Medication|1|||
33347610|NCT00552110|101160116|FG001|Overall Study|Use of Prohibited Medication|1|||
33347611|NCT00552110|101160117|FG002|Overall Study|Use of Prohibited Medication|0|||
33545214|NCT02969018|101898507|FG003|Overall Study|Other|1|||
33545215|NCT02969018|101898508|FG004|Overall Study|Other|0|||
33545216|NCT02969018|101898509|FG005|Overall Study|Other|0|||
33545217|NCT02969018|101898510|FG006|Overall Study|Other|0|||
33545218|NCT02969018|101898511|FG007|Overall Study|Other|2|||
33545219|NCT02969018|101898504|FG000|Overall Study|Pregnancy|0|||
33545220|NCT02969018|101898505|FG001|Overall Study|Pregnancy|0|||
33545221|NCT02969018|101898506|FG002|Overall Study|Pregnancy|0|||
33545222|NCT02969018|101898507|FG003|Overall Study|Pregnancy|0|||
33545223|NCT02969018|101898508|FG004|Overall Study|Pregnancy|0|||
33545224|NCT02969018|101898509|FG005|Overall Study|Pregnancy|1|||
33545225|NCT02969018|101898510|FG006|Overall Study|Pregnancy|0|||
33545226|NCT02969018|101898511|FG007|Overall Study|Pregnancy|0|||
33545227|NCT02969018|101898504|FG000|Overall Study|Protocol Violation|0|||
33545228|NCT02969018|101898505|FG001|Overall Study|Protocol Violation|0|||
33545229|NCT02969018|101898506|FG002|Overall Study|Protocol Violation|1|||
33545230|NCT02969018|101898507|FG003|Overall Study|Protocol Violation|1|||
33545231|NCT02969018|101898508|FG004|Overall Study|Protocol Violation|0|||
33545232|NCT02969018|101898509|FG005|Overall Study|Protocol Violation|0|||
33545233|NCT02969018|101898510|FG006|Overall Study|Protocol Violation|0|||
33545234|NCT02969018|101898511|FG007|Overall Study|Protocol Violation|0|||
33545235|NCT02969018|101898504|FG000|Overall Study|Withdrawal by Subject|0|||
33545236|NCT02969018|101898505|FG001|Overall Study|Withdrawal by Subject|1|||
33545237|NCT02969018|101898506|FG002|Overall Study|Withdrawal by Subject|2|||
33347612|NCT00552110|101160118|FG003|Overall Study|Use of Prohibited Medication|0|||
33347613|NCT00552110|101160119|FG004|Overall Study|Use of Prohibited Medication|0|||
33347614|NCT00552110|101160115|FG000|Overall Study|Delay of Study due to Relabeling|0|||
33347615|NCT00552110|101160116|FG001|Overall Study|Delay of Study due to Relabeling|0|||
33347616|NCT00552110|101160117|FG002|Overall Study|Delay of Study due to Relabeling|0|||
33545238|NCT02969018|101898507|FG003|Overall Study|Withdrawal by Subject|1|||
33545239|NCT02969018|101898508|FG004|Overall Study|Withdrawal by Subject|0|||
33545240|NCT02969018|101898509|FG005|Overall Study|Withdrawal by Subject|4|||
33545241|NCT02969018|101898510|FG006|Overall Study|Withdrawal by Subject|4|||
33545242|NCT02969018|101898511|FG007|Overall Study|Withdrawal by Subject|3|||
33347617|NCT00552110|101160118|FG003|Overall Study|Delay of Study due to Relabeling|1|||
33545243|NCT00071981|101898512|FG000|Overall Study|Lack of Efficacy|37|||
33545244|NCT00071981|101898513|FG001|Overall Study|Lack of Efficacy|29|||
33545245|NCT00071981|101898514|FG002|Overall Study|Lack of Efficacy|30|||
33545246|NCT00071981|101898515|FG003|Overall Study|Lack of Efficacy|43|||
33616813|NCT00264537|102144428|FG001|Overall Study|Lost to Follow-up|4|||
33616814|NCT00264537|102144429|FG002|Overall Study|Lost to Follow-up|7|||
33616815|NCT00264537|102144430|FG003|Overall Study|Lost to Follow-up|6|||
33408962|NCT04668066|101386153|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
33408963|NCT04668066|101386135|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
33408964|NCT04668066|101386136|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
33408965|NCT04668066|101386137|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
33545247|NCT00071981|101898512|FG000|Overall Study|Adverse Event|4|||
33545248|NCT00071981|101898513|FG001|Overall Study|Adverse Event|4|||
33545249|NCT00071981|101898514|FG002|Overall Study|Adverse Event|3|||
33545250|NCT00071981|101898515|FG003|Overall Study|Adverse Event|1|||
33545251|NCT00071981|101898512|FG000|Overall Study|Death|0|||
33545252|NCT00071981|101898513|FG001|Overall Study|Death|0|||
33545253|NCT00071981|101898514|FG002|Overall Study|Death|1|||
33545254|NCT00071981|101898515|FG003|Overall Study|Death|1|||
33545255|NCT00071981|101898512|FG000|Overall Study|Withdrawal by Subject|3|||
33545256|NCT00071981|101898513|FG001|Overall Study|Withdrawal by Subject|1|||
33545257|NCT00071981|101898514|FG002|Overall Study|Withdrawal by Subject|0|||
33545258|NCT00071981|101898515|FG003|Overall Study|Withdrawal by Subject|0|||
33545259|NCT00071981|101898512|FG000|Overall Study|No protocol therapy|2|||
33545260|NCT00071981|101898513|FG001|Overall Study|No protocol therapy|5|||
33545261|NCT00071981|101898514|FG002|Overall Study|No protocol therapy|1|||
33545262|NCT00071981|101898515|FG003|Overall Study|No protocol therapy|0|||
33545263|NCT00071981|101898512|FG000|Overall Study|others (not specified in the study)|0|||
33545264|NCT00071981|101898513|FG001|Overall Study|others (not specified in the study)|2|||
33545265|NCT00071981|101898514|FG002|Overall Study|others (not specified in the study)|2|||
33545266|NCT00071981|101898515|FG003|Overall Study|others (not specified in the study)|0|||
33545267|NCT01551173|101898516|FG000|Overall Study|Withdrawal by Subject|11|||
33545268|NCT01551173|101898517|FG001|Overall Study|Withdrawal by Subject|16|||
33545269|NCT01551173|101898516|FG000|Overall Study|Adverse Event|7|||
33545270|NCT01551173|101898517|FG001|Overall Study|Adverse Event|6|||
33545271|NCT01551173|101898516|FG000|Overall Study|Lost to Follow-up|5|||
33545272|NCT01551173|101898517|FG001|Overall Study|Lost to Follow-up|7|||
33545273|NCT01551173|101898516|FG000|Overall Study|Other|5|||
33545274|NCT01551173|101898517|FG001|Overall Study|Other|3|||
33545275|NCT00143507|101898518|FG000|Overall Study|Death|572|||
33545276|NCT00143507|101898519|FG001|Overall Study|Death|547|||
33545277|NCT00143507|101898518|FG000|Overall Study|Withdrawal by Subject|114|||
33545278|NCT00143507|101898519|FG001|Overall Study|Withdrawal by Subject|102|||
33545279|NCT00143507|101898518|FG000|Overall Study|Lost to Follow-up|1|||
33545280|NCT00143507|101898519|FG001|Overall Study|Lost to Follow-up|0|||
33545281|NCT00143507|101898518|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
33545282|NCT00143507|101898519|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
33545283|NCT02017717|101898520|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33545284|NCT02017717|101898521|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33545285|NCT02017717|101898522|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33545286|NCT02017717|101898523|FG003|Before Treatment Period|Adverse Event unrelated to study drug|1|||
33545287|NCT02017717|101898524|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33545288|NCT02017717|101898525|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33545289|NCT02017717|101898526|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33545290|NCT02017717|101898527|FG007|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33545291|NCT02017717|101898528|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
33545292|NCT02017717|101898520|FG000|Before Treatment Period|Participant request to stop therapy|0|||
33545293|NCT02017717|101898521|FG001|Before Treatment Period|Participant request to stop therapy|0|||
33545294|NCT02017717|101898522|FG002|Before Treatment Period|Participant request to stop therapy|0|||
33545295|NCT02017717|101898523|FG003|Before Treatment Period|Participant request to stop therapy|0|||
33545296|NCT02017717|101898524|FG004|Before Treatment Period|Participant request to stop therapy|5|||
33545297|NCT02017717|101898525|FG005|Before Treatment Period|Participant request to stop therapy|0|||
33545298|NCT02017717|101898526|FG006|Before Treatment Period|Participant request to stop therapy|0|||
33616816|NCT00264537|102144427|FG000|Overall Study|Adverse Event|21|||
33213675|NCT04088409|100679714|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
33408966|NCT04668066|101386138|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
33545299|NCT02017717|101898527|FG007|Before Treatment Period|Participant request to stop therapy|0|||
33545300|NCT02017717|101898528|FG008|Before Treatment Period|Participant request to stop therapy|0|||
33545301|NCT02017717|101898520|FG000|Before Treatment Period|Participant withdrew consent|0|||
33545302|NCT02017717|101898521|FG001|Before Treatment Period|Participant withdrew consent|0|||
33545303|NCT02017717|101898522|FG002|Before Treatment Period|Participant withdrew consent|0|||
33545304|NCT02017717|101898523|FG003|Before Treatment Period|Participant withdrew consent|0|||
33616817|NCT00264537|102144428|FG001|Overall Study|Adverse Event|32|||
33545305|NCT02017717|101898524|FG004|Before Treatment Period|Participant withdrew consent|11|||
33545306|NCT02017717|101898525|FG005|Before Treatment Period|Participant withdrew consent|0|||
33545307|NCT02017717|101898526|FG006|Before Treatment Period|Participant withdrew consent|0|||
33545308|NCT02017717|101898527|FG007|Before Treatment Period|Participant withdrew consent|0|||
33545309|NCT02017717|101898528|FG008|Before Treatment Period|Participant withdrew consent|2|||
33545310|NCT02017717|101898520|FG000|Before Treatment Period|Lost to Follow-up|0|||
33545311|NCT02017717|101898521|FG001|Before Treatment Period|Lost to Follow-up|0|||
33545312|NCT02017717|101898522|FG002|Before Treatment Period|Lost to Follow-up|0|||
33545313|NCT02017717|101898523|FG003|Before Treatment Period|Lost to Follow-up|0|||
33545314|NCT02017717|101898524|FG004|Before Treatment Period|Lost to Follow-up|1|||
33545315|NCT02017717|101898525|FG005|Before Treatment Period|Lost to Follow-up|0|||
33545316|NCT02017717|101898526|FG006|Before Treatment Period|Lost to Follow-up|0|||
33545317|NCT02017717|101898527|FG007|Before Treatment Period|Lost to Follow-up|0|||
33545318|NCT02017717|101898528|FG008|Before Treatment Period|Lost to Follow-up|0|||
33545319|NCT02017717|101898520|FG000|Before Treatment Period|Participant no longer met criteria|0|||
33545320|NCT02017717|101898521|FG001|Before Treatment Period|Participant no longer met criteria|0|||
33545321|NCT02017717|101898522|FG002|Before Treatment Period|Participant no longer met criteria|0|||
33545322|NCT02017717|101898523|FG003|Before Treatment Period|Participant no longer met criteria|1|||
33545323|NCT02017717|101898524|FG004|Before Treatment Period|Participant no longer met criteria|2|||
33545324|NCT02017717|101898525|FG005|Before Treatment Period|Participant no longer met criteria|0|||
33545325|NCT02017717|101898526|FG006|Before Treatment Period|Participant no longer met criteria|0|||
33545326|NCT02017717|101898527|FG007|Before Treatment Period|Participant no longer met criteria|1|||
33545327|NCT02017717|101898528|FG008|Before Treatment Period|Participant no longer met criteria|0|||
33545328|NCT02017717|101898520|FG000|Before Treatment Period|other reason|0|||
33545329|NCT02017717|101898521|FG001|Before Treatment Period|other reason|0|||
33545330|NCT02017717|101898522|FG002|Before Treatment Period|other reason|0|||
33545331|NCT02017717|101898523|FG003|Before Treatment Period|other reason|0|||
33545332|NCT02017717|101898524|FG004|Before Treatment Period|other reason|1|||
33545333|NCT02017717|101898525|FG005|Before Treatment Period|other reason|0|||
33545334|NCT02017717|101898526|FG006|Before Treatment Period|other reason|0|||
33545335|NCT02017717|101898527|FG007|Before Treatment Period|other reason|0|||
33545336|NCT02017717|101898528|FG008|Before Treatment Period|other reason|0|||
33545337|NCT02017717|101898520|FG000|Treatment Period|Disease progression|7|||
33545338|NCT02017717|101898521|FG001|Treatment Period|Disease progression|9|||
33545339|NCT02017717|101898522|FG002|Treatment Period|Disease progression|12|||
33545340|NCT02017717|101898523|FG003|Treatment Period|Disease progression|165|||
33545341|NCT02017717|101898524|FG004|Treatment Period|Disease progression|134|||
33545342|NCT02017717|101898525|FG005|Treatment Period|Disease progression|20|||
33545343|NCT02017717|101898526|FG006|Treatment Period|Disease progression|26|||
33545344|NCT02017717|101898527|FG007|Treatment Period|Disease progression|17|||
33545345|NCT02017717|101898528|FG008|Treatment Period|Disease progression|22|||
33545346|NCT02017717|101898520|FG000|Treatment Period|Study drug toxicity|3|||
33545347|NCT02017717|101898521|FG001|Treatment Period|Study drug toxicity|0|||
33545348|NCT02017717|101898522|FG002|Treatment Period|Study drug toxicity|1|||
33545349|NCT02017717|101898523|FG003|Treatment Period|Study drug toxicity|7|||
33545350|NCT02017717|101898524|FG004|Treatment Period|Study drug toxicity|11|||
33545351|NCT02017717|101898525|FG005|Treatment Period|Study drug toxicity|4|||
33545352|NCT02017717|101898526|FG006|Treatment Period|Study drug toxicity|4|||
33545353|NCT02017717|101898527|FG007|Treatment Period|Study drug toxicity|5|||
33545354|NCT02017717|101898528|FG008|Treatment Period|Study drug toxicity|3|||
33545355|NCT02017717|101898520|FG000|Treatment Period|Death|0|||
33545356|NCT02017717|101898521|FG001|Treatment Period|Death|0|||
33545357|NCT02017717|101898522|FG002|Treatment Period|Death|1|||
33545358|NCT02017717|101898523|FG003|Treatment Period|Death|0|||
33545359|NCT02017717|101898524|FG004|Treatment Period|Death|0|||
33545360|NCT02017717|101898525|FG005|Treatment Period|Death|0|||
33545361|NCT02017717|101898526|FG006|Treatment Period|Death|0|||
33545362|NCT02017717|101898527|FG007|Treatment Period|Death|1|||
33616818|NCT00264537|102144429|FG002|Overall Study|Adverse Event|24|||
33616819|NCT00264537|102144430|FG003|Overall Study|Adverse Event|34|||
33616820|NCT00264537|102144427|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
33616821|NCT00264537|102144428|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
33616822|NCT00264537|102144429|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
33545363|NCT02017717|101898528|FG008|Treatment Period|Death|0|||
33545364|NCT02017717|101898520|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
33545365|NCT02017717|101898521|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
33545366|NCT02017717|101898522|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
33545367|NCT02017717|101898523|FG003|Treatment Period|Adverse event unrelated to study drug|4|||
33545368|NCT02017717|101898524|FG004|Treatment Period|Adverse event unrelated to study drug|5|||
33545369|NCT02017717|101898525|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
33545370|NCT02017717|101898526|FG006|Treatment Period|Adverse event unrelated to study drug|0|||
33545371|NCT02017717|101898527|FG007|Treatment Period|Adverse event unrelated to study drug|0|||
33213676|NCT04088409|100679713|FG000|Part B|Ongoing Treatment|10|||
33545372|NCT02017717|101898528|FG008|Treatment Period|Adverse event unrelated to study drug|1|||
33545373|NCT02017717|101898520|FG000|Treatment Period|Participant request to stop therapy|0|||
33545374|NCT02017717|101898521|FG001|Treatment Period|Participant request to stop therapy|0|||
33545375|NCT02017717|101898522|FG002|Treatment Period|Participant request to stop therapy|3|||
33545376|NCT02017717|101898523|FG003|Treatment Period|Participant request to stop therapy|4|||
33545377|NCT02017717|101898524|FG004|Treatment Period|Participant request to stop therapy|7|||
33213677|NCT04088409|100679714|FG001|Part B|Ongoing Treatment|0|||
33213678|NCT01912612|100679715|FG000|Overall Study|Adverse Event|4|||
33213679|NCT01912612|100679716|FG001|Overall Study|Adverse Event|0|||
33213680|NCT01912612|100679717|FG002|Overall Study|Adverse Event|0|||
33213681|NCT01912612|100679715|FG000|Overall Study|Withdrew consent|1|||
33213682|NCT01912612|100679716|FG001|Overall Study|Withdrew consent|0|||
33213683|NCT01912612|100679717|FG002|Overall Study|Withdrew consent|0|||
33213684|NCT01912612|100679715|FG000|Overall Study|Study design change|0|||
33408967|NCT04668066|101386139|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
33213685|NCT01912612|100679716|FG001|Overall Study|Study design change|0|||
33213686|NCT01912612|100679717|FG002|Overall Study|Study design change|3|||
33213687|NCT03583554|100679720|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
33213688|NCT03583554|100679721|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
33213689|NCT03583554|100679722|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
33213690|NCT01627327|100679729|FG000|Overall Study|Adverse Event|6|||
33213691|NCT01627327|100679730|FG001|Overall Study|Adverse Event|12|||
33213692|NCT01627327|100679729|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
33213693|NCT01627327|100679730|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
33213694|NCT01627327|100679729|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
33213695|NCT01627327|100679730|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
33213696|NCT01627327|100679729|FG000|Overall Study|Protocol Violation|4|||
33213697|NCT01627327|100679730|FG001|Overall Study|Protocol Violation|10|||
33213698|NCT01627327|100679729|FG000|Overall Study|Lost to Follow-up|1|||
33213699|NCT01627327|100679730|FG001|Overall Study|Lost to Follow-up|3|||
33213700|NCT01627327|100679729|FG000|Overall Study|Physician Decision|1|||
33213701|NCT01627327|100679730|FG001|Overall Study|Physician Decision|0|||
33213702|NCT01627327|100679729|FG000|Overall Study|Withdrawal by Subject|3|||
33213703|NCT01627327|100679730|FG001|Overall Study|Withdrawal by Subject|3|||
33213704|NCT02525874|100679731|FG000|Overall Study|Other|1|||
33213705|NCT02525874|100679731|FG000|Overall Study|Investigator Decision|1|||
33213706|NCT02525874|100679731|FG000|Overall Study|Consent withdrawn|22|||
33213707|NCT02525874|100679731|FG000|Overall Study|Non-compliance with study drug|3|||
33213708|NCT02525874|100679731|FG000|Overall Study|Adverse Event|17|||
33213709|NCT02525874|100679731|FG000|Overall Study|Lost to Follow-up|7|||
33213710|NCT02525874|100679731|FG000|Overall Study|Disease progression, defined by protocol|2|||
33213711|NCT02525874|100679731|FG000|Overall Study|Disease relapse|4|||
33213712|NCT02525874|100679731|FG000|Overall Study|Alternative Treatment for MS|2|||
33213713|NCT02525874|100679731|FG000|Overall Study|New lesions in Brain|1|||
33213714|NCT00951275|100679732|FG000|Overall Study|Administrative Reason|1|||
33213715|NCT00951275|100679732|FG000|Overall Study|Adverse Event|7|||
33213716|NCT00951275|100679732|FG000|Overall Study|Withdrawal by Subject|4|||
33213717|NCT00951275|100679732|FG000|Overall Study|Protocol Violation|1|||
33213718|NCT03162224|100679734|FG000|Overall Study|Death|4|||
33213719|NCT03162224|100679735|FG001|Overall Study|Death|5|||
33213720|NCT03162224|100679736|FG002|Overall Study|Death|8|||
33213721|NCT03162224|100679734|FG000|Overall Study|Withdrawal by Subject|1|||
33213722|NCT03162224|100679735|FG001|Overall Study|Withdrawal by Subject|0|||
33213723|NCT03162224|100679736|FG002|Overall Study|Withdrawal by Subject|1|||
33408968|NCT04668066|101386140|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
33408969|NCT04668066|101386141|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
33408970|NCT04668066|101386142|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
33408971|NCT04668066|101386143|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
33408972|NCT04668066|101386144|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
33408973|NCT04668066|101386145|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
33545378|NCT02017717|101898525|FG005|Treatment Period|Participant request to stop therapy|5|||
33616823|NCT00264537|102144430|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
33616824|NCT00264537|102144427|FG000|Overall Study|Other|21|||
33616825|NCT00264537|102144428|FG001|Overall Study|Other|11|||
33616826|NCT00264537|102144429|FG002|Overall Study|Other|10|||
33616827|NCT00264537|102144430|FG003|Overall Study|Other|11|||
33616828|NCT00264537|102144427|FG000|Overall Study|Not treated|0|||
33616829|NCT00264537|102144428|FG001|Overall Study|Not treated|2|||
33616830|NCT00264537|102144429|FG002|Overall Study|Not treated|1|||
33616831|NCT00264537|102144430|FG003|Overall Study|Not treated|0|||
33616832|NCT03710642|102144431|FG000|Overall Study|Adverse Event|5|||
33213724|NCT03162224|100679734|FG000|Overall Study|Lost to Follow-up|0|||
33213725|NCT03162224|100679735|FG001|Overall Study|Lost to Follow-up|1|||
33213726|NCT03162224|100679736|FG002|Overall Study|Lost to Follow-up|0|||
33213727|NCT03162224|100679734|FG000|Overall Study|Other|6|||
33213728|NCT03162224|100679735|FG001|Overall Study|Other|2|||
33545379|NCT02017717|101898526|FG006|Treatment Period|Participant request to stop therapy|0|||
33545380|NCT02017717|101898527|FG007|Treatment Period|Participant request to stop therapy|2|||
33545381|NCT02017717|101898528|FG008|Treatment Period|Participant request to stop therapy|1|||
33545382|NCT02017717|101898520|FG000|Treatment Period|Participant withdrew consent|0|||
33545383|NCT02017717|101898521|FG001|Treatment Period|Participant withdrew consent|0|||
33545384|NCT02017717|101898522|FG002|Treatment Period|Participant withdrew consent|1|||
33545385|NCT02017717|101898523|FG003|Treatment Period|Participant withdrew consent|1|||
33545386|NCT02017717|101898524|FG004|Treatment Period|Participant withdrew consent|4|||
33545387|NCT02017717|101898525|FG005|Treatment Period|Participant withdrew consent|0|||
33545388|NCT02017717|101898526|FG006|Treatment Period|Participant withdrew consent|0|||
33545389|NCT02017717|101898527|FG007|Treatment Period|Participant withdrew consent|2|||
33545390|NCT02017717|101898528|FG008|Treatment Period|Participant withdrew consent|0|||
33545391|NCT02017717|101898520|FG000|Treatment Period|Participant no longer met criteria|0|||
33545392|NCT02017717|101898521|FG001|Treatment Period|Participant no longer met criteria|0|||
33545393|NCT02017717|101898522|FG002|Treatment Period|Participant no longer met criteria|0|||
33545394|NCT02017717|101898523|FG003|Treatment Period|Participant no longer met criteria|0|||
33545395|NCT02017717|101898524|FG004|Treatment Period|Participant no longer met criteria|1|||
33545396|NCT02017717|101898525|FG005|Treatment Period|Participant no longer met criteria|0|||
33616833|NCT03710642|102144432|FG001|Overall Study|Adverse Event|1|||
33616834|NCT03710642|102144431|FG000|Overall Study|non-site physician recommendation|1|||
33616835|NCT03710642|102144432|FG001|Overall Study|non-site physician recommendation|0|||
33616836|NCT03710642|102144431|FG000|Overall Study|Participant unwilling or unable to participate|1|||
33408974|NCT04668066|101386146|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
33408975|NCT04668066|101386147|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
33408976|NCT04668066|101386148|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
33408977|NCT04668066|101386149|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
33408978|NCT04668066|101386150|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
33408979|NCT04668066|101386151|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
33408980|NCT04668066|101386152|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
33408981|NCT04668066|101386153|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
33408982|NCT04668066|101386135|FG000|Part 2: Treatment Phase|Other|0|||
33408983|NCT04668066|101386136|FG001|Part 2: Treatment Phase|Other|0|||
33408984|NCT04668066|101386137|FG002|Part 2: Treatment Phase|Other|0|||
33408985|NCT04668066|101386138|FG003|Part 2: Treatment Phase|Other|0|||
33408986|NCT04668066|101386139|FG004|Part 2: Treatment Phase|Other|0|||
33408987|NCT04668066|101386140|FG005|Part 2: Treatment Phase|Other|0|||
33408988|NCT04668066|101386141|FG006|Part 2: Treatment Phase|Other|0|||
33408989|NCT04668066|101386142|FG007|Part 2: Treatment Phase|Other|0|||
33408990|NCT04668066|101386143|FG008|Part 2: Treatment Phase|Other|0|||
33408991|NCT04668066|101386144|FG009|Part 2: Treatment Phase|Other|0|||
33408992|NCT04668066|101386145|FG010|Part 2: Treatment Phase|Other|0|||
33408993|NCT04668066|101386146|FG011|Part 2: Treatment Phase|Other|0|||
33408994|NCT04668066|101386147|FG012|Part 2: Treatment Phase|Other|0|||
33408995|NCT04668066|101386148|FG013|Part 2: Treatment Phase|Other|0|||
33408996|NCT04668066|101386149|FG014|Part 2: Treatment Phase|Other|0|||
33408997|NCT04668066|101386150|FG015|Part 2: Treatment Phase|Other|0|||
33408998|NCT04668066|101386151|FG016|Part 2: Treatment Phase|Other|0|||
33408999|NCT04668066|101386152|FG017|Part 2: Treatment Phase|Other|0|||
33409000|NCT04668066|101386153|FG018|Part 2: Treatment Phase|Other|1|||
33409001|NCT04668066|101386135|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409002|NCT04668066|101386136|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409003|NCT04668066|101386137|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409004|NCT04668066|101386138|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409005|NCT04668066|101386139|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409006|NCT04668066|101386140|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409007|NCT04668066|101386141|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409008|NCT04668066|101386142|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409009|NCT04668066|101386143|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409010|NCT04668066|101386144|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
33545397|NCT02017717|101898526|FG006|Treatment Period|Participant no longer met criteria|0|||
33616837|NCT03710642|102144432|FG001|Overall Study|Participant unwilling or unable to participate|1|||
33213729|NCT03162224|100679736|FG002|Overall Study|Other|1|||
33213730|NCT02065336|100679738|FG000|Extension Phase|Study Terminated by Sponsor|0|||
33409011|NCT04668066|101386145|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409012|NCT04668066|101386146|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409013|NCT04668066|101386147|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409014|NCT04668066|101386148|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409015|NCT04668066|101386149|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409016|NCT04668066|101386150|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409017|NCT04668066|101386151|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
33409018|NCT04668066|101386152|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
33213731|NCT02065336|100679739|FG001|Extension Phase|Study Terminated by Sponsor|0|||
33409019|NCT04668066|101386153|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
33409020|NCT00399542|101386161|FG000|Overall Study|Adverse Event|18|||
33545398|NCT02017717|101898527|FG007|Treatment Period|Participant no longer met criteria|0|||
33545399|NCT02017717|101898528|FG008|Treatment Period|Participant no longer met criteria|0|||
33545400|NCT02017717|101898520|FG000|Treatment Period|other reasons|0|||
33545401|NCT02017717|101898521|FG001|Treatment Period|other reasons|0|||
33545402|NCT02017717|101898522|FG002|Treatment Period|other reasons|0|||
33545403|NCT02017717|101898523|FG003|Treatment Period|other reasons|0|||
33545404|NCT02017717|101898524|FG004|Treatment Period|other reasons|1|||
33545405|NCT02017717|101898525|FG005|Treatment Period|other reasons|0|||
33545406|NCT02017717|101898526|FG006|Treatment Period|other reasons|0|||
33545407|NCT02017717|101898527|FG007|Treatment Period|other reasons|1|||
33545408|NCT02017717|101898528|FG008|Treatment Period|other reasons|1|||
33545409|NCT02017717|101898520|FG000|Treatment Period|Maximum clinical benefit|0|||
33545410|NCT02017717|101898521|FG001|Treatment Period|Maximum clinical benefit|0|||
33545411|NCT02017717|101898522|FG002|Treatment Period|Maximum clinical benefit|0|||
33545412|NCT02017717|101898523|FG003|Treatment Period|Maximum clinical benefit|0|||
33545413|NCT02017717|101898524|FG004|Treatment Period|Maximum clinical benefit|1|||
33545414|NCT02017717|101898525|FG005|Treatment Period|Maximum clinical benefit|0|||
33545415|NCT02017717|101898526|FG006|Treatment Period|Maximum clinical benefit|0|||
33545416|NCT02017717|101898527|FG007|Treatment Period|Maximum clinical benefit|0|||
33545417|NCT02017717|101898528|FG008|Treatment Period|Maximum clinical benefit|0|||
33545418|NCT03370302|101898531|FG000|Dose Escalation Phase|Other|0|||
33545419|NCT03370302|101898532|FG001|Dose Escalation Phase|Other|1|||
33545420|NCT03370302|101898533|FG002|Dose Escalation Phase|Other|1|||
33545421|NCT03370302|101898534|FG003|Dose Escalation Phase|Other|0|||
33545422|NCT03370302|101898535|FG004|Dose Escalation Phase|Other|0|||
33545423|NCT03370302|101898536|FG005|Dose Escalation Phase|Other|0|||
33545424|NCT03370302|101898531|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
33545425|NCT03370302|101898532|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
33545426|NCT03370302|101898533|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
33545427|NCT03370302|101898534|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
33545428|NCT03370302|101898535|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
33545429|NCT03370302|101898536|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
33347618|NCT00552110|101160119|FG004|Overall Study|Delay of Study due to Relabeling|0|||
33347619|NCT00552110|101160115|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
33347620|NCT00552110|101160116|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
33347621|NCT00552110|101160117|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
33347622|NCT00552110|101160118|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
33347623|NCT00552110|101160119|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
33347624|NCT00552110|101160115|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
33347625|NCT00552110|101160116|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
33347626|NCT00552110|101160117|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
33347627|NCT00552110|101160118|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
33347628|NCT00552110|101160119|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
33347629|NCT01573910|101160122|FG000|Overall Study|Adverse Event|4|||
33347630|NCT01573910|101160123|FG001|Overall Study|Adverse Event|4|||
33347631|NCT01573910|101160122|FG000|Overall Study|Lost to Follow-up|2|||
33347632|NCT01573910|101160123|FG001|Overall Study|Lost to Follow-up|1|||
33347633|NCT01573910|101160122|FG000|Overall Study|Withdrawal by Subject|0|||
33347634|NCT01573910|101160123|FG001|Overall Study|Withdrawal by Subject|1|||
33347635|NCT01573910|101160122|FG000|Overall Study|Protocol Violation|3|||
33347636|NCT01573910|101160123|FG001|Overall Study|Protocol Violation|0|||
33347637|NCT01573910|101160122|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
33545430|NCT03370302|101898531|FG000|Dose Escalation Phase|Adverse Event|1|||
33545431|NCT03370302|101898532|FG001|Dose Escalation Phase|Adverse Event|0|||
33545432|NCT03370302|101898533|FG002|Dose Escalation Phase|Adverse Event|2|||
33545433|NCT03370302|101898534|FG003|Dose Escalation Phase|Adverse Event|0|||
33545434|NCT03370302|101898535|FG004|Dose Escalation Phase|Adverse Event|0|||
33545435|NCT03370302|101898536|FG005|Dose Escalation Phase|Adverse Event|0|||
33545436|NCT03370302|101898531|FG000|Dose Escalation Phase|Progressive Disease|2|||
33213732|NCT02065336|100679740|FG002|Extension Phase|Study Terminated by Sponsor|0|||
33213733|NCT02065336|100679741|FG003|Extension Phase|Study Terminated by Sponsor|0|||
33213734|NCT02065336|100679742|FG004|Extension Phase|Study Terminated by Sponsor|0|||
33213735|NCT02065336|100679743|FG005|Extension Phase|Study Terminated by Sponsor|0|||
33213736|NCT02065336|100679744|FG006|Extension Phase|Study Terminated by Sponsor|0|||
33213737|NCT02065336|100679745|FG007|Extension Phase|Study Terminated by Sponsor|0|||
33545437|NCT03370302|101898532|FG001|Dose Escalation Phase|Progressive Disease|4|||
33545438|NCT03370302|101898533|FG002|Dose Escalation Phase|Progressive Disease|2|||
33545439|NCT03370302|101898534|FG003|Dose Escalation Phase|Progressive Disease|0|||
33545440|NCT03370302|101898535|FG004|Dose Escalation Phase|Progressive Disease|3|||
33545441|NCT03370302|101898536|FG005|Dose Escalation Phase|Progressive Disease|1|||
33545442|NCT03370302|101898531|FG000|Dose Expansion Phase|Progressive Disease|0|||
33347638|NCT01573910|101160123|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
33347639|NCT00130286|101160126|FG000|Overall Study|Withdrawal by Subject|0|||
33347640|NCT00130286|101160127|FG001|Overall Study|Withdrawal by Subject|1|||
33545443|NCT03370302|101898532|FG001|Dose Expansion Phase|Progressive Disease|0|||
33545444|NCT03370302|101898533|FG002|Dose Expansion Phase|Progressive Disease|0|||
33545445|NCT03370302|101898534|FG003|Dose Expansion Phase|Progressive Disease|6|||
33545446|NCT03370302|101898535|FG004|Dose Expansion Phase|Progressive Disease|0|||
33545447|NCT03370302|101898536|FG005|Dose Expansion Phase|Progressive Disease|0|||
33545448|NCT02362451|101898539|FG000|Overall Study|Withdrawal by Subject|0|||
33545449|NCT02362451|101898540|FG001|Overall Study|Withdrawal by Subject|1|||
33545450|NCT02362451|101898539|FG000|Overall Study|Lack of Efficacy|2|||
33545451|NCT02362451|101898540|FG001|Overall Study|Lack of Efficacy|0|||
33545452|NCT02362451|101898539|FG000|Overall Study|Progression|1|||
33545453|NCT02362451|101898540|FG001|Overall Study|Progression|0|||
33545454|NCT02362451|101898539|FG000|Overall Study|Participant chose other therapy.|1|||
33545455|NCT02362451|101898540|FG001|Overall Study|Participant chose other therapy.|0|||
33545456|NCT03617588|101898541|FG000|Overall Study|Withdrawal by Subject|1|||
33545457|NCT03617588|101898542|FG001|Overall Study|Withdrawal by Subject|0|||
33545458|NCT00390013|101898543|FG000|Phase 1|tired|0|||
33545459|NCT00390013|101898544|FG001|Phase 1|tired|0|||
33545460|NCT00390013|101898545|FG002|Phase 1|tired|0|||
33545461|NCT00390013|101898546|FG003|Phase 1|tired|1|||
33545462|NCT00390013|101898543|FG000|Phase 2 First Treatment|tired|1|||
33545463|NCT00390013|101898544|FG001|Phase 2 First Treatment|tired|0|||
33545464|NCT00390013|101898545|FG002|Phase 2 First Treatment|tired|0|||
33545465|NCT00390013|101898546|FG003|Phase 2 First Treatment|tired|0|||
33545466|NCT00390013|101898543|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
33545467|NCT00390013|101898544|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
33545468|NCT00390013|101898545|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
33545469|NCT00390013|101898546|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
33545470|NCT01171534|101898547|FG000|Overall Study|Lost to Follow-up|0|||
33545471|NCT01171534|101898548|FG001|Overall Study|Lost to Follow-up|2|||
33545472|NCT01171534|101898547|FG000|Overall Study|screen failure|0|||
33545473|NCT01171534|101898548|FG001|Overall Study|screen failure|1|||
33545474|NCT01389232|101898549|FG000|Overall Study|Had scaffold removed|15|||
33545475|NCT01389232|101898549|FG000|Overall Study|Personal reasons|2|||
33545476|NCT01389232|101898549|FG000|Overall Study|Adverse Event|1|||
33545477|NCT01389232|101898549|FG000|Overall Study|Death|1|||
33545478|NCT02911116|101898550|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33545479|NCT02911116|101898551|FG001|Overall Study|Insufficient Therapeutic Response|0|||
33545480|NCT02911116|101898550|FG000|Overall Study|Lost to Follow-up|0|||
33545481|NCT02911116|101898551|FG001|Overall Study|Lost to Follow-up|1|||
33545482|NCT00671749|101898553|FG000|Overall Study|Adverse Event|2|||
33545483|NCT00671749|101898553|FG000|Overall Study|Withdrawal by Subject|4|||
33545484|NCT00671749|101898553|FG000|Overall Study|Protocol Violation|1|||
33545485|NCT00671749|101898553|FG000|Overall Study|Lost to Follow-up|1|||
33545486|NCT00165698|101898554|FG000|Overall Study|Adverse Event|2|||
33545487|NCT00165698|101898555|FG001|Overall Study|Adverse Event|10|||
33545488|NCT00165698|101898554|FG000|Overall Study|Lost to Follow-up|2|||
33545489|NCT00165698|101898555|FG001|Overall Study|Lost to Follow-up|2|||
33545490|NCT00165698|101898554|FG000|Overall Study|Withdrawal by Subject|2|||
33545491|NCT00165698|101898555|FG001|Overall Study|Withdrawal by Subject|1|||
33545492|NCT00165698|101898554|FG000|Overall Study|Protocol Violation|1|||
33545493|NCT00165698|101898555|FG001|Overall Study|Protocol Violation|0|||
33545494|NCT00165698|101898554|FG000|Overall Study|Not Taken/Lost the medicine|1|||
33545495|NCT00165698|101898555|FG001|Overall Study|Not Taken/Lost the medicine|2|||
33545496|NCT01461551|101898556|FG000|Overall Study|Physician Decision|2|||
33545497|NCT01461551|101898557|FG001|Overall Study|Physician Decision|1|||
33545498|NCT01461551|101898558|FG002|Overall Study|Physician Decision|2|||
33545499|NCT00005047|101898559|FG000|Overall Study|Withdrawal by Subject|12|||
33545500|NCT00005047|101898560|FG001|Overall Study|Withdrawal by Subject|0|||
33545501|NCT00005047|101898561|FG002|Overall Study|Withdrawal by Subject|0|||
33545502|NCT00005047|101898562|FG003|Overall Study|Withdrawal by Subject|0|||
33545503|NCT00005047|101898559|FG000|Overall Study|Adverse Event|5|||
33545504|NCT00005047|101898560|FG001|Overall Study|Adverse Event|0|||
33545505|NCT00005047|101898561|FG002|Overall Study|Adverse Event|0|||
33213738|NCT02065336|100679746|FG008|Extension Phase|Study Terminated by Sponsor|2|||
33213739|NCT02065336|100679747|FG009|Extension Phase|Study Terminated by Sponsor|8|||
33545506|NCT00005047|101898562|FG003|Overall Study|Adverse Event|0|||
33545507|NCT00005047|101898559|FG000|Overall Study|Lost to Follow-up|1|||
33545508|NCT00005047|101898560|FG001|Overall Study|Lost to Follow-up|0|||
33545509|NCT00005047|101898561|FG002|Overall Study|Lost to Follow-up|0|||
33545510|NCT00005047|101898562|FG003|Overall Study|Lost to Follow-up|0|||
33545511|NCT00005047|101898559|FG000|Overall Study|Lack of Efficacy|1|||
33545512|NCT00005047|101898560|FG001|Overall Study|Lack of Efficacy|0|||
33545513|NCT00005047|101898561|FG002|Overall Study|Lack of Efficacy|0|||
33545514|NCT00005047|101898562|FG003|Overall Study|Lack of Efficacy|0|||
33545515|NCT02114684|101898563|FG000|Overall Study|Death|6|||
33545516|NCT02114684|101898564|FG001|Overall Study|Death|4|||
33545517|NCT02114684|101898563|FG000|Overall Study|Lost to Follow-up|1|||
33545518|NCT02114684|101898564|FG001|Overall Study|Lost to Follow-up|2|||
33545519|NCT02114684|101898563|FG000|Overall Study|Withdrawal by Subject|1|||
33545520|NCT02114684|101898564|FG001|Overall Study|Withdrawal by Subject|2|||
33545521|NCT02114684|101898563|FG000|Overall Study|Relocation|3|||
33545522|NCT02114684|101898564|FG001|Overall Study|Relocation|1|||
33545523|NCT02114684|101898563|FG000|Overall Study|Rifampicin resistant on culture|0|||
33545524|NCT02114684|101898564|FG001|Overall Study|Rifampicin resistant on culture|1|||
33545525|NCT02114684|101898563|FG000|Overall Study|Patient Incarcerated|1|||
33545526|NCT02114684|101898564|FG001|Overall Study|Patient Incarcerated|0|||
33347641|NCT00130286|101160128|FG002|Overall Study|Withdrawal by Subject|2|||
33347642|NCT00130286|101160129|FG003|Overall Study|Withdrawal by Subject|2|||
33347643|NCT00130286|101160126|FG000|Overall Study|Adverse Event|0|||
33213740|NCT00698646|100679748|FG000|Overall Study|Adverse Event|8|||
33213741|NCT00698646|100679749|FG001|Overall Study|Adverse Event|7|||
33213742|NCT00698646|100679750|FG002|Overall Study|Adverse Event|8|||
33213743|NCT00698646|100679748|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
33545527|NCT00870727|101898565|FG000|Overall Study|Lost to Follow-up|0|||
33347644|NCT00130286|101160127|FG001|Overall Study|Adverse Event|0|||
33347645|NCT00130286|101160128|FG002|Overall Study|Adverse Event|2|||
33347646|NCT00130286|101160129|FG003|Overall Study|Adverse Event|0|||
33347647|NCT00130286|101160126|FG000|Overall Study|Missing lab specimens|0|||
33347648|NCT00130286|101160127|FG001|Overall Study|Missing lab specimens|2|||
33545528|NCT00870727|101898566|FG001|Overall Study|Lost to Follow-up|1|||
33545529|NCT00870727|101898565|FG000|Overall Study|Lack of Efficacy|1|||
33213744|NCT00698646|100679749|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
33213745|NCT00698646|100679750|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
33213746|NCT00698646|100679748|FG000|Overall Study|Protocol Deviation|6|||
33213747|NCT00698646|100679749|FG001|Overall Study|Protocol Deviation|2|||
33213748|NCT00698646|100679750|FG002|Overall Study|Protocol Deviation|3|||
33213749|NCT00698646|100679748|FG000|Overall Study|Withdrawal by Subject|10|||
33213750|NCT00698646|100679749|FG001|Overall Study|Withdrawal by Subject|11|||
33213751|NCT00698646|100679750|FG002|Overall Study|Withdrawal by Subject|8|||
33213752|NCT00698646|100679748|FG000|Overall Study|Lost to Follow-up|0|||
33213753|NCT00698646|100679749|FG001|Overall Study|Lost to Follow-up|0|||
33213754|NCT00698646|100679750|FG002|Overall Study|Lost to Follow-up|2|||
33213755|NCT00698646|100679748|FG000|Overall Study|Administrative problems|1|||
33213756|NCT00698646|100679749|FG001|Overall Study|Administrative problems|0|||
33213757|NCT00698646|100679750|FG002|Overall Study|Administrative problems|1|||
33213758|NCT00810264|100679751|FG000|Overall Study|Lost to Follow-up|191|||
33213759|NCT00810264|100679751|FG000|Overall Study|Withdrawal by subject or physician|721|||
33213760|NCT00810264|100679751|FG000|Overall Study|Death|641|||
33213761|NCT00344461|100679752|FG000|Overall Study|Adverse Event|6|||
33213762|NCT00344461|100679752|FG000|Overall Study|Death|1|||
33213763|NCT00344461|100679752|FG000|Overall Study|Lack of Efficacy|2|||
33213764|NCT00344461|100679752|FG000|Overall Study|Lost to Follow-up|2|||
33213765|NCT00344461|100679752|FG000|Overall Study|Physician Decision|2|||
33213766|NCT00344461|100679752|FG000|Overall Study|Protocol Violation|6|||
33213767|NCT00344461|100679752|FG000|Overall Study|Withdrawal by Subject|2|||
33213768|NCT00528775|100679763|FG000|Overall Study|Other not specified|1|||
33213769|NCT02308748|100679765|FG000|Period 1|Withdrawal by Subject|0|||
33213770|NCT02308748|100679766|FG001|Period 1|Withdrawal by Subject|0|||
33213771|NCT02308748|100679767|FG002|Period 1|Withdrawal by Subject|1|||
33213772|NCT02308748|100679768|FG003|Period 1|Withdrawal by Subject|0|||
33213773|NCT02308748|100679769|FG004|Period 1|Withdrawal by Subject|0|||
33213774|NCT02308748|100679770|FG005|Period 1|Withdrawal by Subject|0|||
33213775|NCT02308748|100679771|FG006|Period 1|Withdrawal by Subject|0|||
33213776|NCT02308748|100679772|FG007|Period 1|Withdrawal by Subject|0|||
33213777|NCT02308748|100679773|FG008|Period 1|Withdrawal by Subject|0|||
33545530|NCT00870727|101898566|FG001|Overall Study|Lack of Efficacy|3|||
33545531|NCT00870727|101898565|FG000|Overall Study|Adverse Event|0|||
33545532|NCT00870727|101898566|FG001|Overall Study|Adverse Event|1|||
33545533|NCT01648764|101898567|FG000|Overall Study|Progressive Disease|0|||
33213778|NCT02308748|100679774|FG009|Period 1|Withdrawal by Subject|0|||
33213779|NCT02308748|100679765|FG000|Period 2|Adverse Event|0|||
33213780|NCT02308748|100679766|FG001|Period 2|Adverse Event|0|||
33213781|NCT02308748|100679767|FG002|Period 2|Adverse Event|0|||
33213782|NCT02308748|100679768|FG003|Period 2|Adverse Event|0|||
33213783|NCT02308748|100679769|FG004|Period 2|Adverse Event|0|||
33213784|NCT02308748|100679770|FG005|Period 2|Adverse Event|0|||
33545534|NCT01648764|101898568|FG001|Overall Study|Progressive Disease|1|||
33545535|NCT01648764|101898569|FG002|Overall Study|Progressive Disease|0|||
33631298|NCT03486912|102202916|FG002|Treatment Period|Withdrawal by Subject|3|||
33213785|NCT02308748|100679771|FG006|Period 2|Adverse Event|0|||
33213786|NCT02308748|100679772|FG007|Period 2|Adverse Event|1|||
33213787|NCT02308748|100679773|FG008|Period 2|Adverse Event|0|||
33213788|NCT02308748|100679774|FG009|Period 2|Adverse Event|0|||
33545536|NCT01648764|101898570|FG003|Overall Study|Progressive Disease|0|||
33545537|NCT01648764|101898571|FG004|Overall Study|Progressive Disease|0|||
33213789|NCT02308748|100679765|FG000|Period 3|Protocol Violation|0|||
33213790|NCT02308748|100679766|FG001|Period 3|Protocol Violation|0|||
33347649|NCT00130286|101160128|FG002|Overall Study|Missing lab specimens|0|||
33213791|NCT02308748|100679767|FG002|Period 3|Protocol Violation|0|||
33213792|NCT02308748|100679768|FG003|Period 3|Protocol Violation|0|||
33213793|NCT02308748|100679769|FG004|Period 3|Protocol Violation|0|||
33213794|NCT02308748|100679770|FG005|Period 3|Protocol Violation|0|||
33213795|NCT02308748|100679771|FG006|Period 3|Protocol Violation|0|||
33213796|NCT02308748|100679772|FG007|Period 3|Protocol Violation|0|||
33213797|NCT02308748|100679773|FG008|Period 3|Protocol Violation|0|||
33213798|NCT02308748|100679774|FG009|Period 3|Protocol Violation|1|||
33213799|NCT02308748|100679765|FG000|Period 5|Adverse Event|1|||
33213800|NCT02308748|100679766|FG001|Period 5|Adverse Event|0|||
33213801|NCT02308748|100679767|FG002|Period 5|Adverse Event|0|||
33213802|NCT02308748|100679768|FG003|Period 5|Adverse Event|0|||
33213803|NCT02308748|100679769|FG004|Period 5|Adverse Event|0|||
33213804|NCT02308748|100679770|FG005|Period 5|Adverse Event|0|||
33213805|NCT02308748|100679771|FG006|Period 5|Adverse Event|0|||
33213806|NCT02308748|100679772|FG007|Period 5|Adverse Event|0|||
33213807|NCT02308748|100679773|FG008|Period 5|Adverse Event|1|||
33213808|NCT02308748|100679774|FG009|Period 5|Adverse Event|0|||
33213809|NCT02975973|100679775|FG000|Overall Study|Adverse Event|1|||
33213810|NCT02975973|100679776|FG001|Overall Study|Adverse Event|1|||
33213811|NCT02975973|100679777|FG002|Overall Study|Adverse Event|1|||
33213812|NCT02975973|100679778|FG003|Overall Study|Adverse Event|0|||
33545538|NCT01648764|101898572|FG005|Overall Study|Progressive Disease|1|||
33545539|NCT01648764|101898573|FG006|Overall Study|Progressive Disease|1|||
33545540|NCT01648764|101898574|FG007|Overall Study|Progressive Disease|0|||
33545541|NCT01648764|101898575|FG008|Overall Study|Progressive Disease|0|||
33545542|NCT01648764|101898576|FG009|Overall Study|Progressive Disease|2|||
33545543|NCT01648764|101898577|FG010|Overall Study|Progressive Disease|0|||
33545544|NCT01648764|101898578|FG011|Overall Study|Progressive Disease|1|||
33545545|NCT01648764|101898579|FG012|Overall Study|Progressive Disease|2|||
33545546|NCT01648764|101898580|FG013|Overall Study|Progressive Disease|1|||
33545547|NCT01648764|101898567|FG000|Overall Study|Adverse Event|0|||
33545548|NCT01648764|101898568|FG001|Overall Study|Adverse Event|0|||
33545549|NCT01648764|101898569|FG002|Overall Study|Adverse Event|0|||
33545550|NCT01648764|101898570|FG003|Overall Study|Adverse Event|0|||
33545551|NCT01648764|101898571|FG004|Overall Study|Adverse Event|0|||
33545552|NCT01648764|101898572|FG005|Overall Study|Adverse Event|1|||
33545553|NCT01648764|101898573|FG006|Overall Study|Adverse Event|0|||
33545554|NCT01648764|101898574|FG007|Overall Study|Adverse Event|0|||
33545555|NCT01648764|101898575|FG008|Overall Study|Adverse Event|0|||
33545556|NCT01648764|101898576|FG009|Overall Study|Adverse Event|1|||
33545557|NCT01648764|101898577|FG010|Overall Study|Adverse Event|0|||
33545558|NCT01648764|101898578|FG011|Overall Study|Adverse Event|3|||
33545559|NCT01648764|101898579|FG012|Overall Study|Adverse Event|1|||
33545560|NCT01648764|101898580|FG013|Overall Study|Adverse Event|1|||
33545561|NCT01648764|101898567|FG000|Overall Study|Death|0|||
33545562|NCT01648764|101898568|FG001|Overall Study|Death|0|||
33545563|NCT01648764|101898569|FG002|Overall Study|Death|0|||
33545564|NCT01648764|101898570|FG003|Overall Study|Death|0|||
33545565|NCT01648764|101898571|FG004|Overall Study|Death|0|||
33545566|NCT01648764|101898572|FG005|Overall Study|Death|0|||
33545567|NCT01648764|101898573|FG006|Overall Study|Death|1|||
33545568|NCT01648764|101898574|FG007|Overall Study|Death|0|||
33545569|NCT01648764|101898575|FG008|Overall Study|Death|0|||
33545570|NCT01648764|101898576|FG009|Overall Study|Death|0|||
33545571|NCT01648764|101898577|FG010|Overall Study|Death|0|||
33616838|NCT03710642|102144431|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
33616839|NCT03710642|102144432|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
33213813|NCT04084314|100679779|FG000|Overall Study|Subject/guardian decision|91|||
33213814|NCT04084314|100679779|FG000|Overall Study|Adverse Event|24|||
33213815|NCT04084314|100679779|FG000|Overall Study|Lost to Follow-up|19|||
33213816|NCT04084314|100679779|FG000|Overall Study|New therapy for study indication|9|||
33213817|NCT04084314|100679779|FG000|Overall Study|Pregnancy|9|||
33409021|NCT00399542|101386162|FG001|Overall Study|Adverse Event|15|||
33545572|NCT01648764|101898578|FG011|Overall Study|Death|0|||
33545573|NCT01648764|101898579|FG012|Overall Study|Death|0|||
33213818|NCT04084314|100679779|FG000|Overall Study|Withdrawal of informed consent|8|||
33213819|NCT04084314|100679779|FG000|Overall Study|Physician Decision|4|||
33213820|NCT04084314|100679779|FG000|Overall Study|Protocol Deviation|3|||
33213821|NCT00335322|100679780|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
33213822|NCT00335322|100679781|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
33545574|NCT01648764|101898580|FG013|Overall Study|Death|1|||
33545575|NCT01648764|101898567|FG000|Overall Study|Withdrawal by Subject|0|||
33545576|NCT01648764|101898568|FG001|Overall Study|Withdrawal by Subject|0|||
33545577|NCT01648764|101898569|FG002|Overall Study|Withdrawal by Subject|0|||
33545578|NCT01648764|101898570|FG003|Overall Study|Withdrawal by Subject|0|||
33545579|NCT01648764|101898571|FG004|Overall Study|Withdrawal by Subject|0|||
33545580|NCT01648764|101898572|FG005|Overall Study|Withdrawal by Subject|0|||
33545581|NCT01648764|101898573|FG006|Overall Study|Withdrawal by Subject|2|||
33545582|NCT01648764|101898574|FG007|Overall Study|Withdrawal by Subject|0|||
33545583|NCT01648764|101898575|FG008|Overall Study|Withdrawal by Subject|0|||
33616840|NCT03710642|102144431|FG000|Overall Study|NA-no code provided|1|||
33213823|NCT00335322|100679782|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
33213824|NCT02477111|100679783|FG000|Overall Study|Death|28|||
33213825|NCT02477111|100679783|FG000|Overall Study|Withdrawal by Subject|19|||
33213826|NCT02477111|100679783|FG000|Overall Study|Lost to Follow-up|4|||
33213827|NCT01258608|100679784|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
33213828|NCT01258608|100679785|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
33213829|NCT01258608|100679784|FG000|Overall Study|Clinical progression|1|||
33213830|NCT01258608|100679785|FG001|Overall Study|Clinical progression|0|||
33213831|NCT01258608|100679784|FG000|Overall Study|Sponsor decision|0|||
33213832|NCT01258608|100679785|FG001|Overall Study|Sponsor decision|1|||
33213833|NCT01258608|100679784|FG000|Overall Study|Physician Decision|6|||
33213834|NCT01258608|100679785|FG001|Overall Study|Physician Decision|1|||
33213835|NCT01258608|100679784|FG000|Overall Study|Lost to Follow-up|0|||
33213836|NCT01258608|100679785|FG001|Overall Study|Lost to Follow-up|1|||
33213837|NCT01258608|100679784|FG000|Overall Study|Lack of compliance|1|||
33213838|NCT01258608|100679785|FG001|Overall Study|Lack of compliance|0|||
33213839|NCT01258608|100679784|FG000|Overall Study|Lack of Efficacy|0|||
33213840|NCT01258608|100679785|FG001|Overall Study|Lack of Efficacy|1|||
33213841|NCT01258608|100679784|FG000|Overall Study|Adverse Event|6|||
33213842|NCT01258608|100679785|FG001|Overall Study|Adverse Event|10|||
33213843|NCT01258608|100679784|FG000|Overall Study|Withdrawal by Subject|6|||
33213844|NCT01258608|100679785|FG001|Overall Study|Withdrawal by Subject|5|||
33213845|NCT03355326|100679786|FG000|Overall Study|Protocol Violation|3|||
33213846|NCT03355326|100679787|FG001|Overall Study|Protocol Violation|3|||
33213847|NCT02677116|100679802|FG000|Overall Study|Adverse Event|0|||
33213848|NCT02677116|100679803|FG001|Overall Study|Adverse Event|1|||
33213849|NCT02677116|100679804|FG002|Overall Study|Adverse Event|0|||
33213850|NCT02677116|100679805|FG003|Overall Study|Adverse Event|0|||
33213851|NCT02677116|100679806|FG004|Overall Study|Adverse Event|0|||
33213852|NCT02677116|100679807|FG005|Overall Study|Adverse Event|1|||
33213853|NCT02677116|100679808|FG006|Overall Study|Adverse Event|1|||
33213854|NCT02677116|100679809|FG007|Overall Study|Adverse Event|0|||
33213855|NCT02677116|100679810|FG008|Overall Study|Adverse Event|0|||
33213856|NCT02677116|100679802|FG000|Overall Study|Physician Decision|0|||
33213857|NCT02677116|100679803|FG001|Overall Study|Physician Decision|2|||
33213858|NCT02677116|100679804|FG002|Overall Study|Physician Decision|3|||
33213859|NCT02677116|100679805|FG003|Overall Study|Physician Decision|2|||
33213860|NCT02677116|100679806|FG004|Overall Study|Physician Decision|1|||
33213861|NCT02677116|100679807|FG005|Overall Study|Physician Decision|3|||
33213862|NCT02677116|100679808|FG006|Overall Study|Physician Decision|1|||
33213863|NCT02677116|100679809|FG007|Overall Study|Physician Decision|1|||
33213864|NCT02677116|100679810|FG008|Overall Study|Physician Decision|2|||
33213865|NCT02677116|100679802|FG000|Overall Study|Withdrawal by parent or guardian|2|||
33213866|NCT02677116|100679803|FG001|Overall Study|Withdrawal by parent or guardian|1|||
33213867|NCT02677116|100679804|FG002|Overall Study|Withdrawal by parent or guardian|0|||
33213868|NCT02677116|100679805|FG003|Overall Study|Withdrawal by parent or guardian|1|||
33213869|NCT02677116|100679806|FG004|Overall Study|Withdrawal by parent or guardian|0|||
33213870|NCT02677116|100679807|FG005|Overall Study|Withdrawal by parent or guardian|0|||
33213871|NCT02677116|100679808|FG006|Overall Study|Withdrawal by parent or guardian|2|||
33213872|NCT02677116|100679809|FG007|Overall Study|Withdrawal by parent or guardian|1|||
33213873|NCT02677116|100679810|FG008|Overall Study|Withdrawal by parent or guardian|0|||
33213874|NCT02677116|100679802|FG000|Overall Study|Withdrawal by Subject|1|||
33213875|NCT02677116|100679803|FG001|Overall Study|Withdrawal by Subject|0|||
33213876|NCT02677116|100679804|FG002|Overall Study|Withdrawal by Subject|0|||
33213877|NCT02677116|100679805|FG003|Overall Study|Withdrawal by Subject|0|||
33213878|NCT02677116|100679806|FG004|Overall Study|Withdrawal by Subject|0|||
33213879|NCT02677116|100679807|FG005|Overall Study|Withdrawal by Subject|0|||
33545584|NCT01648764|101898576|FG009|Overall Study|Withdrawal by Subject|0|||
33545585|NCT01648764|101898577|FG010|Overall Study|Withdrawal by Subject|0|||
33545586|NCT01648764|101898578|FG011|Overall Study|Withdrawal by Subject|0|||
33213880|NCT02677116|100679808|FG006|Overall Study|Withdrawal by Subject|0|||
33545587|NCT01648764|101898579|FG012|Overall Study|Withdrawal by Subject|1|||
33545588|NCT01648764|101898580|FG013|Overall Study|Withdrawal by Subject|0|||
33545589|NCT01648764|101898567|FG000|Overall Study|Investigator Decision|0|||
33545590|NCT01648764|101898568|FG001|Overall Study|Investigator Decision|0|||
33545591|NCT01648764|101898569|FG002|Overall Study|Investigator Decision|0|||
33545592|NCT01648764|101898570|FG003|Overall Study|Investigator Decision|0|||
33545593|NCT01648764|101898571|FG004|Overall Study|Investigator Decision|0|||
33545594|NCT01648764|101898572|FG005|Overall Study|Investigator Decision|0|||
33213881|NCT02677116|100679809|FG007|Overall Study|Withdrawal by Subject|0|||
33213882|NCT02677116|100679810|FG008|Overall Study|Withdrawal by Subject|0|||
33213883|NCT04866017|100679812|FG000|Overall Study|Study Terminated by Sponsor|13|||
33213884|NCT04866017|100679813|FG001|Overall Study|Study Terminated by Sponsor|14|||
33213885|NCT04866017|100679814|FG002|Overall Study|Study Terminated by Sponsor|13|||
33213886|NCT04866017|100679812|FG000|Overall Study|Death|8|||
33213887|NCT04866017|100679813|FG001|Overall Study|Death|4|||
33213888|NCT04866017|100679814|FG002|Overall Study|Death|8|||
33409022|NCT00399542|101386161|FG000|Overall Study|Protocol Violation|13|||
33409023|NCT00399542|101386162|FG001|Overall Study|Protocol Violation|3|||
33409024|NCT00399542|101386161|FG000|Overall Study|Withdrawal by Subject|28|||
33409025|NCT00399542|101386162|FG001|Overall Study|Withdrawal by Subject|10|||
33409026|NCT00399542|101386161|FG000|Overall Study|Lack of Efficacy|18|||
33409027|NCT00399542|101386162|FG001|Overall Study|Lack of Efficacy|8|||
33409028|NCT00399542|101386161|FG000|Overall Study|Lost to Follow-up|6|||
33409029|NCT00399542|101386162|FG001|Overall Study|Lost to Follow-up|6|||
33409030|NCT00399542|101386161|FG000|Overall Study|Other|1|||
33409031|NCT00399542|101386162|FG001|Overall Study|Other|0|||
33409032|NCT00399542|101386161|FG000|Overall Study|Physician Decision|0|||
33409033|NCT00399542|101386162|FG001|Overall Study|Physician Decision|1|||
33409034|NCT00334893|101386163|FG000|Overall Study|Not Treated|1|||
33409035|NCT00334893|101386164|FG001|Overall Study|Not Treated|0|||
33409036|NCT00429026|101386165|FG000|Overall Study|Inevaluable for response.|40|||
33409037|NCT02190604|101386169|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33213889|NCT04866017|100679812|FG000|Overall Study|Withdrawal by Subject|1|||
33213890|NCT04866017|100679813|FG001|Overall Study|Withdrawal by Subject|0|||
33213891|NCT04866017|100679814|FG002|Overall Study|Withdrawal by Subject|1|||
33213892|NCT04866017|100679812|FG000|Overall Study|Physician Decision|0|||
33213893|NCT04866017|100679813|FG001|Overall Study|Physician Decision|1|||
33347650|NCT00130286|101160129|FG003|Overall Study|Missing lab specimens|0|||
33409038|NCT02190604|101386170|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33409039|NCT02190604|101386171|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33545595|NCT01648764|101898573|FG006|Overall Study|Investigator Decision|1|||
33545596|NCT01648764|101898574|FG007|Overall Study|Investigator Decision|0|||
33545597|NCT01648764|101898575|FG008|Overall Study|Investigator Decision|0|||
33545598|NCT01648764|101898576|FG009|Overall Study|Investigator Decision|0|||
33545599|NCT01648764|101898577|FG010|Overall Study|Investigator Decision|0|||
33545600|NCT01648764|101898578|FG011|Overall Study|Investigator Decision|1|||
33545601|NCT01648764|101898579|FG012|Overall Study|Investigator Decision|0|||
33545602|NCT01648764|101898580|FG013|Overall Study|Investigator Decision|0|||
33545603|NCT01991795|101898583|FG000|Overall Study|Lost to Follow-up|6|||
33545604|NCT01991795|101898584|FG001|Overall Study|Lost to Follow-up|4|||
33545605|NCT01991795|101898583|FG000|Overall Study|Withdrawal by Subject|117|||
33347651|NCT00927368|101160136|FG000|Overall Study|enrollment in another study|1|||
33409040|NCT02190604|101386172|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33409041|NCT02190604|101386173|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33409042|NCT02190604|101386174|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33409043|NCT02190604|101386175|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33409044|NCT02190604|101386176|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33545606|NCT01991795|101898584|FG001|Overall Study|Withdrawal by Subject|94|||
33545607|NCT01991795|101898583|FG000|Overall Study|Site prematurely closed by sponsor|26|||
33347652|NCT00927368|101160137|FG001|Overall Study|enrollment in another study|1|||
33347653|NCT00927368|101160138|FG002|Overall Study|enrollment in another study|2|||
33347654|NCT00927368|101160136|FG000|Overall Study|Lost to Follow-up|4|||
33347655|NCT00927368|101160137|FG001|Overall Study|Lost to Follow-up|0|||
33347656|NCT00927368|101160138|FG002|Overall Study|Lost to Follow-up|0|||
33347657|NCT00927368|101160136|FG000|Overall Study|equipment failure|1|||
33347658|NCT00927368|101160137|FG001|Overall Study|equipment failure|0|||
33347659|NCT00927368|101160138|FG002|Overall Study|equipment failure|0|||
33347660|NCT00927368|101160136|FG000|Overall Study|ineligible post randomization|0|||
33347661|NCT00927368|101160137|FG001|Overall Study|ineligible post randomization|3|||
33347662|NCT00927368|101160138|FG002|Overall Study|ineligible post randomization|1|||
33347663|NCT00927368|101160136|FG000|Overall Study|cancellation of surgery|0|||
33347664|NCT00927368|101160137|FG001|Overall Study|cancellation of surgery|1|||
33347665|NCT00927368|101160138|FG002|Overall Study|cancellation of surgery|2|||
33347666|NCT02497001|101160145|FG000|Overall Study|Lost to Follow-up|10|||
33347667|NCT02497001|101160146|FG001|Overall Study|Lost to Follow-up|2|||
33347668|NCT02497001|101160147|FG002|Overall Study|Lost to Follow-up|0|||
33347669|NCT02497001|101160148|FG003|Overall Study|Lost to Follow-up|2|||
33409045|NCT02190604|101386177|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33409046|NCT02190604|101386178|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33409047|NCT02190604|101386179|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33545608|NCT01991795|101898584|FG001|Overall Study|Site prematurely closed by sponsor|25|||
33545609|NCT01712516|101898585|FG000|Overall Study|Technical problems|0|||
33409048|NCT02190604|101386180|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33409049|NCT02190604|101386181|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33409050|NCT02190604|101386182|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33409051|NCT02190604|101386183|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
33545610|NCT01712516|101898586|FG001|Overall Study|Technical problems|0|||
33545611|NCT01712516|101898587|FG002|Overall Study|Technical problems|0|||
33213894|NCT04866017|100679814|FG002|Overall Study|Physician Decision|0|||
33347670|NCT02497001|101160145|FG000|Overall Study|Adverse Event|28|||
33347671|NCT02497001|101160146|FG001|Overall Study|Adverse Event|30|||
33347672|NCT02497001|101160147|FG002|Overall Study|Adverse Event|11|||
33409052|NCT02190604|101386184|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33409053|NCT02190604|101386185|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33545612|NCT01712516|101898588|FG003|Overall Study|Technical problems|2|||
33545613|NCT01712516|101898585|FG000|Overall Study|Lost to Follow-up|0|||
33545614|NCT01712516|101898586|FG001|Overall Study|Lost to Follow-up|0|||
33545615|NCT01712516|101898587|FG002|Overall Study|Lost to Follow-up|2|||
33545616|NCT01712516|101898588|FG003|Overall Study|Lost to Follow-up|1|||
33545617|NCT01712516|101898585|FG000|Overall Study|Death|0|||
33545618|NCT01712516|101898586|FG001|Overall Study|Death|1|||
33545619|NCT01712516|101898587|FG002|Overall Study|Death|0|||
33545620|NCT01712516|101898588|FG003|Overall Study|Death|0|||
33545621|NCT01712516|101898585|FG000|Overall Study|Protocol deviation|1|||
33545622|NCT01712516|101898586|FG001|Overall Study|Protocol deviation|0|||
33545623|NCT01712516|101898587|FG002|Overall Study|Protocol deviation|1|||
33545624|NCT01712516|101898588|FG003|Overall Study|Protocol deviation|0|||
33545625|NCT01712516|101898585|FG000|Overall Study|Physician Decision|2|||
33545626|NCT01712516|101898586|FG001|Overall Study|Physician Decision|0|||
33545627|NCT01712516|101898587|FG002|Overall Study|Physician Decision|0|||
33616841|NCT03710642|102144432|FG001|Overall Study|NA-no code provided|0|||
33616842|NCT03710642|102144431|FG000|Overall Study|Withdrawal by Subject|1|||
33616843|NCT03710642|102144432|FG001|Overall Study|Withdrawal by Subject|0|||
33616844|NCT01510158|102144433|FG000|Overall Study|Adverse Event|7|||
33409054|NCT02190604|101386186|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33409055|NCT02190604|101386187|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
33616845|NCT01510158|102144434|FG001|Overall Study|Adverse Event|8|||
33616846|NCT01510158|102144435|FG002|Overall Study|Adverse Event|5|||
33616847|NCT01510158|102144433|FG000|Overall Study|Gout flare|1|||
33545628|NCT01712516|101898588|FG003|Overall Study|Physician Decision|1|||
33616848|NCT01510158|102144434|FG001|Overall Study|Gout flare|0|||
33616849|NCT01510158|102144435|FG002|Overall Study|Gout flare|0|||
33616850|NCT01510158|102144433|FG000|Overall Study|Protocol Violation|17|||
33347673|NCT02497001|101160148|FG003|Overall Study|Adverse Event|11|||
33347674|NCT02497001|101160145|FG000|Overall Study|Withdrawal by Subject|14|||
33347675|NCT02497001|101160146|FG001|Overall Study|Withdrawal by Subject|37|||
33347676|NCT02497001|101160147|FG002|Overall Study|Withdrawal by Subject|19|||
33347677|NCT02497001|101160148|FG003|Overall Study|Withdrawal by Subject|15|||
33347678|NCT02497001|101160145|FG000|Overall Study|Physician Decision|5|||
33347679|NCT02497001|101160146|FG001|Overall Study|Physician Decision|11|||
33347680|NCT02497001|101160147|FG002|Overall Study|Physician Decision|5|||
33347681|NCT02497001|101160148|FG003|Overall Study|Physician Decision|1|||
33347682|NCT02497001|101160145|FG000|Overall Study|subjects that were not treated|1|||
33347683|NCT02497001|101160146|FG001|Overall Study|subjects that were not treated|2|||
33347684|NCT02497001|101160147|FG002|Overall Study|subjects that were not treated|2|||
33347685|NCT02497001|101160148|FG003|Overall Study|subjects that were not treated|1|||
33347686|NCT02497001|101160145|FG000|Overall Study|Major Protocol Deviation|3|||
33347687|NCT02497001|101160146|FG001|Overall Study|Major Protocol Deviation|4|||
33347688|NCT02497001|101160147|FG002|Overall Study|Major Protocol Deviation|4|||
33347689|NCT02497001|101160148|FG003|Overall Study|Major Protocol Deviation|4|||
33347690|NCT02497001|101160145|FG000|Overall Study|Lack of Efficacy|10|||
33347691|NCT02497001|101160146|FG001|Overall Study|Lack of Efficacy|16|||
33347692|NCT02497001|101160147|FG002|Overall Study|Lack of Efficacy|6|||
33347693|NCT02497001|101160148|FG003|Overall Study|Lack of Efficacy|6|||
33347694|NCT02497001|101160145|FG000|Overall Study|Protocol Violation|3|||
33347695|NCT02497001|101160146|FG001|Overall Study|Protocol Violation|1|||
33347696|NCT02497001|101160147|FG002|Overall Study|Protocol Violation|3|||
33347697|NCT02497001|101160148|FG003|Overall Study|Protocol Violation|1|||
33347698|NCT01468311|101160149|FG000|Overall Study|mobilization failure|1|||
33347699|NCT01468311|101160149|FG000|Overall Study|Withdrawal by Subject|1|||
33347700|NCT00542997|101160150|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
33347701|NCT00542997|101160150|FG000|Wash in / Wash Out Period|Adverse Event|3|||
33347702|NCT00542997|101160150|FG000|Efficacy Period|Adverse Event|3|||
33347703|NCT00773279|101160151|FG000|Period 1|Adverse Event|2|||
33347704|NCT00773279|101160152|FG001|Period 1|Adverse Event|1|||
33347705|NCT00773279|101160151|FG000|Period 1|Lack of Efficacy|0|||
33347706|NCT00773279|101160152|FG001|Period 1|Lack of Efficacy|2|||
33347707|NCT00773279|101160151|FG000|Period 1|Unclassified|5|||
33347708|NCT00773279|101160152|FG001|Period 1|Unclassified|1|||
33347709|NCT00773279|101160151|FG000|Period 2|Adverse Event|0|||
33347710|NCT00773279|101160152|FG001|Period 2|Adverse Event|1|||
33347711|NCT00773279|101160151|FG000|Period 2|Lack of Efficacy|1|||
33347712|NCT00773279|101160152|FG001|Period 2|Lack of Efficacy|0|||
33347713|NCT00773279|101160151|FG000|Period 2|Protocol Violation|0|||
33545629|NCT01712516|101898585|FG000|Overall Study|Withdrawal by Subject|3|||
33545630|NCT01712516|101898586|FG001|Overall Study|Withdrawal by Subject|9|||
33545631|NCT01712516|101898587|FG002|Overall Study|Withdrawal by Subject|3|||
33616851|NCT01510158|102144434|FG001|Overall Study|Protocol Violation|16|||
33616852|NCT01510158|102144435|FG002|Overall Study|Protocol Violation|24|||
33347714|NCT00773279|101160152|FG001|Period 2|Protocol Violation|3|||
33347715|NCT00773279|101160151|FG000|Period 2|Unclassified|2|||
33347716|NCT00773279|101160152|FG001|Period 2|Unclassified|2|||
33409056|NCT02190604|101386169|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409057|NCT02190604|101386170|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409058|NCT02190604|101386171|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409059|NCT02190604|101386172|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409060|NCT02190604|101386173|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409061|NCT02190604|101386174|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409062|NCT02190604|101386175|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409063|NCT02190604|101386176|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409064|NCT02190604|101386177|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33347717|NCT05032950|101160157|FG000|Overall Study|Adverse Event|0|||
33347718|NCT05032950|101160158|FG001|Overall Study|Adverse Event|0|||
33347719|NCT05032950|101160159|FG002|Overall Study|Adverse Event|1|||
33347720|NCT05032950|101160160|FG003|Overall Study|Adverse Event|1|||
33347721|NCT05032950|101160161|FG004|Overall Study|Adverse Event|0|||
33347722|NCT05032950|101160162|FG005|Overall Study|Adverse Event|0|||
33347723|NCT00441792|101160163|FG000|Overall Study|Lost to Follow-up|0|||
33347724|NCT00441792|101160164|FG001|Overall Study|Lost to Follow-up|2|||
33347725|NCT02731742|101160165|FG000|Overall Study|Death|1|||
33347726|NCT02731742|101160166|FG001|Overall Study|Death|2|||
33347727|NCT02731742|101160167|FG002|Overall Study|Death|5|||
33347728|NCT02731742|101160168|FG003|Overall Study|Death|0|||
33347729|NCT02731742|101160165|FG000|Overall Study|Physician Decision|0|||
33347730|NCT02731742|101160166|FG001|Overall Study|Physician Decision|0|||
33347731|NCT02731742|101160167|FG002|Overall Study|Physician Decision|0|||
33347732|NCT02731742|101160168|FG003|Overall Study|Physician Decision|1|||
33347733|NCT02731742|101160165|FG000|Overall Study|Study Terminated by Sponsor|2|||
33347734|NCT02731742|101160166|FG001|Overall Study|Study Terminated by Sponsor|1|||
33347735|NCT02731742|101160167|FG002|Overall Study|Study Terminated by Sponsor|1|||
33347736|NCT02731742|101160168|FG003|Overall Study|Study Terminated by Sponsor|1|||
33347737|NCT02949830|101160169|FG000|Overall Study|Adverse Event|1|||
33347738|NCT02949830|101160169|FG000|Overall Study|Withdrawal by Subject|1|||
33347739|NCT02367521|101160173|FG000|Overall Study|severe headache after intervention|2|||
33347740|NCT02367521|101160174|FG001|Overall Study|severe headache after intervention|0|||
33347741|NCT02367521|101160173|FG000|Overall Study|unable to find transportation|2|||
33347742|NCT02367521|101160174|FG001|Overall Study|unable to find transportation|0|||
33347743|NCT01445535|101160175|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
33347744|NCT01445535|101160176|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
33347745|NCT01445535|101160177|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
33347746|NCT01445535|101160178|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
33347747|NCT01445535|101160175|FG000|Overall Study|Disease progression|1|||
33347748|NCT01445535|101160176|FG001|Overall Study|Disease progression|0|||
33347749|NCT01445535|101160177|FG002|Overall Study|Disease progression|1|||
33347750|NCT01445535|101160178|FG003|Overall Study|Disease progression|0|||
33347751|NCT01445535|101160175|FG000|Overall Study|PI discretion|0|||
33347752|NCT01445535|101160176|FG001|Overall Study|PI discretion|0|||
33347753|NCT01445535|101160177|FG002|Overall Study|PI discretion|0|||
33347754|NCT01445535|101160178|FG003|Overall Study|PI discretion|1|||
33347755|NCT02292212|101160179|FG000|ViE Phase|Withdrawal by Subject|1|||
33347756|NCT02292212|101160179|FG000|ViE Phase|Protocol Violation|2|||
33347757|NCT02152345|101160180|FG000|Overall Study|Case Cancellations|2|||
33409065|NCT02190604|101386178|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409066|NCT02190604|101386179|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409067|NCT02190604|101386180|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409068|NCT02190604|101386181|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409069|NCT02190604|101386182|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
33409070|NCT02190604|101386183|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409071|NCT02190604|101386184|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409072|NCT02190604|101386185|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409073|NCT02190604|101386186|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33409074|NCT02190604|101386187|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
33616853|NCT01510158|102144433|FG000|Overall Study|Sponsor terminated study.|2|||
33347758|NCT02152345|101160181|FG001|Overall Study|Case Cancellations|4|||
33347759|NCT02152345|101160180|FG000|Overall Study|Withdrawal by Subject|2|||
33347760|NCT02152345|101160181|FG001|Overall Study|Withdrawal by Subject|1|||
33347761|NCT03665038|101160182|FG000|Overall Study|Lost to Follow-up|0|||
33347762|NCT03665038|101160183|FG001|Overall Study|Lost to Follow-up|0|||
33347763|NCT03665038|101160184|FG002|Overall Study|Lost to Follow-up|1|||
33347764|NCT01231555|101160185|FG000|Overall Study|Study terminated|8|||
33409075|NCT00960869|101386189|FG000|Overall Study|Adverse Event|17|||
33409076|NCT00960869|101386190|FG001|Overall Study|Adverse Event|26|||
33409077|NCT00960869|101386189|FG000|Overall Study|Withdrawal by Subject|16|||
33409078|NCT00960869|101386190|FG001|Overall Study|Withdrawal by Subject|14|||
33409079|NCT00960869|101386189|FG000|Overall Study|Lost to Follow-up|1|||
33409080|NCT00960869|101386190|FG001|Overall Study|Lost to Follow-up|4|||
33616854|NCT01510158|102144434|FG001|Overall Study|Sponsor terminated study.|0|||
33616855|NCT01510158|102144435|FG002|Overall Study|Sponsor terminated study.|2|||
33347765|NCT01231555|101160186|FG001|Overall Study|Study terminated|5|||
33347766|NCT01231555|101160187|FG002|Overall Study|Study terminated|8|||
33347767|NCT01231555|101160185|FG000|Overall Study|Withdrawal by Subject|0|||
33347768|NCT01231555|101160186|FG001|Overall Study|Withdrawal by Subject|2|||
33347769|NCT01231555|101160187|FG002|Overall Study|Withdrawal by Subject|0|||
33347770|NCT00354601|101160188|FG000|Overall Study|Protocol Violation|1|||
33347771|NCT00354601|101160188|FG000|Overall Study|progression|1|||
33347772|NCT02908100|101160189|FG000|Overall Study|Adverse Event|7|||
33347773|NCT02908100|101160190|FG001|Overall Study|Adverse Event|6|||
33347774|NCT02908100|101160191|FG002|Overall Study|Adverse Event|9|||
33347775|NCT02908100|101160189|FG000|Overall Study|Death|2|||
33347776|NCT02908100|101160190|FG001|Overall Study|Death|0|||
33347777|NCT02908100|101160191|FG002|Overall Study|Death|0|||
33347778|NCT02908100|101160189|FG000|Overall Study|Lack of Efficacy|2|||
33347779|NCT02908100|101160190|FG001|Overall Study|Lack of Efficacy|3|||
33347780|NCT02908100|101160191|FG002|Overall Study|Lack of Efficacy|3|||
33347781|NCT02908100|101160189|FG000|Overall Study|Lost to Follow-up|0|||
33347782|NCT02908100|101160190|FG001|Overall Study|Lost to Follow-up|1|||
33347783|NCT02908100|101160191|FG002|Overall Study|Lost to Follow-up|2|||
33347784|NCT02908100|101160189|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33347785|NCT02908100|101160190|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33347786|NCT02908100|101160191|FG002|Overall Study|Non-Compliance With Study Drug|2|||
33347787|NCT02908100|101160189|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
33347788|NCT02908100|101160190|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
33347789|NCT02908100|101160191|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
33347790|NCT02908100|101160189|FG000|Overall Study|Physician Decision|0|||
33347791|NCT02908100|101160190|FG001|Overall Study|Physician Decision|1|||
33347792|NCT02908100|101160191|FG002|Overall Study|Physician Decision|0|||
33347793|NCT02908100|101160189|FG000|Overall Study|Pregnancy|1|||
33347794|NCT02908100|101160190|FG001|Overall Study|Pregnancy|2|||
33347795|NCT02908100|101160191|FG002|Overall Study|Pregnancy|0|||
33347796|NCT02908100|101160189|FG000|Overall Study|Withdrawal by Subject|8|||
33347797|NCT02908100|101160190|FG001|Overall Study|Withdrawal by Subject|7|||
33347798|NCT02908100|101160191|FG002|Overall Study|Withdrawal by Subject|5|||
33347799|NCT02908100|101160189|FG000|Overall Study|Randomised in Error|1|||
33347800|NCT02908100|101160190|FG001|Overall Study|Randomised in Error|0|||
33347801|NCT02908100|101160191|FG002|Overall Study|Randomised in Error|0|||
33347802|NCT03118947|101160192|FG000|Overall Study|Adverse Event|7|||
33347803|NCT03118947|101160192|FG000|Overall Study|Death|3|||
33347804|NCT03118947|101160192|FG000|Overall Study|Lack of Efficacy|4|||
33347805|NCT03118947|101160192|FG000|Overall Study|Non-compliance with study drug|1|||
33347806|NCT03118947|101160192|FG000|Overall Study|Protocol Violation|2|||
33347807|NCT03118947|101160192|FG000|Overall Study|Withdrawal by Subject|3|||
33347808|NCT03118947|101160192|FG000|Overall Study|Withdrawal by caregiver|3|||
33347809|NCT03118947|101160192|FG000|Overall Study|Change in patient's living situation|4|||
33347810|NCT03118947|101160192|FG000|Overall Study|Lost to Follow-up|2|||
33347811|NCT00956943|101160193|FG000|Overall Study|Lost to Follow-up|9|||
33347812|NCT00956943|101160194|FG001|Overall Study|Lost to Follow-up|10|||
33347813|NCT02222714|101160195|FG000|Overall Study|Death|0|||
33347814|NCT02222714|101160196|FG001|Overall Study|Death|2|||
33347815|NCT02222714|101160197|FG002|Overall Study|Death|3|||
33347816|NCT02222714|101160198|FG003|Overall Study|Death|4|||
33347817|NCT02222714|101160199|FG004|Overall Study|Death|6|||
33347818|NCT02222714|101160195|FG000|Overall Study|Withdrawal by Subject|0|||
33347819|NCT02222714|101160196|FG001|Overall Study|Withdrawal by Subject|0|||
33347820|NCT02222714|101160197|FG002|Overall Study|Withdrawal by Subject|1|||
33347821|NCT02222714|101160198|FG003|Overall Study|Withdrawal by Subject|0|||
33347822|NCT02222714|101160199|FG004|Overall Study|Withdrawal by Subject|1|||
33347823|NCT04134494|101160205|FG000|Overall Study|Lost to Follow-up|2|||
33347824|NCT01299766|101160206|FG000|Overall Study|Death|5|||
33347825|NCT01299766|101160207|FG001|Overall Study|Death|4|||
33347826|NCT01299766|101160206|FG000|Overall Study|Withdrawal by Subject|29|||
33347827|NCT01299766|101160207|FG001|Overall Study|Withdrawal by Subject|19|||
33347828|NCT03308188|101160208|FG000|Overall Study|Withdrawal by Subject|0|||
33347829|NCT03308188|101160209|FG001|Overall Study|Withdrawal by Subject|3|||
33347830|NCT03308188|101160208|FG000|Overall Study|Death|0|||
33409081|NCT00960869|101386189|FG000|Overall Study|Misc|19|||
33409082|NCT00960869|101386190|FG001|Overall Study|Misc|18|||
33347831|NCT03308188|101160209|FG001|Overall Study|Death|1|||
33347832|NCT02421887|101160210|FG000|Overall Study|Lost to Follow-up|5|||
33409083|NCT02431559|101386191|FG000|Overall Study|Adverse Event|0|||
33545632|NCT01712516|101898588|FG003|Overall Study|Withdrawal by Subject|9|||
33545633|NCT00134719|101898605|FG000|Primary Vaccination Phase|Adverse Event|4|||
33545634|NCT00134719|101898606|FG001|Primary Vaccination Phase|Adverse Event|0|||
33545635|NCT00134719|101898607|FG002|Primary Vaccination Phase|Adverse Event|0|||
33545636|NCT00134719|101898605|FG000|Primary Vaccination Phase|Protocol Violation|1|||
33545637|NCT00134719|101898606|FG001|Primary Vaccination Phase|Protocol Violation|0|||
33545638|NCT00134719|101898607|FG002|Primary Vaccination Phase|Protocol Violation|0|||
33545639|NCT00134719|101898605|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
33545640|NCT00134719|101898606|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
33545641|NCT00134719|101898607|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
33545642|NCT00134719|101898605|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
33545643|NCT00134719|101898606|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
33545644|NCT00134719|101898607|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
33545645|NCT00134719|101898605|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
33545646|NCT00134719|101898606|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
33545647|NCT00134719|101898607|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
33616856|NCT01510158|102144433|FG000|Overall Study|Lost to Follow-up|13|||
33616857|NCT01510158|102144434|FG001|Overall Study|Lost to Follow-up|16|||
33616858|NCT01510158|102144435|FG002|Overall Study|Lost to Follow-up|9|||
33616859|NCT01510158|102144433|FG000|Overall Study|Withdrawal by Subject|10|||
33616860|NCT01510158|102144434|FG001|Overall Study|Withdrawal by Subject|13|||
33616861|NCT01510158|102144435|FG002|Overall Study|Withdrawal by Subject|10|||
33616862|NCT01510158|102144433|FG000|Overall Study|Death|1|||
33616863|NCT01510158|102144434|FG001|Overall Study|Death|0|||
33616864|NCT01510158|102144435|FG002|Overall Study|Death|0|||
33616865|NCT05258149|102144436|FG000|Period 1|Protocol Deviation|1|||
33616866|NCT05258149|102144437|FG001|Period 1|Protocol Deviation|0|||
33616867|NCT05258149|102144436|FG000|Period 1|Adverse Event|0|||
33616868|NCT05258149|102144437|FG001|Period 1|Adverse Event|1|||
33545648|NCT00134719|101898605|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
33545649|NCT00134719|101898606|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
33545650|NCT00134719|101898607|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
33545651|NCT02313155|101898608|FG000|Overall Study|Lost to Follow-up|0|||
33545652|NCT02313155|101898609|FG001|Overall Study|Lost to Follow-up|1|||
33545653|NCT04919161|101898610|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
33545654|NCT04919161|101898611|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
33545655|NCT04919161|101898610|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
33545656|NCT04919161|101898611|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
33545657|NCT04919161|101898610|FG000|Overall Study|Acute ankle sprain after session 1|0|||
33545658|NCT04919161|101898611|FG001|Overall Study|Acute ankle sprain after session 1|1|||
33545659|NCT03473197|101898612|FG000|Overall Study|Adverse Event|4|||
33545660|NCT03473197|101898612|FG000|Overall Study|Lost to Follow-up|1|||
33545661|NCT03473197|101898612|FG000|Overall Study|Withdrawal by Subject|5|||
33545662|NCT02916927|101898613|FG000|Overall Study|Discharged prior to study drug receipt|0|||
33545663|NCT02916927|101898614|FG001|Overall Study|Discharged prior to study drug receipt|2|||
33545664|NCT02916927|101898613|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
33545665|NCT02916927|101898614|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
33616869|NCT05258149|102144436|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
33616870|NCT05258149|102144437|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
33616871|NCT05258149|102144436|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
33347833|NCT02421887|101160211|FG001|Overall Study|Lost to Follow-up|0|||
33347834|NCT02421887|101160210|FG000|Overall Study|Withdrawal by Subject|8|||
33347835|NCT02421887|101160211|FG001|Overall Study|Withdrawal by Subject|5|||
33347836|NCT02421887|101160210|FG000|Overall Study|Physician Decision|2|||
33347837|NCT02421887|101160211|FG001|Overall Study|Physician Decision|4|||
33347838|NCT02421887|101160210|FG000|Overall Study|Adverse Event|2|||
33347839|NCT02421887|101160211|FG001|Overall Study|Adverse Event|0|||
33347840|NCT02440581|101160215|FG000|Overall Study|Death|0|||
33347841|NCT02440581|101160216|FG001|Overall Study|Death|0|||
33347842|NCT02440581|101160217|FG002|Overall Study|Death|7|||
33347843|NCT02440581|101160218|FG003|Overall Study|Death|5|||
33347844|NCT02440581|101160215|FG000|Overall Study|Transplanted|1|||
33347845|NCT02440581|101160216|FG001|Overall Study|Transplanted|0|||
33347846|NCT02440581|101160217|FG002|Overall Study|Transplanted|3|||
33347847|NCT02440581|101160218|FG003|Overall Study|Transplanted|2|||
33347848|NCT02440581|101160215|FG000|Overall Study|Withdrawal by Subject|4|||
33347849|NCT02440581|101160216|FG001|Overall Study|Withdrawal by Subject|11|||
33545666|NCT02916927|101898613|FG000|Overall Study|Withdrawal before first time point|1|||
33545667|NCT02916927|101898614|FG001|Overall Study|Withdrawal before first time point|0|||
33409084|NCT02431559|101386192|FG001|Overall Study|Adverse Event|1|||
33616872|NCT05258149|102144437|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
33213895|NCT01588184|100679815|FG000|Overall Study|Death|1|||
33347850|NCT02440581|101160217|FG002|Overall Study|Withdrawal by Subject|3|||
33409085|NCT02431559|101386193|FG002|Overall Study|Adverse Event|0|||
33409086|NCT02431559|101386194|FG003|Overall Study|Adverse Event|4|||
33409087|NCT02431559|101386191|FG000|Overall Study|Progressive disease|2|||
33409088|NCT02431559|101386192|FG001|Overall Study|Progressive disease|1|||
33409089|NCT02431559|101386193|FG002|Overall Study|Progressive disease|4|||
33409090|NCT02431559|101386194|FG003|Overall Study|Progressive disease|22|||
33409091|NCT02431559|101386191|FG000|Overall Study|Withdrawal by Subject|0|||
33409092|NCT02431559|101386192|FG001|Overall Study|Withdrawal by Subject|1|||
33409093|NCT02431559|101386193|FG002|Overall Study|Withdrawal by Subject|0|||
33409094|NCT02431559|101386194|FG003|Overall Study|Withdrawal by Subject|4|||
33409095|NCT02431559|101386191|FG000|Overall Study|Physician Decision|0|||
33409096|NCT02431559|101386192|FG001|Overall Study|Physician Decision|0|||
33409097|NCT02431559|101386193|FG002|Overall Study|Physician Decision|0|||
33409098|NCT02431559|101386194|FG003|Overall Study|Physician Decision|1|||
33409099|NCT01801475|101386195|FG000|Overall Study|Withdrawal by Subject|0|||
33409100|NCT01801475|101386196|FG001|Overall Study|Withdrawal by Subject|0|||
33409101|NCT01801475|101386197|FG002|Overall Study|Withdrawal by Subject|0|||
33409102|NCT01801475|101386198|FG003|Overall Study|Withdrawal by Subject|0|||
33409103|NCT01801475|101386199|FG004|Overall Study|Withdrawal by Subject|1|||
33409104|NCT05147311|101386200|FG000|Overall Study|Did not complete survey|2|||
33409105|NCT05147311|101386201|FG001|Overall Study|Did not complete survey|1|||
33409106|NCT05147311|101386200|FG000|Overall Study|Patient too sick|1|||
33409107|NCT05147311|101386201|FG001|Overall Study|Patient too sick|2|||
33409108|NCT05147311|101386200|FG000|Overall Study|Death|0|||
33409109|NCT05147311|101386201|FG001|Overall Study|Death|1|||
33409110|NCT05147311|101386200|FG000|Overall Study|Declined survey|1|||
33409111|NCT05147311|101386201|FG001|Overall Study|Declined survey|0|||
33409112|NCT01884675|101386202|FG000|Overall Study|Study closed/terminated|3|||
33409113|NCT01884675|101386203|FG001|Overall Study|Study closed/terminated|2|||
33409114|NCT03556202|101386204|FG000|Extension Treatment Period|Adverse Event|18|||
33409115|NCT03556202|101386205|FG001|Extension Treatment Period|Adverse Event|14|||
33409116|NCT03556202|101386206|FG002|Extension Treatment Period|Adverse Event|9|||
33409117|NCT03556202|101386204|FG000|Extension Treatment Period|Death|2|||
33409118|NCT03556202|101386205|FG001|Extension Treatment Period|Death|6|||
33409119|NCT03556202|101386206|FG002|Extension Treatment Period|Death|0|||
33409120|NCT03556202|101386204|FG000|Extension Treatment Period|Lack of Efficacy|5|||
33409121|NCT03556202|101386205|FG001|Extension Treatment Period|Lack of Efficacy|12|||
33409122|NCT03556202|101386206|FG002|Extension Treatment Period|Lack of Efficacy|18|||
33409123|NCT03556202|101386204|FG000|Extension Treatment Period|Lost to Follow-up|9|||
33409124|NCT03556202|101386205|FG001|Extension Treatment Period|Lost to Follow-up|20|||
33409125|NCT03556202|101386206|FG002|Extension Treatment Period|Lost to Follow-up|2|||
33545668|NCT02836769|101898615|FG000|Overall Study|Lost to Follow-up|10|||
33545669|NCT02836769|101898615|FG000|Overall Study|Medical withdrawal|2|||
33545670|NCT02836769|101898615|FG000|Overall Study|Withdrawal by Subject|3|||
33545671|NCT00112957|101898616|FG000|Overall Study|Progressive disease|18|||
33545672|NCT00112957|101898616|FG000|Overall Study|Physician Decision|1|||
33545673|NCT00724893|101898620|FG000|Overall Study|Adverse Event|76|||
33545674|NCT00724893|101898621|FG001|Overall Study|Adverse Event|142|||
33545675|NCT00724893|101898620|FG000|Overall Study|Withdrawal by Subject|0|||
33545676|NCT00724893|101898621|FG001|Overall Study|Withdrawal by Subject|1|||
33616873|NCT05258149|102144436|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
33409126|NCT03556202|101386204|FG000|Extension Treatment Period|Pregnancy|2|||
33409127|NCT03556202|101386205|FG001|Extension Treatment Period|Pregnancy|4|||
33409128|NCT03556202|101386206|FG002|Extension Treatment Period|Pregnancy|3|||
33409129|NCT03556202|101386204|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
33545677|NCT00724893|101898620|FG000|Overall Study|Lack of virologic response|94|||
33409130|NCT03556202|101386205|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
33545678|NCT00724893|101898621|FG001|Overall Study|Lack of virologic response|202|||
33545679|NCT00724893|101898620|FG000|Overall Study|Reason not specified|193|||
33409131|NCT03556202|101386206|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
33409132|NCT03556202|101386204|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
33545680|NCT00724893|101898621|FG001|Overall Study|Reason not specified|7|||
33545681|NCT00724893|101898620|FG000|Overall Study|Patient choice|0|||
33545682|NCT00724893|101898621|FG001|Overall Study|Patient choice|26|||
33545683|NCT00724893|101898620|FG000|Overall Study|Geographic reasons|0|||
33545684|NCT00724893|101898621|FG001|Overall Study|Geographic reasons|11|||
33545685|NCT00724893|101898620|FG000|Overall Study|Incarceration|0|||
33545686|NCT00724893|101898621|FG001|Overall Study|Incarceration|9|||
33545687|NCT00724893|101898620|FG000|Overall Study|Substance abuse|0|||
33545688|NCT00724893|101898621|FG001|Overall Study|Substance abuse|3|||
33545689|NCT00724893|101898620|FG000|Overall Study|Financial reasons|0|||
33545690|NCT00724893|101898621|FG001|Overall Study|Financial reasons|2|||
33545691|NCT00724893|101898620|FG000|Overall Study|Assigned shorter treatment|0|||
33545692|NCT00724893|101898621|FG001|Overall Study|Assigned shorter treatment|2|||
33545693|NCT00724893|101898620|FG000|Overall Study|Lost to Follow-up|0|||
33545694|NCT00724893|101898621|FG001|Overall Study|Lost to Follow-up|52|||
33545695|NCT00724893|101898620|FG000|Overall Study|Unknown, missing data|1|||
33545696|NCT00724893|101898621|FG001|Overall Study|Unknown, missing data|1|||
33545697|NCT00676143|101898624|FG000|Overall Study|Adverse Event|34|||
33545698|NCT00676143|101898625|FG001|Overall Study|Adverse Event|60|||
33545699|NCT00676143|101898624|FG000|Overall Study|Death|4|||
33545700|NCT00676143|101898625|FG001|Overall Study|Death|4|||
33545701|NCT00676143|101898624|FG000|Overall Study|Lack of Efficacy|0|||
33545702|NCT00676143|101898625|FG001|Overall Study|Lack of Efficacy|6|||
33545703|NCT00676143|101898624|FG000|Overall Study|Lost to Follow-up|0|||
33347851|NCT02440581|101160218|FG003|Overall Study|Withdrawal by Subject|7|||
33545704|NCT00676143|101898625|FG001|Overall Study|Lost to Follow-up|13|||
33545705|NCT00676143|101898624|FG000|Overall Study|Physician Decision|5|||
33545706|NCT00676143|101898625|FG001|Overall Study|Physician Decision|8|||
33545707|NCT00676143|101898624|FG000|Overall Study|Protocol Violation|4|||
33545708|NCT00676143|101898625|FG001|Overall Study|Protocol Violation|8|||
33545709|NCT00676143|101898624|FG000|Overall Study|Withdrawal by Subject|24|||
33545710|NCT00676143|101898625|FG001|Overall Study|Withdrawal by Subject|42|||
33545711|NCT00676143|101898624|FG000|Overall Study|Discontinuation of study by sponsor|65|||
33545712|NCT00676143|101898625|FG001|Overall Study|Discontinuation of study by sponsor|88|||
33545713|NCT00676143|101898624|FG000|Overall Study|Failed to return|2|||
33545714|NCT00676143|101898625|FG001|Overall Study|Failed to return|1|||
33545715|NCT00676143|101898624|FG000|Overall Study|Loss of caregiver|5|||
33545716|NCT00676143|101898625|FG001|Overall Study|Loss of caregiver|3|||
33545717|NCT00676143|101898624|FG000|Overall Study|Other|11|||
33545718|NCT00676143|101898625|FG001|Overall Study|Other|20|||
33545719|NCT00676143|101898624|FG000|Overall Study|Participant participation unknown|1|||
33545720|NCT00676143|101898625|FG001|Overall Study|Participant participation unknown|4|||
33545721|NCT00676143|101898624|FG000|Overall Study|Vasogenic edema recurrence|1|||
33545722|NCT00676143|101898625|FG001|Overall Study|Vasogenic edema recurrence|3|||
33616874|NCT05258149|102144437|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
33347852|NCT01976806|101160220|FG000|Overall Study|Lost to Follow-up|1|||
33347853|NCT01976806|101160221|FG001|Overall Study|Lost to Follow-up|4|||
33347854|NCT01976806|101160220|FG000|Overall Study|Adverse Event|1|||
33347855|NCT01976806|101160221|FG001|Overall Study|Adverse Event|1|||
33409133|NCT03556202|101386205|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
33545723|NCT03915067|101898628|FG000|Overall Study|Adverse Event|0|||
33545724|NCT03915067|101898629|FG001|Overall Study|Adverse Event|0|||
33545725|NCT03915067|101898630|FG002|Overall Study|Adverse Event|1|||
33545726|NCT03915067|101898628|FG000|Overall Study|Withdrawal by Subject|4|||
33545727|NCT03915067|101898629|FG001|Overall Study|Withdrawal by Subject|3|||
33545728|NCT03915067|101898630|FG002|Overall Study|Withdrawal by Subject|0|||
33545729|NCT03915067|101898628|FG000|Overall Study|Lost to Follow-up|3|||
33545730|NCT03915067|101898629|FG001|Overall Study|Lost to Follow-up|2|||
33545731|NCT03915067|101898630|FG002|Overall Study|Lost to Follow-up|0|||
33545732|NCT03915067|101898628|FG000|Overall Study|Protocol Deviation|0|||
33616875|NCT00536471|102144438|FG000|Overall Study|Lost to Follow-up|48|||
33616876|NCT00536471|102144439|FG001|Overall Study|Lost to Follow-up|23|||
33545733|NCT03915067|101898629|FG001|Overall Study|Protocol Deviation|0|||
33545734|NCT03915067|101898630|FG002|Overall Study|Protocol Deviation|1|||
33545735|NCT03915067|101898628|FG000|Overall Study|Covid-19 Related Issues|2|||
33545736|NCT03915067|101898629|FG001|Overall Study|Covid-19 Related Issues|4|||
33545737|NCT03915067|101898630|FG002|Overall Study|Covid-19 Related Issues|4|||
33545738|NCT03915067|101898628|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
33545739|NCT03915067|101898629|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
33545740|NCT03915067|101898630|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
33347856|NCT01976806|101160220|FG000|Overall Study|Withdrawal by Subject|1|||
33347857|NCT01976806|101160221|FG001|Overall Study|Withdrawal by Subject|1|||
33347858|NCT01756274|101160227|FG000|Overall Study|Protocol Violation|2|||
33347859|NCT01756274|101160227|FG000|Overall Study|Laboratory error|1|||
33347860|NCT04698629|101160228|FG000|Overall Study|Adverse Event|1|||
33545741|NCT01510756|101898631|FG000|Overall Study|Death|1|||
33545742|NCT01510756|101898631|FG000|Overall Study|Lack of Efficacy|2|||
33545743|NCT01510756|101898631|FG000|Overall Study|Physician Decision|1|||
33616877|NCT00536471|102144440|FG002|Overall Study|Lost to Follow-up|48|||
33347861|NCT01225562|101160230|FG000|Overall Study|Withdrawal by Subject|52|||
33616878|NCT00536471|102144441|FG003|Overall Study|Lost to Follow-up|22|||
33616879|NCT00536471|102144438|FG000|Overall Study|Adverse Event|32|||
33616880|NCT00536471|102144439|FG001|Overall Study|Adverse Event|16|||
33616881|NCT00536471|102144440|FG002|Overall Study|Adverse Event|28|||
33616882|NCT00536471|102144441|FG003|Overall Study|Adverse Event|13|||
33616883|NCT00536471|102144438|FG000|Overall Study|Withdrawal by Subject|40|||
33616884|NCT00536471|102144439|FG001|Overall Study|Withdrawal by Subject|24|||
33616885|NCT00536471|102144440|FG002|Overall Study|Withdrawal by Subject|43|||
33616886|NCT00536471|102144441|FG003|Overall Study|Withdrawal by Subject|21|||
33616887|NCT00536471|102144438|FG000|Overall Study|Lack of Efficacy|17|||
33616888|NCT00536471|102144439|FG001|Overall Study|Lack of Efficacy|18|||
33616889|NCT00536471|102144440|FG002|Overall Study|Lack of Efficacy|11|||
33616890|NCT00536471|102144441|FG003|Overall Study|Lack of Efficacy|9|||
33616891|NCT00536471|102144438|FG000|Overall Study|Protocol Violation|8|||
33616892|NCT00536471|102144439|FG001|Overall Study|Protocol Violation|1|||
33616893|NCT00536471|102144440|FG002|Overall Study|Protocol Violation|2|||
33616894|NCT00536471|102144441|FG003|Overall Study|Protocol Violation|3|||
33616895|NCT00536471|102144438|FG000|Overall Study|Physician Decision|11|||
33616896|NCT00536471|102144439|FG001|Overall Study|Physician Decision|1|||
33616897|NCT00536471|102144440|FG002|Overall Study|Physician Decision|3|||
33616898|NCT00536471|102144441|FG003|Overall Study|Physician Decision|2|||
33616899|NCT00536471|102144438|FG000|Overall Study|Death|0|||
33616900|NCT00536471|102144439|FG001|Overall Study|Death|0|||
33616901|NCT00536471|102144440|FG002|Overall Study|Death|1|||
33616902|NCT00536471|102144441|FG003|Overall Study|Death|2|||
33616903|NCT00536471|102144438|FG000|Overall Study|Sponsor Decision|0|||
33616904|NCT00536471|102144439|FG001|Overall Study|Sponsor Decision|1|||
33616905|NCT00536471|102144440|FG002|Overall Study|Sponsor Decision|3|||
33616906|NCT00536471|102144441|FG003|Overall Study|Sponsor Decision|2|||
33616907|NCT02223715|102144442|FG000|Overall Study|Death|31|||
33616908|NCT02223715|102144442|FG000|Overall Study|Lost to Follow-up|73|||
33616909|NCT00719680|102144448|FG000|Overall Study|Adverse Event|1|||
33616910|NCT00719680|102144448|FG000|Overall Study|Lost to Follow-up|1|||
33616911|NCT00719680|102144448|FG000|Overall Study|Withdrawal by Subject|3|||
33616912|NCT01053988|102144450|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
33616913|NCT01053988|102144451|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33545744|NCT01373164|101898632|FG000|Overall Study|Lost to Follow-up|0|||
33545745|NCT01373164|101898633|FG001|Overall Study|Lost to Follow-up|0|||
33545746|NCT01373164|101898634|FG002|Overall Study|Lost to Follow-up|1|||
33545747|NCT01373164|101898635|FG003|Overall Study|Lost to Follow-up|2|||
33545748|NCT01373164|101898636|FG004|Overall Study|Lost to Follow-up|0|||
33545749|NCT01373164|101898632|FG000|Overall Study|Withdrawal by Subject|0|||
33545750|NCT01373164|101898633|FG001|Overall Study|Withdrawal by Subject|1|||
33545751|NCT01373164|101898634|FG002|Overall Study|Withdrawal by Subject|0|||
33545752|NCT01373164|101898635|FG003|Overall Study|Withdrawal by Subject|10|||
33545753|NCT01373164|101898636|FG004|Overall Study|Withdrawal by Subject|2|||
33545754|NCT01881425|101898637|FG000|Overall Study|Death|5|||
33545755|NCT01881425|101898638|FG001|Overall Study|Death|1|||
33545756|NCT01881425|101898637|FG000|Overall Study|Withdrawal by Subject|8|||
33545757|NCT01881425|101898638|FG001|Overall Study|Withdrawal by Subject|3|||
33545758|NCT01881425|101898637|FG000|Overall Study|Physician Decision|2|||
33545759|NCT01881425|101898638|FG001|Overall Study|Physician Decision|1|||
33545760|NCT01881425|101898637|FG000|Overall Study|Adverse Event|3|||
33545761|NCT01881425|101898638|FG001|Overall Study|Adverse Event|0|||
33545762|NCT01881425|101898637|FG000|Overall Study|General Anesthesia panic attack|0|||
33545763|NCT01881425|101898638|FG001|Overall Study|General Anesthesia panic attack|1|||
33545764|NCT01881425|101898637|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
33545765|NCT01881425|101898638|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
33545766|NCT01881425|101898637|FG000|Overall Study|Lost to Follow-up|7|||
33545767|NCT01881425|101898638|FG001|Overall Study|Lost to Follow-up|2|||
33616914|NCT01053988|102144452|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33545768|NCT02452190|101898645|FG000|Overall Study|Withdrawal by Sponsor|1|||
33545769|NCT02452190|101898646|FG001|Overall Study|Withdrawal by Sponsor|3|||
33545770|NCT02452190|101898645|FG000|Overall Study|Pregnancy|1|||
33545771|NCT02452190|101898646|FG001|Overall Study|Pregnancy|0|||
33616915|NCT01053988|102144453|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33616916|NCT01053988|102144454|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33616917|NCT01053988|102144455|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33616918|NCT01053988|102144450|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
33213896|NCT01588184|100679816|FG001|Overall Study|Death|0|||
33616919|NCT01053988|102144451|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33616920|NCT01053988|102144452|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33347862|NCT01225562|101160231|FG001|Overall Study|Withdrawal by Subject|50|||
33545772|NCT02452190|101898645|FG000|Overall Study|Investigator's Decision|2|||
33616921|NCT01053988|102144453|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33545773|NCT02452190|101898646|FG001|Overall Study|Investigator's Decision|0|||
33545774|NCT02452190|101898645|FG000|Overall Study|Lack of Efficacy|3|||
33545775|NCT02452190|101898646|FG001|Overall Study|Lack of Efficacy|1|||
33545776|NCT02452190|101898645|FG000|Overall Study|Lost to Follow-up|4|||
33545777|NCT02452190|101898646|FG001|Overall Study|Lost to Follow-up|3|||
33545778|NCT02452190|101898645|FG000|Overall Study|Adverse Event|2|||
33545779|NCT02452190|101898646|FG001|Overall Study|Adverse Event|5|||
33545780|NCT02452190|101898645|FG000|Overall Study|Withdrawal by Subject|20|||
33545781|NCT02452190|101898646|FG001|Overall Study|Withdrawal by Subject|11|||
33545782|NCT02452190|101898645|FG000|Overall Study|Noncompliance with study drug|1|||
33545783|NCT02452190|101898646|FG001|Overall Study|Noncompliance with study drug|0|||
33545784|NCT02452190|101898645|FG000|Overall Study|Participant traveled abroad|1|||
33545785|NCT02452190|101898646|FG001|Overall Study|Participant traveled abroad|0|||
33545786|NCT02452190|101898645|FG000|Overall Study|Death|0|||
33545787|NCT02452190|101898646|FG001|Overall Study|Death|1|||
33545788|NCT03600350|101898649|FG000|Overall Study|Death|1|||
33545789|NCT03600350|101898649|FG000|Overall Study|On Follow Up|18|||
33545790|NCT00699751|101898650|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
33545791|NCT00699751|101898651|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
33545792|NCT00699751|101898650|FG000|Period 1: Without/Before Drug Switch|Death|28|||
33545793|NCT00699751|101898651|FG001|Period 1: Without/Before Drug Switch|Death|29|||
33545794|NCT00699751|101898650|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
33545795|NCT00699751|101898651|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
33545796|NCT00699751|101898650|FG000|Period 1: Without/Before Drug Switch|Other|30|||
33347863|NCT01225562|101160232|FG002|Overall Study|Withdrawal by Subject|52|||
33347864|NCT01225562|101160230|FG000|Overall Study|Lost to Follow-up|3|||
33347865|NCT01225562|101160231|FG001|Overall Study|Lost to Follow-up|6|||
33347866|NCT01225562|101160232|FG002|Overall Study|Lost to Follow-up|1|||
33347867|NCT01709331|101163806|FG000|Overall Study|Adverse Event|1|||
33347868|NCT01109940|101163810|FG000|Overall Study|Administrative problems|2|||
33347869|NCT01109940|101163811|FG001|Overall Study|Administrative problems|0|||
33545797|NCT00699751|101898651|FG001|Period 1: Without/Before Drug Switch|Other|20|||
33545798|NCT00699751|101898650|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
33545799|NCT00699751|101898651|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
33545800|NCT00699751|101898650|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
33545801|NCT00699751|101898651|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
33545802|NCT00699751|101898650|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
33545803|NCT00699751|101898651|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
33545804|NCT00699751|101898650|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
33545805|NCT00699751|101898651|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
33545806|NCT01462942|101898656|FG000|Overall Study|Adverse Event|7|||
33545807|NCT01462942|101898657|FG001|Overall Study|Adverse Event|12|||
33545808|NCT01462942|101898658|FG002|Overall Study|Adverse Event|10|||
33545809|NCT01462942|101898659|FG003|Overall Study|Adverse Event|11|||
33545810|NCT01462942|101898660|FG004|Overall Study|Adverse Event|11|||
33545811|NCT01462942|101898656|FG000|Overall Study|Other, including COPD exacerbation|3|||
33213897|NCT01588184|100679817|FG002|Overall Study|Death|0|||
33213898|NCT01588184|100679818|FG003|Overall Study|Death|1|||
33213899|NCT01588184|100679819|FG004|Overall Study|Death|1|||
33213900|NCT01588184|100679820|FG005|Overall Study|Death|1|||
33213901|NCT01588184|100679815|FG000|Overall Study|Withdrawal by Subject|2|||
33545812|NCT01462942|101898657|FG001|Overall Study|Other, including COPD exacerbation|5|||
33545813|NCT01462942|101898658|FG002|Overall Study|Other, including COPD exacerbation|2|||
33545814|NCT01462942|101898659|FG003|Overall Study|Other, including COPD exacerbation|8|||
33545815|NCT01462942|101898660|FG004|Overall Study|Other, including COPD exacerbation|5|||
33213902|NCT01588184|100679816|FG001|Overall Study|Withdrawal by Subject|4|||
33213903|NCT01588184|100679817|FG002|Overall Study|Withdrawal by Subject|0|||
33213904|NCT01588184|100679818|FG003|Overall Study|Withdrawal by Subject|1|||
33213905|NCT01588184|100679819|FG004|Overall Study|Withdrawal by Subject|0|||
33213906|NCT01588184|100679820|FG005|Overall Study|Withdrawal by Subject|0|||
33545816|NCT01462942|101898656|FG000|Overall Study|Withdrawal by Subject|14|||
33545817|NCT01462942|101898657|FG001|Overall Study|Withdrawal by Subject|10|||
33545818|NCT01462942|101898658|FG002|Overall Study|Withdrawal by Subject|14|||
33545819|NCT01462942|101898659|FG003|Overall Study|Withdrawal by Subject|16|||
33545820|NCT01462942|101898660|FG004|Overall Study|Withdrawal by Subject|19|||
33545821|NCT01462942|101898656|FG000|Overall Study|Lack of Efficacy|6|||
33545822|NCT01462942|101898657|FG001|Overall Study|Lack of Efficacy|0|||
33545823|NCT01462942|101898658|FG002|Overall Study|Lack of Efficacy|4|||
33545824|NCT01462942|101898659|FG003|Overall Study|Lack of Efficacy|5|||
33545825|NCT01462942|101898660|FG004|Overall Study|Lack of Efficacy|3|||
33545826|NCT01462942|101898656|FG000|Overall Study|Lost to Follow-up|0|||
33545827|NCT01462942|101898657|FG001|Overall Study|Lost to Follow-up|1|||
33545828|NCT01462942|101898658|FG002|Overall Study|Lost to Follow-up|1|||
33545829|NCT01462942|101898659|FG003|Overall Study|Lost to Follow-up|1|||
33545830|NCT01462942|101898660|FG004|Overall Study|Lost to Follow-up|1|||
33545831|NCT01462942|101898656|FG000|Overall Study|Protocol Violation|4|||
33545832|NCT01462942|101898657|FG001|Overall Study|Protocol Violation|6|||
33545833|NCT01462942|101898658|FG002|Overall Study|Protocol Violation|9|||
33545834|NCT01462942|101898659|FG003|Overall Study|Protocol Violation|9|||
33545835|NCT01462942|101898660|FG004|Overall Study|Protocol Violation|6|||
33545836|NCT02555878|101898661|FG000|Overall Study|Lost to Follow-up|2|||
33545837|NCT02555878|101898662|FG001|Overall Study|Lost to Follow-up|3|||
33545838|NCT02555878|101898661|FG000|Overall Study|Withdrawal by Subject|48|||
33545839|NCT02555878|101898662|FG001|Overall Study|Withdrawal by Subject|48|||
33545840|NCT02555878|101898661|FG000|Overall Study|Adverse Event|12|||
33545841|NCT02555878|101898662|FG001|Overall Study|Adverse Event|8|||
33545842|NCT02555878|101898661|FG000|Overall Study|Death|74|||
33545843|NCT02555878|101898662|FG001|Overall Study|Death|59|||
33545844|NCT02555878|101898661|FG000|Overall Study|Protocol Violation|1|||
33545845|NCT02555878|101898662|FG001|Overall Study|Protocol Violation|2|||
33545846|NCT02555878|101898661|FG000|Overall Study|Physician Decision|12|||
33545847|NCT02555878|101898662|FG001|Overall Study|Physician Decision|13|||
33545848|NCT02555878|101898661|FG000|Overall Study|Other|17|||
33545849|NCT02555878|101898662|FG001|Overall Study|Other|17|||
33545850|NCT04900272|101898663|FG000|Overall Study|Lost to Follow-up|2|||
33545851|NCT04900272|101898663|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
33545852|NCT04900272|101898663|FG000|Overall Study|Withdrawal by Subject|1|||
33545853|NCT01069939|101898664|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
33545854|NCT01069939|101898665|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
33545855|NCT01069939|101898664|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
33545856|NCT01069939|101898665|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
33545857|NCT01069939|101898664|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
33545858|NCT01069939|101898665|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
33545859|NCT01069939|101898664|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
33545860|NCT01069939|101898665|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
33545861|NCT01069939|101898664|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
33545862|NCT01069939|101898665|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
33545863|NCT01069939|101898664|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
33545864|NCT01069939|101898665|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
33545865|NCT01069939|101898664|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
33545866|NCT01069939|101898665|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
33545867|NCT01069939|101898664|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
33545868|NCT01069939|101898665|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
33545869|NCT01069939|101898664|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
33545870|NCT01069939|101898665|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
33545871|NCT01069939|101898664|FG000|Randomised and Included in the Analyses|Removal|1|||
33545872|NCT01069939|101898665|FG001|Randomised and Included in the Analyses|Removal|0|||
33545873|NCT02207608|101898666|FG000|Overall Study|Adverse Event|1|||
33545874|NCT02207608|101898667|FG001|Overall Study|Adverse Event|0|||
33545875|NCT05073315|101898668|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
33213907|NCT01588184|100679815|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
33545876|NCT05073315|101898669|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
33545877|NCT05073315|101898670|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
33545878|NCT05073315|101898668|FG000|Period 1 (Lead-in Period)|Death|1|||
33545879|NCT05073315|101898669|FG001|Period 1 (Lead-in Period)|Death|0|||
33545880|NCT05073315|101898670|FG002|Period 1 (Lead-in Period)|Death|0|||
33545881|NCT05073315|101898668|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
33545882|NCT05073315|101898669|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
33545883|NCT05073315|101898670|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
33545884|NCT05073315|101898668|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
33545885|NCT05073315|101898669|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
33545886|NCT05073315|101898670|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
33545887|NCT05073315|101898668|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
33545888|NCT05073315|101898669|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
33545889|NCT05073315|101898670|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
33545890|NCT05073315|101898668|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
33213908|NCT01588184|100679816|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
33213909|NCT01588184|100679817|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
33347870|NCT01109940|101163812|FG002|Overall Study|Administrative problems|0|||
33347871|NCT01109940|101163813|FG003|Overall Study|Administrative problems|0|||
33347872|NCT01109940|101163810|FG000|Overall Study|Serious Adverse Event|2|||
33347873|NCT01109940|101163811|FG001|Overall Study|Serious Adverse Event|1|||
33347874|NCT01109940|101163812|FG002|Overall Study|Serious Adverse Event|0|||
33347875|NCT01109940|101163813|FG003|Overall Study|Serious Adverse Event|0|||
33347876|NCT01109940|101163810|FG000|Overall Study|Lost to Follow-up|1|||
33347877|NCT01109940|101163811|FG001|Overall Study|Lost to Follow-up|0|||
33347878|NCT01109940|101163812|FG002|Overall Study|Lost to Follow-up|0|||
33347879|NCT01109940|101163813|FG003|Overall Study|Lost to Follow-up|0|||
33347880|NCT01109940|101163810|FG000|Overall Study|Patient withdrew consent|1|||
33347881|NCT01109940|101163811|FG001|Overall Study|Patient withdrew consent|1|||
33347882|NCT01109940|101163812|FG002|Overall Study|Patient withdrew consent|0|||
33347883|NCT01109940|101163813|FG003|Overall Study|Patient withdrew consent|0|||
33347884|NCT01109940|101163810|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33347885|NCT01109940|101163811|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33347886|NCT01109940|101163812|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
33347887|NCT01109940|101163813|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
33347888|NCT00234039|101163814|FG000|Overall Study|Adverse Event|2|||
33545891|NCT05073315|101898669|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
33545892|NCT05073315|101898670|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
33545893|NCT05073315|101898668|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
33545894|NCT05073315|101898669|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
33545895|NCT05073315|101898670|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
33545896|NCT05073315|101898668|FG000|Period 2|Adverse Event|0|||
33545897|NCT05073315|101898669|FG001|Period 2|Adverse Event|3|||
33545898|NCT05073315|101898670|FG002|Period 2|Adverse Event|6|||
33545899|NCT05073315|101898668|FG000|Period 2|Lost to Follow-up|0|||
33545900|NCT05073315|101898669|FG001|Period 2|Lost to Follow-up|5|||
33545901|NCT05073315|101898670|FG002|Period 2|Lost to Follow-up|5|||
33545902|NCT05073315|101898668|FG000|Period 2|Withdrawal by Subject|0|||
33545903|NCT05073315|101898669|FG001|Period 2|Withdrawal by Subject|4|||
33545904|NCT05073315|101898670|FG002|Period 2|Withdrawal by Subject|9|||
33545905|NCT05073315|101898668|FG000|Period 2|Protocol Violation|0|||
33545906|NCT05073315|101898669|FG001|Period 2|Protocol Violation|0|||
33545907|NCT05073315|101898670|FG002|Period 2|Protocol Violation|1|||
33545908|NCT00580840|101898671|FG000|Run-in|Adverse Event|17|||
33545909|NCT00580840|101898672|FG001|Run-in|Adverse Event|0|||
33545910|NCT00580840|101898673|FG002|Run-in|Adverse Event|0|||
33545911|NCT00580840|101898674|FG003|Run-in|Adverse Event|0|||
33545912|NCT00580840|101898671|FG000|Run-in|Lack of Efficacy|93|||
33213910|NCT01588184|100679818|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
33347889|NCT00234039|101163814|FG000|Overall Study|Progression/relapse|34|||
33347890|NCT00234039|101163814|FG000|Overall Study|Other - Not Protocol Specified|3|||
33545913|NCT00580840|101898672|FG001|Run-in|Lack of Efficacy|0|||
33347891|NCT00234039|101163814|FG000|Overall Study|Ineligible|9|||
33347892|NCT00234039|101163814|FG000|Overall Study|No Protocol Treatment Received|2|||
33347893|NCT03072160|101163815|FG000|Overall Study|Adverse Event|3|||
33545914|NCT00580840|101898673|FG002|Run-in|Lack of Efficacy|0|||
33545915|NCT00580840|101898674|FG003|Run-in|Lack of Efficacy|0|||
33545916|NCT00580840|101898671|FG000|Run-in|Loss of Efficacy|1|||
33347894|NCT03072160|101163816|FG001|Overall Study|Adverse Event|1|||
33347895|NCT03072160|101163815|FG000|Overall Study|Refused further treatment|6|||
33347896|NCT03072160|101163816|FG001|Overall Study|Refused further treatment|1|||
33347897|NCT03072160|101163815|FG000|Overall Study|Physician Decision|1|||
33347898|NCT03072160|101163816|FG001|Overall Study|Physician Decision|0|||
33347899|NCT03072160|101163815|FG000|Overall Study|Disease progression on study|1|||
33347900|NCT03072160|101163816|FG001|Overall Study|Disease progression on study|1|||
33545917|NCT00580840|101898672|FG001|Run-in|Loss of Efficacy|0|||
33545918|NCT00580840|101898673|FG002|Run-in|Loss of Efficacy|0|||
33545919|NCT00580840|101898674|FG003|Run-in|Loss of Efficacy|0|||
33545920|NCT00580840|101898671|FG000|Run-in|Lost to Follow-up|4|||
33545921|NCT00580840|101898672|FG001|Run-in|Lost to Follow-up|0|||
33213911|NCT01588184|100679819|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
33347901|NCT03072160|101163815|FG000|Overall Study|No contact|0|||
33347902|NCT03072160|101163816|FG001|Overall Study|No contact|1|||
33347903|NCT00802360|101163822|FG000|Overall Study|Stimulation failure|4|||
33347904|NCT00802360|101163823|FG001|Overall Study|Stimulation failure|0|||
33347905|NCT00802360|101163824|FG002|Overall Study|Stimulation failure|3|||
33347906|NCT00802360|101163825|FG003|Overall Study|Stimulation failure|3|||
33347907|NCT00802360|101163822|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
33347908|NCT00802360|101163823|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
33347909|NCT00802360|101163824|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
33347910|NCT00802360|101163825|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
33347911|NCT00802360|101163822|FG000|Overall Study|Cycle cancelled|0|||
33347912|NCT00802360|101163823|FG001|Overall Study|Cycle cancelled|1|||
33347913|NCT00802360|101163824|FG002|Overall Study|Cycle cancelled|1|||
33347914|NCT00802360|101163825|FG003|Overall Study|Cycle cancelled|1|||
33347915|NCT00802360|101163822|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
33347916|NCT00802360|101163823|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
33347917|NCT00802360|101163824|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
33347918|NCT00802360|101163825|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
33347919|NCT00802360|101163822|FG000|Overall Study|No positive serum pregnancy|17|||
33347920|NCT00802360|101163823|FG001|Overall Study|No positive serum pregnancy|20|||
33347921|NCT00802360|101163824|FG002|Overall Study|No positive serum pregnancy|14|||
33347922|NCT00802360|101163825|FG003|Overall Study|No positive serum pregnancy|10|||
33347923|NCT00802360|101163822|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
33347924|NCT00802360|101163823|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
33347925|NCT00802360|101163824|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
33347926|NCT00802360|101163825|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
33347927|NCT00802360|101163822|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
33347928|NCT00802360|101163823|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
33347929|NCT00802360|101163824|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
33347930|NCT00802360|101163825|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
33347931|NCT00802360|101163822|FG000|Overall Study|Other|2|||
33347932|NCT00802360|101163823|FG001|Overall Study|Other|3|||
33347933|NCT00802360|101163824|FG002|Overall Study|Other|6|||
33347934|NCT00802360|101163825|FG003|Overall Study|Other|3|||
33347935|NCT01442181|101163828|FG000|Overall Study|patient refused surgery|1|||
33347936|NCT01442181|101163829|FG001|Overall Study|patient refused surgery|0|||
33347937|NCT01442181|101163828|FG000|Overall Study|no insurance for surgery|1|||
33347938|NCT01442181|101163829|FG001|Overall Study|no insurance for surgery|0|||
33347939|NCT01442181|101163828|FG000|Overall Study|low ejection factor|0|||
33213912|NCT01588184|100679820|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
33213913|NCT01588184|100679815|FG000|Overall Study|multiple reasons|0|||
33213914|NCT01588184|100679816|FG001|Overall Study|multiple reasons|3|||
33213915|NCT01588184|100679817|FG002|Overall Study|multiple reasons|0|||
33213916|NCT01588184|100679818|FG003|Overall Study|multiple reasons|1|||
33347940|NCT01442181|101163829|FG001|Overall Study|low ejection factor|1|||
33409134|NCT03556202|101386206|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
33213917|NCT01588184|100679819|FG004|Overall Study|multiple reasons|0|||
33213918|NCT01588184|100679820|FG005|Overall Study|multiple reasons|0|||
33213919|NCT02794285|100679821|FG000|Overall Study|Adverse Event|11|||
33213920|NCT02794285|100679822|FG001|Overall Study|Adverse Event|4|||
33409135|NCT03556202|101386204|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
33409136|NCT03556202|101386205|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
33409137|NCT03556202|101386206|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
33545922|NCT00580840|101898673|FG002|Run-in|Lost to Follow-up|0|||
33545923|NCT00580840|101898674|FG003|Run-in|Lost to Follow-up|0|||
33545924|NCT00580840|101898671|FG000|Run-in|Withdrawal by Subject|5|||
33545925|NCT00580840|101898672|FG001|Run-in|Withdrawal by Subject|0|||
33545926|NCT00580840|101898673|FG002|Run-in|Withdrawal by Subject|0|||
33545927|NCT00580840|101898674|FG003|Run-in|Withdrawal by Subject|0|||
33213921|NCT02794285|100679823|FG002|Overall Study|Adverse Event|5|||
33213922|NCT02794285|100679824|FG003|Overall Study|Adverse Event|8|||
33213923|NCT02794285|100679821|FG000|Overall Study|Condition Under Investigation Improved|1|||
33347941|NCT01442181|101163828|FG000|Overall Study|Lost to Follow-up|1|||
33347942|NCT01442181|101163829|FG001|Overall Study|Lost to Follow-up|1|||
33347943|NCT01442181|101163828|FG000|Overall Study|patient in an additional study|1|||
33347944|NCT01442181|101163829|FG001|Overall Study|patient in an additional study|0|||
33409138|NCT03556202|101386204|FG000|Extension Treatment Period|Physician Decision|0|||
33409139|NCT03556202|101386205|FG001|Extension Treatment Period|Physician Decision|8|||
33409140|NCT03556202|101386206|FG002|Extension Treatment Period|Physician Decision|2|||
33409141|NCT03556202|101386204|FG000|Extension Treatment Period|Protocol Violation|0|||
33409142|NCT03556202|101386205|FG001|Extension Treatment Period|Protocol Violation|1|||
33409143|NCT03556202|101386206|FG002|Extension Treatment Period|Protocol Violation|1|||
33409144|NCT03556202|101386204|FG000|Extension Treatment Period|Sponsor Decision|0|||
33409145|NCT03556202|101386205|FG001|Extension Treatment Period|Sponsor Decision|1|||
33409146|NCT03556202|101386206|FG002|Extension Treatment Period|Sponsor Decision|0|||
33409147|NCT03556202|101386204|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
33409148|NCT03556202|101386205|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
33409149|NCT03556202|101386206|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
33409150|NCT03556202|101386204|FG000|Follow-Up Period (12 Weeks)|Death|1|||
33409151|NCT03556202|101386205|FG001|Follow-Up Period (12 Weeks)|Death|0|||
33409152|NCT03556202|101386206|FG002|Follow-Up Period (12 Weeks)|Death|0|||
33409153|NCT03556202|101386204|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
33409154|NCT03556202|101386205|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
33409155|NCT03556202|101386206|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
33409156|NCT03556202|101386204|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
33409157|NCT03556202|101386205|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
33409158|NCT03556202|101386206|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
33409159|NCT03556202|101386204|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
33409160|NCT03556202|101386205|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
33409161|NCT03556202|101386206|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
33409162|NCT03556202|101386204|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
33409163|NCT03556202|101386205|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
33409164|NCT03556202|101386206|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
33409165|NCT03556202|101386204|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
33409166|NCT03556202|101386205|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
33409167|NCT03556202|101386206|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
33409168|NCT03556202|101386204|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
33213924|NCT02794285|100679822|FG001|Overall Study|Condition Under Investigation Improved|0|||
33409169|NCT03556202|101386205|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
33409170|NCT03556202|101386206|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
33409171|NCT03556202|101386204|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
33409172|NCT03556202|101386205|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
33409173|NCT03556202|101386206|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
33409174|NCT03556202|101386204|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
33409175|NCT03556202|101386205|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
33409176|NCT03556202|101386206|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
33409177|NCT03556202|101386204|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
33409178|NCT03556202|101386205|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
33409179|NCT03556202|101386206|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
33409180|NCT03556202|101386204|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
33409181|NCT03556202|101386205|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
33409182|NCT03556202|101386206|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
33409183|NCT03556202|101386204|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
33409184|NCT03556202|101386205|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
33409185|NCT03556202|101386206|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
33409186|NCT03556202|101386204|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
33409187|NCT03556202|101386205|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
33409188|NCT03556202|101386206|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
33409189|NCT00265382|101386211|FG000|Overall Study|Adverse Event|21|||
33409190|NCT00265382|101386211|FG000|Overall Study|Laboratory Abnormality|1|||
33409191|NCT00265382|101386211|FG000|Overall Study|Lost to Follow-up|3|||
33409192|NCT00265382|101386211|FG000|Overall Study|Lack of Efficacy|6|||
33409193|NCT00265382|101386211|FG000|Overall Study|Miscellaneous|6|||
33409194|NCT00265382|101386211|FG000|Overall Study|Withdrawal by Subject|13|||
33213925|NCT02794285|100679823|FG002|Overall Study|Condition Under Investigation Improved|0|||
33545928|NCT00580840|101898671|FG000|Run-in|Other: Per Sponsor Request|2|||
33545929|NCT00580840|101898672|FG001|Run-in|Other: Per Sponsor Request|0|||
33545930|NCT00580840|101898673|FG002|Run-in|Other: Per Sponsor Request|0|||
33545931|NCT00580840|101898674|FG003|Run-in|Other: Per Sponsor Request|0|||
33545932|NCT00580840|101898671|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
33545933|NCT00580840|101898672|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
33545934|NCT00580840|101898673|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
33545935|NCT00580840|101898674|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
33545936|NCT00580840|101898671|FG000|Run-in|Other: Exclusionary Lab Value|1|||
33545937|NCT00580840|101898672|FG001|Run-in|Other: Exclusionary Lab Value|0|||
33545938|NCT00580840|101898673|FG002|Run-in|Other: Exclusionary Lab Value|0|||
33545939|NCT00580840|101898674|FG003|Run-in|Other: Exclusionary Lab Value|0|||
33545940|NCT00580840|101898671|FG000|Double-Blind|Adverse Event|0|||
33545941|NCT00580840|101898672|FG001|Double-Blind|Adverse Event|3|||
33545942|NCT00580840|101898673|FG002|Double-Blind|Adverse Event|4|||
33545943|NCT00580840|101898674|FG003|Double-Blind|Adverse Event|1|||
33347945|NCT01442181|101163828|FG000|Overall Study|atrial fibrillation not noted|0|||
33347946|NCT01442181|101163829|FG001|Overall Study|atrial fibrillation not noted|1|||
33347947|NCT02429856|101163830|FG000|Overall Study|Death|12|||
33545944|NCT00580840|101898671|FG000|Double-Blind|Loss of Efficacy|0|||
33616922|NCT01053988|102144454|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33616923|NCT01053988|102144455|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33616924|NCT01053988|102144450|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
33616925|NCT01053988|102144451|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33616926|NCT01053988|102144452|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33616927|NCT01053988|102144453|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33616928|NCT01053988|102144454|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33616929|NCT01053988|102144455|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33616930|NCT01053988|102144450|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
33616931|NCT01053988|102144451|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
33616932|NCT01053988|102144452|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
33616933|NCT01053988|102144453|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
33616934|NCT01053988|102144454|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
33616935|NCT01053988|102144455|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
33616936|NCT01053988|102144450|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
33616937|NCT01053988|102144451|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
33616938|NCT01053988|102144452|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
33616939|NCT01053988|102144453|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
33616940|NCT01053988|102144454|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
33616941|NCT01053988|102144455|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
33616942|NCT01053988|102144450|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
33347948|NCT02429856|101163831|FG001|Overall Study|Death|13|||
33347949|NCT02429856|101163830|FG000|Overall Study|Lost to Follow-up|6|||
33347950|NCT02429856|101163831|FG001|Overall Study|Lost to Follow-up|5|||
33347951|NCT02429856|101163830|FG000|Overall Study|Withdrawal by Subject|1|||
33347952|NCT02429856|101163831|FG001|Overall Study|Withdrawal by Subject|1|||
33347953|NCT03433781|101163832|FG000|Overall Study|Progression of Disease|1|||
33347954|NCT03433781|101163833|FG001|Overall Study|Progression of Disease|0|||
33347955|NCT03433781|101163834|FG002|Overall Study|Progression of Disease|0|||
33347956|NCT03433781|101163832|FG000|Overall Study|Physician Decision|0|||
33347957|NCT03433781|101163833|FG001|Overall Study|Physician Decision|1|||
33347958|NCT03433781|101163834|FG002|Overall Study|Physician Decision|0|||
33347959|NCT00655928|101163835|FG000|Overall Study|Withdrawal by Subject|2|||
33347960|NCT00655928|101163836|FG001|Overall Study|Withdrawal by Subject|1|||
33545945|NCT00580840|101898672|FG001|Double-Blind|Loss of Efficacy|1|||
33545946|NCT00580840|101898673|FG002|Double-Blind|Loss of Efficacy|2|||
33545947|NCT00580840|101898674|FG003|Double-Blind|Loss of Efficacy|10|||
33347961|NCT00655928|101163835|FG000|Overall Study|Physician Decision|1|||
33347962|NCT00655928|101163836|FG001|Overall Study|Physician Decision|1|||
33347963|NCT00684177|101163837|FG000|Overall Study|Adverse Event|4|||
33347964|NCT00684177|101163838|FG001|Overall Study|Adverse Event|3|||
33347965|NCT00684177|101163837|FG000|Overall Study|Lack of Efficacy|10|||
33347966|NCT00684177|101163838|FG001|Overall Study|Lack of Efficacy|15|||
33347967|NCT00684177|101163837|FG000|Overall Study|Protocol Violation|1|||
33347968|NCT00684177|101163838|FG001|Overall Study|Protocol Violation|0|||
33545948|NCT00580840|101898671|FG000|Double-Blind|Lost to Follow-up|0|||
33545949|NCT00580840|101898672|FG001|Double-Blind|Lost to Follow-up|1|||
33545950|NCT00580840|101898673|FG002|Double-Blind|Lost to Follow-up|0|||
33545951|NCT00580840|101898674|FG003|Double-Blind|Lost to Follow-up|2|||
33545952|NCT00580840|101898671|FG000|Double-Blind|Withdrawal by Subject|0|||
33545953|NCT00580840|101898672|FG001|Double-Blind|Withdrawal by Subject|1|||
33409195|NCT00265382|101386211|FG000|Overall Study|Study terminated by sponsor|94|||
33545954|NCT00580840|101898673|FG002|Double-Blind|Withdrawal by Subject|2|||
33213926|NCT02794285|100679824|FG003|Overall Study|Condition Under Investigation Improved|0|||
33409196|NCT00265382|101386211|FG000|Overall Study|Death|1|||
33409197|NCT00071006|101386212|FG000|Overall Study|Lack of Efficacy|7|||
33409198|NCT00071006|101386212|FG000|Overall Study|Adverse Event|1|||
33409199|NCT00071006|101386212|FG000|Overall Study|Withdrawal by Subject|1|||
33409200|NCT00071006|101386212|FG000|Overall Study|Other|3|||
33409201|NCT01871870|101386215|FG000|Overall Study|Hardware issues|7|||
33409202|NCT01871870|101386215|FG000|Overall Study|hyperglycemia|2|||
33409203|NCT01303159|101386223|FG000|Overall Study|Death|16|||
33409204|NCT01303159|101386223|FG000|Overall Study|Study Termination|7|||
33409205|NCT00814502|101386226|FG000|Overall Study|Adverse Event|1|||
33409206|NCT00814502|101386227|FG001|Overall Study|Adverse Event|0|||
33409207|NCT00814502|101386226|FG000|Overall Study|Withdrawal by Subject|0|||
33409208|NCT00814502|101386227|FG001|Overall Study|Withdrawal by Subject|2|||
33409209|NCT04837807|101386228|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
33409210|NCT04837807|101386229|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
33409211|NCT00719706|101386234|FG000|Overall Study|Adverse Event|5|||
33409212|NCT00719706|101386235|FG001|Overall Study|Adverse Event|4|||
33409213|NCT00719706|101386234|FG000|Overall Study|Withdrawal by Subject|1|||
33409214|NCT00719706|101386235|FG001|Overall Study|Withdrawal by Subject|2|||
33409215|NCT00719706|101386234|FG000|Overall Study|Protocol Violation|3|||
33409216|NCT00719706|101386235|FG001|Overall Study|Protocol Violation|0|||
33409217|NCT00690612|101386237|FG000|Overall Study|Adverse Event|1|||
33409218|NCT00690612|101386237|FG000|Overall Study|Withdrawal by Subject|2|||
33409219|NCT01002573|101386238|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
33409220|NCT01002573|101386239|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
33409221|NCT00314262|101389165|FG000|Overall Study|Adverse Event|2|||
33409222|NCT00314262|101389165|FG000|Overall Study|Withdrawal by Subject|2|||
33409223|NCT00314262|101389165|FG000|Overall Study|Physician Decision|1|||
33409224|NCT03781167|101389166|FG000|Overall Study|Adverse Event|23|||
33409225|NCT03781167|101389167|FG001|Overall Study|Adverse Event|25|||
33545955|NCT00580840|101898674|FG003|Double-Blind|Withdrawal by Subject|2|||
33347969|NCT00684177|101163837|FG000|Overall Study|Lost to Follow-up|2|||
33347970|NCT00684177|101163838|FG001|Overall Study|Lost to Follow-up|1|||
33347971|NCT00684177|101163837|FG000|Overall Study|Physician Decision|2|||
33409226|NCT03781167|101389166|FG000|Overall Study|Withdrew consent|16|||
33409227|NCT03781167|101389167|FG001|Overall Study|Withdrew consent|12|||
33409228|NCT03781167|101389166|FG000|Overall Study|Lost to Follow-up|0|||
33409229|NCT03781167|101389167|FG001|Overall Study|Lost to Follow-up|1|||
33409230|NCT03781167|101389166|FG000|Overall Study|Lack of Efficacy|4|||
33409231|NCT03781167|101389167|FG001|Overall Study|Lack of Efficacy|5|||
33409232|NCT03781167|101389166|FG000|Overall Study|Difficulty with drug delivery system|2|||
33545956|NCT00580840|101898671|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
33545957|NCT00580840|101898672|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
33213927|NCT02794285|100679821|FG000|Overall Study|Condition Under Investigation Worsened|0|||
33347972|NCT00684177|101163838|FG001|Overall Study|Physician Decision|0|||
33409233|NCT03781167|101389167|FG001|Overall Study|Difficulty with drug delivery system|3|||
33409234|NCT03781167|101389166|FG000|Overall Study|Other, not specified|2|||
33409235|NCT03781167|101389167|FG001|Overall Study|Other, not specified|2|||
33409236|NCT02059265|101389168|FG000|Overall Study|Ineligible|4|||
33347973|NCT00684177|101163837|FG000|Overall Study|Withdrawal by Subject|1|||
33347974|NCT00684177|101163838|FG001|Overall Study|Withdrawal by Subject|2|||
33347975|NCT00684177|101163837|FG000|Overall Study|Other|1|||
33347976|NCT00684177|101163838|FG001|Overall Study|Other|2|||
33347977|NCT02700984|101163839|FG000|Overall Study|Death|2|||
33347978|NCT02700984|101163840|FG001|Overall Study|Death|1|||
33347979|NCT02700984|101163839|FG000|Overall Study|Lost to Follow-up|2|||
33347980|NCT02700984|101163840|FG001|Overall Study|Lost to Follow-up|1|||
33347981|NCT02700984|101163839|FG000|Overall Study|Physician Decision|0|||
33409237|NCT01608321|101389170|FG000|Overall Study|Withdrawal by Subject|1|||
33409238|NCT01608321|101389171|FG001|Overall Study|Withdrawal by Subject|0|||
33409239|NCT01215968|101389172|FG000|Overall Study|Adverse Event|0|||
33409240|NCT01215968|101389173|FG001|Overall Study|Adverse Event|2|||
33409241|NCT01215968|101389172|FG000|Overall Study|Protocol Violation|2|||
33409242|NCT01215968|101389173|FG001|Overall Study|Protocol Violation|4|||
33409243|NCT01215968|101389172|FG000|Overall Study|Not received study drug|0|||
33409244|NCT01215968|101389173|FG001|Overall Study|Not received study drug|1|||
33409245|NCT00066573|101389174|FG000|Overall Study|Did not received protocol treatment|28|||
33409246|NCT00066573|101389175|FG001|Overall Study|Did not received protocol treatment|28|||
33409247|NCT01258803|101389182|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
33409248|NCT01258803|101389183|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
33409249|NCT01258803|101389184|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
33409250|NCT01258803|101389185|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
33409251|NCT01258803|101389186|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
33409252|NCT01258803|101389187|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
33409253|NCT01258803|101389182|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
33409254|NCT01258803|101389183|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
33409255|NCT01258803|101389184|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
33409256|NCT01258803|101389185|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
33409257|NCT01258803|101389186|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
33409258|NCT01258803|101389187|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
33545958|NCT00580840|101898673|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
33545959|NCT00580840|101898674|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
33545960|NCT00580840|101898671|FG000|Double-Blind|Other: Forbidden Medication|0|||
33409259|NCT01258803|101389182|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
33409260|NCT01258803|101389183|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
33409261|NCT01258803|101389184|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
33409262|NCT01258803|101389185|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
33409263|NCT01258803|101389186|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
33545961|NCT00580840|101898672|FG001|Double-Blind|Other: Forbidden Medication|0|||
33545962|NCT00580840|101898673|FG002|Double-Blind|Other: Forbidden Medication|1|||
33545963|NCT00580840|101898674|FG003|Double-Blind|Other: Forbidden Medication|0|||
33545964|NCT00883181|101898675|FG000|Overall Study|Hematological Adverse Event|26|||
33545965|NCT00883181|101898675|FG000|Overall Study|Non-hematological Adverse Event|55|||
33545966|NCT00883181|101898675|FG000|Overall Study|Disease Progression|94|||
33545967|NCT00883181|101898675|FG000|Overall Study|Administrative Reason|24|||
33545968|NCT00883181|101898675|FG000|Overall Study|Withdrawal by Subject|4|||
33545969|NCT00883181|101898675|FG000|Overall Study|Death|31|||
33545970|NCT00883181|101898675|FG000|Overall Study|Other|38|||
33545971|NCT00883181|101898675|FG000|Overall Study|Protocol Deviation|3|||
33545972|NCT00883181|101898675|FG000|Overall Study|Noncompliance|3|||
33545973|NCT01136954|101898679|FG000|Overall Study|Adverse Event|3|||
33545974|NCT01136954|101898680|FG001|Overall Study|Adverse Event|2|||
33545975|NCT01136954|101898679|FG000|Overall Study|Withdrawal by Subject|6|||
33545976|NCT01136954|101898680|FG001|Overall Study|Withdrawal by Subject|2|||
33545977|NCT01136954|101898679|FG000|Overall Study|Lack of Efficacy|14|||
33545978|NCT01136954|101898680|FG001|Overall Study|Lack of Efficacy|13|||
33545979|NCT01136954|101898679|FG000|Overall Study|Physician Decision|0|||
33545980|NCT01136954|101898680|FG001|Overall Study|Physician Decision|1|||
33545981|NCT01136954|101898679|FG000|Overall Study|Other|1|||
33545982|NCT01136954|101898680|FG001|Overall Study|Other|3|||
33545983|NCT03743194|101898681|FG000|Overall Study|Protocol Violation|7|||
33347982|NCT02700984|101163840|FG001|Overall Study|Physician Decision|1|||
33409264|NCT01258803|101389187|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
33409265|NCT02706327|101389188|FG000|Overall Study|Lost to Follow-up|1|||
33409266|NCT02706327|101389189|FG001|Overall Study|Lost to Follow-up|1|||
33545984|NCT03743194|101898682|FG001|Overall Study|Protocol Violation|7|||
33347983|NCT02700984|101163839|FG000|Overall Study|Withdrawal by Subject|8|||
33409267|NCT02706327|101389190|FG002|Overall Study|Lost to Follow-up|2|||
33409268|NCT01041027|101389198|FG000|Overall Study|Withdrawal by Subject|2|||
33409269|NCT01041027|101389198|FG000|Overall Study|Protocol Violation|1|||
33545985|NCT03743194|101898681|FG000|Overall Study|Physician Decision|0|||
33545986|NCT03743194|101898682|FG001|Overall Study|Physician Decision|2|||
33545987|NCT00768053|101898683|FG000|Overall Study|Adverse Event|10|||
33347984|NCT02700984|101163840|FG001|Overall Study|Withdrawal by Subject|9|||
33347985|NCT02700984|101163839|FG000|Overall Study|Reason not specified|3|||
33409270|NCT01041027|101389198|FG000|Overall Study|Delayed Radiation Therapy|1|||
33409271|NCT01041027|101389198|FG000|Overall Study|Adverse Event|4|||
33409272|NCT01761565|101389199|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
33409273|NCT00663208|101389202|FG000|Treatment Period|Lost to Follow-up|0|||
33409274|NCT00663208|101389203|FG001|Treatment Period|Lost to Follow-up|1|||
33409275|NCT00663208|101389204|FG002|Treatment Period|Lost to Follow-up|0|||
33409276|NCT00663208|101389205|FG003|Treatment Period|Lost to Follow-up|0|||
33409277|NCT00663208|101389206|FG004|Treatment Period|Lost to Follow-up|0|||
33347986|NCT02700984|101163840|FG001|Overall Study|Reason not specified|2|||
33347987|NCT01468987|101163841|FG000|Overall Study|Adverse Event|12|||
33347988|NCT01468987|101163842|FG001|Overall Study|Adverse Event|9|||
33347989|NCT01468987|101163841|FG000|Overall Study|Death|4|||
33347990|NCT01468987|101163842|FG001|Overall Study|Death|1|||
33347991|NCT01468987|101163841|FG000|Overall Study|Lost to Follow-up|10|||
33409278|NCT00663208|101389207|FG005|Treatment Period|Lost to Follow-up|0|||
33409279|NCT00663208|101389208|FG006|Treatment Period|Lost to Follow-up|0|||
33409280|NCT00663208|101389202|FG000|Follow-up Period|Lost to Follow-up|2|||
33409281|NCT00663208|101389203|FG001|Follow-up Period|Lost to Follow-up|0|||
33409282|NCT00663208|101389204|FG002|Follow-up Period|Lost to Follow-up|3|||
33409283|NCT00663208|101389205|FG003|Follow-up Period|Lost to Follow-up|2|||
33409284|NCT00663208|101389206|FG004|Follow-up Period|Lost to Follow-up|0|||
33409285|NCT00663208|101389207|FG005|Follow-up Period|Lost to Follow-up|0|||
33409286|NCT00663208|101389208|FG006|Follow-up Period|Lost to Follow-up|0|||
33409287|NCT00663208|101389202|FG000|Follow-up Period|Other reason|1|||
33409288|NCT00663208|101389203|FG001|Follow-up Period|Other reason|0|||
33409289|NCT00663208|101389204|FG002|Follow-up Period|Other reason|0|||
33409290|NCT00663208|101389205|FG003|Follow-up Period|Other reason|0|||
33409291|NCT00663208|101389206|FG004|Follow-up Period|Other reason|0|||
33409292|NCT00663208|101389207|FG005|Follow-up Period|Other reason|0|||
33409293|NCT00663208|101389208|FG006|Follow-up Period|Other reason|1|||
33409294|NCT00451191|101389209|FG000|Overall Study|withdrawal or received alternate tx|15|||
33409295|NCT00451191|101389210|FG001|Overall Study|withdrawal or received alternate tx|11|||
33409296|NCT03193996|101389211|FG000|Overall Study|Withdrawal by Subject|4|||
33409297|NCT03193996|101389211|FG000|Overall Study|Lost to Follow-up|4|||
33409298|NCT03193996|101389211|FG000|Overall Study|Physician Decision|2|||
33409299|NCT03193996|101389211|FG000|Overall Study|Pregnancy|1|||
33409300|NCT03193996|101389211|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
33409301|NCT03193996|101389211|FG000|Overall Study|Complicating disease|1|||
33409302|NCT02528331|101389212|FG000|Overall Study|Withdrawal by Subject|2|||
33409303|NCT02163759|101389213|FG000|Overall Study|Withdrawal by Subject|1|||
33409304|NCT02163759|101389214|FG001|Overall Study|Withdrawal by Subject|5|||
33409305|NCT02163759|101389215|FG002|Overall Study|Withdrawal by Subject|1|||
33347992|NCT01468987|101163842|FG001|Overall Study|Lost to Follow-up|5|||
33347993|NCT01468987|101163841|FG000|Overall Study|Protocol Violation|8|||
33347994|NCT01468987|101163842|FG001|Overall Study|Protocol Violation|2|||
33347995|NCT01468987|101163841|FG000|Overall Study|Withdrawal by Subject|28|||
33347996|NCT01468987|101163842|FG001|Overall Study|Withdrawal by Subject|28|||
33347997|NCT01468987|101163841|FG000|Overall Study|Physician Decision|8|||
33347998|NCT01468987|101163842|FG001|Overall Study|Physician Decision|15|||
33347999|NCT01468987|101163841|FG000|Overall Study|Sponsor Decision|1|||
33348000|NCT01468987|101163842|FG001|Overall Study|Sponsor Decision|0|||
33348001|NCT01451645|101163845|FG000|Overall Study|Protocol Violation|1|||
33348002|NCT01451645|101163846|FG001|Overall Study|Protocol Violation|0|||
33348003|NCT01451645|101163845|FG000|Overall Study|Adverse Event|0|||
33348004|NCT01451645|101163846|FG001|Overall Study|Adverse Event|3|||
33348005|NCT01451645|101163845|FG000|Overall Study|Withdrawal by Subject|4|||
33348006|NCT01451645|101163846|FG001|Overall Study|Withdrawal by Subject|2|||
33348007|NCT01451645|101163845|FG000|Overall Study|Lost to Follow-up|4|||
33348008|NCT01451645|101163846|FG001|Overall Study|Lost to Follow-up|3|||
33409306|NCT02163759|101389213|FG000|Overall Study|Adverse Event|0|||
33409307|NCT02163759|101389214|FG001|Overall Study|Adverse Event|0|||
33409308|NCT02163759|101389215|FG002|Overall Study|Adverse Event|1|||
33409309|NCT02163759|101389213|FG000|Overall Study|Death|0|||
33616943|NCT01053988|102144451|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33348009|NCT00768898|101163847|FG000|Overall Study|Unrelated injury|1|||
33348010|NCT00768898|101163847|FG000|Overall Study|Headache|1|||
33348011|NCT01960855|101163860|FG000|Overall Study|Subject noncompliant|1|||
33348012|NCT01960855|101163861|FG001|Overall Study|Subject noncompliant|0|||
33409310|NCT02163759|101389214|FG001|Overall Study|Death|0|||
33409311|NCT02163759|101389215|FG002|Overall Study|Death|1|||
33409312|NCT04196023|101389216|FG000|Overall Study|Withdrawal by Subject|0|||
33409313|NCT04196023|101389217|FG001|Overall Study|Withdrawal by Subject|1|||
33409314|NCT04196023|101389216|FG000|Overall Study|Adverse Event|3|||
33409315|NCT04196023|101389217|FG001|Overall Study|Adverse Event|1|||
33409316|NCT04196023|101389216|FG000|Overall Study|Lost to Follow-up|0|||
33409317|NCT04196023|101389217|FG001|Overall Study|Lost to Follow-up|1|||
33409318|NCT01283282|101389223|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
33348013|NCT01960855|101163862|FG002|Overall Study|Subject noncompliant|0|||
33409319|NCT01283282|101389224|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
33409320|NCT01283282|101389223|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
33409321|NCT01283282|101389224|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
33409322|NCT01283282|101389223|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
33409323|NCT01283282|101389224|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
33409324|NCT02213666|101389225|FG000|Overall Study|Withdrawal by Subject|1|||
33409325|NCT04398030|101389228|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
33409326|NCT04398030|101389229|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
33409327|NCT04398030|101389228|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
33409328|NCT04398030|101389229|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
33409329|NCT01945866|101389230|FG000|Overall Study|Eyes did not complete or were dropped|2|||
33409330|NCT01945866|101389231|FG001|Overall Study|Eyes did not complete or were dropped|0|||
33409331|NCT01013207|101389232|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
33409332|NCT00475657|101389236|FG000|Overall Study|Death|1|||
33409333|NCT00475657|101389236|FG000|Overall Study|Sponsor's Decision|3|||
33409334|NCT01605370|101389247|FG000|Overall Study|Adverse Event|1|||
33409335|NCT01605370|101389248|FG001|Overall Study|Adverse Event|0|||
33409336|NCT00598442|101389251|FG000|Overall Study|Adverse Event|3|||
33409337|NCT00598442|101389252|FG001|Overall Study|Adverse Event|0|||
33409338|NCT00598442|101389253|FG002|Overall Study|Adverse Event|0|||
33409339|NCT00598442|101389251|FG000|Overall Study|Death|19|||
33409340|NCT00598442|101389252|FG001|Overall Study|Death|11|||
33409341|NCT00598442|101389253|FG002|Overall Study|Death|11|||
33409342|NCT00598442|101389251|FG000|Overall Study|Lost to Follow-up|4|||
33409343|NCT00598442|101389252|FG001|Overall Study|Lost to Follow-up|3|||
33409344|NCT00598442|101389253|FG002|Overall Study|Lost to Follow-up|3|||
33409345|NCT00598442|101389251|FG000|Overall Study|Physician Decision|2|||
33409346|NCT00598442|101389252|FG001|Overall Study|Physician Decision|1|||
33409347|NCT00598442|101389253|FG002|Overall Study|Physician Decision|1|||
33409348|NCT00598442|101389251|FG000|Overall Study|Withdrawal by Subject|8|||
33409349|NCT00598442|101389252|FG001|Overall Study|Withdrawal by Subject|16|||
33409350|NCT00598442|101389253|FG002|Overall Study|Withdrawal by Subject|6|||
33409351|NCT00598442|101389251|FG000|Overall Study|Noncompliance|0|||
33409352|NCT00598442|101389252|FG001|Overall Study|Noncompliance|2|||
33409353|NCT00598442|101389253|FG002|Overall Study|Noncompliance|1|||
33409354|NCT00598442|101389251|FG000|Overall Study|Relocation|1|||
33409355|NCT00598442|101389252|FG001|Overall Study|Relocation|4|||
33409356|NCT00598442|101389253|FG002|Overall Study|Relocation|0|||
33409357|NCT00598442|101389251|FG000|Overall Study|Renal transplant|0|||
33409358|NCT00598442|101389252|FG001|Overall Study|Renal transplant|0|||
33409359|NCT00598442|101389253|FG002|Overall Study|Renal transplant|1|||
33409360|NCT00598442|101389251|FG000|Overall Study|Site closed by sponsor|5|||
33409361|NCT00598442|101389252|FG001|Overall Study|Site closed by sponsor|2|||
33409362|NCT00598442|101389253|FG002|Overall Study|Site closed by sponsor|1|||
33409363|NCT00598442|101389251|FG000|Overall Study|Started dialysis|1|||
33409364|NCT00598442|101389252|FG001|Overall Study|Started dialysis|0|||
33409365|NCT00598442|101389253|FG002|Overall Study|Started dialysis|0|||
33409366|NCT02764229|101389254|FG000|Overall Study|Withdrawal by Subject|15|||
33409367|NCT02764229|101389254|FG000|Overall Study|Adverse Event|9|||
33409368|NCT02764229|101389254|FG000|Overall Study|Physician Decision|5|||
33409369|NCT02764229|101389254|FG000|Overall Study|Lost to Follow-up|3|||
33409370|NCT02764229|101389254|FG000|Overall Study|Lack of Efficacy|1|||
33409371|NCT02764229|101389254|FG000|Overall Study|Study Stopped by Sponsor|69|||
33409372|NCT00253747|101389255|FG000|Overall Study|Lost to Follow-up|13|||
33409373|NCT00253747|101389256|FG001|Overall Study|Lost to Follow-up|14|||
33348014|NCT01960855|101163863|FG003|Overall Study|Subject noncompliant|0|||
33348015|NCT01960855|101163864|FG004|Overall Study|Subject noncompliant|0|||
33348016|NCT01960855|101163860|FG000|Overall Study|Adverse Event|2|||
33348017|NCT01960855|101163861|FG001|Overall Study|Adverse Event|0|||
33348018|NCT01960855|101163862|FG002|Overall Study|Adverse Event|6|||
33348019|NCT01960855|101163863|FG003|Overall Study|Adverse Event|2|||
33348020|NCT01960855|101163864|FG004|Overall Study|Adverse Event|2|||
33348021|NCT01960855|101163860|FG000|Overall Study|Lack of Efficacy|1|||
33348022|NCT01960855|101163861|FG001|Overall Study|Lack of Efficacy|1|||
33348023|NCT01960855|101163862|FG002|Overall Study|Lack of Efficacy|0|||
33348024|NCT01960855|101163863|FG003|Overall Study|Lack of Efficacy|0|||
33348025|NCT01960855|101163864|FG004|Overall Study|Lack of Efficacy|0|||
33348026|NCT01960855|101163860|FG000|Overall Study|Other|2|||
33348027|NCT01960855|101163861|FG001|Overall Study|Other|1|||
33348028|NCT01960855|101163862|FG002|Overall Study|Other|1|||
33409374|NCT00253747|101389255|FG000|Overall Study|Withdrawal by Subject|10|||
33409375|NCT00253747|101389256|FG001|Overall Study|Withdrawal by Subject|11|||
33213928|NCT02794285|100679822|FG001|Overall Study|Condition Under Investigation Worsened|2|||
33409376|NCT00253747|101389255|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
33409377|NCT00253747|101389256|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
33409378|NCT02743117|101389257|FG000|Overall Study|Lost to Follow-up|0|||
33409379|NCT02743117|101389258|FG001|Overall Study|Lost to Follow-up|1|||
33348029|NCT01960855|101163863|FG003|Overall Study|Other|1|||
33545988|NCT00768053|101898683|FG000|Overall Study|Lost to Follow-up|1|||
33545989|NCT03317496|101898684|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
33545990|NCT03317496|101898685|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
33545991|NCT03317496|101898686|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
33545992|NCT03317496|101898687|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
33545993|NCT03317496|101898688|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
33545994|NCT03317496|101898684|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
33545995|NCT03317496|101898685|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
33545996|NCT03317496|101898686|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
33545997|NCT03317496|101898687|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
33545998|NCT03317496|101898688|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
33348030|NCT01960855|101163864|FG004|Overall Study|Other|0|||
33348031|NCT01960855|101163860|FG000|Overall Study|Consent withdrawn by subject|3|||
33348032|NCT01960855|101163861|FG001|Overall Study|Consent withdrawn by subject|1|||
33348033|NCT01960855|101163862|FG002|Overall Study|Consent withdrawn by subject|2|||
33348034|NCT01960855|101163863|FG003|Overall Study|Consent withdrawn by subject|1|||
33348035|NCT01960855|101163864|FG004|Overall Study|Consent withdrawn by subject|1|||
33348036|NCT01960855|101163860|FG000|Overall Study|Lost to Follow-up|2|||
33348037|NCT01960855|101163861|FG001|Overall Study|Lost to Follow-up|1|||
33348038|NCT01960855|101163862|FG002|Overall Study|Lost to Follow-up|0|||
33348039|NCT01960855|101163863|FG003|Overall Study|Lost to Follow-up|0|||
33348040|NCT01960855|101163864|FG004|Overall Study|Lost to Follow-up|2|||
33348041|NCT03403192|101163866|FG000|Overall Study|Lost to Follow-up|1|||
33348042|NCT03403192|101163867|FG001|Overall Study|Lost to Follow-up|2|||
33348043|NCT03403192|101163868|FG002|Overall Study|Lost to Follow-up|0|||
33545999|NCT03317496|101898684|FG000|Phase 1b Lead-in: Treatment|Death|0|||
33546000|NCT03317496|101898685|FG001|Phase 1b Lead-in: Treatment|Death|0|||
33546001|NCT03317496|101898686|FG002|Phase 1b Lead-in: Treatment|Death|1|||
33546002|NCT03317496|101898687|FG003|Phase 1b Lead-in: Treatment|Death|0|||
33546003|NCT03317496|101898688|FG004|Phase 1b Lead-in: Treatment|Death|0|||
33546004|NCT03317496|101898684|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
33546005|NCT03317496|101898685|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
33546006|NCT03317496|101898686|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
33546007|NCT03317496|101898687|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
33546008|NCT03317496|101898688|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
33546009|NCT03317496|101898684|FG000|Phase 1b Lead-in: Treatment|Other|2|||
33546010|NCT03317496|101898685|FG001|Phase 1b Lead-in: Treatment|Other|1|||
33546011|NCT03317496|101898686|FG002|Phase 1b Lead-in: Treatment|Other|0|||
33546012|NCT03317496|101898687|FG003|Phase 1b Lead-in: Treatment|Other|0|||
33546013|NCT03317496|101898688|FG004|Phase 1b Lead-in: Treatment|Other|0|||
33546014|NCT03317496|101898684|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
33546015|NCT03317496|101898685|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
33546016|NCT03317496|101898686|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
33546017|NCT03317496|101898687|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
33546018|NCT03317496|101898688|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
33546019|NCT03317496|101898684|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
33546020|NCT03317496|101898685|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
33546021|NCT03317496|101898686|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
33546022|NCT03317496|101898687|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
33546023|NCT03317496|101898688|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
33546024|NCT03317496|101898684|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
33546025|NCT03317496|101898685|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
33546026|NCT03317496|101898686|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
33546027|NCT03317496|101898687|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
33546028|NCT03317496|101898688|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
33546029|NCT03317496|101898684|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
33546030|NCT03317496|101898685|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
33546031|NCT03317496|101898686|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
33546032|NCT03317496|101898687|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
33546033|NCT03317496|101898688|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
33546034|NCT03317496|101898684|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
33546035|NCT03317496|101898685|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
33546036|NCT03317496|101898686|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
33546037|NCT03317496|101898687|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
33616944|NCT01053988|102144452|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33348044|NCT03403192|101163869|FG003|Overall Study|Lost to Follow-up|0|||
33546038|NCT03317496|101898688|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
33616945|NCT01053988|102144453|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33348045|NCT03403192|101163866|FG000|Overall Study|Unable to respond|0|||
33348046|NCT03403192|101163867|FG001|Overall Study|Unable to respond|1|||
33348047|NCT03403192|101163868|FG002|Overall Study|Unable to respond|0|||
33348048|NCT03403192|101163869|FG003|Overall Study|Unable to respond|0|||
33546039|NCT03317496|101898684|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
33546040|NCT03317496|101898685|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
33546041|NCT03317496|101898686|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
33546042|NCT03317496|101898687|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
33546043|NCT03317496|101898688|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
33546044|NCT03317496|101898684|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
33546045|NCT03317496|101898685|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
33546046|NCT03317496|101898686|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
33546047|NCT03317496|101898687|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
33546048|NCT03317496|101898688|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
33546049|NCT03317496|101898684|FG000|Phase 2: Treatment|Adverse Event|0|||
33546050|NCT03317496|101898685|FG001|Phase 2: Treatment|Adverse Event|0|||
33546051|NCT03317496|101898686|FG002|Phase 2: Treatment|Adverse Event|0|||
33546052|NCT03317496|101898687|FG003|Phase 2: Treatment|Adverse Event|0|||
33546053|NCT03317496|101898688|FG004|Phase 2: Treatment|Adverse Event|6|||
33546054|NCT03317496|101898684|FG000|Phase 2: Treatment|Progressive disease|0|||
33546055|NCT03317496|101898685|FG001|Phase 2: Treatment|Progressive disease|0|||
33546056|NCT03317496|101898686|FG002|Phase 2: Treatment|Progressive disease|0|||
33546057|NCT03317496|101898687|FG003|Phase 2: Treatment|Progressive disease|0|||
33546058|NCT03317496|101898688|FG004|Phase 2: Treatment|Progressive disease|22|||
33546059|NCT03317496|101898684|FG000|Phase 2: Treatment|Other|0|||
33546060|NCT03317496|101898685|FG001|Phase 2: Treatment|Other|0|||
33546061|NCT03317496|101898686|FG002|Phase 2: Treatment|Other|0|||
33546062|NCT03317496|101898687|FG003|Phase 2: Treatment|Other|0|||
33546063|NCT03317496|101898688|FG004|Phase 2: Treatment|Other|4|||
33546064|NCT03317496|101898684|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
33546065|NCT03317496|101898685|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
33546066|NCT03317496|101898686|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
33546067|NCT03317496|101898687|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
33546068|NCT03317496|101898688|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
33546069|NCT03317496|101898684|FG000|Phase 2: Treatment|Physician Decision|0|||
33546070|NCT03317496|101898685|FG001|Phase 2: Treatment|Physician Decision|0|||
33546071|NCT03317496|101898686|FG002|Phase 2: Treatment|Physician Decision|0|||
33546072|NCT03317496|101898687|FG003|Phase 2: Treatment|Physician Decision|0|||
33546073|NCT03317496|101898688|FG004|Phase 2: Treatment|Physician Decision|1|||
33546074|NCT03317496|101898684|FG000|Phase 2: Treatment|Death|0|||
33546075|NCT03317496|101898685|FG001|Phase 2: Treatment|Death|0|||
33546076|NCT03317496|101898686|FG002|Phase 2: Treatment|Death|0|||
33546077|NCT03317496|101898687|FG003|Phase 2: Treatment|Death|0|||
33546078|NCT03317496|101898688|FG004|Phase 2: Treatment|Death|1|||
33546079|NCT03317496|101898684|FG000|Phase 2: Follow-up|Death|0|||
33546080|NCT03317496|101898685|FG001|Phase 2: Follow-up|Death|0|||
33546081|NCT03317496|101898686|FG002|Phase 2: Follow-up|Death|0|||
33546082|NCT03317496|101898687|FG003|Phase 2: Follow-up|Death|0|||
33546083|NCT03317496|101898688|FG004|Phase 2: Follow-up|Death|24|||
33546084|NCT03317496|101898684|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
33546085|NCT03317496|101898685|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
33546086|NCT03317496|101898686|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
33546087|NCT03317496|101898687|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
33546088|NCT03317496|101898688|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
33546089|NCT03317496|101898684|FG000|Phase 2: Follow-up|Other|0|||
33546090|NCT03317496|101898685|FG001|Phase 2: Follow-up|Other|0|||
33546091|NCT03317496|101898686|FG002|Phase 2: Follow-up|Other|0|||
33546092|NCT03317496|101898687|FG003|Phase 2: Follow-up|Other|0|||
33546093|NCT03317496|101898688|FG004|Phase 2: Follow-up|Other|1|||
33546094|NCT03317496|101898684|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
33546095|NCT03317496|101898685|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
33546096|NCT03317496|101898686|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
33546097|NCT03317496|101898687|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
33546098|NCT03317496|101898688|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
33546099|NCT00976027|101898689|FG000|Overall Study|Serious Adverse Event|36|||
33348049|NCT03403192|101163866|FG000|Overall Study|Incomplete|3|||
33546100|NCT00976027|101898690|FG001|Overall Study|Serious Adverse Event|17|||
33546101|NCT00976027|101898689|FG000|Overall Study|Adverse Event|0|||
33546102|NCT00976027|101898690|FG001|Overall Study|Adverse Event|2|||
33546103|NCT00976027|101898689|FG000|Overall Study|Protocol Violation|60|||
33546104|NCT00976027|101898690|FG001|Overall Study|Protocol Violation|27|||
33546105|NCT00976027|101898689|FG000|Overall Study|Lost to Follow-up|208|||
33546106|NCT00976027|101898690|FG001|Overall Study|Lost to Follow-up|103|||
33348050|NCT03403192|101163867|FG001|Overall Study|Incomplete|1|||
33348051|NCT03403192|101163868|FG002|Overall Study|Incomplete|3|||
33546107|NCT00976027|101898689|FG000|Overall Study|Withdrawal by Subject|107|||
33546108|NCT00976027|101898690|FG001|Overall Study|Withdrawal by Subject|66|||
33546109|NCT00970944|101898691|FG000|Overall Study|Death|1|||
33546110|NCT00970944|101898692|FG001|Overall Study|Death|0|||
33546111|NCT00970944|101898691|FG000|Overall Study|Physician Decision|0|||
33546112|NCT00970944|101898692|FG001|Overall Study|Physician Decision|2|||
33546113|NCT01947933|101898693|FG000|Overall Study|Withdrawal by Subject|0|||
33546114|NCT01947933|101898694|FG001|Overall Study|Withdrawal by Subject|0|||
33546115|NCT01947933|101898695|FG002|Overall Study|Withdrawal by Subject|1|||
33546116|NCT01947933|101898696|FG003|Overall Study|Withdrawal by Subject|0|||
33546117|NCT01947933|101898697|FG004|Overall Study|Withdrawal by Subject|0|||
33546118|NCT01947933|101898698|FG005|Overall Study|Withdrawal by Subject|0|||
33546119|NCT01947933|101898699|FG006|Overall Study|Withdrawal by Subject|0|||
33546120|NCT01947933|101898700|FG007|Overall Study|Withdrawal by Subject|0|||
33546121|NCT01947933|101898701|FG008|Overall Study|Withdrawal by Subject|0|||
33546122|NCT01947933|101898693|FG000|Overall Study|Lost to Follow-up|0|||
33546123|NCT01947933|101898694|FG001|Overall Study|Lost to Follow-up|0|||
33546124|NCT01947933|101898695|FG002|Overall Study|Lost to Follow-up|0|||
33546125|NCT01947933|101898696|FG003|Overall Study|Lost to Follow-up|0|||
33546126|NCT01947933|101898697|FG004|Overall Study|Lost to Follow-up|0|||
33546127|NCT01947933|101898698|FG005|Overall Study|Lost to Follow-up|0|||
33546128|NCT01947933|101898699|FG006|Overall Study|Lost to Follow-up|0|||
33546129|NCT01947933|101898700|FG007|Overall Study|Lost to Follow-up|0|||
33546130|NCT01947933|101898701|FG008|Overall Study|Lost to Follow-up|1|||
33546131|NCT00316004|101898702|FG000|Overall Study|Subject was not given study fluid.|14|||
33546132|NCT00316004|101898703|FG001|Overall Study|Subject was not given study fluid.|14|||
33546133|NCT00316004|101898704|FG002|Overall Study|Subject was not given study fluid.|21|||
33546134|NCT03846479|101898705|FG000|Overall Study|Death|8|||
33546135|NCT03846479|101898705|FG000|Overall Study|Lost to Follow-up|1|||
33546136|NCT01091259|101898706|FG000|Overall Study|Adverse Event|3|||
33546137|NCT01091259|101898706|FG000|Overall Study|Lack of Efficacy|2|||
33546138|NCT02807259|101898711|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
33546139|NCT02807259|101898712|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
33546140|NCT02807259|101898711|FG000|Midline (3 Months)|migration, refusal, not available|30|||
33546141|NCT02807259|101898712|FG001|Midline (3 Months)|migration, refusal, not available|34|||
33546142|NCT02807259|101898711|FG000|Endline (3 Months)|migration, refusal, not available|35|||
33546143|NCT02807259|101898712|FG001|Endline (3 Months)|migration, refusal, not available|87|||
33546144|NCT00782067|101898717|FG000|Overall Study|Adverse Event|35|||
33546145|NCT00782067|101898717|FG000|Overall Study|Subject withdrew consent|11|||
33546146|NCT00782067|101898717|FG000|Overall Study|Lost to Follow-up|2|||
33546147|NCT00782067|101898717|FG000|Overall Study|Administrative problems|14|||
33546148|NCT00782067|101898717|FG000|Overall Study|Death|9|||
33546149|NCT00782067|101898717|FG000|Overall Study|Disease progression|43|||
33546150|NCT00782067|101898717|FG000|Overall Study|Protocol deviation|2|||
33546151|NCT01348269|101898720|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
33546152|NCT01348269|101898721|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
33546153|NCT01348269|101898720|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
33546154|NCT01348269|101898721|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
33546155|NCT01348269|101898720|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
33546156|NCT01348269|101898721|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
33546157|NCT00544882|101898722|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
33546158|NCT00544882|101898723|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
33546159|NCT00544882|101898724|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
33546160|NCT00544882|101898722|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
33546161|NCT00544882|101898723|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
33546162|NCT00544882|101898724|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
33546163|NCT00544882|101898722|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
33546164|NCT00544882|101898723|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
33546165|NCT00544882|101898724|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
33546166|NCT00544882|101898722|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
33546167|NCT00544882|101898723|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
33546168|NCT00544882|101898724|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
33546169|NCT00544882|101898722|FG000|Cycle 3: Follow-up|Noncompliance|0|||
33546170|NCT00544882|101898723|FG001|Cycle 3: Follow-up|Noncompliance|1|||
33546171|NCT00544882|101898724|FG002|Cycle 3: Follow-up|Noncompliance|0|||
33546172|NCT00544882|101898722|FG000|Cycle 3: Follow-up|Pregnancy|0|||
33546173|NCT00544882|101898723|FG001|Cycle 3: Follow-up|Pregnancy|1|||
33546174|NCT00544882|101898724|FG002|Cycle 3: Follow-up|Pregnancy|0|||
33546175|NCT00958074|101898727|FG000|Overall Study|Withdrawal by Subject|0|||
33546176|NCT00958074|101898728|FG001|Overall Study|Withdrawal by Subject|1|||
33546177|NCT01027845|101898731|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
33213929|NCT02794285|100679823|FG002|Overall Study|Condition Under Investigation Worsened|1|||
33213930|NCT02794285|100679824|FG003|Overall Study|Condition Under Investigation Worsened|0|||
33546178|NCT01027845|101898732|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
33546179|NCT01027845|101898733|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
33546180|NCT01027845|101898734|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
33546181|NCT01027845|101898731|FG000|Primary Vaccination Phase|Adverse Event|1|||
33213931|NCT02794285|100679821|FG000|Overall Study|Death|2|||
33546182|NCT01027845|101898732|FG001|Primary Vaccination Phase|Adverse Event|0|||
33546183|NCT01027845|101898733|FG002|Primary Vaccination Phase|Adverse Event|0|||
33546184|NCT01027845|101898734|FG003|Primary Vaccination Phase|Adverse Event|0|||
33546185|NCT01027845|101898731|FG000|Primary Vaccination Phase|Protocol Violation|1|||
33546186|NCT01027845|101898732|FG001|Primary Vaccination Phase|Protocol Violation|0|||
33546187|NCT01027845|101898733|FG002|Primary Vaccination Phase|Protocol Violation|0|||
33546188|NCT01027845|101898734|FG003|Primary Vaccination Phase|Protocol Violation|0|||
33546189|NCT01027845|101898731|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
33546190|NCT01027845|101898732|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
33546191|NCT01027845|101898733|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
33546192|NCT01027845|101898734|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
33546193|NCT01027845|101898731|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
33546194|NCT01027845|101898732|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
33546195|NCT01027845|101898733|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
33546196|NCT01027845|101898734|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
33546197|NCT01027845|101898731|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
33546198|NCT01027845|101898732|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
33546199|NCT01027845|101898733|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
33546200|NCT01027845|101898734|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
33546201|NCT01925794|101898735|FG000|180 Days|Death|2|||
33546202|NCT01925794|101898735|FG000|180 Days|Withdrawal by Subject|2|||
33546203|NCT01925794|101898735|FG000|270 Days|Death|2|||
33546204|NCT01925794|101898735|FG000|270 Days|Protocol Violation|3|||
33546205|NCT00576758|101898736|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
33546206|NCT00576758|101898737|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
33546207|NCT00576758|101898736|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
33546208|NCT00576758|101898737|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
33546209|NCT00576758|101898736|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
33546210|NCT00576758|101898737|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
33546211|NCT00576758|101898736|FG000|Induction Treatment Period|Death|1|||
33546212|NCT00576758|101898737|FG001|Induction Treatment Period|Death|0|||
33546213|NCT00576758|101898736|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
33546214|NCT00576758|101898737|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
33546215|NCT00576758|101898736|FG000|Induction Treatment Period|Withdrew consent|1|||
33546216|NCT00576758|101898737|FG001|Induction Treatment Period|Withdrew consent|0|||
33546217|NCT00576758|101898736|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
33546218|NCT00576758|101898737|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
33546219|NCT00576758|101898736|FG000|Extension Treatment Period|Death|1|||
33546220|NCT00576758|101898737|FG001|Extension Treatment Period|Death|1|||
33546221|NCT00576758|101898736|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
33546222|NCT00576758|101898737|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
33546223|NCT00576758|101898736|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
33546224|NCT00576758|101898737|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
33546225|NCT00576758|101898736|FG000|Extension Treatment Period|Administrative/Other|3|||
33546226|NCT00576758|101898737|FG001|Extension Treatment Period|Administrative/Other|1|||
33546227|NCT00576758|101898736|FG000|Follow-up Period|Administrative/Other|6|||
33546228|NCT00576758|101898737|FG001|Follow-up Period|Administrative/Other|8|||
33546229|NCT00576758|101898736|FG000|Follow-up Period|Death|3|||
33546230|NCT00576758|101898737|FG001|Follow-up Period|Death|3|||
33546231|NCT00576758|101898736|FG000|Follow-up Period|Insufficient therapeutic response|16|||
33546232|NCT00576758|101898737|FG001|Follow-up Period|Insufficient therapeutic response|5|||
33546233|NCT00576758|101898736|FG000|Follow-up Period|Withdrew consent|2|||
33546234|NCT00576758|101898737|FG001|Follow-up Period|Withdrew consent|1|||
33546235|NCT01715285|101898738|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
33546236|NCT01715285|101898739|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
33546237|NCT01715285|101898740|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
33546238|NCT01715285|101898738|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
33348052|NCT03403192|101163869|FG003|Overall Study|Incomplete|6|||
33348053|NCT01929135|101163870|FG000|Overall Study|Lost to Follow-up|1|||
33348054|NCT01929135|101163871|FG001|Overall Study|Lost to Follow-up|1|||
33348055|NCT03038308|101163872|FG000|Overall Study|Surgical resection|1|||
33348056|NCT03038308|101163872|FG000|Overall Study|Withdrawal by Subject|2|||
33348057|NCT03038308|101163872|FG000|Overall Study|Lost to Follow-up|1|||
33348058|NCT00110994|101163873|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
33348059|NCT00110994|101163874|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
33348060|NCT00110994|101163873|FG000|Double-blind (DB) Treatment|Death|1|||
33348061|NCT00110994|101163874|FG001|Double-blind (DB) Treatment|Death|0|||
33348062|NCT00110994|101163873|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
33546239|NCT01715285|101898739|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
33546240|NCT01715285|101898740|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
33348063|NCT00110994|101163874|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
33348064|NCT00110994|101163873|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
33348065|NCT00110994|101163874|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
33409380|NCT02743117|101389257|FG000|Overall Study|Other|1|||
33546241|NCT01715285|101898738|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
33546242|NCT01715285|101898739|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
33546243|NCT01715285|101898740|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
33546244|NCT01715285|101898738|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
33546245|NCT01715285|101898739|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
33546246|NCT01715285|101898740|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
33546247|NCT01715285|101898738|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
33546248|NCT01715285|101898739|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
33546249|NCT01715285|101898740|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
33546250|NCT01715285|101898738|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
33546251|NCT01715285|101898739|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
33546252|NCT01715285|101898740|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
33546253|NCT01715285|101898738|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
33546254|NCT01715285|101898739|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
33546255|NCT01715285|101898740|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
33546256|NCT01715285|101898738|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
33546257|NCT01715285|101898739|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
33546258|NCT01715285|101898740|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
33546259|NCT01715285|101898738|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
33546260|NCT01715285|101898739|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
33546261|NCT01715285|101898740|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
33546262|NCT01715285|101898738|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
33546263|NCT01715285|101898739|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
33546264|NCT01715285|101898740|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
33546265|NCT01715285|101898738|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
33546266|NCT01715285|101898739|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
33546267|NCT01715285|101898740|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
33546268|NCT01715285|101898738|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
33546269|NCT01715285|101898739|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
33546270|NCT01715285|101898740|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
33546271|NCT01715285|101898738|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
33546272|NCT01715285|101898739|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
33546273|NCT01715285|101898740|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
33546274|NCT01715285|101898738|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
33546275|NCT01715285|101898739|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
33546276|NCT01715285|101898740|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
33546277|NCT02780388|101898741|FG000|Overall Study|Lost to Follow-up|0|||
33546278|NCT02780388|101898742|FG001|Overall Study|Lost to Follow-up|1|||
33546279|NCT02780388|101898743|FG002|Overall Study|Lost to Follow-up|0|||
33546280|NCT02780388|101898744|FG003|Overall Study|Lost to Follow-up|0|||
33546281|NCT02780388|101898745|FG004|Overall Study|Lost to Follow-up|0|||
33546282|NCT02780388|101898741|FG000|Overall Study|Withdrawal by Subject|1|||
33546283|NCT02780388|101898742|FG001|Overall Study|Withdrawal by Subject|1|||
33546284|NCT02780388|101898743|FG002|Overall Study|Withdrawal by Subject|0|||
33546285|NCT02780388|101898744|FG003|Overall Study|Withdrawal by Subject|0|||
33546286|NCT02780388|101898745|FG004|Overall Study|Withdrawal by Subject|0|||
33546287|NCT03416179|101898746|FG000|Overall Study|Death|90|||
33546288|NCT03416179|101898747|FG001|Overall Study|Death|87|||
33546289|NCT03416179|101898748|FG002|Overall Study|Death|117|||
33546290|NCT03416179|101898749|FG003|Overall Study|Death|113|||
33546291|NCT03416179|101898746|FG000|Overall Study|Withdrawal by Subject|15|||
33546292|NCT03416179|101898747|FG001|Overall Study|Withdrawal by Subject|20|||
33546293|NCT03416179|101898748|FG002|Overall Study|Withdrawal by Subject|6|||
33546294|NCT03416179|101898749|FG003|Overall Study|Withdrawal by Subject|9|||
33546295|NCT03416179|101898746|FG000|Overall Study|Lost to Follow-up|1|||
33546296|NCT03416179|101898747|FG001|Overall Study|Lost to Follow-up|1|||
33546297|NCT03416179|101898748|FG002|Overall Study|Lost to Follow-up|0|||
33546298|NCT03416179|101898749|FG003|Overall Study|Lost to Follow-up|3|||
33546299|NCT03416179|101898746|FG000|Overall Study|Study participation terminated by Sponsor|93|||
33546300|NCT03416179|101898747|FG001|Overall Study|Study participation terminated by Sponsor|91|||
33546301|NCT03416179|101898748|FG002|Overall Study|Study participation terminated by Sponsor|26|||
33546302|NCT03416179|101898749|FG003|Overall Study|Study participation terminated by Sponsor|31|||
33546303|NCT03416179|101898746|FG000|Overall Study|Other|2|||
33546304|NCT03416179|101898747|FG001|Overall Study|Other|3|||
33546305|NCT03416179|101898748|FG002|Overall Study|Other|1|||
33546306|NCT03416179|101898749|FG003|Overall Study|Other|0|||
33546307|NCT01134042|101898750|FG000|Overall Study|Adverse Event|3|||
33546308|NCT01134042|101898751|FG001|Overall Study|Adverse Event|7|||
33546309|NCT01134042|101898752|FG002|Overall Study|Adverse Event|2|||
33546310|NCT01134042|101898750|FG000|Overall Study|Lack of Efficacy|21|||
33546311|NCT01134042|101898751|FG001|Overall Study|Lack of Efficacy|6|||
33546312|NCT01134042|101898752|FG002|Overall Study|Lack of Efficacy|18|||
33546313|NCT01134042|101898750|FG000|Overall Study|Protocol Violation|5|||
33546314|NCT01134042|101898751|FG001|Overall Study|Protocol Violation|3|||
33546315|NCT01134042|101898752|FG002|Overall Study|Protocol Violation|5|||
33546316|NCT01134042|101898750|FG000|Overall Study|Lost to Follow-up|2|||
33546317|NCT01134042|101898751|FG001|Overall Study|Lost to Follow-up|0|||
33546318|NCT01134042|101898752|FG002|Overall Study|Lost to Follow-up|1|||
33546319|NCT01134042|101898750|FG000|Overall Study|Physician Decision|4|||
33546320|NCT01134042|101898751|FG001|Overall Study|Physician Decision|8|||
33546321|NCT01134042|101898752|FG002|Overall Study|Physician Decision|1|||
33546322|NCT01134042|101898750|FG000|Overall Study|Withdrawal by Subject|13|||
33546323|NCT01134042|101898751|FG001|Overall Study|Withdrawal by Subject|4|||
33546324|NCT01134042|101898752|FG002|Overall Study|Withdrawal by Subject|7|||
33546325|NCT03122106|101898757|FG000|Overall Study|Not enough tissue|1|||
33546326|NCT03122106|101898757|FG000|Overall Study|Disease progression during screening|2|||
33546327|NCT03122106|101898757|FG000|Overall Study|Poor RNA quality for vaccine|1|||
33546328|NCT02583269|101898759|FG000|Overall Study|Patient hospitalized prior to start|1|||
33546329|NCT02583269|101898760|FG001|Overall Study|Patient hospitalized prior to start|0|||
33546330|NCT02583269|101898761|FG002|Overall Study|Patient hospitalized prior to start|0|||
33546331|NCT02583269|101898762|FG003|Overall Study|Patient hospitalized prior to start|0|||
33546332|NCT02583269|101898763|FG004|Overall Study|Patient hospitalized prior to start|0|||
33546333|NCT01431976|101898764|FG000|Overall Study|Adverse Event|6|||
33546334|NCT01431976|101898764|FG000|Overall Study|Lack of Efficacy|2|||
33546335|NCT01431976|101898764|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
33546336|NCT01431976|101898764|FG000|Overall Study|Physician Decision|1|||
33546337|NCT01431976|101898764|FG000|Overall Study|Withdrawal by Subject|1|||
33546338|NCT00724945|101898767|FG000|Period 1|non-compliance|1|||
33546339|NCT00724945|101898768|FG001|Period 1|non-compliance|0|||
33546340|NCT00724945|101898767|FG000|Period 1|Adverse Event|1|||
33546341|NCT00724945|101898768|FG001|Period 1|Adverse Event|1|||
33546342|NCT00724945|101898767|FG000|Period 1|Lost to Follow-up|1|||
33546343|NCT00724945|101898768|FG001|Period 1|Lost to Follow-up|0|||
33546344|NCT00724945|101898767|FG000|Period 2|lens comfort issue|3|||
33546345|NCT00724945|101898768|FG001|Period 2|lens comfort issue|0|||
33546346|NCT00724945|101898767|FG000|Period 2|lens physiology issue|1|||
33546347|NCT00724945|101898768|FG001|Period 2|lens physiology issue|0|||
33546348|NCT02842866|101898769|FG000|Overall Study|Serious Adverse Event|0|||
33546349|NCT02842866|101898770|FG001|Overall Study|Serious Adverse Event|1|||
33546350|NCT02842866|101898769|FG000|Overall Study|Protocol Violation|4|||
33546351|NCT02842866|101898770|FG001|Overall Study|Protocol Violation|2|||
33546352|NCT02842866|101898769|FG000|Overall Study|Lost to Follow-up|2|||
33546353|NCT02842866|101898770|FG001|Overall Study|Lost to Follow-up|0|||
33546354|NCT02842866|101898769|FG000|Overall Study|Withdrawal by Subject|1|||
33546355|NCT02842866|101898770|FG001|Overall Study|Withdrawal by Subject|0|||
33546356|NCT01147458|101898776|FG000|First Intervention|Study terminated by sponsor|8|||
33546357|NCT01147458|101898777|FG001|First Intervention|Study terminated by sponsor|8|||
33546358|NCT01147458|101898778|FG002|First Intervention|Study terminated by sponsor|7|||
33546359|NCT01147458|101898779|FG003|First Intervention|Study terminated by sponsor|8|||
33546360|NCT01147458|101898776|FG000|First Intervention|Protocol Violation|2|||
33546361|NCT01147458|101898777|FG001|First Intervention|Protocol Violation|3|||
33546362|NCT01147458|101898778|FG002|First Intervention|Protocol Violation|2|||
33546363|NCT01147458|101898779|FG003|First Intervention|Protocol Violation|3|||
33546364|NCT01147458|101898776|FG000|First Intervention|Withdrawal by Subject|3|||
33546365|NCT01147458|101898777|FG001|First Intervention|Withdrawal by Subject|0|||
33546366|NCT01147458|101898778|FG002|First Intervention|Withdrawal by Subject|1|||
33546367|NCT01147458|101898779|FG003|First Intervention|Withdrawal by Subject|0|||
33546368|NCT01147458|101898776|FG000|First Intervention|Adverse Event|0|||
33546369|NCT01147458|101898777|FG001|First Intervention|Adverse Event|3|||
33546370|NCT01147458|101898778|FG002|First Intervention|Adverse Event|2|||
33546371|NCT01147458|101898779|FG003|First Intervention|Adverse Event|3|||
33546372|NCT01147458|101898776|FG000|First Intervention|Other|1|||
33409381|NCT02743117|101389258|FG001|Overall Study|Other|0|||
33546373|NCT01147458|101898777|FG001|First Intervention|Other|2|||
33616946|NCT01053988|102144454|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33546374|NCT01147458|101898778|FG002|First Intervention|Other|0|||
33546375|NCT01147458|101898779|FG003|First Intervention|Other|0|||
33546376|NCT01147458|101898776|FG000|Second Intervention|Study terminated by sponsor|7|||
33546377|NCT01147458|101898777|FG001|Second Intervention|Study terminated by sponsor|5|||
33546378|NCT01147458|101898778|FG002|Second Intervention|Study terminated by sponsor|5|||
33546379|NCT01147458|101898779|FG003|Second Intervention|Study terminated by sponsor|3|||
33546380|NCT01147458|101898776|FG000|Second Intervention|Protocol Violation|0|||
33546381|NCT01147458|101898777|FG001|Second Intervention|Protocol Violation|1|||
33546382|NCT01147458|101898778|FG002|Second Intervention|Protocol Violation|1|||
33546383|NCT01147458|101898779|FG003|Second Intervention|Protocol Violation|0|||
33409382|NCT01465958|101389259|FG000|Run-in Phase|Protocol Violation|1|||
33546384|NCT01147458|101898776|FG000|Second Intervention|Withdrawal by Subject|0|||
33546385|NCT01147458|101898777|FG001|Second Intervention|Withdrawal by Subject|1|||
33546386|NCT01147458|101898778|FG002|Second Intervention|Withdrawal by Subject|0|||
33546387|NCT01147458|101898779|FG003|Second Intervention|Withdrawal by Subject|0|||
33546388|NCT01147458|101898776|FG000|Second Intervention|Adverse Event|2|||
33546389|NCT01147458|101898777|FG001|Second Intervention|Adverse Event|0|||
33546390|NCT01147458|101898778|FG002|Second Intervention|Adverse Event|1|||
33546391|NCT01147458|101898779|FG003|Second Intervention|Adverse Event|1|||
33546392|NCT01147458|101898776|FG000|Second Intervention|Other|0|||
33546393|NCT01147458|101898777|FG001|Second Intervention|Other|0|||
33546394|NCT01147458|101898778|FG002|Second Intervention|Other|1|||
33546395|NCT01147458|101898779|FG003|Second Intervention|Other|0|||
33546396|NCT01164475|101898780|FG000|Overall Study|Lack of Efficacy|1|||
33546397|NCT01164475|101898781|FG001|Overall Study|Lack of Efficacy|0|||
33546398|NCT01164475|101898780|FG000|Overall Study|Other|0|||
33546399|NCT01164475|101898781|FG001|Overall Study|Other|1|||
33546400|NCT01164475|101898780|FG000|Overall Study|Progressive disease|0|||
33546401|NCT01164475|101898781|FG001|Overall Study|Progressive disease|1|||
33546402|NCT01164475|101898780|FG000|Overall Study|Protocol Violation|1|||
33546403|NCT01164475|101898781|FG001|Overall Study|Protocol Violation|0|||
33546404|NCT03188185|101898782|FG000|Stage 1|Adverse Event|4|||
33546405|NCT03188185|101898783|FG001|Stage 1|Adverse Event|12|||
33546406|NCT03188185|101898784|FG002|Stage 1|Adverse Event|0|||
33546407|NCT03188185|101898785|FG003|Stage 1|Adverse Event|0|||
33546408|NCT03188185|101898782|FG000|Stage 1|Lack of Efficacy|0|||
33546409|NCT03188185|101898783|FG001|Stage 1|Lack of Efficacy|2|||
33546410|NCT03188185|101898784|FG002|Stage 1|Lack of Efficacy|0|||
33546411|NCT03188185|101898785|FG003|Stage 1|Lack of Efficacy|0|||
33546412|NCT03188185|101898782|FG000|Stage 1|Lost to Follow-up|6|||
33546413|NCT03188185|101898783|FG001|Stage 1|Lost to Follow-up|1|||
33546414|NCT03188185|101898784|FG002|Stage 1|Lost to Follow-up|0|||
33546415|NCT03188185|101898785|FG003|Stage 1|Lost to Follow-up|0|||
33546416|NCT03188185|101898782|FG000|Stage 1|Withdrawal by Subject|9|||
33546417|NCT03188185|101898783|FG001|Stage 1|Withdrawal by Subject|0|||
33546418|NCT03188185|101898784|FG002|Stage 1|Withdrawal by Subject|0|||
33546419|NCT03188185|101898785|FG003|Stage 1|Withdrawal by Subject|0|||
33546420|NCT03188185|101898782|FG000|Stage 1|Identified as a professional patient|0|||
33546421|NCT03188185|101898783|FG001|Stage 1|Identified as a professional patient|1|||
33546422|NCT03188185|101898784|FG002|Stage 1|Identified as a professional patient|0|||
33546423|NCT03188185|101898785|FG003|Stage 1|Identified as a professional patient|0|||
33546424|NCT03188185|101898782|FG000|Stage 2|Adverse Event|0|||
33546425|NCT03188185|101898783|FG001|Stage 2|Adverse Event|0|||
33546426|NCT03188185|101898784|FG002|Stage 2|Adverse Event|2|||
33546427|NCT03188185|101898785|FG003|Stage 2|Adverse Event|4|||
33546428|NCT03188185|101898782|FG000|Stage 2|Lack of Efficacy|0|||
33546429|NCT03188185|101898783|FG001|Stage 2|Lack of Efficacy|0|||
33348066|NCT00110994|101163873|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
33409383|NCT01465958|101389260|FG001|Run-in Phase|Protocol Violation|0|||
33546430|NCT03188185|101898784|FG002|Stage 2|Lack of Efficacy|3|||
33546431|NCT03188185|101898785|FG003|Stage 2|Lack of Efficacy|0|||
33546432|NCT03188185|101898782|FG000|Stage 2|Lost to Follow-up|0|||
33546433|NCT03188185|101898783|FG001|Stage 2|Lost to Follow-up|0|||
33546434|NCT03188185|101898784|FG002|Stage 2|Lost to Follow-up|1|||
33546435|NCT03188185|101898785|FG003|Stage 2|Lost to Follow-up|0|||
33546436|NCT03188185|101898782|FG000|Stage 2|Physician Decision|0|||
33546437|NCT03188185|101898783|FG001|Stage 2|Physician Decision|0|||
33546438|NCT03188185|101898784|FG002|Stage 2|Physician Decision|0|||
33546439|NCT03188185|101898785|FG003|Stage 2|Physician Decision|1|||
33546440|NCT03188185|101898782|FG000|Stage 2|Withdrawal by Subject|0|||
33546441|NCT03188185|101898783|FG001|Stage 2|Withdrawal by Subject|0|||
33546442|NCT03188185|101898784|FG002|Stage 2|Withdrawal by Subject|3|||
33546443|NCT03188185|101898785|FG003|Stage 2|Withdrawal by Subject|1|||
33546444|NCT00141921|101898786|FG000|Overall Study|Remain on Study|28|||
33546445|NCT00141921|101898786|FG000|Overall Study|Withdrawal by Subject|42|||
33546446|NCT00141921|101898786|FG000|Overall Study|Lost to Follow-up|19|||
33546447|NCT00141921|101898786|FG000|Overall Study|Noncompliance|17|||
33546448|NCT00141921|101898786|FG000|Overall Study|Disease Progression|7|||
33546449|NCT00141921|101898786|FG000|Overall Study|Protocol Deviation|7|||
33546450|NCT00141921|101898786|FG000|Overall Study|Adverse Event|5|||
33546451|NCT00141921|101898786|FG000|Overall Study|Administrative Decision|2|||
33546452|NCT00141921|101898786|FG000|Overall Study|Pregnancy|4|||
33546453|NCT00141921|101898786|FG000|Overall Study|Ineligibility Determined|2|||
33546454|NCT00141921|101898786|FG000|Overall Study|Other|8|||
33546455|NCT02691572|101898792|FG000|Overall Study|Withdrawal by Subject|1|||
33546456|NCT02691572|101898793|FG001|Overall Study|Withdrawal by Subject|0|||
33213932|NCT02794285|100679822|FG001|Overall Study|Death|1|||
33213933|NCT02794285|100679823|FG002|Overall Study|Death|2|||
33213934|NCT02794285|100679824|FG003|Overall Study|Death|0|||
33213935|NCT02794285|100679821|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
33213936|NCT02794285|100679822|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
33213937|NCT02794285|100679823|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
33213938|NCT02794285|100679824|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
33213939|NCT02794285|100679821|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
33213940|NCT02794285|100679822|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
33546457|NCT02691572|101898792|FG000|Overall Study|Protocol Violation|0|||
33546458|NCT02691572|101898793|FG001|Overall Study|Protocol Violation|1|||
33546459|NCT03881371|101901448|FG000|Overall Study|Adverse Event|8|||
33546460|NCT03881371|101901449|FG001|Overall Study|Adverse Event|9|||
33546461|NCT03881371|101901448|FG000|Overall Study|Death|1|||
33546462|NCT03881371|101901449|FG001|Overall Study|Death|0|||
33616947|NCT01053988|102144455|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33616948|NCT01053988|102144450|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
33616949|NCT01053988|102144451|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
33616950|NCT01053988|102144452|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
33616951|NCT01053988|102144453|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
33616952|NCT01053988|102144454|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
33616953|NCT01053988|102144455|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
33616954|NCT01053988|102144450|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33546463|NCT03881371|101901448|FG000|Overall Study|Lost to Follow-up|1|||
33546464|NCT03881371|101901449|FG001|Overall Study|Lost to Follow-up|0|||
33546465|NCT03881371|101901448|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33616955|NCT01053988|102144451|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
33616956|NCT01053988|102144452|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
33616957|NCT01053988|102144453|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
33616958|NCT01053988|102144454|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
33616959|NCT01053988|102144455|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33616960|NCT01053988|102144450|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
33213941|NCT02794285|100679823|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
33213942|NCT02794285|100679824|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
33213943|NCT02794285|100679821|FG000|Overall Study|Lack of Efficacy|10|||
33213944|NCT02794285|100679822|FG001|Overall Study|Lack of Efficacy|6|||
33213945|NCT02794285|100679823|FG002|Overall Study|Lack of Efficacy|3|||
33213946|NCT02794285|100679824|FG003|Overall Study|Lack of Efficacy|3|||
33213947|NCT02794285|100679821|FG000|Overall Study|Lost to Follow-up|5|||
33213948|NCT02794285|100679822|FG001|Overall Study|Lost to Follow-up|6|||
33213949|NCT02794285|100679823|FG002|Overall Study|Lost to Follow-up|3|||
33213950|NCT02794285|100679824|FG003|Overall Study|Lost to Follow-up|1|||
33213951|NCT02794285|100679821|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
33213952|NCT02794285|100679822|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
33213953|NCT02794285|100679823|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
33213954|NCT02794285|100679824|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
33213955|NCT02794285|100679821|FG000|Overall Study|Withdrawal by Subject|38|||
33213956|NCT02794285|100679822|FG001|Overall Study|Withdrawal by Subject|29|||
33213957|NCT02794285|100679823|FG002|Overall Study|Withdrawal by Subject|20|||
33213958|NCT02794285|100679824|FG003|Overall Study|Withdrawal by Subject|12|||
33213959|NCT02794285|100679821|FG000|Overall Study|Missing|1|||
33213960|NCT02794285|100679822|FG001|Overall Study|Missing|0|||
33213961|NCT02794285|100679823|FG002|Overall Study|Missing|0|||
33213962|NCT02794285|100679824|FG003|Overall Study|Missing|0|||
33213963|NCT02794285|100679821|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
33213964|NCT02794285|100679822|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
33213965|NCT02794285|100679823|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
33213966|NCT02794285|100679824|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
33213967|NCT02794285|100679821|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
33213968|NCT02794285|100679822|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
33213969|NCT02794285|100679823|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
33213970|NCT02794285|100679824|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
33213971|NCT04322682|100679827|FG000|Overall Study|Withdrawal by Subject|33|||
33213972|NCT04322682|100679828|FG001|Overall Study|Withdrawal by Subject|47|||
33213973|NCT04322682|100679827|FG000|Overall Study|Death|5|||
33213974|NCT04322682|100679828|FG001|Overall Study|Death|9|||
33213975|NCT04322682|100679827|FG000|Overall Study|Lost to Follow-up|4|||
33213976|NCT04322682|100679828|FG001|Overall Study|Lost to Follow-up|8|||
33213977|NCT04322682|100679827|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
33213978|NCT04322682|100679828|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
33213979|NCT00827918|100679829|FG000|Overall Study|Adverse Event|4|||
33213980|NCT00827918|100679830|FG001|Overall Study|Adverse Event|0|||
33213981|NCT00827918|100679831|FG002|Overall Study|Adverse Event|0|||
33213982|NCT00827918|100679829|FG000|Overall Study|Lack of Efficacy|16|||
33213983|NCT00827918|100679830|FG001|Overall Study|Lack of Efficacy|4|||
33213984|NCT00827918|100679831|FG002|Overall Study|Lack of Efficacy|15|||
33213985|NCT00827918|100679829|FG000|Overall Study|Physician Decision|1|||
33213986|NCT00827918|100679830|FG001|Overall Study|Physician Decision|0|||
33213987|NCT00827918|100679831|FG002|Overall Study|Physician Decision|0|||
33213988|NCT00827918|100679829|FG000|Overall Study|Pregnancy|0|||
33213989|NCT00827918|100679830|FG001|Overall Study|Pregnancy|1|||
33213990|NCT00827918|100679831|FG002|Overall Study|Pregnancy|0|||
33213991|NCT00827918|100679829|FG000|Overall Study|Progressive Disease|1|||
33213992|NCT00827918|100679830|FG001|Overall Study|Progressive Disease|1|||
33213993|NCT00827918|100679831|FG002|Overall Study|Progressive Disease|0|||
33213994|NCT00827918|100679829|FG000|Overall Study|Protocol Violation|0|||
33213995|NCT00827918|100679830|FG001|Overall Study|Protocol Violation|1|||
33213996|NCT00827918|100679831|FG002|Overall Study|Protocol Violation|0|||
33213997|NCT00827918|100679829|FG000|Overall Study|Withdrawal by Subject|6|||
33213998|NCT00827918|100679830|FG001|Overall Study|Withdrawal by Subject|2|||
33213999|NCT00827918|100679831|FG002|Overall Study|Withdrawal by Subject|6|||
33214000|NCT05706506|100679832|FG000|Overall Study|Adverse Event|1|||
33214001|NCT05706506|100679832|FG000|Overall Study|Withdrawal by Subject|4|||
33214002|NCT05706506|100679832|FG000|Overall Study|Lost to Follow-up|2|||
33214003|NCT05706506|100679832|FG000|Overall Study|Inadvertent Enrolment|12|||
33214004|NCT05706506|100679832|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
33348067|NCT00110994|101163874|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
33214005|NCT05706506|100679832|FG000|Overall Study|Participant Moved Out of State|1|||
33214006|NCT03565887|100679834|FG000|Overall Study|Adverse Event|1|||
33214007|NCT03565887|100679835|FG001|Overall Study|Adverse Event|0|||
33214008|NCT03565887|100679834|FG000|Overall Study|Withdrawal by Subject|0|||
33214009|NCT03565887|100679835|FG001|Overall Study|Withdrawal by Subject|2|||
33214010|NCT00499031|100679836|FG000|Overall Study|Improper pre-protocol treatment|1|||
33214011|NCT00499031|100679836|FG000|Overall Study|Required test not done|1|||
33214012|NCT00499031|100679836|FG000|Overall Study|Never treated|1|||
33214013|NCT01970982|100679837|FG000|Overall Study|Withdrawal by Subject|0|||
33214014|NCT01970982|100679838|FG001|Overall Study|Withdrawal by Subject|0|||
33214015|NCT01970982|100679839|FG002|Overall Study|Withdrawal by Subject|2|||
33214016|NCT04867369|100679840|FG000|Overall Study|Withdrawal by Subject|1|||
33214017|NCT04867369|100679841|FG001|Overall Study|Withdrawal by Subject|0|||
33214018|NCT03085485|100679843|FG000|Overall Study|Death|1|||
33214019|NCT03085485|100679844|FG001|Overall Study|Death|0|||
33214020|NCT03085485|100679843|FG000|Overall Study|Lost to Follow-up|1|||
33214021|NCT03085485|100679844|FG001|Overall Study|Lost to Follow-up|0|||
33214022|NCT01988779|100682273|FG000|Overall Study|Withdrawal by Subject|2|||
33214023|NCT01988779|100682274|FG001|Overall Study|Withdrawal by Subject|2|||
33214024|NCT01988779|100682273|FG000|Overall Study|Protocol Violation|1|||
33214025|NCT01988779|100682274|FG001|Overall Study|Protocol Violation|0|||
33214026|NCT02061202|100682275|FG000|Overall Study|Lost to Follow-up|1|||
33214027|NCT02061202|100682276|FG001|Overall Study|Lost to Follow-up|1|||
33214028|NCT04004611|100682279|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
33214029|NCT04004611|100682280|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
33214030|NCT04004611|100682281|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
33214031|NCT04004611|100682282|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
33214032|NCT04004611|100682283|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
33214033|NCT04004611|100682284|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
33214034|NCT04004611|100682285|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
33546466|NCT03881371|101901449|FG001|Overall Study|Non-Compliance with Study Drug|2|||
33546467|NCT03881371|101901448|FG000|Overall Study|Physician Decision|3|||
33546468|NCT03881371|101901449|FG001|Overall Study|Physician Decision|3|||
33546469|NCT03881371|101901448|FG000|Overall Study|Withdrawal by Subject|2|||
33546470|NCT03881371|101901449|FG001|Overall Study|Withdrawal by Subject|10|||
33546471|NCT03881371|101901448|FG000|Overall Study|Discontinuation from Study|1|||
33546472|NCT03881371|101901449|FG001|Overall Study|Discontinuation from Study|0|||
33546473|NCT00961415|101901455|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
33214035|NCT04004611|100682286|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
33214036|NCT04004611|100682287|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
33214037|NCT04004611|100682279|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
33214038|NCT04004611|100682280|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
33214039|NCT04004611|100682281|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
33214040|NCT04004611|100682282|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
33214041|NCT04004611|100682283|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
33214042|NCT04004611|100682284|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
33214043|NCT04004611|100682285|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
33214044|NCT04004611|100682286|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
33214045|NCT04004611|100682287|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
33214046|NCT04004611|100682279|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
33214047|NCT04004611|100682280|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
33214048|NCT04004611|100682281|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
33214049|NCT04004611|100682282|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
33214050|NCT04004611|100682283|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
33214051|NCT04004611|100682284|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
33214052|NCT04004611|100682285|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
33214053|NCT04004611|100682286|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
33214054|NCT04004611|100682287|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
33214055|NCT04004611|100682279|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
33214056|NCT04004611|100682280|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
33214057|NCT04004611|100682281|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
33214058|NCT04004611|100682282|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
33214059|NCT04004611|100682283|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
33214060|NCT04004611|100682284|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
33214061|NCT04004611|100682285|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
33214062|NCT04004611|100682286|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
33214063|NCT04004611|100682287|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
33546474|NCT00961415|101901456|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
33214064|NCT04004611|100682279|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
33214065|NCT04004611|100682280|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
33546475|NCT00961415|101901457|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
33546476|NCT00961415|101901455|FG000|Induction Treatment Phase|Death|77|||
33616961|NCT01053988|102144451|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
33214066|NCT04004611|100682281|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
33214067|NCT04004611|100682282|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
33214068|NCT04004611|100682283|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
33214069|NCT04004611|100682284|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
33214070|NCT04004611|100682285|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
33214071|NCT04004611|100682286|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
33214072|NCT04004611|100682287|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
33214073|NCT04004611|100682279|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
33214074|NCT04004611|100682280|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
33214075|NCT04004611|100682281|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
33214076|NCT04004611|100682282|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
33214077|NCT04004611|100682283|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
33214078|NCT04004611|100682284|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
33214079|NCT04004611|100682285|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
33214080|NCT04004611|100682286|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
33214081|NCT04004611|100682287|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
33214082|NCT04435366|100682291|FG000|Year 1 (12 Months)|Adverse Event|3|||
33214083|NCT04435366|100682292|FG001|Year 1 (12 Months)|Adverse Event|0|||
33214084|NCT04435366|100682293|FG002|Year 1 (12 Months)|Adverse Event|2|||
33214085|NCT04435366|100682291|FG000|Year 1 (12 Months)|Death|2|||
33214086|NCT04435366|100682292|FG001|Year 1 (12 Months)|Death|0|||
33214087|NCT04435366|100682293|FG002|Year 1 (12 Months)|Death|1|||
33214088|NCT04435366|100682291|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
33214089|NCT04435366|100682292|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
33214090|NCT04435366|100682293|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
33214091|NCT04435366|100682291|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
33214092|NCT04435366|100682292|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
33214093|NCT04435366|100682293|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
33214094|NCT04435366|100682291|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
33214095|NCT04435366|100682292|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
33214096|NCT04435366|100682293|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
33546477|NCT00961415|101901456|FG001|Induction Treatment Phase|Death|0|||
33546478|NCT00961415|101901457|FG002|Induction Treatment Phase|Death|0|||
33546479|NCT00961415|101901455|FG000|Induction Treatment Phase|Protocol Violation|1|||
33546480|NCT00961415|101901456|FG001|Induction Treatment Phase|Protocol Violation|0|||
33546481|NCT00961415|101901457|FG002|Induction Treatment Phase|Protocol Violation|0|||
33546482|NCT00961415|101901455|FG000|Induction Treatment Phase|Physician Decision|2|||
33546483|NCT00961415|101901456|FG001|Induction Treatment Phase|Physician Decision|0|||
33546484|NCT00961415|101901457|FG002|Induction Treatment Phase|Physician Decision|0|||
33546485|NCT00961415|101901455|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
33546486|NCT00961415|101901456|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
33546487|NCT00961415|101901457|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
33546488|NCT00961415|101901455|FG000|Induction Treatment Phase|Other Reason|5|||
33546489|NCT00961415|101901456|FG001|Induction Treatment Phase|Other Reason|0|||
33546490|NCT00961415|101901457|FG002|Induction Treatment Phase|Other Reason|0|||
33546491|NCT00961415|101901455|FG000|Maintenance Treatment Phase|Death|0|||
33546492|NCT00961415|101901456|FG001|Maintenance Treatment Phase|Death|42|||
33546493|NCT00961415|101901457|FG002|Maintenance Treatment Phase|Death|34|||
33546494|NCT00961415|101901455|FG000|Maintenance Treatment Phase|Investigators decision|0|||
33546495|NCT00961415|101901456|FG001|Maintenance Treatment Phase|Investigators decision|2|||
33546496|NCT00961415|101901457|FG002|Maintenance Treatment Phase|Investigators decision|0|||
33546497|NCT00961415|101901455|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33546498|NCT00961415|101901456|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
33546499|NCT00961415|101901457|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
33546500|NCT00961415|101901455|FG000|Maintenance Treatment Phase|Other reason|0|||
33546501|NCT00961415|101901456|FG001|Maintenance Treatment Phase|Other reason|1|||
33546502|NCT00961415|101901457|FG002|Maintenance Treatment Phase|Other reason|3|||
33546503|NCT00313170|101901458|FG000|Overall Study|Death|2|||
33546504|NCT00313170|101901459|FG001|Overall Study|Death|4|||
33546505|NCT00313170|101901460|FG002|Overall Study|Death|2|||
33546506|NCT00313170|101901458|FG000|Overall Study|Adverse Event|1|||
33546507|NCT00313170|101901459|FG001|Overall Study|Adverse Event|2|||
33348068|NCT00110994|101163873|FG000|Double-blind (DB) Treatment|other reasons|2|||
33348069|NCT00110994|101163874|FG001|Double-blind (DB) Treatment|other reasons|3|||
33546508|NCT00313170|101901460|FG002|Overall Study|Adverse Event|0|||
33546509|NCT00313170|101901458|FG000|Overall Study|Disease progression|31|||
33546510|NCT00313170|101901459|FG001|Overall Study|Disease progression|26|||
33546511|NCT00313170|101901460|FG002|Overall Study|Disease progression|27|||
33546512|NCT00313170|101901458|FG000|Overall Study|Withdrawal by Subject|1|||
33546513|NCT00313170|101901459|FG001|Overall Study|Withdrawal by Subject|0|||
33546514|NCT00313170|101901460|FG002|Overall Study|Withdrawal by Subject|1|||
33546515|NCT00313170|101901458|FG000|Overall Study|Incorrect enrollment|0|||
33546516|NCT00313170|101901459|FG001|Overall Study|Incorrect enrollment|2|||
33546517|NCT00313170|101901460|FG002|Overall Study|Incorrect enrollment|1|||
33546518|NCT00313170|101901458|FG000|Overall Study|Lost to Follow-up|0|||
33546519|NCT00313170|101901459|FG001|Overall Study|Lost to Follow-up|0|||
33546520|NCT00313170|101901460|FG002|Overall Study|Lost to Follow-up|1|||
33546521|NCT00313170|101901458|FG000|Overall Study|Progression (investigators opinion)|1|||
33546522|NCT00313170|101901459|FG001|Overall Study|Progression (investigators opinion)|0|||
33546523|NCT00313170|101901460|FG002|Overall Study|Progression (investigators opinion)|0|||
33546524|NCT00662259|101901463|FG000|Overall Study|Adverse Event|2|||
33546525|NCT00662259|101901464|FG001|Overall Study|Adverse Event|0|||
33546526|NCT04739709|101901468|FG000|Overall Study|Physician Decision|1|||
33546527|NCT04739709|101901469|FG001|Overall Study|Physician Decision|0|||
33546528|NCT01913353|101901476|FG000|Overall Study|Adverse Event|2|||
33546529|NCT01913353|101901477|FG001|Overall Study|Adverse Event|0|||
33546530|NCT01913353|101901476|FG000|Overall Study|Physician Decision|0|||
33546531|NCT01913353|101901477|FG001|Overall Study|Physician Decision|2|||
33546532|NCT01913353|101901476|FG000|Overall Study|Withdrawal by Subject|20|||
33546533|NCT01913353|101901477|FG001|Overall Study|Withdrawal by Subject|6|||
33546534|NCT01913353|101901476|FG000|Overall Study|multiple reasons|10|||
33546535|NCT01913353|101901477|FG001|Overall Study|multiple reasons|7|||
33546536|NCT00435942|101901478|FG000|Overall Study|Death|17|||
33546537|NCT00435942|101901479|FG001|Overall Study|Death|10|||
33546538|NCT00435942|101901478|FG000|Overall Study|Withdrawal by Subject|2|||
33546539|NCT00435942|101901479|FG001|Overall Study|Withdrawal by Subject|0|||
33546540|NCT00435942|101901478|FG000|Overall Study|Lost to Follow-up|0|||
33214097|NCT04435366|100682291|FG000|Year 1 (12 Months)|Not treated|0|||
33214098|NCT04435366|100682292|FG001|Year 1 (12 Months)|Not treated|0|||
33214099|NCT04435366|100682293|FG002|Year 1 (12 Months)|Not treated|1|||
33214100|NCT04435366|100682291|FG000|Year 2 (12 Months)|Death|1|||
33214101|NCT04435366|100682292|FG001|Year 2 (12 Months)|Death|4|||
33214102|NCT04435366|100682293|FG002|Year 2 (12 Months)|Death|6|||
33214103|NCT04435366|100682291|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
33214104|NCT04435366|100682292|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
33214105|NCT04435366|100682293|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
33214106|NCT04435366|100682291|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
33214107|NCT04435366|100682292|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
33214108|NCT04435366|100682293|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
33214109|NCT04435366|100682291|FG000|Year 2 (12 Months)|Adverse Event|2|||
33214110|NCT04435366|100682292|FG001|Year 2 (12 Months)|Adverse Event|1|||
33214111|NCT04435366|100682293|FG002|Year 2 (12 Months)|Adverse Event|6|||
33348070|NCT00110994|101163873|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
33348071|NCT00110994|101163874|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
33348072|NCT00110994|101163873|FG000|Active Follow-up|Other reasons|0|||
33348073|NCT00110994|101163874|FG001|Active Follow-up|Other reasons|2|||
33546541|NCT00435942|101901479|FG001|Overall Study|Lost to Follow-up|16|||
33546542|NCT00435942|101901478|FG000|Overall Study|Conversion to Open Repair|1|||
33546543|NCT00435942|101901479|FG001|Overall Study|Conversion to Open Repair|0|||
33546544|NCT00435942|101901478|FG000|Overall Study|Technical Failure|3|||
33546545|NCT00435942|101901479|FG001|Overall Study|Technical Failure|0|||
33546546|NCT00435942|101901478|FG000|Overall Study|Other|0|||
33546547|NCT00435942|101901479|FG001|Overall Study|Other|1|||
33546548|NCT00479232|101901487|FG000|Overall Study|Adverse Event|0|||
33348074|NCT00110994|101163873|FG000|Long Term Follow-up|Death|19|||
33348075|NCT00110994|101163874|FG001|Long Term Follow-up|Death|17|||
33348076|NCT02090855|101163875|FG000|Overall Study|no evaluable Standard of Truth results|2|||
33348077|NCT03064763|101163876|FG000|Overall Study|Lost to Follow-up|1|||
33546549|NCT00479232|101901488|FG001|Overall Study|Adverse Event|0|||
33546550|NCT00479232|101901489|FG002|Overall Study|Adverse Event|5|||
33546551|NCT00479232|101901490|FG003|Overall Study|Adverse Event|0|||
33546552|NCT00479232|101901491|FG004|Overall Study|Adverse Event|0|||
33546553|NCT00479232|101901492|FG005|Overall Study|Adverse Event|10|||
33214112|NCT03657277|100682294|FG000|Overall Study|Physician Decision|2|||
33348078|NCT03064763|101163876|FG000|Overall Study|Death|8|||
33546554|NCT00479232|101901487|FG000|Overall Study|Deviation from Protocol|0|||
33348079|NCT00891202|101163877|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
33546555|NCT00479232|101901488|FG001|Overall Study|Deviation from Protocol|0|||
33546556|NCT00479232|101901489|FG002|Overall Study|Deviation from Protocol|1|||
33546557|NCT00479232|101901490|FG003|Overall Study|Deviation from Protocol|0|||
33546558|NCT00479232|101901491|FG004|Overall Study|Deviation from Protocol|0|||
33546559|NCT00479232|101901492|FG005|Overall Study|Deviation from Protocol|0|||
33546560|NCT00479232|101901487|FG000|Overall Study|Lack of Efficacy|0|||
33546561|NCT00479232|101901488|FG001|Overall Study|Lack of Efficacy|0|||
33546562|NCT00479232|101901489|FG002|Overall Study|Lack of Efficacy|2|||
33546563|NCT00479232|101901490|FG003|Overall Study|Lack of Efficacy|0|||
33546564|NCT00479232|101901491|FG004|Overall Study|Lack of Efficacy|0|||
33546565|NCT00479232|101901492|FG005|Overall Study|Lack of Efficacy|4|||
33546566|NCT00479232|101901487|FG000|Overall Study|Physician Decision|0|||
33546567|NCT00479232|101901488|FG001|Overall Study|Physician Decision|0|||
33546568|NCT00479232|101901489|FG002|Overall Study|Physician Decision|2|||
33546569|NCT00479232|101901490|FG003|Overall Study|Physician Decision|0|||
33546570|NCT00479232|101901491|FG004|Overall Study|Physician Decision|0|||
33546571|NCT00479232|101901492|FG005|Overall Study|Physician Decision|1|||
33546572|NCT00479232|101901487|FG000|Overall Study|Progressive Disease|3|||
33546573|NCT00479232|101901488|FG001|Overall Study|Progressive Disease|1|||
33546574|NCT00479232|101901489|FG002|Overall Study|Progressive Disease|12|||
33546575|NCT00479232|101901490|FG003|Overall Study|Progressive Disease|3|||
33546576|NCT00479232|101901491|FG004|Overall Study|Progressive Disease|3|||
33546577|NCT00479232|101901492|FG005|Overall Study|Progressive Disease|12|||
33546578|NCT00479232|101901487|FG000|Overall Study|Withdrew Consent|0|||
33546579|NCT00479232|101901488|FG001|Overall Study|Withdrew Consent|2|||
33546580|NCT00479232|101901489|FG002|Overall Study|Withdrew Consent|6|||
33546581|NCT00479232|101901490|FG003|Overall Study|Withdrew Consent|0|||
33546582|NCT00479232|101901491|FG004|Overall Study|Withdrew Consent|1|||
33546583|NCT00479232|101901492|FG005|Overall Study|Withdrew Consent|3|||
33546584|NCT01529268|101901493|FG000|Overall Study|Lost to Follow-up|9|||
33546585|NCT01529268|101901494|FG001|Overall Study|Lost to Follow-up|3|||
33546586|NCT01529268|101901493|FG000|Overall Study|Moved|3|||
33546587|NCT01529268|101901494|FG001|Overall Study|Moved|0|||
33546588|NCT05166876|101901495|FG000|Overall Study|Withdrawal by Subject|1|||
33546589|NCT05166876|101901496|FG001|Overall Study|Withdrawal by Subject|0|||
33546590|NCT05166876|101901497|FG002|Overall Study|Withdrawal by Subject|0|||
33546591|NCT04000724|101901499|FG000|Overall Study|Withdrawal by Subject|5|||
33546592|NCT04000724|101901500|FG001|Overall Study|Withdrawal by Subject|3|||
33546593|NCT04000724|101901501|FG002|Overall Study|Withdrawal by Subject|4|||
33546594|NCT04000724|101901499|FG000|Overall Study|Lost to Follow-up|11|||
33546595|NCT04000724|101901500|FG001|Overall Study|Lost to Follow-up|7|||
33546596|NCT04000724|101901501|FG002|Overall Study|Lost to Follow-up|13|||
33546597|NCT02328105|101901503|FG000|Overall Study|Death|6|||
33546598|NCT02328105|101901503|FG000|Overall Study|Withdrawal by Subject|1|||
33546599|NCT02328105|101901503|FG000|Overall Study|Still On Study in Follow-Up|4|||
33546600|NCT02711137|101901504|FG000|Overall Study|Death|1|||
33546601|NCT02711137|101901505|FG001|Overall Study|Death|4|||
33546602|NCT02711137|101901506|FG002|Overall Study|Death|5|||
33546603|NCT02711137|101901507|FG003|Overall Study|Death|5|||
33546604|NCT02711137|101901508|FG004|Overall Study|Death|3|||
33409384|NCT01465958|101389259|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
33409385|NCT01465958|101389260|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
33409386|NCT00535262|101389261|FG000|Overall Study|No funding|3|||
33409387|NCT03710824|101389262|FG000|Overall Study|Withdrawal by Subject|1|||
33409388|NCT03710824|101389262|FG000|Overall Study|Lost to Follow-up|3|||
33409389|NCT03710824|101389262|FG000|Overall Study|Adverse Event|25|||
33409390|NCT03710824|101389262|FG000|Overall Study|Treatment discontinuation|2|||
33409391|NCT00594958|101389263|FG000|Overall Study|Withdrawal by Subject|1|||
33409392|NCT00594958|101389264|FG001|Overall Study|Withdrawal by Subject|0|||
33546605|NCT02711137|101901509|FG005|Overall Study|Death|1|||
33546606|NCT02711137|101901510|FG006|Overall Study|Death|61|||
33546607|NCT02711137|101901511|FG007|Overall Study|Death|3|||
33546608|NCT02711137|101901512|FG008|Overall Study|Death|0|||
33546609|NCT02711137|101901513|FG009|Overall Study|Death|1|||
33546610|NCT02711137|101901514|FG010|Overall Study|Death|1|||
33546611|NCT02711137|101901515|FG011|Overall Study|Death|1|||
33546612|NCT02711137|101901516|FG012|Overall Study|Death|0|||
33546613|NCT02711137|101901517|FG013|Overall Study|Death|0|||
33546614|NCT02711137|101901518|FG014|Overall Study|Death|0|||
33546615|NCT02711137|101901504|FG000|Overall Study|Study Terminated by Sponsor|0|||
33348080|NCT00891202|101163878|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
33348081|NCT00891202|101163879|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
33348082|NCT00891202|101163880|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
33348083|NCT00891202|101163877|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
33348084|NCT00891202|101163878|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
33348085|NCT00891202|101163879|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
33348086|NCT00891202|101163880|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
33348087|NCT00891202|101163877|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
33546616|NCT02711137|101901505|FG001|Overall Study|Study Terminated by Sponsor|0|||
33546617|NCT02711137|101901506|FG002|Overall Study|Study Terminated by Sponsor|1|||
33546618|NCT02711137|101901507|FG003|Overall Study|Study Terminated by Sponsor|0|||
33214113|NCT03657277|100682294|FG000|Overall Study|Lost to Follow-up|1|||
33214114|NCT03657277|100682294|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
33348088|NCT00891202|101163878|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
33214115|NCT04197713|100682295|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
33348089|NCT00891202|101163879|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
33409393|NCT00594958|101389265|FG002|Overall Study|Withdrawal by Subject|1|||
33409394|NCT00594958|101389263|FG000|Overall Study|Adverse Event|4|||
33546619|NCT02711137|101901508|FG004|Overall Study|Study Terminated by Sponsor|0|||
33546620|NCT02711137|101901509|FG005|Overall Study|Study Terminated by Sponsor|0|||
33546621|NCT02711137|101901510|FG006|Overall Study|Study Terminated by Sponsor|1|||
33546622|NCT02711137|101901511|FG007|Overall Study|Study Terminated by Sponsor|0|||
33214116|NCT04197713|100682296|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
33214117|NCT00951041|100682300|FG000|Overall Study|Withdrawal by Subject|1|||
33214118|NCT00951041|100682301|FG001|Overall Study|Withdrawal by Subject|1|||
33214119|NCT00951041|100682300|FG000|Overall Study|Lost to Follow-up|1|||
33214120|NCT00951041|100682301|FG001|Overall Study|Lost to Follow-up|0|||
33214121|NCT00951041|100682300|FG000|Overall Study|Other|3|||
33214122|NCT00951041|100682301|FG001|Overall Study|Other|0|||
33214123|NCT01506193|100682304|FG000|Overall Study|Protocol Violation|1|||
33546623|NCT02711137|101901512|FG008|Overall Study|Study Terminated by Sponsor|0|||
33546624|NCT02711137|101901513|FG009|Overall Study|Study Terminated by Sponsor|0|||
33546625|NCT02711137|101901514|FG010|Overall Study|Study Terminated by Sponsor|0|||
33546626|NCT02711137|101901515|FG011|Overall Study|Study Terminated by Sponsor|0|||
33546627|NCT02711137|101901516|FG012|Overall Study|Study Terminated by Sponsor|0|||
33546628|NCT02711137|101901517|FG013|Overall Study|Study Terminated by Sponsor|0|||
33546629|NCT02711137|101901518|FG014|Overall Study|Study Terminated by Sponsor|0|||
33546630|NCT02711137|101901504|FG000|Overall Study|Physician Decision|1|||
33616962|NCT01053988|102144452|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
33616963|NCT01053988|102144453|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
33616964|NCT01053988|102144454|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
33616965|NCT01053988|102144455|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
33616966|NCT01053988|102144450|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
33616967|NCT01053988|102144451|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
33616968|NCT01053988|102144452|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
33616969|NCT01053988|102144453|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
33616970|NCT01053988|102144454|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
33616971|NCT01053988|102144455|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
33616972|NCT01053988|102144450|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
33616973|NCT01053988|102144451|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
33616974|NCT01053988|102144452|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
33616975|NCT01053988|102144453|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
33616976|NCT01053988|102144454|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
33616977|NCT01053988|102144455|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
33616978|NCT01053988|102144450|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33616979|NCT01053988|102144451|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
33616980|NCT01053988|102144452|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33616981|NCT01053988|102144453|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
33616982|NCT01053988|102144454|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
33546631|NCT02711137|101901505|FG001|Overall Study|Physician Decision|0|||
33546632|NCT02711137|101901506|FG002|Overall Study|Physician Decision|2|||
33616983|NCT01053988|102144455|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
33546633|NCT02711137|101901507|FG003|Overall Study|Physician Decision|1|||
33546634|NCT02711137|101901508|FG004|Overall Study|Physician Decision|1|||
33546635|NCT02711137|101901509|FG005|Overall Study|Physician Decision|0|||
33546636|NCT02711137|101901510|FG006|Overall Study|Physician Decision|12|||
33214124|NCT01506193|100682305|FG001|Overall Study|Protocol Violation|0|||
33546637|NCT02711137|101901511|FG007|Overall Study|Physician Decision|2|||
33546638|NCT02711137|101901512|FG008|Overall Study|Physician Decision|1|||
33546639|NCT02711137|101901513|FG009|Overall Study|Physician Decision|1|||
33546640|NCT02711137|101901514|FG010|Overall Study|Physician Decision|3|||
33214125|NCT01506193|100682306|FG002|Overall Study|Protocol Violation|1|||
33214126|NCT01506193|100682304|FG000|Overall Study|Migrated/moved from study area|0|||
33214127|NCT01506193|100682305|FG001|Overall Study|Migrated/moved from study area|0|||
33348090|NCT00891202|101163880|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
33348091|NCT00891202|101163877|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
33348092|NCT00891202|101163878|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
33348093|NCT00891202|101163879|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
33348094|NCT00891202|101163880|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
33348095|NCT01737931|101163881|FG000|Overall Study|Withdrawal by Subject|0|||
33348096|NCT01737931|101163882|FG001|Overall Study|Withdrawal by Subject|1|||
33348097|NCT01737931|101163883|FG002|Overall Study|Withdrawal by Subject|1|||
33348098|NCT01737931|101163881|FG000|Overall Study|Physician Decision|0|||
33348099|NCT01737931|101163882|FG001|Overall Study|Physician Decision|1|||
33348100|NCT01737931|101163883|FG002|Overall Study|Physician Decision|0|||
33546641|NCT02711137|101901515|FG011|Overall Study|Physician Decision|2|||
33546642|NCT02711137|101901516|FG012|Overall Study|Physician Decision|1|||
33214128|NCT01506193|100682306|FG002|Overall Study|Migrated/moved from study area|1|||
33348101|NCT02597062|101163884|FG000|Overall Study|Ineligible|1|||
33546643|NCT02711137|101901517|FG013|Overall Study|Physician Decision|1|||
33546644|NCT02711137|101901518|FG014|Overall Study|Physician Decision|2|||
33546645|NCT02711137|101901504|FG000|Overall Study|Other|0|||
33546646|NCT02711137|101901505|FG001|Overall Study|Other|1|||
33546647|NCT02711137|101901506|FG002|Overall Study|Other|0|||
33546648|NCT02711137|101901507|FG003|Overall Study|Other|0|||
33546649|NCT02711137|101901508|FG004|Overall Study|Other|0|||
33616984|NCT01053988|102144450|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
33616985|NCT01053988|102144451|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
33616986|NCT01053988|102144452|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
33616987|NCT01053988|102144453|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
33616988|NCT01053988|102144454|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
33616989|NCT01053988|102144455|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
33616990|NCT01053988|102144450|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
33616991|NCT01053988|102144451|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
33616992|NCT01053988|102144452|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
33616993|NCT01053988|102144453|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
33616994|NCT01053988|102144454|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
33616995|NCT01053988|102144455|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
33616996|NCT01636986|102144457|FG000|Overall Study|Withdrawal by Subject|0|||
33616997|NCT01636986|102144458|FG001|Overall Study|Withdrawal by Subject|1|||
33616998|NCT01636986|102144457|FG000|Overall Study|Corneal Staining|0|||
33616999|NCT01636986|102144458|FG001|Overall Study|Corneal Staining|1|||
33617000|NCT02128724|102144459|FG000|Overall Study|Death|1|||
33617001|NCT02128724|102144460|FG001|Overall Study|Death|0|||
33617002|NCT02128724|102144461|FG002|Overall Study|Death|0|||
33617003|NCT02128724|102144462|FG003|Overall Study|Death|0|||
33617004|NCT02128724|102144459|FG000|Overall Study|Adverse Event|0|||
33617005|NCT02128724|102144460|FG001|Overall Study|Adverse Event|1|||
33617006|NCT02128724|102144461|FG002|Overall Study|Adverse Event|0|||
33617007|NCT02128724|102144462|FG003|Overall Study|Adverse Event|0|||
33617008|NCT02128724|102144459|FG000|Overall Study|Physician Decision|0|||
33546650|NCT02711137|101901509|FG005|Overall Study|Other|0|||
33348102|NCT02527707|101163885|FG000|Overall Study|Adverse Event|1|||
33348103|NCT02527707|101163885|FG000|Overall Study|Adverse Event|1|||
33348104|NCT01987908|101163888|FG000|Placebo Lead-in Period|Adverse Event|2|||
33348105|NCT01987908|101163889|FG001|Placebo Lead-in Period|Adverse Event|0|||
33348106|NCT01987908|101163890|FG002|Placebo Lead-in Period|Adverse Event|0|||
33348107|NCT01987908|101163888|FG000|Placebo Lead-in Period|Physician Decision|2|||
33348108|NCT01987908|101163889|FG001|Placebo Lead-in Period|Physician Decision|0|||
33348109|NCT01987908|101163890|FG002|Placebo Lead-in Period|Physician Decision|0|||
33348110|NCT01987908|101163888|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
33348111|NCT01987908|101163889|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
33348112|NCT01987908|101163890|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
33348113|NCT01987908|101163888|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
33348114|NCT01987908|101163889|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
33348115|NCT01987908|101163890|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
33348116|NCT01987908|101163888|FG000|Treatment Period|Adverse Event|0|||
33348117|NCT01987908|101163889|FG001|Treatment Period|Adverse Event|1|||
33348118|NCT01987908|101163890|FG002|Treatment Period|Adverse Event|1|||
33546651|NCT02711137|101901510|FG006|Overall Study|Other|3|||
33546652|NCT02711137|101901511|FG007|Overall Study|Other|0|||
33546653|NCT02711137|101901512|FG008|Overall Study|Other|0|||
33546654|NCT02711137|101901513|FG009|Overall Study|Other|0|||
33617009|NCT02128724|102144460|FG001|Overall Study|Physician Decision|0|||
33617010|NCT02128724|102144461|FG002|Overall Study|Physician Decision|0|||
33617011|NCT02128724|102144462|FG003|Overall Study|Physician Decision|2|||
33617012|NCT02128724|102144459|FG000|Overall Study|Withdrawal by Subject|0|||
33348119|NCT01987908|101163888|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
33348120|NCT01987908|101163889|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
33348121|NCT01987908|101163890|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
33546655|NCT02711137|101901514|FG010|Overall Study|Other|0|||
33617013|NCT02128724|102144460|FG001|Overall Study|Withdrawal by Subject|0|||
33617014|NCT02128724|102144461|FG002|Overall Study|Withdrawal by Subject|0|||
33546656|NCT02711137|101901515|FG011|Overall Study|Other|0|||
33546657|NCT02711137|101901516|FG012|Overall Study|Other|0|||
33546658|NCT02711137|101901517|FG013|Overall Study|Other|0|||
33348122|NCT01987908|101163888|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
33348123|NCT01987908|101163889|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
33348124|NCT01987908|101163890|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
33348125|NCT00454779|101163891|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
33348126|NCT00454779|101163892|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
33348127|NCT00454779|101163891|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
33348128|NCT00454779|101163892|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
33348129|NCT00454779|101163891|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
33348130|NCT00454779|101163892|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
33348131|NCT00454779|101163891|FG000|First-line Treatment Phase|Protocol Violation|0|||
33348132|NCT00454779|101163892|FG001|First-line Treatment Phase|Protocol Violation|1|||
33348133|NCT00454779|101163891|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
33348134|NCT00454779|101163892|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
33348135|NCT00454779|101163891|FG000|First-line Treatment Phase|Ongoing|1|||
33348136|NCT00454779|101163892|FG001|First-line Treatment Phase|Ongoing|0|||
33546659|NCT02711137|101901518|FG014|Overall Study|Other|1|||
33546660|NCT02711137|101901504|FG000|Overall Study|Withdrawal by Subject|1|||
33546661|NCT02711137|101901505|FG001|Overall Study|Withdrawal by Subject|0|||
33546662|NCT02711137|101901506|FG002|Overall Study|Withdrawal by Subject|0|||
33546663|NCT02711137|101901507|FG003|Overall Study|Withdrawal by Subject|1|||
33617015|NCT02128724|102144462|FG003|Overall Study|Withdrawal by Subject|1|||
33617016|NCT04327024|102144469|FG000|Overall Study|Death|1|||
33617017|NCT04327024|102144470|FG001|Overall Study|Death|2|||
33617018|NCT04327024|102144471|FG002|Overall Study|Death|1|||
33617019|NCT04327024|102144469|FG000|Overall Study|Non-compliance with study drug|0|||
33617020|NCT04327024|102144470|FG001|Overall Study|Non-compliance with study drug|1|||
33617021|NCT04327024|102144471|FG002|Overall Study|Non-compliance with study drug|0|||
33617022|NCT04327024|102144469|FG000|Overall Study|Withdrawal by Subject|1|||
33617023|NCT04327024|102144470|FG001|Overall Study|Withdrawal by Subject|1|||
33617024|NCT04327024|102144471|FG002|Overall Study|Withdrawal by Subject|2|||
33617025|NCT02134925|102147277|FG000|Overall Study|Withdrawal by Subject|1|||
33617026|NCT02134925|102147278|FG001|Overall Study|Withdrawal by Subject|0|||
33546664|NCT02711137|101901508|FG004|Overall Study|Withdrawal by Subject|1|||
33546665|NCT02711137|101901509|FG005|Overall Study|Withdrawal by Subject|0|||
33546666|NCT02711137|101901510|FG006|Overall Study|Withdrawal by Subject|7|||
33546667|NCT02711137|101901511|FG007|Overall Study|Withdrawal by Subject|0|||
33546668|NCT02711137|101901512|FG008|Overall Study|Withdrawal by Subject|0|||
33546669|NCT02711137|101901513|FG009|Overall Study|Withdrawal by Subject|0|||
33546670|NCT02711137|101901514|FG010|Overall Study|Withdrawal by Subject|0|||
33546671|NCT02711137|101901515|FG011|Overall Study|Withdrawal by Subject|0|||
33546672|NCT02711137|101901516|FG012|Overall Study|Withdrawal by Subject|0|||
33546673|NCT02711137|101901517|FG013|Overall Study|Withdrawal by Subject|1|||
33546674|NCT02711137|101901518|FG014|Overall Study|Withdrawal by Subject|0|||
33546675|NCT02711137|101901504|FG000|Overall Study|Lost to Follow-up|1|||
33546676|NCT02711137|101901505|FG001|Overall Study|Lost to Follow-up|0|||
33546677|NCT02711137|101901506|FG002|Overall Study|Lost to Follow-up|0|||
33546678|NCT02711137|101901507|FG003|Overall Study|Lost to Follow-up|0|||
33546679|NCT02711137|101901508|FG004|Overall Study|Lost to Follow-up|0|||
33617027|NCT02134925|102147277|FG000|Overall Study|Cancel|1|||
33617028|NCT02134925|102147278|FG001|Overall Study|Cancel|6|||
33617029|NCT05011513|102147279|FG000|Overall Study|Death|0|||
33617030|NCT05011513|102147280|FG001|Overall Study|Death|1|||
33617031|NCT05011513|102147279|FG000|Overall Study|Lost to Follow-up|4|||
33214129|NCT01506193|100682304|FG000|Overall Study|Adverse event, non-fatal|0|||
33214130|NCT01506193|100682305|FG001|Overall Study|Adverse event, non-fatal|0|||
33214131|NCT01506193|100682306|FG002|Overall Study|Adverse event, non-fatal|1|||
33214132|NCT01506193|100682304|FG000|Overall Study|Withdrawal by Subject|5|||
33214133|NCT01506193|100682305|FG001|Overall Study|Withdrawal by Subject|1|||
33214134|NCT01506193|100682306|FG002|Overall Study|Withdrawal by Subject|8|||
33214135|NCT01506193|100682304|FG000|Overall Study|Lost to Follow-up|8|||
33617032|NCT05011513|102147280|FG001|Overall Study|Lost to Follow-up|0|||
33617033|NCT05011513|102147279|FG000|Overall Study|Withdrawal by Subject|18|||
33214136|NCT01506193|100682305|FG001|Overall Study|Lost to Follow-up|3|||
33214137|NCT01506193|100682306|FG002|Overall Study|Lost to Follow-up|3|||
33409395|NCT00594958|101389264|FG001|Overall Study|Adverse Event|1|||
33546680|NCT02711137|101901509|FG005|Overall Study|Lost to Follow-up|0|||
33546681|NCT02711137|101901510|FG006|Overall Study|Lost to Follow-up|2|||
33617034|NCT05011513|102147280|FG001|Overall Study|Withdrawal by Subject|17|||
33546682|NCT02711137|101901511|FG007|Overall Study|Lost to Follow-up|0|||
33546683|NCT02711137|101901512|FG008|Overall Study|Lost to Follow-up|0|||
33546684|NCT02711137|101901513|FG009|Overall Study|Lost to Follow-up|0|||
33546685|NCT02711137|101901514|FG010|Overall Study|Lost to Follow-up|0|||
33546686|NCT02711137|101901515|FG011|Overall Study|Lost to Follow-up|0|||
33546687|NCT02711137|101901516|FG012|Overall Study|Lost to Follow-up|0|||
33546688|NCT02711137|101901517|FG013|Overall Study|Lost to Follow-up|0|||
33546689|NCT02711137|101901518|FG014|Overall Study|Lost to Follow-up|0|||
33546690|NCT03010501|101901526|FG000|Study Week 1|Withdrawal by Subject|2|||
33546691|NCT03010501|101901527|FG001|Study Week 1|Withdrawal by Subject|1|||
33546692|NCT03010501|101901528|FG002|Study Week 1|Withdrawal by Subject|0|||
33546693|NCT03010501|101901529|FG003|Study Week 1|Withdrawal by Subject|2|||
33546694|NCT03010501|101901530|FG004|Study Week 1|Withdrawal by Subject|0|||
33546695|NCT03010501|101901531|FG005|Study Week 1|Withdrawal by Subject|0|||
33348137|NCT00454779|101163891|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
33348138|NCT00454779|101163892|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
33348139|NCT00454779|101163891|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
33348140|NCT00454779|101163892|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
33348141|NCT00454779|101163891|FG000|Second-line Treatment Phase|Ongoing|0|||
33214138|NCT02703922|100682307|FG000|Overall Study|Death|5|||
33214139|NCT02703922|100682308|FG001|Overall Study|Death|8|||
33214140|NCT02703922|100682307|FG000|Overall Study|Lost to Follow-up|10|||
33214141|NCT02703922|100682308|FG001|Overall Study|Lost to Follow-up|10|||
33214142|NCT00440531|100682309|FG000|Overall Study|Adverse Event|1|||
33214143|NCT00440531|100682310|FG001|Overall Study|Adverse Event|0|||
33214144|NCT00440531|100682311|FG002|Overall Study|Adverse Event|2|||
33214145|NCT00440531|100682309|FG000|Overall Study|Withdrawal by Subject|2|||
33348142|NCT00454779|101163892|FG001|Second-line Treatment Phase|Ongoing|1|||
33348143|NCT01818726|101163895|FG000|Overall Study|Administrative reasons|5|||
33348144|NCT01818726|101163896|FG001|Overall Study|Administrative reasons|1|||
33348145|NCT01818726|101163895|FG000|Overall Study|Withdrawal by Subject|0|||
33348146|NCT01818726|101163896|FG001|Overall Study|Withdrawal by Subject|1|||
33348147|NCT01818726|101163895|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
33348148|NCT01818726|101163896|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
33348149|NCT02494596|101163897|FG000|Overall Study|Insufficient Therapeutic Response|3|||
33348150|NCT02494596|101163898|FG001|Overall Study|Insufficient Therapeutic Response|3|||
33348151|NCT02494596|101163899|FG002|Overall Study|Insufficient Therapeutic Response|1|||
33348152|NCT02494596|101163897|FG000|Overall Study|Adverse Event|0|||
33348153|NCT02494596|101163898|FG001|Overall Study|Adverse Event|1|||
33348154|NCT02494596|101163899|FG002|Overall Study|Adverse Event|0|||
33348155|NCT02494596|101163897|FG000|Overall Study|Refused Treatment|0|||
33348156|NCT02494596|101163898|FG001|Overall Study|Refused Treatment|1|||
33348157|NCT02494596|101163899|FG002|Overall Study|Refused Treatment|0|||
33348158|NCT01679002|101163900|FG000|Overall Study|Adverse Event|1|||
33348159|NCT01679002|101163901|FG001|Overall Study|Adverse Event|1|||
33348160|NCT01679002|101163902|FG002|Overall Study|Adverse Event|0|||
33348161|NCT01446809|101163903|FG000|Overall Study|Adverse Event|0|||
33348162|NCT01446809|101163904|FG001|Overall Study|Adverse Event|0|||
33348163|NCT01446809|101163905|FG002|Overall Study|Adverse Event|1|||
33348164|NCT01446809|101163903|FG000|Overall Study|Failure to complete study procedures|0|||
33348165|NCT01446809|101163904|FG001|Overall Study|Failure to complete study procedures|0|||
33348166|NCT01446809|101163905|FG002|Overall Study|Failure to complete study procedures|1|||
33348167|NCT04067518|101163906|FG000|Overall Study|Adverse Event|1|||
33348168|NCT04067518|101163907|FG001|Overall Study|Adverse Event|3|||
33348169|NCT04067518|101163906|FG000|Overall Study|Screen failures|0|||
33348170|NCT04067518|101163907|FG001|Overall Study|Screen failures|1|||
33348171|NCT04067518|101163906|FG000|Overall Study|Enrolled but not treated|0|||
33348172|NCT04067518|101163907|FG001|Overall Study|Enrolled but not treated|1|||
33348173|NCT00553462|101163910|FG000|Overall Study|Adverse Event|4|||
33348174|NCT00553462|101163910|FG000|Overall Study|Progression|4|||
33546696|NCT03010501|101901526|FG000|Study Week 3|Withdrawal by Subject|0|||
33546697|NCT03010501|101901527|FG001|Study Week 3|Withdrawal by Subject|0|||
33546698|NCT03010501|101901528|FG002|Study Week 3|Withdrawal by Subject|0|||
33214146|NCT00440531|100682310|FG001|Overall Study|Withdrawal by Subject|0|||
33214147|NCT00440531|100682311|FG002|Overall Study|Withdrawal by Subject|0|||
33214148|NCT00440531|100682309|FG000|Overall Study|Protocol Violation|1|||
33214149|NCT00440531|100682310|FG001|Overall Study|Protocol Violation|2|||
33348175|NCT00553462|101163910|FG000|Overall Study|Withdrawal by Subject|5|||
33348176|NCT00553462|101163910|FG000|Overall Study|Physician Decision|1|||
33348177|NCT00947531|101163911|FG000|Overall Study|Withdrawal by Subject|10|||
33546699|NCT03010501|101901529|FG003|Study Week 3|Withdrawal by Subject|1|||
33214150|NCT00440531|100682311|FG002|Overall Study|Protocol Violation|0|||
33348178|NCT00947531|101163912|FG001|Overall Study|Withdrawal by Subject|7|||
33546700|NCT03010501|101901530|FG004|Study Week 3|Withdrawal by Subject|0|||
33214151|NCT00440531|100682309|FG000|Overall Study|Lost to Follow-up|4|||
33214152|NCT00440531|100682310|FG001|Overall Study|Lost to Follow-up|3|||
33214153|NCT00440531|100682311|FG002|Overall Study|Lost to Follow-up|5|||
33546701|NCT03010501|101901531|FG005|Study Week 3|Withdrawal by Subject|0|||
33546702|NCT00866320|101901539|FG000|Overall Study|Withdrawal by Subject|4|||
33546703|NCT00866320|101901539|FG000|Overall Study|Death|2|||
33546704|NCT03738215|101901542|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
33546705|NCT03738215|101901543|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
33546706|NCT03738215|101901544|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
33546707|NCT03738215|101901542|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
33546708|NCT03738215|101901543|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
33546709|NCT03738215|101901544|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33546710|NCT03738215|101901542|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
33546711|NCT03738215|101901543|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
33546712|NCT03738215|101901544|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
33546713|NCT03738215|101901542|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
33546714|NCT03738215|101901543|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
33546715|NCT03738215|101901544|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
33546716|NCT03738215|101901542|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
33546717|NCT03738215|101901543|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
33546718|NCT03738215|101901544|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
33546719|NCT03738215|101901542|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
33546720|NCT03738215|101901543|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
33546721|NCT03738215|101901544|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
33546722|NCT03738215|101901542|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
33546723|NCT03738215|101901543|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
33546724|NCT03738215|101901544|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
33546725|NCT03738215|101901542|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
33546726|NCT03738215|101901543|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
33546727|NCT03738215|101901544|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
33546728|NCT03738215|101901542|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
33546729|NCT03738215|101901543|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
33546730|NCT03738215|101901544|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
33546731|NCT03738215|101901542|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
33546732|NCT03738215|101901543|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
33546733|NCT03738215|101901544|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
33546734|NCT02714153|101901546|FG000|Overall Study|Death|1|||
33546735|NCT01022580|101901547|FG000|Overall Study|Death|18|||
33546736|NCT01022580|101901548|FG001|Overall Study|Death|22|||
33546737|NCT01245751|101901549|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
33214154|NCT00440531|100682309|FG000|Overall Study|see pre-assignment details|2|||
33214155|NCT00440531|100682310|FG001|Overall Study|see pre-assignment details|0|||
33214156|NCT00440531|100682311|FG002|Overall Study|see pre-assignment details|0|||
33214157|NCT00514735|100682312|FG000|Overall Study|Withdrawal by Subject|13|||
33214158|NCT00514735|100682313|FG001|Overall Study|Withdrawal by Subject|5|||
33214159|NCT00514735|100682312|FG000|Overall Study|Death|1|||
33214160|NCT00514735|100682313|FG001|Overall Study|Death|0|||
33214161|NCT00514735|100682312|FG000|Overall Study|Lost to Follow-up|0|||
33214162|NCT00514735|100682313|FG001|Overall Study|Lost to Follow-up|1|||
33214163|NCT03644186|100682314|FG000|Overall Study|Withdrawal by Subject|1|||
33214164|NCT03644186|100682315|FG001|Overall Study|Withdrawal by Subject|1|||
33214165|NCT02243605|100682316|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
33214166|NCT02243605|100682317|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
33214167|NCT02243605|100682316|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
33214168|NCT02243605|100682317|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
33214169|NCT02243605|100682316|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
33214170|NCT02243605|100682317|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
33348179|NCT00947531|101163911|FG000|Overall Study|Administrative Reason|0|||
33546738|NCT01245751|101901550|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
33617035|NCT05011513|102147279|FG000|Overall Study|Other|4|||
33214171|NCT02243605|100682316|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
33546739|NCT01245751|101901551|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
33546740|NCT01245751|101901552|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
33546741|NCT01245751|101901549|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
33546742|NCT01245751|101901550|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
33546743|NCT01245751|101901551|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
33546744|NCT01245751|101901552|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
33546745|NCT01245751|101901549|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
33617036|NCT05011513|102147280|FG001|Overall Study|Other|2|||
33214172|NCT02243605|100682317|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
33214173|NCT02243605|100682316|FG000|Stage 2 - Final Analysis Population|Progression|0|||
33214174|NCT02243605|100682317|FG001|Stage 2 - Final Analysis Population|Progression|1|||
33617037|NCT03672292|102147284|FG000|Overall Study|Adverse Event|3|||
33546746|NCT01245751|101901550|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
33546747|NCT01245751|101901551|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
33546748|NCT01245751|101901552|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
33546749|NCT03704688|101901554|FG000|Overall Study|Adverse Event|0|||
33546750|NCT03704688|101901555|FG001|Overall Study|Adverse Event|0|||
33546751|NCT03704688|101901556|FG002|Overall Study|Adverse Event|0|||
33546752|NCT03704688|101901557|FG003|Overall Study|Adverse Event|4|||
33546753|NCT03704688|101901558|FG004|Overall Study|Adverse Event|1|||
33546754|NCT03704688|101901559|FG005|Overall Study|Adverse Event|0|||
33546755|NCT03704688|101901554|FG000|Overall Study|Disease Progression|0|||
33546756|NCT03704688|101901555|FG001|Overall Study|Disease Progression|0|||
33546757|NCT03704688|101901556|FG002|Overall Study|Disease Progression|0|||
33546758|NCT03704688|101901557|FG003|Overall Study|Disease Progression|3|||
33546759|NCT03704688|101901558|FG004|Overall Study|Disease Progression|1|||
33546760|NCT03704688|101901559|FG005|Overall Study|Disease Progression|0|||
33546761|NCT03704688|101901554|FG000|Overall Study|Death|0|||
33546762|NCT03704688|101901555|FG001|Overall Study|Death|0|||
33546763|NCT03704688|101901556|FG002|Overall Study|Death|0|||
33546764|NCT03704688|101901557|FG003|Overall Study|Death|0|||
33546765|NCT03704688|101901558|FG004|Overall Study|Death|3|||
33546766|NCT03704688|101901559|FG005|Overall Study|Death|0|||
33617038|NCT03672292|102147285|FG001|Overall Study|Adverse Event|1|||
33617039|NCT03672292|102147284|FG000|Overall Study|Physician Decision|0|||
33546767|NCT02949934|101901560|FG000|Natural Drinking Period|Adverse Event|1|||
33348180|NCT00947531|101163912|FG001|Overall Study|Administrative Reason|1|||
33348181|NCT00947531|101163911|FG000|Overall Study|Adverse Event|2|||
33348182|NCT00947531|101163912|FG001|Overall Study|Adverse Event|2|||
33546768|NCT02949934|101901561|FG001|Natural Drinking Period|Adverse Event|0|||
33546769|NCT02949934|101901562|FG002|Natural Drinking Period|Adverse Event|0|||
33546770|NCT02949934|101901563|FG003|Natural Drinking Period|Adverse Event|1|||
33546771|NCT02949934|101901564|FG004|Natural Drinking Period|Adverse Event|0|||
33546772|NCT02949934|101901565|FG005|Natural Drinking Period|Adverse Event|0|||
33546773|NCT02949934|101901560|FG000|Natural Drinking Period|Lost to Follow-up|0|||
33546774|NCT02949934|101901561|FG001|Natural Drinking Period|Lost to Follow-up|0|||
33546775|NCT02949934|101901562|FG002|Natural Drinking Period|Lost to Follow-up|0|||
33546776|NCT02949934|101901563|FG003|Natural Drinking Period|Lost to Follow-up|0|||
33546777|NCT02949934|101901564|FG004|Natural Drinking Period|Lost to Follow-up|1|||
33546778|NCT02949934|101901565|FG005|Natural Drinking Period|Lost to Follow-up|0|||
33546779|NCT02949934|101901560|FG000|Neuroimaging|Protocol Violation|2|||
33546780|NCT02949934|101901561|FG001|Neuroimaging|Protocol Violation|0|||
33546781|NCT02949934|101901562|FG002|Neuroimaging|Protocol Violation|0|||
33348183|NCT00947531|101163911|FG000|Overall Study|Lack of Efficacy|1|||
33348184|NCT00947531|101163912|FG001|Overall Study|Lack of Efficacy|0|||
33348185|NCT00947531|101163911|FG000|Overall Study|Other|1|||
33348186|NCT00947531|101163912|FG001|Overall Study|Other|1|||
33348187|NCT00059202|101163919|FG000|Overall Study|Withdrawal by Subject|5|||
33348188|NCT00059202|101163920|FG001|Overall Study|Withdrawal by Subject|9|||
33348189|NCT00059202|101163919|FG000|Overall Study|Protocol Violation|1|||
33348190|NCT00059202|101163920|FG001|Overall Study|Protocol Violation|3|||
33348191|NCT00059202|101163919|FG000|Overall Study|drug toxicity|0|||
33409396|NCT00594958|101389265|FG002|Overall Study|Adverse Event|2|||
33409397|NCT00594958|101389263|FG000|Overall Study|Pregnancy|0|||
33546782|NCT02949934|101901563|FG003|Neuroimaging|Protocol Violation|0|||
33546783|NCT02949934|101901564|FG004|Neuroimaging|Protocol Violation|1|||
33546784|NCT02949934|101901565|FG005|Neuroimaging|Protocol Violation|0|||
33617040|NCT03672292|102147285|FG001|Overall Study|Physician Decision|1|||
33617041|NCT03672292|102147284|FG000|Overall Study|Withdrawal by Subject|1|||
33617042|NCT03672292|102147285|FG001|Overall Study|Withdrawal by Subject|2|||
33617043|NCT02814175|102147288|FG000|Part 1|Adverse Event|2|||
33617044|NCT02814175|102147289|FG001|Part 1|Adverse Event|3|||
33617045|NCT02814175|102147290|FG002|Part 1|Adverse Event|0|||
33214175|NCT00952367|100682318|FG000|Overall Study|Withdrawal by Subject|2|||
33214176|NCT00952367|100682318|FG000|Overall Study|Noncoordination|1|||
33214177|NCT00952367|100682318|FG000|Overall Study|Protocol Violation|3|||
33348192|NCT00059202|101163920|FG001|Overall Study|drug toxicity|3|||
33348193|NCT01246206|101163922|FG000|Overall Study|Patient did not receive study regiments.|1|||
33409398|NCT00594958|101389264|FG001|Overall Study|Pregnancy|2|||
33546785|NCT02949934|101901560|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
33617046|NCT02814175|102147291|FG003|Part 1|Adverse Event|0|||
33348194|NCT02487108|101163930|FG000|Overall Study|Adverse Event|1|||
33348195|NCT02487108|101163931|FG001|Overall Study|Adverse Event|6|||
33409399|NCT00594958|101389265|FG002|Overall Study|Pregnancy|0|||
33546786|NCT02949934|101901561|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
33546787|NCT02949934|101901562|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
33546788|NCT02949934|101901563|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
33546789|NCT02949934|101901564|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
33617047|NCT02814175|102147292|FG004|Part 1|Adverse Event|0|||
33348196|NCT02487108|101163932|FG002|Overall Study|Adverse Event|12|||
33546790|NCT02949934|101901565|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
33546791|NCT02949934|101901560|FG000|Neuroimaging|Not scanned|0|||
33546792|NCT02949934|101901561|FG001|Neuroimaging|Not scanned|0|||
33546793|NCT02949934|101901562|FG002|Neuroimaging|Not scanned|1|||
33546794|NCT02949934|101901563|FG003|Neuroimaging|Not scanned|0|||
33546795|NCT02949934|101901564|FG004|Neuroimaging|Not scanned|0|||
33214178|NCT03206203|100682319|FG000|Treatment|Death|38|||
33214179|NCT03206203|100682320|FG001|Treatment|Death|26|||
33214180|NCT03206203|100682321|FG002|Treatment|Death|0|||
33214181|NCT03206203|100682319|FG000|Treatment|Withdrawal by Subject|1|||
33214182|NCT03206203|100682320|FG001|Treatment|Withdrawal by Subject|0|||
33214183|NCT03206203|100682321|FG002|Treatment|Withdrawal by Subject|0|||
33214184|NCT03206203|100682319|FG000|Treatment|Lost to Follow-up|4|||
33214185|NCT03206203|100682320|FG001|Treatment|Lost to Follow-up|0|||
33214186|NCT03206203|100682321|FG002|Treatment|Lost to Follow-up|0|||
33214187|NCT03206203|100682319|FG000|Treatment|N/A in Follow-Up|8|||
33214188|NCT03206203|100682320|FG001|Treatment|N/A in Follow-Up|1|||
33214189|NCT03206203|100682321|FG002|Treatment|N/A in Follow-Up|0|||
33214190|NCT03206203|100682319|FG000|Treatment|Disease progression|0|||
33214191|NCT03206203|100682320|FG001|Treatment|Disease progression|1|||
33214192|NCT03206203|100682321|FG002|Treatment|Disease progression|0|||
33214193|NCT03206203|100682319|FG000|Treatment|Refused follow-up|0|||
33214194|NCT03206203|100682320|FG001|Treatment|Refused follow-up|1|||
33214195|NCT03206203|100682321|FG002|Treatment|Refused follow-up|0|||
33214196|NCT03206203|100682319|FG000|Treatment|Cross over to Arm 1|0|||
33214197|NCT03206203|100682320|FG001|Treatment|Cross over to Arm 1|19|||
33214198|NCT03206203|100682321|FG002|Treatment|Cross over to Arm 1|0|||
33214199|NCT03206203|100682319|FG000|Optional Cross-Over|Death|0|||
33214200|NCT03206203|100682320|FG001|Optional Cross-Over|Death|0|||
33214201|NCT03206203|100682321|FG002|Optional Cross-Over|Death|14|||
33214202|NCT03206203|100682319|FG000|Optional Cross-Over|Refused follow-up|0|||
33214203|NCT03206203|100682320|FG001|Optional Cross-Over|Refused follow-up|0|||
33214204|NCT03206203|100682321|FG002|Optional Cross-Over|Refused follow-up|2|||
33214205|NCT04602728|100682325|FG000|Overall Study|Lost to Follow-up|4|||
33214206|NCT04602728|100682326|FG001|Overall Study|Lost to Follow-up|4|||
33214207|NCT04702568|100682331|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
33214208|NCT04702568|100682332|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
33214209|NCT04702568|100682331|FG000|Overall Study|Pregnancy|1|||
33214210|NCT04702568|100682332|FG001|Overall Study|Pregnancy|0|||
33214211|NCT04702568|100682331|FG000|Overall Study|Bone marrow transplant|1|||
33214212|NCT04702568|100682332|FG001|Overall Study|Bone marrow transplant|0|||
33214213|NCT04702568|100682331|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
33214214|NCT04702568|100682332|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
33214215|NCT04702568|100682331|FG000|Overall Study|Withdrawal by Subject|0|||
33348197|NCT02487108|101163933|FG003|Overall Study|Adverse Event|6|||
33348198|NCT02487108|101163930|FG000|Overall Study|Withdrawal by Subject|8|||
33546796|NCT02949934|101901565|FG005|Neuroimaging|Not scanned|2|||
33546797|NCT02949934|101901560|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
33214216|NCT04702568|100682332|FG001|Overall Study|Withdrawal by Subject|2|||
33214217|NCT00773968|100682333|FG000|Overall Study|Adverse Event|2|||
33214218|NCT00773968|100682333|FG000|Overall Study|Death|1|||
33214219|NCT00773968|100682333|FG000|Overall Study|Failure to Return|2|||
33214220|NCT00773968|100682333|FG000|Overall Study|Lack of Efficacy|3|||
33214221|NCT00773968|100682333|FG000|Overall Study|Protocol Violation|1|||
33214222|NCT00773968|100682333|FG000|Overall Study|Withdrawal by Subject|11|||
33348199|NCT02487108|101163931|FG001|Overall Study|Withdrawal by Subject|5|||
33214223|NCT00773968|100682333|FG000|Overall Study|Screen Failure|17|||
33214224|NCT00773968|100682333|FG000|Overall Study|Other|8|||
33617048|NCT02814175|102147293|FG005|Part 1|Adverse Event|0|||
33214225|NCT04212091|100682334|FG000|Overall Study|Lost to Follow-up|0|||
33546798|NCT02949934|101901561|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
33546799|NCT02949934|101901562|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
33546800|NCT02949934|101901563|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
33546801|NCT02949934|101901564|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
33214226|NCT04212091|100682335|FG001|Overall Study|Lost to Follow-up|0|||
33214227|NCT04212091|100682336|FG002|Overall Study|Lost to Follow-up|0|||
33214228|NCT04212091|100682337|FG003|Overall Study|Lost to Follow-up|0|||
33214229|NCT04212091|100682338|FG004|Overall Study|Lost to Follow-up|1|||
33214230|NCT04212091|100682339|FG005|Overall Study|Lost to Follow-up|1|||
33214231|NCT04212091|100682334|FG000|Overall Study|Participant unable to adhere to visit|0|||
33546802|NCT02949934|101901565|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
33546803|NCT02949934|101901560|FG000|Bar Laboratory|Adverse Event|1|||
33546804|NCT02949934|101901561|FG001|Bar Laboratory|Adverse Event|0|||
33546805|NCT02949934|101901562|FG002|Bar Laboratory|Adverse Event|2|||
33546806|NCT02949934|101901563|FG003|Bar Laboratory|Adverse Event|0|||
33617049|NCT02814175|102147288|FG000|Part 1|Withdrawal Consent|8|||
33214232|NCT04212091|100682335|FG001|Overall Study|Participant unable to adhere to visit|0|||
33214233|NCT04212091|100682336|FG002|Overall Study|Participant unable to adhere to visit|0|||
33214234|NCT04212091|100682337|FG003|Overall Study|Participant unable to adhere to visit|0|||
33214235|NCT04212091|100682338|FG004|Overall Study|Participant unable to adhere to visit|1|||
33214236|NCT04212091|100682339|FG005|Overall Study|Participant unable to adhere to visit|0|||
33214237|NCT01112579|100682340|FG000|Overall Study|Missed Visit|1|||
33214238|NCT01112579|100682341|FG001|Overall Study|Missed Visit|1|||
33214239|NCT01112579|100682340|FG000|Overall Study|Death|0|||
33214240|NCT01112579|100682341|FG001|Overall Study|Death|2|||
33214241|NCT04981678|100682342|FG000|Overall Study|Lost to Follow-up|0|||
33214242|NCT04981678|100682343|FG001|Overall Study|Lost to Follow-up|1|||
33214243|NCT05318287|100682344|FG000|Overall Study|Lost to Follow-up|8|||
33214244|NCT04891419|100682345|FG000|Overall Study|Withdrawal by Subject|4|||
33214245|NCT04891419|100682346|FG001|Overall Study|Withdrawal by Subject|0|||
33214246|NCT04891419|100682345|FG000|Overall Study|Lost to Follow-up|1|||
33214247|NCT04891419|100682346|FG001|Overall Study|Lost to Follow-up|3|||
33214248|NCT02626780|100682347|FG000|Overall Study|Withdrawal by Subject|3|||
33214249|NCT00449176|100682351|FG000|Overall Study|Withdrawal by Subject|39|||
33214250|NCT00449176|100682352|FG001|Overall Study|Withdrawal by Subject|43|||
33214251|NCT00449176|100682353|FG002|Overall Study|Withdrawal by Subject|59|||
33214252|NCT00449176|100682351|FG000|Overall Study|Lost to Follow-up|13|||
33214253|NCT00449176|100682352|FG001|Overall Study|Lost to Follow-up|8|||
33214254|NCT00449176|100682353|FG002|Overall Study|Lost to Follow-up|12|||
33214255|NCT00449176|100682351|FG000|Overall Study|Adverse Event|51|||
33348200|NCT02487108|101163932|FG002|Overall Study|Withdrawal by Subject|5|||
33348201|NCT02487108|101163933|FG003|Overall Study|Withdrawal by Subject|0|||
33348202|NCT02487108|101163930|FG000|Overall Study|Non-compliance to study medication|3|||
33348203|NCT02487108|101163931|FG001|Overall Study|Non-compliance to study medication|2|||
33348204|NCT02487108|101163932|FG002|Overall Study|Non-compliance to study medication|5|||
33348205|NCT02487108|101163933|FG003|Overall Study|Non-compliance to study medication|4|||
33348206|NCT02487108|101163930|FG000|Overall Study|Protocol Violation|1|||
33348207|NCT02487108|101163931|FG001|Overall Study|Protocol Violation|1|||
33348208|NCT02487108|101163932|FG002|Overall Study|Protocol Violation|2|||
33348209|NCT02487108|101163933|FG003|Overall Study|Protocol Violation|0|||
33348210|NCT02487108|101163930|FG000|Overall Study|Non-compliance to study procedures|0|||
33348211|NCT02487108|101163931|FG001|Overall Study|Non-compliance to study procedures|0|||
33348212|NCT02487108|101163932|FG002|Overall Study|Non-compliance to study procedures|0|||
33348213|NCT02487108|101163933|FG003|Overall Study|Non-compliance to study procedures|1|||
33348214|NCT02487108|101163930|FG000|Overall Study|Other than specified|3|||
33348215|NCT02487108|101163931|FG001|Overall Study|Other than specified|2|||
33348216|NCT02487108|101163932|FG002|Overall Study|Other than specified|2|||
33348217|NCT02487108|101163933|FG003|Overall Study|Other than specified|0|||
33348218|NCT01869348|101163934|FG000|Overall Study|Withdrawal by Subject|1|||
33348219|NCT01869348|101163935|FG001|Overall Study|Withdrawal by Subject|1|||
33348220|NCT03882424|101163938|FG000|Overall Study|Lost to Follow-up|3|||
33617050|NCT02814175|102147289|FG001|Part 1|Withdrawal Consent|1|||
33617051|NCT02814175|102147290|FG002|Part 1|Withdrawal Consent|0|||
33617052|NCT02814175|102147291|FG003|Part 1|Withdrawal Consent|0|||
33617053|NCT02814175|102147292|FG004|Part 1|Withdrawal Consent|0|||
33617054|NCT02814175|102147293|FG005|Part 1|Withdrawal Consent|0|||
33617055|NCT02814175|102147288|FG000|Part 1|Lost to Follow-up|1|||
33617056|NCT02814175|102147289|FG001|Part 1|Lost to Follow-up|0|||
33617057|NCT02814175|102147290|FG002|Part 1|Lost to Follow-up|0|||
33617058|NCT02814175|102147291|FG003|Part 1|Lost to Follow-up|0|||
33617059|NCT02814175|102147292|FG004|Part 1|Lost to Follow-up|0|||
33348221|NCT03882424|101163939|FG001|Overall Study|Lost to Follow-up|0|||
33348222|NCT03882424|101163940|FG002|Overall Study|Lost to Follow-up|0|||
33348223|NCT03882424|101163938|FG000|Overall Study|schedule conflict|1|||
33348224|NCT03882424|101163939|FG001|Overall Study|schedule conflict|0|||
33214256|NCT00449176|100682352|FG001|Overall Study|Adverse Event|107|||
33617060|NCT02814175|102147293|FG005|Part 1|Lost to Follow-up|0|||
33617061|NCT02814175|102147288|FG000|Part 1|Lack of Efficacy|1|||
33617062|NCT02814175|102147289|FG001|Part 1|Lack of Efficacy|2|||
33617063|NCT02814175|102147290|FG002|Part 1|Lack of Efficacy|0|||
33617064|NCT02814175|102147291|FG003|Part 1|Lack of Efficacy|0|||
33617065|NCT02814175|102147292|FG004|Part 1|Lack of Efficacy|0|||
33617066|NCT02814175|102147293|FG005|Part 1|Lack of Efficacy|0|||
33617067|NCT02814175|102147288|FG000|Part 2|Adverse Event|0|||
33617068|NCT02814175|102147289|FG001|Part 2|Adverse Event|0|||
33617069|NCT02814175|102147290|FG002|Part 2|Adverse Event|0|||
33617070|NCT02814175|102147291|FG003|Part 2|Adverse Event|1|||
33617071|NCT02814175|102147292|FG004|Part 2|Adverse Event|1|||
33617072|NCT02814175|102147293|FG005|Part 2|Adverse Event|2|||
33617073|NCT02814175|102147288|FG000|Part 2|Withdrawal Consent|0|||
33617074|NCT02814175|102147289|FG001|Part 2|Withdrawal Consent|0|||
33617075|NCT02814175|102147290|FG002|Part 2|Withdrawal Consent|0|||
33617076|NCT02814175|102147291|FG003|Part 2|Withdrawal Consent|2|||
33617077|NCT02814175|102147292|FG004|Part 2|Withdrawal Consent|1|||
33617078|NCT02814175|102147293|FG005|Part 2|Withdrawal Consent|1|||
33617079|NCT02814175|102147288|FG000|Part 2|Lost to Follow-up|0|||
33617080|NCT02814175|102147289|FG001|Part 2|Lost to Follow-up|0|||
33214257|NCT00449176|100682353|FG002|Overall Study|Adverse Event|15|||
33214258|NCT00449176|100682351|FG000|Overall Study|Lack of Efficacy|13|||
33214259|NCT00449176|100682352|FG001|Overall Study|Lack of Efficacy|7|||
33214260|NCT00449176|100682353|FG002|Overall Study|Lack of Efficacy|50|||
33214261|NCT00449176|100682351|FG000|Overall Study|Study drug non-compliant|14|||
33214262|NCT00449176|100682352|FG001|Overall Study|Study drug non-compliant|11|||
33546807|NCT02949934|101901564|FG004|Bar Laboratory|Adverse Event|1|||
33546808|NCT02949934|101901565|FG005|Bar Laboratory|Adverse Event|0|||
33348225|NCT03882424|101163940|FG002|Overall Study|schedule conflict|0|||
33348226|NCT02970929|101163947|FG000|Overall Study|Adverse Event|18|||
33546809|NCT02949934|101901560|FG000|Bar Laboratory|Protocol Violation|0|||
33546810|NCT02949934|101901561|FG001|Bar Laboratory|Protocol Violation|0|||
33546811|NCT02949934|101901562|FG002|Bar Laboratory|Protocol Violation|0|||
33348227|NCT02970929|101163947|FG000|Overall Study|Lack of Efficacy|8|||
33348228|NCT02970929|101163947|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
33348229|NCT02970929|101163947|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
33348230|NCT02970929|101163947|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
33348231|NCT02970929|101163947|FG000|Overall Study|LOST TO FOLLOWUP|6|||
33348232|NCT02970929|101163947|FG000|Overall Study|MOVED OUT OF STATE|1|||
33348233|NCT02970929|101163947|FG000|Overall Study|Withdrawal by Subject|16|||
33348234|NCT00403260|101163948|FG000|Overall Study|Adverse Event|5|||
33348235|NCT00403260|101163949|FG001|Overall Study|Adverse Event|4|||
33546812|NCT02949934|101901563|FG003|Bar Laboratory|Protocol Violation|1|||
33546813|NCT02949934|101901564|FG004|Bar Laboratory|Protocol Violation|0|||
33546814|NCT02949934|101901565|FG005|Bar Laboratory|Protocol Violation|0|||
33546815|NCT03880565|101901566|FG000|Overall Study|Withdrawal by Subject|1|||
33546816|NCT03880565|101901567|FG001|Overall Study|Withdrawal by Subject|0|||
33546817|NCT01137786|101901570|FG000|Overall Study|Lost to Follow-up|0|||
33546818|NCT01137786|101901571|FG001|Overall Study|Lost to Follow-up|2|||
33546819|NCT01137786|101901570|FG000|Overall Study|Withdrawal by Subject|1|||
33546820|NCT01137786|101901571|FG001|Overall Study|Withdrawal by Subject|1|||
33546821|NCT01056536|101901573|FG000|Overall Study|Lost to Follow-up|202|||
33546822|NCT01056536|101901574|FG001|Overall Study|Lost to Follow-up|116|||
33546823|NCT01056536|101901575|FG002|Overall Study|Lost to Follow-up|248|||
33546824|NCT00303953|101901579|FG000|Overall Study|Ineligible|1|||
33546825|NCT00303953|101901579|FG000|Overall Study|Death|1|||
33546826|NCT00303953|101901579|FG000|Overall Study|Adverse Event|4|||
33546827|NCT00303953|101901579|FG000|Overall Study|Lack of Efficacy|12|||
33546828|NCT00303953|101901579|FG000|Overall Study|Physician Decision|1|||
33546829|NCT01980888|101901580|FG000|Overall Study|Study Terminated by Sponsor|116|||
33617081|NCT02814175|102147290|FG002|Part 2|Lost to Follow-up|0|||
33617082|NCT02814175|102147291|FG003|Part 2|Lost to Follow-up|1|||
33617083|NCT02814175|102147292|FG004|Part 2|Lost to Follow-up|0|||
33617084|NCT02814175|102147293|FG005|Part 2|Lost to Follow-up|0|||
33617085|NCT02814175|102147288|FG000|Part 2|Lack of Efficacy|0|||
33214263|NCT00449176|100682353|FG002|Overall Study|Study drug non-compliant|11|||
33214264|NCT00449176|100682351|FG000|Overall Study|all other|22|||
33214265|NCT00449176|100682352|FG001|Overall Study|all other|19|||
33546830|NCT01980888|101901581|FG001|Overall Study|Study Terminated by Sponsor|122|||
33546831|NCT01980888|101901580|FG000|Overall Study|Withdrew Consent|17|||
33214266|NCT00449176|100682353|FG002|Overall Study|all other|20|||
33348236|NCT00403260|101163948|FG000|Overall Study|Withdrawal by Subject|5|||
33546832|NCT01980888|101901581|FG001|Overall Study|Withdrew Consent|6|||
33546833|NCT01980888|101901580|FG000|Overall Study|Investigator's Discretion|8|||
33546834|NCT01980888|101901581|FG001|Overall Study|Investigator's Discretion|3|||
33617086|NCT02814175|102147289|FG001|Part 2|Lack of Efficacy|0|||
33617087|NCT02814175|102147290|FG002|Part 2|Lack of Efficacy|0|||
33214267|NCT02612311|100682354|FG000|Overall Study|Adverse Event|16|||
33617088|NCT02814175|102147291|FG003|Part 2|Lack of Efficacy|0|||
33617089|NCT02814175|102147292|FG004|Part 2|Lack of Efficacy|0|||
33214268|NCT02612311|100682355|FG001|Overall Study|Adverse Event|12|||
33214269|NCT02612311|100682356|FG002|Overall Study|Adverse Event|7|||
33214270|NCT02612311|100682357|FG003|Overall Study|Adverse Event|13|||
33214271|NCT02612311|100682354|FG000|Overall Study|Death|29|||
33214272|NCT02612311|100682355|FG001|Overall Study|Death|10|||
33214273|NCT02612311|100682356|FG002|Overall Study|Death|11|||
33214274|NCT02612311|100682357|FG003|Overall Study|Death|11|||
33214275|NCT02612311|100682354|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
33214276|NCT02612311|100682355|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
33214277|NCT02612311|100682356|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
33214278|NCT02612311|100682357|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
33214279|NCT02612311|100682354|FG000|Overall Study|Investigator's Decision|11|||
33214280|NCT02612311|100682355|FG001|Overall Study|Investigator's Decision|15|||
33214281|NCT02612311|100682356|FG002|Overall Study|Investigator's Decision|6|||
33214282|NCT02612311|100682357|FG003|Overall Study|Investigator's Decision|6|||
33214283|NCT02612311|100682354|FG000|Overall Study|Lack of Efficacy|0|||
33214284|NCT02612311|100682355|FG001|Overall Study|Lack of Efficacy|0|||
33214285|NCT02612311|100682356|FG002|Overall Study|Lack of Efficacy|1|||
33214286|NCT02612311|100682357|FG003|Overall Study|Lack of Efficacy|1|||
33214287|NCT02612311|100682354|FG000|Overall Study|Lost to Follow-up|2|||
33214288|NCT02612311|100682355|FG001|Overall Study|Lost to Follow-up|2|||
33214289|NCT02612311|100682356|FG002|Overall Study|Lost to Follow-up|1|||
33214290|NCT02612311|100682357|FG003|Overall Study|Lost to Follow-up|2|||
33214291|NCT02612311|100682354|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
33214292|NCT02612311|100682355|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
33214293|NCT02612311|100682356|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
33214294|NCT02612311|100682357|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
33214295|NCT02612311|100682354|FG000|Overall Study|Site Terminated by Sponsor|29|||
33214296|NCT02612311|100682355|FG001|Overall Study|Site Terminated by Sponsor|12|||
33214297|NCT02612311|100682356|FG002|Overall Study|Site Terminated by Sponsor|13|||
33214298|NCT02612311|100682357|FG003|Overall Study|Site Terminated by Sponsor|5|||
33214299|NCT02612311|100682354|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
33214300|NCT02612311|100682355|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
33214301|NCT02612311|100682356|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
33214302|NCT02612311|100682357|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
33214303|NCT02612311|100682354|FG000|Overall Study|Reason Not Specified|3|||
33214304|NCT02612311|100682355|FG001|Overall Study|Reason Not Specified|7|||
33214305|NCT02612311|100682356|FG002|Overall Study|Reason Not Specified|4|||
33214306|NCT02612311|100682357|FG003|Overall Study|Reason Not Specified|5|||
33214307|NCT02612311|100682354|FG000|Overall Study|Unknown/Missing|10|||
33214308|NCT02612311|100682355|FG001|Overall Study|Unknown/Missing|13|||
33214309|NCT02612311|100682356|FG002|Overall Study|Unknown/Missing|4|||
33214310|NCT02612311|100682357|FG003|Overall Study|Unknown/Missing|0|||
33214311|NCT02612311|100682354|FG000|Overall Study|Non-Compliance with Study|1|||
33214312|NCT02612311|100682355|FG001|Overall Study|Non-Compliance with Study|0|||
33214313|NCT02612311|100682356|FG002|Overall Study|Non-Compliance with Study|0|||
33214314|NCT02612311|100682357|FG003|Overall Study|Non-Compliance with Study|0|||
33214315|NCT03155997|100682358|FG000|Overall Study|Withdrawal by Subject|119|||
33214316|NCT03155997|100682359|FG001|Overall Study|Withdrawal by Subject|134|||
33214317|NCT03155997|100682358|FG000|Overall Study|Lost to Follow-up|12|||
33214318|NCT03155997|100682359|FG001|Overall Study|Lost to Follow-up|13|||
33214319|NCT03155997|100682358|FG000|Overall Study|Missing disposition data|0|||
33214320|NCT03155997|100682359|FG001|Overall Study|Missing disposition data|1|||
33214321|NCT03155997|100682358|FG000|Overall Study|On study treatment|2027|||
33214322|NCT03155997|100682359|FG001|Overall Study|On study treatment|2074|||
33214323|NCT03581981|100682361|FG000|Overall Study|Withdrawal by Subject|12|||
33214324|NCT03581981|100682362|FG001|Overall Study|Withdrawal by Subject|13|||
33214325|NCT03581981|100682361|FG000|Overall Study|Physician Decision|1|||
33214326|NCT03581981|100682362|FG001|Overall Study|Physician Decision|2|||
33214327|NCT03581981|100682361|FG000|Overall Study|Lost to Follow-up|0|||
33214328|NCT03581981|100682362|FG001|Overall Study|Lost to Follow-up|4|||
33214329|NCT00313820|100682363|FG000|Assigned to Treatment|Other|1|||
33214330|NCT00313820|100682364|FG001|Assigned to Treatment|Other|0|||
33214331|NCT00313820|100682363|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
33214332|NCT00313820|100682364|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
33214333|NCT00313820|100682363|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
33214334|NCT00313820|100682364|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
33214335|NCT00313820|100682363|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
33214336|NCT00313820|100682364|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
33214337|NCT00313820|100682363|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
33214338|NCT00313820|100682364|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
33214339|NCT00313820|100682363|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
33214340|NCT00313820|100682364|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
33409400|NCT00594958|101389263|FG000|Overall Study|Protocol Violation|1|||
33409401|NCT00594958|101389264|FG001|Overall Study|Protocol Violation|0|||
33409402|NCT00594958|101389265|FG002|Overall Study|Protocol Violation|2|||
33409403|NCT00594958|101389263|FG000|Overall Study|Lost to Follow-up|5|||
33409404|NCT00594958|101389264|FG001|Overall Study|Lost to Follow-up|0|||
33409405|NCT00594958|101389265|FG002|Overall Study|Lost to Follow-up|3|||
33348237|NCT00403260|101163949|FG001|Overall Study|Withdrawal by Subject|6|||
33409406|NCT00594958|101389263|FG000|Overall Study|administrative|3|||
33546835|NCT01980888|101901580|FG000|Overall Study|Non-Compliance with Study Drug|3|||
33546836|NCT01980888|101901581|FG001|Overall Study|Non-Compliance with Study Drug|2|||
33546837|NCT00915525|101901584|FG000|Overall Study|Protocol Violation|9|||
33546838|NCT00915525|101901585|FG001|Overall Study|Protocol Violation|4|||
33546839|NCT00915525|101901584|FG000|Overall Study|Withdrawal by Subject|59|||
33348238|NCT00403260|101163948|FG000|Overall Study|Lost to Follow-up|49|||
33348239|NCT00403260|101163949|FG001|Overall Study|Lost to Follow-up|25|||
33348240|NCT00403260|101163948|FG000|Overall Study|Re-appearance of P. falciparum|34|||
33348241|NCT00403260|101163949|FG001|Overall Study|Re-appearance of P. falciparum|25|||
33348242|NCT00403260|101163948|FG000|Overall Study|P. vivax infection|26|||
33348243|NCT00403260|101163949|FG001|Overall Study|P. vivax infection|4|||
33348244|NCT00403260|101163948|FG000|Overall Study|Mixed infection with P. vivax|2|||
33348245|NCT00403260|101163949|FG001|Overall Study|Mixed infection with P. vivax|0|||
33348246|NCT00403260|101163948|FG000|Overall Study|Mixed infection with P. falciparum|1|||
33348247|NCT00403260|101163949|FG001|Overall Study|Mixed infection with P. falciparum|0|||
33348248|NCT00403260|101163948|FG000|Overall Study|P. vivax infection at screening|1|||
33348249|NCT00403260|101163949|FG001|Overall Study|P. vivax infection at screening|0|||
33348250|NCT00403260|101163948|FG000|Overall Study|P. ovale infection|1|||
33348251|NCT00403260|101163949|FG001|Overall Study|P. ovale infection|0|||
33348252|NCT00403260|101163948|FG000|Overall Study|Gametocyte re-appearance|1|||
33348253|NCT00403260|101163949|FG001|Overall Study|Gametocyte re-appearance|1|||
33409407|NCT00594958|101389264|FG001|Overall Study|administrative|0|||
33409408|NCT00594958|101389265|FG002|Overall Study|administrative|2|||
33409409|NCT00914940|101389266|FG000|D0 to D100 Post-transplant|Death|2|||
33409410|NCT00914940|101389266|FG000|D101 to 2 Years Post-transplant|Death|8|||
33409411|NCT00914940|101389266|FG000|2 Years to 5 Years Post-transplant|Death|3|||
33546840|NCT00915525|101901585|FG001|Overall Study|Withdrawal by Subject|21|||
33546841|NCT00915525|101901584|FG000|Overall Study|Lost to Follow-up|27|||
33546842|NCT00915525|101901585|FG001|Overall Study|Lost to Follow-up|16|||
33617090|NCT02814175|102147293|FG005|Part 2|Lack of Efficacy|3|||
33348254|NCT00403260|101163948|FG000|Overall Study|Withdrawn from study accidentally|0|||
33348255|NCT00403260|101163949|FG001|Overall Study|Withdrawn from study accidentally|1|||
33348256|NCT02932267|101163952|FG000|Overall Study|Withdrawal by Subject|3|||
33348257|NCT02932267|101163952|FG000|Overall Study|Lost to Follow-up|4|||
33409412|NCT00752895|101389267|FG000|Overall Study|Withdrawal by Subject|8|||
33409413|NCT00752895|101389268|FG001|Overall Study|Withdrawal by Subject|3|||
33546843|NCT00915525|101901584|FG000|Overall Study|Pregnancy|2|||
33546844|NCT00915525|101901585|FG001|Overall Study|Pregnancy|0|||
33617091|NCT01010971|102147294|FG000|Overall Study|Adverse Event|2|||
33348258|NCT02932267|101163952|FG000|Overall Study|Pregnancy|1|||
33348259|NCT01552681|101163955|FG000|Overall Study|Withdrawal by Subject|4|||
33348260|NCT01552681|101163956|FG001|Overall Study|Withdrawal by Subject|0|||
33348261|NCT01552681|101163955|FG000|Overall Study|Physician Decision|1|||
33409414|NCT01409382|101389270|FG000|Overall Study|Lost to Follow-up|1|||
33546845|NCT00915525|101901584|FG000|Overall Study|Lack of Efficacy|15|||
33546846|NCT00915525|101901585|FG001|Overall Study|Lack of Efficacy|32|||
33546847|NCT00915525|101901584|FG000|Overall Study|Adverse Event|29|||
33546848|NCT00915525|101901585|FG001|Overall Study|Adverse Event|13|||
33546849|NCT00915525|101901584|FG000|Overall Study|Missing|12|||
33546850|NCT00915525|101901585|FG001|Overall Study|Missing|1|||
33546851|NCT00915525|101901584|FG000|Overall Study|Other Reason|35|||
33546852|NCT00915525|101901585|FG001|Overall Study|Other Reason|12|||
33546853|NCT00915525|101901584|FG000|Overall Study|Site Closed|27|||
33546854|NCT00915525|101901585|FG001|Overall Study|Site Closed|9|||
33546855|NCT00915525|101901584|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
33214341|NCT02807558|100682365|FG000|Overall Study|Consent withdrawn by participant|4|||
33546856|NCT00915525|101901585|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
33546857|NCT00915525|101901584|FG000|Overall Study|Study Burden|28|||
33546858|NCT00915525|101901585|FG001|Overall Study|Study Burden|12|||
33546859|NCT00915525|101901584|FG000|Overall Study|Non-Compliance|3|||
33348262|NCT01552681|101163956|FG001|Overall Study|Physician Decision|0|||
33348263|NCT01552681|101163955|FG000|Overall Study|Subject moved away|0|||
33348264|NCT01552681|101163956|FG001|Overall Study|Subject moved away|1|||
33348265|NCT04426695|101163957|FG000|Overall Study|Death|2|||
33348266|NCT04426695|101163958|FG001|Overall Study|Death|0|||
33348267|NCT04426695|101163959|FG002|Overall Study|Death|1|||
33348268|NCT04426695|101163960|FG003|Overall Study|Death|27|||
33348269|NCT04426695|101163961|FG004|Overall Study|Death|25|||
33348270|NCT04426695|101163962|FG005|Overall Study|Death|21|||
33348271|NCT04426695|101163963|FG006|Overall Study|Death|42|||
33348272|NCT04426695|101163964|FG007|Overall Study|Death|23|||
33348273|NCT04426695|101163965|FG008|Overall Study|Death|37|||
33348274|NCT04426695|101163966|FG009|Overall Study|Death|14|||
33348275|NCT04426695|101163967|FG010|Overall Study|Death|8|||
33348276|NCT04426695|101163968|FG011|Overall Study|Death|7|||
33409415|NCT01409382|101389271|FG001|Overall Study|Lost to Follow-up|1|||
33409416|NCT01409382|101389270|FG000|Overall Study|Protocol Violation|0|||
33409417|NCT01409382|101389271|FG001|Overall Study|Protocol Violation|3|||
33409418|NCT01409382|101389270|FG000|Overall Study|Multiple pregnancy|2|||
33409419|NCT01409382|101389271|FG001|Overall Study|Multiple pregnancy|4|||
33409420|NCT01409382|101389270|FG000|Overall Study|Still pregnant when study ended|13|||
33409421|NCT01409382|101389271|FG001|Overall Study|Still pregnant when study ended|2|||
33409422|NCT01409382|101389270|FG000|Overall Study|Did not manage to get pregnant|64|||
33409423|NCT01409382|101389271|FG001|Overall Study|Did not manage to get pregnant|70|||
33409424|NCT01409382|101389270|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
33409425|NCT01409382|101389271|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
33409426|NCT00953576|101389272|FG000|Overall Study|Adverse Event|0|||
33409427|NCT00953576|101389273|FG001|Overall Study|Adverse Event|1|||
33409428|NCT00953576|101389272|FG000|Overall Study|Ineligible after Consent|2|||
33409429|NCT00953576|101389273|FG001|Overall Study|Ineligible after Consent|0|||
33348277|NCT04426695|101163969|FG012|Overall Study|Death|13|||
33348278|NCT04426695|101163970|FG013|Overall Study|Death|25|||
33348279|NCT04426695|101163971|FG014|Overall Study|Death|19|||
33348280|NCT04426695|101163972|FG015|Overall Study|Death|7|||
33348281|NCT04426695|101163973|FG016|Overall Study|Death|8|||
33409430|NCT01459016|101389274|FG000|Overall Study|Withdrawal by Subject|11|||
33409431|NCT01459016|101389274|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
33409432|NCT04145531|101389275|FG000|Part A|Adverse Event|2|||
33409433|NCT04145531|101389276|FG001|Part A|Adverse Event|12|||
33409434|NCT04145531|101389277|FG002|Part A|Adverse Event|6|||
33409435|NCT04145531|101389278|FG003|Part A|Adverse Event|0|||
33409436|NCT04145531|101389275|FG000|Part A|Death|1|||
33409437|NCT04145531|101389276|FG001|Part A|Death|2|||
33409438|NCT04145531|101389277|FG002|Part A|Death|0|||
33409439|NCT04145531|101389278|FG003|Part A|Death|0|||
33409440|NCT04145531|101389275|FG000|Part A|Physician Decision|2|||
33409441|NCT04145531|101389276|FG001|Part A|Physician Decision|5|||
33617092|NCT01010971|102147295|FG001|Overall Study|Adverse Event|4|||
33617093|NCT01010971|102147296|FG002|Overall Study|Adverse Event|3|||
33617094|NCT01010971|102147294|FG000|Overall Study|Withdrawal by Subject|0|||
33617095|NCT01010971|102147295|FG001|Overall Study|Withdrawal by Subject|2|||
33617096|NCT01010971|102147296|FG002|Overall Study|Withdrawal by Subject|5|||
33617097|NCT01010971|102147294|FG000|Overall Study|Lost to Follow-up|0|||
33617098|NCT01010971|102147295|FG001|Overall Study|Lost to Follow-up|2|||
33617099|NCT01010971|102147296|FG002|Overall Study|Lost to Follow-up|3|||
33617100|NCT01010971|102147294|FG000|Overall Study|Other|1|||
33617101|NCT01010971|102147295|FG001|Overall Study|Other|0|||
33617102|NCT01010971|102147296|FG002|Overall Study|Other|2|||
33617103|NCT04158583|102147297|FG000|Overall Study|Withdrawal by Subject|1|||
33617104|NCT04158583|102147298|FG001|Overall Study|Withdrawal by Subject|1|||
33617105|NCT04158583|102147299|FG002|Overall Study|Withdrawal by Subject|0|||
33617106|NCT04158583|102147300|FG003|Overall Study|Withdrawal by Subject|0|||
33617107|NCT04158583|102147301|FG004|Overall Study|Withdrawal by Subject|1|||
33617108|NCT04158583|102147302|FG005|Overall Study|Withdrawal by Subject|0|||
33617109|NCT04158583|102147303|FG006|Overall Study|Withdrawal by Subject|0|||
33617110|NCT04158583|102147304|FG007|Overall Study|Withdrawal by Subject|0|||
33617111|NCT04158583|102147305|FG008|Overall Study|Withdrawal by Subject|2|||
33617112|NCT04158583|102147306|FG009|Overall Study|Withdrawal by Subject|0|||
33617113|NCT04158583|102147297|FG000|Overall Study|Study Terminated by Sponsor|0|||
33617114|NCT04158583|102147298|FG001|Overall Study|Study Terminated by Sponsor|0|||
33617115|NCT04158583|102147299|FG002|Overall Study|Study Terminated by Sponsor|0|||
33617116|NCT04158583|102147300|FG003|Overall Study|Study Terminated by Sponsor|1|||
33617117|NCT04158583|102147301|FG004|Overall Study|Study Terminated by Sponsor|0|||
33617118|NCT04158583|102147302|FG005|Overall Study|Study Terminated by Sponsor|0|||
33348282|NCT04426695|101163974|FG017|Overall Study|Death|4|||
33348283|NCT04426695|101163957|FG000|Overall Study|Lost to Follow-up|2|||
33348284|NCT04426695|101163958|FG001|Overall Study|Lost to Follow-up|4|||
33348285|NCT04426695|101163959|FG002|Overall Study|Lost to Follow-up|1|||
33348286|NCT04426695|101163960|FG003|Overall Study|Lost to Follow-up|19|||
33348287|NCT04426695|101163961|FG004|Overall Study|Lost to Follow-up|10|||
33348288|NCT04426695|101163962|FG005|Overall Study|Lost to Follow-up|14|||
33348289|NCT04426695|101163963|FG006|Overall Study|Lost to Follow-up|5|||
33348290|NCT04426695|101163964|FG007|Overall Study|Lost to Follow-up|14|||
33348291|NCT04426695|101163965|FG008|Overall Study|Lost to Follow-up|10|||
33348292|NCT04426695|101163966|FG009|Overall Study|Lost to Follow-up|11|||
33348293|NCT04426695|101163967|FG010|Overall Study|Lost to Follow-up|12|||
33348294|NCT04426695|101163968|FG011|Overall Study|Lost to Follow-up|6|||
33348295|NCT04426695|101163969|FG012|Overall Study|Lost to Follow-up|2|||
33348296|NCT04426695|101163970|FG013|Overall Study|Lost to Follow-up|2|||
33348297|NCT04426695|101163971|FG014|Overall Study|Lost to Follow-up|2|||
33348298|NCT04426695|101163972|FG015|Overall Study|Lost to Follow-up|0|||
33348299|NCT04426695|101163973|FG016|Overall Study|Lost to Follow-up|0|||
33348300|NCT04426695|101163974|FG017|Overall Study|Lost to Follow-up|0|||
33348301|NCT04426695|101163957|FG000|Overall Study|Participant Decision|1|||
33348302|NCT04426695|101163958|FG001|Overall Study|Participant Decision|2|||
33348303|NCT04426695|101163959|FG002|Overall Study|Participant Decision|2|||
33348304|NCT04426695|101163960|FG003|Overall Study|Participant Decision|12|||
33348305|NCT04426695|101163961|FG004|Overall Study|Participant Decision|18|||
33348306|NCT04426695|101163962|FG005|Overall Study|Participant Decision|22|||
33348307|NCT04426695|101163963|FG006|Overall Study|Participant Decision|13|||
33348308|NCT04426695|101163964|FG007|Overall Study|Participant Decision|13|||
33348309|NCT04426695|101163965|FG008|Overall Study|Participant Decision|10|||
33348310|NCT04426695|101163966|FG009|Overall Study|Participant Decision|15|||
33348311|NCT04426695|101163967|FG010|Overall Study|Participant Decision|16|||
33409442|NCT04145531|101389277|FG002|Part A|Physician Decision|2|||
33409443|NCT04145531|101389278|FG003|Part A|Physician Decision|0|||
33409444|NCT04145531|101389275|FG000|Part A|Progressive disease|0|||
33409445|NCT04145531|101389276|FG001|Part A|Progressive disease|2|||
33409446|NCT04145531|101389277|FG002|Part A|Progressive disease|1|||
33409447|NCT04145531|101389278|FG003|Part A|Progressive disease|0|||
33409448|NCT04145531|101389275|FG000|Part A|Protocol deviation|0|||
33617119|NCT04158583|102147303|FG006|Overall Study|Study Terminated by Sponsor|0|||
33617120|NCT04158583|102147304|FG007|Overall Study|Study Terminated by Sponsor|0|||
33409449|NCT04145531|101389276|FG001|Part A|Protocol deviation|0|||
33409450|NCT04145531|101389277|FG002|Part A|Protocol deviation|1|||
33409451|NCT04145531|101389278|FG003|Part A|Protocol deviation|0|||
33617121|NCT04158583|102147305|FG008|Overall Study|Study Terminated by Sponsor|0|||
33546860|NCT00915525|101901585|FG001|Overall Study|Non-Compliance|1|||
33546861|NCT00915525|101901584|FG000|Overall Study|Patient Moved|15|||
33546862|NCT00915525|101901585|FG001|Overall Study|Patient Moved|9|||
33546863|NCT00975923|101901587|FG000|Overall Study|Withdrawal by Subject|0|||
33546864|NCT00975923|101901588|FG001|Overall Study|Withdrawal by Subject|1|||
33546865|NCT01044498|101901591|FG000|Overall Study|Withdrew consent|1|||
33546866|NCT01044498|101901592|FG001|Overall Study|Withdrew consent|1|||
33546867|NCT01044498|101901591|FG000|Overall Study|Adverse Event|1|||
33546868|NCT01044498|101901592|FG001|Overall Study|Adverse Event|1|||
33546869|NCT01044498|101901591|FG000|Overall Study|Other|1|||
33546870|NCT01044498|101901592|FG001|Overall Study|Other|0|||
33546871|NCT02471183|101901595|FG000|Main Treatment Period|Adverse Event|1|||
33546872|NCT02471183|101901595|FG000|Main Treatment Period|Withdrawal by Subject|1|||
33546873|NCT02471183|101901595|FG000|Extended Treatment Period|Lack of Efficacy|1|||
33546874|NCT01500083|101901596|FG000|Overall Study|Adverse Event|4|||
33546875|NCT01500083|101901597|FG001|Overall Study|Adverse Event|17|||
33546876|NCT01500083|101901596|FG000|Overall Study|Death|0|||
33546877|NCT01500083|101901597|FG001|Overall Study|Death|2|||
33546878|NCT01500083|101901596|FG000|Overall Study|Lost to Follow-up|1|||
33546879|NCT01500083|101901597|FG001|Overall Study|Lost to Follow-up|0|||
33546880|NCT01500083|101901596|FG000|Overall Study|Withdrawal of Consent|0|||
33546881|NCT01500083|101901597|FG001|Overall Study|Withdrawal of Consent|1|||
33546882|NCT01500083|101901596|FG000|Overall Study|Disease Progression|2|||
33546883|NCT01500083|101901597|FG001|Overall Study|Disease Progression|10|||
33546884|NCT01500083|101901596|FG000|Overall Study|Investigator Discretion|3|||
33546885|NCT01500083|101901597|FG001|Overall Study|Investigator Discretion|8|||
33546886|NCT01500083|101901596|FG000|Overall Study|Other Reasons|2|||
33546887|NCT01500083|101901597|FG001|Overall Study|Other Reasons|5|||
33546888|NCT02115386|101901598|FG000|Overall Study|Protocol Violation|1|||
33348312|NCT04426695|101163968|FG011|Overall Study|Participant Decision|17|||
33348313|NCT04426695|101163969|FG012|Overall Study|Participant Decision|2|||
33348314|NCT04426695|101163970|FG013|Overall Study|Participant Decision|1|||
33348315|NCT04426695|101163971|FG014|Overall Study|Participant Decision|2|||
33348316|NCT04426695|101163972|FG015|Overall Study|Participant Decision|0|||
33348317|NCT04426695|101163973|FG016|Overall Study|Participant Decision|0|||
33348318|NCT04426695|101163974|FG017|Overall Study|Participant Decision|0|||
33348319|NCT04426695|101163957|FG000|Overall Study|Adverse Event|0|||
33348320|NCT04426695|101163958|FG001|Overall Study|Adverse Event|0|||
33348321|NCT04426695|101163959|FG002|Overall Study|Adverse Event|0|||
33348322|NCT04426695|101163960|FG003|Overall Study|Adverse Event|0|||
33348323|NCT04426695|101163961|FG004|Overall Study|Adverse Event|0|||
33348324|NCT04426695|101163962|FG005|Overall Study|Adverse Event|0|||
33348325|NCT04426695|101163963|FG006|Overall Study|Adverse Event|0|||
33348326|NCT04426695|101163964|FG007|Overall Study|Adverse Event|1|||
33348327|NCT04426695|101163965|FG008|Overall Study|Adverse Event|0|||
33348328|NCT04426695|101163966|FG009|Overall Study|Adverse Event|0|||
33348329|NCT04426695|101163967|FG010|Overall Study|Adverse Event|1|||
33348330|NCT04426695|101163968|FG011|Overall Study|Adverse Event|1|||
33348331|NCT04426695|101163969|FG012|Overall Study|Adverse Event|0|||
33348332|NCT04426695|101163970|FG013|Overall Study|Adverse Event|0|||
33348333|NCT04426695|101163971|FG014|Overall Study|Adverse Event|0|||
33348334|NCT04426695|101163972|FG015|Overall Study|Adverse Event|0|||
33348335|NCT04426695|101163973|FG016|Overall Study|Adverse Event|0|||
33348336|NCT04426695|101163974|FG017|Overall Study|Adverse Event|0|||
33546889|NCT02115386|101901598|FG000|Overall Study|Administrative - trial was terminated|6|||
33546890|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
33546891|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
33546892|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
33546893|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
33348337|NCT04426695|101163957|FG000|Overall Study|Sponsor Request|0|||
33348338|NCT04426695|101163958|FG001|Overall Study|Sponsor Request|0|||
33348339|NCT04426695|101163959|FG002|Overall Study|Sponsor Request|0|||
33546894|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
33546895|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
33546896|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
33546897|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
33546898|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
33348340|NCT04426695|101163960|FG003|Overall Study|Sponsor Request|0|||
33348341|NCT04426695|101163961|FG004|Overall Study|Sponsor Request|0|||
33348342|NCT04426695|101163962|FG005|Overall Study|Sponsor Request|0|||
33546899|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
33546900|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
33546901|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
33546902|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
33546903|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
33546904|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
33546905|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
33546906|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
33546907|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
33546908|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
33546909|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
33546910|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
33546911|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
33546912|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
33348343|NCT04426695|101163963|FG006|Overall Study|Sponsor Request|1|||
33348344|NCT04426695|101163964|FG007|Overall Study|Sponsor Request|0|||
33348345|NCT04426695|101163965|FG008|Overall Study|Sponsor Request|0|||
33348346|NCT04426695|101163966|FG009|Overall Study|Sponsor Request|0|||
33348347|NCT04426695|101163967|FG010|Overall Study|Sponsor Request|0|||
33348348|NCT04426695|101163968|FG011|Overall Study|Sponsor Request|0|||
33348349|NCT04426695|101163969|FG012|Overall Study|Sponsor Request|0|||
33348350|NCT04426695|101163970|FG013|Overall Study|Sponsor Request|0|||
33409452|NCT04145531|101389275|FG000|Part A|Withdrawal by parent or guardian|1|||
33546913|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
33546914|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
33546915|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
33546916|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
33546917|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
33348351|NCT04426695|101163971|FG014|Overall Study|Sponsor Request|0|||
33348352|NCT04426695|101163972|FG015|Overall Study|Sponsor Request|0|||
33546918|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
33546919|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
33546920|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
33546921|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
33546922|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
33617122|NCT04158583|102147306|FG009|Overall Study|Study Terminated by Sponsor|0|||
33617123|NCT04158583|102147297|FG000|Overall Study|Progressive Disease|1|||
33617124|NCT04158583|102147298|FG001|Overall Study|Progressive Disease|0|||
33617125|NCT04158583|102147299|FG002|Overall Study|Progressive Disease|3|||
33617126|NCT04158583|102147300|FG003|Overall Study|Progressive Disease|5|||
33617127|NCT04158583|102147301|FG004|Overall Study|Progressive Disease|0|||
33617128|NCT04158583|102147302|FG005|Overall Study|Progressive Disease|1|||
33617129|NCT04158583|102147303|FG006|Overall Study|Progressive Disease|6|||
33617130|NCT04158583|102147304|FG007|Overall Study|Progressive Disease|2|||
33617131|NCT04158583|102147305|FG008|Overall Study|Progressive Disease|1|||
33617132|NCT04158583|102147306|FG009|Overall Study|Progressive Disease|2|||
33617133|NCT04158583|102147297|FG000|Overall Study|Lost to Follow-up|0|||
33617134|NCT04158583|102147298|FG001|Overall Study|Lost to Follow-up|0|||
33617135|NCT04158583|102147299|FG002|Overall Study|Lost to Follow-up|1|||
33617136|NCT04158583|102147300|FG003|Overall Study|Lost to Follow-up|1|||
33617137|NCT04158583|102147301|FG004|Overall Study|Lost to Follow-up|1|||
33617138|NCT04158583|102147302|FG005|Overall Study|Lost to Follow-up|0|||
33617139|NCT04158583|102147303|FG006|Overall Study|Lost to Follow-up|0|||
33617140|NCT04158583|102147304|FG007|Overall Study|Lost to Follow-up|0|||
33617141|NCT04158583|102147305|FG008|Overall Study|Lost to Follow-up|0|||
33617142|NCT04158583|102147306|FG009|Overall Study|Lost to Follow-up|0|||
33617143|NCT04158583|102147297|FG000|Overall Study|Due To Patient Status|0|||
33409453|NCT04145531|101389276|FG001|Part A|Withdrawal by parent or guardian|0|||
33546923|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
33546924|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
33546925|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
33546926|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
33546927|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
33546928|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
33348353|NCT04426695|101163973|FG016|Overall Study|Sponsor Request|0|||
33348354|NCT04426695|101163974|FG017|Overall Study|Sponsor Request|0|||
33348355|NCT04426695|101163957|FG000|Overall Study|Physician Decision|0|||
33348356|NCT04426695|101163958|FG001|Overall Study|Physician Decision|0|||
33546929|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
33546930|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
33546931|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
33546932|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
33546933|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
33546934|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
33546935|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
33617144|NCT04158583|102147298|FG001|Overall Study|Due To Patient Status|0|||
33617145|NCT04158583|102147299|FG002|Overall Study|Due To Patient Status|0|||
33348357|NCT04426695|101163959|FG002|Overall Study|Physician Decision|0|||
33348358|NCT04426695|101163960|FG003|Overall Study|Physician Decision|0|||
33348359|NCT04426695|101163961|FG004|Overall Study|Physician Decision|0|||
33348360|NCT04426695|101163962|FG005|Overall Study|Physician Decision|0|||
33348361|NCT04426695|101163963|FG006|Overall Study|Physician Decision|0|||
33348362|NCT04426695|101163964|FG007|Overall Study|Physician Decision|0|||
33617146|NCT04158583|102147300|FG003|Overall Study|Due To Patient Status|0|||
33617147|NCT04158583|102147301|FG004|Overall Study|Due To Patient Status|0|||
33617148|NCT04158583|102147302|FG005|Overall Study|Due To Patient Status|0|||
33617149|NCT04158583|102147303|FG006|Overall Study|Due To Patient Status|0|||
33617150|NCT04158583|102147304|FG007|Overall Study|Due To Patient Status|0|||
33617151|NCT04158583|102147305|FG008|Overall Study|Due To Patient Status|1|||
33617152|NCT04158583|102147306|FG009|Overall Study|Due To Patient Status|0|||
33617153|NCT04158583|102147297|FG000|Overall Study|Death|3|||
33617154|NCT04158583|102147298|FG001|Overall Study|Death|4|||
33348363|NCT04426695|101163965|FG008|Overall Study|Physician Decision|0|||
33348364|NCT04426695|101163966|FG009|Overall Study|Physician Decision|1|||
33348365|NCT04426695|101163967|FG010|Overall Study|Physician Decision|0|||
33546936|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
33546937|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
33546938|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
33546939|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
33546940|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
33546941|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
33546942|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
33546943|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
33546944|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
33546945|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
33546946|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
33546947|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
33546948|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
33546949|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
33546950|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
33546951|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
33546952|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
33546953|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
33546954|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
33546955|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
33546956|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
33546957|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
33546958|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
33546959|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
33546960|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
33546961|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
33546962|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
33546963|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
33546964|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
33546965|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
33546966|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
33546967|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
33546968|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
33546969|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
33546970|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
33546971|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
33546972|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
33546973|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
33546974|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
33546975|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
33546976|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
33546977|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
33546978|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
33546979|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
33546980|NCT00090103|101901599|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
33546981|NCT00090103|101901600|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
33546982|NCT00090103|101901601|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
33546983|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
33546984|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
33546985|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
33348366|NCT04426695|101163968|FG011|Overall Study|Physician Decision|0|||
33348367|NCT04426695|101163969|FG012|Overall Study|Physician Decision|1|||
33348368|NCT04426695|101163970|FG013|Overall Study|Physician Decision|0|||
33348369|NCT04426695|101163971|FG014|Overall Study|Physician Decision|0|||
33409454|NCT04145531|101389277|FG002|Part A|Withdrawal by parent or guardian|0|||
33409455|NCT04145531|101389278|FG003|Part A|Withdrawal by parent or guardian|0|||
33409456|NCT04145531|101389275|FG000|Part A|Withdrawal by participant|0|||
33546986|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
33546987|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
33546988|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
33546989|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
33546990|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
33348370|NCT04426695|101163972|FG015|Overall Study|Physician Decision|0|||
33348371|NCT04426695|101163973|FG016|Overall Study|Physician Decision|0|||
33546991|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
33546992|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
33546993|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
33546994|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
33546995|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
33546996|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
33546997|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
33546998|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
33546999|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
33547000|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
33547001|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
33547002|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
33547003|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
33547004|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
33547005|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
33547006|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
33547007|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
33547008|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
33547009|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
33547010|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
33547011|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
33547012|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
33547013|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
33547014|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
33547015|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
33547016|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
33547017|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
33547018|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
33547019|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
33547020|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
33547021|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
33547022|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
33547023|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
33547024|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
33547025|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
33547026|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
33547027|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
33547028|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
33547029|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
33547030|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
33547031|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Death|1|||
33547032|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Death|0|||
33547033|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Death|1|||
33547034|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
33547035|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
33547036|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
33547037|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
33547038|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
33547039|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
33547040|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
33547041|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
33547042|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
33547043|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
33617155|NCT04158583|102147299|FG002|Overall Study|Death|2|||
33617156|NCT04158583|102147300|FG003|Overall Study|Death|2|||
33617157|NCT04158583|102147301|FG004|Overall Study|Death|4|||
33617158|NCT04158583|102147302|FG005|Overall Study|Death|3|||
33617159|NCT04158583|102147303|FG006|Overall Study|Death|5|||
33617160|NCT04158583|102147304|FG007|Overall Study|Death|2|||
33617161|NCT04158583|102147305|FG008|Overall Study|Death|0|||
33617162|NCT04158583|102147306|FG009|Overall Study|Death|1|||
33617163|NCT04158583|102147297|FG000|Overall Study|Clinical Progression Disease|0|||
33617164|NCT04158583|102147298|FG001|Overall Study|Clinical Progression Disease|0|||
33617165|NCT04158583|102147299|FG002|Overall Study|Clinical Progression Disease|0|||
33617166|NCT04158583|102147300|FG003|Overall Study|Clinical Progression Disease|1|||
33214342|NCT02807558|100682366|FG001|Overall Study|Consent withdrawn by participant|0|||
33348372|NCT04426695|101163974|FG017|Overall Study|Physician Decision|0|||
33348373|NCT04426695|101163957|FG000|Overall Study|Randomized but Never Treated|3|||
33348374|NCT04426695|101163958|FG001|Overall Study|Randomized but Never Treated|1|||
33348375|NCT04426695|101163959|FG002|Overall Study|Randomized but Never Treated|0|||
33348376|NCT04426695|101163960|FG003|Overall Study|Randomized but Never Treated|4|||
33348377|NCT04426695|101163961|FG004|Overall Study|Randomized but Never Treated|5|||
33348378|NCT04426695|101163962|FG005|Overall Study|Randomized but Never Treated|5|||
33348379|NCT04426695|101163963|FG006|Overall Study|Randomized but Never Treated|4|||
33348380|NCT04426695|101163964|FG007|Overall Study|Randomized but Never Treated|6|||
33348381|NCT04426695|101163965|FG008|Overall Study|Randomized but Never Treated|6|||
33617167|NCT04158583|102147301|FG004|Overall Study|Clinical Progression Disease|0|||
33617168|NCT04158583|102147302|FG005|Overall Study|Clinical Progression Disease|0|||
33617169|NCT04158583|102147303|FG006|Overall Study|Clinical Progression Disease|0|||
33617170|NCT04158583|102147304|FG007|Overall Study|Clinical Progression Disease|0|||
33617171|NCT04158583|102147305|FG008|Overall Study|Clinical Progression Disease|0|||
33617172|NCT04158583|102147306|FG009|Overall Study|Clinical Progression Disease|0|||
33617173|NCT04158583|102147297|FG000|Overall Study|Clinical Progression|0|||
33617174|NCT04158583|102147298|FG001|Overall Study|Clinical Progression|0|||
33617175|NCT04158583|102147299|FG002|Overall Study|Clinical Progression|0|||
33617176|NCT04158583|102147300|FG003|Overall Study|Clinical Progression|0|||
33617177|NCT04158583|102147301|FG004|Overall Study|Clinical Progression|1|||
33617178|NCT04158583|102147302|FG005|Overall Study|Clinical Progression|0|||
33617179|NCT04158583|102147303|FG006|Overall Study|Clinical Progression|2|||
33617180|NCT04158583|102147304|FG007|Overall Study|Clinical Progression|0|||
33617181|NCT04158583|102147305|FG008|Overall Study|Clinical Progression|0|||
33617182|NCT04158583|102147306|FG009|Overall Study|Clinical Progression|0|||
33214343|NCT02807558|100682367|FG002|Overall Study|Consent withdrawn by participant|4|||
33214344|NCT02807558|100682368|FG003|Overall Study|Consent withdrawn by participant|2|||
33214345|NCT02807558|100682369|FG004|Overall Study|Consent withdrawn by participant|1|||
33214346|NCT02807558|100682370|FG005|Overall Study|Consent withdrawn by participant|0|||
33214347|NCT02807558|100682365|FG000|Overall Study|Non-compliance with Study Drug|0|||
33214348|NCT02807558|100682366|FG001|Overall Study|Non-compliance with Study Drug|0|||
33348382|NCT04426695|101163966|FG009|Overall Study|Randomized but Never Treated|3|||
33348383|NCT04426695|101163967|FG010|Overall Study|Randomized but Never Treated|3|||
33348384|NCT04426695|101163968|FG011|Overall Study|Randomized but Never Treated|6|||
33348385|NCT04426695|101163969|FG012|Overall Study|Randomized but Never Treated|1|||
33348386|NCT04426695|101163970|FG013|Overall Study|Randomized but Never Treated|2|||
33348387|NCT04426695|101163971|FG014|Overall Study|Randomized but Never Treated|0|||
33348388|NCT04426695|101163972|FG015|Overall Study|Randomized but Never Treated|0|||
33348389|NCT04426695|101163973|FG016|Overall Study|Randomized but Never Treated|0|||
33348390|NCT04426695|101163974|FG017|Overall Study|Randomized but Never Treated|0|||
33348391|NCT01107444|101163979|FG000|Overall Study|Withdrawal by Subject|8|||
33348392|NCT01107444|101163980|FG001|Overall Study|Withdrawal by Subject|12|||
33348393|NCT01107444|101163979|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
33348394|NCT01107444|101163980|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
33348395|NCT01524991|101163981|FG000|Overall Study|Adverse Event|12|||
33348396|NCT01524991|101163981|FG000|Overall Study|Death|1|||
33348397|NCT01524991|101163981|FG000|Overall Study|Disease ProgressionDu|17|||
33348398|NCT01524991|101163981|FG000|Overall Study|Other complicating disease|1|||
33348399|NCT01524991|101163981|FG000|Overall Study|Withdrawal by Subject|2|||
33348400|NCT01524991|101163981|FG000|Overall Study|Symptomatic Deterioration|1|||
33348401|NCT02908516|101163983|FG000|Overall Study|Study Terminated|3|||
33348402|NCT02908516|101163984|FG001|Overall Study|Study Terminated|3|||
33348403|NCT03969875|101163985|FG000|Overall Study|did not receive allocated intervention|3|||
33348404|NCT03969875|101163986|FG001|Overall Study|did not receive allocated intervention|3|||
33617183|NCT04158583|102147297|FG000|Overall Study|Clinical Deterioration|0|||
33214349|NCT02807558|100682367|FG002|Overall Study|Non-compliance with Study Drug|1|||
33214350|NCT02807558|100682368|FG003|Overall Study|Non-compliance with Study Drug|0|||
33214351|NCT02807558|100682369|FG004|Overall Study|Non-compliance with Study Drug|0|||
33214352|NCT02807558|100682370|FG005|Overall Study|Non-compliance with Study Drug|0|||
33214353|NCT02807558|100682365|FG000|Overall Study|Adverse Event|0|||
33214354|NCT02807558|100682366|FG001|Overall Study|Adverse Event|0|||
33348405|NCT03969875|101163987|FG002|Overall Study|did not receive allocated intervention|4|||
33348406|NCT03969875|101163985|FG000|Overall Study|Protocol Violation|4|||
33617184|NCT04158583|102147298|FG001|Overall Study|Clinical Deterioration|0|||
33617185|NCT04158583|102147299|FG002|Overall Study|Clinical Deterioration|0|||
33214355|NCT02807558|100682367|FG002|Overall Study|Adverse Event|9|||
33214356|NCT02807558|100682368|FG003|Overall Study|Adverse Event|0|||
33348407|NCT03969875|101163986|FG001|Overall Study|Protocol Violation|2|||
33348408|NCT03969875|101163987|FG002|Overall Study|Protocol Violation|2|||
33617186|NCT04158583|102147300|FG003|Overall Study|Clinical Deterioration|1|||
33348409|NCT00424398|101163988|FG000|Overall Study|Withdrawal by Subject|2|||
33617187|NCT04158583|102147301|FG004|Overall Study|Clinical Deterioration|0|||
33214357|NCT02807558|100682369|FG004|Overall Study|Adverse Event|0|||
33214358|NCT02807558|100682370|FG005|Overall Study|Adverse Event|0|||
33214359|NCT02807558|100682365|FG000|Overall Study|Death|23|||
33214360|NCT02807558|100682366|FG001|Overall Study|Death|2|||
33214361|NCT02807558|100682367|FG002|Overall Study|Death|3|||
33214362|NCT02807558|100682368|FG003|Overall Study|Death|43|||
33214363|NCT02807558|100682369|FG004|Overall Study|Death|24|||
33214364|NCT02807558|100682370|FG005|Overall Study|Death|15|||
33214365|NCT02807558|100682365|FG000|Overall Study|Progressive Disease|0|||
33214366|NCT02807558|100682366|FG001|Overall Study|Progressive Disease|0|||
33214367|NCT02807558|100682367|FG002|Overall Study|Progressive Disease|1|||
33214368|NCT02807558|100682368|FG003|Overall Study|Progressive Disease|0|||
33214369|NCT02807558|100682369|FG004|Overall Study|Progressive Disease|0|||
33214370|NCT02807558|100682370|FG005|Overall Study|Progressive Disease|0|||
33214371|NCT02807558|100682365|FG000|Overall Study|Other than specified|1|||
33214372|NCT02807558|100682366|FG001|Overall Study|Other than specified|0|||
33214373|NCT02807558|100682367|FG002|Overall Study|Other than specified|2|||
33214374|NCT02807558|100682368|FG003|Overall Study|Other than specified|0|||
33214375|NCT02807558|100682369|FG004|Overall Study|Other than specified|1|||
33214376|NCT02807558|100682370|FG005|Overall Study|Other than specified|1|||
33214377|NCT02807558|100682365|FG000|Overall Study|Lack of Efficacy|0|||
33214378|NCT02807558|100682366|FG001|Overall Study|Lack of Efficacy|0|||
33214379|NCT02807558|100682367|FG002|Overall Study|Lack of Efficacy|9|||
33214380|NCT02807558|100682368|FG003|Overall Study|Lack of Efficacy|0|||
33214381|NCT02807558|100682369|FG004|Overall Study|Lack of Efficacy|0|||
33214382|NCT02807558|100682370|FG005|Overall Study|Lack of Efficacy|0|||
33214383|NCT00743366|100682372|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
33214384|NCT00743366|100682373|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
33214385|NCT00765674|100682374|FG000|Overall Study|Adverse Event|7|||
33214386|NCT00765674|100682375|FG001|Overall Study|Adverse Event|2|||
33214387|NCT00765674|100682376|FG002|Overall Study|Adverse Event|8|||
33214388|NCT00765674|100682377|FG003|Overall Study|Adverse Event|11|||
33214389|NCT00765674|100682374|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
33214390|NCT00765674|100682375|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
33214391|NCT00765674|100682376|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
33214392|NCT00765674|100682377|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
33214393|NCT00765674|100682374|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
33214394|NCT00765674|100682375|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
33214395|NCT00765674|100682376|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
33214396|NCT00765674|100682377|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
33214397|NCT00765674|100682374|FG000|Overall Study|Lack of Efficacy|2|||
33214398|NCT00765674|100682375|FG001|Overall Study|Lack of Efficacy|3|||
33214399|NCT00765674|100682376|FG002|Overall Study|Lack of Efficacy|1|||
33214400|NCT00765674|100682377|FG003|Overall Study|Lack of Efficacy|2|||
33214401|NCT00765674|100682374|FG000|Overall Study|Protocol Violation|2|||
33214402|NCT00765674|100682375|FG001|Overall Study|Protocol Violation|0|||
33214403|NCT00765674|100682376|FG002|Overall Study|Protocol Violation|1|||
33214404|NCT00765674|100682377|FG003|Overall Study|Protocol Violation|0|||
33214405|NCT00765674|100682374|FG000|Overall Study|Withdrawal by Subject|5|||
33214406|NCT00765674|100682375|FG001|Overall Study|Withdrawal by Subject|7|||
33214407|NCT00765674|100682376|FG002|Overall Study|Withdrawal by Subject|3|||
33214408|NCT00765674|100682377|FG003|Overall Study|Withdrawal by Subject|8|||
33214409|NCT00765674|100682374|FG000|Overall Study|Lost to Follow-up|4|||
33214410|NCT00765674|100682375|FG001|Overall Study|Lost to Follow-up|6|||
33547044|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
33547045|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
33547046|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
33547047|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
33547048|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
33547049|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
33547050|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
33214411|NCT00765674|100682376|FG002|Overall Study|Lost to Follow-up|2|||
33214412|NCT00765674|100682377|FG003|Overall Study|Lost to Follow-up|1|||
33214413|NCT00765674|100682374|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
33214414|NCT00765674|100682375|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
33214415|NCT00765674|100682376|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
33214416|NCT00765674|100682377|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
33547051|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
33547052|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
33214417|NCT00765388|100682378|FG000|Period 1|Lack of Efficacy|1|||
33214418|NCT00765388|100682379|FG001|Period 1|Lack of Efficacy|2|||
33214419|NCT00765388|100682378|FG000|Period 1|Lost to Follow-up|0|||
33214420|NCT00765388|100682379|FG001|Period 1|Lost to Follow-up|1|||
33214421|NCT00765388|100682378|FG000|Period 1|Herpes Zoster|0|||
33214422|NCT00765388|100682379|FG001|Period 1|Herpes Zoster|1|||
33214423|NCT00765388|100682378|FG000|Period 1|Hip operation|0|||
33214424|NCT00765388|100682379|FG001|Period 1|Hip operation|1|||
33214425|NCT04450264|100682382|FG000|Overall Study|Incomplete survey|13|||
33214426|NCT04450264|100682383|FG001|Overall Study|Incomplete survey|19|||
33214427|NCT00328510|100682385|FG000|Overall Study|Gag disorder, could not use frame|4|||
33214428|NCT00328510|100682386|FG001|Overall Study|Gag disorder, could not use frame|0|||
33214429|NCT00328510|100682385|FG000|Overall Study|Dentition problems, could not use frame|1|||
33214430|NCT00328510|100682386|FG001|Overall Study|Dentition problems, could not use frame|0|||
33214431|NCT00328510|100682385|FG000|Overall Study|Withdrawal by Subject|4|||
33214432|NCT00328510|100682386|FG001|Overall Study|Withdrawal by Subject|2|||
33214433|NCT00328510|100682385|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
33214434|NCT00328510|100682386|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
33214435|NCT00328510|100682385|FG000|Overall Study|Treatment changed to a single fraction|1|||
33214436|NCT00328510|100682386|FG001|Overall Study|Treatment changed to a single fraction|1|||
33214437|NCT04958109|100682389|FG000|Overall Study|Withdrawal by Subject|0|||
33214438|NCT04958109|100682390|FG001|Overall Study|Withdrawal by Subject|1|||
33214439|NCT04958109|100682389|FG000|Overall Study|Lost to Follow-up|0|||
33214440|NCT04958109|100682390|FG001|Overall Study|Lost to Follow-up|1|||
33214441|NCT03575325|100682396|FG000|Overall Study|Death|1|||
33214442|NCT01292928|100682397|FG000|Overall Study|Death|8|||
33214443|NCT01292928|100682397|FG000|Overall Study|Withdrawal by Subject|8|||
33214444|NCT01292928|100682397|FG000|Overall Study|Lost to Follow-up|6|||
33214445|NCT01292928|100682397|FG000|Overall Study|Physician Decision|2|||
33214446|NCT00419263|100682398|FG000|Overall Study|Lost to Follow-up|2|||
33214447|NCT00419263|100682399|FG001|Overall Study|Lost to Follow-up|1|||
33214448|NCT00419263|100682400|FG002|Overall Study|Lost to Follow-up|1|||
33214449|NCT00419263|100682398|FG000|Overall Study|Randomized in Error, Not Treated|1|||
33214450|NCT00419263|100682399|FG001|Overall Study|Randomized in Error, Not Treated|1|||
33214451|NCT00419263|100682400|FG002|Overall Study|Randomized in Error, Not Treated|0|||
33214452|NCT00419263|100682398|FG000|Overall Study|Adverse Event|0|||
33214453|NCT00419263|100682399|FG001|Overall Study|Adverse Event|0|||
33547053|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
33547054|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
33547055|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Depression|0|||
33547056|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Depression|1|||
33547057|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Depression|0|||
33214454|NCT00419263|100682400|FG002|Overall Study|Adverse Event|1|||
33214455|NCT00419263|100682398|FG000|Overall Study|Withdrawal by Subject|0|||
33214456|NCT00419263|100682399|FG001|Overall Study|Withdrawal by Subject|0|||
33214457|NCT00419263|100682400|FG002|Overall Study|Withdrawal by Subject|1|||
33214458|NCT02618967|100682401|FG000|Overall Study|Lost to Follow-up|0|||
33214459|NCT02618967|100682402|FG001|Overall Study|Lost to Follow-up|0|||
33214460|NCT02618967|100682403|FG002|Overall Study|Lost to Follow-up|1|||
33214461|NCT02618967|100682404|FG003|Overall Study|Lost to Follow-up|0|||
33214462|NCT02618967|100682405|FG004|Overall Study|Lost to Follow-up|2|||
33348410|NCT00424398|101163989|FG001|Overall Study|Withdrawal by Subject|1|||
33348411|NCT00424398|101163990|FG002|Overall Study|Withdrawal by Subject|0|||
33348412|NCT00424398|101163988|FG000|Overall Study|Subject met exclusion criteria|1|||
33547058|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
33409457|NCT04145531|101389276|FG001|Part A|Withdrawal by participant|0|||
33409458|NCT04145531|101389277|FG002|Part A|Withdrawal by participant|1|||
33409459|NCT04145531|101389278|FG003|Part A|Withdrawal by participant|0|||
33617188|NCT04158583|102147302|FG005|Overall Study|Clinical Deterioration|0|||
33617189|NCT04158583|102147303|FG006|Overall Study|Clinical Deterioration|0|||
33617190|NCT04158583|102147304|FG007|Overall Study|Clinical Deterioration|0|||
33617191|NCT04158583|102147305|FG008|Overall Study|Clinical Deterioration|0|||
33617192|NCT04158583|102147306|FG009|Overall Study|Clinical Deterioration|1|||
33617193|NCT02255461|102147308|FG000|Overall Study|Adverse Event|0|||
33409460|NCT04145531|101389275|FG000|Part A|Other|0|||
33409461|NCT04145531|101389276|FG001|Part A|Other|0|||
33409462|NCT04145531|101389277|FG002|Part A|Other|1|||
33547059|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
33547060|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
33547061|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Jailed|0|||
33547062|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Jailed|1|||
33547063|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Jailed|0|||
33547064|NCT00090103|101901599|FG000|16-Week Safety Follow-up Period|Other|0|||
33547065|NCT00090103|101901600|FG001|16-Week Safety Follow-up Period|Other|1|||
33547066|NCT00090103|101901601|FG002|16-Week Safety Follow-up Period|Other|0|||
33547067|NCT01006629|101901607|FG000|Overall Study|Adverse Event|1|||
33547068|NCT01006629|101901607|FG000|Overall Study|Parent refused to continue participation|1|||
33547069|NCT01006629|101901607|FG000|Overall Study|Parent unable to perform site visit|4|||
33547070|NCT02239328|101901608|FG000|Overall Study|Benign disease noted at time of surgery|6|||
33547071|NCT02239328|101901608|FG000|Overall Study|Equipment or website malfunction|2|||
33547072|NCT00367458|101901610|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
33547073|NCT00367458|101901611|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
33547074|NCT00729586|101901618|FG000|Overall Study|Ineligible|0|||
33547075|NCT00729586|101901619|FG001|Overall Study|Ineligible|1|||
33547076|NCT00729586|101901618|FG000|Overall Study|never treated|1|||
33547077|NCT00729586|101901619|FG001|Overall Study|never treated|0|||
33547078|NCT02378181|101901622|FG000|Overall Study|Lost to Follow-up|2|||
33547079|NCT02378181|101901623|FG001|Overall Study|Lost to Follow-up|5|||
33547080|NCT02378181|101901622|FG000|Overall Study|Withdrawal by Subject|1|||
33547081|NCT02378181|101901623|FG001|Overall Study|Withdrawal by Subject|1|||
33547082|NCT02378181|101901622|FG000|Overall Study|Incarcerated|0|||
33547083|NCT02378181|101901623|FG001|Overall Study|Incarcerated|1|||
33547084|NCT02202616|101901624|FG000|Overall Study|Screen failed|24|||
33547085|NCT02202616|101901624|FG000|Overall Study|Adverse Event|32|||
33547086|NCT02202616|101901624|FG000|Overall Study|Protocol deviation|18|||
33547087|NCT02202616|101901624|FG000|Overall Study|Patient withdrew consent|12|||
33547088|NCT02202616|101901624|FG000|Overall Study|Lost to Follow-up|6|||
33547089|NCT02202616|101901624|FG000|Overall Study|Administrative problems|6|||
33547090|NCT02202616|101901624|FG000|Overall Study|Abnormal test procedure result|1|||
33547091|NCT02202616|101901624|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33547092|NCT04124965|101901625|FG000|Overall Study|Adverse event, non-fatal|3|||
33547093|NCT04124965|101901626|FG001|Overall Study|Adverse event, non-fatal|1|||
33547094|NCT04124965|101901625|FG000|Overall Study|Withdrawal by Subject|1|||
33547095|NCT04124965|101901626|FG001|Overall Study|Withdrawal by Subject|1|||
33547096|NCT04124965|101901625|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
33547097|NCT04124965|101901626|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
33547098|NCT04124965|101901625|FG000|Overall Study|Pregnancy|1|||
33547099|NCT04124965|101901626|FG001|Overall Study|Pregnancy|0|||
33547100|NCT04124965|101901625|FG000|Overall Study|Sponsor and participant decision|0|||
33547101|NCT04124965|101901626|FG001|Overall Study|Sponsor and participant decision|1|||
33547102|NCT04124965|101901625|FG000|Overall Study|Personal surgery|0|||
33547103|NCT04124965|101901626|FG001|Overall Study|Personal surgery|1|||
33547104|NCT04124965|101901625|FG000|Overall Study|Physician Decision|0|||
33617194|NCT02255461|102147309|FG001|Overall Study|Adverse Event|1|||
33617195|NCT02255461|102147310|FG002|Overall Study|Adverse Event|0|||
33617196|NCT02255461|102147311|FG003|Overall Study|Adverse Event|0|||
33617197|NCT02255461|102147312|FG004|Overall Study|Adverse Event|1|||
33617198|NCT02255461|102147308|FG000|Overall Study|Withdrawal by Subject|0|||
33617199|NCT02255461|102147309|FG001|Overall Study|Withdrawal by Subject|0|||
33617200|NCT02255461|102147310|FG002|Overall Study|Withdrawal by Subject|1|||
33617201|NCT02255461|102147311|FG003|Overall Study|Withdrawal by Subject|0|||
33617202|NCT02255461|102147312|FG004|Overall Study|Withdrawal by Subject|1|||
33547105|NCT04124965|101901626|FG001|Overall Study|Physician Decision|1|||
33409463|NCT04145531|101389278|FG003|Part A|Other|0|||
33409464|NCT04145531|101389275|FG000|Part B|Adverse Event|0|||
33409465|NCT04145531|101389276|FG001|Part B|Adverse Event|0|||
33547106|NCT05417113|101901627|FG000|Overall Study|Lost to Follow-up|2|||
33617203|NCT02255461|102147308|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
33409466|NCT04145531|101389277|FG002|Part B|Adverse Event|0|||
33409467|NCT04145531|101389278|FG003|Part B|Adverse Event|21|||
33547107|NCT05417113|101901628|FG001|Overall Study|Lost to Follow-up|2|||
33547108|NCT01136915|101901629|FG000|Overall Study|Lost to Follow-up|2|||
33547109|NCT01136915|101901630|FG001|Overall Study|Lost to Follow-up|0|||
33547110|NCT01136915|101901629|FG000|Overall Study|Exclusion criterion met|0|||
33547111|NCT01136915|101901630|FG001|Overall Study|Exclusion criterion met|1|||
33547112|NCT01695746|101901631|FG000|Overall Study|Adverse Event|1|||
33214463|NCT02618967|100682406|FG005|Overall Study|Lost to Follow-up|0|||
33214464|NCT02618967|100682407|FG006|Overall Study|Lost to Follow-up|0|||
33214465|NCT02618967|100682408|FG007|Overall Study|Lost to Follow-up|0|||
33214466|NCT02618967|100682401|FG000|Overall Study|Withdrawal by Subject|1|||
33214467|NCT02618967|100682402|FG001|Overall Study|Withdrawal by Subject|0|||
33214468|NCT02618967|100682403|FG002|Overall Study|Withdrawal by Subject|0|||
33214469|NCT02618967|100682404|FG003|Overall Study|Withdrawal by Subject|0|||
33214470|NCT02618967|100682405|FG004|Overall Study|Withdrawal by Subject|0|||
33214471|NCT02618967|100682406|FG005|Overall Study|Withdrawal by Subject|0|||
33214472|NCT02618967|100682407|FG006|Overall Study|Withdrawal by Subject|0|||
33214473|NCT02618967|100682408|FG007|Overall Study|Withdrawal by Subject|0|||
33214474|NCT01292239|100682409|FG000|Overall Study|Other|1|||
33214475|NCT01292239|100682410|FG001|Overall Study|Other|1|||
33214476|NCT01292239|100682409|FG000|Overall Study|Withdrawal by Subject|3|||
33214477|NCT01292239|100682410|FG001|Overall Study|Withdrawal by Subject|6|||
33214478|NCT04508699|100682414|FG000|Overall Study|Lack of Efficacy|2|||
33214479|NCT04508699|100682415|FG001|Overall Study|Lack of Efficacy|15|||
33348413|NCT00424398|101163989|FG001|Overall Study|Subject met exclusion criteria|0|||
33547113|NCT01695746|101901631|FG000|Overall Study|Non-compliance by the participant|3|||
33547114|NCT01695746|101901631|FG000|Overall Study|Protocol Violation|5|||
33547115|NCT01695746|101901631|FG000|Overall Study|Participant not willing to participate|3|||
33547116|NCT00368550|101901643|FG000|Overall Study|Adverse Event|7|||
33547117|NCT00368550|101901644|FG001|Overall Study|Adverse Event|4|||
33547118|NCT00368550|101901643|FG000|Overall Study|Lack of Efficacy|4|||
33547119|NCT00368550|101901644|FG001|Overall Study|Lack of Efficacy|9|||
33547120|NCT00368550|101901643|FG000|Overall Study|Withdrawal by Subject|17|||
33547121|NCT00368550|101901644|FG001|Overall Study|Withdrawal by Subject|10|||
33547122|NCT00844519|101901647|FG000|Overall Study|Withdrawal by Subject|1|||
33547123|NCT00844519|101901648|FG001|Overall Study|Withdrawal by Subject|1|||
33547124|NCT00844519|101901647|FG000|Overall Study|Adverse Event|1|||
33547125|NCT00844519|101901648|FG001|Overall Study|Adverse Event|0|||
33547126|NCT02394275|101901649|FG000|Overall Study|Adverse Event|22|||
33547127|NCT02394275|101901649|FG000|Overall Study|Lost to Follow-up|7|||
33547128|NCT03301714|101901650|FG000|Overall Study|Lost to Follow-up|10|||
33547129|NCT03301714|101901651|FG001|Overall Study|Lost to Follow-up|4|||
33547130|NCT03301714|101901652|FG002|Overall Study|Lost to Follow-up|4|||
33547131|NCT03301714|101901650|FG000|Overall Study|Did not receive allocated intervention|0|||
33547132|NCT03301714|101901651|FG001|Overall Study|Did not receive allocated intervention|2|||
33547133|NCT03301714|101901652|FG002|Overall Study|Did not receive allocated intervention|3|||
33547134|NCT00805532|101901653|FG000|Overall Study|invalid data|0|||
33547135|NCT00805532|101901654|FG001|Overall Study|invalid data|1|||
33547136|NCT00226655|101901661|FG000|Overall Study|Death|13|||
33547137|NCT00226655|101901661|FG000|Overall Study|Withdrawal by Subject|15|||
33547138|NCT00226655|101901661|FG000|Overall Study|Adverse Event|35|||
33547139|NCT00226655|101901661|FG000|Overall Study|Physician Decision|6|||
33547140|NCT00226655|101901661|FG000|Overall Study|Clinical deterioration|10|||
33348414|NCT00424398|101163990|FG002|Overall Study|Subject met exclusion criteria|0|||
33348415|NCT01708057|101163991|FG000|Overall Study|Withdrawal due to study termination.|1|||
33348416|NCT01708057|101163992|FG001|Overall Study|Withdrawal due to study termination.|1|||
33348417|NCT01708057|101163993|FG002|Overall Study|Withdrawal due to study termination.|1|||
33348418|NCT02700451|101163995|FG000|Overall Study|Protocol Violation|2|||
33348419|NCT02700451|101163996|FG001|Overall Study|Protocol Violation|2|||
33348420|NCT02700451|101163997|FG002|Overall Study|Protocol Violation|3|||
33348421|NCT02700451|101163995|FG000|Overall Study|Discontinued intervention|14|||
33348422|NCT02700451|101163996|FG001|Overall Study|Discontinued intervention|15|||
33348423|NCT02700451|101163997|FG002|Overall Study|Discontinued intervention|14|||
33348424|NCT02116621|101163999|FG000|Baseline|Withdrawal by Subject|0|||
33348425|NCT02116621|101164000|FG001|Baseline|Withdrawal by Subject|4|||
33547141|NCT00147238|101901662|FG000|Overall Study|Inevaluable|8|||
33547142|NCT00898807|101901670|FG000|Overall Study|Withdrawal by Subject|5|||
33547143|NCT00898807|101901671|FG001|Overall Study|Withdrawal by Subject|3|||
33547144|NCT00898807|101901670|FG000|Overall Study|Family pressure to discontinue|2|||
33348426|NCT02116621|101163999|FG000|Three Month Follow-up|Death|1|||
33547145|NCT00898807|101901671|FG001|Overall Study|Family pressure to discontinue|2|||
33214480|NCT04508699|100682414|FG000|Overall Study|Withdrawal by Subject|0|||
33214481|NCT04508699|100682415|FG001|Overall Study|Withdrawal by Subject|2|||
33214482|NCT01749982|100682420|FG000|Overall Study|Physician Decision|0|||
33214483|NCT01749982|100682421|FG001|Overall Study|Physician Decision|0|||
33348427|NCT02116621|101164000|FG001|Three Month Follow-up|Death|1|||
33547146|NCT00898807|101901670|FG000|Overall Study|Lost to Follow-up|1|||
33214484|NCT01749982|100682422|FG002|Overall Study|Physician Decision|0|||
33409468|NCT04145531|101389275|FG000|Part B|Physician Decision|0|||
33409469|NCT04145531|101389276|FG001|Part B|Physician Decision|0|||
33409470|NCT04145531|101389277|FG002|Part B|Physician Decision|0|||
33409471|NCT04145531|101389278|FG003|Part B|Physician Decision|7|||
33409472|NCT04145531|101389275|FG000|Part B|Progressive disease|0|||
33409473|NCT04145531|101389276|FG001|Part B|Progressive disease|0|||
33409474|NCT04145531|101389277|FG002|Part B|Progressive disease|0|||
33409475|NCT04145531|101389278|FG003|Part B|Progressive disease|1|||
33409476|NCT04145531|101389275|FG000|Part B|Recurrent disease|0|||
33409477|NCT04145531|101389276|FG001|Part B|Recurrent disease|0|||
33409478|NCT04145531|101389277|FG002|Part B|Recurrent disease|0|||
33409479|NCT04145531|101389278|FG003|Part B|Recurrent disease|1|||
33409480|NCT04145531|101389275|FG000|Part B|Withdrawal by parent or guardian|0|||
33409481|NCT04145531|101389276|FG001|Part B|Withdrawal by parent or guardian|0|||
33409482|NCT04145531|101389277|FG002|Part B|Withdrawal by parent or guardian|0|||
33409483|NCT04145531|101389278|FG003|Part B|Withdrawal by parent or guardian|3|||
33409484|NCT04145531|101389275|FG000|Part B|Withdrawal by participant|0|||
33409485|NCT04145531|101389276|FG001|Part B|Withdrawal by participant|0|||
33409486|NCT04145531|101389277|FG002|Part B|Withdrawal by participant|0|||
33409487|NCT04145531|101389278|FG003|Part B|Withdrawal by participant|1|||
33409488|NCT04145531|101389275|FG000|Part B|Other|0|||
33409489|NCT04145531|101389276|FG001|Part B|Other|0|||
33409490|NCT04145531|101389277|FG002|Part B|Other|0|||
33409491|NCT04145531|101389278|FG003|Part B|Other|1|||
33409492|NCT04221373|101389279|FG000|Overall Study|Physician Decision|4|||
33409493|NCT04221373|101389280|FG001|Overall Study|Physician Decision|0|||
33409494|NCT01545375|101389285|FG000|Overall Study|Adverse Event|2|||
33409495|NCT01545375|101389286|FG001|Overall Study|Adverse Event|1|||
33409496|NCT01545375|101389285|FG000|Overall Study|Lost to Follow-up|34|||
33409497|NCT01545375|101389286|FG001|Overall Study|Lost to Follow-up|31|||
33409498|NCT01545375|101389285|FG000|Overall Study|Protocol Violation|3|||
33409499|NCT01545375|101389286|FG001|Overall Study|Protocol Violation|3|||
33409500|NCT01545375|101389285|FG000|Overall Study|Withdrawal by Subject|58|||
33409501|NCT01545375|101389286|FG001|Overall Study|Withdrawal by Subject|55|||
33409502|NCT04822701|101389287|FG000|Overall Study|Not treated|2|||
33409503|NCT04822701|101389288|FG001|Overall Study|Not treated|0|||
33547147|NCT00898807|101901671|FG001|Overall Study|Lost to Follow-up|3|||
33409504|NCT04822701|101389287|FG000|Overall Study|Lost to Follow-up|1|||
33409505|NCT04822701|101389288|FG001|Overall Study|Lost to Follow-up|0|||
33409506|NCT04822701|101389287|FG000|Overall Study|Withdrawal by Subject|1|||
33409507|NCT04822701|101389288|FG001|Overall Study|Withdrawal by Subject|0|||
33409508|NCT02992743|101389289|FG000|Overall Study|Withdrawal by Subject|1|||
33409509|NCT02992743|101389290|FG001|Overall Study|Withdrawal by Subject|1|||
33409510|NCT02992743|101389289|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
33409511|NCT02992743|101389290|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
33409512|NCT02992743|101389289|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
33547148|NCT00898807|101901670|FG000|Overall Study|Death|0|||
33409513|NCT02992743|101389290|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
33409514|NCT02992743|101389289|FG000|Overall Study|No measurable disease|1|||
33409515|NCT02992743|101389290|FG001|Overall Study|No measurable disease|0|||
33409516|NCT02992743|101389289|FG000|Overall Study|Lost to Follow-up|0|||
33214485|NCT01749982|100682423|FG003|Overall Study|Physician Decision|1|||
33214486|NCT01749982|100682420|FG000|Overall Study|Lost to Follow-up|0|||
33409517|NCT02992743|101389290|FG001|Overall Study|Lost to Follow-up|1|||
33409518|NCT03997383|101389291|FG000|Double-blind Treatment Period|Adverse Event|4|||
33409519|NCT03997383|101389292|FG001|Double-blind Treatment Period|Adverse Event|3|||
33409520|NCT03997383|101389291|FG000|Double-blind Treatment Period|Death|4|||
33409521|NCT03997383|101389292|FG001|Double-blind Treatment Period|Death|4|||
33409522|NCT03997383|101389291|FG000|Double-blind Treatment Period|Physician Decision|2|||
33409523|NCT03997383|101389292|FG001|Double-blind Treatment Period|Physician Decision|0|||
33409524|NCT03997383|101389291|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
33409525|NCT03997383|101389292|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
33409526|NCT03997383|101389291|FG000|Open-label Extension Period|Ongoing|148|||
33409527|NCT03997383|101389292|FG001|Open-label Extension Period|Ongoing|151|||
33409528|NCT03997383|101389291|FG000|Open-label Extension Period|Adverse Event|4|||
33409529|NCT03997383|101389292|FG001|Open-label Extension Period|Adverse Event|1|||
33409530|NCT03997383|101389291|FG000|Open-label Extension Period|Death|8|||
33409531|NCT03997383|101389292|FG001|Open-label Extension Period|Death|9|||
33409532|NCT03997383|101389291|FG000|Open-label Extension Period|Physician Decision|1|||
33348428|NCT02116621|101163999|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
33214487|NCT01749982|100682421|FG001|Overall Study|Lost to Follow-up|0|||
33214488|NCT01749982|100682422|FG002|Overall Study|Lost to Follow-up|0|||
33214489|NCT01749982|100682423|FG003|Overall Study|Lost to Follow-up|1|||
33214490|NCT01749982|100682420|FG000|Overall Study|Withdrawal by Subject|0|||
33214491|NCT01749982|100682421|FG001|Overall Study|Withdrawal by Subject|0|||
33214492|NCT01749982|100682422|FG002|Overall Study|Withdrawal by Subject|0|||
33214493|NCT01749982|100682423|FG003|Overall Study|Withdrawal by Subject|1|||
33348429|NCT02116621|101164000|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
33348430|NCT02116621|101163999|FG000|Three Month Follow-up|Lost to Follow-up|0|||
33348431|NCT02116621|101164000|FG001|Three Month Follow-up|Lost to Follow-up|1|||
33348432|NCT02116621|101163999|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
33348433|NCT02116621|101164000|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
33348434|NCT02116621|101163999|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
33348435|NCT02116621|101164000|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
33348436|NCT02116621|101163999|FG000|Six Month Follow-up|Lost to Follow-up|2|||
33348437|NCT02116621|101164000|FG001|Six Month Follow-up|Lost to Follow-up|1|||
33348438|NCT02116621|101163999|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
33348439|NCT02116621|101164000|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
33348440|NCT02116621|101163999|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
33348441|NCT02116621|101164000|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
33348442|NCT02116621|101163999|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
33348443|NCT02116621|101164000|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
33348444|NCT02116621|101163999|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
33348445|NCT02116621|101164000|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
33348446|NCT02116621|101163999|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
33348447|NCT02116621|101164000|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
33348448|NCT02772757|101164001|FG000|Overall Study|Withdrawal by Subject|1|||
33348449|NCT02772757|101164002|FG001|Overall Study|Withdrawal by Subject|0|||
33409533|NCT03997383|101389292|FG001|Open-label Extension Period|Physician Decision|1|||
33409534|NCT03997383|101389291|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
33409535|NCT03997383|101389292|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
33409536|NCT03997383|101389291|FG000|Open-label Extension Period|Reason Not Specified|2|||
33409537|NCT03997383|101389292|FG001|Open-label Extension Period|Reason Not Specified|0|||
33409538|NCT02501642|101389293|FG000|Overall Study|Lost to Follow-up|7|||
33409539|NCT02501642|101389294|FG001|Overall Study|Lost to Follow-up|11|||
33409540|NCT02319642|101389296|FG000|Overall Study|Adverse Event|2|||
33409541|NCT02319642|101389297|FG001|Overall Study|Adverse Event|4|||
33409542|NCT02319642|101389296|FG000|Overall Study|Lack of Efficacy|1|||
33409543|NCT02319642|101389297|FG001|Overall Study|Lack of Efficacy|1|||
33409544|NCT02319642|101389296|FG000|Overall Study|Withdrawal by Subject|1|||
33214494|NCT00515502|100682424|FG000|Treatment Period 1|Adverse Event|0|||
33348450|NCT02772757|101164003|FG002|Overall Study|Withdrawal by Subject|1|||
33348451|NCT02772757|101164001|FG000|Overall Study|Protocol Violation|0|||
33348452|NCT02772757|101164002|FG001|Overall Study|Protocol Violation|0|||
33409545|NCT02319642|101389297|FG001|Overall Study|Withdrawal by Subject|1|||
33214495|NCT00515502|100682425|FG001|Treatment Period 1|Adverse Event|0|||
33214496|NCT00515502|100682426|FG002|Treatment Period 1|Adverse Event|0|||
33348453|NCT02772757|101164003|FG002|Overall Study|Protocol Violation|1|||
33348454|NCT02772757|101164001|FG000|Overall Study|Physician Decision|0|||
33214497|NCT00515502|100682427|FG003|Treatment Period 1|Adverse Event|0|||
33409546|NCT03339999|101389298|FG000|Overall Study|Adverse Event|1|||
33409547|NCT03339999|101389299|FG001|Overall Study|Adverse Event|2|||
33409548|NCT03339999|101389300|FG002|Overall Study|Adverse Event|2|||
33409549|NCT03339999|101389301|FG003|Overall Study|Adverse Event|1|||
33214498|NCT00515502|100682428|FG004|Treatment Period 1|Adverse Event|0|||
33348455|NCT02772757|101164002|FG001|Overall Study|Physician Decision|3|||
33348456|NCT02772757|101164003|FG002|Overall Study|Physician Decision|3|||
33348457|NCT01505894|101164007|FG000|Overall Study|Adverse Event|1|||
33348458|NCT01505894|101164008|FG001|Overall Study|Adverse Event|0|||
33348459|NCT01505894|101164009|FG002|Overall Study|Adverse Event|0|||
33348460|NCT01505894|101164010|FG003|Overall Study|Adverse Event|0|||
33348461|NCT01505894|101164011|FG004|Overall Study|Adverse Event|0|||
33348462|NCT01505894|101164012|FG005|Overall Study|Adverse Event|0|||
33348463|NCT01505894|101164013|FG006|Overall Study|Adverse Event|0|||
33348464|NCT01505894|101164014|FG007|Overall Study|Adverse Event|0|||
33348465|NCT01505894|101164015|FG008|Overall Study|Adverse Event|0|||
33348466|NCT01505894|101164007|FG000|Overall Study|Other than specified|0|||
33348467|NCT01505894|101164008|FG001|Overall Study|Other than specified|0|||
33348468|NCT01505894|101164009|FG002|Overall Study|Other than specified|0|||
33348469|NCT01505894|101164010|FG003|Overall Study|Other than specified|0|||
33348470|NCT01505894|101164011|FG004|Overall Study|Other than specified|1|||
33348471|NCT01505894|101164012|FG005|Overall Study|Other than specified|0|||
33214499|NCT00515502|100682429|FG005|Treatment Period 1|Adverse Event|0|||
33214500|NCT00515502|100682430|FG006|Treatment Period 1|Adverse Event|1|||
33214501|NCT00515502|100682431|FG007|Treatment Period 1|Adverse Event|0|||
33214502|NCT00515502|100682432|FG008|Treatment Period 1|Adverse Event|1|||
33214503|NCT00515502|100682433|FG009|Treatment Period 1|Adverse Event|0|||
33214504|NCT00515502|100682434|FG010|Treatment Period 1|Adverse Event|0|||
33214505|NCT00515502|100682435|FG011|Treatment Period 1|Adverse Event|1|||
33214506|NCT00515502|100682424|FG000|Treatment Period 2|Adverse Event|0|||
33214507|NCT00515502|100682425|FG001|Treatment Period 2|Adverse Event|1|||
33214508|NCT00515502|100682426|FG002|Treatment Period 2|Adverse Event|0|||
33348472|NCT01505894|101164013|FG006|Overall Study|Other than specified|0|||
33348473|NCT01505894|101164014|FG007|Overall Study|Other than specified|0|||
33348474|NCT01505894|101164015|FG008|Overall Study|Other than specified|0|||
33348475|NCT00727402|101164016|FG000|Overall Study|Physician Decision|116|||
33348476|NCT00501228|101164017|FG000|Overall Study|Withdrawal by Subject|1|||
33348477|NCT00582556|101164023|FG000|Overall Study|Withdrawal by Subject|0|||
33348478|NCT00582556|101164024|FG001|Overall Study|Withdrawal by Subject|1|||
33348479|NCT00582556|101164025|FG002|Overall Study|Withdrawal by Subject|1|||
33348480|NCT00582556|101164023|FG000|Overall Study|Physician Decision|0|||
33348481|NCT00582556|101164024|FG001|Overall Study|Physician Decision|0|||
33348482|NCT00582556|101164025|FG002|Overall Study|Physician Decision|1|||
33409550|NCT03339999|101389298|FG000|Overall Study|Lack of Efficacy|0|||
33409551|NCT03339999|101389299|FG001|Overall Study|Lack of Efficacy|1|||
33409552|NCT03339999|101389300|FG002|Overall Study|Lack of Efficacy|0|||
33214509|NCT00515502|100682427|FG003|Treatment Period 2|Adverse Event|0|||
33348483|NCT00454207|101164026|FG000|Overall Study|Adverse Event|3|||
33348484|NCT00454207|101164027|FG001|Overall Study|Adverse Event|1|||
33348485|NCT00454207|101164026|FG000|Overall Study|Lack of Efficacy|1|||
33348486|NCT00454207|101164027|FG001|Overall Study|Lack of Efficacy|0|||
33348487|NCT00454207|101164026|FG000|Overall Study|Protocol Violation|0|||
33348488|NCT00454207|101164027|FG001|Overall Study|Protocol Violation|1|||
33348489|NCT00275561|101164028|FG000|Overall Study|Withdrawal by Subject|0|||
33348490|NCT00275561|101164029|FG001|Overall Study|Withdrawal by Subject|1|||
33348491|NCT00275561|101164028|FG000|Overall Study|Travel|1|||
33348492|NCT00275561|101164029|FG001|Overall Study|Travel|1|||
33348493|NCT00275561|101164028|FG000|Overall Study|Scheduling|1|||
33348494|NCT00275561|101164029|FG001|Overall Study|Scheduling|2|||
33348495|NCT00275561|101164028|FG000|Overall Study|Family Issues|0|||
33348496|NCT00275561|101164029|FG001|Overall Study|Family Issues|2|||
33348497|NCT01384292|101164030|FG000|Part B|Severe non-compliance to protocol|1|||
33348498|NCT01384292|101164031|FG001|Part B|Severe non-compliance to protocol|0|||
33348499|NCT01384292|101164032|FG002|Part B|Severe non-compliance to protocol|0|||
33348500|NCT04303000|101164035|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
33348501|NCT04303000|101164036|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
33409553|NCT03339999|101389301|FG003|Overall Study|Lack of Efficacy|0|||
33214510|NCT00515502|100682428|FG004|Treatment Period 2|Adverse Event|0|||
33214511|NCT00515502|100682429|FG005|Treatment Period 2|Adverse Event|0|||
33348502|NCT04303000|101164037|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
33348503|NCT00667576|101164038|FG000|Overall Study|Withdrawal by Subject|1|||
33348504|NCT00667576|101164039|FG001|Overall Study|Withdrawal by Subject|0|||
33348505|NCT00667576|101164040|FG002|Overall Study|Withdrawal by Subject|1|||
33409554|NCT03339999|101389298|FG000|Overall Study|Lost to Follow-up|0|||
33214512|NCT00515502|100682430|FG006|Treatment Period 2|Adverse Event|0|||
33348506|NCT00667576|101164041|FG003|Overall Study|Withdrawal by Subject|1|||
33348507|NCT00667576|101164042|FG004|Overall Study|Withdrawal by Subject|1|||
33348508|NCT00667576|101164038|FG000|Overall Study|Adverse Event|1|||
33348509|NCT00667576|101164039|FG001|Overall Study|Adverse Event|1|||
33348510|NCT00667576|101164040|FG002|Overall Study|Adverse Event|0|||
33547149|NCT00898807|101901671|FG001|Overall Study|Death|1|||
33547150|NCT00274456|101901673|FG000|Overall Study|Still on treatment|2|||
33348511|NCT00667576|101164041|FG003|Overall Study|Adverse Event|0|||
33348512|NCT00667576|101164042|FG004|Overall Study|Adverse Event|0|||
33547151|NCT00274456|101901674|FG001|Overall Study|Still on treatment|3|||
33547152|NCT00274456|101901675|FG002|Overall Study|Still on treatment|5|||
33214513|NCT00515502|100682431|FG007|Treatment Period 2|Adverse Event|0|||
33348513|NCT00667576|101164038|FG000|Overall Study|Lost to Follow-up|0|||
33348514|NCT00667576|101164039|FG001|Overall Study|Lost to Follow-up|0|||
33348515|NCT00667576|101164040|FG002|Overall Study|Lost to Follow-up|1|||
33348516|NCT00667576|101164041|FG003|Overall Study|Lost to Follow-up|0|||
33348517|NCT00667576|101164042|FG004|Overall Study|Lost to Follow-up|0|||
33348518|NCT00667576|101164038|FG000|Overall Study|Protocol Violation|0|||
33348519|NCT00667576|101164039|FG001|Overall Study|Protocol Violation|0|||
33348520|NCT00667576|101164040|FG002|Overall Study|Protocol Violation|0|||
33348521|NCT00667576|101164041|FG003|Overall Study|Protocol Violation|1|||
33348522|NCT00667576|101164042|FG004|Overall Study|Protocol Violation|0|||
33348523|NCT00667576|101164038|FG000|Overall Study|Physician Decision|0|||
33348524|NCT00667576|101164039|FG001|Overall Study|Physician Decision|0|||
33348525|NCT00667576|101164040|FG002|Overall Study|Physician Decision|0|||
33348526|NCT00667576|101164041|FG003|Overall Study|Physician Decision|1|||
33348527|NCT00667576|101164042|FG004|Overall Study|Physician Decision|0|||
33348528|NCT00667576|101164038|FG000|Overall Study|Missed Visit|0|||
33348529|NCT00667576|101164039|FG001|Overall Study|Missed Visit|0|||
33348530|NCT00667576|101164040|FG002|Overall Study|Missed Visit|0|||
33348531|NCT00667576|101164041|FG003|Overall Study|Missed Visit|1|||
33348532|NCT00667576|101164042|FG004|Overall Study|Missed Visit|0|||
33348533|NCT02789657|101164044|FG000|Overall Study|Withdrawal by Subject|2|||
33348534|NCT02789657|101164045|FG001|Overall Study|Withdrawal by Subject|0|||
33348535|NCT02789657|101164046|FG002|Overall Study|Withdrawal by Subject|0|||
33348536|NCT02789657|101164047|FG003|Overall Study|Withdrawal by Subject|0|||
33348537|NCT01727258|101164048|FG000|Overall Study|Adverse Event|0|||
33348538|NCT01727258|101164049|FG001|Overall Study|Adverse Event|2|||
33348539|NCT01727258|101164050|FG002|Overall Study|Adverse Event|0|||
33348540|NCT01727258|101164048|FG000|Overall Study|Noncompliance with Study Drug|0|||
33348541|NCT01727258|101164049|FG001|Overall Study|Noncompliance with Study Drug|0|||
33348542|NCT01727258|101164050|FG002|Overall Study|Noncompliance with Study Drug|1|||
33348543|NCT01727258|101164048|FG000|Overall Study|Withdrawal by Subject|1|||
33348544|NCT01727258|101164049|FG001|Overall Study|Withdrawal by Subject|1|||
33348545|NCT01727258|101164050|FG002|Overall Study|Withdrawal by Subject|0|||
33348546|NCT01727258|101164048|FG000|Overall Study|Lost to Follow-up|1|||
33348547|NCT01727258|101164049|FG001|Overall Study|Lost to Follow-up|0|||
33348548|NCT01727258|101164050|FG002|Overall Study|Lost to Follow-up|0|||
33348549|NCT01279057|101164051|FG000|Overall Study|Adverse Event|1|||
33348550|NCT01279057|101164052|FG001|Overall Study|Adverse Event|0|||
33348551|NCT01279057|101164053|FG002|Overall Study|Adverse Event|1|||
33348552|NCT01279057|101164051|FG000|Overall Study|Insufficient therapeutic response|0|||
33348553|NCT01279057|101164052|FG001|Overall Study|Insufficient therapeutic response|0|||
33348554|NCT01279057|101164053|FG002|Overall Study|Insufficient therapeutic response|1|||
33348555|NCT01279057|101164051|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
33348556|NCT01279057|101164052|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
33348557|NCT01279057|101164053|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
33348558|NCT01279057|101164051|FG000|Overall Study|Withdrew consent|2|||
33348559|NCT01279057|101164052|FG001|Overall Study|Withdrew consent|0|||
33348560|NCT01279057|101164053|FG002|Overall Study|Withdrew consent|1|||
33348561|NCT01279057|101164051|FG000|Overall Study|Pregnancy|0|||
33348562|NCT01279057|101164052|FG001|Overall Study|Pregnancy|1|||
33348563|NCT01279057|101164053|FG002|Overall Study|Pregnancy|0|||
33348564|NCT01279057|101164051|FG000|Overall Study|Other|3|||
33348565|NCT01279057|101164052|FG001|Overall Study|Other|3|||
33348566|NCT01279057|101164053|FG002|Overall Study|Other|0|||
33348567|NCT01961544|101164054|FG000|Overall Study|Protocol Violation|1|||
33348568|NCT01961544|101164054|FG000|Overall Study|Withdrawal by Subject|7|||
33547153|NCT00274456|101901676|FG003|Overall Study|Still on treatment|1|||
33547154|NCT00274456|101901673|FG000|Overall Study|Unacceptable toxicity|10|||
33547155|NCT00274456|101901674|FG001|Overall Study|Unacceptable toxicity|5|||
33617204|NCT02255461|102147309|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
33348569|NCT01961544|101164054|FG000|Overall Study|Adverse Event|1|||
33348570|NCT01961544|101164054|FG000|Overall Study|Physician Decision|2|||
33348571|NCT01961544|101164054|FG000|Overall Study|Poor Tolerance|1|||
33348572|NCT01961544|101164054|FG000|Overall Study|Aggravation of Steral Pain|1|||
33348573|NCT00546364|101164058|FG000|Overall Study|Disease progression|5|||
33348574|NCT00546364|101164059|FG001|Overall Study|Disease progression|11|||
33348575|NCT00546364|101164060|FG002|Overall Study|Disease progression|8|||
33547156|NCT00274456|101901675|FG002|Overall Study|Unacceptable toxicity|12|||
33617205|NCT02255461|102147310|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
33617206|NCT02255461|102147311|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
33617207|NCT02255461|102147312|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
33617208|NCT02717494|102147322|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
33617209|NCT02717494|102147323|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
33617210|NCT02717494|102147324|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
33617211|NCT02717494|102147322|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
33617212|NCT02717494|102147323|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
33617213|NCT02717494|102147324|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
33617214|NCT02717494|102147322|FG000|First Intervention (Step 1)|Death|0|||
33617215|NCT02717494|102147323|FG001|First Intervention (Step 1)|Death|0|||
33617216|NCT02717494|102147324|FG002|First Intervention (Step 1)|Death|1|||
33348576|NCT00546364|101164058|FG000|Overall Study|Completed and off treatment|1|||
33348577|NCT00546364|101164059|FG001|Overall Study|Completed and off treatment|0|||
33348578|NCT00546364|101164060|FG002|Overall Study|Completed and off treatment|2|||
33409555|NCT03339999|101389299|FG001|Overall Study|Lost to Follow-up|0|||
33409556|NCT03339999|101389300|FG002|Overall Study|Lost to Follow-up|0|||
33409557|NCT03339999|101389301|FG003|Overall Study|Lost to Follow-up|1|||
33547157|NCT00274456|101901676|FG003|Overall Study|Unacceptable toxicity|16|||
33348579|NCT00546364|101164058|FG000|Overall Study|Administrative reason by sponsor|1|||
33348580|NCT00546364|101164059|FG001|Overall Study|Administrative reason by sponsor|0|||
33348581|NCT00546364|101164060|FG002|Overall Study|Administrative reason by sponsor|0|||
33348582|NCT00546364|101164058|FG000|Overall Study|Poor compliance/noncompliance|0|||
33348583|NCT00546364|101164059|FG001|Overall Study|Poor compliance/noncompliance|0|||
33348584|NCT00546364|101164060|FG002|Overall Study|Poor compliance/noncompliance|1|||
33348585|NCT00546364|101164058|FG000|Overall Study|No longer meets study criteria|1|||
33348586|NCT00546364|101164059|FG001|Overall Study|No longer meets study criteria|1|||
33348587|NCT00546364|101164060|FG002|Overall Study|No longer meets study criteria|0|||
33348588|NCT00546364|101164058|FG000|Overall Study|Withdrawal by Subject|5|||
33348589|NCT00546364|101164059|FG001|Overall Study|Withdrawal by Subject|6|||
33348590|NCT00546364|101164060|FG002|Overall Study|Withdrawal by Subject|3|||
33547158|NCT00274456|101901673|FG000|Overall Study|Adverse Event|0|||
33547159|NCT00274456|101901674|FG001|Overall Study|Adverse Event|1|||
33547160|NCT00274456|101901675|FG002|Overall Study|Adverse Event|2|||
33547161|NCT00274456|101901676|FG003|Overall Study|Adverse Event|2|||
33547162|NCT00274456|101901673|FG000|Overall Study|Physician Decision|7|||
33547163|NCT00274456|101901674|FG001|Overall Study|Physician Decision|5|||
33547164|NCT00274456|101901675|FG002|Overall Study|Physician Decision|6|||
33547165|NCT00274456|101901676|FG003|Overall Study|Physician Decision|13|||
33547166|NCT00274456|101901673|FG000|Overall Study|Lost to Follow-up|0|||
33547167|NCT00274456|101901674|FG001|Overall Study|Lost to Follow-up|0|||
33547168|NCT00274456|101901675|FG002|Overall Study|Lost to Follow-up|1|||
33547169|NCT00274456|101901676|FG003|Overall Study|Lost to Follow-up|0|||
33547170|NCT00274456|101901673|FG000|Overall Study|Withdrawal by Subject|18|||
33547171|NCT00274456|101901674|FG001|Overall Study|Withdrawal by Subject|13|||
33547172|NCT00274456|101901675|FG002|Overall Study|Withdrawal by Subject|9|||
33547173|NCT00274456|101901676|FG003|Overall Study|Withdrawal by Subject|13|||
33348591|NCT00546364|101164058|FG000|Overall Study|Prior taxotere|1|||
33348592|NCT00546364|101164059|FG001|Overall Study|Prior taxotere|0|||
33348593|NCT00546364|101164060|FG002|Overall Study|Prior taxotere|0|||
33348594|NCT00546364|101164058|FG000|Overall Study|Mixed response|1|||
33348595|NCT00546364|101164059|FG001|Overall Study|Mixed response|0|||
33547174|NCT00632359|101901681|FG000|Overall Study|Withdrawal by Subject|2|||
33547175|NCT02278354|101901683|FG000|Overall Study|Lost to Follow-up|2|||
33547176|NCT02278354|101901684|FG001|Overall Study|Lost to Follow-up|2|||
33547177|NCT02278354|101901683|FG000|Overall Study|Withdrawal by Subject|0|||
33547178|NCT02278354|101901684|FG001|Overall Study|Withdrawal by Subject|1|||
33348596|NCT00546364|101164060|FG002|Overall Study|Mixed response|0|||
33348597|NCT00546364|101164058|FG000|Overall Study|Palliative treatment|1|||
33348598|NCT00546364|101164059|FG001|Overall Study|Palliative treatment|0|||
33348599|NCT00546364|101164060|FG002|Overall Study|Palliative treatment|1|||
33214514|NCT00515502|100682432|FG008|Treatment Period 2|Adverse Event|0|||
33409558|NCT03339999|101389298|FG000|Overall Study|Study Terminated by Sponsor|6|||
33547179|NCT02278354|101901683|FG000|Overall Study|<10 professional fights|2|||
33547180|NCT02278354|101901684|FG001|Overall Study|<10 professional fights|0|||
33547181|NCT04766333|101901685|FG000|Overall Study|Lost to Follow-up|40|||
33409559|NCT03339999|101389299|FG001|Overall Study|Study Terminated by Sponsor|3|||
33547182|NCT04766333|101901686|FG001|Overall Study|Lost to Follow-up|826|||
33547183|NCT02595749|101901692|FG000|Overall Study|Withdrawal by Subject|12|||
33547184|NCT02595749|101901693|FG001|Overall Study|Withdrawal by Subject|7|||
33547185|NCT01898078|101901694|FG000|Overall Study|Progressive Disease|1|||
33547186|NCT01898078|101901695|FG001|Overall Study|Progressive Disease|5|||
33547187|NCT01898078|101901694|FG000|Overall Study|Adverse Event|2|||
33547188|NCT01898078|101901695|FG001|Overall Study|Adverse Event|1|||
33547189|NCT01898078|101901694|FG000|Overall Study|Withdrawal by Subject|1|||
33547190|NCT01898078|101901695|FG001|Overall Study|Withdrawal by Subject|1|||
33547191|NCT01898078|101901694|FG000|Overall Study|Symptomatic Deterioration|2|||
33547192|NCT01898078|101901695|FG001|Overall Study|Symptomatic Deterioration|0|||
33547193|NCT01898078|101901694|FG000|Overall Study|Reason not Specified|0|||
33547194|NCT01898078|101901695|FG001|Overall Study|Reason not Specified|1|||
33547195|NCT00876395|101901700|FG000|Overall Study|Untreated|8|||
33547196|NCT00876395|101901701|FG001|Overall Study|Untreated|1|||
33547197|NCT00876395|101901700|FG000|Overall Study|Adverse Event|63|||
33547198|NCT00876395|101901701|FG001|Overall Study|Adverse Event|11|||
33547199|NCT00876395|101901700|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33547200|NCT00876395|101901701|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33547201|NCT00876395|101901700|FG000|Overall Study|Disease progression|259|||
33547202|NCT00876395|101901701|FG001|Overall Study|Disease progression|162|||
33547203|NCT00876395|101901700|FG000|Overall Study|New cancer therapy|25|||
33547204|NCT00876395|101901701|FG001|Overall Study|New cancer therapy|7|||
33547205|NCT00876395|101901700|FG000|Overall Study|Protocol Violation|5|||
33547206|NCT00876395|101901701|FG001|Overall Study|Protocol Violation|2|||
33547207|NCT00876395|101901700|FG000|Overall Study|Withdrawal by Subject|66|||
33547208|NCT00876395|101901701|FG001|Overall Study|Withdrawal by Subject|33|||
33547209|NCT00876395|101901700|FG000|Overall Study|Lost to Follow-up|2|||
33547210|NCT00876395|101901701|FG001|Overall Study|Lost to Follow-up|0|||
33547211|NCT00876395|101901700|FG000|Overall Study|Administrative problems|39|||
33547212|NCT00876395|101901701|FG001|Overall Study|Administrative problems|23|||
33547213|NCT00876395|101901700|FG000|Overall Study|Death|12|||
33547214|NCT00876395|101901701|FG001|Overall Study|Death|0|||
33547215|NCT02065557|101901707|FG000|Induction Period|Withdrawal by Subject|2|||
33547216|NCT02065557|101901708|FG001|Induction Period|Withdrawal by Subject|1|||
33547217|NCT02065557|101901709|FG002|Induction Period|Withdrawal by Subject|0|||
33409560|NCT03339999|101389300|FG002|Overall Study|Study Terminated by Sponsor|4|||
33409561|NCT03339999|101389301|FG003|Overall Study|Study Terminated by Sponsor|3|||
33547218|NCT02065557|101901710|FG003|Induction Period|Withdrawal by Subject|0|||
33547219|NCT02065557|101901711|FG004|Induction Period|Withdrawal by Subject|0|||
33547220|NCT02065557|101901712|FG005|Induction Period|Withdrawal by Subject|0|||
33547221|NCT02065557|101901707|FG000|Induction Period|Lack of Efficacy|2|||
33409562|NCT01864746|101389302|FG000|Overall Study|Disease recurrence|25|||
33409563|NCT01864746|101389303|FG001|Overall Study|Disease recurrence|40|||
33409564|NCT01864746|101389302|FG000|Overall Study|Second primary invasive nonbreast|2|||
33409565|NCT01864746|101389303|FG001|Overall Study|Second primary invasive nonbreast|3|||
33409566|NCT01864746|101389302|FG000|Overall Study|Death|2|||
33409567|NCT01864746|101389303|FG001|Overall Study|Death|1|||
33409568|NCT01864746|101389302|FG000|Overall Study|Adverse Event|33|||
33409569|NCT01864746|101389303|FG001|Overall Study|Adverse Event|5|||
33409570|NCT01864746|101389302|FG000|Overall Study|Withdrawal by Subject|56|||
33409571|NCT01864746|101389303|FG001|Overall Study|Withdrawal by Subject|41|||
33409572|NCT01864746|101389302|FG000|Overall Study|Physician Decision|5|||
33409573|NCT01864746|101389303|FG001|Overall Study|Physician Decision|6|||
33409574|NCT01682876|101389304|FG000|Overall Study|Administrative reason|4|||
33409575|NCT01682876|101389305|FG001|Overall Study|Administrative reason|4|||
33409576|NCT01682876|101389306|FG002|Overall Study|Administrative reason|0|||
33409577|NCT01682876|101389307|FG003|Overall Study|Administrative reason|3|||
33547222|NCT02065557|101901708|FG001|Induction Period|Lack of Efficacy|1|||
33409578|NCT01682876|101389304|FG000|Overall Study|Adverse Event|0|||
33409579|NCT01682876|101389305|FG001|Overall Study|Adverse Event|0|||
33409580|NCT01682876|101389306|FG002|Overall Study|Adverse Event|0|||
33547223|NCT02065557|101901709|FG002|Induction Period|Lack of Efficacy|1|||
33547224|NCT02065557|101901710|FG003|Induction Period|Lack of Efficacy|0|||
33547225|NCT02065557|101901711|FG004|Induction Period|Lack of Efficacy|0|||
33409581|NCT01682876|101389307|FG003|Overall Study|Adverse Event|1|||
33409582|NCT01682876|101389304|FG000|Overall Study|Lost to Follow-up|11|||
33547226|NCT02065557|101901712|FG005|Induction Period|Lack of Efficacy|0|||
33547227|NCT02065557|101901707|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
33547228|NCT02065557|101901708|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
33547229|NCT02065557|101901709|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
33547230|NCT02065557|101901710|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
33547231|NCT02065557|101901711|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
33547232|NCT02065557|101901712|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
33409583|NCT01682876|101389305|FG001|Overall Study|Lost to Follow-up|15|||
33547233|NCT02065557|101901707|FG000|Induction Period|Non-Responder at Week 8|4|||
33547234|NCT02065557|101901708|FG001|Induction Period|Non-Responder at Week 8|4|||
33547235|NCT02065557|101901709|FG002|Induction Period|Non-Responder at Week 8|0|||
33617217|NCT02717494|102147322|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
33547236|NCT02065557|101901710|FG003|Induction Period|Non-Responder at Week 8|0|||
33547237|NCT02065557|101901711|FG004|Induction Period|Non-Responder at Week 8|0|||
33547238|NCT02065557|101901712|FG005|Induction Period|Non-Responder at Week 8|0|||
33547239|NCT02065557|101901707|FG000|Induction Period|Adverse Event|1|||
33547240|NCT02065557|101901708|FG001|Induction Period|Adverse Event|1|||
33547241|NCT02065557|101901709|FG002|Induction Period|Adverse Event|0|||
33547242|NCT02065557|101901710|FG003|Induction Period|Adverse Event|0|||
33547243|NCT02065557|101901711|FG004|Induction Period|Adverse Event|0|||
33547244|NCT02065557|101901712|FG005|Induction Period|Adverse Event|0|||
33547245|NCT02065557|101901707|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
33547246|NCT02065557|101901708|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
33547247|NCT02065557|101901709|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
33547248|NCT02065557|101901710|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
33547249|NCT02065557|101901711|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
33617218|NCT02717494|102147323|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
33617219|NCT02717494|102147324|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
33617220|NCT00265317|102147325|FG000|Lead-In|Objective progression or relapse|6|||
33617221|NCT00265317|102147326|FG001|Lead-In|Objective progression or relapse|11|||
33617222|NCT00265317|102147327|FG002|Lead-In|Objective progression or relapse|0|||
33617223|NCT00265317|102147328|FG003|Lead-In|Objective progression or relapse|0|||
33617224|NCT00265317|102147325|FG000|Lead-In|Adverse Event|2|||
33617225|NCT00265317|102147326|FG001|Lead-In|Adverse Event|1|||
33348600|NCT00546364|101164058|FG000|Overall Study|Target lesions resected|1|||
33348601|NCT00546364|101164059|FG001|Overall Study|Target lesions resected|0|||
33547250|NCT02065557|101901712|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
33547251|NCT02065557|101901707|FG000|Maintenance Period|Withdrawal by Subject|0|||
33617226|NCT00265317|102147327|FG002|Lead-In|Adverse Event|0|||
33617227|NCT00265317|102147328|FG003|Lead-In|Adverse Event|0|||
33617228|NCT00265317|102147325|FG000|Lead-In|Death|3|||
33617229|NCT00265317|102147326|FG001|Lead-In|Death|5|||
33617230|NCT00265317|102147327|FG002|Lead-In|Death|0|||
33617231|NCT00265317|102147328|FG003|Lead-In|Death|0|||
33617232|NCT00265317|102147325|FG000|Lead-In|Withdrawal/other than adverse event|1|||
33617233|NCT00265317|102147326|FG001|Lead-In|Withdrawal/other than adverse event|0|||
33348602|NCT00546364|101164060|FG002|Overall Study|Target lesions resected|0|||
33348603|NCT00546364|101164058|FG000|Overall Study|Physician Decision|0|||
33348604|NCT00546364|101164059|FG001|Overall Study|Physician Decision|0|||
33348605|NCT00546364|101164060|FG002|Overall Study|Physician Decision|1|||
33348606|NCT00546364|101164058|FG000|Overall Study|Sponsor decision|0|||
33348607|NCT00546364|101164059|FG001|Overall Study|Sponsor decision|0|||
33348608|NCT00546364|101164060|FG002|Overall Study|Sponsor decision|1|||
33547252|NCT02065557|101901708|FG001|Maintenance Period|Withdrawal by Subject|0|||
33547253|NCT02065557|101901709|FG002|Maintenance Period|Withdrawal by Subject|0|||
33547254|NCT02065557|101901710|FG003|Maintenance Period|Withdrawal by Subject|0|||
33547255|NCT02065557|101901711|FG004|Maintenance Period|Withdrawal by Subject|2|||
33547256|NCT02065557|101901712|FG005|Maintenance Period|Withdrawal by Subject|1|||
33617234|NCT00265317|102147327|FG002|Lead-In|Withdrawal/other than adverse event|0|||
33547257|NCT02065557|101901707|FG000|Maintenance Period|Lack of Efficacy|0|||
33547258|NCT02065557|101901708|FG001|Maintenance Period|Lack of Efficacy|0|||
33547259|NCT02065557|101901709|FG002|Maintenance Period|Lack of Efficacy|0|||
33547260|NCT02065557|101901710|FG003|Maintenance Period|Lack of Efficacy|0|||
33617235|NCT00265317|102147328|FG003|Lead-In|Withdrawal/other than adverse event|0|||
33348609|NCT00675597|101164064|FG000|Overall Study|Withdrawal by Subject|3|||
33617236|NCT00265317|102147325|FG000|Phase 2|Objective progression or relapse|0|||
33617237|NCT00265317|102147326|FG001|Phase 2|Objective progression or relapse|0|||
33348610|NCT00669617|101164066|FG000|Period 1|Withdrawal by Subject|0|||
33617238|NCT00265317|102147327|FG002|Phase 2|Objective progression or relapse|37|||
33348611|NCT00669617|101164067|FG001|Period 1|Withdrawal by Subject|0|||
33547261|NCT02065557|101901711|FG004|Maintenance Period|Lack of Efficacy|5|||
33547262|NCT02065557|101901712|FG005|Maintenance Period|Lack of Efficacy|2|||
33547263|NCT02065557|101901707|FG000|Maintenance Period|Subject Non-Compliance|0|||
33547264|NCT02065557|101901708|FG001|Maintenance Period|Subject Non-Compliance|0|||
33547265|NCT02065557|101901709|FG002|Maintenance Period|Subject Non-Compliance|0|||
33547266|NCT02065557|101901710|FG003|Maintenance Period|Subject Non-Compliance|0|||
33547267|NCT02065557|101901711|FG004|Maintenance Period|Subject Non-Compliance|0|||
33547268|NCT02065557|101901712|FG005|Maintenance Period|Subject Non-Compliance|1|||
33547269|NCT01113749|101901713|FG000|Overall Study|Lost to Follow-up|1|||
33547270|NCT01113749|101901714|FG001|Overall Study|Lost to Follow-up|2|||
33547271|NCT01432327|101901715|FG000|Posttest 3 Months|depression|3|||
33547272|NCT01432327|101901716|FG001|Posttest 3 Months|depression|0|||
33547273|NCT01432327|101901717|FG002|Posttest 3 Months|depression|0|||
33547274|NCT01432327|101901718|FG003|Posttest 3 Months|depression|0|||
33547275|NCT01432327|101901715|FG000|Posttest 3 Months|Lost to Follow-up|1|||
33547276|NCT01432327|101901716|FG001|Posttest 3 Months|Lost to Follow-up|0|||
33547277|NCT01432327|101901717|FG002|Posttest 3 Months|Lost to Follow-up|2|||
33547278|NCT01432327|101901718|FG003|Posttest 3 Months|Lost to Follow-up|1|||
33547279|NCT01432327|101901715|FG000|Posttest 3 Months|Allergic reaction|0|||
33547280|NCT01432327|101901716|FG001|Posttest 3 Months|Allergic reaction|2|||
33547281|NCT01432327|101901717|FG002|Posttest 3 Months|Allergic reaction|0|||
33547282|NCT01432327|101901718|FG003|Posttest 3 Months|Allergic reaction|0|||
33547283|NCT01432327|101901715|FG000|Posttest 6 Months|Lost to Follow-up|0|||
33547284|NCT01432327|101901716|FG001|Posttest 6 Months|Lost to Follow-up|0|||
33547285|NCT01432327|101901717|FG002|Posttest 6 Months|Lost to Follow-up|3|||
33547286|NCT01432327|101901718|FG003|Posttest 6 Months|Lost to Follow-up|2|||
33547287|NCT01432327|101901715|FG000|Posttest 6 Months|Allergic reaction|0|||
33617239|NCT00265317|102147328|FG003|Phase 2|Objective progression or relapse|38|||
33617240|NCT00265317|102147325|FG000|Phase 2|Global deterioration of health status|0|||
33547288|NCT01432327|101901716|FG001|Posttest 6 Months|Allergic reaction|0|||
33547289|NCT01432327|101901717|FG002|Posttest 6 Months|Allergic reaction|1|||
33547290|NCT01432327|101901718|FG003|Posttest 6 Months|Allergic reaction|0|||
33547291|NCT01432327|101901715|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
33547292|NCT01432327|101901716|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
33547293|NCT01432327|101901717|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
33547294|NCT01432327|101901718|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
33547295|NCT01432327|101901715|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
33547296|NCT01432327|101901716|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
33547297|NCT01432327|101901717|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
33547298|NCT01432327|101901718|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
33348612|NCT00669617|101164068|FG002|Period 1|Withdrawal by Subject|1|||
33348613|NCT00669617|101164069|FG003|Period 1|Withdrawal by Subject|0|||
33348614|NCT00669617|101164070|FG004|Period 1|Withdrawal by Subject|0|||
33547299|NCT01432327|101901715|FG000|Posttest 1 Year|Lost to Follow-up|0|||
33547300|NCT01432327|101901716|FG001|Posttest 1 Year|Lost to Follow-up|0|||
33547301|NCT01432327|101901717|FG002|Posttest 1 Year|Lost to Follow-up|4|||
33547302|NCT01432327|101901718|FG003|Posttest 1 Year|Lost to Follow-up|2|||
33547303|NCT01432327|101901715|FG000|Posttest 1 Year|Allergic reaction|0|||
33547304|NCT01432327|101901716|FG001|Posttest 1 Year|Allergic reaction|0|||
33547305|NCT01432327|101901717|FG002|Posttest 1 Year|Allergic reaction|1|||
33547306|NCT01432327|101901718|FG003|Posttest 1 Year|Allergic reaction|1|||
33547307|NCT01047501|101901719|FG000|Overall Study|Adverse Event|7|||
33547308|NCT01047501|101901720|FG001|Overall Study|Adverse Event|8|||
33547309|NCT01047501|101901721|FG002|Overall Study|Adverse Event|5|||
33617241|NCT00265317|102147326|FG001|Phase 2|Global deterioration of health status|0|||
33547310|NCT01047501|101901719|FG000|Overall Study|Withdrew Consent|6|||
33547311|NCT01047501|101901720|FG001|Overall Study|Withdrew Consent|2|||
33547312|NCT01047501|101901721|FG002|Overall Study|Withdrew Consent|4|||
33547313|NCT01047501|101901719|FG000|Overall Study|Lost to Follow-up|0|||
33547314|NCT01047501|101901720|FG001|Overall Study|Lost to Follow-up|1|||
33547315|NCT01047501|101901721|FG002|Overall Study|Lost to Follow-up|1|||
33617242|NCT00265317|102147327|FG002|Phase 2|Global deterioration of health status|3|||
33348615|NCT00669617|101164066|FG000|Period 1|Protocol Deviation|0|||
33348616|NCT00669617|101164067|FG001|Period 1|Protocol Deviation|0|||
33547316|NCT01047501|101901719|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
33547317|NCT01047501|101901720|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
33547318|NCT01047501|101901721|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
33547319|NCT01047501|101901719|FG000|Overall Study|Death|1|||
33617243|NCT00265317|102147328|FG003|Phase 2|Global deterioration of health status|0|||
33617244|NCT00265317|102147325|FG000|Phase 2|Adverse Event|0|||
33348617|NCT00669617|101164068|FG002|Period 1|Protocol Deviation|0|||
33547320|NCT01047501|101901720|FG001|Overall Study|Death|0|||
33547321|NCT01047501|101901721|FG002|Overall Study|Death|0|||
33547322|NCT01047501|101901719|FG000|Overall Study|Other discontinuation|1|||
33547323|NCT01047501|101901720|FG001|Overall Study|Other discontinuation|0|||
33547324|NCT01047501|101901721|FG002|Overall Study|Other discontinuation|1|||
33547325|NCT01047501|101901719|FG000|Overall Study|Investigator judgement|0|||
33547326|NCT01047501|101901720|FG001|Overall Study|Investigator judgement|0|||
33547327|NCT01047501|101901721|FG002|Overall Study|Investigator judgement|1|||
33547328|NCT01288430|101901722|FG000|Part 1|Progressive disease|2|||
33547329|NCT01288430|101901723|FG001|Part 1|Progressive disease|1|||
33547330|NCT01288430|101901724|FG002|Part 1|Progressive disease|1|||
33547331|NCT01288430|101901725|FG003|Part 1|Progressive disease|6|||
33547332|NCT01288430|101901726|FG004|Part 1|Progressive disease|2|||
33547333|NCT01288430|101901727|FG005|Part 1|Progressive disease|4|||
33547334|NCT01288430|101901728|FG006|Part 1|Progressive disease|2|||
33547335|NCT01288430|101901729|FG007|Part 1|Progressive disease|0|||
33547336|NCT01288430|101901730|FG008|Part 1|Progressive disease|0|||
33547337|NCT01288430|101901731|FG009|Part 1|Progressive disease|0|||
33547338|NCT01288430|101901722|FG000|Part 1|Clinical disease progression|0|||
33547339|NCT01288430|101901723|FG001|Part 1|Clinical disease progression|0|||
33214515|NCT00515502|100682433|FG009|Treatment Period 2|Adverse Event|0|||
33214516|NCT00515502|100682434|FG010|Treatment Period 2|Adverse Event|0|||
33214517|NCT00515502|100682435|FG011|Treatment Period 2|Adverse Event|0|||
33214518|NCT05763628|100682436|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
33547340|NCT01288430|101901724|FG002|Part 1|Clinical disease progression|1|||
33547341|NCT01288430|101901725|FG003|Part 1|Clinical disease progression|0|||
33547342|NCT01288430|101901726|FG004|Part 1|Clinical disease progression|0|||
33547343|NCT01288430|101901727|FG005|Part 1|Clinical disease progression|2|||
33547344|NCT01288430|101901728|FG006|Part 1|Clinical disease progression|2|||
33547345|NCT01288430|101901729|FG007|Part 1|Clinical disease progression|0|||
33547346|NCT01288430|101901730|FG008|Part 1|Clinical disease progression|0|||
33547347|NCT01288430|101901731|FG009|Part 1|Clinical disease progression|0|||
33547348|NCT01288430|101901722|FG000|Part 1|Death due to disease progression|0|||
33547349|NCT01288430|101901723|FG001|Part 1|Death due to disease progression|0|||
33547350|NCT01288430|101901724|FG002|Part 1|Death due to disease progression|0|||
33547351|NCT01288430|101901725|FG003|Part 1|Death due to disease progression|0|||
33547352|NCT01288430|101901726|FG004|Part 1|Death due to disease progression|1|||
33547353|NCT01288430|101901727|FG005|Part 1|Death due to disease progression|0|||
33547354|NCT01288430|101901728|FG006|Part 1|Death due to disease progression|0|||
33547355|NCT01288430|101901729|FG007|Part 1|Death due to disease progression|0|||
33547356|NCT01288430|101901730|FG008|Part 1|Death due to disease progression|0|||
33214519|NCT05763628|100682437|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
33214520|NCT05763628|100682436|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
33214521|NCT05763628|100682437|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
33214522|NCT05763628|100682436|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
33214523|NCT05763628|100682437|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
33214524|NCT02251990|100682438|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
33409584|NCT01682876|101389306|FG002|Overall Study|Lost to Follow-up|9|||
33547357|NCT01288430|101901731|FG009|Part 1|Death due to disease progression|0|||
33547358|NCT01288430|101901722|FG000|Part 1|Adverse Event|0|||
33547359|NCT01288430|101901723|FG001|Part 1|Adverse Event|0|||
33547360|NCT01288430|101901724|FG002|Part 1|Adverse Event|3|||
33547361|NCT01288430|101901725|FG003|Part 1|Adverse Event|1|||
33547362|NCT01288430|101901726|FG004|Part 1|Adverse Event|0|||
33547363|NCT01288430|101901727|FG005|Part 1|Adverse Event|0|||
33547364|NCT01288430|101901728|FG006|Part 1|Adverse Event|2|||
33547365|NCT01288430|101901729|FG007|Part 1|Adverse Event|0|||
33547366|NCT01288430|101901730|FG008|Part 1|Adverse Event|0|||
33547367|NCT01288430|101901731|FG009|Part 1|Adverse Event|0|||
33547368|NCT01288430|101901722|FG000|Part 1|Other|0|||
33547369|NCT01288430|101901723|FG001|Part 1|Other|2|||
33547370|NCT01288430|101901724|FG002|Part 1|Other|0|||
33547371|NCT01288430|101901725|FG003|Part 1|Other|0|||
33547372|NCT01288430|101901726|FG004|Part 1|Other|0|||
33617245|NCT00265317|102147326|FG001|Phase 2|Adverse Event|0|||
33617246|NCT00265317|102147327|FG002|Phase 2|Adverse Event|7|||
33617247|NCT00265317|102147328|FG003|Phase 2|Adverse Event|5|||
33617248|NCT00265317|102147325|FG000|Phase 2|Death|0|||
33617249|NCT00265317|102147326|FG001|Phase 2|Death|0|||
33617250|NCT00265317|102147327|FG002|Phase 2|Death|12|||
33617251|NCT00265317|102147328|FG003|Phase 2|Death|15|||
33617252|NCT00265317|102147325|FG000|Phase 2|Protocol Violation|0|||
33617253|NCT00265317|102147326|FG001|Phase 2|Protocol Violation|0|||
33617254|NCT00265317|102147327|FG002|Phase 2|Protocol Violation|1|||
33617255|NCT00265317|102147328|FG003|Phase 2|Protocol Violation|4|||
33617256|NCT00265317|102147325|FG000|Phase 2|Lost to Follow-up|0|||
33617257|NCT00265317|102147326|FG001|Phase 2|Lost to Follow-up|0|||
33617258|NCT00265317|102147327|FG002|Phase 2|Lost to Follow-up|0|||
33617259|NCT00265317|102147328|FG003|Phase 2|Lost to Follow-up|1|||
33617260|NCT00265317|102147325|FG000|Phase 2|Withdrawal/other than adverse event|0|||
33617261|NCT00265317|102147326|FG001|Phase 2|Withdrawal/other than adverse event|0|||
33547373|NCT01288430|101901727|FG005|Part 1|Other|0|||
33214525|NCT02251990|100682439|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
33214526|NCT02251990|100682438|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
33214527|NCT02251990|100682439|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
33214528|NCT02251990|100682438|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
33214529|NCT02251990|100682439|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
33214530|NCT02251990|100682438|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
33214531|NCT02251990|100682439|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
33214532|NCT02251990|100682438|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
33214533|NCT02251990|100682439|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
33214534|NCT02251990|100682438|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
33214535|NCT02251990|100682439|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
33214536|NCT04072159|100682440|FG000|Overall Study|Lost to Follow-up|6|||
33214537|NCT04072159|100682441|FG001|Overall Study|Lost to Follow-up|6|||
33214538|NCT04072159|100682440|FG000|Overall Study|Withdrawal by Subject|2|||
33214539|NCT04072159|100682441|FG001|Overall Study|Withdrawal by Subject|0|||
33214540|NCT01059565|100682442|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
33214541|NCT01059565|100682443|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
33214542|NCT01059565|100682442|FG000|24-Week Randomized Phase|Adverse Event|5|||
33214543|NCT01059565|100682443|FG001|24-Week Randomized Phase|Adverse Event|0|||
33214544|NCT01059565|100682442|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
33214545|NCT01059565|100682443|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
33214546|NCT01059565|100682442|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
33547374|NCT01288430|101901728|FG006|Part 1|Other|1|||
33547375|NCT01288430|101901729|FG007|Part 1|Other|0|||
33547376|NCT01288430|101901730|FG008|Part 1|Other|0|||
33547377|NCT01288430|101901731|FG009|Part 1|Other|0|||
33547378|NCT01288430|101901722|FG000|Part 2|Progressive disease|0|||
33547379|NCT01288430|101901723|FG001|Part 2|Progressive disease|0|||
33547380|NCT01288430|101901724|FG002|Part 2|Progressive disease|0|||
33214547|NCT01059565|100682443|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
33214548|NCT01059565|100682442|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
33214549|NCT01059565|100682443|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
33214550|NCT01059565|100682442|FG000|24-Week Open-Label Phase|Adverse Event|2|||
33214551|NCT01059565|100682443|FG001|24-Week Open-Label Phase|Adverse Event|0|||
33214552|NCT01059565|100682442|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
33214553|NCT01059565|100682443|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
33214554|NCT01059565|100682442|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
33348618|NCT00669617|101164069|FG003|Period 1|Protocol Deviation|0|||
33348619|NCT00669617|101164070|FG004|Period 1|Protocol Deviation|1|||
33348620|NCT00669617|101164066|FG000|Period 3|Lost to Follow-up|1|||
33348621|NCT00669617|101164067|FG001|Period 3|Lost to Follow-up|0|||
33348622|NCT00669617|101164068|FG002|Period 3|Lost to Follow-up|0|||
33348623|NCT00669617|101164069|FG003|Period 3|Lost to Follow-up|0|||
33348624|NCT00669617|101164070|FG004|Period 3|Lost to Follow-up|0|||
33348625|NCT00151892|101164071|FG000|Overall Study|Lack of Efficacy|50|||
33348626|NCT00151892|101164072|FG001|Overall Study|Lack of Efficacy|57|||
33348627|NCT00151892|101164071|FG000|Overall Study|Patient request|10|||
33348628|NCT00151892|101164072|FG001|Overall Study|Patient request|7|||
33348629|NCT00151892|101164071|FG000|Overall Study|Lost to Follow-up|5|||
33348630|NCT00151892|101164072|FG001|Overall Study|Lost to Follow-up|10|||
33348631|NCT00151892|101164071|FG000|Overall Study|Adverse Event|6|||
33348632|NCT00151892|101164072|FG001|Overall Study|Adverse Event|3|||
33348633|NCT00151892|101164071|FG000|Overall Study|Protocol Violation|3|||
33348634|NCT00151892|101164072|FG001|Overall Study|Protocol Violation|3|||
33348635|NCT00151892|101164071|FG000|Overall Study|Non-compliance|0|||
33348636|NCT00151892|101164072|FG001|Overall Study|Non-compliance|1|||
33348637|NCT00151892|101164071|FG000|Overall Study|Pregnancy|0|||
33348638|NCT00151892|101164072|FG001|Overall Study|Pregnancy|1|||
33348639|NCT00151892|101164071|FG000|Overall Study|Did not return for a visit|1|||
33348640|NCT00151892|101164072|FG001|Overall Study|Did not return for a visit|0|||
33348641|NCT00151892|101164071|FG000|Overall Study|Used prohibited corticosteroids|1|||
33348642|NCT00151892|101164072|FG001|Overall Study|Used prohibited corticosteroids|0|||
33348643|NCT00151892|101164071|FG000|Overall Study|Lack of study medication at center|0|||
33348644|NCT00151892|101164072|FG001|Overall Study|Lack of study medication at center|1|||
33547381|NCT01288430|101901725|FG003|Part 2|Progressive disease|0|||
33547382|NCT01288430|101901726|FG004|Part 2|Progressive disease|0|||
33547383|NCT01288430|101901727|FG005|Part 2|Progressive disease|0|||
33547384|NCT01288430|101901728|FG006|Part 2|Progressive disease|0|||
33214555|NCT01059565|100682443|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
33214556|NCT01059565|100682442|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
33214557|NCT01059565|100682443|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
33214558|NCT01059565|100682442|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
33348645|NCT01454076|101164073|FG000|Overall Study|Other|2|||
33547385|NCT01288430|101901729|FG007|Part 2|Progressive disease|8|||
33547386|NCT01288430|101901730|FG008|Part 2|Progressive disease|7|||
33214559|NCT01059565|100682443|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
33214560|NCT01059565|100682442|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
33348646|NCT01454076|101164074|FG001|Overall Study|Other|0|||
33547387|NCT01288430|101901731|FG009|Part 2|Progressive disease|2|||
33547388|NCT01288430|101901722|FG000|Part 2|Clinical disease progression|0|||
33348647|NCT01454076|101164075|FG002|Overall Study|Other|0|||
33348648|NCT01454076|101164076|FG003|Overall Study|Other|1|||
33348649|NCT01454076|101164077|FG004|Overall Study|Other|2|||
33348650|NCT01454076|101164073|FG000|Overall Study|Withdrawal by Subject|3|||
33348651|NCT01454076|101164074|FG001|Overall Study|Withdrawal by Subject|4|||
33348652|NCT01454076|101164075|FG002|Overall Study|Withdrawal by Subject|2|||
33348653|NCT01454076|101164076|FG003|Overall Study|Withdrawal by Subject|1|||
33348654|NCT01454076|101164077|FG004|Overall Study|Withdrawal by Subject|2|||
33348655|NCT01454076|101164073|FG000|Overall Study|Adverse Event|8|||
33348656|NCT01454076|101164074|FG001|Overall Study|Adverse Event|2|||
33348657|NCT01454076|101164075|FG002|Overall Study|Adverse Event|7|||
33348658|NCT01454076|101164076|FG003|Overall Study|Adverse Event|0|||
33348659|NCT01454076|101164077|FG004|Overall Study|Adverse Event|2|||
33348660|NCT01254669|101164081|FG000|Overall Study|Withdrawal by Subject|0|||
33348661|NCT01254669|101164082|FG001|Overall Study|Withdrawal by Subject|1|||
33348662|NCT01254669|101164081|FG000|Overall Study|time constraint|2|||
33348663|NCT01254669|101164082|FG001|Overall Study|time constraint|2|||
33348664|NCT01254669|101164081|FG000|Overall Study|called to clinic during intervention|1|||
33348665|NCT01254669|101164082|FG001|Overall Study|called to clinic during intervention|1|||
33348666|NCT01444300|101164090|FG000|Overall Study|Adverse Event|4|||
33348667|NCT01444300|101164091|FG001|Overall Study|Adverse Event|0|||
33348668|NCT00289913|101164092|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33348669|NCT00289913|101164093|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
33348670|NCT00289913|101164094|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33348671|NCT00289913|101164095|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33348672|NCT00289913|101164096|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33348673|NCT00289913|101164092|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
33348674|NCT00289913|101164093|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
33348675|NCT00289913|101164094|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
33348676|NCT00289913|101164095|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
33348677|NCT00289913|101164096|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
33348678|NCT00289913|101164092|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
33348679|NCT00289913|101164093|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
33348680|NCT00289913|101164094|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
33348681|NCT00289913|101164095|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
33348682|NCT00289913|101164096|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
33348683|NCT00289913|101164092|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
33348684|NCT00289913|101164093|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
33348685|NCT00289913|101164094|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
33348686|NCT00289913|101164095|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
33348687|NCT00289913|101164096|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
33348688|NCT00289913|101164092|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33348689|NCT00289913|101164093|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33348690|NCT00289913|101164094|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33348691|NCT00289913|101164095|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
33348692|NCT00289913|101164096|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33348693|NCT00289913|101164092|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
33348694|NCT00289913|101164093|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
33348695|NCT00289913|101164094|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
33348696|NCT00289913|101164095|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
33348697|NCT00289913|101164096|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
33348698|NCT00289913|101164092|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
33348699|NCT00289913|101164093|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
33409585|NCT01682876|101389307|FG003|Overall Study|Lost to Follow-up|11|||
33547389|NCT01288430|101901723|FG001|Part 2|Clinical disease progression|0|||
33547390|NCT01288430|101901724|FG002|Part 2|Clinical disease progression|0|||
33547391|NCT01288430|101901725|FG003|Part 2|Clinical disease progression|0|||
33547392|NCT01288430|101901726|FG004|Part 2|Clinical disease progression|0|||
33547393|NCT01288430|101901727|FG005|Part 2|Clinical disease progression|0|||
33547394|NCT01288430|101901728|FG006|Part 2|Clinical disease progression|0|||
33547395|NCT01288430|101901729|FG007|Part 2|Clinical disease progression|2|||
33547396|NCT01288430|101901730|FG008|Part 2|Clinical disease progression|0|||
33547397|NCT01288430|101901731|FG009|Part 2|Clinical disease progression|0|||
33547398|NCT01288430|101901722|FG000|Part 2|Withdrawal by Subject|0|||
33348700|NCT00289913|101164094|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
33348701|NCT00289913|101164095|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
33348702|NCT00289913|101164096|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
33348703|NCT00289913|101164092|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
33348704|NCT00289913|101164093|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
33348705|NCT00289913|101164094|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
33348706|NCT00289913|101164095|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
33348707|NCT00289913|101164096|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
33348708|NCT00289913|101164092|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
33348709|NCT00289913|101164093|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
33348710|NCT00289913|101164094|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
33348711|NCT00289913|101164095|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
33348712|NCT00289913|101164096|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
33348713|NCT00289913|101164092|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33348714|NCT00289913|101164093|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33348715|NCT00289913|101164094|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
33547399|NCT01288430|101901723|FG001|Part 2|Withdrawal by Subject|0|||
33547400|NCT01288430|101901724|FG002|Part 2|Withdrawal by Subject|0|||
33547401|NCT01288430|101901725|FG003|Part 2|Withdrawal by Subject|0|||
33547402|NCT01288430|101901726|FG004|Part 2|Withdrawal by Subject|0|||
33547403|NCT01288430|101901727|FG005|Part 2|Withdrawal by Subject|0|||
33547404|NCT01288430|101901728|FG006|Part 2|Withdrawal by Subject|0|||
33547405|NCT01288430|101901729|FG007|Part 2|Withdrawal by Subject|1|||
33348716|NCT00289913|101164095|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33348717|NCT00289913|101164096|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33409586|NCT01682876|101389304|FG000|Overall Study|Protocol Violation|1|||
33214561|NCT01059565|100682443|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
33348718|NCT00289913|101164092|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
33348719|NCT00289913|101164093|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
33348720|NCT00289913|101164094|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
33348721|NCT00289913|101164095|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
33348722|NCT00289913|101164096|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
33348723|NCT00289913|101164092|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
33348724|NCT00289913|101164093|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
33348725|NCT00289913|101164094|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
33348726|NCT00289913|101164095|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
33348727|NCT00289913|101164096|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
33348728|NCT00289913|101164092|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
33348729|NCT00289913|101164093|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
33348730|NCT00289913|101164094|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
33547406|NCT01288430|101901730|FG008|Part 2|Withdrawal by Subject|4|||
33547407|NCT01288430|101901731|FG009|Part 2|Withdrawal by Subject|0|||
33547408|NCT01288430|101901722|FG000|Part 2|Adverse Event|0|||
33617262|NCT00265317|102147327|FG002|Phase 2|Withdrawal/other than adverse event|2|||
33547409|NCT01288430|101901723|FG001|Part 2|Adverse Event|0|||
33547410|NCT01288430|101901724|FG002|Part 2|Adverse Event|0|||
33547411|NCT01288430|101901725|FG003|Part 2|Adverse Event|0|||
33617263|NCT00265317|102147328|FG003|Phase 2|Withdrawal/other than adverse event|1|||
33617264|NCT00265317|102147325|FG000|Phase 2|Study terminated by sponsor|0|||
33617265|NCT00265317|102147326|FG001|Phase 2|Study terminated by sponsor|0|||
33617266|NCT00265317|102147327|FG002|Phase 2|Study terminated by sponsor|1|||
33617267|NCT00265317|102147328|FG003|Phase 2|Study terminated by sponsor|0|||
33617268|NCT00265317|102147325|FG000|Phase 2|Other|0|||
33547412|NCT01288430|101901726|FG004|Part 2|Adverse Event|0|||
33617269|NCT00265317|102147326|FG001|Phase 2|Other|0|||
33617270|NCT00265317|102147327|FG002|Phase 2|Other|1|||
33617271|NCT00265317|102147328|FG003|Phase 2|Other|1|||
33617272|NCT00279916|102147329|FG000|Overall Study|Withdrawal by Subject|4|||
33617273|NCT00279916|102147330|FG001|Overall Study|Withdrawal by Subject|3|||
33617274|NCT00279916|102147329|FG000|Overall Study|Lost to Follow-up|3|||
33617275|NCT00279916|102147330|FG001|Overall Study|Lost to Follow-up|2|||
33617276|NCT00649428|102147331|FG000|Overall Study|Adverse Event|2|||
33617277|NCT00649428|102147332|FG001|Overall Study|Adverse Event|2|||
33617278|NCT00649428|102147331|FG000|Overall Study|Withdrawal by Subject|6|||
33617279|NCT00649428|102147332|FG001|Overall Study|Withdrawal by Subject|6|||
33547413|NCT01288430|101901727|FG005|Part 2|Adverse Event|0|||
33617280|NCT00649428|102147331|FG000|Overall Study|Lost to Follow-up|1|||
33617281|NCT00649428|102147332|FG001|Overall Study|Lost to Follow-up|3|||
33617282|NCT00649428|102147331|FG000|Overall Study|Insufficient manufacturing yield|5|||
33617283|NCT00649428|102147332|FG001|Overall Study|Insufficient manufacturing yield|1|||
33617284|NCT00649428|102147331|FG000|Overall Study|Protocol Violation|6|||
33617285|NCT00649428|102147332|FG001|Overall Study|Protocol Violation|2|||
33617286|NCT00649428|102147331|FG000|Overall Study|Physician Decision|0|||
33617287|NCT00649428|102147332|FG001|Overall Study|Physician Decision|1|||
33617288|NCT00203424|102147337|FG000|Treatment Period|Withdrawal by Subject|4|||
33617289|NCT00203424|102147337|FG000|Treatment Period|Adverse Event|5|||
33617290|NCT00203424|102147337|FG000|Treatment Period|progressive disease|2|||
33617291|NCT00203424|102147337|FG000|Follow-up Period|Withdrawal by Subject|1|||
33617292|NCT00203424|102147337|FG000|Follow-up Period|progressive disease|4|||
33617293|NCT00203424|102147337|FG000|Follow-up Period|Lost to Follow-up|1|||
33214562|NCT03853109|100682444|FG000|Overall Study|Withdrawal by Subject|0|||
33214563|NCT03853109|100682445|FG001|Overall Study|Withdrawal by Subject|0|||
33547414|NCT01288430|101901728|FG006|Part 2|Adverse Event|0|||
33547415|NCT01288430|101901729|FG007|Part 2|Adverse Event|1|||
33547416|NCT01288430|101901730|FG008|Part 2|Adverse Event|1|||
33547417|NCT01288430|101901731|FG009|Part 2|Adverse Event|0|||
33547418|NCT01288430|101901722|FG000|Part 2|Other|0|||
33617294|NCT01641601|102147338|FG000|Overall Study|Study discontinued.|3|||
33617295|NCT01641601|102147339|FG001|Overall Study|Study discontinued.|5|||
33617296|NCT03305770|102147342|FG000|Overall Study|Physician Decision - prior to dispense|0|||
33617297|NCT03305770|102147343|FG001|Overall Study|Physician Decision - prior to dispense|1|||
33617298|NCT03305770|102147342|FG000|Overall Study|Subject moved|1|||
33617299|NCT03305770|102147343|FG001|Overall Study|Subject moved|0|||
33617300|NCT03386487|102147345|FG000|Overall Study|Lost to Follow-up|5|||
33617301|NCT03386487|102147346|FG001|Overall Study|Lost to Follow-up|6|||
33617302|NCT03386487|102147345|FG000|Overall Study|Withdrawal by Subject|11|||
33617303|NCT03386487|102147346|FG001|Overall Study|Withdrawal by Subject|7|||
33409587|NCT01682876|101389305|FG001|Overall Study|Protocol Violation|1|||
33409588|NCT01682876|101389306|FG002|Overall Study|Protocol Violation|1|||
33409589|NCT01682876|101389307|FG003|Overall Study|Protocol Violation|1|||
33409590|NCT01682876|101389304|FG000|Overall Study|Withdrawal by Subject|4|||
33409591|NCT01682876|101389305|FG001|Overall Study|Withdrawal by Subject|0|||
33409592|NCT01682876|101389306|FG002|Overall Study|Withdrawal by Subject|0|||
33409593|NCT01682876|101389307|FG003|Overall Study|Withdrawal by Subject|2|||
33409594|NCT01682876|101389304|FG000|Overall Study|Other|1|||
33409595|NCT01682876|101389305|FG001|Overall Study|Other|0|||
33409596|NCT01682876|101389306|FG002|Overall Study|Other|1|||
33409597|NCT01682876|101389307|FG003|Overall Study|Other|1|||
33409598|NCT01308476|101389309|FG000|Overall Study|Lost to Follow-up|2|||
33409599|NCT01308476|101389310|FG001|Overall Study|Lost to Follow-up|2|||
33409600|NCT01308476|101389309|FG000|Overall Study|Other|1|||
33409601|NCT01308476|101389310|FG001|Overall Study|Other|0|||
33409602|NCT01869959|101389311|FG000|Randomization Period|Physician Decision|0|||
33409603|NCT01869959|101389312|FG001|Randomization Period|Physician Decision|0|||
33409604|NCT01869959|101389313|FG002|Randomization Period|Physician Decision|0|||
33409605|NCT01869959|101389314|FG003|Randomization Period|Physician Decision|0|||
33409606|NCT01869959|101389315|FG004|Randomization Period|Physician Decision|1|||
33409607|NCT01869959|101389311|FG000|Treatment Period|Adverse Event|1|||
33409608|NCT01869959|101389312|FG001|Treatment Period|Adverse Event|0|||
33409609|NCT01869959|101389313|FG002|Treatment Period|Adverse Event|3|||
33409610|NCT01869959|101389314|FG003|Treatment Period|Adverse Event|1|||
33409611|NCT01869959|101389315|FG004|Treatment Period|Adverse Event|0|||
33409612|NCT01869959|101389311|FG000|Treatment Period|Sponsor decision|0|||
33409613|NCT01869959|101389312|FG001|Treatment Period|Sponsor decision|1|||
33409614|NCT01869959|101389313|FG002|Treatment Period|Sponsor decision|0|||
33409615|NCT01869959|101389314|FG003|Treatment Period|Sponsor decision|1|||
33409616|NCT01869959|101389315|FG004|Treatment Period|Sponsor decision|0|||
33409617|NCT01869959|101389311|FG000|Treatment Period|Withdrawal by Subject|0|||
33409618|NCT01869959|101389312|FG001|Treatment Period|Withdrawal by Subject|1|||
33409619|NCT01869959|101389313|FG002|Treatment Period|Withdrawal by Subject|0|||
33409620|NCT01869959|101389314|FG003|Treatment Period|Withdrawal by Subject|0|||
33409621|NCT01869959|101389315|FG004|Treatment Period|Withdrawal by Subject|0|||
33409622|NCT01980056|101389317|FG000|Overall Study|Death|1|||
33409623|NCT01980056|101389318|FG001|Overall Study|Death|1|||
33409624|NCT01980056|101389319|FG002|Overall Study|Death|0|||
33409625|NCT01333501|101389320|FG000|Overall Study|Adverse Event|3|||
33409626|NCT01333501|101389321|FG001|Overall Study|Adverse Event|1|||
33409627|NCT01333501|101389320|FG000|Overall Study|Abnormal laboratory value|2|||
33409628|NCT01333501|101389321|FG001|Overall Study|Abnormal laboratory value|1|||
33409629|NCT01333501|101389320|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33409630|NCT01333501|101389321|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
33409631|NCT01333501|101389320|FG000|Overall Study|Withdrawn consent|3|||
33409632|NCT01333501|101389321|FG001|Overall Study|Withdrawn consent|12|||
33409633|NCT00779857|101389322|FG000|Overall Study|Death|1|||
33409634|NCT00779857|101389322|FG000|Overall Study|Withdrawal by Subject|3|||
33409635|NCT00779857|101389322|FG000|Overall Study|Missed Visit|2|||
33409636|NCT03704194|101389323|FG000|Overall Study|Withdrawal by Subject|0|||
33409637|NCT03704194|101389324|FG001|Overall Study|Withdrawal by Subject|1|||
33409638|NCT00761462|101389325|FG000|Treatment|Subjects never received study medication|23|||
33409639|NCT00761462|101389326|FG001|Treatment|Subjects never received study medication|12|||
33409640|NCT00761462|101389325|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
33409641|NCT00761462|101389326|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
33409642|NCT00761462|101389325|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
33409643|NCT00761462|101389326|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
33409644|NCT00761462|101389325|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
33617304|NCT03386487|102147345|FG000|Overall Study|Physician Decision|11|||
33617305|NCT03386487|102147346|FG001|Overall Study|Physician Decision|8|||
33409645|NCT00761462|101389326|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
33409646|NCT00229931|101389327|FG000|Overall Study|Death|1|||
33409647|NCT00229931|101389328|FG001|Overall Study|Death|0|||
33409648|NCT00229931|101389327|FG000|Overall Study|Lost to Follow-up|3|||
33409649|NCT00229931|101389328|FG001|Overall Study|Lost to Follow-up|2|||
33409650|NCT01911546|101389329|FG000|Overall Study|Lost to Follow-up|1|||
33409651|NCT01911546|101389329|FG000|Overall Study|Everolimus was discontinued|5|||
33409652|NCT03783026|101389330|FG000|Treatment Phase|Adverse Event|15|||
33409653|NCT03783026|101389330|FG000|Treatment Phase|Lack of Efficacy|11|||
33409654|NCT03783026|101389330|FG000|Treatment Phase|Withdrawal by Subject|6|||
33409655|NCT03783026|101389330|FG000|Treatment Phase|Lost to Follow-up|2|||
33409656|NCT03783026|101389330|FG000|Treatment Phase|Protocol Deviation|8|||
33409657|NCT03783026|101389330|FG000|Treatment Phase|Did Not Receive Treatment|1|||
33409658|NCT03783026|101389330|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
33409659|NCT01241591|101389331|FG000|Overall Study|Lack of Efficacy|5|||
33409660|NCT01241591|101389332|FG001|Overall Study|Lack of Efficacy|2|||
33409661|NCT01241591|101389333|FG002|Overall Study|Lack of Efficacy|2|||
33409662|NCT01241591|101389334|FG003|Overall Study|Lack of Efficacy|3|||
33409663|NCT01241591|101389331|FG000|Overall Study|Protocol Violation|5|||
33409664|NCT01241591|101389332|FG001|Overall Study|Protocol Violation|2|||
33409665|NCT01241591|101389333|FG002|Overall Study|Protocol Violation|3|||
33409666|NCT01241591|101389334|FG003|Overall Study|Protocol Violation|0|||
33409667|NCT01241591|101389331|FG000|Overall Study|Lost to Follow-up|1|||
33409668|NCT01241591|101389332|FG001|Overall Study|Lost to Follow-up|2|||
33409669|NCT01241591|101389333|FG002|Overall Study|Lost to Follow-up|2|||
33409670|NCT01241591|101389334|FG003|Overall Study|Lost to Follow-up|2|||
33409671|NCT01241591|101389331|FG000|Overall Study|Screen Failure|3|||
33409672|NCT01241591|101389332|FG001|Overall Study|Screen Failure|2|||
33409673|NCT01241591|101389333|FG002|Overall Study|Screen Failure|1|||
33409674|NCT01241591|101389334|FG003|Overall Study|Screen Failure|0|||
33409675|NCT01241591|101389331|FG000|Overall Study|Withdrawal by Subject|6|||
33409676|NCT01241591|101389332|FG001|Overall Study|Withdrawal by Subject|4|||
33409677|NCT01241591|101389333|FG002|Overall Study|Withdrawal by Subject|2|||
33409678|NCT01241591|101389334|FG003|Overall Study|Withdrawal by Subject|2|||
33409679|NCT01241591|101389331|FG000|Overall Study|Other|0|||
33409680|NCT01241591|101389332|FG001|Overall Study|Other|1|||
33409681|NCT01241591|101389333|FG002|Overall Study|Other|0|||
33409682|NCT01241591|101389334|FG003|Overall Study|Other|1|||
33409683|NCT01241591|101389331|FG000|Overall Study|Adverse Event|3|||
33409684|NCT01241591|101389332|FG001|Overall Study|Adverse Event|11|||
33409685|NCT01241591|101389333|FG002|Overall Study|Adverse Event|12|||
33409686|NCT01241591|101389334|FG003|Overall Study|Adverse Event|4|||
33409687|NCT01098266|101389335|FG000|Overall Study|Physician Decision|1|||
33409688|NCT01098266|101389336|FG001|Overall Study|Physician Decision|0|||
33409689|NCT01098266|101389335|FG000|Overall Study|Death|3|||
33409690|NCT01098266|101389336|FG001|Overall Study|Death|2|||
33409691|NCT01098266|101389335|FG000|Overall Study|Withdrawal by Subject|3|||
33409692|NCT01098266|101389336|FG001|Overall Study|Withdrawal by Subject|5|||
33409693|NCT02120456|101389338|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33409694|NCT02120456|101389339|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33409695|NCT02120456|101389340|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33409696|NCT02120456|101389341|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33409697|NCT02120456|101389342|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33409698|NCT02120456|101389343|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33409699|NCT02120456|101389344|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
33348731|NCT00289913|101164095|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
33348732|NCT00289913|101164096|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
33348733|NCT00289913|101164092|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
33348734|NCT00289913|101164093|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33348735|NCT00289913|101164094|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
33348736|NCT00289913|101164095|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33348737|NCT00289913|101164096|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33348738|NCT00289913|101164092|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
33348739|NCT00289913|101164093|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
33348740|NCT00289913|101164094|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
33348741|NCT00289913|101164095|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
33348742|NCT00289913|101164096|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
33348743|NCT00289913|101164092|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
33348744|NCT00289913|101164093|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
33348745|NCT00289913|101164094|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
33348746|NCT00289913|101164095|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
33348747|NCT00289913|101164096|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
33348748|NCT00289913|101164092|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
33409700|NCT02120456|101389345|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33409701|NCT02120456|101389346|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
33409702|NCT02120456|101389338|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33409703|NCT02120456|101389339|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33409704|NCT02120456|101389340|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33409705|NCT02120456|101389341|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33409706|NCT02120456|101389342|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33409707|NCT02120456|101389343|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33547419|NCT01288430|101901723|FG001|Part 2|Other|0|||
33617306|NCT02926638|102147350|FG000|Overall Study|Progression|2|||
33617307|NCT02926638|102147351|FG001|Overall Study|Progression|5|||
33617308|NCT02926638|102147350|FG000|Overall Study|Ineligible|1|||
33617309|NCT02926638|102147351|FG001|Overall Study|Ineligible|0|||
33617310|NCT02926638|102147350|FG000|Overall Study|Not protocol specified|1|||
33617311|NCT02926638|102147351|FG001|Overall Study|Not protocol specified|0|||
33617312|NCT03831100|102147352|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
33617313|NCT03831100|102147353|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
33617314|NCT03301350|102147360|FG000|Overall Study|Withdrawal by Subject|4|||
33617315|NCT03301350|102147360|FG000|Overall Study|Adverse Event|1|||
33617316|NCT03301350|102147360|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
33617317|NCT03301350|102147360|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
33617318|NCT03301350|102147360|FG000|Overall Study|no detail provided|1|||
33617319|NCT00394706|102147366|FG000|Overall Study|Withdrawal by Subject|2|||
33617320|NCT00394706|102147367|FG001|Overall Study|Withdrawal by Subject|0|||
33617321|NCT00394706|102147368|FG002|Overall Study|Withdrawal by Subject|1|||
33617322|NCT00394706|102147369|FG003|Overall Study|Withdrawal by Subject|0|||
33617323|NCT00394706|102147370|FG004|Overall Study|Withdrawal by Subject|0|||
33617324|NCT00394706|102147371|FG005|Overall Study|Withdrawal by Subject|2|||
33617325|NCT00394706|102147372|FG006|Overall Study|Withdrawal by Subject|1|||
33617326|NCT00394706|102147373|FG007|Overall Study|Withdrawal by Subject|0|||
33617327|NCT00394706|102147366|FG000|Overall Study|Lost to Follow-up|2|||
33617328|NCT00394706|102147367|FG001|Overall Study|Lost to Follow-up|2|||
33617329|NCT00394706|102147368|FG002|Overall Study|Lost to Follow-up|8|||
33617330|NCT00394706|102147369|FG003|Overall Study|Lost to Follow-up|1|||
33214564|NCT03853109|100682446|FG002|Overall Study|Withdrawal by Subject|1|||
33348749|NCT00289913|101164093|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
33348750|NCT00289913|101164094|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
33348751|NCT00289913|101164095|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
33348752|NCT00289913|101164096|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
33348753|NCT00289913|101164092|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
33348754|NCT00289913|101164093|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
33348755|NCT00289913|101164094|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
33348756|NCT00289913|101164095|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
33348757|NCT00289913|101164096|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
33348758|NCT00289913|101164092|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
33348759|NCT00289913|101164093|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
33348760|NCT00289913|101164094|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
33348761|NCT00289913|101164095|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
33348762|NCT00289913|101164096|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
33348763|NCT00289913|101164092|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
33348764|NCT00289913|101164093|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
33348765|NCT00289913|101164094|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
33348766|NCT00289913|101164095|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
33348767|NCT00289913|101164096|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
33348768|NCT00289913|101164092|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
33348769|NCT00289913|101164093|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
33348770|NCT00289913|101164094|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
33348771|NCT00289913|101164095|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
33348772|NCT00289913|101164096|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
33348773|NCT00289913|101164092|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
33348774|NCT00289913|101164093|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
33348775|NCT00289913|101164094|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
33348776|NCT00289913|101164095|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
33348777|NCT00289913|101164096|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
33348778|NCT00289913|101164092|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
33348779|NCT00289913|101164093|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
33348780|NCT00289913|101164094|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
33348781|NCT00289913|101164095|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
33547420|NCT01288430|101901724|FG002|Part 2|Other|0|||
33617331|NCT00394706|102147370|FG004|Overall Study|Lost to Follow-up|2|||
33617332|NCT00394706|102147371|FG005|Overall Study|Lost to Follow-up|5|||
33214565|NCT03853109|100682447|FG003|Overall Study|Withdrawal by Subject|2|||
33214566|NCT03853109|100682448|FG004|Overall Study|Withdrawal by Subject|1|||
33348782|NCT00289913|101164096|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
33348783|NCT00289913|101164092|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33348784|NCT00289913|101164093|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
33348785|NCT00289913|101164094|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33348786|NCT00289913|101164095|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33348787|NCT00289913|101164096|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
33547421|NCT01288430|101901725|FG003|Part 2|Other|0|||
33547422|NCT01288430|101901726|FG004|Part 2|Other|0|||
33547423|NCT01288430|101901727|FG005|Part 2|Other|0|||
33547424|NCT01288430|101901728|FG006|Part 2|Other|0|||
33547425|NCT01288430|101901729|FG007|Part 2|Other|0|||
33547426|NCT01288430|101901730|FG008|Part 2|Other|0|||
33547427|NCT01288430|101901731|FG009|Part 2|Other|1|||
33547428|NCT03801252|101901732|FG000|Overall Study|Protocol Violation|1|||
33547429|NCT03801252|101901733|FG001|Overall Study|Protocol Violation|2|||
33547430|NCT00485303|101901734|FG000|Overall Study|Adverse Event|5|||
33547431|NCT00485303|101901734|FG000|Overall Study|Progressive Disease|44|||
33547432|NCT00485303|101901734|FG000|Overall Study|Other|3|||
33547433|NCT00485303|101901734|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
33547434|NCT00485303|101901734|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
33547435|NCT03003468|101901738|FG000|Overall Study|Withdrawal by Subject|0|||
33547436|NCT03003468|101901739|FG001|Overall Study|Withdrawal by Subject|0|||
33547437|NCT03003468|101901740|FG002|Overall Study|Withdrawal by Subject|1|||
33547438|NCT03003468|101901738|FG000|Overall Study|No measurable lesions|0|||
33547439|NCT03003468|101901739|FG001|Overall Study|No measurable lesions|0|||
33547440|NCT03003468|101901740|FG002|Overall Study|No measurable lesions|1|||
33547441|NCT02110693|101901741|FG000|Overall Study|Withdrawal by Subject|6|||
33547442|NCT02110693|101901742|FG001|Overall Study|Withdrawal by Subject|7|||
33547443|NCT02110693|101901741|FG000|Overall Study|skipped assessment|15|||
33547444|NCT02110693|101901742|FG001|Overall Study|skipped assessment|18|||
33547445|NCT02110693|101901741|FG000|Overall Study|technical difficulties|6|||
33547446|NCT02110693|101901742|FG001|Overall Study|technical difficulties|4|||
33547447|NCT02110693|101901741|FG000|Overall Study|Other|1|||
33547448|NCT02110693|101901742|FG001|Overall Study|Other|0|||
33348788|NCT00289913|101164092|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
33547449|NCT05399771|101901745|FG000|Overall Study|Physician Decision|3|||
33547450|NCT05399771|101901745|FG000|Overall Study|Adverse Event|1|||
33547451|NCT01155141|101901746|FG000|Overall Study|Withdrawal by Subject|1|||
33547452|NCT01155141|101901746|FG000|Overall Study|Screen Failure|1|||
33547453|NCT00927472|101901748|FG000|Overall Study|Withdrawal by Subject|10|||
33547454|NCT00927472|101901749|FG001|Overall Study|Withdrawal by Subject|11|||
33547455|NCT00927472|101901748|FG000|Overall Study|Lost to Follow-up|1|||
33547456|NCT00927472|101901749|FG001|Overall Study|Lost to Follow-up|6|||
33348789|NCT00289913|101164093|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
33348790|NCT00289913|101164094|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
33348791|NCT00289913|101164095|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
33348792|NCT00289913|101164096|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
33348793|NCT00289913|101164092|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
33348794|NCT00289913|101164093|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
33348795|NCT00289913|101164094|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
33348796|NCT00289913|101164095|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
33348797|NCT00289913|101164096|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
33348798|NCT00289913|101164092|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33348799|NCT00289913|101164093|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33348800|NCT00289913|101164094|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33348801|NCT00289913|101164095|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
33547457|NCT00927472|101901748|FG000|Overall Study|Protocol Violation|0|||
33547458|NCT00927472|101901749|FG001|Overall Study|Protocol Violation|1|||
33547459|NCT00927472|101901748|FG000|Overall Study|Post treatment Assessment out of window|0|||
33547460|NCT00927472|101901749|FG001|Overall Study|Post treatment Assessment out of window|4|||
33547461|NCT00118287|101901752|FG000|Overall Study|Intracranial haemorrhage|1|||
33547462|NCT00118287|101901752|FG000|Overall Study|Muscle pain|1|||
33547463|NCT01750346|101901753|FG000|Overall Study|Adverse Event|1|||
33547464|NCT01750346|101901754|FG001|Overall Study|Adverse Event|0|||
33547465|NCT01750346|101901755|FG002|Overall Study|Adverse Event|0|||
33547466|NCT02311478|101901756|FG000|Overall Study|Withdrawal by Subject|1|||
33547467|NCT02311478|101901756|FG000|Overall Study|Lost to Follow-up|5|||
33547468|NCT02311478|101901756|FG000|Overall Study|Failed IUD Insertion|1|||
33617333|NCT00394706|102147372|FG006|Overall Study|Lost to Follow-up|2|||
33547469|NCT01039675|101901758|FG000|Overall Study|Adverse Event|0|||
33547470|NCT01039675|101901759|FG001|Overall Study|Adverse Event|2|||
33547471|NCT01039675|101901758|FG000|Overall Study|Lack of Efficacy|0|||
33617334|NCT00394706|102147373|FG007|Overall Study|Lost to Follow-up|0|||
33547472|NCT01039675|101901759|FG001|Overall Study|Lack of Efficacy|2|||
33547473|NCT01039675|101901758|FG000|Overall Study|Withdrawal by Subject|0|||
33547474|NCT01039675|101901759|FG001|Overall Study|Withdrawal by Subject|1|||
33547475|NCT01039675|101901758|FG000|Overall Study|Lost to Follow-up|0|||
33547476|NCT01039675|101901759|FG001|Overall Study|Lost to Follow-up|1|||
33547477|NCT01039675|101901758|FG000|Overall Study|Physician Decision|0|||
33547478|NCT01039675|101901759|FG001|Overall Study|Physician Decision|1|||
33547479|NCT01180777|101901760|FG000|Overall Study|Protocol Violation|6|||
33547480|NCT01180777|101901760|FG000|Overall Study|Poor lens fit|4|||
33547481|NCT01180777|101901760|FG000|Overall Study|Lost to Follow-up|1|||
33547482|NCT01180777|101901760|FG000|Overall Study|Adverse Event|1|||
33547483|NCT04115059|101905064|FG000|Overall Study|Withdrawal by Subject|1|||
33547484|NCT04115059|101905064|FG000|Overall Study|Lack of Efficacy|2|||
33547485|NCT04424901|101905065|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
33547486|NCT04424901|101905066|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
33547487|NCT01922011|101905067|FG000|Overall Study|Protocol Violation|0|||
33547488|NCT01922011|101905068|FG001|Overall Study|Protocol Violation|1|||
33547489|NCT01922011|101905067|FG000|Overall Study|Physician Decision|0|||
33547490|NCT01922011|101905068|FG001|Overall Study|Physician Decision|1|||
33547491|NCT01922011|101905067|FG000|Overall Study|Parent/Guardian Decision|3|||
33547492|NCT01922011|101905068|FG001|Overall Study|Parent/Guardian Decision|0|||
33547493|NCT01922011|101905067|FG000|Overall Study|Lost to Follow-up|0|||
33547494|NCT01922011|101905068|FG001|Overall Study|Lost to Follow-up|1|||
33547495|NCT01922011|101905067|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
33547496|NCT01922011|101905068|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
33547497|NCT01922011|101905067|FG000|Overall Study|Not Treated|1|||
33547498|NCT01922011|101905068|FG001|Overall Study|Not Treated|0|||
33547499|NCT01922011|101905067|FG000|Overall Study|Lack of willing home health agency|1|||
33547500|NCT01922011|101905068|FG001|Overall Study|Lack of willing home health agency|0|||
33547501|NCT01922011|101905067|FG000|Overall Study|Randomized in error|1|||
33547502|NCT01922011|101905068|FG001|Overall Study|Randomized in error|0|||
33547503|NCT01341470|101905069|FG000|Overall Study|Sponsor decision|0|||
33547504|NCT01341470|101905070|FG001|Overall Study|Sponsor decision|0|||
33547505|NCT01341470|101905071|FG002|Overall Study|Sponsor decision|1|||
33547506|NCT01341470|101905072|FG003|Overall Study|Sponsor decision|1|||
33547507|NCT01341470|101905073|FG004|Overall Study|Sponsor decision|0|||
33547508|NCT01341470|101905074|FG005|Overall Study|Sponsor decision|1|||
33547509|NCT01432951|101905075|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
33547510|NCT01373229|101905076|FG000|Overall Study|Death|3|||
33547511|NCT01373229|101905076|FG000|Overall Study|Physician Decision|3|||
33547512|NCT00689936|101905077|FG000|Active Treatment Phase|Adverse Event|68|||
33547513|NCT00689936|101905078|FG001|Active Treatment Phase|Adverse Event|71|||
33547514|NCT00689936|101905079|FG002|Active Treatment Phase|Adverse Event|76|||
33547515|NCT00689936|101905077|FG000|Active Treatment Phase|Disease Progression|273|||
33547516|NCT00689936|101905078|FG001|Active Treatment Phase|Disease Progression|362|||
33547517|NCT00689936|101905079|FG002|Active Treatment Phase|Disease Progression|339|||
33547518|NCT00689936|101905077|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
33547519|NCT00689936|101905078|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
33547520|NCT00689936|101905079|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
33547521|NCT00689936|101905077|FG000|Active Treatment Phase|Death|60|||
33547522|NCT00689936|101905078|FG001|Active Treatment Phase|Death|28|||
33547523|NCT00689936|101905079|FG002|Active Treatment Phase|Death|37|||
33547524|NCT00689936|101905077|FG000|Active Treatment Phase|Lost to Follow-up|0|||
33547525|NCT00689936|101905078|FG001|Active Treatment Phase|Lost to Follow-up|2|||
33547526|NCT00689936|101905079|FG002|Active Treatment Phase|Lost to Follow-up|2|||
33547527|NCT00689936|101905077|FG000|Active Treatment Phase|Protocol Violation|2|||
33547528|NCT00689936|101905078|FG001|Active Treatment Phase|Protocol Violation|2|||
33547529|NCT00689936|101905079|FG002|Active Treatment Phase|Protocol Violation|4|||
33547530|NCT00689936|101905077|FG000|Active Treatment Phase|Study Close Out|64|||
33547531|NCT00689936|101905078|FG001|Active Treatment Phase|Study Close Out|26|||
33547532|NCT00689936|101905079|FG002|Active Treatment Phase|Study Close Out|21|||
33547533|NCT00689936|101905077|FG000|Active Treatment Phase|Miscellaneous|52|||
33547534|NCT00689936|101905078|FG001|Active Treatment Phase|Miscellaneous|34|||
33547535|NCT00689936|101905079|FG002|Active Treatment Phase|Miscellaneous|47|||
33547536|NCT00689936|101905077|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
33547537|NCT00689936|101905078|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
33547538|NCT00689936|101905079|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
33547539|NCT05436288|101905082|FG000|Overall Study|Lost to Follow-up|1|||
33547540|NCT05436288|101905082|FG000|Overall Study|Adverse Event|1|||
33547541|NCT01900314|101905085|FG000|Overall Study|Lost to Follow-up|1|||
33617335|NCT03088917|102147374|FG000|Overall Study|In care/cured elsewhere|15|||
33547542|NCT01900314|101905086|FG001|Overall Study|Lost to Follow-up|0|||
33547543|NCT01900314|101905085|FG000|Overall Study|Protocol Violation|0|||
33547544|NCT01900314|101905086|FG001|Overall Study|Protocol Violation|1|||
33547545|NCT01900314|101905085|FG000|Overall Study|Withdrawal by Subject|3|||
33547546|NCT01900314|101905086|FG001|Overall Study|Withdrawal by Subject|3|||
33547547|NCT01125748|101905087|FG000|Overall Study|Adverse Event|0|||
33617336|NCT03088917|102147374|FG000|Overall Study|Refuse re-evaluation|13|||
33547548|NCT01125748|101905088|FG001|Overall Study|Adverse Event|2|||
33547549|NCT01125748|101905087|FG000|Overall Study|Lost to Follow-up|0|||
33547550|NCT01125748|101905088|FG001|Overall Study|Lost to Follow-up|1|||
33547551|NCT01125748|101905087|FG000|Overall Study|Physician Decision|8|||
33547552|NCT01125748|101905088|FG001|Overall Study|Physician Decision|7|||
33547553|NCT01125748|101905087|FG000|Overall Study|Patient Decision to Withdraw|2|||
33547554|NCT01125748|101905088|FG001|Overall Study|Patient Decision to Withdraw|4|||
33547555|NCT01454284|101905089|FG000|Overall Study|Adverse Event|20|||
33547556|NCT01454284|101905090|FG001|Overall Study|Adverse Event|7|||
33547557|NCT01454284|101905089|FG000|Overall Study|Death|0|||
33547558|NCT01454284|101905090|FG001|Overall Study|Death|3|||
33547559|NCT01454284|101905089|FG000|Overall Study|Lost to Follow-up|13|||
33547560|NCT01454284|101905090|FG001|Overall Study|Lost to Follow-up|8|||
33547561|NCT01454284|101905089|FG000|Overall Study|Protocol Violation|9|||
33547562|NCT01454284|101905090|FG001|Overall Study|Protocol Violation|6|||
33547563|NCT01454284|101905089|FG000|Overall Study|Withdrawal by Subject|58|||
33547564|NCT01454284|101905090|FG001|Overall Study|Withdrawal by Subject|36|||
33547565|NCT01454284|101905089|FG000|Overall Study|Physician Decision|16|||
33547566|NCT01454284|101905090|FG001|Overall Study|Physician Decision|11|||
33547567|NCT01454284|101905089|FG000|Overall Study|Sponsor Decision|0|||
33547568|NCT01454284|101905090|FG001|Overall Study|Sponsor Decision|2|||
33547569|NCT01695772|101905091|FG000|Overall Study|Withdrawal by Subject|18|||
33547570|NCT01695772|101905091|FG000|Overall Study|Progressive Disease|8|||
33547571|NCT01695772|101905091|FG000|Overall Study|Investigator Decision|5|||
33547572|NCT01695772|101905091|FG000|Overall Study|Lost to Follow-up|4|||
33547573|NCT01695772|101905091|FG000|Overall Study|Protocol Violation|2|||
33547574|NCT01695772|101905091|FG000|Overall Study|Unspecified Reason|1|||
33547575|NCT02336503|101905092|FG000|Overall Study|Lost to Follow-up|0|||
33547576|NCT02336503|101905093|FG001|Overall Study|Lost to Follow-up|3|||
33547577|NCT02336503|101905094|FG002|Overall Study|Lost to Follow-up|0|||
33547578|NCT02336503|101905095|FG003|Overall Study|Lost to Follow-up|2|||
33547579|NCT02336503|101905092|FG000|Overall Study|Withdrawal by Subject|2|||
33547580|NCT02336503|101905093|FG001|Overall Study|Withdrawal by Subject|0|||
33547581|NCT02336503|101905094|FG002|Overall Study|Withdrawal by Subject|0|||
33547582|NCT02336503|101905095|FG003|Overall Study|Withdrawal by Subject|4|||
33547583|NCT02336503|101905092|FG000|Overall Study|Adverse Event|0|||
33547584|NCT02336503|101905093|FG001|Overall Study|Adverse Event|0|||
33547585|NCT02336503|101905094|FG002|Overall Study|Adverse Event|1|||
33547586|NCT02336503|101905095|FG003|Overall Study|Adverse Event|0|||
33547587|NCT04307394|101905102|FG000|Overall Study|Lost to Follow-up|3|||
33547588|NCT04307394|101905102|FG000|Overall Study|Withdrawal by Subject|2|||
33547589|NCT00460798|101905103|FG000|Overall Study|Death|59|||
33547590|NCT00460798|101905103|FG000|Overall Study|Adverse Event|27|||
33547591|NCT00460798|101905103|FG000|Overall Study|Lost to Follow-up|19|||
33547592|NCT00460798|101905103|FG000|Overall Study|Progressive Disease|99|||
33547593|NCT00460798|101905103|FG000|Overall Study|Other|27|||
33547594|NCT00460798|101905103|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
33547595|NCT00460798|101905103|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
33547596|NCT01983930|101905107|FG000|Overall Study|Withdrawal by Subject|9|||
33547597|NCT01983930|101905108|FG001|Overall Study|Withdrawal by Subject|8|||
33547598|NCT01983930|101905107|FG000|Overall Study|Adverse Event|0|||
33547599|NCT01983930|101905108|FG001|Overall Study|Adverse Event|1|||
33547600|NCT01860404|101905109|FG000|Overall Study|Lost to Follow-up|3|||
33547601|NCT01860404|101905110|FG001|Overall Study|Lost to Follow-up|4|||
33547602|NCT01860404|101905111|FG002|Overall Study|Lost to Follow-up|1|||
33547603|NCT01860404|101905112|FG003|Overall Study|Lost to Follow-up|6|||
33547604|NCT01860404|101905113|FG004|Overall Study|Lost to Follow-up|4|||
33547605|NCT01860404|101905109|FG000|Overall Study|Withdrawal by Subject|0|||
33547606|NCT01860404|101905110|FG001|Overall Study|Withdrawal by Subject|0|||
33547607|NCT01860404|101905111|FG002|Overall Study|Withdrawal by Subject|4|||
33547608|NCT01860404|101905112|FG003|Overall Study|Withdrawal by Subject|0|||
33617337|NCT03088917|102147374|FG000|Overall Study|Contact not established|13|||
33547609|NCT01860404|101905113|FG004|Overall Study|Withdrawal by Subject|0|||
33547610|NCT03329001|101905117|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
33547611|NCT03329001|101905118|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
33547612|NCT03329001|101905119|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
33547613|NCT03329001|101905120|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
33547614|NCT03329001|101905121|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
33547615|NCT03329001|101905122|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
33214567|NCT03853109|100682449|FG005|Overall Study|Withdrawal by Subject|4|||
33214568|NCT03853109|100682450|FG006|Overall Study|Withdrawal by Subject|5|||
33214569|NCT03853109|100682451|FG007|Overall Study|Withdrawal by Subject|3|||
33214570|NCT03853109|100682444|FG000|Overall Study|Decision by Sponsor|0|||
33214571|NCT03853109|100682445|FG001|Overall Study|Decision by Sponsor|0|||
33214572|NCT03853109|100682446|FG002|Overall Study|Decision by Sponsor|1|||
33214573|NCT03853109|100682447|FG003|Overall Study|Decision by Sponsor|0|||
33214574|NCT03853109|100682448|FG004|Overall Study|Decision by Sponsor|1|||
33214575|NCT03853109|100682449|FG005|Overall Study|Decision by Sponsor|1|||
33214576|NCT03853109|100682450|FG006|Overall Study|Decision by Sponsor|10|||
33214577|NCT03853109|100682451|FG007|Overall Study|Decision by Sponsor|2|||
33214578|NCT03853109|100682444|FG000|Overall Study|Lost to Follow-up|0|||
33214579|NCT03853109|100682445|FG001|Overall Study|Lost to Follow-up|0|||
33214580|NCT03853109|100682446|FG002|Overall Study|Lost to Follow-up|0|||
33214581|NCT03853109|100682447|FG003|Overall Study|Lost to Follow-up|0|||
33214582|NCT03853109|100682448|FG004|Overall Study|Lost to Follow-up|1|||
33214583|NCT03853109|100682449|FG005|Overall Study|Lost to Follow-up|3|||
33214584|NCT03853109|100682450|FG006|Overall Study|Lost to Follow-up|0|||
33214585|NCT03853109|100682451|FG007|Overall Study|Lost to Follow-up|0|||
33214586|NCT03853109|100682444|FG000|Overall Study|Death|2|||
33214587|NCT03853109|100682445|FG001|Overall Study|Death|5|||
33214588|NCT03853109|100682446|FG002|Overall Study|Death|8|||
33214589|NCT03853109|100682447|FG003|Overall Study|Death|10|||
33214590|NCT03853109|100682448|FG004|Overall Study|Death|3|||
33214591|NCT03853109|100682449|FG005|Overall Study|Death|20|||
33214592|NCT03853109|100682450|FG006|Overall Study|Death|10|||
33214593|NCT03853109|100682451|FG007|Overall Study|Death|5|||
33214594|NCT00701038|100682453|FG000|Overall Study|study amended pilot group of patients|4|||
33214595|NCT00701038|100682454|FG001|Overall Study|study amended pilot group of patients|4|||
33214596|NCT00713648|100682455|FG000|Overall Study|Adverse Event|1|||
33214597|NCT00713648|100682455|FG000|Overall Study|Unclassified|2|||
33214598|NCT00713648|100682455|FG000|Overall Study|According to Protocol|2|||
33214599|NCT00713648|100682455|FG000|Overall Study|Development of antibodies|3|||
33214600|NCT01328080|100682456|FG000|Overall Study|Lost to Follow-up|5|||
33214601|NCT01563536|100682461|FG000|Overall Study|Withdrawal by Subject|0|||
33214602|NCT01563536|100682462|FG001|Overall Study|Withdrawal by Subject|2|||
33214603|NCT01563536|100682461|FG000|Overall Study|Lost to Follow-up|1|||
33214604|NCT01563536|100682462|FG001|Overall Study|Lost to Follow-up|0|||
33214605|NCT04050865|100682463|FG000|Overall Study|Adverse Event|1|||
33214606|NCT04050865|100682464|FG001|Overall Study|Adverse Event|0|||
33348802|NCT00289913|101164096|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
33348803|NCT00289913|101164092|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
33547616|NCT03329001|101905123|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
33547617|NCT03329001|101905124|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
33547618|NCT03329001|101905117|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
33547619|NCT03329001|101905118|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
33547620|NCT03329001|101905119|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
33547621|NCT03329001|101905120|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
33214607|NCT04050865|100682463|FG000|Overall Study|no insert|1|||
33214608|NCT04050865|100682464|FG001|Overall Study|no insert|0|||
33214609|NCT04050865|100682463|FG000|Overall Study|Only 1 insert|2|||
33214610|NCT04050865|100682464|FG001|Overall Study|Only 1 insert|3|||
33214611|NCT04050865|100682463|FG000|Overall Study|Physician Decision|0|||
33214612|NCT04050865|100682464|FG001|Overall Study|Physician Decision|1|||
33214613|NCT04050865|100682463|FG000|Overall Study|Withdrawal by Subject|0|||
33214614|NCT04050865|100682464|FG001|Overall Study|Withdrawal by Subject|1|||
33214615|NCT02472964|100682465|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
33214616|NCT02472964|100682466|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
33348804|NCT00289913|101164093|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
33617338|NCT03088917|102147374|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
33617339|NCT03088917|102147374|FG000|Overall Study|Moved outside study region|50|||
33617340|NCT01502228|102147375|FG000|Overall Study|Death|1|||
33617341|NCT01433172|102147377|FG000|Overall Study|Withdrawal by Subject|0|||
33547622|NCT03329001|101905121|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
33547623|NCT03329001|101905122|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
33547624|NCT03329001|101905123|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
33547625|NCT03329001|101905124|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
33547626|NCT03329001|101905117|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
33547627|NCT03329001|101905118|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
33547628|NCT03329001|101905119|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
33547629|NCT03329001|101905120|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
33547630|NCT03329001|101905121|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
33547631|NCT03329001|101905122|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
33547632|NCT03329001|101905123|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
33547633|NCT03329001|101905124|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
33547634|NCT03329001|101905117|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
33547635|NCT03329001|101905118|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
33547636|NCT03329001|101905119|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
33547637|NCT03329001|101905120|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
33547638|NCT03329001|101905121|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
33547639|NCT03329001|101905122|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
33547640|NCT03329001|101905123|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
33547641|NCT03329001|101905124|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
33567615|NCT02723955|101973170|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33617342|NCT01433172|102147378|FG001|Overall Study|Withdrawal by Subject|1|||
33617343|NCT01433172|102147379|FG002|Overall Study|Withdrawal by Subject|0|||
33617344|NCT01433172|102147377|FG000|Overall Study|Disease Progression|0|||
33617345|NCT01433172|102147378|FG001|Overall Study|Disease Progression|0|||
33617346|NCT01433172|102147379|FG002|Overall Study|Disease Progression|1|||
33617347|NCT01433172|102147377|FG000|Overall Study|Death|0|||
33617348|NCT01433172|102147378|FG001|Overall Study|Death|2|||
33617349|NCT01433172|102147379|FG002|Overall Study|Death|0|||
33617350|NCT04089761|102147382|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
33617351|NCT04089761|102147382|FG000|"Run In Phase"|Lost to Follow-up|1|||
33617352|NCT04089761|102147382|FG000|"Treatment Phase"|No evaluable data|5|||
33617353|NCT04089761|102147382|FG000|"Treatment Phase"|Lost to Follow-up|1|||
33617354|NCT00256724|102147383|FG000|Overall Study|Physician Decision|2|||
33617355|NCT00256724|102147384|FG001|Overall Study|Physician Decision|5|||
33617356|NCT00256724|102147383|FG000|Overall Study|Protocol Violation|3|||
33617357|NCT00256724|102147384|FG001|Overall Study|Protocol Violation|3|||
33617358|NCT04618744|102147388|FG000|Overall Study|Adverse Event|0|||
33617359|NCT04618744|102147389|FG001|Overall Study|Adverse Event|1|||
33617360|NCT04618744|102147388|FG000|Overall Study|Withdrawal by Subject|0|||
33617361|NCT04618744|102147389|FG001|Overall Study|Withdrawal by Subject|1|||
33617362|NCT02333799|102147390|FG000|Treatment Period|Withdrawal by Subject|1|||
33617363|NCT02333799|102147390|FG000|Treatment Period|Death|6|||
33617364|NCT02333799|102147390|FG000|6 Month Follow Up Period|Physician Decision|1|||
33617365|NCT02333799|102147390|FG000|6 Month Follow Up Period|Death|1|||
33617366|NCT02333799|102147390|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
33617367|NCT02333799|102147390|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
33617368|NCT00714415|102147391|FG000|Overall Study|Lack of Efficacy|1|||
33617369|NCT00714415|102147392|FG001|Overall Study|Lack of Efficacy|0|||
33617370|NCT00714415|102147391|FG000|Overall Study|Death|1|||
33617371|NCT00714415|102147392|FG001|Overall Study|Death|0|||
33617372|NCT00607087|102147393|FG000|Overall Study|Withdrawal by Subject|9|||
33617373|NCT00607087|102147394|FG001|Overall Study|Withdrawal by Subject|4|||
33617374|NCT00607087|102147395|FG002|Overall Study|Withdrawal by Subject|4|||
33617375|NCT00607087|102147393|FG000|Overall Study|Adverse Event|3|||
33617376|NCT00607087|102147394|FG001|Overall Study|Adverse Event|2|||
33617377|NCT00607087|102147395|FG002|Overall Study|Adverse Event|3|||
33214617|NCT02472964|100682465|FG000|Part 1 (up to Week 24)|disease progression|58|||
33348805|NCT00289913|101164094|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
33214618|NCT02472964|100682466|FG001|Part 1 (up to Week 24)|disease progression|47|||
33214619|NCT02472964|100682465|FG000|Part 1 (up to Week 24)|Death|3|||
33348806|NCT00289913|101164095|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
33617378|NCT00607087|102147393|FG000|Overall Study|Other reason|1|||
33617379|NCT00607087|102147394|FG001|Overall Study|Other reason|5|||
33547642|NCT03329001|101905117|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
33547643|NCT03329001|101905118|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
33547644|NCT03329001|101905119|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
33547645|NCT03329001|101905120|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
33547646|NCT03329001|101905121|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
33547647|NCT03329001|101905122|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
33547648|NCT03329001|101905123|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
33547649|NCT03329001|101905124|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
33547650|NCT03329001|101905117|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
33547651|NCT03329001|101905118|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
33547652|NCT03329001|101905119|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
33547653|NCT03329001|101905120|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
33547654|NCT03329001|101905121|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
33547655|NCT03329001|101905122|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
33547656|NCT03329001|101905123|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
33547657|NCT03329001|101905124|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
33547658|NCT03329001|101905117|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
33547659|NCT03329001|101905118|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
33547660|NCT03329001|101905119|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
33547661|NCT03329001|101905120|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
33547662|NCT03329001|101905121|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
33547663|NCT03329001|101905122|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
33547664|NCT03329001|101905123|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
33547665|NCT03329001|101905124|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
33547666|NCT03329001|101905117|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
33547667|NCT03329001|101905118|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
33547668|NCT03329001|101905119|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
33547669|NCT03329001|101905120|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
33547670|NCT03329001|101905121|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
33547671|NCT03329001|101905122|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
33547672|NCT03329001|101905123|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
33547673|NCT03329001|101905124|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
33547674|NCT03329001|101905117|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
33547675|NCT03329001|101905118|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
33547676|NCT03329001|101905119|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
33547677|NCT03329001|101905120|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
33547678|NCT03329001|101905121|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
33617380|NCT00607087|102147395|FG002|Overall Study|Other reason|2|||
33214620|NCT02472964|100682466|FG001|Part 1 (up to Week 24)|Death|6|||
33547679|NCT03329001|101905122|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
33547680|NCT03329001|101905123|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
33617381|NCT00607087|102147393|FG000|Overall Study|Poor compliance to protocol|1|||
33617382|NCT00607087|102147394|FG001|Overall Study|Poor compliance to protocol|0|||
33617383|NCT00607087|102147395|FG002|Overall Study|Poor compliance to protocol|1|||
33617384|NCT00607087|102147393|FG000|Overall Study|Lost to Follow-up|1|||
33617385|NCT00607087|102147394|FG001|Overall Study|Lost to Follow-up|0|||
33617386|NCT00607087|102147395|FG002|Overall Study|Lost to Follow-up|0|||
33617387|NCT00607087|102147393|FG000|Period 1|Withdrawal by Subject|7|||
33617388|NCT00607087|102147394|FG001|Period 1|Withdrawal by Subject|2|||
33617389|NCT00607087|102147395|FG002|Period 1|Withdrawal by Subject|3|||
33617390|NCT00607087|102147393|FG000|Period 1|Adverse Event|3|||
33617391|NCT00607087|102147394|FG001|Period 1|Adverse Event|0|||
33617392|NCT00607087|102147395|FG002|Period 1|Adverse Event|0|||
33617393|NCT00607087|102147393|FG000|Period 1|Poor compliance to protocol|1|||
33617394|NCT00607087|102147394|FG001|Period 1|Poor compliance to protocol|0|||
33617395|NCT00607087|102147395|FG002|Period 1|Poor compliance to protocol|0|||
33617396|NCT00607087|102147393|FG000|Period 1|Lost to Follow-up|1|||
33617397|NCT00607087|102147394|FG001|Period 1|Lost to Follow-up|0|||
33617398|NCT00607087|102147395|FG002|Period 1|Lost to Follow-up|0|||
33617399|NCT00607087|102147393|FG000|Period 1|Other reason|0|||
33617400|NCT00607087|102147394|FG001|Period 1|Other reason|4|||
33617401|NCT00607087|102147395|FG002|Period 1|Other reason|2|||
33617402|NCT00607087|102147393|FG000|Period 2|Withdrawal by Subject|0|||
33617403|NCT00607087|102147394|FG001|Period 2|Withdrawal by Subject|1|||
33617404|NCT00607087|102147395|FG002|Period 2|Withdrawal by Subject|1|||
33617405|NCT00607087|102147393|FG000|Period 2|Other reason|1|||
33617406|NCT00607087|102147394|FG001|Period 2|Other reason|1|||
33617407|NCT00607087|102147395|FG002|Period 2|Other reason|0|||
33617408|NCT00607087|102147393|FG000|Period 2|Adverse Event|0|||
33547681|NCT03329001|101905124|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
33547682|NCT03329001|101905117|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
33547683|NCT03329001|101905118|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
33547684|NCT03329001|101905119|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
33547685|NCT03329001|101905120|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
33547686|NCT03329001|101905121|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
33547687|NCT03329001|101905122|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
33547688|NCT03329001|101905123|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
33547689|NCT03329001|101905124|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
33547690|NCT03329001|101905117|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
33547691|NCT03329001|101905118|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
33547692|NCT03329001|101905119|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
33567616|NCT02723955|101973171|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33617409|NCT00607087|102147394|FG001|Period 2|Adverse Event|1|||
33617410|NCT00607087|102147395|FG002|Period 2|Adverse Event|3|||
33617411|NCT00607087|102147393|FG000|Period 2|Poor compliance to protocol|0|||
33617412|NCT00607087|102147394|FG001|Period 2|Poor compliance to protocol|0|||
33617413|NCT00607087|102147395|FG002|Period 2|Poor compliance to protocol|1|||
33617414|NCT00607087|102147393|FG000|Period 3|Withdrawal by Subject|2|||
33214621|NCT02472964|100682465|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
33214622|NCT02472964|100682466|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
33214623|NCT02472964|100682465|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
33214624|NCT02472964|100682466|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
33214625|NCT02472964|100682465|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
33214626|NCT02472964|100682466|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
33214627|NCT02472964|100682465|FG000|Part 1 (up to Week 24)|Other|2|||
33214628|NCT02472964|100682466|FG001|Part 1 (up to Week 24)|Other|1|||
33214629|NCT02472964|100682465|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
33214630|NCT02472964|100682466|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
33214631|NCT02472964|100682465|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
33617415|NCT00607087|102147394|FG001|Period 3|Withdrawal by Subject|1|||
33617416|NCT00607087|102147395|FG002|Period 3|Withdrawal by Subject|0|||
33617417|NCT00607087|102147393|FG000|Period 3|Adverse Event|0|||
33617418|NCT00607087|102147394|FG001|Period 3|Adverse Event|1|||
33214632|NCT02472964|100682466|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
33214633|NCT02472964|100682465|FG000|Part 2 (Week 24-week 48)|Death|0|||
33617419|NCT00607087|102147395|FG002|Period 3|Adverse Event|0|||
33214634|NCT02472964|100682466|FG001|Part 2 (Week 24-week 48)|Death|1|||
33617420|NCT03549104|102147396|FG000|Overall Study|Withdrawal by Subject|5|||
33214635|NCT02472964|100682465|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
33214636|NCT02472964|100682466|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
33214637|NCT02472964|100682465|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
33617421|NCT03549104|102147397|FG001|Overall Study|Withdrawal by Subject|2|||
33617422|NCT03549104|102147396|FG000|Overall Study|Covid shelter in place|1|||
33214638|NCT02472964|100682466|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
33214639|NCT02472964|100682465|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
33214640|NCT02472964|100682466|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
33214641|NCT02472964|100682465|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
33214642|NCT02472964|100682466|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
33214643|NCT01791725|100682471|FG000|Overall Study|Withdrawal by Subject|0|||
33214644|NCT01791725|100682472|FG001|Overall Study|Withdrawal by Subject|1|||
33214645|NCT01791725|100682473|FG002|Overall Study|Withdrawal by Subject|0|||
33214646|NCT03318523|100682474|FG000|PC Period: Up to Year 1|Adverse Event|1|||
33214647|NCT03318523|100682475|FG001|PC Period: Up to Year 1|Adverse Event|0|||
33214648|NCT03318523|100682476|FG002|PC Period: Up to Year 1|Adverse Event|2|||
33214649|NCT03318523|100682477|FG003|PC Period: Up to Year 1|Adverse Event|0|||
33214650|NCT03318523|100682478|FG004|PC Period: Up to Year 1|Adverse Event|0|||
33214651|NCT03318523|100682479|FG005|PC Period: Up to Year 1|Adverse Event|0|||
33214652|NCT03318523|100682480|FG006|PC Period: Up to Year 1|Adverse Event|0|||
33214653|NCT03318523|100682481|FG007|PC Period: Up to Year 1|Adverse Event|0|||
33214654|NCT03318523|100682482|FG008|PC Period: Up to Year 1|Adverse Event|0|||
33214655|NCT03318523|100682483|FG009|PC Period: Up to Year 1|Adverse Event|0|||
33214656|NCT03318523|100682474|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
33214657|NCT03318523|100682475|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
33214658|NCT03318523|100682476|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
33214659|NCT03318523|100682477|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
33214660|NCT03318523|100682478|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
33214661|NCT03318523|100682479|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
33214662|NCT03318523|100682480|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
33214663|NCT03318523|100682481|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
33214664|NCT03318523|100682482|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
33214665|NCT03318523|100682483|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
33214666|NCT03318523|100682474|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
33214667|NCT03318523|100682475|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
33214668|NCT03318523|100682476|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
33214669|NCT03318523|100682477|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
33214670|NCT03318523|100682478|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
33214671|NCT03318523|100682479|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
33214672|NCT03318523|100682480|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
33214673|NCT03318523|100682481|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
33214674|NCT03318523|100682482|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
33214675|NCT03318523|100682483|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
33214676|NCT03318523|100682474|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
33214677|NCT03318523|100682475|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
33214678|NCT03318523|100682476|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
33214679|NCT03318523|100682477|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
33214680|NCT03318523|100682478|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
33214681|NCT03318523|100682479|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
33214682|NCT03318523|100682480|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
33214683|NCT03318523|100682481|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
33214684|NCT03318523|100682482|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
33214685|NCT03318523|100682483|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
33214686|NCT03318523|100682474|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33214687|NCT03318523|100682475|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33214688|NCT03318523|100682476|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33214689|NCT03318523|100682477|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33214690|NCT03318523|100682478|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33214691|NCT03318523|100682479|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
33214692|NCT03318523|100682480|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33214693|NCT03318523|100682481|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33214694|NCT03318523|100682482|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33214695|NCT03318523|100682483|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
33214696|NCT03318523|100682474|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33214697|NCT03318523|100682475|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33214698|NCT03318523|100682476|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33214699|NCT03318523|100682477|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33214700|NCT03318523|100682478|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33214701|NCT03318523|100682479|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33214702|NCT03318523|100682480|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33214703|NCT03318523|100682481|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33214704|NCT03318523|100682482|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
33214705|NCT03318523|100682483|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
33214706|NCT03318523|100682474|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
33214707|NCT03318523|100682475|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
33214708|NCT03318523|100682476|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
33214709|NCT03318523|100682477|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
33214710|NCT03318523|100682478|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
33214711|NCT03318523|100682479|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
33214712|NCT03318523|100682480|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
33214713|NCT03318523|100682481|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
33214714|NCT03318523|100682482|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
33214715|NCT03318523|100682483|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
33214716|NCT03318523|100682474|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
33214717|NCT03318523|100682475|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
33214718|NCT03318523|100682476|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
33214719|NCT03318523|100682477|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
33214720|NCT03318523|100682478|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
33214721|NCT03318523|100682479|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
33214722|NCT03318523|100682480|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
33214723|NCT03318523|100682481|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
33214724|NCT03318523|100682482|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
33214725|NCT03318523|100682483|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
33214726|NCT03321396|100682484|FG000|Overall Study|Physician Decision|1|||
33214727|NCT01994954|100682485|FG000|Overall Study|Death|1|||
33214728|NCT01994954|100682486|FG001|Overall Study|Death|0|||
33214729|NCT01994954|100682485|FG000|Overall Study|Withdrawal by Subject|9|||
33214730|NCT01994954|100682486|FG001|Overall Study|Withdrawal by Subject|14|||
33214731|NCT01994954|100682485|FG000|Overall Study|Physician Decision|2|||
33214732|NCT01994954|100682486|FG001|Overall Study|Physician Decision|2|||
33547693|NCT03329001|101905120|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
33547694|NCT03329001|101905121|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
33547695|NCT03329001|101905122|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
33547696|NCT03329001|101905123|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
33547697|NCT03329001|101905124|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
33547698|NCT03329001|101905117|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
33547699|NCT03329001|101905118|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
33547700|NCT03329001|101905119|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
33547701|NCT03329001|101905120|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
33547702|NCT03329001|101905121|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
33547703|NCT03329001|101905122|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
33547704|NCT03329001|101905123|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
33547705|NCT03329001|101905124|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
33547706|NCT03329001|101905117|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
33547707|NCT03329001|101905118|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
33547708|NCT03329001|101905119|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
33547709|NCT03329001|101905120|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
33547710|NCT03329001|101905121|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
33214733|NCT01994954|100682485|FG000|Overall Study|Lost to Follow-up|8|||
33214734|NCT01994954|100682486|FG001|Overall Study|Lost to Follow-up|10|||
33214735|NCT01994954|100682485|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
33214736|NCT01994954|100682486|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
33214737|NCT01297959|100682490|FG000|Overall Study|Adverse Event|0|||
33214738|NCT01297959|100682491|FG001|Overall Study|Adverse Event|1|||
33214739|NCT01297959|100682490|FG000|Overall Study|Protocol Violation|2|||
33214740|NCT01297959|100682491|FG001|Overall Study|Protocol Violation|1|||
33214741|NCT01297959|100682490|FG000|Overall Study|Withdrawal by Subject|5|||
33214742|NCT01297959|100682491|FG001|Overall Study|Withdrawal by Subject|4|||
33214743|NCT01297959|100682490|FG000|Overall Study|Physician Decision|0|||
33214744|NCT01297959|100682491|FG001|Overall Study|Physician Decision|1|||
33214745|NCT01297959|100682490|FG000|Overall Study|Unrelated medical illness / complication|0|||
33214746|NCT01297959|100682491|FG001|Overall Study|Unrelated medical illness / complication|2|||
33348807|NCT00289913|101164096|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
33547711|NCT03329001|101905122|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
33547712|NCT03329001|101905123|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
33617423|NCT03549104|102147397|FG001|Overall Study|Covid shelter in place|2|||
33214747|NCT01297959|100682490|FG000|Overall Study|Other|13|||
33348808|NCT00289913|101164092|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
33348809|NCT00289913|101164093|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
33348810|NCT00289913|101164094|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
33348811|NCT00289913|101164095|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
33348812|NCT00289913|101164096|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
33348813|NCT00289913|101164092|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
33348814|NCT00289913|101164093|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
33348815|NCT00289913|101164094|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
33348816|NCT00289913|101164095|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
33348817|NCT00289913|101164096|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
33348818|NCT00289913|101164092|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
33348819|NCT00289913|101164093|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
33348820|NCT00289913|101164094|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
33348821|NCT00289913|101164095|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
33348822|NCT00289913|101164096|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
33348823|NCT03160560|101164097|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
33348824|NCT03160560|101164098|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33348825|NCT03160560|101164099|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33348826|NCT03160560|101164100|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
33348827|NCT03160560|101164097|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
33348828|NCT03160560|101164098|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
33409708|NCT02120456|101389344|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
33617424|NCT03600740|102147398|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
33617425|NCT01219985|102147399|FG000|Overall Study|Physician Decision|20|||
33617426|NCT01288989|102147407|FG000|Overall Study|Death|0|||
33617427|NCT01288989|102147408|FG001|Overall Study|Death|0|||
33617428|NCT01288989|102147409|FG002|Overall Study|Death|0|||
33617429|NCT01288989|102147410|FG003|Overall Study|Death|1|||
33617430|NCT01288989|102147411|FG004|Overall Study|Death|0|||
33617431|NCT01288989|102147407|FG000|Overall Study|Dose limiting toxicity|1|||
33617432|NCT01288989|102147408|FG001|Overall Study|Dose limiting toxicity|0|||
33617433|NCT01288989|102147409|FG002|Overall Study|Dose limiting toxicity|0|||
33617434|NCT01288989|102147410|FG003|Overall Study|Dose limiting toxicity|0|||
33617435|NCT01288989|102147411|FG004|Overall Study|Dose limiting toxicity|0|||
33617436|NCT01288989|102147407|FG000|Overall Study|Adverse Event|0|||
33617437|NCT01288989|102147408|FG001|Overall Study|Adverse Event|0|||
33617438|NCT01288989|102147409|FG002|Overall Study|Adverse Event|0|||
33617439|NCT01288989|102147410|FG003|Overall Study|Adverse Event|0|||
33617440|NCT01288989|102147411|FG004|Overall Study|Adverse Event|2|||
33214748|NCT01297959|100682491|FG001|Overall Study|Other|7|||
33617441|NCT01288989|102147407|FG000|Overall Study|Physician Decision|0|||
33214749|NCT02515279|100682496|FG000|Overall Study|Adverse Event|7|||
33214750|NCT02515279|100682496|FG000|Overall Study|Lack of Efficacy|31|||
33214751|NCT02515279|100682496|FG000|Overall Study|Lost to Follow-up|9|||
33214752|NCT02515279|100682496|FG000|Overall Study|Withdrawal by Subject|18|||
33214753|NCT02515279|100682496|FG000|Overall Study|End-of-treatment visit not attended|17|||
33214754|NCT02515279|100682496|FG000|Overall Study|Other|22|||
33214755|NCT04672941|100682497|FG000|Overall Study|Investigator decision|1|||
33214756|NCT04672941|100682497|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
33214757|NCT04672941|100682497|FG000|Overall Study|COVID-19 related but no adverse event|1|||
33214758|NCT04672941|100682497|FG000|Overall Study|Adverse Event|2|||
33214759|NCT04672941|100682497|FG000|Overall Study|Lost to Follow-up|2|||
33214760|NCT03927950|100682498|FG000|Overall Study|Adverse Event|9|||
33214761|NCT04330638|100682501|FG000|Overall Study|Adverse Event|9|||
33214762|NCT04330638|100682502|FG001|Overall Study|Adverse Event|10|||
33214763|NCT04330638|100682503|FG002|Overall Study|Adverse Event|15|||
33214764|NCT04330638|100682504|FG003|Overall Study|Adverse Event|6|||
33214765|NCT04330638|100682505|FG004|Overall Study|Adverse Event|10|||
33214766|NCT04330638|100682506|FG005|Overall Study|Adverse Event|5|||
33214767|NCT04330638|100682501|FG000|Overall Study|Other|2|||
33214768|NCT04330638|100682502|FG001|Overall Study|Other|2|||
33214769|NCT04330638|100682503|FG002|Overall Study|Other|5|||
33214770|NCT04330638|100682504|FG003|Overall Study|Other|1|||
33214771|NCT04330638|100682505|FG004|Overall Study|Other|3|||
33214772|NCT04330638|100682506|FG005|Overall Study|Other|2|||
33214773|NCT04330638|100682501|FG000|Overall Study|Withdrawal by Subject|4|||
33214774|NCT04330638|100682502|FG001|Overall Study|Withdrawal by Subject|0|||
33617442|NCT01288989|102147408|FG001|Overall Study|Physician Decision|0|||
33617443|NCT01288989|102147409|FG002|Overall Study|Physician Decision|0|||
33617444|NCT01288989|102147410|FG003|Overall Study|Physician Decision|0|||
33617445|NCT01288989|102147411|FG004|Overall Study|Physician Decision|1|||
33617446|NCT01288989|102147407|FG000|Overall Study|Withdrawal by Subject|0|||
33214775|NCT04330638|100682503|FG002|Overall Study|Withdrawal by Subject|0|||
33214776|NCT04330638|100682504|FG003|Overall Study|Withdrawal by Subject|0|||
33214777|NCT04330638|100682505|FG004|Overall Study|Withdrawal by Subject|0|||
33214778|NCT04330638|100682506|FG005|Overall Study|Withdrawal by Subject|0|||
33214779|NCT04330638|100682501|FG000|Overall Study|Lost to Follow-up|3|||
33214780|NCT04330638|100682502|FG001|Overall Study|Lost to Follow-up|2|||
33214781|NCT04330638|100682503|FG002|Overall Study|Lost to Follow-up|3|||
33214782|NCT04330638|100682504|FG003|Overall Study|Lost to Follow-up|2|||
33214783|NCT04330638|100682505|FG004|Overall Study|Lost to Follow-up|3|||
33214784|NCT04330638|100682506|FG005|Overall Study|Lost to Follow-up|0|||
33214785|NCT03535337|100682507|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
33214786|NCT03535337|100682508|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
33214787|NCT03535337|100682509|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
33214788|NCT03535337|100682510|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
33214789|NCT03535337|100682511|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
33547713|NCT03329001|101905124|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
33547714|NCT03329001|101905117|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
33547715|NCT03329001|101905118|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
33547716|NCT03329001|101905119|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
33547717|NCT03329001|101905120|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
33547718|NCT03329001|101905121|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
33547719|NCT03329001|101905122|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
33547720|NCT03329001|101905123|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
33547721|NCT03329001|101905124|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
33547722|NCT03329001|101905117|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
33547723|NCT03329001|101905118|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
33547724|NCT03329001|101905119|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
33547725|NCT03329001|101905120|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
33547726|NCT03329001|101905121|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
33547727|NCT03329001|101905122|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
33547728|NCT03329001|101905123|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
33547729|NCT03329001|101905124|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
33617447|NCT01288989|102147408|FG001|Overall Study|Withdrawal by Subject|0|||
33617448|NCT01288989|102147409|FG002|Overall Study|Withdrawal by Subject|0|||
33617449|NCT01288989|102147410|FG003|Overall Study|Withdrawal by Subject|0|||
33617450|NCT01288989|102147411|FG004|Overall Study|Withdrawal by Subject|3|||
33617451|NCT00291018|102147412|FG000|Overall Study|Not Consented or Declined PAS|12|||
33617452|NCT00291018|102147413|FG001|Overall Study|Not Consented or Declined PAS|15|||
33214790|NCT03535337|100682512|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
33214791|NCT03535337|100682513|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
33214792|NCT03535337|100682514|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
33214793|NCT03535337|100682515|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
33617453|NCT00291018|102147414|FG002|Overall Study|Not Consented or Declined PAS|15|||
33617454|NCT00291018|102147412|FG000|Overall Study|Death|3|||
33547730|NCT03329001|101905117|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
33214794|NCT03535337|100682516|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
33214795|NCT01860703|100682517|FG000|Overall Study|Adverse Event|1|||
33348829|NCT03160560|101164099|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
33348830|NCT03160560|101164100|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
33348831|NCT00254566|101164101|FG000|Overall Study|Death|1|||
33348832|NCT00254566|101164102|FG001|Overall Study|Death|0|||
33348833|NCT00254566|101164101|FG000|Overall Study|Adverse Event|5|||
33348834|NCT00254566|101164102|FG001|Overall Study|Adverse Event|4|||
33348835|NCT00254566|101164101|FG000|Overall Study|Lack of Efficacy|12|||
33214796|NCT01860703|100682518|FG001|Overall Study|Adverse Event|4|||
33214797|NCT01860703|100682519|FG002|Overall Study|Adverse Event|0|||
33214798|NCT01860703|100682520|FG003|Overall Study|Adverse Event|2|||
33348836|NCT00254566|101164102|FG001|Overall Study|Lack of Efficacy|9|||
33348837|NCT00254566|101164101|FG000|Overall Study|Other|1|||
33348838|NCT00254566|101164102|FG001|Overall Study|Other|5|||
33547731|NCT03329001|101905118|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
33547732|NCT03329001|101905119|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
33547733|NCT03329001|101905120|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
33547734|NCT03329001|101905121|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
33547735|NCT03329001|101905122|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
33547736|NCT03329001|101905123|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
33547737|NCT03329001|101905124|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
33547738|NCT03329001|101905117|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
33547739|NCT03329001|101905118|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
33547740|NCT03329001|101905119|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
33547741|NCT03329001|101905120|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
33547742|NCT03329001|101905121|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
33547743|NCT03329001|101905122|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
33547744|NCT03329001|101905123|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
33547745|NCT03329001|101905124|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
33547746|NCT03329001|101905117|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
33547747|NCT03329001|101905118|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
33547748|NCT03329001|101905119|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
33547749|NCT03329001|101905120|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
33547750|NCT03329001|101905121|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
33547751|NCT03329001|101905122|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
33547752|NCT03329001|101905123|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
33547753|NCT03329001|101905124|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
33617455|NCT00291018|102147413|FG001|Overall Study|Death|3|||
33617456|NCT00291018|102147414|FG002|Overall Study|Death|4|||
33547754|NCT03329001|101905117|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
33547755|NCT03329001|101905118|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
33547756|NCT03329001|101905119|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
33547757|NCT03329001|101905120|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
33567617|NCT02723955|101973172|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33214799|NCT01860703|100682517|FG000|Overall Study|Withdrawal by Subject|0|||
33214800|NCT01860703|100682518|FG001|Overall Study|Withdrawal by Subject|1|||
33547758|NCT03329001|101905121|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
33547759|NCT03329001|101905122|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
33547760|NCT03329001|101905123|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
33547761|NCT03329001|101905124|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
33547762|NCT03329001|101905117|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
33547763|NCT03329001|101905118|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
33547764|NCT03329001|101905119|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
33547765|NCT03329001|101905120|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
33547766|NCT03329001|101905121|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
33547767|NCT03329001|101905122|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
33547768|NCT03329001|101905123|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
33547769|NCT03329001|101905124|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
33547770|NCT03329001|101905117|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
33547771|NCT03329001|101905118|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
33547772|NCT03329001|101905119|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
33547773|NCT03329001|101905120|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
33547774|NCT03329001|101905121|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
33547775|NCT03329001|101905122|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
33547776|NCT03329001|101905123|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
33547777|NCT03329001|101905124|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
33547778|NCT03329001|101905117|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
33547779|NCT03329001|101905118|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
33547780|NCT03329001|101905119|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
33547781|NCT03329001|101905120|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
33547782|NCT03329001|101905121|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
33547783|NCT03329001|101905122|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
33547784|NCT03329001|101905123|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
33547785|NCT03329001|101905124|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
33617457|NCT00291018|102147412|FG000|Overall Study|Withdrawal by Subject|2|||
33617458|NCT00291018|102147413|FG001|Overall Study|Withdrawal by Subject|8|||
33617459|NCT00291018|102147414|FG002|Overall Study|Withdrawal by Subject|1|||
33617460|NCT00291018|102147412|FG000|Overall Study|Failures|5|||
33617461|NCT00291018|102147413|FG001|Overall Study|Failures|12|||
33617462|NCT00291018|102147414|FG002|Overall Study|Failures|5|||
33617463|NCT00291018|102147412|FG000|Overall Study|Lost to Follow-up|3|||
33617464|NCT00291018|102147413|FG001|Overall Study|Lost to Follow-up|4|||
33617465|NCT00291018|102147414|FG002|Overall Study|Lost to Follow-up|18|||
33617466|NCT02023996|102147415|FG000|Overall Study|Protocol Violation|6|||
33617467|NCT00592904|102147416|FG000|Overall Study|Adverse Event|15|||
33617468|NCT00592904|102147417|FG001|Overall Study|Adverse Event|25|||
33617469|NCT00592904|102147418|FG002|Overall Study|Adverse Event|13|||
33617470|NCT00592904|102147419|FG003|Overall Study|Adverse Event|5|||
33617471|NCT00592904|102147416|FG000|Overall Study|Protocol Violation|1|||
33617472|NCT00592904|102147417|FG001|Overall Study|Protocol Violation|1|||
33617473|NCT00592904|102147418|FG002|Overall Study|Protocol Violation|0|||
33617474|NCT00592904|102147419|FG003|Overall Study|Protocol Violation|1|||
33617475|NCT00592904|102147416|FG000|Overall Study|Withdrawal by Subject|4|||
33617476|NCT00592904|102147417|FG001|Overall Study|Withdrawal by Subject|16|||
33617477|NCT00592904|102147418|FG002|Overall Study|Withdrawal by Subject|1|||
33617478|NCT00592904|102147419|FG003|Overall Study|Withdrawal by Subject|2|||
33617479|NCT00592904|102147416|FG000|Overall Study|Lack of Efficacy|2|||
33617480|NCT00592904|102147417|FG001|Overall Study|Lack of Efficacy|7|||
33617481|NCT00592904|102147418|FG002|Overall Study|Lack of Efficacy|2|||
33617482|NCT00592904|102147419|FG003|Overall Study|Lack of Efficacy|3|||
33617483|NCT00592904|102147416|FG000|Overall Study|Physician Decision|0|||
33617484|NCT00592904|102147417|FG001|Overall Study|Physician Decision|3|||
33617485|NCT00592904|102147418|FG002|Overall Study|Physician Decision|1|||
33617486|NCT00592904|102147419|FG003|Overall Study|Physician Decision|0|||
33617487|NCT00592904|102147416|FG000|Overall Study|Other|3|||
33617488|NCT00592904|102147417|FG001|Overall Study|Other|3|||
33617489|NCT00592904|102147418|FG002|Overall Study|Other|0|||
33617490|NCT00592904|102147419|FG003|Overall Study|Other|0|||
33617491|NCT00780416|102147420|FG000|Overall Study|Physician Decision|3|||
33617492|NCT00780416|102147421|FG001|Overall Study|Physician Decision|3|||
33617493|NCT00780416|102147420|FG000|Overall Study|Protocol Violation|1|||
33617494|NCT00780416|102147421|FG001|Overall Study|Protocol Violation|0|||
33214801|NCT01860703|100682519|FG002|Overall Study|Withdrawal by Subject|0|||
33214802|NCT01860703|100682520|FG003|Overall Study|Withdrawal by Subject|0|||
33547786|NCT03329001|101905117|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
33617495|NCT00780416|102147420|FG000|Overall Study|Withdrawal by Subject|8|||
33617496|NCT00780416|102147421|FG001|Overall Study|Withdrawal by Subject|6|||
33617497|NCT04325828|102147428|FG000|Overall Study|Ongoing|26|||
33617498|NCT03116685|102147444|FG000|Overall Study|Physician Decision|0|||
33617499|NCT03116685|102147445|FG001|Overall Study|Physician Decision|1|||
33348839|NCT00254566|101164101|FG000|Overall Study|Withdrawal by Subject|5|||
33348840|NCT00254566|101164102|FG001|Overall Study|Withdrawal by Subject|6|||
33348841|NCT00254566|101164101|FG000|Overall Study|Lost to Follow-up|7|||
33348842|NCT00254566|101164102|FG001|Overall Study|Lost to Follow-up|2|||
33348843|NCT01900002|101164105|FG000|Overall Study|Withdrawal by Subject|2|||
33348844|NCT01900002|101164105|FG000|Overall Study|ineligible for Y-90|4|||
33348845|NCT02393209|101164108|FG000|Overall Study|Study Terminated by Sponsor|1|||
33348846|NCT02393209|101164109|FG001|Overall Study|Study Terminated by Sponsor|1|||
33348847|NCT02393209|101164110|FG002|Overall Study|Study Terminated by Sponsor|0|||
33348848|NCT02393209|101164111|FG003|Overall Study|Study Terminated by Sponsor|0|||
33348849|NCT02393209|101164108|FG000|Overall Study|Withdrawal by Patient|1|||
33348850|NCT02393209|101164109|FG001|Overall Study|Withdrawal by Patient|0|||
33348851|NCT02393209|101164110|FG002|Overall Study|Withdrawal by Patient|0|||
33348852|NCT02393209|101164111|FG003|Overall Study|Withdrawal by Patient|0|||
33547787|NCT03329001|101905118|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
33547788|NCT03329001|101905119|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
33547789|NCT03329001|101905120|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
33547790|NCT03329001|101905121|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
33547791|NCT03329001|101905122|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
33547792|NCT03329001|101905123|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
33547793|NCT03329001|101905124|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
33547794|NCT03329001|101905117|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
33547795|NCT03329001|101905118|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
33547796|NCT03329001|101905119|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
33547797|NCT03329001|101905120|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
33547798|NCT03329001|101905121|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
33547799|NCT03329001|101905122|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
33547800|NCT03329001|101905123|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
33547801|NCT03329001|101905124|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
33547802|NCT03329001|101905117|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
33547803|NCT03329001|101905118|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
33547804|NCT03329001|101905119|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
33547805|NCT03329001|101905120|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
33547806|NCT03329001|101905121|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
33547807|NCT03329001|101905122|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
33547808|NCT03329001|101905123|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
33547809|NCT03329001|101905124|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
33547810|NCT03329001|101905117|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
33547811|NCT03329001|101905118|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
33547812|NCT03329001|101905119|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
33547813|NCT03329001|101905120|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
33547814|NCT03329001|101905121|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
33547815|NCT03329001|101905122|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
33547816|NCT03329001|101905123|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
33547817|NCT03329001|101905124|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
33547818|NCT03329001|101905117|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
33547819|NCT03329001|101905118|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
33617500|NCT00731679|102147446|FG000|Overall Study|Adverse Event|7|||
33617501|NCT00731679|102147447|FG001|Overall Study|Adverse Event|8|||
33617502|NCT00731679|102147446|FG000|Overall Study|Withdrawal by Subject|8|||
33617503|NCT00731679|102147447|FG001|Overall Study|Withdrawal by Subject|8|||
33617504|NCT00731679|102147446|FG000|Overall Study|Lost to Follow-up|7|||
33348853|NCT02393209|101164108|FG000|Overall Study|Death|2|||
33348854|NCT02393209|101164109|FG001|Overall Study|Death|2|||
33547820|NCT03329001|101905119|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
33547821|NCT03329001|101905120|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
33547822|NCT03329001|101905121|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
33547823|NCT03329001|101905122|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
33617505|NCT00731679|102147447|FG001|Overall Study|Lost to Follow-up|8|||
33617506|NCT00731679|102147446|FG000|Overall Study|Noncompliance|0|||
33617507|NCT00731679|102147447|FG001|Overall Study|Noncompliance|1|||
33348855|NCT02393209|101164110|FG002|Overall Study|Death|0|||
33617508|NCT00731679|102147446|FG000|Overall Study|Pregnancy|0|||
33617509|NCT00731679|102147447|FG001|Overall Study|Pregnancy|1|||
33348856|NCT02393209|101164111|FG003|Overall Study|Death|0|||
33348857|NCT02393209|101164108|FG000|Overall Study|Death due to Disease Progression|2|||
33348858|NCT02393209|101164109|FG001|Overall Study|Death due to Disease Progression|2|||
33348859|NCT02393209|101164110|FG002|Overall Study|Death due to Disease Progression|0|||
33348860|NCT02393209|101164111|FG003|Overall Study|Death due to Disease Progression|0|||
33348861|NCT02393209|101164108|FG000|Overall Study|Death from Legionella Infection|0|||
33547824|NCT03329001|101905123|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
33547825|NCT03329001|101905124|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
33547826|NCT03329001|101905117|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
33348862|NCT02393209|101164109|FG001|Overall Study|Death from Legionella Infection|1|||
33348863|NCT02393209|101164110|FG002|Overall Study|Death from Legionella Infection|0|||
33348864|NCT02393209|101164111|FG003|Overall Study|Death from Legionella Infection|0|||
33348865|NCT02393209|101164108|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
33348866|NCT02393209|101164109|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
33348867|NCT02393209|101164110|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
33348868|NCT02393209|101164111|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
33348869|NCT02393209|101164108|FG000|Overall Study|Lost to Follow-up|0|||
33348870|NCT02393209|101164109|FG001|Overall Study|Lost to Follow-up|1|||
33547827|NCT03329001|101905118|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
33547828|NCT03329001|101905119|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
33547829|NCT03329001|101905120|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
33547830|NCT03329001|101905121|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
33617510|NCT00931606|102147451|FG000|Overall Study|Death|1|||
33617511|NCT00931606|102147452|FG001|Overall Study|Death|3|||
33617512|NCT00931606|102147453|FG002|Overall Study|Death|2|||
33617513|NCT00931606|102147454|FG003|Overall Study|Death|0|||
33617514|NCT00931606|102147451|FG000|Overall Study|Lost to Follow-up|0|||
33617515|NCT00931606|102147452|FG001|Overall Study|Lost to Follow-up|1|||
33617516|NCT00931606|102147453|FG002|Overall Study|Lost to Follow-up|0|||
33617517|NCT00931606|102147454|FG003|Overall Study|Lost to Follow-up|0|||
33617518|NCT00931606|102147451|FG000|Overall Study|Physician Decision|0|||
33617519|NCT00931606|102147452|FG001|Overall Study|Physician Decision|0|||
33617520|NCT00931606|102147453|FG002|Overall Study|Physician Decision|3|||
33617521|NCT00931606|102147454|FG003|Overall Study|Physician Decision|0|||
33617522|NCT00931606|102147451|FG000|Overall Study|Sponsor Decision|1|||
33617523|NCT00931606|102147452|FG001|Overall Study|Sponsor Decision|4|||
33617524|NCT00931606|102147453|FG002|Overall Study|Sponsor Decision|0|||
33617525|NCT00931606|102147454|FG003|Overall Study|Sponsor Decision|2|||
33617526|NCT00931606|102147451|FG000|Overall Study|Withdrawal by Subject|3|||
33617527|NCT00931606|102147452|FG001|Overall Study|Withdrawal by Subject|1|||
33617528|NCT00931606|102147453|FG002|Overall Study|Withdrawal by Subject|1|||
33617529|NCT00931606|102147454|FG003|Overall Study|Withdrawal by Subject|1|||
33617530|NCT01128244|102147455|FG000|Overall Study|Adverse Event|1|||
33617531|NCT01128244|102147455|FG000|Overall Study|Scheduling conflict|2|||
33617532|NCT00596752|102147456|FG000|Overall Study|Other Reason|44|||
33617533|NCT00596752|102147457|FG001|Overall Study|Other Reason|49|||
33617534|NCT00596752|102147456|FG000|Overall Study|Adverse Event|34|||
33617535|NCT00596752|102147457|FG001|Overall Study|Adverse Event|34|||
33617536|NCT00596752|102147456|FG000|Overall Study|Lost to Follow-up|22|||
33617537|NCT00596752|102147457|FG001|Overall Study|Lost to Follow-up|38|||
33617538|NCT00596752|102147456|FG000|Overall Study|Withdrawal by Subject|12|||
33617539|NCT00596752|102147457|FG001|Overall Study|Withdrawal by Subject|9|||
33617540|NCT00596752|102147456|FG000|Overall Study|Unsatisfactory Compliance|9|||
33617541|NCT00596752|102147457|FG001|Overall Study|Unsatisfactory Compliance|6|||
33617542|NCT00596752|102147456|FG000|Overall Study|Lack of Efficacy|4|||
33617543|NCT00596752|102147457|FG001|Overall Study|Lack of Efficacy|7|||
33617544|NCT00596752|102147456|FG000|Overall Study|Protocol Violation|1|||
33617545|NCT00596752|102147457|FG001|Overall Study|Protocol Violation|0|||
33617546|NCT01973998|102147458|FG000|Overall Study|Death|2|||
33617547|NCT01973998|102147459|FG001|Overall Study|Death|2|||
33617548|NCT00183625|102147460|FG000|Overall Study|Withdrawal by Subject|18|||
33617549|NCT00183625|102147461|FG001|Overall Study|Withdrawal by Subject|18|||
33617550|NCT00183625|102147462|FG002|Overall Study|Withdrawal by Subject|19|||
33617551|NCT00183625|102147463|FG003|Overall Study|Withdrawal by Subject|14|||
33617552|NCT00193206|102147466|FG000|Preoperative Therapy|Lack of Efficacy|2|||
33617553|NCT00193206|102147466|FG000|Preoperative Therapy|Adverse Event|2|||
33617554|NCT00193206|102147466|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
33617555|NCT00193206|102147466|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
33617556|NCT00193206|102147466|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
33348871|NCT02393209|101164110|FG002|Overall Study|Lost to Follow-up|0|||
33348872|NCT02393209|101164111|FG003|Overall Study|Lost to Follow-up|0|||
33547831|NCT03329001|101905122|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
33547832|NCT03329001|101905123|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
33547833|NCT03329001|101905124|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
33547834|NCT03329001|101905117|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
33617557|NCT00193206|102147466|FG000|Postoperative Therapy|Physician Decision|3|||
33617558|NCT00193206|102147466|FG000|Postoperative Therapy|Intercurrent Illness|2|||
33617559|NCT00193206|102147466|FG000|Postoperative Therapy|Lack of Efficacy|1|||
33617560|NCT00193206|102147466|FG000|Postoperative Therapy|Protocol Violation|1|||
33617561|NCT00837213|102147467|FG000|Overall Study|Lost to Follow-up|3|||
33617562|NCT00837213|102147468|FG001|Overall Study|Lost to Follow-up|2|||
33617563|NCT00837213|102147467|FG000|Overall Study|Withdrawal by Subject|2|||
33617564|NCT00837213|102147468|FG001|Overall Study|Withdrawal by Subject|2|||
33617565|NCT00837213|102147467|FG000|Overall Study|not stated|1|||
33617566|NCT00837213|102147468|FG001|Overall Study|not stated|1|||
33348873|NCT00680836|101164113|FG000|Overall Study|Withdrawal by Subject|3|||
33348874|NCT00680836|101164114|FG001|Overall Study|Withdrawal by Subject|0|||
33547835|NCT03329001|101905118|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
33547836|NCT03329001|101905119|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
33547837|NCT03329001|101905120|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
33547838|NCT03329001|101905121|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
33547839|NCT03329001|101905122|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
33547840|NCT03329001|101905123|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
33547841|NCT03329001|101905124|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
33547842|NCT04398134|101905125|FG000|Overall Study|Adverse Event|0|||
33547843|NCT04398134|101905126|FG001|Overall Study|Adverse Event|0|||
33547844|NCT04398134|101905127|FG002|Overall Study|Adverse Event|1|||
33547845|NCT04398134|101905128|FG003|Overall Study|Adverse Event|0|||
33547846|NCT04398134|101905125|FG000|Overall Study|Withdrawal by Subject|2|||
33547847|NCT04398134|101905126|FG001|Overall Study|Withdrawal by Subject|0|||
33547848|NCT04398134|101905127|FG002|Overall Study|Withdrawal by Subject|0|||
33547849|NCT04398134|101905128|FG003|Overall Study|Withdrawal by Subject|1|||
33547850|NCT04398134|101905125|FG000|Overall Study|Study Terminated by Sponsor|30|||
33547851|NCT04398134|101905126|FG001|Overall Study|Study Terminated by Sponsor|11|||
33547852|NCT04398134|101905127|FG002|Overall Study|Study Terminated by Sponsor|32|||
33547853|NCT04398134|101905128|FG003|Overall Study|Study Terminated by Sponsor|11|||
33547854|NCT00933933|101905129|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
33214803|NCT01860703|100682517|FG000|Overall Study|Personal reason|1|||
33214804|NCT01860703|100682518|FG001|Overall Study|Personal reason|0|||
33214805|NCT01860703|100682519|FG002|Overall Study|Personal reason|1|||
33348875|NCT00680836|101164113|FG000|Overall Study|Lost to Follow-up|3|||
33348876|NCT00680836|101164114|FG001|Overall Study|Lost to Follow-up|1|||
33348877|NCT00680836|101164113|FG000|Overall Study|Physician Decision|2|||
33348878|NCT00680836|101164114|FG001|Overall Study|Physician Decision|1|||
33348879|NCT01670994|101164115|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
33348880|NCT01670994|101164116|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
33348881|NCT01670994|101164115|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
33348882|NCT01670994|101164116|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
33348883|NCT01670994|101164115|FG000|Overall Study|Patient experienced DLT|0|||
33348884|NCT01670994|101164116|FG001|Overall Study|Patient experienced DLT|1|||
33348885|NCT03569202|101164122|FG000|Part 3|Physician Decision|1|||
33409709|NCT02120456|101389345|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33348886|NCT03569202|101164123|FG001|Part 3|Physician Decision|0|||
33348887|NCT03569202|101164122|FG000|Part 3|Other|1|||
33348888|NCT03569202|101164123|FG001|Part 3|Other|1|||
33348889|NCT00896532|101164124|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348890|NCT00896532|101164125|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348891|NCT00896532|101164126|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348892|NCT00896532|101164127|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
33348893|NCT00896532|101164128|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348894|NCT00896532|101164129|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
33409710|NCT02120456|101389346|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
33409711|NCT02120456|101389338|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33617567|NCT03755882|102147479|FG000|Period 1|Protocol Violation|1|||
33214806|NCT01860703|100682520|FG003|Overall Study|Personal reason|0|||
33214807|NCT00626028|100682521|FG000|Overall Study|Adverse Event|1|||
33214808|NCT00626028|100682522|FG001|Overall Study|Adverse Event|1|||
33214809|NCT00626028|100682521|FG000|Overall Study|Device Failure|0|||
33214810|NCT00626028|100682522|FG001|Overall Study|Device Failure|1|||
33547855|NCT00933933|101905130|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
33214811|NCT00626028|100682521|FG000|Overall Study|Physician Decision|2|||
33547856|NCT00933933|101905131|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
33409712|NCT02120456|101389339|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33409713|NCT02120456|101389340|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33409714|NCT02120456|101389341|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33409715|NCT02120456|101389342|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33409716|NCT02120456|101389343|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33547857|NCT00933933|101905129|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
33547858|NCT00933933|101905130|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
33547859|NCT00933933|101905131|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
33547860|NCT01334515|101905140|FG000|Overall Study|Adverse Event|1|||
33547861|NCT01334515|101905141|FG001|Overall Study|Adverse Event|6|||
33547862|NCT01334515|101905140|FG000|Overall Study|Death|1|||
33547863|NCT01334515|101905141|FG001|Overall Study|Death|0|||
33547864|NCT01334515|101905140|FG000|Overall Study|Lack of Efficacy|8|||
33547865|NCT01334515|101905141|FG001|Overall Study|Lack of Efficacy|21|||
33547866|NCT01334515|101905140|FG000|Overall Study|Physician Decision|1|||
33547867|NCT01334515|101905141|FG001|Overall Study|Physician Decision|1|||
33547868|NCT01334515|101905140|FG000|Overall Study|Withdrawal by Subject|1|||
33547869|NCT01334515|101905141|FG001|Overall Study|Withdrawal by Subject|1|||
33547870|NCT02593864|101905142|FG000|Overall Study|Withdrawal by Subject|3|||
33547871|NCT02593864|101905142|FG000|Overall Study|Lost to Follow-up|3|||
33617568|NCT03755882|102147480|FG001|Period 1|Protocol Violation|0|||
33348895|NCT00896532|101164130|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348896|NCT00896532|101164131|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348897|NCT00896532|101164132|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348898|NCT00896532|101164133|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348899|NCT00896532|101164134|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348900|NCT00896532|101164135|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348901|NCT00896532|101164136|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348902|NCT00896532|101164137|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348903|NCT00896532|101164138|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348904|NCT00896532|101164139|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348905|NCT00896532|101164140|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348906|NCT00896532|101164141|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348907|NCT00896532|101164142|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348908|NCT00896532|101164143|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348909|NCT00896532|101164144|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348910|NCT00896532|101164145|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348911|NCT00896532|101164146|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
33348912|NCT00896532|101164124|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
33348913|NCT00896532|101164125|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
33348914|NCT00896532|101164126|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
33348915|NCT00896532|101164127|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
33348916|NCT00896532|101164128|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
33348917|NCT00896532|101164129|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
33348918|NCT00896532|101164130|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
33348919|NCT00896532|101164131|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348920|NCT00896532|101164132|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348921|NCT00896532|101164133|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348922|NCT00896532|101164134|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348923|NCT00896532|101164135|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348924|NCT00896532|101164136|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348925|NCT00896532|101164137|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348926|NCT00896532|101164138|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348927|NCT00896532|101164139|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348928|NCT00896532|101164140|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348929|NCT00896532|101164141|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348930|NCT00896532|101164142|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348931|NCT00896532|101164143|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33409717|NCT02120456|101389344|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33547872|NCT04810962|101905143|FG000|Overall Study|Adverse Event|0|||
33547873|NCT04810962|101905144|FG001|Overall Study|Adverse Event|1|||
33547874|NCT04810962|101905143|FG000|Overall Study|Lost to Follow-up|2|||
33547875|NCT04810962|101905144|FG001|Overall Study|Lost to Follow-up|1|||
33547876|NCT04810962|101905143|FG000|Overall Study|Physician Decision|1|||
33547877|NCT04810962|101905144|FG001|Overall Study|Physician Decision|0|||
33547878|NCT04810962|101905143|FG000|Overall Study|Withdrawal by Subject|1|||
33547879|NCT04810962|101905144|FG001|Overall Study|Withdrawal by Subject|3|||
33547880|NCT04810962|101905143|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
33348932|NCT00896532|101164144|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348933|NCT00896532|101164145|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348934|NCT00896532|101164146|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
33348935|NCT00896532|101164124|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
33348936|NCT00896532|101164125|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
33348937|NCT00896532|101164126|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
33547881|NCT04810962|101905144|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
33547882|NCT00800540|101905145|FG000|Period One: 6 Weeks|Noncompliance|1|||
33547883|NCT00800540|101905146|FG001|Period One: 6 Weeks|Noncompliance|0|||
33547884|NCT00800540|101905145|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
33547885|NCT00800540|101905146|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
33547886|NCT00800540|101905145|FG000|Period 2: 6 Weeks|Adverse Event|0|||
33547887|NCT00800540|101905146|FG001|Period 2: 6 Weeks|Adverse Event|1|||
33547888|NCT02530242|101905149|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
33547889|NCT02530242|101905150|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
33547890|NCT01301092|101905151|FG000|Overall Study|Lost to Follow-up|0|||
33547891|NCT01301092|101905152|FG001|Overall Study|Lost to Follow-up|0|||
33547892|NCT01301092|101905153|FG002|Overall Study|Lost to Follow-up|1|||
33547893|NCT03286504|101905159|FG000|Overall Study|Lost to Follow-up|19|||
33547894|NCT03286504|101905160|FG001|Overall Study|Lost to Follow-up|16|||
33547895|NCT01967277|101905161|FG000|Overall Study|Lost to Follow-up|1|||
33547896|NCT01967277|101905162|FG001|Overall Study|Lost to Follow-up|2|||
33214812|NCT00626028|100682522|FG001|Overall Study|Physician Decision|1|||
33214813|NCT00626028|100682521|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
33214814|NCT00626028|100682522|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
33214815|NCT00717860|100682527|FG000|Overall Study|Clinical adverse experience|5|||
33214816|NCT00717860|100682528|FG001|Overall Study|Clinical adverse experience|9|||
33214817|NCT00717860|100682527|FG000|Overall Study|Laboratory adverse experience|2|||
33214818|NCT00717860|100682528|FG001|Overall Study|Laboratory adverse experience|2|||
33348938|NCT00896532|101164127|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
33348939|NCT00896532|101164128|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
33348940|NCT00896532|101164129|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
33348941|NCT00896532|101164130|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
33348942|NCT00896532|101164131|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
33348943|NCT00896532|101164132|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33348944|NCT00896532|101164133|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33348945|NCT00896532|101164134|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33348946|NCT00896532|101164135|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33348947|NCT00896532|101164136|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33348948|NCT00896532|101164137|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33348949|NCT00896532|101164138|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33348950|NCT00896532|101164139|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33348951|NCT00896532|101164140|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33348952|NCT00896532|101164141|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33348953|NCT00896532|101164142|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33348954|NCT00896532|101164143|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33409718|NCT02120456|101389345|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
33409719|NCT02120456|101389346|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
33409720|NCT01347931|101389347|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
33409721|NCT01302366|101389350|FG000|Overall Study|patient choice or noncompliance|5|||
33409722|NCT01821391|101389354|FG000|Overall Study|Adverse Event|1|||
33409723|NCT01821391|101389355|FG001|Overall Study|Adverse Event|0|||
33409724|NCT02734290|101389356|FG000|Overall Study|Adverse Event|1|||
33409725|NCT02734290|101389357|FG001|Overall Study|Adverse Event|0|||
33409726|NCT02734290|101389356|FG000|Overall Study|Death|1|||
33547897|NCT01967277|101905161|FG000|Overall Study|Unrelated illness|0|||
33547898|NCT01967277|101905162|FG001|Overall Study|Unrelated illness|1|||
33547899|NCT02638493|101905163|FG000|Overall Study|Inability to provide semen samples|2|||
33617569|NCT03755882|102147479|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
33617570|NCT03755882|102147480|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
33214819|NCT00717860|100682527|FG000|Overall Study|Lack of Efficacy|7|||
33214820|NCT00717860|100682528|FG001|Overall Study|Lack of Efficacy|13|||
33547900|NCT02638493|101905164|FG001|Overall Study|Inability to provide semen samples|0|||
33617571|NCT00321464|102147483|FG000|Overall Study|Death|169|||
33547901|NCT02638493|101905165|FG002|Overall Study|Inability to provide semen samples|0|||
33547902|NCT04666298|101905173|FG000|Overall Study|Subject decision|1|||
33547903|NCT04666298|101905174|FG001|Overall Study|Subject decision|0|||
33547904|NCT04666298|101905175|FG002|Overall Study|Subject decision|0|||
33547905|NCT04666298|101905176|FG003|Overall Study|Subject decision|2|||
33547906|NCT04666298|101905173|FG000|Overall Study|Death|1|||
33547907|NCT04666298|101905174|FG001|Overall Study|Death|0|||
33547908|NCT04666298|101905175|FG002|Overall Study|Death|0|||
33547909|NCT04666298|101905176|FG003|Overall Study|Death|0|||
33547910|NCT04666298|101905173|FG000|Overall Study|Lost to Follow-up|0|||
33547911|NCT04666298|101905174|FG001|Overall Study|Lost to Follow-up|0|||
33547912|NCT04666298|101905175|FG002|Overall Study|Lost to Follow-up|0|||
33547913|NCT04666298|101905176|FG003|Overall Study|Lost to Follow-up|1|||
33547914|NCT04666298|101905173|FG000|Overall Study|Physician Decision|0|||
33547915|NCT04666298|101905174|FG001|Overall Study|Physician Decision|0|||
33547916|NCT04666298|101905175|FG002|Overall Study|Physician Decision|0|||
33547917|NCT04666298|101905176|FG003|Overall Study|Physician Decision|1|||
33547918|NCT04666298|101905173|FG000|Overall Study|Protocol deviation|0|||
33547919|NCT04666298|101905174|FG001|Overall Study|Protocol deviation|0|||
33547920|NCT04666298|101905175|FG002|Overall Study|Protocol deviation|1|||
33547921|NCT04666298|101905176|FG003|Overall Study|Protocol deviation|0|||
33547922|NCT02421510|101905177|FG000|Overall Study|Other|4|||
33547923|NCT02421510|101905178|FG001|Overall Study|Other|2|||
33547924|NCT02421510|101905179|FG002|Overall Study|Other|3|||
33547925|NCT02421510|101905177|FG000|Overall Study|Protocol Violation|1|||
33547926|NCT02421510|101905178|FG001|Overall Study|Protocol Violation|2|||
33547927|NCT02421510|101905179|FG002|Overall Study|Protocol Violation|0|||
33547928|NCT02421510|101905177|FG000|Overall Study|Death|1|||
33547929|NCT02421510|101905178|FG001|Overall Study|Death|0|||
33547930|NCT02421510|101905179|FG002|Overall Study|Death|0|||
33547931|NCT02421510|101905177|FG000|Overall Study|Noncompliance with study drug|1|||
33547932|NCT02421510|101905178|FG001|Overall Study|Noncompliance with study drug|0|||
33547933|NCT02421510|101905179|FG002|Overall Study|Noncompliance with study drug|0|||
33547934|NCT02421510|101905177|FG000|Overall Study|Physician Decision|1|||
33547935|NCT02421510|101905178|FG001|Overall Study|Physician Decision|1|||
33547936|NCT02421510|101905179|FG002|Overall Study|Physician Decision|3|||
33547937|NCT02421510|101905177|FG000|Overall Study|Adverse Event|9|||
33547938|NCT02421510|101905178|FG001|Overall Study|Adverse Event|10|||
33547939|NCT02421510|101905179|FG002|Overall Study|Adverse Event|18|||
33547940|NCT02421510|101905177|FG000|Overall Study|Pregnancy|1|||
33547941|NCT02421510|101905178|FG001|Overall Study|Pregnancy|1|||
33547942|NCT02421510|101905179|FG002|Overall Study|Pregnancy|0|||
33547943|NCT02421510|101905177|FG000|Overall Study|Withdrawal by Subject|14|||
33547944|NCT02421510|101905178|FG001|Overall Study|Withdrawal by Subject|18|||
33547945|NCT02421510|101905179|FG002|Overall Study|Withdrawal by Subject|12|||
33547946|NCT02421510|101905177|FG000|Overall Study|Lost to Follow-up|1|||
33547947|NCT02421510|101905178|FG001|Overall Study|Lost to Follow-up|1|||
33547948|NCT02421510|101905179|FG002|Overall Study|Lost to Follow-up|0|||
33547949|NCT02184156|101905180|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
33547950|NCT02184156|101905181|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
33547951|NCT02184156|101905180|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
33547952|NCT02184156|101905181|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
33547953|NCT00393367|101905182|FG000|Overall Study|Protocol Violation|2|||
33547954|NCT00393367|101905183|FG001|Overall Study|Protocol Violation|5|||
33547955|NCT00393367|101905182|FG000|Overall Study|Withdrawal by Subject|0|||
33547956|NCT00393367|101905183|FG001|Overall Study|Withdrawal by Subject|2|||
33547957|NCT01245062|101905184|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
33547958|NCT01245062|101905185|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
33547959|NCT01245062|101905186|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
33547960|NCT01245062|101905184|FG000|Randomization and Crossover Phase|Physician Decision|2|||
33547961|NCT01245062|101905185|FG001|Randomization and Crossover Phase|Physician Decision|4|||
33409727|NCT02734290|101389357|FG001|Overall Study|Death|0|||
33547962|NCT01245062|101905186|FG002|Randomization and Crossover Phase|Physician Decision|0|||
33547963|NCT01245062|101905184|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
33547964|NCT01245062|101905185|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
33547965|NCT01245062|101905186|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
33547966|NCT01245062|101905184|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
33547967|NCT01245062|101905185|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
33617572|NCT00321464|102147484|FG001|Overall Study|Death|174|||
33547968|NCT01245062|101905186|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
33547969|NCT01245062|101905184|FG000|Cross-over Phase|Lost to Follow-up|0|||
33547970|NCT01245062|101905185|FG001|Cross-over Phase|Lost to Follow-up|0|||
33547971|NCT01245062|101905186|FG002|Cross-over Phase|Lost to Follow-up|1|||
33547972|NCT01245062|101905184|FG000|Cross-over Phase|Physician Decision|0|||
33547973|NCT01245062|101905185|FG001|Cross-over Phase|Physician Decision|0|||
33547974|NCT01245062|101905186|FG002|Cross-over Phase|Physician Decision|1|||
33547975|NCT01245062|101905184|FG000|Cross-over Phase|Withdrew Consent|0|||
33547976|NCT01245062|101905185|FG001|Cross-over Phase|Withdrew Consent|0|||
33547977|NCT01245062|101905186|FG002|Cross-over Phase|Withdrew Consent|4|||
33547978|NCT01245062|101905184|FG000|Cross-over Phase|Study closed/ terminated|0|||
33547979|NCT01245062|101905185|FG001|Cross-over Phase|Study closed/ terminated|0|||
33547980|NCT01245062|101905186|FG002|Cross-over Phase|Study closed/ terminated|11|||
33547981|NCT03983109|101905189|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
33547982|NCT03983109|101905190|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
33547983|NCT02612155|101905194|FG000|Overall Study|Death|1|||
33547984|NCT02612155|101905195|FG001|Overall Study|Death|1|||
33547985|NCT02612155|101905194|FG000|Overall Study|Lost to Follow-up|2|||
33547986|NCT02612155|101905195|FG001|Overall Study|Lost to Follow-up|2|||
33547987|NCT03572218|101905197|FG000|Overall Study|Lost to Follow-up|3|||
33547988|NCT03572218|101905198|FG001|Overall Study|Lost to Follow-up|2|||
33547989|NCT03572218|101905197|FG000|Overall Study|No longer available for study visits|2|||
33547990|NCT03572218|101905198|FG001|Overall Study|No longer available for study visits|1|||
33547991|NCT03572218|101905197|FG000|Overall Study|No longer interested|1|||
33547992|NCT03572218|101905198|FG001|Overall Study|No longer interested|2|||
33547993|NCT00694161|101905199|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
33547994|NCT00694161|101905199|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
33547995|NCT00694161|101905199|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
33547996|NCT02006654|101905204|FG000|Overall Study|Withdrawal before treatment|4|||
33547997|NCT02006654|101905205|FG001|Overall Study|Withdrawal before treatment|2|||
33547998|NCT02006654|101905204|FG000|Overall Study|Adverse Event|16|||
33547999|NCT02006654|101905205|FG001|Overall Study|Adverse Event|17|||
33548000|NCT02006654|101905204|FG000|Overall Study|Death|1|||
33548001|NCT02006654|101905205|FG001|Overall Study|Death|0|||
33548002|NCT02006654|101905204|FG000|Overall Study|Withdrawal by Subject|14|||
33548003|NCT02006654|101905205|FG001|Overall Study|Withdrawal by Subject|12|||
33548004|NCT02006654|101905204|FG000|Overall Study|Protocol Violation|5|||
33548005|NCT02006654|101905205|FG001|Overall Study|Protocol Violation|8|||
33548006|NCT02006654|101905204|FG000|Overall Study|Lost to Follow-up|1|||
33548007|NCT02006654|101905205|FG001|Overall Study|Lost to Follow-up|0|||
33548008|NCT02006654|101905204|FG000|Overall Study|patient's will|2|||
33548009|NCT02006654|101905205|FG001|Overall Study|patient's will|1|||
33348955|NCT00896532|101164144|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33348956|NCT00896532|101164145|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33348957|NCT00896532|101164146|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
33348958|NCT00896532|101164124|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348959|NCT00896532|101164125|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348960|NCT00896532|101164126|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
33348961|NCT00896532|101164127|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348962|NCT00896532|101164128|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
33348963|NCT00896532|101164129|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348964|NCT00896532|101164130|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348965|NCT00896532|101164131|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348966|NCT00896532|101164132|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348967|NCT00896532|101164133|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348968|NCT00896532|101164134|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348969|NCT00896532|101164135|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348970|NCT00896532|101164136|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348971|NCT00896532|101164137|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348972|NCT00896532|101164138|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348973|NCT00896532|101164139|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348974|NCT00896532|101164140|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348975|NCT00896532|101164141|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348976|NCT00896532|101164142|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348977|NCT00896532|101164143|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348978|NCT00896532|101164144|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348979|NCT00896532|101164145|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348980|NCT00896532|101164146|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
33348981|NCT00896532|101164124|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
33348982|NCT00896532|101164125|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348983|NCT00896532|101164126|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348984|NCT00896532|101164127|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
33348985|NCT00896532|101164128|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348986|NCT00896532|101164129|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348987|NCT00896532|101164130|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348988|NCT00896532|101164131|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348989|NCT00896532|101164132|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348990|NCT00896532|101164133|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348991|NCT00896532|101164134|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348992|NCT00896532|101164135|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348993|NCT00896532|101164136|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348994|NCT00896532|101164137|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348995|NCT00896532|101164138|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348996|NCT00896532|101164139|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348997|NCT00896532|101164140|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348998|NCT00896532|101164141|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33348999|NCT00896532|101164142|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33349000|NCT00896532|101164143|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33349001|NCT00896532|101164144|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33349002|NCT00896532|101164145|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33349003|NCT00896532|101164146|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
33349004|NCT00896532|101164124|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349005|NCT00896532|101164125|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349006|NCT00896532|101164126|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
33349007|NCT00896532|101164127|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349008|NCT00896532|101164128|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349009|NCT00896532|101164129|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349010|NCT00896532|101164130|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349011|NCT00896532|101164131|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33548010|NCT02006654|101905204|FG000|Overall Study|insufficient compliance|1|||
33349012|NCT00896532|101164132|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349013|NCT00896532|101164133|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33548011|NCT02006654|101905205|FG001|Overall Study|insufficient compliance|0|||
33548012|NCT02006654|101905204|FG000|Overall Study|worsening cognitive condition|0|||
33548013|NCT02006654|101905205|FG001|Overall Study|worsening cognitive condition|1|||
33349014|NCT00896532|101164134|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349015|NCT00896532|101164135|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349016|NCT00896532|101164136|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349017|NCT00896532|101164137|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349018|NCT00896532|101164138|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349019|NCT00896532|101164139|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349020|NCT00896532|101164140|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349021|NCT00896532|101164141|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349022|NCT00896532|101164142|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349023|NCT00896532|101164143|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349024|NCT00896532|101164144|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349025|NCT00896532|101164145|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349026|NCT00896532|101164146|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
33349027|NCT00896532|101164124|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349028|NCT00896532|101164125|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349029|NCT00896532|101164126|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
33349030|NCT00896532|101164127|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349031|NCT00896532|101164128|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349032|NCT00896532|101164129|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349033|NCT00896532|101164130|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349034|NCT00896532|101164131|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349035|NCT00896532|101164132|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349036|NCT00896532|101164133|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349037|NCT00896532|101164134|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349038|NCT00896532|101164135|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349039|NCT00896532|101164136|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349040|NCT00896532|101164137|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349041|NCT00896532|101164138|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349042|NCT00896532|101164139|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349043|NCT00896532|101164140|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349044|NCT00896532|101164141|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349045|NCT00896532|101164142|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349046|NCT00896532|101164143|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349047|NCT00896532|101164144|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349048|NCT00896532|101164145|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349049|NCT00896532|101164146|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
33349050|NCT00896532|101164124|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349051|NCT00896532|101164125|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349052|NCT00896532|101164126|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349053|NCT00896532|101164127|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
33349054|NCT00896532|101164128|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349055|NCT00896532|101164129|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349056|NCT00896532|101164130|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349057|NCT00896532|101164131|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349058|NCT00896532|101164132|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349059|NCT00896532|101164133|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349060|NCT00896532|101164134|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349061|NCT00896532|101164135|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349062|NCT00896532|101164136|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349063|NCT00896532|101164137|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349064|NCT00896532|101164138|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349065|NCT00896532|101164139|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349066|NCT00896532|101164140|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33548014|NCT02006654|101905204|FG000|Overall Study|faecal incontinence|0|||
33548015|NCT02006654|101905205|FG001|Overall Study|faecal incontinence|1|||
33548016|NCT02006654|101905204|FG000|Overall Study|mood disorder|0|||
33548017|NCT02006654|101905205|FG001|Overall Study|mood disorder|1|||
33548018|NCT02006654|101905204|FG000|Overall Study|disallowed medication|1|||
33548019|NCT02006654|101905205|FG001|Overall Study|disallowed medication|0|||
33548020|NCT02006654|101905204|FG000|Overall Study|moving out of state|0|||
33548021|NCT02006654|101905205|FG001|Overall Study|moving out of state|1|||
33548022|NCT02393755|101905206|FG000|Overall Study|Withdrawal by Subject|0|||
33548023|NCT02393755|101905207|FG001|Overall Study|Withdrawal by Subject|3|||
33214821|NCT00717860|100682527|FG000|Overall Study|Discontinued for other reason|6|||
33349067|NCT00896532|101164141|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349068|NCT00896532|101164142|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349069|NCT00896532|101164143|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349070|NCT00896532|101164144|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349071|NCT00896532|101164145|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349072|NCT00896532|101164146|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
33349073|NCT00896532|101164124|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349074|NCT00896532|101164125|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
33349075|NCT00896532|101164126|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33548024|NCT02393755|101905206|FG000|Overall Study|Adverse Event|0|||
33548025|NCT02393755|101905207|FG001|Overall Study|Adverse Event|2|||
33548026|NCT02393755|101905206|FG000|Overall Study|Physician Decision|0|||
33548027|NCT02393755|101905207|FG001|Overall Study|Physician Decision|2|||
33548028|NCT02194465|101905208|FG000|Overall Study|Adverse Event|6|||
33548029|NCT02194465|101905209|FG001|Overall Study|Adverse Event|1|||
33548030|NCT02194465|101905210|FG002|Overall Study|Adverse Event|4|||
33548031|NCT02194465|101905211|FG003|Overall Study|Adverse Event|4|||
33548032|NCT02194465|101905212|FG004|Overall Study|Adverse Event|4|||
33548033|NCT02194465|101905213|FG005|Overall Study|Adverse Event|2|||
33548034|NCT02194465|101905214|FG006|Overall Study|Adverse Event|0|||
33349076|NCT00896532|101164127|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
33548035|NCT02194465|101905208|FG000|Overall Study|Lost to Follow-up|0|||
33548036|NCT02194465|101905209|FG001|Overall Study|Lost to Follow-up|0|||
33548037|NCT02194465|101905210|FG002|Overall Study|Lost to Follow-up|0|||
33548038|NCT02194465|101905211|FG003|Overall Study|Lost to Follow-up|1|||
33548039|NCT02194465|101905212|FG004|Overall Study|Lost to Follow-up|0|||
33548040|NCT02194465|101905213|FG005|Overall Study|Lost to Follow-up|1|||
33548041|NCT02194465|101905214|FG006|Overall Study|Lost to Follow-up|0|||
33548042|NCT02194465|101905208|FG000|Overall Study|Physician Decision|1|||
33548043|NCT02194465|101905209|FG001|Overall Study|Physician Decision|0|||
33548044|NCT02194465|101905210|FG002|Overall Study|Physician Decision|0|||
33548045|NCT02194465|101905211|FG003|Overall Study|Physician Decision|0|||
33548046|NCT02194465|101905212|FG004|Overall Study|Physician Decision|0|||
33548047|NCT02194465|101905213|FG005|Overall Study|Physician Decision|0|||
33548048|NCT02194465|101905214|FG006|Overall Study|Physician Decision|0|||
33548049|NCT02194465|101905208|FG000|Overall Study|Protocol Violation|1|||
33548050|NCT02194465|101905209|FG001|Overall Study|Protocol Violation|1|||
33548051|NCT02194465|101905210|FG002|Overall Study|Protocol Violation|2|||
33548052|NCT02194465|101905211|FG003|Overall Study|Protocol Violation|1|||
33548053|NCT02194465|101905212|FG004|Overall Study|Protocol Violation|1|||
33548054|NCT02194465|101905213|FG005|Overall Study|Protocol Violation|0|||
33548055|NCT02194465|101905214|FG006|Overall Study|Protocol Violation|0|||
33548056|NCT02194465|101905208|FG000|Overall Study|Withdrawal by Subject|1|||
33548057|NCT02194465|101905209|FG001|Overall Study|Withdrawal by Subject|3|||
33548058|NCT02194465|101905210|FG002|Overall Study|Withdrawal by Subject|1|||
33548059|NCT02194465|101905211|FG003|Overall Study|Withdrawal by Subject|2|||
33548060|NCT02194465|101905212|FG004|Overall Study|Withdrawal by Subject|2|||
33548061|NCT02194465|101905213|FG005|Overall Study|Withdrawal by Subject|1|||
33214822|NCT00717860|100682528|FG001|Overall Study|Discontinued for other reason|1|||
33214823|NCT00717860|100682527|FG000|Overall Study|Withdrew consent|7|||
33214824|NCT00717860|100682528|FG001|Overall Study|Withdrew consent|3|||
33214825|NCT02732938|100684988|FG000|Overall Study|Death|0|||
33214826|NCT02732938|100684989|FG001|Overall Study|Death|11|||
33349077|NCT00896532|101164128|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
33548062|NCT02194465|101905214|FG006|Overall Study|Withdrawal by Subject|2|||
33548063|NCT02194465|101905208|FG000|Overall Study|Discontinued follow-up period|0|||
33548064|NCT02194465|101905209|FG001|Overall Study|Discontinued follow-up period|2|||
33548065|NCT02194465|101905210|FG002|Overall Study|Discontinued follow-up period|1|||
33548066|NCT02194465|101905211|FG003|Overall Study|Discontinued follow-up period|0|||
33548067|NCT02194465|101905212|FG004|Overall Study|Discontinued follow-up period|2|||
33548068|NCT02194465|101905213|FG005|Overall Study|Discontinued follow-up period|0|||
33214827|NCT02732938|100684990|FG002|Overall Study|Death|0|||
33548069|NCT02194465|101905214|FG006|Overall Study|Discontinued follow-up period|0|||
33548070|NCT02403271|101905216|FG000|Period 1|Other varied reasons|1|||
33548071|NCT02403271|101905217|FG001|Period 1|Other varied reasons|0|||
33214828|NCT02732938|100684988|FG000|Overall Study|Randomized but did not receive treatment|0|||
33548072|NCT02403271|101905216|FG000|Period 2|Withdrawal by Subject|0|||
33548073|NCT02403271|101905217|FG001|Period 2|Withdrawal by Subject|14|||
33548074|NCT02403271|101905216|FG000|Period 2|Death|0|||
33548075|NCT02403271|101905217|FG001|Period 2|Death|84|||
33548076|NCT02403271|101905216|FG000|Period 2|Lost to Follow-up|0|||
33214829|NCT02732938|100684989|FG001|Overall Study|Randomized but did not receive treatment|1|||
33214830|NCT02732938|100684990|FG002|Overall Study|Randomized but did not receive treatment|0|||
33214831|NCT02732938|100684988|FG000|Overall Study|Refused further follow-up|1|||
33214832|NCT02732938|100684989|FG001|Overall Study|Refused further follow-up|0|||
33548077|NCT02403271|101905217|FG001|Period 2|Lost to Follow-up|2|||
33548078|NCT02403271|101905216|FG000|Period 2|Study Terminated by Sponsor|0|||
33548079|NCT02403271|101905217|FG001|Period 2|Study Terminated by Sponsor|14|||
33548080|NCT02403271|101905216|FG000|Period 2|Other varied reasons|0|||
33548081|NCT02403271|101905217|FG001|Period 2|Other varied reasons|10|||
33548082|NCT01143324|101905218|FG000|Overall Study|Lost to Follow-up|11|||
33548083|NCT01143324|101905218|FG000|Overall Study|Withdrawal by Subject|4|||
33548084|NCT01143324|101905218|FG000|Overall Study|Explant of the device|4|||
33548085|NCT03439839|101905219|FG000|Overall Study|Death|3|||
33548086|NCT03439839|101905220|FG001|Overall Study|Death|0|||
33548087|NCT03483103|101905226|FG000|Pre-Treatment Phase|Other reasons|1|||
33548088|NCT03483103|101905226|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
33548089|NCT03483103|101905226|FG000|Pre-Treatment Phase|Disease-related complications|1|||
33548090|NCT03483103|101905226|FG000|Pre-Treatment Phase|Death|5|||
33548091|NCT03483103|101905226|FG000|Treatment Phase|Withdrawal by Subject|7|||
33548092|NCT03483103|101905226|FG000|Treatment Phase|Other reasons|1|||
33548093|NCT03483103|101905226|FG000|Treatment Phase|Death|23|||
33214833|NCT02732938|100684990|FG002|Overall Study|Refused further follow-up|0|||
33214834|NCT02732938|100684988|FG000|Overall Study|Study terminated by sponsor|3|||
33214835|NCT02732938|100684989|FG001|Overall Study|Study terminated by sponsor|6|||
33214836|NCT02732938|100684990|FG002|Overall Study|Study terminated by sponsor|0|||
33214837|NCT03360942|100684991|FG000|Overall Study|Device explanted|2|||
33214838|NCT03360942|100684991|FG000|Overall Study|Study closure|1|||
33214839|NCT03360942|100684991|FG000|Overall Study|Withdrawal by Subject|2|||
33214840|NCT01428076|100684996|FG000|Overall Study|Adverse Event|0|||
33214841|NCT01428076|100684997|FG001|Overall Study|Adverse Event|1|||
33214842|NCT05130970|100684998|FG000|Overall Study|Adverse Event|1|||
33214843|NCT05130970|100684999|FG001|Overall Study|Adverse Event|1|||
33214844|NCT05130970|100684998|FG000|Overall Study|Death|0|||
33214845|NCT05130970|100684999|FG001|Overall Study|Death|1|||
33214846|NCT05130970|100684998|FG000|Overall Study|Lost to Follow-up|0|||
33214847|NCT05130970|100684999|FG001|Overall Study|Lost to Follow-up|1|||
33214848|NCT05130970|100684998|FG000|Overall Study|Physician Decision|0|||
33214849|NCT05130970|100684999|FG001|Overall Study|Physician Decision|1|||
33214850|NCT05130970|100684998|FG000|Overall Study|Withdrawal by Subject|1|||
33214851|NCT05130970|100684999|FG001|Overall Study|Withdrawal by Subject|1|||
33214852|NCT01239030|100685004|FG000|Double Blind|Adverse Event|0|||
33214853|NCT01239030|100685005|FG001|Double Blind|Adverse Event|1|||
33214854|NCT01239030|100685006|FG002|Double Blind|Adverse Event|0|||
33214855|NCT01239030|100685007|FG003|Double Blind|Adverse Event|2|||
33214856|NCT01239030|100685008|FG004|Double Blind|Adverse Event|0|||
33214857|NCT01239030|100685004|FG000|Double Blind|Withdrawal by Subject|0|||
33214858|NCT01239030|100685005|FG001|Double Blind|Withdrawal by Subject|1|||
33214859|NCT01239030|100685006|FG002|Double Blind|Withdrawal by Subject|1|||
33214860|NCT01239030|100685007|FG003|Double Blind|Withdrawal by Subject|0|||
33214861|NCT01239030|100685008|FG004|Double Blind|Withdrawal by Subject|1|||
33214862|NCT01239030|100685004|FG000|Double Blind|Lost to Follow-up|1|||
33548094|NCT03483103|101905226|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
33548095|NCT03483103|101905226|FG000|Treatment Phase|Received nonconforming product|1|||
33214863|NCT01239030|100685005|FG001|Double Blind|Lost to Follow-up|1|||
33214864|NCT01239030|100685006|FG002|Double Blind|Lost to Follow-up|0|||
33214865|NCT01239030|100685007|FG003|Double Blind|Lost to Follow-up|0|||
33214866|NCT01239030|100685008|FG004|Double Blind|Lost to Follow-up|0|||
33548096|NCT01875237|101905227|FG000|Overall Study|GVDH before DLI|1|||
33214867|NCT01239030|100685004|FG000|Double Blind|Physician Decision|0|||
33548097|NCT01875237|101905228|FG001|Overall Study|GVDH before DLI|0|||
33548098|NCT01875237|101905227|FG000|Overall Study|DLI cells could not be produced|1|||
33548099|NCT01875237|101905228|FG001|Overall Study|DLI cells could not be produced|0|||
33548100|NCT00784875|101905233|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
33214868|NCT01239030|100685005|FG001|Double Blind|Physician Decision|1|||
33214869|NCT01239030|100685006|FG002|Double Blind|Physician Decision|0|||
33214870|NCT01239030|100685007|FG003|Double Blind|Physician Decision|0|||
33214871|NCT01239030|100685008|FG004|Double Blind|Physician Decision|0|||
33214872|NCT01239030|100685004|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
33214873|NCT01239030|100685005|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
33214874|NCT01239030|100685006|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
33548101|NCT00784875|101905234|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
33214875|NCT01239030|100685007|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
33548102|NCT00784875|101905235|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
33214876|NCT01239030|100685008|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
33214877|NCT01239030|100685004|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
33214878|NCT01239030|100685005|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
33214879|NCT01239030|100685006|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
33214880|NCT01239030|100685007|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
33214881|NCT01239030|100685008|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
33617573|NCT00321464|102147483|FG000|Overall Study|Disease progression|124|||
33617574|NCT00321464|102147484|FG001|Overall Study|Disease progression|124|||
33617575|NCT00321464|102147483|FG000|Overall Study|Withdrawal by Subject|117|||
33617576|NCT00321464|102147484|FG001|Overall Study|Withdrawal by Subject|118|||
33617577|NCT00321464|102147483|FG000|Overall Study|Participant request|57|||
33617578|NCT00321464|102147484|FG001|Overall Study|Participant request|61|||
33617579|NCT00321464|102147483|FG000|Overall Study|Adverse Event|43|||
33617580|NCT00321464|102147484|FG001|Overall Study|Adverse Event|28|||
33617581|NCT00321464|102147483|FG000|Overall Study|Physician Decision|15|||
33617582|NCT00321464|102147484|FG001|Overall Study|Physician Decision|14|||
33617583|NCT00321464|102147483|FG000|Overall Study|Noncompliance|4|||
33617584|NCT00321464|102147484|FG001|Overall Study|Noncompliance|10|||
33617585|NCT00321464|102147483|FG000|Overall Study|Lost to Follow-up|7|||
33617586|NCT00321464|102147484|FG001|Overall Study|Lost to Follow-up|8|||
33617587|NCT00321464|102147483|FG000|Overall Study|Protocol deviation|0|||
33617588|NCT00321464|102147484|FG001|Overall Study|Protocol deviation|2|||
33617589|NCT00321464|102147483|FG000|Overall Study|Ineligibility determined|2|||
33617590|NCT00321464|102147484|FG001|Overall Study|Ineligibility determined|1|||
33617591|NCT00321464|102147483|FG000|Overall Study|Other|21|||
33617592|NCT00321464|102147484|FG001|Overall Study|Other|18|||
33617593|NCT00930930|102147485|FG000|Overall Study|Death|1|||
33617594|NCT00930930|102147486|FG001|Overall Study|Death|0|||
33617595|NCT00930930|102147485|FG000|Overall Study|Physician Decision|1|||
33617596|NCT00930930|102147486|FG001|Overall Study|Physician Decision|0|||
33617597|NCT00930930|102147485|FG000|Overall Study|Adverse Event|13|||
33617598|NCT00930930|102147486|FG001|Overall Study|Adverse Event|3|||
33617599|NCT00930930|102147485|FG000|Overall Study|Withdrawal by Subject|3|||
33617600|NCT00930930|102147486|FG001|Overall Study|Withdrawal by Subject|1|||
33617601|NCT00930930|102147485|FG000|Overall Study|Disease progression|2|||
33617602|NCT00930930|102147486|FG001|Overall Study|Disease progression|3|||
33617603|NCT00930930|102147485|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
33617604|NCT00930930|102147486|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
33617605|NCT00930930|102147485|FG000|Overall Study|patients not compliant|1|||
33617606|NCT00930930|102147486|FG001|Overall Study|patients not compliant|1|||
33617607|NCT03472326|102147487|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
33617608|NCT03472326|102147488|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
33617609|NCT03472326|102147489|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
33617610|NCT03472326|102147490|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
33617611|NCT03472326|102147487|FG000|Part 2: Combination Therapy|Pregnancy|0|||
33617612|NCT03472326|102147488|FG001|Part 2: Combination Therapy|Pregnancy|0|||
33617613|NCT03472326|102147489|FG002|Part 2: Combination Therapy|Pregnancy|0|||
33617614|NCT03472326|102147490|FG003|Part 2: Combination Therapy|Pregnancy|1|||
33617615|NCT03040674|102147491|FG000|Overall Study|Lost to Follow-up|225|||
33617616|NCT03040674|102147491|FG000|Overall Study|Death|23|||
33617617|NCT02343406|102147494|FG000|Overall Study|Progressive disease|72|||
33617618|NCT02343406|102147495|FG001|Overall Study|Progressive disease|70|||
33617619|NCT02343406|102147496|FG002|Overall Study|Progressive disease|43|||
33617620|NCT02343406|102147497|FG003|Overall Study|Progressive disease|15|||
33214882|NCT01239030|100685004|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
33349078|NCT00896532|101164129|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349079|NCT00896532|101164130|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349080|NCT00896532|101164131|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349081|NCT00896532|101164132|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349082|NCT00896532|101164133|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349083|NCT00896532|101164134|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349084|NCT00896532|101164135|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349085|NCT00896532|101164136|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349086|NCT00896532|101164137|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349087|NCT00896532|101164138|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33214883|NCT01239030|100685005|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
33349088|NCT00896532|101164139|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349089|NCT00896532|101164140|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33617621|NCT02343406|102147498|FG004|Overall Study|Progressive disease|5|||
33617622|NCT02343406|102147494|FG000|Overall Study|Adverse Event|6|||
33617623|NCT02343406|102147495|FG001|Overall Study|Adverse Event|8|||
33617624|NCT02343406|102147496|FG002|Overall Study|Adverse Event|6|||
33617625|NCT02343406|102147497|FG003|Overall Study|Adverse Event|3|||
33617626|NCT02343406|102147498|FG004|Overall Study|Adverse Event|0|||
33617627|NCT02343406|102147494|FG000|Overall Study|Withdrawal by Subject|6|||
33617628|NCT02343406|102147495|FG001|Overall Study|Withdrawal by Subject|4|||
33617629|NCT02343406|102147496|FG002|Overall Study|Withdrawal by Subject|8|||
33617630|NCT02343406|102147497|FG003|Overall Study|Withdrawal by Subject|3|||
33617631|NCT02343406|102147498|FG004|Overall Study|Withdrawal by Subject|0|||
33617632|NCT02343406|102147494|FG000|Overall Study|Death|2|||
33617633|NCT02343406|102147495|FG001|Overall Study|Death|1|||
33617634|NCT02343406|102147496|FG002|Overall Study|Death|0|||
33617635|NCT02343406|102147497|FG003|Overall Study|Death|0|||
33617636|NCT02343406|102147498|FG004|Overall Study|Death|0|||
33617637|NCT02343406|102147494|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
33214884|NCT01239030|100685006|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
33214885|NCT01239030|100685007|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
33214886|NCT01239030|100685008|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
33214887|NCT01239030|100685004|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
33548103|NCT00784875|101905236|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
33548104|NCT00784875|101905233|FG000|Period A - Baseline|Adverse Event|0|||
33548105|NCT00784875|101905234|FG001|Period A - Baseline|Adverse Event|0|||
33548106|NCT00784875|101905235|FG002|Period A - Baseline|Adverse Event|0|||
33548107|NCT00784875|101905236|FG003|Period A - Baseline|Adverse Event|8|||
33548108|NCT00784875|101905233|FG000|Period A - Baseline|Protocol Violation|0|||
33548109|NCT00784875|101905234|FG001|Period A - Baseline|Protocol Violation|0|||
33548110|NCT00784875|101905235|FG002|Period A - Baseline|Protocol Violation|0|||
33548111|NCT00784875|101905236|FG003|Period A - Baseline|Protocol Violation|25|||
33548112|NCT00784875|101905233|FG000|Period A - Baseline|Withdrawal by Subject|0|||
33617638|NCT02343406|102147495|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
33617639|NCT02343406|102147496|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
33617640|NCT02343406|102147497|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
33617641|NCT02343406|102147498|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
33617642|NCT02343406|102147494|FG000|Overall Study|Other primary malignancy|0|||
33617643|NCT02343406|102147495|FG001|Overall Study|Other primary malignancy|1|||
33617644|NCT02343406|102147496|FG002|Overall Study|Other primary malignancy|0|||
33617645|NCT02343406|102147497|FG003|Overall Study|Other primary malignancy|0|||
33214888|NCT01239030|100685005|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
33548113|NCT00784875|101905234|FG001|Period A - Baseline|Withdrawal by Subject|0|||
33617646|NCT02343406|102147498|FG004|Overall Study|Other primary malignancy|0|||
33214889|NCT01239030|100685006|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
33214890|NCT01239030|100685007|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
33349090|NCT00896532|101164141|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349091|NCT00896532|101164142|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349092|NCT00896532|101164143|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349093|NCT00896532|101164144|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33617647|NCT02343406|102147494|FG000|Overall Study|Other, not specified|2|||
33617648|NCT02343406|102147495|FG001|Overall Study|Other, not specified|1|||
33617649|NCT02343406|102147496|FG002|Overall Study|Other, not specified|1|||
33617650|NCT02343406|102147497|FG003|Overall Study|Other, not specified|4|||
33617651|NCT02343406|102147498|FG004|Overall Study|Other, not specified|0|||
33617652|NCT04207749|102147499|FG000|Overall Study|Lost to Follow-up|0|||
33617653|NCT04207749|102147500|FG001|Overall Study|Lost to Follow-up|2|||
33617654|NCT04207749|102147499|FG000|Overall Study|Protocol Violation|0|||
33617655|NCT04207749|102147500|FG001|Overall Study|Protocol Violation|1|||
33617656|NCT04207749|102147499|FG000|Overall Study|Withdrawal by Subject|3|||
33617657|NCT04207749|102147500|FG001|Overall Study|Withdrawal by Subject|0|||
33617658|NCT04207749|102147499|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
33617659|NCT04207749|102147500|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
33617660|NCT03431350|102147502|FG000|Overall Study|ONGOING|0|||
33617661|NCT03431350|102147503|FG001|Overall Study|ONGOING|0|||
33617662|NCT03431350|102147504|FG002|Overall Study|ONGOING|2|||
33617663|NCT03431350|102147505|FG003|Overall Study|ONGOING|0|||
33617664|NCT03431350|102147506|FG004|Overall Study|ONGOING|1|||
33617665|NCT03431350|102147507|FG005|Overall Study|ONGOING|3|||
33617666|NCT03431350|102147508|FG006|Overall Study|ONGOING|0|||
33617667|NCT03431350|102147509|FG007|Overall Study|ONGOING|1|||
33617668|NCT03431350|102147510|FG008|Overall Study|ONGOING|3|||
33617669|NCT03431350|102147511|FG009|Overall Study|ONGOING|4|||
33617670|NCT03431350|102147512|FG010|Overall Study|ONGOING|2|||
33617671|NCT03431350|102147513|FG011|Overall Study|ONGOING|1|||
33617672|NCT03431350|102147502|FG000|Overall Study|Death|6|||
33617673|NCT03431350|102147503|FG001|Overall Study|Death|5|||
33617674|NCT03431350|102147504|FG002|Overall Study|Death|18|||
33617675|NCT03431350|102147505|FG003|Overall Study|Death|7|||
33617676|NCT03431350|102147506|FG004|Overall Study|Death|4|||
33617677|NCT03431350|102147507|FG005|Overall Study|Death|3|||
33617678|NCT03431350|102147508|FG006|Overall Study|Death|2|||
33617679|NCT03431350|102147509|FG007|Overall Study|Death|0|||
33617680|NCT03431350|102147510|FG008|Overall Study|Death|0|||
33617681|NCT03431350|102147511|FG009|Overall Study|Death|0|||
33617682|NCT03431350|102147512|FG010|Overall Study|Death|4|||
33617683|NCT03431350|102147513|FG011|Overall Study|Death|0|||
33617684|NCT03431350|102147502|FG000|Overall Study|Lost to Follow-up|0|||
33617685|NCT03431350|102147503|FG001|Overall Study|Lost to Follow-up|1|||
33617686|NCT03431350|102147504|FG002|Overall Study|Lost to Follow-up|0|||
33617687|NCT03431350|102147505|FG003|Overall Study|Lost to Follow-up|0|||
33349094|NCT00896532|101164145|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349095|NCT00896532|101164146|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
33349096|NCT00896532|101164124|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349097|NCT00896532|101164125|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349098|NCT00896532|101164126|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349099|NCT00896532|101164127|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349100|NCT00896532|101164128|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349101|NCT00896532|101164129|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349102|NCT00896532|101164130|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349103|NCT00896532|101164131|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349104|NCT00896532|101164132|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
33349105|NCT00896532|101164133|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349106|NCT00896532|101164134|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349107|NCT00896532|101164135|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349108|NCT00896532|101164136|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33214891|NCT01239030|100685008|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
33214892|NCT04401267|100685009|FG000|Overall Study|Death|0|||
33214893|NCT04401267|100685010|FG001|Overall Study|Death|1|||
33349109|NCT00896532|101164137|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33617688|NCT03431350|102147506|FG004|Overall Study|Lost to Follow-up|0|||
33617689|NCT03431350|102147507|FG005|Overall Study|Lost to Follow-up|0|||
33617690|NCT03431350|102147508|FG006|Overall Study|Lost to Follow-up|0|||
33617691|NCT03431350|102147509|FG007|Overall Study|Lost to Follow-up|0|||
33617692|NCT03431350|102147510|FG008|Overall Study|Lost to Follow-up|0|||
33617693|NCT03431350|102147511|FG009|Overall Study|Lost to Follow-up|0|||
33617694|NCT03431350|102147512|FG010|Overall Study|Lost to Follow-up|0|||
33617695|NCT03431350|102147513|FG011|Overall Study|Lost to Follow-up|0|||
33349110|NCT00896532|101164138|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349111|NCT00896532|101164139|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33548114|NCT00784875|101905235|FG002|Period A - Baseline|Withdrawal by Subject|0|||
33548115|NCT00784875|101905236|FG003|Period A - Baseline|Withdrawal by Subject|27|||
33548116|NCT00784875|101905233|FG000|Period A - Baseline|Physician Decision|0|||
33548117|NCT00784875|101905234|FG001|Period A - Baseline|Physician Decision|0|||
33548118|NCT00784875|101905235|FG002|Period A - Baseline|Physician Decision|0|||
33548119|NCT00784875|101905236|FG003|Period A - Baseline|Physician Decision|2|||
33548120|NCT00784875|101905233|FG000|Period A - Baseline|Sponsor Decision|0|||
33548121|NCT00784875|101905234|FG001|Period A - Baseline|Sponsor Decision|0|||
33548122|NCT00784875|101905235|FG002|Period A - Baseline|Sponsor Decision|0|||
33548123|NCT00784875|101905236|FG003|Period A - Baseline|Sponsor Decision|113|||
33548124|NCT00784875|101905233|FG000|Period A - Baseline|Lost to Follow-up|0|||
33548125|NCT00784875|101905234|FG001|Period A - Baseline|Lost to Follow-up|0|||
33548126|NCT00784875|101905235|FG002|Period A - Baseline|Lost to Follow-up|0|||
33349112|NCT00896532|101164140|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349113|NCT00896532|101164141|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349114|NCT00896532|101164142|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349115|NCT00896532|101164143|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33548127|NCT00784875|101905236|FG003|Period A - Baseline|Lost to Follow-up|2|||
33617696|NCT03431350|102147502|FG000|Overall Study|Withdrawal by Subject|0|||
33617697|NCT03431350|102147503|FG001|Overall Study|Withdrawal by Subject|0|||
33409728|NCT01243762|101389358|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
33409729|NCT01243762|101389359|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
33409730|NCT01243762|101389360|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
33409731|NCT01243762|101389361|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
33409732|NCT01243762|101389362|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
33409733|NCT01243762|101389363|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
33409734|NCT01243762|101389364|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
33409735|NCT01243762|101389358|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
33409736|NCT01243762|101389359|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
33409737|NCT01243762|101389360|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
33617698|NCT03431350|102147504|FG002|Overall Study|Withdrawal by Subject|0|||
33617699|NCT03431350|102147505|FG003|Overall Study|Withdrawal by Subject|1|||
33548128|NCT00784875|101905233|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
33548129|NCT00784875|101905234|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
33548130|NCT00784875|101905235|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
33548131|NCT00784875|101905236|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
33548132|NCT00784875|101905233|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
33548133|NCT00784875|101905234|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
33214894|NCT04401267|100685009|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
33214895|NCT04401267|100685010|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
33214896|NCT04401267|100685009|FG000|Overall Study|Found to be Ineligible|1|||
33548134|NCT00784875|101905235|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
33548135|NCT00784875|101905236|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
33548136|NCT00784875|101905233|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
33548137|NCT00784875|101905234|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
33548138|NCT00784875|101905235|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
33548139|NCT00784875|101905236|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
33617700|NCT03431350|102147506|FG004|Overall Study|Withdrawal by Subject|1|||
33617701|NCT03431350|102147507|FG005|Overall Study|Withdrawal by Subject|1|||
33548140|NCT00784875|101905233|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
33548141|NCT00784875|101905234|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
33548142|NCT00784875|101905235|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
33548143|NCT00784875|101905236|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
33548144|NCT00784875|101905233|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
33548145|NCT00784875|101905234|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
33548146|NCT00784875|101905235|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
33548147|NCT00784875|101905236|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
33214897|NCT04401267|100685010|FG001|Overall Study|Found to be Ineligible|0|||
33214898|NCT02063828|100685011|FG000|Overall Study|Withdrawal by Subject|4|||
33214899|NCT02063828|100685012|FG001|Overall Study|Withdrawal by Subject|6|||
33409738|NCT01243762|101389361|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
33409739|NCT01243762|101389362|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
33409740|NCT01243762|101389363|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
33409741|NCT01243762|101389364|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
33548148|NCT00784875|101905233|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
33548149|NCT00784875|101905234|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
33548150|NCT00784875|101905235|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
33548151|NCT00784875|101905236|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
33214900|NCT02063828|100685013|FG002|Overall Study|Withdrawal by Subject|3|||
33214901|NCT02063828|100685011|FG000|Overall Study|Death|0|||
33214902|NCT02063828|100685012|FG001|Overall Study|Death|0|||
33214903|NCT02063828|100685013|FG002|Overall Study|Death|1|||
33409742|NCT01243762|101389358|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
33548152|NCT00784875|101905233|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
33617702|NCT03431350|102147508|FG006|Overall Study|Withdrawal by Subject|0|||
33617703|NCT03431350|102147509|FG007|Overall Study|Withdrawal by Subject|0|||
33617704|NCT03431350|102147510|FG008|Overall Study|Withdrawal by Subject|0|||
33548153|NCT00784875|101905234|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
33548154|NCT00784875|101905235|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
33617705|NCT03431350|102147511|FG009|Overall Study|Withdrawal by Subject|2|||
33214904|NCT00643916|100685018|FG000|Overall Study|Protocol Violation|0|||
33349116|NCT00896532|101164144|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349117|NCT00896532|101164145|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33349118|NCT00896532|101164146|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
33548155|NCT00784875|101905236|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
33548156|NCT00784875|101905233|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
33548157|NCT00784875|101905234|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
33548158|NCT00784875|101905235|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
33548159|NCT00784875|101905236|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
33548160|NCT00784875|101905233|FG000|Period C|Adverse Event|1|||
33548161|NCT00784875|101905234|FG001|Period C|Adverse Event|0|||
33548162|NCT00784875|101905235|FG002|Period C|Adverse Event|4|||
33548163|NCT00784875|101905236|FG003|Period C|Adverse Event|2|||
33548164|NCT00784875|101905233|FG000|Period C|Protocol Violation|0|||
33349119|NCT00896532|101164124|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349120|NCT00896532|101164125|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349121|NCT00896532|101164126|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33548165|NCT00784875|101905234|FG001|Period C|Protocol Violation|0|||
33548166|NCT00784875|101905235|FG002|Period C|Protocol Violation|1|||
33548167|NCT00784875|101905236|FG003|Period C|Protocol Violation|2|||
33548168|NCT00784875|101905233|FG000|Period C|Lack of Efficacy|0|||
33548169|NCT00784875|101905234|FG001|Period C|Lack of Efficacy|0|||
33548170|NCT00784875|101905235|FG002|Period C|Lack of Efficacy|1|||
33548171|NCT00784875|101905236|FG003|Period C|Lack of Efficacy|0|||
33548172|NCT00784875|101905233|FG000|Period C|Withdrawal by Subject|1|||
33349122|NCT00896532|101164127|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33548173|NCT00784875|101905234|FG001|Period C|Withdrawal by Subject|1|||
33548174|NCT00784875|101905235|FG002|Period C|Withdrawal by Subject|2|||
33548175|NCT00784875|101905236|FG003|Period C|Withdrawal by Subject|0|||
33548176|NCT00784875|101905233|FG000|Period C|Physician Decision|0|||
33548177|NCT00784875|101905234|FG001|Period C|Physician Decision|0|||
33548178|NCT00784875|101905235|FG002|Period C|Physician Decision|1|||
33548179|NCT00784875|101905236|FG003|Period C|Physician Decision|1|||
33548180|NCT00784875|101905233|FG000|Period C|Sponsor Decision|5|||
33548181|NCT00784875|101905234|FG001|Period C|Sponsor Decision|5|||
33548182|NCT00784875|101905235|FG002|Period C|Sponsor Decision|4|||
33548183|NCT00784875|101905236|FG003|Period C|Sponsor Decision|2|||
33548184|NCT00784875|101905233|FG000|Period D|Adverse Event|0|||
33548185|NCT00784875|101905234|FG001|Period D|Adverse Event|2|||
33548186|NCT00784875|101905235|FG002|Period D|Adverse Event|2|||
33548187|NCT00784875|101905236|FG003|Period D|Adverse Event|0|||
33548188|NCT00784875|101905233|FG000|Period D|Protocol Violation|1|||
33548189|NCT00784875|101905234|FG001|Period D|Protocol Violation|0|||
33548190|NCT00784875|101905235|FG002|Period D|Protocol Violation|0|||
33548191|NCT00784875|101905236|FG003|Period D|Protocol Violation|0|||
33548192|NCT00784875|101905233|FG000|Period D|Withdrawal by Subject|2|||
33548193|NCT00784875|101905234|FG001|Period D|Withdrawal by Subject|0|||
33548194|NCT00784875|101905235|FG002|Period D|Withdrawal by Subject|2|||
33548195|NCT00784875|101905236|FG003|Period D|Withdrawal by Subject|0|||
33548196|NCT00784875|101905233|FG000|Period D|Physician Decision|0|||
33548197|NCT00784875|101905234|FG001|Period D|Physician Decision|1|||
33617706|NCT03431350|102147512|FG010|Overall Study|Withdrawal by Subject|0|||
33349123|NCT00896532|101164128|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349124|NCT00896532|101164129|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349125|NCT00896532|101164130|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349126|NCT00896532|101164131|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349127|NCT00896532|101164132|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349128|NCT00896532|101164133|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349129|NCT00896532|101164134|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349130|NCT00896532|101164135|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33548198|NCT00784875|101905235|FG002|Period D|Physician Decision|0|||
33548199|NCT00784875|101905236|FG003|Period D|Physician Decision|0|||
33548200|NCT00784875|101905233|FG000|Period D|Sponsor Decision|1|||
33548201|NCT00784875|101905234|FG001|Period D|Sponsor Decision|1|||
33548202|NCT00784875|101905235|FG002|Period D|Sponsor Decision|1|||
33548203|NCT00784875|101905236|FG003|Period D|Sponsor Decision|0|||
33548204|NCT00784875|101905233|FG000|Period D|Lost to Follow-up|1|||
33548205|NCT00784875|101905234|FG001|Period D|Lost to Follow-up|0|||
33548206|NCT00784875|101905235|FG002|Period D|Lost to Follow-up|1|||
33548207|NCT00784875|101905236|FG003|Period D|Lost to Follow-up|1|||
33617707|NCT03431350|102147513|FG011|Overall Study|Withdrawal by Subject|1|||
33548208|NCT02401230|101905237|FG000|Overall Study|Adverse Event|3|||
33214905|NCT00643916|100685019|FG001|Overall Study|Protocol Violation|1|||
33548209|NCT02401230|101905238|FG001|Overall Study|Adverse Event|2|||
33548210|NCT02401230|101905239|FG002|Overall Study|Adverse Event|0|||
33548211|NCT02401230|101905237|FG000|Overall Study|Withdrawal by Subject|2|||
33548212|NCT02401230|101905238|FG001|Overall Study|Withdrawal by Subject|1|||
33548213|NCT02401230|101905239|FG002|Overall Study|Withdrawal by Subject|1|||
33214906|NCT00643916|100685020|FG002|Overall Study|Protocol Violation|1|||
33214907|NCT00643916|100685021|FG003|Overall Study|Protocol Violation|1|||
33214908|NCT00643916|100685022|FG004|Overall Study|Protocol Violation|0|||
33214909|NCT00643916|100685023|FG005|Overall Study|Protocol Violation|0|||
33214910|NCT00643916|100685018|FG000|Overall Study|Lost to Follow-up|0|||
33214911|NCT00643916|100685019|FG001|Overall Study|Lost to Follow-up|1|||
33214912|NCT00643916|100685020|FG002|Overall Study|Lost to Follow-up|0|||
33214913|NCT00643916|100685021|FG003|Overall Study|Lost to Follow-up|0|||
33214914|NCT00643916|100685022|FG004|Overall Study|Lost to Follow-up|0|||
33214915|NCT00643916|100685023|FG005|Overall Study|Lost to Follow-up|0|||
33214916|NCT00643916|100685018|FG000|Overall Study|Withdrawal by Subject|2|||
33214917|NCT00643916|100685019|FG001|Overall Study|Withdrawal by Subject|2|||
33214918|NCT00643916|100685020|FG002|Overall Study|Withdrawal by Subject|2|||
33214919|NCT00643916|100685021|FG003|Overall Study|Withdrawal by Subject|1|||
33214920|NCT00643916|100685022|FG004|Overall Study|Withdrawal by Subject|0|||
33214921|NCT00643916|100685023|FG005|Overall Study|Withdrawal by Subject|1|||
33214922|NCT00643916|100685018|FG000|Overall Study|Not Vaccinated|2|||
33214923|NCT00643916|100685019|FG001|Overall Study|Not Vaccinated|2|||
33214924|NCT00643916|100685020|FG002|Overall Study|Not Vaccinated|3|||
33214925|NCT00643916|100685021|FG003|Overall Study|Not Vaccinated|0|||
33214926|NCT00643916|100685022|FG004|Overall Study|Not Vaccinated|2|||
33214927|NCT00643916|100685023|FG005|Overall Study|Not Vaccinated|0|||
33214928|NCT02395042|100685024|FG000|Treatment 1 Period|Adverse Event|1|||
33214929|NCT02395042|100685025|FG001|Treatment 1 Period|Adverse Event|3|||
33214930|NCT02395042|100685026|FG002|Treatment 1 Period|Adverse Event|1|||
33214931|NCT02395042|100685024|FG000|Treatment 1 Period|Lack of Efficacy|1|||
33214932|NCT02395042|100685025|FG001|Treatment 1 Period|Lack of Efficacy|1|||
33214933|NCT02395042|100685026|FG002|Treatment 1 Period|Lack of Efficacy|0|||
33214934|NCT02395042|100685024|FG000|Treatment 1 Period|Lost to Follow-up|1|||
33214935|NCT02395042|100685025|FG001|Treatment 1 Period|Lost to Follow-up|0|||
33214936|NCT02395042|100685026|FG002|Treatment 1 Period|Lost to Follow-up|0|||
33214937|NCT02395042|100685024|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
33409743|NCT01243762|101389359|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
33409744|NCT01243762|101389360|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
33409745|NCT01243762|101389361|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
33409746|NCT01243762|101389362|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
33409747|NCT01243762|101389363|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
33409748|NCT01243762|101389364|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
33409749|NCT01243762|101389358|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
33409750|NCT01243762|101389359|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
33409751|NCT01243762|101389360|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
33409752|NCT01243762|101389361|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
33409753|NCT01243762|101389362|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
33409754|NCT01243762|101389363|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
33409755|NCT01243762|101389364|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
33409756|NCT01243762|101389358|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
33548214|NCT02401230|101905237|FG000|Overall Study|Lost to Follow-up|1|||
33548215|NCT02401230|101905238|FG001|Overall Study|Lost to Follow-up|3|||
33548216|NCT02401230|101905239|FG002|Overall Study|Lost to Follow-up|3|||
33214938|NCT02395042|100685025|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
33214939|NCT02395042|100685026|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
33214940|NCT02395042|100685024|FG000|Treatment 2 Period|Lack of Efficacy|1|||
33214941|NCT02395042|100685025|FG001|Treatment 2 Period|Lack of Efficacy|1|||
33214942|NCT02395042|100685026|FG002|Treatment 2 Period|Lack of Efficacy|0|||
33214943|NCT04528069|100685027|FG000|Overall Study|Adverse Event|1|||
33214944|NCT04528069|100685027|FG000|Overall Study|Lost to Follow-up|1|||
33214945|NCT04528069|100685027|FG000|Overall Study|Patient Unable to Come|1|||
33214946|NCT04528069|100685027|FG000|Overall Study|Patient Unable to Attend|1|||
33214947|NCT00160680|100685028|FG000|Overall Study|Adverse Event|0|||
33214948|NCT00160680|100685029|FG001|Overall Study|Adverse Event|1|||
33214949|NCT00160680|100685028|FG000|Overall Study|Lack of Efficacy|2|||
33214950|NCT00160680|100685029|FG001|Overall Study|Lack of Efficacy|1|||
33214951|NCT00160680|100685028|FG000|Overall Study|Lost to Follow-up|3|||
33214952|NCT00160680|100685029|FG001|Overall Study|Lost to Follow-up|2|||
33214953|NCT00160680|100685028|FG000|Overall Study|Withdrawal by Subject|4|||
33214954|NCT00160680|100685029|FG001|Overall Study|Withdrawal by Subject|9|||
33214955|NCT03280121|100685030|FG000|Overall Study|Physician Decision|1|||
33214956|NCT03280121|100685030|FG000|Overall Study|Lost to Follow-up|1|||
33214957|NCT03280121|100685030|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
33214958|NCT02355002|100685031|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
33214959|NCT02355002|100685032|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
33214960|NCT02355002|100685031|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
33214961|NCT02355002|100685032|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
33214962|NCT02355002|100685031|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
33214963|NCT02355002|100685032|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
33214964|NCT02355002|100685031|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
33214965|NCT02355002|100685032|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
33214966|NCT02355002|100685031|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
33214967|NCT02355002|100685032|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
33214968|NCT02355002|100685031|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
33214969|NCT02355002|100685032|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
33214970|NCT02355002|100685031|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
33214971|NCT02355002|100685032|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
33214972|NCT00917579|100685033|FG000|Washout >= 2 Weeks|Adverse Event|1|||
33214973|NCT00917579|100685034|FG001|Washout >= 2 Weeks|Adverse Event|0|||
33214974|NCT00917579|100685033|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
33214975|NCT00917579|100685034|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
33214976|NCT00483184|100685036|FG000|Overall Study|Withdrawal by Subject|2|||
33214977|NCT00483184|100685037|FG001|Overall Study|Withdrawal by Subject|2|||
33214978|NCT00483184|100685038|FG002|Overall Study|Withdrawal by Subject|0|||
33214979|NCT00483184|100685036|FG000|Overall Study|Lost to Follow-up|1|||
33214980|NCT00483184|100685037|FG001|Overall Study|Lost to Follow-up|0|||
33214981|NCT00483184|100685038|FG002|Overall Study|Lost to Follow-up|0|||
33548217|NCT03720847|101905241|FG000|Washout|Physician Decision|1|||
33548218|NCT03720847|101905242|FG001|Washout|Physician Decision|2|||
33548219|NCT02232698|101905243|FG000|Overall Study|Pregnancy|1|||
33548220|NCT02232698|101905244|FG001|Overall Study|Pregnancy|1|||
33548221|NCT02232698|101905243|FG000|Overall Study|Met exclusion criteria|1|||
33548222|NCT02232698|101905244|FG001|Overall Study|Met exclusion criteria|1|||
33548223|NCT02232698|101905243|FG000|Overall Study|Had device-associated symptoms|7|||
33548224|NCT02232698|101905244|FG001|Overall Study|Had device-associated symptoms|0|||
33548225|NCT02232698|101905243|FG000|Overall Study|Non-compliance with study device|1|||
33548226|NCT02232698|101905244|FG001|Overall Study|Non-compliance with study device|4|||
33548227|NCT02232698|101905243|FG000|Overall Study|Allocated to control group|0|||
33548228|NCT02232698|101905244|FG001|Overall Study|Allocated to control group|3|||
33548229|NCT02232698|101905243|FG000|Overall Study|Withdrawal by Subject|0|||
33548230|NCT02232698|101905244|FG001|Overall Study|Withdrawal by Subject|11|||
33548231|NCT02568423|101905245|FG000|Overall Study|Lost to Follow-up|0|||
33548232|NCT02568423|101905246|FG001|Overall Study|Lost to Follow-up|2|||
33548233|NCT02568423|101905247|FG002|Overall Study|Lost to Follow-up|0|||
33214982|NCT00483184|100685036|FG000|Overall Study|Adverse Event|1|||
33214983|NCT00483184|100685037|FG001|Overall Study|Adverse Event|2|||
33214984|NCT00483184|100685038|FG002|Overall Study|Adverse Event|2|||
33214985|NCT00483184|100685036|FG000|Overall Study|Protocol Violation|1|||
33214986|NCT00483184|100685037|FG001|Overall Study|Protocol Violation|0|||
33214987|NCT00483184|100685038|FG002|Overall Study|Protocol Violation|1|||
33214988|NCT01059175|100685042|FG000|Overall Study|Death|17|||
33214989|NCT01059175|100685043|FG001|Overall Study|Death|17|||
33214990|NCT01059175|100685042|FG000|Overall Study|Adverse Event|4|||
33548234|NCT02568423|101905248|FG003|Overall Study|Lost to Follow-up|0|||
33548235|NCT02568423|101905249|FG004|Overall Study|Lost to Follow-up|0|||
33548236|NCT02568423|101905250|FG005|Overall Study|Lost to Follow-up|0|||
33214991|NCT01059175|100685043|FG001|Overall Study|Adverse Event|2|||
33214992|NCT01059175|100685042|FG000|Overall Study|Lost to Follow-up|0|||
33214993|NCT01059175|100685043|FG001|Overall Study|Lost to Follow-up|1|||
33214994|NCT01338025|100685044|FG000|Overall Study|Unexpected closure of study|10|||
33214995|NCT01338025|100685045|FG001|Overall Study|Unexpected closure of study|9|||
33214996|NCT01338025|100685044|FG000|Overall Study|Withdrawal by Subject|0|||
33214997|NCT01338025|100685045|FG001|Overall Study|Withdrawal by Subject|2|||
33214998|NCT01338025|100685044|FG000|Overall Study|Found ineligible after starting|1|||
33214999|NCT01338025|100685045|FG001|Overall Study|Found ineligible after starting|0|||
33215000|NCT05072080|100685046|FG000|Overall Study|Death|0|||
33215001|NCT05072080|100685047|FG001|Overall Study|Death|0|||
33215002|NCT05072080|100685048|FG002|Overall Study|Death|1|||
33215003|NCT05072080|100685049|FG003|Overall Study|Death|0|||
33215004|NCT05072080|100685046|FG000|Overall Study|Lost to Follow-up|65|||
33215005|NCT05072080|100685047|FG001|Overall Study|Lost to Follow-up|70|||
33215006|NCT05072080|100685048|FG002|Overall Study|Lost to Follow-up|58|||
33215007|NCT05072080|100685049|FG003|Overall Study|Lost to Follow-up|23|||
33215008|NCT05072080|100685046|FG000|Overall Study|Physician Decision|2|||
33215009|NCT05072080|100685047|FG001|Overall Study|Physician Decision|1|||
33215010|NCT05072080|100685048|FG002|Overall Study|Physician Decision|1|||
33215011|NCT05072080|100685049|FG003|Overall Study|Physician Decision|0|||
33215012|NCT05072080|100685046|FG000|Overall Study|Withdrawal by Subject|45|||
33215013|NCT05072080|100685047|FG001|Overall Study|Withdrawal by Subject|30|||
33215014|NCT05072080|100685048|FG002|Overall Study|Withdrawal by Subject|27|||
33215015|NCT05072080|100685049|FG003|Overall Study|Withdrawal by Subject|7|||
33215016|NCT05072080|100685046|FG000|Overall Study|Sponsor Decision|0|||
33215017|NCT05072080|100685047|FG001|Overall Study|Sponsor Decision|1|||
33215018|NCT05072080|100685048|FG002|Overall Study|Sponsor Decision|0|||
33215019|NCT05072080|100685049|FG003|Overall Study|Sponsor Decision|0|||
33215020|NCT05072080|100685046|FG000|Overall Study|Subject moved|1|||
33215021|NCT05072080|100685047|FG001|Overall Study|Subject moved|3|||
33215022|NCT05072080|100685048|FG002|Overall Study|Subject moved|5|||
33215023|NCT05072080|100685049|FG003|Overall Study|Subject moved|2|||
33215024|NCT05072080|100685046|FG000|Overall Study|Withdrawal by parent|0|||
33215025|NCT05072080|100685047|FG001|Overall Study|Withdrawal by parent|0|||
33215026|NCT05072080|100685048|FG002|Overall Study|Withdrawal by parent|1|||
33215027|NCT05072080|100685049|FG003|Overall Study|Withdrawal by parent|0|||
33215028|NCT05072080|100685046|FG000|Overall Study|Subject was deployed|0|||
33215029|NCT05072080|100685047|FG001|Overall Study|Subject was deployed|1|||
33215030|NCT05072080|100685048|FG002|Overall Study|Subject was deployed|0|||
33215031|NCT05072080|100685049|FG003|Overall Study|Subject was deployed|0|||
33215032|NCT05072080|100685046|FG000|Overall Study|Subject left site without receiving dose|0|||
33215033|NCT05072080|100685047|FG001|Overall Study|Subject left site without receiving dose|1|||
33215034|NCT05072080|100685048|FG002|Overall Study|Subject left site without receiving dose|0|||
33215035|NCT05072080|100685049|FG003|Overall Study|Subject left site without receiving dose|0|||
33215036|NCT05072080|100685046|FG000|Overall Study|Subject incarcerated|0|||
33215037|NCT05072080|100685047|FG001|Overall Study|Subject incarcerated|1|||
33215038|NCT05072080|100685048|FG002|Overall Study|Subject incarcerated|0|||
33215039|NCT05072080|100685049|FG003|Overall Study|Subject incarcerated|1|||
33215040|NCT05072080|100685046|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
33215041|NCT05072080|100685047|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
33215042|NCT05072080|100685048|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
33215043|NCT05072080|100685049|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
33215044|NCT05072080|100685046|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
33215045|NCT05072080|100685047|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
33215046|NCT05072080|100685048|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
33548237|NCT02568423|101905251|FG006|Overall Study|Lost to Follow-up|0|||
33548238|NCT02568423|101905252|FG007|Overall Study|Lost to Follow-up|0|||
33548239|NCT02568423|101905245|FG000|Overall Study|Physician Decision|0|||
33548240|NCT02568423|101905246|FG001|Overall Study|Physician Decision|0|||
33617708|NCT03431350|102147502|FG000|Overall Study|Other|0|||
33215047|NCT05072080|100685049|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
33215048|NCT02782169|100685053|FG000|Overall Study|Lost to Follow-up|1|||
33215049|NCT02782169|100685054|FG001|Overall Study|Lost to Follow-up|2|||
33215050|NCT02008890|100685055|FG000|Period 1|Withdrawal by Subject|7|||
33215051|NCT02008890|100685056|FG001|Period 1|Withdrawal by Subject|7|||
33215052|NCT02008890|100685057|FG002|Period 1|Withdrawal by Subject|5|||
33215053|NCT02008890|100685058|FG003|Period 1|Withdrawal by Subject|0|||
33215054|NCT02008890|100685059|FG004|Period 1|Withdrawal by Subject|0|||
33215055|NCT02008890|100685055|FG000|Period 1|Pregnancy|1|||
33215056|NCT02008890|100685056|FG001|Period 1|Pregnancy|0|||
33215057|NCT02008890|100685057|FG002|Period 1|Pregnancy|0|||
33215058|NCT02008890|100685058|FG003|Period 1|Pregnancy|0|||
33548241|NCT02568423|101905247|FG002|Overall Study|Physician Decision|0|||
33548242|NCT02568423|101905248|FG003|Overall Study|Physician Decision|0|||
33215059|NCT02008890|100685059|FG004|Period 1|Pregnancy|0|||
33617709|NCT03431350|102147503|FG001|Overall Study|Other|0|||
33215060|NCT02008890|100685055|FG000|Period 1|Physician Decision|1|||
33215061|NCT02008890|100685056|FG001|Period 1|Physician Decision|0|||
33548243|NCT02568423|101905249|FG004|Overall Study|Physician Decision|0|||
33548244|NCT02568423|101905250|FG005|Overall Study|Physician Decision|1|||
33548245|NCT02568423|101905251|FG006|Overall Study|Physician Decision|0|||
33548246|NCT02568423|101905252|FG007|Overall Study|Physician Decision|0|||
33548247|NCT02326883|101905253|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
33548248|NCT02326883|101905254|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
33548249|NCT02326883|101905255|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
33548250|NCT02323334|101905256|FG000|Period 3|Lost to Follow-up|0|||
33548251|NCT02323334|101905257|FG001|Period 3|Lost to Follow-up|0|||
33548252|NCT02323334|101905258|FG002|Period 3|Lost to Follow-up|1|||
33548253|NCT02323334|101905259|FG003|Period 3|Lost to Follow-up|0|||
33548254|NCT02323334|101905260|FG004|Period 3|Lost to Follow-up|0|||
33548255|NCT02323334|101905261|FG005|Period 3|Lost to Follow-up|0|||
33548256|NCT02323334|101905262|FG006|Period 3|Lost to Follow-up|0|||
33548257|NCT02323334|101905263|FG007|Period 3|Lost to Follow-up|0|||
33548258|NCT02323334|101905264|FG008|Period 3|Lost to Follow-up|0|||
33548259|NCT02323334|101905265|FG009|Period 3|Lost to Follow-up|0|||
33215062|NCT02008890|100685057|FG002|Period 1|Physician Decision|1|||
33215063|NCT02008890|100685058|FG003|Period 1|Physician Decision|0|||
33215064|NCT02008890|100685059|FG004|Period 1|Physician Decision|0|||
33215065|NCT02008890|100685055|FG000|Period 1|Adverse Event|6|||
33215066|NCT02008890|100685056|FG001|Period 1|Adverse Event|8|||
33215067|NCT02008890|100685057|FG002|Period 1|Adverse Event|6|||
33215068|NCT02008890|100685058|FG003|Period 1|Adverse Event|0|||
33215069|NCT02008890|100685059|FG004|Period 1|Adverse Event|0|||
33215070|NCT02008890|100685055|FG000|Period 2|Adverse Event|12|||
33215071|NCT02008890|100685056|FG001|Period 2|Adverse Event|7|||
33215072|NCT02008890|100685057|FG002|Period 2|Adverse Event|0|||
33215073|NCT02008890|100685058|FG003|Period 2|Adverse Event|5|||
33215074|NCT02008890|100685059|FG004|Period 2|Adverse Event|5|||
33215075|NCT02008890|100685055|FG000|Period 2|Withdrawal by Subject|11|||
33548260|NCT02323334|101905266|FG010|Period 3|Lost to Follow-up|0|||
33548261|NCT02323334|101905267|FG011|Period 3|Lost to Follow-up|0|||
33548262|NCT02323334|101905268|FG012|Period 3|Lost to Follow-up|0|||
33215076|NCT02008890|100685056|FG001|Period 2|Withdrawal by Subject|8|||
33215077|NCT02008890|100685057|FG002|Period 2|Withdrawal by Subject|0|||
33215078|NCT02008890|100685058|FG003|Period 2|Withdrawal by Subject|7|||
33215079|NCT02008890|100685059|FG004|Period 2|Withdrawal by Subject|2|||
33548263|NCT02323334|101905269|FG013|Period 3|Lost to Follow-up|0|||
33548264|NCT02323334|101905270|FG014|Period 3|Lost to Follow-up|0|||
33548265|NCT02323334|101905271|FG015|Period 3|Lost to Follow-up|0|||
33548266|NCT02323334|101905272|FG016|Period 3|Lost to Follow-up|0|||
33548267|NCT02323334|101905256|FG000|Period 3|Withdrawal by Subject|1|||
33548268|NCT02323334|101905257|FG001|Period 3|Withdrawal by Subject|0|||
33548269|NCT02323334|101905258|FG002|Period 3|Withdrawal by Subject|0|||
33548270|NCT02323334|101905259|FG003|Period 3|Withdrawal by Subject|0|||
33548271|NCT02323334|101905260|FG004|Period 3|Withdrawal by Subject|0|||
33548272|NCT02323334|101905261|FG005|Period 3|Withdrawal by Subject|0|||
33215080|NCT02008890|100685055|FG000|Period 2|Physician Decision|4|||
33215081|NCT02008890|100685056|FG001|Period 2|Physician Decision|0|||
33215082|NCT02008890|100685057|FG002|Period 2|Physician Decision|0|||
33215083|NCT02008890|100685058|FG003|Period 2|Physician Decision|2|||
33215084|NCT02008890|100685059|FG004|Period 2|Physician Decision|1|||
33349131|NCT00896532|101164136|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
33349132|NCT00896532|101164137|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349133|NCT00896532|101164138|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349134|NCT00896532|101164139|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349135|NCT00896532|101164140|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33548273|NCT02323334|101905262|FG006|Period 3|Withdrawal by Subject|0|||
33548274|NCT02323334|101905263|FG007|Period 3|Withdrawal by Subject|0|||
33548275|NCT02323334|101905264|FG008|Period 3|Withdrawal by Subject|0|||
33548276|NCT02323334|101905265|FG009|Period 3|Withdrawal by Subject|0|||
33548277|NCT02323334|101905266|FG010|Period 3|Withdrawal by Subject|0|||
33548278|NCT02323334|101905267|FG011|Period 3|Withdrawal by Subject|0|||
33548279|NCT02323334|101905268|FG012|Period 3|Withdrawal by Subject|0|||
33548280|NCT02323334|101905269|FG013|Period 3|Withdrawal by Subject|0|||
33548281|NCT02323334|101905270|FG014|Period 3|Withdrawal by Subject|0|||
33548282|NCT02323334|101905271|FG015|Period 3|Withdrawal by Subject|0|||
33548283|NCT02323334|101905272|FG016|Period 3|Withdrawal by Subject|0|||
33548284|NCT00764517|101905273|FG000|Overall Study|Adverse Event|9|||
33548285|NCT00764517|101905274|FG001|Overall Study|Adverse Event|3|||
33548286|NCT00764517|101905273|FG000|Overall Study|Death|3|||
33548287|NCT00764517|101905274|FG001|Overall Study|Death|11|||
33548288|NCT00764517|101905273|FG000|Overall Study|Physician Decision|3|||
33548289|NCT00764517|101905274|FG001|Overall Study|Physician Decision|0|||
33548290|NCT02187055|101905277|FG000|Overall Study|Lack of Efficacy|10|||
33548291|NCT02187055|101905278|FG001|Overall Study|Lack of Efficacy|3|||
33548292|NCT02187055|101905279|FG002|Overall Study|Lack of Efficacy|7|||
33548293|NCT02187055|101905277|FG000|Overall Study|Lost to Follow-up|2|||
33215085|NCT02008890|100685055|FG000|Period 2|Lost to Follow-up|0|||
33215086|NCT02008890|100685056|FG001|Period 2|Lost to Follow-up|0|||
33215087|NCT02008890|100685057|FG002|Period 2|Lost to Follow-up|1|||
33215088|NCT02008890|100685058|FG003|Period 2|Lost to Follow-up|0|||
33215089|NCT02008890|100685059|FG004|Period 2|Lost to Follow-up|0|||
33349136|NCT00896532|101164141|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33548294|NCT02187055|101905278|FG001|Overall Study|Lost to Follow-up|7|||
33548295|NCT02187055|101905279|FG002|Overall Study|Lost to Follow-up|3|||
33548296|NCT02187055|101905277|FG000|Overall Study|No longer meets eligibility criteria|0|||
33548297|NCT02187055|101905278|FG001|Overall Study|No longer meets eligibility criteria|2|||
33548298|NCT02187055|101905279|FG002|Overall Study|No longer meets eligibility criteria|0|||
33548299|NCT02187055|101905277|FG000|Overall Study|No longer willing to participate|6|||
33548300|NCT02187055|101905278|FG001|Overall Study|No longer willing to participate|8|||
33548301|NCT02187055|101905279|FG002|Overall Study|No longer willing to participate|10|||
33215090|NCT02008890|100685055|FG000|Extension Period|Withdrawal by Subject|3|||
33215091|NCT02008890|100685056|FG001|Extension Period|Withdrawal by Subject|2|||
33215092|NCT02008890|100685057|FG002|Extension Period|Withdrawal by Subject|0|||
33548302|NCT02187055|101905277|FG000|Overall Study|Other|5|||
33548303|NCT02187055|101905278|FG001|Overall Study|Other|6|||
33548304|NCT02187055|101905279|FG002|Overall Study|Other|3|||
33548305|NCT02187055|101905277|FG000|Overall Study|Protocol Violation|9|||
33548306|NCT02187055|101905278|FG001|Overall Study|Protocol Violation|9|||
33548307|NCT02187055|101905279|FG002|Overall Study|Protocol Violation|4|||
33548308|NCT02187055|101905277|FG000|Overall Study|Pregnancy|3|||
33548309|NCT02187055|101905278|FG001|Overall Study|Pregnancy|1|||
33548310|NCT02187055|101905279|FG002|Overall Study|Pregnancy|0|||
33548311|NCT02187055|101905277|FG000|Overall Study|Withdrawal by Subject|11|||
33548312|NCT02187055|101905278|FG001|Overall Study|Withdrawal by Subject|11|||
33548313|NCT02187055|101905279|FG002|Overall Study|Withdrawal by Subject|11|||
33548314|NCT02187055|101905277|FG000|Overall Study|Adverse Event|21|||
33548315|NCT02187055|101905278|FG001|Overall Study|Adverse Event|26|||
33548316|NCT02187055|101905279|FG002|Overall Study|Adverse Event|36|||
33548317|NCT02187055|101905277|FG000|Overall Study|Death|2|||
33548318|NCT02187055|101905278|FG001|Overall Study|Death|0|||
33548319|NCT02187055|101905279|FG002|Overall Study|Death|0|||
33548320|NCT04871113|101905280|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
33548321|NCT04871113|101905281|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
33548322|NCT04871113|101905282|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
33548323|NCT04871113|101905283|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
33548324|NCT04871113|101905284|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
33548325|NCT04871113|101905285|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
33548326|NCT04871113|101905286|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
33548327|NCT04871113|101905287|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
33548328|NCT04871113|101905288|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
33548329|NCT04871113|101905289|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
33548330|NCT04871113|101905280|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
33548331|NCT04871113|101905281|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
33548332|NCT04871113|101905282|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
33548333|NCT04871113|101905283|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
33548334|NCT04871113|101905284|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
33548335|NCT04871113|101905285|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
33548336|NCT04871113|101905286|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
33548337|NCT04871113|101905287|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
33548338|NCT04871113|101905288|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
33548339|NCT04871113|101905289|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
33548340|NCT01002105|101905290|FG000|Overall Study|Lost to Follow-up|10|||
33617710|NCT03431350|102147504|FG002|Overall Study|Other|1|||
33617711|NCT03431350|102147505|FG003|Overall Study|Other|3|||
33617712|NCT03431350|102147506|FG004|Overall Study|Other|2|||
33617713|NCT03431350|102147507|FG005|Overall Study|Other|2|||
33215093|NCT02008890|100685058|FG003|Extension Period|Withdrawal by Subject|4|||
33215094|NCT02008890|100685059|FG004|Extension Period|Withdrawal by Subject|2|||
33215095|NCT02008890|100685055|FG000|Extension Period|Lost to Follow-up|1|||
33215096|NCT02008890|100685056|FG001|Extension Period|Lost to Follow-up|0|||
33215097|NCT02008890|100685057|FG002|Extension Period|Lost to Follow-up|0|||
33215098|NCT02008890|100685058|FG003|Extension Period|Lost to Follow-up|0|||
33349137|NCT00896532|101164142|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349138|NCT00896532|101164143|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349139|NCT00896532|101164144|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349140|NCT00896532|101164145|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349141|NCT00896532|101164146|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
33349142|NCT00896532|101164124|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349143|NCT00896532|101164125|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349144|NCT00896532|101164126|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349145|NCT00896532|101164127|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349146|NCT00896532|101164128|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349147|NCT00896532|101164129|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349148|NCT00896532|101164130|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349149|NCT00896532|101164131|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349150|NCT00896532|101164132|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349151|NCT00896532|101164133|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349152|NCT00896532|101164134|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
33349153|NCT00896532|101164135|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349154|NCT00896532|101164136|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
33349155|NCT00896532|101164137|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349156|NCT00896532|101164138|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33215099|NCT02008890|100685059|FG004|Extension Period|Lost to Follow-up|0|||
33215100|NCT02008890|100685055|FG000|Extension Period|Adverse Event|1|||
33215101|NCT02008890|100685056|FG001|Extension Period|Adverse Event|3|||
33215102|NCT02008890|100685057|FG002|Extension Period|Adverse Event|0|||
33215103|NCT02008890|100685058|FG003|Extension Period|Adverse Event|0|||
33215104|NCT02008890|100685059|FG004|Extension Period|Adverse Event|2|||
33215105|NCT02181803|100685060|FG000|Overall Study|Withdrawal by Subject|0|||
33215106|NCT02181803|100685061|FG001|Overall Study|Withdrawal by Subject|2|||
33215107|NCT02181803|100685062|FG002|Overall Study|Withdrawal by Subject|0|||
33215108|NCT02181803|100685063|FG003|Overall Study|Withdrawal by Subject|0|||
33215109|NCT02181803|100685064|FG004|Overall Study|Withdrawal by Subject|0|||
33215110|NCT02181803|100685065|FG005|Overall Study|Withdrawal by Subject|0|||
33215111|NCT02181803|100685066|FG006|Overall Study|Withdrawal by Subject|0|||
33215112|NCT02181803|100685067|FG007|Overall Study|Withdrawal by Subject|0|||
33215113|NCT02181803|100685068|FG008|Overall Study|Withdrawal by Subject|0|||
33215114|NCT02181803|100685060|FG000|Overall Study|Physician Decision|0|||
33215115|NCT02181803|100685061|FG001|Overall Study|Physician Decision|0|||
33215116|NCT02181803|100685062|FG002|Overall Study|Physician Decision|0|||
33215117|NCT02181803|100685063|FG003|Overall Study|Physician Decision|1|||
33215118|NCT02181803|100685064|FG004|Overall Study|Physician Decision|0|||
33215119|NCT02181803|100685065|FG005|Overall Study|Physician Decision|0|||
33215120|NCT02181803|100685066|FG006|Overall Study|Physician Decision|0|||
33215121|NCT02181803|100685067|FG007|Overall Study|Physician Decision|1|||
33215122|NCT02181803|100685068|FG008|Overall Study|Physician Decision|0|||
33215123|NCT02181803|100685060|FG000|Overall Study|Adverse Event|0|||
33215124|NCT02181803|100685061|FG001|Overall Study|Adverse Event|2|||
33215125|NCT02181803|100685062|FG002|Overall Study|Adverse Event|0|||
33215126|NCT02181803|100685063|FG003|Overall Study|Adverse Event|1|||
33215127|NCT02181803|100685064|FG004|Overall Study|Adverse Event|0|||
33215128|NCT02181803|100685065|FG005|Overall Study|Adverse Event|0|||
33215129|NCT02181803|100685066|FG006|Overall Study|Adverse Event|1|||
33215130|NCT02181803|100685067|FG007|Overall Study|Adverse Event|0|||
33215131|NCT02181803|100685068|FG008|Overall Study|Adverse Event|0|||
33215132|NCT01368965|100685069|FG000|Overall Study|Lost to Follow-up|12|||
33215133|NCT02747238|100685070|FG000|Overall Study|Lack of Efficacy|0|||
33215134|NCT02747238|100685071|FG001|Overall Study|Lack of Efficacy|1|||
33215135|NCT02747238|100685070|FG000|Overall Study|Data lost|3|||
33215136|NCT02747238|100685071|FG001|Overall Study|Data lost|5|||
33215137|NCT00584727|100685072|FG000|First Intervention|Discontinuation|0|||
33215138|NCT00584727|100685073|FG001|First Intervention|Discontinuation|0|||
33215139|NCT00584727|100685074|FG002|First Intervention|Discontinuation|1|||
33215140|NCT00584727|100685075|FG003|First Intervention|Discontinuation|0|||
33215141|NCT00584727|100685076|FG004|First Intervention|Discontinuation|0|||
33215142|NCT00584727|100685077|FG005|First Intervention|Discontinuation|0|||
33215143|NCT00584727|100685072|FG000|Third Intervention|Protocol Violation|0|||
33548341|NCT01002105|101905291|FG001|Overall Study|Lost to Follow-up|16|||
33548342|NCT01002105|101905290|FG000|Overall Study|non compliance|5|||
33548343|NCT01002105|101905291|FG001|Overall Study|non compliance|3|||
33548344|NCT01002105|101905290|FG000|Overall Study|condition worsened|4|||
33548345|NCT01002105|101905291|FG001|Overall Study|condition worsened|2|||
33548346|NCT00296335|101905292|FG000|Overall Study|Recurrence|3|||
33548347|NCT00296335|101905293|FG001|Overall Study|Recurrence|51|||
33548348|NCT00296335|101905292|FG000|Overall Study|Adverse Event|17|||
33548349|NCT00296335|101905293|FG001|Overall Study|Adverse Event|27|||
33548350|NCT00296335|101905292|FG000|Overall Study|Lost to Follow-up|7|||
33548351|NCT00296335|101905293|FG001|Overall Study|Lost to Follow-up|33|||
33548352|NCT00296335|101905292|FG000|Overall Study|Physician Decision|3|||
33548353|NCT00296335|101905293|FG001|Overall Study|Physician Decision|11|||
33548354|NCT02107898|101905294|FG000|Overall Study|Adverse Event|4|||
33548355|NCT02107898|101905295|FG001|Overall Study|Adverse Event|7|||
33215144|NCT00584727|100685073|FG001|Third Intervention|Protocol Violation|0|||
33215145|NCT00584727|100685074|FG002|Third Intervention|Protocol Violation|1|||
33215146|NCT00584727|100685075|FG003|Third Intervention|Protocol Violation|0|||
33215147|NCT00584727|100685076|FG004|Third Intervention|Protocol Violation|4|||
33215148|NCT00584727|100685077|FG005|Third Intervention|Protocol Violation|2|||
33215149|NCT02291679|100685078|FG000|Overall Study|Adverse Event|2|||
33349157|NCT00896532|101164139|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33215150|NCT02291679|100685079|FG001|Overall Study|Adverse Event|12|||
33349158|NCT00896532|101164140|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33409757|NCT01243762|101389359|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
33548356|NCT02107898|101905294|FG000|Overall Study|Poor compliance to protocol|0|||
33548357|NCT02107898|101905295|FG001|Overall Study|Poor compliance to protocol|1|||
33548358|NCT02107898|101905294|FG000|Overall Study|Participant moved|0|||
33215151|NCT02291679|100685080|FG002|Overall Study|Adverse Event|19|||
33215152|NCT02291679|100685078|FG000|Overall Study|Protocol Violation|5|||
33215153|NCT02291679|100685079|FG001|Overall Study|Protocol Violation|1|||
33215154|NCT02291679|100685080|FG002|Overall Study|Protocol Violation|7|||
33548359|NCT02107898|101905295|FG001|Overall Study|Participant moved|2|||
33548360|NCT02107898|101905294|FG000|Overall Study|Consent withdrawn by participant|2|||
33215155|NCT02291679|100685078|FG000|Overall Study|Withdrew Consent|18|||
33215156|NCT02291679|100685079|FG001|Overall Study|Withdrew Consent|10|||
33215157|NCT02291679|100685080|FG002|Overall Study|Withdrew Consent|15|||
33215158|NCT02291679|100685078|FG000|Overall Study|Lost to Follow-up|12|||
33215159|NCT02291679|100685079|FG001|Overall Study|Lost to Follow-up|10|||
33215160|NCT02291679|100685080|FG002|Overall Study|Lost to Follow-up|9|||
33215161|NCT02291679|100685078|FG000|Overall Study|Insufficient Therapeutic Response|5|||
33215162|NCT02291679|100685079|FG001|Overall Study|Insufficient Therapeutic Response|5|||
33215163|NCT02291679|100685080|FG002|Overall Study|Insufficient Therapeutic Response|7|||
33215164|NCT02291679|100685078|FG000|Overall Study|Other|2|||
33215165|NCT02291679|100685079|FG001|Overall Study|Other|4|||
33215166|NCT02291679|100685080|FG002|Overall Study|Other|2|||
33215167|NCT01441102|100685081|FG000|Overall Study|Adverse Event|1|||
33215168|NCT01441102|100685081|FG000|Overall Study|Withdrawal by Subject|2|||
33215169|NCT00130533|100685084|FG000|Overall Study|Withdrawal by Subject|33|||
33215170|NCT00130533|100685085|FG001|Overall Study|Withdrawal by Subject|6|||
33215171|NCT00130533|100685084|FG000|Overall Study|Adverse Event|34|||
33548361|NCT02107898|101905295|FG001|Overall Study|Consent withdrawn by participant|1|||
33548362|NCT02107898|101905294|FG000|Overall Study|Randomized but not treated|0|||
33215172|NCT00130533|100685085|FG001|Overall Study|Adverse Event|1|||
33215173|NCT00130533|100685084|FG000|Overall Study|Disease relapse|9|||
33215174|NCT00130533|100685085|FG001|Overall Study|Disease relapse|13|||
33215175|NCT00130533|100685084|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
33215176|NCT00130533|100685085|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
33215177|NCT00130533|100685084|FG000|Overall Study|Death|4|||
33215178|NCT00130533|100685085|FG001|Overall Study|Death|2|||
33215179|NCT00130533|100685084|FG000|Overall Study|Protocol Violation|5|||
33215180|NCT00130533|100685085|FG001|Overall Study|Protocol Violation|1|||
33215181|NCT00130533|100685084|FG000|Overall Study|Lost to Follow-up|1|||
33215182|NCT00130533|100685085|FG001|Overall Study|Lost to Follow-up|1|||
33215183|NCT00130533|100685084|FG000|Overall Study|Sponsor´s decision|2|||
33215184|NCT00130533|100685085|FG001|Overall Study|Sponsor´s decision|0|||
33215185|NCT00130533|100685084|FG000|Overall Study|Second Primary Malignancy|0|||
33215186|NCT00130533|100685085|FG001|Overall Study|Second Primary Malignancy|1|||
33215187|NCT00130533|100685084|FG000|Overall Study|Other|12|||
33215188|NCT00130533|100685085|FG001|Overall Study|Other|5|||
33215189|NCT01939548|100685086|FG000|Overall Study|Non compliance|0|||
33215190|NCT01939548|100685087|FG001|Overall Study|Non compliance|2|||
33215191|NCT01939548|100685088|FG002|Overall Study|Non compliance|0|||
33215192|NCT01939548|100685086|FG000|Overall Study|Study Terminated by Sponsor|17|||
33215193|NCT01939548|100685087|FG001|Overall Study|Study Terminated by Sponsor|19|||
33215194|NCT01939548|100685088|FG002|Overall Study|Study Terminated by Sponsor|12|||
33215195|NCT01939548|100685086|FG000|Overall Study|Insufficient Clinical Response|1|||
33215196|NCT01939548|100685087|FG001|Overall Study|Insufficient Clinical Response|0|||
33215197|NCT01939548|100685088|FG002|Overall Study|Insufficient Clinical Response|0|||
33215198|NCT01939548|100685086|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
33215199|NCT01939548|100685087|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
33215200|NCT01939548|100685088|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
33215201|NCT01939548|100685086|FG000|Overall Study|Withdrawal by Subject|4|||
33215202|NCT01939548|100685087|FG001|Overall Study|Withdrawal by Subject|4|||
33215203|NCT01939548|100685088|FG002|Overall Study|Withdrawal by Subject|1|||
33215204|NCT01939548|100685086|FG000|Overall Study|Protocol Violation|7|||
33215205|NCT01939548|100685087|FG001|Overall Study|Protocol Violation|6|||
33215206|NCT01939548|100685088|FG002|Overall Study|Protocol Violation|5|||
33215207|NCT01939548|100685086|FG000|Overall Study|Lost to Follow-up|5|||
33215208|NCT01939548|100685087|FG001|Overall Study|Lost to Follow-up|5|||
33215209|NCT01939548|100685088|FG002|Overall Study|Lost to Follow-up|3|||
33215210|NCT01939548|100685086|FG000|Overall Study|Adverse Event|2|||
33215211|NCT01939548|100685087|FG001|Overall Study|Adverse Event|9|||
33215212|NCT01939548|100685088|FG002|Overall Study|Adverse Event|7|||
33215213|NCT01939548|100685086|FG000|Overall Study|Death|0|||
33215214|NCT01939548|100685087|FG001|Overall Study|Death|0|||
33215215|NCT01939548|100685088|FG002|Overall Study|Death|1|||
33215216|NCT01939548|100685086|FG000|Overall Study|Participant dropped|0|||
33215217|NCT01939548|100685087|FG001|Overall Study|Participant dropped|0|||
33548363|NCT02107898|101905295|FG001|Overall Study|Randomized but not treated|1|||
33548364|NCT01177410|101905296|FG000|Overall Study|Adverse Event|0|||
33548365|NCT01177410|101905297|FG001|Overall Study|Adverse Event|2|||
33548366|NCT01177410|101905298|FG002|Overall Study|Adverse Event|2|||
33548367|NCT01177410|101905296|FG000|Overall Study|Withdrawal by Subject|1|||
33548368|NCT01177410|101905297|FG001|Overall Study|Withdrawal by Subject|4|||
33215218|NCT01939548|100685088|FG002|Overall Study|Participant dropped|1|||
33215219|NCT01939548|100685086|FG000|Overall Study|Participant unwilling to continue|0|||
33548369|NCT01177410|101905298|FG002|Overall Study|Withdrawal by Subject|3|||
33548370|NCT01177410|101905296|FG000|Overall Study|Lost to Follow-up|0|||
33215220|NCT01939548|100685087|FG001|Overall Study|Participant unwilling to continue|1|||
33215221|NCT01939548|100685088|FG002|Overall Study|Participant unwilling to continue|0|||
33215222|NCT01939548|100685086|FG000|Overall Study|Participant withdrew consent|0|||
33548371|NCT01177410|101905297|FG001|Overall Study|Lost to Follow-up|1|||
33548372|NCT01177410|101905298|FG002|Overall Study|Lost to Follow-up|0|||
33548373|NCT04790201|101905301|FG000|Overall Study|Lost to Follow-up|0|||
33548374|NCT04790201|101905302|FG001|Overall Study|Lost to Follow-up|0|||
33548375|NCT04790201|101905303|FG002|Overall Study|Lost to Follow-up|2|||
33548376|NCT04790201|101905301|FG000|Overall Study|Death|0|||
33548377|NCT04790201|101905302|FG001|Overall Study|Death|1|||
33548378|NCT04790201|101905303|FG002|Overall Study|Death|0|||
33548379|NCT04790201|101905301|FG000|Overall Study|Protocol Violation|1|||
33548380|NCT04790201|101905302|FG001|Overall Study|Protocol Violation|0|||
33548381|NCT04790201|101905303|FG002|Overall Study|Protocol Violation|1|||
33548382|NCT01482221|101905308|FG000|Overall Study|Lack of Efficacy|1|||
33548383|NCT01482221|101905309|FG001|Overall Study|Lack of Efficacy|0|||
33548384|NCT01482221|101905310|FG002|Overall Study|Lack of Efficacy|1|||
33548385|NCT01482221|101905308|FG000|Overall Study|Lost to Follow-up|3|||
33548386|NCT01482221|101905309|FG001|Overall Study|Lost to Follow-up|2|||
33548387|NCT01482221|101905310|FG002|Overall Study|Lost to Follow-up|1|||
33548388|NCT01482221|101905308|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
33548389|NCT01482221|101905309|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
33548390|NCT01482221|101905310|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
33548391|NCT01482221|101905308|FG000|Overall Study|Condition under Investigation Worsened|3|||
33548392|NCT01482221|101905309|FG001|Overall Study|Condition under Investigation Worsened|2|||
33548393|NCT01482221|101905310|FG002|Overall Study|Condition under Investigation Worsened|4|||
33548394|NCT01482221|101905308|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
33548395|NCT01482221|101905309|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
33548396|NCT01482221|101905310|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
33548397|NCT01482221|101905308|FG000|Overall Study|Adverse Event|1|||
33548398|NCT01482221|101905309|FG001|Overall Study|Adverse Event|7|||
33548399|NCT01482221|101905310|FG002|Overall Study|Adverse Event|3|||
33548400|NCT01482221|101905308|FG000|Overall Study|Withdrawal by Subject|10|||
33548401|NCT01482221|101905309|FG001|Overall Study|Withdrawal by Subject|7|||
33548402|NCT01482221|101905310|FG002|Overall Study|Withdrawal by Subject|12|||
33548403|NCT01482221|101905308|FG000|Overall Study|Incorrect randomization|0|||
33548404|NCT01482221|101905309|FG001|Overall Study|Incorrect randomization|1|||
33548405|NCT01482221|101905310|FG002|Overall Study|Incorrect randomization|0|||
33548406|NCT01482221|101905308|FG000|Overall Study|Physician Decision|0|||
33548407|NCT01482221|101905309|FG001|Overall Study|Physician Decision|1|||
33548408|NCT01482221|101905310|FG002|Overall Study|Physician Decision|0|||
33548409|NCT01397747|101905315|FG000|Overall Study|Multitarget DNA test excluded|689|||
33548410|NCT01397747|101905315|FG000|Overall Study|Colonoscopy excluded|304|||
33548411|NCT01397747|101905315|FG000|Overall Study|FIT excluded|34|||
33548412|NCT01499511|101905318|FG000|Overall Study|Death|1|||
33548413|NCT01499511|101905319|FG001|Overall Study|Death|0|||
33215223|NCT01939548|100685087|FG001|Overall Study|Participant withdrew consent|2|||
33215224|NCT01939548|100685088|FG002|Overall Study|Participant withdrew consent|0|||
33215225|NCT01939548|100685086|FG000|Overall Study|Did not complete follow-up|0|||
33215226|NCT01939548|100685087|FG001|Overall Study|Did not complete follow-up|1|||
33215227|NCT01939548|100685088|FG002|Overall Study|Did not complete follow-up|0|||
33215228|NCT03364751|100685093|FG000|Overall Study|Withdrawal by Subject|1|||
33215229|NCT03364751|100685094|FG001|Overall Study|Withdrawal by Subject|0|||
33215230|NCT03364751|100685095|FG002|Overall Study|Withdrawal by Subject|0|||
33215231|NCT03364751|100685096|FG003|Overall Study|Withdrawal by Subject|0|||
33215232|NCT03364751|100685093|FG000|Overall Study|Lost to Follow-up|0|||
33215233|NCT03364751|100685094|FG001|Overall Study|Lost to Follow-up|1|||
33215234|NCT03364751|100685095|FG002|Overall Study|Lost to Follow-up|0|||
33215235|NCT03364751|100685096|FG003|Overall Study|Lost to Follow-up|0|||
33215236|NCT02199028|100685097|FG000|Week 1|Adverse Event|1|||
33215237|NCT02199028|100685098|FG001|Week 1|Adverse Event|0|||
33215238|NCT02199028|100685097|FG000|Week 3|Adverse Event|1|||
33215239|NCT02199028|100685098|FG001|Week 3|Adverse Event|0|||
33215240|NCT01332227|100685102|FG000|Overall Study|Adverse Event|4|||
33215241|NCT01332227|100685103|FG001|Overall Study|Adverse Event|1|||
33215242|NCT01332227|100685102|FG000|Overall Study|Withdrawal by Subject|5|||
33215243|NCT01332227|100685103|FG001|Overall Study|Withdrawal by Subject|1|||
33215244|NCT01332227|100685102|FG000|Overall Study|Lost to Follow-up|2|||
33548414|NCT01564407|101905320|FG000|Overall Study|Lost to Follow-up|0|||
33548415|NCT01564407|101905321|FG001|Overall Study|Lost to Follow-up|1|||
33548416|NCT01564407|101905322|FG002|Overall Study|Lost to Follow-up|0|||
33548417|NCT01564407|101905323|FG003|Overall Study|Lost to Follow-up|0|||
33617714|NCT03431350|102147508|FG006|Overall Study|Other|4|||
33215245|NCT01332227|100685103|FG001|Overall Study|Lost to Follow-up|0|||
33215246|NCT01332227|100685102|FG000|Overall Study|Lack of Efficacy|3|||
33215247|NCT01332227|100685103|FG001|Overall Study|Lack of Efficacy|1|||
33548418|NCT01564407|101905324|FG004|Overall Study|Lost to Follow-up|0|||
33548419|NCT01564407|101905320|FG000|Overall Study|Withdrawal by Subject|0|||
33548420|NCT01564407|101905321|FG001|Overall Study|Withdrawal by Subject|1|||
33215248|NCT01332227|100685102|FG000|Overall Study|Poor compliance/noncompliance|1|||
33548421|NCT01564407|101905322|FG002|Overall Study|Withdrawal by Subject|0|||
33409758|NCT01243762|101389360|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
33409759|NCT01243762|101389361|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
33409760|NCT01243762|101389362|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
33409761|NCT01243762|101389363|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
33409762|NCT01243762|101389364|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
33409763|NCT01243762|101389358|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
33409764|NCT01243762|101389359|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
33409765|NCT01243762|101389360|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
33409766|NCT01243762|101389361|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
33409767|NCT01243762|101389362|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
33409768|NCT01243762|101389363|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
33409769|NCT01243762|101389364|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
33409770|NCT01243762|101389358|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
33409771|NCT01243762|101389359|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
33409772|NCT01243762|101389360|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
33409773|NCT01243762|101389361|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
33409774|NCT01243762|101389362|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
33409775|NCT01243762|101389363|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
33409776|NCT01243762|101389364|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
33409777|NCT01243762|101389358|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
33409778|NCT01243762|101389359|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
33409779|NCT01243762|101389360|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
33409780|NCT01243762|101389361|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
33409781|NCT01243762|101389362|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
33409782|NCT01243762|101389363|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
33409783|NCT01243762|101389364|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
33409784|NCT00779142|101389365|FG000|Overall Study|Screen Failures|3|||
33409785|NCT00938366|101389366|FG000|Overall Study|Withdrawal by Subject|1|||
33409786|NCT00938366|101389367|FG001|Overall Study|Withdrawal by Subject|0|||
33409787|NCT02087865|101389368|FG000|Overall Study|Withdrawal by Subject|6|||
33409788|NCT02087865|101389369|FG001|Overall Study|Withdrawal by Subject|0|||
33409789|NCT02087865|101389370|FG002|Overall Study|Withdrawal by Subject|1|||
33409790|NCT02087865|101389368|FG000|Overall Study|Lost to Follow-up|0|||
33409791|NCT02087865|101389369|FG001|Overall Study|Lost to Follow-up|0|||
33215249|NCT01332227|100685103|FG001|Overall Study|Poor compliance/noncompliance|1|||
33215250|NCT01332227|100685102|FG000|Overall Study|Patient moved from area|1|||
33215251|NCT01332227|100685103|FG001|Overall Study|Patient moved from area|0|||
33215252|NCT01332227|100685102|FG000|Overall Study|Patient began prohibited medication|0|||
33215253|NCT01332227|100685103|FG001|Overall Study|Patient began prohibited medication|1|||
33215254|NCT02134587|100685104|FG000|Overall Study|Did not completed all meetings|30|||
33215255|NCT00156065|100685108|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
33215256|NCT00156065|100685109|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
33215257|NCT00156065|100685110|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
33215258|NCT00156065|100685108|FG000|Overall Study|Adverse Event|8|||
33215259|NCT00156065|100685109|FG001|Overall Study|Adverse Event|11|||
33215260|NCT00156065|100685110|FG002|Overall Study|Adverse Event|4|||
33215261|NCT00156065|100685108|FG000|Overall Study|Lack of Efficacy|2|||
33349159|NCT00896532|101164141|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349160|NCT00896532|101164142|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349161|NCT00896532|101164143|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349162|NCT00896532|101164144|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349163|NCT00896532|101164145|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349164|NCT00896532|101164146|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
33349165|NCT00896532|101164124|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349166|NCT00896532|101164125|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349167|NCT00896532|101164126|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349168|NCT00896532|101164127|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33409792|NCT02087865|101389370|FG002|Overall Study|Lost to Follow-up|1|||
33215262|NCT00156065|100685109|FG001|Overall Study|Lack of Efficacy|9|||
33215263|NCT00156065|100685110|FG002|Overall Study|Lack of Efficacy|3|||
33215264|NCT00156065|100685108|FG000|Overall Study|Withdrawal by Subject|13|||
33215265|NCT00156065|100685109|FG001|Overall Study|Withdrawal by Subject|26|||
33215266|NCT00156065|100685110|FG002|Overall Study|Withdrawal by Subject|16|||
33215267|NCT00156065|100685108|FG000|Overall Study|Lost to Follow-up|5|||
33215268|NCT00156065|100685109|FG001|Overall Study|Lost to Follow-up|7|||
33215269|NCT00156065|100685110|FG002|Overall Study|Lost to Follow-up|1|||
33215270|NCT00156065|100685108|FG000|Overall Study|Other|2|||
33215271|NCT00156065|100685109|FG001|Overall Study|Other|9|||
33215272|NCT00156065|100685110|FG002|Overall Study|Other|3|||
33215273|NCT00831779|100685111|FG000|Overall Study|Lost to Follow-up|1|||
33215274|NCT00831779|100685112|FG001|Overall Study|Lost to Follow-up|0|||
33215275|NCT00831779|100685111|FG000|Overall Study|No longer met criteria|0|||
33215276|NCT00831779|100685112|FG001|Overall Study|No longer met criteria|1|||
33215277|NCT00725452|100685116|FG000|Overall Study|Adverse Event|3|||
33215278|NCT00725452|100685116|FG000|Overall Study|Lack of Efficacy|2|||
33215279|NCT00725452|100685116|FG000|Overall Study|Reason not specified|1|||
33215280|NCT00725452|100685116|FG000|Overall Study|Physician Decision|1|||
33215281|NCT00725452|100685116|FG000|Overall Study|Withdrawal by Subject|3|||
33215282|NCT00725452|100685116|FG000|Overall Study|Lost to Follow-up|1|||
33215283|NCT02030015|100685121|FG000|Overall Study|Withdrawal by Subject|3|||
33215284|NCT02030015|100685121|FG000|Overall Study|Death|13|||
33215285|NCT02184611|100685125|FG000|Overall Study|Lack of Efficacy|11|||
33215286|NCT02184611|100685126|FG001|Overall Study|Lack of Efficacy|15|||
33215287|NCT02184611|100685125|FG000|Overall Study|Withdrawal by Subject|5|||
33215288|NCT02184611|100685126|FG001|Overall Study|Withdrawal by Subject|6|||
33215289|NCT02184611|100685125|FG000|Overall Study|Adverse Event|4|||
33215290|NCT02184611|100685126|FG001|Overall Study|Adverse Event|5|||
33617715|NCT03431350|102147509|FG007|Overall Study|Other|0|||
33617716|NCT03431350|102147510|FG008|Overall Study|Other|14|||
33617717|NCT03431350|102147511|FG009|Overall Study|Other|11|||
33617718|NCT03431350|102147512|FG010|Overall Study|Other|11|||
33617719|NCT03431350|102147513|FG011|Overall Study|Other|15|||
33617720|NCT01483183|102147514|FG000|Overall Study|Physician Decision|0|||
33617721|NCT01483183|102147515|FG001|Overall Study|Physician Decision|0|||
33617722|NCT01483183|102147516|FG002|Overall Study|Physician Decision|0|||
33617723|NCT01483183|102147517|FG003|Overall Study|Physician Decision|0|||
33617724|NCT01483183|102147518|FG004|Overall Study|Physician Decision|0|||
33617725|NCT01483183|102147519|FG005|Overall Study|Physician Decision|0|||
33617726|NCT01483183|102147520|FG006|Overall Study|Physician Decision|2|||
33617727|NCT01483183|102147521|FG007|Overall Study|Physician Decision|0|||
33617728|NCT01483183|102147522|FG008|Overall Study|Physician Decision|0|||
33617729|NCT01483183|102147523|FG009|Overall Study|Physician Decision|0|||
33617730|NCT01483183|102147514|FG000|Overall Study|Withdrawal by Subject|0|||
33215291|NCT02184611|100685125|FG000|Overall Study|Protocol Violation|1|||
33215292|NCT02184611|100685126|FG001|Overall Study|Protocol Violation|1|||
33215293|NCT02184611|100685125|FG000|Overall Study|Protocol defined stopping criteria|0|||
33215294|NCT02184611|100685126|FG001|Overall Study|Protocol defined stopping criteria|1|||
33215295|NCT01400503|100685129|FG000|Overall Study|Withdrawal by Subject|1|||
33215296|NCT01400503|100685129|FG000|Overall Study|Study Terminated by Sponsor|58|||
33215297|NCT01400503|100685129|FG000|Overall Study|Other|1|||
33215298|NCT05711641|100685132|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
33215299|NCT05711641|100685133|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
33215300|NCT05711641|100685132|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
33215301|NCT05711641|100685133|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
33215302|NCT01925950|100685134|FG000|Part 2|Withdrawal by Subject|1|||
33409793|NCT02087865|101389368|FG000|Overall Study|Drug Non-compliance|0|||
33617731|NCT01483183|102147515|FG001|Overall Study|Withdrawal by Subject|0|||
33617732|NCT01483183|102147516|FG002|Overall Study|Withdrawal by Subject|0|||
33617733|NCT01483183|102147517|FG003|Overall Study|Withdrawal by Subject|0|||
33617734|NCT01483183|102147518|FG004|Overall Study|Withdrawal by Subject|0|||
33617735|NCT01483183|102147519|FG005|Overall Study|Withdrawal by Subject|0|||
33617736|NCT01483183|102147520|FG006|Overall Study|Withdrawal by Subject|0|||
33617737|NCT01483183|102147521|FG007|Overall Study|Withdrawal by Subject|0|||
33617738|NCT01483183|102147522|FG008|Overall Study|Withdrawal by Subject|0|||
33215303|NCT01925950|100685135|FG001|Part 2|Withdrawal by Subject|0|||
33215304|NCT00803452|100685138|FG000|Overall Study|Adverse Event|0|||
33215305|NCT00803452|100685139|FG001|Overall Study|Adverse Event|2|||
33215306|NCT00803452|100685138|FG000|Overall Study|Lost to Follow-up|0|||
33215307|NCT00803452|100685139|FG001|Overall Study|Lost to Follow-up|3|||
33215308|NCT02453685|100685140|FG000|Overall Study|Adverse Event|0|||
33215309|NCT02453685|100685141|FG001|Overall Study|Adverse Event|1|||
33215310|NCT02453685|100685140|FG000|Overall Study|Protocol Violation|7|||
33215311|NCT02453685|100685141|FG001|Overall Study|Protocol Violation|4|||
33215312|NCT02453685|100685140|FG000|Overall Study|Lost to Follow-up|0|||
33215313|NCT02453685|100685141|FG001|Overall Study|Lost to Follow-up|1|||
33215314|NCT02453685|100685140|FG000|Overall Study|Withdrawal by Subject|8|||
33215315|NCT02453685|100685141|FG001|Overall Study|Withdrawal by Subject|4|||
33215316|NCT02453685|100685140|FG000|Overall Study|Unclassified|4|||
33215317|NCT02453685|100685141|FG001|Overall Study|Unclassified|2|||
33215318|NCT02013622|100685149|FG000|Overall Study|Lost to Follow-up|10|||
33215319|NCT02013622|100685149|FG000|Overall Study|Adverse Event|3|||
33215320|NCT02013622|100685149|FG000|Overall Study|Met Withdrawal Criteria|3|||
33215321|NCT02013622|100685149|FG000|Overall Study|Withdrawal by Subject|6|||
33215322|NCT02013622|100685149|FG000|Overall Study|Protocol Deviation|1|||
33215323|NCT02013622|100685149|FG000|Overall Study|Lack of Efficacy|1|||
33215324|NCT03393000|100685150|FG000|Overall Study|Death|11|||
33215325|NCT03393000|100685150|FG000|Overall Study|Withdrawal by Subject|2|||
33215326|NCT03393000|100685150|FG000|Overall Study|Physician Decision|1|||
33215327|NCT02816138|100685154|FG000|Overall Study|Adverse Event|1|||
33215328|NCT01970462|100685155|FG000|Overall Study|Lost to Follow-up|0|||
33215329|NCT01970462|100685156|FG001|Overall Study|Lost to Follow-up|2|||
33215330|NCT04530448|100685157|FG000|Overall Study|Physician Decision|3|||
33215331|NCT04530448|100685158|FG001|Overall Study|Physician Decision|0|||
33215332|NCT03311373|100685161|FG000|Overall Study|Adverse Event|1|||
33215333|NCT03311373|100685161|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
33215334|NCT03311373|100685161|FG000|Overall Study|Lost to Follow-up|1|||
33215335|NCT03311373|100685161|FG000|Overall Study|Physician Decision|1|||
33215336|NCT03311373|100685161|FG000|Overall Study|Withdrawal by Subject|3|||
33215337|NCT03263429|100685166|FG000|Overall Study|Withdrawal by Subject|0|||
33215338|NCT03263429|100685167|FG001|Overall Study|Withdrawal by Subject|1|||
33215339|NCT03263429|100685168|FG002|Overall Study|Withdrawal by Subject|0|||
33215340|NCT03263429|100685166|FG000|Overall Study|Follow-Up Period Completed|0|||
33215341|NCT03263429|100685167|FG001|Overall Study|Follow-Up Period Completed|2|||
33215342|NCT03263429|100685168|FG002|Overall Study|Follow-Up Period Completed|0|||
33215343|NCT03263429|100685166|FG000|Overall Study|Death|3|||
33215344|NCT03263429|100685167|FG001|Overall Study|Death|5|||
33215345|NCT03263429|100685168|FG002|Overall Study|Death|16|||
33215346|NCT03263429|100685166|FG000|Overall Study|Participant unable to return|0|||
33215347|NCT03263429|100685167|FG001|Overall Study|Participant unable to return|0|||
33349169|NCT00896532|101164128|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33548422|NCT01564407|101905323|FG003|Overall Study|Withdrawal by Subject|0|||
33548423|NCT01564407|101905324|FG004|Overall Study|Withdrawal by Subject|0|||
33548424|NCT01564407|101905320|FG000|Overall Study|funding lost, study ended|0|||
33548425|NCT01564407|101905321|FG001|Overall Study|funding lost, study ended|0|||
33548426|NCT01564407|101905322|FG002|Overall Study|funding lost, study ended|0|||
33548427|NCT01564407|101905323|FG003|Overall Study|funding lost, study ended|1|||
33548428|NCT01564407|101905324|FG004|Overall Study|funding lost, study ended|0|||
33548429|NCT04575324|101905325|FG000|Overall Study|Lost to Follow-up|29|||
33548430|NCT04575324|101905326|FG001|Overall Study|Lost to Follow-up|25|||
33548431|NCT04575324|101905325|FG000|Overall Study|Death|1|||
33548432|NCT04575324|101905326|FG001|Overall Study|Death|2|||
33548433|NCT04575324|101905325|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
33548434|NCT04575324|101905326|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
33548435|NCT02316613|101905327|FG000|Overall Study|Death|63|||
33215348|NCT03263429|100685168|FG002|Overall Study|Participant unable to return|1|||
33215349|NCT03263429|100685166|FG000|Overall Study|Study Closed|0|||
33215350|NCT03263429|100685167|FG001|Overall Study|Study Closed|0|||
33215351|NCT03263429|100685168|FG002|Overall Study|Study Closed|1|||
33215352|NCT00293267|100685170|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
33215353|NCT00293267|100685171|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
33215354|NCT00293267|100685170|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
33215355|NCT00293267|100685171|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
33215356|NCT00293267|100685170|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
33215357|NCT00293267|100685171|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
33215358|NCT00293267|100685170|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
33215359|NCT00293267|100685171|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
33215360|NCT00293267|100685170|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
33215361|NCT00293267|100685171|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
33215362|NCT00293267|100685170|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
33548436|NCT02316613|101905327|FG000|Overall Study|Lost to Follow-up|9|||
33548437|NCT02316613|101905327|FG000|Overall Study|Lymphoma transformation|2|||
33409794|NCT02087865|101389369|FG001|Overall Study|Drug Non-compliance|2|||
33409795|NCT02087865|101389370|FG002|Overall Study|Drug Non-compliance|0|||
33409796|NCT02087865|101389368|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
33409797|NCT02087865|101389369|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
33409798|NCT02087865|101389370|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
33409799|NCT01004822|101389371|FG000|Overall Study|Objective progression or relapse|3|||
33409800|NCT01004822|101389372|FG001|Overall Study|Objective progression or relapse|3|||
33409801|NCT01004822|101389373|FG002|Overall Study|Objective progression or relapse|0|||
33409802|NCT01004822|101389374|FG003|Overall Study|Objective progression or relapse|1|||
33409803|NCT01004822|101389375|FG004|Overall Study|Objective progression or relapse|2|||
33409804|NCT01004822|101389376|FG005|Overall Study|Objective progression or relapse|2|||
33409805|NCT01004822|101389377|FG006|Overall Study|Objective progression or relapse|1|||
33409806|NCT01004822|101389378|FG007|Overall Study|Objective progression or relapse|4|||
33409807|NCT01004822|101389371|FG000|Overall Study|Global deterioration of health status|0|||
33409808|NCT01004822|101389372|FG001|Overall Study|Global deterioration of health status|0|||
33409809|NCT01004822|101389373|FG002|Overall Study|Global deterioration of health status|0|||
33409810|NCT01004822|101389374|FG003|Overall Study|Global deterioration of health status|1|||
33409811|NCT01004822|101389375|FG004|Overall Study|Global deterioration of health status|0|||
33409812|NCT01004822|101389376|FG005|Overall Study|Global deterioration of health status|0|||
33409813|NCT01004822|101389377|FG006|Overall Study|Global deterioration of health status|1|||
33409814|NCT01004822|101389378|FG007|Overall Study|Global deterioration of health status|0|||
33409815|NCT01004822|101389371|FG000|Overall Study|No longer willing to continue|0|||
33409816|NCT01004822|101389372|FG001|Overall Study|No longer willing to continue|0|||
33409817|NCT01004822|101389373|FG002|Overall Study|No longer willing to continue|0|||
33409818|NCT01004822|101389374|FG003|Overall Study|No longer willing to continue|1|||
33409819|NCT01004822|101389375|FG004|Overall Study|No longer willing to continue|2|||
33409820|NCT01004822|101389376|FG005|Overall Study|No longer willing to continue|1|||
33409821|NCT01004822|101389377|FG006|Overall Study|No longer willing to continue|1|||
33409822|NCT01004822|101389378|FG007|Overall Study|No longer willing to continue|0|||
33409823|NCT01004822|101389371|FG000|Overall Study|Adverse Event|0|||
33409824|NCT01004822|101389372|FG001|Overall Study|Adverse Event|0|||
33409825|NCT01004822|101389373|FG002|Overall Study|Adverse Event|0|||
33409826|NCT01004822|101389374|FG003|Overall Study|Adverse Event|0|||
33548438|NCT02316613|101905327|FG000|Overall Study|Participant moved/changed medical team|11|||
33548439|NCT02316613|101905327|FG000|Overall Study|No data and duplicate cases|5|||
33409827|NCT01004822|101389375|FG004|Overall Study|Adverse Event|0|||
33409828|NCT01004822|101389376|FG005|Overall Study|Adverse Event|0|||
33409829|NCT01004822|101389377|FG006|Overall Study|Adverse Event|1|||
33548440|NCT02316613|101905327|FG000|Overall Study|Did not met selection criteria|14|||
33548441|NCT00577408|101905328|FG000|Overall Study|Stopped attending study visits|9|||
33548442|NCT00577408|101905329|FG001|Overall Study|Stopped attending study visits|11|||
33548443|NCT00577408|101905328|FG000|Overall Study|Continued opioid use|3|||
33548444|NCT00577408|101905329|FG001|Overall Study|Continued opioid use|2|||
33409830|NCT01004822|101389378|FG007|Overall Study|Adverse Event|1|||
33409831|NCT01004822|101389371|FG000|Overall Study|Other|0|||
33409832|NCT01004822|101389372|FG001|Overall Study|Other|0|||
33409833|NCT01004822|101389373|FG002|Overall Study|Other|4|||
33548445|NCT00577408|101905328|FG000|Overall Study|Non-compliance with study meds|0|||
33215363|NCT00293267|100685171|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
33215364|NCT00293267|100685170|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
33215365|NCT00293267|100685171|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
33215366|NCT00293267|100685170|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
33215367|NCT00293267|100685171|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
33215368|NCT00293267|100685170|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
33215369|NCT00293267|100685171|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
33215370|NCT00293267|100685170|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
33215371|NCT00293267|100685171|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
33215372|NCT00293267|100685170|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
33215373|NCT00293267|100685171|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
33349170|NCT00896532|101164129|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349171|NCT00896532|101164130|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349172|NCT00896532|101164131|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349173|NCT00896532|101164132|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349174|NCT00896532|101164133|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349175|NCT00896532|101164134|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349176|NCT00896532|101164135|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349177|NCT00896532|101164136|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
33349178|NCT00896532|101164137|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
33349179|NCT00896532|101164138|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349180|NCT00896532|101164139|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33548446|NCT00577408|101905329|FG001|Overall Study|Non-compliance with study meds|3|||
33548447|NCT00577408|101905328|FG000|Overall Study|Refused Oral Naltrexone|0|||
33548448|NCT00577408|101905329|FG001|Overall Study|Refused Oral Naltrexone|1|||
33548449|NCT00577408|101905328|FG000|Overall Study|Moved out of state|0|||
33548450|NCT00577408|101905329|FG001|Overall Study|Moved out of state|1|||
33548451|NCT00577408|101905328|FG000|Overall Study|Scheduling Issues|0|||
33548452|NCT00577408|101905329|FG001|Overall Study|Scheduling Issues|3|||
33548453|NCT00577408|101905328|FG000|Overall Study|Death|0|||
33548454|NCT00577408|101905329|FG001|Overall Study|Death|1|||
33548455|NCT00577408|101905328|FG000|Overall Study|Psychiatric hospitalization|0|||
33548456|NCT00577408|101905329|FG001|Overall Study|Psychiatric hospitalization|1|||
33548457|NCT00177671|101905339|FG000|Overall Study|Withdrawal by Subject|5|||
33548458|NCT00177671|101905340|FG001|Overall Study|Withdrawal by Subject|6|||
33548459|NCT00177671|101905339|FG000|Overall Study|medical complications|2|||
33548460|NCT00177671|101905340|FG001|Overall Study|medical complications|0|||
33548461|NCT00177671|101905339|FG000|Overall Study|Adverse Event|6|||
33548462|NCT00177671|101905340|FG001|Overall Study|Adverse Event|0|||
33548463|NCT00177671|101905339|FG000|Overall Study|Physician Decision|12|||
33548464|NCT00177671|101905340|FG001|Overall Study|Physician Decision|8|||
33349181|NCT00896532|101164140|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33409834|NCT01004822|101389374|FG003|Overall Study|Other|1|||
33409835|NCT01004822|101389375|FG004|Overall Study|Other|0|||
33548465|NCT02693418|101905343|FG000|Overall Study|Lost to Follow-up|1|||
33548466|NCT02693418|101905344|FG001|Overall Study|Lost to Follow-up|2|||
33548467|NCT02693418|101905345|FG002|Overall Study|Lost to Follow-up|0|||
33548468|NCT02693418|101905346|FG003|Overall Study|Lost to Follow-up|0|||
33548469|NCT02693418|101905347|FG004|Overall Study|Lost to Follow-up|0|||
33548470|NCT02693418|101905343|FG000|Overall Study|Menses during study period|0|||
33548471|NCT02693418|101905344|FG001|Overall Study|Menses during study period|0|||
33548472|NCT02693418|101905345|FG002|Overall Study|Menses during study period|2|||
33548473|NCT02693418|101905346|FG003|Overall Study|Menses during study period|0|||
33548474|NCT02693418|101905347|FG004|Overall Study|Menses during study period|0|||
33548475|NCT04615507|101905348|FG000|Period 1|Covid-19 exposure|2|||
33548476|NCT04615507|101905349|FG001|Period 1|Covid-19 exposure|1|||
33548477|NCT04615507|101905348|FG000|Period 2|Covid-19 exposure|0|||
33548478|NCT04615507|101905349|FG001|Period 2|Covid-19 exposure|1|||
33548479|NCT04615507|101905348|FG000|Period 2|Protocol Violation|1|||
33548480|NCT04615507|101905349|FG001|Period 2|Protocol Violation|0|||
33215374|NCT00293267|100685170|FG000|Extension - Double-Blind Week 49-156|Death|3|||
33215375|NCT00293267|100685171|FG001|Extension - Double-Blind Week 49-156|Death|0|||
33215376|NCT00293267|100685170|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
33215377|NCT00293267|100685171|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
33215378|NCT00293267|100685170|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
33215379|NCT00293267|100685171|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
33215380|NCT00293267|100685170|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
33215381|NCT00293267|100685171|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
33215382|NCT00293267|100685170|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
33215383|NCT00293267|100685171|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
33215384|NCT00293267|100685170|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
33215385|NCT00293267|100685171|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
33215386|NCT00293267|100685170|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
33215387|NCT00293267|100685171|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
33349182|NCT00896532|101164141|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33617739|NCT01483183|102147523|FG009|Overall Study|Withdrawal by Subject|1|||
33215388|NCT00293267|100685170|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
33409836|NCT01004822|101389376|FG005|Overall Study|Other|1|||
33409837|NCT01004822|101389377|FG006|Overall Study|Other|0|||
33409838|NCT01004822|101389378|FG007|Overall Study|Other|0|||
33409839|NCT00525499|101389379|FG000|Overall Study|Lost to Follow-up|2|||
33409840|NCT00525499|101389380|FG001|Overall Study|Lost to Follow-up|4|||
33409841|NCT00525499|101389381|FG002|Overall Study|Lost to Follow-up|1|||
33409842|NCT00525499|101389382|FG003|Overall Study|Lost to Follow-up|4|||
33409843|NCT00525499|101389379|FG000|Overall Study|Adverse Event|0|||
33409844|NCT00525499|101389380|FG001|Overall Study|Adverse Event|1|||
33409845|NCT00525499|101389381|FG002|Overall Study|Adverse Event|0|||
33349183|NCT00896532|101164142|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33409846|NCT00525499|101389382|FG003|Overall Study|Adverse Event|1|||
33409847|NCT00525499|101389379|FG000|Overall Study|Withdrawal by Subject|5|||
33409848|NCT00525499|101389380|FG001|Overall Study|Withdrawal by Subject|1|||
33409849|NCT00525499|101389381|FG002|Overall Study|Withdrawal by Subject|5|||
33409850|NCT00525499|101389382|FG003|Overall Study|Withdrawal by Subject|2|||
33409851|NCT00525499|101389379|FG000|Overall Study|Protocol Violation|0|||
33409852|NCT00525499|101389380|FG001|Overall Study|Protocol Violation|1|||
33409853|NCT00525499|101389381|FG002|Overall Study|Protocol Violation|1|||
33409854|NCT00525499|101389382|FG003|Overall Study|Protocol Violation|0|||
33409855|NCT03426995|101389385|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409856|NCT03426995|101389386|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409857|NCT03426995|101389387|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
33409858|NCT03426995|101389388|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409859|NCT03426995|101389389|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409860|NCT03426995|101389390|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409861|NCT03426995|101389391|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33349184|NCT00896532|101164143|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349185|NCT00896532|101164144|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349186|NCT00896532|101164145|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349187|NCT00896532|101164146|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
33349188|NCT00896532|101164124|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
33349189|NCT00896532|101164125|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
33349190|NCT00896532|101164126|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
33349191|NCT00896532|101164127|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
33349192|NCT00896532|101164128|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
33349193|NCT00896532|101164129|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
33349194|NCT00896532|101164130|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
33409862|NCT03426995|101389392|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409863|NCT03426995|101389393|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409864|NCT03426995|101389394|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409865|NCT03426995|101389395|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409866|NCT03426995|101389396|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33215389|NCT00293267|100685171|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
33215390|NCT00293267|100685170|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
33215391|NCT00293267|100685171|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
33409867|NCT03426995|101389397|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409868|NCT03426995|101389398|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409869|NCT03426995|101389399|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33215392|NCT00293267|100685170|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
33548481|NCT04615507|101905348|FG000|Period 2|Withdrawal by Subject|1|||
33548482|NCT04615507|101905349|FG001|Period 2|Withdrawal by Subject|0|||
33548483|NCT04615507|101905348|FG000|Period 2|Adverse Event|0|||
33548484|NCT04615507|101905349|FG001|Period 2|Adverse Event|1|||
33548485|NCT04615507|101905348|FG000|Period 3|Covid-19 exposure|0|||
33548486|NCT04615507|101905349|FG001|Period 3|Covid-19 exposure|1|||
33548487|NCT04327271|101905354|FG000|Overall Study|Death|1|||
33548488|NCT04327271|101905355|FG001|Overall Study|Death|0|||
33349195|NCT00896532|101164131|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
33349196|NCT00896532|101164132|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
33349197|NCT00896532|101164133|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
33349198|NCT00896532|101164134|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
33349199|NCT00896532|101164135|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
33349200|NCT00896532|101164136|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
33349201|NCT00896532|101164137|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
33349202|NCT00896532|101164138|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
33548489|NCT04327271|101905354|FG000|Overall Study|Withdrawal by Subject|1|||
33548490|NCT04327271|101905355|FG001|Overall Study|Withdrawal by Subject|0|||
33548491|NCT04327271|101905354|FG000|Overall Study|randomization error (data capture)|4|||
33548492|NCT04327271|101905355|FG001|Overall Study|randomization error (data capture)|3|||
33548493|NCT00541229|101905360|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
33548494|NCT00541229|101905361|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
33548495|NCT00541229|101905362|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
33548496|NCT00541229|101905363|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
33548497|NCT00541229|101905364|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
33548498|NCT00541229|101905365|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
33548499|NCT00541229|101905360|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
33548500|NCT00541229|101905361|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
33548501|NCT00541229|101905362|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
33548502|NCT00541229|101905363|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
33548503|NCT00541229|101905364|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
33548504|NCT00541229|101905365|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
33548505|NCT00541229|101905360|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
33548506|NCT00541229|101905361|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
33548507|NCT00541229|101905362|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
33548508|NCT00541229|101905363|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
33548509|NCT00541229|101905364|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
33548510|NCT00541229|101905365|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
33548511|NCT00541229|101905360|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
33548512|NCT00541229|101905361|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
33548513|NCT00541229|101905362|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
33548514|NCT00541229|101905363|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
33548515|NCT00541229|101905364|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
33548516|NCT00541229|101905365|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
33548517|NCT00541229|101905360|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
33548518|NCT00541229|101905361|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
33548519|NCT00541229|101905362|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
33548520|NCT00541229|101905363|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
33548521|NCT00541229|101905364|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
33548522|NCT00541229|101905365|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
33548523|NCT00541229|101905360|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
33548524|NCT00541229|101905361|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
33548525|NCT00541229|101905362|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
33548526|NCT00541229|101905363|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
33548527|NCT00541229|101905364|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
33548528|NCT00541229|101905365|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
33349203|NCT00896532|101164139|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
33349204|NCT00896532|101164140|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
33349205|NCT00896532|101164141|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
33548529|NCT00541229|101905360|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
33548530|NCT00541229|101905361|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
33548531|NCT00541229|101905362|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
33548532|NCT00541229|101905363|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
33617740|NCT00767806|102147530|FG000|Overall Study|Adverse Event|30|||
33617741|NCT00767806|102147531|FG001|Overall Study|Adverse Event|11|||
33349206|NCT00896532|101164142|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
33548533|NCT00541229|101905364|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
33548534|NCT00541229|101905365|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
33548535|NCT00541229|101905360|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
33548536|NCT00541229|101905361|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
33548537|NCT00541229|101905362|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
33548538|NCT00541229|101905363|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
33548539|NCT00541229|101905364|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
33548540|NCT00541229|101905365|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
33548541|NCT00541229|101905360|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
33548542|NCT00541229|101905361|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
33548543|NCT00541229|101905362|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
33548544|NCT00541229|101905363|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
33548545|NCT00541229|101905364|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
33548546|NCT00541229|101905365|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
33548547|NCT00541229|101905360|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
33548548|NCT00541229|101905361|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
33548549|NCT00541229|101905362|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
33548550|NCT00541229|101905363|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
33548551|NCT00541229|101905364|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
33548552|NCT00541229|101905365|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
33548553|NCT00541229|101905360|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
33548554|NCT00541229|101905361|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
33548555|NCT00541229|101905362|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
33548556|NCT00541229|101905363|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
33548557|NCT00541229|101905364|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
33548558|NCT00541229|101905365|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
33548559|NCT00541229|101905360|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
33548560|NCT00541229|101905361|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
33548561|NCT00541229|101905362|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
33548562|NCT00541229|101905363|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
33548563|NCT00541229|101905364|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
33548564|NCT00541229|101905365|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
33548565|NCT00541229|101905360|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
33548566|NCT00541229|101905361|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
33548567|NCT00541229|101905362|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
33548568|NCT00541229|101905363|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
33548569|NCT00541229|101905364|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
33548570|NCT00541229|101905365|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
33548571|NCT00541229|101905360|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
33548572|NCT00541229|101905361|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
33548573|NCT00541229|101905362|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
33548574|NCT00541229|101905363|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
33548575|NCT00541229|101905364|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
33548576|NCT00541229|101905365|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
33548577|NCT00541229|101905360|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
33548578|NCT00541229|101905361|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
33548579|NCT00541229|101905362|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
33548580|NCT00541229|101905363|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
33548581|NCT00541229|101905364|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
33548582|NCT00541229|101905365|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
33215393|NCT00293267|100685171|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
33215394|NCT00293267|100685170|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
33215395|NCT00293267|100685171|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
33215396|NCT00293267|100685170|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
33215397|NCT00293267|100685171|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
33215398|NCT00293267|100685170|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
33548583|NCT00541229|101905360|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
33548584|NCT00541229|101905361|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
33215399|NCT00293267|100685171|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
33215400|NCT00293267|100685170|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
33215401|NCT00293267|100685171|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
33215402|NCT00293267|100685170|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
33215403|NCT00293267|100685171|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
33215404|NCT00293267|100685170|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
33215405|NCT00293267|100685171|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
33215406|NCT00293267|100685170|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
33215407|NCT00293267|100685171|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
33215408|NCT00911534|100685172|FG000|Overall Study|Adverse Event|4|||
33215409|NCT00911534|100685173|FG001|Overall Study|Adverse Event|4|||
33215410|NCT00911534|100685172|FG000|Overall Study|Lost to Follow-up|2|||
33215411|NCT00911534|100685173|FG001|Overall Study|Lost to Follow-up|4|||
33215412|NCT00911534|100685172|FG000|Overall Study|Withdrawal by Subject|2|||
33215413|NCT00911534|100685173|FG001|Overall Study|Withdrawal by Subject|1|||
33215414|NCT00911534|100685172|FG000|Overall Study|Lack of Efficacy|4|||
33215415|NCT00911534|100685173|FG001|Overall Study|Lack of Efficacy|1|||
33215416|NCT00911534|100685172|FG000|Overall Study|Withdrawal of consent|1|||
33215417|NCT00911534|100685173|FG001|Overall Study|Withdrawal of consent|4|||
33215418|NCT00911534|100685172|FG000|Overall Study|Other|2|||
33215419|NCT00911534|100685173|FG001|Overall Study|Other|2|||
33349207|NCT00896532|101164143|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
33349208|NCT00896532|101164144|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
33349209|NCT00896532|101164145|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
33349210|NCT00896532|101164146|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
33349211|NCT00896532|101164124|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349212|NCT00896532|101164125|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349213|NCT00896532|101164126|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349214|NCT00896532|101164127|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349215|NCT00896532|101164128|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349216|NCT00896532|101164129|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349217|NCT00896532|101164130|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349218|NCT00896532|101164131|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349219|NCT00896532|101164132|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349220|NCT00896532|101164133|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349221|NCT00896532|101164134|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349222|NCT00896532|101164135|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349223|NCT00896532|101164136|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33215420|NCT03982186|100685176|FG000|Overall Study|Lost to Follow-up|0|||
33409870|NCT03426995|101389400|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409871|NCT03426995|101389401|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409872|NCT03426995|101389402|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409873|NCT03426995|101389403|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
33409874|NCT03426995|101389385|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409875|NCT03426995|101389386|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409876|NCT03426995|101389387|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409877|NCT03426995|101389388|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409878|NCT03426995|101389389|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409879|NCT03426995|101389390|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
33409880|NCT03426995|101389391|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409881|NCT03426995|101389392|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409882|NCT03426995|101389393|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33617742|NCT00767806|102147530|FG000|Overall Study|Withdrawal by Subject|8|||
33617743|NCT00767806|102147531|FG001|Overall Study|Withdrawal by Subject|13|||
33617744|NCT00767806|102147530|FG000|Overall Study|Protocol Violation|6|||
33617745|NCT00767806|102147531|FG001|Overall Study|Protocol Violation|5|||
33617746|NCT00767806|102147530|FG000|Overall Study|Lack of Efficacy|1|||
33617747|NCT00767806|102147531|FG001|Overall Study|Lack of Efficacy|9|||
33617748|NCT00767806|102147530|FG000|Overall Study|Physician Decision|4|||
33617749|NCT00767806|102147531|FG001|Overall Study|Physician Decision|3|||
33617750|NCT00767806|102147530|FG000|Overall Study|Lost to Follow-up|1|||
33617751|NCT00767806|102147531|FG001|Overall Study|Lost to Follow-up|4|||
33617752|NCT00767806|102147530|FG000|Overall Study|Entry Criteria Not Met|1|||
33617753|NCT00767806|102147531|FG001|Overall Study|Entry Criteria Not Met|1|||
33617754|NCT00767806|102147530|FG000|Overall Study|Sponsor Decision|0|||
33409883|NCT03426995|101389394|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409884|NCT03426995|101389395|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409885|NCT03426995|101389396|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409886|NCT03426995|101389397|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409887|NCT03426995|101389398|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409888|NCT03426995|101389399|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409889|NCT03426995|101389400|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409890|NCT03426995|101389401|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409891|NCT03426995|101389402|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409892|NCT03426995|101389403|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
33409893|NCT03426995|101389385|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33617755|NCT00767806|102147531|FG001|Overall Study|Sponsor Decision|1|||
33617756|NCT04538417|102147534|FG000|Overall Study|Withdrawal by Subject|2|||
33617757|NCT02292446|102147535|FG000|Overall Study|Adverse Event|12|||
33617758|NCT02292446|102147535|FG000|Overall Study|Death|1|||
33617759|NCT02292446|102147535|FG000|Overall Study|Disease progression|2|||
33409894|NCT03426995|101389386|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33409895|NCT03426995|101389387|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33409896|NCT03426995|101389388|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33409897|NCT03426995|101389389|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
33409898|NCT03426995|101389390|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
33409899|NCT03426995|101389391|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33548585|NCT00541229|101905362|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
33548586|NCT00541229|101905363|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
33548587|NCT00541229|101905364|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
33548588|NCT00541229|101905365|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
33548589|NCT02332707|101905368|FG000|Overall Study|Adverse Event|0|||
33548590|NCT02332707|101905369|FG001|Overall Study|Adverse Event|0|||
33548591|NCT02332707|101905370|FG002|Overall Study|Adverse Event|0|||
33548592|NCT02332707|101905371|FG003|Overall Study|Adverse Event|0|||
33548593|NCT02332707|101905372|FG004|Overall Study|Adverse Event|0|||
33548594|NCT02332707|101905373|FG005|Overall Study|Adverse Event|0|||
33548595|NCT02332707|101905374|FG006|Overall Study|Adverse Event|0|||
33548596|NCT02332707|101905375|FG007|Overall Study|Adverse Event|0|||
33548597|NCT02332707|101905376|FG008|Overall Study|Adverse Event|0|||
33548598|NCT02332707|101905377|FG009|Overall Study|Adverse Event|0|||
33548599|NCT02332707|101905378|FG010|Overall Study|Adverse Event|0|||
33548600|NCT02332707|101905379|FG011|Overall Study|Adverse Event|0|||
33548601|NCT02332707|101905380|FG012|Overall Study|Adverse Event|1|||
33548602|NCT02332707|101905381|FG013|Overall Study|Adverse Event|0|||
33409900|NCT03426995|101389392|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33548603|NCT02332707|101905382|FG014|Overall Study|Adverse Event|0|||
33548604|NCT02332707|101905383|FG015|Overall Study|Adverse Event|0|||
33548605|NCT02332707|101905384|FG016|Overall Study|Adverse Event|0|||
33617760|NCT02292446|102147535|FG000|Overall Study|Subject/guardian decision|2|||
33617761|NCT02292446|102147535|FG000|Overall Study|Withdrawal by Subject|3|||
33215421|NCT03982186|100685177|FG001|Overall Study|Lost to Follow-up|1|||
33215422|NCT03982186|100685178|FG002|Overall Study|Lost to Follow-up|2|||
33215423|NCT03982186|100685179|FG003|Overall Study|Lost to Follow-up|1|||
33215424|NCT03982186|100685180|FG004|Overall Study|Lost to Follow-up|1|||
33215425|NCT03982186|100685181|FG005|Overall Study|Lost to Follow-up|0|||
33215426|NCT03982186|100685176|FG000|Overall Study|Physician Decision|0|||
33215427|NCT03982186|100685177|FG001|Overall Study|Physician Decision|1|||
33215428|NCT03982186|100685178|FG002|Overall Study|Physician Decision|0|||
33215429|NCT03982186|100685179|FG003|Overall Study|Physician Decision|0|||
33215430|NCT03982186|100685180|FG004|Overall Study|Physician Decision|0|||
33548606|NCT02332707|101905385|FG017|Overall Study|Adverse Event|0|||
33548607|NCT02332707|101905368|FG000|Overall Study|Lost to Follow-up|0|||
33548608|NCT02332707|101905369|FG001|Overall Study|Lost to Follow-up|0|||
33548609|NCT02332707|101905370|FG002|Overall Study|Lost to Follow-up|0|||
33548610|NCT02332707|101905371|FG003|Overall Study|Lost to Follow-up|0|||
33548611|NCT02332707|101905372|FG004|Overall Study|Lost to Follow-up|0|||
33548612|NCT02332707|101905373|FG005|Overall Study|Lost to Follow-up|1|||
33548613|NCT02332707|101905374|FG006|Overall Study|Lost to Follow-up|0|||
33548614|NCT02332707|101905375|FG007|Overall Study|Lost to Follow-up|0|||
33548615|NCT02332707|101905376|FG008|Overall Study|Lost to Follow-up|0|||
33548616|NCT02332707|101905377|FG009|Overall Study|Lost to Follow-up|0|||
33548617|NCT02332707|101905378|FG010|Overall Study|Lost to Follow-up|2|||
33548618|NCT02332707|101905379|FG011|Overall Study|Lost to Follow-up|0|||
33548619|NCT02332707|101905380|FG012|Overall Study|Lost to Follow-up|3|||
33548620|NCT02332707|101905381|FG013|Overall Study|Lost to Follow-up|0|||
33548621|NCT02332707|101905382|FG014|Overall Study|Lost to Follow-up|0|||
33548622|NCT02332707|101905383|FG015|Overall Study|Lost to Follow-up|0|||
33548623|NCT02332707|101905384|FG016|Overall Study|Lost to Follow-up|0|||
33548624|NCT02332707|101905385|FG017|Overall Study|Lost to Follow-up|0|||
33548625|NCT02332707|101905368|FG000|Overall Study|Physician Decision|0|||
33548626|NCT02332707|101905369|FG001|Overall Study|Physician Decision|0|||
33215431|NCT03982186|100685181|FG005|Overall Study|Physician Decision|0|||
33215432|NCT03982186|100685176|FG000|Overall Study|Withdrawal by Subject|3|||
33215433|NCT03982186|100685177|FG001|Overall Study|Withdrawal by Subject|4|||
33548627|NCT02332707|101905370|FG002|Overall Study|Physician Decision|0|||
33548628|NCT02332707|101905371|FG003|Overall Study|Physician Decision|1|||
33548629|NCT02332707|101905372|FG004|Overall Study|Physician Decision|0|||
33548630|NCT02332707|101905373|FG005|Overall Study|Physician Decision|0|||
33548631|NCT02332707|101905374|FG006|Overall Study|Physician Decision|0|||
33548632|NCT02332707|101905375|FG007|Overall Study|Physician Decision|0|||
33548633|NCT02332707|101905376|FG008|Overall Study|Physician Decision|0|||
33548634|NCT02332707|101905377|FG009|Overall Study|Physician Decision|0|||
33548635|NCT02332707|101905378|FG010|Overall Study|Physician Decision|0|||
33548636|NCT02332707|101905379|FG011|Overall Study|Physician Decision|0|||
33548637|NCT02332707|101905380|FG012|Overall Study|Physician Decision|1|||
33548638|NCT02332707|101905381|FG013|Overall Study|Physician Decision|0|||
33548639|NCT02332707|101905382|FG014|Overall Study|Physician Decision|0|||
33548640|NCT02332707|101905383|FG015|Overall Study|Physician Decision|0|||
33548641|NCT02332707|101905384|FG016|Overall Study|Physician Decision|0|||
33548642|NCT02332707|101905385|FG017|Overall Study|Physician Decision|0|||
33548643|NCT02332707|101905368|FG000|Overall Study|Withdrawal by Subject|0|||
33548644|NCT02332707|101905369|FG001|Overall Study|Withdrawal by Subject|0|||
33548645|NCT02332707|101905370|FG002|Overall Study|Withdrawal by Subject|1|||
33548646|NCT02332707|101905371|FG003|Overall Study|Withdrawal by Subject|0|||
33548647|NCT02332707|101905372|FG004|Overall Study|Withdrawal by Subject|0|||
33548648|NCT02332707|101905373|FG005|Overall Study|Withdrawal by Subject|0|||
33548649|NCT02332707|101905374|FG006|Overall Study|Withdrawal by Subject|0|||
33548650|NCT02332707|101905375|FG007|Overall Study|Withdrawal by Subject|0|||
33548651|NCT02332707|101905376|FG008|Overall Study|Withdrawal by Subject|0|||
33548652|NCT02332707|101905377|FG009|Overall Study|Withdrawal by Subject|3|||
33548653|NCT02332707|101905378|FG010|Overall Study|Withdrawal by Subject|0|||
33548654|NCT02332707|101905379|FG011|Overall Study|Withdrawal by Subject|0|||
33548655|NCT02332707|101905380|FG012|Overall Study|Withdrawal by Subject|0|||
33548656|NCT02332707|101905381|FG013|Overall Study|Withdrawal by Subject|0|||
33548657|NCT02332707|101905382|FG014|Overall Study|Withdrawal by Subject|0|||
33548658|NCT02332707|101905383|FG015|Overall Study|Withdrawal by Subject|0|||
33617762|NCT00413036|102147537|FG000|Overall Study|Adverse Event|44|||
33548659|NCT02332707|101905384|FG016|Overall Study|Withdrawal by Subject|0|||
33548660|NCT02332707|101905385|FG017|Overall Study|Withdrawal by Subject|0|||
33548661|NCT03325439|101905393|FG000|Overall Study|Ineligibility|3|||
33548662|NCT03807843|101905394|FG000|Overall Study|Lost to Follow-up|1|||
33548663|NCT03807843|101905395|FG001|Overall Study|Lost to Follow-up|0|||
33548664|NCT00857389|101905402|FG000|Overall Study|Did not proceed to transplant|2|||
33548665|NCT01704079|101905403|FG000|Overall Study|Withdrawal by Subject|5|||
33548666|NCT01704079|101905404|FG001|Overall Study|Withdrawal by Subject|7|||
33548667|NCT01704079|101905403|FG000|Overall Study|Lost to Follow-up|2|||
33548668|NCT01704079|101905404|FG001|Overall Study|Lost to Follow-up|5|||
33548669|NCT01704079|101905403|FG000|Overall Study|Adverse Event|4|||
33548670|NCT01704079|101905404|FG001|Overall Study|Adverse Event|7|||
33548671|NCT01704079|101905403|FG000|Overall Study|Protocol Violation|1|||
33548672|NCT01704079|101905404|FG001|Overall Study|Protocol Violation|0|||
33548673|NCT01704079|101905403|FG000|Overall Study|Subject noncompliance|2|||
33548674|NCT01704079|101905404|FG001|Overall Study|Subject noncompliance|3|||
33548675|NCT01704079|101905403|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
33548676|NCT01704079|101905404|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
33548677|NCT02547935|101905405|FG000|Overall Study|Other|0|||
33548678|NCT02547935|101905406|FG001|Overall Study|Other|1|||
33548679|NCT02547935|101905407|FG002|Overall Study|Other|0|||
33548680|NCT02547935|101905405|FG000|Overall Study|Withdrawal by Subject|2|||
33548681|NCT02547935|101905406|FG001|Overall Study|Withdrawal by Subject|3|||
33548682|NCT02547935|101905407|FG002|Overall Study|Withdrawal by Subject|4|||
33548683|NCT02547935|101905405|FG000|Overall Study|Screen Failure|2|||
33548684|NCT02547935|101905406|FG001|Overall Study|Screen Failure|0|||
33548685|NCT02547935|101905407|FG002|Overall Study|Screen Failure|0|||
33215434|NCT03982186|100685178|FG002|Overall Study|Withdrawal by Subject|1|||
33215435|NCT03982186|100685179|FG003|Overall Study|Withdrawal by Subject|7|||
33215436|NCT03982186|100685180|FG004|Overall Study|Withdrawal by Subject|2|||
33215437|NCT03982186|100685181|FG005|Overall Study|Withdrawal by Subject|0|||
33215438|NCT03982186|100685176|FG000|Overall Study|Randomized and not treated|0|||
33215439|NCT03982186|100685177|FG001|Overall Study|Randomized and not treated|0|||
33215440|NCT03982186|100685178|FG002|Overall Study|Randomized and not treated|0|||
33215441|NCT03982186|100685179|FG003|Overall Study|Randomized and not treated|1|||
33215442|NCT03982186|100685180|FG004|Overall Study|Randomized and not treated|0|||
33215443|NCT03982186|100685181|FG005|Overall Study|Randomized and not treated|0|||
33215444|NCT03076970|100685182|FG000|Washout Period 2|Adverse Event|0|||
33215445|NCT03076970|100685183|FG001|Washout Period 2|Adverse Event|0|||
33215446|NCT03076970|100685184|FG002|Washout Period 2|Adverse Event|0|||
33215447|NCT03076970|100685185|FG003|Washout Period 2|Adverse Event|0|||
33215448|NCT03076970|100685186|FG004|Washout Period 2|Adverse Event|1|||
33215449|NCT03076970|100685187|FG005|Washout Period 2|Adverse Event|0|||
33215450|NCT03076970|100685182|FG000|Period 3|Withdrawal by Subject|0|||
33215451|NCT03076970|100685183|FG001|Period 3|Withdrawal by Subject|0|||
33215452|NCT03076970|100685184|FG002|Period 3|Withdrawal by Subject|0|||
33215453|NCT03076970|100685185|FG003|Period 3|Withdrawal by Subject|0|||
33349224|NCT00896532|101164137|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349225|NCT00896532|101164138|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349226|NCT00896532|101164139|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
33349227|NCT00896532|101164140|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
33349228|NCT00896532|101164141|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349229|NCT00896532|101164142|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349230|NCT00896532|101164143|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33215454|NCT03076970|100685186|FG004|Period 3|Withdrawal by Subject|0|||
33349231|NCT00896532|101164144|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349232|NCT00896532|101164145|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33349233|NCT00896532|101164146|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
33215455|NCT03076970|100685187|FG005|Period 3|Withdrawal by Subject|1|||
33215456|NCT03076970|100685182|FG000|Period 3|Failure to meet I/E criteria|0|||
33215457|NCT03076970|100685183|FG001|Period 3|Failure to meet I/E criteria|0|||
33215458|NCT03076970|100685184|FG002|Period 3|Failure to meet I/E criteria|0|||
33349234|NCT00896532|101164124|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349235|NCT00896532|101164125|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349236|NCT00896532|101164126|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33548686|NCT02547935|101905405|FG000|Overall Study|Physician Decision|0|||
33548687|NCT02547935|101905406|FG001|Overall Study|Physician Decision|1|||
33548688|NCT02547935|101905407|FG002|Overall Study|Physician Decision|0|||
33548689|NCT02547935|101905405|FG000|Overall Study|Lost to Follow-up|0|||
33548690|NCT02547935|101905406|FG001|Overall Study|Lost to Follow-up|2|||
33548691|NCT02547935|101905407|FG002|Overall Study|Lost to Follow-up|1|||
33548692|NCT02547935|101905405|FG000|Overall Study|Death|1|||
33548693|NCT02547935|101905406|FG001|Overall Study|Death|1|||
33548694|NCT02547935|101905407|FG002|Overall Study|Death|0|||
33215459|NCT03076970|100685185|FG003|Period 3|Failure to meet I/E criteria|0|||
33215460|NCT03076970|100685186|FG004|Period 3|Failure to meet I/E criteria|1|||
33215461|NCT03076970|100685187|FG005|Period 3|Failure to meet I/E criteria|0|||
33215462|NCT04683926|100685188|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
33215463|NCT04683926|100685189|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
33215464|NCT04683926|100685190|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
33215465|NCT04683926|100685191|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
33215466|NCT04259450|100685195|FG000|Overall Study|Adverse event/ Toxicity|0|||
33215467|NCT04259450|100685196|FG001|Overall Study|Adverse event/ Toxicity|3|||
33215468|NCT04259450|100685197|FG002|Overall Study|Adverse event/ Toxicity|0|||
33215469|NCT04259450|100685198|FG003|Overall Study|Adverse event/ Toxicity|1|||
33215470|NCT04259450|100685199|FG004|Overall Study|Adverse event/ Toxicity|0|||
33215471|NCT04259450|100685200|FG005|Overall Study|Adverse event/ Toxicity|0|||
33215472|NCT04259450|100685201|FG006|Overall Study|Adverse event/ Toxicity|0|||
33215473|NCT04259450|100685202|FG007|Overall Study|Adverse event/ Toxicity|1|||
33215474|NCT04259450|100685203|FG008|Overall Study|Adverse event/ Toxicity|0|||
33215475|NCT04259450|100685204|FG009|Overall Study|Adverse event/ Toxicity|3|||
33215476|NCT04259450|100685195|FG000|Overall Study|Disease progression|2|||
33215477|NCT04259450|100685196|FG001|Overall Study|Disease progression|3|||
33215478|NCT04259450|100685197|FG002|Overall Study|Disease progression|4|||
33215479|NCT04259450|100685198|FG003|Overall Study|Disease progression|4|||
33215480|NCT04259450|100685199|FG004|Overall Study|Disease progression|6|||
33215481|NCT04259450|100685200|FG005|Overall Study|Disease progression|6|||
33215482|NCT04259450|100685201|FG006|Overall Study|Disease progression|5|||
33215483|NCT04259450|100685202|FG007|Overall Study|Disease progression|15|||
33215484|NCT04259450|100685203|FG008|Overall Study|Disease progression|6|||
33215485|NCT04259450|100685204|FG009|Overall Study|Disease progression|17|||
33215486|NCT04259450|100685195|FG000|Overall Study|Death|0|||
33215487|NCT04259450|100685196|FG001|Overall Study|Death|0|||
33215488|NCT04259450|100685197|FG002|Overall Study|Death|0|||
33215489|NCT04259450|100685198|FG003|Overall Study|Death|0|||
33215490|NCT04259450|100685199|FG004|Overall Study|Death|0|||
33215491|NCT04259450|100685200|FG005|Overall Study|Death|0|||
33215492|NCT04259450|100685201|FG006|Overall Study|Death|0|||
33215493|NCT04259450|100685202|FG007|Overall Study|Death|1|||
33215494|NCT04259450|100685203|FG008|Overall Study|Death|1|||
33215495|NCT04259450|100685204|FG009|Overall Study|Death|0|||
33215496|NCT04259450|100685195|FG000|Overall Study|Withdrawal by Subject|0|||
33215497|NCT04259450|100685196|FG001|Overall Study|Withdrawal by Subject|0|||
33215498|NCT04259450|100685197|FG002|Overall Study|Withdrawal by Subject|0|||
33215499|NCT04259450|100685198|FG003|Overall Study|Withdrawal by Subject|0|||
33215500|NCT04259450|100685199|FG004|Overall Study|Withdrawal by Subject|0|||
33215501|NCT04259450|100685200|FG005|Overall Study|Withdrawal by Subject|0|||
33215502|NCT04259450|100685201|FG006|Overall Study|Withdrawal by Subject|0|||
33215503|NCT04259450|100685202|FG007|Overall Study|Withdrawal by Subject|1|||
33215504|NCT04259450|100685203|FG008|Overall Study|Withdrawal by Subject|0|||
33215505|NCT04259450|100685204|FG009|Overall Study|Withdrawal by Subject|0|||
33215506|NCT04259450|100685195|FG000|Overall Study|Long Term Adverse Event|0|||
33215507|NCT04259450|100685196|FG001|Overall Study|Long Term Adverse Event|0|||
33215508|NCT04259450|100685197|FG002|Overall Study|Long Term Adverse Event|0|||
33215509|NCT04259450|100685198|FG003|Overall Study|Long Term Adverse Event|0|||
33215510|NCT04259450|100685199|FG004|Overall Study|Long Term Adverse Event|0|||
33215511|NCT04259450|100685200|FG005|Overall Study|Long Term Adverse Event|0|||
33215512|NCT04259450|100685201|FG006|Overall Study|Long Term Adverse Event|0|||
33349237|NCT00896532|101164127|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33548695|NCT05177094|101905408|FG000|Overall Study|Adverse Event|5|||
33548696|NCT05177094|101905409|FG001|Overall Study|Adverse Event|5|||
33215513|NCT04259450|100685202|FG007|Overall Study|Long Term Adverse Event|0|||
33215514|NCT04259450|100685203|FG008|Overall Study|Long Term Adverse Event|0|||
33215515|NCT04259450|100685204|FG009|Overall Study|Long Term Adverse Event|1|||
33215516|NCT04020341|100685216|FG000|Overall Study|Adverse Event|8|||
33215517|NCT04020341|100685217|FG001|Overall Study|Adverse Event|6|||
33215518|NCT04020341|100685216|FG000|Overall Study|Lost to Follow-up|8|||
33215519|NCT04020341|100685217|FG001|Overall Study|Lost to Follow-up|2|||
33215520|NCT04020341|100685216|FG000|Overall Study|Withdrawal by Subject|16|||
33215521|NCT04020341|100685217|FG001|Overall Study|Withdrawal by Subject|16|||
33215522|NCT04020341|100685216|FG000|Overall Study|Participant not able to swallow the tablet|1|||
33215523|NCT04020341|100685217|FG001|Overall Study|Participant not able to swallow the tablet|0|||
33215524|NCT04020341|100685216|FG000|Overall Study|Physician Decision|0|||
33215525|NCT04020341|100685217|FG001|Overall Study|Physician Decision|2|||
33215526|NCT04020341|100685216|FG000|Overall Study|Protocol Deviation|0|||
33349238|NCT00896532|101164128|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33548697|NCT05177094|101905408|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
33215527|NCT04020341|100685217|FG001|Overall Study|Protocol Deviation|2|||
33215528|NCT00924287|100685218|FG000|Overall Study|Death|1|||
33215529|NCT04402866|100685219|FG000|Overall Study|Discontinued Prior to Treatment|0|||
33215530|NCT04402866|100685220|FG001|Overall Study|Discontinued Prior to Treatment|0|||
33215531|NCT04402866|100685221|FG002|Overall Study|Discontinued Prior to Treatment|0|||
33215532|NCT04402866|100685222|FG003|Overall Study|Discontinued Prior to Treatment|0|||
33215533|NCT04402866|100685223|FG004|Overall Study|Discontinued Prior to Treatment|2|||
33215534|NCT04402866|100685224|FG005|Overall Study|Discontinued Prior to Treatment|3|||
33215535|NCT04402866|100685219|FG000|Overall Study|Adverse Event|2|||
33215536|NCT04402866|100685220|FG001|Overall Study|Adverse Event|1|||
33215537|NCT04402866|100685221|FG002|Overall Study|Adverse Event|0|||
33215538|NCT04402866|100685222|FG003|Overall Study|Adverse Event|0|||
33215539|NCT04402866|100685223|FG004|Overall Study|Adverse Event|13|||
33215540|NCT04402866|100685224|FG005|Overall Study|Adverse Event|8|||
33215541|NCT04402866|100685219|FG000|Overall Study|Miscellaneous|0|||
33215542|NCT04402866|100685220|FG001|Overall Study|Miscellaneous|0|||
33215543|NCT04402866|100685221|FG002|Overall Study|Miscellaneous|1|||
33215544|NCT04402866|100685222|FG003|Overall Study|Miscellaneous|0|||
33215545|NCT04402866|100685223|FG004|Overall Study|Miscellaneous|0|||
33215546|NCT04402866|100685224|FG005|Overall Study|Miscellaneous|0|||
33215547|NCT04402866|100685219|FG000|Overall Study|Lost to Follow-up|0|||
33548698|NCT05177094|101905409|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
33548699|NCT05177094|101905408|FG000|Overall Study|Protocol Deviation|3|||
33548700|NCT05177094|101905409|FG001|Overall Study|Protocol Deviation|0|||
33548701|NCT05177094|101905408|FG000|Overall Study|Withdrawal by Subject|6|||
33215548|NCT04402866|100685220|FG001|Overall Study|Lost to Follow-up|0|||
33215549|NCT04402866|100685221|FG002|Overall Study|Lost to Follow-up|0|||
33215550|NCT04402866|100685222|FG003|Overall Study|Lost to Follow-up|0|||
33215551|NCT04402866|100685223|FG004|Overall Study|Lost to Follow-up|0|||
33215552|NCT04402866|100685224|FG005|Overall Study|Lost to Follow-up|1|||
33215553|NCT04402866|100685219|FG000|Overall Study|Withdrawal by Subject|0|||
33215554|NCT04402866|100685220|FG001|Overall Study|Withdrawal by Subject|0|||
33215555|NCT04402866|100685221|FG002|Overall Study|Withdrawal by Subject|0|||
33215556|NCT04402866|100685222|FG003|Overall Study|Withdrawal by Subject|0|||
33215557|NCT04402866|100685223|FG004|Overall Study|Withdrawal by Subject|0|||
33215558|NCT04402866|100685224|FG005|Overall Study|Withdrawal by Subject|2|||
33215559|NCT04307004|100685225|FG000|Randomization 1|Withdrawal by Subject|25|||
33215560|NCT04307004|100685226|FG001|Randomization 1|Withdrawal by Subject|26|||
33215561|NCT04307004|100685227|FG002|Randomization 1|Withdrawal by Subject|0|||
33215562|NCT04307004|100685228|FG003|Randomization 1|Withdrawal by Subject|0|||
33215563|NCT04307004|100685225|FG000|Randomization 2|Withdrawal by Subject|0|||
33215564|NCT04307004|100685226|FG001|Randomization 2|Withdrawal by Subject|0|||
33215565|NCT04307004|100685227|FG002|Randomization 2|Withdrawal by Subject|28|||
33548702|NCT05177094|101905409|FG001|Overall Study|Withdrawal by Subject|3|||
33548703|NCT05177094|101905408|FG000|Overall Study|Participant could not tolerate long study visits|1|||
33548704|NCT05177094|101905409|FG001|Overall Study|Participant could not tolerate long study visits|0|||
33349239|NCT00896532|101164129|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349240|NCT00896532|101164130|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349241|NCT00896532|101164131|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33548705|NCT01847209|101908391|FG000|Overall Study|Withdrawal by Subject|1|||
33548706|NCT01847209|101908391|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
33548707|NCT03677401|101908392|FG000|Overall Study|Adverse Event|4|||
33548708|NCT03677401|101908393|FG001|Overall Study|Adverse Event|14|||
33548709|NCT03677401|101908392|FG000|Overall Study|Lack of Efficacy|3|||
33548710|NCT03677401|101908393|FG001|Overall Study|Lack of Efficacy|1|||
33548711|NCT03677401|101908392|FG000|Overall Study|Withdrawal by Subject|2|||
33548712|NCT03677401|101908393|FG001|Overall Study|Withdrawal by Subject|2|||
33548713|NCT03677401|101908392|FG000|Overall Study|Sponsor decision|0|||
33548714|NCT03677401|101908393|FG001|Overall Study|Sponsor decision|1|||
33548715|NCT03677401|101908392|FG000|Overall Study|Reason Unspecified|1|||
33548716|NCT03677401|101908393|FG001|Overall Study|Reason Unspecified|0|||
33548717|NCT00774748|101908394|FG000|Overall Study|Lost to Follow-up|3|||
33548718|NCT02782104|101908395|FG000|Overall Study|Other|215|||
33548719|NCT02782104|101908395|FG000|Overall Study|Induction Day 28 Non Responder|9|||
33548720|NCT02782104|101908395|FG000|Overall Study|Non-Compliance with Study Drug|2|||
33215566|NCT04307004|100685228|FG003|Randomization 2|Withdrawal by Subject|23|||
33215567|NCT02436330|100685229|FG000|Cohort 1|Lost to Follow-up|5|||
33215568|NCT02436330|100685230|FG001|Cohort 1|Lost to Follow-up|2|||
33215569|NCT02436330|100685229|FG000|Cohort 1|Withdrawal by Subject|0|||
33215570|NCT02436330|100685230|FG001|Cohort 1|Withdrawal by Subject|1|||
33215571|NCT02436330|100685229|FG000|Cohort 2|Lost to Follow-up|2|||
33215572|NCT02436330|100685230|FG001|Cohort 2|Lost to Follow-up|0|||
33215573|NCT02436330|100685229|FG000|Cohort 2|Withdrawal by Subject|2|||
33215574|NCT02436330|100685230|FG001|Cohort 2|Withdrawal by Subject|3|||
33215575|NCT02436330|100685229|FG000|Cohort 3|Lost to Follow-up|1|||
33215576|NCT02436330|100685230|FG001|Cohort 3|Lost to Follow-up|0|||
33548721|NCT02782104|101908395|FG000|Overall Study|Death|8|||
33548722|NCT02782104|101908395|FG000|Overall Study|Pregnancy|6|||
33215577|NCT02436330|100685229|FG000|Cohort 3|Withdrawal by Subject|4|||
33215578|NCT02436330|100685230|FG001|Cohort 3|Withdrawal by Subject|0|||
33215579|NCT02436330|100685229|FG000|Cohort 4|Lost to Follow-up|1|||
33215580|NCT02436330|100685230|FG001|Cohort 4|Lost to Follow-up|0|||
33215581|NCT02436330|100685229|FG000|Cohort 4|Withdrawal by Subject|1|||
33215582|NCT02436330|100685230|FG001|Cohort 4|Withdrawal by Subject|0|||
33215583|NCT02436330|100685229|FG000|Cohort 5|Lost to Follow-up|3|||
33215584|NCT02436330|100685230|FG001|Cohort 5|Lost to Follow-up|2|||
33215585|NCT02436330|100685229|FG000|Cohort 5|Withdrawal by Subject|3|||
33215586|NCT02436330|100685230|FG001|Cohort 5|Withdrawal by Subject|2|||
33215587|NCT02436330|100685229|FG000|Cohort 6|Lost to Follow-up|2|||
33215588|NCT02436330|100685230|FG001|Cohort 6|Lost to Follow-up|0|||
33215589|NCT02436330|100685229|FG000|Cohort 6|Withdrawal by Subject|1|||
33215590|NCT02436330|100685230|FG001|Cohort 6|Withdrawal by Subject|1|||
33215591|NCT01596582|100685234|FG000|Overall Study|Deemed ineligible after study visit|3|||
33215592|NCT01596582|100685235|FG001|Overall Study|Deemed ineligible after study visit|6|||
33215593|NCT01596582|100685234|FG000|Overall Study|Missing all outcome data|1|||
33215594|NCT01596582|100685235|FG001|Overall Study|Missing all outcome data|1|||
33215595|NCT01559844|100688519|FG000|Overall Study|Consent Withdrawn|7|||
33215596|NCT01559844|100688519|FG000|Overall Study|Death|5|||
33215597|NCT01559844|100688519|FG000|Overall Study|Efficacy Failure|10|||
33215598|NCT01559844|100688519|FG000|Overall Study|No Longer A Transplant Candidate|3|||
33215599|NCT02131272|100688521|FG000|Overall Study|Withdrawal by parent|0|||
33215600|NCT02131272|100688522|FG001|Overall Study|Withdrawal by parent|1|||
33215601|NCT02131272|100688521|FG000|Overall Study|Withdrawal by Subject|0|||
33215602|NCT02131272|100688522|FG001|Overall Study|Withdrawal by Subject|1|||
33215603|NCT02131272|100688521|FG000|Overall Study|Withdrawal Criteria|1|||
33215604|NCT02131272|100688522|FG001|Overall Study|Withdrawal Criteria|0|||
33215605|NCT00377403|100688524|FG000|Overall Study|Unable to contact for telephone intervie|4|||
33215606|NCT00377403|100688525|FG001|Overall Study|Unable to contact for telephone intervie|7|||
33215607|NCT00234052|100688526|FG000|Treatment|Withdrawal by Subject|3|||
33215608|NCT00234052|100688526|FG000|Treatment|Adverse Event|5|||
33215609|NCT00234052|100688526|FG000|Treatment|Death|2|||
33215610|NCT00234052|100688526|FG000|Treatment|Progressive Disease|11|||
33215611|NCT00234052|100688526|FG000|Follow-up for 5 Years|Death|41|||
33215612|NCT00234052|100688526|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
33215613|NCT00234052|100688526|FG000|Follow-up for 5 Years|Other|7|||
33215614|NCT00781391|100688530|FG000|Overall Study|never received study drug|24|||
33215615|NCT00781391|100688531|FG001|Overall Study|never received study drug|23|||
33349242|NCT00896532|101164132|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349243|NCT00896532|101164133|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349244|NCT00896532|101164134|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349245|NCT00896532|101164135|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349246|NCT00896532|101164136|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349247|NCT00896532|101164137|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349248|NCT00896532|101164138|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349249|NCT00896532|101164139|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
33349250|NCT00896532|101164140|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
33349251|NCT00896532|101164141|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
33349252|NCT00896532|101164142|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349253|NCT00896532|101164143|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349254|NCT00896532|101164144|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349255|NCT00896532|101164145|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349256|NCT00896532|101164146|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
33349257|NCT00896532|101164124|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349258|NCT00896532|101164125|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349259|NCT00896532|101164126|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349260|NCT00896532|101164127|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33617763|NCT00413036|102147537|FG000|Overall Study|Lack of Efficacy|129|||
33215616|NCT00781391|100688532|FG002|Overall Study|never received study drug|32|||
33215617|NCT00781391|100688530|FG000|Overall Study|Protocol Violation|19|||
33215618|NCT00781391|100688531|FG001|Overall Study|Protocol Violation|17|||
33215619|NCT00781391|100688532|FG002|Overall Study|Protocol Violation|20|||
33215620|NCT00781391|100688530|FG000|Overall Study|Death|789|||
33215621|NCT00781391|100688531|FG001|Overall Study|Death|730|||
33215622|NCT00781391|100688532|FG002|Overall Study|Death|706|||
33215623|NCT00781391|100688530|FG000|Overall Study|Withdrawal by Subject|47|||
33215624|NCT00781391|100688531|FG001|Overall Study|Withdrawal by Subject|37|||
33215625|NCT00781391|100688532|FG002|Overall Study|Withdrawal by Subject|25|||
33215626|NCT00781391|100688530|FG000|Overall Study|Lost to Follow-up|0|||
33215627|NCT00781391|100688531|FG001|Overall Study|Lost to Follow-up|0|||
33215628|NCT00781391|100688532|FG002|Overall Study|Lost to Follow-up|1|||
33215629|NCT00785291|100688533|FG000|Overall Study|Never began treatment|8|||
33215630|NCT00785291|100688534|FG001|Overall Study|Never began treatment|4|||
33215631|NCT00785291|100688535|FG002|Overall Study|Never began treatment|4|||
33215632|NCT00785291|100688533|FG000|Overall Study|Adverse Event|39|||
33215633|NCT00785291|100688534|FG001|Overall Study|Adverse Event|70|||
33215634|NCT00785291|100688535|FG002|Overall Study|Adverse Event|56|||
33215635|NCT00785291|100688533|FG000|Overall Study|Death|7|||
33215636|NCT00785291|100688534|FG001|Overall Study|Death|4|||
33215637|NCT00785291|100688535|FG002|Overall Study|Death|3|||
33215638|NCT00785291|100688533|FG000|Overall Study|Withdrawal by Subject|35|||
33215639|NCT00785291|100688534|FG001|Overall Study|Withdrawal by Subject|36|||
33215640|NCT00785291|100688535|FG002|Overall Study|Withdrawal by Subject|17|||
33215641|NCT00785291|100688533|FG000|Overall Study|Alternative Therapy|12|||
33215642|NCT00785291|100688534|FG001|Overall Study|Alternative Therapy|6|||
33215643|NCT00785291|100688535|FG002|Overall Study|Alternative Therapy|7|||
33215644|NCT00785291|100688533|FG000|Overall Study|Complicating illness|6|||
33215645|NCT00785291|100688534|FG001|Overall Study|Complicating illness|4|||
33215646|NCT00785291|100688535|FG002|Overall Study|Complicating illness|4|||
33215647|NCT00785291|100688533|FG000|Overall Study|Other Medical Reasons|29|||
33215648|NCT00785291|100688534|FG001|Overall Study|Other Medical Reasons|25|||
33215649|NCT00785291|100688535|FG002|Overall Study|Other Medical Reasons|15|||
33215650|NCT02565914|100688538|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
33215651|NCT02565914|100688538|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
33215652|NCT02565914|100688538|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
33215653|NCT02565914|100688538|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
33215654|NCT02565914|100688538|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
33215655|NCT02565914|100688538|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
33215656|NCT02565914|100688538|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
33215657|NCT02565914|100688538|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
33215658|NCT02565914|100688538|FG000|Part A (Up to 96 Weeks)|Other|18|||
33215659|NCT02565914|100688538|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
33215660|NCT02565914|100688538|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
33215661|NCT02565914|100688538|FG000|Part B (Up to 96 Weeks)|Other|1|||
33215662|NCT02565914|100688538|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
33215663|NCT02565914|100688538|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
33215664|NCT02565914|100688538|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
33215665|NCT02565914|100688538|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
33215666|NCT02565914|100688538|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
33215667|NCT02565914|100688538|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
33215668|NCT02565914|100688538|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
33349261|NCT00896532|101164128|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349262|NCT00896532|101164129|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349263|NCT00896532|101164130|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349264|NCT00896532|101164131|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349265|NCT00896532|101164132|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349266|NCT00896532|101164133|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349267|NCT00896532|101164134|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349268|NCT00896532|101164135|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349269|NCT00896532|101164136|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349270|NCT00896532|101164137|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349271|NCT00896532|101164138|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349272|NCT00896532|101164139|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349273|NCT00896532|101164140|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
33349274|NCT00896532|101164141|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33409901|NCT03426995|101389393|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33409902|NCT03426995|101389394|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33409903|NCT03426995|101389395|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33548723|NCT02782104|101908395|FG000|Overall Study|Withdrawal by Subject|63|||
33349275|NCT00896532|101164142|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33215669|NCT02565914|100688538|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
33215670|NCT02565914|100688538|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
33215671|NCT02565914|100688538|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
33215672|NCT02565914|100688538|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
33215673|NCT02565914|100688538|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
33215674|NCT01292876|100688543|FG000|Overall Study|Physician Decision|4|||
33215675|NCT03185481|100688545|FG000|Overall Study|Adverse Event|1|||
33215676|NCT03185481|100688545|FG000|Overall Study|Study Terminated by Sponsor|4|||
33215677|NCT00003508|100688548|FG000|Overall Study|Not evaluable|5|||
33215678|NCT02195986|100688555|FG000|Overall Study|Adverse Event|3|||
33409904|NCT03426995|101389396|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33409905|NCT03426995|101389397|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33409906|NCT03426995|101389398|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33409907|NCT03426995|101389399|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33409908|NCT03426995|101389400|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33409909|NCT03426995|101389401|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33409910|NCT03426995|101389402|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33409911|NCT03426995|101389403|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
33409912|NCT03426995|101389385|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409913|NCT03426995|101389386|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409914|NCT03426995|101389387|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409915|NCT03426995|101389388|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409916|NCT03426995|101389389|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409917|NCT03426995|101389390|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409918|NCT03426995|101389391|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409919|NCT03426995|101389392|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409920|NCT03426995|101389393|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409921|NCT03426995|101389394|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409922|NCT03426995|101389395|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
33409923|NCT03426995|101389396|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409924|NCT03426995|101389397|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409925|NCT03426995|101389398|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409926|NCT03426995|101389399|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409927|NCT03426995|101389400|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409928|NCT03426995|101389401|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409929|NCT03426995|101389402|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409930|NCT03426995|101389403|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
33409931|NCT03426995|101389385|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33409932|NCT03426995|101389386|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33409933|NCT03426995|101389387|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33409934|NCT03426995|101389388|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33409935|NCT03426995|101389389|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33617764|NCT00413036|102147537|FG000|Overall Study|Withdrawal by Subject|7|||
33617765|NCT00413036|102147537|FG000|Overall Study|Death|9|||
33617766|NCT00413036|102147537|FG000|Overall Study|Other|26|||
33617767|NCT00413036|102147537|FG000|Overall Study|Missing|2|||
33617768|NCT03350815|102147538|FG000|Period 1|Adverse Event|10|||
33617769|NCT03350815|102147539|FG001|Period 1|Adverse Event|0|||
33617770|NCT03350815|102147540|FG002|Period 1|Adverse Event|0|||
33617771|NCT03350815|102147541|FG003|Period 1|Adverse Event|0|||
33617772|NCT03350815|102147538|FG000|Period 1|Technical problems|1|||
33617773|NCT03350815|102147539|FG001|Period 1|Technical problems|0|||
33617774|NCT03350815|102147540|FG002|Period 1|Technical problems|0|||
33215679|NCT02195986|100688556|FG001|Overall Study|Adverse Event|0|||
33215680|NCT02195986|100688557|FG002|Overall Study|Adverse Event|0|||
33409936|NCT03426995|101389390|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33409937|NCT03426995|101389391|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33409938|NCT03426995|101389392|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
33548724|NCT02782104|101908395|FG000|Overall Study|Protocol Violation|7|||
33548725|NCT02782104|101908395|FG000|Overall Study|Lack of Efficacy|61|||
33548726|NCT02782104|101908395|FG000|Overall Study|Lost to Follow-up|23|||
33548727|NCT02782104|101908395|FG000|Overall Study|Adverse Event|74|||
33548728|NCT01279200|101908396|FG000|Overall Study|Withdrawal by Subject|1|||
33548729|NCT01279200|101908397|FG001|Overall Study|Withdrawal by Subject|3|||
33548730|NCT01279200|101908396|FG000|Overall Study|Patient withdrawal due to high cost|0|||
33548731|NCT01279200|101908397|FG001|Overall Study|Patient withdrawal due to high cost|1|||
33548732|NCT01279200|101908396|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
33548733|NCT01279200|101908397|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
33548734|NCT01279200|101908396|FG000|Overall Study|ultrasound screening failure|0|||
33548735|NCT01279200|101908397|FG001|Overall Study|ultrasound screening failure|1|||
33548736|NCT01279200|101908396|FG000|Overall Study|Lost to Follow-up|0|||
33548737|NCT01279200|101908397|FG001|Overall Study|Lost to Follow-up|1|||
33548738|NCT01279200|101908396|FG000|Overall Study|Adverse Event|1|||
33548739|NCT01279200|101908397|FG001|Overall Study|Adverse Event|0|||
33548740|NCT04591015|101908398|FG000|Overall Study|Death|6|||
33548741|NCT04591015|101908399|FG001|Overall Study|Death|4|||
33548742|NCT04591015|101908398|FG000|Overall Study|Withdrawal by Subject|6|||
33617775|NCT03350815|102147541|FG003|Period 1|Technical problems|0|||
33617776|NCT03350815|102147538|FG000|Period 1|Lost to Follow-up|3|||
33617777|NCT03350815|102147539|FG001|Period 1|Lost to Follow-up|0|||
33215681|NCT02195986|100688555|FG000|Overall Study|Withdrawal by Subject|0|||
33617778|NCT03350815|102147540|FG002|Period 1|Lost to Follow-up|0|||
33617779|NCT03350815|102147541|FG003|Period 1|Lost to Follow-up|0|||
33617780|NCT03350815|102147538|FG000|Period 1|Physician Decision|1|||
33215682|NCT02195986|100688556|FG001|Overall Study|Withdrawal by Subject|3|||
33215683|NCT02195986|100688557|FG002|Overall Study|Withdrawal by Subject|0|||
33215684|NCT02195986|100688555|FG000|Overall Study|Family Emergency|0|||
33215685|NCT02195986|100688556|FG001|Overall Study|Family Emergency|0|||
33215686|NCT02195986|100688557|FG002|Overall Study|Family Emergency|1|||
33215687|NCT02195986|100688555|FG000|Overall Study|Protocol Violation|0|||
33215688|NCT02195986|100688556|FG001|Overall Study|Protocol Violation|1|||
33215689|NCT02195986|100688557|FG002|Overall Study|Protocol Violation|1|||
33215690|NCT02195986|100688555|FG000|Overall Study|Non-compliance|0|||
33215691|NCT02195986|100688556|FG001|Overall Study|Non-compliance|1|||
33215692|NCT02195986|100688557|FG002|Overall Study|Non-compliance|0|||
33215693|NCT01618864|100688558|FG000|Overall Study|Withdrawal by Subject|2|||
33215694|NCT01618864|100688558|FG000|Overall Study|Lost to Follow-up|2|||
33215695|NCT04198805|100688559|FG000|Overall Study|Death|0|||
33349276|NCT00896532|101164143|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349277|NCT00896532|101164144|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349278|NCT00896532|101164145|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33349279|NCT00896532|101164146|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
33409939|NCT03426995|101389393|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33409940|NCT03426995|101389394|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33617781|NCT03350815|102147539|FG001|Period 1|Physician Decision|0|||
33617782|NCT03350815|102147540|FG002|Period 1|Physician Decision|0|||
33617783|NCT03350815|102147541|FG003|Period 1|Physician Decision|0|||
33617784|NCT03350815|102147538|FG000|Period 1|Withdrawal by Subject|8|||
33617785|NCT03350815|102147539|FG001|Period 1|Withdrawal by Subject|0|||
33617786|NCT03350815|102147540|FG002|Period 1|Withdrawal by Subject|0|||
33617787|NCT03350815|102147541|FG003|Period 1|Withdrawal by Subject|0|||
33617788|NCT03350815|102147538|FG000|Period 1|Lack of Efficacy|15|||
33617789|NCT03350815|102147539|FG001|Period 1|Lack of Efficacy|0|||
33617790|NCT03350815|102147540|FG002|Period 1|Lack of Efficacy|0|||
33617791|NCT03350815|102147541|FG003|Period 1|Lack of Efficacy|0|||
33617792|NCT03350815|102147538|FG000|Period 1|Non-compliance with study treatment|2|||
33617793|NCT03350815|102147539|FG001|Period 1|Non-compliance with study treatment|0|||
33617794|NCT03350815|102147540|FG002|Period 1|Non-compliance with study treatment|0|||
33617795|NCT03350815|102147541|FG003|Period 1|Non-compliance with study treatment|0|||
33617796|NCT03350815|102147538|FG000|Period 1|Protocol Violation|3|||
33617797|NCT03350815|102147539|FG001|Period 1|Protocol Violation|0|||
33617798|NCT03350815|102147540|FG002|Period 1|Protocol Violation|0|||
33617799|NCT03350815|102147541|FG003|Period 1|Protocol Violation|0|||
33617800|NCT03350815|102147538|FG000|Period 2|Adverse Event|0|||
33215696|NCT04198805|100688560|FG001|Overall Study|Death|0|||
33215697|NCT04198805|100688561|FG002|Overall Study|Death|0|||
33215698|NCT04198805|100688562|FG003|Overall Study|Death|1|||
33215699|NCT04198805|100688559|FG000|Overall Study|Early Termination|8|||
33215700|NCT04198805|100688560|FG001|Overall Study|Early Termination|4|||
33617801|NCT03350815|102147539|FG001|Period 2|Adverse Event|3|||
33617802|NCT03350815|102147540|FG002|Period 2|Adverse Event|5|||
33617803|NCT03350815|102147541|FG003|Period 2|Adverse Event|0|||
33617804|NCT03350815|102147538|FG000|Period 2|Technical problem|0|||
33548743|NCT04591015|101908399|FG001|Overall Study|Withdrawal by Subject|3|||
33617805|NCT03350815|102147539|FG001|Period 2|Technical problem|1|||
33617806|NCT03350815|102147540|FG002|Period 2|Technical problem|0|||
33617807|NCT03350815|102147541|FG003|Period 2|Technical problem|0|||
33215701|NCT04198805|100688561|FG002|Overall Study|Early Termination|6|||
33215702|NCT04198805|100688562|FG003|Overall Study|Early Termination|9|||
33215703|NCT02123108|100688564|FG000|Overall Study|Death|2|||
33215704|NCT02123108|100688565|FG001|Overall Study|Death|3|||
33215705|NCT02481310|100688566|FG000|Follow up|Still in follow up|0|||
33215706|NCT02481310|100688567|FG001|Follow up|Still in follow up|3|||
33215707|NCT02481310|100688568|FG002|Follow up|Still in follow up|0|||
33215708|NCT02366910|100688569|FG000|Overall Study|Withdrawal by Subject|2|||
33215709|NCT02366910|100688569|FG000|Overall Study|Screen Failure|3|||
33215710|NCT02191267|100688572|FG000|Overall Study|Withdrawal by Subject|1|||
33215711|NCT02191267|100688573|FG001|Overall Study|Withdrawal by Subject|0|||
33215712|NCT02191267|100688574|FG002|Overall Study|Withdrawal by Subject|0|||
33215713|NCT03432364|100688577|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
33215714|NCT03538951|100688578|FG000|Overall Study|Withdrawal by Subject|1|||
33215715|NCT03538951|100688579|FG001|Overall Study|Withdrawal by Subject|2|||
33349280|NCT00896532|101164124|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
33349281|NCT00896532|101164125|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
33349282|NCT00896532|101164126|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
33349283|NCT00896532|101164127|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
33349284|NCT00896532|101164128|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
33349285|NCT00896532|101164129|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
33349286|NCT00896532|101164130|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
33349287|NCT00896532|101164131|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
33548744|NCT04591015|101908398|FG000|Overall Study|Lost to Follow-up|16|||
33548745|NCT04591015|101908399|FG001|Overall Study|Lost to Follow-up|11|||
33548746|NCT01910441|101908400|FG000|Overall Study|Sponsor decision|0|||
33548747|NCT01910441|101908401|FG001|Overall Study|Sponsor decision|2|||
33548748|NCT01910441|101908400|FG000|Overall Study|Lost to Follow-up|6|||
33548749|NCT01910441|101908401|FG001|Overall Study|Lost to Follow-up|5|||
33548750|NCT01910441|101908400|FG000|Overall Study|Withdrawal by Subject|0|||
33548751|NCT01910441|101908401|FG001|Overall Study|Withdrawal by Subject|1|||
33548752|NCT01910441|101908400|FG000|Overall Study|Non-compliance|0|||
33548753|NCT01910441|101908401|FG001|Overall Study|Non-compliance|1|||
33548754|NCT01910441|101908400|FG000|Overall Study|Adverse Event|1|||
33548755|NCT01910441|101908401|FG001|Overall Study|Adverse Event|0|||
33548756|NCT01910441|101908400|FG000|Overall Study|Physician Decision|0|||
33548757|NCT01910441|101908401|FG001|Overall Study|Physician Decision|1|||
33548758|NCT01350973|101908402|FG000|Overall Study|Adverse Event|4|||
33617808|NCT03350815|102147538|FG000|Period 2|Lost to Follow-up|0|||
33617809|NCT03350815|102147539|FG001|Period 2|Lost to Follow-up|3|||
33548759|NCT01350973|101908403|FG001|Overall Study|Adverse Event|7|||
33548760|NCT01350973|101908404|FG002|Overall Study|Adverse Event|7|||
33548761|NCT01350973|101908402|FG000|Overall Study|Voluntary Withdrawal|2|||
33548762|NCT01350973|101908403|FG001|Overall Study|Voluntary Withdrawal|1|||
33548763|NCT01350973|101908404|FG002|Overall Study|Voluntary Withdrawal|1|||
33548764|NCT02178956|101908410|FG000|Overall Study|Lost to Follow-up|4|||
33548765|NCT02178956|101908411|FG001|Overall Study|Lost to Follow-up|4|||
33548766|NCT02178956|101908410|FG000|Overall Study|Sponsor terminated study|49|||
33617810|NCT03350815|102147540|FG002|Period 2|Lost to Follow-up|3|||
33617811|NCT03350815|102147541|FG003|Period 2|Lost to Follow-up|0|||
33617812|NCT03350815|102147538|FG000|Period 2|Physician Decision|0|||
33215716|NCT03599349|100688596|FG000|Overall Study|Lost to Follow-up|1|||
33215717|NCT00677352|100688597|FG000|Treatment Phase|Adverse Event|14|||
33215718|NCT00677352|100688598|FG001|Treatment Phase|Adverse Event|22|||
33215719|NCT00677352|100688597|FG000|Treatment Phase|Lack of Efficacy|2|||
33215720|NCT00677352|100688598|FG001|Treatment Phase|Lack of Efficacy|3|||
33215721|NCT00677352|100688597|FG000|Treatment Phase|Lost to Follow-up|0|||
33215722|NCT00677352|100688598|FG001|Treatment Phase|Lost to Follow-up|1|||
33215723|NCT00677352|100688597|FG000|Treatment Phase|Withdrawal by Subject|7|||
33215724|NCT00677352|100688598|FG001|Treatment Phase|Withdrawal by Subject|7|||
33215725|NCT00677352|100688597|FG000|Treatment Phase|Physician Decision|1|||
33215726|NCT00677352|100688598|FG001|Treatment Phase|Physician Decision|0|||
33215727|NCT00677352|100688597|FG000|Treatment Phase|Pregnancy|0|||
33215728|NCT00677352|100688598|FG001|Treatment Phase|Pregnancy|1|||
33215729|NCT00677352|100688597|FG000|Treatment Phase|Protocol Violation|1|||
33215730|NCT00677352|100688598|FG001|Treatment Phase|Protocol Violation|1|||
33215731|NCT00677352|100688597|FG000|Treatment Phase|Transference or work related matter|0|||
33215732|NCT00677352|100688598|FG001|Treatment Phase|Transference or work related matter|5|||
33215733|NCT00677352|100688597|FG000|Treatment Phase|Not treated|0|||
33215734|NCT00677352|100688598|FG001|Treatment Phase|Not treated|2|||
33215735|NCT00677352|100688597|FG000|Tapering Phase|Adverse Event|1|||
33215736|NCT00677352|100688598|FG001|Tapering Phase|Adverse Event|5|||
33215737|NCT00677352|100688597|FG000|Tapering Phase|Withdrawal by Subject|5|||
33215738|NCT00677352|100688598|FG001|Tapering Phase|Withdrawal by Subject|3|||
33215739|NCT00677352|100688597|FG000|Tapering Phase|Pregnancy|0|||
33215740|NCT00677352|100688598|FG001|Tapering Phase|Pregnancy|1|||
33215741|NCT00677352|100688597|FG000|Tapering Phase|Job transfer|0|||
33215742|NCT00677352|100688598|FG001|Tapering Phase|Job transfer|1|||
33215743|NCT03365882|100688599|FG000|Randomization|Still Receiving Protocol Treatment|2|||
33215744|NCT03365882|100688600|FG001|Randomization|Still Receiving Protocol Treatment|0|||
33215745|NCT03365882|100688599|FG000|Randomization|Adverse Event|1|||
33215746|NCT03365882|100688600|FG001|Randomization|Adverse Event|2|||
33215747|NCT03365882|100688599|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
33215748|NCT03365882|100688600|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
33215749|NCT03365882|100688599|FG000|Randomization|Progression/Relapse|21|||
33215750|NCT03365882|100688600|FG001|Randomization|Progression/Relapse|3|||
33215751|NCT03365882|100688599|FG000|Randomization|Death|1|||
33215752|NCT03365882|100688600|FG001|Randomization|Death|0|||
33215753|NCT03365882|100688599|FG000|Randomization|Other - Not Protocol Specified|1|||
33215754|NCT03365882|100688600|FG001|Randomization|Other - Not Protocol Specified|1|||
33215755|NCT03365882|100688599|FG000|Randomization|Major Protocol Deviation|0|||
33215756|NCT03365882|100688600|FG001|Randomization|Major Protocol Deviation|1|||
33215757|NCT03365882|100688599|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
33215758|NCT03365882|100688600|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
33215759|NCT03365882|100688599|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
33215760|NCT03365882|100688600|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
33215761|NCT03365882|100688599|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
33215762|NCT03365882|100688600|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
33215763|NCT03365882|100688599|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
33215764|NCT03365882|100688600|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
33215765|NCT04205630|100688601|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
33215766|NCT04205630|100688601|FG000|Overall Study|Disease clinical progression|7|||
33215767|NCT04205630|100688601|FG000|Overall Study|Withdrawal by Subject|2|||
33215768|NCT04205630|100688601|FG000|Overall Study|Adverse Event|17|||
33215769|NCT04205630|100688601|FG000|Overall Study|Other|1|||
33215770|NCT01844284|100688606|FG000|Overall Study|Lost to Follow-up|12|||
33215771|NCT01844284|100688607|FG001|Overall Study|Lost to Follow-up|7|||
33215772|NCT00445679|100688611|FG000|Overall Study|Adverse Event|22|||
33215773|NCT00445679|100688612|FG001|Overall Study|Adverse Event|12|||
33215774|NCT00445679|100688613|FG002|Overall Study|Adverse Event|30|||
33215775|NCT00445679|100688614|FG003|Overall Study|Adverse Event|19|||
33349288|NCT00896532|101164132|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
33349289|NCT00896532|101164133|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
33548767|NCT02178956|101908411|FG001|Overall Study|Sponsor terminated study|58|||
33548768|NCT02178956|101908410|FG000|Overall Study|Withdrawal by Subject|15|||
33548769|NCT02178956|101908411|FG001|Overall Study|Withdrawal by Subject|11|||
33548770|NCT02178956|101908410|FG000|Overall Study|Various Reasons|3|||
33548771|NCT02178956|101908411|FG001|Overall Study|Various Reasons|5|||
33548772|NCT01970371|101908412|FG000|Overall Study|Death|8|||
33548773|NCT01970371|101908413|FG001|Overall Study|Death|13|||
33548774|NCT01970371|101908414|FG002|Overall Study|Death|12|||
33548775|NCT01970371|101908412|FG000|Overall Study|Lost to Follow-up|0|||
33548776|NCT01970371|101908413|FG001|Overall Study|Lost to Follow-up|0|||
33548777|NCT01970371|101908414|FG002|Overall Study|Lost to Follow-up|1|||
33548778|NCT01901562|101908420|FG000|Overall Study|Protocol Violation|5|||
33548779|NCT01901562|101908420|FG000|Overall Study|Excluded intraoperatively|4|||
33548780|NCT00876343|101908421|FG000|Overall Study|Adverse Event|7|||
33548781|NCT00876343|101908422|FG001|Overall Study|Adverse Event|8|||
33548782|NCT00876343|101908423|FG002|Overall Study|Adverse Event|2|||
33548783|NCT00876343|101908421|FG000|Overall Study|Withdrawal by Subject|4|||
33548784|NCT00876343|101908422|FG001|Overall Study|Withdrawal by Subject|4|||
33548785|NCT00876343|101908423|FG002|Overall Study|Withdrawal by Subject|3|||
33548786|NCT00876343|101908421|FG000|Overall Study|Lack of Efficacy|0|||
33548787|NCT00876343|101908422|FG001|Overall Study|Lack of Efficacy|0|||
33548788|NCT00876343|101908423|FG002|Overall Study|Lack of Efficacy|1|||
33548789|NCT00876343|101908421|FG000|Overall Study|Protocol Violation|4|||
33548790|NCT00876343|101908422|FG001|Overall Study|Protocol Violation|1|||
33548791|NCT00876343|101908423|FG002|Overall Study|Protocol Violation|1|||
33548792|NCT00876343|101908421|FG000|Overall Study|Physician Decision|0|||
33215776|NCT00445679|100688611|FG000|Overall Study|Failed to return|1|||
33215777|NCT00445679|100688612|FG001|Overall Study|Failed to return|3|||
33548793|NCT00876343|101908422|FG001|Overall Study|Physician Decision|1|||
33548794|NCT00876343|101908423|FG002|Overall Study|Physician Decision|1|||
33548795|NCT00876343|101908421|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
33548796|NCT00876343|101908422|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
33548797|NCT00876343|101908423|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
33215778|NCT00445679|100688613|FG002|Overall Study|Failed to return|2|||
33215779|NCT00445679|100688614|FG003|Overall Study|Failed to return|2|||
33215780|NCT00445679|100688611|FG000|Overall Study|Physician Decision|0|||
33215781|NCT00445679|100688612|FG001|Overall Study|Physician Decision|0|||
33215782|NCT00445679|100688613|FG002|Overall Study|Physician Decision|1|||
33409941|NCT03426995|101389395|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33548798|NCT00876343|101908421|FG000|Overall Study|Change of residence or other commitments|2|||
33548799|NCT00876343|101908422|FG001|Overall Study|Change of residence or other commitments|2|||
33548800|NCT00876343|101908423|FG002|Overall Study|Change of residence or other commitments|3|||
33548801|NCT02737618|101908425|FG000|Overall Study|Withdrawal by Subject|9|||
33548802|NCT01407367|101908426|FG000|Overall Study|Death|24|||
33548803|NCT01407367|101908427|FG001|Overall Study|Death|32|||
33548804|NCT01407367|101908426|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
33548805|NCT01407367|101908427|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
33548806|NCT01407367|101908426|FG000|Overall Study|Withdrawal by Subject|4|||
33548807|NCT01407367|101908427|FG001|Overall Study|Withdrawal by Subject|15|||
33548808|NCT01407367|101908426|FG000|Overall Study|Lost to Follow-up|0|||
33215783|NCT00445679|100688614|FG003|Overall Study|Physician Decision|0|||
33215784|NCT00445679|100688611|FG000|Overall Study|Lost to Follow-up|10|||
33215785|NCT00445679|100688612|FG001|Overall Study|Lost to Follow-up|6|||
33215786|NCT00445679|100688613|FG002|Overall Study|Lost to Follow-up|6|||
33215787|NCT00445679|100688614|FG003|Overall Study|Lost to Follow-up|5|||
33349290|NCT00896532|101164134|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
33215788|NCT00445679|100688611|FG000|Overall Study|Compliance|3|||
33215789|NCT00445679|100688612|FG001|Overall Study|Compliance|2|||
33215790|NCT00445679|100688613|FG002|Overall Study|Compliance|1|||
33215791|NCT00445679|100688614|FG003|Overall Study|Compliance|2|||
33349291|NCT00896532|101164135|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
33349292|NCT00896532|101164136|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
33349293|NCT00896532|101164137|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
33349294|NCT00896532|101164138|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
33349295|NCT00896532|101164139|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
33349296|NCT00896532|101164140|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
33349297|NCT00896532|101164141|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
33349298|NCT00896532|101164142|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
33548809|NCT01407367|101908427|FG001|Overall Study|Lost to Follow-up|2|||
33548810|NCT02774278|101908428|FG000|Overall Study|Lack of Efficacy|199|||
33548811|NCT02774278|101908428|FG000|Overall Study|Death|29|||
33548812|NCT02774278|101908428|FG000|Overall Study|Adverse event/intercurrent illness|16|||
33548813|NCT02774278|101908428|FG000|Overall Study|Refused treatment/did not cooperate|9|||
33548814|NCT02774278|101908428|FG000|Overall Study|Administrative reasons|6|||
33548815|NCT02774278|101908428|FG000|Overall Study|Withdrawal by Subject|3|||
33548816|NCT02774278|101908428|FG000|Overall Study|Protocol Violation|2|||
33349299|NCT00896532|101164143|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
33349300|NCT00896532|101164144|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
33349301|NCT00896532|101164145|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
33349302|NCT00896532|101164146|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
33349303|NCT00896532|101164124|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349304|NCT00896532|101164125|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349305|NCT00896532|101164126|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349306|NCT00896532|101164127|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349307|NCT00896532|101164128|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349308|NCT00896532|101164129|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349309|NCT00896532|101164130|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349310|NCT00896532|101164131|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349311|NCT00896532|101164132|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33409942|NCT03426995|101389396|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33548817|NCT03770455|101908431|FG000|Overall Study|Screen failures|3|||
33548818|NCT00433290|101908432|FG000|Overall Study|Adverse Event|24|||
33548819|NCT00433290|101908433|FG001|Overall Study|Adverse Event|7|||
33215792|NCT00445679|100688611|FG000|Overall Study|Withdrawal of Informed Consent|0|||
33215793|NCT00445679|100688612|FG001|Overall Study|Withdrawal of Informed Consent|0|||
33215794|NCT00445679|100688613|FG002|Overall Study|Withdrawal of Informed Consent|1|||
33215795|NCT00445679|100688614|FG003|Overall Study|Withdrawal of Informed Consent|0|||
33617813|NCT03350815|102147539|FG001|Period 2|Physician Decision|0|||
33617814|NCT03350815|102147540|FG002|Period 2|Physician Decision|1|||
33617815|NCT03350815|102147541|FG003|Period 2|Physician Decision|0|||
33617816|NCT03350815|102147538|FG000|Period 2|Withdrawal by Subject|0|||
33617817|NCT03350815|102147539|FG001|Period 2|Withdrawal by Subject|3|||
33617818|NCT03350815|102147540|FG002|Period 2|Withdrawal by Subject|4|||
33617819|NCT03350815|102147541|FG003|Period 2|Withdrawal by Subject|0|||
33617820|NCT03350815|102147538|FG000|Period 2|Lack of Efficacy|0|||
33617821|NCT03350815|102147539|FG001|Period 2|Lack of Efficacy|6|||
33617822|NCT03350815|102147540|FG002|Period 2|Lack of Efficacy|2|||
33617823|NCT03350815|102147541|FG003|Period 2|Lack of Efficacy|0|||
33617824|NCT03350815|102147538|FG000|Period 2|Protocol Violation|0|||
33617825|NCT03350815|102147539|FG001|Period 2|Protocol Violation|0|||
33617826|NCT03350815|102147540|FG002|Period 2|Protocol Violation|1|||
33617827|NCT03350815|102147541|FG003|Period 2|Protocol Violation|0|||
33617828|NCT03350815|102147538|FG000|Period 2|New therapy for study indication|0|||
33617829|NCT03350815|102147539|FG001|Period 2|New therapy for study indication|0|||
33617830|NCT03350815|102147540|FG002|Period 2|New therapy for study indication|1|||
33617831|NCT03350815|102147541|FG003|Period 2|New therapy for study indication|0|||
33617832|NCT02100475|102147542|FG000|Overall Study|Unclassified|1|||
33617833|NCT02100475|102147543|FG001|Overall Study|Unclassified|2|||
33617834|NCT02100475|102147542|FG000|Overall Study|Withdrawal criteria|1|||
33617835|NCT02100475|102147543|FG001|Overall Study|Withdrawal criteria|0|||
33617836|NCT02429830|102147546|FG000|Overall Study|Lost to Follow-up|1|||
33617837|NCT02429830|102147546|FG000|Overall Study|Device Explant|2|||
33617838|NCT02644343|102147547|FG000|Overall Study|Withdrawal by Subject|1|||
33617839|NCT04524364|102147548|FG000|Overall Study|Physician Decision|3|||
33617840|NCT04524364|102147549|FG001|Overall Study|Physician Decision|6|||
33617841|NCT04524364|102147548|FG000|Overall Study|Adverse Event|0|||
33617842|NCT04524364|102147549|FG001|Overall Study|Adverse Event|1|||
33617843|NCT04524364|102147548|FG000|Overall Study|Investigational device deficiency|0|||
33617844|NCT04524364|102147549|FG001|Overall Study|Investigational device deficiency|1|||
33617845|NCT04524364|102147548|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
33617846|NCT04524364|102147549|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
33617847|NCT04524364|102147548|FG000|Overall Study|Device unavailability|0|||
33617848|NCT04524364|102147549|FG001|Overall Study|Device unavailability|2|||
33617849|NCT04524364|102147548|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
33617850|NCT04524364|102147549|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
33617851|NCT04524364|102147548|FG000|Overall Study|Low International normalized ratio (INR)|1|||
33617852|NCT04524364|102147549|FG001|Overall Study|Low International normalized ratio (INR)|0|||
33617853|NCT02709330|102147550|FG000|Overall Study|Death|5|||
33349312|NCT00896532|101164133|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349313|NCT00896532|101164134|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33409943|NCT03426995|101389397|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33617854|NCT02709330|102147551|FG001|Overall Study|Death|0|||
33617855|NCT02709330|102147550|FG000|Overall Study|Lost to Follow-up|2|||
33617856|NCT02709330|102147551|FG001|Overall Study|Lost to Follow-up|0|||
33617857|NCT02709330|102147550|FG000|Overall Study|Physician Decision|2|||
33617858|NCT02709330|102147551|FG001|Overall Study|Physician Decision|0|||
33617859|NCT02709330|102147550|FG000|Overall Study|Withdrawal by Subject|4|||
33617860|NCT02709330|102147551|FG001|Overall Study|Withdrawal by Subject|0|||
33617861|NCT03738618|102147552|FG000|Overall Study|Protocol deviation|23|||
33617862|NCT03738618|102147553|FG001|Overall Study|Protocol deviation|0|||
33617863|NCT03738618|102147552|FG000|Overall Study|Adverse Event|4|||
33617864|NCT03738618|102147553|FG001|Overall Study|Adverse Event|0|||
33617865|NCT03738618|102147552|FG000|Overall Study|Lost to Follow-up|2|||
33617866|NCT03738618|102147553|FG001|Overall Study|Lost to Follow-up|0|||
33617867|NCT03738618|102147552|FG000|Overall Study|Randomization failure|1|||
33617868|NCT03738618|102147553|FG001|Overall Study|Randomization failure|0|||
33617869|NCT03738618|102147552|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
33617870|NCT03738618|102147553|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
33617871|NCT03738618|102147552|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
33215796|NCT00445679|100688611|FG000|Overall Study|Protocol Violation|2|||
33215797|NCT00445679|100688612|FG001|Overall Study|Protocol Violation|3|||
33215798|NCT00445679|100688613|FG002|Overall Study|Protocol Violation|3|||
33617872|NCT03738618|102147553|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
33617873|NCT01835158|102147554|FG000|Overall Study|Withdrawal by Subject|1|||
33617874|NCT01835158|102147555|FG001|Overall Study|Withdrawal by Subject|6|||
33617875|NCT05786508|102147556|FG000|Overall Study|Withdrawal by Subject|2|||
33617876|NCT05786508|102147557|FG001|Overall Study|Withdrawal by Subject|0|||
33617877|NCT00337207|102147558|FG000|Overall Study|Withdrawal by Subject|3|||
33617878|NCT04417361|102147566|FG000|Overall Study|Withdrawal by Subject|1|||
33617879|NCT04417361|102147567|FG001|Overall Study|Withdrawal by Subject|0|||
33215799|NCT00445679|100688614|FG003|Overall Study|Protocol Violation|1|||
33617880|NCT04417361|102147566|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
33215800|NCT00445679|100688611|FG000|Overall Study|Withdrawal by Subject|8|||
33215801|NCT00445679|100688612|FG001|Overall Study|Withdrawal by Subject|14|||
33215802|NCT00445679|100688613|FG002|Overall Study|Withdrawal by Subject|20|||
33215803|NCT00445679|100688614|FG003|Overall Study|Withdrawal by Subject|18|||
33215804|NCT00445679|100688611|FG000|Overall Study|Lack of Efficacy|2|||
33215805|NCT00445679|100688612|FG001|Overall Study|Lack of Efficacy|6|||
33215806|NCT00445679|100688613|FG002|Overall Study|Lack of Efficacy|2|||
33215807|NCT00445679|100688614|FG003|Overall Study|Lack of Efficacy|0|||
33215808|NCT02657031|100688618|FG000|Overall Study|Adverse Event|1|||
33215809|NCT02657031|100688619|FG001|Overall Study|Adverse Event|2|||
33215810|NCT00224874|100688623|FG000|Overall Study|Withdrawal by Subject|0|||
33215811|NCT00224874|100688624|FG001|Overall Study|Withdrawal by Subject|0|||
33215812|NCT00224874|100688625|FG002|Overall Study|Withdrawal by Subject|1|||
33215813|NCT00224874|100688626|FG003|Overall Study|Withdrawal by Subject|0|||
33215814|NCT01471054|100688630|FG000|Overall Study|Study terminated prematurely|4|||
33215815|NCT01471054|100688631|FG001|Overall Study|Study terminated prematurely|0|||
33349314|NCT00896532|101164135|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349315|NCT00896532|101164136|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349316|NCT00896532|101164137|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349317|NCT00896532|101164138|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349318|NCT00896532|101164139|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349319|NCT00896532|101164140|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
33349320|NCT00896532|101164141|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349321|NCT00896532|101164142|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33215816|NCT01800968|100688632|FG000|Overall Study|Death|23|||
33215817|NCT01800968|100688633|FG001|Overall Study|Death|16|||
33215818|NCT01800968|100688632|FG000|Overall Study|Lost to Follow-up|5|||
33215819|NCT01800968|100688633|FG001|Overall Study|Lost to Follow-up|7|||
33215820|NCT01800968|100688632|FG000|Overall Study|Withdrawal by Subject|7|||
33215821|NCT01800968|100688633|FG001|Overall Study|Withdrawal by Subject|9|||
33215822|NCT01800968|100688632|FG000|Overall Study|Physician Decision|1|||
33215823|NCT01800968|100688633|FG001|Overall Study|Physician Decision|0|||
33349322|NCT00896532|101164143|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349323|NCT00896532|101164144|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349324|NCT00896532|101164145|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349325|NCT00896532|101164146|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
33349326|NCT00896532|101164124|FG000|Months 48-72: Follow-on Phase|Death|0|||
33349327|NCT00896532|101164125|FG001|Months 48-72: Follow-on Phase|Death|0|||
33349328|NCT00896532|101164126|FG002|Months 48-72: Follow-on Phase|Death|0|||
33349329|NCT00896532|101164127|FG003|Months 48-72: Follow-on Phase|Death|0|||
33349330|NCT00896532|101164128|FG004|Months 48-72: Follow-on Phase|Death|0|||
33349331|NCT00896532|101164129|FG005|Months 48-72: Follow-on Phase|Death|0|||
33349332|NCT00896532|101164130|FG006|Months 48-72: Follow-on Phase|Death|0|||
33349333|NCT00896532|101164131|FG007|Months 48-72: Follow-on Phase|Death|0|||
33349334|NCT00896532|101164132|FG008|Months 48-72: Follow-on Phase|Death|0|||
33409944|NCT03426995|101389398|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33409945|NCT03426995|101389399|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33548820|NCT00433290|101908432|FG000|Overall Study|Lack of Efficacy|1|||
33548821|NCT00433290|101908433|FG001|Overall Study|Lack of Efficacy|5|||
33548822|NCT00433290|101908432|FG000|Overall Study|Withdrawal by Subject|4|||
33548823|NCT00433290|101908433|FG001|Overall Study|Withdrawal by Subject|2|||
33548824|NCT00433290|101908432|FG000|Overall Study|Protocol Violation|3|||
33548825|NCT00433290|101908433|FG001|Overall Study|Protocol Violation|2|||
33548826|NCT00433290|101908432|FG000|Overall Study|Physician Decision|2|||
33548827|NCT00433290|101908433|FG001|Overall Study|Physician Decision|0|||
33409946|NCT03426995|101389400|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33409947|NCT03426995|101389401|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33409948|NCT03426995|101389402|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33409949|NCT03426995|101389403|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
33548828|NCT00433290|101908432|FG000|Overall Study|Entry Criteria Not Met|0|||
33548829|NCT00433290|101908433|FG001|Overall Study|Entry Criteria Not Met|1|||
33548830|NCT00433290|101908432|FG000|Overall Study|Lost to Follow-up|1|||
33548831|NCT00433290|101908433|FG001|Overall Study|Lost to Follow-up|0|||
33548832|NCT02008370|101908436|FG000|Overall Study|Lost to Follow-up|7|||
33548833|NCT03624036|101908441|FG000|Overall Study|Death|2|||
33215824|NCT04058353|100688636|FG000|Overall Study|Adverse Event|2|||
33548834|NCT03624036|101908442|FG001|Overall Study|Death|3|||
33548835|NCT03624036|101908443|FG002|Overall Study|Death|0|||
33215825|NCT04058353|100688637|FG001|Overall Study|Adverse Event|1|||
33215826|NCT04058353|100688636|FG000|Overall Study|Physician Decision|1|||
33215827|NCT04058353|100688637|FG001|Overall Study|Physician Decision|0|||
33215828|NCT04058353|100688636|FG000|Overall Study|Other|1|||
33215829|NCT04058353|100688637|FG001|Overall Study|Other|0|||
33215830|NCT02495025|100688641|FG000|Overall Study|Lost to Follow-up|21|||
33548836|NCT03624036|101908444|FG003|Overall Study|Death|1|||
33548837|NCT03624036|101908441|FG000|Overall Study|Withdrawal by Subject|1|||
33548838|NCT03624036|101908442|FG001|Overall Study|Withdrawal by Subject|0|||
33548839|NCT03624036|101908443|FG002|Overall Study|Withdrawal by Subject|1|||
33548840|NCT03624036|101908444|FG003|Overall Study|Withdrawal by Subject|0|||
33548841|NCT03624036|101908441|FG000|Overall Study|Enrolled but Never Treated|1|||
33548842|NCT03624036|101908442|FG001|Overall Study|Enrolled but Never Treated|0|||
33548843|NCT03624036|101908443|FG002|Overall Study|Enrolled but Never Treated|0|||
33617881|NCT04417361|102147567|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
33215831|NCT02495025|100688642|FG001|Overall Study|Lost to Follow-up|14|||
33215832|NCT02495025|100688641|FG000|Overall Study|Withdrawal by Subject|5|||
33215833|NCT02495025|100688642|FG001|Overall Study|Withdrawal by Subject|0|||
33215834|NCT01298999|100688645|FG000|Overall Study|Physician Decision|0|||
33215835|NCT01298999|100688646|FG001|Overall Study|Physician Decision|1|||
33215836|NCT01298999|100688645|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
33215837|NCT01298999|100688646|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
33215838|NCT00316082|100688647|FG000|Overall Study|Lack of Efficacy|2|||
33215839|NCT00316082|100688648|FG001|Overall Study|Lack of Efficacy|3|||
33215840|NCT00316082|100688649|FG002|Overall Study|Lack of Efficacy|3|||
33215841|NCT00316082|100688650|FG003|Overall Study|Lack of Efficacy|4|||
33215842|NCT00316082|100688651|FG004|Overall Study|Lack of Efficacy|6|||
33215843|NCT00316082|100688647|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
33215844|NCT00316082|100688648|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
33215845|NCT00316082|100688649|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
33215846|NCT00316082|100688650|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
33215847|NCT00316082|100688651|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
33215848|NCT00316082|100688647|FG000|Overall Study|Lost to Follow-up|7|||
33215849|NCT00316082|100688648|FG001|Overall Study|Lost to Follow-up|6|||
33617882|NCT01970306|102147568|FG000|Overall Study|Not eligible|3|||
33617883|NCT01970306|102147568|FG000|Overall Study|Not able to be treated|9|||
33215850|NCT00316082|100688649|FG002|Overall Study|Lost to Follow-up|7|||
33215851|NCT00316082|100688650|FG003|Overall Study|Lost to Follow-up|8|||
33215852|NCT00316082|100688651|FG004|Overall Study|Lost to Follow-up|6|||
33215853|NCT00316082|100688647|FG000|Overall Study|Poor/noncompliance|6|||
33215854|NCT00316082|100688648|FG001|Overall Study|Poor/noncompliance|1|||
33215855|NCT00316082|100688649|FG002|Overall Study|Poor/noncompliance|4|||
33215856|NCT00316082|100688650|FG003|Overall Study|Poor/noncompliance|1|||
33215857|NCT00316082|100688651|FG004|Overall Study|Poor/noncompliance|4|||
33215858|NCT00316082|100688647|FG000|Overall Study|Adverse Event|4|||
33215859|NCT00316082|100688648|FG001|Overall Study|Adverse Event|2|||
33215860|NCT00316082|100688649|FG002|Overall Study|Adverse Event|5|||
33215861|NCT00316082|100688650|FG003|Overall Study|Adverse Event|1|||
33215862|NCT00316082|100688651|FG004|Overall Study|Adverse Event|3|||
33349335|NCT00896532|101164133|FG009|Months 48-72: Follow-on Phase|Death|0|||
33349336|NCT00896532|101164134|FG010|Months 48-72: Follow-on Phase|Death|0|||
33548844|NCT03624036|101908444|FG003|Overall Study|Enrolled but Never Treated|0|||
33548845|NCT03624036|101908441|FG000|Overall Study|Reason not Specified|3|||
33548846|NCT03624036|101908442|FG001|Overall Study|Reason not Specified|0|||
33617884|NCT04538664|102147569|FG000|Overall Study|Withdrawal by Subject|5|||
33617885|NCT04538664|102147570|FG001|Overall Study|Withdrawal by Subject|9|||
33617886|NCT04538664|102147569|FG000|Overall Study|Lost to Follow-up|2|||
33617887|NCT04538664|102147570|FG001|Overall Study|Lost to Follow-up|1|||
33617888|NCT04538664|102147569|FG000|Overall Study|Ongoing|106|||
33617889|NCT04538664|102147570|FG001|Overall Study|Ongoing|115|||
33617890|NCT00080301|102151401|FG000|Overall Study|Randomized but Never Treated|5|||
33617891|NCT00080301|102151402|FG001|Overall Study|Randomized but Never Treated|10|||
33617892|NCT00080301|102151401|FG000|Overall Study|Still on Treatment as of CSR date|0|||
33617893|NCT00080301|102151402|FG001|Overall Study|Still on Treatment as of CSR date|1|||
33617894|NCT02291419|102151403|FG000|Overall Study|Early study termination|1|||
33617895|NCT02291419|102151404|FG001|Overall Study|Early study termination|5|||
33617896|NCT01036321|102151406|FG000|Overall Study|Ineligible after randomization|0|||
33215863|NCT00316082|100688647|FG000|Overall Study|Subject no longer meets study criteria|3|||
33215864|NCT00316082|100688648|FG001|Overall Study|Subject no longer meets study criteria|1|||
33215865|NCT00316082|100688649|FG002|Overall Study|Subject no longer meets study criteria|2|||
33215866|NCT00316082|100688650|FG003|Overall Study|Subject no longer meets study criteria|2|||
33215867|NCT00316082|100688651|FG004|Overall Study|Subject no longer meets study criteria|1|||
33215868|NCT00316082|100688647|FG000|Overall Study|Physician Decision|1|||
33548847|NCT03624036|101908443|FG002|Overall Study|Reason not Specified|2|||
33548848|NCT03624036|101908444|FG003|Overall Study|Reason not Specified|2|||
33617897|NCT01036321|102151407|FG001|Overall Study|Ineligible after randomization|1|||
33617898|NCT01036321|102151406|FG000|Overall Study|Withdrawal by Subject|3|||
33548849|NCT04925934|101908445|FG000|Overall Study|Adverse Event|1|||
33548850|NCT04925934|101908446|FG001|Overall Study|Adverse Event|0|||
33548851|NCT04925934|101908447|FG002|Overall Study|Adverse Event|0|||
33548852|NCT04925934|101908445|FG000|Overall Study|Lost to Follow-up|2|||
33548853|NCT04925934|101908446|FG001|Overall Study|Lost to Follow-up|0|||
33617899|NCT01036321|102151407|FG001|Overall Study|Withdrawal by Subject|2|||
33617900|NCT01036321|102151406|FG000|Overall Study|Adverse Event|2|||
33215869|NCT00316082|100688648|FG001|Overall Study|Physician Decision|1|||
33215870|NCT00316082|100688649|FG002|Overall Study|Physician Decision|2|||
33215871|NCT00316082|100688650|FG003|Overall Study|Physician Decision|1|||
33215872|NCT00316082|100688651|FG004|Overall Study|Physician Decision|1|||
33215873|NCT00316082|100688647|FG000|Overall Study|Death|0|||
33215874|NCT00316082|100688648|FG001|Overall Study|Death|0|||
33215875|NCT00316082|100688649|FG002|Overall Study|Death|1|||
33215876|NCT00316082|100688650|FG003|Overall Study|Death|0|||
33215877|NCT00316082|100688651|FG004|Overall Study|Death|0|||
33215878|NCT00316082|100688647|FG000|Overall Study|Administrative reason by sponsor|0|||
33215879|NCT00316082|100688648|FG001|Overall Study|Administrative reason by sponsor|0|||
33215880|NCT00316082|100688649|FG002|Overall Study|Administrative reason by sponsor|1|||
33215881|NCT00316082|100688650|FG003|Overall Study|Administrative reason by sponsor|0|||
33215882|NCT00316082|100688651|FG004|Overall Study|Administrative reason by sponsor|0|||
33215883|NCT00689221|100688652|FG000|Overall Study|Ongoing at cut-off date|39|||
33215884|NCT00689221|100688653|FG001|Overall Study|Ongoing at cut-off date|36|||
33215885|NCT01688466|100688654|FG000|Overall Study|Withdrawal by Subject|2|||
33215886|NCT01688466|100688655|FG001|Overall Study|Withdrawal by Subject|1|||
33215887|NCT01688466|100688654|FG000|Overall Study|Death|0|||
33215888|NCT01688466|100688655|FG001|Overall Study|Death|1|||
33215889|NCT01688466|100688654|FG000|Overall Study|Adverse Event|0|||
33215890|NCT01688466|100688655|FG001|Overall Study|Adverse Event|4|||
33215891|NCT01688466|100688654|FG000|Overall Study|Not evaluable|0|||
33215892|NCT01688466|100688655|FG001|Overall Study|Not evaluable|1|||
33215893|NCT03945188|100688657|FG000|Overall Study|Protocol Violation|1|||
33215894|NCT03945188|100688658|FG001|Overall Study|Protocol Violation|0|||
33215895|NCT03945188|100688657|FG000|Overall Study|Disease worsening|79|||
33215896|NCT03945188|100688658|FG001|Overall Study|Disease worsening|73|||
33215897|NCT03945188|100688657|FG000|Overall Study|Physician Decision|2|||
33215898|NCT03945188|100688658|FG001|Overall Study|Physician Decision|2|||
33215899|NCT03945188|100688657|FG000|Overall Study|Lack of Efficacy|7|||
33215900|NCT03945188|100688658|FG001|Overall Study|Lack of Efficacy|4|||
33215901|NCT03945188|100688657|FG000|Overall Study|Pregnancy|2|||
33215902|NCT03945188|100688658|FG001|Overall Study|Pregnancy|0|||
33215903|NCT03945188|100688657|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
33215904|NCT03945188|100688658|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
33617901|NCT01036321|102151407|FG001|Overall Study|Adverse Event|1|||
33617902|NCT03801174|102151415|FG000|Overall Study|Withdrawal by Subject|14|||
33215905|NCT03945188|100688657|FG000|Overall Study|Adverse Event|10|||
33215906|NCT03945188|100688658|FG001|Overall Study|Adverse Event|5|||
33215907|NCT03945188|100688657|FG000|Overall Study|Other|2|||
33215908|NCT03945188|100688658|FG001|Overall Study|Other|2|||
33215909|NCT03945188|100688657|FG000|Overall Study|Lost to Follow-up|1|||
33215910|NCT03945188|100688658|FG001|Overall Study|Lost to Follow-up|2|||
33215911|NCT00530855|100688664|FG000|Overall Study|Lack of Efficacy|20|||
33215912|NCT00530855|100688664|FG000|Overall Study|Withdrawal by Subject|30|||
33215913|NCT00530855|100688664|FG000|Overall Study|Fatal Serious AE|3|||
33215914|NCT00530855|100688664|FG000|Overall Study|Non Fatal Serious AE|7|||
33215915|NCT00530855|100688664|FG000|Overall Study|Non Fatal Non Serious AE|12|||
33215916|NCT00530855|100688664|FG000|Overall Study|Protocol Violation|3|||
33215917|NCT00530855|100688664|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
33215918|NCT00530855|100688664|FG000|Overall Study|Lost to Follow-up|9|||
33215919|NCT00530855|100688664|FG000|Overall Study|Other reason for premature termination|17|||
33215920|NCT00645164|100688665|FG000|Overall Study|Lost to Follow-up|2|||
33215921|NCT00645164|100688665|FG000|Overall Study|Withdrawal by Subject|4|||
33215922|NCT00645164|100688665|FG000|Overall Study|Protocol Violation|1|||
33215923|NCT00952822|100688666|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
33215924|NCT00952822|100688667|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
33215925|NCT00952822|100688668|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
33215926|NCT00952822|100688669|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
33215927|NCT00952822|100688666|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
33215928|NCT00952822|100688667|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
33215929|NCT00952822|100688668|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
33215930|NCT00952822|100688669|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
33215931|NCT00683644|100688678|FG000|Overall Study|Withdrawal by Subject|4|||
33215932|NCT00683644|100688679|FG001|Overall Study|Withdrawal by Subject|2|||
33215933|NCT00683644|100688678|FG000|Overall Study|Lost to Follow-up|1|||
33215934|NCT00683644|100688679|FG001|Overall Study|Lost to Follow-up|4|||
33215935|NCT00683644|100688678|FG000|Overall Study|Adverse Event|1|||
33548854|NCT04925934|101908447|FG002|Overall Study|Lost to Follow-up|1|||
33548855|NCT04925934|101908445|FG000|Overall Study|Death|0|||
33617903|NCT03801174|102151416|FG001|Overall Study|Withdrawal by Subject|15|||
33617904|NCT03801174|102151415|FG000|Overall Study|Death|1|||
33617905|NCT03801174|102151416|FG001|Overall Study|Death|0|||
33215936|NCT00683644|100688679|FG001|Overall Study|Adverse Event|2|||
33215937|NCT00683644|100688678|FG000|Overall Study|Low copper, other health problems,|7|||
33349337|NCT00896532|101164135|FG011|Months 48-72: Follow-on Phase|Death|0|||
33349338|NCT00896532|101164136|FG012|Months 48-72: Follow-on Phase|Death|0|||
33349339|NCT00896532|101164137|FG013|Months 48-72: Follow-on Phase|Death|0|||
33349340|NCT00896532|101164138|FG014|Months 48-72: Follow-on Phase|Death|0|||
33349341|NCT00896532|101164139|FG015|Months 48-72: Follow-on Phase|Death|0|||
33548856|NCT04925934|101908446|FG001|Overall Study|Death|1|||
33548857|NCT04925934|101908447|FG002|Overall Study|Death|0|||
33548858|NCT04925934|101908445|FG000|Overall Study|Withdrawal by Subject|8|||
33548859|NCT04925934|101908446|FG001|Overall Study|Withdrawal by Subject|5|||
33548860|NCT04925934|101908447|FG002|Overall Study|Withdrawal by Subject|9|||
33548861|NCT04925934|101908445|FG000|Overall Study|Other|2|||
33548862|NCT04925934|101908446|FG001|Overall Study|Other|2|||
33548863|NCT04925934|101908447|FG002|Overall Study|Other|2|||
33548864|NCT04925934|101908445|FG000|Overall Study|Eastern European Conflict|7|||
33548865|NCT04925934|101908446|FG001|Overall Study|Eastern European Conflict|3|||
33548866|NCT04925934|101908447|FG002|Overall Study|Eastern European Conflict|2|||
33548867|NCT02582632|101908449|FG000|Overall Study|Other|1|||
33548868|NCT01405911|101908456|FG000|Overall Study|Pre-treatment lab AE|0|||
33548869|NCT01405911|101908457|FG001|Overall Study|Pre-treatment lab AE|1|||
33548870|NCT01405911|101908458|FG002|Overall Study|Pre-treatment lab AE|0|||
33548871|NCT01405911|101908456|FG000|Overall Study|Lost to Follow-up|0|||
33548872|NCT01405911|101908457|FG001|Overall Study|Lost to Follow-up|1|||
33548873|NCT01405911|101908458|FG002|Overall Study|Lost to Follow-up|0|||
33548874|NCT01405911|101908456|FG000|Overall Study|Protocol Violation|1|||
33548875|NCT01405911|101908457|FG001|Overall Study|Protocol Violation|0|||
33548876|NCT01405911|101908458|FG002|Overall Study|Protocol Violation|0|||
33548877|NCT01405911|101908456|FG000|Overall Study|Withdrawal by Subject|3|||
33548878|NCT01405911|101908457|FG001|Overall Study|Withdrawal by Subject|1|||
33548879|NCT01405911|101908458|FG002|Overall Study|Withdrawal by Subject|1|||
33548880|NCT01995201|101908461|FG000|From Baseline Until Week 24|Adverse Event|4|||
33548881|NCT01995201|101908462|FG001|From Baseline Until Week 24|Adverse Event|15|||
33548882|NCT01995201|101908463|FG002|From Baseline Until Week 24|Adverse Event|0|||
33548883|NCT01995201|101908464|FG003|From Baseline Until Week 24|Adverse Event|0|||
33548884|NCT01995201|101908465|FG004|From Baseline Until Week 24|Adverse Event|0|||
33548885|NCT01995201|101908466|FG005|From Baseline Until Week 24|Adverse Event|0|||
33548886|NCT01995201|101908467|FG006|From Baseline Until Week 24|Adverse Event|0|||
33548887|NCT01995201|101908461|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
33548888|NCT01995201|101908462|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
33548889|NCT01995201|101908463|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
33548890|NCT01995201|101908464|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
33548891|NCT01995201|101908465|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
33548892|NCT01995201|101908466|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
33548893|NCT01995201|101908467|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
33548894|NCT01995201|101908461|FG000|From Baseline Until Week 24|Death|0|||
33548895|NCT01995201|101908462|FG001|From Baseline Until Week 24|Death|1|||
33548896|NCT01995201|101908463|FG002|From Baseline Until Week 24|Death|0|||
33548897|NCT01995201|101908464|FG003|From Baseline Until Week 24|Death|0|||
33548898|NCT01995201|101908465|FG004|From Baseline Until Week 24|Death|0|||
33548899|NCT01995201|101908466|FG005|From Baseline Until Week 24|Death|0|||
33548900|NCT01995201|101908467|FG006|From Baseline Until Week 24|Death|0|||
33548901|NCT01995201|101908461|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
33548902|NCT01995201|101908462|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
33548903|NCT01995201|101908463|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
33548904|NCT01995201|101908464|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
33548905|NCT01995201|101908465|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
33548906|NCT01995201|101908466|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
33548907|NCT01995201|101908467|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
33548908|NCT01995201|101908461|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
33617906|NCT03801174|102151415|FG000|Overall Study|Pregnancy|2|||
33349342|NCT00896532|101164140|FG016|Months 48-72: Follow-on Phase|Death|0|||
33349343|NCT00896532|101164141|FG017|Months 48-72: Follow-on Phase|Death|0|||
33409950|NCT03426995|101389385|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33548909|NCT01995201|101908462|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
33349344|NCT00896532|101164142|FG018|Months 48-72: Follow-on Phase|Death|1|||
33548910|NCT01995201|101908463|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
33548911|NCT01995201|101908464|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
33548912|NCT01995201|101908465|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
33548913|NCT01995201|101908466|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
33617907|NCT03801174|102151416|FG001|Overall Study|Pregnancy|2|||
33548914|NCT01995201|101908467|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
33548915|NCT01995201|101908461|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
33548916|NCT01995201|101908462|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
33548917|NCT01995201|101908463|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
33548918|NCT01995201|101908464|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
33548919|NCT01995201|101908465|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
33548920|NCT01995201|101908466|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
33548921|NCT01995201|101908467|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
33548922|NCT01995201|101908461|FG000|From Baseline Until Week 24|Physician Decision|0|||
33548923|NCT01995201|101908462|FG001|From Baseline Until Week 24|Physician Decision|2|||
33548924|NCT01995201|101908463|FG002|From Baseline Until Week 24|Physician Decision|0|||
33548925|NCT01995201|101908464|FG003|From Baseline Until Week 24|Physician Decision|0|||
33548926|NCT01995201|101908465|FG004|From Baseline Until Week 24|Physician Decision|0|||
33548927|NCT01995201|101908466|FG005|From Baseline Until Week 24|Physician Decision|0|||
33548928|NCT01995201|101908467|FG006|From Baseline Until Week 24|Physician Decision|0|||
33548929|NCT01995201|101908461|FG000|From Baseline Until Week 24|Protocol Violation|0|||
33548930|NCT01995201|101908462|FG001|From Baseline Until Week 24|Protocol Violation|9|||
33548931|NCT01995201|101908463|FG002|From Baseline Until Week 24|Protocol Violation|0|||
33548932|NCT01995201|101908464|FG003|From Baseline Until Week 24|Protocol Violation|0|||
33548933|NCT01995201|101908465|FG004|From Baseline Until Week 24|Protocol Violation|0|||
33548934|NCT01995201|101908466|FG005|From Baseline Until Week 24|Protocol Violation|0|||
33548935|NCT01995201|101908467|FG006|From Baseline Until Week 24|Protocol Violation|0|||
33548936|NCT01995201|101908461|FG000|From Week 24 Until Week 48|Adverse Event|0|||
33548937|NCT01995201|101908462|FG001|From Week 24 Until Week 48|Adverse Event|0|||
33548938|NCT01995201|101908463|FG002|From Week 24 Until Week 48|Adverse Event|2|||
33548939|NCT01995201|101908464|FG003|From Week 24 Until Week 48|Adverse Event|1|||
33215938|NCT00683644|100688679|FG001|Overall Study|Low copper, other health problems,|6|||
33215939|NCT02822222|100688680|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
33215940|NCT02822222|100688681|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
33215941|NCT02985866|100688685|FG000|Overall Study|Poor CGM data|1|||
33215942|NCT02985866|100688686|FG001|Overall Study|Poor CGM data|1|||
33215943|NCT02723864|100688687|FG000|Overall Study|Refused further treatment|1|||
33215944|NCT02723864|100688688|FG001|Overall Study|Refused further treatment|0|||
33215945|NCT02723864|100688689|FG002|Overall Study|Refused further treatment|0|||
33215946|NCT02723864|100688690|FG003|Overall Study|Refused further treatment|0|||
33215947|NCT02723864|100688691|FG004|Overall Study|Refused further treatment|1|||
33215948|NCT02723864|100688692|FG005|Overall Study|Refused further treatment|2|||
33215949|NCT02723864|100688693|FG006|Overall Study|Refused further treatment|0|||
33215950|NCT02723864|100688687|FG000|Overall Study|Exceed treatment hold time|0|||
33215951|NCT02723864|100688688|FG001|Overall Study|Exceed treatment hold time|1|||
33349345|NCT00896532|101164143|FG019|Months 48-72: Follow-on Phase|Death|0|||
33349346|NCT00896532|101164144|FG020|Months 48-72: Follow-on Phase|Death|0|||
33349347|NCT00896532|101164145|FG021|Months 48-72: Follow-on Phase|Death|0|||
33349348|NCT00896532|101164146|FG022|Months 48-72: Follow-on Phase|Death|0|||
33349349|NCT00896532|101164124|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349350|NCT00896532|101164125|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349351|NCT00896532|101164126|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349352|NCT00896532|101164127|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349353|NCT00896532|101164128|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349354|NCT00896532|101164129|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349355|NCT00896532|101164130|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349356|NCT00896532|101164131|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349357|NCT00896532|101164132|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349358|NCT00896532|101164133|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349359|NCT00896532|101164134|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349360|NCT00896532|101164135|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349361|NCT00896532|101164136|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349362|NCT00896532|101164137|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349363|NCT00896532|101164138|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349364|NCT00896532|101164139|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349365|NCT00896532|101164140|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349366|NCT00896532|101164141|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33548940|NCT01995201|101908465|FG004|From Week 24 Until Week 48|Adverse Event|1|||
33349367|NCT00896532|101164142|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33548941|NCT01995201|101908466|FG005|From Week 24 Until Week 48|Adverse Event|3|||
33548942|NCT01995201|101908467|FG006|From Week 24 Until Week 48|Adverse Event|1|||
33617908|NCT03801174|102151415|FG000|Overall Study|Lost to Follow-up|19|||
33215952|NCT02723864|100688689|FG002|Overall Study|Exceed treatment hold time|0|||
33215953|NCT02723864|100688690|FG003|Overall Study|Exceed treatment hold time|0|||
33349368|NCT00896532|101164143|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33409951|NCT03426995|101389386|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409952|NCT03426995|101389387|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409953|NCT03426995|101389388|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409954|NCT03426995|101389389|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409955|NCT03426995|101389390|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409956|NCT03426995|101389391|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409957|NCT03426995|101389392|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409958|NCT03426995|101389393|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409959|NCT03426995|101389394|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409960|NCT03426995|101389395|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409961|NCT03426995|101389396|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409962|NCT03426995|101389397|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409963|NCT03426995|101389398|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409964|NCT03426995|101389399|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
33409965|NCT03426995|101389400|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
33409966|NCT03426995|101389401|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409967|NCT03426995|101389402|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409968|NCT03426995|101389403|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
33409969|NCT03426995|101389385|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409970|NCT03426995|101389386|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409971|NCT03426995|101389387|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409972|NCT03426995|101389388|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409973|NCT03426995|101389389|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409974|NCT03426995|101389390|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409975|NCT03426995|101389391|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409976|NCT03426995|101389392|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409977|NCT03426995|101389393|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409978|NCT03426995|101389394|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409979|NCT03426995|101389395|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409980|NCT03426995|101389396|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409981|NCT03426995|101389397|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409982|NCT03426995|101389398|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409983|NCT03426995|101389399|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
33409984|NCT03426995|101389400|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
33409985|NCT03426995|101389401|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409986|NCT03426995|101389402|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33548943|NCT01995201|101908461|FG000|From Week 24 Until Week 48|Death|0|||
33548944|NCT01995201|101908462|FG001|From Week 24 Until Week 48|Death|0|||
33548945|NCT01995201|101908463|FG002|From Week 24 Until Week 48|Death|0|||
33548946|NCT01995201|101908464|FG003|From Week 24 Until Week 48|Death|0|||
33548947|NCT01995201|101908465|FG004|From Week 24 Until Week 48|Death|0|||
33548948|NCT01995201|101908466|FG005|From Week 24 Until Week 48|Death|2|||
33548949|NCT01995201|101908467|FG006|From Week 24 Until Week 48|Death|0|||
33548950|NCT01995201|101908461|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
33548951|NCT01995201|101908462|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
33548952|NCT01995201|101908463|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
33548953|NCT01995201|101908464|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
33548954|NCT01995201|101908465|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
33548955|NCT01995201|101908466|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
33548956|NCT01995201|101908467|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
33548957|NCT01995201|101908461|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
33548958|NCT01995201|101908462|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
33548959|NCT01995201|101908463|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
33548960|NCT01995201|101908464|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
33548961|NCT01995201|101908465|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
33548962|NCT01995201|101908466|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
33215954|NCT02723864|100688691|FG004|Overall Study|Exceed treatment hold time|0|||
33349369|NCT00896532|101164144|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349370|NCT00896532|101164145|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
33349371|NCT00896532|101164146|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
33349372|NCT00896532|101164124|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349373|NCT00896532|101164125|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349374|NCT00896532|101164126|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349375|NCT00896532|101164127|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33617909|NCT03801174|102151416|FG001|Overall Study|Lost to Follow-up|10|||
33215955|NCT02723864|100688692|FG005|Overall Study|Exceed treatment hold time|0|||
33349376|NCT00896532|101164128|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33617910|NCT03801174|102151415|FG000|Overall Study|Other|4|||
33617911|NCT03801174|102151416|FG001|Overall Study|Other|3|||
33617912|NCT03801174|102151415|FG000|Overall Study|Lack of Efficacy|4|||
33617913|NCT03801174|102151416|FG001|Overall Study|Lack of Efficacy|0|||
33617914|NCT03801174|102151415|FG000|Overall Study|Unwilling to complete activities|5|||
33617915|NCT03801174|102151416|FG001|Overall Study|Unwilling to complete activities|6|||
33617916|NCT03801174|102151415|FG000|Overall Study|Moved out of area|3|||
33617917|NCT03801174|102151416|FG001|Overall Study|Moved out of area|0|||
33617918|NCT04137731|102151417|FG000|Overall Study|Surgery Cancellation|1|||
33617919|NCT04137731|102151418|FG001|Overall Study|Surgery Cancellation|2|||
33617920|NCT04137731|102151417|FG000|Overall Study|Withdrawal by Subject|2|||
33617921|NCT04137731|102151418|FG001|Overall Study|Withdrawal by Subject|0|||
33617922|NCT04137731|102151417|FG000|Overall Study|Protocol Violation|0|||
33617923|NCT04137731|102151418|FG001|Overall Study|Protocol Violation|1|||
33617924|NCT01292187|102151422|FG000|Overall Study|Adverse Event|10|||
33617925|NCT01292187|102151423|FG001|Overall Study|Adverse Event|5|||
33617926|NCT01292187|102151422|FG000|Overall Study|Withdrawal by Subject|6|||
33409987|NCT03426995|101389403|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
33409988|NCT03557775|101389410|FG000|Overall Study|Withdrawal by Subject|1|||
33409989|NCT03557775|101389411|FG001|Overall Study|Withdrawal by Subject|2|||
33409990|NCT03557775|101389412|FG002|Overall Study|Withdrawal by Subject|4|||
33409991|NCT03557775|101389410|FG000|Overall Study|Physician Decision|0|||
33409992|NCT03557775|101389411|FG001|Overall Study|Physician Decision|1|||
33409993|NCT03557775|101389412|FG002|Overall Study|Physician Decision|0|||
33409994|NCT00509223|101389413|FG000|Overall Study|Lost to Follow-up|1|||
33409995|NCT00509223|101389414|FG001|Overall Study|Lost to Follow-up|1|||
33409996|NCT00509223|101389413|FG000|Overall Study|Adverse Event|1|||
33409997|NCT00509223|101389414|FG001|Overall Study|Adverse Event|1|||
33409998|NCT00509223|101389413|FG000|Overall Study|Withdrawal by Subject|25|||
33409999|NCT00509223|101389414|FG001|Overall Study|Withdrawal by Subject|6|||
33410000|NCT00509223|101389413|FG000|Overall Study|Including: subject change of address|5|||
33410001|NCT00509223|101389414|FG001|Overall Study|Including: subject change of address|2|||
33410002|NCT00509223|101389413|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
33410003|NCT00509223|101389414|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
33410004|NCT02331680|101389415|FG000|Overall Study|Adverse Event|3|||
33410005|NCT02331680|101389416|FG001|Overall Study|Adverse Event|0|||
33410006|NCT02331680|101389417|FG002|Overall Study|Adverse Event|2|||
33410007|NCT02331680|101389415|FG000|Overall Study|Physician Decision|1|||
33410008|NCT02331680|101389416|FG001|Overall Study|Physician Decision|1|||
33410009|NCT02331680|101389417|FG002|Overall Study|Physician Decision|2|||
33410010|NCT02331680|101389415|FG000|Overall Study|Withdrawal by Subject|0|||
33410011|NCT02331680|101389416|FG001|Overall Study|Withdrawal by Subject|1|||
33410012|NCT02331680|101389417|FG002|Overall Study|Withdrawal by Subject|2|||
33410013|NCT02331680|101389415|FG000|Overall Study|Met withdrawal criteria|2|||
33410014|NCT02331680|101389416|FG001|Overall Study|Met withdrawal criteria|2|||
33410015|NCT02331680|101389417|FG002|Overall Study|Met withdrawal criteria|5|||
33410016|NCT02331680|101389415|FG000|Overall Study|Non-compliance with study drug|0|||
33410017|NCT02331680|101389416|FG001|Overall Study|Non-compliance with study drug|0|||
33410018|NCT02331680|101389417|FG002|Overall Study|Non-compliance with study drug|1|||
33410019|NCT02331680|101389415|FG000|Overall Study|Protocol Violation|0|||
33410020|NCT02331680|101389416|FG001|Overall Study|Protocol Violation|0|||
33410021|NCT02331680|101389417|FG002|Overall Study|Protocol Violation|3|||
33410022|NCT01855607|101389418|FG000|Overall Study|Withdrawal by Subject|1|||
33410023|NCT01855607|101389418|FG000|Overall Study|Study was terminated|11|||
33410024|NCT00650806|101389419|FG000|Overall Study|Adverse Event|0|||
33410025|NCT00650806|101389420|FG001|Overall Study|Adverse Event|5|||
33410026|NCT00650806|101389421|FG002|Overall Study|Adverse Event|3|||
33410027|NCT00650806|101389422|FG003|Overall Study|Adverse Event|4|||
33410028|NCT00650806|101389419|FG000|Overall Study|Lost to Follow-up|7|||
33410029|NCT00650806|101389420|FG001|Overall Study|Lost to Follow-up|6|||
33410030|NCT00650806|101389421|FG002|Overall Study|Lost to Follow-up|11|||
33410031|NCT00650806|101389422|FG003|Overall Study|Lost to Follow-up|10|||
33410032|NCT00650806|101389419|FG000|Overall Study|Protocol Violation|0|||
33410033|NCT00650806|101389420|FG001|Overall Study|Protocol Violation|0|||
33410034|NCT00650806|101389421|FG002|Overall Study|Protocol Violation|0|||
33410035|NCT00650806|101389422|FG003|Overall Study|Protocol Violation|1|||
33410036|NCT00650806|101389419|FG000|Overall Study|Pregnancy|0|||
33617927|NCT01292187|102151423|FG001|Overall Study|Withdrawal by Subject|5|||
33617928|NCT01292187|102151422|FG000|Overall Study|All other reasons|1|||
33410037|NCT00650806|101389420|FG001|Overall Study|Pregnancy|0|||
33410038|NCT00650806|101389421|FG002|Overall Study|Pregnancy|0|||
33410039|NCT00650806|101389422|FG003|Overall Study|Pregnancy|1|||
33617929|NCT01292187|102151423|FG001|Overall Study|All other reasons|3|||
33617930|NCT01132313|102151424|FG000|Overall Study|Lack of Efficacy|1|||
33548963|NCT01995201|101908467|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
33548964|NCT01995201|101908461|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
33548965|NCT01995201|101908462|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
33548966|NCT01995201|101908463|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
33548967|NCT01995201|101908464|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
33548968|NCT01995201|101908465|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
33349377|NCT00896532|101164129|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349378|NCT00896532|101164130|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349379|NCT00896532|101164131|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349380|NCT00896532|101164132|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33548969|NCT01995201|101908466|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
33548970|NCT01995201|101908467|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
33548971|NCT01995201|101908461|FG000|From Week 24 Until Week 48|Physician Decision|0|||
33548972|NCT01995201|101908462|FG001|From Week 24 Until Week 48|Physician Decision|0|||
33548973|NCT01995201|101908463|FG002|From Week 24 Until Week 48|Physician Decision|0|||
33548974|NCT01995201|101908464|FG003|From Week 24 Until Week 48|Physician Decision|0|||
33548975|NCT01995201|101908465|FG004|From Week 24 Until Week 48|Physician Decision|1|||
33548976|NCT01995201|101908466|FG005|From Week 24 Until Week 48|Physician Decision|0|||
33548977|NCT01995201|101908467|FG006|From Week 24 Until Week 48|Physician Decision|0|||
33548978|NCT01995201|101908461|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
33548979|NCT01995201|101908462|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
33548980|NCT01995201|101908463|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
33548981|NCT01995201|101908464|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
33548982|NCT01995201|101908465|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
33548983|NCT01995201|101908466|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
33548984|NCT01995201|101908467|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
33548985|NCT01132755|101908473|FG000|Overall Study|Procedure not done due to medical reason|23|||
33548986|NCT01132755|101908473|FG000|Overall Study|Protocol Violation|15|||
33548987|NCT01132755|101908473|FG000|Overall Study|Withdrawal by Subject|4|||
33548988|NCT01107457|101908474|FG000|Part A|Adverse Event|1|||
33548989|NCT01107457|101908475|FG001|Part A|Adverse Event|2|||
33617931|NCT01132313|102151425|FG001|Overall Study|Lack of Efficacy|0|||
33617932|NCT01132313|102151426|FG002|Overall Study|Lack of Efficacy|0|||
33617933|NCT01132313|102151427|FG003|Overall Study|Lack of Efficacy|0|||
33617934|NCT01132313|102151428|FG004|Overall Study|Lack of Efficacy|0|||
33349381|NCT00896532|101164133|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349382|NCT00896532|101164134|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349383|NCT00896532|101164135|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349384|NCT00896532|101164136|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33410040|NCT00650806|101389419|FG000|Overall Study|Withdrawal by Subject|7|||
33548990|NCT01107457|101908476|FG002|Part A|Adverse Event|1|||
33548991|NCT01107457|101908477|FG003|Part A|Adverse Event|0|||
33548992|NCT01107457|101908478|FG004|Part A|Adverse Event|0|||
33548993|NCT01107457|101908479|FG005|Part A|Adverse Event|0|||
33548994|NCT01107457|101908474|FG000|Part A|Withdrawal by Subject|3|||
33548995|NCT01107457|101908475|FG001|Part A|Withdrawal by Subject|3|||
33548996|NCT01107457|101908476|FG002|Part A|Withdrawal by Subject|0|||
33548997|NCT01107457|101908477|FG003|Part A|Withdrawal by Subject|3|||
33617935|NCT01132313|102151429|FG005|Overall Study|Lack of Efficacy|0|||
33617936|NCT01132313|102151430|FG006|Overall Study|Lack of Efficacy|0|||
33617937|NCT01132313|102151431|FG007|Overall Study|Lack of Efficacy|3|||
33617938|NCT01132313|102151432|FG008|Overall Study|Lack of Efficacy|14|||
33617939|NCT01132313|102151433|FG009|Overall Study|Lack of Efficacy|16|||
33617940|NCT01132313|102151434|FG010|Overall Study|Lack of Efficacy|0|||
33617941|NCT01132313|102151435|FG011|Overall Study|Lack of Efficacy|0|||
33617942|NCT01132313|102151424|FG000|Overall Study|Not treated|2|||
33617943|NCT01132313|102151425|FG001|Overall Study|Not treated|0|||
33617944|NCT01132313|102151426|FG002|Overall Study|Not treated|0|||
33617945|NCT01132313|102151427|FG003|Overall Study|Not treated|0|||
33410041|NCT00650806|101389420|FG001|Overall Study|Withdrawal by Subject|5|||
33349385|NCT00896532|101164137|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349386|NCT00896532|101164138|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349387|NCT00896532|101164139|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349388|NCT00896532|101164140|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349389|NCT00896532|101164141|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349390|NCT00896532|101164142|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349391|NCT00896532|101164143|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33548998|NCT01107457|101908478|FG004|Part A|Withdrawal by Subject|1|||
33548999|NCT01107457|101908479|FG005|Part A|Withdrawal by Subject|0|||
33549000|NCT01107457|101908474|FG000|Part A|Lost to Follow-up|0|||
33549001|NCT01107457|101908475|FG001|Part A|Lost to Follow-up|1|||
33549002|NCT01107457|101908476|FG002|Part A|Lost to Follow-up|0|||
33549003|NCT01107457|101908477|FG003|Part A|Lost to Follow-up|0|||
33617946|NCT01132313|102151428|FG004|Overall Study|Not treated|2|||
33617947|NCT01132313|102151429|FG005|Overall Study|Not treated|1|||
33617948|NCT01132313|102151430|FG006|Overall Study|Not treated|3|||
33617949|NCT01132313|102151431|FG007|Overall Study|Not treated|0|||
33617950|NCT01132313|102151432|FG008|Overall Study|Not treated|0|||
33617951|NCT01132313|102151433|FG009|Overall Study|Not treated|0|||
33549004|NCT01107457|101908478|FG004|Part A|Lost to Follow-up|0|||
33549005|NCT01107457|101908479|FG005|Part A|Lost to Follow-up|0|||
33549006|NCT01107457|101908474|FG000|Part A|Lack of Efficacy|1|||
33549007|NCT01107457|101908475|FG001|Part A|Lack of Efficacy|0|||
33549008|NCT01107457|101908476|FG002|Part A|Lack of Efficacy|0|||
33549009|NCT01107457|101908477|FG003|Part A|Lack of Efficacy|0|||
33549010|NCT01107457|101908478|FG004|Part A|Lack of Efficacy|0|||
33549011|NCT01107457|101908479|FG005|Part A|Lack of Efficacy|0|||
33549012|NCT01107457|101908474|FG000|Part A|Protocol Violation|0|||
33349392|NCT00896532|101164144|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33349393|NCT00896532|101164145|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
33349394|NCT00896532|101164146|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
33549013|NCT01107457|101908475|FG001|Part A|Protocol Violation|1|||
33549014|NCT01107457|101908476|FG002|Part A|Protocol Violation|0|||
33549015|NCT01107457|101908477|FG003|Part A|Protocol Violation|0|||
33549016|NCT01107457|101908478|FG004|Part A|Protocol Violation|0|||
33549017|NCT01107457|101908479|FG005|Part A|Protocol Violation|0|||
33549018|NCT01107457|101908474|FG000|Part B and C|Adverse Event|0|||
33549019|NCT01107457|101908475|FG001|Part B and C|Adverse Event|0|||
33549020|NCT01107457|101908476|FG002|Part B and C|Adverse Event|0|||
33549021|NCT01107457|101908477|FG003|Part B and C|Adverse Event|0|||
33549022|NCT01107457|101908478|FG004|Part B and C|Adverse Event|0|||
33549023|NCT01107457|101908479|FG005|Part B and C|Adverse Event|12|||
33549024|NCT01107457|101908474|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
33549025|NCT01107457|101908475|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
33549026|NCT01107457|101908476|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
33549027|NCT01107457|101908477|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
33549028|NCT01107457|101908478|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
33549029|NCT01107457|101908479|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
33549030|NCT01107457|101908474|FG000|Part B and C|Physician Decision|0|||
33549031|NCT01107457|101908475|FG001|Part B and C|Physician Decision|0|||
33549032|NCT01107457|101908476|FG002|Part B and C|Physician Decision|0|||
33549033|NCT01107457|101908477|FG003|Part B and C|Physician Decision|0|||
33215956|NCT02723864|100688693|FG006|Overall Study|Exceed treatment hold time|0|||
33215957|NCT02723864|100688687|FG000|Overall Study|Clinical progression|0|||
33215958|NCT02723864|100688688|FG001|Overall Study|Clinical progression|0|||
33215959|NCT02723864|100688689|FG002|Overall Study|Clinical progression|1|||
33349395|NCT01948830|101164147|FG000|Overall Study|Physician Decision|1|||
33549034|NCT01107457|101908478|FG004|Part B and C|Physician Decision|0|||
33549035|NCT01107457|101908479|FG005|Part B and C|Physician Decision|3|||
33549036|NCT01107457|101908474|FG000|Part B and C|Lack of Efficacy|0|||
33549037|NCT01107457|101908475|FG001|Part B and C|Lack of Efficacy|0|||
33349396|NCT01948830|101164148|FG001|Overall Study|Physician Decision|3|||
33549038|NCT01107457|101908476|FG002|Part B and C|Lack of Efficacy|0|||
33549039|NCT01107457|101908477|FG003|Part B and C|Lack of Efficacy|0|||
33549040|NCT01107457|101908478|FG004|Part B and C|Lack of Efficacy|0|||
33549041|NCT01107457|101908479|FG005|Part B and C|Lack of Efficacy|7|||
33617952|NCT01132313|102151434|FG010|Overall Study|Not treated|0|||
33617953|NCT01132313|102151435|FG011|Overall Study|Not treated|0|||
33410042|NCT00650806|101389421|FG002|Overall Study|Withdrawal by Subject|8|||
33549042|NCT01107457|101908474|FG000|Part B and C|Lost to Follow-up|0|||
33549043|NCT01107457|101908475|FG001|Part B and C|Lost to Follow-up|0|||
33549044|NCT01107457|101908476|FG002|Part B and C|Lost to Follow-up|0|||
33549045|NCT01107457|101908477|FG003|Part B and C|Lost to Follow-up|0|||
33549046|NCT01107457|101908478|FG004|Part B and C|Lost to Follow-up|0|||
33549047|NCT01107457|101908479|FG005|Part B and C|Lost to Follow-up|10|||
33549048|NCT01107457|101908474|FG000|Part B and C|Protocol Violation|0|||
33549049|NCT01107457|101908475|FG001|Part B and C|Protocol Violation|0|||
33549050|NCT01107457|101908476|FG002|Part B and C|Protocol Violation|0|||
33549051|NCT01107457|101908477|FG003|Part B and C|Protocol Violation|0|||
33549052|NCT01107457|101908478|FG004|Part B and C|Protocol Violation|0|||
33549053|NCT01107457|101908479|FG005|Part B and C|Protocol Violation|1|||
33215960|NCT02723864|100688690|FG003|Overall Study|Clinical progression|0|||
33215961|NCT02723864|100688691|FG004|Overall Study|Clinical progression|0|||
33215962|NCT02723864|100688692|FG005|Overall Study|Clinical progression|3|||
33215963|NCT02723864|100688693|FG006|Overall Study|Clinical progression|1|||
33215964|NCT02723864|100688687|FG000|Overall Study|Physician Decision|0|||
33215965|NCT02723864|100688688|FG001|Overall Study|Physician Decision|0|||
33215966|NCT02723864|100688689|FG002|Overall Study|Physician Decision|0|||
33215967|NCT02723864|100688690|FG003|Overall Study|Physician Decision|0|||
33549054|NCT01107457|101908474|FG000|Part B and C|Sponsor Decision|0|||
33549055|NCT01107457|101908475|FG001|Part B and C|Sponsor Decision|0|||
33349397|NCT01948830|101164147|FG000|Overall Study|Protocol deviation|1|||
33349398|NCT01948830|101164148|FG001|Overall Study|Protocol deviation|2|||
33349399|NCT01948830|101164147|FG000|Overall Study|Lost to Follow-up|5|||
33349400|NCT01948830|101164148|FG001|Overall Study|Lost to Follow-up|4|||
33349401|NCT01948830|101164147|FG000|Overall Study|Withdrawal by Subject|14|||
33349402|NCT01948830|101164148|FG001|Overall Study|Withdrawal by Subject|17|||
33549056|NCT01107457|101908476|FG002|Part B and C|Sponsor Decision|0|||
33549057|NCT01107457|101908477|FG003|Part B and C|Sponsor Decision|0|||
33549058|NCT01107457|101908478|FG004|Part B and C|Sponsor Decision|0|||
33549059|NCT01107457|101908479|FG005|Part B and C|Sponsor Decision|66|||
33549060|NCT01107457|101908474|FG000|Part B and C|Withdrawal by Subject|0|||
33549061|NCT01107457|101908475|FG001|Part B and C|Withdrawal by Subject|0|||
33549062|NCT01107457|101908476|FG002|Part B and C|Withdrawal by Subject|0|||
33549063|NCT01107457|101908477|FG003|Part B and C|Withdrawal by Subject|0|||
33549064|NCT01107457|101908478|FG004|Part B and C|Withdrawal by Subject|0|||
33549065|NCT01107457|101908479|FG005|Part B and C|Withdrawal by Subject|16|||
33549066|NCT01107457|101908474|FG000|Part B and C|Clinical Relapse|0|||
33549067|NCT01107457|101908475|FG001|Part B and C|Clinical Relapse|0|||
33549068|NCT01107457|101908476|FG002|Part B and C|Clinical Relapse|0|||
33549069|NCT01107457|101908477|FG003|Part B and C|Clinical Relapse|0|||
33549070|NCT01107457|101908478|FG004|Part B and C|Clinical Relapse|0|||
33549071|NCT01107457|101908479|FG005|Part B and C|Clinical Relapse|4|||
33549072|NCT01859741|101908480|FG000|Overall Study|Death|3|||
33349403|NCT01948830|101164147|FG000|Overall Study|Adverse Event|9|||
33549073|NCT01859741|101908481|FG001|Overall Study|Death|2|||
33549074|NCT01859741|101908482|FG002|Overall Study|Death|4|||
33549075|NCT01859741|101908483|FG003|Overall Study|Death|3|||
33549076|NCT01859741|101908484|FG004|Overall Study|Death|5|||
33549077|NCT01859741|101908485|FG005|Overall Study|Death|4|||
33549078|NCT01859741|101908486|FG006|Overall Study|Death|51|||
33549079|NCT01859741|101908487|FG007|Overall Study|Death|51|||
33549080|NCT01859741|101908480|FG000|Overall Study|Lost to Follow-up|0|||
33549081|NCT01859741|101908481|FG001|Overall Study|Lost to Follow-up|0|||
33549082|NCT01859741|101908482|FG002|Overall Study|Lost to Follow-up|0|||
33549083|NCT01859741|101908483|FG003|Overall Study|Lost to Follow-up|0|||
33215968|NCT02723864|100688691|FG004|Overall Study|Physician Decision|0|||
33349404|NCT01948830|101164148|FG001|Overall Study|Adverse Event|2|||
33349405|NCT01948830|101164147|FG000|Overall Study|Death|3|||
33549084|NCT01859741|101908484|FG004|Overall Study|Lost to Follow-up|0|||
33549085|NCT01859741|101908485|FG005|Overall Study|Lost to Follow-up|1|||
33549086|NCT01859741|101908486|FG006|Overall Study|Lost to Follow-up|0|||
33349406|NCT01948830|101164148|FG001|Overall Study|Death|4|||
33549087|NCT01859741|101908487|FG007|Overall Study|Lost to Follow-up|4|||
33549088|NCT01859741|101908480|FG000|Overall Study|Withdrawal by Subject|0|||
33549089|NCT01859741|101908481|FG001|Overall Study|Withdrawal by Subject|1|||
33549090|NCT01859741|101908482|FG002|Overall Study|Withdrawal by Subject|2|||
33549091|NCT01859741|101908483|FG003|Overall Study|Withdrawal by Subject|0|||
33549092|NCT01859741|101908484|FG004|Overall Study|Withdrawal by Subject|0|||
33549093|NCT01859741|101908485|FG005|Overall Study|Withdrawal by Subject|1|||
33549094|NCT01859741|101908486|FG006|Overall Study|Withdrawal by Subject|1|||
33549095|NCT01859741|101908487|FG007|Overall Study|Withdrawal by Subject|1|||
33549096|NCT01859741|101908480|FG000|Overall Study|Study Terminated by Sponsor|0|||
33549097|NCT01859741|101908481|FG001|Overall Study|Study Terminated by Sponsor|0|||
33549098|NCT01859741|101908482|FG002|Overall Study|Study Terminated by Sponsor|0|||
33549099|NCT01859741|101908483|FG003|Overall Study|Study Terminated by Sponsor|0|||
33549100|NCT01859741|101908484|FG004|Overall Study|Study Terminated by Sponsor|1|||
33549101|NCT01859741|101908485|FG005|Overall Study|Study Terminated by Sponsor|0|||
33549102|NCT01859741|101908486|FG006|Overall Study|Study Terminated by Sponsor|16|||
33549103|NCT01859741|101908487|FG007|Overall Study|Study Terminated by Sponsor|14|||
33549104|NCT01859741|101908480|FG000|Overall Study|Other|0|||
33549105|NCT01859741|101908481|FG001|Overall Study|Other|0|||
33549106|NCT01859741|101908482|FG002|Overall Study|Other|0|||
33549107|NCT01859741|101908483|FG003|Overall Study|Other|0|||
33549108|NCT01859741|101908484|FG004|Overall Study|Other|0|||
33549109|NCT01859741|101908485|FG005|Overall Study|Other|0|||
33349407|NCT01220414|101164149|FG000|Overall Study|Withdrawal by Subject|1|||
33349408|NCT01220414|101164150|FG001|Overall Study|Withdrawal by Subject|0|||
33349409|NCT01220414|101164151|FG002|Overall Study|Withdrawal by Subject|0|||
33349410|NCT01220414|101164152|FG003|Overall Study|Withdrawal by Subject|1|||
33349411|NCT01552902|101164153|FG000|Overall Study|Adverse Event|1|||
33349412|NCT01552902|101164154|FG001|Overall Study|Adverse Event|15|||
33349413|NCT01552902|101164155|FG002|Overall Study|Adverse Event|14|||
33349414|NCT01552902|101164153|FG000|Overall Study|Protocol Violation|3|||
33349415|NCT01552902|101164154|FG001|Overall Study|Protocol Violation|3|||
33349416|NCT01552902|101164155|FG002|Overall Study|Protocol Violation|3|||
33349417|NCT01552902|101164153|FG000|Overall Study|Lack of Efficacy|4|||
33349418|NCT01552902|101164154|FG001|Overall Study|Lack of Efficacy|3|||
33349419|NCT01552902|101164155|FG002|Overall Study|Lack of Efficacy|1|||
33349420|NCT01552902|101164153|FG000|Overall Study|Withdrawal by Subject|1|||
33349421|NCT01552902|101164154|FG001|Overall Study|Withdrawal by Subject|9|||
33349422|NCT01552902|101164155|FG002|Overall Study|Withdrawal by Subject|6|||
33349423|NCT01552902|101164153|FG000|Overall Study|Lost to Follow-up|1|||
33349424|NCT01552902|101164154|FG001|Overall Study|Lost to Follow-up|3|||
33349425|NCT01552902|101164155|FG002|Overall Study|Lost to Follow-up|6|||
33349426|NCT01552902|101164153|FG000|Overall Study|Other|3|||
33349427|NCT01552902|101164154|FG001|Overall Study|Other|4|||
33349428|NCT01552902|101164155|FG002|Overall Study|Other|3|||
33349429|NCT00434967|101164156|FG000|Overall Study|Adverse Event|2|||
33349430|NCT00434967|101164157|FG001|Overall Study|Adverse Event|4|||
33349431|NCT00434967|101164158|FG002|Overall Study|Adverse Event|3|||
33349432|NCT00434967|101164159|FG003|Overall Study|Adverse Event|3|||
33349433|NCT00434967|101164156|FG000|Overall Study|Lost to Follow-up|0|||
33349434|NCT00434967|101164157|FG001|Overall Study|Lost to Follow-up|0|||
33349435|NCT00434967|101164158|FG002|Overall Study|Lost to Follow-up|1|||
33349436|NCT00434967|101164159|FG003|Overall Study|Lost to Follow-up|0|||
33349437|NCT00434967|101164156|FG000|Overall Study|Withdrawal by Subject|2|||
33349438|NCT00434967|101164157|FG001|Overall Study|Withdrawal by Subject|2|||
33349439|NCT00434967|101164158|FG002|Overall Study|Withdrawal by Subject|4|||
33349440|NCT00434967|101164159|FG003|Overall Study|Withdrawal by Subject|6|||
33349441|NCT00434967|101164156|FG000|Overall Study|Randomized in error|0|||
33549110|NCT01859741|101908486|FG006|Overall Study|Other|2|||
33549111|NCT01859741|101908487|FG007|Overall Study|Other|0|||
33549112|NCT00421993|101908490|FG000|Overall Study|Withdrawal by Subject|22|||
33549113|NCT00421993|101908491|FG001|Overall Study|Withdrawal by Subject|23|||
33349442|NCT00434967|101164157|FG001|Overall Study|Randomized in error|0|||
33349443|NCT00434967|101164158|FG002|Overall Study|Randomized in error|0|||
33549114|NCT00421993|101908492|FG002|Overall Study|Withdrawal by Subject|23|||
33617954|NCT01132313|102151424|FG000|Overall Study|Adverse Event|0|||
33349444|NCT00434967|101164159|FG003|Overall Study|Randomized in error|1|||
33349445|NCT00434967|101164156|FG000|Overall Study|Protocol Violation|0|||
33349446|NCT00434967|101164157|FG001|Overall Study|Protocol Violation|1|||
33349447|NCT00434967|101164158|FG002|Overall Study|Protocol Violation|0|||
33349448|NCT00434967|101164159|FG003|Overall Study|Protocol Violation|1|||
33349449|NCT00434967|101164156|FG000|Overall Study|Physician Decision|1|||
33349450|NCT00434967|101164157|FG001|Overall Study|Physician Decision|1|||
33349451|NCT00434967|101164158|FG002|Overall Study|Physician Decision|1|||
33349452|NCT00434967|101164159|FG003|Overall Study|Physician Decision|0|||
33549115|NCT00421993|101908493|FG003|Overall Study|Withdrawal by Subject|24|||
33549116|NCT00421993|101908490|FG000|Overall Study|Lost to Follow-up|18|||
33549117|NCT00421993|101908491|FG001|Overall Study|Lost to Follow-up|19|||
33549118|NCT00421993|101908492|FG002|Overall Study|Lost to Follow-up|22|||
33549119|NCT00421993|101908493|FG003|Overall Study|Lost to Follow-up|20|||
33549120|NCT00421993|101908490|FG000|Overall Study|Adverse Event|11|||
33549121|NCT00421993|101908491|FG001|Overall Study|Adverse Event|1|||
33549122|NCT00421993|101908492|FG002|Overall Study|Adverse Event|6|||
33549123|NCT00421993|101908493|FG003|Overall Study|Adverse Event|4|||
33549124|NCT00421993|101908490|FG000|Overall Study|Protocol Violation|2|||
33549125|NCT00421993|101908491|FG001|Overall Study|Protocol Violation|2|||
33549126|NCT00421993|101908492|FG002|Overall Study|Protocol Violation|0|||
33549127|NCT00421993|101908493|FG003|Overall Study|Protocol Violation|1|||
33549128|NCT00421993|101908490|FG000|Overall Study|Lack of Efficacy|0|||
33549129|NCT00421993|101908491|FG001|Overall Study|Lack of Efficacy|3|||
33549130|NCT00421993|101908492|FG002|Overall Study|Lack of Efficacy|0|||
33549131|NCT00421993|101908493|FG003|Overall Study|Lack of Efficacy|5|||
33215969|NCT02723864|100688692|FG005|Overall Study|Physician Decision|0|||
33215970|NCT02723864|100688693|FG006|Overall Study|Physician Decision|1|||
33215971|NCT02723864|100688687|FG000|Overall Study|Changes in patient condition|0|||
33215972|NCT02723864|100688688|FG001|Overall Study|Changes in patient condition|0|||
33215973|NCT02723864|100688689|FG002|Overall Study|Changes in patient condition|0|||
33215974|NCT02723864|100688690|FG003|Overall Study|Changes in patient condition|0|||
33215975|NCT02723864|100688691|FG004|Overall Study|Changes in patient condition|0|||
33215976|NCT02723864|100688692|FG005|Overall Study|Changes in patient condition|1|||
33215977|NCT02723864|100688693|FG006|Overall Study|Changes in patient condition|0|||
33215978|NCT02723864|100688687|FG000|Overall Study|Patient choice|0|||
33215979|NCT02723864|100688688|FG001|Overall Study|Patient choice|0|||
33215980|NCT02723864|100688689|FG002|Overall Study|Patient choice|0|||
33215981|NCT02723864|100688690|FG003|Overall Study|Patient choice|0|||
33215982|NCT02723864|100688691|FG004|Overall Study|Patient choice|0|||
33215983|NCT02723864|100688692|FG005|Overall Study|Patient choice|1|||
33215984|NCT02723864|100688693|FG006|Overall Study|Patient choice|0|||
33215985|NCT02723864|100688687|FG000|Overall Study|Adverse Event|0|||
33215986|NCT02723864|100688688|FG001|Overall Study|Adverse Event|0|||
33215987|NCT02723864|100688689|FG002|Overall Study|Adverse Event|0|||
33215988|NCT02723864|100688690|FG003|Overall Study|Adverse Event|0|||
33215989|NCT02723864|100688691|FG004|Overall Study|Adverse Event|0|||
33215990|NCT02723864|100688692|FG005|Overall Study|Adverse Event|1|||
33215991|NCT02723864|100688693|FG006|Overall Study|Adverse Event|0|||
33215992|NCT02723864|100688687|FG000|Overall Study|Started new treatment|0|||
33215993|NCT02723864|100688688|FG001|Overall Study|Started new treatment|0|||
33215994|NCT02723864|100688689|FG002|Overall Study|Started new treatment|0|||
33215995|NCT02723864|100688690|FG003|Overall Study|Started new treatment|0|||
33215996|NCT02723864|100688691|FG004|Overall Study|Started new treatment|0|||
33215997|NCT02723864|100688692|FG005|Overall Study|Started new treatment|1|||
33215998|NCT02723864|100688693|FG006|Overall Study|Started new treatment|0|||
33215999|NCT02723864|100688687|FG000|Overall Study|Switched to alternative treatment|0|||
33216000|NCT02723864|100688688|FG001|Overall Study|Switched to alternative treatment|0|||
33216001|NCT02723864|100688689|FG002|Overall Study|Switched to alternative treatment|0|||
33216002|NCT02723864|100688690|FG003|Overall Study|Switched to alternative treatment|0|||
33216003|NCT02723864|100688691|FG004|Overall Study|Switched to alternative treatment|0|||
33216004|NCT02723864|100688692|FG005|Overall Study|Switched to alternative treatment|1|||
33216005|NCT02723864|100688693|FG006|Overall Study|Switched to alternative treatment|0|||
33216006|NCT02723864|100688687|FG000|Overall Study|Late determination of ineligibility|0|||
33216007|NCT02723864|100688688|FG001|Overall Study|Late determination of ineligibility|0|||
33216008|NCT02723864|100688689|FG002|Overall Study|Late determination of ineligibility|0|||
33216009|NCT02723864|100688690|FG003|Overall Study|Late determination of ineligibility|0|||
33216010|NCT02723864|100688691|FG004|Overall Study|Late determination of ineligibility|0|||
33216011|NCT02723864|100688692|FG005|Overall Study|Late determination of ineligibility|1|||
33549132|NCT00421993|101908490|FG000|Overall Study|Pregnancy|0|||
33549133|NCT00421993|101908491|FG001|Overall Study|Pregnancy|1|||
33549134|NCT00421993|101908492|FG002|Overall Study|Pregnancy|1|||
33549135|NCT00421993|101908493|FG003|Overall Study|Pregnancy|2|||
33549136|NCT00421993|101908490|FG000|Overall Study|Subject transportation issues|0|||
33549137|NCT00421993|101908491|FG001|Overall Study|Subject transportation issues|0|||
33549138|NCT00421993|101908492|FG002|Overall Study|Subject transportation issues|0|||
33549139|NCT00421993|101908493|FG003|Overall Study|Subject transportation issues|1|||
33549140|NCT00785629|101908504|FG000|Overall Study|Adverse Event|2|||
33549141|NCT00785629|101908505|FG001|Overall Study|Adverse Event|1|||
33549142|NCT00785629|101908506|FG002|Overall Study|Adverse Event|1|||
33549143|NCT00785629|101908507|FG003|Overall Study|Adverse Event|5|||
33549144|NCT00785629|101908504|FG000|Overall Study|Protocol Violation|1|||
33549145|NCT00785629|101908505|FG001|Overall Study|Protocol Violation|2|||
33216012|NCT02723864|100688693|FG006|Overall Study|Late determination of ineligibility|0|||
33216013|NCT02925676|100688694|FG000|Overall Study|Withdrawal by Subject|1|||
33549146|NCT00785629|101908506|FG002|Overall Study|Protocol Violation|4|||
33216014|NCT01813474|100688701|FG000|Overall Study|Withdrawal by Subject|0|||
33216015|NCT01813474|100688702|FG001|Overall Study|Withdrawal by Subject|0|||
33549147|NCT00785629|101908507|FG003|Overall Study|Protocol Violation|5|||
33549148|NCT00785629|101908504|FG000|Overall Study|administrative decision|5|||
33549149|NCT00785629|101908505|FG001|Overall Study|administrative decision|1|||
33549150|NCT00785629|101908506|FG002|Overall Study|administrative decision|3|||
33549151|NCT00785629|101908507|FG003|Overall Study|administrative decision|4|||
33549152|NCT00785629|101908504|FG000|Overall Study|Withdrawal by Subject|0|||
33549153|NCT00785629|101908505|FG001|Overall Study|Withdrawal by Subject|1|||
33549154|NCT00785629|101908506|FG002|Overall Study|Withdrawal by Subject|2|||
33549155|NCT00785629|101908507|FG003|Overall Study|Withdrawal by Subject|2|||
33549156|NCT03320369|101908508|FG000|Overall Study|Adverse Event|1|||
33549157|NCT03320369|101908508|FG000|Overall Study|Withdrawal by Subject|2|||
33549158|NCT04167670|101908509|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
33216016|NCT01813474|100688703|FG002|Overall Study|Withdrawal by Subject|1|||
33216017|NCT01813474|100688701|FG000|Overall Study|Adverse Event|1|||
33216018|NCT01813474|100688702|FG001|Overall Study|Adverse Event|1|||
33216019|NCT01813474|100688703|FG002|Overall Study|Adverse Event|0|||
33216020|NCT01813474|100688701|FG000|Overall Study|Lack of Efficacy|2|||
33216021|NCT01813474|100688702|FG001|Overall Study|Lack of Efficacy|6|||
33216022|NCT01813474|100688703|FG002|Overall Study|Lack of Efficacy|9|||
33216023|NCT01813474|100688701|FG000|Overall Study|Death|0|||
33216024|NCT01813474|100688702|FG001|Overall Study|Death|0|||
33216025|NCT01813474|100688703|FG002|Overall Study|Death|1|||
33216026|NCT01281644|100688704|FG000|Overall Study|Lost to Follow-up|3|||
33216027|NCT01281644|100688704|FG000|Overall Study|Withdrawal by Subject|2|||
33216028|NCT01515748|100688705|FG000|Overall Study|Withdrawal by Subject|32|||
33216029|NCT01515748|100688706|FG001|Overall Study|Withdrawal by Subject|41|||
33216030|NCT01515748|100688705|FG000|Overall Study|Lost to Follow-up|2|||
33216031|NCT01515748|100688706|FG001|Overall Study|Lost to Follow-up|4|||
33216032|NCT01515748|100688705|FG000|Overall Study|Other than specified above|5|||
33216033|NCT01515748|100688706|FG001|Overall Study|Other than specified above|10|||
33216034|NCT02943408|100688707|FG000|Overall Study|Lost to Follow-up|7|||
33216035|NCT02943408|100688708|FG001|Overall Study|Lost to Follow-up|1|||
33216036|NCT02943408|100688707|FG000|Overall Study|Withdrawal by Subject|0|||
33216037|NCT02943408|100688708|FG001|Overall Study|Withdrawal by Subject|1|||
33216038|NCT01218126|100688712|FG000|Overall Study|Adverse Event|8|||
33216039|NCT01218126|100688713|FG001|Overall Study|Adverse Event|10|||
33216040|NCT01218126|100688714|FG002|Overall Study|Adverse Event|12|||
33216041|NCT01218126|100688715|FG003|Overall Study|Adverse Event|16|||
33216042|NCT01218126|100688712|FG000|Overall Study|Lack of Efficacy|7|||
33216043|NCT01218126|100688713|FG001|Overall Study|Lack of Efficacy|2|||
33216044|NCT01218126|100688714|FG002|Overall Study|Lack of Efficacy|2|||
33216045|NCT01218126|100688715|FG003|Overall Study|Lack of Efficacy|6|||
33549159|NCT04167670|101908510|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
33349453|NCT00434967|101164156|FG000|Overall Study|Patient Disposition Challenges|2|||
33549160|NCT04167670|101908511|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
33216046|NCT01218126|100688712|FG000|Overall Study|Protocol Violation|5|||
33216047|NCT01218126|100688713|FG001|Overall Study|Protocol Violation|2|||
33216048|NCT01218126|100688714|FG002|Overall Study|Protocol Violation|2|||
33216049|NCT01218126|100688715|FG003|Overall Study|Protocol Violation|3|||
33216050|NCT01218126|100688712|FG000|Overall Study|Protocol-defined stopping criteria|1|||
33216051|NCT01218126|100688713|FG001|Overall Study|Protocol-defined stopping criteria|1|||
33216052|NCT01218126|100688714|FG002|Overall Study|Protocol-defined stopping criteria|0|||
33216053|NCT01218126|100688715|FG003|Overall Study|Protocol-defined stopping criteria|0|||
33216054|NCT01218126|100688712|FG000|Overall Study|Lost to Follow-up|0|||
33216055|NCT01218126|100688713|FG001|Overall Study|Lost to Follow-up|0|||
33216056|NCT01218126|100688714|FG002|Overall Study|Lost to Follow-up|0|||
33216057|NCT01218126|100688715|FG003|Overall Study|Lost to Follow-up|2|||
33216058|NCT01218126|100688712|FG000|Overall Study|Physician Decision|1|||
33216059|NCT01218126|100688713|FG001|Overall Study|Physician Decision|2|||
33216060|NCT01218126|100688714|FG002|Overall Study|Physician Decision|4|||
33216061|NCT01218126|100688715|FG003|Overall Study|Physician Decision|2|||
33216062|NCT01218126|100688712|FG000|Overall Study|Withdrawal by Subject|2|||
33216063|NCT01218126|100688713|FG001|Overall Study|Withdrawal by Subject|5|||
33216064|NCT01218126|100688714|FG002|Overall Study|Withdrawal by Subject|4|||
33216065|NCT01218126|100688715|FG003|Overall Study|Withdrawal by Subject|6|||
33216066|NCT02633800|100688716|FG000|Overall Study|Death|3|||
33216067|NCT02633800|100688717|FG001|Overall Study|Death|3|||
33216068|NCT02633800|100688716|FG000|Overall Study|Reason not provided|1|||
33216069|NCT02633800|100688717|FG001|Overall Study|Reason not provided|0|||
33216070|NCT02633800|100688716|FG000|Overall Study|Radiologic(al) progression|23|||
33216071|NCT02633800|100688717|FG001|Overall Study|Radiologic(al) progression|23|||
33216072|NCT02633800|100688716|FG000|Overall Study|Clinical progression|3|||
33216073|NCT02633800|100688717|FG001|Overall Study|Clinical progression|6|||
33216074|NCT02633800|100688716|FG000|Overall Study|Study terminated by sponsor|6|||
33216075|NCT02633800|100688717|FG001|Overall Study|Study terminated by sponsor|5|||
33216076|NCT02633800|100688716|FG000|Overall Study|Adverse event, non-fatal|7|||
33349454|NCT00434967|101164157|FG001|Overall Study|Patient Disposition Challenges|0|||
33349455|NCT00434967|101164158|FG002|Overall Study|Patient Disposition Challenges|0|||
33349456|NCT00434967|101164159|FG003|Overall Study|Patient Disposition Challenges|3|||
33349457|NCT02327260|101164160|FG000|Overall Study|Lost to Follow-up|2|||
33349458|NCT02327260|101164161|FG001|Overall Study|Lost to Follow-up|3|||
33349459|NCT02327260|101164162|FG002|Overall Study|Lost to Follow-up|2|||
33349460|NCT02327260|101164160|FG000|Overall Study|invalid phone number|1|||
33349461|NCT02327260|101164161|FG001|Overall Study|invalid phone number|1|||
33349462|NCT02327260|101164162|FG002|Overall Study|invalid phone number|0|||
33349463|NCT02327260|101164160|FG000|Overall Study|non-adherence to protocol|2|||
33349464|NCT02327260|101164161|FG001|Overall Study|non-adherence to protocol|0|||
33349465|NCT02327260|101164162|FG002|Overall Study|non-adherence to protocol|0|||
33349466|NCT02327260|101164160|FG000|Overall Study|cognitive concerns|1|||
33349467|NCT02327260|101164161|FG001|Overall Study|cognitive concerns|0|||
33349468|NCT02327260|101164162|FG002|Overall Study|cognitive concerns|0|||
33349469|NCT04336163|101164163|FG000|Overall Study|Lost to Follow-up|55|||
33349470|NCT04336163|101164164|FG001|Overall Study|Lost to Follow-up|0|||
33349471|NCT00934102|101164169|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
33216077|NCT02633800|100688717|FG001|Overall Study|Adverse event, non-fatal|2|||
33216078|NCT02633800|100688716|FG000|Overall Study|Withdrawal by Subject|0|||
33349472|NCT00934102|101164170|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
33216079|NCT02633800|100688717|FG001|Overall Study|Withdrawal by Subject|3|||
33349473|NCT00934102|101164171|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
33349474|NCT00771472|101164175|FG000|Overall Study|Physician Decision|2|||
33349475|NCT00771472|101164176|FG001|Overall Study|Physician Decision|3|||
33349476|NCT00771472|101164175|FG000|Overall Study|Progressive Disease|3|||
33349477|NCT00771472|101164176|FG001|Overall Study|Progressive Disease|1|||
33349478|NCT00771472|101164175|FG000|Overall Study|Protocol Violation|1|||
33216080|NCT02633800|100688716|FG000|Overall Study|Patient Request|1|||
33216081|NCT02633800|100688717|FG001|Overall Study|Patient Request|1|||
33216082|NCT01433354|100688721|FG000|Overall Study|Adverse Event|6|||
33216083|NCT01433354|100688721|FG000|Overall Study|Lost to Follow-up|1|||
33216084|NCT01433354|100688721|FG000|Overall Study|Administrative problems|90|||
33216085|NCT01433354|100688721|FG000|Overall Study|Protocol Violation|2|||
33216086|NCT01433354|100688721|FG000|Overall Study|Lack of Efficacy|17|||
33216087|NCT01433354|100688721|FG000|Overall Study|Subject Withdrew Consent|3|||
33216088|NCT04535947|100688724|FG000|Overall Study|Adverse Event|1|||
33216089|NCT04535947|100688725|FG001|Overall Study|Adverse Event|4|||
33216090|NCT04535947|100688724|FG000|Overall Study|Other reasons not specified|2|||
33216091|NCT04535947|100688725|FG001|Overall Study|Other reasons not specified|0|||
33216092|NCT04535947|100688724|FG000|Overall Study|Withdrawal by Subject|1|||
33216093|NCT04535947|100688725|FG001|Overall Study|Withdrawal by Subject|1|||
33216094|NCT04843930|100688726|FG000|Randomization|Withdrawal by Subject|6|||
33216095|NCT04843930|100688727|FG001|Randomization|Withdrawal by Subject|6|||
33349479|NCT00771472|101164176|FG001|Overall Study|Protocol Violation|0|||
33349480|NCT00974220|101164179|FG000|Treatment Period 1|Adverse Event|2|||
33349481|NCT00974220|101164180|FG001|Treatment Period 1|Adverse Event|1|||
33349482|NCT00974220|101164179|FG000|Treatment Period 1|noncompliant subjects|0|||
33349483|NCT00974220|101164180|FG001|Treatment Period 1|noncompliant subjects|1|||
33349484|NCT01552057|101164181|FG000|Overall Study|Adverse Event|14|||
33349485|NCT01552057|101164182|FG001|Overall Study|Adverse Event|15|||
33349486|NCT01552057|101164181|FG000|Overall Study|Lack of Efficacy|8|||
33349487|NCT01552057|101164182|FG001|Overall Study|Lack of Efficacy|23|||
33349488|NCT01552057|101164181|FG000|Overall Study|Withdrawal by Subject|5|||
33349489|NCT01552057|101164182|FG001|Overall Study|Withdrawal by Subject|8|||
33349490|NCT01552057|101164181|FG000|Overall Study|Entry Criteria Not Met|2|||
33349491|NCT01552057|101164182|FG001|Overall Study|Entry Criteria Not Met|2|||
33349492|NCT01552057|101164181|FG000|Overall Study|Physician Decision|1|||
33349493|NCT01552057|101164182|FG001|Overall Study|Physician Decision|0|||
33349494|NCT00531960|101164183|FG000|Overall Study|Adverse Event|5|||
33349495|NCT00531960|101164184|FG001|Overall Study|Adverse Event|4|||
33349496|NCT00531960|101164183|FG000|Overall Study|Death|3|||
33349497|NCT00531960|101164184|FG001|Overall Study|Death|2|||
33349498|NCT00531960|101164183|FG000|Overall Study|Lack of Efficacy|42|||
33349499|NCT00531960|101164184|FG001|Overall Study|Lack of Efficacy|41|||
33349500|NCT00531960|101164183|FG000|Overall Study|Violation of Selection Criteria|2|||
33349501|NCT00531960|101164184|FG001|Overall Study|Violation of Selection Criteria|0|||
33349502|NCT00531960|101164183|FG000|Overall Study|Refused Treatment|5|||
33349503|NCT00531960|101164184|FG001|Overall Study|Refused Treatment|6|||
33349504|NCT00531960|101164183|FG000|Overall Study|Other|4|||
33349505|NCT00531960|101164184|FG001|Overall Study|Other|10|||
33349506|NCT02337387|101167477|FG000|Overall Study|Adverse Event|0|||
33349507|NCT02337387|101167478|FG001|Overall Study|Adverse Event|1|||
33349508|NCT02337387|101167479|FG002|Overall Study|Adverse Event|0|||
33349509|NCT02337387|101167480|FG003|Overall Study|Adverse Event|0|||
33349510|NCT02337387|101167477|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
33349511|NCT02337387|101167478|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
33349512|NCT02337387|101167479|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
33349513|NCT02337387|101167480|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
33349514|NCT03049449|101167481|FG000|Overall Study|Did not receive treatment.|0|||
33349515|NCT03049449|101167482|FG001|Overall Study|Did not receive treatment.|0|||
33349516|NCT03049449|101167483|FG002|Overall Study|Did not receive treatment.|0|||
33349517|NCT03049449|101167484|FG003|Overall Study|Did not receive treatment.|0|||
33349518|NCT03049449|101167485|FG004|Overall Study|Did not receive treatment.|0|||
33349519|NCT03049449|101167486|FG005|Overall Study|Did not receive treatment.|0|||
33349520|NCT03049449|101167487|FG006|Overall Study|Did not receive treatment.|0|||
33349521|NCT03049449|101167488|FG007|Overall Study|Did not receive treatment.|0|||
33349522|NCT03049449|101167489|FG008|Overall Study|Did not receive treatment.|1|||
33349523|NCT03049449|101167490|FG009|Overall Study|Did not receive treatment.|0|||
33349524|NCT03049449|101167481|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
33349525|NCT03049449|101167482|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
33216096|NCT04843930|100688728|FG002|Randomization|Withdrawal by Subject|0|||
33216097|NCT04843930|100688729|FG003|Randomization|Withdrawal by Subject|0|||
33349526|NCT03049449|101167483|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
33349527|NCT03049449|101167484|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
33349528|NCT03049449|101167485|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
33349529|NCT03049449|101167486|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
33216098|NCT04843930|100688726|FG000|Week 6 Assessment|Adverse Event|3|||
33349530|NCT03049449|101167487|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
33349531|NCT03049449|101167488|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
33349532|NCT03049449|101167489|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
33549161|NCT04167670|101908509|FG000|Overall Study|Significant protocol deviation|3|||
33216099|NCT04843930|100688727|FG001|Week 6 Assessment|Adverse Event|0|||
33216100|NCT04843930|100688728|FG002|Week 6 Assessment|Adverse Event|0|||
33349533|NCT03049449|101167490|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
33349534|NCT03049449|101167481|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33349535|NCT03049449|101167482|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33349536|NCT03049449|101167483|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33349537|NCT03049449|101167484|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33349538|NCT03049449|101167485|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33549162|NCT04167670|101908510|FG001|Overall Study|Significant protocol deviation|1|||
33549163|NCT04167670|101908511|FG002|Overall Study|Significant protocol deviation|0|||
33549164|NCT04167670|101908509|FG000|Overall Study|Lost to Follow-up|0|||
33549165|NCT04167670|101908510|FG001|Overall Study|Lost to Follow-up|3|||
33549166|NCT04167670|101908511|FG002|Overall Study|Lost to Follow-up|3|||
33549167|NCT04167670|101908509|FG000|Overall Study|Voluntary Withdrawal|0|||
33549168|NCT04167670|101908510|FG001|Overall Study|Voluntary Withdrawal|1|||
33549169|NCT04167670|101908511|FG002|Overall Study|Voluntary Withdrawal|1|||
33549170|NCT04167670|101908509|FG000|Overall Study|Withdrawal of Consent|4|||
33549171|NCT04167670|101908510|FG001|Overall Study|Withdrawal of Consent|1|||
33549172|NCT04167670|101908511|FG002|Overall Study|Withdrawal of Consent|3|||
33549173|NCT04167670|101908509|FG000|Overall Study|Miscellaneous|7|||
33549174|NCT04167670|101908510|FG001|Overall Study|Miscellaneous|5|||
33549175|NCT04167670|101908511|FG002|Overall Study|Miscellaneous|3|||
33549176|NCT02233413|101908513|FG000|Overall Study|Lost to Follow-up|7|||
33549177|NCT02233413|101908514|FG001|Overall Study|Lost to Follow-up|9|||
33549178|NCT02233413|101908513|FG000|Overall Study|Withdrawal by Subject|4|||
33549179|NCT02233413|101908514|FG001|Overall Study|Withdrawal by Subject|5|||
33549180|NCT00447278|101908518|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
33549181|NCT00447278|101908519|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
33549182|NCT00447278|101908518|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
33549183|NCT00447278|101908519|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
33549184|NCT00447278|101908518|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
33549185|NCT00447278|101908519|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
33549186|NCT00447278|101908518|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
33549187|NCT00447278|101908519|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
33617955|NCT01132313|102151425|FG001|Overall Study|Adverse Event|0|||
33216101|NCT04843930|100688729|FG003|Week 6 Assessment|Adverse Event|0|||
33216102|NCT04843930|100688726|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
33216103|NCT04843930|100688727|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
33216104|NCT04843930|100688728|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
33216105|NCT04843930|100688729|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
33216106|NCT04843930|100688726|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
33216107|NCT04843930|100688727|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
33216108|NCT04843930|100688728|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
33216109|NCT04843930|100688729|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
33216110|NCT03750006|100688735|FG000|Overall Study|Withdrawal by Subject|8|||
33216111|NCT03750006|100688735|FG000|Overall Study|COVID PANDEMIC|11|||
33216112|NCT01877408|100688738|FG000|Overall Study|Lost to Follow-up|0|||
33216113|NCT01877408|100688739|FG001|Overall Study|Lost to Follow-up|2|||
33216114|NCT03284788|100688741|FG000|Overall Study|Withdrawal by Subject|2|||
33617956|NCT01132313|102151426|FG002|Overall Study|Adverse Event|4|||
33617957|NCT01132313|102151427|FG003|Overall Study|Adverse Event|10|||
33617958|NCT01132313|102151428|FG004|Overall Study|Adverse Event|19|||
33617959|NCT01132313|102151429|FG005|Overall Study|Adverse Event|6|||
33617960|NCT01132313|102151430|FG006|Overall Study|Adverse Event|5|||
33617961|NCT01132313|102151431|FG007|Overall Study|Adverse Event|3|||
33617962|NCT01132313|102151432|FG008|Overall Study|Adverse Event|7|||
33617963|NCT01132313|102151433|FG009|Overall Study|Adverse Event|2|||
33617964|NCT01132313|102151434|FG010|Overall Study|Adverse Event|0|||
33617965|NCT01132313|102151435|FG011|Overall Study|Adverse Event|0|||
33617966|NCT01132313|102151424|FG000|Overall Study|Protocol Violation|0|||
33617967|NCT01132313|102151425|FG001|Overall Study|Protocol Violation|0|||
33617968|NCT01132313|102151426|FG002|Overall Study|Protocol Violation|0|||
33617969|NCT01132313|102151427|FG003|Overall Study|Protocol Violation|1|||
33617970|NCT01132313|102151428|FG004|Overall Study|Protocol Violation|0|||
33617971|NCT01132313|102151429|FG005|Overall Study|Protocol Violation|0|||
33617972|NCT01132313|102151430|FG006|Overall Study|Protocol Violation|0|||
33617973|NCT01132313|102151431|FG007|Overall Study|Protocol Violation|0|||
33617974|NCT01132313|102151432|FG008|Overall Study|Protocol Violation|0|||
33617975|NCT01132313|102151433|FG009|Overall Study|Protocol Violation|0|||
33617976|NCT01132313|102151434|FG010|Overall Study|Protocol Violation|0|||
33617977|NCT01132313|102151435|FG011|Overall Study|Protocol Violation|0|||
33617978|NCT01132313|102151424|FG000|Overall Study|Lost to Follow-up|0|||
33617979|NCT01132313|102151425|FG001|Overall Study|Lost to Follow-up|0|||
33617980|NCT01132313|102151426|FG002|Overall Study|Lost to Follow-up|1|||
33617981|NCT01132313|102151427|FG003|Overall Study|Lost to Follow-up|0|||
33617982|NCT01132313|102151428|FG004|Overall Study|Lost to Follow-up|0|||
33617983|NCT01132313|102151429|FG005|Overall Study|Lost to Follow-up|0|||
33617984|NCT01132313|102151430|FG006|Overall Study|Lost to Follow-up|0|||
33617985|NCT01132313|102151431|FG007|Overall Study|Lost to Follow-up|1|||
33617986|NCT01132313|102151432|FG008|Overall Study|Lost to Follow-up|0|||
33617987|NCT01132313|102151433|FG009|Overall Study|Lost to Follow-up|0|||
33617988|NCT01132313|102151434|FG010|Overall Study|Lost to Follow-up|0|||
33617989|NCT01132313|102151435|FG011|Overall Study|Lost to Follow-up|0|||
33617990|NCT01132313|102151424|FG000|Overall Study|Withdrawal by Subject|0|||
33617991|NCT01132313|102151425|FG001|Overall Study|Withdrawal by Subject|0|||
33617992|NCT01132313|102151426|FG002|Overall Study|Withdrawal by Subject|3|||
33617993|NCT01132313|102151427|FG003|Overall Study|Withdrawal by Subject|3|||
33617994|NCT01132313|102151428|FG004|Overall Study|Withdrawal by Subject|6|||
33617995|NCT01132313|102151429|FG005|Overall Study|Withdrawal by Subject|0|||
33617996|NCT01132313|102151430|FG006|Overall Study|Withdrawal by Subject|1|||
33617997|NCT01132313|102151431|FG007|Overall Study|Withdrawal by Subject|0|||
33617998|NCT01132313|102151432|FG008|Overall Study|Withdrawal by Subject|0|||
33617999|NCT01132313|102151433|FG009|Overall Study|Withdrawal by Subject|2|||
33618000|NCT01132313|102151434|FG010|Overall Study|Withdrawal by Subject|0|||
33618001|NCT01132313|102151435|FG011|Overall Study|Withdrawal by Subject|0|||
33618002|NCT01132313|102151424|FG000|Overall Study|Lack of antiviral response|0|||
33618003|NCT01132313|102151425|FG001|Overall Study|Lack of antiviral response|0|||
33216115|NCT01313286|100688742|FG000|Period 1|Withdrawal by Subject|2|||
33349539|NCT03049449|101167486|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33349540|NCT03049449|101167487|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33349541|NCT03049449|101167488|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
33349542|NCT03049449|101167489|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
33349543|NCT03049449|101167490|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
33349544|NCT03896295|101167491|FG000|Overall Study|Adverse Event|0|||
33618004|NCT01132313|102151426|FG002|Overall Study|Lack of antiviral response|12|||
33618005|NCT01132313|102151427|FG003|Overall Study|Lack of antiviral response|18|||
33618006|NCT01132313|102151428|FG004|Overall Study|Lack of antiviral response|18|||
33618007|NCT01132313|102151429|FG005|Overall Study|Lack of antiviral response|18|||
33618008|NCT01132313|102151430|FG006|Overall Study|Lack of antiviral response|21|||
33618009|NCT01132313|102151431|FG007|Overall Study|Lack of antiviral response|0|||
33618010|NCT01132313|102151432|FG008|Overall Study|Lack of antiviral response|0|||
33618011|NCT01132313|102151433|FG009|Overall Study|Lack of antiviral response|0|||
33618012|NCT01132313|102151434|FG010|Overall Study|Lack of antiviral response|1|||
33618013|NCT01132313|102151435|FG011|Overall Study|Lack of antiviral response|0|||
33216116|NCT01313286|100688743|FG001|Period 1|Withdrawal by Subject|0|||
33618014|NCT01132313|102151424|FG000|Overall Study|Other reason not defined above|0|||
33618015|NCT01132313|102151425|FG001|Overall Study|Other reason not defined above|0|||
33618016|NCT01132313|102151426|FG002|Overall Study|Other reason not defined above|0|||
33618017|NCT01132313|102151427|FG003|Overall Study|Other reason not defined above|0|||
33618018|NCT01132313|102151428|FG004|Overall Study|Other reason not defined above|0|||
33618019|NCT01132313|102151429|FG005|Overall Study|Other reason not defined above|0|||
33618020|NCT01132313|102151430|FG006|Overall Study|Other reason not defined above|0|||
33618021|NCT01132313|102151431|FG007|Overall Study|Other reason not defined above|1|||
33618022|NCT01132313|102151432|FG008|Overall Study|Other reason not defined above|0|||
33618023|NCT01132313|102151433|FG009|Overall Study|Other reason not defined above|0|||
33618024|NCT01132313|102151434|FG010|Overall Study|Other reason not defined above|0|||
33618025|NCT01132313|102151435|FG011|Overall Study|Other reason not defined above|0|||
33618026|NCT01442714|102151436|FG000|Overall Study|Death|11|||
33618027|NCT01442714|102151436|FG000|Overall Study|Withdrawal by Subject|1|||
33618028|NCT00930553|102151437|FG000|Overall Study|Adverse Event|1|||
33618029|NCT00930553|102151437|FG000|Overall Study|Lack of Efficacy|7|||
33618030|NCT00930553|102151437|FG000|Overall Study|Physician Decision|39|||
33618031|NCT00930553|102151437|FG000|Overall Study|Protocol Violation|1|||
33618032|NCT00930553|102151437|FG000|Overall Study|Pregnancy|1|||
33618033|NCT00930553|102151437|FG000|Overall Study|Withdrawal by Subject|88|||
33618034|NCT00930553|102151437|FG000|Overall Study|Lost to Follow-up|25|||
33618035|NCT00930553|102151437|FG000|Overall Study|Death|9|||
33618036|NCT00930553|102151437|FG000|Overall Study|Study terminated by sponsor|24|||
33618037|NCT00930553|102151437|FG000|Overall Study|Other than specified above|28|||
33618038|NCT01505374|102151438|FG000|Overall Study|Lost to Follow-up|1|||
33216117|NCT02219048|100688749|FG000|Overall Study|Adverse Event|2|||
33216118|NCT02219048|100688750|FG001|Overall Study|Adverse Event|5|||
33216119|NCT02219048|100688749|FG000|Overall Study|No longer meets eligibility criteria|1|||
33216120|NCT02219048|100688750|FG001|Overall Study|No longer meets eligibility criteria|0|||
33349545|NCT03896295|101167492|FG001|Overall Study|Adverse Event|1|||
33349546|NCT03896295|101167491|FG000|Overall Study|COVID-19|7|||
33349547|NCT03896295|101167492|FG001|Overall Study|COVID-19|29|||
33349548|NCT03486392|101167493|FG000|Overall Study|Lost to Follow-up|0|||
33349549|NCT03486392|101167494|FG001|Overall Study|Lost to Follow-up|0|||
33349550|NCT03486392|101167495|FG002|Overall Study|Lost to Follow-up|8|||
33349551|NCT03486392|101167496|FG003|Overall Study|Lost to Follow-up|5|||
33349552|NCT03486392|101167497|FG004|Overall Study|Lost to Follow-up|2|||
33349553|NCT03486392|101167493|FG000|Overall Study|Withdrawal by Subject|3|||
33349554|NCT03486392|101167494|FG001|Overall Study|Withdrawal by Subject|0|||
33349555|NCT03486392|101167495|FG002|Overall Study|Withdrawal by Subject|6|||
33349556|NCT03486392|101167496|FG003|Overall Study|Withdrawal by Subject|4|||
33349557|NCT03486392|101167497|FG004|Overall Study|Withdrawal by Subject|1|||
33349558|NCT03486392|101167493|FG000|Overall Study|Death|0|||
33349559|NCT03486392|101167494|FG001|Overall Study|Death|0|||
33349560|NCT03486392|101167495|FG002|Overall Study|Death|0|||
33549188|NCT00447278|101908518|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
33549189|NCT00447278|101908519|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
33549190|NCT00447278|101908518|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
33549191|NCT00447278|101908519|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
33549192|NCT00447278|101908518|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
33549193|NCT00447278|101908519|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
33549194|NCT00447278|101908518|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
33549195|NCT00447278|101908519|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
33549196|NCT00447278|101908518|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
33549197|NCT00447278|101908519|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
33549198|NCT00447278|101908518|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
33549199|NCT00447278|101908519|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
33549200|NCT00447278|101908518|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
33549201|NCT00447278|101908519|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
33549202|NCT00447278|101908518|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
33549203|NCT00447278|101908519|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
33549204|NCT00447278|101908518|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
33549205|NCT00447278|101908519|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
33549206|NCT00447278|101908518|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
33549207|NCT00447278|101908519|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
33549208|NCT00827242|101908521|FG000|Overall Study|Withdrawal by Subject|2|||
33549209|NCT00827242|101908522|FG001|Overall Study|Withdrawal by Subject|4|||
33549210|NCT00827242|101908521|FG000|Overall Study|Protocol Violation|1|||
33549211|NCT00827242|101908522|FG001|Overall Study|Protocol Violation|3|||
33549212|NCT00827242|101908521|FG000|Overall Study|Lost to Follow-up|0|||
33549213|NCT00827242|101908522|FG001|Overall Study|Lost to Follow-up|3|||
33549214|NCT00827242|101908521|FG000|Overall Study|Adverse Event Excluding Death|2|||
33549215|NCT00827242|101908522|FG001|Overall Study|Adverse Event Excluding Death|1|||
33549216|NCT00827242|101908521|FG000|Overall Study|Entry Criteria Not Met|4|||
33618039|NCT01505374|102151439|FG001|Overall Study|Lost to Follow-up|0|||
33618040|NCT01797263|102151446|FG000|Overall Study|Withdrawal by Subject|21|||
33618041|NCT01797263|102151447|FG001|Overall Study|Withdrawal by Subject|25|||
33618042|NCT01797263|102151446|FG000|Overall Study|Death|1|||
33549217|NCT00827242|101908522|FG001|Overall Study|Entry Criteria Not Met|1|||
33549218|NCT00827242|101908521|FG000|Overall Study|Physician Decision|2|||
33549219|NCT00827242|101908522|FG001|Overall Study|Physician Decision|0|||
33549220|NCT00827242|101908521|FG000|Overall Study|Death|1|||
33410043|NCT00650806|101389422|FG003|Overall Study|Withdrawal by Subject|6|||
33410044|NCT00650806|101389419|FG000|Overall Study|Noncompliance with study drug regimen|1|||
33410045|NCT00650806|101389420|FG001|Overall Study|Noncompliance with study drug regimen|1|||
33410046|NCT00650806|101389421|FG002|Overall Study|Noncompliance with study drug regimen|0|||
33410047|NCT00650806|101389422|FG003|Overall Study|Noncompliance with study drug regimen|0|||
33410048|NCT00650806|101389419|FG000|Overall Study|Study terminated by sponsor|2|||
33410049|NCT00650806|101389420|FG001|Overall Study|Study terminated by sponsor|3|||
33410050|NCT00650806|101389421|FG002|Overall Study|Study terminated by sponsor|5|||
33410051|NCT00650806|101389422|FG003|Overall Study|Study terminated by sponsor|4|||
33618043|NCT01797263|102151447|FG001|Overall Study|Death|0|||
33618044|NCT01797263|102151446|FG000|Overall Study|Lost to Follow-up|15|||
33618045|NCT01797263|102151447|FG001|Overall Study|Lost to Follow-up|15|||
33618046|NCT03748641|102151448|FG000|Overall Study|Ongoing|155|||
33618047|NCT03748641|102151449|FG001|Overall Study|Ongoing|148|||
33618048|NCT03748641|102151450|FG002|Overall Study|Ongoing|66|||
33618049|NCT03748641|102151451|FG003|Overall Study|Ongoing|79|||
33618050|NCT03748641|102151452|FG004|Overall Study|Ongoing|84|||
33618051|NCT03748641|102151448|FG000|Overall Study|Death|54|||
33618052|NCT03748641|102151449|FG001|Overall Study|Death|59|||
33618053|NCT03748641|102151450|FG002|Overall Study|Death|51|||
33618054|NCT03748641|102151451|FG003|Overall Study|Death|42|||
33618055|NCT03748641|102151452|FG004|Overall Study|Death|9|||
33618056|NCT03748641|102151448|FG000|Overall Study|Lost to Follow-up|0|||
33618057|NCT03748641|102151449|FG001|Overall Study|Lost to Follow-up|2|||
33618058|NCT03748641|102151450|FG002|Overall Study|Lost to Follow-up|1|||
33618059|NCT03748641|102151451|FG003|Overall Study|Lost to Follow-up|0|||
33618060|NCT03748641|102151452|FG004|Overall Study|Lost to Follow-up|0|||
33618061|NCT03748641|102151448|FG000|Overall Study|Withdrawal by Subject|3|||
33618062|NCT03748641|102151449|FG001|Overall Study|Withdrawal by Subject|2|||
33618063|NCT03748641|102151450|FG002|Overall Study|Withdrawal by Subject|5|||
33618064|NCT03748641|102151451|FG003|Overall Study|Withdrawal by Subject|3|||
33618065|NCT03748641|102151452|FG004|Overall Study|Withdrawal by Subject|2|||
33618066|NCT02292719|102151453|FG000|Overall Study|Withdrawal by Subject|0|||
33618067|NCT02292719|102151454|FG001|Overall Study|Withdrawal by Subject|0|||
33618068|NCT02292719|102151455|FG002|Overall Study|Withdrawal by Subject|0|||
33410052|NCT00650806|101389419|FG000|Overall Study|Other|1|||
33410053|NCT00650806|101389420|FG001|Overall Study|Other|1|||
33410054|NCT00650806|101389421|FG002|Overall Study|Other|2|||
33410055|NCT00650806|101389422|FG003|Overall Study|Other|0|||
33549221|NCT00827242|101908522|FG001|Overall Study|Death|0|||
33549222|NCT00827242|101908521|FG000|Overall Study|Lack of Efficacy|1|||
33549223|NCT00827242|101908522|FG001|Overall Study|Lack of Efficacy|0|||
33549224|NCT00992836|101908524|FG000|Overall Study|Lost to Follow-up|1|||
33549225|NCT00992836|101908524|FG000|Overall Study|Withdrawal by Subject|2|||
33549226|NCT00992836|101908524|FG000|Overall Study|Protocol Violation|2|||
33549227|NCT01327703|101908525|FG000|Second Treatment Period|Adverse Event|1|||
33549228|NCT01327703|101908526|FG001|Second Treatment Period|Adverse Event|1|||
33549229|NCT01327703|101908525|FG000|Second Treatment Period|Protocol Violation|0|||
33549230|NCT01327703|101908526|FG001|Second Treatment Period|Protocol Violation|1|||
33549231|NCT01671059|101908529|FG000|Overall Study|Adverse Event|4|||
33549232|NCT01671059|101908529|FG000|Overall Study|Lack of Efficacy|1|||
33549233|NCT02406612|101908530|FG000|Overall Study|Screening Failure|3|||
33549234|NCT02406612|101908531|FG001|Overall Study|Screening Failure|0|||
33549235|NCT02406612|101908530|FG000|Overall Study|Intra-procedural Exclusion|1|||
33549236|NCT02406612|101908531|FG001|Overall Study|Intra-procedural Exclusion|3|||
33549237|NCT02406612|101908530|FG000|Overall Study|Guidewire Failure|0|||
33549238|NCT02406612|101908531|FG001|Overall Study|Guidewire Failure|1|||
33549239|NCT02788045|101908532|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
33549240|NCT02788045|101908533|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
33549241|NCT02788045|101908534|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
33549242|NCT02788045|101908532|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
33549243|NCT02788045|101908533|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
33549244|NCT02788045|101908534|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
33618069|NCT02292719|102151456|FG003|Overall Study|Withdrawal by Subject|1|||
33618070|NCT02292719|102151457|FG004|Overall Study|Withdrawal by Subject|1|||
33618071|NCT02292719|102151458|FG005|Overall Study|Withdrawal by Subject|0|||
33618072|NCT02292719|102151453|FG000|Overall Study|Subject enrolled in new study.|0|||
33618073|NCT02292719|102151454|FG001|Overall Study|Subject enrolled in new study.|0|||
33410056|NCT02067728|101389423|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
33549245|NCT02788045|101908532|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
33549246|NCT02788045|101908533|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
33549247|NCT02788045|101908534|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
33549248|NCT02788045|101908532|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
33549249|NCT02788045|101908533|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
33618074|NCT02292719|102151455|FG002|Overall Study|Subject enrolled in new study.|1|||
33549250|NCT02788045|101908534|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
33549251|NCT02788045|101908532|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
33549252|NCT02788045|101908533|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
33549253|NCT02788045|101908534|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
33549254|NCT02788045|101908532|FG000|Main Study (Up to Week 72)|Other|3|||
33549255|NCT02788045|101908533|FG001|Main Study (Up to Week 72)|Other|0|||
33549256|NCT02788045|101908534|FG002|Main Study (Up to Week 72)|Other|0|||
33549257|NCT02788045|101908532|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
33549258|NCT02788045|101908533|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
33549259|NCT02788045|101908534|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
33549260|NCT02788045|101908532|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
33549261|NCT02788045|101908533|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
33549262|NCT02788045|101908534|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
33549263|NCT02788045|101908532|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
33549264|NCT02788045|101908533|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
33549265|NCT02788045|101908534|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
33549266|NCT01214720|101908535|FG000|Overall Study|Alive and still on treatment|34|||
33349561|NCT03486392|101167496|FG003|Overall Study|Death|0|||
33349562|NCT03486392|101167497|FG004|Overall Study|Death|1|||
33349563|NCT00388947|101167501|FG000|Overall Study|Protocol Violation|47|||
33349564|NCT00473876|101167502|FG000|Overall Study|Lost to Follow-up|3|||
33349565|NCT00473876|101167503|FG001|Overall Study|Lost to Follow-up|1|||
33349566|NCT02197377|101167504|FG000|Overall Study|Insertion Failure|0|||
33349567|NCT02197377|101167505|FG001|Overall Study|Insertion Failure|3|||
33349568|NCT01955707|101167506|FG000|Overall Study|Adverse Event|1|||
33349569|NCT01955707|101167507|FG001|Overall Study|Adverse Event|2|||
33349570|NCT01955707|101167506|FG000|Overall Study|Lost to Follow-up|2|||
33349571|NCT01955707|101167507|FG001|Overall Study|Lost to Follow-up|1|||
33349572|NCT01955707|101167506|FG000|Overall Study|Withdrawal by Subject|0|||
33349573|NCT01955707|101167507|FG001|Overall Study|Withdrawal by Subject|3|||
33349574|NCT01955707|101167506|FG000|Overall Study|Death|13|||
33549267|NCT01214720|101908536|FG001|Overall Study|Alive and still on treatment|18|||
33549268|NCT01214720|101908535|FG000|Overall Study|Alive and in follow-up|45|||
33549269|NCT01214720|101908536|FG001|Overall Study|Alive and in follow-up|48|||
33549270|NCT01214720|101908535|FG000|Overall Study|Lost to Follow-up|6|||
33549271|NCT01214720|101908536|FG001|Overall Study|Lost to Follow-up|2|||
33549272|NCT02709369|101908537|FG000|Overall Study|Lost to Follow-up|15|||
33549273|NCT02709369|101908537|FG000|Overall Study|Withdrawal by Subject|10|||
33549274|NCT02709369|101908537|FG000|Overall Study|Did not received intervention|2|||
33549275|NCT01751685|101908538|FG000|6-mo Followup|Missed study visit|1|||
33549276|NCT01751685|101908539|FG001|6-mo Followup|Missed study visit|0|||
33549277|NCT01751685|101908538|FG000|6-mo Followup|Withdrawal by Subject|2|||
33549278|NCT01751685|101908539|FG001|6-mo Followup|Withdrawal by Subject|2|||
33549279|NCT01751685|101908538|FG000|6-mo Followup|Lost to Follow-up|0|||
33549280|NCT01751685|101908539|FG001|6-mo Followup|Lost to Follow-up|1|||
33549281|NCT01751685|101908538|FG000|12-mo Followup|Lost to Follow-up|5|||
33549282|NCT01751685|101908539|FG001|12-mo Followup|Lost to Follow-up|0|||
33216121|NCT02219048|100688749|FG000|Overall Study|Study terminated by sponsor|16|||
33349575|NCT01955707|101167507|FG001|Overall Study|Death|14|||
33349576|NCT01955707|101167506|FG000|Overall Study|Other|4|||
33349577|NCT01955707|101167507|FG001|Overall Study|Other|2|||
33549283|NCT02441283|101908540|FG000|Overall Study|Withdrew consent|15|||
33549284|NCT02441283|101908540|FG000|Overall Study|Lost to Follow-up|42|||
33549285|NCT02441283|101908540|FG000|Overall Study|Death|1|||
33349578|NCT02949128|101167508|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
33618075|NCT02292719|102151456|FG003|Overall Study|Subject enrolled in new study.|0|||
33549286|NCT02441283|101908540|FG000|Overall Study|Other, not specified|32|||
33549287|NCT03822416|101908541|FG000|Overall Study|Lost to Follow-up|1|||
33549288|NCT03822416|101908542|FG001|Overall Study|Lost to Follow-up|0|||
33549289|NCT03822416|101908541|FG000|Overall Study|Withdrawal by Subject|0|||
33549290|NCT03822416|101908542|FG001|Overall Study|Withdrawal by Subject|1|||
33549291|NCT02181738|101908546|FG000|Overall Study|Participant Withdrew Consent|2|||
33549292|NCT02181738|101908547|FG001|Overall Study|Participant Withdrew Consent|1|||
33216122|NCT02219048|100688750|FG001|Overall Study|Study terminated by sponsor|15|||
33549293|NCT02181738|101908548|FG002|Overall Study|Participant Withdrew Consent|1|||
33549294|NCT02181738|101908549|FG003|Overall Study|Participant Withdrew Consent|1|||
33549295|NCT02181738|101908546|FG000|Overall Study|Lost to Follow-up|1|||
33549296|NCT02181738|101908547|FG001|Overall Study|Lost to Follow-up|2|||
33549297|NCT02181738|101908548|FG002|Overall Study|Lost to Follow-up|1|||
33549298|NCT02181738|101908549|FG003|Overall Study|Lost to Follow-up|1|||
33549299|NCT02181738|101908546|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
33549300|NCT02181738|101908547|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
33549301|NCT02181738|101908548|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
33549302|NCT02181738|101908549|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
33549303|NCT02181738|101908546|FG000|Overall Study|Poor/Non-Compliance|1|||
33549304|NCT02181738|101908547|FG001|Overall Study|Poor/Non-Compliance|0|||
33549305|NCT02181738|101908548|FG002|Overall Study|Poor/Non-Compliance|2|||
33549306|NCT02181738|101908549|FG003|Overall Study|Poor/Non-Compliance|1|||
33549307|NCT02181738|101908546|FG000|Overall Study|Disease Progression|28|||
33549308|NCT02181738|101908547|FG001|Overall Study|Disease Progression|35|||
33549309|NCT02181738|101908548|FG002|Overall Study|Disease Progression|40|||
33549310|NCT02181738|101908549|FG003|Overall Study|Disease Progression|0|||
33549311|NCT02181738|101908546|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
33549312|NCT02181738|101908547|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
33549313|NCT02181738|101908548|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
33549314|NCT02181738|101908549|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
33549315|NCT02181738|101908546|FG000|Overall Study|Study Drug Toxicity|6|||
33549316|NCT02181738|101908547|FG001|Overall Study|Study Drug Toxicity|11|||
33549317|NCT02181738|101908548|FG002|Overall Study|Study Drug Toxicity|8|||
33549318|NCT02181738|101908549|FG003|Overall Study|Study Drug Toxicity|1|||
33549319|NCT02181738|101908546|FG000|Overall Study|Other Reasons|14|||
33549320|NCT02181738|101908547|FG001|Overall Study|Other Reasons|16|||
33549321|NCT02181738|101908548|FG002|Overall Study|Other Reasons|28|||
33618076|NCT02292719|102151457|FG004|Overall Study|Subject enrolled in new study.|0|||
33618077|NCT02292719|102151458|FG005|Overall Study|Subject enrolled in new study.|0|||
33618078|NCT02969356|102151459|FG000|Overall Study|Adverse Event|7|||
33618079|NCT02969356|102151459|FG000|Overall Study|Consent withdrawn|2|||
33618080|NCT02969356|102151459|FG000|Overall Study|Lost to Follow-up|3|||
33618081|NCT02969356|102151459|FG000|Overall Study|Did not need to be reinjected|6|||
33618082|NCT02969356|102151459|FG000|Overall Study|Personal reasons|5|||
33618083|NCT03160898|102151460|FG000|Overall Study|Adverse Event|4|||
33618084|NCT03160898|102151461|FG001|Overall Study|Adverse Event|8|||
33618085|NCT03160898|102151462|FG002|Overall Study|Adverse Event|7|||
33618086|NCT03160898|102151463|FG003|Overall Study|Adverse Event|10|||
33618087|NCT03160898|102151460|FG000|Overall Study|Death|1|||
33618088|NCT03160898|102151461|FG001|Overall Study|Death|0|||
33618089|NCT03160898|102151462|FG002|Overall Study|Death|0|||
33618090|NCT03160898|102151463|FG003|Overall Study|Death|1|||
33618091|NCT03160898|102151460|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
33618092|NCT03160898|102151461|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
33618093|NCT03160898|102151462|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
33618094|NCT03160898|102151463|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
33618095|NCT03160898|102151460|FG000|Overall Study|Lost to Follow-up|1|||
33618096|NCT03160898|102151461|FG001|Overall Study|Lost to Follow-up|1|||
33618097|NCT03160898|102151462|FG002|Overall Study|Lost to Follow-up|1|||
33618098|NCT03160898|102151463|FG003|Overall Study|Lost to Follow-up|2|||
33618099|NCT03160898|102151460|FG000|Overall Study|Physician Decision|1|||
33618100|NCT03160898|102151461|FG001|Overall Study|Physician Decision|0|||
33618101|NCT03160898|102151462|FG002|Overall Study|Physician Decision|0|||
33618102|NCT03160898|102151463|FG003|Overall Study|Physician Decision|1|||
33618103|NCT03160898|102151460|FG000|Overall Study|Progressive Disease|4|||
33618104|NCT03160898|102151461|FG001|Overall Study|Progressive Disease|1|||
33618105|NCT03160898|102151462|FG002|Overall Study|Progressive Disease|2|||
33618106|NCT03160898|102151463|FG003|Overall Study|Progressive Disease|1|||
33618107|NCT03160898|102151460|FG000|Overall Study|Protocol Violation|1|||
33618108|NCT03160898|102151461|FG001|Overall Study|Protocol Violation|0|||
33618109|NCT03160898|102151462|FG002|Overall Study|Protocol Violation|2|||
33618110|NCT03160898|102151463|FG003|Overall Study|Protocol Violation|0|||
33618111|NCT03160898|102151460|FG000|Overall Study|Sponsor Discretion|2|||
33549322|NCT02181738|101908549|FG003|Overall Study|Other Reasons|0|||
33549323|NCT02181738|101908546|FG000|Overall Study|Maximum Clinical Benefit|3|||
33549324|NCT02181738|101908547|FG001|Overall Study|Maximum Clinical Benefit|0|||
33549325|NCT02181738|101908548|FG002|Overall Study|Maximum Clinical Benefit|1|||
33549326|NCT02181738|101908549|FG003|Overall Study|Maximum Clinical Benefit|0|||
33549327|NCT02181738|101908546|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
33549328|NCT02181738|101908547|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
33549329|NCT02181738|101908548|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
33549330|NCT02181738|101908549|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33549331|NCT03259308|101908550|FG000|Overall Study|Adverse Event|5|||
33549332|NCT03259308|101908551|FG001|Overall Study|Adverse Event|4|||
33549333|NCT03259308|101908552|FG002|Overall Study|Adverse Event|1|||
33549334|NCT03259308|101908550|FG000|Overall Study|Withdrawal by Subject|2|||
33549335|NCT03259308|101908551|FG001|Overall Study|Withdrawal by Subject|1|||
33549336|NCT03259308|101908552|FG002|Overall Study|Withdrawal by Subject|3|||
33549337|NCT03259308|101908550|FG000|Overall Study|Lost to Follow-up|0|||
33549338|NCT03259308|101908551|FG001|Overall Study|Lost to Follow-up|0|||
33549339|NCT03259308|101908552|FG002|Overall Study|Lost to Follow-up|1|||
33549340|NCT03259308|101908550|FG000|Overall Study|Pregnancy|0|||
33549341|NCT03259308|101908551|FG001|Overall Study|Pregnancy|0|||
33549342|NCT03259308|101908552|FG002|Overall Study|Pregnancy|1|||
33549343|NCT03259308|101908550|FG000|Overall Study|Protocol Deviation|0|||
33549344|NCT03259308|101908551|FG001|Overall Study|Protocol Deviation|3|||
33549345|NCT03259308|101908552|FG002|Overall Study|Protocol Deviation|0|||
33549346|NCT03259308|101908550|FG000|Overall Study|Lack of Efficacy|0|||
33549347|NCT03259308|101908551|FG001|Overall Study|Lack of Efficacy|0|||
33618112|NCT03160898|102151461|FG001|Overall Study|Sponsor Discretion|0|||
33216123|NCT02219048|100688749|FG000|Overall Study|Withdrawal by Subject|2|||
33549348|NCT03259308|101908552|FG002|Overall Study|Lack of Efficacy|1|||
33618113|NCT03160898|102151462|FG002|Overall Study|Sponsor Discretion|0|||
33618114|NCT03160898|102151463|FG003|Overall Study|Sponsor Discretion|0|||
33618115|NCT03160898|102151460|FG000|Overall Study|Withdrawal by Subject|1|||
33549349|NCT01771913|101908556|FG000|Overall Study|Withdrawal by Subject|1|||
33549350|NCT01771913|101908557|FG001|Overall Study|Withdrawal by Subject|0|||
33549351|NCT00103506|101908560|FG000|Overall Study|Study closed by sponsor|34|||
33618116|NCT03160898|102151461|FG001|Overall Study|Withdrawal by Subject|3|||
33618117|NCT03160898|102151462|FG002|Overall Study|Withdrawal by Subject|2|||
33618118|NCT03160898|102151463|FG003|Overall Study|Withdrawal by Subject|1|||
33549352|NCT00103506|101908561|FG001|Overall Study|Study closed by sponsor|37|||
33549353|NCT00103506|101908560|FG000|Overall Study|Death|257|||
33618119|NCT03160898|102151460|FG000|Overall Study|Other|2|||
33349579|NCT02949128|101167508|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
33349580|NCT02949128|101167508|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
33349581|NCT02949128|101167508|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
33349582|NCT02949128|101167508|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
33618120|NCT03160898|102151461|FG001|Overall Study|Other|0|||
33349583|NCT02949128|101167508|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
33349584|NCT02949128|101167508|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
33349585|NCT02949128|101167508|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
33349586|NCT02949128|101167508|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
33349587|NCT02949128|101167508|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
33349588|NCT04698525|101167509|FG000|Overall Study|Lost to Follow-up|1|||
33349589|NCT04698525|101167510|FG001|Overall Study|Lost to Follow-up|2|||
33349590|NCT04698525|101167509|FG000|Overall Study|Three suffered of Covid-19|2|||
33349591|NCT04698525|101167510|FG001|Overall Study|Three suffered of Covid-19|1|||
33349592|NCT01940484|101167513|FG000|Overall Study|Withdrawal by Subject|3|||
33349593|NCT01940484|101167513|FG000|Overall Study|Underwent transplantation|4|||
33349594|NCT01940484|101167513|FG000|Overall Study|Death|2|||
33349595|NCT01940484|101167513|FG000|Overall Study|Adverse Event|1|||
33349596|NCT03283085|101167514|FG000|Overall Study|Adverse Event|18|||
33349597|NCT03283085|101167515|FG001|Overall Study|Adverse Event|3|||
33349598|NCT03283085|101167516|FG002|Overall Study|Adverse Event|13|||
33549354|NCT00103506|101908561|FG001|Overall Study|Death|253|||
33549355|NCT00103506|101908560|FG000|Overall Study|Lost to Follow-up|13|||
33549356|NCT00103506|101908561|FG001|Overall Study|Lost to Follow-up|13|||
33549357|NCT00103506|101908560|FG000|Overall Study|Withdrawal by Subject|18|||
33549358|NCT00103506|101908561|FG001|Overall Study|Withdrawal by Subject|21|||
33549359|NCT00884949|101908562|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
33549360|NCT00884949|101908562|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
33549361|NCT02347787|101908563|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
33549362|NCT02347787|101908564|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
33549363|NCT02347787|101908563|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
33549364|NCT02347787|101908564|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
33549365|NCT02347787|101908563|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
33349599|NCT03283085|101167517|FG003|Overall Study|Adverse Event|0|||
33349600|NCT03283085|101167518|FG004|Overall Study|Adverse Event|0|||
33349601|NCT03283085|101167519|FG005|Overall Study|Adverse Event|5|||
33349602|NCT03283085|101167514|FG000|Overall Study|Death|0|||
33349603|NCT03283085|101167515|FG001|Overall Study|Death|0|||
33349604|NCT03283085|101167516|FG002|Overall Study|Death|3|||
33349605|NCT03283085|101167517|FG003|Overall Study|Death|1|||
33349606|NCT03283085|101167518|FG004|Overall Study|Death|0|||
33349607|NCT03283085|101167519|FG005|Overall Study|Death|0|||
33549366|NCT02347787|101908564|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
33549367|NCT02347787|101908563|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
33549368|NCT02347787|101908564|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
33549369|NCT01181128|101908565|FG000|Overall Study|Withdrawal by Subject|2|||
33549370|NCT01181128|101908566|FG001|Overall Study|Withdrawal by Subject|2|||
33549371|NCT01181128|101908567|FG002|Overall Study|Withdrawal by Subject|0|||
33549372|NCT01181128|101908565|FG000|Overall Study|Death|1|||
33549373|NCT01181128|101908566|FG001|Overall Study|Death|0|||
33549374|NCT01181128|101908567|FG002|Overall Study|Death|0|||
33549375|NCT01181128|101908565|FG000|Overall Study|Physician Decision|2|||
33549376|NCT01181128|101908566|FG001|Overall Study|Physician Decision|0|||
33549377|NCT01181128|101908567|FG002|Overall Study|Physician Decision|0|||
33549378|NCT01181128|101908565|FG000|Overall Study|Adverse Event|0|||
33549379|NCT01181128|101908566|FG001|Overall Study|Adverse Event|2|||
33549380|NCT01181128|101908567|FG002|Overall Study|Adverse Event|0|||
33549381|NCT01181128|101908565|FG000|Overall Study|Other|1|||
33549382|NCT01181128|101908566|FG001|Overall Study|Other|1|||
33549383|NCT01181128|101908567|FG002|Overall Study|Other|1|||
33549384|NCT00032487|101908568|FG000|Overall Study|Withdrawal by Subject|67|||
33618121|NCT03160898|102151462|FG002|Overall Study|Other|2|||
33618122|NCT03160898|102151463|FG003|Overall Study|Other|2|||
33618123|NCT01959841|102151464|FG000|Overall Study|Adverse Event|1|||
33618124|NCT01959841|102151465|FG001|Overall Study|Adverse Event|3|||
33618125|NCT01959841|102151466|FG002|Overall Study|Adverse Event|2|||
33349608|NCT03283085|101167514|FG000|Overall Study|Withdrawal by Subject|42|||
33349609|NCT03283085|101167515|FG001|Overall Study|Withdrawal by Subject|21|||
33349610|NCT03283085|101167516|FG002|Overall Study|Withdrawal by Subject|66|||
33349611|NCT03283085|101167517|FG003|Overall Study|Withdrawal by Subject|3|||
33349612|NCT03283085|101167518|FG004|Overall Study|Withdrawal by Subject|3|||
33549385|NCT00032487|101908569|FG001|Overall Study|Withdrawal by Subject|43|||
33549386|NCT00032487|101908568|FG000|Overall Study|Adverse Event|3|||
33549387|NCT00032487|101908569|FG001|Overall Study|Adverse Event|7|||
33618126|NCT01959841|102151464|FG000|Overall Study|Lack of Efficacy|5|||
33549388|NCT00032487|101908568|FG000|Overall Study|Lost to Follow-up|57|||
33549389|NCT00032487|101908569|FG001|Overall Study|Lost to Follow-up|58|||
33549390|NCT00032487|101908568|FG000|Overall Study|Had other reason|12|||
33549391|NCT00032487|101908569|FG001|Overall Study|Had other reason|12|||
33549392|NCT00614393|101908570|FG000|Overall Study|Adverse Event|20|||
33549393|NCT00614393|101908571|FG001|Overall Study|Adverse Event|2|||
33549394|NCT00614393|101908572|FG002|Overall Study|Adverse Event|3|||
33549395|NCT00614393|101908573|FG003|Overall Study|Adverse Event|13|||
33549396|NCT00614393|101908574|FG004|Overall Study|Adverse Event|21|||
33549397|NCT00614393|101908570|FG000|Overall Study|Lost to Follow-up|0|||
33549398|NCT00614393|101908571|FG001|Overall Study|Lost to Follow-up|0|||
33549399|NCT00614393|101908572|FG002|Overall Study|Lost to Follow-up|0|||
33549400|NCT00614393|101908573|FG003|Overall Study|Lost to Follow-up|1|||
33549401|NCT00614393|101908574|FG004|Overall Study|Lost to Follow-up|2|||
33549402|NCT00614393|101908570|FG000|Overall Study|Physician Decision|17|||
33549403|NCT00614393|101908571|FG001|Overall Study|Physician Decision|0|||
33549404|NCT00614393|101908572|FG002|Overall Study|Physician Decision|1|||
33349613|NCT03283085|101167519|FG005|Overall Study|Withdrawal by Subject|5|||
33349614|NCT03283085|101167514|FG000|Overall Study|Physician Decision|14|||
33349615|NCT03283085|101167515|FG001|Overall Study|Physician Decision|8|||
33349616|NCT03283085|101167516|FG002|Overall Study|Physician Decision|19|||
33349617|NCT03283085|101167517|FG003|Overall Study|Physician Decision|0|||
33349618|NCT03283085|101167518|FG004|Overall Study|Physician Decision|0|||
33349619|NCT03283085|101167519|FG005|Overall Study|Physician Decision|2|||
33349620|NCT03283085|101167514|FG000|Overall Study|Site Terminated by Sponsor|1|||
33349621|NCT03283085|101167515|FG001|Overall Study|Site Terminated by Sponsor|0|||
33349622|NCT03283085|101167516|FG002|Overall Study|Site Terminated by Sponsor|3|||
33410057|NCT02067728|101389424|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
33410058|NCT02067728|101389423|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
33410059|NCT02067728|101389424|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
33410060|NCT02067728|101389423|FG000|6 Month Measurements|Unable to attend|114|||
33410061|NCT02067728|101389424|FG001|6 Month Measurements|Unable to attend|97|||
33549405|NCT00614393|101908573|FG003|Overall Study|Physician Decision|8|||
33549406|NCT00614393|101908574|FG004|Overall Study|Physician Decision|9|||
33549407|NCT00614393|101908570|FG000|Overall Study|Progressive Disease|118|||
33549408|NCT00614393|101908571|FG001|Overall Study|Progressive Disease|5|||
33549409|NCT00614393|101908572|FG002|Overall Study|Progressive Disease|5|||
33549410|NCT00614393|101908573|FG003|Overall Study|Progressive Disease|138|||
33549411|NCT00614393|101908574|FG004|Overall Study|Progressive Disease|130|||
33549412|NCT00614393|101908570|FG000|Overall Study|Protocol Violation|1|||
33549413|NCT00614393|101908571|FG001|Overall Study|Protocol Violation|0|||
33549414|NCT00614393|101908572|FG002|Overall Study|Protocol Violation|0|||
33549415|NCT00614393|101908573|FG003|Overall Study|Protocol Violation|0|||
33549416|NCT00614393|101908574|FG004|Overall Study|Protocol Violation|0|||
33549417|NCT00614393|101908570|FG000|Overall Study|Terminated by Sponsor|0|||
33549418|NCT00614393|101908571|FG001|Overall Study|Terminated by Sponsor|0|||
33549419|NCT00614393|101908572|FG002|Overall Study|Terminated by Sponsor|0|||
33549420|NCT00614393|101908573|FG003|Overall Study|Terminated by Sponsor|0|||
33349623|NCT03283085|101167517|FG003|Overall Study|Site Terminated by Sponsor|0|||
33410062|NCT00096031|101389425|FG000|Overall Study|Adverse Event|3|||
33410063|NCT00096031|101389425|FG000|Overall Study|Lack of Efficacy|42|||
33410064|NCT00096031|101389425|FG000|Overall Study|Death|4|||
33410065|NCT00096031|101389425|FG000|Overall Study|Withdrawal by Subject|1|||
33410066|NCT00096031|101389425|FG000|Overall Study|Ineligible|8|||
33410067|NCT00096031|101389425|FG000|Overall Study|Not protocol specified|5|||
33410068|NCT03831282|101389427|FG000|Overall Study|Could not place sensor|1|||
33410069|NCT03868059|101389428|FG000|Overall Study|Adverse Event|3|||
33410070|NCT03868059|101389428|FG000|Overall Study|Lost to Follow-up|3|||
33410071|NCT03868059|101389428|FG000|Overall Study|Withdrawal by Subject|6|||
33410072|NCT01326312|101389437|FG000|Overall Study|Adverse Event|11|||
33410073|NCT01326312|101389438|FG001|Overall Study|Adverse Event|11|||
33410074|NCT01326312|101389439|FG002|Overall Study|Adverse Event|1|||
33410075|NCT01326312|101389437|FG000|Overall Study|Withdrawal by Subject|1|||
33549421|NCT00614393|101908574|FG004|Overall Study|Terminated by Sponsor|1|||
33549422|NCT00614393|101908570|FG000|Overall Study|Withdrawal by Subject|20|||
33549423|NCT00614393|101908571|FG001|Overall Study|Withdrawal by Subject|1|||
33549424|NCT00614393|101908572|FG002|Overall Study|Withdrawal by Subject|1|||
33549425|NCT00614393|101908573|FG003|Overall Study|Withdrawal by Subject|16|||
33549426|NCT00614393|101908574|FG004|Overall Study|Withdrawal by Subject|13|||
33549427|NCT00614393|101908570|FG000|Overall Study|Other|4|||
33549428|NCT00614393|101908571|FG001|Overall Study|Other|0|||
33349624|NCT03283085|101167518|FG004|Overall Study|Site Terminated by Sponsor|0|||
33349625|NCT03283085|101167519|FG005|Overall Study|Site Terminated by Sponsor|0|||
33410076|NCT01326312|101389438|FG001|Overall Study|Withdrawal by Subject|2|||
33410077|NCT01326312|101389439|FG002|Overall Study|Withdrawal by Subject|1|||
33410078|NCT01326312|101389437|FG000|Overall Study|Protocol Violation|0|||
33549429|NCT00614393|101908572|FG002|Overall Study|Other|0|||
33549430|NCT00614393|101908573|FG003|Overall Study|Other|4|||
33549431|NCT00614393|101908574|FG004|Overall Study|Other|2|||
33549432|NCT00614393|101908570|FG000|Overall Study|Not Treated|0|||
33549433|NCT00614393|101908571|FG001|Overall Study|Not Treated|0|||
33549434|NCT00614393|101908572|FG002|Overall Study|Not Treated|0|||
33549435|NCT00614393|101908573|FG003|Overall Study|Not Treated|0|||
33549436|NCT00614393|101908574|FG004|Overall Study|Not Treated|2|||
33549437|NCT02448043|101908576|FG000|Overall Study|Withdrawal by Subject|2|||
33549438|NCT02448043|101908577|FG001|Overall Study|Withdrawal by Subject|2|||
33349626|NCT03283085|101167514|FG000|Overall Study|Lost to Follow-up|2|||
33349627|NCT03283085|101167515|FG001|Overall Study|Lost to Follow-up|0|||
33349628|NCT03283085|101167516|FG002|Overall Study|Lost to Follow-up|2|||
33349629|NCT03283085|101167517|FG003|Overall Study|Lost to Follow-up|0|||
33349630|NCT03283085|101167518|FG004|Overall Study|Lost to Follow-up|0|||
33349631|NCT03283085|101167519|FG005|Overall Study|Lost to Follow-up|1|||
33349632|NCT03283085|101167514|FG000|Overall Study|Pregnancy|0|||
33349633|NCT03283085|101167515|FG001|Overall Study|Pregnancy|0|||
33349634|NCT03283085|101167516|FG002|Overall Study|Pregnancy|1|||
33349635|NCT03283085|101167517|FG003|Overall Study|Pregnancy|0|||
33349636|NCT03283085|101167518|FG004|Overall Study|Pregnancy|0|||
33349637|NCT03283085|101167519|FG005|Overall Study|Pregnancy|0|||
33349638|NCT03283085|101167514|FG000|Overall Study|Lack of Efficacy|12|||
33349639|NCT03283085|101167515|FG001|Overall Study|Lack of Efficacy|6|||
33349640|NCT03283085|101167516|FG002|Overall Study|Lack of Efficacy|24|||
33618127|NCT01959841|102151465|FG001|Overall Study|Lack of Efficacy|0|||
33618128|NCT01959841|102151466|FG002|Overall Study|Lack of Efficacy|0|||
33216124|NCT02219048|100688750|FG001|Overall Study|Withdrawal by Subject|0|||
33349641|NCT03283085|101167517|FG003|Overall Study|Lack of Efficacy|1|||
33349642|NCT03283085|101167518|FG004|Overall Study|Lack of Efficacy|1|||
33349643|NCT03283085|101167519|FG005|Overall Study|Lack of Efficacy|0|||
33349644|NCT03283085|101167514|FG000|Overall Study|Reason not Specified|0|||
33349645|NCT03283085|101167515|FG001|Overall Study|Reason not Specified|4|||
33349646|NCT03283085|101167516|FG002|Overall Study|Reason not Specified|8|||
33349647|NCT03283085|101167517|FG003|Overall Study|Reason not Specified|0|||
33349648|NCT03283085|101167518|FG004|Overall Study|Reason not Specified|0|||
33349649|NCT03283085|101167519|FG005|Overall Study|Reason not Specified|1|||
33349650|NCT01756456|101167520|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
33349651|NCT01756456|101167521|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
33349652|NCT01756456|101167522|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
33349653|NCT01756456|101167523|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
33410079|NCT01326312|101389438|FG001|Overall Study|Protocol Violation|1|||
33410080|NCT01326312|101389439|FG002|Overall Study|Protocol Violation|0|||
33410081|NCT01326312|101389437|FG000|Overall Study|Lack of Efficacy|13|||
33410082|NCT01326312|101389438|FG001|Overall Study|Lack of Efficacy|7|||
33410083|NCT01326312|101389439|FG002|Overall Study|Lack of Efficacy|1|||
33410084|NCT01326312|101389437|FG000|Overall Study|Death|1|||
33410085|NCT01326312|101389438|FG001|Overall Study|Death|0|||
33410086|NCT01326312|101389439|FG002|Overall Study|Death|1|||
33410087|NCT01326312|101389437|FG000|Overall Study|progressive disease|0|||
33410088|NCT01326312|101389438|FG001|Overall Study|progressive disease|1|||
33410089|NCT01326312|101389439|FG002|Overall Study|progressive disease|1|||
33410090|NCT01326312|101389437|FG000|Overall Study|Study terminated by Sponsor|8|||
33410091|NCT01326312|101389438|FG001|Overall Study|Study terminated by Sponsor|32|||
33410092|NCT01326312|101389439|FG002|Overall Study|Study terminated by Sponsor|46|||
33410093|NCT01326312|101389437|FG000|Overall Study|Treatment arm terminated|19|||
33410094|NCT01326312|101389438|FG001|Overall Study|Treatment arm terminated|0|||
33410095|NCT01326312|101389439|FG002|Overall Study|Treatment arm terminated|0|||
33410096|NCT01326312|101389437|FG000|Overall Study|QTc > 500|0|||
33410097|NCT01326312|101389438|FG001|Overall Study|QTc > 500|1|||
33410098|NCT01326312|101389439|FG002|Overall Study|QTc > 500|0|||
33410099|NCT00593385|101389441|FG000|Overall Study|Death|14|||
33410100|NCT00593385|101389441|FG000|Overall Study|Lost to Follow-up|17|||
33410101|NCT00593385|101389441|FG000|Overall Study|Withdrawal by Subject|9|||
33410102|NCT00313716|101389442|FG000|Overall Study|Death|3|||
33410103|NCT00313716|101389443|FG001|Overall Study|Death|2|||
33349654|NCT01756456|101167524|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
33349655|NCT01756456|101167525|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
33349656|NCT01756456|101167520|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
33349657|NCT01756456|101167521|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
33349658|NCT01756456|101167522|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
33216125|NCT02219048|100688749|FG000|Overall Study|Other|0|||
33410104|NCT00313716|101389444|FG002|Overall Study|Death|9|||
33349659|NCT01756456|101167523|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
33410105|NCT00313716|101389445|FG003|Overall Study|Death|3|||
33410106|NCT00313716|101389446|FG004|Overall Study|Death|5|||
33549439|NCT02448043|101908576|FG000|Overall Study|Protocol Violation|1|||
33216126|NCT02219048|100688750|FG001|Overall Study|Other|1|||
33410107|NCT00313716|101389447|FG005|Overall Study|Death|9|||
33410108|NCT00313716|101389442|FG000|Overall Study|Lost to Follow-up|2|||
33410109|NCT00313716|101389443|FG001|Overall Study|Lost to Follow-up|5|||
33618129|NCT01959841|102151464|FG000|Overall Study|Lost to Follow-up|1|||
33349660|NCT01756456|101167524|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
33349661|NCT01756456|101167525|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
33349662|NCT01756456|101167520|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
33349663|NCT01756456|101167521|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
33349664|NCT01756456|101167522|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
33349665|NCT01756456|101167523|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
33349666|NCT01756456|101167524|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
33349667|NCT01756456|101167525|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
33549440|NCT02448043|101908577|FG001|Overall Study|Protocol Violation|2|||
33549441|NCT04333498|101908578|FG000|Overall Study|Lost to Follow-up|1|||
33549442|NCT04333498|101908579|FG001|Overall Study|Lost to Follow-up|0|||
33549443|NCT04333498|101908578|FG000|Overall Study|Lost to Follow-up|0|||
33549444|NCT04333498|101908579|FG001|Overall Study|Lost to Follow-up|1|||
33549445|NCT02932943|101908580|FG000|Overall Study|Lost to Follow-up|0|||
33549446|NCT02932943|101908581|FG001|Overall Study|Lost to Follow-up|2|||
33549447|NCT02932943|101908580|FG000|Overall Study|Adverse Event|2|||
33549448|NCT02932943|101908581|FG001|Overall Study|Adverse Event|2|||
33549449|NCT02932943|101908580|FG000|Overall Study|Withdrawal by Subject|3|||
33549450|NCT02932943|101908581|FG001|Overall Study|Withdrawal by Subject|3|||
33549451|NCT01588509|101908583|FG000|Overall Study|Lost to Follow-up|1|||
33549452|NCT01588509|101908584|FG001|Overall Study|Lost to Follow-up|0|||
33549453|NCT02320396|101908585|FG000|Overall Study|Adverse Event|2|||
33549454|NCT02320396|101908586|FG001|Overall Study|Adverse Event|2|||
33549455|NCT02320396|101908585|FG000|Overall Study|Pregnancy|0|||
33549456|NCT02320396|101908586|FG001|Overall Study|Pregnancy|1|||
33549457|NCT02320396|101908585|FG000|Overall Study|Protocol Violation|0|||
33549458|NCT02320396|101908586|FG001|Overall Study|Protocol Violation|1|||
33549459|NCT02320396|101908585|FG000|Overall Study|Withdrawal by Subject|2|||
33549460|NCT02320396|101908586|FG001|Overall Study|Withdrawal by Subject|0|||
33549461|NCT00462462|101908587|FG000|Overall Study|Physician Decision|0|||
33549462|NCT00462462|101908588|FG001|Overall Study|Physician Decision|1|||
33549463|NCT02315625|101908589|FG000|First Intervention|Disease Progression|1|||
33549464|NCT02315625|101908590|FG001|First Intervention|Disease Progression|0|||
33549465|NCT02315625|101908589|FG000|Second Intervention|Physician Decision|2|||
33549466|NCT02315625|101908590|FG001|Second Intervention|Physician Decision|1|||
33549467|NCT02315625|101908589|FG000|Second Intervention|Study closure|1|||
33549468|NCT02315625|101908590|FG001|Second Intervention|Study closure|0|||
33549469|NCT02315625|101908589|FG000|Second Intervention|Disease Progression|1|||
33549470|NCT02315625|101908590|FG001|Second Intervention|Disease Progression|0|||
33549471|NCT01402700|101908593|FG000|Overall Study|Death|3|||
33549472|NCT01402700|101908593|FG000|Overall Study|Withdrawal by Subject|3|||
33549473|NCT01402700|101908593|FG000|Overall Study|Missed Visit|1|||
33549474|NCT00002874|101908596|FG000|Overall Study|Withdrawal by Subject|1|||
33549475|NCT00002874|101908597|FG001|Overall Study|Withdrawal by Subject|1|||
33549476|NCT00002874|101908596|FG000|Overall Study|Protocol Violation|44|||
33549477|NCT00002874|101908597|FG001|Overall Study|Protocol Violation|34|||
33549478|NCT03298061|101908598|FG000|Overall Study|Adverse Event|3|||
33549479|NCT03298061|101908598|FG000|Overall Study|Lack of Efficacy|6|||
33549480|NCT03298061|101908598|FG000|Overall Study|Protocol Violation|1|||
33549481|NCT03298061|101908598|FG000|Overall Study|Physician Decision|7|||
33549482|NCT03298061|101908598|FG000|Overall Study|Withdrawal by Subject|10|||
33549483|NCT02397837|101908606|FG000|Overall Study|Withdrawal by Subject|6|||
33549484|NCT02397837|101908607|FG001|Overall Study|Withdrawal by Subject|5|||
33549485|NCT02397837|101908606|FG000|Overall Study|Physician Decision|1|||
33549486|NCT02397837|101908607|FG001|Overall Study|Physician Decision|1|||
33549487|NCT00954538|101908608|FG000|Part III|Withdrawal by Subject|0|||
33549488|NCT00954538|101908609|FG001|Part III|Withdrawal by Subject|0|||
33549489|NCT00954538|101908610|FG002|Part III|Withdrawal by Subject|0|||
33549490|NCT00954538|101908611|FG003|Part III|Withdrawal by Subject|0|||
33549491|NCT00954538|101908612|FG004|Part III|Withdrawal by Subject|1|||
33549492|NCT00954538|101908613|FG005|Part III|Withdrawal by Subject|0|||
33549493|NCT02965833|101908614|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
33549494|NCT02965833|101908615|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
33549495|NCT02965833|101908614|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
33549496|NCT02965833|101908615|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
33549497|NCT02965833|101908614|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
33549498|NCT02965833|101908615|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
33549499|NCT02965833|101908614|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
33549500|NCT02965833|101908615|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
33549501|NCT02965833|101908614|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
33549502|NCT02965833|101908615|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
33549503|NCT00849472|101908618|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
33549504|NCT00849472|101908618|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
33549505|NCT00849472|101908618|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
33549506|NCT00849472|101908618|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
33549507|NCT00849472|101908618|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
33549508|NCT00849472|101908618|FG000|Weekly Paclitaxel|Disease Progression|1|||
33549509|NCT00849472|101908618|FG000|Weekly Paclitaxel|Adverse Event|11|||
33549510|NCT00849472|101908618|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
33549511|NCT00849472|101908618|FG000|Weekly Paclitaxel|Physician Decision|3|||
33549512|NCT00849472|101908618|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
33549513|NCT00849472|101908618|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
33549514|NCT00849472|101908618|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
33549515|NCT00849472|101908618|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
33549516|NCT00849472|101908618|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
33549517|NCT00849472|101908618|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
33549518|NCT00849472|101908618|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
33549519|NCT00849472|101908618|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
33549520|NCT02665117|101908619|FG000|Overall Study|Physician Decision|1|||
33549521|NCT02665117|101908620|FG001|Overall Study|Physician Decision|0|||
33549522|NCT00504309|101908626|FG000|Overall Study|Death|0|||
33549523|NCT00504309|101908627|FG001|Overall Study|Death|0|||
33549524|NCT00504309|101908628|FG002|Overall Study|Death|0|||
33549525|NCT00504309|101908629|FG003|Overall Study|Death|0|||
33549526|NCT00504309|101908630|FG004|Overall Study|Death|1|||
33549527|NCT00504309|101908631|FG005|Overall Study|Death|0|||
33549528|NCT00504309|101908626|FG000|Overall Study|Withdrawal by Subject|0|||
33549529|NCT00504309|101908627|FG001|Overall Study|Withdrawal by Subject|0|||
33549530|NCT00504309|101908628|FG002|Overall Study|Withdrawal by Subject|1|||
33549531|NCT00504309|101908629|FG003|Overall Study|Withdrawal by Subject|0|||
33549532|NCT00504309|101908630|FG004|Overall Study|Withdrawal by Subject|0|||
33549533|NCT00504309|101908631|FG005|Overall Study|Withdrawal by Subject|0|||
33549534|NCT00920816|101908632|FG000|Overall Study|Death|116|||
33549535|NCT00920816|101908633|FG001|Overall Study|Death|63|||
33549536|NCT00920816|101908634|FG002|Overall Study|Death|8|||
33549537|NCT00920816|101908635|FG003|Overall Study|Death|3|||
33549538|NCT00920816|101908632|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
33549539|NCT00920816|101908633|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
33549540|NCT00920816|101908634|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
33549541|NCT00920816|101908635|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
33549542|NCT00920816|101908632|FG000|Overall Study|Global deterioration of health status|2|||
33549543|NCT00920816|101908633|FG001|Overall Study|Global deterioration of health status|0|||
33549544|NCT00920816|101908634|FG002|Overall Study|Global deterioration of health status|0|||
33549545|NCT00920816|101908635|FG003|Overall Study|Global deterioration of health status|0|||
33549546|NCT00920816|101908632|FG000|Overall Study|Objective progression or relapse|6|||
33549547|NCT00920816|101908633|FG001|Overall Study|Objective progression or relapse|2|||
33549548|NCT00920816|101908634|FG002|Overall Study|Objective progression or relapse|0|||
33349668|NCT01756456|101167520|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
33410110|NCT00313716|101389444|FG002|Overall Study|Lost to Follow-up|2|||
33410111|NCT00313716|101389445|FG003|Overall Study|Lost to Follow-up|1|||
33410112|NCT00313716|101389446|FG004|Overall Study|Lost to Follow-up|0|||
33410113|NCT00313716|101389447|FG005|Overall Study|Lost to Follow-up|4|||
33410114|NCT00313716|101389442|FG000|Overall Study|Withdrawal by Subject|0|||
33410115|NCT00313716|101389443|FG001|Overall Study|Withdrawal by Subject|1|||
33549549|NCT00920816|101908635|FG003|Overall Study|Objective progression or relapse|0|||
33549550|NCT00920816|101908632|FG000|Overall Study|Other|26|||
33549551|NCT00920816|101908633|FG001|Overall Study|Other|15|||
33549552|NCT00920816|101908634|FG002|Overall Study|Other|1|||
33549553|NCT00920816|101908635|FG003|Overall Study|Other|2|||
33349669|NCT01756456|101167521|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
33349670|NCT01756456|101167522|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
33349671|NCT01756456|101167523|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
33349672|NCT01756456|101167524|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
33349673|NCT01756456|101167525|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
33349674|NCT01756456|101167520|FG000|Treatment Period: Phase I/II|Other causes|0|||
33349675|NCT01756456|101167521|FG001|Treatment Period: Phase I/II|Other causes|0|||
33349676|NCT01756456|101167522|FG002|Treatment Period: Phase I/II|Other causes|0|||
33349677|NCT01756456|101167523|FG003|Treatment Period: Phase I/II|Other causes|1|||
33349678|NCT01756456|101167524|FG004|Treatment Period: Phase I/II|Other causes|2|||
33349679|NCT01756456|101167525|FG005|Treatment Period: Phase I/II|Other causes|2|||
33349680|NCT01756456|101167520|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
33349681|NCT01756456|101167521|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
33349682|NCT01756456|101167522|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
33349683|NCT01756456|101167523|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
33410116|NCT00313716|101389444|FG002|Overall Study|Withdrawal by Subject|1|||
33549554|NCT00920816|101908632|FG000|Overall Study|Lost to Follow-up|11|||
33549555|NCT00920816|101908633|FG001|Overall Study|Lost to Follow-up|2|||
33549556|NCT00920816|101908634|FG002|Overall Study|Lost to Follow-up|0|||
33549557|NCT00920816|101908635|FG003|Overall Study|Lost to Follow-up|0|||
33549558|NCT00920816|101908632|FG000|Overall Study|Adverse Event|1|||
33549559|NCT00920816|101908633|FG001|Overall Study|Adverse Event|1|||
33549560|NCT00920816|101908634|FG002|Overall Study|Adverse Event|1|||
33549561|NCT00920816|101908635|FG003|Overall Study|Adverse Event|0|||
33549562|NCT00920816|101908632|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
33549563|NCT00920816|101908633|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
33549564|NCT00920816|101908634|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
33549565|NCT00920816|101908635|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
33549566|NCT00920816|101908632|FG000|Overall Study|Randomized but not treated|3|||
33549567|NCT00920816|101908633|FG001|Overall Study|Randomized but not treated|0|||
33549568|NCT00920816|101908634|FG002|Overall Study|Randomized but not treated|0|||
33549569|NCT00920816|101908635|FG003|Overall Study|Randomized but not treated|0|||
33549570|NCT02100631|101908636|FG000|Overall Study|Withdrawal by Subject|1|||
33549571|NCT02100631|101908637|FG001|Overall Study|Withdrawal by Subject|0|||
33549572|NCT02100631|101908638|FG002|Overall Study|Withdrawal by Subject|0|||
33549573|NCT02100631|101908636|FG000|Overall Study|Lost to Follow-up|3|||
33549574|NCT02100631|101908637|FG001|Overall Study|Lost to Follow-up|4|||
33549575|NCT02100631|101908638|FG002|Overall Study|Lost to Follow-up|0|||
33549576|NCT02100631|101908636|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
33549577|NCT02100631|101908637|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
33549578|NCT02100631|101908638|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
33549579|NCT01001104|101908639|FG000|Overall Study|Adverse Event|2|||
33549580|NCT01001104|101908640|FG001|Overall Study|Adverse Event|1|||
33549581|NCT01001104|101908641|FG002|Overall Study|Adverse Event|0|||
33549582|NCT01001104|101908642|FG003|Overall Study|Adverse Event|0|||
33549583|NCT01001104|101908639|FG000|Overall Study|Lost to Follow-up|0|||
33549584|NCT01001104|101908640|FG001|Overall Study|Lost to Follow-up|0|||
33549585|NCT01001104|101908641|FG002|Overall Study|Lost to Follow-up|1|||
33549586|NCT01001104|101908642|FG003|Overall Study|Lost to Follow-up|0|||
33549587|NCT01001104|101908639|FG000|Overall Study|Entry Criteria Not Met|0|||
33549588|NCT01001104|101908640|FG001|Overall Study|Entry Criteria Not Met|0|||
33549589|NCT01001104|101908641|FG002|Overall Study|Entry Criteria Not Met|0|||
33549590|NCT01001104|101908642|FG003|Overall Study|Entry Criteria Not Met|1|||
33549591|NCT01001104|101908639|FG000|Overall Study|Withdrawal by Subject|0|||
33549592|NCT01001104|101908640|FG001|Overall Study|Withdrawal by Subject|0|||
33549593|NCT01001104|101908641|FG002|Overall Study|Withdrawal by Subject|0|||
33549594|NCT01001104|101908642|FG003|Overall Study|Withdrawal by Subject|2|||
33549595|NCT02412657|101908643|FG000|Overall Study|Lost to Follow-up|1|||
33549596|NCT02412657|101908644|FG001|Overall Study|Lost to Follow-up|0|||
33549597|NCT02412657|101908645|FG002|Overall Study|Lost to Follow-up|0|||
33549598|NCT02412657|101908643|FG000|Overall Study|Protocol Violation|0|||
33549599|NCT02412657|101908644|FG001|Overall Study|Protocol Violation|2|||
33549600|NCT02412657|101908645|FG002|Overall Study|Protocol Violation|3|||
33549601|NCT01757847|101908650|FG000|Overall Study|Withdrawal by Subject|3|||
33549602|NCT01757847|101908651|FG001|Overall Study|Withdrawal by Subject|4|||
33549603|NCT03339453|101908652|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
33549604|NCT03339453|101908653|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
33549605|NCT02034591|101908654|FG000|Overall Study|Withdrawal by Subject|0|||
33549606|NCT02034591|101908655|FG001|Overall Study|Withdrawal by Subject|0|||
33549607|NCT02034591|101908656|FG002|Overall Study|Withdrawal by Subject|0|||
33549608|NCT02034591|101908657|FG003|Overall Study|Withdrawal by Subject|0|||
33549609|NCT02034591|101908658|FG004|Overall Study|Withdrawal by Subject|1|||
33549610|NCT02034591|101908659|FG005|Overall Study|Withdrawal by Subject|0|||
33549611|NCT03086343|101908660|FG000|Period 1|Adverse Event|7|||
33549612|NCT03086343|101908661|FG001|Period 1|Adverse Event|7|||
33549613|NCT03086343|101908662|FG002|Period 1|Adverse Event|0|||
33549614|NCT03086343|101908663|FG003|Period 1|Adverse Event|1|||
33549615|NCT03086343|101908660|FG000|Period 1|Withdrawal by Subject|6|||
33549616|NCT03086343|101908661|FG001|Period 1|Withdrawal by Subject|10|||
33549617|NCT03086343|101908662|FG002|Period 1|Withdrawal by Subject|0|||
33549618|NCT03086343|101908663|FG003|Period 1|Withdrawal by Subject|0|||
33549619|NCT03086343|101908660|FG000|Period 1|Lost to Follow-up|1|||
33549620|NCT03086343|101908661|FG001|Period 1|Lost to Follow-up|3|||
33549621|NCT03086343|101908662|FG002|Period 1|Lost to Follow-up|1|||
33549622|NCT03086343|101908663|FG003|Period 1|Lost to Follow-up|0|||
33549623|NCT03086343|101908660|FG000|Period 1|Other, Not Specified|10|||
33549624|NCT03086343|101908661|FG001|Period 1|Other, Not Specified|12|||
33549625|NCT03086343|101908662|FG002|Period 1|Other, Not Specified|2|||
33549626|NCT03086343|101908663|FG003|Period 1|Other, Not Specified|1|||
33549627|NCT03086343|101908660|FG000|Period 1|Missing|1|||
33549628|NCT03086343|101908661|FG001|Period 1|Missing|0|||
33216127|NCT02454101|100688751|FG000|Overall Study|Adverse Event|2|||
33216128|NCT02454101|100688752|FG001|Overall Study|Adverse Event|3|||
33216129|NCT02454101|100688751|FG000|Overall Study|Lost to Follow-up|3|||
33216130|NCT02454101|100688752|FG001|Overall Study|Lost to Follow-up|4|||
33216131|NCT01324271|100688755|FG000|Overall Study|Lost to Follow-up|3|||
33216132|NCT01324271|100688756|FG001|Overall Study|Lost to Follow-up|0|||
33216133|NCT01324271|100688755|FG000|Overall Study|Physician Decision|1|||
33216134|NCT01324271|100688756|FG001|Overall Study|Physician Decision|0|||
33216135|NCT00279201|100688757|FG000|Initiation|Death|1|||
33216136|NCT00279201|100688758|FG001|Initiation|Death|5|||
33216137|NCT00279201|100688759|FG002|Initiation|Death|0|||
33216138|NCT00279201|100688760|FG003|Initiation|Death|0|||
33216139|NCT00279201|100688761|FG004|Initiation|Death|0|||
33216140|NCT00279201|100688762|FG005|Initiation|Death|0|||
33216141|NCT00279201|100688757|FG000|Initiation|Adverse Event|6|||
33216142|NCT00279201|100688758|FG001|Initiation|Adverse Event|15|||
33216143|NCT00279201|100688759|FG002|Initiation|Adverse Event|0|||
33216144|NCT00279201|100688760|FG003|Initiation|Adverse Event|0|||
33216145|NCT00279201|100688761|FG004|Initiation|Adverse Event|0|||
33216146|NCT00279201|100688762|FG005|Initiation|Adverse Event|0|||
33216147|NCT00279201|100688757|FG000|Initiation|Lost to Follow-up|42|||
33216148|NCT00279201|100688758|FG001|Initiation|Lost to Follow-up|41|||
33216149|NCT00279201|100688759|FG002|Initiation|Lost to Follow-up|0|||
33216150|NCT00279201|100688760|FG003|Initiation|Lost to Follow-up|0|||
33216151|NCT00279201|100688761|FG004|Initiation|Lost to Follow-up|0|||
33216152|NCT00279201|100688762|FG005|Initiation|Lost to Follow-up|0|||
33216153|NCT00279201|100688757|FG000|Initiation|Entry Criteria Exclusion|7|||
33216154|NCT00279201|100688758|FG001|Initiation|Entry Criteria Exclusion|9|||
33216155|NCT00279201|100688759|FG002|Initiation|Entry Criteria Exclusion|0|||
33216156|NCT00279201|100688760|FG003|Initiation|Entry Criteria Exclusion|0|||
33216157|NCT00279201|100688761|FG004|Initiation|Entry Criteria Exclusion|0|||
33216158|NCT00279201|100688762|FG005|Initiation|Entry Criteria Exclusion|0|||
33216159|NCT00279201|100688757|FG000|Initiation|Protocol Violation|9|||
33216160|NCT00279201|100688758|FG001|Initiation|Protocol Violation|10|||
33216161|NCT00279201|100688759|FG002|Initiation|Protocol Violation|0|||
33216162|NCT00279201|100688760|FG003|Initiation|Protocol Violation|0|||
33216163|NCT00279201|100688761|FG004|Initiation|Protocol Violation|0|||
33216164|NCT00279201|100688762|FG005|Initiation|Protocol Violation|0|||
33216165|NCT00279201|100688757|FG000|Initiation|Withdrawal by Subject|35|||
33216166|NCT00279201|100688758|FG001|Initiation|Withdrawal by Subject|41|||
33216167|NCT00279201|100688759|FG002|Initiation|Withdrawal by Subject|0|||
33216168|NCT00279201|100688760|FG003|Initiation|Withdrawal by Subject|0|||
33216169|NCT00279201|100688761|FG004|Initiation|Withdrawal by Subject|0|||
33216170|NCT00279201|100688762|FG005|Initiation|Withdrawal by Subject|0|||
33216171|NCT00279201|100688757|FG000|Initiation|Physician Decision|15|||
33216172|NCT00279201|100688758|FG001|Initiation|Physician Decision|18|||
33216173|NCT00279201|100688759|FG002|Initiation|Physician Decision|0|||
33216174|NCT00279201|100688760|FG003|Initiation|Physician Decision|0|||
33216175|NCT00279201|100688761|FG004|Initiation|Physician Decision|0|||
33216176|NCT00279201|100688762|FG005|Initiation|Physician Decision|0|||
33216177|NCT00279201|100688757|FG000|Initiation|Sponsor Decision|13|||
33216178|NCT00279201|100688758|FG001|Initiation|Sponsor Decision|5|||
33410117|NCT00313716|101389445|FG003|Overall Study|Withdrawal by Subject|0|||
33410118|NCT00313716|101389446|FG004|Overall Study|Withdrawal by Subject|1|||
33410119|NCT00313716|101389447|FG005|Overall Study|Withdrawal by Subject|0|||
33410120|NCT00777920|101392609|FG000|Overall Study|Adverse Event|39|||
33410121|NCT00777920|101392609|FG000|Overall Study|Withdrawal of Consent|4|||
33410122|NCT00777920|101392609|FG000|Overall Study|Lost to Follow-up|1|||
33410123|NCT00777920|101392609|FG000|Overall Study|Investigator's discretion|1|||
33410124|NCT00777920|101392609|FG000|Overall Study|Clinical status did not improve|1|||
33410125|NCT00777920|101392609|FG000|Overall Study|Other, not specified|4|||
33216179|NCT00279201|100688759|FG002|Initiation|Sponsor Decision|0|||
33216180|NCT00279201|100688760|FG003|Initiation|Sponsor Decision|0|||
33549629|NCT03086343|101908662|FG002|Period 1|Missing|0|||
33549630|NCT03086343|101908663|FG003|Period 1|Missing|0|||
33549631|NCT03086343|101908660|FG000|Period 2|Adverse Event|20|||
33549632|NCT03086343|101908661|FG001|Period 2|Adverse Event|11|||
33549633|NCT03086343|101908662|FG002|Period 2|Adverse Event|1|||
33216181|NCT00279201|100688761|FG004|Initiation|Sponsor Decision|0|||
33216182|NCT00279201|100688762|FG005|Initiation|Sponsor Decision|0|||
33216183|NCT00279201|100688757|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
33216184|NCT00279201|100688758|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
33216185|NCT00279201|100688759|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
33410126|NCT03532048|101392610|FG000|Overall Study|Lost to Follow-up|12|||
33216186|NCT00279201|100688760|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
33216187|NCT00279201|100688761|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
33410127|NCT03532048|101392611|FG001|Overall Study|Lost to Follow-up|17|||
33216188|NCT00279201|100688762|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
33216189|NCT00279201|100688757|FG000|Maintenance|Lack of Efficacy|32|||
33549634|NCT03086343|101908663|FG003|Period 2|Adverse Event|2|||
33549635|NCT03086343|101908660|FG000|Period 2|Withdrawal by Subject|15|||
33549636|NCT03086343|101908661|FG001|Period 2|Withdrawal by Subject|25|||
33549637|NCT03086343|101908662|FG002|Period 2|Withdrawal by Subject|2|||
33549638|NCT03086343|101908663|FG003|Period 2|Withdrawal by Subject|2|||
33549639|NCT03086343|101908660|FG000|Period 2|Lost to Follow-up|6|||
33549640|NCT03086343|101908661|FG001|Period 2|Lost to Follow-up|11|||
33216190|NCT00279201|100688758|FG001|Maintenance|Lack of Efficacy|30|||
33216191|NCT00279201|100688759|FG002|Maintenance|Lack of Efficacy|0|||
33216192|NCT00279201|100688760|FG003|Maintenance|Lack of Efficacy|0|||
33216193|NCT00279201|100688761|FG004|Maintenance|Lack of Efficacy|0|||
33216194|NCT00279201|100688762|FG005|Maintenance|Lack of Efficacy|0|||
33216195|NCT00279201|100688757|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
33216196|NCT00279201|100688758|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
33216197|NCT00279201|100688759|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
33216198|NCT00279201|100688760|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
33216199|NCT00279201|100688761|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
33216200|NCT00279201|100688762|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
33216201|NCT00279201|100688757|FG000|Maintenance|Adverse Event|4|||
33216202|NCT00279201|100688758|FG001|Maintenance|Adverse Event|4|||
33216203|NCT00279201|100688759|FG002|Maintenance|Adverse Event|0|||
33216204|NCT00279201|100688760|FG003|Maintenance|Adverse Event|0|||
33216205|NCT00279201|100688761|FG004|Maintenance|Adverse Event|0|||
33216206|NCT00279201|100688762|FG005|Maintenance|Adverse Event|0|||
33216207|NCT00279201|100688757|FG000|Maintenance|Death|4|||
33216208|NCT00279201|100688758|FG001|Maintenance|Death|4|||
33216209|NCT00279201|100688759|FG002|Maintenance|Death|0|||
33216210|NCT00279201|100688760|FG003|Maintenance|Death|0|||
33216211|NCT00279201|100688761|FG004|Maintenance|Death|0|||
33216212|NCT00279201|100688762|FG005|Maintenance|Death|0|||
33216213|NCT00279201|100688757|FG000|Maintenance|Lost to Follow-up|17|||
33216214|NCT00279201|100688758|FG001|Maintenance|Lost to Follow-up|13|||
33216215|NCT00279201|100688759|FG002|Maintenance|Lost to Follow-up|0|||
33216216|NCT00279201|100688760|FG003|Maintenance|Lost to Follow-up|0|||
33216217|NCT00279201|100688761|FG004|Maintenance|Lost to Follow-up|0|||
33216218|NCT00279201|100688762|FG005|Maintenance|Lost to Follow-up|0|||
33216219|NCT00279201|100688757|FG000|Maintenance|Entry Criteria Exclusion|1|||
33216220|NCT00279201|100688758|FG001|Maintenance|Entry Criteria Exclusion|4|||
33216221|NCT00279201|100688759|FG002|Maintenance|Entry Criteria Exclusion|0|||
33216222|NCT00279201|100688760|FG003|Maintenance|Entry Criteria Exclusion|0|||
33216223|NCT00279201|100688761|FG004|Maintenance|Entry Criteria Exclusion|0|||
33216224|NCT00279201|100688762|FG005|Maintenance|Entry Criteria Exclusion|0|||
33216225|NCT00279201|100688757|FG000|Maintenance|Protocol Violation|16|||
33216226|NCT00279201|100688758|FG001|Maintenance|Protocol Violation|24|||
33216227|NCT00279201|100688759|FG002|Maintenance|Protocol Violation|0|||
33216228|NCT00279201|100688760|FG003|Maintenance|Protocol Violation|0|||
33216229|NCT00279201|100688761|FG004|Maintenance|Protocol Violation|0|||
33216230|NCT00279201|100688762|FG005|Maintenance|Protocol Violation|0|||
33216231|NCT00279201|100688757|FG000|Maintenance|Withdrawal by Subject|18|||
33216232|NCT00279201|100688758|FG001|Maintenance|Withdrawal by Subject|18|||
33216233|NCT00279201|100688759|FG002|Maintenance|Withdrawal by Subject|0|||
33216234|NCT00279201|100688760|FG003|Maintenance|Withdrawal by Subject|0|||
33216235|NCT00279201|100688761|FG004|Maintenance|Withdrawal by Subject|0|||
33216236|NCT00279201|100688762|FG005|Maintenance|Withdrawal by Subject|0|||
33216237|NCT00279201|100688757|FG000|Maintenance|Physician Decision|9|||
33549641|NCT03086343|101908662|FG002|Period 2|Lost to Follow-up|1|||
33549642|NCT03086343|101908663|FG003|Period 2|Lost to Follow-up|0|||
33549643|NCT03086343|101908660|FG000|Period 2|COVID-19 Infection|5|||
33549644|NCT03086343|101908661|FG001|Period 2|COVID-19 Infection|0|||
33549645|NCT03086343|101908662|FG002|Period 2|COVID-19 Infection|0|||
33549646|NCT03086343|101908663|FG003|Period 2|COVID-19 Infection|0|||
33549647|NCT03086343|101908660|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
33549648|NCT03086343|101908661|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
33618130|NCT01959841|102151465|FG001|Overall Study|Lost to Follow-up|1|||
33618131|NCT01959841|102151466|FG002|Overall Study|Lost to Follow-up|0|||
33618132|NCT01959841|102151464|FG000|Overall Study|Physician Decision|0|||
33618133|NCT01959841|102151465|FG001|Overall Study|Physician Decision|2|||
33618134|NCT01959841|102151466|FG002|Overall Study|Physician Decision|3|||
33549649|NCT03086343|101908662|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
33216238|NCT00279201|100688758|FG001|Maintenance|Physician Decision|9|||
33216239|NCT00279201|100688759|FG002|Maintenance|Physician Decision|0|||
33549650|NCT03086343|101908663|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
33549651|NCT03086343|101908660|FG000|Period 2|Other, Not Specified|23|||
33549652|NCT03086343|101908661|FG001|Period 2|Other, Not Specified|22|||
33618135|NCT01959841|102151464|FG000|Overall Study|Protocol Violation|16|||
33618136|NCT01959841|102151465|FG001|Overall Study|Protocol Violation|23|||
33618137|NCT01959841|102151466|FG002|Overall Study|Protocol Violation|16|||
33618138|NCT01959841|102151464|FG000|Overall Study|Withdrawal by Subject|7|||
33618139|NCT01959841|102151465|FG001|Overall Study|Withdrawal by Subject|7|||
33216240|NCT00279201|100688760|FG003|Maintenance|Physician Decision|0|||
33216241|NCT00279201|100688761|FG004|Maintenance|Physician Decision|0|||
33216242|NCT00279201|100688762|FG005|Maintenance|Physician Decision|0|||
33549653|NCT03086343|101908662|FG002|Period 2|Other, Not Specified|2|||
33549654|NCT03086343|101908663|FG003|Period 2|Other, Not Specified|4|||
33549655|NCT01104766|101908664|FG000|Overall Study|Did not meet inc/exc criteria|1|||
33549656|NCT01104766|101908665|FG001|Overall Study|Did not meet inc/exc criteria|0|||
33549657|NCT01104766|101908666|FG002|Overall Study|Did not meet inc/exc criteria|0|||
33549658|NCT01104766|101908667|FG003|Overall Study|Did not meet inc/exc criteria|0|||
33549659|NCT01104766|101908664|FG000|Overall Study|Adverse Event|17|||
33549660|NCT01104766|101908665|FG001|Overall Study|Adverse Event|15|||
33549661|NCT01104766|101908666|FG002|Overall Study|Adverse Event|20|||
33549662|NCT01104766|101908667|FG003|Overall Study|Adverse Event|14|||
33549663|NCT01104766|101908664|FG000|Overall Study|Lack of Efficacy|20|||
33549664|NCT01104766|101908665|FG001|Overall Study|Lack of Efficacy|15|||
33549665|NCT01104766|101908666|FG002|Overall Study|Lack of Efficacy|14|||
33549666|NCT01104766|101908667|FG003|Overall Study|Lack of Efficacy|8|||
33549667|NCT01104766|101908664|FG000|Overall Study|Protocol Violation|2|||
33549668|NCT01104766|101908665|FG001|Overall Study|Protocol Violation|0|||
33549669|NCT01104766|101908666|FG002|Overall Study|Protocol Violation|0|||
33549670|NCT01104766|101908667|FG003|Overall Study|Protocol Violation|0|||
33549671|NCT01104766|101908664|FG000|Overall Study|Withdrawal by Subject|17|||
33549672|NCT01104766|101908665|FG001|Overall Study|Withdrawal by Subject|19|||
33549673|NCT01104766|101908666|FG002|Overall Study|Withdrawal by Subject|25|||
33549674|NCT01104766|101908667|FG003|Overall Study|Withdrawal by Subject|15|||
33549675|NCT01104766|101908664|FG000|Overall Study|Lost to Follow-up|1|||
33549676|NCT01104766|101908665|FG001|Overall Study|Lost to Follow-up|2|||
33216243|NCT00279201|100688757|FG000|Maintenance|Sponsor Decision|4|||
33216244|NCT00279201|100688758|FG001|Maintenance|Sponsor Decision|0|||
33216245|NCT00279201|100688759|FG002|Maintenance|Sponsor Decision|0|||
33216246|NCT00279201|100688760|FG003|Maintenance|Sponsor Decision|0|||
33216247|NCT00279201|100688761|FG004|Maintenance|Sponsor Decision|0|||
33216248|NCT00279201|100688762|FG005|Maintenance|Sponsor Decision|0|||
33216249|NCT00279201|100688757|FG000|Maintenance|HbA1c>7.5%|123|||
33216250|NCT00279201|100688758|FG001|Maintenance|HbA1c>7.5%|126|||
33216251|NCT00279201|100688759|FG002|Maintenance|HbA1c>7.5%|0|||
33216252|NCT00279201|100688760|FG003|Maintenance|HbA1c>7.5%|0|||
33216253|NCT00279201|100688761|FG004|Maintenance|HbA1c>7.5%|0|||
33216254|NCT00279201|100688762|FG005|Maintenance|HbA1c>7.5%|0|||
33216255|NCT00279201|100688757|FG000|Intensification Addendum|Withdrawal by Subject|0|||
33216256|NCT00279201|100688758|FG001|Intensification Addendum|Withdrawal by Subject|0|||
33216257|NCT00279201|100688759|FG002|Intensification Addendum|Withdrawal by Subject|12|||
33216258|NCT00279201|100688760|FG003|Intensification Addendum|Withdrawal by Subject|14|||
33216259|NCT00279201|100688761|FG004|Intensification Addendum|Withdrawal by Subject|9|||
33216260|NCT00279201|100688762|FG005|Intensification Addendum|Withdrawal by Subject|18|||
33216261|NCT00279201|100688757|FG000|Intensification Addendum|Lost to Follow-up|0|||
33216262|NCT00279201|100688758|FG001|Intensification Addendum|Lost to Follow-up|0|||
33216263|NCT00279201|100688759|FG002|Intensification Addendum|Lost to Follow-up|4|||
33216264|NCT00279201|100688760|FG003|Intensification Addendum|Lost to Follow-up|6|||
33549677|NCT01104766|101908666|FG002|Overall Study|Lost to Follow-up|1|||
33549678|NCT01104766|101908667|FG003|Overall Study|Lost to Follow-up|1|||
33549679|NCT00088153|101908671|FG000|Overall Study|Physician Decision|3|||
33549680|NCT00088153|101908672|FG001|Overall Study|Physician Decision|3|||
33549681|NCT00088153|101908671|FG000|Overall Study|Withdrawal by Subject|10|||
33549682|NCT00088153|101908672|FG001|Overall Study|Withdrawal by Subject|10|||
33618140|NCT01959841|102151466|FG002|Overall Study|Withdrawal by Subject|5|||
33618141|NCT01959841|102151464|FG000|Overall Study|Clinical laboratory value|2|||
33216265|NCT00279201|100688761|FG004|Intensification Addendum|Lost to Follow-up|7|||
33216266|NCT00279201|100688762|FG005|Intensification Addendum|Lost to Follow-up|7|||
33216267|NCT00279201|100688757|FG000|Intensification Addendum|Protocol Violation|0|||
33216268|NCT00279201|100688758|FG001|Intensification Addendum|Protocol Violation|0|||
33549683|NCT00088153|101908671|FG000|Overall Study|Lost to Follow-up|11|||
33549684|NCT00088153|101908672|FG001|Overall Study|Lost to Follow-up|12|||
33549685|NCT01129128|101908673|FG000|Overall Study|Lost to Follow-up|2|||
33549686|NCT01129128|101908674|FG001|Overall Study|Lost to Follow-up|2|||
33216269|NCT00279201|100688759|FG002|Intensification Addendum|Protocol Violation|2|||
33216270|NCT00279201|100688760|FG003|Intensification Addendum|Protocol Violation|2|||
33216271|NCT00279201|100688761|FG004|Intensification Addendum|Protocol Violation|6|||
33216272|NCT00279201|100688762|FG005|Intensification Addendum|Protocol Violation|6|||
33549687|NCT01129128|101908675|FG002|Overall Study|Lost to Follow-up|1|||
33549688|NCT01129128|101908673|FG000|Overall Study|Protocol Violation|0|||
33549689|NCT01129128|101908674|FG001|Overall Study|Protocol Violation|1|||
33549690|NCT01129128|101908675|FG002|Overall Study|Protocol Violation|0|||
33549691|NCT01129128|101908673|FG000|Overall Study|Withdrawal by Subject|0|||
33549692|NCT01129128|101908674|FG001|Overall Study|Withdrawal by Subject|1|||
33549693|NCT01129128|101908675|FG002|Overall Study|Withdrawal by Subject|3|||
33549694|NCT01129128|101908673|FG000|Overall Study|Physician Decision|1|||
33216273|NCT00279201|100688757|FG000|Intensification Addendum|Adverse Event|0|||
33216274|NCT00279201|100688758|FG001|Intensification Addendum|Adverse Event|0|||
33216275|NCT00279201|100688759|FG002|Intensification Addendum|Adverse Event|0|||
33216276|NCT00279201|100688760|FG003|Intensification Addendum|Adverse Event|4|||
33216277|NCT00279201|100688761|FG004|Intensification Addendum|Adverse Event|1|||
33216278|NCT00279201|100688762|FG005|Intensification Addendum|Adverse Event|3|||
33216279|NCT00279201|100688757|FG000|Intensification Addendum|Physician Decision|0|||
33216280|NCT00279201|100688758|FG001|Intensification Addendum|Physician Decision|0|||
33216281|NCT00279201|100688759|FG002|Intensification Addendum|Physician Decision|4|||
33216282|NCT00279201|100688760|FG003|Intensification Addendum|Physician Decision|1|||
33216283|NCT00279201|100688761|FG004|Intensification Addendum|Physician Decision|3|||
33549695|NCT01129128|101908674|FG001|Overall Study|Physician Decision|0|||
33549696|NCT01129128|101908675|FG002|Overall Study|Physician Decision|0|||
33549697|NCT02930941|101908676|FG000|Overall Study|Lost to Follow-up|1|||
33549698|NCT02930941|101908677|FG001|Overall Study|Lost to Follow-up|2|||
33216284|NCT00279201|100688762|FG005|Intensification Addendum|Physician Decision|2|||
33216285|NCT00279201|100688757|FG000|Intensification Addendum|Sponsor Decision|0|||
33216286|NCT00279201|100688758|FG001|Intensification Addendum|Sponsor Decision|0|||
33216287|NCT00279201|100688759|FG002|Intensification Addendum|Sponsor Decision|0|||
33216288|NCT00279201|100688760|FG003|Intensification Addendum|Sponsor Decision|0|||
33216289|NCT00279201|100688761|FG004|Intensification Addendum|Sponsor Decision|1|||
33216290|NCT00279201|100688762|FG005|Intensification Addendum|Sponsor Decision|1|||
33216291|NCT00279201|100688757|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
33216292|NCT00279201|100688758|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
33216293|NCT00279201|100688759|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
33216294|NCT00279201|100688760|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
33216295|NCT00279201|100688761|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
33216296|NCT00279201|100688762|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
33216297|NCT00279201|100688757|FG000|Intensification Addendum|Lack of Efficacy|0|||
33216298|NCT00279201|100688758|FG001|Intensification Addendum|Lack of Efficacy|0|||
33216299|NCT00279201|100688759|FG002|Intensification Addendum|Lack of Efficacy|0|||
33216300|NCT00279201|100688760|FG003|Intensification Addendum|Lack of Efficacy|1|||
33216301|NCT00279201|100688761|FG004|Intensification Addendum|Lack of Efficacy|1|||
33216302|NCT00279201|100688762|FG005|Intensification Addendum|Lack of Efficacy|0|||
33349684|NCT01756456|101167524|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
33349685|NCT01756456|101167525|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
33349686|NCT01756456|101167520|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
33549699|NCT04167462|101908678|FG000|Overall Study|Other reasons|3|||
33549700|NCT04167462|101908679|FG001|Overall Study|Other reasons|2|||
33549701|NCT04167462|101908678|FG000|Overall Study|Withdrawal by Subject|6|||
33349687|NCT01756456|101167521|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
33349688|NCT01756456|101167522|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
33349689|NCT01756456|101167523|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
33349690|NCT01756456|101167524|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
33549702|NCT04167462|101908679|FG001|Overall Study|Withdrawal by Subject|7|||
33549703|NCT04167462|101908678|FG000|Overall Study|Adverse Event|4|||
33549704|NCT04167462|101908679|FG001|Overall Study|Adverse Event|0|||
33549705|NCT04167462|101908678|FG000|Overall Study|Pregnancy|1|||
33549706|NCT04167462|101908679|FG001|Overall Study|Pregnancy|0|||
33549707|NCT04167462|101908678|FG000|Overall Study|Lack of Efficacy|0|||
33549708|NCT04167462|101908679|FG001|Overall Study|Lack of Efficacy|1|||
33549709|NCT00191100|101908680|FG000|Overall Study|Adverse Event|18|||
33549710|NCT00191100|101908681|FG001|Overall Study|Adverse Event|1|||
33216303|NCT00279201|100688757|FG000|Intensification Addendum|Death|0|||
33216304|NCT00279201|100688758|FG001|Intensification Addendum|Death|0|||
33216305|NCT00279201|100688759|FG002|Intensification Addendum|Death|0|||
33216306|NCT00279201|100688760|FG003|Intensification Addendum|Death|0|||
33549711|NCT00191100|101908680|FG000|Overall Study|Lost to Follow-up|2|||
33549712|NCT00191100|101908681|FG001|Overall Study|Lost to Follow-up|0|||
33549713|NCT00191100|101908680|FG000|Overall Study|Patient Moved|0|||
33549714|NCT00191100|101908681|FG001|Overall Study|Patient Moved|1|||
33216307|NCT00279201|100688761|FG004|Intensification Addendum|Death|1|||
33216308|NCT00279201|100688762|FG005|Intensification Addendum|Death|0|||
33216309|NCT00828984|100688764|FG000|Overall Study|Adverse Event|2|||
33216310|NCT00828984|100688765|FG001|Overall Study|Adverse Event|3|||
33216311|NCT00828984|100688766|FG002|Overall Study|Adverse Event|0|||
33216312|NCT00828984|100688764|FG000|Overall Study|Lost to Follow-up|5|||
33216313|NCT00828984|100688765|FG001|Overall Study|Lost to Follow-up|3|||
33216314|NCT00828984|100688766|FG002|Overall Study|Lost to Follow-up|1|||
33216315|NCT00828984|100688764|FG000|Overall Study|Withdrawal by Subject|4|||
33216316|NCT00828984|100688765|FG001|Overall Study|Withdrawal by Subject|4|||
33410128|NCT03532048|101392610|FG000|Overall Study|Withdrawal by Subject|7|||
33549715|NCT00191100|101908680|FG000|Overall Study|Withdrawal by Subject|9|||
33549716|NCT00191100|101908681|FG001|Overall Study|Withdrawal by Subject|3|||
33216317|NCT00828984|100688766|FG002|Overall Study|Withdrawal by Subject|4|||
33216318|NCT00828984|100688764|FG000|Overall Study|Ineligable|1|||
33216319|NCT00828984|100688765|FG001|Overall Study|Ineligable|2|||
33216320|NCT00828984|100688766|FG002|Overall Study|Ineligable|0|||
33216321|NCT00828984|100688764|FG000|Overall Study|Medical Contraindication|0|||
33216322|NCT00828984|100688765|FG001|Overall Study|Medical Contraindication|1|||
33216323|NCT00828984|100688766|FG002|Overall Study|Medical Contraindication|0|||
33216324|NCT00828984|100688764|FG000|Overall Study|Noncompliant|1|||
33216325|NCT00828984|100688765|FG001|Overall Study|Noncompliant|2|||
33216326|NCT00828984|100688766|FG002|Overall Study|Noncompliant|3|||
33216327|NCT00828984|100688764|FG000|Overall Study|ConMed|1|||
33216328|NCT00828984|100688765|FG001|Overall Study|ConMed|1|||
33216329|NCT00828984|100688766|FG002|Overall Study|ConMed|1|||
33216330|NCT01207102|100688769|FG000|Overall Study|Withdrawal by Subject|5|||
33216331|NCT01207102|100688769|FG000|Overall Study|Adverse Event|2|||
33216332|NCT01207102|100688769|FG000|Overall Study|progression|2|||
33216333|NCT01207102|100688769|FG000|Overall Study|Withdrawal by Treating Physician|1|||
33216334|NCT00886340|100688770|FG000|Overall Study|Withdrawal by Subject|0|||
33216335|NCT00886340|100688771|FG001|Overall Study|Withdrawal by Subject|7|||
33216336|NCT02279043|100688777|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
33216337|NCT02279043|100688778|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
33216338|NCT02279043|100688779|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
33216339|NCT02279043|100688777|FG000|Overall Study|Lost to Follow-up|46|||
33216340|NCT02279043|100688778|FG001|Overall Study|Lost to Follow-up|88|||
33216341|NCT02279043|100688779|FG002|Overall Study|Lost to Follow-up|0|||
33216342|NCT02173548|100688780|FG000|Overall Study|Lost to Follow-up|0|||
33216343|NCT02173548|100688781|FG001|Overall Study|Lost to Follow-up|2|||
33216344|NCT02173548|100688780|FG000|Overall Study|Withdrawal by Subject|1|||
33216345|NCT02173548|100688781|FG001|Overall Study|Withdrawal by Subject|0|||
33216346|NCT04052204|100688785|FG000|Overall Study|Death|1|||
33216347|NCT04052204|100688786|FG001|Overall Study|Death|0|||
33216348|NCT04052204|100688787|FG002|Overall Study|Death|0|||
33216349|NCT04052204|100688785|FG000|Overall Study|Progressive disease|1|||
33216350|NCT04052204|100688786|FG001|Overall Study|Progressive disease|0|||
33216351|NCT04052204|100688787|FG002|Overall Study|Progressive disease|0|||
33216352|NCT04052204|100688785|FG000|Overall Study|Other|1|||
33216353|NCT04052204|100688786|FG001|Overall Study|Other|0|||
33216354|NCT04052204|100688787|FG002|Overall Study|Other|0|||
33216355|NCT02047045|100688792|FG000|Baseline|Withdrawal by Subject|3|||
33216356|NCT02047045|100688793|FG001|Baseline|Withdrawal by Subject|2|||
33216357|NCT02047045|100688792|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
33216358|NCT02047045|100688793|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
33216359|NCT02047045|100688792|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
33216360|NCT02047045|100688793|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
33216361|NCT02047045|100688792|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
33216362|NCT02047045|100688793|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
33216363|NCT02047045|100688792|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
33216364|NCT02047045|100688793|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
33216365|NCT02047045|100688792|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
33216366|NCT02047045|100688793|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
33216367|NCT02047045|100688792|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
33216368|NCT02047045|100688793|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
33216369|NCT02047045|100688792|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
33216370|NCT02047045|100688793|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
33216371|NCT02047045|100688792|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
33216372|NCT02047045|100688793|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
33216373|NCT03151005|100688794|FG000|Overall Study|Lost to Follow-up|5|||
33216374|NCT03151005|100688795|FG001|Overall Study|Lost to Follow-up|5|||
33216375|NCT01592370|100688798|FG000|Overall Study|Disease Progression|62|||
33216376|NCT01592370|100688799|FG001|Overall Study|Disease Progression|16|||
33216377|NCT01592370|100688800|FG002|Overall Study|Disease Progression|52|||
33216378|NCT01592370|100688801|FG003|Overall Study|Disease Progression|3|||
33216379|NCT01592370|100688802|FG004|Overall Study|Disease Progression|3|||
33216380|NCT01592370|100688803|FG005|Overall Study|Disease Progression|31|||
33216381|NCT01592370|100688804|FG006|Overall Study|Disease Progression|14|||
33216382|NCT01592370|100688798|FG000|Overall Study|Study Drug Toxicity|14|||
33216383|NCT01592370|100688799|FG001|Overall Study|Study Drug Toxicity|3|||
33216384|NCT01592370|100688800|FG002|Overall Study|Study Drug Toxicity|0|||
33216385|NCT01592370|100688801|FG003|Overall Study|Study Drug Toxicity|0|||
33216386|NCT01592370|100688802|FG004|Overall Study|Study Drug Toxicity|0|||
33216387|NCT01592370|100688803|FG005|Overall Study|Study Drug Toxicity|0|||
33216388|NCT01592370|100688804|FG006|Overall Study|Study Drug Toxicity|1|||
33216389|NCT01592370|100688798|FG000|Overall Study|AE unrelated to study drug|4|||
33216390|NCT01592370|100688799|FG001|Overall Study|AE unrelated to study drug|3|||
33216391|NCT01592370|100688800|FG002|Overall Study|AE unrelated to study drug|0|||
33216392|NCT01592370|100688801|FG003|Overall Study|AE unrelated to study drug|0|||
33216393|NCT01592370|100688802|FG004|Overall Study|AE unrelated to study drug|0|||
33216394|NCT01592370|100688803|FG005|Overall Study|AE unrelated to study drug|0|||
33216395|NCT01592370|100688804|FG006|Overall Study|AE unrelated to study drug|1|||
33216396|NCT01592370|100688798|FG000|Overall Study|Request to discontinue study treatment|5|||
33216397|NCT01592370|100688799|FG001|Overall Study|Request to discontinue study treatment|0|||
33216398|NCT01592370|100688800|FG002|Overall Study|Request to discontinue study treatment|2|||
33216399|NCT01592370|100688801|FG003|Overall Study|Request to discontinue study treatment|0|||
33216400|NCT01592370|100688802|FG004|Overall Study|Request to discontinue study treatment|1|||
33216401|NCT01592370|100688803|FG005|Overall Study|Request to discontinue study treatment|2|||
33216402|NCT01592370|100688804|FG006|Overall Study|Request to discontinue study treatment|0|||
33216403|NCT01592370|100688798|FG000|Overall Study|Withdrew consent|1|||
33216404|NCT01592370|100688799|FG001|Overall Study|Withdrew consent|2|||
33216405|NCT01592370|100688800|FG002|Overall Study|Withdrew consent|1|||
33216406|NCT01592370|100688801|FG003|Overall Study|Withdrew consent|1|||
33216407|NCT01592370|100688802|FG004|Overall Study|Withdrew consent|0|||
33216408|NCT01592370|100688803|FG005|Overall Study|Withdrew consent|0|||
33216409|NCT01592370|100688804|FG006|Overall Study|Withdrew consent|0|||
33216410|NCT01592370|100688798|FG000|Overall Study|Maximum clinical benefit|11|||
33216411|NCT01592370|100688799|FG001|Overall Study|Maximum clinical benefit|1|||
33216412|NCT01592370|100688800|FG002|Overall Study|Maximum clinical benefit|7|||
33216413|NCT01592370|100688801|FG003|Overall Study|Maximum clinical benefit|1|||
33216414|NCT01592370|100688802|FG004|Overall Study|Maximum clinical benefit|0|||
33216415|NCT01592370|100688803|FG005|Overall Study|Maximum clinical benefit|0|||
33216416|NCT01592370|100688804|FG006|Overall Study|Maximum clinical benefit|0|||
33216417|NCT01592370|100688798|FG000|Overall Study|No longer meets study criteria|1|||
33216418|NCT01592370|100688799|FG001|Overall Study|No longer meets study criteria|0|||
33216419|NCT01592370|100688800|FG002|Overall Study|No longer meets study criteria|0|||
33216420|NCT01592370|100688801|FG003|Overall Study|No longer meets study criteria|0|||
33216421|NCT01592370|100688802|FG004|Overall Study|No longer meets study criteria|0|||
33216422|NCT01592370|100688803|FG005|Overall Study|No longer meets study criteria|0|||
33216423|NCT01592370|100688804|FG006|Overall Study|No longer meets study criteria|0|||
33216424|NCT01592370|100688798|FG000|Overall Study|Other Reasons|6|||
33216425|NCT01592370|100688799|FG001|Overall Study|Other Reasons|0|||
33216426|NCT01592370|100688800|FG002|Overall Study|Other Reasons|10|||
33216427|NCT01592370|100688801|FG003|Overall Study|Other Reasons|0|||
33216428|NCT01592370|100688802|FG004|Overall Study|Other Reasons|0|||
33216429|NCT01592370|100688803|FG005|Overall Study|Other Reasons|1|||
33216430|NCT01592370|100688804|FG006|Overall Study|Other Reasons|0|||
33216431|NCT02077166|100688807|FG000|Overall Study|Death|6|||
33216432|NCT02077166|100688808|FG001|Overall Study|Death|7|||
33216433|NCT02077166|100688809|FG002|Overall Study|Death|5|||
33216434|NCT02077166|100688810|FG003|Overall Study|Death|6|||
33410129|NCT03532048|101392611|FG001|Overall Study|Withdrawal by Subject|0|||
33410130|NCT02503215|101392616|FG000|Overall Study|Unable to wear compression stockings|1|||
33410131|NCT02503215|101392616|FG000|Overall Study|Unable to use positive airway pressure|2|||
33410132|NCT04988035|101392617|FG000|Overall Study|Death|19|||
33410133|NCT04988035|101392618|FG001|Overall Study|Death|13|||
33410134|NCT04988035|101392617|FG000|Overall Study|Lost to Follow-up|12|||
33410135|NCT04988035|101392618|FG001|Overall Study|Lost to Follow-up|6|||
33410136|NCT04988035|101392617|FG000|Overall Study|Protocol Violation|0|||
33410137|NCT04988035|101392618|FG001|Overall Study|Protocol Violation|1|||
33410138|NCT04988035|101392617|FG000|Overall Study|Withdrawal by Subject|2|||
33410139|NCT04988035|101392618|FG001|Overall Study|Withdrawal by Subject|4|||
33410140|NCT04988035|101392617|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
33410141|NCT04988035|101392618|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
33410142|NCT04516291|101392619|FG000|Treatment Period (24 Weeks)|Other|1|||
33410143|NCT04516291|101392620|FG001|Treatment Period (24 Weeks)|Other|0|||
33410144|NCT04516291|101392621|FG002|Treatment Period (24 Weeks)|Other|0|||
33410145|NCT04516291|101392622|FG003|Treatment Period (24 Weeks)|Other|2|||
33410146|NCT04516291|101392623|FG004|Treatment Period (24 Weeks)|Other|2|||
33410147|NCT04516291|101392624|FG005|Treatment Period (24 Weeks)|Other|4|||
33410148|NCT04516291|101392625|FG006|Treatment Period (24 Weeks)|Other|2|||
33410149|NCT04516291|101392626|FG007|Treatment Period (24 Weeks)|Other|0|||
33410150|NCT04516291|101392619|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33410151|NCT04516291|101392620|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
33410152|NCT04516291|101392621|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
33410153|NCT04516291|101392622|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33410154|NCT04516291|101392623|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
33410155|NCT04516291|101392624|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33216435|NCT02077166|100688811|FG004|Overall Study|Death|4|||
33216436|NCT02077166|100688812|FG005|Overall Study|Death|32|||
33216437|NCT02077166|100688813|FG006|Overall Study|Death|22|||
33410156|NCT04516291|101392625|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33410157|NCT04516291|101392626|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33410158|NCT04516291|101392619|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
33410159|NCT04516291|101392620|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
33410160|NCT04516291|101392621|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
33549717|NCT00191100|101908680|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
33549718|NCT00191100|101908681|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
33549719|NCT00191100|101908680|FG000|Overall Study|Clinical Relapse|2|||
33549720|NCT00191100|101908681|FG001|Overall Study|Clinical Relapse|1|||
33549721|NCT00191100|101908680|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
33549722|NCT00191100|101908681|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
33549723|NCT00191100|101908680|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
33549724|NCT00191100|101908681|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
33549725|NCT00191100|101908680|FG000|Overall Study|Physician Decision|3|||
33549726|NCT00191100|101908681|FG001|Overall Study|Physician Decision|1|||
33549727|NCT00191100|101908680|FG000|Overall Study|Death from Study Drug Toxicity|2|||
33549728|NCT00191100|101908681|FG001|Overall Study|Death from Study Drug Toxicity|0|||
33549729|NCT00191100|101908680|FG000|Overall Study|Protocol Violation|1|||
33549730|NCT00191100|101908681|FG001|Overall Study|Protocol Violation|1|||
33549731|NCT00191100|101908680|FG000|Overall Study|Death from Other Cause|1|||
33216438|NCT02077166|100688807|FG000|Overall Study|Study Closure by Sponsor|3|||
33216439|NCT02077166|100688808|FG001|Overall Study|Study Closure by Sponsor|0|||
33216440|NCT02077166|100688809|FG002|Overall Study|Study Closure by Sponsor|2|||
33216441|NCT02077166|100688810|FG003|Overall Study|Study Closure by Sponsor|2|||
33216442|NCT02077166|100688811|FG004|Overall Study|Study Closure by Sponsor|2|||
33216443|NCT02077166|100688812|FG005|Overall Study|Study Closure by Sponsor|12|||
33216444|NCT02077166|100688813|FG006|Overall Study|Study Closure by Sponsor|4|||
33216445|NCT02077166|100688807|FG000|Overall Study|Lost to Follow-up|0|||
33216446|NCT02077166|100688808|FG001|Overall Study|Lost to Follow-up|0|||
33216447|NCT02077166|100688809|FG002|Overall Study|Lost to Follow-up|0|||
33216448|NCT02077166|100688810|FG003|Overall Study|Lost to Follow-up|0|||
33216449|NCT02077166|100688811|FG004|Overall Study|Lost to Follow-up|0|||
33216450|NCT02077166|100688812|FG005|Overall Study|Lost to Follow-up|1|||
33216451|NCT02077166|100688813|FG006|Overall Study|Lost to Follow-up|0|||
33216452|NCT02077166|100688807|FG000|Overall Study|Withdrawal by Subject|3|||
33216453|NCT02077166|100688808|FG001|Overall Study|Withdrawal by Subject|0|||
33216454|NCT02077166|100688809|FG002|Overall Study|Withdrawal by Subject|1|||
33216455|NCT02077166|100688810|FG003|Overall Study|Withdrawal by Subject|1|||
33216456|NCT02077166|100688811|FG004|Overall Study|Withdrawal by Subject|1|||
33216457|NCT02077166|100688812|FG005|Overall Study|Withdrawal by Subject|3|||
33216458|NCT02077166|100688813|FG006|Overall Study|Withdrawal by Subject|0|||
33216459|NCT02077166|100688807|FG000|Overall Study|Other, Not Specified|0|||
33216460|NCT02077166|100688808|FG001|Overall Study|Other, Not Specified|0|||
33216461|NCT02077166|100688809|FG002|Overall Study|Other, Not Specified|1|||
33216462|NCT02077166|100688810|FG003|Overall Study|Other, Not Specified|0|||
33216463|NCT02077166|100688811|FG004|Overall Study|Other, Not Specified|1|||
33216464|NCT02077166|100688812|FG005|Overall Study|Other, Not Specified|7|||
33216465|NCT02077166|100688813|FG006|Overall Study|Other, Not Specified|8|||
33216466|NCT01951625|100688816|FG000|Treatment Period|Protocol Violation|2|||
33216467|NCT01951625|100688817|FG001|Treatment Period|Protocol Violation|0|||
33216468|NCT01951625|100688818|FG002|Treatment Period|Protocol Violation|1|||
33216469|NCT01951625|100688819|FG003|Treatment Period|Protocol Violation|3|||
33216470|NCT01951625|100688820|FG004|Treatment Period|Protocol Violation|2|||
33216471|NCT01951625|100688816|FG000|Treatment Period|Physician Decision|0|||
33216472|NCT01951625|100688817|FG001|Treatment Period|Physician Decision|0|||
33216473|NCT01951625|100688818|FG002|Treatment Period|Physician Decision|0|||
33216474|NCT01951625|100688819|FG003|Treatment Period|Physician Decision|0|||
33216475|NCT01951625|100688820|FG004|Treatment Period|Physician Decision|1|||
33216476|NCT01951625|100688816|FG000|Treatment Period|Protocol driven decision point|0|||
33216477|NCT01951625|100688817|FG001|Treatment Period|Protocol driven decision point|5|||
33216478|NCT01951625|100688818|FG002|Treatment Period|Protocol driven decision point|0|||
33216479|NCT01951625|100688819|FG003|Treatment Period|Protocol driven decision point|2|||
33216480|NCT01951625|100688820|FG004|Treatment Period|Protocol driven decision point|1|||
33216481|NCT01951625|100688816|FG000|Treatment Period|Non compliance with study drug|1|||
33216482|NCT01951625|100688817|FG001|Treatment Period|Non compliance with study drug|2|||
33216483|NCT01951625|100688818|FG002|Treatment Period|Non compliance with study drug|2|||
33216484|NCT01951625|100688819|FG003|Treatment Period|Non compliance with study drug|0|||
33216485|NCT01951625|100688820|FG004|Treatment Period|Non compliance with study drug|0|||
33216486|NCT01951625|100688816|FG000|Treatment Period|Death|3|||
33216487|NCT01951625|100688817|FG001|Treatment Period|Death|2|||
33216488|NCT01951625|100688818|FG002|Treatment Period|Death|2|||
33216489|NCT01951625|100688819|FG003|Treatment Period|Death|1|||
33216490|NCT01951625|100688820|FG004|Treatment Period|Death|2|||
33216491|NCT01951625|100688816|FG000|Treatment Period|Adverse Event|7|||
33216492|NCT01951625|100688817|FG001|Treatment Period|Adverse Event|10|||
33549732|NCT00191100|101908681|FG001|Overall Study|Death from Other Cause|0|||
33216493|NCT01951625|100688818|FG002|Treatment Period|Adverse Event|9|||
33216494|NCT01951625|100688819|FG003|Treatment Period|Adverse Event|8|||
33216495|NCT01951625|100688820|FG004|Treatment Period|Adverse Event|8|||
33216496|NCT01951625|100688816|FG000|Treatment Period|Withdrawal by Subject|5|||
33549733|NCT00191100|101908680|FG000|Overall Study|Reason Not Specified|0|||
33549734|NCT00191100|101908681|FG001|Overall Study|Reason Not Specified|1|||
33216497|NCT01951625|100688817|FG001|Treatment Period|Withdrawal by Subject|2|||
33216498|NCT01951625|100688818|FG002|Treatment Period|Withdrawal by Subject|1|||
33216499|NCT01951625|100688819|FG003|Treatment Period|Withdrawal by Subject|7|||
33216500|NCT01951625|100688820|FG004|Treatment Period|Withdrawal by Subject|3|||
33216501|NCT01951625|100688816|FG000|Treatment Period|Lost to Follow-up|1|||
33216502|NCT01951625|100688817|FG001|Treatment Period|Lost to Follow-up|0|||
33216503|NCT01951625|100688818|FG002|Treatment Period|Lost to Follow-up|0|||
33216504|NCT01951625|100688819|FG003|Treatment Period|Lost to Follow-up|1|||
33216505|NCT01951625|100688820|FG004|Treatment Period|Lost to Follow-up|0|||
33216506|NCT01951625|100688816|FG000|Follow Up Period|Non-compliance with study drug|1|||
33216507|NCT01951625|100688817|FG001|Follow Up Period|Non-compliance with study drug|0|||
33216508|NCT01951625|100688818|FG002|Follow Up Period|Non-compliance with study drug|0|||
33216509|NCT01951625|100688819|FG003|Follow Up Period|Non-compliance with study drug|0|||
33216510|NCT01951625|100688820|FG004|Follow Up Period|Non-compliance with study drug|0|||
33216511|NCT01951625|100688816|FG000|Follow Up Period|Death|1|||
33216512|NCT01951625|100688817|FG001|Follow Up Period|Death|3|||
33216513|NCT01951625|100688818|FG002|Follow Up Period|Death|2|||
33216514|NCT01951625|100688819|FG003|Follow Up Period|Death|2|||
33216515|NCT01951625|100688820|FG004|Follow Up Period|Death|1|||
33216516|NCT01951625|100688816|FG000|Follow Up Period|Logistical difficulties|1|||
33549735|NCT03670628|101908682|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
33549736|NCT03670628|101908683|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
33216517|NCT01951625|100688817|FG001|Follow Up Period|Logistical difficulties|2|||
33216518|NCT01951625|100688818|FG002|Follow Up Period|Logistical difficulties|0|||
33216519|NCT01951625|100688819|FG003|Follow Up Period|Logistical difficulties|0|||
33216520|NCT01951625|100688820|FG004|Follow Up Period|Logistical difficulties|0|||
33216521|NCT01951625|100688816|FG000|Follow Up Period|Adverse Event|0|||
33216522|NCT01951625|100688817|FG001|Follow Up Period|Adverse Event|3|||
33216523|NCT01951625|100688818|FG002|Follow Up Period|Adverse Event|2|||
33216524|NCT01951625|100688819|FG003|Follow Up Period|Adverse Event|3|||
33216525|NCT01951625|100688820|FG004|Follow Up Period|Adverse Event|5|||
33216526|NCT01951625|100688816|FG000|Follow Up Period|Withdrawal by Subject|4|||
33216527|NCT01951625|100688817|FG001|Follow Up Period|Withdrawal by Subject|1|||
33216528|NCT01951625|100688818|FG002|Follow Up Period|Withdrawal by Subject|0|||
33216529|NCT01951625|100688819|FG003|Follow Up Period|Withdrawal by Subject|5|||
33216530|NCT01951625|100688820|FG004|Follow Up Period|Withdrawal by Subject|3|||
33216531|NCT01951625|100688816|FG000|Follow Up Period|Lost to Follow-up|1|||
33216532|NCT01951625|100688817|FG001|Follow Up Period|Lost to Follow-up|0|||
33216533|NCT01951625|100688818|FG002|Follow Up Period|Lost to Follow-up|0|||
33216534|NCT01951625|100688819|FG003|Follow Up Period|Lost to Follow-up|1|||
33216535|NCT01951625|100688820|FG004|Follow Up Period|Lost to Follow-up|1|||
33216536|NCT04120233|100688821|FG000|Overall Study|Adverse Event|0|||
33216537|NCT04120233|100688822|FG001|Overall Study|Adverse Event|0|||
33216538|NCT04120233|100688823|FG002|Overall Study|Adverse Event|0|||
33216539|NCT04120233|100688824|FG003|Overall Study|Adverse Event|0|||
33216540|NCT04120233|100688825|FG004|Overall Study|Adverse Event|1|||
33216541|NCT04120233|100688826|FG005|Overall Study|Adverse Event|0|||
33216542|NCT00500903|100688827|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
33216543|NCT00500903|100688828|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
33216544|NCT00500903|100688829|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
33216545|NCT00500903|100688827|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
33216546|NCT00500903|100688828|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
33216547|NCT00500903|100688829|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
33216548|NCT00500903|100688827|FG000|Overall Study|Progressive Disease|41|||
33216549|NCT00500903|100688828|FG001|Overall Study|Progressive Disease|2|||
33216550|NCT00500903|100688829|FG002|Overall Study|Progressive Disease|15|||
33216551|NCT00500903|100688827|FG000|Overall Study|Patient Declined Further Treatment|0|||
33216552|NCT00500903|100688828|FG001|Overall Study|Patient Declined Further Treatment|0|||
33216553|NCT00500903|100688829|FG002|Overall Study|Patient Declined Further Treatment|3|||
33216554|NCT00500903|100688827|FG000|Overall Study|Symptomatic Deterioration|2|||
33216555|NCT00500903|100688828|FG001|Overall Study|Symptomatic Deterioration|0|||
33216556|NCT00500903|100688829|FG002|Overall Study|Symptomatic Deterioration|0|||
33216557|NCT00500903|100688827|FG000|Overall Study|Reason Not Specified|10|||
33216558|NCT00500903|100688828|FG001|Overall Study|Reason Not Specified|0|||
33567618|NCT02723955|101973173|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33216559|NCT00500903|100688829|FG002|Overall Study|Reason Not Specified|2|||
33216560|NCT04570436|100688833|FG000|Overall Study|Adverse Event|0|||
33216561|NCT04570436|100688834|FG001|Overall Study|Adverse Event|0|||
33216562|NCT04570436|100688835|FG002|Overall Study|Adverse Event|1|||
33216563|NCT04570436|100688836|FG003|Overall Study|Adverse Event|0|||
33216564|NCT04570436|100688837|FG004|Overall Study|Adverse Event|0|||
33216565|NCT04570436|100688838|FG005|Overall Study|Adverse Event|0|||
33216566|NCT04570436|100688839|FG006|Overall Study|Adverse Event|0|||
33216567|NCT04570436|100688840|FG007|Overall Study|Adverse Event|0|||
33216568|NCT04570436|100688841|FG008|Overall Study|Adverse Event|0|||
33216569|NCT04570436|100688842|FG009|Overall Study|Adverse Event|0|||
33216570|NCT04570436|100688833|FG000|Overall Study|Physician Decision|1|||
33216571|NCT04570436|100688834|FG001|Overall Study|Physician Decision|0|||
33216572|NCT04570436|100688835|FG002|Overall Study|Physician Decision|0|||
33216573|NCT04570436|100688836|FG003|Overall Study|Physician Decision|0|||
33216574|NCT04570436|100688837|FG004|Overall Study|Physician Decision|0|||
33216575|NCT04570436|100688838|FG005|Overall Study|Physician Decision|0|||
33216576|NCT04570436|100688839|FG006|Overall Study|Physician Decision|0|||
33216577|NCT04570436|100688840|FG007|Overall Study|Physician Decision|0|||
33216578|NCT04570436|100688841|FG008|Overall Study|Physician Decision|0|||
33216579|NCT04570436|100688842|FG009|Overall Study|Physician Decision|0|||
33216580|NCT03382782|100692132|FG000|Cohort 1|Withdrawal by Subject|11|||
33216581|NCT03382782|100692133|FG001|Cohort 1|Withdrawal by Subject|5|||
33216582|NCT03382782|100692134|FG002|Cohort 1|Withdrawal by Subject|0|||
33216583|NCT03382782|100692132|FG000|Cohort 2|Withdrawal by Subject|1|||
33216584|NCT03382782|100692133|FG001|Cohort 2|Withdrawal by Subject|1|||
33216585|NCT03382782|100692134|FG002|Cohort 2|Withdrawal by Subject|0|||
33216586|NCT03382782|100692132|FG000|Cohort 3|Withdrawal by Subject|1|||
33216587|NCT03382782|100692133|FG001|Cohort 3|Withdrawal by Subject|2|||
33216588|NCT03382782|100692134|FG002|Cohort 3|Withdrawal by Subject|0|||
33216589|NCT02633137|100692135|FG000|Overall Study|Adverse Event|1|||
33216590|NCT02633137|100692135|FG000|Overall Study|Lack of Efficacy|2|||
33216591|NCT02633137|100692135|FG000|Overall Study|Withdrawal by Subject|1|||
33216592|NCT02432105|100692136|FG000|Overall Study|Lost to Follow-up|1|||
33216593|NCT02432105|100692137|FG001|Overall Study|Lost to Follow-up|1|||
33216594|NCT02432105|100692138|FG002|Overall Study|Lost to Follow-up|0|||
33216595|NCT02432105|100692136|FG000|Overall Study|Withdrawal by Subject|1|||
33216596|NCT02432105|100692137|FG001|Overall Study|Withdrawal by Subject|0|||
33216597|NCT02432105|100692138|FG002|Overall Study|Withdrawal by Subject|1|||
33216598|NCT02432105|100692136|FG000|Overall Study|Culture positive for yeast|0|||
33216599|NCT02432105|100692137|FG001|Overall Study|Culture positive for yeast|1|||
33216600|NCT02432105|100692138|FG002|Overall Study|Culture positive for yeast|0|||
33216601|NCT02432105|100692136|FG000|Overall Study|Randomized in error|0|||
33216602|NCT02432105|100692137|FG001|Overall Study|Randomized in error|0|||
33216603|NCT02432105|100692138|FG002|Overall Study|Randomized in error|2|||
33216604|NCT04791761|100692143|FG000|Overall Study|Lost to Follow-up|8|||
33216605|NCT04791761|100692144|FG001|Overall Study|Lost to Follow-up|6|||
33216606|NCT04791761|100692145|FG002|Overall Study|Lost to Follow-up|10|||
33216607|NCT04791761|100692143|FG000|Overall Study|Withdrawal by Subject|0|||
33216608|NCT04791761|100692144|FG001|Overall Study|Withdrawal by Subject|1|||
33216609|NCT04791761|100692145|FG002|Overall Study|Withdrawal by Subject|1|||
33216610|NCT04791761|100692143|FG000|Overall Study|Protocol Violation|0|||
33216611|NCT04791761|100692144|FG001|Overall Study|Protocol Violation|1|||
33410161|NCT04516291|101392622|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
33549737|NCT03670628|101908682|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
33216612|NCT04791761|100692145|FG002|Overall Study|Protocol Violation|1|||
33216613|NCT00857207|100692146|FG000|Overall Study|Withdrawal by Subject|13|||
33216614|NCT00857207|100692147|FG001|Overall Study|Withdrawal by Subject|0|||
33349691|NCT01756456|101167525|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
33349692|NCT01756456|101167520|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
33349693|NCT01756456|101167521|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
33349694|NCT01756456|101167522|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
33349695|NCT01756456|101167523|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
33349696|NCT01756456|101167524|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
33349697|NCT01756456|101167525|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
33349698|NCT01756456|101167520|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
33349699|NCT01756456|101167521|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
33349700|NCT01756456|101167522|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
33349701|NCT01756456|101167523|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
33349702|NCT01756456|101167524|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
33349703|NCT01756456|101167525|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
33349704|NCT01756456|101167520|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
33349705|NCT01756456|101167521|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
33349706|NCT01756456|101167522|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
33216615|NCT00857207|100692146|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
33216616|NCT00857207|100692147|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
33216617|NCT00857207|100692146|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
33349707|NCT01756456|101167523|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
33216618|NCT00857207|100692147|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
33216619|NCT00540124|100692150|FG000|Overall Study|Adverse Event|0|||
33216620|NCT00540124|100692151|FG001|Overall Study|Adverse Event|2|||
33349708|NCT01756456|101167524|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
33349709|NCT01756456|101167525|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
33410162|NCT04516291|101392623|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
33410163|NCT04516291|101392624|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
33410164|NCT04516291|101392625|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
33410165|NCT04516291|101392626|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
33410166|NCT04516291|101392619|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33410167|NCT04516291|101392620|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
33410168|NCT04516291|101392621|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33410169|NCT04516291|101392622|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33410170|NCT04516291|101392623|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33410171|NCT04516291|101392624|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33410172|NCT04516291|101392625|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33410173|NCT04516291|101392626|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33410174|NCT04516291|101392619|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
33410175|NCT04516291|101392620|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
33410176|NCT04516291|101392621|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
33410177|NCT04516291|101392622|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
33410178|NCT04516291|101392623|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
33618142|NCT01959841|102151465|FG001|Overall Study|Clinical laboratory value|6|||
33618143|NCT01959841|102151466|FG002|Overall Study|Clinical laboratory value|6|||
33216621|NCT00540124|100692152|FG002|Overall Study|Adverse Event|1|||
33216622|NCT00540124|100692150|FG000|Overall Study|Entry Criteria Not Met|2|||
33410179|NCT04516291|101392624|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
33410180|NCT04516291|101392625|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
33216623|NCT00540124|100692151|FG001|Overall Study|Entry Criteria Not Met|0|||
33216624|NCT00540124|100692152|FG002|Overall Study|Entry Criteria Not Met|0|||
33349710|NCT01756456|101167520|FG000|Follow Up Period Phase I/II|Other causes|0|||
33410181|NCT04516291|101392626|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
33410182|NCT04516291|101392619|FG000|Follow-up Period (12 Weeks)|Other|0|||
33410183|NCT04516291|101392620|FG001|Follow-up Period (12 Weeks)|Other|1|||
33410184|NCT04516291|101392621|FG002|Follow-up Period (12 Weeks)|Other|0|||
33410185|NCT04516291|101392622|FG003|Follow-up Period (12 Weeks)|Other|2|||
33410186|NCT04516291|101392623|FG004|Follow-up Period (12 Weeks)|Other|0|||
33549738|NCT03670628|101908683|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
33549739|NCT00972738|101908684|FG000|Overall Study|Adverse Event|7|||
33549740|NCT00972738|101908685|FG001|Overall Study|Adverse Event|1|||
33549741|NCT00972738|101908686|FG002|Overall Study|Adverse Event|8|||
33549742|NCT00972738|101908684|FG000|Overall Study|Protocol Violation|2|||
33549743|NCT00972738|101908685|FG001|Overall Study|Protocol Violation|1|||
33349711|NCT01756456|101167521|FG001|Follow Up Period Phase I/II|Other causes|0|||
33349712|NCT01756456|101167522|FG002|Follow Up Period Phase I/II|Other causes|0|||
33349713|NCT01756456|101167523|FG003|Follow Up Period Phase I/II|Other causes|1|||
33349714|NCT01756456|101167524|FG004|Follow Up Period Phase I/II|Other causes|3|||
33349715|NCT01756456|101167525|FG005|Follow Up Period Phase I/II|Other causes|5|||
33349716|NCT03168867|101167526|FG000|Overall Study|Withdrawal by Subject|1|||
33349717|NCT03168867|101167527|FG001|Overall Study|Withdrawal by Subject|5|||
33349718|NCT03370770|101167528|FG000|Overall Study|Patient was followed in another hospital center|1|||
33349719|NCT03370770|101167528|FG000|Overall Study|Progressive Disease|98|||
33349720|NCT03370770|101167528|FG000|Overall Study|Adverse Event|2|||
33349721|NCT03370770|101167528|FG000|Overall Study|Death|5|||
33349722|NCT02472847|101167529|FG000|Overall Study|Withdrawal by Subject|1|||
33349723|NCT02472847|101167530|FG001|Overall Study|Withdrawal by Subject|5|||
33349724|NCT05172544|101167542|FG000|Overall Study|Withdrawal by Subject|1|||
33349725|NCT05172544|101167543|FG001|Overall Study|Withdrawal by Subject|0|||
33349726|NCT05172544|101167544|FG002|Overall Study|Withdrawal by Subject|0|||
33349727|NCT05172544|101167542|FG000|Overall Study|Physician Decision|0|||
33349728|NCT05172544|101167543|FG001|Overall Study|Physician Decision|0|||
33349729|NCT05172544|101167544|FG002|Overall Study|Physician Decision|1|||
33349730|NCT00977470|101167547|FG000|Overall Study|Lack of Efficacy|32|||
33349731|NCT00977470|101167548|FG001|Overall Study|Lack of Efficacy|30|||
33349732|NCT00977470|101167547|FG000|Overall Study|Physician Decision|2|||
33549744|NCT00972738|101908686|FG002|Overall Study|Protocol Violation|3|||
33549745|NCT00972738|101908684|FG000|Overall Study|Lost to Follow-up|1|||
33549746|NCT00972738|101908685|FG001|Overall Study|Lost to Follow-up|0|||
33549747|NCT00972738|101908686|FG002|Overall Study|Lost to Follow-up|1|||
33549748|NCT00972738|101908684|FG000|Overall Study|Lack of Efficacy|5|||
33549749|NCT00972738|101908685|FG001|Overall Study|Lack of Efficacy|1|||
33618144|NCT01959841|102151464|FG000|Overall Study|Platelet count below on day1 or 4|11|||
33216625|NCT00540124|100692150|FG000|Overall Study|Lack of Efficacy|1|||
33216626|NCT00540124|100692151|FG001|Overall Study|Lack of Efficacy|0|||
33349733|NCT00977470|101167548|FG001|Overall Study|Physician Decision|0|||
33410187|NCT04516291|101392624|FG005|Follow-up Period (12 Weeks)|Other|0|||
33410188|NCT04516291|101392625|FG006|Follow-up Period (12 Weeks)|Other|0|||
33410189|NCT04516291|101392626|FG007|Follow-up Period (12 Weeks)|Other|0|||
33410190|NCT04516291|101392619|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33216627|NCT00540124|100692152|FG002|Overall Study|Lack of Efficacy|0|||
33349734|NCT00977470|101167547|FG000|Overall Study|Adverse Event|1|||
33410191|NCT04516291|101392620|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33410192|NCT04516291|101392621|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33410193|NCT04516291|101392622|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33410194|NCT04516291|101392623|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
33410195|NCT04516291|101392624|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33410196|NCT04516291|101392625|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33410197|NCT04516291|101392626|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33410198|NCT04516291|101392619|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
33410199|NCT04516291|101392620|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
33410200|NCT04516291|101392621|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
33410201|NCT04516291|101392622|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
33410202|NCT04516291|101392623|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
33410203|NCT04516291|101392624|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
33410204|NCT04516291|101392625|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
33410205|NCT04516291|101392626|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
33410206|NCT01945034|101392627|FG000|Overall Study|Medication Error|0|||
33410207|NCT01945034|101392628|FG001|Overall Study|Medication Error|1|||
33410208|NCT01945034|101392629|FG002|Overall Study|Medication Error|0|||
33410209|NCT01945034|101392627|FG000|Overall Study|Withdrawal by Subject|0|||
33410210|NCT01945034|101392628|FG001|Overall Study|Withdrawal by Subject|3|||
33410211|NCT01945034|101392629|FG002|Overall Study|Withdrawal by Subject|1|||
33410212|NCT01945034|101392627|FG000|Overall Study|Other|0|||
33410213|NCT01945034|101392628|FG001|Overall Study|Other|1|||
33410214|NCT01945034|101392629|FG002|Overall Study|Other|3|||
33410215|NCT01945034|101392627|FG000|Overall Study|Lost to Follow-up|0|||
33410216|NCT01945034|101392628|FG001|Overall Study|Lost to Follow-up|0|||
33410217|NCT01945034|101392629|FG002|Overall Study|Lost to Follow-up|2|||
33410218|NCT01945034|101392627|FG000|Overall Study|Protocol Violation|1|||
33410219|NCT01945034|101392628|FG001|Overall Study|Protocol Violation|0|||
33410220|NCT01945034|101392629|FG002|Overall Study|Protocol Violation|1|||
33410221|NCT02341482|101392642|FG000|Overall Study|Adverse Event|1|||
33410222|NCT01519700|101392643|FG000|Overall Study|Death|1|||
33410223|NCT01519700|101392644|FG001|Overall Study|Death|0|||
33410224|NCT01519700|101392645|FG002|Overall Study|Death|0|||
33410225|NCT01519700|101392646|FG003|Overall Study|Death|0|||
33410226|NCT01519700|101392643|FG000|Overall Study|Lost to Follow-up|0|||
33410227|NCT01519700|101392644|FG001|Overall Study|Lost to Follow-up|0|||
33549750|NCT00972738|101908686|FG002|Overall Study|Lack of Efficacy|11|||
33216628|NCT00540124|100692150|FG000|Overall Study|Withdrawal by Subject|1|||
33216629|NCT00540124|100692151|FG001|Overall Study|Withdrawal by Subject|1|||
33216630|NCT00540124|100692152|FG002|Overall Study|Withdrawal by Subject|0|||
33216631|NCT01687257|100692153|FG000|Overall Study|Efficacy Failure|6|||
33216632|NCT01687257|100692154|FG001|Overall Study|Efficacy Failure|0|||
33549751|NCT00972738|101908684|FG000|Overall Study|Withdrawal by Subject|5|||
33549752|NCT00972738|101908685|FG001|Overall Study|Withdrawal by Subject|1|||
33549753|NCT00972738|101908686|FG002|Overall Study|Withdrawal by Subject|4|||
33549754|NCT00972738|101908684|FG000|Overall Study|Moved|0|||
33549755|NCT00972738|101908685|FG001|Overall Study|Moved|0|||
33549756|NCT00972738|101908686|FG002|Overall Study|Moved|1|||
33549757|NCT00972738|101908684|FG000|Overall Study|Other|1|||
33549758|NCT00972738|101908685|FG001|Overall Study|Other|2|||
33549759|NCT00972738|101908686|FG002|Overall Study|Other|1|||
33549760|NCT01026038|101908687|FG000|Overall Study|Lost to Follow-up|1|||
33549761|NCT01026038|101908688|FG001|Overall Study|Lost to Follow-up|1|||
33549762|NCT01026038|101908689|FG002|Overall Study|Lost to Follow-up|0|||
33549763|NCT05607043|101908690|FG000|Overall Study|Lost to Follow-up|2|||
33549764|NCT01239680|101908692|FG000|Overall Study|Withdrawal by Subject|2|||
33549765|NCT01239680|101908693|FG001|Overall Study|Withdrawal by Subject|0|||
33549766|NCT01756235|101908694|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
33549767|NCT00790036|101913450|FG000|Overall Study|Abnormal lab values|3|||
33549768|NCT00790036|101913451|FG001|Overall Study|Abnormal lab values|2|||
33549769|NCT00790036|101913450|FG000|Overall Study|Administrative problems|5|||
33549770|NCT00790036|101913451|FG001|Overall Study|Administrative problems|9|||
33549771|NCT00790036|101913450|FG000|Overall Study|Adverse Event|113|||
33549772|NCT00790036|101913451|FG001|Overall Study|Adverse Event|44|||
33216633|NCT01687257|100692155|FG002|Overall Study|Efficacy Failure|5|||
33216634|NCT01687257|100692153|FG000|Overall Study|Subject Withdrew Consent|1|||
33410228|NCT01519700|101392645|FG002|Overall Study|Lost to Follow-up|1|||
33410229|NCT01519700|101392646|FG003|Overall Study|Lost to Follow-up|1|||
33410230|NCT01519700|101392643|FG000|Overall Study|Physician Decision|1|||
33410231|NCT01519700|101392644|FG001|Overall Study|Physician Decision|1|||
33410232|NCT01519700|101392645|FG002|Overall Study|Physician Decision|3|||
33410233|NCT01519700|101392646|FG003|Overall Study|Physician Decision|0|||
33410234|NCT01519700|101392643|FG000|Overall Study|Withdrawal by Subject|5|||
33410235|NCT01519700|101392644|FG001|Overall Study|Withdrawal by Subject|3|||
33410236|NCT01519700|101392645|FG002|Overall Study|Withdrawal by Subject|3|||
33410237|NCT01519700|101392646|FG003|Overall Study|Withdrawal by Subject|2|||
33549773|NCT00790036|101913450|FG000|Overall Study|Death|1|||
33549774|NCT00790036|101913451|FG001|Overall Study|Death|0|||
33216635|NCT01687257|100692154|FG001|Overall Study|Subject Withdrew Consent|1|||
33410238|NCT01519700|101392643|FG000|Overall Study|Other Reason|2|||
33410239|NCT01519700|101392644|FG001|Overall Study|Other Reason|2|||
33410240|NCT01519700|101392645|FG002|Overall Study|Other Reason|0|||
33410241|NCT01519700|101392646|FG003|Overall Study|Other Reason|4|||
33410242|NCT03778021|101392649|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
33410243|NCT03778021|101392650|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
33410244|NCT01589185|101392651|FG000|Overall Study|Death|1|||
33410245|NCT01589185|101392652|FG001|Overall Study|Death|2|||
33410246|NCT01589185|101392653|FG002|Overall Study|Death|2|||
33410247|NCT01589185|101392654|FG003|Overall Study|Death|0|||
33410248|NCT01589185|101392655|FG004|Overall Study|Death|1|||
33410249|NCT01589185|101392651|FG000|Overall Study|Lost to Follow-up|1|||
33410250|NCT01589185|101392652|FG001|Overall Study|Lost to Follow-up|0|||
33410251|NCT01589185|101392653|FG002|Overall Study|Lost to Follow-up|2|||
33410252|NCT01589185|101392654|FG003|Overall Study|Lost to Follow-up|3|||
33410253|NCT01589185|101392655|FG004|Overall Study|Lost to Follow-up|0|||
33410254|NCT00240331|101392656|FG000|Overall Study|Withdrawal by Subject|125|||
33410255|NCT00240331|101392657|FG001|Overall Study|Withdrawal by Subject|132|||
33410256|NCT00240331|101392656|FG000|Overall Study|Option selected by investigator|1|||
33410257|NCT00240331|101392657|FG001|Overall Study|Option selected by investigator|2|||
33410258|NCT01353209|101392658|FG000|Overall Study|Adverse Event|1|||
33410259|NCT01353209|101392659|FG001|Overall Study|Adverse Event|1|||
33410260|NCT00690573|101392662|FG000|Overall Study|Lack of Efficacy|8|||
33410261|NCT00690573|101392662|FG000|Overall Study|Withdrawal by Subject|1|||
33410262|NCT01319994|101392663|FG000|Overall Study|Protocol Violation|7|||
33410263|NCT01319994|101392664|FG001|Overall Study|Protocol Violation|6|||
33410264|NCT00700115|101392665|FG000|Overall Study|Withdrawal by Subject|1|||
33410265|NCT00700115|101392666|FG001|Overall Study|Withdrawal by Subject|0|||
33410266|NCT00700115|101392665|FG000|Overall Study|Lost to Follow-up|0|||
33410267|NCT00700115|101392666|FG001|Overall Study|Lost to Follow-up|1|||
33410268|NCT02219477|101392671|FG000|Overall Study|Adverse Event|0|||
33410269|NCT02219477|101392672|FG001|Overall Study|Adverse Event|1|||
33410270|NCT02219477|101392673|FG002|Overall Study|Adverse Event|1|||
33410271|NCT02219477|101392671|FG000|Overall Study|Withdrawal by Subject|0|||
33410272|NCT02219477|101392672|FG001|Overall Study|Withdrawal by Subject|1|||
33410273|NCT02219477|101392673|FG002|Overall Study|Withdrawal by Subject|0|||
33410274|NCT01593761|101392674|FG000|Overall Study|Lost to Follow-up|1|||
33410275|NCT01593761|101392674|FG000|Overall Study|culture negative for MRSA at baseline|5|||
33410276|NCT01593761|101392674|FG000|Overall Study|positive for hepatitis C virus|1|||
33410277|NCT01593761|101392674|FG000|Overall Study|secondary cellulitis|1|||
33410278|NCT01195662|101392676|FG000|Double Blind Treatment Period|Adverse Event|4|||
33410279|NCT01195662|101392677|FG001|Double Blind Treatment Period|Adverse Event|1|||
33410280|NCT01195662|101392678|FG002|Double Blind Treatment Period|Adverse Event|2|||
33410281|NCT01195662|101392676|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
33410282|NCT01195662|101392677|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
33410283|NCT01195662|101392678|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
33410284|NCT01195662|101392676|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
33410285|NCT01195662|101392677|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
33410286|NCT01195662|101392678|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
33410287|NCT01195662|101392676|FG000|Double Blind Treatment Period|Administrative reason|2|||
33410288|NCT01195662|101392677|FG001|Double Blind Treatment Period|Administrative reason|1|||
33410289|NCT01195662|101392678|FG002|Double Blind Treatment Period|Administrative reason|1|||
33410290|NCT01195662|101392676|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
33410291|NCT01195662|101392677|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
33410292|NCT01195662|101392678|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
33410293|NCT01195662|101392676|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
33549775|NCT00790036|101913450|FG000|Overall Study|Disease progression|24|||
33549776|NCT00790036|101913451|FG001|Overall Study|Disease progression|48|||
33549777|NCT00790036|101913450|FG000|Overall Study|Lost to Follow-up|1|||
33549778|NCT00790036|101913451|FG001|Overall Study|Lost to Follow-up|2|||
33549779|NCT00790036|101913450|FG000|Overall Study|Protocol Violation|10|||
33549780|NCT00790036|101913451|FG001|Overall Study|Protocol Violation|2|||
33549781|NCT00790036|101913450|FG000|Overall Study|Withdrawal by Subject|18|||
33549782|NCT00790036|101913451|FG001|Overall Study|Withdrawal by Subject|7|||
33618145|NCT01959841|102151465|FG001|Overall Study|Platelet count below on day1 or 4|15|||
33410294|NCT01195662|101392677|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
33410295|NCT01195662|101392678|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
33410296|NCT01195662|101392676|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
33410297|NCT01195662|101392677|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
33410298|NCT01195662|101392678|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
33618146|NCT01959841|102151466|FG002|Overall Study|Platelet count below on day1 or 4|11|||
33216636|NCT01687257|100692155|FG002|Overall Study|Subject Withdrew Consent|1|||
33410299|NCT01195662|101392676|FG000|Double Blind Treatment Period|Non-specified|3|||
33410300|NCT01195662|101392677|FG001|Double Blind Treatment Period|Non-specified|0|||
33410301|NCT01195662|101392678|FG002|Double Blind Treatment Period|Non-specified|0|||
33410302|NCT01195662|101392676|FG000|Double Blind Treatment Period|Missing disposition information|0|||
33410303|NCT01195662|101392677|FG001|Double Blind Treatment Period|Missing disposition information|1|||
33410304|NCT01195662|101392678|FG002|Double Blind Treatment Period|Missing disposition information|1|||
33410305|NCT01195662|101392676|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
33410306|NCT01195662|101392677|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
33410307|NCT01195662|101392678|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
33410308|NCT01195662|101392676|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
33410309|NCT01195662|101392677|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
33410310|NCT01195662|101392678|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
33410311|NCT00903357|101392684|FG000|First Intervention|Withdrawal by Subject|5|||
33410312|NCT00903357|101392685|FG001|First Intervention|Withdrawal by Subject|3|||
33410313|NCT00903357|101392684|FG000|First Intervention|Flu|0|||
33410314|NCT00903357|101392685|FG001|First Intervention|Flu|1|||
33410315|NCT00903357|101392684|FG000|Wash Out Period of 2 Weeks|Flu|0|||
33410316|NCT00903357|101392685|FG001|Wash Out Period of 2 Weeks|Flu|1|||
33410317|NCT00903357|101392684|FG000|Second Intervention|Lost to Follow-up|1|||
33410318|NCT00903357|101392685|FG001|Second Intervention|Lost to Follow-up|0|||
33410319|NCT05146999|101392686|FG000|Overall Study|Withdrew consent|6|||
33410320|NCT05146999|101392687|FG001|Overall Study|Withdrew consent|1|||
33549783|NCT00790036|101913450|FG000|Overall Study|Subject/guardian decision|20|||
33549784|NCT00790036|101913451|FG001|Overall Study|Subject/guardian decision|7|||
33349735|NCT00977470|101167548|FG001|Overall Study|Adverse Event|2|||
33349736|NCT00977470|101167547|FG000|Overall Study|Protocol Violation|1|||
33349737|NCT00977470|101167548|FG001|Overall Study|Protocol Violation|0|||
33349738|NCT00977470|101167547|FG000|Overall Study|Withdrawal by Subject|0|||
33349739|NCT00977470|101167548|FG001|Overall Study|Withdrawal by Subject|2|||
33349740|NCT00977470|101167547|FG000|Overall Study|Death|0|||
33349741|NCT00977470|101167548|FG001|Overall Study|Death|2|||
33349742|NCT00977470|101167547|FG000|Overall Study|clinical decline|0|||
33349743|NCT00977470|101167548|FG001|Overall Study|clinical decline|1|||
33349744|NCT00977470|101167547|FG000|Overall Study|prolonged recovery post-surgery|0|||
33349745|NCT00977470|101167548|FG001|Overall Study|prolonged recovery post-surgery|1|||
33349746|NCT00977470|101167547|FG000|Overall Study|Still on-study|2|||
33349747|NCT00977470|101167548|FG001|Overall Study|Still on-study|0|||
33349748|NCT01097629|101167550|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
33349749|NCT01097629|101167551|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
33349750|NCT01097629|101167552|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
33349751|NCT01097629|101167553|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33349752|NCT01097629|101167554|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33349753|NCT01097629|101167555|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33349754|NCT01097629|101167556|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33349755|NCT01097629|101167557|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33349756|NCT01097629|101167550|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
33349757|NCT01097629|101167551|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
33349758|NCT01097629|101167552|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
33349759|NCT01097629|101167553|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33349760|NCT01097629|101167554|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33349761|NCT01097629|101167555|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33349762|NCT01097629|101167556|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33349763|NCT01097629|101167557|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33349764|NCT01097629|101167550|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
33410321|NCT05146999|101392686|FG000|Overall Study|Lost to Follow-up|3|||
33410322|NCT05146999|101392687|FG001|Overall Study|Lost to Follow-up|2|||
33549785|NCT05350423|101913455|FG000|Overall Study|Lost to Follow-up|3|||
33549786|NCT05350423|101913456|FG001|Overall Study|Lost to Follow-up|3|||
33549787|NCT05350423|101913455|FG000|Overall Study|screen failure|5|||
33549788|NCT05350423|101913456|FG001|Overall Study|screen failure|6|||
33549789|NCT00382070|101913462|FG000|Overall Study|No follow up data mapped to Other|17|||
33549790|NCT00382070|101913463|FG001|Overall Study|No follow up data mapped to Other|19|||
33549791|NCT00382070|101913462|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
33549792|NCT00382070|101913463|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
33549793|NCT00382070|101913462|FG000|Overall Study|No clinical assessment|9|||
33618147|NCT00742417|102151467|FG000|Randomized|Withdrawal by legal representative|0|||
33216637|NCT01687257|100692153|FG000|Overall Study|Adverse Event|1|||
33410323|NCT05146999|101392686|FG000|Overall Study|Other|1|||
33410324|NCT05146999|101392687|FG001|Overall Study|Other|3|||
33410325|NCT03000075|101392691|FG000|Part A|Adverse Event|4|||
33410326|NCT03000075|101392692|FG001|Part A|Adverse Event|0|||
33410327|NCT03000075|101392693|FG002|Part A|Adverse Event|0|||
33216638|NCT01687257|100692154|FG001|Overall Study|Adverse Event|0|||
33618148|NCT00742417|102151468|FG001|Randomized|Withdrawal by legal representative|1|||
33618149|NCT00742417|102151467|FG000|Randomized|Withdrawal by Subject|1|||
33618150|NCT00742417|102151468|FG001|Randomized|Withdrawal by Subject|0|||
33618151|NCT00742417|102151467|FG000|Randomized|Physician Decision|1|||
33618152|NCT00742417|102151468|FG001|Randomized|Physician Decision|0|||
33618153|NCT00742417|102151467|FG000|Intensive Period|Withdrawal by Subject|1|||
33618154|NCT00742417|102151468|FG001|Intensive Period|Withdrawal by Subject|1|||
33618155|NCT00742417|102151467|FG000|Intensive Period|Adverse Event|2|||
33618156|NCT00742417|102151468|FG001|Intensive Period|Adverse Event|0|||
33618157|NCT00799903|102151469|FG000|Overall Study|Investigator Site Closed|25|||
33618158|NCT00799903|102151470|FG001|Overall Study|Investigator Site Closed|23|||
33618159|NCT00799903|102151469|FG000|Overall Study|Withdrawal by Subject|179|||
33618160|NCT00799903|102151470|FG001|Overall Study|Withdrawal by Subject|175|||
33618161|NCT00799903|102151469|FG000|Overall Study|Lost to Follow-up|69|||
33618162|NCT00799903|102151470|FG001|Overall Study|Lost to Follow-up|80|||
33618163|NCT03201419|102151471|FG000|Overall Study|Adverse Event|3|||
33618164|NCT03201419|102151472|FG001|Overall Study|Adverse Event|1|||
33618165|NCT03201419|102151473|FG002|Overall Study|Adverse Event|0|||
33618166|NCT03201419|102151474|FG003|Overall Study|Adverse Event|0|||
33618167|NCT03201419|102151475|FG004|Overall Study|Adverse Event|1|||
33618168|NCT03201419|102151476|FG005|Overall Study|Adverse Event|1|||
33618169|NCT03201419|102151477|FG006|Overall Study|Adverse Event|5|||
33618170|NCT03201419|102151478|FG007|Overall Study|Adverse Event|0|||
33618171|NCT03201419|102151479|FG008|Overall Study|Adverse Event|0|||
33618172|NCT03201419|102151471|FG000|Overall Study|Lost to Follow-up|1|||
33618173|NCT03201419|102151472|FG001|Overall Study|Lost to Follow-up|0|||
33618174|NCT03201419|102151473|FG002|Overall Study|Lost to Follow-up|0|||
33618175|NCT03201419|102151474|FG003|Overall Study|Lost to Follow-up|0|||
33618176|NCT03201419|102151475|FG004|Overall Study|Lost to Follow-up|0|||
33618177|NCT03201419|102151476|FG005|Overall Study|Lost to Follow-up|0|||
33618178|NCT03201419|102151477|FG006|Overall Study|Lost to Follow-up|0|||
33618179|NCT03201419|102151478|FG007|Overall Study|Lost to Follow-up|0|||
33618180|NCT03201419|102151479|FG008|Overall Study|Lost to Follow-up|0|||
33618181|NCT03201419|102151471|FG000|Overall Study|Protocol Deviation|0|||
33618182|NCT03201419|102151472|FG001|Overall Study|Protocol Deviation|0|||
33618183|NCT03201419|102151473|FG002|Overall Study|Protocol Deviation|0|||
33618184|NCT03201419|102151474|FG003|Overall Study|Protocol Deviation|0|||
33618185|NCT03201419|102151475|FG004|Overall Study|Protocol Deviation|0|||
33618186|NCT03201419|102151476|FG005|Overall Study|Protocol Deviation|0|||
33618187|NCT03201419|102151477|FG006|Overall Study|Protocol Deviation|1|||
33618188|NCT03201419|102151478|FG007|Overall Study|Protocol Deviation|0|||
33618189|NCT03201419|102151479|FG008|Overall Study|Protocol Deviation|0|||
33618190|NCT03201419|102151471|FG000|Overall Study|Withdrawal by Subject|4|||
33618191|NCT03201419|102151472|FG001|Overall Study|Withdrawal by Subject|2|||
33618192|NCT03201419|102151473|FG002|Overall Study|Withdrawal by Subject|1|||
33618193|NCT03201419|102151474|FG003|Overall Study|Withdrawal by Subject|0|||
33618194|NCT03201419|102151475|FG004|Overall Study|Withdrawal by Subject|0|||
33618195|NCT03201419|102151476|FG005|Overall Study|Withdrawal by Subject|0|||
33618196|NCT03201419|102151477|FG006|Overall Study|Withdrawal by Subject|0|||
33618197|NCT03201419|102151478|FG007|Overall Study|Withdrawal by Subject|1|||
33618198|NCT03201419|102151479|FG008|Overall Study|Withdrawal by Subject|2|||
33618199|NCT03201419|102151471|FG000|Overall Study|Other|0|||
33618200|NCT03201419|102151472|FG001|Overall Study|Other|0|||
33618201|NCT03201419|102151473|FG002|Overall Study|Other|1|||
33618202|NCT03201419|102151474|FG003|Overall Study|Other|0|||
33618203|NCT03201419|102151475|FG004|Overall Study|Other|0|||
33618204|NCT03201419|102151476|FG005|Overall Study|Other|0|||
33618205|NCT03201419|102151477|FG006|Overall Study|Other|0|||
33216639|NCT01687257|100692155|FG002|Overall Study|Adverse Event|0|||
33216640|NCT01687257|100692153|FG000|Overall Study|Investigator's Discretion|0|||
33216641|NCT01687257|100692154|FG001|Overall Study|Investigator's Discretion|3|||
33349765|NCT01097629|101167551|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
33349766|NCT01097629|101167552|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
33349767|NCT01097629|101167553|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33618206|NCT03201419|102151478|FG007|Overall Study|Other|0|||
33618207|NCT03201419|102151479|FG008|Overall Study|Other|0|||
33618208|NCT02525588|102151480|FG000|Overall Study|Death|3|||
33618209|NCT02525588|102151481|FG001|Overall Study|Death|1|||
33618210|NCT02525588|102151480|FG000|Overall Study|Lost to Follow-up|2|||
33618211|NCT02525588|102151481|FG001|Overall Study|Lost to Follow-up|0|||
33618212|NCT02525588|102151480|FG000|Overall Study|Withdrawal by Subject|1|||
33618213|NCT02525588|102151481|FG001|Overall Study|Withdrawal by Subject|1|||
33618214|NCT02525588|102151480|FG000|Overall Study|Adverse Event|0|||
33216642|NCT01687257|100692155|FG002|Overall Study|Investigator's Discretion|0|||
33618215|NCT02525588|102151481|FG001|Overall Study|Adverse Event|1|||
33618216|NCT01008943|102151482|FG000|Overall Study|Withdrawal by Subject|1|||
33618217|NCT02488005|102151483|FG000|Overall Study|Lost to Follow-up|2|||
33618218|NCT00965575|102151487|FG000|Overall Study|subject unwillingness to swallow study c|1|||
33618219|NCT00965575|102151488|FG001|Overall Study|subject unwillingness to swallow study c|0|||
33618220|NCT03592368|102151498|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
33618221|NCT03592368|102151499|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
33618222|NCT03592368|102151500|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
33618223|NCT03592368|102151501|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
33618224|NCT03592368|102151498|FG000|Overall Study|Adverse Event|0|||
33618225|NCT03592368|102151499|FG001|Overall Study|Adverse Event|0|||
33618226|NCT03592368|102151500|FG002|Overall Study|Adverse Event|0|||
33618227|NCT03592368|102151501|FG003|Overall Study|Adverse Event|1|||
33618228|NCT03592368|102151498|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
33618229|NCT03592368|102151499|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
33618230|NCT03592368|102151500|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
33618231|NCT03592368|102151501|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
33618232|NCT00713544|102151502|FG000|Overall Study|Adverse Event|5|||
33618233|NCT00713544|102151503|FG001|Overall Study|Adverse Event|3|||
33618234|NCT00713544|102151504|FG002|Overall Study|Adverse Event|7|||
33618235|NCT00713544|102151505|FG003|Overall Study|Adverse Event|7|||
33618236|NCT00713544|102151506|FG004|Overall Study|Adverse Event|3|||
33618237|NCT00713544|102151507|FG005|Overall Study|Adverse Event|5|||
33618238|NCT00713544|102151502|FG000|Overall Study|Withdrawal by Subject|2|||
33618239|NCT00713544|102151503|FG001|Overall Study|Withdrawal by Subject|0|||
33618240|NCT00713544|102151504|FG002|Overall Study|Withdrawal by Subject|3|||
33618241|NCT00713544|102151505|FG003|Overall Study|Withdrawal by Subject|2|||
33618242|NCT00713544|102151506|FG004|Overall Study|Withdrawal by Subject|3|||
33618243|NCT00713544|102151507|FG005|Overall Study|Withdrawal by Subject|1|||
33618244|NCT00713544|102151502|FG000|Overall Study|Protocol Violation|0|||
33618245|NCT00713544|102151503|FG001|Overall Study|Protocol Violation|0|||
33618246|NCT00713544|102151504|FG002|Overall Study|Protocol Violation|0|||
33618247|NCT00713544|102151505|FG003|Overall Study|Protocol Violation|0|||
33618248|NCT00713544|102151506|FG004|Overall Study|Protocol Violation|0|||
33618249|NCT00713544|102151507|FG005|Overall Study|Protocol Violation|1|||
33618250|NCT00713544|102151502|FG000|Overall Study|Physician Decision|0|||
33618251|NCT00713544|102151503|FG001|Overall Study|Physician Decision|0|||
33618252|NCT00713544|102151504|FG002|Overall Study|Physician Decision|0|||
33618253|NCT00713544|102151505|FG003|Overall Study|Physician Decision|0|||
33618254|NCT00713544|102151506|FG004|Overall Study|Physician Decision|0|||
33618255|NCT00713544|102151507|FG005|Overall Study|Physician Decision|2|||
33618256|NCT00713544|102151502|FG000|Overall Study|Lack of Efficacy|0|||
33618257|NCT00713544|102151503|FG001|Overall Study|Lack of Efficacy|1|||
33618258|NCT00713544|102151504|FG002|Overall Study|Lack of Efficacy|0|||
33618259|NCT00713544|102151505|FG003|Overall Study|Lack of Efficacy|1|||
33349768|NCT01097629|101167554|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33349769|NCT01097629|101167555|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33349770|NCT01097629|101167556|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33349771|NCT01097629|101167557|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33349772|NCT01097629|101167550|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
33349773|NCT01097629|101167551|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
33349774|NCT01097629|101167552|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
33349775|NCT01097629|101167553|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33349776|NCT01097629|101167554|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33349777|NCT01097629|101167555|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33349778|NCT01097629|101167556|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33349779|NCT01097629|101167557|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33349780|NCT01097629|101167550|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
33349781|NCT01097629|101167551|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
33349782|NCT01097629|101167552|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
33349783|NCT01097629|101167553|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33349784|NCT01097629|101167554|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33349785|NCT01097629|101167555|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33349786|NCT01097629|101167556|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33349787|NCT01097629|101167557|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33618260|NCT00713544|102151506|FG004|Overall Study|Lack of Efficacy|1|||
33618261|NCT00713544|102151507|FG005|Overall Study|Lack of Efficacy|0|||
33618262|NCT00713544|102151502|FG000|Overall Study|Lost to Follow-up|0|||
33618263|NCT00713544|102151503|FG001|Overall Study|Lost to Follow-up|0|||
33618264|NCT00713544|102151504|FG002|Overall Study|Lost to Follow-up|1|||
33618265|NCT00713544|102151505|FG003|Overall Study|Lost to Follow-up|0|||
33618266|NCT00713544|102151506|FG004|Overall Study|Lost to Follow-up|0|||
33216643|NCT02338154|100692159|FG000|Overall Study|Death|46|||
33216644|NCT02338154|100692159|FG000|Overall Study|Valve Implant Failure|17|||
33410328|NCT03000075|101392694|FG003|Part A|Adverse Event|0|||
33410329|NCT03000075|101392695|FG004|Part A|Adverse Event|0|||
33410330|NCT03000075|101392696|FG005|Part A|Adverse Event|0|||
33410331|NCT03000075|101392697|FG006|Part A|Adverse Event|0|||
33410332|NCT03000075|101392691|FG000|Part B|Not dosed due to AE|0|||
33410333|NCT03000075|101392692|FG001|Part B|Not dosed due to AE|0|||
33410334|NCT03000075|101392693|FG002|Part B|Not dosed due to AE|0|||
33410335|NCT03000075|101392694|FG003|Part B|Not dosed due to AE|0|||
33410336|NCT03000075|101392695|FG004|Part B|Not dosed due to AE|0|||
33410337|NCT03000075|101392696|FG005|Part B|Not dosed due to AE|2|||
33410338|NCT03000075|101392697|FG006|Part B|Not dosed due to AE|1|||
33410339|NCT03000075|101392691|FG000|Part B|Adverse Event|0|||
33410340|NCT03000075|101392692|FG001|Part B|Adverse Event|0|||
33410341|NCT03000075|101392693|FG002|Part B|Adverse Event|0|||
33410342|NCT03000075|101392694|FG003|Part B|Adverse Event|0|||
33410343|NCT03000075|101392695|FG004|Part B|Adverse Event|1|||
33410344|NCT03000075|101392696|FG005|Part B|Adverse Event|0|||
33410345|NCT03000075|101392697|FG006|Part B|Adverse Event|0|||
33410346|NCT01876901|101392702|FG000|Overall Study|Protocol Violation|10|||
33410347|NCT01876901|101392703|FG001|Overall Study|Protocol Violation|2|||
33410348|NCT01876901|101392702|FG000|Overall Study|No or other surgical intervention|7|||
33410349|NCT01876901|101392703|FG001|Overall Study|No or other surgical intervention|5|||
33410350|NCT00379639|101392704|FG000|Overall Study|Disease Progression|3|||
33410351|NCT00379639|101392705|FG001|Overall Study|Disease Progression|3|||
33410352|NCT00379639|101392706|FG002|Overall Study|Disease Progression|3|||
33410353|NCT00379639|101392707|FG003|Overall Study|Disease Progression|4|||
33410354|NCT00379639|101392708|FG004|Overall Study|Disease Progression|4|||
33410355|NCT00379639|101392704|FG000|Overall Study|Physician Decision|0|||
33410356|NCT00379639|101392705|FG001|Overall Study|Physician Decision|2|||
33410357|NCT00379639|101392706|FG002|Overall Study|Physician Decision|1|||
33410358|NCT00379639|101392707|FG003|Overall Study|Physician Decision|1|||
33410359|NCT00379639|101392708|FG004|Overall Study|Physician Decision|0|||
33410360|NCT00379639|101392704|FG000|Overall Study|Symptomatic Deterioration|0|||
33410361|NCT00379639|101392705|FG001|Overall Study|Symptomatic Deterioration|0|||
33410362|NCT00379639|101392706|FG002|Overall Study|Symptomatic Deterioration|1|||
33410363|NCT00379639|101392707|FG003|Overall Study|Symptomatic Deterioration|0|||
33410364|NCT00379639|101392708|FG004|Overall Study|Symptomatic Deterioration|1|||
33410365|NCT00379639|101392704|FG000|Overall Study|Adverse Event|0|||
33410366|NCT00379639|101392705|FG001|Overall Study|Adverse Event|0|||
33410367|NCT00379639|101392706|FG002|Overall Study|Adverse Event|1|||
33410368|NCT00379639|101392707|FG003|Overall Study|Adverse Event|0|||
33410369|NCT00379639|101392708|FG004|Overall Study|Adverse Event|1|||
33410370|NCT00379639|101392704|FG000|Overall Study|Lost to Follow-up|0|||
33410371|NCT00379639|101392705|FG001|Overall Study|Lost to Follow-up|0|||
33410372|NCT00379639|101392706|FG002|Overall Study|Lost to Follow-up|0|||
33410373|NCT00379639|101392707|FG003|Overall Study|Lost to Follow-up|1|||
33410374|NCT00379639|101392708|FG004|Overall Study|Lost to Follow-up|0|||
33410375|NCT00379639|101392704|FG000|Overall Study|Other|0|||
33410376|NCT00379639|101392705|FG001|Overall Study|Other|0|||
33410377|NCT00379639|101392706|FG002|Overall Study|Other|3|||
33410378|NCT00379639|101392707|FG003|Overall Study|Other|0|||
33410379|NCT00379639|101392708|FG004|Overall Study|Other|0|||
33410380|NCT04366258|101392711|FG000|Baseline Assessments|Screen Failure|21|||
33410381|NCT04366258|101392711|FG000|Baseline Assessments|Early Termination|3|||
33410382|NCT00501969|101392714|FG000|Overall Study|Major Protocol Violation|4|||
33410383|NCT00501969|101392714|FG000|Overall Study|Lack of Efficacy|29|||
33410384|NCT00501969|101392714|FG000|Overall Study|Adverse Event|76|||
33410385|NCT00501969|101392714|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
33410386|NCT00501969|101392714|FG000|Overall Study|Subject withdrew consent|51|||
33410387|NCT00501969|101392714|FG000|Overall Study|Lost to Follow-up|4|||
33410388|NCT00501969|101392714|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
33410389|NCT00501969|101392714|FG000|Overall Study|Other: Sponsors Request|10|||
33410390|NCT00501969|101392714|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
33549794|NCT00382070|101913463|FG001|Overall Study|No clinical assessment|11|||
33549795|NCT04149353|101913464|FG000|Overall Study|Study terminated|1|||
33549796|NCT01311661|101913472|FG000|Overall Study|Adverse Event|2|||
33549797|NCT01311661|101913472|FG000|Overall Study|Protocol Violation|3|||
33549798|NCT01311661|101913472|FG000|Overall Study|Withdrawal by Subject|2|||
33216645|NCT02338154|100692159|FG000|Overall Study|Valve Explant|11|||
33410391|NCT00501969|101392714|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
33410392|NCT00501969|101392714|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
33410393|NCT00501969|101392714|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
33410394|NCT00501969|101392714|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
33410395|NCT00501969|101392714|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
33410396|NCT00501969|101392714|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
33410397|NCT00501969|101392714|FG000|Overall Study|Other: As Required by Local EC|2|||
33410398|NCT00501969|101392714|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
33410399|NCT00501969|101392714|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
33410400|NCT03586427|101392715|FG000|Overall Study|Lost to Follow-up|0|||
33410401|NCT03586427|101392716|FG001|Overall Study|Lost to Follow-up|3|||
33410402|NCT03586427|101392717|FG002|Overall Study|Lost to Follow-up|1|||
33410403|NCT03586427|101392718|FG003|Overall Study|Lost to Follow-up|3|||
33410404|NCT03586427|101392719|FG004|Overall Study|Lost to Follow-up|3|||
33410405|NCT03586427|101392715|FG000|Overall Study|Withdrawal by Subject|0|||
33410406|NCT03586427|101392716|FG001|Overall Study|Withdrawal by Subject|1|||
33410407|NCT03586427|101392717|FG002|Overall Study|Withdrawal by Subject|2|||
33410408|NCT03586427|101392718|FG003|Overall Study|Withdrawal by Subject|1|||
33410409|NCT03586427|101392719|FG004|Overall Study|Withdrawal by Subject|1|||
33410410|NCT03586427|101392715|FG000|Overall Study|Adverse Event|0|||
33410411|NCT03586427|101392716|FG001|Overall Study|Adverse Event|0|||
33410412|NCT03586427|101392717|FG002|Overall Study|Adverse Event|1|||
33410413|NCT03586427|101392718|FG003|Overall Study|Adverse Event|0|||
33549799|NCT02724644|101913473|FG000|Overall Study|Adverse Event|7|||
33349788|NCT01097629|101167550|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
33349789|NCT01097629|101167551|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
33349790|NCT01097629|101167552|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33349791|NCT01097629|101167553|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33349792|NCT01097629|101167554|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33349793|NCT01097629|101167555|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33349794|NCT01097629|101167556|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33349795|NCT01097629|101167557|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33349796|NCT01097629|101167550|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
33349797|NCT01097629|101167551|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
33349798|NCT01097629|101167552|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
33349799|NCT01097629|101167553|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33349800|NCT01097629|101167554|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33349801|NCT01097629|101167555|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33349802|NCT01097629|101167556|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33349803|NCT01097629|101167557|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33349804|NCT01097629|101167550|FG000|DB RO Phase|Withdrawal by Subject|0|||
33349805|NCT01097629|101167551|FG001|DB RO Phase|Withdrawal by Subject|0|||
33349806|NCT01097629|101167552|FG002|DB RO Phase|Withdrawal by Subject|0|||
33349807|NCT01097629|101167553|FG003|DB RO Phase|Withdrawal by Subject|0|||
33349808|NCT01097629|101167554|FG004|DB RO Phase|Withdrawal by Subject|0|||
33349809|NCT01097629|101167555|FG005|DB RO Phase|Withdrawal by Subject|0|||
33349810|NCT01097629|101167556|FG006|DB RO Phase|Withdrawal by Subject|0|||
33349811|NCT01097629|101167557|FG007|DB RO Phase|Withdrawal by Subject|1|||
33349812|NCT01097629|101167550|FG000|DB RO Phase|Protocol Violation|0|||
33349813|NCT01097629|101167551|FG001|DB RO Phase|Protocol Violation|0|||
33349814|NCT01097629|101167552|FG002|DB RO Phase|Protocol Violation|0|||
33349815|NCT01097629|101167553|FG003|DB RO Phase|Protocol Violation|1|||
33349816|NCT01097629|101167554|FG004|DB RO Phase|Protocol Violation|0|||
33349817|NCT01097629|101167555|FG005|DB RO Phase|Protocol Violation|1|||
33349818|NCT01097629|101167556|FG006|DB RO Phase|Protocol Violation|1|||
33349819|NCT01097629|101167557|FG007|DB RO Phase|Protocol Violation|0|||
33349820|NCT01097629|101167550|FG000|DB RO Phase|Lost to Follow-up|0|||
33349821|NCT01097629|101167551|FG001|DB RO Phase|Lost to Follow-up|0|||
33349822|NCT01097629|101167552|FG002|DB RO Phase|Lost to Follow-up|0|||
33349823|NCT01097629|101167553|FG003|DB RO Phase|Lost to Follow-up|0|||
33349824|NCT01097629|101167554|FG004|DB RO Phase|Lost to Follow-up|0|||
33349825|NCT01097629|101167555|FG005|DB RO Phase|Lost to Follow-up|0|||
33349826|NCT01097629|101167556|FG006|DB RO Phase|Lost to Follow-up|2|||
33349827|NCT01097629|101167557|FG007|DB RO Phase|Lost to Follow-up|0|||
33349828|NCT01227967|101167563|FG000|Overall Study|Protocol Violation|3|||
33349829|NCT01227967|101167564|FG001|Overall Study|Protocol Violation|1|||
33349830|NCT01227967|101167563|FG000|Overall Study|Death|0|||
33349831|NCT01227967|101167564|FG001|Overall Study|Death|1|||
33349832|NCT01227967|101167563|FG000|Overall Study|Lost to Follow-up|8|||
33349833|NCT01227967|101167564|FG001|Overall Study|Lost to Follow-up|3|||
33349834|NCT01227967|101167563|FG000|Overall Study|Withdrawal by Subject|4|||
33410414|NCT03586427|101392719|FG004|Overall Study|Adverse Event|0|||
33410415|NCT03586427|101392715|FG000|Overall Study|Protocol Violation|0|||
33410416|NCT03586427|101392716|FG001|Overall Study|Protocol Violation|0|||
33410417|NCT03586427|101392717|FG002|Overall Study|Protocol Violation|1|||
33410418|NCT03586427|101392718|FG003|Overall Study|Protocol Violation|0|||
33549800|NCT02724644|101913474|FG001|Overall Study|Adverse Event|1|||
33349835|NCT01227967|101167564|FG001|Overall Study|Withdrawal by Subject|3|||
33349836|NCT01227967|101167563|FG000|Overall Study|Physician Decision|0|||
33349837|NCT01227967|101167564|FG001|Overall Study|Physician Decision|1|||
33349838|NCT01227967|101167563|FG000|Overall Study|Never Started Treatment|0|||
33349839|NCT01227967|101167564|FG001|Overall Study|Never Started Treatment|4|||
33349840|NCT01227967|101167563|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
33349841|NCT01227967|101167564|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
33349842|NCT02689492|101167565|FG000|Overall Study|Lost to Follow-up|61|||
33410419|NCT03586427|101392719|FG004|Overall Study|Protocol Violation|1|||
33410420|NCT03586427|101392715|FG000|Overall Study|Noncompliance with study drug|0|||
33410421|NCT03586427|101392716|FG001|Overall Study|Noncompliance with study drug|0|||
33410422|NCT03586427|101392717|FG002|Overall Study|Noncompliance with study drug|1|||
33410423|NCT03586427|101392718|FG003|Overall Study|Noncompliance with study drug|0|||
33410424|NCT03586427|101392719|FG004|Overall Study|Noncompliance with study drug|0|||
33410425|NCT02967055|101392720|FG000|Overall Study|Excluded|40|||
33410426|NCT02967055|101392720|FG000|Overall Study|Screen fail|3|||
33410427|NCT02967055|101392720|FG000|Overall Study|Lost to Follow-up|2|||
33410428|NCT02967055|101392720|FG000|Overall Study|Stopped due to side effects|3|||
33410429|NCT02967055|101392720|FG000|Overall Study|Stopped due to drug cost|1|||
33410430|NCT00234533|101392725|FG000|Overall Study|Withdrawal by Subject|6|||
33410431|NCT00234533|101392725|FG000|Overall Study|Adverse Event|2|||
33410432|NCT00234533|101392725|FG000|Overall Study|Enrolled but not treated|3|||
33549801|NCT02724644|101913473|FG000|Overall Study|Lost to Follow-up|6|||
33549802|NCT02724644|101913474|FG001|Overall Study|Lost to Follow-up|2|||
33549803|NCT02724644|101913473|FG000|Overall Study|Withdrawal by Subject|7|||
33549804|NCT02724644|101913474|FG001|Overall Study|Withdrawal by Subject|1|||
33549805|NCT02724644|101913473|FG000|Overall Study|Administrative|1|||
33549806|NCT02724644|101913474|FG001|Overall Study|Administrative|0|||
33549807|NCT02265744|101913475|FG000|Overall Study|Poor/Non-compliance|1|||
33549808|NCT02265744|101913476|FG001|Overall Study|Poor/Non-compliance|1|||
33549809|NCT02265744|101913477|FG002|Overall Study|Poor/Non-compliance|0|||
33549810|NCT02265744|101913478|FG003|Overall Study|Poor/Non-compliance|0|||
33549811|NCT02265744|101913479|FG004|Overall Study|Poor/Non-compliance|2|||
33349843|NCT02689492|101167565|FG000|Overall Study|Withdrawal by Subject|11|||
33549812|NCT02265744|101913475|FG000|Overall Study|Lost to Follow-up|0|||
33549813|NCT02265744|101913476|FG001|Overall Study|Lost to Follow-up|0|||
33549814|NCT02265744|101913477|FG002|Overall Study|Lost to Follow-up|0|||
33549815|NCT02265744|101913478|FG003|Overall Study|Lost to Follow-up|1|||
33549816|NCT02265744|101913479|FG004|Overall Study|Lost to Follow-up|0|||
33549817|NCT02265744|101913475|FG000|Overall Study|Death|0|||
33549818|NCT02265744|101913476|FG001|Overall Study|Death|0|||
33549819|NCT02265744|101913477|FG002|Overall Study|Death|0|||
33549820|NCT02265744|101913478|FG003|Overall Study|Death|2|||
33549821|NCT02265744|101913479|FG004|Overall Study|Death|0|||
33549822|NCT02265744|101913475|FG000|Overall Study|Withdrawal by Subject|2|||
33549823|NCT02265744|101913476|FG001|Overall Study|Withdrawal by Subject|0|||
33549824|NCT02265744|101913477|FG002|Overall Study|Withdrawal by Subject|0|||
33549825|NCT02265744|101913478|FG003|Overall Study|Withdrawal by Subject|2|||
33549826|NCT02265744|101913479|FG004|Overall Study|Withdrawal by Subject|0|||
33549827|NCT02265744|101913475|FG000|Overall Study|Participant request to discontinue|2|||
33549828|NCT02265744|101913476|FG001|Overall Study|Participant request to discontinue|2|||
33549829|NCT02265744|101913477|FG002|Overall Study|Participant request to discontinue|2|||
33549830|NCT02265744|101913478|FG003|Overall Study|Participant request to discontinue|0|||
33549831|NCT02265744|101913479|FG004|Overall Study|Participant request to discontinue|0|||
33549832|NCT02265744|101913475|FG000|Overall Study|Adverse Event|8|||
33549833|NCT02265744|101913476|FG001|Overall Study|Adverse Event|4|||
33549834|NCT02265744|101913477|FG002|Overall Study|Adverse Event|9|||
33549835|NCT02265744|101913478|FG003|Overall Study|Adverse Event|8|||
33549836|NCT02265744|101913479|FG004|Overall Study|Adverse Event|2|||
33549837|NCT02265744|101913475|FG000|Overall Study|Lack of Efficacy|2|||
33549838|NCT02265744|101913476|FG001|Overall Study|Lack of Efficacy|4|||
33549839|NCT02265744|101913477|FG002|Overall Study|Lack of Efficacy|3|||
33549840|NCT02265744|101913478|FG003|Overall Study|Lack of Efficacy|4|||
33549841|NCT02265744|101913479|FG004|Overall Study|Lack of Efficacy|5|||
33549842|NCT02265744|101913475|FG000|Overall Study|Reason not provided by Investigator|1|||
33216646|NCT02338154|100692159|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
33349844|NCT02689492|101167565|FG000|Overall Study|Death|9|||
33349845|NCT02689492|101167565|FG000|Overall Study|Physician Decision|2|||
33349846|NCT02689492|101167565|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
33349847|NCT02689492|101167565|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
33349848|NCT02689492|101167565|FG000|Overall Study|Other than listed|1|||
33349849|NCT03636906|101167576|FG000|Overall Study|Adverse Event|0|||
33549843|NCT02265744|101913476|FG001|Overall Study|Reason not provided by Investigator|0|||
33549844|NCT02265744|101913477|FG002|Overall Study|Reason not provided by Investigator|0|||
33549845|NCT02265744|101913478|FG003|Overall Study|Reason not provided by Investigator|2|||
33549846|NCT02265744|101913479|FG004|Overall Study|Reason not provided by Investigator|0|||
33549847|NCT02265744|101913475|FG000|Overall Study|Administrative reason by sponsor|3|||
33349850|NCT03636906|101167577|FG001|Overall Study|Adverse Event|0|||
33549848|NCT02265744|101913476|FG001|Overall Study|Administrative reason by sponsor|2|||
33549849|NCT02265744|101913477|FG002|Overall Study|Administrative reason by sponsor|2|||
33549850|NCT02265744|101913478|FG003|Overall Study|Administrative reason by sponsor|3|||
33349851|NCT03636906|101167578|FG002|Overall Study|Adverse Event|1|||
33349852|NCT03636906|101167576|FG000|Overall Study|Lost to Follow-up|1|||
33410433|NCT00570492|101392726|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
33410434|NCT00570492|101392727|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
33410435|NCT00570492|101392728|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
33410436|NCT00570492|101392726|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
33410437|NCT00570492|101392727|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
33410438|NCT00570492|101392728|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
33410439|NCT00570492|101392726|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
33410440|NCT00570492|101392727|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
33410441|NCT00570492|101392728|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
33410442|NCT00570492|101392726|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
33410443|NCT00570492|101392727|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
33410444|NCT00570492|101392728|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
33410445|NCT00570492|101392726|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
33410446|NCT00570492|101392727|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
33410447|NCT00570492|101392728|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
33410448|NCT00570492|101392726|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
33410449|NCT00570492|101392727|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
33410450|NCT00570492|101392728|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
33410451|NCT00570492|101392726|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
33410452|NCT00570492|101392727|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
33410453|NCT00570492|101392728|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
33410454|NCT00570492|101392726|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33410455|NCT00570492|101392727|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
33410456|NCT00570492|101392728|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
33410457|NCT00570492|101392726|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
33410458|NCT00570492|101392727|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
33410459|NCT00570492|101392728|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
33410460|NCT00570492|101392726|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
33410461|NCT00570492|101392727|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
33410462|NCT00570492|101392728|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
33410463|NCT00570492|101392726|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
33410464|NCT00570492|101392727|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
33410465|NCT00570492|101392728|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
33410466|NCT00570492|101392726|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
33410467|NCT00570492|101392727|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
33410468|NCT00570492|101392728|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
33410469|NCT00570492|101392726|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
33410470|NCT00570492|101392727|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
33410471|NCT00570492|101392728|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
33410472|NCT00570492|101392726|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
33410473|NCT00570492|101392727|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
33410474|NCT00570492|101392728|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
33410475|NCT02058940|101392729|FG000|Overall Study|Discharged from Critical Care Unit|1|||
33410476|NCT00465101|101392730|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
33410477|NCT00465101|101392730|FG000|Overall Study|Change in health precluded follow up|4|||
33410478|NCT00465101|101392730|FG000|Overall Study|Did not meet study criteria|4|||
33410479|NCT00465101|101392730|FG000|Overall Study|Lost to Follow-up|5|||
33410480|NCT00465101|101392730|FG000|Overall Study|Other|6|||
33410481|NCT00465101|101392730|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
33410482|NCT00465101|101392730|FG000|Overall Study|Patient postponed procedure|1|||
33410483|NCT00465101|101392730|FG000|Overall Study|Site closed due to IRB expiration|1|||
33410484|NCT00465101|101392730|FG000|Overall Study|Unable to obtain IRB approval|1|||
33410485|NCT00465101|101392730|FG000|Overall Study|Death|3|||
33410486|NCT00465101|101392730|FG000|Overall Study|Withdrawal by Subject|25|||
33410487|NCT00465101|101392730|FG000|Overall Study|Physician Decision|1|||
33410488|NCT00465101|101392730|FG000|Overall Study|Withdrew consent prior to procedure|3|||
33410489|NCT02646566|101392733|FG000|Overall Study|Lost to Follow-up|5|||
33410490|NCT02646566|101392734|FG001|Overall Study|Lost to Follow-up|4|||
33410491|NCT02646566|101392735|FG002|Overall Study|Lost to Follow-up|5|||
33410492|NCT02646566|101392733|FG000|Overall Study|Treatment failure|1|||
33410493|NCT02646566|101392734|FG001|Overall Study|Treatment failure|0|||
33410494|NCT02646566|101392735|FG002|Overall Study|Treatment failure|0|||
33549851|NCT02265744|101913479|FG004|Overall Study|Administrative reason by sponsor|3|||
33549852|NCT02265744|101913475|FG000|Overall Study|Subject no longer meets study criteria|0|||
33549853|NCT02265744|101913476|FG001|Overall Study|Subject no longer meets study criteria|0|||
33549854|NCT02265744|101913477|FG002|Overall Study|Subject no longer meets study criteria|0|||
33410495|NCT02696382|101392736|FG000|Overall Study|Death|7|||
33618267|NCT00713544|102151507|FG005|Overall Study|Lost to Follow-up|0|||
33410496|NCT02696382|101392737|FG001|Overall Study|Death|2|||
33410497|NCT02696382|101392736|FG000|Overall Study|Withdrawal by Subject|5|||
33410498|NCT02696382|101392737|FG001|Overall Study|Withdrawal by Subject|12|||
33410499|NCT02696382|101392736|FG000|Overall Study|Lost to Follow-up|4|||
33410500|NCT02696382|101392737|FG001|Overall Study|Lost to Follow-up|7|||
33410501|NCT01846039|101392740|FG000|Overall Study|Protocol Violation|1|||
33410502|NCT01846039|101392740|FG000|Overall Study|Subject Withdrew Consent|1|||
33410503|NCT02545270|101392741|FG000|Overall Study|technical difficulties|0|||
33410504|NCT02545270|101392742|FG001|Overall Study|technical difficulties|1|||
33410505|NCT02545270|101392743|FG002|Overall Study|technical difficulties|0|||
33410506|NCT02545270|101392741|FG000|Overall Study|Videos being too similar to other|0|||
33410507|NCT02545270|101392742|FG001|Overall Study|Videos being too similar to other|0|||
33410508|NCT02545270|101392743|FG002|Overall Study|Videos being too similar to other|2|||
33410509|NCT00483119|101392754|FG000|Overall Study|Adverse Event|0|||
33410510|NCT00483119|101392755|FG001|Overall Study|Adverse Event|1|||
33410511|NCT00483119|101392754|FG000|Overall Study|Physician Decision|1|||
33410512|NCT00483119|101392755|FG001|Overall Study|Physician Decision|0|||
33410513|NCT02147132|101392756|FG000|Overall Study|Lost to Follow-up|1|||
33410514|NCT02147132|101392757|FG001|Overall Study|Lost to Follow-up|0|||
33410515|NCT02147132|101392758|FG002|Overall Study|Lost to Follow-up|0|||
33410516|NCT02147132|101392759|FG003|Overall Study|Lost to Follow-up|0|||
33410517|NCT00812968|101392760|FG000|Overall Study|Relapse after erythroid response|6|||
33410518|NCT00812968|101392760|FG000|Overall Study|Disease progression|1|||
33410519|NCT00812968|101392760|FG000|Overall Study|No further treatment required|1|||
33410520|NCT00812968|101392760|FG000|Overall Study|Study closed due to marketing approval|3|||
33410521|NCT00828009|101392770|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
33410522|NCT00828009|101392770|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
33410523|NCT00828009|101392770|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
33410524|NCT00828009|101392770|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
33410525|NCT00828009|101392770|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
33410526|NCT00828009|101392770|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
33410527|NCT00828009|101392770|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
33410528|NCT00828009|101392770|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
33410529|NCT00828009|101392770|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
33410530|NCT00828009|101392770|FG000|Step 2 - Maintenance Therapy|Death|1|||
33410531|NCT00828009|101392770|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
33410532|NCT00828009|101392770|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
33410533|NCT00828009|101392770|FG000|Step 2 - Maintenance Therapy|Other|1|||
33410534|NCT00965458|101392771|FG000|Overall Study|Adverse Event|1|||
33410535|NCT00965458|101392772|FG001|Overall Study|Adverse Event|0|||
33410536|NCT00965458|101392771|FG000|Overall Study|Lost to Follow-up|1|||
33410537|NCT00965458|101392772|FG001|Overall Study|Lost to Follow-up|3|||
33410538|NCT00965458|101392771|FG000|Overall Study|Withdrawal by Subject|0|||
33410539|NCT00965458|101392772|FG001|Overall Study|Withdrawal by Subject|1|||
33349853|NCT03636906|101167577|FG001|Overall Study|Lost to Follow-up|0|||
33349854|NCT03636906|101167578|FG002|Overall Study|Lost to Follow-up|0|||
33349855|NCT03636906|101167576|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
33349856|NCT03636906|101167577|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
33349857|NCT03636906|101167578|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
33349858|NCT03636906|101167576|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
33349859|NCT03636906|101167577|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
33349860|NCT03636906|101167578|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
33349861|NCT03636906|101167576|FG000|Overall Study|Other|0|||
33349862|NCT03636906|101167577|FG001|Overall Study|Other|0|||
33349863|NCT03636906|101167578|FG002|Overall Study|Other|1|||
33349864|NCT00984204|101167580|FG000|Overall Study|Death|1|||
33349865|NCT00984204|101167580|FG000|Overall Study|Lost to Follow-up|4|||
33349866|NCT00984204|101167580|FG000|Overall Study|Lack of Efficacy|10|||
33349867|NCT00103012|101167583|FG000|Overall Study|Withdrawal by Subject|2|||
33349868|NCT00103012|101167584|FG001|Overall Study|Withdrawal by Subject|1|||
33349869|NCT00103012|101167585|FG002|Overall Study|Withdrawal by Subject|2|||
33349870|NCT00103012|101167583|FG000|Overall Study|Pregnancy|1|||
33410540|NCT00920582|101392773|FG000|Overall Study|Lost to Follow-up|5|||
33410541|NCT00920582|101392774|FG001|Overall Study|Lost to Follow-up|1|||
33349871|NCT00103012|101167584|FG001|Overall Study|Pregnancy|0|||
33349872|NCT00103012|101167585|FG002|Overall Study|Pregnancy|0|||
33349873|NCT00103012|101167583|FG000|Overall Study|Adverse Event|0|||
33410542|NCT00920582|101392775|FG002|Overall Study|Lost to Follow-up|2|||
33410543|NCT00920582|101392776|FG003|Overall Study|Lost to Follow-up|0|||
33410544|NCT00920582|101392773|FG000|Overall Study|Withdrawal by Subject|5|||
33410545|NCT00920582|101392774|FG001|Overall Study|Withdrawal by Subject|4|||
33410546|NCT00920582|101392775|FG002|Overall Study|Withdrawal by Subject|6|||
33410547|NCT00920582|101392776|FG003|Overall Study|Withdrawal by Subject|3|||
33410548|NCT00920582|101392773|FG000|Overall Study|Protocol Violation|1|||
33410549|NCT00920582|101392774|FG001|Overall Study|Protocol Violation|0|||
33216647|NCT02338154|100692159|FG000|Overall Study|Lost to Follow-up|8|||
33216648|NCT02338154|100692159|FG000|Overall Study|Other Reason|3|||
33216649|NCT02338154|100692159|FG000|Overall Study|Patients Without Exit Form|47|||
33216650|NCT02338154|100692159|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
33410550|NCT00920582|101392775|FG002|Overall Study|Protocol Violation|0|||
33410551|NCT00920582|101392776|FG003|Overall Study|Protocol Violation|0|||
33410552|NCT00920582|101392773|FG000|Overall Study|Other|2|||
33410553|NCT00920582|101392774|FG001|Overall Study|Other|1|||
33410554|NCT00920582|101392775|FG002|Overall Study|Other|3|||
33410555|NCT00920582|101392776|FG003|Overall Study|Other|2|||
33410556|NCT01453296|101392777|FG000|Treatment Period 1|Adverse Event|0|||
33410557|NCT01453296|101392778|FG001|Treatment Period 1|Adverse Event|1|||
33410558|NCT01453296|101392777|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
33549855|NCT02265744|101913478|FG003|Overall Study|Subject no longer meets study criteria|0|||
33549856|NCT02265744|101913479|FG004|Overall Study|Subject no longer meets study criteria|1|||
33549857|NCT02265744|101913475|FG000|Overall Study|Pregnancy|1|||
33549858|NCT02265744|101913476|FG001|Overall Study|Pregnancy|2|||
33549859|NCT02265744|101913477|FG002|Overall Study|Pregnancy|1|||
33549860|NCT02265744|101913478|FG003|Overall Study|Pregnancy|1|||
33410559|NCT01453296|101392778|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
33410560|NCT01453296|101392777|FG000|Treatment Period 2|Adverse Event|1|||
33410561|NCT01453296|101392778|FG001|Treatment Period 2|Adverse Event|0|||
33410562|NCT01453296|101392777|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33410563|NCT01453296|101392778|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33410564|NCT02044094|101392783|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
33410565|NCT02044094|101392783|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
33410566|NCT02044094|101392783|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
33410567|NCT02044094|101392783|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
33410568|NCT02044094|101392783|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
33410569|NCT02044094|101392783|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
33410570|NCT02044094|101392783|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
33410571|NCT02044094|101392783|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
33410572|NCT04115488|101392784|FG000|Overall Study|Adverse Event|8|||
33410573|NCT04115488|101392785|FG001|Overall Study|Adverse Event|4|||
33410574|NCT04115488|101392784|FG000|Overall Study|Withdrawal by Subject|3|||
33410575|NCT04115488|101392785|FG001|Overall Study|Withdrawal by Subject|6|||
33410576|NCT04115488|101392784|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
33410577|NCT04115488|101392785|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
33410578|NCT04115488|101392784|FG000|Overall Study|Patient 's location change|1|||
33410579|NCT04115488|101392785|FG001|Overall Study|Patient 's location change|0|||
33410580|NCT04115488|101392784|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
33410581|NCT04115488|101392785|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
33410582|NCT00726882|101392786|FG000|Overall Study|Withdrawal by Subject|5|||
33410583|NCT00726882|101392786|FG000|Overall Study|Lost to Follow-up|7|||
33549861|NCT02265744|101913479|FG004|Overall Study|Pregnancy|0|||
33549862|NCT01331005|101913480|FG000|Overall Study|Lost to Follow-up|2|||
33549863|NCT01331005|101913481|FG001|Overall Study|Lost to Follow-up|1|||
33549864|NCT01331005|101913480|FG000|Overall Study|Withdrawal by Subject|2|||
33549865|NCT01331005|101913481|FG001|Overall Study|Withdrawal by Subject|3|||
33549866|NCT00620542|101913489|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
33410584|NCT00726882|101392786|FG000|Overall Study|Other|10|||
33410585|NCT02268214|101392789|FG000|Overall Study|Subject no longer meets study criteria|0|||
33549867|NCT00620542|101913490|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
33549868|NCT00620542|101913491|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
33549869|NCT00620542|101913492|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
33549870|NCT00620542|101913489|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
33549871|NCT00620542|101913490|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
33549872|NCT00620542|101913491|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
33410586|NCT02268214|101392790|FG001|Overall Study|Subject no longer meets study criteria|2|||
33410587|NCT02268214|101392791|FG002|Overall Study|Subject no longer meets study criteria|0|||
33410588|NCT02268214|101392789|FG000|Overall Study|Pregnancy|2|||
33410589|NCT02268214|101392790|FG001|Overall Study|Pregnancy|2|||
33410590|NCT02268214|101392791|FG002|Overall Study|Pregnancy|1|||
33410591|NCT02268214|101392789|FG000|Overall Study|Lost to Follow-up|3|||
33549873|NCT00620542|101913492|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
33549874|NCT00620542|101913489|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
33549875|NCT00620542|101913490|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
33549876|NCT00620542|101913491|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
33549877|NCT00620542|101913492|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
33549878|NCT00620542|101913489|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
33549879|NCT00620542|101913490|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
33549880|NCT00620542|101913491|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
33549881|NCT00620542|101913492|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
33549882|NCT00620542|101913489|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
33549883|NCT00620542|101913490|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
33549884|NCT00620542|101913491|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
33549885|NCT00620542|101913492|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
33549886|NCT00620542|101913489|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
33549887|NCT00620542|101913490|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
33549888|NCT00620542|101913491|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
33549889|NCT00620542|101913492|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
33549890|NCT00620542|101913489|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
33549891|NCT00620542|101913490|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
33549892|NCT00620542|101913491|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
33549893|NCT00620542|101913492|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
33549894|NCT00620542|101913489|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
33549895|NCT00620542|101913490|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
33549896|NCT00620542|101913491|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
33549897|NCT00620542|101913492|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
33549898|NCT00620542|101913489|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
33549899|NCT00620542|101913490|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
33549900|NCT00620542|101913491|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
33549901|NCT00620542|101913492|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
33549902|NCT00620542|101913489|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
33349874|NCT00103012|101167584|FG001|Overall Study|Adverse Event|0|||
33410592|NCT02268214|101392790|FG001|Overall Study|Lost to Follow-up|3|||
33549903|NCT00620542|101913490|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
33549904|NCT00620542|101913491|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
33549905|NCT00620542|101913492|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
33549906|NCT00620542|101913489|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
33549907|NCT00620542|101913490|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
33549908|NCT00620542|101913491|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
33549909|NCT00620542|101913492|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
33549910|NCT00620542|101913489|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
33549911|NCT00620542|101913490|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
33549912|NCT00620542|101913491|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
33549913|NCT00620542|101913492|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
33549914|NCT00620542|101913489|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
33549915|NCT00620542|101913490|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
33549916|NCT00620542|101913491|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
33549917|NCT00620542|101913492|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
33549918|NCT00620542|101913489|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
33549919|NCT00620542|101913490|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
33549920|NCT00620542|101913491|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
33549921|NCT00620542|101913492|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
33349875|NCT00103012|101167585|FG002|Overall Study|Adverse Event|1|||
33349876|NCT00103012|101167583|FG000|Overall Study|Subject non-compliant with medications|0|||
33349877|NCT00103012|101167584|FG001|Overall Study|Subject non-compliant with medications|0|||
33349878|NCT00103012|101167585|FG002|Overall Study|Subject non-compliant with medications|1|||
33349879|NCT03663166|101167586|FG000|Overall Study|Withdrawal by Subject|1|||
33349880|NCT01354132|101167591|FG000|Randomization|Physician Decision|1|||
33349881|NCT01354132|101167592|FG001|Randomization|Physician Decision|0|||
33349882|NCT01354132|101167591|FG000|Randomization|Withdrawal by Subject|0|||
33349883|NCT01354132|101167592|FG001|Randomization|Withdrawal by Subject|1|||
33349884|NCT01354132|101167591|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
33349885|NCT01354132|101167592|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
33349886|NCT01354132|101167591|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
33349887|NCT01354132|101167592|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
33349888|NCT01354132|101167591|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
33349889|NCT01354132|101167592|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
33349890|NCT01763164|101167594|FG000|Treatment Phase|Participant/Guardian decision|26|||
33349891|NCT01763164|101167595|FG001|Treatment Phase|Participant/Guardian decision|14|||
33349892|NCT01763164|101167594|FG000|Treatment Phase|Protocol Violation|1|||
33349893|NCT01763164|101167595|FG001|Treatment Phase|Protocol Violation|1|||
33349894|NCT01763164|101167594|FG000|Treatment Phase|Progressive Disease|142|||
33349895|NCT01763164|101167595|FG001|Treatment Phase|Progressive Disease|76|||
33349896|NCT01763164|101167594|FG000|Treatment Phase|Physician Decision|24|||
33349897|NCT01763164|101167595|FG001|Treatment Phase|Physician Decision|13|||
33349898|NCT01763164|101167594|FG000|Treatment Phase|Death|10|||
33549922|NCT00620542|101913489|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
33216651|NCT00166296|100692160|FG000|Overall Study|Withdrawal by Subject|1|||
33349899|NCT01763164|101167595|FG001|Treatment Phase|Death|1|||
33349900|NCT01763164|101167594|FG000|Treatment Phase|Adverse Event|66|||
33349901|NCT01763164|101167595|FG001|Treatment Phase|Adverse Event|8|||
33349902|NCT01763164|101167594|FG000|Treatment Phase|Randomized but not Treated|0|||
33349903|NCT01763164|101167595|FG001|Treatment Phase|Randomized but not Treated|19|||
33349904|NCT01763164|101167594|FG000|Treatment Phase|Other|0|||
33216652|NCT00166296|100692161|FG001|Overall Study|Withdrawal by Subject|3|||
33216653|NCT00166296|100692160|FG000|Overall Study|Adverse Event|2|||
33216654|NCT00166296|100692161|FG001|Overall Study|Adverse Event|4|||
33216655|NCT00166296|100692160|FG000|Overall Study|Lost to Follow-up|4|||
33216656|NCT00166296|100692161|FG001|Overall Study|Lost to Follow-up|2|||
33216657|NCT01422408|100692162|FG000|Overall Study|Adverse Event|1|||
33216658|NCT01422408|100692162|FG000|Overall Study|Withdrawal by Subject|3|||
33216659|NCT01812655|100692163|FG000|Overall Study|Protocol Violation|1|||
33216660|NCT01812655|100692164|FG001|Overall Study|Protocol Violation|1|||
33216661|NCT01812655|100692165|FG002|Overall Study|Protocol Violation|0|||
33216662|NCT00175825|100692169|FG000|Overall Study|Adverse Event|3|||
33216663|NCT00175825|100692170|FG001|Overall Study|Adverse Event|2|||
33216664|NCT00175825|100692171|FG002|Overall Study|Adverse Event|1|||
33216665|NCT00175825|100692172|FG003|Overall Study|Adverse Event|1|||
33216666|NCT00175825|100692169|FG000|Overall Study|Lost to Follow-up|1|||
33216667|NCT00175825|100692170|FG001|Overall Study|Lost to Follow-up|2|||
33216668|NCT00175825|100692171|FG002|Overall Study|Lost to Follow-up|0|||
33216669|NCT00175825|100692172|FG003|Overall Study|Lost to Follow-up|0|||
33216670|NCT00175825|100692169|FG000|Overall Study|Withdrawal by Subject|1|||
33216671|NCT00175825|100692170|FG001|Overall Study|Withdrawal by Subject|0|||
33216672|NCT00175825|100692171|FG002|Overall Study|Withdrawal by Subject|0|||
33216673|NCT00175825|100692172|FG003|Overall Study|Withdrawal by Subject|0|||
33216674|NCT01843374|100692175|FG000|Overall Study|Death|155|||
33216675|NCT01843374|100692176|FG001|Overall Study|Death|313|||
33216676|NCT01843374|100692175|FG000|Overall Study|Withdrawal by Subject|14|||
33216677|NCT01843374|100692176|FG001|Overall Study|Withdrawal by Subject|20|||
33216678|NCT01843374|100692175|FG000|Overall Study|Withdrawing due to Other reason|20|||
33216679|NCT01843374|100692176|FG001|Overall Study|Withdrawing due to Other reason|46|||
33349905|NCT01763164|101167595|FG001|Treatment Phase|Other|1|||
33349906|NCT01763164|101167594|FG000|Follow up Phase|New therapy for study indication|12|||
33349907|NCT01763164|101167595|FG001|Follow up Phase|New therapy for study indication|3|||
33349908|NCT01763164|101167594|FG000|Follow up Phase|Death|21|||
33349909|NCT01763164|101167595|FG001|Follow up Phase|Death|4|||
33349910|NCT01763164|101167594|FG000|Follow up Phase|Subject/guardian decision|9|||
33349911|NCT01763164|101167595|FG001|Follow up Phase|Subject/guardian decision|2|||
33349912|NCT01763164|101167594|FG000|Follow up Phase|Progressive disease|127|||
33349913|NCT01763164|101167595|FG001|Follow up Phase|Progressive disease|62|||
33349914|NCT01763164|101167594|FG000|Follow up Phase|Physician Decision|10|||
33349915|NCT01763164|101167595|FG001|Follow up Phase|Physician Decision|3|||
33349916|NCT01763164|101167594|FG000|Follow up Phase|Lost to Follow-up|1|||
33349917|NCT01763164|101167595|FG001|Follow up Phase|Lost to Follow-up|0|||
33349918|NCT01763164|101167594|FG000|Follow up Phase|Adverse Event|17|||
33349919|NCT01763164|101167595|FG001|Follow up Phase|Adverse Event|1|||
33349920|NCT03367871|101167596|FG000|Overall Study|Lost to Follow-up|1|||
33216680|NCT03489304|100692177|FG000|Overall Study|Lost to Follow-up|4|||
33216681|NCT00746590|100692179|FG000|Overall Study|Death|1|||
33216682|NCT00815295|100692182|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
33216683|NCT00815295|100692183|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
33216684|NCT00815295|100692184|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
33216685|NCT00572195|100692185|FG000|Overall Study|Withdrawal by Subject|50|||
33549923|NCT00620542|101913490|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
33549924|NCT00620542|101913491|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
33549925|NCT00620542|101913492|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
33618268|NCT00713544|102151502|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
33618269|NCT00713544|102151503|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
33549926|NCT03601052|101913493|FG000|Overall Study|Lost to Follow-up|2|||
33549927|NCT01013753|101913494|FG000|Overall Study|Adverse Event|8|||
33549928|NCT01013753|101913494|FG000|Overall Study|Protocol Violation|3|||
33549929|NCT01013753|101913494|FG000|Overall Study|Lost to Follow-up|1|||
33549930|NCT01013753|101913494|FG000|Overall Study|Withdrawal by Subject|2|||
33549931|NCT01013753|101913494|FG000|Overall Study|Other|2|||
33549932|NCT01410604|101913495|FG000|Overall Study|Adverse Event|2|||
33549933|NCT01410604|101913496|FG001|Overall Study|Adverse Event|1|||
33618270|NCT00713544|102151504|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
33618271|NCT00713544|102151505|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
33618272|NCT00713544|102151506|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
33618273|NCT00713544|102151507|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
33618274|NCT00713544|102151502|FG000|Overall Study|Incorrect enrollment|0|||
33618275|NCT00713544|102151503|FG001|Overall Study|Incorrect enrollment|1|||
33618276|NCT00713544|102151504|FG002|Overall Study|Incorrect enrollment|0|||
33618277|NCT00713544|102151505|FG003|Overall Study|Incorrect enrollment|0|||
33618278|NCT00713544|102151506|FG004|Overall Study|Incorrect enrollment|0|||
33618279|NCT00713544|102151507|FG005|Overall Study|Incorrect enrollment|0|||
33618280|NCT00713544|102151502|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
33618281|NCT00713544|102151503|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
33618282|NCT00713544|102151504|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
33618283|NCT00713544|102151505|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
33618284|NCT00713544|102151506|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
33618285|NCT00713544|102151507|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
33618286|NCT02737475|102151508|FG000|Overall Study|Other reasons|0|||
33349921|NCT01838044|101167597|FG000|Overall Study|Adverse Event|4|||
33349922|NCT01838044|101167598|FG001|Overall Study|Adverse Event|6|||
33349923|NCT01838044|101167597|FG000|Overall Study|Protocol Violation|3|||
33349924|NCT01838044|101167598|FG001|Overall Study|Protocol Violation|3|||
33349925|NCT01838044|101167597|FG000|Overall Study|Withdrawal by Subject|0|||
33349926|NCT01838044|101167598|FG001|Overall Study|Withdrawal by Subject|2|||
33349927|NCT01838044|101167597|FG000|Overall Study|Insufficient clinical response|1|||
33549934|NCT01410604|101913495|FG000|Overall Study|Lost to Follow-up|1|||
33549935|NCT01410604|101913496|FG001|Overall Study|Lost to Follow-up|0|||
33549936|NCT01410604|101913495|FG000|Overall Study|Physician Decision|0|||
33549937|NCT01410604|101913496|FG001|Overall Study|Physician Decision|1|||
33549938|NCT01348698|101913497|FG000|Overall Study|Does not meet lesion size criteria|1|||
33549939|NCT01348698|101913497|FG000|Overall Study|Death|3|||
33549940|NCT01348698|101913497|FG000|Overall Study|PI decision to close study|68|||
33549941|NCT01078545|101913498|FG000|Overall Study|Lost to Follow-up|13|||
33549942|NCT01078545|101913498|FG000|Overall Study|Physician Decision|6|||
33549943|NCT01078545|101913498|FG000|Overall Study|Withdrawal by Subject|3|||
33549944|NCT01078545|101913498|FG000|Overall Study|Death|3|||
33549945|NCT01078545|101913498|FG000|Overall Study|Participant moved to another physician|1|||
33549946|NCT02927145|101913499|FG000|Initial Recruitment|Withdrawal by Subject|0|||
33549947|NCT02927145|101913500|FG001|Initial Recruitment|Withdrawal by Subject|1|||
33549948|NCT02927145|101913501|FG002|Initial Recruitment|Withdrawal by Subject|1|||
33549949|NCT02927145|101913502|FG003|Initial Recruitment|Withdrawal by Subject|4|||
33549950|NCT02927145|101913503|FG004|Initial Recruitment|Withdrawal by Subject|1|||
33549951|NCT02927145|101913504|FG005|Initial Recruitment|Withdrawal by Subject|1|||
33549952|NCT02927145|101913505|FG006|Initial Recruitment|Withdrawal by Subject|0|||
33549953|NCT02927145|101913506|FG007|Initial Recruitment|Withdrawal by Subject|0|||
33549954|NCT02927145|101913507|FG008|Initial Recruitment|Withdrawal by Subject|2|||
33549955|NCT02927145|101913499|FG000|Initial Recruitment|Adverse Event|0|||
33349928|NCT01838044|101167598|FG001|Overall Study|Insufficient clinical response|2|||
33349929|NCT01838044|101167597|FG000|Overall Study|Medication error without associated AE|0|||
33349930|NCT01838044|101167598|FG001|Overall Study|Medication error without associated AE|1|||
33349931|NCT01838044|101167597|FG000|Overall Study|Lost to Follow-up|0|||
33349932|NCT01838044|101167598|FG001|Overall Study|Lost to Follow-up|2|||
33349933|NCT02397473|101167600|FG000|Treatment Phase|Adverse Event|1|||
33549956|NCT02927145|101913500|FG001|Initial Recruitment|Adverse Event|0|||
33549957|NCT02927145|101913501|FG002|Initial Recruitment|Adverse Event|0|||
33549958|NCT02927145|101913502|FG003|Initial Recruitment|Adverse Event|0|||
33549959|NCT02927145|101913503|FG004|Initial Recruitment|Adverse Event|2|||
33549960|NCT02927145|101913504|FG005|Initial Recruitment|Adverse Event|0|||
33549961|NCT02927145|101913505|FG006|Initial Recruitment|Adverse Event|0|||
33549962|NCT02927145|101913506|FG007|Initial Recruitment|Adverse Event|0|||
33549963|NCT02927145|101913507|FG008|Initial Recruitment|Adverse Event|0|||
33549964|NCT02927145|101913499|FG000|Invitation for Additional Challenge|Pregnancy|0|||
33618287|NCT02737475|102151509|FG001|Overall Study|Other reasons|0|||
33549965|NCT02927145|101913500|FG001|Invitation for Additional Challenge|Pregnancy|0|||
33549966|NCT02927145|101913501|FG002|Invitation for Additional Challenge|Pregnancy|0|||
33549967|NCT02927145|101913502|FG003|Invitation for Additional Challenge|Pregnancy|0|||
33549968|NCT02927145|101913503|FG004|Invitation for Additional Challenge|Pregnancy|0|||
33216686|NCT00572195|100692185|FG000|Overall Study|Death|9|||
33216687|NCT00572195|100692185|FG000|Overall Study|Adverse Event|4|||
33216688|NCT00572195|100692185|FG000|Overall Study|Lost to Follow-up|5|||
33216689|NCT01235403|100692188|FG000|Overall Study|Adverse Event|14|||
33216690|NCT01235403|100692188|FG000|Overall Study|Lost to Follow-up|2|||
33216691|NCT01235403|100692188|FG000|Overall Study|Withdrawal by Subject|4|||
33216692|NCT01235403|100692188|FG000|Overall Study|Lack of Efficacy|2|||
33216693|NCT01235403|100692188|FG000|Overall Study|Other reasons for premature termination|4|||
33216694|NCT00428090|100692189|FG000|Overall Study|Adverse Event|10|||
33216695|NCT00428090|100692190|FG001|Overall Study|Adverse Event|8|||
33216696|NCT00428090|100692191|FG002|Overall Study|Adverse Event|10|||
33216697|NCT00428090|100692192|FG003|Overall Study|Adverse Event|11|||
33216698|NCT00428090|100692189|FG000|Overall Study|Lost to Follow-up|3|||
33216699|NCT00428090|100692190|FG001|Overall Study|Lost to Follow-up|6|||
33216700|NCT00428090|100692191|FG002|Overall Study|Lost to Follow-up|1|||
33216701|NCT00428090|100692192|FG003|Overall Study|Lost to Follow-up|4|||
33216702|NCT00428090|100692189|FG000|Overall Study|Protocol Violation|3|||
33216703|NCT00428090|100692190|FG001|Overall Study|Protocol Violation|1|||
33216704|NCT00428090|100692191|FG002|Overall Study|Protocol Violation|3|||
33216705|NCT00428090|100692192|FG003|Overall Study|Protocol Violation|3|||
33216706|NCT00428090|100692189|FG000|Overall Study|Withdrawal by Subject|10|||
33216707|NCT00428090|100692190|FG001|Overall Study|Withdrawal by Subject|12|||
33216708|NCT00428090|100692191|FG002|Overall Study|Withdrawal by Subject|15|||
33216709|NCT00428090|100692192|FG003|Overall Study|Withdrawal by Subject|5|||
33216710|NCT00428090|100692189|FG000|Overall Study|Sponsor terminated study|0|||
33216711|NCT00428090|100692190|FG001|Overall Study|Sponsor terminated study|1|||
33216712|NCT00428090|100692191|FG002|Overall Study|Sponsor terminated study|0|||
33216713|NCT00428090|100692192|FG003|Overall Study|Sponsor terminated study|0|||
33216714|NCT00428090|100692189|FG000|Overall Study|Non-compliance|4|||
33216715|NCT00428090|100692190|FG001|Overall Study|Non-compliance|0|||
33216716|NCT00428090|100692191|FG002|Overall Study|Non-compliance|1|||
33216717|NCT00428090|100692192|FG003|Overall Study|Non-compliance|3|||
33216718|NCT00428090|100692189|FG000|Overall Study|Par. did not returned to visit|1|||
33216719|NCT00428090|100692190|FG001|Overall Study|Par. did not returned to visit|0|||
33216720|NCT00428090|100692191|FG002|Overall Study|Par. did not returned to visit|0|||
33216721|NCT00428090|100692192|FG003|Overall Study|Par. did not returned to visit|1|||
33216722|NCT00428090|100692189|FG000|Overall Study|Follow-Up visit not possible|1|||
33216723|NCT00428090|100692190|FG001|Overall Study|Follow-Up visit not possible|0|||
33216724|NCT00428090|100692191|FG002|Overall Study|Follow-Up visit not possible|0|||
33216725|NCT00428090|100692192|FG003|Overall Study|Follow-Up visit not possible|0|||
33216726|NCT00428090|100692189|FG000|Overall Study|Prohibited medication used for SAE|1|||
33216727|NCT00428090|100692190|FG001|Overall Study|Prohibited medication used for SAE|0|||
33216728|NCT00428090|100692191|FG002|Overall Study|Prohibited medication used for SAE|0|||
33216729|NCT00428090|100692192|FG003|Overall Study|Prohibited medication used for SAE|0|||
33216730|NCT00428090|100692189|FG000|Overall Study|Death of par.|1|||
33216731|NCT00428090|100692190|FG001|Overall Study|Death of par.|0|||
33618288|NCT02737475|102151510|FG002|Overall Study|Other reasons|0|||
33216732|NCT00428090|100692191|FG002|Overall Study|Death of par.|1|||
33216733|NCT00428090|100692192|FG003|Overall Study|Death of par.|0|||
33216734|NCT00428090|100692189|FG000|Overall Study|Visit 7 exceed the visit window|0|||
33216735|NCT00428090|100692190|FG001|Overall Study|Visit 7 exceed the visit window|1|||
33216736|NCT00428090|100692191|FG002|Overall Study|Visit 7 exceed the visit window|0|||
33216737|NCT00428090|100692192|FG003|Overall Study|Visit 7 exceed the visit window|0|||
33216738|NCT00428090|100692189|FG000|Overall Study|Medical monitor terminated par.|0|||
33216739|NCT00428090|100692190|FG001|Overall Study|Medical monitor terminated par.|1|||
33216740|NCT00428090|100692191|FG002|Overall Study|Medical monitor terminated par.|0|||
33216741|NCT00428090|100692192|FG003|Overall Study|Medical monitor terminated par.|0|||
33216742|NCT00428090|100692189|FG000|Overall Study|Mental status of par. was|0|||
33216743|NCT00428090|100692190|FG001|Overall Study|Mental status of par. was|1|||
33216744|NCT00428090|100692191|FG002|Overall Study|Mental status of par. was|0|||
33216745|NCT00428090|100692192|FG003|Overall Study|Mental status of par. was|0|||
33216746|NCT00428090|100692189|FG000|Overall Study|Worsening of AD|0|||
33216747|NCT00428090|100692190|FG001|Overall Study|Worsening of AD|0|||
33216748|NCT00428090|100692191|FG002|Overall Study|Worsening of AD|1|||
33216749|NCT00428090|100692192|FG003|Overall Study|Worsening of AD|0|||
33216750|NCT00428090|100692189|FG000|Overall Study|Excluded for concerning QTc value|0|||
33216751|NCT00428090|100692190|FG001|Overall Study|Excluded for concerning QTc value|0|||
33216752|NCT00428090|100692191|FG002|Overall Study|Excluded for concerning QTc value|1|||
33216753|NCT00428090|100692192|FG003|Overall Study|Excluded for concerning QTc value|0|||
33216754|NCT00428090|100692189|FG000|Overall Study|Insufficient AD documentation|0|||
33216755|NCT00428090|100692190|FG001|Overall Study|Insufficient AD documentation|0|||
33216756|NCT00428090|100692191|FG002|Overall Study|Insufficient AD documentation|1|||
33216757|NCT00428090|100692192|FG003|Overall Study|Insufficient AD documentation|0|||
33216758|NCT00428090|100692189|FG000|Overall Study|High MMSE scores|0|||
33216759|NCT00428090|100692190|FG001|Overall Study|High MMSE scores|0|||
33216760|NCT00428090|100692191|FG002|Overall Study|High MMSE scores|1|||
33216761|NCT00428090|100692192|FG003|Overall Study|High MMSE scores|0|||
33216762|NCT00428090|100692189|FG000|Overall Study|Deterioration of cognitive status|0|||
33216763|NCT00428090|100692190|FG001|Overall Study|Deterioration of cognitive status|0|||
33216764|NCT00428090|100692191|FG002|Overall Study|Deterioration of cognitive status|1|||
33216765|NCT00428090|100692192|FG003|Overall Study|Deterioration of cognitive status|0|||
33216766|NCT00428090|100692189|FG000|Overall Study|Serious adverse event|0|||
33216767|NCT00428090|100692190|FG001|Overall Study|Serious adverse event|0|||
33216768|NCT00428090|100692191|FG002|Overall Study|Serious adverse event|1|||
33216769|NCT00428090|100692192|FG003|Overall Study|Serious adverse event|0|||
33216770|NCT00428090|100692189|FG000|Overall Study|Excluded for heart insufficiency|0|||
33216771|NCT00428090|100692190|FG001|Overall Study|Excluded for heart insufficiency|0|||
33216772|NCT00428090|100692191|FG002|Overall Study|Excluded for heart insufficiency|1|||
33216773|NCT00428090|100692192|FG003|Overall Study|Excluded for heart insufficiency|0|||
33216774|NCT00428090|100692189|FG000|Overall Study|Raised Creatinine Value|0|||
33216775|NCT00428090|100692190|FG001|Overall Study|Raised Creatinine Value|0|||
33216776|NCT00428090|100692191|FG002|Overall Study|Raised Creatinine Value|0|||
33216777|NCT00428090|100692192|FG003|Overall Study|Raised Creatinine Value|1|||
33216778|NCT01951638|100692197|FG000|Treatment Period|Protocol Violation|0|||
33216779|NCT01951638|100692198|FG001|Treatment Period|Protocol Violation|0|||
33216780|NCT01951638|100692199|FG002|Treatment Period|Protocol Violation|0|||
33216781|NCT01951638|100692200|FG003|Treatment Period|Protocol Violation|2|||
33216782|NCT01951638|100692201|FG004|Treatment Period|Protocol Violation|0|||
33216783|NCT01951638|100692197|FG000|Treatment Period|Protocol-driven decision point|1|||
33216784|NCT01951638|100692198|FG001|Treatment Period|Protocol-driven decision point|3|||
33216785|NCT01951638|100692199|FG002|Treatment Period|Protocol-driven decision point|0|||
33216786|NCT01951638|100692200|FG003|Treatment Period|Protocol-driven decision point|0|||
33216787|NCT01951638|100692201|FG004|Treatment Period|Protocol-driven decision point|0|||
33216788|NCT01951638|100692197|FG000|Treatment Period|Logistical difficulties|0|||
33410593|NCT02268214|101392791|FG002|Overall Study|Lost to Follow-up|4|||
33549969|NCT02927145|101913504|FG005|Invitation for Additional Challenge|Pregnancy|0|||
33216789|NCT01951638|100692198|FG001|Treatment Period|Logistical difficulties|1|||
33349934|NCT02397473|101167601|FG001|Treatment Phase|Adverse Event|2|||
33349935|NCT02397473|101167600|FG000|Treatment Phase|Lack of Efficacy|8|||
33349936|NCT02397473|101167601|FG001|Treatment Phase|Lack of Efficacy|1|||
33349937|NCT02397473|101167600|FG000|Treatment Phase|Lost to Follow-up|1|||
33349938|NCT02397473|101167601|FG001|Treatment Phase|Lost to Follow-up|0|||
33349939|NCT02397473|101167600|FG000|Treatment Phase|Withdrawal by Subject|2|||
33349940|NCT02397473|101167601|FG001|Treatment Phase|Withdrawal by Subject|1|||
33349941|NCT02397473|101167600|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
33410594|NCT02268214|101392789|FG000|Overall Study|Lack of Efficacy|1|||
33410595|NCT02268214|101392790|FG001|Overall Study|Lack of Efficacy|0|||
33410596|NCT02268214|101392791|FG002|Overall Study|Lack of Efficacy|2|||
33410597|NCT02268214|101392789|FG000|Overall Study|Adverse Event|11|||
33410598|NCT02268214|101392790|FG001|Overall Study|Adverse Event|14|||
33410599|NCT02268214|101392791|FG002|Overall Study|Adverse Event|9|||
33410600|NCT02268214|101392789|FG000|Overall Study|Withdrawal by Subject|4|||
33549970|NCT02927145|101913505|FG006|Invitation for Additional Challenge|Pregnancy|1|||
33216790|NCT01951638|100692199|FG002|Treatment Period|Logistical difficulties|1|||
33216791|NCT01951638|100692200|FG003|Treatment Period|Logistical difficulties|0|||
33216792|NCT01951638|100692201|FG004|Treatment Period|Logistical difficulties|0|||
33216793|NCT01951638|100692197|FG000|Treatment Period|Withdrawal by Subject|9|||
33216794|NCT01951638|100692198|FG001|Treatment Period|Withdrawal by Subject|6|||
33349942|NCT02397473|101167601|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
33349943|NCT02397473|101167600|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
33216795|NCT01951638|100692199|FG002|Treatment Period|Withdrawal by Subject|4|||
33410601|NCT02268214|101392790|FG001|Overall Study|Withdrawal by Subject|5|||
33410602|NCT02268214|101392791|FG002|Overall Study|Withdrawal by Subject|10|||
33410603|NCT02268214|101392789|FG000|Overall Study|Subject request to discontinue treatment|10|||
33410604|NCT02268214|101392790|FG001|Overall Study|Subject request to discontinue treatment|8|||
33410605|NCT02268214|101392791|FG002|Overall Study|Subject request to discontinue treatment|6|||
33410606|NCT02268214|101392789|FG000|Overall Study|Poor/non-compliance|2|||
33410607|NCT02268214|101392790|FG001|Overall Study|Poor/non-compliance|1|||
33410608|NCT02268214|101392791|FG002|Overall Study|Poor/non-compliance|2|||
33410609|NCT02268214|101392789|FG000|Overall Study|Other reasons|7|||
33410610|NCT02268214|101392790|FG001|Overall Study|Other reasons|3|||
33410611|NCT02268214|101392791|FG002|Overall Study|Other reasons|3|||
33410612|NCT02268214|101392789|FG000|Overall Study|Not entering long-term period|2|||
33410613|NCT02268214|101392790|FG001|Overall Study|Not entering long-term period|3|||
33410614|NCT02268214|101392791|FG002|Overall Study|Not entering long-term period|5|||
33410615|NCT01361308|101392795|FG000|Overall Study|Withdrawal by Subject|9|||
33410616|NCT01361308|101392796|FG001|Overall Study|Withdrawal by Subject|13|||
33410617|NCT01361308|101392795|FG000|Overall Study|Physician Decision|3|||
33410618|NCT01361308|101392796|FG001|Overall Study|Physician Decision|3|||
33410619|NCT01361308|101392795|FG000|Overall Study|Lack of Efficacy|2|||
33410620|NCT01361308|101392796|FG001|Overall Study|Lack of Efficacy|0|||
33410621|NCT01361308|101392795|FG000|Overall Study|Protocol Violation|1|||
33410622|NCT01361308|101392796|FG001|Overall Study|Protocol Violation|0|||
33410623|NCT01361308|101392795|FG000|Overall Study|Lost to Follow-up|5|||
33410624|NCT01361308|101392796|FG001|Overall Study|Lost to Follow-up|4|||
33410625|NCT01361308|101392795|FG000|Overall Study|Adverse Event|8|||
33410626|NCT01361308|101392796|FG001|Overall Study|Adverse Event|4|||
33410627|NCT01361308|101392795|FG000|Overall Study|Eligibility Criteria Not Met|2|||
33410628|NCT01361308|101392796|FG001|Overall Study|Eligibility Criteria Not Met|3|||
33410629|NCT01361308|101392795|FG000|Overall Study|Failed C-SSRS|5|||
33410630|NCT01361308|101392796|FG001|Overall Study|Failed C-SSRS|2|||
33410631|NCT01361308|101392795|FG000|Overall Study|Other|0|||
33410632|NCT01361308|101392796|FG001|Overall Study|Other|1|||
33410633|NCT04177862|101392804|FG000|Overall Study|Protocol Violation|2|||
33410634|NCT04177862|101392805|FG001|Overall Study|Protocol Violation|7|||
33410635|NCT00131937|101392808|FG000|Overall Study|Adverse Event|3|||
33410636|NCT00131937|101392808|FG000|Overall Study|Withdrawal by Subject|2|||
33410637|NCT00131937|101392808|FG000|Overall Study|Physician Decision|1|||
33410638|NCT00131937|101392808|FG000|Overall Study|Disease Progression|7|||
33410639|NCT00131937|101392808|FG000|Overall Study|Alternative therapy|1|||
33410640|NCT05056311|101392811|FG000|Overall Study|Lost to Follow-up|14|||
33410641|NCT05056311|101392811|FG000|Overall Study|Withdrawal by Subject|1|||
33410642|NCT05056311|101392811|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
33410643|NCT00859313|101392812|FG000|Overall Study|Lack of Efficacy|2|||
33410644|NCT00859313|101392812|FG000|Overall Study|Adverse Event|1|||
33410645|NCT00859313|101392812|FG000|Overall Study|staff error|1|||
33410646|NCT00471237|101392813|FG000|Overall Study|Adverse Event|6|||
33410647|NCT00471237|101392814|FG001|Overall Study|Adverse Event|5|||
33410648|NCT00471237|101392815|FG002|Overall Study|Adverse Event|4|||
33410649|NCT00471237|101392816|FG003|Overall Study|Adverse Event|8|||
33410650|NCT00471237|101392817|FG004|Overall Study|Adverse Event|7|||
33410651|NCT00471237|101392818|FG005|Overall Study|Adverse Event|5|||
33410652|NCT00471237|101392819|FG006|Overall Study|Adverse Event|0|||
33410653|NCT00471237|101392813|FG000|Overall Study|Lost to Follow-up|1|||
33410654|NCT00471237|101392814|FG001|Overall Study|Lost to Follow-up|1|||
33410655|NCT00471237|101392815|FG002|Overall Study|Lost to Follow-up|0|||
33410656|NCT00471237|101392816|FG003|Overall Study|Lost to Follow-up|2|||
33410657|NCT00471237|101392817|FG004|Overall Study|Lost to Follow-up|3|||
33410658|NCT00471237|101392818|FG005|Overall Study|Lost to Follow-up|0|||
33410659|NCT00471237|101392819|FG006|Overall Study|Lost to Follow-up|0|||
33410660|NCT00471237|101392813|FG000|Overall Study|Protocol Violation|3|||
33410661|NCT00471237|101392814|FG001|Overall Study|Protocol Violation|6|||
33410662|NCT00471237|101392815|FG002|Overall Study|Protocol Violation|3|||
33410663|NCT00471237|101392816|FG003|Overall Study|Protocol Violation|2|||
33410664|NCT00471237|101392817|FG004|Overall Study|Protocol Violation|2|||
33410665|NCT00471237|101392818|FG005|Overall Study|Protocol Violation|4|||
33410666|NCT00471237|101392819|FG006|Overall Study|Protocol Violation|1|||
33410667|NCT00471237|101392813|FG000|Overall Study|Withdrawal by Subject|8|||
33549971|NCT02927145|101913506|FG007|Invitation for Additional Challenge|Pregnancy|0|||
33549972|NCT02927145|101913507|FG008|Invitation for Additional Challenge|Pregnancy|0|||
33549973|NCT04339972|101913508|FG000|Overall Study|Scheduling Issues|3|||
33549974|NCT04339972|101913509|FG001|Overall Study|Scheduling Issues|3|||
33410668|NCT00471237|101392814|FG001|Overall Study|Withdrawal by Subject|6|||
33410669|NCT00471237|101392815|FG002|Overall Study|Withdrawal by Subject|5|||
33410670|NCT00471237|101392816|FG003|Overall Study|Withdrawal by Subject|8|||
33410671|NCT00471237|101392817|FG004|Overall Study|Withdrawal by Subject|7|||
33410672|NCT00471237|101392818|FG005|Overall Study|Withdrawal by Subject|4|||
33549975|NCT04339972|101913508|FG000|Overall Study|dropout|1|||
33410673|NCT00471237|101392819|FG006|Overall Study|Withdrawal by Subject|2|||
33410674|NCT00471237|101392813|FG000|Overall Study|Sponsor terminated study|20|||
33410675|NCT00471237|101392814|FG001|Overall Study|Sponsor terminated study|23|||
33410676|NCT00471237|101392815|FG002|Overall Study|Sponsor terminated study|19|||
33410677|NCT00471237|101392816|FG003|Overall Study|Sponsor terminated study|22|||
33410678|NCT00471237|101392817|FG004|Overall Study|Sponsor terminated study|18|||
33410679|NCT00471237|101392818|FG005|Overall Study|Sponsor terminated study|24|||
33410680|NCT00471237|101392819|FG006|Overall Study|Sponsor terminated study|0|||
33410681|NCT00471237|101392813|FG000|Overall Study|Non-compliance|0|||
33410682|NCT00471237|101392814|FG001|Overall Study|Non-compliance|1|||
33410683|NCT00471237|101392815|FG002|Overall Study|Non-compliance|0|||
33410684|NCT00471237|101392816|FG003|Overall Study|Non-compliance|1|||
33410685|NCT00471237|101392817|FG004|Overall Study|Non-compliance|0|||
33410686|NCT00471237|101392818|FG005|Overall Study|Non-compliance|0|||
33410687|NCT00471237|101392819|FG006|Overall Study|Non-compliance|0|||
33410688|NCT00471237|101392813|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
33410689|NCT00471237|101392814|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
33410690|NCT00471237|101392815|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
33410691|NCT00471237|101392816|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
33410692|NCT00471237|101392817|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
33410693|NCT00471237|101392818|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
33410694|NCT00471237|101392819|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
33410695|NCT00471237|101392813|FG000|Overall Study|Early stopping due to non-efficacy|1|||
33410696|NCT00471237|101392814|FG001|Overall Study|Early stopping due to non-efficacy|0|||
33410697|NCT00471237|101392815|FG002|Overall Study|Early stopping due to non-efficacy|0|||
33410698|NCT00471237|101392816|FG003|Overall Study|Early stopping due to non-efficacy|0|||
33410699|NCT00471237|101392817|FG004|Overall Study|Early stopping due to non-efficacy|1|||
33410700|NCT00471237|101392818|FG005|Overall Study|Early stopping due to non-efficacy|0|||
33410701|NCT00471237|101392819|FG006|Overall Study|Early stopping due to non-efficacy|0|||
33410702|NCT00471237|101392813|FG000|Overall Study|Participant planned to travel to abraod|1|||
33410703|NCT00471237|101392814|FG001|Overall Study|Participant planned to travel to abraod|0|||
33410704|NCT00471237|101392815|FG002|Overall Study|Participant planned to travel to abraod|0|||
33410705|NCT00471237|101392816|FG003|Overall Study|Participant planned to travel to abraod|0|||
33410706|NCT00471237|101392817|FG004|Overall Study|Participant planned to travel to abraod|0|||
33410707|NCT00471237|101392818|FG005|Overall Study|Participant planned to travel to abraod|1|||
33410708|NCT00471237|101392819|FG006|Overall Study|Participant planned to travel to abraod|0|||
33410709|NCT00471237|101392813|FG000|Overall Study|High parathyroid hormone|0|||
33410710|NCT00471237|101392814|FG001|Overall Study|High parathyroid hormone|0|||
33410711|NCT00471237|101392815|FG002|Overall Study|High parathyroid hormone|1|||
33410712|NCT00471237|101392816|FG003|Overall Study|High parathyroid hormone|0|||
33410713|NCT00471237|101392817|FG004|Overall Study|High parathyroid hormone|0|||
33410714|NCT00471237|101392818|FG005|Overall Study|High parathyroid hormone|0|||
33410715|NCT00471237|101392819|FG006|Overall Study|High parathyroid hormone|0|||
33410716|NCT00471237|101392813|FG000|Overall Study|Participant lost medication|0|||
33410717|NCT00471237|101392814|FG001|Overall Study|Participant lost medication|0|||
33410718|NCT00471237|101392815|FG002|Overall Study|Participant lost medication|0|||
33410719|NCT00471237|101392816|FG003|Overall Study|Participant lost medication|0|||
33410720|NCT00471237|101392817|FG004|Overall Study|Participant lost medication|1|||
33410721|NCT00471237|101392818|FG005|Overall Study|Participant lost medication|0|||
33410722|NCT00471237|101392819|FG006|Overall Study|Participant lost medication|0|||
33410723|NCT00471237|101392813|FG000|Overall Study|Administration of prohibited medicine|0|||
33410724|NCT00471237|101392814|FG001|Overall Study|Administration of prohibited medicine|0|||
33410725|NCT00471237|101392815|FG002|Overall Study|Administration of prohibited medicine|0|||
33410726|NCT00471237|101392816|FG003|Overall Study|Administration of prohibited medicine|0|||
33410727|NCT00471237|101392817|FG004|Overall Study|Administration of prohibited medicine|1|||
33410728|NCT00471237|101392818|FG005|Overall Study|Administration of prohibited medicine|0|||
33410729|NCT00471237|101392819|FG006|Overall Study|Administration of prohibited medicine|0|||
33410730|NCT00471237|101392813|FG000|Overall Study|Participant shifted residence|0|||
33410731|NCT00471237|101392814|FG001|Overall Study|Participant shifted residence|0|||
33410732|NCT00471237|101392815|FG002|Overall Study|Participant shifted residence|0|||
33410733|NCT00471237|101392816|FG003|Overall Study|Participant shifted residence|0|||
33410734|NCT00471237|101392817|FG004|Overall Study|Participant shifted residence|1|||
33410735|NCT00471237|101392818|FG005|Overall Study|Participant shifted residence|0|||
33410736|NCT00471237|101392819|FG006|Overall Study|Participant shifted residence|0|||
33410737|NCT00471237|101392813|FG000|Overall Study|Participant's decision|0|||
33410738|NCT00471237|101392814|FG001|Overall Study|Participant's decision|0|||
33549976|NCT04339972|101913509|FG001|Overall Study|dropout|1|||
33410739|NCT00471237|101392815|FG002|Overall Study|Participant's decision|0|||
33410740|NCT00471237|101392816|FG003|Overall Study|Participant's decision|0|||
33410741|NCT00471237|101392817|FG004|Overall Study|Participant's decision|0|||
33410742|NCT00471237|101392818|FG005|Overall Study|Participant's decision|1|||
33410743|NCT00471237|101392819|FG006|Overall Study|Participant's decision|0|||
33410744|NCT02551874|101392820|FG000|Overall Study|Lost to Follow-up|0|||
33410745|NCT02551874|101392821|FG001|Overall Study|Lost to Follow-up|2|||
33410746|NCT02551874|101392820|FG000|Overall Study|Pregnancy|0|||
33410747|NCT02551874|101392821|FG001|Overall Study|Pregnancy|1|||
33410748|NCT02551874|101392820|FG000|Overall Study|Reason not reported|10|||
33410749|NCT02551874|101392821|FG001|Overall Study|Reason not reported|4|||
33410750|NCT02551874|101392820|FG000|Overall Study|Did not receive randomized treatment|0|||
33410751|NCT02551874|101392821|FG001|Overall Study|Did not receive randomized treatment|7|||
33410752|NCT02551874|101392820|FG000|Overall Study|Did not enter long-term study|18|||
33410753|NCT02551874|101392821|FG001|Overall Study|Did not enter long-term study|25|||
33410754|NCT00633217|101392822|FG000|Overall Study|Adverse Event|5|||
33410755|NCT00633217|101392823|FG001|Overall Study|Adverse Event|9|||
33410756|NCT00633217|101392822|FG000|Overall Study|Lack of Efficacy|0|||
33410757|NCT00633217|101392823|FG001|Overall Study|Lack of Efficacy|2|||
33410758|NCT00633217|101392822|FG000|Overall Study|Protocol Violation|3|||
33410759|NCT00633217|101392823|FG001|Overall Study|Protocol Violation|7|||
33410760|NCT00633217|101392822|FG000|Overall Study|Lost to Follow-up|2|||
33410761|NCT00633217|101392823|FG001|Overall Study|Lost to Follow-up|2|||
33410762|NCT00633217|101392822|FG000|Overall Study|Investigator Discretion|2|||
33410763|NCT00633217|101392823|FG001|Overall Study|Investigator Discretion|0|||
33410764|NCT00633217|101392822|FG000|Overall Study|Withdrew Consent|3|||
33410765|NCT00633217|101392823|FG001|Overall Study|Withdrew Consent|3|||
33410766|NCT03808298|101392824|FG000|Overall Study|Adverse Event|3|||
33410767|NCT03808298|101392824|FG000|Overall Study|Physician Decision|1|||
33549977|NCT04339972|101913508|FG000|Overall Study|Technical issues|1|||
33549978|NCT04339972|101913509|FG001|Overall Study|Technical issues|0|||
33549979|NCT04339972|101913508|FG000|Overall Study|Claustraphobia|0|||
33549980|NCT04339972|101913509|FG001|Overall Study|Claustraphobia|1|||
33618289|NCT02737475|102151511|FG003|Overall Study|Other reasons|0|||
33618290|NCT02737475|102151512|FG004|Overall Study|Other reasons|1|||
33618291|NCT02737475|102151513|FG005|Overall Study|Other reasons|1|||
33549981|NCT03387046|101913510|FG000|Overall Study|Adverse Event|1|||
33549982|NCT03387046|101913511|FG001|Overall Study|Adverse Event|1|||
33549983|NCT00429299|101913512|FG000|Overall Study|Disease Progression|1|||
33549984|NCT00429299|101913513|FG001|Overall Study|Disease Progression|1|||
33549985|NCT00429299|101913514|FG002|Overall Study|Disease Progression|0|||
33549986|NCT00429299|101913512|FG000|Overall Study|Adverse Event|2|||
33549987|NCT00429299|101913513|FG001|Overall Study|Adverse Event|5|||
33549988|NCT00429299|101913514|FG002|Overall Study|Adverse Event|1|||
33549989|NCT00429299|101913512|FG000|Overall Study|Protocol Violation|1|||
33549990|NCT00429299|101913513|FG001|Overall Study|Protocol Violation|0|||
33549991|NCT00429299|101913514|FG002|Overall Study|Protocol Violation|0|||
33549992|NCT00429299|101913512|FG000|Overall Study|Withdrawal by Subject|0|||
33549993|NCT00429299|101913513|FG001|Overall Study|Withdrawal by Subject|1|||
33549994|NCT00429299|101913514|FG002|Overall Study|Withdrawal by Subject|3|||
33549995|NCT01483651|101913518|FG000|Overall Study|Withdrawal by Subject|0|||
33549996|NCT01483651|101913519|FG001|Overall Study|Withdrawal by Subject|1|||
33549997|NCT01483651|101913520|FG002|Overall Study|Withdrawal by Subject|1|||
33549998|NCT01483651|101913521|FG003|Overall Study|Withdrawal by Subject|0|||
33549999|NCT01483651|101913522|FG004|Overall Study|Withdrawal by Subject|0|||
33550000|NCT01483651|101913523|FG005|Overall Study|Withdrawal by Subject|1|||
33550001|NCT00455455|101913524|FG000|Washout|Withdrawal by Subject|0|||
33550002|NCT00455455|101913525|FG001|Washout|Withdrawal by Subject|1|||
33550003|NCT00455455|101913524|FG000|Washout|Withdrawal by Subject|1|||
33550004|NCT00455455|101913525|FG001|Washout|Withdrawal by Subject|0|||
33550005|NCT02153827|101913526|FG000|Overall Study|Lost to Follow-up|3|||
33550006|NCT02153827|101913527|FG001|Overall Study|Lost to Follow-up|9|||
33550007|NCT00853385|101913528|FG000|Overall Study|Death|0|||
33550008|NCT00853385|101913529|FG001|Overall Study|Death|0|||
33550009|NCT00853385|101913530|FG002|Overall Study|Death|0|||
33550010|NCT00853385|101913531|FG003|Overall Study|Death|0|||
33550011|NCT00853385|101913532|FG004|Overall Study|Death|1|||
33550012|NCT00853385|101913528|FG000|Overall Study|Adverse Event|24|||
33550013|NCT00853385|101913529|FG001|Overall Study|Adverse Event|24|||
33550014|NCT00853385|101913530|FG002|Overall Study|Adverse Event|2|||
33550015|NCT00853385|101913531|FG003|Overall Study|Adverse Event|5|||
33550016|NCT00853385|101913532|FG004|Overall Study|Adverse Event|22|||
33550017|NCT00853385|101913528|FG000|Overall Study|Lack of Efficacy|6|||
33216796|NCT01951638|100692200|FG003|Treatment Period|Withdrawal by Subject|5|||
33410768|NCT03808298|101392824|FG000|Overall Study|Withdrawal by Subject|1|||
33550018|NCT00853385|101913529|FG001|Overall Study|Lack of Efficacy|7|||
33410769|NCT03808298|101392824|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
33550019|NCT00853385|101913530|FG002|Overall Study|Lack of Efficacy|3|||
33410770|NCT00796367|101392825|FG000|Overall Study|Adverse Event|6|||
33410771|NCT00796367|101392826|FG001|Overall Study|Adverse Event|4|||
33410772|NCT00796367|101392827|FG002|Overall Study|Adverse Event|7|||
33410773|NCT00796367|101392825|FG000|Overall Study|Lost to Follow-up|5|||
33410774|NCT00796367|101392826|FG001|Overall Study|Lost to Follow-up|4|||
33550020|NCT00853385|101913531|FG003|Overall Study|Lack of Efficacy|3|||
33550021|NCT00853385|101913532|FG004|Overall Study|Lack of Efficacy|6|||
33618292|NCT02737475|102151514|FG006|Overall Study|Other reasons|0|||
33550022|NCT00853385|101913528|FG000|Overall Study|Lost to Follow-up|2|||
33550023|NCT00853385|101913529|FG001|Overall Study|Lost to Follow-up|1|||
33550024|NCT00853385|101913530|FG002|Overall Study|Lost to Follow-up|0|||
33550025|NCT00853385|101913531|FG003|Overall Study|Lost to Follow-up|0|||
33349944|NCT02397473|101167601|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
33349945|NCT02397473|101167600|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
33349946|NCT02397473|101167601|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
33349947|NCT02397473|101167600|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
33349948|NCT02397473|101167601|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
33349949|NCT02397473|101167600|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
33349950|NCT02397473|101167601|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
33349951|NCT00474240|101167610|FG000|Overall Study|Withdrawal by Subject|1|||
33349952|NCT00474240|101167611|FG001|Overall Study|Withdrawal by Subject|1|||
33349953|NCT00474240|101167612|FG002|Overall Study|Withdrawal by Subject|0|||
33349954|NCT00474240|101167613|FG003|Overall Study|Withdrawal by Subject|2|||
33349955|NCT00474240|101167614|FG004|Overall Study|Withdrawal by Subject|3|||
33349956|NCT00474240|101167615|FG005|Overall Study|Withdrawal by Subject|1|||
33349957|NCT00474240|101167610|FG000|Overall Study|Adverse Event|0|||
33349958|NCT00474240|101167611|FG001|Overall Study|Adverse Event|0|||
33349959|NCT00474240|101167612|FG002|Overall Study|Adverse Event|9|||
33349960|NCT00474240|101167613|FG003|Overall Study|Adverse Event|14|||
33349961|NCT00474240|101167614|FG004|Overall Study|Adverse Event|5|||
33550026|NCT00853385|101913532|FG004|Overall Study|Lost to Follow-up|0|||
33550027|NCT00853385|101913528|FG000|Overall Study|Withdrawal by Subject|4|||
33550028|NCT00853385|101913529|FG001|Overall Study|Withdrawal by Subject|2|||
33550029|NCT00853385|101913530|FG002|Overall Study|Withdrawal by Subject|0|||
33550030|NCT00853385|101913531|FG003|Overall Study|Withdrawal by Subject|1|||
33550031|NCT00853385|101913532|FG004|Overall Study|Withdrawal by Subject|1|||
33550032|NCT00853385|101913528|FG000|Overall Study|Other|18|||
33550033|NCT00853385|101913529|FG001|Overall Study|Other|9|||
33550034|NCT00853385|101913530|FG002|Overall Study|Other|4|||
33550035|NCT00853385|101913531|FG003|Overall Study|Other|4|||
33550036|NCT00853385|101913532|FG004|Overall Study|Other|12|||
33550037|NCT01807520|101913533|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
33550038|NCT01807520|101913534|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
33550039|NCT01807520|101913535|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
33550040|NCT01807520|101913536|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
33550041|NCT01807520|101913537|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
33550042|NCT01807520|101913538|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
33550043|NCT01807520|101913539|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
33550044|NCT01807520|101913533|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
33550045|NCT01807520|101913534|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
33550046|NCT01807520|101913535|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
33550047|NCT01807520|101913536|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
33550048|NCT01807520|101913537|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
33550049|NCT01807520|101913538|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
33550050|NCT01807520|101913539|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
33550051|NCT01807520|101913533|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
33550052|NCT01807520|101913534|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
33550053|NCT01807520|101913535|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
33550054|NCT01807520|101913536|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
33550055|NCT01807520|101913537|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
33550056|NCT01807520|101913538|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
33550057|NCT01807520|101913539|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
33550058|NCT01807520|101913533|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
33550059|NCT01807520|101913534|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
33550060|NCT01807520|101913535|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
33550061|NCT01807520|101913536|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
33550062|NCT01807520|101913537|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
33550063|NCT01807520|101913538|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
33550064|NCT01807520|101913539|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
33349962|NCT00474240|101167615|FG005|Overall Study|Adverse Event|16|||
33349963|NCT00474240|101167610|FG000|Overall Study|Removed due to lab value|0|||
33349964|NCT00474240|101167611|FG001|Overall Study|Removed due to lab value|0|||
33349965|NCT00474240|101167612|FG002|Overall Study|Removed due to lab value|0|||
33618293|NCT02737475|102151515|FG007|Overall Study|Other reasons|0|||
33618294|NCT02737475|102151516|FG008|Overall Study|Other reasons|1|||
33618295|NCT02737475|102151517|FG009|Overall Study|Other reasons|0|||
33618296|NCT02737475|102151518|FG010|Overall Study|Other reasons|1|||
33618297|NCT02737475|102151519|FG011|Overall Study|Other reasons|0|||
33618298|NCT02737475|102151520|FG012|Overall Study|Other reasons|0|||
33618299|NCT02737475|102151521|FG013|Overall Study|Other reasons|0|||
33550065|NCT01807520|101913533|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
33550066|NCT01807520|101913534|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
33550067|NCT01807520|101913535|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
33550068|NCT01807520|101913536|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
33550069|NCT01807520|101913537|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
33550070|NCT01807520|101913538|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
33550071|NCT01807520|101913539|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
33550072|NCT01807520|101913533|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
33550073|NCT01807520|101913534|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
33550074|NCT01807520|101913535|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
33550075|NCT01807520|101913536|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
33410775|NCT00796367|101392827|FG002|Overall Study|Lost to Follow-up|21|||
33410776|NCT00796367|101392825|FG000|Overall Study|Withdrawal by Subject|9|||
33410777|NCT00796367|101392826|FG001|Overall Study|Withdrawal by Subject|11|||
33410778|NCT00796367|101392827|FG002|Overall Study|Withdrawal by Subject|12|||
33410779|NCT00796367|101392825|FG000|Overall Study|Lack of Efficacy|2|||
33410780|NCT00796367|101392826|FG001|Overall Study|Lack of Efficacy|1|||
33410781|NCT00796367|101392827|FG002|Overall Study|Lack of Efficacy|0|||
33410782|NCT00796367|101392825|FG000|Overall Study|non compliance|3|||
33410783|NCT00796367|101392826|FG001|Overall Study|non compliance|1|||
33410784|NCT00796367|101392827|FG002|Overall Study|non compliance|1|||
33410785|NCT00796367|101392825|FG000|Overall Study|Pregnancy|1|||
33410786|NCT00796367|101392826|FG001|Overall Study|Pregnancy|0|||
33410787|NCT00796367|101392827|FG002|Overall Study|Pregnancy|1|||
33410788|NCT00796367|101392825|FG000|Overall Study|Requirement for restricted medication|2|||
33410789|NCT00796367|101392826|FG001|Overall Study|Requirement for restricted medication|0|||
33410790|NCT00796367|101392827|FG002|Overall Study|Requirement for restricted medication|2|||
33410791|NCT00796367|101392825|FG000|Overall Study|other|2|||
33410792|NCT00796367|101392826|FG001|Overall Study|other|4|||
33410793|NCT00796367|101392827|FG002|Overall Study|other|3|||
33410794|NCT04768881|101392828|FG000|Overall Study|Completed Study Follow-up|0|||
33410795|NCT04768881|101392829|FG001|Overall Study|Completed Study Follow-up|2|||
33410796|NCT04768881|101392828|FG000|Overall Study|Death|3|||
33410797|NCT04768881|101392829|FG001|Overall Study|Death|2|||
33410798|NCT04768881|101392828|FG000|Overall Study|Study Terminated by Sponsor|2|||
33410799|NCT04768881|101392829|FG001|Overall Study|Study Terminated by Sponsor|2|||
33410800|NCT04768881|101392828|FG000|Overall Study|Withdrawal by Subject|2|||
33410801|NCT04768881|101392829|FG001|Overall Study|Withdrawal by Subject|0|||
33410802|NCT04768881|101392828|FG000|Overall Study|Other|2|||
33410803|NCT04768881|101392829|FG001|Overall Study|Other|0|||
33410804|NCT00227591|101392835|FG000|Overall Study|Withdrawal by Subject|1|||
33410805|NCT01729559|101392836|FG000|Overall Study|Protocol Violation|31|||
33410806|NCT01729559|101392837|FG001|Overall Study|Protocol Violation|28|||
33410807|NCT00664066|101392838|FG000|Overall Study|Study terminated|3|||
33410808|NCT01965600|101392842|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
33410809|NCT01965600|101392843|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
33410810|NCT01965600|101392844|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
33410811|NCT01965600|101392845|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
33410812|NCT01965600|101392842|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
33410813|NCT01965600|101392843|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
33410814|NCT01965600|101392844|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
33410815|NCT01965600|101392845|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
33410816|NCT01965600|101392842|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
33410817|NCT01965600|101392843|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
33410818|NCT01965600|101392844|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
33550076|NCT01807520|101913537|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
33550077|NCT01807520|101913538|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
33410819|NCT01965600|101392845|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
33410820|NCT01965600|101392842|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
33410821|NCT01965600|101392843|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
33410822|NCT01965600|101392844|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
33618300|NCT02737475|102151522|FG014|Overall Study|Other reasons|0|||
33410823|NCT01965600|101392845|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
33618301|NCT02737475|102151523|FG015|Overall Study|Other reasons|0|||
33410824|NCT01965600|101392842|FG000|Second Intervention|Study terminated by Sponsor|0|||
33410825|NCT01965600|101392843|FG001|Second Intervention|Study terminated by Sponsor|0|||
33410826|NCT01965600|101392844|FG002|Second Intervention|Study terminated by Sponsor|2|||
33410827|NCT01965600|101392845|FG003|Second Intervention|Study terminated by Sponsor|2|||
33410828|NCT03878108|101392846|FG000|Overall Study|Adverse Event|1|||
33410829|NCT03878108|101392847|FG001|Overall Study|Adverse Event|0|||
33410830|NCT03233009|101392848|FG000|Overall Study|Lost to Follow-up|1|||
33410831|NCT03890731|101392849|FG000|Overall Study|Progressive disease|1|||
33410832|NCT03890731|101392849|FG000|Overall Study|Patient's decision|1|||
33410833|NCT03890731|101392849|FG000|Overall Study|Adverse Event|4|||
33410834|NCT01399619|101392850|FG000|Overall Study|Adverse Event|10|||
33410835|NCT01399619|101392851|FG001|Overall Study|Adverse Event|0|||
33410836|NCT01399619|101392852|FG002|Overall Study|Adverse Event|4|||
33410837|NCT01399619|101392853|FG003|Overall Study|Adverse Event|10|||
33410838|NCT01399619|101392850|FG000|Overall Study|Lack of Efficacy|9|||
33410839|NCT01399619|101392851|FG001|Overall Study|Lack of Efficacy|0|||
33410840|NCT01399619|101392852|FG002|Overall Study|Lack of Efficacy|5|||
33410841|NCT01399619|101392853|FG003|Overall Study|Lack of Efficacy|0|||
33410842|NCT01399619|101392850|FG000|Overall Study|Withdrawal by Subject|6|||
33410843|NCT01399619|101392851|FG001|Overall Study|Withdrawal by Subject|0|||
33550078|NCT01807520|101913539|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
33618302|NCT02737475|102151524|FG016|Overall Study|Other reasons|0|||
33618303|NCT02737475|102151525|FG017|Overall Study|Other reasons|0|||
33618304|NCT02737475|102151526|FG018|Overall Study|Other reasons|0|||
33618305|NCT02737475|102151527|FG019|Overall Study|Other reasons|0|||
33618306|NCT02737475|102151528|FG020|Overall Study|Other reasons|0|||
33618307|NCT02737475|102151529|FG021|Overall Study|Other reasons|1|||
33618308|NCT02737475|102151530|FG022|Overall Study|Other reasons|0|||
33349966|NCT00474240|101167613|FG003|Overall Study|Removed due to lab value|0|||
33349967|NCT00474240|101167614|FG004|Overall Study|Removed due to lab value|0|||
33349968|NCT00474240|101167615|FG005|Overall Study|Removed due to lab value|1|||
33349969|NCT02344576|101167616|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
33349970|NCT02344576|101167617|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
33550079|NCT01807520|101913533|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
33550080|NCT01807520|101913534|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
33550081|NCT01807520|101913535|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
33550082|NCT01807520|101913536|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
33550083|NCT01807520|101913537|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
33550084|NCT01807520|101913538|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
33550085|NCT01807520|101913539|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
33550086|NCT01807520|101913533|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
33550087|NCT01807520|101913534|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
33550088|NCT01807520|101913535|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
33550089|NCT01807520|101913536|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
33550090|NCT01807520|101913537|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
33550091|NCT01807520|101913538|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
33550092|NCT01807520|101913539|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
33550093|NCT01807520|101913533|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
33550094|NCT01807520|101913534|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
33550095|NCT01807520|101913535|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
33550096|NCT01807520|101913536|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
33550097|NCT01807520|101913537|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
33550098|NCT01807520|101913538|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
33618309|NCT02737475|102151531|FG023|Overall Study|Other reasons|1|||
33216797|NCT01951638|100692201|FG004|Treatment Period|Withdrawal by Subject|4|||
33216798|NCT01951638|100692197|FG000|Treatment Period|Death|0|||
33349971|NCT02344576|101167618|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
33349972|NCT02344576|101167619|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
33349973|NCT02344576|101167616|FG000|1-Month Follow-Up|Death|13|||
33349974|NCT02344576|101167617|FG001|1-Month Follow-Up|Death|8|||
33550099|NCT01807520|101913539|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
33550100|NCT01807520|101913533|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
33550101|NCT01807520|101913534|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
33550102|NCT01807520|101913535|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
33618310|NCT02737475|102151532|FG024|Overall Study|Other reasons|1|||
33349975|NCT02344576|101167618|FG002|1-Month Follow-Up|Death|0|||
33349976|NCT02344576|101167619|FG003|1-Month Follow-Up|Death|0|||
33410844|NCT01399619|101392852|FG002|Overall Study|Withdrawal by Subject|3|||
33410845|NCT01399619|101392853|FG003|Overall Study|Withdrawal by Subject|4|||
33410846|NCT01399619|101392850|FG000|Overall Study|Protocol Violation|0|||
33618311|NCT02737475|102151533|FG025|Overall Study|Other reasons|1|||
33410847|NCT01399619|101392851|FG001|Overall Study|Protocol Violation|0|||
33410848|NCT01399619|101392852|FG002|Overall Study|Protocol Violation|0|||
33410849|NCT01399619|101392853|FG003|Overall Study|Protocol Violation|1|||
33550103|NCT01807520|101913536|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
33550104|NCT01807520|101913537|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
33550105|NCT01807520|101913538|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
33550106|NCT01807520|101913539|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
33349977|NCT02344576|101167616|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
33349978|NCT02344576|101167617|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
33349979|NCT02344576|101167618|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
33349980|NCT02344576|101167619|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
33349981|NCT02344576|101167616|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
33349982|NCT02344576|101167617|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
33349983|NCT02344576|101167618|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
33349984|NCT02344576|101167619|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
33349985|NCT02344576|101167616|FG000|6-Month Follow-Up|Death|14|||
33349986|NCT02344576|101167617|FG001|6-Month Follow-Up|Death|14|||
33349987|NCT02344576|101167618|FG002|6-Month Follow-Up|Death|0|||
33349988|NCT02344576|101167619|FG003|6-Month Follow-Up|Death|0|||
33349989|NCT02344576|101167616|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
33349990|NCT02344576|101167617|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
33349991|NCT02344576|101167618|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
33349992|NCT02344576|101167619|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
33349993|NCT02344576|101167616|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
33349994|NCT02344576|101167617|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
33349995|NCT02344576|101167618|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
33349996|NCT02344576|101167619|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
33349997|NCT00395967|101167620|FG000|Treatment Period|Failed Mobilization|1|||
33349998|NCT00395967|101167620|FG000|Follow-up Period|Death|1|||
33349999|NCT00395967|101167620|FG000|Follow-up Period|Lost to Follow-up|1|||
33350000|NCT01299727|101167621|FG000|Overall Study|Withdrawal by Subject|1|||
33350001|NCT01299727|101167622|FG001|Overall Study|Withdrawal by Subject|0|||
33350002|NCT01299727|101167623|FG002|Overall Study|Withdrawal by Subject|0|||
33350003|NCT01299727|101167621|FG000|Overall Study|Adverse Event|0|||
33350004|NCT01299727|101167622|FG001|Overall Study|Adverse Event|0|||
33350005|NCT01299727|101167623|FG002|Overall Study|Adverse Event|1|||
33350006|NCT01299727|101167621|FG000|Overall Study|Completed the Treatment Period|3|||
33350007|NCT01299727|101167622|FG001|Overall Study|Completed the Treatment Period|4|||
33350008|NCT01299727|101167623|FG002|Overall Study|Completed the Treatment Period|3|||
33350009|NCT00256295|101167624|FG000|Overall Study|Withdrawal by Subject|3|||
33350010|NCT00256295|101167624|FG000|Overall Study|Death|1|||
33350011|NCT00699192|101167625|FG000|Overall Study|Missing|1|||
33350012|NCT00699192|101167626|FG001|Overall Study|Missing|1|||
33350013|NCT00699192|101167627|FG002|Overall Study|Missing|1|||
33350014|NCT00699192|101167625|FG000|Overall Study|Adverse Event|9|||
33350015|NCT00699192|101167626|FG001|Overall Study|Adverse Event|4|||
33350016|NCT00699192|101167627|FG002|Overall Study|Adverse Event|3|||
33350017|NCT00699192|101167625|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33350018|NCT00699192|101167626|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33350019|NCT00699192|101167627|FG002|Overall Study|Abnormal test procedure result(s)|1|||
33350020|NCT00699192|101167625|FG000|Overall Study|Lack of Efficacy|0|||
33350021|NCT00699192|101167626|FG001|Overall Study|Lack of Efficacy|0|||
33350022|NCT00699192|101167627|FG002|Overall Study|Lack of Efficacy|1|||
33350023|NCT00699192|101167625|FG000|Overall Study|Withdrawal by Subject|3|||
33350024|NCT00699192|101167626|FG001|Overall Study|Withdrawal by Subject|2|||
33350025|NCT00699192|101167627|FG002|Overall Study|Withdrawal by Subject|4|||
33350026|NCT00699192|101167625|FG000|Overall Study|Administrative problems|1|||
33350027|NCT00699192|101167626|FG001|Overall Study|Administrative problems|3|||
33350028|NCT00699192|101167627|FG002|Overall Study|Administrative problems|1|||
33350029|NCT00699192|101167625|FG000|Overall Study|Protocol Violation|2|||
33350030|NCT00699192|101167626|FG001|Overall Study|Protocol Violation|2|||
33350031|NCT00699192|101167627|FG002|Overall Study|Protocol Violation|0|||
33350032|NCT01628926|101167633|FG000|Overall Study|Adverse Event|13|||
33350033|NCT01628926|101167634|FG001|Overall Study|Adverse Event|11|||
33350034|NCT01628926|101167635|FG002|Overall Study|Adverse Event|9|||
33350035|NCT01628926|101167633|FG000|Overall Study|Lack of Efficacy|2|||
33350036|NCT01628926|101167634|FG001|Overall Study|Lack of Efficacy|1|||
33350037|NCT01628926|101167635|FG002|Overall Study|Lack of Efficacy|5|||
33350038|NCT01628926|101167633|FG000|Overall Study|Withdrawal by Subject|6|||
33350039|NCT01628926|101167634|FG001|Overall Study|Withdrawal by Subject|4|||
33350040|NCT01628926|101167635|FG002|Overall Study|Withdrawal by Subject|2|||
33350041|NCT01628926|101167633|FG000|Overall Study|Protocol Violation|0|||
33350042|NCT01628926|101167634|FG001|Overall Study|Protocol Violation|1|||
33350043|NCT01628926|101167635|FG002|Overall Study|Protocol Violation|0|||
33350044|NCT01628926|101167633|FG000|Overall Study|Discontinuation criteria|3|||
33350045|NCT01628926|101167634|FG001|Overall Study|Discontinuation criteria|4|||
33350046|NCT01628926|101167635|FG002|Overall Study|Discontinuation criteria|0|||
33350047|NCT01628926|101167633|FG000|Overall Study|Physician Decision|2|||
33350048|NCT01628926|101167634|FG001|Overall Study|Physician Decision|2|||
33350049|NCT01628926|101167635|FG002|Overall Study|Physician Decision|1|||
33410850|NCT01399619|101392850|FG000|Overall Study|Not treated|0|||
33410851|NCT01399619|101392851|FG001|Overall Study|Not treated|0|||
33410852|NCT01399619|101392852|FG002|Overall Study|Not treated|0|||
33410853|NCT01399619|101392853|FG003|Overall Study|Not treated|2|||
33410854|NCT03292731|101392854|FG000|Overall Study|Protocol Violation|4|||
33410855|NCT03292731|101392855|FG001|Overall Study|Protocol Violation|11|||
33410856|NCT03292731|101392856|FG002|Overall Study|Protocol Violation|1|||
33410857|NCT00167414|101392857|FG000|Overall Study|Death|10|||
33410858|NCT00883129|101392860|FG000|Overall Study|Adverse Event|7|||
33410859|NCT00883129|101392861|FG001|Overall Study|Adverse Event|15|||
33410860|NCT00883129|101392860|FG000|Overall Study|Withdrawal by Subject|8|||
33410861|NCT00883129|101392861|FG001|Overall Study|Withdrawal by Subject|9|||
33410862|NCT00883129|101392860|FG000|Overall Study|Non-compliance|3|||
33410863|NCT00883129|101392861|FG001|Overall Study|Non-compliance|6|||
33410864|NCT00883129|101392860|FG000|Overall Study|Lost to Follow-up|1|||
33410865|NCT00883129|101392861|FG001|Overall Study|Lost to Follow-up|2|||
33410866|NCT00883129|101392860|FG000|Overall Study|Death|1|||
33410867|NCT00883129|101392861|FG001|Overall Study|Death|2|||
33410868|NCT00883129|101392860|FG000|Overall Study|Defined Treatment Failure|0|||
33410869|NCT00883129|101392861|FG001|Overall Study|Defined Treatment Failure|2|||
33410870|NCT03410693|101392865|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
33410871|NCT03410693|101392866|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
33410872|NCT03410693|101392865|FG000|Overall Study|Disc trt: Lost to follow up|0|||
33410873|NCT03410693|101392866|FG001|Overall Study|Disc trt: Lost to follow up|1|||
33410874|NCT03410693|101392865|FG000|Overall Study|Disc trt: radiological progression|58|||
33410875|NCT03410693|101392866|FG001|Overall Study|Disc trt: radiological progression|50|||
33410876|NCT03410693|101392865|FG000|Overall Study|Disc trt: Other|1|||
33410877|NCT03410693|101392866|FG001|Overall Study|Disc trt: Other|0|||
33350050|NCT01587989|101167636|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
33350051|NCT01587989|101167637|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
33350052|NCT01587989|101167638|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
33350053|NCT01587989|101167636|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
33350054|NCT01587989|101167637|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
33350055|NCT01587989|101167638|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
33350056|NCT01587989|101167636|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
33350057|NCT01587989|101167637|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
33350058|NCT01587989|101167638|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
33350059|NCT01587989|101167636|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
33350060|NCT01587989|101167637|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
33350061|NCT01587989|101167638|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
33350062|NCT01587989|101167636|FG000|Randomized Study Treatment|Screening failure|0|||
33350063|NCT01587989|101167637|FG001|Randomized Study Treatment|Screening failure|1|||
33350064|NCT01587989|101167638|FG002|Randomized Study Treatment|Screening failure|0|||
33350065|NCT01587989|101167636|FG000|Randomized Study Treatment|Physician Decision|0|||
33350066|NCT01587989|101167637|FG001|Randomized Study Treatment|Physician Decision|0|||
33350067|NCT01587989|101167638|FG002|Randomized Study Treatment|Physician Decision|1|||
33350068|NCT02764541|101167641|FG000|Overall Study|Withdrawal by Subject|0|||
33350069|NCT02764541|101167642|FG001|Overall Study|Withdrawal by Subject|0|||
33350070|NCT02764541|101167643|FG002|Overall Study|Withdrawal by Subject|0|||
33350071|NCT02764541|101167644|FG003|Overall Study|Withdrawal by Subject|0|||
33350072|NCT02764541|101167645|FG004|Overall Study|Withdrawal by Subject|1|||
33350073|NCT02764541|101167646|FG005|Overall Study|Withdrawal by Subject|1|||
33350074|NCT02764541|101167647|FG006|Overall Study|Withdrawal by Subject|0|||
33350075|NCT02764541|101167648|FG007|Overall Study|Withdrawal by Subject|1|||
33350076|NCT02764541|101167641|FG000|Overall Study|Adverse Event|1|||
33350077|NCT02764541|101167642|FG001|Overall Study|Adverse Event|0|||
33350078|NCT02764541|101167643|FG002|Overall Study|Adverse Event|0|||
33350079|NCT02764541|101167644|FG003|Overall Study|Adverse Event|0|||
33350080|NCT02764541|101167645|FG004|Overall Study|Adverse Event|0|||
33350081|NCT02764541|101167646|FG005|Overall Study|Adverse Event|0|||
33350082|NCT02764541|101167647|FG006|Overall Study|Adverse Event|1|||
33410878|NCT03410693|101392865|FG000|Overall Study|Study drug never administered|1|||
33410879|NCT03410693|101392866|FG001|Overall Study|Study drug never administered|6|||
33410880|NCT03410693|101392865|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
33410881|NCT03410693|101392866|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
33410882|NCT03410693|101392865|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
33350083|NCT02764541|101167648|FG007|Overall Study|Adverse Event|0|||
33410883|NCT03410693|101392866|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
33350084|NCT02764541|101167641|FG000|Overall Study|Metastasis|1|||
33410884|NCT03410693|101392865|FG000|Overall Study|Disc trt: Physician decision|0|||
33410885|NCT03410693|101392866|FG001|Overall Study|Disc trt: Physician decision|5|||
33410886|NCT03410693|101392865|FG000|Overall Study|Disc trt: clinical progression|1|||
33410887|NCT03410693|101392866|FG001|Overall Study|Disc trt: clinical progression|5|||
33410888|NCT03410693|101392865|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
33410889|NCT03410693|101392866|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
33410890|NCT00145795|101392867|FG000|Overall Study|Adverse Event|1|||
33410891|NCT00145795|101392868|FG001|Overall Study|Adverse Event|0|||
33410892|NCT04144140|101392869|FG000|Overall Study|Other|0|||
33410893|NCT04144140|101392870|FG001|Overall Study|Other|0|||
33410894|NCT04144140|101392871|FG002|Overall Study|Other|0|||
33410895|NCT04144140|101392872|FG003|Overall Study|Other|0|||
33410896|NCT04144140|101392873|FG004|Overall Study|Other|0|||
33410897|NCT04144140|101392874|FG005|Overall Study|Other|1|||
33410898|NCT04144140|101392875|FG006|Overall Study|Other|0|||
33410899|NCT01674010|101392876|FG000|Open Treatment Phase 1|Adverse Event|10|||
33410900|NCT01674010|101392877|FG001|Open Treatment Phase 1|Adverse Event|0|||
33410901|NCT01674010|101392878|FG002|Open Treatment Phase 1|Adverse Event|0|||
33410902|NCT01674010|101392876|FG000|Open Treatment Phase 1|Death|1|||
33410903|NCT01674010|101392877|FG001|Open Treatment Phase 1|Death|0|||
33410904|NCT01674010|101392878|FG002|Open Treatment Phase 1|Death|0|||
33410905|NCT01674010|101392876|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
33410906|NCT01674010|101392877|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
33410907|NCT01674010|101392878|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
33410908|NCT01674010|101392876|FG000|Open Treatment Phase 1|Physician Decision|9|||
33410909|NCT01674010|101392877|FG001|Open Treatment Phase 1|Physician Decision|0|||
33410910|NCT01674010|101392878|FG002|Open Treatment Phase 1|Physician Decision|0|||
33410911|NCT01674010|101392876|FG000|Open Treatment Phase 1|Protocol Violation|7|||
33410912|NCT01674010|101392877|FG001|Open Treatment Phase 1|Protocol Violation|0|||
33550107|NCT01807520|101913533|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
33550108|NCT01807520|101913534|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
33550109|NCT01807520|101913535|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
33550110|NCT01807520|101913536|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
33550111|NCT01807520|101913537|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
33550112|NCT01807520|101913538|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
33550113|NCT01807520|101913539|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
33550114|NCT01807520|101913533|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
33550115|NCT01807520|101913534|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
33550116|NCT01807520|101913535|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
33550117|NCT01807520|101913536|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
33550118|NCT01807520|101913537|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
33550119|NCT01807520|101913538|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
33550120|NCT01807520|101913539|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
33550121|NCT01807520|101913533|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
33550122|NCT01807520|101913534|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
33550123|NCT01807520|101913535|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
33550124|NCT01807520|101913536|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
33550125|NCT01807520|101913537|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
33550126|NCT01807520|101913538|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
33550127|NCT01807520|101913539|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
33550128|NCT01807520|101913533|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
33550129|NCT01807520|101913534|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
33550130|NCT01807520|101913535|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
33550131|NCT01807520|101913536|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
33618312|NCT02737475|102151534|FG026|Overall Study|Other reasons|0|||
33618313|NCT02737475|102151508|FG000|Overall Study|Death|1|||
33618314|NCT02737475|102151509|FG001|Overall Study|Death|0|||
33618315|NCT02737475|102151510|FG002|Overall Study|Death|0|||
33618316|NCT02737475|102151511|FG003|Overall Study|Death|1|||
33350085|NCT02764541|101167642|FG001|Overall Study|Metastasis|0|||
33350086|NCT02764541|101167643|FG002|Overall Study|Metastasis|0|||
33350087|NCT02764541|101167644|FG003|Overall Study|Metastasis|0|||
33350088|NCT02764541|101167645|FG004|Overall Study|Metastasis|0|||
33350089|NCT02764541|101167646|FG005|Overall Study|Metastasis|0|||
33350090|NCT02764541|101167647|FG006|Overall Study|Metastasis|0|||
33350091|NCT02764541|101167648|FG007|Overall Study|Metastasis|0|||
33350092|NCT02764541|101167641|FG000|Overall Study|Disease progression|1|||
33350093|NCT02764541|101167642|FG001|Overall Study|Disease progression|1|||
33350094|NCT02764541|101167643|FG002|Overall Study|Disease progression|0|||
33350095|NCT02764541|101167644|FG003|Overall Study|Disease progression|0|||
33410913|NCT01674010|101392878|FG002|Open Treatment Phase 1|Protocol Violation|0|||
33410914|NCT01674010|101392876|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
33350096|NCT02764541|101167645|FG004|Overall Study|Disease progression|0|||
33350097|NCT02764541|101167646|FG005|Overall Study|Disease progression|0|||
33410915|NCT01674010|101392877|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
33410916|NCT01674010|101392878|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
33350098|NCT02764541|101167647|FG006|Overall Study|Disease progression|0|||
33410917|NCT01674010|101392876|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
33410918|NCT01674010|101392877|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
33410919|NCT01674010|101392878|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
33618317|NCT02737475|102151512|FG004|Overall Study|Death|0|||
33410920|NCT01674010|101392876|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
33410921|NCT01674010|101392877|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
33410922|NCT01674010|101392878|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
33410923|NCT01674010|101392876|FG000|Randomization Phase 2|Adverse Event|0|||
33410924|NCT01674010|101392877|FG001|Randomization Phase 2|Adverse Event|1|||
33410925|NCT01674010|101392878|FG002|Randomization Phase 2|Adverse Event|1|||
33410926|NCT01674010|101392876|FG000|Randomization Phase 2|Lost to Follow-up|0|||
33410927|NCT01674010|101392877|FG001|Randomization Phase 2|Lost to Follow-up|1|||
33410928|NCT01674010|101392878|FG002|Randomization Phase 2|Lost to Follow-up|2|||
33410929|NCT01674010|101392876|FG000|Randomization Phase 2|Mood episode recurrence|0|||
33410930|NCT01674010|101392877|FG001|Randomization Phase 2|Mood episode recurrence|8|||
33410931|NCT01674010|101392878|FG002|Randomization Phase 2|Mood episode recurrence|2|||
33410932|NCT01674010|101392876|FG000|Randomization Phase 2|Physician Decision|0|||
33410933|NCT01674010|101392877|FG001|Randomization Phase 2|Physician Decision|0|||
33410934|NCT01674010|101392878|FG002|Randomization Phase 2|Physician Decision|2|||
33410935|NCT01674010|101392876|FG000|Randomization Phase 2|Pregnancy|0|||
33618318|NCT02737475|102151513|FG005|Overall Study|Death|0|||
33618319|NCT02737475|102151514|FG006|Overall Study|Death|0|||
33618320|NCT02737475|102151515|FG007|Overall Study|Death|2|||
33618321|NCT02737475|102151516|FG008|Overall Study|Death|0|||
33618322|NCT02737475|102151517|FG009|Overall Study|Death|0|||
33618323|NCT02737475|102151518|FG010|Overall Study|Death|0|||
33618324|NCT02737475|102151519|FG011|Overall Study|Death|4|||
33216799|NCT01951638|100692198|FG001|Treatment Period|Death|0|||
33216800|NCT01951638|100692199|FG002|Treatment Period|Death|0|||
33216801|NCT01951638|100692200|FG003|Treatment Period|Death|3|||
33216802|NCT01951638|100692201|FG004|Treatment Period|Death|1|||
33216803|NCT01951638|100692197|FG000|Treatment Period|Adverse Event|3|||
33216804|NCT01951638|100692198|FG001|Treatment Period|Adverse Event|4|||
33216805|NCT01951638|100692199|FG002|Treatment Period|Adverse Event|8|||
33618325|NCT02737475|102151520|FG012|Overall Study|Death|2|||
33618326|NCT02737475|102151521|FG013|Overall Study|Death|2|||
33618327|NCT02737475|102151522|FG014|Overall Study|Death|0|||
33618328|NCT02737475|102151523|FG015|Overall Study|Death|2|||
33618329|NCT02737475|102151524|FG016|Overall Study|Death|2|||
33618330|NCT02737475|102151525|FG017|Overall Study|Death|2|||
33618331|NCT02737475|102151526|FG018|Overall Study|Death|1|||
33216806|NCT01951638|100692200|FG003|Treatment Period|Adverse Event|6|||
33216807|NCT01951638|100692201|FG004|Treatment Period|Adverse Event|5|||
33410936|NCT01674010|101392877|FG001|Randomization Phase 2|Pregnancy|1|||
33410937|NCT01674010|101392878|FG002|Randomization Phase 2|Pregnancy|1|||
33618332|NCT02737475|102151527|FG019|Overall Study|Death|0|||
33216808|NCT01951638|100692197|FG000|Follow-up Period|Protocol Violation|0|||
33216809|NCT01951638|100692198|FG001|Follow-up Period|Protocol Violation|0|||
33216810|NCT01951638|100692199|FG002|Follow-up Period|Protocol Violation|0|||
33216811|NCT01951638|100692200|FG003|Follow-up Period|Protocol Violation|1|||
33410938|NCT01674010|101392876|FG000|Randomization Phase 2|Protocol Violation|0|||
33410939|NCT01674010|101392877|FG001|Randomization Phase 2|Protocol Violation|1|||
33410940|NCT01674010|101392878|FG002|Randomization Phase 2|Protocol Violation|1|||
33618333|NCT02737475|102151528|FG020|Overall Study|Death|0|||
33618334|NCT02737475|102151529|FG021|Overall Study|Death|0|||
33618335|NCT02737475|102151530|FG022|Overall Study|Death|0|||
33618336|NCT02737475|102151531|FG023|Overall Study|Death|0|||
33618337|NCT02737475|102151532|FG024|Overall Study|Death|0|||
33350099|NCT02764541|101167648|FG007|Overall Study|Disease progression|1|||
33350100|NCT02764541|101167641|FG000|Overall Study|Protocol Violation|0|||
33350101|NCT02764541|101167642|FG001|Overall Study|Protocol Violation|0|||
33350102|NCT02764541|101167643|FG002|Overall Study|Protocol Violation|0|||
33350103|NCT02764541|101167644|FG003|Overall Study|Protocol Violation|1|||
33350104|NCT02764541|101167645|FG004|Overall Study|Protocol Violation|0|||
33350105|NCT02764541|101167646|FG005|Overall Study|Protocol Violation|1|||
33350106|NCT02764541|101167647|FG006|Overall Study|Protocol Violation|0|||
33350107|NCT02764541|101167648|FG007|Overall Study|Protocol Violation|0|||
33350108|NCT02764541|101167641|FG000|Overall Study|Physician Decision|0|||
33350109|NCT02764541|101167642|FG001|Overall Study|Physician Decision|0|||
33350110|NCT02764541|101167643|FG002|Overall Study|Physician Decision|0|||
33350111|NCT02764541|101167644|FG003|Overall Study|Physician Decision|1|||
33216812|NCT01951638|100692201|FG004|Follow-up Period|Protocol Violation|0|||
33216813|NCT01951638|100692197|FG000|Follow-up Period|Logistical difficulties|0|||
33216814|NCT01951638|100692198|FG001|Follow-up Period|Logistical difficulties|2|||
33550132|NCT01807520|101913537|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
33550133|NCT01807520|101913538|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
33550134|NCT01807520|101913539|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
33550135|NCT01807520|101913533|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
33550136|NCT01807520|101913534|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
33550137|NCT01807520|101913535|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
33550138|NCT01807520|101913536|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
33550139|NCT01807520|101913537|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
33550140|NCT01807520|101913538|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
33550141|NCT01807520|101913539|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
33550142|NCT01807520|101913533|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
33550143|NCT01807520|101913534|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
33550144|NCT01807520|101913535|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
33550145|NCT01807520|101913536|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
33216815|NCT01951638|100692199|FG002|Follow-up Period|Logistical difficulties|0|||
33216816|NCT01951638|100692200|FG003|Follow-up Period|Logistical difficulties|0|||
33216817|NCT01951638|100692201|FG004|Follow-up Period|Logistical difficulties|1|||
33350112|NCT02764541|101167645|FG004|Overall Study|Physician Decision|0|||
33550146|NCT01807520|101913537|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
33550147|NCT01807520|101913538|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
33216818|NCT01951638|100692197|FG000|Follow-up Period|Withdrawal by Subject|1|||
33550148|NCT01807520|101913539|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
33550149|NCT01807520|101913533|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
33550150|NCT01807520|101913534|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
33550151|NCT01807520|101913535|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
33350113|NCT02764541|101167646|FG005|Overall Study|Physician Decision|0|||
33350114|NCT02764541|101167647|FG006|Overall Study|Physician Decision|0|||
33550152|NCT01807520|101913536|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
33550153|NCT01807520|101913537|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
33550154|NCT01807520|101913538|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
33550155|NCT01807520|101913539|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
33550156|NCT01625182|101913542|FG000|Overall Study|Administrative problems|1|||
33550157|NCT01625182|101913543|FG001|Overall Study|Administrative problems|0|||
33550158|NCT01625182|101913542|FG000|Overall Study|Protocol deviation|0|||
33550159|NCT01625182|101913543|FG001|Overall Study|Protocol deviation|2|||
33550160|NCT01625182|101913542|FG000|Overall Study|Adverse Event|2|||
33350115|NCT02764541|101167648|FG007|Overall Study|Physician Decision|1|||
33350116|NCT02764541|101167641|FG000|Overall Study|Three Cycles completed before surgery|0|||
33350117|NCT02764541|101167642|FG001|Overall Study|Three Cycles completed before surgery|0|||
33350118|NCT02764541|101167643|FG002|Overall Study|Three Cycles completed before surgery|0|||
33550161|NCT01625182|101913543|FG001|Overall Study|Adverse Event|0|||
33550162|NCT01625182|101913542|FG000|Overall Study|Withdrawal by Subject|5|||
33550163|NCT01625182|101913543|FG001|Overall Study|Withdrawal by Subject|1|||
33550164|NCT01625182|101913542|FG000|Overall Study|Lack of Efficacy|12|||
33550165|NCT01625182|101913543|FG001|Overall Study|Lack of Efficacy|8|||
33550166|NCT00081458|101913544|FG000|Overall Study|Adverse Event|1|||
33550167|NCT00081458|101913545|FG001|Overall Study|Adverse Event|5|||
33550168|NCT00081458|101913546|FG002|Overall Study|Adverse Event|2|||
33350119|NCT02764541|101167644|FG003|Overall Study|Three Cycles completed before surgery|1|||
33350120|NCT02764541|101167645|FG004|Overall Study|Three Cycles completed before surgery|0|||
33350121|NCT02764541|101167646|FG005|Overall Study|Three Cycles completed before surgery|0|||
33350122|NCT02764541|101167647|FG006|Overall Study|Three Cycles completed before surgery|0|||
33550169|NCT00081458|101913544|FG000|Overall Study|Withdrawal by Subject|0|||
33550170|NCT00081458|101913545|FG001|Overall Study|Withdrawal by Subject|3|||
33550171|NCT00081458|101913546|FG002|Overall Study|Withdrawal by Subject|1|||
33550172|NCT00081458|101913544|FG000|Overall Study|Randomized but not dosed|0|||
33550173|NCT00081458|101913545|FG001|Overall Study|Randomized but not dosed|0|||
33550174|NCT00081458|101913546|FG002|Overall Study|Randomized but not dosed|1|||
33550175|NCT03142750|101913549|FG000|Overall Study|Lost to Follow-up|4|||
33550176|NCT03142750|101913550|FG001|Overall Study|Lost to Follow-up|1|||
33550177|NCT00286455|101913552|FG000|Overall Study|Hyperglycemia rescue|19|||
33550178|NCT00286455|101913553|FG001|Overall Study|Hyperglycemia rescue|13|||
33550179|NCT00286455|101913554|FG002|Overall Study|Hyperglycemia rescue|10|||
33550180|NCT00286455|101913552|FG000|Overall Study|Adverse Event|1|||
33550181|NCT00286455|101913553|FG001|Overall Study|Adverse Event|3|||
33550182|NCT00286455|101913554|FG002|Overall Study|Adverse Event|2|||
33550183|NCT00286455|101913552|FG000|Overall Study|Lost to Follow-up|0|||
33550184|NCT00286455|101913553|FG001|Overall Study|Lost to Follow-up|3|||
33550185|NCT00286455|101913554|FG002|Overall Study|Lost to Follow-up|3|||
33350123|NCT02764541|101167648|FG007|Overall Study|Three Cycles completed before surgery|0|||
33350124|NCT02764541|101167641|FG000|Overall Study|Patient Compliance|0|||
33550186|NCT00286455|101913552|FG000|Overall Study|Physician Decision|3|||
33550187|NCT00286455|101913553|FG001|Overall Study|Physician Decision|0|||
33550188|NCT00286455|101913554|FG002|Overall Study|Physician Decision|2|||
33350125|NCT02764541|101167642|FG001|Overall Study|Patient Compliance|0|||
33350126|NCT02764541|101167643|FG002|Overall Study|Patient Compliance|1|||
33550189|NCT00286455|101913552|FG000|Overall Study|Protocol Violation|1|||
33550190|NCT00286455|101913553|FG001|Overall Study|Protocol Violation|1|||
33550191|NCT00286455|101913554|FG002|Overall Study|Protocol Violation|0|||
33550192|NCT00286455|101913552|FG000|Overall Study|Participant Non-compliance|1|||
33550193|NCT00286455|101913553|FG001|Overall Study|Participant Non-compliance|0|||
33550194|NCT00286455|101913554|FG002|Overall Study|Participant Non-compliance|0|||
33550195|NCT00286455|101913552|FG000|Overall Study|Withdrawal by Subject|0|||
33550196|NCT00286455|101913553|FG001|Overall Study|Withdrawal by Subject|8|||
33550197|NCT00286455|101913554|FG002|Overall Study|Withdrawal by Subject|7|||
33550198|NCT00976898|101913557|FG000|Overall Study|Protocol Violation|1|||
33550199|NCT00976898|101913557|FG000|Overall Study|Adverse Event|1|||
33550200|NCT00976898|101913557|FG000|Overall Study|Physician Decision|1|||
33550201|NCT00976898|101913557|FG000|Overall Study|Liver Transplant|1|||
33550202|NCT00976898|101913557|FG000|Overall Study|Progressive Disease|1|||
33550203|NCT03349515|101913563|FG000|Overall Study|Lack of Efficacy|2|||
33550204|NCT03349515|101913564|FG001|Overall Study|Lack of Efficacy|0|||
33550205|NCT03349515|101913563|FG000|Overall Study|Physician Decision|3|||
33550206|NCT03349515|101913564|FG001|Overall Study|Physician Decision|1|||
33550207|NCT00433537|101913565|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
33550208|NCT00433537|101913566|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
33550209|NCT00433537|101913567|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
33550210|NCT00433537|101913565|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
33550211|NCT00433537|101913566|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
33550212|NCT00433537|101913567|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
33550213|NCT00433537|101913565|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
33550214|NCT00433537|101913566|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
33550215|NCT00433537|101913567|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
33550216|NCT00433537|101913565|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
33550217|NCT00433537|101913566|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
33550218|NCT00433537|101913567|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
33550219|NCT00433537|101913565|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
33550220|NCT00433537|101913566|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
33550221|NCT00433537|101913567|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
33550222|NCT00433537|101913565|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
33216819|NCT01951638|100692198|FG001|Follow-up Period|Withdrawal by Subject|5|||
33350127|NCT02764541|101167644|FG003|Overall Study|Patient Compliance|0|||
33350128|NCT02764541|101167645|FG004|Overall Study|Patient Compliance|0|||
33550223|NCT00433537|101913566|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
33550224|NCT00433537|101913567|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
33550225|NCT00433537|101913565|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
33550226|NCT00433537|101913566|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
33550227|NCT00433537|101913567|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
33550228|NCT00433537|101913565|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
33550229|NCT00433537|101913566|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
33550230|NCT00433537|101913567|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
33550231|NCT00433537|101913565|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
33550232|NCT00433537|101913566|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
33550233|NCT00433537|101913567|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
33550234|NCT00221104|101913568|FG000|Overall Study|Adverse Event|1|||
33550235|NCT00221104|101913569|FG001|Overall Study|Adverse Event|0|||
33550236|NCT00221104|101913568|FG000|Overall Study|Physician Decision|1|||
33550237|NCT00221104|101913569|FG001|Overall Study|Physician Decision|0|||
33550238|NCT00221104|101913568|FG000|Overall Study|Protocol Violation|2|||
33550239|NCT00221104|101913569|FG001|Overall Study|Protocol Violation|0|||
33550240|NCT00221104|101913568|FG000|Overall Study|Withdrawal by Subject|42|||
33550241|NCT00221104|101913569|FG001|Overall Study|Withdrawal by Subject|29|||
33550242|NCT00221104|101913568|FG000|Overall Study|Others|37|||
33550243|NCT00221104|101913569|FG001|Overall Study|Others|47|||
33550244|NCT01755637|101913570|FG000|Period 1|Adverse Event|0|||
33550245|NCT01755637|101913571|FG001|Period 1|Adverse Event|1|||
33550246|NCT02939781|101913574|FG000|Overall Study|Protocol Violation|8|||
33550247|NCT02939781|101913574|FG000|Overall Study|Withdrawal by Subject|1|||
33550248|NCT00450749|101913577|FG000|Overall Study|Withdrawal by Subject|0|||
33550249|NCT00450749|101913578|FG001|Overall Study|Withdrawal by Subject|0|||
33550250|NCT00450749|101913579|FG002|Overall Study|Withdrawal by Subject|2|||
33550251|NCT00450749|101913577|FG000|Overall Study|Noncompliant|0|||
33550252|NCT00450749|101913578|FG001|Overall Study|Noncompliant|1|||
33550253|NCT00450749|101913579|FG002|Overall Study|Noncompliant|0|||
33550254|NCT02260986|101913580|FG000|Overall Study|Adverse Event|24|||
33550255|NCT02260986|101913581|FG001|Overall Study|Adverse Event|0|||
33550256|NCT02260986|101913582|FG002|Overall Study|Adverse Event|11|||
33550257|NCT02260986|101913580|FG000|Overall Study|Lack of Efficacy|27|||
33550258|NCT02260986|101913581|FG001|Overall Study|Lack of Efficacy|3|||
33550259|NCT02260986|101913582|FG002|Overall Study|Lack of Efficacy|0|||
33550260|NCT02260986|101913580|FG000|Overall Study|Protocol Violation|14|||
33216820|NCT01951638|100692199|FG002|Follow-up Period|Withdrawal by Subject|2|||
33350129|NCT02764541|101167646|FG005|Overall Study|Patient Compliance|0|||
33550261|NCT02260986|101913581|FG001|Overall Study|Protocol Violation|5|||
33550262|NCT02260986|101913582|FG002|Overall Study|Protocol Violation|16|||
33550263|NCT02260986|101913580|FG000|Overall Study|Car accident|0|||
33550264|NCT02260986|101913581|FG001|Overall Study|Car accident|0|||
33550265|NCT02260986|101913582|FG002|Overall Study|Car accident|1|||
33550266|NCT02260986|101913580|FG000|Overall Study|Withdrawal by Subject|17|||
33618338|NCT02737475|102151533|FG025|Overall Study|Death|0|||
33350130|NCT02764541|101167647|FG006|Overall Study|Patient Compliance|0|||
33216821|NCT01951638|100692200|FG003|Follow-up Period|Withdrawal by Subject|1|||
33216822|NCT01951638|100692201|FG004|Follow-up Period|Withdrawal by Subject|2|||
33216823|NCT01951638|100692197|FG000|Follow-up Period|Lost to Follow-up|0|||
33216824|NCT01951638|100692198|FG001|Follow-up Period|Lost to Follow-up|1|||
33216825|NCT01951638|100692199|FG002|Follow-up Period|Lost to Follow-up|0|||
33216826|NCT01951638|100692200|FG003|Follow-up Period|Lost to Follow-up|1|||
33550267|NCT02260986|101913581|FG001|Overall Study|Withdrawal by Subject|4|||
33550268|NCT02260986|101913582|FG002|Overall Study|Withdrawal by Subject|9|||
33216827|NCT01951638|100692201|FG004|Follow-up Period|Lost to Follow-up|0|||
33216828|NCT01951638|100692197|FG000|Follow-up Period|Death|1|||
33216829|NCT01951638|100692198|FG001|Follow-up Period|Death|0|||
33216830|NCT01951638|100692199|FG002|Follow-up Period|Death|1|||
33550269|NCT02260986|101913580|FG000|Overall Study|Incorrect randomization|0|||
33550270|NCT02260986|101913581|FG001|Overall Study|Incorrect randomization|1|||
33550271|NCT02260986|101913582|FG002|Overall Study|Incorrect randomization|0|||
33550272|NCT02260986|101913580|FG000|Overall Study|Lack of investigation product supply|2|||
33550273|NCT02260986|101913581|FG001|Overall Study|Lack of investigation product supply|0|||
33550274|NCT02260986|101913582|FG002|Overall Study|Lack of investigation product supply|1|||
33216831|NCT01951638|100692200|FG003|Follow-up Period|Death|4|||
33216832|NCT01951638|100692201|FG004|Follow-up Period|Death|1|||
33216833|NCT01951638|100692197|FG000|Follow-up Period|Adverse Event|0|||
33216834|NCT01951638|100692198|FG001|Follow-up Period|Adverse Event|1|||
33216835|NCT01951638|100692199|FG002|Follow-up Period|Adverse Event|2|||
33216836|NCT01951638|100692200|FG003|Follow-up Period|Adverse Event|1|||
33216837|NCT01951638|100692201|FG004|Follow-up Period|Adverse Event|1|||
33216838|NCT03315143|100692202|FG000|Overall Study|Death|240|||
33216839|NCT03315143|100692203|FG001|Overall Study|Death|246|||
33216840|NCT03315143|100692202|FG000|Overall Study|Withdrawal by Subject|57|||
33216841|NCT03315143|100692203|FG001|Overall Study|Withdrawal by Subject|68|||
33216842|NCT03315143|100692202|FG000|Overall Study|Site Terminated by Sponsor|256|||
33216843|NCT03315143|100692203|FG001|Overall Study|Site Terminated by Sponsor|282|||
33216844|NCT03315143|100692202|FG000|Overall Study|Study Terminated by Sponsor|4723|||
33216845|NCT03315143|100692203|FG001|Overall Study|Study Terminated by Sponsor|4664|||
33216846|NCT03315143|100692202|FG000|Overall Study|Reason not Specified|16|||
33216847|NCT03315143|100692203|FG001|Overall Study|Reason not Specified|32|||
33216848|NCT01936857|100692207|FG000|Overall Study|Sent to prison or 06 center|11|||
33216849|NCT01936857|100692208|FG001|Overall Study|Sent to prison or 06 center|12|||
33216850|NCT01936857|100692207|FG000|Overall Study|Lost to Follow-up|10|||
33216851|NCT01936857|100692208|FG001|Overall Study|Lost to Follow-up|7|||
33216852|NCT01936857|100692207|FG000|Overall Study|Death|7|||
33216853|NCT01936857|100692208|FG001|Overall Study|Death|3|||
33216854|NCT01936857|100692207|FG000|Overall Study|Moved|2|||
33216855|NCT01936857|100692208|FG001|Overall Study|Moved|1|||
33216856|NCT01936857|100692207|FG000|Overall Study|Withdrawal by Subject|1|||
33216857|NCT01936857|100692208|FG001|Overall Study|Withdrawal by Subject|0|||
33216858|NCT01936857|100692207|FG000|Overall Study|Side effect of medication|1|||
33216859|NCT01936857|100692208|FG001|Overall Study|Side effect of medication|0|||
33216860|NCT01936857|100692207|FG000|Overall Study|Other|2|||
33216861|NCT01936857|100692208|FG001|Overall Study|Other|2|||
33216862|NCT01944631|100692209|FG000|Overall Study|Adverse Event|1|||
33216863|NCT01944631|100692210|FG001|Overall Study|Adverse Event|0|||
33216864|NCT01944631|100692209|FG000|Overall Study|Lost to Follow-up|3|||
33216865|NCT01944631|100692210|FG001|Overall Study|Lost to Follow-up|1|||
33216866|NCT01944631|100692209|FG000|Overall Study|Withdrawal by Subject|0|||
33216867|NCT01944631|100692210|FG001|Overall Study|Withdrawal by Subject|1|||
33216868|NCT03494166|100692211|FG000|Overall Study|Death|0|||
33550275|NCT02260986|101913580|FG000|Overall Study|Lost to Follow-up|4|||
33550276|NCT02260986|101913581|FG001|Overall Study|Lost to Follow-up|0|||
33550277|NCT02260986|101913582|FG002|Overall Study|Lost to Follow-up|3|||
33550278|NCT02260986|101913580|FG000|Overall Study|Pregnancy|2|||
33550279|NCT02260986|101913581|FG001|Overall Study|Pregnancy|0|||
33550280|NCT02260986|101913582|FG002|Overall Study|Pregnancy|0|||
33550281|NCT01149538|101913585|FG000|Overall Study|Lost to Follow-up|0|||
33550282|NCT01149538|101913586|FG001|Overall Study|Lost to Follow-up|1|||
33550283|NCT01149538|101913585|FG000|Overall Study|Withdrawal by Subject|5|||
33550284|NCT01149538|101913586|FG001|Overall Study|Withdrawal by Subject|3|||
33550285|NCT04491994|101913588|FG000|Overall Study|Withdrawal by Subject|10|||
33216869|NCT03494166|100692212|FG001|Overall Study|Death|0|||
33216870|NCT03494166|100692213|FG002|Overall Study|Death|0|||
33216871|NCT03494166|100692214|FG003|Overall Study|Death|1|||
33216872|NCT03494166|100692215|FG004|Overall Study|Death|3|||
33216873|NCT03494166|100692216|FG005|Overall Study|Death|0|||
33216874|NCT03494166|100692211|FG000|Overall Study|Lost to Follow-up|2|||
33216875|NCT03494166|100692212|FG001|Overall Study|Lost to Follow-up|2|||
33216876|NCT03494166|100692213|FG002|Overall Study|Lost to Follow-up|2|||
33216877|NCT03494166|100692214|FG003|Overall Study|Lost to Follow-up|2|||
33216878|NCT03494166|100692215|FG004|Overall Study|Lost to Follow-up|14|||
33216879|NCT03494166|100692216|FG005|Overall Study|Lost to Follow-up|0|||
33216880|NCT03494166|100692211|FG000|Overall Study|Withdrawal by Subject|10|||
33350131|NCT02764541|101167648|FG007|Overall Study|Patient Compliance|0|||
33216881|NCT03494166|100692212|FG001|Overall Study|Withdrawal by Subject|7|||
33216882|NCT03494166|100692213|FG002|Overall Study|Withdrawal by Subject|0|||
33216883|NCT03494166|100692214|FG003|Overall Study|Withdrawal by Subject|5|||
33216884|NCT03494166|100692215|FG004|Overall Study|Withdrawal by Subject|3|||
33216885|NCT03494166|100692216|FG005|Overall Study|Withdrawal by Subject|17|||
33216886|NCT03494166|100692211|FG000|Overall Study|Screen failure|1|||
33216887|NCT03494166|100692212|FG001|Overall Study|Screen failure|0|||
33350132|NCT02764541|101167641|FG000|Overall Study|Death|0|||
33350133|NCT02764541|101167642|FG001|Overall Study|Death|0|||
33350134|NCT02764541|101167643|FG002|Overall Study|Death|0|||
33350135|NCT02764541|101167644|FG003|Overall Study|Death|0|||
33350136|NCT02764541|101167645|FG004|Overall Study|Death|0|||
33550286|NCT04491994|101913589|FG001|Overall Study|Withdrawal by Subject|5|||
33550287|NCT04491994|101913588|FG000|Overall Study|developed fever > 3 days|4|||
33550288|NCT04491994|101913589|FG001|Overall Study|developed fever > 3 days|1|||
33550289|NCT04491994|101913588|FG000|Overall Study|Protocol Violation|11|||
33550290|NCT04491994|101913589|FG001|Overall Study|Protocol Violation|2|||
33550291|NCT04491994|101913588|FG000|Overall Study|Lost to Follow-up|4|||
33350137|NCT02764541|101167646|FG005|Overall Study|Death|0|||
33350138|NCT02764541|101167647|FG006|Overall Study|Death|1|||
33350139|NCT02764541|101167648|FG007|Overall Study|Death|0|||
33350140|NCT02764541|101167641|FG000|Overall Study|Insurance reasons|0|||
33410941|NCT01674010|101392876|FG000|Randomization Phase 2|Sponsor Decision|0|||
33550292|NCT04491994|101913589|FG001|Overall Study|Lost to Follow-up|3|||
33550293|NCT02405962|101913590|FG000|Overall Study|Lost to Follow-up|1|||
33550294|NCT02405962|101913591|FG001|Overall Study|Lost to Follow-up|4|||
33550295|NCT02405962|101913590|FG000|Overall Study|A participant has moved to another place|0|||
33618339|NCT02737475|102151534|FG026|Overall Study|Death|0|||
33216888|NCT03494166|100692213|FG002|Overall Study|Screen failure|0|||
33350141|NCT02764541|101167642|FG001|Overall Study|Insurance reasons|0|||
33410942|NCT01674010|101392877|FG001|Randomization Phase 2|Sponsor Decision|42|||
33410943|NCT01674010|101392878|FG002|Randomization Phase 2|Sponsor Decision|45|||
33410944|NCT01674010|101392876|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
33410945|NCT01674010|101392877|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
33410946|NCT01674010|101392878|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
33410947|NCT05182840|101397013|FG000|Run-in Period|Not treated|0|||
33410948|NCT05182840|101397014|FG001|Run-in Period|Not treated|1|||
33410949|NCT05182840|101397015|FG002|Run-in Period|Not treated|0|||
33410950|NCT05182840|101397016|FG003|Run-in Period|Not treated|0|||
33410951|NCT05182840|101397017|FG004|Run-in Period|Not treated|0|||
33410952|NCT05182840|101397018|FG005|Run-in Period|Not treated|0|||
33410953|NCT05182840|101397019|FG006|Run-in Period|Not treated|0|||
33410954|NCT05182840|101397020|FG007|Run-in Period|Not treated|0|||
33410955|NCT05182840|101397021|FG008|Run-in Period|Not treated|0|||
33410956|NCT05182840|101397022|FG009|Run-in Period|Not treated|0|||
33410957|NCT05182840|101397013|FG000|Run-in Period|Other reason but not sponsor termination|14|||
33410958|NCT05182840|101397014|FG001|Run-in Period|Other reason but not sponsor termination|18|||
33410959|NCT05182840|101397015|FG002|Run-in Period|Other reason but not sponsor termination|0|||
33410960|NCT05182840|101397016|FG003|Run-in Period|Other reason but not sponsor termination|0|||
33410961|NCT05182840|101397017|FG004|Run-in Period|Other reason but not sponsor termination|0|||
33410962|NCT05182840|101397018|FG005|Run-in Period|Other reason but not sponsor termination|0|||
33410963|NCT05182840|101397019|FG006|Run-in Period|Other reason but not sponsor termination|0|||
33410964|NCT05182840|101397020|FG007|Run-in Period|Other reason but not sponsor termination|0|||
33410965|NCT05182840|101397021|FG008|Run-in Period|Other reason but not sponsor termination|0|||
33410966|NCT05182840|101397022|FG009|Run-in Period|Other reason but not sponsor termination|0|||
33410967|NCT05182840|101397013|FG000|Run-in Period|No reason available|2|||
33410968|NCT05182840|101397014|FG001|Run-in Period|No reason available|2|||
33410969|NCT05182840|101397015|FG002|Run-in Period|No reason available|0|||
33410970|NCT05182840|101397016|FG003|Run-in Period|No reason available|0|||
33410971|NCT05182840|101397017|FG004|Run-in Period|No reason available|0|||
33410972|NCT05182840|101397018|FG005|Run-in Period|No reason available|0|||
33410973|NCT05182840|101397019|FG006|Run-in Period|No reason available|0|||
33410974|NCT05182840|101397020|FG007|Run-in Period|No reason available|0|||
33410975|NCT05182840|101397021|FG008|Run-in Period|No reason available|0|||
33410976|NCT05182840|101397022|FG009|Run-in Period|No reason available|0|||
33410977|NCT05182840|101397013|FG000|Run-in Period|Burden of study procedures|2|||
33410978|NCT05182840|101397014|FG001|Run-in Period|Burden of study procedures|2|||
33410979|NCT05182840|101397015|FG002|Run-in Period|Burden of study procedures|0|||
33410980|NCT05182840|101397016|FG003|Run-in Period|Burden of study procedures|0|||
33410981|NCT05182840|101397017|FG004|Run-in Period|Burden of study procedures|0|||
33410982|NCT05182840|101397018|FG005|Run-in Period|Burden of study procedures|0|||
33410983|NCT05182840|101397019|FG006|Run-in Period|Burden of study procedures|0|||
33410984|NCT05182840|101397020|FG007|Run-in Period|Burden of study procedures|0|||
33410985|NCT05182840|101397021|FG008|Run-in Period|Burden of study procedures|0|||
33410986|NCT05182840|101397022|FG009|Run-in Period|Burden of study procedures|0|||
33410987|NCT05182840|101397013|FG000|Run-in Period|Change of residence|1|||
33410988|NCT05182840|101397014|FG001|Run-in Period|Change of residence|0|||
33410989|NCT05182840|101397015|FG002|Run-in Period|Change of residence|0|||
33410990|NCT05182840|101397016|FG003|Run-in Period|Change of residence|0|||
33410991|NCT05182840|101397017|FG004|Run-in Period|Change of residence|0|||
33410992|NCT05182840|101397018|FG005|Run-in Period|Change of residence|0|||
33410993|NCT05182840|101397019|FG006|Run-in Period|Change of residence|0|||
33410994|NCT05182840|101397020|FG007|Run-in Period|Change of residence|0|||
33410995|NCT05182840|101397021|FG008|Run-in Period|Change of residence|0|||
33550296|NCT02405962|101913591|FG001|Overall Study|A participant has moved to another place|1|||
33550297|NCT02299167|101913592|FG000|Overall Study|patients were excluded from the study|11|||
33550298|NCT00471354|101913593|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
33550299|NCT00471354|101913593|FG000|Overall Study|Adverse Event|13|||
33550300|NCT00471354|101913593|FG000|Overall Study|Protocol Violation|12|||
33550301|NCT00471354|101913593|FG000|Overall Study|Withdrawal by Subject|1|||
33550302|NCT00471354|101913593|FG000|Overall Study|Physician Decision|4|||
33550303|NCT00471354|101913593|FG000|Overall Study|Sponsor Decision|1|||
33216889|NCT03494166|100692214|FG003|Overall Study|Screen failure|0|||
33410996|NCT05182840|101397022|FG009|Run-in Period|Change of residence|0|||
33216890|NCT03494166|100692215|FG004|Overall Study|Screen failure|1|||
33216891|NCT03494166|100692216|FG005|Overall Study|Screen failure|0|||
33410997|NCT05182840|101397013|FG000|Run-in Period|Adverse Event|5|||
33410998|NCT05182840|101397014|FG001|Run-in Period|Adverse Event|5|||
33410999|NCT05182840|101397015|FG002|Run-in Period|Adverse Event|0|||
33411000|NCT05182840|101397016|FG003|Run-in Period|Adverse Event|0|||
33411001|NCT05182840|101397017|FG004|Run-in Period|Adverse Event|0|||
33411002|NCT05182840|101397018|FG005|Run-in Period|Adverse Event|0|||
33411003|NCT05182840|101397019|FG006|Run-in Period|Adverse Event|0|||
33411004|NCT05182840|101397020|FG007|Run-in Period|Adverse Event|0|||
33411005|NCT05182840|101397021|FG008|Run-in Period|Adverse Event|0|||
33411006|NCT05182840|101397022|FG009|Run-in Period|Adverse Event|0|||
33411007|NCT05182840|101397013|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
33411008|NCT05182840|101397014|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
33411009|NCT05182840|101397015|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
33411010|NCT05182840|101397016|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
33411011|NCT05182840|101397017|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
33550304|NCT00471354|101913593|FG000|Overall Study|Lost to Follow-up|3|||
33550305|NCT00471354|101913593|FG000|Overall Study|Lack of Efficacy|5|||
33550306|NCT00471354|101913593|FG000|Overall Study|Patient/Caregiver Decision|12|||
33550307|NCT01290731|101913594|FG000|Overall Study|Withdrawal by Subject|1|||
33550308|NCT01800058|101913595|FG000|Overall Study|Lost to Follow-up|1|||
33550309|NCT00308685|101913597|FG000|Overall Study|Lost to Follow-up|1|||
33550310|NCT00308685|101913598|FG001|Overall Study|Lost to Follow-up|0|||
33550311|NCT00308685|101913597|FG000|Overall Study|Need to administer prohibited medication|1|||
33550312|NCT00308685|101913598|FG001|Overall Study|Need to administer prohibited medication|2|||
33550313|NCT00308685|101913597|FG000|Overall Study|Other than specified|1|||
33550314|NCT00308685|101913598|FG001|Overall Study|Other than specified|3|||
33550315|NCT01227395|101913600|FG000|Overall Study|Protocol Violation|0|||
33550316|NCT01227395|101913601|FG001|Overall Study|Protocol Violation|1|||
33550317|NCT01138046|101913602|FG000|Overall Study|Withdrawal due to death|6|||
33550318|NCT00416949|101913607|FG000|Overall Study|Patients refused to participate|5|||
33550319|NCT02691663|101913608|FG000|Overall Study|Screen failure after baseline|2|||
33550320|NCT02691663|101913609|FG001|Overall Study|Screen failure after baseline|2|||
33550321|NCT02691663|101913608|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
33550322|NCT02691663|101913609|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
33550323|NCT02691663|101913608|FG000|Overall Study|Withdrawn after Follow up 2|1|||
33550324|NCT02691663|101913609|FG001|Overall Study|Withdrawn after Follow up 2|1|||
33550325|NCT02691663|101913608|FG000|Overall Study|Lost to Follow-up|3|||
33550326|NCT02691663|101913609|FG001|Overall Study|Lost to Follow-up|2|||
33550327|NCT01033942|101913612|FG000|Overall Study|Withdrawal by Subject|1|||
33550328|NCT01033942|101913613|FG001|Overall Study|Withdrawal by Subject|1|||
33550329|NCT01033942|101913614|FG002|Overall Study|Withdrawal by Subject|1|||
33550330|NCT01033942|101913612|FG000|Overall Study|Lost to Follow-up|1|||
33550331|NCT01033942|101913613|FG001|Overall Study|Lost to Follow-up|0|||
33550332|NCT01033942|101913614|FG002|Overall Study|Lost to Follow-up|0|||
33550333|NCT01033942|101913612|FG000|Overall Study|Enrolled in Extension Study|0|||
33550334|NCT01033942|101913613|FG001|Overall Study|Enrolled in Extension Study|3|||
33550335|NCT01033942|101913614|FG002|Overall Study|Enrolled in Extension Study|0|||
33550336|NCT04073407|101913615|FG000|Part 1|Withdrawal by Subject|1|||
33550337|NCT04073407|101913616|FG001|Part 1|Withdrawal by Subject|0|||
33618340|NCT02737475|102151508|FG000|Overall Study|Participant withdrew consent|0|||
33550338|NCT04073407|101913615|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
33550339|NCT04073407|101913616|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
33550340|NCT04073407|101913615|FG000|Part 2|Withdrawal by Subject|0|||
33550341|NCT04073407|101913616|FG001|Part 2|Withdrawal by Subject|1|||
33550342|NCT01198548|101913623|FG000|Overall Study|Disease Progression|9|||
33550343|NCT01198548|101913623|FG000|Overall Study|Administrative Decision|1|||
33216892|NCT00754338|100692218|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
33350142|NCT02764541|101167643|FG002|Overall Study|Insurance reasons|0|||
33550344|NCT03147287|101913624|FG000|Overall Study|Randomized Not Treated|2|||
33550345|NCT03147287|101913625|FG001|Overall Study|Randomized Not Treated|1|||
33550346|NCT03147287|101913626|FG002|Overall Study|Randomized Not Treated|1|||
33550347|NCT03147287|101913624|FG000|Overall Study|Progressive Disease RECIST|31|||
33550348|NCT03147287|101913625|FG001|Overall Study|Progressive Disease RECIST|72|||
33550349|NCT03147287|101913626|FG002|Overall Study|Progressive Disease RECIST|32|||
33550350|NCT03147287|101913624|FG000|Overall Study|Progressive Disease not RECIST|13|||
33550351|NCT03147287|101913625|FG001|Overall Study|Progressive Disease not RECIST|21|||
33350143|NCT02764541|101167644|FG003|Overall Study|Insurance reasons|0|||
33550352|NCT03147287|101913626|FG002|Overall Study|Progressive Disease not RECIST|13|||
33550353|NCT03147287|101913624|FG000|Overall Study|Physician Decision|1|||
33550354|NCT03147287|101913625|FG001|Overall Study|Physician Decision|2|||
33550355|NCT03147287|101913626|FG002|Overall Study|Physician Decision|1|||
33550356|NCT03147287|101913624|FG000|Overall Study|Intercurrent illness|0|||
33550357|NCT03147287|101913625|FG001|Overall Study|Intercurrent illness|1|||
33550358|NCT03147287|101913626|FG002|Overall Study|Intercurrent illness|0|||
33550359|NCT03147287|101913624|FG000|Overall Study|Withdrawal by Subject|2|||
33550360|NCT03147287|101913625|FG001|Overall Study|Withdrawal by Subject|3|||
33550361|NCT03147287|101913626|FG002|Overall Study|Withdrawal by Subject|2|||
33550362|NCT03147287|101913624|FG000|Overall Study|Patient Non-Compliance|0|||
33550363|NCT03147287|101913625|FG001|Overall Study|Patient Non-Compliance|2|||
33550364|NCT03147287|101913626|FG002|Overall Study|Patient Non-Compliance|0|||
33550365|NCT03147287|101913624|FG000|Overall Study|Patient moved|0|||
33550366|NCT03147287|101913625|FG001|Overall Study|Patient moved|1|||
33550367|NCT03147287|101913626|FG002|Overall Study|Patient moved|0|||
33550368|NCT03147287|101913624|FG000|Overall Study|Arm A crossover without PD|1|||
33550369|NCT03147287|101913625|FG001|Overall Study|Arm A crossover without PD|0|||
33550370|NCT03147287|101913626|FG002|Overall Study|Arm A crossover without PD|0|||
33550371|NCT03147287|101913624|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
33550372|NCT03147287|101913625|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
33550373|NCT03147287|101913626|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
33550374|NCT00294398|101913627|FG000|Overall Study|Lost to Follow-up|21|||
33550375|NCT00294398|101913628|FG001|Overall Study|Lost to Follow-up|26|||
33550376|NCT02097277|101913629|FG000|Overall Study|Subject no longer meets study criteria|0|||
33550377|NCT02097277|101913630|FG001|Overall Study|Subject no longer meets study criteria|1|||
33550378|NCT02097277|101913631|FG002|Overall Study|Subject no longer meets study criteria|0|||
33550379|NCT02097277|101913632|FG003|Overall Study|Subject no longer meets study criteria|1|||
33550380|NCT02097277|101913633|FG004|Overall Study|Subject no longer meets study criteria|0|||
33550381|NCT02097277|101913629|FG000|Overall Study|Subject request to discontinue treatment|0|||
33550382|NCT02097277|101913630|FG001|Overall Study|Subject request to discontinue treatment|0|||
33550383|NCT02097277|101913631|FG002|Overall Study|Subject request to discontinue treatment|0|||
33550384|NCT02097277|101913632|FG003|Overall Study|Subject request to discontinue treatment|0|||
33550385|NCT02097277|101913633|FG004|Overall Study|Subject request to discontinue treatment|1|||
33550386|NCT02097277|101913629|FG000|Overall Study|Lost to Follow-up|0|||
33550387|NCT02097277|101913630|FG001|Overall Study|Lost to Follow-up|1|||
33216893|NCT00754338|100692219|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
33216894|NCT00754338|100692220|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
33216895|NCT00754338|100692221|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
33350144|NCT02764541|101167645|FG004|Overall Study|Insurance reasons|0|||
33350145|NCT02764541|101167646|FG005|Overall Study|Insurance reasons|0|||
33350146|NCT02764541|101167647|FG006|Overall Study|Insurance reasons|1|||
33350147|NCT02764541|101167648|FG007|Overall Study|Insurance reasons|0|||
33350148|NCT02502864|101167658|FG000|Overall Study|Withdrawal by Subject|1|||
33350149|NCT02159807|101167659|FG000|Overall Study|Adverse Event|0|||
33350150|NCT02159807|101167660|FG001|Overall Study|Adverse Event|0|||
33350151|NCT02159807|101167661|FG002|Overall Study|Adverse Event|1|||
33350152|NCT02159807|101167659|FG000|Overall Study|No CSF|1|||
33350153|NCT02159807|101167660|FG001|Overall Study|No CSF|1|||
33350154|NCT02159807|101167661|FG002|Overall Study|No CSF|1|||
33350155|NCT02159807|101167659|FG000|Overall Study|elevated blood pressure|0|||
33350156|NCT02159807|101167660|FG001|Overall Study|elevated blood pressure|0|||
33350157|NCT02159807|101167661|FG002|Overall Study|elevated blood pressure|1|||
33350158|NCT01268293|101167666|FG000|Overall Study|Disease progression|7|||
33550388|NCT02097277|101913631|FG002|Overall Study|Lost to Follow-up|1|||
33550389|NCT02097277|101913632|FG003|Overall Study|Lost to Follow-up|0|||
33618341|NCT02737475|102151509|FG001|Overall Study|Participant withdrew consent|0|||
33350159|NCT01268293|101167666|FG000|Overall Study|Adverse Event|1|||
33216896|NCT00754338|100692218|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
33216897|NCT00754338|100692219|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
33216898|NCT00754338|100692220|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
33216899|NCT00754338|100692221|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
33216900|NCT00441701|100692222|FG000|Overall Study|Adverse Event|3|||
33216901|NCT00441701|100692223|FG001|Overall Study|Adverse Event|2|||
33216902|NCT00441701|100692224|FG002|Overall Study|Adverse Event|1|||
33216903|NCT00441701|100692225|FG003|Overall Study|Adverse Event|0|||
33216904|NCT00441701|100692226|FG004|Overall Study|Adverse Event|2|||
33216905|NCT00441701|100692227|FG005|Overall Study|Adverse Event|2|||
33216906|NCT00441701|100692228|FG006|Overall Study|Adverse Event|0|||
33216907|NCT00441701|100692229|FG007|Overall Study|Adverse Event|0|||
33216908|NCT00441701|100692230|FG008|Overall Study|Adverse Event|0|||
33216909|NCT00441701|100692231|FG009|Overall Study|Adverse Event|0|||
33216910|NCT00441701|100692222|FG000|Overall Study|Lack of Efficacy|2|||
33216911|NCT00441701|100692223|FG001|Overall Study|Lack of Efficacy|0|||
33350160|NCT01268293|101167666|FG000|Overall Study|Subject choice|1|||
33618342|NCT02737475|102151510|FG002|Overall Study|Participant withdrew consent|0|||
33618343|NCT02737475|102151511|FG003|Overall Study|Participant withdrew consent|0|||
33618344|NCT02737475|102151512|FG004|Overall Study|Participant withdrew consent|0|||
33350161|NCT02959814|101167672|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
33350162|NCT02959814|101167672|FG000|Overall Study|Excluded based on anatomical criteria|2|||
33350163|NCT02959814|101167672|FG000|Overall Study|Protocol Violation|7|||
33350164|NCT02959814|101167672|FG000|Overall Study|FFR not measured|2|||
33350165|NCT02959814|101167672|FG000|Overall Study|In-procedure QFR not computed|6|||
33350166|NCT02959814|101167672|FG000|Overall Study|Excluded by FFR core-lab|24|||
33350167|NCT00189462|101167673|FG000|Overall Study|Lack of Efficacy|5|||
33350168|NCT00189462|101167674|FG001|Overall Study|Lack of Efficacy|1|||
33350169|NCT00189462|101167673|FG000|Overall Study|Lost to Follow-up|18|||
33350170|NCT00189462|101167674|FG001|Overall Study|Lost to Follow-up|20|||
33350171|NCT02251912|101167675|FG000|Overall Study|Withdrawal by Subject|2|||
33350172|NCT02251912|101167676|FG001|Overall Study|Withdrawal by Subject|3|||
33350173|NCT02251912|101167675|FG000|Overall Study|Adverse Event|0|||
33350174|NCT02251912|101167676|FG001|Overall Study|Adverse Event|2|||
33411012|NCT05182840|101397018|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
33550390|NCT02097277|101913633|FG004|Overall Study|Lost to Follow-up|0|||
33550391|NCT02097277|101913629|FG000|Overall Study|Withdrawal by Subject|2|||
33550392|NCT02097277|101913630|FG001|Overall Study|Withdrawal by Subject|1|||
33550393|NCT02097277|101913631|FG002|Overall Study|Withdrawal by Subject|0|||
33550394|NCT02097277|101913632|FG003|Overall Study|Withdrawal by Subject|1|||
33618345|NCT02737475|102151513|FG005|Overall Study|Participant withdrew consent|2|||
33618346|NCT02737475|102151514|FG006|Overall Study|Participant withdrew consent|0|||
33618347|NCT02737475|102151515|FG007|Overall Study|Participant withdrew consent|0|||
33618348|NCT02737475|102151516|FG008|Overall Study|Participant withdrew consent|0|||
33618349|NCT02737475|102151517|FG009|Overall Study|Participant withdrew consent|0|||
33550395|NCT02097277|101913633|FG004|Overall Study|Withdrawal by Subject|0|||
33550396|NCT02097277|101913629|FG000|Overall Study|Adverse Event|0|||
33550397|NCT02097277|101913630|FG001|Overall Study|Adverse Event|0|||
33550398|NCT02097277|101913631|FG002|Overall Study|Adverse Event|1|||
33550399|NCT02097277|101913632|FG003|Overall Study|Adverse Event|2|||
33550400|NCT02097277|101913633|FG004|Overall Study|Adverse Event|0|||
33550401|NCT00105508|101913634|FG000|Overall Study|Prephase Dropout|1|||
33550402|NCT00105508|101913635|FG001|Overall Study|Prephase Dropout|0|||
33550403|NCT00105508|101913634|FG000|Overall Study|Adverse Event|16|||
33550404|NCT00105508|101913635|FG001|Overall Study|Adverse Event|19|||
33550405|NCT00105508|101913634|FG000|Overall Study|Insufficient Efficacy|1|||
33550406|NCT00105508|101913635|FG001|Overall Study|Insufficient Efficacy|0|||
33550407|NCT00105508|101913634|FG000|Overall Study|Withdrawal by Subject|10|||
33550408|NCT00105508|101913635|FG001|Overall Study|Withdrawal by Subject|6|||
33550409|NCT00105508|101913634|FG000|Overall Study|Lost to Follow-up|3|||
33550410|NCT00105508|101913635|FG001|Overall Study|Lost to Follow-up|0|||
33550411|NCT00105508|101913634|FG000|Overall Study|Protocol Violation|1|||
33618350|NCT02737475|102151518|FG010|Overall Study|Participant withdrew consent|0|||
33216912|NCT00441701|100692224|FG002|Overall Study|Lack of Efficacy|2|||
33216913|NCT00441701|100692225|FG003|Overall Study|Lack of Efficacy|2|||
33216914|NCT00441701|100692226|FG004|Overall Study|Lack of Efficacy|0|||
33216915|NCT00441701|100692227|FG005|Overall Study|Lack of Efficacy|1|||
33350175|NCT00420511|101167677|FG000|Overall Study|Adverse Event|1|||
33350176|NCT00420511|101167678|FG001|Overall Study|Adverse Event|1|||
33350177|NCT00420511|101167677|FG000|Overall Study|Lost to Follow-up|1|||
33350178|NCT00420511|101167678|FG001|Overall Study|Lost to Follow-up|0|||
33216916|NCT00441701|100692228|FG006|Overall Study|Lack of Efficacy|0|||
33216917|NCT00441701|100692229|FG007|Overall Study|Lack of Efficacy|0|||
33216918|NCT00441701|100692230|FG008|Overall Study|Lack of Efficacy|0|||
33350179|NCT00393718|101167679|FG000|Overall Study|Adverse Event|20|||
33350180|NCT00393718|101167680|FG001|Overall Study|Adverse Event|8|||
33411013|NCT05182840|101397019|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
33411014|NCT05182840|101397020|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
33411015|NCT05182840|101397021|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
33411016|NCT05182840|101397022|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
33411017|NCT05182840|101397013|FG000|Treatment Period|Reason missing|0|||
33411018|NCT05182840|101397014|FG001|Treatment Period|Reason missing|0|||
33411019|NCT05182840|101397015|FG002|Treatment Period|Reason missing|1|||
33411020|NCT05182840|101397016|FG003|Treatment Period|Reason missing|0|||
33411021|NCT05182840|101397017|FG004|Treatment Period|Reason missing|0|||
33550412|NCT00105508|101913635|FG001|Overall Study|Protocol Violation|2|||
33550413|NCT00105508|101913634|FG000|Overall Study|Other|8|||
33216919|NCT00441701|100692231|FG009|Overall Study|Lack of Efficacy|0|||
33216920|NCT00441701|100692222|FG000|Overall Study|Withdrawal by Subject|0|||
33216921|NCT00441701|100692223|FG001|Overall Study|Withdrawal by Subject|2|||
33216922|NCT00441701|100692224|FG002|Overall Study|Withdrawal by Subject|1|||
33216923|NCT00441701|100692225|FG003|Overall Study|Withdrawal by Subject|1|||
33216924|NCT00441701|100692226|FG004|Overall Study|Withdrawal by Subject|0|||
33216925|NCT00441701|100692227|FG005|Overall Study|Withdrawal by Subject|0|||
33216926|NCT00441701|100692228|FG006|Overall Study|Withdrawal by Subject|0|||
33216927|NCT00441701|100692229|FG007|Overall Study|Withdrawal by Subject|0|||
33216928|NCT00441701|100692230|FG008|Overall Study|Withdrawal by Subject|0|||
33216929|NCT00441701|100692231|FG009|Overall Study|Withdrawal by Subject|0|||
33550414|NCT00105508|101913635|FG001|Overall Study|Other|9|||
33550415|NCT00004859|101913636|FG000|Overall Study|Lack of Efficacy|43|||
33550416|NCT00004859|101913637|FG001|Overall Study|Lack of Efficacy|113|||
33550417|NCT00004859|101913636|FG000|Overall Study|Adverse Event|31|||
33550418|NCT00004859|101913637|FG001|Overall Study|Adverse Event|93|||
33550419|NCT00004859|101913636|FG000|Overall Study|Death|5|||
33550420|NCT00004859|101913637|FG001|Overall Study|Death|5|||
33550421|NCT00004859|101913636|FG000|Overall Study|Withdrawal by Subject|7|||
33550422|NCT00004859|101913637|FG001|Overall Study|Withdrawal by Subject|33|||
33550423|NCT00004859|101913636|FG000|Overall Study|Protocol Violation|2|||
33550424|NCT00004859|101913637|FG001|Overall Study|Protocol Violation|2|||
33550425|NCT00004859|101913636|FG000|Overall Study|other disease|0|||
33550426|NCT00004859|101913637|FG001|Overall Study|other disease|3|||
33550427|NCT00004859|101913636|FG000|Overall Study|error|3|||
33550428|NCT00004859|101913637|FG001|Overall Study|error|1|||
33550429|NCT00004859|101913636|FG000|Overall Study|missing data|14|||
33550430|NCT00004859|101913637|FG001|Overall Study|missing data|11|||
33550431|NCT00004859|101913636|FG000|Overall Study|Other|13|||
33618351|NCT02737475|102151519|FG011|Overall Study|Participant withdrew consent|0|||
33216930|NCT01696981|100692232|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
33350181|NCT00393718|101167679|FG000|Overall Study|Protocol Violation|1|||
33350182|NCT00393718|101167680|FG001|Overall Study|Protocol Violation|2|||
33350183|NCT00393718|101167679|FG000|Overall Study|Lack of Efficacy|10|||
33350184|NCT00393718|101167680|FG001|Overall Study|Lack of Efficacy|9|||
33350185|NCT00393718|101167679|FG000|Overall Study|Hypoglycaemia|3|||
33350186|NCT00393718|101167680|FG001|Overall Study|Hypoglycaemia|2|||
33350187|NCT00393718|101167679|FG000|Overall Study|Subject decision|5|||
33350188|NCT00393718|101167680|FG001|Overall Study|Subject decision|0|||
33350189|NCT00393718|101167679|FG000|Overall Study|Withdrawal of consent|2|||
33350190|NCT00393718|101167680|FG001|Overall Study|Withdrawal of consent|1|||
33350191|NCT00393718|101167679|FG000|Overall Study|Missed measurement|1|||
33350192|NCT00393718|101167680|FG001|Overall Study|Missed measurement|0|||
33350193|NCT00393718|101167679|FG000|Overall Study|Move|1|||
33350194|NCT00393718|101167680|FG001|Overall Study|Move|0|||
33350195|NCT00755079|101167681|FG000|Overall Study|Lost to Follow-up|1|||
33350196|NCT00755079|101167682|FG001|Overall Study|Lost to Follow-up|3|||
33350197|NCT00755079|101167681|FG000|Overall Study|Adverse Event|0|||
33350198|NCT00755079|101167682|FG001|Overall Study|Adverse Event|1|||
33350199|NCT00755079|101167681|FG000|Overall Study|Withdrawal by Subject|0|||
33350200|NCT00755079|101167682|FG001|Overall Study|Withdrawal by Subject|2|||
33550432|NCT00004859|101913637|FG001|Overall Study|Other|21|||
33550433|NCT01105130|101913638|FG000|Overall Study|Withdrawal by Subject|4|||
33550434|NCT01105130|101913639|FG001|Overall Study|Withdrawal by Subject|6|||
33550435|NCT01105130|101913640|FG002|Overall Study|Withdrawal by Subject|2|||
33618352|NCT02737475|102151520|FG012|Overall Study|Participant withdrew consent|0|||
33216931|NCT01696981|100692233|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
33216932|NCT01696981|100692232|FG000|Overall Study|Died Before Randomization|3|||
33216933|NCT01696981|100692233|FG001|Overall Study|Died Before Randomization|8|||
33216934|NCT01696981|100692232|FG000|Overall Study|Died Before ASU (Control)|278|||
33216935|NCT01696981|100692233|FG001|Overall Study|Died Before ASU (Control)|0|||
33350201|NCT02965378|101167685|FG000|Overall Study|Progression|16|||
33550436|NCT01105130|101913638|FG000|Overall Study|Never Started|2|||
33550437|NCT01105130|101913639|FG001|Overall Study|Never Started|2|||
33350202|NCT02965378|101167686|FG001|Overall Study|Progression|4|||
33550438|NCT01105130|101913640|FG002|Overall Study|Never Started|4|||
33550439|NCT01105130|101913638|FG000|Overall Study|Toxicity|1|||
33550440|NCT01105130|101913639|FG001|Overall Study|Toxicity|3|||
33550441|NCT01105130|101913640|FG002|Overall Study|Toxicity|2|||
33550442|NCT01105130|101913638|FG000|Overall Study|Multiple Reasons|3|||
33550443|NCT01105130|101913639|FG001|Overall Study|Multiple Reasons|0|||
33550444|NCT01105130|101913640|FG002|Overall Study|Multiple Reasons|2|||
33550445|NCT02989389|101913641|FG000|Period 1|Lost to Follow-up|0|||
33550446|NCT02989389|101913642|FG001|Period 1|Lost to Follow-up|1|||
33618353|NCT02737475|102151521|FG013|Overall Study|Participant withdrew consent|0|||
33618354|NCT02737475|102151522|FG014|Overall Study|Participant withdrew consent|1|||
33618355|NCT02737475|102151523|FG015|Overall Study|Participant withdrew consent|0|||
33618356|NCT02737475|102151524|FG016|Overall Study|Participant withdrew consent|0|||
33618357|NCT02737475|102151525|FG017|Overall Study|Participant withdrew consent|2|||
33618358|NCT02737475|102151526|FG018|Overall Study|Participant withdrew consent|1|||
33618359|NCT02737475|102151527|FG019|Overall Study|Participant withdrew consent|0|||
33618360|NCT02737475|102151528|FG020|Overall Study|Participant withdrew consent|2|||
33618361|NCT02737475|102151529|FG021|Overall Study|Participant withdrew consent|0|||
33618362|NCT02737475|102151530|FG022|Overall Study|Participant withdrew consent|0|||
33618363|NCT02737475|102151531|FG023|Overall Study|Participant withdrew consent|0|||
33618364|NCT02737475|102151532|FG024|Overall Study|Participant withdrew consent|0|||
33618365|NCT02737475|102151533|FG025|Overall Study|Participant withdrew consent|0|||
33350203|NCT02965378|101167685|FG000|Overall Study|Adverse Event|5|||
33350204|NCT02965378|101167686|FG001|Overall Study|Adverse Event|2|||
33350205|NCT02965378|101167685|FG000|Overall Study|Death|2|||
33550447|NCT02989389|101913643|FG002|Period 1|Lost to Follow-up|0|||
33550448|NCT02989389|101913644|FG003|Period 1|Lost to Follow-up|0|||
33550449|NCT02989389|101913645|FG004|Period 1|Lost to Follow-up|0|||
33550450|NCT02989389|101913646|FG005|Period 1|Lost to Follow-up|0|||
33618366|NCT02737475|102151534|FG026|Overall Study|Participant withdrew consent|0|||
33618367|NCT02737475|102151508|FG000|Overall Study|Lost to Follow-up|0|||
33350206|NCT02965378|101167686|FG001|Overall Study|Death|0|||
33350207|NCT02965378|101167685|FG000|Overall Study|Refusal|2|||
33350208|NCT02965378|101167686|FG001|Overall Study|Refusal|1|||
33411022|NCT05182840|101397018|FG005|Treatment Period|Reason missing|0|||
33350209|NCT02965378|101167685|FG000|Overall Study|Not protocol specified|0|||
33350210|NCT02965378|101167686|FG001|Overall Study|Not protocol specified|2|||
33350211|NCT01111604|101167687|FG000|Overall Study|Lost to Follow-up|0|||
33350212|NCT01111604|101167688|FG001|Overall Study|Lost to Follow-up|0|||
33350213|NCT01111604|101167689|FG002|Overall Study|Lost to Follow-up|1|||
33350214|NCT01111604|101167687|FG000|Overall Study|Withdrew Consent|3|||
33350215|NCT01111604|101167688|FG001|Overall Study|Withdrew Consent|0|||
33350216|NCT01111604|101167689|FG002|Overall Study|Withdrew Consent|2|||
33350217|NCT01111604|101167687|FG000|Overall Study|Withdrawal by Subject|2|||
33350218|NCT01111604|101167688|FG001|Overall Study|Withdrawal by Subject|0|||
33350219|NCT01111604|101167689|FG002|Overall Study|Withdrawal by Subject|0|||
33350220|NCT01111604|101167687|FG000|Overall Study|Death|1|||
33350221|NCT01111604|101167688|FG001|Overall Study|Death|0|||
33350222|NCT01111604|101167689|FG002|Overall Study|Death|0|||
33350223|NCT01111604|101167687|FG000|Overall Study|Met Exclusion Criteria|2|||
33350224|NCT01111604|101167688|FG001|Overall Study|Met Exclusion Criteria|0|||
33350225|NCT01111604|101167689|FG002|Overall Study|Met Exclusion Criteria|0|||
33350226|NCT01169779|101167690|FG000|Overall Study|Adverse Event|3|||
33350227|NCT01169779|101167691|FG001|Overall Study|Adverse Event|11|||
33350228|NCT01169779|101167690|FG000|Overall Study|Lack of Efficacy|1|||
33350229|NCT01169779|101167691|FG001|Overall Study|Lack of Efficacy|0|||
33350230|NCT01169779|101167690|FG000|Overall Study|Protocol Violation|1|||
33350231|NCT01169779|101167691|FG001|Overall Study|Protocol Violation|1|||
33350232|NCT01169779|101167690|FG000|Overall Study|Withdrawal by Subject|3|||
33350233|NCT01169779|101167691|FG001|Overall Study|Withdrawal by Subject|2|||
33350234|NCT01169779|101167690|FG000|Overall Study|Familial and personal reasons|3|||
33350235|NCT01169779|101167691|FG001|Overall Study|Familial and personal reasons|3|||
33618368|NCT02737475|102151509|FG001|Overall Study|Lost to Follow-up|0|||
33350236|NCT01243268|101167692|FG000|Overall Study|Lost to Follow-up|4|||
33350237|NCT01243268|101167692|FG000|Overall Study|Protocol Violation|51|||
33350238|NCT01243268|101167692|FG000|Overall Study|Deviation with contract date|7|||
33350239|NCT01243268|101167692|FG000|Overall Study|Duplicate subject|2|||
33350240|NCT00548548|101167698|FG000|Overall Study|Death|345|||
33350241|NCT00548548|101167699|FG001|Overall Study|Death|348|||
33350242|NCT00548548|101167698|FG000|Overall Study|Lost to Follow-up|17|||
33350243|NCT00548548|101167699|FG001|Overall Study|Lost to Follow-up|18|||
33350244|NCT02586805|101167708|FG000|Overall Study|Withdrawal by Subject|3|||
33350245|NCT02586805|101167709|FG001|Overall Study|Withdrawal by Subject|1|||
33350246|NCT02586805|101167710|FG002|Overall Study|Withdrawal by Subject|1|||
33618369|NCT02737475|102151510|FG002|Overall Study|Lost to Follow-up|0|||
33350247|NCT02586805|101167711|FG003|Overall Study|Withdrawal by Subject|2|||
33350248|NCT02586805|101167708|FG000|Overall Study|Adverse Event|2|||
33350249|NCT02586805|101167709|FG001|Overall Study|Adverse Event|0|||
33350250|NCT02586805|101167710|FG002|Overall Study|Adverse Event|1|||
33350251|NCT02586805|101167711|FG003|Overall Study|Adverse Event|0|||
33350252|NCT02586805|101167708|FG000|Overall Study|Lost to Follow-up|0|||
33350253|NCT02586805|101167709|FG001|Overall Study|Lost to Follow-up|0|||
33350254|NCT02586805|101167710|FG002|Overall Study|Lost to Follow-up|1|||
33350255|NCT02586805|101167711|FG003|Overall Study|Lost to Follow-up|0|||
33350256|NCT02586805|101167708|FG000|Overall Study|Physician Decision|1|||
33350257|NCT02586805|101167709|FG001|Overall Study|Physician Decision|0|||
33350258|NCT02586805|101167710|FG002|Overall Study|Physician Decision|0|||
33350259|NCT02586805|101167711|FG003|Overall Study|Physician Decision|0|||
33350260|NCT00808444|101167712|FG000|Overall Study|Withdrawal by Subject|1|||
33350261|NCT00808444|101167713|FG001|Overall Study|Withdrawal by Subject|0|||
33350262|NCT00808444|101167712|FG000|Overall Study|Lost to Follow-up|0|||
33350263|NCT00808444|101167713|FG001|Overall Study|Lost to Follow-up|1|||
33350264|NCT00382967|101167714|FG000|Overall Study|Protocol Violation|1|||
33350265|NCT00382967|101167715|FG001|Overall Study|Protocol Violation|1|||
33350266|NCT01889602|101167722|FG000|First Intervention|Adverse Event|1|||
33350267|NCT01889602|101167723|FG001|First Intervention|Adverse Event|1|||
33350268|NCT01889602|101167724|FG002|First Intervention|Adverse Event|1|||
33411023|NCT05182840|101397019|FG006|Treatment Period|Reason missing|0|||
33411024|NCT05182840|101397020|FG007|Treatment Period|Reason missing|0|||
33411025|NCT05182840|101397021|FG008|Treatment Period|Reason missing|0|||
33411026|NCT05182840|101397022|FG009|Treatment Period|Reason missing|0|||
33550451|NCT02989389|101913647|FG006|Period 1|Lost to Follow-up|0|||
33550452|NCT02989389|101913648|FG007|Period 1|Lost to Follow-up|0|||
33550453|NCT02989389|101913649|FG008|Period 1|Lost to Follow-up|0|||
33550454|NCT02989389|101913650|FG009|Period 1|Lost to Follow-up|0|||
33550455|NCT02989389|101913641|FG000|Period 1|Physician Decision|0|||
33550456|NCT02989389|101913642|FG001|Period 1|Physician Decision|0|||
33550457|NCT02989389|101913643|FG002|Period 1|Physician Decision|0|||
33618370|NCT02737475|102151511|FG003|Overall Study|Lost to Follow-up|0|||
33618371|NCT02737475|102151512|FG004|Overall Study|Lost to Follow-up|0|||
33618372|NCT02737475|102151513|FG005|Overall Study|Lost to Follow-up|0|||
33550458|NCT02989389|101913644|FG003|Period 1|Physician Decision|0|||
33550459|NCT02989389|101913645|FG004|Period 1|Physician Decision|0|||
33618373|NCT02737475|102151514|FG006|Overall Study|Lost to Follow-up|0|||
33618374|NCT02737475|102151515|FG007|Overall Study|Lost to Follow-up|0|||
33550460|NCT02989389|101913646|FG005|Period 1|Physician Decision|0|||
33550461|NCT02989389|101913647|FG006|Period 1|Physician Decision|0|||
33550462|NCT02989389|101913648|FG007|Period 1|Physician Decision|0|||
33550463|NCT02989389|101913649|FG008|Period 1|Physician Decision|1|||
33550464|NCT02989389|101913650|FG009|Period 1|Physician Decision|0|||
33550465|NCT00266812|101913657|FG000|Overall Study|Disease Progression|9|||
33550466|NCT00266812|101913658|FG001|Overall Study|Disease Progression|3|||
33550467|NCT00266812|101913657|FG000|Overall Study|Death|5|||
33550468|NCT00266812|101913658|FG001|Overall Study|Death|4|||
33550469|NCT00266812|101913657|FG000|Overall Study|Adverse Event|3|||
33550470|NCT00266812|101913658|FG001|Overall Study|Adverse Event|1|||
33550471|NCT00266812|101913657|FG000|Overall Study|Protocol Violation|0|||
33550472|NCT00266812|101913658|FG001|Overall Study|Protocol Violation|1|||
33550473|NCT00266812|101913657|FG000|Overall Study|Withdrawal by Subject|0|||
33550474|NCT00266812|101913658|FG001|Overall Study|Withdrawal by Subject|2|||
33550475|NCT00266812|101913657|FG000|Overall Study|Discontinued before starting study drug|4|||
33550476|NCT00266812|101913658|FG001|Overall Study|Discontinued before starting study drug|0|||
33550477|NCT01555931|101913659|FG000|Overall Study|Lost to Follow-up|2|||
33550478|NCT01555931|101913660|FG001|Overall Study|Lost to Follow-up|5|||
33550479|NCT00790933|101913669|FG000|Overall Study|Adverse Event|94|||
33550480|NCT00790933|101913670|FG001|Overall Study|Adverse Event|119|||
33550481|NCT00790933|101913671|FG002|Overall Study|Adverse Event|65|||
33550482|NCT00790933|101913672|FG003|Overall Study|Adverse Event|5|||
33618375|NCT02737475|102151516|FG008|Overall Study|Lost to Follow-up|0|||
33618376|NCT02737475|102151517|FG009|Overall Study|Lost to Follow-up|0|||
33618377|NCT02737475|102151518|FG010|Overall Study|Lost to Follow-up|0|||
33618378|NCT02737475|102151519|FG011|Overall Study|Lost to Follow-up|0|||
33350269|NCT01889602|101167722|FG000|First Intervention|Protocol Violation|0|||
33350270|NCT01889602|101167723|FG001|First Intervention|Protocol Violation|1|||
33350271|NCT01889602|101167724|FG002|First Intervention|Protocol Violation|1|||
33350272|NCT01889602|101167722|FG000|First Intervention|Study ending|0|||
33350273|NCT01889602|101167723|FG001|First Intervention|Study ending|1|||
33350274|NCT01889602|101167724|FG002|First Intervention|Study ending|0|||
33411027|NCT05182840|101397013|FG000|Treatment Period|Other but not sponsor termination|0|||
33550483|NCT00790933|101913673|FG004|Overall Study|Adverse Event|69|||
33550484|NCT00790933|101913669|FG000|Overall Study|Protocol Violation(s)|8|||
33550485|NCT00790933|101913670|FG001|Overall Study|Protocol Violation(s)|18|||
33550486|NCT00790933|101913671|FG002|Overall Study|Protocol Violation(s)|7|||
33550487|NCT00790933|101913672|FG003|Overall Study|Protocol Violation(s)|0|||
33618379|NCT02737475|102151520|FG012|Overall Study|Lost to Follow-up|0|||
33550488|NCT00790933|101913673|FG004|Overall Study|Protocol Violation(s)|12|||
33550489|NCT00790933|101913669|FG000|Overall Study|Lack of Efficacy|192|||
33550490|NCT00790933|101913670|FG001|Overall Study|Lack of Efficacy|176|||
33550491|NCT00790933|101913671|FG002|Overall Study|Lack of Efficacy|130|||
33550492|NCT00790933|101913672|FG003|Overall Study|Lack of Efficacy|1|||
33550493|NCT00790933|101913673|FG004|Overall Study|Lack of Efficacy|121|||
33550494|NCT00790933|101913669|FG000|Overall Study|Study Terminated by Sponsor|0|||
33550495|NCT00790933|101913670|FG001|Overall Study|Study Terminated by Sponsor|0|||
33550496|NCT00790933|101913671|FG002|Overall Study|Study Terminated by Sponsor|1|||
33550497|NCT00790933|101913672|FG003|Overall Study|Study Terminated by Sponsor|0|||
33550498|NCT00790933|101913673|FG004|Overall Study|Study Terminated by Sponsor|0|||
33550499|NCT00790933|101913669|FG000|Overall Study|Withdrawal by Subject|123|||
33550500|NCT00790933|101913670|FG001|Overall Study|Withdrawal by Subject|120|||
33550501|NCT00790933|101913671|FG002|Overall Study|Withdrawal by Subject|52|||
33550502|NCT00790933|101913672|FG003|Overall Study|Withdrawal by Subject|6|||
33550503|NCT00790933|101913673|FG004|Overall Study|Withdrawal by Subject|50|||
33550504|NCT00790933|101913669|FG000|Overall Study|Lost to Follow-up|13|||
33550505|NCT00790933|101913670|FG001|Overall Study|Lost to Follow-up|31|||
33550506|NCT00790933|101913671|FG002|Overall Study|Lost to Follow-up|10|||
33550507|NCT00790933|101913672|FG003|Overall Study|Lost to Follow-up|1|||
33550508|NCT00790933|101913673|FG004|Overall Study|Lost to Follow-up|15|||
33550509|NCT00790933|101913669|FG000|Overall Study|Reason Not Specified|8|||
33550510|NCT00790933|101913670|FG001|Overall Study|Reason Not Specified|16|||
33550511|NCT00790933|101913671|FG002|Overall Study|Reason Not Specified|4|||
33550512|NCT00790933|101913672|FG003|Overall Study|Reason Not Specified|1|||
33550513|NCT00790933|101913673|FG004|Overall Study|Reason Not Specified|9|||
33550514|NCT01370538|101913678|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
33550515|NCT01370538|101913679|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
33550516|NCT01370538|101913678|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33550517|NCT01370538|101913679|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33550518|NCT01370538|101913678|FG000|Overall Study|Adverse Event|1|||
33550519|NCT01370538|101913679|FG001|Overall Study|Adverse Event|0|||
33618380|NCT02737475|102151521|FG013|Overall Study|Lost to Follow-up|0|||
33618381|NCT02737475|102151522|FG014|Overall Study|Lost to Follow-up|0|||
33618382|NCT02737475|102151523|FG015|Overall Study|Lost to Follow-up|1|||
33618383|NCT02737475|102151524|FG016|Overall Study|Lost to Follow-up|0|||
33618384|NCT02737475|102151525|FG017|Overall Study|Lost to Follow-up|0|||
33618385|NCT02737475|102151526|FG018|Overall Study|Lost to Follow-up|0|||
33618386|NCT02737475|102151527|FG019|Overall Study|Lost to Follow-up|0|||
33618387|NCT02737475|102151528|FG020|Overall Study|Lost to Follow-up|0|||
33618388|NCT02737475|102151529|FG021|Overall Study|Lost to Follow-up|0|||
33618389|NCT02737475|102151530|FG022|Overall Study|Lost to Follow-up|0|||
33618390|NCT02737475|102151531|FG023|Overall Study|Lost to Follow-up|0|||
33618391|NCT02737475|102151532|FG024|Overall Study|Lost to Follow-up|0|||
33618392|NCT02737475|102151533|FG025|Overall Study|Lost to Follow-up|0|||
33618393|NCT02737475|102151534|FG026|Overall Study|Lost to Follow-up|0|||
33618394|NCT02737475|102151508|FG000|Overall Study|Disease Progression|0|||
33618395|NCT02737475|102151509|FG001|Overall Study|Disease Progression|0|||
33618396|NCT02737475|102151510|FG002|Overall Study|Disease Progression|0|||
33618397|NCT02737475|102151511|FG003|Overall Study|Disease Progression|0|||
33618398|NCT02737475|102151512|FG004|Overall Study|Disease Progression|0|||
33618399|NCT02737475|102151513|FG005|Overall Study|Disease Progression|0|||
33618400|NCT02737475|102151514|FG006|Overall Study|Disease Progression|0|||
33618401|NCT02737475|102151515|FG007|Overall Study|Disease Progression|0|||
33618402|NCT02737475|102151516|FG008|Overall Study|Disease Progression|0|||
33618403|NCT02737475|102151517|FG009|Overall Study|Disease Progression|0|||
33618404|NCT02737475|102151518|FG010|Overall Study|Disease Progression|0|||
33618405|NCT02737475|102151519|FG011|Overall Study|Disease Progression|0|||
33618406|NCT02737475|102151520|FG012|Overall Study|Disease Progression|0|||
33618407|NCT02737475|102151521|FG013|Overall Study|Disease Progression|0|||
33618408|NCT02737475|102151522|FG014|Overall Study|Disease Progression|0|||
33618409|NCT02737475|102151523|FG015|Overall Study|Disease Progression|0|||
33618410|NCT02737475|102151524|FG016|Overall Study|Disease Progression|0|||
33550520|NCT01370538|101913678|FG000|Overall Study|Protocol Violation|8|||
33550521|NCT01370538|101913679|FG001|Overall Study|Protocol Violation|5|||
33550522|NCT01370538|101913678|FG000|Overall Study|Development of study specific withdrawal|1|||
33550523|NCT01370538|101913679|FG001|Overall Study|Development of study specific withdrawal|1|||
33550524|NCT01370538|101913678|FG000|Overall Study|Lost to follow up|6|||
33550525|NCT01370538|101913679|FG001|Overall Study|Lost to follow up|10|||
33618411|NCT02737475|102151525|FG017|Overall Study|Disease Progression|0|||
33618412|NCT02737475|102151526|FG018|Overall Study|Disease Progression|0|||
33618413|NCT02737475|102151527|FG019|Overall Study|Disease Progression|0|||
33618414|NCT02737475|102151528|FG020|Overall Study|Disease Progression|0|||
33618415|NCT02737475|102151529|FG021|Overall Study|Disease Progression|0|||
33618416|NCT02737475|102151530|FG022|Overall Study|Disease Progression|0|||
33618417|NCT02737475|102151531|FG023|Overall Study|Disease Progression|0|||
33618418|NCT02737475|102151532|FG024|Overall Study|Disease Progression|0|||
33618419|NCT02737475|102151533|FG025|Overall Study|Disease Progression|0|||
33618420|NCT02737475|102151534|FG026|Overall Study|Disease Progression|1|||
33550526|NCT01174459|101913680|FG000|Overall Study|case report form (CRF) not collected|5|||
33550527|NCT03033901|101913681|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
33550528|NCT03033901|101913681|FG000|Overall Study|Refused PSG|23|||
33550529|NCT03033901|101913681|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
33550530|NCT03033901|101913681|FG000|Overall Study|Missing Oximetry Data|3|||
33550531|NCT02487199|101913684|FG000|Overall Study|Withdrew Consent|0|||
33550532|NCT02487199|101913685|FG001|Overall Study|Withdrew Consent|1|||
33550533|NCT01479530|101913690|FG000|Overall Study|Adverse Event|5|||
33550534|NCT01479530|101913691|FG001|Overall Study|Adverse Event|6|||
33550535|NCT01479530|101913690|FG000|Overall Study|Lack of Efficacy|0|||
33550536|NCT01479530|101913691|FG001|Overall Study|Lack of Efficacy|1|||
33550537|NCT01479530|101913690|FG000|Overall Study|Protocol Violation|2|||
33550538|NCT01479530|101913691|FG001|Overall Study|Protocol Violation|3|||
33550539|NCT01479530|101913690|FG000|Overall Study|Withdrawal of Consent|3|||
33550540|NCT01479530|101913691|FG001|Overall Study|Withdrawal of Consent|2|||
33550541|NCT00762788|101913692|FG000|Overall Study|Lost to Follow-up|26|||
33550542|NCT00762788|101913693|FG001|Overall Study|Lost to Follow-up|37|||
33550543|NCT00762788|101913694|FG002|Overall Study|Lost to Follow-up|21|||
33550544|NCT00762788|101913695|FG003|Overall Study|Lost to Follow-up|26|||
33550545|NCT00762788|101913696|FG004|Overall Study|Lost to Follow-up|13|||
33550546|NCT00762788|101913697|FG005|Overall Study|Lost to Follow-up|21|||
33550547|NCT00694122|101913698|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
33550548|NCT00694122|101913699|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
33550549|NCT00694122|101913698|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
33550550|NCT00694122|101913699|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
33550551|NCT00694122|101913698|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
33550552|NCT00694122|101913699|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
33550553|NCT03718000|101913700|FG000|Overall Study|Relocation|2|||
33550554|NCT03718000|101913701|FG001|Overall Study|Relocation|4|||
33550555|NCT03718000|101913700|FG000|Overall Study|Pregnancy|0|||
33550556|NCT03718000|101913701|FG001|Overall Study|Pregnancy|1|||
33550557|NCT01200355|101913709|FG000|Overall Study|Death|7|||
33550558|NCT01200355|101913710|FG001|Overall Study|Death|2|||
33550559|NCT04518410|101913717|FG000|Overall Study|Lost to Follow-up|1|||
33550560|NCT04518410|101913718|FG001|Overall Study|Lost to Follow-up|1|||
33550561|NCT04518410|101913719|FG002|Overall Study|Lost to Follow-up|8|||
33550562|NCT04518410|101913720|FG003|Overall Study|Lost to Follow-up|5|||
33550563|NCT04518410|101913721|FG004|Overall Study|Lost to Follow-up|92|||
33550564|NCT04518410|101913722|FG005|Overall Study|Lost to Follow-up|25|||
33550565|NCT04518410|101913723|FG006|Overall Study|Lost to Follow-up|25|||
33550566|NCT04518410|101913724|FG007|Overall Study|Lost to Follow-up|3|||
33550567|NCT04518410|101913725|FG008|Overall Study|Lost to Follow-up|2|||
33550568|NCT04518410|101913726|FG009|Overall Study|Lost to Follow-up|13|||
33550569|NCT04518410|101913727|FG010|Overall Study|Lost to Follow-up|9|||
33550570|NCT04518410|101913728|FG011|Overall Study|Lost to Follow-up|13|||
33550571|NCT04518410|101913729|FG012|Overall Study|Lost to Follow-up|9|||
33550572|NCT04518410|101913730|FG013|Overall Study|Lost to Follow-up|13|||
33550573|NCT04518410|101913731|FG014|Overall Study|Lost to Follow-up|8|||
33550574|NCT04518410|101913732|FG015|Overall Study|Lost to Follow-up|10|||
33550575|NCT04518410|101913733|FG016|Overall Study|Lost to Follow-up|6|||
33550576|NCT04518410|101913734|FG017|Overall Study|Lost to Follow-up|13|||
33550577|NCT04518410|101913735|FG018|Overall Study|Lost to Follow-up|21|||
33550578|NCT04518410|101913736|FG019|Overall Study|Lost to Follow-up|6|||
33550579|NCT04518410|101913737|FG020|Overall Study|Lost to Follow-up|7|||
33550580|NCT04518410|101913738|FG021|Overall Study|Lost to Follow-up|21|||
33550581|NCT04518410|101913739|FG022|Overall Study|Lost to Follow-up|1|||
33550582|NCT04518410|101913740|FG023|Overall Study|Lost to Follow-up|7|||
33550583|NCT04518410|101913741|FG024|Overall Study|Lost to Follow-up|6|||
33550584|NCT04518410|101913717|FG000|Overall Study|Withdrawal by Subject|1|||
33550585|NCT04518410|101913718|FG001|Overall Study|Withdrawal by Subject|2|||
33550586|NCT04518410|101913719|FG002|Overall Study|Withdrawal by Subject|2|||
33550587|NCT04518410|101913720|FG003|Overall Study|Withdrawal by Subject|3|||
33550588|NCT04518410|101913721|FG004|Overall Study|Withdrawal by Subject|20|||
33550589|NCT04518410|101913722|FG005|Overall Study|Withdrawal by Subject|20|||
33550590|NCT04518410|101913723|FG006|Overall Study|Withdrawal by Subject|25|||
33550591|NCT04518410|101913724|FG007|Overall Study|Withdrawal by Subject|6|||
33550592|NCT04518410|101913725|FG008|Overall Study|Withdrawal by Subject|1|||
33550593|NCT04518410|101913726|FG009|Overall Study|Withdrawal by Subject|12|||
33550594|NCT04518410|101913727|FG010|Overall Study|Withdrawal by Subject|5|||
33550595|NCT04518410|101913728|FG011|Overall Study|Withdrawal by Subject|7|||
33550596|NCT04518410|101913729|FG012|Overall Study|Withdrawal by Subject|2|||
33550597|NCT04518410|101913730|FG013|Overall Study|Withdrawal by Subject|13|||
33550598|NCT04518410|101913731|FG014|Overall Study|Withdrawal by Subject|4|||
33550599|NCT04518410|101913732|FG015|Overall Study|Withdrawal by Subject|9|||
33550600|NCT04518410|101913733|FG016|Overall Study|Withdrawal by Subject|0|||
33550601|NCT04518410|101913734|FG017|Overall Study|Withdrawal by Subject|15|||
33550602|NCT04518410|101913735|FG018|Overall Study|Withdrawal by Subject|12|||
33550603|NCT04518410|101913736|FG019|Overall Study|Withdrawal by Subject|9|||
33550604|NCT04518410|101913737|FG020|Overall Study|Withdrawal by Subject|14|||
33550605|NCT04518410|101913738|FG021|Overall Study|Withdrawal by Subject|3|||
33550606|NCT04518410|101913739|FG022|Overall Study|Withdrawal by Subject|2|||
33550607|NCT04518410|101913740|FG023|Overall Study|Withdrawal by Subject|9|||
33550608|NCT04518410|101913741|FG024|Overall Study|Withdrawal by Subject|8|||
33550609|NCT04518410|101913717|FG000|Overall Study|Other|1|||
33550610|NCT04518410|101913718|FG001|Overall Study|Other|0|||
33550611|NCT04518410|101913719|FG002|Overall Study|Other|0|||
33550612|NCT04518410|101913720|FG003|Overall Study|Other|1|||
33550613|NCT04518410|101913721|FG004|Overall Study|Other|6|||
33550614|NCT04518410|101913722|FG005|Overall Study|Other|6|||
33550615|NCT04518410|101913723|FG006|Overall Study|Other|5|||
33618421|NCT00991939|102151535|FG000|Overall Study|Lost to Follow-up|0|||
33618422|NCT00991939|102151536|FG001|Overall Study|Lost to Follow-up|1|||
33618423|NCT00991939|102151535|FG000|Overall Study|Withdrawal by Subject|1|||
33618424|NCT00991939|102151536|FG001|Overall Study|Withdrawal by Subject|0|||
33618425|NCT00991939|102151535|FG000|Overall Study|Entire study terminated|4|||
33618426|NCT00991939|102151536|FG001|Overall Study|Entire study terminated|1|||
33618427|NCT00832416|102151537|FG000|Overall Study|Lack of Efficacy|17|||
33618428|NCT00832416|102151538|FG001|Overall Study|Lack of Efficacy|15|||
33618429|NCT00832416|102151539|FG002|Overall Study|Lack of Efficacy|13|||
33618430|NCT00832416|102151540|FG003|Overall Study|Lack of Efficacy|52|||
33618431|NCT00832416|102151537|FG000|Overall Study|Withdrawal by Subject|5|||
33618432|NCT00832416|102151538|FG001|Overall Study|Withdrawal by Subject|7|||
33350275|NCT01889602|101167722|FG000|Second Intervention|Adverse Event|0|||
33350276|NCT01889602|101167723|FG001|Second Intervention|Adverse Event|0|||
33350277|NCT01889602|101167724|FG002|Second Intervention|Adverse Event|1|||
33350278|NCT01889602|101167722|FG000|Second Intervention|Study ending|1|||
33216936|NCT01696981|100692232|FG000|Overall Study|Refused ASU (Control)|920|||
33350279|NCT01889602|101167723|FG001|Second Intervention|Study ending|0|||
33350280|NCT01889602|101167724|FG002|Second Intervention|Study ending|0|||
33350281|NCT01889602|101167722|FG000|Second Intervention|Withdrawal by Subject|0|||
33350282|NCT01889602|101167723|FG001|Second Intervention|Withdrawal by Subject|0|||
33350283|NCT01889602|101167724|FG002|Second Intervention|Withdrawal by Subject|1|||
33350284|NCT01889602|101167722|FG000|Third Intervention|Protocol Violation|1|||
33350285|NCT01889602|101167723|FG001|Third Intervention|Protocol Violation|0|||
33350286|NCT01889602|101167724|FG002|Third Intervention|Protocol Violation|0|||
33350287|NCT01889602|101167722|FG000|Third Intervention|Withdrawal by Subject|2|||
33350288|NCT01889602|101167723|FG001|Third Intervention|Withdrawal by Subject|2|||
33350289|NCT01889602|101167724|FG002|Third Intervention|Withdrawal by Subject|0|||
33350290|NCT00709202|101167725|FG000|Overall Study|Withdrawal by Subject|6|||
33350291|NCT00709202|101167726|FG001|Overall Study|Withdrawal by Subject|6|||
33350292|NCT00607048|101167727|FG000|Overall Study|Adverse Event|0|||
33350293|NCT00607048|101167728|FG001|Overall Study|Adverse Event|1|||
33350294|NCT00607048|101167729|FG002|Overall Study|Adverse Event|0|||
33350295|NCT00607048|101167730|FG003|Overall Study|Adverse Event|0|||
33350296|NCT00607048|101167731|FG004|Overall Study|Adverse Event|4|||
33350297|NCT00607048|101167732|FG005|Overall Study|Adverse Event|0|||
33350298|NCT00607048|101167727|FG000|Overall Study|Global deterioration of health|1|||
33350299|NCT00607048|101167728|FG001|Overall Study|Global deterioration of health|0|||
33350300|NCT00607048|101167729|FG002|Overall Study|Global deterioration of health|0|||
33350301|NCT00607048|101167730|FG003|Overall Study|Global deterioration of health|0|||
33350302|NCT00607048|101167731|FG004|Overall Study|Global deterioration of health|0|||
33350303|NCT00607048|101167732|FG005|Overall Study|Global deterioration of health|0|||
33350304|NCT00607048|101167727|FG000|Overall Study|Objective disease progression - relapse|1|||
33350305|NCT00607048|101167728|FG001|Overall Study|Objective disease progression - relapse|2|||
33350306|NCT00607048|101167729|FG002|Overall Study|Objective disease progression - relapse|4|||
33550616|NCT04518410|101913724|FG007|Overall Study|Other|2|||
33350307|NCT00607048|101167730|FG003|Overall Study|Objective disease progression - relapse|2|||
33550617|NCT04518410|101913725|FG008|Overall Study|Other|0|||
33550618|NCT04518410|101913726|FG009|Overall Study|Other|1|||
33350308|NCT00607048|101167731|FG004|Overall Study|Objective disease progression - relapse|2|||
33550619|NCT04518410|101913727|FG010|Overall Study|Other|0|||
33550620|NCT04518410|101913728|FG011|Overall Study|Other|2|||
33618433|NCT00832416|102151539|FG002|Overall Study|Withdrawal by Subject|2|||
33618434|NCT00832416|102151540|FG003|Overall Study|Withdrawal by Subject|10|||
33550621|NCT04518410|101913729|FG012|Overall Study|Other|0|||
33550622|NCT04518410|101913730|FG013|Overall Study|Other|0|||
33550623|NCT04518410|101913731|FG014|Overall Study|Other|0|||
33618435|NCT00832416|102151537|FG000|Overall Study|Physician Decision|2|||
33350309|NCT00607048|101167732|FG005|Overall Study|Objective disease progression - relapse|2|||
33350310|NCT00607048|101167727|FG000|Overall Study|Withdrawal by Subject|0|||
33350311|NCT00607048|101167728|FG001|Overall Study|Withdrawal by Subject|0|||
33350312|NCT00607048|101167729|FG002|Overall Study|Withdrawal by Subject|0|||
33350313|NCT00607048|101167730|FG003|Overall Study|Withdrawal by Subject|1|||
33350314|NCT00607048|101167731|FG004|Overall Study|Withdrawal by Subject|0|||
33350315|NCT00607048|101167732|FG005|Overall Study|Withdrawal by Subject|2|||
33350316|NCT00607048|101167727|FG000|Overall Study|Other|1|||
33350317|NCT00607048|101167728|FG001|Overall Study|Other|1|||
33350318|NCT00607048|101167729|FG002|Overall Study|Other|0|||
33350319|NCT00607048|101167730|FG003|Overall Study|Other|0|||
33350320|NCT00607048|101167731|FG004|Overall Study|Other|0|||
33350321|NCT00607048|101167732|FG005|Overall Study|Other|1|||
33350322|NCT00480857|101167733|FG000|Overall Study|Lack of Efficacy|2|||
33350323|NCT00600171|101167734|FG000|Overall Study|Adverse Event|0|||
33350324|NCT00600171|101167735|FG001|Overall Study|Adverse Event|1|||
33350325|NCT00600171|101167736|FG002|Overall Study|Adverse Event|0|||
33411028|NCT05182840|101397014|FG001|Treatment Period|Other but not sponsor termination|0|||
33411029|NCT05182840|101397015|FG002|Treatment Period|Other but not sponsor termination|8|||
33411030|NCT05182840|101397016|FG003|Treatment Period|Other but not sponsor termination|6|||
33411031|NCT05182840|101397017|FG004|Treatment Period|Other but not sponsor termination|6|||
33350326|NCT00600171|101167737|FG003|Overall Study|Adverse Event|0|||
33350327|NCT00600171|101167738|FG004|Overall Study|Adverse Event|1|||
33411032|NCT05182840|101397018|FG005|Treatment Period|Other but not sponsor termination|7|||
33411033|NCT05182840|101397019|FG006|Treatment Period|Other but not sponsor termination|5|||
33411034|NCT05182840|101397020|FG007|Treatment Period|Other but not sponsor termination|8|||
33411035|NCT05182840|101397021|FG008|Treatment Period|Other but not sponsor termination|7|||
33411036|NCT05182840|101397022|FG009|Treatment Period|Other but not sponsor termination|2|||
33411037|NCT05182840|101397013|FG000|Treatment Period|Protocol deviation|0|||
33550624|NCT04518410|101913732|FG015|Overall Study|Other|3|||
33350328|NCT00600171|101167739|FG005|Overall Study|Adverse Event|0|||
33350329|NCT00600171|101167734|FG000|Overall Study|Lack of Efficacy|9|||
33350330|NCT00600171|101167735|FG001|Overall Study|Lack of Efficacy|12|||
33411038|NCT05182840|101397014|FG001|Treatment Period|Protocol deviation|0|||
33350331|NCT00600171|101167736|FG002|Overall Study|Lack of Efficacy|3|||
33350332|NCT00600171|101167737|FG003|Overall Study|Lack of Efficacy|5|||
33350333|NCT00600171|101167738|FG004|Overall Study|Lack of Efficacy|4|||
33350334|NCT00600171|101167739|FG005|Overall Study|Lack of Efficacy|0|||
33350335|NCT00600171|101167734|FG000|Overall Study|Protocol Violation|1|||
33350336|NCT00600171|101167735|FG001|Overall Study|Protocol Violation|2|||
33350337|NCT00600171|101167736|FG002|Overall Study|Protocol Violation|0|||
33350338|NCT00600171|101167737|FG003|Overall Study|Protocol Violation|1|||
33350339|NCT00600171|101167738|FG004|Overall Study|Protocol Violation|0|||
33350340|NCT00600171|101167739|FG005|Overall Study|Protocol Violation|0|||
33350341|NCT00600171|101167734|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
33350342|NCT00600171|101167735|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33350343|NCT00600171|101167736|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
33350344|NCT00600171|101167737|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
33350345|NCT00600171|101167738|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
33350346|NCT00600171|101167739|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
33550625|NCT04518410|101913733|FG016|Overall Study|Other|1|||
33550626|NCT04518410|101913734|FG017|Overall Study|Other|1|||
33550627|NCT04518410|101913735|FG018|Overall Study|Other|1|||
33550628|NCT04518410|101913736|FG019|Overall Study|Other|0|||
33550629|NCT04518410|101913737|FG020|Overall Study|Other|1|||
33550630|NCT04518410|101913738|FG021|Overall Study|Other|0|||
33550631|NCT04518410|101913739|FG022|Overall Study|Other|1|||
33550632|NCT04518410|101913740|FG023|Overall Study|Other|2|||
33550633|NCT04518410|101913741|FG024|Overall Study|Other|2|||
33550634|NCT04518410|101913717|FG000|Overall Study|Protocol Violation|0|||
33550635|NCT04518410|101913718|FG001|Overall Study|Protocol Violation|0|||
33550636|NCT04518410|101913719|FG002|Overall Study|Protocol Violation|0|||
33550637|NCT04518410|101913720|FG003|Overall Study|Protocol Violation|2|||
33550638|NCT04518410|101913721|FG004|Overall Study|Protocol Violation|17|||
33550639|NCT04518410|101913722|FG005|Overall Study|Protocol Violation|1|||
33550640|NCT04518410|101913723|FG006|Overall Study|Protocol Violation|2|||
33550641|NCT04518410|101913724|FG007|Overall Study|Protocol Violation|1|||
33550642|NCT04518410|101913725|FG008|Overall Study|Protocol Violation|0|||
33550643|NCT04518410|101913726|FG009|Overall Study|Protocol Violation|0|||
33550644|NCT04518410|101913727|FG010|Overall Study|Protocol Violation|0|||
33550645|NCT04518410|101913728|FG011|Overall Study|Protocol Violation|0|||
33550646|NCT04518410|101913729|FG012|Overall Study|Protocol Violation|0|||
33550647|NCT04518410|101913730|FG013|Overall Study|Protocol Violation|0|||
33550648|NCT04518410|101913731|FG014|Overall Study|Protocol Violation|0|||
33550649|NCT04518410|101913732|FG015|Overall Study|Protocol Violation|0|||
33550650|NCT04518410|101913733|FG016|Overall Study|Protocol Violation|1|||
33550651|NCT04518410|101913734|FG017|Overall Study|Protocol Violation|1|||
33550652|NCT04518410|101913735|FG018|Overall Study|Protocol Violation|0|||
33550653|NCT04518410|101913736|FG019|Overall Study|Protocol Violation|0|||
33550654|NCT04518410|101913737|FG020|Overall Study|Protocol Violation|1|||
33550655|NCT04518410|101913738|FG021|Overall Study|Protocol Violation|2|||
33550656|NCT04518410|101913739|FG022|Overall Study|Protocol Violation|0|||
33550657|NCT04518410|101913740|FG023|Overall Study|Protocol Violation|3|||
33550658|NCT04518410|101913741|FG024|Overall Study|Protocol Violation|0|||
33550659|NCT04518410|101913717|FG000|Overall Study|Death|0|||
33550660|NCT04518410|101913718|FG001|Overall Study|Death|0|||
33550661|NCT04518410|101913719|FG002|Overall Study|Death|0|||
33550662|NCT04518410|101913720|FG003|Overall Study|Death|0|||
33550663|NCT04518410|101913721|FG004|Overall Study|Death|12|||
33550664|NCT04518410|101913722|FG005|Overall Study|Death|2|||
33350347|NCT00600171|101167734|FG000|Overall Study|Withdrawal by Subject|3|||
33550665|NCT04518410|101913723|FG006|Overall Study|Death|11|||
33550666|NCT04518410|101913724|FG007|Overall Study|Death|0|||
33550667|NCT04518410|101913725|FG008|Overall Study|Death|1|||
33550668|NCT04518410|101913726|FG009|Overall Study|Death|0|||
33550669|NCT04518410|101913727|FG010|Overall Study|Death|0|||
33350348|NCT00600171|101167735|FG001|Overall Study|Withdrawal by Subject|0|||
33550670|NCT04518410|101913728|FG011|Overall Study|Death|0|||
33550671|NCT04518410|101913729|FG012|Overall Study|Death|0|||
33550672|NCT04518410|101913730|FG013|Overall Study|Death|1|||
33550673|NCT04518410|101913731|FG014|Overall Study|Death|1|||
33550674|NCT04518410|101913732|FG015|Overall Study|Death|0|||
33550675|NCT04518410|101913733|FG016|Overall Study|Death|0|||
33550676|NCT04518410|101913734|FG017|Overall Study|Death|1|||
33550677|NCT04518410|101913735|FG018|Overall Study|Death|4|||
33550678|NCT04518410|101913736|FG019|Overall Study|Death|4|||
33550679|NCT04518410|101913737|FG020|Overall Study|Death|1|||
33550680|NCT04518410|101913738|FG021|Overall Study|Death|0|||
33550681|NCT04518410|101913739|FG022|Overall Study|Death|0|||
33550682|NCT04518410|101913740|FG023|Overall Study|Death|0|||
33550683|NCT04518410|101913741|FG024|Overall Study|Death|0|||
33550684|NCT04518410|101913717|FG000|Overall Study|Requirement to start alternative therapy|0|||
33550685|NCT04518410|101913718|FG001|Overall Study|Requirement to start alternative therapy|0|||
33550686|NCT04518410|101913719|FG002|Overall Study|Requirement to start alternative therapy|1|||
33550687|NCT04518410|101913720|FG003|Overall Study|Requirement to start alternative therapy|0|||
33550688|NCT04518410|101913721|FG004|Overall Study|Requirement to start alternative therapy|0|||
33550689|NCT04518410|101913722|FG005|Overall Study|Requirement to start alternative therapy|0|||
33550690|NCT04518410|101913723|FG006|Overall Study|Requirement to start alternative therapy|0|||
33550691|NCT04518410|101913724|FG007|Overall Study|Requirement to start alternative therapy|0|||
33550692|NCT04518410|101913725|FG008|Overall Study|Requirement to start alternative therapy|0|||
33550693|NCT04518410|101913726|FG009|Overall Study|Requirement to start alternative therapy|0|||
33550694|NCT04518410|101913727|FG010|Overall Study|Requirement to start alternative therapy|0|||
33550695|NCT04518410|101913728|FG011|Overall Study|Requirement to start alternative therapy|0|||
33550696|NCT04518410|101913729|FG012|Overall Study|Requirement to start alternative therapy|0|||
33550697|NCT04518410|101913730|FG013|Overall Study|Requirement to start alternative therapy|0|||
33550698|NCT04518410|101913731|FG014|Overall Study|Requirement to start alternative therapy|0|||
33550699|NCT04518410|101913732|FG015|Overall Study|Requirement to start alternative therapy|0|||
33550700|NCT04518410|101913733|FG016|Overall Study|Requirement to start alternative therapy|0|||
33550701|NCT04518410|101913734|FG017|Overall Study|Requirement to start alternative therapy|0|||
33550702|NCT04518410|101913735|FG018|Overall Study|Requirement to start alternative therapy|0|||
33550703|NCT04518410|101913736|FG019|Overall Study|Requirement to start alternative therapy|0|||
33550704|NCT04518410|101913737|FG020|Overall Study|Requirement to start alternative therapy|0|||
33618436|NCT00832416|102151538|FG001|Overall Study|Physician Decision|12|||
33618437|NCT00832416|102151539|FG002|Overall Study|Physician Decision|5|||
33350349|NCT00600171|101167736|FG002|Overall Study|Withdrawal by Subject|0|||
33350350|NCT00600171|101167737|FG003|Overall Study|Withdrawal by Subject|1|||
33350351|NCT00600171|101167738|FG004|Overall Study|Withdrawal by Subject|1|||
33350352|NCT00600171|101167739|FG005|Overall Study|Withdrawal by Subject|1|||
33350353|NCT00600171|101167734|FG000|Overall Study|Physician Decision|0|||
33350354|NCT00600171|101167735|FG001|Overall Study|Physician Decision|1|||
33350355|NCT00600171|101167736|FG002|Overall Study|Physician Decision|0|||
33350356|NCT00600171|101167737|FG003|Overall Study|Physician Decision|1|||
33411039|NCT05182840|101397015|FG002|Treatment Period|Protocol deviation|0|||
33411040|NCT05182840|101397016|FG003|Treatment Period|Protocol deviation|0|||
33411041|NCT05182840|101397017|FG004|Treatment Period|Protocol deviation|0|||
33411042|NCT05182840|101397018|FG005|Treatment Period|Protocol deviation|0|||
33411043|NCT05182840|101397019|FG006|Treatment Period|Protocol deviation|0|||
33411044|NCT05182840|101397020|FG007|Treatment Period|Protocol deviation|0|||
33411045|NCT05182840|101397021|FG008|Treatment Period|Protocol deviation|1|||
33411046|NCT05182840|101397022|FG009|Treatment Period|Protocol deviation|0|||
33411047|NCT05182840|101397013|FG000|Treatment Period|No reason available|0|||
33411048|NCT05182840|101397014|FG001|Treatment Period|No reason available|0|||
33411049|NCT05182840|101397015|FG002|Treatment Period|No reason available|0|||
33411050|NCT05182840|101397016|FG003|Treatment Period|No reason available|1|||
33411051|NCT05182840|101397017|FG004|Treatment Period|No reason available|0|||
33411052|NCT05182840|101397018|FG005|Treatment Period|No reason available|2|||
33411053|NCT05182840|101397019|FG006|Treatment Period|No reason available|0|||
33411054|NCT05182840|101397020|FG007|Treatment Period|No reason available|1|||
33411055|NCT05182840|101397021|FG008|Treatment Period|No reason available|0|||
33411056|NCT05182840|101397022|FG009|Treatment Period|No reason available|0|||
33411057|NCT05182840|101397013|FG000|Treatment Period|Burden of study procedures|0|||
33411058|NCT05182840|101397014|FG001|Treatment Period|Burden of study procedures|0|||
33411059|NCT05182840|101397015|FG002|Treatment Period|Burden of study procedures|0|||
33411060|NCT05182840|101397016|FG003|Treatment Period|Burden of study procedures|0|||
33411061|NCT05182840|101397017|FG004|Treatment Period|Burden of study procedures|1|||
33411062|NCT05182840|101397018|FG005|Treatment Period|Burden of study procedures|0|||
33411063|NCT05182840|101397019|FG006|Treatment Period|Burden of study procedures|0|||
33411064|NCT05182840|101397020|FG007|Treatment Period|Burden of study procedures|0|||
33411065|NCT05182840|101397021|FG008|Treatment Period|Burden of study procedures|0|||
33411066|NCT05182840|101397022|FG009|Treatment Period|Burden of study procedures|0|||
33411067|NCT05182840|101397013|FG000|Treatment Period|Change of residence|0|||
33550705|NCT04518410|101913738|FG021|Overall Study|Requirement to start alternative therapy|0|||
33350357|NCT00600171|101167738|FG004|Overall Study|Physician Decision|0|||
33350358|NCT00600171|101167739|FG005|Overall Study|Physician Decision|2|||
33411068|NCT05182840|101397014|FG001|Treatment Period|Change of residence|0|||
33411069|NCT05182840|101397015|FG002|Treatment Period|Change of residence|0|||
33411070|NCT05182840|101397016|FG003|Treatment Period|Change of residence|0|||
33411071|NCT05182840|101397017|FG004|Treatment Period|Change of residence|0|||
33411072|NCT05182840|101397018|FG005|Treatment Period|Change of residence|1|||
33550706|NCT04518410|101913739|FG022|Overall Study|Requirement to start alternative therapy|0|||
33350359|NCT00600171|101167734|FG000|Overall Study|Lost to Follow-up|0|||
33350360|NCT00600171|101167735|FG001|Overall Study|Lost to Follow-up|0|||
33550707|NCT04518410|101913740|FG023|Overall Study|Requirement to start alternative therapy|0|||
33550708|NCT04518410|101913741|FG024|Overall Study|Requirement to start alternative therapy|0|||
33550709|NCT04518410|101913717|FG000|Overall Study|Randomized but not treated|0|||
33550710|NCT04518410|101913718|FG001|Overall Study|Randomized but not treated|0|||
33550711|NCT04518410|101913719|FG002|Overall Study|Randomized but not treated|0|||
33550712|NCT04518410|101913720|FG003|Overall Study|Randomized but not treated|2|||
33550713|NCT04518410|101913721|FG004|Overall Study|Randomized but not treated|6|||
33550714|NCT04518410|101913722|FG005|Overall Study|Randomized but not treated|4|||
33550715|NCT04518410|101913723|FG006|Overall Study|Randomized but not treated|3|||
33550716|NCT04518410|101913724|FG007|Overall Study|Randomized but not treated|3|||
33550717|NCT04518410|101913725|FG008|Overall Study|Randomized but not treated|0|||
33550718|NCT04518410|101913726|FG009|Overall Study|Randomized but not treated|4|||
33550719|NCT04518410|101913727|FG010|Overall Study|Randomized but not treated|0|||
33550720|NCT04518410|101913728|FG011|Overall Study|Randomized but not treated|0|||
33550721|NCT04518410|101913729|FG012|Overall Study|Randomized but not treated|1|||
33550722|NCT04518410|101913730|FG013|Overall Study|Randomized but not treated|3|||
33550723|NCT04518410|101913731|FG014|Overall Study|Randomized but not treated|3|||
33550724|NCT04518410|101913732|FG015|Overall Study|Randomized but not treated|3|||
33550725|NCT04518410|101913733|FG016|Overall Study|Randomized but not treated|4|||
33550726|NCT04518410|101913734|FG017|Overall Study|Randomized but not treated|5|||
33550727|NCT04518410|101913735|FG018|Overall Study|Randomized but not treated|4|||
33550728|NCT04518410|101913736|FG019|Overall Study|Randomized but not treated|0|||
33550729|NCT04518410|101913737|FG020|Overall Study|Randomized but not treated|0|||
33550730|NCT04518410|101913738|FG021|Overall Study|Randomized but not treated|5|||
33550731|NCT04518410|101913739|FG022|Overall Study|Randomized but not treated|0|||
33550732|NCT04518410|101913740|FG023|Overall Study|Randomized but not treated|3|||
33550733|NCT04518410|101913741|FG024|Overall Study|Randomized but not treated|1|||
33550734|NCT04518410|101913717|FG000|Overall Study|Screen Fail but Randomized|0|||
33550735|NCT04518410|101913718|FG001|Overall Study|Screen Fail but Randomized|0|||
33550736|NCT04518410|101913719|FG002|Overall Study|Screen Fail but Randomized|0|||
33550737|NCT04518410|101913720|FG003|Overall Study|Screen Fail but Randomized|0|||
33550738|NCT04518410|101913721|FG004|Overall Study|Screen Fail but Randomized|2|||
33550739|NCT04518410|101913722|FG005|Overall Study|Screen Fail but Randomized|0|||
33550740|NCT04518410|101913723|FG006|Overall Study|Screen Fail but Randomized|0|||
33550741|NCT04518410|101913724|FG007|Overall Study|Screen Fail but Randomized|0|||
33550742|NCT04518410|101913725|FG008|Overall Study|Screen Fail but Randomized|0|||
33550743|NCT04518410|101913726|FG009|Overall Study|Screen Fail but Randomized|0|||
33550744|NCT04518410|101913727|FG010|Overall Study|Screen Fail but Randomized|0|||
33550745|NCT04518410|101913728|FG011|Overall Study|Screen Fail but Randomized|0|||
33550746|NCT04518410|101913729|FG012|Overall Study|Screen Fail but Randomized|0|||
33550747|NCT04518410|101913730|FG013|Overall Study|Screen Fail but Randomized|0|||
33550748|NCT04518410|101913731|FG014|Overall Study|Screen Fail but Randomized|0|||
33550749|NCT04518410|101913732|FG015|Overall Study|Screen Fail but Randomized|0|||
33550750|NCT04518410|101913733|FG016|Overall Study|Screen Fail but Randomized|0|||
33550751|NCT04518410|101913734|FG017|Overall Study|Screen Fail but Randomized|0|||
33216937|NCT01696981|100692233|FG001|Overall Study|Refused ASU (Control)|0|||
33216938|NCT01696981|100692232|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
33550752|NCT04518410|101913735|FG018|Overall Study|Screen Fail but Randomized|0|||
33550753|NCT04518410|101913736|FG019|Overall Study|Screen Fail but Randomized|0|||
33550754|NCT04518410|101913737|FG020|Overall Study|Screen Fail but Randomized|0|||
33550755|NCT04518410|101913738|FG021|Overall Study|Screen Fail but Randomized|0|||
33550756|NCT04518410|101913739|FG022|Overall Study|Screen Fail but Randomized|0|||
33550757|NCT04518410|101913740|FG023|Overall Study|Screen Fail but Randomized|0|||
33550758|NCT04518410|101913741|FG024|Overall Study|Screen Fail but Randomized|0|||
33216939|NCT01696981|100692233|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
33216940|NCT02034708|100692234|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
33216941|NCT02034708|100692235|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
33216942|NCT02034708|100692234|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
33216943|NCT02034708|100692235|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
33216944|NCT02034708|100692234|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
33216945|NCT02034708|100692235|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
33350361|NCT00600171|101167736|FG002|Overall Study|Lost to Follow-up|0|||
33350362|NCT00600171|101167737|FG003|Overall Study|Lost to Follow-up|1|||
33350363|NCT00600171|101167738|FG004|Overall Study|Lost to Follow-up|0|||
33350364|NCT00600171|101167739|FG005|Overall Study|Lost to Follow-up|0|||
33350365|NCT00961961|101167740|FG000|Phase I|Withdrawal by Subject|7|||
33550759|NCT04518410|101913717|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33550760|NCT04518410|101913718|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33550761|NCT04518410|101913719|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33567619|NCT02723955|101973174|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33216946|NCT02034708|100692234|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
33216947|NCT02034708|100692235|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
33216948|NCT00689026|100692236|FG000|Overall Study|Withdrawal by Subject|13|||
33216949|NCT00689026|100692237|FG001|Overall Study|Withdrawal by Subject|6|||
33216950|NCT04987762|100692241|FG000|Overall Study|Study was Terminated by Sponsor|103|||
33216951|NCT00511875|100692242|FG000|Overall Study|Lost to Follow-up|4|||
33216952|NCT00511875|100692243|FG001|Overall Study|Lost to Follow-up|0|||
33216953|NCT00511875|100692242|FG000|Overall Study|Missing variables|1|||
33216954|NCT00511875|100692243|FG001|Overall Study|Missing variables|0|||
33216955|NCT00569582|100692246|FG000|Overall Study|Withdrawal by Subject|5|||
33216956|NCT00569582|100692246|FG000|Overall Study|Death|2|||
33216957|NCT00569582|100692246|FG000|Overall Study|Adverse Event|7|||
33216958|NCT00569582|100692246|FG000|Overall Study|Subject was too ill to travel.|1|||
33216959|NCT00569582|100692246|FG000|Overall Study|Subject was non-compliant.|1|||
33216960|NCT02275065|100692250|FG000|Overall Study|Randomized but not treated|1|||
33216961|NCT02275065|100692251|FG001|Overall Study|Randomized but not treated|0|||
33216962|NCT02275065|100692252|FG002|Overall Study|Randomized but not treated|1|||
33216963|NCT02275065|100692253|FG003|Overall Study|Randomized but not treated|1|||
33216964|NCT02275065|100692254|FG004|Overall Study|Randomized but not treated|0|||
33216965|NCT00833560|100692255|FG000|Overall Study|Toxicity|13|||
33216966|NCT00833560|100692255|FG000|Overall Study|Adverse Event|11|||
33216967|NCT00833560|100692255|FG000|Overall Study|Protocol Violation|6|||
33216968|NCT00833560|100692255|FG000|Overall Study|Lack of Efficacy|4|||
33216969|NCT00833560|100692255|FG000|Overall Study|Death|2|||
33216970|NCT00833560|100692255|FG000|Overall Study|Pregression of other disease|1|||
33216971|NCT00833560|100692255|FG000|Overall Study|Other|5|||
33216972|NCT01499082|100692258|FG000|Overall Study|Randomized but not Treated|0|||
33216973|NCT01499082|100692259|FG001|Overall Study|Randomized but not Treated|1|||
33216974|NCT01499082|100692258|FG000|Overall Study|Adverse Event|12|||
33216975|NCT01499082|100692259|FG001|Overall Study|Adverse Event|16|||
33216976|NCT01499082|100692258|FG000|Overall Study|Lack of Efficacy|1|||
33216977|NCT01499082|100692259|FG001|Overall Study|Lack of Efficacy|1|||
33216978|NCT01499082|100692258|FG000|Overall Study|Protocol Violation|6|||
33216979|NCT01499082|100692259|FG001|Overall Study|Protocol Violation|8|||
33216980|NCT01499082|100692258|FG000|Overall Study|Diverse Reasons|18|||
33216981|NCT01499082|100692259|FG001|Overall Study|Diverse Reasons|14|||
33216982|NCT01499082|100692258|FG000|Overall Study|Site Closure for Noncompliance|5|||
33216983|NCT01499082|100692259|FG001|Overall Study|Site Closure for Noncompliance|2|||
33216984|NCT01499082|100692258|FG000|Overall Study|Hypoglycemia|2|||
33216985|NCT01499082|100692259|FG001|Overall Study|Hypoglycemia|3|||
33216986|NCT01499082|100692258|FG000|Overall Study|Lost to Follow-up|1|||
33216987|NCT01499082|100692259|FG001|Overall Study|Lost to Follow-up|3|||
33216988|NCT03371940|100692264|FG000|Overall Study|Withdrawal by Subject|8|||
33216989|NCT03371940|100692265|FG001|Overall Study|Withdrawal by Subject|1|||
33216990|NCT03371940|100692266|FG002|Overall Study|Withdrawal by Subject|3|||
33216991|NCT03371940|100692267|FG003|Overall Study|Withdrawal by Subject|4|||
33216992|NCT01693068|100692268|FG000|Randomization Period|On-study|2|||
33216993|NCT01693068|100692269|FG001|Randomization Period|On-study|5|||
33216994|NCT01693068|100692270|FG002|Randomization Period|On-study|0|||
33216995|NCT01693068|100692268|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
33216996|NCT01693068|100692269|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
33216997|NCT01693068|100692270|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
33216998|NCT02883062|100692271|FG000|Overall Study|Withdrawal by Subject|6|||
33216999|NCT02883062|100692272|FG001|Overall Study|Withdrawal by Subject|0|||
33217000|NCT02151266|100692273|FG000|Overall Study|Lost to Follow-up|1|||
33217001|NCT02151266|100692274|FG001|Overall Study|Lost to Follow-up|4|||
33350366|NCT00961961|101167741|FG001|Phase I|Withdrawal by Subject|0|||
33350367|NCT00961961|101167742|FG002|Phase I|Withdrawal by Subject|0|||
33350368|NCT00961961|101167743|FG003|Phase I|Withdrawal by Subject|0|||
33350369|NCT00961961|101167740|FG000|Phase I|Lost to Follow-up|10|||
33350370|NCT00961961|101167741|FG001|Phase I|Lost to Follow-up|0|||
33350371|NCT00961961|101167742|FG002|Phase I|Lost to Follow-up|0|||
33350372|NCT00961961|101167743|FG003|Phase I|Lost to Follow-up|0|||
33350373|NCT00961961|101167740|FG000|Phase I|Lack of Efficacy|94|||
33217002|NCT02151266|100692275|FG002|Overall Study|Lost to Follow-up|1|||
33217003|NCT02151266|100692273|FG000|Overall Study|Did NOT receive intervention|3|||
33217004|NCT02151266|100692274|FG001|Overall Study|Did NOT receive intervention|6|||
33217005|NCT02151266|100692275|FG002|Overall Study|Did NOT receive intervention|2|||
33217006|NCT02151266|100692273|FG000|Overall Study|Not able to exercise|4|||
33217007|NCT02151266|100692274|FG001|Overall Study|Not able to exercise|5|||
33217008|NCT02151266|100692275|FG002|Overall Study|Not able to exercise|4|||
33217009|NCT05159622|100692276|FG000|Overall Study|Lost to Follow-up|4|||
33217010|NCT05159622|100692277|FG001|Overall Study|Lost to Follow-up|5|||
33217011|NCT00736645|100692278|FG000|Overall Study|Adverse Event|0|||
33217012|NCT00736645|100692279|FG001|Overall Study|Adverse Event|2|||
33217013|NCT00736645|100692280|FG002|Overall Study|Adverse Event|0|||
33217014|NCT00736645|100692281|FG003|Overall Study|Adverse Event|0|||
33350374|NCT00961961|101167741|FG001|Phase I|Lack of Efficacy|0|||
33217015|NCT01552954|100692282|FG000|Overall Study|Adverse Event|1|||
33217016|NCT01552954|100692283|FG001|Overall Study|Adverse Event|2|||
33217017|NCT01552954|100692282|FG000|Overall Study|Lost to Follow-up|1|||
33217018|NCT01552954|100692283|FG001|Overall Study|Lost to Follow-up|1|||
33217019|NCT01552954|100692282|FG000|Overall Study|Withdrawal by Subject|1|||
33217020|NCT01552954|100692283|FG001|Overall Study|Withdrawal by Subject|1|||
33217021|NCT01552954|100692282|FG000|Overall Study|Protocol Violation|1|||
33217022|NCT01552954|100692283|FG001|Overall Study|Protocol Violation|2|||
33217023|NCT01552954|100692282|FG000|Overall Study|diagnosed DM|1|||
33217024|NCT01552954|100692283|FG001|Overall Study|diagnosed DM|0|||
33217025|NCT02276222|100692284|FG000|Overall Study|Adverse Event|62|||
33217026|NCT02276222|100692285|FG001|Overall Study|Adverse Event|11|||
33217027|NCT02276222|100692284|FG000|Overall Study|Death|3|||
33217028|NCT02276222|100692285|FG001|Overall Study|Death|4|||
33217029|NCT02276222|100692284|FG000|Overall Study|Lack of Efficacy|13|||
33217030|NCT02276222|100692285|FG001|Overall Study|Lack of Efficacy|3|||
33217031|NCT02276222|100692284|FG000|Overall Study|Protocol Violation|3|||
33217032|NCT02276222|100692285|FG001|Overall Study|Protocol Violation|2|||
33217033|NCT02276222|100692284|FG000|Overall Study|Withdrawal by Subject|79|||
33217034|NCT02276222|100692285|FG001|Overall Study|Withdrawal by Subject|33|||
33217035|NCT02276222|100692284|FG000|Overall Study|non compliance with study medication|6|||
33217036|NCT02276222|100692285|FG001|Overall Study|non compliance with study medication|2|||
33217037|NCT02276222|100692284|FG000|Overall Study|sponsor decision|0|||
33217038|NCT02276222|100692285|FG001|Overall Study|sponsor decision|3|||
33217039|NCT02276222|100692284|FG000|Overall Study|Lost to Follow-up|15|||
33217040|NCT02276222|100692285|FG001|Overall Study|Lost to Follow-up|5|||
33217041|NCT02276222|100692284|FG000|Overall Study|Physician Decision|2|||
33217042|NCT02276222|100692285|FG001|Overall Study|Physician Decision|1|||
33217043|NCT02276222|100692284|FG000|Overall Study|sheduling conflict|1|||
33217044|NCT02276222|100692285|FG001|Overall Study|sheduling conflict|0|||
33217045|NCT02276222|100692284|FG000|Overall Study|subject withdrew after randomization|1|||
33217046|NCT02276222|100692285|FG001|Overall Study|subject withdrew after randomization|0|||
33217047|NCT00633464|100692286|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
33217048|NCT00633464|100692287|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
33217049|NCT00633464|100692286|FG000|Overall Study|Never Treated (Randomized in error)|0|||
33217050|NCT00633464|100692287|FG001|Overall Study|Never Treated (Randomized in error)|1|||
33217051|NCT01621126|100692288|FG000|Overall Study|Physician Decision|6|||
33217052|NCT01477853|100692292|FG000|Phase A|Adverse Event|1|||
33217053|NCT01477853|100692293|FG001|Phase A|Adverse Event|2|||
33217054|NCT01477853|100692294|FG002|Phase A|Adverse Event|2|||
33217055|NCT01477853|100692292|FG000|Phase A|Lost to Follow-up|4|||
33217056|NCT01477853|100692293|FG001|Phase A|Lost to Follow-up|3|||
33217057|NCT01477853|100692294|FG002|Phase A|Lost to Follow-up|2|||
33350375|NCT00961961|101167742|FG002|Phase I|Lack of Efficacy|0|||
33350376|NCT00961961|101167743|FG003|Phase I|Lack of Efficacy|0|||
33350377|NCT00961961|101167740|FG000|Phase I|Adverse Event|7|||
33350378|NCT00961961|101167741|FG001|Phase I|Adverse Event|0|||
33217058|NCT01477853|100692292|FG000|Phase A|Physician Decision|1|||
33217059|NCT01477853|100692293|FG001|Phase A|Physician Decision|0|||
33217060|NCT01477853|100692294|FG002|Phase A|Physician Decision|1|||
33217061|NCT01477853|100692292|FG000|Phase A|Study terminated by sponsor|37|||
33217062|NCT01477853|100692293|FG001|Phase A|Study terminated by sponsor|40|||
33217063|NCT01477853|100692294|FG002|Phase A|Study terminated by sponsor|39|||
33217064|NCT01477853|100692292|FG000|Phase B|Lost to Follow-up|0|||
33217065|NCT01477853|100692293|FG001|Phase B|Lost to Follow-up|1|||
33217066|NCT01477853|100692294|FG002|Phase B|Lost to Follow-up|0|||
33217067|NCT01477853|100692292|FG000|Phase B|Study terminated by sponsor|12|||
33217068|NCT01477853|100692293|FG001|Phase B|Study terminated by sponsor|10|||
33217069|NCT01477853|100692294|FG002|Phase B|Study terminated by sponsor|11|||
33217070|NCT01274182|100692295|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
33217071|NCT01274182|100692296|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33217072|NCT01274182|100692297|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
33350379|NCT00961961|101167742|FG002|Phase I|Adverse Event|0|||
33350380|NCT00961961|101167743|FG003|Phase I|Adverse Event|0|||
33350381|NCT00961961|101167740|FG000|Phase I|Physician Decision|8|||
33350382|NCT00961961|101167741|FG001|Phase I|Physician Decision|0|||
33350383|NCT00961961|101167742|FG002|Phase I|Physician Decision|0|||
33350384|NCT00961961|101167743|FG003|Phase I|Physician Decision|0|||
33350385|NCT00961961|101167740|FG000|Phase II|Lost to Follow-up|0|||
33350386|NCT00961961|101167741|FG001|Phase II|Lost to Follow-up|0|||
33350387|NCT00961961|101167742|FG002|Phase II|Lost to Follow-up|10|||
33350388|NCT00961961|101167743|FG003|Phase II|Lost to Follow-up|7|||
33350389|NCT00961961|101167740|FG000|Phase II|Adverse Event|0|||
33350390|NCT00961961|101167741|FG001|Phase II|Adverse Event|0|||
33350391|NCT00961961|101167742|FG002|Phase II|Adverse Event|0|||
33350392|NCT00961961|101167743|FG003|Phase II|Adverse Event|1|||
33350393|NCT00961961|101167740|FG000|Phase II|Physician Decision|0|||
33350394|NCT00961961|101167741|FG001|Phase II|Physician Decision|0|||
33350395|NCT00961961|101167742|FG002|Phase II|Physician Decision|1|||
33350396|NCT00961961|101167743|FG003|Phase II|Physician Decision|0|||
33350397|NCT00961961|101167740|FG000|Phase II|Withdrawal by Subject|0|||
33350398|NCT00961961|101167741|FG001|Phase II|Withdrawal by Subject|0|||
33350399|NCT00961961|101167742|FG002|Phase II|Withdrawal by Subject|1|||
33350400|NCT00961961|101167743|FG003|Phase II|Withdrawal by Subject|0|||
33350401|NCT01661790|101167746|FG000|Overall Study|Lost to Follow-up|0|||
33350402|NCT01661790|101167747|FG001|Overall Study|Lost to Follow-up|2|||
33350403|NCT01856114|101167748|FG000|Overall Study|Withdrawal by Subject|1|||
33350404|NCT01856114|101167749|FG001|Overall Study|Withdrawal by Subject|0|||
33350405|NCT01856114|101167748|FG000|Overall Study|Adverse Event|1|||
33550762|NCT04518410|101913720|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33350406|NCT01856114|101167749|FG001|Overall Study|Adverse Event|0|||
33350407|NCT00611247|101167750|FG000|Overall Study|Death|1|||
33350408|NCT00611247|101167751|FG001|Overall Study|Death|5|||
33350409|NCT00611247|101167750|FG000|Overall Study|Lack of Efficacy|1|||
33350410|NCT00611247|101167751|FG001|Overall Study|Lack of Efficacy|16|||
33350411|NCT04897867|101167752|FG000|Overall Study|Withdrawal of Consent|1|||
33350412|NCT04897867|101167752|FG000|Overall Study|Pregnancy|1|||
33350413|NCT04897867|101167752|FG000|Overall Study|Lost to Follow-up|7|||
33350414|NCT04897867|101167752|FG000|Overall Study|Reason not Specified|2|||
33550763|NCT04518410|101913721|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
33550764|NCT04518410|101913722|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
33550765|NCT04518410|101913723|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
33550766|NCT04518410|101913724|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
33550767|NCT04518410|101913725|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
33550768|NCT04518410|101913726|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
33550769|NCT04518410|101913727|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
33550770|NCT04518410|101913728|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33217073|NCT01274182|100692295|FG000|Overall Study|Adverse Event|4|||
33217074|NCT01274182|100692296|FG001|Overall Study|Adverse Event|5|||
33217075|NCT01274182|100692297|FG002|Overall Study|Adverse Event|3|||
33217076|NCT01274182|100692295|FG000|Overall Study|Withdrawal by Subject|5|||
33217077|NCT01274182|100692296|FG001|Overall Study|Withdrawal by Subject|5|||
33350415|NCT00490542|101167757|FG000|Overall Study|Lost to Follow-up|3|||
33350416|NCT00490542|101167758|FG001|Overall Study|Lost to Follow-up|0|||
33350417|NCT00490542|101167757|FG000|Overall Study|Adverse Event|3|||
33350418|NCT00490542|101167758|FG001|Overall Study|Adverse Event|3|||
33350419|NCT00490542|101167757|FG000|Overall Study|Lack of Efficacy|1|||
33350420|NCT00490542|101167758|FG001|Overall Study|Lack of Efficacy|1|||
33350421|NCT03588741|101167759|FG000|Overall Study|Withdrawal by Subject|1|||
33350422|NCT00688909|101167760|FG000|Overall Study|Adverse Event|28|||
33350423|NCT00688909|101167760|FG000|Overall Study|Patient withdrew consent|2|||
33350424|NCT00688909|101167760|FG000|Overall Study|Administrative problems|1|||
33350425|NCT00688909|101167760|FG000|Overall Study|Protocol Violation|2|||
33350426|NCT01961115|101167764|FG000|Overall Study|Disease Progression|1|||
33350427|NCT01961115|101167765|FG001|Overall Study|Disease Progression|0|||
33350428|NCT01961115|101167766|FG002|Overall Study|Disease Progression|3|||
33350429|NCT01961115|101167764|FG000|Overall Study|Adverse Event|1|||
33411073|NCT05182840|101397019|FG006|Treatment Period|Change of residence|0|||
33411074|NCT05182840|101397020|FG007|Treatment Period|Change of residence|0|||
33411075|NCT05182840|101397021|FG008|Treatment Period|Change of residence|0|||
33411076|NCT05182840|101397022|FG009|Treatment Period|Change of residence|0|||
33411077|NCT05182840|101397013|FG000|Treatment Period|Adverse Event|0|||
33411078|NCT05182840|101397014|FG001|Treatment Period|Adverse Event|0|||
33411079|NCT05182840|101397015|FG002|Treatment Period|Adverse Event|4|||
33411080|NCT05182840|101397016|FG003|Treatment Period|Adverse Event|16|||
33411081|NCT05182840|101397017|FG004|Treatment Period|Adverse Event|12|||
33411082|NCT05182840|101397018|FG005|Treatment Period|Adverse Event|6|||
33411083|NCT05182840|101397019|FG006|Treatment Period|Adverse Event|4|||
33411084|NCT05182840|101397020|FG007|Treatment Period|Adverse Event|8|||
33411085|NCT05182840|101397021|FG008|Treatment Period|Adverse Event|16|||
33411086|NCT05182840|101397022|FG009|Treatment Period|Adverse Event|5|||
33411087|NCT05182840|101397013|FG000|Treatment Period|Not treated with study drug|0|||
33411088|NCT05182840|101397014|FG001|Treatment Period|Not treated with study drug|0|||
33411089|NCT05182840|101397015|FG002|Treatment Period|Not treated with study drug|0|||
33411090|NCT05182840|101397016|FG003|Treatment Period|Not treated with study drug|1|||
33411091|NCT05182840|101397017|FG004|Treatment Period|Not treated with study drug|0|||
33411092|NCT05182840|101397018|FG005|Treatment Period|Not treated with study drug|0|||
33217078|NCT01274182|100692297|FG002|Overall Study|Withdrawal by Subject|3|||
33217079|NCT01274182|100692295|FG000|Overall Study|Lost to Follow-up|2|||
33217080|NCT01274182|100692296|FG001|Overall Study|Lost to Follow-up|3|||
33217081|NCT01274182|100692297|FG002|Overall Study|Lost to Follow-up|1|||
33217082|NCT01274182|100692295|FG000|Overall Study|Protocol Violation|3|||
33217083|NCT01274182|100692296|FG001|Overall Study|Protocol Violation|2|||
33217084|NCT01274182|100692297|FG002|Overall Study|Protocol Violation|0|||
33217085|NCT01274182|100692295|FG000|Overall Study|Death|1|||
33217086|NCT01274182|100692296|FG001|Overall Study|Death|0|||
33217087|NCT01274182|100692297|FG002|Overall Study|Death|1|||
33350430|NCT01961115|101167765|FG001|Overall Study|Adverse Event|0|||
33411093|NCT05182840|101397019|FG006|Treatment Period|Not treated with study drug|1|||
33411094|NCT05182840|101397020|FG007|Treatment Period|Not treated with study drug|1|||
33411095|NCT05182840|101397021|FG008|Treatment Period|Not treated with study drug|0|||
33411096|NCT05182840|101397022|FG009|Treatment Period|Not treated with study drug|0|||
33411097|NCT00111007|101397023|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
33411098|NCT00111007|101397024|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
33411099|NCT00111007|101397023|FG000|Double-blind (DB) Treatment|Death|5|||
33411100|NCT00111007|101397024|FG001|Double-blind (DB) Treatment|Death|2|||
33411101|NCT00111007|101397023|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
33411102|NCT00111007|101397024|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
33411103|NCT00111007|101397023|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
33411104|NCT00111007|101397024|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
33411105|NCT00111007|101397023|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
33411106|NCT00111007|101397024|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
33411107|NCT00111007|101397023|FG000|Double-blind (DB) Treatment|Relapse|1|||
33411108|NCT00111007|101397024|FG001|Double-blind (DB) Treatment|Relapse|0|||
33411109|NCT00111007|101397023|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
33550771|NCT04518410|101913729|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33550772|NCT04518410|101913730|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
33550773|NCT04518410|101913731|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
33550774|NCT04518410|101913732|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
33550775|NCT04518410|101913733|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
33411110|NCT00111007|101397024|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
33411111|NCT00111007|101397023|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
33217088|NCT04040751|100692298|FG000|Overall Study|Withdrawal by Subject|2|||
33217089|NCT04040751|100692299|FG001|Overall Study|Withdrawal by Subject|0|||
33217090|NCT04040751|100692300|FG002|Overall Study|Withdrawal by Subject|2|||
33217091|NCT04040751|100692301|FG003|Overall Study|Withdrawal by Subject|0|||
33217092|NCT01738984|100692305|FG000|Overall Study|Pregnancy|4|||
33411112|NCT00111007|101397024|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
33411113|NCT00111007|101397023|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
33411114|NCT00111007|101397024|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
33411115|NCT00111007|101397023|FG000|Active Follow-up|Adverse Event|1|||
33411116|NCT00111007|101397024|FG001|Active Follow-up|Adverse Event|0|||
33411117|NCT00111007|101397023|FG000|Active Follow-up|Death|2|||
33411118|NCT00111007|101397024|FG001|Active Follow-up|Death|0|||
33350431|NCT01961115|101167766|FG002|Overall Study|Adverse Event|1|||
33411119|NCT00111007|101397023|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
33411120|NCT00111007|101397024|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
33411121|NCT00111007|101397023|FG000|Long Term Follow-up|Death|34|||
33411122|NCT00111007|101397024|FG001|Long Term Follow-up|Death|39|||
33411123|NCT00111007|101397023|FG000|Long Term Follow-up|Lost to Follow-up|1|||
33350432|NCT03157531|101167771|FG000|Overall Study|Death|2|||
33350433|NCT03157531|101167771|FG000|Overall Study|Lost to Follow-up|4|||
33350434|NCT00950170|101167772|FG000|Overall Study|Parent/Legal Guardian Request|1|||
33350435|NCT00950170|101167772|FG000|Overall Study|Adverse Event|2|||
33350436|NCT00950170|101167772|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
33350437|NCT01707992|101167773|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
33350438|NCT01707992|101167774|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
33350439|NCT01707992|101167775|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
33411124|NCT00111007|101397024|FG001|Long Term Follow-up|Lost to Follow-up|1|||
33618438|NCT00832416|102151540|FG003|Overall Study|Physician Decision|10|||
33618439|NCT00832416|102151537|FG000|Overall Study|Administrative|0|||
33618440|NCT00832416|102151538|FG001|Overall Study|Administrative|0|||
33618441|NCT00832416|102151539|FG002|Overall Study|Administrative|0|||
33618442|NCT00832416|102151540|FG003|Overall Study|Administrative|1|||
33618443|NCT00832416|102151537|FG000|Overall Study|Adverse Event|21|||
33411125|NCT00111007|101397023|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
33411126|NCT00111007|101397024|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
33411127|NCT00111007|101397023|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
33411128|NCT00111007|101397024|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
33618444|NCT00832416|102151538|FG001|Overall Study|Adverse Event|19|||
33618445|NCT00832416|102151539|FG002|Overall Study|Adverse Event|41|||
33618446|NCT00832416|102151540|FG003|Overall Study|Adverse Event|10|||
33618447|NCT00832416|102151537|FG000|Overall Study|Death|1|||
33550776|NCT04518410|101913734|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
33550777|NCT04518410|101913735|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
33550778|NCT04518410|101913736|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
33550779|NCT04518410|101913737|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
33550780|NCT04518410|101913738|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
33550781|NCT04518410|101913739|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
33550782|NCT04518410|101913740|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
33350440|NCT01707992|101167776|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
33550783|NCT04518410|101913741|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
33550784|NCT04518410|101913717|FG000|Overall Study|Dual Enrolled Subject|0|||
33550785|NCT04518410|101913718|FG001|Overall Study|Dual Enrolled Subject|0|||
33550786|NCT04518410|101913719|FG002|Overall Study|Dual Enrolled Subject|0|||
33550787|NCT04518410|101913720|FG003|Overall Study|Dual Enrolled Subject|0|||
33550788|NCT04518410|101913721|FG004|Overall Study|Dual Enrolled Subject|0|||
33550789|NCT04518410|101913722|FG005|Overall Study|Dual Enrolled Subject|0|||
33550790|NCT04518410|101913723|FG006|Overall Study|Dual Enrolled Subject|0|||
33550791|NCT04518410|101913724|FG007|Overall Study|Dual Enrolled Subject|0|||
33550792|NCT04518410|101913725|FG008|Overall Study|Dual Enrolled Subject|0|||
33550793|NCT04518410|101913726|FG009|Overall Study|Dual Enrolled Subject|0|||
33550794|NCT04518410|101913727|FG010|Overall Study|Dual Enrolled Subject|0|||
33550795|NCT04518410|101913728|FG011|Overall Study|Dual Enrolled Subject|0|||
33550796|NCT04518410|101913729|FG012|Overall Study|Dual Enrolled Subject|0|||
33350441|NCT01707992|101167777|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
33618448|NCT00832416|102151538|FG001|Overall Study|Death|0|||
33350442|NCT01707992|101167778|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
33350443|NCT01707992|101167773|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
33350444|NCT01707992|101167774|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
33350445|NCT01707992|101167775|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
33350446|NCT01707992|101167776|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
33350447|NCT01707992|101167777|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
33350448|NCT01707992|101167778|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
33350449|NCT01707992|101167773|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
33350450|NCT01707992|101167774|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
33350451|NCT01707992|101167775|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
33350452|NCT01707992|101167776|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
33350453|NCT01707992|101167777|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
33350454|NCT01707992|101167778|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
33350455|NCT01707992|101167773|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
33350456|NCT01707992|101167774|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
33350457|NCT01707992|101167775|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
33350458|NCT01707992|101167776|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
33350459|NCT01707992|101167777|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
33350460|NCT01707992|101167778|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
33350461|NCT01707992|101167773|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
33350462|NCT01707992|101167774|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
33350463|NCT01707992|101167775|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
33350464|NCT01707992|101167776|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
33350465|NCT01707992|101167777|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
33350466|NCT01707992|101167778|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
33350467|NCT01707992|101167773|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
33350468|NCT01707992|101167774|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
33350469|NCT01707992|101167775|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
33350470|NCT01707992|101167776|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
33350471|NCT01707992|101167777|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
33350472|NCT01707992|101167778|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
33350473|NCT01707992|101167773|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
33411129|NCT00111007|101397023|FG000|Long Term Follow-up|Missing|10|||
33411130|NCT00111007|101397024|FG001|Long Term Follow-up|Missing|3|||
33411131|NCT00347776|101397025|FG000|1.5 Month Follow-up|Death|2|||
33411132|NCT00347776|101397026|FG001|1.5 Month Follow-up|Death|0|||
33411133|NCT00347776|101397027|FG002|1.5 Month Follow-up|Death|0|||
33411134|NCT00347776|101397025|FG000|1.5 Month Follow-up|reached the endpoint|12|||
33411135|NCT00347776|101397026|FG001|1.5 Month Follow-up|reached the endpoint|8|||
33411136|NCT00347776|101397027|FG002|1.5 Month Follow-up|reached the endpoint|12|||
33411137|NCT00347776|101397025|FG000|6 Month Follow-up|Death|2|||
33411138|NCT00347776|101397026|FG001|6 Month Follow-up|Death|1|||
33411139|NCT00347776|101397027|FG002|6 Month Follow-up|Death|3|||
33411140|NCT00347776|101397025|FG000|6 Month Follow-up|reached endpont|20|||
33411141|NCT00347776|101397026|FG001|6 Month Follow-up|reached endpont|12|||
33411142|NCT00347776|101397027|FG002|6 Month Follow-up|reached endpont|15|||
33411143|NCT00347776|101397025|FG000|12 Month Follow-up|Lost to Follow-up|7|||
33411144|NCT00347776|101397026|FG001|12 Month Follow-up|Lost to Follow-up|6|||
33411145|NCT00347776|101397027|FG002|12 Month Follow-up|Lost to Follow-up|6|||
33411146|NCT00347776|101397025|FG000|12 Month Follow-up|Death|3|||
33411147|NCT00347776|101397026|FG001|12 Month Follow-up|Death|4|||
33411148|NCT00347776|101397027|FG002|12 Month Follow-up|Death|4|||
33411149|NCT00347776|101397025|FG000|12 Month Follow-up|Reached endpoint|13|||
33411150|NCT00347776|101397026|FG001|12 Month Follow-up|Reached endpoint|6|||
33411151|NCT00347776|101397027|FG002|12 Month Follow-up|Reached endpoint|9|||
33411152|NCT00674440|101397028|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
33411153|NCT00674440|101397028|FG000|Overall Study|did not have surgery, so unevaluable|7|||
33411154|NCT00674440|101397028|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
33411155|NCT01301625|101397030|FG000|Overall Study|Death|5|||
33411156|NCT01301625|101397030|FG000|Overall Study|Not Due|21|||
33411157|NCT01301625|101397030|FG000|Overall Study|Expected|8|||
33411158|NCT01301625|101397030|FG000|Overall Study|Lost to Follow-up|1|||
33411159|NCT00908375|101397031|FG000|Overall Study|Withdrawal by Subject|2|||
33411160|NCT00908375|101397032|FG001|Overall Study|Withdrawal by Subject|4|||
33550797|NCT04518410|101913730|FG013|Overall Study|Dual Enrolled Subject|0|||
33550798|NCT04518410|101913731|FG014|Overall Study|Dual Enrolled Subject|0|||
33550799|NCT04518410|101913732|FG015|Overall Study|Dual Enrolled Subject|0|||
33550800|NCT04518410|101913733|FG016|Overall Study|Dual Enrolled Subject|0|||
33550801|NCT04518410|101913734|FG017|Overall Study|Dual Enrolled Subject|1|||
33550802|NCT04518410|101913735|FG018|Overall Study|Dual Enrolled Subject|0|||
33550803|NCT04518410|101913736|FG019|Overall Study|Dual Enrolled Subject|0|||
33550804|NCT04518410|101913737|FG020|Overall Study|Dual Enrolled Subject|0|||
33550805|NCT04518410|101913738|FG021|Overall Study|Dual Enrolled Subject|0|||
33550806|NCT04518410|101913739|FG022|Overall Study|Dual Enrolled Subject|0|||
33550807|NCT04518410|101913740|FG023|Overall Study|Dual Enrolled Subject|0|||
33550808|NCT04518410|101913741|FG024|Overall Study|Dual Enrolled Subject|0|||
33550809|NCT00250718|101913744|FG000|Overall Study|Death|1|||
33550810|NCT00250718|101913744|FG000|Overall Study|Adverse Event|1|||
33550811|NCT00250718|101913744|FG000|Overall Study|Withdrawal by Subject|1|||
33550812|NCT04964388|101913751|FG000|Overall Study|Lost to Follow-up|3|||
33550813|NCT04964388|101913752|FG001|Overall Study|Lost to Follow-up|2|||
33550814|NCT02536794|101913753|FG000|Reached 1st Response Assessment|Adverse Event|2|||
33550815|NCT02536794|101913753|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
33550816|NCT02536794|101913753|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
33550817|NCT02536794|101913753|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
33550818|NCT02536794|101913753|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
33550819|NCT02536794|101913753|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
33550820|NCT01049828|101913764|FG000|Overall Study|Claustrophibia and Frustration|2|||
33550821|NCT00997126|101913765|FG000|Overall Study|Physician Decision|7|||
33550822|NCT00997126|101913766|FG001|Overall Study|Physician Decision|11|||
33550823|NCT01481779|101913767|FG000|Overall Study|Adverse Event|23|||
33411161|NCT00908375|101397031|FG000|Overall Study|Lost to Follow-up|8|||
33411162|NCT00908375|101397032|FG001|Overall Study|Lost to Follow-up|6|||
33411163|NCT00594568|101397033|FG000|Initial Treatment|Adverse Event|51|||
33411164|NCT00594568|101397034|FG001|Initial Treatment|Adverse Event|121|||
33411165|NCT00594568|101397035|FG002|Initial Treatment|Adverse Event|144|||
33411166|NCT00594568|101397033|FG000|Initial Treatment|Death|6|||
33411167|NCT00594568|101397034|FG001|Initial Treatment|Death|11|||
33411168|NCT00594568|101397035|FG002|Initial Treatment|Death|15|||
33411169|NCT00594568|101397033|FG000|Initial Treatment|Lost to Follow-up|4|||
33411170|NCT00594568|101397034|FG001|Initial Treatment|Lost to Follow-up|1|||
33411171|NCT00594568|101397035|FG002|Initial Treatment|Lost to Follow-up|4|||
33411172|NCT00594568|101397033|FG000|Initial Treatment|Physician Decision|3|||
33411173|NCT00594568|101397034|FG001|Initial Treatment|Physician Decision|2|||
33550824|NCT01481779|101913768|FG001|Overall Study|Adverse Event|5|||
33550825|NCT01481779|101913767|FG000|Overall Study|Lost to Follow-up|3|||
33550826|NCT01481779|101913768|FG001|Overall Study|Lost to Follow-up|2|||
33550827|NCT01481779|101913767|FG000|Overall Study|Protocol Violation|2|||
33550828|NCT01481779|101913768|FG001|Overall Study|Protocol Violation|3|||
33550829|NCT01481779|101913767|FG000|Overall Study|Withdrawal by Subject|26|||
33550830|NCT01481779|101913768|FG001|Overall Study|Withdrawal by Subject|13|||
33550831|NCT01481779|101913767|FG000|Overall Study|Physician Decision|13|||
33350474|NCT01707992|101167774|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
33350475|NCT01707992|101167775|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
33350476|NCT01707992|101167776|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
33350477|NCT01707992|101167777|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
33350478|NCT01707992|101167778|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
33350479|NCT01707992|101167773|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
33350480|NCT01707992|101167774|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
33350481|NCT01707992|101167775|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
33350482|NCT01707992|101167776|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
33618449|NCT00832416|102151539|FG002|Overall Study|Death|0|||
33618450|NCT00832416|102151540|FG003|Overall Study|Death|0|||
33618451|NCT02446717|102151541|FG000|Overall Study|Adverse Event|0|||
33618452|NCT02446717|102151542|FG001|Overall Study|Adverse Event|0|||
33217093|NCT01738984|100692306|FG001|Overall Study|Pregnancy|0|||
33217094|NCT01738984|100692305|FG000|Overall Study|Withdrawal by Subject|1|||
33217095|NCT01738984|100692306|FG001|Overall Study|Withdrawal by Subject|0|||
33350483|NCT01707992|101167777|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
33350484|NCT01707992|101167778|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
33411174|NCT00594568|101397035|FG002|Initial Treatment|Physician Decision|4|||
33411175|NCT00594568|101397033|FG000|Initial Treatment|Protocol Violation|2|||
33411176|NCT00594568|101397034|FG001|Initial Treatment|Protocol Violation|2|||
33411177|NCT00594568|101397035|FG002|Initial Treatment|Protocol Violation|5|||
33550832|NCT01481779|101913768|FG001|Overall Study|Physician Decision|4|||
33550833|NCT01481779|101913767|FG000|Overall Study|Sponsor Decision|3|||
33550834|NCT01481779|101913768|FG001|Overall Study|Sponsor Decision|1|||
33550835|NCT01732783|101913771|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
33550836|NCT01732783|101913772|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
33550837|NCT01732783|101913773|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
33550838|NCT01732783|101913771|FG000|Overall Study|Death|13|||
33550839|NCT01732783|101913772|FG001|Overall Study|Death|4|||
33550840|NCT01732783|101913773|FG002|Overall Study|Death|1|||
33550841|NCT01732783|101913771|FG000|Overall Study|Lost to Follow-up|7|||
33550842|NCT01732783|101913772|FG001|Overall Study|Lost to Follow-up|1|||
33550843|NCT01732783|101913773|FG002|Overall Study|Lost to Follow-up|1|||
33550844|NCT01732783|101913771|FG000|Overall Study|Administrative Decision|8|||
33550845|NCT01732783|101913772|FG001|Overall Study|Administrative Decision|2|||
33550846|NCT01732783|101913773|FG002|Overall Study|Administrative Decision|1|||
33550847|NCT01732783|101913771|FG000|Overall Study|Withdrawal by Subject|1|||
33550848|NCT01732783|101913772|FG001|Overall Study|Withdrawal by Subject|0|||
33550849|NCT01732783|101913773|FG002|Overall Study|Withdrawal by Subject|0|||
33550850|NCT04913675|101913776|FG000|Main Study (Up to Week 36)|Death|0|||
33550851|NCT04913675|101913777|FG001|Main Study (Up to Week 36)|Death|2|||
33550852|NCT04913675|101913778|FG002|Main Study (Up to Week 36)|Death|2|||
33550853|NCT04913675|101913779|FG003|Main Study (Up to Week 36)|Death|0|||
33550854|NCT04913675|101913776|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
33550855|NCT04913675|101913777|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
33550856|NCT04913675|101913778|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
33550857|NCT04913675|101913779|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
33550858|NCT04913675|101913776|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
33550859|NCT04913675|101913777|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
33550860|NCT04913675|101913778|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
33550861|NCT04913675|101913779|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
33550862|NCT04913675|101913776|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
33618453|NCT02446717|102151543|FG002|Overall Study|Adverse Event|1|||
33350485|NCT01707992|101167773|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
33350486|NCT01707992|101167774|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
33350487|NCT01707992|101167775|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
33350488|NCT01707992|101167776|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
33350489|NCT01707992|101167777|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
33350490|NCT01707992|101167778|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
33350491|NCT01707992|101167773|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
33350492|NCT01707992|101167774|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
33350493|NCT01707992|101167775|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
33350494|NCT01707992|101167776|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
33350495|NCT01707992|101167777|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
33350496|NCT01707992|101167778|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
33350497|NCT01707992|101167773|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
33350498|NCT01707992|101167774|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
33350499|NCT01707992|101167775|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
33350500|NCT01707992|101167776|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
33350501|NCT01707992|101167777|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
33350502|NCT01707992|101167778|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
33350503|NCT01707992|101167773|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
33350504|NCT01707992|101167774|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
33350505|NCT01707992|101167775|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
33550863|NCT04913675|101913777|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
33550864|NCT04913675|101913778|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
33550865|NCT04913675|101913779|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
33550866|NCT04913675|101913776|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
33550867|NCT04913675|101913777|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
33550868|NCT04913675|101913778|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
33217096|NCT01738984|100692305|FG000|Overall Study|Lost to Follow-up|59|||
33350506|NCT01707992|101167776|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
33350507|NCT01707992|101167777|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
33550869|NCT04913675|101913779|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
33550870|NCT03312907|101913780|FG000|Overall Study|Adverse Event|1|||
33550871|NCT03312907|101913781|FG001|Overall Study|Adverse Event|6|||
33550872|NCT03312907|101913782|FG002|Overall Study|Adverse Event|1|||
33550873|NCT03312907|101913780|FG000|Overall Study|Protocol Violation|2|||
33550874|NCT03312907|101913781|FG001|Overall Study|Protocol Violation|3|||
33550875|NCT03312907|101913782|FG002|Overall Study|Protocol Violation|4|||
33550876|NCT03312907|101913780|FG000|Overall Study|Lost to Follow-up|2|||
33550877|NCT03312907|101913781|FG001|Overall Study|Lost to Follow-up|3|||
33550878|NCT03312907|101913782|FG002|Overall Study|Lost to Follow-up|2|||
33550879|NCT03312907|101913780|FG000|Overall Study|Physician Decision|3|||
33550880|NCT03312907|101913781|FG001|Overall Study|Physician Decision|4|||
33550881|NCT03312907|101913782|FG002|Overall Study|Physician Decision|2|||
33550882|NCT03312907|101913780|FG000|Overall Study|Withdrawal by Subject|9|||
33550883|NCT03312907|101913781|FG001|Overall Study|Withdrawal by Subject|14|||
33550884|NCT03312907|101913782|FG002|Overall Study|Withdrawal by Subject|10|||
33550885|NCT04727749|101913783|FG000|Overall Study|Lost to Follow-up|10|||
33550886|NCT04727749|101913784|FG001|Overall Study|Lost to Follow-up|3|||
33550887|NCT01363440|101913787|FG000|Overall Study|Adverse Event|5|||
33550888|NCT01363440|101913788|FG001|Overall Study|Adverse Event|4|||
33618454|NCT02446717|102151544|FG003|Overall Study|Adverse Event|0|||
33618455|NCT02446717|102151545|FG004|Overall Study|Adverse Event|0|||
33618456|NCT02446717|102151541|FG000|Overall Study|Lost to Follow-up|0|||
33618457|NCT02446717|102151542|FG001|Overall Study|Lost to Follow-up|1|||
33550889|NCT01363440|101913789|FG002|Overall Study|Adverse Event|4|||
33550890|NCT01363440|101913787|FG000|Overall Study|Death|3|||
33550891|NCT01363440|101913788|FG001|Overall Study|Death|7|||
33550892|NCT01363440|101913789|FG002|Overall Study|Death|5|||
33618458|NCT02446717|102151543|FG002|Overall Study|Lost to Follow-up|1|||
33550893|NCT01363440|101913787|FG000|Overall Study|Withdrawal by Subject|9|||
33550894|NCT01363440|101913788|FG001|Overall Study|Withdrawal by Subject|11|||
33550895|NCT01363440|101913789|FG002|Overall Study|Withdrawal by Subject|11|||
33550896|NCT01363440|101913787|FG000|Overall Study|Lost to Follow-up|2|||
33550897|NCT01363440|101913788|FG001|Overall Study|Lost to Follow-up|4|||
33550898|NCT01363440|101913789|FG002|Overall Study|Lost to Follow-up|5|||
33550899|NCT01363440|101913787|FG000|Overall Study|Other|4|||
33550900|NCT01363440|101913788|FG001|Overall Study|Other|5|||
33550901|NCT01363440|101913789|FG002|Overall Study|Other|2|||
33550902|NCT00690898|101913792|FG000|SCREENING|Screen failure|18|||
33550903|NCT00690898|101913792|FG000|TREATMENT|Adverse Event|3|||
33550904|NCT00690898|101913792|FG000|TREATMENT|Lack of Efficacy|18|||
33550905|NCT00690898|101913792|FG000|TREATMENT|Withdrawal by Subject|4|||
33550906|NCT00690898|101913792|FG000|TREATMENT|Other (not otherwise specified)|1|||
33550907|NCT02293499|101916788|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
33550908|NCT02293499|101916789|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
33550909|NCT02293499|101916790|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
33550910|NCT02293499|101916788|FG000|Intervention - Camp|Withdrawal by Subject|3|||
33550911|NCT02293499|101916789|FG001|Intervention - Camp|Withdrawal by Subject|6|||
33550912|NCT02293499|101916790|FG002|Intervention - Camp|Withdrawal by Subject|2|||
33550913|NCT02293499|101916788|FG000|Intervention - Camp|these are those not showing up at camp|24|||
33550914|NCT02293499|101916789|FG001|Intervention - Camp|these are those not showing up at camp|28|||
33550915|NCT02293499|101916790|FG002|Intervention - Camp|these are those not showing up at camp|4|||
33550916|NCT02293499|101916788|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
33550917|NCT02293499|101916789|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
33550918|NCT02293499|101916790|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
33550919|NCT02293499|101916788|FG000|3 Month Follow Up|Lost to Follow-up|14|||
33550920|NCT02293499|101916789|FG001|3 Month Follow Up|Lost to Follow-up|15|||
33550921|NCT02293499|101916790|FG002|3 Month Follow Up|Lost to Follow-up|6|||
33550922|NCT02293499|101916788|FG000|6 Month Follow Up|Lost to Follow-up|17|||
33550923|NCT02293499|101916789|FG001|6 Month Follow Up|Lost to Follow-up|27|||
33550924|NCT02293499|101916790|FG002|6 Month Follow Up|Lost to Follow-up|6|||
33550925|NCT02293499|101916788|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
33550926|NCT02293499|101916789|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
33550927|NCT02293499|101916790|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
33550928|NCT02293499|101916788|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
33550929|NCT02293499|101916789|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
33550930|NCT02293499|101916790|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
33550931|NCT02293499|101916788|FG000|9 Month Follow Up|Lost to Follow-up|24|||
33550932|NCT02293499|101916789|FG001|9 Month Follow Up|Lost to Follow-up|28|||
33550933|NCT02293499|101916790|FG002|9 Month Follow Up|Lost to Follow-up|4|||
33550934|NCT02293499|101916788|FG000|12 Month Follow Up|Lost to Follow-up|26|||
33550935|NCT02293499|101916789|FG001|12 Month Follow Up|Lost to Follow-up|25|||
33550936|NCT02293499|101916790|FG002|12 Month Follow Up|Lost to Follow-up|6|||
33550937|NCT02293499|101916788|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
33550938|NCT02293499|101916789|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
33550939|NCT02293499|101916790|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
33550940|NCT02293499|101916788|FG000|15 Month Follow Up|Lost to Follow-up|22|||
33550941|NCT02293499|101916789|FG001|15 Month Follow Up|Lost to Follow-up|22|||
33550942|NCT02293499|101916790|FG002|15 Month Follow Up|Lost to Follow-up|7|||
33550943|NCT04795323|101916793|FG000|Overall Study|Did not interact with TARA|1|||
33550944|NCT04795323|101916794|FG001|Overall Study|Did not interact with TARA|0|||
33550945|NCT04069520|101916801|FG000|Overall Study|Lost to Follow-up|0|||
33550946|NCT04069520|101916802|FG001|Overall Study|Lost to Follow-up|2|||
33550947|NCT04069520|101916801|FG000|Overall Study|Withdrawal by Subject|0|||
33550948|NCT04069520|101916802|FG001|Overall Study|Withdrawal by Subject|1|||
33550949|NCT04069520|101916801|FG000|Overall Study|Prior Injury|1|||
33550950|NCT04069520|101916802|FG001|Overall Study|Prior Injury|0|||
33550951|NCT04069520|101916801|FG000|Overall Study|Orthodontia|1|||
33550952|NCT04069520|101916802|FG001|Overall Study|Orthodontia|0|||
33550953|NCT04069520|101916801|FG000|Overall Study|Cut from team|0|||
33550954|NCT04069520|101916802|FG001|Overall Study|Cut from team|2|||
33550955|NCT02447029|101916803|FG000|Overall Study|Withdrawal by Subject|3|||
33550956|NCT02447029|101916804|FG001|Overall Study|Withdrawal by Subject|2|||
33550957|NCT03595748|101916805|FG000|Overall Study|Death|11|||
33550958|NCT03595748|101916806|FG001|Overall Study|Death|12|||
33550959|NCT03595748|101916805|FG000|Overall Study|Withdrawal by Subject|28|||
33550960|NCT03595748|101916806|FG001|Overall Study|Withdrawal by Subject|29|||
33550961|NCT03595748|101916805|FG000|Overall Study|Protocol Violation|0|||
33550962|NCT03595748|101916806|FG001|Overall Study|Protocol Violation|1|||
33550963|NCT00021255|101916807|FG000|Overall Study|Death|1|||
33550964|NCT00021255|101916808|FG001|Overall Study|Death|0|||
33550965|NCT00021255|101916809|FG002|Overall Study|Death|2|||
33550966|NCT00021255|101916807|FG000|Overall Study|Breast cancer relapse|5|||
33550967|NCT00021255|101916808|FG001|Overall Study|Breast cancer relapse|18|||
33550968|NCT00021255|101916809|FG002|Overall Study|Breast cancer relapse|11|||
33550969|NCT00021255|101916807|FG000|Overall Study|Second primary malignancy|0|||
33550970|NCT00021255|101916808|FG001|Overall Study|Second primary malignancy|4|||
33550971|NCT00021255|101916809|FG002|Overall Study|Second primary malignancy|1|||
33550972|NCT00021255|101916807|FG000|Overall Study|Withdrawal by Subject|41|||
33550973|NCT00021255|101916808|FG001|Overall Study|Withdrawal by Subject|64|||
33550974|NCT00021255|101916809|FG002|Overall Study|Withdrawal by Subject|26|||
33550975|NCT00021255|101916807|FG000|Overall Study|Lost to Follow-up|0|||
33550976|NCT00021255|101916808|FG001|Overall Study|Lost to Follow-up|2|||
33550977|NCT00021255|101916809|FG002|Overall Study|Lost to Follow-up|3|||
33550978|NCT00021255|101916807|FG000|Overall Study|Cardiac toxicity|0|||
33550979|NCT00021255|101916808|FG001|Overall Study|Cardiac toxicity|61|||
33550980|NCT00021255|101916809|FG002|Overall Study|Cardiac toxicity|32|||
33550981|NCT00021255|101916807|FG000|Overall Study|Herceptin toxicity|0|||
33550982|NCT00021255|101916808|FG001|Overall Study|Herceptin toxicity|22|||
33550983|NCT00021255|101916809|FG002|Overall Study|Herceptin toxicity|6|||
33550984|NCT00021255|101916807|FG000|Overall Study|Adverse Event|46|||
33550985|NCT00021255|101916808|FG001|Overall Study|Adverse Event|30|||
33550986|NCT00021255|101916809|FG002|Overall Study|Adverse Event|18|||
33550987|NCT00021255|101916807|FG000|Overall Study|Protocol Violation|0|||
33550988|NCT00021255|101916808|FG001|Overall Study|Protocol Violation|2|||
33550989|NCT00021255|101916809|FG002|Overall Study|Protocol Violation|0|||
33550990|NCT00021255|101916807|FG000|Overall Study|Other than specified above|0|||
33550991|NCT00021255|101916808|FG001|Overall Study|Other than specified above|38|||
33550992|NCT00021255|101916809|FG002|Overall Study|Other than specified above|19|||
33550993|NCT00021255|101916807|FG000|Overall Study|Missing|0|||
33550994|NCT00021255|101916808|FG001|Overall Study|Missing|27|||
33550995|NCT00021255|101916809|FG002|Overall Study|Missing|13|||
33550996|NCT00021255|101916807|FG000|Overall Study|Randomized but not treated|28|||
33550997|NCT00021255|101916808|FG001|Overall Study|Randomized but not treated|2|||
33550998|NCT00021255|101916809|FG002|Overall Study|Randomized but not treated|18|||
33550999|NCT00114777|101916810|FG000|Randomization to Month 36|Death|10|||
33551000|NCT00114777|101916811|FG001|Randomization to Month 36|Death|4|||
33350508|NCT01707992|101167778|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
33350509|NCT01707992|101167773|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
33551001|NCT00114777|101916812|FG002|Randomization to Month 36|Death|3|||
33551002|NCT00114777|101916810|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
33551003|NCT00114777|101916811|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
33551004|NCT00114777|101916812|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
33217097|NCT01738984|100692306|FG001|Overall Study|Lost to Follow-up|39|||
33551005|NCT00114777|101916810|FG000|Randomization to Month 36|Lack of Efficacy|19|||
33551006|NCT00114777|101916811|FG001|Randomization to Month 36|Lack of Efficacy|15|||
33551007|NCT00114777|101916812|FG002|Randomization to Month 36|Lack of Efficacy|17|||
33551008|NCT00114777|101916810|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
33551009|NCT00114777|101916811|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
33551010|NCT00114777|101916812|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
33551011|NCT00114777|101916810|FG000|Randomization to Month 36|Adverse Event|34|||
33551012|NCT00114777|101916811|FG001|Randomization to Month 36|Adverse Event|35|||
33551013|NCT00114777|101916812|FG002|Randomization to Month 36|Adverse Event|44|||
33551014|NCT00114777|101916810|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
33551015|NCT00114777|101916811|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
33551016|NCT00114777|101916812|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
33551017|NCT00114777|101916810|FG000|Randomization to Month 36|Other|9|||
33551018|NCT00114777|101916811|FG001|Randomization to Month 36|Other|3|||
33551019|NCT00114777|101916812|FG002|Randomization to Month 36|Other|12|||
33551020|NCT00114777|101916810|FG000|Long-Term Extension to Month 84|Death|8|||
33551021|NCT00114777|101916811|FG001|Long-Term Extension to Month 84|Death|13|||
33551022|NCT00114777|101916812|FG002|Long-Term Extension to Month 84|Death|7|||
33551023|NCT00114777|101916810|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
33551024|NCT00114777|101916811|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
33551025|NCT00114777|101916812|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
33551026|NCT00114777|101916810|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
33551027|NCT00114777|101916811|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
33551028|NCT00114777|101916812|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
33350510|NCT01707992|101167774|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
33350511|NCT01707992|101167775|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
33350512|NCT01707992|101167776|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
33350513|NCT01707992|101167777|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
33350514|NCT01707992|101167778|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
33350515|NCT01707992|101167773|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
33350516|NCT01707992|101167774|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
33350517|NCT01707992|101167775|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
33618459|NCT02446717|102151544|FG003|Overall Study|Lost to Follow-up|0|||
33618460|NCT02446717|102151545|FG004|Overall Study|Lost to Follow-up|1|||
33618461|NCT02446717|102151541|FG000|Overall Study|Withdrew consent|0|||
33618462|NCT02446717|102151542|FG001|Overall Study|Withdrew consent|0|||
33618463|NCT02446717|102151543|FG002|Overall Study|Withdrew consent|0|||
33411178|NCT00594568|101397033|FG000|Initial Treatment|Withdrawal by Subject|25|||
33411179|NCT00594568|101397034|FG001|Initial Treatment|Withdrawal by Subject|31|||
33411180|NCT00594568|101397035|FG002|Initial Treatment|Withdrawal by Subject|46|||
33411181|NCT00594568|101397033|FG000|Initial Treatment|Sponsor decision|193|||
33411182|NCT00594568|101397034|FG001|Initial Treatment|Sponsor decision|142|||
33551029|NCT00114777|101916810|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
33551030|NCT00114777|101916811|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
33551031|NCT00114777|101916812|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
33551032|NCT00114777|101916810|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
33551033|NCT00114777|101916811|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
33551034|NCT00114777|101916812|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
33551035|NCT00114777|101916810|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
33551036|NCT00114777|101916811|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
33551037|NCT00114777|101916812|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
33551038|NCT00114777|101916810|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
33551039|NCT00114777|101916811|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
33551040|NCT00114777|101916812|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
33551041|NCT00114777|101916810|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
33551042|NCT00114777|101916811|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
33618464|NCT02446717|102151544|FG003|Overall Study|Withdrew consent|1|||
33350518|NCT01707992|101167776|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
33350519|NCT01707992|101167777|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
33350520|NCT01707992|101167778|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
33411183|NCT00594568|101397035|FG002|Initial Treatment|Sponsor decision|147|||
33411184|NCT00594568|101397033|FG000|Initial Treatment|Caregiver decision|21|||
33618465|NCT02446717|102151545|FG004|Overall Study|Withdrew consent|0|||
33618466|NCT01397461|102151546|FG000|Overall Study|Withdrawal by Subject|2|||
33618467|NCT01397461|102151547|FG001|Overall Study|Withdrawal by Subject|1|||
33618468|NCT01397461|102151548|FG002|Overall Study|Withdrawal by Subject|0|||
33618469|NCT01397461|102151546|FG000|Overall Study|Lost to Follow-up|0|||
33618470|NCT01397461|102151547|FG001|Overall Study|Lost to Follow-up|2|||
33618471|NCT01397461|102151548|FG002|Overall Study|Lost to Follow-up|1|||
33618472|NCT01397461|102151546|FG000|Overall Study|Lack of Efficacy|0|||
33618473|NCT01397461|102151547|FG001|Overall Study|Lack of Efficacy|3|||
33618474|NCT01397461|102151548|FG002|Overall Study|Lack of Efficacy|0|||
33618475|NCT01397461|102151546|FG000|Overall Study|Not treated|0|||
33618476|NCT01397461|102151547|FG001|Overall Study|Not treated|0|||
33618477|NCT01397461|102151548|FG002|Overall Study|Not treated|1|||
33618478|NCT04034004|102151551|FG000|Overall Study|Withdrawal by Subject|1|||
33618479|NCT04034004|102151552|FG001|Overall Study|Withdrawal by Subject|2|||
33618480|NCT04034004|102151553|FG002|Overall Study|Withdrawal by Subject|2|||
33618481|NCT04034004|102151554|FG003|Overall Study|Withdrawal by Subject|3|||
33618482|NCT04034004|102151551|FG000|Overall Study|could not find vein to administer IV|2|||
33618483|NCT04034004|102151552|FG001|Overall Study|could not find vein to administer IV|1|||
33350521|NCT01707992|101167773|FG000|Active Treatment Phase (24 Months)|Death|0|||
33411185|NCT00594568|101397034|FG001|Initial Treatment|Caregiver decision|36|||
33618484|NCT04034004|102151553|FG002|Overall Study|could not find vein to administer IV|0|||
33618485|NCT04034004|102151554|FG003|Overall Study|could not find vein to administer IV|0|||
33551043|NCT00114777|101916812|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
33551044|NCT00114777|101916810|FG000|Long-Term Extension to Month 84|Other|2|||
33551045|NCT00114777|101916811|FG001|Long-Term Extension to Month 84|Other|0|||
33551046|NCT00114777|101916812|FG002|Long-Term Extension to Month 84|Other|2|||
33551047|NCT01500096|101916815|FG000|Overall Study|Lost to Follow-up|1|||
33551048|NCT01500096|101916816|FG001|Overall Study|Lost to Follow-up|0|||
33551049|NCT01500096|101916817|FG002|Overall Study|Lost to Follow-up|0|||
33551050|NCT01500096|101916818|FG003|Overall Study|Lost to Follow-up|2|||
33551051|NCT02513199|101916819|FG000|Treatment|Death|1|||
33551052|NCT02513199|101916819|FG000|Treatment|Lost to Follow-up|1|||
33551053|NCT02513199|101916819|FG000|Follow-Up|Death|11|||
33551054|NCT01732692|101916820|FG000|Overall Study|Adverse Event|0|||
33551055|NCT01732692|101916821|FG001|Overall Study|Adverse Event|1|||
33551056|NCT00441896|101916822|FG000|Overall Study|Withdrawal by Subject|0|||
33350522|NCT01707992|101167774|FG001|Active Treatment Phase (24 Months)|Death|0|||
33350523|NCT01707992|101167775|FG002|Active Treatment Phase (24 Months)|Death|0|||
33350524|NCT01707992|101167776|FG003|Active Treatment Phase (24 Months)|Death|2|||
33350525|NCT01707992|101167777|FG004|Active Treatment Phase (24 Months)|Death|0|||
33350526|NCT01707992|101167778|FG005|Active Treatment Phase (24 Months)|Death|0|||
33350527|NCT01707992|101167773|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
33350528|NCT01707992|101167774|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
33350529|NCT01707992|101167775|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
33350530|NCT01707992|101167776|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
33350531|NCT01707992|101167777|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
33350532|NCT01707992|101167778|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
33350533|NCT01707992|101167773|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
33350534|NCT01707992|101167774|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
33350535|NCT01707992|101167775|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
33350536|NCT01707992|101167776|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
33411186|NCT00594568|101397035|FG002|Initial Treatment|Caregiver decision|36|||
33411187|NCT00594568|101397033|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
33411188|NCT00594568|101397034|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
33411189|NCT00594568|101397035|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
33411190|NCT00594568|101397033|FG000|Initial Treatment|Entry criteria exclusion|0|||
33411191|NCT00594568|101397034|FG001|Initial Treatment|Entry criteria exclusion|1|||
33411192|NCT00594568|101397035|FG002|Initial Treatment|Entry criteria exclusion|1|||
33551057|NCT00441896|101916823|FG001|Overall Study|Withdrawal by Subject|0|||
33551058|NCT00441896|101916824|FG002|Overall Study|Withdrawal by Subject|0|||
33551059|NCT00441896|101916825|FG003|Overall Study|Withdrawal by Subject|1|||
33551060|NCT00441896|101916826|FG004|Overall Study|Withdrawal by Subject|0|||
33551061|NCT00441896|101916827|FG005|Overall Study|Withdrawal by Subject|0|||
33551062|NCT00441896|101916828|FG006|Overall Study|Withdrawal by Subject|0|||
33551063|NCT00441896|101916829|FG007|Overall Study|Withdrawal by Subject|0|||
33551064|NCT00441896|101916830|FG008|Overall Study|Withdrawal by Subject|0|||
33551065|NCT00441896|101916831|FG009|Overall Study|Withdrawal by Subject|0|||
33551066|NCT00441896|101916822|FG000|Overall Study|Other|0|||
33551067|NCT00441896|101916823|FG001|Overall Study|Other|0|||
33551068|NCT00441896|101916824|FG002|Overall Study|Other|0|||
33551069|NCT00441896|101916825|FG003|Overall Study|Other|0|||
33551070|NCT00441896|101916826|FG004|Overall Study|Other|1|||
33551071|NCT00441896|101916827|FG005|Overall Study|Other|0|||
33551072|NCT00441896|101916828|FG006|Overall Study|Other|0|||
33551073|NCT00441896|101916829|FG007|Overall Study|Other|0|||
33551074|NCT00441896|101916830|FG008|Overall Study|Other|0|||
33551075|NCT00441896|101916831|FG009|Overall Study|Other|0|||
33551076|NCT00986232|101916833|FG000|Overall Study|Adverse Event|1|||
33551077|NCT00986232|101916834|FG001|Overall Study|Adverse Event|2|||
33217098|NCT02709005|100692307|FG000|Overall Study|Lost to Follow-up|1|||
33411193|NCT00594568|101397033|FG000|Delayed Start|Death|0|||
33411194|NCT00594568|101397034|FG001|Delayed Start|Death|0|||
33551078|NCT00986232|101916835|FG002|Overall Study|Adverse Event|3|||
33551079|NCT00986232|101916836|FG003|Overall Study|Adverse Event|0|||
33217099|NCT02709005|100692308|FG001|Overall Study|Lost to Follow-up|1|||
33217100|NCT02709005|100692307|FG000|Overall Study|Withdrawal by Subject|3|||
33411195|NCT00594568|101397035|FG002|Delayed Start|Death|1|||
33551080|NCT00986232|101916833|FG000|Overall Study|Lost to Follow-up|19|||
33551081|NCT00986232|101916834|FG001|Overall Study|Lost to Follow-up|12|||
33551082|NCT00986232|101916835|FG002|Overall Study|Lost to Follow-up|12|||
33551083|NCT00986232|101916836|FG003|Overall Study|Lost to Follow-up|7|||
33551084|NCT00986232|101916833|FG000|Overall Study|Protocol Violation|2|||
33551085|NCT00986232|101916834|FG001|Overall Study|Protocol Violation|3|||
33551086|NCT00986232|101916835|FG002|Overall Study|Protocol Violation|0|||
33551087|NCT00986232|101916836|FG003|Overall Study|Protocol Violation|1|||
33551088|NCT00986232|101916833|FG000|Overall Study|Withdrawal by Subject|13|||
33551089|NCT00986232|101916834|FG001|Overall Study|Withdrawal by Subject|16|||
33551090|NCT00986232|101916835|FG002|Overall Study|Withdrawal by Subject|12|||
33551091|NCT00986232|101916836|FG003|Overall Study|Withdrawal by Subject|3|||
33551092|NCT00986232|101916833|FG000|Overall Study|Missed one or more bleeds|13|||
33551093|NCT00986232|101916834|FG001|Overall Study|Missed one or more bleeds|10|||
33551094|NCT00986232|101916835|FG002|Overall Study|Missed one or more bleeds|6|||
33551095|NCT00986232|101916836|FG003|Overall Study|Missed one or more bleeds|7|||
33551096|NCT00986232|101916833|FG000|Overall Study|Incomplete safety follow-up|3|||
33551097|NCT00986232|101916834|FG001|Overall Study|Incomplete safety follow-up|7|||
33551098|NCT00986232|101916835|FG002|Overall Study|Incomplete safety follow-up|2|||
33551099|NCT00986232|101916836|FG003|Overall Study|Incomplete safety follow-up|2|||
33551100|NCT01851369|101916837|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
33551101|NCT01851369|101916838|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
33551102|NCT01851369|101916839|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
33551103|NCT01851369|101916840|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
33551104|NCT01851369|101916841|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
33551105|NCT01851369|101916842|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
33551106|NCT01851369|101916843|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
33551107|NCT01851369|101916844|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
33551108|NCT01851369|101916845|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
33551109|NCT01851369|101916846|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
33551110|NCT01851369|101916847|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
33551111|NCT01851369|101916848|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
33551112|NCT01851369|101916849|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
33551113|NCT02606253|101916850|FG000|Overall Study|Adverse Event|2|||
33551114|NCT02606253|101916851|FG001|Overall Study|Adverse Event|0|||
33551115|NCT02606253|101916852|FG002|Overall Study|Adverse Event|0|||
33551116|NCT02606253|101916850|FG000|Overall Study|Protocol Violation|2|||
33551117|NCT02606253|101916851|FG001|Overall Study|Protocol Violation|1|||
33551118|NCT02606253|101916852|FG002|Overall Study|Protocol Violation|0|||
33551119|NCT02606253|101916850|FG000|Overall Study|Physician Decision|1|||
33551120|NCT02606253|101916851|FG001|Overall Study|Physician Decision|1|||
33551121|NCT02606253|101916852|FG002|Overall Study|Physician Decision|0|||
33551122|NCT03520387|101916855|FG000|Pre-Randomization|Withdrawal by Subject|1|||
33551123|NCT03520387|101916856|FG001|Pre-Randomization|Withdrawal by Subject|0|||
33551124|NCT03520387|101916857|FG002|Pre-Randomization|Withdrawal by Subject|0|||
33551125|NCT03520387|101916858|FG003|Pre-Randomization|Withdrawal by Subject|0|||
33217101|NCT02709005|100692308|FG001|Overall Study|Withdrawal by Subject|0|||
33217102|NCT04124926|100692309|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
33217103|NCT04124926|100692310|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
33217104|NCT04124926|100692311|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
33217105|NCT04124926|100692312|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
33217106|NCT04124926|100692313|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
33217107|NCT04124926|100692309|FG000|Healing Phase|Protocol Violation|0|||
33217108|NCT04124926|100692310|FG001|Healing Phase|Protocol Violation|1|||
33217109|NCT04124926|100692311|FG002|Healing Phase|Protocol Violation|0|||
33217110|NCT04124926|100692312|FG003|Healing Phase|Protocol Violation|0|||
33217111|NCT04124926|100692313|FG004|Healing Phase|Protocol Violation|0|||
33350537|NCT01707992|101167777|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
33350538|NCT01707992|101167778|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
33350539|NCT01707992|101167773|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
33350540|NCT01707992|101167774|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
33350541|NCT01707992|101167775|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
33350542|NCT01707992|101167776|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
33350543|NCT01707992|101167777|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
33350544|NCT01707992|101167778|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
33551126|NCT03520387|101916859|FG004|Pre-Randomization|Withdrawal by Subject|0|||
33618486|NCT04034004|102151551|FG000|Overall Study|nurse accidentally unblinded subject|0|||
33217112|NCT04124926|100692309|FG000|Healing Phase|Lost to Follow-up|5|||
33217113|NCT04124926|100692310|FG001|Healing Phase|Lost to Follow-up|4|||
33217114|NCT04124926|100692311|FG002|Healing Phase|Lost to Follow-up|0|||
33217115|NCT04124926|100692312|FG003|Healing Phase|Lost to Follow-up|0|||
33217116|NCT04124926|100692313|FG004|Healing Phase|Lost to Follow-up|0|||
33217117|NCT04124926|100692309|FG000|Healing Phase|Voluntary Withdrawal|10|||
33217118|NCT04124926|100692310|FG001|Healing Phase|Voluntary Withdrawal|7|||
33217119|NCT04124926|100692311|FG002|Healing Phase|Voluntary Withdrawal|0|||
33551127|NCT03520387|101916855|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
33217120|NCT04124926|100692312|FG003|Healing Phase|Voluntary Withdrawal|0|||
33217121|NCT04124926|100692313|FG004|Healing Phase|Voluntary Withdrawal|0|||
33217122|NCT04124926|100692309|FG000|Healing Phase|Withdrawal of Consent|5|||
33217123|NCT04124926|100692310|FG001|Healing Phase|Withdrawal of Consent|3|||
33217124|NCT04124926|100692311|FG002|Healing Phase|Withdrawal of Consent|0|||
33551128|NCT03520387|101916856|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
33551129|NCT03520387|101916857|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
33551130|NCT03520387|101916858|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
33551131|NCT03520387|101916859|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
33551132|NCT01033071|101916860|FG000|Overall Study|Adverse Event|28|||
33551133|NCT01033071|101916861|FG001|Overall Study|Adverse Event|51|||
33551134|NCT01033071|101916862|FG002|Overall Study|Adverse Event|26|||
33551135|NCT01033071|101916860|FG000|Overall Study|Protocol Violation|0|||
33551136|NCT01033071|101916861|FG001|Overall Study|Protocol Violation|2|||
33217125|NCT04124926|100692312|FG003|Healing Phase|Withdrawal of Consent|0|||
33217126|NCT04124926|100692313|FG004|Healing Phase|Withdrawal of Consent|0|||
33217127|NCT04124926|100692309|FG000|Healing Phase|Miscellaneous|8|||
33350545|NCT01707992|101167773|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
33350546|NCT01707992|101167774|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
33350547|NCT01707992|101167775|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
33350548|NCT01707992|101167776|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
33350549|NCT01707992|101167777|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
33350550|NCT01707992|101167778|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
33350551|NCT01285349|101167779|FG000|Overall Study|Lost to Follow-up|27|||
33350552|NCT01285349|101167780|FG001|Overall Study|Lost to Follow-up|20|||
33350553|NCT01285349|101167781|FG002|Overall Study|Lost to Follow-up|27|||
33350554|NCT03068715|101167782|FG000|Overall Study|No longer met inclusion criteria|1|||
33350555|NCT03068715|101167783|FG001|Overall Study|No longer met inclusion criteria|0|||
33350556|NCT00404092|101167784|FG000|Overall Study|Death|1|||
33350557|NCT00404092|101167785|FG001|Overall Study|Death|0|||
33350558|NCT00404092|101167786|FG002|Overall Study|Death|0|||
33350559|NCT00404092|101167787|FG003|Overall Study|Death|0|||
33350560|NCT00404092|101167784|FG000|Overall Study|Adverse Event|0|||
33350561|NCT00404092|101167785|FG001|Overall Study|Adverse Event|0|||
33350562|NCT00404092|101167786|FG002|Overall Study|Adverse Event|1|||
33350563|NCT00404092|101167787|FG003|Overall Study|Adverse Event|0|||
33350564|NCT02928952|101167788|FG000|Overall Study|Lost to Follow-up|5|||
33350565|NCT02928952|101167789|FG001|Overall Study|Lost to Follow-up|5|||
33350566|NCT02928952|101167788|FG000|Overall Study|Withdrawal by Subject|5|||
33350567|NCT02928952|101167789|FG001|Overall Study|Withdrawal by Subject|1|||
33350568|NCT02928952|101167788|FG000|Overall Study|Physician Decision|0|||
33350569|NCT02928952|101167789|FG001|Overall Study|Physician Decision|1|||
33350570|NCT01946178|101167790|FG000|Overall Study|Pregnancy|1|||
33350571|NCT01946178|101167790|FG000|Overall Study|Lost to Follow-up|1|||
33350572|NCT05340504|101167791|FG000|Overall Study|Withdrawal by Subject|1|||
33350573|NCT05340504|101167792|FG001|Overall Study|Withdrawal by Subject|0|||
33350574|NCT00723957|101167795|FG000|Overall Study|Adverse event unrelated to study drug|1|||
33350575|NCT00723957|101167796|FG001|Overall Study|Adverse event unrelated to study drug|4|||
33350576|NCT00723957|101167795|FG000|Overall Study|Death|3|||
33350577|NCT00723957|101167796|FG001|Overall Study|Death|4|||
33350578|NCT00723957|101167795|FG000|Overall Study|Disease progression|27|||
33350579|NCT00723957|101167796|FG001|Overall Study|Disease progression|25|||
33350580|NCT00723957|101167795|FG000|Overall Study|Maximum clinical benefit|4|||
33350581|NCT00723957|101167796|FG001|Overall Study|Maximum clinical benefit|5|||
33350582|NCT00723957|101167795|FG000|Overall Study|Investigator decision|1|||
33350583|NCT00723957|101167796|FG001|Overall Study|Investigator decision|1|||
33350584|NCT00723957|101167795|FG000|Overall Study|Study drug toxicity|4|||
33350585|NCT00723957|101167796|FG001|Overall Study|Study drug toxicity|6|||
33350586|NCT00723957|101167795|FG000|Overall Study|Withdrawal by Subject|7|||
33350587|NCT00723957|101167796|FG001|Overall Study|Withdrawal by Subject|5|||
33350588|NCT00723957|101167795|FG000|Overall Study|Reason not analyzed|1|||
33350589|NCT00723957|101167796|FG001|Overall Study|Reason not analyzed|0|||
33350590|NCT00723957|101167795|FG000|Overall Study|Never received treatment|3|||
33350591|NCT00723957|101167796|FG001|Overall Study|Never received treatment|3|||
33350592|NCT03838484|101167797|FG000|Overall Study|Lost to Follow-up|0|||
33350593|NCT03838484|101167798|FG001|Overall Study|Lost to Follow-up|1|||
33350594|NCT03838484|101167799|FG002|Overall Study|Lost to Follow-up|0|||
33411196|NCT00594568|101397033|FG000|Delayed Start|Adverse Event|12|||
33411197|NCT00594568|101397034|FG001|Delayed Start|Adverse Event|2|||
33551137|NCT01033071|101916862|FG002|Overall Study|Protocol Violation|1|||
33217128|NCT04124926|100692310|FG001|Healing Phase|Miscellaneous|7|||
33350595|NCT03838484|101167800|FG003|Overall Study|Lost to Follow-up|0|||
33350596|NCT00883493|101167801|FG000|Overall Study|Adverse Event|11|||
33217129|NCT04124926|100692311|FG002|Healing Phase|Miscellaneous|0|||
33350597|NCT00883493|101167802|FG001|Overall Study|Adverse Event|12|||
33551138|NCT01033071|101916860|FG000|Overall Study|Lost to Follow-up|4|||
33411198|NCT00594568|101397035|FG002|Delayed Start|Adverse Event|2|||
33411199|NCT00594568|101397033|FG000|Delayed Start|Withdrawal by Subject|4|||
33411200|NCT00594568|101397034|FG001|Delayed Start|Withdrawal by Subject|3|||
33411201|NCT00594568|101397035|FG002|Delayed Start|Withdrawal by Subject|0|||
33411202|NCT00594568|101397033|FG000|Delayed Start|Physician Decision|0|||
33411203|NCT00594568|101397034|FG001|Delayed Start|Physician Decision|0|||
33411204|NCT00594568|101397035|FG002|Delayed Start|Physician Decision|1|||
33411205|NCT00594568|101397033|FG000|Delayed Start|Lost to Follow-up|0|||
33411206|NCT00594568|101397034|FG001|Delayed Start|Lost to Follow-up|0|||
33411207|NCT00594568|101397035|FG002|Delayed Start|Lost to Follow-up|1|||
33411208|NCT00594568|101397033|FG000|Delayed Start|Caregiver Decision|5|||
33411209|NCT00594568|101397034|FG001|Delayed Start|Caregiver Decision|6|||
33411210|NCT00594568|101397035|FG002|Delayed Start|Caregiver Decision|2|||
33411211|NCT00594568|101397033|FG000|Delayed Start|Sponsor Decision|77|||
33411212|NCT00594568|101397034|FG001|Delayed Start|Sponsor Decision|66|||
33411213|NCT00594568|101397035|FG002|Delayed Start|Sponsor Decision|59|||
33411214|NCT00594568|101397033|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
33411215|NCT00594568|101397034|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
33411216|NCT00594568|101397035|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
33411217|NCT00594568|101397033|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
33411218|NCT00594568|101397034|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
33411219|NCT00594568|101397035|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
33411220|NCT00594568|101397033|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
33411221|NCT00594568|101397034|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
33411222|NCT00594568|101397035|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
33411223|NCT00594568|101397033|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
33411224|NCT00594568|101397034|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
33411225|NCT00594568|101397035|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
33411226|NCT00594568|101397033|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
33411227|NCT00594568|101397034|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
33551139|NCT01033071|101916861|FG001|Overall Study|Lost to Follow-up|5|||
33551140|NCT01033071|101916862|FG002|Overall Study|Lost to Follow-up|5|||
33551141|NCT01033071|101916860|FG000|Overall Study|Withdrawal by Subject|17|||
33551142|NCT01033071|101916861|FG001|Overall Study|Withdrawal by Subject|14|||
33551143|NCT01033071|101916862|FG002|Overall Study|Withdrawal by Subject|11|||
33551144|NCT01033071|101916860|FG000|Overall Study|Lack of Efficacy|0|||
33551145|NCT01033071|101916861|FG001|Overall Study|Lack of Efficacy|1|||
33551146|NCT01033071|101916862|FG002|Overall Study|Lack of Efficacy|1|||
33411228|NCT00594568|101397035|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
33411229|NCT00594568|101397033|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
33551147|NCT01033071|101916860|FG000|Overall Study|Other|6|||
33551148|NCT01033071|101916861|FG001|Overall Study|Other|4|||
33551149|NCT01033071|101916862|FG002|Overall Study|Other|3|||
33551150|NCT02068599|101916863|FG000|Overall Study|Adverse Event|4|||
33551151|NCT02068599|101916864|FG001|Overall Study|Adverse Event|1|||
33551152|NCT02068599|101916865|FG002|Overall Study|Adverse Event|1|||
33551153|NCT02068599|101916863|FG000|Overall Study|Withdrawal by Subject|2|||
33551154|NCT02068599|101916864|FG001|Overall Study|Withdrawal by Subject|7|||
33551155|NCT02068599|101916865|FG002|Overall Study|Withdrawal by Subject|5|||
33551156|NCT02068599|101916863|FG000|Overall Study|Protocol Violation|4|||
33551157|NCT02068599|101916864|FG001|Overall Study|Protocol Violation|2|||
33551158|NCT02068599|101916865|FG002|Overall Study|Protocol Violation|3|||
33551159|NCT02068599|101916863|FG000|Overall Study|Lost to Follow-up|1|||
33551160|NCT02068599|101916864|FG001|Overall Study|Lost to Follow-up|0|||
33551161|NCT02068599|101916865|FG002|Overall Study|Lost to Follow-up|0|||
33551162|NCT02068599|101916863|FG000|Overall Study|Lack of Efficacy|0|||
33551163|NCT02068599|101916864|FG001|Overall Study|Lack of Efficacy|0|||
33551164|NCT02068599|101916865|FG002|Overall Study|Lack of Efficacy|3|||
33551165|NCT02068599|101916863|FG000|Overall Study|Noncompliance|0|||
33551166|NCT02068599|101916864|FG001|Overall Study|Noncompliance|0|||
33217130|NCT04124926|100692312|FG003|Healing Phase|Miscellaneous|0|||
33411230|NCT00594568|101397034|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
33411231|NCT00594568|101397035|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
33411232|NCT04640168|101397036|FG000|Overall Study|Withdrawal by Subject|8|||
33551167|NCT02068599|101916865|FG002|Overall Study|Noncompliance|1|||
33551168|NCT00726557|101916866|FG000|Overall Study|Screening failure|4|||
33551169|NCT00726557|101916866|FG000|Overall Study|No end of treatment documentation|37|||
33551170|NCT00726557|101916866|FG000|Overall Study|No follow-up documentation available|55|||
33551171|NCT00726557|101916866|FG000|Overall Study|Treatment less than 3 months|17|||
33551172|NCT00726557|101916866|FG000|Overall Study|Inclusion criteria not met|15|||
33551173|NCT03723070|101916867|FG000|Overall Study|Lost to Follow-up|2|||
33551174|NCT03723070|101916867|FG000|Overall Study|Physician Decision|1|||
33551175|NCT03723070|101916867|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
33551176|NCT00927082|101916871|FG000|Overall Study|Lost to Follow-up|9|||
33551177|NCT00927082|101916872|FG001|Overall Study|Lost to Follow-up|8|||
33551178|NCT00927082|101916873|FG002|Overall Study|Lost to Follow-up|12|||
33551179|NCT00927082|101916874|FG003|Overall Study|Lost to Follow-up|16|||
33551180|NCT00927082|101916871|FG000|Overall Study|Withdrawal by Subject|3|||
33551181|NCT00927082|101916872|FG001|Overall Study|Withdrawal by Subject|2|||
33551182|NCT00927082|101916873|FG002|Overall Study|Withdrawal by Subject|7|||
33551183|NCT00927082|101916874|FG003|Overall Study|Withdrawal by Subject|2|||
33551184|NCT00927082|101916871|FG000|Overall Study|Death|0|||
33551185|NCT00927082|101916872|FG001|Overall Study|Death|0|||
33551186|NCT00927082|101916873|FG002|Overall Study|Death|1|||
33551187|NCT00927082|101916874|FG003|Overall Study|Death|0|||
33551188|NCT00927082|101916871|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
33551189|NCT00927082|101916872|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
33551190|NCT00927082|101916873|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
33551191|NCT00927082|101916874|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
33551192|NCT04602000|101916875|FG000|Overall Study|Withdrawal by Subject|3|||
33551193|NCT04602000|101916876|FG001|Overall Study|Withdrawal by Subject|6|||
33551194|NCT04602000|101916877|FG002|Overall Study|Withdrawal by Subject|3|||
33551195|NCT04602000|101916878|FG003|Overall Study|Withdrawal by Subject|27|||
33551196|NCT04602000|101916879|FG004|Overall Study|Withdrawal by Subject|39|||
33551197|NCT04602000|101916875|FG000|Overall Study|Physician Decision|1|||
33551198|NCT04602000|101916876|FG001|Overall Study|Physician Decision|0|||
33551199|NCT04602000|101916877|FG002|Overall Study|Physician Decision|0|||
33551200|NCT04602000|101916878|FG003|Overall Study|Physician Decision|2|||
33551201|NCT04602000|101916879|FG004|Overall Study|Physician Decision|2|||
33551202|NCT04602000|101916875|FG000|Overall Study|Death|0|||
33551203|NCT04602000|101916876|FG001|Overall Study|Death|1|||
33551204|NCT04602000|101916877|FG002|Overall Study|Death|0|||
33551205|NCT04602000|101916878|FG003|Overall Study|Death|1|||
33551206|NCT04602000|101916879|FG004|Overall Study|Death|2|||
33551207|NCT04602000|101916875|FG000|Overall Study|Lost to Follow-up|0|||
33551208|NCT04602000|101916876|FG001|Overall Study|Lost to Follow-up|0|||
33551209|NCT04602000|101916877|FG002|Overall Study|Lost to Follow-up|0|||
33551210|NCT04602000|101916878|FG003|Overall Study|Lost to Follow-up|3|||
33551211|NCT04602000|101916879|FG004|Overall Study|Lost to Follow-up|4|||
33551212|NCT04602000|101916875|FG000|Overall Study|Other|4|||
33551213|NCT04602000|101916876|FG001|Overall Study|Other|1|||
33551214|NCT04602000|101916877|FG002|Overall Study|Other|2|||
33551215|NCT04602000|101916878|FG003|Overall Study|Other|5|||
33551216|NCT04602000|101916879|FG004|Overall Study|Other|4|||
33551217|NCT04602000|101916875|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
33551218|NCT04602000|101916876|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
33551219|NCT04602000|101916877|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
33551220|NCT04602000|101916878|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
33551221|NCT04602000|101916879|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
33551222|NCT00368849|101916882|FG000|Overall Study|Withdrawal by Subject|0|||
33551223|NCT00368849|101916883|FG001|Overall Study|Withdrawal by Subject|1|||
33551224|NCT00368849|101916882|FG000|Overall Study|Physician Decision|0|||
33551225|NCT00368849|101916883|FG001|Overall Study|Physician Decision|1|||
33551226|NCT05161936|101916887|FG000|Overall Study|Study terminated by Sponsor|1|||
33551227|NCT05161936|101916888|FG001|Overall Study|Study terminated by Sponsor|0|||
33551228|NCT05161936|101916889|FG002|Overall Study|Study terminated by Sponsor|0|||
33551229|NCT05161936|101916887|FG000|Overall Study|Withdrawal by Subject|0|||
33551230|NCT05161936|101916888|FG001|Overall Study|Withdrawal by Subject|0|||
33551231|NCT05161936|101916889|FG002|Overall Study|Withdrawal by Subject|1|||
33551232|NCT02497755|101916890|FG000|Overall Study|Protocol Violation|1|||
33551233|NCT02497755|101916891|FG001|Overall Study|Protocol Violation|0|||
33551234|NCT01436500|101916892|FG000|Overall Study|Death|1|||
33551235|NCT01436500|101916893|FG001|Overall Study|Death|0|||
33551236|NCT01436500|101916894|FG002|Overall Study|Death|0|||
33551237|NCT01436500|101916895|FG003|Overall Study|Death|0|||
33551238|NCT01436500|101916896|FG004|Overall Study|Death|0|||
33551239|NCT01436500|101916892|FG000|Overall Study|Adverse Event|0|||
33551240|NCT01436500|101916893|FG001|Overall Study|Adverse Event|2|||
33551241|NCT01436500|101916894|FG002|Overall Study|Adverse Event|2|||
33551242|NCT01436500|101916895|FG003|Overall Study|Adverse Event|0|||
33551243|NCT01436500|101916896|FG004|Overall Study|Adverse Event|1|||
33551244|NCT01436500|101916892|FG000|Overall Study|Withdrawal by Subject|0|||
33551245|NCT01436500|101916893|FG001|Overall Study|Withdrawal by Subject|0|||
33551246|NCT01436500|101916894|FG002|Overall Study|Withdrawal by Subject|2|||
33551247|NCT01436500|101916895|FG003|Overall Study|Withdrawal by Subject|0|||
33551248|NCT01436500|101916896|FG004|Overall Study|Withdrawal by Subject|2|||
33551249|NCT01436500|101916892|FG000|Overall Study|Physician Decision|0|||
33551250|NCT01436500|101916893|FG001|Overall Study|Physician Decision|0|||
33551251|NCT01436500|101916894|FG002|Overall Study|Physician Decision|1|||
33551252|NCT01436500|101916895|FG003|Overall Study|Physician Decision|0|||
33618487|NCT04034004|102151552|FG001|Overall Study|nurse accidentally unblinded subject|0|||
33618488|NCT04034004|102151553|FG002|Overall Study|nurse accidentally unblinded subject|0|||
33618489|NCT04034004|102151554|FG003|Overall Study|nurse accidentally unblinded subject|1|||
33618490|NCT02586623|102151555|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
33618491|NCT02586623|102151556|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
33618492|NCT02586623|102151557|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
33618493|NCT02586623|102151555|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
33618494|NCT02586623|102151556|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
33618495|NCT02586623|102151557|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
33618496|NCT02586623|102151555|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
33618497|NCT02586623|102151556|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
33618498|NCT02586623|102151557|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
33618499|NCT02586623|102151555|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
33618500|NCT02586623|102151556|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
33618501|NCT02586623|102151557|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
33618502|NCT02586623|102151555|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
33618503|NCT02586623|102151556|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
33618504|NCT02586623|102151557|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
33618505|NCT02586623|102151555|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
33618506|NCT02586623|102151556|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
33618507|NCT02586623|102151557|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
33618508|NCT02586623|102151555|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
33618509|NCT02586623|102151556|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
33618510|NCT02586623|102151557|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
33618511|NCT02586623|102151555|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
33618512|NCT02586623|102151556|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
33618513|NCT02586623|102151557|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
33618514|NCT02586623|102151555|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
33618515|NCT02586623|102151556|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
33618516|NCT02586623|102151557|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
33618517|NCT02586623|102151555|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
33618518|NCT02586623|102151556|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
33618519|NCT02586623|102151557|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
33618520|NCT02586623|102151555|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
33618521|NCT02586623|102151556|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
33618522|NCT02586623|102151557|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
33618523|NCT02586623|102151555|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
33618524|NCT02586623|102151556|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
33618525|NCT02586623|102151557|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
33618526|NCT02586623|102151555|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
33618527|NCT02586623|102151556|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
33618528|NCT02586623|102151557|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
33618529|NCT02586623|102151555|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
33618530|NCT02586623|102151556|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
33618531|NCT02586623|102151557|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
33618532|NCT02586623|102151555|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
33618533|NCT02586623|102151556|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
33618534|NCT02586623|102151557|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
33618535|NCT02586623|102151555|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
33618536|NCT02586623|102151556|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
33618537|NCT02586623|102151557|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
33618538|NCT02586623|102151555|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
33618539|NCT02586623|102151556|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
33618540|NCT02586623|102151557|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
33618541|NCT02586623|102151555|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
33618542|NCT02586623|102151556|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
33618543|NCT02586623|102151557|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
33618544|NCT02586623|102151555|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
33618545|NCT02586623|102151556|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
33618546|NCT02586623|102151557|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
33618547|NCT02586623|102151555|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
33618548|NCT02586623|102151556|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
33618549|NCT02586623|102151557|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
33618550|NCT02586623|102151555|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
33618551|NCT02586623|102151556|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
33618552|NCT02586623|102151557|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
33618553|NCT04531241|102151558|FG000|Period 1|Withdrawal by Subject|2|||
33618554|NCT04531241|102151559|FG001|Period 1|Withdrawal by Subject|0|||
33618555|NCT04531241|102151558|FG000|Period 1|Dispesed incorrect lens power|1|||
33618556|NCT04531241|102151559|FG001|Period 1|Dispesed incorrect lens power|0|||
33618557|NCT04531241|102151558|FG000|Period 1|Protocol Violation|1|||
33618558|NCT04531241|102151559|FG001|Period 1|Protocol Violation|0|||
33618559|NCT04531241|102151558|FG000|Period 1|No longer eligible|0|||
33618560|NCT04531241|102151559|FG001|Period 1|No longer eligible|1|||
33618561|NCT04531241|102151558|FG000|Period 1|Lens Discomfort|0|||
33618562|NCT04531241|102151559|FG001|Period 1|Lens Discomfort|1|||
33618563|NCT04531241|102151558|FG000|Period 2|Covid-19 Related|1|||
33618564|NCT04531241|102151559|FG001|Period 2|Covid-19 Related|1|||
33618565|NCT01979952|102151560|FG000|Overall Study|Adverse Event|4|||
33618566|NCT01979952|102151561|FG001|Overall Study|Adverse Event|5|||
33618567|NCT01979952|102151560|FG000|Overall Study|Protocol Violation|1|||
33618568|NCT01979952|102151561|FG001|Overall Study|Protocol Violation|0|||
33618569|NCT01979952|102151560|FG000|Overall Study|Withdrawal by Subject|2|||
33618570|NCT01979952|102151561|FG001|Overall Study|Withdrawal by Subject|1|||
33618571|NCT01979952|102151560|FG000|Overall Study|Other than specified above|1|||
33618572|NCT01979952|102151561|FG001|Overall Study|Other than specified above|0|||
33618573|NCT00891228|102151563|FG000|Overall Study|Adverse Event|0|||
33618574|NCT00891228|102151564|FG001|Overall Study|Adverse Event|2|||
33618575|NCT00891228|102151565|FG002|Overall Study|Adverse Event|3|||
33618576|NCT00891228|102151563|FG000|Overall Study|Withdrawal by Subject|2|||
33618577|NCT00891228|102151564|FG001|Overall Study|Withdrawal by Subject|4|||
33618578|NCT00891228|102151565|FG002|Overall Study|Withdrawal by Subject|5|||
33618579|NCT00891228|102151563|FG000|Overall Study|Protocol Violation|3|||
33618580|NCT00891228|102151564|FG001|Overall Study|Protocol Violation|1|||
33618581|NCT00891228|102151565|FG002|Overall Study|Protocol Violation|2|||
33618582|NCT00891228|102151563|FG000|Overall Study|Physician Decision|2|||
33618583|NCT00891228|102151564|FG001|Overall Study|Physician Decision|1|||
33618584|NCT00891228|102151565|FG002|Overall Study|Physician Decision|0|||
33618585|NCT00891228|102151563|FG000|Overall Study|Lost to Follow-up|4|||
33618586|NCT00891228|102151564|FG001|Overall Study|Lost to Follow-up|4|||
33618587|NCT00891228|102151565|FG002|Overall Study|Lost to Follow-up|5|||
33618588|NCT00891228|102151563|FG000|Overall Study|Pregnancy|0|||
33618589|NCT00891228|102151564|FG001|Overall Study|Pregnancy|1|||
33618590|NCT00891228|102151565|FG002|Overall Study|Pregnancy|0|||
33618591|NCT01388907|102151566|FG000|Overall Study|Adverse Event|2|||
33618592|NCT01388907|102151567|FG001|Overall Study|Adverse Event|0|||
33618593|NCT02837029|102151572|FG000|Screening|Failed to meet screening requirements.|7|||
33618594|NCT02837029|102151573|FG001|Screening|Failed to meet screening requirements.|3|||
33618595|NCT02837029|102151574|FG002|Screening|Failed to meet screening requirements.|0|||
33618596|NCT02837029|102151572|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
33618597|NCT02837029|102151573|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
33618598|NCT02837029|102151574|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
33618599|NCT02837029|102151572|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
33618600|NCT02837029|102151573|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
33618601|NCT02837029|102151574|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
33618602|NCT02837029|102151572|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
33618603|NCT02837029|102151573|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
33618604|NCT02837029|102151574|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
33618605|NCT02837029|102151572|FG000|Cycle 2 and Beyond|Adverse Event|1|||
33618606|NCT02837029|102151573|FG001|Cycle 2 and Beyond|Adverse Event|0|||
33618607|NCT02837029|102151574|FG002|Cycle 2 and Beyond|Adverse Event|0|||
33618608|NCT02837029|102151572|FG000|2 Year Follow-up|Death|6|||
33618609|NCT02837029|102151573|FG001|2 Year Follow-up|Death|7|||
33618610|NCT02837029|102151574|FG002|2 Year Follow-up|Death|0|||
33618611|NCT01420926|102151575|FG000|Overall Study|Adverse Event|6|||
33618612|NCT01420926|102151576|FG001|Overall Study|Adverse Event|4|||
33618613|NCT01420926|102151575|FG000|Overall Study|Death|18|||
33618614|NCT01420926|102151576|FG001|Overall Study|Death|17|||
33618615|NCT01420926|102151575|FG000|Overall Study|Withdrawal by Subject|11|||
33618616|NCT01420926|102151576|FG001|Overall Study|Withdrawal by Subject|17|||
33618617|NCT01420926|102151575|FG000|Overall Study|Non-protocol treatment|17|||
33618618|NCT01420926|102151576|FG001|Overall Study|Non-protocol treatment|20|||
33618619|NCT01420926|102151575|FG000|Overall Study|Physician Decision|8|||
33618620|NCT01420926|102151576|FG001|Overall Study|Physician Decision|5|||
33618621|NCT03948334|102151577|FG000|Overall Study|Adverse Event|1|||
33411233|NCT04640168|101397037|FG001|Overall Study|Withdrawal by Subject|7|||
33618622|NCT03948334|102151578|FG001|Overall Study|Adverse Event|4|||
33618623|NCT03948334|102151577|FG000|Overall Study|Lack of Efficacy|2|||
33618624|NCT03948334|102151578|FG001|Overall Study|Lack of Efficacy|0|||
33618625|NCT03948334|102151577|FG000|Overall Study|Lost to Follow-up|1|||
33618626|NCT03948334|102151578|FG001|Overall Study|Lost to Follow-up|0|||
33618627|NCT03948334|102151577|FG000|Overall Study|Physician Decision|1|||
33618628|NCT03948334|102151578|FG001|Overall Study|Physician Decision|0|||
33618629|NCT03948334|102151577|FG000|Overall Study|Pregnancy|0|||
33618630|NCT03948334|102151578|FG001|Overall Study|Pregnancy|1|||
33411234|NCT04640168|101397036|FG000|Overall Study|Lost to Follow-up|1|||
33411235|NCT04640168|101397037|FG001|Overall Study|Lost to Follow-up|0|||
33411236|NCT04640168|101397036|FG000|Overall Study|Enrolled but not treated|12|||
33411237|NCT04640168|101397037|FG001|Overall Study|Enrolled but not treated|12|||
33411238|NCT03246152|101397038|FG000|Overall Study|Lost to Follow-up|2|||
33411239|NCT03246152|101397038|FG000|Overall Study|Protocol Violation|1|||
33411240|NCT04983589|101397039|FG000|Overall Study|Withdrawal by Subject|0|||
33411241|NCT04983589|101397040|FG001|Overall Study|Withdrawal by Subject|3|||
33411242|NCT04983589|101397039|FG000|Overall Study|COVID-19 Infection|1|||
33411243|NCT04983589|101397040|FG001|Overall Study|COVID-19 Infection|0|||
33411244|NCT04983589|101397039|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
33411245|NCT04983589|101397040|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
33411246|NCT00834366|101397042|FG000|Treatment Period 1|Adverse Event|1|||
33411247|NCT00834366|101397043|FG001|Treatment Period 1|Adverse Event|1|||
33411248|NCT02222246|101397046|FG000|Overall Study|No Emergency Department Visits|27|||
33411249|NCT02222246|101397047|FG001|Overall Study|No Emergency Department Visits|26|||
33411250|NCT02222246|101397046|FG000|Overall Study|Physician Decision|0|||
33411251|NCT02222246|101397047|FG001|Overall Study|Physician Decision|1|||
33411252|NCT03186794|101397048|FG000|Overall Study|Physician Decision|2|||
33411253|NCT03186794|101397048|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
33411254|NCT02046993|101397049|FG000|Overall Study|Withdrawal by Subject|2|||
33411255|NCT02046993|101397050|FG001|Overall Study|Withdrawal by Subject|10|||
33411256|NCT02046993|101397049|FG000|Overall Study|Lost to Follow-up|1|||
33411257|NCT02046993|101397050|FG001|Overall Study|Lost to Follow-up|1|||
33411258|NCT00656669|101397052|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
33411259|NCT00656669|101397052|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
33411260|NCT00656669|101397052|FG000|AC (Cycles 6-9)|Adverse Event|1|||
33411261|NCT00656669|101397052|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
33411262|NCT00494234|101397057|FG000|Overall Study|Withdrawal by Subject|1|||
33411263|NCT00494234|101397058|FG001|Overall Study|Withdrawal by Subject|0|||
33411264|NCT00494234|101397057|FG000|Overall Study|Disease progression|11|||
33411265|NCT00494234|101397058|FG001|Overall Study|Disease progression|8|||
33411266|NCT00494234|101397057|FG000|Overall Study|Death|2|||
33411267|NCT00494234|101397058|FG001|Overall Study|Death|1|||
33411268|NCT00965562|101397059|FG000|Overall Study|Lost to Follow-up|1|||
33411269|NCT00965562|101397060|FG001|Overall Study|Lost to Follow-up|2|||
33411270|NCT00965562|101397061|FG002|Overall Study|Lost to Follow-up|3|||
33411271|NCT00965562|101397059|FG000|Overall Study|Withdrawal by Subject|2|||
33411272|NCT00965562|101397060|FG001|Overall Study|Withdrawal by Subject|2|||
33411273|NCT00965562|101397061|FG002|Overall Study|Withdrawal by Subject|0|||
33411274|NCT02396849|101397063|FG000|Overall Study|Lost to Follow-up|1|||
33411275|NCT02396849|101397064|FG001|Overall Study|Lost to Follow-up|1|||
33411276|NCT02396849|101397063|FG000|Overall Study|Did not tolerate intervention|1|||
33411277|NCT02396849|101397064|FG001|Overall Study|Did not tolerate intervention|1|||
33411278|NCT01958619|101397068|FG000|Overall Study|Protocol Violation|2|||
33411279|NCT01958619|101397069|FG001|Overall Study|Protocol Violation|0|||
33411280|NCT01958619|101397070|FG002|Overall Study|Protocol Violation|1|||
33411281|NCT01958619|101397071|FG003|Overall Study|Protocol Violation|0|||
33411282|NCT01519635|101397072|FG000|Overall Study|Withdrawal by Subject|0|||
33411283|NCT01519635|101397073|FG001|Overall Study|Withdrawal by Subject|1|||
33411284|NCT01519635|101397072|FG000|Overall Study|No possibility to put a catheter|1|||
33411285|NCT01519635|101397073|FG001|Overall Study|No possibility to put a catheter|2|||
33411286|NCT02687815|101397078|FG000|Overall Study|Lost to Follow-up|2|||
33411287|NCT02687815|101397079|FG001|Overall Study|Lost to Follow-up|4|||
33411288|NCT02687815|101397078|FG000|Overall Study|Withdrawal by Subject|2|||
33411289|NCT02687815|101397079|FG001|Overall Study|Withdrawal by Subject|4|||
33411290|NCT02392377|101397081|FG000|Overall Study|Withdrawal by Subject|0|||
33551253|NCT01436500|101916896|FG004|Overall Study|Physician Decision|0|||
33551254|NCT01436500|101916892|FG000|Overall Study|liver transplant|1|||
33551255|NCT01436500|101916893|FG001|Overall Study|liver transplant|0|||
33217131|NCT04124926|100692313|FG004|Healing Phase|Miscellaneous|0|||
33217132|NCT04124926|100692309|FG000|Healing Phase|Randomized but not Treated|0|||
33411291|NCT02392377|101397082|FG001|Overall Study|Withdrawal by Subject|1|||
33411292|NCT03732534|101397084|FG000|Overall Study|Study terminated by Sponsor|6|||
33411293|NCT01683565|101397085|FG000|Overall Study|Lost to Follow-up|2|||
33350598|NCT00883493|101167801|FG000|Overall Study|Lack of Efficacy|4|||
33411294|NCT01683565|101397086|FG001|Overall Study|Lost to Follow-up|0|||
33411295|NCT01683565|101397085|FG000|Overall Study|Discontinued Intervention|1|||
33350599|NCT00883493|101167802|FG001|Overall Study|Lack of Efficacy|3|||
33350600|NCT00883493|101167801|FG000|Overall Study|Lost to Follow-up|7|||
33350601|NCT00883493|101167802|FG001|Overall Study|Lost to Follow-up|6|||
33350602|NCT00883493|101167801|FG000|Overall Study|Withdrawal by Subject|11|||
33350603|NCT00883493|101167802|FG001|Overall Study|Withdrawal by Subject|20|||
33350604|NCT00883493|101167801|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
33350605|NCT00883493|101167802|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
33411296|NCT01683565|101397086|FG001|Overall Study|Discontinued Intervention|1|||
33551256|NCT01436500|101916894|FG002|Overall Study|liver transplant|0|||
33217133|NCT04124926|100692310|FG001|Healing Phase|Randomized but not Treated|3|||
33217134|NCT04124926|100692311|FG002|Healing Phase|Randomized but not Treated|0|||
33217135|NCT04124926|100692312|FG003|Healing Phase|Randomized but not Treated|0|||
33217136|NCT04124926|100692313|FG004|Healing Phase|Randomized but not Treated|0|||
33217137|NCT04124926|100692309|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
33217138|NCT04124926|100692310|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
33217139|NCT04124926|100692311|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
33217140|NCT04124926|100692312|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
33217141|NCT04124926|100692313|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
33217142|NCT04124926|100692309|FG000|Maintenance Phase|Protocol Violation|0|||
33217143|NCT04124926|100692310|FG001|Maintenance Phase|Protocol Violation|0|||
33217144|NCT04124926|100692311|FG002|Maintenance Phase|Protocol Violation|3|||
33217145|NCT04124926|100692312|FG003|Maintenance Phase|Protocol Violation|0|||
33217146|NCT04124926|100692313|FG004|Maintenance Phase|Protocol Violation|0|||
33217147|NCT04124926|100692309|FG000|Maintenance Phase|Lost to Follow-up|0|||
33217148|NCT04124926|100692310|FG001|Maintenance Phase|Lost to Follow-up|0|||
33217149|NCT04124926|100692311|FG002|Maintenance Phase|Lost to Follow-up|7|||
33217150|NCT04124926|100692312|FG003|Maintenance Phase|Lost to Follow-up|8|||
33217151|NCT04124926|100692313|FG004|Maintenance Phase|Lost to Follow-up|9|||
33217152|NCT04124926|100692309|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
33217153|NCT04124926|100692310|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
33217154|NCT04124926|100692311|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
33217155|NCT04124926|100692312|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
33551257|NCT01436500|101916895|FG003|Overall Study|liver transplant|0|||
33551258|NCT01436500|101916896|FG004|Overall Study|liver transplant|0|||
33551259|NCT01436500|101916892|FG000|Overall Study|initiation of dialysis|0|||
33551260|NCT01436500|101916893|FG001|Overall Study|initiation of dialysis|0|||
33217156|NCT04124926|100692313|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
33217157|NCT04124926|100692309|FG000|Maintenance Phase|Pregnancy|0|||
33217158|NCT04124926|100692310|FG001|Maintenance Phase|Pregnancy|0|||
33217159|NCT04124926|100692311|FG002|Maintenance Phase|Pregnancy|0|||
33217160|NCT04124926|100692312|FG003|Maintenance Phase|Pregnancy|1|||
33217161|NCT04124926|100692313|FG004|Maintenance Phase|Pregnancy|0|||
33217162|NCT04124926|100692309|FG000|Maintenance Phase|Lack of Efficacy|0|||
33217163|NCT04124926|100692310|FG001|Maintenance Phase|Lack of Efficacy|0|||
33217164|NCT04124926|100692311|FG002|Maintenance Phase|Lack of Efficacy|0|||
33217165|NCT04124926|100692312|FG003|Maintenance Phase|Lack of Efficacy|0|||
33217166|NCT04124926|100692313|FG004|Maintenance Phase|Lack of Efficacy|1|||
33217167|NCT04124926|100692309|FG000|Maintenance Phase|Withdrawal of Consent|0|||
33217168|NCT04124926|100692310|FG001|Maintenance Phase|Withdrawal of Consent|0|||
33217169|NCT04124926|100692311|FG002|Maintenance Phase|Withdrawal of Consent|5|||
33551261|NCT01436500|101916894|FG002|Overall Study|initiation of dialysis|0|||
33551262|NCT01436500|101916895|FG003|Overall Study|initiation of dialysis|0|||
33551263|NCT01436500|101916896|FG004|Overall Study|initiation of dialysis|1|||
33551264|NCT01436500|101916892|FG000|Overall Study|discontinued study drug|1|||
33350606|NCT00883493|101167801|FG000|Overall Study|Study specific disc. criteria|2|||
33551265|NCT01436500|101916893|FG001|Overall Study|discontinued study drug|0|||
33217170|NCT04124926|100692312|FG003|Maintenance Phase|Withdrawal of Consent|5|||
33217171|NCT04124926|100692313|FG004|Maintenance Phase|Withdrawal of Consent|5|||
33217172|NCT04124926|100692309|FG000|Maintenance Phase|Miscellaneous|0|||
33350607|NCT00883493|101167802|FG001|Overall Study|Study specific disc. criteria|0|||
33551266|NCT01436500|101916894|FG002|Overall Study|discontinued study drug|0|||
33551267|NCT01436500|101916895|FG003|Overall Study|discontinued study drug|0|||
33551268|NCT01436500|101916896|FG004|Overall Study|discontinued study drug|0|||
33411297|NCT00077766|101397098|FG000|Overall Study|Adverse Event|1|||
33411298|NCT00077766|101397099|FG001|Overall Study|Adverse Event|1|||
33411299|NCT00077766|101397098|FG000|Overall Study|Withdrawal by Subject|4|||
33411300|NCT00077766|101397099|FG001|Overall Study|Withdrawal by Subject|3|||
33411301|NCT00077766|101397098|FG000|Overall Study|Death|12|||
33411302|NCT00077766|101397099|FG001|Overall Study|Death|10|||
33411303|NCT00077766|101397098|FG000|Overall Study|Lost to Follow-up|2|||
33411304|NCT00077766|101397099|FG001|Overall Study|Lost to Follow-up|0|||
33411305|NCT00077766|101397098|FG000|Overall Study|Protocol Violation|1|||
33551269|NCT01436500|101916892|FG000|Overall Study|Other|0|||
33551270|NCT01436500|101916893|FG001|Overall Study|Other|1|||
33551271|NCT01436500|101916894|FG002|Overall Study|Other|0|||
33551272|NCT01436500|101916895|FG003|Overall Study|Other|1|||
33551273|NCT01436500|101916896|FG004|Overall Study|Other|0|||
33551274|NCT02280499|101916897|FG000|Overall Study|Death|14|||
33551275|NCT02280499|101916897|FG000|Overall Study|Lost to Follow-up|42|||
33551276|NCT02280499|101916897|FG000|Overall Study|Adverse Event|5|||
33551277|NCT00853047|101916900|FG000|Core Phase|Participant Request|0|||
33217173|NCT04124926|100692310|FG001|Maintenance Phase|Miscellaneous|0|||
33217174|NCT04124926|100692311|FG002|Maintenance Phase|Miscellaneous|1|||
33551278|NCT00853047|101916901|FG001|Core Phase|Participant Request|0|||
33551279|NCT00853047|101916902|FG002|Core Phase|Participant Request|0|||
33551280|NCT00853047|101916903|FG003|Core Phase|Participant Request|1|||
33551281|NCT00853047|101916904|FG004|Core Phase|Participant Request|0|||
33551282|NCT00853047|101916905|FG005|Core Phase|Participant Request|0|||
33551283|NCT00853047|101916900|FG000|Open-Label Extension Phase|Participant Request|0|||
33551284|NCT00853047|101916901|FG001|Open-Label Extension Phase|Participant Request|0|||
33551285|NCT00853047|101916902|FG002|Open-Label Extension Phase|Participant Request|0|||
33551286|NCT00853047|101916903|FG003|Open-Label Extension Phase|Participant Request|0|||
33551287|NCT00853047|101916904|FG004|Open-Label Extension Phase|Participant Request|0|||
33551288|NCT00853047|101916905|FG005|Open-Label Extension Phase|Participant Request|7|||
33551289|NCT00853047|101916900|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
33551290|NCT00853047|101916901|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
33551291|NCT00853047|101916902|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
33551292|NCT00853047|101916903|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
33551293|NCT00853047|101916904|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
33350608|NCT00883493|101167801|FG000|Overall Study|Other|5|||
33350609|NCT00883493|101167802|FG001|Overall Study|Other|3|||
33350610|NCT01499290|101167803|FG000|Overall Study|Withdrawal by Subject|22|||
33350611|NCT01499290|101167804|FG001|Overall Study|Withdrawal by Subject|15|||
33350612|NCT01499290|101167803|FG000|Overall Study|Not specified in study report|11|||
33217175|NCT04124926|100692312|FG003|Maintenance Phase|Miscellaneous|2|||
33217176|NCT04124926|100692313|FG004|Maintenance Phase|Miscellaneous|4|||
33217177|NCT04124926|100692309|FG000|Maintenance Phase|Randomized but not Treated|0|||
33217178|NCT04124926|100692310|FG001|Maintenance Phase|Randomized but not Treated|0|||
33350613|NCT01499290|101167804|FG001|Overall Study|Not specified in study report|5|||
33217179|NCT04124926|100692311|FG002|Maintenance Phase|Randomized but not Treated|2|||
33350614|NCT01499290|101167803|FG000|Overall Study|Condition improved/subject recovered|1|||
33350615|NCT01499290|101167804|FG001|Overall Study|Condition improved/subject recovered|0|||
33411306|NCT00077766|101397099|FG001|Overall Study|Protocol Violation|0|||
33411307|NCT00077766|101397098|FG000|Overall Study|Kidney Transplantation|9|||
33411308|NCT00077766|101397099|FG001|Overall Study|Kidney Transplantation|5|||
33411309|NCT00077766|101397098|FG000|Overall Study|Transplantation|5|||
33411310|NCT00077766|101397099|FG001|Overall Study|Transplantation|1|||
33411311|NCT00077766|101397098|FG000|Overall Study|Investigators Discretion|1|||
33551294|NCT00853047|101916905|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
33551295|NCT00853047|101916900|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
33551296|NCT00853047|101916901|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
33551297|NCT00853047|101916902|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
33551298|NCT00853047|101916903|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
33551299|NCT00853047|101916904|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
33217180|NCT04124926|100692312|FG003|Maintenance Phase|Randomized but not Treated|2|||
33217181|NCT04124926|100692313|FG004|Maintenance Phase|Randomized but not Treated|0|||
33217182|NCT01666951|100692314|FG000|Overall Study|Not dosed|1|||
33217183|NCT01666951|100692315|FG001|Overall Study|Not dosed|1|||
33217184|NCT02618616|100692316|FG000|Overall Study|Lack of Efficacy|4|||
33350616|NCT01499290|101167803|FG000|Overall Study|Lack of Efficacy|7|||
33350617|NCT01499290|101167804|FG001|Overall Study|Lack of Efficacy|8|||
33411312|NCT00077766|101397099|FG001|Overall Study|Investigators Discretion|0|||
33350618|NCT01499290|101167803|FG000|Overall Study|Adverse Event|14|||
33350619|NCT01499290|101167804|FG001|Overall Study|Adverse Event|7|||
33350620|NCT00888355|101167805|FG000|Overall Study|Adverse Event|10|||
33350621|NCT00888355|101167806|FG001|Overall Study|Adverse Event|0|||
33551300|NCT00853047|101916905|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
33551301|NCT00853047|101916900|FG000|Open-Label Extension Phase|Investigator Decision|0|||
33551302|NCT00853047|101916901|FG001|Open-Label Extension Phase|Investigator Decision|0|||
33551303|NCT00853047|101916902|FG002|Open-Label Extension Phase|Investigator Decision|0|||
33551304|NCT00853047|101916903|FG003|Open-Label Extension Phase|Investigator Decision|0|||
33551305|NCT00853047|101916904|FG004|Open-Label Extension Phase|Investigator Decision|0|||
33551306|NCT00853047|101916905|FG005|Open-Label Extension Phase|Investigator Decision|1|||
33551307|NCT00853047|101916900|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
33551308|NCT00853047|101916901|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
33551309|NCT00853047|101916902|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
33551310|NCT00853047|101916903|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
33411313|NCT00077766|101397098|FG000|Overall Study|Participant's decision|1|||
33411314|NCT00077766|101397099|FG001|Overall Study|Participant's decision|0|||
33411315|NCT00077766|101397098|FG000|Overall Study|Dialysis Discontinued|1|||
33411316|NCT00077766|101397099|FG001|Overall Study|Dialysis Discontinued|0|||
33551311|NCT00853047|101916904|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
33551312|NCT00853047|101916905|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
33551313|NCT00683384|101916907|FG000|Overall Study|Death|1|||
33551314|NCT00683384|101916907|FG000|Overall Study|Adverse Event|1|||
33551315|NCT01567085|101916908|FG000|Overall Study|Death|6|||
33551316|NCT01567085|101916908|FG000|Overall Study|Adverse Event|6|||
33350622|NCT00888355|101167807|FG002|Overall Study|Adverse Event|3|||
33350623|NCT00888355|101167808|FG003|Overall Study|Adverse Event|3|||
33411317|NCT00077766|101397098|FG000|Overall Study|Dialysis|0|||
33411318|NCT00077766|101397099|FG001|Overall Study|Dialysis|1|||
33411319|NCT00077766|101397098|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
33411320|NCT00077766|101397099|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
33411321|NCT00077766|101397098|FG000|Overall Study|Started Nocturnal Dialysis|0|||
33551317|NCT01567085|101916908|FG000|Overall Study|Lost to Follow-up|3|||
33350624|NCT00888355|101167805|FG000|Overall Study|Lack of Efficacy|9|||
33350625|NCT00888355|101167806|FG001|Overall Study|Lack of Efficacy|2|||
33350626|NCT00888355|101167807|FG002|Overall Study|Lack of Efficacy|5|||
33551318|NCT01567085|101916908|FG000|Overall Study|Graft loss|2|||
33551319|NCT01567085|101916908|FG000|Overall Study|Renal transplantectomy|1|||
33551320|NCT01567085|101916908|FG000|Overall Study|Returned to chronic dialysis|1|||
33551321|NCT01567085|101916908|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
33411322|NCT00077766|101397099|FG001|Overall Study|Started Nocturnal Dialysis|1|||
33411323|NCT00077766|101397098|FG000|Overall Study|Stop Dialysis|0|||
33217185|NCT02618616|100692317|FG001|Overall Study|Lack of Efficacy|0|||
33411324|NCT00077766|101397099|FG001|Overall Study|Stop Dialysis|1|||
33350627|NCT00888355|101167808|FG003|Overall Study|Lack of Efficacy|2|||
33551322|NCT01131585|101916909|FG000|Overall Study|Adverse Event|0|||
33551323|NCT01131585|101916910|FG001|Overall Study|Adverse Event|2|||
33551324|NCT01131585|101916909|FG000|Overall Study|Abnormal laboratory value|1|||
33217186|NCT02618616|100692316|FG000|Overall Study|Pregnancy|0|||
33217187|NCT02618616|100692317|FG001|Overall Study|Pregnancy|1|||
33217188|NCT02618616|100692316|FG000|Overall Study|Adverse Event|8|||
33217189|NCT02618616|100692317|FG001|Overall Study|Adverse Event|0|||
33217190|NCT02618616|100692316|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
33217191|NCT02618616|100692317|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
33217192|NCT02618616|100692316|FG000|Overall Study|Consent withdrawn by subject|8|||
33217193|NCT02618616|100692317|FG001|Overall Study|Consent withdrawn by subject|5|||
33217194|NCT02618616|100692316|FG000|Overall Study|Lost to Follow-up|0|||
33411325|NCT00077766|101397098|FG000|Overall Study|Participants Vacation|2|||
33411326|NCT00077766|101397099|FG001|Overall Study|Participants Vacation|1|||
33217195|NCT02618616|100692317|FG001|Overall Study|Lost to Follow-up|1|||
33217196|NCT00677833|100692321|FG000|Overall Study|Withdrawal by Subject|4|||
33217197|NCT00677833|100692322|FG001|Overall Study|Withdrawal by Subject|0|||
33217198|NCT00677833|100692323|FG002|Overall Study|Withdrawal by Subject|1|||
33217199|NCT00677833|100692324|FG003|Overall Study|Withdrawal by Subject|3|||
33217200|NCT00677833|100692321|FG000|Overall Study|Lost to Follow-up|0|||
33217201|NCT00677833|100692322|FG001|Overall Study|Lost to Follow-up|0|||
33217202|NCT00677833|100692323|FG002|Overall Study|Lost to Follow-up|1|||
33217203|NCT00677833|100692324|FG003|Overall Study|Lost to Follow-up|0|||
33217204|NCT03466086|100692331|FG000|Period 1|Sponsor decision due to study timeline|1|||
33217205|NCT03466086|100692332|FG001|Period 1|Sponsor decision due to study timeline|0|||
33217206|NCT03466086|100692331|FG000|Period 1|Withdrawal by Subject|1|||
33217207|NCT03466086|100692332|FG001|Period 1|Withdrawal by Subject|0|||
33217208|NCT03232983|100692339|FG000|Period 1|Physician Decision|0|||
33217209|NCT03232983|100692340|FG001|Period 1|Physician Decision|0|||
33217210|NCT03232983|100692341|FG002|Period 1|Physician Decision|1|||
33217211|NCT03232983|100692342|FG003|Period 1|Physician Decision|0|||
33217212|NCT03232983|100692339|FG000|Washout Period 2|Physician Decision|0|||
33217213|NCT03232983|100692340|FG001|Washout Period 2|Physician Decision|0|||
33217214|NCT03232983|100692341|FG002|Washout Period 2|Physician Decision|1|||
33217215|NCT03232983|100692342|FG003|Washout Period 2|Physician Decision|0|||
33217216|NCT03232983|100692339|FG000|Washout Period 2|Withdrawal by Subject|0|||
33217217|NCT03232983|100692340|FG001|Washout Period 2|Withdrawal by Subject|0|||
33217218|NCT03232983|100692341|FG002|Washout Period 2|Withdrawal by Subject|0|||
33217219|NCT03232983|100692342|FG003|Washout Period 2|Withdrawal by Subject|1|||
33217220|NCT03232983|100692339|FG000|Period 4|Withdrawal by Subject|1|||
33217221|NCT03232983|100692340|FG001|Period 4|Withdrawal by Subject|0|||
33217222|NCT03232983|100692341|FG002|Period 4|Withdrawal by Subject|0|||
33411327|NCT00083226|101397109|FG000|Overall Study|Lack of Efficacy|19|||
33411328|NCT00083226|101397109|FG000|Overall Study|Adverse Event|9|||
33411329|NCT00083226|101397109|FG000|Overall Study|Death|4|||
33411330|NCT00083226|101397109|FG000|Overall Study|Withdrawal by Subject|4|||
33551325|NCT01131585|101916910|FG001|Overall Study|Abnormal laboratory value|0|||
33551326|NCT01131585|101916909|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33217223|NCT03232983|100692342|FG003|Period 4|Withdrawal by Subject|0|||
33217224|NCT01649232|100692343|FG000|Overall Study|Physician Decision|2|||
33217225|NCT01649232|100692344|FG001|Overall Study|Physician Decision|0|||
33217226|NCT00082173|100692345|FG000|Overall Study|Withdrawal by Subject|3|||
33217227|NCT00082173|100692346|FG001|Overall Study|Withdrawal by Subject|5|||
33551327|NCT01131585|101916910|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33551328|NCT01131585|101916909|FG000|Overall Study|Protocol Violation|2|||
33551329|NCT01131585|101916910|FG001|Overall Study|Protocol Violation|1|||
33551330|NCT01131585|101916909|FG000|Overall Study|Withdrawal by Subject|3|||
33551331|NCT01131585|101916910|FG001|Overall Study|Withdrawal by Subject|3|||
33551332|NCT01131585|101916909|FG000|Overall Study|Lost to Follow-up|0|||
33551333|NCT01131585|101916910|FG001|Overall Study|Lost to Follow-up|1|||
33217228|NCT00082173|100692345|FG000|Overall Study|Lost to Follow-up|1|||
33217229|NCT00082173|100692346|FG001|Overall Study|Lost to Follow-up|0|||
33217230|NCT00082173|100692345|FG000|Overall Study|Adverse Event|1|||
33217231|NCT00082173|100692346|FG001|Overall Study|Adverse Event|0|||
33217232|NCT00082173|100692345|FG000|Overall Study|Culture negative or resistant at baselin|5|||
33217233|NCT00082173|100692346|FG001|Overall Study|Culture negative or resistant at baselin|6|||
33217234|NCT02384759|100692347|FG000|Overall Study|Patients not treated|3|||
33217235|NCT02384759|100692348|FG001|Overall Study|Patients not treated|2|||
33217236|NCT01040260|100692349|FG000|Overall Study|Withdrawal by Subject|12|||
33217237|NCT01040260|100692350|FG001|Overall Study|Withdrawal by Subject|6|||
33217238|NCT01040260|100692349|FG000|Overall Study|Lost to Follow-up|3|||
33217239|NCT01040260|100692350|FG001|Overall Study|Lost to Follow-up|5|||
33217240|NCT02778100|100692351|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
33217241|NCT02778100|100692352|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
33217242|NCT02690974|100692353|FG000|Overall Study|Adverse Event|16|||
33217243|NCT02690974|100692353|FG000|Overall Study|Death|9|||
33217244|NCT02690974|100692353|FG000|Overall Study|Subject/guardian decision|4|||
33217245|NCT02690974|100692353|FG000|Overall Study|Lost to Follow-up|3|||
33217246|NCT02690974|100692353|FG000|Overall Study|Withdrawal of Informed Consent|3|||
33217247|NCT02690974|100692353|FG000|Overall Study|Physician Decision|2|||
33217248|NCT02690974|100692353|FG000|Overall Study|Non-compliance with study treatment|1|||
33217249|NCT02690974|100692353|FG000|Overall Study|Protocol-defined stopping criteria|1|||
33217250|NCT02690974|100692353|FG000|Overall Study|Protocol Deviation|1|||
33217251|NCT01971723|100692354|FG000|Overall Study|Withdrawal by Subject|1|||
33217252|NCT01971723|100692355|FG001|Overall Study|Withdrawal by Subject|1|||
33217253|NCT01971723|100692354|FG000|Overall Study|Protocol Violation|1|||
33217254|NCT01971723|100692355|FG001|Overall Study|Protocol Violation|2|||
33217255|NCT00671931|100692356|FG000|Overall Study|Physician Decision|1|||
33217256|NCT00671931|100692357|FG001|Overall Study|Physician Decision|0|||
33217257|NCT00671931|100692358|FG002|Overall Study|Physician Decision|0|||
33217258|NCT00671931|100692359|FG003|Overall Study|Physician Decision|2|||
33217259|NCT00671931|100692360|FG004|Overall Study|Physician Decision|1|||
33217260|NCT01569438|100692361|FG000|Overall Study|Lack of Efficacy|1|||
33217261|NCT01569438|100692362|FG001|Overall Study|Lack of Efficacy|2|||
33217262|NCT01569438|100692361|FG000|Overall Study|Withdrawal by Subject|0|||
33217263|NCT01569438|100692362|FG001|Overall Study|Withdrawal by Subject|3|||
33217264|NCT01569438|100692361|FG000|Overall Study|Adverse Event|2|||
33217265|NCT01569438|100692362|FG001|Overall Study|Adverse Event|15|||
33217266|NCT01569438|100692361|FG000|Overall Study|Protocol Violation|2|||
33217267|NCT01569438|100692362|FG001|Overall Study|Protocol Violation|0|||
33217268|NCT01569438|100692361|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
33217269|NCT01569438|100692362|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
33350628|NCT00888355|101167805|FG000|Overall Study|Lost to Follow-up|0|||
33350629|NCT00888355|101167806|FG001|Overall Study|Lost to Follow-up|2|||
33551334|NCT01131585|101916909|FG000|Overall Study|Administrative problems|1|||
33217270|NCT01569438|100692361|FG000|Overall Study|Sponsor/Physician decision|1|||
33350630|NCT00888355|101167807|FG002|Overall Study|Lost to Follow-up|2|||
33551335|NCT01131585|101916910|FG001|Overall Study|Administrative problems|1|||
33551336|NCT01131585|101916909|FG000|Overall Study|Study termination|78|||
33217271|NCT01569438|100692362|FG001|Overall Study|Sponsor/Physician decision|1|||
33217272|NCT01569438|100692361|FG000|Overall Study|Unable to adhere to study schedule|0|||
33217273|NCT01569438|100692362|FG001|Overall Study|Unable to adhere to study schedule|1|||
33217274|NCT01256411|100692364|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
33217275|NCT01256411|100692365|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
33217276|NCT01256411|100692366|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
33217277|NCT01256411|100692367|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
33350631|NCT00888355|101167808|FG003|Overall Study|Lost to Follow-up|0|||
33551337|NCT01131585|101916910|FG001|Overall Study|Study termination|32|||
33551338|NCT02061592|101916912|FG000|Period 1|Withdrawal by Subject|1|||
33217278|NCT01256411|100692368|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
33217279|NCT01256411|100692369|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
33217280|NCT01256411|100692364|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
33217281|NCT01256411|100692365|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
33217282|NCT01256411|100692366|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
33217283|NCT01256411|100692367|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
33217284|NCT01256411|100692368|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
33217285|NCT01256411|100692369|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
33217286|NCT01256411|100692364|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
33217287|NCT01256411|100692365|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
33217288|NCT01256411|100692366|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
33217289|NCT01256411|100692367|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
33217290|NCT01256411|100692368|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
33217291|NCT01256411|100692369|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
33217292|NCT01256411|100692364|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
33217293|NCT01256411|100692365|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
33217294|NCT01256411|100692366|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
33217295|NCT01256411|100692367|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
33217296|NCT01256411|100692368|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
33217297|NCT01256411|100692369|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
33217298|NCT01256411|100692364|FG000|Extension by Maximum Treatment|Adverse Event|4|||
33217299|NCT01256411|100692365|FG001|Extension by Maximum Treatment|Adverse Event|2|||
33217300|NCT01256411|100692366|FG002|Extension by Maximum Treatment|Adverse Event|1|||
33217301|NCT01256411|100692367|FG003|Extension by Maximum Treatment|Adverse Event|0|||
33217302|NCT01256411|100692368|FG004|Extension by Maximum Treatment|Adverse Event|0|||
33217303|NCT01256411|100692369|FG005|Extension by Maximum Treatment|Adverse Event|0|||
33217304|NCT01256411|100692364|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
33217305|NCT01256411|100692365|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
33217306|NCT01256411|100692366|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
33217307|NCT01256411|100692367|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
33217308|NCT01256411|100692368|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
33217309|NCT01256411|100692369|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
33217310|NCT01256411|100692364|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
33217311|NCT01256411|100692365|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
33217312|NCT01256411|100692366|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
33217313|NCT01256411|100692367|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
33217314|NCT01256411|100692368|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
33217315|NCT01256411|100692369|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
33217316|NCT01256411|100692364|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
33217317|NCT01256411|100692365|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
33217318|NCT01256411|100692366|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
33217319|NCT01256411|100692367|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
33217320|NCT01256411|100692368|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
33217321|NCT01256411|100692369|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
33217322|NCT01256411|100692364|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
33217323|NCT01256411|100692365|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
33217324|NCT01256411|100692366|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
33217325|NCT01256411|100692367|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
33217326|NCT01256411|100692368|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
33217327|NCT01256411|100692369|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
33217328|NCT01256411|100692364|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
33217329|NCT01256411|100692365|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
33217330|NCT01256411|100692366|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
33217331|NCT01256411|100692367|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
33217332|NCT01256411|100692368|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
33217333|NCT01256411|100692369|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
33618631|NCT03948334|102151577|FG000|Overall Study|Protocol Deviation|1|||
33618632|NCT03948334|102151578|FG001|Overall Study|Protocol Deviation|0|||
33618633|NCT03948334|102151577|FG000|Overall Study|Study terminated by Sponsor|50|||
33618634|NCT03948334|102151578|FG001|Overall Study|Study terminated by Sponsor|51|||
33618635|NCT03948334|102151577|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
33217334|NCT01362439|100692376|FG000|Overall Study|Adverse Event|1|||
33217335|NCT01362439|100692376|FG000|Overall Study|Lack of Efficacy|3|||
33217336|NCT01362439|100692376|FG000|Overall Study|Lost to Follow-up|2|||
33618636|NCT03948334|102151578|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
33618637|NCT01919229|102151579|FG000|Overall Study|Subject/guardian decision|0|||
33618638|NCT01919229|102151580|FG001|Overall Study|Subject/guardian decision|0|||
33217337|NCT01362439|100692376|FG000|Overall Study|Study medication non-compliant|1|||
33217338|NCT01362439|100692376|FG000|Overall Study|Participant who withdrew consent|8|||
33217339|NCT02807636|100692381|FG000|Overall Study|Lost to Follow-up|9|||
33217340|NCT02807636|100692382|FG001|Overall Study|Lost to Follow-up|12|||
33217341|NCT02807636|100692383|FG002|Overall Study|Lost to Follow-up|6|||
33217342|NCT02807636|100692381|FG000|Overall Study|Protocol Deviation|2|||
33217343|NCT02807636|100692382|FG001|Overall Study|Protocol Deviation|0|||
33217344|NCT02807636|100692383|FG002|Overall Study|Protocol Deviation|0|||
33217345|NCT02807636|100692381|FG000|Overall Study|Symptomatic Deterioration|0|||
33217346|NCT02807636|100692382|FG001|Overall Study|Symptomatic Deterioration|1|||
33217347|NCT02807636|100692383|FG002|Overall Study|Symptomatic Deterioration|0|||
33217348|NCT02807636|100692381|FG000|Overall Study|Withdrawal by Subject|39|||
33217349|NCT02807636|100692382|FG001|Overall Study|Withdrawal by Subject|27|||
33217350|NCT02807636|100692383|FG002|Overall Study|Withdrawal by Subject|23|||
33217351|NCT02807636|100692381|FG000|Overall Study|Death|298|||
33217352|NCT02807636|100692382|FG001|Overall Study|Death|327|||
33217353|NCT02807636|100692383|FG002|Overall Study|Death|266|||
33217354|NCT02807636|100692381|FG000|Overall Study|Ongoing in Study|52|||
33217355|NCT02807636|100692382|FG001|Overall Study|Ongoing in Study|84|||
33217356|NCT02807636|100692383|FG002|Overall Study|Ongoing in Study|67|||
33217357|NCT00553696|100692384|FG000|Overall Study|Adverse Event|2|||
33217358|NCT00553696|100692385|FG001|Overall Study|Adverse Event|4|||
33217359|NCT00553696|100692386|FG002|Overall Study|Adverse Event|0|||
33217360|NCT00553696|100692387|FG003|Overall Study|Adverse Event|1|||
33217361|NCT00553696|100692384|FG000|Overall Study|Global deterioration of health status|0|||
33350632|NCT00888355|101167805|FG000|Overall Study|Protocol Violation|3|||
33350633|NCT00888355|101167806|FG001|Overall Study|Protocol Violation|2|||
33411331|NCT00083226|101397109|FG000|Overall Study|Other|2|||
33411332|NCT00083226|101397109|FG000|Overall Study|ineligible or not receiving treatment|4|||
33411333|NCT03743571|101397110|FG000|Overall Study|Withdrawal by Subject|1|||
33411334|NCT03743571|101397111|FG001|Overall Study|Withdrawal by Subject|1|||
33411335|NCT03743571|101397110|FG000|Overall Study|Lost to Follow-up|1|||
33411336|NCT03743571|101397111|FG001|Overall Study|Lost to Follow-up|2|||
33411337|NCT00752206|101397112|FG000|Overall Study|Disease progression|8|||
33411338|NCT00752206|101397113|FG001|Overall Study|Disease progression|11|||
33350634|NCT00888355|101167807|FG002|Overall Study|Protocol Violation|1|||
33350635|NCT00888355|101167808|FG003|Overall Study|Protocol Violation|2|||
33350636|NCT00888355|101167805|FG000|Overall Study|Withdrawal by Subject|0|||
33350637|NCT00888355|101167806|FG001|Overall Study|Withdrawal by Subject|3|||
33350638|NCT00888355|101167807|FG002|Overall Study|Withdrawal by Subject|1|||
33350639|NCT00888355|101167808|FG003|Overall Study|Withdrawal by Subject|3|||
33350640|NCT02076165|101167809|FG000|Overall Study|Lost to Follow-up|7|||
33350641|NCT02076165|101167810|FG001|Overall Study|Lost to Follow-up|5|||
33350642|NCT02076165|101167809|FG000|Overall Study|Refused follow-up assessment|1|||
33350643|NCT02076165|101167810|FG001|Overall Study|Refused follow-up assessment|1|||
33350644|NCT00191854|101167811|FG000|Overall Study|Death|26|||
33350645|NCT00191854|101167812|FG001|Overall Study|Death|23|||
33350646|NCT00191854|101167813|FG002|Overall Study|Death|29|||
33350647|NCT00191854|101167811|FG000|Overall Study|Lost to Follow-up|7|||
33350648|NCT00191854|101167812|FG001|Overall Study|Lost to Follow-up|5|||
33350649|NCT00191854|101167813|FG002|Overall Study|Lost to Follow-up|5|||
33350650|NCT00191854|101167811|FG000|Overall Study|Withdrawal by Subject|4|||
33350651|NCT00191854|101167812|FG001|Overall Study|Withdrawal by Subject|2|||
33350652|NCT00191854|101167813|FG002|Overall Study|Withdrawal by Subject|3|||
33350653|NCT00191854|101167811|FG000|Overall Study|Sponsor Decision|0|||
33350654|NCT00191854|101167812|FG001|Overall Study|Sponsor Decision|0|||
33350655|NCT00191854|101167813|FG002|Overall Study|Sponsor Decision|1|||
33350656|NCT00191854|101167811|FG000|Overall Study|Screen Failure|0|||
33350657|NCT00191854|101167812|FG001|Overall Study|Screen Failure|0|||
33350658|NCT00191854|101167813|FG002|Overall Study|Screen Failure|1|||
33350659|NCT00670007|101167819|FG000|Overall Study|Drug abuse|1|||
33411339|NCT00752206|101397112|FG000|Overall Study|Pregnancy|1|||
33551339|NCT02061592|101916913|FG001|Period 1|Withdrawal by Subject|0|||
33411340|NCT00752206|101397113|FG001|Overall Study|Pregnancy|0|||
33551340|NCT02061592|101916912|FG000|Period 1|Protocol Violation|1|||
33217362|NCT00553696|100692385|FG001|Overall Study|Global deterioration of health status|2|||
33217363|NCT00553696|100692386|FG002|Overall Study|Global deterioration of health status|0|||
33217364|NCT00553696|100692387|FG003|Overall Study|Global deterioration of health status|0|||
33217365|NCT00553696|100692384|FG000|Overall Study|Objective progression or relapse|2|||
33217366|NCT00553696|100692385|FG001|Overall Study|Objective progression or relapse|9|||
33217367|NCT00553696|100692386|FG002|Overall Study|Objective progression or relapse|6|||
33350660|NCT00670007|101167819|FG000|Overall Study|Lung transplant|1|||
33350661|NCT00670007|101167819|FG000|Overall Study|Travel/Vacation|1|||
33350662|NCT00670007|101167819|FG000|Overall Study|Adverse event, serious fatal|1|||
33350663|NCT00670007|101167819|FG000|Overall Study|Adverse Event|1|||
33350664|NCT00670007|101167819|FG000|Overall Study|Withdrawal by Subject|4|||
33350665|NCT04348851|101167822|FG000|Post-Test 1|Withdrawal by Subject|0|||
33411341|NCT03446157|101397114|FG000|Overall Study|Death|11|||
33217368|NCT00553696|100692387|FG003|Overall Study|Objective progression or relapse|0|||
33217369|NCT00553696|100692384|FG000|Overall Study|Withdrawal by Subject|0|||
33217370|NCT00553696|100692385|FG001|Overall Study|Withdrawal by Subject|1|||
33217371|NCT00553696|100692386|FG002|Overall Study|Withdrawal by Subject|0|||
33217372|NCT00553696|100692387|FG003|Overall Study|Withdrawal by Subject|0|||
33217373|NCT04162769|100692389|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
33217374|NCT04162769|100692390|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
33217375|NCT04162769|100692391|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
33217376|NCT04162769|100692392|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
33217377|NCT04162769|100692389|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
33217378|NCT04162769|100692390|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
33217379|NCT04162769|100692391|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
33217380|NCT04162769|100692392|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
33217381|NCT04162769|100692389|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
33217382|NCT04162769|100692390|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
33217383|NCT04162769|100692391|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
33217384|NCT04162769|100692392|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
33217385|NCT04162769|100692389|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
33217386|NCT04162769|100692390|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
33217387|NCT04162769|100692391|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
33217388|NCT04162769|100692392|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
33217389|NCT04162769|100692389|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
33217390|NCT04162769|100692390|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
33217391|NCT04162769|100692391|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
33217392|NCT04162769|100692392|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
33217393|NCT04162769|100692389|FG000|Double-blind Treatment (12-Week)|Other|0|||
33217394|NCT04162769|100692390|FG001|Double-blind Treatment (12-Week)|Other|1|||
33217395|NCT04162769|100692391|FG002|Double-blind Treatment (12-Week)|Other|1|||
33217396|NCT04162769|100692392|FG003|Double-blind Treatment (12-Week)|Other|0|||
33217397|NCT04162769|100692389|FG000|OLE Period (52-Week)|Adverse Event|0|||
33217398|NCT04162769|100692390|FG001|OLE Period (52-Week)|Adverse Event|0|||
33217399|NCT04162769|100692391|FG002|OLE Period (52-Week)|Adverse Event|0|||
33217400|NCT04162769|100692392|FG003|OLE Period (52-Week)|Adverse Event|5|||
33217401|NCT04162769|100692389|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
33217402|NCT04162769|100692390|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
33217403|NCT04162769|100692391|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
33217404|NCT04162769|100692392|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
33217405|NCT04162769|100692389|FG000|OLE Period (52-Week)|Physician Decision|0|||
33217406|NCT04162769|100692390|FG001|OLE Period (52-Week)|Physician Decision|0|||
33217407|NCT04162769|100692391|FG002|OLE Period (52-Week)|Physician Decision|0|||
33217408|NCT04162769|100692392|FG003|OLE Period (52-Week)|Physician Decision|1|||
33217409|NCT04162769|100692389|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
33217410|NCT04162769|100692390|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
33217411|NCT04162769|100692391|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
33217412|NCT04162769|100692392|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
33217413|NCT04162769|100692389|FG000|OLE Period (52-Week)|Protocol deviation|0|||
33350666|NCT04348851|101167823|FG001|Post-Test 1|Withdrawal by Subject|1|||
33350667|NCT04348851|101167824|FG002|Post-Test 1|Withdrawal by Subject|0|||
33350668|NCT04348851|101167825|FG003|Post-Test 1|Withdrawal by Subject|0|||
33350669|NCT04348851|101167822|FG000|Post-Test 1|Lost to Follow-up|0|||
33350670|NCT04348851|101167823|FG001|Post-Test 1|Lost to Follow-up|1|||
33350671|NCT04348851|101167824|FG002|Post-Test 1|Lost to Follow-up|0|||
33350672|NCT04348851|101167825|FG003|Post-Test 1|Lost to Follow-up|0|||
33350673|NCT04348851|101167822|FG000|Post-Test 2|Stroke survivor death|0|||
33350674|NCT04348851|101167823|FG001|Post-Test 2|Stroke survivor death|1|||
33350675|NCT04348851|101167824|FG002|Post-Test 2|Stroke survivor death|0|||
33350676|NCT04348851|101167825|FG003|Post-Test 2|Stroke survivor death|1|||
33350677|NCT00619957|101167826|FG000|Month 24 Double-Blind|Adverse Event|9|||
33350678|NCT00619957|101167827|FG001|Month 24 Double-Blind|Adverse Event|7|||
33350679|NCT00619957|101167826|FG000|Month 24 Double-Blind|Protocol Violation|1|||
33217414|NCT04162769|100692390|FG001|OLE Period (52-Week)|Protocol deviation|0|||
33217415|NCT04162769|100692391|FG002|OLE Period (52-Week)|Protocol deviation|0|||
33217416|NCT04162769|100692392|FG003|OLE Period (52-Week)|Protocol deviation|2|||
33217417|NCT00338884|100692393|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
33350680|NCT00619957|101167827|FG001|Month 24 Double-Blind|Protocol Violation|0|||
33411342|NCT03446157|101397115|FG001|Overall Study|Death|9|||
33411343|NCT03446157|101397114|FG000|Overall Study|Lost to Follow-up|0|||
33411344|NCT03446157|101397115|FG001|Overall Study|Lost to Follow-up|1|||
33618639|NCT01919229|102151581|FG002|Overall Study|Subject/guardian decision|1|||
33411345|NCT03446157|101397114|FG000|Overall Study|Withdrawal by Subject|2|||
33217418|NCT00338884|100692393|FG000|Overall Study|Adverse Event|14|||
33217419|NCT00338884|100692393|FG000|Overall Study|Death|8|||
33350681|NCT00619957|101167826|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
33350682|NCT00619957|101167827|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
33350683|NCT00619957|101167826|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
33350684|NCT00619957|101167827|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
33350685|NCT00619957|101167826|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
33350686|NCT00619957|101167827|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
33350687|NCT00619957|101167826|FG000|Month 48 Open-Label|Adverse Event|4|||
33350688|NCT00619957|101167827|FG001|Month 48 Open-Label|Adverse Event|4|||
33350689|NCT00619957|101167826|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
33350690|NCT00619957|101167827|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
33217420|NCT00338884|100692393|FG000|Overall Study|Other|4|||
33217421|NCT00338884|100692393|FG000|Overall Study|Global Deterioration of Health Status|3|||
33411346|NCT03446157|101397115|FG001|Overall Study|Withdrawal by Subject|1|||
33217422|NCT00338884|100692393|FG000|Overall Study|Withdrawal by Subject|3|||
33350691|NCT00619957|101167826|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
33350692|NCT00619957|101167827|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
33411347|NCT00346775|101397116|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
33411348|NCT00346775|101397117|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
33411349|NCT00346775|101397116|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
33411350|NCT00346775|101397117|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
33411351|NCT00346775|101397116|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
33411352|NCT00346775|101397117|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
33411353|NCT01298362|101397118|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
33411354|NCT01298362|101397119|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
33411355|NCT05111548|101397120|FG000|Overall Study|Withdrawal by Subject|2|||
33411356|NCT05111548|101397121|FG001|Overall Study|Withdrawal by Subject|1|||
33411357|NCT05111548|101397120|FG000|Overall Study|Adverse Event|1|||
33411358|NCT05111548|101397121|FG001|Overall Study|Adverse Event|0|||
33551341|NCT02061592|101916913|FG001|Period 1|Protocol Violation|0|||
33551342|NCT02061592|101916912|FG000|Period 2|Lost to Follow-up|0|||
33350693|NCT04187092|101167830|FG000|Overall Study|Lost to Follow-up|1|||
33350694|NCT04187092|101167831|FG001|Overall Study|Lost to Follow-up|1|||
33551343|NCT02061592|101916913|FG001|Period 2|Lost to Follow-up|1|||
33551344|NCT00724503|101916914|FG000|Overall Study|Lost to Follow-up|4|||
33551345|NCT00724503|101916915|FG001|Overall Study|Lost to Follow-up|8|||
33551346|NCT00724503|101916914|FG000|Overall Study|Withdrawal by Subject|11|||
33551347|NCT00724503|101916915|FG001|Overall Study|Withdrawal by Subject|23|||
33551348|NCT00724503|101916914|FG000|Overall Study|Death|190|||
33551349|NCT00724503|101916915|FG001|Overall Study|Death|182|||
33551350|NCT00724503|101916914|FG000|Overall Study|Adverse Event|1|||
33551351|NCT00724503|101916915|FG001|Overall Study|Adverse Event|0|||
33551352|NCT00724503|101916914|FG000|Overall Study|Not otherwise specified|4|||
33551353|NCT00724503|101916915|FG001|Overall Study|Not otherwise specified|7|||
33217423|NCT00338884|100692393|FG000|Overall Study|Lost to Follow-up|1|||
33350695|NCT04187092|101167830|FG000|Overall Study|Withdrawal by Subject|1|||
33350696|NCT04187092|101167831|FG001|Overall Study|Withdrawal by Subject|1|||
33350697|NCT04187092|101167830|FG000|Overall Study|Adverse Event|0|||
33350698|NCT04187092|101167831|FG001|Overall Study|Adverse Event|1|||
33350699|NCT01731002|101167834|FG000|Overall Study|Adverse Event|0|||
33350700|NCT01731002|101167835|FG001|Overall Study|Adverse Event|2|||
33350701|NCT01731002|101167836|FG002|Overall Study|Adverse Event|2|||
33350702|NCT01731002|101167834|FG000|Overall Study|Non-Compliant|0|||
33350703|NCT01731002|101167835|FG001|Overall Study|Non-Compliant|1|||
33350704|NCT01731002|101167836|FG002|Overall Study|Non-Compliant|0|||
33350705|NCT01731002|101167834|FG000|Overall Study|Lost to Follow-up|1|||
33350706|NCT01731002|101167835|FG001|Overall Study|Lost to Follow-up|0|||
33350707|NCT01731002|101167836|FG002|Overall Study|Lost to Follow-up|0|||
33350708|NCT01731002|101167834|FG000|Overall Study|Test Agent Discontinuation|0|||
33350709|NCT01731002|101167835|FG001|Overall Study|Test Agent Discontinuation|1|||
33350710|NCT01731002|101167836|FG002|Overall Study|Test Agent Discontinuation|0|||
33350711|NCT01731002|101167834|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
33350712|NCT01731002|101167835|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
33350713|NCT01731002|101167836|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
33350714|NCT01731002|101167834|FG000|Overall Study|Elevated IOP|1|||
33411359|NCT02389621|101397122|FG000|Treatment Period|Withdrawal by Subject|1|||
33411360|NCT02389621|101397123|FG001|Treatment Period|Withdrawal by Subject|1|||
33411361|NCT02389621|101397122|FG000|Posttreatment Period|Adverse Event|3|||
33411362|NCT02389621|101397123|FG001|Posttreatment Period|Adverse Event|1|||
33411363|NCT02389621|101397122|FG000|Posttreatment Period|Withdrawal by Subject|3|||
33411364|NCT02389621|101397123|FG001|Posttreatment Period|Withdrawal by Subject|2|||
33411365|NCT02389621|101397122|FG000|Posttreatment Period|Lost to Follow-up|1|||
33411366|NCT02389621|101397123|FG001|Posttreatment Period|Lost to Follow-up|1|||
33551354|NCT01028391|101916917|FG000|Overall Study|Adverse Event|4|||
33350715|NCT01731002|101167835|FG001|Overall Study|Elevated IOP|0|||
33551355|NCT01028391|101916918|FG001|Overall Study|Adverse Event|0|||
33551356|NCT01028391|101916917|FG000|Overall Study|Lack of Efficacy|0|||
33217424|NCT00338884|100692393|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
33217425|NCT00981084|100692394|FG000|Post Intervention (Data Analysis)|poor effort|1|||
33217426|NCT00981084|100692395|FG001|Post Intervention (Data Analysis)|poor effort|1|||
33217427|NCT00981084|100692394|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
33217428|NCT00981084|100692395|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
33217429|NCT01685138|100692397|FG000|Overall Study|Lost to Follow-up|1|||
33217430|NCT01685138|100692397|FG000|Overall Study|Protocol Violation|1|||
33217431|NCT01685138|100692397|FG000|Overall Study|No longer requires treatment|1|||
33217432|NCT01685138|100692397|FG000|Overall Study|Subject/guardian decision|2|||
33217433|NCT01685138|100692397|FG000|Overall Study|Physician Decision|6|||
33217434|NCT01685138|100692397|FG000|Overall Study|Death|10|||
33217435|NCT01685138|100692397|FG000|Overall Study|Adverse Event|18|||
33217436|NCT01685138|100692397|FG000|Overall Study|Progressive disease|53|||
33217437|NCT04102579|100692398|FG000|Overall Study|Withdrawal by Subject|3|||
33217438|NCT04102579|100692399|FG001|Overall Study|Withdrawal by Subject|4|||
33217439|NCT04102579|100692398|FG000|Overall Study|Lost to Follow-up|0|||
33217440|NCT04102579|100692399|FG001|Overall Study|Lost to Follow-up|1|||
33217441|NCT04102579|100692398|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
33217442|NCT04102579|100692399|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
33217443|NCT04102579|100692398|FG000|Overall Study|Other than Specified|1|||
33217444|NCT04102579|100692399|FG001|Overall Study|Other than Specified|0|||
33217445|NCT04102579|100692398|FG000|Overall Study|Not Dosed with Study Drug|0|||
33217446|NCT04102579|100692399|FG001|Overall Study|Not Dosed with Study Drug|1|||
33217447|NCT01050816|100692400|FG000|Overall Study|Lost to Follow-up|2|||
33350716|NCT01731002|101167836|FG002|Overall Study|Elevated IOP|0|||
33551357|NCT01028391|101916918|FG001|Overall Study|Lack of Efficacy|2|||
33551358|NCT01028391|101916917|FG000|Overall Study|Lost to Follow-up|3|||
33551359|NCT01028391|101916918|FG001|Overall Study|Lost to Follow-up|4|||
33551360|NCT01028391|101916917|FG000|Overall Study|Physician Decision|0|||
33551361|NCT01028391|101916918|FG001|Overall Study|Physician Decision|1|||
33551362|NCT01028391|101916917|FG000|Overall Study|Withdrawal by Subject|6|||
33551363|NCT01028391|101916918|FG001|Overall Study|Withdrawal by Subject|3|||
33217448|NCT01050816|100692400|FG000|Overall Study|patient's refusal|2|||
33551364|NCT01028391|101916917|FG000|Overall Study|Needed excluded medication|1|||
33551365|NCT01028391|101916918|FG001|Overall Study|Needed excluded medication|1|||
33551366|NCT01769443|101916927|FG000|Overall Study|Study closure|1|||
33551367|NCT01769443|101916928|FG001|Overall Study|Study closure|0|||
33551368|NCT01783938|101916929|FG000|Overall Study|Disease Progression|18|||
33551369|NCT01783938|101916930|FG001|Overall Study|Disease Progression|41|||
33551370|NCT01783938|101916929|FG000|Overall Study|Study Drug Toxicity|27|||
33551371|NCT01783938|101916930|FG001|Overall Study|Study Drug Toxicity|14|||
33217449|NCT01169675|100692401|FG000|Overall Study|Progressive disease|13|||
33217450|NCT01169675|100692402|FG001|Overall Study|Progressive disease|2|||
33217451|NCT01169675|100692403|FG002|Overall Study|Progressive disease|5|||
33618640|NCT02097030|102151582|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
33551372|NCT01783938|101916929|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
33551373|NCT01783938|101916930|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
33551374|NCT01783938|101916929|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
33551375|NCT01783938|101916930|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
33551376|NCT01783938|101916929|FG000|Overall Study|Participant Withdrew Consent|2|||
33551377|NCT01783938|101916930|FG001|Overall Study|Participant Withdrew Consent|0|||
33551378|NCT01783938|101916929|FG000|Overall Study|Maximum Clinical Benefit|1|||
33551379|NCT01783938|101916930|FG001|Overall Study|Maximum Clinical Benefit|0|||
33551380|NCT01783938|101916929|FG000|Overall Study|Other Reasons|3|||
33551381|NCT01783938|101916930|FG001|Overall Study|Other Reasons|1|||
33551382|NCT00770484|101916931|FG000|Overall Study|Withdrawal by Subject|1|||
33551383|NCT00770484|101916932|FG001|Overall Study|Withdrawal by Subject|0|||
33618641|NCT02097030|102151583|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
33217452|NCT01169675|100692404|FG003|Overall Study|Progressive disease|15|||
33217453|NCT01169675|100692405|FG004|Overall Study|Progressive disease|1|||
33217454|NCT01169675|100692401|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
33217455|NCT01169675|100692402|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33217456|NCT01169675|100692403|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33217457|NCT01169675|100692404|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33217458|NCT01169675|100692405|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
33217459|NCT01169675|100692401|FG000|Overall Study|Adverse Event|5|||
33217460|NCT01169675|100692402|FG001|Overall Study|Adverse Event|1|||
33217461|NCT01169675|100692403|FG002|Overall Study|Adverse Event|2|||
33217462|NCT01169675|100692404|FG003|Overall Study|Adverse Event|0|||
33217463|NCT01169675|100692405|FG004|Overall Study|Adverse Event|0|||
33217464|NCT01169675|100692401|FG000|Overall Study|Withdrawal by Subject|1|||
33217465|NCT01169675|100692402|FG001|Overall Study|Withdrawal by Subject|0|||
33217466|NCT01169675|100692403|FG002|Overall Study|Withdrawal by Subject|0|||
33217467|NCT01169675|100692404|FG003|Overall Study|Withdrawal by Subject|1|||
33217468|NCT01169675|100692405|FG004|Overall Study|Withdrawal by Subject|2|||
33217469|NCT01169675|100692401|FG000|Overall Study|Other Reason Not Defined Above|0|||
33217470|NCT01169675|100692402|FG001|Overall Study|Other Reason Not Defined Above|0|||
33350717|NCT01731002|101167834|FG000|Overall Study|Inappropriate use of study medications|0|||
33350718|NCT01731002|101167835|FG001|Overall Study|Inappropriate use of study medications|0|||
33350719|NCT01731002|101167836|FG002|Overall Study|Inappropriate use of study medications|1|||
33350720|NCT02305563|101167837|FG000|Treatment Period|Disease progression|0|||
33618642|NCT02097030|102151582|FG000|First Intervention (3 Days)|Visual Acuity|0|||
33618643|NCT02097030|102151583|FG001|First Intervention (3 Days)|Visual Acuity|1|||
33217471|NCT01169675|100692403|FG002|Overall Study|Other Reason Not Defined Above|0|||
33217472|NCT01169675|100692404|FG003|Overall Study|Other Reason Not Defined Above|1|||
33217473|NCT01169675|100692405|FG004|Overall Study|Other Reason Not Defined Above|1|||
33217474|NCT00587964|100692420|FG000|Overall Study|Withdrawal by Subject|1|||
33217475|NCT00587964|100692420|FG000|Overall Study|Lost to Follow-up|1|||
33217476|NCT00587964|100692420|FG000|Overall Study|Patient found to be ineligible|1|||
33217477|NCT00587964|100692420|FG000|Overall Study|Patient did not receive intervention|5|||
33217478|NCT00587964|100692420|FG000|Overall Study|Progression of Disease|4|||
33217479|NCT04385368|100692421|FG000|Overall Study|Death|5|||
33217480|NCT04385368|100692422|FG001|Overall Study|Death|5|||
33350721|NCT02305563|101167838|FG001|Treatment Period|Disease progression|0|||
33350722|NCT02305563|101167839|FG002|Treatment Period|Disease progression|15|||
33350723|NCT02305563|101167840|FG003|Treatment Period|Disease progression|6|||
33551384|NCT00639379|101916933|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
33350724|NCT02305563|101167841|FG004|Treatment Period|Disease progression|6|||
33350725|NCT02305563|101167837|FG000|Treatment Period|Study drug toxicity|0|||
33350726|NCT02305563|101167838|FG001|Treatment Period|Study drug toxicity|0|||
33350727|NCT02305563|101167839|FG002|Treatment Period|Study drug toxicity|0|||
33350728|NCT02305563|101167840|FG003|Treatment Period|Study drug toxicity|1|||
33350729|NCT02305563|101167841|FG004|Treatment Period|Study drug toxicity|2|||
33350730|NCT02305563|101167837|FG000|Treatment Period|Death|0|||
33350731|NCT02305563|101167838|FG001|Treatment Period|Death|0|||
33350732|NCT02305563|101167839|FG002|Treatment Period|Death|1|||
33350733|NCT02305563|101167840|FG003|Treatment Period|Death|2|||
33350734|NCT02305563|101167841|FG004|Treatment Period|Death|1|||
33350735|NCT02305563|101167837|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
33350736|NCT02305563|101167838|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
33350737|NCT02305563|101167839|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
33350738|NCT02305563|101167840|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
33350739|NCT02305563|101167841|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
33350740|NCT02305563|101167837|FG000|Treatment Period|Participant request to stop therapy|0|||
33350741|NCT02305563|101167838|FG001|Treatment Period|Participant request to stop therapy|2|||
33350742|NCT02305563|101167839|FG002|Treatment Period|Participant request to stop therapy|0|||
33350743|NCT02305563|101167840|FG003|Treatment Period|Participant request to stop therapy|1|||
33350744|NCT02305563|101167841|FG004|Treatment Period|Participant request to stop therapy|0|||
33350745|NCT02305563|101167837|FG000|Treatment Period|Participant withdrew consent|0|||
33350746|NCT02305563|101167838|FG001|Treatment Period|Participant withdrew consent|0|||
33350747|NCT02305563|101167839|FG002|Treatment Period|Participant withdrew consent|1|||
33350748|NCT02305563|101167840|FG003|Treatment Period|Participant withdrew consent|1|||
33350749|NCT02305563|101167841|FG004|Treatment Period|Participant withdrew consent|1|||
33350750|NCT02305563|101167837|FG000|Treatment Period|Maximum clinical benefit|0|||
33350751|NCT02305563|101167838|FG001|Treatment Period|Maximum clinical benefit|0|||
33350752|NCT02305563|101167839|FG002|Treatment Period|Maximum clinical benefit|0|||
33350753|NCT02305563|101167840|FG003|Treatment Period|Maximum clinical benefit|0|||
33350754|NCT02305563|101167841|FG004|Treatment Period|Maximum clinical benefit|1|||
33350755|NCT02305563|101167837|FG000|Treatment Period|Poor/non-compliance|0|||
33350756|NCT02305563|101167838|FG001|Treatment Period|Poor/non-compliance|0|||
33350757|NCT02305563|101167839|FG002|Treatment Period|Poor/non-compliance|0|||
33350758|NCT02305563|101167840|FG003|Treatment Period|Poor/non-compliance|0|||
33350759|NCT02305563|101167841|FG004|Treatment Period|Poor/non-compliance|1|||
33350760|NCT02305563|101167837|FG000|Treatment Period|Administrative reason by Sponsor|0|||
33350761|NCT02305563|101167838|FG001|Treatment Period|Administrative reason by Sponsor|0|||
33350762|NCT02305563|101167839|FG002|Treatment Period|Administrative reason by Sponsor|0|||
33350763|NCT02305563|101167840|FG003|Treatment Period|Administrative reason by Sponsor|0|||
33350764|NCT02305563|101167841|FG004|Treatment Period|Administrative reason by Sponsor|1|||
33350765|NCT02305563|101167837|FG000|Treatment Period|other reason|2|||
33350766|NCT02305563|101167838|FG001|Treatment Period|other reason|0|||
33350767|NCT02305563|101167839|FG002|Treatment Period|other reason|2|||
33350768|NCT02305563|101167840|FG003|Treatment Period|other reason|2|||
33350769|NCT02305563|101167841|FG004|Treatment Period|other reason|1|||
33350770|NCT02305563|101167837|FG000|Treatment Period|Randomized but not treated|0|||
33350771|NCT02305563|101167838|FG001|Treatment Period|Randomized but not treated|0|||
33350772|NCT02305563|101167839|FG002|Treatment Period|Randomized but not treated|0|||
33350773|NCT02305563|101167840|FG003|Treatment Period|Randomized but not treated|0|||
33350774|NCT02305563|101167841|FG004|Treatment Period|Randomized but not treated|2|||
33411367|NCT02389621|101397122|FG000|Posttreatment Period|Other - Miscellaneous|2|||
33411368|NCT02389621|101397123|FG001|Posttreatment Period|Other - Miscellaneous|0|||
33411369|NCT02851069|101397124|FG000|Overall Study|Failure to Return|3|||
33411370|NCT02851069|101397124|FG000|Overall Study|Other|3|||
33551385|NCT00639379|101916934|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
33551386|NCT00639379|101916933|FG000|Period 1 - 2 Weeks|lens issue|3|||
33217481|NCT04385368|100692421|FG000|Overall Study|Physician Decision|3|||
33350775|NCT02305563|101167837|FG000|Treatment Period|added ULO, then disease progression|0|||
33350776|NCT02305563|101167838|FG001|Treatment Period|added ULO, then disease progression|0|||
33411371|NCT04888377|101397125|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
33551387|NCT00639379|101916934|FG001|Period 1 - 2 Weeks|lens issue|0|||
33350777|NCT02305563|101167839|FG002|Treatment Period|added ULO, then disease progression|0|||
33350778|NCT02305563|101167840|FG003|Treatment Period|added ULO, then disease progression|0|||
33350779|NCT02305563|101167841|FG004|Treatment Period|added ULO, then disease progression|4|||
33350780|NCT02305563|101167837|FG000|Treatment Period|added ULO; then other reason|0|||
33551388|NCT00387127|101916935|FG000|Overall Study|Lost to Follow-up|0|||
33350781|NCT02305563|101167838|FG001|Treatment Period|added ULO; then other reason|0|||
33350782|NCT02305563|101167839|FG002|Treatment Period|added ULO; then other reason|0|||
33551389|NCT00387127|101916936|FG001|Overall Study|Lost to Follow-up|4|||
33551390|NCT00387127|101916935|FG000|Overall Study|Death|16|||
33350783|NCT02305563|101167840|FG003|Treatment Period|added ULO; then other reason|0|||
33350784|NCT02305563|101167841|FG004|Treatment Period|added ULO; then other reason|1|||
33350785|NCT02305563|101167837|FG000|Treatment Period|added ULO, then request to stop|0|||
33411372|NCT04888377|101397126|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
33411373|NCT04888377|101397125|FG000|Overall Study|Physician Decision|6|||
33411374|NCT04888377|101397126|FG001|Overall Study|Physician Decision|6|||
33411375|NCT04888377|101397125|FG000|Overall Study|Withdrawal by Subject|7|||
33350786|NCT02305563|101167838|FG001|Treatment Period|added ULO, then request to stop|0|||
33350787|NCT02305563|101167839|FG002|Treatment Period|added ULO, then request to stop|0|||
33350788|NCT02305563|101167840|FG003|Treatment Period|added ULO, then request to stop|0|||
33350789|NCT02305563|101167841|FG004|Treatment Period|added ULO, then request to stop|1|||
33350790|NCT02305563|101167837|FG000|Follow-up Period|Death|0|||
33350791|NCT02305563|101167838|FG001|Follow-up Period|Death|0|||
33350792|NCT02305563|101167839|FG002|Follow-up Period|Death|5|||
33350793|NCT02305563|101167840|FG003|Follow-up Period|Death|4|||
33350794|NCT02305563|101167841|FG004|Follow-up Period|Death|7|||
33350795|NCT02305563|101167837|FG000|Follow-up Period|Participant withdrew consent|0|||
33350796|NCT02305563|101167838|FG001|Follow-up Period|Participant withdrew consent|0|||
33350797|NCT02305563|101167839|FG002|Follow-up Period|Participant withdrew consent|2|||
33350798|NCT02305563|101167840|FG003|Follow-up Period|Participant withdrew consent|1|||
33350799|NCT02305563|101167841|FG004|Follow-up Period|Participant withdrew consent|0|||
33350800|NCT02305563|101167837|FG000|Follow-up Period|other reason|0|||
33350801|NCT02305563|101167838|FG001|Follow-up Period|other reason|0|||
33350802|NCT02305563|101167839|FG002|Follow-up Period|other reason|0|||
33350803|NCT02305563|101167840|FG003|Follow-up Period|other reason|0|||
33350804|NCT02305563|101167841|FG004|Follow-up Period|other reason|1|||
33350805|NCT02305563|101167837|FG000|Follow-up Period|Followup no longer required per protocol|3|||
33350806|NCT02305563|101167838|FG001|Follow-up Period|Followup no longer required per protocol|3|||
33350807|NCT02305563|101167839|FG002|Follow-up Period|Followup no longer required per protocol|4|||
33350808|NCT02305563|101167840|FG003|Follow-up Period|Followup no longer required per protocol|1|||
33350809|NCT02305563|101167841|FG004|Follow-up Period|Followup no longer required per protocol|4|||
33350810|NCT00929240|101172176|FG000|Initial Treatment Phase|Adverse Event|31|||
33350811|NCT00929240|101172177|FG001|Initial Treatment Phase|Adverse Event|0|||
33350812|NCT00929240|101172178|FG002|Initial Treatment Phase|Adverse Event|0|||
33350813|NCT00929240|101172176|FG000|Initial Treatment Phase|Disease progression|41|||
33411376|NCT04888377|101397126|FG001|Overall Study|Withdrawal by Subject|3|||
33411377|NCT04066894|101397127|FG000|Overall Study|Lack of Efficacy|1|||
33551391|NCT00387127|101916936|FG001|Overall Study|Death|16|||
33551392|NCT00387127|101916935|FG000|Overall Study|Physician Decision|0|||
33551393|NCT00387127|101916936|FG001|Overall Study|Physician Decision|1|||
33618644|NCT03499314|102151584|FG000|Overall Study|Time Commitment|1|||
33350814|NCT00929240|101172177|FG001|Initial Treatment Phase|Disease progression|0|||
33350815|NCT00929240|101172178|FG002|Initial Treatment Phase|Disease progression|0|||
33350816|NCT00929240|101172176|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
33411378|NCT04066894|101397127|FG000|Overall Study|Screen Failure|1|||
33350817|NCT00929240|101172177|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
33350818|NCT00929240|101172178|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
33551394|NCT00387127|101916935|FG000|Overall Study|Withdrawal by Subject|3|||
33551395|NCT00387127|101916936|FG001|Overall Study|Withdrawal by Subject|2|||
33411379|NCT02422186|101397135|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
33411380|NCT02422186|101397136|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
33411381|NCT02422186|101397135|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
33411382|NCT02422186|101397136|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
33411383|NCT02422186|101397135|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
33411384|NCT02422186|101397136|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
33411385|NCT02422186|101397135|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
33411386|NCT02422186|101397136|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
33411387|NCT02422186|101397135|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
33411388|NCT02422186|101397136|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
33411389|NCT02422186|101397135|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
33411390|NCT02422186|101397136|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
33411391|NCT02422186|101397135|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
33411392|NCT02422186|101397136|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
33411393|NCT02422186|101397135|FG000|Follow-up Phase (2 Weeks)|Other|3|||
33411394|NCT02422186|101397136|FG001|Follow-up Phase (2 Weeks)|Other|0|||
33411395|NCT01846442|101397137|FG000|Overall Study|Adverse Event|2|||
33411396|NCT01846442|101397138|FG001|Overall Study|Adverse Event|4|||
33411397|NCT01846442|101397139|FG002|Overall Study|Adverse Event|2|||
33411398|NCT01846442|101397140|FG003|Overall Study|Adverse Event|1|||
33411399|NCT01846442|101397137|FG000|Overall Study|Lost to Follow-up|0|||
33411400|NCT01846442|101397138|FG001|Overall Study|Lost to Follow-up|0|||
33411401|NCT01846442|101397139|FG002|Overall Study|Lost to Follow-up|1|||
33411402|NCT01846442|101397140|FG003|Overall Study|Lost to Follow-up|0|||
33411403|NCT01846442|101397137|FG000|Overall Study|Withdrawal by Subject|3|||
33411404|NCT01846442|101397138|FG001|Overall Study|Withdrawal by Subject|2|||
33411405|NCT01846442|101397139|FG002|Overall Study|Withdrawal by Subject|0|||
33411406|NCT01846442|101397140|FG003|Overall Study|Withdrawal by Subject|1|||
33411407|NCT01846442|101397137|FG000|Overall Study|Left the city/Lost medication|1|||
33411408|NCT01846442|101397138|FG001|Overall Study|Left the city/Lost medication|0|||
33411409|NCT01846442|101397139|FG002|Overall Study|Left the city/Lost medication|1|||
33411410|NCT01846442|101397140|FG003|Overall Study|Left the city/Lost medication|1|||
33411411|NCT00198107|101397143|FG000|Double-Blind Period|Adverse Event|1|||
33411412|NCT00198107|101397144|FG001|Double-Blind Period|Adverse Event|1|||
33411413|NCT00198107|101397145|FG002|Double-Blind Period|Adverse Event|0|||
33411414|NCT00198107|101397143|FG000|Double-Blind Period|Lack of Efficacy|2|||
33411415|NCT00198107|101397144|FG001|Double-Blind Period|Lack of Efficacy|0|||
33411416|NCT00198107|101397145|FG002|Double-Blind Period|Lack of Efficacy|0|||
33411417|NCT00198107|101397143|FG000|Double-Blind Period|Lost to Follow-up|2|||
33411418|NCT00198107|101397144|FG001|Double-Blind Period|Lost to Follow-up|1|||
33411419|NCT00198107|101397145|FG002|Double-Blind Period|Lost to Follow-up|0|||
33411420|NCT00198107|101397143|FG000|Double-Blind Period|Physician Decision|1|||
33411421|NCT00198107|101397144|FG001|Double-Blind Period|Physician Decision|0|||
33411422|NCT00198107|101397145|FG002|Double-Blind Period|Physician Decision|0|||
33411423|NCT00198107|101397143|FG000|Double-Blind Period|Withdrawal by Subject|0|||
33411424|NCT00198107|101397144|FG001|Double-Blind Period|Withdrawal by Subject|1|||
33411425|NCT00198107|101397145|FG002|Double-Blind Period|Withdrawal by Subject|0|||
33411426|NCT00198107|101397143|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
33411427|NCT00198107|101397144|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
33411428|NCT00198107|101397145|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
33411429|NCT00151775|101397146|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
33411430|NCT00151775|101397147|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
33411431|NCT00151775|101397148|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33411432|NCT00151775|101397149|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33411433|NCT00151775|101397150|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33411434|NCT00151775|101397151|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33411435|NCT00151775|101397152|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33411436|NCT00151775|101397153|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33411437|NCT00151775|101397154|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33411438|NCT00151775|101397155|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33411439|NCT00151775|101397156|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33411440|NCT00151775|101397157|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
33411441|NCT00151775|101397146|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
33411442|NCT00151775|101397147|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33551396|NCT00387127|101916935|FG000|Overall Study|Required by Protocol Amendment #4|12|||
33551397|NCT00387127|101916936|FG001|Overall Study|Required by Protocol Amendment #4|10|||
33618645|NCT03499314|102151585|FG001|Overall Study|Time Commitment|2|||
33618646|NCT03499314|102151584|FG000|Overall Study|Medical issue unrelated to research study|1|||
33618647|NCT03499314|102151585|FG001|Overall Study|Medical issue unrelated to research study|1|||
33618648|NCT01456169|102151586|FG000|Overall Study|Adverse Event|1|||
33618649|NCT01456169|102151587|FG001|Overall Study|Adverse Event|2|||
33618650|NCT01456169|102151588|FG002|Overall Study|Adverse Event|7|||
33618651|NCT01456169|102151586|FG000|Overall Study|Major Protocol Deviation|3|||
33618652|NCT01456169|102151587|FG001|Overall Study|Major Protocol Deviation|2|||
33618653|NCT01456169|102151588|FG002|Overall Study|Major Protocol Deviation|3|||
33618654|NCT01456169|102151586|FG000|Overall Study|Voluntary Withdrawal|3|||
33618655|NCT01456169|102151587|FG001|Overall Study|Voluntary Withdrawal|0|||
33618656|NCT01456169|102151588|FG002|Overall Study|Voluntary Withdrawal|2|||
33618657|NCT01456169|102151586|FG000|Overall Study|Lack of Efficacy|2|||
33217482|NCT04385368|100692422|FG001|Overall Study|Physician Decision|0|||
33217483|NCT04385368|100692421|FG000|Overall Study|Withdrawal by Subject|4|||
33350819|NCT00929240|101172176|FG000|Initial Treatment Phase|Protocol Violation|5|||
33350820|NCT00929240|101172177|FG001|Initial Treatment Phase|Protocol Violation|0|||
33350821|NCT00929240|101172178|FG002|Initial Treatment Phase|Protocol Violation|0|||
33350822|NCT00929240|101172176|FG000|Initial Treatment Phase|Death|2|||
33350823|NCT00929240|101172177|FG001|Initial Treatment Phase|Death|0|||
33350824|NCT00929240|101172178|FG002|Initial Treatment Phase|Death|0|||
33350825|NCT00929240|101172176|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
33350826|NCT00929240|101172177|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
33350827|NCT00929240|101172178|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
33350828|NCT00929240|101172176|FG000|Initial Treatment Phase|Physician Decision|4|||
33350829|NCT00929240|101172177|FG001|Initial Treatment Phase|Physician Decision|0|||
33350830|NCT00929240|101172178|FG002|Initial Treatment Phase|Physician Decision|0|||
33350831|NCT00929240|101172176|FG000|Maintenance Phase|Disease progression|0|||
33350832|NCT00929240|101172177|FG001|Maintenance Phase|Disease progression|73|||
33350833|NCT00929240|101172178|FG002|Maintenance Phase|Disease progression|60|||
33350834|NCT00929240|101172176|FG000|Maintenance Phase|Adverse Event|0|||
33350835|NCT00929240|101172177|FG001|Maintenance Phase|Adverse Event|9|||
33350836|NCT00929240|101172178|FG002|Maintenance Phase|Adverse Event|12|||
33350837|NCT00929240|101172176|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33350838|NCT00929240|101172177|FG001|Maintenance Phase|Withdrawal by Subject|2|||
33350839|NCT00929240|101172178|FG002|Maintenance Phase|Withdrawal by Subject|6|||
33350840|NCT00929240|101172176|FG000|Maintenance Phase|Protocol Violation|0|||
33350841|NCT00929240|101172177|FG001|Maintenance Phase|Protocol Violation|1|||
33350842|NCT00929240|101172178|FG002|Maintenance Phase|Protocol Violation|0|||
33350843|NCT00929240|101172176|FG000|Maintenance Phase|Health authority/Study termination|0|||
33350844|NCT00929240|101172177|FG001|Maintenance Phase|Health authority/Study termination|1|||
33350845|NCT00929240|101172178|FG002|Maintenance Phase|Health authority/Study termination|2|||
33350846|NCT00929240|101172176|FG000|Maintenance Phase|Physician Decision|0|||
33350847|NCT00929240|101172177|FG001|Maintenance Phase|Physician Decision|2|||
33350848|NCT00929240|101172178|FG002|Maintenance Phase|Physician Decision|1|||
33350849|NCT00929240|101172176|FG000|Maintenance Phase|Change of treatment|0|||
33350850|NCT00929240|101172177|FG001|Maintenance Phase|Change of treatment|4|||
33350851|NCT00929240|101172178|FG002|Maintenance Phase|Change of treatment|0|||
33350852|NCT00929240|101172176|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
33350853|NCT00929240|101172177|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
33350854|NCT00929240|101172178|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
33350855|NCT00929240|101172176|FG000|Maintenance Phase|Participant not treated|0|||
33350856|NCT00929240|101172177|FG001|Maintenance Phase|Participant not treated|2|||
33350857|NCT00929240|101172178|FG002|Maintenance Phase|Participant not treated|0|||
33350858|NCT00675025|101172179|FG000|Overall Study|Study Terminated by Sponsor|38|||
33350859|NCT00675025|101172180|FG001|Overall Study|Study Terminated by Sponsor|42|||
33350860|NCT00675025|101172179|FG000|Overall Study|Adverse Event|6|||
33350861|NCT00675025|101172180|FG001|Overall Study|Adverse Event|11|||
33350862|NCT00675025|101172179|FG000|Overall Study|Lost to Follow-up|6|||
33350863|NCT00675025|101172180|FG001|Overall Study|Lost to Follow-up|4|||
33350864|NCT00675025|101172179|FG000|Overall Study|Withdrawal by Subject|4|||
33350865|NCT00675025|101172180|FG001|Overall Study|Withdrawal by Subject|6|||
33350866|NCT01658514|101172181|FG000|Overall Study|Protocol Violation|1|||
33350867|NCT01658514|101172182|FG001|Overall Study|Protocol Violation|0|||
33350868|NCT01658514|101172183|FG002|Overall Study|Protocol Violation|2|||
33350869|NCT01562028|101172186|FG000|Overall Study|Withdrawal by Subject|1|||
33350870|NCT01562028|101172187|FG001|Overall Study|Withdrawal by Subject|1|||
33618658|NCT01456169|102151587|FG001|Overall Study|Lack of Efficacy|0|||
33618659|NCT01456169|102151588|FG002|Overall Study|Lack of Efficacy|0|||
33618660|NCT01456169|102151586|FG000|Overall Study|Other|1|||
33618661|NCT01456169|102151587|FG001|Overall Study|Other|1|||
33350871|NCT01562028|101172186|FG000|Overall Study|Lost to Follow-up|2|||
33618662|NCT01456169|102151588|FG002|Overall Study|Other|0|||
33618663|NCT01587040|102151589|FG000|Overall Study|Protocol Violation|0|||
33618664|NCT01587040|102151590|FG001|Overall Study|Protocol Violation|0|||
33350872|NCT01562028|101172187|FG001|Overall Study|Lost to Follow-up|1|||
33350873|NCT01752023|101172188|FG000|Overall Study|Physician Decision|2|||
33350874|NCT01752023|101172189|FG001|Overall Study|Physician Decision|1|||
33350875|NCT02853760|101172191|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
33350876|NCT02853760|101172192|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
33551398|NCT00387127|101916935|FG000|Overall Study|Serious Adverse Event|1|||
33551399|NCT00387127|101916936|FG001|Overall Study|Serious Adverse Event|1|||
33551400|NCT00387127|101916935|FG000|Overall Study|Sponsor Unblinded|1|||
33551401|NCT00387127|101916936|FG001|Overall Study|Sponsor Unblinded|0|||
33551402|NCT01312129|101916939|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
33551403|NCT01312129|101916940|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
33551404|NCT01121926|101916941|FG000|First Intervention Period|Adverse Event|1|||
33551405|NCT01121926|101916942|FG001|First Intervention Period|Adverse Event|0|||
33551406|NCT01121926|101916941|FG000|Washout Period|Adverse Event|0|||
33551407|NCT01121926|101916942|FG001|Washout Period|Adverse Event|1|||
33551408|NCT01121926|101916941|FG000|Washout Period|Positive pregnancy test|0|||
33551409|NCT01121926|101916942|FG001|Washout Period|Positive pregnancy test|1|||
33551410|NCT02609633|101916946|FG000|Overall Study|Consent Withdrawn|0|||
33551411|NCT02609633|101916947|FG001|Overall Study|Consent Withdrawn|1|||
33551412|NCT02609633|101916946|FG000|Overall Study|Protocol Deviation|1|||
33551413|NCT02609633|101916947|FG001|Overall Study|Protocol Deviation|0|||
33551414|NCT02609633|101916946|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
33551415|NCT02609633|101916947|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
33551416|NCT02609633|101916946|FG000|Overall Study|Reason not Specified|2|||
33551417|NCT02609633|101916947|FG001|Overall Study|Reason not Specified|1|||
33551418|NCT03501277|101916948|FG000|Intervention Period 1 (4 Days)|Other|0|||
33551419|NCT03501277|101916949|FG001|Intervention Period 1 (4 Days)|Other|0|||
33551420|NCT03501277|101916950|FG002|Intervention Period 1 (4 Days)|Other|1|||
33551421|NCT03501277|101916951|FG003|Intervention Period 1 (4 Days)|Other|0|||
33551422|NCT03501277|101916948|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
33551423|NCT03501277|101916949|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
33551424|NCT03501277|101916950|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
33551425|NCT03501277|101916951|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
33551426|NCT03501277|101916948|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
33551427|NCT03501277|101916949|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
33551428|NCT03501277|101916950|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
33350877|NCT02853760|101172193|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
33350878|NCT02853760|101172194|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
33350879|NCT02853760|101172195|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
33350880|NCT02853760|101172196|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
33551429|NCT03501277|101916951|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
33551430|NCT03501277|101916948|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
33551431|NCT03501277|101916949|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
33551432|NCT03501277|101916950|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
33551433|NCT03501277|101916951|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
33551434|NCT00710970|101916952|FG000|Overall Study|Never took drug|3|||
33551435|NCT00066170|101916954|FG000|Overall Study|Adverse Event|2|||
33551436|NCT00066170|101916955|FG001|Overall Study|Adverse Event|4|||
33551437|NCT00066170|101916956|FG002|Overall Study|Adverse Event|1|||
33551438|NCT00066170|101916957|FG003|Overall Study|Adverse Event|7|||
33350881|NCT00355121|101172199|FG000|Overall Study|Did not receive study vaccine|1|||
33350882|NCT00355121|101172200|FG001|Overall Study|Did not receive study vaccine|0|||
33350883|NCT00355121|101172201|FG002|Overall Study|Did not receive study vaccine|1|||
33350884|NCT00355121|101172199|FG000|Overall Study|Adverse Event|0|||
33350885|NCT00355121|101172200|FG001|Overall Study|Adverse Event|1|||
33350886|NCT00355121|101172201|FG002|Overall Study|Adverse Event|0|||
33350887|NCT00355121|101172199|FG000|Overall Study|Protocol Violation|7|||
33350888|NCT00355121|101172200|FG001|Overall Study|Protocol Violation|9|||
33350889|NCT00355121|101172201|FG002|Overall Study|Protocol Violation|1|||
33350890|NCT00355121|101172199|FG000|Overall Study|Lost to Follow-up|4|||
33350891|NCT00355121|101172200|FG001|Overall Study|Lost to Follow-up|7|||
33350892|NCT00355121|101172201|FG002|Overall Study|Lost to Follow-up|1|||
33350893|NCT00355121|101172199|FG000|Overall Study|Withdrawal by Subject|9|||
33350894|NCT00355121|101172200|FG001|Overall Study|Withdrawal by Subject|10|||
33350895|NCT00355121|101172201|FG002|Overall Study|Withdrawal by Subject|2|||
33551439|NCT00066170|101916954|FG000|Overall Study|Serious Adverse Event|0|||
33551440|NCT00066170|101916955|FG001|Overall Study|Serious Adverse Event|0|||
33551441|NCT00066170|101916956|FG002|Overall Study|Serious Adverse Event|1|||
33551442|NCT00066170|101916957|FG003|Overall Study|Serious Adverse Event|1|||
33350896|NCT00355121|101172199|FG000|Overall Study|Serious adverse events|0|||
33350897|NCT00355121|101172200|FG001|Overall Study|Serious adverse events|2|||
33350898|NCT00355121|101172201|FG002|Overall Study|Serious adverse events|0|||
33350899|NCT01523873|101172202|FG000|Overall Study|Protocol Violation|422|||
33350900|NCT02318784|101172203|FG000|Overall Study|Adverse Event|13|||
33551443|NCT00066170|101916954|FG000|Overall Study|Lost to Follow-up|0|||
33551444|NCT00066170|101916955|FG001|Overall Study|Lost to Follow-up|1|||
33551445|NCT00066170|101916956|FG002|Overall Study|Lost to Follow-up|0|||
33551446|NCT00066170|101916957|FG003|Overall Study|Lost to Follow-up|0|||
33551447|NCT00066170|101916954|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
33551448|NCT00066170|101916955|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
33551449|NCT00066170|101916956|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
33551450|NCT00066170|101916957|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
33551451|NCT00066170|101916954|FG000|Overall Study|Protocol Violation|3|||
33551452|NCT00066170|101916955|FG001|Overall Study|Protocol Violation|0|||
33551453|NCT00066170|101916956|FG002|Overall Study|Protocol Violation|0|||
33551454|NCT00066170|101916957|FG003|Overall Study|Protocol Violation|0|||
33551455|NCT00066170|101916954|FG000|Overall Study|Other|1|||
33551456|NCT00066170|101916955|FG001|Overall Study|Other|5|||
33551457|NCT00066170|101916956|FG002|Overall Study|Other|2|||
33551458|NCT00066170|101916957|FG003|Overall Study|Other|0|||
33551459|NCT00086307|101916958|FG000|Overall Study|Lack of Efficacy|1|||
33551460|NCT00086307|101916959|FG001|Overall Study|Lack of Efficacy|1|||
33551461|NCT00086307|101916960|FG002|Overall Study|Lack of Efficacy|2|||
33551462|NCT00086307|101916958|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
33350901|NCT02318784|101172203|FG000|Overall Study|Death|2|||
33350902|NCT02318784|101172203|FG000|Overall Study|Progressive Disease|37|||
33350903|NCT02318784|101172203|FG000|Overall Study|Withdrawal by Subject|10|||
33350904|NCT00348140|101172204|FG000|Overall Study|Adverse Event|46|||
33350905|NCT00348140|101172205|FG001|Overall Study|Adverse Event|49|||
33350906|NCT00348140|101172206|FG002|Overall Study|Adverse Event|78|||
33350907|NCT00348140|101172204|FG000|Overall Study|Lost to Follow-up|4|||
33350908|NCT00348140|101172205|FG001|Overall Study|Lost to Follow-up|4|||
33350909|NCT00348140|101172206|FG002|Overall Study|Lost to Follow-up|4|||
33350910|NCT00348140|101172204|FG000|Overall Study|Protocol Violation|12|||
33350911|NCT00348140|101172205|FG001|Overall Study|Protocol Violation|13|||
33350912|NCT00348140|101172206|FG002|Overall Study|Protocol Violation|14|||
33350913|NCT00348140|101172204|FG000|Overall Study|Withdrawal by Subject|32|||
33350914|NCT00348140|101172205|FG001|Overall Study|Withdrawal by Subject|40|||
33350915|NCT00348140|101172206|FG002|Overall Study|Withdrawal by Subject|40|||
33350916|NCT00348140|101172204|FG000|Overall Study|Non-compliance|8|||
33350917|NCT00348140|101172205|FG001|Overall Study|Non-compliance|13|||
33350918|NCT00348140|101172206|FG002|Overall Study|Non-compliance|5|||
33411443|NCT00151775|101397148|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33411444|NCT00151775|101397149|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33411445|NCT00151775|101397150|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33411446|NCT00151775|101397151|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33411447|NCT00151775|101397152|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
33411448|NCT00151775|101397153|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33411449|NCT00151775|101397154|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33411450|NCT00151775|101397155|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33411451|NCT00151775|101397156|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
33411452|NCT00151775|101397157|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
33411453|NCT00151775|101397146|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33411454|NCT00151775|101397147|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
33411455|NCT00151775|101397148|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33411456|NCT00151775|101397149|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33411457|NCT00151775|101397150|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33411458|NCT00151775|101397151|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33411459|NCT00151775|101397152|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33411460|NCT00151775|101397153|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33551463|NCT00086307|101916959|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
33551464|NCT00086307|101916960|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
33551465|NCT00086307|101916958|FG000|Overall Study|Nausea and headaches|0|||
33551466|NCT00086307|101916959|FG001|Overall Study|Nausea and headaches|0|||
33350919|NCT00348140|101172204|FG000|Overall Study|Participant at risk due to study drug|2|||
33350920|NCT00348140|101172205|FG001|Overall Study|Participant at risk due to study drug|0|||
33350921|NCT00348140|101172206|FG002|Overall Study|Participant at risk due to study drug|0|||
33350922|NCT00348140|101172204|FG000|Overall Study|Conditional medication increased dose|1|||
33350923|NCT00348140|101172205|FG001|Overall Study|Conditional medication increased dose|0|||
33350924|NCT00348140|101172206|FG002|Overall Study|Conditional medication increased dose|0|||
33551467|NCT00086307|101916960|FG002|Overall Study|Nausea and headaches|1|||
33551468|NCT00086307|101916958|FG000|Overall Study|Constipation and sleepiness|0|||
33551469|NCT00086307|101916959|FG001|Overall Study|Constipation and sleepiness|0|||
33551470|NCT00086307|101916960|FG002|Overall Study|Constipation and sleepiness|1|||
33551471|NCT00086307|101916958|FG000|Overall Study|Suicidal ideation|0|||
33551472|NCT00086307|101916959|FG001|Overall Study|Suicidal ideation|0|||
33551473|NCT00086307|101916960|FG002|Overall Study|Suicidal ideation|1|||
33551474|NCT00086307|101916958|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
33551475|NCT00086307|101916959|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
33551476|NCT00086307|101916960|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
33618665|NCT01587040|102151591|FG002|Overall Study|Protocol Violation|1|||
33618666|NCT01587040|102151592|FG003|Overall Study|Protocol Violation|0|||
33618667|NCT01587040|102151589|FG000|Overall Study|Adverse Event|0|||
33618668|NCT01587040|102151590|FG001|Overall Study|Adverse Event|1|||
33618669|NCT01587040|102151591|FG002|Overall Study|Adverse Event|10|||
33618670|NCT01587040|102151592|FG003|Overall Study|Adverse Event|0|||
33618671|NCT01587040|102151589|FG000|Overall Study|Disease progression|12|||
33618672|NCT01587040|102151590|FG001|Overall Study|Disease progression|1|||
33618673|NCT01587040|102151591|FG002|Overall Study|Disease progression|15|||
33618674|NCT01587040|102151592|FG003|Overall Study|Disease progression|3|||
33618675|NCT01587040|102151589|FG000|Overall Study|Other than specified|5|||
33618676|NCT01587040|102151590|FG001|Overall Study|Other than specified|1|||
33618677|NCT01587040|102151591|FG002|Overall Study|Other than specified|11|||
33618678|NCT01587040|102151592|FG003|Overall Study|Other than specified|1|||
33618679|NCT01327599|102151593|FG000|Overall Study|Adverse Event|1|||
33618680|NCT01327599|102151593|FG000|Overall Study|Could Not Attend Visit|1|||
33618681|NCT01327599|102151593|FG000|Overall Study|Withdrawal of Consent|1|||
33618682|NCT00824473|102151594|FG000|Overall Study|Adverse Event|4|||
33618683|NCT00824473|102151595|FG001|Overall Study|Adverse Event|5|||
33618684|NCT00824473|102151594|FG000|Overall Study|Lack of Efficacy|2|||
33350925|NCT00348140|101172204|FG000|Overall Study|Caregiver related|4|||
33350926|NCT00348140|101172205|FG001|Overall Study|Caregiver related|7|||
33350927|NCT00348140|101172206|FG002|Overall Study|Caregiver related|3|||
33350928|NCT00348140|101172204|FG000|Overall Study|Participant hospitalised|3|||
33350929|NCT00348140|101172205|FG001|Overall Study|Participant hospitalised|0|||
33350930|NCT00348140|101172206|FG002|Overall Study|Participant hospitalised|0|||
33350931|NCT00348140|101172204|FG000|Overall Study|Efficacy related|1|||
33350932|NCT00348140|101172205|FG001|Overall Study|Efficacy related|1|||
33350933|NCT00348140|101172206|FG002|Overall Study|Efficacy related|0|||
33350934|NCT00348140|101172204|FG000|Overall Study|Administration related|3|||
33350935|NCT00348140|101172205|FG001|Overall Study|Administration related|1|||
33350936|NCT00348140|101172206|FG002|Overall Study|Administration related|1|||
33350937|NCT00348140|101172204|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
33618685|NCT00824473|102151595|FG001|Overall Study|Lack of Efficacy|2|||
33618686|NCT00824473|102151594|FG000|Overall Study|Protocol Violation|2|||
33618687|NCT00824473|102151595|FG001|Overall Study|Protocol Violation|0|||
33618688|NCT00824473|102151594|FG000|Overall Study|Non-Compliance|4|||
33618689|NCT00824473|102151595|FG001|Overall Study|Non-Compliance|2|||
33618690|NCT00824473|102151594|FG000|Overall Study|Withdrawal by Subject|2|||
33618691|NCT00824473|102151595|FG001|Overall Study|Withdrawal by Subject|3|||
33618692|NCT00824473|102151594|FG000|Overall Study|Other|1|||
33350938|NCT00348140|101172205|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
33350939|NCT00348140|101172206|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
33350940|NCT00348140|101172204|FG000|Overall Study|Participant unwell|1|||
33350941|NCT00348140|101172205|FG001|Overall Study|Participant unwell|0|||
33618693|NCT00824473|102151595|FG001|Overall Study|Other|1|||
33618694|NCT02489318|102151598|FG000|Randomized|Withdrawal by Subject|0|||
33618695|NCT02489318|102151599|FG001|Randomized|Withdrawal by Subject|1|||
33618696|NCT02489318|102151598|FG000|Treated|Adverse Event|19|||
33217484|NCT04385368|100692422|FG001|Overall Study|Withdrawal by Subject|3|||
33350942|NCT00348140|101172206|FG002|Overall Study|Participant unwell|0|||
33618697|NCT02489318|102151599|FG001|Treated|Adverse Event|62|||
33618698|NCT02489318|102151598|FG000|Treated|Death|13|||
33618699|NCT02489318|102151599|FG001|Treated|Death|11|||
33618700|NCT02489318|102151598|FG000|Treated|Physician Decision|4|||
33350943|NCT00348140|101172204|FG000|Overall Study|Screen failure|1|||
33350944|NCT00348140|101172205|FG001|Overall Study|Screen failure|0|||
33350945|NCT00348140|101172206|FG002|Overall Study|Screen failure|0|||
33618701|NCT02489318|102151599|FG001|Treated|Physician Decision|6|||
33618702|NCT02489318|102151598|FG000|Treated|Protocol Violation|1|||
33618703|NCT02489318|102151599|FG001|Treated|Protocol Violation|2|||
33618704|NCT02489318|102151598|FG000|Treated|Withdrawal by Subject|37|||
33350946|NCT00348140|101172204|FG000|Overall Study|Investigator decided to discontinue|4|||
33618705|NCT02489318|102151599|FG001|Treated|Withdrawal by Subject|36|||
33618706|NCT02489318|102151598|FG000|Treated|Other: Progressive Disease|245|||
33618707|NCT02489318|102151599|FG001|Treated|Other: Progressive Disease|138|||
33618708|NCT02489318|102151598|FG000|Treated|Other|0|||
33618709|NCT02489318|102151599|FG001|Treated|Other|2|||
33618710|NCT02489318|102151598|FG000|Treated|Ongoing|0|||
33618711|NCT02489318|102151599|FG001|Treated|Ongoing|267|||
33618712|NCT01012258|102151602|FG000|Overall Study|Death|14|||
33618713|NCT01012258|102151602|FG000|Overall Study|Lost to Follow-up|1|||
33618714|NCT01012258|102151602|FG000|Overall Study|Adverse Event|1|||
33618715|NCT01012258|102151602|FG000|Overall Study|Progressive Disease (PD)|18|||
33618716|NCT01012258|102151602|FG000|Overall Study|Symptomatic Deterioration|1|||
33618717|NCT01012258|102151602|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
33618718|NCT01012258|102151602|FG000|Overall Study|Another Tumor Discovered|1|||
33618719|NCT01012258|102151602|FG000|Overall Study|Ongoing|29|||
33618720|NCT02630472|102151609|FG000|Overall Study|Physician Decision|10|||
33618721|NCT02630472|102151610|FG001|Overall Study|Physician Decision|0|||
33618722|NCT02915263|102151611|FG000|Overall Study|Covid|3|||
33618723|NCT02915263|102151612|FG001|Overall Study|Covid|2|||
33618724|NCT00785980|102151615|FG000|7 Day Washout Period|Protocol Violation|3|||
33618725|NCT00773513|102151616|FG000|Overall Study|Renal Transplant|254|||
33618726|NCT00773513|102151617|FG001|Overall Study|Renal Transplant|263|||
33618727|NCT00773513|102151616|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
33618728|NCT00773513|102151617|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
33618729|NCT00773513|102151616|FG000|Overall Study|Withdrew Consent|68|||
33618730|NCT00773513|102151617|FG001|Overall Study|Withdrew Consent|69|||
33618731|NCT00773513|102151616|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
33618732|NCT00773513|102151617|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
33618733|NCT00773513|102151616|FG000|Overall Study|Failure to Return|22|||
33618734|NCT00773513|102151617|FG001|Overall Study|Failure to Return|8|||
33618735|NCT00773513|102151616|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33618736|NCT00773513|102151617|FG001|Overall Study|Insufficient Therapeutic Response|18|||
33618737|NCT00773513|102151616|FG000|Overall Study|Reason Not Specified|159|||
33618738|NCT00773513|102151617|FG001|Overall Study|Reason Not Specified|126|||
33618739|NCT00773513|102151616|FG000|Overall Study|Death|531|||
33618740|NCT00773513|102151617|FG001|Overall Study|Death|545|||
33618741|NCT00855816|102151618|FG000|Overall Study|Withdrawal by Subject|22|||
33618742|NCT00855816|102151619|FG001|Overall Study|Withdrawal by Subject|15|||
33618743|NCT00855816|102151618|FG000|Overall Study|Lost to Follow-up|3|||
33618744|NCT00855816|102151619|FG001|Overall Study|Lost to Follow-up|5|||
33551477|NCT00086307|101916958|FG000|Overall Study|Withdrawal by Subject|0|||
33551478|NCT00086307|101916959|FG001|Overall Study|Withdrawal by Subject|0|||
33551479|NCT00086307|101916960|FG002|Overall Study|Withdrawal by Subject|2|||
33551480|NCT01257542|101916961|FG000|Overall Study|Protocol Violation|3|||
33551481|NCT01257542|101916962|FG001|Overall Study|Protocol Violation|5|||
33551482|NCT01257542|101916961|FG000|Overall Study|Withdrawal by Subject|0|||
33551483|NCT01257542|101916962|FG001|Overall Study|Withdrawal by Subject|2|||
33551484|NCT01428128|101916967|FG000|Overall Study|Withdrawal by Subject|4|||
33551485|NCT01428128|101916967|FG000|Overall Study|Screen failure by p53|10|||
33551486|NCT01428128|101916967|FG000|Overall Study|Received Neulasta in one cycle|2|||
33551487|NCT01428128|101916967|FG000|Overall Study|Adverse Event|1|||
33551488|NCT00456612|101916969|FG000|Overall Study|Withdrawal by Subject|3|||
33551489|NCT00864513|101916970|FG000|Overall Study|Withdrawal by Subject|3|||
33551490|NCT00376506|101916971|FG000|Overall Study|Death|0|||
33551491|NCT00376506|101916972|FG001|Overall Study|Death|2|||
33551492|NCT00604383|101916973|FG000|Overall Study|Withdrawal by Subject|33|||
33551493|NCT00604383|101916974|FG001|Overall Study|Withdrawal by Subject|31|||
33551494|NCT00604383|101916973|FG000|Overall Study|Lost to Follow-up|24|||
33551495|NCT00604383|101916974|FG001|Overall Study|Lost to Follow-up|19|||
33551496|NCT00604383|101916973|FG000|Overall Study|Death|14|||
33551497|NCT00604383|101916974|FG001|Overall Study|Death|22|||
33551498|NCT00604383|101916973|FG000|Overall Study|Adverse Event|16|||
33551499|NCT00604383|101916974|FG001|Overall Study|Adverse Event|9|||
33551500|NCT00604383|101916973|FG000|Overall Study|Physician Decision|0|||
33551501|NCT00604383|101916974|FG001|Overall Study|Physician Decision|3|||
33618745|NCT00855816|102151618|FG000|Overall Study|Death|1|||
33618746|NCT00855816|102151619|FG001|Overall Study|Death|0|||
33618747|NCT00855816|102151618|FG000|Overall Study|Became ineligible|0|||
33618748|NCT00855816|102151619|FG001|Overall Study|Became ineligible|1|||
33551502|NCT00549328|101916975|FG000|Overall Study|Adverse Event|2|||
33551503|NCT00549328|101916975|FG000|Overall Study|Disease Progression|10|||
33551504|NCT00549328|101916975|FG000|Overall Study|Death|1|||
33551505|NCT00549328|101916975|FG000|Overall Study|Use of Prohibited Medication|1|||
33551506|NCT01668537|101916976|FG000|Overall Study|Request to Discontinue Prematurely|1|||
33551507|NCT01668537|101916977|FG001|Overall Study|Request to Discontinue Prematurely|1|||
33551508|NCT01668537|101916976|FG000|Overall Study|Subject unwilling/unable to comply|5|||
33618749|NCT04439539|102151620|FG000|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|1|||
33618750|NCT04439539|102151621|FG001|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|0|||
33618751|NCT04439539|102151622|FG002|IP:W0-36(Post-PA5)/W52(Prior-PA5)|Withdrawal by Subject|2|||
33618752|NCT04439539|102151620|FG000|Follow-up (FU): FU Week 0 to 48|Ongoing|0|||
33618753|NCT04439539|102151621|FG001|Follow-up (FU): FU Week 0 to 48|Ongoing|5|||
33618754|NCT04439539|102151622|FG002|Follow-up (FU): FU Week 0 to 48|Ongoing|17|||
33618755|NCT04439539|102151620|FG000|Follow-up (FU): FU Week 0 to 48|Other|0|||
33618756|NCT04439539|102151621|FG001|Follow-up (FU): FU Week 0 to 48|Other|1|||
33618757|NCT04439539|102151622|FG002|Follow-up (FU): FU Week 0 to 48|Other|0|||
33350947|NCT00348140|101172205|FG001|Overall Study|Investigator decided to discontinue|1|||
33350948|NCT00348140|101172206|FG002|Overall Study|Investigator decided to discontinue|4|||
33350949|NCT00348140|101172204|FG000|Overall Study|Decided to discontinue on their own|1|||
33350950|NCT00348140|101172205|FG001|Overall Study|Decided to discontinue on their own|4|||
33350951|NCT00348140|101172206|FG002|Overall Study|Decided to discontinue on their own|1|||
33350952|NCT00348140|101172204|FG000|Overall Study|Use of prohibited drug|1|||
33350953|NCT00348140|101172205|FG001|Overall Study|Use of prohibited drug|0|||
33350954|NCT00348140|101172206|FG002|Overall Study|Use of prohibited drug|2|||
33551509|NCT01668537|101916977|FG001|Overall Study|Subject unwilling/unable to comply|0|||
33551510|NCT01668537|101916976|FG000|Overall Study|Reason Precludes Participation|1|||
33551511|NCT01668537|101916977|FG001|Overall Study|Reason Precludes Participation|0|||
33551512|NCT01668537|101916976|FG000|Overall Study|Lost to Follow-up|13|||
33551513|NCT01668537|101916977|FG001|Overall Study|Lost to Follow-up|6|||
33551514|NCT01668537|101916976|FG000|Overall Study|Other|2|||
33551515|NCT01668537|101916977|FG001|Overall Study|Other|3|||
33551516|NCT01108055|101916978|FG000|Overall Study|Ineligible|11|||
33551517|NCT01108055|101916978|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
33551518|NCT03188705|101916979|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
33551519|NCT03188705|101916979|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
33551520|NCT01896986|101916981|FG000|Overall Study|samples lost|14|||
33551521|NCT01896986|101916982|FG001|Overall Study|samples lost|23|||
33551522|NCT01797185|101916983|FG000|Overall Study|Adverse Event|5|||
33551523|NCT01797185|101916984|FG001|Overall Study|Adverse Event|15|||
33551524|NCT01797185|101916985|FG002|Overall Study|Adverse Event|6|||
33551525|NCT01797185|101916983|FG000|Overall Study|Withdrawal by Subject|6|||
33551526|NCT01797185|101916984|FG001|Overall Study|Withdrawal by Subject|9|||
33411461|NCT00151775|101397154|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33411462|NCT00151775|101397155|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33551527|NCT01797185|101916985|FG002|Overall Study|Withdrawal by Subject|5|||
33551528|NCT01797185|101916983|FG000|Overall Study|Site terminated|8|||
33551529|NCT01797185|101916984|FG001|Overall Study|Site terminated|4|||
33551530|NCT01797185|101916985|FG002|Overall Study|Site terminated|0|||
33551531|NCT01797185|101916983|FG000|Overall Study|Lost to Follow-up|2|||
33551532|NCT01797185|101916984|FG001|Overall Study|Lost to Follow-up|6|||
33551533|NCT01797185|101916985|FG002|Overall Study|Lost to Follow-up|1|||
33618758|NCT04487080|102151623|FG000|Overall Study|Withdrawal by Subject|19|||
33618759|NCT04487080|102151624|FG001|Overall Study|Withdrawal by Subject|18|||
33411463|NCT00151775|101397156|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33411464|NCT00151775|101397157|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
33411465|NCT00151775|101397146|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
33411466|NCT00151775|101397147|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
33411467|NCT00151775|101397148|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
33411468|NCT00151775|101397149|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
33411469|NCT00151775|101397150|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
33411470|NCT00151775|101397151|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
33411471|NCT00151775|101397152|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
33411472|NCT00151775|101397153|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
33618760|NCT04487080|102151625|FG002|Overall Study|Withdrawal by Subject|13|||
33618761|NCT04487080|102151623|FG000|Overall Study|Lost to Follow-up|3|||
33618762|NCT04487080|102151624|FG001|Overall Study|Lost to Follow-up|1|||
33618763|NCT04487080|102151625|FG002|Overall Study|Lost to Follow-up|0|||
33618764|NCT04487080|102151623|FG000|Overall Study|Ongoing|313|||
33618765|NCT04487080|102151624|FG001|Overall Study|Ongoing|297|||
33618766|NCT04487080|102151625|FG002|Overall Study|Ongoing|149|||
33618767|NCT03081884|102151636|FG000|Overall Study|deferred prostate cancer treatment|1|||
33411473|NCT00151775|101397154|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
33411474|NCT00151775|101397155|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
33411475|NCT00151775|101397156|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
33551534|NCT01797185|101916983|FG000|Overall Study|Withdrawn per sponsor|5|||
33551535|NCT01797185|101916984|FG001|Overall Study|Withdrawn per sponsor|0|||
33551536|NCT01797185|101916985|FG002|Overall Study|Withdrawn per sponsor|0|||
33618768|NCT03081884|102151636|FG000|Overall Study|metastasis managed with systemic therapy|3|||
33350955|NCT00348140|101172204|FG000|Overall Study|Disease progression|1|||
33350956|NCT00348140|101172205|FG001|Overall Study|Disease progression|2|||
33350957|NCT00348140|101172206|FG002|Overall Study|Disease progression|5|||
33551537|NCT01797185|101916983|FG000|Overall Study|Physician Decision|1|||
33618769|NCT02855268|102151639|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
33618770|NCT02855268|102151640|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
33551538|NCT01797185|101916984|FG001|Overall Study|Physician Decision|3|||
33551539|NCT01797185|101916985|FG002|Overall Study|Physician Decision|0|||
33551540|NCT01797185|101916983|FG000|Overall Study|Protocol Violation|1|||
33551541|NCT01797185|101916984|FG001|Overall Study|Protocol Violation|1|||
33551542|NCT01797185|101916985|FG002|Overall Study|Protocol Violation|0|||
33551543|NCT00120874|101916990|FG000|Overall Study|Death|0|||
33551544|NCT00120874|101916991|FG001|Overall Study|Death|1|||
33551545|NCT01623752|101916992|FG000|Phase 1 (78 Weeks)|No Data|249|||
33551546|NCT01623752|101916993|FG001|Phase 1 (78 Weeks)|No Data|66|||
33551547|NCT01623752|101916994|FG002|Phase 1 (78 Weeks)|No Data|2|||
33551548|NCT01623752|101916992|FG000|Phase 1 (78 Weeks)|Other|33|||
33551549|NCT01623752|101916993|FG001|Phase 1 (78 Weeks)|Other|20|||
33551550|NCT01623752|101916994|FG002|Phase 1 (78 Weeks)|Other|0|||
33551551|NCT01623752|101916992|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
33551552|NCT01623752|101916993|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
33551553|NCT01623752|101916994|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
33551554|NCT01623752|101916992|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
33551555|NCT01623752|101916993|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
33551556|NCT01623752|101916994|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
33551557|NCT01623752|101916992|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
33551558|NCT01623752|101916993|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
33551559|NCT01623752|101916994|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
33551560|NCT01623752|101916992|FG000|Phase 2 (78 Weeks)|Other|5|||
33551561|NCT01623752|101916993|FG001|Phase 2 (78 Weeks)|Other|1|||
33551562|NCT01623752|101916994|FG002|Phase 2 (78 Weeks)|Other|0|||
33551563|NCT01623752|101916992|FG000|Phase 2 (78 Weeks)|No Data|43|||
33551564|NCT01623752|101916993|FG001|Phase 2 (78 Weeks)|No Data|11|||
33551565|NCT01623752|101916994|FG002|Phase 2 (78 Weeks)|No Data|0|||
33551566|NCT01623752|101916992|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
33551567|NCT01623752|101916993|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
33551568|NCT01623752|101916994|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
33551569|NCT00837330|101916997|FG000|Overall Study|Lost to Follow-up|1|||
33551570|NCT00837330|101916998|FG001|Overall Study|Lost to Follow-up|3|||
33551571|NCT00601107|101917003|FG000|Overall Study|Adverse Event|0|||
33551572|NCT00601107|101917004|FG001|Overall Study|Adverse Event|1|||
33551573|NCT00601107|101917005|FG002|Overall Study|Adverse Event|3|||
33551574|NCT00601107|101917006|FG003|Overall Study|Adverse Event|0|||
33551575|NCT00601107|101917003|FG000|Overall Study|Withdrawal by Subject|5|||
33551576|NCT00601107|101917004|FG001|Overall Study|Withdrawal by Subject|4|||
33551577|NCT00601107|101917005|FG002|Overall Study|Withdrawal by Subject|7|||
33551578|NCT00601107|101917006|FG003|Overall Study|Withdrawal by Subject|4|||
33350958|NCT00348140|101172204|FG000|Overall Study|Increased risk of cardiac infarction|0|||
33350959|NCT00348140|101172205|FG001|Overall Study|Increased risk of cardiac infarction|1|||
33350960|NCT00348140|101172206|FG002|Overall Study|Increased risk of cardiac infarction|0|||
33350961|NCT00348140|101172204|FG000|Overall Study|Serious adverse event|0|||
33350962|NCT00348140|101172205|FG001|Overall Study|Serious adverse event|1|||
33350963|NCT00348140|101172206|FG002|Overall Study|Serious adverse event|0|||
33350964|NCT00348140|101172204|FG000|Overall Study|Abnormal ECG|0|||
33350965|NCT00348140|101172205|FG001|Overall Study|Abnormal ECG|1|||
33350966|NCT00348140|101172206|FG002|Overall Study|Abnormal ECG|3|||
33350967|NCT00348140|101172204|FG000|Overall Study|Participant died|0|||
33350968|NCT00348140|101172205|FG001|Overall Study|Participant died|1|||
33411476|NCT00151775|101397157|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
33411477|NCT00151775|101397146|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33411478|NCT00151775|101397147|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33411479|NCT00151775|101397148|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33411480|NCT00151775|101397149|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33411481|NCT00151775|101397150|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33411482|NCT00151775|101397151|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
33411483|NCT00151775|101397152|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33411484|NCT00151775|101397153|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33411485|NCT00151775|101397154|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33551579|NCT00601107|101917003|FG000|Overall Study|Lost to Follow-up|3|||
33551580|NCT00601107|101917004|FG001|Overall Study|Lost to Follow-up|3|||
33551581|NCT00601107|101917005|FG002|Overall Study|Lost to Follow-up|0|||
33350969|NCT00348140|101172206|FG002|Overall Study|Participant died|0|||
33350970|NCT00348140|101172204|FG000|Overall Study|Exclusion criteria met|0|||
33350971|NCT00348140|101172205|FG001|Overall Study|Exclusion criteria met|0|||
33350972|NCT00348140|101172206|FG002|Overall Study|Exclusion criteria met|1|||
33350973|NCT00348140|101172204|FG000|Overall Study|Memory declined|0|||
33551582|NCT00601107|101917006|FG003|Overall Study|Lost to Follow-up|3|||
33551583|NCT00601107|101917003|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
33551584|NCT00601107|101917004|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
33551585|NCT00601107|101917005|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
33551586|NCT00601107|101917006|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
33411486|NCT00151775|101397155|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33411487|NCT00151775|101397156|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33551587|NCT00601107|101917003|FG000|Overall Study|Worsening of Psoriasis|4|||
33551588|NCT00601107|101917004|FG001|Overall Study|Worsening of Psoriasis|1|||
33551589|NCT00601107|101917005|FG002|Overall Study|Worsening of Psoriasis|1|||
33551590|NCT00601107|101917006|FG003|Overall Study|Worsening of Psoriasis|4|||
33551591|NCT00601107|101917003|FG000|Overall Study|Undefined|1|||
33551592|NCT00601107|101917004|FG001|Overall Study|Undefined|0|||
33551593|NCT00601107|101917005|FG002|Overall Study|Undefined|1|||
33551594|NCT00601107|101917006|FG003|Overall Study|Undefined|0|||
33551595|NCT04401293|101917007|FG000|Overall Study|Withdrawal by Subject|1|||
33551596|NCT04401293|101917008|FG001|Overall Study|Withdrawal by Subject|3|||
33551597|NCT02337946|101917010|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
33551598|NCT02337946|101917011|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
33551599|NCT02337946|101917012|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
33551600|NCT02337946|101917010|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
33551601|NCT02337946|101917011|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
33551602|NCT02337946|101917012|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
33551603|NCT02337946|101917010|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
33551604|NCT02337946|101917011|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
33551605|NCT02337946|101917012|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
33551606|NCT02337946|101917010|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
33551607|NCT02337946|101917011|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
33217485|NCT02182973|100692423|FG000|Overall Study|Withdrawal by Subject|3|||
33217486|NCT02182973|100692424|FG001|Overall Study|Withdrawal by Subject|0|||
33217487|NCT03238300|100692425|FG000|Baseline (Before Intervention)|Physician Decision|0|||
33217488|NCT03238300|100692426|FG001|Baseline (Before Intervention)|Physician Decision|1|||
33350974|NCT00348140|101172205|FG001|Overall Study|Memory declined|0|||
33350975|NCT00348140|101172206|FG002|Overall Study|Memory declined|1|||
33350976|NCT02582658|101172208|FG000|Overall Study|Failure to Return|10|||
33217489|NCT03238300|100692425|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
33217490|NCT03238300|100692426|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
33217491|NCT03238300|100692425|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
33350977|NCT02582658|101172208|FG000|Overall Study|Insufficient Virological Response|2|||
33350978|NCT02582658|101172208|FG000|Overall Study|Withdrawn Consent|1|||
33350979|NCT02582658|101172208|FG000|Overall Study|Death|1|||
33350980|NCT02582658|101172208|FG000|Overall Study|Not further specified|11|||
33411488|NCT00151775|101397157|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
33411489|NCT00151775|101397146|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33411490|NCT00151775|101397147|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33411491|NCT00151775|101397148|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33411492|NCT00151775|101397149|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33411493|NCT00151775|101397150|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33411494|NCT00151775|101397151|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
33411495|NCT00151775|101397152|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33411496|NCT00151775|101397153|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33411497|NCT00151775|101397154|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33411498|NCT00151775|101397155|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33551608|NCT02337946|101917012|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
33551609|NCT02337946|101917010|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
33551610|NCT02337946|101917011|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
33551611|NCT02337946|101917012|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
33217492|NCT03238300|100692426|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
33350981|NCT01511445|101172209|FG000|Overall Study|Lost to Follow-up|3|||
33350982|NCT01511445|101172210|FG001|Overall Study|Lost to Follow-up|1|||
33350983|NCT01511445|101172209|FG000|Overall Study|Protocol Violation|1|||
33350984|NCT01511445|101172210|FG001|Overall Study|Protocol Violation|3|||
33350985|NCT01511445|101172209|FG000|Overall Study|Protocol Violation|1|||
33618771|NCT02855268|102151639|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
33618772|NCT02855268|102151640|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
33618773|NCT02855268|102151639|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
33618774|NCT02855268|102151640|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
33618775|NCT02855268|102151639|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
33618776|NCT02855268|102151640|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
33618777|NCT02855268|102151639|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
33618778|NCT02855268|102151640|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
33618779|NCT02855268|102151639|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
33217493|NCT03238300|100692425|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
33217494|NCT03238300|100692426|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
33217495|NCT02163733|100692427|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
33217496|NCT02163733|100692428|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
33217497|NCT02163733|100692429|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
33217498|NCT02163733|100692427|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
33217499|NCT02163733|100692428|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
33217500|NCT02163733|100692429|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
33217501|NCT00522301|100692442|FG000|Overall Study|Withdrawal by Subject|1|||
33217502|NCT00522301|100692442|FG000|Overall Study|Adverse Event|5|||
33217503|NCT01123382|100692448|FG000|Overall Study|Withdrawal by Subject|1|||
33217504|NCT01123382|100692449|FG001|Overall Study|Withdrawal by Subject|4|||
33350986|NCT01511445|101172210|FG001|Overall Study|Protocol Violation|0|||
33350987|NCT03619213|101172211|FG000|Overall Study|Lost to Follow-up|2|||
33350988|NCT03619213|101172212|FG001|Overall Study|Lost to Follow-up|1|||
33350989|NCT03619213|101172211|FG000|Overall Study|Withdrawal by Subject|8|||
33350990|NCT03619213|101172212|FG001|Overall Study|Withdrawal by Subject|10|||
33350991|NCT02203149|101172217|FG000|Part 1|Adverse Event|0|||
33350992|NCT02203149|101172218|FG001|Part 1|Adverse Event|1|||
33350993|NCT02203149|101172219|FG002|Part 1|Adverse Event|0|||
33350994|NCT02203149|101172220|FG003|Part 1|Adverse Event|0|||
33350995|NCT02203149|101172221|FG004|Part 1|Adverse Event|0|||
33350996|NCT02203149|101172217|FG000|Part 2|Death|0|||
33350997|NCT02203149|101172218|FG001|Part 2|Death|0|||
33350998|NCT02203149|101172219|FG002|Part 2|Death|1|||
33350999|NCT02203149|101172220|FG003|Part 2|Death|1|||
33351000|NCT02203149|101172221|FG004|Part 2|Death|0|||
33351001|NCT02203149|101172217|FG000|Part 2|Withdrawal by Subject|0|||
33351002|NCT02203149|101172218|FG001|Part 2|Withdrawal by Subject|0|||
33351003|NCT02203149|101172219|FG002|Part 2|Withdrawal by Subject|0|||
33618780|NCT02855268|102151640|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
33618781|NCT00742183|102151641|FG000|Overall Study|Adverse Event|2|||
33618782|NCT00742183|102151642|FG001|Overall Study|Adverse Event|2|||
33618783|NCT00742183|102151641|FG000|Overall Study|Death|1|||
33618784|NCT00742183|102151642|FG001|Overall Study|Death|0|||
33618785|NCT00742183|102151641|FG000|Overall Study|Physician Decision|0|||
33618786|NCT00742183|102151642|FG001|Overall Study|Physician Decision|2|||
33618787|NCT00742183|102151641|FG000|Overall Study|Lost to Follow-up|4|||
33618788|NCT00742183|102151642|FG001|Overall Study|Lost to Follow-up|4|||
33618789|NCT00742183|102151641|FG000|Overall Study|Required skin-graft|1|||
33618790|NCT00742183|102151642|FG001|Overall Study|Required skin-graft|1|||
33618791|NCT00742183|102151641|FG000|Overall Study|Withdrawal by Subject|1|||
33618792|NCT00742183|102151642|FG001|Overall Study|Withdrawal by Subject|0|||
33217505|NCT01123382|100692448|FG000|Overall Study|Lost to Follow-up|1|||
33217506|NCT01123382|100692449|FG001|Overall Study|Lost to Follow-up|2|||
33351004|NCT02203149|101172220|FG003|Part 2|Withdrawal by Subject|1|||
33351005|NCT02203149|101172221|FG004|Part 2|Withdrawal by Subject|0|||
33351006|NCT02203149|101172217|FG000|Part 2|Adverse Event|0|||
33351007|NCT02203149|101172218|FG001|Part 2|Adverse Event|0|||
33351008|NCT02203149|101172219|FG002|Part 2|Adverse Event|0|||
33351009|NCT02203149|101172220|FG003|Part 2|Adverse Event|1|||
33351010|NCT02203149|101172221|FG004|Part 2|Adverse Event|1|||
33351011|NCT03437447|101172222|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33351012|NCT03437447|101172223|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33351013|NCT03437447|101172224|FG002|Treatment Period 1|Withdrawal by Subject|1|||
33351014|NCT01070329|101172227|FG000|Overall Study|Adverse Event|13|||
33351015|NCT01070329|101172228|FG001|Overall Study|Adverse Event|10|||
33351016|NCT01070329|101172227|FG000|Overall Study|Lost to Follow-up|22|||
33351017|NCT01070329|101172228|FG001|Overall Study|Lost to Follow-up|12|||
33351018|NCT01070329|101172227|FG000|Overall Study|Withdrawal by Subject|9|||
33351019|NCT01070329|101172228|FG001|Overall Study|Withdrawal by Subject|11|||
33351020|NCT01070329|101172227|FG000|Overall Study|Protocol Violation|3|||
33411499|NCT00151775|101397156|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33411500|NCT00151775|101397157|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
33411501|NCT00151775|101397146|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33411502|NCT00151775|101397147|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33618793|NCT00742183|102151641|FG000|Overall Study|Lack of Efficacy|0|||
33351021|NCT01070329|101172228|FG001|Overall Study|Protocol Violation|8|||
33351022|NCT01070329|101172227|FG000|Overall Study|Lack of Efficacy|2|||
33351023|NCT01070329|101172228|FG001|Overall Study|Lack of Efficacy|6|||
33351024|NCT01070329|101172227|FG000|Overall Study|Physician Decision|2|||
33351025|NCT01070329|101172228|FG001|Overall Study|Physician Decision|1|||
33351026|NCT01070329|101172227|FG000|Overall Study|Entry Criteria Not Met|1|||
33351027|NCT01070329|101172228|FG001|Overall Study|Entry Criteria Not Met|0|||
33351028|NCT01070329|101172227|FG000|Overall Study|Sponsor Decision|0|||
33351029|NCT01070329|101172228|FG001|Overall Study|Sponsor Decision|1|||
33351030|NCT00542191|101172229|FG000|Overall Study|Death|3|||
33351031|NCT01126580|101172232|FG000|Overall Study|Adverse Event|14|||
33351032|NCT01126580|101172233|FG001|Overall Study|Adverse Event|8|||
33351033|NCT01126580|101172234|FG002|Overall Study|Adverse Event|12|||
33351034|NCT01126580|101172232|FG000|Overall Study|Withdrawal by Subject|11|||
33411503|NCT00151775|101397148|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33411504|NCT00151775|101397149|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33217507|NCT04225988|100692450|FG000|Overall Study|Withdrawal by Subject|2|||
33217508|NCT04225988|100692451|FG001|Overall Study|Withdrawal by Subject|0|||
33217509|NCT00504426|100692453|FG000|Overall Study|Adverse Event|0|||
33217510|NCT00504426|100692454|FG001|Overall Study|Adverse Event|0|||
33411505|NCT00151775|101397150|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33411506|NCT00151775|101397151|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33411507|NCT00151775|101397152|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
33411508|NCT00151775|101397153|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33411509|NCT00151775|101397154|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33411510|NCT00151775|101397155|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33411511|NCT00151775|101397156|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33411512|NCT00151775|101397157|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
33411513|NCT00151775|101397146|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33411514|NCT00151775|101397147|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33411515|NCT00151775|101397148|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33411516|NCT00151775|101397149|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33411517|NCT00151775|101397150|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33411518|NCT00151775|101397151|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
33411519|NCT00151775|101397152|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33411520|NCT00151775|101397153|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33411521|NCT00151775|101397154|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33411522|NCT00151775|101397155|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33411523|NCT00151775|101397156|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33411524|NCT00151775|101397157|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
33411525|NCT00151775|101397146|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
33411526|NCT00151775|101397147|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
33411527|NCT00151775|101397148|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
33411528|NCT00151775|101397149|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
33411529|NCT00151775|101397150|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
33411530|NCT00151775|101397151|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
33411531|NCT00151775|101397152|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
33551612|NCT02337946|101917010|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
33551613|NCT02337946|101917011|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
33551614|NCT02337946|101917012|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
33551615|NCT02337946|101917010|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
33551616|NCT02337946|101917011|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
33551617|NCT02337946|101917012|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
33551618|NCT02337946|101917010|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
33551619|NCT02337946|101917011|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
33551620|NCT02337946|101917012|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
33551621|NCT02337946|101917010|FG000|In-between Period|Without Informed Consent|1|||
33551622|NCT02337946|101917011|FG001|In-between Period|Without Informed Consent|0|||
33551623|NCT02337946|101917012|FG002|In-between Period|Without Informed Consent|0|||
33551624|NCT02337946|101917010|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
33551625|NCT02337946|101917011|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
33551626|NCT02337946|101917012|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
33551627|NCT02337946|101917010|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
33551628|NCT02337946|101917011|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
33551629|NCT02337946|101917012|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
33551630|NCT02337946|101917010|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
33551631|NCT02337946|101917011|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
33551632|NCT02337946|101917012|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
33551633|NCT02337946|101917010|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
33551634|NCT02337946|101917011|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
33551635|NCT02337946|101917012|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
33551636|NCT02337946|101917010|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
33551637|NCT02337946|101917011|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
33551638|NCT02337946|101917012|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
33551639|NCT02337946|101917010|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
33551640|NCT02337946|101917011|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
33551641|NCT02337946|101917012|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
33551642|NCT00968968|101917017|FG000|Overall Study|Study closed/terminated|10|||
33551643|NCT00968968|101917018|FG001|Overall Study|Study closed/terminated|10|||
33551644|NCT00968968|101917017|FG000|Overall Study|Protocol defined stopping criteria|3|||
33551645|NCT00968968|101917018|FG001|Overall Study|Protocol defined stopping criteria|1|||
33551646|NCT00968968|101917017|FG000|Overall Study|Withdrawal by Subject|2|||
33551647|NCT00968968|101917018|FG001|Overall Study|Withdrawal by Subject|0|||
33551648|NCT00968968|101917017|FG000|Overall Study|Physician Decision|1|||
33551649|NCT00968968|101917018|FG001|Overall Study|Physician Decision|2|||
33551650|NCT00968968|101917017|FG000|Overall Study|Lost to Follow-up|0|||
33551651|NCT00968968|101917018|FG001|Overall Study|Lost to Follow-up|1|||
33351035|NCT01126580|101172233|FG001|Overall Study|Withdrawal by Subject|19|||
33351036|NCT01126580|101172234|FG002|Overall Study|Withdrawal by Subject|14|||
33351037|NCT01126580|101172232|FG000|Overall Study|Sponsor Decision|5|||
33351038|NCT01126580|101172233|FG001|Overall Study|Sponsor Decision|4|||
33351039|NCT01126580|101172234|FG002|Overall Study|Sponsor Decision|7|||
33351040|NCT01126580|101172232|FG000|Overall Study|Physician Decision|1|||
33351041|NCT01126580|101172233|FG001|Overall Study|Physician Decision|1|||
33351042|NCT01126580|101172234|FG002|Overall Study|Physician Decision|2|||
33351043|NCT01126580|101172232|FG000|Overall Study|Entry Criteria Not Met|1|||
33351044|NCT01126580|101172233|FG001|Overall Study|Entry Criteria Not Met|1|||
33351045|NCT01126580|101172234|FG002|Overall Study|Entry Criteria Not Met|2|||
33351046|NCT01126580|101172232|FG000|Overall Study|Lack of Efficacy|2|||
33351047|NCT01126580|101172233|FG001|Overall Study|Lack of Efficacy|3|||
33351048|NCT01126580|101172234|FG002|Overall Study|Lack of Efficacy|4|||
33351049|NCT01126580|101172232|FG000|Overall Study|Protocol Violation|0|||
33351050|NCT01126580|101172233|FG001|Overall Study|Protocol Violation|1|||
33351051|NCT01126580|101172234|FG002|Overall Study|Protocol Violation|2|||
33351052|NCT01126580|101172232|FG000|Overall Study|Lost to Follow-up|15|||
33351053|NCT01126580|101172233|FG001|Overall Study|Lost to Follow-up|13|||
33351054|NCT01126580|101172234|FG002|Overall Study|Lost to Follow-up|9|||
33351055|NCT01126580|101172232|FG000|Overall Study|Treatment Non-compliance|0|||
33351056|NCT01126580|101172233|FG001|Overall Study|Treatment Non-compliance|2|||
33351057|NCT01126580|101172234|FG002|Overall Study|Treatment Non-compliance|3|||
33351058|NCT02347631|101172235|FG000|First Intervention (2 Months)|Adverse Event|1|||
33351059|NCT02347631|101172236|FG001|First Intervention (2 Months)|Adverse Event|1|||
33351060|NCT02347631|101172235|FG000|First Intervention (2 Months)|Pregnancy|1|||
33351061|NCT02347631|101172236|FG001|First Intervention (2 Months)|Pregnancy|0|||
33351062|NCT02347631|101172235|FG000|First Intervention (2 Months)|Moved out of area|0|||
33351063|NCT02347631|101172236|FG001|First Intervention (2 Months)|Moved out of area|2|||
33351064|NCT02347631|101172235|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
33351065|NCT02347631|101172236|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
33351066|NCT02347631|101172235|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
33351067|NCT02347631|101172236|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
33351068|NCT02347631|101172235|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
33351069|NCT02347631|101172236|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
33351070|NCT02347631|101172235|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
33351071|NCT02347631|101172236|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
33351072|NCT02347631|101172235|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
33551652|NCT03097315|101917019|FG000|Overall Study|Withdrawal by Subject|1|||
33551653|NCT00311168|101917020|FG000|First Intervention|Withdrawal by Subject|2|||
33551654|NCT00311168|101917021|FG001|First Intervention|Withdrawal by Subject|2|||
33551655|NCT00311168|101917020|FG000|First Intervention|Lost to Follow-up|1|||
33551656|NCT00311168|101917021|FG001|First Intervention|Lost to Follow-up|1|||
33618794|NCT00742183|102151642|FG001|Overall Study|Lack of Efficacy|3|||
33351073|NCT02347631|101172236|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
33351074|NCT02939131|101172237|FG000|Overall Study|Unable to get to clinic|6|||
33351075|NCT02939131|101172238|FG001|Overall Study|Unable to get to clinic|4|||
33351076|NCT02939131|101172237|FG000|Overall Study|Lost to Follow-up|2|||
33351077|NCT02939131|101172238|FG001|Overall Study|Lost to Follow-up|4|||
33351078|NCT02939131|101172237|FG000|Overall Study|severe debilitation|1|||
33351079|NCT02939131|101172238|FG001|Overall Study|severe debilitation|0|||
33351080|NCT02939131|101172237|FG000|Overall Study|Other|0|||
33351081|NCT02939131|101172238|FG001|Overall Study|Other|1|||
33618795|NCT00511134|102151643|FG000|Overall Study|Withdrawal by Subject|0|||
33618796|NCT00511134|102151644|FG001|Overall Study|Withdrawal by Subject|2|||
33618797|NCT02396212|102151655|FG000|Overall Study|Adverse Event|1|||
33618798|NCT02396212|102151655|FG000|Overall Study|Lack of Efficacy|2|||
33618799|NCT03818035|102151657|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
33618800|NCT03818035|102151658|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
33618801|NCT03818035|102151659|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
33618802|NCT03818035|102151660|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
33618803|NCT03818035|102151657|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
33618804|NCT03818035|102151658|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
33351082|NCT02939131|101172237|FG000|Overall Study|not willing to adhere to protocol|2|||
33351083|NCT02939131|101172238|FG001|Overall Study|not willing to adhere to protocol|0|||
33618805|NCT03818035|102151659|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
33618806|NCT03818035|102151660|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
33618807|NCT03818035|102151657|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
33618808|NCT03818035|102151658|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
33618809|NCT03818035|102151659|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
33618810|NCT03818035|102151660|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
33618811|NCT03818035|102151657|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
33551657|NCT00311168|101917020|FG000|First Intervention|Protocol Violation|1|||
33551658|NCT00311168|101917021|FG001|First Intervention|Protocol Violation|1|||
33551659|NCT00311168|101917020|FG000|First Intervention|Adverse Event|1|||
33551660|NCT00311168|101917021|FG001|First Intervention|Adverse Event|0|||
33551661|NCT00311168|101917020|FG000|First Intervention|Other|2|||
33551662|NCT00311168|101917021|FG001|First Intervention|Other|2|||
33618812|NCT03818035|102151658|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
33618813|NCT03818035|102151659|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
33618814|NCT03818035|102151660|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
33618815|NCT03818035|102151657|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
33618816|NCT03818035|102151658|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
33618817|NCT03818035|102151659|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
33618818|NCT03818035|102151660|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
33351084|NCT00054132|101172239|FG000|Overall Study|Not Treated|1|||
33351085|NCT03521791|101172240|FG000|Overall Study|Protocol Violation|7|||
33351086|NCT03521791|101172241|FG001|Overall Study|Protocol Violation|17|||
33351087|NCT00862251|101172242|FG000|Overall Study|Adverse Event|8|||
33351088|NCT00862251|101172243|FG001|Overall Study|Adverse Event|3|||
33351089|NCT00862251|101172244|FG002|Overall Study|Adverse Event|1|||
33351090|NCT00862251|101172242|FG000|Overall Study|Lost to Follow-up|0|||
33351091|NCT00862251|101172243|FG001|Overall Study|Lost to Follow-up|0|||
33351092|NCT00862251|101172244|FG002|Overall Study|Lost to Follow-up|1|||
33351093|NCT00862251|101172242|FG000|Overall Study|Protocol Violation|2|||
33351094|NCT00862251|101172243|FG001|Overall Study|Protocol Violation|0|||
33351095|NCT00862251|101172244|FG002|Overall Study|Protocol Violation|1|||
33351096|NCT00862251|101172242|FG000|Overall Study|Withdrawal by Subject|9|||
33351097|NCT00862251|101172243|FG001|Overall Study|Withdrawal by Subject|2|||
33351098|NCT00862251|101172244|FG002|Overall Study|Withdrawal by Subject|6|||
33351099|NCT01993888|101172245|FG000|Overall Study|Death|1|||
33351100|NCT01993888|101172246|FG001|Overall Study|Death|1|||
33351101|NCT01993888|101172245|FG000|Overall Study|Lost to Follow-up|1|||
33351102|NCT01993888|101172246|FG001|Overall Study|Lost to Follow-up|1|||
33351103|NCT01993888|101172245|FG000|Overall Study|Withdrawal by Subject|0|||
33351104|NCT01993888|101172246|FG001|Overall Study|Withdrawal by Subject|1|||
33351105|NCT01535235|101172247|FG000|Overall Study|Adverse Event|1|||
33351106|NCT01535235|101172248|FG001|Overall Study|Adverse Event|0|||
33351107|NCT02613208|101172249|FG000|Overall Study|Withdrawal by Subject|1|||
33551663|NCT00311168|101917020|FG000|Second Intervention|Lost to Follow-up|9|||
33551664|NCT00311168|101917021|FG001|Second Intervention|Lost to Follow-up|2|||
33551665|NCT00311168|101917020|FG000|Second Intervention|Withdrawal by Subject|0|||
33551666|NCT00311168|101917021|FG001|Second Intervention|Withdrawal by Subject|1|||
33551667|NCT00311168|101917020|FG000|Second Intervention|Other|1|||
33551668|NCT00311168|101917021|FG001|Second Intervention|Other|1|||
33551669|NCT01137812|101917022|FG000|Overall Study|Adverse Event|21|||
33551670|NCT01137812|101917023|FG001|Overall Study|Adverse Event|14|||
33551671|NCT01137812|101917022|FG000|Overall Study|Lost to Follow-up|6|||
33551672|NCT01137812|101917023|FG001|Overall Study|Lost to Follow-up|8|||
33351108|NCT02613208|101172249|FG000|Overall Study|Change of address|2|||
33351109|NCT02613208|101172249|FG000|Overall Study|Physician Decision|2|||
33351110|NCT02613208|101172249|FG000|Overall Study|Lost to Follow-up|5|||
33551673|NCT01137812|101917022|FG000|Overall Study|Physician Decision|25|||
33551674|NCT01137812|101917023|FG001|Overall Study|Physician Decision|17|||
33551675|NCT01137812|101917022|FG000|Overall Study|Protocol Violation|5|||
33551676|NCT01137812|101917023|FG001|Overall Study|Protocol Violation|4|||
33618819|NCT03818035|102151657|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
33618820|NCT03818035|102151658|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
33618821|NCT03818035|102151659|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
33618822|NCT03818035|102151660|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
33217511|NCT00504426|100692455|FG002|Overall Study|Adverse Event|2|||
33217512|NCT00504426|100692456|FG003|Overall Study|Adverse Event|0|||
33217513|NCT00504426|100692453|FG000|Overall Study|Protocol Violation|1|||
33217514|NCT00504426|100692454|FG001|Overall Study|Protocol Violation|1|||
33217515|NCT00504426|100692455|FG002|Overall Study|Protocol Violation|2|||
33217516|NCT00504426|100692456|FG003|Overall Study|Protocol Violation|0|||
33411532|NCT00151775|101397153|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
33411533|NCT00151775|101397154|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
33411534|NCT00151775|101397155|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
33411535|NCT00151775|101397156|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
33411536|NCT00151775|101397157|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
33411537|NCT00151775|101397146|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33411538|NCT00151775|101397147|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33411539|NCT00151775|101397148|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33411540|NCT00151775|101397149|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33411541|NCT00151775|101397150|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33411542|NCT00151775|101397151|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33411543|NCT00151775|101397152|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
33551677|NCT01137812|101917022|FG000|Overall Study|Withdrawal by Subject|5|||
33551678|NCT01137812|101917023|FG001|Overall Study|Withdrawal by Subject|13|||
33551679|NCT01137812|101917022|FG000|Overall Study|Death|2|||
33551680|NCT01137812|101917023|FG001|Overall Study|Death|0|||
33217517|NCT00504426|100692453|FG000|Overall Study|Withdrawal by Subject|2|||
33217518|NCT00504426|100692454|FG001|Overall Study|Withdrawal by Subject|0|||
33217519|NCT00504426|100692455|FG002|Overall Study|Withdrawal by Subject|0|||
33217520|NCT00504426|100692456|FG003|Overall Study|Withdrawal by Subject|0|||
33217521|NCT00538590|100692457|FG000|Overall Study|Death|1|||
33217522|NCT00538590|100692458|FG001|Overall Study|Death|0|||
33217523|NCT02110901|100692459|FG000|Overall Study|Death|6|||
33217524|NCT02110901|100692460|FG001|Overall Study|Death|3|||
33351111|NCT02613208|101172249|FG000|Overall Study|Death|37|||
33351112|NCT00430755|101172255|FG000|Overall Study|Withdrawal by Subject|53|||
33351113|NCT01929083|101172256|FG000|Intervention 1|Lost to Follow-up|2|||
33351114|NCT01929083|101172257|FG001|Intervention 1|Lost to Follow-up|0|||
33351115|NCT01929083|101172256|FG000|Intervention 1|Nonadherent to study medications|1|||
33351116|NCT01929083|101172257|FG001|Intervention 1|Nonadherent to study medications|0|||
33351117|NCT01929083|101172256|FG000|Intervention 2|Adverse Event|0|||
33411544|NCT00151775|101397153|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33411545|NCT00151775|101397154|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33411546|NCT00151775|101397155|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33411547|NCT00151775|101397156|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33551681|NCT01137812|101917022|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
33551682|NCT01137812|101917023|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
33551683|NCT01137812|101917022|FG000|Overall Study|Other|19|||
33551684|NCT01137812|101917023|FG001|Overall Study|Other|27|||
33551685|NCT01774370|101917024|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
33551686|NCT01774370|101917024|FG000|Overall Study|Administered prior to the contract date|4|||
33551687|NCT01774370|101917024|FG000|Overall Study|Subjects of contraindications|34|||
33551688|NCT01774370|101917024|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
33551689|NCT01774370|101917024|FG000|Overall Study|Follow-up failure|34|||
33551690|NCT00875667|101917033|FG000|Overall Study|Adverse Event|29|||
33551691|NCT00875667|101917034|FG001|Overall Study|Adverse Event|10|||
33551692|NCT00875667|101917033|FG000|Overall Study|Withdrawal by Subject|17|||
33551693|NCT00875667|101917034|FG001|Overall Study|Withdrawal by Subject|5|||
33551694|NCT00875667|101917033|FG000|Overall Study|Death|7|||
33551695|NCT00875667|101917034|FG001|Overall Study|Death|2|||
33551696|NCT00875667|101917033|FG000|Overall Study|Protocol Violation|2|||
33551697|NCT00875667|101917034|FG001|Overall Study|Protocol Violation|0|||
33551698|NCT00875667|101917033|FG000|Overall Study|Disease Progression|100|||
33217525|NCT02110901|100692459|FG000|Overall Study|Lost to Follow-up|12|||
33551699|NCT00875667|101917034|FG001|Overall Study|Disease Progression|49|||
33551700|NCT00875667|101917033|FG000|Overall Study|Miscellaneous|12|||
33551701|NCT00875667|101917034|FG001|Overall Study|Miscellaneous|6|||
33551702|NCT00875667|101917033|FG000|Overall Study|Randomized but no Study Drug Given|3|||
33551703|NCT00875667|101917034|FG001|Overall Study|Randomized but no Study Drug Given|1|||
33551704|NCT04171999|101917035|FG000|Overall Study|deemed ineligible after randomization|2|||
33217526|NCT02110901|100692460|FG001|Overall Study|Lost to Follow-up|8|||
33351118|NCT01929083|101172257|FG001|Intervention 2|Adverse Event|1|||
33217527|NCT02110901|100692459|FG000|Overall Study|Withdrawal by Subject|7|||
33351119|NCT02663895|101172260|FG000|Overall Study|Adverse Event|3|||
33351120|NCT02663895|101172260|FG000|Overall Study|Physician Decision|2|||
33351121|NCT02663895|101172260|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
33351122|NCT02663895|101172260|FG000|Overall Study|Withdrawal by Subject|1|||
33351123|NCT00619502|101172262|FG000|Overall Study|Lost to Follow-up|8|||
33217528|NCT02110901|100692460|FG001|Overall Study|Withdrawal by Subject|3|||
33217529|NCT02110901|100692459|FG000|Overall Study|received a kidney transplant|5|||
33217530|NCT02110901|100692460|FG001|Overall Study|received a kidney transplant|0|||
33217531|NCT01533493|100692461|FG000|Overall Study|Adverse Event|2|||
33217532|NCT01533493|100692462|FG001|Overall Study|Adverse Event|1|||
33351124|NCT00619502|101172263|FG001|Overall Study|Lost to Follow-up|10|||
33351125|NCT00712348|101172265|FG000|Overall Study|Withdrawal by Subject|1|||
33351126|NCT01157117|101172266|FG000|Overall Study|Dosing Symptoms|0|||
33351127|NCT01157117|101172267|FG001|Overall Study|Dosing Symptoms|4|||
33351128|NCT01157117|101172268|FG002|Overall Study|Dosing Symptoms|0|||
33351129|NCT01157117|101172266|FG000|Overall Study|Withdrawal by Subject|4|||
33351130|NCT01157117|101172267|FG001|Overall Study|Withdrawal by Subject|1|||
33351131|NCT01157117|101172268|FG002|Overall Study|Withdrawal by Subject|1|||
33351132|NCT01157117|101172266|FG000|Overall Study|Lack of Efficacy|1|||
33351133|NCT01157117|101172267|FG001|Overall Study|Lack of Efficacy|1|||
33351134|NCT01157117|101172268|FG002|Overall Study|Lack of Efficacy|0|||
33411548|NCT00151775|101397157|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
33411549|NCT00151775|101397146|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33411550|NCT00151775|101397147|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33411551|NCT00151775|101397148|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
33411552|NCT00151775|101397149|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33411553|NCT00151775|101397150|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33411554|NCT00151775|101397151|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33411555|NCT00151775|101397152|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33411556|NCT00151775|101397153|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33411557|NCT00151775|101397154|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33411558|NCT00151775|101397155|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33411559|NCT00151775|101397156|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33411560|NCT00151775|101397157|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
33411561|NCT00151775|101397146|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33411562|NCT00151775|101397147|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33411563|NCT00151775|101397148|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
33411564|NCT00151775|101397149|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33411565|NCT00151775|101397150|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33411566|NCT00151775|101397151|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33411567|NCT00151775|101397152|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33411568|NCT00151775|101397153|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33411569|NCT00151775|101397154|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33411570|NCT00151775|101397155|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33411571|NCT00151775|101397156|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33411572|NCT00151775|101397157|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
33411573|NCT00151775|101397146|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33411574|NCT00151775|101397147|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33411575|NCT00151775|101397148|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33351135|NCT01157117|101172266|FG000|Overall Study|Lost to Follow-up|0|||
33351136|NCT01157117|101172267|FG001|Overall Study|Lost to Follow-up|0|||
33351137|NCT01157117|101172268|FG002|Overall Study|Lost to Follow-up|1|||
33351138|NCT01157117|101172266|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
33351139|NCT01157117|101172267|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
33351140|NCT01157117|101172268|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
33351141|NCT01392183|101172269|FG000|First Drug Administration|Adverse Event|3|||
33411576|NCT00151775|101397149|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33551705|NCT04171999|101917036|FG001|Overall Study|deemed ineligible after randomization|1|||
33351142|NCT01392183|101172270|FG001|First Drug Administration|Adverse Event|2|||
33411577|NCT00151775|101397150|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33551706|NCT00498485|101917038|FG000|Overall Study|Adverse Event|1|||
33551707|NCT00498485|101917039|FG001|Overall Study|Adverse Event|5|||
33551708|NCT00962650|101917042|FG000|Overall Study|Transgastric DP was not completed|2|||
33551709|NCT03558672|101917043|FG000|Overall Study|Study Early Termination|10|||
33551710|NCT00599313|101917046|FG000|Overall Study|Adverse Event|19|||
33551711|NCT00599313|101917046|FG000|Overall Study|Disease Progression|12|||
33551712|NCT00599313|101917046|FG000|Overall Study|Patient Request|4|||
33551713|NCT00599313|101917046|FG000|Overall Study|Ineligible|1|||
33551714|NCT01281306|101917048|FG000|Overall Study|Lack of Efficacy|0|||
33551715|NCT01281306|101917049|FG001|Overall Study|Lack of Efficacy|1|||
33551716|NCT01281306|101917050|FG002|Overall Study|Lack of Efficacy|3|||
33551717|NCT01281306|101917051|FG003|Overall Study|Lack of Efficacy|0|||
33351143|NCT01392183|101172269|FG000|First Drug Administration|Death|1|||
33351144|NCT01392183|101172270|FG001|First Drug Administration|Death|0|||
33351145|NCT01392183|101172269|FG000|First Drug Administration|Withdrawal by Subject|10|||
33351146|NCT01392183|101172270|FG001|First Drug Administration|Withdrawal by Subject|17|||
33351147|NCT01596257|101172271|FG000|Overall Study|Inadequate Collection|23|||
33351148|NCT01596257|101172272|FG001|Overall Study|Inadequate Collection|19|||
33411578|NCT00151775|101397151|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33551718|NCT01281306|101917052|FG004|Overall Study|Lack of Efficacy|2|||
33551719|NCT01281306|101917053|FG005|Overall Study|Lack of Efficacy|0|||
33551720|NCT01281306|101917054|FG006|Overall Study|Lack of Efficacy|1|||
33551721|NCT01281306|101917048|FG000|Overall Study|Withdrawal by Subject|1|||
33551722|NCT01281306|101917049|FG001|Overall Study|Withdrawal by Subject|0|||
33551723|NCT01281306|101917050|FG002|Overall Study|Withdrawal by Subject|2|||
33551724|NCT01281306|101917051|FG003|Overall Study|Withdrawal by Subject|4|||
33551725|NCT01281306|101917052|FG004|Overall Study|Withdrawal by Subject|1|||
33551726|NCT01281306|101917053|FG005|Overall Study|Withdrawal by Subject|3|||
33551727|NCT01281306|101917054|FG006|Overall Study|Withdrawal by Subject|1|||
33551728|NCT01281306|101917048|FG000|Overall Study|Protocol deviation|0|||
33551729|NCT01281306|101917049|FG001|Overall Study|Protocol deviation|1|||
33411579|NCT00151775|101397152|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33411580|NCT00151775|101397153|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33411581|NCT00151775|101397154|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33411582|NCT00151775|101397155|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33411583|NCT00151775|101397156|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
33411584|NCT00151775|101397157|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
33411585|NCT00151775|101397146|FG000|Period 4: Open Label|Increased blood pressure|0|||
33411586|NCT00151775|101397147|FG001|Period 4: Open Label|Increased blood pressure|0|||
33411587|NCT00151775|101397148|FG002|Period 4: Open Label|Increased blood pressure|0|||
33411588|NCT00151775|101397149|FG003|Period 4: Open Label|Increased blood pressure|0|||
33411589|NCT00151775|101397150|FG004|Period 4: Open Label|Increased blood pressure|1|||
33411590|NCT00151775|101397151|FG005|Period 4: Open Label|Increased blood pressure|0|||
33411591|NCT00151775|101397152|FG006|Period 4: Open Label|Increased blood pressure|0|||
33411592|NCT00151775|101397153|FG007|Period 4: Open Label|Increased blood pressure|0|||
33411593|NCT00151775|101397154|FG008|Period 4: Open Label|Increased blood pressure|0|||
33411594|NCT00151775|101397155|FG009|Period 4: Open Label|Increased blood pressure|1|||
33351149|NCT00355264|101172273|FG000|Extension (Variable Duration)|Adverse Event|1|||
33351150|NCT00355264|101172273|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
33351151|NCT01075178|101172277|FG000|Subject Matching|eligible but not matched|130|||
33351152|NCT01075178|101172278|FG001|Subject Matching|eligible but not matched|403|||
33351153|NCT01075178|101172277|FG000|Subject Chart Review|died before chart review period|0|||
33351154|NCT01075178|101172278|FG001|Subject Chart Review|died before chart review period|2|||
33351155|NCT01075178|101172277|FG000|Subject Chart Review|no data collected due to site closure|3|||
33351156|NCT01075178|101172278|FG001|Subject Chart Review|no data collected due to site closure|4|||
33351157|NCT01075178|101172277|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
33351158|NCT01075178|101172278|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
33351159|NCT00840827|101172279|FG000|Overall Study|Adverse Event|1|||
33351160|NCT00840827|101172279|FG000|Overall Study|Lack of Efficacy|4|||
33351161|NCT00840827|101172279|FG000|Overall Study|Physician Decision|1|||
33351162|NCT00849017|101172284|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
33351163|NCT00849017|101172285|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
33351164|NCT00849017|101172286|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
33351165|NCT00849017|101172284|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
33351166|NCT00849017|101172285|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
33351167|NCT00849017|101172286|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
33351168|NCT00849017|101172284|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
33351169|NCT00849017|101172285|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
33351170|NCT00849017|101172286|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
33351171|NCT00849017|101172284|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
33351172|NCT00849017|101172285|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
33351173|NCT00849017|101172286|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
33351174|NCT00849017|101172284|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
33351175|NCT00849017|101172285|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
33351176|NCT00849017|101172286|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
33351177|NCT00849017|101172284|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
33351178|NCT00849017|101172285|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
33351179|NCT00849017|101172286|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
33351180|NCT00849017|101172284|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
33351181|NCT00849017|101172285|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
33551730|NCT01281306|101917050|FG002|Overall Study|Protocol deviation|1|||
33351182|NCT00849017|101172286|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
33351183|NCT00849017|101172284|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
33551731|NCT01281306|101917051|FG003|Overall Study|Protocol deviation|1|||
33551732|NCT01281306|101917052|FG004|Overall Study|Protocol deviation|1|||
33551733|NCT01281306|101917053|FG005|Overall Study|Protocol deviation|0|||
33551734|NCT01281306|101917054|FG006|Overall Study|Protocol deviation|0|||
33551735|NCT01281306|101917048|FG000|Overall Study|Condition no longer requires study drug|1|||
33551736|NCT01281306|101917049|FG001|Overall Study|Condition no longer requires study drug|0|||
33551737|NCT01281306|101917050|FG002|Overall Study|Condition no longer requires study drug|0|||
33551738|NCT01281306|101917051|FG003|Overall Study|Condition no longer requires study drug|0|||
33551739|NCT01281306|101917052|FG004|Overall Study|Condition no longer requires study drug|0|||
33551740|NCT01281306|101917053|FG005|Overall Study|Condition no longer requires study drug|1|||
33551741|NCT01281306|101917054|FG006|Overall Study|Condition no longer requires study drug|1|||
33551742|NCT01281306|101917048|FG000|Overall Study|Lost to Follow-up|1|||
33551743|NCT01281306|101917049|FG001|Overall Study|Lost to Follow-up|0|||
33551744|NCT01281306|101917050|FG002|Overall Study|Lost to Follow-up|0|||
33551745|NCT01281306|101917051|FG003|Overall Study|Lost to Follow-up|2|||
33551746|NCT01281306|101917052|FG004|Overall Study|Lost to Follow-up|0|||
33551747|NCT01281306|101917053|FG005|Overall Study|Lost to Follow-up|0|||
33551748|NCT01281306|101917054|FG006|Overall Study|Lost to Follow-up|1|||
33551749|NCT01281306|101917048|FG000|Overall Study|Death|1|||
33551750|NCT01281306|101917049|FG001|Overall Study|Death|0|||
33551751|NCT01281306|101917050|FG002|Overall Study|Death|0|||
33551752|NCT01281306|101917051|FG003|Overall Study|Death|0|||
33551753|NCT01281306|101917052|FG004|Overall Study|Death|0|||
33551754|NCT01281306|101917053|FG005|Overall Study|Death|0|||
33551755|NCT01281306|101917054|FG006|Overall Study|Death|0|||
33551756|NCT01281306|101917048|FG000|Overall Study|Adverse Event|3|||
33551757|NCT01281306|101917049|FG001|Overall Study|Adverse Event|2|||
33551758|NCT01281306|101917050|FG002|Overall Study|Adverse Event|2|||
33551759|NCT01281306|101917051|FG003|Overall Study|Adverse Event|3|||
33551760|NCT01281306|101917052|FG004|Overall Study|Adverse Event|5|||
33551761|NCT01281306|101917053|FG005|Overall Study|Adverse Event|3|||
33551762|NCT01281306|101917054|FG006|Overall Study|Adverse Event|3|||
33618823|NCT03818035|102151657|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
33217533|NCT01533493|100692461|FG000|Overall Study|Withdrawal by Subject|1|||
33217534|NCT01533493|100692462|FG001|Overall Study|Withdrawal by Subject|2|||
33411595|NCT00151775|101397156|FG010|Period 4: Open Label|Increased blood pressure|0|||
33411596|NCT00151775|101397157|FG011|Period 4: Open Label|Increased blood pressure|0|||
33411597|NCT00151775|101397146|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
33411598|NCT00151775|101397147|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
33411599|NCT00151775|101397148|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
33411600|NCT00151775|101397149|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
33411601|NCT00151775|101397150|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
33411602|NCT00151775|101397151|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
33411603|NCT00151775|101397152|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
33411604|NCT00151775|101397153|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
33411605|NCT00151775|101397154|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
33411606|NCT00151775|101397155|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
33411607|NCT00151775|101397156|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
33411608|NCT00151775|101397157|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
33411609|NCT00151775|101397146|FG000|Period 4: Open Label|Adverse Event|0|||
33411610|NCT00151775|101397147|FG001|Period 4: Open Label|Adverse Event|0|||
33411611|NCT00151775|101397148|FG002|Period 4: Open Label|Adverse Event|0|||
33411612|NCT00151775|101397149|FG003|Period 4: Open Label|Adverse Event|0|||
33411613|NCT00151775|101397150|FG004|Period 4: Open Label|Adverse Event|1|||
33411614|NCT00151775|101397151|FG005|Period 4: Open Label|Adverse Event|0|||
33551763|NCT01281306|101917048|FG000|Overall Study|Randomized in error|1|||
33551764|NCT01281306|101917049|FG001|Overall Study|Randomized in error|0|||
33551765|NCT01281306|101917050|FG002|Overall Study|Randomized in error|0|||
33551766|NCT01281306|101917051|FG003|Overall Study|Randomized in error|1|||
33551767|NCT01281306|101917052|FG004|Overall Study|Randomized in error|0|||
33411615|NCT00151775|101397152|FG006|Period 4: Open Label|Adverse Event|0|||
33411616|NCT00151775|101397153|FG007|Period 4: Open Label|Adverse Event|0|||
33411617|NCT00151775|101397154|FG008|Period 4: Open Label|Adverse Event|0|||
33551768|NCT01281306|101917053|FG005|Overall Study|Randomized in error|0|||
33551769|NCT01281306|101917054|FG006|Overall Study|Randomized in error|0|||
33551770|NCT03418675|101917055|FG000|Overall Study|Lost to Follow-up|13|||
33551771|NCT03418675|101917056|FG001|Overall Study|Lost to Follow-up|10|||
33551772|NCT03418675|101917055|FG000|Overall Study|Adverse Event|2|||
33551773|NCT03418675|101917056|FG001|Overall Study|Adverse Event|0|||
33551774|NCT02945046|101917057|FG000|Overall Study|Adverse Event|1|||
33551775|NCT02945046|101917058|FG001|Overall Study|Adverse Event|0|||
33551776|NCT02945046|101917059|FG002|Overall Study|Adverse Event|2|||
33551777|NCT02945046|101917057|FG000|Overall Study|Withdrawal by Subject|3|||
33551778|NCT02945046|101917058|FG001|Overall Study|Withdrawal by Subject|3|||
33551779|NCT02945046|101917059|FG002|Overall Study|Withdrawal by Subject|3|||
33551780|NCT02945046|101917057|FG000|Overall Study|Protocol Violation|2|||
33551781|NCT02945046|101917058|FG001|Overall Study|Protocol Violation|3|||
33551782|NCT02945046|101917059|FG002|Overall Study|Protocol Violation|2|||
33551783|NCT02945046|101917057|FG000|Overall Study|Lost to Follow-up|1|||
33551784|NCT02945046|101917058|FG001|Overall Study|Lost to Follow-up|1|||
33551785|NCT02945046|101917059|FG002|Overall Study|Lost to Follow-up|0|||
33551786|NCT02945046|101917057|FG000|Overall Study|Lack of Efficacy|1|||
33551787|NCT02945046|101917058|FG001|Overall Study|Lack of Efficacy|2|||
33551788|NCT02945046|101917059|FG002|Overall Study|Lack of Efficacy|1|||
33551789|NCT02945046|101917057|FG000|Overall Study|Other than specified|5|||
33551790|NCT02945046|101917058|FG001|Overall Study|Other than specified|4|||
33551791|NCT02945046|101917059|FG002|Overall Study|Other than specified|7|||
33551792|NCT04027946|101917060|FG000|Overall Study|Screen failures|3|||
33551793|NCT01793935|101917061|FG000|Overall Study|Pregnancy|1|||
33551794|NCT01793935|101917062|FG001|Overall Study|Pregnancy|0|||
33551795|NCT01793935|101917061|FG000|Overall Study|Protocol Violation|2|||
33551796|NCT01793935|101917062|FG001|Overall Study|Protocol Violation|1|||
33551797|NCT01793935|101917061|FG000|Overall Study|Adverse Event|2|||
33551798|NCT01793935|101917062|FG001|Overall Study|Adverse Event|0|||
33551799|NCT01793935|101917061|FG000|Overall Study|Patient did not take study medication|1|||
33351184|NCT00849017|101172285|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
33351185|NCT00849017|101172286|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
33351186|NCT00849017|101172284|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
33351187|NCT00849017|101172285|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
33351188|NCT00849017|101172286|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
33351189|NCT00849017|101172284|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
33351190|NCT00849017|101172285|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
33351191|NCT00849017|101172286|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
33351192|NCT00849017|101172284|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
33351193|NCT00849017|101172285|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
33351194|NCT00849017|101172286|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
33351195|NCT00849017|101172284|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
33351196|NCT00849017|101172285|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
33351197|NCT00849017|101172286|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
33351198|NCT00849017|101172284|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
33351199|NCT00849017|101172285|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
33351200|NCT00849017|101172286|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
33351201|NCT00849017|101172284|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
33351202|NCT00849017|101172285|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
33351203|NCT00849017|101172286|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
33351204|NCT00849017|101172284|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
33351205|NCT00849017|101172285|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
33351206|NCT00849017|101172286|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
33351207|NCT00849017|101172284|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
33351208|NCT00849017|101172285|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
33351209|NCT00849017|101172286|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
33351210|NCT00849017|101172284|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
33351211|NCT00849017|101172285|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
33351212|NCT00849017|101172286|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
33351213|NCT00849017|101172284|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
33351214|NCT00849017|101172285|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
33351215|NCT00849017|101172286|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
33551800|NCT01793935|101917062|FG001|Overall Study|Patient did not take study medication|1|||
33551801|NCT01793935|101917061|FG000|Overall Study|Lost to Follow-up|0|||
33551802|NCT01793935|101917062|FG001|Overall Study|Lost to Follow-up|1|||
33618824|NCT03818035|102151658|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
33351216|NCT00849017|101172284|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
33351217|NCT00849017|101172285|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
33351218|NCT00849017|101172286|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
33351219|NCT01990261|101172298|FG000|Overall Study|Death Before Treatment Start|2|||
33551803|NCT01068912|101917064|FG000|Overall Study|Adverse Event|2|||
33551804|NCT01068912|101917065|FG001|Overall Study|Adverse Event|3|||
33551805|NCT01068912|101917066|FG002|Overall Study|Adverse Event|2|||
33551806|NCT01068912|101917064|FG000|Overall Study|Withdrawal by Subject|5|||
33217535|NCT01533493|100692461|FG000|Overall Study|Lost to Follow-up|2|||
33551807|NCT01068912|101917065|FG001|Overall Study|Withdrawal by Subject|6|||
33551808|NCT01068912|101917066|FG002|Overall Study|Withdrawal by Subject|6|||
33551809|NCT01068912|101917064|FG000|Overall Study|Lost to Follow-up|3|||
33551810|NCT01068912|101917065|FG001|Overall Study|Lost to Follow-up|7|||
33551811|NCT01068912|101917066|FG002|Overall Study|Lost to Follow-up|3|||
33551812|NCT01068912|101917064|FG000|Overall Study|Protocol Violation|0|||
33551813|NCT01068912|101917065|FG001|Overall Study|Protocol Violation|2|||
33551814|NCT01068912|101917066|FG002|Overall Study|Protocol Violation|0|||
33551815|NCT01068912|101917064|FG000|Overall Study|aggravation influenza|1|||
33551816|NCT01068912|101917065|FG001|Overall Study|aggravation influenza|1|||
33551817|NCT01068912|101917066|FG002|Overall Study|aggravation influenza|1|||
33551818|NCT01068912|101917064|FG000|Overall Study|other underlying illness|0|||
33351220|NCT01990261|101172298|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
33351221|NCT01990261|101172298|FG000|Overall Study|Death From other Causes|1|||
33351222|NCT01990261|101172298|FG000|Overall Study|Disease Progression (PD)|8|||
33351223|NCT01990261|101172298|FG000|Overall Study|PD Before Treatment Start|1|||
33351224|NCT01990261|101172298|FG000|Overall Study|Dossier not Approved|1|||
33351225|NCT01990261|101172298|FG000|Overall Study|Lost to Follow-up|2|||
33351226|NCT03219164|101172299|FG000|Overall Study|Study Terminated by Sponsor|16|||
33351227|NCT03219164|101172300|FG001|Overall Study|Study Terminated by Sponsor|12|||
33351228|NCT03219164|101172299|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
33351229|NCT03219164|101172300|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
33351230|NCT03219164|101172299|FG000|Overall Study|Lost to Follow-up|1|||
33411618|NCT00151775|101397155|FG009|Period 4: Open Label|Adverse Event|2|||
33551819|NCT01068912|101917065|FG001|Overall Study|other underlying illness|3|||
33551820|NCT01068912|101917066|FG002|Overall Study|other underlying illness|3|||
33551821|NCT00407030|101917067|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
33551822|NCT00407030|101917068|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
33618825|NCT03818035|102151659|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
33618826|NCT03818035|102151660|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
33411619|NCT00151775|101397156|FG010|Period 4: Open Label|Adverse Event|0|||
33551823|NCT00407030|101917069|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
33551824|NCT00407030|101917067|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
33551825|NCT00407030|101917068|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
33551826|NCT00407030|101917069|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
33551827|NCT00407030|101917067|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
33551828|NCT00407030|101917068|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
33551829|NCT00407030|101917069|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
33551830|NCT00407030|101917067|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
33551831|NCT00407030|101917068|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
33551832|NCT00407030|101917069|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
33551833|NCT00407030|101917067|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
33551834|NCT00407030|101917068|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
33551835|NCT00407030|101917069|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
33551836|NCT00407030|101917067|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
33551837|NCT00407030|101917068|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
33551838|NCT00407030|101917069|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
33551839|NCT00407030|101917067|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
33551840|NCT00407030|101917068|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
33551841|NCT00407030|101917069|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
33551842|NCT00407030|101917067|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
33551843|NCT00407030|101917068|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
33551844|NCT00407030|101917069|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
33411620|NCT00151775|101397157|FG011|Period 4: Open Label|Adverse Event|0|||
33411621|NCT00151775|101397146|FG000|Period 4: Open Label|Lost to Follow-up|0|||
33411622|NCT00151775|101397147|FG001|Period 4: Open Label|Lost to Follow-up|0|||
33411623|NCT00151775|101397148|FG002|Period 4: Open Label|Lost to Follow-up|0|||
33551845|NCT00407030|101917067|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
33551846|NCT00407030|101917068|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
33551847|NCT00407030|101917069|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
33551848|NCT00407030|101917067|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
33551849|NCT00407030|101917068|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
33551850|NCT00407030|101917069|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
33618827|NCT03818035|102151657|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
33351231|NCT03219164|101172300|FG001|Overall Study|Lost to Follow-up|1|||
33351232|NCT03219164|101172299|FG000|Overall Study|Adverse Event|1|||
33411624|NCT00151775|101397149|FG003|Period 4: Open Label|Lost to Follow-up|0|||
33551851|NCT00407030|101917067|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
33551852|NCT00407030|101917068|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
33551853|NCT00407030|101917069|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
33551854|NCT00407030|101917067|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
33351233|NCT03219164|101172300|FG001|Overall Study|Adverse Event|0|||
33351234|NCT03219164|101172299|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33351235|NCT03219164|101172300|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33351236|NCT03219164|101172299|FG000|Overall Study|Protocol Violation|0|||
33351237|NCT03219164|101172300|FG001|Overall Study|Protocol Violation|1|||
33351238|NCT03219164|101172299|FG000|Overall Study|Withdrew Assent|1|||
33351239|NCT03219164|101172300|FG001|Overall Study|Withdrew Assent|0|||
33351240|NCT01267955|101172304|FG000|Stage 1 (6 Months)|Death|3|||
33351241|NCT01267955|101172304|FG000|Stage 2 (6 Months)|Death|5|||
33351242|NCT01267955|101172304|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
33351243|NCT01341457|101172307|FG000|Overall Study|Adverse Event|2|||
33351244|NCT01341457|101172308|FG001|Overall Study|Adverse Event|0|||
33351245|NCT01700829|101172309|FG000|Overall Study|Withdrawal by Subject|1|||
33351246|NCT01700829|101172310|FG001|Overall Study|Withdrawal by Subject|1|||
33351247|NCT03514914|101172311|FG000|Overall Study|Death|3|||
33351248|NCT03514914|101172312|FG001|Overall Study|Death|3|||
33351249|NCT03514914|101172311|FG000|Overall Study|Lost to Follow-up|117|||
33351250|NCT03514914|101172312|FG001|Overall Study|Lost to Follow-up|89|||
33351251|NCT00832819|101172314|FG000|Overall Study|Adverse Event|0|||
33351252|NCT00832819|101172315|FG001|Overall Study|Adverse Event|1|||
33351253|NCT00832819|101172316|FG002|Overall Study|Adverse Event|0|||
33351254|NCT00832819|101172314|FG000|Overall Study|Protocol Violation|0|||
33351255|NCT00832819|101172315|FG001|Overall Study|Protocol Violation|0|||
33351256|NCT00832819|101172316|FG002|Overall Study|Protocol Violation|1|||
33351257|NCT02581995|101172320|FG000|Overall Study|Unspecified other|3|||
33351258|NCT02581995|101172320|FG000|Overall Study|Adverse Event|6|||
33351259|NCT02581995|101172320|FG000|Overall Study|Lost to Follow-up|5|||
33351260|NCT02581995|101172320|FG000|Overall Study|Withdrawal by participant|12|||
33351261|NCT02581995|101172320|FG000|Overall Study|Physician Decision|1|||
33351262|NCT02581995|101172320|FG000|Overall Study|Death|4|||
33351263|NCT03371355|101172321|FG000|Overall Study|Investigator judgment|0|||
33351264|NCT03371355|101172322|FG001|Overall Study|Investigator judgment|0|||
33351265|NCT03371355|101172323|FG002|Overall Study|Investigator judgment|1|||
33351266|NCT03371355|101172324|FG003|Overall Study|Investigator judgment|1|||
33351267|NCT03371355|101172321|FG000|Overall Study|Voluntary withdrawal|1|||
33351268|NCT03371355|101172322|FG001|Overall Study|Voluntary withdrawal|0|||
33351269|NCT03371355|101172323|FG002|Overall Study|Voluntary withdrawal|1|||
33351270|NCT03371355|101172324|FG003|Overall Study|Voluntary withdrawal|2|||
33351271|NCT03371355|101172321|FG000|Overall Study|Adverse Event|0|||
33351272|NCT03371355|101172322|FG001|Overall Study|Adverse Event|1|||
33351273|NCT03371355|101172323|FG002|Overall Study|Adverse Event|2|||
33351274|NCT03371355|101172324|FG003|Overall Study|Adverse Event|3|||
33351275|NCT03371355|101172321|FG000|Overall Study|Reason not Specified|0|||
33351276|NCT03371355|101172322|FG001|Overall Study|Reason not Specified|1|||
33351277|NCT03371355|101172323|FG002|Overall Study|Reason not Specified|0|||
33351278|NCT03371355|101172324|FG003|Overall Study|Reason not Specified|1|||
33411625|NCT00151775|101397150|FG004|Period 4: Open Label|Lost to Follow-up|17|||
33411626|NCT00151775|101397151|FG005|Period 4: Open Label|Lost to Follow-up|0|||
33411627|NCT00151775|101397152|FG006|Period 4: Open Label|Lost to Follow-up|0|||
33411628|NCT00151775|101397153|FG007|Period 4: Open Label|Lost to Follow-up|0|||
33411629|NCT00151775|101397154|FG008|Period 4: Open Label|Lost to Follow-up|0|||
33411630|NCT00151775|101397155|FG009|Period 4: Open Label|Lost to Follow-up|7|||
33411631|NCT00151775|101397156|FG010|Period 4: Open Label|Lost to Follow-up|0|||
33411632|NCT00151775|101397157|FG011|Period 4: Open Label|Lost to Follow-up|0|||
33411633|NCT00151775|101397146|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
33411634|NCT00151775|101397147|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
33217536|NCT01533493|100692462|FG001|Overall Study|Lost to Follow-up|0|||
33217537|NCT00696410|100692463|FG000|Overall Study|Lost to Follow-up|2|||
33217538|NCT00696410|100692464|FG001|Overall Study|Lost to Follow-up|0|||
33351279|NCT02921425|101172325|FG000|Overall Study|Protocol Violation|9|||
33351280|NCT00432809|101172326|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
33351281|NCT00432809|101172327|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
33351282|NCT00432809|101172328|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
33351283|NCT00432809|101172326|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
33411635|NCT00151775|101397148|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
33411636|NCT00151775|101397149|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
33411637|NCT00151775|101397150|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
33351284|NCT00432809|101172327|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
33217539|NCT00696410|100692463|FG000|Overall Study|Withdrawal by Subject|8|||
33351285|NCT00432809|101172328|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
33351286|NCT01553149|101172335|FG000|Overall Study|Adverse Event|0|||
33217540|NCT00696410|100692464|FG001|Overall Study|Withdrawal by Subject|0|||
33217541|NCT00696410|100692463|FG000|Overall Study|Physician Decision|3|||
33217542|NCT00696410|100692464|FG001|Overall Study|Physician Decision|0|||
33217543|NCT03086330|100692465|FG000|Overall Study|Withdrawal by Subject|3|||
33217544|NCT03086330|100692466|FG001|Overall Study|Withdrawal by Subject|2|||
33217545|NCT03086330|100692465|FG000|Overall Study|Lost to Follow-up|1|||
33551855|NCT00407030|101917068|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
33551856|NCT00407030|101917069|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
33217546|NCT03086330|100692466|FG001|Overall Study|Lost to Follow-up|2|||
33217547|NCT03703466|100692467|FG000|Overall Study|Death|2|||
33551857|NCT00407030|101917067|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
33551858|NCT00407030|101917068|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
33551859|NCT00407030|101917069|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
33551860|NCT01111292|101917070|FG000|Treatment|Physician Decision|1|||
33551861|NCT01111292|101917071|FG001|Treatment|Physician Decision|1|||
33551862|NCT02852434|101917074|FG000|Overall Study|Withdrawal by Subject|0|||
33551863|NCT02852434|101917075|FG001|Overall Study|Withdrawal by Subject|1|||
33551864|NCT02852434|101917074|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
33551865|NCT02852434|101917075|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
33618828|NCT03818035|102151658|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
33618829|NCT03818035|102151659|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
33217548|NCT03703466|100692468|FG001|Overall Study|Death|1|||
33217549|NCT03703466|100692469|FG002|Overall Study|Death|0|||
33217550|NCT03703466|100692467|FG000|Overall Study|Withdrawal by Subject|0|||
33217551|NCT03703466|100692468|FG001|Overall Study|Withdrawal by Subject|3|||
33351287|NCT01553149|101172336|FG001|Overall Study|Adverse Event|9|||
33551866|NCT01363076|101917076|FG000|Overall Study|Withdrawal by Subject|0|||
33551867|NCT01363076|101917077|FG001|Overall Study|Withdrawal by Subject|1|||
33551868|NCT02384460|101917078|FG000|Overall Study|Protocol Violation|0|||
33551869|NCT02384460|101917079|FG001|Overall Study|Protocol Violation|1|||
33551870|NCT02384460|101917078|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
33551871|NCT02384460|101917079|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
33551872|NCT02384460|101917078|FG000|Overall Study|Adverse Event|5|||
33551873|NCT02384460|101917079|FG001|Overall Study|Adverse Event|2|||
33551874|NCT02384460|101917078|FG000|Overall Study|Withdrawal by Subject|0|||
33551875|NCT02384460|101917079|FG001|Overall Study|Withdrawal by Subject|3|||
33551876|NCT02384460|101917078|FG000|Overall Study|Elective medical treatment|1|||
33551877|NCT02384460|101917079|FG001|Overall Study|Elective medical treatment|0|||
33551878|NCT02384460|101917078|FG000|Overall Study|Non-compliance|1|||
33551879|NCT02384460|101917079|FG001|Overall Study|Non-compliance|0|||
33551880|NCT03345004|101917080|FG000|Overall Study|Physician Decision|1|||
33551881|NCT03345004|101917081|FG001|Overall Study|Physician Decision|0|||
33551882|NCT03345004|101917080|FG000|Overall Study|Withdrawal by Subject|0|||
33551883|NCT03345004|101917081|FG001|Overall Study|Withdrawal by Subject|1|||
33551884|NCT03695094|101917082|FG000|Overall Study|Adverse Event|1|||
33551885|NCT03695094|101917083|FG001|Overall Study|Adverse Event|1|||
33551886|NCT03695094|101917082|FG000|Overall Study|Withdrawal by Subject|1|||
33551887|NCT03695094|101917083|FG001|Overall Study|Withdrawal by Subject|0|||
33551888|NCT01716156|101920079|FG000|Overall Study|Protocol Violation|1|||
33551889|NCT01716156|101920080|FG001|Overall Study|Protocol Violation|0|||
33551890|NCT01716156|101920081|FG002|Overall Study|Protocol Violation|0|||
33551891|NCT01716156|101920079|FG000|Overall Study|Withdrawal by Subject|0|||
33551892|NCT01716156|101920080|FG001|Overall Study|Withdrawal by Subject|1|||
33551893|NCT01716156|101920081|FG002|Overall Study|Withdrawal by Subject|2|||
33551894|NCT01716156|101920079|FG000|Overall Study|Lost to Follow-up|1|||
33551895|NCT01716156|101920080|FG001|Overall Study|Lost to Follow-up|0|||
33551896|NCT01716156|101920081|FG002|Overall Study|Lost to Follow-up|0|||
33551897|NCT00127933|101920085|FG000|Overall Study|Randomized but not dosed|1|||
33551898|NCT00127933|101920086|FG001|Overall Study|Randomized but not dosed|0|||
33551899|NCT01696968|101920093|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
33551900|NCT01696968|101920094|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
33551901|NCT01696968|101920093|FG000|Overall Study|Died Before Randomization|3|||
33551902|NCT01696968|101920094|FG001|Overall Study|Died Before Randomization|8|||
33551903|NCT01696968|101920093|FG000|Overall Study|Died Before ASU (Control)|278|||
33411638|NCT00151775|101397151|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
33411639|NCT00151775|101397152|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
33411640|NCT00151775|101397153|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
33551904|NCT01696968|101920094|FG001|Overall Study|Died Before ASU (Control)|0|||
33411641|NCT00151775|101397154|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
33411642|NCT00151775|101397155|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
33411643|NCT00151775|101397156|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
33411644|NCT00151775|101397157|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
33411645|NCT00151775|101397146|FG000|Period 4: Open Label|Other|0|||
33411646|NCT00151775|101397147|FG001|Period 4: Open Label|Other|0|||
33411647|NCT00151775|101397148|FG002|Period 4: Open Label|Other|0|||
33411648|NCT00151775|101397149|FG003|Period 4: Open Label|Other|0|||
33411649|NCT00151775|101397150|FG004|Period 4: Open Label|Other|1|||
33411650|NCT00151775|101397151|FG005|Period 4: Open Label|Other|0|||
33411651|NCT00151775|101397152|FG006|Period 4: Open Label|Other|0|||
33411652|NCT00151775|101397153|FG007|Period 4: Open Label|Other|0|||
33411653|NCT00151775|101397154|FG008|Period 4: Open Label|Other|0|||
33411654|NCT00151775|101397155|FG009|Period 4: Open Label|Other|3|||
33411655|NCT00151775|101397156|FG010|Period 4: Open Label|Other|0|||
33411656|NCT00151775|101397157|FG011|Period 4: Open Label|Other|0|||
33411657|NCT00151775|101397146|FG000|Period 4: Open Label|Physician Decision|0|||
33411658|NCT00151775|101397147|FG001|Period 4: Open Label|Physician Decision|0|||
33411659|NCT00151775|101397148|FG002|Period 4: Open Label|Physician Decision|0|||
33411660|NCT00151775|101397149|FG003|Period 4: Open Label|Physician Decision|0|||
33411661|NCT00151775|101397150|FG004|Period 4: Open Label|Physician Decision|0|||
33411662|NCT00151775|101397151|FG005|Period 4: Open Label|Physician Decision|0|||
33411663|NCT00151775|101397152|FG006|Period 4: Open Label|Physician Decision|0|||
33411664|NCT00151775|101397153|FG007|Period 4: Open Label|Physician Decision|0|||
33411665|NCT00151775|101397154|FG008|Period 4: Open Label|Physician Decision|0|||
33411666|NCT00151775|101397155|FG009|Period 4: Open Label|Physician Decision|2|||
33411667|NCT00151775|101397156|FG010|Period 4: Open Label|Physician Decision|0|||
33411668|NCT00151775|101397157|FG011|Period 4: Open Label|Physician Decision|0|||
33411669|NCT00151775|101397146|FG000|Period 4: Open Label|Protocol Violation|0|||
33411670|NCT00151775|101397147|FG001|Period 4: Open Label|Protocol Violation|0|||
33411671|NCT00151775|101397148|FG002|Period 4: Open Label|Protocol Violation|0|||
33411672|NCT00151775|101397149|FG003|Period 4: Open Label|Protocol Violation|0|||
33411673|NCT00151775|101397150|FG004|Period 4: Open Label|Protocol Violation|1|||
33411674|NCT00151775|101397151|FG005|Period 4: Open Label|Protocol Violation|0|||
33411675|NCT00151775|101397152|FG006|Period 4: Open Label|Protocol Violation|0|||
33411676|NCT00151775|101397153|FG007|Period 4: Open Label|Protocol Violation|0|||
33411677|NCT00151775|101397154|FG008|Period 4: Open Label|Protocol Violation|0|||
33411678|NCT00151775|101397155|FG009|Period 4: Open Label|Protocol Violation|0|||
33411679|NCT00151775|101397156|FG010|Period 4: Open Label|Protocol Violation|0|||
33551905|NCT01696968|101920093|FG000|Overall Study|Refused ASU (Control)|920|||
33551906|NCT01696968|101920094|FG001|Overall Study|Refused ASU (Control)|0|||
33551907|NCT01696968|101920093|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
33551908|NCT01696968|101920094|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
33411680|NCT00151775|101397157|FG011|Period 4: Open Label|Protocol Violation|0|||
33551909|NCT02112552|101920097|FG000|Overall Study|Withdrawal by Subject|1|||
33551910|NCT02112552|101920097|FG000|Overall Study|Adverse Event|1|||
33551911|NCT00896233|101920098|FG000|Overall Study|Claustrophobia during MRI|1|||
33411681|NCT04120116|101397158|FG000|Overall Study|Lost to Follow-up|0|||
33411682|NCT04120116|101397159|FG001|Overall Study|Lost to Follow-up|1|||
33411683|NCT04120116|101397160|FG002|Overall Study|Lost to Follow-up|0|||
33411684|NCT04120116|101397161|FG003|Overall Study|Lost to Follow-up|2|||
33411685|NCT04120116|101397158|FG000|Overall Study|Withdrawal by Subject|1|||
33411686|NCT04120116|101397159|FG001|Overall Study|Withdrawal by Subject|0|||
33411687|NCT04120116|101397160|FG002|Overall Study|Withdrawal by Subject|1|||
33411688|NCT04120116|101397161|FG003|Overall Study|Withdrawal by Subject|1|||
33618830|NCT03818035|102151660|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
33618831|NCT03818035|102151657|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
33618832|NCT03818035|102151658|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
33618833|NCT03818035|102151659|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
33618834|NCT03818035|102151660|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
33618835|NCT03818035|102151657|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
33618836|NCT03818035|102151658|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
33618837|NCT03818035|102151659|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
33618838|NCT03818035|102151660|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
33618839|NCT03818035|102151657|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
33618840|NCT03818035|102151658|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
33618841|NCT03818035|102151659|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
33618842|NCT03818035|102151660|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
33618843|NCT03818035|102151657|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
33618844|NCT03818035|102151658|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
33618845|NCT03818035|102151659|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
33618846|NCT03818035|102151660|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
33618847|NCT03818035|102151657|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
33618848|NCT03818035|102151658|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
33618849|NCT03818035|102151659|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
33618850|NCT03818035|102151660|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
33618851|NCT03818035|102151657|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
33618852|NCT03818035|102151658|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
33618853|NCT03818035|102151659|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
33618854|NCT03818035|102151660|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
33618855|NCT03818035|102151657|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
33618856|NCT03818035|102151658|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
33618857|NCT03818035|102151659|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
33618858|NCT03818035|102151660|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
33618859|NCT02362464|102151662|FG000|Overall Study|Switched to alternative therapy|1|||
33618860|NCT02362464|102151662|FG000|Overall Study|Refused further treatment|1|||
33618861|NCT02362464|102151662|FG000|Overall Study|Physician Decision|4|||
33618862|NCT03792256|102151667|FG000|Overall Study|Death|0|||
33618863|NCT03792256|102151668|FG001|Overall Study|Death|1|||
33618864|NCT03792256|102151667|FG000|Overall Study|Lack of Efficacy|0|||
33618865|NCT03792256|102151668|FG001|Overall Study|Lack of Efficacy|1|||
33618866|NCT03792256|102151667|FG000|Overall Study|Withdrawal by Subject|0|||
33217552|NCT03703466|100692469|FG002|Overall Study|Withdrawal by Subject|0|||
33217553|NCT03703466|100692467|FG000|Overall Study|Completed < 3 Cycles|2|||
33217554|NCT03703466|100692468|FG001|Overall Study|Completed < 3 Cycles|2|||
33217555|NCT03703466|100692469|FG002|Overall Study|Completed < 3 Cycles|2|||
33618867|NCT03792256|102151668|FG001|Overall Study|Withdrawal by Subject|1|||
33618868|NCT06385483|102151669|FG000|Overall Study|Withdrawal by Subject|2|||
33618869|NCT06385483|102151669|FG000|Overall Study|Never start protocol therapy|2|||
33618870|NCT06385483|102151669|FG000|Overall Study|Disease progression|15|||
33618871|NCT02021643|102151673|FG000|Overall Study|Enrolled but Never Treated|1|||
33618872|NCT02021643|102151674|FG001|Overall Study|Enrolled but Never Treated|0|||
33618873|NCT02021643|102151675|FG002|Overall Study|Enrolled but Never Treated|0|||
33618874|NCT02021643|102151676|FG003|Overall Study|Enrolled but Never Treated|0|||
33618875|NCT02021643|102151673|FG000|Overall Study|Adverse Event|0|||
33618876|NCT02021643|102151674|FG001|Overall Study|Adverse Event|1|||
33618877|NCT02021643|102151675|FG002|Overall Study|Adverse Event|0|||
33618878|NCT02021643|102151676|FG003|Overall Study|Adverse Event|0|||
33618879|NCT02021643|102151673|FG000|Overall Study|Death|0|||
33618880|NCT02021643|102151674|FG001|Overall Study|Death|1|||
33618881|NCT02021643|102151675|FG002|Overall Study|Death|0|||
33217556|NCT00696384|100692470|FG000|Open Label Phase|Adverse Event|27|||
33217557|NCT00696384|100692471|FG001|Open Label Phase|Adverse Event|0|||
33411689|NCT04120116|101397158|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
33417269|NCT05004181|101420250|FG000|Overall Study|Withdrawal of consent|0|||
33618882|NCT02021643|102151676|FG003|Overall Study|Death|0|||
33618883|NCT02021643|102151673|FG000|Overall Study|Investigator's Discretion|1|||
33618884|NCT02021643|102151674|FG001|Overall Study|Investigator's Discretion|0|||
33618885|NCT02021643|102151675|FG002|Overall Study|Investigator's Discretion|0|||
33618886|NCT02021643|102151676|FG003|Overall Study|Investigator's Discretion|0|||
33618887|NCT02021643|102151673|FG000|Overall Study|Lack of Efficacy|7|||
33618888|NCT02021643|102151674|FG001|Overall Study|Lack of Efficacy|6|||
33618889|NCT02021643|102151675|FG002|Overall Study|Lack of Efficacy|0|||
33618890|NCT02021643|102151676|FG003|Overall Study|Lack of Efficacy|12|||
33618891|NCT02021643|102151673|FG000|Overall Study|Lost to Follow-up|0|||
33217558|NCT00696384|100692472|FG002|Open Label Phase|Adverse Event|0|||
33217559|NCT00696384|100692470|FG000|Open Label Phase|Protocol Violation|18|||
33618892|NCT02021643|102151674|FG001|Overall Study|Lost to Follow-up|1|||
33618893|NCT02021643|102151675|FG002|Overall Study|Lost to Follow-up|0|||
33351288|NCT01553149|101172335|FG000|Overall Study|Physician Decision|5|||
33351289|NCT01553149|101172336|FG001|Overall Study|Physician Decision|10|||
33351290|NCT01553149|101172335|FG000|Overall Study|Ineligible|0|||
33351291|NCT01553149|101172336|FG001|Overall Study|Ineligible|1|||
33351292|NCT00702143|101172338|FG000|Overall Study|Lost to Follow-up|0|||
33351293|NCT00702143|101172339|FG001|Overall Study|Lost to Follow-up|0|||
33351294|NCT00702143|101172340|FG002|Overall Study|Lost to Follow-up|1|||
33411690|NCT04120116|101397159|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
33411691|NCT04120116|101397160|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
33411692|NCT04120116|101397161|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
33411693|NCT02983305|101397162|FG000|Overall Study|incomplete data|2|||
33411694|NCT02983305|101397163|FG001|Overall Study|incomplete data|0|||
33411695|NCT03358407|101397164|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33411696|NCT03358407|101397165|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33411697|NCT03358407|101397166|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
33411698|NCT03358407|101397167|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33411699|NCT03358407|101397168|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33411700|NCT03358407|101397169|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33411701|NCT03358407|101397170|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33411702|NCT03358407|101397171|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33411703|NCT03358407|101397172|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33411704|NCT03358407|101397173|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
33411705|NCT03358407|101397164|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33411706|NCT03358407|101397165|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33411707|NCT03358407|101397166|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33551912|NCT03123588|101920101|FG000|Overall Study|Study Terminated by Sponsor|2|||
33551913|NCT03123588|101920102|FG001|Overall Study|Study Terminated by Sponsor|5|||
33411708|NCT03358407|101397167|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33492091|NCT00838526|101693884|FG000|Overall Study|Adverse Event|3|||
33351295|NCT02304926|101172347|FG000|Overall Study|Lost to Follow-up|2|||
33351296|NCT02304926|101172348|FG001|Overall Study|Lost to Follow-up|1|||
33351297|NCT04343651|101172349|FG000|Overall Study|Physician Decision|2|||
33351298|NCT04343651|101172350|FG001|Overall Study|Physician Decision|1|||
33351299|NCT04343651|101172349|FG000|Overall Study|Lost to Follow-up|2|||
33351300|NCT04343651|101172350|FG001|Overall Study|Lost to Follow-up|1|||
33351301|NCT04343651|101172349|FG000|Overall Study|Protocol Violation|4|||
33351302|NCT04343651|101172350|FG001|Overall Study|Protocol Violation|6|||
33351303|NCT04343651|101172349|FG000|Overall Study|Missing|3|||
33351304|NCT04343651|101172350|FG001|Overall Study|Missing|9|||
33351305|NCT04343651|101172349|FG000|Overall Study|Withdrawal by Subject|0|||
33351306|NCT04343651|101172350|FG001|Overall Study|Withdrawal by Subject|4|||
33351307|NCT04343651|101172349|FG000|Overall Study|Death|0|||
33351308|NCT04343651|101172350|FG001|Overall Study|Death|1|||
33351309|NCT04343651|101172349|FG000|Overall Study|Did not start treatment|1|||
33492092|NCT00838526|101693885|FG001|Overall Study|Adverse Event|12|||
33492093|NCT00838526|101693884|FG000|Overall Study|Lost to Follow-up|4|||
33351310|NCT04343651|101172350|FG001|Overall Study|Did not start treatment|1|||
33351311|NCT04343651|101172349|FG000|Overall Study|Patient did not complete visits 3-6|0|||
33351312|NCT04343651|101172350|FG001|Overall Study|Patient did not complete visits 3-6|1|||
33351313|NCT05499520|101172353|FG000|Overall Study|Lost to Follow-up|0|||
33351314|NCT05499520|101172354|FG001|Overall Study|Lost to Follow-up|0|||
33351315|NCT05499520|101172355|FG002|Overall Study|Lost to Follow-up|38|||
33492094|NCT00838526|101693885|FG001|Overall Study|Lost to Follow-up|12|||
33492095|NCT00838526|101693884|FG000|Overall Study|Withdrawal by Subject|4|||
33492096|NCT00838526|101693885|FG001|Overall Study|Withdrawal by Subject|5|||
33492097|NCT00838526|101693884|FG000|Overall Study|Lack of Efficacy|2|||
33492098|NCT00838526|101693885|FG001|Overall Study|Lack of Efficacy|3|||
33492099|NCT00838526|101693884|FG000|Overall Study|Other|11|||
33492100|NCT00838526|101693885|FG001|Overall Study|Other|7|||
33492101|NCT02383017|101693886|FG000|Overall Study|Injury Sustained Outside Study|1|||
33492102|NCT02383017|101693887|FG001|Overall Study|Injury Sustained Outside Study|0|||
33492103|NCT02383017|101693886|FG000|Overall Study|Compliance|3|||
33492104|NCT02383017|101693887|FG001|Overall Study|Compliance|2|||
33492105|NCT02383017|101693886|FG000|Overall Study|Found to be Hypogonadal|1|||
33492106|NCT02383017|101693887|FG001|Overall Study|Found to be Hypogonadal|0|||
33492107|NCT02601014|101693890|FG000|Overall Study|Adverse Event|3|||
33492108|NCT02601014|101693891|FG001|Overall Study|Adverse Event|3|||
33492109|NCT02601014|101693890|FG000|Overall Study|Death|3|||
33492110|NCT02601014|101693891|FG001|Overall Study|Death|1|||
33492111|NCT02601014|101693890|FG000|Overall Study|Disease progression|4|||
33492112|NCT02601014|101693891|FG001|Overall Study|Disease progression|8|||
33492113|NCT00618371|101693893|FG000|Overall Study|Withdrawal by Subject|2|||
33492114|NCT03052751|101693894|FG000|Dosing Period 1|Adverse Event|0|||
33492115|NCT03052751|101693895|FG001|Dosing Period 1|Adverse Event|1|||
33351316|NCT05499520|101172356|FG003|Overall Study|Lost to Follow-up|41|||
33351317|NCT05499520|101172357|FG004|Overall Study|Lost to Follow-up|46|||
33351318|NCT05499520|101172358|FG005|Overall Study|Lost to Follow-up|0|||
33351319|NCT05499520|101172359|FG006|Overall Study|Lost to Follow-up|31|||
33351320|NCT05499520|101172360|FG007|Overall Study|Lost to Follow-up|45|||
33351321|NCT05499520|101172361|FG008|Overall Study|Lost to Follow-up|42|||
33351322|NCT05499520|101172362|FG009|Overall Study|Lost to Follow-up|0|||
33351323|NCT05499520|101172363|FG010|Overall Study|Lost to Follow-up|0|||
33351324|NCT05499520|101172364|FG011|Overall Study|Lost to Follow-up|37|||
33351325|NCT05499520|101172365|FG012|Overall Study|Lost to Follow-up|53|||
33351326|NCT05499520|101172366|FG013|Overall Study|Lost to Follow-up|49|||
33351327|NCT05499520|101172367|FG014|Overall Study|Lost to Follow-up|0|||
33351328|NCT05499520|101172368|FG015|Overall Study|Lost to Follow-up|36|||
33351329|NCT05499520|101172369|FG016|Overall Study|Lost to Follow-up|58|||
33351330|NCT05499520|101172370|FG017|Overall Study|Lost to Follow-up|53|||
33351331|NCT03430310|101172371|FG000|Overall Study|Protocol Violation|2|||
33351332|NCT03430310|101172372|FG001|Overall Study|Protocol Violation|0|||
33351333|NCT03430310|101172371|FG000|Overall Study|Withdrawal by Subject|3|||
33351334|NCT03430310|101172372|FG001|Overall Study|Withdrawal by Subject|2|||
33351335|NCT03430310|101172371|FG000|Overall Study|COVID shutdown March 2020|0|||
33351336|NCT03430310|101172372|FG001|Overall Study|COVID shutdown March 2020|1|||
33351337|NCT00331760|101172373|FG000|Overall Study|Ineligible / no protocol treatment|15|||
33351338|NCT00331760|101172374|FG001|Overall Study|Ineligible / no protocol treatment|8|||
33351339|NCT01032629|101172375|FG000|Overall Study|Closed Site|21|||
33351340|NCT01032629|101172376|FG001|Overall Study|Closed Site|18|||
33351341|NCT01032629|101172377|FG002|Overall Study|Closed Site|16|||
33351342|NCT01032629|101172375|FG000|Overall Study|Withdrawal by Subject|50|||
33351343|NCT01032629|101172376|FG001|Overall Study|Withdrawal by Subject|36|||
33351344|NCT01032629|101172377|FG002|Overall Study|Withdrawal by Subject|35|||
33351345|NCT01032629|101172375|FG000|Overall Study|Lost to Follow-up|74|||
33351346|NCT01032629|101172376|FG001|Overall Study|Lost to Follow-up|47|||
33351347|NCT01032629|101172377|FG002|Overall Study|Lost to Follow-up|37|||
33351348|NCT01485614|101172378|FG000|Randomization|Not Treated|1|||
33351349|NCT01485614|101172379|FG001|Randomization|Not Treated|0|||
33351350|NCT01485614|101172380|FG002|Randomization|Not Treated|0|||
33351351|NCT01485614|101172381|FG003|Randomization|Not Treated|0|||
33351352|NCT01485614|101172378|FG000|Weeks 0-20|Lost to Follow-up|2|||
33351353|NCT01485614|101172379|FG001|Weeks 0-20|Lost to Follow-up|0|||
33351354|NCT01485614|101172380|FG002|Weeks 0-20|Lost to Follow-up|0|||
33351355|NCT01485614|101172381|FG003|Weeks 0-20|Lost to Follow-up|0|||
33351356|NCT01485614|101172378|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
33351357|NCT01485614|101172379|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
33351358|NCT01485614|101172380|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
33351359|NCT01485614|101172381|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
33351360|NCT01485614|101172378|FG000|Weeks 0-20|Withdrawal by Subject|3|||
33351361|NCT01485614|101172379|FG001|Weeks 0-20|Withdrawal by Subject|2|||
33351362|NCT01485614|101172380|FG002|Weeks 0-20|Withdrawal by Subject|1|||
33351363|NCT01485614|101172381|FG003|Weeks 0-20|Withdrawal by Subject|0|||
33351364|NCT01485614|101172378|FG000|Weeks 20-54|Lost to Follow-up|4|||
33351365|NCT01485614|101172379|FG001|Weeks 20-54|Lost to Follow-up|3|||
33351366|NCT01485614|101172380|FG002|Weeks 20-54|Lost to Follow-up|1|||
33351367|NCT01485614|101172381|FG003|Weeks 20-54|Lost to Follow-up|0|||
33351368|NCT01485614|101172378|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
33351369|NCT01485614|101172379|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
33351370|NCT01485614|101172380|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
33351371|NCT01485614|101172381|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
33351372|NCT01485614|101172378|FG000|Weeks 20-54|Withdrawal by Subject|5|||
33351373|NCT01485614|101172379|FG001|Weeks 20-54|Withdrawal by Subject|3|||
33351374|NCT01485614|101172380|FG002|Weeks 20-54|Withdrawal by Subject|0|||
33351375|NCT01485614|101172381|FG003|Weeks 20-54|Withdrawal by Subject|0|||
33351376|NCT00924703|101172382|FG000|Overall Study|Withdrawal by Subject|11|||
33351377|NCT00924703|101172382|FG000|Overall Study|Physician Decision|5|||
33551914|NCT03123588|101920101|FG000|Overall Study|Withdrawal by Subject|1|||
33551915|NCT03123588|101920102|FG001|Overall Study|Withdrawal by Subject|0|||
33217560|NCT00696384|100692471|FG001|Open Label Phase|Protocol Violation|0|||
33217561|NCT00696384|100692472|FG002|Open Label Phase|Protocol Violation|0|||
33351378|NCT00924703|101172382|FG000|Overall Study|Lost to Follow-up|3|||
33351379|NCT00924703|101172382|FG000|Overall Study|Adverse Event|2|||
33351380|NCT00924703|101172382|FG000|Overall Study|Withdrawal by Sponsor|1|||
33351381|NCT01805180|101172383|FG000|Lead-in Donor Phase|screen failure|1|||
33351382|NCT01805180|101172384|FG001|Lead-in Donor Phase|screen failure|0|||
33351383|NCT01805180|101172385|FG002|Lead-in Donor Phase|screen failure|0|||
33351384|NCT01147926|101172399|FG000|Overall Study|Subject Withdrew Consent|9|||
33351385|NCT01147926|101172400|FG001|Overall Study|Subject Withdrew Consent|10|||
33351386|NCT01147926|101172399|FG000|Overall Study|Adverse Event|7|||
33351387|NCT01147926|101172400|FG001|Overall Study|Adverse Event|6|||
33351388|NCT01147926|101172399|FG000|Overall Study|Subject Non-Compliant|5|||
33351389|NCT01147926|101172400|FG001|Overall Study|Subject Non-Compliant|4|||
33551916|NCT03123588|101920101|FG000|Overall Study|Adverse Event|1|||
33351390|NCT01147926|101172399|FG000|Overall Study|Principal investigator left hospital|1|||
33351391|NCT01147926|101172400|FG001|Overall Study|Principal investigator left hospital|3|||
33351392|NCT01147926|101172399|FG000|Overall Study|Selection criteria not met|3|||
33351393|NCT01147926|101172400|FG001|Overall Study|Selection criteria not met|1|||
33351394|NCT01147926|101172399|FG000|Overall Study|Lost to Follow-up|0|||
33351395|NCT01147926|101172400|FG001|Overall Study|Lost to Follow-up|2|||
33351396|NCT01147926|101172399|FG000|Overall Study|Sponsor's Decision|0|||
33351397|NCT01147926|101172400|FG001|Overall Study|Sponsor's Decision|1|||
33351398|NCT01147926|101172399|FG000|Overall Study|Lack of Efficacy|1|||
33351399|NCT01147926|101172400|FG001|Overall Study|Lack of Efficacy|0|||
33351400|NCT01147926|101172399|FG000|Overall Study|Too busy, no time for study|1|||
33351401|NCT01147926|101172400|FG001|Overall Study|Too busy, no time for study|0|||
33351402|NCT01147926|101172399|FG000|Overall Study|Went on holiday|0|||
33351403|NCT01147926|101172400|FG001|Overall Study|Went on holiday|1|||
33351404|NCT01147926|101172399|FG000|Overall Study|Colonoscopy result|0|||
33351405|NCT01147926|101172400|FG001|Overall Study|Colonoscopy result|1|||
33351406|NCT01662648|101172401|FG000|Overall Study|Death|1|||
33351407|NCT01662648|101172402|FG001|Overall Study|Death|3|||
33351408|NCT01662648|101172401|FG000|Overall Study|Adverse Event|40|||
33351409|NCT01662648|101172402|FG001|Overall Study|Adverse Event|37|||
33351410|NCT01662648|101172401|FG000|Overall Study|Lack of Efficacy|17|||
33351411|NCT01662648|101172402|FG001|Overall Study|Lack of Efficacy|16|||
33351412|NCT01662648|101172401|FG000|Overall Study|Participant ineligible to continue trial|1|||
33351413|NCT01662648|101172402|FG001|Overall Study|Participant ineligible to continue trial|1|||
33351414|NCT01662648|101172401|FG000|Overall Study|Lost to Follow-up|24|||
33351415|NCT01662648|101172402|FG001|Overall Study|Lost to Follow-up|36|||
33351416|NCT01662648|101172401|FG000|Overall Study|Withdrawal by Subject|36|||
33351417|NCT01662648|101172402|FG001|Overall Study|Withdrawal by Subject|53|||
33351418|NCT01662648|101172401|FG000|Overall Study|Participant non-compliant|16|||
33351419|NCT01662648|101172402|FG001|Overall Study|Participant non-compliant|20|||
33351420|NCT01662648|101172401|FG000|Overall Study|Other|8|||
33351421|NCT01662648|101172402|FG001|Overall Study|Other|11|||
33351422|NCT01662648|101172401|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
33351423|NCT01662648|101172402|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
33351424|NCT01662648|101172401|FG000|Overall Study|LOE and other reason unspecified|1|||
33351425|NCT01662648|101172402|FG001|Overall Study|LOE and other reason unspecified|0|||
33351426|NCT01662648|101172401|FG000|Overall Study|LOE and Participant non-compliant|0|||
33351427|NCT01662648|101172402|FG001|Overall Study|LOE and Participant non-compliant|1|||
33351428|NCT03968419|101172406|FG000|Treatment Period|Adverse Event|0|||
33351429|NCT03968419|101172407|FG001|Treatment Period|Adverse Event|0|||
33351430|NCT03968419|101172408|FG002|Treatment Period|Adverse Event|1|||
33351431|NCT03968419|101172406|FG000|Safety Follow-up Period|Death|3|||
33351432|NCT03968419|101172407|FG001|Safety Follow-up Period|Death|2|||
33351433|NCT03968419|101172408|FG002|Safety Follow-up Period|Death|1|||
33351434|NCT03968419|101172406|FG000|Safety Follow-up Period|Subject Decision|2|||
33351435|NCT03968419|101172407|FG001|Safety Follow-up Period|Subject Decision|1|||
33351436|NCT03968419|101172408|FG002|Safety Follow-up Period|Subject Decision|0|||
33351437|NCT00100048|101172415|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
33351438|NCT00100048|101172416|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
33351439|NCT00100048|101172417|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
33351440|NCT00100048|101172418|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
33351441|NCT00100048|101172419|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
33351442|NCT00100048|101172420|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
33351443|NCT00100048|101172415|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
33351444|NCT00100048|101172416|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
33351445|NCT00100048|101172417|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
33351446|NCT00100048|101172418|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
33351447|NCT00100048|101172419|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
33351448|NCT00100048|101172420|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
33351449|NCT00100048|101172415|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
33351450|NCT00100048|101172416|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
33351451|NCT00100048|101172417|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
33351452|NCT00100048|101172418|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
33351453|NCT00100048|101172419|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
33351454|NCT00100048|101172420|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
33411709|NCT03358407|101397168|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
33351455|NCT00100048|101172415|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
33351456|NCT00100048|101172416|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
33351457|NCT00100048|101172417|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
33351458|NCT00100048|101172418|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
33351459|NCT00100048|101172419|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
33351460|NCT00100048|101172420|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
33351461|NCT00100048|101172415|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
33351462|NCT00100048|101172416|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
33351463|NCT00100048|101172417|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
33351464|NCT00100048|101172418|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
33351465|NCT00100048|101172419|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
33351466|NCT00100048|101172420|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
33351467|NCT00100048|101172415|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
33351468|NCT00100048|101172416|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
33351469|NCT00100048|101172417|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
33351470|NCT00100048|101172418|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
33351471|NCT00100048|101172419|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
33351472|NCT00100048|101172420|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
33351473|NCT00100048|101172415|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
33351474|NCT00100048|101172416|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
33351475|NCT00100048|101172417|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
33351476|NCT00100048|101172418|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
33351477|NCT00100048|101172419|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
33351478|NCT00100048|101172420|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
33351479|NCT00100048|101172415|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
33351480|NCT00100048|101172416|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
33351481|NCT00100048|101172417|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
33351482|NCT00100048|101172418|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
33351483|NCT00100048|101172419|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
33351484|NCT00100048|101172420|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
33351485|NCT04223609|101172421|FG000|Overall Study|Adverse Event|0|||
33351486|NCT04223609|101172422|FG001|Overall Study|Adverse Event|1|||
33618894|NCT02021643|102151676|FG003|Overall Study|Lost to Follow-up|0|||
33618895|NCT02021643|102151673|FG000|Overall Study|Withdrew Consent|0|||
33618896|NCT02021643|102151674|FG001|Overall Study|Withdrew Consent|1|||
33551917|NCT03123588|101920102|FG001|Overall Study|Adverse Event|0|||
33551918|NCT03123588|101920101|FG000|Overall Study|Physician Decision|2|||
33551919|NCT03123588|101920102|FG001|Overall Study|Physician Decision|1|||
33551920|NCT01750281|101920105|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
33551921|NCT01750281|101920106|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
33551922|NCT01750281|101920107|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
33551923|NCT01750281|101920105|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
33551924|NCT01750281|101920106|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
33551925|NCT01750281|101920107|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
33551926|NCT01750281|101920105|FG000|Overall Study|Did not receive treatment|0|||
33551927|NCT01750281|101920106|FG001|Overall Study|Did not receive treatment|1|||
33551928|NCT01750281|101920107|FG002|Overall Study|Did not receive treatment|0|||
33551929|NCT04625972|101920109|FG000|Overall Study|Death|3|||
33551930|NCT04625972|101920110|FG001|Overall Study|Death|2|||
33551931|NCT04625972|101920109|FG000|Overall Study|Lost to Follow-up|82|||
33551932|NCT04625972|101920110|FG001|Overall Study|Lost to Follow-up|38|||
33551933|NCT04625972|101920109|FG000|Overall Study|Physician Decision|2|||
33618897|NCT02021643|102151675|FG002|Overall Study|Withdrew Consent|0|||
33217562|NCT00696384|100692470|FG000|Open Label Phase|Lost to Follow-up|24|||
33217563|NCT00696384|100692471|FG001|Open Label Phase|Lost to Follow-up|0|||
33351487|NCT04223609|101172421|FG000|Overall Study|Missed last visit|0|||
33351488|NCT04223609|101172422|FG001|Overall Study|Missed last visit|1|||
33351489|NCT03440944|101172425|FG000|Overall Study|Physician Decision|1|||
33351490|NCT03440944|101172426|FG001|Overall Study|Physician Decision|0|||
33351491|NCT03440944|101172425|FG000|Overall Study|No Acceptable Vasculature|0|||
33351492|NCT03440944|101172426|FG001|Overall Study|No Acceptable Vasculature|1|||
33351493|NCT01413958|101172427|FG000|Overall Study|Lost to Follow-up|0|||
33351494|NCT01413958|101172428|FG001|Overall Study|Lost to Follow-up|1|||
33351495|NCT01381094|101172431|FG000|Overall Study|Adverse Event|1|||
33351496|NCT01381094|101172432|FG001|Overall Study|Adverse Event|2|||
33351497|NCT01381094|101172433|FG002|Overall Study|Adverse Event|0|||
33351498|NCT01381094|101172434|FG003|Overall Study|Adverse Event|1|||
33411710|NCT03358407|101397169|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33411711|NCT03358407|101397170|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33551934|NCT04625972|101920110|FG001|Overall Study|Physician Decision|0|||
33551935|NCT04625972|101920109|FG000|Overall Study|Protocol Violation|0|||
33618898|NCT02021643|102151676|FG003|Overall Study|Withdrew Consent|0|||
33618899|NCT04303572|102151681|FG000|Overall Study|Study closed due to poor enrollment|1|||
33217564|NCT00696384|100692472|FG002|Open Label Phase|Lost to Follow-up|0|||
33551936|NCT04625972|101920110|FG001|Overall Study|Protocol Violation|1|||
33551937|NCT04625972|101920109|FG000|Overall Study|Withdrawal by Subject|37|||
33551938|NCT04625972|101920110|FG001|Overall Study|Withdrawal by Subject|24|||
33351499|NCT01381094|101172435|FG004|Overall Study|Adverse Event|0|||
33351500|NCT01381094|101172431|FG000|Overall Study|Lost to Follow-up|0|||
33351501|NCT01381094|101172432|FG001|Overall Study|Lost to Follow-up|0|||
33351502|NCT01381094|101172433|FG002|Overall Study|Lost to Follow-up|0|||
33351503|NCT01381094|101172434|FG003|Overall Study|Lost to Follow-up|0|||
33351504|NCT01381094|101172435|FG004|Overall Study|Lost to Follow-up|1|||
33551939|NCT04625972|101920109|FG000|Overall Study|Not specified elsewhere|8|||
33551940|NCT04625972|101920110|FG001|Overall Study|Not specified elsewhere|6|||
33551941|NCT03019588|101920111|FG000|Overall Study|Death|44|||
33551942|NCT03019588|101920112|FG001|Overall Study|Death|46|||
33551943|NCT03019588|101920111|FG000|Overall Study|Study terminated by Sponsor|3|||
33618900|NCT00687804|102151682|FG000|Core Study|Adverse Event|5|||
33618901|NCT00687804|102151683|FG001|Core Study|Adverse Event|3|||
33618902|NCT00687804|102151684|FG002|Core Study|Adverse Event|3|||
33618903|NCT00687804|102151682|FG000|Core Study|Abnormal laboratory value(s)|1|||
33618904|NCT00687804|102151683|FG001|Core Study|Abnormal laboratory value(s)|0|||
33618905|NCT00687804|102151684|FG002|Core Study|Abnormal laboratory value(s)|0|||
33618906|NCT00687804|102151682|FG000|Core Study|Lack of Efficacy|1|||
33618907|NCT00687804|102151683|FG001|Core Study|Lack of Efficacy|1|||
33618908|NCT00687804|102151684|FG002|Core Study|Lack of Efficacy|1|||
33618909|NCT00687804|102151682|FG000|Core Study|Withdrawal by Subject|4|||
33618910|NCT00687804|102151683|FG001|Core Study|Withdrawal by Subject|7|||
33618911|NCT00687804|102151684|FG002|Core Study|Withdrawal by Subject|7|||
33618912|NCT00687804|102151682|FG000|Core Study|Lost to Follow-up|0|||
33618913|NCT00687804|102151683|FG001|Core Study|Lost to Follow-up|1|||
33618914|NCT00687804|102151684|FG002|Core Study|Lost to Follow-up|0|||
33618915|NCT00687804|102151682|FG000|Core Study|Death|2|||
33351505|NCT01381094|101172431|FG000|Overall Study|Withdrawal of informed consent|0|||
33351506|NCT01381094|101172432|FG001|Overall Study|Withdrawal of informed consent|1|||
33351507|NCT01381094|101172433|FG002|Overall Study|Withdrawal of informed consent|0|||
33351508|NCT01381094|101172434|FG003|Overall Study|Withdrawal of informed consent|0|||
33351509|NCT01381094|101172435|FG004|Overall Study|Withdrawal of informed consent|0|||
33351510|NCT01381094|101172431|FG000|Overall Study|Participant given Aranesp injection|1|||
33551944|NCT03019588|101920112|FG001|Overall Study|Study terminated by Sponsor|1|||
33551945|NCT00182637|101920113|FG000|Overall Study|Adverse Event|2|||
33551946|NCT00182637|101920113|FG000|Overall Study|Disease Progression|1|||
33551947|NCT01011283|101920117|FG000|Overall Study|Adverse Event|4|||
33551948|NCT01011283|101920118|FG001|Overall Study|Adverse Event|2|||
33551949|NCT01011283|101920117|FG000|Overall Study|Progressive Disease|0|||
33618916|NCT00687804|102151683|FG001|Core Study|Death|2|||
33551950|NCT01011283|101920118|FG001|Overall Study|Progressive Disease|2|||
33551951|NCT01011283|101920117|FG000|Overall Study|Terminated by Sponsor|5|||
33551952|NCT01011283|101920118|FG001|Overall Study|Terminated by Sponsor|5|||
33551953|NCT01011283|101920117|FG000|Overall Study|Other|2|||
33551954|NCT01011283|101920118|FG001|Overall Study|Other|2|||
33551955|NCT03828383|101920120|FG000|Overall Study|Lost to Follow-up|3|||
33551956|NCT03828383|101920121|FG001|Overall Study|Lost to Follow-up|2|||
33551957|NCT03828383|101920120|FG000|Overall Study|Withdrawal by Subject|4|||
33618917|NCT00687804|102151684|FG002|Core Study|Death|2|||
33618918|NCT00687804|102151682|FG000|Core Study|Protocol Violation|1|||
33618919|NCT00687804|102151683|FG001|Core Study|Protocol Violation|1|||
33618920|NCT00687804|102151684|FG002|Core Study|Protocol Violation|0|||
33618921|NCT00687804|102151682|FG000|Open-Label Extension Study|Adverse Event|2|||
33618922|NCT00687804|102151683|FG001|Open-Label Extension Study|Adverse Event|2|||
33618923|NCT00687804|102151684|FG002|Open-Label Extension Study|Adverse Event|2|||
33618924|NCT00687804|102151682|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
33551958|NCT03828383|101920121|FG001|Overall Study|Withdrawal by Subject|5|||
33551959|NCT01905683|101920126|FG000|Overall Study|Protocol Violation|1|||
33551960|NCT01905683|101920126|FG000|Overall Study|Re-injection criteria not met; others|13|||
33618925|NCT00687804|102151683|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
33618926|NCT00687804|102151684|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
33618927|NCT00687804|102151682|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
33618928|NCT00687804|102151683|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
33351511|NCT01381094|101172432|FG001|Overall Study|Participant given Aranesp injection|0|||
33618929|NCT00687804|102151684|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
33618930|NCT00687804|102151682|FG000|Open-Label Extension Study|Administrative problems|1|||
33618931|NCT00687804|102151683|FG001|Open-Label Extension Study|Administrative problems|1|||
33351512|NCT01381094|101172433|FG002|Overall Study|Participant given Aranesp injection|0|||
33351513|NCT01381094|101172434|FG003|Overall Study|Participant given Aranesp injection|0|||
33551961|NCT01905683|101920126|FG000|Overall Study|Physician Decision|1|||
33551962|NCT01905683|101920126|FG000|Overall Study|Lack of Efficacy|8|||
33551963|NCT01905683|101920126|FG000|Overall Study|Withdrawal by Subject|20|||
33551964|NCT01905683|101920126|FG000|Overall Study|Adverse Event|4|||
33551965|NCT01905683|101920126|FG000|Overall Study|Lost to Follow-up|4|||
33351514|NCT01381094|101172435|FG004|Overall Study|Participant given Aranesp injection|0|||
33351515|NCT00603239|101172436|FG000|Overall Study|Adverse Event|4|||
33351516|NCT00603239|101172437|FG001|Overall Study|Adverse Event|1|||
33351517|NCT00603239|101172436|FG000|Overall Study|Entry criteria not met|0|||
33351518|NCT00603239|101172437|FG001|Overall Study|Entry criteria not met|1|||
33351519|NCT00603239|101172436|FG000|Overall Study|Loss of glucose control|3|||
33351520|NCT00603239|101172437|FG001|Overall Study|Loss of glucose control|0|||
33351521|NCT00603239|101172436|FG000|Overall Study|Lost to Follow-up|2|||
33351522|NCT00603239|101172437|FG001|Overall Study|Lost to Follow-up|1|||
33351523|NCT00603239|101172436|FG000|Overall Study|Physician Decision|2|||
33351524|NCT00603239|101172437|FG001|Overall Study|Physician Decision|0|||
33351525|NCT00603239|101172436|FG000|Overall Study|Protocol Violation|2|||
33351526|NCT00603239|101172437|FG001|Overall Study|Protocol Violation|0|||
33351527|NCT00603239|101172436|FG000|Overall Study|Subject decision|2|||
33351528|NCT00603239|101172437|FG001|Overall Study|Subject decision|1|||
33551966|NCT00923702|101920129|FG000|Overall Study|Ongoing enrollment|0|||
33551967|NCT00923702|101920130|FG001|Overall Study|Ongoing enrollment|0|||
33551968|NCT00923702|101920131|FG002|Overall Study|Ongoing enrollment|0|||
33551969|NCT00923702|101920132|FG003|Overall Study|Ongoing enrollment|0|||
33551970|NCT00923702|101920133|FG004|Overall Study|Ongoing enrollment|354|||
33551971|NCT03637374|101920137|FG000|Overall Study|Death|2|||
33551972|NCT03637374|101920138|FG001|Overall Study|Death|0|||
33551973|NCT00977561|101920139|FG000|Overall Study|Death|3|||
33551974|NCT00977561|101920140|FG001|Overall Study|Death|2|||
33551975|NCT00977561|101920139|FG000|Overall Study|Study terminated|0|||
33551976|NCT00977561|101920140|FG001|Overall Study|Study terminated|2|||
33551977|NCT00977561|101920139|FG000|Overall Study|Other|2|||
33551978|NCT00977561|101920140|FG001|Overall Study|Other|0|||
33551979|NCT01018953|101920143|FG000|Overall Study|Adverse Event|2|||
33551980|NCT01018953|101920143|FG000|Overall Study|Withdrawal by Subject|1|||
33351529|NCT01879410|101172442|FG000|Overall Study|Adverse Event|9|||
33351530|NCT01879410|101172443|FG001|Overall Study|Adverse Event|14|||
33351531|NCT01879410|101172442|FG000|Overall Study|Lack of Efficacy|4|||
33351532|NCT01879410|101172443|FG001|Overall Study|Lack of Efficacy|6|||
33351533|NCT01879410|101172442|FG000|Overall Study|Protocol Violation|1|||
33351534|NCT01879410|101172443|FG001|Overall Study|Protocol Violation|7|||
33351535|NCT01879410|101172442|FG000|Overall Study|Lost to Follow-up|2|||
33351536|NCT01879410|101172443|FG001|Overall Study|Lost to Follow-up|1|||
33351537|NCT01879410|101172442|FG000|Overall Study|Withdrawal by Subject|7|||
33351538|NCT01879410|101172443|FG001|Overall Study|Withdrawal by Subject|8|||
33351539|NCT01879410|101172442|FG000|Overall Study|Randomised in Error|1|||
33351540|NCT01879410|101172443|FG001|Overall Study|Randomised in Error|2|||
33351541|NCT00484315|101172444|FG000|12-Month Clinical Follow-up|Death|6|||
33551981|NCT01018953|101920143|FG000|Overall Study|Study termination by sponsor|5|||
33551982|NCT02755090|101920144|FG000|Overall Study|equipment malfunction|1|||
33551983|NCT02755090|101920145|FG001|Overall Study|equipment malfunction|0|||
33551984|NCT00327171|101920148|FG000|Overall Study|Did not receive study medication|3|||
33551985|NCT00327171|101920149|FG001|Overall Study|Did not receive study medication|0|||
33551986|NCT00327171|101920148|FG000|Overall Study|Adverse Event|23|||
33551987|NCT00327171|101920149|FG001|Overall Study|Adverse Event|23|||
33551988|NCT00327171|101920148|FG000|Overall Study|Disease progression/lack of efficacy|68|||
33551989|NCT00327171|101920149|FG001|Overall Study|Disease progression/lack of efficacy|69|||
33551990|NCT00327171|101920148|FG000|Overall Study|Investigator/participant request|1|||
33551991|NCT00327171|101920149|FG001|Overall Study|Investigator/participant request|8|||
33551992|NCT00327171|101920148|FG000|Overall Study|Clinical progression|12|||
33551993|NCT00327171|101920149|FG001|Overall Study|Clinical progression|8|||
33351542|NCT00484315|101172445|FG001|12-Month Clinical Follow-up|Death|2|||
33351543|NCT00484315|101172444|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
33351544|NCT00484315|101172445|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
33351545|NCT00484315|101172444|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
33351546|NCT00484315|101172445|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
33351547|NCT00484315|101172444|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
33351548|NCT00484315|101172445|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
33551994|NCT00327171|101920148|FG000|Overall Study|Undisclosed history of ischemia|0|||
33551995|NCT00327171|101920149|FG001|Overall Study|Undisclosed history of ischemia|1|||
33551996|NCT00327171|101920148|FG000|Overall Study|Other|1|||
33551997|NCT00327171|101920149|FG001|Overall Study|Other|0|||
33551998|NCT01155323|101920152|FG000|First Intervention|exclusion criteria|1|||
33551999|NCT01155323|101920153|FG001|First Intervention|exclusion criteria|1|||
33351549|NCT00484315|101172444|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
33351550|NCT00484315|101172445|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
33351551|NCT00484315|101172444|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
33351552|NCT00484315|101172445|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
33351553|NCT00484315|101172444|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
33351554|NCT00484315|101172445|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
33351555|NCT05047523|101172446|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
33351556|NCT05047523|101172447|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
33351557|NCT05047523|101172448|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
33351558|NCT05047523|101172449|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
33351559|NCT05047523|101172450|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
33351560|NCT05047523|101172451|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
33351561|NCT05047523|101172446|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
33618932|NCT00687804|102151684|FG002|Open-Label Extension Study|Administrative problems|0|||
33618933|NCT00687804|102151682|FG000|Open-Label Extension Study|Death|2|||
33618934|NCT00687804|102151683|FG001|Open-Label Extension Study|Death|3|||
33618935|NCT00687804|102151684|FG002|Open-Label Extension Study|Death|3|||
33618936|NCT05307692|102151687|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
33618937|NCT05307692|102151688|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
33618938|NCT05307692|102151689|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
33618939|NCT05307692|102151690|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
33618940|NCT05307692|102151687|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
33631299|NCT03486912|102202917|FG003|Treatment Period|Withdrawal by Subject|2|||
33492116|NCT03052751|101693896|FG002|Dosing Period 1|Adverse Event|0|||
33492117|NCT03052751|101693897|FG003|Dosing Period 1|Adverse Event|0|||
33492118|NCT03052751|101693898|FG004|Dosing Period 1|Adverse Event|0|||
33492119|NCT03052751|101693899|FG005|Dosing Period 1|Adverse Event|0|||
33492120|NCT03052751|101693894|FG000|Dosing Period 2|Adverse Event|0|||
33492121|NCT03052751|101693895|FG001|Dosing Period 2|Adverse Event|0|||
33492122|NCT03052751|101693896|FG002|Dosing Period 2|Adverse Event|3|||
33492123|NCT03052751|101693897|FG003|Dosing Period 2|Adverse Event|0|||
33492124|NCT03052751|101693898|FG004|Dosing Period 2|Adverse Event|0|||
33492125|NCT03052751|101693899|FG005|Dosing Period 2|Adverse Event|0|||
33492126|NCT03052751|101693894|FG000|Observation Period|Adverse Event|0|||
33492127|NCT03052751|101693895|FG001|Observation Period|Adverse Event|0|||
33492128|NCT03052751|101693896|FG002|Observation Period|Adverse Event|0|||
33492129|NCT03052751|101693897|FG003|Observation Period|Adverse Event|0|||
33492130|NCT03052751|101693898|FG004|Observation Period|Adverse Event|1|||
33492131|NCT03052751|101693899|FG005|Observation Period|Adverse Event|0|||
33492132|NCT03238651|101693903|FG000|Overall Study|Other|0|||
33492133|NCT03238651|101693904|FG001|Overall Study|Other|0|||
33492134|NCT03238651|101693905|FG002|Overall Study|Other|0|||
33492135|NCT03238651|101693906|FG003|Overall Study|Other|0|||
33492136|NCT03238651|101693907|FG004|Overall Study|Other|1|||
33492137|NCT03238651|101693903|FG000|Overall Study|Progressive Disease|2|||
33492138|NCT03238651|101693904|FG001|Overall Study|Progressive Disease|2|||
33492139|NCT03238651|101693905|FG002|Overall Study|Progressive Disease|2|||
33492140|NCT03238651|101693906|FG003|Overall Study|Progressive Disease|2|||
33492141|NCT03238651|101693907|FG004|Overall Study|Progressive Disease|0|||
33492142|NCT03238651|101693903|FG000|Overall Study|Withdrawal by Subject|0|||
33492143|NCT03238651|101693904|FG001|Overall Study|Withdrawal by Subject|1|||
33492144|NCT03238651|101693905|FG002|Overall Study|Withdrawal by Subject|0|||
33492145|NCT03238651|101693906|FG003|Overall Study|Withdrawal by Subject|1|||
33492146|NCT03238651|101693907|FG004|Overall Study|Withdrawal by Subject|0|||
33492147|NCT03238651|101693903|FG000|Overall Study|Adverse Event|1|||
33492148|NCT03238651|101693904|FG001|Overall Study|Adverse Event|3|||
33492149|NCT03238651|101693905|FG002|Overall Study|Adverse Event|2|||
33492150|NCT03238651|101693906|FG003|Overall Study|Adverse Event|0|||
33492151|NCT03238651|101693907|FG004|Overall Study|Adverse Event|0|||
33492152|NCT02115607|101693916|FG000|Overall Study|Withdrawal by Subject|1|||
33492153|NCT00725920|101693917|FG000|Overall Study|Lack of Efficacy|3|||
33492154|NCT00725920|101693918|FG001|Overall Study|Lack of Efficacy|6|||
33492155|NCT02654054|101693919|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
33492156|NCT02654054|101693920|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
33492157|NCT02654054|101693921|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
33492158|NCT02654054|101693919|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
33492159|NCT02654054|101693920|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33492160|NCT02654054|101693921|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
33492161|NCT02654054|101693919|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
33492162|NCT02654054|101693920|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
33492163|NCT02654054|101693921|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
33411712|NCT03358407|101397171|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33411713|NCT03358407|101397172|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33552000|NCT01155323|101920152|FG000|Second Intervention|Lost to Follow-up|1|||
33552001|NCT01155323|101920153|FG001|Second Intervention|Lost to Follow-up|1|||
33552002|NCT03111732|101920155|FG000|Overall Study|Enrolled in different study|1|||
33552003|NCT03111732|101920155|FG000|Overall Study|Progressive disease|3|||
33552004|NCT03111732|101920155|FG000|Overall Study|Withdrawal by Subject|1|||
33552005|NCT02134028|101920156|FG000|Overall Study|Lack of Efficacy|1|||
33552006|NCT02134028|101920157|FG001|Overall Study|Lack of Efficacy|0|||
33552007|NCT02134028|101920158|FG002|Overall Study|Lack of Efficacy|3|||
33552008|NCT02134028|101920159|FG003|Overall Study|Lack of Efficacy|2|||
33618941|NCT05307692|102151688|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
33618942|NCT05307692|102151689|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
33618943|NCT05307692|102151690|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
33618944|NCT05307692|102151687|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
33217565|NCT00696384|100692470|FG000|Open Label Phase|Withdrawal by Subject|37|||
33351562|NCT05047523|101172447|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
33351563|NCT05047523|101172448|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
33351564|NCT05047523|101172449|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
33351565|NCT05047523|101172450|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
33351566|NCT05047523|101172451|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
33351567|NCT05047523|101172446|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
33351568|NCT05047523|101172447|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
33351569|NCT05047523|101172448|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
33351570|NCT05047523|101172449|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
33351571|NCT05047523|101172450|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
33351572|NCT05047523|101172451|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
33351573|NCT05047523|101172446|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
33351574|NCT05047523|101172447|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
33351575|NCT05047523|101172448|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
33351576|NCT05047523|101172449|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
33351577|NCT05047523|101172450|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
33351578|NCT05047523|101172451|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
33351579|NCT05047523|101172446|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
33351580|NCT05047523|101172447|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
33351581|NCT05047523|101172448|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
33351582|NCT05047523|101172449|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
33351583|NCT05047523|101172450|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
33351584|NCT05047523|101172451|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
33351585|NCT05047523|101172446|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
33351586|NCT05047523|101172447|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
33351587|NCT05047523|101172448|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
33351588|NCT05047523|101172449|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
33351589|NCT05047523|101172450|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
33351590|NCT05047523|101172451|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
33351591|NCT02658448|101172452|FG000|Overall Study|Lost to Follow-up|1|||
33351592|NCT00008385|101172453|FG000|Overall Study|Off treatment reasons not reported|79|||
33351593|NCT00008385|101172454|FG001|Overall Study|Off treatment reasons not reported|70|||
33351594|NCT00008385|101172453|FG000|Overall Study|Progressive disease|52|||
33217566|NCT00696384|100692471|FG001|Open Label Phase|Withdrawal by Subject|0|||
33217567|NCT00696384|100692472|FG002|Open Label Phase|Withdrawal by Subject|0|||
33217568|NCT00696384|100692470|FG000|Open Label Phase|Other|6|||
33217569|NCT00696384|100692471|FG001|Open Label Phase|Other|0|||
33351595|NCT00008385|101172454|FG001|Overall Study|Progressive disease|117|||
33351596|NCT00008385|101172453|FG000|Overall Study|Adverse Event|8|||
33351597|NCT00008385|101172454|FG001|Overall Study|Adverse Event|20|||
33411714|NCT03358407|101397173|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33411715|NCT03358407|101397164|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33411716|NCT03358407|101397165|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33411717|NCT03358407|101397166|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33217570|NCT00696384|100692472|FG002|Open Label Phase|Other|0|||
33351598|NCT00008385|101172453|FG000|Overall Study|Death|12|||
33552009|NCT02134028|101920160|FG004|Overall Study|Lack of Efficacy|1|||
33217571|NCT00696384|100692470|FG000|Open Label Phase|Lack of Efficacy|3|||
33351599|NCT00008385|101172454|FG001|Overall Study|Death|18|||
33351600|NCT00008385|101172453|FG000|Overall Study|Withdrawal by Subject|67|||
33351601|NCT00008385|101172454|FG001|Overall Study|Withdrawal by Subject|157|||
33552010|NCT02134028|101920161|FG005|Overall Study|Lack of Efficacy|2|||
33217572|NCT00696384|100692471|FG001|Open Label Phase|Lack of Efficacy|0|||
33411718|NCT03358407|101397167|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33411719|NCT03358407|101397168|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33411720|NCT03358407|101397169|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
33411721|NCT03358407|101397170|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33411722|NCT03358407|101397171|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
33411723|NCT03358407|101397172|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33351602|NCT00008385|101172453|FG000|Overall Study|Start non-protocol therapy|3|||
33351603|NCT00008385|101172454|FG001|Overall Study|Start non-protocol therapy|1|||
33351604|NCT00008385|101172453|FG000|Overall Study|Other complicating disease|17|||
33351605|NCT00008385|101172454|FG001|Overall Study|Other complicating disease|30|||
33411724|NCT03358407|101397173|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
33411725|NCT03358407|101397164|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33552011|NCT02134028|101920162|FG006|Overall Study|Lack of Efficacy|1|||
33618945|NCT05307692|102151688|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
33618946|NCT05307692|102151689|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
33351606|NCT00008385|101172453|FG000|Overall Study|Maximum dose reached|0|||
33351607|NCT00008385|101172454|FG001|Overall Study|Maximum dose reached|2|||
33351608|NCT00008385|101172453|FG000|Overall Study|Other|105|||
33351609|NCT00008385|101172454|FG001|Overall Study|Other|212|||
33351610|NCT00008385|101172453|FG000|Overall Study|Not start protocol therapy|44|||
33351611|NCT00008385|101172454|FG001|Overall Study|Not start protocol therapy|175|||
33351612|NCT03502330|101172455|FG000|Overall Study|Adverse Event|2|||
33351613|NCT03502330|101172456|FG001|Overall Study|Adverse Event|1|||
33351614|NCT03502330|101172457|FG002|Overall Study|Adverse Event|0|||
33351615|NCT03502330|101172458|FG003|Overall Study|Adverse Event|0|||
33351616|NCT03502330|101172459|FG004|Overall Study|Adverse Event|1|||
33411726|NCT03358407|101397165|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33552012|NCT02134028|101920163|FG007|Overall Study|Lack of Efficacy|0|||
33552013|NCT02134028|101920156|FG000|Overall Study|Poor compliance to protocol|1|||
33552014|NCT02134028|101920157|FG001|Overall Study|Poor compliance to protocol|1|||
33552015|NCT02134028|101920158|FG002|Overall Study|Poor compliance to protocol|3|||
33552016|NCT02134028|101920159|FG003|Overall Study|Poor compliance to protocol|7|||
33552017|NCT02134028|101920160|FG004|Overall Study|Poor compliance to protocol|1|||
33552018|NCT02134028|101920161|FG005|Overall Study|Poor compliance to protocol|1|||
33618947|NCT05307692|102151690|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
33618948|NCT05307692|102151687|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
33618949|NCT05307692|102151688|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
33618950|NCT05307692|102151689|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
33618951|NCT05307692|102151690|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
33618952|NCT05307692|102151687|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
33618953|NCT05307692|102151688|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
33618954|NCT05307692|102151689|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
33618955|NCT05307692|102151690|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
33618956|NCT05307692|102151687|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
33351617|NCT03502330|101172460|FG005|Overall Study|Adverse Event|0|||
33552019|NCT02134028|101920162|FG006|Overall Study|Poor compliance to protocol|0|||
33351618|NCT03502330|101172461|FG006|Overall Study|Adverse Event|1|||
33351619|NCT03502330|101172462|FG007|Overall Study|Adverse Event|1|||
33351620|NCT03502330|101172463|FG008|Overall Study|Adverse Event|0|||
33552020|NCT02134028|101920163|FG007|Overall Study|Poor compliance to protocol|0|||
33552021|NCT02134028|101920156|FG000|Overall Study|Other unspecified|4|||
33411727|NCT03358407|101397166|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33411728|NCT03358407|101397167|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33411729|NCT03358407|101397168|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33411730|NCT03358407|101397169|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
33411731|NCT03358407|101397170|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33411732|NCT03358407|101397171|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
33411733|NCT03358407|101397172|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33411734|NCT03358407|101397173|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
33351621|NCT03502330|101172455|FG000|Overall Study|Lack of Efficacy|1|||
33351622|NCT03502330|101172456|FG001|Overall Study|Lack of Efficacy|5|||
33411735|NCT03358407|101397164|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33411736|NCT03358407|101397165|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33618957|NCT05307692|102151688|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
33618958|NCT05307692|102151689|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
33618959|NCT05307692|102151690|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
33618960|NCT05307692|102151687|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
33552022|NCT02134028|101920157|FG001|Overall Study|Other unspecified|22|||
33552023|NCT02134028|101920158|FG002|Overall Study|Other unspecified|33|||
33552024|NCT02134028|101920159|FG003|Overall Study|Other unspecified|64|||
33552025|NCT02134028|101920160|FG004|Overall Study|Other unspecified|8|||
33552026|NCT02134028|101920161|FG005|Overall Study|Other unspecified|6|||
33217573|NCT00696384|100692472|FG002|Open Label Phase|Lack of Efficacy|0|||
33217574|NCT00696384|100692470|FG000|Open Label Phase|Physician Decision|4|||
33217575|NCT00696384|100692471|FG001|Open Label Phase|Physician Decision|0|||
33217576|NCT00696384|100692472|FG002|Open Label Phase|Physician Decision|0|||
33351623|NCT03502330|101172457|FG002|Overall Study|Lack of Efficacy|3|||
33618961|NCT05307692|102151688|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
33618962|NCT05307692|102151689|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
33618963|NCT05307692|102151690|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
33618964|NCT05307692|102151687|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
33618965|NCT05307692|102151688|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
33618966|NCT05307692|102151689|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
33618967|NCT05307692|102151690|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
33618968|NCT01496469|102151692|FG000|Overall Study|Adverse Event|1|||
33411737|NCT03358407|101397166|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33411738|NCT03358407|101397167|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33411739|NCT03358407|101397168|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33552027|NCT02134028|101920162|FG006|Overall Study|Other unspecified|2|||
33552028|NCT02134028|101920163|FG007|Overall Study|Other unspecified|1|||
33552029|NCT02134028|101920156|FG000|Overall Study|Adverse Event|3|||
33351624|NCT03502330|101172458|FG003|Overall Study|Lack of Efficacy|5|||
33351625|NCT03502330|101172459|FG004|Overall Study|Lack of Efficacy|1|||
33351626|NCT03502330|101172460|FG005|Overall Study|Lack of Efficacy|5|||
33351627|NCT03502330|101172461|FG006|Overall Study|Lack of Efficacy|5|||
33351628|NCT03502330|101172462|FG007|Overall Study|Lack of Efficacy|6|||
33351629|NCT03502330|101172463|FG008|Overall Study|Lack of Efficacy|0|||
33411740|NCT03358407|101397169|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
33552030|NCT02134028|101920157|FG001|Overall Study|Adverse Event|19|||
33618969|NCT01496469|102151693|FG001|Overall Study|Adverse Event|0|||
33618970|NCT01496469|102151692|FG000|Overall Study|Protocol Violation|2|||
33618971|NCT01496469|102151693|FG001|Overall Study|Protocol Violation|0|||
33618972|NCT01496469|102151692|FG000|Overall Study|Lost to Follow-up|1|||
33552031|NCT02134028|101920158|FG002|Overall Study|Adverse Event|13|||
33552032|NCT02134028|101920159|FG003|Overall Study|Adverse Event|32|||
33552033|NCT02134028|101920160|FG004|Overall Study|Adverse Event|4|||
33552034|NCT02134028|101920161|FG005|Overall Study|Adverse Event|5|||
33552035|NCT02134028|101920162|FG006|Overall Study|Adverse Event|1|||
33552036|NCT02134028|101920163|FG007|Overall Study|Adverse Event|2|||
33552037|NCT00629239|101920164|FG000|Overall Study|Adverse Event|7|||
33552038|NCT00629239|101920165|FG001|Overall Study|Adverse Event|4|||
33618973|NCT01496469|102151693|FG001|Overall Study|Lost to Follow-up|1|||
33552039|NCT00629239|101920164|FG000|Overall Study|Physician Decision|1|||
33351630|NCT03502330|101172455|FG000|Overall Study|Physician Decision|0|||
33351631|NCT03502330|101172456|FG001|Overall Study|Physician Decision|0|||
33351632|NCT03502330|101172457|FG002|Overall Study|Physician Decision|0|||
33552040|NCT00629239|101920165|FG001|Overall Study|Physician Decision|0|||
33552041|NCT00397930|101920171|FG000|Overall Study|Personal reasons|14|||
33552042|NCT00397930|101920172|FG001|Overall Study|Personal reasons|8|||
33217577|NCT00696384|100692470|FG000|Double Blind Phase|Adverse Event|0|||
33217578|NCT00696384|100692471|FG001|Double Blind Phase|Adverse Event|2|||
33217579|NCT00696384|100692472|FG002|Double Blind Phase|Adverse Event|2|||
33217580|NCT00696384|100692470|FG000|Double Blind Phase|Lost to Follow-up|0|||
33217581|NCT00696384|100692471|FG001|Double Blind Phase|Lost to Follow-up|2|||
33217582|NCT00696384|100692472|FG002|Double Blind Phase|Lost to Follow-up|1|||
33217583|NCT00696384|100692470|FG000|Double Blind Phase|Withdrawal by Subject|0|||
33217584|NCT00696384|100692471|FG001|Double Blind Phase|Withdrawal by Subject|4|||
33217585|NCT00696384|100692472|FG002|Double Blind Phase|Withdrawal by Subject|3|||
33217586|NCT00696384|100692470|FG000|Double Blind Phase|Lack of Efficacy|0|||
33217587|NCT00696384|100692471|FG001|Double Blind Phase|Lack of Efficacy|1|||
33217588|NCT00696384|100692472|FG002|Double Blind Phase|Lack of Efficacy|0|||
33217589|NCT00696384|100692470|FG000|Double Blind Phase|Physician Decision|0|||
33217590|NCT00696384|100692471|FG001|Double Blind Phase|Physician Decision|2|||
33217591|NCT00696384|100692472|FG002|Double Blind Phase|Physician Decision|0|||
33217592|NCT04918784|100692475|FG000|Overall Study|Amputation - no longer eligible|1|||
33217593|NCT04918784|100692476|FG001|Overall Study|Amputation - no longer eligible|2|||
33217594|NCT04918784|100692475|FG000|Overall Study|Death|1|||
33217595|NCT04918784|100692476|FG001|Overall Study|Death|0|||
33217596|NCT04918784|100692475|FG000|Overall Study|patient non-compliance|3|||
33217597|NCT04918784|100692476|FG001|Overall Study|patient non-compliance|1|||
33217598|NCT04918784|100692475|FG000|Overall Study|Adverse Event|1|||
33217599|NCT04918784|100692476|FG001|Overall Study|Adverse Event|0|||
33217600|NCT01132326|100692477|FG000|Overall Study|Lack of Efficacy|25|||
33217601|NCT01132326|100692477|FG000|Overall Study|Adverse Event|37|||
33217602|NCT01132326|100692477|FG000|Overall Study|Protocol Violation|1|||
33217603|NCT01132326|100692477|FG000|Overall Study|Lost to Follow-up|16|||
33217604|NCT01132326|100692477|FG000|Overall Study|Withdrawal by Subject|40|||
33217605|NCT01132326|100692477|FG000|Overall Study|Physician Decision|10|||
33217606|NCT01132326|100692477|FG000|Overall Study|Study Termination|80|||
33217607|NCT01132326|100692477|FG000|Overall Study|Declining Health|1|||
33217608|NCT01132326|100692477|FG000|Overall Study|Pregnancy|1|||
33351633|NCT03502330|101172458|FG003|Overall Study|Physician Decision|0|||
33351634|NCT03502330|101172459|FG004|Overall Study|Physician Decision|1|||
33351635|NCT03502330|101172460|FG005|Overall Study|Physician Decision|0|||
33351636|NCT03502330|101172461|FG006|Overall Study|Physician Decision|0|||
33552043|NCT00397930|101920171|FG000|Overall Study|Other medical|9|||
33552044|NCT00397930|101920172|FG001|Overall Study|Other medical|4|||
33552045|NCT00397930|101920171|FG000|Overall Study|Unknown reasons|9|||
33552046|NCT00397930|101920172|FG001|Overall Study|Unknown reasons|14|||
33351637|NCT03502330|101172462|FG007|Overall Study|Physician Decision|0|||
33351638|NCT03502330|101172463|FG008|Overall Study|Physician Decision|0|||
33351639|NCT03502330|101172455|FG000|Overall Study|Withdrawal by Subject|0|||
33552047|NCT00397930|101920171|FG000|Overall Study|Noncompliant|3|||
33552048|NCT00397930|101920172|FG001|Overall Study|Noncompliant|2|||
33552049|NCT00397930|101920171|FG000|Overall Study|Too time-consuming|2|||
33552050|NCT00397930|101920172|FG001|Overall Study|Too time-consuming|9|||
33552051|NCT00397930|101920171|FG000|Overall Study|Started own yoga program|1|||
33552052|NCT00397930|101920172|FG001|Overall Study|Started own yoga program|1|||
33552053|NCT00397930|101920171|FG000|Overall Study|Did not want to be in control group|0|||
33552054|NCT00397930|101920172|FG001|Overall Study|Did not want to be in control group|1|||
33552055|NCT00397930|101920171|FG000|Overall Study|Withdrawal by Subject|0|||
33552056|NCT00397930|101920172|FG001|Overall Study|Withdrawal by Subject|8|||
33552057|NCT00397930|101920171|FG000|Overall Study|Missing data|0|||
33552058|NCT00397930|101920172|FG001|Overall Study|Missing data|4|||
33552059|NCT02762604|101920173|FG000|Overall Study|Lost to Follow-up|2|||
33618974|NCT01496469|102151692|FG000|Overall Study|Withdrawal by Subject|4|||
33618975|NCT01496469|102151693|FG001|Overall Study|Withdrawal by Subject|4|||
33552060|NCT02762604|101920174|FG001|Overall Study|Lost to Follow-up|7|||
33552061|NCT02762604|101920173|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
33552062|NCT02762604|101920174|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
33351640|NCT03502330|101172456|FG001|Overall Study|Withdrawal by Subject|0|||
33351641|NCT03502330|101172457|FG002|Overall Study|Withdrawal by Subject|0|||
33351642|NCT03502330|101172458|FG003|Overall Study|Withdrawal by Subject|0|||
33351643|NCT03502330|101172459|FG004|Overall Study|Withdrawal by Subject|0|||
33351644|NCT03502330|101172460|FG005|Overall Study|Withdrawal by Subject|1|||
33351645|NCT03502330|101172461|FG006|Overall Study|Withdrawal by Subject|0|||
33351646|NCT03502330|101172462|FG007|Overall Study|Withdrawal by Subject|1|||
33351647|NCT03502330|101172463|FG008|Overall Study|Withdrawal by Subject|0|||
33351648|NCT03502330|101172455|FG000|Overall Study|Death|0|||
33351649|NCT03502330|101172456|FG001|Overall Study|Death|0|||
33351650|NCT03502330|101172457|FG002|Overall Study|Death|0|||
33351651|NCT03502330|101172458|FG003|Overall Study|Death|0|||
33351652|NCT03502330|101172459|FG004|Overall Study|Death|0|||
33351653|NCT03502330|101172460|FG005|Overall Study|Death|0|||
33351654|NCT03502330|101172461|FG006|Overall Study|Death|2|||
33351655|NCT03502330|101172462|FG007|Overall Study|Death|0|||
33351656|NCT03502330|101172463|FG008|Overall Study|Death|0|||
33217609|NCT01132326|100692477|FG000|Overall Study|Caregiver Withdrew Consent|1|||
33217610|NCT01132326|100692477|FG000|Overall Study|Death|5|||
33217611|NCT01132326|100692477|FG000|Overall Study|Subject Unable to Come To Visits|1|||
33224372|NCT05044325|100721813|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
33224373|NCT05044325|100721814|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
33351657|NCT03403400|101172467|FG000|Overall Study|Lost to Follow-up|1|||
33351658|NCT03403400|101172468|FG001|Overall Study|Lost to Follow-up|0|||
33351659|NCT03403400|101172469|FG002|Overall Study|Lost to Follow-up|1|||
33351660|NCT03403400|101172467|FG000|Overall Study|Hospitalization|1|||
33224374|NCT05044325|100721815|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
33224375|NCT05044325|100721816|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
33224376|NCT05044325|100721817|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
33224377|NCT05044325|100721818|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
33224378|NCT05044325|100721819|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
33224379|NCT05044325|100721820|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
33224380|NCT05044325|100721811|FG000|Part A:Treatment Period 1|Physician Decision|0|||
33224381|NCT05044325|100721812|FG001|Part A:Treatment Period 1|Physician Decision|0|||
33351661|NCT03403400|101172468|FG001|Overall Study|Hospitalization|0|||
33351662|NCT03403400|101172469|FG002|Overall Study|Hospitalization|0|||
33351663|NCT03403400|101172467|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
33224382|NCT05044325|100721813|FG002|Part A:Treatment Period 1|Physician Decision|0|||
33224383|NCT05044325|100721814|FG003|Part A:Treatment Period 1|Physician Decision|0|||
33351664|NCT03403400|101172468|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
33351665|NCT03403400|101172469|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
33351666|NCT01023789|101172470|FG000|3 - Year Visit|Death|29|||
33351667|NCT01023789|101172470|FG000|3 - Year Visit|Withdrawal of consent|1|||
33351668|NCT01023789|101172470|FG000|3 - Year Visit|Lost to Follow-up|13|||
33351669|NCT01324830|101172471|FG000|Overall Study|Progressive Disease|3|||
33351670|NCT01324830|101172472|FG001|Overall Study|Progressive Disease|2|||
33351671|NCT01324830|101172473|FG002|Overall Study|Progressive Disease|3|||
33552063|NCT03679884|101920180|FG000|Overall Study|Other|12|||
33224384|NCT05044325|100721815|FG004|Part A:Treatment Period 1|Physician Decision|0|||
33552064|NCT03679884|101920181|FG001|Overall Study|Other|12|||
33552065|NCT03679884|101920182|FG002|Overall Study|Other|12|||
33552066|NCT03679884|101920183|FG003|Overall Study|Other|7|||
33552067|NCT03679884|101920184|FG004|Overall Study|Other|8|||
33552068|NCT03679884|101920180|FG000|Overall Study|Lack of Efficacy|15|||
33552069|NCT03679884|101920181|FG001|Overall Study|Lack of Efficacy|29|||
33552070|NCT03679884|101920182|FG002|Overall Study|Lack of Efficacy|13|||
33552071|NCT03679884|101920183|FG003|Overall Study|Lack of Efficacy|29|||
33552072|NCT03679884|101920184|FG004|Overall Study|Lack of Efficacy|10|||
33552073|NCT03679884|101920180|FG000|Overall Study|Death|1|||
33552074|NCT03679884|101920181|FG001|Overall Study|Death|0|||
33552075|NCT03679884|101920182|FG002|Overall Study|Death|0|||
33552076|NCT03679884|101920183|FG003|Overall Study|Death|0|||
33618976|NCT01496469|102151692|FG000|Overall Study|BP exceeds protocol limits|1|||
33351672|NCT01324830|101172474|FG003|Overall Study|Progressive Disease|3|||
33351673|NCT01324830|101172475|FG004|Overall Study|Progressive Disease|6|||
33351674|NCT01324830|101172476|FG005|Overall Study|Progressive Disease|6|||
33351675|NCT01324830|101172477|FG006|Overall Study|Progressive Disease|3|||
33351676|NCT01324830|101172478|FG007|Overall Study|Progressive Disease|3|||
33351677|NCT01324830|101172479|FG008|Overall Study|Progressive Disease|3|||
33351678|NCT01324830|101172480|FG009|Overall Study|Progressive Disease|6|||
33351679|NCT01324830|101172481|FG010|Overall Study|Progressive Disease|2|||
33552077|NCT03679884|101920184|FG004|Overall Study|Death|0|||
33552078|NCT03679884|101920180|FG000|Overall Study|Adverse Event|2|||
33552079|NCT03679884|101920181|FG001|Overall Study|Adverse Event|10|||
33351680|NCT01324830|101172482|FG011|Overall Study|Progressive Disease|1|||
33351681|NCT01324830|101172483|FG012|Overall Study|Progressive Disease|1|||
33552080|NCT03679884|101920182|FG002|Overall Study|Adverse Event|9|||
33618977|NCT01496469|102151693|FG001|Overall Study|BP exceeds protocol limits|2|||
33552081|NCT03679884|101920183|FG003|Overall Study|Adverse Event|6|||
33552082|NCT03679884|101920184|FG004|Overall Study|Adverse Event|6|||
33552083|NCT03679884|101920180|FG000|Overall Study|Withdrawal by Subject|12|||
33552084|NCT03679884|101920181|FG001|Overall Study|Withdrawal by Subject|23|||
33552085|NCT03679884|101920182|FG002|Overall Study|Withdrawal by Subject|8|||
33552086|NCT03679884|101920183|FG003|Overall Study|Withdrawal by Subject|8|||
33552087|NCT03679884|101920184|FG004|Overall Study|Withdrawal by Subject|9|||
33552088|NCT03679884|101920180|FG000|Overall Study|Lost to Follow-up|1|||
33552089|NCT03679884|101920181|FG001|Overall Study|Lost to Follow-up|4|||
33552090|NCT03679884|101920182|FG002|Overall Study|Lost to Follow-up|2|||
33552091|NCT03679884|101920183|FG003|Overall Study|Lost to Follow-up|0|||
33552092|NCT03679884|101920184|FG004|Overall Study|Lost to Follow-up|3|||
33552093|NCT02541903|101920185|FG000|Overall Study|Death|1|||
33552094|NCT04914000|101920186|FG000|Overall Study|Lost to Follow-up|8|||
33552095|NCT04914000|101920186|FG000|Overall Study|Withdrawal by Subject|1|||
33552096|NCT01531153|101920187|FG000|Overall Study|Withdrawal by Subject|10|||
33552097|NCT01531153|101920188|FG001|Overall Study|Withdrawal by Subject|9|||
33552098|NCT01531153|101920189|FG002|Overall Study|Withdrawal by Subject|15|||
33552099|NCT03467945|101920193|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33552100|NCT03467945|101920194|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33552101|NCT03467945|101920195|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33552102|NCT03467945|101920196|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33552103|NCT03467945|101920193|FG000|Treatment Period 3|Withdrawal by Subject|1|||
33552104|NCT03467945|101920194|FG001|Treatment Period 3|Withdrawal by Subject|0|||
33552105|NCT03467945|101920195|FG002|Treatment Period 3|Withdrawal by Subject|2|||
33552106|NCT03467945|101920196|FG003|Treatment Period 3|Withdrawal by Subject|1|||
33552107|NCT03158311|101920197|FG000|Overall Study|Subject/Guardian Decision|10|||
33217612|NCT04839965|100695805|FG000|Overall Study|Death|6|||
33217613|NCT04839965|100695806|FG001|Overall Study|Death|6|||
33217614|NCT04839965|100695805|FG000|Overall Study|Lost to Follow-up|1|||
33217615|NCT04839965|100695806|FG001|Overall Study|Lost to Follow-up|0|||
33351682|NCT01324830|101172484|FG013|Overall Study|Progressive Disease|1|||
33351683|NCT01324830|101172485|FG014|Overall Study|Progressive Disease|1|||
33351684|NCT01324830|101172486|FG015|Overall Study|Progressive Disease|3|||
33351685|NCT01324830|101172487|FG016|Overall Study|Progressive Disease|2|||
33351686|NCT01324830|101172488|FG017|Overall Study|Progressive Disease|3|||
33351687|NCT01324830|101172489|FG018|Overall Study|Progressive Disease|4|||
33351688|NCT01324830|101172471|FG000|Overall Study|Dose limiting toxicity|0|||
33351689|NCT01324830|101172472|FG001|Overall Study|Dose limiting toxicity|0|||
33351690|NCT01324830|101172473|FG002|Overall Study|Dose limiting toxicity|0|||
33351691|NCT01324830|101172474|FG003|Overall Study|Dose limiting toxicity|0|||
33351692|NCT01324830|101172475|FG004|Overall Study|Dose limiting toxicity|1|||
33351693|NCT01324830|101172476|FG005|Overall Study|Dose limiting toxicity|0|||
33351694|NCT01324830|101172477|FG006|Overall Study|Dose limiting toxicity|0|||
33351695|NCT01324830|101172478|FG007|Overall Study|Dose limiting toxicity|0|||
33351696|NCT01324830|101172479|FG008|Overall Study|Dose limiting toxicity|0|||
33351697|NCT01324830|101172480|FG009|Overall Study|Dose limiting toxicity|0|||
33351698|NCT01324830|101172481|FG010|Overall Study|Dose limiting toxicity|0|||
33351699|NCT01324830|101172482|FG011|Overall Study|Dose limiting toxicity|0|||
33351700|NCT01324830|101172483|FG012|Overall Study|Dose limiting toxicity|0|||
33351701|NCT01324830|101172484|FG013|Overall Study|Dose limiting toxicity|0|||
33351702|NCT01324830|101172485|FG014|Overall Study|Dose limiting toxicity|0|||
33217616|NCT00238433|100695807|FG000|Overall Study|Screen failure|1|||
33217617|NCT00238433|100695807|FG000|Overall Study|Lost to Follow-up|1|||
33217618|NCT00238433|100695807|FG000|Overall Study|Death|1|||
33217619|NCT02332720|100695808|FG000|Part A and Part B|Lost to Follow-up|1|||
33217620|NCT02332720|100695809|FG001|Part A and Part B|Lost to Follow-up|0|||
33217621|NCT02332720|100695810|FG002|Part A and Part B|Lost to Follow-up|0|||
33217622|NCT02332720|100695811|FG003|Part A and Part B|Lost to Follow-up|0|||
33351703|NCT01324830|101172486|FG015|Overall Study|Dose limiting toxicity|0|||
33351704|NCT01324830|101172487|FG016|Overall Study|Dose limiting toxicity|1|||
33217623|NCT02332720|100695812|FG004|Part A and Part B|Lost to Follow-up|0|||
33351705|NCT01324830|101172488|FG017|Overall Study|Dose limiting toxicity|1|||
33351706|NCT01324830|101172489|FG018|Overall Study|Dose limiting toxicity|1|||
33351707|NCT01324830|101172471|FG000|Overall Study|Reason not mentioned above|0|||
33351708|NCT01324830|101172472|FG001|Overall Study|Reason not mentioned above|0|||
33351709|NCT01324830|101172473|FG002|Overall Study|Reason not mentioned above|0|||
33552108|NCT03158311|101920198|FG001|Overall Study|Subject/Guardian Decision|6|||
33552109|NCT03158311|101920199|FG002|Overall Study|Subject/Guardian Decision|11|||
33552110|NCT03158311|101920197|FG000|Overall Study|Adverse Event|5|||
33552111|NCT03158311|101920198|FG001|Overall Study|Adverse Event|3|||
33552112|NCT03158311|101920199|FG002|Overall Study|Adverse Event|3|||
33552113|NCT03158311|101920197|FG000|Overall Study|Techinical Problems|3|||
33552114|NCT03158311|101920198|FG001|Overall Study|Techinical Problems|1|||
33351710|NCT01324830|101172474|FG003|Overall Study|Reason not mentioned above|0|||
33351711|NCT01324830|101172475|FG004|Overall Study|Reason not mentioned above|0|||
33217624|NCT02332720|100695813|FG005|Part A and Part B|Lost to Follow-up|2|||
33217625|NCT02332720|100695814|FG006|Part A and Part B|Lost to Follow-up|1|||
33217626|NCT02332720|100695815|FG007|Part A and Part B|Lost to Follow-up|1|||
33217627|NCT02332720|100695816|FG008|Part A and Part B|Lost to Follow-up|0|||
33217628|NCT02332720|100695817|FG009|Part A and Part B|Lost to Follow-up|0|||
33217629|NCT02332720|100695818|FG010|Part A and Part B|Lost to Follow-up|0|||
33217630|NCT02332720|100695819|FG011|Part A and Part B|Lost to Follow-up|0|||
33217631|NCT02332720|100695820|FG012|Part A and Part B|Lost to Follow-up|0|||
33217632|NCT02332720|100695821|FG013|Part A and Part B|Lost to Follow-up|0|||
33217633|NCT02332720|100695822|FG014|Part A and Part B|Lost to Follow-up|0|||
33217634|NCT02332720|100695823|FG015|Part A and Part B|Lost to Follow-up|1|||
33552115|NCT03158311|101920199|FG002|Overall Study|Techinical Problems|5|||
33552116|NCT03158311|101920197|FG000|Overall Study|Physician Decision|2|||
33552117|NCT03158311|101920198|FG001|Overall Study|Physician Decision|3|||
33552118|NCT03158311|101920199|FG002|Overall Study|Physician Decision|7|||
33552119|NCT03158311|101920197|FG000|Overall Study|Lost to Follow-up|1|||
33552120|NCT03158311|101920198|FG001|Overall Study|Lost to Follow-up|1|||
33217635|NCT02332720|100695824|FG016|Part A and Part B|Lost to Follow-up|0|||
33217636|NCT02332720|100695825|FG017|Part A and Part B|Lost to Follow-up|0|||
33217637|NCT02332720|100695826|FG018|Part A and Part B|Lost to Follow-up|0|||
33217638|NCT02332720|100695827|FG019|Part A and Part B|Lost to Follow-up|0|||
33217639|NCT02332720|100695828|FG020|Part A and Part B|Lost to Follow-up|0|||
33217640|NCT02332720|100695829|FG021|Part A and Part B|Lost to Follow-up|0|||
33217641|NCT02332720|100695830|FG022|Part A and Part B|Lost to Follow-up|0|||
33217642|NCT02332720|100695808|FG000|Part A and Part B|Adverse Event|0|||
33217643|NCT02332720|100695809|FG001|Part A and Part B|Adverse Event|0|||
33217644|NCT02332720|100695810|FG002|Part A and Part B|Adverse Event|0|||
33217645|NCT02332720|100695811|FG003|Part A and Part B|Adverse Event|0|||
33217646|NCT02332720|100695812|FG004|Part A and Part B|Adverse Event|0|||
33217647|NCT02332720|100695813|FG005|Part A and Part B|Adverse Event|0|||
33217648|NCT02332720|100695814|FG006|Part A and Part B|Adverse Event|0|||
33217649|NCT02332720|100695815|FG007|Part A and Part B|Adverse Event|0|||
33217650|NCT02332720|100695816|FG008|Part A and Part B|Adverse Event|0|||
33217651|NCT02332720|100695817|FG009|Part A and Part B|Adverse Event|0|||
33217652|NCT02332720|100695818|FG010|Part A and Part B|Adverse Event|0|||
33217653|NCT02332720|100695819|FG011|Part A and Part B|Adverse Event|0|||
33217654|NCT02332720|100695820|FG012|Part A and Part B|Adverse Event|0|||
33217655|NCT02332720|100695821|FG013|Part A and Part B|Adverse Event|0|||
33217656|NCT02332720|100695822|FG014|Part A and Part B|Adverse Event|0|||
33217657|NCT02332720|100695823|FG015|Part A and Part B|Adverse Event|0|||
33217658|NCT02332720|100695824|FG016|Part A and Part B|Adverse Event|0|||
33217659|NCT02332720|100695825|FG017|Part A and Part B|Adverse Event|1|||
33351712|NCT01324830|101172476|FG005|Overall Study|Reason not mentioned above|0|||
33351713|NCT01324830|101172477|FG006|Overall Study|Reason not mentioned above|0|||
33351714|NCT01324830|101172478|FG007|Overall Study|Reason not mentioned above|0|||
33351715|NCT01324830|101172479|FG008|Overall Study|Reason not mentioned above|0|||
33351716|NCT01324830|101172480|FG009|Overall Study|Reason not mentioned above|0|||
33351717|NCT01324830|101172481|FG010|Overall Study|Reason not mentioned above|0|||
33351718|NCT01324830|101172482|FG011|Overall Study|Reason not mentioned above|0|||
33351719|NCT01324830|101172483|FG012|Overall Study|Reason not mentioned above|0|||
33351720|NCT01324830|101172484|FG013|Overall Study|Reason not mentioned above|0|||
33351721|NCT01324830|101172485|FG014|Overall Study|Reason not mentioned above|0|||
33351722|NCT01324830|101172486|FG015|Overall Study|Reason not mentioned above|0|||
33351723|NCT01324830|101172487|FG016|Overall Study|Reason not mentioned above|0|||
33552121|NCT03158311|101920199|FG002|Overall Study|Lost to Follow-up|1|||
33552122|NCT03158311|101920197|FG000|Overall Study|Sponsor decision|1|||
33552123|NCT03158311|101920198|FG001|Overall Study|Sponsor decision|0|||
33552124|NCT03158311|101920199|FG002|Overall Study|Sponsor decision|0|||
33552125|NCT03158311|101920197|FG000|Overall Study|Pregnancy|0|||
33552126|NCT03158311|101920198|FG001|Overall Study|Pregnancy|2|||
33217660|NCT02332720|100695826|FG018|Part A and Part B|Adverse Event|0|||
33217661|NCT02332720|100695827|FG019|Part A and Part B|Adverse Event|0|||
33351724|NCT01324830|101172488|FG017|Overall Study|Reason not mentioned above|1|||
33351725|NCT01324830|101172489|FG018|Overall Study|Reason not mentioned above|0|||
33351726|NCT01324830|101172471|FG000|Overall Study|Adverse Event, serious fatal|0|||
33217662|NCT02332720|100695828|FG020|Part A and Part B|Adverse Event|0|||
33217663|NCT02332720|100695829|FG021|Part A and Part B|Adverse Event|0|||
33217664|NCT02332720|100695830|FG022|Part A and Part B|Adverse Event|0|||
33217665|NCT02332720|100695808|FG000|Part A and Part B|Physician Decision|0|||
33217666|NCT02332720|100695809|FG001|Part A and Part B|Physician Decision|0|||
33217667|NCT02332720|100695810|FG002|Part A and Part B|Physician Decision|0|||
33217668|NCT02332720|100695811|FG003|Part A and Part B|Physician Decision|0|||
33217669|NCT02332720|100695812|FG004|Part A and Part B|Physician Decision|0|||
33351727|NCT01324830|101172472|FG001|Overall Study|Adverse Event, serious fatal|1|||
33552127|NCT03158311|101920199|FG002|Overall Study|Pregnancy|0|||
33552128|NCT03158311|101920197|FG000|Overall Study|Randomized in error|0|||
33217670|NCT02332720|100695813|FG005|Part A and Part B|Physician Decision|0|||
33217671|NCT02332720|100695814|FG006|Part A and Part B|Physician Decision|0|||
33217672|NCT02332720|100695815|FG007|Part A and Part B|Physician Decision|0|||
33217673|NCT02332720|100695816|FG008|Part A and Part B|Physician Decision|0|||
33217674|NCT02332720|100695817|FG009|Part A and Part B|Physician Decision|0|||
33217675|NCT02332720|100695818|FG010|Part A and Part B|Physician Decision|0|||
33217676|NCT02332720|100695819|FG011|Part A and Part B|Physician Decision|0|||
33217677|NCT02332720|100695820|FG012|Part A and Part B|Physician Decision|0|||
33217678|NCT02332720|100695821|FG013|Part A and Part B|Physician Decision|0|||
33217679|NCT02332720|100695822|FG014|Part A and Part B|Physician Decision|0|||
33217680|NCT02332720|100695823|FG015|Part A and Part B|Physician Decision|0|||
33217681|NCT02332720|100695824|FG016|Part A and Part B|Physician Decision|0|||
33217682|NCT02332720|100695825|FG017|Part A and Part B|Physician Decision|0|||
33217683|NCT02332720|100695826|FG018|Part A and Part B|Physician Decision|1|||
33217684|NCT02332720|100695827|FG019|Part A and Part B|Physician Decision|0|||
33217685|NCT02332720|100695828|FG020|Part A and Part B|Physician Decision|0|||
33217686|NCT02332720|100695829|FG021|Part A and Part B|Physician Decision|0|||
33217687|NCT02332720|100695830|FG022|Part A and Part B|Physician Decision|0|||
33217688|NCT02332720|100695808|FG000|Part A and Part B|Withdrawal by Subject|0|||
33217689|NCT02332720|100695809|FG001|Part A and Part B|Withdrawal by Subject|0|||
33351728|NCT01324830|101172473|FG002|Overall Study|Adverse Event, serious fatal|0|||
33351729|NCT01324830|101172474|FG003|Overall Study|Adverse Event, serious fatal|0|||
33351730|NCT01324830|101172475|FG004|Overall Study|Adverse Event, serious fatal|0|||
33351731|NCT01324830|101172476|FG005|Overall Study|Adverse Event, serious fatal|0|||
33351732|NCT01324830|101172477|FG006|Overall Study|Adverse Event, serious fatal|0|||
33351733|NCT01324830|101172478|FG007|Overall Study|Adverse Event, serious fatal|0|||
33351734|NCT01324830|101172479|FG008|Overall Study|Adverse Event, serious fatal|0|||
33351735|NCT01324830|101172480|FG009|Overall Study|Adverse Event, serious fatal|0|||
33351736|NCT01324830|101172481|FG010|Overall Study|Adverse Event, serious fatal|0|||
33351737|NCT01324830|101172482|FG011|Overall Study|Adverse Event, serious fatal|0|||
33351738|NCT01324830|101172483|FG012|Overall Study|Adverse Event, serious fatal|0|||
33351739|NCT01324830|101172484|FG013|Overall Study|Adverse Event, serious fatal|0|||
33351740|NCT01324830|101172485|FG014|Overall Study|Adverse Event, serious fatal|0|||
33351741|NCT01324830|101172486|FG015|Overall Study|Adverse Event, serious fatal|0|||
33351742|NCT01324830|101172487|FG016|Overall Study|Adverse Event, serious fatal|0|||
33351743|NCT01324830|101172488|FG017|Overall Study|Adverse Event, serious fatal|0|||
33351744|NCT01324830|101172489|FG018|Overall Study|Adverse Event, serious fatal|0|||
33351745|NCT01324830|101172471|FG000|Overall Study|Adverse Event, non-fatal|0|||
33351746|NCT01324830|101172472|FG001|Overall Study|Adverse Event, non-fatal|0|||
33411741|NCT03358407|101397170|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
33411742|NCT03358407|101397171|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33411743|NCT03358407|101397172|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33411744|NCT03358407|101397173|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
33411745|NCT03358407|101397164|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
33552129|NCT03158311|101920198|FG001|Overall Study|Randomized in error|0|||
33552130|NCT03158311|101920199|FG002|Overall Study|Randomized in error|1|||
33552131|NCT01873833|101920200|FG000|Overall Study|Withdrawal by Subject|1|||
33552132|NCT03072875|101920203|FG000|Overall Study|Lost to Follow-up|1|||
33351747|NCT01324830|101172473|FG002|Overall Study|Adverse Event, non-fatal|0|||
33411746|NCT03358407|101397165|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
33552133|NCT04706403|101920204|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
33552134|NCT04706403|101920205|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
33552135|NCT04706403|101920206|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
33552136|NCT04706403|101920207|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
33351748|NCT01324830|101172474|FG003|Overall Study|Adverse Event, non-fatal|0|||
33217690|NCT02332720|100695810|FG002|Part A and Part B|Withdrawal by Subject|0|||
33217691|NCT02332720|100695811|FG003|Part A and Part B|Withdrawal by Subject|0|||
33217692|NCT02332720|100695812|FG004|Part A and Part B|Withdrawal by Subject|0|||
33217693|NCT02332720|100695813|FG005|Part A and Part B|Withdrawal by Subject|1|||
33217694|NCT02332720|100695814|FG006|Part A and Part B|Withdrawal by Subject|0|||
33217695|NCT02332720|100695815|FG007|Part A and Part B|Withdrawal by Subject|0|||
33217696|NCT02332720|100695816|FG008|Part A and Part B|Withdrawal by Subject|0|||
33411747|NCT03358407|101397166|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
33411748|NCT03358407|101397167|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
33411749|NCT03358407|101397168|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
33411750|NCT03358407|101397169|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
33411751|NCT03358407|101397170|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
33411752|NCT03358407|101397171|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
33411753|NCT03358407|101397172|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
33411754|NCT03358407|101397173|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
33411755|NCT03075826|101397178|FG000|Overall Study|Withdrawal by Subject|1|||
33411756|NCT03075826|101397178|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
33411757|NCT01339273|101397191|FG000|Overall Study|Lost to Follow-up|8|||
33411758|NCT01339273|101397192|FG001|Overall Study|Lost to Follow-up|8|||
33411759|NCT03329404|101397194|FG000|Overall Study|The study was suspended.|1|||
33411760|NCT03329404|101397195|FG001|Overall Study|The study was suspended.|4|||
33411761|NCT02184988|101397196|FG000|Overall Study|Pregnancy|2|||
33618978|NCT01496469|102151692|FG000|Overall Study|Other|1|||
33618979|NCT01496469|102151693|FG001|Overall Study|Other|1|||
33618980|NCT00871338|102151694|FG000|Prior to Booster|Withdrawal by Subject|1|||
33618981|NCT00871338|102151695|FG001|Prior to Booster|Withdrawal by Subject|3|||
33618982|NCT00871338|102151694|FG000|Prior to Booster|Lost to Follow-up|1|||
33618983|NCT00871338|102151695|FG001|Prior to Booster|Lost to Follow-up|0|||
33618984|NCT00226811|102151696|FG000|Overall Study|Death|8|||
33618985|NCT00226811|102151696|FG000|Overall Study|Adverse Event|11|||
33618986|NCT00226811|102151696|FG000|Overall Study|Lack of Efficacy|55|||
33618987|NCT00226811|102151696|FG000|Overall Study|Withdrawal by Subject|2|||
33618988|NCT03259087|102151697|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
33618989|NCT03259087|102151698|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
33618990|NCT03259087|102151699|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
33618991|NCT03259087|102151700|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
33351749|NCT01324830|101172475|FG004|Overall Study|Adverse Event, non-fatal|0|||
33351750|NCT01324830|101172476|FG005|Overall Study|Adverse Event, non-fatal|0|||
33351751|NCT01324830|101172477|FG006|Overall Study|Adverse Event, non-fatal|0|||
33351752|NCT01324830|101172478|FG007|Overall Study|Adverse Event, non-fatal|0|||
33351753|NCT01324830|101172479|FG008|Overall Study|Adverse Event, non-fatal|2|||
33351754|NCT01324830|101172480|FG009|Overall Study|Adverse Event, non-fatal|0|||
33351755|NCT01324830|101172481|FG010|Overall Study|Adverse Event, non-fatal|1|||
33351756|NCT01324830|101172482|FG011|Overall Study|Adverse Event, non-fatal|0|||
33618992|NCT03259087|102151701|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
33618993|NCT03259087|102151697|FG000|Period 2 of Part 2|Adverse Event|0|||
33618994|NCT03259087|102151698|FG001|Period 2 of Part 2|Adverse Event|0|||
33618995|NCT03259087|102151699|FG002|Period 2 of Part 2|Adverse Event|0|||
33618996|NCT03259087|102151700|FG003|Period 2 of Part 2|Adverse Event|0|||
33618997|NCT03259087|102151701|FG004|Period 2 of Part 2|Adverse Event|1|||
33618998|NCT03370718|102151704|FG000|Overall Study|Withdrawal by Subject|1|||
33618999|NCT02491983|102151707|FG000|Overall Study|Physician Decision|1|||
33619000|NCT02491983|102151708|FG001|Overall Study|Physician Decision|0|||
33619001|NCT02491983|102151707|FG000|Overall Study|Not meet selection criteria|1|||
33619002|NCT02491983|102151708|FG001|Overall Study|Not meet selection criteria|0|||
33619003|NCT02491983|102151707|FG000|Overall Study|Withdrawal by Subject|0|||
33619004|NCT02491983|102151708|FG001|Overall Study|Withdrawal by Subject|1|||
33351757|NCT01324830|101172483|FG012|Overall Study|Adverse Event, non-fatal|0|||
33411762|NCT02184988|101397196|FG000|Overall Study|Adverse Event|2|||
33411763|NCT02184988|101397196|FG000|Overall Study|moving away/travelling/unable to complet|6|||
33411764|NCT02184988|101397196|FG000|Overall Study|work scheduling issues|4|||
33351758|NCT01324830|101172484|FG013|Overall Study|Adverse Event, non-fatal|0|||
33351759|NCT01324830|101172485|FG014|Overall Study|Adverse Event, non-fatal|0|||
33411765|NCT02184988|101397196|FG000|Overall Study|various other reasons|9|||
33411766|NCT02184988|101397196|FG000|Overall Study|Lost to Follow-up|32|||
33411767|NCT00344968|101397197|FG000|Overall Study|Adverse Event|5|||
33619005|NCT03329092|102151709|FG000|Overall Study|Other|2|||
33619006|NCT03329092|102151710|FG001|Overall Study|Other|2|||
33619007|NCT03329092|102151709|FG000|Overall Study|Withdrawal by Subject|16|||
33619008|NCT03329092|102151710|FG001|Overall Study|Withdrawal by Subject|3|||
33619009|NCT03329092|102151709|FG000|Overall Study|Physician Decision|1|||
33619010|NCT03329092|102151710|FG001|Overall Study|Physician Decision|0|||
33351760|NCT01324830|101172486|FG015|Overall Study|Adverse Event, non-fatal|0|||
33351761|NCT01324830|101172487|FG016|Overall Study|Adverse Event, non-fatal|0|||
33351762|NCT01324830|101172488|FG017|Overall Study|Adverse Event, non-fatal|1|||
33351763|NCT01324830|101172489|FG018|Overall Study|Adverse Event, non-fatal|0|||
33351764|NCT01324830|101172471|FG000|Overall Study|Withdrawal by Subject|0|||
33411768|NCT00344968|101397198|FG001|Overall Study|Adverse Event|4|||
33411769|NCT00344968|101397199|FG002|Overall Study|Adverse Event|15|||
33411770|NCT00344968|101397197|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
33619011|NCT03329092|102151709|FG000|Overall Study|Death|17|||
33619012|NCT03329092|102151710|FG001|Overall Study|Death|11|||
33351765|NCT01324830|101172472|FG001|Overall Study|Withdrawal by Subject|0|||
33351766|NCT01324830|101172473|FG002|Overall Study|Withdrawal by Subject|0|||
33351767|NCT01324830|101172474|FG003|Overall Study|Withdrawal by Subject|0|||
33351768|NCT01324830|101172475|FG004|Overall Study|Withdrawal by Subject|0|||
33351769|NCT01324830|101172476|FG005|Overall Study|Withdrawal by Subject|1|||
33351770|NCT01324830|101172477|FG006|Overall Study|Withdrawal by Subject|0|||
33351771|NCT01324830|101172478|FG007|Overall Study|Withdrawal by Subject|0|||
33351772|NCT01324830|101172479|FG008|Overall Study|Withdrawal by Subject|0|||
33351773|NCT01324830|101172480|FG009|Overall Study|Withdrawal by Subject|0|||
33351774|NCT01324830|101172481|FG010|Overall Study|Withdrawal by Subject|1|||
33351775|NCT01324830|101172482|FG011|Overall Study|Withdrawal by Subject|0|||
33351776|NCT01324830|101172483|FG012|Overall Study|Withdrawal by Subject|0|||
33351777|NCT01324830|101172484|FG013|Overall Study|Withdrawal by Subject|0|||
33351778|NCT01324830|101172485|FG014|Overall Study|Withdrawal by Subject|0|||
33351779|NCT01324830|101172486|FG015|Overall Study|Withdrawal by Subject|0|||
33351780|NCT01324830|101172487|FG016|Overall Study|Withdrawal by Subject|0|||
33351781|NCT01324830|101172488|FG017|Overall Study|Withdrawal by Subject|0|||
33351782|NCT01324830|101172489|FG018|Overall Study|Withdrawal by Subject|1|||
33351783|NCT00716976|101172490|FG000|Overall Study|Adverse Event|2|||
33351784|NCT00716976|101172491|FG001|Overall Study|Adverse Event|0|||
33351785|NCT00716976|101172490|FG000|Overall Study|Death|1|||
33351786|NCT00716976|101172491|FG001|Overall Study|Death|0|||
33351787|NCT00716976|101172490|FG000|Overall Study|Physician Decision|2|||
33351788|NCT00716976|101172491|FG001|Overall Study|Physician Decision|2|||
33351789|NCT00716976|101172490|FG000|Overall Study|Withdrawal by Subject|5|||
33351790|NCT00716976|101172491|FG001|Overall Study|Withdrawal by Subject|1|||
33351791|NCT00716976|101172490|FG000|Overall Study|Premature discontinuation cisplatin|5|||
33351792|NCT00716976|101172491|FG001|Overall Study|Premature discontinuation cisplatin|4|||
33351793|NCT00716976|101172490|FG000|Overall Study|Radiation during protocol|1|||
33351794|NCT00716976|101172491|FG001|Overall Study|Radiation during protocol|0|||
33351795|NCT00716976|101172490|FG000|Overall Study|Ineligibles|4|||
33351796|NCT00716976|101172491|FG001|Overall Study|Ineligibles|2|||
33351797|NCT00868790|101172492|FG000|Period 1|Adverse Event|1|||
33351798|NCT00868790|101172493|FG001|Period 1|Adverse Event|0|||
33351799|NCT00868790|101172494|FG002|Period 1|Adverse Event|0|||
33351800|NCT00868790|101172495|FG003|Period 1|Adverse Event|0|||
33351801|NCT00868790|101172496|FG004|Period 1|Adverse Event|0|||
33351802|NCT00868790|101172497|FG005|Period 1|Adverse Event|0|||
33351803|NCT00868790|101172498|FG006|Period 1|Adverse Event|0|||
33351804|NCT00868790|101172499|FG007|Period 1|Adverse Event|3|||
33351805|NCT00868790|101172500|FG008|Period 1|Adverse Event|1|||
33351806|NCT00868790|101172501|FG009|Period 1|Adverse Event|0|||
33351807|NCT00868790|101172502|FG010|Period 1|Adverse Event|0|||
33351808|NCT00868790|101172503|FG011|Period 1|Adverse Event|0|||
33351809|NCT00868790|101172504|FG012|Period 1|Adverse Event|0|||
33351810|NCT00868790|101172505|FG013|Period 1|Adverse Event|1|||
33351811|NCT00868790|101172492|FG000|Period 1|Protocol Violation|1|||
33351812|NCT00868790|101172493|FG001|Period 1|Protocol Violation|0|||
33351813|NCT00868790|101172494|FG002|Period 1|Protocol Violation|0|||
33351814|NCT00868790|101172495|FG003|Period 1|Protocol Violation|0|||
33351815|NCT00868790|101172496|FG004|Period 1|Protocol Violation|0|||
33351816|NCT00868790|101172497|FG005|Period 1|Protocol Violation|0|||
33351817|NCT00868790|101172498|FG006|Period 1|Protocol Violation|0|||
33351818|NCT00868790|101172499|FG007|Period 1|Protocol Violation|0|||
33351819|NCT00868790|101172500|FG008|Period 1|Protocol Violation|0|||
33351820|NCT00868790|101172501|FG009|Period 1|Protocol Violation|0|||
33351821|NCT00868790|101172502|FG010|Period 1|Protocol Violation|0|||
33351822|NCT00868790|101172503|FG011|Period 1|Protocol Violation|0|||
33351823|NCT00868790|101172504|FG012|Period 1|Protocol Violation|0|||
33351824|NCT00868790|101172505|FG013|Period 1|Protocol Violation|0|||
33351825|NCT00868790|101172492|FG000|Period 1|Withdrawal by Subject|0|||
33351826|NCT00868790|101172493|FG001|Period 1|Withdrawal by Subject|1|||
33411771|NCT00344968|101397198|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33411772|NCT00344968|101397199|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
33411773|NCT00344968|101397197|FG000|Overall Study|Protocol Violation|2|||
33411774|NCT00344968|101397198|FG001|Overall Study|Protocol Violation|2|||
33351827|NCT00868790|101172494|FG002|Period 1|Withdrawal by Subject|0|||
33351828|NCT00868790|101172495|FG003|Period 1|Withdrawal by Subject|0|||
33351829|NCT00868790|101172496|FG004|Period 1|Withdrawal by Subject|0|||
33351830|NCT00868790|101172497|FG005|Period 1|Withdrawal by Subject|0|||
33351831|NCT00868790|101172498|FG006|Period 1|Withdrawal by Subject|0|||
33351832|NCT00868790|101172499|FG007|Period 1|Withdrawal by Subject|0|||
33351833|NCT00868790|101172500|FG008|Period 1|Withdrawal by Subject|0|||
33351834|NCT00868790|101172501|FG009|Period 1|Withdrawal by Subject|0|||
33351835|NCT00868790|101172502|FG010|Period 1|Withdrawal by Subject|0|||
33351836|NCT00868790|101172503|FG011|Period 1|Withdrawal by Subject|0|||
33411775|NCT00344968|101397199|FG002|Overall Study|Protocol Violation|5|||
33351837|NCT00868790|101172504|FG012|Period 1|Withdrawal by Subject|0|||
33351838|NCT00868790|101172505|FG013|Period 1|Withdrawal by Subject|1|||
33351839|NCT00868790|101172492|FG000|Period 1|Abnormal Triglycerides|0|||
33351840|NCT00868790|101172493|FG001|Period 1|Abnormal Triglycerides|0|||
33351841|NCT00868790|101172494|FG002|Period 1|Abnormal Triglycerides|0|||
33351842|NCT00868790|101172495|FG003|Period 1|Abnormal Triglycerides|0|||
33351843|NCT00868790|101172496|FG004|Period 1|Abnormal Triglycerides|1|||
33552137|NCT04706403|101920208|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
33552138|NCT04243837|101920211|FG000|Overall Study|Adverse Event|2|||
33552139|NCT04243837|101920212|FG001|Overall Study|Adverse Event|1|||
33552140|NCT04243837|101920211|FG000|Overall Study|Withdrawal by Subject|4|||
33552141|NCT04243837|101920212|FG001|Overall Study|Withdrawal by Subject|2|||
33552142|NCT04243837|101920211|FG000|Overall Study|Covid-19 lock down|1|||
33552143|NCT04243837|101920212|FG001|Overall Study|Covid-19 lock down|0|||
33552144|NCT04243837|101920211|FG000|Overall Study|Study Terminated by Sponsor|11|||
33552145|NCT04243837|101920212|FG001|Overall Study|Study Terminated by Sponsor|12|||
33552146|NCT02547987|101920213|FG000|Overall Study|Withdrawal by Subject|1|||
33552147|NCT02547987|101920213|FG000|Overall Study|Adverse Event|2|||
33552148|NCT00800384|101920214|FG000|Overall Study|Withdrawal by Subject|24|||
33552149|NCT00800384|101920215|FG001|Overall Study|Withdrawal by Subject|17|||
33552150|NCT00800384|101920214|FG000|Overall Study|Lost to Follow-up|17|||
33552151|NCT00800384|101920215|FG001|Overall Study|Lost to Follow-up|26|||
33552152|NCT01898130|101920216|FG000|Treatment|Withdrawal by Subject|2|||
33552153|NCT01898130|101920216|FG000|Treatment|Progressive Disease|4|||
33552154|NCT01898130|101920216|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
33552155|NCT01946802|101920218|FG000|Overall Study|Death|1|||
33552156|NCT01946802|101920218|FG000|Overall Study|Withdrawal by Subject|2|||
33552157|NCT01946802|101920218|FG000|Overall Study|Combined septic shock|1|||
33552158|NCT01946802|101920218|FG000|Overall Study|Protocol Violation|1|||
33552159|NCT00326495|101920223|FG000|Overall Study|Switched to alternative treatment|1|||
33552160|NCT00326495|101920223|FG000|Overall Study|Disease progression before treatment|1|||
33552161|NCT00326495|101920223|FG000|Overall Study|Refused further treatment|2|||
33552162|NCT00326495|101920223|FG000|Overall Study|Subject off study before assessment|1|||
33552163|NCT01145222|101920227|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
33552164|NCT01145222|101920228|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
33552165|NCT01145222|101920229|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
33552166|NCT01145222|101920230|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
33552167|NCT01145222|101920227|FG000|Overall Study|Poor bowel preparation|0|||
33552168|NCT01145222|101920228|FG001|Overall Study|Poor bowel preparation|0|||
33552169|NCT01145222|101920229|FG002|Overall Study|Poor bowel preparation|0|||
33552170|NCT01145222|101920230|FG003|Overall Study|Poor bowel preparation|1|||
33552171|NCT02370394|101920231|FG000|Overall Study|Lost to Follow-up|2|||
33552172|NCT02370394|101920232|FG001|Overall Study|Lost to Follow-up|1|||
33552173|NCT02370394|101920231|FG000|Overall Study|Withdrawal by Subject|0|||
33552174|NCT02370394|101920232|FG001|Overall Study|Withdrawal by Subject|1|||
33552175|NCT03331562|101920236|FG000|Overall Study|Adverse Event|2|||
33552176|NCT03331562|101920237|FG001|Overall Study|Adverse Event|0|||
33552177|NCT03331562|101920236|FG000|Overall Study|Death|1|||
33552178|NCT03331562|101920237|FG001|Overall Study|Death|0|||
33552179|NCT00676052|101920238|FG000|Overall Study|Adverse Event|0|||
33552180|NCT00676052|101920239|FG001|Overall Study|Adverse Event|1|||
33552181|NCT00676052|101920240|FG002|Overall Study|Adverse Event|1|||
33552182|NCT00676052|101920241|FG003|Overall Study|Adverse Event|2|||
33552183|NCT00676052|101920242|FG004|Overall Study|Adverse Event|2|||
33351844|NCT00868790|101172497|FG005|Period 1|Abnormal Triglycerides|0|||
33552184|NCT00676052|101920243|FG005|Overall Study|Adverse Event|2|||
33552185|NCT00676052|101920238|FG000|Overall Study|Lack of Efficacy|2|||
33552186|NCT00676052|101920239|FG001|Overall Study|Lack of Efficacy|2|||
33351845|NCT00868790|101172498|FG006|Period 1|Abnormal Triglycerides|0|||
33351846|NCT00868790|101172499|FG007|Period 1|Abnormal Triglycerides|0|||
33351847|NCT00868790|101172500|FG008|Period 1|Abnormal Triglycerides|0|||
33351848|NCT00868790|101172501|FG009|Period 1|Abnormal Triglycerides|0|||
33351849|NCT00868790|101172502|FG010|Period 1|Abnormal Triglycerides|0|||
33351850|NCT00868790|101172503|FG011|Period 1|Abnormal Triglycerides|0|||
33351851|NCT00868790|101172504|FG012|Period 1|Abnormal Triglycerides|0|||
33351852|NCT00868790|101172505|FG013|Period 1|Abnormal Triglycerides|0|||
33552187|NCT00676052|101920240|FG002|Overall Study|Lack of Efficacy|1|||
33552188|NCT00676052|101920241|FG003|Overall Study|Lack of Efficacy|1|||
33552189|NCT00676052|101920242|FG004|Overall Study|Lack of Efficacy|2|||
33351853|NCT00868790|101172492|FG000|Period 1|Lost to Follow-up|0|||
33552190|NCT00676052|101920243|FG005|Overall Study|Lack of Efficacy|1|||
33552191|NCT00676052|101920238|FG000|Overall Study|Protocol Violation|5|||
33552192|NCT00676052|101920239|FG001|Overall Study|Protocol Violation|3|||
33552193|NCT00676052|101920240|FG002|Overall Study|Protocol Violation|2|||
33351854|NCT00868790|101172493|FG001|Period 1|Lost to Follow-up|0|||
33351855|NCT00868790|101172494|FG002|Period 1|Lost to Follow-up|0|||
33351856|NCT00868790|101172495|FG003|Period 1|Lost to Follow-up|0|||
33351857|NCT00868790|101172496|FG004|Period 1|Lost to Follow-up|0|||
33552194|NCT00676052|101920241|FG003|Overall Study|Protocol Violation|2|||
33552195|NCT00676052|101920242|FG004|Overall Study|Protocol Violation|1|||
33351858|NCT00868790|101172497|FG005|Period 1|Lost to Follow-up|1|||
33552196|NCT00676052|101920243|FG005|Overall Study|Protocol Violation|2|||
33552197|NCT00676052|101920238|FG000|Overall Study|Lost to Follow-up|0|||
33552198|NCT00676052|101920239|FG001|Overall Study|Lost to Follow-up|0|||
33552199|NCT00676052|101920240|FG002|Overall Study|Lost to Follow-up|0|||
33552200|NCT00676052|101920241|FG003|Overall Study|Lost to Follow-up|0|||
33552201|NCT00676052|101920242|FG004|Overall Study|Lost to Follow-up|1|||
33351859|NCT00868790|101172498|FG006|Period 1|Lost to Follow-up|0|||
33351860|NCT00868790|101172499|FG007|Period 1|Lost to Follow-up|0|||
33351861|NCT00868790|101172500|FG008|Period 1|Lost to Follow-up|0|||
33351862|NCT00868790|101172501|FG009|Period 1|Lost to Follow-up|0|||
33619013|NCT03329092|102151709|FG000|Overall Study|Adverse Event|3|||
33619014|NCT03329092|102151710|FG001|Overall Study|Adverse Event|1|||
33619015|NCT03329092|102151709|FG000|Overall Study|Lost to Follow-up|1|||
33619016|NCT03329092|102151710|FG001|Overall Study|Lost to Follow-up|1|||
33619017|NCT01518374|102151716|FG000|Overall Study|Withdrawal by Subject|2|||
33619018|NCT01518374|102151716|FG000|Overall Study|Protocol Violation|3|||
33552202|NCT00676052|101920243|FG005|Overall Study|Lost to Follow-up|0|||
33552203|NCT00676052|101920238|FG000|Overall Study|Physician Decision|1|||
33552204|NCT00676052|101920239|FG001|Overall Study|Physician Decision|1|||
33552205|NCT00676052|101920240|FG002|Overall Study|Physician Decision|1|||
33552206|NCT00676052|101920241|FG003|Overall Study|Physician Decision|0|||
33552207|NCT00676052|101920242|FG004|Overall Study|Physician Decision|0|||
33552208|NCT00676052|101920243|FG005|Overall Study|Physician Decision|1|||
33619019|NCT01518374|102151716|FG000|Overall Study|Lost to Follow-up|2|||
33619020|NCT03018691|102151721|FG000|Overall Study|Adverse Event|1|||
33217697|NCT02332720|100695817|FG009|Part A and Part B|Withdrawal by Subject|0|||
33217698|NCT02332720|100695818|FG010|Part A and Part B|Withdrawal by Subject|0|||
33217699|NCT02332720|100695819|FG011|Part A and Part B|Withdrawal by Subject|0|||
33217700|NCT02332720|100695820|FG012|Part A and Part B|Withdrawal by Subject|0|||
33351863|NCT00868790|101172502|FG010|Period 1|Lost to Follow-up|0|||
33351864|NCT00868790|101172503|FG011|Period 1|Lost to Follow-up|0|||
33351865|NCT00868790|101172504|FG012|Period 1|Lost to Follow-up|0|||
33351866|NCT00868790|101172505|FG013|Period 1|Lost to Follow-up|0|||
33351867|NCT00868790|101172492|FG000|Period 2|Adverse Event|0|||
33351868|NCT00868790|101172493|FG001|Period 2|Adverse Event|0|||
33351869|NCT00868790|101172494|FG002|Period 2|Adverse Event|0|||
33351870|NCT00868790|101172495|FG003|Period 2|Adverse Event|0|||
33552209|NCT00676052|101920238|FG000|Overall Study|Withdrawal by Subject|1|||
33552210|NCT00676052|101920239|FG001|Overall Study|Withdrawal by Subject|0|||
33552211|NCT00676052|101920240|FG002|Overall Study|Withdrawal by Subject|1|||
33552212|NCT00676052|101920241|FG003|Overall Study|Withdrawal by Subject|0|||
33552213|NCT00676052|101920242|FG004|Overall Study|Withdrawal by Subject|0|||
33217701|NCT02332720|100695821|FG013|Part A and Part B|Withdrawal by Subject|0|||
33217702|NCT02332720|100695822|FG014|Part A and Part B|Withdrawal by Subject|0|||
33217703|NCT02332720|100695823|FG015|Part A and Part B|Withdrawal by Subject|0|||
33351871|NCT00868790|101172496|FG004|Period 2|Adverse Event|0|||
33351872|NCT00868790|101172497|FG005|Period 2|Adverse Event|0|||
33351873|NCT00868790|101172498|FG006|Period 2|Adverse Event|0|||
33552214|NCT00676052|101920243|FG005|Overall Study|Withdrawal by Subject|0|||
33552215|NCT02958527|101920244|FG000|Overall Study|Not collected CRFs|12|||
33552216|NCT00309244|101920249|FG000|Overall Study|Adverse Event|29|||
33552217|NCT00309244|101920250|FG001|Overall Study|Adverse Event|12|||
33351874|NCT00868790|101172499|FG007|Period 2|Adverse Event|0|||
33552218|NCT00309244|101920249|FG000|Overall Study|Lost to Follow-up|6|||
33552219|NCT00309244|101920250|FG001|Overall Study|Lost to Follow-up|22|||
33552220|NCT00309244|101920249|FG000|Overall Study|Physician Decision|5|||
33552221|NCT00309244|101920250|FG001|Overall Study|Physician Decision|8|||
33552222|NCT00309244|101920249|FG000|Overall Study|Protocol Violation|6|||
33552223|NCT00309244|101920250|FG001|Overall Study|Protocol Violation|3|||
33552224|NCT00309244|101920249|FG000|Overall Study|Withdrawal by Subject|50|||
33552225|NCT00309244|101920250|FG001|Overall Study|Withdrawal by Subject|32|||
33552226|NCT00309244|101920249|FG000|Overall Study|Various|7|||
33552227|NCT00309244|101920250|FG001|Overall Study|Various|7|||
33552228|NCT00309244|101920249|FG000|Overall Study|Randomized but not dosed|11|||
33552229|NCT00309244|101920250|FG001|Overall Study|Randomized but not dosed|12|||
33552230|NCT00309244|101920249|FG000|Overall Study|Death|4|||
33552231|NCT00309244|101920250|FG001|Overall Study|Death|1|||
33552232|NCT01945242|101920251|FG000|Overall Study|Physician Decision|3|||
33552233|NCT01945242|101920252|FG001|Overall Study|Physician Decision|3|||
33552234|NCT00541775|101920253|FG000|Overall Study|Adverse Event|3|||
33552235|NCT00541775|101920254|FG001|Overall Study|Adverse Event|2|||
33552236|NCT00541775|101920255|FG002|Overall Study|Adverse Event|1|||
33552237|NCT00541775|101920253|FG000|Overall Study|Lack of Efficacy|0|||
33552238|NCT00541775|101920254|FG001|Overall Study|Lack of Efficacy|0|||
33552239|NCT00541775|101920255|FG002|Overall Study|Lack of Efficacy|3|||
33552240|NCT00541775|101920253|FG000|Overall Study|Lost to Follow-up|0|||
33552241|NCT00541775|101920254|FG001|Overall Study|Lost to Follow-up|0|||
33411776|NCT00344968|101397197|FG000|Overall Study|Withdrawal by Subject|14|||
33411777|NCT00344968|101397198|FG001|Overall Study|Withdrawal by Subject|31|||
33411778|NCT00344968|101397199|FG002|Overall Study|Withdrawal by Subject|27|||
33619021|NCT03018691|102151722|FG001|Overall Study|Adverse Event|1|||
33619022|NCT03018691|102151723|FG002|Overall Study|Adverse Event|4|||
33619023|NCT03018691|102151721|FG000|Overall Study|Lack of Efficacy|0|||
33619024|NCT03018691|102151722|FG001|Overall Study|Lack of Efficacy|0|||
33619025|NCT03018691|102151723|FG002|Overall Study|Lack of Efficacy|1|||
33619026|NCT03018691|102151721|FG000|Overall Study|Withdrawal by Subject|0|||
33619027|NCT03018691|102151722|FG001|Overall Study|Withdrawal by Subject|0|||
33619028|NCT03018691|102151723|FG002|Overall Study|Withdrawal by Subject|1|||
33619029|NCT03018691|102151721|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33411779|NCT00344968|101397197|FG000|Overall Study|Lost to Follow-up|24|||
33411780|NCT00344968|101397198|FG001|Overall Study|Lost to Follow-up|37|||
33411781|NCT00344968|101397199|FG002|Overall Study|Lost to Follow-up|37|||
33411782|NCT00344968|101397197|FG000|Overall Study|Death|11|||
33411783|NCT00344968|101397198|FG001|Overall Study|Death|27|||
33411784|NCT00344968|101397199|FG002|Overall Study|Death|31|||
33411785|NCT00344968|101397197|FG000|Overall Study|Other|0|||
33411786|NCT00344968|101397198|FG001|Overall Study|Other|1|||
33411787|NCT00344968|101397199|FG002|Overall Study|Other|0|||
33411788|NCT01473602|101397200|FG000|Overall Study|Adverse Event|1|||
33411789|NCT01473602|101397201|FG001|Overall Study|Adverse Event|2|||
33411790|NCT01473602|101397200|FG000|Overall Study|Death|0|||
33411791|NCT01473602|101397201|FG001|Overall Study|Death|1|||
33411792|NCT01473602|101397200|FG000|Overall Study|Lost to Follow-up|1|||
33411793|NCT01473602|101397201|FG001|Overall Study|Lost to Follow-up|1|||
33411794|NCT01473602|101397200|FG000|Overall Study|Withdrawal by Subject|5|||
33411795|NCT01473602|101397201|FG001|Overall Study|Withdrawal by Subject|4|||
33411796|NCT01473602|101397200|FG000|Overall Study|Physician Decision|1|||
33411797|NCT01473602|101397201|FG001|Overall Study|Physician Decision|0|||
33411798|NCT05022121|101397206|FG000|Overall Study|Lack of Efficacy|1|||
33411799|NCT05022121|101397207|FG001|Overall Study|Lack of Efficacy|0|||
33411800|NCT05022121|101397206|FG000|Overall Study|Lost to Follow-up|0|||
33411801|NCT05022121|101397207|FG001|Overall Study|Lost to Follow-up|2|||
33411802|NCT04409509|101397208|FG000|Overall Study|Failure to meet randomization requirement|1|||
33619030|NCT03018691|102151722|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33619031|NCT03018691|102151723|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33619032|NCT03077919|102151724|FG000|Overall Study|Lost to Follow-up|4|||
33619033|NCT03077919|102151725|FG001|Overall Study|Lost to Follow-up|1|||
33619034|NCT04523207|102151726|FG000|Overall Study|Adverse Event|5|||
33552242|NCT00541775|101920255|FG002|Overall Study|Lost to Follow-up|2|||
33552243|NCT00541775|101920253|FG000|Overall Study|Protocol Violation|1|||
33411803|NCT04409509|101397209|FG001|Overall Study|Failure to meet randomization requirement|0|||
33411804|NCT04409509|101397208|FG000|Overall Study|Adverse Event|0|||
33411805|NCT04409509|101397209|FG001|Overall Study|Adverse Event|1|||
33411806|NCT04409509|101397208|FG000|Overall Study|Death|11|||
33411807|NCT04409509|101397209|FG001|Overall Study|Death|10|||
33492381|NCT00560391|101693966|FG001|Overall Study|Still on treatment|0|||
33492382|NCT00560391|101693967|FG002|Overall Study|Still on treatment|0|||
33492383|NCT00560391|101693968|FG003|Overall Study|Still on treatment|1|||
33492384|NCT00560391|101693969|FG004|Overall Study|Still on treatment|2|||
33492385|NCT02575833|101693972|FG000|Overall Study|Withdrawal by Subject|0|||
33492386|NCT02575833|101693973|FG001|Overall Study|Withdrawal by Subject|1|||
33492387|NCT02575833|101693972|FG000|Overall Study|Lost to Follow-up|1|||
33492388|NCT02575833|101693973|FG001|Overall Study|Lost to Follow-up|0|||
33411808|NCT04409509|101397208|FG000|Overall Study|Non-compliance with study drug|0|||
33411809|NCT04409509|101397209|FG001|Overall Study|Non-compliance with study drug|1|||
33411810|NCT04409509|101397208|FG000|Overall Study|Lost to Follow-up|0|||
33411811|NCT04409509|101397209|FG001|Overall Study|Lost to Follow-up|3|||
33411812|NCT04409509|101397208|FG000|Overall Study|Withdrawal by Subject|0|||
33411813|NCT04409509|101397209|FG001|Overall Study|Withdrawal by Subject|3|||
33411814|NCT04409509|101397208|FG000|Overall Study|Randomized by mistake|0|||
33411815|NCT04409509|101397209|FG001|Overall Study|Randomized by mistake|1|||
33411816|NCT04409509|101397208|FG000|Overall Study|Other|1|||
33411817|NCT04409509|101397209|FG001|Overall Study|Other|1|||
33411818|NCT00578448|101397218|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
33411819|NCT00578448|101397218|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
33411820|NCT00578448|101397218|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
33411821|NCT00578448|101397218|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
33411822|NCT02329834|101397222|FG000|Overall Study|Physician Decision|1|||
33411823|NCT02329834|101397223|FG001|Overall Study|Physician Decision|0|||
33411824|NCT01798056|101397226|FG000|Overall Study|Serious Adverse Event|13|||
33411825|NCT01798056|101397227|FG001|Overall Study|Serious Adverse Event|12|||
33411826|NCT01798056|101397226|FG000|Overall Study|Withdrawal by Subject|12|||
33411827|NCT01798056|101397227|FG001|Overall Study|Withdrawal by Subject|9|||
33411828|NCT01798056|101397226|FG000|Overall Study|Migrated/moved from study area|1|||
33411829|NCT01798056|101397227|FG001|Overall Study|Migrated/moved from study area|1|||
33411830|NCT01798056|101397226|FG000|Overall Study|Lost to Follow-up|1|||
33411831|NCT01798056|101397227|FG001|Overall Study|Lost to Follow-up|1|||
33411832|NCT01798056|101397226|FG000|Overall Study|Other|0|||
33411833|NCT01798056|101397227|FG001|Overall Study|Other|2|||
33411834|NCT00975000|101397228|FG000|Overall Study|Other|1|||
33411835|NCT00975000|101397229|FG001|Overall Study|Other|0|||
33411836|NCT00975000|101397228|FG000|Overall Study|Adverse Event|1|||
33411837|NCT00975000|101397229|FG001|Overall Study|Adverse Event|1|||
33411838|NCT00975000|101397228|FG000|Overall Study|Withdrawal by Subject|2|||
33411839|NCT00975000|101397229|FG001|Overall Study|Withdrawal by Subject|2|||
33411840|NCT00975000|101397228|FG000|Overall Study|Lost to Follow-up|0|||
33411841|NCT00975000|101397229|FG001|Overall Study|Lost to Follow-up|1|||
33351875|NCT00868790|101172500|FG008|Period 2|Adverse Event|1|||
33351876|NCT00868790|101172501|FG009|Period 2|Adverse Event|0|||
33351877|NCT00868790|101172502|FG010|Period 2|Adverse Event|0|||
33351878|NCT00868790|101172503|FG011|Period 2|Adverse Event|0|||
33351879|NCT00868790|101172504|FG012|Period 2|Adverse Event|0|||
33351880|NCT00868790|101172505|FG013|Period 2|Adverse Event|0|||
33351881|NCT00868790|101172492|FG000|Period 2|Lost to Follow-up|0|||
33351882|NCT00868790|101172493|FG001|Period 2|Lost to Follow-up|1|||
33351883|NCT00868790|101172494|FG002|Period 2|Lost to Follow-up|0|||
33351884|NCT00868790|101172495|FG003|Period 2|Lost to Follow-up|0|||
33351885|NCT00868790|101172496|FG004|Period 2|Lost to Follow-up|0|||
33351886|NCT00868790|101172497|FG005|Period 2|Lost to Follow-up|1|||
33351887|NCT00868790|101172498|FG006|Period 2|Lost to Follow-up|0|||
33351888|NCT00868790|101172499|FG007|Period 2|Lost to Follow-up|0|||
33351889|NCT00868790|101172500|FG008|Period 2|Lost to Follow-up|0|||
33351890|NCT00868790|101172501|FG009|Period 2|Lost to Follow-up|0|||
33351891|NCT00868790|101172502|FG010|Period 2|Lost to Follow-up|0|||
33351892|NCT00868790|101172503|FG011|Period 2|Lost to Follow-up|0|||
33351893|NCT00868790|101172504|FG012|Period 2|Lost to Follow-up|0|||
33351894|NCT00868790|101172505|FG013|Period 2|Lost to Follow-up|0|||
33351895|NCT00868790|101172492|FG000|Period 2|Withdrawal by Subject|0|||
33351896|NCT00868790|101172493|FG001|Period 2|Withdrawal by Subject|0|||
33351897|NCT00868790|101172494|FG002|Period 2|Withdrawal by Subject|0|||
33411842|NCT00975000|101397228|FG000|Overall Study|Protocol-specified Criteria|1|||
33411843|NCT00975000|101397229|FG001|Overall Study|Protocol-specified Criteria|0|||
33411844|NCT00975000|101397228|FG000|Overall Study|Non-compliance|0|||
33411845|NCT00975000|101397229|FG001|Overall Study|Non-compliance|1|||
33552244|NCT00541775|101920254|FG001|Overall Study|Protocol Violation|0|||
33552245|NCT00541775|101920255|FG002|Overall Study|Protocol Violation|0|||
33552246|NCT00541775|101920253|FG000|Overall Study|Withdrawal by Subject and Other|5|||
33552247|NCT00541775|101920254|FG001|Overall Study|Withdrawal by Subject and Other|0|||
33351898|NCT00868790|101172495|FG003|Period 2|Withdrawal by Subject|0|||
33351899|NCT00868790|101172496|FG004|Period 2|Withdrawal by Subject|0|||
33411846|NCT00910000|101397235|FG000|Overall Study|Adverse Event|0|||
33411847|NCT00910000|101397236|FG001|Overall Study|Adverse Event|3|||
33411848|NCT00910000|101397237|FG002|Overall Study|Adverse Event|2|||
33411849|NCT00910000|101397238|FG003|Overall Study|Adverse Event|2|||
33351900|NCT00868790|101172497|FG005|Period 2|Withdrawal by Subject|0|||
33411850|NCT00910000|101397239|FG004|Overall Study|Adverse Event|0|||
33552248|NCT00541775|101920255|FG002|Overall Study|Withdrawal by Subject and Other|2|||
33351901|NCT00868790|101172498|FG006|Period 2|Withdrawal by Subject|0|||
33351902|NCT00868790|101172499|FG007|Period 2|Withdrawal by Subject|0|||
33351903|NCT00868790|101172500|FG008|Period 2|Withdrawal by Subject|1|||
33351904|NCT00868790|101172501|FG009|Period 2|Withdrawal by Subject|0|||
33411851|NCT00910000|101397240|FG005|Overall Study|Adverse Event|1|||
33619035|NCT04523207|102151727|FG001|Overall Study|Adverse Event|1|||
33619036|NCT04523207|102151726|FG000|Overall Study|Lost to Follow-up|2|||
33619037|NCT04523207|102151727|FG001|Overall Study|Lost to Follow-up|0|||
33619038|NCT04523207|102151726|FG000|Overall Study|Withdrawal by Subject|2|||
33619039|NCT04523207|102151727|FG001|Overall Study|Withdrawal by Subject|0|||
33619040|NCT04523207|102151726|FG000|Overall Study|Progressive Disease|2|||
33619041|NCT04523207|102151727|FG001|Overall Study|Progressive Disease|1|||
33619042|NCT04523207|102151726|FG000|Overall Study|Other|7|||
33619043|NCT04523207|102151727|FG001|Overall Study|Other|1|||
33619044|NCT00550407|102151728|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
33619045|NCT00550407|102151729|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
33619046|NCT00550407|102151730|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
33619047|NCT00550407|102151728|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
33619048|NCT00550407|102151729|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
33619049|NCT00550407|102151730|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
33619050|NCT00550407|102151728|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
33619051|NCT00550407|102151729|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
33411852|NCT00910000|101397235|FG000|Overall Study|Withdrawal by Subject|0|||
33411853|NCT00910000|101397236|FG001|Overall Study|Withdrawal by Subject|0|||
33411854|NCT00910000|101397237|FG002|Overall Study|Withdrawal by Subject|1|||
33411855|NCT00910000|101397238|FG003|Overall Study|Withdrawal by Subject|0|||
33411856|NCT00910000|101397239|FG004|Overall Study|Withdrawal by Subject|1|||
33411857|NCT00910000|101397240|FG005|Overall Study|Withdrawal by Subject|0|||
33411858|NCT01317199|101397241|FG000|Dose-escalation Phase 1|Physician Decision|5|||
33411859|NCT01317199|101397242|FG001|Dose-escalation Phase 1|Physician Decision|0|||
33411860|NCT01317199|101397243|FG002|Dose-escalation Phase 1|Physician Decision|0|||
33351905|NCT00868790|101172502|FG010|Period 2|Withdrawal by Subject|0|||
33351906|NCT00868790|101172503|FG011|Period 2|Withdrawal by Subject|0|||
33351907|NCT00868790|101172504|FG012|Period 2|Withdrawal by Subject|0|||
33351908|NCT00868790|101172505|FG013|Period 2|Withdrawal by Subject|1|||
33351909|NCT00868790|101172492|FG000|Period 3|Adverse Event|0|||
33351910|NCT00868790|101172493|FG001|Period 3|Adverse Event|0|||
33351911|NCT00868790|101172494|FG002|Period 3|Adverse Event|0|||
33351912|NCT00868790|101172495|FG003|Period 3|Adverse Event|0|||
33351913|NCT00868790|101172496|FG004|Period 3|Adverse Event|0|||
33351914|NCT00868790|101172497|FG005|Period 3|Adverse Event|0|||
33351915|NCT00868790|101172498|FG006|Period 3|Adverse Event|0|||
33411861|NCT01317199|101397244|FG003|Dose-escalation Phase 1|Physician Decision|0|||
33411862|NCT01317199|101397241|FG000|Dose-escalation Phase 1|Disease progression|1|||
33411863|NCT01317199|101397242|FG001|Dose-escalation Phase 1|Disease progression|0|||
33411864|NCT01317199|101397243|FG002|Dose-escalation Phase 1|Disease progression|0|||
33411865|NCT01317199|101397244|FG003|Dose-escalation Phase 1|Disease progression|0|||
33411866|NCT01317199|101397241|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
33411867|NCT01317199|101397242|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
33411868|NCT01317199|101397243|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
33411869|NCT01317199|101397244|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
33411870|NCT01317199|101397241|FG000|Randomized Phase 2|Disease progression|0|||
33411871|NCT01317199|101397242|FG001|Randomized Phase 2|Disease progression|3|||
33619052|NCT00550407|102151730|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
33619053|NCT00550407|102151728|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
33619054|NCT00550407|102151729|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
33619055|NCT00550407|102151730|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
33619056|NCT00550407|102151728|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
33619057|NCT00550407|102151729|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
33619058|NCT00550407|102151730|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
33619059|NCT00550407|102151728|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
33619060|NCT00550407|102151729|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
33619061|NCT00550407|102151730|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
33619062|NCT00550407|102151728|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
33351916|NCT00868790|101172499|FG007|Period 3|Adverse Event|0|||
33351917|NCT00868790|101172500|FG008|Period 3|Adverse Event|0|||
33411872|NCT01317199|101397243|FG002|Randomized Phase 2|Disease progression|7|||
33411873|NCT01317199|101397244|FG003|Randomized Phase 2|Disease progression|5|||
33411874|NCT01317199|101397241|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
33351918|NCT00868790|101172501|FG009|Period 3|Adverse Event|1|||
33351919|NCT00868790|101172502|FG010|Period 3|Adverse Event|0|||
33351920|NCT00868790|101172503|FG011|Period 3|Adverse Event|0|||
33351921|NCT00868790|101172504|FG012|Period 3|Adverse Event|0|||
33351922|NCT00868790|101172505|FG013|Period 3|Adverse Event|0|||
33351923|NCT00868790|101172492|FG000|Period 3|Protocol Violation|0|||
33351924|NCT00868790|101172493|FG001|Period 3|Protocol Violation|0|||
33351925|NCT00868790|101172494|FG002|Period 3|Protocol Violation|0|||
33351926|NCT00868790|101172495|FG003|Period 3|Protocol Violation|0|||
33351927|NCT00868790|101172496|FG004|Period 3|Protocol Violation|0|||
33351928|NCT00868790|101172497|FG005|Period 3|Protocol Violation|0|||
33351929|NCT00868790|101172498|FG006|Period 3|Protocol Violation|0|||
33351930|NCT00868790|101172499|FG007|Period 3|Protocol Violation|0|||
33351931|NCT00868790|101172500|FG008|Period 3|Protocol Violation|0|||
33351932|NCT00868790|101172501|FG009|Period 3|Protocol Violation|0|||
33351933|NCT00868790|101172502|FG010|Period 3|Protocol Violation|1|||
33351934|NCT00868790|101172503|FG011|Period 3|Protocol Violation|0|||
33351935|NCT00868790|101172504|FG012|Period 3|Protocol Violation|0|||
33351936|NCT00868790|101172505|FG013|Period 3|Protocol Violation|0|||
33351937|NCT00868790|101172492|FG000|Period 3|Study Terminated by Sponsor|0|||
33351938|NCT00868790|101172493|FG001|Period 3|Study Terminated by Sponsor|0|||
33351939|NCT00868790|101172494|FG002|Period 3|Study Terminated by Sponsor|0|||
33351940|NCT00868790|101172495|FG003|Period 3|Study Terminated by Sponsor|1|||
33411875|NCT01317199|101397242|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
33411876|NCT01317199|101397243|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
33552249|NCT00663351|101920258|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
33552250|NCT00663351|101920259|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
33552251|NCT00663351|101920258|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
33552252|NCT00663351|101920259|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
33552253|NCT00663351|101920258|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
33552254|NCT00663351|101920259|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
33552255|NCT00663351|101920258|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
33552256|NCT00663351|101920259|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
33552257|NCT00663351|101920258|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
33552258|NCT00663351|101920259|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
33552259|NCT00663351|101920258|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
33552260|NCT00663351|101920259|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
33552261|NCT00471107|101920260|FG000|Overall Study|Technical problems/data loss|3|||
33552262|NCT00471107|101920261|FG001|Overall Study|Technical problems/data loss|1|||
33552263|NCT00471107|101920262|FG002|Overall Study|Technical problems/data loss|3|||
33552264|NCT00363467|101920266|FG000|Overall Study|Physician Decision|1|||
33552265|NCT00356590|101920270|FG000|Overall Study|Adverse Event|54|||
33552266|NCT00356590|101920270|FG000|Overall Study|Death|10|||
33552267|NCT00356590|101920270|FG000|Overall Study|Lost to Follow-up|35|||
33552268|NCT00356590|101920270|FG000|Overall Study|Physician Decision|46|||
33552269|NCT00356590|101920270|FG000|Overall Study|Withdrawal by Subject|41|||
33552270|NCT00356590|101920270|FG000|Overall Study|Completed month 12 only|2|||
33619063|NCT00550407|102151729|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
33411877|NCT01317199|101397244|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
33619064|NCT00550407|102151730|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
33217704|NCT02332720|100695824|FG016|Part A and Part B|Withdrawal by Subject|0|||
33351941|NCT00868790|101172496|FG004|Period 3|Study Terminated by Sponsor|0|||
33351942|NCT00868790|101172497|FG005|Period 3|Study Terminated by Sponsor|0|||
33552271|NCT00356590|101920270|FG000|Overall Study|Protocol issues|6|||
33351943|NCT00868790|101172498|FG006|Period 3|Study Terminated by Sponsor|0|||
33351944|NCT00868790|101172499|FG007|Period 3|Study Terminated by Sponsor|0|||
33351945|NCT00868790|101172500|FG008|Period 3|Study Terminated by Sponsor|0|||
33351946|NCT00868790|101172501|FG009|Period 3|Study Terminated by Sponsor|0|||
33351947|NCT00868790|101172502|FG010|Period 3|Study Terminated by Sponsor|0|||
33351948|NCT00868790|101172503|FG011|Period 3|Study Terminated by Sponsor|0|||
33351949|NCT00868790|101172504|FG012|Period 3|Study Terminated by Sponsor|0|||
33351950|NCT00868790|101172505|FG013|Period 3|Study Terminated by Sponsor|0|||
33552272|NCT00356590|101920270|FG000|Overall Study|Response status|28|||
33552273|NCT00356590|101920270|FG000|Overall Study|Other|52|||
33552274|NCT00625378|101920271|FG000|Overall Study|Adverse Event|22|||
33552275|NCT00625378|101920272|FG001|Overall Study|Adverse Event|0|||
33552276|NCT00625378|101920271|FG000|Overall Study|Withdrawal by Subject|16|||
33552277|NCT00625378|101920272|FG001|Overall Study|Withdrawal by Subject|0|||
33552278|NCT00625378|101920271|FG000|Overall Study|Death|38|||
33552279|NCT00625378|101920272|FG001|Overall Study|Death|0|||
33552280|NCT00625378|101920271|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
33552281|NCT00625378|101920272|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
33552282|NCT00625378|101920271|FG000|Overall Study|Lost to Follow-up|17|||
33552283|NCT00625378|101920272|FG001|Overall Study|Lost to Follow-up|0|||
33552284|NCT00625378|101920271|FG000|Overall Study|Non-compliant with study medication|3|||
33552285|NCT00625378|101920272|FG001|Overall Study|Non-compliant with study medication|0|||
33552286|NCT00625378|101920271|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
33552287|NCT00625378|101920272|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
33552288|NCT00625378|101920271|FG000|Overall Study|Medical decision|1|||
33552289|NCT00625378|101920272|FG001|Overall Study|Medical decision|0|||
33552290|NCT00625378|101920271|FG000|Overall Study|Multiple toxicities|1|||
33351951|NCT00868790|101172492|FG000|Period 4|Adverse Event|0|||
33351952|NCT00868790|101172493|FG001|Period 4|Adverse Event|0|||
33351953|NCT00868790|101172494|FG002|Period 4|Adverse Event|0|||
33351954|NCT00868790|101172495|FG003|Period 4|Adverse Event|0|||
33351955|NCT00868790|101172496|FG004|Period 4|Adverse Event|0|||
33351956|NCT00868790|101172497|FG005|Period 4|Adverse Event|0|||
33351957|NCT00868790|101172498|FG006|Period 4|Adverse Event|0|||
33351958|NCT00868790|101172499|FG007|Period 4|Adverse Event|1|||
33351959|NCT00868790|101172500|FG008|Period 4|Adverse Event|0|||
33351960|NCT00868790|101172501|FG009|Period 4|Adverse Event|0|||
33351961|NCT00868790|101172502|FG010|Period 4|Adverse Event|1|||
33351962|NCT00868790|101172503|FG011|Period 4|Adverse Event|0|||
33351963|NCT00868790|101172504|FG012|Period 4|Adverse Event|1|||
33351964|NCT00868790|101172505|FG013|Period 4|Adverse Event|0|||
33351965|NCT00868790|101172492|FG000|Period 4|Lost to Follow-up|0|||
33351966|NCT00868790|101172493|FG001|Period 4|Lost to Follow-up|0|||
33351967|NCT00868790|101172494|FG002|Period 4|Lost to Follow-up|0|||
33351968|NCT00868790|101172495|FG003|Period 4|Lost to Follow-up|0|||
33351969|NCT00868790|101172496|FG004|Period 4|Lost to Follow-up|0|||
33351970|NCT00868790|101172497|FG005|Period 4|Lost to Follow-up|0|||
33411878|NCT01317199|101397241|FG000|Randomized Phase 2|Adverse Event|0|||
33411879|NCT01317199|101397242|FG001|Randomized Phase 2|Adverse Event|0|||
33552291|NCT00625378|101920272|FG001|Overall Study|Multiple toxicities|0|||
33552292|NCT00625378|101920271|FG000|Overall Study|New cancer|1|||
33351971|NCT00868790|101172498|FG006|Period 4|Lost to Follow-up|0|||
33351972|NCT00868790|101172499|FG007|Period 4|Lost to Follow-up|1|||
33351973|NCT00868790|101172500|FG008|Period 4|Lost to Follow-up|0|||
33351974|NCT00868790|101172501|FG009|Period 4|Lost to Follow-up|0|||
33351975|NCT00868790|101172502|FG010|Period 4|Lost to Follow-up|0|||
33411880|NCT01317199|101397243|FG002|Randomized Phase 2|Adverse Event|0|||
33351976|NCT00868790|101172503|FG011|Period 4|Lost to Follow-up|0|||
33351977|NCT00868790|101172504|FG012|Period 4|Lost to Follow-up|0|||
33552293|NCT00625378|101920272|FG001|Overall Study|New cancer|0|||
33552294|NCT00625378|101920271|FG000|Overall Study|PTA program|2|||
33552295|NCT00625378|101920272|FG001|Overall Study|PTA program|0|||
33552296|NCT00625378|101920271|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
33552297|NCT00625378|101920272|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
33552298|NCT00625378|101920271|FG000|Overall Study|Sponsor decision|1|||
33552299|NCT00625378|101920272|FG001|Overall Study|Sponsor decision|0|||
33552300|NCT00625378|101920271|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
33552301|NCT00625378|101920272|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
33552302|NCT00625378|101920271|FG000|Overall Study|Switch to commercial drug|6|||
33552303|NCT00625378|101920272|FG001|Overall Study|Switch to commercial drug|1|||
33552304|NCT00625378|101920271|FG000|Overall Study|Missing|2|||
33552305|NCT00625378|101920272|FG001|Overall Study|Missing|0|||
33552306|NCT00625378|101920271|FG000|Overall Study|End of treatment not available|2|||
33552307|NCT00625378|101920272|FG001|Overall Study|End of treatment not available|0|||
33552308|NCT00625378|101920271|FG000|Overall Study|Never treated|2|||
33552309|NCT00625378|101920272|FG001|Overall Study|Never treated|0|||
33552310|NCT02568254|101920276|FG000|Period 2|Adverse Event|0|||
33552311|NCT02568254|101920277|FG001|Period 2|Adverse Event|0|||
33552312|NCT02568254|101920278|FG002|Period 2|Adverse Event|1|||
33552313|NCT02568254|101920279|FG003|Period 2|Adverse Event|0|||
33552314|NCT02568254|101920280|FG004|Period 2|Adverse Event|0|||
33552315|NCT02568254|101920281|FG005|Period 2|Adverse Event|0|||
33552316|NCT02568254|101920276|FG000|Period 3|Unstatisfactory Lens fitting|0|||
33552317|NCT02568254|101920277|FG001|Period 3|Unstatisfactory Lens fitting|0|||
33552318|NCT02568254|101920278|FG002|Period 3|Unstatisfactory Lens fitting|0|||
33552319|NCT02568254|101920279|FG003|Period 3|Unstatisfactory Lens fitting|0|||
33552320|NCT02568254|101920280|FG004|Period 3|Unstatisfactory Lens fitting|1|||
33552321|NCT02568254|101920281|FG005|Period 3|Unstatisfactory Lens fitting|0|||
33552322|NCT02218268|101920286|FG000|24 Hour Washout|Physician Decision|11|||
33552323|NCT02218268|101920287|FG001|24 Hour Washout|Physician Decision|9|||
33552324|NCT01657500|101920290|FG000|Overall Study|set impropperly matched|3|||
33552325|NCT01657500|101920291|FG001|Overall Study|set impropperly matched|3|||
33552326|NCT01657500|101920290|FG000|Overall Study|Lost to Follow-up|2|||
33552327|NCT01657500|101920291|FG001|Overall Study|Lost to Follow-up|2|||
33552328|NCT02697422|101920295|FG000|Overall Study|Declined exit survey|9|||
33552329|NCT02697422|101920296|FG001|Overall Study|Declined exit survey|2|||
33552330|NCT02697422|101920295|FG000|Overall Study|Lost to Follow-up|13|||
33552331|NCT02697422|101920296|FG001|Overall Study|Lost to Follow-up|8|||
33552332|NCT02697422|101920295|FG000|Overall Study|Death|2|||
33552333|NCT02697422|101920296|FG001|Overall Study|Death|1|||
33552334|NCT02697422|101920295|FG000|Overall Study|Withdrawal by Subject|0|||
33552335|NCT02697422|101920296|FG001|Overall Study|Withdrawal by Subject|1|||
33552336|NCT02697422|101920295|FG000|Overall Study|Physician Decision|1|||
33552337|NCT02697422|101920296|FG001|Overall Study|Physician Decision|1|||
33552338|NCT02697422|101920295|FG000|Overall Study|Exit survey data lost|1|||
33552339|NCT02697422|101920296|FG001|Overall Study|Exit survey data lost|0|||
33552340|NCT02391584|101920313|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
33552341|NCT02391584|101920314|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
33552342|NCT02391584|101920313|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
33552343|NCT02391584|101920314|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
33552344|NCT02391584|101920313|FG000|3 Month|Lost to Follow-up|1|||
33552345|NCT02391584|101920314|FG001|3 Month|Lost to Follow-up|0|||
33552346|NCT02391584|101920313|FG000|6 Month|Withdrawal by Subject|1|||
33552347|NCT02391584|101920314|FG001|6 Month|Withdrawal by Subject|0|||
33411881|NCT01317199|101397244|FG003|Randomized Phase 2|Adverse Event|1|||
33411882|NCT01317199|101397241|FG000|Randomized Phase 2|Comorbidities|0|||
33411883|NCT01317199|101397242|FG001|Randomized Phase 2|Comorbidities|2|||
33411884|NCT01317199|101397243|FG002|Randomized Phase 2|Comorbidities|2|||
33411885|NCT01317199|101397244|FG003|Randomized Phase 2|Comorbidities|2|||
33411886|NCT01317199|101397241|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
33411887|NCT01317199|101397242|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
33411888|NCT01317199|101397243|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
33411889|NCT01317199|101397244|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
33411890|NCT01317199|101397241|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
33411891|NCT01317199|101397242|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
33411892|NCT01317199|101397243|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
33552348|NCT02391584|101920313|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
33552349|NCT02391584|101920314|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
33552350|NCT04137887|101920315|FG000|Overall Study|Death|102|||
33552351|NCT04137887|101920316|FG001|Overall Study|Death|92|||
33552352|NCT04137887|101920315|FG000|Overall Study|Withdrawal by Subject|2|||
33552353|NCT04137887|101920316|FG001|Overall Study|Withdrawal by Subject|3|||
33552354|NCT04137887|101920315|FG000|Overall Study|Randomized but not treated|0|||
33552355|NCT04137887|101920316|FG001|Overall Study|Randomized but not treated|1|||
33552356|NCT01699685|101920317|FG000|Period 1|Adverse Event|1|||
33552357|NCT01699685|101920318|FG001|Period 1|Adverse Event|1|||
33552358|NCT01699685|101920317|FG000|Period 1|Medical or ethical, noncompliance|2|||
33411893|NCT01317199|101397244|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
33411894|NCT01317199|101397241|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
33552359|NCT01699685|101920318|FG001|Period 1|Medical or ethical, noncompliance|0|||
33552360|NCT01699685|101920317|FG000|Period 1|Other|0|||
33552361|NCT01699685|101920318|FG001|Period 1|Other|1|||
33619065|NCT00550407|102151728|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
33552362|NCT01699685|101920317|FG000|Period 1|Patient request|0|||
33552363|NCT01699685|101920318|FG001|Period 1|Patient request|1|||
33552364|NCT01699685|101920317|FG000|Period 2|Lost to Follow-up|1|||
33552365|NCT01699685|101920318|FG001|Period 2|Lost to Follow-up|0|||
33552366|NCT01617967|101920319|FG000|Overall Study|Protocol Violation|0|||
33552367|NCT01617967|101920320|FG001|Overall Study|Protocol Violation|0|||
33552368|NCT01617967|101920321|FG002|Overall Study|Protocol Violation|0|||
33619066|NCT00550407|102151729|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
33619067|NCT00550407|102151730|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
33619068|NCT00550407|102151728|FG000|26-Week Randomized Phase|Adverse Event|0|||
33619069|NCT00550407|102151729|FG001|26-Week Randomized Phase|Adverse Event|5|||
33619070|NCT00550407|102151730|FG002|26-Week Randomized Phase|Adverse Event|2|||
33619071|NCT00550407|102151728|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
33619072|NCT00550407|102151729|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
33619073|NCT00550407|102151730|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
33619074|NCT00550407|102151728|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
33619075|NCT00550407|102151729|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
33619076|NCT00550407|102151730|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
33619077|NCT00550407|102151728|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
33619078|NCT00550407|102151729|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
33619079|NCT00550407|102151730|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
33619080|NCT03354273|102151731|FG000|Overall Study|Adverse Event|5|||
33619081|NCT03354273|102151731|FG000|Overall Study|Screen Failure|21|||
33619082|NCT03354273|102151731|FG000|Overall Study|Withdrawal by Subject|34|||
33619083|NCT03354273|102151731|FG000|Overall Study|Technical Problems|30|||
33619084|NCT03354273|102151731|FG000|Overall Study|Lost to Follow-up|4|||
33619085|NCT03354273|102151731|FG000|Overall Study|Investigator Decision|3|||
33619086|NCT03354273|102151731|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
33619087|NCT03354273|102151731|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
33619088|NCT03354273|102151731|FG000|Overall Study|COVID-19 Restrictions|9|||
33619089|NCT03354273|102151731|FG000|Overall Study|Other|5|||
33619090|NCT04970654|102151732|FG000|Overall Study|Withdrawal by parents/guardian|1|||
33619091|NCT04970654|102151733|FG001|Overall Study|Withdrawal by parents/guardian|2|||
33619092|NCT04970654|102151732|FG000|Overall Study|Unclassified|2|||
33619093|NCT04970654|102151733|FG001|Overall Study|Unclassified|1|||
33619094|NCT04970654|102151732|FG000|Overall Study|Lost to Follow-up|1|||
33619095|NCT04970654|102151733|FG001|Overall Study|Lost to Follow-up|0|||
33619096|NCT00410956|102154925|FG000|Overall Study|Adverse Event|1|||
33217705|NCT02332720|100695825|FG017|Part A and Part B|Withdrawal by Subject|0|||
33351978|NCT00868790|101172505|FG013|Period 4|Lost to Follow-up|0|||
33351979|NCT00868790|101172492|FG000|Period 4|Study Terminated by Sponsor|2|||
33351980|NCT00868790|101172493|FG001|Period 4|Study Terminated by Sponsor|0|||
33351981|NCT00868790|101172494|FG002|Period 4|Study Terminated by Sponsor|0|||
33351982|NCT00868790|101172495|FG003|Period 4|Study Terminated by Sponsor|0|||
33351983|NCT00868790|101172496|FG004|Period 4|Study Terminated by Sponsor|0|||
33619097|NCT00410956|102154925|FG000|Overall Study|Death|2|||
33619098|NCT00410956|102154925|FG000|Overall Study|Lack of Efficacy|10|||
33619099|NCT00410956|102154925|FG000|Overall Study|Physician Decision|6|||
33619100|NCT02175017|102154926|FG000|Overall Study|Did not receive the investigational product|1|||
33619101|NCT02175017|102154927|FG001|Overall Study|Did not receive the investigational product|2|||
33351984|NCT00868790|101172497|FG005|Period 4|Study Terminated by Sponsor|0|||
33552369|NCT01617967|101920322|FG003|Overall Study|Protocol Violation|1|||
33552370|NCT01617967|101920323|FG004|Overall Study|Protocol Violation|0|||
33552371|NCT01617967|101920324|FG005|Overall Study|Protocol Violation|0|||
33619102|NCT02175017|102154926|FG000|Overall Study|Withdrawal by Subject|6|||
33619103|NCT02175017|102154927|FG001|Overall Study|Withdrawal by Subject|3|||
33619104|NCT02175017|102154926|FG000|Overall Study|Met an exclusion criteria|0|||
33619105|NCT02175017|102154927|FG001|Overall Study|Met an exclusion criteria|1|||
33619106|NCT02175017|102154926|FG000|Overall Study|Adverse Event|3|||
33619107|NCT02175017|102154927|FG001|Overall Study|Adverse Event|10|||
33619108|NCT02175017|102154926|FG000|Overall Study|Disease progression|20|||
33619109|NCT02175017|102154927|FG001|Overall Study|Disease progression|27|||
33619110|NCT02175017|102154926|FG000|Overall Study|Other than above reasons|3|||
33619111|NCT02175017|102154927|FG001|Overall Study|Other than above reasons|0|||
33619112|NCT00981461|102154932|FG000|Overall Study|Lost to Follow-up|5|||
33619113|NCT00981461|102154933|FG001|Overall Study|Lost to Follow-up|2|||
33619114|NCT01632020|102154934|FG000|Overall Study|Withdrawal by Subject|1|||
33351985|NCT00868790|101172498|FG006|Period 4|Study Terminated by Sponsor|0|||
33351986|NCT00868790|101172499|FG007|Period 4|Study Terminated by Sponsor|1|||
33351987|NCT00868790|101172500|FG008|Period 4|Study Terminated by Sponsor|2|||
33351988|NCT00868790|101172501|FG009|Period 4|Study Terminated by Sponsor|0|||
33351989|NCT00868790|101172502|FG010|Period 4|Study Terminated by Sponsor|2|||
33351990|NCT00868790|101172503|FG011|Period 4|Study Terminated by Sponsor|1|||
33351991|NCT00868790|101172504|FG012|Period 4|Study Terminated by Sponsor|0|||
33351992|NCT00868790|101172505|FG013|Period 4|Study Terminated by Sponsor|1|||
33351993|NCT00868790|101172492|FG000|Period 4|Abnormal ALT/AST|0|||
33351994|NCT00868790|101172493|FG001|Period 4|Abnormal ALT/AST|0|||
33351995|NCT00868790|101172494|FG002|Period 4|Abnormal ALT/AST|1|||
33351996|NCT00868790|101172495|FG003|Period 4|Abnormal ALT/AST|0|||
33351997|NCT00868790|101172496|FG004|Period 4|Abnormal ALT/AST|0|||
33351998|NCT00868790|101172497|FG005|Period 4|Abnormal ALT/AST|0|||
33351999|NCT00868790|101172498|FG006|Period 4|Abnormal ALT/AST|0|||
33619115|NCT01632020|102154935|FG001|Overall Study|Withdrawal by Subject|0|||
33619116|NCT01632020|102154934|FG000|Overall Study|Adverse Event|1|||
33352000|NCT00868790|101172499|FG007|Period 4|Abnormal ALT/AST|0|||
33352001|NCT00868790|101172500|FG008|Period 4|Abnormal ALT/AST|0|||
33619117|NCT01632020|102154935|FG001|Overall Study|Adverse Event|0|||
33619118|NCT00622505|102154936|FG000|Overall Study|Adverse Event|9|||
33619119|NCT00622505|102154937|FG001|Overall Study|Adverse Event|7|||
33619120|NCT00622505|102154936|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
33619121|NCT00622505|102154937|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
33352002|NCT00868790|101172501|FG009|Period 4|Abnormal ALT/AST|0|||
33619122|NCT00622505|102154936|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
33619123|NCT00622505|102154937|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
33411895|NCT01317199|101397242|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
33411896|NCT01317199|101397243|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
33411897|NCT01317199|101397244|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
33411898|NCT01317199|101397241|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
33411899|NCT01317199|101397242|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
33411900|NCT01317199|101397243|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
33411901|NCT01317199|101397244|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
33411902|NCT02543918|101397245|FG000|Overall Study|Never treated|0|||
33411903|NCT02543918|101397246|FG001|Overall Study|Never treated|1|||
33411904|NCT02543918|101397245|FG000|Overall Study|Lost to Follow-up|1|||
33411905|NCT02543918|101397246|FG001|Overall Study|Lost to Follow-up|1|||
33411906|NCT02543918|101397245|FG000|Overall Study|Withdrawal by Subject|1|||
33411907|NCT02543918|101397246|FG001|Overall Study|Withdrawal by Subject|1|||
33411908|NCT02543918|101397245|FG000|Overall Study|Adverse Event|1|||
33411909|NCT02543918|101397246|FG001|Overall Study|Adverse Event|1|||
33411910|NCT00761969|101397247|FG000|Overall Study|Death|112|||
33411911|NCT00761969|101397248|FG001|Overall Study|Death|47|||
33411912|NCT00761969|101397247|FG000|Overall Study|Lost to Follow-up|88|||
33411913|NCT00761969|101397248|FG001|Overall Study|Lost to Follow-up|93|||
33411914|NCT00381680|101397252|FG000|Overall Study|Adverse Event|9|||
33411915|NCT00381680|101397253|FG001|Overall Study|Adverse Event|3|||
33411916|NCT00381680|101397252|FG000|Overall Study|Death|10|||
33411917|NCT00381680|101397253|FG001|Overall Study|Death|7|||
33411918|NCT00381680|101397252|FG000|Overall Study|Lost to Follow-up|3|||
33411919|NCT00381680|101397253|FG001|Overall Study|Lost to Follow-up|2|||
33411920|NCT00381680|101397252|FG000|Overall Study|Physician Decision|25|||
33411921|NCT00381680|101397253|FG001|Overall Study|Physician Decision|6|||
33411922|NCT00381680|101397252|FG000|Overall Study|Withdrawal by Subject|3|||
33411923|NCT00381680|101397253|FG001|Overall Study|Withdrawal by Subject|1|||
33411924|NCT00381680|101397252|FG000|Overall Study|Entry onto another COG Trial|1|||
33411925|NCT00381680|101397253|FG001|Overall Study|Entry onto another COG Trial|2|||
33411926|NCT00381680|101397252|FG000|Overall Study|Alternative Therapy|11|||
33411927|NCT00381680|101397253|FG001|Overall Study|Alternative Therapy|5|||
33411928|NCT00381680|101397252|FG000|Overall Study|Secondary Malignancy|3|||
33411929|NCT00381680|101397253|FG001|Overall Study|Secondary Malignancy|0|||
33411930|NCT00381680|101397252|FG000|Overall Study|Delay initiation|1|||
33411931|NCT00381680|101397253|FG001|Overall Study|Delay initiation|0|||
33411932|NCT00381680|101397252|FG000|Overall Study|Stem Cell Transplant|26|||
33411933|NCT00381680|101397253|FG001|Overall Study|Stem Cell Transplant|10|||
33411934|NCT00381680|101397252|FG000|Overall Study|Relapse|18|||
33411935|NCT00381680|101397253|FG001|Overall Study|Relapse|9|||
33411936|NCT00381680|101397252|FG000|Overall Study|Induction Failure|4|||
33411937|NCT00381680|101397253|FG001|Overall Study|Induction Failure|1|||
33411938|NCT00381680|101397252|FG000|Overall Study|Progression|1|||
33411939|NCT00381680|101397253|FG001|Overall Study|Progression|1|||
33411940|NCT00381680|101397252|FG000|Overall Study|Other not otherwise specified|7|||
33411941|NCT00381680|101397253|FG001|Overall Study|Other not otherwise specified|2|||
33411942|NCT00381680|101397252|FG000|Overall Study|Ineligible|3|||
33411943|NCT00381680|101397253|FG001|Overall Study|Ineligible|1|||
33411944|NCT03433482|101397254|FG000|Overall Study|Lost to Follow-up|1|||
33411945|NCT03433482|101397255|FG001|Overall Study|Lost to Follow-up|0|||
33411946|NCT03433482|101397256|FG002|Overall Study|Lost to Follow-up|1|||
33411947|NCT03433482|101397257|FG003|Overall Study|Lost to Follow-up|1|||
33411948|NCT03433482|101397254|FG000|Overall Study|Withdrawal by Subject|0|||
33619124|NCT00622505|102154936|FG000|Overall Study|Withdrawal by Subject|12|||
33619125|NCT00622505|102154937|FG001|Overall Study|Withdrawal by Subject|5|||
33619126|NCT00622505|102154936|FG000|Overall Study|Administrative Problems|2|||
33619127|NCT00622505|102154937|FG001|Overall Study|Administrative Problems|4|||
33619128|NCT00622505|102154936|FG000|Overall Study|Death|2|||
33352003|NCT00868790|101172502|FG010|Period 4|Abnormal ALT/AST|0|||
33352004|NCT00868790|101172503|FG011|Period 4|Abnormal ALT/AST|0|||
33352005|NCT00868790|101172504|FG012|Period 4|Abnormal ALT/AST|0|||
33352006|NCT00868790|101172505|FG013|Period 4|Abnormal ALT/AST|0|||
33352007|NCT00868790|101172492|FG000|Post-study|Withdrawal by Subject|0|||
33352008|NCT00868790|101172493|FG001|Post-study|Withdrawal by Subject|0|||
33352009|NCT00868790|101172494|FG002|Post-study|Withdrawal by Subject|0|||
33352010|NCT00868790|101172495|FG003|Post-study|Withdrawal by Subject|0|||
33352011|NCT00868790|101172496|FG004|Post-study|Withdrawal by Subject|1|||
33352012|NCT00868790|101172497|FG005|Post-study|Withdrawal by Subject|0|||
33352013|NCT00868790|101172498|FG006|Post-study|Withdrawal by Subject|0|||
33352014|NCT00868790|101172499|FG007|Post-study|Withdrawal by Subject|0|||
33352015|NCT00868790|101172500|FG008|Post-study|Withdrawal by Subject|0|||
33352016|NCT00868790|101172501|FG009|Post-study|Withdrawal by Subject|0|||
33352017|NCT00868790|101172502|FG010|Post-study|Withdrawal by Subject|0|||
33352018|NCT00868790|101172503|FG011|Post-study|Withdrawal by Subject|0|||
33352019|NCT00868790|101172504|FG012|Post-study|Withdrawal by Subject|0|||
33352020|NCT00868790|101172505|FG013|Post-study|Withdrawal by Subject|0|||
33352021|NCT00868790|101172492|FG000|Post-study|Excluded Medication|0|||
33411949|NCT03433482|101397255|FG001|Overall Study|Withdrawal by Subject|0|||
33411950|NCT03433482|101397256|FG002|Overall Study|Withdrawal by Subject|1|||
33619129|NCT00622505|102154937|FG001|Overall Study|Death|2|||
33619130|NCT03275285|102154938|FG000|Overall Study|Ongoing|45|||
33619131|NCT03275285|102154939|FG001|Overall Study|Ongoing|69|||
33619132|NCT00369577|102154942|FG000|Overall Study|Withdrawal by Subject|0|||
33619133|NCT00369577|102154943|FG001|Overall Study|Withdrawal by Subject|0|||
33217706|NCT02332720|100695826|FG018|Part A and Part B|Withdrawal by Subject|0|||
33217707|NCT02332720|100695827|FG019|Part A and Part B|Withdrawal by Subject|1|||
33411951|NCT03433482|101397257|FG003|Overall Study|Withdrawal by Subject|0|||
33411952|NCT03433482|101397254|FG000|Overall Study|Unknown reason|0|||
33411953|NCT03433482|101397255|FG001|Overall Study|Unknown reason|0|||
33411954|NCT03433482|101397256|FG002|Overall Study|Unknown reason|2|||
33411955|NCT03433482|101397257|FG003|Overall Study|Unknown reason|0|||
33619134|NCT00369577|102154944|FG002|Overall Study|Withdrawal by Subject|1|||
33619135|NCT03777059|102154947|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
33619136|NCT03777059|102154948|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
33352022|NCT00868790|101172493|FG001|Post-study|Excluded Medication|0|||
33352023|NCT00868790|101172494|FG002|Post-study|Excluded Medication|0|||
33352024|NCT00868790|101172495|FG003|Post-study|Excluded Medication|0|||
33352025|NCT00868790|101172496|FG004|Post-study|Excluded Medication|0|||
33352026|NCT00868790|101172497|FG005|Post-study|Excluded Medication|0|||
33352027|NCT00868790|101172498|FG006|Post-study|Excluded Medication|0|||
33352028|NCT00868790|101172499|FG007|Post-study|Excluded Medication|2|||
33411956|NCT00795886|101397260|FG000|Overall Study|Death|10|||
33352029|NCT00868790|101172500|FG008|Post-study|Excluded Medication|0|||
33352030|NCT00868790|101172501|FG009|Post-study|Excluded Medication|1|||
33352031|NCT00868790|101172502|FG010|Post-study|Excluded Medication|0|||
33352032|NCT00868790|101172503|FG011|Post-study|Excluded Medication|0|||
33352033|NCT00868790|101172504|FG012|Post-study|Excluded Medication|0|||
33352034|NCT00868790|101172505|FG013|Post-study|Excluded Medication|0|||
33619137|NCT03777059|102154949|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
33619138|NCT03777059|102154950|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
33619139|NCT03777059|102154947|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
33619140|NCT03777059|102154948|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
33619141|NCT03777059|102154949|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
33619142|NCT03777059|102154950|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
33619143|NCT03777059|102154947|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
33619144|NCT03777059|102154948|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
33619145|NCT03777059|102154949|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
33619146|NCT03777059|102154950|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
33619147|NCT03777059|102154947|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
33619148|NCT03777059|102154948|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
33619149|NCT03777059|102154949|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
33619150|NCT03777059|102154950|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
33619151|NCT03777059|102154947|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
33619152|NCT03777059|102154948|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
33619153|NCT03777059|102154949|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
33619154|NCT03777059|102154950|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
33619155|NCT03777059|102154947|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
33352035|NCT02604264|101172506|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
33411957|NCT00938015|101397261|FG000|Overall Study|Death|2|||
33619156|NCT03777059|102154948|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
33619157|NCT03777059|102154949|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
33619158|NCT03777059|102154950|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
33619159|NCT03777059|102154947|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
33619160|NCT03777059|102154948|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
33619161|NCT03777059|102154949|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
33619162|NCT03777059|102154950|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
33619163|NCT03777059|102154947|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
33619164|NCT03777059|102154948|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
33619165|NCT03777059|102154949|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
33352036|NCT02604264|101172507|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
33352037|NCT01614964|101172511|FG000|Overall Study|Withdrawal by Subject|2|||
33352038|NCT01614964|101172512|FG001|Overall Study|Withdrawal by Subject|0|||
33411958|NCT00938015|101397261|FG000|Overall Study|Lost to Follow-up|32|||
33411959|NCT00938015|101397261|FG000|Overall Study|Adverse Event|32|||
33411960|NCT00938015|101397261|FG000|Overall Study|Non-responder|52|||
33411961|NCT00938015|101397261|FG000|Overall Study|Reason not related to Etanercept|29|||
33411962|NCT01711736|101397262|FG000|Overall Study|Lost to Follow-up|4|||
33411963|NCT01711736|101397263|FG001|Overall Study|Lost to Follow-up|1|||
33411964|NCT01711736|101397262|FG000|Overall Study|Withdrawal by Subject|6|||
33619166|NCT03777059|102154950|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
33619167|NCT03777059|102154947|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
33619168|NCT03777059|102154948|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
33619169|NCT03777059|102154949|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
33619170|NCT03777059|102154950|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
33619171|NCT03777059|102154947|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
33619172|NCT03777059|102154948|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
33619173|NCT03777059|102154949|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
33352039|NCT01614964|101172511|FG000|Overall Study|Lost to Follow-up|3|||
33352040|NCT01614964|101172512|FG001|Overall Study|Lost to Follow-up|0|||
33352041|NCT01551745|101172515|FG000|Overall Study|Withdrawal by Subject|1|||
33352042|NCT01551745|101172515|FG000|Overall Study|Disease Progression|2|||
33352043|NCT03093402|101172518|FG000|Overall Study|Lost to Follow-up|1|||
33352044|NCT03093402|101172519|FG001|Overall Study|Lost to Follow-up|0|||
33352045|NCT03093402|101172520|FG002|Overall Study|Lost to Follow-up|0|||
33352046|NCT03093402|101172521|FG003|Overall Study|Lost to Follow-up|0|||
33352047|NCT03093402|101172518|FG000|Overall Study|Withdrawal by Subject|3|||
33352048|NCT03093402|101172519|FG001|Overall Study|Withdrawal by Subject|3|||
33352049|NCT03093402|101172520|FG002|Overall Study|Withdrawal by Subject|0|||
33352050|NCT03093402|101172521|FG003|Overall Study|Withdrawal by Subject|1|||
33352051|NCT03093402|101172518|FG000|Overall Study|Withdrew prior to dosing|2|||
33352052|NCT03093402|101172519|FG001|Overall Study|Withdrew prior to dosing|1|||
33352053|NCT03093402|101172520|FG002|Overall Study|Withdrew prior to dosing|2|||
33352054|NCT03093402|101172521|FG003|Overall Study|Withdrew prior to dosing|3|||
33352055|NCT03093402|101172518|FG000|Overall Study|Ineligible for study|1|||
33352056|NCT03093402|101172519|FG001|Overall Study|Ineligible for study|0|||
33352057|NCT03093402|101172520|FG002|Overall Study|Ineligible for study|0|||
33352058|NCT03093402|101172521|FG003|Overall Study|Ineligible for study|0|||
33352059|NCT03093402|101172518|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
33352060|NCT03093402|101172519|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
33352061|NCT03093402|101172520|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
33352062|NCT03093402|101172521|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
33352063|NCT03772327|101172522|FG000|Overall Study|Lost to Follow-up|3|||
33352064|NCT03772327|101172523|FG001|Overall Study|Lost to Follow-up|4|||
33352065|NCT03772327|101172522|FG000|Overall Study|Withdrawal by Subject|2|||
33352066|NCT03772327|101172523|FG001|Overall Study|Withdrawal by Subject|3|||
33352067|NCT00260208|101172524|FG000|Overall Study|Subject withdrew consent|11|||
33352068|NCT00260208|101172525|FG001|Overall Study|Subject withdrew consent|7|||
33352069|NCT00260208|101172524|FG000|Overall Study|Lost to Follow-up|6|||
33352070|NCT00260208|101172525|FG001|Overall Study|Lost to Follow-up|1|||
33352071|NCT00260208|101172524|FG000|Overall Study|Death|12|||
33352072|NCT00260208|101172525|FG001|Overall Study|Death|10|||
33352073|NCT00260208|101172524|FG000|Overall Study|Missing|18|||
33352074|NCT00260208|101172525|FG001|Overall Study|Missing|16|||
33352075|NCT03182738|101172526|FG000|Overall Study|Lost to Follow-up|9|||
33352076|NCT03182738|101172527|FG001|Overall Study|Lost to Follow-up|3|||
33352077|NCT03182738|101172526|FG000|Overall Study|Pregnancy|0|||
33352078|NCT03182738|101172527|FG001|Overall Study|Pregnancy|1|||
33411965|NCT01711736|101397263|FG001|Overall Study|Withdrawal by Subject|6|||
33619174|NCT03777059|102154950|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
33619175|NCT03777059|102154947|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
33619176|NCT03777059|102154948|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
33619177|NCT03777059|102154949|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
33619178|NCT03777059|102154950|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
33619179|NCT01687296|102154952|FG000|Overall Study|Lack of Efficacy|1|||
33619180|NCT01687296|102154953|FG001|Overall Study|Lack of Efficacy|1|||
33619181|NCT01687296|102154952|FG000|Overall Study|Protocol Violation|0|||
33411966|NCT01711736|101397262|FG000|Overall Study|Migrated/moved from study area|2|||
33619182|NCT01687296|102154953|FG001|Overall Study|Protocol Violation|1|||
33352079|NCT03182738|101172526|FG000|Overall Study|Withdrawal by Subject|0|||
33352080|NCT03182738|101172527|FG001|Overall Study|Withdrawal by Subject|1|||
33352081|NCT01145560|101172544|FG000|Overall Study|Withdrawal by Subject|2|||
33352082|NCT01145560|101172545|FG001|Overall Study|Withdrawal by Subject|1|||
33352083|NCT01145560|101172546|FG002|Overall Study|Withdrawal by Subject|0|||
33352084|NCT01145560|101172544|FG000|Overall Study|Lost to Follow-up|1|||
33352085|NCT01145560|101172545|FG001|Overall Study|Lost to Follow-up|1|||
33352086|NCT01145560|101172546|FG002|Overall Study|Lost to Follow-up|1|||
33352087|NCT01145560|101172544|FG000|Overall Study|No study drug by 24h after organ failure|1|||
33411967|NCT01711736|101397263|FG001|Overall Study|Migrated/moved from study area|1|||
33411968|NCT01740297|101397264|FG000|Overall Study|Withdrawal by Subject|4|||
33411969|NCT01740297|101397265|FG001|Overall Study|Withdrawal by Subject|16|||
33411970|NCT01740297|101397266|FG002|Overall Study|Withdrawal by Subject|17|||
33411971|NCT01740297|101397264|FG000|Overall Study|Death|8|||
33411972|NCT01740297|101397265|FG001|Overall Study|Death|46|||
33619183|NCT01687296|102154952|FG000|Overall Study|Withdrawal by Subject|6|||
33619184|NCT01687296|102154953|FG001|Overall Study|Withdrawal by Subject|3|||
33619185|NCT01217463|102154954|FG000|Overall Study|Adverse Event|8|||
33619186|NCT01217463|102154955|FG001|Overall Study|Adverse Event|5|||
33619187|NCT01217463|102154954|FG000|Overall Study|Physician Decision|0|||
33619188|NCT01217463|102154955|FG001|Overall Study|Physician Decision|1|||
33619189|NCT01217463|102154954|FG000|Overall Study|Withdrawal by Subject|3|||
33619190|NCT01217463|102154955|FG001|Overall Study|Withdrawal by Subject|0|||
33619191|NCT01217463|102154954|FG000|Overall Study|Surgery on the Target Limb|0|||
33619192|NCT01217463|102154955|FG001|Overall Study|Surgery on the Target Limb|1|||
33619193|NCT01217463|102154954|FG000|Overall Study|Patient Non-compliant|1|||
33619194|NCT01217463|102154955|FG001|Overall Study|Patient Non-compliant|0|||
33619195|NCT01217463|102154954|FG000|Overall Study|Other|1|||
33619196|NCT01217463|102154955|FG001|Overall Study|Other|1|||
33619197|NCT02475278|102154965|FG000|Overall Study|Lost to Follow-up|1|||
33619198|NCT02475278|102154965|FG000|Overall Study|Reason Not Specified|1|||
33552372|NCT01617967|101920319|FG000|Overall Study|Withdrawal by Subject|0|||
33552373|NCT01617967|101920320|FG001|Overall Study|Withdrawal by Subject|0|||
33552374|NCT01617967|101920321|FG002|Overall Study|Withdrawal by Subject|0|||
33552375|NCT01617967|101920322|FG003|Overall Study|Withdrawal by Subject|0|||
33552376|NCT01617967|101920323|FG004|Overall Study|Withdrawal by Subject|0|||
33552377|NCT01617967|101920324|FG005|Overall Study|Withdrawal by Subject|1|||
33552378|NCT01617967|101920319|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
33552379|NCT01617967|101920320|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
33552380|NCT01617967|101920321|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
33552381|NCT01617967|101920322|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
33552382|NCT01617967|101920323|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
33552383|NCT01617967|101920324|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
33552384|NCT01717859|101920325|FG000|Overall Study|Adverse Event|5|||
33552385|NCT01717859|101920325|FG000|Overall Study|Moved out of state|1|||
33552386|NCT01717859|101920325|FG000|Overall Study|Patient concerned about mental health|1|||
33552387|NCT01717859|101920325|FG000|Overall Study|Lost to Follow-up|1|||
33552388|NCT01717859|101920325|FG000|Overall Study|Withdrawal by Subject|2|||
33552389|NCT01316900|101920326|FG000|Overall Study|Adverse Event|10|||
33552390|NCT01316900|101920327|FG001|Overall Study|Adverse Event|10|||
33552391|NCT01316900|101920328|FG002|Overall Study|Adverse Event|15|||
33552392|NCT01316900|101920329|FG003|Overall Study|Adverse Event|9|||
33552393|NCT01316900|101920326|FG000|Overall Study|Lack of Efficacy|17|||
33552394|NCT01316900|101920327|FG001|Overall Study|Lack of Efficacy|9|||
33552395|NCT01316900|101920328|FG002|Overall Study|Lack of Efficacy|5|||
33552396|NCT01316900|101920329|FG003|Overall Study|Lack of Efficacy|7|||
33552397|NCT01316900|101920326|FG000|Overall Study|Protocol Violation|7|||
33552398|NCT01316900|101920327|FG001|Overall Study|Protocol Violation|1|||
33552399|NCT01316900|101920328|FG002|Overall Study|Protocol Violation|4|||
33552400|NCT01316900|101920329|FG003|Overall Study|Protocol Violation|0|||
33552401|NCT01316900|101920326|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
33552402|NCT01316900|101920327|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
33552403|NCT01316900|101920328|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
33552404|NCT01316900|101920329|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
33552405|NCT01316900|101920326|FG000|Overall Study|Lost to Follow-up|1|||
33552406|NCT01316900|101920327|FG001|Overall Study|Lost to Follow-up|0|||
33552407|NCT01316900|101920328|FG002|Overall Study|Lost to Follow-up|1|||
33552408|NCT01316900|101920329|FG003|Overall Study|Lost to Follow-up|1|||
33552409|NCT01316900|101920326|FG000|Overall Study|Withdrawal by Subject|7|||
33552410|NCT01316900|101920327|FG001|Overall Study|Withdrawal by Subject|8|||
33552411|NCT01316900|101920328|FG002|Overall Study|Withdrawal by Subject|6|||
33552412|NCT01316900|101920329|FG003|Overall Study|Withdrawal by Subject|9|||
33552413|NCT03018938|101920338|FG000|Overall Study|Death|0|||
33552414|NCT03018938|101920339|FG001|Overall Study|Death|1|||
33552415|NCT03018938|101920338|FG000|Overall Study|Lost to Follow-up|21|||
33552416|NCT03018938|101920339|FG001|Overall Study|Lost to Follow-up|32|||
33552417|NCT03018938|101920338|FG000|Overall Study|Withdrawal by Subject|38|||
33552418|NCT03018938|101920339|FG001|Overall Study|Withdrawal by Subject|45|||
33552419|NCT03018938|101920338|FG000|Overall Study|Physician Decision|3|||
33552420|NCT03018938|101920339|FG001|Overall Study|Physician Decision|2|||
33552421|NCT03018938|101920338|FG000|Overall Study|Sponsor Decision|0|||
33619199|NCT02678351|102154966|FG000|Overall Study|Withdrawal by Subject|1|||
33619200|NCT00082407|102154967|FG000|Overall Study|Adverse Event|20|||
33619201|NCT00082407|102154968|FG001|Overall Study|Adverse Event|0|||
33619202|NCT00082407|102154967|FG000|Overall Study|Protocol Violation|14|||
33411973|NCT01740297|101397266|FG002|Overall Study|Death|40|||
33411974|NCT01740297|101397264|FG000|Overall Study|Lost to Follow-up|1|||
33411975|NCT01740297|101397265|FG001|Overall Study|Lost to Follow-up|2|||
33411976|NCT01740297|101397266|FG002|Overall Study|Lost to Follow-up|4|||
33411977|NCT02513732|101397267|FG000|Overall Study|Lost to Follow-up|11|||
33411978|NCT02513732|101397267|FG000|Overall Study|Death|9|||
33411979|NCT02513732|101397267|FG000|Overall Study|Changing hospital|2|||
33411980|NCT03417245|101397271|FG000|Overall Study|Adverse Event|1|||
33411981|NCT03417245|101397272|FG001|Overall Study|Adverse Event|0|||
33352088|NCT01145560|101172545|FG001|Overall Study|No study drug by 24h after organ failure|0|||
33352089|NCT01145560|101172546|FG002|Overall Study|No study drug by 24h after organ failure|0|||
33352090|NCT01145560|101172544|FG000|Overall Study|Accidental unblinding of study treatment|0|||
33352091|NCT01145560|101172545|FG001|Overall Study|Accidental unblinding of study treatment|1|||
33352092|NCT01145560|101172546|FG002|Overall Study|Accidental unblinding of study treatment|0|||
33352093|NCT01145560|101172544|FG000|Overall Study|False insurance information|0|||
33352094|NCT01145560|101172545|FG001|Overall Study|False insurance information|1|||
33352095|NCT01145560|101172546|FG002|Overall Study|False insurance information|0|||
33352096|NCT01145560|101172544|FG000|Overall Study|Withdrawal of therapy|0|||
33352097|NCT01145560|101172545|FG001|Overall Study|Withdrawal of therapy|0|||
33352098|NCT01145560|101172546|FG002|Overall Study|Withdrawal of therapy|1|||
33352099|NCT02601573|101172547|FG000|Overall Study|Lost to Follow-up|0|||
33352100|NCT02601573|101172548|FG001|Overall Study|Lost to Follow-up|3|||
33352101|NCT02601573|101172549|FG002|Overall Study|Lost to Follow-up|1|||
33352102|NCT02601573|101172550|FG003|Overall Study|Lost to Follow-up|0|||
33352103|NCT02601573|101172551|FG004|Overall Study|Lost to Follow-up|2|||
33352104|NCT02601573|101172547|FG000|Overall Study|Withdrawal by Subject|0|||
33352105|NCT02601573|101172548|FG001|Overall Study|Withdrawal by Subject|1|||
33352106|NCT02601573|101172549|FG002|Overall Study|Withdrawal by Subject|0|||
33352107|NCT02601573|101172550|FG003|Overall Study|Withdrawal by Subject|1|||
33352108|NCT02601573|101172551|FG004|Overall Study|Withdrawal by Subject|0|||
33352109|NCT01431287|101176429|FG000|Overall Study|not treated|0|||
33352110|NCT01431287|101176430|FG001|Overall Study|not treated|0|||
33352111|NCT01431287|101176431|FG002|Overall Study|not treated|1|||
33352112|NCT01431287|101176432|FG003|Overall Study|not treated|0|||
33352113|NCT01431287|101176433|FG004|Overall Study|not treated|0|||
33352114|NCT01431287|101176429|FG000|Overall Study|Adverse Event|59|||
33352115|NCT01431287|101176430|FG001|Overall Study|Adverse Event|57|||
33352116|NCT01431287|101176431|FG002|Overall Study|Adverse Event|53|||
33352117|NCT01431287|101176432|FG003|Overall Study|Adverse Event|33|||
33352118|NCT01431287|101176433|FG004|Overall Study|Adverse Event|41|||
33352119|NCT01431287|101176429|FG000|Overall Study|Non compliant with protocol|6|||
33352120|NCT01431287|101176430|FG001|Overall Study|Non compliant with protocol|6|||
33352121|NCT01431287|101176431|FG002|Overall Study|Non compliant with protocol|5|||
33352122|NCT01431287|101176432|FG003|Overall Study|Non compliant with protocol|6|||
33352123|NCT01431287|101176433|FG004|Overall Study|Non compliant with protocol|5|||
33352124|NCT01431287|101176429|FG000|Overall Study|Lost to Follow-up|0|||
33352125|NCT01431287|101176430|FG001|Overall Study|Lost to Follow-up|3|||
33352126|NCT01431287|101176431|FG002|Overall Study|Lost to Follow-up|2|||
33352127|NCT01431287|101176432|FG003|Overall Study|Lost to Follow-up|3|||
33352128|NCT01431287|101176433|FG004|Overall Study|Lost to Follow-up|1|||
33352129|NCT01431287|101176429|FG000|Overall Study|Consent withdrawn not due to AE|29|||
33352130|NCT01431287|101176430|FG001|Overall Study|Consent withdrawn not due to AE|30|||
33352131|NCT01431287|101176431|FG002|Overall Study|Consent withdrawn not due to AE|34|||
33352132|NCT01431287|101176432|FG003|Overall Study|Consent withdrawn not due to AE|19|||
33411982|NCT03417245|101397271|FG000|Overall Study|Protocol Violation|1|||
33217708|NCT02332720|100695828|FG020|Part A and Part B|Withdrawal by Subject|0|||
33217709|NCT02332720|100695829|FG021|Part A and Part B|Withdrawal by Subject|0|||
33352133|NCT01431287|101176433|FG004|Overall Study|Consent withdrawn not due to AE|29|||
33352134|NCT01431287|101176429|FG000|Overall Study|not stated above|4|||
33352135|NCT01431287|101176430|FG001|Overall Study|not stated above|2|||
33352136|NCT01431287|101176431|FG002|Overall Study|not stated above|2|||
33352137|NCT01431287|101176432|FG003|Overall Study|not stated above|2|||
33352138|NCT01431287|101176433|FG004|Overall Study|not stated above|1|||
33352139|NCT00793793|101176434|FG000|Overall Study|Adverse Event|0|||
33352140|NCT00793793|101176435|FG001|Overall Study|Adverse Event|0|||
33352141|NCT00793793|101176436|FG002|Overall Study|Adverse Event|1|||
33352142|NCT00793793|101176437|FG003|Overall Study|Adverse Event|1|||
33352143|NCT00793793|101176438|FG004|Overall Study|Adverse Event|0|||
33352144|NCT00793793|101176439|FG005|Overall Study|Adverse Event|1|||
33411983|NCT03417245|101397272|FG001|Overall Study|Protocol Violation|0|||
33411984|NCT03417245|101397271|FG000|Overall Study|Withdrawal by Subject|1|||
33217710|NCT02332720|100695830|FG022|Part A and Part B|Withdrawal by Subject|0|||
33217711|NCT03338894|100695832|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
33352145|NCT00793793|101176440|FG006|Overall Study|Adverse Event|2|||
33352146|NCT00793793|101176441|FG007|Overall Study|Adverse Event|0|||
33352147|NCT00793793|101176442|FG008|Overall Study|Adverse Event|0|||
33352148|NCT00793793|101176443|FG009|Overall Study|Adverse Event|0|||
33352149|NCT00793793|101176444|FG010|Overall Study|Adverse Event|0|||
33352150|NCT00793793|101176445|FG011|Overall Study|Adverse Event|2|||
33352151|NCT00793793|101176434|FG000|Overall Study|Protocol Violation|0|||
33352152|NCT00793793|101176435|FG001|Overall Study|Protocol Violation|0|||
33352153|NCT00793793|101176436|FG002|Overall Study|Protocol Violation|0|||
33352154|NCT00793793|101176437|FG003|Overall Study|Protocol Violation|1|||
33352155|NCT00793793|101176438|FG004|Overall Study|Protocol Violation|0|||
33352156|NCT00793793|101176439|FG005|Overall Study|Protocol Violation|0|||
33352157|NCT00793793|101176440|FG006|Overall Study|Protocol Violation|0|||
33352158|NCT00793793|101176441|FG007|Overall Study|Protocol Violation|0|||
33352159|NCT00793793|101176442|FG008|Overall Study|Protocol Violation|0|||
33352160|NCT00793793|101176443|FG009|Overall Study|Protocol Violation|0|||
33352161|NCT00793793|101176444|FG010|Overall Study|Protocol Violation|0|||
33352162|NCT00793793|101176445|FG011|Overall Study|Protocol Violation|0|||
33352163|NCT00793793|101176434|FG000|Overall Study|Lost to Follow-up|0|||
33352164|NCT00793793|101176435|FG001|Overall Study|Lost to Follow-up|0|||
33352165|NCT00793793|101176436|FG002|Overall Study|Lost to Follow-up|1|||
33411985|NCT03417245|101397272|FG001|Overall Study|Withdrawal by Subject|1|||
33411986|NCT00483717|101397277|FG000|Overall Study|Protocol Violation|5|||
33411987|NCT00483717|101397278|FG001|Overall Study|Protocol Violation|7|||
33411988|NCT00483717|101397277|FG000|Overall Study|Time of dosing missing|1|||
33411989|NCT00483717|101397278|FG001|Overall Study|Time of dosing missing|1|||
33411990|NCT00483717|101397277|FG000|Overall Study|No treatment for migraine|16|||
33411991|NCT00483717|101397278|FG001|Overall Study|No treatment for migraine|13|||
33411992|NCT00483717|101397277|FG000|Overall Study|Lost to Follow-up|1|||
33411993|NCT00483717|101397278|FG001|Overall Study|Lost to Follow-up|0|||
33411994|NCT00483717|101397277|FG000|Overall Study|Withdrawal by Subject|1|||
33411995|NCT00483717|101397278|FG001|Overall Study|Withdrawal by Subject|0|||
33411996|NCT00909857|101397279|FG000|Overall Study|Withdrawal by Subject|6|||
33217712|NCT01514448|100695835|FG000|Overall Study|Death|7|||
33217713|NCT01514448|100695836|FG001|Overall Study|Death|8|||
33217714|NCT01514448|100695835|FG000|Overall Study|Withdrawal by Subject|2|||
33411997|NCT00909857|101397280|FG001|Overall Study|Withdrawal by Subject|10|||
33411998|NCT00909857|101397279|FG000|Overall Study|Adverse Event|5|||
33411999|NCT00909857|101397280|FG001|Overall Study|Adverse Event|5|||
33412000|NCT00909857|101397279|FG000|Overall Study|Lost to Follow-up|2|||
33412001|NCT00909857|101397280|FG001|Overall Study|Lost to Follow-up|5|||
33412002|NCT00909857|101397279|FG000|Overall Study|Protocol Violation|2|||
33412003|NCT00909857|101397280|FG001|Overall Study|Protocol Violation|1|||
33412004|NCT00909857|101397279|FG000|Overall Study|Pregnancy|1|||
33412005|NCT00909857|101397280|FG001|Overall Study|Pregnancy|0|||
33412006|NCT00909857|101397279|FG000|Overall Study|Other|1|||
33412007|NCT00909857|101397280|FG001|Overall Study|Other|0|||
33412008|NCT00909857|101397279|FG000|Overall Study|Did not receive study medication|19|||
33412009|NCT00909857|101397280|FG001|Overall Study|Did not receive study medication|24|||
33412010|NCT00978120|101397282|FG000|Overall Study|Death|0|||
33412011|NCT00978120|101397283|FG001|Overall Study|Death|0|||
33412012|NCT00978120|101397284|FG002|Overall Study|Death|0|||
33412013|NCT00978120|101397285|FG003|Overall Study|Death|1|||
33412014|NCT00978120|101397282|FG000|Overall Study|Lost to Follow-up|0|||
33217715|NCT01514448|100695836|FG001|Overall Study|Withdrawal by Subject|0|||
33352166|NCT00793793|101176437|FG003|Overall Study|Lost to Follow-up|0|||
33352167|NCT00793793|101176438|FG004|Overall Study|Lost to Follow-up|0|||
33352168|NCT00793793|101176439|FG005|Overall Study|Lost to Follow-up|0|||
33352169|NCT00793793|101176440|FG006|Overall Study|Lost to Follow-up|0|||
33352170|NCT00793793|101176441|FG007|Overall Study|Lost to Follow-up|0|||
33352171|NCT00793793|101176442|FG008|Overall Study|Lost to Follow-up|1|||
33412015|NCT00978120|101397283|FG001|Overall Study|Lost to Follow-up|0|||
33412016|NCT00978120|101397284|FG002|Overall Study|Lost to Follow-up|3|||
33412017|NCT00978120|101397285|FG003|Overall Study|Lost to Follow-up|0|||
33412018|NCT00978120|101397282|FG000|Overall Study|Withdrawal by Subject|2|||
33412019|NCT00978120|101397283|FG001|Overall Study|Withdrawal by Subject|0|||
33412020|NCT00978120|101397284|FG002|Overall Study|Withdrawal by Subject|0|||
33412021|NCT00978120|101397285|FG003|Overall Study|Withdrawal by Subject|0|||
33412022|NCT00978120|101397282|FG000|Overall Study|Moved out of state|0|||
33412023|NCT00978120|101397283|FG001|Overall Study|Moved out of state|0|||
33352172|NCT00793793|101176443|FG009|Overall Study|Lost to Follow-up|3|||
33412024|NCT00978120|101397284|FG002|Overall Study|Moved out of state|0|||
33412025|NCT00978120|101397285|FG003|Overall Study|Moved out of state|1|||
33412026|NCT02322866|101397286|FG000|Overall Study|Adverse Event|6|||
33412027|NCT02322866|101397287|FG001|Overall Study|Adverse Event|11|||
33412028|NCT02322866|101397286|FG000|Overall Study|Withdrawal of Consent|16|||
33412029|NCT02322866|101397287|FG001|Overall Study|Withdrawal of Consent|25|||
33412030|NCT02322866|101397286|FG000|Overall Study|Lost to Follow-up|36|||
33412031|NCT02322866|101397287|FG001|Overall Study|Lost to Follow-up|39|||
33412032|NCT02322866|101397286|FG000|Overall Study|Protocol Violation|1|||
33412033|NCT02322866|101397287|FG001|Overall Study|Protocol Violation|0|||
33412034|NCT02322866|101397286|FG000|Overall Study|Noncompliance with Treatment|3|||
33412035|NCT02322866|101397287|FG001|Overall Study|Noncompliance with Treatment|4|||
33412036|NCT02322866|101397286|FG000|Overall Study|Lack of Efficacy|3|||
33352173|NCT00793793|101176444|FG010|Overall Study|Lost to Follow-up|1|||
33552422|NCT03018938|101920339|FG001|Overall Study|Sponsor Decision|1|||
33552423|NCT03018938|101920338|FG000|Overall Study|Screen failure-After randomization|4|||
33552424|NCT03018938|101920339|FG001|Overall Study|Screen failure-After randomization|2|||
33552425|NCT03018938|101920338|FG000|Overall Study|Not recorded|0|||
33552426|NCT03018938|101920339|FG001|Overall Study|Not recorded|2|||
33552427|NCT02782468|101920340|FG000|Overall Study|Progressive Disease|2|||
33552428|NCT02782468|101920341|FG001|Overall Study|Progressive Disease|5|||
33552429|NCT02782468|101920342|FG002|Overall Study|Progressive Disease|0|||
33352174|NCT00793793|101176445|FG011|Overall Study|Lost to Follow-up|0|||
33352175|NCT00793793|101176434|FG000|Overall Study|Withdrawal by Subject|0|||
33352176|NCT00793793|101176435|FG001|Overall Study|Withdrawal by Subject|0|||
33352177|NCT00793793|101176436|FG002|Overall Study|Withdrawal by Subject|0|||
33352178|NCT00793793|101176437|FG003|Overall Study|Withdrawal by Subject|0|||
33352179|NCT00793793|101176438|FG004|Overall Study|Withdrawal by Subject|1|||
33352180|NCT00793793|101176439|FG005|Overall Study|Withdrawal by Subject|0|||
33352181|NCT00793793|101176440|FG006|Overall Study|Withdrawal by Subject|0|||
33352182|NCT00793793|101176441|FG007|Overall Study|Withdrawal by Subject|0|||
33352183|NCT00793793|101176442|FG008|Overall Study|Withdrawal by Subject|1|||
33412037|NCT02322866|101397287|FG001|Overall Study|Lack of Efficacy|1|||
33412038|NCT02322866|101397286|FG000|Overall Study|Other Miscellaneous Reasons|6|||
33412039|NCT02322866|101397287|FG001|Overall Study|Other Miscellaneous Reasons|6|||
33412040|NCT02325739|101397293|FG000|Phase I Part|Adverse Event|1|||
33552430|NCT02782468|101920343|FG003|Overall Study|Progressive Disease|4|||
33552431|NCT02782468|101920340|FG000|Overall Study|Adverse Event|0|||
33217716|NCT01514448|100695835|FG000|Overall Study|Lost to Follow-up|2|||
33217717|NCT01514448|100695836|FG001|Overall Study|Lost to Follow-up|0|||
33552432|NCT02782468|101920341|FG001|Overall Study|Adverse Event|2|||
33352184|NCT00793793|101176443|FG009|Overall Study|Withdrawal by Subject|0|||
33352185|NCT00793793|101176444|FG010|Overall Study|Withdrawal by Subject|0|||
33352186|NCT00793793|101176445|FG011|Overall Study|Withdrawal by Subject|0|||
33412041|NCT02325739|101397294|FG001|Phase I Part|Adverse Event|0|||
33352187|NCT00793793|101176434|FG000|Overall Study|reason not specified|0|||
33352188|NCT00793793|101176435|FG001|Overall Study|reason not specified|1|||
33352189|NCT00793793|101176436|FG002|Overall Study|reason not specified|0|||
33352190|NCT00793793|101176437|FG003|Overall Study|reason not specified|1|||
33352191|NCT00793793|101176438|FG004|Overall Study|reason not specified|1|||
33352192|NCT00793793|101176439|FG005|Overall Study|reason not specified|1|||
33352193|NCT00793793|101176440|FG006|Overall Study|reason not specified|2|||
33352194|NCT00793793|101176441|FG007|Overall Study|reason not specified|0|||
33552433|NCT02782468|101920342|FG002|Overall Study|Adverse Event|2|||
33552434|NCT02782468|101920343|FG003|Overall Study|Adverse Event|3|||
33552435|NCT02782468|101920340|FG000|Overall Study|Other|0|||
33552436|NCT02782468|101920341|FG001|Overall Study|Other|0|||
33552437|NCT02782468|101920342|FG002|Overall Study|Other|1|||
33552438|NCT02782468|101920343|FG003|Overall Study|Other|1|||
33552439|NCT02782468|101920340|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
33552440|NCT02782468|101920341|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
33552441|NCT02782468|101920342|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
33552442|NCT02782468|101920343|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
33552443|NCT02782468|101920340|FG000|Overall Study|Symptomatic Deterioration|0|||
33552444|NCT02782468|101920341|FG001|Overall Study|Symptomatic Deterioration|0|||
33412042|NCT02325739|101397295|FG002|Phase I Part|Adverse Event|1|||
33412043|NCT02325739|101397296|FG003|Phase I Part|Adverse Event|2|||
33412044|NCT02325739|101397297|FG004|Phase I Part|Adverse Event|3|||
33412045|NCT02325739|101397298|FG005|Phase I Part|Adverse Event|1|||
33412046|NCT02325739|101397299|FG006|Phase I Part|Adverse Event|0|||
33412047|NCT02325739|101397300|FG007|Phase I Part|Adverse Event|2|||
33412048|NCT02325739|101397301|FG008|Phase I Part|Adverse Event|0|||
33412049|NCT02325739|101397302|FG009|Phase I Part|Adverse Event|0|||
33412050|NCT02325739|101397303|FG010|Phase I Part|Adverse Event|0|||
33412051|NCT02325739|101397293|FG000|Phase I Part|Progressive disease|9|||
33412052|NCT02325739|101397294|FG001|Phase I Part|Progressive disease|6|||
33412053|NCT02325739|101397295|FG002|Phase I Part|Progressive disease|3|||
33412054|NCT02325739|101397296|FG003|Phase I Part|Progressive disease|23|||
33412055|NCT02325739|101397297|FG004|Phase I Part|Progressive disease|14|||
33412056|NCT02325739|101397298|FG005|Phase I Part|Progressive disease|6|||
33412057|NCT02325739|101397299|FG006|Phase I Part|Progressive disease|6|||
33619203|NCT00082407|102154968|FG001|Overall Study|Protocol Violation|12|||
33619204|NCT00082407|102154967|FG000|Overall Study|Patient Decision|13|||
33619205|NCT00082407|102154968|FG001|Overall Study|Patient Decision|6|||
33619206|NCT00082407|102154967|FG000|Overall Study|Physician Decision|5|||
33619207|NCT00082407|102154968|FG001|Overall Study|Physician Decision|3|||
33619208|NCT00082407|102154967|FG000|Overall Study|Loss of Glucose Control|2|||
33352195|NCT00793793|101176442|FG008|Overall Study|reason not specified|7|||
33552445|NCT02782468|101920342|FG002|Overall Study|Symptomatic Deterioration|0|||
33552446|NCT02782468|101920343|FG003|Overall Study|Symptomatic Deterioration|1|||
33552447|NCT02782468|101920340|FG000|Overall Study|Withdrawal by Subject|1|||
33552448|NCT02782468|101920341|FG001|Overall Study|Withdrawal by Subject|0|||
33552449|NCT02782468|101920342|FG002|Overall Study|Withdrawal by Subject|0|||
33552450|NCT02782468|101920343|FG003|Overall Study|Withdrawal by Subject|0|||
33552451|NCT01210443|101920344|FG000|Overall Study|Study terminated by sponsor|2|||
33619209|NCT00082407|102154968|FG001|Overall Study|Loss of Glucose Control|2|||
33619210|NCT00082407|102154967|FG000|Overall Study|Death|2|||
33352196|NCT00793793|101176443|FG009|Overall Study|reason not specified|6|||
33412058|NCT02325739|101397300|FG007|Phase I Part|Progressive disease|3|||
33552452|NCT00669331|101920350|FG000|Randomisation to First Dose|Adverse Event|1|||
33552453|NCT00669331|101920351|FG001|Randomisation to First Dose|Adverse Event|0|||
33552454|NCT00669331|101920350|FG000|Randomisation to First Dose|Protocol Violation|1|||
33552455|NCT00669331|101920351|FG001|Randomisation to First Dose|Protocol Violation|0|||
33619211|NCT00082407|102154968|FG001|Overall Study|Death|1|||
33619212|NCT00082407|102154967|FG000|Overall Study|Lost to Follow-up|0|||
33352197|NCT00793793|101176444|FG010|Overall Study|reason not specified|2|||
33412059|NCT02325739|101397301|FG008|Phase I Part|Progressive disease|0|||
33412060|NCT02325739|101397302|FG009|Phase I Part|Progressive disease|0|||
33412061|NCT02325739|101397303|FG010|Phase I Part|Progressive disease|0|||
33552456|NCT00669331|101920350|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
33552457|NCT00669331|101920351|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
33412062|NCT02325739|101397293|FG000|Phase I Part|Subject/guardian decision|1|||
33412063|NCT02325739|101397294|FG001|Phase I Part|Subject/guardian decision|0|||
33412064|NCT02325739|101397295|FG002|Phase I Part|Subject/guardian decision|1|||
33412065|NCT02325739|101397296|FG003|Phase I Part|Subject/guardian decision|1|||
33412066|NCT02325739|101397297|FG004|Phase I Part|Subject/guardian decision|0|||
33412067|NCT02325739|101397298|FG005|Phase I Part|Subject/guardian decision|0|||
33412068|NCT02325739|101397299|FG006|Phase I Part|Subject/guardian decision|0|||
33412069|NCT02325739|101397300|FG007|Phase I Part|Subject/guardian decision|1|||
33412070|NCT02325739|101397301|FG008|Phase I Part|Subject/guardian decision|0|||
33412071|NCT02325739|101397302|FG009|Phase I Part|Subject/guardian decision|0|||
33412072|NCT02325739|101397303|FG010|Phase I Part|Subject/guardian decision|0|||
33412073|NCT02325739|101397293|FG000|Phase I Part|Death|0|||
33412074|NCT02325739|101397294|FG001|Phase I Part|Death|0|||
33412075|NCT02325739|101397295|FG002|Phase I Part|Death|0|||
33412076|NCT02325739|101397296|FG003|Phase I Part|Death|0|||
33412077|NCT02325739|101397297|FG004|Phase I Part|Death|2|||
33412078|NCT02325739|101397298|FG005|Phase I Part|Death|0|||
33412079|NCT02325739|101397299|FG006|Phase I Part|Death|0|||
33412080|NCT02325739|101397300|FG007|Phase I Part|Death|0|||
33412081|NCT02325739|101397301|FG008|Phase I Part|Death|0|||
33552458|NCT00669331|101920350|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
33552459|NCT00669331|101920351|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
33552460|NCT00669331|101920350|FG000|Randomisation to First Dose|Death|1|||
33552461|NCT00669331|101920351|FG001|Randomisation to First Dose|Death|0|||
33552462|NCT00669331|101920350|FG000|Randomisation to First Dose|Sponsor decision|0|||
33352198|NCT00793793|101176445|FG011|Overall Study|reason not specified|4|||
33352199|NCT00981526|101176448|FG000|Overall Study|Withdrawal by Subject|0|||
33352200|NCT00981526|101176449|FG001|Overall Study|Withdrawal by Subject|2|||
33352201|NCT00981526|101176448|FG000|Overall Study|Physician Decision|4|||
33352202|NCT00981526|101176449|FG001|Overall Study|Physician Decision|4|||
33352203|NCT01193686|101176450|FG000|Overall Study|Withdrawal by Subject|4|||
33352204|NCT01193686|101176451|FG001|Overall Study|Withdrawal by Subject|1|||
33352205|NCT01193686|101176450|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
33352206|NCT01193686|101176451|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
33412082|NCT02325739|101397302|FG009|Phase I Part|Death|0|||
33552463|NCT00669331|101920351|FG001|Randomisation to First Dose|Sponsor decision|1|||
33552464|NCT00669331|101920350|FG000|Randomisation to First Dose|Randomised in error|3|||
33552465|NCT00669331|101920351|FG001|Randomisation to First Dose|Randomised in error|10|||
33552466|NCT00669331|101920350|FG000|Blinded Treatment Period|Adverse Event|16|||
33552467|NCT00669331|101920351|FG001|Blinded Treatment Period|Adverse Event|10|||
33552468|NCT00669331|101920350|FG000|Blinded Treatment Period|Protocol Violation|1|||
33552469|NCT00669331|101920351|FG001|Blinded Treatment Period|Protocol Violation|1|||
33552470|NCT00669331|101920350|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
33552471|NCT00669331|101920351|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
33552472|NCT00669331|101920350|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
33552473|NCT00669331|101920351|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
33552474|NCT00669331|101920350|FG000|Blinded Treatment Period|Death|0|||
33552475|NCT00669331|101920351|FG001|Blinded Treatment Period|Death|2|||
33552476|NCT00669331|101920350|FG000|Blinded Treatment Period|Physician Decision|3|||
33552477|NCT00669331|101920351|FG001|Blinded Treatment Period|Physician Decision|3|||
33552478|NCT00669331|101920350|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
33552479|NCT00669331|101920351|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
33552480|NCT02506036|101920352|FG000|First Intervention (4-6 Weeks)|Death|1|||
33352207|NCT00127127|101176452|FG000|Overall Study|Adverse Event|0|||
33412083|NCT02325739|101397303|FG010|Phase I Part|Death|0|||
33412084|NCT02325739|101397293|FG000|Phase II Part|Adverse Event|0|||
33412085|NCT02325739|101397294|FG001|Phase II Part|Adverse Event|0|||
33552481|NCT02506036|101920353|FG001|First Intervention (4-6 Weeks)|Death|0|||
33552482|NCT02506036|101920352|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
33552483|NCT02506036|101920353|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
33352208|NCT00127127|101176453|FG001|Overall Study|Adverse Event|2|||
33352209|NCT00127127|101176454|FG002|Overall Study|Adverse Event|0|||
33412086|NCT02325739|101397295|FG002|Phase II Part|Adverse Event|0|||
33412087|NCT02325739|101397296|FG003|Phase II Part|Adverse Event|0|||
33412088|NCT02325739|101397297|FG004|Phase II Part|Adverse Event|0|||
33352210|NCT00127127|101176455|FG003|Overall Study|Adverse Event|1|||
33352211|NCT00127127|101176452|FG000|Overall Study|Lack of Efficacy|1|||
33412089|NCT02325739|101397298|FG005|Phase II Part|Adverse Event|0|||
33352212|NCT00127127|101176453|FG001|Overall Study|Lack of Efficacy|3|||
33412090|NCT02325739|101397299|FG006|Phase II Part|Adverse Event|0|||
33412091|NCT02325739|101397300|FG007|Phase II Part|Adverse Event|0|||
33412092|NCT02325739|101397301|FG008|Phase II Part|Adverse Event|4|||
33412093|NCT02325739|101397302|FG009|Phase II Part|Adverse Event|5|||
33412094|NCT02325739|101397303|FG010|Phase II Part|Adverse Event|1|||
33552484|NCT02506036|101920352|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
33552485|NCT02506036|101920353|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
33552486|NCT00973973|101920354|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
33552487|NCT00973973|101920355|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
33552488|NCT00973973|101920354|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
33552489|NCT00973973|101920355|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
33552490|NCT00973973|101920354|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
33552491|NCT00973973|101920355|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
33552492|NCT00973973|101920354|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
33619213|NCT00082407|102154968|FG001|Overall Study|Lost to Follow-up|3|||
33619214|NCT02370420|102154969|FG000|Overall Study|Physician Decision|3|||
33217718|NCT01514448|100695835|FG000|Overall Study|New Cancer Therapy|1|||
33217719|NCT01514448|100695836|FG001|Overall Study|New Cancer Therapy|0|||
33217720|NCT01024608|100695838|FG000|Overall Study|Adverse Event|1|||
33217721|NCT01024608|100695839|FG001|Overall Study|Adverse Event|0|||
33552493|NCT00973973|101920355|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
33552494|NCT00973973|101920354|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
33552495|NCT00973973|101920355|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
33552496|NCT00973973|101920354|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
33552497|NCT00973973|101920355|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
33619215|NCT02370420|102154970|FG001|Overall Study|Physician Decision|3|||
33619216|NCT02370420|102154969|FG000|Overall Study|Lost to Follow-up|11|||
33619217|NCT02370420|102154970|FG001|Overall Study|Lost to Follow-up|9|||
33619218|NCT02114606|102154971|FG000|Overall Study|Unable to swallow Cytosponge|6|||
33619219|NCT00801216|102154974|FG000|Overall Study|Screening Failure|2|||
33619220|NCT02598297|102154977|FG000|Overall Study|Study terminated by Sponsor|21|||
33619221|NCT02598297|102154978|FG001|Overall Study|Study terminated by Sponsor|23|||
33619222|NCT02598297|102154977|FG000|Overall Study|Adverse Event|1|||
33619223|NCT02598297|102154978|FG001|Overall Study|Adverse Event|1|||
33619224|NCT02598297|102154977|FG000|Overall Study|Physician Decision|1|||
33619225|NCT02598297|102154978|FG001|Overall Study|Physician Decision|0|||
33619226|NCT02598297|102154977|FG000|Overall Study|Subject/guardian decision|1|||
33619227|NCT02598297|102154978|FG001|Overall Study|Subject/guardian decision|0|||
33619228|NCT02598297|102154977|FG000|Overall Study|Followed for survival|1|||
33619229|NCT02598297|102154978|FG001|Overall Study|Followed for survival|0|||
33619230|NCT01136408|102154979|FG000|Overall Study|Adverse Event|4|||
33619231|NCT01136408|102154980|FG001|Overall Study|Adverse Event|8|||
33619232|NCT01136408|102154981|FG002|Overall Study|Adverse Event|4|||
33619233|NCT01136408|102154979|FG000|Overall Study|Protocol Violation|1|||
33217722|NCT01024608|100695838|FG000|Overall Study|Withdrawal by Subject|1|||
33217723|NCT01024608|100695839|FG001|Overall Study|Withdrawal by Subject|0|||
33217724|NCT01024608|100695838|FG000|Overall Study|Lost to Follow-up|0|||
33217725|NCT01024608|100695839|FG001|Overall Study|Lost to Follow-up|1|||
33217726|NCT01024608|100695838|FG000|Overall Study|Protocol Violation|0|||
33217727|NCT01024608|100695839|FG001|Overall Study|Protocol Violation|3|||
33217728|NCT01024608|100695838|FG000|Overall Study|Never received study treatment|2|||
33412095|NCT02325739|101397293|FG000|Phase II Part|Physician Decision|0|||
33412096|NCT02325739|101397294|FG001|Phase II Part|Physician Decision|0|||
33412097|NCT02325739|101397295|FG002|Phase II Part|Physician Decision|0|||
33217729|NCT01024608|100695839|FG001|Overall Study|Never received study treatment|0|||
33217730|NCT04721925|100695842|FG000|2-Month Assessment|Lost to Follow-up|5|||
33217731|NCT04721925|100695843|FG001|2-Month Assessment|Lost to Follow-up|3|||
33217732|NCT04721925|100695842|FG000|4-Month Assessment|Lost to Follow-up|3|||
33352213|NCT00127127|101176454|FG002|Overall Study|Lack of Efficacy|0|||
33352214|NCT00127127|101176455|FG003|Overall Study|Lack of Efficacy|2|||
33352215|NCT02162862|101176456|FG000|Overall Study|Lost to Follow-up|0|||
33412098|NCT02325739|101397296|FG003|Phase II Part|Physician Decision|0|||
33412099|NCT02325739|101397297|FG004|Phase II Part|Physician Decision|0|||
33412100|NCT02325739|101397298|FG005|Phase II Part|Physician Decision|0|||
33412101|NCT02325739|101397299|FG006|Phase II Part|Physician Decision|0|||
33412102|NCT02325739|101397300|FG007|Phase II Part|Physician Decision|0|||
33412103|NCT02325739|101397301|FG008|Phase II Part|Physician Decision|0|||
33412104|NCT02325739|101397302|FG009|Phase II Part|Physician Decision|1|||
33412105|NCT02325739|101397303|FG010|Phase II Part|Physician Decision|0|||
33412106|NCT02325739|101397293|FG000|Phase II Part|Progressive disease|0|||
33412107|NCT02325739|101397294|FG001|Phase II Part|Progressive disease|0|||
33412108|NCT02325739|101397295|FG002|Phase II Part|Progressive disease|0|||
33412109|NCT02325739|101397296|FG003|Phase II Part|Progressive disease|0|||
33412110|NCT02325739|101397297|FG004|Phase II Part|Progressive disease|0|||
33412111|NCT02325739|101397298|FG005|Phase II Part|Progressive disease|0|||
33412112|NCT02325739|101397299|FG006|Phase II Part|Progressive disease|0|||
33412113|NCT02325739|101397300|FG007|Phase II Part|Progressive disease|0|||
33412114|NCT02325739|101397301|FG008|Phase II Part|Progressive disease|22|||
33412115|NCT02325739|101397302|FG009|Phase II Part|Progressive disease|29|||
33412116|NCT02325739|101397303|FG010|Phase II Part|Progressive disease|18|||
33412117|NCT02325739|101397293|FG000|Phase II Part|Subject/guardian decision|0|||
33352216|NCT02162862|101176457|FG001|Overall Study|Lost to Follow-up|11|||
33352217|NCT02162862|101176458|FG002|Overall Study|Lost to Follow-up|0|||
33352218|NCT02162862|101176456|FG000|Overall Study|Subject did not feel the med was needed|0|||
33352219|NCT02162862|101176457|FG001|Overall Study|Subject did not feel the med was needed|0|||
33352220|NCT02162862|101176458|FG002|Overall Study|Subject did not feel the med was needed|4|||
33352221|NCT02945657|101176459|FG000|Overall Study|Adverse Event|1|||
33352222|NCT02945657|101176459|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
33352223|NCT03244059|101176460|FG000|Specific Aim 1|Physician Decision|1|||
33352224|NCT03244059|101176461|FG001|Specific Aim 1|Physician Decision|0|||
33352225|NCT03244059|101176460|FG000|Specific Aim 2|Physician Decision|1|||
33352226|NCT03244059|101176461|FG001|Specific Aim 2|Physician Decision|0|||
33352227|NCT01624194|101176466|FG000|Overall Study|Lost to Follow-up|1|||
33412118|NCT02325739|101397294|FG001|Phase II Part|Subject/guardian decision|0|||
33412119|NCT02325739|101397295|FG002|Phase II Part|Subject/guardian decision|0|||
33412120|NCT02325739|101397296|FG003|Phase II Part|Subject/guardian decision|0|||
33412121|NCT02325739|101397297|FG004|Phase II Part|Subject/guardian decision|0|||
33412122|NCT02325739|101397298|FG005|Phase II Part|Subject/guardian decision|0|||
33412123|NCT02325739|101397299|FG006|Phase II Part|Subject/guardian decision|0|||
33552498|NCT00973973|101920354|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
33552499|NCT00973973|101920355|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
33552500|NCT00973973|101920354|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
33552501|NCT00973973|101920355|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
33552502|NCT00973973|101920354|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
33552503|NCT00973973|101920355|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
33552504|NCT00973973|101920354|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
33552505|NCT00973973|101920355|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
33552506|NCT00973973|101920354|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
33552507|NCT00973973|101920355|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
33412124|NCT02325739|101397300|FG007|Phase II Part|Subject/guardian decision|0|||
33412125|NCT02325739|101397301|FG008|Phase II Part|Subject/guardian decision|4|||
33217733|NCT04721925|100695843|FG001|4-Month Assessment|Lost to Follow-up|6|||
33217734|NCT03645759|100695844|FG000|Overall Study|Lost to Follow-up|3|||
33217735|NCT03645759|100695845|FG001|Overall Study|Lost to Follow-up|2|||
33352228|NCT01624194|101176467|FG001|Overall Study|Lost to Follow-up|0|||
33352229|NCT01624194|101176466|FG000|Overall Study|Withdrawal by Subject|1|||
33352230|NCT01624194|101176467|FG001|Overall Study|Withdrawal by Subject|0|||
33352231|NCT01335971|101176468|FG000|Overall Study|Withdrawal by Subject|1|||
33352232|NCT01335971|101176469|FG001|Overall Study|Withdrawal by Subject|0|||
33412126|NCT02325739|101397302|FG009|Phase II Part|Subject/guardian decision|1|||
33412127|NCT02325739|101397303|FG010|Phase II Part|Subject/guardian decision|1|||
33412128|NCT00351611|101397305|FG000|Overall Study|Adverse Event|11|||
33412129|NCT00351611|101397306|FG001|Overall Study|Adverse Event|3|||
33412130|NCT00351611|101397305|FG000|Overall Study|Death|1|||
33412131|NCT00351611|101397306|FG001|Overall Study|Death|0|||
33412132|NCT00351611|101397305|FG000|Overall Study|Lost to Follow-up|1|||
33412133|NCT00351611|101397306|FG001|Overall Study|Lost to Follow-up|0|||
33412134|NCT00351611|101397305|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
33412135|NCT00351611|101397306|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
33412136|NCT00351611|101397305|FG000|Overall Study|Other|1|||
33412137|NCT00351611|101397306|FG001|Overall Study|Other|0|||
33412138|NCT00351611|101397305|FG000|Overall Study|Protocol Violation|0|||
33412139|NCT00351611|101397306|FG001|Overall Study|Protocol Violation|2|||
33412140|NCT04629534|101397310|FG000|Overall Study|Physician Decision|1|||
33412141|NCT04629534|101397311|FG001|Overall Study|Physician Decision|0|||
33412142|NCT04629534|101397310|FG000|Overall Study|Protocol Violation|0|||
33412143|NCT04629534|101397311|FG001|Overall Study|Protocol Violation|2|||
33412144|NCT00422058|101397312|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
33412145|NCT00422058|101397313|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
33412146|NCT00422058|101397314|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
33412147|NCT00422058|101397315|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
33412148|NCT00422058|101397316|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
33412149|NCT00422058|101397317|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
33412150|NCT00422058|101397312|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
33412151|NCT00422058|101397313|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
33412152|NCT00422058|101397314|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
33412153|NCT00422058|101397315|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
33412154|NCT00422058|101397316|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
33412155|NCT00422058|101397317|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
33412156|NCT00422058|101397312|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
33412157|NCT00422058|101397313|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
33412158|NCT00422058|101397314|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
33217736|NCT00136955|100695846|FG000|Overall Study|Adverse Event|8|||
33352233|NCT01335971|101176470|FG002|Overall Study|Withdrawal by Subject|0|||
33352234|NCT01335971|101176468|FG000|Overall Study|Did not complete bronchoscopy|1|||
33352235|NCT01335971|101176469|FG001|Overall Study|Did not complete bronchoscopy|1|||
33352236|NCT01335971|101176470|FG002|Overall Study|Did not complete bronchoscopy|1|||
33352237|NCT03192904|101176474|FG000|Overall Study|Physician Decision|3|||
33352238|NCT03192904|101176475|FG001|Overall Study|Physician Decision|1|||
33352239|NCT03192904|101176474|FG000|Overall Study|Lost to Follow-up|0|||
33352240|NCT03192904|101176475|FG001|Overall Study|Lost to Follow-up|1|||
33352241|NCT00891735|101176476|FG000|Overall Study|Adverse Event|2|||
33352242|NCT00891735|101176477|FG001|Overall Study|Adverse Event|0|||
33352243|NCT00891735|101176478|FG002|Overall Study|Adverse Event|2|||
33352244|NCT00891735|101176479|FG003|Overall Study|Adverse Event|0|||
33352245|NCT00891735|101176476|FG000|Overall Study|Death|8|||
33352246|NCT00891735|101176477|FG001|Overall Study|Death|5|||
33352247|NCT00891735|101176478|FG002|Overall Study|Death|4|||
33352248|NCT00891735|101176479|FG003|Overall Study|Death|5|||
33352249|NCT00891735|101176476|FG000|Overall Study|Lost to Follow-up|2|||
33352250|NCT00891735|101176477|FG001|Overall Study|Lost to Follow-up|2|||
33352251|NCT00891735|101176478|FG002|Overall Study|Lost to Follow-up|2|||
33352252|NCT00891735|101176479|FG003|Overall Study|Lost to Follow-up|2|||
33352253|NCT00891735|101176476|FG000|Overall Study|Physician's decision to withdraw patient|1|||
33352254|NCT00891735|101176477|FG001|Overall Study|Physician's decision to withdraw patient|0|||
33412159|NCT00422058|101397315|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
33412160|NCT00422058|101397316|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
33412161|NCT00422058|101397317|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
33412162|NCT00422058|101397312|FG000|Double-Blind, Week 0-20|Other|11|||
33412163|NCT00422058|101397313|FG001|Double-Blind, Week 0-20|Other|3|||
33412164|NCT00422058|101397314|FG002|Double-Blind, Week 0-20|Other|8|||
33412165|NCT00422058|101397315|FG003|Double-Blind, Week 0-20|Other|8|||
33412166|NCT00422058|101397316|FG004|Double-Blind, Week 0-20|Other|4|||
33412167|NCT00422058|101397317|FG005|Double-Blind, Week 0-20|Other|10|||
33412168|NCT00422058|101397312|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
33412169|NCT00422058|101397313|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
33619234|NCT01136408|102154980|FG001|Overall Study|Protocol Violation|1|||
33412170|NCT00422058|101397314|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
33412171|NCT00422058|101397315|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
33412172|NCT00422058|101397316|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
33352255|NCT00891735|101176478|FG002|Overall Study|Physician's decision to withdraw patient|0|||
33352256|NCT00891735|101176479|FG003|Overall Study|Physician's decision to withdraw patient|0|||
33352257|NCT00891735|101176476|FG000|Overall Study|Patient's decision to withdraw|4|||
33352258|NCT00891735|101176477|FG001|Overall Study|Patient's decision to withdraw|9|||
33352259|NCT00891735|101176478|FG002|Overall Study|Patient's decision to withdraw|4|||
33412173|NCT00422058|101397317|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
33412174|NCT00422058|101397312|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
33412175|NCT00422058|101397313|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
33412176|NCT00422058|101397314|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
33412177|NCT00422058|101397315|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
33412178|NCT00422058|101397316|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
33412179|NCT00422058|101397317|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
33412180|NCT00422058|101397312|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
33412181|NCT00422058|101397313|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
33412182|NCT00422058|101397314|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
33412183|NCT00422058|101397315|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
33412184|NCT00422058|101397316|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
33412185|NCT00422058|101397317|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
33412186|NCT00422058|101397312|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
33412187|NCT00422058|101397313|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
33412188|NCT00422058|101397314|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
33412189|NCT00422058|101397315|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
33412190|NCT00422058|101397316|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
33412191|NCT00422058|101397317|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
33412192|NCT00422058|101397312|FG000|Open-Label Extension, Week 20-104|Other|13|||
33412193|NCT00422058|101397313|FG001|Open-Label Extension, Week 20-104|Other|14|||
33412194|NCT00422058|101397314|FG002|Open-Label Extension, Week 20-104|Other|6|||
33412195|NCT00422058|101397315|FG003|Open-Label Extension, Week 20-104|Other|13|||
33412196|NCT00422058|101397316|FG004|Open-Label Extension, Week 20-104|Other|16|||
33412197|NCT00422058|101397317|FG005|Open-Label Extension, Week 20-104|Other|18|||
33412198|NCT02842736|101397318|FG000|Overall Study|Lost to Follow-up|13|||
33412199|NCT02842736|101397318|FG000|Overall Study|Intervention for menstrual bleeding|17|||
33217737|NCT00136955|100695846|FG000|Overall Study|Lost to Follow-up|1|||
33217738|NCT00136955|100695846|FG000|Overall Study|Withdrawal by Subject|2|||
33217739|NCT00136955|100695846|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
33217740|NCT02120027|100695850|FG000|Overall Study|Adverse Event|4|||
33412200|NCT02842736|101397318|FG000|Overall Study|Withdrawal by Subject|4|||
33412201|NCT02842736|101397318|FG000|Overall Study|Pregnancy|3|||
33412202|NCT02842736|101397318|FG000|Overall Study|Hysterectomy for fibroids|2|||
33412203|NCT02842736|101397318|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
33412204|NCT02842736|101397318|FG000|Overall Study|IUD: Mirena|1|||
33412205|NCT03575806|101397322|FG000|Overall Study|Withdrawal by Subject|0|||
33412206|NCT03575806|101397323|FG001|Overall Study|Withdrawal by Subject|2|||
33412207|NCT03575806|101397322|FG000|Overall Study|Protocol Violation|0|||
33412208|NCT03575806|101397323|FG001|Overall Study|Protocol Violation|2|||
33412209|NCT01541644|101397328|FG000|Overall Study|Withdrawal by Subject|3|||
33412210|NCT03843775|101397332|FG000|Overall Study|Adverse Event|1|||
33412211|NCT03843775|101397333|FG001|Overall Study|Adverse Event|1|||
33412212|NCT03843775|101397332|FG000|Overall Study|Lack of Efficacy|2|||
33412213|NCT03843775|101397333|FG001|Overall Study|Lack of Efficacy|6|||
33217741|NCT02120027|100695851|FG001|Overall Study|Adverse Event|5|||
33217742|NCT02120027|100695850|FG000|Overall Study|Lack of Efficacy|3|||
33217743|NCT02120027|100695851|FG001|Overall Study|Lack of Efficacy|5|||
33217744|NCT02120027|100695850|FG000|Overall Study|Lost to Follow-up|5|||
33217745|NCT02120027|100695851|FG001|Overall Study|Lost to Follow-up|13|||
33217746|NCT02120027|100695850|FG000|Overall Study|Other|4|||
33217747|NCT02120027|100695851|FG001|Overall Study|Other|0|||
33217748|NCT02120027|100695850|FG000|Overall Study|Physician Decision|4|||
33217749|NCT02120027|100695851|FG001|Overall Study|Physician Decision|3|||
33217750|NCT02120027|100695850|FG000|Overall Study|Protocol Violation|18|||
33217751|NCT02120027|100695851|FG001|Overall Study|Protocol Violation|21|||
33412214|NCT03843775|101397332|FG000|Overall Study|Withdrawal by Subject|0|||
33412215|NCT03843775|101397333|FG001|Overall Study|Withdrawal by Subject|1|||
33412216|NCT00483574|101397336|FG000|Overall Study|Adverse Event|6|||
33412217|NCT00483574|101397337|FG001|Overall Study|Adverse Event|0|||
33412218|NCT00483574|101397336|FG000|Overall Study|Protocol Violation|28|||
33412219|NCT00483574|101397337|FG001|Overall Study|Protocol Violation|9|||
33412220|NCT00483574|101397336|FG000|Overall Study|Lost to Follow-up|16|||
33217752|NCT02120027|100695850|FG000|Overall Study|Study terminated by Sponsor|45|||
33217753|NCT02120027|100695851|FG001|Overall Study|Study terminated by Sponsor|47|||
33217754|NCT02120027|100695850|FG000|Overall Study|Withdrawal by Subject|33|||
33217755|NCT02120027|100695851|FG001|Overall Study|Withdrawal by Subject|25|||
33412221|NCT00483574|101397337|FG001|Overall Study|Lost to Follow-up|4|||
33217756|NCT04512066|100695856|FG000|Double-blind Treatment Period|Adverse Event|6|||
33412222|NCT00483574|101397336|FG000|Overall Study|Withdrawal by Subject|52|||
33412223|NCT00483574|101397337|FG001|Overall Study|Withdrawal by Subject|0|||
33412224|NCT02057549|101397341|FG000|Overall Study|Lost to Follow-up|1|||
33412225|NCT02057549|101397342|FG001|Overall Study|Lost to Follow-up|0|||
33412226|NCT02057549|101397341|FG000|Overall Study|Physician Decision|1|||
33412227|NCT02057549|101397342|FG001|Overall Study|Physician Decision|0|||
33412228|NCT02057549|101397341|FG000|Overall Study|Withdrawal by Subject|1|||
33412229|NCT02057549|101397342|FG001|Overall Study|Withdrawal by Subject|0|||
33412230|NCT02777554|101397343|FG000|Overall Study|Adverse Event|4|||
33412231|NCT02777554|101397344|FG001|Overall Study|Adverse Event|4|||
33412232|NCT02777554|101397345|FG002|Overall Study|Adverse Event|0|||
33412233|NCT02777554|101397346|FG003|Overall Study|Adverse Event|1|||
33412234|NCT02777554|101397347|FG004|Overall Study|Adverse Event|0|||
33412235|NCT02777554|101397348|FG005|Overall Study|Adverse Event|0|||
33412236|NCT02777554|101397343|FG000|Overall Study|Withdrawal by Subject|3|||
33412237|NCT02777554|101397344|FG001|Overall Study|Withdrawal by Subject|1|||
33412238|NCT02777554|101397345|FG002|Overall Study|Withdrawal by Subject|1|||
33412239|NCT02777554|101397346|FG003|Overall Study|Withdrawal by Subject|0|||
33412240|NCT02777554|101397347|FG004|Overall Study|Withdrawal by Subject|0|||
33412241|NCT02777554|101397348|FG005|Overall Study|Withdrawal by Subject|0|||
33412242|NCT02777554|101397343|FG000|Overall Study|Discharged early due to hurricane|22|||
33412243|NCT02777554|101397344|FG001|Overall Study|Discharged early due to hurricane|20|||
33412244|NCT02777554|101397345|FG002|Overall Study|Discharged early due to hurricane|0|||
33412245|NCT02777554|101397346|FG003|Overall Study|Discharged early due to hurricane|0|||
33412246|NCT02777554|101397347|FG004|Overall Study|Discharged early due to hurricane|0|||
33412247|NCT02777554|101397348|FG005|Overall Study|Discharged early due to hurricane|0|||
33412248|NCT02777554|101397343|FG000|Overall Study|Other - Miscellaneous|1|||
33412249|NCT02777554|101397344|FG001|Overall Study|Other - Miscellaneous|0|||
33412250|NCT02777554|101397345|FG002|Overall Study|Other - Miscellaneous|0|||
33412251|NCT02777554|101397346|FG003|Overall Study|Other - Miscellaneous|0|||
33552508|NCT00973973|101920354|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
33552509|NCT00973973|101920355|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
33552510|NCT00888849|101920358|FG000|Overall Study|Death|4|||
33412252|NCT02777554|101397347|FG004|Overall Study|Other - Miscellaneous|0|||
33412253|NCT02777554|101397348|FG005|Overall Study|Other - Miscellaneous|0|||
33412254|NCT01714726|101399901|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
33552511|NCT00888849|101920359|FG001|Overall Study|Death|7|||
33552512|NCT00888849|101920358|FG000|Overall Study|Lost to Follow-up|1|||
33412255|NCT01714726|101399902|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
33412256|NCT01714726|101399903|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
33552513|NCT00888849|101920359|FG001|Overall Study|Lost to Follow-up|2|||
33552514|NCT01968785|101920362|FG000|Overall Study|Withdrawal by Subject|1|||
33552515|NCT01968785|101920363|FG001|Overall Study|Withdrawal by Subject|0|||
33352260|NCT00891735|101176479|FG003|Overall Study|Patient's decision to withdraw|8|||
33352261|NCT03851510|101176483|FG000|Overall Study|Screen Fail|1|||
33352262|NCT03851510|101176483|FG000|Overall Study|Adverse Event|1|||
33352263|NCT03851510|101176483|FG000|Overall Study|Withdrawal by Subject|1|||
33352264|NCT01097044|101176485|FG000|Overall Study|Withdrawal by Subject|4|||
33352265|NCT01097044|101176486|FG001|Overall Study|Withdrawal by Subject|4|||
33352266|NCT01097044|101176485|FG000|Overall Study|Lost to Follow-up|1|||
33352267|NCT01097044|101176486|FG001|Overall Study|Lost to Follow-up|0|||
33352268|NCT01097044|101176485|FG000|Overall Study|Withdrawal by Sponsor|0|||
33352269|NCT01097044|101176486|FG001|Overall Study|Withdrawal by Sponsor|1|||
33352270|NCT00693706|101176491|FG000|Overall Study|Protocol Violation|0|||
33352271|NCT00693706|101176492|FG001|Overall Study|Protocol Violation|1|||
33352272|NCT04007159|101176493|FG000|Induction Phase|(missed study visits)|16|||
33352273|NCT04007159|101176493|FG000|Induction Phase|Withdrawal by Subject|4|||
33352274|NCT04007159|101176493|FG000|Induction Phase|Adverse Event|2|||
33352275|NCT04007159|101176493|FG000|Challenge Phase|missed study visits|3|||
33352276|NCT00179959|101176494|FG000|Overall Study|Lost to Follow-up|3|||
33352277|NCT00179959|101176495|FG001|Overall Study|Lost to Follow-up|1|||
33352278|NCT00179959|101176494|FG000|Overall Study|Withdrawal by Subject|3|||
33352279|NCT00179959|101176495|FG001|Overall Study|Withdrawal by Subject|2|||
33552516|NCT01028053|101920364|FG000|Overall Study|Screen Failure|113|||
33352280|NCT03823391|101176503|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
33352281|NCT03823391|101176504|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
33352282|NCT03823391|101176503|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
33552517|NCT01028053|101920364|FG000|Overall Study|Patient Request|11|||
33552518|NCT01028053|101920364|FG000|Overall Study|Protocol Violation|1|||
33552519|NCT01028053|101920364|FG000|Overall Study|Physician Decision|2|||
33552520|NCT01028053|101920364|FG000|Overall Study|Technical Problem|1|||
33352283|NCT03823391|101176504|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
33352284|NCT02620020|101176505|FG000|Overall Study|Adverse Event|8|||
33352285|NCT02620020|101176506|FG001|Overall Study|Adverse Event|4|||
33352286|NCT02620020|101176507|FG002|Overall Study|Adverse Event|3|||
33352287|NCT02620020|101176508|FG003|Overall Study|Adverse Event|5|||
33412257|NCT01714726|101399904|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
33412258|NCT01714726|101399901|FG000|Double-Blinded Induction Period|Adverse Event|0|||
33412259|NCT01714726|101399902|FG001|Double-Blinded Induction Period|Adverse Event|1|||
33412260|NCT01714726|101399903|FG002|Double-Blinded Induction Period|Adverse Event|0|||
33412261|NCT01714726|101399904|FG003|Double-Blinded Induction Period|Adverse Event|0|||
33352288|NCT02620020|101176505|FG000|Overall Study|Lost to Follow-up|4|||
33352289|NCT02620020|101176506|FG001|Overall Study|Lost to Follow-up|8|||
33352290|NCT02620020|101176507|FG002|Overall Study|Lost to Follow-up|1|||
33352291|NCT02620020|101176508|FG003|Overall Study|Lost to Follow-up|4|||
33352292|NCT02620020|101176505|FG000|Overall Study|Physician Decision|7|||
33352293|NCT02620020|101176506|FG001|Overall Study|Physician Decision|4|||
33352294|NCT02620020|101176507|FG002|Overall Study|Physician Decision|3|||
33352295|NCT02620020|101176508|FG003|Overall Study|Physician Decision|4|||
33352296|NCT02620020|101176505|FG000|Overall Study|Protocol Violation|5|||
33352297|NCT02620020|101176506|FG001|Overall Study|Protocol Violation|2|||
33352298|NCT02620020|101176507|FG002|Overall Study|Protocol Violation|1|||
33352299|NCT02620020|101176508|FG003|Overall Study|Protocol Violation|1|||
33352300|NCT02620020|101176505|FG000|Overall Study|Withdrawal by Subject|20|||
33352301|NCT02620020|101176506|FG001|Overall Study|Withdrawal by Subject|16|||
33352302|NCT02620020|101176507|FG002|Overall Study|Withdrawal by Subject|17|||
33352303|NCT02620020|101176508|FG003|Overall Study|Withdrawal by Subject|12|||
33352304|NCT02620020|101176505|FG000|Overall Study|Death|0|||
33352305|NCT02620020|101176506|FG001|Overall Study|Death|1|||
33352306|NCT02620020|101176507|FG002|Overall Study|Death|0|||
33352307|NCT02620020|101176508|FG003|Overall Study|Death|0|||
33352308|NCT00500266|101176515|FG000|Overall Study|Death|3|||
33352309|NCT00500266|101176515|FG000|Overall Study|Lost to Follow-up|3|||
33352310|NCT00500266|101176515|FG000|Overall Study|Withdrawal by Subject|3|||
33352311|NCT00500266|101176515|FG000|Overall Study|Assigned, not treated|4|||
33352312|NCT01147497|101176518|FG000|Overall Study|failed insertion|2|||
33412262|NCT01714726|101399901|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
33412263|NCT01714726|101399902|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
33412264|NCT01714726|101399903|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
33412265|NCT01714726|101399904|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
33412266|NCT01714726|101399901|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
33412267|NCT01714726|101399902|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
33412268|NCT01714726|101399903|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
33412269|NCT01714726|101399904|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
33412270|NCT01714726|101399901|FG000|Open-Label Period|Other|0|||
33412271|NCT01714726|101399902|FG001|Open-Label Period|Other|0|||
33412272|NCT01714726|101399903|FG002|Open-Label Period|Other|1|||
33412273|NCT01714726|101399904|FG003|Open-Label Period|Other|3|||
33412274|NCT01714726|101399901|FG000|Open-Label Period|Adverse Event|0|||
33412275|NCT01714726|101399902|FG001|Open-Label Period|Adverse Event|0|||
33412276|NCT01714726|101399903|FG002|Open-Label Period|Adverse Event|1|||
33412277|NCT01714726|101399904|FG003|Open-Label Period|Adverse Event|0|||
33412278|NCT01714726|101399901|FG000|Open-Label Period|Withdrawal by Subject|0|||
33412279|NCT01714726|101399902|FG001|Open-Label Period|Withdrawal by Subject|0|||
33412280|NCT01714726|101399903|FG002|Open-Label Period|Withdrawal by Subject|9|||
33412281|NCT01714726|101399904|FG003|Open-Label Period|Withdrawal by Subject|19|||
33412282|NCT01714726|101399901|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
33412283|NCT01714726|101399902|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
33412284|NCT01714726|101399903|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
33412285|NCT01714726|101399904|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
33412286|NCT01714726|101399901|FG000|Open-Label Period|Lost to Follow-up|0|||
33412287|NCT01714726|101399902|FG001|Open-Label Period|Lost to Follow-up|0|||
33412288|NCT01714726|101399903|FG002|Open-Label Period|Lost to Follow-up|3|||
33412289|NCT01714726|101399904|FG003|Open-Label Period|Lost to Follow-up|4|||
33412290|NCT02946515|101399905|FG000|Overall Study|Lost to Follow-up|2|||
33412291|NCT02946515|101399906|FG001|Overall Study|Lost to Follow-up|1|||
33412292|NCT00122954|101399918|FG000|Overall Study|Withdrawal by Subject|2|||
33412293|NCT00122954|101399919|FG001|Overall Study|Withdrawal by Subject|2|||
33412294|NCT00122954|101399918|FG000|Overall Study|Protocol Violation|0|||
33412295|NCT00122954|101399919|FG001|Overall Study|Protocol Violation|1|||
33552521|NCT01028053|101920364|FG000|Overall Study|Terminated by Sponsor|1|||
33412296|NCT00308555|101399920|FG000|Overall Study|Withdrawal by Subject|1|||
33412297|NCT00308555|101399921|FG001|Overall Study|Withdrawal by Subject|0|||
33412298|NCT00308555|101399920|FG000|Overall Study|Physician Decision|2|||
33352313|NCT01147497|101176519|FG001|Overall Study|failed insertion|0|||
33352314|NCT01427309|101176520|FG000|Overall Study|Lost to Follow-up|130|||
33352315|NCT01427309|101176521|FG001|Overall Study|Lost to Follow-up|145|||
33352316|NCT01427309|101176522|FG002|Overall Study|Lost to Follow-up|122|||
33352317|NCT01427309|101176523|FG003|Overall Study|Lost to Follow-up|135|||
33352318|NCT01427309|101176520|FG000|Overall Study|Protocol Violation|42|||
33352319|NCT01427309|101176521|FG001|Overall Study|Protocol Violation|69|||
33352320|NCT01427309|101176522|FG002|Overall Study|Protocol Violation|125|||
33412299|NCT00308555|101399921|FG001|Overall Study|Physician Decision|0|||
33412300|NCT00625846|101399922|FG000|Overall Study|Withdrawal by Subject|2|||
33412301|NCT00625846|101399923|FG001|Overall Study|Withdrawal by Subject|0|||
33412302|NCT00625846|101399924|FG002|Overall Study|Withdrawal by Subject|1|||
33412303|NCT00625846|101399925|FG003|Overall Study|Withdrawal by Subject|2|||
33412304|NCT01250418|101399926|FG000|Overall Study|monitor data failure|1|||
33412305|NCT01250418|101399927|FG001|Overall Study|monitor data failure|1|||
33412306|NCT01018680|101399928|FG000|Overall Study|Adverse Event|23|||
33412307|NCT01018680|101399929|FG001|Overall Study|Adverse Event|40|||
33412308|NCT01018680|101399928|FG000|Overall Study|Withdrawal by Subject|10|||
33412309|NCT01018680|101399929|FG001|Overall Study|Withdrawal by Subject|10|||
33412310|NCT01018680|101399928|FG000|Overall Study|Protocol Violation|5|||
33412311|NCT01018680|101399929|FG001|Overall Study|Protocol Violation|8|||
33412312|NCT01018680|101399928|FG000|Overall Study|Sponsor Decision|6|||
33412313|NCT01018680|101399929|FG001|Overall Study|Sponsor Decision|7|||
33352321|NCT01427309|101176523|FG003|Overall Study|Protocol Violation|124|||
33412314|NCT01018680|101399928|FG000|Overall Study|Lack of Efficacy|8|||
33412315|NCT01018680|101399929|FG001|Overall Study|Lack of Efficacy|2|||
33412316|NCT01018680|101399928|FG000|Overall Study|Lost to Follow-up|5|||
33412317|NCT01018680|101399929|FG001|Overall Study|Lost to Follow-up|3|||
33412318|NCT01018680|101399928|FG000|Overall Study|Entry Criteria Not Met|1|||
33412319|NCT01018680|101399929|FG001|Overall Study|Entry Criteria Not Met|4|||
33412320|NCT01018680|101399928|FG000|Overall Study|Physician Decision|3|||
33412321|NCT01018680|101399929|FG001|Overall Study|Physician Decision|1|||
33412322|NCT00869362|101399930|FG000|Overall Study|Death|0|||
33412323|NCT00869362|101399931|FG001|Overall Study|Death|2|||
33412324|NCT00869362|101399930|FG000|Overall Study|Lost to Follow-up|1|||
33412325|NCT00869362|101399931|FG001|Overall Study|Lost to Follow-up|3|||
33412326|NCT03919669|101399932|FG000|Overall Study|Withdrawal by Subject|1|||
33412327|NCT03919669|101399933|FG001|Overall Study|Withdrawal by Subject|0|||
33412328|NCT03919669|101399934|FG002|Overall Study|Withdrawal by Subject|0|||
33412329|NCT00219349|101399942|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
33412330|NCT00219349|101399942|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
33412331|NCT00219349|101399942|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
33412332|NCT00219349|101399942|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
33412333|NCT01976104|101399952|FG000|Overall Study|Adverse Event|0|||
33412334|NCT01976104|101399953|FG001|Overall Study|Adverse Event|0|||
33412335|NCT01976104|101399954|FG002|Overall Study|Adverse Event|1|||
33412336|NCT01976104|101399955|FG003|Overall Study|Adverse Event|0|||
33412337|NCT01976104|101399952|FG000|Overall Study|Lost to Follow-up|3|||
33412338|NCT01976104|101399953|FG001|Overall Study|Lost to Follow-up|0|||
33412339|NCT01976104|101399954|FG002|Overall Study|Lost to Follow-up|1|||
33412340|NCT01976104|101399955|FG003|Overall Study|Lost to Follow-up|1|||
33412341|NCT01976104|101399952|FG000|Overall Study|Subject Choice|0|||
33412342|NCT01976104|101399953|FG001|Overall Study|Subject Choice|1|||
33412343|NCT01976104|101399954|FG002|Overall Study|Subject Choice|0|||
33412344|NCT01976104|101399955|FG003|Overall Study|Subject Choice|1|||
33552522|NCT01028053|101920364|FG000|Overall Study|Various reasons|4|||
33552523|NCT01727154|101920365|FG000|Overall Study|Death|17|||
33552524|NCT01727154|101920365|FG000|Overall Study|Withdrawal by Subject|14|||
33352322|NCT01427309|101176520|FG000|Overall Study|Adverse Event|0|||
33352323|NCT01427309|101176521|FG001|Overall Study|Adverse Event|0|||
33352324|NCT01427309|101176522|FG002|Overall Study|Adverse Event|3|||
33352325|NCT01427309|101176523|FG003|Overall Study|Adverse Event|1|||
33352326|NCT01427309|101176520|FG000|Overall Study|Serious adverse event|52|||
33352327|NCT01427309|101176521|FG001|Overall Study|Serious adverse event|45|||
33352328|NCT01427309|101176522|FG002|Overall Study|Serious adverse event|50|||
33352329|NCT01427309|101176523|FG003|Overall Study|Serious adverse event|61|||
33352330|NCT01427309|101176520|FG000|Overall Study|Withdrawal by Subject|148|||
33352331|NCT01427309|101176521|FG001|Overall Study|Withdrawal by Subject|148|||
33352332|NCT01427309|101176522|FG002|Overall Study|Withdrawal by Subject|61|||
33352333|NCT01427309|101176523|FG003|Overall Study|Withdrawal by Subject|55|||
33352334|NCT02357420|101176527|FG000|Overall Study|Adverse Event|3|||
33352335|NCT02357420|101176528|FG001|Overall Study|Adverse Event|3|||
33352336|NCT02357420|101176529|FG002|Overall Study|Adverse Event|8|||
33352337|NCT02357420|101176530|FG003|Overall Study|Adverse Event|9|||
33352338|NCT02357420|101176527|FG000|Overall Study|Investigator Decision|1|||
33352339|NCT02357420|101176528|FG001|Overall Study|Investigator Decision|0|||
33352340|NCT02357420|101176529|FG002|Overall Study|Investigator Decision|0|||
33352341|NCT02357420|101176530|FG003|Overall Study|Investigator Decision|0|||
33352342|NCT02357420|101176527|FG000|Overall Study|Prohibited Medication|1|||
33352343|NCT02357420|101176528|FG001|Overall Study|Prohibited Medication|1|||
33352344|NCT02357420|101176529|FG002|Overall Study|Prohibited Medication|0|||
33352345|NCT02357420|101176530|FG003|Overall Study|Prohibited Medication|0|||
33352346|NCT02357420|101176527|FG000|Overall Study|Protocol Non-compliance|0|||
33352347|NCT02357420|101176528|FG001|Overall Study|Protocol Non-compliance|0|||
33352348|NCT02357420|101176529|FG002|Overall Study|Protocol Non-compliance|0|||
33412345|NCT01976104|101399952|FG000|Overall Study|Withdrawal by Subject|3|||
33412346|NCT01976104|101399953|FG001|Overall Study|Withdrawal by Subject|0|||
33412347|NCT01976104|101399954|FG002|Overall Study|Withdrawal by Subject|0|||
33412348|NCT01976104|101399955|FG003|Overall Study|Withdrawal by Subject|1|||
33412349|NCT01976104|101399952|FG000|Overall Study|Other|0|||
33412350|NCT01976104|101399953|FG001|Overall Study|Other|1|||
33412351|NCT01976104|101399954|FG002|Overall Study|Other|0|||
33412352|NCT01976104|101399955|FG003|Overall Study|Other|0|||
33412353|NCT03155269|101399956|FG000|Overall Study|Withdrawal by Subject|4|||
33412354|NCT03155269|101399957|FG001|Overall Study|Withdrawal by Subject|5|||
33412355|NCT03155269|101399956|FG000|Overall Study|Lost to Follow-up|1|||
33552525|NCT01727154|101920365|FG000|Overall Study|Subject Withdrew Consent|18|||
33552526|NCT01727154|101920365|FG000|Overall Study|Study Terminated|6|||
33552527|NCT01727154|101920365|FG000|Overall Study|No Discontinuation Documentation|4|||
33552528|NCT02413346|101920366|FG000|Overall Study|Adverse Event|6|||
33552529|NCT02413346|101920367|FG001|Overall Study|Adverse Event|6|||
33552530|NCT02413346|101920366|FG000|Overall Study|Withdrawal by Subject|30|||
33552531|NCT02413346|101920367|FG001|Overall Study|Withdrawal by Subject|40|||
33552532|NCT02413346|101920366|FG000|Overall Study|Lost to Follow-up|17|||
33217757|NCT04512066|100695857|FG001|Double-blind Treatment Period|Adverse Event|4|||
33217758|NCT04512066|100695858|FG002|Double-blind Treatment Period|Adverse Event|5|||
33217759|NCT04512066|100695859|FG003|Double-blind Treatment Period|Adverse Event|1|||
33217760|NCT04512066|100695860|FG004|Double-blind Treatment Period|Adverse Event|0|||
33217761|NCT04512066|100695861|FG005|Double-blind Treatment Period|Adverse Event|0|||
33412356|NCT03155269|101399957|FG001|Overall Study|Lost to Follow-up|2|||
33552533|NCT02413346|101920367|FG001|Overall Study|Lost to Follow-up|21|||
33552534|NCT02413346|101920366|FG000|Overall Study|Protocol Violation|2|||
33552535|NCT02413346|101920367|FG001|Overall Study|Protocol Violation|0|||
33412357|NCT03733301|101399958|FG000|Overall Study|Screen Fail|1|||
33412358|NCT03733301|101399959|FG001|Overall Study|Screen Fail|0|||
33217762|NCT04512066|100695856|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
33217763|NCT04512066|100695857|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
33217764|NCT04512066|100695858|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
33217765|NCT04512066|100695859|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
33217766|NCT04512066|100695860|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
33552536|NCT02413346|101920366|FG000|Overall Study|Other Miscellaneous Reasons|4|||
33552537|NCT02413346|101920367|FG001|Overall Study|Other Miscellaneous Reasons|3|||
33552538|NCT00303628|101920368|FG000|Overall Study|Disease progression|0|||
33552539|NCT00303628|101920369|FG001|Overall Study|Disease progression|1|||
33552540|NCT00303628|101920368|FG000|Overall Study|Adverse Event|26|||
33552541|NCT00303628|101920369|FG001|Overall Study|Adverse Event|36|||
33552542|NCT00303628|101920368|FG000|Overall Study|Death|0|||
33552543|NCT00303628|101920369|FG001|Overall Study|Death|1|||
33552544|NCT00303628|101920368|FG000|Overall Study|Withdrawal by Subject|11|||
33552545|NCT00303628|101920369|FG001|Overall Study|Withdrawal by Subject|20|||
33552546|NCT00303628|101920368|FG000|Overall Study|Alternative therapy|2|||
33552547|NCT00303628|101920369|FG001|Overall Study|Alternative therapy|0|||
33552548|NCT00303628|101920368|FG000|Overall Study|Other complicating disease|0|||
33552549|NCT00303628|101920369|FG001|Overall Study|Other complicating disease|1|||
33352349|NCT02357420|101176530|FG003|Overall Study|Protocol Non-compliance|1|||
33352350|NCT02357420|101176527|FG000|Overall Study|Withdrawn Consent|4|||
33352351|NCT02357420|101176528|FG001|Overall Study|Withdrawn Consent|8|||
33352352|NCT02357420|101176529|FG002|Overall Study|Withdrawn Consent|6|||
33352353|NCT02357420|101176530|FG003|Overall Study|Withdrawn Consent|6|||
33352354|NCT02357420|101176527|FG000|Overall Study|Lost to Follow-up|3|||
33352355|NCT02357420|101176528|FG001|Overall Study|Lost to Follow-up|0|||
33352356|NCT02357420|101176529|FG002|Overall Study|Lost to Follow-up|2|||
33352357|NCT02357420|101176530|FG003|Overall Study|Lost to Follow-up|3|||
33352358|NCT03029832|101176531|FG000|Overall Study|Safety Follow-Up Completed|2|||
33352359|NCT03029832|101176532|FG001|Overall Study|Safety Follow-Up Completed|0|||
33412359|NCT03733301|101399960|FG002|Overall Study|Screen Fail|0|||
33552550|NCT00303628|101920368|FG000|Overall Study|Not start protocol therapy|3|||
33552551|NCT00303628|101920369|FG001|Overall Study|Not start protocol therapy|5|||
33552552|NCT00303628|101920368|FG000|Overall Study|Other|8|||
33552553|NCT00303628|101920369|FG001|Overall Study|Other|9|||
33552554|NCT01646216|101920370|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
33552555|NCT01646216|101920371|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
33619235|NCT01136408|102154981|FG002|Overall Study|Protocol Violation|1|||
33217767|NCT04512066|100695861|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
33352360|NCT03029832|101176531|FG000|Overall Study|Death due to Disease Progression|1|||
33352361|NCT03029832|101176532|FG001|Overall Study|Death due to Disease Progression|0|||
33352362|NCT03029832|101176531|FG000|Overall Study|Study Terminated By Sponsor|1|||
33412360|NCT03733301|101399958|FG000|Overall Study|Non-compliance|1|||
33412361|NCT03733301|101399959|FG001|Overall Study|Non-compliance|0|||
33412362|NCT03733301|101399960|FG002|Overall Study|Non-compliance|0|||
33412363|NCT03733301|101399958|FG000|Overall Study|Lack of Efficacy|2|||
33352363|NCT03029832|101176532|FG001|Overall Study|Study Terminated By Sponsor|1|||
33352364|NCT00206726|101176533|FG000|Overall Study|Delayed recovery of blood counts|1|||
33412364|NCT03733301|101399959|FG001|Overall Study|Lack of Efficacy|3|||
33412365|NCT03733301|101399960|FG002|Overall Study|Lack of Efficacy|0|||
33412366|NCT03733301|101399958|FG000|Overall Study|Adverse Event|0|||
33412367|NCT03733301|101399959|FG001|Overall Study|Adverse Event|1|||
33412368|NCT03733301|101399960|FG002|Overall Study|Adverse Event|3|||
33412369|NCT03733301|101399958|FG000|Overall Study|Withdrawal by Subject|3|||
33412370|NCT03733301|101399959|FG001|Overall Study|Withdrawal by Subject|5|||
33412371|NCT03733301|101399960|FG002|Overall Study|Withdrawal by Subject|1|||
33412372|NCT01646268|101399963|FG000|Overall Study|Adverse Event|6|||
33412373|NCT01646268|101399964|FG001|Overall Study|Adverse Event|7|||
33412374|NCT01646268|101399963|FG000|Overall Study|Lack of Efficacy|1|||
33552556|NCT01646216|101920370|FG000|Overall Study|Did not complete training|0|||
33552557|NCT01646216|101920371|FG001|Overall Study|Did not complete training|2|||
33552558|NCT01646216|101920370|FG000|Overall Study|Investigator decision|1|||
33619236|NCT04915729|102154982|FG000|Overall Study|Lost to Follow-up|20|||
33619237|NCT04915729|102154983|FG001|Overall Study|Lost to Follow-up|10|||
33619238|NCT04915729|102154982|FG000|Overall Study|Withdrawal by Subject|12|||
33352365|NCT00206726|101176533|FG000|Overall Study|Progressive disease or relapsed disease|18|||
33352366|NCT00206726|101176533|FG000|Overall Study|Placed on new protocol|1|||
33352367|NCT00206726|101176533|FG000|Overall Study|Bone marrow transplant|1|||
33352368|NCT00206726|101176533|FG000|Overall Study|Adverse Event|17|||
33352369|NCT00206726|101176533|FG000|Overall Study|Death|4|||
33352370|NCT00206726|101176533|FG000|Overall Study|Protocol Violation|1|||
33352371|NCT00206726|101176533|FG000|Overall Study|Withdrawal by Subject|8|||
33352372|NCT02690701|101176534|FG000|Treatment Period 1|Adverse Event|2|||
33352373|NCT02690701|101176535|FG001|Treatment Period 1|Adverse Event|2|||
33352374|NCT02690701|101176534|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33352375|NCT02690701|101176535|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33352376|NCT02690701|101176534|FG000|Treatment Period 2|Adverse Event|2|||
33352377|NCT02690701|101176535|FG001|Treatment Period 2|Adverse Event|0|||
33352378|NCT02690701|101176534|FG000|Treatment Period 2|Lack of Efficacy|1|||
33352379|NCT02690701|101176535|FG001|Treatment Period 2|Lack of Efficacy|0|||
33352380|NCT02690701|101176534|FG000|Treatment Period 2|Lost to Follow-up|0|||
33352381|NCT02690701|101176535|FG001|Treatment Period 2|Lost to Follow-up|2|||
33352382|NCT02690701|101176534|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33352383|NCT02690701|101176535|FG001|Treatment Period 2|Withdrawal by Subject|2|||
33352384|NCT02690701|101176534|FG000|Treatment Period 2|Protocol Violation|0|||
33352385|NCT02690701|101176535|FG001|Treatment Period 2|Protocol Violation|1|||
33352386|NCT02612909|101176537|FG000|Phase 2|Withdrawal by Subject|2|||
33352387|NCT02612909|101176538|FG001|Phase 2|Withdrawal by Subject|5|||
33552559|NCT01646216|101920371|FG001|Overall Study|Investigator decision|1|||
33552560|NCT03338023|101920372|FG000|Overall Study|Withdrawal by Subject|3|||
33552561|NCT03338023|101920373|FG001|Overall Study|Withdrawal by Subject|4|||
33552562|NCT03338023|101920372|FG000|Overall Study|Protocol Violation|3|||
33552563|NCT03338023|101920373|FG001|Overall Study|Protocol Violation|3|||
33552564|NCT03338023|101920372|FG000|Overall Study|Lost to Follow-up|2|||
33552565|NCT03338023|101920373|FG001|Overall Study|Lost to Follow-up|1|||
33552566|NCT03338023|101920372|FG000|Overall Study|Physician Decision|1|||
33552567|NCT03338023|101920373|FG001|Overall Study|Physician Decision|2|||
33552568|NCT00806026|101920376|FG000|Overall Study|Death|0|||
33552569|NCT00806026|101920377|FG001|Overall Study|Death|0|||
33552570|NCT00806026|101920378|FG002|Overall Study|Death|0|||
33552571|NCT00806026|101920379|FG003|Overall Study|Death|1|||
33552572|NCT00806026|101920380|FG004|Overall Study|Death|0|||
33552573|NCT00806026|101920381|FG005|Overall Study|Death|0|||
33552574|NCT00806026|101920376|FG000|Overall Study|Did not meet entrance criteria|4|||
33552575|NCT00806026|101920377|FG001|Overall Study|Did not meet entrance criteria|1|||
33552576|NCT00806026|101920378|FG002|Overall Study|Did not meet entrance criteria|2|||
33552577|NCT00806026|101920379|FG003|Overall Study|Did not meet entrance criteria|1|||
33552578|NCT00806026|101920380|FG004|Overall Study|Did not meet entrance criteria|0|||
33619239|NCT04915729|102154983|FG001|Overall Study|Withdrawal by Subject|5|||
33619240|NCT04915729|102154982|FG000|Overall Study|Death|34|||
33352388|NCT02612909|101176539|FG002|Phase 2|Withdrawal by Subject|0|||
33352389|NCT02612909|101176540|FG003|Phase 2|Withdrawal by Subject|0|||
33352390|NCT02612909|101176541|FG004|Phase 2|Withdrawal by Subject|0|||
33352391|NCT02612909|101176537|FG000|Phase 2|Pregnancy|0|||
33352392|NCT02612909|101176538|FG001|Phase 2|Pregnancy|0|||
33352393|NCT02612909|101176539|FG002|Phase 2|Pregnancy|1|||
33352394|NCT02612909|101176540|FG003|Phase 2|Pregnancy|0|||
33352395|NCT02612909|101176541|FG004|Phase 2|Pregnancy|0|||
33352396|NCT02612909|101176537|FG000|Phase 3|Withdrawal by Subject|0|||
33412375|NCT01646268|101399964|FG001|Overall Study|Lack of Efficacy|3|||
33412376|NCT01646268|101399963|FG000|Overall Study|Protocol Violation|0|||
33412377|NCT01646268|101399964|FG001|Overall Study|Protocol Violation|1|||
33552579|NCT00806026|101920381|FG005|Overall Study|Did not meet entrance criteria|0|||
33552580|NCT00806026|101920376|FG000|Overall Study|Lack of Efficacy|5|||
33619241|NCT04915729|102154983|FG001|Overall Study|Death|44|||
33352397|NCT02612909|101176538|FG001|Phase 3|Withdrawal by Subject|0|||
33352398|NCT02612909|101176539|FG002|Phase 3|Withdrawal by Subject|0|||
33352399|NCT02612909|101176540|FG003|Phase 3|Withdrawal by Subject|1|||
33352400|NCT02612909|101176541|FG004|Phase 3|Withdrawal by Subject|0|||
33352401|NCT03195894|101176542|FG000|Overall Study|"An example is Started other treatment."|4|||
33352402|NCT03195894|101176543|FG001|Overall Study|"An example is Started other treatment."|5|||
33352403|NCT03195894|101176542|FG000|Overall Study|Withdrawal by Subject|15|||
33352404|NCT03195894|101176543|FG001|Overall Study|Withdrawal by Subject|4|||
33352405|NCT03195894|101176542|FG000|Overall Study|Lost to Follow-up|14|||
33352406|NCT03195894|101176543|FG001|Overall Study|Lost to Follow-up|19|||
33352407|NCT00522392|101176544|FG000|Overall Study|Disease progression|0|||
33352408|NCT00522392|101176545|FG001|Overall Study|Disease progression|3|||
33352409|NCT00522392|101176544|FG000|Overall Study|Adverse Event|7|||
33352410|NCT00522392|101176545|FG001|Overall Study|Adverse Event|7|||
33352411|NCT00522392|101176544|FG000|Overall Study|Withdrawal by Subject|1|||
33352412|NCT00522392|101176545|FG001|Overall Study|Withdrawal by Subject|1|||
33352413|NCT00522392|101176544|FG000|Overall Study|Physician Decision|0|||
33352414|NCT00522392|101176545|FG001|Overall Study|Physician Decision|1|||
33352415|NCT00522392|101176544|FG000|Overall Study|Non-compliance|0|||
33352416|NCT00522392|101176545|FG001|Overall Study|Non-compliance|1|||
33352417|NCT00140855|101176554|FG000|Overall Study|Progressive disease|2|||
33352418|NCT01053429|101176555|FG000|Overall Study|Adverse Event|64|||
33352419|NCT01053429|101176555|FG000|Overall Study|Other|309|||
33412378|NCT01646268|101399963|FG000|Overall Study|Withdrawal by Subject|2|||
33412379|NCT01646268|101399964|FG001|Overall Study|Withdrawal by Subject|5|||
33412380|NCT01646268|101399963|FG000|Overall Study|Other|2|||
33217768|NCT04512066|100695856|FG000|Double-blind Treatment Period|Physician Decision|1|||
33412381|NCT01646268|101399964|FG001|Overall Study|Other|0|||
33412382|NCT04882085|101399967|FG000|Overall Study|Death|6|||
33412383|NCT04882085|101399968|FG001|Overall Study|Death|9|||
33412384|NCT04882085|101399967|FG000|Overall Study|Withdrawal by Subject|0|||
33412385|NCT04882085|101399968|FG001|Overall Study|Withdrawal by Subject|3|||
33412386|NCT04882085|101399967|FG000|Overall Study|Randomized not treated|1|||
33412387|NCT04882085|101399968|FG001|Overall Study|Randomized not treated|0|||
33412388|NCT01283009|101399971|FG000|Overall Study|Death|83|||
33412389|NCT01283009|101399972|FG001|Overall Study|Death|78|||
33412390|NCT01283009|101399971|FG000|Overall Study|Study ended early|23|||
33552581|NCT00806026|101920377|FG001|Overall Study|Lack of Efficacy|18|||
33552582|NCT00806026|101920378|FG002|Overall Study|Lack of Efficacy|13|||
33552583|NCT00806026|101920379|FG003|Overall Study|Lack of Efficacy|4|||
33552584|NCT00806026|101920380|FG004|Overall Study|Lack of Efficacy|8|||
33552585|NCT00806026|101920381|FG005|Overall Study|Lack of Efficacy|7|||
33552586|NCT00806026|101920376|FG000|Overall Study|Lost to Follow-up|8|||
33552587|NCT00806026|101920377|FG001|Overall Study|Lost to Follow-up|15|||
33552588|NCT00806026|101920378|FG002|Overall Study|Lost to Follow-up|8|||
33552589|NCT00806026|101920379|FG003|Overall Study|Lost to Follow-up|2|||
33552590|NCT00806026|101920380|FG004|Overall Study|Lost to Follow-up|6|||
33552591|NCT00806026|101920381|FG005|Overall Study|Lost to Follow-up|6|||
33552592|NCT00806026|101920376|FG000|Overall Study|Withdrawal by Subject|14|||
33552593|NCT00806026|101920377|FG001|Overall Study|Withdrawal by Subject|17|||
33552594|NCT00806026|101920378|FG002|Overall Study|Withdrawal by Subject|9|||
33552595|NCT00806026|101920379|FG003|Overall Study|Withdrawal by Subject|2|||
33552596|NCT00806026|101920380|FG004|Overall Study|Withdrawal by Subject|5|||
33552597|NCT00806026|101920381|FG005|Overall Study|Withdrawal by Subject|3|||
33552598|NCT00806026|101920376|FG000|Overall Study|Other|3|||
33552599|NCT00806026|101920377|FG001|Overall Study|Other|6|||
33217769|NCT04512066|100695857|FG001|Double-blind Treatment Period|Physician Decision|0|||
33352420|NCT00925600|101176557|FG000|Overall Study|Withdrawal by Subject|16|||
33352421|NCT00925600|101176558|FG001|Overall Study|Withdrawal by Subject|14|||
33552600|NCT00806026|101920378|FG002|Overall Study|Other|8|||
33552601|NCT00806026|101920379|FG003|Overall Study|Other|2|||
33552602|NCT00806026|101920380|FG004|Overall Study|Other|0|||
33352422|NCT00925600|101176557|FG000|Overall Study|Death|4|||
33352423|NCT00925600|101176558|FG001|Overall Study|Death|3|||
33352424|NCT00925600|101176557|FG000|Overall Study|Lost to Follow-up|2|||
33352425|NCT00925600|101176558|FG001|Overall Study|Lost to Follow-up|2|||
33412391|NCT01283009|101399972|FG001|Overall Study|Study ended early|26|||
33412392|NCT01283009|101399971|FG000|Overall Study|Withdrawal by Subject|10|||
33412393|NCT01283009|101399972|FG001|Overall Study|Withdrawal by Subject|8|||
33412394|NCT01283009|101399971|FG000|Overall Study|Physician Decision|1|||
33412395|NCT01283009|101399972|FG001|Overall Study|Physician Decision|1|||
33412396|NCT01283009|101399971|FG000|Overall Study|Lost to Follow-up|1|||
33412397|NCT01283009|101399972|FG001|Overall Study|Lost to Follow-up|0|||
33412398|NCT01283009|101399971|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
33412399|NCT01283009|101399972|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
33412400|NCT00905437|101399978|FG000|Overall Study|Adverse Event|3|||
33412401|NCT00905437|101399979|FG001|Overall Study|Adverse Event|2|||
33412402|NCT00905437|101399978|FG000|Overall Study|Lost to Follow-up|0|||
33412403|NCT00905437|101399979|FG001|Overall Study|Lost to Follow-up|1|||
33412404|NCT00905437|101399978|FG000|Overall Study|Withdrawal by Subject|0|||
33412405|NCT00905437|101399979|FG001|Overall Study|Withdrawal by Subject|1|||
33412406|NCT00905437|101399978|FG000|Overall Study|Other|5|||
33412407|NCT00905437|101399979|FG001|Overall Study|Other|6|||
33412408|NCT00621309|101399982|FG000|Overall Study|Withdrawal by Subject|2|||
33412409|NCT00621309|101399983|FG001|Overall Study|Withdrawal by Subject|0|||
33412410|NCT00621309|101399984|FG002|Overall Study|Withdrawal by Subject|1|||
33412411|NCT00621309|101399985|FG003|Overall Study|Withdrawal by Subject|1|||
33412412|NCT00621309|101399986|FG004|Overall Study|Withdrawal by Subject|1|||
33412413|NCT00621309|101399987|FG005|Overall Study|Withdrawal by Subject|1|||
33412414|NCT01275170|101399988|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
33412415|NCT01275170|101399989|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
33412416|NCT01275170|101399990|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
33412417|NCT01275170|101399991|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
33412418|NCT01275170|101399992|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
33412419|NCT01275170|101399993|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
33412420|NCT01275170|101399994|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
33412421|NCT01275170|101399995|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
33412422|NCT00548340|101399996|FG000|Overall Study|Protocol Violation|2|||
33412423|NCT00548340|101399997|FG001|Overall Study|Protocol Violation|3|||
33412424|NCT00548340|101399998|FG002|Overall Study|Protocol Violation|3|||
33412425|NCT00548340|101399996|FG000|Overall Study|Adverse Event|2|||
33412426|NCT00548340|101399997|FG001|Overall Study|Adverse Event|2|||
33412427|NCT00548340|101399998|FG002|Overall Study|Adverse Event|2|||
33412428|NCT00548340|101399996|FG000|Overall Study|Lost to Follow-up|1|||
33412429|NCT00548340|101399997|FG001|Overall Study|Lost to Follow-up|1|||
33412430|NCT00548340|101399998|FG002|Overall Study|Lost to Follow-up|0|||
33412431|NCT00548340|101399996|FG000|Overall Study|Withdrawal by Subject|2|||
33412432|NCT00548340|101399997|FG001|Overall Study|Withdrawal by Subject|4|||
33412433|NCT00548340|101399998|FG002|Overall Study|Withdrawal by Subject|3|||
33412434|NCT00548340|101399996|FG000|Overall Study|Other|1|||
33412435|NCT00548340|101399997|FG001|Overall Study|Other|1|||
33412436|NCT00548340|101399998|FG002|Overall Study|Other|1|||
33412437|NCT00698009|101399999|FG000|Overall Study|Withdrawal by Subject|1|||
33412438|NCT01012609|101400005|FG000|Overall Study|Withdrawal by Subject|1|||
33412439|NCT01012609|101400006|FG001|Overall Study|Withdrawal by Subject|1|||
33412440|NCT01096017|101400007|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
33412441|NCT01096017|101400008|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
33412442|NCT05102162|101400009|FG000|Overall Study|Withdrawal by Subject|3|||
33412443|NCT05102162|101400010|FG001|Overall Study|Withdrawal by Subject|0|||
33412444|NCT05102162|101400009|FG000|Overall Study|Baseline cultures negative|4|||
33412445|NCT05102162|101400010|FG001|Overall Study|Baseline cultures negative|2|||
33412446|NCT05102162|101400009|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
33412447|NCT05102162|101400010|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
33552603|NCT00806026|101920381|FG005|Overall Study|Other|4|||
33552604|NCT00806026|101920376|FG000|Overall Study|Protocol Violation|6|||
33552605|NCT00806026|101920377|FG001|Overall Study|Protocol Violation|9|||
33552606|NCT00806026|101920378|FG002|Overall Study|Protocol Violation|9|||
33552607|NCT00806026|101920379|FG003|Overall Study|Protocol Violation|0|||
33552608|NCT00806026|101920380|FG004|Overall Study|Protocol Violation|2|||
33412448|NCT05102162|101400009|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
33412449|NCT05102162|101400010|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
33412450|NCT04113746|101400011|FG000|Overall Study|Lost to Follow-up|4|||
33412451|NCT04113746|101400012|FG001|Overall Study|Lost to Follow-up|4|||
33412452|NCT03014570|101400013|FG000|Overall Study|COVID-19 Restrictions|38|||
33412453|NCT03014570|101400014|FG001|Overall Study|COVID-19 Restrictions|24|||
33412454|NCT03014570|101400013|FG000|Overall Study|Death|70|||
33412455|NCT03014570|101400014|FG001|Overall Study|Death|79|||
33412456|NCT03014570|101400013|FG000|Overall Study|Transfer from facility|11|||
33552609|NCT00806026|101920381|FG005|Overall Study|Protocol Violation|3|||
33352426|NCT00925600|101176557|FG000|Overall Study|Disease Progression|1|||
33352427|NCT00925600|101176558|FG001|Overall Study|Disease Progression|3|||
33352428|NCT00925600|101176557|FG000|Overall Study|Administrative Decision|1|||
33352429|NCT00925600|101176558|FG001|Overall Study|Administrative Decision|1|||
33352430|NCT00925600|101176557|FG000|Overall Study|Noncompliance|2|||
33352431|NCT00925600|101176558|FG001|Overall Study|Noncompliance|0|||
33352432|NCT00925600|101176557|FG000|Overall Study|Ineligibility Determined|2|||
33352433|NCT00925600|101176558|FG001|Overall Study|Ineligibility Determined|0|||
33412457|NCT03014570|101400014|FG001|Overall Study|Transfer from facility|14|||
33412458|NCT03014570|101400013|FG000|Overall Study|Hospitalized|5|||
33412459|NCT03014570|101400014|FG001|Overall Study|Hospitalized|3|||
33412460|NCT03014570|101400013|FG000|Overall Study|Transfer within facility|1|||
33412461|NCT03014570|101400014|FG001|Overall Study|Transfer within facility|0|||
33412462|NCT03014570|101400013|FG000|Overall Study|Site refusal|0|||
33412463|NCT03014570|101400014|FG001|Overall Study|Site refusal|11|||
33412464|NCT00124709|101400019|FG000|Overall Study|Randomized but did not take medication|3|||
33412465|NCT00124709|101400020|FG001|Overall Study|Randomized but did not take medication|1|||
33412466|NCT00124709|101400019|FG000|Overall Study|Adverse Event|3|||
33552610|NCT00806026|101920376|FG000|Overall Study|Adverse Event|52|||
33352434|NCT00925600|101176557|FG000|Overall Study|Protocol Deviation|0|||
33352435|NCT00925600|101176558|FG001|Overall Study|Protocol Deviation|1|||
33352436|NCT00925600|101176557|FG000|Overall Study|Requirement for Alternative Therapy|0|||
33412467|NCT00124709|101400020|FG001|Overall Study|Adverse Event|0|||
33552611|NCT00806026|101920377|FG001|Overall Study|Adverse Event|35|||
33552612|NCT00806026|101920378|FG002|Overall Study|Adverse Event|44|||
33552613|NCT00806026|101920379|FG003|Overall Study|Adverse Event|17|||
33552614|NCT00806026|101920380|FG004|Overall Study|Adverse Event|9|||
33552615|NCT00806026|101920381|FG005|Overall Study|Adverse Event|9|||
33552616|NCT01127061|101920382|FG000|Overall Study|Lost to Follow-up|7|||
33552617|NCT01127061|101920383|FG001|Overall Study|Lost to Follow-up|10|||
33552618|NCT01127061|101920382|FG000|Overall Study|Physician Decision|3|||
33552619|NCT01127061|101920383|FG001|Overall Study|Physician Decision|3|||
33552620|NCT02569242|101920384|FG000|Overall Study|Death|1|||
33552621|NCT02569242|101920385|FG001|Overall Study|Death|0|||
33552622|NCT02569242|101920384|FG000|Overall Study|Withdrawal by Subject|0|||
33552623|NCT02569242|101920385|FG001|Overall Study|Withdrawal by Subject|1|||
33552624|NCT02923180|101920386|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
33552625|NCT02923180|101920386|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
33552626|NCT01827943|101923504|FG000|Overall Study|Protocol Violation|8|||
33552627|NCT01827943|101923504|FG000|Overall Study|Never treated because of an rapid progression|1|||
33552628|NCT00509600|101923508|FG000|Overall Study|Adverse Event|1|||
33412468|NCT00124709|101400019|FG000|Overall Study|Lack of Efficacy|5|||
33412469|NCT00124709|101400020|FG001|Overall Study|Lack of Efficacy|10|||
33552629|NCT01653262|101923509|FG000|Overall Study|Lack of Efficacy|1|||
33352437|NCT00925600|101176558|FG001|Overall Study|Requirement for Alternative Therapy|1|||
33352438|NCT00925600|101176557|FG000|Overall Study|Other|3|||
33352439|NCT00925600|101176558|FG001|Overall Study|Other|1|||
33412470|NCT00124709|101400019|FG000|Overall Study|Protocol Violation|3|||
33412471|NCT00124709|101400020|FG001|Overall Study|Protocol Violation|5|||
33412472|NCT00124709|101400019|FG000|Overall Study|Withdrawal by Subject|127|||
33552630|NCT01653262|101923509|FG000|Overall Study|SAE, non-fatal|1|||
33552631|NCT01653262|101923509|FG000|Overall Study|AE, non-serious non-fatal|1|||
33552632|NCT01362270|101923510|FG000|Overall Study|Withdrawal by Subject|1|||
33552633|NCT01362270|101923511|FG001|Overall Study|Withdrawal by Subject|0|||
33352440|NCT00925600|101176557|FG000|Overall Study|Adverse Event|1|||
33352441|NCT00925600|101176558|FG001|Overall Study|Adverse Event|2|||
33352442|NCT02507349|101176567|FG000|Overall Study|Death|12|||
33352443|NCT02507349|101176568|FG001|Overall Study|Death|16|||
33352444|NCT02507349|101176567|FG000|Overall Study|Withdrawal by Subject|1|||
33352445|NCT02507349|101176568|FG001|Overall Study|Withdrawal by Subject|1|||
33352446|NCT02507349|101176567|FG000|Overall Study|Lost to Follow-up|174|||
33352447|NCT02507349|101176568|FG001|Overall Study|Lost to Follow-up|144|||
33552634|NCT01362270|101923510|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
33552635|NCT01362270|101923511|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
33552636|NCT01362270|101923510|FG000|Overall Study|Met excl. criteria before 1st session|1|||
33552637|NCT01362270|101923511|FG001|Overall Study|Met excl. criteria before 1st session|1|||
33552638|NCT00394472|101923512|FG000|Overall Study|Protocol Violation|1|||
33552639|NCT00394472|101923513|FG001|Overall Study|Protocol Violation|3|||
33552640|NCT00394472|101923512|FG000|Overall Study|incorrect enrolment|4|||
33552641|NCT00394472|101923513|FG001|Overall Study|incorrect enrolment|2|||
33552642|NCT00394472|101923512|FG000|Overall Study|Adverse Event|4|||
33552643|NCT00394472|101923513|FG001|Overall Study|Adverse Event|2|||
33552644|NCT00394472|101923512|FG000|Overall Study|Withdrawal by Subject|0|||
33552645|NCT00394472|101923513|FG001|Overall Study|Withdrawal by Subject|2|||
33552646|NCT00394472|101923512|FG000|Overall Study|Physician Decision|0|||
33552647|NCT00394472|101923513|FG001|Overall Study|Physician Decision|1|||
33552648|NCT00394472|101923512|FG000|Overall Study|Lost to Follow-up|0|||
33552649|NCT00394472|101923513|FG001|Overall Study|Lost to Follow-up|1|||
33552650|NCT05427916|101923514|FG000|Overall Study|Adverse Event|3|||
33552651|NCT05427916|101923515|FG001|Overall Study|Adverse Event|0|||
33552652|NCT05427916|101923514|FG000|Overall Study|Lack of Efficacy|6|||
33552653|NCT05427916|101923515|FG001|Overall Study|Lack of Efficacy|0|||
33552654|NCT05427916|101923514|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
33552655|NCT05427916|101923515|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
33552656|NCT00776997|101923519|FG000|Overall Study|Adverse Event|2|||
33552657|NCT00290238|101923520|FG000|Overall Study|Study terminated|27|||
33352448|NCT02786901|101176569|FG000|Overall Study|Adverse Event|1|||
33352449|NCT02786901|101176570|FG001|Overall Study|Adverse Event|1|||
33352450|NCT02786901|101176571|FG002|Overall Study|Adverse Event|2|||
33352451|NCT02786901|101176569|FG000|Overall Study|Physician Decision|1|||
33552658|NCT00290238|101923521|FG001|Overall Study|Study terminated|27|||
33552659|NCT00290238|101923520|FG000|Overall Study|Lost to Follow-up|0|||
33552660|NCT00290238|101923521|FG001|Overall Study|Lost to Follow-up|1|||
33552661|NCT00290238|101923520|FG000|Overall Study|Withdrawal by Subject|15|||
33552662|NCT00290238|101923521|FG001|Overall Study|Withdrawal by Subject|13|||
33552663|NCT02636283|101923522|FG000|Overall Study|Adverse Event|2|||
33552664|NCT02636283|101923523|FG001|Overall Study|Adverse Event|0|||
33552665|NCT02636283|101923522|FG000|Overall Study|Trial Terminated Prematurely|0|||
33552666|NCT02636283|101923523|FG001|Overall Study|Trial Terminated Prematurely|3|||
33352452|NCT02786901|101176570|FG001|Overall Study|Physician Decision|0|||
33412473|NCT00124709|101400020|FG001|Overall Study|Withdrawal by Subject|136|||
33552667|NCT00812097|101923524|FG000|Overall Study|Death|3|||
33552668|NCT00812097|101923525|FG001|Overall Study|Death|10|||
33552669|NCT00812097|101923526|FG002|Overall Study|Death|3|||
33552670|NCT00812097|101923527|FG003|Overall Study|Death|3|||
33552671|NCT00812097|101923524|FG000|Overall Study|Withdrawal by Subject|14|||
33552672|NCT00812097|101923525|FG001|Overall Study|Withdrawal by Subject|12|||
33552673|NCT00812097|101923526|FG002|Overall Study|Withdrawal by Subject|8|||
33552674|NCT00812097|101923527|FG003|Overall Study|Withdrawal by Subject|2|||
33352453|NCT02786901|101176571|FG002|Overall Study|Physician Decision|0|||
33352454|NCT02786901|101176569|FG000|Overall Study|Rescue Therapy Use|71|||
33352455|NCT02786901|101176570|FG001|Overall Study|Rescue Therapy Use|49|||
33352456|NCT02786901|101176571|FG002|Overall Study|Rescue Therapy Use|33|||
33412474|NCT00124709|101400019|FG000|Overall Study|Lost to Follow-up|114|||
33552675|NCT00812097|101923524|FG000|Overall Study|Lost to Follow-up|90|||
33552676|NCT00812097|101923525|FG001|Overall Study|Lost to Follow-up|14|||
33352457|NCT02786901|101176569|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
33352458|NCT02786901|101176570|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
33352459|NCT02786901|101176571|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
33352460|NCT02786901|101176569|FG000|Overall Study|Disallowed medication|1|||
33352461|NCT02786901|101176570|FG001|Overall Study|Disallowed medication|1|||
33352462|NCT02786901|101176571|FG002|Overall Study|Disallowed medication|0|||
33352463|NCT02786901|101176569|FG000|Overall Study|Randomized in error|2|||
33352464|NCT02786901|101176570|FG001|Overall Study|Randomized in error|0|||
33352465|NCT02786901|101176571|FG002|Overall Study|Randomized in error|1|||
33352466|NCT00828464|101176572|FG000|Overall Study|Withdrawal by Subject|1|||
33352467|NCT00706628|101176573|FG000|Overall Study|Other Adverse Event|16|||
33352468|NCT00706628|101176574|FG001|Overall Study|Other Adverse Event|5|||
33352469|NCT00706628|101176575|FG002|Overall Study|Other Adverse Event|5|||
33552677|NCT00812097|101923526|FG002|Overall Study|Lost to Follow-up|17|||
33552678|NCT00812097|101923527|FG003|Overall Study|Lost to Follow-up|5|||
33552679|NCT00812097|101923524|FG000|Overall Study|Explantation of study device(s)|27|||
33552680|NCT00812097|101923525|FG001|Overall Study|Explantation of study device(s)|29|||
33552681|NCT00812097|101923526|FG002|Overall Study|Explantation of study device(s)|14|||
33552682|NCT00812097|101923527|FG003|Overall Study|Explantation of study device(s)|20|||
33552683|NCT00812097|101923524|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
33552684|NCT00812097|101923525|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
33552685|NCT00812097|101923526|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
33552686|NCT00812097|101923527|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
33552687|NCT02489773|101923533|FG000|Overall Study|Lost to Follow-up|4|||
33552688|NCT02489773|101923534|FG001|Overall Study|Lost to Follow-up|1|||
33552689|NCT02489773|101923533|FG000|Overall Study|Physician Decision|1|||
33552690|NCT02489773|101923534|FG001|Overall Study|Physician Decision|0|||
33552691|NCT02489773|101923533|FG000|Overall Study|Withdrawal by Subject|1|||
33552692|NCT02489773|101923534|FG001|Overall Study|Withdrawal by Subject|0|||
33552693|NCT02489773|101923533|FG000|Overall Study|Leave the country or the state|1|||
33552694|NCT02489773|101923534|FG001|Overall Study|Leave the country or the state|1|||
33552695|NCT03211832|101923535|FG000|Overall Study|No longer with agency|32|||
33552696|NCT03211832|101923536|FG001|Overall Study|No longer with agency|49|||
33552697|NCT03211832|101923537|FG002|Overall Study|No longer with agency|30|||
33552698|NCT03211832|101923535|FG000|Overall Study|Declined survey|3|||
33552699|NCT03211832|101923536|FG001|Overall Study|Declined survey|3|||
33552700|NCT03211832|101923537|FG002|Overall Study|Declined survey|2|||
33552701|NCT03211832|101923535|FG000|Overall Study|Not available during data collection|1|||
33552702|NCT03211832|101923536|FG001|Overall Study|Not available during data collection|0|||
33552703|NCT03211832|101923537|FG002|Overall Study|Not available during data collection|2|||
33552704|NCT00289900|101923546|FG000|Overall Study|Adverse Event|28|||
33552705|NCT00289900|101923547|FG001|Overall Study|Adverse Event|40|||
33552706|NCT00289900|101923548|FG002|Overall Study|Adverse Event|13|||
33552707|NCT00289900|101923549|FG003|Overall Study|Adverse Event|19|||
33217770|NCT04512066|100695858|FG002|Double-blind Treatment Period|Physician Decision|1|||
33217771|NCT04512066|100695859|FG003|Double-blind Treatment Period|Physician Decision|0|||
33352470|NCT00706628|101176576|FG003|Overall Study|Other Adverse Event|2|||
33352471|NCT00706628|101176573|FG000|Overall Study|Non compliant with protocol|0|||
33352472|NCT00706628|101176574|FG001|Overall Study|Non compliant with protocol|1|||
33352473|NCT00706628|101176575|FG002|Overall Study|Non compliant with protocol|0|||
33552708|NCT00289900|101923550|FG004|Overall Study|Adverse Event|20|||
33552709|NCT00289900|101923551|FG005|Overall Study|Adverse Event|33|||
33552710|NCT00289900|101923546|FG000|Overall Study|Lost to Follow-up|7|||
33552711|NCT00289900|101923547|FG001|Overall Study|Lost to Follow-up|7|||
33552712|NCT00289900|101923548|FG002|Overall Study|Lost to Follow-up|8|||
33552713|NCT00289900|101923549|FG003|Overall Study|Lost to Follow-up|8|||
33552714|NCT00289900|101923550|FG004|Overall Study|Lost to Follow-up|4|||
33552715|NCT00289900|101923551|FG005|Overall Study|Lost to Follow-up|8|||
33217772|NCT04512066|100695860|FG004|Double-blind Treatment Period|Physician Decision|0|||
33217773|NCT04512066|100695861|FG005|Double-blind Treatment Period|Physician Decision|0|||
33352474|NCT00706628|101176576|FG003|Overall Study|Non compliant with protocol|0|||
33352475|NCT00706628|101176573|FG000|Overall Study|Consent withdrawn|6|||
33352476|NCT00706628|101176574|FG001|Overall Study|Consent withdrawn|1|||
33352477|NCT00706628|101176575|FG002|Overall Study|Consent withdrawn|3|||
33412475|NCT00124709|101400020|FG001|Overall Study|Lost to Follow-up|120|||
33619242|NCT04915729|102154982|FG000|Overall Study|not treated|3|||
33619243|NCT04915729|102154983|FG001|Overall Study|not treated|6|||
33619244|NCT04915729|102154982|FG000|Overall Study|Investigator removed subject|1|||
33619245|NCT04915729|102154983|FG001|Overall Study|Investigator removed subject|2|||
33619246|NCT04915729|102154982|FG000|Overall Study|questionnaire result not evaluated|1|||
33619247|NCT04915729|102154983|FG001|Overall Study|questionnaire result not evaluated|0|||
33619248|NCT04915729|102154982|FG000|Overall Study|refuse of hospital visit|1|||
33619249|NCT04915729|102154983|FG001|Overall Study|refuse of hospital visit|3|||
33619250|NCT04915729|102154982|FG000|Overall Study|Subject withdrew|1|||
33552716|NCT00289900|101923546|FG000|Overall Study|Participant had flushing|18|||
33552717|NCT00289900|101923547|FG001|Overall Study|Participant had flushing|42|||
33552718|NCT00289900|101923548|FG002|Overall Study|Participant had flushing|1|||
33552719|NCT00289900|101923549|FG003|Overall Study|Participant had flushing|2|||
33552720|NCT00289900|101923550|FG004|Overall Study|Participant had flushing|0|||
33552721|NCT00289900|101923551|FG005|Overall Study|Participant had flushing|4|||
33412476|NCT01340794|101400023|FG000|Overall Study|Withdrawal by Subject|0|||
33412477|NCT01340794|101400024|FG001|Overall Study|Withdrawal by Subject|1|||
33552722|NCT00289900|101923546|FG000|Overall Study|Other|0|||
33412478|NCT00604175|101400025|FG000|Entry Through Week 28|Death|2|||
33552723|NCT00289900|101923547|FG001|Overall Study|Other|0|||
33552724|NCT00289900|101923548|FG002|Overall Study|Other|0|||
33552725|NCT00289900|101923549|FG003|Overall Study|Other|5|||
33552726|NCT00289900|101923550|FG004|Overall Study|Other|1|||
33552727|NCT00289900|101923551|FG005|Overall Study|Other|0|||
33552728|NCT00289900|101923546|FG000|Overall Study|Participant moved|1|||
33552729|NCT00289900|101923547|FG001|Overall Study|Participant moved|0|||
33552730|NCT00289900|101923548|FG002|Overall Study|Participant moved|0|||
33552731|NCT00289900|101923549|FG003|Overall Study|Participant moved|1|||
33552732|NCT00289900|101923550|FG004|Overall Study|Participant moved|1|||
33552733|NCT00289900|101923551|FG005|Overall Study|Participant moved|1|||
33552734|NCT00289900|101923546|FG000|Overall Study|Withdrawal by Subject|10|||
33552735|NCT00289900|101923547|FG001|Overall Study|Withdrawal by Subject|21|||
33552736|NCT00289900|101923548|FG002|Overall Study|Withdrawal by Subject|8|||
33552737|NCT00289900|101923549|FG003|Overall Study|Withdrawal by Subject|18|||
33552738|NCT00289900|101923550|FG004|Overall Study|Withdrawal by Subject|12|||
33552739|NCT00289900|101923551|FG005|Overall Study|Withdrawal by Subject|11|||
33619251|NCT04915729|102154983|FG001|Overall Study|Subject withdrew|0|||
33619252|NCT01922271|102154984|FG000|WASHOUT Period|Withdrawal by Subject|1|||
33412479|NCT00604175|101400026|FG001|Entry Through Week 28|Death|0|||
33412480|NCT00604175|101400027|FG002|Entry Through Week 28|Death|0|||
33412481|NCT00604175|101400025|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
33412482|NCT00604175|101400026|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
33412483|NCT00604175|101400027|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
33412484|NCT00604175|101400025|FG000|Entry Through Week 28|Lost to Follow-up|4|||
33412485|NCT00604175|101400026|FG001|Entry Through Week 28|Lost to Follow-up|3|||
33412486|NCT00604175|101400027|FG002|Entry Through Week 28|Lost to Follow-up|0|||
33552740|NCT00289900|101923546|FG000|Overall Study|Protocol Violation|3|||
33552741|NCT00289900|101923547|FG001|Overall Study|Protocol Violation|9|||
33552742|NCT00289900|101923548|FG002|Overall Study|Protocol Violation|2|||
33552743|NCT00289900|101923549|FG003|Overall Study|Protocol Violation|6|||
33552744|NCT00289900|101923550|FG004|Overall Study|Protocol Violation|7|||
33552745|NCT00289900|101923551|FG005|Overall Study|Protocol Violation|4|||
33552746|NCT00289900|101923546|FG000|Overall Study|site terminated|1|||
33552747|NCT00289900|101923547|FG001|Overall Study|site terminated|0|||
33552748|NCT00289900|101923548|FG002|Overall Study|site terminated|1|||
33619253|NCT01922271|102154985|FG001|WASHOUT Period|Withdrawal by Subject|0|||
33619254|NCT02326597|102154986|FG000|Overall Study|Lost to Follow-up|42|||
33412487|NCT00604175|101400025|FG000|Entry Through Week 28|Ineligible|1|||
33412488|NCT00604175|101400026|FG001|Entry Through Week 28|Ineligible|0|||
33412489|NCT00604175|101400027|FG002|Entry Through Week 28|Ineligible|0|||
33412490|NCT00604175|101400025|FG000|Entry Through Week 28|Did not start intervention|2|||
33412491|NCT00604175|101400026|FG001|Entry Through Week 28|Did not start intervention|0|||
33412492|NCT00604175|101400027|FG002|Entry Through Week 28|Did not start intervention|1|||
33412493|NCT00604175|101400025|FG000|Week 29 Through Week 72|Death|0|||
33552749|NCT00289900|101923549|FG003|Overall Study|site terminated|0|||
33552750|NCT00289900|101923550|FG004|Overall Study|site terminated|0|||
33217774|NCT04512066|100695856|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
33217775|NCT04512066|100695857|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
33217776|NCT04512066|100695858|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
33217777|NCT04512066|100695859|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
33217778|NCT04512066|100695860|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
33552751|NCT00289900|101923551|FG005|Overall Study|site terminated|0|||
33552752|NCT00289900|101923546|FG000|Overall Study|Not treated|0|||
33552753|NCT00289900|101923547|FG001|Overall Study|Not treated|1|||
33552754|NCT00289900|101923548|FG002|Overall Study|Not treated|0|||
33552755|NCT00289900|101923549|FG003|Overall Study|Not treated|0|||
33552756|NCT00289900|101923550|FG004|Overall Study|Not treated|0|||
33552757|NCT00289900|101923551|FG005|Overall Study|Not treated|0|||
33552758|NCT01898091|101923553|FG000|Overall Study|Lost to Follow-up|1|||
33217779|NCT04512066|100695861|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
33217780|NCT04512066|100695856|FG000|Extension Period|Adverse Event|0|||
33217781|NCT04512066|100695857|FG001|Extension Period|Adverse Event|1|||
33352478|NCT00706628|101176576|FG003|Overall Study|Consent withdrawn|0|||
33352479|NCT00706628|101176573|FG000|Overall Study|Progressive disease|20|||
33352480|NCT00706628|101176574|FG001|Overall Study|Progressive disease|13|||
33352481|NCT00706628|101176575|FG002|Overall Study|Progressive disease|8|||
33352482|NCT00706628|101176576|FG003|Overall Study|Progressive disease|1|||
33352483|NCT00706628|101176573|FG000|Overall Study|Other than those stated above|4|||
33352484|NCT00706628|101176574|FG001|Overall Study|Other than those stated above|0|||
33352485|NCT00706628|101176575|FG002|Overall Study|Other than those stated above|0|||
33352486|NCT00706628|101176576|FG003|Overall Study|Other than those stated above|0|||
33352487|NCT00706628|101176573|FG000|Overall Study|Not treated|1|||
33352488|NCT00706628|101176574|FG001|Overall Study|Not treated|1|||
33352489|NCT00706628|101176575|FG002|Overall Study|Not treated|0|||
33352490|NCT00706628|101176576|FG003|Overall Study|Not treated|0|||
33352491|NCT00781365|101176580|FG000|Overall Study|Withdrawal by Subject|13|||
33352492|NCT00781365|101176581|FG001|Overall Study|Withdrawal by Subject|8|||
33352493|NCT00781365|101176580|FG000|Overall Study|Did Not Attend Visit|20|||
33352494|NCT00781365|101176581|FG001|Overall Study|Did Not Attend Visit|28|||
33352495|NCT00781365|101176580|FG000|Overall Study|Language barrier|1|||
33352496|NCT00781365|101176581|FG001|Overall Study|Language barrier|0|||
33352497|NCT01245673|101176582|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
33352498|NCT00376961|101176584|FG000|Initial Registration|Adverse Event|1|||
33352499|NCT00376961|101176585|FG001|Initial Registration|Adverse Event|0|||
33352500|NCT00376961|101176584|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
33352501|NCT00376961|101176585|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
33352502|NCT00376961|101176584|FG000|Initial Registration|Progression/relapse|1|||
33352503|NCT00376961|101176585|FG001|Initial Registration|Progression/relapse|0|||
33352504|NCT00376961|101176584|FG000|Initial Registration|Ineligible|3|||
33352505|NCT00376961|101176585|FG001|Initial Registration|Ineligible|0|||
33352506|NCT00376961|101176584|FG000|Maintenance|Adverse Event|0|||
33352507|NCT00376961|101176585|FG001|Maintenance|Adverse Event|1|||
33352508|NCT00376961|101176584|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
33352509|NCT00376961|101176585|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
33352510|NCT00376961|101176584|FG000|Maintenance|Progression/relapse|0|||
33352511|NCT00376961|101176585|FG001|Maintenance|Progression/relapse|18|||
33352512|NCT00376961|101176584|FG000|Maintenance|Ineligible|0|||
33352513|NCT00376961|101176585|FG001|Maintenance|Ineligible|3|||
33352514|NCT00855439|101176586|FG000|Overall Study|Withdrawal by Subject|2|||
33352515|NCT00855439|101176587|FG001|Overall Study|Withdrawal by Subject|0|||
33352516|NCT00855439|101176586|FG000|Overall Study|Pregnancy|1|||
33352517|NCT00855439|101176587|FG001|Overall Study|Pregnancy|0|||
33352518|NCT00666562|101176588|FG000|Overall Study|Withdrawal by Subject|0|||
33352519|NCT00666562|101176589|FG001|Overall Study|Withdrawal by Subject|1|||
33352520|NCT00666562|101176590|FG002|Overall Study|Withdrawal by Subject|0|||
33352521|NCT00666562|101176588|FG000|Overall Study|Concomitant Medication|0|||
33412494|NCT00604175|101400026|FG001|Week 29 Through Week 72|Death|0|||
33412495|NCT00604175|101400027|FG002|Week 29 Through Week 72|Death|1|||
33552759|NCT01898091|101923554|FG001|Overall Study|Lost to Follow-up|1|||
33552760|NCT01898091|101923553|FG000|Overall Study|Withdrawal by Subject|1|||
33552761|NCT01898091|101923554|FG001|Overall Study|Withdrawal by Subject|5|||
33552762|NCT00478140|101923555|FG000|Overall Study|Clinical Disease Progression|1|||
33552763|NCT02441114|101923556|FG000|Washout2|Withdrawal by Subject|4|||
33552764|NCT00871000|101923557|FG000|Overall Study|Withdrawal by Subject|1|||
33412496|NCT00604175|101400025|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
33412497|NCT00604175|101400026|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
33412498|NCT00604175|101400027|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
33412499|NCT00604175|101400025|FG000|Week 29 Through Week 72|Site closure|0|||
33412500|NCT00604175|101400026|FG001|Week 29 Through Week 72|Site closure|1|||
33412501|NCT00604175|101400027|FG002|Week 29 Through Week 72|Site closure|0|||
33412502|NCT00604175|101400025|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
33412503|NCT00604175|101400026|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
33412504|NCT00604175|101400027|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
33412505|NCT01381068|101400028|FG000|Overall Study|Death|1|||
33412506|NCT01381068|101400029|FG001|Overall Study|Death|0|||
33412507|NCT02064231|101400030|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
33412508|NCT02064231|101400031|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
33412509|NCT02064231|101400032|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
33412510|NCT02064231|101400033|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
33412511|NCT02064231|101400030|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
33412512|NCT02064231|101400031|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
33412513|NCT02064231|101400032|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
33412514|NCT02064231|101400033|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
33352522|NCT00666562|101176589|FG001|Overall Study|Concomitant Medication|1|||
33352523|NCT00666562|101176590|FG002|Overall Study|Concomitant Medication|0|||
33412515|NCT02064231|101400030|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
33412516|NCT02064231|101400031|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
33412517|NCT02064231|101400032|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
33412518|NCT02064231|101400033|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
33412519|NCT02064231|101400030|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
33352524|NCT03770403|101176591|FG000|Overall Study|Adverse Event|8|||
33352525|NCT03770403|101176591|FG000|Overall Study|Death|5|||
33217782|NCT04512066|100695858|FG002|Extension Period|Adverse Event|4|||
33217783|NCT04512066|100695859|FG003|Extension Period|Adverse Event|3|||
33217784|NCT04512066|100695860|FG004|Extension Period|Adverse Event|1|||
33352526|NCT03770403|101176591|FG000|Overall Study|Physician Decision|1|||
33352527|NCT03770403|101176591|FG000|Overall Study|Sponsor decision|1|||
33352528|NCT03770403|101176591|FG000|Overall Study|Study terminated by Sponsor|1|||
33352529|NCT03770403|101176591|FG000|Overall Study|Withdrawal by Subject|13|||
33352530|NCT03770403|101176591|FG000|Overall Study|Other|88|||
33352531|NCT00461175|101176592|FG000|Overall Study|Protocol Violation|522|||
33352532|NCT00461175|101176593|FG001|Overall Study|Protocol Violation|365|||
33352533|NCT00880750|101176594|FG000|First Intervention|Adverse Event|1|||
33412520|NCT02064231|101400031|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
33412521|NCT02064231|101400032|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
33412522|NCT02064231|101400033|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
33412523|NCT00627094|101400035|FG000|Overall Study|Adverse Event|8|||
33412524|NCT00627094|101400036|FG001|Overall Study|Adverse Event|7|||
33352534|NCT00880750|101176595|FG001|First Intervention|Adverse Event|0|||
33352535|NCT00880750|101176594|FG000|First Intervention|Unable to collect urine|4|||
33352536|NCT00880750|101176595|FG001|First Intervention|Unable to collect urine|0|||
33352537|NCT00880750|101176594|FG000|First Intervention|Non-compliance with meals|0|||
33352538|NCT00880750|101176595|FG001|First Intervention|Non-compliance with meals|1|||
33352539|NCT00880750|101176594|FG000|First Intervention|Withdrawal by Subject|2|||
33352540|NCT00880750|101176595|FG001|First Intervention|Withdrawal by Subject|0|||
33352541|NCT00880750|101176594|FG000|First Intervention|Lost to Follow-up|2|||
33352542|NCT00880750|101176595|FG001|First Intervention|Lost to Follow-up|0|||
33352543|NCT00880750|101176594|FG000|Second Intervention|Withdrawal by Subject|2|||
33412525|NCT00627094|101400035|FG000|Overall Study|Lost to Follow-up|1|||
33619255|NCT02326597|102154987|FG001|Overall Study|Lost to Follow-up|32|||
33217785|NCT04512066|100695861|FG005|Extension Period|Adverse Event|3|||
33412526|NCT00627094|101400036|FG001|Overall Study|Lost to Follow-up|0|||
33412527|NCT00627094|101400035|FG000|Overall Study|Withdrawal by Subject|1|||
33217786|NCT04512066|100695856|FG000|Extension Period|Death|0|||
33217787|NCT04512066|100695857|FG001|Extension Period|Death|0|||
33412528|NCT00627094|101400036|FG001|Overall Study|Withdrawal by Subject|1|||
33412529|NCT00627094|101400035|FG000|Overall Study|ulcer healed|1|||
33217788|NCT04512066|100695858|FG002|Extension Period|Death|0|||
33217789|NCT04512066|100695859|FG003|Extension Period|Death|0|||
33352544|NCT00880750|101176595|FG001|Second Intervention|Withdrawal by Subject|2|||
33412530|NCT00627094|101400036|FG001|Overall Study|ulcer healed|7|||
33352545|NCT00880750|101176594|FG000|Second Intervention|Protocol Violation|1|||
33412531|NCT00627094|101400035|FG000|Overall Study|Other reason|1|||
33412532|NCT00627094|101400036|FG001|Overall Study|Other reason|0|||
33352546|NCT00880750|101176595|FG001|Second Intervention|Protocol Violation|0|||
33412533|NCT05299359|101400040|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
33412534|NCT05299359|101400041|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
33412535|NCT05299359|101400040|FG000|Main Part: Day 1 up to Day 366|Other|2|||
33352547|NCT00880750|101176594|FG000|Second Intervention|Unable to collect urine|1|||
33352548|NCT00880750|101176595|FG001|Second Intervention|Unable to collect urine|0|||
33352549|NCT00737529|101176596|FG000|Overall Study|Disease Progression|95|||
33352550|NCT00737529|101176596|FG000|Overall Study|Adverse Event|24|||
33352551|NCT00737529|101176596|FG000|Overall Study|Withdrawal by Subject|5|||
33352552|NCT00737529|101176596|FG000|Overall Study|Death|4|||
33352553|NCT00737529|101176596|FG000|Overall Study|Protocol Violation|1|||
33352554|NCT00737529|101176596|FG000|Overall Study|Other|4|||
33352555|NCT02041962|101176597|FG000|Overall Study|Lost Aetna Coverage|43|||
33352556|NCT02041962|101176598|FG001|Overall Study|Lost Aetna Coverage|40|||
33352557|NCT02041962|101176597|FG000|Overall Study|Death|1|||
33352558|NCT02041962|101176598|FG001|Overall Study|Death|1|||
33352559|NCT02041962|101176597|FG000|Overall Study|Lost to Follow-up|37|||
33352560|NCT02041962|101176598|FG001|Overall Study|Lost to Follow-up|32|||
33352561|NCT02041962|101176597|FG000|Overall Study|Withdrawal by Subject|0|||
33352562|NCT02041962|101176598|FG001|Overall Study|Withdrawal by Subject|11|||
33352563|NCT00928070|101176599|FG000|Overall Study|Lost to Follow-up|1|||
33352564|NCT00928070|101176600|FG001|Overall Study|Lost to Follow-up|2|||
33352565|NCT00928070|101176599|FG000|Overall Study|Withdrawal by Subject|10|||
33352566|NCT00928070|101176600|FG001|Overall Study|Withdrawal by Subject|3|||
33352567|NCT00928070|101176599|FG000|Overall Study|Adverse Event|14|||
33352568|NCT00928070|101176600|FG001|Overall Study|Adverse Event|26|||
33352569|NCT00928070|101176599|FG000|Overall Study|Lack of Efficacy|9|||
33352570|NCT00928070|101176600|FG001|Overall Study|Lack of Efficacy|5|||
33352571|NCT00928070|101176599|FG000|Overall Study|Did not meet entrance criteria|16|||
33352572|NCT00928070|101176600|FG001|Overall Study|Did not meet entrance criteria|9|||
33352573|NCT00928070|101176599|FG000|Overall Study|Protocol Violation|6|||
33352574|NCT00928070|101176600|FG001|Overall Study|Protocol Violation|5|||
33352575|NCT00928070|101176599|FG000|Overall Study|Randomized but not treated|2|||
33352576|NCT00928070|101176600|FG001|Overall Study|Randomized but not treated|2|||
33352577|NCT00928070|101176599|FG000|Overall Study|Other|5|||
33352578|NCT00928070|101176600|FG001|Overall Study|Other|5|||
33352579|NCT02537678|101176602|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
33352580|NCT02537678|101176603|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
33352581|NCT02537678|101176602|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
33352582|NCT02537678|101176603|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
33352583|NCT02537678|101176602|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
33352584|NCT02537678|101176603|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
33352585|NCT02537678|101176602|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
33352586|NCT02537678|101176603|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
33352587|NCT02537678|101176602|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
33352588|NCT02537678|101176603|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
33352589|NCT02537678|101176602|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
33352590|NCT02537678|101176603|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
33352591|NCT02537678|101176602|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
33352592|NCT02537678|101176603|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
33352593|NCT00222105|101176605|FG000|Overall Study|Removed due to wrong diagnosis|1|||
33352594|NCT00222105|101176605|FG000|Overall Study|Withdrawal by Subject|1|||
33352595|NCT00222105|101176605|FG000|Overall Study|Adverse Event|8|||
33352596|NCT00222105|101176605|FG000|Overall Study|Treatment delays|2|||
33352597|NCT00222105|101176605|FG000|Overall Study|Death|2|||
33352598|NCT01237951|101176606|FG000|Overall Study|Death|1|||
33352599|NCT03041311|101176607|FG000|Overall Study|Death|39|||
33352600|NCT03041311|101176608|FG001|Overall Study|Death|42|||
33352601|NCT03041311|101176607|FG000|Overall Study|Lost to Follow-up|0|||
33352602|NCT03041311|101176608|FG001|Overall Study|Lost to Follow-up|1|||
33352603|NCT03041311|101176607|FG000|Overall Study|Withdrawal by Subject|8|||
33352604|NCT03041311|101176608|FG001|Overall Study|Withdrawal by Subject|5|||
33352605|NCT03041311|101176607|FG000|Overall Study|Sponsor Terminated Study|2|||
33352606|NCT03041311|101176608|FG001|Overall Study|Sponsor Terminated Study|4|||
33352607|NCT03041311|101176607|FG000|Overall Study|Disease Progression|3|||
33352608|NCT03041311|101176608|FG001|Overall Study|Disease Progression|1|||
33352609|NCT03041311|101176607|FG000|Overall Study|Randomized in error, did not receive drug|2|||
33352610|NCT03041311|101176608|FG001|Overall Study|Randomized in error, did not receive drug|0|||
33352611|NCT05148884|101176609|FG000|Overall Study|Withdrawal by Subject|3|||
33352612|NCT05148884|101176610|FG001|Overall Study|Withdrawal by Subject|0|||
33412536|NCT05299359|101400041|FG001|Main Part: Day 1 up to Day 366|Other|0|||
33619256|NCT01200368|102154991|FG000|Infant Series|Adverse Event|2|||
33217790|NCT04512066|100695860|FG004|Extension Period|Death|0|||
33352613|NCT05148884|101176609|FG000|Overall Study|Deep brain stimulation operation|0|||
33352614|NCT05148884|101176610|FG001|Overall Study|Deep brain stimulation operation|1|||
33352615|NCT04826900|101176611|FG000|Overall Study|Family factor|1|||
33412537|NCT05299359|101400040|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
33619257|NCT01200368|102154992|FG001|Infant Series|Adverse Event|2|||
33352616|NCT04826900|101176612|FG001|Overall Study|Family factor|1|||
33352617|NCT01238120|101176613|FG000|Overall Study|Withdrawal by Subject|4|||
33352618|NCT01238120|101176614|FG001|Overall Study|Withdrawal by Subject|1|||
33352619|NCT01238120|101176615|FG002|Overall Study|Withdrawal by Subject|2|||
33352620|NCT01238120|101176616|FG003|Overall Study|Withdrawal by Subject|5|||
33352621|NCT01238120|101176613|FG000|Overall Study|Lost to Follow-up|2|||
33352622|NCT01238120|101176614|FG001|Overall Study|Lost to Follow-up|0|||
33352623|NCT01238120|101176615|FG002|Overall Study|Lost to Follow-up|1|||
33352624|NCT01238120|101176616|FG003|Overall Study|Lost to Follow-up|1|||
33352625|NCT01238120|101176613|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
33352626|NCT01238120|101176614|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
33352627|NCT01238120|101176615|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
33352628|NCT01238120|101176616|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
33352629|NCT03124459|101176617|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
33352630|NCT03124459|101176618|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
33352631|NCT03124459|101176619|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
33352632|NCT03124459|101176620|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
33552765|NCT00871000|101923558|FG001|Overall Study|Withdrawal by Subject|0|||
33552766|NCT03439514|101923559|FG000|Double-Blind Treatment Period|Other|4|||
33552767|NCT03439514|101923560|FG001|Double-Blind Treatment Period|Other|1|||
33552768|NCT03439514|101923559|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
33552769|NCT03439514|101923560|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
33552770|NCT03439514|101923559|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
33552771|NCT03439514|101923560|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
33552772|NCT03439514|101923559|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
33552773|NCT03439514|101923560|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
33552774|NCT03439514|101923559|FG000|Double-Blind Treatment Period|Death|1|||
33552775|NCT03439514|101923560|FG001|Double-Blind Treatment Period|Death|2|||
33552776|NCT00454142|101923564|FG000|Overall Study|Withdrawal by Subject|1|||
33619258|NCT01200368|102154993|FG002|Infant Series|Adverse Event|3|||
33619259|NCT01200368|102154991|FG000|Infant Series|Withdrawal by Subject|0|||
33619260|NCT01200368|102154992|FG001|Infant Series|Withdrawal by Subject|2|||
33619261|NCT01200368|102154993|FG002|Infant Series|Withdrawal by Subject|2|||
33352633|NCT03124459|101176621|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
33352634|NCT03124459|101176622|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
33352635|NCT03124459|101176617|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
33352636|NCT03124459|101176618|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
33552777|NCT00501085|101923565|FG000|Overall Study|Lost to Follow-up|195|||
33619262|NCT01200368|102154991|FG000|Infant Series|Did not meet entrance criteria|0|||
33619263|NCT01200368|102154992|FG001|Infant Series|Did not meet entrance criteria|1|||
33619264|NCT01200368|102154993|FG002|Infant Series|Did not meet entrance criteria|0|||
33619265|NCT01200368|102154991|FG000|Infant Series|Randomized, not vaccinated|0|||
33352637|NCT03124459|101176619|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
33352638|NCT03124459|101176620|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
33352639|NCT03124459|101176621|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
33352640|NCT03124459|101176622|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
33352641|NCT03124459|101176617|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
33352642|NCT03124459|101176618|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
33352643|NCT03124459|101176619|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
33352644|NCT03124459|101176620|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
33352645|NCT03124459|101176621|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
33352646|NCT03124459|101176622|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
33352647|NCT03124459|101176617|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
33352648|NCT03124459|101176618|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
33352649|NCT03124459|101176619|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
33352650|NCT03124459|101176620|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
33352651|NCT03124459|101176621|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
33352652|NCT03124459|101176622|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
33352653|NCT03124459|101176617|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
33352654|NCT03124459|101176618|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
33352655|NCT03124459|101176619|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
33352656|NCT03124459|101176620|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
33352657|NCT03124459|101176621|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
33352658|NCT03124459|101176622|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
33552778|NCT00501085|101923565|FG000|Overall Study|Withdrawal by Subject|34|||
33552779|NCT00501085|101923565|FG000|Overall Study|Subject Decision|1|||
33552780|NCT00501085|101923565|FG000|Overall Study|Revision Surgery|7|||
33552781|NCT00501085|101923565|FG000|Overall Study|Explantation Surgery|26|||
33552782|NCT00501085|101923565|FG000|Overall Study|Adverse Event|4|||
33552783|NCT00501085|101923565|FG000|Overall Study|Non-Compliance|24|||
33552784|NCT00501085|101923565|FG000|Overall Study|Study closed by sponsor|109|||
33552785|NCT00501085|101923565|FG000|Overall Study|Other loss to follow-up|32|||
33552786|NCT03767894|101923566|FG000|Overall Study|Withdrawal by Subject|1|||
33552787|NCT00710554|101923567|FG000|Overall Study|Adverse Event|24|||
33552788|NCT00710554|101923568|FG001|Overall Study|Adverse Event|7|||
33552789|NCT00710554|101923567|FG000|Overall Study|Withdrawal by Subject|7|||
33552790|NCT00710554|101923568|FG001|Overall Study|Withdrawal by Subject|3|||
33552791|NCT00710554|101923567|FG000|Overall Study|Lost to Follow-up|7|||
33552792|NCT00710554|101923568|FG001|Overall Study|Lost to Follow-up|1|||
33552793|NCT00710554|101923567|FG000|Overall Study|Lack of Efficacy|11|||
33552794|NCT00710554|101923568|FG001|Overall Study|Lack of Efficacy|12|||
33552795|NCT00710554|101923567|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
33552796|NCT00710554|101923568|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
33552797|NCT01986751|101923569|FG000|Overall Study|improperly consented|10|||
33552798|NCT01986751|101923570|FG001|Overall Study|improperly consented|2|||
33552799|NCT01703221|101923571|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
33552800|NCT01703221|101923572|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
33552801|NCT01703221|101923573|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
33552802|NCT01703221|101923571|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
33552803|NCT01703221|101923572|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
33552804|NCT01703221|101923573|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
33552805|NCT01703221|101923571|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
33552806|NCT01703221|101923572|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33552807|NCT01703221|101923573|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33552808|NCT01703221|101923571|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
33552809|NCT01703221|101923572|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
33552810|NCT01703221|101923573|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
33552811|NCT01703221|101923571|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33552812|NCT01703221|101923572|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33552813|NCT01703221|101923573|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
33552814|NCT01703221|101923571|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
33552815|NCT01703221|101923572|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
33552816|NCT01703221|101923573|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
33552817|NCT01703221|101923571|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
33552818|NCT01703221|101923572|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
33552819|NCT01703221|101923573|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
33552820|NCT01703221|101923571|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
33552821|NCT01703221|101923572|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
33352659|NCT03124459|101176617|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
33352660|NCT03124459|101176618|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
33352661|NCT03124459|101176619|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
33352662|NCT03124459|101176620|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
33352663|NCT03124459|101176621|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
33352664|NCT03124459|101176622|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
33352665|NCT02770807|101176623|FG000|Overall Study|Adverse Event|3|||
33352666|NCT02770807|101176624|FG001|Overall Study|Adverse Event|3|||
33352667|NCT02770807|101176625|FG002|Overall Study|Adverse Event|1|||
33352668|NCT02770807|101176623|FG000|Overall Study|Withdrawal by Subject|7|||
33352669|NCT02770807|101176624|FG001|Overall Study|Withdrawal by Subject|3|||
33352670|NCT02770807|101176625|FG002|Overall Study|Withdrawal by Subject|4|||
33352671|NCT02770807|101176623|FG000|Overall Study|Other|0|||
33352672|NCT02770807|101176624|FG001|Overall Study|Other|1|||
33352673|NCT02770807|101176625|FG002|Overall Study|Other|0|||
33352674|NCT02770807|101176623|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
33352675|NCT02770807|101176624|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
33352676|NCT02770807|101176625|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
33352677|NCT02770807|101176623|FG000|Overall Study|Physician Decision|0|||
33352678|NCT02770807|101176624|FG001|Overall Study|Physician Decision|0|||
33352679|NCT02770807|101176625|FG002|Overall Study|Physician Decision|1|||
33352680|NCT00316264|101176626|FG000|Overall Study|Lost to Follow-up|0|||
33352681|NCT00316264|101176627|FG001|Overall Study|Lost to Follow-up|1|||
33352682|NCT00316264|101176628|FG002|Overall Study|Lost to Follow-up|0|||
33352683|NCT00316264|101176626|FG000|Overall Study|Withdrawal of Consent|3|||
33552822|NCT01703221|101923573|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
33552823|NCT02018887|101923581|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
33552824|NCT02018887|101923582|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33352684|NCT00316264|101176627|FG001|Overall Study|Withdrawal of Consent|5|||
33352685|NCT00316264|101176628|FG002|Overall Study|Withdrawal of Consent|6|||
33352686|NCT00316264|101176626|FG000|Overall Study|Death|2|||
33352687|NCT00316264|101176627|FG001|Overall Study|Death|0|||
33352688|NCT00316264|101176628|FG002|Overall Study|Death|0|||
33552825|NCT02018887|101923583|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33552826|NCT02018887|101923584|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33552827|NCT02018887|101923585|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33552828|NCT02018887|101923586|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33352689|NCT00316264|101176626|FG000|Overall Study|Other|1|||
33352690|NCT00316264|101176627|FG001|Overall Study|Other|1|||
33352691|NCT00316264|101176628|FG002|Overall Study|Other|0|||
33352692|NCT05300087|101176629|FG000|Overall Study|Withdrawal by Subject|0|||
33352693|NCT05300087|101176630|FG001|Overall Study|Withdrawal by Subject|1|||
33352694|NCT02006576|101176631|FG000|Overall Study|Withdrawal by Subject|4|||
33352695|NCT02006576|101176632|FG001|Overall Study|Withdrawal by Subject|6|||
33352696|NCT02006576|101176633|FG002|Overall Study|Withdrawal by Subject|2|||
33352697|NCT02006576|101176631|FG000|Overall Study|Death|0|||
33352698|NCT02006576|101176632|FG001|Overall Study|Death|0|||
33352699|NCT02006576|101176633|FG002|Overall Study|Death|1|||
33352700|NCT02006576|101176631|FG000|Overall Study|Lost to Follow-up|1|||
33352701|NCT02006576|101176632|FG001|Overall Study|Lost to Follow-up|0|||
33552829|NCT02018887|101923587|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33552830|NCT02018887|101923588|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33552831|NCT02018887|101923589|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33552832|NCT02018887|101923590|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33552833|NCT02018887|101923591|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
33552834|NCT02018887|101923581|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33352702|NCT02006576|101176633|FG002|Overall Study|Lost to Follow-up|1|||
33352703|NCT02006576|101176631|FG000|Overall Study|Screen Failure, too sick, other|13|||
33352704|NCT02006576|101176632|FG001|Overall Study|Screen Failure, too sick, other|1|||
33352705|NCT02006576|101176633|FG002|Overall Study|Screen Failure, too sick, other|13|||
33352706|NCT02983604|101176636|FG000|Overall Study|Enrolled but not Treated|0|||
33352707|NCT02983604|101176637|FG001|Overall Study|Enrolled but not Treated|0|||
33352708|NCT02983604|101176638|FG002|Overall Study|Enrolled but not Treated|1|||
33352709|NCT02983604|101176639|FG003|Overall Study|Enrolled but not Treated|0|||
33352710|NCT00618722|101176640|FG000|Overall Study|Refusal of Treatment|0|||
33352711|NCT00618722|101176641|FG001|Overall Study|Refusal of Treatment|0|||
33352712|NCT00618722|101176642|FG002|Overall Study|Refusal of Treatment|1|||
33352713|NCT00618722|101176643|FG003|Overall Study|Refusal of Treatment|0|||
33352714|NCT00618722|101176640|FG000|Overall Study|Patient Request|1|||
33552835|NCT02018887|101923582|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33552836|NCT02018887|101923583|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33552837|NCT02018887|101923584|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33552838|NCT02018887|101923585|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
33552839|NCT02018887|101923586|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33552840|NCT02018887|101923587|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
33552841|NCT02018887|101923588|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
33552842|NCT02018887|101923589|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33552843|NCT02018887|101923590|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33552844|NCT02018887|101923591|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
33352715|NCT00618722|101176641|FG001|Overall Study|Patient Request|1|||
33352716|NCT00618722|101176642|FG002|Overall Study|Patient Request|1|||
33352717|NCT00618722|101176643|FG003|Overall Study|Patient Request|1|||
33352718|NCT00618722|101176640|FG000|Overall Study|Inability to Complete Study Procedure|0|||
33352719|NCT00618722|101176641|FG001|Overall Study|Inability to Complete Study Procedure|1|||
33352720|NCT00618722|101176642|FG002|Overall Study|Inability to Complete Study Procedure|0|||
33352721|NCT00618722|101176643|FG003|Overall Study|Inability to Complete Study Procedure|0|||
33352722|NCT00618722|101176640|FG000|Overall Study|Lost to Follow-up|2|||
33352723|NCT00618722|101176641|FG001|Overall Study|Lost to Follow-up|0|||
33352724|NCT00618722|101176642|FG002|Overall Study|Lost to Follow-up|0|||
33352725|NCT00618722|101176643|FG003|Overall Study|Lost to Follow-up|2|||
33352726|NCT00618722|101176640|FG000|Overall Study|Miscellaneous Reasons|0|||
33552845|NCT02018887|101923581|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
33552846|NCT02018887|101923582|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
33352727|NCT00618722|101176641|FG001|Overall Study|Miscellaneous Reasons|0|||
33352728|NCT00618722|101176642|FG002|Overall Study|Miscellaneous Reasons|1|||
33352729|NCT00618722|101176643|FG003|Overall Study|Miscellaneous Reasons|1|||
33352730|NCT01642212|101176645|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
33352731|NCT01642212|101176646|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
33352732|NCT01642212|101176647|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
33352733|NCT01642212|101176648|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
33352734|NCT01642212|101176649|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
33352735|NCT01642212|101176645|FG000|Double-blind Treatment|Other|0|||
33352736|NCT01642212|101176646|FG001|Double-blind Treatment|Other|2|||
33619266|NCT01200368|102154992|FG001|Infant Series|Randomized, not vaccinated|1|||
33619267|NCT01200368|102154993|FG002|Infant Series|Randomized, not vaccinated|1|||
33352737|NCT01642212|101176647|FG002|Double-blind Treatment|Other|1|||
33352738|NCT01642212|101176648|FG003|Double-blind Treatment|Other|0|||
33352739|NCT01642212|101176649|FG004|Double-blind Treatment|Other|0|||
33552847|NCT02018887|101923583|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
33552848|NCT02018887|101923584|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
33552849|NCT02018887|101923585|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
33352740|NCT01642212|101176645|FG000|Double-blind Treatment|Non-compliance|0|||
33552850|NCT02018887|101923586|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
33552851|NCT02018887|101923587|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
33552852|NCT02018887|101923588|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
33552853|NCT02018887|101923589|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
33552854|NCT02018887|101923590|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
33552855|NCT02018887|101923591|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
33552856|NCT02018887|101923581|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
33552857|NCT02018887|101923582|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
33552858|NCT02018887|101923583|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
33352741|NCT01642212|101176646|FG001|Double-blind Treatment|Non-compliance|1|||
33352742|NCT01642212|101176647|FG002|Double-blind Treatment|Non-compliance|0|||
33352743|NCT01642212|101176648|FG003|Double-blind Treatment|Non-compliance|0|||
33352744|NCT01642212|101176649|FG004|Double-blind Treatment|Non-compliance|0|||
33352745|NCT01642212|101176645|FG000|Double-blind Treatment|Adverse Event|0|||
33352746|NCT01642212|101176646|FG001|Double-blind Treatment|Adverse Event|0|||
33352747|NCT01642212|101176647|FG002|Double-blind Treatment|Adverse Event|1|||
33352748|NCT01642212|101176648|FG003|Double-blind Treatment|Adverse Event|0|||
33352749|NCT01642212|101176649|FG004|Double-blind Treatment|Adverse Event|0|||
33352750|NCT01642212|101176645|FG000|Open-label Extension|Adverse Event|0|||
33352751|NCT01642212|101176646|FG001|Open-label Extension|Adverse Event|0|||
33352752|NCT01642212|101176647|FG002|Open-label Extension|Adverse Event|0|||
33352753|NCT01642212|101176648|FG003|Open-label Extension|Adverse Event|3|||
33352754|NCT01642212|101176649|FG004|Open-label Extension|Adverse Event|0|||
33352755|NCT01642212|101176645|FG000|Open-label Extension|Sponsor Decision|0|||
33352756|NCT01642212|101176646|FG001|Open-label Extension|Sponsor Decision|0|||
33352757|NCT01642212|101176647|FG002|Open-label Extension|Sponsor Decision|0|||
33352758|NCT01642212|101176648|FG003|Open-label Extension|Sponsor Decision|7|||
33352759|NCT01642212|101176649|FG004|Open-label Extension|Sponsor Decision|4|||
33352760|NCT01642212|101176645|FG000|Open-label Extension|Consent Withdrawn|0|||
33352761|NCT01642212|101176646|FG001|Open-label Extension|Consent Withdrawn|0|||
33352762|NCT01642212|101176647|FG002|Open-label Extension|Consent Withdrawn|0|||
33352763|NCT01642212|101176648|FG003|Open-label Extension|Consent Withdrawn|0|||
33352764|NCT01642212|101176649|FG004|Open-label Extension|Consent Withdrawn|2|||
33352765|NCT01642212|101176645|FG000|Open-label Extension|Lost to Follow-up|0|||
33352766|NCT01642212|101176646|FG001|Open-label Extension|Lost to Follow-up|0|||
33352767|NCT01642212|101176647|FG002|Open-label Extension|Lost to Follow-up|0|||
33352768|NCT01642212|101176648|FG003|Open-label Extension|Lost to Follow-up|0|||
33352769|NCT01642212|101176649|FG004|Open-label Extension|Lost to Follow-up|1|||
33352770|NCT01642212|101176645|FG000|Open-label Extension|Other|0|||
33352771|NCT01642212|101176646|FG001|Open-label Extension|Other|0|||
33352772|NCT01642212|101176647|FG002|Open-label Extension|Other|0|||
33352773|NCT01642212|101176648|FG003|Open-label Extension|Other|0|||
33352774|NCT01642212|101176649|FG004|Open-label Extension|Other|1|||
33352775|NCT04026568|101176654|FG000|Overall Study|study terminated|0|||
33352776|NCT04026568|101176655|FG001|Overall Study|study terminated|1|||
33352777|NCT00749190|101176658|FG000|Overall Study|Adverse Event|0|||
33352778|NCT00749190|101176659|FG001|Overall Study|Adverse Event|2|||
33352779|NCT00749190|101176660|FG002|Overall Study|Adverse Event|0|||
33352780|NCT00749190|101176661|FG003|Overall Study|Adverse Event|4|||
33352781|NCT00749190|101176662|FG004|Overall Study|Adverse Event|0|||
33352782|NCT00749190|101176663|FG005|Overall Study|Adverse Event|3|||
33352783|NCT00749190|101176664|FG006|Overall Study|Adverse Event|0|||
33352784|NCT00749190|101176658|FG000|Overall Study|Lack of Efficacy|3|||
33352785|NCT00749190|101176659|FG001|Overall Study|Lack of Efficacy|1|||
33352786|NCT00749190|101176660|FG002|Overall Study|Lack of Efficacy|1|||
33352787|NCT00749190|101176661|FG003|Overall Study|Lack of Efficacy|0|||
33352788|NCT00749190|101176662|FG004|Overall Study|Lack of Efficacy|0|||
33352789|NCT00749190|101176663|FG005|Overall Study|Lack of Efficacy|1|||
33352790|NCT00749190|101176664|FG006|Overall Study|Lack of Efficacy|0|||
33352791|NCT00749190|101176658|FG000|Overall Study|Withdrawal by Subject|2|||
33352792|NCT00749190|101176659|FG001|Overall Study|Withdrawal by Subject|1|||
33352793|NCT00749190|101176660|FG002|Overall Study|Withdrawal by Subject|0|||
33352794|NCT00749190|101176661|FG003|Overall Study|Withdrawal by Subject|0|||
33352795|NCT00749190|101176662|FG004|Overall Study|Withdrawal by Subject|0|||
33352796|NCT00749190|101176663|FG005|Overall Study|Withdrawal by Subject|1|||
33552859|NCT02018887|101923584|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
33552860|NCT02018887|101923585|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
33552861|NCT02018887|101923586|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
33352797|NCT00749190|101176664|FG006|Overall Study|Withdrawal by Subject|0|||
33352798|NCT00749190|101176658|FG000|Overall Study|Protocol Violation|0|||
33352799|NCT00749190|101176659|FG001|Overall Study|Protocol Violation|1|||
33352800|NCT00749190|101176660|FG002|Overall Study|Protocol Violation|0|||
33352801|NCT00749190|101176661|FG003|Overall Study|Protocol Violation|0|||
33352802|NCT00749190|101176662|FG004|Overall Study|Protocol Violation|0|||
33552862|NCT02018887|101923587|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
33619268|NCT01200368|102154991|FG000|Infant Series|Other|1|||
33352803|NCT00749190|101176663|FG005|Overall Study|Protocol Violation|0|||
33552863|NCT02018887|101923588|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
33352804|NCT00749190|101176664|FG006|Overall Study|Protocol Violation|1|||
33352805|NCT00749190|101176658|FG000|Overall Study|Other reason not defined above|0|||
33352806|NCT00749190|101176659|FG001|Overall Study|Other reason not defined above|0|||
33352807|NCT00749190|101176660|FG002|Overall Study|Other reason not defined above|0|||
33352808|NCT00749190|101176661|FG003|Overall Study|Other reason not defined above|1|||
33352809|NCT00749190|101176662|FG004|Overall Study|Other reason not defined above|0|||
33352810|NCT00749190|101176663|FG005|Overall Study|Other reason not defined above|0|||
33352811|NCT00749190|101176664|FG006|Overall Study|Other reason not defined above|0|||
33352812|NCT01705691|101176669|FG000|Overall Study|Death|1|||
33352813|NCT01705691|101176670|FG001|Overall Study|Death|2|||
33352814|NCT01705691|101176669|FG000|Overall Study|Withdrawal by Subject|1|||
33352815|NCT01705691|101176670|FG001|Overall Study|Withdrawal by Subject|2|||
33352816|NCT01705691|101176669|FG000|Overall Study|Lost to Follow-up|1|||
33352817|NCT01705691|101176670|FG001|Overall Study|Lost to Follow-up|1|||
33352818|NCT01705691|101176669|FG000|Overall Study|Other|0|||
33352819|NCT01705691|101176670|FG001|Overall Study|Other|1|||
33352820|NCT02886702|101176673|FG000|Overall Study|Other|4|||
33352821|NCT02886702|101176674|FG001|Overall Study|Other|3|||
33352822|NCT02886702|101176675|FG002|Overall Study|Other|9|||
33352823|NCT02886702|101176673|FG000|Overall Study|Withdrawal by Subject|24|||
33352824|NCT02886702|101176674|FG001|Overall Study|Withdrawal by Subject|18|||
33352825|NCT02886702|101176675|FG002|Overall Study|Withdrawal by Subject|22|||
33352826|NCT02886702|101176673|FG000|Overall Study|Significant Worsening of Condition|0|||
33352827|NCT02886702|101176674|FG001|Overall Study|Significant Worsening of Condition|1|||
33352828|NCT02886702|101176675|FG002|Overall Study|Significant Worsening of Condition|0|||
33352829|NCT02886702|101176673|FG000|Overall Study|Protocol Violation|2|||
33352830|NCT02886702|101176674|FG001|Overall Study|Protocol Violation|2|||
33352831|NCT02886702|101176675|FG002|Overall Study|Protocol Violation|1|||
33352832|NCT02886702|101176673|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33352833|NCT02886702|101176674|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33352834|NCT02886702|101176675|FG002|Overall Study|Non-Compliance With Study Drug|4|||
33352835|NCT02886702|101176673|FG000|Overall Study|Lost to Follow-up|11|||
33352836|NCT02886702|101176674|FG001|Overall Study|Lost to Follow-up|13|||
33352837|NCT02886702|101176675|FG002|Overall Study|Lost to Follow-up|8|||
33352838|NCT02886702|101176673|FG000|Overall Study|Lack of Efficacy|3|||
33352839|NCT02886702|101176674|FG001|Overall Study|Lack of Efficacy|4|||
33352840|NCT02886702|101176675|FG002|Overall Study|Lack of Efficacy|5|||
33352841|NCT02886702|101176673|FG000|Overall Study|Adverse Event|4|||
33352842|NCT02886702|101176674|FG001|Overall Study|Adverse Event|9|||
33352843|NCT02886702|101176675|FG002|Overall Study|Adverse Event|3|||
33352844|NCT02886702|101176673|FG000|Overall Study|Administrative Reasons|0|||
33352845|NCT02886702|101176674|FG001|Overall Study|Administrative Reasons|0|||
33352846|NCT02886702|101176675|FG002|Overall Study|Administrative Reasons|1|||
33352847|NCT00623831|101176679|FG000|Overall Study|Withdrawal by Subject|1|||
33352848|NCT00623831|101176680|FG001|Overall Study|Withdrawal by Subject|0|||
33352849|NCT00623831|101176679|FG000|Overall Study|Progressive Disease|0|||
33352850|NCT00623831|101176680|FG001|Overall Study|Progressive Disease|1|||
33352851|NCT01475734|101176686|FG000|Overall Study|Withdrawal by Subject|1|||
33352852|NCT01475734|101176687|FG001|Overall Study|Withdrawal by Subject|0|||
33552864|NCT02018887|101923589|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
33552865|NCT02018887|101923590|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
33552866|NCT02018887|101923591|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
33552867|NCT00981175|101923595|FG000|Primary Dose Vaccination|Adverse Event|1|||
33552868|NCT00981175|101923596|FG001|Primary Dose Vaccination|Adverse Event|0|||
33552869|NCT00981175|101923595|FG000|Primary Dose Vaccination|Protocol Violation|0|||
33552870|NCT00981175|101923596|FG001|Primary Dose Vaccination|Protocol Violation|1|||
33552871|NCT00981175|101923595|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
33552872|NCT00981175|101923596|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
33552873|NCT00981175|101923595|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
33217791|NCT04512066|100695861|FG005|Extension Period|Death|1|||
33352853|NCT01475734|101176686|FG000|Overall Study|Protocol Violation|1|||
33352854|NCT01475734|101176687|FG001|Overall Study|Protocol Violation|0|||
33352855|NCT01475734|101176686|FG000|Overall Study|Physician Decision|0|||
33352856|NCT01475734|101176687|FG001|Overall Study|Physician Decision|1|||
33552874|NCT00981175|101923596|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
33552875|NCT01016015|101923597|FG000|Overall Study|Not Treated|3|||
33552876|NCT01016015|101923597|FG000|Overall Study|Withdrawal by Subject|1|||
33552877|NCT01016015|101923597|FG000|Overall Study|Adverse Event|15|||
33352857|NCT03502187|101176688|FG000|Overall Study|Withdrawal by Subject|4|||
33412538|NCT05299359|101400041|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
33552878|NCT02400580|101923602|FG000|Overall Study|Withdrawal by Subject|1|||
33352858|NCT03502187|101176689|FG001|Overall Study|Withdrawal by Subject|3|||
33352859|NCT03502187|101176690|FG002|Overall Study|Withdrawal by Subject|3|||
33352860|NCT03502187|101176688|FG000|Overall Study|Lost to Follow-up|5|||
33352861|NCT03502187|101176689|FG001|Overall Study|Lost to Follow-up|4|||
33352862|NCT03502187|101176690|FG002|Overall Study|Lost to Follow-up|5|||
33352863|NCT02272790|101176694|FG000|Overall Study|Physician Decision|0|||
33352864|NCT02272790|101176695|FG001|Overall Study|Physician Decision|1|||
33352865|NCT02272790|101176696|FG002|Overall Study|Physician Decision|0|||
33352866|NCT02272790|101176697|FG003|Overall Study|Physician Decision|0|||
33352867|NCT02272790|101176698|FG004|Overall Study|Physician Decision|0|||
33352868|NCT02272790|101176699|FG005|Overall Study|Physician Decision|0|||
33352869|NCT00450580|101176702|FG000|Overall Study|Adverse Event|5|||
33352870|NCT00450580|101176703|FG001|Overall Study|Adverse Event|7|||
33352871|NCT00450580|101176702|FG000|Overall Study|Lost to Follow-up|4|||
33352872|NCT00450580|101176703|FG001|Overall Study|Lost to Follow-up|5|||
33352873|NCT00450580|101176702|FG000|Overall Study|Withdrawal by Subject|2|||
33352874|NCT00450580|101176703|FG001|Overall Study|Withdrawal by Subject|2|||
33352875|NCT00450580|101176702|FG000|Overall Study|Protocol Violation|1|||
33352876|NCT00450580|101176703|FG001|Overall Study|Protocol Violation|1|||
33352877|NCT00450580|101176702|FG000|Overall Study|Protocol-defined virologic failure|1|||
33352878|NCT00450580|101176703|FG001|Overall Study|Protocol-defined virologic failure|0|||
33352879|NCT00450580|101176702|FG000|Overall Study|Could not comply with scheduled visits|1|||
33552879|NCT02400580|101923603|FG001|Overall Study|Withdrawal by Subject|1|||
33552880|NCT02400580|101923602|FG000|Overall Study|Adverse Event|1|||
33352880|NCT00450580|101176703|FG001|Overall Study|Could not comply with scheduled visits|0|||
33412539|NCT05299359|101400040|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
33412540|NCT05299359|101400041|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
33412541|NCT05299359|101400040|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
33412542|NCT05299359|101400041|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
33412543|NCT05299359|101400040|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
33412544|NCT05299359|101400041|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
33412545|NCT05299359|101400040|FG000|Extension Part: Day 1 to Day 366|Other|0|||
33412546|NCT05299359|101400041|FG001|Extension Part: Day 1 to Day 366|Other|1|||
33412547|NCT04281030|101400042|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
33412548|NCT04281030|101400043|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
33412549|NCT04281030|101400042|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
33412550|NCT04281030|101400043|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
33412551|NCT03526549|101400046|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
33412552|NCT03526549|101400047|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
33412553|NCT03526549|101400046|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
33412554|NCT03526549|101400047|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
33412555|NCT03526549|101400046|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
33552881|NCT02400580|101923603|FG001|Overall Study|Adverse Event|0|||
33552882|NCT00976391|101923607|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
33552883|NCT00976391|101923608|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
33552884|NCT00976391|101923607|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
33552885|NCT00976391|101923608|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
33352881|NCT00450580|101176702|FG000|Overall Study|Patient went to Brazil|1|||
33352882|NCT00450580|101176703|FG001|Overall Study|Patient went to Brazil|0|||
33352883|NCT00450580|101176702|FG000|Overall Study|Patient could not swallow Norvir|1|||
33352884|NCT00450580|101176703|FG001|Overall Study|Patient could not swallow Norvir|0|||
33352885|NCT00450580|101176702|FG000|Overall Study|Withdrawal due to pregnancy|0|||
33352886|NCT00450580|101176703|FG001|Overall Study|Withdrawal due to pregnancy|1|||
33352887|NCT01400932|101176704|FG000|Overall Study|Adverse Event|10|||
33352888|NCT01400932|101176705|FG001|Overall Study|Adverse Event|5|||
33352889|NCT01400932|101176704|FG000|Overall Study|Lack of Efficacy|0|||
33352890|NCT01400932|101176705|FG001|Overall Study|Lack of Efficacy|3|||
33352891|NCT01400932|101176704|FG000|Overall Study|Withdrawal by Subject|2|||
33352892|NCT01400932|101176705|FG001|Overall Study|Withdrawal by Subject|6|||
33352893|NCT01400932|101176704|FG000|Overall Study|Lost to Follow-up|1|||
33352894|NCT01400932|101176705|FG001|Overall Study|Lost to Follow-up|0|||
33352895|NCT01400932|101176704|FG000|Overall Study|Protocol Deviation|0|||
33352896|NCT01400932|101176705|FG001|Overall Study|Protocol Deviation|1|||
33352897|NCT01400932|101176704|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33352898|NCT01400932|101176705|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
33352899|NCT04672083|101176706|FG000|Overall Study|Lost to Follow-up|1|||
33352900|NCT04672083|101176707|FG001|Overall Study|Lost to Follow-up|0|||
33352901|NCT04672083|101176708|FG002|Overall Study|Lost to Follow-up|0|||
33352902|NCT04672083|101176709|FG003|Overall Study|Lost to Follow-up|0|||
33352903|NCT04672083|101176710|FG004|Overall Study|Lost to Follow-up|0|||
33352904|NCT01085682|101176713|FG000|Overall Study|Withdrawal by Subject|25|||
33352905|NCT01085682|101176714|FG001|Overall Study|Withdrawal by Subject|25|||
33552886|NCT00976391|101923607|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
33552887|NCT00976391|101923608|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
33552888|NCT00976391|101923607|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
33552889|NCT00976391|101923608|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
33552890|NCT00976391|101923607|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
33552891|NCT00976391|101923608|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
33552892|NCT00976391|101923607|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
33552893|NCT00976391|101923608|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
33552894|NCT00976391|101923607|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
33552895|NCT00976391|101923608|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
33552896|NCT00976391|101923607|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
33552897|NCT00976391|101923608|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
33552898|NCT00976391|101923607|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
33552899|NCT00976391|101923608|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
33552900|NCT00976391|101923607|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
33552901|NCT00976391|101923608|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
33552902|NCT00976391|101923607|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
33552903|NCT00976391|101923608|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
33552904|NCT00976391|101923607|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
33552905|NCT00976391|101923608|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
33552906|NCT00976391|101923607|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
33552907|NCT00976391|101923608|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
33552908|NCT00976391|101923607|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
33552909|NCT00976391|101923608|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
33552910|NCT01058005|101923609|FG000|Overall Study|Adverse Event|0|||
33552911|NCT01058005|101923610|FG001|Overall Study|Adverse Event|2|||
33552912|NCT01058005|101923611|FG002|Overall Study|Adverse Event|1|||
33552913|NCT01058005|101923609|FG000|Overall Study|Physician Decision|2|||
33552914|NCT01058005|101923610|FG001|Overall Study|Physician Decision|2|||
33552915|NCT01058005|101923611|FG002|Overall Study|Physician Decision|0|||
33552916|NCT01058005|101923609|FG000|Overall Study|Withdrawal by Subject|4|||
33552917|NCT01058005|101923610|FG001|Overall Study|Withdrawal by Subject|5|||
33552918|NCT01058005|101923611|FG002|Overall Study|Withdrawal by Subject|11|||
33352906|NCT01950819|101176715|FG000|Overall Study|Graft Loss|35|||
33352907|NCT01950819|101176716|FG001|Overall Study|Graft Loss|30|||
33352908|NCT01950819|101176715|FG000|Overall Study|Death|29|||
33352909|NCT01950819|101176716|FG001|Overall Study|Death|34|||
33352910|NCT01950819|101176715|FG000|Overall Study|Subject / Gardian decision|54|||
33352911|NCT01950819|101176716|FG001|Overall Study|Subject / Gardian decision|51|||
33552919|NCT01058005|101923609|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
33552920|NCT01058005|101923610|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
33552921|NCT01058005|101923611|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
33552922|NCT01058005|101923609|FG000|Overall Study|Reason Missing|5|||
33352912|NCT01950819|101176715|FG000|Overall Study|technical problems|2|||
33352913|NCT01950819|101176716|FG001|Overall Study|technical problems|0|||
33552923|NCT01058005|101923610|FG001|Overall Study|Reason Missing|3|||
33552924|NCT01058005|101923611|FG002|Overall Study|Reason Missing|1|||
33552925|NCT01696214|101923613|FG000|Overall Study|Lost to Follow-up|1|||
33552926|NCT01696214|101923614|FG001|Overall Study|Lost to Follow-up|0|||
33552927|NCT01696214|101923615|FG002|Overall Study|Lost to Follow-up|0|||
33352914|NCT01950819|101176715|FG000|Overall Study|Pregnancy|0|||
33352915|NCT01950819|101176716|FG001|Overall Study|Pregnancy|2|||
33352916|NCT01950819|101176715|FG000|Overall Study|Lost to Follow-up|9|||
33352917|NCT01950819|101176716|FG001|Overall Study|Lost to Follow-up|17|||
33352918|NCT00332202|101176717|FG000|Overall Study|Adverse Event|72|||
33352919|NCT00332202|101176718|FG001|Overall Study|Adverse Event|28|||
33352920|NCT00332202|101176717|FG000|Overall Study|Lost to Follow-up|2|||
33352921|NCT00332202|101176718|FG001|Overall Study|Lost to Follow-up|1|||
33352922|NCT00332202|101176717|FG000|Overall Study|Physician Decision|6|||
33352923|NCT00332202|101176718|FG001|Overall Study|Physician Decision|8|||
33352924|NCT00332202|101176717|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
33352925|NCT00332202|101176718|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
33352926|NCT00332202|101176717|FG000|Overall Study|Protocol Violation|7|||
33352927|NCT00332202|101176718|FG001|Overall Study|Protocol Violation|2|||
33352928|NCT00332202|101176717|FG000|Overall Study|Sponsor Decision|1|||
33352929|NCT00332202|101176718|FG001|Overall Study|Sponsor Decision|2|||
33352930|NCT00332202|101176717|FG000|Overall Study|Withdrawal by Subject|36|||
33352931|NCT00332202|101176718|FG001|Overall Study|Withdrawal by Subject|17|||
33352932|NCT00332202|101176717|FG000|Overall Study|Progressive Disease|106|||
33352933|NCT00332202|101176718|FG001|Overall Study|Progressive Disease|60|||
33352934|NCT00332202|101176717|FG000|Overall Study|Death|5|||
33352935|NCT00332202|101176718|FG001|Overall Study|Death|2|||
33352936|NCT03926143|101176719|FG000|Overall Study|Physician Decision|3|||
33352937|NCT03926143|101176719|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
33352938|NCT03926143|101176719|FG000|Overall Study|Adverse Event|2|||
33352939|NCT03926143|101176719|FG000|Overall Study|Progressive disease|3|||
33412556|NCT03526549|101400047|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
33412557|NCT03526549|101400046|FG000|Open-label Phase|Adverse Event|4|||
33412558|NCT03526549|101400047|FG001|Open-label Phase|Adverse Event|0|||
33412559|NCT03526549|101400046|FG000|Open-label Phase|Withdrawal by Subject|54|||
33412560|NCT03526549|101400047|FG001|Open-label Phase|Withdrawal by Subject|0|||
33412561|NCT03526549|101400046|FG000|Open-label Phase|Lost to Follow-up|35|||
33412562|NCT03526549|101400047|FG001|Open-label Phase|Lost to Follow-up|0|||
33412563|NCT03526549|101400046|FG000|Open-label Phase|Other than Specified|5|||
33412564|NCT03526549|101400047|FG001|Open-label Phase|Other than Specified|0|||
33412565|NCT00270205|101400048|FG000|Overall Study|Lost to Follow-up|1|||
33412566|NCT00270205|101400049|FG001|Overall Study|Lost to Follow-up|0|||
33412567|NCT00270205|101400050|FG002|Overall Study|Lost to Follow-up|0|||
33412568|NCT00270205|101400051|FG003|Overall Study|Lost to Follow-up|1|||
33412569|NCT03290131|101400052|FG000|Overall Study|Adverse Event|22|||
33412570|NCT03290131|101400053|FG001|Overall Study|Adverse Event|57|||
33412571|NCT03290131|101400054|FG002|Overall Study|Adverse Event|11|||
33412572|NCT03290131|101400052|FG000|Overall Study|Withdrawal by Subject|18|||
33412573|NCT03290131|101400053|FG001|Overall Study|Withdrawal by Subject|13|||
33412574|NCT03290131|101400054|FG002|Overall Study|Withdrawal by Subject|8|||
33412575|NCT03290131|101400052|FG000|Overall Study|MS Relapse|2|||
33412576|NCT03290131|101400053|FG001|Overall Study|MS Relapse|1|||
33217792|NCT04512066|100695856|FG000|Extension Period|Lack of Efficacy|0|||
33217793|NCT04512066|100695857|FG001|Extension Period|Lack of Efficacy|4|||
33217794|NCT04512066|100695858|FG002|Extension Period|Lack of Efficacy|4|||
33217795|NCT04512066|100695859|FG003|Extension Period|Lack of Efficacy|1|||
33352940|NCT01228747|101176720|FG000|Overall Study|Adverse Event|8|||
33352941|NCT01228747|101176721|FG001|Overall Study|Adverse Event|4|||
33552928|NCT01696214|101923616|FG003|Overall Study|Lost to Follow-up|0|||
33552929|NCT03336866|101923626|FG000|Overall Study|Lost to Follow-up|2|||
33352942|NCT01228747|101176720|FG000|Overall Study|Lack of Efficacy|40|||
33352943|NCT01228747|101176721|FG001|Overall Study|Lack of Efficacy|27|||
33352944|NCT01228747|101176720|FG000|Overall Study|Protocol Violation|6|||
33352945|NCT01228747|101176721|FG001|Overall Study|Protocol Violation|5|||
33352946|NCT01228747|101176720|FG000|Overall Study|Lost to Follow-up|4|||
33352947|NCT01228747|101176721|FG001|Overall Study|Lost to Follow-up|3|||
33352948|NCT01228747|101176720|FG000|Overall Study|Withdrawal by Subject|5|||
33352949|NCT01228747|101176721|FG001|Overall Study|Withdrawal by Subject|1|||
33352950|NCT01228747|101176720|FG000|Overall Study|Other Reason|2|||
33412577|NCT03290131|101400054|FG002|Overall Study|MS Relapse|0|||
33412578|NCT03290131|101400052|FG000|Overall Study|Unknown reason|0|||
33412579|NCT03290131|101400053|FG001|Overall Study|Unknown reason|1|||
33552930|NCT03336866|101923627|FG001|Overall Study|Lost to Follow-up|0|||
33352951|NCT01228747|101176721|FG001|Overall Study|Other Reason|5|||
33352952|NCT00733902|101176725|FG000|Overall Study|Death|0|||
33352953|NCT00733902|101176726|FG001|Overall Study|Death|0|||
33352954|NCT00733902|101176727|FG002|Overall Study|Death|0|||
33352955|NCT00733902|101176728|FG003|Overall Study|Death|1|||
33352956|NCT00733902|101176725|FG000|Overall Study|Adverse Event|3|||
33352957|NCT00733902|101176726|FG001|Overall Study|Adverse Event|4|||
33352958|NCT00733902|101176727|FG002|Overall Study|Adverse Event|7|||
33352959|NCT00733902|101176728|FG003|Overall Study|Adverse Event|11|||
33352960|NCT00733902|101176725|FG000|Overall Study|Lack of Efficacy|56|||
33352961|NCT00733902|101176726|FG001|Overall Study|Lack of Efficacy|21|||
33352962|NCT00733902|101176727|FG002|Overall Study|Lack of Efficacy|34|||
33352963|NCT00733902|101176728|FG003|Overall Study|Lack of Efficacy|23|||
33352964|NCT00733902|101176725|FG000|Overall Study|Protocol Violation|4|||
33352965|NCT00733902|101176726|FG001|Overall Study|Protocol Violation|6|||
33352966|NCT00733902|101176727|FG002|Overall Study|Protocol Violation|3|||
33352967|NCT00733902|101176728|FG003|Overall Study|Protocol Violation|3|||
33352968|NCT00733902|101176725|FG000|Overall Study|Withdrawal by Subject|10|||
33352969|NCT00733902|101176726|FG001|Overall Study|Withdrawal by Subject|5|||
33352970|NCT00733902|101176727|FG002|Overall Study|Withdrawal by Subject|4|||
33352971|NCT00733902|101176728|FG003|Overall Study|Withdrawal by Subject|16|||
33352972|NCT00733902|101176725|FG000|Overall Study|Entered extension study|89|||
33352973|NCT00733902|101176726|FG001|Overall Study|Entered extension study|124|||
33352974|NCT00733902|101176727|FG002|Overall Study|Entered extension study|111|||
33352975|NCT00733902|101176728|FG003|Overall Study|Entered extension study|109|||
33552931|NCT03336866|101923628|FG002|Overall Study|Lost to Follow-up|3|||
33552932|NCT03336866|101923626|FG000|Overall Study|Withdrawal by Subject|1|||
33552933|NCT03336866|101923627|FG001|Overall Study|Withdrawal by Subject|1|||
33552934|NCT03336866|101923628|FG002|Overall Study|Withdrawal by Subject|0|||
33552935|NCT03336866|101923626|FG000|Overall Study|Noncompliance with clinic house rules|0|||
33552936|NCT03336866|101923627|FG001|Overall Study|Noncompliance with clinic house rules|0|||
33552937|NCT03336866|101923628|FG002|Overall Study|Noncompliance with clinic house rules|1|||
33552938|NCT00530075|101923631|FG000|Overall Study|Adverse Event|1|||
33552939|NCT00530075|101923631|FG000|Overall Study|Death|1|||
33552940|NCT00530075|101923631|FG000|Overall Study|Lack of Efficacy|3|||
33552941|NCT00530075|101923631|FG000|Overall Study|Protocol Violation|1|||
33552942|NCT00530075|101923631|FG000|Overall Study|Withdrawal by Subject|1|||
33552943|NCT03174275|101923632|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
33552944|NCT03174275|101923632|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
33552945|NCT03174275|101923632|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
33552946|NCT03174275|101923632|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
33552947|NCT03174275|101923632|FG000|Adjuvant Chemotherapy|Progression|1|||
33352976|NCT00733902|101176725|FG000|Overall Study|Randomized but not treated|2|||
33352977|NCT00733902|101176726|FG001|Overall Study|Randomized but not treated|2|||
33352978|NCT00733902|101176727|FG002|Overall Study|Randomized but not treated|2|||
33352979|NCT00733902|101176728|FG003|Overall Study|Randomized but not treated|1|||
33352980|NCT03358472|101176729|FG000|Overall Study|Death|6|||
33352981|NCT03358472|101176730|FG001|Overall Study|Death|3|||
33412580|NCT03290131|101400054|FG002|Overall Study|Unknown reason|0|||
33552948|NCT03174275|101923632|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
33552949|NCT03174275|101923632|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
33552950|NCT03174275|101923632|FG000|Adjuvant Durvalumab|Progression|1|||
33412581|NCT04165824|101400055|FG000|Overall Study|Adverse Event|23|||
33552951|NCT03174275|101923632|FG000|Adjuvant Durvalumab|Adverse Event|3|||
33552952|NCT03174275|101923632|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
33352982|NCT03358472|101176731|FG002|Overall Study|Death|10|||
33352983|NCT03358472|101176729|FG000|Overall Study|Physician Decision|0|||
33352984|NCT03358472|101176730|FG001|Overall Study|Physician Decision|1|||
33352985|NCT03358472|101176731|FG002|Overall Study|Physician Decision|0|||
33552953|NCT03174275|101923632|FG000|Adjuvant Radiotherapy|Progression|1|||
33412582|NCT04165824|101400055|FG000|Overall Study|Physician Decision|1|||
33217796|NCT04512066|100695860|FG004|Extension Period|Lack of Efficacy|3|||
33217797|NCT04512066|100695861|FG005|Extension Period|Lack of Efficacy|3|||
33217798|NCT04512066|100695856|FG000|Extension Period|Lost to Follow-up|0|||
33217799|NCT04512066|100695857|FG001|Extension Period|Lost to Follow-up|1|||
33217800|NCT04512066|100695858|FG002|Extension Period|Lost to Follow-up|5|||
33217801|NCT04512066|100695859|FG003|Extension Period|Lost to Follow-up|2|||
33217802|NCT04512066|100695860|FG004|Extension Period|Lost to Follow-up|3|||
33217803|NCT04512066|100695861|FG005|Extension Period|Lost to Follow-up|2|||
33217804|NCT04512066|100695856|FG000|Extension Period|Non-compliance with study drug|0|||
33217805|NCT04512066|100695857|FG001|Extension Period|Non-compliance with study drug|1|||
33217806|NCT04512066|100695858|FG002|Extension Period|Non-compliance with study drug|0|||
33217807|NCT04512066|100695859|FG003|Extension Period|Non-compliance with study drug|0|||
33217808|NCT04512066|100695860|FG004|Extension Period|Non-compliance with study drug|0|||
33217809|NCT04512066|100695861|FG005|Extension Period|Non-compliance with study drug|1|||
33217810|NCT04512066|100695856|FG000|Extension Period|Other|0|||
33217811|NCT04512066|100695857|FG001|Extension Period|Other|2|||
33217812|NCT04512066|100695858|FG002|Extension Period|Other|0|||
33217813|NCT04512066|100695859|FG003|Extension Period|Other|0|||
33217814|NCT04512066|100695860|FG004|Extension Period|Other|0|||
33217815|NCT04512066|100695861|FG005|Extension Period|Other|0|||
33217816|NCT04512066|100695856|FG000|Extension Period|Physician Decision|0|||
33217817|NCT04512066|100695857|FG001|Extension Period|Physician Decision|2|||
33217818|NCT04512066|100695858|FG002|Extension Period|Physician Decision|0|||
33217819|NCT04512066|100695859|FG003|Extension Period|Physician Decision|1|||
33217820|NCT04512066|100695860|FG004|Extension Period|Physician Decision|1|||
33217821|NCT04512066|100695861|FG005|Extension Period|Physician Decision|0|||
33217822|NCT04512066|100695856|FG000|Extension Period|Withdrawal by Subject|0|||
33217823|NCT04512066|100695857|FG001|Extension Period|Withdrawal by Subject|3|||
33217824|NCT04512066|100695858|FG002|Extension Period|Withdrawal by Subject|7|||
33217825|NCT04512066|100695859|FG003|Extension Period|Withdrawal by Subject|11|||
33217826|NCT04512066|100695860|FG004|Extension Period|Withdrawal by Subject|8|||
33217827|NCT04512066|100695861|FG005|Extension Period|Withdrawal by Subject|4|||
33217828|NCT01059630|100695862|FG000|Overall Study|Death|100|||
33217829|NCT01059630|100695863|FG001|Overall Study|Death|84|||
33217830|NCT01059630|100695862|FG000|Overall Study|Lost to Follow-up|4|||
33217831|NCT01059630|100695863|FG001|Overall Study|Lost to Follow-up|1|||
33217832|NCT01059630|100695862|FG000|Overall Study|Physician Decision|2|||
33217833|NCT01059630|100695863|FG001|Overall Study|Physician Decision|4|||
33217834|NCT01059630|100695862|FG000|Overall Study|Withdrawal by Subject|21|||
33217835|NCT01059630|100695863|FG001|Overall Study|Withdrawal by Subject|14|||
33352986|NCT03358472|101176729|FG000|Overall Study|Withdrawal by Subject|0|||
33352987|NCT03358472|101176730|FG001|Overall Study|Withdrawal by Subject|0|||
33352988|NCT03358472|101176731|FG002|Overall Study|Withdrawal by Subject|1|||
33352989|NCT03358472|101176729|FG000|Overall Study|On-going at clinical cut off date|9|||
33352990|NCT03358472|101176730|FG001|Overall Study|On-going at clinical cut off date|6|||
33352991|NCT03358472|101176731|FG002|Overall Study|On-going at clinical cut off date|5|||
33352992|NCT01409928|101176732|FG000|Overall Study|Physician Decision|12|||
33217836|NCT04870710|100695864|FG000|Overall Study|Lost to Follow-up|3|||
33217837|NCT00724152|100695865|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
33217838|NCT00724152|100695866|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
33217839|NCT00724152|100695867|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
33217840|NCT00724152|100695865|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
33352993|NCT01287754|101176733|FG000|Overall Study|Death|2|||
33352994|NCT01287754|101176734|FG001|Overall Study|Death|12|||
33352995|NCT01287754|101176733|FG000|Overall Study|Lost to Follow-up|1|||
33352996|NCT01287754|101176734|FG001|Overall Study|Lost to Follow-up|6|||
33352997|NCT01287754|101176733|FG000|Overall Study|Protocol Violation|0|||
33352998|NCT01287754|101176734|FG001|Overall Study|Protocol Violation|3|||
33352999|NCT02013544|101176735|FG000|Overall Study|Adverse Event|5|||
33353000|NCT02013544|101176736|FG001|Overall Study|Adverse Event|5|||
33353001|NCT02013544|101176735|FG000|Overall Study|Lost to Follow-up|2|||
33353002|NCT02013544|101176736|FG001|Overall Study|Lost to Follow-up|3|||
33353003|NCT02013544|101176735|FG000|Overall Study|Withdrawal by Subject|2|||
33353004|NCT02013544|101176736|FG001|Overall Study|Withdrawal by Subject|8|||
33353005|NCT02013544|101176735|FG000|Overall Study|Physician Decision|0|||
33353006|NCT02013544|101176736|FG001|Overall Study|Physician Decision|1|||
33353007|NCT02013544|101176735|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
33353008|NCT02013544|101176736|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
33353009|NCT02209766|101176739|FG000|Overall Study|Withdrawal by Subject|0|||
33353010|NCT02209766|101176740|FG001|Overall Study|Withdrawal by Subject|0|||
33353011|NCT02209766|101176741|FG002|Overall Study|Withdrawal by Subject|0|||
33353012|NCT02209766|101176742|FG003|Overall Study|Withdrawal by Subject|1|||
33353013|NCT02209766|101176743|FG004|Overall Study|Withdrawal by Subject|0|||
33353014|NCT00935883|101176744|FG000|Treatment Period|Physician Decision|1|||
33353015|NCT00935883|101176745|FG001|Treatment Period|Physician Decision|0|||
33353016|NCT00935883|101176744|FG000|Treatment Period|Withdrawal by Subject|0|||
33353017|NCT00935883|101176745|FG001|Treatment Period|Withdrawal by Subject|2|||
33353018|NCT02500537|101176749|FG000|Overall Study|Death|2|||
33353019|NCT02500537|101176750|FG001|Overall Study|Death|0|||
33353020|NCT02500537|101176749|FG000|Overall Study|Lost to Follow-up|0|||
33353021|NCT02500537|101176750|FG001|Overall Study|Lost to Follow-up|1|||
33353022|NCT02500537|101176749|FG000|Overall Study|Withdrawal by Subject|1|||
33353023|NCT02500537|101176750|FG001|Overall Study|Withdrawal by Subject|0|||
33353024|NCT01193335|101180556|FG000|After Infant Series|Lost to Follow-up|1|||
33353025|NCT01193335|101180557|FG001|After Infant Series|Lost to Follow-up|2|||
33353026|NCT01193335|101180556|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
33353027|NCT01193335|101180557|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
33353028|NCT01193335|101180556|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
33353029|NCT01193335|101180557|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
33353030|NCT01193335|101180556|FG000|1-Year Follow-up|Lost to Follow-up|4|||
33353031|NCT01193335|101180557|FG001|1-Year Follow-up|Lost to Follow-up|0|||
33217841|NCT00724152|100695866|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
33217842|NCT00724152|100695867|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
33217843|NCT02314624|100695876|FG000|Overall Study|No participating patient|16|||
33217844|NCT02314624|100695877|FG001|Overall Study|No participating patient|13|||
33217845|NCT02314624|100695876|FG000|Overall Study|Participant withdrew|7|||
33217846|NCT02314624|100695877|FG001|Overall Study|Participant withdrew|2|||
33217847|NCT02314624|100695876|FG000|Overall Study|Lost to Follow-up|2|||
33217848|NCT02314624|100695877|FG001|Overall Study|Lost to Follow-up|5|||
33217849|NCT02314624|100695876|FG000|Overall Study|Dropped/Excluded by PI|6|||
33619269|NCT01200368|102154992|FG001|Infant Series|Other|0|||
33619270|NCT01200368|102154993|FG002|Infant Series|Other|0|||
33619271|NCT01200368|102154991|FG000|After Infant Series|Adverse Event|6|||
33619272|NCT01200368|102154992|FG001|After Infant Series|Adverse Event|6|||
33619273|NCT01200368|102154993|FG002|After Infant Series|Adverse Event|3|||
33619274|NCT01200368|102154991|FG000|After Infant Series|Withdrawal by Subject|10|||
33619275|NCT01200368|102154992|FG001|After Infant Series|Withdrawal by Subject|8|||
33619276|NCT01200368|102154993|FG002|After Infant Series|Withdrawal by Subject|4|||
33619277|NCT01200368|102154991|FG000|After Infant Series|Lost to Follow-up|1|||
33619278|NCT01200368|102154992|FG001|After Infant Series|Lost to Follow-up|0|||
33619279|NCT01200368|102154993|FG002|After Infant Series|Lost to Follow-up|0|||
33619280|NCT01200368|102154991|FG000|After Infant Series|Other|1|||
33619281|NCT01200368|102154992|FG001|After Infant Series|Other|2|||
33619282|NCT01200368|102154993|FG002|After Infant Series|Other|2|||
33619283|NCT01200368|102154991|FG000|Toddler Dose|Adverse Event|0|||
33619284|NCT01200368|102154992|FG001|Toddler Dose|Adverse Event|3|||
33619285|NCT01200368|102154993|FG002|Toddler Dose|Adverse Event|1|||
33619286|NCT03386721|102154994|FG000|Overall Study|Death|12|||
33619287|NCT03386721|102154995|FG001|Overall Study|Death|21|||
33619288|NCT03386721|102154996|FG002|Overall Study|Death|2|||
33619289|NCT03386721|102154997|FG003|Overall Study|Death|5|||
33619290|NCT03386721|102154998|FG004|Overall Study|Death|1|||
33619291|NCT03386721|102154999|FG005|Overall Study|Death|12|||
33619292|NCT03386721|102155000|FG006|Overall Study|Death|1|||
33619293|NCT03386721|102155001|FG007|Overall Study|Death|1|||
33619294|NCT03386721|102155002|FG008|Overall Study|Death|12|||
33217850|NCT02314624|100695877|FG001|Overall Study|Dropped/Excluded by PI|6|||
33217851|NCT01137474|100695878|FG000|Overall Study|Adverse Event|3|||
33217852|NCT01137474|100695879|FG001|Overall Study|Adverse Event|5|||
33217853|NCT01137474|100695880|FG002|Overall Study|Adverse Event|1|||
33619295|NCT03386721|102155003|FG009|Overall Study|Death|20|||
33619296|NCT03386721|102155004|FG010|Overall Study|Death|21|||
33619297|NCT03386721|102155005|FG011|Overall Study|Death|21|||
33619298|NCT03386721|102155006|FG012|Overall Study|Death|14|||
33619299|NCT03386721|102155007|FG013|Overall Study|Death|2|||
33619300|NCT03386721|102155008|FG014|Overall Study|Death|1|||
33619301|NCT03386721|102154994|FG000|Overall Study|Lost to Follow-up|1|||
33619302|NCT03386721|102154995|FG001|Overall Study|Lost to Follow-up|3|||
33619303|NCT03386721|102154996|FG002|Overall Study|Lost to Follow-up|0|||
33619304|NCT03386721|102154997|FG003|Overall Study|Lost to Follow-up|0|||
33217854|NCT01137474|100695881|FG003|Overall Study|Adverse Event|3|||
33353032|NCT01193335|101180556|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
33353033|NCT01193335|101180557|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
33353034|NCT01193335|101180556|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
33353035|NCT01193335|101180557|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
33353036|NCT00686543|101180558|FG000|Overall Study|Adverse Event|9|||
33353037|NCT00686543|101180559|FG001|Overall Study|Adverse Event|1|||
33353038|NCT00686543|101180560|FG002|Overall Study|Adverse Event|3|||
33353039|NCT00686543|101180561|FG003|Overall Study|Adverse Event|2|||
33353040|NCT00686543|101180558|FG000|Overall Study|Withdrawal by Subject|2|||
33353041|NCT00686543|101180559|FG001|Overall Study|Withdrawal by Subject|0|||
33353042|NCT00686543|101180560|FG002|Overall Study|Withdrawal by Subject|0|||
33353043|NCT00686543|101180561|FG003|Overall Study|Withdrawal by Subject|0|||
33353044|NCT00686543|101180558|FG000|Overall Study|Protocol Violation|3|||
33353045|NCT00686543|101180559|FG001|Overall Study|Protocol Violation|0|||
33353046|NCT00686543|101180560|FG002|Overall Study|Protocol Violation|2|||
33353047|NCT00686543|101180561|FG003|Overall Study|Protocol Violation|1|||
33353048|NCT00609622|101180566|FG000|Overall Study|Adverse Event|14|||
33353049|NCT00609622|101180567|FG001|Overall Study|Adverse Event|10|||
33353050|NCT00609622|101180566|FG000|Overall Study|Withdrawal by Subject|4|||
33353051|NCT00609622|101180567|FG001|Overall Study|Withdrawal by Subject|20|||
33353052|NCT00609622|101180566|FG000|Overall Study|Death|1|||
33353053|NCT00609622|101180567|FG001|Overall Study|Death|4|||
33353054|NCT00609622|101180566|FG000|Overall Study|Protocol Violation|1|||
33353055|NCT00609622|101180567|FG001|Overall Study|Protocol Violation|1|||
33353056|NCT00609622|101180566|FG000|Overall Study|Objective progression or relapse|47|||
33353057|NCT00609622|101180567|FG001|Overall Study|Objective progression or relapse|41|||
33353058|NCT00609622|101180566|FG000|Overall Study|Study terminated by sponsor|16|||
33353059|NCT00609622|101180567|FG001|Overall Study|Study terminated by sponsor|3|||
33552954|NCT03174275|101923632|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
33552955|NCT01913470|101923633|FG000|Overall Study|Lost to Follow-up|0|||
33552956|NCT01913470|101923634|FG001|Overall Study|Lost to Follow-up|1|||
33552957|NCT01913470|101923633|FG000|Overall Study|Physician Decision|0|||
33552958|NCT01913470|101923634|FG001|Overall Study|Physician Decision|1|||
33552959|NCT01913470|101923633|FG000|Overall Study|Withdrawal by Subject|0|||
33353060|NCT00609622|101180566|FG000|Overall Study|Other|7|||
33353061|NCT00609622|101180567|FG001|Overall Study|Other|14|||
33353062|NCT00609622|101180566|FG000|Overall Study|Global deterioration of health status|6|||
33353063|NCT00609622|101180567|FG001|Overall Study|Global deterioration of health status|2|||
33353064|NCT02698189|101180574|FG000|Overall Study|Physician Decision|3|||
33353065|NCT02698189|101180575|FG001|Overall Study|Physician Decision|0|||
33353066|NCT02698189|101180574|FG000|Overall Study|Progressive disease|0|||
33353067|NCT02698189|101180575|FG001|Overall Study|Progressive disease|5|||
33353068|NCT02698189|101180574|FG000|Overall Study|Study terminated by sponsor|0|||
33353069|NCT02698189|101180575|FG001|Overall Study|Study terminated by sponsor|1|||
33619305|NCT03386721|102154998|FG004|Overall Study|Lost to Follow-up|0|||
33353070|NCT00469079|101180576|FG000|Overall Study|Lack of Efficacy|3|||
33353071|NCT00469079|101180577|FG001|Overall Study|Lack of Efficacy|8|||
33353072|NCT00469079|101180578|FG002|Overall Study|Lack of Efficacy|5|||
33619306|NCT03386721|102154999|FG005|Overall Study|Lost to Follow-up|2|||
33619307|NCT03386721|102155000|FG006|Overall Study|Lost to Follow-up|1|||
33619308|NCT03386721|102155001|FG007|Overall Study|Lost to Follow-up|0|||
33619309|NCT03386721|102155002|FG008|Overall Study|Lost to Follow-up|1|||
33552960|NCT01913470|101923634|FG001|Overall Study|Withdrawal by Subject|1|||
33552961|NCT03753542|101923635|FG000|Overall Study|Lost to Follow-up|9|||
33353073|NCT00469079|101180576|FG000|Overall Study|Adverse Event|1|||
33552962|NCT03753542|101923636|FG001|Overall Study|Lost to Follow-up|14|||
33619310|NCT03386721|102155003|FG009|Overall Study|Lost to Follow-up|2|||
33619311|NCT03386721|102155004|FG010|Overall Study|Lost to Follow-up|1|||
33619312|NCT03386721|102155005|FG011|Overall Study|Lost to Follow-up|0|||
33619313|NCT03386721|102155006|FG012|Overall Study|Lost to Follow-up|0|||
33619314|NCT03386721|102155007|FG013|Overall Study|Lost to Follow-up|0|||
33619315|NCT03386721|102155008|FG014|Overall Study|Lost to Follow-up|0|||
33619316|NCT03386721|102154994|FG000|Overall Study|Reason not specified|3|||
33619317|NCT03386721|102154995|FG001|Overall Study|Reason not specified|0|||
33619318|NCT03386721|102154996|FG002|Overall Study|Reason not specified|0|||
33619319|NCT03386721|102154997|FG003|Overall Study|Reason not specified|0|||
33619320|NCT03386721|102154998|FG004|Overall Study|Reason not specified|0|||
33619321|NCT03386721|102154999|FG005|Overall Study|Reason not specified|3|||
33619322|NCT03386721|102155000|FG006|Overall Study|Reason not specified|1|||
33619323|NCT03386721|102155001|FG007|Overall Study|Reason not specified|0|||
33619324|NCT03386721|102155002|FG008|Overall Study|Reason not specified|0|||
33619325|NCT03386721|102155003|FG009|Overall Study|Reason not specified|1|||
33619326|NCT03386721|102155004|FG010|Overall Study|Reason not specified|2|||
33619327|NCT03386721|102155005|FG011|Overall Study|Reason not specified|6|||
33619328|NCT03386721|102155006|FG012|Overall Study|Reason not specified|1|||
33619329|NCT03386721|102155007|FG013|Overall Study|Reason not specified|0|||
33619330|NCT03386721|102155008|FG014|Overall Study|Reason not specified|0|||
33619331|NCT03386721|102154994|FG000|Overall Study|Progressive Disease|0|||
33619332|NCT03386721|102154995|FG001|Overall Study|Progressive Disease|0|||
33619333|NCT03386721|102154996|FG002|Overall Study|Progressive Disease|1|||
33619334|NCT03386721|102154997|FG003|Overall Study|Progressive Disease|0|||
33619335|NCT03386721|102154998|FG004|Overall Study|Progressive Disease|0|||
33619336|NCT03386721|102154999|FG005|Overall Study|Progressive Disease|1|||
33353074|NCT00469079|101180577|FG001|Overall Study|Adverse Event|3|||
33353075|NCT00469079|101180578|FG002|Overall Study|Adverse Event|2|||
33353076|NCT00469079|101180576|FG000|Overall Study|Lost to Follow-up|4|||
33353077|NCT00469079|101180577|FG001|Overall Study|Lost to Follow-up|8|||
33552963|NCT03684057|101923638|FG000|Overall Study|Withdrawal by Subject|4|||
33552964|NCT03684057|101923639|FG001|Overall Study|Withdrawal by Subject|5|||
33552965|NCT02827708|101923644|FG000|Overall Study|Lost to Follow-up|3|||
33552966|NCT02827708|101923645|FG001|Overall Study|Lost to Follow-up|1|||
33552967|NCT02827708|101923644|FG000|Overall Study|Withdrawal by Subject|1|||
33552968|NCT02827708|101923645|FG001|Overall Study|Withdrawal by Subject|2|||
33552969|NCT02827708|101923644|FG000|Overall Study|Death|1|||
33552970|NCT02827708|101923645|FG001|Overall Study|Death|2|||
33552971|NCT01370642|101923646|FG000|Overall Study|Adverse Event|2|||
33552972|NCT01370642|101923647|FG001|Overall Study|Adverse Event|1|||
33552973|NCT01370642|101923648|FG002|Overall Study|Adverse Event|1|||
33552974|NCT01370642|101923646|FG000|Overall Study|Detectable HCV RNA|0|||
33552975|NCT01370642|101923647|FG001|Overall Study|Detectable HCV RNA|0|||
33552976|NCT01370642|101923648|FG002|Overall Study|Detectable HCV RNA|22|||
33619337|NCT03386721|102155000|FG006|Overall Study|Progressive Disease|0|||
33619338|NCT03386721|102155001|FG007|Overall Study|Progressive Disease|0|||
33552977|NCT01370642|101923646|FG000|Overall Study|Lost to Follow-up|0|||
33552978|NCT01370642|101923647|FG001|Overall Study|Lost to Follow-up|0|||
33552979|NCT01370642|101923648|FG002|Overall Study|Lost to Follow-up|1|||
33619339|NCT03386721|102155002|FG008|Overall Study|Progressive Disease|2|||
33619340|NCT03386721|102155003|FG009|Overall Study|Progressive Disease|1|||
33619341|NCT03386721|102155004|FG010|Overall Study|Progressive Disease|1|||
33619342|NCT03386721|102155005|FG011|Overall Study|Progressive Disease|0|||
33619343|NCT03386721|102155006|FG012|Overall Study|Progressive Disease|1|||
33619344|NCT03386721|102155007|FG013|Overall Study|Progressive Disease|0|||
33619345|NCT03386721|102155008|FG014|Overall Study|Progressive Disease|0|||
33619346|NCT03386721|102154994|FG000|Overall Study|Site Terminated by Sponsor|5|||
33619347|NCT03386721|102154995|FG001|Overall Study|Site Terminated by Sponsor|5|||
33552980|NCT01370642|101923646|FG000|Overall Study|Physician Decision|4|||
33552981|NCT01370642|101923647|FG001|Overall Study|Physician Decision|1|||
33412583|NCT04165824|101400055|FG000|Overall Study|Withdrawal by Subject|17|||
33412584|NCT04165824|101400055|FG000|Overall Study|Other|5|||
33412585|NCT01238861|101400057|FG000|Overall Study|Lost to Follow-up|4|||
33412586|NCT01238861|101400058|FG001|Overall Study|Lost to Follow-up|2|||
33552982|NCT01370642|101923648|FG002|Overall Study|Physician Decision|2|||
33353078|NCT00469079|101180578|FG002|Overall Study|Lost to Follow-up|10|||
33353079|NCT00469079|101180576|FG000|Overall Study|Withdrawal by Subject|1|||
33353080|NCT00469079|101180577|FG001|Overall Study|Withdrawal by Subject|2|||
33353081|NCT00469079|101180578|FG002|Overall Study|Withdrawal by Subject|2|||
33353082|NCT00469079|101180576|FG000|Overall Study|Ineligible|0|||
33353083|NCT00469079|101180577|FG001|Overall Study|Ineligible|1|||
33353084|NCT00469079|101180578|FG002|Overall Study|Ineligible|0|||
33353085|NCT05292755|101180579|FG000|Overall Study|Lost to Follow-up|5|||
33353086|NCT05292755|101180580|FG001|Overall Study|Lost to Follow-up|9|||
33353087|NCT00502840|101180581|FG000|Overall Study|Adverse Event|5|||
33353088|NCT00502840|101180581|FG000|Overall Study|Additional or changed therapy|48|||
33353089|NCT00502840|101180581|FG000|Overall Study|Lack of Efficacy|11|||
33353090|NCT00502840|101180581|FG000|Overall Study|Protocol Violation|4|||
33353091|NCT00502840|101180581|FG000|Overall Study|Withdrawal by Subject|5|||
33353092|NCT00502840|101180581|FG000|Overall Study|Lost to Follow-up|6|||
33353093|NCT00502840|101180581|FG000|Overall Study|Administrative problems|1|||
33353094|NCT00502840|101180581|FG000|Overall Study|Other|20|||
33353095|NCT02661594|101180588|FG000|Overall Study|Protocol Violation|1|||
33353096|NCT02661594|101180589|FG001|Overall Study|Protocol Violation|0|||
33353097|NCT02661594|101180590|FG002|Overall Study|Protocol Violation|1|||
33353098|NCT02661594|101180591|FG003|Overall Study|Protocol Violation|0|||
33353099|NCT01412229|101180594|FG000|Overall Study|Physician Decision|1|||
33353100|NCT01892722|101180595|FG000|Overall Study|Protocol deviation|0|||
33353101|NCT01892722|101180596|FG001|Overall Study|Protocol deviation|1|||
33353102|NCT01892722|101180595|FG000|Overall Study|Administrative problems|0|||
33353103|NCT01892722|101180596|FG001|Overall Study|Administrative problems|1|||
33353104|NCT01892722|101180595|FG000|Overall Study|Patient/guardian decision|0|||
33353105|NCT01892722|101180596|FG001|Overall Study|Patient/guardian decision|2|||
33353106|NCT01892722|101180595|FG000|Overall Study|Physician Decision|1|||
33353107|NCT01892722|101180596|FG001|Overall Study|Physician Decision|2|||
33353108|NCT01892722|101180595|FG000|Overall Study|Adverse Event|3|||
33353109|NCT01892722|101180596|FG001|Overall Study|Adverse Event|2|||
33353110|NCT01892722|101180595|FG000|Overall Study|Lack of Efficacy|0|||
33353111|NCT01892722|101180596|FG001|Overall Study|Lack of Efficacy|7|||
33353112|NCT01892722|101180595|FG000|Overall Study|Withdrawal by Subject|3|||
33353113|NCT01892722|101180596|FG001|Overall Study|Withdrawal by Subject|5|||
33353114|NCT00642642|101180597|FG000|Treatment & Follow Up|Adverse Event|2|||
33353115|NCT00642642|101180597|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
33353116|NCT00642642|101180597|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
33353117|NCT00317044|101180600|FG000|Overall Study|Protocol Violation|28|||
33353118|NCT00317044|101180601|FG001|Overall Study|Protocol Violation|22|||
33353119|NCT00317044|101180602|FG002|Overall Study|Protocol Violation|20|||
33353120|NCT00317044|101180600|FG000|Overall Study|Adverse Event|4|||
33353121|NCT00317044|101180601|FG001|Overall Study|Adverse Event|7|||
33353122|NCT00317044|101180602|FG002|Overall Study|Adverse Event|4|||
33353123|NCT00317044|101180600|FG000|Overall Study|Withdrawal by Subject|10|||
33353124|NCT00317044|101180601|FG001|Overall Study|Withdrawal by Subject|7|||
33353125|NCT00317044|101180602|FG002|Overall Study|Withdrawal by Subject|12|||
33353126|NCT00317044|101180600|FG000|Overall Study|Lost to Follow-up|0|||
33353127|NCT00317044|101180601|FG001|Overall Study|Lost to Follow-up|2|||
33353128|NCT00317044|101180602|FG002|Overall Study|Lost to Follow-up|3|||
33353129|NCT00317044|101180600|FG000|Overall Study|Multiple Reasons|6|||
33353130|NCT00317044|101180601|FG001|Overall Study|Multiple Reasons|2|||
33353131|NCT00317044|101180602|FG002|Overall Study|Multiple Reasons|6|||
33353132|NCT01672957|101180603|FG000|Overall Study|Protocol Violation|48|||
33353133|NCT01672957|101180603|FG000|Overall Study|Death|2|||
33353134|NCT01672957|101180603|FG000|Overall Study|ICF Signed After Transplantation|5|||
33353135|NCT02370121|101180604|FG000|Overall Study|Lost to Follow-up|1|||
33412587|NCT01238861|101400059|FG002|Overall Study|Lost to Follow-up|3|||
33552983|NCT01370642|101923646|FG000|Overall Study|Withdrawal by Subject|2|||
33552984|NCT01370642|101923647|FG001|Overall Study|Withdrawal by Subject|4|||
33353136|NCT02370121|101180605|FG001|Overall Study|Lost to Follow-up|1|||
33353137|NCT05195528|101180606|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
33353138|NCT05195528|101180607|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
33353139|NCT05195528|101180608|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
33353140|NCT05195528|101180609|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
33412588|NCT01238861|101400060|FG003|Overall Study|Lost to Follow-up|1|||
33353141|NCT05195528|101180610|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
33353142|NCT05195528|101180606|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
33353143|NCT05195528|101180607|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
33353144|NCT05195528|101180608|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
33353145|NCT05195528|101180609|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
33353146|NCT05195528|101180610|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
33353147|NCT05195528|101180606|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
33353148|NCT05195528|101180607|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
33353149|NCT05195528|101180608|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
33353150|NCT05195528|101180609|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
33353151|NCT05195528|101180610|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
33353152|NCT05195528|101180606|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
33353153|NCT05195528|101180607|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
33353154|NCT05195528|101180608|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
33412589|NCT01238861|101400061|FG004|Overall Study|Lost to Follow-up|1|||
33412590|NCT01238861|101400062|FG005|Overall Study|Lost to Follow-up|2|||
33412591|NCT01238861|101400057|FG000|Overall Study|Unplanned surgery|1|||
33412592|NCT01238861|101400058|FG001|Overall Study|Unplanned surgery|0|||
33412593|NCT01238861|101400059|FG002|Overall Study|Unplanned surgery|0|||
33412594|NCT01238861|101400060|FG003|Overall Study|Unplanned surgery|0|||
33412595|NCT01238861|101400061|FG004|Overall Study|Unplanned surgery|0|||
33412596|NCT01238861|101400062|FG005|Overall Study|Unplanned surgery|0|||
33353155|NCT05195528|101180609|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
33353156|NCT05195528|101180610|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
33353157|NCT05195528|101180606|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
33353158|NCT05195528|101180607|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
33353159|NCT05195528|101180608|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
33353160|NCT05195528|101180609|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
33353161|NCT05195528|101180610|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
33353162|NCT05195528|101180606|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
33353163|NCT05195528|101180607|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
33353164|NCT05195528|101180608|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
33353165|NCT05195528|101180609|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
33353166|NCT05195528|101180610|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
33353167|NCT05195528|101180606|FG000|Placebo-controlled Treatment Period|Other|0|||
33353168|NCT05195528|101180607|FG001|Placebo-controlled Treatment Period|Other|0|||
33353169|NCT05195528|101180608|FG002|Placebo-controlled Treatment Period|Other|1|||
33353170|NCT05195528|101180609|FG003|Placebo-controlled Treatment Period|Other|0|||
33353171|NCT05195528|101180610|FG004|Placebo-controlled Treatment Period|Other|0|||
33353172|NCT05195528|101180606|FG000|Extension Period|PTE or AE or SAE|0|||
33353173|NCT05195528|101180607|FG001|Extension Period|PTE or AE or SAE|4|||
33353174|NCT05195528|101180608|FG002|Extension Period|PTE or AE or SAE|5|||
33353175|NCT05195528|101180609|FG003|Extension Period|PTE or AE or SAE|4|||
33353176|NCT05195528|101180610|FG004|Extension Period|PTE or AE or SAE|4|||
33353177|NCT05195528|101180606|FG000|Extension Period|Protocol Violation|0|||
33412597|NCT01238861|101400057|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
33412598|NCT01238861|101400058|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
33412599|NCT01238861|101400059|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
33412600|NCT01238861|101400060|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
33412601|NCT01238861|101400061|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
33412602|NCT01238861|101400062|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
33412603|NCT01238861|101400057|FG000|Overall Study|Incorrect enrollment/randomization|0|||
33412604|NCT01238861|101400058|FG001|Overall Study|Incorrect enrollment/randomization|0|||
33412605|NCT01238861|101400059|FG002|Overall Study|Incorrect enrollment/randomization|1|||
33412606|NCT01238861|101400060|FG003|Overall Study|Incorrect enrollment/randomization|0|||
33412607|NCT01238861|101400061|FG004|Overall Study|Incorrect enrollment/randomization|1|||
33412608|NCT01238861|101400062|FG005|Overall Study|Incorrect enrollment/randomization|0|||
33412609|NCT01238861|101400057|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
33412610|NCT01238861|101400058|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
33412611|NCT01238861|101400059|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
33412612|NCT01238861|101400060|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
33412613|NCT01238861|101400061|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
33412614|NCT01238861|101400062|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
33412615|NCT01238861|101400057|FG000|Overall Study|Subject moved out of state/area|0|||
33552985|NCT01370642|101923648|FG002|Overall Study|Withdrawal by Subject|3|||
33552986|NCT00835978|101923649|FG000|Overall Study|Death|33|||
33552987|NCT00835978|101923650|FG001|Overall Study|Death|40|||
33552988|NCT00835978|101923651|FG002|Overall Study|Death|49|||
33552989|NCT00835978|101923652|FG003|Overall Study|Death|4|||
33353178|NCT05195528|101180607|FG001|Extension Period|Protocol Violation|2|||
33353179|NCT05195528|101180608|FG002|Extension Period|Protocol Violation|1|||
33353180|NCT05195528|101180609|FG003|Extension Period|Protocol Violation|0|||
33353181|NCT05195528|101180610|FG004|Extension Period|Protocol Violation|1|||
33412616|NCT01238861|101400058|FG001|Overall Study|Subject moved out of state/area|0|||
33412617|NCT01238861|101400059|FG002|Overall Study|Subject moved out of state/area|1|||
33412618|NCT01238861|101400060|FG003|Overall Study|Subject moved out of state/area|1|||
33412619|NCT01238861|101400061|FG004|Overall Study|Subject moved out of state/area|0|||
33412620|NCT01238861|101400062|FG005|Overall Study|Subject moved out of state/area|0|||
33412621|NCT01238861|101400057|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
33353182|NCT05195528|101180606|FG000|Extension Period|Lost to Follow-up|0|||
33353183|NCT05195528|101180607|FG001|Extension Period|Lost to Follow-up|6|||
33353184|NCT05195528|101180608|FG002|Extension Period|Lost to Follow-up|13|||
33353185|NCT05195528|101180609|FG003|Extension Period|Lost to Follow-up|3|||
33353186|NCT05195528|101180610|FG004|Extension Period|Lost to Follow-up|7|||
33353187|NCT05195528|101180606|FG000|Extension Period|Withdrawal by Subject|0|||
33353188|NCT05195528|101180607|FG001|Extension Period|Withdrawal by Subject|12|||
33353189|NCT05195528|101180608|FG002|Extension Period|Withdrawal by Subject|9|||
33353190|NCT05195528|101180609|FG003|Extension Period|Withdrawal by Subject|6|||
33353191|NCT05195528|101180610|FG004|Extension Period|Withdrawal by Subject|5|||
33353192|NCT05195528|101180606|FG000|Extension Period|Lack of Efficacy|0|||
33353193|NCT05195528|101180607|FG001|Extension Period|Lack of Efficacy|3|||
33353194|NCT05195528|101180608|FG002|Extension Period|Lack of Efficacy|0|||
33353195|NCT05195528|101180609|FG003|Extension Period|Lack of Efficacy|0|||
33353196|NCT05195528|101180610|FG004|Extension Period|Lack of Efficacy|2|||
33412622|NCT01238861|101400058|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
33412623|NCT01238861|101400059|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
33353197|NCT05195528|101180606|FG000|Extension Period|Not Treated|0|||
33353198|NCT05195528|101180607|FG001|Extension Period|Not Treated|0|||
33353199|NCT05195528|101180608|FG002|Extension Period|Not Treated|2|||
33412624|NCT01238861|101400060|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
33412625|NCT01238861|101400061|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
33412626|NCT01238861|101400062|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
33412627|NCT01238861|101400057|FG000|Overall Study|Personal problems|0|||
33412628|NCT01238861|101400058|FG001|Overall Study|Personal problems|0|||
33412629|NCT01238861|101400059|FG002|Overall Study|Personal problems|0|||
33412630|NCT01238861|101400060|FG003|Overall Study|Personal problems|1|||
33412631|NCT01238861|101400061|FG004|Overall Study|Personal problems|0|||
33412632|NCT01238861|101400062|FG005|Overall Study|Personal problems|0|||
33412633|NCT01238861|101400057|FG000|Overall Study|Unable to continue visits|0|||
33412634|NCT01238861|101400058|FG001|Overall Study|Unable to continue visits|0|||
33412635|NCT01238861|101400059|FG002|Overall Study|Unable to continue visits|0|||
33412636|NCT01238861|101400060|FG003|Overall Study|Unable to continue visits|1|||
33412637|NCT01238861|101400061|FG004|Overall Study|Unable to continue visits|0|||
33619348|NCT03386721|102154996|FG002|Overall Study|Site Terminated by Sponsor|0|||
33619349|NCT03386721|102154997|FG003|Overall Study|Site Terminated by Sponsor|0|||
33619350|NCT03386721|102154998|FG004|Overall Study|Site Terminated by Sponsor|1|||
33619351|NCT03386721|102154999|FG005|Overall Study|Site Terminated by Sponsor|3|||
33619352|NCT03386721|102155000|FG006|Overall Study|Site Terminated by Sponsor|0|||
33619353|NCT03386721|102155001|FG007|Overall Study|Site Terminated by Sponsor|1|||
33619354|NCT03386721|102155002|FG008|Overall Study|Site Terminated by Sponsor|4|||
33619355|NCT03386721|102155003|FG009|Overall Study|Site Terminated by Sponsor|5|||
33619356|NCT03386721|102155004|FG010|Overall Study|Site Terminated by Sponsor|3|||
33619357|NCT03386721|102155005|FG011|Overall Study|Site Terminated by Sponsor|11|||
33619358|NCT03386721|102155006|FG012|Overall Study|Site Terminated by Sponsor|6|||
33619359|NCT03386721|102155007|FG013|Overall Study|Site Terminated by Sponsor|0|||
33619360|NCT03386721|102155008|FG014|Overall Study|Site Terminated by Sponsor|0|||
33619361|NCT03386721|102154994|FG000|Overall Study|Symptomatic Deterioration|0|||
33619362|NCT03386721|102154995|FG001|Overall Study|Symptomatic Deterioration|0|||
33619363|NCT03386721|102154996|FG002|Overall Study|Symptomatic Deterioration|0|||
33619364|NCT03386721|102154997|FG003|Overall Study|Symptomatic Deterioration|0|||
33619365|NCT03386721|102154998|FG004|Overall Study|Symptomatic Deterioration|0|||
33619366|NCT03386721|102154999|FG005|Overall Study|Symptomatic Deterioration|0|||
33619367|NCT03386721|102155000|FG006|Overall Study|Symptomatic Deterioration|0|||
33619368|NCT03386721|102155001|FG007|Overall Study|Symptomatic Deterioration|0|||
33619369|NCT03386721|102155002|FG008|Overall Study|Symptomatic Deterioration|1|||
33619370|NCT03386721|102155003|FG009|Overall Study|Symptomatic Deterioration|0|||
33619371|NCT03386721|102155004|FG010|Overall Study|Symptomatic Deterioration|0|||
33619372|NCT03386721|102155005|FG011|Overall Study|Symptomatic Deterioration|1|||
33353200|NCT05195528|101180609|FG003|Extension Period|Not Treated|3|||
33353201|NCT05195528|101180610|FG004|Extension Period|Not Treated|0|||
33353202|NCT05195528|101180606|FG000|Extension Period|Other|0|||
33353203|NCT05195528|101180607|FG001|Extension Period|Other|1|||
33412638|NCT01238861|101400062|FG005|Overall Study|Unable to continue visits|1|||
33619373|NCT03386721|102155006|FG012|Overall Study|Symptomatic Deterioration|0|||
33412639|NCT01238861|101400057|FG000|Overall Study|Serious adverse event|0|||
33412640|NCT01238861|101400058|FG001|Overall Study|Serious adverse event|0|||
33353204|NCT05195528|101180608|FG002|Extension Period|Other|1|||
33353205|NCT05195528|101180609|FG003|Extension Period|Other|0|||
33353206|NCT05195528|101180610|FG004|Extension Period|Other|0|||
33353207|NCT01309737|101180611|FG000|Week 0 to 16|Death|1|||
33353208|NCT01309737|101180612|FG001|Week 0 to 16|Death|0|||
33353209|NCT01309737|101180613|FG002|Week 0 to 16|Death|1|||
33353210|NCT01309737|101180614|FG003|Week 0 to 16|Death|0|||
33353211|NCT01309737|101180615|FG004|Week 0 to 16|Death|0|||
33353212|NCT01309737|101180611|FG000|Week 0 to 16|Adverse Event|11|||
33353213|NCT01309737|101180612|FG001|Week 0 to 16|Adverse Event|10|||
33552990|NCT00835978|101923649|FG000|Overall Study|Lost to Follow-up|3|||
33552991|NCT00835978|101923650|FG001|Overall Study|Lost to Follow-up|4|||
33552992|NCT00835978|101923651|FG002|Overall Study|Lost to Follow-up|2|||
33552993|NCT00835978|101923652|FG003|Overall Study|Lost to Follow-up|1|||
33552994|NCT00835978|101923649|FG000|Overall Study|Other|5|||
33552995|NCT00835978|101923650|FG001|Overall Study|Other|1|||
33552996|NCT00835978|101923651|FG002|Overall Study|Other|8|||
33552997|NCT00835978|101923652|FG003|Overall Study|Other|0|||
33552998|NCT00835978|101923649|FG000|Overall Study|Objective progression or relapse|2|||
33552999|NCT00835978|101923650|FG001|Overall Study|Objective progression or relapse|0|||
33353214|NCT01309737|101180613|FG002|Week 0 to 16|Adverse Event|5|||
33353215|NCT01309737|101180614|FG003|Week 0 to 16|Adverse Event|0|||
33353216|NCT01309737|101180615|FG004|Week 0 to 16|Adverse Event|0|||
33353217|NCT01309737|101180611|FG000|Week 0 to 16|Lack of Efficacy|15|||
33353218|NCT01309737|101180612|FG001|Week 0 to 16|Lack of Efficacy|2|||
33353219|NCT01309737|101180613|FG002|Week 0 to 16|Lack of Efficacy|24|||
33353220|NCT01309737|101180614|FG003|Week 0 to 16|Lack of Efficacy|0|||
33353221|NCT01309737|101180615|FG004|Week 0 to 16|Lack of Efficacy|0|||
33353222|NCT01309737|101180611|FG000|Week 0 to 16|Lost to Follow-up|7|||
33353223|NCT01309737|101180612|FG001|Week 0 to 16|Lost to Follow-up|8|||
33353224|NCT01309737|101180613|FG002|Week 0 to 16|Lost to Follow-up|3|||
33353225|NCT01309737|101180614|FG003|Week 0 to 16|Lost to Follow-up|0|||
33353226|NCT01309737|101180615|FG004|Week 0 to 16|Lost to Follow-up|0|||
33353227|NCT01309737|101180611|FG000|Week 0 to 16|Withdrawal by Subject|7|||
33353228|NCT01309737|101180612|FG001|Week 0 to 16|Withdrawal by Subject|6|||
33353229|NCT01309737|101180613|FG002|Week 0 to 16|Withdrawal by Subject|7|||
33553000|NCT00835978|101923651|FG002|Overall Study|Objective progression or relapse|1|||
33553001|NCT00835978|101923652|FG003|Overall Study|Objective progression or relapse|0|||
33553002|NCT00835978|101923649|FG000|Overall Study|Adverse Event|1|||
33553003|NCT00835978|101923650|FG001|Overall Study|Adverse Event|0|||
33553004|NCT00835978|101923651|FG002|Overall Study|Adverse Event|1|||
33353230|NCT01309737|101180614|FG003|Week 0 to 16|Withdrawal by Subject|0|||
33353231|NCT01309737|101180615|FG004|Week 0 to 16|Withdrawal by Subject|0|||
33353232|NCT01309737|101180611|FG000|Week 0 to 16|Other|10|||
33353233|NCT01309737|101180612|FG001|Week 0 to 16|Other|14|||
33353234|NCT01309737|101180613|FG002|Week 0 to 16|Other|4|||
33553005|NCT00835978|101923652|FG003|Overall Study|Adverse Event|0|||
33553006|NCT00835978|101923649|FG000|Overall Study|Withdrawal by Subject|0|||
33553007|NCT00835978|101923650|FG001|Overall Study|Withdrawal by Subject|3|||
33631300|NCT03486912|102202914|FG000|Treatment Period|Other Reasons|0|||
33353235|NCT01309737|101180614|FG003|Week 0 to 16|Other|0|||
33353236|NCT01309737|101180615|FG004|Week 0 to 16|Other|0|||
33353237|NCT01309737|101180611|FG000|Week 0 to 16|Randomized, but not treated|1|||
33353238|NCT01309737|101180612|FG001|Week 0 to 16|Randomized, but not treated|0|||
33353239|NCT01309737|101180613|FG002|Week 0 to 16|Randomized, but not treated|0|||
33353240|NCT01309737|101180614|FG003|Week 0 to 16|Randomized, but not treated|0|||
33353241|NCT01309737|101180615|FG004|Week 0 to 16|Randomized, but not treated|0|||
33353242|NCT01309737|101180611|FG000|Week 16 to 52|Death|0|||
33353243|NCT01309737|101180612|FG001|Week 16 to 52|Death|0|||
33353244|NCT01309737|101180613|FG002|Week 16 to 52|Death|0|||
33353245|NCT01309737|101180614|FG003|Week 16 to 52|Death|0|||
33353246|NCT01309737|101180615|FG004|Week 16 to 52|Death|1|||
33353247|NCT01309737|101180611|FG000|Week 16 to 52|Adverse Event|7|||
33353248|NCT01309737|101180612|FG001|Week 16 to 52|Adverse Event|7|||
33353249|NCT01309737|101180613|FG002|Week 16 to 52|Adverse Event|0|||
33353250|NCT01309737|101180614|FG003|Week 16 to 52|Adverse Event|6|||
33353251|NCT01309737|101180615|FG004|Week 16 to 52|Adverse Event|5|||
33353252|NCT01309737|101180611|FG000|Week 16 to 52|Lack of Efficacy|107|||
33353253|NCT01309737|101180612|FG001|Week 16 to 52|Lack of Efficacy|76|||
33353254|NCT01309737|101180613|FG002|Week 16 to 52|Lack of Efficacy|0|||
33353255|NCT01309737|101180614|FG003|Week 16 to 52|Lack of Efficacy|25|||
33353256|NCT01309737|101180615|FG004|Week 16 to 52|Lack of Efficacy|21|||
33353257|NCT01309737|101180611|FG000|Week 16 to 52|Lost to Follow-up|4|||
33353258|NCT01309737|101180612|FG001|Week 16 to 52|Lost to Follow-up|2|||
33353259|NCT01309737|101180613|FG002|Week 16 to 52|Lost to Follow-up|0|||
33353260|NCT01309737|101180614|FG003|Week 16 to 52|Lost to Follow-up|1|||
33353261|NCT01309737|101180615|FG004|Week 16 to 52|Lost to Follow-up|4|||
33353262|NCT01309737|101180611|FG000|Week 16 to 52|Withdrawal by Subject|5|||
33353263|NCT01309737|101180612|FG001|Week 16 to 52|Withdrawal by Subject|6|||
33353264|NCT01309737|101180613|FG002|Week 16 to 52|Withdrawal by Subject|0|||
33353265|NCT01309737|101180614|FG003|Week 16 to 52|Withdrawal by Subject|0|||
33353266|NCT01309737|101180615|FG004|Week 16 to 52|Withdrawal by Subject|2|||
33353267|NCT01309737|101180611|FG000|Week 16 to 52|Other|10|||
33353268|NCT01309737|101180612|FG001|Week 16 to 52|Other|12|||
33353269|NCT01309737|101180613|FG002|Week 16 to 52|Other|0|||
33353270|NCT01309737|101180614|FG003|Week 16 to 52|Other|2|||
33353271|NCT01309737|101180615|FG004|Week 16 to 52|Other|0|||
33353272|NCT02029976|101180616|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
33353273|NCT02029976|101180617|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
33353274|NCT02029976|101180616|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
33353275|NCT02029976|101180617|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
33353276|NCT02029976|101180616|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
33353277|NCT02029976|101180617|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
33353278|NCT02029976|101180616|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
33353279|NCT02029976|101180617|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
33353280|NCT02706938|101180624|FG000|First Period, 6 Weeks|Adverse Event|8|||
33353281|NCT02706938|101180625|FG001|First Period, 6 Weeks|Adverse Event|0|||
33353282|NCT02706938|101180624|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
33353283|NCT02706938|101180625|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
33353284|NCT02706938|101180624|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
33353285|NCT02706938|101180625|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
33353286|NCT02706938|101180624|FG000|Second Period, 6 Weeks|Adverse Event|0|||
33353287|NCT02706938|101180625|FG001|Second Period, 6 Weeks|Adverse Event|7|||
33353288|NCT02706938|101180624|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
33353289|NCT02706938|101180625|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
33353290|NCT01769105|101180628|FG000|First Intervention|Protocol Violation|2|||
33353291|NCT01769105|101180629|FG001|First Intervention|Protocol Violation|2|||
33353292|NCT01769105|101180628|FG000|Cross-over|Lost to Follow-up|5|||
33353293|NCT01769105|101180629|FG001|Cross-over|Lost to Follow-up|0|||
33353294|NCT00398112|101180630|FG000|Overall Study|Adverse Event|4|||
33619374|NCT03386721|102155007|FG013|Overall Study|Symptomatic Deterioration|0|||
33217855|NCT01137474|100695878|FG000|Overall Study|Withdrawal by Subject|7|||
33353295|NCT00398112|101180630|FG000|Overall Study|Disease progression|9|||
33353296|NCT00398112|101180630|FG000|Overall Study|Alternative treatment|1|||
33353297|NCT00398112|101180630|FG000|Overall Study|Withdrawal by Subject|3|||
33353298|NCT00398112|101180630|FG000|Overall Study|Death|1|||
33353299|NCT00486603|101180631|FG000|Overall Study|Withdrawal by Subject|1|||
33353300|NCT00486603|101180632|FG001|Overall Study|Withdrawal by Subject|0|||
33353301|NCT00486603|101180633|FG002|Overall Study|Withdrawal by Subject|0|||
33353302|NCT00486603|101180634|FG003|Overall Study|Withdrawal by Subject|0|||
33353303|NCT00486603|101180635|FG004|Overall Study|Withdrawal by Subject|0|||
33353304|NCT00486603|101180631|FG000|Overall Study|Physician Decision|0|||
33353305|NCT00486603|101180632|FG001|Overall Study|Physician Decision|1|||
33353306|NCT00486603|101180633|FG002|Overall Study|Physician Decision|0|||
33353307|NCT00486603|101180634|FG003|Overall Study|Physician Decision|0|||
33353308|NCT00486603|101180635|FG004|Overall Study|Physician Decision|0|||
33353309|NCT00365989|101180636|FG000|Overall Study|Withdrawal by Subject|1|||
33353310|NCT00365989|101180636|FG000|Overall Study|Non-compliance|1|||
33353311|NCT01128387|101180638|FG000|Overall Study|Physician Decision|0|||
33353312|NCT01128387|101180639|FG001|Overall Study|Physician Decision|1|||
33353313|NCT04525703|101180643|FG000|Overall Study|Lost to Follow-up|6|||
33353314|NCT04525703|101180644|FG001|Overall Study|Lost to Follow-up|15|||
33353315|NCT04525703|101180645|FG002|Overall Study|Lost to Follow-up|8|||
33353316|NCT01361711|101180646|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
33353317|NCT01361711|101180646|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
33353318|NCT01361711|101180646|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
33353319|NCT01361711|101180646|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
33353320|NCT01361711|101180646|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
33353321|NCT01361711|101180646|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
33353322|NCT01361711|101180646|FG000|Completed Week 18 of Treatment|Other|9|||
33353323|NCT01361711|101180646|FG000|10 Year Follow-up|Still in follow-up|22|||
33353324|NCT01361711|101180646|FG000|10 Year Follow-up|Death|7|||
33353325|NCT01361711|101180646|FG000|10 Year Follow-up|Developed new cancer|1|||
33353326|NCT01361711|101180646|FG000|10 Year Follow-up|Lost to Follow-up|2|||
33353327|NCT01361711|101180646|FG000|10 Year Follow-up|New treatment started|6|||
33353328|NCT01361711|101180646|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
33353329|NCT01361711|101180646|FG000|10 Year Follow-up|Progressive Disease|1|||
33353330|NCT03417440|101180647|FG000|Overall Study|Lost to Follow-up|0|||
33217856|NCT01137474|100695879|FG001|Overall Study|Withdrawal by Subject|2|||
33217857|NCT01137474|100695880|FG002|Overall Study|Withdrawal by Subject|6|||
33217858|NCT01137474|100695881|FG003|Overall Study|Withdrawal by Subject|9|||
33353331|NCT03417440|101180648|FG001|Overall Study|Lost to Follow-up|1|||
33353332|NCT03417440|101180649|FG002|Overall Study|Lost to Follow-up|0|||
33353333|NCT03417440|101180650|FG003|Overall Study|Lost to Follow-up|0|||
33353334|NCT03417440|101180651|FG004|Overall Study|Lost to Follow-up|1|||
33353335|NCT03417440|101180652|FG005|Overall Study|Lost to Follow-up|0|||
33353336|NCT03417440|101180653|FG006|Overall Study|Lost to Follow-up|0|||
33353337|NCT03417440|101180654|FG007|Overall Study|Lost to Follow-up|0|||
33353338|NCT03417440|101180647|FG000|Overall Study|Withdrawal by Subject|2|||
33353339|NCT03417440|101180648|FG001|Overall Study|Withdrawal by Subject|0|||
33353340|NCT03417440|101180649|FG002|Overall Study|Withdrawal by Subject|2|||
33353341|NCT03417440|101180650|FG003|Overall Study|Withdrawal by Subject|1|||
33353342|NCT03417440|101180651|FG004|Overall Study|Withdrawal by Subject|1|||
33353343|NCT03417440|101180652|FG005|Overall Study|Withdrawal by Subject|0|||
33412641|NCT01238861|101400059|FG002|Overall Study|Serious adverse event|0|||
33412642|NCT01238861|101400060|FG003|Overall Study|Serious adverse event|0|||
33412643|NCT01238861|101400061|FG004|Overall Study|Serious adverse event|0|||
33412644|NCT01238861|101400062|FG005|Overall Study|Serious adverse event|1|||
33412645|NCT01238861|101400057|FG000|Overall Study|Lack of compliance|0|||
33412646|NCT01238861|101400058|FG001|Overall Study|Lack of compliance|0|||
33353344|NCT03417440|101180653|FG006|Overall Study|Withdrawal by Subject|0|||
33353345|NCT03417440|101180654|FG007|Overall Study|Withdrawal by Subject|1|||
33353346|NCT03871491|101180655|FG000|Overall Study|Withdrawal by Subject|14|||
33353347|NCT03871491|101180656|FG001|Overall Study|Withdrawal by Subject|14|||
33353348|NCT03871491|101180657|FG002|Overall Study|Withdrawal by Subject|14|||
33353349|NCT03871491|101180658|FG003|Overall Study|Withdrawal by Subject|14|||
33353350|NCT03871491|101180655|FG000|Overall Study|Physician Decision|0|||
33353351|NCT03871491|101180656|FG001|Overall Study|Physician Decision|0|||
33353352|NCT03871491|101180657|FG002|Overall Study|Physician Decision|1|||
33353353|NCT03871491|101180658|FG003|Overall Study|Physician Decision|1|||
33353354|NCT03871491|101180655|FG000|Overall Study|Lost to Follow-up|50|||
33353355|NCT03871491|101180656|FG001|Overall Study|Lost to Follow-up|15|||
33353356|NCT03871491|101180657|FG002|Overall Study|Lost to Follow-up|36|||
33353357|NCT03871491|101180658|FG003|Overall Study|Lost to Follow-up|11|||
33412647|NCT01238861|101400059|FG002|Overall Study|Lack of compliance|0|||
33412648|NCT01238861|101400060|FG003|Overall Study|Lack of compliance|0|||
33353358|NCT03593915|101180659|FG000|Overall Study|Adverse Event|0|||
33353359|NCT03593915|101180660|FG001|Overall Study|Adverse Event|0|||
33353360|NCT03593915|101180661|FG002|Overall Study|Adverse Event|0|||
33353361|NCT03593915|101180662|FG003|Overall Study|Adverse Event|1|||
33353362|NCT03593915|101180663|FG004|Overall Study|Adverse Event|0|||
33353363|NCT03593915|101180664|FG005|Overall Study|Adverse Event|0|||
33353364|NCT03593915|101180659|FG000|Overall Study|Physician Decision|0|||
33353365|NCT03593915|101180660|FG001|Overall Study|Physician Decision|0|||
33553008|NCT00835978|101923651|FG002|Overall Study|Withdrawal by Subject|0|||
33553009|NCT00835978|101923652|FG003|Overall Study|Withdrawal by Subject|5|||
33553010|NCT00835978|101923649|FG000|Overall Study|Study terminated by sponsor|12|||
33553011|NCT00835978|101923650|FG001|Overall Study|Study terminated by sponsor|8|||
33553012|NCT00835978|101923651|FG002|Overall Study|Study terminated by sponsor|30|||
33553013|NCT00835978|101923652|FG003|Overall Study|Study terminated by sponsor|0|||
33553014|NCT02287025|101923653|FG000|Overall Study|Not treated|2|||
33553015|NCT02287025|101923654|FG001|Overall Study|Not treated|0|||
33553016|NCT02287025|101923653|FG000|Overall Study|Progression of disease|3|||
33553017|NCT02287025|101923654|FG001|Overall Study|Progression of disease|2|||
33553018|NCT02287025|101923653|FG000|Overall Study|Adverse Event|2|||
33553019|NCT02287025|101923654|FG001|Overall Study|Adverse Event|4|||
33553020|NCT02287025|101923653|FG000|Overall Study|Withdrawal by Subject|2|||
33553021|NCT02287025|101923654|FG001|Overall Study|Withdrawal by Subject|2|||
33553022|NCT02287025|101923653|FG000|Overall Study|Screening failed|1|||
33553023|NCT02287025|101923654|FG001|Overall Study|Screening failed|1|||
33553024|NCT00985790|101923661|FG000|Overall Study|Withdrawal by Subject|1|||
33553025|NCT00985790|101923662|FG001|Overall Study|Withdrawal by Subject|1|||
33553026|NCT00985790|101923661|FG000|Overall Study|Lost to Follow-up|6|||
33553027|NCT00985790|101923662|FG001|Overall Study|Lost to Follow-up|7|||
33553028|NCT02383173|101923663|FG000|Overall Study|Palliative Care Team withdrew|0|||
33353366|NCT03593915|101180661|FG002|Overall Study|Physician Decision|0|||
33353367|NCT03593915|101180662|FG003|Overall Study|Physician Decision|0|||
33353368|NCT03593915|101180663|FG004|Overall Study|Physician Decision|0|||
33353369|NCT03593915|101180664|FG005|Overall Study|Physician Decision|1|||
33353370|NCT00238264|101180667|FG000|Overall Study|Death|7|||
33353371|NCT00238264|101180667|FG000|Overall Study|Lost to Follow-up|18|||
33353372|NCT00238264|101180667|FG000|Overall Study|Withdrawal by Subject|4|||
33353373|NCT00238264|101180667|FG000|Overall Study|Ineligible|7|||
33353374|NCT00158184|101180673|FG000|Overall Study|personal issues|3|||
33353375|NCT00158184|101180674|FG001|Overall Study|personal issues|1|||
33353376|NCT00158184|101180673|FG000|Overall Study|failed for follow unit/study rules|2|||
33353377|NCT00158184|101180674|FG001|Overall Study|failed for follow unit/study rules|0|||
33353378|NCT00158184|101180673|FG000|Overall Study|Adverse Event|1|||
33553029|NCT02383173|101923664|FG001|Overall Study|Palliative Care Team withdrew|2|||
33553030|NCT01283386|101923665|FG000|Overall Study|Death|2|||
33553031|NCT01283386|101923666|FG001|Overall Study|Death|0|||
33553032|NCT01283386|101923665|FG000|Overall Study|Withdrawal by Subject|2|||
33553033|NCT01283386|101923666|FG001|Overall Study|Withdrawal by Subject|1|||
33553034|NCT01283386|101923665|FG000|Overall Study|Relapse of underlying disease|1|||
33553035|NCT01283386|101923666|FG001|Overall Study|Relapse of underlying disease|3|||
33553036|NCT01283386|101923665|FG000|Overall Study|Progression of underlying disease|2|||
33553037|NCT01283386|101923666|FG001|Overall Study|Progression of underlying disease|7|||
33553038|NCT01283386|101923665|FG000|Overall Study|Reason not specified|1|||
33553039|NCT01283386|101923666|FG001|Overall Study|Reason not specified|0|||
33553040|NCT01283386|101923665|FG000|Overall Study|Protocol Violation|0|||
33553041|NCT01283386|101923666|FG001|Overall Study|Protocol Violation|1|||
33553042|NCT01623154|101923667|FG000|Overall Study|Did not drink Pranactin Citric|4|||
33553043|NCT01027416|101923668|FG000|Overall Study|Withdrawal by Subject|0|||
33553044|NCT01027416|101923669|FG001|Overall Study|Withdrawal by Subject|1|||
33553045|NCT01027416|101923668|FG000|Overall Study|Physician Decision|1|||
33353379|NCT00158184|101180674|FG001|Overall Study|Adverse Event|1|||
33353380|NCT03304522|101180678|FG000|Overall Study|Adverse Event|0|||
33353381|NCT03304522|101180679|FG001|Overall Study|Adverse Event|4|||
33353382|NCT03304522|101180678|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
33353383|NCT03304522|101180679|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
33553046|NCT01027416|101923669|FG001|Overall Study|Physician Decision|4|||
33353384|NCT03304522|101180678|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
33353385|NCT03304522|101180679|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
33353386|NCT03304522|101180678|FG000|Overall Study|Other|0|||
33353387|NCT03304522|101180679|FG001|Overall Study|Other|1|||
33553047|NCT01960842|101923673|FG000|Overall Study|Adverse Event|1|||
33553048|NCT01960842|101923673|FG000|Overall Study|Withdrawal by Subject|2|||
33553049|NCT00090402|101923676|FG000|Overall Study|Death|1|||
33553050|NCT00090402|101923677|FG001|Overall Study|Death|1|||
33553051|NCT00090402|101923678|FG002|Overall Study|Death|0|||
33553052|NCT00090402|101923676|FG000|Overall Study|subject moved|0|||
33553053|NCT00090402|101923677|FG001|Overall Study|subject moved|1|||
33553054|NCT00090402|101923678|FG002|Overall Study|subject moved|0|||
33553055|NCT00090402|101923676|FG000|Overall Study|stopped taking study medication|1|||
33553056|NCT00090402|101923677|FG001|Overall Study|stopped taking study medication|0|||
33553057|NCT00090402|101923678|FG002|Overall Study|stopped taking study medication|1|||
33553058|NCT01186419|101923681|FG000|Overall Study|Withdrawal by Subject|5|||
33553059|NCT01186419|101923682|FG001|Overall Study|Withdrawal by Subject|3|||
33553060|NCT01186419|101923681|FG000|Overall Study|Adverse Event|1|||
33553061|NCT01186419|101923682|FG001|Overall Study|Adverse Event|2|||
33553062|NCT01186419|101923681|FG000|Overall Study|Physician Decision|0|||
33553063|NCT01186419|101923682|FG001|Overall Study|Physician Decision|3|||
33553064|NCT01186419|101923681|FG000|Overall Study|Other|1|||
33553065|NCT01186419|101923682|FG001|Overall Study|Other|1|||
33553066|NCT01121575|101923683|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
33553067|NCT01121575|101923684|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
33553068|NCT01121575|101923685|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
33553069|NCT01121575|101923686|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
33553070|NCT01121575|101923687|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
33553071|NCT01121575|101923688|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
33553072|NCT01121575|101923683|FG000|Overall Study|Unspecified Reasons|8|||
33553073|NCT01121575|101923684|FG001|Overall Study|Unspecified Reasons|6|||
33553074|NCT01121575|101923685|FG002|Overall Study|Unspecified Reasons|7|||
33217859|NCT01137474|100695878|FG000|Overall Study|No longer met study criteria|6|||
33217860|NCT01137474|100695879|FG001|Overall Study|No longer met study criteria|1|||
33217861|NCT01137474|100695880|FG002|Overall Study|No longer met study criteria|0|||
33217862|NCT01137474|100695881|FG003|Overall Study|No longer met study criteria|5|||
33217863|NCT01137474|100695878|FG000|Overall Study|Lost to Follow-up|5|||
33217864|NCT01137474|100695879|FG001|Overall Study|Lost to Follow-up|1|||
33217865|NCT01137474|100695880|FG002|Overall Study|Lost to Follow-up|0|||
33217866|NCT01137474|100695881|FG003|Overall Study|Lost to Follow-up|2|||
33217867|NCT01137474|100695878|FG000|Overall Study|Lack of Efficacy|0|||
33217868|NCT01137474|100695879|FG001|Overall Study|Lack of Efficacy|0|||
33553075|NCT01121575|101923686|FG003|Overall Study|Unspecified Reasons|5|||
33553076|NCT01121575|101923687|FG004|Overall Study|Unspecified Reasons|13|||
33553077|NCT01121575|101923688|FG005|Overall Study|Unspecified Reasons|10|||
33553078|NCT01121575|101923683|FG000|Overall Study|Death|6|||
33553079|NCT01121575|101923684|FG001|Overall Study|Death|0|||
33553080|NCT01121575|101923685|FG002|Overall Study|Death|0|||
33553081|NCT01121575|101923686|FG003|Overall Study|Death|1|||
33553082|NCT01121575|101923687|FG004|Overall Study|Death|7|||
33553083|NCT01121575|101923688|FG005|Overall Study|Death|1|||
33553084|NCT02460380|101923693|FG000|Overall Study|Withdrawal by Subject|10|||
33553085|NCT02460380|101923694|FG001|Overall Study|Withdrawal by Subject|5|||
33553086|NCT03055195|101923696|FG000|Overall Study|Lack of Efficacy|1|||
33553087|NCT03055195|101923697|FG001|Overall Study|Lack of Efficacy|0|||
33553088|NCT03055195|101923696|FG000|Overall Study|Withdrawal by Subject|6|||
33553089|NCT03055195|101923697|FG001|Overall Study|Withdrawal by Subject|7|||
33553090|NCT03055195|101923696|FG000|Overall Study|Study Terminated by Sponsor|2|||
33553091|NCT03055195|101923697|FG001|Overall Study|Study Terminated by Sponsor|6|||
33553092|NCT03055195|101923696|FG000|Overall Study|Protocol Violation|2|||
33553093|NCT03055195|101923697|FG001|Overall Study|Protocol Violation|1|||
33553094|NCT03055195|101923696|FG000|Overall Study|Physician Decision|1|||
33553095|NCT03055195|101923697|FG001|Overall Study|Physician Decision|0|||
33553096|NCT01452789|101923698|FG000|Overall Study|Withdrawal by Subject|3|||
33553097|NCT01452789|101923699|FG001|Overall Study|Withdrawal by Subject|2|||
33553098|NCT01936974|101923700|FG000|Overall Study|Physician Decision|2|||
33553099|NCT01936974|101923701|FG001|Overall Study|Physician Decision|5|||
33553100|NCT01684033|101923703|FG000|Period 1, First 30 Days|Adverse Event|1|||
33553101|NCT01684033|101923704|FG001|Period 1, First 30 Days|Adverse Event|1|||
33553102|NCT01684033|101923703|FG000|Period 1, First 30 Days|Noncompliance|1|||
33553103|NCT01684033|101923704|FG001|Period 1, First 30 Days|Noncompliance|0|||
33553104|NCT01684033|101923703|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
33553105|NCT01684033|101923704|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
33553106|NCT01684033|101923703|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
33553107|NCT01684033|101923704|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
33553108|NCT01684033|101923703|FG000|Period 2, Second 30 Days|Adverse Event|1|||
33553109|NCT01684033|101923704|FG001|Period 2, Second 30 Days|Adverse Event|0|||
33619375|NCT03386721|102155008|FG014|Overall Study|Symptomatic Deterioration|0|||
33217869|NCT01137474|100695880|FG002|Overall Study|Lack of Efficacy|0|||
33217870|NCT01137474|100695881|FG003|Overall Study|Lack of Efficacy|2|||
33217871|NCT01137474|100695878|FG000|Overall Study|Other|3|||
33217872|NCT01137474|100695879|FG001|Overall Study|Other|1|||
33553110|NCT00120250|101923707|FG000|Overall Study|Lost to Follow-up|1|||
33553111|NCT00120250|101923708|FG001|Overall Study|Lost to Follow-up|1|||
33553112|NCT00120250|101923707|FG000|Overall Study|Protocol Violation|0|||
33553113|NCT00120250|101923708|FG001|Overall Study|Protocol Violation|1|||
33553114|NCT01243424|101923715|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
33553115|NCT01243424|101923716|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
33619376|NCT03386721|102154994|FG000|Overall Study|Withdrawal by Subject|1|||
33619377|NCT03386721|102154995|FG001|Overall Study|Withdrawal by Subject|2|||
33553116|NCT01243424|101923715|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
33553117|NCT01243424|101923716|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
33553118|NCT01243424|101923715|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
33553119|NCT01243424|101923716|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
33553120|NCT01243424|101923715|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
33553121|NCT01243424|101923716|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
33553122|NCT01243424|101923715|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
33553123|NCT01243424|101923716|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
33553124|NCT01243424|101923715|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
33553125|NCT01243424|101923716|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
33553126|NCT01243424|101923715|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
33553127|NCT01243424|101923716|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
33553128|NCT01243424|101923715|FG000|Discontinuation From Treatment|Not treated|5|||
33553129|NCT01243424|101923716|FG001|Discontinuation From Treatment|Not treated|4|||
33553130|NCT01243424|101923715|FG000|Discontinuation From Treatment|Adverse Event|457|||
33553131|NCT01243424|101923716|FG001|Discontinuation From Treatment|Adverse Event|523|||
33553132|NCT01243424|101923715|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
33553133|NCT01243424|101923716|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
33553134|NCT01243424|101923715|FG000|Discontinuation From Treatment|Protocol Violation|46|||
33553135|NCT01243424|101923716|FG001|Discontinuation From Treatment|Protocol Violation|47|||
33553136|NCT01243424|101923715|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
33553137|NCT01243424|101923716|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
33553138|NCT01243424|101923715|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
33553139|NCT01243424|101923716|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
33553140|NCT01243424|101923715|FG000|Discontinuation From Treatment|Other than listed above|230|||
33553141|NCT01243424|101923716|FG001|Discontinuation From Treatment|Other than listed above|211|||
33553142|NCT01953354|101923717|FG000|Overall Study|Withdrawal by Subject|0|||
33553143|NCT01953354|101923718|FG001|Overall Study|Withdrawal by Subject|1|||
33553144|NCT01953354|101923717|FG000|Overall Study|Decision of Sponsor|0|||
33553145|NCT01953354|101923718|FG001|Overall Study|Decision of Sponsor|1|||
33553146|NCT01953354|101923717|FG000|Overall Study|Disease Exacerbation|1|||
33553147|NCT01953354|101923718|FG001|Overall Study|Disease Exacerbation|0|||
33553148|NCT02545127|101923735|FG000|Overall Study|Lost to Follow-up|1|||
33553149|NCT02545127|101923736|FG001|Overall Study|Lost to Follow-up|0|||
33553150|NCT04621786|101923741|FG000|Overall Study|Lost to Follow-up|9|||
33553151|NCT04621786|101923741|FG000|Overall Study|Protocol Violation|3|||
33553152|NCT03022630|101923742|FG000|Overall Study|Death|9|||
33553153|NCT03022630|101923743|FG001|Overall Study|Death|7|||
33553154|NCT03022630|101923742|FG000|Overall Study|Withdrawal by Subject|0|||
33553155|NCT03022630|101923743|FG001|Overall Study|Withdrawal by Subject|5|||
33553156|NCT02942407|101923744|FG000|Overall Study|Lost to Follow-up|3|||
33553157|NCT02942407|101923745|FG001|Overall Study|Lost to Follow-up|2|||
33553158|NCT02942407|101923744|FG000|Overall Study|Withdrawal by Subject|7|||
33553159|NCT02942407|101923745|FG001|Overall Study|Withdrawal by Subject|9|||
33553160|NCT02942407|101923744|FG000|Overall Study|Death|16|||
33553161|NCT02942407|101923745|FG001|Overall Study|Death|13|||
33553162|NCT00924651|101923747|FG000|Overall Study|Chemo started too soon|2|||
33553163|NCT00924651|101923748|FG001|Overall Study|Chemo started too soon|3|||
33553164|NCT00924651|101923747|FG000|Overall Study|No Reason|3|||
33553165|NCT00924651|101923748|FG001|Overall Study|No Reason|7|||
33553166|NCT00924651|101923747|FG000|Overall Study|Overwhelmed|6|||
33553167|NCT00924651|101923748|FG001|Overall Study|Overwhelmed|6|||
33553168|NCT00924651|101923747|FG000|Overall Study|Noncompliant|1|||
33553169|NCT00924651|101923748|FG001|Overall Study|Noncompliant|4|||
33553170|NCT00924651|101923747|FG000|Overall Study|Medical|1|||
33553171|NCT00924651|101923748|FG001|Overall Study|Medical|3|||
33553172|NCT00924651|101923747|FG000|Overall Study|Changed Mind|10|||
33553173|NCT00924651|101923748|FG001|Overall Study|Changed Mind|1|||
33553174|NCT00924651|101923747|FG000|Overall Study|Incomplete Form|2|||
33553175|NCT00924651|101923748|FG001|Overall Study|Incomplete Form|1|||
33553176|NCT00899847|101923749|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
33553177|NCT03994120|101923750|FG000|Overall Study|Lost to Follow-up|3|||
33553178|NCT03994120|101923751|FG001|Overall Study|Lost to Follow-up|1|||
33412649|NCT01238861|101400061|FG004|Overall Study|Lack of compliance|0|||
33412650|NCT01238861|101400062|FG005|Overall Study|Lack of compliance|1|||
33619378|NCT03386721|102154996|FG002|Overall Study|Withdrawal by Subject|0|||
33553179|NCT01178411|101923754|FG000|Overall Study|Adverse Event|5|||
33553180|NCT01178411|101923754|FG000|Overall Study|Withdrawal by Subject|4|||
33553181|NCT01178411|101923754|FG000|Overall Study|Protocol Violation|1|||
33553182|NCT01178411|101923754|FG000|Overall Study|Progressive disease per RECIST|32|||
33553183|NCT01178411|101923754|FG000|Overall Study|Progressive disease per clinician|9|||
33553184|NCT01178411|101923754|FG000|Overall Study|Physician Decision|6|||
33553185|NCT01178411|101923754|FG000|Overall Study|Death|1|||
33553186|NCT01178411|101923754|FG000|Overall Study|No reason provided|1|||
33217873|NCT01137474|100695880|FG002|Overall Study|Other|0|||
33217874|NCT01137474|100695881|FG003|Overall Study|Other|0|||
33217875|NCT01137474|100695878|FG000|Overall Study|Pregnancy|0|||
33217876|NCT01137474|100695879|FG001|Overall Study|Pregnancy|1|||
33217877|NCT01137474|100695880|FG002|Overall Study|Pregnancy|0|||
33412651|NCT01238861|101400057|FG000|Overall Study|Adverse Event|0|||
33412652|NCT01238861|101400058|FG001|Overall Study|Adverse Event|1|||
33553187|NCT01178411|101923754|FG000|Overall Study|Drug manufacturing ended|1|||
33553188|NCT00564070|101923755|FG000|Overall Study|Lost to Follow-up|9|||
33553189|NCT00564070|101923756|FG001|Overall Study|Lost to Follow-up|7|||
33553190|NCT00564070|101923755|FG000|Overall Study|Worsening depression, referred to care|3|||
33553191|NCT00564070|101923756|FG001|Overall Study|Worsening depression, referred to care|0|||
33553192|NCT01184118|101923757|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
33553193|NCT01184118|101923757|FG000|Overall Study|No physiologic confirmation of asthma|8|||
33553194|NCT01184118|101923757|FG000|Overall Study|FEV1 <60% predicted|2|||
33553195|NCT01184118|101923757|FG000|Overall Study|Exclusionary medical condition|2|||
33619379|NCT03386721|102154997|FG003|Overall Study|Withdrawal by Subject|0|||
33619380|NCT03386721|102154998|FG004|Overall Study|Withdrawal by Subject|0|||
33619381|NCT03386721|102154999|FG005|Overall Study|Withdrawal by Subject|0|||
33619382|NCT03386721|102155000|FG006|Overall Study|Withdrawal by Subject|0|||
33619383|NCT03386721|102155001|FG007|Overall Study|Withdrawal by Subject|0|||
33619384|NCT03386721|102155002|FG008|Overall Study|Withdrawal by Subject|2|||
33217878|NCT01137474|100695881|FG003|Overall Study|Pregnancy|0|||
33217879|NCT01137474|100695878|FG000|Overall Study|Administrative reason by sponsor|0|||
33217880|NCT01137474|100695879|FG001|Overall Study|Administrative reason by sponsor|1|||
33353388|NCT00110305|101180680|FG000|Overall Study|Adverse Event|46|||
33353389|NCT00110305|101180681|FG001|Overall Study|Adverse Event|13|||
33353390|NCT00110305|101180680|FG000|Overall Study|Sponsors Decision|1|||
33353391|NCT00110305|101180681|FG001|Overall Study|Sponsors Decision|0|||
33353392|NCT00110305|101180680|FG000|Overall Study|Subject Non-Compliant|9|||
33353393|NCT00110305|101180681|FG001|Overall Study|Subject Non-Compliant|2|||
33353394|NCT00110305|101180680|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
33353395|NCT00110305|101180681|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
33412653|NCT01238861|101400059|FG002|Overall Study|Adverse Event|0|||
33412654|NCT01238861|101400060|FG003|Overall Study|Adverse Event|0|||
33553196|NCT01184118|101923757|FG000|Overall Study|Withdrawal by Subject|5|||
33619385|NCT03386721|102155003|FG009|Overall Study|Withdrawal by Subject|1|||
33553197|NCT02573467|101923758|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
33217881|NCT01137474|100695880|FG002|Overall Study|Administrative reason by sponsor|0|||
33217882|NCT01137474|100695881|FG003|Overall Study|Administrative reason by sponsor|0|||
33217883|NCT01984684|100695882|FG000|Overall Study|Lost to Follow-up|25|||
33217884|NCT01984684|100695883|FG001|Overall Study|Lost to Follow-up|24|||
33217885|NCT01984684|100695882|FG000|Overall Study|Adverse Event|8|||
33217886|NCT01984684|100695883|FG001|Overall Study|Adverse Event|12|||
33553198|NCT02573467|101923759|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
33217887|NCT01984684|100695882|FG000|Overall Study|Withdrawal by Subject|9|||
33217888|NCT01984684|100695883|FG001|Overall Study|Withdrawal by Subject|9|||
33217889|NCT01984684|100695882|FG000|Overall Study|Lack of Efficacy|3|||
33217890|NCT01984684|100695883|FG001|Overall Study|Lack of Efficacy|6|||
33217891|NCT01984684|100695882|FG000|Overall Study|Physician Decision|4|||
33217892|NCT01984684|100695883|FG001|Overall Study|Physician Decision|2|||
33217893|NCT01984684|100695882|FG000|Overall Study|Protocol Violation|4|||
33217894|NCT01984684|100695883|FG001|Overall Study|Protocol Violation|2|||
33217895|NCT01984684|100695882|FG000|Overall Study|Death|0|||
33217896|NCT01984684|100695883|FG001|Overall Study|Death|1|||
33217897|NCT01984684|100695882|FG000|Overall Study|Noncompliance with study drug|2|||
33217898|NCT01984684|100695883|FG001|Overall Study|Noncompliance with study drug|1|||
33217899|NCT01984684|100695882|FG000|Overall Study|Subject incarcerated|1|||
33217900|NCT01984684|100695883|FG001|Overall Study|Subject incarcerated|0|||
33217901|NCT01984684|100695882|FG000|Overall Study|Study drug not available at site|1|||
33217902|NCT01984684|100695883|FG001|Overall Study|Study drug not available at site|1|||
33217903|NCT01984684|100695882|FG000|Overall Study|Subject had inadequate IV access|0|||
33217904|NCT01984684|100695883|FG001|Overall Study|Subject had inadequate IV access|1|||
33217905|NCT03017079|100695884|FG000|Overall Study|Physician Decision|1|||
33217906|NCT03017079|100695885|FG001|Overall Study|Physician Decision|1|||
33217907|NCT03017079|100695884|FG000|Overall Study|Death|3|||
33217908|NCT03017079|100695885|FG001|Overall Study|Death|2|||
33353396|NCT00110305|101180680|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
33353397|NCT00110305|101180681|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
33353398|NCT00110305|101180680|FG000|Overall Study|Protocol Violation|0|||
33353399|NCT00110305|101180681|FG001|Overall Study|Protocol Violation|1|||
33353400|NCT00110305|101180680|FG000|Overall Study|Withdrawal by Subject|7|||
33353401|NCT00110305|101180681|FG001|Overall Study|Withdrawal by Subject|7|||
33353402|NCT00110305|101180680|FG000|Overall Study|Lost to Follow-up|20|||
33353403|NCT00110305|101180681|FG001|Overall Study|Lost to Follow-up|3|||
33553199|NCT02573467|101923760|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
33553200|NCT02573467|101923761|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
33553201|NCT02573467|101923758|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
33553202|NCT02573467|101923759|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
33553203|NCT02573467|101923760|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
33553204|NCT02573467|101923761|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
33553205|NCT02573467|101923758|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
33553206|NCT02573467|101923759|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
33553207|NCT02573467|101923760|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
33353404|NCT00110305|101180680|FG000|Overall Study|Other|8|||
33353405|NCT00110305|101180681|FG001|Overall Study|Other|2|||
33353406|NCT04003610|101180682|FG000|Overall Study|Lost to Follow-up|0|||
33553208|NCT02573467|101923761|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
33553209|NCT02573467|101923758|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
33217909|NCT03017079|100695884|FG000|Overall Study|Lack of Efficacy|2|||
33217910|NCT03017079|100695885|FG001|Overall Study|Lack of Efficacy|2|||
33217911|NCT03017079|100695884|FG000|Overall Study|Protocol Violation|0|||
33553210|NCT02573467|101923759|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
33619386|NCT03386721|102155004|FG010|Overall Study|Withdrawal by Subject|3|||
33217912|NCT03017079|100695885|FG001|Overall Study|Protocol Violation|1|||
33353407|NCT04003610|101180683|FG001|Overall Study|Lost to Follow-up|1|||
33412655|NCT01238861|101400061|FG004|Overall Study|Adverse Event|0|||
33412656|NCT01238861|101400062|FG005|Overall Study|Adverse Event|0|||
33412657|NCT01238861|101400057|FG000|Overall Study|Withdrawal by Subject|6|||
33412658|NCT01238861|101400058|FG001|Overall Study|Withdrawal by Subject|5|||
33553211|NCT02573467|101923760|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
33412659|NCT01238861|101400059|FG002|Overall Study|Withdrawal by Subject|4|||
33412660|NCT01238861|101400060|FG003|Overall Study|Withdrawal by Subject|8|||
33412661|NCT01238861|101400061|FG004|Overall Study|Withdrawal by Subject|10|||
33412662|NCT01238861|101400062|FG005|Overall Study|Withdrawal by Subject|9|||
33412663|NCT01484691|101400063|FG000|Overall Study|Withdrawal by Subject|1|||
33412664|NCT01484691|101400064|FG001|Overall Study|Withdrawal by Subject|1|||
33412665|NCT01484691|101400065|FG002|Overall Study|Withdrawal by Subject|1|||
33412666|NCT01484691|101400063|FG000|Overall Study|Physician Decision|0|||
33412667|NCT01484691|101400064|FG001|Overall Study|Physician Decision|2|||
33412668|NCT01484691|101400065|FG002|Overall Study|Physician Decision|1|||
33412669|NCT01118949|101400068|FG000|Overall Study|Adverse Event|5|||
33412670|NCT01118949|101400068|FG000|Overall Study|Withdrawal by Subject|4|||
33412671|NCT00998166|101400069|FG000|Overall Study|Early Study Termination|8|||
33412672|NCT04505592|101400074|FG000|Overall Study|Death|2|||
33412673|NCT04505592|101400075|FG001|Overall Study|Death|1|||
33412674|NCT04887922|101400076|FG000|1st Randomization|Decided not to have surgery|0|||
33412675|NCT04887922|101400077|FG001|1st Randomization|Decided not to have surgery|1|||
33412676|NCT04887922|101400078|FG002|1st Randomization|Decided not to have surgery|0|||
33412677|NCT04887922|101400079|FG003|1st Randomization|Decided not to have surgery|0|||
33412678|NCT04887922|101400080|FG004|1st Randomization|Decided not to have surgery|0|||
33412679|NCT01458535|101400091|FG000|Overall Study|Other|0|||
33412680|NCT01458535|101400092|FG001|Overall Study|Other|0|||
33412681|NCT01458535|101400093|FG002|Overall Study|Other|0|||
33412682|NCT01458535|101400094|FG003|Overall Study|Other|0|||
33412683|NCT01458535|101400095|FG004|Overall Study|Other|1|||
33553212|NCT02573467|101923761|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
33553213|NCT02573467|101923758|FG000|Post-treatment Follow up Epoch|Death|1|||
33553214|NCT02573467|101923759|FG001|Post-treatment Follow up Epoch|Death|1|||
33553215|NCT02573467|101923760|FG002|Post-treatment Follow up Epoch|Death|0|||
33553216|NCT02573467|101923761|FG003|Post-treatment Follow up Epoch|Death|1|||
33553217|NCT02573467|101923758|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
33553218|NCT02573467|101923759|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
33553219|NCT02573467|101923760|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
33553220|NCT02573467|101923761|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
33553221|NCT02573467|101923758|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
33553222|NCT02573467|101923759|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
33553223|NCT02573467|101923760|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
33553224|NCT02573467|101923761|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
33553225|NCT03478787|101923762|FG000|Overall Study|Adverse Event|5|||
33553226|NCT03478787|101923763|FG001|Overall Study|Adverse Event|1|||
33553227|NCT03478787|101923762|FG000|Overall Study|Protocol Violation|3|||
33553228|NCT03478787|101923763|FG001|Overall Study|Protocol Violation|0|||
33553229|NCT03478787|101923762|FG000|Overall Study|Lack of Efficacy|7|||
33553230|NCT03478787|101923763|FG001|Overall Study|Lack of Efficacy|1|||
33412684|NCT01458535|101400096|FG005|Overall Study|Other|1|||
33412685|NCT01458535|101400091|FG000|Overall Study|Withdrawal by Subject|0|||
33217913|NCT04465357|100695888|FG000|Overall Study|Adverse Event|2|||
33412686|NCT01458535|101400092|FG001|Overall Study|Withdrawal by Subject|0|||
33412687|NCT01458535|101400093|FG002|Overall Study|Withdrawal by Subject|2|||
33412688|NCT01458535|101400094|FG003|Overall Study|Withdrawal by Subject|0|||
33412689|NCT01458535|101400095|FG004|Overall Study|Withdrawal by Subject|1|||
33412690|NCT01458535|101400096|FG005|Overall Study|Withdrawal by Subject|1|||
33553231|NCT03478787|101923762|FG000|Overall Study|Lost to Follow-up|9|||
33553232|NCT03478787|101923763|FG001|Overall Study|Lost to Follow-up|5|||
33553233|NCT03478787|101923762|FG000|Overall Study|Withdrawal by Subject|2|||
33553234|NCT03478787|101923763|FG001|Overall Study|Withdrawal by Subject|6|||
33553235|NCT03478787|101923762|FG000|Overall Study|Other, Not Specified|3|||
33553236|NCT03478787|101923763|FG001|Overall Study|Other, Not Specified|0|||
33553237|NCT00215553|101923764|FG000|Overall Study|Adverse Event|0|||
33553238|NCT00215553|101923765|FG001|Overall Study|Adverse Event|1|||
33553239|NCT00215553|101923766|FG002|Overall Study|Adverse Event|2|||
33553240|NCT00215553|101923767|FG003|Overall Study|Adverse Event|1|||
33553241|NCT00215553|101923768|FG004|Overall Study|Adverse Event|2|||
33217914|NCT04465357|100695888|FG000|Overall Study|Lack of Efficacy|1|||
33553242|NCT00215553|101923769|FG005|Overall Study|Adverse Event|6|||
33553243|NCT00215553|101923770|FG006|Overall Study|Adverse Event|0|||
33553244|NCT03520569|101923771|FG000|Overall Study|Withdrawal by Subject|1|||
33553245|NCT01543503|101923772|FG000|Overall Study|Lost to Follow-up|32|||
33553246|NCT01543503|101923773|FG001|Overall Study|Lost to Follow-up|36|||
33553247|NCT01543503|101923772|FG000|Overall Study|Adverse Event|9|||
33553248|NCT01543503|101923773|FG001|Overall Study|Adverse Event|13|||
33553249|NCT01543503|101923772|FG000|Overall Study|Lack of Efficacy|4|||
33553250|NCT01543503|101923773|FG001|Overall Study|Lack of Efficacy|16|||
33553251|NCT01543503|101923772|FG000|Overall Study|Participant withdrew informed consent|8|||
33553252|NCT01543503|101923773|FG001|Overall Study|Participant withdrew informed consent|10|||
33553253|NCT01543503|101923772|FG000|Overall Study|Change of jobs|0|||
33553254|NCT01543503|101923773|FG001|Overall Study|Change of jobs|1|||
33553255|NCT01543503|101923772|FG000|Overall Study|Intolerance to the biologic treatment|0|||
33553256|NCT01543503|101923773|FG001|Overall Study|Intolerance to the biologic treatment|1|||
33553257|NCT01543503|101923772|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
33553258|NCT01543503|101923773|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
33553259|NCT01543503|101923772|FG000|Overall Study|Participant did not complete last visit|0|||
33553260|NCT01543503|101923773|FG001|Overall Study|Participant did not complete last visit|2|||
33553261|NCT01543503|101923772|FG000|Overall Study|Refused to continue treatment|7|||
33553262|NCT01543503|101923773|FG001|Overall Study|Refused to continue treatment|0|||
33553263|NCT01543503|101923772|FG000|Overall Study|Incorrect medication received|1|||
33553264|NCT01543503|101923773|FG001|Overall Study|Incorrect medication received|0|||
33553265|NCT01543503|101923772|FG000|Overall Study|Participant moved to another city|2|||
33553266|NCT01543503|101923773|FG001|Overall Study|Participant moved to another city|0|||
33553267|NCT01543503|101923772|FG000|Overall Study|Participant will not return for visits|0|||
33553268|NCT01543503|101923773|FG001|Overall Study|Participant will not return for visits|2|||
33553269|NCT01543503|101923772|FG000|Overall Study|Participant transferred to another city|1|||
33553270|NCT01543503|101923773|FG001|Overall Study|Participant transferred to another city|0|||
33553271|NCT01543503|101923772|FG000|Overall Study|Participant moved to Scotland|1|||
33553272|NCT01543503|101923773|FG001|Overall Study|Participant moved to Scotland|0|||
33553273|NCT01543503|101923772|FG000|Overall Study|Participant decision to stop treatment|1|||
33553274|NCT01543503|101923773|FG001|Overall Study|Participant decision to stop treatment|0|||
33553275|NCT01543503|101923772|FG000|Overall Study|Investigator did not wish to participate|1|||
33553276|NCT01543503|101923773|FG001|Overall Study|Investigator did not wish to participate|1|||
33553277|NCT01543503|101923772|FG000|Overall Study|Participant recruited after closing date|0|||
33553278|NCT01543503|101923773|FG001|Overall Study|Participant recruited after closing date|1|||
33553279|NCT01543503|101923772|FG000|Overall Study|Site stopped participation|5|||
33553280|NCT01543503|101923773|FG001|Overall Study|Site stopped participation|1|||
33217915|NCT04465357|100695888|FG000|Overall Study|Lost to Follow-up|2|||
33631301|NCT03486912|102202915|FG001|Treatment Period|Other Reasons|2|||
33553281|NCT01543503|101923772|FG000|Overall Study|Participant did not attend a visit|1|||
33553282|NCT01543503|101923773|FG001|Overall Study|Participant did not attend a visit|0|||
33553283|NCT01543503|101923772|FG000|Overall Study|Moved to other rheumatologic site|0|||
33553284|NCT01543503|101923773|FG001|Overall Study|Moved to other rheumatologic site|1|||
33553285|NCT01543503|101923772|FG000|Overall Study|Participant consented to another study|0|||
33553286|NCT01543503|101923773|FG001|Overall Study|Participant consented to another study|2|||
33553287|NCT01543503|101923772|FG000|Overall Study|Participant went to United States|1|||
33412691|NCT01458535|101400091|FG000|Overall Study|Lost to Follow-up|0|||
33412692|NCT01458535|101400092|FG001|Overall Study|Lost to Follow-up|2|||
33412693|NCT01458535|101400093|FG002|Overall Study|Lost to Follow-up|0|||
33412694|NCT01458535|101400094|FG003|Overall Study|Lost to Follow-up|3|||
33412695|NCT01458535|101400095|FG004|Overall Study|Lost to Follow-up|2|||
33412696|NCT01458535|101400096|FG005|Overall Study|Lost to Follow-up|2|||
33412697|NCT01458535|101400091|FG000|Overall Study|Adverse Event|0|||
33412698|NCT01458535|101400092|FG001|Overall Study|Adverse Event|0|||
33412699|NCT01458535|101400093|FG002|Overall Study|Adverse Event|0|||
33412700|NCT01458535|101400094|FG003|Overall Study|Adverse Event|1|||
33412701|NCT01458535|101400095|FG004|Overall Study|Adverse Event|0|||
33412702|NCT01458535|101400096|FG005|Overall Study|Adverse Event|0|||
33412703|NCT00678652|101400098|FG000|Overall Study|Protocol Violation|2|||
33553288|NCT01543503|101923773|FG001|Overall Study|Participant went to United States|0|||
33553289|NCT01543503|101923772|FG000|Overall Study|Screen failure|1|||
33553290|NCT01543503|101923773|FG001|Overall Study|Screen failure|0|||
33553291|NCT01441414|101923774|FG000|Overall Study|Participant died|9|||
33553292|NCT01441414|101923774|FG000|Overall Study|Other reasons|3|||
33553293|NCT01441414|101923774|FG000|Overall Study|Study terminated by sponsor|2|||
33553294|NCT01441414|101923774|FG000|Overall Study|Subject refused further follow-up|1|||
33553295|NCT04648241|101923775|FG000|Overall Study|Lost to Follow-up|1|||
33553296|NCT04648241|101923776|FG001|Overall Study|Lost to Follow-up|0|||
33553297|NCT01691092|101923777|FG000|Overall Study|Lost to Follow-up|10|||
33553298|NCT01691092|101923777|FG000|Overall Study|Physician Decision|4|||
33553299|NCT01691092|101923777|FG000|Overall Study|Withdrawal by Subject|3|||
33553300|NCT01691092|101923777|FG000|Overall Study|non-compliance|3|||
33553301|NCT01691092|101923777|FG000|Overall Study|used for different study|2|||
33553302|NCT01691092|101923777|FG000|Overall Study|screen fail|19|||
33553303|NCT01160744|101923778|FG000|Overall Study|Withdrawal by Subject|11|||
33553304|NCT01160744|101923779|FG001|Overall Study|Withdrawal by Subject|5|||
33553305|NCT01160744|101923780|FG002|Overall Study|Withdrawal by Subject|6|||
33553306|NCT01160744|101923781|FG003|Overall Study|Withdrawal by Subject|4|||
33553307|NCT01160744|101923778|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
33553308|NCT01160744|101923779|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
33553309|NCT01160744|101923780|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
33553310|NCT01160744|101923781|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
33553311|NCT00834587|101923782|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
33553312|NCT00834587|101923783|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
33553313|NCT01879852|101923786|FG000|Overall Study|Withdrawal by Subject|2|||
33553314|NCT01879852|101923787|FG001|Overall Study|Withdrawal by Subject|0|||
33553315|NCT00964678|101923791|FG000|Overall Study|Physician Decision|4|||
33553316|NCT03422718|101923792|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
33553317|NCT03422718|101923793|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
33553318|NCT03422718|101923794|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
33553319|NCT03422718|101923795|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
33553320|NCT03422718|101923796|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
33553321|NCT03422718|101923797|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
33553322|NCT03422718|101923798|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
33553323|NCT03422718|101923799|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
33553324|NCT03422718|101923792|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
33553325|NCT03422718|101923793|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
33553326|NCT03422718|101923794|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
33553327|NCT03422718|101923795|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
33553328|NCT03422718|101923796|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
33553329|NCT03422718|101923797|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
33412704|NCT00678652|101400099|FG001|Overall Study|Protocol Violation|0|||
33412705|NCT00678652|101400100|FG002|Overall Study|Protocol Violation|0|||
33553330|NCT03422718|101923798|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
33553331|NCT03422718|101923799|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
33553332|NCT03422718|101923792|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
33553333|NCT03422718|101923793|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
33217916|NCT04465357|100695888|FG000|Overall Study|Withdrawal by Subject|6|||
33412706|NCT00678652|101400101|FG003|Overall Study|Protocol Violation|0|||
33412707|NCT00678652|101400098|FG000|Overall Study|Pregnancy|0|||
33631302|NCT03486912|102202916|FG002|Treatment Period|Other Reasons|1|||
33412708|NCT00678652|101400099|FG001|Overall Study|Pregnancy|0|||
33412709|NCT00678652|101400100|FG002|Overall Study|Pregnancy|1|||
33553334|NCT03422718|101923794|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
33553335|NCT03422718|101923795|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
33619387|NCT03386721|102155005|FG011|Overall Study|Withdrawal by Subject|2|||
33619388|NCT03386721|102155006|FG012|Overall Study|Withdrawal by Subject|3|||
33619389|NCT03386721|102155007|FG013|Overall Study|Withdrawal by Subject|0|||
33619390|NCT03386721|102155008|FG014|Overall Study|Withdrawal by Subject|0|||
33619391|NCT00602420|102155009|FG000|Overall Study|Death|1|||
33619392|NCT00602420|102155010|FG001|Overall Study|Death|4|||
33619393|NCT00602420|102155009|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
33619394|NCT00602420|102155010|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
33619395|NCT00602420|102155009|FG000|Overall Study|Withdrawal by Subject|18|||
33619396|NCT00602420|102155010|FG001|Overall Study|Withdrawal by Subject|17|||
33619397|NCT00602420|102155009|FG000|Overall Study|Adverse Event|1|||
33619398|NCT00602420|102155010|FG001|Overall Study|Adverse Event|0|||
33619399|NCT00398567|102155011|FG000|Overall Study|Disease Progression|3|||
33619400|NCT00398567|102155012|FG001|Overall Study|Disease Progression|4|||
33619401|NCT00398567|102155013|FG002|Overall Study|Disease Progression|27|||
33619402|NCT00398567|102155011|FG000|Overall Study|Withdrawal by Subject|1|||
33553336|NCT03422718|101923796|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
33553337|NCT03422718|101923797|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
33553338|NCT03422718|101923798|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
33619403|NCT00398567|102155012|FG001|Overall Study|Withdrawal by Subject|0|||
33619404|NCT00398567|102155013|FG002|Overall Study|Withdrawal by Subject|4|||
33619405|NCT00398567|102155011|FG000|Overall Study|Adverse Event|0|||
33619406|NCT00398567|102155012|FG001|Overall Study|Adverse Event|0|||
33619407|NCT00398567|102155013|FG002|Overall Study|Adverse Event|2|||
33553339|NCT03422718|101923799|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
33553340|NCT03422718|101923792|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
33553341|NCT03422718|101923793|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
33553342|NCT03422718|101923794|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
33553343|NCT03422718|101923795|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
33553344|NCT03422718|101923796|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
33553345|NCT03422718|101923797|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
33553346|NCT03422718|101923798|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
33553347|NCT03422718|101923799|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
33553348|NCT03422718|101923792|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
33553349|NCT03422718|101923793|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
33553350|NCT03422718|101923794|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
33553351|NCT03422718|101923795|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
33553352|NCT03422718|101923796|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
33553353|NCT03422718|101923797|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
33553354|NCT03422718|101923798|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
33553355|NCT03422718|101923799|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
33553356|NCT03422718|101923792|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
33553357|NCT03422718|101923793|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
33553358|NCT03422718|101923794|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
33553359|NCT03422718|101923795|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
33553360|NCT03422718|101923796|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
33553361|NCT03422718|101923797|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
33553362|NCT03422718|101923798|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
33553363|NCT03422718|101923799|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
33553364|NCT02082483|101923803|FG000|Overall Study|Lost to Follow-up|1|||
33553365|NCT02082483|101923804|FG001|Overall Study|Lost to Follow-up|1|||
33553366|NCT02082483|101923803|FG000|Overall Study|Withdrawal by Subject|2|||
33553367|NCT02082483|101923804|FG001|Overall Study|Withdrawal by Subject|1|||
33553368|NCT02082483|101923803|FG000|Overall Study|Physician Decision|1|||
33619408|NCT00398567|102155011|FG000|Overall Study|Protocol Violation|0|||
33619409|NCT00398567|102155012|FG001|Overall Study|Protocol Violation|0|||
33619410|NCT00398567|102155013|FG002|Overall Study|Protocol Violation|1|||
33619411|NCT01871519|102155014|FG000|Overall Study|Death|26|||
33619412|NCT01871519|102155014|FG000|Overall Study|Lost to Follow-up|15|||
33619413|NCT01871519|102155014|FG000|Overall Study|Withdrawal by Subject|49|||
33412710|NCT00678652|101400101|FG003|Overall Study|Pregnancy|0|||
33553369|NCT02082483|101923804|FG001|Overall Study|Physician Decision|1|||
33553370|NCT02082483|101923803|FG000|Overall Study|Death|2|||
33553371|NCT02082483|101923804|FG001|Overall Study|Death|3|||
33619414|NCT02871635|102155015|FG000|Overall Study|Primary lack of efficacy|4|||
33619415|NCT02871635|102155016|FG001|Overall Study|Primary lack of efficacy|4|||
33619416|NCT02871635|102155015|FG000|Overall Study|Protocol Violation|3|||
33619417|NCT02871635|102155016|FG001|Overall Study|Protocol Violation|1|||
33619418|NCT02871635|102155015|FG000|Overall Study|Lost to Follow-up|1|||
33412711|NCT00678652|101400098|FG000|Overall Study|Relocation|1|||
33553372|NCT02665455|101923805|FG000|Overall Study|Withdrawal by Subject|6|||
33553373|NCT02665455|101923805|FG000|Overall Study|Lost to Follow-up|1|||
33553374|NCT02665455|101923805|FG000|Overall Study|Adverse Event|1|||
33553375|NCT02665455|101923805|FG000|Overall Study|Protocol Violation|1|||
33553376|NCT00855582|101923806|FG000|Overall Study|Adverse Event|2|||
33553377|NCT00855582|101923807|FG001|Overall Study|Adverse Event|6|||
33553378|NCT00855582|101923808|FG002|Overall Study|Adverse Event|3|||
33553379|NCT00855582|101923806|FG000|Overall Study|Death|1|||
33553380|NCT00855582|101923807|FG001|Overall Study|Death|0|||
33553381|NCT00855582|101923808|FG002|Overall Study|Death|0|||
33553382|NCT00855582|101923806|FG000|Overall Study|Lack of Efficacy|1|||
33553383|NCT00855582|101923807|FG001|Overall Study|Lack of Efficacy|3|||
33553384|NCT00855582|101923808|FG002|Overall Study|Lack of Efficacy|8|||
33553385|NCT00855582|101923806|FG000|Overall Study|Lost to Follow-up|1|||
33553386|NCT00855582|101923807|FG001|Overall Study|Lost to Follow-up|3|||
33553387|NCT00855582|101923808|FG002|Overall Study|Lost to Follow-up|1|||
33553388|NCT00855582|101923806|FG000|Overall Study|Physician Decision|0|||
33553389|NCT00855582|101923807|FG001|Overall Study|Physician Decision|0|||
33553390|NCT00855582|101923808|FG002|Overall Study|Physician Decision|1|||
33553391|NCT00855582|101923806|FG000|Overall Study|Protocol Violation|6|||
33553392|NCT00855582|101923807|FG001|Overall Study|Protocol Violation|2|||
33553393|NCT00855582|101923808|FG002|Overall Study|Protocol Violation|6|||
33553394|NCT00855582|101923806|FG000|Overall Study|Entry Criteria Not Met|8|||
33553395|NCT00855582|101923807|FG001|Overall Study|Entry Criteria Not Met|6|||
33553396|NCT00855582|101923808|FG002|Overall Study|Entry Criteria Not Met|3|||
33553397|NCT00855582|101923806|FG000|Overall Study|Withdrawal by Subject|7|||
33553398|NCT00855582|101923807|FG001|Overall Study|Withdrawal by Subject|4|||
33553399|NCT00855582|101923808|FG002|Overall Study|Withdrawal by Subject|8|||
33553400|NCT02346370|101923809|FG000|Overall Study|Not treated|1|||
33553401|NCT02346370|101923810|FG001|Overall Study|Not treated|0|||
33553402|NCT02346370|101923811|FG002|Overall Study|Not treated|0|||
33553403|NCT02346370|101923809|FG000|Overall Study|Withdrawal of consent|1|||
33553404|NCT02346370|101923810|FG001|Overall Study|Withdrawal of consent|0|||
33553405|NCT02346370|101923811|FG002|Overall Study|Withdrawal of consent|0|||
33553406|NCT02346370|101923809|FG000|Overall Study|Death|1|||
33553407|NCT02346370|101923810|FG001|Overall Study|Death|3|||
33553408|NCT02346370|101923811|FG002|Overall Study|Death|1|||
33553409|NCT02346370|101923809|FG000|Overall Study|Sponsor discontinued study|5|||
33553410|NCT02346370|101923810|FG001|Overall Study|Sponsor discontinued study|0|||
33553411|NCT02346370|101923811|FG002|Overall Study|Sponsor discontinued study|2|||
33553412|NCT02346370|101923809|FG000|Overall Study|Radiologic progression|0|||
33553413|NCT02346370|101923810|FG001|Overall Study|Radiologic progression|0|||
33553414|NCT02346370|101923811|FG002|Overall Study|Radiologic progression|1|||
33553415|NCT02346370|101923809|FG000|Overall Study|Physician Decision|0|||
33553416|NCT02346370|101923810|FG001|Overall Study|Physician Decision|1|||
33553417|NCT02346370|101923811|FG002|Overall Study|Physician Decision|0|||
33553418|NCT01814332|101923812|FG000|Overall Study|Adverse Event|8|||
33553419|NCT01814332|101923813|FG001|Overall Study|Adverse Event|3|||
33553420|NCT01814332|101923812|FG000|Overall Study|Withdrawal by Subject|3|||
33553421|NCT01814332|101923813|FG001|Overall Study|Withdrawal by Subject|8|||
33553422|NCT01814332|101923812|FG000|Overall Study|Protocol Violation|0|||
33553423|NCT01814332|101923813|FG001|Overall Study|Protocol Violation|4|||
33553424|NCT01814332|101923812|FG000|Overall Study|Lost to Follow-up|5|||
33553425|NCT01814332|101923813|FG001|Overall Study|Lost to Follow-up|1|||
33553426|NCT00552058|101923814|FG000|Overall Study|Adverse Event|8|||
33553427|NCT00552058|101923815|FG001|Overall Study|Adverse Event|7|||
33412712|NCT00678652|101400099|FG001|Overall Study|Relocation|0|||
33412713|NCT00678652|101400100|FG002|Overall Study|Relocation|0|||
33412714|NCT00678652|101400101|FG003|Overall Study|Relocation|0|||
33412715|NCT01808508|101400106|FG000|Overall Study|Lost to Follow-up|1|||
33412716|NCT01808508|101400107|FG001|Overall Study|Lost to Follow-up|0|||
33553428|NCT00552058|101923814|FG000|Overall Study|Lack of Efficacy|1|||
33553429|NCT00552058|101923815|FG001|Overall Study|Lack of Efficacy|5|||
33553430|NCT00552058|101923814|FG000|Overall Study|Lost to Follow-up|1|||
33553431|NCT00552058|101923815|FG001|Overall Study|Lost to Follow-up|0|||
33553432|NCT00552058|101923814|FG000|Overall Study|Withdrawal by Subject|4|||
33553433|NCT00552058|101923815|FG001|Overall Study|Withdrawal by Subject|4|||
33553434|NCT00552058|101923814|FG000|Overall Study|Other: Protocol Violation|0|||
33553435|NCT00552058|101923815|FG001|Overall Study|Other: Protocol Violation|1|||
33553436|NCT00552058|101923814|FG000|Overall Study|Other: Non Compliance|1|||
33553437|NCT00552058|101923815|FG001|Overall Study|Other: Non Compliance|2|||
33553438|NCT00552058|101923814|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
33412717|NCT01808508|101400108|FG002|Overall Study|Lost to Follow-up|0|||
33553439|NCT00552058|101923815|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
33553440|NCT00552058|101923814|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
33553441|NCT00552058|101923815|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
33553442|NCT00552058|101923814|FG000|Overall Study|Other: Positive Stool Result|0|||
33553443|NCT00552058|101923815|FG001|Overall Study|Other: Positive Stool Result|1|||
33553444|NCT00552058|101923814|FG000|Overall Study|Other: Randomized in error|0|||
33553445|NCT00552058|101923815|FG001|Overall Study|Other: Randomized in error|1|||
33553446|NCT00552058|101923814|FG000|Overall Study|Other: Sponsors Decision|0|||
33553447|NCT00552058|101923815|FG001|Overall Study|Other: Sponsors Decision|1|||
33553448|NCT00552058|101923814|FG000|Overall Study|Other: Early Roll Over|1|||
33553449|NCT00552058|101923815|FG001|Overall Study|Other: Early Roll Over|0|||
33553450|NCT01472835|101923817|FG000|Overall Study|Lost to Follow-up|2|||
33553451|NCT01472835|101923818|FG001|Overall Study|Lost to Follow-up|0|||
33553452|NCT01060111|101923819|FG000|Overall Study|Adverse Event|9|||
33553453|NCT01060111|101923820|FG001|Overall Study|Adverse Event|5|||
33553454|NCT01060111|101923821|FG002|Overall Study|Adverse Event|18|||
33553455|NCT01060111|101923819|FG000|Overall Study|Lack of Efficacy|2|||
33553456|NCT01060111|101923820|FG001|Overall Study|Lack of Efficacy|1|||
33553457|NCT01060111|101923821|FG002|Overall Study|Lack of Efficacy|0|||
33553458|NCT01060111|101923819|FG000|Overall Study|Inappropriate participant|5|||
33553459|NCT01060111|101923820|FG001|Overall Study|Inappropriate participant|4|||
33553460|NCT01060111|101923821|FG002|Overall Study|Inappropriate participant|5|||
33553461|NCT01060111|101923819|FG000|Overall Study|Participants' evasion for hospital visit|0|||
33553462|NCT01060111|101923820|FG001|Overall Study|Participants' evasion for hospital visit|3|||
33553463|NCT01060111|101923821|FG002|Overall Study|Participants' evasion for hospital visit|2|||
33553464|NCT01060111|101923819|FG000|Overall Study|Participants' non-cooperation|8|||
33553465|NCT01060111|101923820|FG001|Overall Study|Participants' non-cooperation|6|||
33353408|NCT04003610|101180684|FG002|Overall Study|Lost to Follow-up|0|||
33353409|NCT04003610|101180682|FG000|Overall Study|Death|0|||
33353410|NCT04003610|101180683|FG001|Overall Study|Death|0|||
33353411|NCT04003610|101180684|FG002|Overall Study|Death|3|||
33353412|NCT04003610|101180682|FG000|Overall Study|Study Terminated by Sponsor|0|||
33353413|NCT04003610|101180683|FG001|Overall Study|Study Terminated by Sponsor|0|||
33353414|NCT04003610|101180684|FG002|Overall Study|Study Terminated by Sponsor|3|||
33353415|NCT00851903|101180685|FG000|Overall Study|Withdrawal by Subject|2|||
33353416|NCT01891643|101180686|FG000|Overall Study|Adverse event unrelated to study drug|2|||
33353417|NCT01891643|101180687|FG001|Overall Study|Adverse event unrelated to study drug|5|||
33553466|NCT01060111|101923821|FG002|Overall Study|Participants' non-cooperation|6|||
33353418|NCT01891643|101180686|FG000|Overall Study|Disease Progression|4|||
33353419|NCT01891643|101180687|FG001|Overall Study|Disease Progression|3|||
33353420|NCT01891643|101180686|FG000|Overall Study|Study Drug Toxicity|3|||
33353421|NCT01891643|101180687|FG001|Overall Study|Study Drug Toxicity|0|||
33353422|NCT01891643|101180686|FG000|Overall Study|Maximum Clinical Benefit|0|||
33353423|NCT01891643|101180687|FG001|Overall Study|Maximum Clinical Benefit|1|||
33353424|NCT01891643|101180686|FG000|Overall Study|Poor/Non-compliance|0|||
33353425|NCT01891643|101180687|FG001|Overall Study|Poor/Non-compliance|1|||
33553467|NCT01060111|101923819|FG000|Overall Study|Adverse event and insufficient effect|0|||
33553468|NCT01060111|101923820|FG001|Overall Study|Adverse event and insufficient effect|1|||
33553469|NCT01060111|101923821|FG002|Overall Study|Adverse event and insufficient effect|0|||
33553470|NCT01060111|101923819|FG000|Overall Study|Participants' non-cooperation|1|||
33553471|NCT01060111|101923820|FG001|Overall Study|Participants' non-cooperation|0|||
33553472|NCT01060111|101923821|FG002|Overall Study|Participants' non-cooperation|0|||
33553473|NCT01060111|101923819|FG000|Overall Study|Other|2|||
33553474|NCT01060111|101923820|FG001|Overall Study|Other|3|||
33553475|NCT01060111|101923821|FG002|Overall Study|Other|4|||
33553476|NCT02830087|101923825|FG000|Overall Study|No study staff to follow-up patients|4|||
33553477|NCT02830087|101923826|FG001|Overall Study|No study staff to follow-up patients|4|||
33553478|NCT02830087|101923827|FG002|Overall Study|No study staff to follow-up patients|4|||
33553479|NCT02830087|101923828|FG003|Overall Study|No study staff to follow-up patients|3|||
33553480|NCT02830087|101923829|FG004|Overall Study|No study staff to follow-up patients|3|||
33553481|NCT02830087|101923830|FG005|Overall Study|No study staff to follow-up patients|3|||
33353426|NCT01891643|101180686|FG000|Overall Study|Participant request to discontinue|1|||
33553482|NCT00245570|101923831|FG000|Washout Between Periods III and IV|Adverse Event|0|||
33553483|NCT00245570|101923832|FG001|Washout Between Periods III and IV|Adverse Event|1|||
33553484|NCT00245570|101923833|FG002|Washout Between Periods III and IV|Adverse Event|0|||
33553485|NCT00245570|101923834|FG003|Washout Between Periods III and IV|Adverse Event|0|||
33353427|NCT01891643|101180687|FG001|Overall Study|Participant request to discontinue|0|||
33412718|NCT03971422|101400111|FG000|Overall Study|Lost to Follow-up|0|||
33412719|NCT03971422|101400112|FG001|Overall Study|Lost to Follow-up|1|||
33553486|NCT00245570|101923835|FG004|Washout Between Periods III and IV|Adverse Event|0|||
33553487|NCT00245570|101923836|FG005|Washout Between Periods III and IV|Adverse Event|0|||
33553488|NCT01786109|101923837|FG000|Overall Study|fail manometry barostat tube placement|1|||
33553489|NCT01786109|101923838|FG001|Overall Study|fail manometry barostat tube placement|0|||
33553490|NCT01786109|101923839|FG002|Overall Study|fail manometry barostat tube placement|0|||
33553491|NCT01786109|101923837|FG000|Overall Study|unrelated illness|0|||
33553492|NCT01786109|101923838|FG001|Overall Study|unrelated illness|0|||
33553493|NCT01786109|101923839|FG002|Overall Study|unrelated illness|1|||
33553494|NCT01786109|101923837|FG000|Overall Study|adverse effects colon preparation|0|||
33553495|NCT01786109|101923838|FG001|Overall Study|adverse effects colon preparation|0|||
33553496|NCT01786109|101923839|FG002|Overall Study|adverse effects colon preparation|1|||
33567620|NCT02723955|101973175|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567621|NCT02723955|101973176|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567622|NCT02723955|101973177|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567623|NCT02723955|101973178|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567624|NCT02723955|101973179|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567625|NCT02723955|101973180|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567626|NCT02723955|101973181|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567627|NCT02723955|101973182|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567628|NCT02723955|101973183|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567629|NCT02723955|101973184|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567630|NCT02723955|101973185|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567631|NCT02723955|101973186|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567632|NCT02723955|101973187|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567633|NCT02723955|101973188|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567634|NCT02723955|101973189|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567635|NCT02723955|101973190|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567636|NCT02723955|101973191|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567637|NCT02723955|101973192|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567638|NCT02723955|101973193|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567639|NCT02723955|101973194|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567640|NCT02723955|101973195|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567641|NCT02723955|101973196|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567642|NCT02723955|101973197|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567643|NCT02723955|101973198|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567644|NCT02723955|101973199|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33217917|NCT04465357|100695888|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
33567645|NCT02723955|101973200|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567646|NCT02723955|101973201|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567647|NCT02723955|101973202|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33619419|NCT02871635|102155016|FG001|Overall Study|Lost to Follow-up|2|||
33553497|NCT01618708|101927683|FG000|Overall Study|Adverse Event|10|||
33553498|NCT01618708|101927684|FG001|Overall Study|Adverse Event|10|||
33553499|NCT01618708|101927683|FG000|Overall Study|Lost to Follow-up|3|||
33553500|NCT01618708|101927684|FG001|Overall Study|Lost to Follow-up|3|||
33553501|NCT01618708|101927683|FG000|Overall Study|Withdrawal by Subject|17|||
33553502|NCT01618708|101927684|FG001|Overall Study|Withdrawal by Subject|22|||
33553503|NCT01618708|101927683|FG000|Overall Study|Lack of Efficacy|8|||
33553504|NCT01618708|101927684|FG001|Overall Study|Lack of Efficacy|8|||
33553505|NCT01618708|101927683|FG000|Overall Study|Technical problems|2|||
33553506|NCT01618708|101927684|FG001|Overall Study|Technical problems|0|||
33553507|NCT01618708|101927683|FG000|Overall Study|Other than specified above|1|||
33553508|NCT01618708|101927684|FG001|Overall Study|Other than specified above|1|||
33553509|NCT01618708|101927683|FG000|Overall Study|Randomized but not treated|3|||
33553510|NCT01618708|101927684|FG001|Overall Study|Randomized but not treated|2|||
33553511|NCT01666314|101927685|FG000|Overall Study|Adverse Event|3|||
33553512|NCT01666314|101927686|FG001|Overall Study|Adverse Event|13|||
33553513|NCT01666314|101927687|FG002|Overall Study|Adverse Event|7|||
33553514|NCT01666314|101927688|FG003|Overall Study|Adverse Event|7|||
33553515|NCT01666314|101927685|FG000|Overall Study|Progressive Disease|11|||
33553516|NCT01666314|101927686|FG001|Overall Study|Progressive Disease|9|||
33553517|NCT01666314|101927687|FG002|Overall Study|Progressive Disease|19|||
33553518|NCT01666314|101927688|FG003|Overall Study|Progressive Disease|20|||
33553519|NCT01666314|101927685|FG000|Overall Study|Symptomatic Deterioration|1|||
33553520|NCT01666314|101927686|FG001|Overall Study|Symptomatic Deterioration|0|||
33553521|NCT01666314|101927687|FG002|Overall Study|Symptomatic Deterioration|2|||
33553522|NCT01666314|101927688|FG003|Overall Study|Symptomatic Deterioration|0|||
33553523|NCT01666314|101927685|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
33553524|NCT01666314|101927686|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
33553525|NCT01666314|101927687|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
33553526|NCT01666314|101927688|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
33553527|NCT01666314|101927685|FG000|Overall Study|Withdrawal by Subject|1|||
33553528|NCT01666314|101927686|FG001|Overall Study|Withdrawal by Subject|1|||
33619420|NCT02871635|102155015|FG000|Overall Study|Pregnancy|0|||
33619421|NCT02871635|102155016|FG001|Overall Study|Pregnancy|2|||
33619422|NCT02871635|102155015|FG000|Overall Study|Physician Decision|1|||
33353428|NCT02034123|101180689|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33353429|NCT02034123|101180690|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33353430|NCT02034123|101180691|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33353431|NCT02034123|101180692|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33353432|NCT02034123|101180693|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
33353433|NCT02034123|101180694|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33353434|NCT02034123|101180695|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33353435|NCT02034123|101180696|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
33353436|NCT02034123|101180697|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
33353437|NCT02034123|101180698|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33353438|NCT02034123|101180699|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33353439|NCT02034123|101180700|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33353440|NCT02034123|101180701|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33353441|NCT02034123|101180702|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33353442|NCT02034123|101180703|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33353443|NCT02034123|101180704|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33412720|NCT03971422|101400113|FG002|Overall Study|Lost to Follow-up|0|||
33412721|NCT03971422|101400111|FG000|Overall Study|Lack of Efficacy|5|||
33412722|NCT03971422|101400112|FG001|Overall Study|Lack of Efficacy|1|||
33412723|NCT03971422|101400113|FG002|Overall Study|Lack of Efficacy|1|||
33412724|NCT03971422|101400111|FG000|Overall Study|Adverse event, not fatal|2|||
33412725|NCT03971422|101400112|FG001|Overall Study|Adverse event, not fatal|2|||
33412726|NCT03971422|101400113|FG002|Overall Study|Adverse event, not fatal|5|||
33412727|NCT03971422|101400111|FG000|Overall Study|Worsening of MG Symptoms|1|||
33553529|NCT01666314|101927687|FG002|Overall Study|Withdrawal by Subject|2|||
33553530|NCT01666314|101927688|FG003|Overall Study|Withdrawal by Subject|3|||
33619423|NCT02871635|102155016|FG001|Overall Study|Physician Decision|1|||
33353444|NCT02034123|101180705|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33412728|NCT03971422|101400112|FG001|Overall Study|Worsening of MG Symptoms|4|||
33412729|NCT03971422|101400113|FG002|Overall Study|Worsening of MG Symptoms|2|||
33412730|NCT03971422|101400111|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
33553531|NCT01666314|101927685|FG000|Overall Study|Reason not Specified|10|||
33619424|NCT02871635|102155015|FG000|Overall Study|Withdrawal by Subject|3|||
33553532|NCT01666314|101927686|FG001|Overall Study|Reason not Specified|7|||
33619425|NCT02871635|102155016|FG001|Overall Study|Withdrawal by Subject|4|||
33353445|NCT02034123|101180706|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
33353446|NCT02034123|101180689|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353447|NCT02034123|101180690|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353448|NCT02034123|101180691|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33553533|NCT01666314|101927687|FG002|Overall Study|Reason not Specified|5|||
33553534|NCT01666314|101927688|FG003|Overall Study|Reason not Specified|5|||
33553535|NCT02453191|101927692|FG000|Overall Study|Withdrawal by Subject|1|||
33553536|NCT01093885|101927693|FG000|Overall Study|Adverse Event|4|||
33553537|NCT01093885|101927693|FG000|Overall Study|Lost to Follow-up|1|||
33353449|NCT02034123|101180692|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
33353450|NCT02034123|101180693|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353451|NCT02034123|101180694|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353452|NCT02034123|101180695|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353453|NCT02034123|101180696|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353454|NCT02034123|101180697|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353455|NCT02034123|101180698|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353456|NCT02034123|101180699|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353457|NCT02034123|101180700|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353458|NCT02034123|101180701|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353459|NCT02034123|101180702|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353460|NCT02034123|101180703|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353461|NCT02034123|101180704|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353462|NCT02034123|101180705|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353463|NCT02034123|101180706|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
33353464|NCT02034123|101180689|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353465|NCT02034123|101180690|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353466|NCT02034123|101180691|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353467|NCT02034123|101180692|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353468|NCT02034123|101180693|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33553538|NCT00337194|101927698|FG000|Overall Study|Adverse Event|5|||
33553539|NCT00337194|101927699|FG001|Overall Study|Adverse Event|1|||
33553540|NCT00337194|101927698|FG000|Overall Study|Death|2|||
33553541|NCT00337194|101927699|FG001|Overall Study|Death|0|||
33553542|NCT00337194|101927698|FG000|Overall Study|Withdrawal by Subject|1|||
33553543|NCT00337194|101927699|FG001|Overall Study|Withdrawal by Subject|0|||
33553544|NCT00337194|101927698|FG000|Overall Study|Disease progression|1|||
33553545|NCT00337194|101927699|FG001|Overall Study|Disease progression|2|||
33553546|NCT00337194|101927698|FG000|Overall Study|Subsequent non-protocol therapy|3|||
33553547|NCT00337194|101927699|FG001|Overall Study|Subsequent non-protocol therapy|1|||
33553548|NCT02056288|101927700|FG000|In-Hospital Data|Surgery cancelled|1|||
33553549|NCT02056288|101927701|FG001|In-Hospital Data|Surgery cancelled|0|||
33553550|NCT02056288|101927700|FG000|In-Hospital Data|Protocol Violation|3|||
33553551|NCT02056288|101927701|FG001|In-Hospital Data|Protocol Violation|0|||
33553552|NCT02056288|101927700|FG000|In-Hospital Data|Physician Decision|1|||
33553553|NCT02056288|101927701|FG001|In-Hospital Data|Physician Decision|0|||
33553554|NCT02056288|101927700|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
33553555|NCT02056288|101927701|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
33553556|NCT00574951|101927702|FG000|Overall Study|Ineligible - improper prior treatment|1|||
33553557|NCT00153920|101927705|FG000|Overall Study|Adverse Event|9|||
33553558|NCT00153920|101927705|FG000|Overall Study|Progressive Disease|9|||
33553559|NCT00153920|101927705|FG000|Overall Study|Physician Decision|3|||
33553560|NCT00153920|101927705|FG000|Overall Study|Lack of Response|3|||
33553561|NCT00153920|101927705|FG000|Overall Study|Death|2|||
33553562|NCT00153920|101927705|FG000|Overall Study|Withdrawal by Subject|1|||
33553563|NCT00153920|101927705|FG000|Overall Study|Non-Protocol Therapy|1|||
33553564|NCT00153920|101927705|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
33553565|NCT00153920|101927705|FG000|Overall Study|Progressive Disease before Trt|1|||
33553566|NCT01663987|101927706|FG000|Overall Study|Adverse Event|7|||
33619426|NCT02871635|102155015|FG000|Overall Study|Adverse Event|4|||
33553567|NCT01663987|101927707|FG001|Overall Study|Adverse Event|2|||
33553568|NCT01663987|101927706|FG000|Overall Study|Lost to Follow-up|1|||
33553569|NCT01663987|101927707|FG001|Overall Study|Lost to Follow-up|1|||
33553570|NCT01663987|101927706|FG000|Overall Study|Withdrawal by Subject|2|||
33619427|NCT02871635|102155016|FG001|Overall Study|Adverse Event|4|||
33412731|NCT03971422|101400112|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
33412732|NCT03971422|101400113|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
33412733|NCT03971422|101400111|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
33412734|NCT03971422|101400112|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
33412735|NCT03971422|101400113|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
33412736|NCT03971422|101400111|FG000|Overall Study|Due to COVID-19 pandemic|0|||
33412737|NCT03971422|101400112|FG001|Overall Study|Due to COVID-19 pandemic|1|||
33412738|NCT03971422|101400113|FG002|Overall Study|Due to COVID-19 pandemic|1|||
33412739|NCT02279888|101400114|FG000|Overall Study|Death|326|||
33412740|NCT02279888|101400114|FG000|Overall Study|Withdrawal by Subject|38|||
33412741|NCT02279888|101400114|FG000|Overall Study|Lost to Follow-up|21|||
33412742|NCT02279888|101400114|FG000|Overall Study|Physician Decision|62|||
33412743|NCT02279888|101400114|FG000|Overall Study|Subject Non-compliance|43|||
33412744|NCT02279888|101400114|FG000|Overall Study|Not implanted|14|||
33553571|NCT01663987|101927707|FG001|Overall Study|Withdrawal by Subject|3|||
33553572|NCT01663987|101927706|FG000|Overall Study|Other reason not defined above|3|||
33553573|NCT01663987|101927707|FG001|Overall Study|Other reason not defined above|0|||
33412745|NCT02279888|101400114|FG000|Overall Study|Visit not performed|26|||
33553574|NCT01975285|101927709|FG000|Overall Study|Failed Block and follow up|2|||
33553575|NCT01975285|101927710|FG001|Overall Study|Failed Block and follow up|2|||
33553576|NCT04289298|101927711|FG000|Overall Study|Lost to Follow-up|5|||
33553577|NCT04289298|101927712|FG001|Overall Study|Lost to Follow-up|0|||
33553578|NCT04289298|101927711|FG000|Overall Study|Withdrawal by Subject|2|||
33553579|NCT04289298|101927712|FG001|Overall Study|Withdrawal by Subject|0|||
33553580|NCT00728182|101927713|FG000|Overall Study|Adverse Event|1|||
33412746|NCT01269346|101400115|FG000|Treatment Phase|Disease progression|3|||
33412747|NCT01269346|101400115|FG000|Treatment Phase|Adverse Event|3|||
33412748|NCT01269346|101400115|FG000|Treatment Phase|Withdrawal by Subject|1|||
33412749|NCT01269346|101400115|FG000|Treatment Phase|Other|2|||
33412750|NCT01269346|101400115|FG000|Extension Phase|Adverse Event|6|||
33553581|NCT00728182|101927714|FG001|Overall Study|Adverse Event|0|||
33553582|NCT00728182|101927713|FG000|Overall Study|Lost to Follow-up|2|||
33553583|NCT00728182|101927714|FG001|Overall Study|Lost to Follow-up|0|||
33619428|NCT02871635|102155015|FG000|Overall Study|Secondary lack of efficacy|2|||
33619429|NCT02871635|102155016|FG001|Overall Study|Secondary lack of efficacy|1|||
33619430|NCT05274958|102155023|FG000|Overall Study|Only completed 1 set of PROMs|22|||
33619431|NCT05274958|102155024|FG001|Overall Study|Only completed 1 set of PROMs|35|||
33619432|NCT01450761|102155025|FG000|Randomization|Subject no longer meets study criteria|1|||
33619433|NCT01450761|102155026|FG001|Randomization|Subject no longer meets study criteria|2|||
33619434|NCT01450761|102155025|FG000|Randomization|Withdrawal by Subject|2|||
33619435|NCT01450761|102155026|FG001|Randomization|Withdrawal by Subject|0|||
33619436|NCT01450761|102155025|FG000|Randomization|Disease progression|0|||
33619437|NCT01450761|102155026|FG001|Randomization|Disease progression|2|||
33619438|NCT01450761|102155025|FG000|Randomization|Adverse Event unrelated to study drug|1|||
33412751|NCT01269346|101400115|FG000|Extension Phase|Withdrawal by Subject|4|||
33553584|NCT00728182|101927713|FG000|Overall Study|Death|0|||
33412752|NCT01269346|101400115|FG000|Extension Phase|Disease progression|22|||
33553585|NCT00728182|101927714|FG001|Overall Study|Death|2|||
33553586|NCT00728182|101927713|FG000|Overall Study|Protocol Noncompliance|0|||
33553587|NCT00728182|101927714|FG001|Overall Study|Protocol Noncompliance|1|||
33619439|NCT01450761|102155026|FG001|Randomization|Adverse Event unrelated to study drug|0|||
33412753|NCT01269346|101400115|FG000|Extension Phase|Physician decision or participant choice|9|||
33553588|NCT03888482|101927717|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
33619440|NCT01450761|102155025|FG000|Randomization|Other|0|||
33412754|NCT01269346|101400115|FG000|Extension Phase|Clinical progression|1|||
33353469|NCT02034123|101180694|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353470|NCT02034123|101180695|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353471|NCT02034123|101180696|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353472|NCT02034123|101180697|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
33353473|NCT02034123|101180698|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353474|NCT02034123|101180699|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353475|NCT02034123|101180700|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33412755|NCT01269346|101400115|FG000|Extension Phase|Started a prohibited con med|1|||
33412756|NCT03628781|101400116|FG000|Overall Study|Lost to Follow-up|16|||
33412757|NCT03628781|101400117|FG001|Overall Study|Lost to Follow-up|8|||
33412758|NCT03628781|101400116|FG000|Overall Study|Withdrawal by Subject|16|||
33412759|NCT03628781|101400117|FG001|Overall Study|Withdrawal by Subject|1|||
33412760|NCT00536991|101400122|FG000|Overall Study|Withdrawal by Subject|10|||
33412761|NCT00536991|101400122|FG000|Overall Study|Physician Decision|1|||
33412762|NCT00536991|101400122|FG000|Overall Study|patient ineligible|2|||
33412763|NCT00437294|101400132|FG000|Overall Study|Adverse Event|5|||
33412764|NCT00437294|101400133|FG001|Overall Study|Adverse Event|4|||
33553589|NCT03888482|101927718|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
33412765|NCT00437294|101400132|FG000|Overall Study|Death|5|||
33412766|NCT00437294|101400133|FG001|Overall Study|Death|2|||
33412767|NCT00437294|101400132|FG000|Overall Study|Physician Decision|0|||
33553590|NCT03888482|101927717|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
33553591|NCT03888482|101927718|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
33553592|NCT00300495|101927719|FG000|Overall Study|Protocol Violation|4|||
33553593|NCT00300495|101927720|FG001|Overall Study|Protocol Violation|1|||
33553594|NCT01666652|101927721|FG000|Overall Study|Serious Adverse Event|0|||
33553595|NCT01666652|101927722|FG001|Overall Study|Serious Adverse Event|0|||
33553596|NCT01666652|101927723|FG002|Overall Study|Serious Adverse Event|0|||
33553597|NCT01666652|101927724|FG003|Overall Study|Serious Adverse Event|1|||
33553598|NCT01666652|101927725|FG004|Overall Study|Serious Adverse Event|0|||
33553599|NCT01666652|101927721|FG000|Overall Study|Withdrawal by Subject|0|||
33553600|NCT01666652|101927722|FG001|Overall Study|Withdrawal by Subject|0|||
33553601|NCT01666652|101927723|FG002|Overall Study|Withdrawal by Subject|0|||
33553602|NCT01666652|101927724|FG003|Overall Study|Withdrawal by Subject|0|||
33553603|NCT01666652|101927725|FG004|Overall Study|Withdrawal by Subject|1|||
33553604|NCT01666652|101927721|FG000|Overall Study|Moved from study area|1|||
33553605|NCT01666652|101927722|FG001|Overall Study|Moved from study area|0|||
33553606|NCT01666652|101927723|FG002|Overall Study|Moved from study area|0|||
33553607|NCT01666652|101927724|FG003|Overall Study|Moved from study area|2|||
33553608|NCT01666652|101927725|FG004|Overall Study|Moved from study area|0|||
33553609|NCT01666652|101927721|FG000|Overall Study|Lost to Follow-up|1|||
33553610|NCT01666652|101927722|FG001|Overall Study|Lost to Follow-up|1|||
33553611|NCT01666652|101927723|FG002|Overall Study|Lost to Follow-up|1|||
33553612|NCT01666652|101927724|FG003|Overall Study|Lost to Follow-up|1|||
33553613|NCT01666652|101927725|FG004|Overall Study|Lost to Follow-up|0|||
33553614|NCT03600428|101927726|FG000|Overall Study|Not eligible|0|||
33412768|NCT00437294|101400133|FG001|Overall Study|Physician Decision|3|||
33412769|NCT00437294|101400132|FG000|Overall Study|Withdrawal by Subject|5|||
33412770|NCT00437294|101400133|FG001|Overall Study|Withdrawal by Subject|0|||
33412771|NCT00437294|101400132|FG000|Overall Study|Progressive Disease|19|||
33412772|NCT00437294|101400133|FG001|Overall Study|Progressive Disease|23|||
33412773|NCT00437294|101400132|FG000|Overall Study|Sponsor Decision|8|||
33412774|NCT00437294|101400133|FG001|Overall Study|Sponsor Decision|9|||
33412775|NCT00437294|101400132|FG000|Overall Study|Protocol Violation|0|||
33412776|NCT00437294|101400133|FG001|Overall Study|Protocol Violation|1|||
33412777|NCT00437294|101400132|FG000|Overall Study|Entry criteria not met|1|||
33412778|NCT00437294|101400133|FG001|Overall Study|Entry criteria not met|1|||
33412779|NCT01418365|101400134|FG000|First Intervention|Withdrawal by Subject|0|||
33412780|NCT01418365|101400135|FG001|First Intervention|Withdrawal by Subject|1|||
33553615|NCT03600428|101927727|FG001|Overall Study|Not eligible|1|||
33553616|NCT03600428|101927726|FG000|Overall Study|Lost to Follow-up|5|||
33553617|NCT03600428|101927727|FG001|Overall Study|Lost to Follow-up|4|||
33412781|NCT01418365|101400134|FG000|First Intervention|Non-compliance|1|||
33553618|NCT01208051|101927728|FG000|Total Enrollment|Withdrawal by Subject|0|||
33553619|NCT01208051|101927729|FG001|Total Enrollment|Withdrawal by Subject|1|||
33553620|NCT01208051|101927730|FG002|Total Enrollment|Withdrawal by Subject|0|||
33553621|NCT01208051|101927731|FG003|Total Enrollment|Withdrawal by Subject|0|||
33412782|NCT01418365|101400135|FG001|First Intervention|Non-compliance|0|||
33412783|NCT01418365|101400134|FG000|Second Intervention|Withdrawal by Subject|0|||
33412784|NCT01418365|101400135|FG001|Second Intervention|Withdrawal by Subject|1|||
33412785|NCT02116309|101400137|FG000|Overall Study|Lost to Follow-up|0|||
33412786|NCT02116309|101400138|FG001|Overall Study|Lost to Follow-up|1|||
33412787|NCT00572910|101400140|FG000|Overall Study|Adverse Event|1|||
33412788|NCT00572910|101400141|FG001|Overall Study|Adverse Event|2|||
33412789|NCT00572910|101400142|FG002|Overall Study|Adverse Event|0|||
33412790|NCT00572910|101400143|FG003|Overall Study|Adverse Event|2|||
33412791|NCT00572910|101400144|FG004|Overall Study|Adverse Event|0|||
33412792|NCT00572910|101400145|FG005|Overall Study|Adverse Event|0|||
33412793|NCT00572910|101400146|FG006|Overall Study|Adverse Event|4|||
33412794|NCT00572910|101400147|FG007|Overall Study|Adverse Event|2|||
33412795|NCT00572910|101400148|FG008|Overall Study|Adverse Event|1|||
33412796|NCT00572910|101400149|FG009|Overall Study|Adverse Event|3|||
33412797|NCT00572910|101400150|FG010|Overall Study|Adverse Event|2|||
33553622|NCT01208051|101927732|FG004|Total Enrollment|Withdrawal by Subject|2|||
33553623|NCT01208051|101927728|FG000|Total Enrollment|Brain metastases|0|||
33553624|NCT01208051|101927729|FG001|Total Enrollment|Brain metastases|0|||
33553625|NCT01208051|101927730|FG002|Total Enrollment|Brain metastases|1|||
33553626|NCT01208051|101927731|FG003|Total Enrollment|Brain metastases|0|||
33553627|NCT01208051|101927732|FG004|Total Enrollment|Brain metastases|0|||
33412798|NCT00572910|101400140|FG000|Overall Study|Lost to Follow-up|0|||
33412799|NCT00572910|101400141|FG001|Overall Study|Lost to Follow-up|1|||
33412800|NCT00572910|101400142|FG002|Overall Study|Lost to Follow-up|1|||
33412801|NCT00572910|101400143|FG003|Overall Study|Lost to Follow-up|2|||
33412802|NCT00572910|101400144|FG004|Overall Study|Lost to Follow-up|1|||
33412803|NCT00572910|101400145|FG005|Overall Study|Lost to Follow-up|0|||
33412804|NCT00572910|101400146|FG006|Overall Study|Lost to Follow-up|0|||
33412805|NCT00572910|101400147|FG007|Overall Study|Lost to Follow-up|0|||
33412806|NCT00572910|101400148|FG008|Overall Study|Lost to Follow-up|0|||
33412807|NCT00572910|101400149|FG009|Overall Study|Lost to Follow-up|1|||
33412808|NCT00572910|101400150|FG010|Overall Study|Lost to Follow-up|0|||
33412809|NCT00572910|101400140|FG000|Overall Study|Withdrawal by Subject|3|||
33412810|NCT00572910|101400141|FG001|Overall Study|Withdrawal by Subject|0|||
33412811|NCT00572910|101400142|FG002|Overall Study|Withdrawal by Subject|1|||
33412812|NCT00572910|101400143|FG003|Overall Study|Withdrawal by Subject|0|||
33412813|NCT00572910|101400144|FG004|Overall Study|Withdrawal by Subject|1|||
33412814|NCT00572910|101400145|FG005|Overall Study|Withdrawal by Subject|3|||
33412815|NCT00572910|101400146|FG006|Overall Study|Withdrawal by Subject|0|||
33412816|NCT00572910|101400147|FG007|Overall Study|Withdrawal by Subject|2|||
33412817|NCT00572910|101400148|FG008|Overall Study|Withdrawal by Subject|2|||
33412818|NCT00572910|101400149|FG009|Overall Study|Withdrawal by Subject|2|||
33553628|NCT03436420|101927734|FG000|Overall Study|Lack of Efficacy|3|||
33553629|NCT00620035|101927740|FG000|Overall Study|Adverse Event|106|||
33553630|NCT00620035|101927740|FG000|Overall Study|Withdrawal of Informed Consent|1|||
33353476|NCT02034123|101180701|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353477|NCT02034123|101180702|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353478|NCT02034123|101180703|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353479|NCT02034123|101180704|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353480|NCT02034123|101180705|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353481|NCT02034123|101180706|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
33353482|NCT02034123|101180689|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353483|NCT02034123|101180690|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353484|NCT02034123|101180691|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33412819|NCT00572910|101400150|FG010|Overall Study|Withdrawal by Subject|1|||
33412820|NCT04478994|101400151|FG000|Overall Study|Withdrawal by Subject|1|||
33553631|NCT00620035|101927740|FG000|Overall Study|Other Reason|38|||
33553632|NCT00474968|101927741|FG000|Overall Study|Withdrawal by Subject|8|||
33553633|NCT00474968|101927742|FG001|Overall Study|Withdrawal by Subject|7|||
33553634|NCT00474968|101927741|FG000|Overall Study|Protocol Violation|9|||
33553635|NCT00474968|101927742|FG001|Overall Study|Protocol Violation|8|||
33553636|NCT00474968|101927741|FG000|Overall Study|Sample not collected|1|||
33553637|NCT00474968|101927742|FG001|Overall Study|Sample not collected|1|||
33553638|NCT02965976|101927743|FG000|Overall Study|Withdrawal by Subject|2|||
33412821|NCT04478994|101400152|FG001|Overall Study|Withdrawal by Subject|1|||
33412822|NCT01153971|101400155|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
33412823|NCT01153971|101400155|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
33412824|NCT01153971|101400155|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
33412825|NCT01153971|101400155|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
33412826|NCT01153971|101400155|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
33412827|NCT01153971|101400155|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
33553639|NCT02965976|101927744|FG001|Overall Study|Withdrawal by Subject|0|||
33553640|NCT01259024|101927753|FG000|Overall Study|Physician Decision|1|||
33553641|NCT02493855|101927754|FG000|Overall Study|Non-compliance|1|||
33553642|NCT02493855|101927755|FG001|Overall Study|Non-compliance|0|||
33553643|NCT02493855|101927756|FG002|Overall Study|Non-compliance|0|||
33553644|NCT02493855|101927754|FG000|Overall Study|Adverse Event|0|||
33553645|NCT02493855|101927755|FG001|Overall Study|Adverse Event|1|||
33553646|NCT02493855|101927756|FG002|Overall Study|Adverse Event|0|||
33553647|NCT02493855|101927754|FG000|Overall Study|Withdrawal by Subject|1|||
33553648|NCT02493855|101927755|FG001|Overall Study|Withdrawal by Subject|0|||
33553649|NCT02493855|101927756|FG002|Overall Study|Withdrawal by Subject|0|||
33553650|NCT00025233|101927757|FG000|Overall Study|Ineligible: wrong cell type|1|||
33553651|NCT00025233|101927757|FG000|Overall Study|Ineligible: wrong primary|1|||
33553652|NCT00025233|101927757|FG000|Overall Study|Ineligible: improper prior treatment|1|||
33553653|NCT00025233|101927757|FG000|Overall Study|Never treated|1|||
33553654|NCT00504231|101927760|FG000|Overall Study|Discrepant chart documentation re route|0|||
33553655|NCT00504231|101927761|FG001|Overall Study|Discrepant chart documentation re route|0|||
33553656|NCT00504231|101927762|FG002|Overall Study|Discrepant chart documentation re route|1|||
33553657|NCT00504231|101927763|FG003|Overall Study|Discrepant chart documentation re route|0|||
33553658|NCT01530256|101927768|FG000|Overall Study|Death|2|||
33553659|NCT00500110|101927769|FG000|Overall Study|Withdrawal by Subject|3|||
33553660|NCT01245049|101927770|FG000|Overall Study|Migrated/moved from study area|0|||
33553661|NCT01245049|101927771|FG001|Overall Study|Migrated/moved from study area|1|||
33553662|NCT01245049|101927770|FG000|Overall Study|Withdrawal by Subject|0|||
33553663|NCT01245049|101927771|FG001|Overall Study|Withdrawal by Subject|1|||
33553664|NCT01245049|101927770|FG000|Overall Study|Lost to Follow-up|1|||
33553665|NCT01245049|101927771|FG001|Overall Study|Lost to Follow-up|2|||
33553666|NCT03607695|101927774|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
33553667|NCT03607695|101927774|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
33553668|NCT00887588|101927775|FG000|Core Period|Death|1|||
33553669|NCT00887588|101927776|FG001|Core Period|Death|1|||
33553670|NCT00887588|101927775|FG000|Core Period|Lost to Follow-up|3|||
33553671|NCT00887588|101927776|FG001|Core Period|Lost to Follow-up|1|||
33553672|NCT00887588|101927775|FG000|Core Period|Withdrawal by Subject|6|||
33553673|NCT00887588|101927776|FG001|Core Period|Withdrawal by Subject|8|||
33553674|NCT00887588|101927775|FG000|Core Period|Adverse Event|9|||
33553675|NCT00887588|101927776|FG001|Core Period|Adverse Event|11|||
33553676|NCT00887588|101927775|FG000|Extension Period|Adverse Event|4|||
33553677|NCT00887588|101927776|FG001|Extension Period|Adverse Event|4|||
33553678|NCT00887588|101927775|FG000|Extension Period|Death|0|||
33553679|NCT00887588|101927776|FG001|Extension Period|Death|1|||
33553680|NCT00887588|101927775|FG000|Extension Period|Protocol deviation|1|||
33553681|NCT00887588|101927776|FG001|Extension Period|Protocol deviation|0|||
33553682|NCT00887588|101927775|FG000|Extension Period|Lost to Follow-up|1|||
33553683|NCT00887588|101927776|FG001|Extension Period|Lost to Follow-up|0|||
33553684|NCT04621760|101927777|FG000|Overall Study|Lost to Follow-up|2|||
33553685|NCT04621760|101927778|FG001|Overall Study|Lost to Follow-up|4|||
33553686|NCT04621760|101927777|FG000|Overall Study|Withdrawal by Subject|1|||
33553687|NCT04621760|101927778|FG001|Overall Study|Withdrawal by Subject|0|||
33553688|NCT01691482|101927779|FG000|Treatment Period 2|Adverse Event|0|||
33553689|NCT01691482|101927780|FG001|Treatment Period 2|Adverse Event|1|||
33553690|NCT01691482|101927779|FG000|Treatment Period 2|Protocol Violation|1|||
33553691|NCT01691482|101927780|FG001|Treatment Period 2|Protocol Violation|1|||
33553692|NCT01390584|101927781|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
33553693|NCT01390584|101927782|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
33553694|NCT01390584|101927783|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
33553695|NCT01902303|101927784|FG000|Overall Study|Adverse Event|0|||
33553696|NCT01902303|101927785|FG001|Overall Study|Adverse Event|1|||
33553697|NCT01902303|101927784|FG000|Overall Study|Lost to Follow-up|0|||
33553698|NCT01902303|101927785|FG001|Overall Study|Lost to Follow-up|1|||
33553699|NCT01902303|101927784|FG000|Overall Study|Protocol Violation|2|||
33553700|NCT01902303|101927785|FG001|Overall Study|Protocol Violation|2|||
33553701|NCT01902303|101927784|FG000|Overall Study|subject lost investigational product|0|||
33553702|NCT01902303|101927785|FG001|Overall Study|subject lost investigational product|1|||
33553703|NCT01902303|101927784|FG000|Overall Study|Did not develop a cold sore|21|||
33553704|NCT01902303|101927785|FG001|Overall Study|Did not develop a cold sore|19|||
33553705|NCT00992394|101927788|FG000|Overall Study|Lack of Efficacy|6|||
33553706|NCT00992394|101927789|FG001|Overall Study|Lack of Efficacy|3|||
33553707|NCT00992394|101927788|FG000|Overall Study|Adverse Event|4|||
33553708|NCT00992394|101927789|FG001|Overall Study|Adverse Event|5|||
33553709|NCT00992394|101927788|FG000|Overall Study|Withdrawal by Subject|8|||
33553710|NCT00992394|101927789|FG001|Overall Study|Withdrawal by Subject|2|||
33553711|NCT00992394|101927788|FG000|Overall Study|Physician Decision|1|||
33553712|NCT00992394|101927789|FG001|Overall Study|Physician Decision|0|||
33619441|NCT01450761|102155026|FG001|Randomization|Other|1|||
33619442|NCT01450761|102155025|FG000|Lead-in Chemotherapy|Disease progression|33|||
33619443|NCT01450761|102155026|FG001|Lead-in Chemotherapy|Disease progression|32|||
33619444|NCT01450761|102155025|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
33619445|NCT01450761|102155026|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
33412828|NCT01153971|101400155|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
33412829|NCT03053102|101400156|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
33412830|NCT03053102|101400156|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
33412831|NCT00467051|101400157|FG000|Overall Study|Adverse Event|2|||
33412832|NCT00585468|101400158|FG000|First Intervention|Withdrawal by Subject|1|||
33412833|NCT00585468|101400159|FG001|First Intervention|Withdrawal by Subject|1|||
33412834|NCT02158949|101400160|FG000|Overall Study|Withdrawal by Subject|1|||
33412835|NCT02158949|101400161|FG001|Overall Study|Withdrawal by Subject|0|||
33412836|NCT02158949|101400160|FG000|Overall Study|Lost to Follow-up|5|||
33412837|NCT02158949|101400161|FG001|Overall Study|Lost to Follow-up|11|||
33412838|NCT03323034|101400164|FG000|Overall Study|Lack of Efficacy|5|||
33412839|NCT03323034|101400165|FG001|Overall Study|Lack of Efficacy|5|||
33412840|NCT03323034|101400166|FG002|Overall Study|Lack of Efficacy|6|||
33412841|NCT03323034|101400167|FG003|Overall Study|Lack of Efficacy|5|||
33412842|NCT03323034|101400168|FG004|Overall Study|Lack of Efficacy|5|||
33412843|NCT03323034|101400164|FG000|Overall Study|Physician Decision|0|||
33412844|NCT03323034|101400165|FG001|Overall Study|Physician Decision|0|||
33412845|NCT03323034|101400166|FG002|Overall Study|Physician Decision|0|||
33412846|NCT03323034|101400167|FG003|Overall Study|Physician Decision|0|||
33412847|NCT03323034|101400168|FG004|Overall Study|Physician Decision|1|||
33412848|NCT03323034|101400164|FG000|Overall Study|Withdrawal by Subject|1|||
33412849|NCT03323034|101400165|FG001|Overall Study|Withdrawal by Subject|1|||
33412850|NCT03323034|101400166|FG002|Overall Study|Withdrawal by Subject|0|||
33412851|NCT03323034|101400167|FG003|Overall Study|Withdrawal by Subject|1|||
33412852|NCT03323034|101400168|FG004|Overall Study|Withdrawal by Subject|0|||
33412853|NCT00762073|101403470|FG000|Overall Study|Lack of Efficacy|1|||
33412854|NCT00762073|101403471|FG001|Overall Study|Lack of Efficacy|1|||
33412855|NCT00762073|101403472|FG002|Overall Study|Lack of Efficacy|0|||
33412856|NCT00762073|101403473|FG003|Overall Study|Lack of Efficacy|0|||
33412857|NCT00762073|101403470|FG000|Overall Study|Adverse Event|1|||
33412858|NCT00762073|101403471|FG001|Overall Study|Adverse Event|0|||
33412859|NCT00762073|101403472|FG002|Overall Study|Adverse Event|1|||
33412860|NCT00762073|101403473|FG003|Overall Study|Adverse Event|1|||
33412861|NCT00762073|101403470|FG000|Overall Study|Significant Subject Noncompliance|0|||
33412862|NCT00762073|101403471|FG001|Overall Study|Significant Subject Noncompliance|1|||
33412863|NCT00762073|101403472|FG002|Overall Study|Significant Subject Noncompliance|0|||
33412864|NCT00762073|101403473|FG003|Overall Study|Significant Subject Noncompliance|1|||
33412865|NCT00762073|101403470|FG000|Overall Study|Withdrawal by Subject|1|||
33412866|NCT00762073|101403471|FG001|Overall Study|Withdrawal by Subject|2|||
33412867|NCT00762073|101403472|FG002|Overall Study|Withdrawal by Subject|1|||
33412868|NCT00762073|101403473|FG003|Overall Study|Withdrawal by Subject|1|||
33412869|NCT00762073|101403470|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
33412870|NCT00762073|101403471|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
33412871|NCT00762073|101403472|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
33412872|NCT00762073|101403473|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
33412873|NCT01495793|101403474|FG000|Overall Study|Lost to Follow-up|1|||
33412874|NCT01495793|101403474|FG000|Overall Study|Violation of inclusion criteria|1|||
33412875|NCT03901339|101403476|FG000|Overall Study|Death|220|||
33412876|NCT03901339|101403477|FG001|Overall Study|Death|192|||
33412877|NCT03901339|101403476|FG000|Overall Study|Informed consent withdrawn|13|||
33412878|NCT03901339|101403477|FG001|Overall Study|Informed consent withdrawn|40|||
33412879|NCT03901339|101403476|FG000|Overall Study|Sponsor request|30|||
33412880|NCT03901339|101403477|FG001|Overall Study|Sponsor request|23|||
33412881|NCT03901339|101403476|FG000|Overall Study|Reason not specified|5|||
33412882|NCT03901339|101403477|FG001|Overall Study|Reason not specified|7|||
33412883|NCT03901339|101403476|FG000|Overall Study|Lost to Follow-up|4|||
33412884|NCT03901339|101403477|FG001|Overall Study|Lost to Follow-up|7|||
33412885|NCT03901339|101403476|FG000|Overall Study|Covid19|0|||
33412886|NCT03901339|101403477|FG001|Overall Study|Covid19|2|||
33412887|NCT03839693|101403478|FG000|Overall Study|Lost to Follow-up|0|||
33412888|NCT03839693|101403479|FG001|Overall Study|Lost to Follow-up|2|||
33412889|NCT03839693|101403480|FG002|Overall Study|Lost to Follow-up|2|||
33412890|NCT03839693|101403478|FG000|Overall Study|Withdrawal by Subject|1|||
33412891|NCT03839693|101403479|FG001|Overall Study|Withdrawal by Subject|0|||
33619446|NCT01450761|102155025|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
33412892|NCT03839693|101403480|FG002|Overall Study|Withdrawal by Subject|2|||
33619447|NCT01450761|102155026|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
33412893|NCT03839693|101403478|FG000|Overall Study|subject moved out of the area|1|||
33412894|NCT03839693|101403479|FG001|Overall Study|subject moved out of the area|0|||
33412895|NCT03839693|101403480|FG002|Overall Study|subject moved out of the area|0|||
33412896|NCT01748162|101403481|FG000|Overall Study|no additional croup episodes to evaluate|2|||
33412897|NCT01748162|101403482|FG001|Overall Study|no additional croup episodes to evaluate|2|||
33412898|NCT01748162|101403481|FG000|Overall Study|participant consented but did not begin|0|||
33412899|NCT01748162|101403482|FG001|Overall Study|participant consented but did not begin|1|||
33412900|NCT01748162|101403481|FG000|Overall Study|reasons not available|3|||
33412901|NCT01748162|101403482|FG001|Overall Study|reasons not available|2|||
33412902|NCT00824993|101403485|FG000|Overall Study|Withdrawal by Subject|1|||
33412903|NCT00824993|101403486|FG001|Overall Study|Withdrawal by Subject|1|||
33412904|NCT00824993|101403485|FG000|Overall Study|Malignancy Relapse|9|||
33412905|NCT00824993|101403486|FG001|Overall Study|Malignancy Relapse|10|||
33412906|NCT00824993|101403485|FG000|Overall Study|Rapid Bone Loss|0|||
33619448|NCT01450761|102155025|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
33631303|NCT03486912|102202917|FG003|Treatment Period|Other Reasons|1|||
33353485|NCT02034123|101180692|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
33353486|NCT02034123|101180693|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
33353487|NCT02034123|101180694|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353488|NCT02034123|101180695|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353489|NCT02034123|101180696|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353490|NCT02034123|101180697|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353491|NCT02034123|101180698|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353492|NCT02034123|101180699|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353493|NCT02034123|101180700|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353494|NCT02034123|101180701|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353495|NCT02034123|101180702|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353496|NCT02034123|101180703|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353497|NCT02034123|101180704|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353498|NCT02034123|101180705|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353499|NCT02034123|101180706|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
33353500|NCT00927485|101180707|FG000|Overall Study|Adverse Event|4|||
33353501|NCT00927485|101180708|FG001|Overall Study|Adverse Event|2|||
33353502|NCT00927485|101180707|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
33353503|NCT00927485|101180708|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
33353504|NCT00870688|101180709|FG000|Overall Study|Lost to Follow-up|2|||
33353505|NCT00870688|101180709|FG000|Overall Study|Death, Unrelated|1|||
33353506|NCT00870688|101180709|FG000|Overall Study|Granules in the Stools|1|||
33353507|NCT01276288|101180710|FG000|Overall Study|Adverse Event|1|||
33353508|NCT01276288|101180711|FG001|Overall Study|Adverse Event|1|||
33353509|NCT01276288|101180712|FG002|Overall Study|Adverse Event|0|||
33353510|NCT01276288|101180713|FG003|Overall Study|Adverse Event|0|||
33353511|NCT01276288|101180710|FG000|Overall Study|not treated|1|||
33353512|NCT01276288|101180711|FG001|Overall Study|not treated|0|||
33353513|NCT01276288|101180712|FG002|Overall Study|not treated|0|||
33353514|NCT01276288|101180713|FG003|Overall Study|not treated|0|||
33353515|NCT01717638|101180715|FG000|Overall Study|Lost to Follow-up|0|||
33353516|NCT01717638|101180716|FG001|Overall Study|Lost to Follow-up|0|||
33353517|NCT01717638|101180717|FG002|Overall Study|Lost to Follow-up|0|||
33353518|NCT01717638|101180718|FG003|Overall Study|Lost to Follow-up|0|||
33353519|NCT01717638|101180719|FG004|Overall Study|Lost to Follow-up|0|||
33353520|NCT01717638|101180720|FG005|Overall Study|Lost to Follow-up|1|||
33353521|NCT01717638|101180721|FG006|Overall Study|Lost to Follow-up|0|||
33353522|NCT01717638|101180722|FG007|Overall Study|Lost to Follow-up|0|||
33353523|NCT01717638|101180723|FG008|Overall Study|Lost to Follow-up|0|||
33353524|NCT01717638|101180724|FG009|Overall Study|Lost to Follow-up|0|||
33353525|NCT01717638|101180725|FG010|Overall Study|Lost to Follow-up|0|||
33353526|NCT01717638|101180726|FG011|Overall Study|Lost to Follow-up|0|||
33353527|NCT01717638|101180727|FG012|Overall Study|Lost to Follow-up|0|||
33353528|NCT01717638|101180715|FG000|Overall Study|Father in hospital|0|||
33353529|NCT01717638|101180716|FG001|Overall Study|Father in hospital|0|||
33353530|NCT01717638|101180717|FG002|Overall Study|Father in hospital|0|||
33353531|NCT01717638|101180718|FG003|Overall Study|Father in hospital|0|||
33353532|NCT01717638|101180719|FG004|Overall Study|Father in hospital|0|||
33353533|NCT01717638|101180720|FG005|Overall Study|Father in hospital|0|||
33353534|NCT01717638|101180721|FG006|Overall Study|Father in hospital|0|||
33353535|NCT01717638|101180722|FG007|Overall Study|Father in hospital|0|||
33353536|NCT01717638|101180723|FG008|Overall Study|Father in hospital|0|||
33353537|NCT01717638|101180724|FG009|Overall Study|Father in hospital|0|||
33412907|NCT00824993|101403486|FG001|Overall Study|Rapid Bone Loss|1|||
33412908|NCT00824993|101403485|FG000|Overall Study|Non-Compliant|2|||
33353538|NCT01717638|101180725|FG010|Overall Study|Father in hospital|0|||
33353539|NCT01717638|101180726|FG011|Overall Study|Father in hospital|0|||
33353540|NCT01717638|101180727|FG012|Overall Study|Father in hospital|1|||
33353541|NCT01717638|101180715|FG000|Overall Study|Withdrawal by Subject|0|||
33353542|NCT01717638|101180716|FG001|Overall Study|Withdrawal by Subject|1|||
33353543|NCT01717638|101180717|FG002|Overall Study|Withdrawal by Subject|1|||
33353544|NCT01717638|101180718|FG003|Overall Study|Withdrawal by Subject|0|||
33353545|NCT01717638|101180719|FG004|Overall Study|Withdrawal by Subject|1|||
33619449|NCT01450761|102155026|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
33619450|NCT01450761|102155025|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
33619451|NCT01450761|102155026|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
33619452|NCT01450761|102155025|FG000|Lead-in Chemotherapy|Death|3|||
33619453|NCT01450761|102155026|FG001|Lead-in Chemotherapy|Death|3|||
33619454|NCT01450761|102155025|FG000|Lead-in Chemotherapy|Other|2|||
33619455|NCT01450761|102155026|FG001|Lead-in Chemotherapy|Other|2|||
33619456|NCT01450761|102155025|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
33619457|NCT01450761|102155026|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
33619458|NCT01450761|102155025|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
33619459|NCT01450761|102155026|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
33619460|NCT01450761|102155025|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
33619461|NCT01450761|102155026|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
33619462|NCT01450761|102155025|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
33619463|NCT01450761|102155026|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
33619464|NCT01450761|102155025|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
33619465|NCT01450761|102155026|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
33619466|NCT01450761|102155025|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
33619467|NCT01450761|102155026|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
33619468|NCT01450761|102155025|FG000|Treatment With Blinded Study Therapy|Death|5|||
33619469|NCT01450761|102155026|FG001|Treatment With Blinded Study Therapy|Death|6|||
33619470|NCT01450761|102155025|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
33619471|NCT01450761|102155026|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
33619472|NCT01450761|102155025|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
33619473|NCT01450761|102155026|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
33619474|NCT01450761|102155025|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
33619475|NCT01450761|102155026|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
33619476|NCT01450761|102155025|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
33619477|NCT01450761|102155026|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
33619478|NCT01450761|102155025|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
33619479|NCT01450761|102155026|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
33619480|NCT01450761|102155025|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
33619481|NCT01450761|102155026|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
33619482|NCT01450761|102155025|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
33619483|NCT01450761|102155026|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
33619484|NCT02277444|102155027|FG000|Overall Study|Adverse Event|10|||
33619485|NCT02277444|102155027|FG000|Overall Study|Withdrawal by Subject|3|||
33619486|NCT02277444|102155027|FG000|Overall Study|Other|1|||
33619487|NCT02277444|102155027|FG000|Overall Study|Enrolled and not Treated|3|||
33619488|NCT02277444|102155027|FG000|Overall Study|Ongoing|113|||
33619489|NCT01726582|102155028|FG000|Overall Study|Physician Decision|99|||
33353546|NCT01717638|101180720|FG005|Overall Study|Withdrawal by Subject|0|||
33353547|NCT01717638|101180721|FG006|Overall Study|Withdrawal by Subject|2|||
33353548|NCT01717638|101180722|FG007|Overall Study|Withdrawal by Subject|1|||
33353549|NCT01717638|101180723|FG008|Overall Study|Withdrawal by Subject|2|||
33353550|NCT01717638|101180724|FG009|Overall Study|Withdrawal by Subject|1|||
33353551|NCT01717638|101180725|FG010|Overall Study|Withdrawal by Subject|0|||
33353552|NCT01717638|101180726|FG011|Overall Study|Withdrawal by Subject|0|||
33353553|NCT01717638|101180727|FG012|Overall Study|Withdrawal by Subject|18|||
33353554|NCT02722044|101180728|FG000|Overall Study|Adverse Event|2|||
33353555|NCT02722044|101180728|FG000|Overall Study|Physician Decision|1|||
33353556|NCT02722044|101180728|FG000|Overall Study|Withdrawal by Subject|1|||
33353557|NCT02722044|101180728|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
33353558|NCT00195650|101180729|FG000|Overall Study|Adverse Event|194|||
33353559|NCT00195650|101180729|FG000|Overall Study|Lack of Efficacy|99|||
33353560|NCT00195650|101180729|FG000|Overall Study|Withdrawal by Subject|67|||
33619490|NCT01726582|102155028|FG000|Overall Study|Death|85|||
33619491|NCT01818596|102155029|FG000|Overall Study|Enrolled but Not Treated|4|||
33619492|NCT01818596|102155030|FG001|Overall Study|Enrolled but Not Treated|0|||
33353561|NCT00195650|101180729|FG000|Overall Study|Lost to Follow-up|44|||
33353562|NCT00195650|101180729|FG000|Overall Study|Death|23|||
33353563|NCT00195650|101180729|FG000|Overall Study|Protocol Violation|15|||
33353564|NCT00195650|101180729|FG000|Overall Study|Administrative reasons|83|||
33353565|NCT00486902|101180730|FG000|Overall Study|Withdrawal by Subject|1|||
33353566|NCT00486902|101180731|FG001|Overall Study|Withdrawal by Subject|2|||
33353567|NCT00486902|101180730|FG000|Overall Study|decision for postpartum tubal ligation|3|||
33353568|NCT00486902|101180731|FG001|Overall Study|decision for postpartum tubal ligation|1|||
33353569|NCT00486902|101180730|FG000|Overall Study|spinal anesthetic protocal violation|1|||
33353570|NCT00486902|101180731|FG001|Overall Study|spinal anesthetic protocal violation|1|||
33353571|NCT00486902|101180730|FG000|Overall Study|Did not meet inclusion criteria|1|||
33353572|NCT00486902|101180731|FG001|Overall Study|Did not meet inclusion criteria|0|||
33353573|NCT00486902|101180730|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
33353574|NCT00486902|101180731|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
33353575|NCT00591734|101180734|FG000|Overall Study|Lack of Efficacy|35|||
33353576|NCT00591734|101180734|FG000|Overall Study|Adverse Event|5|||
33353577|NCT00591734|101180734|FG000|Overall Study|Physician Decision|5|||
33353578|NCT00591734|101180734|FG000|Overall Study|Intercurrent Illness|8|||
33353579|NCT01914679|101180735|FG000|Overall Study|Lack of Efficacy|1|||
33412909|NCT00824993|101403486|FG001|Overall Study|Non-Compliant|1|||
33412910|NCT00824993|101403485|FG000|Overall Study|Insurance Issue|2|||
33412911|NCT00824993|101403486|FG001|Overall Study|Insurance Issue|1|||
33412912|NCT00824993|101403485|FG000|Overall Study|Death|0|||
33412913|NCT00824993|101403486|FG001|Overall Study|Death|3|||
33412914|NCT02230332|101403494|FG000|Overall Study|Adverse Event|2|||
33412915|NCT02230332|101403495|FG001|Overall Study|Adverse Event|1|||
33412916|NCT02230332|101403494|FG000|Overall Study|Lost to Follow-up|1|||
33412917|NCT02230332|101403495|FG001|Overall Study|Lost to Follow-up|0|||
33412918|NCT02230332|101403494|FG000|Overall Study|Protocol Violation|1|||
33412919|NCT02230332|101403495|FG001|Overall Study|Protocol Violation|0|||
33412920|NCT01015118|101403496|FG000|Overall Study|Protocol Violation|5|||
33412921|NCT01015118|101403497|FG001|Overall Study|Protocol Violation|6|||
33412922|NCT01015118|101403496|FG000|Overall Study|Withdrawal by Subject|103|||
33412923|NCT01015118|101403497|FG001|Overall Study|Withdrawal by Subject|27|||
33412924|NCT01015118|101403496|FG000|Overall Study|Other Adverse Event (AE)|141|||
33412925|NCT01015118|101403497|FG001|Overall Study|Other Adverse Event (AE)|33|||
33412926|NCT01015118|101403496|FG000|Overall Study|Worsening or AE of underlying disease|5|||
33412927|NCT01015118|101403497|FG001|Overall Study|Worsening or AE of underlying disease|4|||
33412928|NCT01015118|101403496|FG000|Overall Study|Progressive disease|364|||
33412929|NCT01015118|101403497|FG001|Overall Study|Progressive disease|229|||
33412930|NCT01015118|101403496|FG000|Overall Study|Not treated|9|||
33412931|NCT01015118|101403497|FG001|Overall Study|Not treated|5|||
33412932|NCT01015118|101403496|FG000|Overall Study|Other than stated above|42|||
33412933|NCT01015118|101403497|FG001|Overall Study|Other than stated above|23|||
33412934|NCT00061568|101403500|FG000|Overall Study|Lost to Follow-up|12|||
33412935|NCT00061568|101403501|FG001|Overall Study|Lost to Follow-up|0|||
33412936|NCT00061568|101403500|FG000|Overall Study|Death|6|||
33412937|NCT00061568|101403501|FG001|Overall Study|Death|0|||
33412938|NCT00061568|101403500|FG000|Overall Study|Withdrawal by Subject|1|||
33217918|NCT03508843|100695889|FG000|Overall Study|Withdrawal by Subject|1|||
33217919|NCT03508843|100695889|FG000|Overall Study|technical difficulties|2|||
33412939|NCT00061568|101403501|FG001|Overall Study|Withdrawal by Subject|0|||
33412940|NCT00090259|101403502|FG000|Overall Study|Lost to Follow-up|30|||
33217920|NCT02586025|100695890|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
33412941|NCT00090259|101403503|FG001|Overall Study|Lost to Follow-up|26|||
33412942|NCT00090259|101403502|FG000|Overall Study|Withdrawal by Subject|21|||
33412943|NCT00090259|101403503|FG001|Overall Study|Withdrawal by Subject|15|||
33412944|NCT00090259|101403502|FG000|Overall Study|Investigator site closed|11|||
33412945|NCT00090259|101403503|FG001|Overall Study|Investigator site closed|7|||
33412946|NCT00054639|101403511|FG000|Overall Study|Lack of Efficacy|1|||
33412947|NCT00054639|101403511|FG000|Overall Study|Physician Decision|1|||
33412948|NCT03522506|101403514|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33412949|NCT03522506|101403515|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33353580|NCT01914679|101180735|FG000|Overall Study|Sponsor terminated study|4|||
33353581|NCT03812510|101180736|FG000|Overall Study|Lost to Follow-up|39|||
33353582|NCT03812510|101180736|FG000|Overall Study|Withdrawal by Subject|42|||
33553713|NCT00992394|101927788|FG000|Overall Study|Protocol Violation|2|||
33553714|NCT00992394|101927789|FG001|Overall Study|Protocol Violation|4|||
33553715|NCT00992394|101927788|FG000|Overall Study|Lost to Follow-up|2|||
33553716|NCT00992394|101927789|FG001|Overall Study|Lost to Follow-up|0|||
33553717|NCT00992394|101927788|FG000|Overall Study|Other event|1|||
33553718|NCT00992394|101927789|FG001|Overall Study|Other event|0|||
33553719|NCT00472641|101927790|FG000|Overall Study|Lack of Efficacy|3|||
33553720|NCT00472641|101927790|FG000|Overall Study|Adverse Event|3|||
33217921|NCT02586025|100695891|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
33553721|NCT00472641|101927790|FG000|Overall Study|Lost to Follow-up|1|||
33553722|NCT01778985|101927791|FG000|Overall Study|Lost to Follow-up|1|||
33553723|NCT01778985|101927792|FG001|Overall Study|Lost to Follow-up|0|||
33553724|NCT01778985|101927791|FG000|Overall Study|Physician Decision|2|||
33553725|NCT01778985|101927792|FG001|Overall Study|Physician Decision|2|||
33553726|NCT01778985|101927791|FG000|Overall Study|Protocol Violation|4|||
33553727|NCT01778985|101927792|FG001|Overall Study|Protocol Violation|1|||
33217922|NCT02586025|100695890|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
33553728|NCT02205359|101927795|FG000|Overall Study|Death|293|||
33553729|NCT02205359|101927796|FG001|Overall Study|Death|327|||
33553730|NCT02205359|101927795|FG000|Overall Study|Lost to Follow-up|182|||
33553731|NCT02205359|101927796|FG001|Overall Study|Lost to Follow-up|162|||
33553732|NCT02205359|101927795|FG000|Overall Study|Physician Decision|51|||
33553733|NCT02205359|101927796|FG001|Overall Study|Physician Decision|53|||
33553734|NCT02205359|101927795|FG000|Overall Study|Withdrawal by Subject|167|||
33553735|NCT02205359|101927796|FG001|Overall Study|Withdrawal by Subject|169|||
33553736|NCT01089543|101927797|FG000|Overall Study|Withdrawal by Subject|2|||
33619493|NCT01818596|102155029|FG000|Overall Study|Adverse Event|7|||
33553737|NCT01089543|101927798|FG001|Overall Study|Withdrawal by Subject|3|||
33553738|NCT01089543|101927799|FG002|Overall Study|Withdrawal by Subject|3|||
33553739|NCT01089543|101927800|FG003|Overall Study|Withdrawal by Subject|1|||
33553740|NCT01089543|101927797|FG000|Overall Study|Physician Decision|1|||
33553741|NCT01089543|101927798|FG001|Overall Study|Physician Decision|0|||
33553742|NCT01089543|101927799|FG002|Overall Study|Physician Decision|0|||
33217923|NCT02586025|100695891|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
33217924|NCT02586025|100695890|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
33553743|NCT01089543|101927800|FG003|Overall Study|Physician Decision|1|||
33553744|NCT01089543|101927797|FG000|Overall Study|Adverse Event|0|||
33217925|NCT02586025|100695891|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
33353583|NCT03812510|101180736|FG000|Overall Study|Physician Decision|2|||
33353584|NCT03812510|101180736|FG000|Overall Study|Study Terminated by Sponsor|9|||
33353585|NCT03812510|101180736|FG000|Overall Study|Did Not Start Study Medication|55|||
33353586|NCT03812510|101180736|FG000|Overall Study|Adverse Event|5|||
33217926|NCT02586025|100695890|FG000|Neoadjuvant Treatment|Death|1|||
33553745|NCT01089543|101927798|FG001|Overall Study|Adverse Event|1|||
33619494|NCT01818596|102155030|FG001|Overall Study|Adverse Event|0|||
33412950|NCT03522506|101403516|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33412951|NCT03522506|101403517|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
33412952|NCT03522506|101403514|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
33412953|NCT03522506|101403515|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
33412954|NCT03522506|101403516|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
33619495|NCT01818596|102155029|FG000|Overall Study|Death|3|||
33619496|NCT01818596|102155030|FG001|Overall Study|Death|0|||
33619497|NCT01818596|102155029|FG000|Overall Study|Investigator's Discretion|4|||
33619498|NCT01818596|102155030|FG001|Overall Study|Investigator's Discretion|0|||
33619499|NCT01818596|102155029|FG000|Overall Study|Protocol Violation|1|||
33619500|NCT01818596|102155030|FG001|Overall Study|Protocol Violation|0|||
33619501|NCT01818596|102155029|FG000|Overall Study|Withdrew Consent|5|||
33619502|NCT01818596|102155030|FG001|Overall Study|Withdrew Consent|0|||
33619503|NCT01818596|102155029|FG000|Overall Study|Lost to Follow-up|7|||
33619504|NCT01818596|102155030|FG001|Overall Study|Lost to Follow-up|0|||
33619505|NCT03343626|102155034|FG000|Overall Study|Lost to Follow-up|4|||
33619506|NCT03343626|102155035|FG001|Overall Study|Lost to Follow-up|3|||
33619507|NCT03343626|102155036|FG002|Overall Study|Lost to Follow-up|2|||
33619508|NCT03343626|102155037|FG003|Overall Study|Lost to Follow-up|5|||
33619509|NCT03343626|102155038|FG004|Overall Study|Lost to Follow-up|4|||
33412955|NCT03522506|101403517|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
33412956|NCT02074982|101403518|FG000|Overall Study|Adverse Event|15|||
33412957|NCT02074982|101403519|FG001|Overall Study|Adverse Event|7|||
33412958|NCT02074982|101403518|FG000|Overall Study|Lack of Efficacy|6|||
33412959|NCT02074982|101403519|FG001|Overall Study|Lack of Efficacy|1|||
33412960|NCT02074982|101403518|FG000|Overall Study|Lost to Follow-up|9|||
33412961|NCT02074982|101403519|FG001|Overall Study|Lost to Follow-up|10|||
33412962|NCT02074982|101403518|FG000|Overall Study|Non-compliance with study treatment|0|||
33353587|NCT01859403|101180741|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
33353588|NCT01859403|101180742|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
33353589|NCT01859403|101180741|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
33353590|NCT01859403|101180742|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
33353591|NCT01859403|101180741|FG000|Primary Endpoint Measure|Physician Decision|0|||
33353592|NCT01859403|101180742|FG001|Primary Endpoint Measure|Physician Decision|1|||
33353593|NCT01859403|101180741|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
33353594|NCT01859403|101180742|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
33353595|NCT04725682|101180745|FG000|Overall Study|Withdrawal by Subject|7|||
33353596|NCT04725682|101180746|FG001|Overall Study|Withdrawal by Subject|5|||
33353597|NCT04725682|101180745|FG000|Overall Study|Failed to comply with the requirements|2|||
33353598|NCT04725682|101180746|FG001|Overall Study|Failed to comply with the requirements|1|||
33353599|NCT04725682|101180745|FG000|Overall Study|Adverse Event|1|||
33353600|NCT04725682|101180746|FG001|Overall Study|Adverse Event|1|||
33353601|NCT04725682|101180745|FG000|Overall Study|Death|0|||
33353602|NCT04725682|101180746|FG001|Overall Study|Death|1|||
33353603|NCT02292849|101180747|FG000|Overall Study|Lost to Follow-up|0|||
33353604|NCT02292849|101180748|FG001|Overall Study|Lost to Follow-up|2|||
33412963|NCT02074982|101403519|FG001|Overall Study|Non-compliance with study treatment|2|||
33412964|NCT02074982|101403518|FG000|Overall Study|Physician Decision|1|||
33412965|NCT02074982|101403519|FG001|Overall Study|Physician Decision|1|||
33412966|NCT02074982|101403518|FG000|Overall Study|Pregnancy|1|||
33619510|NCT03343626|102155039|FG005|Overall Study|Lost to Follow-up|4|||
33353605|NCT02292849|101180749|FG002|Overall Study|Lost to Follow-up|2|||
33412967|NCT02074982|101403519|FG001|Overall Study|Pregnancy|2|||
33412968|NCT02074982|101403518|FG000|Overall Study|Protocol deviation|4|||
33619511|NCT03343626|102155040|FG006|Overall Study|Lost to Follow-up|4|||
33412969|NCT02074982|101403519|FG001|Overall Study|Protocol deviation|3|||
33412970|NCT02074982|101403518|FG000|Overall Study|Technical problems|0|||
33619512|NCT03343626|102155041|FG007|Overall Study|Lost to Follow-up|7|||
33619513|NCT03343626|102155034|FG000|Overall Study|Withdrawal of Consent|2|||
33619514|NCT03343626|102155035|FG001|Overall Study|Withdrawal of Consent|1|||
33353606|NCT02292849|101180747|FG000|Overall Study|Physician Decision|4|||
33353607|NCT02292849|101180748|FG001|Overall Study|Physician Decision|0|||
33353608|NCT02292849|101180749|FG002|Overall Study|Physician Decision|0|||
33353609|NCT02909153|101180750|FG000|Overall Study|Withdrawal by Subject|0|||
33353610|NCT02909153|101180751|FG001|Overall Study|Withdrawal by Subject|1|||
33353611|NCT02909153|101180752|FG002|Overall Study|Withdrawal by Subject|0|||
33353612|NCT02909153|101180753|FG003|Overall Study|Withdrawal by Subject|0|||
33353613|NCT02909153|101180754|FG004|Overall Study|Withdrawal by Subject|0|||
33353614|NCT01264939|101180758|FG000|Overall Study|Adverse Event|1|||
33353615|NCT01264939|101180759|FG001|Overall Study|Adverse Event|3|||
33353616|NCT01264939|101180758|FG000|Overall Study|Lost to Follow-up|0|||
33353617|NCT01264939|101180759|FG001|Overall Study|Lost to Follow-up|3|||
33353618|NCT01264939|101180758|FG000|Overall Study|Physician Decision|1|||
33353619|NCT01264939|101180759|FG001|Overall Study|Physician Decision|1|||
33353620|NCT01264939|101180758|FG000|Overall Study|Patient/Guardian Decision|8|||
33353621|NCT01264939|101180759|FG001|Overall Study|Patient/Guardian Decision|10|||
33353622|NCT01264939|101180758|FG000|Overall Study|Disease Progression|8|||
33353623|NCT01264939|101180759|FG001|Overall Study|Disease Progression|11|||
33353624|NCT01151137|101180760|FG000|Overall Study|Death|15|||
33353625|NCT01151137|101180761|FG001|Overall Study|Death|27|||
33353626|NCT01151137|101180760|FG000|Overall Study|Lost to Follow-up|1|||
33353627|NCT01151137|101180761|FG001|Overall Study|Lost to Follow-up|1|||
33353628|NCT01147809|101180762|FG000|Phase I (168 Days)|Adverse Event|0|||
33353629|NCT01147809|101180763|FG001|Phase I (168 Days)|Adverse Event|0|||
33353630|NCT01147809|101180764|FG002|Phase I (168 Days)|Adverse Event|0|||
33353631|NCT01147809|101180765|FG003|Phase I (168 Days)|Adverse Event|1|||
33353632|NCT01147809|101180766|FG004|Phase I (168 Days)|Adverse Event|0|||
33353633|NCT01147809|101180767|FG005|Phase I (168 Days)|Adverse Event|0|||
33353634|NCT01147809|101180762|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
33619515|NCT03343626|102155036|FG002|Overall Study|Withdrawal of Consent|0|||
33353635|NCT01147809|101180763|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
33353636|NCT01147809|101180764|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
33353637|NCT01147809|101180765|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
33353638|NCT01147809|101180766|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
33353639|NCT01147809|101180767|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
33353640|NCT01147809|101180762|FG000|Phase I (168 Days)|Physician Decision|0|||
33353641|NCT01147809|101180763|FG001|Phase I (168 Days)|Physician Decision|1|||
33353642|NCT01147809|101180764|FG002|Phase I (168 Days)|Physician Decision|2|||
33353643|NCT01147809|101180765|FG003|Phase I (168 Days)|Physician Decision|0|||
33353644|NCT01147809|101180766|FG004|Phase I (168 Days)|Physician Decision|0|||
33353645|NCT01147809|101180767|FG005|Phase I (168 Days)|Physician Decision|0|||
33353646|NCT01147809|101180762|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
33353647|NCT01147809|101180763|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
33353648|NCT01147809|101180764|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
33353649|NCT01147809|101180765|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
33353650|NCT01147809|101180766|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
33353651|NCT01147809|101180767|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
33353652|NCT01147809|101180762|FG000|Phase II (168 Days)|Adverse Event|0|||
33353653|NCT01147809|101180763|FG001|Phase II (168 Days)|Adverse Event|0|||
33353654|NCT01147809|101180764|FG002|Phase II (168 Days)|Adverse Event|0|||
33353655|NCT01147809|101180765|FG003|Phase II (168 Days)|Adverse Event|0|||
33353656|NCT01147809|101180766|FG004|Phase II (168 Days)|Adverse Event|3|||
33353657|NCT01147809|101180767|FG005|Phase II (168 Days)|Adverse Event|6|||
33353658|NCT01147809|101180762|FG000|Phase II (168 Days)|Protocol Violation|0|||
33353659|NCT01147809|101180763|FG001|Phase II (168 Days)|Protocol Violation|0|||
33353660|NCT01147809|101180764|FG002|Phase II (168 Days)|Protocol Violation|0|||
33353661|NCT01147809|101180765|FG003|Phase II (168 Days)|Protocol Violation|0|||
33353662|NCT01147809|101180766|FG004|Phase II (168 Days)|Protocol Violation|0|||
33353663|NCT01147809|101180767|FG005|Phase II (168 Days)|Protocol Violation|1|||
33353664|NCT01147809|101180762|FG000|Phase II (168 Days)|Physician Decision|0|||
33353665|NCT01147809|101180763|FG001|Phase II (168 Days)|Physician Decision|0|||
33353666|NCT01147809|101180764|FG002|Phase II (168 Days)|Physician Decision|0|||
33353667|NCT01147809|101180765|FG003|Phase II (168 Days)|Physician Decision|0|||
33353668|NCT01147809|101180766|FG004|Phase II (168 Days)|Physician Decision|5|||
33353669|NCT01147809|101180767|FG005|Phase II (168 Days)|Physician Decision|11|||
33353670|NCT01147809|101180762|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
33353671|NCT01147809|101180763|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
33353672|NCT01147809|101180764|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
33353673|NCT01147809|101180765|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
33353674|NCT01147809|101180766|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
33353675|NCT01147809|101180767|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
33353676|NCT01147809|101180762|FG000|Phase II (168 Days)|Ongoing|0|||
33353677|NCT01147809|101180763|FG001|Phase II (168 Days)|Ongoing|0|||
33353678|NCT01147809|101180764|FG002|Phase II (168 Days)|Ongoing|0|||
33353679|NCT01147809|101180765|FG003|Phase II (168 Days)|Ongoing|0|||
33353680|NCT01147809|101180766|FG004|Phase II (168 Days)|Ongoing|1|||
33353681|NCT01147809|101180767|FG005|Phase II (168 Days)|Ongoing|0|||
33217927|NCT02586025|100695891|FG001|Neoadjuvant Treatment|Death|0|||
33353682|NCT04429022|101180771|FG000|Overall Study|Protocol Violation|18|||
33353683|NCT04429022|101180772|FG001|Overall Study|Protocol Violation|1|||
33353684|NCT02443402|101180776|FG000|Overall Study|Withdrawal by Subject|3|||
33353685|NCT02443402|101180777|FG001|Overall Study|Withdrawal by Subject|1|||
33353686|NCT02443402|101180776|FG000|Overall Study|Screen Failure|1|||
33353687|NCT02443402|101180777|FG001|Overall Study|Screen Failure|2|||
33353688|NCT01564784|101180779|FG000|Overall Study|Other|1|||
33353689|NCT01564784|101180780|FG001|Overall Study|Other|0|||
33353690|NCT01564784|101180779|FG000|Overall Study|Subject refused further follow-up|1|||
33353691|NCT01564784|101180780|FG001|Overall Study|Subject refused further follow-up|6|||
33353692|NCT01564784|101180779|FG000|Overall Study|Lost to Follow-up|1|||
33353693|NCT01564784|101180780|FG001|Overall Study|Lost to Follow-up|1|||
33353694|NCT01564784|101180779|FG000|Overall Study|Death|131|||
33353695|NCT01564784|101180780|FG001|Overall Study|Death|126|||
33353696|NCT00628355|101180781|FG000|Overall Study|Withdrawal by Subject|1|||
33353697|NCT00628355|101180782|FG001|Overall Study|Withdrawal by Subject|1|||
33353698|NCT05900115|101180786|FG000|Overall Study|Lost to Follow-up|129|||
33353699|NCT05900115|101180787|FG001|Overall Study|Lost to Follow-up|98|||
33353700|NCT01412879|101180788|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
33412971|NCT02074982|101403519|FG001|Overall Study|Technical problems|2|||
33412972|NCT02074982|101403518|FG000|Overall Study|Subject/guardian decision|15|||
33412973|NCT02074982|101403519|FG001|Overall Study|Subject/guardian decision|24|||
33412974|NCT02074982|101403518|FG000|Overall Study|Death|0|||
33412975|NCT02074982|101403519|FG001|Overall Study|Death|2|||
33412976|NCT03480243|101403523|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
33412977|NCT03480243|101403523|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
33412978|NCT03605758|101403524|FG000|Overall Study|Lost to Follow-up|2|||
33412979|NCT03605758|101403525|FG001|Overall Study|Lost to Follow-up|1|||
33412980|NCT03605758|101403524|FG000|Overall Study|Illness|0|||
33412981|NCT03605758|101403525|FG001|Overall Study|Illness|1|||
33412982|NCT03605758|101403524|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
33412983|NCT03605758|101403525|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
33412984|NCT00620776|101403526|FG000|Overall Study|Did not receive treatment|3|||
33412985|NCT00620776|101403527|FG001|Overall Study|Did not receive treatment|5|||
33553746|NCT01089543|101927799|FG002|Overall Study|Adverse Event|0|||
33553747|NCT01089543|101927800|FG003|Overall Study|Adverse Event|0|||
33553748|NCT01521364|101927802|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
33553749|NCT01521364|101927802|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
33553750|NCT04102111|101927804|FG000|Overall Study|Withdrawal by Subject|2|||
33553751|NCT04102111|101927805|FG001|Overall Study|Withdrawal by Subject|3|||
33553752|NCT04102111|101927804|FG000|Overall Study|Adverse Event|1|||
33553753|NCT04102111|101927805|FG001|Overall Study|Adverse Event|1|||
33353701|NCT01412879|101180789|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
33353702|NCT01412879|101180790|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
33353703|NCT01412879|101180788|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
33353704|NCT01412879|101180789|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
33353705|NCT01412879|101180790|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
33353706|NCT01412879|101180788|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
33353707|NCT01412879|101180789|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
33353708|NCT01412879|101180790|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
33353709|NCT01412879|101180788|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
33353710|NCT01412879|101180789|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
33353711|NCT01412879|101180790|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
33353712|NCT01412879|101180788|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
33353713|NCT01412879|101180789|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
33353714|NCT01412879|101180790|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
33412986|NCT00620776|101403526|FG000|Overall Study|Adverse Event|2|||
33553754|NCT04102111|101927804|FG000|Overall Study|Study terminated by sponsor|1|||
33553755|NCT04102111|101927805|FG001|Overall Study|Study terminated by sponsor|3|||
33553756|NCT00003456|101927808|FG000|Overall Study|Not evaluable|8|||
33553757|NCT02070991|101927809|FG000|Overall Study|Death|2|||
33553758|NCT02070991|101927810|FG001|Overall Study|Death|0|||
33553759|NCT02070991|101927809|FG000|Overall Study|Withdrawal by Subject|1|||
33553760|NCT02070991|101927810|FG001|Overall Study|Withdrawal by Subject|0|||
33553761|NCT00425854|101927811|FG000|Overall Study|Progressive Disease|19|||
33553762|NCT00425854|101927812|FG001|Overall Study|Progressive Disease|12|||
33553763|NCT00425854|101927811|FG000|Overall Study|Dose reduction toxicity AE|8|||
33553764|NCT00425854|101927812|FG001|Overall Study|Dose reduction toxicity AE|7|||
33553765|NCT00425854|101927811|FG000|Overall Study|Other Adverse Event|2|||
33553766|NCT00425854|101927812|FG001|Overall Study|Other Adverse Event|2|||
33553767|NCT00927186|101927813|FG000|12 Months Primary Study|Adverse Event|5|||
33553768|NCT00927186|101927814|FG001|12 Months Primary Study|Adverse Event|2|||
33553769|NCT00927186|101927813|FG000|12 Months Primary Study|Lost to Follow-up|1|||
33553770|NCT00927186|101927814|FG001|12 Months Primary Study|Lost to Follow-up|0|||
33553771|NCT00927186|101927813|FG000|12 Months Primary Study|Protocol Violation|0|||
33553772|NCT00927186|101927814|FG001|12 Months Primary Study|Protocol Violation|1|||
33553773|NCT00927186|101927813|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
33553774|NCT00927186|101927814|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
33553775|NCT01301001|101927815|FG000|First Intervention|Lost to Follow-up|4|||
33553776|NCT01301001|101927816|FG001|First Intervention|Lost to Follow-up|4|||
33553777|NCT01301001|101927815|FG000|First Intervention|Withdrawal by Subject|1|||
33553778|NCT01301001|101927816|FG001|First Intervention|Withdrawal by Subject|4|||
33553779|NCT01301001|101927815|FG000|First Intervention|Adverse Event|5|||
33553780|NCT01301001|101927816|FG001|First Intervention|Adverse Event|0|||
33553781|NCT01301001|101927815|FG000|First Intervention|Protocol Violation|0|||
33553782|NCT01301001|101927816|FG001|First Intervention|Protocol Violation|1|||
33553783|NCT01301001|101927815|FG000|Second Intervention|Adverse Event|2|||
33553784|NCT01301001|101927816|FG001|Second Intervention|Adverse Event|0|||
33553785|NCT01301001|101927815|FG000|Second Intervention|Withdrawal by Subject|2|||
33553786|NCT01301001|101927816|FG001|Second Intervention|Withdrawal by Subject|0|||
33553787|NCT01429623|101927817|FG000|Overall Study|Death|1|||
33553788|NCT01429623|101927818|FG001|Overall Study|Death|0|||
33553789|NCT01429623|101927817|FG000|Overall Study|Adverse Event|7|||
33217928|NCT02586025|100695890|FG000|Neoadjuvant Treatment|Adverse Event|1|||
33353715|NCT01390389|101180797|FG000|Overall Study|Withdrawal by Subject|2|||
33353716|NCT01390389|101180798|FG001|Overall Study|Withdrawal by Subject|0|||
33353717|NCT01390389|101180797|FG000|Overall Study|Screen Fail|2|||
33353718|NCT01390389|101180798|FG001|Overall Study|Screen Fail|1|||
33553790|NCT01429623|101927818|FG001|Overall Study|Adverse Event|14|||
33553791|NCT01429623|101927817|FG000|Overall Study|Withdrawal by Subject|19|||
33217929|NCT02586025|100695891|FG001|Neoadjuvant Treatment|Adverse Event|0|||
33217930|NCT02586025|100695890|FG000|Neoadjuvant Treatment|Physician Decision|2|||
33217931|NCT02586025|100695891|FG001|Neoadjuvant Treatment|Physician Decision|1|||
33412987|NCT00620776|101403527|FG001|Overall Study|Adverse Event|3|||
33217932|NCT02586025|100695890|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
33412988|NCT00620776|101403526|FG000|Overall Study|Lack of Efficacy|2|||
33412989|NCT00620776|101403527|FG001|Overall Study|Lack of Efficacy|1|||
33412990|NCT00620776|101403526|FG000|Overall Study|Lost to Follow-up|2|||
33412991|NCT00620776|101403527|FG001|Overall Study|Lost to Follow-up|5|||
33412992|NCT00620776|101403526|FG000|Overall Study|Withdrawal by Subject|3|||
33412993|NCT00620776|101403527|FG001|Overall Study|Withdrawal by Subject|2|||
33412994|NCT01374516|101403528|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
33412995|NCT01374516|101403529|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
33217933|NCT02586025|100695891|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
33217934|NCT02586025|100695890|FG000|Adjuvant Treatment|Recurrent Disease|4|||
33217935|NCT02586025|100695891|FG001|Adjuvant Treatment|Recurrent Disease|5|||
33217936|NCT02586025|100695890|FG000|Adjuvant Treatment|Physician Decision|0|||
33217937|NCT02586025|100695891|FG001|Adjuvant Treatment|Physician Decision|1|||
33217938|NCT02586025|100695890|FG000|Adjuvant Treatment|Pregnancy|1|||
33217939|NCT02586025|100695891|FG001|Adjuvant Treatment|Pregnancy|0|||
33217940|NCT02586025|100695890|FG000|Treatment-Free Follow-Up|Death|11|||
33217941|NCT02586025|100695891|FG001|Treatment-Free Follow-Up|Death|11|||
33412996|NCT01374516|101403528|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
33412997|NCT01374516|101403529|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
33412998|NCT01374516|101403528|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
33412999|NCT01374516|101403529|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
33413000|NCT01374516|101403528|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
33413001|NCT01374516|101403529|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
33413002|NCT01374516|101403528|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
33413003|NCT01374516|101403529|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
33413004|NCT01374516|101403528|FG000|Surveillance Expansion Period|Protocol Violation|386|||
33413005|NCT01374516|101403529|FG001|Surveillance Expansion Period|Protocol Violation|217|||
33413006|NCT01374516|101403528|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
33413007|NCT01374516|101403529|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
33413008|NCT01374516|101403528|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
33413009|NCT01374516|101403529|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
33413010|NCT01374516|101403528|FG000|Surveillance Expansion Period|Serious adverse event|20|||
33413011|NCT01374516|101403529|FG001|Surveillance Expansion Period|Serious adverse event|5|||
33413012|NCT05637515|101403530|FG000|Overall Study|Withdrawal by Subject|17|||
33413013|NCT05637515|101403531|FG001|Overall Study|Withdrawal by Subject|17|||
33413014|NCT02526017|101403539|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33413015|NCT02526017|101403540|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33413016|NCT02526017|101403541|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33413017|NCT02526017|101403542|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33413018|NCT02526017|101403543|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
33413019|NCT02526017|101403544|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33413020|NCT02526017|101403545|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33413021|NCT02526017|101403546|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33217942|NCT02586025|100695890|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
33413022|NCT02526017|101403547|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
33413023|NCT01891669|101403549|FG000|Overall Study|Death|0|||
33413024|NCT01891669|101403550|FG001|Overall Study|Death|0|||
33217943|NCT02586025|100695891|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
33217944|NCT02586025|100695890|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
33217945|NCT02586025|100695891|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
33353719|NCT01966731|101180799|FG000|Overall Study|Death|2|||
33353720|NCT01966731|101180799|FG000|Overall Study|Lost to Follow-up|1|||
33353721|NCT01966731|101180799|FG000|Overall Study|Physician Decision|2|||
33353722|NCT01966731|101180799|FG000|Overall Study|Follow up is not complete|600|||
33353723|NCT01966731|101180799|FG000|Overall Study|Screening Failure|29|||
33353724|NCT01966731|101180799|FG000|Overall Study|Found to be ineligible|1|||
33353725|NCT03584009|101180803|FG000|Overall Study|Death|25|||
33353726|NCT03584009|101180804|FG001|Overall Study|Death|18|||
33353727|NCT03584009|101180803|FG000|Overall Study|Lost to Follow-up|0|||
33353728|NCT03584009|101180804|FG001|Overall Study|Lost to Follow-up|1|||
33353729|NCT03584009|101180803|FG000|Overall Study|Physician Decision|1|||
33353730|NCT03584009|101180804|FG001|Overall Study|Physician Decision|1|||
33353731|NCT03584009|101180803|FG000|Overall Study|Study Terminated by Sponsor|22|||
33353732|NCT03584009|101180804|FG001|Overall Study|Study Terminated by Sponsor|30|||
33353733|NCT03584009|101180803|FG000|Overall Study|Withdrawal by Subject|3|||
33353734|NCT03584009|101180804|FG001|Overall Study|Withdrawal by Subject|2|||
33353735|NCT00432237|101180807|FG000|Overall Study|Adverse Event|0|||
33353736|NCT00432237|101180808|FG001|Overall Study|Adverse Event|0|||
33353737|NCT00432237|101180809|FG002|Overall Study|Adverse Event|0|||
33353738|NCT00432237|101180810|FG003|Overall Study|Adverse Event|1|||
33353739|NCT00432237|101180807|FG000|Overall Study|Lack of Efficacy|0|||
33353740|NCT00432237|101180808|FG001|Overall Study|Lack of Efficacy|0|||
33353741|NCT00432237|101180809|FG002|Overall Study|Lack of Efficacy|0|||
33353742|NCT00432237|101180810|FG003|Overall Study|Lack of Efficacy|1|||
33353743|NCT00432237|101180807|FG000|Overall Study|Lost to Follow-up|10|||
33353744|NCT00432237|101180808|FG001|Overall Study|Lost to Follow-up|10|||
33353745|NCT00432237|101180809|FG002|Overall Study|Lost to Follow-up|18|||
33413025|NCT01891669|101403551|FG002|Overall Study|Death|0|||
33413026|NCT01891669|101403552|FG003|Overall Study|Death|0|||
33413027|NCT01891669|101403553|FG004|Overall Study|Death|0|||
33413028|NCT01891669|101403554|FG005|Overall Study|Death|0|||
33413029|NCT01891669|101403555|FG006|Overall Study|Death|0|||
33413030|NCT01891669|101403556|FG007|Overall Study|Death|1|||
33413031|NCT01891669|101403557|FG008|Overall Study|Death|0|||
33413032|NCT01891669|101403558|FG009|Overall Study|Death|1|||
33413033|NCT01891669|101403549|FG000|Overall Study|Withdrawal by Subject|1|||
33413034|NCT01891669|101403550|FG001|Overall Study|Withdrawal by Subject|1|||
33413035|NCT01891669|101403551|FG002|Overall Study|Withdrawal by Subject|0|||
33413036|NCT01891669|101403552|FG003|Overall Study|Withdrawal by Subject|0|||
33413037|NCT01891669|101403553|FG004|Overall Study|Withdrawal by Subject|0|||
33413038|NCT01891669|101403554|FG005|Overall Study|Withdrawal by Subject|0|||
33413039|NCT01891669|101403555|FG006|Overall Study|Withdrawal by Subject|1|||
33413040|NCT01891669|101403556|FG007|Overall Study|Withdrawal by Subject|2|||
33413041|NCT01891669|101403557|FG008|Overall Study|Withdrawal by Subject|1|||
33413042|NCT01891669|101403558|FG009|Overall Study|Withdrawal by Subject|1|||
33413043|NCT01891669|101403549|FG000|Overall Study|Other|1|||
33413044|NCT01891669|101403550|FG001|Overall Study|Other|0|||
33413045|NCT01891669|101403551|FG002|Overall Study|Other|0|||
33413046|NCT01891669|101403552|FG003|Overall Study|Other|0|||
33413047|NCT01891669|101403553|FG004|Overall Study|Other|0|||
33413048|NCT01891669|101403554|FG005|Overall Study|Other|0|||
33413049|NCT01891669|101403555|FG006|Overall Study|Other|0|||
33413050|NCT01891669|101403556|FG007|Overall Study|Other|1|||
33413051|NCT01891669|101403557|FG008|Overall Study|Other|0|||
33413052|NCT01891669|101403558|FG009|Overall Study|Other|0|||
33413053|NCT02575807|101403559|FG000|Overall Study|Death|8|||
33413054|NCT02575807|101403560|FG001|Overall Study|Death|3|||
33413055|NCT02575807|101403561|FG002|Overall Study|Death|7|||
33217946|NCT02586025|100695890|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
33217947|NCT02586025|100695891|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
33353746|NCT00432237|101180810|FG003|Overall Study|Lost to Follow-up|18|||
33413056|NCT02575807|101403562|FG003|Overall Study|Death|0|||
33413057|NCT02575807|101403563|FG004|Overall Study|Death|1|||
33413058|NCT02575807|101403559|FG000|Overall Study|Study terminated by Sponsor|0|||
33413059|NCT02575807|101403560|FG001|Overall Study|Study terminated by Sponsor|1|||
33413060|NCT02575807|101403561|FG002|Overall Study|Study terminated by Sponsor|7|||
33413061|NCT02575807|101403562|FG003|Overall Study|Study terminated by Sponsor|0|||
33413062|NCT02575807|101403563|FG004|Overall Study|Study terminated by Sponsor|1|||
33413063|NCT02575807|101403559|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
33413064|NCT02575807|101403560|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
33413065|NCT02575807|101403561|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
33413066|NCT02575807|101403562|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
33413067|NCT02575807|101403563|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
33413068|NCT02575807|101403559|FG000|Overall Study|Terminated due to physician decision|0|||
33353747|NCT00432237|101180807|FG000|Overall Study|Physician Decision|1|||
33353748|NCT00432237|101180808|FG001|Overall Study|Physician Decision|3|||
33353749|NCT00432237|101180809|FG002|Overall Study|Physician Decision|2|||
33353750|NCT00432237|101180810|FG003|Overall Study|Physician Decision|1|||
33353751|NCT00432237|101180807|FG000|Overall Study|Pregnancy|0|||
33353752|NCT00432237|101180808|FG001|Overall Study|Pregnancy|1|||
33353753|NCT00432237|101180809|FG002|Overall Study|Pregnancy|0|||
33553792|NCT01429623|101927818|FG001|Overall Study|Withdrawal by Subject|13|||
33553793|NCT01429623|101927817|FG000|Overall Study|Physician Decision|2|||
33353754|NCT00432237|101180810|FG003|Overall Study|Pregnancy|0|||
33353755|NCT00432237|101180807|FG000|Overall Study|Protocol Violation|13|||
33353756|NCT00432237|101180808|FG001|Overall Study|Protocol Violation|10|||
33353757|NCT00432237|101180809|FG002|Overall Study|Protocol Violation|11|||
33353758|NCT00432237|101180810|FG003|Overall Study|Protocol Violation|8|||
33353759|NCT00432237|101180807|FG000|Overall Study|Withdrawal by Subject|5|||
33353760|NCT00432237|101180808|FG001|Overall Study|Withdrawal by Subject|6|||
33353761|NCT00432237|101180809|FG002|Overall Study|Withdrawal by Subject|9|||
33353762|NCT00432237|101180810|FG003|Overall Study|Withdrawal by Subject|11|||
33413069|NCT02575807|101403560|FG001|Overall Study|Terminated due to physician decision|0|||
33553794|NCT01429623|101927818|FG001|Overall Study|Physician Decision|3|||
33553795|NCT01429623|101927817|FG000|Overall Study|Protocol Violation|3|||
33553796|NCT01429623|101927818|FG001|Overall Study|Protocol Violation|2|||
33553797|NCT01429623|101927817|FG000|Overall Study|Assorted|1|||
33553798|NCT01429623|101927818|FG001|Overall Study|Assorted|2|||
33553799|NCT01429623|101927817|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
33553800|NCT01429623|101927818|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
33553801|NCT01429623|101927817|FG000|Overall Study|No post baseline data|4|||
33553802|NCT01429623|101927818|FG001|Overall Study|No post baseline data|4|||
33553803|NCT00819832|101927819|FG000|Overall Study|Sponsor Termination of Study|3|||
33553804|NCT00819832|101927820|FG001|Overall Study|Sponsor Termination of Study|0|||
33553805|NCT00819832|101927821|FG002|Overall Study|Sponsor Termination of Study|0|||
33553806|NCT00819832|101927822|FG003|Overall Study|Sponsor Termination of Study|0|||
33553807|NCT00819832|101927823|FG004|Overall Study|Sponsor Termination of Study|0|||
33553808|NCT00819832|101927824|FG005|Overall Study|Sponsor Termination of Study|0|||
33553809|NCT02503865|101927825|FG000|Overall Study|Moved out of area|1|||
33553810|NCT02503865|101927826|FG001|Overall Study|Moved out of area|8|||
33553811|NCT02503865|101927827|FG002|Overall Study|Moved out of area|0|||
33553812|NCT02503865|101927825|FG000|Overall Study|Refused treatment|4|||
33553813|NCT02503865|101927826|FG001|Overall Study|Refused treatment|39|||
33553814|NCT02503865|101927827|FG002|Overall Study|Refused treatment|2|||
33553815|NCT01560988|101927828|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
33553816|NCT01560988|101927829|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
33553817|NCT01560988|101927828|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
33553818|NCT01560988|101927829|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
33553819|NCT01560988|101927828|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
33553820|NCT01560988|101927829|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
33553821|NCT01292473|101927831|FG000|Overall Study|Adverse Event|1|||
33553822|NCT01292473|101927832|FG001|Overall Study|Adverse Event|0|||
33553823|NCT01292473|101927833|FG002|Overall Study|Adverse Event|1|||
33553824|NCT01292473|101927834|FG003|Overall Study|Adverse Event|1|||
33553825|NCT01292473|101927831|FG000|Overall Study|Lost to Follow-up|1|||
33553826|NCT01292473|101927832|FG001|Overall Study|Lost to Follow-up|1|||
33553827|NCT01292473|101927833|FG002|Overall Study|Lost to Follow-up|2|||
33553828|NCT01292473|101927834|FG003|Overall Study|Lost to Follow-up|2|||
33553829|NCT01292473|101927831|FG000|Overall Study|Withdrawal by Subject|3|||
33553830|NCT01292473|101927832|FG001|Overall Study|Withdrawal by Subject|4|||
33553831|NCT01292473|101927833|FG002|Overall Study|Withdrawal by Subject|3|||
33553832|NCT01292473|101927834|FG003|Overall Study|Withdrawal by Subject|3|||
33553833|NCT01292473|101927831|FG000|Overall Study|Physician Decision|0|||
33553834|NCT01292473|101927832|FG001|Overall Study|Physician Decision|1|||
33553835|NCT01292473|101927833|FG002|Overall Study|Physician Decision|0|||
33553836|NCT01292473|101927834|FG003|Overall Study|Physician Decision|0|||
33553837|NCT01292473|101927831|FG000|Overall Study|Disease Progression|0|||
33553838|NCT01292473|101927832|FG001|Overall Study|Disease Progression|1|||
33553839|NCT01292473|101927833|FG002|Overall Study|Disease Progression|3|||
33553840|NCT01292473|101927834|FG003|Overall Study|Disease Progression|6|||
33553841|NCT00621322|101927835|FG000|Overall Study|Lost to Follow-up|0|||
33553842|NCT00621322|101927836|FG001|Overall Study|Lost to Follow-up|0|||
33553843|NCT00621322|101927837|FG002|Overall Study|Lost to Follow-up|0|||
33553844|NCT00621322|101927838|FG003|Overall Study|Lost to Follow-up|0|||
33413070|NCT02575807|101403561|FG002|Overall Study|Terminated due to physician decision|1|||
33553845|NCT00621322|101927839|FG004|Overall Study|Lost to Follow-up|1|||
33553846|NCT00621322|101927840|FG005|Overall Study|Lost to Follow-up|0|||
33553847|NCT00621322|101927835|FG000|Overall Study|Physician Decision|0|||
33553848|NCT00621322|101927836|FG001|Overall Study|Physician Decision|0|||
33553849|NCT00621322|101927837|FG002|Overall Study|Physician Decision|1|||
33553850|NCT00621322|101927838|FG003|Overall Study|Physician Decision|1|||
33553851|NCT00621322|101927839|FG004|Overall Study|Physician Decision|0|||
33553852|NCT00621322|101927840|FG005|Overall Study|Physician Decision|0|||
33553853|NCT00621322|101927835|FG000|Overall Study|Withdrawal by Subject|0|||
33553854|NCT00621322|101927836|FG001|Overall Study|Withdrawal by Subject|0|||
33553855|NCT00621322|101927837|FG002|Overall Study|Withdrawal by Subject|0|||
33353763|NCT00432237|101180807|FG000|Overall Study|Lack of Qualifying Event|38|||
33217948|NCT02586025|100695890|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
33413071|NCT02575807|101403562|FG003|Overall Study|Terminated due to physician decision|0|||
33413072|NCT02575807|101403563|FG004|Overall Study|Terminated due to physician decision|0|||
33413073|NCT02575807|101403559|FG000|Overall Study|Subject ineligible - medical implant|0|||
33413074|NCT02575807|101403560|FG001|Overall Study|Subject ineligible - medical implant|0|||
33413075|NCT02575807|101403561|FG002|Overall Study|Subject ineligible - medical implant|0|||
33413076|NCT02575807|101403562|FG003|Overall Study|Subject ineligible - medical implant|1|||
33413077|NCT02575807|101403563|FG004|Overall Study|Subject ineligible - medical implant|0|||
33619516|NCT03343626|102155037|FG003|Overall Study|Withdrawal of Consent|3|||
33619517|NCT03343626|102155038|FG004|Overall Study|Withdrawal of Consent|3|||
33619518|NCT03343626|102155039|FG005|Overall Study|Withdrawal of Consent|1|||
33619519|NCT03343626|102155040|FG006|Overall Study|Withdrawal of Consent|1|||
33619520|NCT03343626|102155041|FG007|Overall Study|Withdrawal of Consent|2|||
33619521|NCT03343626|102155034|FG000|Overall Study|Reason not Specified|0|||
33619522|NCT03343626|102155035|FG001|Overall Study|Reason not Specified|1|||
33413078|NCT02575807|101403559|FG000|Overall Study|Withdrawal by Subject|0|||
33413079|NCT02575807|101403560|FG001|Overall Study|Withdrawal by Subject|0|||
33413080|NCT02575807|101403561|FG002|Overall Study|Withdrawal by Subject|1|||
33619523|NCT03343626|102155036|FG002|Overall Study|Reason not Specified|0|||
33413081|NCT02575807|101403562|FG003|Overall Study|Withdrawal by Subject|1|||
33413082|NCT02575807|101403563|FG004|Overall Study|Withdrawal by Subject|2|||
33413083|NCT04812548|101403564|FG000|Overall Study|Adverse Event|2|||
33413084|NCT04812548|101403565|FG001|Overall Study|Adverse Event|7|||
33619524|NCT03343626|102155037|FG003|Overall Study|Reason not Specified|0|||
33619525|NCT03343626|102155038|FG004|Overall Study|Reason not Specified|0|||
33619526|NCT03343626|102155039|FG005|Overall Study|Reason not Specified|0|||
33619527|NCT03343626|102155040|FG006|Overall Study|Reason not Specified|0|||
33619528|NCT03343626|102155041|FG007|Overall Study|Reason not Specified|1|||
33619529|NCT03343626|102155034|FG000|Overall Study|Data Entry Error|0|||
33619530|NCT03343626|102155035|FG001|Overall Study|Data Entry Error|0|||
33413085|NCT04812548|101403564|FG000|Overall Study|HSCT Planned|2|||
33413086|NCT04812548|101403565|FG001|Overall Study|HSCT Planned|3|||
33413087|NCT04812548|101403564|FG000|Overall Study|Progressive Disease|0|||
33413088|NCT04812548|101403565|FG001|Overall Study|Progressive Disease|2|||
33619531|NCT03343626|102155036|FG002|Overall Study|Data Entry Error|0|||
33619532|NCT03343626|102155037|FG003|Overall Study|Data Entry Error|0|||
33619533|NCT03343626|102155038|FG004|Overall Study|Data Entry Error|0|||
33619534|NCT03343626|102155039|FG005|Overall Study|Data Entry Error|0|||
33353764|NCT00432237|101180808|FG001|Overall Study|Lack of Qualifying Event|71|||
33353765|NCT00432237|101180809|FG002|Overall Study|Lack of Qualifying Event|69|||
33353766|NCT00432237|101180810|FG003|Overall Study|Lack of Qualifying Event|84|||
33353767|NCT00785577|101180813|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
33353768|NCT00785577|101180814|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
33353769|NCT00785577|101180815|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
33353770|NCT00785577|101180816|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
33353771|NCT00785577|101180817|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
33353772|NCT00785577|101180813|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
33353773|NCT00785577|101180814|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
33353774|NCT00785577|101180815|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
33353775|NCT00785577|101180816|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
33353776|NCT00785577|101180817|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
33353777|NCT00785577|101180813|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
33353778|NCT00785577|101180814|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
33353779|NCT00785577|101180815|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
33353780|NCT00785577|101180816|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
33353781|NCT00785577|101180817|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
33353782|NCT00785577|101180813|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
33353783|NCT00785577|101180814|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
33353784|NCT00785577|101180815|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
33353785|NCT00785577|101180816|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
33353786|NCT00785577|101180817|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
33353787|NCT00785577|101180813|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
33413089|NCT04812548|101403564|FG000|Overall Study|Death|0|||
33413090|NCT04812548|101403565|FG001|Overall Study|Death|1|||
33413091|NCT04812548|101403564|FG000|Overall Study|Post Study Access to Treatment|0|||
33553856|NCT00621322|101927838|FG003|Overall Study|Withdrawal by Subject|1|||
33619535|NCT03343626|102155040|FG006|Overall Study|Data Entry Error|0|||
33619536|NCT03343626|102155041|FG007|Overall Study|Data Entry Error|1|||
33619537|NCT04273893|102155043|FG000|Overall Study|Withdrawal by Subject|0|||
33619538|NCT04273893|102155044|FG001|Overall Study|Withdrawal by Subject|2|||
33353788|NCT00785577|101180814|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
33413092|NCT04812548|101403565|FG001|Overall Study|Post Study Access to Treatment|1|||
33413093|NCT04812548|101403564|FG000|Overall Study|Withdrawal by Subject|0|||
33413094|NCT04812548|101403565|FG001|Overall Study|Withdrawal by Subject|1|||
33553857|NCT00621322|101927839|FG004|Overall Study|Withdrawal by Subject|0|||
33553858|NCT00621322|101927840|FG005|Overall Study|Withdrawal by Subject|2|||
33553859|NCT00621322|101927835|FG000|Overall Study|Migrated/moved from study area|1|||
33553860|NCT00621322|101927836|FG001|Overall Study|Migrated/moved from study area|0|||
33553861|NCT00621322|101927837|FG002|Overall Study|Migrated/moved from study area|1|||
33553862|NCT00621322|101927838|FG003|Overall Study|Migrated/moved from study area|1|||
33413095|NCT04812548|101403564|FG000|Overall Study|Physician Decision|1|||
33413096|NCT04812548|101403565|FG001|Overall Study|Physician Decision|0|||
33413097|NCT04780776|101403566|FG000|Titration Week 1-5|Lost to Follow-up|2|||
33553863|NCT00621322|101927839|FG004|Overall Study|Migrated/moved from study area|0|||
33553864|NCT00621322|101927840|FG005|Overall Study|Migrated/moved from study area|2|||
33553865|NCT00452400|101927841|FG000|Overall Study|Adverse Event|1|||
33553866|NCT00452400|101927842|FG001|Overall Study|Adverse Event|1|||
33553867|NCT00452400|101927843|FG002|Overall Study|Adverse Event|5|||
33553868|NCT00452400|101927844|FG003|Overall Study|Adverse Event|0|||
33553869|NCT00452400|101927845|FG004|Overall Study|Adverse Event|2|||
33553870|NCT00452400|101927841|FG000|Overall Study|Protocol Violation|0|||
33553871|NCT00452400|101927842|FG001|Overall Study|Protocol Violation|0|||
33553872|NCT00452400|101927843|FG002|Overall Study|Protocol Violation|1|||
33619539|NCT04273893|102155043|FG000|Overall Study|Treatment of Disease Progression|0|||
33619540|NCT04273893|102155044|FG001|Overall Study|Treatment of Disease Progression|2|||
33619541|NCT04273893|102155043|FG000|Overall Study|Death|1|||
33413098|NCT04780776|101403567|FG001|Titration Week 1-5|Lost to Follow-up|8|||
33413099|NCT04780776|101403566|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
33413100|NCT04780776|101403567|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
33413101|NCT04780776|101403566|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
33413102|NCT04780776|101403567|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
33413103|NCT00442572|101403572|FG000|Overall Study|Relapse|8|||
33413104|NCT00442572|101403573|FG001|Overall Study|Relapse|1|||
33413105|NCT00442572|101403572|FG000|Overall Study|Lost to Follow-up|0|||
33553873|NCT00452400|101927844|FG003|Overall Study|Protocol Violation|0|||
33553874|NCT00452400|101927845|FG004|Overall Study|Protocol Violation|0|||
33553875|NCT00452400|101927841|FG000|Overall Study|Lost to Follow-up|1|||
33553876|NCT00452400|101927842|FG001|Overall Study|Lost to Follow-up|0|||
33619542|NCT04273893|102155044|FG001|Overall Study|Death|2|||
33619543|NCT04273893|102155043|FG000|Overall Study|Lost to Follow-up|0|||
33619544|NCT04273893|102155044|FG001|Overall Study|Lost to Follow-up|2|||
33619545|NCT04273893|102155043|FG000|Overall Study|Physician Decision|1|||
33619546|NCT04273893|102155044|FG001|Overall Study|Physician Decision|0|||
33619547|NCT03828617|102155052|FG000|Overall Study|Lost to Follow-up|22|||
33619548|NCT03828617|102155053|FG001|Overall Study|Lost to Follow-up|12|||
33619549|NCT03828617|102155054|FG002|Overall Study|Lost to Follow-up|23|||
33619550|NCT03828617|102155055|FG003|Overall Study|Lost to Follow-up|7|||
33619551|NCT03828617|102155052|FG000|Overall Study|No longer met eligibility criteria|0|||
33619552|NCT03828617|102155053|FG001|Overall Study|No longer met eligibility criteria|1|||
33619553|NCT03828617|102155054|FG002|Overall Study|No longer met eligibility criteria|1|||
33619554|NCT03828617|102155055|FG003|Overall Study|No longer met eligibility criteria|3|||
33619555|NCT03828617|102155052|FG000|Overall Study|Protocol Violation|0|||
33619556|NCT03828617|102155053|FG001|Overall Study|Protocol Violation|2|||
33619557|NCT03828617|102155054|FG002|Overall Study|Protocol Violation|0|||
33619558|NCT03828617|102155055|FG003|Overall Study|Protocol Violation|0|||
33619559|NCT03828617|102155052|FG000|Overall Study|Withdrawal by Subject|2|||
33619560|NCT03828617|102155053|FG001|Overall Study|Withdrawal by Subject|0|||
33553877|NCT00452400|101927843|FG002|Overall Study|Lost to Follow-up|0|||
33553878|NCT00452400|101927844|FG003|Overall Study|Lost to Follow-up|0|||
33619561|NCT03828617|102155054|FG002|Overall Study|Withdrawal by Subject|2|||
33619562|NCT03828617|102155055|FG003|Overall Study|Withdrawal by Subject|0|||
33619563|NCT02588261|102155067|FG000|Overall Study|Study Terminated by Sponsor|157|||
33619564|NCT02588261|102155068|FG001|Overall Study|Study Terminated by Sponsor|142|||
33619565|NCT02588261|102155067|FG000|Overall Study|Protocol Deviation|1|||
33619566|NCT02588261|102155068|FG001|Overall Study|Protocol Deviation|0|||
33619567|NCT02588261|102155067|FG000|Overall Study|Death|1|||
33619568|NCT02588261|102155068|FG001|Overall Study|Death|2|||
33619569|NCT02588261|102155067|FG000|Overall Study|Withdrawal by Subject|12|||
33619570|NCT02588261|102155068|FG001|Overall Study|Withdrawal by Subject|8|||
33619571|NCT02588261|102155067|FG000|Overall Study|Noncompliance with Study Drug|0|||
33413106|NCT00442572|101403573|FG001|Overall Study|Lost to Follow-up|1|||
33413107|NCT00442572|101403572|FG000|Overall Study|Withdrawal by Subject|0|||
33553879|NCT00452400|101927845|FG004|Overall Study|Lost to Follow-up|0|||
33553880|NCT00452400|101927841|FG000|Overall Study|Withdrawal by Subject|1|||
33553881|NCT00452400|101927842|FG001|Overall Study|Withdrawal by Subject|0|||
33553882|NCT00452400|101927843|FG002|Overall Study|Withdrawal by Subject|1|||
33553883|NCT00452400|101927844|FG003|Overall Study|Withdrawal by Subject|0|||
33553884|NCT00452400|101927845|FG004|Overall Study|Withdrawal by Subject|0|||
33553885|NCT00452400|101927841|FG000|Overall Study|Lack of Efficacy|2|||
33553886|NCT00452400|101927842|FG001|Overall Study|Lack of Efficacy|0|||
33553887|NCT00452400|101927843|FG002|Overall Study|Lack of Efficacy|0|||
33217949|NCT02586025|100695891|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
33553888|NCT00452400|101927844|FG003|Overall Study|Lack of Efficacy|0|||
33553889|NCT00452400|101927845|FG004|Overall Study|Lack of Efficacy|0|||
33553890|NCT00452400|101927841|FG000|Overall Study|Other reasons not listed above|0|||
33553891|NCT00452400|101927842|FG001|Overall Study|Other reasons not listed above|0|||
33553892|NCT00452400|101927843|FG002|Overall Study|Other reasons not listed above|0|||
33553893|NCT00452400|101927844|FG003|Overall Study|Other reasons not listed above|1|||
33553894|NCT00452400|101927845|FG004|Overall Study|Other reasons not listed above|1|||
33553895|NCT01346709|101927848|FG000|Overall Study|Protocol Violation|35|||
33553896|NCT01346709|101927848|FG000|Overall Study|Lost to Follow-up|31|||
33553897|NCT01346709|101927848|FG000|Overall Study|Missing data in candidate risk factor|285|||
33553898|NCT00682435|101927850|FG000|Overall Study|Insufficient data|5|||
33553899|NCT00682435|101927850|FG000|Overall Study|Erroneously enrolled twice|2|||
33553900|NCT03055221|101927852|FG000|Overall Study|Adverse Event|2|||
33553901|NCT03055221|101927852|FG000|Overall Study|Withdrawal by Subject|4|||
33553902|NCT03055221|101927852|FG000|Overall Study|Death|6|||
33553903|NCT03055221|101927852|FG000|Overall Study|Physician Decision|1|||
33553904|NCT03055221|101927852|FG000|Overall Study|Study terminated by Sponsor|3|||
33553905|NCT03055221|101927852|FG000|Overall Study|Lost to Follow-up|4|||
33553906|NCT03073109|101927854|FG000|Overall Study|Adverse Event|0|||
33553907|NCT03073109|101927855|FG001|Overall Study|Adverse Event|1|||
33553908|NCT03073109|101927854|FG000|Overall Study|Other|2|||
33553909|NCT03073109|101927855|FG001|Overall Study|Other|0|||
33553910|NCT03073109|101927854|FG000|Overall Study|Lost to Follow-up|8|||
33553911|NCT03073109|101927855|FG001|Overall Study|Lost to Follow-up|1|||
33553912|NCT03446573|101927856|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
33553913|NCT03446573|101927857|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
33553914|NCT03446573|101927856|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
33619572|NCT02588261|102155068|FG001|Overall Study|Noncompliance with Study Drug|1|||
33619573|NCT02588261|102155067|FG000|Overall Study|Miscellaneous|5|||
33619574|NCT02588261|102155068|FG001|Overall Study|Miscellaneous|4|||
33619575|NCT02588261|102155067|FG000|Overall Study|Progressive Disease|61|||
33619576|NCT02588261|102155068|FG001|Overall Study|Progressive Disease|82|||
33553915|NCT03446573|101927857|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
33217950|NCT01353222|100695892|FG000|Overall Study|Death|30|||
33217951|NCT01353222|100695893|FG001|Overall Study|Death|30|||
33217952|NCT01353222|100695892|FG000|Overall Study|Withdrawal by Subject|8|||
33217953|NCT01353222|100695893|FG001|Overall Study|Withdrawal by Subject|5|||
33217954|NCT01353222|100695892|FG000|Overall Study|Study Terminated|31|||
33217955|NCT01353222|100695893|FG001|Overall Study|Study Terminated|37|||
33217956|NCT01353222|100695892|FG000|Overall Study|Site closed research department|1|||
33217957|NCT01353222|100695893|FG001|Overall Study|Site closed research department|0|||
33217958|NCT01615328|100695895|FG000|Overall Study|Lost to Follow-up|3|||
33553916|NCT03446573|101927856|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
33553917|NCT03446573|101927857|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
33553918|NCT03446573|101927856|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
33553919|NCT03446573|101927857|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
33619577|NCT02588261|102155067|FG000|Overall Study|Adverse Event|29|||
33217959|NCT01615328|100695896|FG001|Overall Study|Lost to Follow-up|5|||
33217960|NCT00330174|100695897|FG000|Overall Study|Withdrawal by Subject|7|||
33217961|NCT00330174|100695898|FG001|Overall Study|Withdrawal by Subject|7|||
33217962|NCT00330174|100695897|FG000|Overall Study|Lost to Follow-up|4|||
33217963|NCT00330174|100695898|FG001|Overall Study|Lost to Follow-up|1|||
33217964|NCT00330174|100695897|FG000|Overall Study|Clinical deterioration|1|||
33553920|NCT03446573|101927856|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
33553921|NCT03446573|101927857|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
33553922|NCT03446573|101927856|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
33553923|NCT03446573|101927857|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
33619578|NCT02588261|102155068|FG001|Overall Study|Adverse Event|24|||
33619579|NCT02588261|102155067|FG000|Overall Study|Lost to Follow-up|1|||
33217965|NCT00330174|100695898|FG001|Overall Study|Clinical deterioration|2|||
33217966|NCT00330174|100695897|FG000|Overall Study|Excessive missed visits|3|||
33619580|NCT02588261|102155068|FG001|Overall Study|Lost to Follow-up|0|||
33619581|NCT00413218|102155069|FG000|Overall Study|Randomized but didn't receive study drug|2|||
33619582|NCT00413218|102155070|FG001|Overall Study|Randomized but didn't receive study drug|8|||
33619583|NCT00413218|102155069|FG000|Overall Study|Death|57|||
33619584|NCT00413218|102155070|FG001|Overall Study|Death|56|||
33217967|NCT00330174|100695898|FG001|Overall Study|Excessive missed visits|8|||
33217968|NCT00330174|100695897|FG000|Overall Study|Miscellaneous reasons|7|||
33217969|NCT00330174|100695898|FG001|Overall Study|Miscellaneous reasons|1|||
33217970|NCT01410474|100695899|FG000|Overall Study|Withdrawal by Subject|0|||
33217971|NCT01410474|100695900|FG001|Overall Study|Withdrawal by Subject|1|||
33217972|NCT02954354|100695901|FG000|Overall Study|Adverse Event|2|||
33217973|NCT02954354|100695902|FG001|Overall Study|Adverse Event|2|||
33217974|NCT02954354|100695903|FG002|Overall Study|Adverse Event|4|||
33217975|NCT02954354|100695901|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
33217976|NCT02954354|100695902|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
33217977|NCT02954354|100695903|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
33217978|NCT02954354|100695901|FG000|Overall Study|Lack of Efficacy|0|||
33217979|NCT02954354|100695902|FG001|Overall Study|Lack of Efficacy|2|||
33217980|NCT02954354|100695903|FG002|Overall Study|Lack of Efficacy|0|||
33217981|NCT02954354|100695901|FG000|Overall Study|Withdrawal by Subject|17|||
33217982|NCT02954354|100695902|FG001|Overall Study|Withdrawal by Subject|9|||
33217983|NCT02954354|100695903|FG002|Overall Study|Withdrawal by Subject|11|||
33217984|NCT02954354|100695901|FG000|Overall Study|Lost to Follow-up|12|||
33217985|NCT02954354|100695902|FG001|Overall Study|Lost to Follow-up|5|||
33217986|NCT02954354|100695903|FG002|Overall Study|Lost to Follow-up|0|||
33217987|NCT02954354|100695901|FG000|Overall Study|Miscellaneous|2|||
33217988|NCT02954354|100695902|FG001|Overall Study|Miscellaneous|2|||
33217989|NCT02954354|100695903|FG002|Overall Study|Miscellaneous|1|||
33353789|NCT00785577|101180815|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
33353790|NCT00785577|101180816|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
33353791|NCT00785577|101180817|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
33353792|NCT00785577|101180813|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
33353793|NCT00785577|101180814|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
33353794|NCT00785577|101180815|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
33353795|NCT00785577|101180816|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
33353796|NCT00785577|101180817|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
33353797|NCT00785577|101180813|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
33353798|NCT00785577|101180814|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
33353799|NCT00785577|101180815|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
33353800|NCT00785577|101180816|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
33353801|NCT00785577|101180817|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
33353802|NCT00785577|101180813|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
33353803|NCT00785577|101180814|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
33353804|NCT00785577|101180815|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
33353805|NCT00785577|101180816|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
33353806|NCT00785577|101180817|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
33353807|NCT00785577|101180813|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
33353808|NCT00785577|101180814|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
33353809|NCT00785577|101180815|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
33353810|NCT00785577|101180816|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
33353811|NCT00785577|101180817|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
33353812|NCT00785577|101180813|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
33353813|NCT00785577|101180814|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
33353814|NCT00785577|101180815|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
33353815|NCT00785577|101180816|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
33353816|NCT00785577|101180817|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
33353817|NCT01934504|101180818|FG000|Overall Study|Protocol Deviation|0|||
33353818|NCT01934504|101180819|FG001|Overall Study|Protocol Deviation|0|||
33619585|NCT00413218|102155069|FG000|Overall Study|Lost to Follow-up|14|||
33217990|NCT02255357|100695905|FG000|Overall Study|Physician Decision|10|||
33217991|NCT02255357|100695906|FG001|Overall Study|Physician Decision|24|||
33217992|NCT00077064|100695907|FG000|Overall Study|Adverse Event|0|||
33217993|NCT00077064|100695908|FG001|Overall Study|Adverse Event|4|||
33353819|NCT01934504|101180820|FG002|Overall Study|Protocol Deviation|0|||
33353820|NCT01934504|101180821|FG003|Overall Study|Protocol Deviation|2|||
33353821|NCT01934504|101180818|FG000|Overall Study|Study Terminated by Sponsor|1|||
33619586|NCT00413218|102155070|FG001|Overall Study|Lost to Follow-up|17|||
33217994|NCT00077064|100695907|FG000|Overall Study|Patient refusal|0|||
33217995|NCT00077064|100695908|FG001|Overall Study|Patient refusal|2|||
33217996|NCT03298451|100695909|FG000|Overall Study|Death|275|||
33217997|NCT03298451|100695910|FG001|Overall Study|Death|260|||
33353822|NCT01934504|101180819|FG001|Overall Study|Study Terminated by Sponsor|0|||
33619587|NCT00413218|102155069|FG000|Overall Study|Admin|20|||
33619588|NCT00413218|102155070|FG001|Overall Study|Admin|14|||
33619589|NCT00413218|102155069|FG000|Overall Study|Missing|1|||
33619590|NCT00413218|102155070|FG001|Overall Study|Missing|0|||
33619591|NCT00413218|102155069|FG000|Overall Study|Withdrawal by Subject|9|||
33619592|NCT00413218|102155070|FG001|Overall Study|Withdrawal by Subject|1|||
33619593|NCT01486966|102155071|FG000|Overall Study|Adverse Event|0|||
33619594|NCT01486966|102155072|FG001|Overall Study|Adverse Event|1|||
33553924|NCT03446573|101927856|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
33553925|NCT03446573|101927857|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
33553926|NCT03446573|101927856|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
33553927|NCT03446573|101927857|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
33553928|NCT03446573|101927856|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
33553929|NCT03446573|101927857|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
33553930|NCT03446573|101927856|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
33553931|NCT03446573|101927857|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
33553932|NCT03446573|101927856|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
33553933|NCT03446573|101927857|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
33353823|NCT01934504|101180820|FG002|Overall Study|Study Terminated by Sponsor|5|||
33353824|NCT01934504|101180821|FG003|Overall Study|Study Terminated by Sponsor|5|||
33353825|NCT00943683|101180822|FG000|Overall Study|Adverse Event|3|||
33553934|NCT03446573|101927856|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
33553935|NCT03446573|101927857|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
33553936|NCT03446573|101927856|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
33553937|NCT03446573|101927857|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
33553938|NCT03528577|101927858|FG000|Sequence 1|Failed Spirometry|1|||
33553939|NCT03528577|101927858|FG000|Sequence 1|Restricted medication|1|||
33553940|NCT03528577|101927858|FG000|Sequence 2|Adverse Event|1|||
33553941|NCT03528577|101927858|FG000|Sequence 2|Withdrawal by Subject|1|||
33553942|NCT03528577|101927858|FG000|Sequence 2|Failed Spirometry|1|||
33553943|NCT03528577|101927858|FG000|Sequence 3|Failed Spirometry|1|||
33553944|NCT03528577|101927858|FG000|Sequence 4|Failed Spirometry|2|||
33553945|NCT03528577|101927858|FG000|Sequence 4|Adverse Event|1|||
33553946|NCT01421134|101927859|FG000|Overall Study|Adverse Event|3|||
33553947|NCT01421134|101927860|FG001|Overall Study|Adverse Event|5|||
33553948|NCT01421134|101927859|FG000|Overall Study|Lack of Efficacy|2|||
33353826|NCT00943683|101180823|FG001|Overall Study|Adverse Event|3|||
33353827|NCT00943683|101180822|FG000|Overall Study|Lost to Follow-up|1|||
33353828|NCT00943683|101180823|FG001|Overall Study|Lost to Follow-up|1|||
33413108|NCT00442572|101403573|FG001|Overall Study|Withdrawal by Subject|1|||
33413109|NCT01463631|101403577|FG000|Overall Study|Withdrawal by Subject|0|||
33553949|NCT01421134|101927860|FG001|Overall Study|Lack of Efficacy|4|||
33553950|NCT01421134|101927859|FG000|Overall Study|Protocol Violation|0|||
33553951|NCT01421134|101927860|FG001|Overall Study|Protocol Violation|3|||
33619595|NCT01486966|102155071|FG000|Overall Study|Withdrawal by Subject|0|||
33217998|NCT03298451|100695911|FG002|Overall Study|Death|122|||
33353829|NCT00943683|101180822|FG000|Overall Study|Protocol Violation|1|||
33413110|NCT01463631|101403578|FG001|Overall Study|Withdrawal by Subject|0|||
33413111|NCT01463631|101403579|FG002|Overall Study|Withdrawal by Subject|0|||
33553952|NCT01421134|101927859|FG000|Overall Study|Withdrawal by Subject|1|||
33553953|NCT01421134|101927860|FG001|Overall Study|Withdrawal by Subject|1|||
33619596|NCT01486966|102155072|FG001|Overall Study|Withdrawal by Subject|1|||
33619597|NCT02950480|102155073|FG000|Overall Study|Withdrawal by Subject|1|||
33619598|NCT02950480|102155074|FG001|Overall Study|Withdrawal by Subject|0|||
33353830|NCT00943683|101180823|FG001|Overall Study|Protocol Violation|2|||
33353831|NCT00943683|101180822|FG000|Overall Study|Withdrawal by Subject|1|||
33353832|NCT00943683|101180823|FG001|Overall Study|Withdrawal by Subject|0|||
33353833|NCT00943683|101180822|FG000|Overall Study|Patient Moved|1|||
33353834|NCT00943683|101180823|FG001|Overall Study|Patient Moved|0|||
33353835|NCT02599402|101180828|FG000|Overall Study|Disease progression|153|||
33353836|NCT02599402|101180828|FG000|Overall Study|Study drug toxicity|201|||
33353837|NCT02599402|101180828|FG000|Overall Study|Death|26|||
33353838|NCT02599402|101180828|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
33553954|NCT01421134|101927859|FG000|Overall Study|Administrative|0|||
33553955|NCT01421134|101927860|FG001|Overall Study|Administrative|1|||
33553956|NCT01421134|101927859|FG000|Overall Study|Lost to Follow-up|1|||
33553957|NCT01421134|101927860|FG001|Overall Study|Lost to Follow-up|1|||
33553958|NCT00191152|101927861|FG000|Initial Treatment|Adverse Event|43|||
33553959|NCT00191152|101927862|FG001|Initial Treatment|Adverse Event|67|||
33553960|NCT00191152|101927861|FG000|Initial Treatment|Physician Decision|40|||
33553961|NCT00191152|101927862|FG001|Initial Treatment|Physician Decision|31|||
33553962|NCT00191152|101927861|FG000|Initial Treatment|Withdrawal by Subject|40|||
33553963|NCT00191152|101927862|FG001|Initial Treatment|Withdrawal by Subject|28|||
33553964|NCT00191152|101927861|FG000|Initial Treatment|Lost to Follow-up|0|||
33553965|NCT00191152|101927862|FG001|Initial Treatment|Lost to Follow-up|6|||
33553966|NCT00191152|101927861|FG000|Initial Treatment|Other|18|||
33553967|NCT00191152|101927862|FG001|Initial Treatment|Other|21|||
33553968|NCT00191152|101927861|FG000|Crossover Treatment|Adverse Event|8|||
33353839|NCT02599402|101180828|FG000|Overall Study|Participant request to discontinue study treatment|13|||
33353840|NCT02599402|101180828|FG000|Overall Study|Participant withdrew consent|5|||
33353841|NCT02599402|101180828|FG000|Overall Study|Lost to Follow-up|1|||
33353842|NCT02599402|101180828|FG000|Overall Study|Maximum Clinical Benefit|7|||
33353843|NCT02599402|101180828|FG000|Overall Study|Poor/non-compliance|1|||
33353844|NCT02599402|101180828|FG000|Overall Study|Pregnancy|1|||
33353845|NCT02599402|101180828|FG000|Overall Study|Participant no longer met study criteria|7|||
33353846|NCT02599402|101180828|FG000|Overall Study|Other Reasons|95|||
33353847|NCT01974817|101180829|FG000|Overall Study|Death|4|||
33353848|NCT01974817|101180829|FG000|Overall Study|Lost to Follow-up|2|||
33353849|NCT01974817|101180829|FG000|Overall Study|Protocol Violation|2|||
33353850|NCT03213665|101180830|FG000|Overall Study|Adverse Event|1|||
33353851|NCT03213665|101180830|FG000|Overall Study|Physician Decision|2|||
33353852|NCT03213665|101180830|FG000|Overall Study|Withdrawal by Subject|3|||
33353853|NCT03213665|101180830|FG000|Overall Study|Progressive Disease|13|||
33353854|NCT00496366|101180833|FG000|Overall Study|Death|1|||
33353855|NCT02318095|101180834|FG000|Overall Study|Adverse Event|1|||
33353856|NCT01122927|101180835|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
33353857|NCT01122927|101180836|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
33353858|NCT01122927|101180835|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
33353859|NCT01122927|101180836|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
33353860|NCT01122927|101180835|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
33353861|NCT01122927|101180836|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
33353862|NCT01122927|101180835|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
33353863|NCT01122927|101180836|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
33353864|NCT01122927|101180835|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
33353865|NCT01122927|101180836|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
33353866|NCT01122927|101180835|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
33353867|NCT01122927|101180836|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
33353868|NCT01122927|101180835|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
33353869|NCT01122927|101180836|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
33353870|NCT01122927|101180835|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
33353871|NCT01122927|101180836|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
33353872|NCT01122927|101180835|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
33353873|NCT01122927|101180836|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
33353874|NCT01122927|101180835|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
33353875|NCT01122927|101180836|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
33353876|NCT01122927|101180835|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
33353877|NCT01122927|101180836|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
33353878|NCT01122927|101180835|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
33353879|NCT01122927|101180836|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
33353880|NCT00833092|101180837|FG000|Overall Study|Withdrawal by Subject|2|||
33619599|NCT04303559|102155075|FG000|Overall Study|Study closed due to poor enrollment.|1|||
33619600|NCT04276233|102155082|FG000|Overall Study|Adverse Event|1|||
33353881|NCT00833092|101180838|FG001|Overall Study|Withdrawal by Subject|3|||
33353882|NCT00833092|101180837|FG000|Overall Study|Protocol Violation|2|||
33353883|NCT00833092|101180838|FG001|Overall Study|Protocol Violation|1|||
33353884|NCT00833092|101180837|FG000|Overall Study|Diarrhea|0|||
33353885|NCT00833092|101180838|FG001|Overall Study|Diarrhea|2|||
33353886|NCT00833092|101180837|FG000|Overall Study|constipation|0|||
33413112|NCT01463631|101403580|FG003|Overall Study|Withdrawal by Subject|1|||
33413113|NCT01463631|101403577|FG000|Overall Study|Death|0|||
33413114|NCT01463631|101403578|FG001|Overall Study|Death|0|||
33413115|NCT01463631|101403579|FG002|Overall Study|Death|1|||
33353887|NCT00833092|101180838|FG001|Overall Study|constipation|1|||
33353888|NCT00809133|101180839|FG000|Overall Study|Progressive disease|2|||
33413116|NCT01463631|101403580|FG003|Overall Study|Death|0|||
33353889|NCT00809133|101180840|FG001|Overall Study|Progressive disease|5|||
33353890|NCT00809133|101180841|FG002|Overall Study|Progressive disease|5|||
33353891|NCT00809133|101180842|FG003|Overall Study|Progressive disease|3|||
33353892|NCT00809133|101180843|FG004|Overall Study|Progressive disease|4|||
33553969|NCT00191152|101927862|FG001|Crossover Treatment|Adverse Event|8|||
33553970|NCT00191152|101927861|FG000|Crossover Treatment|Physician Decision|7|||
33353893|NCT00809133|101180844|FG005|Overall Study|Progressive disease|1|||
33353894|NCT00809133|101180845|FG006|Overall Study|Progressive disease|3|||
33353895|NCT00809133|101180846|FG007|Overall Study|Progressive disease|3|||
33353896|NCT00809133|101180847|FG008|Overall Study|Progressive disease|3|||
33353897|NCT00809133|101180848|FG009|Overall Study|Progressive disease|9|||
33353898|NCT00809133|101180849|FG010|Overall Study|Progressive disease|5|||
33353899|NCT00809133|101180850|FG011|Overall Study|Progressive disease|7|||
33353900|NCT00809133|101180851|FG012|Overall Study|Progressive disease|5|||
33353901|NCT00809133|101180852|FG013|Overall Study|Progressive disease|4|||
33353902|NCT00809133|101180839|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33353903|NCT00809133|101180840|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33353904|NCT00809133|101180841|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33353905|NCT00809133|101180842|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33353906|NCT00809133|101180843|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33353907|NCT00809133|101180844|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
33413117|NCT01463631|101403577|FG000|Overall Study|Progressive Disease|0|||
33413118|NCT01463631|101403578|FG001|Overall Study|Progressive Disease|0|||
33413119|NCT01463631|101403579|FG002|Overall Study|Progressive Disease|0|||
33413120|NCT01463631|101403580|FG003|Overall Study|Progressive Disease|5|||
33413121|NCT01422876|101403582|FG000|Week 24|Lost to Follow-up|1|||
33413122|NCT01422876|101403583|FG001|Week 24|Lost to Follow-up|1|||
33413123|NCT01422876|101403584|FG002|Week 24|Lost to Follow-up|2|||
33413124|NCT01422876|101403585|FG003|Week 24|Lost to Follow-up|4|||
33553971|NCT00191152|101927862|FG001|Crossover Treatment|Physician Decision|7|||
33553972|NCT00191152|101927861|FG000|Crossover Treatment|Withdrawal by Subject|6|||
33553973|NCT00191152|101927862|FG001|Crossover Treatment|Withdrawal by Subject|9|||
33553974|NCT00191152|101927861|FG000|Crossover Treatment|Lost to Follow-up|2|||
33553975|NCT00191152|101927862|FG001|Crossover Treatment|Lost to Follow-up|1|||
33553976|NCT00191152|101927861|FG000|Crossover Treatment|Other|4|||
33553977|NCT00191152|101927862|FG001|Crossover Treatment|Other|3|||
33353908|NCT00809133|101180845|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
33353909|NCT00809133|101180846|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
33353910|NCT00809133|101180847|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33353911|NCT00809133|101180848|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33353912|NCT00809133|101180849|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33353913|NCT00809133|101180850|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33353914|NCT00809133|101180851|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33413125|NCT01422876|101403586|FG004|Week 24|Lost to Follow-up|2|||
33413126|NCT01422876|101403587|FG005|Week 24|Lost to Follow-up|0|||
33553978|NCT01297244|101927871|FG000|Overall Study|Progressive disease|22|||
33553979|NCT01297244|101927872|FG001|Overall Study|Progressive disease|3|||
33553980|NCT01297244|101927871|FG000|Overall Study|Adverse Event|9|||
33553981|NCT01297244|101927872|FG001|Overall Study|Adverse Event|1|||
33553982|NCT01297244|101927871|FG000|Overall Study|Death|1|||
33553983|NCT01297244|101927872|FG001|Overall Study|Death|1|||
33619601|NCT04276233|102155082|FG000|Overall Study|Lost to Follow-up|3|||
33619602|NCT04276233|102155082|FG000|Overall Study|Physician Decision|4|||
33413127|NCT01422876|101403588|FG006|Week 24|Lost to Follow-up|1|||
33413128|NCT01422876|101403589|FG007|Week 24|Lost to Follow-up|3|||
33413129|NCT01422876|101403590|FG008|Week 24|Lost to Follow-up|3|||
33413130|NCT01422876|101403591|FG009|Week 24|Lost to Follow-up|4|||
33413131|NCT01422876|101403582|FG000|Week 24|Consent withdrawn|5|||
33353915|NCT00809133|101180852|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
33353916|NCT00809133|101180839|FG000|Overall Study|Other adverse event|1|||
33353917|NCT00809133|101180840|FG001|Overall Study|Other adverse event|1|||
33413132|NCT01422876|101403583|FG001|Week 24|Consent withdrawn|1|||
33553984|NCT01297244|101927871|FG000|Overall Study|Clinical progression|1|||
33553985|NCT01297244|101927872|FG001|Overall Study|Clinical progression|1|||
33553986|NCT01297244|101927871|FG000|Overall Study|Withdrawal by Subject|2|||
33413133|NCT01422876|101403584|FG002|Week 24|Consent withdrawn|3|||
33413134|NCT01422876|101403585|FG003|Week 24|Consent withdrawn|4|||
33413135|NCT01422876|101403586|FG004|Week 24|Consent withdrawn|5|||
33413136|NCT01422876|101403587|FG005|Week 24|Consent withdrawn|6|||
33353918|NCT00809133|101180841|FG002|Overall Study|Other adverse event|1|||
33553987|NCT01297244|101927872|FG001|Overall Study|Withdrawal by Subject|0|||
33553988|NCT01158404|101927873|FG000|Overall Study|Withdrawal by Subject|0|||
33353919|NCT00809133|101180842|FG003|Overall Study|Other adverse event|0|||
33353920|NCT00809133|101180843|FG004|Overall Study|Other adverse event|0|||
33353921|NCT00809133|101180844|FG005|Overall Study|Other adverse event|3|||
33353922|NCT00809133|101180845|FG006|Overall Study|Other adverse event|2|||
33353923|NCT00809133|101180846|FG007|Overall Study|Other adverse event|4|||
33353924|NCT00809133|101180847|FG008|Overall Study|Other adverse event|0|||
33553989|NCT01158404|101927874|FG001|Overall Study|Withdrawal by Subject|1|||
33553990|NCT01158404|101927875|FG002|Overall Study|Withdrawal by Subject|0|||
33553991|NCT01158404|101927876|FG003|Overall Study|Withdrawal by Subject|0|||
33553992|NCT01158404|101927877|FG004|Overall Study|Withdrawal by Subject|3|||
33553993|NCT01158404|101927878|FG005|Overall Study|Withdrawal by Subject|1|||
33553994|NCT01158404|101927879|FG006|Overall Study|Withdrawal by Subject|0|||
33553995|NCT01158404|101927880|FG007|Overall Study|Withdrawal by Subject|1|||
33553996|NCT01158404|101927873|FG000|Overall Study|Physician Decision|0|||
33553997|NCT01158404|101927874|FG001|Overall Study|Physician Decision|0|||
33553998|NCT01158404|101927875|FG002|Overall Study|Physician Decision|0|||
33553999|NCT01158404|101927876|FG003|Overall Study|Physician Decision|0|||
33554000|NCT01158404|101927877|FG004|Overall Study|Physician Decision|0|||
33554001|NCT01158404|101927878|FG005|Overall Study|Physician Decision|0|||
33554002|NCT01158404|101927879|FG006|Overall Study|Physician Decision|0|||
33554003|NCT01158404|101927880|FG007|Overall Study|Physician Decision|1|||
33554004|NCT01158404|101927873|FG000|Overall Study|Progressive Disease|0|||
33554005|NCT01158404|101927874|FG001|Overall Study|Progressive Disease|0|||
33554006|NCT01158404|101927875|FG002|Overall Study|Progressive Disease|0|||
33554007|NCT01158404|101927876|FG003|Overall Study|Progressive Disease|0|||
33554008|NCT01158404|101927877|FG004|Overall Study|Progressive Disease|0|||
33554009|NCT01158404|101927878|FG005|Overall Study|Progressive Disease|0|||
33554010|NCT01158404|101927879|FG006|Overall Study|Progressive Disease|1|||
33554011|NCT01158404|101927880|FG007|Overall Study|Progressive Disease|0|||
33554012|NCT02931539|101927884|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
33554013|NCT02931539|101927885|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
33554014|NCT02931539|101927886|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
33554015|NCT02931539|101927884|FG000|Period 1: Treatment Phase|Adverse Event|5|||
33554016|NCT02931539|101927885|FG001|Period 1: Treatment Phase|Adverse Event|1|||
33554017|NCT02931539|101927886|FG002|Period 1: Treatment Phase|Adverse Event|0|||
33554018|NCT02931539|101927884|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
33554019|NCT02931539|101927885|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
33554020|NCT02931539|101927886|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
33554021|NCT02931539|101927884|FG000|Period 1: Treatment Phase|Death|8|||
33554022|NCT02931539|101927885|FG001|Period 1: Treatment Phase|Death|24|||
33554023|NCT02931539|101927886|FG002|Period 1: Treatment Phase|Death|0|||
33554024|NCT02931539|101927884|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
33554025|NCT02931539|101927885|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
33554026|NCT02931539|101927886|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
33554027|NCT02931539|101927884|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
33554028|NCT02931539|101927885|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
33554029|NCT02931539|101927886|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
33554030|NCT02931539|101927884|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
33554031|NCT02931539|101927885|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
33554032|NCT02931539|101927886|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
33554033|NCT02931539|101927884|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
33554034|NCT02931539|101927885|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
33554035|NCT02931539|101927886|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
33554036|NCT01112267|101927887|FG000|Overall Study|Adverse Event|24|||
33554037|NCT01112267|101927888|FG001|Overall Study|Adverse Event|6|||
33554038|NCT01112267|101927887|FG000|Overall Study|Withdrawal by Subject|3|||
33554039|NCT01112267|101927888|FG001|Overall Study|Withdrawal by Subject|5|||
33554040|NCT01112267|101927887|FG000|Overall Study|Protocol Violation|5|||
33554041|NCT01112267|101927888|FG001|Overall Study|Protocol Violation|3|||
33619603|NCT04276233|102155082|FG000|Overall Study|Withdrawal by Subject|2|||
33353925|NCT00809133|101180848|FG009|Overall Study|Other adverse event|0|||
33353926|NCT00809133|101180849|FG010|Overall Study|Other adverse event|1|||
33353927|NCT00809133|101180850|FG011|Overall Study|Other adverse event|1|||
33353928|NCT00809133|101180851|FG012|Overall Study|Other adverse event|0|||
33353929|NCT00809133|101180852|FG013|Overall Study|Other adverse event|1|||
33353930|NCT00809133|101180839|FG000|Overall Study|Lost to Follow-up|0|||
33554042|NCT01112267|101927887|FG000|Overall Study|Participants not compliant|1|||
33554043|NCT01112267|101927888|FG001|Overall Study|Participants not compliant|2|||
33554044|NCT01112267|101927887|FG000|Overall Study|Participants not receive any study drug|1|||
33554045|NCT01112267|101927888|FG001|Overall Study|Participants not receive any study drug|2|||
33353931|NCT00809133|101180840|FG001|Overall Study|Lost to Follow-up|0|||
33353932|NCT00809133|101180841|FG002|Overall Study|Lost to Follow-up|0|||
33353933|NCT00809133|101180842|FG003|Overall Study|Lost to Follow-up|0|||
33353934|NCT00809133|101180843|FG004|Overall Study|Lost to Follow-up|0|||
33353935|NCT00809133|101180844|FG005|Overall Study|Lost to Follow-up|1|||
33353936|NCT00809133|101180845|FG006|Overall Study|Lost to Follow-up|0|||
33353937|NCT00809133|101180846|FG007|Overall Study|Lost to Follow-up|0|||
33353938|NCT00809133|101180847|FG008|Overall Study|Lost to Follow-up|0|||
33554046|NCT00366535|101927894|FG000|First Phase: 12 Weeks|Adverse Event|1|||
33554047|NCT00366535|101927895|FG001|First Phase: 12 Weeks|Adverse Event|3|||
33554048|NCT00366535|101927894|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
33554049|NCT00366535|101927895|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
33554050|NCT00366535|101927894|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
33554051|NCT00366535|101927895|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
33554052|NCT00366535|101927894|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
33554053|NCT00366535|101927895|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
33554054|NCT02821000|101927906|FG000|Overall Study|Death|89|||
33554055|NCT02821000|101927906|FG000|Overall Study|Sponsor Decision|12|||
33554056|NCT02821000|101927906|FG000|Overall Study|Withdrawal by Subject|2|||
33554057|NCT03462563|101927907|FG000|Overall Study|Death|1|||
33554058|NCT03462563|101927908|FG001|Overall Study|Death|1|||
33554059|NCT03462563|101927907|FG000|Overall Study|Termination of study|2|||
33554060|NCT03462563|101927908|FG001|Overall Study|Termination of study|1|||
33554061|NCT03462563|101927907|FG000|Overall Study|Adverse Event|1|||
33554062|NCT03462563|101927908|FG001|Overall Study|Adverse Event|3|||
33619604|NCT02034877|102155083|FG000|Overall Study|Lost to Follow-up|0|||
33619605|NCT02034877|102155084|FG001|Overall Study|Lost to Follow-up|3|||
33619606|NCT02034877|102155083|FG000|Overall Study|No Longer Willing to Participate|0|||
33619607|NCT02034877|102155084|FG001|Overall Study|No Longer Willing to Participate|3|||
33619608|NCT00782717|102155085|FG000|Overall Study|Adverse Event|2|||
33619609|NCT00782717|102155086|FG001|Overall Study|Adverse Event|5|||
33619610|NCT00782717|102155085|FG000|Overall Study|Patient decision unrelated to AE|6|||
33619611|NCT00782717|102155086|FG001|Overall Study|Patient decision unrelated to AE|3|||
33619612|NCT00782717|102155085|FG000|Overall Study|Noncompliance|2|||
33619613|NCT00782717|102155086|FG001|Overall Study|Noncompliance|1|||
33619614|NCT00782717|102155085|FG000|Overall Study|Treatment failure|3|||
33619615|NCT00782717|102155086|FG001|Overall Study|Treatment failure|14|||
33619616|NCT00782717|102155085|FG000|Overall Study|Enrollment close prior to surgery|1|||
33619617|NCT00782717|102155086|FG001|Overall Study|Enrollment close prior to surgery|0|||
33619618|NCT00782717|102155085|FG000|Overall Study|Did not meet entrance criteria|1|||
33619619|NCT00782717|102155086|FG001|Overall Study|Did not meet entrance criteria|3|||
33619620|NCT00782717|102155085|FG000|Overall Study|Exited in error|0|||
33619621|NCT00782717|102155086|FG001|Overall Study|Exited in error|2|||
33619622|NCT03066193|102155089|FG000|Overall Study|Withdrawal by Subject|1|||
33619623|NCT03078556|102155090|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
33619624|NCT03078556|102155091|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
33353939|NCT00809133|101180848|FG009|Overall Study|Lost to Follow-up|0|||
33353940|NCT00809133|101180849|FG010|Overall Study|Lost to Follow-up|0|||
33353941|NCT00809133|101180850|FG011|Overall Study|Lost to Follow-up|0|||
33353942|NCT00809133|101180851|FG012|Overall Study|Lost to Follow-up|0|||
33353943|NCT00809133|101180852|FG013|Overall Study|Lost to Follow-up|0|||
33353944|NCT00809133|101180839|FG000|Overall Study|Consent withdrawn|0|||
33353945|NCT00809133|101180840|FG001|Overall Study|Consent withdrawn|0|||
33353946|NCT00809133|101180841|FG002|Overall Study|Consent withdrawn|0|||
33353947|NCT00809133|101180842|FG003|Overall Study|Consent withdrawn|0|||
33353948|NCT00809133|101180843|FG004|Overall Study|Consent withdrawn|1|||
33353949|NCT00809133|101180844|FG005|Overall Study|Consent withdrawn|0|||
33353950|NCT00809133|101180845|FG006|Overall Study|Consent withdrawn|0|||
33353951|NCT00809133|101180846|FG007|Overall Study|Consent withdrawn|0|||
33353952|NCT00809133|101180847|FG008|Overall Study|Consent withdrawn|0|||
33353953|NCT00809133|101180848|FG009|Overall Study|Consent withdrawn|0|||
33353954|NCT00809133|101180849|FG010|Overall Study|Consent withdrawn|0|||
33353955|NCT00809133|101180850|FG011|Overall Study|Consent withdrawn|0|||
33619625|NCT03078556|102155092|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
33353956|NCT00809133|101180851|FG012|Overall Study|Consent withdrawn|0|||
33353957|NCT00809133|101180852|FG013|Overall Study|Consent withdrawn|0|||
33353958|NCT00809133|101180839|FG000|Overall Study|Other not mentioned above|0|||
33353959|NCT00809133|101180840|FG001|Overall Study|Other not mentioned above|1|||
33353960|NCT00809133|101180841|FG002|Overall Study|Other not mentioned above|0|||
33619626|NCT03078556|102155093|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
33619627|NCT03078556|102155090|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
33619628|NCT03078556|102155091|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
33353961|NCT00809133|101180842|FG003|Overall Study|Other not mentioned above|0|||
33619629|NCT03078556|102155092|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
33631304|NCT03486912|102202914|FG000|Treatment Period|Adverse Event|0|||
33353962|NCT00809133|101180843|FG004|Overall Study|Other not mentioned above|0|||
33353963|NCT00809133|101180844|FG005|Overall Study|Other not mentioned above|1|||
33554063|NCT03462563|101927907|FG000|Overall Study|Unspecified reason|10|||
33554064|NCT03462563|101927908|FG001|Overall Study|Unspecified reason|12|||
33619630|NCT03078556|102155093|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
33619631|NCT03078556|102155090|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
33619632|NCT03078556|102155091|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
33619633|NCT03078556|102155092|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
33619634|NCT03078556|102155093|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
33619635|NCT03078556|102155090|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
33619636|NCT03078556|102155091|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
33619637|NCT03078556|102155092|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
33619638|NCT03078556|102155093|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
33619639|NCT01698814|102155094|FG000|Overall Study|Adverse Event|0|||
33619640|NCT01698814|102155095|FG001|Overall Study|Adverse Event|2|||
33619641|NCT01698814|102155094|FG000|Overall Study|Lost to Follow-up|0|||
33619642|NCT01698814|102155095|FG001|Overall Study|Lost to Follow-up|1|||
33619643|NCT01698814|102155094|FG000|Overall Study|Pregnancy|1|||
33619644|NCT01698814|102155095|FG001|Overall Study|Pregnancy|0|||
33554065|NCT03462563|101927907|FG000|Overall Study|Physician Decision|1|||
33554066|NCT03462563|101927908|FG001|Overall Study|Physician Decision|0|||
33554067|NCT03016403|101927909|FG000|Baseline|Death|5|||
33554068|NCT03016403|101927910|FG001|Baseline|Death|8|||
33554069|NCT03016403|101927911|FG002|Baseline|Death|1|||
33554070|NCT03016403|101927912|FG003|Baseline|Death|0|||
33554071|NCT03016403|101927909|FG000|Baseline|Withdrawal by Subject|2|||
33619645|NCT01698814|102155094|FG000|Overall Study|Randomized in error|1|||
33619646|NCT01698814|102155095|FG001|Overall Study|Randomized in error|0|||
33619647|NCT02294058|102155096|FG000|Overall Study|Adverse Event|16|||
33619648|NCT02294058|102155097|FG001|Overall Study|Adverse Event|7|||
33619649|NCT02294058|102155098|FG002|Overall Study|Adverse Event|13|||
33619650|NCT02294058|102155096|FG000|Overall Study|Lack of Efficacy|3|||
33619651|NCT02294058|102155097|FG001|Overall Study|Lack of Efficacy|3|||
33619652|NCT02294058|102155098|FG002|Overall Study|Lack of Efficacy|0|||
33619653|NCT02294058|102155096|FG000|Overall Study|Lost to Follow-up|1|||
33619654|NCT02294058|102155097|FG001|Overall Study|Lost to Follow-up|0|||
33554072|NCT03016403|101927910|FG001|Baseline|Withdrawal by Subject|8|||
33554073|NCT03016403|101927911|FG002|Baseline|Withdrawal by Subject|4|||
33619655|NCT02294058|102155098|FG002|Overall Study|Lost to Follow-up|2|||
33619656|NCT02294058|102155096|FG000|Overall Study|Withdrawal by Subject|10|||
33631305|NCT03486912|102202915|FG001|Treatment Period|Adverse Event|1|||
33554074|NCT03016403|101927912|FG003|Baseline|Withdrawal by Subject|10|||
33554075|NCT03016403|101927909|FG000|Baseline|Lost to Follow-up|9|||
33554076|NCT03016403|101927910|FG001|Baseline|Lost to Follow-up|11|||
33554077|NCT03016403|101927911|FG002|Baseline|Lost to Follow-up|6|||
33554078|NCT03016403|101927912|FG003|Baseline|Lost to Follow-up|24|||
33554079|NCT03016403|101927909|FG000|6-week Follow-up|Death|1|||
33554080|NCT03016403|101927910|FG001|6-week Follow-up|Death|4|||
33554081|NCT03016403|101927911|FG002|6-week Follow-up|Death|0|||
33554082|NCT03016403|101927912|FG003|6-week Follow-up|Death|0|||
33554083|NCT03016403|101927909|FG000|6-week Follow-up|Lost to Follow-up|2|||
33554084|NCT03016403|101927910|FG001|6-week Follow-up|Lost to Follow-up|7|||
33619657|NCT02294058|102155097|FG001|Overall Study|Withdrawal by Subject|14|||
33619658|NCT02294058|102155098|FG002|Overall Study|Withdrawal by Subject|13|||
33619659|NCT02294058|102155096|FG000|Overall Study|Physician Decision|2|||
33619660|NCT02294058|102155097|FG001|Overall Study|Physician Decision|1|||
33619661|NCT02294058|102155098|FG002|Overall Study|Physician Decision|0|||
33619662|NCT02294058|102155096|FG000|Overall Study|Miscellaneous|4|||
33554085|NCT03016403|101927911|FG002|6-week Follow-up|Lost to Follow-up|4|||
33554086|NCT03016403|101927912|FG003|6-week Follow-up|Lost to Follow-up|8|||
33554087|NCT03016403|101927909|FG000|6-week Follow-up|Withdrawal by Subject|0|||
33619663|NCT02294058|102155097|FG001|Overall Study|Miscellaneous|1|||
33619664|NCT02294058|102155098|FG002|Overall Study|Miscellaneous|1|||
33413137|NCT01422876|101403588|FG006|Week 24|Consent withdrawn|5|||
33413138|NCT01422876|101403589|FG007|Week 24|Consent withdrawn|4|||
33413139|NCT01422876|101403590|FG008|Week 24|Consent withdrawn|3|||
33413140|NCT01422876|101403591|FG009|Week 24|Consent withdrawn|6|||
33619665|NCT00740584|102155099|FG000|Overall Study|Withdrawal by Subject|1|||
33619666|NCT01054456|102155100|FG000|Overall Study|Other|1|||
33619667|NCT03191630|102155103|FG000|Overall Study|Lost to Follow-up|7|||
33619668|NCT03191630|102155104|FG001|Overall Study|Lost to Follow-up|7|||
33353964|NCT00809133|101180845|FG006|Overall Study|Other not mentioned above|0|||
33353965|NCT00809133|101180846|FG007|Overall Study|Other not mentioned above|0|||
33353966|NCT00809133|101180847|FG008|Overall Study|Other not mentioned above|0|||
33353967|NCT00809133|101180848|FG009|Overall Study|Other not mentioned above|0|||
33353968|NCT00809133|101180849|FG010|Overall Study|Other not mentioned above|0|||
33353969|NCT00809133|101180850|FG011|Overall Study|Other not mentioned above|0|||
33353970|NCT00809133|101180851|FG012|Overall Study|Other not mentioned above|0|||
33353971|NCT00809133|101180852|FG013|Overall Study|Other not mentioned above|0|||
33353972|NCT00828451|101180855|FG000|Overall Study|Death|2|||
33353973|NCT00828451|101180855|FG000|Overall Study|Lack of intravenous line|7|||
33353974|NCT00828451|101180855|FG000|Overall Study|Withdrawal by Subject|1|||
33353975|NCT00828451|101180855|FG000|Overall Study|Deterioration in clinical status|1|||
33353976|NCT01850615|101180856|FG000|Overall Study|Protocol Violation|4|||
33353977|NCT01850615|101180857|FG001|Overall Study|Protocol Violation|1|||
33353978|NCT01850615|101180856|FG000|Overall Study|Adverse Event|2|||
33353979|NCT01850615|101180857|FG001|Overall Study|Adverse Event|1|||
33353980|NCT01850615|101180856|FG000|Overall Study|Withdrawal by Subject|3|||
33353981|NCT01850615|101180857|FG001|Overall Study|Withdrawal by Subject|1|||
33353982|NCT01850615|101180856|FG000|Overall Study|Lost to Follow-up|0|||
33353983|NCT01850615|101180857|FG001|Overall Study|Lost to Follow-up|1|||
33353984|NCT01850615|101180856|FG000|Overall Study|Unclassified|0|||
33353985|NCT01850615|101180857|FG001|Overall Study|Unclassified|1|||
33353986|NCT01262898|101180858|FG000|Overall Study|Protocol Violation|1|||
33353987|NCT01262898|101180859|FG001|Overall Study|Protocol Violation|1|||
33353988|NCT01262898|101180860|FG002|Overall Study|Protocol Violation|0|||
33353989|NCT01262898|101180861|FG003|Overall Study|Protocol Violation|0|||
33353990|NCT01262898|101180858|FG000|Overall Study|Lost to Follow-up|1|||
33353991|NCT01262898|101180859|FG001|Overall Study|Lost to Follow-up|0|||
33353992|NCT01262898|101180860|FG002|Overall Study|Lost to Follow-up|0|||
33353993|NCT01262898|101180861|FG003|Overall Study|Lost to Follow-up|0|||
33353994|NCT01262898|101180858|FG000|Overall Study|Withdrawal by Subject|1|||
33353995|NCT01262898|101180859|FG001|Overall Study|Withdrawal by Subject|1|||
33353996|NCT01262898|101180860|FG002|Overall Study|Withdrawal by Subject|0|||
33353997|NCT01262898|101180861|FG003|Overall Study|Withdrawal by Subject|0|||
33353998|NCT02498821|101180862|FG000|Overall Study|Screen failure|3|||
33353999|NCT02498821|101180863|FG001|Overall Study|Screen failure|5|||
33354000|NCT03258814|101180864|FG000|Overall Study|Early Termination|4|||
33354001|NCT03258814|101180865|FG001|Overall Study|Early Termination|3|||
33354002|NCT03258814|101180866|FG002|Overall Study|Early Termination|10|||
33354003|NCT01445171|101180867|FG000|Overall Study|Lost to Follow-up|11|||
33354004|NCT01445171|101180867|FG000|Overall Study|Withdrawal by Subject|16|||
33354005|NCT01445171|101180867|FG000|Overall Study|Death|51|||
33354006|NCT01445171|101180867|FG000|Overall Study|Subjects declined to return for followup|9|||
33554088|NCT03016403|101927910|FG001|6-week Follow-up|Withdrawal by Subject|2|||
33554089|NCT03016403|101927911|FG002|6-week Follow-up|Withdrawal by Subject|0|||
33554090|NCT03016403|101927912|FG003|6-week Follow-up|Withdrawal by Subject|1|||
33619669|NCT01702025|102155109|FG000|Overall Study|Equipment failure|1|||
33619670|NCT01702025|102155110|FG001|Overall Study|Equipment failure|0|||
33413141|NCT01422876|101403582|FG000|Week 24|Death|0|||
33413142|NCT01422876|101403583|FG001|Week 24|Death|1|||
33554091|NCT03016403|101927909|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
33554092|NCT03016403|101927910|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
33554093|NCT03016403|101927911|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
33554094|NCT03016403|101927912|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
33554095|NCT03016403|101927909|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
33554096|NCT03016403|101927910|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
33554097|NCT03016403|101927911|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
33554098|NCT03016403|101927912|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
33554099|NCT03016403|101927909|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
33413143|NCT01422876|101403584|FG002|Week 24|Death|0|||
33413144|NCT01422876|101403585|FG003|Week 24|Death|0|||
33354007|NCT01445171|101180867|FG000|Overall Study|Consented but did not receive device|8|||
33354008|NCT04317690|101180868|FG000|Overall Study|did not have complete information for primary outcome|0|||
33354009|NCT04317690|101180869|FG001|Overall Study|did not have complete information for primary outcome|4|||
33354010|NCT04317690|101180870|FG002|Overall Study|did not have complete information for primary outcome|0|||
33354011|NCT04317690|101180871|FG003|Overall Study|did not have complete information for primary outcome|2|||
33354012|NCT04317690|101180872|FG004|Overall Study|did not have complete information for primary outcome|0|||
33354013|NCT01061008|101180875|FG000|Overall Study|Badiocephalic fistula failed|3|||
33354014|NCT01061008|101180876|FG001|Overall Study|Badiocephalic fistula failed|2|||
33354015|NCT01061008|101180875|FG000|Overall Study|Death|1|||
33354016|NCT01061008|101180876|FG001|Overall Study|Death|0|||
33354017|NCT01061008|101180875|FG000|Overall Study|Withdrawal by Subject|1|||
33354018|NCT01061008|101180876|FG001|Overall Study|Withdrawal by Subject|3|||
33354019|NCT01061008|101180875|FG000|Overall Study|Unable to exercise following surgery|1|||
33413145|NCT01422876|101403586|FG004|Week 24|Death|0|||
33554100|NCT03016403|101927910|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
33619671|NCT01702025|102155111|FG002|Overall Study|Equipment failure|0|||
33619672|NCT01702025|102155112|FG003|Overall Study|Equipment failure|0|||
33413146|NCT01422876|101403587|FG005|Week 24|Death|0|||
33413147|NCT01422876|101403588|FG006|Week 24|Death|0|||
33413148|NCT01422876|101403589|FG007|Week 24|Death|0|||
33413149|NCT01422876|101403590|FG008|Week 24|Death|0|||
33413150|NCT01422876|101403591|FG009|Week 24|Death|0|||
33619673|NCT01702025|102155109|FG000|Overall Study|Adverse Event|1|||
33619674|NCT01702025|102155110|FG001|Overall Study|Adverse Event|1|||
33619675|NCT01702025|102155111|FG002|Overall Study|Adverse Event|1|||
33619676|NCT01702025|102155112|FG003|Overall Study|Adverse Event|0|||
33619677|NCT03462719|102155113|FG000|Overall Study|Withdrawal by Subject|4|||
33619678|NCT03462719|102155114|FG001|Overall Study|Withdrawal by Subject|3|||
33619679|NCT03462719|102155113|FG000|Overall Study|Ongoing|87|||
33619680|NCT03462719|102155114|FG001|Overall Study|Ongoing|72|||
33619681|NCT01684202|102155115|FG000|Dose-escalation Period|Adverse Event|0|||
33619682|NCT01684202|102155116|FG001|Dose-escalation Period|Adverse Event|1|||
33619683|NCT01684202|102155117|FG002|Dose-escalation Period|Adverse Event|0|||
33619684|NCT01684202|102155118|FG003|Dose-escalation Period|Adverse Event|0|||
33619685|NCT01684202|102155115|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
33619686|NCT01684202|102155116|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
33619687|NCT01684202|102155117|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
33619688|NCT01684202|102155118|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
33619689|NCT01684202|102155115|FG000|Maintenance Period|Adverse Event|1|||
33619690|NCT01684202|102155116|FG001|Maintenance Period|Adverse Event|1|||
33619691|NCT01684202|102155117|FG002|Maintenance Period|Adverse Event|1|||
33619692|NCT01684202|102155118|FG003|Maintenance Period|Adverse Event|1|||
33619693|NCT01684202|102155115|FG000|Maintenance Period|Physician Decision|0|||
33619694|NCT01684202|102155116|FG001|Maintenance Period|Physician Decision|1|||
33619695|NCT01684202|102155117|FG002|Maintenance Period|Physician Decision|0|||
33619696|NCT01684202|102155118|FG003|Maintenance Period|Physician Decision|0|||
33619697|NCT01684202|102155115|FG000|Maintenance Period|Withdrawal by Subject|0|||
33619698|NCT01684202|102155116|FG001|Maintenance Period|Withdrawal by Subject|1|||
33619699|NCT01684202|102155117|FG002|Maintenance Period|Withdrawal by Subject|0|||
33413151|NCT01422876|101403582|FG000|Week 52|Lost to Follow-up|3|||
33413152|NCT01422876|101403583|FG001|Week 52|Lost to Follow-up|5|||
33413153|NCT01422876|101403584|FG002|Week 52|Lost to Follow-up|7|||
33619700|NCT01684202|102155118|FG003|Maintenance Period|Withdrawal by Subject|0|||
33413154|NCT01422876|101403585|FG003|Week 52|Lost to Follow-up|5|||
33413155|NCT01422876|101403586|FG004|Week 52|Lost to Follow-up|8|||
33554101|NCT03016403|101927911|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
33619701|NCT03713281|102155123|FG000|Overall Study|Lens handling difficuluties|2|||
33217999|NCT03298451|100695912|FG003|Overall Study|Death|280|||
33619702|NCT03713281|102155123|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
33619703|NCT01369784|102155124|FG000|Overall Study|Protocol Violation|12|||
33413156|NCT01422876|101403587|FG005|Week 52|Lost to Follow-up|5|||
33413157|NCT01422876|101403588|FG006|Week 52|Lost to Follow-up|5|||
33619704|NCT01359904|102155127|FG000|Overall Study|Withdrawal by Subject|1|||
33619705|NCT01359904|102155128|FG001|Overall Study|Withdrawal by Subject|0|||
33619706|NCT01987102|102155129|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
33619707|NCT01987102|102155130|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
33619708|NCT01987102|102155129|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
33619709|NCT01987102|102155130|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
33619710|NCT01987102|102155129|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
33619711|NCT01987102|102155130|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
33619712|NCT01987102|102155129|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
33619713|NCT01987102|102155130|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
33619714|NCT01987102|102155129|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
33619715|NCT01987102|102155130|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
33619716|NCT01987102|102155129|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
33619717|NCT01987102|102155130|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
33619718|NCT04683029|102155131|FG000|Overall Study|Withdrawal by Subject|1|||
33354020|NCT01061008|101180876|FG001|Overall Study|Unable to exercise following surgery|0|||
33354021|NCT01061008|101180875|FG000|Overall Study|Adverse Event|0|||
33354022|NCT01061008|101180876|FG001|Overall Study|Adverse Event|1|||
33354023|NCT00629083|101180891|FG000|Overall Study|Adverse Event|0|||
33354024|NCT00629083|101180892|FG001|Overall Study|Adverse Event|2|||
33354025|NCT00629083|101180891|FG000|Overall Study|Lack of Efficacy|3|||
33354026|NCT00629083|101180892|FG001|Overall Study|Lack of Efficacy|1|||
33354027|NCT00629083|101180891|FG000|Overall Study|Withdrawal by Subject|10|||
33354028|NCT00629083|101180892|FG001|Overall Study|Withdrawal by Subject|2|||
33354029|NCT00629083|101180891|FG000|Overall Study|Lost to Follow-up|12|||
33354030|NCT00629083|101180892|FG001|Overall Study|Lost to Follow-up|8|||
33354031|NCT00629083|101180891|FG000|Overall Study|Moved out of country/state|2|||
33354032|NCT00629083|101180892|FG001|Overall Study|Moved out of country/state|1|||
33354033|NCT00629083|101180891|FG000|Overall Study|Refused to return for 12 month visit|1|||
33354034|NCT00629083|101180892|FG001|Overall Study|Refused to return for 12 month visit|0|||
33354035|NCT04025632|101183965|FG000|Overall Study|Adverse Event|1|||
33413158|NCT01422876|101403589|FG007|Week 52|Lost to Follow-up|8|||
33413159|NCT01422876|101403590|FG008|Week 52|Lost to Follow-up|7|||
33413160|NCT01422876|101403591|FG009|Week 52|Lost to Follow-up|8|||
33413161|NCT01422876|101403582|FG000|Week 52|Consent withdrawn|9|||
33413162|NCT01422876|101403583|FG001|Week 52|Consent withdrawn|4|||
33413163|NCT01422876|101403584|FG002|Week 52|Consent withdrawn|6|||
33413164|NCT01422876|101403585|FG003|Week 52|Consent withdrawn|12|||
33413165|NCT01422876|101403586|FG004|Week 52|Consent withdrawn|7|||
33413166|NCT01422876|101403587|FG005|Week 52|Consent withdrawn|12|||
33413167|NCT01422876|101403588|FG006|Week 52|Consent withdrawn|10|||
33413168|NCT01422876|101403589|FG007|Week 52|Consent withdrawn|12|||
33413169|NCT01422876|101403590|FG008|Week 52|Consent withdrawn|13|||
33413170|NCT01422876|101403591|FG009|Week 52|Consent withdrawn|9|||
33554102|NCT03016403|101927912|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
33554103|NCT00290758|101927913|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
33554104|NCT00290758|101927914|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
33554105|NCT00290758|101927913|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
33554106|NCT00290758|101927914|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
33554107|NCT00290758|101927913|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
33554108|NCT00290758|101927914|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
33554109|NCT00290758|101927913|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
33554110|NCT00290758|101927914|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
33554111|NCT00290758|101927913|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
33554112|NCT00290758|101927914|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
33554113|NCT00290758|101927913|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
33554114|NCT00290758|101927914|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
33554115|NCT00290758|101927913|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
33554116|NCT00290758|101927914|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
33554117|NCT00290758|101927913|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
33554118|NCT00290758|101927914|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
33554119|NCT01096186|101927917|FG000|Overall Study|Adverse Event|16|||
33554120|NCT01096186|101927917|FG000|Overall Study|Death|4|||
33554121|NCT01096186|101927917|FG000|Overall Study|Lack of Efficacy|4|||
33554122|NCT01096186|101927917|FG000|Overall Study|Lost to Follow-up|2|||
33554123|NCT01096186|101927917|FG000|Overall Study|Withdrawal by Subject|22|||
33554124|NCT01096186|101927917|FG000|Overall Study|Physician Decision|1|||
33354036|NCT04025632|101183966|FG001|Overall Study|Adverse Event|1|||
33354037|NCT04025632|101183965|FG000|Overall Study|Withdrawal by Subject|1|||
33413171|NCT01422876|101403582|FG000|Week 52|Death|0|||
33413172|NCT01422876|101403583|FG001|Week 52|Death|1|||
33413173|NCT01422876|101403584|FG002|Week 52|Death|0|||
33413174|NCT01422876|101403585|FG003|Week 52|Death|1|||
33413175|NCT01422876|101403586|FG004|Week 52|Death|0|||
33413176|NCT01422876|101403587|FG005|Week 52|Death|0|||
33413177|NCT01422876|101403588|FG006|Week 52|Death|1|||
33413178|NCT01422876|101403589|FG007|Week 52|Death|3|||
33413179|NCT01422876|101403590|FG008|Week 52|Death|1|||
33413180|NCT01422876|101403591|FG009|Week 52|Death|0|||
33413181|NCT00943826|101403594|FG000|Concurrent Phase|Adverse Event|50|||
33413182|NCT00943826|101403595|FG001|Concurrent Phase|Adverse Event|27|||
33413183|NCT00943826|101403594|FG000|Concurrent Phase|Withdrew consent|3|||
33413184|NCT00943826|101403595|FG001|Concurrent Phase|Withdrew consent|7|||
33413185|NCT00943826|101403594|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
33413186|NCT00943826|101403595|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
33413187|NCT00943826|101403594|FG000|Concurrent Phase|Administrative reasons|2|||
33413188|NCT00943826|101403595|FG001|Concurrent Phase|Administrative reasons|1|||
33413189|NCT00943826|101403594|FG000|Concurrent Phase|Protocol Violation|1|||
33413190|NCT00943826|101403595|FG001|Concurrent Phase|Protocol Violation|0|||
33413191|NCT00943826|101403594|FG000|Maintenance Phase|Adverse Event|31|||
33413192|NCT00943826|101403595|FG001|Maintenance Phase|Adverse Event|30|||
33413193|NCT00943826|101403594|FG000|Maintenance Phase|Withdrew consent|2|||
33413194|NCT00943826|101403595|FG001|Maintenance Phase|Withdrew consent|4|||
33413195|NCT00943826|101403594|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
33413196|NCT00943826|101403595|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
33413197|NCT00943826|101403594|FG000|Maintenance Phase|Administrative reasons|4|||
33413198|NCT00943826|101403595|FG001|Maintenance Phase|Administrative reasons|1|||
33413199|NCT00943826|101403594|FG000|Maintenance Phase|Failure to return|0|||
33413200|NCT00943826|101403595|FG001|Maintenance Phase|Failure to return|1|||
33413201|NCT00943826|101403594|FG000|Monotherapy Phase|Adverse Event|42|||
33413202|NCT00943826|101403595|FG001|Monotherapy Phase|Adverse Event|5|||
33413203|NCT00943826|101403594|FG000|Monotherapy Phase|Administrative reasons|11|||
33413204|NCT00943826|101403595|FG001|Monotherapy Phase|Administrative reasons|5|||
33413205|NCT00943826|101403594|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
33413206|NCT00943826|101403595|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
33619719|NCT04683029|102155132|FG001|Overall Study|Withdrawal by Subject|0|||
33619720|NCT01391663|102155133|FG000|Overall Study|Withdrawal by Subject|0|||
33619721|NCT01391663|102155134|FG001|Overall Study|Withdrawal by Subject|0|||
33619722|NCT01391663|102155135|FG002|Overall Study|Withdrawal by Subject|1|||
33619723|NCT01391663|102155136|FG003|Overall Study|Withdrawal by Subject|0|||
33413207|NCT00943826|101403594|FG000|Monotherapy Phase|Withdrew Consent|2|||
33413208|NCT00943826|101403595|FG001|Monotherapy Phase|Withdrew Consent|3|||
33413209|NCT00943826|101403594|FG000|Monotherapy Phase|Failure to return|2|||
33413210|NCT00943826|101403595|FG001|Monotherapy Phase|Failure to return|1|||
33413211|NCT00943826|101403594|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
33413212|NCT00943826|101403595|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
33413213|NCT00943826|101403594|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
33413214|NCT00943826|101403595|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
33413215|NCT00943826|101403594|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
33413216|NCT00943826|101403595|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
33413217|NCT00943826|101403594|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
33413218|NCT00943826|101403595|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
33413219|NCT03185949|101403598|FG000|ITT Analysis|Withdrawal by Subject|4|||
33554125|NCT01096186|101927917|FG000|Overall Study|Noncompliance with study drug|1|||
33554126|NCT03722030|101927923|FG000|Overall Study|Withdrawal by Subject|1|||
33554127|NCT03722030|101927924|FG001|Overall Study|Withdrawal by Subject|0|||
33554128|NCT03178942|101927926|FG000|Overall Study|Withdrawal by Subject|2|||
33554129|NCT03178942|101927927|FG001|Overall Study|Withdrawal by Subject|0|||
33554130|NCT03178942|101927926|FG000|Overall Study|Lost to Follow-up|1|||
33554131|NCT03178942|101927927|FG001|Overall Study|Lost to Follow-up|2|||
33554132|NCT00736476|101927934|FG000|Overall Study|Adverse Event|1|||
33619724|NCT03500640|102155137|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
33619725|NCT03500640|102155138|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
33413220|NCT03185949|101403599|FG001|ITT Analysis|Withdrawal by Subject|3|||
33413221|NCT03185949|101403598|FG000|PP Analysis|Protocol Violation|2|||
33413222|NCT03185949|101403599|FG001|PP Analysis|Protocol Violation|2|||
33413223|NCT03185949|101403598|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
33413224|NCT03185949|101403599|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
33413225|NCT00956813|101403600|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
33413226|NCT00956813|101403601|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
33413227|NCT00956813|101403600|FG000|Flaxseed and Placebo|Ineligible|3|||
33554133|NCT00736476|101927935|FG001|Overall Study|Adverse Event|0|||
33413228|NCT00956813|101403601|FG001|Flaxseed and Placebo|Ineligible|1|||
33413229|NCT01898884|101403603|FG000|Multiple Dose Period|Adverse Event|0|||
33413230|NCT01898884|101403604|FG001|Multiple Dose Period|Adverse Event|0|||
33413231|NCT01898884|101403605|FG002|Multiple Dose Period|Adverse Event|0|||
33413232|NCT01898884|101403606|FG003|Multiple Dose Period|Adverse Event|0|||
33413233|NCT01898884|101403607|FG004|Multiple Dose Period|Adverse Event|0|||
33413234|NCT01898884|101403608|FG005|Multiple Dose Period|Adverse Event|0|||
33413235|NCT01898884|101403609|FG006|Multiple Dose Period|Adverse Event|1|||
33413236|NCT01898884|101403610|FG007|Multiple Dose Period|Adverse Event|0|||
33413237|NCT01898884|101403611|FG008|Multiple Dose Period|Adverse Event|0|||
33413238|NCT01898884|101403603|FG000|Multiple Dose Period|Randomized Not Treated|0|||
33413239|NCT01898884|101403604|FG001|Multiple Dose Period|Randomized Not Treated|0|||
33554134|NCT02318277|101927936|FG000|Overall Study|Physician Decision|0|||
33554135|NCT02318277|101927937|FG001|Overall Study|Physician Decision|0|||
33354038|NCT04025632|101183966|FG001|Overall Study|Withdrawal by Subject|1|||
33354039|NCT04025632|101183965|FG000|Overall Study|Study Terminated by Sponsor|10|||
33354040|NCT04025632|101183966|FG001|Overall Study|Study Terminated by Sponsor|9|||
33354041|NCT04025632|101183965|FG000|Overall Study|Physician Decision|3|||
33354042|NCT04025632|101183966|FG001|Overall Study|Physician Decision|1|||
33354043|NCT01491178|101183967|FG000|Overall Study|Adverse Event|1016|||
33354044|NCT01491178|101183967|FG000|Overall Study|Improvement of NVAF|210|||
33354045|NCT01491178|101183967|FG000|Overall Study|To conduct invasive treatment|59|||
33354046|NCT01491178|101183967|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
33354047|NCT01491178|101183967|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
33354048|NCT01491178|101183967|FG000|Overall Study|To take a contraindication|20|||
33354049|NCT01491178|101183967|FG000|Overall Study|Other than specified above|657|||
33354050|NCT00087438|101183968|FG000|Overall Study|Ineligible / No protocol treatment|4|||
33354051|NCT02115308|101183972|FG000|Overall Study|Safety Screening|2|||
33354052|NCT02115308|101183973|FG001|Overall Study|Safety Screening|2|||
33354053|NCT00749203|101183974|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
33354054|NCT00749203|101183975|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
33354055|NCT00749203|101183974|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
33354056|NCT00749203|101183975|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
33354057|NCT00749203|101183974|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
33354058|NCT00749203|101183975|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
33354059|NCT00749203|101183974|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
33354060|NCT00749203|101183975|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
33354061|NCT00749203|101183974|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
33354062|NCT00749203|101183975|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
33354063|NCT00749203|101183974|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
33354064|NCT00749203|101183975|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
33354065|NCT02185521|101183976|FG000|Overall Study|Withdrawal by Subject|1|||
33354066|NCT02185521|101183976|FG000|Overall Study|Protocol Violation|1|||
33354067|NCT00104871|101183979|FG000|Overall Study|Not evaluable|1|||
33354068|NCT04125680|101183988|FG000|Overall Study|Lost to Follow-up|15|||
33354069|NCT01287104|101183993|FG000|Overall Study|Patient developed progressive disease|1|||
33354070|NCT01287104|101183994|FG001|Overall Study|Patient developed progressive disease|1|||
33354071|NCT01287104|101183995|FG002|Overall Study|Patient developed progressive disease|3|||
33354072|NCT01287104|101183996|FG003|Overall Study|Patient developed progressive disease|2|||
33354073|NCT01287104|101183993|FG000|Overall Study|Donor anaphylaxis|0|||
33354074|NCT01287104|101183994|FG001|Overall Study|Donor anaphylaxis|1|||
33354075|NCT01287104|101183995|FG002|Overall Study|Donor anaphylaxis|0|||
33354076|NCT01287104|101183996|FG003|Overall Study|Donor anaphylaxis|1|||
33354077|NCT01287104|101183993|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
33354078|NCT01287104|101183994|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
33354079|NCT01287104|101183995|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
33354080|NCT01287104|101183996|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
33554136|NCT02318277|101927938|FG002|Overall Study|Physician Decision|0|||
33554137|NCT02318277|101927939|FG003|Overall Study|Physician Decision|0|||
33554138|NCT02318277|101927940|FG004|Overall Study|Physician Decision|0|||
33554139|NCT02318277|101927941|FG005|Overall Study|Physician Decision|0|||
33554140|NCT02318277|101927942|FG006|Overall Study|Physician Decision|0|||
33554141|NCT02318277|101927943|FG007|Overall Study|Physician Decision|1|||
33554142|NCT02318277|101927936|FG000|Overall Study|Other|0|||
33554143|NCT02318277|101927937|FG001|Overall Study|Other|0|||
33554144|NCT02318277|101927938|FG002|Overall Study|Other|0|||
33554145|NCT02318277|101927939|FG003|Overall Study|Other|0|||
33554146|NCT02318277|101927940|FG004|Overall Study|Other|0|||
33354081|NCT01287104|101183993|FG000|Overall Study|Low donor chimerism|0|||
33354082|NCT01287104|101183994|FG001|Overall Study|Low donor chimerism|1|||
33413240|NCT01898884|101403605|FG002|Multiple Dose Period|Randomized Not Treated|0|||
33554147|NCT02318277|101927941|FG005|Overall Study|Other|0|||
33554148|NCT02318277|101927942|FG006|Overall Study|Other|1|||
33554149|NCT02318277|101927943|FG007|Overall Study|Other|0|||
33554150|NCT02318277|101927936|FG000|Overall Study|Withdrawal by Subject|0|||
33554151|NCT02318277|101927937|FG001|Overall Study|Withdrawal by Subject|0|||
33554152|NCT02318277|101927938|FG002|Overall Study|Withdrawal by Subject|1|||
33413241|NCT01898884|101403606|FG003|Multiple Dose Period|Randomized Not Treated|0|||
33619726|NCT03500640|102155139|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
33619727|NCT03500640|102155137|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
33619728|NCT03500640|102155138|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
33619729|NCT03500640|102155139|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
33619730|NCT03500640|102155137|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
33619731|NCT03500640|102155138|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
33619732|NCT03500640|102155139|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
33619733|NCT03500640|102155137|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
33619734|NCT03500640|102155138|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
33619735|NCT03500640|102155139|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
33619736|NCT03500640|102155137|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
33619737|NCT03500640|102155138|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
33619738|NCT03500640|102155139|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
33554153|NCT02318277|101927939|FG003|Overall Study|Withdrawal by Subject|0|||
33554154|NCT02318277|101927940|FG004|Overall Study|Withdrawal by Subject|1|||
33554155|NCT02318277|101927941|FG005|Overall Study|Withdrawal by Subject|1|||
33554156|NCT02318277|101927942|FG006|Overall Study|Withdrawal by Subject|6|||
33554157|NCT02318277|101927943|FG007|Overall Study|Withdrawal by Subject|14|||
33554158|NCT02318277|101927936|FG000|Overall Study|Participant trial terminated by sponsor|0|||
33554159|NCT02318277|101927937|FG001|Overall Study|Participant trial terminated by sponsor|0|||
33554160|NCT02318277|101927938|FG002|Overall Study|Participant trial terminated by sponsor|1|||
33554161|NCT02318277|101927939|FG003|Overall Study|Participant trial terminated by sponsor|0|||
33554162|NCT02318277|101927940|FG004|Overall Study|Participant trial terminated by sponsor|1|||
33554163|NCT02318277|101927941|FG005|Overall Study|Participant trial terminated by sponsor|2|||
33554164|NCT02318277|101927942|FG006|Overall Study|Participant trial terminated by sponsor|5|||
33554165|NCT02318277|101927943|FG007|Overall Study|Participant trial terminated by sponsor|16|||
33554166|NCT02318277|101927936|FG000|Overall Study|Lost to Follow-up|1|||
33554167|NCT02318277|101927937|FG001|Overall Study|Lost to Follow-up|0|||
33554168|NCT02318277|101927938|FG002|Overall Study|Lost to Follow-up|1|||
33554169|NCT02318277|101927939|FG003|Overall Study|Lost to Follow-up|0|||
33554170|NCT02318277|101927940|FG004|Overall Study|Lost to Follow-up|0|||
33554171|NCT02318277|101927941|FG005|Overall Study|Lost to Follow-up|0|||
33554172|NCT02318277|101927942|FG006|Overall Study|Lost to Follow-up|3|||
33554173|NCT02318277|101927943|FG007|Overall Study|Lost to Follow-up|4|||
33554174|NCT02318277|101927936|FG000|Overall Study|Death|5|||
33619739|NCT03500640|102155137|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
33619740|NCT03500640|102155138|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
33619741|NCT03500640|102155139|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
33619742|NCT03500640|102155137|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
33619743|NCT03500640|102155138|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
33619744|NCT03500640|102155139|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
33619745|NCT03500640|102155137|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
33619746|NCT03500640|102155138|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
33619747|NCT03500640|102155139|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
33554175|NCT02318277|101927937|FG001|Overall Study|Death|3|||
33554176|NCT02318277|101927938|FG002|Overall Study|Death|1|||
33619748|NCT03500640|102155137|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
33619749|NCT03500640|102155138|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
33619750|NCT03500640|102155139|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
33413242|NCT01898884|101403607|FG004|Multiple Dose Period|Randomized Not Treated|0|||
33413243|NCT01898884|101403608|FG005|Multiple Dose Period|Randomized Not Treated|0|||
33413244|NCT01898884|101403609|FG006|Multiple Dose Period|Randomized Not Treated|0|||
33413245|NCT01898884|101403610|FG007|Multiple Dose Period|Randomized Not Treated|0|||
33413246|NCT01898884|101403611|FG008|Multiple Dose Period|Randomized Not Treated|1|||
33413247|NCT01725217|101403618|FG000|Overall Study|Withdrawal by Subject|1|||
33413248|NCT01725217|101403619|FG001|Overall Study|Withdrawal by Subject|0|||
33413249|NCT01725217|101403620|FG002|Overall Study|Withdrawal by Subject|0|||
33413250|NCT00539006|101403627|FG000|Pre-treatment|Other|0|||
33619751|NCT03500640|102155137|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
33619752|NCT03500640|102155138|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
33619753|NCT03500640|102155139|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
33413251|NCT00539006|101403628|FG001|Pre-treatment|Other|1|||
33413252|NCT00539006|101403629|FG002|Pre-treatment|Other|0|||
33554177|NCT02318277|101927939|FG003|Overall Study|Death|4|||
33554178|NCT02318277|101927940|FG004|Overall Study|Death|6|||
33554179|NCT02318277|101927941|FG005|Overall Study|Death|5|||
33619754|NCT04585789|102155140|FG000|Overall Study|Withdrawal by Subject|1|||
33619755|NCT04585789|102155141|FG001|Overall Study|Withdrawal by Subject|0|||
33554180|NCT02318277|101927942|FG006|Overall Study|Death|34|||
33554181|NCT02318277|101927943|FG007|Overall Study|Death|58|||
33554182|NCT02318277|101927936|FG000|Overall Study|Transitioned to Hospice|0|||
33619756|NCT04585789|102155140|FG000|Overall Study|Ongoing|9|||
33619757|NCT04585789|102155141|FG001|Overall Study|Ongoing|10|||
33619758|NCT00377858|102155142|FG000|Overall Study|Withdrawal by Subject|12|||
33619759|NCT00377858|102155143|FG001|Overall Study|Withdrawal by Subject|11|||
33619760|NCT00377858|102155142|FG000|Overall Study|Lost to Follow-up|6|||
33619761|NCT00377858|102155143|FG001|Overall Study|Lost to Follow-up|1|||
33619762|NCT00377858|102155142|FG000|Overall Study|Physician Decision|5|||
33619763|NCT00377858|102155143|FG001|Overall Study|Physician Decision|5|||
33619764|NCT00377858|102155142|FG000|Overall Study|Protocol Violation|3|||
33619765|NCT00377858|102155143|FG001|Overall Study|Protocol Violation|4|||
33619766|NCT00377858|102155142|FG000|Overall Study|Adverse Event|2|||
33619767|NCT00377858|102155143|FG001|Overall Study|Adverse Event|1|||
33619768|NCT00377858|102155142|FG000|Overall Study|Entry Criteria Not Met|2|||
33619769|NCT00377858|102155143|FG001|Overall Study|Entry Criteria Not Met|0|||
33619770|NCT00377858|102155142|FG000|Overall Study|Sponsor Decision|1|||
33619771|NCT00377858|102155143|FG001|Overall Study|Sponsor Decision|2|||
33619772|NCT00377858|102155142|FG000|Overall Study|Death|0|||
33619773|NCT00377858|102155143|FG001|Overall Study|Death|3|||
33619774|NCT01345188|102155144|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
33619775|NCT01345188|102155144|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
33619776|NCT03819049|102155148|FG000|Overall Study|Lost to Follow-up|1|||
33619777|NCT03819049|102155149|FG001|Overall Study|Lost to Follow-up|2|||
33619778|NCT03819049|102155150|FG002|Overall Study|Lost to Follow-up|9|||
33619779|NCT03819049|102155151|FG003|Overall Study|Lost to Follow-up|0|||
33619780|NCT03819049|102155152|FG004|Overall Study|Lost to Follow-up|3|||
33619781|NCT03819049|102155153|FG005|Overall Study|Lost to Follow-up|1|||
33619782|NCT03819049|102155154|FG006|Overall Study|Lost to Follow-up|0|||
33619783|NCT03819049|102155148|FG000|Overall Study|Withdrawal by Subject|0|||
33619784|NCT03819049|102155149|FG001|Overall Study|Withdrawal by Subject|0|||
33619785|NCT03819049|102155150|FG002|Overall Study|Withdrawal by Subject|18|||
33619786|NCT03819049|102155151|FG003|Overall Study|Withdrawal by Subject|0|||
33619787|NCT03819049|102155152|FG004|Overall Study|Withdrawal by Subject|10|||
33354083|NCT01287104|101183995|FG002|Overall Study|Low donor chimerism|0|||
33354084|NCT01287104|101183996|FG003|Overall Study|Low donor chimerism|0|||
33354085|NCT01287104|101183993|FG000|Overall Study|NK cells did not meet release criteria|0|||
33354086|NCT01287104|101183994|FG001|Overall Study|NK cells did not meet release criteria|1|||
33354087|NCT01287104|101183995|FG002|Overall Study|NK cells did not meet release criteria|0|||
33354088|NCT01287104|101183996|FG003|Overall Study|NK cells did not meet release criteria|0|||
33354089|NCT01573442|101183997|FG000|Overall Study|Cancels|9|||
33354090|NCT01573442|101183998|FG001|Overall Study|Cancels|10|||
33413253|NCT00539006|101403630|FG003|Pre-treatment|Other|0|||
33619788|NCT03819049|102155153|FG005|Overall Study|Withdrawal by Subject|9|||
33619789|NCT03819049|102155154|FG006|Overall Study|Withdrawal by Subject|1|||
33619790|NCT03819049|102155148|FG000|Overall Study|Ongoing|0|||
33619791|NCT03819049|102155149|FG001|Overall Study|Ongoing|0|||
33619792|NCT03819049|102155150|FG002|Overall Study|Ongoing|75|||
33619793|NCT03819049|102155151|FG003|Overall Study|Ongoing|0|||
33619794|NCT03819049|102155152|FG004|Overall Study|Ongoing|41|||
33619795|NCT03819049|102155153|FG005|Overall Study|Ongoing|0|||
33619796|NCT03819049|102155154|FG006|Overall Study|Ongoing|0|||
33619797|NCT03819049|102155148|FG000|Overall Study|Other|0|||
33619798|NCT03819049|102155149|FG001|Overall Study|Other|0|||
33619799|NCT03819049|102155150|FG002|Overall Study|Other|2|||
33619800|NCT03819049|102155151|FG003|Overall Study|Other|0|||
33619801|NCT03819049|102155152|FG004|Overall Study|Other|0|||
33619802|NCT03819049|102155153|FG005|Overall Study|Other|0|||
33619803|NCT03819049|102155154|FG006|Overall Study|Other|0|||
33619804|NCT03819049|102155148|FG000|Overall Study|Randomized but not vaccinated|0|||
33619805|NCT03819049|102155149|FG001|Overall Study|Randomized but not vaccinated|0|||
33619806|NCT03819049|102155150|FG002|Overall Study|Randomized but not vaccinated|0|||
33619807|NCT03819049|102155151|FG003|Overall Study|Randomized but not vaccinated|1|||
33619808|NCT03819049|102155152|FG004|Overall Study|Randomized but not vaccinated|0|||
33354091|NCT04574999|101183999|FG000|Overall Study|Adverse Event|1|||
33354092|NCT04574999|101184000|FG001|Overall Study|Adverse Event|0|||
33413254|NCT00539006|101403627|FG000|Treatment Period 1|Lost to Follow-up|0|||
33554183|NCT02318277|101927937|FG001|Overall Study|Transitioned to Hospice|0|||
33619809|NCT03819049|102155153|FG005|Overall Study|Randomized but not vaccinated|2|||
33619810|NCT03819049|102155154|FG006|Overall Study|Randomized but not vaccinated|1|||
33619811|NCT03819049|102155148|FG000|Overall Study|Physician Decision|0|||
33619812|NCT03819049|102155149|FG001|Overall Study|Physician Decision|0|||
33619813|NCT03819049|102155150|FG002|Overall Study|Physician Decision|0|||
33619814|NCT03819049|102155151|FG003|Overall Study|Physician Decision|0|||
33619815|NCT03819049|102155152|FG004|Overall Study|Physician Decision|0|||
33619816|NCT03819049|102155153|FG005|Overall Study|Physician Decision|0|||
33619817|NCT03819049|102155154|FG006|Overall Study|Physician Decision|1|||
33619818|NCT01550757|102155155|FG000|Overall Study|Lost to Follow-up|21|||
33619819|NCT01550757|102155156|FG001|Overall Study|Lost to Follow-up|14|||
33619820|NCT01550757|102155157|FG002|Overall Study|Lost to Follow-up|42|||
33619821|NCT01550757|102155158|FG003|Overall Study|Lost to Follow-up|53|||
33218000|NCT03298451|100695909|FG000|Overall Study|Lost to Follow-up|1|||
33218001|NCT03298451|100695910|FG001|Overall Study|Lost to Follow-up|1|||
33218002|NCT03298451|100695911|FG002|Overall Study|Lost to Follow-up|0|||
33218003|NCT03298451|100695912|FG003|Overall Study|Lost to Follow-up|7|||
33218004|NCT03298451|100695909|FG000|Overall Study|Withdrawal by Subject|9|||
33218005|NCT03298451|100695910|FG001|Overall Study|Withdrawal by Subject|7|||
33218006|NCT03298451|100695911|FG002|Overall Study|Withdrawal by Subject|1|||
33218007|NCT03298451|100695912|FG003|Overall Study|Withdrawal by Subject|20|||
33218008|NCT00541450|100695913|FG000|Phase A|Adverse Event|3|||
33218009|NCT00541450|100695914|FG001|Phase A|Adverse Event|0|||
33218010|NCT00541450|100695913|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
33218011|NCT00541450|100695914|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
33218012|NCT00541450|100695913|FG000|Phase A|Hyperglycemia|0|||
33218013|NCT00541450|100695914|FG001|Phase A|Hyperglycemia|1|||
33354093|NCT04574999|101183999|FG000|Overall Study|Lack of Efficacy|2|||
33354094|NCT04574999|101184000|FG001|Overall Study|Lack of Efficacy|3|||
33354095|NCT04574999|101183999|FG000|Overall Study|Protocol Violation|1|||
33354096|NCT04574999|101184000|FG001|Overall Study|Protocol Violation|0|||
33354097|NCT04574999|101183999|FG000|Overall Study|Withdrawal by Subject|2|||
33354098|NCT04574999|101184000|FG001|Overall Study|Withdrawal by Subject|2|||
33354099|NCT04574999|101183999|FG000|Overall Study|Lost to Follow-up|1|||
33354100|NCT04574999|101184000|FG001|Overall Study|Lost to Follow-up|0|||
33354101|NCT04574999|101183999|FG000|Overall Study|Personal problems|1|||
33354102|NCT04574999|101184000|FG001|Overall Study|Personal problems|0|||
33354103|NCT04574999|101183999|FG000|Overall Study|Previous planned surgery|1|||
33354104|NCT04574999|101184000|FG001|Overall Study|Previous planned surgery|0|||
33354105|NCT03133767|101184001|FG000|Overall Study|Lost to Follow-up|38|||
33354106|NCT03133767|101184002|FG001|Overall Study|Lost to Follow-up|24|||
33354107|NCT03133767|101184001|FG000|Overall Study|Protocol Violation|0|||
33354108|NCT03133767|101184002|FG001|Overall Study|Protocol Violation|1|||
33413255|NCT00539006|101403628|FG001|Treatment Period 1|Lost to Follow-up|0|||
33413256|NCT00539006|101403629|FG002|Treatment Period 1|Lost to Follow-up|1|||
33413257|NCT00539006|101403630|FG003|Treatment Period 1|Lost to Follow-up|0|||
33413258|NCT00539006|101403627|FG000|Treatment Period 1|Protocol Violation|0|||
33413259|NCT00539006|101403628|FG001|Treatment Period 1|Protocol Violation|0|||
33413260|NCT00539006|101403629|FG002|Treatment Period 1|Protocol Violation|1|||
33413261|NCT00539006|101403630|FG003|Treatment Period 1|Protocol Violation|0|||
33413262|NCT00539006|101403627|FG000|Treatment Period 1|Lack of Efficacy|0|||
33413263|NCT00539006|101403628|FG001|Treatment Period 1|Lack of Efficacy|0|||
33413264|NCT00539006|101403629|FG002|Treatment Period 1|Lack of Efficacy|0|||
33413265|NCT00539006|101403630|FG003|Treatment Period 1|Lack of Efficacy|1|||
33413266|NCT00539006|101403627|FG000|Washout|Adverse Event|2|||
33413267|NCT00539006|101403628|FG001|Washout|Adverse Event|1|||
33413268|NCT00539006|101403629|FG002|Washout|Adverse Event|0|||
33413269|NCT00539006|101403630|FG003|Washout|Adverse Event|0|||
33413270|NCT00539006|101403627|FG000|Washout|Protocol Violation|1|||
33413271|NCT00539006|101403628|FG001|Washout|Protocol Violation|1|||
33413272|NCT00539006|101403629|FG002|Washout|Protocol Violation|0|||
33413273|NCT00539006|101403630|FG003|Washout|Protocol Violation|0|||
33413274|NCT00539006|101403627|FG000|Washout|Withdrawal by Subject|0|||
33413275|NCT00539006|101403628|FG001|Washout|Withdrawal by Subject|2|||
33413276|NCT00539006|101403629|FG002|Washout|Withdrawal by Subject|0|||
33413277|NCT00539006|101403630|FG003|Washout|Withdrawal by Subject|0|||
33413278|NCT00539006|101403627|FG000|Washout|Failed to meet continuation criteria|16|||
33413279|NCT00539006|101403628|FG001|Washout|Failed to meet continuation criteria|5|||
33554184|NCT02318277|101927938|FG002|Overall Study|Transitioned to Hospice|0|||
33554185|NCT02318277|101927939|FG003|Overall Study|Transitioned to Hospice|0|||
33554186|NCT02318277|101927940|FG004|Overall Study|Transitioned to Hospice|0|||
33554187|NCT02318277|101927941|FG005|Overall Study|Transitioned to Hospice|1|||
33554188|NCT02318277|101927942|FG006|Overall Study|Transitioned to Hospice|0|||
33554189|NCT02318277|101927943|FG007|Overall Study|Transitioned to Hospice|0|||
33554190|NCT03197935|101927944|FG000|Overall Study|Death due to any cause|26|||
33554191|NCT03197935|101927945|FG001|Overall Study|Death due to any cause|15|||
33554192|NCT03197935|101927944|FG000|Overall Study|Lost to Follow-up|3|||
33554193|NCT03197935|101927945|FG001|Overall Study|Lost to Follow-up|5|||
33554194|NCT03197935|101927944|FG000|Overall Study|Physician Decision|2|||
33218014|NCT00541450|100695913|FG000|Phase A|Lost to Follow-up|6|||
33413280|NCT00539006|101403629|FG002|Washout|Failed to meet continuation criteria|14|||
33413281|NCT00539006|101403630|FG003|Washout|Failed to meet continuation criteria|6|||
33554195|NCT03197935|101927945|FG001|Overall Study|Physician Decision|1|||
33354109|NCT00345605|101184003|FG000|Arm 1|Adverse Event|0|||
33354110|NCT00345605|101184004|FG001|Arm 1|Adverse Event|1|||
33554196|NCT03197935|101927944|FG000|Overall Study|Withdrawal by Subject|16|||
33554197|NCT03197935|101927945|FG001|Overall Study|Withdrawal by Subject|8|||
33619822|NCT01550757|102155155|FG000|Overall Study|Withdrawal by Subject|2|||
33218015|NCT00541450|100695914|FG001|Phase A|Lost to Follow-up|4|||
33218016|NCT00541450|100695913|FG000|Phase A|Physician Decision|2|||
33218017|NCT00541450|100695914|FG001|Phase A|Physician Decision|0|||
33413282|NCT00539006|101403627|FG000|Washout|Other|1|||
33218018|NCT00541450|100695913|FG000|Phase A|Protocol Violation|2|||
33218019|NCT00541450|100695914|FG001|Phase A|Protocol Violation|3|||
33218020|NCT00541450|100695913|FG000|Phase A|Withdrawal by Subject|7|||
33354111|NCT00345605|101184003|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
33619823|NCT01550757|102155156|FG001|Overall Study|Withdrawal by Subject|0|||
33619824|NCT01550757|102155157|FG002|Overall Study|Withdrawal by Subject|3|||
33619825|NCT01550757|102155158|FG003|Overall Study|Withdrawal by Subject|1|||
33619826|NCT02754726|102155159|FG000|Overall Study|Progressive Disease by RECIST|13|||
33619827|NCT02754726|102155159|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
33619828|NCT02754726|102155159|FG000|Overall Study|Clinical Disease Progression|5|||
33619829|NCT02754726|102155159|FG000|Overall Study|Adverse Event|3|||
33619830|NCT02754726|102155159|FG000|Overall Study|Withdrawal by Subject|1|||
33554198|NCT00537082|101927948|FG000|Overall Study|Adverse Event|6|||
33554199|NCT00537082|101927949|FG001|Overall Study|Adverse Event|6|||
33554200|NCT00537082|101927950|FG002|Overall Study|Adverse Event|3|||
33554201|NCT00537082|101927948|FG000|Overall Study|Protocol Violation|0|||
33554202|NCT00537082|101927949|FG001|Overall Study|Protocol Violation|2|||
33554203|NCT00537082|101927950|FG002|Overall Study|Protocol Violation|1|||
33554204|NCT00537082|101927948|FG000|Overall Study|Lack of Efficacy|0|||
33554205|NCT00537082|101927949|FG001|Overall Study|Lack of Efficacy|0|||
33554206|NCT00537082|101927950|FG002|Overall Study|Lack of Efficacy|2|||
33554207|NCT00537082|101927948|FG000|Overall Study|Withdrawal by Subject|0|||
33554208|NCT00537082|101927949|FG001|Overall Study|Withdrawal by Subject|1|||
33619831|NCT02754726|102155159|FG000|Overall Study|Tolerability|1|||
33619832|NCT01424501|102155162|FG000|Overall Study|Withdrawal by Subject|1|||
33619833|NCT01424501|102155163|FG001|Overall Study|Withdrawal by Subject|0|||
33619834|NCT01424501|102155164|FG002|Overall Study|Withdrawal by Subject|1|||
33619835|NCT01424501|102155165|FG003|Overall Study|Withdrawal by Subject|0|||
33619836|NCT01424501|102155166|FG004|Overall Study|Withdrawal by Subject|0|||
33619837|NCT01424501|102155167|FG005|Overall Study|Withdrawal by Subject|0|||
33619838|NCT01424501|102155162|FG000|Overall Study|Lost to Follow-up|0|||
33619839|NCT01424501|102155163|FG001|Overall Study|Lost to Follow-up|1|||
33619840|NCT01424501|102155164|FG002|Overall Study|Lost to Follow-up|1|||
33619841|NCT01424501|102155165|FG003|Overall Study|Lost to Follow-up|0|||
33619842|NCT01424501|102155166|FG004|Overall Study|Lost to Follow-up|0|||
33619843|NCT01424501|102155167|FG005|Overall Study|Lost to Follow-up|0|||
33619844|NCT01964963|102155169|FG000|Overall Study|Case Report Forms Uncollected|888|||
33619845|NCT01964963|102155169|FG000|Overall Study|Protocol Deviation|50|||
33619846|NCT01964963|102155169|FG000|Overall Study|Data Reliability was not Assured|5|||
33619847|NCT03030417|102155174|FG000|Dose Expansion|Disease progression before treatment|0|||
33619848|NCT03030417|102155175|FG001|Dose Expansion|Disease progression before treatment|0|||
33619849|NCT03030417|102155176|FG002|Dose Expansion|Disease progression before treatment|0|||
33619850|NCT03030417|102155177|FG003|Dose Expansion|Disease progression before treatment|0|||
33619851|NCT03030417|102155178|FG004|Dose Expansion|Disease progression before treatment|0|||
33619852|NCT03030417|102155179|FG005|Dose Expansion|Disease progression before treatment|0|||
33619853|NCT03030417|102155180|FG006|Dose Expansion|Disease progression before treatment|0|||
33619854|NCT03030417|102155181|FG007|Dose Expansion|Disease progression before treatment|0|||
33619855|NCT03030417|102155182|FG008|Dose Expansion|Disease progression before treatment|0|||
33619856|NCT03030417|102155183|FG009|Dose Expansion|Disease progression before treatment|0|||
33619857|NCT03030417|102155184|FG010|Dose Expansion|Disease progression before treatment|0|||
33619858|NCT03030417|102155185|FG011|Dose Expansion|Disease progression before treatment|0|||
33619859|NCT03030417|102155186|FG012|Dose Expansion|Disease progression before treatment|1|||
33619860|NCT00700713|102155189|FG000|Overall Study|Protocol Violation|1|||
33619861|NCT00700713|102155190|FG001|Overall Study|Protocol Violation|0|||
33619862|NCT00700713|102155191|FG002|Overall Study|Protocol Violation|1|||
33619863|NCT00700713|102155189|FG000|Overall Study|Withdrawal by Subject|0|||
33619864|NCT00700713|102155190|FG001|Overall Study|Withdrawal by Subject|0|||
33619865|NCT00700713|102155191|FG002|Overall Study|Withdrawal by Subject|1|||
33619866|NCT00570310|102155192|FG000|Overall Study|Adverse Event|1|||
33619867|NCT00570310|102155193|FG001|Overall Study|Adverse Event|2|||
33619868|NCT00570310|102155192|FG000|Overall Study|Lack of Efficacy|1|||
33354112|NCT00345605|101184004|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
33619869|NCT00570310|102155193|FG001|Overall Study|Lack of Efficacy|4|||
33619870|NCT04170543|102155201|FG000|Overall Study|Death|1|||
33354113|NCT00778830|101184005|FG000|Overall Study|Ongoing at data cut-off|0|||
33619871|NCT04170543|102155202|FG001|Overall Study|Death|1|||
33619872|NCT04170543|102155203|FG002|Overall Study|Death|1|||
33619873|NCT04170543|102155204|FG003|Overall Study|Death|1|||
33619874|NCT04170543|102155205|FG004|Overall Study|Death|1|||
33619875|NCT04170543|102155201|FG000|Overall Study|Lost to Follow-up|3|||
33619876|NCT04170543|102155202|FG001|Overall Study|Lost to Follow-up|3|||
33619877|NCT04170543|102155203|FG002|Overall Study|Lost to Follow-up|0|||
33619878|NCT04170543|102155204|FG003|Overall Study|Lost to Follow-up|3|||
33218021|NCT00541450|100695914|FG001|Phase A|Withdrawal by Subject|7|||
33354114|NCT00778830|101184006|FG001|Overall Study|Ongoing at data cut-off|1|||
33554209|NCT00537082|101927950|FG002|Overall Study|Withdrawal by Subject|0|||
33619879|NCT04170543|102155205|FG004|Overall Study|Lost to Follow-up|1|||
33619880|NCT04170543|102155201|FG000|Overall Study|Withdrawal by Subject|13|||
33619881|NCT04170543|102155202|FG001|Overall Study|Withdrawal by Subject|6|||
33619882|NCT04170543|102155203|FG002|Overall Study|Withdrawal by Subject|5|||
33619883|NCT04170543|102155204|FG003|Overall Study|Withdrawal by Subject|4|||
33619884|NCT04170543|102155205|FG004|Overall Study|Withdrawal by Subject|9|||
33619885|NCT04170543|102155201|FG000|Overall Study|Not able to transition to phase 2b|8|||
33619886|NCT04170543|102155202|FG001|Overall Study|Not able to transition to phase 2b|0|||
33619887|NCT04170543|102155203|FG002|Overall Study|Not able to transition to phase 2b|10|||
33619888|NCT04170543|102155204|FG003|Overall Study|Not able to transition to phase 2b|0|||
33619889|NCT04170543|102155205|FG004|Overall Study|Not able to transition to phase 2b|6|||
33619890|NCT04170543|102155201|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
33619891|NCT04170543|102155202|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
33619892|NCT04170543|102155203|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
33619893|NCT04170543|102155204|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
33619894|NCT04170543|102155205|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
33619895|NCT04170543|102155201|FG000|Overall Study|Not Treated|0|||
33619896|NCT04170543|102155202|FG001|Overall Study|Not Treated|0|||
33619897|NCT04170543|102155203|FG002|Overall Study|Not Treated|0|||
33619898|NCT04170543|102155204|FG003|Overall Study|Not Treated|0|||
33619899|NCT04170543|102155205|FG004|Overall Study|Not Treated|2|||
33619900|NCT04170543|102155201|FG000|Overall Study|(CRF)|16|||
33619901|NCT04170543|102155202|FG001|Overall Study|(CRF)|15|||
33619902|NCT04170543|102155203|FG002|Overall Study|(CRF)|12|||
33619903|NCT04170543|102155204|FG003|Overall Study|(CRF)|17|||
33619904|NCT04170543|102155205|FG004|Overall Study|(CRF)|17|||
33619905|NCT04170543|102155201|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
33619906|NCT04170543|102155202|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
33619907|NCT04170543|102155203|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
33619908|NCT04170543|102155204|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
33619909|NCT04170543|102155205|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
33619910|NCT04809285|102155206|FG000|Phase 1|Lost to Follow-up|6|||
33619911|NCT04809285|102155206|FG000|Phase 1|Protocol Violation|2|||
33619912|NCT04809285|102155206|FG000|Phase 1|Physician Decision|3|||
33619913|NCT04809285|102155206|FG000|Phase 1|Withdrawal by Subject|29|||
33619914|NCT04809285|102155206|FG000|Phase 2|Protocol Violation|3|||
33619915|NCT04809285|102155206|FG000|Phase 2|Withdrawal by Subject|4|||
33619916|NCT03472950|102155207|FG000|Overall Study|Lost to Follow-up|0|||
33619917|NCT03472950|102155208|FG001|Overall Study|Lost to Follow-up|1|||
33619918|NCT03472950|102155207|FG000|Overall Study|Adverse Event|0|||
33619919|NCT03472950|102155208|FG001|Overall Study|Adverse Event|3|||
33619920|NCT05128578|102157949|FG000|Overall Study|Withdrawal by Subject|9|||
33619921|NCT05128578|102157949|FG000|Overall Study|Lost to Follow-up|5|||
33619922|NCT03551626|102157950|FG000|Overall Study|Adverse Event|88|||
33619923|NCT03551626|102157950|FG000|Overall Study|Disease relapse|18|||
33619924|NCT03551626|102157950|FG000|Overall Study|Withdrawal of informed consent|6|||
33619925|NCT03551626|102157950|FG000|Overall Study|Patient decision|5|||
33619926|NCT03551626|102157950|FG000|Overall Study|Physician Decision|4|||
33619927|NCT03551626|102157950|FG000|Overall Study|Lost to Follow-up|3|||
33619928|NCT03551626|102157950|FG000|Overall Study|Pregnancy|1|||
33619929|NCT03551626|102157950|FG000|Overall Study|Protocol deviation|1|||
33619930|NCT03551626|102157950|FG000|Overall Study|Technical problems|1|||
33619931|NCT03826186|102157951|FG000|Overall Study|Protocol Violation|2|||
33619932|NCT03826186|102157952|FG001|Overall Study|Protocol Violation|0|||
33619933|NCT03826186|102157951|FG000|Overall Study|Withdrawal by Subject|1|||
33619934|NCT03826186|102157952|FG001|Overall Study|Withdrawal by Subject|0|||
33619935|NCT02506192|102157953|FG000|Overall Study|Withdrawal by Subject|1|||
33619936|NCT02506192|102157954|FG001|Overall Study|Withdrawal by Subject|1|||
33619937|NCT00801229|102157958|FG000|Signed Consent|Withdrawal by Subject|2|||
33619938|NCT00801229|102157959|FG001|Signed Consent|Withdrawal by Subject|2|||
33619939|NCT00801229|102157958|FG000|Signed Consent|Found Ineligible|1|||
33619940|NCT00801229|102157959|FG001|Signed Consent|Found Ineligible|1|||
33619941|NCT00801229|102157958|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
33619942|NCT00801229|102157959|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
33619943|NCT00801229|102157958|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
33619944|NCT00801229|102157959|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
33619945|NCT00801229|102157958|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
33619946|NCT00801229|102157959|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
33619947|NCT00801229|102157958|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
33619948|NCT00801229|102157959|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
33619949|NCT00801229|102157958|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
33619950|NCT00801229|102157959|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
33619951|NCT00801229|102157958|FG000|Received Study Drug/Placebo|Adverse Event|1|||
33619952|NCT00801229|102157959|FG001|Received Study Drug/Placebo|Adverse Event|1|||
33619953|NCT05661851|102157964|FG000|Overall Study|Protocol Violation|1|||
33619954|NCT05661851|102157965|FG001|Overall Study|Protocol Violation|1|||
33619955|NCT05661851|102157964|FG000|Overall Study|Covid-19 Related|3|||
33619956|NCT05661851|102157965|FG001|Overall Study|Covid-19 Related|4|||
33619957|NCT05661851|102157964|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
33619958|NCT05661851|102157965|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
33619959|NCT05661851|102157964|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
33619960|NCT05661851|102157965|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
33619961|NCT03461146|102157966|FG000|Overall Study|Adverse Event|2|||
33619962|NCT03461146|102157966|FG000|Overall Study|Physician Decision|1|||
33619963|NCT02221674|102157975|FG000|Overall Study|Lost to Follow-up|1|||
33619964|NCT02221674|102157976|FG001|Overall Study|Lost to Follow-up|0|||
33354115|NCT02210780|101184007|FG000|Overall Study|Adverse Event|0|||
33354116|NCT02210780|101184008|FG001|Overall Study|Adverse Event|5|||
33354117|NCT02210780|101184007|FG000|Overall Study|Lost to Follow-up|2|||
33354118|NCT02210780|101184008|FG001|Overall Study|Lost to Follow-up|1|||
33354119|NCT02210780|101184007|FG000|Overall Study|Withdrawal by Subject|1|||
33354120|NCT02210780|101184008|FG001|Overall Study|Withdrawal by Subject|1|||
33354121|NCT02210780|101184007|FG000|Overall Study|Physician Decision|1|||
33354122|NCT02210780|101184008|FG001|Overall Study|Physician Decision|0|||
33354123|NCT02210780|101184007|FG000|Overall Study|Protocol Violation|1|||
33354124|NCT02210780|101184008|FG001|Overall Study|Protocol Violation|0|||
33354125|NCT02210780|101184007|FG000|Overall Study|Other than specified above|0|||
33354126|NCT02210780|101184008|FG001|Overall Study|Other than specified above|1|||
33354127|NCT02333227|101184009|FG000|Overall Study|Lost to Follow-up|137|||
33354128|NCT02333227|101184010|FG001|Overall Study|Lost to Follow-up|106|||
33354129|NCT02333227|101184009|FG000|Overall Study|Pregnancy Interrupted|42|||
33354130|NCT02333227|101184010|FG001|Overall Study|Pregnancy Interrupted|89|||
33354131|NCT02333227|101184009|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
33354132|NCT02333227|101184010|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
33354133|NCT02091440|101184015|FG000|Overall Study|Death|2|||
33354134|NCT02485717|101184016|FG000|Overall Study|Lost to Follow-up|6|||
33354135|NCT02485717|101184017|FG001|Overall Study|Lost to Follow-up|0|||
33354136|NCT02485717|101184018|FG002|Overall Study|Lost to Follow-up|0|||
33354137|NCT02485717|101184016|FG000|Overall Study|Withdrawal by Subject|0|||
33354138|NCT02485717|101184017|FG001|Overall Study|Withdrawal by Subject|0|||
33354139|NCT02485717|101184018|FG002|Overall Study|Withdrawal by Subject|1|||
33354140|NCT02485717|101184016|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
33354141|NCT02485717|101184017|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
33354142|NCT02485717|101184018|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
33354143|NCT02485717|101184016|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
33354144|NCT02485717|101184017|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
33354145|NCT02485717|101184018|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
33354146|NCT03277196|101184019|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
33354147|NCT03277196|101184019|FG000|Overall Study|Lost to Follow-up|3|||
33354148|NCT03277196|101184019|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
33354149|NCT03277196|101184019|FG000|Overall Study|Other|2|||
33619965|NCT02221674|102157977|FG002|Overall Study|Lost to Follow-up|0|||
33619966|NCT01858363|102157980|FG000|Overall Study|Death|35|||
33619967|NCT01858363|102157981|FG001|Overall Study|Death|9|||
33354150|NCT00619229|101184020|FG000|Overall Study|Withdrawal by Subject|1|||
33354151|NCT00619229|101184021|FG001|Overall Study|Withdrawal by Subject|1|||
33354152|NCT00619229|101184020|FG000|Overall Study|Lost to Follow-up|1|||
33354153|NCT00619229|101184021|FG001|Overall Study|Lost to Follow-up|0|||
33354154|NCT00619229|101184020|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
33619968|NCT01858363|102157980|FG000|Overall Study|Withdrawal by Subject|28|||
33619969|NCT01858363|102157981|FG001|Overall Study|Withdrawal by Subject|14|||
33619970|NCT01858363|102157980|FG000|Overall Study|Lost to Follow-up|13|||
33619971|NCT01858363|102157981|FG001|Overall Study|Lost to Follow-up|3|||
33619972|NCT01946152|102157982|FG000|Overall Study|Adverse Event|1|||
33619973|NCT01946152|102157983|FG001|Overall Study|Adverse Event|0|||
33619974|NCT01946152|102157984|FG002|Overall Study|Adverse Event|0|||
33619975|NCT01946152|102157985|FG003|Overall Study|Adverse Event|0|||
33619976|NCT01946152|102157982|FG000|Overall Study|Withdrawal by Subject|0|||
33619977|NCT01946152|102157983|FG001|Overall Study|Withdrawal by Subject|2|||
33619978|NCT01946152|102157984|FG002|Overall Study|Withdrawal by Subject|0|||
33619979|NCT01946152|102157985|FG003|Overall Study|Withdrawal by Subject|0|||
33619980|NCT01946152|102157982|FG000|Overall Study|Progression|0|||
33619981|NCT01946152|102157983|FG001|Overall Study|Progression|1|||
33619982|NCT01946152|102157984|FG002|Overall Study|Progression|4|||
33619983|NCT01946152|102157985|FG003|Overall Study|Progression|7|||
33619984|NCT01946152|102157982|FG000|Overall Study|Physician Decision|0|||
33619985|NCT01946152|102157983|FG001|Overall Study|Physician Decision|0|||
33619986|NCT01946152|102157984|FG002|Overall Study|Physician Decision|1|||
33619987|NCT01946152|102157985|FG003|Overall Study|Physician Decision|0|||
33619988|NCT01946152|102157982|FG000|Overall Study|Second malignancy|0|||
33619989|NCT01946152|102157983|FG001|Overall Study|Second malignancy|0|||
33619990|NCT01946152|102157984|FG002|Overall Study|Second malignancy|1|||
33619991|NCT01946152|102157985|FG003|Overall Study|Second malignancy|0|||
33619992|NCT01946152|102157982|FG000|Overall Study|Adverse Event|0|||
33619993|NCT01946152|102157983|FG001|Overall Study|Adverse Event|0|||
33619994|NCT01946152|102157984|FG002|Overall Study|Adverse Event|0|||
33619995|NCT01946152|102157985|FG003|Overall Study|Adverse Event|1|||
33619996|NCT01449006|102157986|FG000|Overall Study|Lost to Follow-up|1|||
33619997|NCT01449006|102157987|FG001|Overall Study|Lost to Follow-up|0|||
33619998|NCT01449006|102157986|FG000|Overall Study|Withdrawal by Subject|1|||
33619999|NCT01449006|102157987|FG001|Overall Study|Withdrawal by Subject|0|||
33620000|NCT01449006|102157986|FG000|Overall Study|Protocol Violation|1|||
33620001|NCT01449006|102157987|FG001|Overall Study|Protocol Violation|0|||
33620002|NCT03980730|102157988|FG000|Overall Study|Study Terminated by Sponsor|0|||
33620003|NCT03980730|102157989|FG001|Overall Study|Study Terminated by Sponsor|3|||
33620004|NCT03980730|102157988|FG000|Overall Study|Adverse Event|2|||
33620005|NCT03980730|102157989|FG001|Overall Study|Adverse Event|0|||
33620006|NCT03980730|102157988|FG000|Overall Study|Sponsor Request|0|||
33620007|NCT03980730|102157989|FG001|Overall Study|Sponsor Request|1|||
33620008|NCT00699608|102157990|FG000|First Intervention|Withdrawal by Subject|0|||
33620009|NCT00699608|102157991|FG001|First Intervention|Withdrawal by Subject|0|||
33620010|NCT00699608|102157992|FG002|First Intervention|Withdrawal by Subject|1|||
33620011|NCT00699608|102157993|FG003|First Intervention|Withdrawal by Subject|0|||
33620012|NCT00699608|102157994|FG004|First Intervention|Withdrawal by Subject|0|||
33620013|NCT00699608|102157995|FG005|First Intervention|Withdrawal by Subject|0|||
33620014|NCT00699608|102157990|FG000|First Intervention|Protocol Violation|0|||
33620015|NCT00699608|102157991|FG001|First Intervention|Protocol Violation|0|||
33620016|NCT00699608|102157992|FG002|First Intervention|Protocol Violation|0|||
33620017|NCT00699608|102157993|FG003|First Intervention|Protocol Violation|0|||
33354155|NCT00619229|101184021|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
33354156|NCT00619229|101184020|FG000|Overall Study|Investigator planned Cataract Operation|1|||
33354157|NCT00619229|101184021|FG001|Overall Study|Investigator planned Cataract Operation|0|||
33354158|NCT00190775|101184022|FG000|Overall Study|Adverse Event|57|||
33354159|NCT00190775|101184023|FG001|Overall Study|Adverse Event|22|||
33354160|NCT00190775|101184022|FG000|Overall Study|Satisfactory Response|1|||
33354161|NCT00190775|101184023|FG001|Overall Study|Satisfactory Response|0|||
33354162|NCT00190775|101184022|FG000|Overall Study|Lack of Efficacy|28|||
33354163|NCT00190775|101184023|FG001|Overall Study|Lack of Efficacy|32|||
33354164|NCT00190775|101184022|FG000|Overall Study|Lost to Follow-up|31|||
33354165|NCT00190775|101184023|FG001|Overall Study|Lost to Follow-up|23|||
33354166|NCT00190775|101184022|FG000|Overall Study|Participant Moved|0|||
33620018|NCT00699608|102157994|FG004|First Intervention|Protocol Violation|1|||
33354167|NCT00190775|101184023|FG001|Overall Study|Participant Moved|1|||
33620019|NCT00699608|102157995|FG005|First Intervention|Protocol Violation|0|||
33620020|NCT00699608|102157990|FG000|Second Intervention|Adverse Event|0|||
33620021|NCT00699608|102157991|FG001|Second Intervention|Adverse Event|0|||
33354168|NCT00190775|101184022|FG000|Overall Study|Withdrawal by Subject|24|||
33620022|NCT00699608|102157992|FG002|Second Intervention|Adverse Event|1|||
33620023|NCT00699608|102157993|FG003|Second Intervention|Adverse Event|0|||
33620024|NCT00699608|102157994|FG004|Second Intervention|Adverse Event|0|||
33620025|NCT00699608|102157995|FG005|Second Intervention|Adverse Event|0|||
33620026|NCT00699608|102157990|FG000|Second Intervention|Withdrawal by Subject|0|||
33620027|NCT00699608|102157991|FG001|Second Intervention|Withdrawal by Subject|0|||
33620028|NCT00699608|102157992|FG002|Second Intervention|Withdrawal by Subject|0|||
33620029|NCT00699608|102157993|FG003|Second Intervention|Withdrawal by Subject|1|||
33620030|NCT00699608|102157994|FG004|Second Intervention|Withdrawal by Subject|0|||
33218022|NCT00541450|100695913|FG000|Phase B|Adverse Event|6|||
33620031|NCT00699608|102157995|FG005|Second Intervention|Withdrawal by Subject|0|||
33620032|NCT01928927|102157996|FG000|Overall Study|Lost to Follow-up|1|||
33620033|NCT01928927|102157997|FG001|Overall Study|Lost to Follow-up|0|||
33620034|NCT01928927|102157996|FG000|Overall Study|Withdrawal by Subject|1|||
33620035|NCT01928927|102157997|FG001|Overall Study|Withdrawal by Subject|1|||
33620036|NCT00687739|102157998|FG000|Overall Study|Lost to Follow-up|2|||
33620037|NCT00687739|102157999|FG001|Overall Study|Lost to Follow-up|2|||
33620038|NCT00687739|102158000|FG002|Overall Study|Lost to Follow-up|1|||
33620039|NCT00687739|102158001|FG003|Overall Study|Lost to Follow-up|2|||
33620040|NCT00687739|102157998|FG000|Overall Study|Adverse Event|0|||
33620041|NCT00687739|102157999|FG001|Overall Study|Adverse Event|1|||
33620042|NCT00687739|102158000|FG002|Overall Study|Adverse Event|1|||
33620043|NCT00687739|102158001|FG003|Overall Study|Adverse Event|0|||
33620044|NCT01650194|102158004|FG000|Overall Study|Progressive Disease (PD)|35|||
33620045|NCT01650194|102158004|FG000|Overall Study|Withdrawal by Subject|2|||
33620046|NCT01650194|102158004|FG000|Overall Study|Miscellaneous|10|||
33620047|NCT01367834|102158005|FG000|Overall Study|Withdrawal by Subject|2|||
33620048|NCT01367834|102158006|FG001|Overall Study|Withdrawal by Subject|2|||
33620049|NCT01367834|102158005|FG000|Overall Study|Study was ended.|0|||
33620050|NCT01367834|102158006|FG001|Overall Study|Study was ended.|1|||
33620051|NCT01150097|102158007|FG000|Months 24 to 36 Post-transplantation|Death|2|||
33354169|NCT00190775|101184023|FG001|Overall Study|Withdrawal by Subject|13|||
33354170|NCT00190775|101184022|FG000|Overall Study|Sponsor Decision|1|||
33354171|NCT00190775|101184023|FG001|Overall Study|Sponsor Decision|0|||
33354172|NCT00190775|101184022|FG000|Overall Study|Physician Decision|3|||
33354173|NCT00190775|101184023|FG001|Overall Study|Physician Decision|0|||
33354174|NCT00190775|101184022|FG000|Overall Study|Noncompliance|3|||
33354175|NCT00190775|101184023|FG001|Overall Study|Noncompliance|5|||
33354176|NCT00190775|101184022|FG000|Overall Study|Protocol Violation|0|||
33354177|NCT00190775|101184023|FG001|Overall Study|Protocol Violation|1|||
33354178|NCT00190775|101184022|FG000|Overall Study|Exclusion Criteria Met|1|||
33354179|NCT00190775|101184023|FG001|Overall Study|Exclusion Criteria Met|3|||
33354180|NCT01276821|101184035|FG000|Overall Study|Protocol Violation|0|||
33354181|NCT01276821|101184036|FG001|Overall Study|Protocol Violation|1|||
33354182|NCT01360996|101184040|FG000|Overall Study|Withdrawal by Subject|4|||
33354183|NCT01360996|101184041|FG001|Overall Study|Withdrawal by Subject|3|||
33354184|NCT01360996|101184042|FG002|Overall Study|Withdrawal by Subject|2|||
33354185|NCT01360996|101184040|FG000|Overall Study|Noncompliant|2|||
33413283|NCT00539006|101403628|FG001|Washout|Other|1|||
33554210|NCT00537082|101927948|FG000|Overall Study|Discontinued before initiating treatment|3|||
33554211|NCT00537082|101927949|FG001|Overall Study|Discontinued before initiating treatment|0|||
33554212|NCT00537082|101927950|FG002|Overall Study|Discontinued before initiating treatment|0|||
33554213|NCT03309605|101927951|FG000|Overall Study|Adverse Event|0|||
33413284|NCT00539006|101403629|FG002|Washout|Other|2|||
33413285|NCT00539006|101403630|FG003|Washout|Other|3|||
33413286|NCT00539006|101403627|FG000|Treatment Period 2|Protocol Violation|1|||
33413287|NCT00539006|101403628|FG001|Treatment Period 2|Protocol Violation|0|||
33413288|NCT00539006|101403629|FG002|Treatment Period 2|Protocol Violation|0|||
33413289|NCT00539006|101403630|FG003|Treatment Period 2|Protocol Violation|0|||
33413290|NCT00539006|101403627|FG000|Treatment Period 2|Other|0|||
33554214|NCT03309605|101927952|FG001|Overall Study|Adverse Event|0|||
33554215|NCT03309605|101927953|FG002|Overall Study|Adverse Event|0|||
33554216|NCT03309605|101927954|FG003|Overall Study|Adverse Event|1|||
33554217|NCT03309605|101927955|FG004|Overall Study|Adverse Event|0|||
33554218|NCT03309605|101927956|FG005|Overall Study|Adverse Event|0|||
33554219|NCT03309605|101927957|FG006|Overall Study|Adverse Event|2|||
33554220|NCT03309605|101927958|FG007|Overall Study|Adverse Event|1|||
33554221|NCT03309605|101927951|FG000|Overall Study|Withdrawal by Subject|0|||
33554222|NCT03309605|101927952|FG001|Overall Study|Withdrawal by Subject|0|||
33620052|NCT01150097|102158008|FG001|Months 24 to 36 Post-transplantation|Death|0|||
33620053|NCT01150097|102158009|FG002|Months 24 to 36 Post-transplantation|Death|0|||
33620054|NCT01150097|102158007|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
33620055|NCT01150097|102158008|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
33620056|NCT01150097|102158009|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
33620057|NCT01150097|102158007|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
33620058|NCT01150097|102158008|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
33218023|NCT00541450|100695914|FG001|Phase B|Adverse Event|6|||
33354186|NCT01360996|101184041|FG001|Overall Study|Noncompliant|0|||
33354187|NCT01360996|101184042|FG002|Overall Study|Noncompliant|0|||
33354188|NCT02317510|101184043|FG000|Overall Study|Adverse Event|0|||
33620059|NCT01150097|102158009|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
33354189|NCT02317510|101184044|FG001|Overall Study|Adverse Event|1|||
33413291|NCT00539006|101403628|FG001|Treatment Period 2|Other|1|||
33620060|NCT01150097|102158007|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
33354190|NCT03617705|101184056|FG000|Overall Study|Withdrawal by Subject|2|||
33413292|NCT00539006|101403629|FG002|Treatment Period 2|Other|0|||
33413293|NCT00539006|101403630|FG003|Treatment Period 2|Other|0|||
33354191|NCT03617705|101184056|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
33354192|NCT03617705|101184056|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
33354193|NCT05369806|101184059|FG000|Overall Study|Lost to Follow-up|1|||
33354194|NCT00282243|101184062|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
33354195|NCT00282243|101184062|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
33354196|NCT00282243|101184062|FG000|Extension Treatment Period|Adverse Event|15|||
33354197|NCT00282243|101184062|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
33354198|NCT00282243|101184062|FG000|Extension Treatment Period|Non-compliance|2|||
33354199|NCT00282243|101184062|FG000|Extension Treatment Period|Physician Decision|1|||
33354200|NCT03180736|101184064|FG000|Overall Study|Adverse Event|3|||
33354201|NCT03180736|101184065|FG001|Overall Study|Adverse Event|4|||
33354202|NCT03180736|101184064|FG000|Overall Study|Death|10|||
33354203|NCT03180736|101184065|FG001|Overall Study|Death|7|||
33354204|NCT03180736|101184064|FG000|Overall Study|Withdrawal by Subject|5|||
33354205|NCT03180736|101184065|FG001|Overall Study|Withdrawal by Subject|12|||
33354206|NCT03180736|101184064|FG000|Overall Study|Lost to Follow-up|1|||
33354207|NCT03180736|101184065|FG001|Overall Study|Lost to Follow-up|0|||
33354208|NCT03180736|101184064|FG000|Overall Study|Lack of Efficacy|66|||
33413294|NCT02684370|101403631|FG000|Part A|Adverse Event|2|||
33413295|NCT02684370|101403632|FG001|Part A|Adverse Event|0|||
33413296|NCT02684370|101403633|FG002|Part A|Adverse Event|1|||
33413297|NCT02684370|101403634|FG003|Part A|Adverse Event|0|||
33413298|NCT02684370|101403635|FG004|Part A|Adverse Event|0|||
33413299|NCT02684370|101403636|FG005|Part A|Adverse Event|0|||
33413300|NCT02684370|101403631|FG000|Part A|Lost to Follow-up|1|||
33413301|NCT02684370|101403632|FG001|Part A|Lost to Follow-up|1|||
33413302|NCT02684370|101403633|FG002|Part A|Lost to Follow-up|0|||
33413303|NCT02684370|101403634|FG003|Part A|Lost to Follow-up|0|||
33413304|NCT02684370|101403635|FG004|Part A|Lost to Follow-up|0|||
33413305|NCT02684370|101403636|FG005|Part A|Lost to Follow-up|0|||
33413306|NCT02684370|101403631|FG000|Part A|Subject Withdrawal|1|||
33413307|NCT02684370|101403632|FG001|Part A|Subject Withdrawal|0|||
33413308|NCT02684370|101403633|FG002|Part A|Subject Withdrawal|3|||
33413309|NCT02684370|101403634|FG003|Part A|Subject Withdrawal|0|||
33413310|NCT02684370|101403635|FG004|Part A|Subject Withdrawal|0|||
33413311|NCT02684370|101403636|FG005|Part A|Subject Withdrawal|0|||
33413312|NCT02684370|101403631|FG000|Part A|Other|0|||
33413313|NCT02684370|101403632|FG001|Part A|Other|0|||
33413314|NCT02684370|101403633|FG002|Part A|Other|1|||
33413315|NCT02684370|101403634|FG003|Part A|Other|0|||
33413316|NCT02684370|101403635|FG004|Part A|Other|0|||
33413317|NCT02684370|101403636|FG005|Part A|Other|0|||
33620061|NCT01150097|102158008|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
33620062|NCT01150097|102158009|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
33620063|NCT01150097|102158007|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
33620064|NCT01150097|102158008|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
33620065|NCT01150097|102158009|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
33620066|NCT01150097|102158007|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
33620067|NCT01150097|102158008|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
33620068|NCT01150097|102158009|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
33354209|NCT03180736|101184065|FG001|Overall Study|Lack of Efficacy|87|||
33354210|NCT03180736|101184064|FG000|Overall Study|Physician Decision|4|||
33354211|NCT03180736|101184065|FG001|Overall Study|Physician Decision|7|||
33354212|NCT03180736|101184064|FG000|Overall Study|randomized but not treated|2|||
33354213|NCT03180736|101184065|FG001|Overall Study|randomized but not treated|3|||
33354214|NCT04433117|101184076|FG000|Overall Study|Withdrawal by Subject|1|||
33354215|NCT04433117|101184077|FG001|Overall Study|Withdrawal by Subject|0|||
33354216|NCT00144170|101184078|FG000|Overall Study|Adverse Event|84|||
33354217|NCT00144170|101184079|FG001|Overall Study|Adverse Event|41|||
33354218|NCT00144170|101184078|FG000|Overall Study|Protocol Violation|23|||
33413318|NCT02684370|101403631|FG000|Part B|Adverse Event|0|||
33620069|NCT01150097|102158007|FG000|Months 24 to 48 Post-transplantation|Death|2|||
33413319|NCT02684370|101403632|FG001|Part B|Adverse Event|0|||
33413320|NCT02684370|101403633|FG002|Part B|Adverse Event|0|||
33413321|NCT02684370|101403634|FG003|Part B|Adverse Event|0|||
33413322|NCT02684370|101403635|FG004|Part B|Adverse Event|2|||
33354219|NCT00144170|101184079|FG001|Overall Study|Protocol Violation|16|||
33354220|NCT00144170|101184078|FG000|Overall Study|Lost to Follow-up|5|||
33413323|NCT02684370|101403636|FG005|Part B|Adverse Event|1|||
33413324|NCT02684370|101403631|FG000|Part B|Lost to Follow-up|0|||
33413325|NCT02684370|101403632|FG001|Part B|Lost to Follow-up|0|||
33413326|NCT02684370|101403633|FG002|Part B|Lost to Follow-up|0|||
33413327|NCT02684370|101403634|FG003|Part B|Lost to Follow-up|1|||
33413328|NCT02684370|101403635|FG004|Part B|Lost to Follow-up|2|||
33413329|NCT02684370|101403636|FG005|Part B|Lost to Follow-up|5|||
33413330|NCT02684370|101403631|FG000|Part B|Subject Withdrawal|0|||
33413331|NCT02684370|101403632|FG001|Part B|Subject Withdrawal|0|||
33354221|NCT00144170|101184079|FG001|Overall Study|Lost to Follow-up|10|||
33354222|NCT00144170|101184078|FG000|Overall Study|Withdrawal by Subject|29|||
33354223|NCT00144170|101184079|FG001|Overall Study|Withdrawal by Subject|13|||
33354224|NCT00144170|101184078|FG000|Overall Study|Other reason not defined above|211|||
33354225|NCT00144170|101184079|FG001|Overall Study|Other reason not defined above|316|||
33620070|NCT01150097|102158008|FG001|Months 24 to 48 Post-transplantation|Death|0|||
33620071|NCT01150097|102158009|FG002|Months 24 to 48 Post-transplantation|Death|0|||
33620072|NCT04112303|102158011|FG000|Overall Study|Death|1|||
33620073|NCT00718510|102158018|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
33620074|NCT00718510|102158019|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33620075|NCT00718510|102158018|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
33620076|NCT00718510|102158019|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
33620077|NCT00191308|102158024|FG000|Overall Study|Adverse Event|1|||
33620078|NCT02532465|102158027|FG000|Overall Study|Protocol Violation|1|||
33620079|NCT02532465|102158028|FG001|Overall Study|Protocol Violation|0|||
33354226|NCT02338843|101184080|FG000|Overall Study|Adverse Event|2|||
33354227|NCT02338843|101184081|FG001|Overall Study|Adverse Event|1|||
33354228|NCT02338843|101184080|FG000|Overall Study|Death|40|||
33354229|NCT02338843|101184081|FG001|Overall Study|Death|53|||
33354230|NCT02338843|101184080|FG000|Overall Study|Physician Decision|1|||
33354231|NCT02338843|101184081|FG001|Overall Study|Physician Decision|0|||
33354232|NCT02338843|101184080|FG000|Overall Study|Withdrawal by Subject|0|||
33354233|NCT02338843|101184081|FG001|Overall Study|Withdrawal by Subject|2|||
33354234|NCT02338843|101184080|FG000|Overall Study|Subject Recovered|0|||
33554223|NCT03309605|101927953|FG002|Overall Study|Withdrawal by Subject|0|||
33554224|NCT03309605|101927954|FG003|Overall Study|Withdrawal by Subject|0|||
33554225|NCT03309605|101927955|FG004|Overall Study|Withdrawal by Subject|1|||
33554226|NCT03309605|101927956|FG005|Overall Study|Withdrawal by Subject|0|||
33554227|NCT03309605|101927957|FG006|Overall Study|Withdrawal by Subject|1|||
33554228|NCT03309605|101927958|FG007|Overall Study|Withdrawal by Subject|1|||
33554229|NCT04389671|101927961|FG000|Overall Study|Death|7|||
33554230|NCT00356421|101927962|FG000|Overall Study|Lack of Efficacy|3|||
33554231|NCT00356421|101927963|FG001|Overall Study|Lack of Efficacy|0|||
33554232|NCT00356421|101927962|FG000|Overall Study|Withdrawal by Subject|9|||
33554233|NCT00356421|101927963|FG001|Overall Study|Withdrawal by Subject|2|||
33554234|NCT00356421|101927962|FG000|Overall Study|Related to study drug|15|||
33554235|NCT00356421|101927963|FG001|Overall Study|Related to study drug|12|||
33554236|NCT00356421|101927962|FG000|Overall Study|Not related to study drug|5|||
33554237|NCT00356421|101927963|FG001|Overall Study|Not related to study drug|3|||
33554238|NCT05064800|101927964|FG000|Period 3|Withdrawal by Subject|0|||
33554239|NCT05064800|101927965|FG001|Period 3|Withdrawal by Subject|0|||
33554240|NCT05064800|101927966|FG002|Period 3|Withdrawal by Subject|0|||
33554241|NCT05064800|101927967|FG003|Period 3|Withdrawal by Subject|0|||
33554242|NCT05064800|101927968|FG004|Period 3|Withdrawal by Subject|1|||
33554243|NCT05064800|101927969|FG005|Period 3|Withdrawal by Subject|0|||
33554244|NCT04233580|101927972|FG000|Overall Study|Adverse Event|3|||
33554245|NCT04233580|101927973|FG001|Overall Study|Adverse Event|3|||
33554246|NCT04233580|101927972|FG000|Overall Study|Withdrawal by Subject|2|||
33554247|NCT04233580|101927973|FG001|Overall Study|Withdrawal by Subject|1|||
33554248|NCT00567112|101927978|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
33554249|NCT00567112|101927979|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
33554250|NCT00567112|101927980|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
33554251|NCT00567112|101927978|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
33554252|NCT00567112|101927979|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
33554253|NCT00567112|101927980|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
33554254|NCT00567112|101927978|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
33554255|NCT00567112|101927979|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
33554256|NCT00567112|101927980|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
33554257|NCT00560404|101927981|FG000|Overall Study|Adverse Event|2|||
33554258|NCT00560404|101927982|FG001|Overall Study|Adverse Event|3|||
33554259|NCT00560404|101927981|FG000|Overall Study|Death|3|||
33554260|NCT00560404|101927982|FG001|Overall Study|Death|3|||
33554261|NCT00560404|101927981|FG000|Overall Study|Protocol Violation|12|||
33554262|NCT00560404|101927982|FG001|Overall Study|Protocol Violation|7|||
33554263|NCT00560404|101927981|FG000|Overall Study|Administrative Reasons|1|||
33554264|NCT00560404|101927982|FG001|Overall Study|Administrative Reasons|1|||
33620080|NCT02532465|102158027|FG000|Overall Study|Lack of Efficacy|0|||
33554265|NCT00560404|101927981|FG000|Overall Study|Withdrew Consent|4|||
33554266|NCT00560404|101927982|FG001|Overall Study|Withdrew Consent|0|||
33554267|NCT00560404|101927981|FG000|Overall Study|Failure to return|1|||
33554268|NCT00560404|101927982|FG001|Overall Study|Failure to return|2|||
33620081|NCT02532465|102158028|FG001|Overall Study|Lack of Efficacy|1|||
33620082|NCT04628780|102158032|FG000|Overall Study|Death|0|||
33620083|NCT04628780|102158033|FG001|Overall Study|Death|1|||
33354235|NCT02338843|101184081|FG001|Overall Study|Subject Recovered|2|||
33554269|NCT00560404|101927981|FG000|Overall Study|Other withdrawal reason|13|||
33554270|NCT00560404|101927982|FG001|Overall Study|Other withdrawal reason|5|||
33554271|NCT00585585|101927983|FG000|Overall Study|Adverse Event|1|||
33554272|NCT03548415|101927984|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
33554273|NCT03548415|101927985|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
33554274|NCT03548415|101927986|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
33354236|NCT02338843|101184080|FG000|Overall Study|Discontinued prior to randomizat|1|||
33354237|NCT02338843|101184081|FG001|Overall Study|Discontinued prior to randomizat|0|||
33354238|NCT01254344|101184087|FG000|Overall Study|Adverse Event|2|||
33354239|NCT01254344|101184088|FG001|Overall Study|Adverse Event|5|||
33354240|NCT01254344|101184087|FG000|Overall Study|Physician Decision|7|||
33354241|NCT01254344|101184088|FG001|Overall Study|Physician Decision|4|||
33354242|NCT01254344|101184087|FG000|Overall Study|Protocol Violation|1|||
33354243|NCT01254344|101184088|FG001|Overall Study|Protocol Violation|4|||
33354244|NCT01254344|101184087|FG000|Overall Study|Withdrawal by Subject|3|||
33354245|NCT01254344|101184088|FG001|Overall Study|Withdrawal by Subject|6|||
33554275|NCT03548415|101927987|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
33554276|NCT03548415|101927988|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
33554277|NCT00723944|101927989|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
33554278|NCT00723944|101927990|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
33554279|NCT00723944|101927989|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
33554280|NCT00723944|101927990|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
33554281|NCT00723944|101927989|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
33554282|NCT00723944|101927990|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
33554283|NCT01658735|101927991|FG000|Overall Study|Lack of Efficacy|1|||
33554284|NCT01658735|101927992|FG001|Overall Study|Lack of Efficacy|0|||
33554285|NCT01658735|101927993|FG002|Overall Study|Lack of Efficacy|1|||
33554286|NCT01658735|101927991|FG000|Overall Study|Lost to Follow-up|1|||
33554287|NCT01658735|101927992|FG001|Overall Study|Lost to Follow-up|1|||
33554288|NCT01658735|101927993|FG002|Overall Study|Lost to Follow-up|0|||
33554289|NCT01658735|101927991|FG000|Overall Study|Protocol Violation|0|||
33554290|NCT01658735|101927992|FG001|Overall Study|Protocol Violation|1|||
33554291|NCT01658735|101927993|FG002|Overall Study|Protocol Violation|0|||
33554292|NCT01658735|101927991|FG000|Overall Study|Withdrawal by Subject|3|||
33554293|NCT01658735|101927992|FG001|Overall Study|Withdrawal by Subject|5|||
33554294|NCT01658735|101927993|FG002|Overall Study|Withdrawal by Subject|3|||
33554295|NCT02175758|101927995|FG000|Treatment Phase|Lost to Follow-up|0|||
33554296|NCT02175758|101927996|FG001|Treatment Phase|Lost to Follow-up|1|||
33554297|NCT02175758|101927997|FG002|Treatment Phase|Lost to Follow-up|0|||
33554298|NCT02175758|101927998|FG003|Treatment Phase|Lost to Follow-up|0|||
33554299|NCT02175758|101927999|FG004|Treatment Phase|Lost to Follow-up|0|||
33554300|NCT02175758|101928000|FG005|Treatment Phase|Lost to Follow-up|0|||
33554301|NCT02175758|101927995|FG000|Treatment Phase|Adverse Event|0|||
33554302|NCT02175758|101927996|FG001|Treatment Phase|Adverse Event|0|||
33554303|NCT02175758|101927997|FG002|Treatment Phase|Adverse Event|0|||
33554304|NCT02175758|101927998|FG003|Treatment Phase|Adverse Event|0|||
33554305|NCT02175758|101927999|FG004|Treatment Phase|Adverse Event|1|||
33554306|NCT02175758|101928000|FG005|Treatment Phase|Adverse Event|0|||
33554307|NCT01117350|101928005|FG000|Comparative Period|Not Treated|5|||
33554308|NCT01117350|101928006|FG001|Comparative Period|Not Treated|8|||
33554309|NCT01117350|101928005|FG000|Comparative Period|Adverse Event|6|||
33554310|NCT01117350|101928006|FG001|Comparative Period|Adverse Event|33|||
33554311|NCT01117350|101928005|FG000|Comparative Period|Lost to Follow-up|11|||
33554312|NCT01117350|101928006|FG001|Comparative Period|Lost to Follow-up|7|||
33554313|NCT01117350|101928005|FG000|Comparative Period|Withdrawal by Subject|9|||
33554314|NCT01117350|101928006|FG001|Comparative Period|Withdrawal by Subject|13|||
33554315|NCT01117350|101928005|FG000|Comparative Period|Protocol Violation|8|||
33554316|NCT01117350|101928006|FG001|Comparative Period|Protocol Violation|12|||
33554317|NCT01117350|101928005|FG000|Comparative Period|Lack of Efficacy|1|||
33554318|NCT01117350|101928006|FG001|Comparative Period|Lack of Efficacy|0|||
33554319|NCT01117350|101928005|FG000|Comparative Period|Physician Decision|0|||
33554320|NCT01117350|101928006|FG001|Comparative Period|Physician Decision|1|||
33554321|NCT01117350|101928005|FG000|Comparative Period|Move to another city/country|2|||
33554322|NCT01117350|101928006|FG001|Comparative Period|Move to another city/country|1|||
33554323|NCT01117350|101928005|FG000|Extension Period|Not included in extension, not treated|0|||
33554324|NCT01117350|101928006|FG001|Extension Period|Not included in extension, not treated|50|||
33554325|NCT01117350|101928005|FG000|Extension Period|Adverse Event|0|||
33554326|NCT01117350|101928006|FG001|Extension Period|Adverse Event|2|||
33554327|NCT01117350|101928005|FG000|Extension Period|Protocol Violation|0|||
33554328|NCT01117350|101928006|FG001|Extension Period|Protocol Violation|2|||
33554329|NCT01117350|101928005|FG000|Extension Period|Lost to Follow-up|0|||
33554330|NCT01117350|101928006|FG001|Extension Period|Lost to Follow-up|2|||
33554331|NCT01117350|101928005|FG000|Extension Period|Withdrawal by Subject|0|||
33554332|NCT01117350|101928006|FG001|Extension Period|Withdrawal by Subject|3|||
33554333|NCT01117350|101928005|FG000|Extension Period|Lack of Efficacy|0|||
33554334|NCT01117350|101928006|FG001|Extension Period|Lack of Efficacy|2|||
33354246|NCT00023322|101184089|FG000|Overall Study|Lost to Follow-up|1|||
33354247|NCT00963807|101184093|FG000|Overall Study|Physician Decision|2|||
33354248|NCT00963807|101184093|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
33354249|NCT00963807|101184093|FG000|Overall Study|Disease progression|15|||
33354250|NCT00389207|101184101|FG000|Overall Study|Adverse Event|26|||
33354251|NCT00389207|101184102|FG001|Overall Study|Adverse Event|32|||
33354252|NCT00389207|101184103|FG002|Overall Study|Adverse Event|10|||
33413332|NCT02684370|101403633|FG002|Part B|Subject Withdrawal|0|||
33413333|NCT02684370|101403634|FG003|Part B|Subject Withdrawal|1|||
33413334|NCT02684370|101403635|FG004|Part B|Subject Withdrawal|1|||
33413335|NCT02684370|101403636|FG005|Part B|Subject Withdrawal|2|||
33413336|NCT04150107|101403637|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
33413337|NCT04150107|101403638|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
33413338|NCT04150107|101403637|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
33413339|NCT04150107|101403638|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
33413340|NCT01160770|101403642|FG000|Overall Study|Adverse Event|10|||
33413341|NCT01160770|101403642|FG000|Overall Study|Protocol Violation|2|||
33413342|NCT01160770|101403642|FG000|Overall Study|Subject/parent/caregiver request|33|||
33413343|NCT01160770|101403642|FG000|Overall Study|Physician Decision|1|||
33413344|NCT01160770|101403642|FG000|Overall Study|Lost to Follow-up|7|||
33354253|NCT00389207|101184101|FG000|Overall Study|Protocol Violation|3|||
33354254|NCT00389207|101184102|FG001|Overall Study|Protocol Violation|1|||
33354255|NCT00389207|101184103|FG002|Overall Study|Protocol Violation|4|||
33354256|NCT00389207|101184101|FG000|Overall Study|Lost to Follow-up|12|||
33413345|NCT01160770|101403642|FG000|Overall Study|Study termination or sponsor request|1|||
33413346|NCT01160770|101403642|FG000|Overall Study|Death|9|||
33413347|NCT01160770|101403642|FG000|Overall Study|Lack of Efficacy|15|||
33413348|NCT01160770|101403642|FG000|Overall Study|Other Reasons|1|||
33413349|NCT04621227|101403643|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
33413350|NCT04621227|101403643|FG000|Period 3 (29 Days)|Adverse Event|1|||
33413351|NCT04621227|101403643|FG000|Period 8 (2 Days)|Adverse Event|1|||
33413352|NCT01366846|101403646|FG000|Overall Study|Withdrawal by Subject|2|||
33413353|NCT01366846|101403647|FG001|Overall Study|Withdrawal by Subject|0|||
33413354|NCT01366846|101403648|FG002|Overall Study|Withdrawal by Subject|0|||
33413355|NCT01366846|101403649|FG003|Overall Study|Withdrawal by Subject|0|||
33413356|NCT01366846|101403646|FG000|Overall Study|Communication Difficulties|1|||
33413357|NCT01366846|101403647|FG001|Overall Study|Communication Difficulties|4|||
33413358|NCT01366846|101403648|FG002|Overall Study|Communication Difficulties|0|||
33554335|NCT01117350|101928005|FG000|Extension Period|Inclusion criteria not respected|0|||
33554336|NCT01117350|101928006|FG001|Extension Period|Inclusion criteria not respected|1|||
33554337|NCT01117350|101928005|FG000|Extension Period|Prohibited medication|0|||
33554338|NCT01117350|101928006|FG001|Extension Period|Prohibited medication|1|||
33554339|NCT03518203|101928007|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
33554340|NCT03518203|101928007|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
33554341|NCT00585169|101928009|FG000|Overall Study|Withdrawal by Subject|1|||
33354257|NCT00389207|101184102|FG001|Overall Study|Lost to Follow-up|9|||
33354258|NCT00389207|101184103|FG002|Overall Study|Lost to Follow-up|7|||
33354259|NCT00389207|101184101|FG000|Overall Study|Withdrawal by Subject|5|||
33354260|NCT00389207|101184102|FG001|Overall Study|Withdrawal by Subject|7|||
33354261|NCT00389207|101184103|FG002|Overall Study|Withdrawal by Subject|11|||
33354262|NCT00389207|101184101|FG000|Overall Study|Other|17|||
33354263|NCT00389207|101184102|FG001|Overall Study|Other|23|||
33354264|NCT00389207|101184103|FG002|Overall Study|Other|9|||
33354265|NCT03377634|101184105|FG000|Study Period|Adverse Event|1|||
33354266|NCT03377634|101184106|FG001|Study Period|Adverse Event|0|||
33354267|NCT03377634|101184105|FG000|Study Period|Withdrawal by Subject|1|||
33354268|NCT03377634|101184106|FG001|Study Period|Withdrawal by Subject|0|||
33354269|NCT01171612|101184110|FG000|Overall Study|Lost to Follow-up|51|||
33354270|NCT00885365|101184111|FG000|4 Weeks ON Treatment|Adverse Event|2|||
33354271|NCT00885365|101184112|FG001|4 Weeks ON Treatment|Adverse Event|4|||
33354272|NCT00885365|101184111|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
33354273|NCT00885365|101184112|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
33354274|NCT00885365|101184111|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
33354275|NCT00885365|101184112|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
33354276|NCT02388295|101184113|FG000|Dose Escalation Week 1|Adverse Event|1|||
33354277|NCT02388295|101184114|FG001|Dose Escalation Week 1|Adverse Event|2|||
33413359|NCT01366846|101403649|FG003|Overall Study|Communication Difficulties|1|||
33354278|NCT02388295|101184115|FG002|Dose Escalation Week 1|Adverse Event|1|||
33413360|NCT01366846|101403646|FG000|Overall Study|Scheduling Conflicts|0|||
33354279|NCT02388295|101184113|FG000|Dose Escalation Week 1|Determined not eligible|1|||
33413361|NCT01366846|101403647|FG001|Overall Study|Scheduling Conflicts|0|||
33413362|NCT01366846|101403648|FG002|Overall Study|Scheduling Conflicts|1|||
33413363|NCT01366846|101403649|FG003|Overall Study|Scheduling Conflicts|0|||
33413364|NCT04633434|101403650|FG000|Overall Study|Lost to Follow-up|32|||
33413365|NCT04633434|101403651|FG001|Overall Study|Lost to Follow-up|32|||
33354280|NCT02388295|101184114|FG001|Dose Escalation Week 1|Determined not eligible|1|||
33413366|NCT03735680|101403655|FG000|Overall Study|Withdrawal by Subject|0|||
33354281|NCT02388295|101184115|FG002|Dose Escalation Week 1|Determined not eligible|1|||
33354282|NCT02388295|101184113|FG000|Dose Escalation Week 2|Protocol Violation|0|||
33354283|NCT02388295|101184114|FG001|Dose Escalation Week 2|Protocol Violation|1|||
33354284|NCT02388295|101184115|FG002|Dose Escalation Week 2|Protocol Violation|0|||
33354285|NCT02388295|101184113|FG000|Dose Escalation Week 2|Determined not eligible|1|||
33354286|NCT02388295|101184114|FG001|Dose Escalation Week 2|Determined not eligible|1|||
33354287|NCT02388295|101184115|FG002|Dose Escalation Week 2|Determined not eligible|1|||
33354288|NCT02388295|101184113|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
33354289|NCT02388295|101184114|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
33354290|NCT02388295|101184115|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
33354291|NCT01307423|101184120|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
33354292|NCT01307423|101184121|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
33354293|NCT01307423|101184122|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
33354294|NCT01307423|101184123|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33354295|NCT01307423|101184124|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33354296|NCT01307423|101184125|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33354297|NCT01307423|101184126|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33354298|NCT01307423|101184127|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33354299|NCT01307423|101184128|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33354300|NCT01307423|101184120|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
33354301|NCT01307423|101184121|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
33413367|NCT03735680|101403656|FG001|Overall Study|Withdrawal by Subject|1|||
33620084|NCT04628780|102158034|FG002|Overall Study|Death|0|||
33413368|NCT03735680|101403657|FG002|Overall Study|Withdrawal by Subject|0|||
33413369|NCT03735680|101403658|FG003|Overall Study|Withdrawal by Subject|0|||
33413370|NCT03735680|101403659|FG004|Overall Study|Withdrawal by Subject|0|||
33413371|NCT03735680|101403660|FG005|Overall Study|Withdrawal by Subject|1|||
33413372|NCT03735680|101403655|FG000|Overall Study|Patient unable or unwilling to continue|0|||
33620085|NCT04628780|102158035|FG003|Overall Study|Death|0|||
33620086|NCT04628780|102158036|FG004|Overall Study|Death|1|||
33413373|NCT03735680|101403656|FG001|Overall Study|Patient unable or unwilling to continue|0|||
33413374|NCT03735680|101403657|FG002|Overall Study|Patient unable or unwilling to continue|1|||
33413375|NCT03735680|101403658|FG003|Overall Study|Patient unable or unwilling to continue|0|||
33413376|NCT03735680|101403659|FG004|Overall Study|Patient unable or unwilling to continue|0|||
33413377|NCT03735680|101403660|FG005|Overall Study|Patient unable or unwilling to continue|0|||
33620087|NCT04628780|102158037|FG005|Overall Study|Death|0|||
33620088|NCT04628780|102158032|FG000|Overall Study|Physician Decision|2|||
33620089|NCT04628780|102158033|FG001|Overall Study|Physician Decision|0|||
33620090|NCT04628780|102158034|FG002|Overall Study|Physician Decision|0|||
33620091|NCT04628780|102158035|FG003|Overall Study|Physician Decision|0|||
33620092|NCT04628780|102158036|FG004|Overall Study|Physician Decision|2|||
33620093|NCT04628780|102158037|FG005|Overall Study|Physician Decision|0|||
33620094|NCT04628780|102158032|FG000|Overall Study|Progressive disease|2|||
33413378|NCT01826201|101403661|FG000|Overall Study|Non compliance with protocol|4|||
33413379|NCT01207219|101403664|FG000|Overall Study|changed diagnosis during study period|5|||
33413380|NCT01207219|101403665|FG001|Overall Study|changed diagnosis during study period|3|||
33413381|NCT01207219|101403666|FG002|Overall Study|changed diagnosis during study period|1|||
33413382|NCT01207219|101403664|FG000|Overall Study|Lost to Follow-up|6|||
33413383|NCT01207219|101403665|FG001|Overall Study|Lost to Follow-up|8|||
33413384|NCT01207219|101403666|FG002|Overall Study|Lost to Follow-up|6|||
33413385|NCT01068418|101403667|FG000|Overall Study|Physician Decision|12|||
33413386|NCT03917654|101403668|FG000|Year 1|Withdrawal by Subject|1|||
33413387|NCT03917654|101403669|FG001|Year 1|Withdrawal by Subject|0|||
33413388|NCT03917654|101403670|FG002|Year 1|Withdrawal by Subject|0|||
33413389|NCT03917654|101403671|FG003|Year 1|Withdrawal by Subject|0|||
33413390|NCT03917654|101403672|FG004|Year 1|Withdrawal by Subject|0|||
33413391|NCT03917654|101403673|FG005|Year 1|Withdrawal by Subject|1|||
33413392|NCT03917654|101403674|FG006|Year 1|Withdrawal by Subject|6|||
33413393|NCT03917654|101403675|FG007|Year 1|Withdrawal by Subject|2|||
33413394|NCT03917654|101403676|FG008|Year 1|Withdrawal by Subject|5|||
33413395|NCT03917654|101403677|FG009|Year 1|Withdrawal by Subject|3|||
33413396|NCT03917654|101403678|FG010|Year 1|Withdrawal by Subject|1|||
33413397|NCT03917654|101403679|FG011|Year 1|Withdrawal by Subject|0|||
33413398|NCT03917654|101403668|FG000|Year 1|Travel|0|||
33620095|NCT04628780|102158033|FG001|Overall Study|Progressive disease|2|||
33620096|NCT04628780|102158034|FG002|Overall Study|Progressive disease|2|||
33620097|NCT04628780|102158035|FG003|Overall Study|Progressive disease|3|||
33354302|NCT01307423|101184122|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
33413399|NCT03917654|101403669|FG001|Year 1|Travel|1|||
33413400|NCT03917654|101403670|FG002|Year 1|Travel|1|||
33413401|NCT03917654|101403671|FG003|Year 1|Travel|0|||
33413402|NCT03917654|101403672|FG004|Year 1|Travel|4|||
33620098|NCT04628780|102158036|FG004|Overall Study|Progressive disease|9|||
33620099|NCT04628780|102158037|FG005|Overall Study|Progressive disease|4|||
33620100|NCT04628780|102158032|FG000|Overall Study|Withdrawal by Subject|0|||
33631306|NCT03486912|102202916|FG002|Treatment Period|Adverse Event|1|||
33354303|NCT01307423|101184123|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33354304|NCT01307423|101184124|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33354305|NCT01307423|101184125|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33354306|NCT01307423|101184126|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33354307|NCT01307423|101184127|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33354308|NCT01307423|101184128|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33354309|NCT01307423|101184120|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
33354310|NCT01307423|101184121|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
33354311|NCT01307423|101184122|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
33354312|NCT01307423|101184123|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33354313|NCT01307423|101184124|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33354314|NCT01307423|101184125|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33354315|NCT01307423|101184126|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33354316|NCT01307423|101184127|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33354317|NCT01307423|101184128|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33354318|NCT01307423|101184120|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33354319|NCT01307423|101184121|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33354320|NCT01307423|101184122|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
33354321|NCT01307423|101184123|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33354322|NCT01307423|101184124|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33354323|NCT01307423|101184125|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33354324|NCT01307423|101184126|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33354325|NCT01307423|101184127|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33354326|NCT01307423|101184128|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33354327|NCT01307423|101184120|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
33354328|NCT01307423|101184121|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
33354329|NCT01307423|101184122|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
33354330|NCT01307423|101184123|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33354331|NCT01307423|101184124|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33354332|NCT01307423|101184125|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33354333|NCT01307423|101184126|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33354334|NCT01307423|101184127|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33354335|NCT01307423|101184128|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33354336|NCT01307423|101184120|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
33354337|NCT01307423|101184121|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33354338|NCT01307423|101184122|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33354339|NCT01307423|101184123|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33354340|NCT01307423|101184124|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33354341|NCT01307423|101184125|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33354342|NCT01307423|101184126|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33354343|NCT01307423|101184127|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33354344|NCT01307423|101184128|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33354345|NCT01307423|101184120|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
33354346|NCT01307423|101184121|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
33354347|NCT01307423|101184122|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33354348|NCT01307423|101184123|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33354349|NCT01307423|101184124|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33354350|NCT01307423|101184125|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33354351|NCT01307423|101184126|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33354352|NCT01307423|101184127|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33354353|NCT01307423|101184128|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33354354|NCT01307423|101184120|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
33354355|NCT01307423|101184121|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
33354356|NCT01307423|101184122|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
33354357|NCT01307423|101184123|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
33354358|NCT01307423|101184124|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
33413403|NCT03917654|101403673|FG005|Year 1|Travel|4|||
33554342|NCT00514917|101928013|FG000|Overall Study|Death|4|||
33554343|NCT00514917|101928014|FG001|Overall Study|Death|10|||
33554344|NCT00514917|101928013|FG000|Overall Study|Protocol Violation|1|||
33554345|NCT00514917|101928014|FG001|Overall Study|Protocol Violation|0|||
33554346|NCT00514917|101928013|FG000|Overall Study|Lost to Follow-up|4|||
33554347|NCT00514917|101928014|FG001|Overall Study|Lost to Follow-up|3|||
33554348|NCT00514917|101928013|FG000|Overall Study|Withdrawal by Subject|18|||
33554349|NCT00514917|101928014|FG001|Overall Study|Withdrawal by Subject|16|||
33218024|NCT00541450|100695913|FG000|Phase B|Hyperglycemia|10|||
33413404|NCT03917654|101403674|FG006|Year 1|Travel|10|||
33413405|NCT03917654|101403675|FG007|Year 1|Travel|8|||
33413406|NCT03917654|101403676|FG008|Year 1|Travel|2|||
33413407|NCT03917654|101403677|FG009|Year 1|Travel|5|||
33413408|NCT03917654|101403678|FG010|Year 1|Travel|3|||
33413409|NCT03917654|101403679|FG011|Year 1|Travel|3|||
33413410|NCT03917654|101403668|FG000|Year 1|Subject moved away from site|0|||
33413411|NCT03917654|101403669|FG001|Year 1|Subject moved away from site|1|||
33413412|NCT03917654|101403670|FG002|Year 1|Subject moved away from site|0|||
33413413|NCT03917654|101403671|FG003|Year 1|Subject moved away from site|0|||
33413414|NCT03917654|101403672|FG004|Year 1|Subject moved away from site|0|||
33413415|NCT03917654|101403673|FG005|Year 1|Subject moved away from site|0|||
33413416|NCT03917654|101403674|FG006|Year 1|Subject moved away from site|1|||
33413417|NCT03917654|101403675|FG007|Year 1|Subject moved away from site|2|||
33413418|NCT03917654|101403676|FG008|Year 1|Subject moved away from site|1|||
33413419|NCT03917654|101403677|FG009|Year 1|Subject moved away from site|0|||
33413420|NCT03917654|101403678|FG010|Year 1|Subject moved away from site|0|||
33413421|NCT03917654|101403679|FG011|Year 1|Subject moved away from site|3|||
33413422|NCT03917654|101403668|FG000|Year 1|Spouse/Family member request|0|||
33413423|NCT03917654|101403669|FG001|Year 1|Spouse/Family member request|0|||
33413424|NCT03917654|101403670|FG002|Year 1|Spouse/Family member request|1|||
33413425|NCT03917654|101403671|FG003|Year 1|Spouse/Family member request|0|||
33413426|NCT03917654|101403672|FG004|Year 1|Spouse/Family member request|1|||
33413427|NCT03917654|101403673|FG005|Year 1|Spouse/Family member request|0|||
33554350|NCT00514917|101928013|FG000|Overall Study|Discontinued due to study closure|88|||
33554351|NCT00514917|101928014|FG001|Overall Study|Discontinued due to study closure|81|||
33554352|NCT00514917|101928013|FG000|Overall Study|Undefined|11|||
33554353|NCT00514917|101928014|FG001|Overall Study|Undefined|5|||
33413428|NCT03917654|101403674|FG006|Year 1|Spouse/Family member request|0|||
33413429|NCT03917654|101403675|FG007|Year 1|Spouse/Family member request|2|||
33413430|NCT03917654|101403676|FG008|Year 1|Spouse/Family member request|0|||
33413431|NCT03917654|101403677|FG009|Year 1|Spouse/Family member request|0|||
33413432|NCT03917654|101403678|FG010|Year 1|Spouse/Family member request|0|||
33413433|NCT03917654|101403679|FG011|Year 1|Spouse/Family member request|1|||
33413434|NCT03917654|101403668|FG000|Year 1|Death|0|||
33413435|NCT03917654|101403669|FG001|Year 1|Death|0|||
33413436|NCT03917654|101403670|FG002|Year 1|Death|0|||
33413437|NCT03917654|101403671|FG003|Year 1|Death|0|||
33413438|NCT03917654|101403672|FG004|Year 1|Death|0|||
33413439|NCT03917654|101403673|FG005|Year 1|Death|0|||
33554354|NCT02571244|101928020|FG000|Overall Study|Lost to Follow-up|0|||
33413440|NCT03917654|101403674|FG006|Year 1|Death|0|||
33620101|NCT04628780|102158033|FG001|Overall Study|Withdrawal by Subject|1|||
33620102|NCT04628780|102158034|FG002|Overall Study|Withdrawal by Subject|2|||
33620103|NCT04628780|102158035|FG003|Overall Study|Withdrawal by Subject|0|||
33354359|NCT01307423|101184125|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
33354360|NCT01307423|101184126|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
33354361|NCT01307423|101184127|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
33354362|NCT01307423|101184128|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
33354363|NCT01307423|101184120|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
33354364|NCT01307423|101184121|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
33354365|NCT01307423|101184122|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
33354366|NCT01307423|101184123|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
33354367|NCT01307423|101184124|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
33354368|NCT01307423|101184125|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
33354369|NCT01307423|101184126|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
33354370|NCT01307423|101184127|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
33354371|NCT01307423|101184128|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
33354372|NCT01307423|101184120|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
33354373|NCT01307423|101184121|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
33354374|NCT01307423|101184122|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
33354375|NCT01307423|101184123|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
33354376|NCT01307423|101184124|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
33354377|NCT01307423|101184125|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
33354378|NCT01307423|101184126|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
33413441|NCT03917654|101403675|FG007|Year 1|Death|0|||
33413442|NCT03917654|101403676|FG008|Year 1|Death|1|||
33413443|NCT03917654|101403677|FG009|Year 1|Death|1|||
33413444|NCT03917654|101403678|FG010|Year 1|Death|0|||
33413445|NCT03917654|101403679|FG011|Year 1|Death|0|||
33413446|NCT03917654|101403668|FG000|Year 1|Lost to Follow-up|0|||
33413447|NCT03917654|101403669|FG001|Year 1|Lost to Follow-up|0|||
33554355|NCT02571244|101928021|FG001|Overall Study|Lost to Follow-up|1|||
33554356|NCT02571244|101928020|FG000|Overall Study|Unable to reach out post discharge|3|||
33554357|NCT02571244|101928021|FG001|Overall Study|Unable to reach out post discharge|0|||
33554358|NCT01454063|101928026|FG000|Randomized|Adverse Event|1|||
33554359|NCT01454063|101928027|FG001|Randomized|Adverse Event|1|||
33554360|NCT01454063|101928026|FG000|Randomized|Protocol Violation|0|||
33554361|NCT01454063|101928027|FG001|Randomized|Protocol Violation|1|||
33554362|NCT00122187|101928028|FG000|Overall Study|Withdrew because of resource limitations|2|||
33554363|NCT00122187|101928029|FG001|Overall Study|Withdrew because of resource limitations|2|||
33554364|NCT03335566|101928031|FG000|Overall Study|Adverse Event|0|||
33554365|NCT03335566|101928032|FG001|Overall Study|Adverse Event|1|||
33554366|NCT03335566|101928031|FG000|Overall Study|Lost to Follow-up|1|||
33554367|NCT03335566|101928032|FG001|Overall Study|Lost to Follow-up|0|||
33554368|NCT03335566|101928031|FG000|Overall Study|Technical Problems|1|||
33554369|NCT03335566|101928032|FG001|Overall Study|Technical Problems|0|||
33554370|NCT03335566|101928031|FG000|Overall Study|Protocol Violation|1|||
33554371|NCT03335566|101928032|FG001|Overall Study|Protocol Violation|0|||
33554372|NCT03335566|101928031|FG000|Overall Study|Other than specified above|1|||
33554373|NCT03335566|101928032|FG001|Overall Study|Other than specified above|2|||
33554374|NCT01169337|101931748|FG000|Overall Study|Lack of Efficacy|5|||
33554375|NCT01169337|101931749|FG001|Overall Study|Lack of Efficacy|7|||
33620104|NCT04628780|102158036|FG004|Overall Study|Withdrawal by Subject|3|||
33620105|NCT04628780|102158037|FG005|Overall Study|Withdrawal by Subject|1|||
33620106|NCT04628780|102158032|FG000|Overall Study|Global deterioration of health status|0|||
33354379|NCT01307423|101184127|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
33354380|NCT01307423|101184128|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
33354381|NCT01307423|101184120|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33354382|NCT01307423|101184121|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33354383|NCT01307423|101184122|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33354384|NCT01307423|101184123|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33354385|NCT01307423|101184124|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33354386|NCT01307423|101184125|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
33354387|NCT01307423|101184126|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33354388|NCT01307423|101184127|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33354389|NCT01307423|101184128|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
33354390|NCT01307423|101184120|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
33354391|NCT01307423|101184121|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
33354392|NCT01307423|101184122|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
33354393|NCT01307423|101184123|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
33354394|NCT01307423|101184124|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
33354395|NCT01307423|101184125|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
33354396|NCT01307423|101184126|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
33354397|NCT01307423|101184127|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
33354398|NCT01307423|101184128|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
33354399|NCT01307423|101184120|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33354400|NCT01307423|101184121|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33354401|NCT01307423|101184122|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33354402|NCT01307423|101184123|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
33354403|NCT01307423|101184124|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33354404|NCT01307423|101184125|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33354405|NCT01307423|101184126|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33354406|NCT01307423|101184127|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33354407|NCT01307423|101184128|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
33354408|NCT01307423|101184120|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
33354409|NCT01307423|101184121|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
33354410|NCT01307423|101184122|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
33354411|NCT01307423|101184123|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
33354412|NCT01307423|101184124|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
33354413|NCT01307423|101184125|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
33354414|NCT01307423|101184126|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
33354415|NCT01307423|101184127|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
33354416|NCT01307423|101184128|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
33354417|NCT01307423|101184120|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33354418|NCT01307423|101184121|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33354419|NCT01307423|101184122|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33413448|NCT03917654|101403670|FG002|Year 1|Lost to Follow-up|0|||
33354420|NCT01307423|101184123|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33413449|NCT03917654|101403671|FG003|Year 1|Lost to Follow-up|0|||
33554376|NCT01169337|101931750|FG002|Overall Study|Lack of Efficacy|0|||
33554377|NCT01169337|101931748|FG000|Overall Study|Adverse Event|12|||
33554378|NCT01169337|101931749|FG001|Overall Study|Adverse Event|18|||
33413450|NCT03917654|101403672|FG004|Year 1|Lost to Follow-up|0|||
33413451|NCT03917654|101403673|FG005|Year 1|Lost to Follow-up|0|||
33413452|NCT03917654|101403674|FG006|Year 1|Lost to Follow-up|2|||
33413453|NCT03917654|101403675|FG007|Year 1|Lost to Follow-up|0|||
33413454|NCT03917654|101403676|FG008|Year 1|Lost to Follow-up|0|||
33413455|NCT03917654|101403677|FG009|Year 1|Lost to Follow-up|0|||
33554379|NCT01169337|101931750|FG002|Overall Study|Adverse Event|0|||
33554380|NCT01169337|101931748|FG000|Overall Study|Death|2|||
33554381|NCT01169337|101931749|FG001|Overall Study|Death|0|||
33554382|NCT01169337|101931750|FG002|Overall Study|Death|0|||
33554383|NCT01169337|101931748|FG000|Overall Study|Withdrawal by Subject|11|||
33554384|NCT01169337|101931749|FG001|Overall Study|Withdrawal by Subject|11|||
33554385|NCT01169337|101931750|FG002|Overall Study|Withdrawal by Subject|6|||
33554386|NCT01169337|101931748|FG000|Overall Study|Noncompliance|2|||
33554387|NCT01169337|101931749|FG001|Overall Study|Noncompliance|0|||
33354421|NCT01307423|101184124|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33354422|NCT01307423|101184125|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
33620107|NCT04628780|102158033|FG001|Overall Study|Global deterioration of health status|0|||
33620108|NCT04628780|102158034|FG002|Overall Study|Global deterioration of health status|0|||
33620109|NCT04628780|102158035|FG003|Overall Study|Global deterioration of health status|0|||
33620110|NCT04628780|102158036|FG004|Overall Study|Global deterioration of health status|1|||
33620111|NCT04628780|102158037|FG005|Overall Study|Global deterioration of health status|1|||
33620112|NCT01776840|102158038|FG000|Overall Study|Lost to Follow-up|4|||
33620113|NCT01776840|102158039|FG001|Overall Study|Lost to Follow-up|4|||
33620114|NCT01776840|102158038|FG000|Overall Study|Withdrawal by Subject|42|||
33354423|NCT01307423|101184126|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33354424|NCT01307423|101184127|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33620115|NCT01776840|102158039|FG001|Overall Study|Withdrawal by Subject|22|||
33620116|NCT01776840|102158038|FG000|Overall Study|Ongoing|112|||
33620117|NCT01776840|102158039|FG001|Overall Study|Ongoing|129|||
33620118|NCT00655629|102158040|FG000|Overall Study|Adverse Event|4|||
33620119|NCT00655629|102158041|FG001|Overall Study|Adverse Event|1|||
33620120|NCT00655629|102158040|FG000|Overall Study|Lack of Efficacy|2|||
33620121|NCT00655629|102158041|FG001|Overall Study|Lack of Efficacy|12|||
33620122|NCT00655629|102158040|FG000|Overall Study|Lost to Follow-up|4|||
33620123|NCT00655629|102158041|FG001|Overall Study|Lost to Follow-up|3|||
33620124|NCT00655629|102158040|FG000|Overall Study|Protocol Violation|5|||
33620125|NCT00655629|102158041|FG001|Overall Study|Protocol Violation|3|||
33620126|NCT00655629|102158040|FG000|Overall Study|consent withdrawn|6|||
33620127|NCT00655629|102158041|FG001|Overall Study|consent withdrawn|4|||
33620128|NCT02219334|102158042|FG000|Overall Study|Withdrawal by Subject|1|||
33620129|NCT02219334|102158043|FG001|Overall Study|Withdrawal by Subject|0|||
33620130|NCT02219334|102158042|FG000|Overall Study|Protocol Violation|7|||
33620131|NCT02219334|102158043|FG001|Overall Study|Protocol Violation|3|||
33620132|NCT03712787|102158044|FG000|Overall Study|Adverse Event|2|||
33620133|NCT03712787|102158045|FG001|Overall Study|Adverse Event|3|||
33620134|NCT03712787|102158046|FG002|Overall Study|Adverse Event|0|||
33620135|NCT03712787|102158047|FG003|Overall Study|Adverse Event|4|||
33620136|NCT03712787|102158044|FG000|Overall Study|Withdrawal by Subject|4|||
33354425|NCT01307423|101184128|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
33354426|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33354427|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
33354428|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
33354429|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33354430|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33413456|NCT03917654|101403678|FG010|Year 1|Lost to Follow-up|0|||
33413457|NCT03917654|101403679|FG011|Year 1|Lost to Follow-up|0|||
33413458|NCT03917654|101403668|FG000|Year 1|Missed visits|0|||
33620137|NCT03712787|102158045|FG001|Overall Study|Withdrawal by Subject|14|||
33620138|NCT03712787|102158046|FG002|Overall Study|Withdrawal by Subject|12|||
33620139|NCT03712787|102158047|FG003|Overall Study|Withdrawal by Subject|8|||
33620140|NCT03712787|102158044|FG000|Overall Study|Lost to Follow-up|1|||
33620141|NCT03712787|102158045|FG001|Overall Study|Lost to Follow-up|1|||
33218025|NCT00541450|100695914|FG001|Phase B|Hyperglycemia|9|||
33620142|NCT03712787|102158046|FG002|Overall Study|Lost to Follow-up|2|||
33620143|NCT03712787|102158047|FG003|Overall Study|Lost to Follow-up|1|||
33620144|NCT03712787|102158044|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
33620145|NCT03712787|102158045|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
33218026|NCT00541450|100695913|FG000|Phase B|Lost to Follow-up|6|||
33218027|NCT00541450|100695914|FG001|Phase B|Lost to Follow-up|4|||
33218028|NCT00541450|100695913|FG000|Phase B|Physician Decision|4|||
33218029|NCT00541450|100695914|FG001|Phase B|Physician Decision|2|||
33413459|NCT03917654|101403669|FG001|Year 1|Missed visits|0|||
33413460|NCT03917654|101403670|FG002|Year 1|Missed visits|0|||
33554388|NCT01169337|101931750|FG002|Overall Study|Noncompliance|0|||
33554389|NCT01169337|101931748|FG000|Overall Study|Other complicating disease|1|||
33554390|NCT01169337|101931749|FG001|Overall Study|Other complicating disease|1|||
33620146|NCT03712787|102158046|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
33620147|NCT03712787|102158047|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
33620148|NCT03712787|102158044|FG000|Overall Study|COVID-19 Infection|0|||
33620149|NCT03712787|102158045|FG001|Overall Study|COVID-19 Infection|1|||
33620150|NCT03712787|102158046|FG002|Overall Study|COVID-19 Infection|0|||
33620151|NCT03712787|102158047|FG003|Overall Study|COVID-19 Infection|0|||
33620152|NCT03712787|102158044|FG000|Overall Study|Other, Not Specified|79|||
33620153|NCT03712787|102158045|FG001|Overall Study|Other, Not Specified|77|||
33620154|NCT03712787|102158046|FG002|Overall Study|Other, Not Specified|74|||
33620155|NCT03712787|102158047|FG003|Overall Study|Other, Not Specified|78|||
33620156|NCT04794270|102158048|FG000|Period 1|Non Compliance|1|||
33620157|NCT04794270|102158049|FG001|Period 1|Non Compliance|0|||
33620158|NCT04794270|102158048|FG000|Period 1|Adverse Event|1|||
33620159|NCT04794270|102158049|FG001|Period 1|Adverse Event|0|||
33620160|NCT04794270|102158048|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
33620161|NCT04794270|102158049|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
33620162|NCT00412893|102158050|FG000|Overall Study|Adverse Event|31|||
33620163|NCT00412893|102158051|FG001|Overall Study|Adverse Event|53|||
33620164|NCT00412893|102158050|FG000|Overall Study|Death|17|||
33620165|NCT00412893|102158051|FG001|Overall Study|Death|21|||
33620166|NCT00412893|102158050|FG000|Overall Study|Insufficient Therapeutic Response|39|||
33620167|NCT00412893|102158051|FG001|Overall Study|Insufficient Therapeutic Response|23|||
33620168|NCT00412893|102158050|FG000|Overall Study|Lost to Follow-up|2|||
33620169|NCT00412893|102158051|FG001|Overall Study|Lost to Follow-up|1|||
33620170|NCT00412893|102158050|FG000|Overall Study|Violation of Selection at Entry|17|||
33620171|NCT00412893|102158051|FG001|Overall Study|Violation of Selection at Entry|10|||
33620172|NCT00412893|102158050|FG000|Overall Study|Other Protocol Violation|10|||
33620173|NCT00412893|102158051|FG001|Overall Study|Other Protocol Violation|6|||
33620174|NCT00412893|102158050|FG000|Overall Study|Did Not Cooperate|12|||
33620175|NCT00412893|102158051|FG001|Overall Study|Did Not Cooperate|9|||
33620176|NCT00412893|102158050|FG000|Overall Study|Administrative Reason|12|||
33620177|NCT00412893|102158051|FG001|Overall Study|Administrative Reason|15|||
33620178|NCT00412893|102158050|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
33620179|NCT00412893|102158051|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
33620180|NCT03089580|102158054|FG000|Overall Study|Lost to Follow-up|2|||
33554391|NCT01169337|101931750|FG002|Overall Study|Other complicating disease|0|||
33554392|NCT01169337|101931748|FG000|Overall Study|Physician Decision|1|||
33554393|NCT01169337|101931749|FG001|Overall Study|Physician Decision|5|||
33554394|NCT01169337|101931750|FG002|Overall Study|Physician Decision|0|||
33554395|NCT01169337|101931748|FG000|Overall Study|Alternative therapy|0|||
33554396|NCT01169337|101931749|FG001|Overall Study|Alternative therapy|2|||
33554397|NCT01169337|101931750|FG002|Overall Study|Alternative therapy|0|||
33554398|NCT01169337|101931748|FG000|Overall Study|Changed hospital|0|||
33554399|NCT01169337|101931749|FG001|Overall Study|Changed hospital|1|||
33554400|NCT01169337|101931750|FG002|Overall Study|Changed hospital|0|||
33554401|NCT01169337|101931748|FG000|Overall Study|Never started treatment|0|||
33554402|NCT01169337|101931749|FG001|Overall Study|Never started treatment|2|||
33554403|NCT01169337|101931750|FG002|Overall Study|Never started treatment|0|||
33554404|NCT01169337|101931748|FG000|Overall Study|Reason not reported|1|||
33554405|NCT01169337|101931749|FG001|Overall Study|Reason not reported|0|||
33554406|NCT01169337|101931750|FG002|Overall Study|Reason not reported|0|||
33554407|NCT01169337|101931748|FG000|Overall Study|Continuing lenalidomide|9|||
33554408|NCT01169337|101931749|FG001|Overall Study|Continuing lenalidomide|43|||
33554409|NCT01169337|101931750|FG002|Overall Study|Continuing lenalidomide|0|||
33554410|NCT01734928|101931751|FG000|Randomization|Physician Decision|0|||
33554411|NCT01734928|101931752|FG001|Randomization|Physician Decision|1|||
33554412|NCT01734928|101931751|FG000|Randomization|clinical progression|0|||
33554413|NCT01734928|101931752|FG001|Randomization|clinical progression|1|||
33554414|NCT01734928|101931751|FG000|Randomization|progressive disease|0|||
33554415|NCT01734928|101931752|FG001|Randomization|progressive disease|2|||
33554416|NCT01734928|101931751|FG000|Randomization|Withdrew informed consent|0|||
33554417|NCT01734928|101931752|FG001|Randomization|Withdrew informed consent|4|||
33554418|NCT01734928|101931751|FG000|Randomization|Death|1|||
33554419|NCT01734928|101931752|FG001|Randomization|Death|0|||
33554420|NCT01734928|101931751|FG000|Randomization|Randomization error|1|||
33554421|NCT01734928|101931752|FG001|Randomization|Randomization error|0|||
33554422|NCT01734928|101931751|FG000|Randomization|Lost to Follow-up|1|||
33554423|NCT01734928|101931752|FG001|Randomization|Lost to Follow-up|0|||
33554424|NCT01734928|101931751|FG000|Treatment Period|Lost to Follow-up|0|||
33554425|NCT01734928|101931752|FG001|Treatment Period|Lost to Follow-up|2|||
33620181|NCT03329846|102158055|FG000|Overall Study|Disease progression|4|||
33620182|NCT03329846|102158056|FG001|Overall Study|Disease progression|6|||
33620183|NCT03329846|102158055|FG000|Overall Study|Study drug toxicity|1|||
33554426|NCT01734928|101931751|FG000|Treatment Period|Progressive Disease|167|||
33554427|NCT01734928|101931752|FG001|Treatment Period|Progressive Disease|165|||
33554428|NCT01734928|101931751|FG000|Treatment Period|Adverse Event|39|||
33554429|NCT01734928|101931752|FG001|Treatment Period|Adverse Event|52|||
33554430|NCT01734928|101931751|FG000|Treatment Period|Withdrawal of Consent|25|||
33554431|NCT01734928|101931752|FG001|Treatment Period|Withdrawal of Consent|22|||
33554432|NCT01734928|101931751|FG000|Treatment Period|Death|20|||
33554433|NCT01734928|101931752|FG001|Treatment Period|Death|9|||
33554434|NCT01734928|101931751|FG000|Treatment Period|Other Reasons|27|||
33554435|NCT01734928|101931752|FG001|Treatment Period|Other Reasons|19|||
33554436|NCT01734928|101931751|FG000|Treatment Period|Pregnancy|0|||
33554437|NCT01734928|101931752|FG001|Treatment Period|Pregnancy|1|||
33554438|NCT00799864|101931753|FG000|Overall Study|Participant reached a virologic endpoint|9|||
33554439|NCT00799864|101931754|FG001|Overall Study|Participant reached a virologic endpoint|2|||
33554440|NCT00799864|101931755|FG002|Overall Study|Participant reached a virologic endpoint|2|||
33554441|NCT00799864|101931756|FG003|Overall Study|Participant reached a virologic endpoint|0|||
33554442|NCT00799864|101931757|FG004|Overall Study|Participant reached a virologic endpoint|0|||
33554443|NCT00799864|101931753|FG000|Overall Study|Other|2|||
33554444|NCT00799864|101931754|FG001|Overall Study|Other|1|||
33554445|NCT00799864|101931755|FG002|Overall Study|Other|0|||
33554446|NCT00799864|101931756|FG003|Overall Study|Other|0|||
33554447|NCT00799864|101931757|FG004|Overall Study|Other|0|||
33413461|NCT03917654|101403671|FG003|Year 1|Missed visits|0|||
33413462|NCT03917654|101403672|FG004|Year 1|Missed visits|0|||
33413463|NCT03917654|101403673|FG005|Year 1|Missed visits|0|||
33413464|NCT03917654|101403674|FG006|Year 1|Missed visits|0|||
33413465|NCT03917654|101403675|FG007|Year 1|Missed visits|0|||
33413466|NCT03917654|101403676|FG008|Year 1|Missed visits|0|||
33413467|NCT03917654|101403677|FG009|Year 1|Missed visits|0|||
33413468|NCT03917654|101403678|FG010|Year 1|Missed visits|1|||
33554448|NCT01795937|101931760|FG000|Overall Study|Withdrawal by Subject|1|||
33554449|NCT01795937|101931761|FG001|Overall Study|Withdrawal by Subject|0|||
33554450|NCT01795937|101931762|FG002|Overall Study|Withdrawal by Subject|0|||
33554451|NCT01795937|101931760|FG000|Overall Study|Physician Decision|0|||
33554452|NCT01795937|101931761|FG001|Overall Study|Physician Decision|1|||
33554453|NCT01795937|101931762|FG002|Overall Study|Physician Decision|0|||
33554454|NCT01829165|101931763|FG000|Overall Study|Did not complete intervention|2|||
33554455|NCT01829165|101931764|FG001|Overall Study|Did not complete intervention|0|||
33554456|NCT00003474|101931765|FG000|Overall Study|Not Evaluable|14|||
33554457|NCT04090749|101931766|FG000|Open Label Pilot|Lost to Follow-up|1|||
33554458|NCT04090749|101931767|FG001|Open Label Pilot|Lost to Follow-up|0|||
33554459|NCT04090749|101931768|FG002|Open Label Pilot|Lost to Follow-up|0|||
33554460|NCT04090749|101931766|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
33554461|NCT04090749|101931767|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
33554462|NCT04090749|101931768|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
33554463|NCT04090749|101931766|FG000|Pilot Trial|Lost to Follow-up|0|||
33554464|NCT04090749|101931767|FG001|Pilot Trial|Lost to Follow-up|1|||
33554465|NCT04090749|101931768|FG002|Pilot Trial|Lost to Follow-up|1|||
33554466|NCT00655746|101931769|FG000|Overall Study|Withdrawal by Subject|1|||
33554467|NCT00754559|101931770|FG000|Overall Study|Adverse Event|15|||
33554468|NCT00754559|101931770|FG000|Overall Study|Protocol Violation|11|||
33554469|NCT00754559|101931770|FG000|Overall Study|Lack of Efficacy|10|||
33554470|NCT00754559|101931770|FG000|Overall Study|Lost to Follow-up|2|||
33554471|NCT00754559|101931770|FG000|Overall Study|Administrative reason|1|||
33554472|NCT00754559|101931770|FG000|Overall Study|Other|5|||
33554473|NCT00754559|101931770|FG000|Overall Study|Withdrawal by Subject|3|||
33554474|NCT04359680|101931773|FG000|Overall Study|Withdrawal by Subject|29|||
33554475|NCT04359680|101931774|FG001|Overall Study|Withdrawal by Subject|24|||
33554476|NCT04359680|101931773|FG000|Overall Study|Adverse Event|6|||
33554477|NCT04359680|101931774|FG001|Overall Study|Adverse Event|2|||
33554478|NCT04359680|101931773|FG000|Overall Study|Lost to Follow-up|56|||
33554479|NCT04359680|101931774|FG001|Overall Study|Lost to Follow-up|59|||
33554480|NCT04359680|101931773|FG000|Overall Study|Protocol Violation|3|||
33413469|NCT03917654|101403679|FG011|Year 1|Missed visits|1|||
33554481|NCT04359680|101931774|FG001|Overall Study|Protocol Violation|5|||
33554482|NCT04359680|101931773|FG000|Overall Study|Physician Decision|1|||
33413470|NCT03917654|101403668|FG000|Year 1|Pregnancy|0|||
33413471|NCT03917654|101403669|FG001|Year 1|Pregnancy|0|||
33413472|NCT03917654|101403670|FG002|Year 1|Pregnancy|0|||
33413473|NCT03917654|101403671|FG003|Year 1|Pregnancy|0|||
33413474|NCT03917654|101403672|FG004|Year 1|Pregnancy|0|||
33413475|NCT03917654|101403673|FG005|Year 1|Pregnancy|0|||
33554483|NCT04359680|101931774|FG001|Overall Study|Physician Decision|1|||
33554484|NCT04359680|101931773|FG000|Overall Study|Sponsor Decision|0|||
33554485|NCT04359680|101931774|FG001|Overall Study|Sponsor Decision|1|||
33554486|NCT03632720|101931777|FG000|Overall Study|Adverse Event|2|||
33554487|NCT03632720|101931778|FG001|Overall Study|Adverse Event|0|||
33554488|NCT03632720|101931779|FG002|Overall Study|Adverse Event|0|||
33554489|NCT03632720|101931777|FG000|Overall Study|Lost to Follow-up|0|||
33554490|NCT03632720|101931778|FG001|Overall Study|Lost to Follow-up|1|||
33554491|NCT03632720|101931779|FG002|Overall Study|Lost to Follow-up|0|||
33554492|NCT03632720|101931777|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
33554493|NCT03632720|101931778|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
33554494|NCT03632720|101931779|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
33554495|NCT03632720|101931777|FG000|Overall Study|Screen failure|0|||
33554496|NCT03632720|101931778|FG001|Overall Study|Screen failure|1|||
33554497|NCT03632720|101931779|FG002|Overall Study|Screen failure|0|||
33554498|NCT02366130|101931782|FG000|Overall Study|Withdrawal by Subject|3|||
33554499|NCT02366130|101931782|FG000|Overall Study|Ineligible|6|||
33554500|NCT05938010|101931785|FG000|Overall Study|Lost to Follow-up|2|||
33554501|NCT02528305|101931790|FG000|Overall Study|Withdrawal by Subject|1|||
33554502|NCT02528305|101931790|FG000|Overall Study|Adverse Event|1|||
33554503|NCT02528305|101931790|FG000|Overall Study|Physician Decision|1|||
33554504|NCT01489358|101931795|FG000|Overall Study|Lost to Follow-up|0|||
33620184|NCT03329846|102158056|FG001|Overall Study|Study drug toxicity|0|||
33620185|NCT03329846|102158055|FG000|Overall Study|Participant request to discontinue treatment|0|||
33620186|NCT03329846|102158056|FG001|Overall Study|Participant request to discontinue treatment|1|||
33620187|NCT03329846|102158055|FG000|Overall Study|Participant withdrew consent|1|||
33554505|NCT01489358|101931796|FG001|Overall Study|Lost to Follow-up|0|||
33554506|NCT01489358|101931797|FG002|Overall Study|Lost to Follow-up|2|||
33554507|NCT03164356|101931798|FG000|Overall Study|Lost to Follow-up|1|||
33554508|NCT03164356|101931799|FG001|Overall Study|Lost to Follow-up|1|||
33554509|NCT03164356|101931800|FG002|Overall Study|Lost to Follow-up|2|||
33554510|NCT03164356|101931801|FG003|Overall Study|Lost to Follow-up|1|||
33554511|NCT03164356|101931798|FG000|Overall Study|Physician Decision|0|||
33554512|NCT03164356|101931799|FG001|Overall Study|Physician Decision|0|||
33554513|NCT03164356|101931800|FG002|Overall Study|Physician Decision|3|||
33554514|NCT03164356|101931801|FG003|Overall Study|Physician Decision|0|||
33554515|NCT03164356|101931798|FG000|Overall Study|Protocol Violation|2|||
33620188|NCT03329846|102158056|FG001|Overall Study|Participant withdrew consent|0|||
33620189|NCT03329846|102158055|FG000|Overall Study|Other reasons|2|||
33620190|NCT03329846|102158056|FG001|Overall Study|Other reasons|2|||
33620191|NCT04854551|102158067|FG000|Overall Study|Withdrawal by Subject|1|||
33620192|NCT04854551|102158068|FG001|Overall Study|Withdrawal by Subject|1|||
33620193|NCT01633541|102158069|FG000|Overall Study|Death|1|||
33620194|NCT01633541|102158070|FG001|Overall Study|Death|0|||
33620195|NCT02517541|102158076|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
33620196|NCT02517541|102158076|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
33620197|NCT02517541|102158076|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
33620198|NCT02517541|102158076|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
33620199|NCT02517541|102158076|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
33620200|NCT02517541|102158076|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
33620201|NCT05066165|102158077|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
33620202|NCT05066165|102158078|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
33620203|NCT05066165|102158077|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
33620204|NCT05066165|102158078|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
33620205|NCT04950465|102158079|FG000|Overall Study|Lost to Follow-up|1|||
33620206|NCT04950465|102158080|FG001|Overall Study|Lost to Follow-up|0|||
33620207|NCT04950465|102158081|FG002|Overall Study|Lost to Follow-up|0|||
33620208|NCT04775953|102158082|FG000|Overall Study|Lost to Follow-up|6|||
33620209|NCT04775953|102158083|FG001|Overall Study|Lost to Follow-up|11|||
33620210|NCT04775953|102158082|FG000|Overall Study|Death|5|||
33620211|NCT04775953|102158083|FG001|Overall Study|Death|4|||
33620212|NCT04775953|102158082|FG000|Overall Study|Withdrawal by Subject|3|||
33620213|NCT04775953|102158083|FG001|Overall Study|Withdrawal by Subject|3|||
33620214|NCT04775953|102158082|FG000|Overall Study|Protocol Violation|2|||
33620215|NCT04775953|102158083|FG001|Overall Study|Protocol Violation|0|||
33620216|NCT04775953|102158082|FG000|Overall Study|Participant non-compliance|0|||
33620217|NCT04775953|102158083|FG001|Overall Study|Participant non-compliance|1|||
33620218|NCT00286494|102158091|FG000|Overall Study|Hyperglycemic rescue|12|||
33218030|NCT00541450|100695913|FG000|Phase B|Pregnancy|0|||
33554516|NCT03164356|101931799|FG001|Overall Study|Protocol Violation|1|||
33218031|NCT00541450|100695914|FG001|Phase B|Pregnancy|1|||
33554517|NCT03164356|101931800|FG002|Overall Study|Protocol Violation|0|||
33554518|NCT03164356|101931801|FG003|Overall Study|Protocol Violation|0|||
33218032|NCT00541450|100695913|FG000|Phase B|Protocol Violation|3|||
33554519|NCT03164356|101931798|FG000|Overall Study|Withdrawal by Subject|1|||
33554520|NCT03164356|101931799|FG001|Overall Study|Withdrawal by Subject|0|||
33554521|NCT03164356|101931800|FG002|Overall Study|Withdrawal by Subject|0|||
33554522|NCT03164356|101931801|FG003|Overall Study|Withdrawal by Subject|0|||
33620219|NCT00286494|102158092|FG001|Overall Study|Hyperglycemic rescue|19|||
33620220|NCT00286494|102158093|FG002|Overall Study|Hyperglycemic rescue|18|||
33620221|NCT00286494|102158091|FG000|Overall Study|Withdrawal by Subject|2|||
33620222|NCT00286494|102158092|FG001|Overall Study|Withdrawal by Subject|10|||
33620223|NCT00286494|102158093|FG002|Overall Study|Withdrawal by Subject|9|||
33620224|NCT00286494|102158091|FG000|Overall Study|Adverse Event|3|||
33620225|NCT00286494|102158092|FG001|Overall Study|Adverse Event|8|||
33620226|NCT00286494|102158093|FG002|Overall Study|Adverse Event|6|||
33620227|NCT00286494|102158091|FG000|Overall Study|Physician Decision|5|||
33354431|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33354432|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
33413476|NCT03917654|101403674|FG006|Year 1|Pregnancy|0|||
33620228|NCT00286494|102158092|FG001|Overall Study|Physician Decision|5|||
33354433|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
33620229|NCT00286494|102158093|FG002|Overall Study|Physician Decision|1|||
33354434|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
33354435|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33354436|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
33354437|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
33354438|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33354439|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33354440|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33354441|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
33354442|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
33354443|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
33354444|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33354445|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33354446|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
33354447|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33354448|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33354449|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33354450|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33354451|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33354452|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
33354453|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33354454|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
33354455|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
33354456|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33354457|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33354458|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33354459|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33354460|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
33354461|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
33354462|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33354463|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
33354464|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33354465|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33354466|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33354467|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33354468|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
33354469|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
33354470|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
33354471|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33354472|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
33354473|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
33354474|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33354475|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33354476|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33354477|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
33354478|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
33354479|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
33354480|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33354481|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
33354482|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
33354483|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33354484|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33354485|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33354486|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
33354487|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
33354488|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
33354489|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
33354490|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
33620230|NCT00286494|102158091|FG000|Overall Study|Lost to Follow-up|3|||
33620231|NCT00286494|102158092|FG001|Overall Study|Lost to Follow-up|1|||
33354491|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
33354492|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
33354493|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
33354494|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
33354495|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
33354496|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
33354497|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
33354498|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33354499|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
33354500|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
33354501|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33354502|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33354503|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33354504|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33354505|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
33354506|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
33354507|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33354508|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
33354509|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
33354510|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33354511|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33354512|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33354513|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
33354514|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
33354515|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
33354516|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33354517|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
33354518|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33354519|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33354520|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33354521|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33354522|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33354523|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
33354524|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
33354525|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33354526|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
33354527|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33354528|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33354529|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33354530|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33354531|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33354532|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33354533|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
33354534|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33354535|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
33354536|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33354537|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33354538|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33354539|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33354540|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33354541|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
33354542|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
33354543|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33354544|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
33354545|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
33354546|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33354547|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33354548|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33354549|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33354550|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
33354551|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
33354552|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33354553|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33354554|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
33354555|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33354556|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33354557|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33354558|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33413477|NCT03917654|101403675|FG007|Year 1|Pregnancy|1|||
33413478|NCT03917654|101403676|FG008|Year 1|Pregnancy|0|||
33413479|NCT03917654|101403677|FG009|Year 1|Pregnancy|1|||
33413480|NCT03917654|101403678|FG010|Year 1|Pregnancy|0|||
33554523|NCT03164356|101931798|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
33554524|NCT03164356|101931799|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
33554525|NCT03164356|101931800|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
33554526|NCT03164356|101931801|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
33554527|NCT03164356|101931798|FG000|Overall Study|Subject Incarcerated|0|||
33554528|NCT03164356|101931799|FG001|Overall Study|Subject Incarcerated|1|||
33554529|NCT03164356|101931800|FG002|Overall Study|Subject Incarcerated|0|||
33554530|NCT03164356|101931801|FG003|Overall Study|Subject Incarcerated|0|||
33554531|NCT03164356|101931798|FG000|Overall Study|Prosthetist unable to participate|0|||
33554532|NCT03164356|101931799|FG001|Overall Study|Prosthetist unable to participate|2|||
33554533|NCT03164356|101931800|FG002|Overall Study|Prosthetist unable to participate|1|||
33554534|NCT03164356|101931801|FG003|Overall Study|Prosthetist unable to participate|0|||
33554535|NCT00212355|101931803|FG000|Overall Study|Adverse Event|1|||
33554536|NCT00212355|101931803|FG000|Overall Study|Withdrawal by Subject|1|||
33554537|NCT00212355|101931803|FG000|Overall Study|A change of address|1|||
33554538|NCT03020888|101931806|FG000|Overall Study|Physician Decision|4|||
33554539|NCT03020888|101931806|FG000|Overall Study|Withdrawal by Subject|6|||
33554540|NCT03020888|101931806|FG000|Overall Study|Insurance coverage|2|||
33554541|NCT03020888|101931806|FG000|Overall Study|Lost to Follow-up|1|||
33554542|NCT01263028|101931809|FG000|Overall Study|Withdrawal by Subject|1|||
33554543|NCT01263028|101931809|FG000|Overall Study|Adverse Event|1|||
33554544|NCT01263028|101931809|FG000|Overall Study|Study terminated due to low enrollment.|4|||
33554545|NCT00422461|101931810|FG000|Overall Study|Adverse Event|1|||
33554546|NCT00422461|101931811|FG001|Overall Study|Adverse Event|2|||
33554547|NCT00422461|101931812|FG002|Overall Study|Adverse Event|1|||
33554548|NCT00422461|101931813|FG003|Overall Study|Adverse Event|1|||
33554549|NCT00422461|101931810|FG000|Overall Study|Other|0|||
33554550|NCT00422461|101931811|FG001|Overall Study|Other|0|||
33554551|NCT00422461|101931812|FG002|Overall Study|Other|0|||
33554552|NCT00422461|101931813|FG003|Overall Study|Other|2|||
33620232|NCT00286494|102158093|FG002|Overall Study|Lost to Follow-up|3|||
33620233|NCT00286494|102158091|FG000|Overall Study|Protocol Violation|1|||
33620234|NCT00286494|102158092|FG001|Overall Study|Protocol Violation|1|||
33620235|NCT00286494|102158093|FG002|Overall Study|Protocol Violation|2|||
33620236|NCT01597635|102158106|FG000|Part A|Adverse Event|3|||
33620237|NCT01597635|102158107|FG001|Part A|Adverse Event|0|||
33620238|NCT01597635|102158108|FG002|Part A|Adverse Event|0|||
33620239|NCT01597635|102158106|FG000|Part B|Adverse Event|0|||
33620240|NCT01597635|102158107|FG001|Part B|Adverse Event|0|||
33620241|NCT01597635|102158108|FG002|Part B|Adverse Event|1|||
33620242|NCT01597635|102158106|FG000|Part B|Protocol Violation|0|||
33620243|NCT01597635|102158107|FG001|Part B|Protocol Violation|1|||
33620244|NCT01597635|102158108|FG002|Part B|Protocol Violation|0|||
33620245|NCT01597635|102158106|FG000|Part B|Protocol-defined stopping criteria|0|||
33620246|NCT01597635|102158107|FG001|Part B|Protocol-defined stopping criteria|4|||
33620247|NCT01597635|102158108|FG002|Part B|Protocol-defined stopping criteria|3|||
33620248|NCT01597635|102158106|FG000|Part B|Withdrawal by Subject|0|||
33413481|NCT03917654|101403679|FG011|Year 1|Pregnancy|0|||
33413482|NCT03917654|101403668|FG000|Year 2|Travel|1|||
33413483|NCT03917654|101403669|FG001|Year 2|Travel|0|||
33413484|NCT03917654|101403670|FG002|Year 2|Travel|0|||
33413485|NCT03917654|101403671|FG003|Year 2|Travel|0|||
33413486|NCT03917654|101403672|FG004|Year 2|Travel|1|||
33413487|NCT03917654|101403673|FG005|Year 2|Travel|1|||
33413488|NCT03917654|101403674|FG006|Year 2|Travel|2|||
33413489|NCT03917654|101403675|FG007|Year 2|Travel|1|||
33413490|NCT03917654|101403676|FG008|Year 2|Travel|0|||
33413491|NCT03917654|101403677|FG009|Year 2|Travel|1|||
33413492|NCT03917654|101403678|FG010|Year 2|Travel|0|||
33413493|NCT03917654|101403679|FG011|Year 2|Travel|1|||
33554553|NCT00422461|101931810|FG000|Overall Study|Participants no longer willing to participate in study|1|||
33554554|NCT00422461|101931811|FG001|Overall Study|Participants no longer willing to participate in study|0|||
33554555|NCT00422461|101931812|FG002|Overall Study|Participants no longer willing to participate in study|0|||
33554556|NCT00422461|101931813|FG003|Overall Study|Participants no longer willing to participate in study|0|||
33620249|NCT01597635|102158107|FG001|Part B|Withdrawal by Subject|1|||
33413494|NCT03917654|101403668|FG000|Year 2|Married|1|||
33413495|NCT03917654|101403669|FG001|Year 2|Married|0|||
33413496|NCT03917654|101403670|FG002|Year 2|Married|0|||
33413497|NCT03917654|101403671|FG003|Year 2|Married|0|||
33413498|NCT03917654|101403672|FG004|Year 2|Married|0|||
33413499|NCT03917654|101403673|FG005|Year 2|Married|0|||
33620250|NCT01597635|102158108|FG002|Part B|Withdrawal by Subject|0|||
33620251|NCT02045095|102158109|FG000|Overall Study|Other|0|||
33620252|NCT02045095|102158110|FG001|Overall Study|Other|0|||
33620253|NCT02045095|102158111|FG002|Overall Study|Other|1|||
33620254|NCT02045095|102158112|FG003|Overall Study|Other|0|||
33554557|NCT00422461|101931810|FG000|Overall Study|Randomized but not treated|1|||
33554558|NCT00422461|101931811|FG001|Overall Study|Randomized but not treated|1|||
33554559|NCT00422461|101931812|FG002|Overall Study|Randomized but not treated|0|||
33354559|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33554560|NCT00422461|101931813|FG003|Overall Study|Randomized but not treated|0|||
33554561|NCT00395512|101931814|FG000|Overall Study|Adverse Event|3|||
33554562|NCT00395512|101931815|FG001|Overall Study|Adverse Event|8|||
33554563|NCT00395512|101931816|FG002|Overall Study|Adverse Event|6|||
33554564|NCT00395512|101931817|FG003|Overall Study|Adverse Event|6|||
33554565|NCT00395512|101931814|FG000|Overall Study|Protocol Violation|2|||
33554566|NCT00395512|101931815|FG001|Overall Study|Protocol Violation|3|||
33554567|NCT00395512|101931816|FG002|Overall Study|Protocol Violation|6|||
33554568|NCT00395512|101931817|FG003|Overall Study|Protocol Violation|7|||
33554569|NCT00395512|101931814|FG000|Overall Study|Lost to Follow-up|2|||
33554570|NCT00395512|101931815|FG001|Overall Study|Lost to Follow-up|6|||
33554571|NCT00395512|101931816|FG002|Overall Study|Lost to Follow-up|5|||
33554572|NCT00395512|101931817|FG003|Overall Study|Lost to Follow-up|5|||
33554573|NCT00395512|101931814|FG000|Overall Study|Withdrawal by Subject|6|||
33554574|NCT00395512|101931815|FG001|Overall Study|Withdrawal by Subject|5|||
33554575|NCT00395512|101931816|FG002|Overall Study|Withdrawal by Subject|5|||
33554576|NCT00395512|101931817|FG003|Overall Study|Withdrawal by Subject|12|||
33218033|NCT00541450|100695914|FG001|Phase B|Protocol Violation|3|||
33354560|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
33354561|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33354562|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33354563|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33354564|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33354565|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33354566|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33354567|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33354568|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
33354569|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
33354570|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33354571|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
33354572|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
33354573|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33354574|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33354575|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33354576|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33354577|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
33354578|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
33354579|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33354580|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
33354581|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
33354582|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33354583|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33354584|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33354585|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33354586|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33354587|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
33354588|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33354589|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
33354590|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
33354591|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33354592|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33354593|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33354594|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33354595|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33354596|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
33354597|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33354598|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
33354599|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33354600|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33354601|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33554577|NCT00395512|101931814|FG000|Overall Study|Physician Decision|6|||
33354602|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33554578|NCT00395512|101931815|FG001|Overall Study|Physician Decision|4|||
33554579|NCT00395512|101931816|FG002|Overall Study|Physician Decision|2|||
33554580|NCT00395512|101931817|FG003|Overall Study|Physician Decision|2|||
33554581|NCT00395512|101931814|FG000|Overall Study|Other|1|||
33354603|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33354604|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33413500|NCT03917654|101403674|FG006|Year 2|Married|1|||
33413501|NCT03917654|101403675|FG007|Year 2|Married|1|||
33413502|NCT03917654|101403676|FG008|Year 2|Married|0|||
33413503|NCT03917654|101403677|FG009|Year 2|Married|0|||
33413504|NCT03917654|101403678|FG010|Year 2|Married|0|||
33413505|NCT03917654|101403679|FG011|Year 2|Married|0|||
33413506|NCT03917654|101403668|FG000|Year 2|Subject moved away from site|1|||
33413507|NCT03917654|101403669|FG001|Year 2|Subject moved away from site|0|||
33413508|NCT03917654|101403670|FG002|Year 2|Subject moved away from site|0|||
33413509|NCT03917654|101403671|FG003|Year 2|Subject moved away from site|0|||
33413510|NCT03917654|101403672|FG004|Year 2|Subject moved away from site|1|||
33413511|NCT03917654|101403673|FG005|Year 2|Subject moved away from site|0|||
33413512|NCT03917654|101403674|FG006|Year 2|Subject moved away from site|2|||
33413513|NCT03917654|101403675|FG007|Year 2|Subject moved away from site|3|||
33413514|NCT03917654|101403676|FG008|Year 2|Subject moved away from site|0|||
33413515|NCT03917654|101403677|FG009|Year 2|Subject moved away from site|2|||
33413516|NCT03917654|101403678|FG010|Year 2|Subject moved away from site|0|||
33413517|NCT03917654|101403679|FG011|Year 2|Subject moved away from site|1|||
33413518|NCT03917654|101403668|FG000|Year 2|Year 2 Screening failure|0|||
33413519|NCT03917654|101403669|FG001|Year 2|Year 2 Screening failure|1|||
33413520|NCT03917654|101403670|FG002|Year 2|Year 2 Screening failure|0|||
33413521|NCT03917654|101403671|FG003|Year 2|Year 2 Screening failure|0|||
33413522|NCT03917654|101403672|FG004|Year 2|Year 2 Screening failure|2|||
33413523|NCT03917654|101403673|FG005|Year 2|Year 2 Screening failure|0|||
33413524|NCT03917654|101403674|FG006|Year 2|Year 2 Screening failure|4|||
33413525|NCT03917654|101403675|FG007|Year 2|Year 2 Screening failure|3|||
33413526|NCT03917654|101403676|FG008|Year 2|Year 2 Screening failure|10|||
33413527|NCT03917654|101403677|FG009|Year 2|Year 2 Screening failure|2|||
33413528|NCT03917654|101403678|FG010|Year 2|Year 2 Screening failure|1|||
33413529|NCT03917654|101403679|FG011|Year 2|Year 2 Screening failure|1|||
33413530|NCT03917654|101403668|FG000|Year 2|Death|0|||
33413531|NCT03917654|101403669|FG001|Year 2|Death|0|||
33413532|NCT03917654|101403670|FG002|Year 2|Death|0|||
33413533|NCT03917654|101403671|FG003|Year 2|Death|0|||
33413534|NCT03917654|101403672|FG004|Year 2|Death|0|||
33413535|NCT03917654|101403673|FG005|Year 2|Death|1|||
33413536|NCT03917654|101403674|FG006|Year 2|Death|0|||
33413537|NCT03917654|101403675|FG007|Year 2|Death|0|||
33413538|NCT03917654|101403676|FG008|Year 2|Death|1|||
33413539|NCT03917654|101403677|FG009|Year 2|Death|1|||
33413540|NCT03917654|101403678|FG010|Year 2|Death|0|||
33413541|NCT03917654|101403679|FG011|Year 2|Death|0|||
33413542|NCT03917654|101403668|FG000|Year 2|Withdrawal by Subject|0|||
33413543|NCT03917654|101403669|FG001|Year 2|Withdrawal by Subject|0|||
33413544|NCT03917654|101403670|FG002|Year 2|Withdrawal by Subject|0|||
33413545|NCT03917654|101403671|FG003|Year 2|Withdrawal by Subject|0|||
33413546|NCT03917654|101403672|FG004|Year 2|Withdrawal by Subject|0|||
33413547|NCT03917654|101403673|FG005|Year 2|Withdrawal by Subject|0|||
33413548|NCT03917654|101403674|FG006|Year 2|Withdrawal by Subject|3|||
33413549|NCT03917654|101403675|FG007|Year 2|Withdrawal by Subject|0|||
33413550|NCT03917654|101403676|FG008|Year 2|Withdrawal by Subject|2|||
33413551|NCT03917654|101403677|FG009|Year 2|Withdrawal by Subject|5|||
33413552|NCT03917654|101403678|FG010|Year 2|Withdrawal by Subject|0|||
33413553|NCT03917654|101403679|FG011|Year 2|Withdrawal by Subject|0|||
33413554|NCT03917654|101403668|FG000|Year 2|Spouse/family member request|0|||
33413555|NCT03917654|101403669|FG001|Year 2|Spouse/family member request|0|||
33413556|NCT03917654|101403670|FG002|Year 2|Spouse/family member request|0|||
33413557|NCT03917654|101403671|FG003|Year 2|Spouse/family member request|0|||
33413558|NCT03917654|101403672|FG004|Year 2|Spouse/family member request|0|||
33354605|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
33354606|NCT01307423|101184120|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33354607|NCT01307423|101184121|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33354608|NCT01307423|101184122|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
33354609|NCT01307423|101184123|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33354610|NCT01307423|101184124|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33354611|NCT01307423|101184125|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33354612|NCT01307423|101184126|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
33413559|NCT03917654|101403673|FG005|Year 2|Spouse/family member request|0|||
33413560|NCT03917654|101403674|FG006|Year 2|Spouse/family member request|1|||
33413561|NCT03917654|101403675|FG007|Year 2|Spouse/family member request|0|||
33413562|NCT03917654|101403676|FG008|Year 2|Spouse/family member request|0|||
33413563|NCT03917654|101403677|FG009|Year 2|Spouse/family member request|0|||
33413564|NCT03917654|101403678|FG010|Year 2|Spouse/family member request|0|||
33413565|NCT03917654|101403679|FG011|Year 2|Spouse/family member request|0|||
33413566|NCT03917654|101403668|FG000|Year 2|Lost to Follow-up|0|||
33413567|NCT03917654|101403669|FG001|Year 2|Lost to Follow-up|0|||
33413568|NCT03917654|101403670|FG002|Year 2|Lost to Follow-up|0|||
33413569|NCT03917654|101403671|FG003|Year 2|Lost to Follow-up|0|||
33413570|NCT03917654|101403672|FG004|Year 2|Lost to Follow-up|0|||
33413571|NCT03917654|101403673|FG005|Year 2|Lost to Follow-up|0|||
33413572|NCT03917654|101403674|FG006|Year 2|Lost to Follow-up|1|||
33413573|NCT03917654|101403675|FG007|Year 2|Lost to Follow-up|0|||
33413574|NCT03917654|101403676|FG008|Year 2|Lost to Follow-up|1|||
33413575|NCT03917654|101403677|FG009|Year 2|Lost to Follow-up|0|||
33413576|NCT03917654|101403678|FG010|Year 2|Lost to Follow-up|0|||
33413577|NCT03917654|101403679|FG011|Year 2|Lost to Follow-up|1|||
33413578|NCT03917654|101403668|FG000|Year 2|Adverse Event|0|||
33413579|NCT03917654|101403669|FG001|Year 2|Adverse Event|0|||
33413580|NCT03917654|101403670|FG002|Year 2|Adverse Event|0|||
33554582|NCT00395512|101931815|FG001|Overall Study|Other|1|||
33554583|NCT00395512|101931816|FG002|Overall Study|Other|0|||
33218034|NCT00541450|100695913|FG000|Phase B|Withdrawal by Subject|8|||
33354613|NCT01307423|101184127|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
33354614|NCT01307423|101184128|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
33354615|NCT02582671|101184130|FG000|Overall Study|Failure to return|1|||
33354616|NCT02582671|101184130|FG000|Overall Study|Other, not specified|1|||
33218035|NCT00541450|100695914|FG001|Phase B|Withdrawal by Subject|6|||
33218036|NCT00464815|100695915|FG000|Overall Study|Withdrawal by Subject|6|||
33218037|NCT00464815|100695916|FG001|Overall Study|Withdrawal by Subject|3|||
33218038|NCT01181726|100695917|FG000|First Intervention|Adverse Event|1|||
33354617|NCT00686127|101184131|FG000|Overall Study|Withdrawal by Subject|14|||
33354618|NCT00686127|101184132|FG001|Overall Study|Withdrawal by Subject|6|||
33354619|NCT00270894|101184134|FG000|Overall Study|Adverse Event|1|||
33354620|NCT00270894|101184134|FG000|Overall Study|Withdrawal by Subject|1|||
33354621|NCT02048904|101184135|FG000|Overall Study|Withdrawal by Subject|7|||
33354622|NCT02048904|101184135|FG000|Overall Study|Physician Decision|70|||
33354623|NCT01624142|101184136|FG000|Overall Study|Withdrawal by Subject|14|||
33354624|NCT01624142|101184137|FG001|Overall Study|Withdrawal by Subject|4|||
33354625|NCT01624142|101184136|FG000|Overall Study|Death|3|||
33354626|NCT01624142|101184137|FG001|Overall Study|Death|6|||
33354627|NCT01624142|101184136|FG000|Overall Study|Study Closure|12|||
33354628|NCT01624142|101184137|FG001|Overall Study|Study Closure|6|||
33354629|NCT01624142|101184136|FG000|Overall Study|Lost to Follow-up|2|||
33354630|NCT01624142|101184137|FG001|Overall Study|Lost to Follow-up|0|||
33354631|NCT01624142|101184136|FG000|Overall Study|Other|1|||
33354632|NCT01624142|101184137|FG001|Overall Study|Other|0|||
33354633|NCT03367156|101184138|FG000|Overall Study|Lack of interest|3|||
33354634|NCT03367156|101184139|FG001|Overall Study|Lack of interest|1|||
33354635|NCT03367156|101184138|FG000|Overall Study|Death|2|||
33354636|NCT03367156|101184139|FG001|Overall Study|Death|0|||
33354637|NCT03367156|101184138|FG000|Overall Study|Lost to Follow-up|2|||
33354638|NCT03367156|101184139|FG001|Overall Study|Lost to Follow-up|1|||
33354639|NCT03367156|101184138|FG000|Overall Study|Became ineligible|1|||
33354640|NCT03367156|101184139|FG001|Overall Study|Became ineligible|2|||
33354641|NCT03367156|101184138|FG000|Overall Study|Hospitalization|1|||
33354642|NCT03367156|101184139|FG001|Overall Study|Hospitalization|0|||
33354643|NCT03367156|101184138|FG000|Overall Study|Concerned about Treatment|11|||
33354644|NCT03367156|101184139|FG001|Overall Study|Concerned about Treatment|3|||
33354645|NCT03367156|101184138|FG000|Overall Study|Started new treatment|4|||
33354646|NCT03367156|101184139|FG001|Overall Study|Started new treatment|1|||
33354647|NCT01331161|101184140|FG000|Overall Study|Physician Decision|1|||
33354648|NCT01331161|101184141|FG001|Overall Study|Physician Decision|0|||
33354649|NCT01331161|101184140|FG000|Overall Study|Lost to Follow-up|0|||
33354650|NCT01331161|101184141|FG001|Overall Study|Lost to Follow-up|1|||
33354651|NCT01331161|101184140|FG000|Overall Study|Pregnancy|0|||
33354652|NCT01331161|101184141|FG001|Overall Study|Pregnancy|1|||
33354653|NCT01526148|101184142|FG000|Overall Study|Adverse Event|6|||
33354654|NCT01526148|101184143|FG001|Overall Study|Adverse Event|5|||
33354655|NCT01526148|101184142|FG000|Overall Study|Lost to Follow-up|3|||
33354656|NCT01526148|101184143|FG001|Overall Study|Lost to Follow-up|6|||
33354657|NCT01526148|101184142|FG000|Overall Study|Withdrawal by Subject|2|||
33554584|NCT00395512|101931817|FG003|Overall Study|Other|0|||
33554585|NCT00395512|101931814|FG000|Overall Study|Hyperglycemic Rescue|18|||
33554586|NCT00395512|101931815|FG001|Overall Study|Hyperglycemic Rescue|10|||
33554587|NCT00395512|101931816|FG002|Overall Study|Hyperglycemic Rescue|4|||
33554588|NCT00395512|101931817|FG003|Overall Study|Hyperglycemic Rescue|6|||
33554589|NCT01570192|101931818|FG000|Overall Study|no qualifying organism|6|||
33554590|NCT01570192|101931819|FG001|Overall Study|no qualifying organism|12|||
33354658|NCT01526148|101184143|FG001|Overall Study|Withdrawal by Subject|0|||
33554591|NCT01570192|101931818|FG000|Overall Study|changed to palliative care|1|||
33218039|NCT01181726|100695918|FG001|First Intervention|Adverse Event|0|||
33354659|NCT01526148|101184142|FG000|Overall Study|Unstable Medical Condition|1|||
33354660|NCT01526148|101184143|FG001|Overall Study|Unstable Medical Condition|0|||
33354661|NCT01526148|101184142|FG000|Overall Study|Unable to discontinue concomitant med|1|||
33354662|NCT01526148|101184143|FG001|Overall Study|Unable to discontinue concomitant med|0|||
33354663|NCT01526148|101184142|FG000|Overall Study|Moved out of state|1|||
33354664|NCT01526148|101184143|FG001|Overall Study|Moved out of state|0|||
33354665|NCT01526148|101184142|FG000|Overall Study|Incarcerated|0|||
33354666|NCT01526148|101184143|FG001|Overall Study|Incarcerated|2|||
33413581|NCT03917654|101403671|FG003|Year 2|Adverse Event|0|||
33413582|NCT03917654|101403672|FG004|Year 2|Adverse Event|0|||
33413583|NCT03917654|101403673|FG005|Year 2|Adverse Event|0|||
33218040|NCT01843192|100695927|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
33218041|NCT01843192|100695928|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
33218042|NCT01843192|100695929|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
33218043|NCT00654901|100695930|FG000|Overall Study|Lost to Follow-up|1|||
33218044|NCT00654901|100695931|FG001|Overall Study|Lost to Follow-up|0|||
33218045|NCT00654901|100695932|FG002|Overall Study|Lost to Follow-up|1|||
33218046|NCT00654901|100695933|FG003|Overall Study|Lost to Follow-up|0|||
33218047|NCT00654901|100695930|FG000|Overall Study|Withdrawal by Subject|3|||
33218048|NCT00654901|100695931|FG001|Overall Study|Withdrawal by Subject|0|||
33354667|NCT04052139|101184148|FG000|Overall Study|Lost to Follow-up|2|||
33354668|NCT04052139|101184149|FG001|Overall Study|Lost to Follow-up|0|||
33354669|NCT04052139|101184150|FG002|Overall Study|Lost to Follow-up|0|||
33354670|NCT04052139|101184148|FG000|Overall Study|Withdrawal by Subject|1|||
33354671|NCT04052139|101184149|FG001|Overall Study|Withdrawal by Subject|0|||
33354672|NCT04052139|101184150|FG002|Overall Study|Withdrawal by Subject|0|||
33354673|NCT01822561|101184153|FG000|Overall Study|Withdrawal by Subject|2|||
33354674|NCT00592683|101184156|FG000|Overall Study|Found ineligible|0|||
33354675|NCT00592683|101184157|FG001|Overall Study|Found ineligible|1|||
33354676|NCT00592683|101184156|FG000|Overall Study|Withdrawal by Subject|1|||
33354677|NCT00592683|101184157|FG001|Overall Study|Withdrawal by Subject|0|||
33354678|NCT00592683|101184156|FG000|Overall Study|Adverse Event|0|||
33354679|NCT00592683|101184157|FG001|Overall Study|Adverse Event|2|||
33354680|NCT00592683|101184156|FG000|Overall Study|Protocol Violation|1|||
33354681|NCT00592683|101184157|FG001|Overall Study|Protocol Violation|0|||
33354682|NCT00592683|101184156|FG000|Overall Study|Study drug expired|1|||
33354683|NCT00592683|101184157|FG001|Overall Study|Study drug expired|0|||
33354684|NCT00592683|101184156|FG000|Overall Study|Other|1|||
33354685|NCT00592683|101184157|FG001|Overall Study|Other|0|||
33354686|NCT00592683|101184156|FG000|Overall Study|Lost to Follow-up|0|||
33354687|NCT00592683|101184157|FG001|Overall Study|Lost to Follow-up|1|||
33354688|NCT01299025|101184160|FG000|Overall Study|Withdrawal by Subject|2|||
33354689|NCT01299025|101184161|FG001|Overall Study|Withdrawal by Subject|1|||
33354690|NCT01299025|101184160|FG000|Overall Study|Lost to Follow-up|1|||
33354691|NCT01299025|101184161|FG001|Overall Study|Lost to Follow-up|0|||
33354692|NCT02040142|101184162|FG000|Overall Study|Lost to Follow-up|5|||
33354693|NCT02040142|101184162|FG000|Overall Study|Death|17|||
33354694|NCT02040142|101184162|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
33354695|NCT00917384|101184165|FG000|Overall Study|Lost to Follow-up|4|||
33354696|NCT00917384|101184166|FG001|Overall Study|Lost to Follow-up|2|||
33354697|NCT00917384|101184165|FG000|Overall Study|Withdrawal by Subject|10|||
33354698|NCT00917384|101184166|FG001|Overall Study|Withdrawal by Subject|2|||
33354699|NCT03263091|101184169|FG000|OL Component|Withdrawal by Subject|1|||
33354700|NCT03263091|101184170|FG001|OL Component|Withdrawal by Subject|1|||
33354701|NCT03263091|101184171|FG002|OL Component|Withdrawal by Subject|0|||
33354702|NCT03263091|101184172|FG003|OL Component|Withdrawal by Subject|0|||
33354703|NCT03263091|101184173|FG004|OL Component|Withdrawal by Subject|0|||
33354704|NCT03263091|101184174|FG005|OL Component|Withdrawal by Subject|0|||
33354705|NCT03263091|101184169|FG000|OL Component|Physician Decision|0|||
33354706|NCT03263091|101184170|FG001|OL Component|Physician Decision|1|||
33354707|NCT03263091|101184171|FG002|OL Component|Physician Decision|2|||
33354708|NCT03263091|101184172|FG003|OL Component|Physician Decision|0|||
33354709|NCT03263091|101184173|FG004|OL Component|Physician Decision|0|||
33354710|NCT03263091|101184174|FG005|OL Component|Physician Decision|0|||
33354711|NCT03263091|101184169|FG000|OL Component|Death|1|||
33354712|NCT03263091|101184170|FG001|OL Component|Death|0|||
33354713|NCT03263091|101184171|FG002|OL Component|Death|0|||
33354714|NCT03263091|101184172|FG003|OL Component|Death|0|||
33354715|NCT03263091|101184173|FG004|OL Component|Death|0|||
33354716|NCT03263091|101184174|FG005|OL Component|Death|0|||
33413584|NCT03917654|101403674|FG006|Year 2|Adverse Event|0|||
33413585|NCT03917654|101403675|FG007|Year 2|Adverse Event|0|||
33413586|NCT03917654|101403676|FG008|Year 2|Adverse Event|0|||
33413587|NCT03917654|101403677|FG009|Year 2|Adverse Event|1|||
33218049|NCT00654901|100695932|FG002|Overall Study|Withdrawal by Subject|1|||
33218050|NCT00654901|100695933|FG003|Overall Study|Withdrawal by Subject|0|||
33354717|NCT03263091|101184169|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
33354718|NCT03263091|101184170|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
33354719|NCT03263091|101184171|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
33354720|NCT03263091|101184172|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
33354721|NCT03263091|101184173|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
33354722|NCT03263091|101184174|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
33354723|NCT03263091|101184169|FG000|OL High-EPO Component|Physician Decision|0|||
33354724|NCT03263091|101184170|FG001|OL High-EPO Component|Physician Decision|0|||
33354725|NCT03263091|101184171|FG002|OL High-EPO Component|Physician Decision|0|||
33354726|NCT03263091|101184172|FG003|OL High-EPO Component|Physician Decision|1|||
33354727|NCT03263091|101184173|FG004|OL High-EPO Component|Physician Decision|0|||
33354728|NCT03263091|101184174|FG005|OL High-EPO Component|Physician Decision|0|||
33413588|NCT03917654|101403678|FG010|Year 2|Adverse Event|0|||
33354729|NCT03263091|101184169|FG000|OL High-EPO Component|Death|0|||
33354730|NCT03263091|101184170|FG001|OL High-EPO Component|Death|0|||
33354731|NCT03263091|101184171|FG002|OL High-EPO Component|Death|0|||
33354732|NCT03263091|101184172|FG003|OL High-EPO Component|Death|3|||
33354733|NCT03263091|101184173|FG004|OL High-EPO Component|Death|0|||
33354734|NCT03263091|101184174|FG005|OL High-EPO Component|Death|0|||
33354735|NCT03263091|101184169|FG000|DB Component|Withdrawal by Subject|0|||
33554592|NCT01570192|101931819|FG001|Overall Study|changed to palliative care|0|||
33554593|NCT01570192|101931818|FG000|Overall Study|Physician Decision|0|||
33554594|NCT01570192|101931819|FG001|Overall Study|Physician Decision|1|||
33554595|NCT02829957|101931820|FG000|Overall Study|Lost to Follow-up|2|||
33554596|NCT02829957|101931821|FG001|Overall Study|Lost to Follow-up|1|||
33554597|NCT04432298|101931822|FG000|Overall Study|Other than specified|1|||
33554598|NCT04432298|101931823|FG001|Overall Study|Other than specified|0|||
33554599|NCT04432298|101931822|FG000|Overall Study|Lost to Follow-up|0|||
33354736|NCT03263091|101184170|FG001|DB Component|Withdrawal by Subject|0|||
33354737|NCT03263091|101184171|FG002|DB Component|Withdrawal by Subject|0|||
33354738|NCT03263091|101184172|FG003|DB Component|Withdrawal by Subject|0|||
33354739|NCT03263091|101184173|FG004|DB Component|Withdrawal by Subject|22|||
33354740|NCT03263091|101184174|FG005|DB Component|Withdrawal by Subject|8|||
33354741|NCT03263091|101184169|FG000|DB Component|Physician Decision|0|||
33354742|NCT03263091|101184170|FG001|DB Component|Physician Decision|0|||
33354743|NCT03263091|101184171|FG002|DB Component|Physician Decision|0|||
33354744|NCT03263091|101184172|FG003|DB Component|Physician Decision|0|||
33354745|NCT03263091|101184173|FG004|DB Component|Physician Decision|3|||
33354746|NCT03263091|101184174|FG005|DB Component|Physician Decision|1|||
33354747|NCT03263091|101184169|FG000|DB Component|Adverse Event|0|||
33354748|NCT03263091|101184170|FG001|DB Component|Adverse Event|0|||
33354749|NCT03263091|101184171|FG002|DB Component|Adverse Event|0|||
33354750|NCT03263091|101184172|FG003|DB Component|Adverse Event|0|||
33354751|NCT03263091|101184173|FG004|DB Component|Adverse Event|2|||
33354752|NCT03263091|101184174|FG005|DB Component|Adverse Event|1|||
33354753|NCT03263091|101184169|FG000|DB Component|Lost to Follow-up|0|||
33354754|NCT03263091|101184170|FG001|DB Component|Lost to Follow-up|0|||
33354755|NCT03263091|101184171|FG002|DB Component|Lost to Follow-up|0|||
33354756|NCT03263091|101184172|FG003|DB Component|Lost to Follow-up|0|||
33354757|NCT03263091|101184173|FG004|DB Component|Lost to Follow-up|2|||
33354758|NCT03263091|101184174|FG005|DB Component|Lost to Follow-up|1|||
33354759|NCT03263091|101184169|FG000|DB Component|Death|0|||
33354760|NCT03263091|101184170|FG001|DB Component|Death|0|||
33354761|NCT03263091|101184171|FG002|DB Component|Death|0|||
33354762|NCT03263091|101184172|FG003|DB Component|Death|0|||
33354763|NCT03263091|101184173|FG004|DB Component|Death|7|||
33354764|NCT03263091|101184174|FG005|DB Component|Death|4|||
33354765|NCT03263091|101184169|FG000|DB Component|Other than specified|0|||
33354766|NCT03263091|101184170|FG001|DB Component|Other than specified|0|||
33354767|NCT03263091|101184171|FG002|DB Component|Other than specified|0|||
33354768|NCT03263091|101184172|FG003|DB Component|Other than specified|0|||
33354769|NCT03263091|101184173|FG004|DB Component|Other than specified|8|||
33354770|NCT03263091|101184174|FG005|DB Component|Other than specified|6|||
33354771|NCT03293654|101184175|FG000|Overall Study|Lost to Follow-up|0|||
33354772|NCT03293654|101184176|FG001|Overall Study|Lost to Follow-up|1|||
33354773|NCT03293654|101184177|FG002|Overall Study|Lost to Follow-up|0|||
33354774|NCT00947349|101184178|FG000|Triple Treatment Combination Period|Adverse Event|0|||
33354775|NCT00947349|101184179|FG001|Triple Treatment Combination Period|Adverse Event|1|||
33354776|NCT00947349|101184180|FG002|Triple Treatment Combination Period|Adverse Event|0|||
33413589|NCT03917654|101403679|FG011|Year 2|Adverse Event|0|||
33413590|NCT05993299|101403682|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
33413591|NCT05993299|101403682|FG000|Overall Study|Ongoing|4|||
33554600|NCT04432298|101931823|FG001|Overall Study|Lost to Follow-up|1|||
33354777|NCT00947349|101184181|FG003|Triple Treatment Combination Period|Adverse Event|0|||
33354778|NCT00947349|101184178|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
33354779|NCT00947349|101184179|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
33413592|NCT02325414|101403683|FG000|Overall Study|Withdrawal by Subject|3|||
33554601|NCT04432298|101931822|FG000|Overall Study|Death|3|||
33554602|NCT04432298|101931823|FG001|Overall Study|Death|2|||
33354780|NCT00947349|101184180|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
33354781|NCT00947349|101184181|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
33354782|NCT00947349|101184178|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
33354783|NCT00947349|101184179|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
33354784|NCT00947349|101184180|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
33354785|NCT00947349|101184181|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
33354786|NCT00947349|101184178|FG000|Overall Study Standard of Care|Other|0|||
33354787|NCT00947349|101184179|FG001|Overall Study Standard of Care|Other|0|||
33413593|NCT02325414|101403684|FG001|Overall Study|Withdrawal by Subject|1|||
33218051|NCT01194570|100695945|FG000|Overall Study|Adverse Event|22|||
33554603|NCT04432298|101931822|FG000|Overall Study|Withdrawal by Subject|2|||
33554604|NCT04432298|101931823|FG001|Overall Study|Withdrawal by Subject|0|||
33554605|NCT01783015|101931824|FG000|Blinded Treatment|Adverse Event|0|||
33218052|NCT01194570|100695946|FG001|Overall Study|Adverse Event|40|||
33218053|NCT01194570|100695945|FG000|Overall Study|Death|6|||
33354788|NCT00947349|101184180|FG002|Overall Study Standard of Care|Other|0|||
33354789|NCT00947349|101184181|FG003|Overall Study Standard of Care|Other|1|||
33354790|NCT01607892|101184182|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
33354791|NCT01607892|101184183|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
33354792|NCT01607892|101184184|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
33354793|NCT01607892|101184185|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
33354794|NCT01607892|101184186|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
33354795|NCT01607892|101184182|FG000|Overall Study|Death|4|||
33354796|NCT01607892|101184183|FG001|Overall Study|Death|2|||
33354797|NCT01607892|101184184|FG002|Overall Study|Death|8|||
33354798|NCT01607892|101184185|FG003|Overall Study|Death|10|||
33354799|NCT01607892|101184186|FG004|Overall Study|Death|3|||
33354800|NCT01607892|101184182|FG000|Overall Study|Investigator discretion|2|||
33354801|NCT01607892|101184183|FG001|Overall Study|Investigator discretion|4|||
33354802|NCT01607892|101184184|FG002|Overall Study|Investigator discretion|4|||
33354803|NCT01607892|101184185|FG003|Overall Study|Investigator discretion|8|||
33354804|NCT01607892|101184186|FG004|Overall Study|Investigator discretion|0|||
33354805|NCT01607892|101184182|FG000|Overall Study|Other treatments became available|1|||
33354806|NCT01607892|101184183|FG001|Overall Study|Other treatments became available|1|||
33354807|NCT01607892|101184184|FG002|Overall Study|Other treatments became available|0|||
33354808|NCT01607892|101184185|FG003|Overall Study|Other treatments became available|0|||
33354809|NCT01607892|101184186|FG004|Overall Study|Other treatments became available|2|||
33354810|NCT01607892|101184182|FG000|Overall Study|Intercurrent illness|1|||
33354811|NCT01607892|101184183|FG001|Overall Study|Intercurrent illness|0|||
33354812|NCT01607892|101184184|FG002|Overall Study|Intercurrent illness|0|||
33354813|NCT01607892|101184185|FG003|Overall Study|Intercurrent illness|3|||
33354814|NCT01607892|101184186|FG004|Overall Study|Intercurrent illness|0|||
33354815|NCT01607892|101184182|FG000|Overall Study|Non-Compliance with study procedures|0|||
33354816|NCT01607892|101184183|FG001|Overall Study|Non-Compliance with study procedures|0|||
33354817|NCT01607892|101184184|FG002|Overall Study|Non-Compliance with study procedures|1|||
33354818|NCT01607892|101184185|FG003|Overall Study|Non-Compliance with study procedures|0|||
33354819|NCT01607892|101184186|FG004|Overall Study|Non-Compliance with study procedures|0|||
33354820|NCT01607892|101184182|FG000|Overall Study|Consent withdrawn by participant|9|||
33354821|NCT01607892|101184183|FG001|Overall Study|Consent withdrawn by participant|4|||
33354822|NCT01607892|101184184|FG002|Overall Study|Consent withdrawn by participant|24|||
33354823|NCT01607892|101184185|FG003|Overall Study|Consent withdrawn by participant|14|||
33354824|NCT01607892|101184186|FG004|Overall Study|Consent withdrawn by participant|4|||
33354825|NCT01607892|101184182|FG000|Overall Study|Disease progression|38|||
33354826|NCT01607892|101184183|FG001|Overall Study|Disease progression|13|||
33354827|NCT01607892|101184184|FG002|Overall Study|Disease progression|37|||
33354828|NCT01607892|101184185|FG003|Overall Study|Disease progression|57|||
33354829|NCT01607892|101184186|FG004|Overall Study|Disease progression|9|||
33354830|NCT01607892|101184182|FG000|Overall Study|Incidence or severity of Adverse events|3|||
33354831|NCT01607892|101184183|FG001|Overall Study|Incidence or severity of Adverse events|3|||
33354832|NCT01607892|101184184|FG002|Overall Study|Incidence or severity of Adverse events|7|||
33354833|NCT01607892|101184185|FG003|Overall Study|Incidence or severity of Adverse events|2|||
33354834|NCT01607892|101184186|FG004|Overall Study|Incidence or severity of Adverse events|6|||
33354835|NCT01802281|101184187|FG000|Overall Study|Death|1|||
33354836|NCT01802281|101184188|FG001|Overall Study|Death|2|||
33354837|NCT01802281|101184187|FG000|Overall Study|Withdrawal by Subject|2|||
33354838|NCT01802281|101184188|FG001|Overall Study|Withdrawal by Subject|1|||
33354839|NCT01802281|101184187|FG000|Overall Study|Ineligible|5|||
33354840|NCT01802281|101184188|FG001|Overall Study|Ineligible|3|||
33554606|NCT01783015|101931825|FG001|Blinded Treatment|Adverse Event|1|||
33554607|NCT01783015|101931826|FG002|Blinded Treatment|Adverse Event|0|||
33218054|NCT01194570|100695946|FG001|Overall Study|Death|20|||
33218055|NCT01194570|100695945|FG000|Overall Study|Lack of Efficacy|32|||
33354841|NCT03539432|101184189|FG000|Overall Study|Lost to Follow-up|0|||
33354842|NCT03539432|101184190|FG001|Overall Study|Lost to Follow-up|1|||
33354843|NCT04358458|101184191|FG000|Overall Study|Death|1|||
33354844|NCT04358458|101184192|FG001|Overall Study|Death|1|||
33354845|NCT04358458|101184193|FG002|Overall Study|Death|3|||
33354846|NCT04358458|101184194|FG003|Overall Study|Death|8|||
33554608|NCT01783015|101931824|FG000|Blinded Treatment|Protocol Violation|0|||
33218056|NCT01194570|100695946|FG001|Overall Study|Lack of Efficacy|33|||
33354847|NCT04358458|101184195|FG004|Overall Study|Death|1|||
33354848|NCT04358458|101184196|FG005|Overall Study|Death|6|||
33218057|NCT01194570|100695945|FG000|Overall Study|Lost to Follow-up|4|||
33354849|NCT04358458|101184197|FG006|Overall Study|Death|2|||
33354850|NCT04358458|101184198|FG007|Overall Study|Death|3|||
33354851|NCT04358458|101184191|FG000|Overall Study|Lost to Follow-up|0|||
33354852|NCT04358458|101184192|FG001|Overall Study|Lost to Follow-up|0|||
33354853|NCT04358458|101184193|FG002|Overall Study|Lost to Follow-up|0|||
33354854|NCT04358458|101184194|FG003|Overall Study|Lost to Follow-up|0|||
33354855|NCT04358458|101184195|FG004|Overall Study|Lost to Follow-up|0|||
33354856|NCT04358458|101184196|FG005|Overall Study|Lost to Follow-up|0|||
33354857|NCT04358458|101184197|FG006|Overall Study|Lost to Follow-up|0|||
33354858|NCT04358458|101184198|FG007|Overall Study|Lost to Follow-up|1|||
33354859|NCT04358458|101184191|FG000|Overall Study|Site is closing study participation|0|||
33354860|NCT04358458|101184192|FG001|Overall Study|Site is closing study participation|0|||
33354861|NCT04358458|101184193|FG002|Overall Study|Site is closing study participation|0|||
33354862|NCT04358458|101184194|FG003|Overall Study|Site is closing study participation|1|||
33354863|NCT04358458|101184195|FG004|Overall Study|Site is closing study participation|0|||
33354864|NCT04358458|101184196|FG005|Overall Study|Site is closing study participation|0|||
33354865|NCT04358458|101184197|FG006|Overall Study|Site is closing study participation|0|||
33354866|NCT04358458|101184198|FG007|Overall Study|Site is closing study participation|0|||
33354867|NCT04358458|101184191|FG000|Overall Study|Sponsor request|2|||
33354868|NCT04358458|101184192|FG001|Overall Study|Sponsor request|3|||
33354869|NCT04358458|101184193|FG002|Overall Study|Sponsor request|3|||
33354870|NCT04358458|101184194|FG003|Overall Study|Sponsor request|0|||
33354871|NCT04358458|101184195|FG004|Overall Study|Sponsor request|2|||
33354872|NCT04358458|101184196|FG005|Overall Study|Sponsor request|3|||
33354873|NCT04358458|101184197|FG006|Overall Study|Sponsor request|1|||
33354874|NCT04358458|101184198|FG007|Overall Study|Sponsor request|1|||
33413594|NCT02325414|101403683|FG000|Overall Study|Lost to Follow-up|5|||
33413595|NCT02325414|101403684|FG001|Overall Study|Lost to Follow-up|5|||
33413596|NCT03996694|101403685|FG000|First Washout (7 Days)|positive urine drug screen|0|||
33554609|NCT01783015|101931825|FG001|Blinded Treatment|Protocol Violation|1|||
33554610|NCT01783015|101931826|FG002|Blinded Treatment|Protocol Violation|0|||
33554611|NCT01783015|101931824|FG000|Blinded Treatment|Withdrawal by Subject|0|||
33554612|NCT01783015|101931825|FG001|Blinded Treatment|Withdrawal by Subject|1|||
33554613|NCT01783015|101931826|FG002|Blinded Treatment|Withdrawal by Subject|0|||
33554614|NCT01783015|101931824|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
33554615|NCT01783015|101931825|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
33554616|NCT01783015|101931826|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
33554617|NCT01783015|101931824|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
33554618|NCT01783015|101931825|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
33554619|NCT01783015|101931826|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
33554620|NCT01630811|101931827|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
33554621|NCT01630811|101931828|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
33554622|NCT01412983|101931829|FG000|1st Period|Ineligible|0|||
33554623|NCT01412983|101931830|FG001|1st Period|Ineligible|1|||
33554624|NCT01412983|101931829|FG000|1st Period|Positive slit lamp finding|0|||
33554625|NCT01412983|101931830|FG001|1st Period|Positive slit lamp finding|1|||
33554626|NCT01412983|101931829|FG000|1st Period|Unacceptable lens movement|0|||
33413597|NCT03996694|101403686|FG001|First Washout (7 Days)|positive urine drug screen|0|||
33413598|NCT03996694|101403687|FG002|First Washout (7 Days)|positive urine drug screen|1|||
33413599|NCT03996694|101403688|FG003|First Washout (7 Days)|positive urine drug screen|0|||
33413600|NCT03996694|101403689|FG004|First Washout (7 Days)|positive urine drug screen|0|||
33413601|NCT03996694|101403690|FG005|First Washout (7 Days)|positive urine drug screen|0|||
33413602|NCT03996694|101403685|FG000|First Washout (7 Days)|Adverse Event|0|||
33413603|NCT03996694|101403686|FG001|First Washout (7 Days)|Adverse Event|1|||
33413604|NCT03996694|101403687|FG002|First Washout (7 Days)|Adverse Event|0|||
33413605|NCT03996694|101403688|FG003|First Washout (7 Days)|Adverse Event|0|||
33413606|NCT03996694|101403689|FG004|First Washout (7 Days)|Adverse Event|0|||
33413607|NCT03996694|101403690|FG005|First Washout (7 Days)|Adverse Event|0|||
33413608|NCT03996694|101403685|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
33413609|NCT03996694|101403686|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
33413610|NCT03996694|101403687|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
33413611|NCT03996694|101403688|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
33413612|NCT03996694|101403689|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
33554627|NCT01412983|101931830|FG001|1st Period|Unacceptable lens movement|1|||
33554628|NCT01412983|101931829|FG000|1st Period|Inability to maintain wear|0|||
33554629|NCT01412983|101931830|FG001|1st Period|Inability to maintain wear|1|||
33354875|NCT04358458|101184191|FG000|Overall Study|Withdrawal by Subject|0|||
33354876|NCT04358458|101184192|FG001|Overall Study|Withdrawal by Subject|0|||
33354877|NCT04358458|101184193|FG002|Overall Study|Withdrawal by Subject|1|||
33354878|NCT04358458|101184194|FG003|Overall Study|Withdrawal by Subject|1|||
33354879|NCT04358458|101184195|FG004|Overall Study|Withdrawal by Subject|0|||
33354880|NCT04358458|101184196|FG005|Overall Study|Withdrawal by Subject|1|||
33413613|NCT03996694|101403690|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
33554630|NCT00965094|101931833|FG000|Overall Study|Adverse Event|5|||
33413614|NCT03996694|101403685|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
33413615|NCT03996694|101403686|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
33413616|NCT03996694|101403687|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
33413617|NCT03996694|101403688|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
33413618|NCT03996694|101403689|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
33413619|NCT03996694|101403690|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
33413620|NCT01682681|101403692|FG000|Overall Study|Lack of Efficacy|62|||
33413621|NCT01682681|101403692|FG000|Overall Study|Withdrawal by Subject|1|||
33413622|NCT01682681|101403692|FG000|Overall Study|Moved to other hospital|10|||
33413623|NCT01682681|101403692|FG000|Overall Study|Lost to Follow-up|174|||
33413624|NCT01682681|101403692|FG000|Overall Study|Adverse Event|46|||
33413625|NCT01682681|101403692|FG000|Overall Study|tapering of topiramate|5|||
33413626|NCT01682681|101403692|FG000|Overall Study|Other|21|||
33413627|NCT01682681|101403692|FG000|Overall Study|Low compliance|13|||
33413628|NCT02940392|101403693|FG000|Overall Study|Lost to Follow-up|3|||
33413629|NCT02940392|101403693|FG000|Overall Study|Retreatment|3|||
33413630|NCT02940392|101403693|FG000|Overall Study|Death|2|||
33413631|NCT01329562|101403696|FG000|Overall Study|Protocol Violation|5|||
33413632|NCT01329562|101403697|FG001|Overall Study|Protocol Violation|3|||
33413633|NCT01329562|101403696|FG000|Overall Study|Lost to Follow-up|1|||
33620255|NCT02045095|102158113|FG004|Overall Study|Other|0|||
33620256|NCT02045095|102158114|FG005|Overall Study|Other|2|||
33620257|NCT02045095|102158115|FG006|Overall Study|Other|0|||
33620258|NCT02045095|102158109|FG000|Overall Study|Progressive Disease|3|||
33620259|NCT02045095|102158110|FG001|Overall Study|Progressive Disease|3|||
33620260|NCT02045095|102158111|FG002|Overall Study|Progressive Disease|2|||
33620261|NCT02045095|102158112|FG003|Overall Study|Progressive Disease|4|||
33620262|NCT02045095|102158113|FG004|Overall Study|Progressive Disease|2|||
33620263|NCT02045095|102158114|FG005|Overall Study|Progressive Disease|4|||
33620264|NCT02045095|102158115|FG006|Overall Study|Progressive Disease|1|||
33620265|NCT02045095|102158109|FG000|Overall Study|Withdrawal by Subject|0|||
33620266|NCT02045095|102158110|FG001|Overall Study|Withdrawal by Subject|0|||
33620267|NCT02045095|102158111|FG002|Overall Study|Withdrawal by Subject|0|||
33620268|NCT02045095|102158112|FG003|Overall Study|Withdrawal by Subject|0|||
33620269|NCT02045095|102158113|FG004|Overall Study|Withdrawal by Subject|3|||
33620270|NCT02045095|102158114|FG005|Overall Study|Withdrawal by Subject|0|||
33620271|NCT02045095|102158115|FG006|Overall Study|Withdrawal by Subject|0|||
33620272|NCT02045095|102158109|FG000|Overall Study|Adverse Event|0|||
33620273|NCT02045095|102158110|FG001|Overall Study|Adverse Event|1|||
33620274|NCT02045095|102158111|FG002|Overall Study|Adverse Event|1|||
33620275|NCT02045095|102158112|FG003|Overall Study|Adverse Event|0|||
33620276|NCT02045095|102158113|FG004|Overall Study|Adverse Event|0|||
33620277|NCT02045095|102158114|FG005|Overall Study|Adverse Event|2|||
33620278|NCT02045095|102158115|FG006|Overall Study|Adverse Event|0|||
33218058|NCT01194570|100695946|FG001|Overall Study|Lost to Follow-up|15|||
33218059|NCT01194570|100695945|FG000|Overall Study|Non-Compliance|2|||
33354881|NCT04358458|101184197|FG006|Overall Study|Withdrawal by Subject|0|||
33354882|NCT04358458|101184198|FG007|Overall Study|Withdrawal by Subject|1|||
33354883|NCT01478958|101184211|FG000|Overall Study|Withdrawal by Subject|1|||
33354884|NCT01478958|101184212|FG001|Overall Study|Withdrawal by Subject|1|||
33354885|NCT01478958|101184213|FG002|Overall Study|Withdrawal by Subject|1|||
33354886|NCT01478958|101184211|FG000|Overall Study|Weight loss|1|||
33354887|NCT01478958|101184212|FG001|Overall Study|Weight loss|0|||
33354888|NCT01478958|101184213|FG002|Overall Study|Weight loss|0|||
33354889|NCT01478958|101184211|FG000|Overall Study|Re-located|0|||
33354890|NCT01478958|101184212|FG001|Overall Study|Re-located|1|||
33354891|NCT01478958|101184213|FG002|Overall Study|Re-located|0|||
33354892|NCT01478958|101184211|FG000|Overall Study|Unable to comply|0|||
33354893|NCT01478958|101184212|FG001|Overall Study|Unable to comply|0|||
33354894|NCT01478958|101184213|FG002|Overall Study|Unable to comply|2|||
33354895|NCT00957853|101184214|FG000|Overall Study|Withdrawal by Subject|1|||
33354896|NCT00957853|101184215|FG001|Overall Study|Withdrawal by Subject|0|||
33413634|NCT01329562|101403697|FG001|Overall Study|Lost to Follow-up|1|||
33413635|NCT01329562|101403696|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
33413636|NCT01329562|101403697|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
33413637|NCT01329562|101403696|FG000|Overall Study|Physician Decision|0|||
33413638|NCT01329562|101403697|FG001|Overall Study|Physician Decision|1|||
33413639|NCT00679042|101403698|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
33413640|NCT00679042|101403698|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
33413641|NCT00679042|101403698|FG000|5-Year Follow Up|Death|1|||
33413642|NCT00679042|101403698|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
33620279|NCT01362348|102158118|FG000|Overall Study|Protocol-defined stopping criteria|9|||
33620280|NCT01362348|102158118|FG000|Overall Study|Study closed/terminated|5|||
33620281|NCT03571204|102158119|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
33620282|NCT03571204|102158120|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
33620283|NCT03571204|102158121|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
33620284|NCT03571204|102158119|FG000|Overall Study|Physician Decision|0|||
33620285|NCT03571204|102158120|FG001|Overall Study|Physician Decision|1|||
33620286|NCT03571204|102158121|FG002|Overall Study|Physician Decision|0|||
33620287|NCT01358825|102158123|FG000|Overall Study|Blood sample not drawn|0|||
33620288|NCT01358825|102158124|FG001|Overall Study|Blood sample not drawn|1|||
33620289|NCT02634333|102158127|FG000|Overall Study|Completed out of Window|3|||
33620290|NCT02634333|102158128|FG001|Overall Study|Completed out of Window|2|||
33620291|NCT02634333|102158127|FG000|Overall Study|Missed Visit|5|||
33620292|NCT02634333|102158128|FG001|Overall Study|Missed Visit|2|||
33620293|NCT02634333|102158127|FG000|Overall Study|Lost to Follow-up|12|||
33620294|NCT02634333|102158128|FG001|Overall Study|Lost to Follow-up|7|||
33620295|NCT02634333|102158127|FG000|Overall Study|Withdrawal by Subject|9|||
33620296|NCT02634333|102158128|FG001|Overall Study|Withdrawal by Subject|13|||
33620297|NCT02634333|102158127|FG000|Overall Study|Death|11|||
33620298|NCT02634333|102158128|FG001|Overall Study|Death|8|||
33554631|NCT00965094|101931834|FG001|Overall Study|Adverse Event|0|||
33554632|NCT00965094|101931833|FG000|Overall Study|Lost to Follow-up|0|||
33554633|NCT00965094|101931834|FG001|Overall Study|Lost to Follow-up|1|||
33554634|NCT04193527|101931837|FG000|Overall Study|Other|1|||
33554635|NCT04193527|101931838|FG001|Overall Study|Other|1|||
33554636|NCT04193527|101931839|FG002|Overall Study|Other|0|||
33554637|NCT04576949|101931840|FG000|Overall Study|Adverse Event|1|||
33554638|NCT04576949|101931841|FG001|Overall Study|Adverse Event|3|||
33554639|NCT04576949|101931842|FG002|Overall Study|Adverse Event|2|||
33554640|NCT04576949|101931840|FG000|Overall Study|Withdrawal by Subject|41|||
33620299|NCT02442349|102158129|FG000|Overall Study|Death|14|||
33620300|NCT02442349|102158129|FG000|Overall Study|Withdrawal by Subject|8|||
33620301|NCT02442349|102158129|FG000|Overall Study|On-going Study at Data Cut-off|149|||
33620302|NCT01362608|102158137|FG000|Overall Study|Protocol Violation|0|||
33620303|NCT01362608|102158138|FG001|Overall Study|Protocol Violation|1|||
33620304|NCT01362608|102158137|FG000|Overall Study|Lost to Follow-up|3|||
33620305|NCT01362608|102158138|FG001|Overall Study|Lost to Follow-up|1|||
33620306|NCT01362608|102158137|FG000|Overall Study|Withdrawal by Subject|1|||
33620307|NCT01362608|102158138|FG001|Overall Study|Withdrawal by Subject|2|||
33620308|NCT01362608|102158137|FG000|Overall Study|Lack of Efficacy|0|||
33620309|NCT01362608|102158138|FG001|Overall Study|Lack of Efficacy|2|||
33620310|NCT01362608|102158137|FG000|Overall Study|Adverse Event|0|||
33620311|NCT01362608|102158138|FG001|Overall Study|Adverse Event|2|||
33620312|NCT01380769|102158141|FG000|Overall Study|Withdrawal by Subject|7|||
33620313|NCT01380769|102158142|FG001|Overall Study|Withdrawal by Subject|11|||
33218060|NCT01194570|100695946|FG001|Overall Study|Non-Compliance|2|||
33218061|NCT01194570|100695945|FG000|Overall Study|Non-Compliance With Study Drug|2|||
33218062|NCT01194570|100695946|FG001|Overall Study|Non-Compliance With Study Drug|2|||
33218063|NCT01194570|100695945|FG000|Overall Study|Other|18|||
33218064|NCT01194570|100695946|FG001|Overall Study|Other|47|||
33218065|NCT01194570|100695945|FG000|Overall Study|Physician Decision|10|||
33218066|NCT01194570|100695946|FG001|Overall Study|Physician Decision|25|||
33218067|NCT01194570|100695945|FG000|Overall Study|Protocol Violation|1|||
33218068|NCT01194570|100695946|FG001|Overall Study|Protocol Violation|2|||
33218069|NCT01194570|100695945|FG000|Overall Study|Study Terminated By Sponsor|0|||
33218070|NCT01194570|100695946|FG001|Overall Study|Study Terminated By Sponsor|1|||
33218071|NCT01194570|100695945|FG000|Overall Study|Withdrawal by Subject|57|||
33218072|NCT01194570|100695946|FG001|Overall Study|Withdrawal by Subject|82|||
33218073|NCT01194570|100695945|FG000|Overall Study|Pregnancy|1|||
33218074|NCT01194570|100695946|FG001|Overall Study|Pregnancy|1|||
33218075|NCT01345630|100695947|FG000|Overall Study|Adverse Event|22|||
33218076|NCT01345630|100695948|FG001|Overall Study|Adverse Event|23|||
33218077|NCT01345630|100695947|FG000|Overall Study|Lost to Follow-up|17|||
33218078|NCT01345630|100695948|FG001|Overall Study|Lost to Follow-up|16|||
33218079|NCT01345630|100695947|FG000|Overall Study|Protocol Violation|4|||
33218080|NCT01345630|100695948|FG001|Overall Study|Protocol Violation|1|||
33218081|NCT01345630|100695947|FG000|Overall Study|Medication error without associated AE|0|||
33218082|NCT01345630|100695948|FG001|Overall Study|Medication error without associated AE|1|||
33218083|NCT01345630|100695947|FG000|Overall Study|Study terminated by sponsor|254|||
33218084|NCT01345630|100695948|FG001|Overall Study|Study terminated by sponsor|285|||
33554641|NCT04576949|101931841|FG001|Overall Study|Withdrawal by Subject|26|||
33620314|NCT01380769|102158141|FG000|Overall Study|Physician Decision|1|||
33620315|NCT01380769|102158142|FG001|Overall Study|Physician Decision|1|||
33218085|NCT01345630|100695947|FG000|Overall Study|Other reasons|6|||
33218086|NCT01345630|100695948|FG001|Overall Study|Other reasons|8|||
33554642|NCT04576949|101931842|FG002|Overall Study|Withdrawal by Subject|18|||
33554643|NCT04576949|101931840|FG000|Overall Study|Physician Decision|3|||
33554644|NCT04576949|101931841|FG001|Overall Study|Physician Decision|0|||
33218087|NCT01345630|100695947|FG000|Overall Study|Withdrawn due to pregnancy|1|||
33218088|NCT01345630|100695948|FG001|Overall Study|Withdrawn due to pregnancy|2|||
33554645|NCT04576949|101931842|FG002|Overall Study|Physician Decision|0|||
33620316|NCT01380769|102158141|FG000|Overall Study|Adverse Event|1|||
33620317|NCT01380769|102158142|FG001|Overall Study|Adverse Event|1|||
33620318|NCT01380769|102158141|FG000|Overall Study|Protocol Violation|0|||
33620319|NCT01380769|102158142|FG001|Overall Study|Protocol Violation|1|||
33620320|NCT01525615|102158143|FG000|Overall Study|Adverse Event|11|||
33620321|NCT01525615|102158144|FG001|Overall Study|Adverse Event|7|||
33620322|NCT01525615|102158145|FG002|Overall Study|Adverse Event|5|||
33218089|NCT01345630|100695947|FG000|Overall Study|No longer willing to participate|9|||
33218090|NCT01345630|100695948|FG001|Overall Study|No longer willing to participate|12|||
33218091|NCT01345630|100695947|FG000|Overall Study|Insufficient clinical response|48|||
33218092|NCT01345630|100695948|FG001|Overall Study|Insufficient clinical response|11|||
33218093|NCT00765843|100695950|FG000|Overall Study|Lost to Follow-up|1|||
33218094|NCT00765843|100695951|FG001|Overall Study|Lost to Follow-up|3|||
33218095|NCT00765843|100695952|FG002|Overall Study|Lost to Follow-up|2|||
33218096|NCT00765843|100695950|FG000|Overall Study|did not return to receive intervention|0|||
33218097|NCT00765843|100695951|FG001|Overall Study|did not return to receive intervention|1|||
33218098|NCT00765843|100695952|FG002|Overall Study|did not return to receive intervention|0|||
33218099|NCT00765843|100695950|FG000|Overall Study|Adverse Event|0|||
33218100|NCT00765843|100695951|FG001|Overall Study|Adverse Event|0|||
33218101|NCT00765843|100695952|FG002|Overall Study|Adverse Event|1|||
33218102|NCT00542880|100695958|FG000|Period 1|Eligibility criteria not fulfilled|2|||
33218103|NCT00542880|100695959|FG001|Period 1|Eligibility criteria not fulfilled|6|||
33218104|NCT00542880|100695958|FG000|Period 1|Adverse Event|2|||
33218105|NCT00542880|100695959|FG001|Period 1|Adverse Event|2|||
33218106|NCT00542880|100695958|FG000|Period 1|Development of study-specific criteria|1|||
33218107|NCT00542880|100695959|FG001|Period 1|Development of study-specific criteria|2|||
33218108|NCT00542880|100695958|FG000|Period 1|Withdrawal by Subject|1|||
33218109|NCT00542880|100695959|FG001|Period 1|Withdrawal by Subject|1|||
33218110|NCT00542880|100695958|FG000|Period 1|Protocol Violation|0|||
33218111|NCT00542880|100695959|FG001|Period 1|Protocol Violation|1|||
33218112|NCT00542880|100695958|FG000|Period 2|Adverse Event|5|||
33354897|NCT00957853|101184216|FG002|Overall Study|Withdrawal by Subject|0|||
33354898|NCT00098787|101184217|FG000|Overall Study|Never started treatment|3|||
33354899|NCT00098787|101184218|FG001|Overall Study|Never started treatment|2|||
33354900|NCT00098787|101184219|FG002|Overall Study|Never started treatment|1|||
33354901|NCT00098787|101184217|FG000|Overall Study|Ineligible|9|||
33354902|NCT00098787|101184218|FG001|Overall Study|Ineligible|7|||
33354903|NCT00098787|101184219|FG002|Overall Study|Ineligible|3|||
33354904|NCT00098787|101184217|FG000|Overall Study|Disease progression|28|||
33354905|NCT00098787|101184218|FG001|Overall Study|Disease progression|17|||
33354906|NCT00098787|101184219|FG002|Overall Study|Disease progression|23|||
33354907|NCT00098787|101184217|FG000|Overall Study|Adverse Event|8|||
33354908|NCT00098787|101184218|FG001|Overall Study|Adverse Event|17|||
33354909|NCT00098787|101184219|FG002|Overall Study|Adverse Event|8|||
33354910|NCT00098787|101184217|FG000|Overall Study|Death|6|||
33354911|NCT00098787|101184218|FG001|Overall Study|Death|1|||
33354912|NCT00098787|101184219|FG002|Overall Study|Death|0|||
33354913|NCT00098787|101184217|FG000|Overall Study|Withdrawal by Subject|4|||
33354914|NCT00098787|101184218|FG001|Overall Study|Withdrawal by Subject|12|||
33354915|NCT00098787|101184219|FG002|Overall Study|Withdrawal by Subject|6|||
33354916|NCT00098787|101184217|FG000|Overall Study|Alternative therapy|8|||
33354917|NCT00098787|101184218|FG001|Overall Study|Alternative therapy|13|||
33354918|NCT00098787|101184219|FG002|Overall Study|Alternative therapy|13|||
33354919|NCT00098787|101184217|FG000|Overall Study|Other|7|||
33354920|NCT00098787|101184218|FG001|Overall Study|Other|6|||
33354921|NCT00098787|101184219|FG002|Overall Study|Other|9|||
33354922|NCT01591330|101184220|FG000|Period 1|Adverse Event|1|||
33354923|NCT01591330|101184221|FG001|Period 1|Adverse Event|0|||
33354924|NCT01591330|101184222|FG002|Period 1|Adverse Event|0|||
33354925|NCT01591330|101184223|FG003|Period 1|Adverse Event|0|||
33354926|NCT01591330|101184220|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
33354927|NCT01591330|101184221|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
33354928|NCT01591330|101184222|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
33354929|NCT01591330|101184223|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
33354930|NCT01591330|101184220|FG000|Period 2|Adverse Event|1|||
33354931|NCT01591330|101184221|FG001|Period 2|Adverse Event|0|||
33354932|NCT01591330|101184222|FG002|Period 2|Adverse Event|0|||
33354933|NCT01591330|101184223|FG003|Period 2|Adverse Event|0|||
33620323|NCT01525615|102158143|FG000|Overall Study|Lost to Follow-up|1|||
33218113|NCT00542880|100695959|FG001|Period 2|Adverse Event|7|||
33354934|NCT01748071|101184224|FG000|Overall Study|Adverse Event|2|||
33413643|NCT00679042|101403698|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
33218114|NCT00542880|100695958|FG000|Period 2|Eligibility not fulfilled|0|||
33218115|NCT00542880|100695959|FG001|Period 2|Eligibility not fulfilled|1|||
33218116|NCT00542880|100695958|FG000|Period 2|Discontinuation criteria|2|||
33218117|NCT00542880|100695959|FG001|Period 2|Discontinuation criteria|0|||
33218118|NCT00542880|100695958|FG000|Period 2|Severe non-compliance|0|||
33354935|NCT01748071|101184225|FG001|Overall Study|Adverse Event|2|||
33354936|NCT01748071|101184226|FG002|Overall Study|Adverse Event|0|||
33354937|NCT04325503|101184228|FG000|Overall Study|Withdrawal by Subject|1|||
33354938|NCT04325503|101184228|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
33354939|NCT05408858|101184231|FG000|Overall Study|no longer met eligibility criteria|1|||
33354940|NCT02054702|101187752|FG000|Overall Study|Lost to Follow-up|3|||
33354941|NCT02054702|101187753|FG001|Overall Study|Lost to Follow-up|5|||
33354942|NCT02054702|101187752|FG000|Overall Study|Adverse Event|3|||
33620324|NCT01525615|102158144|FG001|Overall Study|Lost to Follow-up|0|||
33620325|NCT01525615|102158145|FG002|Overall Study|Lost to Follow-up|0|||
33620326|NCT01525615|102158143|FG000|Overall Study|Withdrawal by Subject|1|||
33620327|NCT01525615|102158144|FG001|Overall Study|Withdrawal by Subject|0|||
33620328|NCT01525615|102158145|FG002|Overall Study|Withdrawal by Subject|0|||
33620329|NCT01525615|102158143|FG000|Overall Study|Other reason not described above|1|||
33620330|NCT01525615|102158144|FG001|Overall Study|Other reason not described above|0|||
33620331|NCT01525615|102158145|FG002|Overall Study|Other reason not described above|1|||
33620332|NCT02680665|102158146|FG000|Overall Study|No visit after the first prescription|5|||
33620333|NCT00836186|102158147|FG000|Overall Study|Blood could not be drawn|1|||
33620334|NCT03863509|102158149|FG000|Overall Study|COVID-19 shutdown period|0|||
33620335|NCT03863509|102158150|FG001|Overall Study|COVID-19 shutdown period|4|||
33620336|NCT03863509|102158151|FG002|Overall Study|COVID-19 shutdown period|0|||
33620337|NCT03863509|102158149|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
33620338|NCT03863509|102158150|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
33620339|NCT03863509|102158151|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
33620340|NCT03863509|102158149|FG000|Overall Study|Lost to Follow-up|8|||
33620341|NCT03863509|102158150|FG001|Overall Study|Lost to Follow-up|0|||
33620342|NCT03863509|102158151|FG002|Overall Study|Lost to Follow-up|2|||
33620343|NCT03863509|102158149|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
33620344|NCT03863509|102158150|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
33620345|NCT03863509|102158151|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
33620346|NCT03863509|102158149|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
33620347|NCT03863509|102158150|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
33620348|NCT03863509|102158151|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
33620349|NCT01176058|102158152|FG000|Overall Study|Adverse Event|1|||
33620350|NCT01176058|102158153|FG001|Overall Study|Adverse Event|0|||
33620351|NCT01176058|102158152|FG000|Overall Study|Insufficient clinical response|2|||
33620352|NCT01176058|102158153|FG001|Overall Study|Insufficient clinical response|2|||
33620353|NCT01176058|102158152|FG000|Overall Study|Insufficient mycological response|0|||
33620354|NCT01176058|102158153|FG001|Overall Study|Insufficient mycological response|1|||
33620355|NCT01176058|102158152|FG000|Overall Study|Withdrawal by Subject|1|||
33620356|NCT01176058|102158153|FG001|Overall Study|Withdrawal by Subject|0|||
33620357|NCT00732875|102158155|FG000|Overall Study|Adverse Event|16|||
33354943|NCT02054702|101187753|FG001|Overall Study|Adverse Event|1|||
33354944|NCT02054702|101187752|FG000|Overall Study|Met Withdrawal Criteria|4|||
33354945|NCT02054702|101187753|FG001|Overall Study|Met Withdrawal Criteria|1|||
33554646|NCT04576949|101931840|FG000|Overall Study|Death|0|||
33620358|NCT00732875|102158155|FG000|Overall Study|Withdrawal by Subject|6|||
33620359|NCT00732875|102158155|FG000|Overall Study|Lack of Efficacy|13|||
33354946|NCT02054702|101187752|FG000|Overall Study|Physician Decision|0|||
33554647|NCT04576949|101931841|FG001|Overall Study|Death|1|||
33554648|NCT04576949|101931842|FG002|Overall Study|Death|0|||
33554649|NCT04576949|101931840|FG000|Overall Study|Lost to Follow-up|29|||
33554650|NCT04576949|101931841|FG001|Overall Study|Lost to Follow-up|37|||
33554651|NCT04576949|101931842|FG002|Overall Study|Lost to Follow-up|24|||
33554652|NCT04576949|101931840|FG000|Overall Study|Other, Not Specified|2|||
33554653|NCT04576949|101931841|FG001|Overall Study|Other, Not Specified|3|||
33554654|NCT04576949|101931842|FG002|Overall Study|Other, Not Specified|1|||
33554655|NCT04576949|101931840|FG000|Overall Study|Other|1|||
33554656|NCT04576949|101931841|FG001|Overall Study|Other|0|||
33554657|NCT04576949|101931842|FG002|Overall Study|Other|0|||
33554658|NCT01524705|101931843|FG000|Overall Study|Adverse Event|2|||
33554659|NCT01524705|101931844|FG001|Overall Study|Adverse Event|0|||
33554660|NCT01524705|101931843|FG000|Overall Study|Death|1|||
33554661|NCT01524705|101931844|FG001|Overall Study|Death|0|||
33554662|NCT01524705|101931843|FG000|Overall Study|Lost to Follow-up|0|||
33554663|NCT01524705|101931844|FG001|Overall Study|Lost to Follow-up|1|||
33554664|NCT01524705|101931843|FG000|Overall Study|Withdrawal by Subject|0|||
33554665|NCT01524705|101931844|FG001|Overall Study|Withdrawal by Subject|1|||
33554666|NCT01524705|101931843|FG000|Overall Study|Pancreatic Cancer|0|||
33554667|NCT01524705|101931844|FG001|Overall Study|Pancreatic Cancer|1|||
33554668|NCT02619812|101931846|FG000|Overall Study|Withdrawal by Subject|0|||
33554669|NCT02619812|101931847|FG001|Overall Study|Withdrawal by Subject|0|||
33554670|NCT02619812|101931848|FG002|Overall Study|Withdrawal by Subject|1|||
33554671|NCT02619812|101931849|FG003|Overall Study|Withdrawal by Subject|2|||
33554672|NCT01654250|101931850|FG000|Overall Study|Lost to Follow-up|1|||
33554673|NCT01654250|101931851|FG001|Overall Study|Lost to Follow-up|0|||
33554674|NCT01185366|101931855|FG000|First Line Therapy|Insurance Coverage Denied|1|||
33554675|NCT01185366|101931856|FG001|First Line Therapy|Insurance Coverage Denied|1|||
33554676|NCT01185366|101931855|FG000|First Line Therapy|Withdrawal by Subject|1|||
33620360|NCT02741596|102158156|FG000|Overall Study|Adverse Event|1|||
33620361|NCT02741596|102158157|FG001|Overall Study|Adverse Event|5|||
33620362|NCT02741596|102158156|FG000|Overall Study|Lost to Follow-up|1|||
33218119|NCT00542880|100695959|FG001|Period 2|Severe non-compliance|1|||
33218120|NCT00542880|100695958|FG000|Period 2|Other|0|||
33218121|NCT00542880|100695959|FG001|Period 2|Other|1|||
33218122|NCT00542880|100695958|FG000|Period 3|Adverse Event|0|||
33354947|NCT02054702|101187753|FG001|Overall Study|Physician Decision|1|||
33554677|NCT01185366|101931856|FG001|First Line Therapy|Withdrawal by Subject|0|||
33554678|NCT01185366|101931855|FG000|First Line Therapy|Lack of Metastatic Site|1|||
33554679|NCT01185366|101931856|FG001|First Line Therapy|Lack of Metastatic Site|0|||
33554680|NCT01185366|101931855|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
33554681|NCT01185366|101931856|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
33554682|NCT01185366|101931855|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
33554683|NCT01185366|101931856|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
33554684|NCT01185366|101931855|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
33554685|NCT01185366|101931856|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
33554686|NCT01185366|101931855|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
33620363|NCT02741596|102158157|FG001|Overall Study|Lost to Follow-up|1|||
33620364|NCT02741596|102158156|FG000|Overall Study|Physician Decision|2|||
33620365|NCT02741596|102158157|FG001|Overall Study|Physician Decision|1|||
33620366|NCT02741596|102158156|FG000|Overall Study|Pregnancy|3|||
33620367|NCT02741596|102158157|FG001|Overall Study|Pregnancy|1|||
33620368|NCT02741596|102158156|FG000|Overall Study|Other (Unspecified)|0|||
33620369|NCT02741596|102158157|FG001|Overall Study|Other (Unspecified)|3|||
33620370|NCT02741596|102158156|FG000|Overall Study|Subject withdrawn-Other|17|||
33620371|NCT02741596|102158157|FG001|Overall Study|Subject withdrawn-Other|4|||
33620372|NCT02741596|102158156|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
33354948|NCT02054702|101187752|FG000|Overall Study|Withdrawal by Subject|14|||
33620373|NCT02741596|102158157|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
33620374|NCT02342223|102158164|FG000|Overall Study|Lost to Follow-up|1|||
33620375|NCT00462306|102158165|FG000|Overall Study|insufficient data|0|||
33620376|NCT00462306|102158166|FG001|Overall Study|insufficient data|13|||
33620377|NCT02330055|102158167|FG000|Overall Study|technical issues|2|||
33620378|NCT02330055|102158168|FG001|Overall Study|technical issues|0|||
33620379|NCT02330055|102158167|FG000|Overall Study|participant forgot to wear device|5|||
33620380|NCT02330055|102158168|FG001|Overall Study|participant forgot to wear device|5|||
33620381|NCT02330055|102158167|FG000|Overall Study|data for less than 60 minutes|3|||
33620382|NCT02330055|102158168|FG001|Overall Study|data for less than 60 minutes|3|||
33620383|NCT02330055|102158167|FG000|Overall Study|participant did not sleep|0|||
33620384|NCT02330055|102158168|FG001|Overall Study|participant did not sleep|1|||
33620385|NCT00269919|102158175|FG000|Overall Study|Other|26|||
33620386|NCT00269919|102158175|FG000|Overall Study|Started but not treated|1|||
33620387|NCT00239928|102158178|FG000|Overall Study|Lack of Efficacy|1|||
33620388|NCT00239928|102158178|FG000|Overall Study|Adverse Event|4|||
33620389|NCT00239928|102158178|FG000|Overall Study|Not need to continue study|3|||
33620390|NCT00239928|102158178|FG000|Overall Study|Withdrawal by Subject|2|||
33620391|NCT01402817|102158179|FG000|Overall Study|Withdrawal by Subject|3|||
33620392|NCT01402817|102158179|FG000|Overall Study|Study Suspended by FDA|8|||
33620393|NCT00411671|102158182|FG000|Overall Study|Adverse Event|15|||
33620394|NCT00411671|102158182|FG000|Overall Study|Death|2|||
33218123|NCT00542880|100695959|FG001|Period 3|Adverse Event|2|||
33218124|NCT03260868|100695960|FG000|Overall Study|Poor Compliance to Protocol|0|||
33354949|NCT02054702|101187753|FG001|Overall Study|Withdrawal by Subject|4|||
33354950|NCT00752986|101187756|FG000|Overall Study|Withdrawal by Subject|2|||
33354951|NCT00752986|101187757|FG001|Overall Study|Withdrawal by Subject|1|||
33354952|NCT00752986|101187758|FG002|Overall Study|Withdrawal by Subject|2|||
33354953|NCT00752986|101187756|FG000|Overall Study|Protocol Violation|3|||
33354954|NCT00752986|101187757|FG001|Overall Study|Protocol Violation|0|||
33354955|NCT00752986|101187758|FG002|Overall Study|Protocol Violation|0|||
33354956|NCT00541307|101187761|FG000|Overall Study|Death|5|||
33413644|NCT01071278|101403701|FG000|Overall Study|Premature Discontinuation|254|||
33413645|NCT01071278|101403701|FG000|Overall Study|Completion Status Unknown|459|||
33413646|NCT03644927|101403702|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
33413647|NCT03644927|101403703|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
33554687|NCT01185366|101931856|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
33554688|NCT00160615|101931863|FG000|Overall Study|Adverse Event|5|||
33620395|NCT00411671|102158182|FG000|Overall Study|Lost to Follow-up|3|||
33218125|NCT03260868|100695961|FG001|Overall Study|Poor Compliance to Protocol|2|||
33218126|NCT03260868|100695960|FG000|Overall Study|Study Terminated By Sponsor|2|||
33554689|NCT00160615|101931864|FG001|Overall Study|Adverse Event|12|||
33620396|NCT02362724|102158184|FG000|Overall Study|Withdrawal by Subject|3|||
33620397|NCT02362724|102158185|FG001|Overall Study|Withdrawal by Subject|1|||
33620398|NCT02362724|102158184|FG000|Overall Study|Adverse Event|3|||
33620399|NCT02362724|102158185|FG001|Overall Study|Adverse Event|0|||
33620400|NCT01965704|102158186|FG000|Overall Study|Withdrawal by Subject|2|||
33620401|NCT01965704|102158187|FG001|Overall Study|Withdrawal by Subject|2|||
33620402|NCT01965704|102158188|FG002|Overall Study|Withdrawal by Subject|1|||
33554690|NCT00160615|101931863|FG000|Overall Study|Withdrawal by Subject|0|||
33554691|NCT00160615|101931864|FG001|Overall Study|Withdrawal by Subject|2|||
33554692|NCT00160615|101931863|FG000|Overall Study|Lack of Efficacy|11|||
33554693|NCT00160615|101931864|FG001|Overall Study|Lack of Efficacy|23|||
33554694|NCT00160615|101931863|FG000|Overall Study|Patient decision|1|||
33620403|NCT01965704|102158189|FG003|Overall Study|Withdrawal by Subject|1|||
33620404|NCT01965704|102158186|FG000|Overall Study|Delivered at home|1|||
33620405|NCT01965704|102158187|FG001|Overall Study|Delivered at home|1|||
33620406|NCT01965704|102158188|FG002|Overall Study|Delivered at home|0|||
33620407|NCT01965704|102158189|FG003|Overall Study|Delivered at home|0|||
33620408|NCT01965704|102158186|FG000|Overall Study|Experienced complications|0|||
33354957|NCT00541307|101187761|FG000|Overall Study|Physician Decision|3|||
33354958|NCT00541307|101187761|FG000|Overall Study|Withdrawal by Subject|6|||
33354959|NCT00541307|101187761|FG000|Overall Study|Lost to Follow-up|4|||
33354960|NCT00541307|101187761|FG000|Overall Study|Subject returned early (outside window)|1|||
33354961|NCT00541307|101187761|FG000|Overall Study|Surgical Bypass|5|||
33354962|NCT00684814|101187762|FG000|Washout Period of 7 Days|Adverse Event|1|||
33354963|NCT00684814|101187763|FG001|Washout Period of 7 Days|Adverse Event|2|||
33354964|NCT00684814|101187762|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
33354965|NCT00684814|101187763|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
33354966|NCT00684814|101187762|FG000|Second Intervention|Adverse Event|1|||
33354967|NCT00684814|101187763|FG001|Second Intervention|Adverse Event|0|||
33554695|NCT00160615|101931864|FG001|Overall Study|Patient decision|2|||
33554696|NCT00160615|101931863|FG000|Overall Study|Investigator decision|1|||
33554697|NCT00160615|101931864|FG001|Overall Study|Investigator decision|1|||
33554698|NCT00160615|101931863|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
33554699|NCT00160615|101931864|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
33554700|NCT00160615|101931863|FG000|Overall Study|Switch to surgical treatment|0|||
33554701|NCT00160615|101931864|FG001|Overall Study|Switch to surgical treatment|2|||
33554702|NCT00160615|101931863|FG000|Overall Study|Non-compliance was suspected|0|||
33554703|NCT00160615|101931864|FG001|Overall Study|Non-compliance was suspected|1|||
33554704|NCT00160615|101931863|FG000|Overall Study|Poor compliance|0|||
33554705|NCT00160615|101931864|FG001|Overall Study|Poor compliance|1|||
33554706|NCT00284934|101931867|FG000|Overall Study|Adverse Event|1|||
33554707|NCT00284934|101931868|FG001|Overall Study|Adverse Event|2|||
33554708|NCT00284934|101931867|FG000|Overall Study|Other reasons|3|||
33554709|NCT00284934|101931868|FG001|Overall Study|Other reasons|1|||
33554710|NCT05085405|101931870|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
33554711|NCT05085405|101931871|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
33554712|NCT05085405|101931872|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
33554713|NCT05085405|101931873|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
33554714|NCT05085405|101931874|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
33554715|NCT05085405|101931875|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
33554716|NCT05085405|101931870|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
33554717|NCT05085405|101931871|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
33554718|NCT05085405|101931872|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
33554719|NCT05085405|101931873|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
33554720|NCT05085405|101931874|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
33554721|NCT05085405|101931875|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
33554722|NCT00378560|101931876|FG000|Overall Study|Adverse Event|1|||
33554723|NCT00378560|101931877|FG001|Overall Study|Adverse Event|0|||
33554724|NCT00378560|101931876|FG000|Overall Study|Lost to Follow-up|24|||
33554725|NCT00378560|101931877|FG001|Overall Study|Lost to Follow-up|29|||
33554726|NCT00378560|101931876|FG000|Overall Study|Protocol Violation|2|||
33554727|NCT00378560|101931877|FG001|Overall Study|Protocol Violation|0|||
33554728|NCT00378560|101931876|FG000|Overall Study|Withdrawal by Subject|17|||
33554729|NCT00378560|101931877|FG001|Overall Study|Withdrawal by Subject|21|||
33554730|NCT00378560|101931876|FG000|Overall Study|Moved|4|||
33554731|NCT00378560|101931877|FG001|Overall Study|Moved|3|||
33554732|NCT00378560|101931876|FG000|Overall Study|Pregnancy|7|||
33554733|NCT00378560|101931877|FG001|Overall Study|Pregnancy|5|||
33620409|NCT01965704|102158187|FG001|Overall Study|Experienced complications|0|||
33354968|NCT00768560|101187764|FG000|Intervention Set 1|Adverse Event|0|||
33354969|NCT00768560|101187765|FG001|Intervention Set 1|Adverse Event|1|||
33354970|NCT00768560|101187766|FG002|Intervention Set 1|Adverse Event|0|||
33354971|NCT00768560|101187767|FG003|Intervention Set 1|Adverse Event|0|||
33413648|NCT04359758|101403704|FG000|Overall Study|Protocol Violation|3|||
33413649|NCT04359758|101403705|FG001|Overall Study|Protocol Violation|2|||
33413650|NCT00761735|101403706|FG000|Overall Study|Lost to Follow-up|6|||
33413651|NCT00761735|101403706|FG000|Overall Study|Withdrawal by Subject|6|||
33413652|NCT00761735|101403706|FG000|Overall Study|Non-compliance with protocol|1|||
33413653|NCT00761735|101403706|FG000|Overall Study|Administrative|1|||
33620410|NCT01965704|102158188|FG002|Overall Study|Experienced complications|2|||
33620411|NCT01965704|102158189|FG003|Overall Study|Experienced complications|2|||
33620412|NCT01965704|102158186|FG000|Overall Study|Adverse Event|0|||
33554734|NCT00378560|101931876|FG000|Overall Study|Laboratory test values abnormal|1|||
33554735|NCT00378560|101931877|FG001|Overall Study|Laboratory test values abnormal|0|||
33554736|NCT01166945|101931878|FG000|Randomized|diagnosed with Group A strep|4|||
33554737|NCT01166945|101931879|FG001|Randomized|diagnosed with Group A strep|4|||
33554738|NCT01166945|101931878|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
33554739|NCT01166945|101931879|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
33554740|NCT01166945|101931878|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
33620413|NCT01965704|102158187|FG001|Overall Study|Adverse Event|0|||
33620414|NCT01965704|102158188|FG002|Overall Study|Adverse Event|1|||
33413654|NCT03958045|101403707|FG000|Overall Study|Withdrawal by Subject|1|||
33620415|NCT01965704|102158189|FG003|Overall Study|Adverse Event|1|||
33620416|NCT01965704|102158186|FG000|Overall Study|Did not meet inclusion criteria|0|||
33620417|NCT01965704|102158187|FG001|Overall Study|Did not meet inclusion criteria|0|||
33620418|NCT01965704|102158188|FG002|Overall Study|Did not meet inclusion criteria|1|||
33620419|NCT01965704|102158189|FG003|Overall Study|Did not meet inclusion criteria|1|||
33620420|NCT03229109|102158192|FG000|Overall Study|Withdrawal by Subject|0|||
33620421|NCT03229109|102158193|FG001|Overall Study|Withdrawal by Subject|0|||
33620422|NCT03229109|102158194|FG002|Overall Study|Withdrawal by Subject|0|||
33620423|NCT03229109|102158195|FG003|Overall Study|Withdrawal by Subject|1|||
33620424|NCT01370265|102158196|FG000|First Intervention|Adverse Event|1|||
33620425|NCT01370265|102158197|FG001|First Intervention|Adverse Event|1|||
33620426|NCT01426958|102158200|FG000|Overall Study|Adverse Event|2|||
33620427|NCT01559675|102158201|FG000|Overall Study|Protocol Violation|1|||
33620428|NCT01559675|102158202|FG001|Overall Study|Protocol Violation|2|||
33620429|NCT01559675|102158201|FG000|Overall Study|2nd operation on same patient excluded|14|||
33413655|NCT01556490|101403708|FG000|Randomized Patients Summary|Protocol Violation|22|||
33620430|NCT01559675|102158202|FG001|Overall Study|2nd operation on same patient excluded|12|||
33354972|NCT00768560|101187768|FG004|Intervention Set 1|Adverse Event|0|||
33354973|NCT00768560|101187769|FG005|Intervention Set 1|Adverse Event|0|||
33354974|NCT03487445|101187771|FG000|Randomization|Not treated for administrative reasons|1|||
33354975|NCT03487445|101187772|FG001|Randomization|Not treated for administrative reasons|0|||
33354976|NCT00002850|101187773|FG000|Overall Study|Death|4|||
33354977|NCT00002850|101187774|FG001|Overall Study|Death|1|||
33354978|NCT00002850|101187775|FG002|Overall Study|Death|3|||
33354979|NCT00002850|101187773|FG000|Overall Study|Protocol Violation|1|||
33354980|NCT00002850|101187774|FG001|Overall Study|Protocol Violation|0|||
33354981|NCT00002850|101187775|FG002|Overall Study|Protocol Violation|1|||
33354982|NCT00002850|101187773|FG000|Overall Study|Withdrawal by Subject|0|||
33354983|NCT00002850|101187774|FG001|Overall Study|Withdrawal by Subject|1|||
33354984|NCT00002850|101187775|FG002|Overall Study|Withdrawal by Subject|0|||
33354985|NCT00503399|101187776|FG000|Overall Study|Death|2|||
33354986|NCT00503399|101187777|FG001|Overall Study|Death|1|||
33354987|NCT00503399|101187776|FG000|Overall Study|Protocol Violation|1|||
33354988|NCT00503399|101187777|FG001|Overall Study|Protocol Violation|0|||
33354989|NCT00503399|101187776|FG000|Overall Study|Withdrawal by Subject|4|||
33354990|NCT00503399|101187777|FG001|Overall Study|Withdrawal by Subject|2|||
33354991|NCT00503399|101187776|FG000|Overall Study|Adverse Event|0|||
33354992|NCT00503399|101187777|FG001|Overall Study|Adverse Event|3|||
33354993|NCT00503399|101187776|FG000|Overall Study|Lost to Follow-up|0|||
33354994|NCT00503399|101187777|FG001|Overall Study|Lost to Follow-up|2|||
33354995|NCT00613626|101187780|FG000|Overall Study|Ineligible|0|||
33354996|NCT00613626|101187781|FG001|Overall Study|Ineligible|1|||
33354997|NCT00613626|101187782|FG002|Overall Study|Ineligible|0|||
33354998|NCT04398732|101187783|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
33354999|NCT02978222|101187784|FG000|Overall Study|Withdrawal by Subject|2|||
33355000|NCT02978222|101187785|FG001|Overall Study|Withdrawal by Subject|2|||
33355001|NCT02978222|101187784|FG000|Overall Study|Physician Decision|2|||
33355002|NCT02978222|101187785|FG001|Overall Study|Physician Decision|0|||
33355003|NCT02978222|101187784|FG000|Overall Study|Adverse Event|0|||
33355004|NCT02978222|101187785|FG001|Overall Study|Adverse Event|1|||
33355005|NCT02978222|101187784|FG000|Overall Study|Death|1|||
33355006|NCT02978222|101187785|FG001|Overall Study|Death|0|||
33355007|NCT02978222|101187784|FG000|Overall Study|Disease Progression|32|||
33413656|NCT01556490|101403709|FG001|Randomized Patients Summary|Protocol Violation|23|||
33413657|NCT01556490|101403708|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
33554741|NCT01166945|101931879|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
33554742|NCT01166945|101931878|FG000|Day 30|Lost to Follow-up|4|||
33554743|NCT01166945|101931879|FG001|Day 30|Lost to Follow-up|3|||
33554744|NCT01108796|101931882|FG000|Overall Study|Adverse Event|0|||
33554745|NCT01108796|101931883|FG001|Overall Study|Adverse Event|1|||
33554746|NCT01108796|101931882|FG000|Overall Study|Lost to Follow-up|7|||
33620431|NCT03294590|102158205|FG000|Overall Study|Lost to Follow-up|105|||
33620432|NCT03294590|102158206|FG001|Overall Study|Lost to Follow-up|107|||
33620433|NCT02741635|102158207|FG000|Overall Study|Withdrawal by Subject|1|||
33355008|NCT02978222|101187785|FG001|Overall Study|Disease Progression|32|||
33355009|NCT02978222|101187784|FG000|Overall Study|Early Study Termination|24|||
33355010|NCT02978222|101187785|FG001|Overall Study|Early Study Termination|21|||
33355011|NCT02635204|101187788|FG000|Overall Study|Adverse Event|1|||
33355012|NCT02635204|101187789|FG001|Overall Study|Adverse Event|0|||
33355013|NCT02635204|101187788|FG000|Overall Study|Lost to Follow-up|1|||
33355014|NCT02635204|101187789|FG001|Overall Study|Lost to Follow-up|1|||
33355015|NCT01059448|101187793|FG000|Overall Study|Adverse Event|1|||
33355016|NCT01059448|101187794|FG001|Overall Study|Adverse Event|3|||
33620434|NCT00867165|102158210|FG000|Overall Study|Adverse Event|3|||
33620435|NCT00867165|102158211|FG001|Overall Study|Adverse Event|0|||
33355017|NCT01059448|101187795|FG002|Overall Study|Adverse Event|0|||
33355018|NCT01059448|101187796|FG003|Overall Study|Adverse Event|1|||
33355019|NCT01059448|101187793|FG000|Overall Study|Withdrawal by Subject|2|||
33413658|NCT01556490|101403709|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
33620436|NCT00867165|102158210|FG000|Overall Study|Withdrawal by Subject|1|||
33620437|NCT00867165|102158211|FG001|Overall Study|Withdrawal by Subject|0|||
33620438|NCT00950846|102158212|FG000|Overall Study|Death|6|||
33620439|NCT00950846|102158212|FG000|Overall Study|Lost to Follow-up|3|||
33620440|NCT00950846|102158212|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
33620441|NCT01016600|102161625|FG000|Overall Study|Did not start treatment|1|||
33355020|NCT01059448|101187794|FG001|Overall Study|Withdrawal by Subject|0|||
33413659|NCT03128931|101403713|FG000|Overall Study|Physician Decision|1|||
33554747|NCT01108796|101931883|FG001|Overall Study|Lost to Follow-up|6|||
33554748|NCT00147537|101931884|FG000|Phase 1b|Death|0|||
33554749|NCT00147537|101931885|FG001|Phase 1b|Death|1|||
33554750|NCT00147537|101931886|FG002|Phase 1b|Death|2|||
33554751|NCT00147537|101931887|FG003|Phase 1b|Death|1|||
33554752|NCT00147537|101931888|FG004|Phase 1b|Death|2|||
33554753|NCT00147537|101931889|FG005|Phase 1b|Death|2|||
33554754|NCT00147537|101931890|FG006|Phase 1b|Death|1|||
33554755|NCT00147537|101931891|FG007|Phase 1b|Death|3|||
33554756|NCT00147537|101931892|FG008|Phase 1b|Death|9|||
33554757|NCT00147537|101931893|FG009|Phase 1b|Death|0|||
33554758|NCT00147537|101931894|FG010|Phase 1b|Death|0|||
33554759|NCT00147537|101931884|FG000|Phase 1b|Lost to Follow-up|2|||
33554760|NCT00147537|101931885|FG001|Phase 1b|Lost to Follow-up|1|||
33554761|NCT00147537|101931886|FG002|Phase 1b|Lost to Follow-up|0|||
33554762|NCT00147537|101931887|FG003|Phase 1b|Lost to Follow-up|0|||
33554763|NCT00147537|101931888|FG004|Phase 1b|Lost to Follow-up|0|||
33554764|NCT00147537|101931889|FG005|Phase 1b|Lost to Follow-up|0|||
33554765|NCT00147537|101931890|FG006|Phase 1b|Lost to Follow-up|2|||
33554766|NCT00147537|101931891|FG007|Phase 1b|Lost to Follow-up|0|||
33554767|NCT00147537|101931892|FG008|Phase 1b|Lost to Follow-up|1|||
33554768|NCT00147537|101931893|FG009|Phase 1b|Lost to Follow-up|0|||
33554769|NCT00147537|101931894|FG010|Phase 1b|Lost to Follow-up|0|||
33554770|NCT00147537|101931884|FG000|Phase 1b|Other|0|||
33554771|NCT00147537|101931885|FG001|Phase 1b|Other|0|||
33554772|NCT00147537|101931886|FG002|Phase 1b|Other|2|||
33554773|NCT00147537|101931887|FG003|Phase 1b|Other|1|||
33554774|NCT00147537|101931888|FG004|Phase 1b|Other|1|||
33554775|NCT00147537|101931889|FG005|Phase 1b|Other|1|||
33554776|NCT00147537|101931890|FG006|Phase 1b|Other|14|||
33554777|NCT00147537|101931891|FG007|Phase 1b|Other|4|||
33554778|NCT00147537|101931892|FG008|Phase 1b|Other|4|||
33554779|NCT00147537|101931893|FG009|Phase 1b|Other|0|||
33554780|NCT00147537|101931894|FG010|Phase 1b|Other|0|||
33554781|NCT00147537|101931884|FG000|Phase 1b|Withdrawal by Subject|0|||
33554782|NCT00147537|101931885|FG001|Phase 1b|Withdrawal by Subject|0|||
33554783|NCT00147537|101931886|FG002|Phase 1b|Withdrawal by Subject|0|||
33554784|NCT00147537|101931887|FG003|Phase 1b|Withdrawal by Subject|0|||
33554785|NCT00147537|101931888|FG004|Phase 1b|Withdrawal by Subject|0|||
33554786|NCT00147537|101931889|FG005|Phase 1b|Withdrawal by Subject|0|||
33554787|NCT00147537|101931890|FG006|Phase 1b|Withdrawal by Subject|0|||
33554788|NCT00147537|101931891|FG007|Phase 1b|Withdrawal by Subject|0|||
33554789|NCT00147537|101931892|FG008|Phase 1b|Withdrawal by Subject|2|||
33554790|NCT00147537|101931893|FG009|Phase 1b|Withdrawal by Subject|0|||
33554791|NCT00147537|101931894|FG010|Phase 1b|Withdrawal by Subject|0|||
33554792|NCT00147537|101931884|FG000|Phase 1b|Randomized but not treated|0|||
33554793|NCT00147537|101931885|FG001|Phase 1b|Randomized but not treated|0|||
33554794|NCT00147537|101931886|FG002|Phase 1b|Randomized but not treated|0|||
33355021|NCT01059448|101187795|FG002|Overall Study|Withdrawal by Subject|2|||
33554795|NCT00147537|101931887|FG003|Phase 1b|Randomized but not treated|0|||
33554796|NCT00147537|101931888|FG004|Phase 1b|Randomized but not treated|0|||
33554797|NCT00147537|101931889|FG005|Phase 1b|Randomized but not treated|0|||
33554798|NCT00147537|101931890|FG006|Phase 1b|Randomized but not treated|1|||
33554799|NCT00147537|101931891|FG007|Phase 1b|Randomized but not treated|0|||
33554800|NCT00147537|101931892|FG008|Phase 1b|Randomized but not treated|1|||
33554801|NCT00147537|101931893|FG009|Phase 1b|Randomized but not treated|0|||
33554802|NCT00147537|101931894|FG010|Phase 1b|Randomized but not treated|0|||
33554803|NCT00147537|101931884|FG000|Phase 2|Death|0|||
33620442|NCT01016600|102161626|FG001|Overall Study|Did not start treatment|0|||
33620443|NCT01016600|102161627|FG002|Overall Study|Did not start treatment|0|||
33620444|NCT01016600|102161628|FG003|Overall Study|Did not start treatment|0|||
33620445|NCT04050618|102161629|FG000|First Intervention|Withdrawal by Subject|2|||
33620446|NCT04050618|102161630|FG001|First Intervention|Withdrawal by Subject|0|||
33620447|NCT04050618|102161629|FG000|Second Intervention|Withdrawal by Subject|1|||
33620448|NCT04050618|102161630|FG001|Second Intervention|Withdrawal by Subject|0|||
33620449|NCT00844376|102161634|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
33620450|NCT00844376|102161635|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
33620451|NCT04566601|102161640|FG000|Overall Study|Other than listed|13|||
33620452|NCT04566601|102161641|FG001|Overall Study|Other than listed|4|||
33620453|NCT04566601|102161642|FG002|Overall Study|Other than listed|2|||
33620454|NCT04566601|102161643|FG003|Overall Study|Other than listed|1|||
33620455|NCT04566601|102161644|FG004|Overall Study|Other than listed|4|||
33620456|NCT04566601|102161640|FG000|Overall Study|Protocol deviation|3|||
33620457|NCT04566601|102161641|FG001|Overall Study|Protocol deviation|0|||
33620458|NCT04566601|102161642|FG002|Overall Study|Protocol deviation|1|||
33620459|NCT04566601|102161643|FG003|Overall Study|Protocol deviation|1|||
33620460|NCT04566601|102161644|FG004|Overall Study|Protocol deviation|1|||
33620461|NCT04566601|102161640|FG000|Overall Study|Technical problems|0|||
33620462|NCT04566601|102161641|FG001|Overall Study|Technical problems|0|||
33620463|NCT04566601|102161642|FG002|Overall Study|Technical problems|1|||
33620464|NCT04566601|102161643|FG003|Overall Study|Technical problems|0|||
33620465|NCT04566601|102161644|FG004|Overall Study|Technical problems|0|||
33620466|NCT04566601|102161640|FG000|Overall Study|No reason available|3|||
33620467|NCT04566601|102161641|FG001|Overall Study|No reason available|2|||
33620468|NCT04566601|102161642|FG002|Overall Study|No reason available|7|||
33620469|NCT04566601|102161643|FG003|Overall Study|No reason available|1|||
33620470|NCT04566601|102161644|FG004|Overall Study|No reason available|5|||
33620471|NCT04566601|102161640|FG000|Overall Study|Burden of study procedures|3|||
33620472|NCT04566601|102161641|FG001|Overall Study|Burden of study procedures|0|||
33620473|NCT04566601|102161642|FG002|Overall Study|Burden of study procedures|0|||
33620474|NCT04566601|102161643|FG003|Overall Study|Burden of study procedures|3|||
33620475|NCT04566601|102161644|FG004|Overall Study|Burden of study procedures|1|||
33620476|NCT04566601|102161640|FG000|Overall Study|Change of residence|2|||
33620477|NCT04566601|102161641|FG001|Overall Study|Change of residence|2|||
33620478|NCT04566601|102161642|FG002|Overall Study|Change of residence|0|||
33620479|NCT04566601|102161643|FG003|Overall Study|Change of residence|1|||
33620480|NCT04566601|102161644|FG004|Overall Study|Change of residence|2|||
33620481|NCT04566601|102161640|FG000|Overall Study|Perceived lack of efficacy|2|||
33620482|NCT04566601|102161641|FG001|Overall Study|Perceived lack of efficacy|0|||
33620483|NCT04566601|102161642|FG002|Overall Study|Perceived lack of efficacy|1|||
33620484|NCT04566601|102161643|FG003|Overall Study|Perceived lack of efficacy|1|||
33620485|NCT04566601|102161644|FG004|Overall Study|Perceived lack of efficacy|2|||
33620486|NCT04566601|102161640|FG000|Overall Study|Adverse Event|7|||
33620487|NCT04566601|102161641|FG001|Overall Study|Adverse Event|4|||
33620488|NCT04566601|102161642|FG002|Overall Study|Adverse Event|6|||
33620489|NCT04566601|102161643|FG003|Overall Study|Adverse Event|5|||
33620490|NCT04566601|102161644|FG004|Overall Study|Adverse Event|12|||
33620491|NCT02910466|102161647|FG000|Overall Study|Adverse Event|1|||
33620492|NCT02910466|102161647|FG000|Overall Study|Withdrawal by Subject|3|||
33620493|NCT02910466|102161647|FG000|Overall Study|Lost to Follow-up|5|||
33554804|NCT00147537|101931885|FG001|Phase 2|Death|0|||
33554805|NCT00147537|101931886|FG002|Phase 2|Death|0|||
33554806|NCT00147537|101931887|FG003|Phase 2|Death|0|||
33554807|NCT00147537|101931888|FG004|Phase 2|Death|0|||
33554808|NCT00147537|101931889|FG005|Phase 2|Death|0|||
33554809|NCT00147537|101931890|FG006|Phase 2|Death|0|||
33554810|NCT00147537|101931891|FG007|Phase 2|Death|0|||
33554811|NCT00147537|101931892|FG008|Phase 2|Death|0|||
33554812|NCT00147537|101931893|FG009|Phase 2|Death|85|||
33554813|NCT00147537|101931894|FG010|Phase 2|Death|31|||
33554814|NCT00147537|101931884|FG000|Phase 2|Lost to Follow-up|0|||
33554815|NCT00147537|101931885|FG001|Phase 2|Lost to Follow-up|0|||
33554816|NCT00147537|101931886|FG002|Phase 2|Lost to Follow-up|0|||
33620494|NCT02910466|102161647|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
33620495|NCT02910466|102161647|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
33554817|NCT00147537|101931887|FG003|Phase 2|Lost to Follow-up|0|||
33554818|NCT00147537|101931888|FG004|Phase 2|Lost to Follow-up|0|||
33554819|NCT00147537|101931889|FG005|Phase 2|Lost to Follow-up|0|||
33554820|NCT00147537|101931890|FG006|Phase 2|Lost to Follow-up|0|||
33554821|NCT00147537|101931891|FG007|Phase 2|Lost to Follow-up|0|||
33554822|NCT00147537|101931892|FG008|Phase 2|Lost to Follow-up|0|||
33620496|NCT01395901|102161649|FG000|Overall Study|Lost to Follow-up|4|||
33620497|NCT01395901|102161650|FG001|Overall Study|Lost to Follow-up|0|||
33620498|NCT01395901|102161649|FG000|Overall Study|Randomized but not received study drug|5|||
33620499|NCT01395901|102161650|FG001|Overall Study|Randomized but not received study drug|4|||
33620500|NCT01395901|102161649|FG000|Overall Study|Adverse Event|0|||
33620501|NCT01395901|102161650|FG001|Overall Study|Adverse Event|1|||
33620502|NCT01395901|102161649|FG000|Overall Study|Withdrawal of consent|1|||
33620503|NCT01395901|102161650|FG001|Overall Study|Withdrawal of consent|0|||
33620504|NCT03087513|102161653|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
33413660|NCT03128931|101403713|FG000|Overall Study|Equipment Issues|3|||
33413661|NCT01977482|101403714|FG000|Overall Study|Adverse Event|0|||
33413662|NCT01977482|101403715|FG001|Overall Study|Adverse Event|1|||
33413663|NCT01977482|101403716|FG002|Overall Study|Adverse Event|1|||
33413664|NCT01977482|101403717|FG003|Overall Study|Adverse Event|0|||
33413665|NCT01977482|101403718|FG004|Overall Study|Adverse Event|2|||
33413666|NCT01977482|101403719|FG005|Overall Study|Adverse Event|0|||
33413667|NCT01977482|101403714|FG000|Overall Study|Lost to Follow-up|1|||
33413668|NCT01977482|101403715|FG001|Overall Study|Lost to Follow-up|0|||
33413669|NCT01977482|101403716|FG002|Overall Study|Lost to Follow-up|0|||
33413670|NCT01977482|101403717|FG003|Overall Study|Lost to Follow-up|0|||
33413671|NCT01977482|101403718|FG004|Overall Study|Lost to Follow-up|0|||
33413672|NCT01977482|101403719|FG005|Overall Study|Lost to Follow-up|0|||
33413673|NCT01977482|101403714|FG000|Overall Study|Physician Decision|0|||
33413674|NCT01977482|101403715|FG001|Overall Study|Physician Decision|1|||
33413675|NCT01977482|101403716|FG002|Overall Study|Physician Decision|0|||
33413676|NCT01977482|101403717|FG003|Overall Study|Physician Decision|0|||
33413677|NCT01977482|101403718|FG004|Overall Study|Physician Decision|0|||
33413678|NCT01977482|101403719|FG005|Overall Study|Physician Decision|0|||
33413679|NCT01977482|101403714|FG000|Overall Study|Protocol Violation|0|||
33413680|NCT01977482|101403715|FG001|Overall Study|Protocol Violation|0|||
33413681|NCT01977482|101403716|FG002|Overall Study|Protocol Violation|1|||
33413682|NCT01977482|101403717|FG003|Overall Study|Protocol Violation|0|||
33413683|NCT01977482|101403718|FG004|Overall Study|Protocol Violation|0|||
33413684|NCT01977482|101403719|FG005|Overall Study|Protocol Violation|0|||
33413685|NCT01977482|101403714|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
33413686|NCT01977482|101403715|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
33413687|NCT01977482|101403716|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
33413688|NCT01977482|101403717|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
33554823|NCT00147537|101931893|FG009|Phase 2|Lost to Follow-up|12|||
33554824|NCT00147537|101931894|FG010|Phase 2|Lost to Follow-up|4|||
33554825|NCT00147537|101931884|FG000|Phase 2|Other|0|||
33554826|NCT00147537|101931885|FG001|Phase 2|Other|0|||
33554827|NCT00147537|101931886|FG002|Phase 2|Other|0|||
33554828|NCT00147537|101931887|FG003|Phase 2|Other|0|||
33554829|NCT00147537|101931888|FG004|Phase 2|Other|0|||
33554830|NCT00147537|101931889|FG005|Phase 2|Other|0|||
33554831|NCT00147537|101931890|FG006|Phase 2|Other|0|||
33554832|NCT00147537|101931891|FG007|Phase 2|Other|0|||
33554833|NCT00147537|101931892|FG008|Phase 2|Other|0|||
33554834|NCT00147537|101931893|FG009|Phase 2|Other|47|||
33554835|NCT00147537|101931894|FG010|Phase 2|Other|12|||
33554836|NCT00147537|101931884|FG000|Phase 2|Withdrawal by Subject|0|||
33554837|NCT00147537|101931885|FG001|Phase 2|Withdrawal by Subject|0|||
33554838|NCT00147537|101931886|FG002|Phase 2|Withdrawal by Subject|0|||
33554839|NCT00147537|101931887|FG003|Phase 2|Withdrawal by Subject|0|||
33554840|NCT00147537|101931888|FG004|Phase 2|Withdrawal by Subject|0|||
33554841|NCT00147537|101931889|FG005|Phase 2|Withdrawal by Subject|0|||
33554842|NCT00147537|101931890|FG006|Phase 2|Withdrawal by Subject|0|||
33554843|NCT00147537|101931891|FG007|Phase 2|Withdrawal by Subject|0|||
33554844|NCT00147537|101931892|FG008|Phase 2|Withdrawal by Subject|0|||
33554845|NCT00147537|101931893|FG009|Phase 2|Withdrawal by Subject|16|||
33554846|NCT00147537|101931894|FG010|Phase 2|Withdrawal by Subject|4|||
33554847|NCT00147537|101931884|FG000|Phase 2|Randomized but not treated|0|||
33554848|NCT00147537|101931885|FG001|Phase 2|Randomized but not treated|0|||
33554849|NCT00147537|101931886|FG002|Phase 2|Randomized but not treated|0|||
33554850|NCT00147537|101931887|FG003|Phase 2|Randomized but not treated|0|||
33554851|NCT00147537|101931888|FG004|Phase 2|Randomized but not treated|0|||
33554852|NCT00147537|101931889|FG005|Phase 2|Randomized but not treated|0|||
33554853|NCT00147537|101931890|FG006|Phase 2|Randomized but not treated|0|||
33554854|NCT00147537|101931891|FG007|Phase 2|Randomized but not treated|0|||
33554855|NCT00147537|101931892|FG008|Phase 2|Randomized but not treated|0|||
33554856|NCT00147537|101931893|FG009|Phase 2|Randomized but not treated|1|||
33413689|NCT01977482|101403718|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
33554857|NCT00147537|101931894|FG010|Phase 2|Randomized but not treated|1|||
33554858|NCT00281580|101931895|FG000|Overall Study|Adverse Event|2|||
33554859|NCT00281580|101931896|FG001|Overall Study|Adverse Event|0|||
33554860|NCT00281580|101931897|FG002|Overall Study|Adverse Event|2|||
33554861|NCT00281580|101931898|FG003|Overall Study|Adverse Event|4|||
33554862|NCT00281580|101931899|FG004|Overall Study|Adverse Event|1|||
33554863|NCT00281580|101931900|FG005|Overall Study|Adverse Event|0|||
33413690|NCT01977482|101403719|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
33413691|NCT01977482|101403714|FG000|Overall Study|Withdrawal by Subject|2|||
33413692|NCT01977482|101403715|FG001|Overall Study|Withdrawal by Subject|4|||
33413693|NCT01977482|101403716|FG002|Overall Study|Withdrawal by Subject|1|||
33413694|NCT01977482|101403717|FG003|Overall Study|Withdrawal by Subject|3|||
33413695|NCT01977482|101403718|FG004|Overall Study|Withdrawal by Subject|1|||
33413696|NCT01977482|101403719|FG005|Overall Study|Withdrawal by Subject|5|||
33554864|NCT00281580|101931901|FG006|Overall Study|Adverse Event|1|||
33554865|NCT00281580|101931902|FG007|Overall Study|Adverse Event|0|||
33355022|NCT01059448|101187796|FG003|Overall Study|Withdrawal by Subject|4|||
33355023|NCT01059448|101187793|FG000|Overall Study|Disease Progression|2|||
33355024|NCT01059448|101187794|FG001|Overall Study|Disease Progression|1|||
33355025|NCT01059448|101187795|FG002|Overall Study|Disease Progression|4|||
33355026|NCT01059448|101187796|FG003|Overall Study|Disease Progression|2|||
33355027|NCT01059448|101187793|FG000|Overall Study|Administrative Decision|43|||
33355028|NCT01059448|101187794|FG001|Overall Study|Administrative Decision|49|||
33355029|NCT01059448|101187795|FG002|Overall Study|Administrative Decision|45|||
33355030|NCT01059448|101187796|FG003|Overall Study|Administrative Decision|46|||
33355031|NCT01059448|101187793|FG000|Overall Study|Lost to Follow-up|0|||
33355032|NCT01059448|101187794|FG001|Overall Study|Lost to Follow-up|0|||
33554866|NCT00281580|101931903|FG008|Overall Study|Adverse Event|1|||
33554867|NCT00281580|101931904|FG009|Overall Study|Adverse Event|6|||
33554868|NCT00281580|101931905|FG010|Overall Study|Adverse Event|0|||
33554869|NCT00281580|101931906|FG011|Overall Study|Adverse Event|5|||
33554870|NCT00281580|101931907|FG012|Overall Study|Adverse Event|8|||
33554871|NCT00281580|101931908|FG013|Overall Study|Adverse Event|2|||
33554872|NCT00281580|101931909|FG014|Overall Study|Adverse Event|3|||
33554873|NCT00281580|101931910|FG015|Overall Study|Adverse Event|3|||
33554874|NCT00281580|101931895|FG000|Overall Study|Protocol Violation|0|||
33554875|NCT00281580|101931896|FG001|Overall Study|Protocol Violation|0|||
33554876|NCT00281580|101931897|FG002|Overall Study|Protocol Violation|1|||
33554877|NCT00281580|101931898|FG003|Overall Study|Protocol Violation|1|||
33554878|NCT00281580|101931899|FG004|Overall Study|Protocol Violation|0|||
33554879|NCT00281580|101931900|FG005|Overall Study|Protocol Violation|0|||
33554880|NCT00281580|101931901|FG006|Overall Study|Protocol Violation|1|||
33554881|NCT00281580|101931902|FG007|Overall Study|Protocol Violation|0|||
33554882|NCT00281580|101931903|FG008|Overall Study|Protocol Violation|2|||
33554883|NCT00281580|101931904|FG009|Overall Study|Protocol Violation|0|||
33554884|NCT00281580|101931905|FG010|Overall Study|Protocol Violation|1|||
33554885|NCT00281580|101931906|FG011|Overall Study|Protocol Violation|2|||
33554886|NCT00281580|101931907|FG012|Overall Study|Protocol Violation|0|||
33554887|NCT00281580|101931908|FG013|Overall Study|Protocol Violation|1|||
33554888|NCT00281580|101931909|FG014|Overall Study|Protocol Violation|1|||
33554889|NCT00281580|101931910|FG015|Overall Study|Protocol Violation|3|||
33554890|NCT00281580|101931895|FG000|Overall Study|Withdrawal by Subject|3|||
33554891|NCT00281580|101931896|FG001|Overall Study|Withdrawal by Subject|0|||
33554892|NCT00281580|101931897|FG002|Overall Study|Withdrawal by Subject|1|||
33554893|NCT00281580|101931898|FG003|Overall Study|Withdrawal by Subject|1|||
33554894|NCT00281580|101931899|FG004|Overall Study|Withdrawal by Subject|1|||
33554895|NCT00281580|101931900|FG005|Overall Study|Withdrawal by Subject|2|||
33554896|NCT00281580|101931901|FG006|Overall Study|Withdrawal by Subject|2|||
33554897|NCT00281580|101931902|FG007|Overall Study|Withdrawal by Subject|0|||
33554898|NCT00281580|101931903|FG008|Overall Study|Withdrawal by Subject|1|||
33554899|NCT00281580|101931904|FG009|Overall Study|Withdrawal by Subject|4|||
33554900|NCT00281580|101931905|FG010|Overall Study|Withdrawal by Subject|1|||
33554901|NCT00281580|101931906|FG011|Overall Study|Withdrawal by Subject|1|||
33554902|NCT00281580|101931907|FG012|Overall Study|Withdrawal by Subject|2|||
33554903|NCT00281580|101931908|FG013|Overall Study|Withdrawal by Subject|2|||
33554904|NCT00281580|101931909|FG014|Overall Study|Withdrawal by Subject|1|||
33554905|NCT00281580|101931910|FG015|Overall Study|Withdrawal by Subject|5|||
33554906|NCT00281580|101931895|FG000|Overall Study|Lack of Efficacy|2|||
33554907|NCT00281580|101931896|FG001|Overall Study|Lack of Efficacy|1|||
33554908|NCT00281580|101931897|FG002|Overall Study|Lack of Efficacy|1|||
33554909|NCT00281580|101931898|FG003|Overall Study|Lack of Efficacy|6|||
33554910|NCT00281580|101931899|FG004|Overall Study|Lack of Efficacy|2|||
33554911|NCT00281580|101931900|FG005|Overall Study|Lack of Efficacy|0|||
33554912|NCT00281580|101931901|FG006|Overall Study|Lack of Efficacy|0|||
33554913|NCT00281580|101931902|FG007|Overall Study|Lack of Efficacy|0|||
33554914|NCT00281580|101931903|FG008|Overall Study|Lack of Efficacy|0|||
33355033|NCT01059448|101187795|FG002|Overall Study|Lost to Follow-up|2|||
33355034|NCT01059448|101187796|FG003|Overall Study|Lost to Follow-up|0|||
33554915|NCT00281580|101931904|FG009|Overall Study|Lack of Efficacy|0|||
33554916|NCT00281580|101931905|FG010|Overall Study|Lack of Efficacy|0|||
33554917|NCT00281580|101931906|FG011|Overall Study|Lack of Efficacy|1|||
33554918|NCT00281580|101931907|FG012|Overall Study|Lack of Efficacy|0|||
33554919|NCT00281580|101931908|FG013|Overall Study|Lack of Efficacy|2|||
33355035|NCT01059448|101187793|FG000|Overall Study|Death|0|||
33355036|NCT01059448|101187794|FG001|Overall Study|Death|1|||
33355037|NCT01059448|101187795|FG002|Overall Study|Death|0|||
33355038|NCT01059448|101187796|FG003|Overall Study|Death|0|||
33554920|NCT00281580|101931909|FG014|Overall Study|Lack of Efficacy|1|||
33554921|NCT00281580|101931910|FG015|Overall Study|Lack of Efficacy|0|||
33554922|NCT00281580|101931895|FG000|Overall Study|Lost to Follow-up|0|||
33554923|NCT00281580|101931896|FG001|Overall Study|Lost to Follow-up|0|||
33554924|NCT00281580|101931897|FG002|Overall Study|Lost to Follow-up|0|||
33554925|NCT00281580|101931898|FG003|Overall Study|Lost to Follow-up|3|||
33554926|NCT00281580|101931899|FG004|Overall Study|Lost to Follow-up|0|||
33355039|NCT01059448|101187793|FG000|Overall Study|Other|1|||
33554927|NCT00281580|101931900|FG005|Overall Study|Lost to Follow-up|1|||
33620505|NCT01125800|102161658|FG000|Phase I|Protocol Violation|0|||
33620506|NCT01125800|102161659|FG001|Phase I|Protocol Violation|3|||
33620507|NCT01125800|102161660|FG002|Phase I|Protocol Violation|1|||
33620508|NCT01125800|102161661|FG003|Phase I|Protocol Violation|1|||
33620509|NCT01125800|102161662|FG004|Phase I|Protocol Violation|0|||
33620510|NCT01125800|102161658|FG000|Phase I|Adverse Event|2|||
33620511|NCT01125800|102161659|FG001|Phase I|Adverse Event|2|||
33620512|NCT01125800|102161660|FG002|Phase I|Adverse Event|1|||
33620513|NCT01125800|102161661|FG003|Phase I|Adverse Event|7|||
33620514|NCT01125800|102161662|FG004|Phase I|Adverse Event|0|||
33620515|NCT01125800|102161658|FG000|Phase I|Administrative problems|1|||
33620516|NCT01125800|102161659|FG001|Phase I|Administrative problems|0|||
33355040|NCT01059448|101187794|FG001|Overall Study|Other|1|||
33355041|NCT01059448|101187795|FG002|Overall Study|Other|0|||
33355042|NCT01059448|101187796|FG003|Overall Study|Other|1|||
33355043|NCT03715465|101187797|FG000|Overall Study|Withdrawal by Subject|1|||
33355044|NCT03715465|101187798|FG001|Overall Study|Withdrawal by Subject|2|||
33355045|NCT03874234|101187799|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33355046|NCT03874234|101187800|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33355047|NCT03874234|101187801|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33355048|NCT03874234|101187802|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
33355049|NCT03874234|101187803|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33355050|NCT03874234|101187804|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33355051|NCT03874234|101187805|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33355052|NCT03874234|101187806|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33355053|NCT03874234|101187807|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33355054|NCT03874234|101187808|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33355055|NCT03874234|101187809|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33355056|NCT03874234|101187810|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33355057|NCT03874234|101187811|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
33355058|NCT03874234|101187799|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
33355059|NCT03874234|101187800|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33355060|NCT03874234|101187801|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33355061|NCT03874234|101187802|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33355062|NCT03874234|101187803|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33355063|NCT03874234|101187804|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33355064|NCT03874234|101187805|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33355065|NCT03874234|101187806|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33355066|NCT03874234|101187807|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33355067|NCT03874234|101187808|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33355068|NCT03874234|101187809|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33355069|NCT03874234|101187810|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33355070|NCT03874234|101187811|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
33355071|NCT03874234|101187799|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33355072|NCT03874234|101187800|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33355073|NCT03874234|101187801|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33355074|NCT03874234|101187802|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
33355075|NCT03874234|101187803|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33355076|NCT03874234|101187804|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33355077|NCT03874234|101187805|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33355078|NCT03874234|101187806|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33355079|NCT03874234|101187807|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33355080|NCT03874234|101187808|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33355081|NCT03874234|101187809|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33355082|NCT03874234|101187810|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33355083|NCT03874234|101187811|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
33355084|NCT03874234|101187799|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33355085|NCT03874234|101187800|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33355086|NCT03874234|101187801|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33355087|NCT03874234|101187802|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33355088|NCT03874234|101187803|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
33620517|NCT01125800|102161660|FG002|Phase I|Administrative problems|0|||
33620518|NCT01125800|102161661|FG003|Phase I|Administrative problems|0|||
33355089|NCT03874234|101187804|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33355090|NCT03874234|101187805|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33355091|NCT03874234|101187806|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33355092|NCT03874234|101187807|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33620519|NCT01125800|102161662|FG004|Phase I|Administrative problems|0|||
33554928|NCT00281580|101931901|FG006|Overall Study|Lost to Follow-up|0|||
33620520|NCT01125800|102161658|FG000|Phase I|Withdrawal by Subject|0|||
33620521|NCT01125800|102161659|FG001|Phase I|Withdrawal by Subject|0|||
33355093|NCT03874234|101187808|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33355094|NCT03874234|101187809|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33355095|NCT03874234|101187810|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33355096|NCT03874234|101187811|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
33355097|NCT03874234|101187799|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33355098|NCT03874234|101187800|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33355099|NCT03874234|101187801|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33355100|NCT03874234|101187802|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33355101|NCT03874234|101187803|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33355102|NCT03874234|101187804|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33355103|NCT03874234|101187805|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33355104|NCT03874234|101187806|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
33355105|NCT03874234|101187807|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33355106|NCT03874234|101187808|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33355107|NCT03874234|101187809|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33355108|NCT03874234|101187810|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33355109|NCT03874234|101187811|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
33355110|NCT03874234|101187799|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33355111|NCT03874234|101187800|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33355112|NCT03874234|101187801|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33355113|NCT03874234|101187802|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33355114|NCT03874234|101187803|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
33355115|NCT03874234|101187804|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
33355116|NCT03874234|101187805|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33355117|NCT03874234|101187806|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33355118|NCT03874234|101187807|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33355119|NCT03874234|101187808|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33355120|NCT03874234|101187809|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33355121|NCT03874234|101187810|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33355122|NCT03874234|101187811|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
33355123|NCT03874234|101187799|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33355124|NCT03874234|101187800|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33355125|NCT03874234|101187801|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33355126|NCT03874234|101187802|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33554929|NCT00281580|101931902|FG007|Overall Study|Lost to Follow-up|1|||
33554930|NCT00281580|101931903|FG008|Overall Study|Lost to Follow-up|2|||
33554931|NCT00281580|101931904|FG009|Overall Study|Lost to Follow-up|1|||
33554932|NCT00281580|101931905|FG010|Overall Study|Lost to Follow-up|1|||
33355127|NCT03874234|101187803|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33413697|NCT03107715|101403724|FG000|Overall Study|did not deliver at the home hospital|4|||
33413698|NCT03107715|101403725|FG001|Overall Study|did not deliver at the home hospital|6|||
33413699|NCT03107715|101403724|FG000|Overall Study|infant stillborn|0|||
33413700|NCT03107715|101403725|FG001|Overall Study|infant stillborn|1|||
33413701|NCT03209973|101403726|FG000|Overall Study|Withdrawal by Subject|7|||
33413702|NCT03209973|101403726|FG000|Overall Study|Lost to Follow-up|2|||
33413703|NCT03209973|101403726|FG000|Overall Study|Death|8|||
33413704|NCT03209973|101403726|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
33413705|NCT03209973|101403726|FG000|Overall Study|Sponsor Decision|18|||
33413706|NCT03209973|101403726|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
33413707|NCT03209973|101403726|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
33413708|NCT01789476|101403733|FG000|Overall Study|Lack of Efficacy|6|||
33413709|NCT01789476|101403734|FG001|Overall Study|Lack of Efficacy|2|||
33413710|NCT01789476|101403733|FG000|Overall Study|Adverse Event|1|||
33413711|NCT01789476|101403734|FG001|Overall Study|Adverse Event|0|||
33413712|NCT01789476|101403733|FG000|Overall Study|Unable to get IV access|1|||
33413713|NCT01789476|101403734|FG001|Overall Study|Unable to get IV access|0|||
33413714|NCT00924313|101403735|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
33413715|NCT00807040|101403736|FG000|Overall Study|Death|24|||
33413716|NCT00807040|101403737|FG001|Overall Study|Death|29|||
33413717|NCT00807040|101403736|FG000|Overall Study|Withdrawal by Subject|8|||
33413718|NCT00807040|101403737|FG001|Overall Study|Withdrawal by Subject|6|||
33413719|NCT00807040|101403736|FG000|Overall Study|Lost to Follow-up|4|||
33554933|NCT00281580|101931906|FG011|Overall Study|Lost to Follow-up|0|||
33554934|NCT00281580|101931907|FG012|Overall Study|Lost to Follow-up|1|||
33413720|NCT00807040|101403737|FG001|Overall Study|Lost to Follow-up|6|||
33413721|NCT00449761|101403741|FG000|Overall Study|Disease progression|12|||
33413722|NCT00449761|101403741|FG000|Overall Study|Death|5|||
33413723|NCT00449761|101403741|FG000|Overall Study|New cancer therapy|1|||
33413724|NCT00938392|101403742|FG000|Overall Study|Adverse Event|0|||
33554935|NCT00281580|101931908|FG013|Overall Study|Lost to Follow-up|0|||
33554936|NCT00281580|101931909|FG014|Overall Study|Lost to Follow-up|0|||
33554937|NCT00281580|101931910|FG015|Overall Study|Lost to Follow-up|0|||
33554938|NCT00281580|101931895|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
33554939|NCT00281580|101931896|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
33554940|NCT00281580|101931897|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
33554941|NCT00281580|101931898|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
33554942|NCT00281580|101931899|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
33554943|NCT00281580|101931900|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
33554944|NCT00281580|101931901|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
33554945|NCT00281580|101931902|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
33554946|NCT00281580|101931903|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
33554947|NCT00281580|101931904|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
33554948|NCT00281580|101931905|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
33554949|NCT00281580|101931906|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
33554950|NCT00281580|101931907|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
33554951|NCT00281580|101931908|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
33620522|NCT01125800|102161660|FG002|Phase I|Withdrawal by Subject|1|||
33620523|NCT01125800|102161661|FG003|Phase I|Withdrawal by Subject|0|||
33620524|NCT01125800|102161662|FG004|Phase I|Withdrawal by Subject|0|||
33620525|NCT01125800|102161658|FG000|Phase I|Disease progression|5|||
33620526|NCT01125800|102161659|FG001|Phase I|Disease progression|4|||
33620527|NCT01125800|102161660|FG002|Phase I|Disease progression|1|||
33620528|NCT01125800|102161661|FG003|Phase I|Disease progression|3|||
33620529|NCT01125800|102161662|FG004|Phase I|Disease progression|0|||
33554952|NCT00281580|101931909|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
33554953|NCT00281580|101931910|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
33554954|NCT05029362|101931912|FG000|Overall Study|Lost to Follow-up|9|||
33554955|NCT00756444|101931915|FG000|Overall Study|Adverse Event|1|||
33554956|NCT00756444|101931916|FG001|Overall Study|Adverse Event|1|||
33554957|NCT00756444|101931915|FG000|Overall Study|Withdrawal by Subject|6|||
33554958|NCT00756444|101931916|FG001|Overall Study|Withdrawal by Subject|8|||
33554959|NCT00756444|101931915|FG000|Overall Study|Lost to Follow-up|0|||
33620530|NCT01125800|102161658|FG000|Phase II|Protocol Violation|0|||
33620531|NCT01125800|102161659|FG001|Phase II|Protocol Violation|0|||
33620532|NCT01125800|102161660|FG002|Phase II|Protocol Violation|0|||
33355128|NCT03874234|101187804|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33355129|NCT03874234|101187805|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
33355130|NCT03874234|101187806|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33355131|NCT03874234|101187807|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33355132|NCT03874234|101187808|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33355133|NCT03874234|101187809|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33355134|NCT03874234|101187810|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33355135|NCT03874234|101187811|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
33620533|NCT01125800|102161661|FG003|Phase II|Protocol Violation|0|||
33620534|NCT01125800|102161662|FG004|Phase II|Protocol Violation|1|||
33620535|NCT01125800|102161658|FG000|Phase II|Adverse Event|0|||
33620536|NCT01125800|102161659|FG001|Phase II|Adverse Event|0|||
33355136|NCT03874234|101187799|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33355137|NCT03874234|101187800|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33355138|NCT03874234|101187801|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33355139|NCT03874234|101187802|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33355140|NCT03874234|101187803|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
33355141|NCT03874234|101187804|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33355142|NCT03874234|101187805|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33355143|NCT03874234|101187806|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33355144|NCT03874234|101187807|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33355145|NCT03874234|101187808|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33355146|NCT03874234|101187809|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33554960|NCT00756444|101931916|FG001|Overall Study|Lost to Follow-up|1|||
33554961|NCT00756444|101931915|FG000|Overall Study|Death|5|||
33554962|NCT00756444|101931916|FG001|Overall Study|Death|4|||
33554963|NCT00756444|101931915|FG000|Overall Study|Disease Progression|2|||
33554964|NCT00756444|101931916|FG001|Overall Study|Disease Progression|7|||
33554965|NCT00756444|101931915|FG000|Overall Study|Ineligibility Determined|1|||
33620537|NCT01125800|102161660|FG002|Phase II|Adverse Event|0|||
33620538|NCT01125800|102161661|FG003|Phase II|Adverse Event|0|||
33355147|NCT03874234|101187810|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33355148|NCT03874234|101187811|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
33355149|NCT00813995|101187816|FG000|Overall Study|Clinical adverse event|9|||
33413725|NCT00938392|101403743|FG001|Overall Study|Adverse Event|1|||
33620539|NCT01125800|102161662|FG004|Phase II|Adverse Event|2|||
33620540|NCT01125800|102161658|FG000|Phase II|Disease progression|0|||
33620541|NCT01125800|102161659|FG001|Phase II|Disease progression|0|||
33620542|NCT01125800|102161660|FG002|Phase II|Disease progression|0|||
33620543|NCT01125800|102161661|FG003|Phase II|Disease progression|1|||
33620544|NCT01125800|102161662|FG004|Phase II|Disease progression|8|||
33554966|NCT00756444|101931916|FG001|Overall Study|Ineligibility Determined|0|||
33355150|NCT00813995|101187817|FG001|Overall Study|Clinical adverse event|3|||
33355151|NCT00813995|101187816|FG000|Overall Study|Laboratory adverse event|0|||
33355152|NCT00813995|101187817|FG001|Overall Study|Laboratory adverse event|2|||
33355153|NCT00813995|101187816|FG000|Overall Study|Lack of Efficacy|1|||
33554967|NCT03315689|101931917|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
33554968|NCT03315689|101931918|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
33554969|NCT03315689|101931917|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
33554970|NCT03315689|101931918|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
33554971|NCT03315689|101931917|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
33554972|NCT03315689|101931918|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
33554973|NCT04865978|101931922|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
33554974|NCT04865978|101931923|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
33554975|NCT03364686|101931926|FG000|Overall Study|Physician Decision|2|||
33620545|NCT00786799|102161663|FG000|Overall Study|Lost to Follow-up|1|||
33620546|NCT00786799|102161664|FG001|Overall Study|Lost to Follow-up|1|||
33620547|NCT01080807|102161668|FG000|Overall Study|Adverse Event|9|||
33620548|NCT01080807|102161669|FG001|Overall Study|Adverse Event|1|||
33620549|NCT01080807|102161668|FG000|Overall Study|Lack of Efficacy|0|||
33620550|NCT01080807|102161669|FG001|Overall Study|Lack of Efficacy|1|||
33620551|NCT01080807|102161668|FG000|Overall Study|Withdrawal by Subject|7|||
33620552|NCT01080807|102161669|FG001|Overall Study|Withdrawal by Subject|2|||
33413726|NCT00938392|101403742|FG000|Overall Study|Withdrawal by Subject|0|||
33413727|NCT00938392|101403743|FG001|Overall Study|Withdrawal by Subject|1|||
33413728|NCT00938392|101403742|FG000|Overall Study|Lost to Follow-up|2|||
33355154|NCT00813995|101187817|FG001|Overall Study|Lack of Efficacy|0|||
33355155|NCT00813995|101187816|FG000|Overall Study|Lost to Follow-up|4|||
33355156|NCT00813995|101187817|FG001|Overall Study|Lost to Follow-up|2|||
33355157|NCT00813995|101187816|FG000|Overall Study|Other reason|2|||
33355158|NCT00813995|101187817|FG001|Overall Study|Other reason|2|||
33413729|NCT00938392|101403743|FG001|Overall Study|Lost to Follow-up|2|||
33554976|NCT01134614|101931927|FG000|Overall Study|Still on treatment as of March 2013|21|||
33413730|NCT03205046|101403747|FG000|Overall Study|Death|10|||
33413731|NCT03205046|101403748|FG001|Overall Study|Death|6|||
33413732|NCT03205046|101403747|FG000|Overall Study|Withdrawal by Subject|1|||
33413733|NCT03205046|101403748|FG001|Overall Study|Withdrawal by Subject|2|||
33413734|NCT03205046|101403747|FG000|Overall Study|Lost to Follow-up|0|||
33413735|NCT03205046|101403748|FG001|Overall Study|Lost to Follow-up|1|||
33413736|NCT03205046|101403747|FG000|Overall Study|Study terminated by sponsor|2|||
33413737|NCT03205046|101403748|FG001|Overall Study|Study terminated by sponsor|1|||
33413738|NCT02787746|101403749|FG000|Overall Study|Adverse Event|42|||
33413739|NCT02787746|101403749|FG000|Overall Study|Withdrawal by Subject|65|||
33413740|NCT02787746|101403749|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
33554977|NCT01134614|101931928|FG001|Overall Study|Still on treatment as of March 2013|13|||
33554978|NCT01134614|101931927|FG000|Overall Study|Progressive disease|60|||
33620553|NCT01080807|102161668|FG000|Overall Study|Protocol Violation|7|||
33620554|NCT01080807|102161669|FG001|Overall Study|Protocol Violation|6|||
33620555|NCT01080807|102161668|FG000|Overall Study|Lost to Follow-up|6|||
33620556|NCT01080807|102161669|FG001|Overall Study|Lost to Follow-up|4|||
33620557|NCT01080807|102161668|FG000|Overall Study|Noncompliance with drug administration|1|||
33620558|NCT01080807|102161669|FG001|Overall Study|Noncompliance with drug administration|1|||
33620559|NCT01080807|102161668|FG000|Overall Study|Noncompliance to study procedures|1|||
33620560|NCT01080807|102161669|FG001|Overall Study|Noncompliance to study procedures|1|||
33620561|NCT01080807|102161668|FG000|Overall Study|Began working day shift|0|||
33620562|NCT01080807|102161669|FG001|Overall Study|Began working day shift|2|||
33620563|NCT01080807|102161668|FG000|Overall Study|Laid off or terminated from job|1|||
33620564|NCT01080807|102161669|FG001|Overall Study|Laid off or terminated from job|2|||
33620565|NCT01080807|102161668|FG000|Overall Study|Stopped working consistent night shifts|0|||
33620566|NCT01080807|102161669|FG001|Overall Study|Stopped working consistent night shifts|1|||
33620567|NCT01080807|102161668|FG000|Overall Study|Work schedule changing|1|||
33620568|NCT01080807|102161669|FG001|Overall Study|Work schedule changing|1|||
33413741|NCT00209560|101403750|FG000|Overall Study|Lack of Efficacy|1|||
33554979|NCT01134614|101931928|FG001|Overall Study|Progressive disease|54|||
33554980|NCT01134614|101931927|FG000|Overall Study|Adverse Event|26|||
33554981|NCT01134614|101931928|FG001|Overall Study|Adverse Event|39|||
33620569|NCT01080807|102161668|FG000|Overall Study|Work schedule and travel|0|||
33620570|NCT01080807|102161669|FG001|Overall Study|Work schedule and travel|1|||
33413742|NCT00209560|101403751|FG001|Overall Study|Lack of Efficacy|0|||
33413743|NCT00684645|101403752|FG000|Overall Study|Death|2|||
33355159|NCT00813995|101187816|FG000|Overall Study|Protocol Violation|3|||
33355160|NCT00813995|101187817|FG001|Overall Study|Protocol Violation|2|||
33413744|NCT00684645|101403752|FG000|Overall Study|Progressive disease|67|||
33413745|NCT00684645|101403752|FG000|Overall Study|Adverse Event|27|||
33413746|NCT00684645|101403752|FG000|Overall Study|Lost to Follow-up|3|||
33413747|NCT00684645|101403752|FG000|Overall Study|Other|15|||
33413748|NCT00718809|101403755|FG000|Overall Study|Disease progression|9|||
33413749|NCT00718809|101403756|FG001|Overall Study|Disease progression|7|||
33413750|NCT00718809|101403755|FG000|Overall Study|Adverse Event|1|||
33413751|NCT00718809|101403756|FG001|Overall Study|Adverse Event|1|||
33413752|NCT00718809|101403755|FG000|Overall Study|Withdrawal by Subject|0|||
33413753|NCT00718809|101403756|FG001|Overall Study|Withdrawal by Subject|1|||
33413754|NCT00718809|101403755|FG000|Overall Study|Lost to Follow-up|1|||
33413755|NCT00718809|101403756|FG001|Overall Study|Lost to Follow-up|0|||
33413756|NCT00718809|101403755|FG000|Overall Study|Noncompliance|1|||
33413757|NCT00718809|101403756|FG001|Overall Study|Noncompliance|0|||
33413758|NCT01058707|101403757|FG000|Overall Study|Disease Progression|15|||
33413759|NCT01058707|101403758|FG001|Overall Study|Disease Progression|20|||
33413760|NCT01058707|101403759|FG002|Overall Study|Disease Progression|20|||
33413761|NCT01058707|101403760|FG003|Overall Study|Disease Progression|15|||
33413762|NCT01058707|101403761|FG004|Overall Study|Disease Progression|23|||
33413763|NCT01058707|101403762|FG005|Overall Study|Disease Progression|10|||
33413764|NCT01058707|101403763|FG006|Overall Study|Disease Progression|12|||
33413765|NCT01058707|101403757|FG000|Overall Study|Adverse Event|11|||
33413766|NCT01058707|101403758|FG001|Overall Study|Adverse Event|4|||
33413767|NCT01058707|101403759|FG002|Overall Study|Adverse Event|7|||
33413768|NCT01058707|101403760|FG003|Overall Study|Adverse Event|6|||
33413769|NCT01058707|101403761|FG004|Overall Study|Adverse Event|7|||
33413770|NCT01058707|101403762|FG005|Overall Study|Adverse Event|3|||
33413771|NCT01058707|101403763|FG006|Overall Study|Adverse Event|1|||
33413772|NCT01058707|101403757|FG000|Overall Study|Subject Decision|5|||
33413773|NCT01058707|101403758|FG001|Overall Study|Subject Decision|3|||
33620571|NCT01080807|102161668|FG000|Overall Study|Switched to first shift|1|||
33620572|NCT01080807|102161669|FG001|Overall Study|Switched to first shift|0|||
33620573|NCT01080807|102161668|FG000|Overall Study|Moved away without notifying center|1|||
33620574|NCT01080807|102161669|FG001|Overall Study|Moved away without notifying center|0|||
33355161|NCT00813995|101187816|FG000|Overall Study|Subject moved|4|||
33355162|NCT00813995|101187817|FG001|Overall Study|Subject moved|0|||
33355163|NCT00813995|101187816|FG000|Overall Study|Withdrawal by Subject|0|||
33355164|NCT00813995|101187817|FG001|Overall Study|Withdrawal by Subject|5|||
33355165|NCT05817045|101187821|FG000|Overall Study|Protocol Violation|0|||
33355166|NCT05817045|101187822|FG001|Overall Study|Protocol Violation|3|||
33355167|NCT05817045|101187821|FG000|Overall Study|Withdrawal by Subject|10|||
33355168|NCT05817045|101187822|FG001|Overall Study|Withdrawal by Subject|7|||
33355169|NCT05817045|101187821|FG000|Overall Study|Physician Decision|3|||
33355170|NCT05817045|101187822|FG001|Overall Study|Physician Decision|0|||
33355171|NCT05817045|101187821|FG000|Overall Study|Lost to Follow-up|0|||
33355172|NCT05817045|101187822|FG001|Overall Study|Lost to Follow-up|1|||
33355173|NCT05817045|101187821|FG000|Overall Study|Device Deficiency|1|||
33355174|NCT05817045|101187822|FG001|Overall Study|Device Deficiency|0|||
33355175|NCT05817045|101187821|FG000|Overall Study|System Error|1|||
33355176|NCT05817045|101187822|FG001|Overall Study|System Error|0|||
33413774|NCT01058707|101403759|FG002|Overall Study|Subject Decision|3|||
33413775|NCT01058707|101403760|FG003|Overall Study|Subject Decision|1|||
33413776|NCT01058707|101403761|FG004|Overall Study|Subject Decision|2|||
33413777|NCT01058707|101403762|FG005|Overall Study|Subject Decision|3|||
33413778|NCT01058707|101403763|FG006|Overall Study|Subject Decision|6|||
33413779|NCT01058707|101403757|FG000|Overall Study|Lost to Follow-up|0|||
33413780|NCT01058707|101403758|FG001|Overall Study|Lost to Follow-up|0|||
33413781|NCT01058707|101403759|FG002|Overall Study|Lost to Follow-up|1|||
33413782|NCT01058707|101403760|FG003|Overall Study|Lost to Follow-up|0|||
33554982|NCT01134614|101931927|FG000|Overall Study|Death|5|||
33554983|NCT01134614|101931928|FG001|Overall Study|Death|8|||
33554984|NCT01134614|101931927|FG000|Overall Study|Withdrawal by Subject|3|||
33554985|NCT01134614|101931928|FG001|Overall Study|Withdrawal by Subject|2|||
33554986|NCT01134614|101931927|FG000|Overall Study|Alternative therapy|2|||
33554987|NCT01134614|101931928|FG001|Overall Study|Alternative therapy|0|||
33554988|NCT01134614|101931927|FG000|Overall Study|Complicating disease|2|||
33554989|NCT01134614|101931928|FG001|Overall Study|Complicating disease|1|||
33554990|NCT01134614|101931927|FG000|Overall Study|Physician's decision|0|||
33554991|NCT01134614|101931928|FG001|Overall Study|Physician's decision|1|||
33554992|NCT01134614|101931927|FG000|Overall Study|Never started treatment|4|||
33554993|NCT01134614|101931928|FG001|Overall Study|Never started treatment|1|||
33554994|NCT01134614|101931927|FG000|Overall Study|Pt received tx not allowed on study|0|||
33554995|NCT01134614|101931928|FG001|Overall Study|Pt received tx not allowed on study|1|||
33554996|NCT01134614|101931927|FG000|Overall Study|Symptomatic deterioration|0|||
33554997|NCT01134614|101931928|FG001|Overall Study|Symptomatic deterioration|1|||
33554998|NCT01134614|101931927|FG000|Overall Study|Patient in hospice care|0|||
33554999|NCT01134614|101931928|FG001|Overall Study|Patient in hospice care|1|||
33555000|NCT00784927|101931932|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
33555001|NCT00784927|101931932|FG000|Overall Study|Protocol Violation|1|||
33555002|NCT00784927|101931932|FG000|Overall Study|Ineligible|1|||
33620575|NCT03400852|102161670|FG000|Blinded Treatment Period|Physician Decision|0|||
33620576|NCT03400852|102161671|FG001|Blinded Treatment Period|Physician Decision|1|||
33620577|NCT03400852|102161672|FG002|Blinded Treatment Period|Physician Decision|0|||
33620578|NCT03400852|102161670|FG000|Blinded Treatment Period|Adverse Event|1|||
33620579|NCT03400852|102161671|FG001|Blinded Treatment Period|Adverse Event|1|||
33620580|NCT03400852|102161672|FG002|Blinded Treatment Period|Adverse Event|0|||
33620581|NCT03400852|102161670|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
33620582|NCT03400852|102161671|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
33620583|NCT03400852|102161672|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
33620584|NCT03400852|102161670|FG000|Open Label Period|Physician Decision|0|||
33620585|NCT03400852|102161671|FG001|Open Label Period|Physician Decision|0|||
33620586|NCT03400852|102161672|FG002|Open Label Period|Physician Decision|1|||
33620587|NCT03400852|102161670|FG000|Open Label Period|Study terminated by sponsor|0|||
33620588|NCT03400852|102161671|FG001|Open Label Period|Study terminated by sponsor|0|||
33620589|NCT03400852|102161672|FG002|Open Label Period|Study terminated by sponsor|21|||
33620590|NCT02487095|102161673|FG000|Dose Expansion|Unable to scan/restage participant|0|||
33620591|NCT02487095|102161674|FG001|Dose Expansion|Unable to scan/restage participant|0|||
33620592|NCT02487095|102161675|FG002|Dose Expansion|Unable to scan/restage participant|0|||
33620593|NCT02487095|102161676|FG003|Dose Expansion|Unable to scan/restage participant|0|||
33620594|NCT02487095|102161677|FG004|Dose Expansion|Unable to scan/restage participant|1|||
33620595|NCT02274792|102161680|FG000|Overall Study|Withdrawal by Subject|13|||
33620596|NCT02274792|102161680|FG000|Overall Study|Lost to Follow-up|8|||
33620597|NCT02274792|102161680|FG000|Overall Study|Protocol Specified Criteria|2|||
33620598|NCT02274792|102161680|FG000|Overall Study|Sponsor Decision|2|||
33620599|NCT00181766|102161685|FG000|Overall Study|Lost to Follow-up|6|||
33620600|NCT00181766|102161685|FG000|Overall Study|Adverse Event|4|||
33620601|NCT00181766|102161685|FG000|Overall Study|non-compliance|2|||
33620602|NCT01076959|102161693|FG000|Overall Study|Adverse Event|767|||
33620603|NCT01076959|102161693|FG000|Overall Study|Lack of Efficacy|849|||
33620604|NCT01076959|102161693|FG000|Overall Study|Non-compliance|274|||
33620605|NCT01076959|102161693|FG000|Overall Study|Lost to Follow-up|241|||
33620606|NCT01076959|102161693|FG000|Overall Study|Other|119|||
33620607|NCT03956550|102161694|FG000|Overall Study|Sponsor decision|65|||
33620608|NCT03956550|102161695|FG001|Overall Study|Sponsor decision|66|||
33620609|NCT03956550|102161696|FG002|Overall Study|Sponsor decision|64|||
33620610|NCT03956550|102161694|FG000|Overall Study|Adverse Event|0|||
33620611|NCT03956550|102161695|FG001|Overall Study|Adverse Event|1|||
33620612|NCT03956550|102161696|FG002|Overall Study|Adverse Event|0|||
33620613|NCT03956550|102161694|FG000|Overall Study|Withdrawal by Subject|5|||
33620614|NCT03956550|102161695|FG001|Overall Study|Withdrawal by Subject|5|||
33620615|NCT03956550|102161696|FG002|Overall Study|Withdrawal by Subject|6|||
33620616|NCT03359174|102161697|FG000|Overall Study|Adverse Event|1|||
33620617|NCT00604565|102161698|FG000|Overall Study|Study terminated|0|||
33620618|NCT00604565|102161699|FG001|Overall Study|Study terminated|3|||
33620619|NCT00806988|102161700|FG000|Overall Study|Death|15|||
33620620|NCT00806988|102161701|FG001|Overall Study|Death|16|||
33620621|NCT00806988|102161700|FG000|Overall Study|Withdrawal by Subject|8|||
33620622|NCT00806988|102161701|FG001|Overall Study|Withdrawal by Subject|8|||
33620623|NCT00806988|102161700|FG000|Overall Study|Lost to Follow-up|4|||
33620624|NCT00806988|102161701|FG001|Overall Study|Lost to Follow-up|19|||
33620625|NCT01479868|102161705|FG000|Overall Study|Adverse Event|1|||
33620626|NCT01479868|102161705|FG000|Overall Study|Lost to Follow-up|4|||
33620627|NCT01479868|102161705|FG000|Overall Study|Protocol Violation|1|||
33620628|NCT01479868|102161705|FG000|Overall Study|Withdrawal by Subject|1|||
33620629|NCT01479868|102161705|FG000|Overall Study|Sponsor's Decision|1|||
33620630|NCT01479868|102161705|FG000|Overall Study|Initiation of new HCV Therapy|1|||
33620631|NCT04390243|102161706|FG000|Overall Study|Death|1|||
33620632|NCT04390243|102161706|FG000|Overall Study|Disease Progression|4|||
33620633|NCT04390243|102161706|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
33620634|NCT00483405|102161708|FG000|Overall Study|Adverse Event|8|||
33620635|NCT00483405|102161708|FG000|Overall Study|Lack of Efficacy|14|||
33620636|NCT00483405|102161708|FG000|Overall Study|Death|3|||
33620637|NCT00483405|102161708|FG000|Overall Study|Withdrawal by Subject|2|||
33620638|NCT00483405|102161708|FG000|Overall Study|Other complicating disease|1|||
33620639|NCT02222558|102161709|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
33620640|NCT02222558|102161710|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
33355177|NCT00635102|101187823|FG000|Overall Study|Withdrawal by Subject|7|||
33620641|NCT02222558|102161711|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
33620642|NCT02222558|102161712|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
33620643|NCT02222558|102161713|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
33620644|NCT02222558|102161714|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
33355178|NCT00635102|101187824|FG001|Overall Study|Withdrawal by Subject|8|||
33355179|NCT00442598|101187826|FG000|Overall Study|Adverse Event|1|||
33620645|NCT02222558|102161709|FG000|Period 3|Withdrawal by Subject|0|||
33620646|NCT02222558|102161710|FG001|Period 3|Withdrawal by Subject|0|||
33620647|NCT02222558|102161711|FG002|Period 3|Withdrawal by Subject|0|||
33620648|NCT02222558|102161712|FG003|Period 3|Withdrawal by Subject|0|||
33620649|NCT02222558|102161713|FG004|Period 3|Withdrawal by Subject|0|||
33620650|NCT02222558|102161714|FG005|Period 3|Withdrawal by Subject|1|||
33620651|NCT00936702|102161716|FG000|Overall Study|Disease progression|34|||
33620652|NCT00936702|102161716|FG000|Overall Study|Adverse Event|8|||
33620653|NCT00936702|102161716|FG000|Overall Study|Withdrawal by Subject|2|||
33620654|NCT00936702|102161716|FG000|Overall Study|Alternative Treatment|1|||
33620655|NCT00936702|102161716|FG000|Overall Study|Other|1|||
33620656|NCT02640547|102161717|FG000|Overall Study|Failure to Return|1|||
33620657|NCT02640547|102161717|FG000|Overall Study|Withdrawal by Subject|1|||
33620658|NCT02640547|102161717|FG000|Overall Study|Death|6|||
33620659|NCT02640547|102161717|FG000|Overall Study|Miscellaneous|3|||
33620660|NCT00466440|102161718|FG000|Overall Study|Adverse Event|0|||
33620661|NCT00466440|102161719|FG001|Overall Study|Adverse Event|3|||
33620662|NCT00466440|102161720|FG002|Overall Study|Adverse Event|1|||
33620663|NCT00466440|102161718|FG000|Overall Study|Death|1|||
33620664|NCT00466440|102161719|FG001|Overall Study|Death|1|||
33620665|NCT00466440|102161720|FG002|Overall Study|Death|0|||
33620666|NCT00466440|102161718|FG000|Overall Study|Progressive disease|13|||
33620667|NCT00466440|102161719|FG001|Overall Study|Progressive disease|5|||
33620668|NCT00466440|102161720|FG002|Overall Study|Progressive disease|4|||
33620669|NCT00466440|102161718|FG000|Overall Study|Lost to Follow-up|0|||
33620670|NCT00466440|102161719|FG001|Overall Study|Lost to Follow-up|1|||
33620671|NCT00466440|102161720|FG002|Overall Study|Lost to Follow-up|0|||
33620672|NCT00466440|102161718|FG000|Overall Study|Physician Decision|0|||
33620673|NCT00466440|102161719|FG001|Overall Study|Physician Decision|1|||
33620674|NCT00466440|102161720|FG002|Overall Study|Physician Decision|2|||
33620675|NCT00466440|102161718|FG000|Overall Study|Protocol entry criteria not met|0|||
33620676|NCT00466440|102161719|FG001|Overall Study|Protocol entry criteria not met|0|||
33620677|NCT00466440|102161720|FG002|Overall Study|Protocol entry criteria not met|4|||
33620678|NCT00466440|102161718|FG000|Overall Study|Withdrawal by Subject|0|||
33620679|NCT00466440|102161719|FG001|Overall Study|Withdrawal by Subject|1|||
33620680|NCT00466440|102161720|FG002|Overall Study|Withdrawal by Subject|0|||
33620681|NCT00466440|102161718|FG000|Overall Study|Sponsor decision|0|||
33620682|NCT00466440|102161719|FG001|Overall Study|Sponsor decision|0|||
33620683|NCT00466440|102161720|FG002|Overall Study|Sponsor decision|1|||
33620684|NCT00496080|102161725|FG000|Overall Study|Lost to Follow-up|9|||
33620685|NCT00496080|102161725|FG000|Overall Study|Surgical re-intervention|7|||
33620686|NCT00496080|102161725|FG000|Overall Study|Withdrawal by Subject|5|||
33620687|NCT00496080|102161725|FG000|Overall Study|Physician Decision|6|||
33620688|NCT02544503|102161732|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
33620689|NCT02544503|102161733|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
33620690|NCT02544503|102161732|FG000|Overall Study|Lost to Follow-up|9|||
33620691|NCT02544503|102161733|FG001|Overall Study|Lost to Follow-up|0|||
33620692|NCT02544503|102161732|FG000|Overall Study|Withdrawal by Subject|1|||
33620693|NCT02544503|102161733|FG001|Overall Study|Withdrawal by Subject|0|||
33620694|NCT02587520|102161737|FG000|Overall Study|Protocol Violation|2|||
33620695|NCT02587520|102161738|FG001|Overall Study|Protocol Violation|0|||
33620696|NCT02587520|102161739|FG002|Overall Study|Protocol Violation|0|||
33620697|NCT02587520|102161740|FG003|Overall Study|Protocol Violation|2|||
33620698|NCT02587520|102161741|FG004|Overall Study|Protocol Violation|0|||
33620699|NCT02587520|102161742|FG005|Overall Study|Protocol Violation|1|||
33620700|NCT02587520|102161743|FG006|Overall Study|Protocol Violation|1|||
33620701|NCT02587520|102161744|FG007|Overall Study|Protocol Violation|1|||
33620702|NCT02587520|102161745|FG008|Overall Study|Protocol Violation|3|||
33620703|NCT02587520|102161746|FG009|Overall Study|Protocol Violation|3|||
33620704|NCT02587520|102161747|FG010|Overall Study|Protocol Violation|1|||
33620705|NCT02587520|102161748|FG011|Overall Study|Protocol Violation|2|||
33355180|NCT00442598|101187827|FG001|Overall Study|Adverse Event|0|||
33620706|NCT02587520|102161749|FG012|Overall Study|Protocol Violation|0|||
33620707|NCT02587520|102161750|FG013|Overall Study|Protocol Violation|0|||
33620708|NCT02587520|102161751|FG014|Overall Study|Protocol Violation|0|||
33620709|NCT02587520|102161752|FG015|Overall Study|Protocol Violation|0|||
33620710|NCT02587520|102161753|FG016|Overall Study|Protocol Violation|0|||
33620711|NCT02587520|102161754|FG017|Overall Study|Protocol Violation|0|||
33620712|NCT02587520|102161737|FG000|Overall Study|Adverse Event|0|||
33620713|NCT02587520|102161738|FG001|Overall Study|Adverse Event|0|||
33620714|NCT02587520|102161739|FG002|Overall Study|Adverse Event|0|||
33620715|NCT02587520|102161740|FG003|Overall Study|Adverse Event|0|||
33620716|NCT02587520|102161741|FG004|Overall Study|Adverse Event|0|||
33620717|NCT02587520|102161742|FG005|Overall Study|Adverse Event|0|||
33620718|NCT02587520|102161743|FG006|Overall Study|Adverse Event|0|||
33620719|NCT02587520|102161744|FG007|Overall Study|Adverse Event|0|||
33620720|NCT02587520|102161745|FG008|Overall Study|Adverse Event|0|||
33413783|NCT01058707|101403761|FG004|Overall Study|Lost to Follow-up|0|||
33620721|NCT02587520|102161746|FG009|Overall Study|Adverse Event|0|||
33620722|NCT02587520|102161747|FG010|Overall Study|Adverse Event|0|||
33620723|NCT02587520|102161748|FG011|Overall Study|Adverse Event|1|||
33620724|NCT02587520|102161749|FG012|Overall Study|Adverse Event|0|||
33620725|NCT02587520|102161750|FG013|Overall Study|Adverse Event|0|||
33620726|NCT02587520|102161751|FG014|Overall Study|Adverse Event|0|||
33620727|NCT02587520|102161752|FG015|Overall Study|Adverse Event|0|||
33620728|NCT02587520|102161753|FG016|Overall Study|Adverse Event|0|||
33620729|NCT02587520|102161754|FG017|Overall Study|Adverse Event|0|||
33355181|NCT00442598|101187828|FG002|Overall Study|Adverse Event|0|||
33355182|NCT00442598|101187826|FG000|Overall Study|Tumor progression|3|||
33355183|NCT00442598|101187827|FG001|Overall Study|Tumor progression|4|||
33620730|NCT02587520|102161737|FG000|Overall Study|Withdrawal by Subject|0|||
33620731|NCT02587520|102161738|FG001|Overall Study|Withdrawal by Subject|0|||
33620732|NCT02587520|102161739|FG002|Overall Study|Withdrawal by Subject|1|||
33620733|NCT02587520|102161740|FG003|Overall Study|Withdrawal by Subject|1|||
33620734|NCT02587520|102161741|FG004|Overall Study|Withdrawal by Subject|0|||
33620735|NCT02587520|102161742|FG005|Overall Study|Withdrawal by Subject|1|||
33620736|NCT02587520|102161743|FG006|Overall Study|Withdrawal by Subject|1|||
33620737|NCT02587520|102161744|FG007|Overall Study|Withdrawal by Subject|0|||
33620738|NCT02587520|102161745|FG008|Overall Study|Withdrawal by Subject|0|||
33620739|NCT02587520|102161746|FG009|Overall Study|Withdrawal by Subject|0|||
33620740|NCT02587520|102161747|FG010|Overall Study|Withdrawal by Subject|0|||
33620741|NCT02587520|102161748|FG011|Overall Study|Withdrawal by Subject|0|||
33620742|NCT02587520|102161749|FG012|Overall Study|Withdrawal by Subject|0|||
33620743|NCT02587520|102161750|FG013|Overall Study|Withdrawal by Subject|1|||
33620744|NCT02587520|102161751|FG014|Overall Study|Withdrawal by Subject|0|||
33620745|NCT02587520|102161752|FG015|Overall Study|Withdrawal by Subject|0|||
33620746|NCT02587520|102161753|FG016|Overall Study|Withdrawal by Subject|0|||
33620747|NCT02587520|102161754|FG017|Overall Study|Withdrawal by Subject|0|||
33620748|NCT02587520|102161737|FG000|Overall Study|Lost to Follow-up|0|||
33620749|NCT02587520|102161738|FG001|Overall Study|Lost to Follow-up|2|||
33620750|NCT02587520|102161739|FG002|Overall Study|Lost to Follow-up|0|||
33620751|NCT02587520|102161740|FG003|Overall Study|Lost to Follow-up|2|||
33620752|NCT02587520|102161741|FG004|Overall Study|Lost to Follow-up|0|||
33620753|NCT02587520|102161742|FG005|Overall Study|Lost to Follow-up|1|||
33620754|NCT02587520|102161743|FG006|Overall Study|Lost to Follow-up|1|||
33620755|NCT02587520|102161744|FG007|Overall Study|Lost to Follow-up|1|||
33620756|NCT02587520|102161745|FG008|Overall Study|Lost to Follow-up|0|||
33620757|NCT02587520|102161746|FG009|Overall Study|Lost to Follow-up|2|||
33620758|NCT02587520|102161747|FG010|Overall Study|Lost to Follow-up|2|||
33620759|NCT02587520|102161748|FG011|Overall Study|Lost to Follow-up|1|||
33620760|NCT02587520|102161749|FG012|Overall Study|Lost to Follow-up|0|||
33620761|NCT02587520|102161750|FG013|Overall Study|Lost to Follow-up|0|||
33620762|NCT02587520|102161751|FG014|Overall Study|Lost to Follow-up|0|||
33620763|NCT02587520|102161752|FG015|Overall Study|Lost to Follow-up|0|||
33620764|NCT02587520|102161753|FG016|Overall Study|Lost to Follow-up|0|||
33620765|NCT02587520|102161754|FG017|Overall Study|Lost to Follow-up|0|||
33620766|NCT03038126|102161755|FG000|Overall Study|Death|1|||
33620767|NCT03038126|102161756|FG001|Overall Study|Death|1|||
33620768|NCT03038126|102161755|FG000|Overall Study|Withdrawal by Subject|5|||
33620769|NCT03038126|102161756|FG001|Overall Study|Withdrawal by Subject|0|||
33620770|NCT03038126|102161755|FG000|Overall Study|Lost to Follow-up|0|||
33620771|NCT03038126|102161756|FG001|Overall Study|Lost to Follow-up|1|||
33620772|NCT03038126|102161755|FG000|Overall Study|Long Term Hospitalization|2|||
33620773|NCT03038126|102161756|FG001|Overall Study|Long Term Hospitalization|0|||
33620774|NCT03038126|102161755|FG000|Overall Study|Too Ill to Participate|1|||
33620775|NCT03038126|102161756|FG001|Overall Study|Too Ill to Participate|2|||
33620776|NCT03384940|102161757|FG000|Overall Study|Progressive disease|36|||
33620777|NCT03384940|102161758|FG001|Overall Study|Progressive disease|11|||
33620778|NCT03384940|102161759|FG002|Overall Study|Progressive disease|13|||
33620779|NCT03384940|102161757|FG000|Overall Study|Clinical progression|4|||
33620780|NCT03384940|102161758|FG001|Overall Study|Clinical progression|0|||
33620781|NCT03384940|102161759|FG002|Overall Study|Clinical progression|3|||
33355184|NCT00442598|101187828|FG002|Overall Study|Tumor progression|0|||
33620782|NCT03384940|102161757|FG000|Overall Study|Adverse Event|7|||
33620783|NCT03384940|102161758|FG001|Overall Study|Adverse Event|1|||
33620784|NCT03384940|102161759|FG002|Overall Study|Adverse Event|1|||
33620785|NCT03384940|102161757|FG000|Overall Study|Withdrawal by Subject|3|||
33620786|NCT03384940|102161758|FG001|Overall Study|Withdrawal by Subject|1|||
33620787|NCT03384940|102161759|FG002|Overall Study|Withdrawal by Subject|0|||
33620788|NCT03384940|102161757|FG000|Overall Study|Physician Decision|1|||
33620789|NCT03384940|102161758|FG001|Overall Study|Physician Decision|1|||
33620790|NCT03384940|102161759|FG002|Overall Study|Physician Decision|0|||
33620791|NCT03384940|102161757|FG000|Overall Study|Death|2|||
33620792|NCT03384940|102161758|FG001|Overall Study|Death|1|||
33620793|NCT03384940|102161759|FG002|Overall Study|Death|0|||
33620794|NCT03384940|102161757|FG000|Overall Study|Other|0|||
33355185|NCT00442598|101187826|FG000|Overall Study|Clinical deterioration|1|||
33620795|NCT03384940|102161758|FG001|Overall Study|Other|0|||
33620796|NCT03384940|102161759|FG002|Overall Study|Other|1|||
33620797|NCT00671034|102161761|FG000|Overall Study|Adverse Event|5|||
33620798|NCT00671034|102161762|FG001|Overall Study|Adverse Event|7|||
33555003|NCT00617903|101931934|FG000|Overall Study|Withdrawal by Subject|2|||
33555004|NCT00617903|101931935|FG001|Overall Study|Withdrawal by Subject|3|||
33555005|NCT00617903|101931934|FG000|Overall Study|Lost to Follow-up|1|||
33555006|NCT00617903|101931935|FG001|Overall Study|Lost to Follow-up|1|||
33555007|NCT00617903|101931934|FG000|Overall Study|Lack of Efficacy|0|||
33555008|NCT00617903|101931935|FG001|Overall Study|Lack of Efficacy|1|||
33555009|NCT00617903|101931934|FG000|Overall Study|Adverse Event|0|||
33555010|NCT00617903|101931935|FG001|Overall Study|Adverse Event|1|||
33555011|NCT00617903|101931934|FG000|Overall Study|noncompliance|0|||
33555012|NCT00617903|101931935|FG001|Overall Study|noncompliance|1|||
33555013|NCT00756314|101931938|FG000|Overall Study|Lost to Follow-up|2|||
33555014|NCT00756314|101931939|FG001|Overall Study|Lost to Follow-up|59|||
33555015|NCT01862029|101931940|FG000|Overall Study|Physician Decision|1|||
33555016|NCT02975700|101931942|FG000|Overall Study|Adverse Event|1|||
33555017|NCT02975700|101931942|FG000|Overall Study|Progressive disease|3|||
33555018|NCT02975700|101931942|FG000|Overall Study|Failed screening criteria|2|||
33555019|NCT00263562|101931943|FG000|Overall Study|Protocol Violation|3|||
33555020|NCT00263562|101931944|FG001|Overall Study|Protocol Violation|0|||
33555021|NCT02255279|101931945|FG000|Overall Study|Lost to Follow-up|2|||
33555022|NCT02255279|101931946|FG001|Overall Study|Lost to Follow-up|2|||
33555023|NCT02255279|101931945|FG000|Overall Study|Protocol Violation|0|||
33555024|NCT02255279|101931946|FG001|Overall Study|Protocol Violation|1|||
33555025|NCT02255279|101931945|FG000|Overall Study|Withdrawal by Subject|3|||
33555026|NCT02255279|101931946|FG001|Overall Study|Withdrawal by Subject|6|||
33555027|NCT03437733|101931947|FG000|Overall Study|Eligibility criteria not met|0|||
33555028|NCT03437733|101931948|FG001|Overall Study|Eligibility criteria not met|3|||
33555029|NCT02369159|101931949|FG000|Overall Study|Adverse Event|0|||
33555030|NCT02369159|101931950|FG001|Overall Study|Adverse Event|1|||
33555031|NCT02369159|101931949|FG000|Overall Study|Lost to Follow-up|1|||
33555032|NCT02369159|101931950|FG001|Overall Study|Lost to Follow-up|1|||
33555033|NCT02369159|101931949|FG000|Overall Study|Withdrawal by Subject|7|||
33555034|NCT02369159|101931950|FG001|Overall Study|Withdrawal by Subject|0|||
33555035|NCT00195429|101931951|FG000|Overall Study|Adverse Event|2|||
33555036|NCT00195429|101931952|FG001|Overall Study|Adverse Event|4|||
33555037|NCT00195429|101931951|FG000|Overall Study|Lack of Efficacy|2|||
33555038|NCT00195429|101931952|FG001|Overall Study|Lack of Efficacy|1|||
33555039|NCT00195429|101931951|FG000|Overall Study|Lost to Follow-up|1|||
33555040|NCT00195429|101931952|FG001|Overall Study|Lost to Follow-up|0|||
33555041|NCT05059080|101931953|FG000|Overall Study|Withdrawal by Subject|3|||
33555042|NCT05059080|101931953|FG000|Overall Study|Study Terminated by Sponsor|64|||
33555043|NCT01348490|101931956|FG000|Overall Study|Death|1|||
33555044|NCT01348490|101931956|FG000|Overall Study|Adverse Event|3|||
33555045|NCT01348490|101931956|FG000|Overall Study|Consent withdrawn|7|||
33555046|NCT01348490|101931956|FG000|Overall Study|Disease progression|3|||
33555047|NCT01348490|101931956|FG000|Overall Study|Lost to Follow-up|1|||
33555048|NCT01348490|101931956|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
33555049|NCT01348490|101931956|FG000|Overall Study|Other Unspecified|8|||
33555050|NCT01803737|101931960|FG000|Overall Study|Lack of Time|1|||
33555051|NCT01803737|101931961|FG001|Overall Study|Lack of Time|0|||
33620799|NCT00671034|102161763|FG002|Overall Study|Adverse Event|1|||
33620800|NCT00671034|102161761|FG000|Overall Study|Death|3|||
33620801|NCT00671034|102161762|FG001|Overall Study|Death|2|||
33620802|NCT00671034|102161763|FG002|Overall Study|Death|1|||
33620803|NCT00671034|102161761|FG000|Overall Study|Physician Decision|12|||
33620804|NCT00671034|102161762|FG001|Overall Study|Physician Decision|4|||
33620805|NCT00671034|102161763|FG002|Overall Study|Physician Decision|5|||
33355186|NCT00442598|101187827|FG001|Overall Study|Clinical deterioration|2|||
33355187|NCT00442598|101187828|FG002|Overall Study|Clinical deterioration|0|||
33355188|NCT00442598|101187826|FG000|Overall Study|CA125 progression|0|||
33355189|NCT00442598|101187827|FG001|Overall Study|CA125 progression|1|||
33413784|NCT01058707|101403762|FG005|Overall Study|Lost to Follow-up|0|||
33355190|NCT00442598|101187828|FG002|Overall Study|CA125 progression|0|||
33355191|NCT00442598|101187826|FG000|Overall Study|Reduced creatinine clearance|1|||
33355192|NCT00442598|101187827|FG001|Overall Study|Reduced creatinine clearance|0|||
33355193|NCT00442598|101187828|FG002|Overall Study|Reduced creatinine clearance|0|||
33355194|NCT00442598|101187826|FG000|Overall Study|Death|0|||
33355195|NCT00442598|101187827|FG001|Overall Study|Death|1|||
33355196|NCT00442598|101187828|FG002|Overall Study|Death|0|||
33355197|NCT03596164|101187829|FG000|Overall Study|Adverse Event|0|||
33355198|NCT03596164|101187830|FG001|Overall Study|Adverse Event|1|||
33355199|NCT03596164|101187829|FG000|Overall Study|Death|1|||
33355200|NCT03596164|101187830|FG001|Overall Study|Death|0|||
33355201|NCT02318602|101187831|FG000|Overall Study|Adverse Event|0|||
33355202|NCT02318602|101187832|FG001|Overall Study|Adverse Event|1|||
33355203|NCT02318602|101187833|FG002|Overall Study|Adverse Event|1|||
33355204|NCT02318602|101187831|FG000|Overall Study|Withdrawal by Subject|0|||
33355205|NCT02318602|101187832|FG001|Overall Study|Withdrawal by Subject|3|||
33355206|NCT02318602|101187833|FG002|Overall Study|Withdrawal by Subject|0|||
33355207|NCT02318602|101187831|FG000|Overall Study|Death|1|||
33355208|NCT02318602|101187832|FG001|Overall Study|Death|0|||
33355209|NCT02318602|101187833|FG002|Overall Study|Death|0|||
33620806|NCT00671034|102161761|FG000|Overall Study|VHR ALL feature|8|||
33620807|NCT00671034|102161762|FG001|Overall Study|VHR ALL feature|3|||
33620808|NCT00671034|102161763|FG002|Overall Study|VHR ALL feature|5|||
33620809|NCT00671034|102161761|FG000|Overall Study|Refusal|5|||
33620810|NCT00671034|102161762|FG001|Overall Study|Refusal|3|||
33620811|NCT00671034|102161763|FG002|Overall Study|Refusal|5|||
33620812|NCT00671034|102161761|FG000|Overall Study|includes Alternative therapy, etc.|6|||
33620813|NCT00671034|102161762|FG001|Overall Study|includes Alternative therapy, etc.|1|||
33620814|NCT00671034|102161763|FG002|Overall Study|includes Alternative therapy, etc.|7|||
33620815|NCT00300755|102161766|FG000|Overall Study|Adverse Event|1|||
33620816|NCT00300755|102161767|FG001|Overall Study|Adverse Event|2|||
33620817|NCT00300755|102161768|FG002|Overall Study|Adverse Event|1|||
33620818|NCT00300755|102161766|FG000|Overall Study|Withdrawal by Subject|0|||
33620819|NCT00300755|102161767|FG001|Overall Study|Withdrawal by Subject|2|||
33620820|NCT00300755|102161768|FG002|Overall Study|Withdrawal by Subject|0|||
33355210|NCT02318602|101187831|FG000|Overall Study|Guardian decision to withdraw|0|||
33355211|NCT02318602|101187832|FG001|Overall Study|Guardian decision to withdraw|0|||
33355212|NCT02318602|101187833|FG002|Overall Study|Guardian decision to withdraw|1|||
33355213|NCT00813748|101187834|FG000|Skin Test Substudy|Physician Decision|0|||
33355214|NCT00813748|101187835|FG001|Skin Test Substudy|Physician Decision|1|||
33355215|NCT00817414|101187836|FG000|Overall Study|Adverse Event|1|||
33355216|NCT00817414|101187837|FG001|Overall Study|Adverse Event|1|||
33355217|NCT00817414|101187838|FG002|Overall Study|Adverse Event|1|||
33355218|NCT00817414|101187839|FG003|Overall Study|Adverse Event|0|||
33355219|NCT00817414|101187840|FG004|Overall Study|Adverse Event|0|||
33355220|NCT00817414|101187836|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
33620821|NCT00300755|102161766|FG000|Overall Study|Protocol Violation|0|||
33620822|NCT00300755|102161767|FG001|Overall Study|Protocol Violation|0|||
33620823|NCT00300755|102161768|FG002|Overall Study|Protocol Violation|1|||
33620824|NCT02562716|102161769|FG000|Overall Study|Adverse Event|7|||
33620825|NCT02562716|102161770|FG001|Overall Study|Adverse Event|14|||
33620826|NCT02562716|102161769|FG000|Overall Study|Withdrawal unrelated to AE|7|||
33620827|NCT02562716|102161770|FG001|Overall Study|Withdrawal unrelated to AE|1|||
33620828|NCT02562716|102161769|FG000|Overall Study|Progression|8|||
33620829|NCT02562716|102161770|FG001|Overall Study|Progression|10|||
33355221|NCT00817414|101187837|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
33413785|NCT01058707|101403763|FG006|Overall Study|Lost to Follow-up|0|||
33620830|NCT02562716|102161769|FG000|Overall Study|Death|2|||
33620831|NCT02562716|102161770|FG001|Overall Study|Death|1|||
33620832|NCT02562716|102161769|FG000|Overall Study|Not protocol specified|4|||
33620833|NCT02562716|102161770|FG001|Overall Study|Not protocol specified|2|||
33355222|NCT00817414|101187838|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
33355223|NCT00817414|101187839|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
33620834|NCT02420379|102161775|FG000|Overall Study|Withdrawal by Subject|0|||
33620835|NCT02420379|102161776|FG001|Overall Study|Withdrawal by Subject|3|||
33620836|NCT02420379|102161775|FG000|Overall Study|Unable to complete due to schooling|0|||
33620837|NCT02420379|102161776|FG001|Overall Study|Unable to complete due to schooling|1|||
33620838|NCT02420379|102161775|FG000|Overall Study|Transitioned to commercial drug|1|||
33620839|NCT02420379|102161776|FG001|Overall Study|Transitioned to commercial drug|0|||
33620840|NCT03109184|102161777|FG000|Overall Study|Lost to Follow-up|6|||
33620841|NCT03109184|102161778|FG001|Overall Study|Lost to Follow-up|6|||
33620842|NCT03109184|102161777|FG000|Overall Study|Withdrawal by Subject|1|||
33620843|NCT03109184|102161778|FG001|Overall Study|Withdrawal by Subject|1|||
33620844|NCT01910402|102161782|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
33620845|NCT01910402|102161783|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
33620846|NCT01910402|102161784|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
33620847|NCT01910402|102161782|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
33620848|NCT01910402|102161783|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
33620849|NCT01910402|102161784|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
33620850|NCT01910402|102161782|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
33620851|NCT01910402|102161783|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
33620852|NCT01910402|102161784|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
33355224|NCT00817414|101187840|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
33355225|NCT00817414|101187836|FG000|Overall Study|Withdrawal by Subject|1|||
33355226|NCT00817414|101187837|FG001|Overall Study|Withdrawal by Subject|1|||
33355227|NCT00817414|101187838|FG002|Overall Study|Withdrawal by Subject|0|||
33355228|NCT00817414|101187839|FG003|Overall Study|Withdrawal by Subject|0|||
33355229|NCT00817414|101187840|FG004|Overall Study|Withdrawal by Subject|0|||
33355230|NCT00817414|101187836|FG000|Overall Study|Lost to Follow-up|0|||
33355231|NCT00817414|101187837|FG001|Overall Study|Lost to Follow-up|0|||
33355232|NCT00817414|101187838|FG002|Overall Study|Lost to Follow-up|1|||
33355233|NCT00817414|101187839|FG003|Overall Study|Lost to Follow-up|1|||
33355234|NCT00817414|101187840|FG004|Overall Study|Lost to Follow-up|1|||
33355235|NCT00817414|101187836|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
33355236|NCT00817414|101187837|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
33355237|NCT00817414|101187838|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
33355238|NCT00817414|101187839|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
33355239|NCT00817414|101187840|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
33355240|NCT00817414|101187836|FG000|Overall Study|Protocol Violation|0|||
33355241|NCT00817414|101187837|FG001|Overall Study|Protocol Violation|0|||
33355242|NCT00817414|101187838|FG002|Overall Study|Protocol Violation|0|||
33355243|NCT00817414|101187839|FG003|Overall Study|Protocol Violation|0|||
33355244|NCT00817414|101187840|FG004|Overall Study|Protocol Violation|1|||
33355245|NCT04513158|101187843|FG000|Overall Study|Screen Failure|1|||
33355246|NCT01389245|101187844|FG000|Overall Study|Protocol Violation|10|||
33555052|NCT01803737|101931960|FG000|Overall Study|Medical Reason|0|||
33555053|NCT01803737|101931961|FG001|Overall Study|Medical Reason|1|||
33555054|NCT01803737|101931960|FG000|Overall Study|Lost to Follow-up|0|||
33555055|NCT01803737|101931961|FG001|Overall Study|Lost to Follow-up|2|||
33555056|NCT02186171|101931965|FG000|Overall Study|Withdrawal by Subject|1|||
33555057|NCT02186171|101931966|FG001|Overall Study|Withdrawal by Subject|9|||
33555058|NCT02186171|101931965|FG000|Overall Study|Lost to Follow-up|2|||
33555059|NCT02186171|101931966|FG001|Overall Study|Lost to Follow-up|2|||
33555060|NCT02186171|101931965|FG000|Overall Study|Death|1|||
33555061|NCT02186171|101931966|FG001|Overall Study|Death|2|||
33555062|NCT02186171|101931965|FG000|Overall Study|Protocol-specified Criteria|0|||
33555063|NCT02186171|101931966|FG001|Overall Study|Protocol-specified Criteria|2|||
33555064|NCT01529112|101931967|FG000|Overall Study|Adverse Event|2|||
33355247|NCT01389245|101187844|FG000|Overall Study|Lost to Follow-up|3|||
33355248|NCT01389245|101187844|FG000|Overall Study|Withdrawal by Subject|2|||
33555065|NCT01529112|101931968|FG001|Overall Study|Adverse Event|0|||
33555066|NCT01529112|101931967|FG000|Overall Study|Death|59|||
33555067|NCT01529112|101931968|FG001|Overall Study|Death|38|||
33555068|NCT01529112|101931967|FG000|Overall Study|Protocol Violation|1|||
33620853|NCT01910402|102161782|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
33620854|NCT01910402|102161783|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
33355249|NCT03040024|101187845|FG000|Overall Study|Adverse Event|0|||
33355250|NCT03040024|101187846|FG001|Overall Study|Adverse Event|1|||
33555069|NCT01529112|101931968|FG001|Overall Study|Protocol Violation|0|||
33555070|NCT01529112|101931967|FG000|Overall Study|Withdrawal by Subject|7|||
33555071|NCT01529112|101931968|FG001|Overall Study|Withdrawal by Subject|3|||
33355251|NCT03040024|101187847|FG002|Overall Study|Adverse Event|0|||
33355252|NCT03040024|101187845|FG000|Overall Study|Death|0|||
33355253|NCT03040024|101187846|FG001|Overall Study|Death|1|||
33355254|NCT03040024|101187847|FG002|Overall Study|Death|0|||
33355255|NCT03040024|101187845|FG000|Overall Study|Physician Decision|0|||
33355256|NCT03040024|101187846|FG001|Overall Study|Physician Decision|0|||
33355257|NCT03040024|101187847|FG002|Overall Study|Physician Decision|1|||
33355258|NCT00097539|101187850|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
33355259|NCT00097539|101187851|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
33355260|NCT00097539|101187852|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
33555072|NCT02916433|101931969|FG000|Overall Study|Withdrawal by Subject|1|||
33555073|NCT02916433|101931970|FG001|Overall Study|Withdrawal by Subject|0|||
33555074|NCT02916433|101931969|FG000|Overall Study|Physician Decision|1|||
33620855|NCT01910402|102161784|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
33620856|NCT01910402|102161782|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
33620857|NCT01910402|102161783|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
33620858|NCT01910402|102161784|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
33620859|NCT01910402|102161782|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
33620860|NCT01910402|102161783|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
33620861|NCT01910402|102161784|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
33620862|NCT01910402|102161782|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
33620863|NCT01910402|102161783|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
33620864|NCT01910402|102161784|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
33620865|NCT01910402|102161782|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
33620866|NCT01910402|102161783|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
33620867|NCT01910402|102161784|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
33620868|NCT01910402|102161782|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
33620869|NCT01910402|102161783|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
33620870|NCT01910402|102161784|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
33555075|NCT02916433|101931970|FG001|Overall Study|Physician Decision|0|||
33555076|NCT03954938|101931971|FG000|Overall Study|Withdrawal by Subject|2|||
33555077|NCT03954938|101931971|FG000|Overall Study|Adverse Event|1|||
33555078|NCT03061214|101931972|FG000|Overall Study|Withdrawal by Subject|21|||
33555079|NCT03061214|101931973|FG001|Overall Study|Withdrawal by Subject|26|||
33555080|NCT03061214|101931974|FG002|Overall Study|Withdrawal by Subject|9|||
33555081|NCT03061214|101931972|FG000|Overall Study|Lost to Follow-up|3|||
33555082|NCT03061214|101931973|FG001|Overall Study|Lost to Follow-up|1|||
33555083|NCT03061214|101931974|FG002|Overall Study|Lost to Follow-up|1|||
33555084|NCT03061214|101931972|FG000|Overall Study|Death|1|||
33555085|NCT03061214|101931973|FG001|Overall Study|Death|1|||
33555086|NCT03061214|101931974|FG002|Overall Study|Death|0|||
33620871|NCT01910402|102161782|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
33620872|NCT01910402|102161783|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
33620873|NCT01910402|102161784|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
33620874|NCT01910402|102161782|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
33620875|NCT01910402|102161783|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
33620876|NCT01910402|102161784|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
33620877|NCT01910402|102161782|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
33620878|NCT01910402|102161783|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
33355261|NCT00097539|101187853|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
33355262|NCT00097539|101187854|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
33555087|NCT03142451|101931976|FG000|Overall Study|Adverse Event|5|||
33620879|NCT01910402|102161784|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
33620880|NCT01910402|102161782|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
33620881|NCT01910402|102161783|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
33631307|NCT03486912|102202917|FG003|Treatment Period|Adverse Event|0|||
33555088|NCT03142451|101931977|FG001|Overall Study|Adverse Event|2|||
33355263|NCT00097539|101187855|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
33355264|NCT00097539|101187856|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
33355265|NCT00097539|101187850|FG000|Overall Study|Withdrawal by Subject|925|||
33355266|NCT00097539|101187851|FG001|Overall Study|Withdrawal by Subject|323|||
33355267|NCT00097539|101187852|FG002|Overall Study|Withdrawal by Subject|346|||
33355268|NCT00097539|101187853|FG003|Overall Study|Withdrawal by Subject|217|||
33355269|NCT00097539|101187854|FG004|Overall Study|Withdrawal by Subject|68|||
33355270|NCT00097539|101187855|FG005|Overall Study|Withdrawal by Subject|229|||
33355271|NCT00097539|101187856|FG006|Overall Study|Withdrawal by Subject|3|||
33413786|NCT01058707|101403757|FG000|Overall Study|Reason Not Specified|0|||
33413787|NCT01058707|101403758|FG001|Overall Study|Reason Not Specified|3|||
33413788|NCT01058707|101403759|FG002|Overall Study|Reason Not Specified|2|||
33413789|NCT01058707|101403760|FG003|Overall Study|Reason Not Specified|0|||
33413790|NCT01058707|101403761|FG004|Overall Study|Reason Not Specified|7|||
33413791|NCT01058707|101403762|FG005|Overall Study|Reason Not Specified|1|||
33413792|NCT01058707|101403763|FG006|Overall Study|Reason Not Specified|7|||
33413793|NCT02596009|101403764|FG000|Overall Study|Administrative problems|0|||
33555089|NCT03142451|101931976|FG000|Overall Study|Lost to Follow-up|25|||
33555090|NCT03142451|101931977|FG001|Overall Study|Lost to Follow-up|8|||
33413794|NCT02596009|101403765|FG001|Overall Study|Administrative problems|1|||
33413795|NCT02596009|101403766|FG002|Overall Study|Administrative problems|0|||
33413796|NCT02596009|101403767|FG003|Overall Study|Administrative problems|0|||
33413797|NCT02596009|101403768|FG004|Overall Study|Administrative problems|0|||
33413798|NCT02596009|101403769|FG005|Overall Study|Administrative problems|0|||
33413799|NCT00648739|101403776|FG000|Overall Study|Adverse Event|1|||
33413800|NCT00648739|101403777|FG001|Overall Study|Adverse Event|0|||
33413801|NCT00648739|101403778|FG002|Overall Study|Adverse Event|1|||
33555091|NCT03142451|101931976|FG000|Overall Study|Participant request|24|||
33555092|NCT03142451|101931977|FG001|Overall Study|Participant request|12|||
33555093|NCT03142451|101931976|FG000|Overall Study|Protocol Violation|3|||
33555094|NCT03142451|101931977|FG001|Overall Study|Protocol Violation|1|||
33555095|NCT03142451|101931976|FG000|Overall Study|Other|1|||
33555096|NCT03142451|101931977|FG001|Overall Study|Other|1|||
33555097|NCT00894647|101931978|FG000|Overall Study|Adverse Event|5|||
33555098|NCT00894647|101931979|FG001|Overall Study|Adverse Event|4|||
33555099|NCT00894647|101931978|FG000|Overall Study|Withdrawal by Subject|4|||
33555100|NCT00894647|101931979|FG001|Overall Study|Withdrawal by Subject|4|||
33555101|NCT00894647|101931978|FG000|Overall Study|Lost to Follow-up|0|||
33555102|NCT00894647|101931979|FG001|Overall Study|Lost to Follow-up|2|||
33555103|NCT00894647|101931978|FG000|Overall Study|Non-compliance with study procedures|0|||
33555104|NCT00894647|101931979|FG001|Overall Study|Non-compliance with study procedures|2|||
33555105|NCT00894647|101931978|FG000|Overall Study|Other, not due to AE|1|||
33555106|NCT00894647|101931979|FG001|Overall Study|Other, not due to AE|2|||
33555107|NCT01698008|101931982|FG000|Overall Study|Withdrawal by Subject|1|||
33555108|NCT01698008|101931983|FG001|Overall Study|Withdrawal by Subject|2|||
33555109|NCT01522976|101931986|FG000|Overall Study|Ineligible|4|||
33555110|NCT01522976|101931987|FG001|Overall Study|Ineligible|0|||
33555111|NCT01522976|101931988|FG002|Overall Study|Ineligible|1|||
33555112|NCT01522976|101931986|FG000|Overall Study|Death|7|||
33555113|NCT01522976|101931987|FG001|Overall Study|Death|6|||
33555114|NCT01522976|101931988|FG002|Overall Study|Death|2|||
33555115|NCT01522976|101931986|FG000|Overall Study|Still on treatment|9|||
33555116|NCT01522976|101931987|FG001|Overall Study|Still on treatment|9|||
33555117|NCT01522976|101931988|FG002|Overall Study|Still on treatment|6|||
33413802|NCT00648739|101403779|FG003|Overall Study|Adverse Event|2|||
33355272|NCT00097539|101187850|FG000|Overall Study|Participant Non-compliant|2140|||
33413803|NCT00648739|101403780|FG004|Overall Study|Adverse Event|1|||
33413804|NCT00648739|101403781|FG005|Overall Study|Adverse Event|0|||
33413805|NCT00648739|101403782|FG006|Overall Study|Adverse Event|0|||
33413806|NCT00648739|101403776|FG000|Overall Study|Withdrawal by Subject|1|||
33355273|NCT00097539|101187851|FG001|Overall Study|Participant Non-compliant|567|||
33555118|NCT01522976|101931986|FG000|Overall Study|Disease progression|28|||
33555119|NCT01522976|101931987|FG001|Overall Study|Disease progression|30|||
33355274|NCT00097539|101187852|FG002|Overall Study|Participant Non-compliant|1067|||
33355275|NCT00097539|101187853|FG003|Overall Study|Participant Non-compliant|353|||
33355276|NCT00097539|101187854|FG004|Overall Study|Participant Non-compliant|136|||
33355277|NCT00097539|101187855|FG005|Overall Study|Participant Non-compliant|543|||
33355278|NCT00097539|101187856|FG006|Overall Study|Participant Non-compliant|18|||
33355279|NCT00097539|101187850|FG000|Overall Study|Lack of Efficacy|249|||
33355280|NCT00097539|101187851|FG001|Overall Study|Lack of Efficacy|122|||
33355281|NCT00097539|101187852|FG002|Overall Study|Lack of Efficacy|202|||
33355282|NCT00097539|101187853|FG003|Overall Study|Lack of Efficacy|105|||
33355283|NCT00097539|101187854|FG004|Overall Study|Lack of Efficacy|45|||
33355284|NCT00097539|101187855|FG005|Overall Study|Lack of Efficacy|228|||
33355285|NCT00097539|101187856|FG006|Overall Study|Lack of Efficacy|5|||
33355286|NCT00097539|101187850|FG000|Overall Study|Adverse Event|78|||
33355287|NCT00097539|101187851|FG001|Overall Study|Adverse Event|133|||
33355288|NCT00097539|101187852|FG002|Overall Study|Adverse Event|37|||
33355289|NCT00097539|101187853|FG003|Overall Study|Adverse Event|27|||
33355290|NCT00097539|101187854|FG004|Overall Study|Adverse Event|30|||
33355291|NCT00097539|101187855|FG005|Overall Study|Adverse Event|59|||
33355292|NCT00097539|101187856|FG006|Overall Study|Adverse Event|1|||
33355293|NCT00097539|101187850|FG000|Overall Study|Death|2|||
33355294|NCT00097539|101187851|FG001|Overall Study|Death|7|||
33355295|NCT00097539|101187852|FG002|Overall Study|Death|0|||
33355296|NCT00097539|101187853|FG003|Overall Study|Death|0|||
33355297|NCT00097539|101187854|FG004|Overall Study|Death|1|||
33355298|NCT00097539|101187855|FG005|Overall Study|Death|3|||
33355299|NCT00097539|101187856|FG006|Overall Study|Death|0|||
33355300|NCT00097539|101187850|FG000|Overall Study|Reasons Other Than Above|3602|||
33355301|NCT00097539|101187851|FG001|Overall Study|Reasons Other Than Above|1382|||
33355302|NCT00097539|101187852|FG002|Overall Study|Reasons Other Than Above|1757|||
33413807|NCT00648739|101403777|FG001|Overall Study|Withdrawal by Subject|0|||
33413808|NCT00648739|101403778|FG002|Overall Study|Withdrawal by Subject|1|||
33413809|NCT00648739|101403779|FG003|Overall Study|Withdrawal by Subject|0|||
33413810|NCT00648739|101403780|FG004|Overall Study|Withdrawal by Subject|0|||
33413811|NCT00648739|101403781|FG005|Overall Study|Withdrawal by Subject|2|||
33413812|NCT00648739|101403782|FG006|Overall Study|Withdrawal by Subject|0|||
33413813|NCT00648739|101403776|FG000|Overall Study|Lack of Efficacy|0|||
33413814|NCT00648739|101403777|FG001|Overall Study|Lack of Efficacy|0|||
33413815|NCT00648739|101403778|FG002|Overall Study|Lack of Efficacy|0|||
33413816|NCT00648739|101403779|FG003|Overall Study|Lack of Efficacy|0|||
33413817|NCT00648739|101403780|FG004|Overall Study|Lack of Efficacy|1|||
33413818|NCT00648739|101403781|FG005|Overall Study|Lack of Efficacy|2|||
33413819|NCT00648739|101403782|FG006|Overall Study|Lack of Efficacy|0|||
33555120|NCT01522976|101931988|FG002|Overall Study|Disease progression|25|||
33555121|NCT01522976|101931986|FG000|Overall Study|Adverse Event|17|||
33555122|NCT01522976|101931987|FG001|Overall Study|Adverse Event|7|||
33555123|NCT01522976|101931988|FG002|Overall Study|Adverse Event|18|||
33355303|NCT00097539|101187853|FG003|Overall Study|Reasons Other Than Above|692|||
33620882|NCT01910402|102161784|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
33620883|NCT02025179|102161785|FG000|Overall Study|Lost to Follow-up|0|||
33620884|NCT02025179|102161786|FG001|Overall Study|Lost to Follow-up|0|||
33555124|NCT01522976|101931986|FG000|Overall Study|Refusal unrelated to adverse event|10|||
33555125|NCT01522976|101931987|FG001|Overall Study|Refusal unrelated to adverse event|13|||
33555126|NCT01522976|101931988|FG002|Overall Study|Refusal unrelated to adverse event|14|||
33555127|NCT01522976|101931986|FG000|Overall Study|Not protocol specified|22|||
33555128|NCT01522976|101931987|FG001|Overall Study|Not protocol specified|27|||
33620885|NCT02025179|102161787|FG002|Overall Study|Lost to Follow-up|1|||
33555129|NCT01522976|101931988|FG002|Overall Study|Not protocol specified|27|||
33620886|NCT04317040|102161792|FG000|Overall Study|Lost to Follow-up|2|||
33620887|NCT04317040|102161793|FG001|Overall Study|Lost to Follow-up|0|||
33620888|NCT04317040|102161792|FG000|Overall Study|Death|16|||
33355304|NCT00097539|101187854|FG004|Overall Study|Reasons Other Than Above|361|||
33355305|NCT00097539|101187855|FG005|Overall Study|Reasons Other Than Above|1244|||
33355306|NCT00097539|101187856|FG006|Overall Study|Reasons Other Than Above|34|||
33413820|NCT00648739|101403776|FG000|Overall Study|Investigator Considered it Advisable|0|||
33355307|NCT00097539|101187850|FG000|Overall Study|Reason not Specified|111|||
33355308|NCT00097539|101187851|FG001|Overall Study|Reason not Specified|49|||
33355309|NCT00097539|101187852|FG002|Overall Study|Reason not Specified|53|||
33413821|NCT00648739|101403777|FG001|Overall Study|Investigator Considered it Advisable|0|||
33555130|NCT01633112|101931993|FG000|Overall Study|Lack of Efficacy|1|||
33620889|NCT04317040|102161793|FG001|Overall Study|Death|18|||
33355310|NCT00097539|101187853|FG003|Overall Study|Reason not Specified|21|||
33355311|NCT00097539|101187854|FG004|Overall Study|Reason not Specified|11|||
33355312|NCT00097539|101187855|FG005|Overall Study|Reason not Specified|40|||
33355313|NCT00097539|101187856|FG006|Overall Study|Reason not Specified|2|||
33620890|NCT04317040|102161792|FG000|Overall Study|Withdrawal by Subject|0|||
33413822|NCT00648739|101403778|FG002|Overall Study|Investigator Considered it Advisable|0|||
33620891|NCT04317040|102161793|FG001|Overall Study|Withdrawal by Subject|1|||
33620892|NCT04317040|102161792|FG000|Overall Study|Incomplete assessments|0|||
33620893|NCT04317040|102161793|FG001|Overall Study|Incomplete assessments|1|||
33620894|NCT02336230|102161794|FG000|Overall Study|Adverse Event|1|||
33620895|NCT02336230|102161794|FG000|Overall Study|Withdrawal of consent|1|||
33620896|NCT02336230|102161794|FG000|Overall Study|Death|9|||
33620897|NCT02336230|102161794|FG000|Overall Study|Dose not received due to shipping delay|1|||
33620898|NCT02336230|102161794|FG000|Overall Study|Discontinuation of MSC infusion|1|||
33620899|NCT01574274|102161795|FG000|Overall Study|Ineligible|0|||
33620900|NCT01574274|102161796|FG001|Overall Study|Ineligible|1|||
33620901|NCT01574274|102161795|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
33620902|NCT01574274|102161796|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
33620903|NCT01574274|102161795|FG000|Overall Study|Ph+ B-ALL|3|||
33620904|NCT01574274|102161796|FG001|Overall Study|Ph+ B-ALL|4|||
33620905|NCT01574274|102161795|FG000|Overall Study|Induction Death|2|||
33620906|NCT01574274|102161796|FG001|Overall Study|Induction Death|0|||
33620907|NCT01574274|102161795|FG000|Overall Study|Induction Failure|4|||
33620908|NCT01574274|102161796|FG001|Overall Study|Induction Failure|1|||
33620909|NCT01574274|102161795|FG000|Overall Study|Adverse Event|16|||
33620910|NCT01574274|102161796|FG001|Overall Study|Adverse Event|13|||
33620911|NCT01574274|102161795|FG000|Overall Study|Remission Death|1|||
33620912|NCT01574274|102161796|FG001|Overall Study|Remission Death|0|||
33620913|NCT01574274|102161795|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
33620914|NCT01574274|102161796|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
33620915|NCT01574274|102161795|FG000|Overall Study|Other, unknown|3|||
33620916|NCT01574274|102161796|FG001|Overall Study|Other, unknown|2|||
33620917|NCT00502671|102161799|FG000|Overall Study|Disease Progression|13|||
33620918|NCT00502671|102161799|FG000|Overall Study|Personal Reasons|22|||
33620919|NCT00502671|102161799|FG000|Overall Study|Lost to Follow-up|7|||
33620920|NCT00502671|102161799|FG000|Overall Study|Protocol Violation|16|||
33620921|NCT00502671|102161799|FG000|Overall Study|Adverse Event|19|||
33620922|NCT00354679|102161801|FG000|Overall Study|Patient Not Treated|1|||
33620923|NCT01521507|102161813|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
33620924|NCT01521507|102161814|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
33620925|NCT01521507|102161813|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
33620926|NCT01521507|102161814|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
33620927|NCT01521507|102161813|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
33620928|NCT01521507|102161814|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
33620929|NCT01521507|102161813|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
33620930|NCT01521507|102161814|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
33620931|NCT01521507|102161813|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
33620932|NCT01521507|102161814|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
33620933|NCT01521507|102161813|FG000|Stage 2: Observational Design|Physician Decision|1|||
33620934|NCT01521507|102161814|FG001|Stage 2: Observational Design|Physician Decision|0|||
33620935|NCT00626275|102161815|FG000|Part A - Treatment Period 1|Adverse Event|1|||
33620936|NCT00626275|102161816|FG001|Part A - Treatment Period 1|Adverse Event|0|||
33620937|NCT00626275|102161817|FG002|Part A - Treatment Period 1|Adverse Event|0|||
33620938|NCT00626275|102161818|FG003|Part A - Treatment Period 1|Adverse Event|0|||
33620939|NCT00626275|102161819|FG004|Part A - Treatment Period 1|Adverse Event|0|||
33620940|NCT00626275|102161820|FG005|Part A - Treatment Period 1|Adverse Event|0|||
33620941|NCT00626275|102161821|FG006|Part A - Treatment Period 1|Adverse Event|0|||
33620942|NCT00626275|102161822|FG007|Part A - Treatment Period 1|Adverse Event|0|||
33620943|NCT00626275|102161815|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
33620944|NCT00626275|102161816|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
33620945|NCT00626275|102161817|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
33620946|NCT00626275|102161818|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
33620947|NCT00626275|102161819|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
33355314|NCT01903876|101187858|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
33355315|NCT01903876|101187859|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
33355316|NCT01903876|101187858|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
33620948|NCT00626275|102161820|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
33620949|NCT00626275|102161821|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
33620950|NCT00626275|102161822|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
33620951|NCT00626275|102161815|FG000|Part B|Lost to Follow-up|0|||
33355317|NCT01903876|101187859|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
33620952|NCT00626275|102161816|FG001|Part B|Lost to Follow-up|0|||
33620953|NCT00626275|102161817|FG002|Part B|Lost to Follow-up|0|||
33620954|NCT00626275|102161818|FG003|Part B|Lost to Follow-up|0|||
33620955|NCT00626275|102161819|FG004|Part B|Lost to Follow-up|0|||
33620956|NCT00626275|102161820|FG005|Part B|Lost to Follow-up|0|||
33620957|NCT00626275|102161821|FG006|Part B|Lost to Follow-up|1|||
33620958|NCT00626275|102161822|FG007|Part B|Lost to Follow-up|0|||
33555131|NCT01633112|101931994|FG001|Overall Study|Lack of Efficacy|6|||
33555132|NCT01633112|101931995|FG002|Overall Study|Lack of Efficacy|13|||
33555133|NCT01633112|101931993|FG000|Overall Study|Abnormal laboratory value(s)|3|||
33555134|NCT01633112|101931994|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33555135|NCT01633112|101931995|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33555136|NCT01633112|101931993|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33555137|NCT01633112|101931994|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33555138|NCT01633112|101931995|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33555139|NCT01633112|101931993|FG000|Overall Study|Administrative problems|1|||
33555140|NCT01633112|101931994|FG001|Overall Study|Administrative problems|2|||
33555141|NCT01633112|101931995|FG002|Overall Study|Administrative problems|5|||
33555142|NCT01633112|101931993|FG000|Overall Study|Adverse Event|16|||
33555143|NCT01633112|101931994|FG001|Overall Study|Adverse Event|18|||
33555144|NCT01633112|101931995|FG002|Overall Study|Adverse Event|20|||
33555145|NCT01633112|101931993|FG000|Overall Study|Lost to Follow-up|7|||
33555146|NCT01633112|101931994|FG001|Overall Study|Lost to Follow-up|19|||
33555147|NCT01633112|101931995|FG002|Overall Study|Lost to Follow-up|6|||
33555148|NCT01633112|101931993|FG000|Overall Study|Protocol Violation|4|||
33555149|NCT01633112|101931994|FG001|Overall Study|Protocol Violation|0|||
33555150|NCT01633112|101931995|FG002|Overall Study|Protocol Violation|2|||
33555151|NCT01633112|101931993|FG000|Overall Study|Subject no longer requires study drug|0|||
33555152|NCT01633112|101931994|FG001|Overall Study|Subject no longer requires study drug|0|||
33555153|NCT01633112|101931995|FG002|Overall Study|Subject no longer requires study drug|1|||
33555154|NCT01633112|101931993|FG000|Overall Study|Withdrawal by Subject|20|||
33555155|NCT01633112|101931994|FG001|Overall Study|Withdrawal by Subject|12|||
33555156|NCT01633112|101931995|FG002|Overall Study|Withdrawal by Subject|41|||
33555157|NCT01633112|101931993|FG000|Overall Study|missing Study Completion CRF|1|||
33555158|NCT01633112|101931994|FG001|Overall Study|missing Study Completion CRF|1|||
33555159|NCT01633112|101931995|FG002|Overall Study|missing Study Completion CRF|4|||
33555160|NCT00933166|101931996|FG000|Overall Study|Lost to Follow-up|4|||
33555161|NCT00933166|101931996|FG000|Overall Study|Lack of Efficacy|9|||
33555162|NCT00933166|101931996|FG000|Overall Study|Unavailable|4|||
33555163|NCT00933166|101931996|FG000|Overall Study|Withdrawal by Subject|1|||
33555164|NCT04341662|101931999|FG000|Overall Study|Did not have source-verified blood loss data|423|||
33555165|NCT04341662|101932000|FG001|Overall Study|Did not have source-verified blood loss data|514|||
33555166|NCT00098293|101932002|FG000|Double-blind (DB) Phase|Adverse Event|14|||
33555167|NCT00098293|101932003|FG001|Double-blind (DB) Phase|Adverse Event|27|||
33555168|NCT00098293|101932004|FG002|Double-blind (DB) Phase|Adverse Event|60|||
33555169|NCT00098293|101932005|FG003|Double-blind (DB) Phase|Adverse Event|0|||
33555170|NCT00098293|101932006|FG004|Double-blind (DB) Phase|Adverse Event|0|||
33555171|NCT00098293|101932002|FG000|Double-blind (DB) Phase|Pregnancy|0|||
33555172|NCT00098293|101932003|FG001|Double-blind (DB) Phase|Pregnancy|7|||
33555173|NCT00098293|101932004|FG002|Double-blind (DB) Phase|Pregnancy|9|||
33555174|NCT00098293|101932005|FG003|Double-blind (DB) Phase|Pregnancy|0|||
33555175|NCT00098293|101932006|FG004|Double-blind (DB) Phase|Pregnancy|0|||
33555176|NCT00098293|101932002|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
33555177|NCT00098293|101932003|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
33555178|NCT00098293|101932004|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
33555179|NCT00098293|101932005|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
33555180|NCT00098293|101932006|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
33555181|NCT00098293|101932002|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
33555182|NCT00098293|101932003|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
33620959|NCT00626275|102161815|FG000|Part B|Withdrawal by Subject|0|||
33620960|NCT00626275|102161816|FG001|Part B|Withdrawal by Subject|0|||
33555183|NCT00098293|101932004|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
33555184|NCT00098293|101932005|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
33555185|NCT00098293|101932006|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
33555186|NCT00098293|101932002|FG000|Double-blind (DB) Phase|Death|1|||
33555187|NCT00098293|101932003|FG001|Double-blind (DB) Phase|Death|2|||
33555188|NCT00098293|101932004|FG002|Double-blind (DB) Phase|Death|2|||
33555189|NCT00098293|101932005|FG003|Double-blind (DB) Phase|Death|0|||
33555190|NCT00098293|101932006|FG004|Double-blind (DB) Phase|Death|0|||
33555191|NCT00098293|101932002|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
33620961|NCT00626275|102161817|FG002|Part B|Withdrawal by Subject|0|||
33620962|NCT00626275|102161818|FG003|Part B|Withdrawal by Subject|0|||
33620963|NCT00626275|102161819|FG004|Part B|Withdrawal by Subject|0|||
33555192|NCT00098293|101932003|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
33555193|NCT00098293|101932004|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
33555194|NCT00098293|101932005|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
33555195|NCT00098293|101932006|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
33620964|NCT00626275|102161820|FG005|Part B|Withdrawal by Subject|0|||
33620965|NCT00626275|102161821|FG006|Part B|Withdrawal by Subject|0|||
33620966|NCT00626275|102161822|FG007|Part B|Withdrawal by Subject|1|||
33555196|NCT00098293|101932002|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
33620967|NCT02079038|102161823|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
33555197|NCT00098293|101932003|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
33555198|NCT00098293|101932004|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
33555199|NCT00098293|101932005|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
33555200|NCT00098293|101932006|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
33555201|NCT00098293|101932002|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
33555202|NCT00098293|101932003|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
33620968|NCT02079038|102161824|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
33620969|NCT02079038|102161823|FG000|Modified Intent to Treat Population|Death|1|||
33620970|NCT02079038|102161824|FG001|Modified Intent to Treat Population|Death|0|||
33620971|NCT02079038|102161823|FG000|Completed 6 Months|Lost to Follow-up|2|||
33620972|NCT02079038|102161824|FG001|Completed 6 Months|Lost to Follow-up|1|||
33620973|NCT02300259|102161825|FG000|Period 1|Adverse Event|0|||
33620974|NCT02300259|102161826|FG001|Period 1|Adverse Event|0|||
33620975|NCT02300259|102161827|FG002|Period 1|Adverse Event|1|||
33620976|NCT02300259|102161825|FG000|Period 1|Withdrawal by Subject|0|||
33620977|NCT02300259|102161826|FG001|Period 1|Withdrawal by Subject|0|||
33620978|NCT02300259|102161827|FG002|Period 1|Withdrawal by Subject|1|||
33620979|NCT02300259|102161825|FG000|Period 2|Adverse Event|1|||
33620980|NCT02300259|102161826|FG001|Period 2|Adverse Event|0|||
33620981|NCT02300259|102161827|FG002|Period 2|Adverse Event|0|||
33620982|NCT02300259|102161825|FG000|Period 2|Withdrawal by Subject|0|||
33355318|NCT00960076|101187862|FG000|Overall Study|Adverse Event|1|||
33355319|NCT00960076|101187863|FG001|Overall Study|Adverse Event|7|||
33355320|NCT00960076|101187862|FG000|Overall Study|No longer met study criteria|1|||
33355321|NCT00960076|101187863|FG001|Overall Study|No longer met study criteria|5|||
33355322|NCT00960076|101187862|FG000|Overall Study|Withdrawal by Subject|1|||
33355323|NCT00960076|101187863|FG001|Overall Study|Withdrawal by Subject|2|||
33355324|NCT00960076|101187862|FG000|Overall Study|Lost to Follow-up|3|||
33355325|NCT00960076|101187863|FG001|Overall Study|Lost to Follow-up|3|||
33355326|NCT00960076|101187862|FG000|Overall Study|Severe non-compliance to protocol|1|||
33355327|NCT00960076|101187863|FG001|Overall Study|Severe non-compliance to protocol|2|||
33355328|NCT00960076|101187862|FG000|Overall Study|Hyperglycemia|1|||
33355329|NCT00960076|101187863|FG001|Overall Study|Hyperglycemia|5|||
33355330|NCT00960076|101187862|FG000|Overall Study|Did not attend the termination visit|0|||
33355331|NCT00960076|101187863|FG001|Overall Study|Did not attend the termination visit|1|||
33355332|NCT04426630|101187867|FG000|Overall Study|Death|4|||
33355333|NCT04426630|101187867|FG000|Overall Study|Lost to Follow-up|2|||
33355334|NCT00466505|101187868|FG000|Overall Study|disease progression|13|||
33355335|NCT00466505|101187868|FG000|Overall Study|Adverse Event|4|||
33355336|NCT03567187|101187869|FG000|Overall Study|Lost to Follow-up|18|||
33355337|NCT01686568|101187872|FG000|Main Study|Withdrawal by Subject|1|||
33355338|NCT01686568|101187873|FG001|Main Study|Withdrawal by Subject|3|||
33355339|NCT01686568|101187872|FG000|Main Study|Noncompliance with protocol|0|||
33355340|NCT01686568|101187873|FG001|Main Study|Noncompliance with protocol|1|||
33355341|NCT01686568|101187872|FG000|Main Study|Liver enzymes above range of exclusion|1|||
33355342|NCT01686568|101187873|FG001|Main Study|Liver enzymes above range of exclusion|0|||
33355343|NCT01686568|101187872|FG000|Sub-Study|Not consented for sub-study|2|||
33355344|NCT01686568|101187873|FG001|Sub-Study|Not consented for sub-study|2|||
33355345|NCT03545282|101187874|FG000|Overall Study|Lost to Follow-up|15|||
33355346|NCT03545282|101187875|FG001|Overall Study|Lost to Follow-up|10|||
33355347|NCT03545282|101187874|FG000|Overall Study|Withdrawal by Subject|2|||
33355348|NCT03545282|101187875|FG001|Overall Study|Withdrawal by Subject|2|||
33355349|NCT05502289|101187876|FG000|Period 1|Out Of Window|1|||
33355350|NCT05502289|101187877|FG001|Period 1|Out Of Window|0|||
33355351|NCT02649634|101187888|FG000|Overall Study|Withdrawal by Subject|3|||
33355352|NCT02649634|101187889|FG001|Overall Study|Withdrawal by Subject|5|||
33355353|NCT02649634|101187888|FG000|Overall Study|Lost to Follow-up|0|||
33355354|NCT02649634|101187889|FG001|Overall Study|Lost to Follow-up|1|||
33355355|NCT01355289|101187890|FG000|Core Study|Adverse Event, Non-Fatal|1|||
33355356|NCT01355289|101187891|FG001|Core Study|Adverse Event, Non-Fatal|0|||
33355357|NCT01355289|101187892|FG002|Core Study|Adverse Event, Non-Fatal|0|||
33355358|NCT01355289|101187893|FG003|Core Study|Adverse Event, Non-Fatal|0|||
33413823|NCT00648739|101403779|FG003|Overall Study|Investigator Considered it Advisable|0|||
33620983|NCT02300259|102161826|FG001|Period 2|Withdrawal by Subject|0|||
33620984|NCT02300259|102161827|FG002|Period 2|Withdrawal by Subject|1|||
33620985|NCT00920855|102161828|FG000|Overall Study|Adverse Event|1|||
33355359|NCT01355289|101187894|FG004|Core Study|Adverse Event, Non-Fatal|0|||
33355360|NCT01355289|101187890|FG000|Core Study|Inadequate Therapeutic Effect|0|||
33355361|NCT01355289|101187891|FG001|Core Study|Inadequate Therapeutic Effect|0|||
33355362|NCT01355289|101187892|FG002|Core Study|Inadequate Therapeutic Effect|0|||
33413824|NCT00648739|101403780|FG004|Overall Study|Investigator Considered it Advisable|0|||
33620986|NCT00920855|102161829|FG001|Overall Study|Adverse Event|1|||
33620987|NCT00920855|102161830|FG002|Overall Study|Adverse Event|4|||
33620988|NCT00920855|102161828|FG000|Overall Study|Withdrawal by Subject|2|||
33355363|NCT01355289|101187893|FG003|Core Study|Inadequate Therapeutic Effect|1|||
33355364|NCT01355289|101187894|FG004|Core Study|Inadequate Therapeutic Effect|0|||
33555203|NCT00098293|101932004|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
33413825|NCT00648739|101403781|FG005|Overall Study|Investigator Considered it Advisable|1|||
33355365|NCT01355289|101187890|FG000|Core Study|Other|0|||
33355366|NCT01355289|101187891|FG001|Core Study|Other|0|||
33355367|NCT01355289|101187892|FG002|Core Study|Other|0|||
33355368|NCT01355289|101187893|FG003|Core Study|Other|1|||
33355369|NCT01355289|101187894|FG004|Core Study|Other|0|||
33355370|NCT01355289|101187890|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
33355371|NCT01355289|101187891|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
33355372|NCT01355289|101187892|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
33355373|NCT01355289|101187893|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
33355374|NCT01355289|101187894|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
33355375|NCT01355289|101187890|FG000|Open Label Extension|Lost to Follow-up|0|||
33355376|NCT01355289|101187891|FG001|Open Label Extension|Lost to Follow-up|0|||
33355377|NCT01355289|101187892|FG002|Open Label Extension|Lost to Follow-up|0|||
33355378|NCT01355289|101187893|FG003|Open Label Extension|Lost to Follow-up|0|||
33355379|NCT01355289|101187894|FG004|Open Label Extension|Lost to Follow-up|1|||
33355380|NCT01355289|101187890|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
33413826|NCT00648739|101403782|FG006|Overall Study|Investigator Considered it Advisable|1|||
33413827|NCT00648739|101403776|FG000|Overall Study|Death|0|||
33413828|NCT00648739|101403777|FG001|Overall Study|Death|1|||
33413829|NCT00648739|101403778|FG002|Overall Study|Death|0|||
33413830|NCT00648739|101403779|FG003|Overall Study|Death|0|||
33413831|NCT00648739|101403780|FG004|Overall Study|Death|0|||
33413832|NCT00648739|101403781|FG005|Overall Study|Death|0|||
33413833|NCT00648739|101403782|FG006|Overall Study|Death|0|||
33413834|NCT00648739|101403776|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
33413835|NCT00648739|101403777|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
33413836|NCT00648739|101403778|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
33413837|NCT00648739|101403779|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
33413838|NCT00648739|101403780|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
33413839|NCT00648739|101403781|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
33413840|NCT00648739|101403782|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
33413841|NCT00648739|101403776|FG000|Overall Study|Follow-up Visits Not Completed|0|||
33413842|NCT00648739|101403777|FG001|Overall Study|Follow-up Visits Not Completed|1|||
33413843|NCT00648739|101403778|FG002|Overall Study|Follow-up Visits Not Completed|0|||
33413844|NCT00648739|101403779|FG003|Overall Study|Follow-up Visits Not Completed|0|||
33413845|NCT00648739|101403780|FG004|Overall Study|Follow-up Visits Not Completed|0|||
33413846|NCT00648739|101403781|FG005|Overall Study|Follow-up Visits Not Completed|0|||
33413847|NCT00648739|101403782|FG006|Overall Study|Follow-up Visits Not Completed|0|||
33555204|NCT00098293|101932005|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
33555205|NCT00098293|101932006|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
33555206|NCT00098293|101932002|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
33555207|NCT00098293|101932003|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
33555208|NCT00098293|101932004|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
33555209|NCT00098293|101932005|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
33555210|NCT00098293|101932006|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
33555211|NCT00098293|101932002|FG000|Open-label (OL) Phase|Adverse Event|0|||
33555212|NCT00098293|101932003|FG001|Open-label (OL) Phase|Adverse Event|3|||
33555213|NCT00098293|101932004|FG002|Open-label (OL) Phase|Adverse Event|7|||
33555214|NCT00098293|101932005|FG003|Open-label (OL) Phase|Adverse Event|6|||
33555215|NCT00098293|101932006|FG004|Open-label (OL) Phase|Adverse Event|0|||
33555216|NCT00098293|101932002|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
33555217|NCT00098293|101932003|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
33555218|NCT00098293|101932004|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
33555219|NCT00098293|101932005|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
33555220|NCT00098293|101932006|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
33555221|NCT00098293|101932002|FG000|Open-label (OL) Phase|Pregnancy|0|||
33555222|NCT00098293|101932003|FG001|Open-label (OL) Phase|Pregnancy|1|||
33555223|NCT00098293|101932004|FG002|Open-label (OL) Phase|Pregnancy|0|||
33555224|NCT00098293|101932005|FG003|Open-label (OL) Phase|Pregnancy|3|||
33355381|NCT01355289|101187891|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
33413848|NCT04753606|101403783|FG000|Overall Study|Adverse Event|1|||
33413849|NCT04753606|101403784|FG001|Overall Study|Adverse Event|0|||
33355382|NCT01355289|101187892|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
33413850|NCT04753606|101403785|FG002|Overall Study|Adverse Event|0|||
33413851|NCT00474994|101403786|FG000|Overall Study|Patient Not treated|1|||
33413852|NCT00474994|101403786|FG000|Overall Study|Patient evaluable for toxicity only|3|||
33555225|NCT00098293|101932006|FG004|Open-label (OL) Phase|Pregnancy|0|||
33555226|NCT00098293|101932002|FG000|Open-label (OL) Phase|Protocol Violation|0|||
33555227|NCT00098293|101932003|FG001|Open-label (OL) Phase|Protocol Violation|6|||
33555228|NCT00098293|101932004|FG002|Open-label (OL) Phase|Protocol Violation|13|||
33555229|NCT00098293|101932005|FG003|Open-label (OL) Phase|Protocol Violation|16|||
33355383|NCT01355289|101187893|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
33355384|NCT01355289|101187894|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
33355385|NCT01355289|101187890|FG000|Open Label Extension|Other|0|||
33355386|NCT01355289|101187891|FG001|Open Label Extension|Other|0|||
33355387|NCT01355289|101187892|FG002|Open Label Extension|Other|0|||
33355388|NCT01355289|101187893|FG003|Open Label Extension|Other|0|||
33355389|NCT01355289|101187894|FG004|Open Label Extension|Other|3|||
33355390|NCT05127486|101187895|FG000|Overall Study|Adverse Event|2|||
33355391|NCT05127486|101187896|FG001|Overall Study|Adverse Event|4|||
33355392|NCT05127486|101187895|FG000|Overall Study|Lack of Efficacy|1|||
33355393|NCT05127486|101187896|FG001|Overall Study|Lack of Efficacy|0|||
33355394|NCT05127486|101187895|FG000|Overall Study|Pregnancy|0|||
33355395|NCT05127486|101187896|FG001|Overall Study|Pregnancy|1|||
33355396|NCT05127486|101187895|FG000|Overall Study|Physician Decision|4|||
33355397|NCT05127486|101187896|FG001|Overall Study|Physician Decision|1|||
33355398|NCT05127486|101187895|FG000|Overall Study|Withdrawal by Subject|14|||
33355399|NCT05127486|101187896|FG001|Overall Study|Withdrawal by Subject|13|||
33355400|NCT05127486|101187895|FG000|Overall Study|Lost to Follow-up|5|||
33355401|NCT05127486|101187896|FG001|Overall Study|Lost to Follow-up|8|||
33355402|NCT04178590|101187899|FG000|Overall Study|Pregnancy|1|||
33355403|NCT04178590|101187899|FG000|Overall Study|Lost to Follow-up|1|||
33355404|NCT01009294|101187903|FG000|Overall Study|Study discontinued by Sponsor|6|||
33355405|NCT00900796|101187904|FG000|Phase 1|Lacked sufficient information|4|||
33355406|NCT00900796|101187904|FG000|Phase 1|Missing information at Week 16|7|||
33355407|NCT00900796|101187904|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
33355408|NCT00900796|101187904|FG000|Phase 2|Lost to Follow-up|5|||
33355409|NCT03293680|101187906|FG000|Overall Study|Death|1|||
33355410|NCT03293680|101187906|FG000|Overall Study|Did not meet inclusion criteria|8|||
33355411|NCT02360098|101187907|FG000|Overall Study|Physician Decision|7|||
33355412|NCT00826748|101187908|FG000|Overall Study|Withdrawal by Subject|0|||
33355413|NCT00826748|101187909|FG001|Overall Study|Withdrawal by Subject|0|||
33355414|NCT00826748|101187910|FG002|Overall Study|Withdrawal by Subject|2|||
33355415|NCT00826748|101187908|FG000|Overall Study|Physician Decision|0|||
33355416|NCT00826748|101187909|FG001|Overall Study|Physician Decision|0|||
33355417|NCT00826748|101187910|FG002|Overall Study|Physician Decision|1|||
33355418|NCT00826748|101187908|FG000|Overall Study|Samples Did Not pass QC|0|||
33355419|NCT00826748|101187909|FG001|Overall Study|Samples Did Not pass QC|0|||
33355420|NCT00826748|101187910|FG002|Overall Study|Samples Did Not pass QC|1|||
33355421|NCT02582515|101187917|FG000|Overall Study|Withdrawal by Subject|0|||
33355422|NCT02582515|101187918|FG001|Overall Study|Withdrawal by Subject|1|||
33355423|NCT00200057|101187919|FG000|Overall Study|Lack of Efficacy|3|||
33355424|NCT00200057|101187919|FG000|Overall Study|Exited due to terminal illness of PI|2|||
33355425|NCT00200057|101187919|FG000|Overall Study|Withdrawal by Subject|1|||
33355426|NCT00200057|101187919|FG000|Overall Study|Change in medical condition|1|||
33355427|NCT00200057|101187919|FG000|Overall Study|Infection|1|||
33355428|NCT00200057|101187919|FG000|Overall Study|Death|1|||
33355429|NCT00049127|101187924|FG000|Overall Study|Withdrawal by Subject|0|||
33355430|NCT00049127|101187925|FG001|Overall Study|Withdrawal by Subject|0|||
33355431|NCT00049127|101187926|FG002|Overall Study|Withdrawal by Subject|1|||
33355432|NCT00049127|101187927|FG003|Overall Study|Withdrawal by Subject|0|||
33355433|NCT00049127|101187928|FG004|Overall Study|Withdrawal by Subject|0|||
33355434|NCT01719757|101187929|FG000|Overall Study|Adverse Event|38|||
33355435|NCT01719757|101187929|FG000|Overall Study|Withdrawal by Subject|15|||
33355436|NCT01719757|101187929|FG000|Overall Study|Lost to Follow-up|20|||
33355437|NCT01719757|101187929|FG000|Overall Study|Protocol Violation|1|||
33355438|NCT01719757|101187929|FG000|Overall Study|well controlled pain|27|||
33355439|NCT01021007|101187930|FG000|Overall Study|Lost to Follow-up|1|||
33355440|NCT01021007|101187931|FG001|Overall Study|Lost to Follow-up|1|||
33355441|NCT01021007|101187930|FG000|Overall Study|Adverse Event|1|||
33355442|NCT01021007|101187931|FG001|Overall Study|Adverse Event|3|||
33355443|NCT03075839|101187935|FG000|Overall Study|Lost to Follow-up|4|||
33355444|NCT01051739|101187936|FG000|Overall Study|Death|3|||
33355445|NCT01051739|101187937|FG001|Overall Study|Death|3|||
33355446|NCT01051739|101187936|FG000|Overall Study|Withdrawal by Subject|25|||
33355447|NCT01051739|101187937|FG001|Overall Study|Withdrawal by Subject|10|||
33355448|NCT02432807|101187941|FG000|Overall Study|Adverse Event|0|||
33355449|NCT02432807|101187942|FG001|Overall Study|Adverse Event|2|||
33413853|NCT00474994|101403786|FG000|Overall Study|Patient found to be ineligible|1|||
33413854|NCT00968539|101403790|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
33355450|NCT02432807|101187941|FG000|Overall Study|Lost to Follow-up|1|||
33355451|NCT02432807|101187942|FG001|Overall Study|Lost to Follow-up|0|||
33355452|NCT02432807|101187941|FG000|Overall Study|Withdrawal by Subject|1|||
33355453|NCT02432807|101187942|FG001|Overall Study|Withdrawal by Subject|1|||
33355454|NCT02432807|101187941|FG000|Overall Study|Other|1|||
33355455|NCT02432807|101187942|FG001|Overall Study|Other|1|||
33355456|NCT00283387|101187943|FG000|First Intervention|Subject non-compliant|1|||
33355457|NCT00283387|101187944|FG001|First Intervention|Subject non-compliant|1|||
33355458|NCT00283387|101187943|FG000|First Intervention|Withdrawal by Subject|0|||
33355459|NCT00283387|101187944|FG001|First Intervention|Withdrawal by Subject|1|||
33355460|NCT02499952|101187945|FG000|Overall Study|Lost to Follow-up|1|||
33355461|NCT02499952|101187945|FG000|Overall Study|Death|9|||
33355462|NCT01028352|101187950|FG000|Overall Study|Ineligible due to baseline average pain|5|||
33355463|NCT01028352|101187950|FG000|Overall Study|Withdrawal by Subject|1|||
33355464|NCT02300129|101187951|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
33355465|NCT02300129|101187952|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
33355466|NCT02300129|101187953|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
33355467|NCT02300129|101187954|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
33355468|NCT02300129|101187951|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
33355469|NCT02300129|101187952|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
33355470|NCT02300129|101187953|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
33355471|NCT02300129|101187954|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
33355472|NCT02300129|101187951|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
33355473|NCT02300129|101187952|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
33355474|NCT02300129|101187953|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
33355475|NCT02300129|101187954|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
33355476|NCT02966314|101187955|FG000|Overall Study|Lost to Follow-up|1|||
33355477|NCT02966314|101187956|FG001|Overall Study|Lost to Follow-up|0|||
33355478|NCT05089708|101187958|FG000|Overall Study|Lost to Follow-up|9|||
33355479|NCT05089708|101187959|FG001|Overall Study|Lost to Follow-up|7|||
33355480|NCT05089708|101187958|FG000|Overall Study|Withdrawal by Subject|3|||
33355481|NCT05089708|101187959|FG001|Overall Study|Withdrawal by Subject|1|||
33355482|NCT05089708|101187958|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
33355483|NCT05089708|101187959|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
33355484|NCT05089708|101187958|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
33355485|NCT05089708|101187959|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
33355486|NCT01295125|101187962|FG000|Overall Study|Study stopped prematurely|9|||
33355487|NCT04800315|101187963|FG000|Randomization|Did not receive study treatment|1|||
33355488|NCT04800315|101187964|FG001|Randomization|Did not receive study treatment|0|||
33355489|NCT04800315|101187965|FG002|Randomization|Did not receive study treatment|0|||
33355490|NCT04800315|101187966|FG003|Randomization|Did not receive study treatment|0|||
33355491|NCT04800315|101187963|FG000|Treatment Period|Adverse Event|4|||
33355492|NCT04800315|101187964|FG001|Treatment Period|Adverse Event|2|||
33355493|NCT04800315|101187965|FG002|Treatment Period|Adverse Event|1|||
33355494|NCT04800315|101187966|FG003|Treatment Period|Adverse Event|2|||
33355495|NCT04800315|101187963|FG000|Treatment Period|Lack of Efficacy|1|||
33355496|NCT04800315|101187964|FG001|Treatment Period|Lack of Efficacy|0|||
33355497|NCT04800315|101187965|FG002|Treatment Period|Lack of Efficacy|0|||
33355498|NCT04800315|101187966|FG003|Treatment Period|Lack of Efficacy|3|||
33355499|NCT04800315|101187963|FG000|Treatment Period|Lost to Follow-up|0|||
33355500|NCT04800315|101187964|FG001|Treatment Period|Lost to Follow-up|1|||
33355501|NCT04800315|101187965|FG002|Treatment Period|Lost to Follow-up|2|||
33355502|NCT04800315|101187966|FG003|Treatment Period|Lost to Follow-up|2|||
33355503|NCT04800315|101187963|FG000|Treatment Period|Withdrawal by participant|0|||
33355504|NCT04800315|101187964|FG001|Treatment Period|Withdrawal by participant|0|||
33355505|NCT04800315|101187965|FG002|Treatment Period|Withdrawal by participant|0|||
33355506|NCT04800315|101187966|FG003|Treatment Period|Withdrawal by participant|4|||
33355507|NCT04800315|101187963|FG000|Treatment Period|Other Reasons|0|||
33355508|NCT04800315|101187964|FG001|Treatment Period|Other Reasons|2|||
33355509|NCT04800315|101187965|FG002|Treatment Period|Other Reasons|0|||
33355510|NCT04800315|101187966|FG003|Treatment Period|Other Reasons|1|||
33355511|NCT04091217|101187967|FG000|Overall Study|Lost to Follow-up|2|||
33355512|NCT00162773|101187968|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
33355513|NCT02698410|101187969|FG000|Overall Study|Adverse Event|2|||
33355514|NCT02698410|101187969|FG000|Overall Study|Withdrawal by Subject|1|||
33355515|NCT02698410|101187969|FG000|Overall Study|Other|1|||
33355516|NCT04927312|101187970|FG000|Overall Study|Adverse Event|1|||
33355517|NCT04927312|101187970|FG000|Overall Study|Death|1|||
33355518|NCT04927312|101187970|FG000|Overall Study|Withdrawal by Subject|1|||
33355519|NCT04927312|101187970|FG000|Overall Study|Other|1|||
33355520|NCT03577990|101187971|FG000|Overall Study|Lost to Follow-up|4|||
33355521|NCT03577990|101187972|FG001|Overall Study|Lost to Follow-up|6|||
33355522|NCT03577990|101187971|FG000|Overall Study|Withdrawal by Subject|4|||
33355523|NCT03577990|101187972|FG001|Overall Study|Withdrawal by Subject|7|||
33355524|NCT02209506|101187973|FG000|Overall Study|Withdrawal by Subject|0|||
33355525|NCT02209506|101187974|FG001|Overall Study|Withdrawal by Subject|0|||
33355526|NCT02209506|101187975|FG002|Overall Study|Withdrawal by Subject|0|||
33355527|NCT02209506|101187976|FG003|Overall Study|Withdrawal by Subject|0|||
33355528|NCT02209506|101187977|FG004|Overall Study|Withdrawal by Subject|1|||
33355529|NCT00476086|101187985|FG000|Overall Study|Alternative therapy|1|||
33355530|NCT00476086|101187985|FG000|Overall Study|Progressive Disease|4|||
33413855|NCT00968539|101403791|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
33413856|NCT03602976|101403795|FG000|Overall Study|Withdrawal by Subject|1|||
33413857|NCT01100073|101406417|FG000|Overall Study|Lack of Efficacy|4|||
33413858|NCT01100073|101406417|FG000|Overall Study|Insufficient Tolerability|21|||
33413859|NCT01100073|101406417|FG000|Overall Study|Withdrawal by Subject|13|||
33413860|NCT01100073|101406417|FG000|Overall Study|Lost to Follow-up|39|||
33413861|NCT01100073|101406417|FG000|Overall Study|Lack of effect + patient's wish|2|||
33413862|NCT01100073|101406417|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
33413863|NCT01100073|101406417|FG000|Overall Study|Other|8|||
33413864|NCT01100073|101406417|FG000|Overall Study|Missing|5|||
33413865|NCT02297438|101406418|FG000|Overall Study|Death|79|||
33413866|NCT02297438|101406419|FG001|Overall Study|Death|86|||
33413867|NCT02297438|101406418|FG000|Overall Study|Lost to Follow-up|9|||
33413868|NCT02297438|101406419|FG001|Overall Study|Lost to Follow-up|7|||
33413869|NCT02297438|101406418|FG000|Overall Study|Withdrawal by Subject|7|||
33413870|NCT02297438|101406419|FG001|Overall Study|Withdrawal by Subject|0|||
33413871|NCT02297438|101406418|FG000|Overall Study|Other|9|||
33413872|NCT02297438|101406419|FG001|Overall Study|Other|5|||
33413873|NCT02297438|101406418|FG000|Overall Study|Ongoing|65|||
33413874|NCT02297438|101406419|FG001|Overall Study|Ongoing|73|||
33413875|NCT00285012|101406420|FG000|Assigned to Study Treatment (Tx)|Other|2|||
33413876|NCT00285012|101406421|FG001|Assigned to Study Treatment (Tx)|Other|3|||
33413877|NCT00285012|101406420|FG000|Received Study Tx|Death|2|||
33413878|NCT00285012|101406421|FG001|Received Study Tx|Death|1|||
33413879|NCT00285012|101406420|FG000|Received Study Tx|Adverse Event|5|||
33413880|NCT00285012|101406421|FG001|Received Study Tx|Adverse Event|11|||
33413881|NCT00285012|101406420|FG000|Received Study Tx|Lack of Efficacy|0|||
33413882|NCT00285012|101406421|FG001|Received Study Tx|Lack of Efficacy|3|||
33413883|NCT00285012|101406420|FG000|Received Study Tx|Lost to Follow-up|29|||
33555230|NCT00098293|101932006|FG004|Open-label (OL) Phase|Protocol Violation|0|||
33355531|NCT01682044|101187986|FG000|Overall Study|Death|1|||
33355532|NCT01682044|101187986|FG000|Overall Study|Progression|3|||
33620989|NCT00920855|102161829|FG001|Overall Study|Withdrawal by Subject|1|||
33620990|NCT00920855|102161830|FG002|Overall Study|Withdrawal by Subject|6|||
33620991|NCT00920855|102161828|FG000|Overall Study|Disease progression|2|||
33620992|NCT00920855|102161829|FG001|Overall Study|Disease progression|1|||
33620993|NCT00920855|102161830|FG002|Overall Study|Disease progression|10|||
33620994|NCT00920855|102161828|FG000|Overall Study|Noncompliance to study medication|0|||
33620995|NCT00920855|102161829|FG001|Overall Study|Noncompliance to study medication|0|||
33355533|NCT05139030|101187989|FG000|Overall Study|Withdrawal by Subject|1|||
33355534|NCT05139030|101187990|FG001|Overall Study|Withdrawal by Subject|3|||
33355535|NCT05139030|101187989|FG000|Overall Study|Adverse Event|0|||
33355536|NCT05139030|101187990|FG001|Overall Study|Adverse Event|1|||
33355537|NCT05139030|101187989|FG000|Overall Study|Failure to meet continuation criteria|0|||
33355538|NCT05139030|101187990|FG001|Overall Study|Failure to meet continuation criteria|1|||
33355539|NCT01973283|101187994|FG000|Overall Study|Lost to Follow-up|4|||
33355540|NCT01931865|101187995|FG000|Overall Study|Lost to Follow-up|2|||
33355541|NCT01931865|101187995|FG000|Overall Study|Withdrawal by Subject|2|||
33355542|NCT02561156|101187996|FG000|Part 2|Adverse Event|0|||
33355543|NCT02561156|101187997|FG001|Part 2|Adverse Event|0|||
33355544|NCT02561156|101187998|FG002|Part 2|Adverse Event|0|||
33355545|NCT02561156|101187999|FG003|Part 2|Adverse Event|0|||
33355546|NCT02561156|101188000|FG004|Part 2|Adverse Event|0|||
33555231|NCT00098293|101932002|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
33555232|NCT00098293|101932003|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
33555233|NCT00098293|101932004|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
33555234|NCT00098293|101932005|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
33555235|NCT00098293|101932006|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
33555236|NCT00098293|101932002|FG000|Open-label (OL) Phase|Death|0|||
33555237|NCT00098293|101932003|FG001|Open-label (OL) Phase|Death|2|||
33555238|NCT00098293|101932004|FG002|Open-label (OL) Phase|Death|3|||
33555239|NCT00098293|101932005|FG003|Open-label (OL) Phase|Death|0|||
33620996|NCT00920855|102161830|FG002|Overall Study|Noncompliance to study medication|1|||
33620997|NCT00920855|102161828|FG000|Overall Study|Response plateau; started maintenance|0|||
33620998|NCT00920855|102161829|FG001|Overall Study|Response plateau; started maintenance|0|||
33413884|NCT00285012|101406421|FG001|Received Study Tx|Lost to Follow-up|31|||
33355547|NCT02561156|101188001|FG005|Part 2|Adverse Event|0|||
33355548|NCT02561156|101188002|FG006|Part 2|Adverse Event|0|||
33413885|NCT00285012|101406420|FG000|Received Study Tx|Withdrawal by Subject|31|||
33413886|NCT00285012|101406421|FG001|Received Study Tx|Withdrawal by Subject|43|||
33413887|NCT00285012|101406420|FG000|Received Study Tx|Other|5|||
33413888|NCT00285012|101406421|FG001|Received Study Tx|Other|5|||
33413889|NCT00924820|101406448|FG000|Overall Study|Death|2|||
33413890|NCT00924820|101406448|FG000|Overall Study|Ineligible, Screen Failure|5|||
33555240|NCT00098293|101932006|FG004|Open-label (OL) Phase|Death|0|||
33555241|NCT00098293|101932002|FG000|Supplemental Phase (SP)|Death|0|||
33355549|NCT02561156|101188003|FG007|Part 2|Adverse Event|0|||
33355550|NCT02561156|101188004|FG008|Part 2|Adverse Event|0|||
33555242|NCT00098293|101932003|FG001|Supplemental Phase (SP)|Death|0|||
33555243|NCT00098293|101932004|FG002|Supplemental Phase (SP)|Death|0|||
33555244|NCT00098293|101932005|FG003|Supplemental Phase (SP)|Death|0|||
33555245|NCT00098293|101932006|FG004|Supplemental Phase (SP)|Death|1|||
33555246|NCT00098293|101932002|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
33555247|NCT00098293|101932003|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
33555248|NCT00098293|101932004|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
33555249|NCT00098293|101932005|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
33555250|NCT00098293|101932006|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
33620999|NCT00920855|102161830|FG002|Overall Study|Response plateau; started maintenance|1|||
33621000|NCT02679755|102161833|FG000|Overall Study|Death|0|||
33621001|NCT02679755|102161834|FG001|Overall Study|Death|3|||
33621002|NCT02679755|102161833|FG000|Overall Study|Global deterioration of health status|1|||
33621003|NCT02679755|102161834|FG001|Overall Study|Global deterioration of health status|8|||
33621004|NCT02679755|102161833|FG000|Overall Study|Lost to Follow-up|1|||
33621005|NCT02679755|102161834|FG001|Overall Study|Lost to Follow-up|0|||
33621006|NCT02679755|102161833|FG000|Overall Study|Objective progression or relapse|24|||
33621007|NCT02679755|102161834|FG001|Overall Study|Objective progression or relapse|83|||
33621008|NCT02679755|102161833|FG000|Overall Study|Not defined|0|||
33621009|NCT02679755|102161834|FG001|Overall Study|Not defined|2|||
33621010|NCT02679755|102161833|FG000|Overall Study|Withdrawal by participant|6|||
33621011|NCT02679755|102161834|FG001|Overall Study|Withdrawal by participant|3|||
33621012|NCT02679755|102161833|FG000|Overall Study|Adverse Event|1|||
33621013|NCT02679755|102161834|FG001|Overall Study|Adverse Event|4|||
33621014|NCT02679755|102161833|FG000|Overall Study|Adverse events not related to study drug|1|||
33621015|NCT02679755|102161834|FG001|Overall Study|Adverse events not related to study drug|2|||
33621016|NCT00556894|102161839|FG000|Overall Study|Adverse Event|2|||
33621017|NCT00556894|102161840|FG001|Overall Study|Adverse Event|3|||
33621018|NCT00556894|102161841|FG002|Overall Study|Adverse Event|3|||
33621019|NCT00556894|102161839|FG000|Overall Study|Death|1|||
33621020|NCT00556894|102161840|FG001|Overall Study|Death|0|||
33621021|NCT00556894|102161841|FG002|Overall Study|Death|0|||
33621022|NCT00556894|102161839|FG000|Overall Study|regulatory decision in Bulgaria|10|||
33621023|NCT00556894|102161840|FG001|Overall Study|regulatory decision in Bulgaria|14|||
33621024|NCT00556894|102161841|FG002|Overall Study|regulatory decision in Bulgaria|13|||
33621025|NCT00556894|102161839|FG000|Overall Study|Change in therapy|2|||
33621026|NCT00556894|102161840|FG001|Overall Study|Change in therapy|1|||
33621027|NCT00556894|102161841|FG002|Overall Study|Change in therapy|2|||
33621028|NCT00556894|102161839|FG000|Overall Study|Withdrawal by Subject|1|||
33621029|NCT00556894|102161840|FG001|Overall Study|Withdrawal by Subject|1|||
33621030|NCT00556894|102161841|FG002|Overall Study|Withdrawal by Subject|1|||
33621031|NCT02380287|102161842|FG000|Overall Study|Adverse Event|0|||
33621032|NCT02380287|102161843|FG001|Overall Study|Adverse Event|0|||
33555251|NCT00098293|101932002|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
33555252|NCT00098293|101932003|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
33555253|NCT00098293|101932004|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
33555254|NCT00098293|101932005|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
33555255|NCT00098293|101932006|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
33555256|NCT00098293|101932002|FG000|Supplemental Phase (SP)|Other|0|||
33555257|NCT00098293|101932003|FG001|Supplemental Phase (SP)|Other|0|||
33555258|NCT00098293|101932004|FG002|Supplemental Phase (SP)|Other|0|||
33555259|NCT00098293|101932005|FG003|Supplemental Phase (SP)|Other|0|||
33555260|NCT00098293|101932006|FG004|Supplemental Phase (SP)|Other|22|||
33555261|NCT01712074|101932007|FG000|Placebo Run-in Period|Adverse Event|2|||
33555262|NCT01712074|101932008|FG001|Placebo Run-in Period|Adverse Event|0|||
33555263|NCT01712074|101932009|FG002|Placebo Run-in Period|Adverse Event|0|||
33555264|NCT01712074|101932007|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
33555265|NCT01712074|101932008|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
33621033|NCT02380287|102161844|FG002|Overall Study|Adverse Event|1|||
33621034|NCT02380287|102161845|FG003|Overall Study|Adverse Event|0|||
33621035|NCT02380287|102161846|FG004|Overall Study|Adverse Event|0|||
33621036|NCT02380287|102161847|FG005|Overall Study|Adverse Event|0|||
33621037|NCT02380287|102161848|FG006|Overall Study|Adverse Event|0|||
33621038|NCT02380287|102161849|FG007|Overall Study|Adverse Event|0|||
33355551|NCT02561156|101188005|FG009|Part 2|Adverse Event|0|||
33555266|NCT01712074|101932009|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
33555267|NCT01712074|101932007|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
33555268|NCT01712074|101932008|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
33555269|NCT01712074|101932009|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
33555270|NCT01712074|101932007|FG000|Placebo Run-in Period|Other|1|||
33555271|NCT01712074|101932008|FG001|Placebo Run-in Period|Other|0|||
33555272|NCT01712074|101932009|FG002|Placebo Run-in Period|Other|0|||
33555273|NCT01712074|101932007|FG000|Placebo Run-in Period|No longer willing to participate|1|||
33555274|NCT01712074|101932008|FG001|Placebo Run-in Period|No longer willing to participate|0|||
33555275|NCT01712074|101932009|FG002|Placebo Run-in Period|No longer willing to participate|0|||
33555276|NCT01712074|101932007|FG000|Double Blind Period|Adverse Event|0|||
33555277|NCT01712074|101932008|FG001|Double Blind Period|Adverse Event|2|||
33555278|NCT01712074|101932009|FG002|Double Blind Period|Adverse Event|1|||
33555279|NCT01712074|101932007|FG000|Double Blind Period|No longer willing to participate|0|||
33555280|NCT01712074|101932008|FG001|Double Blind Period|No longer willing to participate|2|||
33555281|NCT01712074|101932009|FG002|Double Blind Period|No longer willing to participate|4|||
33555282|NCT01712074|101932007|FG000|Double Blind Period|Death|0|||
33555283|NCT01712074|101932008|FG001|Double Blind Period|Death|1|||
33555284|NCT01712074|101932009|FG002|Double Blind Period|Death|0|||
33555285|NCT01712074|101932007|FG000|Double Blind Period|Lost to Follow-up|0|||
33555286|NCT01712074|101932008|FG001|Double Blind Period|Lost to Follow-up|2|||
33555287|NCT01712074|101932009|FG002|Double Blind Period|Lost to Follow-up|1|||
33555288|NCT01712074|101932007|FG000|Double Blind Period|Other|0|||
33555289|NCT01712074|101932008|FG001|Double Blind Period|Other|4|||
33555290|NCT01712074|101932009|FG002|Double Blind Period|Other|1|||
33555291|NCT01712074|101932007|FG000|Double Blind Period|Protocol Violation|0|||
33555292|NCT01712074|101932008|FG001|Double Blind Period|Protocol Violation|0|||
33555293|NCT01712074|101932009|FG002|Double Blind Period|Protocol Violation|1|||
33555294|NCT01712074|101932007|FG000|Double Blind Period|No longer met eligibility criteria|0|||
33555295|NCT01712074|101932008|FG001|Double Blind Period|No longer met eligibility criteria|3|||
33555296|NCT01712074|101932009|FG002|Double Blind Period|No longer met eligibility criteria|0|||
33555297|NCT04584554|101932010|FG000|Overall Study|Withdrawal by Subject|2|||
33555298|NCT04584554|101932011|FG001|Overall Study|Withdrawal by Subject|2|||
33555299|NCT02400736|101932012|FG000|Overall Study|Lost to Follow-up|6|||
33555300|NCT02400736|101932013|FG001|Overall Study|Lost to Follow-up|6|||
33555301|NCT02400736|101932012|FG000|Overall Study|Withdrawal by Subject|2|||
33555302|NCT02400736|101932013|FG001|Overall Study|Withdrawal by Subject|1|||
33555303|NCT02400736|101932012|FG000|Overall Study|Moved from the area|3|||
33555304|NCT02400736|101932013|FG001|Overall Study|Moved from the area|1|||
33555305|NCT00145327|101932017|FG000|Overall Study|Withdrawal by Subject|77|||
33555306|NCT00145327|101932018|FG001|Overall Study|Withdrawal by Subject|72|||
33555307|NCT00145327|101932019|FG002|Overall Study|Withdrawal by Subject|164|||
33555308|NCT00145327|101932017|FG000|Overall Study|Death|26|||
33555309|NCT00145327|101932018|FG001|Overall Study|Death|18|||
33621039|NCT04816214|102161857|FG000|Overall Study|Progressive Disease|4|||
33621040|NCT04816214|102161858|FG001|Overall Study|Progressive Disease|0|||
33621041|NCT04816214|102161859|FG002|Overall Study|Progressive Disease|0|||
33621042|NCT04816214|102161857|FG000|Overall Study|Death|1|||
33621043|NCT04816214|102161858|FG001|Overall Study|Death|0|||
33621044|NCT04816214|102161859|FG002|Overall Study|Death|0|||
33621045|NCT04816214|102161857|FG000|Overall Study|Study Terminated by Sponsor|1|||
33621046|NCT04816214|102161858|FG001|Overall Study|Study Terminated by Sponsor|0|||
33621047|NCT04816214|102161859|FG002|Overall Study|Study Terminated by Sponsor|0|||
33355552|NCT02561156|101188006|FG010|Part 2|Adverse Event|0|||
33555310|NCT00145327|101932019|FG002|Overall Study|Death|30|||
33555311|NCT00145327|101932017|FG000|Overall Study|Adverse Event|14|||
33555312|NCT00145327|101932018|FG001|Overall Study|Adverse Event|11|||
33555313|NCT00145327|101932019|FG002|Overall Study|Adverse Event|22|||
33555314|NCT00145327|101932017|FG000|Overall Study|Lost to Follow-up|9|||
33555315|NCT00145327|101932018|FG001|Overall Study|Lost to Follow-up|14|||
33555316|NCT00145327|101932019|FG002|Overall Study|Lost to Follow-up|14|||
33555317|NCT00145327|101932017|FG000|Overall Study|Administrative problems|12|||
33621048|NCT03594773|102161860|FG000|Overall Study|Withdrawal by Subject|3|||
33621049|NCT03594773|102161861|FG001|Overall Study|Withdrawal by Subject|2|||
33621050|NCT03594773|102161860|FG000|Overall Study|Lost to Follow-up|3|||
33621051|NCT03594773|102161861|FG001|Overall Study|Lost to Follow-up|4|||
33621052|NCT02698826|102161862|FG000|Overall Study|Death|13|||
33621053|NCT02698826|102161862|FG000|Overall Study|Adverse Event|1|||
33355553|NCT02561156|101188007|FG011|Part 2|Adverse Event|1|||
33355554|NCT02561156|101188008|FG012|Part 2|Adverse Event|0|||
33218127|NCT03260868|100695961|FG001|Overall Study|Study Terminated By Sponsor|1|||
33355555|NCT03815175|101188009|FG000|Overall Study|Subject Lost to Follow-up|6|||
33355556|NCT03815175|101188009|FG000|Overall Study|Subject Withdrew Consent|48|||
33355557|NCT03815175|101188009|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
33355558|NCT03815175|101188009|FG000|Overall Study|Death|86|||
33355559|NCT03815175|101188009|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
33355560|NCT03815175|101188009|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
33355561|NCT03815175|101188009|FG000|Overall Study|Other Status Change Reason|1|||
33355562|NCT03815175|101188009|FG000|Overall Study|Missed Visit|12|||
33355563|NCT02468193|101188013|FG000|Overall Study|Adverse Event|4|||
33355564|NCT02468193|101188013|FG000|Overall Study|Subject/ Guardian decision|2|||
33355565|NCT00986349|101188014|FG000|Overall Study|Unsuccessful implant procedure|3|||
33355566|NCT00986349|101188014|FG000|Overall Study|Adverse Event|2|||
33355567|NCT00986349|101188014|FG000|Overall Study|Physician Decision|1|||
33355568|NCT00986349|101188014|FG000|Overall Study|device migration|1|||
33355569|NCT02120417|101188015|FG000|Overall Study|Death|5|||
33355570|NCT02120417|101188016|FG001|Overall Study|Death|1|||
33355571|NCT02120417|101188015|FG000|Overall Study|Adverse Event|3|||
33355572|NCT02120417|101188016|FG001|Overall Study|Adverse Event|9|||
33355573|NCT02120417|101188015|FG000|Overall Study|Participant decision|4|||
33355574|NCT02120417|101188016|FG001|Overall Study|Participant decision|4|||
33355575|NCT02120417|101188015|FG000|Overall Study|Disease progression|41|||
33355576|NCT02120417|101188016|FG001|Overall Study|Disease progression|45|||
33355577|NCT02120417|101188015|FG000|Overall Study|Noncompliance with study treatment|0|||
33413891|NCT04003103|101406449|FG000|Overall Study|Death|1|||
33413892|NCT04003103|101406450|FG001|Overall Study|Death|0|||
33413893|NCT04003103|101406451|FG002|Overall Study|Death|0|||
33413894|NCT04003103|101406449|FG000|Overall Study|Lost to Follow-up|4|||
33413895|NCT04003103|101406450|FG001|Overall Study|Lost to Follow-up|3|||
33413896|NCT04003103|101406451|FG002|Overall Study|Lost to Follow-up|2|||
33413897|NCT04003103|101406449|FG000|Overall Study|Withdrawal by Subject|10|||
33413898|NCT04003103|101406450|FG001|Overall Study|Withdrawal by Subject|1|||
33413899|NCT04003103|101406451|FG002|Overall Study|Withdrawal by Subject|1|||
33413900|NCT04003103|101406449|FG000|Overall Study|Status not recorded|0|||
33413901|NCT04003103|101406450|FG001|Overall Study|Status not recorded|2|||
33413902|NCT04003103|101406451|FG002|Overall Study|Status not recorded|0|||
33413903|NCT01060007|101406452|FG000|Overall Study|Withdrawal by Subject|1|||
33413904|NCT01060007|101406452|FG000|Overall Study|Inevaluable for response at surgery|3|||
33413905|NCT04054011|101406453|FG000|Overall Study|COVID|3|||
33413906|NCT03668613|101406454|FG000|Overall Study|Adverse Event|1|||
33413907|NCT03668613|101406455|FG001|Overall Study|Adverse Event|2|||
33413908|NCT03668613|101406454|FG000|Overall Study|Lack of Efficacy|5|||
33555318|NCT00145327|101932018|FG001|Overall Study|Administrative problems|9|||
33555319|NCT00145327|101932019|FG002|Overall Study|Administrative problems|13|||
33555320|NCT00145327|101932017|FG000|Overall Study|Protocol Violation|2|||
33555321|NCT00145327|101932018|FG001|Overall Study|Protocol Violation|0|||
33555322|NCT00145327|101932019|FG002|Overall Study|Protocol Violation|2|||
33555323|NCT00145327|101932017|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33555324|NCT00145327|101932018|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33555325|NCT00145327|101932019|FG002|Overall Study|Abnormal laboratory value(s)|2|||
33555326|NCT00145327|101932017|FG000|Overall Study|Missing - not stated|1|||
33555327|NCT00145327|101932018|FG001|Overall Study|Missing - not stated|0|||
33621054|NCT00330759|102161865|FG000|Overall Study|Death|316|||
33621055|NCT00330759|102161866|FG001|Overall Study|Death|310|||
33621056|NCT00330759|102161865|FG000|Overall Study|Disease progression|104|||
33621057|NCT00330759|102161866|FG001|Overall Study|Disease progression|126|||
33355578|NCT02120417|101188016|FG001|Overall Study|Noncompliance with study treatment|2|||
33355579|NCT02120417|101188015|FG000|Overall Study|Physician Decision|2|||
33355580|NCT02120417|101188016|FG001|Overall Study|Physician Decision|3|||
33355581|NCT02120417|101188015|FG000|Overall Study|Other unspecified|5|||
33355582|NCT02120417|101188016|FG001|Overall Study|Other unspecified|4|||
33413909|NCT03668613|101406455|FG001|Overall Study|Lack of Efficacy|1|||
33413910|NCT03668613|101406454|FG000|Overall Study|Pregnancy|0|||
33555328|NCT00145327|101932019|FG002|Overall Study|Missing - not stated|1|||
33218128|NCT03260868|100695960|FG000|Overall Study|Other than specified above|1|||
33355583|NCT02469246|101188018|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
33355584|NCT02469246|101188019|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
33355585|NCT02469246|101188018|FG000|Double-Blind Phase|Adverse Event|12|||
33355586|NCT02469246|101188019|FG001|Double-Blind Phase|Adverse Event|9|||
33355587|NCT02469246|101188018|FG000|Double-Blind Phase|Death|2|||
33355588|NCT02469246|101188019|FG001|Double-Blind Phase|Death|0|||
33413911|NCT03668613|101406455|FG001|Overall Study|Pregnancy|2|||
33621058|NCT00330759|102161865|FG000|Overall Study|Withdrawal by Subject|143|||
33355589|NCT02469246|101188018|FG000|Double-Blind Phase|Lack of Efficacy|2|||
33355590|NCT02469246|101188019|FG001|Double-Blind Phase|Lack of Efficacy|1|||
33355591|NCT02469246|101188018|FG000|Double-Blind Phase|Investigator's Discretion|8|||
33355592|NCT02469246|101188019|FG001|Double-Blind Phase|Investigator's Discretion|8|||
33355593|NCT02469246|101188018|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
33355594|NCT02469246|101188019|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
33355595|NCT02469246|101188018|FG000|Double-Blind Phase|Protocol Violation|1|||
33355596|NCT02469246|101188019|FG001|Double-Blind Phase|Protocol Violation|1|||
33355597|NCT02469246|101188018|FG000|Double-Blind Phase|Withdrew Consent|25|||
33355598|NCT02469246|101188019|FG001|Double-Blind Phase|Withdrew Consent|25|||
33355599|NCT02469246|101188018|FG000|Double-Blind Phase|Lost to Follow-up|9|||
33355600|NCT02469246|101188019|FG001|Double-Blind Phase|Lost to Follow-up|5|||
33355601|NCT00742781|101188021|FG000|Overall Study|Withdrawal by Subject|3|||
33355602|NCT03830281|101188022|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
33355603|NCT03830281|101188023|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
33355604|NCT03830281|101188022|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
33355605|NCT03830281|101188023|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
33355606|NCT03830281|101188022|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
33355607|NCT03830281|101188023|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
33355608|NCT03830281|101188022|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
33355609|NCT03830281|101188023|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
33355610|NCT03830281|101188022|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
33355611|NCT03830281|101188023|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
33355612|NCT03830281|101188022|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
33355613|NCT03830281|101188023|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
33355614|NCT03830281|101188022|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
33355615|NCT03830281|101188023|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
33355616|NCT03830281|101188022|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
33355617|NCT03830281|101188023|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
33355618|NCT03830281|101188022|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
33355619|NCT03830281|101188023|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
33355620|NCT02951052|101188024|FG000|Overall Study|Adverse Event|13|||
33355621|NCT02951052|101188025|FG001|Overall Study|Adverse Event|5|||
33355622|NCT02951052|101188024|FG000|Overall Study|Withdrawal by Subject|1|||
33355623|NCT02951052|101188025|FG001|Overall Study|Withdrawal by Subject|5|||
33355624|NCT02951052|101188024|FG000|Overall Study|Physician Decision|2|||
33355625|NCT02951052|101188025|FG001|Overall Study|Physician Decision|0|||
33355626|NCT02951052|101188024|FG000|Overall Study|Lost to Follow-up|1|||
33355627|NCT02951052|101188025|FG001|Overall Study|Lost to Follow-up|1|||
33355628|NCT02951052|101188024|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
33355629|NCT02951052|101188025|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
33355630|NCT02951052|101188024|FG000|Overall Study|Protocol Violation|5|||
33355631|NCT02951052|101188025|FG001|Overall Study|Protocol Violation|3|||
33355632|NCT02951052|101188024|FG000|Overall Study|Lack of Efficacy|3|||
33355633|NCT02951052|101188025|FG001|Overall Study|Lack of Efficacy|4|||
33355634|NCT02951052|101188024|FG000|Overall Study|Ongoing|1|||
33355635|NCT02951052|101188025|FG001|Overall Study|Ongoing|0|||
33355636|NCT01076179|101188031|FG000|Overall Study|Withdrawal by Subject|1|||
33355637|NCT03323749|101188032|FG000|Double-blind Period|Lost to Follow-up|4|||
33355638|NCT03323749|101188033|FG001|Double-blind Period|Lost to Follow-up|5|||
33355639|NCT03323749|101188032|FG000|Double-blind Period|Adverse Event|3|||
33355640|NCT03323749|101188033|FG001|Double-blind Period|Adverse Event|1|||
33355641|NCT03323749|101188032|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
33355642|NCT03323749|101188033|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
33355643|NCT03323749|101188032|FG000|Open-Label Period|Adverse Event|3|||
33355644|NCT03323749|101188033|FG001|Open-Label Period|Adverse Event|10|||
33355645|NCT03323749|101188032|FG000|Open-Label Period|Withdrawal by Subject|7|||
33355646|NCT03323749|101188033|FG001|Open-Label Period|Withdrawal by Subject|5|||
33355647|NCT04964258|101188034|FG000|Overall Study|Lost to Follow-up|1|||
33355648|NCT04964258|101188035|FG001|Overall Study|Lost to Follow-up|0|||
33355649|NCT04964258|101188036|FG002|Overall Study|Lost to Follow-up|0|||
33355650|NCT04964258|101188037|FG003|Overall Study|Lost to Follow-up|0|||
33355651|NCT04964258|101188038|FG004|Overall Study|Lost to Follow-up|0|||
33355652|NCT04964258|101188039|FG005|Overall Study|Lost to Follow-up|1|||
33355653|NCT04964258|101188040|FG006|Overall Study|Lost to Follow-up|0|||
33355654|NCT04964258|101188041|FG007|Overall Study|Lost to Follow-up|0|||
33355655|NCT04964258|101188042|FG008|Overall Study|Lost to Follow-up|0|||
33355656|NCT04964258|101188043|FG009|Overall Study|Lost to Follow-up|0|||
33621059|NCT00330759|102161866|FG001|Overall Study|Withdrawal by Subject|124|||
33355657|NCT04964258|101188044|FG010|Overall Study|Lost to Follow-up|0|||
33355658|NCT03311126|101188050|FG000|Induction|Death|1|||
33355659|NCT03311126|101188050|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
33355660|NCT01650805|101188051|FG000|Overall Study|Withdrawal by Subject|1|||
33621060|NCT00330759|102161865|FG000|Overall Study|Adverse Event|48|||
33413912|NCT03668613|101406454|FG000|Overall Study|Protocol Violation|1|||
33355661|NCT01650805|101188052|FG001|Overall Study|Withdrawal by Subject|0|||
33355662|NCT02207907|101188053|FG000|Overall Study|Lost to Follow-up|3|||
33355663|NCT02207907|101188054|FG001|Overall Study|Lost to Follow-up|1|||
33355664|NCT02207907|101188053|FG000|Overall Study|Withdrawal by Subject|5|||
33355665|NCT02207907|101188054|FG001|Overall Study|Withdrawal by Subject|6|||
33355666|NCT02207907|101188053|FG000|Overall Study|Did not meet study criteria|3|||
33355667|NCT02207907|101188054|FG001|Overall Study|Did not meet study criteria|0|||
33355668|NCT02207907|101188053|FG000|Overall Study|Pregnancy|0|||
33355669|NCT02207907|101188054|FG001|Overall Study|Pregnancy|1|||
33355670|NCT00519077|101188055|FG000|Overall Study|Death|6|||
33355671|NCT00519077|101188055|FG000|Overall Study|Other|2|||
33355672|NCT03486314|101191367|FG000|Part A|Adverse Event|1|||
33355673|NCT03486314|101191368|FG001|Part A|Adverse Event|0|||
33355674|NCT03486314|101191369|FG002|Part A|Adverse Event|0|||
33355675|NCT03486314|101191367|FG000|Part A|Symptomatic Deterioration|2|||
33355676|NCT03486314|101191368|FG001|Part A|Symptomatic Deterioration|0|||
33355677|NCT03486314|101191369|FG002|Part A|Symptomatic Deterioration|0|||
33355678|NCT03542682|101191371|FG000|Overall Study|COVID-19 Protocol|0|||
33355679|NCT03542682|101191372|FG001|Overall Study|COVID-19 Protocol|1|||
33355680|NCT00363415|101191373|FG000|Overall Study|Progressive Disease|196|||
33355681|NCT00363415|101191374|FG001|Overall Study|Progressive Disease|107|||
33355682|NCT00363415|101191373|FG000|Overall Study|Sponsor Decision|67|||
33355683|NCT00363415|101191374|FG001|Overall Study|Sponsor Decision|31|||
33355684|NCT00363415|101191373|FG000|Overall Study|Death|32|||
33355685|NCT00363415|101191374|FG001|Overall Study|Death|29|||
33355686|NCT00363415|101191373|FG000|Overall Study|Adverse Event|24|||
33355687|NCT00363415|101191374|FG001|Overall Study|Adverse Event|15|||
33355688|NCT00363415|101191373|FG000|Overall Study|Physician Decision|18|||
33355689|NCT00363415|101191374|FG001|Overall Study|Physician Decision|35|||
33355690|NCT00363415|101191373|FG000|Overall Study|Entry Criteria Not Met|11|||
33413913|NCT03668613|101406455|FG001|Overall Study|Protocol Violation|0|||
33413914|NCT03668613|101406454|FG000|Overall Study|Physician Decision|1|||
33413915|NCT03668613|101406455|FG001|Overall Study|Physician Decision|0|||
33413916|NCT03668613|101406454|FG000|Overall Study|Withdrawal by Subject|2|||
33413917|NCT03668613|101406455|FG001|Overall Study|Withdrawal by Subject|1|||
33413918|NCT03668613|101406454|FG000|Overall Study|Guardian decision|1|||
33413919|NCT03668613|101406455|FG001|Overall Study|Guardian decision|0|||
33413920|NCT02797951|101406458|FG000|Overall Study|Adverse Event|4|||
33413921|NCT02797951|101406458|FG000|Overall Study|Death|1|||
33413922|NCT02797951|101406458|FG000|Overall Study|Lack of Efficacy|19|||
33413923|NCT02797951|101406458|FG000|Overall Study|Lost to Follow-up|4|||
33413924|NCT02797951|101406458|FG000|Overall Study|Physician Decision|6|||
33413925|NCT02797951|101406458|FG000|Overall Study|Withdrawal by Subject|15|||
33413926|NCT01300741|101406459|FG000|Overall Study|Lens deposits|1|||
33413927|NCT01300741|101406459|FG000|Overall Study|Lost to Follow-up|1|||
33413928|NCT01300741|101406459|FG000|Overall Study|Discomfort|1|||
33413929|NCT04513665|101406460|FG000|Overall Study|Adverse Event|2|||
33355691|NCT00363415|101191374|FG001|Overall Study|Entry Criteria Not Met|10|||
33355692|NCT00363415|101191373|FG000|Overall Study|Withdrawal by Subject|9|||
33355693|NCT00363415|101191374|FG001|Overall Study|Withdrawal by Subject|15|||
33355694|NCT00363415|101191373|FG000|Overall Study|Lost to Follow-up|3|||
33355695|NCT00363415|101191374|FG001|Overall Study|Lost to Follow-up|3|||
33355696|NCT00363415|101191373|FG000|Overall Study|Protocol Violation|1|||
33355697|NCT00363415|101191374|FG001|Overall Study|Protocol Violation|4|||
33355698|NCT04030195|101191378|FG000|Overall Study|Withdrawal by Subject|2|||
33355699|NCT04030195|101191379|FG001|Overall Study|Withdrawal by Subject|0|||
33355700|NCT04030195|101191380|FG002|Overall Study|Withdrawal by Subject|0|||
33355701|NCT00246259|101191387|FG000|Overall Study|Other|3|||
33355702|NCT00246259|101191388|FG001|Overall Study|Other|3|||
33355703|NCT00246259|101191387|FG000|Overall Study|Not stable by Week 18|2|||
33355704|NCT00246259|101191388|FG001|Overall Study|Not stable by Week 18|1|||
33413930|NCT04513665|101406461|FG001|Overall Study|Adverse Event|0|||
33413931|NCT04513665|101406460|FG000|Overall Study|Lack of Efficacy|14|||
33621061|NCT00330759|102161866|FG001|Overall Study|Adverse Event|36|||
33218129|NCT03260868|100695961|FG001|Overall Study|Other than specified above|0|||
33355705|NCT00246259|101191387|FG000|Overall Study|Participant non-compliant|4|||
33355706|NCT00246259|101191388|FG001|Overall Study|Participant non-compliant|9|||
33355707|NCT00246259|101191387|FG000|Overall Study|Lack of Efficacy|2|||
33355708|NCT00246259|101191388|FG001|Overall Study|Lack of Efficacy|2|||
33355709|NCT00246259|101191387|FG000|Overall Study|Investigator withdrew participant|2|||
33355710|NCT00246259|101191388|FG001|Overall Study|Investigator withdrew participant|0|||
33355711|NCT00246259|101191387|FG000|Overall Study|Adverse Event|5|||
33355712|NCT00246259|101191388|FG001|Overall Study|Adverse Event|0|||
33355713|NCT00246259|101191387|FG000|Overall Study|Lost to Follow-up|3|||
33413932|NCT04513665|101406461|FG001|Overall Study|Lack of Efficacy|0|||
33413933|NCT02975882|101406462|FG000|Overall Study|Adverse Event|1|||
33355714|NCT00246259|101191388|FG001|Overall Study|Lost to Follow-up|4|||
33355715|NCT00246259|101191387|FG000|Overall Study|Withdrawal by Subject|5|||
33355716|NCT00246259|101191388|FG001|Overall Study|Withdrawal by Subject|1|||
33621062|NCT00330759|102161865|FG000|Overall Study|Participant request|31|||
33621063|NCT00330759|102161866|FG001|Overall Study|Participant request|22|||
33355717|NCT00246259|101191387|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
33355718|NCT00246259|101191388|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
33355719|NCT02580058|101191389|FG000|Overall Study|Adverse Event|16|||
33355720|NCT02580058|101191390|FG001|Overall Study|Adverse Event|30|||
33355721|NCT02580058|101191391|FG002|Overall Study|Adverse Event|20|||
33355722|NCT02580058|101191389|FG000|Overall Study|Death|4|||
33355723|NCT02580058|101191390|FG001|Overall Study|Death|4|||
33555329|NCT01740427|101932020|FG000|Overall Study|Objective Progression or Relapse|286|||
33555330|NCT01740427|101932021|FG001|Overall Study|Objective Progression or Relapse|172|||
33555331|NCT01740427|101932020|FG000|Overall Study|Adverse Event|32|||
33555332|NCT01740427|101932021|FG001|Overall Study|Adverse Event|9|||
33555333|NCT01740427|101932020|FG000|Overall Study|Global Deterioration of Health Status|28|||
33555334|NCT01740427|101932021|FG001|Overall Study|Global Deterioration of Health Status|12|||
33555335|NCT01740427|101932020|FG000|Overall Study|Participant Refused Continued Treatment|27|||
33555336|NCT01740427|101932021|FG001|Overall Study|Participant Refused Continued Treatment|15|||
33555337|NCT01740427|101932020|FG000|Overall Study|Unspecified reasons|52|||
33555338|NCT01740427|101932021|FG001|Overall Study|Unspecified reasons|8|||
33555339|NCT01740427|101932020|FG000|Overall Study|Death|10|||
33555340|NCT01740427|101932021|FG001|Overall Study|Death|3|||
33555341|NCT01740427|101932020|FG000|Overall Study|Protocol Violation|5|||
33555342|NCT01740427|101932021|FG001|Overall Study|Protocol Violation|3|||
33555343|NCT01740427|101932020|FG000|Overall Study|Lost to Follow-up|3|||
33555344|NCT01740427|101932021|FG001|Overall Study|Lost to Follow-up|0|||
33555345|NCT01740427|101932020|FG000|Overall Study|Site Terminated by Sponsor|1|||
33555346|NCT01740427|101932021|FG001|Overall Study|Site Terminated by Sponsor|0|||
33555347|NCT00176254|101932025|FG000|Overall Study|Lost to Follow-up|1|||
33555348|NCT02151604|101932026|FG000|Overall Study|Lost to Follow-up|3|||
33555349|NCT02151604|101932026|FG000|Overall Study|Withdrawal by Subject|2|||
33555350|NCT02151604|101932026|FG000|Overall Study|Physician Decision|3|||
33555351|NCT02151604|101932026|FG000|Overall Study|Death|1|||
33555352|NCT00063999|101932027|FG000|Overall Study|Withdrawal by Subject|1|||
33555353|NCT00063999|101932028|FG001|Overall Study|Withdrawal by Subject|0|||
33555354|NCT00063999|101932027|FG000|Overall Study|Ineligible|44|||
33555355|NCT00063999|101932028|FG001|Overall Study|Ineligible|24|||
33555356|NCT00553475|101932033|FG000|Overall Study|Adverse Event|7|||
33555357|NCT00553475|101932034|FG001|Overall Study|Adverse Event|17|||
33555358|NCT00553475|101932035|FG002|Overall Study|Adverse Event|13|||
33555359|NCT00553475|101932033|FG000|Overall Study|Lack of Efficacy|7|||
33555360|NCT00553475|101932034|FG001|Overall Study|Lack of Efficacy|1|||
33555361|NCT00553475|101932035|FG002|Overall Study|Lack of Efficacy|0|||
33555362|NCT00553475|101932033|FG000|Overall Study|Withdrawal by Subject|1|||
33555363|NCT00553475|101932034|FG001|Overall Study|Withdrawal by Subject|1|||
33555364|NCT00553475|101932035|FG002|Overall Study|Withdrawal by Subject|0|||
33555365|NCT00553475|101932033|FG000|Overall Study|Physician Decision|1|||
33555366|NCT00553475|101932034|FG001|Overall Study|Physician Decision|0|||
33555367|NCT00553475|101932035|FG002|Overall Study|Physician Decision|0|||
33555368|NCT00553475|101932033|FG000|Overall Study|Due to moving|0|||
33555369|NCT00553475|101932034|FG001|Overall Study|Due to moving|1|||
33621064|NCT00330759|102161865|FG000|Overall Study|Lost to Follow-up|16|||
33621065|NCT00330759|102161866|FG001|Overall Study|Lost to Follow-up|22|||
33621066|NCT00330759|102161865|FG000|Overall Study|Noncompliance|15|||
33621067|NCT00330759|102161866|FG001|Overall Study|Noncompliance|17|||
33621068|NCT00330759|102161865|FG000|Overall Study|Physician Decision|1|||
33621069|NCT00330759|102161866|FG001|Overall Study|Physician Decision|2|||
33621070|NCT00330759|102161865|FG000|Overall Study|Protocol deviation|0|||
33621071|NCT00330759|102161866|FG001|Overall Study|Protocol deviation|2|||
33355724|NCT02580058|101191391|FG002|Overall Study|Death|5|||
33355725|NCT02580058|101191389|FG000|Overall Study|Physician Decision|1|||
33555370|NCT00553475|101932035|FG002|Overall Study|Due to moving|0|||
33355726|NCT02580058|101191390|FG001|Overall Study|Physician Decision|3|||
33555371|NCT01502072|101932036|FG000|Overall Study|Withdrawal by Subject|1|||
33555372|NCT01502072|101932037|FG001|Overall Study|Withdrawal by Subject|0|||
33555373|NCT01502072|101932038|FG002|Overall Study|Withdrawal by Subject|0|||
33555374|NCT01502072|101932036|FG000|Overall Study|Death|0|||
33555375|NCT01502072|101932037|FG001|Overall Study|Death|1|||
33555376|NCT01502072|101932038|FG002|Overall Study|Death|0|||
33555377|NCT00602641|101932039|FG000|Overall Study|Never started protocol therapy|6|||
33555378|NCT00602641|101932040|FG001|Overall Study|Never started protocol therapy|2|||
33621072|NCT00330759|102161865|FG000|Overall Study|Ineligibility determined|2|||
33621073|NCT00330759|102161866|FG001|Overall Study|Ineligibility determined|1|||
33355727|NCT02580058|101191391|FG002|Overall Study|Physician Decision|11|||
33555379|NCT00602641|101932039|FG000|Overall Study|Still on treatment at time of analysis|8|||
33621074|NCT00330759|102161865|FG000|Overall Study|Other|36|||
33555380|NCT00602641|101932040|FG001|Overall Study|Still on treatment at time of analysis|15|||
33555381|NCT00602641|101932039|FG000|Overall Study|Adverse Event|62|||
33555382|NCT00602641|101932040|FG001|Overall Study|Adverse Event|53|||
33555383|NCT00602641|101932039|FG000|Overall Study|Disease progression|38|||
33555384|NCT00602641|101932040|FG001|Overall Study|Disease progression|55|||
33555385|NCT00602641|101932039|FG000|Overall Study|Death|6|||
33555386|NCT00602641|101932040|FG001|Overall Study|Death|5|||
33555387|NCT00602641|101932039|FG000|Overall Study|Withdrawal by Subject|15|||
33555388|NCT00602641|101932040|FG001|Overall Study|Withdrawal by Subject|12|||
33621075|NCT00330759|102161866|FG001|Overall Study|Other|44|||
33413934|NCT02975882|101406463|FG001|Overall Study|Adverse Event|2|||
33413935|NCT02975882|101406464|FG002|Overall Study|Adverse Event|1|||
33413936|NCT02975882|101406465|FG003|Overall Study|Adverse Event|1|||
33413937|NCT02975882|101406462|FG000|Overall Study|Death|0|||
33621076|NCT00410761|102161867|FG000|Overall Study|Adverse Event|29|||
33621077|NCT00410761|102161868|FG001|Overall Study|Adverse Event|3|||
33355728|NCT02580058|101191389|FG000|Overall Study|Other|5|||
33355729|NCT02580058|101191390|FG001|Overall Study|Other|1|||
33355730|NCT02580058|101191391|FG002|Overall Study|Other|3|||
33355731|NCT02580058|101191389|FG000|Overall Study|Withdrawal by Subject|4|||
33355732|NCT02580058|101191390|FG001|Overall Study|Withdrawal by Subject|7|||
33355733|NCT02580058|101191391|FG002|Overall Study|Withdrawal by Subject|31|||
33355734|NCT02580058|101191389|FG000|Overall Study|Global Deterioration of Health Status|19|||
33555389|NCT00602641|101932039|FG000|Overall Study|Alternative therapy|5|||
33555390|NCT00602641|101932040|FG001|Overall Study|Alternative therapy|2|||
33555391|NCT00602641|101932039|FG000|Overall Study|Other Complicating Disease|5|||
33555392|NCT00602641|101932040|FG001|Overall Study|Other Complicating Disease|2|||
33555393|NCT00602641|101932039|FG000|Overall Study|Physician Decision|5|||
33555394|NCT00602641|101932040|FG001|Overall Study|Physician Decision|4|||
33555395|NCT00602641|101932039|FG000|Overall Study|Administrative Closure|1|||
33555396|NCT00602641|101932040|FG001|Overall Study|Administrative Closure|1|||
33555397|NCT00602641|101932039|FG000|Overall Study|Other|3|||
33555398|NCT00602641|101932040|FG001|Overall Study|Other|1|||
33555399|NCT00052715|101932043|FG000|Overall Study|wrong histology|1|||
33555400|NCT04495478|101932047|FG000|Overall Study|Withdrawal by Subject|0|||
33355735|NCT02580058|101191390|FG001|Overall Study|Global Deterioration of Health Status|18|||
33355736|NCT02580058|101191391|FG002|Overall Study|Global Deterioration of Health Status|24|||
33355737|NCT02580058|101191389|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
33355738|NCT02580058|101191390|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33355739|NCT02580058|101191391|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
33355740|NCT02580058|101191389|FG000|Overall Study|Progressive Disease|137|||
33355741|NCT02580058|101191390|FG001|Overall Study|Progressive Disease|125|||
33355742|NCT02580058|101191391|FG002|Overall Study|Progressive Disease|94|||
33355743|NCT02580058|101191389|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33355744|NCT02580058|101191390|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33355745|NCT02580058|101191391|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33355746|NCT00768222|101191392|FG000|Overall Study|Lost to Follow-up|1|||
33355747|NCT00768222|101191393|FG001|Overall Study|Lost to Follow-up|1|||
33355748|NCT00768222|101191392|FG000|Overall Study|Withdrawal by Subject|3|||
33355749|NCT00768222|101191393|FG001|Overall Study|Withdrawal by Subject|1|||
33355750|NCT00768222|101191392|FG000|Overall Study|Protocol Violation|0|||
33413938|NCT02975882|101406463|FG001|Overall Study|Death|1|||
33555401|NCT04495478|101932048|FG001|Overall Study|Withdrawal by Subject|0|||
33621078|NCT00410761|102161867|FG000|Overall Study|objective disease progression|71|||
33621079|NCT00410761|102161868|FG001|Overall Study|objective disease progression|55|||
33621080|NCT00410761|102161867|FG000|Overall Study|Withdrawal by Subject|8|||
33621081|NCT00410761|102161868|FG001|Overall Study|Withdrawal by Subject|4|||
33621082|NCT00410761|102161867|FG000|Overall Study|Other|12|||
33621083|NCT00410761|102161868|FG001|Overall Study|Other|9|||
33218130|NCT00526630|100695964|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
33218131|NCT00526630|100695965|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
33355751|NCT00768222|101191393|FG001|Overall Study|Protocol Violation|2|||
33355752|NCT00811252|101191394|FG000|Overall Study|Adverse Event|6|||
33355753|NCT00811252|101191395|FG001|Overall Study|Adverse Event|10|||
33355754|NCT00811252|101191396|FG002|Overall Study|Adverse Event|15|||
33355755|NCT00811252|101191394|FG000|Overall Study|Lack of Efficacy|7|||
33555402|NCT04495478|101932049|FG002|Overall Study|Withdrawal by Subject|0|||
33555403|NCT04495478|101932050|FG003|Overall Study|Withdrawal by Subject|1|||
33555404|NCT04495478|101932051|FG004|Overall Study|Withdrawal by Subject|0|||
33413939|NCT02975882|101406464|FG002|Overall Study|Death|0|||
33555405|NCT04495478|101932052|FG005|Overall Study|Withdrawal by Subject|0|||
33555406|NCT04495478|101932053|FG006|Overall Study|Withdrawal by Subject|0|||
33355756|NCT00811252|101191395|FG001|Overall Study|Lack of Efficacy|2|||
33355757|NCT00811252|101191396|FG002|Overall Study|Lack of Efficacy|0|||
33355758|NCT00811252|101191394|FG000|Overall Study|Protocol Violation|3|||
33355759|NCT00811252|101191395|FG001|Overall Study|Protocol Violation|3|||
33355760|NCT00811252|101191396|FG002|Overall Study|Protocol Violation|2|||
33355761|NCT00811252|101191394|FG000|Overall Study|Withdrawal of Consent|1|||
33355762|NCT00811252|101191395|FG001|Overall Study|Withdrawal of Consent|2|||
33355763|NCT00811252|101191396|FG002|Overall Study|Withdrawal of Consent|2|||
33355764|NCT00811252|101191394|FG000|Overall Study|Lost to Follow-up|0|||
33355765|NCT00811252|101191395|FG001|Overall Study|Lost to Follow-up|0|||
33355766|NCT00811252|101191396|FG002|Overall Study|Lost to Follow-up|2|||
33355767|NCT00811252|101191394|FG000|Overall Study|Administrative or Other Reasons|0|||
33355768|NCT00811252|101191395|FG001|Overall Study|Administrative or Other Reasons|3|||
33355769|NCT00811252|101191396|FG002|Overall Study|Administrative or Other Reasons|2|||
33355770|NCT03312218|101191399|FG000|Overall Study|Never signed in to access the app|54|||
33355771|NCT03312218|101191400|FG001|Overall Study|Never signed in to access the app|58|||
33355772|NCT03212261|101191401|FG000|Overall Study|Became ineligible d/t tech|2|||
33355773|NCT03212261|101191401|FG000|Overall Study|Tech Trouble- No first study visit|1|||
33355774|NCT03212261|101191401|FG000|Overall Study|Lost to Follow-up|7|||
33355775|NCT03212261|101191401|FG000|Overall Study|Family Emergency|1|||
33355776|NCT03212261|101191401|FG000|Overall Study|Too busy/ No time|5|||
33355777|NCT02251743|101191404|FG000|Overall Study|Withdrawal by Subject|1|||
33355778|NCT02251743|101191405|FG001|Overall Study|Withdrawal by Subject|1|||
33355779|NCT03022461|101191406|FG000|Overall Study|Death|3|||
33355780|NCT03138564|101191407|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
33355781|NCT03138564|101191408|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
33355782|NCT03138564|101191407|FG000|Overall Study|Lost to Follow-up|16|||
33355783|NCT03138564|101191408|FG001|Overall Study|Lost to Follow-up|2|||
33355784|NCT03138564|101191407|FG000|Overall Study|Withdrawal by Subject|48|||
33355785|NCT03138564|101191408|FG001|Overall Study|Withdrawal by Subject|4|||
33355786|NCT03138564|101191407|FG000|Overall Study|No longer met eligibility criteria|2|||
33355787|NCT03138564|101191408|FG001|Overall Study|No longer met eligibility criteria|0|||
33355788|NCT03138564|101191407|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
33355789|NCT03138564|101191408|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
33355790|NCT03138564|101191407|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
33355791|NCT03138564|101191408|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
33355792|NCT03138564|101191407|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
33355793|NCT03138564|101191408|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
33355794|NCT03138564|101191407|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
33355795|NCT03138564|101191408|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
33355796|NCT01725165|101191409|FG000|Overall Study|Death|11|||
33355797|NCT01725165|101191410|FG001|Overall Study|Death|18|||
33355798|NCT01670500|101191411|FG000|Overall Study|Withdrawal by Subject|1|||
33355799|NCT01670500|101191412|FG001|Overall Study|Withdrawal by Subject|0|||
33355800|NCT00587223|101191418|FG000|Overall Study|Adverse Event|1|||
33355801|NCT03406962|101191420|FG000|Overall Study|Death|2|||
33355802|NCT03406962|101191420|FG000|Overall Study|Adverse Event|1|||
33355803|NCT01925703|101191421|FG000|Overall Study|Physician Decision|1|||
33355804|NCT01925703|101191421|FG000|Overall Study|Lost to Follow-up|2|||
33355805|NCT01925703|101191421|FG000|Overall Study|Discharge prior to full iron repletion|1|||
33355806|NCT00561353|101191423|FG000|Overall Study|Subject reached a virologic endpoint|2|||
33355807|NCT00561353|101191424|FG001|Overall Study|Subject reached a virologic endpoint|1|||
33355808|NCT00561353|101191425|FG002|Overall Study|Subject reached a virologic endpoint|1|||
33355809|NCT00561353|101191426|FG003|Overall Study|Subject reached a virologic endpoint|4|||
33355810|NCT00561353|101191427|FG004|Overall Study|Subject reached a virologic endpoint|1|||
33355811|NCT00561353|101191428|FG005|Overall Study|Subject reached a virologic endpoint|3|||
33355812|NCT00561353|101191429|FG006|Overall Study|Subject reached a virologic endpoint|4|||
33355813|NCT00561353|101191430|FG007|Overall Study|Subject reached a virologic endpoint|4|||
33355814|NCT00561353|101191431|FG008|Overall Study|Subject reached a virologic endpoint|5|||
33355815|NCT00561353|101191432|FG009|Overall Study|Subject reached a virologic endpoint|0|||
33355816|NCT00561353|101191423|FG000|Overall Study|Subject ineligible to continue the trial|0|||
33413940|NCT02975882|101406465|FG003|Overall Study|Death|0|||
33413941|NCT02975882|101406462|FG000|Overall Study|Lack of Efficacy|3|||
33555407|NCT04495478|101932047|FG000|Overall Study|Physician Decision|0|||
33555408|NCT04495478|101932048|FG001|Overall Study|Physician Decision|1|||
33355817|NCT00561353|101191424|FG001|Overall Study|Subject ineligible to continue the trial|0|||
33355818|NCT00561353|101191425|FG002|Overall Study|Subject ineligible to continue the trial|0|||
33355819|NCT00561353|101191426|FG003|Overall Study|Subject ineligible to continue the trial|0|||
33355820|NCT00561353|101191427|FG004|Overall Study|Subject ineligible to continue the trial|0|||
33355821|NCT00561353|101191428|FG005|Overall Study|Subject ineligible to continue the trial|1|||
33413942|NCT02975882|101406463|FG001|Overall Study|Lack of Efficacy|7|||
33355822|NCT00561353|101191429|FG006|Overall Study|Subject ineligible to continue the trial|1|||
33355823|NCT00561353|101191430|FG007|Overall Study|Subject ineligible to continue the trial|0|||
33355824|NCT00561353|101191431|FG008|Overall Study|Subject ineligible to continue the trial|2|||
33355825|NCT00561353|101191432|FG009|Overall Study|Subject ineligible to continue the trial|1|||
33355826|NCT00561353|101191423|FG000|Overall Study|Other|1|||
33355827|NCT00561353|101191424|FG001|Overall Study|Other|0|||
33355828|NCT00561353|101191425|FG002|Overall Study|Other|1|||
33355829|NCT00561353|101191426|FG003|Overall Study|Other|0|||
33355830|NCT00561353|101191427|FG004|Overall Study|Other|0|||
33355831|NCT00561353|101191428|FG005|Overall Study|Other|2|||
33355832|NCT00561353|101191429|FG006|Overall Study|Other|0|||
33355833|NCT00561353|101191430|FG007|Overall Study|Other|0|||
33355834|NCT00561353|101191431|FG008|Overall Study|Other|0|||
33355835|NCT00561353|101191432|FG009|Overall Study|Other|0|||
33355836|NCT00561353|101191423|FG000|Overall Study|Adverse Event|0|||
33355837|NCT00561353|101191424|FG001|Overall Study|Adverse Event|0|||
33355838|NCT00561353|101191425|FG002|Overall Study|Adverse Event|0|||
33355839|NCT00561353|101191426|FG003|Overall Study|Adverse Event|2|||
33355840|NCT00561353|101191427|FG004|Overall Study|Adverse Event|0|||
33355841|NCT00561353|101191428|FG005|Overall Study|Adverse Event|0|||
33355842|NCT00561353|101191429|FG006|Overall Study|Adverse Event|1|||
33355843|NCT00561353|101191430|FG007|Overall Study|Adverse Event|0|||
33355844|NCT00561353|101191431|FG008|Overall Study|Adverse Event|0|||
33355845|NCT00561353|101191432|FG009|Overall Study|Adverse Event|1|||
33355846|NCT00561353|101191423|FG000|Overall Study|Lost to Follow-up|2|||
33355847|NCT00561353|101191424|FG001|Overall Study|Lost to Follow-up|0|||
33355848|NCT00561353|101191425|FG002|Overall Study|Lost to Follow-up|1|||
33355849|NCT00561353|101191426|FG003|Overall Study|Lost to Follow-up|0|||
33355850|NCT00561353|101191427|FG004|Overall Study|Lost to Follow-up|0|||
33355851|NCT00561353|101191428|FG005|Overall Study|Lost to Follow-up|0|||
33355852|NCT00561353|101191429|FG006|Overall Study|Lost to Follow-up|0|||
33355853|NCT00561353|101191430|FG007|Overall Study|Lost to Follow-up|0|||
33355854|NCT00561353|101191431|FG008|Overall Study|Lost to Follow-up|0|||
33355855|NCT00561353|101191432|FG009|Overall Study|Lost to Follow-up|0|||
33355856|NCT00561353|101191423|FG000|Overall Study|Withdrawal by Subject|0|||
33355857|NCT00561353|101191424|FG001|Overall Study|Withdrawal by Subject|2|||
33355858|NCT00561353|101191425|FG002|Overall Study|Withdrawal by Subject|0|||
33355859|NCT00561353|101191426|FG003|Overall Study|Withdrawal by Subject|0|||
33355860|NCT00561353|101191427|FG004|Overall Study|Withdrawal by Subject|0|||
33355861|NCT00561353|101191428|FG005|Overall Study|Withdrawal by Subject|0|||
33355862|NCT00561353|101191429|FG006|Overall Study|Withdrawal by Subject|0|||
33355863|NCT00561353|101191430|FG007|Overall Study|Withdrawal by Subject|0|||
33355864|NCT00561353|101191431|FG008|Overall Study|Withdrawal by Subject|0|||
33355865|NCT00561353|101191432|FG009|Overall Study|Withdrawal by Subject|0|||
33355866|NCT01856673|101191433|FG000|Overall Study|Withdrawal by Subject|44|||
33355867|NCT01856673|101191434|FG001|Overall Study|Withdrawal by Subject|50|||
33355868|NCT01856673|101191435|FG002|Overall Study|Withdrawal by Subject|33|||
33355869|NCT01856673|101191433|FG000|Overall Study|Lost to Follow-up|31|||
33355870|NCT01856673|101191434|FG001|Overall Study|Lost to Follow-up|34|||
33355871|NCT01856673|101191435|FG002|Overall Study|Lost to Follow-up|0|||
33355872|NCT01856673|101191433|FG000|Overall Study|Unknown reasons|9|||
33355873|NCT01856673|101191434|FG001|Overall Study|Unknown reasons|0|||
33355874|NCT01856673|101191435|FG002|Overall Study|Unknown reasons|0|||
33355875|NCT01856673|101191433|FG000|Overall Study|Psychologist decision|1|||
33355876|NCT01856673|101191434|FG001|Overall Study|Psychologist decision|0|||
33355877|NCT01856673|101191435|FG002|Overall Study|Psychologist decision|0|||
33355878|NCT01856673|101191433|FG000|Overall Study|Paperwork errors|8|||
33355879|NCT01856673|101191434|FG001|Overall Study|Paperwork errors|0|||
33355880|NCT01856673|101191435|FG002|Overall Study|Paperwork errors|0|||
33355881|NCT01856673|101191433|FG000|Overall Study|Death|1|||
33355882|NCT01856673|101191434|FG001|Overall Study|Death|1|||
33355883|NCT01856673|101191435|FG002|Overall Study|Death|0|||
33355884|NCT01856673|101191433|FG000|Overall Study|Protocol Violation|1|||
33355885|NCT01856673|101191434|FG001|Overall Study|Protocol Violation|0|||
33355886|NCT01856673|101191435|FG002|Overall Study|Protocol Violation|1|||
33355887|NCT00004980|101191438|FG000|Overall Study|Withdrawal by Subject|1|||
33355888|NCT00004980|101191439|FG001|Overall Study|Withdrawal by Subject|0|||
33355889|NCT00004980|101191438|FG000|Overall Study|memory difficulties|1|||
33355890|NCT00004980|101191439|FG001|Overall Study|memory difficulties|1|||
33355891|NCT00004980|101191438|FG000|Overall Study|Physician Decision|0|||
33355892|NCT00004980|101191439|FG001|Overall Study|Physician Decision|1|||
33355893|NCT01241786|101191440|FG000|Overall Study|Lack of Efficacy|5|||
33355894|NCT01974323|101191441|FG000|Overall Study|Other Reasons|25|||
33355895|NCT01974323|101191442|FG001|Overall Study|Other Reasons|28|||
33355896|NCT01974323|101191441|FG000|Overall Study|Protocol Violation|2|||
33355897|NCT01974323|101191442|FG001|Overall Study|Protocol Violation|2|||
33355898|NCT01974323|101191441|FG000|Overall Study|Personal Reasons|15|||
33355899|NCT01974323|101191442|FG001|Overall Study|Personal Reasons|19|||
33355900|NCT01974323|101191441|FG000|Overall Study|Lost to Follow-up|45|||
33355901|NCT01974323|101191442|FG001|Overall Study|Lost to Follow-up|40|||
33355902|NCT01974323|101191441|FG000|Overall Study|Pregnancy|2|||
33355903|NCT01974323|101191442|FG001|Overall Study|Pregnancy|1|||
33355904|NCT01974323|101191441|FG000|Overall Study|Lack of Efficacy|1|||
33355905|NCT01974323|101191442|FG001|Overall Study|Lack of Efficacy|1|||
33355906|NCT01974323|101191441|FG000|Overall Study|Adverse Event|2|||
33355907|NCT01974323|101191442|FG001|Overall Study|Adverse Event|2|||
33355908|NCT00446030|101191443|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
33413943|NCT02975882|101406464|FG002|Overall Study|Lack of Efficacy|4|||
33413944|NCT02975882|101406465|FG003|Overall Study|Lack of Efficacy|3|||
33413945|NCT02975882|101406462|FG000|Overall Study|Physician Decision|0|||
33413946|NCT02975882|101406463|FG001|Overall Study|Physician Decision|2|||
33555409|NCT04495478|101932049|FG002|Overall Study|Physician Decision|0|||
33555410|NCT04495478|101932050|FG003|Overall Study|Physician Decision|0|||
33555411|NCT04495478|101932051|FG004|Overall Study|Physician Decision|1|||
33355909|NCT00446030|101191444|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
33355910|NCT00446030|101191443|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
33355911|NCT00446030|101191444|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
33355912|NCT00446030|101191443|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
33355913|NCT00446030|101191444|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
33355914|NCT00446030|101191443|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
33355915|NCT00446030|101191444|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
33355916|NCT00446030|101191443|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
33355917|NCT00446030|101191444|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
33355918|NCT00446030|101191443|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
33355919|NCT00446030|101191444|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
33355920|NCT00446030|101191443|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
33355921|NCT00446030|101191444|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
33355922|NCT00446030|101191443|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
33355923|NCT00446030|101191444|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
33355924|NCT00446030|101191443|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
33355925|NCT00446030|101191444|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
33355926|NCT00446030|101191443|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
33355927|NCT00446030|101191444|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
33355928|NCT00446030|101191443|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
33355929|NCT00446030|101191444|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
33355930|NCT00446030|101191443|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
33355931|NCT00446030|101191444|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
33355932|NCT00446030|101191443|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
33355933|NCT00446030|101191444|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
33355934|NCT00446030|101191443|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
33355935|NCT00446030|101191444|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
33355936|NCT00446030|101191443|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
33355937|NCT00446030|101191444|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
33355938|NCT00446030|101191443|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
33355939|NCT00446030|101191444|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
33355940|NCT00446030|101191443|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
33355941|NCT00446030|101191444|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
33355942|NCT00446030|101191443|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
33355943|NCT00446030|101191444|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
33355944|NCT00446030|101191443|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
33355945|NCT00446030|101191444|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
33355946|NCT04925570|101191445|FG000|Overall Study|Protocol Violation|24|||
33355947|NCT04925570|101191446|FG001|Overall Study|Protocol Violation|30|||
33355948|NCT04925570|101191445|FG000|Overall Study|Withdrawal by Subject|0|||
33355949|NCT04925570|101191446|FG001|Overall Study|Withdrawal by Subject|2|||
33355950|NCT00942162|101191453|FG000|Overall Study|Death|45|||
33355951|NCT00942162|101191454|FG001|Overall Study|Death|35|||
33355952|NCT00942162|101191455|FG002|Overall Study|Death|0|||
33355953|NCT00942162|101191453|FG000|Overall Study|Withdrawal by Subject|7|||
33355954|NCT00942162|101191454|FG001|Overall Study|Withdrawal by Subject|2|||
33355955|NCT00942162|101191455|FG002|Overall Study|Withdrawal by Subject|0|||
33355956|NCT00942162|101191453|FG000|Overall Study|Lost to Follow-up|4|||
33355957|NCT00942162|101191454|FG001|Overall Study|Lost to Follow-up|0|||
33355958|NCT00942162|101191455|FG002|Overall Study|Lost to Follow-up|0|||
33355959|NCT00942162|101191453|FG000|Overall Study|Other|14|||
33413947|NCT02975882|101406464|FG002|Overall Study|Physician Decision|4|||
33555412|NCT04495478|101932052|FG005|Overall Study|Physician Decision|0|||
33355960|NCT00942162|101191454|FG001|Overall Study|Other|13|||
33355961|NCT00942162|101191455|FG002|Overall Study|Other|2|||
33355962|NCT01901224|101191456|FG000|Overall Study|study was not funded and terminated|2|||
33355963|NCT02863848|101191462|FG000|Overall Study|Lost to Follow-up|1|||
33555413|NCT04495478|101932053|FG006|Overall Study|Physician Decision|0|||
33555414|NCT04605588|101934833|FG000|Overall Study|Withdrawal by Subject|1|||
33555415|NCT04605588|101934834|FG001|Overall Study|Withdrawal by Subject|0|||
33355964|NCT02863848|101191463|FG001|Overall Study|Lost to Follow-up|1|||
33355965|NCT02863848|101191462|FG000|Overall Study|Protocol Violation|1|||
33355966|NCT02863848|101191463|FG001|Overall Study|Protocol Violation|2|||
33355967|NCT00538681|101191464|FG000|Overall Study|Progressive Disease|7|||
33355968|NCT00538681|101191465|FG001|Overall Study|Progressive Disease|0|||
33355969|NCT00538681|101191466|FG002|Overall Study|Progressive Disease|1|||
33413948|NCT02975882|101406465|FG003|Overall Study|Physician Decision|2|||
33413949|NCT02975882|101406462|FG000|Overall Study|Ineligible|0|||
33413950|NCT02975882|101406463|FG001|Overall Study|Ineligible|1|||
33413951|NCT02975882|101406464|FG002|Overall Study|Ineligible|0|||
33355970|NCT00538681|101191467|FG003|Overall Study|Progressive Disease|0|||
33355971|NCT00538681|101191464|FG000|Overall Study|Sponsor Decision|1|||
33355972|NCT00538681|101191465|FG001|Overall Study|Sponsor Decision|3|||
33413952|NCT02975882|101406465|FG003|Overall Study|Ineligible|0|||
33413953|NCT00464308|101406468|FG000|Overall Study|Adverse Event|22|||
33413954|NCT00464308|101406469|FG001|Overall Study|Adverse Event|27|||
33413955|NCT00464308|101406470|FG002|Overall Study|Adverse Event|16|||
33413956|NCT00464308|101406468|FG000|Overall Study|Lost to Follow-up|29|||
33413957|NCT00464308|101406469|FG001|Overall Study|Lost to Follow-up|19|||
33413958|NCT00464308|101406470|FG002|Overall Study|Lost to Follow-up|20|||
33413959|NCT00464308|101406468|FG000|Overall Study|Patient discontinued and other reasons|17|||
33413960|NCT00464308|101406469|FG001|Overall Study|Patient discontinued and other reasons|17|||
33413961|NCT00464308|101406470|FG002|Overall Study|Patient discontinued and other reasons|23|||
33413962|NCT00464308|101406468|FG000|Overall Study|Physician Decision|1|||
33413963|NCT00464308|101406469|FG001|Overall Study|Physician Decision|0|||
33355973|NCT00538681|101191466|FG002|Overall Study|Sponsor Decision|8|||
33355974|NCT00538681|101191467|FG003|Overall Study|Sponsor Decision|9|||
33355975|NCT00538681|101191464|FG000|Overall Study|Adverse Event|1|||
33355976|NCT00538681|101191465|FG001|Overall Study|Adverse Event|1|||
33355977|NCT00538681|101191466|FG002|Overall Study|Adverse Event|1|||
33355978|NCT00538681|101191467|FG003|Overall Study|Adverse Event|0|||
33355979|NCT00538681|101191464|FG000|Overall Study|Death|0|||
33413964|NCT00464308|101406470|FG002|Overall Study|Physician Decision|0|||
33413965|NCT02660489|101406474|FG000|Overall Study|Lost to Follow-up|1|||
33413966|NCT02660489|101406475|FG001|Overall Study|Lost to Follow-up|1|||
33413967|NCT02660489|101406474|FG000|Overall Study|Adverse Event|1|||
33555416|NCT00825175|101934835|FG000|Overall Study|Withdrawal by Subject|0|||
33555417|NCT00825175|101934836|FG001|Overall Study|Withdrawal by Subject|5|||
33555418|NCT02583477|101934837|FG000|Overall Study|Adverse Event|0|||
33555419|NCT02583477|101934838|FG001|Overall Study|Adverse Event|2|||
33555420|NCT02583477|101934837|FG000|Overall Study|Death|1|||
33555421|NCT02583477|101934838|FG001|Overall Study|Death|16|||
33555422|NCT02583477|101934837|FG000|Overall Study|Study terminated|2|||
33555423|NCT02583477|101934838|FG001|Overall Study|Study terminated|2|||
33555424|NCT01602666|101934841|FG000|Induction Chemotherapy|Death|2|||
33555425|NCT01602666|101934842|FG001|Induction Chemotherapy|Death|1|||
33555426|NCT01602666|101934841|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
33555427|NCT01602666|101934842|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
33555428|NCT01602666|101934841|FG000|Induction Chemotherapy|Physician Decision|12|||
33555429|NCT01602666|101934842|FG001|Induction Chemotherapy|Physician Decision|5|||
33555430|NCT01602666|101934841|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
33555431|NCT01602666|101934842|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
33555432|NCT01602666|101934841|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
33555433|NCT01602666|101934842|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
33555434|NCT01602666|101934841|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
33555435|NCT01602666|101934842|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
33555436|NCT01602666|101934841|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
33555437|NCT01602666|101934842|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
33555438|NCT01602666|101934841|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
33555439|NCT01602666|101934842|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
33555440|NCT01602666|101934841|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
33555441|NCT01602666|101934842|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
33555442|NCT01602666|101934841|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
33555443|NCT01602666|101934842|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
33555444|NCT01602666|101934841|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
33555445|NCT01602666|101934842|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
33555446|NCT02176525|101934843|FG000|Overall Study|Adverse Event|0|||
33555447|NCT02176525|101934844|FG001|Overall Study|Adverse Event|0|||
33555448|NCT02176525|101934845|FG002|Overall Study|Adverse Event|0|||
33621084|NCT00410761|102161867|FG000|Overall Study|Never received randomised treatment|0|||
33355980|NCT00538681|101191465|FG001|Overall Study|Death|0|||
33355981|NCT00538681|101191466|FG002|Overall Study|Death|1|||
33413968|NCT02660489|101406475|FG001|Overall Study|Adverse Event|3|||
33355982|NCT00538681|101191467|FG003|Overall Study|Death|1|||
33413969|NCT02660489|101406474|FG000|Overall Study|no rhinovirus infection|4|||
33413970|NCT02660489|101406475|FG001|Overall Study|no rhinovirus infection|4|||
33621085|NCT00410761|102161868|FG001|Overall Study|Never received randomised treatment|1|||
33621086|NCT02366312|102161872|FG000|Overall Study|Lost to Follow-up|0|||
33621087|NCT02366312|102161873|FG001|Overall Study|Lost to Follow-up|1|||
33621088|NCT03827655|102161874|FG000|Overall Study|Death|0|||
33621089|NCT03827655|102161875|FG001|Overall Study|Death|0|||
33621090|NCT03827655|102161876|FG002|Overall Study|Death|0|||
33621091|NCT03827655|102161877|FG003|Overall Study|Death|0|||
33621092|NCT03827655|102161878|FG004|Overall Study|Death|1|||
33621093|NCT03827655|102161874|FG000|Overall Study|Protocol Deviation|1|||
33621094|NCT03827655|102161875|FG001|Overall Study|Protocol Deviation|0|||
33621095|NCT03827655|102161876|FG002|Overall Study|Protocol Deviation|1|||
33621096|NCT03827655|102161877|FG003|Overall Study|Protocol Deviation|1|||
33621097|NCT03827655|102161878|FG004|Overall Study|Protocol Deviation|0|||
33621098|NCT03827655|102161874|FG000|Overall Study|Withdrawal by Subject|3|||
33621099|NCT03827655|102161875|FG001|Overall Study|Withdrawal by Subject|2|||
33413971|NCT00944125|101406476|FG000|3 to 6 Months|Withdrawal by Subject|0|||
33413972|NCT00944125|101406477|FG001|3 to 6 Months|Withdrawal by Subject|2|||
33413973|NCT00944125|101406476|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
33413974|NCT00944125|101406477|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
33413975|NCT00554788|101406478|FG000|Overall Study|Adverse Event|0|||
33413976|NCT00554788|101406479|FG001|Overall Study|Adverse Event|1|||
33413977|NCT00554788|101406480|FG002|Overall Study|Adverse Event|2|||
33413978|NCT00554788|101406478|FG000|Overall Study|Lost to Follow-up|4|||
33413979|NCT00554788|101406479|FG001|Overall Study|Lost to Follow-up|3|||
33413980|NCT00554788|101406480|FG002|Overall Study|Lost to Follow-up|3|||
33413981|NCT00554788|101406478|FG000|Overall Study|Physician Decision|1|||
33413982|NCT00554788|101406479|FG001|Overall Study|Physician Decision|1|||
33413983|NCT00554788|101406480|FG002|Overall Study|Physician Decision|3|||
33413984|NCT00554788|101406478|FG000|Overall Study|Withdrawal by Subject|0|||
33413985|NCT00554788|101406479|FG001|Overall Study|Withdrawal by Subject|0|||
33621100|NCT03827655|102161876|FG002|Overall Study|Withdrawal by Subject|2|||
33621101|NCT03827655|102161877|FG003|Overall Study|Withdrawal by Subject|0|||
33621102|NCT03827655|102161878|FG004|Overall Study|Withdrawal by Subject|1|||
33621103|NCT03827655|102161874|FG000|Overall Study|Reason not Specified|3|||
33621104|NCT03827655|102161875|FG001|Overall Study|Reason not Specified|1|||
33355983|NCT00538681|101191464|FG000|Overall Study|Investigator Decision|0|||
33355984|NCT00538681|101191465|FG001|Overall Study|Investigator Decision|0|||
33355985|NCT00538681|101191466|FG002|Overall Study|Investigator Decision|0|||
33355986|NCT00538681|101191467|FG003|Overall Study|Investigator Decision|1|||
33355987|NCT03716726|101191468|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
33355988|NCT03716726|101191469|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
33355989|NCT03716726|101191468|FG000|12 Months Followup|Lost to Follow-up|10|||
33355990|NCT03716726|101191469|FG001|12 Months Followup|Lost to Follow-up|17|||
33355991|NCT02665689|101191470|FG000|Overall Study|Adverse Event|1|||
33355992|NCT02665689|101191471|FG001|Overall Study|Adverse Event|0|||
33355993|NCT02665689|101191470|FG000|Overall Study|Trial termination|1|||
33355994|NCT02665689|101191471|FG001|Overall Study|Trial termination|1|||
33355995|NCT02665689|101191470|FG000|Overall Study|Lost to Follow-up|0|||
33355996|NCT02665689|101191471|FG001|Overall Study|Lost to Follow-up|1|||
33355997|NCT03717922|101191486|FG000|Overall Study|Lost to Follow-up|2|||
33355998|NCT03717922|101191487|FG001|Overall Study|Lost to Follow-up|2|||
33355999|NCT03615222|101191488|FG000|Overall Study|Ineligible|26|||
33356000|NCT03615222|101191488|FG000|Overall Study|Withdrawal by Subject|7|||
33356001|NCT03615222|101191488|FG000|Overall Study|Death|1|||
33356002|NCT00384956|101191489|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
33356003|NCT01451515|101191492|FG000|Overall Study|Death|0|||
33356004|NCT01451515|101191493|FG001|Overall Study|Death|1|||
33356005|NCT01451515|101191494|FG002|Overall Study|Death|0|||
33356006|NCT01451515|101191492|FG000|Overall Study|Withdrawal by Subject|0|||
33356007|NCT01451515|101191493|FG001|Overall Study|Withdrawal by Subject|1|||
33621105|NCT03827655|102161876|FG002|Overall Study|Reason not Specified|1|||
33356008|NCT01451515|101191494|FG002|Overall Study|Withdrawal by Subject|0|||
33621106|NCT03827655|102161877|FG003|Overall Study|Reason not Specified|1|||
33621107|NCT03827655|102161878|FG004|Overall Study|Reason not Specified|1|||
33621108|NCT03573323|102161879|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
33621109|NCT03573323|102161880|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
33356009|NCT01451515|101191492|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
33356010|NCT01451515|101191493|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
33356011|NCT01451515|101191494|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
33356012|NCT01451515|101191492|FG000|Overall Study|Relapse (except CNS)|1|||
33356013|NCT01451515|101191493|FG001|Overall Study|Relapse (except CNS)|1|||
33413986|NCT00554788|101406480|FG002|Overall Study|Withdrawal by Subject|1|||
33413987|NCT00554788|101406478|FG000|Overall Study|Refusal of further protocol therapy|0|||
33413988|NCT00554788|101406479|FG001|Overall Study|Refusal of further protocol therapy|1|||
33413989|NCT00554788|101406480|FG002|Overall Study|Refusal of further protocol therapy|1|||
33413990|NCT00554788|101406478|FG000|Overall Study|Progressive disease|0|||
33413991|NCT00554788|101406479|FG001|Overall Study|Progressive disease|0|||
33413992|NCT00554788|101406480|FG002|Overall Study|Progressive disease|3|||
33413993|NCT00554788|101406478|FG000|Overall Study|Ineligible|2|||
33413994|NCT00554788|101406479|FG001|Overall Study|Ineligible|0|||
33413995|NCT00554788|101406480|FG002|Overall Study|Ineligible|1|||
33413996|NCT03253809|101406481|FG000|Overall Study|Unable to obtain study related data|14|||
33413997|NCT00326625|101406486|FG000|Overall Study|Adverse Event|20|||
33413998|NCT00326625|101406487|FG001|Overall Study|Adverse Event|9|||
33413999|NCT00326625|101406486|FG000|Overall Study|Withdrawal by Subject|15|||
33414000|NCT00326625|101406487|FG001|Overall Study|Withdrawal by Subject|12|||
33414001|NCT00326625|101406486|FG000|Overall Study|Death|18|||
33414002|NCT00326625|101406487|FG001|Overall Study|Death|16|||
33414003|NCT00326625|101406486|FG000|Overall Study|Lost to Follow-up|1|||
33414004|NCT00326625|101406487|FG001|Overall Study|Lost to Follow-up|0|||
33414005|NCT00326625|101406486|FG000|Overall Study|prescheduled medical intervention|0|||
33414006|NCT00326625|101406487|FG001|Overall Study|prescheduled medical intervention|1|||
33414007|NCT03280628|101406488|FG000|Overall Study|Lost to Follow-up|8|||
33414008|NCT03280628|101406489|FG001|Overall Study|Lost to Follow-up|6|||
33414009|NCT03280628|101406490|FG002|Overall Study|Lost to Follow-up|11|||
33414010|NCT04158739|101406491|FG000|Overall Study|Adverse Event|1|||
33414011|NCT04158739|101406492|FG001|Overall Study|Adverse Event|0|||
33414012|NCT04158739|101406491|FG000|Overall Study|Death|0|||
33414013|NCT04158739|101406492|FG001|Overall Study|Death|1|||
33414014|NCT04158739|101406491|FG000|Overall Study|Lack of Efficacy|3|||
33414015|NCT04158739|101406492|FG001|Overall Study|Lack of Efficacy|7|||
33414016|NCT04158739|101406491|FG000|Overall Study|Physician Decision|0|||
33414017|NCT04158739|101406492|FG001|Overall Study|Physician Decision|1|||
33414018|NCT04158739|101406491|FG000|Overall Study|Withdrawal by Subject|3|||
33414019|NCT04158739|101406492|FG001|Overall Study|Withdrawal by Subject|0|||
33414020|NCT01432600|101406493|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
33555449|NCT02176525|101934846|FG003|Overall Study|Adverse Event|1|||
33555450|NCT02176525|101934847|FG004|Overall Study|Adverse Event|1|||
33555451|NCT02176525|101934848|FG005|Overall Study|Adverse Event|0|||
33555452|NCT02176525|101934849|FG006|Overall Study|Adverse Event|1|||
33555453|NCT02176525|101934850|FG007|Overall Study|Adverse Event|0|||
33555454|NCT02176525|101934843|FG000|Overall Study|not treated|1|||
33555455|NCT02176525|101934844|FG001|Overall Study|not treated|0|||
33555456|NCT02176525|101934845|FG002|Overall Study|not treated|0|||
33414021|NCT01432600|101406494|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
33414022|NCT01432600|101406495|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
33555457|NCT02176525|101934846|FG003|Overall Study|not treated|0|||
33414023|NCT00247416|101406496|FG000|Overall Study|3 patients were found to be ineligible|1|||
33555458|NCT02176525|101934847|FG004|Overall Study|not treated|0|||
33218132|NCT00526630|100695964|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
33414024|NCT00247416|101406497|FG001|Overall Study|3 patients were found to be ineligible|2|||
33555459|NCT02176525|101934848|FG005|Overall Study|not treated|1|||
33555460|NCT02176525|101934849|FG006|Overall Study|not treated|0|||
33356014|NCT01451515|101191494|FG002|Overall Study|Relapse (except CNS)|0|||
33356015|NCT02201940|101191502|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
33356016|NCT02201940|101191503|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
33356017|NCT02201940|101191502|FG000|Overall Study|Lack of Efficacy|2|||
33356018|NCT02201940|101191503|FG001|Overall Study|Lack of Efficacy|113|||
33356019|NCT02201940|101191502|FG000|Overall Study|Lost to Follow-up|5|||
33356020|NCT02201940|101191503|FG001|Overall Study|Lost to Follow-up|0|||
33621110|NCT03573323|102161879|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
33621111|NCT03573323|102161880|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
33621112|NCT03573323|102161879|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
33621113|NCT03573323|102161880|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
33621114|NCT03573323|102161879|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
33621115|NCT03573323|102161880|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
33621116|NCT03573323|102161879|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
33621117|NCT03573323|102161880|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
33621118|NCT03573323|102161879|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
33621119|NCT03573323|102161880|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
33621120|NCT03573323|102161879|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
33621121|NCT03573323|102161880|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
33621122|NCT03573323|102161879|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
33621123|NCT03573323|102161880|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
33621124|NCT03573323|102161879|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
33621125|NCT03573323|102161880|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
33218133|NCT00526630|100695965|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
33621126|NCT03573323|102161879|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
33218134|NCT02001194|100695967|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
33356021|NCT02201940|101191502|FG000|Overall Study|Withdrew Consent|2|||
33356022|NCT02201940|101191503|FG001|Overall Study|Withdrew Consent|1|||
33356023|NCT02201940|101191502|FG000|Overall Study|Investigator's Discretion|1|||
33356024|NCT02201940|101191503|FG001|Overall Study|Investigator's Discretion|1|||
33356025|NCT02201940|101191502|FG000|Overall Study|Death|1|||
33356026|NCT02201940|101191503|FG001|Overall Study|Death|0|||
33356027|NCT02201940|101191502|FG000|Overall Study|Adverse Event|0|||
33356028|NCT02201940|101191503|FG001|Overall Study|Adverse Event|1|||
33356029|NCT02717507|101191504|FG000|Overall Study|Lost to Follow-up|5|||
33356030|NCT02717507|101191505|FG001|Overall Study|Lost to Follow-up|8|||
33356031|NCT02717507|101191504|FG000|Overall Study|Pregnancy|1|||
33356032|NCT02717507|101191505|FG001|Overall Study|Pregnancy|1|||
33356033|NCT02717507|101191504|FG000|Overall Study|Protocol Violation|2|||
33356034|NCT02717507|101191505|FG001|Overall Study|Protocol Violation|2|||
33356035|NCT02717507|101191504|FG000|Overall Study|Withdrawal by Subject|20|||
33356036|NCT02717507|101191505|FG001|Overall Study|Withdrawal by Subject|20|||
33356037|NCT02717507|101191504|FG000|Overall Study|Relapse|1|||
33356038|NCT02717507|101191505|FG001|Overall Study|Relapse|1|||
33356039|NCT02717507|101191504|FG000|Overall Study|Cardiac Event|2|||
33356040|NCT02717507|101191505|FG001|Overall Study|Cardiac Event|6|||
33356041|NCT04488822|101191511|FG000|Overall Study|Adverse Event|8|||
33356042|NCT04488822|101191511|FG000|Overall Study|Withdrawal by Subject|1|||
33356043|NCT02015819|101191520|FG000|Overall Study|Rickham catheter was misaligned|0|||
33356044|NCT02015819|101191521|FG001|Overall Study|Rickham catheter was misaligned|0|||
33356045|NCT02015819|101191522|FG002|Overall Study|Rickham catheter was misaligned|0|||
33356046|NCT02015819|101191523|FG003|Overall Study|Rickham catheter was misaligned|1|||
33356047|NCT02017444|101191524|FG000|Overall Study|Physician Decision|1|||
33356048|NCT02017444|101191525|FG001|Overall Study|Physician Decision|0|||
33356049|NCT02017444|101191524|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
33356050|NCT02017444|101191525|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
33356051|NCT01154101|101191526|FG000|Overall Study|Adverse Event|0|||
33356052|NCT01154101|101191527|FG001|Overall Study|Adverse Event|2|||
33356053|NCT01154101|101191528|FG002|Overall Study|Adverse Event|1|||
33356054|NCT01154101|101191529|FG003|Overall Study|Adverse Event|1|||
33356055|NCT01154101|101191530|FG004|Overall Study|Adverse Event|0|||
33356056|NCT01154101|101191526|FG000|Overall Study|Lost to Follow-up|0|||
33356057|NCT01154101|101191527|FG001|Overall Study|Lost to Follow-up|1|||
33356058|NCT01154101|101191528|FG002|Overall Study|Lost to Follow-up|0|||
33356059|NCT01154101|101191529|FG003|Overall Study|Lost to Follow-up|1|||
33356060|NCT01154101|101191530|FG004|Overall Study|Lost to Follow-up|0|||
33356061|NCT01154101|101191526|FG000|Overall Study|Withdrawal by Subject|0|||
33356062|NCT01154101|101191527|FG001|Overall Study|Withdrawal by Subject|1|||
33356063|NCT01154101|101191528|FG002|Overall Study|Withdrawal by Subject|2|||
33356064|NCT01154101|101191529|FG003|Overall Study|Withdrawal by Subject|0|||
33356065|NCT01154101|101191530|FG004|Overall Study|Withdrawal by Subject|1|||
33356066|NCT00613314|101191531|FG000|Overall Study|Adverse Event|5|||
33555461|NCT02176525|101934850|FG007|Overall Study|not treated|0|||
33621127|NCT03573323|102161880|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
33621128|NCT03573323|102161879|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
33621129|NCT03573323|102161880|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
33621130|NCT03573323|102161879|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
33621131|NCT03573323|102161880|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
33356067|NCT00613314|101191531|FG000|Overall Study|Protocol Violation|14|||
33356068|NCT00613314|101191531|FG000|Overall Study|Lost to Follow-up|46|||
33356069|NCT00613314|101191531|FG000|Overall Study|Other reason not defined above|90|||
33356070|NCT00504257|101191535|FG000|Overall Study|Withdrawal by Subject|2|||
33356071|NCT00504257|101191535|FG000|Overall Study|ineligible histology|2|||
33356072|NCT03459040|101191536|FG000|Overall Study|Death|8|||
33356073|NCT03459040|101191536|FG000|Overall Study|Withdrawal by Subject|1|||
33356074|NCT03822884|101191537|FG000|Overall Study|Withdrawal by Subject|0|||
33356075|NCT03822884|101191538|FG001|Overall Study|Withdrawal by Subject|0|||
33356076|NCT03822884|101191539|FG002|Overall Study|Withdrawal by Subject|0|||
33356077|NCT03822884|101191540|FG003|Overall Study|Withdrawal by Subject|0|||
33356078|NCT03822884|101191541|FG004|Overall Study|Withdrawal by Subject|1|||
33356079|NCT03822884|101191542|FG005|Overall Study|Withdrawal by Subject|0|||
33356080|NCT03191786|101191548|FG000|Overall Study|Death|236|||
33356081|NCT03191786|101191549|FG001|Overall Study|Death|127|||
33356082|NCT03191786|101191548|FG000|Overall Study|Lost to Follow-up|9|||
33356083|NCT03191786|101191549|FG001|Overall Study|Lost to Follow-up|3|||
33356084|NCT03191786|101191548|FG000|Overall Study|Physician Decision|1|||
33356085|NCT03191786|101191549|FG001|Overall Study|Physician Decision|0|||
33356086|NCT03191786|101191548|FG000|Overall Study|Moved to Post Trial Access Program|30|||
33356087|NCT03191786|101191549|FG001|Overall Study|Moved to Post Trial Access Program|5|||
33356088|NCT03191786|101191548|FG000|Overall Study|Withdrawal by Subject|26|||
33356089|NCT03191786|101191549|FG001|Overall Study|Withdrawal by Subject|16|||
33356090|NCT02868892|101191550|FG000|Overall Study|Investigator left site and no follow-up|6|||
33356091|NCT00892437|101191552|FG000|Randomized Phase|Randomized but not treated|6|||
33356092|NCT00892437|101191553|FG001|Randomized Phase|Randomized but not treated|0|||
33356093|NCT00892437|101191552|FG000|Randomized Phase|Adverse Event|2|||
33356094|NCT00892437|101191553|FG001|Randomized Phase|Adverse Event|2|||
33356095|NCT00892437|101191552|FG000|Randomized Phase|Lost to Follow-up|1|||
33356096|NCT00892437|101191553|FG001|Randomized Phase|Lost to Follow-up|3|||
33356097|NCT00892437|101191552|FG000|Randomized Phase|Investigator's Discretion|1|||
33356098|NCT00892437|101191553|FG001|Randomized Phase|Investigator's Discretion|0|||
33356099|NCT00892437|101191552|FG000|Randomized Phase|Withdrew Consent|1|||
33356100|NCT00892437|101191553|FG001|Randomized Phase|Withdrew Consent|0|||
33356101|NCT00892437|101191552|FG000|Open-Label Extension Phase|Adverse Event|4|||
33356102|NCT00892437|101191553|FG001|Open-Label Extension Phase|Adverse Event|2|||
33356103|NCT00892437|101191552|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
33356104|NCT00892437|101191553|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
33356105|NCT00892437|101191552|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
33356106|NCT00892437|101191553|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
33356107|NCT00892437|101191552|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
33356108|NCT00892437|101191553|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
33356109|NCT00892437|101191552|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
33356110|NCT00892437|101191553|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
33356111|NCT03832387|101191554|FG000|Overall Study|Protocol Violation|2|||
33356112|NCT03832387|101191555|FG001|Overall Study|Protocol Violation|6|||
33356113|NCT03832387|101191554|FG000|Overall Study|EXCLUSION CRITERIA|3|||
33356114|NCT03832387|101191555|FG001|Overall Study|EXCLUSION CRITERIA|1|||
33621132|NCT03573323|102161879|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
33621133|NCT03573323|102161880|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
33621134|NCT03573323|102161879|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
33621135|NCT03573323|102161880|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
33621136|NCT03573323|102161879|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
33621137|NCT03573323|102161880|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
33621138|NCT03573323|102161879|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
33621139|NCT03573323|102161880|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
33621140|NCT03573323|102161879|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
33621141|NCT03573323|102161880|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
33621142|NCT03573323|102161879|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
33621143|NCT03573323|102161880|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
33621144|NCT03573323|102161879|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
33356115|NCT00775021|101191557|FG000|First Intervention|Lost to Follow-up|1|||
33356116|NCT00775021|101191558|FG001|First Intervention|Lost to Follow-up|0|||
33356117|NCT00775021|101191557|FG000|Second Intervention|Adverse Event|0|||
33414025|NCT01569074|101406498|FG000|Overall Study|Study stopped|6|||
33414026|NCT01569074|101406499|FG001|Overall Study|Study stopped|6|||
33414027|NCT01569074|101406500|FG002|Overall Study|Study stopped|8|||
33414028|NCT01569074|101406501|FG003|Overall Study|Study stopped|7|||
33414029|NCT01569074|101406502|FG004|Overall Study|Study stopped|7|||
33414030|NCT01569074|101406498|FG000|Overall Study|Study-specific discontinuation criteria|0|||
33414031|NCT01569074|101406499|FG001|Overall Study|Study-specific discontinuation criteria|1|||
33414032|NCT01569074|101406500|FG002|Overall Study|Study-specific discontinuation criteria|0|||
33414033|NCT01569074|101406501|FG003|Overall Study|Study-specific discontinuation criteria|0|||
33414034|NCT01569074|101406502|FG004|Overall Study|Study-specific discontinuation criteria|0|||
33414035|NCT01569074|101406498|FG000|Overall Study|Severe non-compliance to protocol|0|||
33621145|NCT03573323|102161880|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
33621146|NCT00584415|102161881|FG000|Overall Study|Adverse Event|7|||
33621147|NCT04014062|102161885|FG000|Period I: Dosing|Medical Grounds|4|||
33621148|NCT04014062|102161886|FG001|Period I: Dosing|Medical Grounds|5|||
33621149|NCT04014062|102161885|FG000|Period I: Dosing|Withdrawal by Subject|3|||
33621150|NCT04014062|102161886|FG001|Period I: Dosing|Withdrawal by Subject|1|||
33621151|NCT02611817|102161887|FG000|Open-label Induction Phase|Reason not Specified|9|||
33621152|NCT02611817|102161888|FG001|Open-label Induction Phase|Reason not Specified|0|||
33621153|NCT02611817|102161889|FG002|Open-label Induction Phase|Reason not Specified|0|||
33621154|NCT02611817|102161887|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
33621155|NCT02611817|102161888|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
33621156|NCT02611817|102161889|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
33621157|NCT02611817|102161887|FG000|Open-label Induction Phase|Pregnancy|1|||
33621158|NCT02611817|102161888|FG001|Open-label Induction Phase|Pregnancy|0|||
33621159|NCT02611817|102161889|FG002|Open-label Induction Phase|Pregnancy|0|||
33621160|NCT02611817|102161887|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
33621161|NCT02611817|102161888|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
33621162|NCT02611817|102161889|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
33621163|NCT02611817|102161887|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
33621164|NCT02611817|102161888|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
33621165|NCT02611817|102161889|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
33356118|NCT00775021|101191558|FG001|Second Intervention|Adverse Event|1|||
33356119|NCT00816036|101191559|FG000|Overall Study|Death|47|||
33356120|NCT00816036|101191560|FG001|Overall Study|Death|28|||
33356121|NCT00816036|101191559|FG000|Overall Study|Lost to Follow-up|75|||
33356122|NCT00816036|101191560|FG001|Overall Study|Lost to Follow-up|57|||
33414036|NCT01569074|101406499|FG001|Overall Study|Severe non-compliance to protocol|0|||
33414037|NCT01569074|101406500|FG002|Overall Study|Severe non-compliance to protocol|1|||
33414038|NCT01569074|101406501|FG003|Overall Study|Severe non-compliance to protocol|0|||
33414039|NCT01569074|101406502|FG004|Overall Study|Severe non-compliance to protocol|0|||
33356123|NCT00816036|101191559|FG000|Overall Study|Withdrawal by Subject|54|||
33356124|NCT00816036|101191560|FG001|Overall Study|Withdrawal by Subject|23|||
33356125|NCT01531725|101191561|FG000|Overall Study|Protocol Violation|5|||
33356126|NCT01217606|101191563|FG000|Initial Treatment Phase|Other Reasons|0|||
33356127|NCT01217606|101191564|FG001|Initial Treatment Phase|Other Reasons|2|||
33356128|NCT01217606|101191563|FG000|Initial Treatment Phase|Protocol Violation|3|||
33356129|NCT01217606|101191564|FG001|Initial Treatment Phase|Protocol Violation|2|||
33356130|NCT01217606|101191563|FG000|Initial Treatment Phase|Personal Reasons|0|||
33356131|NCT01217606|101191564|FG001|Initial Treatment Phase|Personal Reasons|2|||
33356132|NCT01217606|101191563|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
33356133|NCT01217606|101191564|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
33356134|NCT01217606|101191563|FG000|Initial Treatment Phase|Adverse Event|10|||
33356135|NCT01217606|101191564|FG001|Initial Treatment Phase|Adverse Event|6|||
33356136|NCT01217606|101191563|FG000|9-Month Masked Extension|Adverse Event|3|||
33356137|NCT01217606|101191564|FG001|9-Month Masked Extension|Adverse Event|6|||
33356138|NCT01217606|101191563|FG000|9-Month Masked Extension|Other Reasons|4|||
33356139|NCT01217606|101191564|FG001|9-Month Masked Extension|Other Reasons|4|||
33356140|NCT01217606|101191563|FG000|9-Month Masked Extension|Personal Reasons|2|||
33621166|NCT02611817|102161887|FG000|Open-label Induction Phase|Protocol Violation|5|||
33621167|NCT02611817|102161888|FG001|Open-label Induction Phase|Protocol Violation|0|||
33356141|NCT01217606|101191564|FG001|9-Month Masked Extension|Personal Reasons|1|||
33356142|NCT01217606|101191563|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
33356143|NCT01217606|101191564|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
33356144|NCT01217606|101191563|FG000|9-Month Masked Extension|Pregnancy|1|||
33356145|NCT01217606|101191564|FG001|9-Month Masked Extension|Pregnancy|0|||
33414040|NCT01569074|101406498|FG000|Overall Study|eg change in circumstances|0|||
33218135|NCT02001194|100695968|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
33356146|NCT01217606|101191563|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
33356147|NCT01217606|101191564|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
33414041|NCT01569074|101406499|FG001|Overall Study|eg change in circumstances|2|||
33414042|NCT01569074|101406500|FG002|Overall Study|eg change in circumstances|0|||
33621168|NCT02611817|102161889|FG002|Open-label Induction Phase|Protocol Violation|0|||
33621169|NCT02611817|102161887|FG000|Open-label Induction Phase|Adverse Event|16|||
33218136|NCT02001194|100695969|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
33356148|NCT01967225|101191565|FG000|Overall Study|Adverse Event|3|||
33356149|NCT01967225|101191566|FG001|Overall Study|Adverse Event|1|||
33356150|NCT01967225|101191565|FG000|Overall Study|Withdrawal by Subject|2|||
33356151|NCT01967225|101191566|FG001|Overall Study|Withdrawal by Subject|1|||
33356152|NCT01967225|101191565|FG000|Overall Study|Lack of Efficacy|1|||
33356153|NCT01967225|101191566|FG001|Overall Study|Lack of Efficacy|1|||
33555462|NCT02314247|101934856|FG000|Overall Study|Adverse Event|2|||
33555463|NCT02314247|101934857|FG001|Overall Study|Adverse Event|1|||
33555464|NCT02314247|101934858|FG002|Overall Study|Adverse Event|0|||
33555465|NCT02314247|101934856|FG000|Overall Study|Withdrawal by Subject|1|||
33555466|NCT02314247|101934857|FG001|Overall Study|Withdrawal by Subject|3|||
33555467|NCT02314247|101934858|FG002|Overall Study|Withdrawal by Subject|1|||
33555468|NCT02314247|101934856|FG000|Overall Study|Progression of Disease|6|||
33555469|NCT02314247|101934857|FG001|Overall Study|Progression of Disease|2|||
33555470|NCT02314247|101934858|FG002|Overall Study|Progression of Disease|0|||
33555471|NCT00689052|101934859|FG000|Overall Study|Adverse Event|4|||
33555472|NCT00689052|101934860|FG001|Overall Study|Adverse Event|6|||
33555473|NCT00689052|101934859|FG000|Overall Study|Protocol Violation|1|||
33555474|NCT00689052|101934860|FG001|Overall Study|Protocol Violation|0|||
33555475|NCT00689052|101934859|FG000|Overall Study|Lost to Follow-up|2|||
33555476|NCT00689052|101934860|FG001|Overall Study|Lost to Follow-up|0|||
33555477|NCT00689052|101934859|FG000|Overall Study|Withdrawal by Subject|2|||
33555478|NCT00689052|101934860|FG001|Overall Study|Withdrawal by Subject|0|||
33555479|NCT00689052|101934859|FG000|Overall Study|Early termination of the trial|22|||
33555480|NCT00689052|101934860|FG001|Overall Study|Early termination of the trial|24|||
33555481|NCT03302936|101934861|FG000|Overall Study|Protocol Violation|3|||
33555482|NCT03302936|101934862|FG001|Overall Study|Protocol Violation|4|||
33555483|NCT00362609|101934863|FG000|Overall Study|Withdrawal by Subject|0|||
33555484|NCT00362609|101934864|FG001|Overall Study|Withdrawal by Subject|1|||
33555485|NCT00362609|101934863|FG000|Overall Study|Protocol Violation|0|||
33555486|NCT00362609|101934864|FG001|Overall Study|Protocol Violation|1|||
33555487|NCT02872142|101934865|FG000|Overall Study|Adverse Event|2|||
33555488|NCT02872142|101934865|FG000|Overall Study|Death|1|||
33555489|NCT02872142|101934865|FG000|Overall Study|Participant Decision|3|||
33555490|NCT01943825|101934871|FG000|Overall Study|Lost to Follow-up|9|||
33555491|NCT01943825|101934872|FG001|Overall Study|Lost to Follow-up|3|||
33555492|NCT01943825|101934873|FG002|Overall Study|Lost to Follow-up|12|||
33555493|NCT01943825|101934874|FG003|Overall Study|Lost to Follow-up|8|||
33555494|NCT01943825|101934871|FG000|Overall Study|Withdrawal by Subject|1|||
33555495|NCT01943825|101934872|FG001|Overall Study|Withdrawal by Subject|0|||
33555496|NCT01943825|101934873|FG002|Overall Study|Withdrawal by Subject|3|||
33356154|NCT01967225|101191565|FG000|Overall Study|Switching to other therapy|2|||
33356155|NCT01967225|101191566|FG001|Overall Study|Switching to other therapy|0|||
33356156|NCT01967225|101191565|FG000|Overall Study|Protocol driven decision point|1|||
33356157|NCT01967225|101191566|FG001|Overall Study|Protocol driven decision point|0|||
33356158|NCT01967225|101191565|FG000|Overall Study|Logistical difficulties|1|||
33414043|NCT01569074|101406501|FG003|Overall Study|eg change in circumstances|1|||
33414044|NCT01569074|101406502|FG004|Overall Study|eg change in circumstances|1|||
33414045|NCT01569074|101406498|FG000|Overall Study|Adverse Event|1|||
33414046|NCT01569074|101406499|FG001|Overall Study|Adverse Event|0|||
33414047|NCT01569074|101406500|FG002|Overall Study|Adverse Event|3|||
33414048|NCT01569074|101406501|FG003|Overall Study|Adverse Event|0|||
33555497|NCT01943825|101934874|FG003|Overall Study|Withdrawal by Subject|2|||
33555498|NCT01943825|101934871|FG000|Overall Study|Other than specified above|0|||
33555499|NCT01943825|101934872|FG001|Overall Study|Other than specified above|1|||
33621170|NCT02611817|102161888|FG001|Open-label Induction Phase|Adverse Event|0|||
33555500|NCT01943825|101934873|FG002|Overall Study|Other than specified above|0|||
33555501|NCT01943825|101934874|FG003|Overall Study|Other than specified above|1|||
33555502|NCT05215847|101934880|FG000|Overall Study|Lost to Follow-up|1|||
33555503|NCT03412890|101934883|FG000|Overall Study|Adverse Event|5|||
33555504|NCT03412890|101934884|FG001|Overall Study|Adverse Event|5|||
33555505|NCT03412890|101934885|FG002|Overall Study|Adverse Event|9|||
33621171|NCT02611817|102161889|FG002|Open-label Induction Phase|Adverse Event|0|||
33621172|NCT02611817|102161887|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
33621173|NCT02611817|102161888|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
33621174|NCT02611817|102161889|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
33621175|NCT02611817|102161887|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
33218137|NCT02001194|100695970|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
33356159|NCT01967225|101191566|FG001|Overall Study|Logistical difficulties|0|||
33555506|NCT03412890|101934883|FG000|Overall Study|Protocol deviation|2|||
33555507|NCT03412890|101934884|FG001|Overall Study|Protocol deviation|1|||
33555508|NCT03412890|101934885|FG002|Overall Study|Protocol deviation|2|||
33356160|NCT01967225|101191565|FG000|Overall Study|Protocol Violation|2|||
33414049|NCT01569074|101406502|FG004|Overall Study|Adverse Event|0|||
33414050|NCT02873195|101406503|FG000|Overall Study|Ineligible|5|||
33555509|NCT03412890|101934883|FG000|Overall Study|Lost to Follow-up|7|||
33356161|NCT01967225|101191566|FG001|Overall Study|Protocol Violation|0|||
33356162|NCT00278629|101191567|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
33356163|NCT05087030|101191568|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
33356164|NCT05087030|101191569|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
33356165|NCT05087030|101191570|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
33356166|NCT05087030|101191571|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
33356167|NCT05087030|101191572|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
33356168|NCT05087030|101191568|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
33356169|NCT05087030|101191569|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
33356170|NCT05087030|101191570|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
33356171|NCT05087030|101191571|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
33356172|NCT05087030|101191572|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
33356173|NCT05087030|101191568|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
33356174|NCT05087030|101191569|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
33414051|NCT02873195|101406504|FG001|Overall Study|Ineligible|0|||
33414052|NCT00877799|101406505|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
33414053|NCT00877799|101406506|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
33356175|NCT05087030|101191570|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
33356176|NCT05087030|101191571|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
33356177|NCT05087030|101191572|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
33356178|NCT05087030|101191568|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
33356179|NCT05087030|101191569|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
33356180|NCT05087030|101191570|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
33356181|NCT05087030|101191571|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
33356182|NCT05087030|101191572|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
33356183|NCT05087030|101191568|FG000|Main Period (Week 0 to Week 52)|Death|0|||
33356184|NCT05087030|101191569|FG001|Main Period (Week 0 to Week 52)|Death|1|||
33356185|NCT05087030|101191570|FG002|Main Period (Week 0 to Week 52)|Death|0|||
33356186|NCT05087030|101191571|FG003|Main Period (Week 0 to Week 52)|Death|0|||
33356187|NCT05087030|101191572|FG004|Main Period (Week 0 to Week 52)|Death|0|||
33356188|NCT05087030|101191568|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
33356189|NCT05087030|101191569|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
33356190|NCT05087030|101191570|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
33356191|NCT05087030|101191571|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
33356192|NCT05087030|101191572|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
33356193|NCT05087030|101191568|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
33356194|NCT05087030|101191569|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
33356195|NCT05087030|101191570|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
33356196|NCT05087030|101191571|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
33356197|NCT05087030|101191572|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
33356198|NCT05087030|101191568|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
33356199|NCT05087030|101191569|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
33356200|NCT05087030|101191570|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
33356201|NCT05087030|101191571|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
33356202|NCT05087030|101191572|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
33356203|NCT05087030|101191568|FG000|Main Period (Week 0 to Week 52)|Other|1|||
33356204|NCT05087030|101191569|FG001|Main Period (Week 0 to Week 52)|Other|2|||
33356205|NCT05087030|101191570|FG002|Main Period (Week 0 to Week 52)|Other|0|||
33555510|NCT03412890|101934884|FG001|Overall Study|Lost to Follow-up|10|||
33555511|NCT03412890|101934885|FG002|Overall Study|Lost to Follow-up|10|||
33555512|NCT03412890|101934883|FG000|Overall Study|Withdrawal by Subject|9|||
33555513|NCT03412890|101934884|FG001|Overall Study|Withdrawal by Subject|12|||
33356206|NCT05087030|101191571|FG003|Main Period (Week 0 to Week 52)|Other|0|||
33414054|NCT00877799|101406507|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
33555514|NCT03412890|101934885|FG002|Overall Study|Withdrawal by Subject|11|||
33555515|NCT03412890|101934883|FG000|Overall Study|Lack of Efficacy|2|||
33555516|NCT03412890|101934884|FG001|Overall Study|Lack of Efficacy|7|||
33555517|NCT03412890|101934885|FG002|Overall Study|Lack of Efficacy|5|||
33555518|NCT03412890|101934883|FG000|Overall Study|Other|5|||
33555519|NCT03412890|101934884|FG001|Overall Study|Other|6|||
33555520|NCT03412890|101934885|FG002|Overall Study|Other|5|||
33555521|NCT03412890|101934883|FG000|Overall Study|Participants who did not receive any study drug|0|||
33555522|NCT03412890|101934884|FG001|Overall Study|Participants who did not receive any study drug|1|||
33555523|NCT03412890|101934885|FG002|Overall Study|Participants who did not receive any study drug|0|||
33555524|NCT01471574|101934886|FG000|Treatment Period|Lack of Efficacy|12|||
33555525|NCT01471574|101934887|FG001|Treatment Period|Lack of Efficacy|4|||
33555526|NCT01471574|101934888|FG002|Treatment Period|Lack of Efficacy|14|||
33555527|NCT01471574|101934889|FG003|Treatment Period|Lack of Efficacy|1|||
33555528|NCT01471574|101934886|FG000|Treatment Period|Adverse Event|7|||
33356207|NCT05087030|101191572|FG004|Main Period (Week 0 to Week 52)|Other|0|||
33555529|NCT01471574|101934887|FG001|Treatment Period|Adverse Event|3|||
33555530|NCT01471574|101934888|FG002|Treatment Period|Adverse Event|6|||
33356208|NCT05087030|101191568|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
33356209|NCT05087030|101191569|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
33356210|NCT05087030|101191570|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
33356211|NCT05087030|101191571|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
33356212|NCT05087030|101191572|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
33356213|NCT02591615|101191574|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
33356214|NCT02591615|101191575|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
33356215|NCT02591615|101191576|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
33356216|NCT02591615|101191577|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
33356217|NCT02591615|101191574|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
33356218|NCT02591615|101191575|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
33356219|NCT02591615|101191576|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
33356220|NCT02591615|101191577|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
33356221|NCT02591615|101191574|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
33356222|NCT02591615|101191575|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
33356223|NCT02591615|101191576|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
33356224|NCT02591615|101191577|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
33356225|NCT02591615|101191574|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
33356226|NCT02591615|101191575|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
33356227|NCT02591615|101191576|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
33356228|NCT02591615|101191577|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
33356229|NCT02591615|101191574|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
33356230|NCT02591615|101191575|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
33356231|NCT02591615|101191576|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
33356232|NCT02591615|101191577|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
33356233|NCT02591615|101191574|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
33356234|NCT02591615|101191575|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
33356235|NCT02591615|101191576|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
33356236|NCT02591615|101191577|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
33356237|NCT02591615|101191574|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
33356238|NCT02591615|101191575|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
33356239|NCT02591615|101191576|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
33356240|NCT02591615|101191577|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
33356241|NCT02591615|101191574|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
33356242|NCT02591615|101191575|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
33356243|NCT02591615|101191576|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
33356244|NCT02591615|101191577|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
33356245|NCT02591615|101191574|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
33356246|NCT02591615|101191575|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
33356247|NCT02591615|101191576|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
33356248|NCT02591615|101191577|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
33356249|NCT02591615|101191574|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
33356250|NCT02591615|101191575|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
33555531|NCT01471574|101934889|FG003|Treatment Period|Adverse Event|1|||
33555532|NCT01471574|101934886|FG000|Treatment Period|Withdrawal by Subject|5|||
33555533|NCT01471574|101934887|FG001|Treatment Period|Withdrawal by Subject|1|||
33555534|NCT01471574|101934888|FG002|Treatment Period|Withdrawal by Subject|1|||
33555535|NCT01471574|101934889|FG003|Treatment Period|Withdrawal by Subject|0|||
33555536|NCT01471574|101934886|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
33621176|NCT02611817|102161888|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
33621177|NCT02611817|102161889|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
33621178|NCT02611817|102161887|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
33621179|NCT02611817|102161888|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
33621180|NCT02611817|102161889|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
33621181|NCT02611817|102161887|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
33621182|NCT02611817|102161888|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
33621183|NCT02611817|102161889|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
33621184|NCT02611817|102161887|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
33621185|NCT02611817|102161888|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
33555537|NCT01471574|101934887|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
33555538|NCT01471574|101934888|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
33555539|NCT01471574|101934889|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
33621186|NCT02611817|102161889|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
33356251|NCT02591615|101191576|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
33356252|NCT02591615|101191577|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
33356253|NCT02591615|101191574|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
33356254|NCT02591615|101191575|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
33356255|NCT02591615|101191576|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
33356256|NCT02591615|101191577|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
33356257|NCT02591615|101191574|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
33356258|NCT02591615|101191575|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
33356259|NCT02591615|101191576|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
33356260|NCT02591615|101191577|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
33356261|NCT02591615|101191574|FG000|Maintenance MK-3475|Adverse Event|0|||
33356262|NCT02591615|101191575|FG001|Maintenance MK-3475|Adverse Event|3|||
33356263|NCT02591615|101191576|FG002|Maintenance MK-3475|Adverse Event|1|||
33356264|NCT02591615|101191577|FG003|Maintenance MK-3475|Adverse Event|2|||
33356265|NCT02591615|101191574|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
33356266|NCT02591615|101191575|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
33356267|NCT02591615|101191576|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
33356268|NCT02591615|101191577|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
33356269|NCT02591615|101191574|FG000|Maintenance MK-3475|Death|0|||
33356270|NCT02591615|101191575|FG001|Maintenance MK-3475|Death|1|||
33356271|NCT02591615|101191576|FG002|Maintenance MK-3475|Death|1|||
33356272|NCT02591615|101191577|FG003|Maintenance MK-3475|Death|0|||
33356273|NCT02591615|101191574|FG000|Maintenance MK-3475|Physician discretion|0|||
33356274|NCT02591615|101191575|FG001|Maintenance MK-3475|Physician discretion|0|||
33356275|NCT02591615|101191576|FG002|Maintenance MK-3475|Physician discretion|1|||
33356276|NCT02591615|101191577|FG003|Maintenance MK-3475|Physician discretion|0|||
33356277|NCT02591615|101191574|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
33414055|NCT00877799|101406508|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
33414056|NCT00877799|101406509|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
33414057|NCT00877799|101406505|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
33414058|NCT00877799|101406506|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
33555540|NCT01471574|101934886|FG000|Treatment Period|Lost to Follow-up|1|||
33555541|NCT01471574|101934887|FG001|Treatment Period|Lost to Follow-up|2|||
33555542|NCT01471574|101934888|FG002|Treatment Period|Lost to Follow-up|2|||
33555543|NCT01471574|101934889|FG003|Treatment Period|Lost to Follow-up|0|||
33555544|NCT01471574|101934886|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
33555545|NCT01471574|101934887|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
33555546|NCT01471574|101934888|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
33555547|NCT01471574|101934889|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
33555548|NCT01471574|101934886|FG000|Treatment Period|Other|1|||
33555549|NCT01471574|101934887|FG001|Treatment Period|Other|0|||
33555550|NCT01471574|101934888|FG002|Treatment Period|Other|0|||
33555551|NCT01471574|101934889|FG003|Treatment Period|Other|0|||
33555552|NCT01471574|101934886|FG000|Follow-up Period|Withdrawal by Subject|3|||
33555553|NCT01471574|101934887|FG001|Follow-up Period|Withdrawal by Subject|0|||
33555554|NCT01471574|101934888|FG002|Follow-up Period|Withdrawal by Subject|3|||
33555555|NCT01471574|101934889|FG003|Follow-up Period|Withdrawal by Subject|1|||
33555556|NCT01471574|101934886|FG000|Follow-up Period|Lost to Follow-up|4|||
33555557|NCT01471574|101934887|FG001|Follow-up Period|Lost to Follow-up|1|||
33555558|NCT01471574|101934888|FG002|Follow-up Period|Lost to Follow-up|3|||
33555559|NCT01471574|101934889|FG003|Follow-up Period|Lost to Follow-up|2|||
33555560|NCT01471574|101934886|FG000|Follow-up Period|Death|0|||
33555561|NCT01471574|101934887|FG001|Follow-up Period|Death|0|||
33555562|NCT01471574|101934888|FG002|Follow-up Period|Death|1|||
33555563|NCT01471574|101934889|FG003|Follow-up Period|Death|0|||
33555564|NCT01471574|101934886|FG000|Follow-up Period|Follow-up no longer required|0|||
33555565|NCT01471574|101934887|FG001|Follow-up Period|Follow-up no longer required|1|||
33555566|NCT01471574|101934888|FG002|Follow-up Period|Follow-up no longer required|0|||
33356278|NCT02591615|101191575|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
33356279|NCT02591615|101191576|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
33356280|NCT02591615|101191577|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
33356281|NCT02591615|101191574|FG000|Maintenance MK-3475|In active treatment|2|||
33555567|NCT01471574|101934889|FG003|Follow-up Period|Follow-up no longer required|0|||
33356282|NCT02591615|101191575|FG001|Maintenance MK-3475|In active treatment|0|||
33356283|NCT02591615|101191576|FG002|Maintenance MK-3475|In active treatment|0|||
33356284|NCT02591615|101191577|FG003|Maintenance MK-3475|In active treatment|1|||
33555568|NCT03156621|101934894|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
33555569|NCT03156621|101934895|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
33555570|NCT03156621|101934894|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33356285|NCT03794986|101191578|FG000|Overall Study|0 Sessions Attended|34|||
33356286|NCT03794986|101191579|FG001|Overall Study|0 Sessions Attended|37|||
33356287|NCT03794986|101191578|FG000|Overall Study|Withdrawal by Subject|4|||
33356288|NCT03794986|101191579|FG001|Overall Study|Withdrawal by Subject|6|||
33356289|NCT03794986|101191578|FG000|Overall Study|Protocol Violation|1|||
33356290|NCT03794986|101191579|FG001|Overall Study|Protocol Violation|0|||
33356291|NCT00805207|101191580|FG000|Overall Study|Protocol Violation|0|||
33356292|NCT00805207|101191581|FG001|Overall Study|Protocol Violation|0|||
33356293|NCT00805207|101191582|FG002|Overall Study|Protocol Violation|1|||
33356294|NCT00805207|101191583|FG003|Overall Study|Protocol Violation|0|||
33356295|NCT00805207|101191584|FG004|Overall Study|Protocol Violation|0|||
33356296|NCT00805207|101191585|FG005|Overall Study|Protocol Violation|0|||
33356297|NCT00805207|101191586|FG006|Overall Study|Protocol Violation|0|||
33356298|NCT00805207|101191587|FG007|Overall Study|Protocol Violation|0|||
33356299|NCT00805207|101191588|FG008|Overall Study|Protocol Violation|0|||
33356300|NCT00805207|101191580|FG000|Overall Study|Physician Decision|0|||
33356301|NCT00805207|101191581|FG001|Overall Study|Physician Decision|1|||
33356302|NCT00805207|101191582|FG002|Overall Study|Physician Decision|0|||
33356303|NCT00805207|101191583|FG003|Overall Study|Physician Decision|0|||
33356304|NCT00805207|101191584|FG004|Overall Study|Physician Decision|0|||
33621187|NCT02611817|102161887|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
33621188|NCT02611817|102161888|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
33621189|NCT02611817|102161889|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
33621190|NCT02611817|102161887|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
33621191|NCT02611817|102161888|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
33621192|NCT02611817|102161889|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
33621193|NCT01220167|102161892|FG000|Period 3|Urine positive for substance abuse|0|||
33621194|NCT01220167|102161893|FG001|Period 3|Urine positive for substance abuse|1|||
33621195|NCT01220167|102161894|FG002|Period 3|Urine positive for substance abuse|0|||
33621196|NCT03515824|102161895|FG000|Overall Study|Death|3|||
33621197|NCT03515824|102161896|FG001|Overall Study|Death|2|||
33621198|NCT03515824|102161897|FG002|Overall Study|Death|6|||
33621199|NCT03515824|102161898|FG003|Overall Study|Death|0|||
33621200|NCT03515824|102161895|FG000|Overall Study|Lost to Follow-up|0|||
33621201|NCT03515824|102161896|FG001|Overall Study|Lost to Follow-up|1|||
33621202|NCT03515824|102161897|FG002|Overall Study|Lost to Follow-up|1|||
33356305|NCT00805207|101191585|FG005|Overall Study|Physician Decision|1|||
33356306|NCT00805207|101191586|FG006|Overall Study|Physician Decision|0|||
33356307|NCT00805207|101191587|FG007|Overall Study|Physician Decision|0|||
33356308|NCT00805207|101191588|FG008|Overall Study|Physician Decision|0|||
33356309|NCT00805207|101191580|FG000|Overall Study|Withdrawal by Subject|0|||
33621203|NCT03515824|102161898|FG003|Overall Study|Lost to Follow-up|0|||
33621204|NCT03515824|102161895|FG000|Overall Study|Study terminated by sponsor|0|||
33621205|NCT03515824|102161896|FG001|Overall Study|Study terminated by sponsor|1|||
33621206|NCT03515824|102161897|FG002|Overall Study|Study terminated by sponsor|6|||
33621207|NCT03515824|102161898|FG003|Overall Study|Study terminated by sponsor|0|||
33621208|NCT03515824|102161895|FG000|Overall Study|Status not recorded|0|||
33621209|NCT03515824|102161896|FG001|Overall Study|Status not recorded|0|||
33621210|NCT03515824|102161897|FG002|Overall Study|Status not recorded|2|||
33621211|NCT03515824|102161898|FG003|Overall Study|Status not recorded|0|||
33621212|NCT04098809|102161899|FG000|Overall Study|Withdrawal by Subject|1|||
33621213|NCT04098809|102161900|FG001|Overall Study|Withdrawal by Subject|3|||
33621214|NCT04098809|102161899|FG000|Overall Study|Physician Decision|2|||
33621215|NCT04098809|102161900|FG001|Overall Study|Physician Decision|1|||
33621216|NCT00452790|102161901|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
33621217|NCT00452790|102161902|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
33621218|NCT00452790|102161901|FG000|Infant Series|Parent/legal guardian request|8|||
33621219|NCT00452790|102161902|FG001|Infant Series|Parent/legal guardian request|6|||
33621220|NCT00452790|102161901|FG000|Infant Series|Failed to return|4|||
33621221|NCT00452790|102161902|FG001|Infant Series|Failed to return|1|||
33621222|NCT00452790|102161901|FG000|Infant Series|Protocol Violation|1|||
33356310|NCT00805207|101191581|FG001|Overall Study|Withdrawal by Subject|1|||
33356311|NCT00805207|101191582|FG002|Overall Study|Withdrawal by Subject|0|||
33356312|NCT00805207|101191583|FG003|Overall Study|Withdrawal by Subject|0|||
33356313|NCT00805207|101191584|FG004|Overall Study|Withdrawal by Subject|1|||
33414059|NCT00877799|101406507|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
33356314|NCT00805207|101191585|FG005|Overall Study|Withdrawal by Subject|2|||
33356315|NCT00805207|101191586|FG006|Overall Study|Withdrawal by Subject|0|||
33414060|NCT00877799|101406508|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
33621223|NCT00452790|102161902|FG001|Infant Series|Protocol Violation|3|||
33621224|NCT00452790|102161901|FG000|Infant Series|Lost to Follow-up|2|||
33621225|NCT00452790|102161902|FG001|Infant Series|Lost to Follow-up|2|||
33621226|NCT00452790|102161901|FG000|Infant Series|Adverse Event|1|||
33621227|NCT00452790|102161902|FG001|Infant Series|Adverse Event|2|||
33621228|NCT00452790|102161901|FG000|Infant Series|Other reasons|1|||
33356316|NCT00805207|101191587|FG007|Overall Study|Withdrawal by Subject|0|||
33356317|NCT00805207|101191588|FG008|Overall Study|Withdrawal by Subject|0|||
33621229|NCT00452790|102161902|FG001|Infant Series|Other reasons|2|||
33621230|NCT00452790|102161901|FG000|Infant Series|Investigator request|0|||
33621231|NCT00452790|102161902|FG001|Infant Series|Investigator request|1|||
33621232|NCT00452790|102161901|FG000|Infant Series|Death|0|||
33621233|NCT00452790|102161902|FG001|Infant Series|Death|1|||
33621234|NCT00452790|102161901|FG000|After Infant Series|Investigator request|10|||
33621235|NCT00452790|102161902|FG001|After Infant Series|Investigator request|10|||
33621236|NCT00452790|102161901|FG000|After Infant Series|Adverse Event|4|||
33621237|NCT00452790|102161902|FG001|After Infant Series|Adverse Event|1|||
33621238|NCT00452790|102161901|FG000|After Infant Series|Parent/legal guardian request|1|||
33621239|NCT00452790|102161902|FG001|After Infant Series|Parent/legal guardian request|3|||
33621240|NCT00452790|102161901|FG000|After Infant Series|Lost to Follow-up|4|||
33621241|NCT00452790|102161902|FG001|After Infant Series|Lost to Follow-up|0|||
33621242|NCT00452790|102161901|FG000|After Infant Series|Failed to return|1|||
33621243|NCT00452790|102161902|FG001|After Infant Series|Failed to return|0|||
33621244|NCT00452790|102161901|FG000|After Infant Series|Other reasons|1|||
33621245|NCT00452790|102161902|FG001|After Infant Series|Other reasons|0|||
33621246|NCT00452790|102161901|FG000|Toddler Dose|Failed to return|0|||
33621247|NCT00452790|102161902|FG001|Toddler Dose|Failed to return|1|||
33621248|NCT00452790|102161901|FG000|Toddler Dose|Parent/legal guardian request|0|||
33621249|NCT00452790|102161902|FG001|Toddler Dose|Parent/legal guardian request|1|||
33621250|NCT02741245|102161903|FG000|Overall Study|Adverse Event|0|||
33621251|NCT02741245|102161904|FG001|Overall Study|Adverse Event|0|||
33621252|NCT02741245|102161905|FG002|Overall Study|Adverse Event|0|||
33621253|NCT02741245|102161906|FG003|Overall Study|Adverse Event|2|||
33621254|NCT02741245|102161907|FG004|Overall Study|Adverse Event|2|||
33621255|NCT02741245|102161903|FG000|Overall Study|Protocol Violation|0|||
33621256|NCT02741245|102161904|FG001|Overall Study|Protocol Violation|1|||
33555571|NCT03156621|101934895|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
33555572|NCT00676689|101934896|FG000|Overall Study|Screen Failure|2|||
33555573|NCT00676689|101934896|FG000|Overall Study|Death|2|||
33555574|NCT00676689|101934896|FG000|Overall Study|Lost to Follow-up|4|||
33555575|NCT00676689|101934896|FG000|Overall Study|Physician Decision|1|||
33555576|NCT00676689|101934896|FG000|Overall Study|Withdrawal by Subject|3|||
33555577|NCT00676689|101934896|FG000|Overall Study|Continuing FU|49|||
33555578|NCT00609973|101934897|FG000|Overall Study|Adverse Event|2|||
33555579|NCT00609973|101934898|FG001|Overall Study|Adverse Event|1|||
33555580|NCT00609973|101934897|FG000|Overall Study|Protocol Violation|4|||
33555581|NCT00609973|101934898|FG001|Overall Study|Protocol Violation|3|||
33555582|NCT00609973|101934897|FG000|Overall Study|Lost to Follow-up|2|||
33555583|NCT00609973|101934898|FG001|Overall Study|Lost to Follow-up|1|||
33555584|NCT00609973|101934897|FG000|Overall Study|Withdrawal by Subject|0|||
33555585|NCT00609973|101934898|FG001|Overall Study|Withdrawal by Subject|1|||
33555586|NCT01052428|101934899|FG000|Overall Study|Death|1|||
33555587|NCT01052428|101934900|FG001|Overall Study|Death|0|||
33555588|NCT01052428|101934899|FG000|Overall Study|Withdrawal by Subject|0|||
33555589|NCT01052428|101934900|FG001|Overall Study|Withdrawal by Subject|1|||
33555590|NCT00983957|101934901|FG000|Overall Study|Adverse Event|1|||
33555591|NCT00983957|101934901|FG000|Overall Study|Personal Reasons|1|||
33555592|NCT01720602|101934902|FG000|Overall Study|Adverse Event|3|||
33555593|NCT01720602|101934902|FG000|Overall Study|Progressive disease on therapy|2|||
33555594|NCT02294019|101934909|FG000|Overall Study|Adverse Event|2|||
33555595|NCT02294019|101934909|FG000|Overall Study|Protocol Violation|68|||
33555596|NCT02294019|101934909|FG000|Overall Study|Lost to Follow-up|31|||
33555597|NCT02294019|101934909|FG000|Overall Study|Other|1|||
33555598|NCT02294019|101934909|FG000|Overall Study|Withdrawal by Subject|1|||
33555599|NCT00974233|101934910|FG000|Induction Chemoimmunotherapy|Death|2|||
33555600|NCT00974233|101934910|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
33555601|NCT00974233|101934910|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
33555602|NCT00974233|101934910|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
33555603|NCT00974233|101934910|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
33555604|NCT00974233|101934910|FG000|Maintenance Lenalidomide|Adverse Event|8|||
33621257|NCT02741245|102161905|FG002|Overall Study|Protocol Violation|0|||
33621258|NCT02741245|102161906|FG003|Overall Study|Protocol Violation|1|||
33621259|NCT02741245|102161907|FG004|Overall Study|Protocol Violation|0|||
33621260|NCT02741245|102161903|FG000|Overall Study|Withdrawal by Subject|0|||
33621261|NCT02741245|102161904|FG001|Overall Study|Withdrawal by Subject|0|||
33621262|NCT02741245|102161905|FG002|Overall Study|Withdrawal by Subject|0|||
33621263|NCT02741245|102161906|FG003|Overall Study|Withdrawal by Subject|1|||
33356318|NCT00824564|101191589|FG000|Overall Study|Lost to Follow-up|5|||
33555605|NCT01336972|101934912|FG000|Overall Study|Adverse Event|1|||
33555606|NCT01336972|101934913|FG001|Overall Study|Adverse Event|1|||
33555607|NCT01336972|101934914|FG002|Overall Study|Adverse Event|0|||
33555608|NCT00930176|101934915|FG000|Overall Study|Death|1|||
33555609|NCT03636269|101934918|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
33621264|NCT02741245|102161907|FG004|Overall Study|Withdrawal by Subject|0|||
33621265|NCT00428948|102161910|FG000|Overall Study|Lost to Follow-up|15|||
33555610|NCT03636269|101934919|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
33555611|NCT03636269|101934920|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
33555612|NCT03636269|101934918|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
33555613|NCT03636269|101934919|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
33555614|NCT03636269|101934920|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
33555615|NCT03636269|101934918|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
33555616|NCT03636269|101934919|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
33555617|NCT03636269|101934920|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
33555618|NCT03636269|101934918|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
33555619|NCT03636269|101934919|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
33555620|NCT03636269|101934920|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
33555621|NCT03636269|101934918|FG000|Period 1: Double-blind Phase|Other|6|||
33555622|NCT03636269|101934919|FG001|Period 1: Double-blind Phase|Other|3|||
33555623|NCT03636269|101934920|FG002|Period 1: Double-blind Phase|Other|0|||
33555624|NCT03636269|101934918|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
33555625|NCT03636269|101934919|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
33555626|NCT03636269|101934920|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
33555627|NCT03636269|101934918|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
33555628|NCT03636269|101934919|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
33555629|NCT03636269|101934920|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
33555630|NCT03636269|101934918|FG000|Period 2: Open-label Phase|Adverse Event|0|||
33555631|NCT03636269|101934919|FG001|Period 2: Open-label Phase|Adverse Event|0|||
33555632|NCT03636269|101934920|FG002|Period 2: Open-label Phase|Adverse Event|21|||
33555633|NCT03636269|101934918|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
33555634|NCT03636269|101934919|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
33555635|NCT03636269|101934920|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
33555636|NCT03636269|101934918|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
33555637|NCT03636269|101934919|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
33555638|NCT03636269|101934920|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
33555639|NCT03636269|101934918|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
33555640|NCT03636269|101934919|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
33555641|NCT03636269|101934920|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
33555642|NCT03636269|101934918|FG000|Period 2: Open-label Phase|Administrative|0|||
33555643|NCT03636269|101934919|FG001|Period 2: Open-label Phase|Administrative|0|||
33555644|NCT03636269|101934920|FG002|Period 2: Open-label Phase|Administrative|36|||
33555645|NCT03636269|101934918|FG000|Period 2: Open-label Phase|Other|0|||
33555646|NCT03636269|101934919|FG001|Period 2: Open-label Phase|Other|0|||
33356319|NCT00824564|101191590|FG001|Overall Study|Lost to Follow-up|7|||
33356320|NCT00824564|101191589|FG000|Overall Study|Withdrawal by Subject|1|||
33356321|NCT00824564|101191590|FG001|Overall Study|Withdrawal by Subject|1|||
33356322|NCT00824564|101191589|FG000|Overall Study|Other|1|||
33356323|NCT00824564|101191590|FG001|Overall Study|Other|2|||
33555647|NCT03636269|101934920|FG002|Period 2: Open-label Phase|Other|9|||
33356324|NCT00824564|101191589|FG000|Overall Study|Randomized, but not treated|1|||
33555648|NCT03636269|101934918|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
33555649|NCT03636269|101934919|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
33356325|NCT00824564|101191590|FG001|Overall Study|Randomized, but not treated|0|||
33356326|NCT00995371|101191591|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
33555650|NCT03636269|101934920|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
33555651|NCT01852214|101934921|FG000|Period 1|Adverse Event|1|||
33555652|NCT01852214|101934922|FG001|Period 1|Adverse Event|2|||
33555653|NCT01852214|101934921|FG000|Period 1|Withdrawal by Subject|0|||
33555654|NCT01852214|101934922|FG001|Period 1|Withdrawal by Subject|1|||
33555655|NCT01852214|101934921|FG000|Washout Period|Withdrawal by Subject|0|||
33555656|NCT01852214|101934922|FG001|Washout Period|Withdrawal by Subject|1|||
33555657|NCT01905267|101934924|FG000|Overall Study|Physician Decision|2|||
33555658|NCT01905267|101934925|FG001|Overall Study|Physician Decision|2|||
33555659|NCT03093870|101934926|FG000|Overall Study|Withdrawal by Subject|2|||
33555660|NCT03093870|101934927|FG001|Overall Study|Withdrawal by Subject|6|||
33555661|NCT03093870|101934928|FG002|Overall Study|Withdrawal by Subject|5|||
33555662|NCT03093870|101934926|FG000|Overall Study|Death|1|||
33555663|NCT03093870|101934927|FG001|Overall Study|Death|35|||
33555664|NCT03093870|101934928|FG002|Overall Study|Death|35|||
33555665|NCT03093870|101934926|FG000|Overall Study|Radiographic disease progression|10|||
33555666|NCT03093870|101934927|FG001|Overall Study|Radiographic disease progression|0|||
33555667|NCT03093870|101934928|FG002|Overall Study|Radiographic disease progression|0|||
33555668|NCT03093870|101934926|FG000|Overall Study|Clinical disease progression|1|||
33555669|NCT03093870|101934927|FG001|Overall Study|Clinical disease progression|0|||
33555670|NCT03093870|101934928|FG002|Overall Study|Clinical disease progression|0|||
33555671|NCT03093870|101934926|FG000|Overall Study|Physician Decision|2|||
33555672|NCT03093870|101934927|FG001|Overall Study|Physician Decision|0|||
33555673|NCT03093870|101934928|FG002|Overall Study|Physician Decision|0|||
33555674|NCT03093870|101934926|FG000|Overall Study|Adverse Event|7|||
33555675|NCT03093870|101934927|FG001|Overall Study|Adverse Event|0|||
33555676|NCT03093870|101934928|FG002|Overall Study|Adverse Event|0|||
33555677|NCT03093870|101934926|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
33555678|NCT03093870|101934927|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
33555679|NCT03093870|101934928|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
33555680|NCT03093870|101934926|FG000|Overall Study|Lost to Follow-up|0|||
33555681|NCT03093870|101934927|FG001|Overall Study|Lost to Follow-up|0|||
33356327|NCT00995371|101191592|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
33555682|NCT03093870|101934928|FG002|Overall Study|Lost to Follow-up|1|||
33555683|NCT03808909|101934929|FG000|Overall Study|Lost to Follow-up|3|||
33555684|NCT03808909|101934930|FG001|Overall Study|Lost to Follow-up|0|||
33555685|NCT01362530|101934931|FG000|Base Study (Cycle 1)|Adverse Event|2|||
33555686|NCT01362530|101934932|FG001|Base Study (Cycle 1)|Adverse Event|0|||
33555687|NCT01362530|101934931|FG000|Base Study (Cycle 1)|Physician Decision|0|||
33356328|NCT01672892|101191600|FG000|Overall Study|Protocol Violation|7|||
33356329|NCT01672892|101191601|FG001|Overall Study|Protocol Violation|3|||
33356330|NCT01750918|101191604|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
33356331|NCT01750918|101191605|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
33356332|NCT01750918|101191606|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
33356333|NCT01750918|101191607|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
33356334|NCT01750918|101191608|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
33356335|NCT01750918|101191609|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
33356336|NCT01750918|101191610|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
33356337|NCT01750918|101191611|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
33356338|NCT01750918|101191604|FG000|Overall Study|Lost to Follow-up|0|||
33555688|NCT01362530|101934932|FG001|Base Study (Cycle 1)|Physician Decision|1|||
33555689|NCT01362530|101934931|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
33621266|NCT00428948|102161911|FG001|Overall Study|Lost to Follow-up|8|||
33621267|NCT00428948|102161910|FG000|Overall Study|Adverse Event|148|||
33555690|NCT01362530|101934932|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
33555691|NCT01362530|101934931|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
33555692|NCT01362530|101934932|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
33621268|NCT00428948|102161911|FG001|Overall Study|Adverse Event|24|||
33621269|NCT00428948|102161910|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
33621270|NCT00428948|102161911|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
33621271|NCT00428948|102161910|FG000|Overall Study|Investigator Withdrew Subject|3|||
33621272|NCT00428948|102161911|FG001|Overall Study|Investigator Withdrew Subject|4|||
33621273|NCT00428948|102161910|FG000|Overall Study|Subject Withdrew Consent|50|||
33621274|NCT00428948|102161911|FG001|Overall Study|Subject Withdrew Consent|30|||
33621275|NCT00428948|102161910|FG000|Overall Study|Protocol Deviation|1|||
33218138|NCT02001194|100695967|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
33356339|NCT01750918|101191605|FG001|Overall Study|Lost to Follow-up|0|||
33555693|NCT01362530|101934931|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
33555694|NCT01362530|101934932|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
33555695|NCT01362530|101934931|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
33356340|NCT01750918|101191606|FG002|Overall Study|Lost to Follow-up|2|||
33555696|NCT01362530|101934932|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
33555697|NCT01362530|101934931|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
33555698|NCT01362530|101934932|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
33555699|NCT01362530|101934931|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
33555700|NCT01362530|101934932|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
33555701|NCT01362530|101934931|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
33555702|NCT01362530|101934932|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
33555703|NCT01362530|101934931|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
33555704|NCT01362530|101934932|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
33555705|NCT01362530|101934931|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
33555706|NCT01362530|101934932|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
33555707|NCT01362530|101934931|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
33555708|NCT01362530|101934932|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
33555709|NCT01362530|101934931|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
33555710|NCT01362530|101934932|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
33555711|NCT03511066|101934935|FG000|Overall Study|Withdrawal by Subject|1|||
33555712|NCT03511066|101934936|FG001|Overall Study|Withdrawal by Subject|2|||
33555713|NCT03511066|101934937|FG002|Overall Study|Withdrawal by Subject|3|||
33555714|NCT03511066|101934935|FG000|Overall Study|Lost to Follow-up|2|||
33555715|NCT03511066|101934936|FG001|Overall Study|Lost to Follow-up|3|||
33555716|NCT03511066|101934937|FG002|Overall Study|Lost to Follow-up|0|||
33555717|NCT03473301|101934938|FG000|Overall Study|Protocol Violation|4|||
33555718|NCT03473301|101934939|FG001|Overall Study|Protocol Violation|0|||
33555719|NCT03473301|101934940|FG002|Overall Study|Protocol Violation|0|||
33356341|NCT01750918|101191607|FG003|Overall Study|Lost to Follow-up|2|||
33356342|NCT01750918|101191608|FG004|Overall Study|Lost to Follow-up|0|||
33356343|NCT01750918|101191609|FG005|Overall Study|Lost to Follow-up|0|||
33356344|NCT01750918|101191610|FG006|Overall Study|Lost to Follow-up|0|||
33356345|NCT01750918|101191611|FG007|Overall Study|Lost to Follow-up|1|||
33356346|NCT01750918|101191604|FG000|Overall Study|Withdrawal by Subject|0|||
33356347|NCT01750918|101191605|FG001|Overall Study|Withdrawal by Subject|0|||
33356348|NCT01750918|101191606|FG002|Overall Study|Withdrawal by Subject|1|||
33356349|NCT01750918|101191607|FG003|Overall Study|Withdrawal by Subject|2|||
33356350|NCT01750918|101191608|FG004|Overall Study|Withdrawal by Subject|1|||
33356351|NCT01750918|101191609|FG005|Overall Study|Withdrawal by Subject|1|||
33356352|NCT01750918|101191610|FG006|Overall Study|Withdrawal by Subject|2|||
33356353|NCT01750918|101191611|FG007|Overall Study|Withdrawal by Subject|2|||
33356354|NCT00826514|101191612|FG000|Overall Study|Adverse Event|1|||
33356355|NCT00826514|101191613|FG001|Overall Study|Adverse Event|1|||
33356356|NCT00826514|101191612|FG000|Overall Study|Lack of Efficacy|0|||
33356357|NCT00826514|101191613|FG001|Overall Study|Lack of Efficacy|1|||
33356358|NCT00826514|101191612|FG000|Overall Study|Withdrawal by Subject|2|||
33356359|NCT00826514|101191613|FG001|Overall Study|Withdrawal by Subject|3|||
33356360|NCT00488631|101191616|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
33356361|NCT00488631|101191617|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
33356362|NCT00488631|101191618|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
33356363|NCT00488631|101191619|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
33356364|NCT00488631|101191620|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
33356365|NCT00488631|101191621|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
33356366|NCT00488631|101191622|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
33356367|NCT00488631|101191623|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
33356368|NCT00488631|101191624|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
33356369|NCT00488631|101191625|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
33356370|NCT00488631|101191616|FG000|Double Blind Period (Week 0-54)|Death|0|||
33356371|NCT00488631|101191617|FG001|Double Blind Period (Week 0-54)|Death|0|||
33356372|NCT00488631|101191618|FG002|Double Blind Period (Week 0-54)|Death|0|||
33356373|NCT00488631|101191619|FG003|Double Blind Period (Week 0-54)|Death|0|||
33356374|NCT00488631|101191620|FG004|Double Blind Period (Week 0-54)|Death|0|||
33356375|NCT00488631|101191621|FG005|Double Blind Period (Week 0-54)|Death|1|||
33356376|NCT00488631|101191622|FG006|Double Blind Period (Week 0-54)|Death|0|||
33356377|NCT00488631|101191623|FG007|Double Blind Period (Week 0-54)|Death|0|||
33356378|NCT00488631|101191624|FG008|Double Blind Period (Week 0-54)|Death|0|||
33356379|NCT00488631|101191625|FG009|Double Blind Period (Week 0-54)|Death|0|||
33356380|NCT00488631|101191616|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
33555720|NCT03473301|101934938|FG000|Overall Study|Withdrawal by Subject|0|||
33356381|NCT00488631|101191617|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
33356382|NCT00488631|101191618|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
33356383|NCT00488631|101191619|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
33356384|NCT00488631|101191620|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
33356385|NCT00488631|101191621|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
33356386|NCT00488631|101191622|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
33356387|NCT00488631|101191623|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
33356388|NCT00488631|101191624|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
33356389|NCT00488631|101191625|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
33356390|NCT00488631|101191616|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
33414061|NCT00877799|101406509|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
33414062|NCT00877799|101406505|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
33414063|NCT00877799|101406506|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
33356391|NCT00488631|101191617|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
33356392|NCT00488631|101191618|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
33356393|NCT00488631|101191619|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
33356394|NCT00488631|101191620|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
33356395|NCT00488631|101191621|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
33356396|NCT00488631|101191622|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
33356397|NCT00488631|101191623|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
33356398|NCT00488631|101191624|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
33356399|NCT00488631|101191625|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
33356400|NCT00488631|101191616|FG000|Double Blind Period (Week 0-54)|Other|6|||
33356401|NCT00488631|101191617|FG001|Double Blind Period (Week 0-54)|Other|12|||
33356402|NCT00488631|101191618|FG002|Double Blind Period (Week 0-54)|Other|10|||
33356403|NCT00488631|101191619|FG003|Double Blind Period (Week 0-54)|Other|11|||
33356404|NCT00488631|101191620|FG004|Double Blind Period (Week 0-54)|Other|14|||
33356405|NCT00488631|101191621|FG005|Double Blind Period (Week 0-54)|Other|34|||
33356406|NCT00488631|101191622|FG006|Double Blind Period (Week 0-54)|Other|0|||
33414064|NCT00877799|101406507|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
33356407|NCT00488631|101191623|FG007|Double Blind Period (Week 0-54)|Other|0|||
33356408|NCT00488631|101191624|FG008|Double Blind Period (Week 0-54)|Other|0|||
33356409|NCT00488631|101191625|FG009|Double Blind Period (Week 0-54)|Other|0|||
33356410|NCT00488631|101191616|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
33356411|NCT00488631|101191617|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
33356412|NCT00488631|101191618|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
33356413|NCT00488631|101191619|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
33414065|NCT00877799|101406508|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
33414066|NCT00877799|101406509|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
33414067|NCT00877799|101406505|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
33414068|NCT00877799|101406506|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
33414069|NCT00877799|101406507|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
33414070|NCT00877799|101406508|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
33414071|NCT00877799|101406509|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
33414072|NCT00877799|101406505|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
33414073|NCT00877799|101406506|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
33414074|NCT00877799|101406507|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
33414075|NCT00877799|101406508|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
33414076|NCT00877799|101406509|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
33414077|NCT03707145|101406510|FG000|Overall Study|Lost to Follow-up|0|||
33414078|NCT03707145|101406511|FG001|Overall Study|Lost to Follow-up|1|||
33414079|NCT03707145|101406512|FG002|Overall Study|Lost to Follow-up|1|||
33414080|NCT03707145|101406513|FG003|Overall Study|Lost to Follow-up|0|||
33555721|NCT03473301|101934939|FG001|Overall Study|Withdrawal by Subject|1|||
33555722|NCT03473301|101934940|FG002|Overall Study|Withdrawal by Subject|0|||
33555723|NCT03473301|101934938|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
33555724|NCT03473301|101934939|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
33356414|NCT00488631|101191620|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
33356415|NCT00488631|101191621|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
33356416|NCT00488631|101191622|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
33356417|NCT00488631|101191623|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
33356418|NCT00488631|101191624|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
33356419|NCT00488631|101191625|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
33356420|NCT00488631|101191616|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
33356421|NCT00488631|101191617|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
33356422|NCT00488631|101191618|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
33356423|NCT00488631|101191619|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
33555725|NCT03473301|101934940|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
33555726|NCT03892915|101934941|FG000|Overall Study|Lost to Follow-up|6|||
33356424|NCT00488631|101191620|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
33356425|NCT00488631|101191621|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
33356426|NCT00488631|101191622|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
33356427|NCT00488631|101191623|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
33356428|NCT00488631|101191624|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
33356429|NCT00488631|101191625|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
33356430|NCT00488631|101191616|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
33356431|NCT00488631|101191617|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
33356432|NCT00488631|101191618|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
33356433|NCT00488631|101191619|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
33356434|NCT00488631|101191620|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
33356435|NCT00488631|101191621|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
33555727|NCT03892915|101934942|FG001|Overall Study|Lost to Follow-up|12|||
33555728|NCT03892915|101934941|FG000|Overall Study|Death|0|||
33621276|NCT00428948|102161911|FG001|Overall Study|Protocol Deviation|1|||
33621277|NCT00479336|102161912|FG000|Overall Study|Adverse Event|1|||
33621278|NCT00479336|102161913|FG001|Overall Study|Adverse Event|1|||
33621279|NCT00479336|102161914|FG002|Overall Study|Adverse Event|1|||
33621280|NCT00479336|102161915|FG003|Overall Study|Adverse Event|3|||
33621281|NCT00479336|102161912|FG000|Overall Study|Lack of Efficacy|1|||
33621282|NCT00479336|102161913|FG001|Overall Study|Lack of Efficacy|0|||
33621283|NCT00479336|102161914|FG002|Overall Study|Lack of Efficacy|0|||
33621284|NCT00479336|102161915|FG003|Overall Study|Lack of Efficacy|0|||
33621285|NCT00479336|102161912|FG000|Overall Study|Protocol Violation|0|||
33621286|NCT00479336|102161913|FG001|Overall Study|Protocol Violation|1|||
33621287|NCT00479336|102161914|FG002|Overall Study|Protocol Violation|0|||
33621288|NCT00479336|102161915|FG003|Overall Study|Protocol Violation|0|||
33621289|NCT00479336|102161912|FG000|Overall Study|Withdrawal by Subject|1|||
33621290|NCT00479336|102161913|FG001|Overall Study|Withdrawal by Subject|2|||
33621291|NCT00479336|102161914|FG002|Overall Study|Withdrawal by Subject|0|||
33621292|NCT00479336|102161915|FG003|Overall Study|Withdrawal by Subject|0|||
33621293|NCT00479336|102161912|FG000|Overall Study|Physician Decision|0|||
33621294|NCT00479336|102161913|FG001|Overall Study|Physician Decision|1|||
33621295|NCT00479336|102161914|FG002|Overall Study|Physician Decision|0|||
33621296|NCT00479336|102161915|FG003|Overall Study|Physician Decision|2|||
33621297|NCT00479336|102161912|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
33621298|NCT00479336|102161913|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
33621299|NCT00479336|102161914|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
33621300|NCT00479336|102161915|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
33356436|NCT00488631|101191622|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
33356437|NCT00488631|101191623|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
33555729|NCT03892915|101934942|FG001|Overall Study|Death|2|||
33555730|NCT03892915|101934941|FG000|Overall Study|Withdrawal by Subject|1|||
33555731|NCT03892915|101934942|FG001|Overall Study|Withdrawal by Subject|1|||
33555732|NCT03892915|101934941|FG000|Overall Study|unsuccessful delivery|13|||
33555733|NCT03892915|101934942|FG001|Overall Study|unsuccessful delivery|18|||
33555734|NCT02614066|101934943|FG000|Overall Study|Death|6|||
33555735|NCT02614066|101934944|FG001|Overall Study|Death|14|||
33555736|NCT02614066|101934945|FG002|Overall Study|Death|11|||
33555737|NCT02614066|101934946|FG003|Overall Study|Death|29|||
33555738|NCT02614066|101934943|FG000|Overall Study|Full consent withdrawn|0|||
33555739|NCT02614066|101934944|FG001|Overall Study|Full consent withdrawn|1|||
33555740|NCT02614066|101934945|FG002|Overall Study|Full consent withdrawn|0|||
33555741|NCT02614066|101934946|FG003|Overall Study|Full consent withdrawn|8|||
33555742|NCT02614066|101934943|FG000|Overall Study|Lost to Follow-up|0|||
33555743|NCT02614066|101934944|FG001|Overall Study|Lost to Follow-up|2|||
33555744|NCT02614066|101934945|FG002|Overall Study|Lost to Follow-up|2|||
33555745|NCT02614066|101934946|FG003|Overall Study|Lost to Follow-up|2|||
33555746|NCT02614066|101934943|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
33555747|NCT02614066|101934944|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
33555748|NCT02614066|101934945|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
33555749|NCT02614066|101934946|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
33555750|NCT02614066|101934943|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
33555751|NCT02614066|101934944|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
33555752|NCT02614066|101934945|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
33555753|NCT02614066|101934946|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
33621301|NCT02510001|102161918|FG000|Overall Study|Early disease progression|0|||
33621302|NCT02510001|102161919|FG001|Overall Study|Early disease progression|0|||
33621303|NCT02510001|102161920|FG002|Overall Study|Early disease progression|0|||
33621304|NCT02510001|102161921|FG003|Overall Study|Early disease progression|1|||
33621305|NCT02510001|102161922|FG004|Overall Study|Early disease progression|1|||
33555754|NCT02614066|101934943|FG000|Overall Study|Reason not specified|0|||
33621306|NCT02510001|102161923|FG005|Overall Study|Early disease progression|1|||
33621307|NCT02510001|102161924|FG006|Overall Study|Early disease progression|0|||
33555755|NCT02614066|101934944|FG001|Overall Study|Reason not specified|2|||
33555756|NCT02614066|101934945|FG002|Overall Study|Reason not specified|1|||
33621308|NCT02510001|102161925|FG007|Overall Study|Early disease progression|0|||
33621309|NCT02510001|102161918|FG000|Overall Study|Adverse Event|0|||
33621310|NCT02510001|102161919|FG001|Overall Study|Adverse Event|0|||
33621311|NCT02510001|102161920|FG002|Overall Study|Adverse Event|0|||
33621312|NCT02510001|102161921|FG003|Overall Study|Adverse Event|1|||
33621313|NCT02510001|102161922|FG004|Overall Study|Adverse Event|2|||
33621314|NCT02510001|102161923|FG005|Overall Study|Adverse Event|1|||
33621315|NCT02510001|102161924|FG006|Overall Study|Adverse Event|2|||
33621316|NCT02510001|102161925|FG007|Overall Study|Adverse Event|5|||
33356438|NCT00488631|101191624|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
33414081|NCT01308762|101406514|FG000|Overall Study|Protocol Violation|0|||
33414082|NCT01308762|101406515|FG001|Overall Study|Protocol Violation|1|||
33414083|NCT01308762|101406516|FG002|Overall Study|Protocol Violation|0|||
33356439|NCT00488631|101191625|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
33356440|NCT00488631|101191616|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33356441|NCT00488631|101191617|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33356442|NCT00488631|101191618|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33356443|NCT00488631|101191619|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33356444|NCT00488631|101191620|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33356445|NCT00488631|101191621|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33356446|NCT00488631|101191622|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
33356447|NCT00488631|101191623|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33356448|NCT00488631|101191624|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
33356449|NCT00488631|101191625|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
33356450|NCT00488631|101191616|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
33356451|NCT00488631|101191617|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
33356452|NCT00488631|101191618|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
33356453|NCT00488631|101191619|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
33356454|NCT00488631|101191620|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
33356455|NCT00488631|101191621|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
33356456|NCT00488631|101191622|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
33356457|NCT00488631|101191623|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
33555757|NCT02614066|101934946|FG003|Overall Study|Reason not specified|1|||
33555758|NCT00985192|101934947|FG000|Overall Study|Withdrawal by Subject|1|||
33555759|NCT00985192|101934947|FG000|Overall Study|Disease Progression|1|||
33555760|NCT00985192|101934947|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
33555761|NCT04076579|101934948|FG000|Overall Study|Adverse Event|2|||
33555762|NCT04076579|101934949|FG001|Overall Study|Adverse Event|0|||
33555763|NCT04076579|101934948|FG000|Overall Study|discontinued due to toxicity|1|||
33555764|NCT04076579|101934949|FG001|Overall Study|discontinued due to toxicity|0|||
33555765|NCT04076579|101934948|FG000|Overall Study|Physician Decision|1|||
33555766|NCT04076579|101934949|FG001|Overall Study|Physician Decision|0|||
33555767|NCT04076579|101934948|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
33555768|NCT04076579|101934949|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
33555769|NCT04076579|101934948|FG000|Overall Study|Noncompliance|0|||
33555770|NCT04076579|101934949|FG001|Overall Study|Noncompliance|1|||
33555771|NCT04076579|101934948|FG000|Overall Study|Withdrawal by Subject|0|||
33555772|NCT04076579|101934949|FG001|Overall Study|Withdrawal by Subject|2|||
33555773|NCT01530997|101934952|FG000|Overall Study|Physician Decision|1|||
33555774|NCT01530997|101934952|FG000|Overall Study|Withdrawal by Subject|1|||
33555775|NCT01189227|101934953|FG000|Overall Study|Study terminated due to low accrual|6|||
33555776|NCT01189227|101934954|FG001|Overall Study|Study terminated due to low accrual|3|||
33555777|NCT06074523|101934959|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
33555778|NCT06074523|101934959|FG000|Overall Study|Withdrawal by Subject|1|||
33555779|NCT02802865|101934971|FG000|Overall Study|Pregnancy|1|||
33555780|NCT02802865|101934972|FG001|Overall Study|Pregnancy|1|||
33555781|NCT02802865|101934971|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
33555782|NCT02802865|101934972|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
33356458|NCT00488631|101191624|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
33356459|NCT00488631|101191625|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
33356460|NCT00761215|101191626|FG000|Overall Study|Randomized but didn't receive drug|1|||
33414084|NCT04964960|101406518|FG000|Overall Study|Withdrawal by Subject|1|||
33555783|NCT00414609|101934973|FG000|Core Study|Adverse Event|9|||
33555784|NCT00414609|101934974|FG001|Core Study|Adverse Event|11|||
33555785|NCT00414609|101934975|FG002|Core Study|Adverse Event|0|||
33555786|NCT00414609|101934973|FG000|Core Study|Abnormal laboratory values|0|||
33414085|NCT00953017|101406519|FG000|Overall Study|DId not show up for colonoscopy|4|||
33555787|NCT00414609|101934974|FG001|Core Study|Abnormal laboratory values|1|||
33621317|NCT02510001|102161918|FG000|Overall Study|Physician Decision|0|||
33621318|NCT02510001|102161919|FG001|Overall Study|Physician Decision|0|||
33621319|NCT02510001|102161920|FG002|Overall Study|Physician Decision|0|||
33414086|NCT00953017|101406520|FG001|Overall Study|DId not show up for colonoscopy|4|||
33414087|NCT00953017|101406521|FG002|Overall Study|DId not show up for colonoscopy|5|||
33414088|NCT00953017|101406522|FG003|Overall Study|DId not show up for colonoscopy|4|||
33414089|NCT00953017|101406519|FG000|Overall Study|Incomplete data|1|||
33414090|NCT00953017|101406520|FG001|Overall Study|Incomplete data|1|||
33414091|NCT00953017|101406521|FG002|Overall Study|Incomplete data|0|||
33414092|NCT00953017|101406522|FG003|Overall Study|Incomplete data|0|||
33414093|NCT00953017|101406519|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
33414094|NCT00953017|101406520|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
33414095|NCT00953017|101406521|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
33414096|NCT00953017|101406522|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
33414097|NCT00953017|101406519|FG000|Overall Study|Brown stool prior to procedure|0|||
33414098|NCT00953017|101406520|FG001|Overall Study|Brown stool prior to procedure|0|||
33414099|NCT00953017|101406521|FG002|Overall Study|Brown stool prior to procedure|1|||
33414100|NCT00953017|101406522|FG003|Overall Study|Brown stool prior to procedure|0|||
33414101|NCT03563716|101406523|FG000|Overall Study|Death|20|||
33414102|NCT03563716|101406524|FG001|Overall Study|Death|14|||
33414103|NCT03563716|101406523|FG000|Overall Study|Withdrawal by Subject|3|||
33414104|NCT03563716|101406524|FG001|Overall Study|Withdrawal by Subject|3|||
33414105|NCT03563716|101406523|FG000|Overall Study|Still on Study|45|||
33414106|NCT03563716|101406524|FG001|Overall Study|Still on Study|50|||
33414107|NCT03985293|101406535|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
33218139|NCT02001194|100695968|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
33218140|NCT02001194|100695969|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
33218141|NCT02001194|100695970|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
33218142|NCT03685591|100695971|FG000|Overall Study|Global Deterioration of Health Status|0|||
33414108|NCT03985293|101406536|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
33414109|NCT03985293|101406537|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
33414110|NCT03985293|101406538|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
33414111|NCT03985293|101406539|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
33414112|NCT03985293|101406540|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
33414113|NCT03985293|101406535|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
33555788|NCT00414609|101934975|FG002|Core Study|Abnormal laboratory values|0|||
33555789|NCT00414609|101934973|FG000|Core Study|Abnormal test procedure results|1|||
33555790|NCT00414609|101934974|FG001|Core Study|Abnormal test procedure results|1|||
33555791|NCT00414609|101934975|FG002|Core Study|Abnormal test procedure results|0|||
33555792|NCT00414609|101934973|FG000|Core Study|Protocol deviation|0|||
33555793|NCT00414609|101934974|FG001|Core Study|Protocol deviation|1|||
33555794|NCT00414609|101934975|FG002|Core Study|Protocol deviation|0|||
33555795|NCT00414609|101934973|FG000|Core Study|Patient withdrew consent|10|||
33555796|NCT00414609|101934974|FG001|Core Study|Patient withdrew consent|11|||
33555797|NCT00414609|101934975|FG002|Core Study|Patient withdrew consent|0|||
33555798|NCT00414609|101934973|FG000|Core Study|Lost to Follow-up|7|||
33555799|NCT00414609|101934974|FG001|Core Study|Lost to Follow-up|4|||
33555800|NCT00414609|101934975|FG002|Core Study|Lost to Follow-up|0|||
33555801|NCT00414609|101934973|FG000|Core Study|Administrative problems|0|||
33555802|NCT00414609|101934974|FG001|Core Study|Administrative problems|2|||
33555803|NCT00414609|101934975|FG002|Core Study|Administrative problems|0|||
33555804|NCT00414609|101934973|FG000|Core Study|Death|7|||
33555805|NCT00414609|101934974|FG001|Core Study|Death|14|||
33555806|NCT00414609|101934975|FG002|Core Study|Death|0|||
33555807|NCT00414609|101934973|FG000|Extension Study|Adverse Event|0|||
33555808|NCT00414609|101934974|FG001|Extension Study|Adverse Event|0|||
33555809|NCT00414609|101934975|FG002|Extension Study|Adverse Event|14|||
33555810|NCT00414609|101934973|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
33555811|NCT00414609|101934974|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
33555812|NCT00414609|101934975|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
33555813|NCT00414609|101934973|FG000|Extension Study|Withdrawal by Subject|0|||
33555814|NCT00414609|101934974|FG001|Extension Study|Withdrawal by Subject|0|||
33555815|NCT00414609|101934975|FG002|Extension Study|Withdrawal by Subject|13|||
33555816|NCT00414609|101934973|FG000|Extension Study|Lost to Follow-up|0|||
33555817|NCT00414609|101934974|FG001|Extension Study|Lost to Follow-up|0|||
33555818|NCT00414609|101934975|FG002|Extension Study|Lost to Follow-up|10|||
33555819|NCT00414609|101934973|FG000|Extension Study|Administrative problems|0|||
33555820|NCT00414609|101934974|FG001|Extension Study|Administrative problems|0|||
33218143|NCT03685591|100695972|FG001|Overall Study|Global Deterioration of Health Status|0|||
33414114|NCT03985293|101406536|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
33555821|NCT00414609|101934975|FG002|Extension Study|Administrative problems|1|||
33555822|NCT00414609|101934973|FG000|Extension Study|Death|0|||
33555823|NCT00414609|101934974|FG001|Extension Study|Death|0|||
33555824|NCT00414609|101934975|FG002|Extension Study|Death|17|||
33555825|NCT00276380|101934976|FG000|Overall Study|Adverse Event|5|||
33414115|NCT03985293|101406537|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
33414116|NCT03985293|101406538|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
33555826|NCT00276380|101934977|FG001|Overall Study|Adverse Event|3|||
33621320|NCT02510001|102161921|FG003|Overall Study|Physician Decision|0|||
33621321|NCT02510001|102161922|FG004|Overall Study|Physician Decision|1|||
33621322|NCT02510001|102161923|FG005|Overall Study|Physician Decision|0|||
33621323|NCT02510001|102161924|FG006|Overall Study|Physician Decision|0|||
33621324|NCT02510001|102161925|FG007|Overall Study|Physician Decision|0|||
33621325|NCT02510001|102161918|FG000|Overall Study|Withdrawal by Subject|0|||
33621326|NCT02510001|102161919|FG001|Overall Study|Withdrawal by Subject|0|||
33621327|NCT02510001|102161920|FG002|Overall Study|Withdrawal by Subject|0|||
33621328|NCT02510001|102161921|FG003|Overall Study|Withdrawal by Subject|0|||
33621329|NCT02510001|102161922|FG004|Overall Study|Withdrawal by Subject|0|||
33621330|NCT02510001|102161923|FG005|Overall Study|Withdrawal by Subject|0|||
33621331|NCT02510001|102161924|FG006|Overall Study|Withdrawal by Subject|0|||
33621332|NCT02510001|102161925|FG007|Overall Study|Withdrawal by Subject|2|||
33621333|NCT00539994|102161929|FG000|Overall Study|Lost to Follow-up|2|||
33621334|NCT00539994|102161930|FG001|Overall Study|Lost to Follow-up|1|||
33621335|NCT00539994|102161931|FG002|Overall Study|Lost to Follow-up|0|||
33621336|NCT00539994|102161929|FG000|Overall Study|Withdrawal by Subject|1|||
33621337|NCT00539994|102161930|FG001|Overall Study|Withdrawal by Subject|0|||
33621338|NCT00539994|102161931|FG002|Overall Study|Withdrawal by Subject|1|||
33621339|NCT00539994|102161929|FG000|Overall Study|Physician Decision|0|||
33621340|NCT00539994|102161930|FG001|Overall Study|Physician Decision|0|||
33621341|NCT00539994|102161931|FG002|Overall Study|Physician Decision|1|||
33621342|NCT01100320|102161937|FG000|Period 1|Withdrawal by Subject|2|||
33621343|NCT01100320|102161938|FG001|Period 1|Withdrawal by Subject|4|||
33621344|NCT01100320|102161937|FG000|Period 1|Positive Drug Screen|1|||
33621345|NCT01100320|102161938|FG001|Period 1|Positive Drug Screen|1|||
33621346|NCT01100320|102161937|FG000|Period 1|Adverse Event|2|||
33621347|NCT01100320|102161938|FG001|Period 1|Adverse Event|2|||
33621348|NCT01100320|102161937|FG000|Period 2|Withdrawal by Subject|1|||
33621349|NCT01100320|102161938|FG001|Period 2|Withdrawal by Subject|1|||
33621350|NCT01216683|102161939|FG000|Induction|Never started treatment|0|||
33621351|NCT01216683|102161940|FG001|Induction|Never started treatment|6|||
33621352|NCT01216683|102161941|FG002|Induction|Never started treatment|3|||
33621353|NCT01216683|102161939|FG000|Induction|Lack of Efficacy|4|||
33621354|NCT01216683|102161940|FG001|Induction|Lack of Efficacy|3|||
33356461|NCT00761215|101191627|FG001|Overall Study|Randomized but didn't receive drug|1|||
33356462|NCT00761215|101191628|FG002|Overall Study|Randomized but didn't receive drug|2|||
33621355|NCT01216683|102161941|FG002|Induction|Lack of Efficacy|7|||
33621356|NCT01216683|102161939|FG000|Induction|Adverse Event|0|||
33621357|NCT01216683|102161940|FG001|Induction|Adverse Event|5|||
33621358|NCT01216683|102161941|FG002|Induction|Adverse Event|5|||
33621359|NCT01216683|102161939|FG000|Induction|Death|0|||
33621360|NCT01216683|102161940|FG001|Induction|Death|0|||
33621361|NCT01216683|102161941|FG002|Induction|Death|2|||
33621362|NCT01216683|102161939|FG000|Induction|Withdrawal by Subject|0|||
33621363|NCT01216683|102161940|FG001|Induction|Withdrawal by Subject|4|||
33621364|NCT01216683|102161941|FG002|Induction|Withdrawal by Subject|2|||
33621365|NCT01216683|102161939|FG000|Induction|Other disease|0|||
33621366|NCT01216683|102161940|FG001|Induction|Other disease|1|||
33621367|NCT01216683|102161941|FG002|Induction|Other disease|2|||
33621368|NCT01216683|102161939|FG000|Continuation|Lack of Efficacy|3|||
33621369|NCT01216683|102161940|FG001|Continuation|Lack of Efficacy|2|||
33621370|NCT01216683|102161941|FG002|Continuation|Lack of Efficacy|7|||
33621371|NCT01216683|102161939|FG000|Continuation|Adverse Event|5|||
33621372|NCT01216683|102161940|FG001|Continuation|Adverse Event|3|||
33621373|NCT01216683|102161941|FG002|Continuation|Adverse Event|16|||
33621374|NCT01216683|102161939|FG000|Continuation|Death|1|||
33621375|NCT01216683|102161940|FG001|Continuation|Death|0|||
33621376|NCT01216683|102161941|FG002|Continuation|Death|2|||
33621377|NCT01216683|102161939|FG000|Continuation|Withdrawal by Subject|4|||
33356463|NCT00761215|101191626|FG000|Overall Study|Lost to Follow-up|6|||
33356464|NCT00761215|101191627|FG001|Overall Study|Lost to Follow-up|3|||
33356465|NCT00761215|101191628|FG002|Overall Study|Lost to Follow-up|6|||
33356466|NCT00761215|101191626|FG000|Overall Study|Withdrawal by Subject|1|||
33621378|NCT01216683|102161940|FG001|Continuation|Withdrawal by Subject|5|||
33356467|NCT00761215|101191627|FG001|Overall Study|Withdrawal by Subject|0|||
33621379|NCT01216683|102161941|FG002|Continuation|Withdrawal by Subject|9|||
33621380|NCT01216683|102161939|FG000|Continuation|Other diseases|0|||
33621381|NCT01216683|102161940|FG001|Continuation|Other diseases|2|||
33621382|NCT01216683|102161941|FG002|Continuation|Other diseases|1|||
33621383|NCT01216683|102161939|FG000|Continuation|Physician Decision|1|||
33621384|NCT01216683|102161940|FG001|Continuation|Physician Decision|0|||
33621385|NCT01216683|102161941|FG002|Continuation|Physician Decision|1|||
33621386|NCT01216683|102161939|FG000|Continuation|Non-compliance|1|||
33356468|NCT00761215|101191628|FG002|Overall Study|Withdrawal by Subject|0|||
33356469|NCT00761215|101191626|FG000|Overall Study|Bacteremia|1|||
33621387|NCT01216683|102161940|FG001|Continuation|Non-compliance|0|||
33621388|NCT01216683|102161941|FG002|Continuation|Non-compliance|1|||
33621389|NCT01216683|102161939|FG000|Continuation|Insurance change|0|||
33621390|NCT01216683|102161940|FG001|Continuation|Insurance change|1|||
33621391|NCT01216683|102161941|FG002|Continuation|Insurance change|0|||
33621392|NCT01216683|102161939|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
33356470|NCT00761215|101191627|FG001|Overall Study|Bacteremia|0|||
33621393|NCT01216683|102161940|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
33621394|NCT01216683|102161941|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
33621395|NCT01216683|102161939|FG000|Continuation|Not reported|0|||
33356471|NCT00761215|101191628|FG002|Overall Study|Bacteremia|0|||
33356472|NCT03633331|101191629|FG000|Overall Study|Withdrawal by Subject|1|||
33356473|NCT01120626|101191630|FG000|Overall Study|Withdrawal by Subject|1|||
33356474|NCT01120626|101191631|FG001|Overall Study|Withdrawal by Subject|0|||
33356475|NCT03476239|101191635|FG000|Overall Study|Withdrawal by Subject|10|||
33356476|NCT03476239|101191635|FG000|Overall Study|Death|80|||
33356477|NCT03476239|101191635|FG000|Overall Study|Lost to Follow-up|8|||
33356478|NCT01025635|101191636|FG000|Overall Study|Withdrawal by Subject|6|||
33356479|NCT01025635|101191637|FG001|Overall Study|Withdrawal by Subject|7|||
33356480|NCT01025635|101191636|FG000|Overall Study|Protocol Violation|4|||
33356481|NCT01025635|101191637|FG001|Overall Study|Protocol Violation|2|||
33356482|NCT01025635|101191636|FG000|Overall Study|Lack of Efficacy|0|||
33356483|NCT01025635|101191637|FG001|Overall Study|Lack of Efficacy|1|||
33356484|NCT01025635|101191636|FG000|Overall Study|Lost to Follow-up|9|||
33356485|NCT01025635|101191637|FG001|Overall Study|Lost to Follow-up|13|||
33356486|NCT01025635|101191636|FG000|Overall Study|Reason not known|4|||
33356487|NCT01025635|101191637|FG001|Overall Study|Reason not known|2|||
33356488|NCT01829048|101191638|FG000|Overall Study|Withdrawal by Subject|0|||
33356489|NCT01829048|101191639|FG001|Overall Study|Withdrawal by Subject|0|||
33356490|NCT01829048|101191640|FG002|Overall Study|Withdrawal by Subject|0|||
33356491|NCT01829048|101191641|FG003|Overall Study|Withdrawal by Subject|2|||
33356492|NCT01829048|101191642|FG004|Overall Study|Withdrawal by Subject|0|||
33356493|NCT05029622|101191643|FG000|Overall Study|Lost to Follow-up|1|||
33356494|NCT02609399|101191644|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
33356495|NCT02609399|101191645|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
33356496|NCT02609399|101191644|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
33356497|NCT02609399|101191645|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
33356498|NCT02609399|101191644|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
33414117|NCT03985293|101406539|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
33414118|NCT03985293|101406540|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
33414119|NCT03985293|101406535|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
33414120|NCT03985293|101406536|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
33414121|NCT03985293|101406537|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
33414122|NCT03985293|101406538|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
33414123|NCT03985293|101406539|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
33414124|NCT03985293|101406540|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
33414125|NCT03985293|101406535|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
33414126|NCT03985293|101406536|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
33414127|NCT03985293|101406537|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
33414128|NCT03985293|101406538|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
33414129|NCT03985293|101406539|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
33414130|NCT03985293|101406540|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
33414131|NCT03985293|101406535|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
33414132|NCT03985293|101406536|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
33414133|NCT03985293|101406537|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
33414134|NCT03985293|101406538|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
33414135|NCT03985293|101406539|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
33414136|NCT03985293|101406540|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
33414137|NCT03985293|101406535|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
33414138|NCT03985293|101406536|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
33414139|NCT03985293|101406537|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
33414140|NCT03985293|101406538|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
33356499|NCT02609399|101191645|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
33414141|NCT03985293|101406539|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
33414142|NCT03985293|101406540|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
33414143|NCT03985293|101406535|FG000|FOLLOW-UP|Lost to Follow-up|0|||
33414144|NCT03985293|101406536|FG001|FOLLOW-UP|Lost to Follow-up|0|||
33414145|NCT03985293|101406537|FG002|FOLLOW-UP|Lost to Follow-up|1|||
33621396|NCT01216683|102161940|FG001|Continuation|Not reported|0|||
33621397|NCT01216683|102161941|FG002|Continuation|Not reported|1|||
33621398|NCT01216683|102161939|FG000|Continuation|Never started treatment|0|||
33414146|NCT03985293|101406538|FG003|FOLLOW-UP|Lost to Follow-up|0|||
33414147|NCT03985293|101406539|FG004|FOLLOW-UP|Lost to Follow-up|0|||
33414148|NCT03985293|101406540|FG005|FOLLOW-UP|Lost to Follow-up|0|||
33414149|NCT05257109|101406541|FG000|Overall Study|Withdrawal by Subject|1|||
33621399|NCT01216683|102161940|FG001|Continuation|Never started treatment|1|||
33414150|NCT05257109|101406542|FG001|Overall Study|Withdrawal by Subject|0|||
33621400|NCT01216683|102161941|FG002|Continuation|Never started treatment|5|||
33621401|NCT01799226|102161951|FG000|Overall Study|Withdrawal by Subject|1|||
33356500|NCT02424149|101191649|FG000|Overall Study|surgery cancelled|2|||
33356501|NCT02424149|101191650|FG001|Overall Study|surgery cancelled|0|||
33621402|NCT01799226|102161952|FG001|Overall Study|Withdrawal by Subject|0|||
33621403|NCT01799226|102161951|FG000|Overall Study|Disqualified at Day 14|1|||
33621404|NCT01799226|102161952|FG001|Overall Study|Disqualified at Day 14|0|||
33621405|NCT00703924|102161953|FG000|Overall Study|Withdrawal by Subject|1|||
33621406|NCT00703924|102161954|FG001|Overall Study|Withdrawal by Subject|1|||
33621407|NCT01236521|102161956|FG000|Overall Study|Withdrawal by Subject|12|||
33621408|NCT01236521|102161957|FG001|Overall Study|Withdrawal by Subject|17|||
33621409|NCT01236521|102161956|FG000|Overall Study|Death|2|||
33621410|NCT01236521|102161957|FG001|Overall Study|Death|1|||
33621411|NCT01236521|102161956|FG000|Overall Study|Lost to Follow-up|9|||
33621412|NCT01236521|102161957|FG001|Overall Study|Lost to Follow-up|7|||
33621413|NCT02471014|102161958|FG000|Overall Study|Lost to Follow-up|2|||
33621414|NCT02471014|102161959|FG001|Overall Study|Lost to Follow-up|2|||
33621415|NCT02478463|102161963|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
33621416|NCT02478463|102161963|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
33621417|NCT02478463|102161963|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
33621418|NCT03361293|102165743|FG000|Overall Study|Lost to Follow-up|0|||
33621419|NCT03361293|102165744|FG001|Overall Study|Lost to Follow-up|2|||
33621420|NCT03361293|102165743|FG000|Overall Study|Withdrawal by Subject|1|||
33621421|NCT03361293|102165744|FG001|Overall Study|Withdrawal by Subject|3|||
33621422|NCT00191334|102165752|FG000|Overall Study|Adverse Event|4|||
33621423|NCT00191334|102165752|FG000|Overall Study|Disease Progression or Relapse|8|||
33621424|NCT00191334|102165752|FG000|Overall Study|Physician Decision|1|||
33621425|NCT00191334|102165752|FG000|Overall Study|Withdrawal by Subject|4|||
33621426|NCT04549545|102165753|FG000|Initial Period|Withdrawal by Subject|4|||
33621427|NCT04549545|102165754|FG001|Initial Period|Withdrawal by Subject|0|||
33621428|NCT04549545|102165753|FG000|Initial Period|Additional ENT Procedure|3|||
33621429|NCT04549545|102165754|FG001|Initial Period|Additional ENT Procedure|0|||
33621430|NCT04549545|102165753|FG000|Initial Period|Lost to Follow-up|3|||
33621431|NCT04549545|102165754|FG001|Initial Period|Lost to Follow-up|1|||
33621432|NCT04549545|102165753|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
33621433|NCT04549545|102165754|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
33621434|NCT04549545|102165753|FG000|Crossover Period|Additional ENT Procedure|0|||
33621435|NCT04549545|102165754|FG001|Crossover Period|Additional ENT Procedure|6|||
33621436|NCT04549545|102165753|FG000|Crossover Period|Lost to Follow-up|0|||
33621437|NCT04549545|102165754|FG001|Crossover Period|Lost to Follow-up|1|||
33356502|NCT02424149|101191649|FG000|Overall Study|Withdrawal by Subject|0|||
33356503|NCT02424149|101191650|FG001|Overall Study|Withdrawal by Subject|1|||
33356504|NCT03301857|101191651|FG000|Overall Study|Death|0|||
33356505|NCT03301857|101191652|FG001|Overall Study|Death|2|||
33356506|NCT03301857|101191651|FG000|Overall Study|Lost to Follow-up|4|||
33356507|NCT03301857|101191652|FG001|Overall Study|Lost to Follow-up|2|||
33356508|NCT03301857|101191651|FG000|Overall Study|Decision by Sponsor|6|||
33356509|NCT03301857|101191652|FG001|Overall Study|Decision by Sponsor|0|||
33356510|NCT03301857|101191651|FG000|Overall Study|Withdrawal by Subject|12|||
33356511|NCT03301857|101191652|FG001|Overall Study|Withdrawal by Subject|4|||
33356512|NCT03116113|101191654|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
33356513|NCT03116113|101191655|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
33356514|NCT03116113|101191656|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
33356515|NCT03116113|101191657|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
33356516|NCT03116113|101191658|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
33414151|NCT05257109|101406543|FG002|Overall Study|Withdrawal by Subject|0|||
33555827|NCT00276380|101934976|FG000|Overall Study|Lost to Follow-up|1|||
33555828|NCT00276380|101934977|FG001|Overall Study|Lost to Follow-up|1|||
33555829|NCT00276380|101934976|FG000|Overall Study|Withdrawal by Subject|3|||
33555830|NCT00276380|101934977|FG001|Overall Study|Withdrawal by Subject|6|||
33555831|NCT00276380|101934976|FG000|Overall Study|Death|5|||
33555832|NCT00276380|101934977|FG001|Overall Study|Death|3|||
33555833|NCT00276380|101934976|FG000|Overall Study|Abnormal aPPT Levels|0|||
33555834|NCT00276380|101934977|FG001|Overall Study|Abnormal aPPT Levels|1|||
33555835|NCT01716559|101934978|FG000|Overall Study|Adverse Event|11|||
33555836|NCT01716559|101934978|FG000|Overall Study|Death|21|||
33555837|NCT01716559|101934978|FG000|Overall Study|Withdrawal by Subject|4|||
33555838|NCT01716559|101934978|FG000|Overall Study|Other withdrawal reason|75|||
33555839|NCT02639559|101934979|FG000|Overall Study|Mobilization failure|0|||
33555840|NCT02639559|101934980|FG001|Overall Study|Mobilization failure|3|||
33555841|NCT02639559|101934979|FG000|Overall Study|Issues with vascular acess|1|||
33621438|NCT04549545|102165753|FG000|Crossover Period|Withdrawal by Subject|0|||
33621439|NCT04549545|102165754|FG001|Crossover Period|Withdrawal by Subject|4|||
33621440|NCT00685165|102165755|FG000|Washout Period of 14 Days|Adverse Event|1|||
33621441|NCT00685165|102165756|FG001|Washout Period of 14 Days|Adverse Event|0|||
33555842|NCT02639559|101934980|FG001|Overall Study|Issues with vascular acess|0|||
33356517|NCT03116113|101191659|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
33356518|NCT03116113|101191660|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
33356519|NCT03116113|101191661|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
33356520|NCT03116113|101191662|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
33356521|NCT00730236|101191664|FG000|Overall Study|Adverse Event|4|||
33621442|NCT02869633|102165757|FG000|Overall Study|Death|2|||
33621443|NCT02869633|102165758|FG001|Overall Study|Death|1|||
33621444|NCT02869633|102165757|FG000|Overall Study|Patient refused follow-up|1|||
33621445|NCT02869633|102165758|FG001|Overall Study|Patient refused follow-up|0|||
33621446|NCT02869633|102165757|FG000|Overall Study|Provider discretion|1|||
33621447|NCT02869633|102165758|FG001|Overall Study|Provider discretion|0|||
33621448|NCT02869633|102165757|FG000|Overall Study|Investigator decision|1|||
33621449|NCT02869633|102165758|FG001|Overall Study|Investigator decision|0|||
33218144|NCT03685591|100695973|FG002|Overall Study|Global Deterioration of Health Status|0|||
33218145|NCT03685591|100695974|FG003|Overall Study|Global Deterioration of Health Status|1|||
33555843|NCT02048813|101934981|FG000|Overall Study|Still on treatment|279|||
33555844|NCT02048813|101934982|FG001|Overall Study|Still on treatment|0|||
33555845|NCT02048813|101934981|FG000|Overall Study|Adverse Event|40|||
33555846|NCT02048813|101934982|FG001|Overall Study|Adverse Event|38|||
33555847|NCT02048813|101934981|FG000|Overall Study|Disease progression|13|||
33555848|NCT02048813|101934982|FG001|Overall Study|Disease progression|3|||
33555849|NCT02048813|101934981|FG000|Overall Study|Withdrawal by Subject|7|||
33555850|NCT02048813|101934982|FG001|Overall Study|Withdrawal by Subject|8|||
33555851|NCT02048813|101934981|FG000|Overall Study|Death|2|||
33555852|NCT02048813|101934982|FG001|Overall Study|Death|1|||
33555853|NCT02048813|101934981|FG000|Overall Study|Complication|2|||
33555854|NCT02048813|101934982|FG001|Overall Study|Complication|2|||
33555855|NCT02048813|101934981|FG000|Overall Study|Non-protocol therapy|0|||
33218146|NCT03685591|100695975|FG004|Overall Study|Global Deterioration of Health Status|2|||
33218147|NCT03685591|100695976|FG005|Overall Study|Global Deterioration of Health Status|4|||
33218148|NCT03685591|100695977|FG006|Overall Study|Global Deterioration of Health Status|1|||
33218149|NCT03685591|100695978|FG007|Overall Study|Global Deterioration of Health Status|1|||
33218150|NCT03685591|100695979|FG008|Overall Study|Global Deterioration of Health Status|0|||
33218151|NCT03685591|100695971|FG000|Overall Study|Progressive Disease|1|||
33218152|NCT03685591|100695972|FG001|Overall Study|Progressive Disease|1|||
33218153|NCT03685591|100695973|FG002|Overall Study|Progressive Disease|0|||
33218154|NCT03685591|100695974|FG003|Overall Study|Progressive Disease|3|||
33356522|NCT00730236|101191664|FG000|Overall Study|Withdrawal by Subject|1|||
33356523|NCT00730236|101191664|FG000|Overall Study|Non-compliance|1|||
33356524|NCT01244737|101191667|FG000|Overall Study|Physician Decision|2|||
33356525|NCT01244737|101191668|FG001|Overall Study|Physician Decision|18|||
33356526|NCT01244737|101191669|FG002|Overall Study|Physician Decision|5|||
33356527|NCT01244737|101191667|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
33356528|NCT01244737|101191668|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
33356529|NCT01244737|101191669|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
33356530|NCT01244737|101191667|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
33356531|NCT01244737|101191668|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
33356532|NCT01244737|101191669|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
33356533|NCT01244737|101191667|FG000|Overall Study|MIB immunopathology results not available|3|||
33356534|NCT01244737|101191668|FG001|Overall Study|MIB immunopathology results not available|2|||
33356535|NCT01244737|101191669|FG002|Overall Study|MIB immunopathology results not available|0|||
33356536|NCT01244737|101191667|FG000|Overall Study|PET data failure|0|||
33356537|NCT01244737|101191668|FG001|Overall Study|PET data failure|1|||
33356538|NCT01244737|101191669|FG002|Overall Study|PET data failure|0|||
33414152|NCT05257109|101406544|FG003|Overall Study|Withdrawal by Subject|0|||
33555856|NCT02048813|101934982|FG001|Overall Study|Non-protocol therapy|1|||
33555857|NCT02048813|101934981|FG000|Overall Study|Second primary cancer|2|||
33555858|NCT02048813|101934982|FG001|Overall Study|Second primary cancer|0|||
33555859|NCT02048813|101934981|FG000|Overall Study|Insurance|2|||
33555860|NCT02048813|101934982|FG001|Overall Study|Insurance|0|||
33621450|NCT02869633|102165757|FG000|Overall Study|Lost to Follow-up|0|||
33356539|NCT01244737|101191667|FG000|Overall Study|Withdrawal by Subject|0|||
33356540|NCT01244737|101191668|FG001|Overall Study|Withdrawal by Subject|0|||
33555861|NCT02048813|101934981|FG000|Overall Study|Wound infection/healing|2|||
33621451|NCT02869633|102165758|FG001|Overall Study|Lost to Follow-up|1|||
33621452|NCT02869633|102165757|FG000|Overall Study|Not eligible|6|||
33621453|NCT02869633|102165758|FG001|Overall Study|Not eligible|1|||
33621454|NCT02869633|102165757|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
33621455|NCT02869633|102165758|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
33621456|NCT02869633|102165757|FG000|Overall Study|Withdrawal by Subject|0|||
33356541|NCT01244737|101191669|FG002|Overall Study|Withdrawal by Subject|1|||
33356542|NCT03885284|101191670|FG000|Overall Study|Disease Progression|1|||
33414153|NCT04637815|101406546|FG000|Overall Study|Death|1|||
33414154|NCT04637815|101406547|FG001|Overall Study|Death|0|||
33414155|NCT04637815|101406546|FG000|Overall Study|Lost to Follow-up|5|||
33414156|NCT04637815|101406547|FG001|Overall Study|Lost to Follow-up|2|||
33414157|NCT00278473|101406550|FG000|Overall Study|drop out|4|||
33414158|NCT00278473|101406551|FG001|Overall Study|drop out|3|||
33414159|NCT01353586|101406552|FG000|Overall Study|Procedure terminated prior to ablation|3|||
33414160|NCT01353586|101406553|FG001|Overall Study|Procedure terminated prior to ablation|0|||
33414161|NCT01353586|101406552|FG000|Overall Study|Never had insertion of study catheter|4|||
33414162|NCT01353586|101406553|FG001|Overall Study|Never had insertion of study catheter|1|||
33414163|NCT01353586|101406552|FG000|Overall Study|Neurological exam not done|0|||
33414164|NCT01353586|101406553|FG001|Overall Study|Neurological exam not done|1|||
33621457|NCT02869633|102165758|FG001|Overall Study|Withdrawal by Subject|1|||
33621458|NCT00871871|102165765|FG000|Part I|Adverse Event|0|||
33555862|NCT02048813|101934982|FG001|Overall Study|Wound infection/healing|0|||
33555863|NCT02048813|101934981|FG000|Overall Study|Missed appointment|3|||
33555864|NCT02048813|101934982|FG001|Overall Study|Missed appointment|0|||
33555865|NCT02048813|101934981|FG000|Overall Study|Never started treatment|2|||
33555866|NCT02048813|101934982|FG001|Overall Study|Never started treatment|17|||
33555867|NCT02739828|101934983|FG000|Overall Study|Adverse Event|1|||
33555868|NCT02739828|101934983|FG000|Overall Study|Lost to Follow-up|4|||
33555869|NCT03142334|101934984|FG000|Overall Study|Death|18|||
33555870|NCT03142334|101934985|FG001|Overall Study|Death|33|||
33555871|NCT03142334|101934984|FG000|Overall Study|Withdrawal by Subject|15|||
33555872|NCT03142334|101934985|FG001|Overall Study|Withdrawal by Subject|11|||
33555873|NCT03142334|101934984|FG000|Overall Study|Ongoing on trial follow up|463|||
33555874|NCT03142334|101934985|FG001|Overall Study|Ongoing on trial follow up|454|||
33555875|NCT00433511|101934989|FG000|Step 1|Adverse Event|50|||
33356543|NCT03885284|101191671|FG001|Overall Study|Disease Progression|3|||
33356544|NCT03885284|101191670|FG000|Overall Study|Physician Decision|0|||
33356545|NCT03885284|101191671|FG001|Overall Study|Physician Decision|1|||
33356546|NCT04321343|101191678|FG000|Overall Study|Adverse Event|0|||
33356547|NCT04321343|101191679|FG001|Overall Study|Adverse Event|0|||
33356548|NCT04321343|101191680|FG002|Overall Study|Adverse Event|1|||
33356549|NCT04321343|101191681|FG003|Overall Study|Adverse Event|0|||
33356550|NCT04321343|101191678|FG000|Overall Study|Death|0|||
33356551|NCT04321343|101191679|FG001|Overall Study|Death|0|||
33356552|NCT04321343|101191680|FG002|Overall Study|Death|0|||
33356553|NCT04321343|101191681|FG003|Overall Study|Death|1|||
33356554|NCT04321343|101191678|FG000|Overall Study|Pregnancy|1|||
33356555|NCT04321343|101191679|FG001|Overall Study|Pregnancy|0|||
33414165|NCT01036594|101406554|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
33414166|NCT01036594|101406555|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
33414167|NCT01036594|101406554|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
33414168|NCT01036594|101406555|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
33414169|NCT01036594|101406554|FG000|Week 12 Evaluation|Adverse Event|5|||
33414170|NCT01036594|101406555|FG001|Week 12 Evaluation|Adverse Event|0|||
33414171|NCT01036594|101406554|FG000|Week 12 Evaluation|Physician Decision|1|||
33555876|NCT00433511|101934990|FG001|Step 1|Adverse Event|157|||
33555877|NCT00433511|101934991|FG002|Step 1|Adverse Event|153|||
33555878|NCT00433511|101934989|FG000|Step 1|Withdrawal by Subject|45|||
33555879|NCT00433511|101934990|FG001|Step 1|Withdrawal by Subject|143|||
33555880|NCT00433511|101934991|FG002|Step 1|Withdrawal by Subject|154|||
33414172|NCT01036594|101406555|FG001|Week 12 Evaluation|Physician Decision|0|||
33555881|NCT00433511|101934989|FG000|Step 1|Death|3|||
33555882|NCT00433511|101934990|FG001|Step 1|Death|1|||
33414173|NCT01036594|101406554|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
33414174|NCT01036594|101406555|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
33555883|NCT00433511|101934991|FG002|Step 1|Death|1|||
33555884|NCT00433511|101934989|FG000|Step 1|Physician Decision|1|||
33621459|NCT00871871|102165766|FG001|Part I|Adverse Event|2|||
33621460|NCT00871871|102165767|FG002|Part I|Adverse Event|0|||
33621461|NCT00871871|102165768|FG003|Part I|Adverse Event|0|||
33356556|NCT04321343|101191680|FG002|Overall Study|Pregnancy|0|||
33356557|NCT04321343|101191681|FG003|Overall Study|Pregnancy|0|||
33555885|NCT00433511|101934990|FG001|Step 1|Physician Decision|4|||
33621462|NCT00871871|102165765|FG000|Part I|Withdrawal by Subject|3|||
33356558|NCT04321343|101191678|FG000|Overall Study|Protocol Violation|1|||
33356559|NCT04321343|101191679|FG001|Overall Study|Protocol Violation|1|||
33356560|NCT04321343|101191680|FG002|Overall Study|Protocol Violation|1|||
33555886|NCT00433511|101934991|FG002|Step 1|Physician Decision|3|||
33555887|NCT00433511|101934989|FG000|Step 1|Never started protocol therapy|28|||
33555888|NCT00433511|101934990|FG001|Step 1|Never started protocol therapy|64|||
33218155|NCT03685591|100695975|FG004|Overall Study|Progressive Disease|5|||
33218156|NCT03685591|100695976|FG005|Overall Study|Progressive Disease|4|||
33218157|NCT03685591|100695977|FG006|Overall Study|Progressive Disease|3|||
33218158|NCT03685591|100695978|FG007|Overall Study|Progressive Disease|2|||
33218159|NCT03685591|100695979|FG008|Overall Study|Progressive Disease|1|||
33218160|NCT03685591|100695971|FG000|Overall Study|Other|0|||
33218161|NCT03685591|100695972|FG001|Overall Study|Other|0|||
33218162|NCT03685591|100695973|FG002|Overall Study|Other|1|||
33218163|NCT03685591|100695974|FG003|Overall Study|Other|0|||
33218164|NCT03685591|100695975|FG004|Overall Study|Other|2|||
33218165|NCT03685591|100695976|FG005|Overall Study|Other|3|||
33356561|NCT04321343|101191681|FG003|Overall Study|Protocol Violation|1|||
33555889|NCT00433511|101934991|FG002|Step 1|Never started protocol therapy|66|||
33555890|NCT00433511|101934989|FG000|Step 1|Alternative therapy|2|||
33414175|NCT01036594|101406554|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
33414176|NCT01036594|101406555|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
33555891|NCT00433511|101934990|FG001|Step 1|Alternative therapy|1|||
33555892|NCT00433511|101934991|FG002|Step 1|Alternative therapy|3|||
33555893|NCT00433511|101934989|FG000|Step 1|Disease progression, relapse|5|||
33555894|NCT00433511|101934990|FG001|Step 1|Disease progression, relapse|3|||
33555895|NCT00433511|101934991|FG002|Step 1|Disease progression, relapse|3|||
33555896|NCT00433511|101934989|FG000|Step 1|Other complicating disease|2|||
33555897|NCT00433511|101934990|FG001|Step 1|Other complicating disease|6|||
33555898|NCT00433511|101934991|FG002|Step 1|Other complicating disease|3|||
33555899|NCT00433511|101934989|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
33555900|NCT00433511|101934990|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
33555901|NCT00433511|101934991|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
33555902|NCT00433511|101934989|FG000|Step 1|Suspected recurrence|0|||
33555903|NCT00433511|101934990|FG001|Step 1|Suspected recurrence|1|||
33555904|NCT00433511|101934991|FG002|Step 1|Suspected recurrence|0|||
33555905|NCT00433511|101934989|FG000|Step 1|Insurance/drug distribution issues|0|||
33555906|NCT00433511|101934990|FG001|Step 1|Insurance/drug distribution issues|1|||
33555907|NCT00433511|101934991|FG002|Step 1|Insurance/drug distribution issues|2|||
33555908|NCT00433511|101934989|FG000|Step 1|Patient moved|0|||
33555909|NCT00433511|101934990|FG001|Step 1|Patient moved|0|||
33555910|NCT00433511|101934991|FG002|Step 1|Patient moved|1|||
33555911|NCT00433511|101934989|FG000|Step 2 (Arm D)|Adverse Event|0|||
33555912|NCT00433511|101934990|FG001|Step 2 (Arm D)|Adverse Event|0|||
33555913|NCT00433511|101934991|FG002|Step 2 (Arm D)|Adverse Event|135|||
33555914|NCT00433511|101934989|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
33621463|NCT00871871|102165766|FG001|Part I|Withdrawal by Subject|0|||
33621464|NCT00871871|102165767|FG002|Part I|Withdrawal by Subject|0|||
33621465|NCT00871871|102165768|FG003|Part I|Withdrawal by Subject|0|||
33621466|NCT00871871|102165765|FG000|Part I|Laboratory abnormality|0|||
33414177|NCT01036594|101406554|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
33414178|NCT01036594|101406555|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
33555915|NCT00433511|101934990|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
33621467|NCT00871871|102165766|FG001|Part I|Laboratory abnormality|1|||
33621468|NCT00871871|102165767|FG002|Part I|Laboratory abnormality|0|||
33218166|NCT03685591|100695977|FG006|Overall Study|Other|0|||
33356562|NCT04321343|101191678|FG000|Overall Study|Withdrawal by Subject|0|||
33356563|NCT04321343|101191679|FG001|Overall Study|Withdrawal by Subject|6|||
33356564|NCT04321343|101191680|FG002|Overall Study|Withdrawal by Subject|0|||
33356565|NCT04321343|101191681|FG003|Overall Study|Withdrawal by Subject|2|||
33356566|NCT04321343|101191678|FG000|Overall Study|Lost to Follow-up|2|||
33356567|NCT04321343|101191679|FG001|Overall Study|Lost to Follow-up|2|||
33356568|NCT04321343|101191680|FG002|Overall Study|Lost to Follow-up|1|||
33356569|NCT04321343|101191681|FG003|Overall Study|Lost to Follow-up|3|||
33356570|NCT02919306|101191684|FG000|Overall Study|Withdrawal by Subject|1|||
33356571|NCT02919306|101191685|FG001|Overall Study|Withdrawal by Subject|0|||
33555916|NCT00433511|101934991|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
33555917|NCT00433511|101934989|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
33555918|NCT00433511|101934990|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
33555919|NCT00433511|101934991|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
33555920|NCT00433511|101934989|FG000|Step 2 (Arm D)|Physician Decision|0|||
33555921|NCT00433511|101934990|FG001|Step 2 (Arm D)|Physician Decision|0|||
33555922|NCT00433511|101934991|FG002|Step 2 (Arm D)|Physician Decision|9|||
33555923|NCT00433511|101934989|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
33555924|NCT00433511|101934990|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
33621469|NCT00871871|102165768|FG003|Part I|Laboratory abnormality|0|||
33218167|NCT03685591|100695978|FG007|Overall Study|Other|0|||
33218168|NCT03685591|100695979|FG008|Overall Study|Other|0|||
33218169|NCT03685591|100695971|FG000|Overall Study|Withdrawal by Subject|0|||
33218170|NCT03685591|100695972|FG001|Overall Study|Withdrawal by Subject|0|||
33356572|NCT02919306|101191684|FG000|Overall Study|Protocol Violation|1|||
33356573|NCT02919306|101191685|FG001|Overall Study|Protocol Violation|0|||
33356574|NCT02240706|101191687|FG000|Overall Study|Lack of Efficacy|2|||
33356575|NCT02240706|101191688|FG001|Overall Study|Lack of Efficacy|2|||
33414179|NCT01036594|101406554|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
33414180|NCT01036594|101406555|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
33414181|NCT01036594|101406554|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
33414182|NCT01036594|101406555|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
33414183|NCT01157065|101406560|FG000|Overall Study|Death|0|||
33414184|NCT01157065|101406561|FG001|Overall Study|Death|1|||
33414185|NCT00326118|101406562|FG000|Active Phase|Withdrawal by Subject|4|||
33414186|NCT00326118|101406563|FG001|Active Phase|Withdrawal by Subject|1|||
33414187|NCT05168657|101406564|FG000|Overall Study|Adverse Event|0|||
33555925|NCT00433511|101934991|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
33621470|NCT00871871|102165765|FG000|Part II|Lack of Efficacy|0|||
33621471|NCT00871871|102165766|FG001|Part II|Lack of Efficacy|0|||
33621472|NCT00871871|102165767|FG002|Part II|Lack of Efficacy|1|||
33621473|NCT00871871|102165768|FG003|Part II|Lack of Efficacy|0|||
33356576|NCT02240706|101191689|FG002|Overall Study|Lack of Efficacy|2|||
33356577|NCT02240706|101191690|FG003|Overall Study|Lack of Efficacy|2|||
33356578|NCT02240706|101191691|FG004|Overall Study|Lack of Efficacy|5|||
33356579|NCT02240706|101191692|FG005|Overall Study|Lack of Efficacy|0|||
33356580|NCT02240706|101191693|FG006|Overall Study|Lack of Efficacy|0|||
33356581|NCT02240706|101191687|FG000|Overall Study|Adverse Event|1|||
33356582|NCT02240706|101191688|FG001|Overall Study|Adverse Event|0|||
33356583|NCT02240706|101191689|FG002|Overall Study|Adverse Event|1|||
33356584|NCT02240706|101191690|FG003|Overall Study|Adverse Event|0|||
33356585|NCT02240706|101191691|FG004|Overall Study|Adverse Event|2|||
33356586|NCT02240706|101191692|FG005|Overall Study|Adverse Event|0|||
33356587|NCT02240706|101191693|FG006|Overall Study|Adverse Event|0|||
33356588|NCT02240706|101191687|FG000|Overall Study|Progressive disease|0|||
33356589|NCT02240706|101191688|FG001|Overall Study|Progressive disease|0|||
33356590|NCT02240706|101191689|FG002|Overall Study|Progressive disease|0|||
33356591|NCT02240706|101191690|FG003|Overall Study|Progressive disease|0|||
33356592|NCT02240706|101191691|FG004|Overall Study|Progressive disease|1|||
33356593|NCT02240706|101191692|FG005|Overall Study|Progressive disease|0|||
33356594|NCT02240706|101191693|FG006|Overall Study|Progressive disease|0|||
33356595|NCT02240706|101191687|FG000|Overall Study|Dose limiting toxicity|0|||
33356596|NCT02240706|101191688|FG001|Overall Study|Dose limiting toxicity|0|||
33356597|NCT02240706|101191689|FG002|Overall Study|Dose limiting toxicity|0|||
33356598|NCT02240706|101191690|FG003|Overall Study|Dose limiting toxicity|0|||
33356599|NCT02240706|101191691|FG004|Overall Study|Dose limiting toxicity|1|||
33356600|NCT02240706|101191692|FG005|Overall Study|Dose limiting toxicity|0|||
33356601|NCT02240706|101191693|FG006|Overall Study|Dose limiting toxicity|0|||
33555926|NCT00433511|101934989|FG000|Step 2 (Arm D)|Other complicating disease|0|||
33555927|NCT00433511|101934990|FG001|Step 2 (Arm D)|Other complicating disease|0|||
33555928|NCT00433511|101934991|FG002|Step 2 (Arm D)|Other complicating disease|3|||
33555929|NCT00433511|101934989|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
33555930|NCT00433511|101934990|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
33555931|NCT00433511|101934991|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
33356602|NCT02240706|101191687|FG000|Overall Study|Refused to continue taking medication|0|||
33555932|NCT00433511|101934989|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
33356603|NCT02240706|101191688|FG001|Overall Study|Refused to continue taking medication|1|||
33356604|NCT02240706|101191689|FG002|Overall Study|Refused to continue taking medication|3|||
33356605|NCT02240706|101191690|FG003|Overall Study|Refused to continue taking medication|1|||
33356606|NCT02240706|101191691|FG004|Overall Study|Refused to continue taking medication|2|||
33356607|NCT02240706|101191692|FG005|Overall Study|Refused to continue taking medication|0|||
33356608|NCT02240706|101191693|FG006|Overall Study|Refused to continue taking medication|0|||
33356609|NCT02240706|101191687|FG000|Overall Study|Insurance billing concerns|0|||
33356610|NCT02240706|101191688|FG001|Overall Study|Insurance billing concerns|0|||
33356611|NCT02240706|101191689|FG002|Overall Study|Insurance billing concerns|0|||
33356612|NCT02240706|101191690|FG003|Overall Study|Insurance billing concerns|1|||
33356613|NCT02240706|101191691|FG004|Overall Study|Insurance billing concerns|0|||
33356614|NCT02240706|101191692|FG005|Overall Study|Insurance billing concerns|0|||
33356615|NCT02240706|101191693|FG006|Overall Study|Insurance billing concerns|0|||
33356616|NCT01877655|101191694|FG000|Overall Study|Death|57|||
33414188|NCT05168657|101406565|FG001|Overall Study|Adverse Event|0|||
33414189|NCT05168657|101406566|FG002|Overall Study|Adverse Event|1|||
33356617|NCT01877655|101191695|FG001|Overall Study|Death|52|||
33555933|NCT00433511|101934990|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
33621474|NCT00871871|102165765|FG000|Part II|Withdrawal by Subject|0|||
33356618|NCT01877655|101191694|FG000|Overall Study|Withdrawal by Subject|18|||
33356619|NCT01877655|101191695|FG001|Overall Study|Withdrawal by Subject|26|||
33356620|NCT01877655|101191694|FG000|Overall Study|Physician Decision|11|||
33414190|NCT05168657|101406567|FG003|Overall Study|Adverse Event|0|||
33414191|NCT05168657|101406568|FG004|Overall Study|Adverse Event|0|||
33414192|NCT05168657|101406569|FG005|Overall Study|Adverse Event|0|||
33621475|NCT00871871|102165766|FG001|Part II|Withdrawal by Subject|0|||
33356621|NCT01877655|101191695|FG001|Overall Study|Physician Decision|10|||
33414193|NCT05168657|101406570|FG006|Overall Study|Adverse Event|0|||
33356622|NCT01877655|101191694|FG000|Overall Study|Miscellaneous|4|||
33356623|NCT01877655|101191695|FG001|Overall Study|Miscellaneous|4|||
33356624|NCT01877655|101191694|FG000|Overall Study|Randomized but Never Received Drug|8|||
33356625|NCT01877655|101191695|FG001|Overall Study|Randomized but Never Received Drug|5|||
33356626|NCT00886938|101191696|FG000|Overall Study|Adverse Event|1|||
33356627|NCT00886938|101191696|FG000|Overall Study|Withdrawal by Subject|1|||
33356628|NCT02031679|101191697|FG000|Overall Study|Protocol Violation|0|||
33356629|NCT02031679|101191698|FG001|Overall Study|Protocol Violation|1|||
33356630|NCT02031679|101191697|FG000|Overall Study|Lack of Efficacy|0|||
33356631|NCT02031679|101191698|FG001|Overall Study|Lack of Efficacy|1|||
33356632|NCT01794780|101195246|FG000|Overall Study|Adverse Event|0|||
33356633|NCT01794780|101195247|FG001|Overall Study|Adverse Event|1|||
33356634|NCT01794780|101195248|FG002|Overall Study|Adverse Event|2|||
33356635|NCT01794780|101195249|FG003|Overall Study|Adverse Event|0|||
33356636|NCT01794780|101195250|FG004|Overall Study|Adverse Event|0|||
33356637|NCT01794780|101195251|FG005|Overall Study|Adverse Event|0|||
33356638|NCT01794780|101195252|FG006|Overall Study|Adverse Event|0|||
33356639|NCT01794780|101195253|FG007|Overall Study|Adverse Event|0|||
33356640|NCT01794780|101195246|FG000|Overall Study|Death|0|||
33356641|NCT01794780|101195247|FG001|Overall Study|Death|2|||
33555934|NCT00433511|101934991|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
33555935|NCT00433511|101934989|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
33555936|NCT00433511|101934990|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
33555937|NCT00433511|101934991|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
33555938|NCT00433511|101934989|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
33555939|NCT00433511|101934990|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
33555940|NCT00433511|101934991|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
33555941|NCT02191397|101934994|FG000|Overall Study|Adverse Event|28|||
33555942|NCT02191397|101934995|FG001|Overall Study|Adverse Event|17|||
33555943|NCT02191397|101934994|FG000|Overall Study|Lack of Efficacy|10|||
33555944|NCT02191397|101934995|FG001|Overall Study|Lack of Efficacy|5|||
33555945|NCT02191397|101934994|FG000|Overall Study|Protocol Violation|0|||
33555946|NCT02191397|101934995|FG001|Overall Study|Protocol Violation|3|||
33555947|NCT02191397|101934994|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
33555948|NCT02191397|101934995|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
33555949|NCT02191397|101934994|FG000|Overall Study|Lost to Follow-up|10|||
33555950|NCT02191397|101934995|FG001|Overall Study|Lost to Follow-up|11|||
33555951|NCT02191397|101934994|FG000|Overall Study|Physician Decision|8|||
33555952|NCT02191397|101934995|FG001|Overall Study|Physician Decision|3|||
33555953|NCT02191397|101934994|FG000|Overall Study|Withdrawal by Subject|22|||
33555954|NCT02191397|101934995|FG001|Overall Study|Withdrawal by Subject|27|||
33555955|NCT01129284|101934997|FG000|Overall Study|Adverse Event|2|||
33555956|NCT01129284|101934998|FG001|Overall Study|Adverse Event|0|||
33555957|NCT01129284|101934999|FG002|Overall Study|Adverse Event|1|||
33555958|NCT00070499|101935004|FG000|Overall Study|Adverse Event|6|||
33555959|NCT00070499|101935005|FG001|Overall Study|Adverse Event|6|||
33555960|NCT00070499|101935006|FG002|Overall Study|Adverse Event|19|||
33555961|NCT00070499|101935007|FG003|Overall Study|Adverse Event|15|||
33555962|NCT00070499|101935004|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
33555963|NCT00070499|101935005|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
33555964|NCT00070499|101935006|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
33555965|NCT00070499|101935007|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
33555966|NCT00070499|101935004|FG000|Overall Study|Progression/relapse|4|||
33555967|NCT00070499|101935005|FG001|Overall Study|Progression/relapse|2|||
33555968|NCT00070499|101935006|FG002|Overall Study|Progression/relapse|1|||
33555969|NCT00070499|101935007|FG003|Overall Study|Progression/relapse|4|||
33555970|NCT00070499|101935004|FG000|Overall Study|Death|1|||
33555971|NCT00070499|101935005|FG001|Overall Study|Death|1|||
33555972|NCT00070499|101935006|FG002|Overall Study|Death|1|||
33555973|NCT00070499|101935007|FG003|Overall Study|Death|2|||
33218171|NCT03685591|100695973|FG002|Overall Study|Withdrawal by Subject|0|||
33356642|NCT01794780|101195248|FG002|Overall Study|Death|14|||
33356643|NCT01794780|101195249|FG003|Overall Study|Death|1|||
33356644|NCT01794780|101195250|FG004|Overall Study|Death|0|||
33356645|NCT01794780|101195251|FG005|Overall Study|Death|9|||
33555974|NCT00070499|101935004|FG000|Overall Study|Other - not protocol specified|7|||
33555975|NCT00070499|101935005|FG001|Overall Study|Other - not protocol specified|3|||
33555976|NCT00070499|101935006|FG002|Overall Study|Other - not protocol specified|12|||
33555977|NCT00070499|101935007|FG003|Overall Study|Other - not protocol specified|20|||
33555978|NCT00070499|101935004|FG000|Overall Study|Still on protocol treatment|10|||
33621476|NCT00871871|102165767|FG002|Part II|Withdrawal by Subject|2|||
33356646|NCT01794780|101195252|FG006|Overall Study|Death|4|||
33356647|NCT01794780|101195253|FG007|Overall Study|Death|0|||
33356648|NCT01794780|101195246|FG000|Overall Study|Lost to Follow-up|10|||
33356649|NCT01794780|101195247|FG001|Overall Study|Lost to Follow-up|64|||
33356650|NCT01794780|101195248|FG002|Overall Study|Lost to Follow-up|165|||
33621477|NCT00871871|102165768|FG003|Part II|Withdrawal by Subject|1|||
33621478|NCT00871871|102165765|FG000|Part II|Adverse Event|0|||
33621479|NCT00871871|102165766|FG001|Part II|Adverse Event|0|||
33621480|NCT00871871|102165767|FG002|Part II|Adverse Event|1|||
33621481|NCT00871871|102165768|FG003|Part II|Adverse Event|2|||
33621482|NCT00871871|102165765|FG000|Part II|Protocol Violation|0|||
33356651|NCT01794780|101195249|FG003|Overall Study|Lost to Follow-up|53|||
33356652|NCT01794780|101195250|FG004|Overall Study|Lost to Follow-up|2|||
33356653|NCT01794780|101195251|FG005|Overall Study|Lost to Follow-up|99|||
33356654|NCT01794780|101195252|FG006|Overall Study|Lost to Follow-up|30|||
33356655|NCT01794780|101195253|FG007|Overall Study|Lost to Follow-up|5|||
33356656|NCT01794780|101195246|FG000|Overall Study|Withdrew informed consent|7|||
33356657|NCT01794780|101195247|FG001|Overall Study|Withdrew informed consent|17|||
33356658|NCT01794780|101195248|FG002|Overall Study|Withdrew informed consent|36|||
33356659|NCT01794780|101195249|FG003|Overall Study|Withdrew informed consent|9|||
33356660|NCT01794780|101195250|FG004|Overall Study|Withdrew informed consent|0|||
33356661|NCT01794780|101195251|FG005|Overall Study|Withdrew informed consent|48|||
33356662|NCT01794780|101195252|FG006|Overall Study|Withdrew informed consent|4|||
33356663|NCT01794780|101195253|FG007|Overall Study|Withdrew informed consent|3|||
33356664|NCT01794780|101195246|FG000|Overall Study|Other|0|||
33356665|NCT01794780|101195247|FG001|Overall Study|Other|12|||
33414194|NCT05168657|101406571|FG007|Overall Study|Adverse Event|0|||
33414195|NCT02916056|101406572|FG000|Overall Study|Adverse Event|6|||
33414196|NCT02916056|101406572|FG000|Overall Study|Lost to Follow-up|1|||
33356666|NCT01794780|101195248|FG002|Overall Study|Other|25|||
33414197|NCT02916056|101406572|FG000|Overall Study|Other|12|||
33414198|NCT02916056|101406572|FG000|Overall Study|Protocol Violation|1|||
33414199|NCT02916056|101406572|FG000|Overall Study|Withdrawal by Subject|8|||
33414200|NCT02916056|101406572|FG000|Overall Study|Study Terminated by Sponsor|269|||
33414201|NCT03239340|101406573|FG000|Overall Study|Other|26|||
33414202|NCT03239340|101406573|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
33414203|NCT03239340|101406573|FG000|Overall Study|Death|40|||
33414204|NCT03239340|101406573|FG000|Overall Study|Lost to Follow-up|2|||
33414205|NCT03239340|101406573|FG000|Overall Study|Physician Decision|16|||
33414206|NCT03239340|101406573|FG000|Overall Study|Withdrawal by Subject|27|||
33414207|NCT03179462|101406588|FG000|Overall Study|screening failure|1|||
33414208|NCT03179462|101406589|FG001|Overall Study|screening failure|2|||
33414209|NCT03179462|101406590|FG002|Overall Study|screening failure|0|||
33414210|NCT00457249|101406591|FG000|Overall Study|Lost to Follow-up|3|||
33414211|NCT00457249|101406592|FG001|Overall Study|Lost to Follow-up|0|||
33414212|NCT00457249|101406591|FG000|Overall Study|Protocol Violation|4|||
33414213|NCT00457249|101406592|FG001|Overall Study|Protocol Violation|1|||
33414214|NCT00457249|101406591|FG000|Overall Study|Withdrawal by Subject|3|||
33414215|NCT00457249|101406592|FG001|Overall Study|Withdrawal by Subject|1|||
33414216|NCT00457249|101406591|FG000|Overall Study|Serious Adverse Events|2|||
33414217|NCT00457249|101406592|FG001|Overall Study|Serious Adverse Events|0|||
33414218|NCT01640964|101406593|FG000|Overall Study|Lost to Follow-up|0|||
33414219|NCT01640964|101406594|FG001|Overall Study|Lost to Follow-up|0|||
33414220|NCT01640964|101406595|FG002|Overall Study|Lost to Follow-up|1|||
33414221|NCT01640964|101406593|FG000|Overall Study|Protocol Deviation|1|||
33414222|NCT01640964|101406594|FG001|Overall Study|Protocol Deviation|1|||
33414223|NCT01640964|101406595|FG002|Overall Study|Protocol Deviation|2|||
33414224|NCT00798161|101406596|FG000|Overall Study|Adverse Event|3|||
33414225|NCT00798161|101406597|FG001|Overall Study|Adverse Event|4|||
33414226|NCT00798161|101406598|FG002|Overall Study|Adverse Event|6|||
33414227|NCT00798161|101406599|FG003|Overall Study|Adverse Event|6|||
33414228|NCT00798161|101406600|FG004|Overall Study|Adverse Event|5|||
33414229|NCT00798161|101406601|FG005|Overall Study|Adverse Event|2|||
33356667|NCT01794780|101195249|FG003|Overall Study|Other|20|||
33356668|NCT01794780|101195250|FG004|Overall Study|Other|1|||
33356669|NCT01794780|101195251|FG005|Overall Study|Other|24|||
33356670|NCT01794780|101195252|FG006|Overall Study|Other|4|||
33356671|NCT01794780|101195253|FG007|Overall Study|Other|1|||
33356672|NCT03240081|101195254|FG000|Overall Study|Withdrawal by Subject|0|||
33414230|NCT00798161|101406602|FG006|Overall Study|Adverse Event|4|||
33414231|NCT00798161|101406596|FG000|Overall Study|Protocol Violation|2|||
33414232|NCT00798161|101406597|FG001|Overall Study|Protocol Violation|1|||
33414233|NCT00798161|101406598|FG002|Overall Study|Protocol Violation|3|||
33414234|NCT00798161|101406599|FG003|Overall Study|Protocol Violation|3|||
33414235|NCT00798161|101406600|FG004|Overall Study|Protocol Violation|3|||
33356673|NCT03240081|101195255|FG001|Overall Study|Withdrawal by Subject|2|||
33356674|NCT03240081|101195254|FG000|Overall Study|Lost to Follow-up|0|||
33356675|NCT03240081|101195255|FG001|Overall Study|Lost to Follow-up|1|||
33414236|NCT00798161|101406601|FG005|Overall Study|Protocol Violation|2|||
33414237|NCT00798161|101406602|FG006|Overall Study|Protocol Violation|0|||
33414238|NCT00798161|101406596|FG000|Overall Study|Lost to Follow-up|1|||
33414239|NCT00798161|101406597|FG001|Overall Study|Lost to Follow-up|3|||
33621483|NCT00871871|102165766|FG001|Part II|Protocol Violation|0|||
33414240|NCT00798161|101406598|FG002|Overall Study|Lost to Follow-up|4|||
33414241|NCT00798161|101406599|FG003|Overall Study|Lost to Follow-up|3|||
33414242|NCT00798161|101406600|FG004|Overall Study|Lost to Follow-up|4|||
33414243|NCT00798161|101406601|FG005|Overall Study|Lost to Follow-up|0|||
33414244|NCT00798161|101406602|FG006|Overall Study|Lost to Follow-up|0|||
33414245|NCT00798161|101406596|FG000|Overall Study|Withdrawal by Subject|5|||
33414246|NCT00798161|101406597|FG001|Overall Study|Withdrawal by Subject|4|||
33414247|NCT00798161|101406598|FG002|Overall Study|Withdrawal by Subject|5|||
33414248|NCT00798161|101406599|FG003|Overall Study|Withdrawal by Subject|4|||
33414249|NCT00798161|101406600|FG004|Overall Study|Withdrawal by Subject|2|||
33414250|NCT00798161|101406601|FG005|Overall Study|Withdrawal by Subject|3|||
33414251|NCT00798161|101406602|FG006|Overall Study|Withdrawal by Subject|1|||
33414252|NCT00798161|101406596|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
33414253|NCT00798161|101406597|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
33414254|NCT00798161|101406598|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
33414255|NCT00798161|101406599|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
33414256|NCT00798161|101406600|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
33414257|NCT00798161|101406601|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
33414258|NCT00798161|101406602|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
33414259|NCT03930615|101406603|FG000|Overall Study|Death|9|||
33414260|NCT03930615|101406604|FG001|Overall Study|Death|3|||
33414261|NCT03930615|101406603|FG000|Overall Study|Lost to Follow-up|1|||
33414262|NCT03930615|101406604|FG001|Overall Study|Lost to Follow-up|2|||
33414263|NCT03930615|101406603|FG000|Overall Study|Physician Decision|3|||
33414264|NCT03930615|101406604|FG001|Overall Study|Physician Decision|4|||
33414265|NCT03930615|101406603|FG000|Overall Study|Withdrawal by Subject|13|||
33414266|NCT03930615|101406604|FG001|Overall Study|Withdrawal by Subject|2|||
33414267|NCT03930615|101406603|FG000|Overall Study|Not treated|1|||
33414268|NCT03930615|101406604|FG001|Overall Study|Not treated|1|||
33414269|NCT01371981|101406609|FG000|Overall Study|Adverse Event|12|||
33414270|NCT01371981|101406610|FG001|Overall Study|Adverse Event|17|||
33414271|NCT01371981|101406611|FG002|Overall Study|Adverse Event|0|||
33414272|NCT01371981|101406612|FG003|Overall Study|Adverse Event|4|||
33414273|NCT01371981|101406613|FG004|Overall Study|Adverse Event|1|||
33414274|NCT01371981|101406614|FG005|Overall Study|Adverse Event|0|||
33414275|NCT01371981|101406609|FG000|Overall Study|Death|22|||
33414276|NCT01371981|101406610|FG001|Overall Study|Death|16|||
33414277|NCT01371981|101406611|FG002|Overall Study|Death|0|||
33414278|NCT01371981|101406612|FG003|Overall Study|Death|0|||
33414279|NCT01371981|101406613|FG004|Overall Study|Death|2|||
33414280|NCT01371981|101406614|FG005|Overall Study|Death|2|||
33414281|NCT01371981|101406609|FG000|Overall Study|Lack of Efficacy|69|||
33414282|NCT01371981|101406610|FG001|Overall Study|Lack of Efficacy|61|||
33414283|NCT01371981|101406611|FG002|Overall Study|Lack of Efficacy|4|||
33414284|NCT01371981|101406612|FG003|Overall Study|Lack of Efficacy|8|||
33414285|NCT01371981|101406613|FG004|Overall Study|Lack of Efficacy|5|||
33414286|NCT01371981|101406614|FG005|Overall Study|Lack of Efficacy|0|||
33414287|NCT01371981|101406609|FG000|Overall Study|Physician Decision|48|||
33414288|NCT01371981|101406610|FG001|Overall Study|Physician Decision|63|||
33414289|NCT01371981|101406611|FG002|Overall Study|Physician Decision|1|||
33414290|NCT01371981|101406612|FG003|Overall Study|Physician Decision|7|||
33414291|NCT01371981|101406613|FG004|Overall Study|Physician Decision|14|||
33414292|NCT01371981|101406614|FG005|Overall Study|Physician Decision|3|||
33414293|NCT01371981|101406609|FG000|Overall Study|Withdrawal by Subject|12|||
33414294|NCT01371981|101406610|FG001|Overall Study|Withdrawal by Subject|19|||
33414295|NCT01371981|101406611|FG002|Overall Study|Withdrawal by Subject|1|||
33414296|NCT01371981|101406612|FG003|Overall Study|Withdrawal by Subject|2|||
33414297|NCT01371981|101406613|FG004|Overall Study|Withdrawal by Subject|10|||
33555979|NCT00070499|101935005|FG001|Overall Study|Still on protocol treatment|4|||
33555980|NCT00070499|101935006|FG002|Overall Study|Still on protocol treatment|79|||
33555981|NCT00070499|101935007|FG003|Overall Study|Still on protocol treatment|57|||
33555982|NCT00070499|101935004|FG000|Overall Study|Did not start treatment|1|||
33555983|NCT00070499|101935005|FG001|Overall Study|Did not start treatment|0|||
33555984|NCT00070499|101935006|FG002|Overall Study|Did not start treatment|0|||
33414298|NCT01371981|101406614|FG005|Overall Study|Withdrawal by Subject|3|||
33414299|NCT01371981|101406609|FG000|Overall Study|Ineligible|19|||
33414300|NCT01371981|101406610|FG001|Overall Study|Ineligible|13|||
33414301|NCT01371981|101406611|FG002|Overall Study|Ineligible|0|||
33414302|NCT01371981|101406612|FG003|Overall Study|Ineligible|0|||
33414303|NCT01371981|101406613|FG004|Overall Study|Ineligible|0|||
33414304|NCT01371981|101406614|FG005|Overall Study|Ineligible|4|||
33414305|NCT01371981|101406609|FG000|Overall Study|Did not start treatment|2|||
33414306|NCT01371981|101406610|FG001|Overall Study|Did not start treatment|3|||
33414307|NCT01371981|101406611|FG002|Overall Study|Did not start treatment|0|||
33414308|NCT01371981|101406612|FG003|Overall Study|Did not start treatment|0|||
33555985|NCT00070499|101935007|FG003|Overall Study|Did not start treatment|2|||
33414309|NCT01371981|101406613|FG004|Overall Study|Did not start treatment|0|||
33414310|NCT01371981|101406614|FG005|Overall Study|Did not start treatment|2|||
33555986|NCT00070499|101935004|FG000|Overall Study|Not eligible|2|||
33356676|NCT01662999|101195260|FG000|Period 3|Withdrawal by Subject|0|||
33356677|NCT01662999|101195261|FG001|Period 3|Withdrawal by Subject|1|||
33356678|NCT01662999|101195262|FG002|Period 3|Withdrawal by Subject|0|||
33356679|NCT01662999|101195263|FG003|Period 3|Withdrawal by Subject|0|||
33356680|NCT01662999|101195264|FG004|Period 3|Withdrawal by Subject|0|||
33356681|NCT01662999|101195265|FG005|Period 3|Withdrawal by Subject|0|||
33356682|NCT00784758|101195266|FG000|Overall Study|Withdrawal by Subject|3|||
33356683|NCT00784758|101195267|FG001|Overall Study|Withdrawal by Subject|0|||
33356684|NCT00784758|101195266|FG000|Overall Study|Adverse Event|1|||
33621484|NCT00871871|102165767|FG002|Part II|Protocol Violation|0|||
33621485|NCT00871871|102165768|FG003|Part II|Protocol Violation|1|||
33621486|NCT02657889|102165769|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
33356685|NCT00784758|101195267|FG001|Overall Study|Adverse Event|0|||
33555987|NCT00070499|101935005|FG001|Overall Study|Not eligible|5|||
33356686|NCT00364793|101195268|FG000|Overall Study|Adverse Event|2|||
33356687|NCT00364793|101195269|FG001|Overall Study|Adverse Event|0|||
33356688|NCT00364793|101195270|FG002|Overall Study|Adverse Event|0|||
33555988|NCT00070499|101935006|FG002|Overall Study|Not eligible|3|||
33555989|NCT00070499|101935007|FG003|Overall Study|Not eligible|2|||
33555990|NCT02070380|101935010|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
33555991|NCT02070380|101935011|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
33621487|NCT02657889|102165770|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
33356689|NCT00364793|101195271|FG003|Overall Study|Adverse Event|0|||
33621488|NCT02657889|102165771|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
33621489|NCT02657889|102165772|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
33356690|NCT00364793|101195268|FG000|Overall Study|Death|1|||
33356691|NCT00364793|101195269|FG001|Overall Study|Death|0|||
33621490|NCT02657889|102165769|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
33621491|NCT02657889|102165770|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
33621492|NCT02657889|102165771|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
33621493|NCT02657889|102165772|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
33621494|NCT02657889|102165769|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
33621495|NCT02657889|102165770|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
33356692|NCT00364793|101195270|FG002|Overall Study|Death|1|||
33356693|NCT00364793|101195271|FG003|Overall Study|Death|0|||
33356694|NCT00364793|101195268|FG000|Overall Study|Lack of Efficacy|3|||
33356695|NCT00364793|101195269|FG001|Overall Study|Lack of Efficacy|3|||
33356696|NCT00364793|101195270|FG002|Overall Study|Lack of Efficacy|1|||
33356697|NCT00364793|101195271|FG003|Overall Study|Lack of Efficacy|1|||
33356698|NCT00364793|101195268|FG000|Overall Study|Lost to Follow-up|1|||
33621496|NCT02657889|102165771|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
33621497|NCT02657889|102165772|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
33621498|NCT02657889|102165769|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
33356699|NCT00364793|101195269|FG001|Overall Study|Lost to Follow-up|0|||
33356700|NCT00364793|101195270|FG002|Overall Study|Lost to Follow-up|2|||
33356701|NCT00364793|101195271|FG003|Overall Study|Lost to Follow-up|0|||
33356702|NCT00364793|101195268|FG000|Overall Study|Poor or non-compliance|1|||
33356703|NCT00364793|101195269|FG001|Overall Study|Poor or non-compliance|1|||
33621499|NCT02657889|102165770|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
33621500|NCT02657889|102165771|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
33621501|NCT02657889|102165772|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
33621502|NCT02657889|102165769|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
33621503|NCT02657889|102165770|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
33621504|NCT02657889|102165771|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
33621505|NCT02657889|102165772|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
33621506|NCT02657889|102165769|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
33621507|NCT02657889|102165770|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
33621508|NCT02657889|102165771|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
33621509|NCT02657889|102165772|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
33621510|NCT02657889|102165769|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
33621511|NCT02657889|102165770|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
33621512|NCT02657889|102165771|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
33621513|NCT02657889|102165772|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
33621514|NCT02657889|102165769|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
33621515|NCT02657889|102165770|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
33621516|NCT02657889|102165771|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
33621517|NCT02657889|102165772|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
33621518|NCT02657889|102165769|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
33621519|NCT02657889|102165770|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
33621520|NCT02657889|102165771|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
33621521|NCT02657889|102165772|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
33356704|NCT00364793|101195270|FG002|Overall Study|Poor or non-compliance|0|||
33356705|NCT00364793|101195271|FG003|Overall Study|Poor or non-compliance|1|||
33621522|NCT02657889|102165769|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
33621523|NCT02657889|102165770|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
33621524|NCT02657889|102165771|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
33621525|NCT02657889|102165772|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
33621526|NCT02657889|102165769|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
33621527|NCT02657889|102165770|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
33621528|NCT02657889|102165771|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
33621529|NCT02657889|102165772|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
33621530|NCT02657889|102165769|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
33621531|NCT02657889|102165770|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
33621532|NCT02657889|102165771|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
33621533|NCT02657889|102165772|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
33621534|NCT01695135|102165773|FG000|Double-blind Treatment Phase|Progressive disease|50|||
33621535|NCT01695135|102165774|FG001|Double-blind Treatment Phase|Progressive disease|110|||
33356706|NCT00364793|101195268|FG000|Overall Study|No longer meets criteria|0|||
33356707|NCT00364793|101195269|FG001|Overall Study|No longer meets criteria|0|||
33356708|NCT00364793|101195270|FG002|Overall Study|No longer meets criteria|0|||
33356709|NCT00364793|101195271|FG003|Overall Study|No longer meets criteria|1|||
33356710|NCT00364793|101195268|FG000|Overall Study|Withdrawal by Subject|0|||
33356711|NCT00364793|101195269|FG001|Overall Study|Withdrawal by Subject|1|||
33356712|NCT00364793|101195270|FG002|Overall Study|Withdrawal by Subject|0|||
33356713|NCT00364793|101195271|FG003|Overall Study|Withdrawal by Subject|0|||
33356714|NCT03185130|101195272|FG000|Overall Study|Withdrawal by Subject|0|||
33356715|NCT03185130|101195273|FG001|Overall Study|Withdrawal by Subject|2|||
33356716|NCT05113940|101195274|FG000|Part A (18 Days)|Adverse Event|0|||
33356717|NCT05113940|101195275|FG001|Part A (18 Days)|Adverse Event|0|||
33356718|NCT05113940|101195276|FG002|Part A (18 Days)|Adverse Event|1|||
33621536|NCT01695135|102165775|FG002|Double-blind Treatment Phase|Progressive disease|0|||
33621537|NCT01695135|102165776|FG003|Double-blind Treatment Phase|Progressive disease|0|||
33621538|NCT01695135|102165773|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
33621539|NCT01695135|102165774|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
33621540|NCT01695135|102165775|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33356719|NCT05113940|101195277|FG003|Part A (18 Days)|Adverse Event|1|||
33356720|NCT05113940|101195278|FG004|Part A (18 Days)|Adverse Event|1|||
33414311|NCT06067191|101406615|FG000|Overall Study|Withdrawal by Subject|0|||
33356721|NCT05113940|101195279|FG005|Part A (18 Days)|Adverse Event|0|||
33356722|NCT05113940|101195280|FG006|Part A (18 Days)|Adverse Event|0|||
33356723|NCT05113940|101195281|FG007|Part A (18 Days)|Adverse Event|0|||
33356724|NCT05113940|101195282|FG008|Part A (18 Days)|Adverse Event|0|||
33356725|NCT05113940|101195283|FG009|Part A (18 Days)|Adverse Event|0|||
33356726|NCT05113940|101195284|FG010|Part A (18 Days)|Adverse Event|0|||
33356727|NCT05113940|101195285|FG011|Part A (18 Days)|Adverse Event|2|||
33356728|NCT05113940|101195286|FG012|Part A (18 Days)|Adverse Event|0|||
33356729|NCT05113940|101195287|FG013|Part A (18 Days)|Adverse Event|0|||
33356730|NCT05113940|101195288|FG014|Part A (18 Days)|Adverse Event|0|||
33356731|NCT05113940|101195274|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
33356732|NCT05113940|101195275|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
33356733|NCT05113940|101195276|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
33356734|NCT05113940|101195277|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
33356735|NCT05113940|101195278|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
33356736|NCT05113940|101195279|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
33356737|NCT05113940|101195280|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
33621541|NCT01695135|102165776|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33621542|NCT01695135|102165773|FG000|Double-blind Treatment Phase|Adverse Event|7|||
33621543|NCT01695135|102165774|FG001|Double-blind Treatment Phase|Adverse Event|7|||
33621544|NCT01695135|102165775|FG002|Double-blind Treatment Phase|Adverse Event|0|||
33621545|NCT01695135|102165776|FG003|Double-blind Treatment Phase|Adverse Event|0|||
33621546|NCT01695135|102165773|FG000|Double-blind Treatment Phase|Other|1|||
33621547|NCT01695135|102165774|FG001|Double-blind Treatment Phase|Other|3|||
33621548|NCT01695135|102165775|FG002|Double-blind Treatment Phase|Other|0|||
33621549|NCT01695135|102165776|FG003|Double-blind Treatment Phase|Other|0|||
33621550|NCT01695135|102165773|FG000|Double-blind Treatment Phase|Physician Decision|6|||
33621551|NCT01695135|102165774|FG001|Double-blind Treatment Phase|Physician Decision|3|||
33621552|NCT01695135|102165775|FG002|Double-blind Treatment Phase|Physician Decision|0|||
33621553|NCT01695135|102165776|FG003|Double-blind Treatment Phase|Physician Decision|0|||
33621554|NCT01695135|102165773|FG000|Double-blind Treatment Phase|Death|1|||
33621555|NCT01695135|102165774|FG001|Double-blind Treatment Phase|Death|1|||
33621556|NCT01695135|102165775|FG002|Double-blind Treatment Phase|Death|0|||
33621557|NCT01695135|102165776|FG003|Double-blind Treatment Phase|Death|0|||
33621558|NCT01695135|102165773|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
33621559|NCT01695135|102165774|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
33621560|NCT01695135|102165775|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
33356738|NCT05113940|101195281|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
33356739|NCT05113940|101195282|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
33356740|NCT05113940|101195283|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
33356741|NCT05113940|101195284|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
33356742|NCT05113940|101195285|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
33356743|NCT05113940|101195286|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
33414312|NCT06067191|101406616|FG001|Overall Study|Withdrawal by Subject|1|||
33621561|NCT01695135|102165776|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
33621562|NCT01695135|102165773|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
33621563|NCT01695135|102165774|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
33621564|NCT01695135|102165775|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
33621565|NCT01695135|102165776|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
33621566|NCT01695135|102165773|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
33356744|NCT05113940|101195287|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
33414313|NCT00026312|101406617|FG000|Overall Study|Adverse Event|0|||
33414314|NCT00026312|101406618|FG001|Overall Study|Adverse Event|32|||
33414315|NCT00026312|101406617|FG000|Overall Study|Death|1|||
33414316|NCT00026312|101406618|FG001|Overall Study|Death|7|||
33414317|NCT00026312|101406617|FG000|Overall Study|Lack of Efficacy|19|||
33414318|NCT00026312|101406618|FG001|Overall Study|Lack of Efficacy|114|||
33414319|NCT00026312|101406617|FG000|Overall Study|Lost to Follow-up|0|||
33414320|NCT00026312|101406618|FG001|Overall Study|Lost to Follow-up|5|||
33414321|NCT00026312|101406617|FG000|Overall Study|Physician Decision|1|||
33414322|NCT00026312|101406618|FG001|Overall Study|Physician Decision|37|||
33414323|NCT00026312|101406617|FG000|Overall Study|Protocol Violation|0|||
33414324|NCT00026312|101406618|FG001|Overall Study|Protocol Violation|3|||
33414325|NCT00026312|101406617|FG000|Overall Study|Withdrawal by Subject|1|||
33414326|NCT00026312|101406618|FG001|Overall Study|Withdrawal by Subject|6|||
33414327|NCT00026312|101406617|FG000|Overall Study|Ineligible|4|||
33414328|NCT00026312|101406618|FG001|Overall Study|Ineligible|5|||
33414329|NCT00026312|101406617|FG000|Overall Study|Entry onto another COG study|0|||
33621567|NCT01695135|102165774|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
33356745|NCT05113940|101195288|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
33356746|NCT03263806|101195289|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
33356747|NCT03263806|101195290|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
33356748|NCT03263806|101195289|FG000|Overall Study|Withdrawal by Subject|0|||
33356749|NCT03263806|101195290|FG001|Overall Study|Withdrawal by Subject|1|||
33414330|NCT00026312|101406618|FG001|Overall Study|Entry onto another COG study|1|||
33414331|NCT00026312|101406617|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
33414332|NCT00026312|101406618|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
33414333|NCT03345485|101406619|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
33621568|NCT01695135|102165775|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
33621569|NCT01695135|102165776|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
33621570|NCT01695135|102165773|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
33621571|NCT01695135|102165774|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
33621572|NCT01695135|102165775|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
33621573|NCT01695135|102165776|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
33621574|NCT01695135|102165773|FG000|Open Label Extension Treatment Phase|Other|0|||
33356750|NCT03263806|101195289|FG000|Overall Study|Study Termination|5|||
33356751|NCT03263806|101195290|FG001|Overall Study|Study Termination|6|||
33555992|NCT02070380|101935012|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
33555993|NCT02070380|101935013|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
33555994|NCT02070380|101935010|FG000|Second Injection|Image sets missing or technically inadeq|0|||
33621575|NCT01695135|102165774|FG001|Open Label Extension Treatment Phase|Other|0|||
33621576|NCT01695135|102165775|FG002|Open Label Extension Treatment Phase|Other|4|||
33621577|NCT01695135|102165776|FG003|Open Label Extension Treatment Phase|Other|7|||
33621578|NCT01695135|102165773|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
33621579|NCT01695135|102165774|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
33621580|NCT01695135|102165775|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
33621581|NCT01695135|102165776|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
33621582|NCT01695135|102165773|FG000|Open Label Extension Treatment Phase|Death|0|||
33621583|NCT01695135|102165774|FG001|Open Label Extension Treatment Phase|Death|0|||
33621584|NCT01695135|102165775|FG002|Open Label Extension Treatment Phase|Death|2|||
33621585|NCT01695135|102165776|FG003|Open Label Extension Treatment Phase|Death|7|||
33621586|NCT01695135|102165773|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
33621587|NCT01695135|102165774|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
33621588|NCT01695135|102165775|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
33621589|NCT01695135|102165776|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
33621590|NCT01473732|102165777|FG000|Overall Study|Adverse Event|1|||
33621591|NCT01473732|102165778|FG001|Overall Study|Adverse Event|0|||
33621592|NCT01473732|102165777|FG000|Overall Study|Death|1|||
33621593|NCT01473732|102165778|FG001|Overall Study|Death|0|||
33621594|NCT03155724|102165779|FG000|Overall Study|Death|3|||
33621595|NCT03155724|102165779|FG000|Overall Study|Physician Decision|1|||
33621596|NCT03155724|102165779|FG000|Overall Study|Study closure|7|||
33555995|NCT02070380|101935011|FG001|Second Injection|Image sets missing or technically inadeq|1|||
33555996|NCT02070380|101935012|FG002|Second Injection|Image sets missing or technically inadeq|0|||
33555997|NCT02070380|101935013|FG003|Second Injection|Image sets missing or technically inadeq|0|||
33555998|NCT02070380|101935010|FG000|Second Injection|Protocol Violation|0|||
33555999|NCT02070380|101935011|FG001|Second Injection|Protocol Violation|1|||
33556000|NCT02070380|101935012|FG002|Second Injection|Protocol Violation|1|||
33556001|NCT02070380|101935013|FG003|Second Injection|Protocol Violation|5|||
33556002|NCT02565186|101935014|FG000|Overall Study|Adverse Event|113|||
33556003|NCT02565186|101935015|FG001|Overall Study|Adverse Event|148|||
33556004|NCT02565186|101935014|FG000|Overall Study|Lost to Follow-up|102|||
33556005|NCT02565186|101935015|FG001|Overall Study|Lost to Follow-up|93|||
33621597|NCT02003534|102165780|FG000|Overall Study|Lost to Follow-up|47|||
33621598|NCT04378270|102165781|FG000|Overall Study|Lack of Efficacy|1|||
33621599|NCT04378270|102165781|FG000|Overall Study|Withdrawal by Subject|1|||
33621600|NCT04378270|102165781|FG000|Overall Study|Screen Failure|1|||
33621601|NCT04378270|102165781|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
33621602|NCT02532517|102165784|FG000|Overall Study|Did not complete 24-Month visit|4|||
33621603|NCT02532517|102165784|FG000|Overall Study|Failed Angiographic eligibility|1|||
33621604|NCT02532517|102165784|FG000|Overall Study|Lost to Follow-up|4|||
33621605|NCT02532517|102165784|FG000|Overall Study|Withdrawal by Subject|4|||
33621606|NCT02532517|102165784|FG000|Overall Study|Death|4|||
33621607|NCT01980095|102165785|FG000|Overall Study|Lost to Follow-up|6|||
33621608|NCT01980095|102165786|FG001|Overall Study|Lost to Follow-up|7|||
33621609|NCT01980095|102165785|FG000|Overall Study|Withdrawal by Subject|2|||
33621610|NCT01980095|102165786|FG001|Overall Study|Withdrawal by Subject|3|||
33621611|NCT01980095|102165785|FG000|Overall Study|Poor compliance|5|||
33621612|NCT01980095|102165786|FG001|Overall Study|Poor compliance|0|||
33621613|NCT01980095|102165785|FG000|Overall Study|Safety issue|0|||
33621614|NCT01980095|102165786|FG001|Overall Study|Safety issue|1|||
33621615|NCT01980095|102165785|FG000|Overall Study|Study drug discontinued|1|||
33621616|NCT01980095|102165786|FG001|Overall Study|Study drug discontinued|0|||
33556006|NCT02565186|101935014|FG000|Overall Study|Non-Compliance|57|||
33621617|NCT01980095|102165785|FG000|Overall Study|Randomized by mistake|1|||
33621618|NCT01980095|102165786|FG001|Overall Study|Randomized by mistake|0|||
33556007|NCT02565186|101935015|FG001|Overall Study|Non-Compliance|55|||
33556008|NCT02565186|101935014|FG000|Overall Study|Withdrawal by Subject|229|||
33556009|NCT02565186|101935015|FG001|Overall Study|Withdrawal by Subject|214|||
33556010|NCT02565186|101935014|FG000|Overall Study|Physician Decision|18|||
33556011|NCT02565186|101935015|FG001|Overall Study|Physician Decision|16|||
33556012|NCT02565186|101935014|FG000|Overall Study|Sponsor Request|5|||
33556013|NCT02565186|101935015|FG001|Overall Study|Sponsor Request|9|||
33556014|NCT02565186|101935014|FG000|Overall Study|Missing|1|||
33556015|NCT02565186|101935015|FG001|Overall Study|Missing|0|||
33556016|NCT02565186|101935014|FG000|Overall Study|Did Not Receive Study Drug|55|||
33556017|NCT02565186|101935015|FG001|Overall Study|Did Not Receive Study Drug|86|||
33556018|NCT02539394|101935018|FG000|Overall Study|Protocol Violation|1|||
33556019|NCT02539394|101935019|FG001|Overall Study|Protocol Violation|3|||
33556020|NCT02539394|101935018|FG000|Overall Study|Lost to Follow-up|1|||
33556021|NCT02539394|101935019|FG001|Overall Study|Lost to Follow-up|2|||
33556022|NCT02539394|101935018|FG000|Overall Study|Incomplete dataset|6|||
33556023|NCT02539394|101935019|FG001|Overall Study|Incomplete dataset|6|||
33556024|NCT00576407|101935020|FG000|Overall Study|Death|7|||
33556025|NCT00576407|101935020|FG000|Overall Study|Physician Decision|1|||
33556026|NCT01694771|101935021|FG000|Overall Study|Adverse Event|18|||
33556027|NCT01694771|101935022|FG001|Overall Study|Adverse Event|16|||
33556028|NCT01694771|101935021|FG000|Overall Study|Lack of Efficacy|1|||
33621619|NCT02734693|102165792|FG000|Overall Study|Adverse Event|1|||
33621620|NCT02734693|102165793|FG001|Overall Study|Adverse Event|3|||
33621621|NCT02734693|102165794|FG002|Overall Study|Adverse Event|3|||
33621622|NCT02734693|102165792|FG000|Overall Study|Lack of Efficacy|1|||
33621623|NCT02734693|102165793|FG001|Overall Study|Lack of Efficacy|0|||
33621624|NCT02734693|102165794|FG002|Overall Study|Lack of Efficacy|0|||
33621625|NCT02734693|102165792|FG000|Overall Study|Lost to Follow-up|2|||
33556029|NCT01694771|101935022|FG001|Overall Study|Lack of Efficacy|0|||
33556030|NCT01694771|101935021|FG000|Overall Study|Non compliance protocol|7|||
33556031|NCT01694771|101935022|FG001|Overall Study|Non compliance protocol|6|||
33556032|NCT01694771|101935021|FG000|Overall Study|Lost to Follow-up|2|||
33556033|NCT01694771|101935022|FG001|Overall Study|Lost to Follow-up|3|||
33556034|NCT01694771|101935021|FG000|Overall Study|Consent withdrawn|7|||
33556035|NCT01694771|101935022|FG001|Overall Study|Consent withdrawn|9|||
33556036|NCT01694771|101935021|FG000|Overall Study|Other reasons|5|||
33556037|NCT01694771|101935022|FG001|Overall Study|Other reasons|6|||
33556038|NCT02533674|101935028|FG000|Dose Level I|Progressive disease|1|||
33556039|NCT02533674|101935029|FG001|Dose Level I|Progressive disease|0|||
33556040|NCT02533674|101935030|FG002|Dose Level I|Progressive disease|0|||
33556041|NCT02533674|101935031|FG003|Dose Level I|Progressive disease|0|||
33556042|NCT02533674|101935032|FG004|Dose Level I|Progressive disease|0|||
33556043|NCT02533674|101935033|FG005|Dose Level I|Progressive disease|0|||
33556044|NCT02533674|101935034|FG006|Dose Level I|Progressive disease|0|||
33556045|NCT02533674|101935035|FG007|Dose Level I|Progressive disease|0|||
33556046|NCT02533674|101935028|FG000|Dose Level I|Withdrawal by Subject|1|||
33556047|NCT02533674|101935029|FG001|Dose Level I|Withdrawal by Subject|0|||
33556048|NCT02533674|101935030|FG002|Dose Level I|Withdrawal by Subject|0|||
33556049|NCT02533674|101935031|FG003|Dose Level I|Withdrawal by Subject|0|||
33556050|NCT02533674|101935032|FG004|Dose Level I|Withdrawal by Subject|0|||
33556051|NCT02533674|101935033|FG005|Dose Level I|Withdrawal by Subject|0|||
33556052|NCT02533674|101935034|FG006|Dose Level I|Withdrawal by Subject|0|||
33556053|NCT02533674|101935035|FG007|Dose Level I|Withdrawal by Subject|0|||
33556054|NCT02533674|101935028|FG000|Dose Level I|Physician Decision|1|||
33556055|NCT02533674|101935029|FG001|Dose Level I|Physician Decision|0|||
33556056|NCT02533674|101935030|FG002|Dose Level I|Physician Decision|0|||
33556057|NCT02533674|101935031|FG003|Dose Level I|Physician Decision|0|||
33621626|NCT02734693|102165793|FG001|Overall Study|Lost to Follow-up|0|||
33621627|NCT02734693|102165794|FG002|Overall Study|Lost to Follow-up|0|||
33218172|NCT03685591|100695974|FG003|Overall Study|Withdrawal by Subject|0|||
33556058|NCT02533674|101935032|FG004|Dose Level I|Physician Decision|0|||
33556059|NCT02533674|101935033|FG005|Dose Level I|Physician Decision|0|||
33556060|NCT02533674|101935034|FG006|Dose Level I|Physician Decision|0|||
33556061|NCT02533674|101935035|FG007|Dose Level I|Physician Decision|0|||
33556062|NCT02533674|101935028|FG000|Dose Level I|Death|1|||
33556063|NCT02533674|101935029|FG001|Dose Level I|Death|0|||
33556064|NCT02533674|101935030|FG002|Dose Level I|Death|0|||
33556065|NCT02533674|101935031|FG003|Dose Level I|Death|0|||
33621628|NCT02734693|102165792|FG000|Overall Study|Protocol Violation|1|||
33621629|NCT02734693|102165793|FG001|Overall Study|Protocol Violation|0|||
33621630|NCT02734693|102165794|FG002|Overall Study|Protocol Violation|0|||
33218173|NCT03685591|100695975|FG004|Overall Study|Withdrawal by Subject|3|||
33556066|NCT02533674|101935032|FG004|Dose Level I|Death|0|||
33621631|NCT02734693|102165792|FG000|Overall Study|Withdrawal by Subject|1|||
33621632|NCT02734693|102165793|FG001|Overall Study|Withdrawal by Subject|0|||
33556067|NCT02533674|101935033|FG005|Dose Level I|Death|0|||
33556068|NCT02533674|101935034|FG006|Dose Level I|Death|0|||
33556069|NCT02533674|101935035|FG007|Dose Level I|Death|0|||
33556070|NCT02533674|101935028|FG000|Dose Level I|Never Treated|1|||
33621633|NCT02734693|102165794|FG002|Overall Study|Withdrawal by Subject|0|||
33556071|NCT02533674|101935029|FG001|Dose Level I|Never Treated|0|||
33556072|NCT02533674|101935030|FG002|Dose Level I|Never Treated|0|||
33556073|NCT02533674|101935031|FG003|Dose Level I|Never Treated|0|||
33556074|NCT02533674|101935032|FG004|Dose Level I|Never Treated|0|||
33556075|NCT02533674|101935033|FG005|Dose Level I|Never Treated|0|||
33556076|NCT02533674|101935034|FG006|Dose Level I|Never Treated|0|||
33556077|NCT02533674|101935035|FG007|Dose Level I|Never Treated|0|||
33556078|NCT02533674|101935028|FG000|Dose Level II|Progressive disease|0|||
33556079|NCT02533674|101935029|FG001|Dose Level II|Progressive disease|3|||
33556080|NCT02533674|101935030|FG002|Dose Level II|Progressive disease|0|||
33621634|NCT01855412|102165797|FG000|Overall Study|Death|77|||
33621635|NCT01855412|102165798|FG001|Overall Study|Death|123|||
33621636|NCT01855412|102165799|FG002|Overall Study|Death|30|||
33414334|NCT03345485|101406620|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
33621637|NCT01855412|102165797|FG000|Overall Study|Lost to Follow-up|28|||
33621638|NCT01855412|102165798|FG001|Overall Study|Lost to Follow-up|46|||
33621639|NCT01855412|102165799|FG002|Overall Study|Lost to Follow-up|15|||
33621640|NCT01855412|102165797|FG000|Overall Study|Withdrawal by Subject|77|||
33621641|NCT01855412|102165798|FG001|Overall Study|Withdrawal by Subject|123|||
33621642|NCT01855412|102165799|FG002|Overall Study|Withdrawal by Subject|24|||
33621643|NCT01855412|102165797|FG000|Overall Study|Physician Decision|25|||
33621644|NCT01855412|102165798|FG001|Overall Study|Physician Decision|31|||
33621645|NCT01855412|102165799|FG002|Overall Study|Physician Decision|3|||
33621646|NCT01855412|102165797|FG000|Overall Study|Site Closure|4|||
33621647|NCT01855412|102165798|FG001|Overall Study|Site Closure|18|||
33621648|NCT01855412|102165799|FG002|Overall Study|Site Closure|1|||
33621649|NCT01855412|102165797|FG000|Overall Study|Reason not Specified|1|||
33621650|NCT01855412|102165798|FG001|Overall Study|Reason not Specified|2|||
33621651|NCT01855412|102165799|FG002|Overall Study|Reason not Specified|3|||
33621652|NCT01253291|102165800|FG000|Overall Study|Withdrawal by Subject|1|||
33414335|NCT03345485|101406621|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
33414336|NCT03345485|101406622|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
33556081|NCT02533674|101935031|FG003|Dose Level II|Progressive disease|0|||
33621653|NCT01253291|102165801|FG001|Overall Study|Withdrawal by Subject|1|||
33621654|NCT01253291|102165802|FG002|Overall Study|Withdrawal by Subject|0|||
33621655|NCT01253291|102165803|FG003|Overall Study|Withdrawal by Subject|0|||
33621656|NCT01253291|102165804|FG004|Overall Study|Withdrawal by Subject|0|||
33556082|NCT02533674|101935032|FG004|Dose Level II|Progressive disease|0|||
33556083|NCT02533674|101935033|FG005|Dose Level II|Progressive disease|0|||
33621657|NCT01253291|102165800|FG000|Overall Study|Adverse Event|0|||
33621658|NCT01253291|102165801|FG001|Overall Study|Adverse Event|1|||
33556084|NCT02533674|101935034|FG006|Dose Level II|Progressive disease|0|||
33556085|NCT02533674|101935035|FG007|Dose Level II|Progressive disease|0|||
33556086|NCT02533674|101935028|FG000|Dose Level II|Withdrawal by Subject|0|||
33556087|NCT02533674|101935029|FG001|Dose Level II|Withdrawal by Subject|1|||
33556088|NCT02533674|101935030|FG002|Dose Level II|Withdrawal by Subject|0|||
33556089|NCT02533674|101935031|FG003|Dose Level II|Withdrawal by Subject|0|||
33556090|NCT02533674|101935032|FG004|Dose Level II|Withdrawal by Subject|0|||
33556091|NCT02533674|101935033|FG005|Dose Level II|Withdrawal by Subject|0|||
33556092|NCT02533674|101935034|FG006|Dose Level II|Withdrawal by Subject|0|||
33556093|NCT02533674|101935035|FG007|Dose Level II|Withdrawal by Subject|0|||
33556094|NCT02533674|101935028|FG000|Dose Level II|Treatment-related AE|0|||
33556095|NCT02533674|101935029|FG001|Dose Level II|Treatment-related AE|1|||
33556096|NCT02533674|101935030|FG002|Dose Level II|Treatment-related AE|0|||
33556097|NCT02533674|101935031|FG003|Dose Level II|Treatment-related AE|0|||
33556098|NCT02533674|101935032|FG004|Dose Level II|Treatment-related AE|0|||
33556099|NCT02533674|101935033|FG005|Dose Level II|Treatment-related AE|0|||
33556100|NCT02533674|101935034|FG006|Dose Level II|Treatment-related AE|0|||
33556101|NCT02533674|101935035|FG007|Dose Level II|Treatment-related AE|0|||
33556102|NCT02533674|101935028|FG000|Dose Level II|Physician Decision|0|||
33556103|NCT02533674|101935029|FG001|Dose Level II|Physician Decision|1|||
33556104|NCT02533674|101935030|FG002|Dose Level II|Physician Decision|0|||
33556105|NCT02533674|101935031|FG003|Dose Level II|Physician Decision|0|||
33556106|NCT02533674|101935032|FG004|Dose Level II|Physician Decision|0|||
33556107|NCT02533674|101935033|FG005|Dose Level II|Physician Decision|0|||
33556108|NCT02533674|101935034|FG006|Dose Level II|Physician Decision|0|||
33556109|NCT02533674|101935035|FG007|Dose Level II|Physician Decision|0|||
33556110|NCT02533674|101935028|FG000|Dose Level II|Non-treatment-related AE|0|||
33556111|NCT02533674|101935029|FG001|Dose Level II|Non-treatment-related AE|1|||
33556112|NCT02533674|101935030|FG002|Dose Level II|Non-treatment-related AE|0|||
33556113|NCT02533674|101935031|FG003|Dose Level II|Non-treatment-related AE|0|||
33556114|NCT02533674|101935032|FG004|Dose Level II|Non-treatment-related AE|0|||
33218174|NCT03685591|100695976|FG005|Overall Study|Withdrawal by Subject|2|||
33218175|NCT03685591|100695977|FG006|Overall Study|Withdrawal by Subject|0|||
33218176|NCT03685591|100695978|FG007|Overall Study|Withdrawal by Subject|0|||
33218177|NCT03685591|100695979|FG008|Overall Study|Withdrawal by Subject|1|||
33218178|NCT03685591|100695971|FG000|Overall Study|Adverse Event|0|||
33218179|NCT03685591|100695972|FG001|Overall Study|Adverse Event|0|||
33218180|NCT03685591|100695973|FG002|Overall Study|Adverse Event|0|||
33356752|NCT00847613|101195291|FG000|Overall Study|Ongoing at cut-off date|250|||
33356753|NCT00847613|101195292|FG001|Overall Study|Ongoing at cut-off date|265|||
33356754|NCT00847613|101195293|FG002|Overall Study|Ongoing at cut-off date|64|||
33356755|NCT00847613|101195294|FG003|Overall Study|Ongoing at cut-off date|64|||
33356756|NCT00847613|101195291|FG000|Overall Study|Death|1|||
33356757|NCT00847613|101195292|FG001|Overall Study|Death|1|||
33356758|NCT00847613|101195293|FG002|Overall Study|Death|0|||
33356759|NCT00847613|101195294|FG003|Overall Study|Death|0|||
33356760|NCT00847613|101195291|FG000|Overall Study|Adverse Event|36|||
33356761|NCT00847613|101195292|FG001|Overall Study|Adverse Event|26|||
33356762|NCT00847613|101195293|FG002|Overall Study|Adverse Event|5|||
33356763|NCT00847613|101195294|FG003|Overall Study|Adverse Event|6|||
33356764|NCT00847613|101195291|FG000|Overall Study|Lack of Efficacy|7|||
33356765|NCT00847613|101195292|FG001|Overall Study|Lack of Efficacy|3|||
33356766|NCT00847613|101195293|FG002|Overall Study|Lack of Efficacy|3|||
33356767|NCT00847613|101195294|FG003|Overall Study|Lack of Efficacy|1|||
33356768|NCT00847613|101195291|FG000|Overall Study|Study terminated by Sponsor|1|||
33356769|NCT00847613|101195292|FG001|Overall Study|Study terminated by Sponsor|0|||
33356770|NCT00847613|101195293|FG002|Overall Study|Study terminated by Sponsor|2|||
33356771|NCT00847613|101195294|FG003|Overall Study|Study terminated by Sponsor|1|||
33356772|NCT00847613|101195291|FG000|Overall Study|Lost to Follow-up|5|||
33356773|NCT00847613|101195292|FG001|Overall Study|Lost to Follow-up|0|||
33356774|NCT00847613|101195293|FG002|Overall Study|Lost to Follow-up|0|||
33356775|NCT00847613|101195294|FG003|Overall Study|Lost to Follow-up|3|||
33356776|NCT00847613|101195291|FG000|Overall Study|Protocol Violation|6|||
33556115|NCT02533674|101935033|FG005|Dose Level II|Non-treatment-related AE|0|||
33556116|NCT02533674|101935034|FG006|Dose Level II|Non-treatment-related AE|0|||
33556117|NCT02533674|101935035|FG007|Dose Level II|Non-treatment-related AE|0|||
33556118|NCT02533674|101935028|FG000|Dose Level III|Progressive disease|0|||
33556119|NCT02533674|101935029|FG001|Dose Level III|Progressive disease|0|||
33556120|NCT02533674|101935030|FG002|Dose Level III|Progressive disease|2|||
33556121|NCT02533674|101935031|FG003|Dose Level III|Progressive disease|0|||
33218181|NCT03685591|100695974|FG003|Overall Study|Adverse Event|1|||
33218182|NCT03685591|100695975|FG004|Overall Study|Adverse Event|1|||
33356777|NCT00847613|101195292|FG001|Overall Study|Protocol Violation|6|||
33356778|NCT00847613|101195293|FG002|Overall Study|Protocol Violation|3|||
33356779|NCT00847613|101195294|FG003|Overall Study|Protocol Violation|1|||
33356780|NCT00847613|101195291|FG000|Overall Study|Pregnancy|1|||
33356781|NCT00847613|101195292|FG001|Overall Study|Pregnancy|1|||
33556122|NCT02533674|101935032|FG004|Dose Level III|Progressive disease|0|||
33556123|NCT02533674|101935033|FG005|Dose Level III|Progressive disease|0|||
33556124|NCT02533674|101935034|FG006|Dose Level III|Progressive disease|0|||
33556125|NCT02533674|101935035|FG007|Dose Level III|Progressive disease|0|||
33556126|NCT02533674|101935028|FG000|Dose Level III|Withdrawal by Subject|0|||
33556127|NCT02533674|101935029|FG001|Dose Level III|Withdrawal by Subject|0|||
33556128|NCT02533674|101935030|FG002|Dose Level III|Withdrawal by Subject|1|||
33556129|NCT02533674|101935031|FG003|Dose Level III|Withdrawal by Subject|0|||
33556130|NCT02533674|101935032|FG004|Dose Level III|Withdrawal by Subject|0|||
33556131|NCT02533674|101935033|FG005|Dose Level III|Withdrawal by Subject|0|||
33556132|NCT02533674|101935034|FG006|Dose Level III|Withdrawal by Subject|0|||
33556133|NCT02533674|101935035|FG007|Dose Level III|Withdrawal by Subject|0|||
33556134|NCT02533674|101935028|FG000|Dose Level III|Treatment-related AE|0|||
33556135|NCT02533674|101935029|FG001|Dose Level III|Treatment-related AE|0|||
33556136|NCT02533674|101935030|FG002|Dose Level III|Treatment-related AE|1|||
33556137|NCT02533674|101935031|FG003|Dose Level III|Treatment-related AE|0|||
33556138|NCT02533674|101935032|FG004|Dose Level III|Treatment-related AE|0|||
33556139|NCT02533674|101935033|FG005|Dose Level III|Treatment-related AE|0|||
33556140|NCT02533674|101935034|FG006|Dose Level III|Treatment-related AE|0|||
33556141|NCT02533674|101935035|FG007|Dose Level III|Treatment-related AE|0|||
33556142|NCT02533674|101935028|FG000|Dose Level IV|Progressive disease|0|||
33556143|NCT02533674|101935029|FG001|Dose Level IV|Progressive disease|0|||
33556144|NCT02533674|101935030|FG002|Dose Level IV|Progressive disease|0|||
33556145|NCT02533674|101935031|FG003|Dose Level IV|Progressive disease|3|||
33556146|NCT02533674|101935032|FG004|Dose Level IV|Progressive disease|0|||
33556147|NCT02533674|101935033|FG005|Dose Level IV|Progressive disease|0|||
33556148|NCT02533674|101935034|FG006|Dose Level IV|Progressive disease|0|||
33556149|NCT02533674|101935035|FG007|Dose Level IV|Progressive disease|0|||
33556150|NCT02533674|101935028|FG000|Dose Level IV|Withdrawal by Subject|0|||
33556151|NCT02533674|101935029|FG001|Dose Level IV|Withdrawal by Subject|0|||
33556152|NCT02533674|101935030|FG002|Dose Level IV|Withdrawal by Subject|0|||
33556153|NCT02533674|101935031|FG003|Dose Level IV|Withdrawal by Subject|1|||
33556154|NCT02533674|101935032|FG004|Dose Level IV|Withdrawal by Subject|0|||
33556155|NCT02533674|101935033|FG005|Dose Level IV|Withdrawal by Subject|0|||
33556156|NCT02533674|101935034|FG006|Dose Level IV|Withdrawal by Subject|0|||
33556157|NCT02533674|101935035|FG007|Dose Level IV|Withdrawal by Subject|0|||
33556158|NCT02533674|101935028|FG000|Dose Level IV|Physician Decision|0|||
33556159|NCT02533674|101935029|FG001|Dose Level IV|Physician Decision|0|||
33556160|NCT02533674|101935030|FG002|Dose Level IV|Physician Decision|0|||
33556161|NCT02533674|101935031|FG003|Dose Level IV|Physician Decision|1|||
33556162|NCT02533674|101935032|FG004|Dose Level IV|Physician Decision|0|||
33556163|NCT02533674|101935033|FG005|Dose Level IV|Physician Decision|0|||
33556164|NCT02533674|101935034|FG006|Dose Level IV|Physician Decision|0|||
33556165|NCT02533674|101935035|FG007|Dose Level IV|Physician Decision|0|||
33556166|NCT02533674|101935028|FG000|Dose Level V|Progressive disease|0|||
33556167|NCT02533674|101935029|FG001|Dose Level V|Progressive disease|0|||
33556168|NCT02533674|101935030|FG002|Dose Level V|Progressive disease|0|||
33556169|NCT02533674|101935031|FG003|Dose Level V|Progressive disease|0|||
33556170|NCT02533674|101935032|FG004|Dose Level V|Progressive disease|3|||
33556171|NCT02533674|101935033|FG005|Dose Level V|Progressive disease|0|||
33556172|NCT02533674|101935034|FG006|Dose Level V|Progressive disease|0|||
33556173|NCT02533674|101935035|FG007|Dose Level V|Progressive disease|0|||
33556174|NCT02533674|101935028|FG000|Dose Level V|Withdrawal by Subject|0|||
33621659|NCT01253291|102165802|FG002|Overall Study|Adverse Event|0|||
33621660|NCT01253291|102165803|FG003|Overall Study|Adverse Event|0|||
33621661|NCT01253291|102165804|FG004|Overall Study|Adverse Event|0|||
33621662|NCT01253291|102165800|FG000|Overall Study|Lack of Efficacy|1|||
33621663|NCT01253291|102165801|FG001|Overall Study|Lack of Efficacy|0|||
33621664|NCT01253291|102165802|FG002|Overall Study|Lack of Efficacy|0|||
33621665|NCT01253291|102165803|FG003|Overall Study|Lack of Efficacy|0|||
33621666|NCT01253291|102165804|FG004|Overall Study|Lack of Efficacy|0|||
33621667|NCT01253291|102165800|FG000|Overall Study|Physician Decision|2|||
33621668|NCT01253291|102165801|FG001|Overall Study|Physician Decision|0|||
33621669|NCT01253291|102165802|FG002|Overall Study|Physician Decision|0|||
33621670|NCT01253291|102165803|FG003|Overall Study|Physician Decision|0|||
33621671|NCT01253291|102165804|FG004|Overall Study|Physician Decision|2|||
33621672|NCT03553758|102165805|FG000|Overall Study|Lost to Follow-up|1|||
33621673|NCT01453140|102165812|FG000|Overall Study|Adverse Event|3|||
33621674|NCT00684996|102165813|FG000|Overall Study|Adverse Event|1|||
33556175|NCT02533674|101935029|FG001|Dose Level V|Withdrawal by Subject|0|||
33556176|NCT02533674|101935030|FG002|Dose Level V|Withdrawal by Subject|0|||
33556177|NCT02533674|101935031|FG003|Dose Level V|Withdrawal by Subject|0|||
33556178|NCT02533674|101935032|FG004|Dose Level V|Withdrawal by Subject|1|||
33556179|NCT02533674|101935033|FG005|Dose Level V|Withdrawal by Subject|0|||
33621675|NCT00684996|102165813|FG000|Overall Study|Refusal unrelated to adverse event|1|||
33556180|NCT02533674|101935034|FG006|Dose Level V|Withdrawal by Subject|0|||
33556181|NCT02533674|101935035|FG007|Dose Level V|Withdrawal by Subject|0|||
33556182|NCT02533674|101935028|FG000|Dose Level V|Physician Decision|0|||
33556183|NCT02533674|101935029|FG001|Dose Level V|Physician Decision|0|||
33556184|NCT02533674|101935030|FG002|Dose Level V|Physician Decision|0|||
33556185|NCT02533674|101935031|FG003|Dose Level V|Physician Decision|0|||
33556186|NCT02533674|101935032|FG004|Dose Level V|Physician Decision|1|||
33556187|NCT02533674|101935033|FG005|Dose Level V|Physician Decision|0|||
33556188|NCT02533674|101935034|FG006|Dose Level V|Physician Decision|0|||
33556189|NCT02533674|101935035|FG007|Dose Level V|Physician Decision|0|||
33556190|NCT02533674|101935028|FG000|Dose Level VI|Progressive disease|0|||
33556191|NCT02533674|101935029|FG001|Dose Level VI|Progressive disease|0|||
33556192|NCT02533674|101935030|FG002|Dose Level VI|Progressive disease|0|||
33556193|NCT02533674|101935031|FG003|Dose Level VI|Progressive disease|0|||
33556194|NCT02533674|101935032|FG004|Dose Level VI|Progressive disease|0|||
33556195|NCT02533674|101935033|FG005|Dose Level VI|Progressive disease|7|||
33556196|NCT02533674|101935034|FG006|Dose Level VI|Progressive disease|0|||
33356782|NCT00847613|101195293|FG002|Overall Study|Pregnancy|0|||
33356783|NCT00847613|101195294|FG003|Overall Study|Pregnancy|0|||
33356784|NCT00847613|101195291|FG000|Overall Study|Site closure|1|||
33356785|NCT00847613|101195292|FG001|Overall Study|Site closure|0|||
33356786|NCT00847613|101195293|FG002|Overall Study|Site closure|0|||
33356787|NCT00847613|101195294|FG003|Overall Study|Site closure|1|||
33356788|NCT00847613|101195291|FG000|Overall Study|Withdrawal by Subject|8|||
33356789|NCT00847613|101195292|FG001|Overall Study|Withdrawal by Subject|11|||
33356790|NCT00847613|101195293|FG002|Overall Study|Withdrawal by Subject|2|||
33356791|NCT00847613|101195294|FG003|Overall Study|Withdrawal by Subject|2|||
33356792|NCT00847613|101195291|FG000|Overall Study|Participant moved|4|||
33356793|NCT00847613|101195292|FG001|Overall Study|Participant moved|1|||
33356794|NCT00847613|101195293|FG002|Overall Study|Participant moved|0|||
33356795|NCT00847613|101195294|FG003|Overall Study|Participant moved|0|||
33356796|NCT00847613|101195291|FG000|Overall Study|Sponsor request|0|||
33356797|NCT00847613|101195292|FG001|Overall Study|Sponsor request|1|||
33356798|NCT00847613|101195293|FG002|Overall Study|Sponsor request|0|||
33356799|NCT00847613|101195294|FG003|Overall Study|Sponsor request|0|||
33356800|NCT00847613|101195291|FG000|Overall Study|Randomized, but not treated|0|||
33356801|NCT00847613|101195292|FG001|Overall Study|Randomized, but not treated|3|||
33356802|NCT00847613|101195293|FG002|Overall Study|Randomized, but not treated|0|||
33356803|NCT00847613|101195294|FG003|Overall Study|Randomized, but not treated|0|||
33356804|NCT00847613|101195291|FG000|Overall Study|Other|1|||
33356805|NCT00847613|101195292|FG001|Overall Study|Other|1|||
33556197|NCT02533674|101935035|FG007|Dose Level VI|Progressive disease|0|||
33556198|NCT02533674|101935028|FG000|Dose Level VI|Withdrawal by Subject|0|||
33556199|NCT02533674|101935029|FG001|Dose Level VI|Withdrawal by Subject|0|||
33556200|NCT02533674|101935030|FG002|Dose Level VI|Withdrawal by Subject|0|||
33556201|NCT02533674|101935031|FG003|Dose Level VI|Withdrawal by Subject|0|||
33556202|NCT02533674|101935032|FG004|Dose Level VI|Withdrawal by Subject|0|||
33556203|NCT02533674|101935033|FG005|Dose Level VI|Withdrawal by Subject|1|||
33556204|NCT02533674|101935034|FG006|Dose Level VI|Withdrawal by Subject|0|||
33556205|NCT02533674|101935035|FG007|Dose Level VI|Withdrawal by Subject|0|||
33556206|NCT02533674|101935028|FG000|Dose Level VI|Treatment-related AE|0|||
33556207|NCT02533674|101935029|FG001|Dose Level VI|Treatment-related AE|0|||
33556208|NCT02533674|101935030|FG002|Dose Level VI|Treatment-related AE|0|||
33556209|NCT02533674|101935031|FG003|Dose Level VI|Treatment-related AE|0|||
33556210|NCT02533674|101935032|FG004|Dose Level VI|Treatment-related AE|0|||
33556211|NCT02533674|101935033|FG005|Dose Level VI|Treatment-related AE|1|||
33556212|NCT02533674|101935034|FG006|Dose Level VI|Treatment-related AE|0|||
33556213|NCT02533674|101935035|FG007|Dose Level VI|Treatment-related AE|0|||
33556214|NCT02533674|101935028|FG000|Dose Level VII|Progressive disease|0|||
33556215|NCT02533674|101935029|FG001|Dose Level VII|Progressive disease|0|||
33556216|NCT02533674|101935030|FG002|Dose Level VII|Progressive disease|0|||
33556217|NCT02533674|101935031|FG003|Dose Level VII|Progressive disease|0|||
33556218|NCT02533674|101935032|FG004|Dose Level VII|Progressive disease|0|||
33556219|NCT02533674|101935033|FG005|Dose Level VII|Progressive disease|0|||
33356806|NCT00847613|101195293|FG002|Overall Study|Other|2|||
33356807|NCT00847613|101195294|FG003|Overall Study|Other|0|||
33356808|NCT02112448|101195295|FG000|Overall Study|lab values precluding use of ketorolac|2|||
33356809|NCT02112448|101195296|FG001|Overall Study|lab values precluding use of ketorolac|2|||
33356810|NCT02112448|101195295|FG000|Overall Study|Protocol Violation|1|||
33556220|NCT02533674|101935034|FG006|Dose Level VII|Progressive disease|10|||
33556221|NCT02533674|101935035|FG007|Dose Level VII|Progressive disease|0|||
33556222|NCT02533674|101935028|FG000|Dose Level VII|Withdrawal by Subject|0|||
33556223|NCT02533674|101935029|FG001|Dose Level VII|Withdrawal by Subject|0|||
33218183|NCT03685591|100695976|FG005|Overall Study|Adverse Event|4|||
33356811|NCT02112448|101195296|FG001|Overall Study|Protocol Violation|2|||
33356812|NCT02112448|101195295|FG000|Overall Study|Physician Decision|4|||
33356813|NCT02112448|101195296|FG001|Overall Study|Physician Decision|6|||
33356814|NCT02112448|101195295|FG000|Overall Study|required heparin so could not use ketoro|1|||
33356815|NCT02112448|101195296|FG001|Overall Study|required heparin so could not use ketoro|0|||
33556224|NCT02533674|101935030|FG002|Dose Level VII|Withdrawal by Subject|0|||
33356816|NCT01982630|101195297|FG000|Overall Study|Adverse Event|2|||
33356817|NCT01982630|101195298|FG001|Overall Study|Adverse Event|0|||
33356818|NCT01982630|101195299|FG002|Overall Study|Adverse Event|1|||
33356819|NCT01982630|101195300|FG003|Overall Study|Adverse Event|0|||
33356820|NCT01982630|101195301|FG004|Overall Study|Adverse Event|1|||
33356821|NCT01982630|101195302|FG005|Overall Study|Adverse Event|2|||
33356822|NCT01982630|101195303|FG006|Overall Study|Adverse Event|1|||
33356823|NCT01982630|101195304|FG007|Overall Study|Adverse Event|0|||
33356824|NCT01982630|101195297|FG000|Overall Study|Physician Decision|1|||
33356825|NCT01982630|101195298|FG001|Overall Study|Physician Decision|0|||
33356826|NCT01982630|101195299|FG002|Overall Study|Physician Decision|2|||
33356827|NCT01982630|101195300|FG003|Overall Study|Physician Decision|1|||
33356828|NCT01982630|101195301|FG004|Overall Study|Physician Decision|2|||
33356829|NCT01982630|101195302|FG005|Overall Study|Physician Decision|0|||
33356830|NCT01982630|101195303|FG006|Overall Study|Physician Decision|0|||
33356831|NCT01982630|101195304|FG007|Overall Study|Physician Decision|0|||
33356832|NCT01982630|101195297|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
33356833|NCT01982630|101195298|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
33356834|NCT01982630|101195299|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
33356835|NCT01982630|101195300|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
33356836|NCT01982630|101195301|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
33356837|NCT01982630|101195302|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
33356838|NCT01982630|101195303|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
33356839|NCT01982630|101195304|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
33356840|NCT01982630|101195297|FG000|Overall Study|Withdrawal by Subject|0|||
33356841|NCT01982630|101195298|FG001|Overall Study|Withdrawal by Subject|0|||
33356842|NCT01982630|101195299|FG002|Overall Study|Withdrawal by Subject|0|||
33356843|NCT01982630|101195300|FG003|Overall Study|Withdrawal by Subject|0|||
33356844|NCT01982630|101195301|FG004|Overall Study|Withdrawal by Subject|0|||
33356845|NCT01982630|101195302|FG005|Overall Study|Withdrawal by Subject|1|||
33356846|NCT01982630|101195303|FG006|Overall Study|Withdrawal by Subject|0|||
33356847|NCT01982630|101195304|FG007|Overall Study|Withdrawal by Subject|0|||
33356848|NCT00491530|101195305|FG000|Overall Study|Adverse Event|6|||
33356849|NCT00491530|101195306|FG001|Overall Study|Adverse Event|1|||
33356850|NCT00491530|101195307|FG002|Overall Study|Adverse Event|2|||
33556225|NCT02533674|101935031|FG003|Dose Level VII|Withdrawal by Subject|0|||
33556226|NCT02533674|101935032|FG004|Dose Level VII|Withdrawal by Subject|0|||
33556227|NCT02533674|101935033|FG005|Dose Level VII|Withdrawal by Subject|0|||
33556228|NCT02533674|101935034|FG006|Dose Level VII|Withdrawal by Subject|3|||
33556229|NCT02533674|101935035|FG007|Dose Level VII|Withdrawal by Subject|0|||
33556230|NCT02533674|101935028|FG000|Dose Level VII|Treatment-related AE|0|||
33556231|NCT02533674|101935029|FG001|Dose Level VII|Treatment-related AE|0|||
33556232|NCT02533674|101935030|FG002|Dose Level VII|Treatment-related AE|0|||
33556233|NCT02533674|101935031|FG003|Dose Level VII|Treatment-related AE|0|||
33556234|NCT02533674|101935032|FG004|Dose Level VII|Treatment-related AE|0|||
33556235|NCT02533674|101935033|FG005|Dose Level VII|Treatment-related AE|0|||
33556236|NCT02533674|101935034|FG006|Dose Level VII|Treatment-related AE|1|||
33556237|NCT02533674|101935035|FG007|Dose Level VII|Treatment-related AE|0|||
33556238|NCT02533674|101935028|FG000|Dose Level VII|Death|0|||
33556239|NCT02533674|101935029|FG001|Dose Level VII|Death|0|||
33556240|NCT02533674|101935030|FG002|Dose Level VII|Death|0|||
33556241|NCT02533674|101935031|FG003|Dose Level VII|Death|0|||
33556242|NCT02533674|101935032|FG004|Dose Level VII|Death|0|||
33556243|NCT02533674|101935033|FG005|Dose Level VII|Death|0|||
33556244|NCT02533674|101935034|FG006|Dose Level VII|Death|2|||
33556245|NCT02533674|101935035|FG007|Dose Level VII|Death|0|||
33556246|NCT02533674|101935028|FG000|Dose Level VIII|Progressive disease|0|||
33556247|NCT02533674|101935029|FG001|Dose Level VIII|Progressive disease|0|||
33556248|NCT02533674|101935030|FG002|Dose Level VIII|Progressive disease|0|||
33556249|NCT02533674|101935031|FG003|Dose Level VIII|Progressive disease|0|||
33556250|NCT02533674|101935032|FG004|Dose Level VIII|Progressive disease|0|||
33556251|NCT02533674|101935033|FG005|Dose Level VIII|Progressive disease|0|||
33556252|NCT02533674|101935034|FG006|Dose Level VIII|Progressive disease|0|||
33556253|NCT02533674|101935035|FG007|Dose Level VIII|Progressive disease|3|||
33556254|NCT02533674|101935028|FG000|Dose Level VIII|Withdrawal by Subject|0|||
33556255|NCT02533674|101935029|FG001|Dose Level VIII|Withdrawal by Subject|0|||
33556256|NCT02533674|101935030|FG002|Dose Level VIII|Withdrawal by Subject|0|||
33556257|NCT02533674|101935031|FG003|Dose Level VIII|Withdrawal by Subject|0|||
33556258|NCT02533674|101935032|FG004|Dose Level VIII|Withdrawal by Subject|0|||
33556259|NCT02533674|101935033|FG005|Dose Level VIII|Withdrawal by Subject|0|||
33556260|NCT02533674|101935034|FG006|Dose Level VIII|Withdrawal by Subject|0|||
33218184|NCT03685591|100695977|FG006|Overall Study|Adverse Event|0|||
33356851|NCT00491530|101195305|FG000|Overall Study|Withdrawal by Subject|3|||
33356852|NCT00491530|101195306|FG001|Overall Study|Withdrawal by Subject|0|||
33356853|NCT00491530|101195307|FG002|Overall Study|Withdrawal by Subject|0|||
33556261|NCT02533674|101935035|FG007|Dose Level VIII|Withdrawal by Subject|1|||
33356854|NCT00491530|101195305|FG000|Overall Study|Lost to Follow-up|3|||
33356855|NCT00491530|101195306|FG001|Overall Study|Lost to Follow-up|2|||
33356856|NCT00491530|101195307|FG002|Overall Study|Lost to Follow-up|2|||
33356857|NCT00491530|101195305|FG000|Overall Study|Lack of Efficacy|0|||
33356858|NCT00491530|101195306|FG001|Overall Study|Lack of Efficacy|1|||
33356859|NCT00491530|101195307|FG002|Overall Study|Lack of Efficacy|0|||
33356860|NCT00491530|101195305|FG000|Overall Study|Investigator Discretion|0|||
33356861|NCT00491530|101195306|FG001|Overall Study|Investigator Discretion|1|||
33356862|NCT00491530|101195307|FG002|Overall Study|Investigator Discretion|0|||
33356863|NCT00491530|101195305|FG000|Overall Study|Patient Request|0|||
33356864|NCT00491530|101195306|FG001|Overall Study|Patient Request|1|||
33356865|NCT00491530|101195307|FG002|Overall Study|Patient Request|0|||
33356866|NCT00491530|101195305|FG000|Overall Study|Use of Prohibited Medication|0|||
33356867|NCT00491530|101195306|FG001|Overall Study|Use of Prohibited Medication|0|||
33356868|NCT00491530|101195307|FG002|Overall Study|Use of Prohibited Medication|1|||
33356869|NCT01896232|101195311|FG000|Overall Study|Death|6|||
33356870|NCT01896232|101195312|FG001|Overall Study|Death|10|||
33356871|NCT01896232|101195311|FG000|Overall Study|Withdrawal by Subject|32|||
33356872|NCT01896232|101195312|FG001|Overall Study|Withdrawal by Subject|31|||
33356873|NCT01896232|101195311|FG000|Overall Study|Sponsor Decision|2|||
33356874|NCT01896232|101195312|FG001|Overall Study|Sponsor Decision|0|||
33356875|NCT01896232|101195311|FG000|Overall Study|Lost to Follow-up|9|||
33356876|NCT01896232|101195312|FG001|Overall Study|Lost to Follow-up|12|||
33356877|NCT02986373|101195313|FG000|Overall Study|Adverse Event|4|||
33356878|NCT02986373|101195313|FG000|Overall Study|Lost to Follow-up|1|||
33356879|NCT02986373|101195313|FG000|Overall Study|Withdrawal by Subject|10|||
33356880|NCT02986373|101195313|FG000|Overall Study|Other|24|||
33356881|NCT01844076|101195314|FG000|Overall Study|Adverse Event|1|||
33356882|NCT01844076|101195315|FG001|Overall Study|Adverse Event|0|||
33356883|NCT01844076|101195316|FG002|Overall Study|Adverse Event|0|||
33356884|NCT01844076|101195317|FG003|Overall Study|Adverse Event|0|||
33356885|NCT01844076|101195314|FG000|Overall Study|Withdrawal by Subject|1|||
33356886|NCT01844076|101195315|FG001|Overall Study|Withdrawal by Subject|0|||
33356887|NCT01844076|101195316|FG002|Overall Study|Withdrawal by Subject|0|||
33356888|NCT01844076|101195317|FG003|Overall Study|Withdrawal by Subject|0|||
33356889|NCT00586690|101195319|FG000|Overall Study|Death|2|||
33356890|NCT00586690|101195320|FG001|Overall Study|Death|0|||
33356891|NCT00586690|101195319|FG000|Overall Study|Disease Progression|10|||
33356892|NCT00586690|101195320|FG001|Overall Study|Disease Progression|0|||
33356893|NCT00586690|101195319|FG000|Overall Study|Adverse Event|1|||
33356894|NCT00586690|101195320|FG001|Overall Study|Adverse Event|0|||
33356895|NCT00586690|101195319|FG000|Overall Study|Lack of Efficacy|2|||
33556262|NCT02533674|101935028|FG000|Dose Level VIII|Treatment-related AE|0|||
33556263|NCT02533674|101935029|FG001|Dose Level VIII|Treatment-related AE|0|||
33556264|NCT02533674|101935030|FG002|Dose Level VIII|Treatment-related AE|0|||
33556265|NCT02533674|101935031|FG003|Dose Level VIII|Treatment-related AE|0|||
33556266|NCT02533674|101935032|FG004|Dose Level VIII|Treatment-related AE|0|||
33556267|NCT02533674|101935033|FG005|Dose Level VIII|Treatment-related AE|0|||
33556268|NCT02533674|101935034|FG006|Dose Level VIII|Treatment-related AE|0|||
33556269|NCT02533674|101935035|FG007|Dose Level VIII|Treatment-related AE|1|||
33556270|NCT02533674|101935028|FG000|Dose Level VIII|Never treated|0|||
33556271|NCT02533674|101935029|FG001|Dose Level VIII|Never treated|0|||
33556272|NCT02533674|101935030|FG002|Dose Level VIII|Never treated|0|||
33556273|NCT02533674|101935031|FG003|Dose Level VIII|Never treated|0|||
33621676|NCT00684996|102165813|FG000|Overall Study|Progression/relapse|2|||
33621677|NCT00684996|102165813|FG000|Overall Study|Other reasons not protocol specified|1|||
33621678|NCT04528641|102165819|FG000|Overall Study|Withdrawal by Subject|0|||
33621679|NCT04528641|102165820|FG001|Overall Study|Withdrawal by Subject|0|||
33621680|NCT04528641|102165821|FG002|Overall Study|Withdrawal by Subject|0|||
33621681|NCT04528641|102165822|FG003|Overall Study|Withdrawal by Subject|1|||
33621682|NCT04528641|102165823|FG004|Overall Study|Withdrawal by Subject|0|||
33621683|NCT04528641|102165824|FG005|Overall Study|Withdrawal by Subject|1|||
33621684|NCT00580723|102165825|FG000|Overall Study|Did not want to participate in extension|3|||
33621685|NCT00580723|102165825|FG000|Overall Study|Lost to Follow-up|5|||
33356896|NCT00586690|101195320|FG001|Overall Study|Lack of Efficacy|0|||
33356897|NCT00586690|101195319|FG000|Overall Study|Lab can't accommodate|1|||
33356898|NCT00586690|101195320|FG001|Overall Study|Lab can't accommodate|0|||
33356899|NCT02032524|101195321|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
33356900|NCT02032524|101195322|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
33356901|NCT02032524|101195323|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
33218185|NCT03685591|100695978|FG007|Overall Study|Adverse Event|1|||
33356902|NCT02032524|101195324|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
33356903|NCT02032524|101195325|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
33356904|NCT02032524|101195326|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
33556274|NCT02533674|101935032|FG004|Dose Level VIII|Never treated|0|||
33356905|NCT02032524|101195321|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
33414337|NCT03345485|101406623|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
33621686|NCT01156714|102165826|FG000|Overall Study|Withdrawal by Subject|9|||
33356906|NCT02032524|101195322|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
33356907|NCT02032524|101195323|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
33356908|NCT02032524|101195324|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
33356909|NCT02032524|101195325|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
33356910|NCT02032524|101195326|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
33356911|NCT02032524|101195321|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
33356912|NCT02032524|101195322|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
33356913|NCT02032524|101195323|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
33356914|NCT02032524|101195324|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
33356915|NCT02032524|101195325|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
33356916|NCT02032524|101195326|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
33356917|NCT02032524|101195321|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
33556275|NCT02533674|101935033|FG005|Dose Level VIII|Never treated|0|||
33556276|NCT02533674|101935034|FG006|Dose Level VIII|Never treated|0|||
33556277|NCT02533674|101935035|FG007|Dose Level VIII|Never treated|1|||
33556278|NCT00421733|101935042|FG000|Overall Study|Adverse Event|4|||
33556279|NCT00421733|101935043|FG001|Overall Study|Adverse Event|9|||
33556280|NCT00421733|101935044|FG002|Overall Study|Adverse Event|2|||
33556281|NCT00421733|101935042|FG000|Overall Study|Lost to Follow-up|1|||
33556282|NCT00421733|101935043|FG001|Overall Study|Lost to Follow-up|2|||
33556283|NCT00421733|101935044|FG002|Overall Study|Lost to Follow-up|4|||
33556284|NCT00421733|101935042|FG000|Overall Study|Withdrawal by Subject|1|||
33556285|NCT00421733|101935043|FG001|Overall Study|Withdrawal by Subject|2|||
33556286|NCT00421733|101935044|FG002|Overall Study|Withdrawal by Subject|7|||
33556287|NCT00421733|101935042|FG000|Overall Study|Death|0|||
33556288|NCT00421733|101935043|FG001|Overall Study|Death|3|||
33556289|NCT00421733|101935044|FG002|Overall Study|Death|0|||
33556290|NCT00421733|101935042|FG000|Overall Study|Required dialysis|1|||
33556291|NCT00421733|101935043|FG001|Overall Study|Required dialysis|0|||
33556292|NCT00421733|101935044|FG002|Overall Study|Required dialysis|0|||
33556293|NCT00421733|101935042|FG000|Overall Study|Administrative|2|||
33556294|NCT00421733|101935043|FG001|Overall Study|Administrative|0|||
33556295|NCT00421733|101935044|FG002|Overall Study|Administrative|0|||
33556296|NCT00421733|101935042|FG000|Overall Study|Did not satisfy entry criteria|1|||
33556297|NCT00421733|101935043|FG001|Overall Study|Did not satisfy entry criteria|3|||
33556298|NCT00421733|101935044|FG002|Overall Study|Did not satisfy entry criteria|2|||
33556299|NCT00421733|101935042|FG000|Overall Study|Sponsor request|1|||
33556300|NCT00421733|101935043|FG001|Overall Study|Sponsor request|0|||
33556301|NCT00421733|101935044|FG002|Overall Study|Sponsor request|3|||
33621687|NCT01156714|102165827|FG001|Overall Study|Withdrawal by Subject|4|||
33621688|NCT01156714|102165828|FG002|Overall Study|Withdrawal by Subject|3|||
33621689|NCT01787461|102165829|FG000|Overall Study|Adverse Event|4|||
33621690|NCT01787461|102165830|FG001|Overall Study|Adverse Event|3|||
33621691|NCT01787461|102165829|FG000|Overall Study|Lost to Follow-up|3|||
33621692|NCT01787461|102165830|FG001|Overall Study|Lost to Follow-up|2|||
33621693|NCT01787461|102165829|FG000|Overall Study|No longer met eligibility criteria|1|||
33621694|NCT01787461|102165830|FG001|Overall Study|No longer met eligibility criteria|0|||
33621695|NCT01787461|102165829|FG000|Overall Study|Withdrawal by Subject|3|||
33621696|NCT01787461|102165830|FG001|Overall Study|Withdrawal by Subject|4|||
33621697|NCT01787461|102165829|FG000|Overall Study|Protocol Violation|3|||
33621698|NCT01787461|102165830|FG001|Overall Study|Protocol Violation|0|||
33621699|NCT02354235|102165831|FG000|Overall Study|Adverse Event|2|||
33621700|NCT02354235|102165832|FG001|Overall Study|Adverse Event|2|||
33621701|NCT02354235|102165831|FG000|Overall Study|Physician Decision|0|||
33621702|NCT02354235|102165832|FG001|Overall Study|Physician Decision|1|||
33621703|NCT02354235|102165831|FG000|Overall Study|Withdrawal by Subject|1|||
33621704|NCT02354235|102165832|FG001|Overall Study|Withdrawal by Subject|3|||
33621705|NCT02354235|102165831|FG000|Overall Study|Conflict with the stopping criteria|0|||
33621706|NCT02354235|102165832|FG001|Overall Study|Conflict with the stopping criteria|1|||
33621707|NCT01011673|102165833|FG000|Randomized|Secondary headache|2|||
33621708|NCT01011673|102165834|FG001|Randomized|Secondary headache|1|||
33621709|NCT01011673|102165833|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
33621710|NCT01011673|102165834|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
33621711|NCT04073186|102165837|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
33621712|NCT04073186|102165837|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
33621713|NCT04073186|102165837|FG000|First Wearing Cycle|Protocol Violation|1|||
33621714|NCT04073186|102165837|FG000|First Wearing Cycle|Lens Discomfort|2|||
33621715|NCT04073186|102165837|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
33621716|NCT04073186|102165837|FG000|Second Wearing Cycle|Adverse Event|1|||
33621717|NCT02611479|102165838|FG000|Baseline Enrollment|Exited study|13|||
33621718|NCT02611479|102165838|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
33621719|NCT02611479|102165838|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
33556302|NCT00421733|101935042|FG000|Overall Study|Protocol deviation|4|||
33556303|NCT00421733|101935043|FG001|Overall Study|Protocol deviation|7|||
33621720|NCT02611479|102165838|FG000|Data Cleaning|No baseline function or pain metrics|2|||
33556304|NCT00421733|101935044|FG002|Overall Study|Protocol deviation|2|||
33218186|NCT03685591|100695979|FG008|Overall Study|Adverse Event|1|||
33218187|NCT02365519|100695983|FG000|Randomized and Treated|Adverse Event|0|||
33414338|NCT03345485|101406624|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
33356918|NCT02032524|101195322|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
33356919|NCT02032524|101195323|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
33356920|NCT02032524|101195324|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
33356921|NCT02032524|101195325|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
33356922|NCT02032524|101195326|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
33356923|NCT02032524|101195321|FG000|Period 2: LTS13769 Study|Other|0|||
33356924|NCT02032524|101195322|FG001|Period 2: LTS13769 Study|Other|0|||
33356925|NCT02032524|101195323|FG002|Period 2: LTS13769 Study|Other|0|||
33356926|NCT02032524|101195324|FG003|Period 2: LTS13769 Study|Other|0|||
33356927|NCT02032524|101195325|FG004|Period 2: LTS13769 Study|Other|0|||
33356928|NCT02032524|101195326|FG005|Period 2: LTS13769 Study|Other|1|||
33356929|NCT01173653|101195327|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
33356930|NCT01173653|101195328|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
33356931|NCT00509106|101195329|FG000|Overall Study|Adverse Event|3|||
33556305|NCT04091438|101935045|FG000|Treatment Period 1 (1 Day)|Other|1|||
33556306|NCT04091438|101935046|FG001|Treatment Period 1 (1 Day)|Other|0|||
33556307|NCT04091438|101935045|FG000|Washout Period (1 Day)|Protocol deviation|0|||
33556308|NCT04091438|101935046|FG001|Washout Period (1 Day)|Protocol deviation|1|||
33556309|NCT04091438|101935045|FG000|Washout Period (1 Day)|Other|0|||
33556310|NCT04091438|101935046|FG001|Washout Period (1 Day)|Other|1|||
33556311|NCT05156125|101935048|FG000|Overall Study|Lack of Efficacy|1|||
33356932|NCT00509106|101195330|FG001|Overall Study|Adverse Event|2|||
33356933|NCT00509106|101195329|FG000|Overall Study|Noncompliance|0|||
33356934|NCT00509106|101195330|FG001|Overall Study|Noncompliance|1|||
33556312|NCT05156125|101935049|FG001|Overall Study|Lack of Efficacy|1|||
33556313|NCT05156125|101935050|FG002|Overall Study|Lack of Efficacy|1|||
33556314|NCT05156125|101935048|FG000|Overall Study|Physician Decision|0|||
33556315|NCT05156125|101935049|FG001|Overall Study|Physician Decision|0|||
33556316|NCT05156125|101935050|FG002|Overall Study|Physician Decision|1|||
33556317|NCT05156125|101935048|FG000|Overall Study|Non-compliance|0|||
33556318|NCT05156125|101935049|FG001|Overall Study|Non-compliance|1|||
33556319|NCT05156125|101935050|FG002|Overall Study|Non-compliance|1|||
33621721|NCT01101035|102165844|FG000|Overall Study|Adverse Event|191|||
33621722|NCT01101035|102165845|FG001|Overall Study|Adverse Event|172|||
33621723|NCT01101035|102165844|FG000|Overall Study|Major Protocol Deviation|52|||
33621724|NCT01101035|102165845|FG001|Overall Study|Major Protocol Deviation|46|||
33356935|NCT00509106|101195329|FG000|Overall Study|At the request of sponsor/investigator|1|||
33356936|NCT00509106|101195330|FG001|Overall Study|At the request of sponsor/investigator|2|||
33356937|NCT00509106|101195329|FG000|Overall Study|Withdrew consent|4|||
33356938|NCT00509106|101195330|FG001|Overall Study|Withdrew consent|8|||
33356939|NCT00509106|101195329|FG000|Overall Study|Lost to Follow-up|16|||
33356940|NCT00509106|101195330|FG001|Overall Study|Lost to Follow-up|10|||
33356941|NCT00509106|101195329|FG000|Overall Study|Other|1|||
33356942|NCT00509106|101195330|FG001|Overall Study|Other|0|||
33356943|NCT00509106|101195329|FG000|Overall Study|Death|6|||
33356944|NCT00509106|101195330|FG001|Overall Study|Death|6|||
33356945|NCT00659438|101195331|FG000|Overall Study|Withdrawal by Subject|2|||
33356946|NCT00659438|101195332|FG001|Overall Study|Withdrawal by Subject|2|||
33556320|NCT05156125|101935048|FG000|Overall Study|Withdrawal by Subject|0|||
33556321|NCT05156125|101935049|FG001|Overall Study|Withdrawal by Subject|0|||
33556322|NCT05156125|101935050|FG002|Overall Study|Withdrawal by Subject|1|||
33621725|NCT01101035|102165844|FG000|Overall Study|Lost to Follow-up|226|||
33621726|NCT01101035|102165845|FG001|Overall Study|Lost to Follow-up|223|||
33621727|NCT01101035|102165844|FG000|Overall Study|Voluntary Withdrawal|595|||
33621728|NCT01101035|102165845|FG001|Overall Study|Voluntary Withdrawal|587|||
33621729|NCT01101035|102165844|FG000|Overall Study|Reason not Specified|333|||
33621730|NCT01101035|102165845|FG001|Overall Study|Reason not Specified|363|||
33621731|NCT00988884|102165846|FG000|Overall Study|Adverse Event|0|||
33621732|NCT00988884|102165847|FG001|Overall Study|Adverse Event|1|||
33621733|NCT00988884|102165846|FG000|Overall Study|Lost to Follow-up|20|||
33621734|NCT00988884|102165847|FG001|Overall Study|Lost to Follow-up|16|||
33621735|NCT00988884|102165846|FG000|Overall Study|Protocol Violation|0|||
33621736|NCT00988884|102165847|FG001|Overall Study|Protocol Violation|1|||
33621737|NCT00988884|102165846|FG000|Overall Study|Withdrawal by Subject|15|||
33621738|NCT00988884|102165847|FG001|Overall Study|Withdrawal by Subject|18|||
33621739|NCT04862065|102165850|FG000|Screening|Protocol Violation|54|||
33621740|NCT04862065|102165851|FG001|Screening|Protocol Violation|0|||
33621741|NCT04862065|102165852|FG002|Screening|Protocol Violation|0|||
33621742|NCT04862065|102165850|FG000|Screening|Insufficient Sample|1|||
33621743|NCT04862065|102165851|FG001|Screening|Insufficient Sample|0|||
33356947|NCT00659438|101195331|FG000|Overall Study|Death|11|||
33356948|NCT00659438|101195332|FG001|Overall Study|Death|6|||
33556323|NCT05156125|101935048|FG000|Overall Study|Adverse Event|2|||
33556324|NCT05156125|101935049|FG001|Overall Study|Adverse Event|1|||
33556325|NCT05156125|101935050|FG002|Overall Study|Adverse Event|0|||
33621744|NCT04862065|102165852|FG002|Screening|Insufficient Sample|0|||
33621745|NCT04862065|102165850|FG000|Follow-Up|Lost to Follow-up|3|||
33356949|NCT00659438|101195331|FG000|Overall Study|Lost to Follow-up|1|||
33356950|NCT00659438|101195332|FG001|Overall Study|Lost to Follow-up|0|||
33356951|NCT00374556|101195334|FG000|Overall Study|Lost to Follow-up|1|||
33356952|NCT00374556|101195335|FG001|Overall Study|Lost to Follow-up|0|||
33356953|NCT00374556|101195334|FG000|Overall Study|Removed at baseline due to medical cond|0|||
33356954|NCT00374556|101195335|FG001|Overall Study|Removed at baseline due to medical cond|1|||
33356955|NCT02500550|101195343|FG000|Overall Study|Death|7|||
33356956|NCT02397655|101195350|FG000|Overall Study|data not completed|1301|||
33356957|NCT04375878|101195351|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
33356958|NCT04375878|101195352|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
33356959|NCT04375878|101195353|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
33356960|NCT04375878|101195354|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
33356961|NCT04375878|101195355|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
33356962|NCT04375878|101195356|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
33356963|NCT04375878|101195351|FG000|Crossover First and Second Interventions|Adverse Event|0|||
33356964|NCT04375878|101195352|FG001|Crossover First and Second Interventions|Adverse Event|0|||
33356965|NCT04375878|101195353|FG002|Crossover First and Second Interventions|Adverse Event|1|||
33356966|NCT04375878|101195354|FG003|Crossover First and Second Interventions|Adverse Event|0|||
33356967|NCT04375878|101195355|FG004|Crossover First and Second Interventions|Adverse Event|0|||
33356968|NCT04375878|101195356|FG005|Crossover First and Second Interventions|Adverse Event|0|||
33356969|NCT04375878|101195351|FG000|Extension Phase|Withdrawal by Subject|0|||
33356970|NCT04375878|101195352|FG001|Extension Phase|Withdrawal by Subject|0|||
33356971|NCT04375878|101195353|FG002|Extension Phase|Withdrawal by Subject|0|||
33356972|NCT04375878|101195354|FG003|Extension Phase|Withdrawal by Subject|0|||
33356973|NCT04375878|101195355|FG004|Extension Phase|Withdrawal by Subject|1|||
33356974|NCT04375878|101195356|FG005|Extension Phase|Withdrawal by Subject|0|||
33356975|NCT01242111|101195361|FG000|Overall Study|Adverse Event|1|||
33356976|NCT01242111|101195361|FG000|Overall Study|Withdrawal by Subject|1|||
33356977|NCT01242111|101195361|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
33356978|NCT00195351|101195362|FG000|Overall Study|Lost to Follow-up|9|||
33356979|NCT00195351|101195363|FG001|Overall Study|Lost to Follow-up|9|||
33356980|NCT00195351|101195362|FG000|Overall Study|Withdrawal by Subject|6|||
33556326|NCT03438656|101935051|FG000|Overall Study|Lost to Follow-up|2|||
33556327|NCT00401830|101935052|FG000|Overall Study|Adverse Event|10|||
33556328|NCT00401830|101935053|FG001|Overall Study|Adverse Event|18|||
33556329|NCT00401830|101935052|FG000|Overall Study|Lack of Efficacy|11|||
33556330|NCT00401830|101935053|FG001|Overall Study|Lack of Efficacy|5|||
33556331|NCT00401830|101935052|FG000|Overall Study|Withdrawal by Subject|4|||
33556332|NCT00401830|101935053|FG001|Overall Study|Withdrawal by Subject|3|||
33556333|NCT00401830|101935052|FG000|Overall Study|Protocol Violation|3|||
33556334|NCT00401830|101935053|FG001|Overall Study|Protocol Violation|3|||
33556335|NCT00401830|101935052|FG000|Overall Study|Non-compliance with drug study|1|||
33556336|NCT00401830|101935053|FG001|Overall Study|Non-compliance with drug study|0|||
33556337|NCT00401830|101935052|FG000|Overall Study|Lost to Follow-up|1|||
33556338|NCT00401830|101935053|FG001|Overall Study|Lost to Follow-up|3|||
33556339|NCT00401830|101935052|FG000|Overall Study|Other: Personal / Family problems|1|||
33556340|NCT00401830|101935053|FG001|Overall Study|Other: Personal / Family problems|0|||
33556341|NCT01034657|101935054|FG000|Core Phase|Withdrawal by Subject|1|||
33556342|NCT01034657|101935055|FG001|Core Phase|Withdrawal by Subject|0|||
33556343|NCT01034657|101935056|FG002|Core Phase|Withdrawal by Subject|0|||
33218188|NCT02365519|100695984|FG001|Randomized and Treated|Adverse Event|1|||
33356981|NCT00195351|101195363|FG001|Overall Study|Withdrawal by Subject|3|||
33356982|NCT00195351|101195362|FG000|Overall Study|Protocol Deviation|3|||
33356983|NCT00195351|101195363|FG001|Overall Study|Protocol Deviation|2|||
33556344|NCT01034657|101935054|FG000|Core Phase|Lack of Efficacy|2|||
33356984|NCT00195351|101195362|FG000|Overall Study|Death|3|||
33556345|NCT01034657|101935055|FG001|Core Phase|Lack of Efficacy|0|||
33556346|NCT01034657|101935056|FG002|Core Phase|Lack of Efficacy|0|||
33556347|NCT01034657|101935054|FG000|Core Phase|Abnormal laboratory value|1|||
33556348|NCT01034657|101935055|FG001|Core Phase|Abnormal laboratory value|0|||
33218189|NCT02365519|100695985|FG002|Randomized and Treated|Adverse Event|0|||
33356985|NCT00195351|101195363|FG001|Overall Study|Death|1|||
33356986|NCT00195351|101195362|FG000|Overall Study|Lack of Efficacy|0|||
33356987|NCT00195351|101195363|FG001|Overall Study|Lack of Efficacy|1|||
33356988|NCT03368859|101195364|FG000|Overall Study|Withdrew Consent|5|||
33356989|NCT03368859|101195365|FG001|Overall Study|Withdrew Consent|4|||
33356990|NCT03368859|101195364|FG000|Overall Study|Death|12|||
33356991|NCT03368859|101195365|FG001|Overall Study|Death|6|||
33356992|NCT03368859|101195364|FG000|Overall Study|Study terminated by Sponsor|18|||
33356993|NCT03368859|101195365|FG001|Overall Study|Study terminated by Sponsor|23|||
33356994|NCT03368859|101195364|FG000|Overall Study|Other|1|||
33356995|NCT03368859|101195365|FG001|Overall Study|Other|1|||
33356996|NCT01123889|101195366|FG000|Overall Study|Lost to Follow-up|3|||
33356997|NCT01123889|101195367|FG001|Overall Study|Lost to Follow-up|1|||
33356998|NCT03853694|101195368|FG000|Overall Study|Protocol Violation|3|||
33356999|NCT03853694|101195369|FG001|Overall Study|Protocol Violation|5|||
33357000|NCT03853694|101195370|FG002|Overall Study|Protocol Violation|3|||
33357001|NCT03853694|101195368|FG000|Overall Study|Delivered early|0|||
33357002|NCT03853694|101195369|FG001|Overall Study|Delivered early|1|||
33556349|NCT01034657|101935056|FG002|Core Phase|Abnormal laboratory value|0|||
33556350|NCT01034657|101935054|FG000|Core Phase|Adverse Event|8|||
33556351|NCT01034657|101935055|FG001|Core Phase|Adverse Event|0|||
33556352|NCT01034657|101935056|FG002|Core Phase|Adverse Event|0|||
33556353|NCT01034657|101935054|FG000|Core Phase|Protocol Violation|2|||
33556354|NCT01034657|101935055|FG001|Core Phase|Protocol Violation|0|||
33556355|NCT01034657|101935056|FG002|Core Phase|Protocol Violation|0|||
33556356|NCT01034657|101935054|FG000|Randomized Phase|Withdrawal by Subject|0|||
33556357|NCT01034657|101935055|FG001|Randomized Phase|Withdrawal by Subject|2|||
33556358|NCT01034657|101935056|FG002|Randomized Phase|Withdrawal by Subject|0|||
33556359|NCT01034657|101935054|FG000|Randomized Phase|Lack of Efficacy|5|||
33556360|NCT01034657|101935055|FG001|Randomized Phase|Lack of Efficacy|1|||
33556361|NCT01034657|101935056|FG002|Randomized Phase|Lack of Efficacy|0|||
33556362|NCT01034657|101935054|FG000|Randomized Phase|Abnormal laboratory value|0|||
33556363|NCT01034657|101935055|FG001|Randomized Phase|Abnormal laboratory value|1|||
33556364|NCT01034657|101935056|FG002|Randomized Phase|Abnormal laboratory value|0|||
33556365|NCT01034657|101935054|FG000|Randomized Phase|Adverse Event|0|||
33556366|NCT01034657|101935055|FG001|Randomized Phase|Adverse Event|2|||
33556367|NCT01034657|101935056|FG002|Randomized Phase|Adverse Event|1|||
33556368|NCT03225989|101935057|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
33556369|NCT03225989|101935058|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
33556370|NCT03225989|101935059|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
33556371|NCT03225989|101935057|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
33556372|NCT03225989|101935058|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
33556373|NCT03225989|101935059|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
33556374|NCT03225989|101935057|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
33556375|NCT03225989|101935058|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
33556376|NCT03225989|101935059|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
33556377|NCT03225989|101935057|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
33621746|NCT04862065|102165851|FG001|Follow-Up|Lost to Follow-up|0|||
33621747|NCT04862065|102165852|FG002|Follow-Up|Lost to Follow-up|0|||
33357003|NCT03853694|101195370|FG002|Overall Study|Delivered early|0|||
33556378|NCT03225989|101935058|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
33556379|NCT03225989|101935059|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
33556380|NCT03225989|101935057|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
33556381|NCT03225989|101935058|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
33556382|NCT03225989|101935059|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
33621748|NCT02518971|102165853|FG000|Overall Study|Lost to Follow-up|0|||
33621749|NCT02518971|102165854|FG001|Overall Study|Lost to Follow-up|1|||
33621750|NCT02518971|102165853|FG000|Overall Study|Physician Decision|6|||
33621751|NCT02518971|102165854|FG001|Overall Study|Physician Decision|6|||
33621752|NCT02518971|102165853|FG000|Overall Study|Protocol Violation|6|||
33357004|NCT03853694|101195368|FG000|Overall Study|not suitable to proceed|0|||
33357005|NCT03853694|101195369|FG001|Overall Study|not suitable to proceed|1|||
33357006|NCT03853694|101195370|FG002|Overall Study|not suitable to proceed|0|||
33357007|NCT03853694|101195368|FG000|Overall Study|difficult surgery|0|||
33357008|NCT03853694|101195369|FG001|Overall Study|difficult surgery|0|||
33556383|NCT03225989|101935057|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
33621753|NCT02518971|102165854|FG001|Overall Study|Protocol Violation|4|||
33357009|NCT03853694|101195370|FG002|Overall Study|difficult surgery|1|||
33556384|NCT03225989|101935058|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
33357010|NCT03853694|101195368|FG000|Overall Study|Lost to Follow-up|0|||
33357011|NCT03853694|101195369|FG001|Overall Study|Lost to Follow-up|1|||
33357012|NCT03853694|101195370|FG002|Overall Study|Lost to Follow-up|0|||
33357013|NCT03853694|101195368|FG000|Overall Study|Withdrawal by Subject|0|||
33357014|NCT03853694|101195369|FG001|Overall Study|Withdrawal by Subject|1|||
33357015|NCT03853694|101195370|FG002|Overall Study|Withdrawal by Subject|0|||
33357016|NCT05480514|101195371|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
33556385|NCT03225989|101935059|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
33556386|NCT03225989|101935057|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
33556387|NCT03225989|101935058|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
33556388|NCT03225989|101935059|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
33357017|NCT05480514|101195372|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
33414339|NCT03345485|101406625|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
33556389|NCT03225989|101935057|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
33556390|NCT03225989|101935058|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
33556391|NCT03225989|101935059|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
33556392|NCT03225989|101935057|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
33556393|NCT03225989|101935058|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
33556394|NCT03225989|101935059|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
33556395|NCT03225989|101935057|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
33556396|NCT03225989|101935058|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
33556397|NCT03225989|101935059|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
33556398|NCT03225989|101935057|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
33556399|NCT03225989|101935058|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
33556400|NCT03225989|101935059|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
33556401|NCT03225989|101935057|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
33556402|NCT03225989|101935058|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
33556403|NCT03225989|101935059|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
33556404|NCT05569954|101935060|FG000|Overall Study|Lost to Follow-up|3|||
33556405|NCT05569954|101935061|FG001|Overall Study|Lost to Follow-up|4|||
33556406|NCT05569954|101935060|FG000|Overall Study|Protocol Violation|1|||
33556407|NCT05569954|101935061|FG001|Overall Study|Protocol Violation|2|||
33556408|NCT05569954|101935060|FG000|Overall Study|Withdrawal by Subject|4|||
33556409|NCT05569954|101935061|FG001|Overall Study|Withdrawal by Subject|2|||
33556410|NCT00231465|101935062|FG000|Overall Study|Completed only one cycle|1|||
33556411|NCT00231465|101935062|FG000|Overall Study|Did not have follow up CT scans|1|||
33556412|NCT01399099|101935063|FG000|Overall Study|Lost to Follow-up|14|||
33556413|NCT01399099|101935063|FG000|Overall Study|Physician Decision|1|||
33556414|NCT01399099|101935063|FG000|Overall Study|Protocol Violation|1|||
33556415|NCT01399099|101935063|FG000|Overall Study|Skin Irritation|13|||
33556416|NCT01399099|101935063|FG000|Overall Study|Infection|1|||
33621754|NCT02518971|102165853|FG000|Overall Study|Withdrawal by Subject|4|||
33621755|NCT02518971|102165854|FG001|Overall Study|Withdrawal by Subject|5|||
33621756|NCT02518971|102165853|FG000|Overall Study|Side effects|1|||
33621757|NCT02518971|102165854|FG001|Overall Study|Side effects|0|||
33357018|NCT05480514|101195371|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
33357019|NCT05480514|101195372|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
33357020|NCT05480514|101195371|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
33357021|NCT05480514|101195372|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
33357022|NCT05480514|101195371|FG000|Period 1|Covid-19 Related|1|||
33357023|NCT05480514|101195372|FG001|Period 1|Covid-19 Related|0|||
33414340|NCT03345485|101406626|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
33556417|NCT01399099|101935063|FG000|Overall Study|Miscellaneous|4|||
33556418|NCT03928704|101935064|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
33556419|NCT03928704|101935065|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
33556420|NCT03928704|101935066|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
33556421|NCT03928704|101935067|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
33556422|NCT03928704|101935068|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
33556423|NCT03928704|101935069|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
33556424|NCT03928704|101935064|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
33556425|NCT03928704|101935065|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
33556426|NCT03928704|101935066|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
33556427|NCT03928704|101935067|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
33556428|NCT03928704|101935068|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
33556429|NCT03928704|101935069|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
33556430|NCT03928704|101935064|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
33556431|NCT03928704|101935065|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
33556432|NCT03928704|101935066|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
33556433|NCT03928704|101935067|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
33556434|NCT03928704|101935068|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
33556435|NCT03928704|101935069|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
33556436|NCT03928704|101935064|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
33556437|NCT03928704|101935065|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
33556438|NCT03928704|101935066|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
33556439|NCT03928704|101935067|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
33556440|NCT03928704|101935068|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
33556441|NCT03928704|101935069|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
33556442|NCT03928704|101935064|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
33556443|NCT03928704|101935065|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
33556444|NCT03928704|101935066|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
33556445|NCT03928704|101935067|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
33556446|NCT03928704|101935068|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
33556447|NCT03928704|101935069|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
33556448|NCT03928704|101935064|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
33556449|NCT03928704|101935065|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
33556450|NCT03928704|101935066|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
33556451|NCT03928704|101935067|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
33556452|NCT03928704|101935068|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
33556453|NCT03928704|101935069|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
33556454|NCT03928704|101935064|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
33556455|NCT03928704|101935065|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
33556456|NCT03928704|101935066|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
33556457|NCT03928704|101935067|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
33556458|NCT03928704|101935068|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
33556459|NCT03928704|101935069|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
33556460|NCT03928704|101935064|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
33556461|NCT03928704|101935065|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
33556462|NCT03928704|101935066|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
33556463|NCT03928704|101935067|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
33556464|NCT03928704|101935068|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
33556465|NCT03928704|101935069|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
33357024|NCT05480514|101195371|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
33357025|NCT05480514|101195372|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
33414341|NCT03345485|101406627|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
33414342|NCT03345485|101406628|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
33218190|NCT02365519|100695983|FG000|Randomized and Treated|Withdrawal by Subject|0|||
33218191|NCT02365519|100695984|FG001|Randomized and Treated|Withdrawal by Subject|1|||
33218192|NCT02365519|100695985|FG002|Randomized and Treated|Withdrawal by Subject|1|||
33218193|NCT03248375|100695988|FG000|Overall Study|Lost to Follow-up|5|||
33556466|NCT03928704|101935064|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
33556467|NCT03928704|101935065|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
33556468|NCT03928704|101935066|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
33556469|NCT03928704|101935067|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
33556470|NCT03928704|101935068|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
33556471|NCT03928704|101935069|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
33556472|NCT03928704|101935064|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
33556473|NCT03928704|101935065|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
33556474|NCT03928704|101935066|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
33556475|NCT03928704|101935067|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
33218194|NCT04241094|100695989|FG000|Overall Study|Dropped out of treatment|4|||
33218195|NCT04241094|100695989|FG000|Overall Study|Ineligible after clinical assessment|2|||
33218196|NCT04241094|100695989|FG000|Overall Study|Lost to Follow-up|2|||
33218197|NCT01357616|100695996|FG000|Overall Study|Adverse Event|1|||
33218198|NCT01357616|100695997|FG001|Overall Study|Adverse Event|1|||
33218199|NCT01357616|100695996|FG000|Overall Study|Lost to Follow-up|4|||
33218200|NCT01357616|100695997|FG001|Overall Study|Lost to Follow-up|3|||
33218201|NCT01357616|100695996|FG000|Overall Study|Protocol Violation|0|||
33218202|NCT01357616|100695997|FG001|Overall Study|Protocol Violation|2|||
33218203|NCT01357616|100695996|FG000|Overall Study|Inadequate Control of IOP|1|||
33218204|NCT01357616|100695997|FG001|Overall Study|Inadequate Control of IOP|2|||
33218205|NCT01357616|100695996|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
33357026|NCT02835495|101195373|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
33357027|NCT02835495|101195374|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
33357028|NCT02835495|101195373|FG000|Overall Study|Declined in-person follow-up visit|4|||
33357029|NCT02835495|101195374|FG001|Overall Study|Declined in-person follow-up visit|2|||
33357030|NCT01739595|101195380|FG000|Overall Study|Adverse Event|3|||
33357031|NCT01739595|101195381|FG001|Overall Study|Adverse Event|0|||
33357032|NCT01739595|101195382|FG002|Overall Study|Adverse Event|0|||
33357033|NCT01739595|101195380|FG000|Overall Study|Lost to Follow-up|2|||
33357034|NCT01739595|101195381|FG001|Overall Study|Lost to Follow-up|0|||
33357035|NCT01739595|101195382|FG002|Overall Study|Lost to Follow-up|0|||
33357036|NCT01739595|101195380|FG000|Overall Study|Withdrawal by Subject|2|||
33357037|NCT01739595|101195381|FG001|Overall Study|Withdrawal by Subject|1|||
33357038|NCT01739595|101195382|FG002|Overall Study|Withdrawal by Subject|2|||
33357039|NCT01739595|101195380|FG000|Overall Study|Eligibility issue|3|||
33357040|NCT01739595|101195381|FG001|Overall Study|Eligibility issue|0|||
33357041|NCT01739595|101195382|FG002|Overall Study|Eligibility issue|0|||
33357042|NCT01739595|101195380|FG000|Overall Study|Protocol Violation|1|||
33357043|NCT01739595|101195381|FG001|Overall Study|Protocol Violation|0|||
33357044|NCT01739595|101195382|FG002|Overall Study|Protocol Violation|0|||
33357045|NCT01739595|101195380|FG000|Overall Study|Lab assessment|1|||
33357046|NCT01739595|101195381|FG001|Overall Study|Lab assessment|0|||
33357047|NCT01739595|101195382|FG002|Overall Study|Lab assessment|0|||
33218206|NCT01357616|100695997|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
33357048|NCT01739595|101195380|FG000|Overall Study|Drug discrepancy|1|||
33357049|NCT01739595|101195381|FG001|Overall Study|Drug discrepancy|0|||
33357050|NCT01739595|101195382|FG002|Overall Study|Drug discrepancy|0|||
33357051|NCT01071070|101195383|FG000|Overall Study|Adverse Event|0|||
33357052|NCT01071070|101195384|FG001|Overall Study|Adverse Event|3|||
33218207|NCT01357616|100695996|FG000|Overall Study|Withdrawal by Subject|1|||
33218208|NCT01357616|100695997|FG001|Overall Study|Withdrawal by Subject|0|||
33218209|NCT00611858|100695998|FG000|Overall Study|Adverse Event|2|||
33218210|NCT00611858|100695998|FG000|Overall Study|Withdrawal by Subject|2|||
33218211|NCT01445652|100695999|FG000|Overall Study|Not comfortable in lenses|5|||
33218212|NCT01445652|100696000|FG001|Overall Study|Not comfortable in lenses|0|||
33218213|NCT01445652|100695999|FG000|Overall Study|Failed to attend scheduled visit|2|||
33218214|NCT01445652|100696000|FG001|Overall Study|Failed to attend scheduled visit|3|||
33218215|NCT01445652|100695999|FG000|Overall Study|Failed teach session|2|||
33357053|NCT01071070|101195383|FG000|Overall Study|Withdrawal by Subject|1|||
33357054|NCT01071070|101195384|FG001|Overall Study|Withdrawal by Subject|0|||
33556476|NCT03928704|101935068|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
33556477|NCT03928704|101935069|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
33218216|NCT01445652|100696000|FG001|Overall Study|Failed teach session|0|||
33218217|NCT01445652|100695999|FG000|Overall Study|Adverse Event|1|||
33357055|NCT01071070|101195383|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
33357056|NCT01071070|101195384|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
33357057|NCT01071070|101195383|FG000|Overall Study|Hypercalcemia|1|||
33357058|NCT01071070|101195384|FG001|Overall Study|Hypercalcemia|0|||
33357059|NCT05847881|101195385|FG000|Overall Study|Principal Investigator Decision|8|||
33357060|NCT05847881|101195385|FG000|Overall Study|Withdrawal by Subject|2|||
33357061|NCT00391976|101195386|FG000|Overall Study|Adverse Event|0|||
33357062|NCT00391976|101195387|FG001|Overall Study|Adverse Event|0|||
33556478|NCT04146909|101935070|FG000|Overall Study|Withdrawal by Subject|3|||
33556479|NCT04146909|101935070|FG000|Overall Study|Did not qualify after consented|1|||
33218218|NCT01445652|100696000|FG001|Overall Study|Adverse Event|0|||
33218219|NCT02889133|100696003|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
33357063|NCT00391976|101195388|FG002|Overall Study|Adverse Event|1|||
33357064|NCT00391976|101195386|FG000|Overall Study|Withdrawal of consent|0|||
33357065|NCT00391976|101195387|FG001|Overall Study|Withdrawal of consent|1|||
33357066|NCT00391976|101195388|FG002|Overall Study|Withdrawal of consent|1|||
33357067|NCT00391976|101195386|FG000|Overall Study|Lost to Follow-up|1|||
33357068|NCT00391976|101195387|FG001|Overall Study|Lost to Follow-up|2|||
33357069|NCT00391976|101195388|FG002|Overall Study|Lost to Follow-up|0|||
33357070|NCT00391976|101195386|FG000|Overall Study|Inappropriate enrollment|1|||
33357071|NCT00391976|101195387|FG001|Overall Study|Inappropriate enrollment|1|||
33357072|NCT00391976|101195388|FG002|Overall Study|Inappropriate enrollment|0|||
33357073|NCT00391976|101195386|FG000|Overall Study|Protocol deviation/violation|4|||
33357074|NCT00391976|101195387|FG001|Overall Study|Protocol deviation/violation|2|||
33357075|NCT00391976|101195388|FG002|Overall Study|Protocol deviation/violation|1|||
33357076|NCT00391976|101195386|FG000|Overall Study|Recurrence/no eradication of infection|21|||
33357077|NCT00391976|101195387|FG001|Overall Study|Recurrence/no eradication of infection|19|||
33357078|NCT00391976|101195388|FG002|Overall Study|Recurrence/no eradication of infection|0|||
33357079|NCT00391976|101195386|FG000|Overall Study|Unable to classify|0|||
33357080|NCT00391976|101195387|FG001|Overall Study|Unable to classify|0|||
33357081|NCT00391976|101195388|FG002|Overall Study|Unable to classify|1|||
33357082|NCT00391976|101195386|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
33357083|NCT00391976|101195387|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
33357084|NCT00391976|101195388|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
33357085|NCT02224664|101195389|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
33357086|NCT02224664|101195390|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
33357087|NCT02224664|101195391|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
33357088|NCT02224664|101195392|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
33357089|NCT02224664|101195393|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
33357090|NCT02224664|101195389|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
33357091|NCT02224664|101195390|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
33357092|NCT02224664|101195391|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
33357093|NCT02224664|101195392|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
33357094|NCT02224664|101195393|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
33357095|NCT02224664|101195389|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
33357096|NCT02224664|101195390|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
33357097|NCT02224664|101195391|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
33357098|NCT02224664|101195392|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
33357099|NCT02224664|101195393|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
33357100|NCT03245814|101195401|FG000|Overall Study|Lost to Follow-up|5|||
33357101|NCT03245814|101195402|FG001|Overall Study|Lost to Follow-up|8|||
33357102|NCT03245814|101195401|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
33357103|NCT03245814|101195402|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
33357104|NCT00524303|101195405|FG000|Overall Study|Lost to Follow-up|6|||
33357105|NCT00524303|101195406|FG001|Overall Study|Lost to Follow-up|0|||
33357106|NCT00524303|101195407|FG002|Overall Study|Lost to Follow-up|3|||
33357107|NCT00524303|101195405|FG000|Overall Study|Protocol Violation|0|||
33357108|NCT00524303|101195406|FG001|Overall Study|Protocol Violation|1|||
33357109|NCT00524303|101195407|FG002|Overall Study|Protocol Violation|1|||
33357110|NCT00524303|101195405|FG000|Overall Study|Withdrawal by Subject|3|||
33357111|NCT00524303|101195406|FG001|Overall Study|Withdrawal by Subject|0|||
33357112|NCT00524303|101195407|FG002|Overall Study|Withdrawal by Subject|4|||
33357113|NCT00524303|101195405|FG000|Overall Study|Death|0|||
33357114|NCT00524303|101195406|FG001|Overall Study|Death|2|||
33357115|NCT00524303|101195407|FG002|Overall Study|Death|3|||
33357116|NCT00524303|101195405|FG000|Overall Study|Adverse Event|1|||
33414343|NCT03345485|101406629|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
33357117|NCT00524303|101195406|FG001|Overall Study|Adverse Event|2|||
33357118|NCT00524303|101195407|FG002|Overall Study|Adverse Event|3|||
33357119|NCT00524303|101195405|FG000|Overall Study|Did not Complete Study Dosing|1|||
33357120|NCT00524303|101195406|FG001|Overall Study|Did not Complete Study Dosing|0|||
33357121|NCT00524303|101195407|FG002|Overall Study|Did not Complete Study Dosing|0|||
33621758|NCT02518971|102165853|FG000|Overall Study|medication lost in mail|0|||
33621759|NCT02518971|102165854|FG001|Overall Study|medication lost in mail|1|||
33621760|NCT02518971|102165853|FG000|Overall Study|eligibility criteria no longer met|6|||
33621761|NCT02518971|102165854|FG001|Overall Study|eligibility criteria no longer met|3|||
33621762|NCT02756338|102165858|FG000|Overall Study|Withdrawn by Investigator|1|||
33621763|NCT02756338|102165858|FG000|Overall Study|Device Replaced with Pacemaker|4|||
33621764|NCT00086047|102165859|FG000|Overall Study|Lost to Follow-up|7|||
33621765|NCT00086047|102165860|FG001|Overall Study|Lost to Follow-up|6|||
33621766|NCT00086047|102165859|FG000|Overall Study|Physician Decision|0|||
33621767|NCT00086047|102165860|FG001|Overall Study|Physician Decision|1|||
33621768|NCT00836589|102165861|FG000|Overall Study|Lost to Follow-up|246|||
33621769|NCT00836589|102165861|FG000|Overall Study|Death|429|||
33621770|NCT00836589|102165861|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
33357122|NCT00524303|101195405|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
33357123|NCT00524303|101195406|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
33621771|NCT03920254|102165863|FG000|Overall Study|Adverse Event|1|||
33621772|NCT03920254|102165864|FG001|Overall Study|Adverse Event|0|||
33621773|NCT03920254|102165865|FG002|Overall Study|Adverse Event|0|||
33621774|NCT03920254|102165863|FG000|Overall Study|Physician Decision|0|||
33621775|NCT03920254|102165864|FG001|Overall Study|Physician Decision|1|||
33621776|NCT03920254|102165865|FG002|Overall Study|Physician Decision|2|||
33621777|NCT03920254|102165863|FG000|Overall Study|Study Terminated By Sponsor|12|||
33621778|NCT03920254|102165864|FG001|Overall Study|Study Terminated By Sponsor|17|||
33621779|NCT03920254|102165865|FG002|Overall Study|Study Terminated By Sponsor|12|||
33621780|NCT03920254|102165863|FG000|Overall Study|Withdrawal by Subject|0|||
33621781|NCT03920254|102165864|FG001|Overall Study|Withdrawal by Subject|0|||
33621782|NCT03920254|102165865|FG002|Overall Study|Withdrawal by Subject|1|||
33621783|NCT02420093|102165866|FG000|Overall Study|Withdrawal by Subject|1|||
33621784|NCT02420093|102165867|FG001|Overall Study|Withdrawal by Subject|1|||
33621785|NCT01721161|102165868|FG000|Overall Study|Adverse Event|2|||
33621786|NCT01721161|102165869|FG001|Overall Study|Adverse Event|3|||
33621787|NCT01721161|102165868|FG000|Overall Study|Lost to Follow-up|1|||
33621788|NCT01721161|102165869|FG001|Overall Study|Lost to Follow-up|2|||
33218220|NCT02889133|100696004|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
33621789|NCT01721161|102165868|FG000|Overall Study|Withdrawal by Subject|1|||
33621790|NCT01721161|102165869|FG001|Overall Study|Withdrawal by Subject|1|||
33621791|NCT01721161|102165868|FG000|Overall Study|Other|0|||
33621792|NCT01721161|102165869|FG001|Overall Study|Other|1|||
33621793|NCT00880698|102165873|FG000|Overall Study|Death|0|||
33621794|NCT00880698|102165874|FG001|Overall Study|Death|0|||
33621795|NCT00880698|102165875|FG002|Overall Study|Death|1|||
33621796|NCT00880698|102165876|FG003|Overall Study|Death|2|||
33621797|NCT00880698|102165873|FG000|Overall Study|Lost to Follow-up|1|||
33621798|NCT00880698|102165874|FG001|Overall Study|Lost to Follow-up|3|||
33621799|NCT00880698|102165875|FG002|Overall Study|Lost to Follow-up|0|||
33621800|NCT00880698|102165876|FG003|Overall Study|Lost to Follow-up|1|||
33218221|NCT02889133|100696003|FG000|Completed Primary Outcome|Manufacturing error|3|||
33218222|NCT02889133|100696004|FG001|Completed Primary Outcome|Manufacturing error|8|||
33218223|NCT02889133|100696003|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
33556480|NCT01239745|101935081|FG000|Overall Study|Study terminated by sponsor|45|||
33218224|NCT02889133|100696004|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
33556481|NCT01239745|101935081|FG000|Overall Study|Adverse Event|1|||
33556482|NCT02123511|101935082|FG000|Overall Study|Cancelled treatment|1|||
33556483|NCT02123511|101935083|FG001|Overall Study|Cancelled treatment|0|||
33556484|NCT02123511|101935082|FG000|Overall Study|Incomplete data|1|||
33556485|NCT02123511|101935083|FG001|Overall Study|Incomplete data|3|||
33556486|NCT02123511|101935082|FG000|Overall Study|Ineligible|0|||
33556487|NCT02123511|101935083|FG001|Overall Study|Ineligible|1|||
33556488|NCT01061710|101935084|FG000|Overall Study|Protocol Violation|14|||
33621801|NCT01290757|102165877|FG000|Overall Study|Adverse Event|1|||
33621802|NCT01290757|102165878|FG001|Overall Study|Adverse Event|0|||
33621803|NCT01290757|102165877|FG000|Overall Study|Protocol Violation|1|||
33621804|NCT01290757|102165878|FG001|Overall Study|Protocol Violation|1|||
33621805|NCT01290757|102165877|FG000|Overall Study|Other|0|||
33621806|NCT01290757|102165878|FG001|Overall Study|Other|1|||
33621807|NCT01078441|102165879|FG000|Overall Study|Withdrawal by Subject|1|||
33621808|NCT01569841|102165883|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
33621809|NCT01569841|102165884|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
33621810|NCT00556998|102165885|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
33621811|NCT00556998|102165885|FG000|Voriconazole Intravenous (IV)|Other|4|||
33621812|NCT00556998|102165885|FG000|Voriconazole Oral|Adverse Event|1|||
33621813|NCT00556998|102165885|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
33621814|NCT00108862|102165886|FG000|Overall Study|Death|31|||
33621815|NCT00108862|102165887|FG001|Overall Study|Death|37|||
33621816|NCT00108862|102165886|FG000|Overall Study|Withdrawal by Subject|10|||
33621817|NCT00108862|102165887|FG001|Overall Study|Withdrawal by Subject|6|||
33621818|NCT00108862|102165886|FG000|Overall Study|Lost to Follow-up|27|||
33621819|NCT00108862|102165887|FG001|Overall Study|Lost to Follow-up|19|||
33621820|NCT02792231|102165890|FG000|Overall Study|Patient/guardian decision|32|||
33621821|NCT02792231|102165891|FG001|Overall Study|Patient/guardian decision|42|||
33621822|NCT02792231|102165890|FG000|Overall Study|Adverse Event|15|||
33621823|NCT02792231|102165891|FG001|Overall Study|Adverse Event|11|||
33621824|NCT02792231|102165890|FG000|Overall Study|Physician Decision|14|||
33556489|NCT00507507|101935085|FG000|Treatment Period|Lost to Follow-up|0|||
33621825|NCT02792231|102165891|FG001|Overall Study|Physician Decision|12|||
33621826|NCT02792231|102165890|FG000|Overall Study|Lack of Efficacy|7|||
33621827|NCT02792231|102165891|FG001|Overall Study|Lack of Efficacy|9|||
33621828|NCT02792231|102165890|FG000|Overall Study|Lost to Follow-up|9|||
33621829|NCT02792231|102165891|FG001|Overall Study|Lost to Follow-up|5|||
33621830|NCT02792231|102165890|FG000|Overall Study|Pregnancy|1|||
33556490|NCT00507507|101935086|FG001|Treatment Period|Lost to Follow-up|2|||
33556491|NCT00507507|101935085|FG000|Treatment Period|Physician Decision|4|||
33556492|NCT00507507|101935086|FG001|Treatment Period|Physician Decision|1|||
33556493|NCT00507507|101935085|FG000|Treatment Period|Protocol Violation|1|||
33556494|NCT00507507|101935086|FG001|Treatment Period|Protocol Violation|2|||
33556495|NCT00507507|101935085|FG000|Treatment Period|Adverse Event|1|||
33556496|NCT00507507|101935086|FG001|Treatment Period|Adverse Event|1|||
33556497|NCT00507507|101935085|FG000|Treatment Period|Withdrawal by Subject|46|||
33556498|NCT00507507|101935086|FG001|Treatment Period|Withdrawal by Subject|47|||
33556499|NCT00507507|101935085|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
33556500|NCT00507507|101935086|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
33556501|NCT00507507|101935085|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
33556502|NCT00507507|101935086|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
33556503|NCT00507507|101935085|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
33556504|NCT00507507|101935086|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
33556505|NCT00562861|101935087|FG000|Overall Study|Adverse Event|1|||
33556506|NCT00562861|101935088|FG001|Overall Study|Adverse Event|1|||
33556507|NCT00562861|101935087|FG000|Overall Study|Lack of Efficacy|5|||
33556508|NCT00562861|101935088|FG001|Overall Study|Lack of Efficacy|5|||
33556509|NCT00562861|101935087|FG000|Overall Study|noncompliance, moved|7|||
33556510|NCT00562861|101935088|FG001|Overall Study|noncompliance, moved|2|||
33556511|NCT00562861|101935087|FG000|Overall Study|Lost to Follow-up|7|||
33556512|NCT00562861|101935088|FG001|Overall Study|Lost to Follow-up|3|||
33556513|NCT02959892|101935089|FG000|Overall Study|PET tracer synthesis failure|1|||
33556514|NCT02959892|101935090|FG001|Overall Study|PET tracer synthesis failure|0|||
33621831|NCT02792231|102165891|FG001|Overall Study|Pregnancy|3|||
33621832|NCT02792231|102165890|FG000|Overall Study|Non-compliance with study treatment|2|||
33621833|NCT02792231|102165891|FG001|Overall Study|Non-compliance with study treatment|1|||
33621834|NCT02792231|102165890|FG000|Overall Study|Protocol deviation|2|||
33621835|NCT02792231|102165891|FG001|Overall Study|Protocol deviation|0|||
33621836|NCT02792231|102165890|FG000|Overall Study|Technical problems|0|||
33621837|NCT02792231|102165891|FG001|Overall Study|Technical problems|1|||
33621838|NCT03883581|102165892|FG000|Overall Study|Withdrawal by Subject|4|||
33621839|NCT01061359|102165895|FG000|Overall Study|Death|32|||
33621840|NCT01061359|102165895|FG000|Overall Study|Lost to Follow-up|1072|||
33621841|NCT01061359|102165895|FG000|Overall Study|Relapse|187|||
33621842|NCT01061359|102165895|FG000|Overall Study|Secondary neoplasm|11|||
33621843|NCT01618669|102165897|FG000|Overall Study|Lost to Follow-up|1|||
33621844|NCT01618669|102165898|FG001|Overall Study|Lost to Follow-up|1|||
33621845|NCT01618669|102165897|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
33621846|NCT01618669|102165898|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
33621847|NCT01618669|102165897|FG000|Overall Study|Adverse Event|16|||
33621848|NCT01618669|102165898|FG001|Overall Study|Adverse Event|7|||
33621849|NCT01618669|102165897|FG000|Overall Study|Protocol Violation|5|||
33621850|NCT01618669|102165898|FG001|Overall Study|Protocol Violation|3|||
33621851|NCT01618669|102165897|FG000|Overall Study|Withdrawal by Subject|9|||
33621852|NCT01618669|102165898|FG001|Overall Study|Withdrawal by Subject|9|||
33621853|NCT01618669|102165897|FG000|Overall Study|Miscellaneous Reason|0|||
33621854|NCT01618669|102165898|FG001|Overall Study|Miscellaneous Reason|1|||
33621855|NCT01425801|102165904|FG000|Period 1|Withdrawal by Subject|0|||
33621856|NCT01425801|102165905|FG001|Period 1|Withdrawal by Subject|0|||
33621857|NCT01425801|102165906|FG002|Period 1|Withdrawal by Subject|0|||
33621858|NCT01425801|102165907|FG003|Period 1|Withdrawal by Subject|0|||
33621859|NCT01425801|102165908|FG004|Period 1|Withdrawal by Subject|1|||
33621860|NCT01425801|102165909|FG005|Period 1|Withdrawal by Subject|0|||
33621861|NCT01425801|102165904|FG000|Period 2|Withdrawal by Subject|0|||
33621862|NCT01425801|102165905|FG001|Period 2|Withdrawal by Subject|0|||
33621863|NCT01425801|102165906|FG002|Period 2|Withdrawal by Subject|0|||
33621864|NCT01425801|102165907|FG003|Period 2|Withdrawal by Subject|0|||
33621865|NCT01425801|102165908|FG004|Period 2|Withdrawal by Subject|1|||
33621866|NCT01425801|102165909|FG005|Period 2|Withdrawal by Subject|0|||
33621867|NCT01425801|102165904|FG000|Period 3|Stability criteria not fullfilled|0|||
33621868|NCT01425801|102165905|FG001|Period 3|Stability criteria not fullfilled|0|||
33621869|NCT01425801|102165906|FG002|Period 3|Stability criteria not fullfilled|1|||
33621870|NCT01425801|102165907|FG003|Period 3|Stability criteria not fullfilled|0|||
33621871|NCT01425801|102165908|FG004|Period 3|Stability criteria not fullfilled|0|||
33621872|NCT01425801|102165909|FG005|Period 3|Stability criteria not fullfilled|0|||
33621873|NCT01425801|102165904|FG000|Period 4|Not able to maintain visit schedule|0|||
33621874|NCT01425801|102165905|FG001|Period 4|Not able to maintain visit schedule|0|||
33556515|NCT02959892|101935089|FG000|Overall Study|Study termination|0|||
33556516|NCT02959892|101935090|FG001|Overall Study|Study termination|1|||
33621875|NCT01425801|102165906|FG002|Period 4|Not able to maintain visit schedule|1|||
33621876|NCT01425801|102165907|FG003|Period 4|Not able to maintain visit schedule|0|||
33218225|NCT02889133|100696003|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
33414344|NCT03345485|101406630|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
33414345|NCT03345485|101406631|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
33414346|NCT03099161|101406639|FG000|Overall Study|Adverse Event|0|||
33414347|NCT03099161|101406640|FG001|Overall Study|Adverse Event|0|||
33414348|NCT03099161|101406641|FG002|Overall Study|Adverse Event|2|||
33414349|NCT03099161|101406639|FG000|Overall Study|Physician Decision|2|||
33414350|NCT03099161|101406640|FG001|Overall Study|Physician Decision|0|||
33414351|NCT03099161|101406641|FG002|Overall Study|Physician Decision|0|||
33414352|NCT03099161|101406639|FG000|Overall Study|Progressive Disease|1|||
33414353|NCT03099161|101406640|FG001|Overall Study|Progressive Disease|4|||
33414354|NCT03099161|101406641|FG002|Overall Study|Progressive Disease|1|||
33414355|NCT01569594|101406645|FG000|Overall Study|Physician Decision|4|||
33218226|NCT02889133|100696004|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
33218227|NCT02889133|100696003|FG000|Completed Primary Outcome|Protocol Violation|1|||
33218228|NCT02889133|100696004|FG001|Completed Primary Outcome|Protocol Violation|0|||
33357124|NCT00524303|101195407|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
33357125|NCT00524303|101195405|FG000|Overall Study|Disease Progression|0|||
33357126|NCT00524303|101195406|FG001|Overall Study|Disease Progression|4|||
33357127|NCT00524303|101195407|FG002|Overall Study|Disease Progression|1|||
33357128|NCT00524303|101195405|FG000|Overall Study|Disease Recurrence|0|||
33357129|NCT00524303|101195406|FG001|Overall Study|Disease Recurrence|1|||
33414356|NCT01569594|101406645|FG000|Overall Study|Death|13|||
33414357|NCT01569594|101406645|FG000|Overall Study|Lost to Follow-up|22|||
33414358|NCT01569594|101406645|FG000|Overall Study|Adverse Event|2|||
33414359|NCT01569594|101406645|FG000|Overall Study|Withdrawal by Subject|13|||
33414360|NCT01569594|101406645|FG000|Overall Study|Other|4|||
33556517|NCT02562040|101935091|FG000|Overall Study|Lost to Follow-up|20|||
33556518|NCT02562040|101935092|FG001|Overall Study|Lost to Follow-up|28|||
33357130|NCT00524303|101195407|FG002|Overall Study|Disease Recurrence|0|||
33414361|NCT01569594|101406645|FG000|Overall Study|No ECM used|9|||
33556519|NCT02562040|101935091|FG000|Overall Study|Withdrawal by Subject|8|||
33556520|NCT02562040|101935092|FG001|Overall Study|Withdrawal by Subject|7|||
33556521|NCT02562040|101935091|FG000|Overall Study|Adverse Event|1|||
33556522|NCT02562040|101935092|FG001|Overall Study|Adverse Event|0|||
33556523|NCT01229111|101937833|FG000|Overall Study|Death|1|||
33556524|NCT01152385|101937835|FG000|Overall Study|Withdrawal by Subject|3|||
33556525|NCT01152385|101937836|FG001|Overall Study|Withdrawal by Subject|1|||
33556526|NCT01152385|101937837|FG002|Overall Study|Withdrawal by Subject|1|||
33218229|NCT02889133|100696003|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
33357131|NCT00524303|101195405|FG000|Overall Study|Sponsor Request|0|||
33357132|NCT00524303|101195406|FG001|Overall Study|Sponsor Request|0|||
33357133|NCT00524303|101195407|FG002|Overall Study|Sponsor Request|1|||
33357134|NCT00524303|101195405|FG000|Overall Study|Physician Decision|0|||
33414362|NCT00530621|101406648|FG000|Overall Study|Adverse Event|11|||
33414363|NCT00530621|101406649|FG001|Overall Study|Adverse Event|8|||
33414364|NCT00530621|101406648|FG000|Overall Study|Physician Decision|2|||
33414365|NCT00530621|101406649|FG001|Overall Study|Physician Decision|4|||
33556527|NCT01152385|101937838|FG003|Overall Study|Withdrawal by Subject|1|||
33556528|NCT01152385|101937835|FG000|Overall Study|Protocol Violation|0|||
33556529|NCT01152385|101937836|FG001|Overall Study|Protocol Violation|0|||
33357135|NCT00524303|101195406|FG001|Overall Study|Physician Decision|0|||
33621877|NCT01425801|102165908|FG004|Period 4|Not able to maintain visit schedule|0|||
33621878|NCT01425801|102165909|FG005|Period 4|Not able to maintain visit schedule|0|||
33621879|NCT01272232|102165910|FG000|Weeks 0-56|Adverse Event|39|||
33621880|NCT01272232|102165911|FG001|Weeks 0-56|Adverse Event|18|||
33357136|NCT00524303|101195407|FG002|Overall Study|Physician Decision|1|||
33357137|NCT00524303|101195405|FG000|Overall Study|Completed 5 years|0|||
33357138|NCT00524303|101195406|FG001|Overall Study|Completed 5 years|0|||
33357139|NCT00524303|101195407|FG002|Overall Study|Completed 5 years|1|||
33357140|NCT00594399|101195408|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
33357141|NCT00594399|101195409|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
33357142|NCT00594399|101195410|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
33357143|NCT00594399|101195408|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
33357144|NCT00594399|101195409|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
33414366|NCT00530621|101406648|FG000|Overall Study|Progressive Disease (PD)|47|||
33621881|NCT01272232|102165912|FG002|Weeks 0-56|Adverse Event|7|||
33621882|NCT01272232|102165910|FG000|Weeks 0-56|Lack of Efficacy|0|||
33621883|NCT01272232|102165911|FG001|Weeks 0-56|Lack of Efficacy|0|||
33621884|NCT01272232|102165912|FG002|Weeks 0-56|Lack of Efficacy|3|||
33357145|NCT00594399|101195410|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
33357146|NCT00594399|101195408|FG000|Initial 3 Month Counseling|Personal issues|2|||
33357147|NCT00594399|101195409|FG001|Initial 3 Month Counseling|Personal issues|0|||
33357148|NCT00594399|101195410|FG002|Initial 3 Month Counseling|Personal issues|0|||
33357149|NCT00594399|101195408|FG000|Initial 3 Month Counseling|Too busy|7|||
33357150|NCT00594399|101195409|FG001|Initial 3 Month Counseling|Too busy|1|||
33357151|NCT00594399|101195410|FG002|Initial 3 Month Counseling|Too busy|0|||
33357152|NCT00594399|101195408|FG000|Initial 3 Month Counseling|Pain|2|||
33414367|NCT00530621|101406649|FG001|Overall Study|Progressive Disease (PD)|40|||
33414368|NCT00530621|101406648|FG000|Overall Study|Sponsor Decision|12|||
33414369|NCT00530621|101406649|FG001|Overall Study|Sponsor Decision|15|||
33414370|NCT00530621|101406648|FG000|Overall Study|Subject Decision|4|||
33414371|NCT00530621|101406649|FG001|Overall Study|Subject Decision|7|||
33414372|NCT00530621|101406648|FG000|Overall Study|Death|3|||
33414373|NCT00530621|101406649|FG001|Overall Study|Death|6|||
33414374|NCT00530621|101406648|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
33414375|NCT00530621|101406649|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
33556530|NCT01152385|101937837|FG002|Overall Study|Protocol Violation|0|||
33556531|NCT01152385|101937838|FG003|Overall Study|Protocol Violation|1|||
33556532|NCT01152385|101937835|FG000|Overall Study|Adverse Event|1|||
33556533|NCT01152385|101937836|FG001|Overall Study|Adverse Event|1|||
33556534|NCT01152385|101937837|FG002|Overall Study|Adverse Event|0|||
33556535|NCT01152385|101937838|FG003|Overall Study|Adverse Event|0|||
33556536|NCT01152385|101937835|FG000|Overall Study|Study-specific withdrawal criteria|1|||
33556537|NCT01152385|101937836|FG001|Overall Study|Study-specific withdrawal criteria|1|||
33556538|NCT01152385|101937837|FG002|Overall Study|Study-specific withdrawal criteria|2|||
33556539|NCT01152385|101937838|FG003|Overall Study|Study-specific withdrawal criteria|0|||
33556540|NCT01152385|101937835|FG000|Overall Study|Other|4|||
33556541|NCT01152385|101937836|FG001|Overall Study|Other|3|||
33556542|NCT01152385|101937837|FG002|Overall Study|Other|2|||
33556543|NCT01152385|101937838|FG003|Overall Study|Other|3|||
33556544|NCT00225758|101937839|FG000|Overall Study|Adverse Event|4|||
33556545|NCT03760068|101937842|FG000|Overall Study|Withdrawal by Subject|7|||
33556546|NCT03760068|101937843|FG001|Overall Study|Withdrawal by Subject|8|||
33556547|NCT03760068|101937842|FG000|Overall Study|Adverse Event|1|||
33556548|NCT03760068|101937843|FG001|Overall Study|Adverse Event|2|||
33556549|NCT03760068|101937842|FG000|Overall Study|Administrative Decision by Sponsor|0|||
33556550|NCT03760068|101937843|FG001|Overall Study|Administrative Decision by Sponsor|2|||
33556551|NCT03760068|101937842|FG000|Overall Study|Physician Decision|1|||
33556552|NCT03760068|101937843|FG001|Overall Study|Physician Decision|2|||
33621885|NCT01272232|102165910|FG000|Weeks 0-56|Protocol Violation|12|||
33357153|NCT00594399|101195409|FG001|Initial 3 Month Counseling|Pain|0|||
33357154|NCT00594399|101195410|FG002|Initial 3 Month Counseling|Pain|0|||
33414376|NCT00685763|101406652|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
33357155|NCT00594399|101195408|FG000|Initial 3 Month Counseling|Moved|1|||
33357156|NCT00594399|101195409|FG001|Initial 3 Month Counseling|Moved|0|||
33414377|NCT00685763|101406652|FG000|Overall Study|Protocol Violation|1|||
33357157|NCT00594399|101195410|FG002|Initial 3 Month Counseling|Moved|0|||
33414378|NCT01392469|101406653|FG000|Overall Study|Adverse Event|2|||
33414379|NCT01392469|101406653|FG000|Overall Study|Withdrawal by Subject|1|||
33556553|NCT03760068|101937842|FG000|Overall Study|Lost to Follow-up|4|||
33556554|NCT03760068|101937843|FG001|Overall Study|Lost to Follow-up|9|||
33556555|NCT03760068|101937842|FG000|Overall Study|Subject Moved Out of State|1|||
33621886|NCT01272232|102165911|FG001|Weeks 0-56|Protocol Violation|8|||
33621887|NCT01272232|102165912|FG002|Weeks 0-56|Protocol Violation|13|||
33357158|NCT00594399|101195408|FG000|Initial 3 Month Counseling|Family illness|1|||
33357159|NCT00594399|101195409|FG001|Initial 3 Month Counseling|Family illness|0|||
33357160|NCT00594399|101195410|FG002|Initial 3 Month Counseling|Family illness|0|||
33357161|NCT00594399|101195408|FG000|Rerandomization Arm 1 Only|Death|2|||
33357162|NCT00594399|101195409|FG001|Rerandomization Arm 1 Only|Death|1|||
33357163|NCT00594399|101195410|FG002|Rerandomization Arm 1 Only|Death|0|||
33357164|NCT00594399|101195408|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
33357165|NCT00594399|101195409|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
33357166|NCT00594399|101195410|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
33357167|NCT02725788|101195411|FG000|Overall Study|Lost to Follow-up|1|||
33357168|NCT02725788|101195412|FG001|Overall Study|Lost to Follow-up|1|||
33357169|NCT02725788|101195411|FG000|Overall Study|Protocol Violation|0|||
33357170|NCT02725788|101195412|FG001|Overall Study|Protocol Violation|1|||
33357171|NCT01059812|101195413|FG000|Overall Study|Adverse Event|9|||
33357172|NCT01059812|101195414|FG001|Overall Study|Adverse Event|5|||
33357173|NCT01059812|101195413|FG000|Overall Study|Lack of Efficacy|2|||
33357174|NCT01059812|101195414|FG001|Overall Study|Lack of Efficacy|2|||
33357175|NCT01059812|101195413|FG000|Overall Study|Protocol Violation|3|||
33357176|NCT01059812|101195414|FG001|Overall Study|Protocol Violation|1|||
33357177|NCT01059812|101195413|FG000|Overall Study|Withdrawal Criteria|9|||
33357178|NCT01059812|101195414|FG001|Overall Study|Withdrawal Criteria|4|||
33357179|NCT01059812|101195413|FG000|Overall Study|Unclassified|14|||
33357180|NCT01059812|101195414|FG001|Overall Study|Unclassified|4|||
33357181|NCT03022422|101195416|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
33357182|NCT03022422|101195417|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
33357183|NCT03022422|101195418|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
33357184|NCT03022422|101195419|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
33357185|NCT03022422|101195420|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
33357186|NCT03022422|101195421|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
33357187|NCT01584024|101195422|FG000|Overall Study|Lost to Follow-up|10|||
33357188|NCT01584024|101195422|FG000|Overall Study|Withdrawal by Subject|3|||
33357189|NCT01157169|101195425|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
33357190|NCT01157169|101195426|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
33357191|NCT01157169|101195425|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
33357192|NCT01157169|101195426|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
33357193|NCT00998738|101195427|FG000|Overall Study|Uknown|1|||
33357194|NCT02286960|101195436|FG000|Overall Study|Lost to Follow-up|3|||
33357195|NCT02286960|101195437|FG001|Overall Study|Lost to Follow-up|3|||
33357196|NCT01503021|101195439|FG000|Overall Study|Adverse Event|7|||
33357197|NCT01503021|101195440|FG001|Overall Study|Adverse Event|6|||
33357198|NCT01503021|101195439|FG000|Overall Study|Death|0|||
33357199|NCT01503021|101195440|FG001|Overall Study|Death|2|||
33357200|NCT01503021|101195439|FG000|Overall Study|Lost to Follow-up|2|||
33357201|NCT01503021|101195440|FG001|Overall Study|Lost to Follow-up|0|||
33357202|NCT01503021|101195439|FG000|Overall Study|Physician Decision|3|||
33357203|NCT01503021|101195440|FG001|Overall Study|Physician Decision|0|||
33357204|NCT01503021|101195439|FG000|Overall Study|Protocol Violation|1|||
33357205|NCT01503021|101195440|FG001|Overall Study|Protocol Violation|3|||
33556556|NCT03760068|101937843|FG001|Overall Study|Subject Moved Out of State|0|||
33556557|NCT02037984|101937846|FG000|Overall Study|Lack of Efficacy|0|||
33556558|NCT02037984|101937847|FG001|Overall Study|Lack of Efficacy|0|||
33556559|NCT02037984|101937848|FG002|Overall Study|Lack of Efficacy|3|||
33556560|NCT02037984|101937849|FG003|Overall Study|Lack of Efficacy|10|||
33556561|NCT02037984|101937850|FG004|Overall Study|Lack of Efficacy|2|||
33556562|NCT02037984|101937851|FG005|Overall Study|Lack of Efficacy|2|||
33556563|NCT02037984|101937852|FG006|Overall Study|Lack of Efficacy|4|||
33556564|NCT02037984|101937853|FG007|Overall Study|Lack of Efficacy|3|||
33556565|NCT02037984|101937846|FG000|Overall Study|Lost to Follow-up|1|||
33556566|NCT02037984|101937847|FG001|Overall Study|Lost to Follow-up|0|||
33556567|NCT02037984|101937848|FG002|Overall Study|Lost to Follow-up|3|||
33556568|NCT02037984|101937849|FG003|Overall Study|Lost to Follow-up|5|||
33556569|NCT02037984|101937850|FG004|Overall Study|Lost to Follow-up|2|||
33556570|NCT02037984|101937851|FG005|Overall Study|Lost to Follow-up|2|||
33357206|NCT01503021|101195439|FG000|Overall Study|Withdrawal by Subject|9|||
33357207|NCT01503021|101195440|FG001|Overall Study|Withdrawal by Subject|8|||
33357208|NCT01503021|101195439|FG000|Overall Study|Moved, received transplant, etc.|5|||
33414380|NCT01392469|101406653|FG000|Overall Study|Protocol Violation|1|||
33556571|NCT02037984|101937852|FG006|Overall Study|Lost to Follow-up|2|||
33556572|NCT02037984|101937853|FG007|Overall Study|Lost to Follow-up|4|||
33357209|NCT01503021|101195440|FG001|Overall Study|Moved, received transplant, etc.|7|||
33357210|NCT00467649|101195441|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
33357211|NCT00467649|101195442|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
33556573|NCT02037984|101937846|FG000|Overall Study|Physician Decision|0|||
33556574|NCT02037984|101937847|FG001|Overall Study|Physician Decision|0|||
33556575|NCT02037984|101937848|FG002|Overall Study|Physician Decision|0|||
33357212|NCT00467649|101195443|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
33357213|NCT00467649|101195444|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
33357214|NCT00467649|101195445|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
33357215|NCT00467649|101195446|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
33357216|NCT00467649|101195441|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
33357217|NCT00467649|101195442|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
33357218|NCT00467649|101195443|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
33357219|NCT00467649|101195444|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
33357220|NCT00467649|101195445|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
33357221|NCT00467649|101195446|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
33357222|NCT00467649|101195441|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
33357223|NCT00467649|101195442|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
33357224|NCT00467649|101195443|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
33357225|NCT00467649|101195444|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
33357226|NCT00467649|101195445|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
33357227|NCT00467649|101195446|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
33357228|NCT00467649|101195441|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
33357229|NCT00467649|101195442|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
33357230|NCT00467649|101195443|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
33357231|NCT00467649|101195444|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
33414381|NCT03039686|101406654|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
33414382|NCT03039686|101406655|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
33414383|NCT03039686|101406656|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
33414384|NCT03039686|101406654|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
33414385|NCT03039686|101406655|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
33556576|NCT02037984|101937849|FG003|Overall Study|Physician Decision|0|||
33556577|NCT02037984|101937850|FG004|Overall Study|Physician Decision|0|||
33556578|NCT02037984|101937851|FG005|Overall Study|Physician Decision|0|||
33556579|NCT02037984|101937852|FG006|Overall Study|Physician Decision|1|||
33556580|NCT02037984|101937853|FG007|Overall Study|Physician Decision|0|||
33556581|NCT02037984|101937846|FG000|Overall Study|Protocol Violation|0|||
33357232|NCT00467649|101195445|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
33357233|NCT00467649|101195446|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
33357234|NCT00467649|101195441|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
33357235|NCT00467649|101195442|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
33357236|NCT00467649|101195443|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
33357237|NCT00467649|101195444|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
33357238|NCT00467649|101195445|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
33357239|NCT00467649|101195446|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
33357240|NCT00467649|101195441|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
33357241|NCT00467649|101195442|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
33357242|NCT00467649|101195443|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
33357243|NCT00467649|101195444|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
33414386|NCT03039686|101406656|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
33414387|NCT03039686|101406654|FG000|Double-blind Period|Withdrawal by Subject|2|||
33414388|NCT03039686|101406655|FG001|Double-blind Period|Withdrawal by Subject|2|||
33414389|NCT03039686|101406656|FG002|Double-blind Period|Withdrawal by Subject|1|||
33414390|NCT03039686|101406654|FG000|Double-blind Period|Death|0|||
33414391|NCT03039686|101406655|FG001|Double-blind Period|Death|0|||
33414392|NCT03039686|101406656|FG002|Double-blind Period|Death|1|||
33414393|NCT03039686|101406654|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
33414394|NCT03039686|101406655|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
33414395|NCT03039686|101406656|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
33414396|NCT03039686|101406654|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
33414397|NCT03039686|101406655|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
33414398|NCT03039686|101406656|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
33414399|NCT03039686|101406654|FG000|Open Label Period|Withdrawal by Subject|0|||
33556582|NCT02037984|101937847|FG001|Overall Study|Protocol Violation|0|||
33556583|NCT02037984|101937848|FG002|Overall Study|Protocol Violation|0|||
33357244|NCT00467649|101195445|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
33357245|NCT00467649|101195446|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
33357246|NCT00467649|101195441|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
33414400|NCT03039686|101406655|FG001|Open Label Period|Withdrawal by Subject|3|||
33621888|NCT01272232|102165910|FG000|Weeks 0-56|Withdrawal criteria|32|||
33621889|NCT01272232|102165911|FG001|Weeks 0-56|Withdrawal criteria|14|||
33621890|NCT01272232|102165912|FG002|Weeks 0-56|Withdrawal criteria|37|||
33621891|NCT01272232|102165910|FG000|Weeks 0-56|Unclassified|16|||
33621892|NCT01272232|102165911|FG001|Weeks 0-56|Unclassified|7|||
33357247|NCT00467649|101195442|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
33357248|NCT00467649|101195443|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
33357249|NCT00467649|101195444|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
33357250|NCT00467649|101195445|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
33357251|NCT00467649|101195446|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
33357252|NCT00942409|101195447|FG000|Overall Study|Lack of Efficacy|1|||
33357253|NCT00942409|101195447|FG000|Overall Study|study drug unavailable|2|||
33357254|NCT02111811|101195448|FG000|Treatment Phase|Lost to Follow-up|22|||
33357255|NCT02111811|101195449|FG001|Treatment Phase|Lost to Follow-up|18|||
33357256|NCT02111811|101195448|FG000|Treatment Phase|Death|2|||
33357257|NCT02111811|101195449|FG001|Treatment Phase|Death|0|||
33357258|NCT02111811|101195448|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
33357259|NCT02111811|101195449|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
33357260|NCT02111811|101195448|FG000|Follow up Period (Aim 2)|Death|2|||
33357261|NCT02111811|101195449|FG001|Follow up Period (Aim 2)|Death|0|||
33357262|NCT03114969|101195452|FG000|Overall Study|Lost to Follow-up|0|||
33357263|NCT03114969|101195453|FG001|Overall Study|Lost to Follow-up|0|||
33357264|NCT03114969|101195454|FG002|Overall Study|Lost to Follow-up|3|||
33357265|NCT03114969|101195455|FG003|Overall Study|Lost to Follow-up|2|||
33357266|NCT03114969|101195456|FG004|Overall Study|Lost to Follow-up|0|||
33357267|NCT03114969|101195457|FG005|Overall Study|Lost to Follow-up|0|||
33357268|NCT03114969|101195458|FG006|Overall Study|Lost to Follow-up|0|||
33357269|NCT03114969|101195459|FG007|Overall Study|Lost to Follow-up|0|||
33357270|NCT03114969|101195460|FG008|Overall Study|Lost to Follow-up|0|||
33357271|NCT03114969|101195452|FG000|Overall Study|Adverse Event|0|||
33357272|NCT03114969|101195453|FG001|Overall Study|Adverse Event|0|||
33357273|NCT03114969|101195454|FG002|Overall Study|Adverse Event|1|||
33357274|NCT03114969|101195455|FG003|Overall Study|Adverse Event|0|||
33357275|NCT03114969|101195456|FG004|Overall Study|Adverse Event|0|||
33357276|NCT03114969|101195457|FG005|Overall Study|Adverse Event|1|||
33357277|NCT03114969|101195458|FG006|Overall Study|Adverse Event|1|||
33357278|NCT03114969|101195459|FG007|Overall Study|Adverse Event|0|||
33357279|NCT03114969|101195460|FG008|Overall Study|Adverse Event|2|||
33357280|NCT03215277|101195463|FG000|Overall Study|Adverse Event|2|||
33357281|NCT03215277|101195464|FG001|Overall Study|Adverse Event|3|||
33357282|NCT03215277|101195463|FG000|Overall Study|Death|1|||
33357283|NCT03215277|101195464|FG001|Overall Study|Death|0|||
33357284|NCT03215277|101195463|FG000|Overall Study|Lost to Follow-up|0|||
33357285|NCT03215277|101195464|FG001|Overall Study|Lost to Follow-up|1|||
33556584|NCT02037984|101937849|FG003|Overall Study|Protocol Violation|0|||
33556585|NCT02037984|101937850|FG004|Overall Study|Protocol Violation|0|||
33556586|NCT02037984|101937851|FG005|Overall Study|Protocol Violation|1|||
33556587|NCT02037984|101937852|FG006|Overall Study|Protocol Violation|2|||
33556588|NCT02037984|101937853|FG007|Overall Study|Protocol Violation|0|||
33556589|NCT02037984|101937846|FG000|Overall Study|Technical Problems|0|||
33556590|NCT02037984|101937847|FG001|Overall Study|Technical Problems|0|||
33556591|NCT02037984|101937848|FG002|Overall Study|Technical Problems|3|||
33556592|NCT02037984|101937849|FG003|Overall Study|Technical Problems|3|||
33556593|NCT02037984|101937850|FG004|Overall Study|Technical Problems|2|||
33556594|NCT02037984|101937851|FG005|Overall Study|Technical Problems|3|||
33556595|NCT02037984|101937852|FG006|Overall Study|Technical Problems|4|||
33556596|NCT02037984|101937853|FG007|Overall Study|Technical Problems|2|||
33556597|NCT02037984|101937846|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33556598|NCT02037984|101937847|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33556599|NCT02037984|101937848|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
33556600|NCT02037984|101937849|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
33556601|NCT02037984|101937850|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
33556602|NCT02037984|101937851|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
33556603|NCT02037984|101937852|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
33556604|NCT02037984|101937853|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
33556605|NCT02037984|101937846|FG000|Overall Study|Withdrawal by Subject|0|||
33556606|NCT02037984|101937847|FG001|Overall Study|Withdrawal by Subject|0|||
33556607|NCT02037984|101937848|FG002|Overall Study|Withdrawal by Subject|0|||
33556608|NCT02037984|101937849|FG003|Overall Study|Withdrawal by Subject|1|||
33556609|NCT02037984|101937850|FG004|Overall Study|Withdrawal by Subject|1|||
33556610|NCT02037984|101937851|FG005|Overall Study|Withdrawal by Subject|3|||
33556611|NCT02037984|101937852|FG006|Overall Study|Withdrawal by Subject|0|||
33556612|NCT02037984|101937853|FG007|Overall Study|Withdrawal by Subject|1|||
33556613|NCT03931785|101937854|FG000|Overall Study|Lost to Follow-up|4|||
33556614|NCT03931785|101937855|FG001|Overall Study|Lost to Follow-up|1|||
33556615|NCT03931785|101937856|FG002|Overall Study|Lost to Follow-up|4|||
33621893|NCT01272232|102165912|FG002|Weeks 0-56|Unclassified|12|||
33556616|NCT03931785|101937857|FG003|Overall Study|Lost to Follow-up|3|||
33556617|NCT03931785|101937854|FG000|Overall Study|Adverse Event|1|||
33556618|NCT03931785|101937855|FG001|Overall Study|Adverse Event|0|||
33556619|NCT03931785|101937856|FG002|Overall Study|Adverse Event|3|||
33556620|NCT03931785|101937857|FG003|Overall Study|Adverse Event|4|||
33556621|NCT03931785|101937854|FG000|Overall Study|Protocol Violation|0|||
33556622|NCT03931785|101937855|FG001|Overall Study|Protocol Violation|1|||
33556623|NCT03931785|101937856|FG002|Overall Study|Protocol Violation|0|||
33556624|NCT03931785|101937857|FG003|Overall Study|Protocol Violation|0|||
33556625|NCT03931785|101937854|FG000|Overall Study|Noncompliance With Study drug|0|||
33556626|NCT03931785|101937855|FG001|Overall Study|Noncompliance With Study drug|1|||
33556627|NCT03931785|101937856|FG002|Overall Study|Noncompliance With Study drug|0|||
33556628|NCT03931785|101937857|FG003|Overall Study|Noncompliance With Study drug|0|||
33556629|NCT03931785|101937854|FG000|Overall Study|Other Not specified|0|||
33556630|NCT03931785|101937855|FG001|Overall Study|Other Not specified|2|||
33556631|NCT03931785|101937856|FG002|Overall Study|Other Not specified|2|||
33556632|NCT03931785|101937857|FG003|Overall Study|Other Not specified|2|||
33556633|NCT03931785|101937854|FG000|Overall Study|Withdrawal by Subject|0|||
33556634|NCT03931785|101937855|FG001|Overall Study|Withdrawal by Subject|2|||
33556635|NCT03931785|101937856|FG002|Overall Study|Withdrawal by Subject|4|||
33556636|NCT03931785|101937857|FG003|Overall Study|Withdrawal by Subject|1|||
33556637|NCT03931785|101937854|FG000|Overall Study|Pregnancy|0|||
33556638|NCT03931785|101937855|FG001|Overall Study|Pregnancy|0|||
33556639|NCT03931785|101937856|FG002|Overall Study|Pregnancy|0|||
33556640|NCT03931785|101937857|FG003|Overall Study|Pregnancy|1|||
33556641|NCT02003209|101937858|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
33556642|NCT02003209|101937859|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
33556643|NCT02301429|101937861|FG000|Overall Study|not acceptable vascular anatomy|3|||
33556644|NCT01655069|101937862|FG000|Overall Study|Physician Decision|0|||
33556645|NCT01655069|101937863|FG001|Overall Study|Physician Decision|0|||
33556646|NCT01655069|101937864|FG002|Overall Study|Physician Decision|0|||
33556647|NCT01655069|101937865|FG003|Overall Study|Physician Decision|1|||
33556648|NCT01655069|101937862|FG000|Overall Study|Adverse Event|6|||
33556649|NCT01655069|101937863|FG001|Overall Study|Adverse Event|7|||
33556650|NCT01655069|101937864|FG002|Overall Study|Adverse Event|2|||
33556651|NCT01655069|101937865|FG003|Overall Study|Adverse Event|3|||
33556652|NCT01655069|101937862|FG000|Overall Study|Lack of Efficacy|0|||
33556653|NCT01655069|101937863|FG001|Overall Study|Lack of Efficacy|1|||
33556654|NCT01655069|101937864|FG002|Overall Study|Lack of Efficacy|0|||
33556655|NCT01655069|101937865|FG003|Overall Study|Lack of Efficacy|0|||
33556656|NCT01655069|101937862|FG000|Overall Study|No Treatment Needed|0|||
33556657|NCT01655069|101937863|FG001|Overall Study|No Treatment Needed|1|||
33556658|NCT01655069|101937864|FG002|Overall Study|No Treatment Needed|0|||
33556659|NCT01655069|101937865|FG003|Overall Study|No Treatment Needed|0|||
33556660|NCT01655069|101937862|FG000|Overall Study|Withdrawal by Subject|2|||
33556661|NCT01655069|101937863|FG001|Overall Study|Withdrawal by Subject|3|||
33556662|NCT01655069|101937864|FG002|Overall Study|Withdrawal by Subject|0|||
33556663|NCT01655069|101937865|FG003|Overall Study|Withdrawal by Subject|0|||
33556664|NCT01065766|101937872|FG000|Overall Study|Assessed before the contracted date|1|||
33556665|NCT01065766|101937872|FG000|Overall Study|Contraindication to administration|6|||
33556666|NCT01065766|101937872|FG000|Overall Study|Violated dosage/administration|25|||
33556667|NCT00183391|101937875|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
33556668|NCT00183391|101937876|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
33556669|NCT00183391|101937875|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
33556670|NCT00183391|101937876|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
33556671|NCT01063881|101937877|FG000|Overall Study|Adverse Event|12|||
33556672|NCT01063881|101937878|FG001|Overall Study|Adverse Event|2|||
33556673|NCT01063881|101937879|FG002|Overall Study|Adverse Event|0|||
33556674|NCT01063881|101937877|FG000|Overall Study|Lost to Follow-up|13|||
33556675|NCT01063881|101937878|FG001|Overall Study|Lost to Follow-up|7|||
33556676|NCT01063881|101937879|FG002|Overall Study|Lost to Follow-up|1|||
33556677|NCT01063881|101937877|FG000|Overall Study|Withdrawal by Subject|25|||
33556678|NCT01063881|101937878|FG001|Overall Study|Withdrawal by Subject|1|||
33556679|NCT01063881|101937879|FG002|Overall Study|Withdrawal by Subject|0|||
33556680|NCT01063881|101937877|FG000|Overall Study|Reason for not completed not specified|5|||
33556681|NCT01063881|101937878|FG001|Overall Study|Reason for not completed not specified|1|||
33556682|NCT01063881|101937879|FG002|Overall Study|Reason for not completed not specified|0|||
33556683|NCT00890097|101937881|FG000|Overall Study|Adverse Event|21|||
33556684|NCT00890097|101937882|FG001|Overall Study|Adverse Event|32|||
33556685|NCT00890097|101937883|FG002|Overall Study|Adverse Event|28|||
33556686|NCT00890097|101937881|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
33556687|NCT00890097|101937882|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
33556688|NCT00890097|101937883|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
33556689|NCT00890097|101937881|FG000|Overall Study|Withdrew Consent|9|||
33556690|NCT00890097|101937882|FG001|Overall Study|Withdrew Consent|6|||
33556691|NCT00890097|101937883|FG002|Overall Study|Withdrew Consent|9|||
33556692|NCT00890097|101937881|FG000|Overall Study|Lost to Follow-up|5|||
33556693|NCT00890097|101937882|FG001|Overall Study|Lost to Follow-up|5|||
33556694|NCT00890097|101937883|FG002|Overall Study|Lost to Follow-up|5|||
33556695|NCT00890097|101937881|FG000|Overall Study|Noncompliance|0|||
33556696|NCT00890097|101937882|FG001|Overall Study|Noncompliance|4|||
33556697|NCT00890097|101937883|FG002|Overall Study|Noncompliance|4|||
33556698|NCT00890097|101937881|FG000|Overall Study|Sponsor Decision|7|||
33556699|NCT00890097|101937882|FG001|Overall Study|Sponsor Decision|11|||
33556700|NCT00890097|101937883|FG002|Overall Study|Sponsor Decision|7|||
33556701|NCT00890097|101937881|FG000|Overall Study|Did not attend final visit|2|||
33556702|NCT00890097|101937882|FG001|Overall Study|Did not attend final visit|3|||
33556703|NCT00890097|101937883|FG002|Overall Study|Did not attend final visit|0|||
33556704|NCT00890097|101937881|FG000|Overall Study|Subject Decision|3|||
33556705|NCT00890097|101937882|FG001|Overall Study|Subject Decision|2|||
33556706|NCT00890097|101937883|FG002|Overall Study|Subject Decision|6|||
33556707|NCT00890097|101937881|FG000|Overall Study|Randomization Error|2|||
33556708|NCT00890097|101937882|FG001|Overall Study|Randomization Error|0|||
33556709|NCT00890097|101937883|FG002|Overall Study|Randomization Error|0|||
33556710|NCT00890097|101937881|FG000|Overall Study|Failed inclusion criteria|3|||
33556711|NCT00890097|101937882|FG001|Overall Study|Failed inclusion criteria|4|||
33556712|NCT00890097|101937883|FG002|Overall Study|Failed inclusion criteria|0|||
33556713|NCT00890097|101937881|FG000|Overall Study|Transportation|0|||
33556714|NCT00890097|101937882|FG001|Overall Study|Transportation|2|||
33556715|NCT00890097|101937883|FG002|Overall Study|Transportation|0|||
33556716|NCT00890097|101937881|FG000|Overall Study|Subject Moved|0|||
33556717|NCT00890097|101937882|FG001|Overall Study|Subject Moved|4|||
33556718|NCT00890097|101937883|FG002|Overall Study|Subject Moved|0|||
33556719|NCT00890097|101937881|FG000|Overall Study|Protocol Deviation|1|||
33556720|NCT00890097|101937882|FG001|Overall Study|Protocol Deviation|1|||
33556721|NCT00890097|101937883|FG002|Overall Study|Protocol Deviation|1|||
33556722|NCT04191733|101937886|FG000|Overall Study|Withdrawn due to study closure|13|||
33556723|NCT04191733|101937887|FG001|Overall Study|Withdrawn due to study closure|14|||
33556724|NCT04191733|101937886|FG000|Overall Study|Withdrawal by Subject|2|||
33556725|NCT04191733|101937887|FG001|Overall Study|Withdrawal by Subject|4|||
33556726|NCT04191733|101937886|FG000|Overall Study|Physician Decision|1|||
33556727|NCT04191733|101937887|FG001|Overall Study|Physician Decision|1|||
33556728|NCT04191733|101937886|FG000|Overall Study|Lost to Follow-up|5|||
33556729|NCT04191733|101937887|FG001|Overall Study|Lost to Follow-up|6|||
33556730|NCT04191733|101937886|FG000|Overall Study|Death|0|||
33556731|NCT04191733|101937887|FG001|Overall Study|Death|1|||
33556732|NCT03681093|101937888|FG000|Overall Study|Subject decision|0|||
33556733|NCT03681093|101937889|FG001|Overall Study|Subject decision|2|||
33556734|NCT03681093|101937890|FG002|Overall Study|Subject decision|1|||
33556735|NCT01230814|101937891|FG000|Overall Study|Lost to Follow-up|11|||
33556736|NCT01230814|101937892|FG001|Overall Study|Lost to Follow-up|3|||
33556737|NCT01230814|101937891|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
33556738|NCT01230814|101937892|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
33556739|NCT02143778|101937896|FG000|Overall Study|Withdrawal by Subject|2|||
33556740|NCT02143778|101937896|FG000|Overall Study|Device malfunction|1|||
33556741|NCT02775851|101937897|FG000|Overall Study|Adverse Event|1|||
33556742|NCT02775851|101937898|FG001|Overall Study|Adverse Event|10|||
33556743|NCT02775851|101937897|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
33556744|NCT02775851|101937898|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
33556745|NCT02775851|101937897|FG000|Overall Study|Progression/Relapse|0|||
33556746|NCT02775851|101937898|FG001|Overall Study|Progression/Relapse|4|||
33556747|NCT02775851|101937897|FG000|Overall Study|Other - Not Protocol Specified|0|||
33556748|NCT02775851|101937898|FG001|Overall Study|Other - Not Protocol Specified|7|||
33556749|NCT02775851|101937897|FG000|Overall Study|Withdrawal by Subject|1|||
33621894|NCT01272232|102165910|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
33556750|NCT02775851|101937898|FG001|Overall Study|Withdrawal by Subject|0|||
33556751|NCT00520572|101937899|FG000|Overall Study|Adverse Event|9|||
33556752|NCT00520572|101937900|FG001|Overall Study|Adverse Event|3|||
33556753|NCT00520572|101937901|FG002|Overall Study|Adverse Event|6|||
33556754|NCT00520572|101937902|FG003|Overall Study|Adverse Event|9|||
33556755|NCT00520572|101937903|FG004|Overall Study|Adverse Event|7|||
33556756|NCT00520572|101937904|FG005|Overall Study|Adverse Event|2|||
33556757|NCT00520572|101937899|FG000|Overall Study|Withdrawal by Subject|0|||
33556758|NCT00520572|101937900|FG001|Overall Study|Withdrawal by Subject|9|||
33556759|NCT00520572|101937901|FG002|Overall Study|Withdrawal by Subject|5|||
33556760|NCT00520572|101937902|FG003|Overall Study|Withdrawal by Subject|2|||
33556761|NCT00520572|101937903|FG004|Overall Study|Withdrawal by Subject|2|||
33556762|NCT00520572|101937904|FG005|Overall Study|Withdrawal by Subject|0|||
33556763|NCT00520572|101937899|FG000|Overall Study|Protocol Violation|0|||
33556764|NCT00520572|101937900|FG001|Overall Study|Protocol Violation|0|||
33556765|NCT00520572|101937901|FG002|Overall Study|Protocol Violation|1|||
33556766|NCT00520572|101937902|FG003|Overall Study|Protocol Violation|0|||
33556767|NCT00520572|101937903|FG004|Overall Study|Protocol Violation|0|||
33357286|NCT03215277|101195463|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
33556768|NCT00520572|101937904|FG005|Overall Study|Protocol Violation|0|||
33556769|NCT00520572|101937899|FG000|Overall Study|Lack of Efficacy|1|||
33357287|NCT03215277|101195464|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
33357288|NCT03401749|101195469|FG000|Overall Study|Lost to Follow-up|20|||
33357289|NCT03401749|101195470|FG001|Overall Study|Lost to Follow-up|16|||
33357290|NCT03401749|101195471|FG002|Overall Study|Lost to Follow-up|26|||
33357291|NCT01273818|101195472|FG000|Overall Study|Physician Decision|13|||
33357292|NCT01273818|101195473|FG001|Overall Study|Physician Decision|2|||
33357293|NCT01273818|101195474|FG002|Overall Study|Physician Decision|9|||
33357294|NCT04840667|101195476|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
33357295|NCT03015532|101195477|FG000|Overall Study|Adverse Event|0|||
33556770|NCT00520572|101937900|FG001|Overall Study|Lack of Efficacy|1|||
33556771|NCT00520572|101937901|FG002|Overall Study|Lack of Efficacy|1|||
33556772|NCT00520572|101937902|FG003|Overall Study|Lack of Efficacy|2|||
33556773|NCT00520572|101937903|FG004|Overall Study|Lack of Efficacy|1|||
33556774|NCT00520572|101937904|FG005|Overall Study|Lack of Efficacy|0|||
33621895|NCT01272232|102165911|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
33621896|NCT01272232|102165912|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
33621897|NCT01272232|102165910|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
33621898|NCT01272232|102165911|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
33621899|NCT01272232|102165912|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
33556775|NCT00520572|101937899|FG000|Overall Study|Lost to Follow-up|0|||
33556776|NCT00520572|101937900|FG001|Overall Study|Lost to Follow-up|0|||
33556777|NCT00520572|101937901|FG002|Overall Study|Lost to Follow-up|0|||
33556778|NCT00520572|101937902|FG003|Overall Study|Lost to Follow-up|0|||
33556779|NCT00520572|101937903|FG004|Overall Study|Lost to Follow-up|1|||
33556780|NCT00520572|101937904|FG005|Overall Study|Lost to Follow-up|0|||
33556781|NCT00520572|101937899|FG000|Overall Study|Incorrect enrollment|1|||
33556782|NCT00520572|101937900|FG001|Overall Study|Incorrect enrollment|0|||
33556783|NCT00520572|101937901|FG002|Overall Study|Incorrect enrollment|1|||
33556784|NCT00520572|101937902|FG003|Overall Study|Incorrect enrollment|0|||
33556785|NCT00520572|101937903|FG004|Overall Study|Incorrect enrollment|1|||
33556786|NCT00520572|101937904|FG005|Overall Study|Incorrect enrollment|0|||
33556787|NCT00520572|101937899|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
33556788|NCT00520572|101937900|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
33556789|NCT00520572|101937901|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
33556790|NCT00520572|101937902|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
33556791|NCT00520572|101937903|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
33556792|NCT00520572|101937904|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
33556793|NCT00520572|101937899|FG000|Overall Study|Long break in taking Medication|0|||
33556794|NCT00520572|101937900|FG001|Overall Study|Long break in taking Medication|0|||
33556795|NCT00520572|101937901|FG002|Overall Study|Long break in taking Medication|0|||
33556796|NCT00520572|101937902|FG003|Overall Study|Long break in taking Medication|1|||
33556797|NCT00520572|101937903|FG004|Overall Study|Long break in taking Medication|0|||
33556798|NCT00520572|101937904|FG005|Overall Study|Long break in taking Medication|0|||
33556799|NCT00520572|101937899|FG000|Overall Study|Did not receive Treatment|1|||
33556800|NCT00520572|101937900|FG001|Overall Study|Did not receive Treatment|0|||
33556801|NCT00520572|101937901|FG002|Overall Study|Did not receive Treatment|1|||
33556802|NCT00520572|101937902|FG003|Overall Study|Did not receive Treatment|0|||
33621900|NCT01272232|102165910|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
33621901|NCT01272232|102165911|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
33621902|NCT01272232|102165912|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
33621903|NCT01272232|102165910|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
33621904|NCT01272232|102165911|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
33621905|NCT01272232|102165912|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
33357296|NCT03015532|101195478|FG001|Overall Study|Adverse Event|0|||
33357297|NCT03015532|101195479|FG002|Overall Study|Adverse Event|0|||
33556803|NCT00520572|101937903|FG004|Overall Study|Did not receive Treatment|0|||
33556804|NCT00520572|101937904|FG005|Overall Study|Did not receive Treatment|0|||
33556805|NCT01133977|101937905|FG000|Overall Study|Adverse Event|0|||
33556806|NCT01133977|101937906|FG001|Overall Study|Adverse Event|0|||
33556807|NCT01133977|101937907|FG002|Overall Study|Adverse Event|1|||
33556808|NCT01133977|101937908|FG003|Overall Study|Adverse Event|0|||
33556809|NCT01133977|101937909|FG004|Overall Study|Adverse Event|0|||
33556810|NCT01133977|101937905|FG000|Overall Study|Death|1|||
33556811|NCT01133977|101937906|FG001|Overall Study|Death|1|||
33556812|NCT01133977|101937907|FG002|Overall Study|Death|1|||
33556813|NCT01133977|101937908|FG003|Overall Study|Death|7|||
33556814|NCT01133977|101937909|FG004|Overall Study|Death|3|||
33556815|NCT01133977|101937905|FG000|Overall Study|Started a New Line of Therapy|2|||
33556816|NCT01133977|101937906|FG001|Overall Study|Started a New Line of Therapy|6|||
33556817|NCT01133977|101937907|FG002|Overall Study|Started a New Line of Therapy|4|||
33556818|NCT01133977|101937908|FG003|Overall Study|Started a New Line of Therapy|25|||
33556819|NCT01133977|101937909|FG004|Overall Study|Started a New Line of Therapy|33|||
33556820|NCT01133977|101937905|FG000|Overall Study|Lost to Follow-up|0|||
33357298|NCT03015532|101195480|FG003|Overall Study|Adverse Event|0|||
33357299|NCT03015532|101195481|FG004|Overall Study|Adverse Event|0|||
33357300|NCT03015532|101195482|FG005|Overall Study|Adverse Event|2|||
33357301|NCT03015532|101195483|FG006|Overall Study|Adverse Event|1|||
33556821|NCT01133977|101937906|FG001|Overall Study|Lost to Follow-up|0|||
33556822|NCT01133977|101937907|FG002|Overall Study|Lost to Follow-up|0|||
33556823|NCT01133977|101937908|FG003|Overall Study|Lost to Follow-up|2|||
33556824|NCT01133977|101937909|FG004|Overall Study|Lost to Follow-up|1|||
33556825|NCT01133977|101937905|FG000|Overall Study|Withdrawal by Subject|0|||
33556826|NCT01133977|101937906|FG001|Overall Study|Withdrawal by Subject|0|||
33556827|NCT01133977|101937907|FG002|Overall Study|Withdrawal by Subject|0|||
33556828|NCT01133977|101937908|FG003|Overall Study|Withdrawal by Subject|5|||
33556829|NCT01133977|101937909|FG004|Overall Study|Withdrawal by Subject|1|||
33556830|NCT01392495|101937911|FG000|Overall Study|Death|3|||
33556831|NCT01392495|101937911|FG000|Overall Study|Administrative problems|8|||
33556832|NCT01392495|101937911|FG000|Overall Study|Withdrawal by Subject|2|||
33556833|NCT01392495|101937911|FG000|Overall Study|Adverse Event|3|||
33556834|NCT02469961|101937912|FG000|Overall Study|Physician Decision|4|||
33556835|NCT02469961|101937913|FG001|Overall Study|Physician Decision|1|||
33556836|NCT03180138|101937914|FG000|Overall Study|Mobile-phone could not be verified|2|||
33556837|NCT03180138|101937915|FG001|Overall Study|Mobile-phone could not be verified|13|||
33556838|NCT03180138|101937916|FG002|Overall Study|Mobile-phone could not be verified|15|||
33556839|NCT03180138|101937914|FG000|Overall Study|No prior immunization records|17|||
33556840|NCT03180138|101937915|FG001|Overall Study|No prior immunization records|0|||
33556841|NCT03180138|101937916|FG002|Overall Study|No prior immunization records|6|||
33556842|NCT03180138|101937914|FG000|Overall Study|Found to be >24 mon after randomization|3|||
33556843|NCT03180138|101937915|FG001|Overall Study|Found to be >24 mon after randomization|0|||
33218230|NCT02889133|100696004|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
33218231|NCT02889133|100696003|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
33218232|NCT02889133|100696004|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
33218233|NCT02889133|100696003|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
33218234|NCT02889133|100696004|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
33218235|NCT02889133|100696003|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
33357302|NCT03015532|101195484|FG007|Overall Study|Adverse Event|0|||
33556844|NCT03180138|101937916|FG002|Overall Study|Found to be >24 mon after randomization|3|||
33556845|NCT00432991|101937917|FG000|Overall Study|Protocol Violation|7|||
33556846|NCT00432991|101937918|FG001|Overall Study|Protocol Violation|12|||
33556847|NCT02168439|101937919|FG000|Overall Study|Protocol Violation|0|||
33556848|NCT02168439|101937920|FG001|Overall Study|Protocol Violation|2|||
33556849|NCT04525183|101937921|FG000|Overall Study|Withdrawal by Subject|0|||
33556850|NCT04525183|101937922|FG001|Overall Study|Withdrawal by Subject|0|||
33556851|NCT04525183|101937923|FG002|Overall Study|Withdrawal by Subject|3|||
33218236|NCT02889133|100696004|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
33218237|NCT02889133|100696003|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
33218238|NCT02889133|100696004|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
33218239|NCT02342886|100696007|FG000|Overall Study|Treatment non-compliance|1|||
33218240|NCT02342886|100696008|FG001|Overall Study|Treatment non-compliance|0|||
33218241|NCT02342886|100696009|FG002|Overall Study|Treatment non-compliance|0|||
33218242|NCT02342886|100696010|FG003|Overall Study|Treatment non-compliance|1|||
33218243|NCT02342886|100696011|FG004|Overall Study|Treatment non-compliance|0|||
33218244|NCT02342886|100696007|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
33218245|NCT02342886|100696008|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
33218246|NCT02342886|100696009|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
33218247|NCT02342886|100696010|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
33218248|NCT02342886|100696011|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
33218249|NCT02342886|100696007|FG000|Overall Study|Adverse event/specific toxicity|4|||
33218250|NCT02342886|100696008|FG001|Overall Study|Adverse event/specific toxicity|3|||
33218251|NCT02342886|100696009|FG002|Overall Study|Adverse event/specific toxicity|11|||
33218252|NCT02342886|100696010|FG003|Overall Study|Adverse event/specific toxicity|2|||
33218253|NCT02342886|100696011|FG004|Overall Study|Adverse event/specific toxicity|1|||
33218254|NCT02342886|100696007|FG000|Overall Study|Lost to Follow-up|1|||
33218255|NCT02342886|100696008|FG001|Overall Study|Lost to Follow-up|0|||
33218256|NCT02342886|100696009|FG002|Overall Study|Lost to Follow-up|0|||
33218257|NCT02342886|100696010|FG003|Overall Study|Lost to Follow-up|0|||
33621906|NCT01272232|102165910|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
33621907|NCT01272232|102165911|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
33218258|NCT02342886|100696011|FG004|Overall Study|Lost to Follow-up|0|||
33218259|NCT02342886|100696007|FG000|Overall Study|Death|1|||
33218260|NCT02342886|100696008|FG001|Overall Study|Death|2|||
33218261|NCT02342886|100696009|FG002|Overall Study|Death|1|||
33218262|NCT02342886|100696010|FG003|Overall Study|Death|0|||
33357303|NCT03015532|101195477|FG000|Overall Study|Withdrawal by Subject|0|||
33357304|NCT03015532|101195478|FG001|Overall Study|Withdrawal by Subject|0|||
33357305|NCT03015532|101195479|FG002|Overall Study|Withdrawal by Subject|0|||
33357306|NCT03015532|101195480|FG003|Overall Study|Withdrawal by Subject|0|||
33357307|NCT03015532|101195481|FG004|Overall Study|Withdrawal by Subject|0|||
33357308|NCT03015532|101195482|FG005|Overall Study|Withdrawal by Subject|0|||
33357309|NCT03015532|101195483|FG006|Overall Study|Withdrawal by Subject|1|||
33357310|NCT03015532|101195484|FG007|Overall Study|Withdrawal by Subject|0|||
33357311|NCT05309083|101195488|FG000|Overall Study|Withdrawal by Subject|2|||
33357312|NCT01440101|101195491|FG000|Overall Study|Adverse Event|2|||
33357313|NCT01440101|101195492|FG001|Overall Study|Adverse Event|0|||
33556852|NCT04525183|101937921|FG000|Overall Study|Study non-compliance|0|||
33556853|NCT04525183|101937922|FG001|Overall Study|Study non-compliance|0|||
33556854|NCT04525183|101937923|FG002|Overall Study|Study non-compliance|1|||
33556855|NCT04525183|101937921|FG000|Overall Study|Recurrent disease before starting on study|0|||
33556856|NCT04525183|101937922|FG001|Overall Study|Recurrent disease before starting on study|0|||
33556857|NCT04525183|101937923|FG002|Overall Study|Recurrent disease before starting on study|1|||
33556858|NCT00452530|101937924|FG000|Overall Study|Death|1|||
33556859|NCT00452530|101937925|FG001|Overall Study|Death|0|||
33556860|NCT00452530|101937924|FG000|Overall Study|Adverse Event|40|||
33556861|NCT00452530|101937925|FG001|Overall Study|Adverse Event|44|||
33621908|NCT01272232|102165912|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
33621909|NCT00615017|102165913|FG000|Overall Study|Adverse Event|0|||
33621910|NCT00615017|102165914|FG001|Overall Study|Adverse Event|1|||
33621911|NCT00615017|102165915|FG002|Overall Study|Adverse Event|2|||
33357314|NCT01440101|101195493|FG002|Overall Study|Adverse Event|0|||
33357315|NCT01440101|101195491|FG000|Overall Study|Withdrawal by Subject|0|||
33621912|NCT00615017|102165916|FG003|Overall Study|Adverse Event|0|||
33621913|NCT00615017|102165917|FG004|Overall Study|Adverse Event|0|||
33621914|NCT00615017|102165918|FG005|Overall Study|Adverse Event|1|||
33621915|NCT00615017|102165913|FG000|Overall Study|Death|0|||
33621916|NCT00615017|102165914|FG001|Overall Study|Death|0|||
33621917|NCT00615017|102165915|FG002|Overall Study|Death|2|||
33218263|NCT02342886|100696011|FG004|Overall Study|Death|1|||
33218264|NCT02342886|100696007|FG000|Overall Study|Withdrawal by Subject|0|||
33218265|NCT02342886|100696008|FG001|Overall Study|Withdrawal by Subject|1|||
33218266|NCT02342886|100696009|FG002|Overall Study|Withdrawal by Subject|0|||
33357316|NCT01440101|101195492|FG001|Overall Study|Withdrawal by Subject|3|||
33357317|NCT01440101|101195493|FG002|Overall Study|Withdrawal by Subject|1|||
33357318|NCT01440101|101195491|FG000|Overall Study|Other|0|||
33621918|NCT00615017|102165916|FG003|Overall Study|Death|0|||
33621919|NCT00615017|102165917|FG004|Overall Study|Death|1|||
33218267|NCT02342886|100696010|FG003|Overall Study|Withdrawal by Subject|1|||
33218268|NCT02342886|100696011|FG004|Overall Study|Withdrawal by Subject|0|||
33556862|NCT00452530|101937924|FG000|Overall Study|Withdrawal by Subject|68|||
33556863|NCT00452530|101937925|FG001|Overall Study|Withdrawal by Subject|57|||
33621920|NCT00615017|102165918|FG005|Overall Study|Death|1|||
33357319|NCT01440101|101195492|FG001|Overall Study|Other|1|||
33357320|NCT01440101|101195493|FG002|Overall Study|Other|0|||
33357321|NCT01697345|101195496|FG000|Overall Study|Withdrawal by Subject|1|||
33357322|NCT02371629|101195497|FG000|Overall Study|Patient decision|14|||
33357323|NCT02371629|101195498|FG001|Overall Study|Patient decision|10|||
33357324|NCT02371629|101195497|FG000|Overall Study|Adverse Event|8|||
33357325|NCT02371629|101195498|FG001|Overall Study|Adverse Event|8|||
33357326|NCT02371629|101195497|FG000|Overall Study|Physician Decision|2|||
33357327|NCT02371629|101195498|FG001|Overall Study|Physician Decision|3|||
33357328|NCT02371629|101195497|FG000|Overall Study|Death|1|||
33357329|NCT02371629|101195498|FG001|Overall Study|Death|1|||
33357330|NCT02371629|101195497|FG000|Overall Study|Noncompliance with study treatment|1|||
33357331|NCT02371629|101195498|FG001|Overall Study|Noncompliance with study treatment|0|||
33357332|NCT02371629|101195497|FG000|Overall Study|Lack of Efficacy|0|||
33357333|NCT02371629|101195498|FG001|Overall Study|Lack of Efficacy|2|||
33357334|NCT02371629|101195497|FG000|Overall Study|Protocol deviation|0|||
33357335|NCT02371629|101195498|FG001|Overall Study|Protocol deviation|1|||
33357336|NCT00860470|101195501|FG000|Overall Study|Death|6|||
33357337|NCT00860470|101195502|FG001|Overall Study|Death|10|||
33357338|NCT00860470|101195501|FG000|Overall Study|Moved away|8|||
33357339|NCT00860470|101195502|FG001|Overall Study|Moved away|10|||
33357340|NCT00860470|101195501|FG000|Overall Study|Lost to Follow-up|34|||
33357341|NCT00860470|101195502|FG001|Overall Study|Lost to Follow-up|39|||
33357342|NCT04919564|101195507|FG000|Overall Study|Lost to Follow-up|1|||
33357343|NCT04919564|101195508|FG001|Overall Study|Lost to Follow-up|0|||
33357344|NCT04919564|101195507|FG000|Overall Study|Physician Decision|1|||
33357345|NCT04919564|101195508|FG001|Overall Study|Physician Decision|1|||
33357346|NCT00845429|101195509|FG000|Overall Study|Protocol Violation|5|||
33357347|NCT00845429|101195510|FG001|Overall Study|Protocol Violation|4|||
33556864|NCT00452530|101937924|FG000|Overall Study|Lost to Follow-up|1|||
33556865|NCT00452530|101937925|FG001|Overall Study|Lost to Follow-up|0|||
33556866|NCT00452530|101937924|FG000|Overall Study|Poor compliance/noncompliance|1|||
33556867|NCT00452530|101937925|FG001|Overall Study|Poor compliance/noncompliance|2|||
33556868|NCT00452530|101937924|FG000|Overall Study|No longer met study criteria|18|||
33556869|NCT00452530|101937925|FG001|Overall Study|No longer met study criteria|22|||
33556870|NCT00452530|101937924|FG000|Overall Study|Other|7|||
33556871|NCT00452530|101937925|FG001|Overall Study|Other|11|||
33556872|NCT01950390|101937929|FG000|Overall Study|Never started treatment|3|||
33556873|NCT01950390|101937930|FG001|Overall Study|Never started treatment|2|||
33556874|NCT01950390|101937929|FG000|Overall Study|Disease progression|45|||
33556875|NCT01950390|101937930|FG001|Overall Study|Disease progression|52|||
33556876|NCT01950390|101937929|FG000|Overall Study|Adverse Event|22|||
33556877|NCT01950390|101937930|FG001|Overall Study|Adverse Event|16|||
33556878|NCT01950390|101937929|FG000|Overall Study|Death|5|||
33357348|NCT00845429|101195511|FG002|Overall Study|Protocol Violation|7|||
33357349|NCT00845429|101195509|FG000|Overall Study|Lost to Follow-up|7|||
33357350|NCT00845429|101195510|FG001|Overall Study|Lost to Follow-up|9|||
33414401|NCT03039686|101406656|FG002|Open Label Period|Withdrawal by Subject|1|||
33414402|NCT03940742|101406657|FG000|Overall Study|Lost to Follow-up|0|||
33357351|NCT00845429|101195511|FG002|Overall Study|Lost to Follow-up|10|||
33357352|NCT00845429|101195509|FG000|Overall Study|Withdrawal by Subject|2|||
33357353|NCT00845429|101195510|FG001|Overall Study|Withdrawal by Subject|2|||
33357354|NCT00845429|101195511|FG002|Overall Study|Withdrawal by Subject|2|||
33357355|NCT00845429|101195509|FG000|Overall Study|Serious adverse event|0|||
33556879|NCT01950390|101937930|FG001|Overall Study|Death|3|||
33556880|NCT01950390|101937929|FG000|Overall Study|Withdrawal by Subject|5|||
33556881|NCT01950390|101937930|FG001|Overall Study|Withdrawal by Subject|1|||
33556882|NCT01950390|101937929|FG000|Overall Study|Alternative therapy|0|||
33556883|NCT01950390|101937930|FG001|Overall Study|Alternative therapy|3|||
33556884|NCT01950390|101937929|FG000|Overall Study|Complicating disease|1|||
33556885|NCT01950390|101937930|FG001|Overall Study|Complicating disease|0|||
33357356|NCT00845429|101195510|FG001|Overall Study|Serious adverse event|0|||
33357357|NCT00845429|101195511|FG002|Overall Study|Serious adverse event|1|||
33357358|NCT01756157|101195519|FG000|First Intervention Period|Withdrawal by Subject|1|||
33357359|NCT01756157|101195520|FG001|First Intervention Period|Withdrawal by Subject|0|||
33357360|NCT01756157|101195519|FG000|First Intervention Period|Lost to Follow-up|0|||
33357361|NCT01756157|101195520|FG001|First Intervention Period|Lost to Follow-up|2|||
33357362|NCT01937312|101195521|FG000|Overall Study|Adverse Event|10|||
33357363|NCT01937312|101195522|FG001|Overall Study|Adverse Event|1|||
33357364|NCT01937312|101195521|FG000|Overall Study|Lack of Efficacy|0|||
33357365|NCT01937312|101195522|FG001|Overall Study|Lack of Efficacy|1|||
33357366|NCT01937312|101195521|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
33357367|NCT01937312|101195522|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
33357368|NCT01733329|101195523|FG000|Overall Study|Protocol Violation|1|||
33357369|NCT01733329|101195524|FG001|Overall Study|Protocol Violation|1|||
33357370|NCT01733329|101195523|FG000|Overall Study|Uterine artery injury|1|||
33357371|NCT01733329|101195524|FG001|Overall Study|Uterine artery injury|0|||
33357372|NCT01676961|101195525|FG000|Overall Study|Death|3|||
33357373|NCT01676961|101195525|FG000|Overall Study|Lost to Follow-up|1|||
33357374|NCT01676961|101195525|FG000|Overall Study|Withdrawal by Subject|1|||
33556886|NCT01950390|101937929|FG000|Overall Study|On treatment|1|||
33556887|NCT01950390|101937930|FG001|Overall Study|On treatment|0|||
33556888|NCT01950390|101937929|FG000|Overall Study|Symptomatic deterioration|2|||
33556889|NCT01950390|101937930|FG001|Overall Study|Symptomatic deterioration|1|||
33556890|NCT01950390|101937929|FG000|Overall Study|Physician Decision|0|||
33556891|NCT01950390|101937930|FG001|Overall Study|Physician Decision|4|||
33357375|NCT04331899|101195527|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
33357376|NCT04331899|101195528|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
33357377|NCT00075881|101195540|FG000|Overall Study|Lack of Efficacy|18|||
33357378|NCT00075881|101195540|FG000|Overall Study|Adverse Event|7|||
33357379|NCT00075881|101195540|FG000|Overall Study|Death|1|||
33357380|NCT00075881|101195540|FG000|Overall Study|Withdrawal by Subject|2|||
33556892|NCT01950390|101937929|FG000|Overall Study|Lack of clinical benefit|0|||
33621921|NCT00615017|102165913|FG000|Overall Study|Sepsis resolved|0|||
33621922|NCT00615017|102165914|FG001|Overall Study|Sepsis resolved|0|||
33621923|NCT00615017|102165915|FG002|Overall Study|Sepsis resolved|1|||
33621924|NCT00615017|102165916|FG003|Overall Study|Sepsis resolved|0|||
33357381|NCT00075881|101195540|FG000|Overall Study|Protocol Violation|4|||
33357382|NCT00075881|101195540|FG000|Overall Study|other complicating disease|3|||
33357383|NCT00075881|101195540|FG000|Overall Study|other|4|||
33357384|NCT00075881|101195540|FG000|Overall Study|missing data|2|||
33357385|NCT00075881|101195540|FG000|Overall Study|Ineligible|1|||
33357386|NCT00075881|101195540|FG000|Overall Study|never start protocol therapy|1|||
33621925|NCT00615017|102165917|FG004|Overall Study|Sepsis resolved|0|||
33621926|NCT00615017|102165918|FG005|Overall Study|Sepsis resolved|0|||
33621927|NCT00615017|102165913|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
33621928|NCT00615017|102165914|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
33621929|NCT00615017|102165915|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
33621930|NCT00615017|102165916|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
33621931|NCT00615017|102165917|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
33621932|NCT00615017|102165918|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
33621933|NCT00615017|102165913|FG000|Overall Study|Physician discontinued drug|0|||
33621934|NCT00615017|102165914|FG001|Overall Study|Physician discontinued drug|0|||
33621935|NCT00615017|102165915|FG002|Overall Study|Physician discontinued drug|0|||
33621936|NCT00615017|102165916|FG003|Overall Study|Physician discontinued drug|0|||
33621937|NCT00615017|102165917|FG004|Overall Study|Physician discontinued drug|0|||
33621938|NCT00615017|102165918|FG005|Overall Study|Physician discontinued drug|1|||
33621939|NCT02995980|102165919|FG000|Overall Study|Lost to Follow-up|14|||
33621940|NCT00506350|102165920|FG000|Overall Study|Serious Adverse Event|1|||
33621941|NCT00506350|102165921|FG001|Overall Study|Serious Adverse Event|0|||
33621942|NCT00506350|102165922|FG002|Overall Study|Serious Adverse Event|0|||
33357387|NCT00356915|101195543|FG000|Overall Study|Non compliance|1|||
33357388|NCT00356915|101195544|FG001|Overall Study|Non compliance|2|||
33357389|NCT00356915|101195545|FG002|Overall Study|Non compliance|1|||
33556893|NCT01950390|101937930|FG001|Overall Study|Lack of clinical benefit|1|||
33556894|NCT01950390|101937929|FG000|Overall Study|Maintained PR and moved to observation only|0|||
33556895|NCT01950390|101937930|FG001|Overall Study|Maintained PR and moved to observation only|1|||
33621943|NCT00506350|102165923|FG003|Overall Study|Serious Adverse Event|0|||
33621944|NCT00506350|102165924|FG004|Overall Study|Serious Adverse Event|0|||
33621945|NCT00506350|102165925|FG005|Overall Study|Serious Adverse Event|0|||
33357390|NCT00356915|101195543|FG000|Overall Study|Protocol Violation|2|||
33357391|NCT00356915|101195544|FG001|Overall Study|Protocol Violation|3|||
33357392|NCT00356915|101195545|FG002|Overall Study|Protocol Violation|2|||
33357393|NCT00356915|101195543|FG000|Overall Study|Withdrawal by Subject|14|||
33556896|NCT03566550|101937936|FG000|Overall Study|Withdrawal by Subject|0|||
33556897|NCT03566550|101937937|FG001|Overall Study|Withdrawal by Subject|1|||
33556898|NCT00758043|101937938|FG000|Overall Study|Adverse Event|1|||
33218269|NCT02342886|100696007|FG000|Overall Study|Investigator/sponsor decision|0|||
33218270|NCT02342886|100696008|FG001|Overall Study|Investigator/sponsor decision|2|||
33357394|NCT00356915|101195544|FG001|Overall Study|Withdrawal by Subject|14|||
33357395|NCT00356915|101195545|FG002|Overall Study|Withdrawal by Subject|10|||
33357396|NCT00356915|101195543|FG000|Overall Study|Lack of Efficacy|0|||
33357397|NCT00356915|101195544|FG001|Overall Study|Lack of Efficacy|0|||
33357398|NCT00356915|101195545|FG002|Overall Study|Lack of Efficacy|3|||
33357399|NCT00356915|101195543|FG000|Overall Study|Lost to Follow-up|27|||
33357400|NCT00356915|101195544|FG001|Overall Study|Lost to Follow-up|34|||
33357401|NCT00356915|101195545|FG002|Overall Study|Lost to Follow-up|14|||
33357402|NCT00356915|101195543|FG000|Overall Study|Administrative Decision|0|||
33357403|NCT00356915|101195544|FG001|Overall Study|Administrative Decision|0|||
33357404|NCT00356915|101195545|FG002|Overall Study|Administrative Decision|1|||
33357405|NCT00356915|101195543|FG000|Overall Study|Physician Decision|0|||
33357406|NCT00356915|101195544|FG001|Overall Study|Physician Decision|2|||
33357407|NCT00356915|101195545|FG002|Overall Study|Physician Decision|0|||
33357408|NCT00356915|101195543|FG000|Overall Study|Adverse Event|21|||
33357409|NCT00356915|101195544|FG001|Overall Study|Adverse Event|31|||
33357410|NCT00356915|101195545|FG002|Overall Study|Adverse Event|8|||
33357411|NCT00356915|101195543|FG000|Overall Study|Miscellaneous reasons|11|||
33357412|NCT00356915|101195544|FG001|Overall Study|Miscellaneous reasons|8|||
33357413|NCT00356915|101195545|FG002|Overall Study|Miscellaneous reasons|3|||
33357414|NCT02799381|101195548|FG000|Overall Study|Withdrew consent|3|||
33357415|NCT02799381|101195549|FG001|Overall Study|Withdrew consent|2|||
33357416|NCT02799381|101195548|FG000|Overall Study|Adverse Event|0|||
33357417|NCT02799381|101195549|FG001|Overall Study|Adverse Event|1|||
33357418|NCT02799381|101195548|FG000|Overall Study|Participant did not take any study drug|1|||
33357419|NCT02799381|101195549|FG001|Overall Study|Participant did not take any study drug|0|||
33357420|NCT04938648|101195550|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
33357421|NCT04938648|101195551|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
33357422|NCT04938648|101195550|FG000|Overall Study|Patient too ill|0|||
33357423|NCT04938648|101195551|FG001|Overall Study|Patient too ill|1|||
33357424|NCT04938648|101195550|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
33357425|NCT04938648|101195551|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
33357426|NCT04938648|101195550|FG000|Overall Study|Patient did not have memory problems|1|||
33357427|NCT04938648|101195551|FG001|Overall Study|Patient did not have memory problems|1|||
33357428|NCT04938648|101195550|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
33357429|NCT04938648|101195551|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
33357430|NCT04938648|101195550|FG000|Overall Study|Care partner could not be reached|0|||
33357431|NCT04938648|101195551|FG001|Overall Study|Care partner could not be reached|1|||
33357432|NCT04938648|101195550|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
33357433|NCT04938648|101195551|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
33357434|NCT04938648|101195550|FG000|Overall Study|Withdrawal by Subject|2|||
33357435|NCT04938648|101195551|FG001|Overall Study|Withdrawal by Subject|1|||
33357436|NCT00224016|101195552|FG000|Titration Period|Withdrawal by Subject|0|||
33357437|NCT00224016|101195553|FG001|Titration Period|Withdrawal by Subject|1|||
33357438|NCT00224016|101195552|FG000|Titration Period|Lost to Follow-up|1|||
33357439|NCT00224016|101195553|FG001|Titration Period|Lost to Follow-up|0|||
33357440|NCT00224016|101195552|FG000|Maintenance Period|Withdrawal by Subject|2|||
33357441|NCT00224016|101195553|FG001|Maintenance Period|Withdrawal by Subject|0|||
33357442|NCT00224016|101195552|FG000|Maintenance Period|Lost to Follow-up|0|||
33357443|NCT00224016|101195553|FG001|Maintenance Period|Lost to Follow-up|1|||
33357444|NCT01985321|101195554|FG000|Overall Study|Protocol Violation|4|||
33357445|NCT01985321|101195555|FG001|Overall Study|Protocol Violation|3|||
33357446|NCT01985321|101195554|FG000|Overall Study|Withdrawal by Subject|1|||
33357447|NCT01985321|101195555|FG001|Overall Study|Withdrawal by Subject|0|||
33357448|NCT01985321|101195554|FG000|Overall Study|Lost to Follow-up|5|||
33357449|NCT01985321|101195555|FG001|Overall Study|Lost to Follow-up|2|||
33357450|NCT01985321|101195554|FG000|Overall Study|Subject treated wrong type of sore|1|||
33357451|NCT01985321|101195555|FG001|Overall Study|Subject treated wrong type of sore|0|||
33357452|NCT00472303|101195556|FG000|Titration Phase|Adverse Event|22|||
33556899|NCT00758043|101937939|FG001|Overall Study|Adverse Event|20|||
33556900|NCT00758043|101937940|FG002|Overall Study|Adverse Event|12|||
33556901|NCT00758043|101937941|FG003|Overall Study|Adverse Event|62|||
33556902|NCT00758043|101937938|FG000|Overall Study|Lack of Efficacy|0|||
33218271|NCT02342886|100696009|FG002|Overall Study|Investigator/sponsor decision|0|||
33357453|NCT00472303|101195557|FG001|Titration Phase|Adverse Event|12|||
33357454|NCT00472303|101195558|FG002|Titration Phase|Adverse Event|0|||
33357455|NCT00472303|101195556|FG000|Titration Phase|Death|4|||
33357456|NCT00472303|101195557|FG001|Titration Phase|Death|2|||
33357457|NCT00472303|101195558|FG002|Titration Phase|Death|0|||
33357458|NCT00472303|101195556|FG000|Titration Phase|Lack of Efficacy|10|||
33357459|NCT00472303|101195557|FG001|Titration Phase|Lack of Efficacy|0|||
33556903|NCT00758043|101937939|FG001|Overall Study|Lack of Efficacy|6|||
33556904|NCT00758043|101937940|FG002|Overall Study|Lack of Efficacy|18|||
33357460|NCT00472303|101195558|FG002|Titration Phase|Lack of Efficacy|0|||
33357461|NCT00472303|101195556|FG000|Titration Phase|Withdrawal by Subject|16|||
33357462|NCT00472303|101195557|FG001|Titration Phase|Withdrawal by Subject|13|||
33357463|NCT00472303|101195558|FG002|Titration Phase|Withdrawal by Subject|0|||
33357464|NCT00472303|101195556|FG000|Titration Phase|Trial Medication non-compliant|4|||
33357465|NCT00472303|101195557|FG001|Titration Phase|Trial Medication non-compliant|1|||
33357466|NCT00472303|101195558|FG002|Titration Phase|Trial Medication non-compliant|0|||
33357467|NCT00472303|101195556|FG000|Titration Phase|Other|3|||
33357468|NCT00472303|101195557|FG001|Titration Phase|Other|1|||
33357469|NCT00472303|101195558|FG002|Titration Phase|Other|0|||
33357470|NCT00472303|101195556|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
33357471|NCT00472303|101195557|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
33357472|NCT00472303|101195558|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
33357473|NCT00472303|101195556|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
33357474|NCT00472303|101195557|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
33357475|NCT00472303|101195558|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
33357476|NCT00472303|101195556|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
33357477|NCT00472303|101195557|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
33357478|NCT00472303|101195558|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
33357479|NCT00472303|101195556|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
33357480|NCT00472303|101195557|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
33357481|NCT00472303|101195558|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
33357482|NCT00472303|101195556|FG000|Discontinuations After Titration Phase|Other|5|||
33357483|NCT00472303|101195557|FG001|Discontinuations After Titration Phase|Other|0|||
33357484|NCT00472303|101195558|FG002|Discontinuations After Titration Phase|Other|0|||
33357485|NCT00472303|101195556|FG000|Maintenance Phase|Adverse Event|5|||
33357486|NCT00472303|101195557|FG001|Maintenance Phase|Adverse Event|6|||
33357487|NCT00472303|101195558|FG002|Maintenance Phase|Adverse Event|6|||
33357488|NCT00472303|101195556|FG000|Maintenance Phase|Death|3|||
33357489|NCT00472303|101195557|FG001|Maintenance Phase|Death|0|||
33357490|NCT00472303|101195558|FG002|Maintenance Phase|Death|2|||
33357491|NCT00472303|101195556|FG000|Maintenance Phase|Lack of Efficacy|2|||
33357492|NCT00472303|101195557|FG001|Maintenance Phase|Lack of Efficacy|2|||
33357493|NCT00472303|101195558|FG002|Maintenance Phase|Lack of Efficacy|4|||
33357494|NCT00472303|101195556|FG000|Maintenance Phase|Withdrawal by Subject|6|||
33357495|NCT00472303|101195557|FG001|Maintenance Phase|Withdrawal by Subject|7|||
33357496|NCT00472303|101195558|FG002|Maintenance Phase|Withdrawal by Subject|3|||
33357497|NCT00472303|101195556|FG000|Maintenance Phase|Trial medication non-compliant|0|||
33357498|NCT00472303|101195557|FG001|Maintenance Phase|Trial medication non-compliant|0|||
33357499|NCT00472303|101195558|FG002|Maintenance Phase|Trial medication non-compliant|1|||
33357500|NCT00472303|101195556|FG000|Maintenance Phase|Resolution of pain|0|||
33357501|NCT00472303|101195557|FG001|Maintenance Phase|Resolution of pain|0|||
33357502|NCT00472303|101195558|FG002|Maintenance Phase|Resolution of pain|1|||
33357503|NCT00472303|101195556|FG000|Maintenance Phase|Other|1|||
33357504|NCT00472303|101195557|FG001|Maintenance Phase|Other|1|||
33357505|NCT00472303|101195558|FG002|Maintenance Phase|Other|0|||
33357506|NCT01073943|101195559|FG000|Overall Study|Withdrawal by Subject|8|||
33357507|NCT01073943|101195560|FG001|Overall Study|Withdrawal by Subject|2|||
33357508|NCT01073943|101195559|FG000|Overall Study|Protocol Violation|2|||
33357509|NCT01073943|101195560|FG001|Overall Study|Protocol Violation|1|||
33556905|NCT00758043|101937941|FG003|Overall Study|Lack of Efficacy|12|||
33556906|NCT00758043|101937938|FG000|Overall Study|Refused Further Treatment|0|||
33556907|NCT00758043|101937939|FG001|Overall Study|Refused Further Treatment|11|||
33556908|NCT00758043|101937940|FG002|Overall Study|Refused Further Treatment|5|||
33556909|NCT00758043|101937941|FG003|Overall Study|Refused Further Treatment|8|||
33556910|NCT00758043|101937938|FG000|Overall Study|Lost to Follow-up|0|||
33556911|NCT00758043|101937939|FG001|Overall Study|Lost to Follow-up|2|||
33556912|NCT00758043|101937940|FG002|Overall Study|Lost to Follow-up|2|||
33556913|NCT00758043|101937941|FG003|Overall Study|Lost to Follow-up|5|||
33556914|NCT00758043|101937938|FG000|Overall Study|Withdrawal by Subject|0|||
33556915|NCT00758043|101937939|FG001|Overall Study|Withdrawal by Subject|1|||
33357510|NCT01073943|101195559|FG000|Overall Study|Adverse Event|1|||
33357511|NCT01073943|101195560|FG001|Overall Study|Adverse Event|1|||
33357512|NCT01073943|101195559|FG000|Overall Study|Lost to Follow-up|0|||
33357513|NCT01073943|101195560|FG001|Overall Study|Lost to Follow-up|2|||
33357514|NCT01073943|101195559|FG000|Overall Study|Power outage; colonoscopy not done|1|||
33357515|NCT01073943|101195560|FG001|Overall Study|Power outage; colonoscopy not done|0|||
33357516|NCT01073943|101195559|FG000|Overall Study|Subject forgot|0|||
33556916|NCT00758043|101937940|FG002|Overall Study|Withdrawal by Subject|1|||
33556917|NCT00758043|101937941|FG003|Overall Study|Withdrawal by Subject|4|||
33556918|NCT00758043|101937938|FG000|Overall Study|Required Prohibited Medication|0|||
33556919|NCT00758043|101937939|FG001|Overall Study|Required Prohibited Medication|0|||
33556920|NCT00758043|101937940|FG002|Overall Study|Required Prohibited Medication|1|||
33357517|NCT01073943|101195560|FG001|Overall Study|Subject forgot|1|||
33556921|NCT00758043|101937941|FG003|Overall Study|Required Prohibited Medication|3|||
33556922|NCT00758043|101937938|FG000|Overall Study|Non-Compliant With study Drug|0|||
33556923|NCT00758043|101937939|FG001|Overall Study|Non-Compliant With study Drug|0|||
33556924|NCT00758043|101937940|FG002|Overall Study|Non-Compliant With study Drug|0|||
33556925|NCT00758043|101937941|FG003|Overall Study|Non-Compliant With study Drug|1|||
33621946|NCT00506350|102165926|FG006|Overall Study|Serious Adverse Event|0|||
33621947|NCT00506350|102165927|FG007|Overall Study|Serious Adverse Event|0|||
33621948|NCT00506350|102165928|FG008|Overall Study|Serious Adverse Event|0|||
33621949|NCT00506350|102165920|FG000|Overall Study|Adverse Event|0|||
33621950|NCT00506350|102165921|FG001|Overall Study|Adverse Event|0|||
33621951|NCT00506350|102165922|FG002|Overall Study|Adverse Event|0|||
33621952|NCT00506350|102165923|FG003|Overall Study|Adverse Event|0|||
33621953|NCT00506350|102165924|FG004|Overall Study|Adverse Event|0|||
33621954|NCT00506350|102165925|FG005|Overall Study|Adverse Event|0|||
33621955|NCT00506350|102165926|FG006|Overall Study|Adverse Event|0|||
33621956|NCT00506350|102165927|FG007|Overall Study|Adverse Event|1|||
33621957|NCT00506350|102165928|FG008|Overall Study|Adverse Event|1|||
33621958|NCT00506350|102165920|FG000|Overall Study|Protocol Violation|0|||
33621959|NCT00506350|102165921|FG001|Overall Study|Protocol Violation|0|||
33621960|NCT00506350|102165922|FG002|Overall Study|Protocol Violation|1|||
33621961|NCT00506350|102165923|FG003|Overall Study|Protocol Violation|0|||
33621962|NCT00506350|102165924|FG004|Overall Study|Protocol Violation|0|||
33621963|NCT00506350|102165925|FG005|Overall Study|Protocol Violation|0|||
33621964|NCT00506350|102165926|FG006|Overall Study|Protocol Violation|1|||
33621965|NCT00506350|102165927|FG007|Overall Study|Protocol Violation|0|||
33621966|NCT00506350|102165928|FG008|Overall Study|Protocol Violation|0|||
33621967|NCT00506350|102165920|FG000|Overall Study|Withdrawal by Subject|0|||
33357518|NCT01073943|101195559|FG000|Overall Study|Unable to return for follow-up|0|||
33357519|NCT01073943|101195560|FG001|Overall Study|Unable to return for follow-up|1|||
33357520|NCT01073943|101195559|FG000|Overall Study|Could not tolerate prep|1|||
33357521|NCT01073943|101195560|FG001|Overall Study|Could not tolerate prep|0|||
33357522|NCT00996840|101195561|FG000|Overall Study|Adverse Event|0|||
33357523|NCT00996840|101195562|FG001|Overall Study|Adverse Event|1|||
33357524|NCT00996840|101195563|FG002|Overall Study|Adverse Event|0|||
33357525|NCT00996840|101195564|FG003|Overall Study|Adverse Event|0|||
33357526|NCT00996840|101195565|FG004|Overall Study|Adverse Event|0|||
33357527|NCT00996840|101195561|FG000|Overall Study|Physician Decision|0|||
33556926|NCT00758043|101937938|FG000|Overall Study|Other Reasons|0|||
33556927|NCT00758043|101937939|FG001|Overall Study|Other Reasons|1|||
33621968|NCT00506350|102165921|FG001|Overall Study|Withdrawal by Subject|1|||
33621969|NCT00506350|102165922|FG002|Overall Study|Withdrawal by Subject|1|||
33621970|NCT00506350|102165923|FG003|Overall Study|Withdrawal by Subject|1|||
33621971|NCT00506350|102165924|FG004|Overall Study|Withdrawal by Subject|4|||
33621972|NCT00506350|102165925|FG005|Overall Study|Withdrawal by Subject|1|||
33621973|NCT00506350|102165926|FG006|Overall Study|Withdrawal by Subject|1|||
33218272|NCT02342886|100696010|FG003|Overall Study|Investigator/sponsor decision|3|||
33357528|NCT00996840|101195562|FG001|Overall Study|Physician Decision|0|||
33556928|NCT00758043|101937940|FG002|Overall Study|Other Reasons|0|||
33556929|NCT00758043|101937941|FG003|Overall Study|Other Reasons|5|||
33556930|NCT00862277|101937942|FG000|Overall Study|Protocol Violation|1|||
33556931|NCT00862277|101937943|FG001|Overall Study|Protocol Violation|2|||
33556932|NCT00862277|101937944|FG002|Overall Study|Protocol Violation|5|||
33556933|NCT04882215|101937949|FG000|Overall Study|Withdrawal by Subject|5|||
33556934|NCT04882215|101937950|FG001|Overall Study|Withdrawal by Subject|0|||
33556935|NCT03721965|101937952|FG000|Overall Study|Death|1|||
33556936|NCT03721965|101937952|FG000|Overall Study|Study Terminated by Sponsor|1|||
33556937|NCT04191096|101937955|FG000|Overall Study|Death|102|||
33556938|NCT04191096|101937956|FG001|Overall Study|Death|89|||
33556939|NCT04191096|101937955|FG000|Overall Study|Lost to Follow-up|1|||
33556940|NCT04191096|101937956|FG001|Overall Study|Lost to Follow-up|1|||
33556941|NCT04191096|101937955|FG000|Overall Study|Withdrawal by Subject|5|||
33556942|NCT04191096|101937956|FG001|Overall Study|Withdrawal by Subject|5|||
33556943|NCT04191096|101937955|FG000|Overall Study|Participants Ongoing|518|||
33556944|NCT04191096|101937956|FG001|Overall Study|Participants Ongoing|530|||
33556945|NCT02773537|101937965|FG000|Overall Study|Lost to Follow-up|0|||
33556946|NCT02773537|101937966|FG001|Overall Study|Lost to Follow-up|1|||
33556947|NCT02773537|101937967|FG002|Overall Study|Lost to Follow-up|4|||
33621974|NCT00506350|102165927|FG007|Overall Study|Withdrawal by Subject|2|||
33621975|NCT00506350|102165928|FG008|Overall Study|Withdrawal by Subject|0|||
33621976|NCT00506350|102165920|FG000|Overall Study|Lost to Follow-up|1|||
33621977|NCT00506350|102165921|FG001|Overall Study|Lost to Follow-up|1|||
33357529|NCT00996840|101195563|FG002|Overall Study|Physician Decision|1|||
33357530|NCT00996840|101195564|FG003|Overall Study|Physician Decision|1|||
33556948|NCT01064622|101937968|FG000|Randomized Phase II|Withdrawal by Subject|2|||
33556949|NCT01064622|101937969|FG001|Randomized Phase II|Withdrawal by Subject|2|||
33556950|NCT01064622|101937968|FG000|Randomized Phase II|Protocol Violation|0|||
33556951|NCT01064622|101937969|FG001|Randomized Phase II|Protocol Violation|1|||
33414403|NCT03940742|101406658|FG001|Overall Study|Lost to Follow-up|0|||
33556952|NCT04595370|101937972|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
33556953|NCT04595370|101937973|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
33556954|NCT04595370|101937974|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
33556955|NCT04595370|101937975|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
33556956|NCT04595370|101937976|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
33556957|NCT04595370|101937977|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
33556958|NCT04595370|101937972|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
33556959|NCT04595370|101937973|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
33556960|NCT04595370|101937974|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
33556961|NCT04595370|101937975|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
33556962|NCT04595370|101937976|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
33556963|NCT04595370|101937977|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
33556964|NCT04595370|101937972|FG000|Overall Study|Adverse Event|0|||
33556965|NCT04595370|101937973|FG001|Overall Study|Adverse Event|4|||
33556966|NCT04595370|101937974|FG002|Overall Study|Adverse Event|3|||
33556967|NCT04595370|101937975|FG003|Overall Study|Adverse Event|1|||
33556968|NCT04595370|101937976|FG004|Overall Study|Adverse Event|1|||
33556969|NCT04595370|101937977|FG005|Overall Study|Adverse Event|1|||
33556970|NCT04595370|101937972|FG000|Overall Study|Withdrawal of Consent|1|||
33556971|NCT04595370|101937973|FG001|Overall Study|Withdrawal of Consent|1|||
33556972|NCT04595370|101937974|FG002|Overall Study|Withdrawal of Consent|1|||
33556973|NCT04595370|101937975|FG003|Overall Study|Withdrawal of Consent|0|||
33556974|NCT04595370|101937976|FG004|Overall Study|Withdrawal of Consent|0|||
33556975|NCT04595370|101937977|FG005|Overall Study|Withdrawal of Consent|0|||
33556976|NCT04595370|101937972|FG000|Overall Study|Death|0|||
33556977|NCT04595370|101937973|FG001|Overall Study|Death|1|||
33556978|NCT04595370|101937974|FG002|Overall Study|Death|0|||
33556979|NCT04595370|101937975|FG003|Overall Study|Death|0|||
33556980|NCT04595370|101937976|FG004|Overall Study|Death|1|||
33556981|NCT04595370|101937977|FG005|Overall Study|Death|0|||
33556982|NCT04595370|101937972|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33556983|NCT04595370|101937973|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33556984|NCT04595370|101937974|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
33556985|NCT04595370|101937975|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33556986|NCT04595370|101937976|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33556987|NCT04595370|101937977|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33556988|NCT04595370|101937972|FG000|Overall Study|Withdrawal by Subject|0|||
33556989|NCT04595370|101937973|FG001|Overall Study|Withdrawal by Subject|0|||
33556990|NCT04595370|101937974|FG002|Overall Study|Withdrawal by Subject|1|||
33556991|NCT04595370|101937975|FG003|Overall Study|Withdrawal by Subject|0|||
33556992|NCT04595370|101937976|FG004|Overall Study|Withdrawal by Subject|2|||
33556993|NCT04595370|101937977|FG005|Overall Study|Withdrawal by Subject|0|||
33556994|NCT04595370|101937972|FG000|Overall Study|Lost to Follow-up|0|||
33556995|NCT04595370|101937973|FG001|Overall Study|Lost to Follow-up|0|||
33556996|NCT04595370|101937974|FG002|Overall Study|Lost to Follow-up|0|||
33556997|NCT04595370|101937975|FG003|Overall Study|Lost to Follow-up|0|||
33556998|NCT04595370|101937976|FG004|Overall Study|Lost to Follow-up|1|||
33556999|NCT04595370|101937977|FG005|Overall Study|Lost to Follow-up|0|||
33557000|NCT04595370|101937972|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
33557001|NCT04595370|101937973|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
33557002|NCT04595370|101937974|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
33557003|NCT04595370|101937975|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
33557004|NCT04595370|101937976|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
33557005|NCT04595370|101937977|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
33557006|NCT03656562|101937982|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
33557007|NCT03656562|101937983|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
33557008|NCT03656562|101937984|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
33557009|NCT03656562|101937985|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
33621978|NCT00506350|102165922|FG002|Overall Study|Lost to Follow-up|1|||
33621979|NCT00506350|102165923|FG003|Overall Study|Lost to Follow-up|1|||
33621980|NCT00506350|102165924|FG004|Overall Study|Lost to Follow-up|2|||
33621981|NCT00506350|102165925|FG005|Overall Study|Lost to Follow-up|1|||
33557010|NCT03656562|101937982|FG000|Overall Study|Physician Decision|1|||
33557011|NCT03656562|101937983|FG001|Overall Study|Physician Decision|2|||
33557012|NCT03656562|101937984|FG002|Overall Study|Physician Decision|0|||
33557013|NCT03656562|101937985|FG003|Overall Study|Physician Decision|0|||
33557014|NCT03656562|101937982|FG000|Overall Study|Subject Decision|3|||
33557015|NCT03656562|101937983|FG001|Overall Study|Subject Decision|5|||
33414404|NCT03940742|101406659|FG002|Overall Study|Lost to Follow-up|0|||
33557016|NCT03656562|101937984|FG002|Overall Study|Subject Decision|0|||
33557017|NCT03656562|101937985|FG003|Overall Study|Subject Decision|2|||
33557018|NCT04829214|101937986|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
33557019|NCT04829214|101937987|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
33557020|NCT04829214|101937986|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
33557021|NCT04829214|101937987|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
33357531|NCT00996840|101195565|FG004|Overall Study|Physician Decision|2|||
33357532|NCT00996840|101195561|FG000|Overall Study|Withdrawal by Subject|1|||
33357533|NCT00996840|101195562|FG001|Overall Study|Withdrawal by Subject|1|||
33357534|NCT00996840|101195563|FG002|Overall Study|Withdrawal by Subject|0|||
33357535|NCT00996840|101195564|FG003|Overall Study|Withdrawal by Subject|0|||
33557022|NCT00420056|101937988|FG000|Overall Study|Objective progression or relapse|17|||
33557023|NCT02520154|101937989|FG000|Overall Study|Death|1|||
33557024|NCT02520154|101937989|FG000|Overall Study|Withdrawal by Subject|2|||
33557025|NCT02520154|101937989|FG000|Overall Study|Physician Decision|2|||
33557026|NCT03760666|101937990|FG000|Overall Study|Adverse Event|2|||
33557027|NCT03760666|101937991|FG001|Overall Study|Adverse Event|4|||
33557028|NCT03760666|101937992|FG002|Overall Study|Adverse Event|1|||
33557029|NCT03760666|101937990|FG000|Overall Study|AML Disease Progression|3|||
33557030|NCT03760666|101937991|FG001|Overall Study|AML Disease Progression|3|||
33557031|NCT03760666|101937992|FG002|Overall Study|AML Disease Progression|0|||
33557032|NCT03760666|101937990|FG000|Overall Study|Physician Decision|0|||
33557033|NCT03760666|101937991|FG001|Overall Study|Physician Decision|3|||
33557034|NCT03760666|101937992|FG002|Overall Study|Physician Decision|0|||
33557035|NCT03760666|101937990|FG000|Overall Study|Withdrawal by Subject|0|||
33557036|NCT03760666|101937991|FG001|Overall Study|Withdrawal by Subject|1|||
33557037|NCT03760666|101937992|FG002|Overall Study|Withdrawal by Subject|0|||
33557038|NCT02004275|101937993|FG000|Phase 1|Ineligible|0|||
33557039|NCT02004275|101937994|FG001|Phase 1|Ineligible|0|||
33557040|NCT02004275|101937995|FG002|Phase 1|Ineligible|0|||
33557041|NCT02004275|101937996|FG003|Phase 1|Ineligible|1|||
33557042|NCT02004275|101937997|FG004|Phase 1|Ineligible|1|||
33557043|NCT02004275|101937998|FG005|Phase 1|Ineligible|0|||
33557044|NCT02004275|101937993|FG000|Phase 1|Protocol Violation|0|||
33557045|NCT02004275|101937994|FG001|Phase 1|Protocol Violation|0|||
33557046|NCT02004275|101937995|FG002|Phase 1|Protocol Violation|0|||
33557047|NCT02004275|101937996|FG003|Phase 1|Protocol Violation|1|||
33557048|NCT02004275|101937997|FG004|Phase 1|Protocol Violation|0|||
33557049|NCT02004275|101937998|FG005|Phase 1|Protocol Violation|5|||
33557050|NCT02004275|101937993|FG000|Phase 2 Part 1|Ineligible|6|||
33557051|NCT02004275|101937994|FG001|Phase 2 Part 1|Ineligible|9|||
33557052|NCT02004275|101937995|FG002|Phase 2 Part 1|Ineligible|0|||
33557053|NCT02004275|101937996|FG003|Phase 2 Part 1|Ineligible|0|||
33557054|NCT02004275|101937997|FG004|Phase 2 Part 1|Ineligible|0|||
33557055|NCT02004275|101937998|FG005|Phase 2 Part 1|Ineligible|0|||
33557056|NCT02004275|101937993|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
33557057|NCT02004275|101937994|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
33557058|NCT02004275|101937995|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
33557059|NCT02004275|101937996|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
33557060|NCT02004275|101937997|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
33557061|NCT02004275|101937998|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
33557062|NCT04634331|101937999|FG000|Overall Study|Withdrawal by Subject|2|||
33557063|NCT04634331|101938000|FG001|Overall Study|Withdrawal by Subject|2|||
33557064|NCT03055013|101938001|FG000|Overall Study|Adverse Event|78|||
33557065|NCT03055013|101938002|FG001|Overall Study|Adverse Event|0|||
33557066|NCT03055013|101938001|FG000|Overall Study|Death|6|||
33621982|NCT00506350|102165926|FG006|Overall Study|Lost to Follow-up|0|||
33621983|NCT00506350|102165927|FG007|Overall Study|Lost to Follow-up|0|||
33621984|NCT00506350|102165928|FG008|Overall Study|Lost to Follow-up|2|||
33357536|NCT00996840|101195565|FG004|Overall Study|Withdrawal by Subject|0|||
33414405|NCT03940742|101406660|FG003|Overall Study|Lost to Follow-up|1|||
33414406|NCT00352664|101406666|FG000|Overall Study|Withdrawal by Subject|7|||
33557067|NCT03055013|101938002|FG001|Overall Study|Death|0|||
33557068|NCT03055013|101938001|FG000|Overall Study|Disease relapse|33|||
33557069|NCT03055013|101938002|FG001|Overall Study|Disease relapse|0|||
33557070|NCT03055013|101938001|FG000|Overall Study|Withdrawal by Subject|28|||
33557071|NCT03055013|101938002|FG001|Overall Study|Withdrawal by Subject|0|||
33557072|NCT03055013|101938001|FG000|Overall Study|Other complicating disease|5|||
33557073|NCT03055013|101938002|FG001|Overall Study|Other complicating disease|0|||
33557074|NCT03055013|101938001|FG000|Overall Study|Physician Decision|1|||
33557075|NCT03055013|101938002|FG001|Overall Study|Physician Decision|0|||
33621985|NCT00506350|102165920|FG000|Overall Study|Medical Reason|0|||
33357537|NCT02886715|101195566|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33357538|NCT02886715|101195567|FG001|Overall Study|Non-Compliance With Study Drug|2|||
33357539|NCT02886715|101195568|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33557076|NCT03055013|101938001|FG000|Overall Study|Benign mass/non-RCC|4|||
33557077|NCT03055013|101938002|FG001|Overall Study|Benign mass/non-RCC|0|||
33557078|NCT03055013|101938001|FG000|Overall Study|Enrolled in another trial|1|||
33557079|NCT03055013|101938002|FG001|Overall Study|Enrolled in another trial|0|||
33621986|NCT00506350|102165921|FG001|Overall Study|Medical Reason|0|||
33621987|NCT00506350|102165922|FG002|Overall Study|Medical Reason|0|||
33621988|NCT00506350|102165923|FG003|Overall Study|Medical Reason|0|||
33621989|NCT00506350|102165924|FG004|Overall Study|Medical Reason|1|||
33357540|NCT02886715|101195566|FG000|Overall Study|Adverse Event|4|||
33357541|NCT02886715|101195567|FG001|Overall Study|Adverse Event|2|||
33357542|NCT02886715|101195568|FG002|Overall Study|Adverse Event|0|||
33357543|NCT02886715|101195566|FG000|Overall Study|Lack of Efficacy|0|||
33357544|NCT02886715|101195567|FG001|Overall Study|Lack of Efficacy|2|||
33357545|NCT02886715|101195568|FG002|Overall Study|Lack of Efficacy|1|||
33357546|NCT02886715|101195566|FG000|Overall Study|Lost to Follow-up|29|||
33357547|NCT02886715|101195567|FG001|Overall Study|Lost to Follow-up|26|||
33357548|NCT02886715|101195568|FG002|Overall Study|Lost to Follow-up|10|||
33357549|NCT02886715|101195566|FG000|Overall Study|Pregnancy|1|||
33357550|NCT02886715|101195567|FG001|Overall Study|Pregnancy|1|||
33357551|NCT02886715|101195568|FG002|Overall Study|Pregnancy|1|||
33357552|NCT02886715|101195566|FG000|Overall Study|Protocol Violation|3|||
33357553|NCT02886715|101195567|FG001|Overall Study|Protocol Violation|2|||
33357554|NCT02886715|101195568|FG002|Overall Study|Protocol Violation|1|||
33357555|NCT02886715|101195566|FG000|Overall Study|Withdrawal by Subject|20|||
33357556|NCT02886715|101195567|FG001|Overall Study|Withdrawal by Subject|18|||
33357557|NCT02886715|101195568|FG002|Overall Study|Withdrawal by Subject|5|||
33357558|NCT02886715|101195566|FG000|Overall Study|missing|7|||
33357559|NCT02886715|101195567|FG001|Overall Study|missing|2|||
33357560|NCT02886715|101195568|FG002|Overall Study|missing|2|||
33357561|NCT01919307|101195573|FG000|Overall Study|Withdrawal by Subject|9|||
33357562|NCT00609609|101195574|FG000|Overall Study|Withdrawal by Subject|2|||
33357563|NCT00609609|101195575|FG001|Overall Study|Withdrawal by Subject|0|||
33357564|NCT00609609|101195574|FG000|Overall Study|Progression|4|||
33357565|NCT00609609|101195575|FG001|Overall Study|Progression|2|||
33357566|NCT02111369|101195576|FG000|Overall Study|Lost to Follow-up|2|||
33357567|NCT02111369|101195576|FG000|Overall Study|Withdrawal by Subject|1|||
33357568|NCT01687673|101195577|FG000|Overall Study|Physician Decision|1|||
33357569|NCT01491945|101195578|FG000|Overall Study|Death|30|||
33357570|NCT01491945|101195578|FG000|Overall Study|Withdrwan/LTF|16|||
33357571|NCT01491945|101195578|FG000|Overall Study|Conversion|4|||
33357572|NCT01491945|101195578|FG000|Overall Study|Missed Visit|1|||
33357573|NCT03095703|101198294|FG000|Overall Study|Withdrawal by Subject|1|||
33621990|NCT00506350|102165925|FG005|Overall Study|Medical Reason|0|||
33621991|NCT00506350|102165926|FG006|Overall Study|Medical Reason|0|||
33621992|NCT00506350|102165927|FG007|Overall Study|Medical Reason|0|||
33621993|NCT00506350|102165928|FG008|Overall Study|Medical Reason|0|||
33621994|NCT00506350|102165920|FG000|Overall Study|Other|1|||
33621995|NCT00506350|102165921|FG001|Overall Study|Other|1|||
33621996|NCT00506350|102165922|FG002|Overall Study|Other|3|||
33621997|NCT00506350|102165923|FG003|Overall Study|Other|0|||
33621998|NCT00506350|102165924|FG004|Overall Study|Other|3|||
33621999|NCT00506350|102165925|FG005|Overall Study|Other|0|||
33622000|NCT00506350|102165926|FG006|Overall Study|Other|0|||
33622001|NCT00506350|102165927|FG007|Overall Study|Other|2|||
33357574|NCT03427073|101198296|FG000|Overall Study|Disease Progression|1|||
33357575|NCT03427073|101198297|FG001|Overall Study|Disease Progression|1|||
33357576|NCT03427073|101198298|FG002|Overall Study|Disease Progression|1|||
33357577|NCT03427073|101198299|FG003|Overall Study|Disease Progression|3|||
33357578|NCT03427073|101198300|FG004|Overall Study|Disease Progression|3|||
33357579|NCT03427073|101198301|FG005|Overall Study|Disease Progression|4|||
33357580|NCT03427073|101198302|FG006|Overall Study|Disease Progression|2|||
33357581|NCT03427073|101198303|FG007|Overall Study|Disease Progression|3|||
33622002|NCT00506350|102165928|FG008|Overall Study|Other|2|||
33622003|NCT02043938|102165929|FG000|Overall Study|Withdrawal by Subject|7|||
33622004|NCT02043938|102165929|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
33357582|NCT03427073|101198296|FG000|Overall Study|Physician Decision|0|||
33357583|NCT03427073|101198297|FG001|Overall Study|Physician Decision|0|||
33357584|NCT03427073|101198298|FG002|Overall Study|Physician Decision|0|||
33357585|NCT03427073|101198299|FG003|Overall Study|Physician Decision|0|||
33357586|NCT03427073|101198300|FG004|Overall Study|Physician Decision|0|||
33622005|NCT02043938|102165929|FG000|Overall Study|No show by subject|1|||
33622006|NCT02043938|102165929|FG000|Overall Study|Investigator decision|1|||
33622007|NCT05579977|102165931|FG000|Treatment Phase|Other|0|||
33622008|NCT05579977|102165932|FG001|Treatment Phase|Other|0|||
33622009|NCT05579977|102165933|FG002|Treatment Phase|Other|0|||
33622010|NCT05579977|102165934|FG003|Treatment Phase|Other|2|||
33622011|NCT05579977|102165935|FG004|Treatment Phase|Other|1|||
33357587|NCT03427073|101198301|FG005|Overall Study|Physician Decision|0|||
33357588|NCT03427073|101198302|FG006|Overall Study|Physician Decision|1|||
33357589|NCT03427073|101198303|FG007|Overall Study|Physician Decision|1|||
33357590|NCT02286102|101198305|FG000|Overall Study|Screen Failure|1|||
33357591|NCT02286102|101198306|FG001|Overall Study|Screen Failure|1|||
33357592|NCT00883753|101198307|FG000|Overall Study|Adverse Event|37|||
33357593|NCT00883753|101198307|FG000|Overall Study|Death|2|||
33622012|NCT05579977|102165936|FG005|Treatment Phase|Other|2|||
33622013|NCT05579977|102165937|FG006|Treatment Phase|Other|1|||
33622014|NCT05579977|102165938|FG007|Treatment Phase|Other|2|||
33622015|NCT05579977|102165939|FG008|Treatment Phase|Other|2|||
33622016|NCT05579977|102165940|FG009|Treatment Phase|Other|1|||
33622017|NCT05579977|102165941|FG010|Treatment Phase|Other|0|||
33622018|NCT05579977|102165942|FG011|Treatment Phase|Other|0|||
33622019|NCT05579977|102165943|FG012|Treatment Phase|Other|3|||
33622020|NCT05579977|102165931|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
33622021|NCT05579977|102165932|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
33622022|NCT05579977|102165933|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
33622023|NCT05579977|102165934|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
33622024|NCT05579977|102165935|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
33622025|NCT05579977|102165936|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
33622026|NCT05579977|102165937|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
33622027|NCT05579977|102165938|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
33622028|NCT05579977|102165939|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
33622029|NCT05579977|102165940|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
33622030|NCT05579977|102165941|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
33622031|NCT05579977|102165942|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
33622032|NCT05579977|102165943|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
33622033|NCT05579977|102165931|FG000|Treatment Phase|Withdrawal by Subject|2|||
33622034|NCT05579977|102165932|FG001|Treatment Phase|Withdrawal by Subject|0|||
33622035|NCT05579977|102165933|FG002|Treatment Phase|Withdrawal by Subject|0|||
33622036|NCT05579977|102165934|FG003|Treatment Phase|Withdrawal by Subject|1|||
33622037|NCT05579977|102165935|FG004|Treatment Phase|Withdrawal by Subject|2|||
33622038|NCT05579977|102165936|FG005|Treatment Phase|Withdrawal by Subject|0|||
33622039|NCT05579977|102165937|FG006|Treatment Phase|Withdrawal by Subject|1|||
33622040|NCT05579977|102165938|FG007|Treatment Phase|Withdrawal by Subject|8|||
33622041|NCT05579977|102165939|FG008|Treatment Phase|Withdrawal by Subject|3|||
33622042|NCT05579977|102165940|FG009|Treatment Phase|Withdrawal by Subject|3|||
33622043|NCT05579977|102165941|FG010|Treatment Phase|Withdrawal by Subject|5|||
33622044|NCT05579977|102165942|FG011|Treatment Phase|Withdrawal by Subject|1|||
33622045|NCT05579977|102165943|FG012|Treatment Phase|Withdrawal by Subject|3|||
33622046|NCT05579977|102165931|FG000|Treatment Phase|Study terminated by sponsor|70|||
33622047|NCT05579977|102165932|FG001|Treatment Phase|Study terminated by sponsor|70|||
33622048|NCT05579977|102165933|FG002|Treatment Phase|Study terminated by sponsor|61|||
33622049|NCT05579977|102165934|FG003|Treatment Phase|Study terminated by sponsor|59|||
33622050|NCT05579977|102165935|FG004|Treatment Phase|Study terminated by sponsor|63|||
33622051|NCT05579977|102165936|FG005|Treatment Phase|Study terminated by sponsor|53|||
33622052|NCT05579977|102165937|FG006|Treatment Phase|Study terminated by sponsor|66|||
33622053|NCT05579977|102165938|FG007|Treatment Phase|Study terminated by sponsor|48|||
33622054|NCT05579977|102165939|FG008|Treatment Phase|Study terminated by sponsor|47|||
33622055|NCT05579977|102165940|FG009|Treatment Phase|Study terminated by sponsor|37|||
33622056|NCT05579977|102165941|FG010|Treatment Phase|Study terminated by sponsor|44|||
33622057|NCT05579977|102165942|FG011|Treatment Phase|Study terminated by sponsor|36|||
33622058|NCT05579977|102165943|FG012|Treatment Phase|Study terminated by sponsor|32|||
33622059|NCT05579977|102165931|FG000|Treatment Phase|Pregnancy|0|||
33622060|NCT05579977|102165932|FG001|Treatment Phase|Pregnancy|0|||
33622061|NCT05579977|102165933|FG002|Treatment Phase|Pregnancy|0|||
33622062|NCT05579977|102165934|FG003|Treatment Phase|Pregnancy|0|||
33622063|NCT05579977|102165935|FG004|Treatment Phase|Pregnancy|0|||
33622064|NCT05579977|102165936|FG005|Treatment Phase|Pregnancy|0|||
33557080|NCT03055013|101938001|FG000|Overall Study|Non-protocol therapy|1|||
33557081|NCT03055013|101938002|FG001|Overall Study|Non-protocol therapy|0|||
33557082|NCT03055013|101938001|FG000|Overall Study|Incompliance|1|||
33557083|NCT03055013|101938002|FG001|Overall Study|Incompliance|0|||
33557084|NCT03055013|101938001|FG000|Overall Study|Insurance issues|1|||
33557085|NCT03055013|101938002|FG001|Overall Study|Insurance issues|0|||
33557086|NCT03055013|101938001|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
33557087|NCT03055013|101938002|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
33557088|NCT03055013|101938001|FG000|Overall Study|Did not receive nivolumab|10|||
33557089|NCT03055013|101938002|FG001|Overall Study|Did not receive nivolumab|0|||
33557090|NCT03055013|101938001|FG000|Overall Study|Did not receive surgery|0|||
33557091|NCT03055013|101938002|FG001|Overall Study|Did not receive surgery|28|||
33622065|NCT05579977|102165937|FG006|Treatment Phase|Pregnancy|0|||
33218273|NCT02342886|100696011|FG004|Overall Study|Investigator/sponsor decision|1|||
33557092|NCT02057666|101938003|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
33622066|NCT05579977|102165938|FG007|Treatment Phase|Pregnancy|0|||
33622067|NCT05579977|102165939|FG008|Treatment Phase|Pregnancy|0|||
33622068|NCT05579977|102165940|FG009|Treatment Phase|Pregnancy|1|||
33622069|NCT05579977|102165941|FG010|Treatment Phase|Pregnancy|0|||
33622070|NCT05579977|102165942|FG011|Treatment Phase|Pregnancy|0|||
33622071|NCT05579977|102165943|FG012|Treatment Phase|Pregnancy|0|||
33557093|NCT02057666|101938004|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
33357594|NCT00883753|101198307|FG000|Overall Study|Insufficient therapeutic response|16|||
33357595|NCT00883753|101198307|FG000|Overall Study|Lost to Follow-up|4|||
33357596|NCT00883753|101198307|FG000|Overall Study|Violation of selection criteria at entry|7|||
33357597|NCT00883753|101198307|FG000|Overall Study|Protocol Violation|2|||
33357598|NCT00883753|101198307|FG000|Overall Study|Refused treatment|4|||
33357599|NCT00883753|101198307|FG000|Overall Study|Withdrew consent|10|||
33357600|NCT00883753|101198307|FG000|Overall Study|Investigator's decision|17|||
33357601|NCT00883753|101198307|FG000|Overall Study|Administrative/Other|8|||
33357602|NCT02504541|101198308|FG000|Overall Study|Adverse Event|4|||
33357603|NCT02504541|101198308|FG000|Overall Study|Withdrawal by Subject|4|||
33357604|NCT02504541|101198308|FG000|Overall Study|Lost to Follow-up|1|||
33357605|NCT02504541|101198308|FG000|Overall Study|Met Stopping Criteria|1|||
33357606|NCT02504541|101198308|FG000|Overall Study|Protocol Violation|2|||
33357607|NCT02504541|101198308|FG000|Overall Study|Termination by Sponsor|1|||
33357608|NCT02504541|101198308|FG000|Overall Study|Other|2|||
33357609|NCT02504541|101198308|FG000|Overall Study|Multiple|5|||
33357610|NCT02498652|101198313|FG000|Overall Study|Protocol Violation|0|||
33557094|NCT02057666|101938003|FG000|Double Blind Treatment Period|Poor tolerability|7|||
33357611|NCT02498652|101198314|FG001|Overall Study|Protocol Violation|1|||
33357612|NCT01486264|101198322|FG000|Overall Study|Death|1|||
33357613|NCT01486264|101198323|FG001|Overall Study|Death|1|||
33357614|NCT01486264|101198322|FG000|Overall Study|Adverse Event|3|||
33557095|NCT02057666|101938004|FG001|Double Blind Treatment Period|Poor tolerability|2|||
33557096|NCT02057666|101938003|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
33557097|NCT02057666|101938004|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
33557098|NCT02057666|101938003|FG000|Double Blind Treatment Period|Physician Decision|1|||
33557099|NCT02057666|101938004|FG001|Double Blind Treatment Period|Physician Decision|0|||
33557100|NCT02057666|101938003|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
33557101|NCT02057666|101938004|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
33622072|NCT05579977|102165931|FG000|Treatment Phase|Physician Decision|0|||
33622073|NCT05579977|102165932|FG001|Treatment Phase|Physician Decision|0|||
33622074|NCT05579977|102165933|FG002|Treatment Phase|Physician Decision|0|||
33622075|NCT05579977|102165934|FG003|Treatment Phase|Physician Decision|0|||
33622076|NCT05579977|102165935|FG004|Treatment Phase|Physician Decision|0|||
33622077|NCT05579977|102165936|FG005|Treatment Phase|Physician Decision|0|||
33622078|NCT05579977|102165937|FG006|Treatment Phase|Physician Decision|0|||
33622079|NCT05579977|102165938|FG007|Treatment Phase|Physician Decision|0|||
33622080|NCT05579977|102165939|FG008|Treatment Phase|Physician Decision|0|||
33622081|NCT05579977|102165940|FG009|Treatment Phase|Physician Decision|0|||
33622082|NCT05579977|102165941|FG010|Treatment Phase|Physician Decision|0|||
33622083|NCT05579977|102165942|FG011|Treatment Phase|Physician Decision|1|||
33622084|NCT05579977|102165943|FG012|Treatment Phase|Physician Decision|0|||
33622085|NCT05579977|102165931|FG000|Treatment Phase|Lost to Follow-up|0|||
33622086|NCT05579977|102165932|FG001|Treatment Phase|Lost to Follow-up|0|||
33622087|NCT05579977|102165933|FG002|Treatment Phase|Lost to Follow-up|0|||
33622088|NCT05579977|102165934|FG003|Treatment Phase|Lost to Follow-up|1|||
33622089|NCT05579977|102165935|FG004|Treatment Phase|Lost to Follow-up|1|||
33622090|NCT05579977|102165936|FG005|Treatment Phase|Lost to Follow-up|1|||
33622091|NCT05579977|102165937|FG006|Treatment Phase|Lost to Follow-up|0|||
33622092|NCT05579977|102165938|FG007|Treatment Phase|Lost to Follow-up|1|||
33622093|NCT05579977|102165939|FG008|Treatment Phase|Lost to Follow-up|2|||
33622094|NCT05579977|102165940|FG009|Treatment Phase|Lost to Follow-up|2|||
33622095|NCT05579977|102165941|FG010|Treatment Phase|Lost to Follow-up|1|||
33622096|NCT05579977|102165942|FG011|Treatment Phase|Lost to Follow-up|4|||
33622097|NCT05579977|102165943|FG012|Treatment Phase|Lost to Follow-up|3|||
33357615|NCT01486264|101198323|FG001|Overall Study|Adverse Event|3|||
33357616|NCT01486264|101198322|FG000|Overall Study|Lack of Efficacy|6|||
33357617|NCT01486264|101198323|FG001|Overall Study|Lack of Efficacy|10|||
33357618|NCT01486264|101198322|FG000|Overall Study|Withdrawal by Subject|7|||
33357619|NCT01486264|101198323|FG001|Overall Study|Withdrawal by Subject|18|||
33357620|NCT01486264|101198322|FG000|Overall Study|Physician Decision|1|||
33357621|NCT01486264|101198323|FG001|Overall Study|Physician Decision|1|||
33357622|NCT01486264|101198322|FG000|Overall Study|Protocol Violation|3|||
33357623|NCT01486264|101198323|FG001|Overall Study|Protocol Violation|0|||
33357624|NCT01486264|101198322|FG000|Overall Study|Lost to Follow-up|3|||
33622098|NCT05579977|102165931|FG000|Treatment Phase|Death|1|||
33622099|NCT05579977|102165932|FG001|Treatment Phase|Death|0|||
33622100|NCT05579977|102165933|FG002|Treatment Phase|Death|0|||
33622101|NCT05579977|102165934|FG003|Treatment Phase|Death|0|||
33622102|NCT05579977|102165935|FG004|Treatment Phase|Death|0|||
33357625|NCT01486264|101198323|FG001|Overall Study|Lost to Follow-up|2|||
33622103|NCT05579977|102165936|FG005|Treatment Phase|Death|0|||
33622104|NCT05579977|102165937|FG006|Treatment Phase|Death|0|||
33622105|NCT05579977|102165938|FG007|Treatment Phase|Death|0|||
33622106|NCT05579977|102165939|FG008|Treatment Phase|Death|0|||
33622107|NCT05579977|102165940|FG009|Treatment Phase|Death|0|||
33622108|NCT05579977|102165941|FG010|Treatment Phase|Death|0|||
33218274|NCT02342886|100696007|FG000|Overall Study|Pregnancy|0|||
33218275|NCT02342886|100696008|FG001|Overall Study|Pregnancy|0|||
33218276|NCT02342886|100696009|FG002|Overall Study|Pregnancy|2|||
33218277|NCT02342886|100696010|FG003|Overall Study|Pregnancy|0|||
33218278|NCT02342886|100696011|FG004|Overall Study|Pregnancy|0|||
33218279|NCT02342886|100696007|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
33218280|NCT02342886|100696008|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
33218281|NCT02342886|100696009|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
33218282|NCT02342886|100696010|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
33218283|NCT02342886|100696011|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
33218284|NCT02342886|100696007|FG000|Overall Study|Protocol Violation|0|||
33218285|NCT02342886|100696008|FG001|Overall Study|Protocol Violation|0|||
33218286|NCT02342886|100696009|FG002|Overall Study|Protocol Violation|0|||
33218287|NCT02342886|100696010|FG003|Overall Study|Protocol Violation|2|||
33218288|NCT02342886|100696011|FG004|Overall Study|Protocol Violation|0|||
33218289|NCT03751631|100696012|FG000|Overall Study|Withdrawal by Subject|0|||
33218290|NCT03751631|100696013|FG001|Overall Study|Withdrawal by Subject|0|||
33218291|NCT03751631|100696014|FG002|Overall Study|Withdrawal by Subject|1|||
33357626|NCT01486264|101198322|FG000|Overall Study|Other|5|||
33357627|NCT01486264|101198323|FG001|Overall Study|Other|11|||
33357628|NCT01486264|101198322|FG000|Overall Study|Not treated|0|||
33622109|NCT05579977|102165942|FG011|Treatment Phase|Death|0|||
33622110|NCT05579977|102165943|FG012|Treatment Phase|Death|0|||
33622111|NCT05579977|102165931|FG000|Treatment Phase|Adverse Event|0|||
33622112|NCT05579977|102165932|FG001|Treatment Phase|Adverse Event|3|||
33622113|NCT05579977|102165933|FG002|Treatment Phase|Adverse Event|11|||
33622114|NCT05579977|102165934|FG003|Treatment Phase|Adverse Event|10|||
33357629|NCT01486264|101198323|FG001|Overall Study|Not treated|1|||
33357630|NCT04112914|101198329|FG000|Overall Study|Lost to Follow-up|13|||
33357631|NCT04112914|101198330|FG001|Overall Study|Lost to Follow-up|9|||
33622115|NCT05579977|102165935|FG004|Treatment Phase|Adverse Event|5|||
33622116|NCT05579977|102165936|FG005|Treatment Phase|Adverse Event|17|||
33622117|NCT05579977|102165937|FG006|Treatment Phase|Adverse Event|5|||
33218292|NCT03751631|100696015|FG003|Overall Study|Withdrawal by Subject|1|||
33218293|NCT03751631|100696016|FG004|Overall Study|Withdrawal by Subject|0|||
33218294|NCT03751631|100696017|FG005|Overall Study|Withdrawal by Subject|0|||
33218295|NCT04517864|100696019|FG000|Placebo-Controlled Phase|Adverse Event|1|||
33357632|NCT04112914|101198329|FG000|Overall Study|Withdrawal by Subject|1|||
33218296|NCT04517864|100696020|FG001|Placebo-Controlled Phase|Adverse Event|0|||
33622118|NCT05579977|102165938|FG007|Treatment Phase|Adverse Event|5|||
33622119|NCT05579977|102165939|FG008|Treatment Phase|Adverse Event|12|||
33622120|NCT05579977|102165940|FG009|Treatment Phase|Adverse Event|20|||
33622121|NCT05579977|102165941|FG010|Treatment Phase|Adverse Event|15|||
33357633|NCT04112914|101198330|FG001|Overall Study|Withdrawal by Subject|0|||
33357634|NCT00815308|101198331|FG000|Overall Study|Adverse Event|4|||
33357635|NCT00815308|101198331|FG000|Overall Study|Withdrawal by Subject|0|||
33357636|NCT00815308|101198331|FG000|Overall Study|Protocol Violation|6|||
33357637|NCT00957372|101198332|FG000|PART I|Lost to Follow-up|0|||
33357638|NCT00957372|101198333|FG001|PART I|Lost to Follow-up|0|||
33357639|NCT00957372|101198334|FG002|PART I|Lost to Follow-up|1|||
33357640|NCT00957372|101198335|FG003|PART I|Lost to Follow-up|0|||
33357641|NCT00957372|101198332|FG000|PART II|Withdrawal by Subject|0|||
33357642|NCT00957372|101198333|FG001|PART II|Withdrawal by Subject|0|||
33357643|NCT00957372|101198334|FG002|PART II|Withdrawal by Subject|0|||
33357644|NCT00957372|101198335|FG003|PART II|Withdrawal by Subject|8|||
33357645|NCT00957372|101198332|FG000|PART II|Physician Decision|0|||
33357646|NCT00957372|101198333|FG001|PART II|Physician Decision|0|||
33357647|NCT00957372|101198334|FG002|PART II|Physician Decision|0|||
33357648|NCT00957372|101198335|FG003|PART II|Physician Decision|1|||
33357649|NCT00957372|101198332|FG000|PART II|Pregnancy|0|||
33357650|NCT00957372|101198333|FG001|PART II|Pregnancy|0|||
33357651|NCT00957372|101198334|FG002|PART II|Pregnancy|0|||
33357652|NCT00957372|101198335|FG003|PART II|Pregnancy|1|||
33357653|NCT00957372|101198332|FG000|PART II|Not Know|0|||
33357654|NCT00957372|101198333|FG001|PART II|Not Know|0|||
33357655|NCT00957372|101198334|FG002|PART II|Not Know|0|||
33357656|NCT00957372|101198335|FG003|PART II|Not Know|20|||
33357657|NCT00957372|101198332|FG000|PART II|Adverse Event|0|||
33357658|NCT00957372|101198333|FG001|PART II|Adverse Event|0|||
33357659|NCT00957372|101198334|FG002|PART II|Adverse Event|0|||
33357660|NCT00957372|101198335|FG003|PART II|Adverse Event|10|||
33357661|NCT00957372|101198332|FG000|PART II|Patient non-compliance|0|||
33357662|NCT00957372|101198333|FG001|PART II|Patient non-compliance|0|||
33357663|NCT00957372|101198334|FG002|PART II|Patient non-compliance|0|||
33357664|NCT00957372|101198335|FG003|PART II|Patient non-compliance|4|||
33357665|NCT01826214|101198339|FG000|Overall Study|Adverse Event|7|||
33357666|NCT01826214|101198340|FG001|Overall Study|Adverse Event|6|||
33622122|NCT05579977|102165942|FG011|Treatment Phase|Adverse Event|24|||
33622123|NCT05579977|102165943|FG012|Treatment Phase|Adverse Event|23|||
33622124|NCT05579977|102165931|FG000|Treatment Phase|Randomized not treated|0|||
33622125|NCT05579977|102165932|FG001|Treatment Phase|Randomized not treated|0|||
33357667|NCT01826214|101198339|FG000|Overall Study|Death|3|||
33357668|NCT01826214|101198340|FG001|Overall Study|Death|1|||
33357669|NCT01826214|101198339|FG000|Overall Study|Lost to Follow-up|1|||
33414407|NCT00352664|101406667|FG001|Overall Study|Withdrawal by Subject|0|||
33414408|NCT00560573|101406668|FG000|Overall Study|Death|4|||
33414409|NCT00560573|101406669|FG001|Overall Study|Death|1|||
33622126|NCT05579977|102165933|FG002|Treatment Phase|Randomized not treated|0|||
33622127|NCT05579977|102165934|FG003|Treatment Phase|Randomized not treated|0|||
33622128|NCT05579977|102165935|FG004|Treatment Phase|Randomized not treated|1|||
33622129|NCT05579977|102165936|FG005|Treatment Phase|Randomized not treated|0|||
33622130|NCT05579977|102165937|FG006|Treatment Phase|Randomized not treated|0|||
33622131|NCT05579977|102165938|FG007|Treatment Phase|Randomized not treated|0|||
33622132|NCT05579977|102165939|FG008|Treatment Phase|Randomized not treated|0|||
33622133|NCT05579977|102165940|FG009|Treatment Phase|Randomized not treated|0|||
33357670|NCT01826214|101198340|FG001|Overall Study|Lost to Follow-up|0|||
33357671|NCT01826214|101198339|FG000|Overall Study|Physician Decision|0|||
33357672|NCT01826214|101198340|FG001|Overall Study|Physician Decision|2|||
33357673|NCT01826214|101198339|FG000|Overall Study|Progressive disease|22|||
33557102|NCT02057666|101938003|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
33357674|NCT01826214|101198340|FG001|Overall Study|Progressive disease|21|||
33357675|NCT01826214|101198339|FG000|Overall Study|Study terminated by Sponsor|0|||
33357676|NCT01826214|101198340|FG001|Overall Study|Study terminated by Sponsor|1|||
33357677|NCT01826214|101198339|FG000|Overall Study|Subject/guardian decision|2|||
33357678|NCT01826214|101198340|FG001|Overall Study|Subject/guardian decision|3|||
33357679|NCT02626338|101198344|FG000|Overall Study|Lack of Efficacy|3|||
33622134|NCT05579977|102165941|FG010|Treatment Phase|Randomized not treated|0|||
33357680|NCT02626338|101198345|FG001|Overall Study|Lack of Efficacy|2|||
33357681|NCT02626338|101198346|FG002|Overall Study|Lack of Efficacy|0|||
33357682|NCT03846947|101198351|FG000|Overall Study|technical issues with imaging sequence|2|||
33357683|NCT01773473|101198358|FG000|Overall Study|Adverse Event|3|||
33622135|NCT05579977|102165942|FG011|Treatment Phase|Randomized not treated|0|||
33357684|NCT01773473|101198359|FG001|Overall Study|Adverse Event|2|||
33357685|NCT01773473|101198358|FG000|Overall Study|Protocol Violation|0|||
33357686|NCT01773473|101198359|FG001|Overall Study|Protocol Violation|4|||
33357687|NCT01773473|101198358|FG000|Overall Study|Physician Decision|3|||
33357688|NCT01773473|101198359|FG001|Overall Study|Physician Decision|5|||
33357689|NCT01773473|101198358|FG000|Overall Study|Sponsor Decision|2|||
33557103|NCT02057666|101938004|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
33557104|NCT02057666|101938003|FG000|Double Blind Treatment Period|Sponsor's request|70|||
33557105|NCT02057666|101938004|FG001|Double Blind Treatment Period|Sponsor's request|34|||
33557106|NCT02057666|101938003|FG000|Open-Label Treatment Period|Poor tolerability|0|||
33557107|NCT02057666|101938004|FG001|Open-Label Treatment Period|Poor tolerability|1|||
33557108|NCT02057666|101938003|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
33557109|NCT02057666|101938004|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
33557110|NCT02057666|101938003|FG000|Open-Label Treatment Period|Sponsor's request|0|||
33557111|NCT02057666|101938004|FG001|Open-Label Treatment Period|Sponsor's request|4|||
33557112|NCT03511209|101938005|FG000|Overall Study|Withdrawal by Subject|2|||
33557113|NCT03511209|101938006|FG001|Overall Study|Withdrawal by Subject|4|||
33557114|NCT03511209|101938005|FG000|Overall Study|Death|1|||
33557115|NCT03511209|101938006|FG001|Overall Study|Death|0|||
33218297|NCT04517864|100696019|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
33218298|NCT04517864|100696020|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
33218299|NCT04517864|100696019|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
33218300|NCT04517864|100696020|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
33357690|NCT01773473|101198359|FG001|Overall Study|Sponsor Decision|0|||
33357691|NCT01773473|101198358|FG000|Overall Study|Lack of Efficacy|0|||
33357692|NCT01773473|101198359|FG001|Overall Study|Lack of Efficacy|1|||
33357693|NCT01773473|101198358|FG000|Overall Study|Non-Compliance with study drug|1|||
33357694|NCT01773473|101198359|FG001|Overall Study|Non-Compliance with study drug|4|||
33357695|NCT01773473|101198358|FG000|Overall Study|Withdrawal by Subject|5|||
33357696|NCT01773473|101198359|FG001|Overall Study|Withdrawal by Subject|3|||
33622136|NCT05579977|102165943|FG012|Treatment Phase|Randomized not treated|0|||
33622137|NCT05579977|102165931|FG000|Follow up|Death|1|||
33622138|NCT05579977|102165932|FG001|Follow up|Death|0|||
33622139|NCT05579977|102165933|FG002|Follow up|Death|0|||
33622140|NCT05579977|102165934|FG003|Follow up|Death|0|||
33357697|NCT01773473|101198358|FG000|Overall Study|Lost to Follow-up|2|||
33357698|NCT01773473|101198359|FG001|Overall Study|Lost to Follow-up|0|||
33357699|NCT00104104|101198360|FG000|Overall Study|Adverse Event|8|||
33357700|NCT00104104|101198361|FG001|Overall Study|Adverse Event|8|||
33414410|NCT00560573|101406670|FG002|Overall Study|Death|4|||
33557116|NCT03511209|101938005|FG000|Overall Study|Lost to Follow-up|0|||
33622141|NCT05579977|102165935|FG004|Follow up|Death|0|||
33622142|NCT05579977|102165936|FG005|Follow up|Death|0|||
33622143|NCT05579977|102165937|FG006|Follow up|Death|0|||
33357701|NCT00104104|101198360|FG000|Overall Study|Abnormal laboratory value(s)|20|||
33357702|NCT00104104|101198361|FG001|Overall Study|Abnormal laboratory value(s)|14|||
33357703|NCT00104104|101198360|FG000|Overall Study|Lack of Efficacy|0|||
33557117|NCT03511209|101938006|FG001|Overall Study|Lost to Follow-up|2|||
33557118|NCT04560309|101938009|FG000|Overall Study|Meet drop out criteria|1|||
33622144|NCT05579977|102165938|FG007|Follow up|Death|0|||
33622145|NCT05579977|102165939|FG008|Follow up|Death|0|||
33622146|NCT05579977|102165940|FG009|Follow up|Death|0|||
33622147|NCT05579977|102165941|FG010|Follow up|Death|0|||
33622148|NCT05579977|102165942|FG011|Follow up|Death|0|||
33357704|NCT00104104|101198361|FG001|Overall Study|Lack of Efficacy|3|||
33357705|NCT00104104|101198360|FG000|Overall Study|Condition no longer requires study drug|7|||
33357706|NCT00104104|101198361|FG001|Overall Study|Condition no longer requires study drug|4|||
33357707|NCT00104104|101198360|FG000|Overall Study|Protocol Violation|5|||
33357708|NCT00104104|101198361|FG001|Overall Study|Protocol Violation|2|||
33357709|NCT00104104|101198360|FG000|Overall Study|Withdrawal by Subject|11|||
33357710|NCT00104104|101198361|FG001|Overall Study|Withdrawal by Subject|15|||
33357711|NCT00104104|101198360|FG000|Overall Study|Lost to Follow-up|3|||
33357712|NCT00104104|101198361|FG001|Overall Study|Lost to Follow-up|7|||
33357713|NCT00104104|101198360|FG000|Overall Study|Administrative problems|12|||
33357714|NCT00104104|101198361|FG001|Overall Study|Administrative problems|13|||
33357715|NCT00104104|101198360|FG000|Overall Study|Death|9|||
33357716|NCT00104104|101198361|FG001|Overall Study|Death|6|||
33357717|NCT02452359|101198367|FG000|Overall Study|Adverse Event|1|||
33357718|NCT02452359|101198367|FG000|Overall Study|Lost to Follow-up|15|||
33357719|NCT02452359|101198367|FG000|Overall Study|Pregnancy|1|||
33357720|NCT02452359|101198367|FG000|Overall Study|Withdrawal by Subject|4|||
33357721|NCT01981187|101198384|FG000|Overall Study|Participant/guardian decision|2|||
33357722|NCT01981187|101198384|FG000|Overall Study|Physician Decision|1|||
33357723|NCT01981187|101198384|FG000|Overall Study|Disease progression|2|||
33357724|NCT01981187|101198384|FG000|Overall Study|Adverse Event|7|||
33357725|NCT02259231|101198399|FG000|Overall Study|Adverse Event|1|||
33357726|NCT02259231|101198400|FG001|Overall Study|Adverse Event|1|||
33357727|NCT02259231|101198401|FG002|Overall Study|Adverse Event|2|||
33357728|NCT02259231|101198402|FG003|Overall Study|Adverse Event|0|||
33357729|NCT02259231|101198403|FG004|Overall Study|Adverse Event|0|||
33357730|NCT02259231|101198404|FG005|Overall Study|Adverse Event|0|||
33357731|NCT02259231|101198405|FG006|Overall Study|Adverse Event|0|||
33357732|NCT02259231|101198399|FG000|Overall Study|Progressive Disease|4|||
33357733|NCT02259231|101198400|FG001|Overall Study|Progressive Disease|5|||
33357734|NCT02259231|101198401|FG002|Overall Study|Progressive Disease|4|||
33357735|NCT02259231|101198402|FG003|Overall Study|Progressive Disease|5|||
33357736|NCT02259231|101198403|FG004|Overall Study|Progressive Disease|4|||
33357737|NCT02259231|101198404|FG005|Overall Study|Progressive Disease|5|||
33357738|NCT02259231|101198405|FG006|Overall Study|Progressive Disease|4|||
33357739|NCT02259231|101198399|FG000|Overall Study|Sponsor termination of study|1|||
33357740|NCT02259231|101198400|FG001|Overall Study|Sponsor termination of study|0|||
33357741|NCT02259231|101198401|FG002|Overall Study|Sponsor termination of study|0|||
33357742|NCT02259231|101198402|FG003|Overall Study|Sponsor termination of study|1|||
33357743|NCT02259231|101198403|FG004|Overall Study|Sponsor termination of study|2|||
33357744|NCT02259231|101198404|FG005|Overall Study|Sponsor termination of study|1|||
33357745|NCT02259231|101198405|FG006|Overall Study|Sponsor termination of study|1|||
33357746|NCT00440401|101198408|FG000|Overall Study|Adverse Event|2|||
33357747|NCT00440401|101198409|FG001|Overall Study|Adverse Event|1|||
33357748|NCT00440401|101198408|FG000|Overall Study|Other|2|||
33357749|NCT00440401|101198409|FG001|Overall Study|Other|5|||
33357750|NCT00117312|101198417|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
33357751|NCT00117312|101198418|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
33357752|NCT00117312|101198419|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
33357753|NCT00117312|101198420|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
33357754|NCT00117312|101198417|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
33357755|NCT00117312|101198418|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
33357756|NCT00117312|101198419|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
33357757|NCT00117312|101198420|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
33357758|NCT00117312|101198417|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
33357759|NCT00117312|101198418|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
33357760|NCT00117312|101198419|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
33357761|NCT00117312|101198420|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
33414411|NCT00560573|101406671|FG003|Overall Study|Death|5|||
33414412|NCT00560573|101406672|FG004|Overall Study|Death|1|||
33414413|NCT00560573|101406673|FG005|Overall Study|Death|10|||
33414414|NCT00560573|101406668|FG000|Overall Study|Lost to Follow-up|0|||
33357762|NCT00117312|101198417|FG000|Overall Study|Other|0|||
33357763|NCT00117312|101198418|FG001|Overall Study|Other|1|||
33357764|NCT00117312|101198419|FG002|Overall Study|Other|3|||
33357765|NCT00117312|101198420|FG003|Overall Study|Other|1|||
33357766|NCT00117312|101198417|FG000|Overall Study|Patient choice|0|||
33357767|NCT00117312|101198418|FG001|Overall Study|Patient choice|0|||
33357768|NCT00117312|101198419|FG002|Overall Study|Patient choice|2|||
33357769|NCT00117312|101198420|FG003|Overall Study|Patient choice|1|||
33357770|NCT00117312|101198417|FG000|Overall Study|Adverse Event|0|||
33357771|NCT00117312|101198418|FG001|Overall Study|Adverse Event|2|||
33357772|NCT00117312|101198419|FG002|Overall Study|Adverse Event|0|||
33357773|NCT00117312|101198420|FG003|Overall Study|Adverse Event|0|||
33622149|NCT05579977|102165943|FG012|Follow up|Death|0|||
33357774|NCT00117312|101198417|FG000|Overall Study|Protocol Violation|0|||
33622150|NCT05579977|102165931|FG000|Follow up|Lost to Follow-up|0|||
33357775|NCT00117312|101198418|FG001|Overall Study|Protocol Violation|1|||
33357776|NCT00117312|101198419|FG002|Overall Study|Protocol Violation|3|||
33357777|NCT00117312|101198420|FG003|Overall Study|Protocol Violation|0|||
33357778|NCT00117312|101198417|FG000|Overall Study|PSA decrease <=50%|0|||
33357779|NCT00117312|101198418|FG001|Overall Study|PSA decrease <=50%|2|||
33357780|NCT00117312|101198419|FG002|Overall Study|PSA decrease <=50%|2|||
33357781|NCT00117312|101198420|FG003|Overall Study|PSA decrease <=50%|4|||
33357782|NCT00117312|101198417|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
33357783|NCT00117312|101198418|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
33357784|NCT00117312|101198419|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
33357785|NCT00117312|101198420|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
33357786|NCT00117312|101198417|FG000|Overall Study|Hepatic abnormality|0|||
33357787|NCT00117312|101198418|FG001|Overall Study|Hepatic abnormality|1|||
33357788|NCT00117312|101198419|FG002|Overall Study|Hepatic abnormality|0|||
33357789|NCT00117312|101198420|FG003|Overall Study|Hepatic abnormality|1|||
33357790|NCT00117312|101198417|FG000|Overall Study|Withdrawal by Subject|0|||
33357791|NCT00117312|101198418|FG001|Overall Study|Withdrawal by Subject|2|||
33357792|NCT00117312|101198419|FG002|Overall Study|Withdrawal by Subject|0|||
33357793|NCT00117312|101198420|FG003|Overall Study|Withdrawal by Subject|0|||
33357794|NCT01548638|101198421|FG000|Overall Study|Protocol Violation|3|||
33357795|NCT01548638|101198421|FG000|Overall Study|Withdrawal by Subject|1|||
33357796|NCT01025336|101198426|FG000|Overall Study|Protocol Violation|0|||
33357797|NCT01025336|101198427|FG001|Overall Study|Protocol Violation|0|||
33357798|NCT01025336|101198428|FG002|Overall Study|Protocol Violation|0|||
33357799|NCT01025336|101198429|FG003|Overall Study|Protocol Violation|2|||
33357800|NCT01025336|101198430|FG004|Overall Study|Protocol Violation|0|||
33357801|NCT00215150|101198431|FG000|Open Label Phase|Lost to Follow-up|7|||
33557119|NCT04560309|101938010|FG001|Overall Study|Meet drop out criteria|1|||
33557120|NCT03787212|101938013|FG000|Period 1|Study Termination|2|||
33557121|NCT03787212|101938014|FG001|Period 1|Study Termination|2|||
33557122|NCT01520714|101938015|FG000|Overall Study|Protocol Violation|0|||
33557123|NCT01520714|101938016|FG001|Overall Study|Protocol Violation|3|||
33557124|NCT01520714|101938015|FG000|Overall Study|Adverse Event|0|||
33557125|NCT01520714|101938016|FG001|Overall Study|Adverse Event|2|||
33557126|NCT01520714|101938015|FG000|Overall Study|Lack of Efficacy|0|||
33557127|NCT01520714|101938016|FG001|Overall Study|Lack of Efficacy|1|||
33557128|NCT02852005|101938020|FG000|Overall Study|Lost to Follow-up|0|||
33557129|NCT02852005|101938021|FG001|Overall Study|Lost to Follow-up|0|||
33557130|NCT02852005|101938022|FG002|Overall Study|Lost to Follow-up|0|||
33557131|NCT02852005|101938023|FG003|Overall Study|Lost to Follow-up|0|||
33557132|NCT02852005|101938024|FG004|Overall Study|Lost to Follow-up|1|||
33557133|NCT02852005|101938020|FG000|Overall Study|Withdrawal by Subject|1|||
33557134|NCT02852005|101938021|FG001|Overall Study|Withdrawal by Subject|0|||
33557135|NCT02852005|101938022|FG002|Overall Study|Withdrawal by Subject|0|||
33557136|NCT02852005|101938023|FG003|Overall Study|Withdrawal by Subject|0|||
33557137|NCT02852005|101938024|FG004|Overall Study|Withdrawal by Subject|0|||
33557138|NCT02642679|101938027|FG000|Overall Study|Withdrawal by Subject|1|||
33557139|NCT02642679|101938027|FG000|Overall Study|Physician Decision|1|||
33557140|NCT02642679|101938027|FG000|Overall Study|Physician Decision|1|||
33357802|NCT00215150|101198431|FG000|Open Label Phase|Withdrawal by Subject|1|||
33357803|NCT00215150|101198431|FG000|Open Label Phase|Did not complete a post base visit|13|||
33357804|NCT00215150|101198431|FG000|Open Label Phase|Did not meet randomization criteria|9|||
33557141|NCT01835431|101938030|FG000|Overall Study|Adverse Event|1|||
33557142|NCT01835431|101938031|FG001|Overall Study|Adverse Event|0|||
33557143|NCT01835431|101938030|FG000|Overall Study|other|0|||
33557144|NCT01835431|101938031|FG001|Overall Study|other|2|||
33557145|NCT01835431|101938030|FG000|Overall Study|Withdrawal by Subject|6|||
33557146|NCT01835431|101938031|FG001|Overall Study|Withdrawal by Subject|10|||
33557147|NCT01835431|101938030|FG000|Overall Study|Protocol Violation|1|||
33557148|NCT01835431|101938031|FG001|Overall Study|Protocol Violation|0|||
33557149|NCT00159874|101938048|FG000|Overall Study|Adverse Event|2|||
33557150|NCT00159874|101938049|FG001|Overall Study|Adverse Event|2|||
33622151|NCT05579977|102165932|FG001|Follow up|Lost to Follow-up|0|||
33622152|NCT05579977|102165933|FG002|Follow up|Lost to Follow-up|0|||
33557151|NCT00159874|101938050|FG002|Overall Study|Adverse Event|5|||
33557152|NCT00159874|101938051|FG003|Overall Study|Adverse Event|1|||
33557153|NCT00159874|101938052|FG004|Overall Study|Adverse Event|1|||
33557154|NCT00159874|101938053|FG005|Overall Study|Adverse Event|2|||
33557155|NCT00159874|101938054|FG006|Overall Study|Adverse Event|0|||
33357805|NCT00215150|101198431|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
33357806|NCT00215150|101198431|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
33357807|NCT00215150|101198431|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
33357808|NCT02750410|101198432|FG000|Double-Blind Treatment Period|Adverse Event|2|||
33357809|NCT02750410|101198433|FG001|Double-Blind Treatment Period|Adverse Event|2|||
33357810|NCT02750410|101198432|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33557156|NCT00159874|101938048|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
33557157|NCT00159874|101938049|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
33557158|NCT00159874|101938050|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
33357811|NCT02750410|101198433|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33357812|NCT02750410|101198432|FG000|Open-Label Extension Period|Adverse Event|5|||
33357813|NCT02750410|101198433|FG001|Open-Label Extension Period|Adverse Event|3|||
33357814|NCT02750410|101198432|FG000|Open-Label Extension Period|Protocol Violation|0|||
33357815|NCT02750410|101198433|FG001|Open-Label Extension Period|Protocol Violation|1|||
33357816|NCT02750410|101198432|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
33357817|NCT02750410|101198433|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
33357818|NCT00840463|101198437|FG000|Overall Study|Adverse Event|1|||
33357819|NCT00840463|101198438|FG001|Overall Study|Adverse Event|0|||
33357820|NCT02158533|101198439|FG000|Stage 1|Adverse Event|6|||
33357821|NCT02158533|101198440|FG001|Stage 1|Adverse Event|4|||
33357822|NCT02158533|101198441|FG002|Stage 1|Adverse Event|7|||
33357823|NCT02158533|101198442|FG003|Stage 1|Adverse Event|0|||
33357824|NCT02158533|101198443|FG004|Stage 1|Adverse Event|0|||
33414415|NCT00560573|101406669|FG001|Overall Study|Lost to Follow-up|0|||
33414416|NCT00560573|101406670|FG002|Overall Study|Lost to Follow-up|0|||
33557159|NCT00159874|101938051|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
33622153|NCT05579977|102165934|FG003|Follow up|Lost to Follow-up|1|||
33622154|NCT05579977|102165935|FG004|Follow up|Lost to Follow-up|1|||
33622155|NCT05579977|102165936|FG005|Follow up|Lost to Follow-up|2|||
33622156|NCT05579977|102165937|FG006|Follow up|Lost to Follow-up|1|||
33622157|NCT05579977|102165938|FG007|Follow up|Lost to Follow-up|1|||
33622158|NCT05579977|102165939|FG008|Follow up|Lost to Follow-up|3|||
33622159|NCT05579977|102165940|FG009|Follow up|Lost to Follow-up|2|||
33622160|NCT05579977|102165941|FG010|Follow up|Lost to Follow-up|2|||
33622161|NCT05579977|102165942|FG011|Follow up|Lost to Follow-up|4|||
33622162|NCT05579977|102165943|FG012|Follow up|Lost to Follow-up|4|||
33622163|NCT05579977|102165931|FG000|Follow up|Withdrawal by Subject|2|||
33622164|NCT05579977|102165932|FG001|Follow up|Withdrawal by Subject|0|||
33357825|NCT02158533|101198444|FG005|Stage 1|Adverse Event|0|||
33357826|NCT02158533|101198439|FG000|Stage 1|Withdrawal by Subject|3|||
33357827|NCT02158533|101198440|FG001|Stage 1|Withdrawal by Subject|2|||
33357828|NCT02158533|101198441|FG002|Stage 1|Withdrawal by Subject|1|||
33357829|NCT02158533|101198442|FG003|Stage 1|Withdrawal by Subject|0|||
33414417|NCT00560573|101406671|FG003|Overall Study|Lost to Follow-up|1|||
33357830|NCT02158533|101198443|FG004|Stage 1|Withdrawal by Subject|0|||
33357831|NCT02158533|101198444|FG005|Stage 1|Withdrawal by Subject|0|||
33557160|NCT00159874|101938052|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
33557161|NCT00159874|101938053|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
33557162|NCT00159874|101938054|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
33557163|NCT00159874|101938048|FG000|Overall Study|Lack of Efficacy|2|||
33557164|NCT00159874|101938049|FG001|Overall Study|Lack of Efficacy|0|||
33557165|NCT00159874|101938050|FG002|Overall Study|Lack of Efficacy|1|||
33557166|NCT00159874|101938051|FG003|Overall Study|Lack of Efficacy|1|||
33557167|NCT00159874|101938052|FG004|Overall Study|Lack of Efficacy|0|||
33557168|NCT00159874|101938053|FG005|Overall Study|Lack of Efficacy|3|||
33557169|NCT00159874|101938054|FG006|Overall Study|Lack of Efficacy|0|||
33557170|NCT00159874|101938048|FG000|Overall Study|Lost to Follow-up|1|||
33557171|NCT00159874|101938049|FG001|Overall Study|Lost to Follow-up|0|||
33557172|NCT00159874|101938050|FG002|Overall Study|Lost to Follow-up|3|||
33557173|NCT00159874|101938051|FG003|Overall Study|Lost to Follow-up|0|||
33557174|NCT00159874|101938052|FG004|Overall Study|Lost to Follow-up|1|||
33557175|NCT00159874|101938053|FG005|Overall Study|Lost to Follow-up|2|||
33557176|NCT00159874|101938054|FG006|Overall Study|Lost to Follow-up|1|||
33557177|NCT00159874|101938048|FG000|Overall Study|Other|8|||
33557178|NCT00159874|101938049|FG001|Overall Study|Other|8|||
33557179|NCT00159874|101938050|FG002|Overall Study|Other|8|||
33557180|NCT00159874|101938051|FG003|Overall Study|Other|0|||
33557181|NCT00159874|101938052|FG004|Overall Study|Other|2|||
33557182|NCT00159874|101938053|FG005|Overall Study|Other|1|||
33557183|NCT00159874|101938054|FG006|Overall Study|Other|3|||
33557184|NCT00159874|101938048|FG000|Overall Study|Protocol Violation|0|||
33557185|NCT00159874|101938049|FG001|Overall Study|Protocol Violation|5|||
33557186|NCT00159874|101938050|FG002|Overall Study|Protocol Violation|2|||
33557187|NCT00159874|101938051|FG003|Overall Study|Protocol Violation|0|||
33557188|NCT00159874|101938052|FG004|Overall Study|Protocol Violation|0|||
33557189|NCT00159874|101938053|FG005|Overall Study|Protocol Violation|0|||
33557190|NCT00159874|101938054|FG006|Overall Study|Protocol Violation|0|||
33557191|NCT00159874|101938048|FG000|Overall Study|Death|3|||
33557192|NCT00159874|101938049|FG001|Overall Study|Death|8|||
33557193|NCT00159874|101938050|FG002|Overall Study|Death|15|||
33557194|NCT00159874|101938051|FG003|Overall Study|Death|0|||
33557195|NCT00159874|101938052|FG004|Overall Study|Death|1|||
33557196|NCT00159874|101938053|FG005|Overall Study|Death|2|||
33557197|NCT00159874|101938054|FG006|Overall Study|Death|0|||
33557198|NCT00159874|101938048|FG000|Overall Study|Withdrawal by Subject|2|||
33557199|NCT00159874|101938049|FG001|Overall Study|Withdrawal by Subject|6|||
33557200|NCT00159874|101938050|FG002|Overall Study|Withdrawal by Subject|8|||
33557201|NCT00159874|101938051|FG003|Overall Study|Withdrawal by Subject|4|||
33357832|NCT02158533|101198439|FG000|Stage 1|Lack of Efficacy|1|||
33357833|NCT02158533|101198440|FG001|Stage 1|Lack of Efficacy|0|||
33357834|NCT02158533|101198441|FG002|Stage 1|Lack of Efficacy|0|||
33357835|NCT02158533|101198442|FG003|Stage 1|Lack of Efficacy|0|||
33357836|NCT02158533|101198443|FG004|Stage 1|Lack of Efficacy|0|||
33357837|NCT02158533|101198444|FG005|Stage 1|Lack of Efficacy|0|||
33357838|NCT02158533|101198439|FG000|Stage 1|Lost to Follow-up|3|||
33357839|NCT02158533|101198440|FG001|Stage 1|Lost to Follow-up|1|||
33357840|NCT02158533|101198441|FG002|Stage 1|Lost to Follow-up|0|||
33357841|NCT02158533|101198442|FG003|Stage 1|Lost to Follow-up|0|||
33357842|NCT02158533|101198443|FG004|Stage 1|Lost to Follow-up|0|||
33622165|NCT05579977|102165933|FG002|Follow up|Withdrawal by Subject|0|||
33357843|NCT02158533|101198444|FG005|Stage 1|Lost to Follow-up|0|||
33357844|NCT02158533|101198439|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
33357845|NCT02158533|101198440|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
33622166|NCT05579977|102165934|FG003|Follow up|Withdrawal by Subject|0|||
33357846|NCT02158533|101198441|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
33414418|NCT00560573|101406672|FG004|Overall Study|Lost to Follow-up|1|||
33357847|NCT02158533|101198442|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
33357848|NCT02158533|101198443|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
33357849|NCT02158533|101198444|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
33357850|NCT02158533|101198439|FG000|Stage 1|Non-compliance with study visits|1|||
33622167|NCT05579977|102165935|FG004|Follow up|Withdrawal by Subject|1|||
33557202|NCT00159874|101938052|FG004|Overall Study|Withdrawal by Subject|3|||
33557203|NCT00159874|101938053|FG005|Overall Study|Withdrawal by Subject|2|||
33557204|NCT00159874|101938054|FG006|Overall Study|Withdrawal by Subject|1|||
33622168|NCT05579977|102165936|FG005|Follow up|Withdrawal by Subject|0|||
33622169|NCT05579977|102165937|FG006|Follow up|Withdrawal by Subject|1|||
33357851|NCT02158533|101198440|FG001|Stage 1|Non-compliance with study visits|0|||
33357852|NCT02158533|101198441|FG002|Stage 1|Non-compliance with study visits|0|||
33357853|NCT02158533|101198442|FG003|Stage 1|Non-compliance with study visits|0|||
33357854|NCT02158533|101198443|FG004|Stage 1|Non-compliance with study visits|0|||
33357855|NCT02158533|101198444|FG005|Stage 1|Non-compliance with study visits|0|||
33357856|NCT02158533|101198439|FG000|Stage 2|Adverse Event|0|||
33357857|NCT02158533|101198440|FG001|Stage 2|Adverse Event|0|||
33357858|NCT02158533|101198441|FG002|Stage 2|Adverse Event|0|||
33622170|NCT05579977|102165938|FG007|Follow up|Withdrawal by Subject|4|||
33622171|NCT05579977|102165939|FG008|Follow up|Withdrawal by Subject|2|||
33622172|NCT05579977|102165940|FG009|Follow up|Withdrawal by Subject|3|||
33622173|NCT05579977|102165941|FG010|Follow up|Withdrawal by Subject|3|||
33622174|NCT05579977|102165942|FG011|Follow up|Withdrawal by Subject|1|||
33357859|NCT02158533|101198442|FG003|Stage 2|Adverse Event|0|||
33357860|NCT02158533|101198443|FG004|Stage 2|Adverse Event|0|||
33357861|NCT02158533|101198444|FG005|Stage 2|Adverse Event|1|||
33357862|NCT02158533|101198439|FG000|Stage 2|Lack of Efficacy|0|||
33357863|NCT02158533|101198440|FG001|Stage 2|Lack of Efficacy|0|||
33357864|NCT02158533|101198441|FG002|Stage 2|Lack of Efficacy|0|||
33357865|NCT02158533|101198442|FG003|Stage 2|Lack of Efficacy|0|||
33557205|NCT00159874|101938048|FG000|Overall Study|Pregnancy|1|||
33557206|NCT00159874|101938049|FG001|Overall Study|Pregnancy|1|||
33557207|NCT00159874|101938050|FG002|Overall Study|Pregnancy|0|||
33557208|NCT00159874|101938051|FG003|Overall Study|Pregnancy|0|||
33557209|NCT00159874|101938052|FG004|Overall Study|Pregnancy|0|||
33622175|NCT05579977|102165943|FG012|Follow up|Withdrawal by Subject|3|||
33622176|NCT00999544|102165945|FG000|Overall Study|Withdrawal by Subject|1|||
33622177|NCT01759420|102165946|FG000|Overall Study|Screen failure|5|||
33622178|NCT01759420|102165946|FG000|Overall Study|Inaccurate EKG machine readings|1|||
33622179|NCT02098746|102165947|FG000|Overall Study|Changes of Investigator|2|||
33622180|NCT02098746|102165947|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33622181|NCT02098746|102165947|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
33622182|NCT02098746|102165947|FG000|Overall Study|Data Not Available After Treatment|1|||
33622183|NCT00100789|102165950|FG000|Overall Study|Adverse Event|10|||
33622184|NCT00100789|102165950|FG000|Overall Study|Withdrawal by Subject|1|||
33622185|NCT00100789|102165950|FG000|Overall Study|Progression/relapse|42|||
33622186|NCT00100789|102165950|FG000|Overall Study|Death|2|||
33622187|NCT00100789|102165950|FG000|Overall Study|Not protocol specified|5|||
33622188|NCT00100789|102165950|FG000|Overall Study|Ineligible|3|||
33622189|NCT00100789|102165950|FG000|Overall Study|Never received treatment|1|||
33622190|NCT01774799|102165951|FG000|Overall Study|Lost to Follow-up|1|||
33622191|NCT01774799|102165952|FG001|Overall Study|Lost to Follow-up|1|||
33622192|NCT01774799|102165953|FG002|Overall Study|Lost to Follow-up|0|||
33622193|NCT01774799|102165954|FG003|Overall Study|Lost to Follow-up|0|||
33622194|NCT01535807|102165955|FG000|Overall Study|Withdrawal by Subject|1|||
33622195|NCT01535807|102165956|FG001|Overall Study|Withdrawal by Subject|1|||
33622196|NCT01535807|102165955|FG000|Overall Study|Data collection error|1|||
33622197|NCT01535807|102165956|FG001|Overall Study|Data collection error|1|||
33622198|NCT03010527|102165960|FG000|Overall Study|Death|0|||
33622199|NCT03010527|102165961|FG001|Overall Study|Death|0|||
33622200|NCT03010527|102165962|FG002|Overall Study|Death|1|||
33622201|NCT03010527|102165960|FG000|Overall Study|Adverse Event|0|||
33557210|NCT00159874|101938053|FG005|Overall Study|Pregnancy|0|||
33557211|NCT00159874|101938054|FG006|Overall Study|Pregnancy|0|||
33357866|NCT02158533|101198443|FG004|Stage 2|Lack of Efficacy|1|||
33357867|NCT02158533|101198444|FG005|Stage 2|Lack of Efficacy|0|||
33357868|NCT02158533|101198439|FG000|Stage 2|Lost to Follow-up|0|||
33357869|NCT02158533|101198440|FG001|Stage 2|Lost to Follow-up|0|||
33357870|NCT02158533|101198441|FG002|Stage 2|Lost to Follow-up|0|||
33557212|NCT04191616|101938055|FG000|Overall Study|Death|26|||
33622202|NCT03010527|102165961|FG001|Overall Study|Adverse Event|4|||
33557213|NCT04191616|101938055|FG000|Overall Study|Withdrawal by Subject|1|||
33622203|NCT03010527|102165962|FG002|Overall Study|Adverse Event|2|||
33622204|NCT03010527|102165960|FG000|Overall Study|Protocol Violation|0|||
33622205|NCT03010527|102165961|FG001|Overall Study|Protocol Violation|1|||
33622206|NCT03010527|102165962|FG002|Overall Study|Protocol Violation|0|||
33357871|NCT02158533|101198442|FG003|Stage 2|Lost to Follow-up|1|||
33557214|NCT04191616|101938055|FG000|Overall Study|Sponsor decision|2|||
33622207|NCT03010527|102165960|FG000|Overall Study|Lost to Follow-up|0|||
33622208|NCT03010527|102165961|FG001|Overall Study|Lost to Follow-up|2|||
33622209|NCT03010527|102165962|FG002|Overall Study|Lost to Follow-up|1|||
33622210|NCT03010527|102165960|FG000|Overall Study|Withdrawal by Subject|0|||
33622211|NCT03010527|102165961|FG001|Overall Study|Withdrawal by Subject|3|||
33622212|NCT03010527|102165962|FG002|Overall Study|Withdrawal by Subject|4|||
33622213|NCT03010527|102165960|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
33622214|NCT03010527|102165961|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
33622215|NCT03010527|102165962|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
33622216|NCT03010527|102165960|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
33622217|NCT03010527|102165961|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
33622218|NCT03010527|102165962|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
33622219|NCT03010527|102165960|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
33622220|NCT03010527|102165961|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
33622221|NCT03010527|102165962|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
33622222|NCT03077542|102165965|FG000|Overall Study|Death|4|||
33622223|NCT03077542|102165966|FG001|Overall Study|Death|0|||
33622224|NCT03077542|102165965|FG000|Overall Study|Physician Decision|6|||
33622225|NCT03077542|102165966|FG001|Overall Study|Physician Decision|1|||
33622226|NCT03077542|102165965|FG000|Overall Study|Withdrawal by Subject|0|||
33622227|NCT03077542|102165966|FG001|Overall Study|Withdrawal by Subject|1|||
33622228|NCT01271725|102165967|FG000|Part A|Progressive disease according to RECIST|8|||
33622229|NCT01271725|102165968|FG001|Part A|Progressive disease according to RECIST|0|||
33622230|NCT01271725|102165967|FG000|Part A|Clinical signs/symptoms of progression|2|||
33622231|NCT01271725|102165968|FG001|Part A|Clinical signs/symptoms of progression|0|||
33622232|NCT01271725|102165967|FG000|Part A|Other Adverse Event|8|||
33622233|NCT01271725|102165968|FG001|Part A|Other Adverse Event|0|||
33622234|NCT01271725|102165967|FG000|Part A|Lost to Follow-up|1|||
33622235|NCT01271725|102165968|FG001|Part A|Lost to Follow-up|0|||
33622236|NCT01271725|102165967|FG000|Part A|Withdrawal by Subject|12|||
33622237|NCT01271725|102165968|FG001|Part A|Withdrawal by Subject|0|||
33622238|NCT01271725|102165967|FG000|Part A|Other than specified|3|||
33622239|NCT01271725|102165968|FG001|Part A|Other than specified|0|||
33357872|NCT02158533|101198443|FG004|Stage 2|Lost to Follow-up|1|||
33357873|NCT02158533|101198444|FG005|Stage 2|Lost to Follow-up|2|||
33357874|NCT02158533|101198439|FG000|Stage 2|Withdrawal by Subject|0|||
33357875|NCT02158533|101198440|FG001|Stage 2|Withdrawal by Subject|0|||
33357876|NCT02158533|101198441|FG002|Stage 2|Withdrawal by Subject|0|||
33357877|NCT02158533|101198442|FG003|Stage 2|Withdrawal by Subject|0|||
33357878|NCT02158533|101198443|FG004|Stage 2|Withdrawal by Subject|1|||
33357879|NCT02158533|101198444|FG005|Stage 2|Withdrawal by Subject|2|||
33357880|NCT02158533|101198439|FG000|Stage 2|Physician Decision|0|||
33357881|NCT02158533|101198440|FG001|Stage 2|Physician Decision|0|||
33357882|NCT02158533|101198441|FG002|Stage 2|Physician Decision|0|||
33357883|NCT02158533|101198442|FG003|Stage 2|Physician Decision|0|||
33357884|NCT02158533|101198443|FG004|Stage 2|Physician Decision|1|||
33357885|NCT02158533|101198444|FG005|Stage 2|Physician Decision|0|||
33357886|NCT02158533|101198439|FG000|Stage 2|Pregnancy|0|||
33357887|NCT02158533|101198440|FG001|Stage 2|Pregnancy|0|||
33357888|NCT02158533|101198441|FG002|Stage 2|Pregnancy|0|||
33357889|NCT02158533|101198442|FG003|Stage 2|Pregnancy|1|||
33357890|NCT02158533|101198443|FG004|Stage 2|Pregnancy|0|||
33357891|NCT02158533|101198444|FG005|Stage 2|Pregnancy|0|||
33357892|NCT02158533|101198439|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
33357893|NCT02158533|101198440|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
33622240|NCT01271725|102165967|FG000|Part A|Protocol Violation|1|||
33622241|NCT01271725|102165968|FG001|Part A|Protocol Violation|0|||
33622242|NCT01271725|102165967|FG000|Part B|Other than specified|0|||
33622243|NCT01271725|102165968|FG001|Part B|Other than specified|2|||
33622244|NCT01271725|102165967|FG000|Part B|Clinical signs/symptoms of progression|0|||
33622245|NCT01271725|102165968|FG001|Part B|Clinical signs/symptoms of progression|2|||
33622246|NCT01271725|102165967|FG000|Part B|Other Adverse Event|0|||
33622247|NCT01271725|102165968|FG001|Part B|Other Adverse Event|1|||
33622248|NCT01271725|102165967|FG000|Part B|Protocol Violation|0|||
33357894|NCT02158533|101198441|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
33357895|NCT02158533|101198442|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
33357896|NCT02158533|101198443|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
33357897|NCT02158533|101198444|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
33622249|NCT01271725|102165968|FG001|Part B|Protocol Violation|1|||
33622250|NCT01271725|102165967|FG000|Part B|Withdrawal by Subject|0|||
33622251|NCT01271725|102165968|FG001|Part B|Withdrawal by Subject|6|||
33622252|NCT01929226|102165971|FG000|Overall Study|Lost to Follow-up|4|||
33357898|NCT02158533|101198439|FG000|Stage 2|Non-adherence with study visits|0|||
33357899|NCT02158533|101198440|FG001|Stage 2|Non-adherence with study visits|0|||
33357900|NCT02158533|101198441|FG002|Stage 2|Non-adherence with study visits|0|||
33622253|NCT01929226|102165972|FG001|Overall Study|Lost to Follow-up|0|||
33622254|NCT01929226|102165971|FG000|Overall Study|Withdrawal by Subject|1|||
33622255|NCT01929226|102165972|FG001|Overall Study|Withdrawal by Subject|1|||
33622256|NCT01745367|102165976|FG000|Overall Study|Death|1|||
33622257|NCT01745367|102165977|FG001|Overall Study|Death|0|||
33622258|NCT01745367|102165976|FG000|Overall Study|Withdrawal by Subject|1|||
33622259|NCT01745367|102165977|FG001|Overall Study|Withdrawal by Subject|2|||
33357901|NCT02158533|101198442|FG003|Stage 2|Non-adherence with study visits|0|||
33357902|NCT02158533|101198443|FG004|Stage 2|Non-adherence with study visits|0|||
33557215|NCT04191616|101938055|FG000|Overall Study|Continuing study|25|||
33557216|NCT03506633|101938057|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
33557217|NCT03506633|101938058|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
33557218|NCT03166631|101938059|FG000|Overall Study|Progressive disease|2|||
33557219|NCT03166631|101938060|FG001|Overall Study|Progressive disease|1|||
33557220|NCT03166631|101938061|FG002|Overall Study|Progressive disease|3|||
33557221|NCT03166631|101938062|FG003|Overall Study|Progressive disease|4|||
33557222|NCT03166631|101938063|FG004|Overall Study|Progressive disease|2|||
33557223|NCT03166631|101938064|FG005|Overall Study|Progressive disease|2|||
33557224|NCT03166631|101938065|FG006|Overall Study|Progressive disease|5|||
33557225|NCT03166631|101938066|FG007|Overall Study|Progressive disease|6|||
33557226|NCT03166631|101938067|FG008|Overall Study|Progressive disease|11|||
33557227|NCT03166631|101938068|FG009|Overall Study|Progressive disease|5|||
33557228|NCT03166631|101938069|FG010|Overall Study|Progressive disease|7|||
33557229|NCT03166631|101938059|FG000|Overall Study|Physician Decision|0|||
33557230|NCT03166631|101938060|FG001|Overall Study|Physician Decision|0|||
33557231|NCT03166631|101938061|FG002|Overall Study|Physician Decision|0|||
33557232|NCT03166631|101938062|FG003|Overall Study|Physician Decision|0|||
33557233|NCT03166631|101938063|FG004|Overall Study|Physician Decision|0|||
33557234|NCT03166631|101938064|FG005|Overall Study|Physician Decision|0|||
33557235|NCT03166631|101938065|FG006|Overall Study|Physician Decision|1|||
33557236|NCT03166631|101938066|FG007|Overall Study|Physician Decision|0|||
33557237|NCT03166631|101938067|FG008|Overall Study|Physician Decision|1|||
33557238|NCT03166631|101938068|FG009|Overall Study|Physician Decision|0|||
33557239|NCT03166631|101938069|FG010|Overall Study|Physician Decision|1|||
33557240|NCT03166631|101938059|FG000|Overall Study|Death|0|||
33557241|NCT03166631|101938060|FG001|Overall Study|Death|0|||
33557242|NCT03166631|101938061|FG002|Overall Study|Death|0|||
33557243|NCT03166631|101938062|FG003|Overall Study|Death|0|||
33557244|NCT03166631|101938063|FG004|Overall Study|Death|1|||
33557245|NCT03166631|101938064|FG005|Overall Study|Death|0|||
33557246|NCT03166631|101938065|FG006|Overall Study|Death|1|||
33557247|NCT03166631|101938066|FG007|Overall Study|Death|0|||
33557248|NCT03166631|101938067|FG008|Overall Study|Death|0|||
33557249|NCT03166631|101938068|FG009|Overall Study|Death|0|||
33557250|NCT03166631|101938069|FG010|Overall Study|Death|0|||
33557251|NCT03166631|101938059|FG000|Overall Study|Adverse Event|1|||
33557252|NCT03166631|101938060|FG001|Overall Study|Adverse Event|0|||
33557253|NCT03166631|101938061|FG002|Overall Study|Adverse Event|0|||
33557254|NCT03166631|101938062|FG003|Overall Study|Adverse Event|0|||
33557255|NCT03166631|101938063|FG004|Overall Study|Adverse Event|0|||
33557256|NCT03166631|101938064|FG005|Overall Study|Adverse Event|1|||
33557257|NCT03166631|101938065|FG006|Overall Study|Adverse Event|1|||
33557258|NCT03166631|101938066|FG007|Overall Study|Adverse Event|0|||
33557259|NCT03166631|101938067|FG008|Overall Study|Adverse Event|1|||
33557260|NCT03166631|101938068|FG009|Overall Study|Adverse Event|2|||
33557261|NCT03166631|101938069|FG010|Overall Study|Adverse Event|1|||
33557262|NCT03166631|101938059|FG000|Overall Study|Withdrawal by Subject|0|||
33557263|NCT03166631|101938060|FG001|Overall Study|Withdrawal by Subject|0|||
33557264|NCT03166631|101938061|FG002|Overall Study|Withdrawal by Subject|0|||
33557265|NCT03166631|101938062|FG003|Overall Study|Withdrawal by Subject|0|||
33557266|NCT03166631|101938063|FG004|Overall Study|Withdrawal by Subject|0|||
33557267|NCT03166631|101938064|FG005|Overall Study|Withdrawal by Subject|0|||
33557268|NCT03166631|101938065|FG006|Overall Study|Withdrawal by Subject|0|||
33557269|NCT03166631|101938066|FG007|Overall Study|Withdrawal by Subject|0|||
33557270|NCT03166631|101938067|FG008|Overall Study|Withdrawal by Subject|1|||
33557271|NCT03166631|101938068|FG009|Overall Study|Withdrawal by Subject|1|||
33557272|NCT03166631|101938069|FG010|Overall Study|Withdrawal by Subject|0|||
33557273|NCT01478087|101938070|FG000|Overall Study|due to sponsor closing study|1|||
33557274|NCT05463705|101938071|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
33357903|NCT02158533|101198444|FG005|Stage 2|Non-adherence with study visits|1|||
33357904|NCT02388776|101198445|FG000|Overall Study|Death|1|||
33557275|NCT05463705|101938072|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
33557276|NCT05463705|101938073|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
33557277|NCT05463705|101938074|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
33557278|NCT05463705|101938075|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
33622260|NCT01745367|102165976|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
33357905|NCT02388776|101198445|FG000|Overall Study|Lost to Follow-up|1|||
33557279|NCT05463705|101938076|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
33557280|NCT01657942|101938077|FG000|Overall Study|Alternative Treatment|7|||
33557281|NCT01657942|101938077|FG000|Overall Study|Lost to Follow-up|1|||
33557282|NCT02991859|101938078|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557283|NCT02991859|101938079|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
33557284|NCT02991859|101938080|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557285|NCT02991859|101938081|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557286|NCT02991859|101938082|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
33557287|NCT02991859|101938083|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557288|NCT02991859|101938084|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557289|NCT02991859|101938085|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557290|NCT02991859|101938086|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557291|NCT02991859|101938087|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557292|NCT02991859|101938088|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557293|NCT02991859|101938089|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557294|NCT02991859|101938090|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557295|NCT02991859|101938091|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557296|NCT02991859|101938092|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557297|NCT02991859|101938093|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557298|NCT02991859|101938094|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
33557299|NCT02991859|101938078|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557300|NCT02991859|101938079|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557301|NCT02991859|101938080|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557302|NCT02991859|101938081|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557303|NCT02991859|101938082|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557304|NCT02991859|101938083|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557305|NCT02991859|101938084|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557306|NCT02991859|101938085|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557307|NCT02991859|101938086|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557308|NCT02991859|101938087|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557309|NCT02991859|101938088|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557310|NCT02991859|101938089|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557311|NCT02991859|101938090|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
33557312|NCT02991859|101938091|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
33557313|NCT02991859|101938092|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557314|NCT02991859|101938093|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557315|NCT02991859|101938094|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
33557316|NCT02991859|101938078|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557317|NCT02991859|101938079|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557318|NCT02991859|101938080|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557319|NCT02991859|101938081|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557320|NCT02991859|101938082|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557321|NCT02991859|101938083|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
33557322|NCT02991859|101938084|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557323|NCT02991859|101938085|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557324|NCT02991859|101938086|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557325|NCT02991859|101938087|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557326|NCT02991859|101938088|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557327|NCT02991859|101938089|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557328|NCT02991859|101938090|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557329|NCT02991859|101938091|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557330|NCT02991859|101938092|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557331|NCT02991859|101938093|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557332|NCT02991859|101938094|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
33557333|NCT02991859|101938078|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557334|NCT02991859|101938079|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557335|NCT02991859|101938080|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557336|NCT02991859|101938081|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557337|NCT02991859|101938082|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557338|NCT02991859|101938083|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557339|NCT02991859|101938084|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557340|NCT02991859|101938085|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557341|NCT02991859|101938086|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557342|NCT02991859|101938087|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
33557343|NCT02991859|101938088|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557344|NCT02991859|101938089|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557345|NCT02991859|101938090|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33218301|NCT04517864|100696019|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
33622261|NCT01745367|102165977|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
33622262|NCT01745367|102165976|FG000|Overall Study|Other Reasons Unspecified|0|||
33622263|NCT01745367|102165977|FG001|Overall Study|Other Reasons Unspecified|2|||
33622264|NCT02714569|102165979|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
33557346|NCT02991859|101938091|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557347|NCT02991859|101938092|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557348|NCT02991859|101938093|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557349|NCT02991859|101938094|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
33557350|NCT02991859|101938078|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33218302|NCT04517864|100696020|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
33218303|NCT04517864|100696019|FG000|Active Therapy Extension Phase|Adverse Event|1|||
33218304|NCT04517864|100696020|FG001|Active Therapy Extension Phase|Adverse Event|0|||
33218305|NCT04517864|100696019|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
33218306|NCT04517864|100696020|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
33218307|NCT04517864|100696019|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
33414419|NCT00560573|101406673|FG005|Overall Study|Lost to Follow-up|0|||
33414420|NCT00560573|101406668|FG000|Overall Study|Withdrawal by Subject|0|||
33557351|NCT02991859|101938079|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33557352|NCT02991859|101938080|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33557353|NCT02991859|101938081|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33557354|NCT02991859|101938082|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33557355|NCT02991859|101938083|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33557356|NCT02991859|101938084|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33557357|NCT02991859|101938085|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33557358|NCT02991859|101938086|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
33557359|NCT02991859|101938087|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33557360|NCT02991859|101938088|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33557361|NCT02991859|101938089|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33622265|NCT02714569|102165980|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
33622266|NCT02714569|102165981|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
33622267|NCT02714569|102165982|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
33622268|NCT02714569|102165983|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
33218308|NCT04517864|100696020|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
33218309|NCT04517864|100696019|FG000|Active Therapy Extension Phase|Physician Decision|1|||
33218310|NCT04517864|100696020|FG001|Active Therapy Extension Phase|Physician Decision|0|||
33218311|NCT04517864|100696019|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
33218312|NCT04517864|100696020|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
33622269|NCT02714569|102165984|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
33622270|NCT02714569|102165985|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
33622271|NCT02714569|102165986|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
33622272|NCT02714569|102165987|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
33622273|NCT02714569|102165988|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
33622274|NCT02714569|102165989|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
33622275|NCT02714569|102165979|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33622276|NCT02714569|102165980|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33622277|NCT02714569|102165981|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33622278|NCT02714569|102165982|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
33622279|NCT02714569|102165983|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33622280|NCT02714569|102165984|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33622281|NCT02714569|102165985|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33622282|NCT02714569|102165986|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33622283|NCT02714569|102165987|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33622284|NCT02714569|102165988|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33622285|NCT02714569|102165989|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
33622286|NCT02714569|102165979|FG000|Part A Third Intervention|Adverse Event|0|||
33622287|NCT02714569|102165980|FG001|Part A Third Intervention|Adverse Event|0|||
33622288|NCT02714569|102165981|FG002|Part A Third Intervention|Adverse Event|1|||
33622289|NCT02714569|102165982|FG003|Part A Third Intervention|Adverse Event|0|||
33622290|NCT02714569|102165983|FG004|Part A Third Intervention|Adverse Event|0|||
33622291|NCT02714569|102165984|FG005|Part A Third Intervention|Adverse Event|0|||
33622292|NCT02714569|102165985|FG006|Part A Third Intervention|Adverse Event|0|||
33622293|NCT02714569|102165986|FG007|Part A Third Intervention|Adverse Event|0|||
33622294|NCT02714569|102165987|FG008|Part A Third Intervention|Adverse Event|0|||
33622295|NCT02714569|102165988|FG009|Part A Third Intervention|Adverse Event|0|||
33622296|NCT02714569|102165989|FG010|Part A Third Intervention|Adverse Event|0|||
33622297|NCT02714569|102165979|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
33622298|NCT02714569|102165980|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33622299|NCT02714569|102165981|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33622300|NCT02714569|102165982|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33622301|NCT02714569|102165983|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33622302|NCT02714569|102165984|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
33622303|NCT02714569|102165985|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33622304|NCT02714569|102165986|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33622305|NCT02714569|102165987|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33622306|NCT02714569|102165988|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33622307|NCT02714569|102165989|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
33622308|NCT02714569|102165979|FG000|Part B (Overall)|Lost to Follow-up|0|||
33622309|NCT02714569|102165980|FG001|Part B (Overall)|Lost to Follow-up|0|||
33622310|NCT02714569|102165981|FG002|Part B (Overall)|Lost to Follow-up|0|||
33622311|NCT02714569|102165982|FG003|Part B (Overall)|Lost to Follow-up|0|||
33622312|NCT02714569|102165983|FG004|Part B (Overall)|Lost to Follow-up|0|||
33622313|NCT02714569|102165984|FG005|Part B (Overall)|Lost to Follow-up|0|||
33622314|NCT02714569|102165985|FG006|Part B (Overall)|Lost to Follow-up|1|||
33622315|NCT02714569|102165986|FG007|Part B (Overall)|Lost to Follow-up|0|||
33622316|NCT02714569|102165987|FG008|Part B (Overall)|Lost to Follow-up|0|||
33622317|NCT02714569|102165988|FG009|Part B (Overall)|Lost to Follow-up|0|||
33218313|NCT04517864|100696019|FG000|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|20|||
33218314|NCT04517864|100696020|FG001|Active Therapy Extension Phase|44 participants in this row remained ongoing in the Active Therapy Extension Phase|24|||
33218315|NCT02172625|100696021|FG000|Overall Study|Adverse Event|0|||
33218316|NCT02172625|100696022|FG001|Overall Study|Adverse Event|1|||
33218317|NCT02172625|100696021|FG000|Overall Study|Pregnancy|0|||
33218318|NCT02172625|100696022|FG001|Overall Study|Pregnancy|1|||
33622318|NCT02714569|102165989|FG010|Part B (Overall)|Lost to Follow-up|0|||
33622319|NCT02714569|102165979|FG000|Part B (Overall)|Withdrawal by Subject|0|||
33622320|NCT02714569|102165980|FG001|Part B (Overall)|Withdrawal by Subject|0|||
33622321|NCT02714569|102165981|FG002|Part B (Overall)|Withdrawal by Subject|0|||
33622322|NCT02714569|102165982|FG003|Part B (Overall)|Withdrawal by Subject|0|||
33622323|NCT02714569|102165983|FG004|Part B (Overall)|Withdrawal by Subject|0|||
33622324|NCT02714569|102165984|FG005|Part B (Overall)|Withdrawal by Subject|0|||
33414421|NCT00560573|101406669|FG001|Overall Study|Withdrawal by Subject|0|||
33414422|NCT00560573|101406670|FG002|Overall Study|Withdrawal by Subject|0|||
33357906|NCT04734873|101198449|FG000|Overall Study|Lost to Follow-up|1|||
33357907|NCT04734873|101198450|FG001|Overall Study|Lost to Follow-up|3|||
33414423|NCT00560573|101406671|FG003|Overall Study|Withdrawal by Subject|1|||
33414424|NCT00560573|101406672|FG004|Overall Study|Withdrawal by Subject|1|||
33357908|NCT04734873|101198451|FG002|Overall Study|Lost to Follow-up|2|||
33357909|NCT04734873|101198449|FG000|Overall Study|Randomized but not dosed|1|||
33357910|NCT04734873|101198450|FG001|Overall Study|Randomized but not dosed|0|||
33414425|NCT00560573|101406673|FG005|Overall Study|Withdrawal by Subject|0|||
33414426|NCT00560573|101406668|FG000|Overall Study|Other|2|||
33414427|NCT00560573|101406669|FG001|Overall Study|Other|2|||
33357911|NCT04734873|101198451|FG002|Overall Study|Randomized but not dosed|1|||
33357912|NCT02782715|101198454|FG000|Overall Study|Withdrawal by Subject|1|||
33357913|NCT02900092|101198455|FG000|Overall Study|Adverse Event|1|||
33357914|NCT03658889|101198456|FG000|Overall Study|Protocol Violation|2|||
33414428|NCT00560573|101406670|FG002|Overall Study|Other|2|||
33414429|NCT00560573|101406671|FG003|Overall Study|Other|3|||
33414430|NCT00560573|101406672|FG004|Overall Study|Other|3|||
33414431|NCT00560573|101406673|FG005|Overall Study|Other|3|||
33414432|NCT00560573|101406668|FG000|Overall Study|Enrolled, not treated|0|||
33414433|NCT00560573|101406669|FG001|Overall Study|Enrolled, not treated|0|||
33414434|NCT00560573|101406670|FG002|Overall Study|Enrolled, not treated|0|||
33414435|NCT00560573|101406671|FG003|Overall Study|Enrolled, not treated|0|||
33414436|NCT00560573|101406672|FG004|Overall Study|Enrolled, not treated|1|||
33414437|NCT00560573|101406673|FG005|Overall Study|Enrolled, not treated|0|||
33414438|NCT01035229|101406678|FG000|Overall Study|Adverse Event|61|||
33414439|NCT01035229|101406679|FG001|Overall Study|Adverse Event|14|||
33414440|NCT01035229|101406678|FG000|Overall Study|Withdrawal by Subject|20|||
33414441|NCT01035229|101406679|FG001|Overall Study|Withdrawal by Subject|7|||
33414442|NCT01035229|101406678|FG000|Overall Study|Lost to Follow-up|1|||
33414443|NCT01035229|101406679|FG001|Overall Study|Lost to Follow-up|0|||
33622325|NCT02714569|102165985|FG006|Part B (Overall)|Withdrawal by Subject|0|||
33622326|NCT02714569|102165986|FG007|Part B (Overall)|Withdrawal by Subject|1|||
33622327|NCT02714569|102165987|FG008|Part B (Overall)|Withdrawal by Subject|0|||
33622328|NCT02714569|102165988|FG009|Part B (Overall)|Withdrawal by Subject|1|||
33622329|NCT02714569|102165989|FG010|Part B (Overall)|Withdrawal by Subject|0|||
33622330|NCT02714569|102165979|FG000|Part B (Overall)|Adverse Event|0|||
33622331|NCT02714569|102165980|FG001|Part B (Overall)|Adverse Event|0|||
33622332|NCT02714569|102165981|FG002|Part B (Overall)|Adverse Event|0|||
33622333|NCT02714569|102165982|FG003|Part B (Overall)|Adverse Event|0|||
33622334|NCT02714569|102165983|FG004|Part B (Overall)|Adverse Event|0|||
33622335|NCT02714569|102165984|FG005|Part B (Overall)|Adverse Event|0|||
33622336|NCT02714569|102165985|FG006|Part B (Overall)|Adverse Event|0|||
33622337|NCT02714569|102165986|FG007|Part B (Overall)|Adverse Event|0|||
33622338|NCT02714569|102165987|FG008|Part B (Overall)|Adverse Event|0|||
33622339|NCT02714569|102165988|FG009|Part B (Overall)|Adverse Event|1|||
33622340|NCT02714569|102165989|FG010|Part B (Overall)|Adverse Event|0|||
33357915|NCT03658889|101198457|FG001|Overall Study|Protocol Violation|0|||
33357916|NCT01259466|101198458|FG000|Overall Study|Withdrawal by Subject|1|||
33414444|NCT01035229|101406678|FG000|Overall Study|Administrative problems|1|||
33414445|NCT01035229|101406679|FG001|Overall Study|Administrative problems|1|||
33414446|NCT01035229|101406678|FG000|Overall Study|Death|13|||
33414447|NCT01035229|101406679|FG001|Overall Study|Death|5|||
33414448|NCT01035229|101406678|FG000|Overall Study|New cancer therapy|2|||
33414449|NCT01035229|101406679|FG001|Overall Study|New cancer therapy|0|||
33414450|NCT01035229|101406678|FG000|Overall Study|Protocol Violation|0|||
33622341|NCT00587158|102165990|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
33622342|NCT00587158|102165991|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
33622343|NCT00587158|102165990|FG000|Overall Study|Physician Decision|0|||
33622344|NCT00587158|102165991|FG001|Overall Study|Physician Decision|1|||
33622345|NCT00587158|102165990|FG000|Overall Study|Lost to Follow-up|1|||
33622346|NCT00587158|102165991|FG001|Overall Study|Lost to Follow-up|2|||
33622347|NCT00587158|102165990|FG000|Overall Study|Death|0|||
33622348|NCT00587158|102165991|FG001|Overall Study|Death|1|||
33622349|NCT00587158|102165990|FG000|Overall Study|Subject did not want to take study med|0|||
33622350|NCT00587158|102165991|FG001|Overall Study|Subject did not want to take study med|1|||
33622351|NCT02610777|102165992|FG000|Overall Study|Lost to Follow-up|1|||
33622352|NCT02610777|102165993|FG001|Overall Study|Lost to Follow-up|0|||
33622353|NCT02610777|102165992|FG000|Overall Study|Site Terminated by Sponsor|9|||
33622354|NCT02610777|102165993|FG001|Overall Study|Site Terminated by Sponsor|8|||
33622355|NCT02610777|102165992|FG000|Overall Study|Withdrawal by Subject|2|||
33622356|NCT02610777|102165993|FG001|Overall Study|Withdrawal by Subject|2|||
33622357|NCT02610777|102165992|FG000|Overall Study|Reason not Specified|0|||
33622358|NCT02610777|102165993|FG001|Overall Study|Reason not Specified|1|||
33622359|NCT02610777|102165992|FG000|Overall Study|Death|50|||
33622360|NCT02610777|102165993|FG001|Overall Study|Death|47|||
33622361|NCT04701333|102165994|FG000|Overall Study|Lost to Follow-up|3|||
33622362|NCT04701333|102165995|FG001|Overall Study|Lost to Follow-up|7|||
33622363|NCT04701333|102165994|FG000|Overall Study|Withdrawal by Subject|0|||
33622364|NCT04701333|102165995|FG001|Overall Study|Withdrawal by Subject|1|||
33622365|NCT00985465|102165998|FG000|Overall Study|Withdrawal by Subject|1|||
33622366|NCT00985465|102165999|FG001|Overall Study|Withdrawal by Subject|2|||
33622367|NCT00985465|102165998|FG000|Overall Study|Considered to be part of the other group|0|||
33622368|NCT00985465|102165999|FG001|Overall Study|Considered to be part of the other group|1|||
33622369|NCT00872599|102166000|FG000|Second Washout Period|Adverse Event|1|||
33622370|NCT00872599|102166001|FG001|Second Washout Period|Adverse Event|1|||
33622371|NCT01168349|102166016|FG000|Overall Study|Death|157|||
33622372|NCT01168349|102166016|FG000|Overall Study|Lost to Follow-up|34|||
33622373|NCT01168349|102166016|FG000|Overall Study|Withdrawal by Subject|9|||
33622374|NCT01168349|102166016|FG000|Overall Study|Kidney transplantation|3|||
33622375|NCT01168349|102166016|FG000|Overall Study|Other|22|||
33622376|NCT01168349|102166016|FG000|Overall Study|Protocol Violation|76|||
33622377|NCT03579940|102166020|FG000|Period 2|Withdrawal by Subject|0|||
33622378|NCT03579940|102166021|FG001|Period 2|Withdrawal by Subject|0|||
33622379|NCT03579940|102166022|FG002|Period 2|Withdrawal by Subject|1|||
33622380|NCT03579940|102166023|FG003|Period 2|Withdrawal by Subject|0|||
33622381|NCT03579940|102166024|FG004|Period 2|Withdrawal by Subject|0|||
33622382|NCT03579940|102166025|FG005|Period 2|Withdrawal by Subject|0|||
33622383|NCT03579940|102166026|FG006|Period 2|Withdrawal by Subject|0|||
33622384|NCT03579940|102166027|FG007|Period 2|Withdrawal by Subject|0|||
33622385|NCT03579940|102166028|FG008|Period 2|Withdrawal by Subject|0|||
33622386|NCT03579940|102166029|FG009|Period 2|Withdrawal by Subject|0|||
33414451|NCT01035229|101406679|FG001|Overall Study|Protocol Violation|2|||
33414452|NCT01035229|101406678|FG000|Overall Study|Sponsor's decision to end study|3|||
33414453|NCT01035229|101406679|FG001|Overall Study|Sponsor's decision to end study|3|||
33414454|NCT01035229|101406678|FG000|Overall Study|Disease Progression|261|||
33414455|NCT01035229|101406679|FG001|Overall Study|Disease Progression|152|||
33414456|NCT02243709|101406680|FG000|Phase 1|Lost to Follow-up|0|||
33414457|NCT02243709|101406681|FG001|Phase 1|Lost to Follow-up|1|||
33414458|NCT02243709|101406680|FG000|Phase 1|Withdrawal by Subject|1|||
33414459|NCT02243709|101406681|FG001|Phase 1|Withdrawal by Subject|0|||
33414460|NCT02243709|101406680|FG000|Phase 1|Protocol Violation|0|||
33414461|NCT02243709|101406681|FG001|Phase 1|Protocol Violation|1|||
33414462|NCT02243709|101406680|FG000|Phase 1|Adverse Event|0|||
33414463|NCT02243709|101406681|FG001|Phase 1|Adverse Event|1|||
33414464|NCT02861534|101406686|FG000|Overall Study|Death|541|||
33414465|NCT02861534|101406687|FG001|Overall Study|Death|552|||
33414466|NCT02861534|101406686|FG000|Overall Study|Lost to Follow-up|14|||
33414467|NCT02861534|101406687|FG001|Overall Study|Lost to Follow-up|14|||
33414468|NCT02861534|101406686|FG000|Overall Study|Site Terminated by Sponsor|4|||
33622387|NCT03579940|102166030|FG010|Period 2|Withdrawal by Subject|0|||
33622388|NCT00479713|102166033|FG000|Overall Study|Adverse Event|8|||
33622389|NCT00479713|102166034|FG001|Overall Study|Adverse Event|6|||
33622390|NCT00479713|102166033|FG000|Overall Study|Death|1|||
33622391|NCT00479713|102166034|FG001|Overall Study|Death|0|||
33622392|NCT00479713|102166033|FG000|Overall Study|Lost to Follow-up|0|||
33622393|NCT00479713|102166034|FG001|Overall Study|Lost to Follow-up|1|||
33414469|NCT02861534|101406687|FG001|Overall Study|Site Terminated by Sponsor|3|||
33414470|NCT02861534|101406686|FG000|Overall Study|Withdrawal by Subject|15|||
33357917|NCT01259466|101198459|FG001|Overall Study|Withdrawal by Subject|9|||
33357918|NCT01357239|101198463|FG000|Stratum: All Patients|Adverse Event|0|||
33357919|NCT01357239|101198464|FG001|Stratum: All Patients|Adverse Event|0|||
33357920|NCT01357239|101198465|FG002|Stratum: All Patients|Adverse Event|1|||
33357921|NCT01357239|101198466|FG003|Stratum: All Patients|Adverse Event|1|||
33357922|NCT01357239|101198463|FG000|Stratum: All Patients|Subject withdrew consent|0|||
33357923|NCT01357239|101198464|FG001|Stratum: All Patients|Subject withdrew consent|0|||
33357924|NCT01357239|101198465|FG002|Stratum: All Patients|Subject withdrew consent|1|||
33622394|NCT00479713|102166033|FG000|Overall Study|Protocol Violation|0|||
33622395|NCT00479713|102166034|FG001|Overall Study|Protocol Violation|1|||
33622396|NCT00479713|102166033|FG000|Overall Study|Withdrawal by Subject|4|||
33622397|NCT00479713|102166034|FG001|Overall Study|Withdrawal by Subject|1|||
33622398|NCT00795535|102166035|FG000|Overall Study|incomplete data and technical problems|20|||
33622399|NCT00402168|102166036|FG000|Randomized|Lost to Follow-up|1|||
33622400|NCT00402168|102166037|FG001|Randomized|Lost to Follow-up|0|||
33622401|NCT00402168|102166036|FG000|Randomized|Withdrawal by Subject|0|||
33622402|NCT00402168|102166037|FG001|Randomized|Withdrawal by Subject|1|||
33622403|NCT00402168|102166036|FG000|Treatment (up to 12 Months)|Death|0|||
33218319|NCT02172625|100696021|FG000|Overall Study|car accident|0|||
33218320|NCT02172625|100696022|FG001|Overall Study|car accident|1|||
33218321|NCT00045305|100696025|FG000|Overall Study|Lack of Efficacy|6|||
33218322|NCT00045305|100696025|FG000|Overall Study|Adverse Event|3|||
33622404|NCT00402168|102166037|FG001|Treatment (up to 12 Months)|Death|1|||
33218323|NCT00045305|100696025|FG000|Overall Study|Death|3|||
33218324|NCT00045305|100696025|FG000|Overall Study|site error|2|||
33218325|NCT02057874|100696026|FG000|Overall Study|participant did not return for scan|1|||
33357925|NCT01357239|101198466|FG003|Stratum: All Patients|Subject withdrew consent|1|||
33357926|NCT01357239|101198463|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
33357927|NCT01357239|101198464|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
33414471|NCT02861534|101406687|FG001|Overall Study|Withdrawal by Subject|18|||
33414472|NCT02769832|101406690|FG000|Overall Study|Death|30|||
33557362|NCT02991859|101938090|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33557363|NCT02991859|101938091|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33557364|NCT02991859|101938092|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33557365|NCT02991859|101938093|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33557366|NCT02991859|101938094|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
33557367|NCT03382561|101938095|FG000|Overall Study|Disease progression|47|||
33557368|NCT03382561|101938096|FG001|Overall Study|Disease progression|6|||
33557369|NCT03382561|101938095|FG000|Overall Study|Adverse Event|10|||
33557370|NCT03382561|101938096|FG001|Overall Study|Adverse Event|2|||
33557371|NCT03382561|101938095|FG000|Overall Study|Death|8|||
33557372|NCT03382561|101938096|FG001|Overall Study|Death|3|||
33557373|NCT03382561|101938095|FG000|Overall Study|Withdrawal by Subject|6|||
33557374|NCT03382561|101938096|FG001|Overall Study|Withdrawal by Subject|5|||
33557375|NCT03382561|101938095|FG000|Overall Study|Alternative therapy|2|||
33557376|NCT03382561|101938096|FG001|Overall Study|Alternative therapy|8|||
33557377|NCT03382561|101938095|FG000|Overall Study|Never started treatment|3|||
33557378|NCT03382561|101938096|FG001|Overall Study|Never started treatment|6|||
33557379|NCT03382561|101938095|FG000|Overall Study|Lack of Efficacy|0|||
33557380|NCT03382561|101938096|FG001|Overall Study|Lack of Efficacy|1|||
33622405|NCT00402168|102166036|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
33622406|NCT00402168|102166037|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
33622407|NCT00402168|102166036|FG000|Treatment (up to 12 Months)|non-specified|0|||
33622408|NCT00402168|102166037|FG001|Treatment (up to 12 Months)|non-specified|1|||
33622409|NCT00402168|102166036|FG000|Long Term (LT)|Adverse Event|1|||
33622410|NCT00402168|102166037|FG001|Long Term (LT)|Adverse Event|5|||
33622411|NCT00402168|102166036|FG000|Long Term (LT)|Withdrawal by Subject|4|||
33622412|NCT00402168|102166037|FG001|Long Term (LT)|Withdrawal by Subject|7|||
33622413|NCT00402168|102166036|FG000|Long Term (LT)|Pregnancy|0|||
33622414|NCT00402168|102166037|FG001|Long Term (LT)|Pregnancy|1|||
33622415|NCT00402168|102166036|FG000|Long Term (LT)|Lost to Follow-up|1|||
33622416|NCT00402168|102166037|FG001|Long Term (LT)|Lost to Follow-up|0|||
33622417|NCT00402168|102166036|FG000|Long Term (LT)|Death|4|||
33622418|NCT00402168|102166037|FG001|Long Term (LT)|Death|0|||
33622419|NCT00402168|102166036|FG000|Long Term (LT)|Lack of Efficacy|0|||
33622420|NCT00402168|102166037|FG001|Long Term (LT)|Lack of Efficacy|2|||
33622421|NCT00402168|102166036|FG000|Long Term (LT)|non-specified|1|||
33622422|NCT00402168|102166037|FG001|Long Term (LT)|non-specified|2|||
33622423|NCT00402168|102166036|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
33622424|NCT00402168|102166037|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
33622425|NCT00402168|102166036|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
33622426|NCT00402168|102166037|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
33622427|NCT00795704|102166038|FG000|Overall Study|Withdrawal by Subject|3|||
33622428|NCT00795704|102166039|FG001|Overall Study|Withdrawal by Subject|2|||
33622429|NCT00795704|102166038|FG000|Overall Study|Adverse Event|1|||
33622430|NCT00795704|102166039|FG001|Overall Study|Adverse Event|1|||
33622431|NCT01276639|102166040|FG000|Week 0 to 16|Death|1|||
33622432|NCT01276639|102166041|FG001|Week 0 to 16|Death|0|||
33622433|NCT01276639|102166042|FG002|Week 0 to 16|Death|0|||
33622434|NCT01276639|102166043|FG003|Week 0 to 16|Death|0|||
33622435|NCT01276639|102166044|FG004|Week 0 to 16|Death|0|||
33622436|NCT01276639|102166040|FG000|Week 0 to 16|Adverse Event|11|||
33622437|NCT01276639|102166041|FG001|Week 0 to 16|Adverse Event|8|||
33622438|NCT01276639|102166042|FG002|Week 0 to 16|Adverse Event|11|||
33622439|NCT01276639|102166043|FG003|Week 0 to 16|Adverse Event|0|||
33622440|NCT01276639|102166044|FG004|Week 0 to 16|Adverse Event|0|||
33622441|NCT01276639|102166040|FG000|Week 0 to 16|Lack of Efficacy|20|||
33622442|NCT01276639|102166041|FG001|Week 0 to 16|Lack of Efficacy|15|||
33622443|NCT01276639|102166042|FG002|Week 0 to 16|Lack of Efficacy|25|||
33622444|NCT01276639|102166043|FG003|Week 0 to 16|Lack of Efficacy|0|||
33218326|NCT04123067|100696027|FG000|Overall Study|Lost to Follow-up|0|||
33557381|NCT03382561|101938095|FG000|Overall Study|Physician Decision|0|||
33557382|NCT03382561|101938096|FG001|Overall Study|Physician Decision|1|||
33622445|NCT01276639|102166044|FG004|Week 0 to 16|Lack of Efficacy|0|||
33622446|NCT01276639|102166040|FG000|Week 0 to 16|Lost to Follow-up|3|||
33622447|NCT01276639|102166041|FG001|Week 0 to 16|Lost to Follow-up|5|||
33622448|NCT01276639|102166042|FG002|Week 0 to 16|Lost to Follow-up|3|||
33622449|NCT01276639|102166043|FG003|Week 0 to 16|Lost to Follow-up|0|||
33622450|NCT01276639|102166044|FG004|Week 0 to 16|Lost to Follow-up|0|||
33622451|NCT01276639|102166040|FG000|Week 0 to 16|Withdrawal by Subject|8|||
33622452|NCT01276639|102166041|FG001|Week 0 to 16|Withdrawal by Subject|5|||
33557383|NCT03382561|101938095|FG000|Overall Study|Other complicating disease|0|||
33557384|NCT03382561|101938096|FG001|Overall Study|Other complicating disease|1|||
33557385|NCT01371565|101938107|FG000|Overall Study|Withdrawal by Subject|1|||
33557386|NCT01371565|101938107|FG000|Overall Study|Death|1|||
33557387|NCT01371565|101938107|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
33557388|NCT04941898|101938110|FG000|Overall Study|Protocol Violation|1|||
33557389|NCT01708954|101938115|FG000|Step 1|Disease progression|26|||
33557390|NCT01708954|101938116|FG001|Step 1|Disease progression|17|||
33557391|NCT01708954|101938117|FG002|Step 1|Disease progression|14|||
33557392|NCT01708954|101938115|FG000|Step 1|Adverse Event|3|||
33357928|NCT01357239|101198465|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
33357929|NCT01357239|101198466|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
33357930|NCT01357239|101198463|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
33357931|NCT01357239|101198464|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
33357932|NCT01357239|101198465|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
33357933|NCT01357239|101198466|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
33357934|NCT01357239|101198463|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
33357935|NCT01357239|101198464|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
33357936|NCT01357239|101198465|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
33357937|NCT01357239|101198466|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
33357938|NCT04090164|101198468|FG000|Overall Study|incomplete data on file|245|||
33357939|NCT04090164|101198469|FG001|Overall Study|incomplete data on file|0|||
33357940|NCT04246047|101198470|FG000|Overall Study|Death|50|||
33357941|NCT04246047|101198471|FG001|Overall Study|Death|77|||
33357942|NCT04246047|101198470|FG000|Overall Study|Lost to Follow-up|1|||
33357943|NCT04246047|101198471|FG001|Overall Study|Lost to Follow-up|3|||
33357944|NCT04246047|101198470|FG000|Overall Study|Physician Decision|4|||
33357945|NCT04246047|101198471|FG001|Overall Study|Physician Decision|10|||
33357946|NCT04246047|101198470|FG000|Overall Study|Withdrawal by Subject|19|||
33357947|NCT04246047|101198471|FG001|Overall Study|Withdrawal by Subject|26|||
33357948|NCT04246047|101198470|FG000|Overall Study|Ongoing|169|||
33357949|NCT04246047|101198471|FG001|Overall Study|Ongoing|135|||
33357950|NCT01362322|101198472|FG000|Overall Study|Withdrawal by Subject|3|||
33357951|NCT01362322|101198473|FG001|Overall Study|Withdrawal by Subject|1|||
33357952|NCT01362322|101198472|FG000|Overall Study|Lost to Follow-up|2|||
33557393|NCT01708954|101938116|FG001|Step 1|Adverse Event|11|||
33557394|NCT01708954|101938117|FG002|Step 1|Adverse Event|13|||
33557395|NCT01708954|101938115|FG000|Step 1|Death|3|||
33557396|NCT01708954|101938116|FG001|Step 1|Death|2|||
33557397|NCT01708954|101938117|FG002|Step 1|Death|3|||
33557398|NCT01708954|101938115|FG000|Step 1|Withdrawal by Subject|2|||
33557399|NCT01708954|101938116|FG001|Step 1|Withdrawal by Subject|5|||
33557400|NCT01708954|101938117|FG002|Step 1|Withdrawal by Subject|3|||
33557401|NCT01708954|101938115|FG000|Step 1|Other complicating disease|0|||
33557402|NCT01708954|101938116|FG001|Step 1|Other complicating disease|2|||
33557403|NCT01708954|101938117|FG002|Step 1|Other complicating disease|0|||
33557404|NCT01708954|101938115|FG000|Step 1|Crossed over to Step 2|2|||
33557405|NCT01708954|101938116|FG001|Step 1|Crossed over to Step 2|0|||
33557406|NCT01708954|101938117|FG002|Step 1|Crossed over to Step 2|0|||
33557407|NCT01708954|101938115|FG000|Step 1|Symptomatic deterioration|1|||
33557408|NCT01708954|101938116|FG001|Step 1|Symptomatic deterioration|0|||
33557409|NCT01708954|101938117|FG002|Step 1|Symptomatic deterioration|1|||
33557410|NCT01708954|101938115|FG000|Step 1|Off-treatment reason not submitted|1|||
33557411|NCT01708954|101938116|FG001|Step 1|Off-treatment reason not submitted|1|||
33557412|NCT01708954|101938117|FG002|Step 1|Off-treatment reason not submitted|1|||
33557413|NCT01708954|101938115|FG000|Step 1|Ineligible or never received treatment|4|||
33557414|NCT01708954|101938116|FG001|Step 1|Ineligible or never received treatment|2|||
33557415|NCT01708954|101938117|FG002|Step 1|Ineligible or never received treatment|8|||
33557416|NCT01708954|101938115|FG000|Step 2|Disease progression|9|||
33557417|NCT01708954|101938116|FG001|Step 2|Disease progression|4|||
33622453|NCT01276639|102166042|FG002|Week 0 to 16|Withdrawal by Subject|4|||
33357953|NCT01362322|101198473|FG001|Overall Study|Lost to Follow-up|6|||
33557418|NCT01708954|101938117|FG002|Step 2|Disease progression|0|||
33557419|NCT01708954|101938115|FG000|Step 2|Adverse Event|3|||
33557420|NCT01708954|101938116|FG001|Step 2|Adverse Event|2|||
33557421|NCT01708954|101938117|FG002|Step 2|Adverse Event|0|||
33557422|NCT01708954|101938115|FG000|Step 2|Withdrawal by Subject|1|||
33557423|NCT01708954|101938116|FG001|Step 2|Withdrawal by Subject|1|||
33557424|NCT01708954|101938117|FG002|Step 2|Withdrawal by Subject|0|||
33357954|NCT00650585|101198474|FG000|Overall Study|Lost to Follow-up|505|||
33357955|NCT00650585|101198475|FG001|Overall Study|Lost to Follow-up|482|||
33357956|NCT00650585|101198474|FG000|Overall Study|No parental consent|935|||
33357957|NCT00650585|101198475|FG001|Overall Study|No parental consent|866|||
33357958|NCT00650585|101198474|FG000|Overall Study|Excluded/ruled ineligible|357|||
33357959|NCT00650585|101198475|FG001|Overall Study|Excluded/ruled ineligible|129|||
33357960|NCT01006356|101198483|FG000|Overall Study|Adverse Event|6|||
33557425|NCT00972478|101938118|FG000|Overall Study|Adverse Event|3|||
33557426|NCT00972478|101938119|FG001|Overall Study|Adverse Event|16|||
33557427|NCT00972478|101938118|FG000|Overall Study|Withdrawal by Subject|1|||
33557428|NCT00972478|101938119|FG001|Overall Study|Withdrawal by Subject|8|||
33557429|NCT00972478|101938118|FG000|Overall Study|Progression/Relapse|0|||
33557430|NCT00972478|101938119|FG001|Overall Study|Progression/Relapse|2|||
33557431|NCT00972478|101938118|FG000|Overall Study|Death|0|||
33557432|NCT00972478|101938119|FG001|Overall Study|Death|2|||
33557433|NCT00972478|101938118|FG000|Overall Study|Not protocol specified|1|||
33557434|NCT00972478|101938119|FG001|Overall Study|Not protocol specified|1|||
33557435|NCT00972478|101938118|FG000|Overall Study|Ineligible|1|||
33557436|NCT00972478|101938119|FG001|Overall Study|Ineligible|7|||
33557437|NCT00972478|101938118|FG000|Overall Study|Not start protocol treatment|1|||
33557438|NCT00972478|101938119|FG001|Overall Study|Not start protocol treatment|2|||
33557439|NCT00420407|101938122|FG000|Overall Study|Lost to Follow-up|0|||
33557440|NCT00420407|101938123|FG001|Overall Study|Lost to Follow-up|3|||
33557441|NCT00420407|101938122|FG000|Overall Study|Physician Decision|2|||
33557442|NCT00420407|101938123|FG001|Overall Study|Physician Decision|1|||
33557443|NCT00420407|101938122|FG000|Overall Study|subject identified as detainee|1|||
33557444|NCT00420407|101938123|FG001|Overall Study|subject identified as detainee|0|||
33557445|NCT00420407|101938122|FG000|Overall Study|subject identified as Jehovah's witness|1|||
33557446|NCT00420407|101938123|FG001|Overall Study|subject identified as Jehovah's witness|0|||
33557447|NCT00420407|101938122|FG000|Overall Study|Withdrawal by Subject|0|||
33557448|NCT00420407|101938123|FG001|Overall Study|Withdrawal by Subject|2|||
33557449|NCT03721107|101938124|FG000|Overall Study|Adverse Event|1|||
33557450|NCT03721107|101938125|FG001|Overall Study|Adverse Event|1|||
33557451|NCT03721107|101938126|FG002|Overall Study|Adverse Event|6|||
33557452|NCT03721107|101938127|FG003|Overall Study|Adverse Event|5|||
33557453|NCT03721107|101938124|FG000|Overall Study|Lost to Follow-up|2|||
33557454|NCT03721107|101938125|FG001|Overall Study|Lost to Follow-up|0|||
33557455|NCT03721107|101938126|FG002|Overall Study|Lost to Follow-up|3|||
33557456|NCT03721107|101938127|FG003|Overall Study|Lost to Follow-up|0|||
33557457|NCT03721107|101938124|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
33557458|NCT03721107|101938125|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
33557459|NCT03721107|101938126|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
33557460|NCT03721107|101938127|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
33557461|NCT03721107|101938124|FG000|Overall Study|Physician Decision|0|||
33557462|NCT03721107|101938125|FG001|Overall Study|Physician Decision|1|||
33557463|NCT03721107|101938126|FG002|Overall Study|Physician Decision|0|||
33557464|NCT03721107|101938127|FG003|Overall Study|Physician Decision|0|||
33557465|NCT03721107|101938124|FG000|Overall Study|Pregnancy|0|||
33557466|NCT03721107|101938125|FG001|Overall Study|Pregnancy|0|||
33357961|NCT01006356|101198483|FG000|Overall Study|Physician Decision|1|||
33357962|NCT01006356|101198483|FG000|Overall Study|Paticipants did not cooperate|6|||
33357963|NCT01006356|101198483|FG000|Overall Study|Withdrawal by Subject|1|||
33557467|NCT03721107|101938126|FG002|Overall Study|Pregnancy|1|||
33557468|NCT03721107|101938127|FG003|Overall Study|Pregnancy|0|||
33557469|NCT03721107|101938124|FG000|Overall Study|Withdrawal by Subject|1|||
33557470|NCT03721107|101938125|FG001|Overall Study|Withdrawal by Subject|1|||
33557471|NCT03721107|101938126|FG002|Overall Study|Withdrawal by Subject|5|||
33557472|NCT03721107|101938127|FG003|Overall Study|Withdrawal by Subject|5|||
33557473|NCT03721107|101938124|FG000|Overall Study|Other|1|||
33557474|NCT03721107|101938125|FG001|Overall Study|Other|0|||
33557475|NCT03721107|101938126|FG002|Overall Study|Other|0|||
33557476|NCT03721107|101938127|FG003|Overall Study|Other|1|||
33557477|NCT01755156|101938128|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
33557478|NCT01755156|101938129|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
33557479|NCT01755156|101938128|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
33557480|NCT01755156|101938129|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
33557481|NCT01755156|101938128|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
33557482|NCT01755156|101938129|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
33557483|NCT01755156|101938128|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
33557484|NCT01755156|101938129|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
33557485|NCT01755156|101938128|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
33557486|NCT01755156|101938129|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
33557487|NCT01755156|101938128|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
33557488|NCT01755156|101938129|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
33557489|NCT01755156|101938128|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
33557490|NCT01755156|101938129|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
33557491|NCT01755156|101938128|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
33557492|NCT01755156|101938129|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
33357964|NCT01006356|101198483|FG000|Overall Study|Choice by participants|2|||
33557493|NCT01755156|101938128|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
33557494|NCT01755156|101938129|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
33557495|NCT01755156|101938128|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
33557496|NCT01755156|101938129|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
33557497|NCT01755156|101938128|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
33557498|NCT01755156|101938129|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
33557499|NCT05587998|101938131|FG000|Overall Study|Withdrawal by Subject|1|||
33557500|NCT05587998|101938132|FG001|Overall Study|Withdrawal by Subject|1|||
33557501|NCT05587998|101938131|FG000|Overall Study|Not treated|3|||
33557502|NCT05587998|101938132|FG001|Overall Study|Not treated|1|||
33557503|NCT05587998|101938131|FG000|Overall Study|Non-compliance with study procedures|0|||
33557504|NCT05587998|101938132|FG001|Overall Study|Non-compliance with study procedures|1|||
33557505|NCT02883049|101941047|FG000|Induction|Adverse Event|52|||
33557506|NCT02883049|101941048|FG001|Induction|Adverse Event|2|||
33557507|NCT02883049|101941049|FG002|Induction|Adverse Event|0|||
33557508|NCT02883049|101941050|FG003|Induction|Adverse Event|0|||
33557509|NCT02883049|101941051|FG004|Induction|Adverse Event|0|||
33557510|NCT02883049|101941052|FG005|Induction|Adverse Event|0|||
33557511|NCT02883049|101941053|FG006|Induction|Adverse Event|0|||
33557512|NCT02883049|101941054|FG007|Induction|Adverse Event|0|||
33557513|NCT02883049|101941055|FG008|Induction|Adverse Event|0|||
33557514|NCT02883049|101941056|FG009|Induction|Adverse Event|0|||
33557515|NCT02883049|101941057|FG010|Induction|Adverse Event|0|||
33557516|NCT02883049|101941058|FG011|Induction|Adverse Event|0|||
33622454|NCT01276639|102166043|FG003|Week 0 to 16|Withdrawal by Subject|0|||
33622455|NCT01276639|102166044|FG004|Week 0 to 16|Withdrawal by Subject|0|||
33557517|NCT02883049|101941059|FG012|Induction|Adverse Event|0|||
33557518|NCT02883049|101941060|FG013|Induction|Adverse Event|0|||
33557519|NCT02883049|101941061|FG014|Induction|Adverse Event|0|||
33557520|NCT02883049|101941062|FG015|Induction|Adverse Event|0|||
33557521|NCT02883049|101941047|FG000|Induction|Death|76|||
33557522|NCT02883049|101941048|FG001|Induction|Death|8|||
33557523|NCT02883049|101941049|FG002|Induction|Death|0|||
33557524|NCT02883049|101941050|FG003|Induction|Death|0|||
33557525|NCT02883049|101941051|FG004|Induction|Death|0|||
33557526|NCT02883049|101941052|FG005|Induction|Death|0|||
33557527|NCT02883049|101941053|FG006|Induction|Death|0|||
33557528|NCT02883049|101941054|FG007|Induction|Death|0|||
33557529|NCT02883049|101941055|FG008|Induction|Death|0|||
33557530|NCT02883049|101941056|FG009|Induction|Death|0|||
33557531|NCT02883049|101941057|FG010|Induction|Death|0|||
33557532|NCT02883049|101941058|FG011|Induction|Death|0|||
33557533|NCT02883049|101941059|FG012|Induction|Death|0|||
33557534|NCT02883049|101941060|FG013|Induction|Death|0|||
33557535|NCT02883049|101941061|FG014|Induction|Death|0|||
33557536|NCT02883049|101941062|FG015|Induction|Death|0|||
33557537|NCT02883049|101941047|FG000|Induction|Lost to Follow-up|2|||
33557538|NCT02883049|101941048|FG001|Induction|Lost to Follow-up|0|||
33557539|NCT02883049|101941049|FG002|Induction|Lost to Follow-up|0|||
33557540|NCT02883049|101941050|FG003|Induction|Lost to Follow-up|0|||
33557541|NCT02883049|101941051|FG004|Induction|Lost to Follow-up|0|||
33557542|NCT02883049|101941052|FG005|Induction|Lost to Follow-up|0|||
33557543|NCT02883049|101941053|FG006|Induction|Lost to Follow-up|0|||
33557544|NCT02883049|101941054|FG007|Induction|Lost to Follow-up|0|||
33557545|NCT02883049|101941055|FG008|Induction|Lost to Follow-up|0|||
33557546|NCT02883049|101941056|FG009|Induction|Lost to Follow-up|0|||
33557547|NCT02883049|101941057|FG010|Induction|Lost to Follow-up|0|||
33557548|NCT02883049|101941058|FG011|Induction|Lost to Follow-up|0|||
33557549|NCT02883049|101941059|FG012|Induction|Lost to Follow-up|0|||
33557550|NCT02883049|101941060|FG013|Induction|Lost to Follow-up|0|||
33557551|NCT02883049|101941061|FG014|Induction|Lost to Follow-up|0|||
33414473|NCT01656850|101406691|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
33414474|NCT01656850|101406692|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
33557552|NCT02883049|101941062|FG015|Induction|Lost to Follow-up|0|||
33557553|NCT02883049|101941047|FG000|Induction|Physician Decision|1407|||
33557554|NCT02883049|101941048|FG001|Induction|Physician Decision|8|||
33557555|NCT02883049|101941049|FG002|Induction|Physician Decision|0|||
33557556|NCT02883049|101941050|FG003|Induction|Physician Decision|0|||
33557557|NCT02883049|101941051|FG004|Induction|Physician Decision|0|||
33557558|NCT02883049|101941052|FG005|Induction|Physician Decision|0|||
33557559|NCT02883049|101941053|FG006|Induction|Physician Decision|0|||
33557560|NCT02883049|101941054|FG007|Induction|Physician Decision|0|||
33557561|NCT02883049|101941055|FG008|Induction|Physician Decision|0|||
33557562|NCT02883049|101941056|FG009|Induction|Physician Decision|0|||
33557563|NCT02883049|101941057|FG010|Induction|Physician Decision|0|||
33557564|NCT02883049|101941058|FG011|Induction|Physician Decision|0|||
33622456|NCT01276639|102166040|FG000|Week 0 to 16|Other|7|||
33557565|NCT02883049|101941059|FG012|Induction|Physician Decision|0|||
33557566|NCT02883049|101941060|FG013|Induction|Physician Decision|0|||
33557567|NCT02883049|101941061|FG014|Induction|Physician Decision|0|||
33557568|NCT02883049|101941062|FG015|Induction|Physician Decision|0|||
33557569|NCT02883049|101941047|FG000|Induction|Protocol Violation|6|||
33557570|NCT02883049|101941048|FG001|Induction|Protocol Violation|0|||
33557571|NCT02883049|101941049|FG002|Induction|Protocol Violation|0|||
33557572|NCT02883049|101941050|FG003|Induction|Protocol Violation|0|||
33557573|NCT02883049|101941051|FG004|Induction|Protocol Violation|0|||
33557574|NCT02883049|101941052|FG005|Induction|Protocol Violation|0|||
33557575|NCT02883049|101941053|FG006|Induction|Protocol Violation|0|||
33557576|NCT02883049|101941054|FG007|Induction|Protocol Violation|0|||
33557577|NCT02883049|101941055|FG008|Induction|Protocol Violation|0|||
33557578|NCT02883049|101941056|FG009|Induction|Protocol Violation|0|||
33557579|NCT02883049|101941057|FG010|Induction|Protocol Violation|0|||
33557580|NCT02883049|101941058|FG011|Induction|Protocol Violation|0|||
33557581|NCT02883049|101941059|FG012|Induction|Protocol Violation|0|||
33557582|NCT02883049|101941060|FG013|Induction|Protocol Violation|0|||
33557583|NCT02883049|101941061|FG014|Induction|Protocol Violation|0|||
33557584|NCT02883049|101941062|FG015|Induction|Protocol Violation|0|||
33557585|NCT02883049|101941047|FG000|Induction|Withdrawal by Subject|6|||
33557586|NCT02883049|101941048|FG001|Induction|Withdrawal by Subject|0|||
33557587|NCT02883049|101941049|FG002|Induction|Withdrawal by Subject|0|||
33557588|NCT02883049|101941050|FG003|Induction|Withdrawal by Subject|0|||
33557589|NCT02883049|101941051|FG004|Induction|Withdrawal by Subject|0|||
33557590|NCT02883049|101941052|FG005|Induction|Withdrawal by Subject|0|||
33557591|NCT02883049|101941053|FG006|Induction|Withdrawal by Subject|0|||
33557592|NCT02883049|101941054|FG007|Induction|Withdrawal by Subject|0|||
33557593|NCT02883049|101941055|FG008|Induction|Withdrawal by Subject|0|||
33557594|NCT02883049|101941056|FG009|Induction|Withdrawal by Subject|0|||
33557595|NCT02883049|101941057|FG010|Induction|Withdrawal by Subject|0|||
33557596|NCT02883049|101941058|FG011|Induction|Withdrawal by Subject|0|||
33557597|NCT02883049|101941059|FG012|Induction|Withdrawal by Subject|0|||
33557598|NCT02883049|101941060|FG013|Induction|Withdrawal by Subject|0|||
33557599|NCT02883049|101941061|FG014|Induction|Withdrawal by Subject|0|||
33557600|NCT02883049|101941062|FG015|Induction|Withdrawal by Subject|0|||
33557601|NCT02883049|101941047|FG000|Induction|Ineligible|35|||
33557602|NCT02883049|101941048|FG001|Induction|Ineligible|1|||
33557603|NCT02883049|101941049|FG002|Induction|Ineligible|0|||
33557604|NCT02883049|101941050|FG003|Induction|Ineligible|0|||
33557605|NCT02883049|101941051|FG004|Induction|Ineligible|0|||
33557606|NCT02883049|101941052|FG005|Induction|Ineligible|0|||
33557607|NCT02883049|101941053|FG006|Induction|Ineligible|0|||
33557608|NCT02883049|101941054|FG007|Induction|Ineligible|0|||
33557609|NCT02883049|101941055|FG008|Induction|Ineligible|0|||
33557610|NCT02883049|101941056|FG009|Induction|Ineligible|0|||
33557611|NCT02883049|101941057|FG010|Induction|Ineligible|0|||
33557612|NCT02883049|101941058|FG011|Induction|Ineligible|0|||
33557613|NCT02883049|101941059|FG012|Induction|Ineligible|0|||
33557614|NCT02883049|101941060|FG013|Induction|Ineligible|0|||
33557615|NCT02883049|101941061|FG014|Induction|Ineligible|0|||
33557616|NCT02883049|101941062|FG015|Induction|Ineligible|0|||
33557617|NCT02883049|101941047|FG000|Induction|Refusal of further protocol therapy|466|||
33557618|NCT02883049|101941048|FG001|Induction|Refusal of further protocol therapy|2|||
33557619|NCT02883049|101941049|FG002|Induction|Refusal of further protocol therapy|0|||
33557620|NCT02883049|101941050|FG003|Induction|Refusal of further protocol therapy|0|||
33557621|NCT02883049|101941051|FG004|Induction|Refusal of further protocol therapy|0|||
33557622|NCT02883049|101941052|FG005|Induction|Refusal of further protocol therapy|0|||
33557623|NCT02883049|101941053|FG006|Induction|Refusal of further protocol therapy|0|||
33557624|NCT02883049|101941054|FG007|Induction|Refusal of further protocol therapy|0|||
33557625|NCT02883049|101941055|FG008|Induction|Refusal of further protocol therapy|0|||
33557626|NCT02883049|101941056|FG009|Induction|Refusal of further protocol therapy|0|||
33557627|NCT02883049|101941057|FG010|Induction|Refusal of further protocol therapy|0|||
33557628|NCT02883049|101941058|FG011|Induction|Refusal of further protocol therapy|0|||
33557629|NCT02883049|101941059|FG012|Induction|Refusal of further protocol therapy|0|||
33557630|NCT02883049|101941060|FG013|Induction|Refusal of further protocol therapy|0|||
33557631|NCT02883049|101941061|FG014|Induction|Refusal of further protocol therapy|0|||
33557632|NCT02883049|101941062|FG015|Induction|Refusal of further protocol therapy|0|||
33557633|NCT02883049|101941047|FG000|Induction|Identified as Ph+ patients|279|||
33557634|NCT02883049|101941048|FG001|Induction|Identified as Ph+ patients|1|||
33557635|NCT02883049|101941049|FG002|Induction|Identified as Ph+ patients|0|||
33557636|NCT02883049|101941050|FG003|Induction|Identified as Ph+ patients|0|||
33557637|NCT02883049|101941051|FG004|Induction|Identified as Ph+ patients|0|||
33557638|NCT02883049|101941052|FG005|Induction|Identified as Ph+ patients|0|||
33557639|NCT02883049|101941053|FG006|Induction|Identified as Ph+ patients|0|||
33557640|NCT02883049|101941054|FG007|Induction|Identified as Ph+ patients|0|||
33557641|NCT02883049|101941055|FG008|Induction|Identified as Ph+ patients|0|||
33557642|NCT02883049|101941056|FG009|Induction|Identified as Ph+ patients|0|||
33557643|NCT02883049|101941057|FG010|Induction|Identified as Ph+ patients|0|||
33557644|NCT02883049|101941058|FG011|Induction|Identified as Ph+ patients|0|||
33557645|NCT02883049|101941059|FG012|Induction|Identified as Ph+ patients|0|||
33557646|NCT02883049|101941060|FG013|Induction|Identified as Ph+ patients|0|||
33557647|NCT02883049|101941061|FG014|Induction|Identified as Ph+ patients|0|||
33557648|NCT02883049|101941062|FG015|Induction|Identified as Ph+ patients|0|||
33557649|NCT02883049|101941047|FG000|Induction|M3 Marrow at Day29|8|||
33557650|NCT02883049|101941048|FG001|Induction|M3 Marrow at Day29|1|||
33557651|NCT02883049|101941049|FG002|Induction|M3 Marrow at Day29|0|||
33557652|NCT02883049|101941050|FG003|Induction|M3 Marrow at Day29|0|||
33557653|NCT02883049|101941051|FG004|Induction|M3 Marrow at Day29|0|||
33557654|NCT02883049|101941052|FG005|Induction|M3 Marrow at Day29|0|||
33557655|NCT02883049|101941053|FG006|Induction|M3 Marrow at Day29|0|||
33557656|NCT02883049|101941054|FG007|Induction|M3 Marrow at Day29|0|||
33557657|NCT02883049|101941055|FG008|Induction|M3 Marrow at Day29|0|||
33557658|NCT02883049|101941056|FG009|Induction|M3 Marrow at Day29|0|||
33557659|NCT02883049|101941057|FG010|Induction|M3 Marrow at Day29|0|||
33557660|NCT02883049|101941058|FG011|Induction|M3 Marrow at Day29|0|||
33557661|NCT02883049|101941059|FG012|Induction|M3 Marrow at Day29|0|||
33557662|NCT02883049|101941060|FG013|Induction|M3 Marrow at Day29|0|||
33557663|NCT02883049|101941061|FG014|Induction|M3 Marrow at Day29|0|||
33557664|NCT02883049|101941062|FG015|Induction|M3 Marrow at Day29|0|||
33557665|NCT02883049|101941047|FG000|Induction|Inevaluable|33|||
33557666|NCT02883049|101941048|FG001|Induction|Inevaluable|1|||
33622457|NCT01276639|102166041|FG001|Week 0 to 16|Other|7|||
33622458|NCT01276639|102166042|FG002|Week 0 to 16|Other|2|||
33622459|NCT01276639|102166043|FG003|Week 0 to 16|Other|0|||
33557667|NCT02883049|101941049|FG002|Induction|Inevaluable|0|||
33557668|NCT02883049|101941050|FG003|Induction|Inevaluable|0|||
33557669|NCT02883049|101941051|FG004|Induction|Inevaluable|0|||
33557670|NCT02883049|101941052|FG005|Induction|Inevaluable|0|||
33557671|NCT02883049|101941053|FG006|Induction|Inevaluable|0|||
33557672|NCT02883049|101941054|FG007|Induction|Inevaluable|0|||
33557673|NCT02883049|101941055|FG008|Induction|Inevaluable|0|||
33557674|NCT02883049|101941056|FG009|Induction|Inevaluable|0|||
33557675|NCT02883049|101941057|FG010|Induction|Inevaluable|0|||
33557676|NCT02883049|101941058|FG011|Induction|Inevaluable|0|||
33557677|NCT02883049|101941059|FG012|Induction|Inevaluable|0|||
33557678|NCT02883049|101941060|FG013|Induction|Inevaluable|0|||
33557679|NCT02883049|101941061|FG014|Induction|Inevaluable|0|||
33557680|NCT02883049|101941062|FG015|Induction|Inevaluable|0|||
33557681|NCT02883049|101941047|FG000|Induction|Identified as VHR at end of Induction|244|||
33557682|NCT02883049|101941048|FG001|Induction|Identified as VHR at end of Induction|0|||
33557683|NCT02883049|101941049|FG002|Induction|Identified as VHR at end of Induction|0|||
33557684|NCT02883049|101941050|FG003|Induction|Identified as VHR at end of Induction|0|||
33557685|NCT02883049|101941051|FG004|Induction|Identified as VHR at end of Induction|0|||
33557686|NCT02883049|101941052|FG005|Induction|Identified as VHR at end of Induction|0|||
33557687|NCT02883049|101941053|FG006|Induction|Identified as VHR at end of Induction|0|||
33557688|NCT02883049|101941054|FG007|Induction|Identified as VHR at end of Induction|0|||
33557689|NCT02883049|101941055|FG008|Induction|Identified as VHR at end of Induction|0|||
33557690|NCT02883049|101941056|FG009|Induction|Identified as VHR at end of Induction|0|||
33557691|NCT02883049|101941057|FG010|Induction|Identified as VHR at end of Induction|0|||
33557692|NCT02883049|101941058|FG011|Induction|Identified as VHR at end of Induction|0|||
33557693|NCT02883049|101941059|FG012|Induction|Identified as VHR at end of Induction|0|||
33557694|NCT02883049|101941060|FG013|Induction|Identified as VHR at end of Induction|0|||
33557695|NCT02883049|101941061|FG014|Induction|Identified as VHR at end of Induction|0|||
33557696|NCT02883049|101941062|FG015|Induction|Identified as VHR at end of Induction|0|||
33557697|NCT02883049|101941047|FG000|Induction|Moved to another non-COG institution|3|||
33557698|NCT02883049|101941048|FG001|Induction|Moved to another non-COG institution|0|||
33557699|NCT02883049|101941049|FG002|Induction|Moved to another non-COG institution|0|||
33557700|NCT02883049|101941050|FG003|Induction|Moved to another non-COG institution|0|||
33557701|NCT02883049|101941051|FG004|Induction|Moved to another non-COG institution|0|||
33557702|NCT02883049|101941052|FG005|Induction|Moved to another non-COG institution|0|||
33557703|NCT02883049|101941053|FG006|Induction|Moved to another non-COG institution|0|||
33557704|NCT02883049|101941054|FG007|Induction|Moved to another non-COG institution|0|||
33557705|NCT02883049|101941055|FG008|Induction|Moved to another non-COG institution|0|||
33557706|NCT02883049|101941056|FG009|Induction|Moved to another non-COG institution|0|||
33557707|NCT02883049|101941057|FG010|Induction|Moved to another non-COG institution|0|||
33557708|NCT02883049|101941058|FG011|Induction|Moved to another non-COG institution|0|||
33557709|NCT02883049|101941059|FG012|Induction|Moved to another non-COG institution|0|||
33557710|NCT02883049|101941060|FG013|Induction|Moved to another non-COG institution|0|||
33557711|NCT02883049|101941061|FG014|Induction|Moved to another non-COG institution|0|||
33557712|NCT02883049|101941062|FG015|Induction|Moved to another non-COG institution|0|||
33557713|NCT02883049|101941047|FG000|Induction|Randomization closed|41|||
33557714|NCT02883049|101941048|FG001|Induction|Randomization closed|0|||
33557715|NCT02883049|101941049|FG002|Induction|Randomization closed|0|||
33557716|NCT02883049|101941050|FG003|Induction|Randomization closed|0|||
33622460|NCT01276639|102166044|FG004|Week 0 to 16|Other|0|||
33557717|NCT02883049|101941051|FG004|Induction|Randomization closed|0|||
33557718|NCT02883049|101941052|FG005|Induction|Randomization closed|0|||
33557719|NCT02883049|101941053|FG006|Induction|Randomization closed|0|||
33557720|NCT02883049|101941054|FG007|Induction|Randomization closed|0|||
33557721|NCT02883049|101941055|FG008|Induction|Randomization closed|0|||
33557722|NCT02883049|101941056|FG009|Induction|Randomization closed|0|||
33557723|NCT02883049|101941057|FG010|Induction|Randomization closed|0|||
33557724|NCT02883049|101941058|FG011|Induction|Randomization closed|0|||
33557725|NCT02883049|101941059|FG012|Induction|Randomization closed|0|||
33622461|NCT01276639|102166040|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
33557726|NCT02883049|101941060|FG013|Induction|Randomization closed|0|||
33557727|NCT02883049|101941061|FG014|Induction|Randomization closed|0|||
33557728|NCT02883049|101941062|FG015|Induction|Randomization closed|0|||
33357965|NCT01006356|101198483|FG000|Overall Study|Protocol Violation|3|||
33357966|NCT01006356|101198483|FG000|Overall Study|Other|23|||
33357967|NCT01634243|101198491|FG000|Overall Study|Adverse Event|5|||
33357968|NCT01634243|101198492|FG001|Overall Study|Adverse Event|5|||
33357969|NCT01634243|101198491|FG000|Overall Study|Lack of Efficacy|1|||
33357970|NCT01634243|101198492|FG001|Overall Study|Lack of Efficacy|0|||
33357971|NCT00824421|101198493|FG000|Overall Study|Adverse Event|6|||
33357972|NCT00824421|101198494|FG001|Overall Study|Adverse Event|6|||
33357973|NCT00824421|101198495|FG002|Overall Study|Adverse Event|6|||
33622462|NCT01276639|102166041|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
33357974|NCT00824421|101198493|FG000|Overall Study|Death|0|||
33357975|NCT00824421|101198494|FG001|Overall Study|Death|1|||
33357976|NCT00824421|101198495|FG002|Overall Study|Death|0|||
33557729|NCT02883049|101941047|FG000|Induction|MRD negative|36|||
33557730|NCT02883049|101941048|FG001|Induction|MRD negative|0|||
33557731|NCT02883049|101941049|FG002|Induction|MRD negative|0|||
33557732|NCT02883049|101941050|FG003|Induction|MRD negative|0|||
33557733|NCT02883049|101941051|FG004|Induction|MRD negative|0|||
33357977|NCT00824421|101198493|FG000|Overall Study|Lack of Efficacy|5|||
33557734|NCT02883049|101941052|FG005|Induction|MRD negative|0|||
33622463|NCT01276639|102166042|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
33622464|NCT01276639|102166043|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
33357978|NCT00824421|101198494|FG001|Overall Study|Lack of Efficacy|7|||
33557735|NCT02883049|101941053|FG006|Induction|MRD negative|0|||
33557736|NCT02883049|101941054|FG007|Induction|MRD negative|0|||
33557737|NCT02883049|101941055|FG008|Induction|MRD negative|0|||
33557738|NCT02883049|101941056|FG009|Induction|MRD negative|0|||
33557739|NCT02883049|101941057|FG010|Induction|MRD negative|0|||
33557740|NCT02883049|101941058|FG011|Induction|MRD negative|0|||
33557741|NCT02883049|101941059|FG012|Induction|MRD negative|0|||
33557742|NCT02883049|101941060|FG013|Induction|MRD negative|0|||
33557743|NCT02883049|101941061|FG014|Induction|MRD negative|0|||
33557744|NCT02883049|101941062|FG015|Induction|MRD negative|0|||
33557745|NCT02883049|101941047|FG000|Induction|Identified as HR patients|165|||
33557746|NCT02883049|101941048|FG001|Induction|Identified as HR patients|0|||
33557747|NCT02883049|101941049|FG002|Induction|Identified as HR patients|0|||
33557748|NCT02883049|101941050|FG003|Induction|Identified as HR patients|0|||
33557749|NCT02883049|101941051|FG004|Induction|Identified as HR patients|0|||
33557750|NCT02883049|101941052|FG005|Induction|Identified as HR patients|0|||
33557751|NCT02883049|101941053|FG006|Induction|Identified as HR patients|0|||
33557752|NCT02883049|101941054|FG007|Induction|Identified as HR patients|0|||
33557753|NCT02883049|101941055|FG008|Induction|Identified as HR patients|0|||
33557754|NCT02883049|101941056|FG009|Induction|Identified as HR patients|0|||
33557755|NCT02883049|101941057|FG010|Induction|Identified as HR patients|0|||
33622465|NCT01276639|102166044|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
33622466|NCT01276639|102166040|FG000|Week 16 to 52|Death|1|||
33218327|NCT04123067|100696028|FG001|Overall Study|Lost to Follow-up|1|||
33357979|NCT00824421|101198495|FG002|Overall Study|Lack of Efficacy|4|||
33557756|NCT02883049|101941058|FG011|Induction|Identified as HR patients|0|||
33557757|NCT02883049|101941059|FG012|Induction|Identified as HR patients|0|||
33357980|NCT00824421|101198493|FG000|Overall Study|Lost to Follow-up|2|||
33357981|NCT00824421|101198494|FG001|Overall Study|Lost to Follow-up|3|||
33557758|NCT02883049|101941060|FG013|Induction|Identified as HR patients|0|||
33557759|NCT02883049|101941061|FG014|Induction|Identified as HR patients|0|||
33557760|NCT02883049|101941062|FG015|Induction|Identified as HR patients|0|||
33557761|NCT02883049|101941047|FG000|Induction|Developed SMN|0|||
33557762|NCT02883049|101941048|FG001|Induction|Developed SMN|1|||
33557763|NCT02883049|101941049|FG002|Induction|Developed SMN|0|||
33557764|NCT02883049|101941050|FG003|Induction|Developed SMN|0|||
33557765|NCT02883049|101941051|FG004|Induction|Developed SMN|0|||
33557766|NCT02883049|101941052|FG005|Induction|Developed SMN|0|||
33557767|NCT02883049|101941053|FG006|Induction|Developed SMN|0|||
33557768|NCT02883049|101941054|FG007|Induction|Developed SMN|0|||
33557769|NCT02883049|101941055|FG008|Induction|Developed SMN|0|||
33557770|NCT02883049|101941056|FG009|Induction|Developed SMN|0|||
33557771|NCT02883049|101941057|FG010|Induction|Developed SMN|0|||
33557772|NCT02883049|101941058|FG011|Induction|Developed SMN|0|||
33557773|NCT02883049|101941059|FG012|Induction|Developed SMN|0|||
33557774|NCT02883049|101941060|FG013|Induction|Developed SMN|0|||
33557775|NCT02883049|101941061|FG014|Induction|Developed SMN|0|||
33557776|NCT02883049|101941062|FG015|Induction|Developed SMN|0|||
33557777|NCT02883049|101941047|FG000|Induction|Enrolled onto another COG study|72|||
33557778|NCT02883049|101941048|FG001|Induction|Enrolled onto another COG study|0|||
33557779|NCT02883049|101941049|FG002|Induction|Enrolled onto another COG study|0|||
33557780|NCT02883049|101941050|FG003|Induction|Enrolled onto another COG study|0|||
33557781|NCT02883049|101941051|FG004|Induction|Enrolled onto another COG study|0|||
33557782|NCT02883049|101941052|FG005|Induction|Enrolled onto another COG study|0|||
33557783|NCT02883049|101941053|FG006|Induction|Enrolled onto another COG study|0|||
33557784|NCT02883049|101941054|FG007|Induction|Enrolled onto another COG study|0|||
33557785|NCT02883049|101941055|FG008|Induction|Enrolled onto another COG study|0|||
33557786|NCT02883049|101941056|FG009|Induction|Enrolled onto another COG study|0|||
33557787|NCT02883049|101941057|FG010|Induction|Enrolled onto another COG study|0|||
33557788|NCT02883049|101941058|FG011|Induction|Enrolled onto another COG study|0|||
33557789|NCT02883049|101941059|FG012|Induction|Enrolled onto another COG study|0|||
33557790|NCT02883049|101941060|FG013|Induction|Enrolled onto another COG study|0|||
33557791|NCT02883049|101941061|FG014|Induction|Enrolled onto another COG study|0|||
33557792|NCT02883049|101941062|FG015|Induction|Enrolled onto another COG study|0|||
33622467|NCT01276639|102166041|FG001|Week 16 to 52|Death|0|||
33218328|NCT00453986|100696029|FG000|Overall Study|Lost to Follow-up|6|||
33218329|NCT00453986|100696030|FG001|Overall Study|Lost to Follow-up|5|||
33218330|NCT00453986|100696031|FG002|Overall Study|Lost to Follow-up|6|||
33357982|NCT00824421|101198495|FG002|Overall Study|Lost to Follow-up|0|||
33557793|NCT02883049|101941047|FG000|Induction|Incomplete induction data|17|||
33557794|NCT02883049|101941048|FG001|Induction|Incomplete induction data|0|||
33557795|NCT02883049|101941049|FG002|Induction|Incomplete induction data|0|||
33622468|NCT01276639|102166042|FG002|Week 16 to 52|Death|0|||
33357983|NCT00824421|101198493|FG000|Overall Study|Pregnancy|1|||
33357984|NCT00824421|101198494|FG001|Overall Study|Pregnancy|0|||
33357985|NCT00824421|101198495|FG002|Overall Study|Pregnancy|1|||
33357986|NCT00824421|101198493|FG000|Overall Study|Withdrawal by Subject|2|||
33357987|NCT00824421|101198494|FG001|Overall Study|Withdrawal by Subject|3|||
33357988|NCT00824421|101198495|FG002|Overall Study|Withdrawal by Subject|3|||
33357989|NCT00824421|101198493|FG000|Overall Study|Randomized but not Treated|1|||
33557796|NCT02883049|101941050|FG003|Induction|Incomplete induction data|0|||
33622469|NCT01276639|102166043|FG003|Week 16 to 52|Death|0|||
33622470|NCT01276639|102166044|FG004|Week 16 to 52|Death|0|||
33622471|NCT01276639|102166040|FG000|Week 16 to 52|Adverse Event|10|||
33622472|NCT01276639|102166041|FG001|Week 16 to 52|Adverse Event|13|||
33622473|NCT01276639|102166042|FG002|Week 16 to 52|Adverse Event|0|||
33622474|NCT01276639|102166043|FG003|Week 16 to 52|Adverse Event|1|||
33622475|NCT01276639|102166044|FG004|Week 16 to 52|Adverse Event|3|||
33622476|NCT01276639|102166040|FG000|Week 16 to 52|Lack of Efficacy|99|||
33622477|NCT01276639|102166041|FG001|Week 16 to 52|Lack of Efficacy|71|||
33622478|NCT01276639|102166042|FG002|Week 16 to 52|Lack of Efficacy|0|||
33622479|NCT01276639|102166043|FG003|Week 16 to 52|Lack of Efficacy|14|||
33357990|NCT00824421|101198494|FG001|Overall Study|Randomized but not Treated|1|||
33357991|NCT00824421|101198495|FG002|Overall Study|Randomized but not Treated|0|||
33557797|NCT02883049|101941051|FG004|Induction|Incomplete induction data|0|||
33622480|NCT01276639|102166044|FG004|Week 16 to 52|Lack of Efficacy|13|||
33622481|NCT01276639|102166040|FG000|Week 16 to 52|Lost to Follow-up|3|||
33622482|NCT01276639|102166041|FG001|Week 16 to 52|Lost to Follow-up|1|||
33622483|NCT01276639|102166042|FG002|Week 16 to 52|Lost to Follow-up|0|||
33557798|NCT02883049|101941052|FG005|Induction|Incomplete induction data|0|||
33557799|NCT02883049|101941053|FG006|Induction|Incomplete induction data|0|||
33557800|NCT02883049|101941054|FG007|Induction|Incomplete induction data|0|||
33557801|NCT02883049|101941055|FG008|Induction|Incomplete induction data|0|||
33557802|NCT02883049|101941056|FG009|Induction|Incomplete induction data|0|||
33557803|NCT02883049|101941057|FG010|Induction|Incomplete induction data|0|||
33557804|NCT02883049|101941058|FG011|Induction|Incomplete induction data|0|||
33557805|NCT02883049|101941059|FG012|Induction|Incomplete induction data|0|||
33357992|NCT00824421|101198493|FG000|Overall Study|Other|0|||
33357993|NCT00824421|101198494|FG001|Overall Study|Other|1|||
33357994|NCT00824421|101198495|FG002|Overall Study|Other|0|||
33357995|NCT03826914|101198496|FG000|Overall Study|Withdrawal by Subject|1|||
33557806|NCT02883049|101941060|FG013|Induction|Incomplete induction data|0|||
33557807|NCT02883049|101941061|FG014|Induction|Incomplete induction data|0|||
33557808|NCT02883049|101941062|FG015|Induction|Incomplete induction data|0|||
33557809|NCT02883049|101941047|FG000|Post Induction|Adverse Event|0|||
33622484|NCT01276639|102166043|FG003|Week 16 to 52|Lost to Follow-up|0|||
33622485|NCT01276639|102166044|FG004|Week 16 to 52|Lost to Follow-up|1|||
33622486|NCT01276639|102166040|FG000|Week 16 to 52|Withdrawal by Subject|4|||
33622487|NCT01276639|102166041|FG001|Week 16 to 52|Withdrawal by Subject|4|||
33622488|NCT01276639|102166042|FG002|Week 16 to 52|Withdrawal by Subject|0|||
33622489|NCT01276639|102166043|FG003|Week 16 to 52|Withdrawal by Subject|0|||
33622490|NCT01276639|102166044|FG004|Week 16 to 52|Withdrawal by Subject|1|||
33557810|NCT02883049|101941048|FG001|Post Induction|Adverse Event|0|||
33357996|NCT03826914|101198497|FG001|Overall Study|Withdrawal by Subject|1|||
33557811|NCT02883049|101941049|FG002|Post Induction|Adverse Event|0|||
33622491|NCT01276639|102166040|FG000|Week 16 to 52|Other|10|||
33622492|NCT01276639|102166041|FG001|Week 16 to 52|Other|12|||
33622493|NCT01276639|102166042|FG002|Week 16 to 52|Other|0|||
33557812|NCT02883049|101941050|FG003|Post Induction|Adverse Event|7|||
33557813|NCT02883049|101941051|FG004|Post Induction|Adverse Event|8|||
33557814|NCT02883049|101941052|FG005|Post Induction|Adverse Event|3|||
33557815|NCT02883049|101941053|FG006|Post Induction|Adverse Event|4|||
33557816|NCT02883049|101941054|FG007|Post Induction|Adverse Event|5|||
33557817|NCT02883049|101941055|FG008|Post Induction|Adverse Event|6|||
33557818|NCT02883049|101941056|FG009|Post Induction|Adverse Event|7|||
33557819|NCT02883049|101941057|FG010|Post Induction|Adverse Event|2|||
33357997|NCT01772134|101198498|FG000|Overall Study|Adverse Event|6|||
33357998|NCT01772134|101198499|FG001|Overall Study|Adverse Event|5|||
33557820|NCT02883049|101941058|FG011|Post Induction|Adverse Event|2|||
33557821|NCT02883049|101941059|FG012|Post Induction|Adverse Event|0|||
33557822|NCT02883049|101941060|FG013|Post Induction|Adverse Event|0|||
33557823|NCT02883049|101941061|FG014|Post Induction|Adverse Event|5|||
33557824|NCT02883049|101941062|FG015|Post Induction|Adverse Event|2|||
33557825|NCT02883049|101941047|FG000|Post Induction|Death|0|||
33557826|NCT02883049|101941048|FG001|Post Induction|Death|0|||
33557827|NCT02883049|101941049|FG002|Post Induction|Death|0|||
33557828|NCT02883049|101941050|FG003|Post Induction|Death|9|||
33557829|NCT02883049|101941051|FG004|Post Induction|Death|9|||
33557830|NCT02883049|101941052|FG005|Post Induction|Death|0|||
33557831|NCT02883049|101941053|FG006|Post Induction|Death|1|||
33557832|NCT02883049|101941054|FG007|Post Induction|Death|6|||
33557833|NCT02883049|101941055|FG008|Post Induction|Death|5|||
33557834|NCT02883049|101941056|FG009|Post Induction|Death|3|||
33557835|NCT02883049|101941057|FG010|Post Induction|Death|1|||
33557836|NCT02883049|101941058|FG011|Post Induction|Death|0|||
33557837|NCT02883049|101941059|FG012|Post Induction|Death|1|||
33557838|NCT02883049|101941060|FG013|Post Induction|Death|1|||
33557839|NCT02883049|101941061|FG014|Post Induction|Death|10|||
33357999|NCT01772134|101198500|FG002|Overall Study|Adverse Event|10|||
33557840|NCT02883049|101941062|FG015|Post Induction|Death|2|||
33557841|NCT02883049|101941047|FG000|Post Induction|Lost to Follow-up|0|||
33557842|NCT02883049|101941048|FG001|Post Induction|Lost to Follow-up|0|||
33358000|NCT01772134|101198498|FG000|Overall Study|Withdrew Consent|3|||
33557843|NCT02883049|101941049|FG002|Post Induction|Lost to Follow-up|0|||
33557844|NCT02883049|101941050|FG003|Post Induction|Lost to Follow-up|0|||
33557845|NCT02883049|101941051|FG004|Post Induction|Lost to Follow-up|1|||
33557846|NCT02883049|101941052|FG005|Post Induction|Lost to Follow-up|1|||
33557847|NCT02883049|101941053|FG006|Post Induction|Lost to Follow-up|0|||
33557848|NCT02883049|101941054|FG007|Post Induction|Lost to Follow-up|0|||
33557849|NCT02883049|101941055|FG008|Post Induction|Lost to Follow-up|3|||
33557850|NCT02883049|101941056|FG009|Post Induction|Lost to Follow-up|0|||
33557851|NCT02883049|101941057|FG010|Post Induction|Lost to Follow-up|1|||
33557852|NCT02883049|101941058|FG011|Post Induction|Lost to Follow-up|0|||
33557853|NCT02883049|101941059|FG012|Post Induction|Lost to Follow-up|0|||
33557854|NCT02883049|101941060|FG013|Post Induction|Lost to Follow-up|0|||
33557855|NCT02883049|101941061|FG014|Post Induction|Lost to Follow-up|0|||
33557856|NCT02883049|101941062|FG015|Post Induction|Lost to Follow-up|0|||
33218331|NCT00453986|100696032|FG003|Overall Study|Lost to Follow-up|2|||
33218332|NCT00453986|100696033|FG004|Overall Study|Lost to Follow-up|0|||
33218333|NCT01064297|100696034|FG000|Overall Study|Lost to Follow-up|791|||
33218334|NCT01064297|100696035|FG001|Overall Study|Lost to Follow-up|48|||
33218335|NCT01064297|100696036|FG002|Overall Study|Lost to Follow-up|133|||
33218336|NCT00567190|100696037|FG000|Overall Study|Death|235|||
33218337|NCT00567190|100696038|FG001|Overall Study|Death|280|||
33218338|NCT00567190|100696037|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
33218339|NCT00567190|100696038|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
33218340|NCT00430248|100696043|FG000|Overall Study|Adverse Event|49|||
33218341|NCT00430248|100696044|FG001|Overall Study|Adverse Event|61|||
33218342|NCT00430248|100696045|FG002|Overall Study|Adverse Event|64|||
33218343|NCT00430248|100696043|FG000|Overall Study|Protocol Violation|10|||
33218344|NCT00430248|100696044|FG001|Overall Study|Protocol Violation|2|||
33218345|NCT00430248|100696045|FG002|Overall Study|Protocol Violation|4|||
33218346|NCT00430248|100696043|FG000|Overall Study|Personal Reasons|12|||
33218347|NCT00430248|100696044|FG001|Overall Study|Personal Reasons|24|||
33218348|NCT00430248|100696045|FG002|Overall Study|Personal Reasons|9|||
33218349|NCT00430248|100696043|FG000|Overall Study|Lost to Follow-up|28|||
33218350|NCT00430248|100696044|FG001|Overall Study|Lost to Follow-up|33|||
33218351|NCT00430248|100696045|FG002|Overall Study|Lost to Follow-up|28|||
33218352|NCT00430248|100696043|FG000|Overall Study|Therapeutic Failure|1|||
33218353|NCT00430248|100696044|FG001|Overall Study|Therapeutic Failure|1|||
33218354|NCT00430248|100696045|FG002|Overall Study|Therapeutic Failure|1|||
33218355|NCT00430248|100696043|FG000|Overall Study|Withdrawal by Subject|14|||
33218356|NCT00430248|100696044|FG001|Overall Study|Withdrawal by Subject|20|||
33218357|NCT00430248|100696045|FG002|Overall Study|Withdrawal by Subject|16|||
33218358|NCT00430248|100696043|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33218359|NCT00430248|100696044|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
33218360|NCT00430248|100696045|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33218361|NCT00430248|100696043|FG000|Overall Study|Gout Flare|3|||
33218362|NCT00430248|100696044|FG001|Overall Study|Gout Flare|7|||
33218363|NCT00430248|100696045|FG002|Overall Study|Gout Flare|2|||
33218364|NCT00430248|100696043|FG000|Overall Study|Reason Not Specified|8|||
33218365|NCT00430248|100696044|FG001|Overall Study|Reason Not Specified|8|||
33218366|NCT00430248|100696045|FG002|Overall Study|Reason Not Specified|11|||
33218367|NCT02487810|100696046|FG000|Overall Study|Withdrawal by Subject|1|||
33557857|NCT02883049|101941047|FG000|Post Induction|Physician Decision|0|||
33557858|NCT02883049|101941048|FG001|Post Induction|Physician Decision|0|||
33557859|NCT02883049|101941049|FG002|Post Induction|Physician Decision|0|||
33557860|NCT02883049|101941050|FG003|Post Induction|Physician Decision|27|||
33557861|NCT02883049|101941051|FG004|Post Induction|Physician Decision|27|||
33557862|NCT02883049|101941052|FG005|Post Induction|Physician Decision|23|||
33557863|NCT02883049|101941053|FG006|Post Induction|Physician Decision|30|||
33557864|NCT02883049|101941054|FG007|Post Induction|Physician Decision|56|||
33557865|NCT02883049|101941055|FG008|Post Induction|Physician Decision|85|||
33557866|NCT02883049|101941056|FG009|Post Induction|Physician Decision|12|||
33557867|NCT02883049|101941057|FG010|Post Induction|Physician Decision|5|||
33557868|NCT02883049|101941058|FG011|Post Induction|Physician Decision|14|||
33557869|NCT02883049|101941059|FG012|Post Induction|Physician Decision|1|||
33557870|NCT02883049|101941060|FG013|Post Induction|Physician Decision|11|||
33557871|NCT02883049|101941061|FG014|Post Induction|Physician Decision|19|||
33557872|NCT02883049|101941062|FG015|Post Induction|Physician Decision|5|||
33218368|NCT02487810|100696047|FG001|Overall Study|Withdrawal by Subject|0|||
33218369|NCT00558064|100696048|FG000|Overall Study|Adverse Event|3|||
33218370|NCT00558064|100696049|FG001|Overall Study|Adverse Event|2|||
33218371|NCT00558064|100696048|FG000|Overall Study|Lack of Efficacy|0|||
33218372|NCT00558064|100696049|FG001|Overall Study|Lack of Efficacy|1|||
33218373|NCT00558064|100696048|FG000|Overall Study|Protocol Violation|1|||
33218374|NCT00558064|100696049|FG001|Overall Study|Protocol Violation|0|||
33218375|NCT00558064|100696048|FG000|Overall Study|Lost to Follow-up|0|||
33557873|NCT02883049|101941047|FG000|Post Induction|Protocol Violation|0|||
33557874|NCT02883049|101941048|FG001|Post Induction|Protocol Violation|0|||
33218376|NCT00558064|100696049|FG001|Overall Study|Lost to Follow-up|1|||
33218377|NCT00558064|100696048|FG000|Overall Study|Withdrawal by Subject|0|||
33218378|NCT00558064|100696049|FG001|Overall Study|Withdrawal by Subject|1|||
33218379|NCT00558064|100696048|FG000|Overall Study|No visit within allowance period|1|||
33218380|NCT00558064|100696049|FG001|Overall Study|No visit within allowance period|0|||
33218381|NCT02119260|100696050|FG000|Overall Study|Adverse Event|1|||
33218382|NCT02119260|100696051|FG001|Overall Study|Adverse Event|0|||
33218383|NCT02119260|100696052|FG002|Overall Study|Adverse Event|0|||
33218384|NCT02119260|100696053|FG003|Overall Study|Adverse Event|0|||
33218385|NCT02119260|100696054|FG004|Overall Study|Adverse Event|0|||
33218386|NCT02119260|100696055|FG005|Overall Study|Adverse Event|0|||
33218387|NCT02119260|100696056|FG006|Overall Study|Adverse Event|0|||
33218388|NCT02119260|100696050|FG000|Overall Study|Withdrew consent|0|||
33218389|NCT02119260|100696051|FG001|Overall Study|Withdrew consent|1|||
33218390|NCT02119260|100696052|FG002|Overall Study|Withdrew consent|1|||
33218391|NCT02119260|100696053|FG003|Overall Study|Withdrew consent|0|||
33218392|NCT02119260|100696054|FG004|Overall Study|Withdrew consent|0|||
33218393|NCT02119260|100696055|FG005|Overall Study|Withdrew consent|0|||
33218394|NCT02119260|100696056|FG006|Overall Study|Withdrew consent|0|||
33218395|NCT01559454|100696057|FG000|Overall Study|Lost to Follow-up|3|||
33218396|NCT01559454|100696058|FG001|Overall Study|Lost to Follow-up|2|||
33218397|NCT01559454|100696057|FG000|Overall Study|Withdrawal by Subject|0|||
33218398|NCT01559454|100696058|FG001|Overall Study|Withdrawal by Subject|1|||
33358001|NCT01772134|101198499|FG001|Overall Study|Withdrew Consent|1|||
33358002|NCT01772134|101198500|FG002|Overall Study|Withdrew Consent|5|||
33358003|NCT01772134|101198498|FG000|Overall Study|Lost to Follow-up|2|||
33557875|NCT02883049|101941049|FG002|Post Induction|Protocol Violation|0|||
33557876|NCT02883049|101941050|FG003|Post Induction|Protocol Violation|0|||
33557877|NCT02883049|101941051|FG004|Post Induction|Protocol Violation|0|||
33557878|NCT02883049|101941052|FG005|Post Induction|Protocol Violation|0|||
33557879|NCT02883049|101941053|FG006|Post Induction|Protocol Violation|0|||
33557880|NCT02883049|101941054|FG007|Post Induction|Protocol Violation|1|||
33557881|NCT02883049|101941055|FG008|Post Induction|Protocol Violation|0|||
33557882|NCT02883049|101941056|FG009|Post Induction|Protocol Violation|0|||
33557883|NCT02883049|101941057|FG010|Post Induction|Protocol Violation|0|||
33557884|NCT02883049|101941058|FG011|Post Induction|Protocol Violation|0|||
33557885|NCT02883049|101941059|FG012|Post Induction|Protocol Violation|0|||
33557886|NCT02883049|101941060|FG013|Post Induction|Protocol Violation|0|||
33557887|NCT02883049|101941061|FG014|Post Induction|Protocol Violation|0|||
33622494|NCT01276639|102166043|FG003|Week 16 to 52|Other|1|||
33622495|NCT01276639|102166044|FG004|Week 16 to 52|Other|3|||
33622496|NCT01508169|102166045|FG000|Overall Study|Adverse Event|1|||
33622497|NCT01508169|102166046|FG001|Overall Study|Adverse Event|0|||
33622498|NCT01508169|102166045|FG000|Overall Study|Withdrawal by Subject|1|||
33557888|NCT02883049|101941062|FG015|Post Induction|Protocol Violation|0|||
33622499|NCT01508169|102166046|FG001|Overall Study|Withdrawal by Subject|0|||
33622500|NCT01508169|102166045|FG000|Overall Study|Lost to Follow-up|1|||
33622501|NCT01508169|102166046|FG001|Overall Study|Lost to Follow-up|2|||
33622502|NCT01620086|102166047|FG000|Overall Study|Withdrawal by Subject|3|||
33622503|NCT01620086|102166048|FG001|Overall Study|Withdrawal by Subject|3|||
33622504|NCT01620086|102166049|FG002|Overall Study|Withdrawal by Subject|0|||
33622505|NCT01620086|102166047|FG000|Overall Study|failed study criteria|1|||
33622506|NCT01620086|102166048|FG001|Overall Study|failed study criteria|4|||
33622507|NCT01620086|102166049|FG002|Overall Study|failed study criteria|0|||
33622508|NCT01620086|102166047|FG000|Overall Study|Physician Decision|1|||
33622509|NCT01620086|102166048|FG001|Overall Study|Physician Decision|0|||
33622510|NCT01620086|102166049|FG002|Overall Study|Physician Decision|0|||
33622511|NCT01633788|102166050|FG000|Overall Study|Adverse Event|1|||
33622512|NCT01633788|102166051|FG001|Overall Study|Adverse Event|3|||
33622513|NCT01633788|102166052|FG002|Overall Study|Adverse Event|3|||
33622514|NCT01633788|102166053|FG003|Overall Study|Adverse Event|3|||
33622515|NCT01633788|102166050|FG000|Overall Study|Lost to Follow-up|2|||
33622516|NCT01633788|102166051|FG001|Overall Study|Lost to Follow-up|2|||
33622517|NCT01633788|102166052|FG002|Overall Study|Lost to Follow-up|2|||
33622518|NCT01633788|102166053|FG003|Overall Study|Lost to Follow-up|0|||
33622519|NCT01633788|102166050|FG000|Overall Study|Personal Reasons|3|||
33218399|NCT01559454|100696057|FG000|Overall Study|Physician Decision|0|||
33358004|NCT01772134|101198499|FG001|Overall Study|Lost to Follow-up|0|||
33358005|NCT01772134|101198500|FG002|Overall Study|Lost to Follow-up|0|||
33622520|NCT01633788|102166051|FG001|Overall Study|Personal Reasons|1|||
33622521|NCT01633788|102166052|FG002|Overall Study|Personal Reasons|1|||
33622522|NCT01633788|102166053|FG003|Overall Study|Personal Reasons|3|||
33622523|NCT01633788|102166050|FG000|Overall Study|Protocol Violation|1|||
33622524|NCT01633788|102166051|FG001|Overall Study|Protocol Violation|0|||
33557889|NCT02883049|101941047|FG000|Post Induction|Withdrawal by Subject|0|||
33218400|NCT01559454|100696058|FG001|Overall Study|Physician Decision|1|||
33218401|NCT01559454|100696057|FG000|Overall Study|Protocol Violation|0|||
33218402|NCT01559454|100696058|FG001|Overall Study|Protocol Violation|1|||
33218403|NCT01559454|100696057|FG000|Overall Study|Lack of Efficacy|0|||
33218404|NCT01559454|100696058|FG001|Overall Study|Lack of Efficacy|1|||
33218405|NCT02450331|100696061|FG000|Overall Study|Death|162|||
33218406|NCT02450331|100696062|FG001|Overall Study|Death|171|||
33218407|NCT02450331|100696061|FG000|Overall Study|Lost to Follow-up|14|||
33218408|NCT02450331|100696062|FG001|Overall Study|Lost to Follow-up|12|||
33218409|NCT02450331|100696061|FG000|Overall Study|Withdrawal by Subject|55|||
33218410|NCT02450331|100696062|FG001|Overall Study|Withdrawal by Subject|44|||
33218411|NCT02450331|100696061|FG000|Overall Study|Non-specified other|1|||
33218412|NCT02450331|100696062|FG001|Overall Study|Non-specified other|1|||
33218413|NCT01235546|100696063|FG000|Overall Study|Staff error, medication not administered|1|||
33218414|NCT01235546|100696064|FG001|Overall Study|Staff error, medication not administered|0|||
33218415|NCT01235546|100696063|FG000|Overall Study|Protocol Violation|1|||
33218416|NCT01235546|100696064|FG001|Overall Study|Protocol Violation|1|||
33358006|NCT01772134|101198498|FG000|Overall Study|Protocol Deviation|4|||
33218417|NCT00119405|100696065|FG000|Overall Study|Withdrawal by Subject|1|||
33218418|NCT00512148|100696070|FG000|Primay Study Period|Withdrawal by Subject|1|||
33218419|NCT03214367|100696073|FG000|Lead-in Period|Withdrawal by Subject|50|||
33218420|NCT03214367|100696074|FG001|Lead-in Period|Withdrawal by Subject|0|||
33218421|NCT03214367|100696075|FG002|Lead-in Period|Withdrawal by Subject|0|||
33218422|NCT03214367|100696076|FG003|Lead-in Period|Withdrawal by Subject|0|||
33218423|NCT03214367|100696077|FG004|Lead-in Period|Withdrawal by Subject|2|||
33218424|NCT03214367|100696078|FG005|Lead-in Period|Withdrawal by Subject|0|||
33218425|NCT03214367|100696079|FG006|Lead-in Period|Withdrawal by Subject|0|||
33358007|NCT01772134|101198499|FG001|Overall Study|Protocol Deviation|3|||
33358008|NCT01772134|101198500|FG002|Overall Study|Protocol Deviation|3|||
33622525|NCT01633788|102166052|FG002|Overall Study|Protocol Violation|1|||
33622526|NCT01633788|102166053|FG003|Overall Study|Protocol Violation|0|||
33622527|NCT01633788|102166050|FG000|Overall Study|Other Reasons|0|||
33622528|NCT01633788|102166051|FG001|Overall Study|Other Reasons|2|||
33622529|NCT01633788|102166052|FG002|Overall Study|Other Reasons|3|||
33622530|NCT01633788|102166053|FG003|Overall Study|Other Reasons|7|||
33622531|NCT00743249|102166056|FG000|Overall Study|Adverse Event|0|||
33622532|NCT00743249|102166057|FG001|Overall Study|Adverse Event|4|||
33622533|NCT00743249|102166056|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
33622534|NCT00743249|102166057|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
33622535|NCT00743249|102166056|FG000|Overall Study|Unsuccessful insertion of stent|2|||
33622536|NCT00743249|102166057|FG001|Overall Study|Unsuccessful insertion of stent|1|||
33622537|NCT02524171|102166060|FG000|6-month Follow-up|Lost to Follow-up|53|||
33622538|NCT02524171|102166061|FG001|6-month Follow-up|Lost to Follow-up|45|||
33622539|NCT02524171|102166060|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
33622540|NCT02524171|102166061|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
33622541|NCT00165672|102166063|FG000|Overall Study|Adverse Event|0|||
33622542|NCT00165672|102166064|FG001|Overall Study|Adverse Event|1|||
33622543|NCT00880620|102166067|FG000|Overall Study|Adverse Event|4|||
33622544|NCT00880620|102166068|FG001|Overall Study|Adverse Event|5|||
33622545|NCT00880620|102166069|FG002|Overall Study|Adverse Event|15|||
33622546|NCT00880620|102166070|FG003|Overall Study|Adverse Event|15|||
33622547|NCT00880620|102166067|FG000|Overall Study|Death|0|||
33622548|NCT00880620|102166068|FG001|Overall Study|Death|0|||
33622549|NCT00880620|102166069|FG002|Overall Study|Death|1|||
33622550|NCT00880620|102166070|FG003|Overall Study|Death|0|||
33622551|NCT00880620|102166067|FG000|Overall Study|Lack of Efficacy|12|||
33622552|NCT00880620|102166068|FG001|Overall Study|Lack of Efficacy|4|||
33622553|NCT00880620|102166069|FG002|Overall Study|Lack of Efficacy|0|||
33622554|NCT00880620|102166070|FG003|Overall Study|Lack of Efficacy|1|||
33622555|NCT00880620|102166067|FG000|Overall Study|Lost to Follow-up|0|||
33622556|NCT00880620|102166068|FG001|Overall Study|Lost to Follow-up|1|||
33622557|NCT00880620|102166069|FG002|Overall Study|Lost to Follow-up|1|||
33622558|NCT00880620|102166070|FG003|Overall Study|Lost to Follow-up|0|||
33622559|NCT00880620|102166067|FG000|Overall Study|Protocol Violation|0|||
33218426|NCT03214367|100696080|FG007|Lead-in Period|Withdrawal by Subject|0|||
33622560|NCT00880620|102166068|FG001|Overall Study|Protocol Violation|1|||
33218427|NCT03214367|100696073|FG000|Lead-in Period|Adverse Event|3|||
33218428|NCT03214367|100696074|FG001|Lead-in Period|Adverse Event|0|||
33218429|NCT03214367|100696075|FG002|Lead-in Period|Adverse Event|0|||
33358009|NCT01772134|101198498|FG000|Overall Study|Lack of Efficacy|11|||
33358010|NCT01772134|101198499|FG001|Overall Study|Lack of Efficacy|5|||
33622561|NCT00880620|102166069|FG002|Overall Study|Protocol Violation|0|||
33622562|NCT00880620|102166070|FG003|Overall Study|Protocol Violation|2|||
33622563|NCT00880620|102166067|FG000|Overall Study|Withdrawal by Subject|4|||
33622564|NCT00880620|102166068|FG001|Overall Study|Withdrawal by Subject|3|||
33622565|NCT00880620|102166069|FG002|Overall Study|Withdrawal by Subject|1|||
33622566|NCT00880620|102166070|FG003|Overall Study|Withdrawal by Subject|3|||
33557890|NCT02883049|101941048|FG001|Post Induction|Withdrawal by Subject|0|||
33557891|NCT02883049|101941049|FG002|Post Induction|Withdrawal by Subject|0|||
33557892|NCT02883049|101941050|FG003|Post Induction|Withdrawal by Subject|5|||
33557893|NCT02883049|101941051|FG004|Post Induction|Withdrawal by Subject|2|||
33557894|NCT02883049|101941052|FG005|Post Induction|Withdrawal by Subject|1|||
33557895|NCT02883049|101941053|FG006|Post Induction|Withdrawal by Subject|0|||
33557896|NCT02883049|101941054|FG007|Post Induction|Withdrawal by Subject|0|||
33557897|NCT02883049|101941055|FG008|Post Induction|Withdrawal by Subject|2|||
33557898|NCT02883049|101941056|FG009|Post Induction|Withdrawal by Subject|0|||
33557899|NCT02883049|101941057|FG010|Post Induction|Withdrawal by Subject|1|||
33557900|NCT02883049|101941058|FG011|Post Induction|Withdrawal by Subject|1|||
33557901|NCT02883049|101941059|FG012|Post Induction|Withdrawal by Subject|0|||
33557902|NCT02883049|101941060|FG013|Post Induction|Withdrawal by Subject|0|||
33557903|NCT02883049|101941061|FG014|Post Induction|Withdrawal by Subject|1|||
33557904|NCT02883049|101941062|FG015|Post Induction|Withdrawal by Subject|0|||
33557905|NCT02883049|101941047|FG000|Post Induction|Ineligible|0|||
33557906|NCT02883049|101941048|FG001|Post Induction|Ineligible|0|||
33557907|NCT02883049|101941049|FG002|Post Induction|Ineligible|2|||
33557908|NCT02883049|101941050|FG003|Post Induction|Ineligible|0|||
33557909|NCT02883049|101941051|FG004|Post Induction|Ineligible|0|||
33557910|NCT02883049|101941052|FG005|Post Induction|Ineligible|0|||
33557911|NCT02883049|101941053|FG006|Post Induction|Ineligible|1|||
33557912|NCT02883049|101941054|FG007|Post Induction|Ineligible|0|||
33557913|NCT02883049|101941055|FG008|Post Induction|Ineligible|0|||
33557914|NCT02883049|101941056|FG009|Post Induction|Ineligible|0|||
33557915|NCT02883049|101941057|FG010|Post Induction|Ineligible|1|||
33557916|NCT02883049|101941058|FG011|Post Induction|Ineligible|0|||
33557917|NCT02883049|101941059|FG012|Post Induction|Ineligible|0|||
33557918|NCT02883049|101941060|FG013|Post Induction|Ineligible|0|||
33557919|NCT02883049|101941061|FG014|Post Induction|Ineligible|0|||
33557920|NCT02883049|101941062|FG015|Post Induction|Ineligible|1|||
33557921|NCT02883049|101941047|FG000|Post Induction|Refusal of further protocol therapy|0|||
33557922|NCT02883049|101941048|FG001|Post Induction|Refusal of further protocol therapy|0|||
33557923|NCT02883049|101941049|FG002|Post Induction|Refusal of further protocol therapy|0|||
33557924|NCT02883049|101941050|FG003|Post Induction|Refusal of further protocol therapy|11|||
33557925|NCT02883049|101941051|FG004|Post Induction|Refusal of further protocol therapy|15|||
33557926|NCT02883049|101941052|FG005|Post Induction|Refusal of further protocol therapy|9|||
33557927|NCT02883049|101941053|FG006|Post Induction|Refusal of further protocol therapy|13|||
33557928|NCT02883049|101941054|FG007|Post Induction|Refusal of further protocol therapy|5|||
33557929|NCT02883049|101941055|FG008|Post Induction|Refusal of further protocol therapy|21|||
33557930|NCT02883049|101941056|FG009|Post Induction|Refusal of further protocol therapy|7|||
33557931|NCT02883049|101941057|FG010|Post Induction|Refusal of further protocol therapy|0|||
33557932|NCT02883049|101941058|FG011|Post Induction|Refusal of further protocol therapy|7|||
33557933|NCT02883049|101941059|FG012|Post Induction|Refusal of further protocol therapy|3|||
33557934|NCT02883049|101941060|FG013|Post Induction|Refusal of further protocol therapy|0|||
33557935|NCT02883049|101941061|FG014|Post Induction|Refusal of further protocol therapy|4|||
33557936|NCT02883049|101941062|FG015|Post Induction|Refusal of further protocol therapy|1|||
33557937|NCT02883049|101941047|FG000|Post Induction|Inevaluable|0|||
33557938|NCT02883049|101941048|FG001|Post Induction|Inevaluable|0|||
33557939|NCT02883049|101941049|FG002|Post Induction|Inevaluable|0|||
33557940|NCT02883049|101941050|FG003|Post Induction|Inevaluable|1|||
33557941|NCT02883049|101941051|FG004|Post Induction|Inevaluable|1|||
33557942|NCT02883049|101941052|FG005|Post Induction|Inevaluable|2|||
33557943|NCT02883049|101941053|FG006|Post Induction|Inevaluable|7|||
33622567|NCT00880620|102166067|FG000|Overall Study|Noncompliance|0|||
33622568|NCT00880620|102166068|FG001|Overall Study|Noncompliance|0|||
33622569|NCT00880620|102166069|FG002|Overall Study|Noncompliance|1|||
33622570|NCT00880620|102166070|FG003|Overall Study|Noncompliance|1|||
33622571|NCT00880620|102166067|FG000|Overall Study|Other|1|||
33622572|NCT00880620|102166068|FG001|Overall Study|Other|1|||
33622573|NCT00880620|102166069|FG002|Overall Study|Other|2|||
33622574|NCT00880620|102166070|FG003|Overall Study|Other|2|||
33622575|NCT00584012|102169318|FG000|Overall Study|Withdrawal by Subject|1|||
33622576|NCT04332107|102169321|FG000|Day 3|Lost to Follow-up|23|||
33622577|NCT04332107|102169322|FG001|Day 3|Lost to Follow-up|14|||
33358011|NCT01772134|101198500|FG002|Overall Study|Lack of Efficacy|3|||
33557944|NCT02883049|101941054|FG007|Post Induction|Inevaluable|6|||
33557945|NCT02883049|101941055|FG008|Post Induction|Inevaluable|4|||
33557946|NCT02883049|101941056|FG009|Post Induction|Inevaluable|4|||
33557947|NCT02883049|101941057|FG010|Post Induction|Inevaluable|1|||
33557948|NCT02883049|101941058|FG011|Post Induction|Inevaluable|1|||
33557949|NCT02883049|101941059|FG012|Post Induction|Inevaluable|2|||
33557950|NCT02883049|101941060|FG013|Post Induction|Inevaluable|0|||
33557951|NCT02883049|101941061|FG014|Post Induction|Inevaluable|0|||
33622578|NCT04332107|102169321|FG000|Day 3|Missing outcome data|3|||
33622579|NCT04332107|102169322|FG001|Day 3|Missing outcome data|6|||
33622580|NCT04332107|102169321|FG000|Day 14|Lost to Follow-up|13|||
33622581|NCT04332107|102169322|FG001|Day 14|Lost to Follow-up|4|||
33557952|NCT02883049|101941062|FG015|Post Induction|Inevaluable|1|||
33557953|NCT02883049|101941047|FG000|Post Induction|Moved to another non-COG institution|0|||
33557954|NCT02883049|101941048|FG001|Post Induction|Moved to another non-COG institution|0|||
33557955|NCT02883049|101941049|FG002|Post Induction|Moved to another non-COG institution|0|||
33557956|NCT02883049|101941050|FG003|Post Induction|Moved to another non-COG institution|0|||
33557957|NCT02883049|101941051|FG004|Post Induction|Moved to another non-COG institution|0|||
33557958|NCT02883049|101941052|FG005|Post Induction|Moved to another non-COG institution|0|||
33557959|NCT02883049|101941053|FG006|Post Induction|Moved to another non-COG institution|0|||
33557960|NCT02883049|101941054|FG007|Post Induction|Moved to another non-COG institution|2|||
33557961|NCT02883049|101941055|FG008|Post Induction|Moved to another non-COG institution|2|||
33557962|NCT02883049|101941056|FG009|Post Induction|Moved to another non-COG institution|0|||
33557963|NCT02883049|101941057|FG010|Post Induction|Moved to another non-COG institution|0|||
33557964|NCT02883049|101941058|FG011|Post Induction|Moved to another non-COG institution|1|||
33557965|NCT02883049|101941059|FG012|Post Induction|Moved to another non-COG institution|0|||
33557966|NCT02883049|101941060|FG013|Post Induction|Moved to another non-COG institution|0|||
33557967|NCT02883049|101941061|FG014|Post Induction|Moved to another non-COG institution|0|||
33557968|NCT02883049|101941062|FG015|Post Induction|Moved to another non-COG institution|0|||
33557969|NCT02883049|101941047|FG000|Post Induction|Randomization closed|0|||
33557970|NCT02883049|101941048|FG001|Post Induction|Randomization closed|0|||
33557971|NCT02883049|101941049|FG002|Post Induction|Randomization closed|0|||
33557972|NCT02883049|101941050|FG003|Post Induction|Randomization closed|0|||
33557973|NCT02883049|101941051|FG004|Post Induction|Randomization closed|0|||
33557974|NCT02883049|101941052|FG005|Post Induction|Randomization closed|0|||
33557975|NCT02883049|101941053|FG006|Post Induction|Randomization closed|0|||
33557976|NCT02883049|101941054|FG007|Post Induction|Randomization closed|20|||
33557977|NCT02883049|101941055|FG008|Post Induction|Randomization closed|0|||
33557978|NCT02883049|101941056|FG009|Post Induction|Randomization closed|0|||
33557979|NCT02883049|101941057|FG010|Post Induction|Randomization closed|0|||
33557980|NCT02883049|101941058|FG011|Post Induction|Randomization closed|0|||
33557981|NCT02883049|101941059|FG012|Post Induction|Randomization closed|0|||
33557982|NCT02883049|101941060|FG013|Post Induction|Randomization closed|0|||
33557983|NCT02883049|101941061|FG014|Post Induction|Randomization closed|0|||
33557984|NCT02883049|101941062|FG015|Post Induction|Randomization closed|0|||
33557985|NCT02883049|101941047|FG000|Post Induction|MRD negative|0|||
33557986|NCT02883049|101941048|FG001|Post Induction|MRD negative|0|||
33557987|NCT02883049|101941049|FG002|Post Induction|MRD negative|0|||
33557988|NCT02883049|101941050|FG003|Post Induction|MRD negative|0|||
33557989|NCT02883049|101941051|FG004|Post Induction|MRD negative|0|||
33557990|NCT02883049|101941052|FG005|Post Induction|MRD negative|0|||
33557991|NCT02883049|101941053|FG006|Post Induction|MRD negative|0|||
33557992|NCT02883049|101941054|FG007|Post Induction|MRD negative|11|||
33557993|NCT02883049|101941055|FG008|Post Induction|MRD negative|0|||
33557994|NCT02883049|101941056|FG009|Post Induction|MRD negative|0|||
33557995|NCT02883049|101941057|FG010|Post Induction|MRD negative|0|||
33557996|NCT02883049|101941058|FG011|Post Induction|MRD negative|0|||
33557997|NCT02883049|101941059|FG012|Post Induction|MRD negative|0|||
33557998|NCT02883049|101941060|FG013|Post Induction|MRD negative|0|||
33557999|NCT02883049|101941061|FG014|Post Induction|MRD negative|0|||
33558000|NCT02883049|101941062|FG015|Post Induction|MRD negative|0|||
33558001|NCT02883049|101941047|FG000|Post Induction|Developed SMN|0|||
33558002|NCT02883049|101941048|FG001|Post Induction|Developed SMN|0|||
33558003|NCT02883049|101941049|FG002|Post Induction|Developed SMN|0|||
33558004|NCT02883049|101941050|FG003|Post Induction|Developed SMN|0|||
33558005|NCT02883049|101941051|FG004|Post Induction|Developed SMN|1|||
33558006|NCT02883049|101941052|FG005|Post Induction|Developed SMN|0|||
33558007|NCT02883049|101941053|FG006|Post Induction|Developed SMN|1|||
33558008|NCT02883049|101941054|FG007|Post Induction|Developed SMN|0|||
33558009|NCT02883049|101941055|FG008|Post Induction|Developed SMN|0|||
33558010|NCT02883049|101941056|FG009|Post Induction|Developed SMN|0|||
33358012|NCT01772134|101198498|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
33558011|NCT02883049|101941057|FG010|Post Induction|Developed SMN|1|||
33558012|NCT02883049|101941058|FG011|Post Induction|Developed SMN|1|||
33558013|NCT02883049|101941059|FG012|Post Induction|Developed SMN|0|||
33558014|NCT02883049|101941060|FG013|Post Induction|Developed SMN|0|||
33558015|NCT02883049|101941061|FG014|Post Induction|Developed SMN|1|||
33558016|NCT02883049|101941062|FG015|Post Induction|Developed SMN|0|||
33558017|NCT02883049|101941047|FG000|Post Induction|Enrolled onto another COG study|0|||
33218430|NCT03214367|100696076|FG003|Lead-in Period|Adverse Event|0|||
33218431|NCT03214367|100696077|FG004|Lead-in Period|Adverse Event|0|||
33558018|NCT02883049|101941048|FG001|Post Induction|Enrolled onto another COG study|0|||
33558019|NCT02883049|101941049|FG002|Post Induction|Enrolled onto another COG study|0|||
33558020|NCT02883049|101941050|FG003|Post Induction|Enrolled onto another COG study|1|||
33558021|NCT02883049|101941051|FG004|Post Induction|Enrolled onto another COG study|1|||
33558022|NCT02883049|101941052|FG005|Post Induction|Enrolled onto another COG study|0|||
33558023|NCT02883049|101941053|FG006|Post Induction|Enrolled onto another COG study|0|||
33558024|NCT02883049|101941054|FG007|Post Induction|Enrolled onto another COG study|4|||
33558025|NCT02883049|101941055|FG008|Post Induction|Enrolled onto another COG study|0|||
33558026|NCT02883049|101941056|FG009|Post Induction|Enrolled onto another COG study|0|||
33558027|NCT02883049|101941057|FG010|Post Induction|Enrolled onto another COG study|0|||
33558028|NCT02883049|101941058|FG011|Post Induction|Enrolled onto another COG study|2|||
33558029|NCT02883049|101941059|FG012|Post Induction|Enrolled onto another COG study|0|||
33558030|NCT02883049|101941060|FG013|Post Induction|Enrolled onto another COG study|1|||
33558031|NCT02883049|101941061|FG014|Post Induction|Enrolled onto another COG study|0|||
33558032|NCT02883049|101941062|FG015|Post Induction|Enrolled onto another COG study|0|||
33558033|NCT02883049|101941047|FG000|Post Induction|Recurrent leukemia|0|||
33558034|NCT02883049|101941048|FG001|Post Induction|Recurrent leukemia|0|||
33558035|NCT02883049|101941049|FG002|Post Induction|Recurrent leukemia|0|||
33558036|NCT02883049|101941050|FG003|Post Induction|Recurrent leukemia|17|||
33558037|NCT02883049|101941051|FG004|Post Induction|Recurrent leukemia|12|||
33558038|NCT02883049|101941052|FG005|Post Induction|Recurrent leukemia|4|||
33558039|NCT02883049|101941053|FG006|Post Induction|Recurrent leukemia|1|||
33558040|NCT02883049|101941054|FG007|Post Induction|Recurrent leukemia|13|||
33558041|NCT02883049|101941055|FG008|Post Induction|Recurrent leukemia|27|||
33558042|NCT02883049|101941056|FG009|Post Induction|Recurrent leukemia|5|||
33558043|NCT02883049|101941057|FG010|Post Induction|Recurrent leukemia|3|||
33558044|NCT02883049|101941058|FG011|Post Induction|Recurrent leukemia|12|||
33558045|NCT02883049|101941059|FG012|Post Induction|Recurrent leukemia|1|||
33218432|NCT03214367|100696078|FG005|Lead-in Period|Adverse Event|0|||
33558046|NCT02883049|101941060|FG013|Post Induction|Recurrent leukemia|1|||
33558047|NCT02883049|101941061|FG014|Post Induction|Recurrent leukemia|9|||
33558048|NCT02883049|101941062|FG015|Post Induction|Recurrent leukemia|3|||
33558049|NCT02883049|101941047|FG000|Post Induction|Induction Failure|0|||
33558050|NCT02883049|101941048|FG001|Post Induction|Induction Failure|0|||
33558051|NCT02883049|101941049|FG002|Post Induction|Induction Failure|0|||
33218433|NCT03214367|100696079|FG006|Lead-in Period|Adverse Event|0|||
33558052|NCT02883049|101941050|FG003|Post Induction|Induction Failure|0|||
33558053|NCT02883049|101941051|FG004|Post Induction|Induction Failure|0|||
33558054|NCT02883049|101941052|FG005|Post Induction|Induction Failure|0|||
33558055|NCT02883049|101941053|FG006|Post Induction|Induction Failure|0|||
33558056|NCT02883049|101941054|FG007|Post Induction|Induction Failure|2|||
33558057|NCT02883049|101941055|FG008|Post Induction|Induction Failure|2|||
33558058|NCT02883049|101941056|FG009|Post Induction|Induction Failure|0|||
33558059|NCT02883049|101941057|FG010|Post Induction|Induction Failure|0|||
33558060|NCT02883049|101941058|FG011|Post Induction|Induction Failure|0|||
33558061|NCT02883049|101941059|FG012|Post Induction|Induction Failure|0|||
33558062|NCT02883049|101941060|FG013|Post Induction|Induction Failure|2|||
33558063|NCT02883049|101941061|FG014|Post Induction|Induction Failure|0|||
33558064|NCT02883049|101941062|FG015|Post Induction|Induction Failure|0|||
33558065|NCT05524948|101941067|FG000|Overall Study|Withdrawal by Subject|1|||
33558066|NCT05524948|101941068|FG001|Overall Study|Withdrawal by Subject|0|||
33558067|NCT05524948|101941067|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
33558068|NCT05524948|101941068|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
33558069|NCT03927846|101941071|FG000|Overall Study|Lost to Follow-up|10|||
33558070|NCT03927846|101941072|FG001|Overall Study|Lost to Follow-up|11|||
33558071|NCT00348374|101941073|FG000|Overall Study|Adverse Event|1|||
33358013|NCT01772134|101198499|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
33358014|NCT01772134|101198500|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
33358015|NCT01772134|101198498|FG000|Overall Study|Randomized Study Medication Not Received|2|||
33358016|NCT01772134|101198499|FG001|Overall Study|Randomized Study Medication Not Received|0|||
33358017|NCT01772134|101198500|FG002|Overall Study|Randomized Study Medication Not Received|1|||
33358018|NCT00618956|101198503|FG000|Overall Study|Adverse Event|10|||
33358019|NCT00618956|101198504|FG001|Overall Study|Adverse Event|34|||
33358020|NCT00618956|101198503|FG000|Overall Study|Lack of Efficacy|2|||
33358021|NCT00618956|101198504|FG001|Overall Study|Lack of Efficacy|1|||
33358022|NCT00618956|101198503|FG000|Overall Study|Withdrawal by Subject|5|||
33358023|NCT00618956|101198504|FG001|Overall Study|Withdrawal by Subject|7|||
33358024|NCT00618956|101198503|FG000|Overall Study|Lost to Follow-up|4|||
33358025|NCT00618956|101198504|FG001|Overall Study|Lost to Follow-up|5|||
33358026|NCT00618956|101198503|FG000|Overall Study|Protocol Violation|2|||
33358027|NCT00618956|101198504|FG001|Overall Study|Protocol Violation|2|||
33358028|NCT00618956|101198503|FG000|Overall Study|did not meet criteria, non-compliance|2|||
33358029|NCT00618956|101198504|FG001|Overall Study|did not meet criteria, non-compliance|1|||
33358030|NCT01480180|101198507|FG000|Main Phase|Withdrawal criteria|12|||
33358031|NCT01480180|101198508|FG001|Main Phase|Withdrawal criteria|1|||
33558072|NCT00348374|101941074|FG001|Overall Study|Adverse Event|4|||
33558073|NCT00348374|101941073|FG000|Overall Study|Lost to Follow-up|1|||
33558074|NCT00348374|101941074|FG001|Overall Study|Lost to Follow-up|3|||
33558075|NCT00348374|101941073|FG000|Overall Study|Withdrawal by Subject|5|||
33558076|NCT00348374|101941074|FG001|Overall Study|Withdrawal by Subject|5|||
33558077|NCT00348374|101941073|FG000|Overall Study|Other|11|||
33558078|NCT00348374|101941074|FG001|Overall Study|Other|12|||
33558079|NCT00348374|101941073|FG000|Overall Study|ongoing at date of cutoff|1|||
33558080|NCT00348374|101941074|FG001|Overall Study|ongoing at date of cutoff|1|||
33558081|NCT00348374|101941073|FG000|Overall Study|randomized but did not receive treatment|0|||
33558082|NCT00348374|101941074|FG001|Overall Study|randomized but did not receive treatment|7|||
33558083|NCT01748552|101941075|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
33358032|NCT01480180|101198509|FG002|Main Phase|Withdrawal criteria|0|||
33358033|NCT01480180|101198510|FG003|Main Phase|Withdrawal criteria|0|||
33358034|NCT01480180|101198511|FG004|Main Phase|Withdrawal criteria|0|||
33358035|NCT01480180|101198512|FG005|Main Phase|Withdrawal criteria|0|||
33558084|NCT01748552|101941076|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
33558085|NCT01748552|101941077|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
33558086|NCT01748552|101941078|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
33218434|NCT03214367|100696080|FG007|Lead-in Period|Adverse Event|0|||
33358036|NCT01480180|101198507|FG000|Main Phase|Lack of Efficacy|1|||
33558087|NCT01748552|101941079|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
33558088|NCT01748552|101941080|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
33622582|NCT04332107|102169321|FG000|Day 14|Missing outcome data|4|||
33414475|NCT02871921|101406693|FG000|Overall Study|Withdrawal by Subject|34|||
33414476|NCT02871921|101406694|FG001|Overall Study|Withdrawal by Subject|27|||
33414477|NCT02871921|101406695|FG002|Overall Study|Withdrawal by Subject|27|||
33414478|NCT02871921|101406696|FG003|Overall Study|Withdrawal by Subject|30|||
33558089|NCT01748552|101941081|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
33558090|NCT01748552|101941082|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
33558091|NCT01748552|101941083|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
33558092|NCT01748552|101941084|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
33558093|NCT01748552|101941085|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
33558094|NCT01748552|101941086|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
33558095|NCT01748552|101941075|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33558096|NCT01748552|101941076|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33558097|NCT01748552|101941077|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33558098|NCT01748552|101941078|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33558099|NCT01748552|101941079|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33558100|NCT01748552|101941080|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33558101|NCT01748552|101941081|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
33558102|NCT01748552|101941082|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
33558103|NCT01748552|101941083|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
33558104|NCT01748552|101941084|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33558105|NCT01748552|101941085|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33558106|NCT01748552|101941086|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
33558107|NCT04744831|101941087|FG000|Overall Study|Progressive Disease|31|||
33558108|NCT04744831|101941088|FG001|Overall Study|Progressive Disease|27|||
33558109|NCT04744831|101941089|FG002|Overall Study|Progressive Disease|25|||
33558110|NCT04744831|101941087|FG000|Overall Study|Adverse Event|3|||
33558111|NCT04744831|101941088|FG001|Overall Study|Adverse Event|3|||
33558112|NCT04744831|101941089|FG002|Overall Study|Adverse Event|3|||
33558113|NCT04744831|101941087|FG000|Overall Study|Clinical Progression|3|||
33558114|NCT04744831|101941088|FG001|Overall Study|Clinical Progression|2|||
33558115|NCT04744831|101941089|FG002|Overall Study|Clinical Progression|5|||
33558116|NCT04744831|101941087|FG000|Overall Study|Other|0|||
33558117|NCT04744831|101941088|FG001|Overall Study|Other|2|||
33558118|NCT04744831|101941089|FG002|Overall Study|Other|1|||
33558119|NCT04744831|101941087|FG000|Overall Study|Death|0|||
33558120|NCT04744831|101941088|FG001|Overall Study|Death|2|||
33558121|NCT04744831|101941089|FG002|Overall Study|Death|1|||
33558122|NCT05463952|101941090|FG000|Treatment|Progressive disease|4|||
33558123|NCT05463952|101941090|FG000|Treatment|Ongoing|2|||
33558124|NCT00527748|101941091|FG000|Overall Study|Other|3|||
33558125|NCT01682603|101941092|FG000|Overall Study|Lost to Follow-up|3|||
33558126|NCT02112916|101941093|FG000|Overall Study|Adverse Event|6|||
33558127|NCT02112916|101941094|FG001|Overall Study|Adverse Event|9|||
33558128|NCT02112916|101941095|FG002|Overall Study|Adverse Event|3|||
33558129|NCT02112916|101941096|FG003|Overall Study|Adverse Event|2|||
33558130|NCT02112916|101941093|FG000|Overall Study|Death|9|||
33558131|NCT02112916|101941094|FG001|Overall Study|Death|9|||
33558132|NCT02112916|101941095|FG002|Overall Study|Death|3|||
33558133|NCT02112916|101941096|FG003|Overall Study|Death|4|||
33558134|NCT02112916|101941093|FG000|Overall Study|Lost to Follow-up|1|||
33558135|NCT02112916|101941094|FG001|Overall Study|Lost to Follow-up|0|||
33218435|NCT03214367|100696073|FG000|Lead-in Period|Lost to Follow-up|12|||
33218436|NCT03214367|100696074|FG001|Lead-in Period|Lost to Follow-up|0|||
33218437|NCT03214367|100696075|FG002|Lead-in Period|Lost to Follow-up|0|||
33414479|NCT05153629|101406703|FG000|Overall Study|Withdrawal by Subject|0|||
33414480|NCT05153629|101406704|FG001|Overall Study|Withdrawal by Subject|2|||
33414481|NCT00761761|101406705|FG000|Overall Study|Lost to Follow-up|3|||
33414482|NCT00761761|101406706|FG001|Overall Study|Lost to Follow-up|1|||
33414483|NCT00761761|101406705|FG000|Overall Study|Withdrawal by Subject|3|||
33558136|NCT02112916|101941095|FG002|Overall Study|Lost to Follow-up|0|||
33558137|NCT02112916|101941096|FG003|Overall Study|Lost to Follow-up|0|||
33558138|NCT02112916|101941093|FG000|Overall Study|Physician Decision|94|||
33558139|NCT02112916|101941094|FG001|Overall Study|Physician Decision|72|||
33558140|NCT02112916|101941095|FG002|Overall Study|Physician Decision|24|||
33558141|NCT02112916|101941096|FG003|Overall Study|Physician Decision|15|||
33558142|NCT02112916|101941093|FG000|Overall Study|Withdrawal by Subject|5|||
33558143|NCT02112916|101941094|FG001|Overall Study|Withdrawal by Subject|3|||
33414484|NCT00761761|101406706|FG001|Overall Study|Withdrawal by Subject|0|||
33414485|NCT00822237|101406709|FG000|Dose 1 Vaccination|Not vaccinated|3|||
33558144|NCT02112916|101941095|FG002|Overall Study|Withdrawal by Subject|1|||
33358037|NCT01480180|101198508|FG001|Main Phase|Lack of Efficacy|0|||
33558145|NCT02112916|101941096|FG003|Overall Study|Withdrawal by Subject|1|||
33558146|NCT02112916|101941093|FG000|Overall Study|Ineligible|4|||
33558147|NCT02112916|101941094|FG001|Overall Study|Ineligible|8|||
33558148|NCT02112916|101941095|FG002|Overall Study|Ineligible|3|||
33558149|NCT02112916|101941096|FG003|Overall Study|Ineligible|8|||
33558150|NCT02112916|101941093|FG000|Overall Study|Inevaluable|6|||
33558151|NCT02112916|101941094|FG001|Overall Study|Inevaluable|4|||
33558152|NCT02112916|101941095|FG002|Overall Study|Inevaluable|5|||
33558153|NCT02112916|101941096|FG003|Overall Study|Inevaluable|5|||
33558154|NCT02112916|101941093|FG000|Overall Study|Refusal of further protocol therapy|19|||
33558155|NCT02112916|101941094|FG001|Overall Study|Refusal of further protocol therapy|16|||
33558156|NCT02112916|101941095|FG002|Overall Study|Refusal of further protocol therapy|1|||
33558157|NCT02112916|101941096|FG003|Overall Study|Refusal of further protocol therapy|7|||
33558158|NCT02112916|101941093|FG000|Overall Study|Development of SMN|1|||
33558159|NCT02112916|101941094|FG001|Overall Study|Development of SMN|0|||
33558160|NCT02112916|101941095|FG002|Overall Study|Development of SMN|0|||
33358038|NCT01480180|101198509|FG002|Main Phase|Lack of Efficacy|0|||
33358039|NCT01480180|101198510|FG003|Main Phase|Lack of Efficacy|0|||
33358040|NCT01480180|101198511|FG004|Main Phase|Lack of Efficacy|0|||
33358041|NCT01480180|101198512|FG005|Main Phase|Lack of Efficacy|0|||
33358042|NCT01480180|101198507|FG000|Main Phase|Non-compliance|3|||
33558161|NCT02112916|101941096|FG003|Overall Study|Development of SMN|1|||
33558162|NCT02112916|101941093|FG000|Overall Study|Relapse/Progression|10|||
33558163|NCT02112916|101941094|FG001|Overall Study|Relapse/Progression|18|||
33558164|NCT02112916|101941095|FG002|Overall Study|Relapse/Progression|15|||
33558165|NCT02112916|101941096|FG003|Overall Study|Relapse/Progression|2|||
33558166|NCT02112916|101941093|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
33558167|NCT02112916|101941094|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
33558168|NCT02112916|101941095|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
33558169|NCT02112916|101941096|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
33558170|NCT02112916|101941093|FG000|Overall Study|Still on Therapy|44|||
33558171|NCT02112916|101941094|FG001|Overall Study|Still on Therapy|47|||
33558172|NCT02112916|101941095|FG002|Overall Study|Still on Therapy|3|||
33558173|NCT02112916|101941096|FG003|Overall Study|Still on Therapy|2|||
33622583|NCT04332107|102169322|FG001|Day 14|Missing outcome data|4|||
33622584|NCT04332107|102169321|FG000|Day 21|Lost to Follow-up|10|||
33622585|NCT04332107|102169322|FG001|Day 21|Lost to Follow-up|2|||
33622586|NCT00757237|102169323|FG000|Overall Study|Lost to Follow-up|0|||
33622587|NCT00757237|102169324|FG001|Overall Study|Lost to Follow-up|1|||
33358043|NCT01480180|101198508|FG001|Main Phase|Non-compliance|0|||
33558174|NCT02112916|101941093|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
33558175|NCT02112916|101941094|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
33558176|NCT02112916|101941095|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
33558177|NCT02112916|101941096|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
33558178|NCT02112916|101941093|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
33558179|NCT02112916|101941094|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
33558180|NCT02112916|101941095|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
33558181|NCT02112916|101941096|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
33558182|NCT04576481|101941102|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
33558183|NCT04576481|101941103|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
33558184|NCT04576481|101941104|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
33558185|NCT04576481|101941105|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
33558186|NCT03425188|101941106|FG000|Overall Study|Withdrawal by Subject|1|||
33558187|NCT03737994|101941109|FG000|Overall Study|Withdrawal by Subject|0|||
33558188|NCT03737994|101941110|FG001|Overall Study|Withdrawal by Subject|0|||
33558189|NCT03737994|101941111|FG002|Overall Study|Withdrawal by Subject|0|||
33558190|NCT03737994|101941112|FG003|Overall Study|Withdrawal by Subject|0|||
33558191|NCT03737994|101941113|FG004|Overall Study|Withdrawal by Subject|0|||
33558192|NCT03737994|101941114|FG005|Overall Study|Withdrawal by Subject|0|||
33558193|NCT03737994|101941115|FG006|Overall Study|Withdrawal by Subject|1|||
33558194|NCT02596893|101941116|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
33558195|NCT02596893|101941117|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
33558196|NCT02596893|101941118|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
33414486|NCT00822237|101406710|FG001|Dose 1 Vaccination|Not vaccinated|0|||
33558197|NCT02596893|101941119|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
33558198|NCT02596893|101941116|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
33558199|NCT02596893|101941117|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
33558200|NCT02596893|101941118|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
33622588|NCT00757237|102169323|FG000|Overall Study|Protocol Violation|0|||
33358044|NCT01480180|101198509|FG002|Main Phase|Non-compliance|0|||
33622589|NCT00757237|102169324|FG001|Overall Study|Protocol Violation|2|||
33558201|NCT02596893|101941119|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
33558202|NCT02596893|101941116|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
33558203|NCT02596893|101941117|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
33558204|NCT02596893|101941118|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
33558205|NCT02596893|101941119|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
33558206|NCT02596893|101941116|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
33558207|NCT02596893|101941117|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
33558208|NCT02596893|101941118|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
33558209|NCT02596893|101941119|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
33558210|NCT02596893|101941116|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
33558211|NCT02596893|101941117|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
33558212|NCT02596893|101941118|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
33558213|NCT02596893|101941119|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
33558214|NCT02596893|101941116|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
33558215|NCT02596893|101941117|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
33558216|NCT02596893|101941118|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
33558217|NCT02596893|101941119|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
33558218|NCT02596893|101941116|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
33558219|NCT02596893|101941117|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
33558220|NCT02596893|101941118|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
33558221|NCT02596893|101941119|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
33558222|NCT02596893|101941116|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
33558223|NCT02596893|101941117|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
33558224|NCT02596893|101941118|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
33558225|NCT02596893|101941119|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
33558226|NCT02596893|101941116|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
33558227|NCT02596893|101941117|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
33558228|NCT02596893|101941118|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
33558229|NCT02596893|101941119|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
33558230|NCT02596893|101941116|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
33558231|NCT02596893|101941117|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
33558232|NCT02596893|101941118|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
33558233|NCT02596893|101941119|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
33558234|NCT02596893|101941116|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
33558235|NCT02596893|101941117|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
33558236|NCT02596893|101941118|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
33558237|NCT02596893|101941119|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
33558238|NCT03021005|101941120|FG000|Overall Study|Lost to Follow-up|39|||
33558239|NCT03021005|101941121|FG001|Overall Study|Lost to Follow-up|26|||
33558240|NCT04818086|101941122|FG000|Overall Study|Physician Decision|1|||
33558241|NCT04818086|101941123|FG001|Overall Study|Physician Decision|0|||
33558242|NCT04818086|101941122|FG000|Overall Study|Withdrawal by Subject|0|||
33558243|NCT04818086|101941123|FG001|Overall Study|Withdrawal by Subject|1|||
33558244|NCT01682720|101941124|FG000|Overall Study|Randomized but Not Treated|0|||
33622590|NCT00757237|102169323|FG000|Overall Study|Physician Decision|2|||
33622591|NCT00757237|102169324|FG001|Overall Study|Physician Decision|3|||
33218438|NCT03214367|100696076|FG003|Lead-in Period|Lost to Follow-up|0|||
33218439|NCT03214367|100696077|FG004|Lead-in Period|Lost to Follow-up|0|||
33218440|NCT03214367|100696078|FG005|Lead-in Period|Lost to Follow-up|0|||
33218441|NCT03214367|100696079|FG006|Lead-in Period|Lost to Follow-up|0|||
33218442|NCT03214367|100696080|FG007|Lead-in Period|Lost to Follow-up|0|||
33218443|NCT03214367|100696073|FG000|Lead-in Period|Sponsor Decision|11|||
33558245|NCT01682720|101941125|FG001|Overall Study|Randomized but Not Treated|1|||
33558246|NCT01682720|101941126|FG002|Overall Study|Randomized but Not Treated|1|||
33558247|NCT01682720|101941127|FG003|Overall Study|Randomized but Not Treated|0|||
33558248|NCT01682720|101941124|FG000|Overall Study|Terminated by Sponsor|83|||
33558249|NCT01682720|101941125|FG001|Overall Study|Terminated by Sponsor|0|||
33218444|NCT03214367|100696074|FG001|Lead-in Period|Sponsor Decision|0|||
33218445|NCT03214367|100696075|FG002|Lead-in Period|Sponsor Decision|0|||
33218446|NCT03214367|100696076|FG003|Lead-in Period|Sponsor Decision|0|||
33358045|NCT01480180|101198510|FG003|Main Phase|Non-compliance|0|||
33558250|NCT01682720|101941126|FG002|Overall Study|Terminated by Sponsor|0|||
33358046|NCT01480180|101198511|FG004|Main Phase|Non-compliance|0|||
33358047|NCT01480180|101198512|FG005|Main Phase|Non-compliance|0|||
33358048|NCT01480180|101198507|FG000|Main Phase|Unclassified|3|||
33358049|NCT01480180|101198508|FG001|Main Phase|Unclassified|0|||
33358050|NCT01480180|101198509|FG002|Main Phase|Unclassified|0|||
33358051|NCT01480180|101198510|FG003|Main Phase|Unclassified|0|||
33358052|NCT01480180|101198511|FG004|Main Phase|Unclassified|0|||
33358053|NCT01480180|101198512|FG005|Main Phase|Unclassified|0|||
33358054|NCT01480180|101198507|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
33558251|NCT01682720|101941127|FG003|Overall Study|Terminated by Sponsor|0|||
33558252|NCT01682720|101941124|FG000|Overall Study|Efficacy Failure|0|||
33558253|NCT01682720|101941125|FG001|Overall Study|Efficacy Failure|3|||
33558254|NCT01682720|101941126|FG002|Overall Study|Efficacy Failure|3|||
33558255|NCT01682720|101941127|FG003|Overall Study|Efficacy Failure|30|||
33558256|NCT01682720|101941124|FG000|Overall Study|Lost to Follow-up|1|||
33558257|NCT01682720|101941125|FG001|Overall Study|Lost to Follow-up|1|||
33558258|NCT01682720|101941126|FG002|Overall Study|Lost to Follow-up|0|||
33558259|NCT01682720|101941127|FG003|Overall Study|Lost to Follow-up|6|||
33558260|NCT01682720|101941124|FG000|Overall Study|Subject Withdrew Consent|0|||
33558261|NCT01682720|101941125|FG001|Overall Study|Subject Withdrew Consent|0|||
33558262|NCT01682720|101941126|FG002|Overall Study|Subject Withdrew Consent|2|||
33558263|NCT01682720|101941127|FG003|Overall Study|Subject Withdrew Consent|2|||
33558264|NCT01682720|101941124|FG000|Overall Study|Adverse Event|1|||
33558265|NCT01682720|101941125|FG001|Overall Study|Adverse Event|0|||
33558266|NCT01682720|101941126|FG002|Overall Study|Adverse Event|1|||
33558267|NCT01682720|101941127|FG003|Overall Study|Adverse Event|1|||
33558268|NCT01964560|101941128|FG000|Overall Study|Adverse Event|23|||
33558269|NCT01964560|101941128|FG000|Overall Study|Lack of Efficacy|46|||
33558270|NCT01964560|101941128|FG000|Overall Study|Protocol deviation|2|||
33558271|NCT01964560|101941128|FG000|Overall Study|Lost to Follow-up|4|||
33558272|NCT01964560|101941128|FG000|Overall Study|Withdrawal by Subject|64|||
33558273|NCT01964560|101941128|FG000|Overall Study|Surgery-hemispherotomy|1|||
33558274|NCT01964560|101941128|FG000|Overall Study|Surgery|1|||
33558275|NCT01964560|101941128|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
33558276|NCT01964560|101941128|FG000|Overall Study|Patient and Investigator choice|1|||
33558277|NCT01964560|101941128|FG000|Overall Study|Patient was prescribed CBD|1|||
33622592|NCT00757237|102169323|FG000|Overall Study|Withdrawal by Subject|8|||
33622593|NCT00757237|102169324|FG001|Overall Study|Withdrawal by Subject|12|||
33622594|NCT00757237|102169323|FG000|Overall Study|Safety or Tolerability|3|||
33622595|NCT00757237|102169324|FG001|Overall Study|Safety or Tolerability|5|||
33622596|NCT00757237|102169323|FG000|Overall Study|Other|0|||
33622597|NCT00757237|102169324|FG001|Overall Study|Other|2|||
33622598|NCT00799266|102169328|FG000|Overall Study|Adverse Event|0|||
33622599|NCT00799266|102169329|FG001|Overall Study|Adverse Event|1|||
33622600|NCT00799266|102169328|FG000|Overall Study|Subject withdrew consent|3|||
33622601|NCT00799266|102169329|FG001|Overall Study|Subject withdrew consent|0|||
33622602|NCT00148759|102169331|FG000|Overall Study|Withdrawal by Subject|1|||
33622603|NCT00148759|102169332|FG001|Overall Study|Withdrawal by Subject|1|||
33622604|NCT00148759|102169331|FG000|Overall Study|Lost to Follow-up|1|||
33622605|NCT00148759|102169332|FG001|Overall Study|Lost to Follow-up|0|||
33622606|NCT01338818|102169334|FG000|Overall Study|Adverse Event|8|||
33622607|NCT01338818|102169334|FG000|Overall Study|Lack of Efficacy|5|||
33622608|NCT01338818|102169334|FG000|Overall Study|no longer require study drug|1|||
33622609|NCT01338818|102169334|FG000|Overall Study|Withdrawal by Subject|11|||
33622610|NCT01338818|102169334|FG000|Overall Study|Lost to Follow-up|4|||
33358055|NCT01480180|101198508|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
33358056|NCT01480180|101198509|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
33358057|NCT01480180|101198510|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
33558278|NCT01964560|101941128|FG000|Overall Study|Participant moved to another country|1|||
33558279|NCT03769116|101941129|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
33622611|NCT01338818|102169334|FG000|Overall Study|Administrative problems|3|||
33622612|NCT01338818|102169334|FG000|Overall Study|Protocol Deviation|4|||
33622613|NCT03244917|102169338|FG000|Overall Study|Lost to Follow-up|2|||
33622614|NCT03244917|102169339|FG001|Overall Study|Lost to Follow-up|2|||
33622615|NCT00430716|102169345|FG000|Double Blind Phase|Death|1|||
33622616|NCT00430716|102169346|FG001|Double Blind Phase|Death|0|||
33622617|NCT00430716|102169347|FG002|Double Blind Phase|Death|0|||
33622618|NCT00430716|102169345|FG000|Double Blind Phase|No longer willing to participate|2|||
33622619|NCT00430716|102169346|FG001|Double Blind Phase|No longer willing to participate|1|||
33622620|NCT00430716|102169347|FG002|Double Blind Phase|No longer willing to participate|1|||
33622621|NCT00430716|102169345|FG000|Double Blind Phase|Other|0|||
33622622|NCT00430716|102169346|FG001|Double Blind Phase|Other|2|||
33622623|NCT00430716|102169347|FG002|Double Blind Phase|Other|0|||
33622624|NCT00430716|102169345|FG000|Double Blind Phase|Study terminated by sponsor|1|||
33622625|NCT00430716|102169346|FG001|Double Blind Phase|Study terminated by sponsor|1|||
33622626|NCT00430716|102169347|FG002|Double Blind Phase|Study terminated by sponsor|2|||
33622627|NCT00430716|102169345|FG000|Double Blind Phase|Adverse Event|1|||
33622628|NCT00430716|102169346|FG001|Double Blind Phase|Adverse Event|1|||
33218447|NCT03214367|100696077|FG004|Lead-in Period|Sponsor Decision|0|||
33218448|NCT03214367|100696078|FG005|Lead-in Period|Sponsor Decision|0|||
33218449|NCT03214367|100696079|FG006|Lead-in Period|Sponsor Decision|0|||
33218450|NCT03214367|100696080|FG007|Lead-in Period|Sponsor Decision|0|||
33218451|NCT03214367|100696073|FG000|Lead-in Period|Physician Decision|12|||
33218452|NCT03214367|100696074|FG001|Lead-in Period|Physician Decision|0|||
33218453|NCT03214367|100696075|FG002|Lead-in Period|Physician Decision|0|||
33218454|NCT03214367|100696076|FG003|Lead-in Period|Physician Decision|0|||
33218455|NCT03214367|100696077|FG004|Lead-in Period|Physician Decision|0|||
33218456|NCT03214367|100696078|FG005|Lead-in Period|Physician Decision|0|||
33218457|NCT03214367|100696079|FG006|Lead-in Period|Physician Decision|0|||
33218458|NCT03214367|100696080|FG007|Lead-in Period|Physician Decision|0|||
33218459|NCT03214367|100696073|FG000|Lead-in Period|Protocol Violation|5|||
33218460|NCT03214367|100696074|FG001|Lead-in Period|Protocol Violation|0|||
33218461|NCT03214367|100696075|FG002|Lead-in Period|Protocol Violation|0|||
33218462|NCT03214367|100696076|FG003|Lead-in Period|Protocol Violation|0|||
33218463|NCT03214367|100696077|FG004|Lead-in Period|Protocol Violation|0|||
33218464|NCT03214367|100696078|FG005|Lead-in Period|Protocol Violation|0|||
33218465|NCT03214367|100696079|FG006|Lead-in Period|Protocol Violation|0|||
33218466|NCT03214367|100696080|FG007|Lead-in Period|Protocol Violation|0|||
33218467|NCT03214367|100696073|FG000|Lead-in Period|Treatment Interruption|1|||
33218468|NCT03214367|100696074|FG001|Lead-in Period|Treatment Interruption|0|||
33218469|NCT03214367|100696075|FG002|Lead-in Period|Treatment Interruption|0|||
33218470|NCT03214367|100696076|FG003|Lead-in Period|Treatment Interruption|0|||
33218471|NCT03214367|100696077|FG004|Lead-in Period|Treatment Interruption|0|||
33218472|NCT03214367|100696078|FG005|Lead-in Period|Treatment Interruption|0|||
33218473|NCT03214367|100696079|FG006|Lead-in Period|Treatment Interruption|0|||
33218474|NCT03214367|100696080|FG007|Lead-in Period|Treatment Interruption|0|||
33218475|NCT03214367|100696073|FG000|Treatment Period|Adverse Event|0|||
33218476|NCT03214367|100696074|FG001|Treatment Period|Adverse Event|1|||
33622629|NCT00430716|102169347|FG002|Double Blind Phase|Adverse Event|3|||
33622630|NCT00430716|102169345|FG000|Double Blind Phase|Not treated|1|||
33218477|NCT03214367|100696075|FG002|Treatment Period|Adverse Event|4|||
33218478|NCT03214367|100696076|FG003|Treatment Period|Adverse Event|2|||
33218479|NCT03214367|100696077|FG004|Treatment Period|Adverse Event|0|||
33218480|NCT03214367|100696078|FG005|Treatment Period|Adverse Event|0|||
33218481|NCT03214367|100696079|FG006|Treatment Period|Adverse Event|0|||
33218482|NCT03214367|100696080|FG007|Treatment Period|Adverse Event|0|||
33218483|NCT03214367|100696073|FG000|Treatment Period|Death|0|||
33622631|NCT00430716|102169346|FG001|Double Blind Phase|Not treated|0|||
33622632|NCT00430716|102169347|FG002|Double Blind Phase|Not treated|0|||
33622633|NCT00430716|102169345|FG000|Open Label Phase|Lost to Follow-up|1|||
33218484|NCT03214367|100696074|FG001|Treatment Period|Death|1|||
33218485|NCT03214367|100696075|FG002|Treatment Period|Death|1|||
33218486|NCT03214367|100696076|FG003|Treatment Period|Death|1|||
33218487|NCT03214367|100696077|FG004|Treatment Period|Death|0|||
33218488|NCT03214367|100696078|FG005|Treatment Period|Death|0|||
33218489|NCT03214367|100696079|FG006|Treatment Period|Death|0|||
33218490|NCT03214367|100696080|FG007|Treatment Period|Death|0|||
33218491|NCT03214367|100696073|FG000|Treatment Period|Lost to Follow-up|0|||
33218492|NCT03214367|100696074|FG001|Treatment Period|Lost to Follow-up|5|||
33218493|NCT03214367|100696075|FG002|Treatment Period|Lost to Follow-up|3|||
33218494|NCT03214367|100696076|FG003|Treatment Period|Lost to Follow-up|2|||
33414487|NCT00822237|101406709|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
33414488|NCT00822237|101406710|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
33414489|NCT00822237|101406709|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
33414490|NCT00822237|101406710|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
33414491|NCT00822237|101406709|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
33414492|NCT00822237|101406710|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
33218495|NCT03214367|100696077|FG004|Treatment Period|Lost to Follow-up|0|||
33218496|NCT03214367|100696078|FG005|Treatment Period|Lost to Follow-up|2|||
33218497|NCT03214367|100696079|FG006|Treatment Period|Lost to Follow-up|1|||
33358058|NCT01480180|101198511|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
33358059|NCT01480180|101198512|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
33358060|NCT01480180|101198507|FG000|Extension Phase, Part 1|Unclassified|0|||
33358061|NCT01480180|101198508|FG001|Extension Phase, Part 1|Unclassified|0|||
33358062|NCT01480180|101198509|FG002|Extension Phase, Part 1|Unclassified|1|||
33358063|NCT01480180|101198510|FG003|Extension Phase, Part 1|Unclassified|0|||
33358064|NCT01480180|101198511|FG004|Extension Phase, Part 1|Unclassified|0|||
33358065|NCT01480180|101198512|FG005|Extension Phase, Part 1|Unclassified|0|||
33358066|NCT01480180|101198507|FG000|Extension Phase, Part 1|Adverse Event|0|||
33358067|NCT01480180|101198508|FG001|Extension Phase, Part 1|Adverse Event|0|||
33358068|NCT01480180|101198509|FG002|Extension Phase, Part 1|Adverse Event|4|||
33358069|NCT01480180|101198510|FG003|Extension Phase, Part 1|Adverse Event|1|||
33358070|NCT01480180|101198511|FG004|Extension Phase, Part 1|Adverse Event|0|||
33358071|NCT01480180|101198512|FG005|Extension Phase, Part 1|Adverse Event|0|||
33358072|NCT01480180|101198507|FG000|Extension Phase, Part 1|Change of treatment|0|||
33358073|NCT01480180|101198508|FG001|Extension Phase, Part 1|Change of treatment|0|||
33358074|NCT01480180|101198509|FG002|Extension Phase, Part 1|Change of treatment|0|||
33218498|NCT03214367|100696080|FG007|Treatment Period|Lost to Follow-up|0|||
33218499|NCT03214367|100696073|FG000|Treatment Period|Sponsor Decision|0|||
33358075|NCT01480180|101198510|FG003|Extension Phase, Part 1|Change of treatment|9|||
33358076|NCT01480180|101198511|FG004|Extension Phase, Part 1|Change of treatment|0|||
33414493|NCT00822237|101406709|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
33218500|NCT03214367|100696074|FG001|Treatment Period|Sponsor Decision|3|||
33358077|NCT01480180|101198512|FG005|Extension Phase, Part 1|Change of treatment|0|||
33358078|NCT01480180|101198507|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
33358079|NCT01480180|101198508|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
33358080|NCT01480180|101198509|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
33358081|NCT01480180|101198510|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
33358082|NCT01480180|101198511|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
33358083|NCT01480180|101198512|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
33358084|NCT01480180|101198507|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
33358085|NCT01480180|101198508|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
33358086|NCT01480180|101198509|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
33358087|NCT01480180|101198510|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
33358088|NCT01480180|101198511|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
33358089|NCT01480180|101198512|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
33358090|NCT01480180|101198507|FG000|Extension Phase, Part 2|Unclassified|0|||
33358091|NCT01480180|101198508|FG001|Extension Phase, Part 2|Unclassified|0|||
33358092|NCT01480180|101198509|FG002|Extension Phase, Part 2|Unclassified|3|||
33358093|NCT01480180|101198510|FG003|Extension Phase, Part 2|Unclassified|1|||
33358094|NCT01480180|101198511|FG004|Extension Phase, Part 2|Unclassified|1|||
33358095|NCT01480180|101198512|FG005|Extension Phase, Part 2|Unclassified|0|||
33622634|NCT00430716|102169346|FG001|Open Label Phase|Lost to Follow-up|0|||
33622635|NCT00430716|102169347|FG002|Open Label Phase|Lost to Follow-up|1|||
33622636|NCT00430716|102169345|FG000|Open Label Phase|No longer willing to participate|0|||
33622637|NCT00430716|102169346|FG001|Open Label Phase|No longer willing to participate|1|||
33622638|NCT00430716|102169347|FG002|Open Label Phase|No longer willing to participate|1|||
33622639|NCT00430716|102169345|FG000|Open Label Phase|Other|3|||
33622640|NCT00430716|102169346|FG001|Open Label Phase|Other|1|||
33622641|NCT00430716|102169347|FG002|Open Label Phase|Other|1|||
33622642|NCT00430716|102169345|FG000|Open Label Phase|Protocol Violation|1|||
33622643|NCT00430716|102169346|FG001|Open Label Phase|Protocol Violation|0|||
33622644|NCT00430716|102169347|FG002|Open Label Phase|Protocol Violation|0|||
33622645|NCT00430716|102169345|FG000|Open Label Phase|Study terminated by sponsor|4|||
33622646|NCT00430716|102169346|FG001|Open Label Phase|Study terminated by sponsor|5|||
33622647|NCT00430716|102169347|FG002|Open Label Phase|Study terminated by sponsor|4|||
33622648|NCT03187132|102169348|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
33622649|NCT03187132|102169349|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
33622650|NCT03187132|102169348|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
33622651|NCT03187132|102169349|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
33622652|NCT03187132|102169348|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
33622653|NCT03187132|102169349|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
33622654|NCT03187132|102169348|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
33622655|NCT03187132|102169349|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
33622656|NCT03187132|102169348|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
33622657|NCT03187132|102169349|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
33622658|NCT03187132|102169348|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
33622659|NCT03187132|102169349|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
33622660|NCT03187132|102169348|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
33622661|NCT03187132|102169349|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
33622662|NCT03187132|102169348|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
33622663|NCT03187132|102169349|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
33622664|NCT03187132|102169348|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
33622665|NCT03187132|102169349|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
33622666|NCT03187132|102169348|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
33622667|NCT03187132|102169349|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
33622668|NCT03187132|102169348|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
33622669|NCT03187132|102169349|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
33622670|NCT03058692|102169350|FG000|Overall Study|Lost to Follow-up|2|||
33622671|NCT03058692|102169351|FG001|Overall Study|Lost to Follow-up|1|||
33622672|NCT03058692|102169350|FG000|Overall Study|Withdrawal by Subject|1|||
33622673|NCT03058692|102169351|FG001|Overall Study|Withdrawal by Subject|1|||
33622674|NCT03649074|102169352|FG000|Overall Study|Lost to Follow-up|2|||
33622675|NCT03649074|102169353|FG001|Overall Study|Lost to Follow-up|1|||
33622676|NCT03649074|102169352|FG000|Overall Study|Adverse Event|1|||
33358096|NCT02493751|101198514|FG000|Overall Study|Withdrawal by Subject|2|||
33622677|NCT03649074|102169353|FG001|Overall Study|Adverse Event|0|||
33218501|NCT03214367|100696075|FG002|Treatment Period|Sponsor Decision|0|||
33414494|NCT00822237|101406710|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
33414495|NCT01907516|101406711|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
33414496|NCT01907516|101406712|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
33414497|NCT01907516|101406711|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
33414498|NCT01907516|101406712|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
33414499|NCT01907516|101406711|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
33414500|NCT01907516|101406712|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
33414501|NCT01907516|101406711|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
33414502|NCT01907516|101406712|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
33414503|NCT00446134|101406713|FG000|Overall Study|Adverse Event|7|||
33414504|NCT00446134|101406714|FG001|Overall Study|Adverse Event|17|||
33414505|NCT00446134|101406715|FG002|Overall Study|Adverse Event|13|||
33558280|NCT03769116|101941130|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
33558281|NCT03769116|101941129|FG000|Part 3 - Open Label|Physician Decision|1|||
33414506|NCT00446134|101406716|FG003|Overall Study|Adverse Event|18|||
33414507|NCT00446134|101406713|FG000|Overall Study|Lack of Efficacy|19|||
33218502|NCT03214367|100696076|FG003|Treatment Period|Sponsor Decision|0|||
33358097|NCT02493751|101198515|FG001|Overall Study|Withdrawal by Subject|8|||
33358098|NCT02493751|101198514|FG000|Overall Study|Death|6|||
33558282|NCT03769116|101941130|FG001|Part 3 - Open Label|Physician Decision|0|||
33558283|NCT03769116|101941129|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
33558284|NCT03769116|101941130|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
33558285|NCT02605967|101941132|FG000|Overall Study|subject / guardian decision|1|||
33558286|NCT02605967|101941133|FG001|Overall Study|subject / guardian decision|2|||
33558287|NCT02605967|101941132|FG000|Overall Study|Physician Decision|10|||
33558288|NCT02605967|101941133|FG001|Overall Study|Physician Decision|1|||
33558289|NCT02605967|101941132|FG000|Overall Study|Death|4|||
33558290|NCT02605967|101941133|FG001|Overall Study|Death|2|||
33558291|NCT02605967|101941132|FG000|Overall Study|Adverse Event|1|||
33558292|NCT02605967|101941133|FG001|Overall Study|Adverse Event|0|||
33558293|NCT02605967|101941132|FG000|Overall Study|progressive disease|66|||
33558294|NCT02605967|101941133|FG001|Overall Study|progressive disease|35|||
33558295|NCT04439903|101941134|FG000|Overall Study|Withdrawal by Subject|2|||
33558296|NCT04439903|101941134|FG000|Overall Study|Screen Failure|1|||
33558297|NCT00545948|101941135|FG000|Overall Study|Not Treated|1|||
33558298|NCT00545948|101941136|FG001|Overall Study|Not Treated|1|||
33558299|NCT00545948|101941137|FG002|Overall Study|Not Treated|7|||
33558300|NCT02662582|101941138|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
33558301|NCT02662582|101941139|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
33558302|NCT02662582|101941138|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
33558303|NCT02662582|101941139|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
33558304|NCT02662582|101941138|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
33558305|NCT02662582|101941139|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
33558306|NCT02662582|101941138|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33558307|NCT02662582|101941139|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33558308|NCT00569127|101941140|FG000|Overall Study|Adverse Event|57|||
33558309|NCT00569127|101941141|FG001|Overall Study|Adverse Event|47|||
33558310|NCT00569127|101941140|FG000|Overall Study|Withdrawal by Subject|13|||
33558311|NCT00569127|101941141|FG001|Overall Study|Withdrawal by Subject|27|||
33558312|NCT00569127|101941140|FG000|Overall Study|Progression|99|||
33558313|NCT00569127|101941141|FG001|Overall Study|Progression|100|||
33558314|NCT00569127|101941140|FG000|Overall Study|Death|4|||
33558315|NCT00569127|101941141|FG001|Overall Study|Death|3|||
33558316|NCT00569127|101941140|FG000|Overall Study|Other|20|||
33558317|NCT00569127|101941141|FG001|Overall Study|Other|19|||
33358099|NCT02493751|101198515|FG001|Overall Study|Death|13|||
33414508|NCT00446134|101406714|FG001|Overall Study|Lack of Efficacy|19|||
33414509|NCT00446134|101406715|FG002|Overall Study|Lack of Efficacy|24|||
33414510|NCT00446134|101406716|FG003|Overall Study|Lack of Efficacy|19|||
33414511|NCT00446134|101406713|FG000|Overall Study|Protocol Violation|0|||
33414512|NCT00446134|101406714|FG001|Overall Study|Protocol Violation|2|||
33414513|NCT00446134|101406715|FG002|Overall Study|Protocol Violation|1|||
33414514|NCT00446134|101406716|FG003|Overall Study|Protocol Violation|0|||
33414515|NCT00446134|101406713|FG000|Overall Study|Lost to Follow-up|1|||
33414516|NCT00446134|101406714|FG001|Overall Study|Lost to Follow-up|3|||
33414517|NCT00446134|101406715|FG002|Overall Study|Lost to Follow-up|1|||
33414518|NCT00446134|101406716|FG003|Overall Study|Lost to Follow-up|1|||
33558318|NCT00569127|101941140|FG000|Overall Study|Lost to Follow-up|0|||
33558319|NCT00569127|101941141|FG001|Overall Study|Lost to Follow-up|3|||
33358100|NCT02493751|101198514|FG000|Overall Study|Lost to Follow-up|2|||
33358101|NCT02493751|101198515|FG001|Overall Study|Lost to Follow-up|3|||
33358102|NCT02493751|101198514|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
33358103|NCT02493751|101198515|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
33358104|NCT01887912|101198516|FG000|Overall Study|Serious adverse event|400|||
33358105|NCT01887912|101198517|FG001|Overall Study|Serious adverse event|198|||
33358106|NCT01887912|101198516|FG000|Overall Study|Other Adverse Event|34|||
33358107|NCT01887912|101198517|FG001|Overall Study|Other Adverse Event|15|||
33358108|NCT01887912|101198516|FG000|Overall Study|Protocol Violation|67|||
33358109|NCT01887912|101198517|FG001|Overall Study|Protocol Violation|37|||
33358110|NCT01887912|101198516|FG000|Overall Study|Lost to Follow-up|163|||
33358111|NCT01887912|101198517|FG001|Overall Study|Lost to Follow-up|74|||
33358112|NCT01887912|101198516|FG000|Overall Study|Withdrawal by Subject|606|||
33358113|NCT01887912|101198517|FG001|Overall Study|Withdrawal by Subject|349|||
33358114|NCT01887912|101198516|FG000|Overall Study|Other|122|||
33358115|NCT01887912|101198517|FG001|Overall Study|Other|58|||
33358116|NCT02515669|101198518|FG000|228 Week Open-Label Phase|Other|0|||
33358117|NCT02515669|101198519|FG001|228 Week Open-Label Phase|Other|0|||
33358118|NCT02515669|101198520|FG002|228 Week Open-Label Phase|Other|1|||
33358119|NCT02515669|101198521|FG003|228 Week Open-Label Phase|Other|4|||
33358120|NCT02515669|101198518|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
33358121|NCT02515669|101198519|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
33358122|NCT02515669|101198520|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
33358123|NCT02515669|101198521|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
33358124|NCT02515669|101198518|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
33358125|NCT02515669|101198519|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
33358126|NCT02515669|101198520|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
33358127|NCT02515669|101198521|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
33358128|NCT02515669|101198518|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
33358129|NCT02515669|101198519|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
33358130|NCT02515669|101198520|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
33358131|NCT02515669|101198521|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
33358132|NCT02515669|101198518|FG000|228 Week Open-Label Phase|Missing|0|||
33358133|NCT02515669|101198519|FG001|228 Week Open-Label Phase|Missing|2|||
33358134|NCT02515669|101198520|FG002|228 Week Open-Label Phase|Missing|2|||
33358135|NCT02515669|101198521|FG003|228 Week Open-Label Phase|Missing|2|||
33358136|NCT02522377|101198522|FG000|Overall Study|Withdrawal by Subject|1|||
33358137|NCT02522377|101198523|FG001|Overall Study|Withdrawal by Subject|0|||
33358138|NCT02522377|101198522|FG000|Overall Study|Remission Achieved|3|||
33358139|NCT02522377|101198523|FG001|Overall Study|Remission Achieved|0|||
33358140|NCT01609933|101198524|FG000|Overall Study|Adverse Event|1|||
33358141|NCT01609933|101198524|FG000|Overall Study|Withdrawal by Subject|3|||
33358142|NCT00327444|101198527|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
33358143|NCT00327444|101198528|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
33358144|NCT00327444|101198527|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
33358145|NCT00327444|101198528|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
33358146|NCT00327444|101198527|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
33358147|NCT00327444|101198528|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
33358148|NCT00327444|101198527|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
33358149|NCT00327444|101198528|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
33358150|NCT00327444|101198527|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
33414519|NCT00446134|101406713|FG000|Overall Study|Withdrawal by Subject|3|||
33414520|NCT00446134|101406714|FG001|Overall Study|Withdrawal by Subject|3|||
33414521|NCT00446134|101406715|FG002|Overall Study|Withdrawal by Subject|1|||
33218503|NCT03214367|100696077|FG004|Treatment Period|Sponsor Decision|0|||
33218504|NCT03214367|100696078|FG005|Treatment Period|Sponsor Decision|0|||
33218505|NCT03214367|100696079|FG006|Treatment Period|Sponsor Decision|0|||
33358151|NCT00327444|101198528|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
33358152|NCT00327444|101198527|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
33414522|NCT00446134|101406716|FG003|Overall Study|Withdrawal by Subject|3|||
33414523|NCT00446134|101406713|FG000|Overall Study|Physician Decision|0|||
33414524|NCT00446134|101406714|FG001|Overall Study|Physician Decision|0|||
33414525|NCT00446134|101406715|FG002|Overall Study|Physician Decision|0|||
33414526|NCT00446134|101406716|FG003|Overall Study|Physician Decision|2|||
33414527|NCT00446134|101406713|FG000|Overall Study|Adverse Event-Diarrhea|1|||
33414528|NCT00446134|101406714|FG001|Overall Study|Adverse Event-Diarrhea|1|||
33414529|NCT00446134|101406715|FG002|Overall Study|Adverse Event-Diarrhea|2|||
33414530|NCT00446134|101406716|FG003|Overall Study|Adverse Event-Diarrhea|0|||
33414531|NCT00446134|101406713|FG000|Overall Study|Reason Not Completed|3|||
33414532|NCT00446134|101406714|FG001|Overall Study|Reason Not Completed|0|||
33414533|NCT00446134|101406715|FG002|Overall Study|Reason Not Completed|1|||
33358153|NCT00327444|101198528|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
33358154|NCT00327444|101198527|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
33358155|NCT00327444|101198528|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
33358156|NCT00327444|101198527|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
33358157|NCT00327444|101198528|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
33358158|NCT02109029|101198529|FG000|Part B|Adverse Event|0|||
33358159|NCT02109029|101198530|FG001|Part B|Adverse Event|0|||
33358160|NCT02109029|101198531|FG002|Part B|Adverse Event|0|||
33414534|NCT00446134|101406716|FG003|Overall Study|Reason Not Completed|2|||
33358161|NCT02109029|101198532|FG003|Part B|Adverse Event|0|||
33358162|NCT02109029|101198533|FG004|Part B|Adverse Event|1|||
33558320|NCT00569127|101941140|FG000|Overall Study|Not Eligible|14|||
33558321|NCT00569127|101941141|FG001|Overall Study|Not Eligible|11|||
33558322|NCT00569127|101941140|FG000|Overall Study|Still on Treatment|7|||
33558323|NCT00569127|101941141|FG001|Overall Study|Still on Treatment|3|||
33558324|NCT04971837|101941142|FG000|Overall Study|Long Term Illness|1|||
33558325|NCT04971837|101941142|FG000|Overall Study|BMI too low|9|||
33358163|NCT02109029|101198534|FG005|Part B|Adverse Event|1|||
33358164|NCT01748760|101198538|FG000|Overall Study|Withdrawal by Subject|1|||
33358165|NCT01748760|101198539|FG001|Overall Study|Withdrawal by Subject|1|||
33414535|NCT02304302|101406717|FG000|Overall Study|Adverse Event|2|||
33414536|NCT02304302|101406718|FG001|Overall Study|Adverse Event|3|||
33414537|NCT02304302|101406717|FG000|Overall Study|Lost to Follow-up|1|||
33558326|NCT04971837|101941142|FG000|Overall Study|geographic location|1|||
33558327|NCT04971837|101941142|FG000|Overall Study|Discontinued scheduling conflict|1|||
33558328|NCT05261490|101941143|FG000|Overall Study|Other|1|||
33558329|NCT05261490|101941144|FG001|Overall Study|Other|0|||
33558330|NCT05261490|101941145|FG002|Overall Study|Other|0|||
33414538|NCT02304302|101406718|FG001|Overall Study|Lost to Follow-up|4|||
33414539|NCT02304302|101406717|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
33414540|NCT02304302|101406718|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
33414541|NCT03170271|101409829|FG000|Overall Study|Adverse Event|7|||
33414542|NCT03170271|101409830|FG001|Overall Study|Adverse Event|2|||
33414543|NCT03170271|101409829|FG000|Overall Study|Lost to Follow-up|0|||
33414544|NCT03170271|101409830|FG001|Overall Study|Lost to Follow-up|1|||
33414545|NCT03170271|101409829|FG000|Overall Study|Physician Decision|1|||
33558331|NCT05261490|101941143|FG000|Overall Study|Study Terminated by Sponsor|1|||
33558332|NCT05261490|101941144|FG001|Overall Study|Study Terminated by Sponsor|1|||
33558333|NCT05261490|101941145|FG002|Overall Study|Study Terminated by Sponsor|4|||
33558334|NCT05261490|101941143|FG000|Overall Study|Death|1|||
33558335|NCT05261490|101941144|FG001|Overall Study|Death|2|||
33622678|NCT03649074|102169352|FG000|Overall Study|Physician Decision|1|||
33622679|NCT03649074|102169353|FG001|Overall Study|Physician Decision|0|||
33622680|NCT03649074|102169352|FG000|Overall Study|Withdrawal by Subject|0|||
33558336|NCT05261490|101941145|FG002|Overall Study|Death|0|||
33622681|NCT03649074|102169353|FG001|Overall Study|Withdrawal by Subject|2|||
33558337|NCT02613507|101941146|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
33558338|NCT02613507|101941147|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
33558339|NCT02613507|101941146|FG000|Pre-Treamtent|Participant withdrew consent|0|||
33622682|NCT03649074|102169352|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
33622683|NCT03649074|102169353|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
33358166|NCT01748760|101198538|FG000|Overall Study|Lost to Follow-up|5|||
33358167|NCT01748760|101198539|FG001|Overall Study|Lost to Follow-up|1|||
33358168|NCT03233048|101198542|FG000|Overall Study|Withdrawal by Subject|1|||
33414546|NCT03170271|101409830|FG001|Overall Study|Physician Decision|0|||
33558340|NCT02613507|101941147|FG001|Pre-Treamtent|Participant withdrew consent|4|||
33622684|NCT03649074|102169352|FG000|Overall Study|Other|1|||
33218506|NCT03214367|100696080|FG007|Treatment Period|Sponsor Decision|0|||
33414547|NCT03170271|101409829|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
33558341|NCT02613507|101941146|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
33558342|NCT02613507|101941147|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
33558343|NCT02613507|101941146|FG000|Treatment|Not reported|3|||
33558344|NCT02613507|101941147|FG001|Treatment|Not reported|0|||
33558345|NCT02613507|101941146|FG000|Treatment|Other reasons|8|||
33558346|NCT02613507|101941147|FG001|Treatment|Other reasons|0|||
33558347|NCT02613507|101941146|FG000|Treatment|Participant no longer meets criteria|3|||
33558348|NCT02613507|101941147|FG001|Treatment|Participant no longer meets criteria|0|||
33558349|NCT02613507|101941146|FG000|Treatment|Maximum clinical benefit|5|||
33558350|NCT02613507|101941147|FG001|Treatment|Maximum clinical benefit|10|||
33558351|NCT02613507|101941146|FG000|Treatment|Lost to Follow-up|1|||
33558352|NCT02613507|101941147|FG001|Treatment|Lost to Follow-up|0|||
33558353|NCT02613507|101941146|FG000|Treatment|Participant withdrew consent|0|||
33558354|NCT02613507|101941147|FG001|Treatment|Participant withdrew consent|2|||
33558355|NCT02613507|101941146|FG000|Treatment|Participant request to discontinue study treatment|13|||
33558356|NCT02613507|101941147|FG001|Treatment|Participant request to discontinue study treatment|17|||
33558357|NCT02613507|101941146|FG000|Treatment|Adverse event unrelated to study drug|20|||
33558358|NCT02613507|101941147|FG001|Treatment|Adverse event unrelated to study drug|3|||
33558359|NCT02613507|101941146|FG000|Treatment|Death|2|||
33558360|NCT02613507|101941147|FG001|Treatment|Death|0|||
33558361|NCT02613507|101941146|FG000|Treatment|Study drug toxicity|19|||
33558362|NCT02613507|101941147|FG001|Treatment|Study drug toxicity|14|||
33558363|NCT02613507|101941146|FG000|Treatment|Disease progression|263|||
33558364|NCT02613507|101941147|FG001|Treatment|Disease progression|110|||
33558365|NCT04128228|101941148|FG000|Overall Study|Withdrawal by Subject|3|||
33558366|NCT04128228|101941149|FG001|Overall Study|Withdrawal by Subject|3|||
33558367|NCT04128228|101941150|FG002|Overall Study|Withdrawal by Subject|0|||
33558368|NCT04128228|101941151|FG003|Overall Study|Withdrawal by Subject|0|||
33558369|NCT04128228|101941148|FG000|Overall Study|noncompliance|2|||
33558370|NCT04128228|101941149|FG001|Overall Study|noncompliance|2|||
33558371|NCT04128228|101941150|FG002|Overall Study|noncompliance|0|||
33558372|NCT04128228|101941151|FG003|Overall Study|noncompliance|0|||
33558373|NCT01386385|101941152|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
33558374|NCT01386385|101941153|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
33558375|NCT01386385|101941154|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
33558376|NCT01386385|101941155|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
33558377|NCT01386385|101941156|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
33558378|NCT01386385|101941157|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
33558379|NCT01386385|101941158|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
33358169|NCT01508676|101198543|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
33558380|NCT01386385|101941159|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
33358170|NCT01508676|101198544|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
33358171|NCT01508676|101198543|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
33358172|NCT01508676|101198544|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
33358173|NCT01508676|101198543|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
33358174|NCT01508676|101198544|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
33358175|NCT01508676|101198543|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
33414548|NCT03170271|101409830|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
33414549|NCT03170271|101409829|FG000|Overall Study|Withdrawal by Subject|17|||
33358176|NCT01508676|101198544|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
33358177|NCT01508676|101198543|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
33358178|NCT01508676|101198544|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
33414550|NCT03170271|101409830|FG001|Overall Study|Withdrawal by Subject|5|||
33558381|NCT01386385|101941152|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
33558382|NCT01386385|101941153|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
33558383|NCT01386385|101941154|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
33558384|NCT01386385|101941155|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
33558385|NCT01386385|101941156|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
33558386|NCT01386385|101941157|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
33558387|NCT01386385|101941158|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
33558388|NCT01386385|101941159|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
33558389|NCT01386385|101941152|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
33622685|NCT03649074|102169353|FG001|Overall Study|Other|0|||
33622686|NCT02936635|102169356|FG000|Overall Study|Adverse Event|43|||
33622687|NCT02936635|102169357|FG001|Overall Study|Adverse Event|25|||
33622688|NCT02936635|102169356|FG000|Overall Study|Progressive Disease|10|||
33558390|NCT01386385|101941153|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
33558391|NCT01386385|101941154|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
33558392|NCT01386385|101941155|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
33558393|NCT01386385|101941156|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
33558394|NCT01386385|101941157|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
33558395|NCT01386385|101941158|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
33558396|NCT01386385|101941159|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
33558397|NCT01386385|101941152|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
33558398|NCT01386385|101941153|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
33558399|NCT01386385|101941154|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
33558400|NCT01386385|101941155|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
33558401|NCT01386385|101941156|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
33558402|NCT01386385|101941157|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
33558403|NCT01386385|101941158|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
33558404|NCT01386385|101941159|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
33558405|NCT01386385|101941152|FG000|Phase II Concurrent CRT|Adverse Event|0|||
33558406|NCT01386385|101941153|FG001|Phase II Concurrent CRT|Adverse Event|0|||
33558407|NCT01386385|101941154|FG002|Phase II Concurrent CRT|Adverse Event|0|||
33558408|NCT01386385|101941155|FG003|Phase II Concurrent CRT|Adverse Event|0|||
33558409|NCT01386385|101941156|FG004|Phase II Concurrent CRT|Adverse Event|0|||
33558410|NCT01386385|101941157|FG005|Phase II Concurrent CRT|Adverse Event|0|||
33558411|NCT01386385|101941158|FG006|Phase II Concurrent CRT|Adverse Event|3|||
33558412|NCT01386385|101941159|FG007|Phase II Concurrent CRT|Adverse Event|3|||
33558413|NCT01386385|101941152|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
33558414|NCT01386385|101941153|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
33558415|NCT01386385|101941154|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
33558416|NCT01386385|101941155|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
33558417|NCT01386385|101941156|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
33558418|NCT01386385|101941157|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
33558419|NCT01386385|101941158|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
33558420|NCT01386385|101941159|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
33622689|NCT02936635|102169357|FG001|Overall Study|Progressive Disease|18|||
33622690|NCT02936635|102169356|FG000|Overall Study|Sponsor Discretion|10|||
33622691|NCT02936635|102169357|FG001|Overall Study|Sponsor Discretion|16|||
33622692|NCT02936635|102169356|FG000|Overall Study|Death|9|||
33622693|NCT02936635|102169357|FG001|Overall Study|Death|15|||
33622694|NCT02936635|102169356|FG000|Overall Study|Withdrawal by Subject|8|||
33622695|NCT02936635|102169357|FG001|Overall Study|Withdrawal by Subject|15|||
33622696|NCT02936635|102169356|FG000|Overall Study|Physician Decision|2|||
33622697|NCT02936635|102169357|FG001|Overall Study|Physician Decision|9|||
33622698|NCT02936635|102169356|FG000|Overall Study|Lost to Follow-up|1|||
33622699|NCT02936635|102169357|FG001|Overall Study|Lost to Follow-up|2|||
33622700|NCT02936635|102169356|FG000|Overall Study|Protocol Violation|1|||
33622701|NCT02936635|102169357|FG001|Overall Study|Protocol Violation|0|||
33622702|NCT02936635|102169356|FG000|Overall Study|Lack of effect/Entry into other study|31|||
33622703|NCT02936635|102169357|FG001|Overall Study|Lack of effect/Entry into other study|65|||
33622704|NCT01946139|102169360|FG000|Overall Study|Withdrawal by Subject|8|||
33622705|NCT01946139|102169360|FG000|Overall Study|ineligible|8|||
33622706|NCT01946139|102169360|FG000|Overall Study|Specimens not available|4|||
33622707|NCT00549640|102169361|FG000|Overall Study|Withdrawal by Subject|6|||
33622708|NCT00549640|102169362|FG001|Overall Study|Withdrawal by Subject|12|||
33622709|NCT00549640|102169361|FG000|Overall Study|Adverse Event|5|||
33622710|NCT00549640|102169362|FG001|Overall Study|Adverse Event|0|||
33622711|NCT00549640|102169361|FG000|Overall Study|Lost to Follow-up|7|||
33622712|NCT00549640|102169362|FG001|Overall Study|Lost to Follow-up|4|||
33622713|NCT01544920|102169365|FG000|Overall Study|Adverse Event|0|||
33622714|NCT01544920|102169366|FG001|Overall Study|Adverse Event|3|||
33622715|NCT01544920|102169365|FG000|Overall Study|Death|0|||
33622716|NCT01544920|102169366|FG001|Overall Study|Death|1|||
33622717|NCT01544920|102169365|FG000|Overall Study|Lost to Follow-up|11|||
33558421|NCT01386385|101941152|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
33558422|NCT01386385|101941153|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
33558423|NCT01386385|101941154|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
33622718|NCT01544920|102169366|FG001|Overall Study|Lost to Follow-up|12|||
33622719|NCT01544920|102169365|FG000|Overall Study|Protocol Violation|0|||
33622720|NCT01544920|102169366|FG001|Overall Study|Protocol Violation|2|||
33622721|NCT01544920|102169365|FG000|Overall Study|Physician Decision|4|||
33622722|NCT01544920|102169366|FG001|Overall Study|Physician Decision|1|||
33622723|NCT01544920|102169365|FG000|Overall Study|Withdrawal by Subject|4|||
33218507|NCT03214367|100696073|FG000|Treatment Period|Physician Decision|0|||
33218508|NCT03214367|100696074|FG001|Treatment Period|Physician Decision|1|||
33558424|NCT01386385|101941155|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
33558425|NCT01386385|101941156|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
33622724|NCT01544920|102169366|FG001|Overall Study|Withdrawal by Subject|4|||
33218509|NCT03214367|100696075|FG002|Treatment Period|Physician Decision|2|||
33218510|NCT03214367|100696076|FG003|Treatment Period|Physician Decision|0|||
33218511|NCT03214367|100696077|FG004|Treatment Period|Physician Decision|0|||
33218512|NCT03214367|100696078|FG005|Treatment Period|Physician Decision|0|||
33218513|NCT03214367|100696079|FG006|Treatment Period|Physician Decision|0|||
33218514|NCT03214367|100696080|FG007|Treatment Period|Physician Decision|0|||
33218515|NCT03214367|100696073|FG000|Treatment Period|Protocol Violation|0|||
33218516|NCT03214367|100696074|FG001|Treatment Period|Protocol Violation|3|||
33218517|NCT03214367|100696075|FG002|Treatment Period|Protocol Violation|0|||
33218518|NCT03214367|100696076|FG003|Treatment Period|Protocol Violation|0|||
33218519|NCT03214367|100696077|FG004|Treatment Period|Protocol Violation|0|||
33218520|NCT03214367|100696078|FG005|Treatment Period|Protocol Violation|0|||
33218521|NCT03214367|100696079|FG006|Treatment Period|Protocol Violation|0|||
33218522|NCT03214367|100696080|FG007|Treatment Period|Protocol Violation|0|||
33218523|NCT03214367|100696073|FG000|Treatment Period|Withdrawal by Subject|0|||
33218524|NCT03214367|100696074|FG001|Treatment Period|Withdrawal by Subject|20|||
33218525|NCT03214367|100696075|FG002|Treatment Period|Withdrawal by Subject|23|||
33358179|NCT00754390|101198545|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
33358180|NCT00754390|101198545|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
33622725|NCT05051579|102169367|FG000|Overall Study|Withdrawal by Subject|3|||
33218526|NCT03214367|100696076|FG003|Treatment Period|Withdrawal by Subject|14|||
33218527|NCT03214367|100696077|FG004|Treatment Period|Withdrawal by Subject|0|||
33358181|NCT00754390|101198545|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
33358182|NCT00754390|101198545|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
33218528|NCT03214367|100696078|FG005|Treatment Period|Withdrawal by Subject|1|||
33558426|NCT01386385|101941157|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
33558427|NCT01386385|101941158|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
33558428|NCT01386385|101941159|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
33558429|NCT01386385|101941152|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
33558430|NCT01386385|101941153|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
33558431|NCT01386385|101941154|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
33558432|NCT01386385|101941155|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
33558433|NCT01386385|101941156|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
33558434|NCT01386385|101941157|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
33558435|NCT01386385|101941158|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
33558436|NCT01386385|101941159|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
33558437|NCT01386385|101941152|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
33558438|NCT01386385|101941153|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
33558439|NCT01386385|101941154|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
33558440|NCT01386385|101941155|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
33558441|NCT01386385|101941156|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
33558442|NCT01386385|101941157|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
33558443|NCT01386385|101941158|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
33558444|NCT01386385|101941159|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
33558445|NCT01565694|101941163|FG000|Dose-Titration Period|Adverse Event|4|||
33558446|NCT01565694|101941163|FG000|Dose-Titration Period|Protocol Violation|10|||
33558447|NCT01565694|101941163|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
33558448|NCT01286272|101941164|FG000|Overall Study|Ineligible after beginning treatment|1|||
33558449|NCT01286272|101941165|FG001|Overall Study|Ineligible after beginning treatment|3|||
33558450|NCT02181413|101941167|FG000|Overall Study|Withdrawal by Subject|45|||
33558451|NCT02181413|101941168|FG001|Overall Study|Withdrawal by Subject|61|||
33622726|NCT05051579|102169368|FG001|Overall Study|Withdrawal by Subject|5|||
33622727|NCT05051579|102169369|FG002|Overall Study|Withdrawal by Subject|2|||
33622728|NCT05051579|102169370|FG003|Overall Study|Withdrawal by Subject|1|||
33622729|NCT05051579|102169371|FG004|Overall Study|Withdrawal by Subject|4|||
33622730|NCT05051579|102169372|FG005|Overall Study|Withdrawal by Subject|0|||
33622731|NCT05051579|102169373|FG006|Overall Study|Withdrawal by Subject|4|||
33622732|NCT05051579|102169367|FG000|Overall Study|Lost to Follow-up|1|||
33358183|NCT00553787|101198546|FG000|Overall Study|Adverse Event|34|||
33622733|NCT05051579|102169368|FG001|Overall Study|Lost to Follow-up|0|||
33622734|NCT05051579|102169369|FG002|Overall Study|Lost to Follow-up|0|||
33622735|NCT05051579|102169370|FG003|Overall Study|Lost to Follow-up|0|||
33622736|NCT05051579|102169371|FG004|Overall Study|Lost to Follow-up|1|||
33622737|NCT05051579|102169372|FG005|Overall Study|Lost to Follow-up|0|||
33358184|NCT00553787|101198547|FG001|Overall Study|Adverse Event|21|||
33218529|NCT03214367|100696079|FG006|Treatment Period|Withdrawal by Subject|1|||
33218530|NCT03214367|100696080|FG007|Treatment Period|Withdrawal by Subject|1|||
33218531|NCT02068495|100696082|FG000|Overall Study|Case Report Forms Uncollected|60|||
33218532|NCT02068495|100696082|FG000|Overall Study|Protocol Deviation|49|||
33218533|NCT00733980|100696083|FG000|Overall Study|Adverse Event|5|||
33218534|NCT00733980|100696084|FG001|Overall Study|Adverse Event|2|||
33218535|NCT00733980|100696083|FG000|Overall Study|Lack of Efficacy|0|||
33218536|NCT00733980|100696084|FG001|Overall Study|Lack of Efficacy|1|||
33218537|NCT00733980|100696083|FG000|Overall Study|Protocol Violation|2|||
33358185|NCT00553787|101198548|FG002|Overall Study|Adverse Event|67|||
33358186|NCT00553787|101198546|FG000|Overall Study|Lost to Follow-up|132|||
33358187|NCT00553787|101198547|FG001|Overall Study|Lost to Follow-up|44|||
33622738|NCT05051579|102169373|FG006|Overall Study|Lost to Follow-up|1|||
33622739|NCT05051579|102169367|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
33622740|NCT05051579|102169368|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
33622741|NCT05051579|102169369|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
33622742|NCT05051579|102169370|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
33622743|NCT05051579|102169371|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
33622744|NCT05051579|102169372|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
33622745|NCT05051579|102169373|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
33622746|NCT05051579|102169367|FG000|Overall Study|Adverse Event|2|||
33622747|NCT05051579|102169368|FG001|Overall Study|Adverse Event|1|||
33622748|NCT05051579|102169369|FG002|Overall Study|Adverse Event|0|||
33622749|NCT05051579|102169370|FG003|Overall Study|Adverse Event|4|||
33622750|NCT05051579|102169371|FG004|Overall Study|Adverse Event|1|||
33622751|NCT05051579|102169372|FG005|Overall Study|Adverse Event|2|||
33622752|NCT05051579|102169373|FG006|Overall Study|Adverse Event|0|||
33622753|NCT05051579|102169367|FG000|Overall Study|Inadvertent Enrollment|0|||
33622754|NCT05051579|102169368|FG001|Overall Study|Inadvertent Enrollment|0|||
33622755|NCT05051579|102169369|FG002|Overall Study|Inadvertent Enrollment|0|||
33622756|NCT05051579|102169370|FG003|Overall Study|Inadvertent Enrollment|0|||
33622757|NCT05051579|102169371|FG004|Overall Study|Inadvertent Enrollment|0|||
33622758|NCT05051579|102169372|FG005|Overall Study|Inadvertent Enrollment|0|||
33622759|NCT05051579|102169373|FG006|Overall Study|Inadvertent Enrollment|1|||
33622760|NCT05051579|102169367|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
33622761|NCT05051579|102169368|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
33622762|NCT05051579|102169369|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
33622763|NCT05051579|102169370|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
33622764|NCT05051579|102169371|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
33622765|NCT05051579|102169372|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
33622766|NCT05051579|102169373|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
33622767|NCT05051579|102169367|FG000|Overall Study|Sponsor Decision|0|||
33622768|NCT05051579|102169368|FG001|Overall Study|Sponsor Decision|0|||
33622769|NCT05051579|102169369|FG002|Overall Study|Sponsor Decision|0|||
33622770|NCT05051579|102169370|FG003|Overall Study|Sponsor Decision|0|||
33622771|NCT05051579|102169371|FG004|Overall Study|Sponsor Decision|1|||
33622772|NCT05051579|102169372|FG005|Overall Study|Sponsor Decision|0|||
33358188|NCT00553787|101198548|FG002|Overall Study|Lost to Follow-up|78|||
33358189|NCT00553787|101198546|FG000|Overall Study|Withdrawal by Subject|151|||
33358190|NCT00553787|101198547|FG001|Overall Study|Withdrawal by Subject|40|||
33558452|NCT02181413|101941167|FG000|Overall Study|Reason Not Specified|2|||
33558453|NCT02181413|101941168|FG001|Overall Study|Reason Not Specified|5|||
33558454|NCT02181413|101941167|FG000|Overall Study|Lost to Follow-up|8|||
33558455|NCT02181413|101941168|FG001|Overall Study|Lost to Follow-up|7|||
33558456|NCT04579380|101941169|FG000|Overall Study|Death|9|||
33558457|NCT04579380|101941170|FG001|Overall Study|Death|22|||
33558458|NCT04579380|101941171|FG002|Overall Study|Death|22|||
33558459|NCT04579380|101941172|FG003|Overall Study|Death|17|||
33558460|NCT04579380|101941173|FG004|Overall Study|Death|6|||
33558461|NCT04579380|101941174|FG005|Overall Study|Death|21|||
33558462|NCT04579380|101941175|FG006|Overall Study|Death|10|||
33558463|NCT04579380|101941176|FG007|Overall Study|Death|11|||
33558464|NCT04579380|101941177|FG008|Overall Study|Death|25|||
33558465|NCT04579380|101941169|FG000|Overall Study|Withdrawal by Subject|0|||
33558466|NCT04579380|101941170|FG001|Overall Study|Withdrawal by Subject|3|||
33558467|NCT04579380|101941171|FG002|Overall Study|Withdrawal by Subject|4|||
33558468|NCT04579380|101941172|FG003|Overall Study|Withdrawal by Subject|0|||
33558469|NCT04579380|101941173|FG004|Overall Study|Withdrawal by Subject|1|||
33622773|NCT05051579|102169373|FG006|Overall Study|Sponsor Decision|0|||
33218538|NCT00733980|100696084|FG001|Overall Study|Protocol Violation|1|||
33218539|NCT00733980|100696083|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
33218540|NCT00733980|100696084|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
33558470|NCT04579380|101941174|FG005|Overall Study|Withdrawal by Subject|2|||
33622774|NCT05051579|102169367|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
33622775|NCT05051579|102169368|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
33622776|NCT05051579|102169369|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
33622777|NCT05051579|102169370|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
33622778|NCT05051579|102169371|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
33622779|NCT05051579|102169372|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
33622780|NCT05051579|102169373|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
33622781|NCT02836652|102169375|FG000|Overall Study|Death|3|||
33622782|NCT02836652|102169376|FG001|Overall Study|Death|3|||
33622783|NCT02836652|102169375|FG000|Overall Study|Transplant/Explant|3|||
33622784|NCT02836652|102169376|FG001|Overall Study|Transplant/Explant|4|||
33622785|NCT02836652|102169375|FG000|Overall Study|Withdrawn|9|||
33622786|NCT02836652|102169376|FG001|Overall Study|Withdrawn|9|||
33218541|NCT00733980|100696083|FG000|Overall Study|Lost to Follow-up|6|||
33218542|NCT00733980|100696084|FG001|Overall Study|Lost to Follow-up|11|||
33218543|NCT00733980|100696083|FG000|Overall Study|Physician Decision|2|||
33218544|NCT00733980|100696084|FG001|Overall Study|Physician Decision|3|||
33218545|NCT00733980|100696083|FG000|Overall Study|Withdrawal by Subject|6|||
33218546|NCT00733980|100696084|FG001|Overall Study|Withdrawal by Subject|2|||
33218547|NCT01256567|100696085|FG000|Overall Study|Withdrawal by Subject|1|||
33218548|NCT02220894|100696086|FG000|Overall Study|Adverse Event|127|||
33218549|NCT02220894|100696087|FG001|Overall Study|Adverse Event|74|||
33218550|NCT02220894|100696086|FG000|Overall Study|Death|418|||
33218551|NCT02220894|100696087|FG001|Overall Study|Death|508|||
33218552|NCT02220894|100696086|FG000|Overall Study|Lost to Follow-up|0|||
33218553|NCT02220894|100696087|FG001|Overall Study|Lost to Follow-up|4|||
33622787|NCT02836652|102169375|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
33622788|NCT02836652|102169376|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
33622789|NCT01454596|102169380|FG000|Overall Study|Death|0|||
33622790|NCT01454596|102169381|FG001|Overall Study|Death|0|||
33622791|NCT01454596|102169382|FG002|Overall Study|Death|0|||
33622792|NCT01454596|102169383|FG003|Overall Study|Death|0|||
33622793|NCT01454596|102169384|FG004|Overall Study|Death|0|||
33218554|NCT02220894|100696086|FG000|Overall Study|Site Terminated by Sponsor|2|||
33218555|NCT02220894|100696087|FG001|Overall Study|Site Terminated by Sponsor|0|||
33218556|NCT02220894|100696086|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
33622794|NCT01454596|102169385|FG005|Overall Study|Death|0|||
33622795|NCT01454596|102169386|FG006|Overall Study|Death|0|||
33218557|NCT02220894|100696087|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
33218558|NCT02220894|100696086|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33218559|NCT02220894|100696087|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33622796|NCT01454596|102169387|FG007|Overall Study|Death|0|||
33622797|NCT01454596|102169388|FG008|Overall Study|Death|0|||
33622798|NCT01454596|102169389|FG009|Overall Study|Death|1|||
33218560|NCT02220894|100696086|FG000|Overall Study|Withdrawal by Subject|10|||
33218561|NCT02220894|100696087|FG001|Overall Study|Withdrawal by Subject|9|||
33218562|NCT00763958|100696088|FG000|Overall Study|did not meet final criteria|4|||
33218563|NCT00763958|100696089|FG001|Overall Study|did not meet final criteria|4|||
33218564|NCT00763958|100696088|FG000|Overall Study|Lost to Follow-up|10|||
33218565|NCT00763958|100696089|FG001|Overall Study|Lost to Follow-up|2|||
33218566|NCT00763958|100696088|FG000|Overall Study|Believed they were receiving placebo|0|||
33218567|NCT00763958|100696089|FG001|Overall Study|Believed they were receiving placebo|5|||
33622799|NCT01454596|102169390|FG010|Overall Study|Death|1|||
33622800|NCT01454596|102169391|FG011|Overall Study|Death|0|||
33622801|NCT01594931|102169392|FG000|Overall Study|Adverse Event|3|||
33622802|NCT01594931|102169393|FG001|Overall Study|Adverse Event|1|||
33622803|NCT01594931|102169394|FG002|Overall Study|Adverse Event|1|||
33622804|NCT01594931|102169392|FG000|Overall Study|Withdrawal by Subject|2|||
33622805|NCT01594931|102169393|FG001|Overall Study|Withdrawal by Subject|1|||
33558471|NCT04579380|101941175|FG006|Overall Study|Withdrawal by Subject|0|||
33558472|NCT04579380|101941176|FG007|Overall Study|Withdrawal by Subject|1|||
33558473|NCT04579380|101941177|FG008|Overall Study|Withdrawal by Subject|2|||
33558474|NCT04579380|101941169|FG000|Overall Study|Ongoing|2|||
33558475|NCT04579380|101941170|FG001|Overall Study|Ongoing|6|||
33558476|NCT04579380|101941171|FG002|Overall Study|Ongoing|4|||
33558477|NCT04579380|101941172|FG003|Overall Study|Ongoing|8|||
33558478|NCT04579380|101941173|FG004|Overall Study|Ongoing|5|||
33558479|NCT04579380|101941174|FG005|Overall Study|Ongoing|8|||
33558480|NCT04579380|101941175|FG006|Overall Study|Ongoing|3|||
33558481|NCT04579380|101941176|FG007|Overall Study|Ongoing|19|||
33558482|NCT04579380|101941177|FG008|Overall Study|Ongoing|6|||
33558483|NCT05529173|101941178|FG000|Overall Study|Physician Decision|3|||
33558484|NCT05529173|101941179|FG001|Overall Study|Physician Decision|6|||
33558485|NCT05529173|101941178|FG000|Overall Study|Sample shipment delay more than one day|4|||
33558486|NCT05529173|101941179|FG001|Overall Study|Sample shipment delay more than one day|0|||
33558487|NCT04189588|101941180|FG000|Overall Study|Death|0|||
33558488|NCT04189588|101941181|FG001|Overall Study|Death|1|||
33558489|NCT04189588|101941180|FG000|Overall Study|Lost to Follow-up|0|||
33558490|NCT04189588|101941181|FG001|Overall Study|Lost to Follow-up|1|||
33558491|NCT02181621|101941182|FG000|Overall Study|Adverse Event|1|||
33558492|NCT02181621|101941183|FG001|Overall Study|Adverse Event|0|||
33622806|NCT01594931|102169394|FG002|Overall Study|Withdrawal by Subject|1|||
33218568|NCT03014674|100696091|FG000|Overall Study|Withdrawal by Subject|1|||
33218569|NCT03014674|100696092|FG001|Overall Study|Withdrawal by Subject|0|||
33218570|NCT03014674|100696093|FG002|Overall Study|Withdrawal by Subject|0|||
33558493|NCT02181621|101941182|FG000|Overall Study|Previously Enrolled|0|||
33622807|NCT01594931|102169392|FG000|Overall Study|Lack of Efficacy|7|||
33622808|NCT01594931|102169393|FG001|Overall Study|Lack of Efficacy|2|||
33558494|NCT02181621|101941183|FG001|Overall Study|Previously Enrolled|1|||
33558495|NCT02181621|101941182|FG000|Overall Study|Enrollment Hold|1|||
33558496|NCT02181621|101941183|FG001|Overall Study|Enrollment Hold|1|||
33558497|NCT03671148|101941187|FG000|Overall Study|Adverse Event|3|||
33622809|NCT01594931|102169394|FG002|Overall Study|Lack of Efficacy|2|||
33358191|NCT00553787|101198548|FG002|Overall Study|Withdrawal by Subject|83|||
33358192|NCT00553787|101198546|FG000|Overall Study|Lack of Efficacy|31|||
33358193|NCT00553787|101198547|FG001|Overall Study|Lack of Efficacy|1|||
33358194|NCT00553787|101198548|FG002|Overall Study|Lack of Efficacy|3|||
33358195|NCT00553787|101198546|FG000|Overall Study|Pregnancy|0|||
33358196|NCT00553787|101198547|FG001|Overall Study|Pregnancy|1|||
33358197|NCT00553787|101198548|FG002|Overall Study|Pregnancy|2|||
33358198|NCT00553787|101198546|FG000|Overall Study|non compliance|4|||
33358199|NCT00553787|101198547|FG001|Overall Study|non compliance|0|||
33358200|NCT00553787|101198548|FG002|Overall Study|non compliance|11|||
33358201|NCT00553787|101198546|FG000|Overall Study|Requirement for restricted medication|8|||
33358202|NCT00553787|101198547|FG001|Overall Study|Requirement for restricted medication|7|||
33358203|NCT00553787|101198548|FG002|Overall Study|Requirement for restricted medication|5|||
33358204|NCT00553787|101198546|FG000|Overall Study|Other|18|||
33358205|NCT00553787|101198547|FG001|Overall Study|Other|10|||
33622810|NCT01594931|102169392|FG000|Overall Study|Lost to Follow-up|4|||
33622811|NCT01594931|102169393|FG001|Overall Study|Lost to Follow-up|3|||
33622812|NCT01594931|102169394|FG002|Overall Study|Lost to Follow-up|3|||
33622813|NCT01594931|102169392|FG000|Overall Study|Protocol Violation|2|||
33622814|NCT01594931|102169393|FG001|Overall Study|Protocol Violation|1|||
33622815|NCT01594931|102169394|FG002|Overall Study|Protocol Violation|0|||
33622816|NCT01594931|102169392|FG000|Overall Study|No defiined|11|||
33622817|NCT01594931|102169393|FG001|Overall Study|No defiined|4|||
33622818|NCT01594931|102169394|FG002|Overall Study|No defiined|7|||
33622819|NCT01384734|102169395|FG000|Overall Study|Adverse Event|0|||
33622820|NCT01384734|102169396|FG001|Overall Study|Adverse Event|3|||
33622821|NCT01384734|102169397|FG002|Overall Study|Adverse Event|0|||
33622822|NCT01384734|102169398|FG003|Overall Study|Adverse Event|2|||
33622823|NCT01384734|102169399|FG004|Overall Study|Adverse Event|7|||
33622824|NCT01384734|102169395|FG000|Overall Study|Death|1|||
33622825|NCT01384734|102169396|FG001|Overall Study|Death|0|||
33622826|NCT01384734|102169397|FG002|Overall Study|Death|1|||
33622827|NCT01384734|102169398|FG003|Overall Study|Death|0|||
33622828|NCT01384734|102169399|FG004|Overall Study|Death|0|||
33622829|NCT01384734|102169395|FG000|Overall Study|Continuation criteria not met|0|||
33622830|NCT01384734|102169396|FG001|Overall Study|Continuation criteria not met|0|||
33622831|NCT01384734|102169397|FG002|Overall Study|Continuation criteria not met|1|||
33622832|NCT01384734|102169398|FG003|Overall Study|Continuation criteria not met|1|||
33622833|NCT01384734|102169399|FG004|Overall Study|Continuation criteria not met|0|||
33622834|NCT01384734|102169395|FG000|Overall Study|Lack of Efficacy|3|||
33622835|NCT01384734|102169396|FG001|Overall Study|Lack of Efficacy|7|||
33622836|NCT01384734|102169397|FG002|Overall Study|Lack of Efficacy|4|||
33622837|NCT01384734|102169398|FG003|Overall Study|Lack of Efficacy|4|||
33622838|NCT01384734|102169399|FG004|Overall Study|Lack of Efficacy|2|||
33622839|NCT01384734|102169395|FG000|Overall Study|Lost to Follow-up|5|||
33622840|NCT01384734|102169396|FG001|Overall Study|Lost to Follow-up|3|||
33622841|NCT01384734|102169397|FG002|Overall Study|Lost to Follow-up|3|||
33622842|NCT01384734|102169398|FG003|Overall Study|Lost to Follow-up|8|||
33622843|NCT01384734|102169399|FG004|Overall Study|Lost to Follow-up|5|||
33622844|NCT01384734|102169395|FG000|Overall Study|Non-compliance with study drug|1|||
33622845|NCT01384734|102169396|FG001|Overall Study|Non-compliance with study drug|2|||
33622846|NCT01384734|102169397|FG002|Overall Study|Non-compliance with study drug|6|||
33622847|NCT01384734|102169398|FG003|Overall Study|Non-compliance with study drug|0|||
33622848|NCT01384734|102169399|FG004|Overall Study|Non-compliance with study drug|2|||
33622849|NCT01384734|102169395|FG000|Overall Study|Pregnancy|0|||
33622850|NCT01384734|102169396|FG001|Overall Study|Pregnancy|1|||
33622851|NCT01384734|102169397|FG002|Overall Study|Pregnancy|0|||
33622852|NCT01384734|102169398|FG003|Overall Study|Pregnancy|0|||
33622853|NCT01384734|102169399|FG004|Overall Study|Pregnancy|1|||
33622854|NCT01384734|102169395|FG000|Overall Study|Sponsor terminated|0|||
33622855|NCT01384734|102169396|FG001|Overall Study|Sponsor terminated|0|||
33358206|NCT00553787|101198548|FG002|Overall Study|Other|13|||
33622856|NCT01384734|102169397|FG002|Overall Study|Sponsor terminated|0|||
33622857|NCT01384734|102169398|FG003|Overall Study|Sponsor terminated|0|||
33622858|NCT01384734|102169399|FG004|Overall Study|Sponsor terminated|1|||
33622859|NCT01384734|102169395|FG000|Overall Study|Withdrawal by Subject|5|||
33622860|NCT01384734|102169396|FG001|Overall Study|Withdrawal by Subject|5|||
33622861|NCT01384734|102169397|FG002|Overall Study|Withdrawal by Subject|6|||
33622862|NCT01384734|102169398|FG003|Overall Study|Withdrawal by Subject|7|||
33358207|NCT02579603|101198549|FG000|Overall Study|Not treated|1|||
33358208|NCT02579603|101198550|FG001|Overall Study|Not treated|0|||
33622863|NCT01384734|102169399|FG004|Overall Study|Withdrawal by Subject|9|||
33358209|NCT02579603|101198549|FG000|Overall Study|Adverse Event|2|||
33622864|NCT01384734|102169395|FG000|Overall Study|Investigator relocating|0|||
33622865|NCT01384734|102169396|FG001|Overall Study|Investigator relocating|2|||
33558498|NCT03671148|101941188|FG001|Overall Study|Adverse Event|2|||
33558499|NCT03671148|101941187|FG000|Overall Study|Withdrawal by Subject|8|||
33558500|NCT03671148|101941188|FG001|Overall Study|Withdrawal by Subject|2|||
33558501|NCT03671148|101941187|FG000|Overall Study|Lost to Follow-up|1|||
33558502|NCT03671148|101941188|FG001|Overall Study|Lost to Follow-up|2|||
33558503|NCT03671148|101941187|FG000|Overall Study|Lack of Efficacy|7|||
33558504|NCT03671148|101941188|FG001|Overall Study|Lack of Efficacy|2|||
33558505|NCT03671148|101941187|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
33558506|NCT03671148|101941188|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
33558507|NCT03671148|101941187|FG000|Overall Study|Other|1|||
33558508|NCT03671148|101941188|FG001|Overall Study|Other|0|||
33558509|NCT03671148|101941187|FG000|Overall Study|Incomplete Randomization Visit|1|||
33558510|NCT03671148|101941188|FG001|Overall Study|Incomplete Randomization Visit|0|||
33558511|NCT02152982|101941192|FG000|Overall Study|Ineligible|4|||
33558512|NCT02152982|101941193|FG001|Overall Study|Ineligible|4|||
33558513|NCT02152982|101941192|FG000|Overall Study|Did not start treatment|12|||
33558514|NCT02152982|101941193|FG001|Overall Study|Did not start treatment|6|||
33558515|NCT02362412|101941194|FG000|Treatment Period III|Lost to Follow-up|0|||
33558516|NCT02362412|101941195|FG001|Treatment Period III|Lost to Follow-up|1|||
33558517|NCT01725282|101941196|FG000|Overall Study|Adverse Event|1|||
33558518|NCT01725282|101941197|FG001|Overall Study|Adverse Event|3|||
33558519|NCT01725282|101941198|FG002|Overall Study|Adverse Event|6|||
33558520|NCT01725282|101941199|FG003|Overall Study|Adverse Event|4|||
33218571|NCT02497287|100696102|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
33218572|NCT02497287|100696102|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
33558521|NCT01725282|101941196|FG000|Overall Study|Exacerbation of Target Disease|1|||
33558522|NCT01725282|101941197|FG001|Overall Study|Exacerbation of Target Disease|0|||
33558523|NCT01725282|101941198|FG002|Overall Study|Exacerbation of Target Disease|0|||
33558524|NCT01725282|101941199|FG003|Overall Study|Exacerbation of Target Disease|1|||
33358210|NCT02579603|101198550|FG001|Overall Study|Adverse Event|2|||
33358211|NCT02579603|101198549|FG000|Overall Study|Other than stated|1|||
33358212|NCT02579603|101198550|FG001|Overall Study|Other than stated|0|||
33358213|NCT01333189|101198556|FG000|Overall Study|Time constraints|1|||
33414551|NCT03170271|101409829|FG000|Overall Study|Other|2|||
33558525|NCT01725282|101941196|FG000|Overall Study|Met Exclusion Criteria|0|||
33558526|NCT01725282|101941197|FG001|Overall Study|Met Exclusion Criteria|0|||
33558527|NCT01725282|101941198|FG002|Overall Study|Met Exclusion Criteria|1|||
33558528|NCT01725282|101941199|FG003|Overall Study|Met Exclusion Criteria|0|||
33558529|NCT01725282|101941196|FG000|Overall Study|Study Site Withdrawal|0|||
33358214|NCT01333189|101198557|FG001|Overall Study|Time constraints|0|||
33358215|NCT01333189|101198556|FG000|Overall Study|Adverse Event|1|||
33358216|NCT01333189|101198557|FG001|Overall Study|Adverse Event|0|||
33358217|NCT01333189|101198556|FG000|Overall Study|Transportation difficulties|0|||
33358218|NCT01333189|101198557|FG001|Overall Study|Transportation difficulties|1|||
33358219|NCT01333189|101198556|FG000|Overall Study|Moved from region|0|||
33358220|NCT01333189|101198557|FG001|Overall Study|Moved from region|1|||
33358221|NCT00907738|101198560|FG000|Overall Study|Adverse Event|2|||
33358222|NCT00907738|101198561|FG001|Overall Study|Adverse Event|0|||
33358223|NCT00907738|101198562|FG002|Overall Study|Adverse Event|1|||
33358224|NCT00907738|101198563|FG003|Overall Study|Adverse Event|0|||
33358225|NCT00907738|101198564|FG004|Overall Study|Adverse Event|0|||
33358226|NCT00907738|101198560|FG000|Overall Study|not specified or withdrew consent|3|||
33414552|NCT03170271|101409830|FG001|Overall Study|Other|2|||
33414553|NCT03170271|101409829|FG000|Overall Study|Randomized in error|4|||
33558530|NCT01725282|101941197|FG001|Overall Study|Study Site Withdrawal|1|||
33218573|NCT02497287|100696102|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
33218574|NCT02497287|100696102|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
33218575|NCT02497287|100696102|FG000|Induction Phase (4 Weeks)|Other|13|||
33218576|NCT02497287|100696102|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
33218577|NCT02497287|100696102|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
33414554|NCT03170271|101409830|FG001|Overall Study|Randomized in error|0|||
33414555|NCT03387423|101409831|FG000|Overall Study|Lost to Follow-up|16|||
33558531|NCT01725282|101941198|FG002|Overall Study|Study Site Withdrawal|0|||
33414556|NCT03387423|101409832|FG001|Overall Study|Lost to Follow-up|12|||
33558532|NCT01725282|101941199|FG003|Overall Study|Study Site Withdrawal|0|||
33558533|NCT01725282|101941196|FG000|Overall Study|Withdrawal by Subject|0|||
33558534|NCT01725282|101941197|FG001|Overall Study|Withdrawal by Subject|0|||
33558535|NCT01725282|101941198|FG002|Overall Study|Withdrawal by Subject|1|||
33558536|NCT01725282|101941199|FG003|Overall Study|Withdrawal by Subject|1|||
33558537|NCT01725282|101941196|FG000|Overall Study|Lack of Efficacy|0|||
33558538|NCT01725282|101941197|FG001|Overall Study|Lack of Efficacy|1|||
33558539|NCT01725282|101941198|FG002|Overall Study|Lack of Efficacy|0|||
33558540|NCT01725282|101941199|FG003|Overall Study|Lack of Efficacy|1|||
33558541|NCT00461812|101941200|FG000|Overall Study|study terminated|10|||
33558542|NCT00770809|101941206|FG000|Overall Study|Adverse Event|9|||
33558543|NCT00770809|101941207|FG001|Overall Study|Adverse Event|1|||
33558544|NCT00770809|101941208|FG002|Overall Study|Adverse Event|12|||
33558545|NCT00770809|101941206|FG000|Overall Study|Death|1|||
33558546|NCT00770809|101941207|FG001|Overall Study|Death|0|||
33558547|NCT00770809|101941208|FG002|Overall Study|Death|0|||
33622866|NCT01384734|102169397|FG002|Overall Study|Investigator relocating|0|||
33622867|NCT01384734|102169398|FG003|Overall Study|Investigator relocating|3|||
33622868|NCT01384734|102169399|FG004|Overall Study|Investigator relocating|1|||
33622869|NCT01384734|102169395|FG000|Overall Study|Unable to come back for visit|1|||
33622870|NCT01384734|102169396|FG001|Overall Study|Unable to come back for visit|0|||
33358227|NCT00907738|101198561|FG001|Overall Study|not specified or withdrew consent|0|||
33358228|NCT00907738|101198562|FG002|Overall Study|not specified or withdrew consent|0|||
33358229|NCT00907738|101198563|FG003|Overall Study|not specified or withdrew consent|0|||
33358230|NCT00907738|101198564|FG004|Overall Study|not specified or withdrew consent|0|||
33358231|NCT00907738|101198560|FG000|Overall Study|Disease progression|8|||
33358232|NCT00907738|101198561|FG001|Overall Study|Disease progression|1|||
33358233|NCT00907738|101198562|FG002|Overall Study|Disease progression|6|||
33358234|NCT00907738|101198563|FG003|Overall Study|Disease progression|4|||
33358235|NCT00907738|101198564|FG004|Overall Study|Disease progression|2|||
33358236|NCT02179398|101198569|FG000|Overall Study|Lack of obligatory data|3|||
33358237|NCT02179398|101198570|FG001|Overall Study|Lack of obligatory data|3|||
33358238|NCT02179398|101198569|FG000|Overall Study|Lost to Follow-up|0|||
33358239|NCT02179398|101198570|FG001|Overall Study|Lost to Follow-up|1|||
33358240|NCT00473694|101198572|FG000|Overall Study|Adverse Event|0|||
33358241|NCT00473694|101198573|FG001|Overall Study|Adverse Event|1|||
33358242|NCT00473694|101198574|FG002|Overall Study|Adverse Event|0|||
33358243|NCT00473694|101198575|FG003|Overall Study|Adverse Event|0|||
33358244|NCT00473694|101198572|FG000|Overall Study|Participants did not receive treatment|11|||
33358245|NCT00473694|101198573|FG001|Overall Study|Participants did not receive treatment|3|||
33358246|NCT00473694|101198574|FG002|Overall Study|Participants did not receive treatment|5|||
33358247|NCT00473694|101198575|FG003|Overall Study|Participants did not receive treatment|6|||
33358248|NCT00473694|101198572|FG000|Overall Study|Lost to Follow-up|0|||
33358249|NCT00473694|101198573|FG001|Overall Study|Lost to Follow-up|0|||
33358250|NCT00473694|101198574|FG002|Overall Study|Lost to Follow-up|0|||
33358251|NCT00473694|101198575|FG003|Overall Study|Lost to Follow-up|1|||
33358252|NCT03842709|101198576|FG000|Overall Study|Withdrawal by Subject|3|||
33358253|NCT03842709|101198577|FG001|Overall Study|Withdrawal by Subject|3|||
33358254|NCT03842709|101198576|FG000|Overall Study|Lost to Follow-up|1|||
33358255|NCT03842709|101198577|FG001|Overall Study|Lost to Follow-up|0|||
33358256|NCT03414359|101198578|FG000|Overall Study|Lack of Efficacy|1|||
33358257|NCT03414359|101198579|FG001|Overall Study|Lack of Efficacy|1|||
33358258|NCT03414359|101198578|FG000|Overall Study|Protocol Violation|0|||
33358259|NCT03414359|101198579|FG001|Overall Study|Protocol Violation|1|||
33358260|NCT00506389|101198582|FG000|In-treatment Period|Other|3|||
33358261|NCT00506389|101198583|FG001|In-treatment Period|Other|3|||
33358262|NCT00506389|101198584|FG002|In-treatment Period|Other|4|||
33358263|NCT00506389|101198582|FG000|In-treatment Period|Lost to Follow-up|0|||
33358264|NCT00506389|101198583|FG001|In-treatment Period|Lost to Follow-up|0|||
33358265|NCT00506389|101198584|FG002|In-treatment Period|Lost to Follow-up|1|||
33358266|NCT00506389|101198582|FG000|In-treatment Period|Lack of compliance|1|||
33414557|NCT03387423|101409833|FG002|Overall Study|Lost to Follow-up|1|||
33414558|NCT03387423|101409834|FG003|Overall Study|Lost to Follow-up|0|||
33622871|NCT01384734|102169397|FG002|Overall Study|Unable to come back for visit|1|||
33622872|NCT01384734|102169398|FG003|Overall Study|Unable to come back for visit|1|||
33358267|NCT00506389|101198583|FG001|In-treatment Period|Lack of compliance|0|||
33358268|NCT00506389|101198584|FG002|In-treatment Period|Lack of compliance|0|||
33358269|NCT00506389|101198582|FG000|In-treatment Period|Reasons not related to trial|4|||
33358270|NCT00506389|101198583|FG001|In-treatment Period|Reasons not related to trial|1|||
33414559|NCT03387423|101409831|FG000|Overall Study|Other|0|||
33358271|NCT00506389|101198584|FG002|In-treatment Period|Reasons not related to trial|0|||
33358272|NCT00506389|101198582|FG000|In-treatment Period|Withdrawal by Subject|3|||
33358273|NCT00506389|101198583|FG001|In-treatment Period|Withdrawal by Subject|3|||
33358274|NCT00506389|101198584|FG002|In-treatment Period|Withdrawal by Subject|4|||
33358275|NCT00506389|101198582|FG000|In-treatment Period|Lack of Efficacy|0|||
33622873|NCT01384734|102169399|FG004|Overall Study|Unable to come back for visit|0|||
33622874|NCT01384734|102169395|FG000|Overall Study|Prison|0|||
33358276|NCT00506389|101198583|FG001|In-treatment Period|Lack of Efficacy|2|||
33358277|NCT00506389|101198584|FG002|In-treatment Period|Lack of Efficacy|0|||
33358278|NCT00506389|101198582|FG000|In-treatment Period|Adverse Event|11|||
33358279|NCT00506389|101198583|FG001|In-treatment Period|Adverse Event|5|||
33358280|NCT00506389|101198584|FG002|In-treatment Period|Adverse Event|2|||
33358281|NCT00506389|101198582|FG000|In-treatment Period|Randomized but not treated|4|||
33358282|NCT00506389|101198583|FG001|In-treatment Period|Randomized but not treated|1|||
33358283|NCT00506389|101198584|FG002|In-treatment Period|Randomized but not treated|1|||
33358284|NCT02704429|101198587|FG000|Part A: 24 Weeks|Adverse Event|3|||
33358285|NCT02704429|101198588|FG001|Part A: 24 Weeks|Adverse Event|0|||
33358286|NCT02704429|101198587|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
33558548|NCT00770809|101941206|FG000|Overall Study|Withdrawal by Subject|3|||
33558549|NCT00770809|101941207|FG001|Overall Study|Withdrawal by Subject|3|||
33558550|NCT00770809|101941208|FG002|Overall Study|Withdrawal by Subject|7|||
33558551|NCT00770809|101941206|FG000|Overall Study|Progression|2|||
33558552|NCT00770809|101941207|FG001|Overall Study|Progression|2|||
33558553|NCT00770809|101941208|FG002|Overall Study|Progression|0|||
33558554|NCT00770809|101941206|FG000|Overall Study|Complicating illness|0|||
33558555|NCT00770809|101941207|FG001|Overall Study|Complicating illness|0|||
33558556|NCT00770809|101941208|FG002|Overall Study|Complicating illness|1|||
33558557|NCT00770809|101941206|FG000|Overall Study|Other Medical Reasons|2|||
33558558|NCT00770809|101941207|FG001|Overall Study|Other Medical Reasons|4|||
33558559|NCT00770809|101941208|FG002|Overall Study|Other Medical Reasons|3|||
33558560|NCT01725308|101941214|FG000|Treatment Period I|Did Not Receive Drug|1|||
33558561|NCT01725308|101941215|FG001|Treatment Period I|Did Not Receive Drug|0|||
33558562|NCT01725308|101941216|FG002|Treatment Period I|Did Not Receive Drug|0|||
33558563|NCT01725308|101941214|FG000|Treatment Period I|Adverse Event|5|||
33558564|NCT01725308|101941215|FG001|Treatment Period I|Adverse Event|4|||
33558565|NCT01725308|101941216|FG002|Treatment Period I|Adverse Event|21|||
33558566|NCT01725308|101941214|FG000|Treatment Period I|Insufficient Response|7|||
33622875|NCT01384734|102169396|FG001|Overall Study|Prison|0|||
33558567|NCT01725308|101941215|FG001|Treatment Period I|Insufficient Response|0|||
33558568|NCT01725308|101941216|FG002|Treatment Period I|Insufficient Response|5|||
33622876|NCT01384734|102169397|FG002|Overall Study|Prison|1|||
33622877|NCT01384734|102169398|FG003|Overall Study|Prison|0|||
33622878|NCT01384734|102169399|FG004|Overall Study|Prison|0|||
33622879|NCT01384734|102169395|FG000|Overall Study|As per Exclusion criteria|0|||
33358287|NCT02704429|101198588|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
33358288|NCT02732951|101198589|FG000|Overall Study|Other than listed|1|||
33358289|NCT02732951|101198590|FG001|Overall Study|Other than listed|0|||
33358290|NCT02732951|101198589|FG000|Overall Study|Lost to Follow-up|0|||
33622880|NCT01384734|102169396|FG001|Overall Study|As per Exclusion criteria|1|||
33358291|NCT02732951|101198590|FG001|Overall Study|Lost to Follow-up|1|||
33358292|NCT02732951|101198589|FG000|Overall Study|Adverse Event|4|||
33358293|NCT02732951|101198590|FG001|Overall Study|Adverse Event|4|||
33358294|NCT02732951|101198589|FG000|Overall Study|Protocol Violation|0|||
33358295|NCT02732951|101198590|FG001|Overall Study|Protocol Violation|1|||
33358296|NCT05299892|101198591|FG000|Overall Study|Withdrawal by Subject|2|||
33358297|NCT02519231|101198592|FG000|Overall Study|Lost to Follow-up|2|||
33358298|NCT02519231|101198593|FG001|Overall Study|Lost to Follow-up|5|||
33358299|NCT02519231|101198592|FG000|Overall Study|Withdrawal by Subject|0|||
33358300|NCT02519231|101198593|FG001|Overall Study|Withdrawal by Subject|1|||
33358301|NCT02638012|101198594|FG000|Overall Study|Lost to Follow-up|1|||
33358302|NCT00756002|101198595|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
33358303|NCT00756002|101198596|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
33358304|NCT00756002|101198595|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33358305|NCT00756002|101198596|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
33358306|NCT00756002|101198595|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
33358307|NCT00756002|101198596|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
33358308|NCT00756002|101198595|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
33358309|NCT00756002|101198596|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
33358310|NCT00756002|101198595|FG000|Double-Blind Treatment Period|Other|2|||
33358311|NCT00756002|101198596|FG001|Double-Blind Treatment Period|Other|2|||
33358312|NCT05593432|101198597|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
33358313|NCT05593432|101198598|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
33358314|NCT05593432|101198599|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
33558569|NCT01725308|101941214|FG000|Treatment Period I|Worsening of the Target Disease|8|||
33558570|NCT01725308|101941215|FG001|Treatment Period I|Worsening of the Target Disease|0|||
33558571|NCT01725308|101941216|FG002|Treatment Period I|Worsening of the Target Disease|2|||
33558572|NCT01725308|101941214|FG000|Treatment Period I|Changes in the Episodes|3|||
33558573|NCT01725308|101941215|FG001|Treatment Period I|Changes in the Episodes|0|||
33558574|NCT01725308|101941216|FG002|Treatment Period I|Changes in the Episodes|2|||
33558575|NCT01725308|101941214|FG000|Treatment Period I|Withdrawal of Consent|12|||
33622881|NCT01384734|102169397|FG002|Overall Study|As per Exclusion criteria|0|||
33622882|NCT01384734|102169398|FG003|Overall Study|As per Exclusion criteria|0|||
33622883|NCT01384734|102169399|FG004|Overall Study|As per Exclusion criteria|0|||
33622884|NCT01384734|102169395|FG000|Overall Study|Missed End of treatment visit|0|||
33622885|NCT01384734|102169396|FG001|Overall Study|Missed End of treatment visit|0|||
33622886|NCT01384734|102169397|FG002|Overall Study|Missed End of treatment visit|0|||
33622887|NCT01384734|102169398|FG003|Overall Study|Missed End of treatment visit|1|||
33622888|NCT01384734|102169399|FG004|Overall Study|Missed End of treatment visit|0|||
33558576|NCT01725308|101941215|FG001|Treatment Period I|Withdrawal of Consent|7|||
33558577|NCT01725308|101941216|FG002|Treatment Period I|Withdrawal of Consent|5|||
33558578|NCT01725308|101941214|FG000|Treatment Period I|Lost to Follow-up|3|||
33558579|NCT01725308|101941215|FG001|Treatment Period I|Lost to Follow-up|2|||
33558580|NCT01725308|101941216|FG002|Treatment Period I|Lost to Follow-up|2|||
33622889|NCT01384734|102169395|FG000|Overall Study|Adhesion problem|0|||
33622890|NCT01384734|102169396|FG001|Overall Study|Adhesion problem|0|||
33358315|NCT05593432|101198600|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
33414560|NCT03387423|101409832|FG001|Overall Study|Other|3|||
33414561|NCT03387423|101409833|FG002|Overall Study|Other|0|||
33414562|NCT03387423|101409834|FG003|Overall Study|Other|0|||
33414563|NCT03387423|101409831|FG000|Overall Study|Administrative Reason|166|||
33414564|NCT03387423|101409832|FG001|Overall Study|Administrative Reason|89|||
33622891|NCT01384734|102169397|FG002|Overall Study|Adhesion problem|0|||
33358316|NCT05593432|101198597|FG000|16-Week OLE Period|Lack of Efficacy|0|||
33558581|NCT01725308|101941214|FG000|Treatment Period I|Protocol Deviations|3|||
33558582|NCT01725308|101941215|FG001|Treatment Period I|Protocol Deviations|1|||
33558583|NCT01725308|101941216|FG002|Treatment Period I|Protocol Deviations|1|||
33622892|NCT01384734|102169398|FG003|Overall Study|Adhesion problem|1|||
33622893|NCT01384734|102169399|FG004|Overall Study|Adhesion problem|0|||
33358317|NCT05593432|101198598|FG001|16-Week OLE Period|Lack of Efficacy|0|||
33358318|NCT05593432|101198599|FG002|16-Week OLE Period|Lack of Efficacy|0|||
33358319|NCT05593432|101198600|FG003|16-Week OLE Period|Lack of Efficacy|1|||
33358320|NCT05593432|101198597|FG000|16-Week OLE Period|Lost to Follow-up|0|||
33358321|NCT05593432|101198598|FG001|16-Week OLE Period|Lost to Follow-up|0|||
33358322|NCT05593432|101198599|FG002|16-Week OLE Period|Lost to Follow-up|1|||
33358323|NCT05593432|101198600|FG003|16-Week OLE Period|Lost to Follow-up|2|||
33358324|NCT05593432|101198597|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
33558584|NCT01725308|101941214|FG000|Treatment Period I|Miscellaneous|2|||
33218578|NCT02497287|100696102|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
33218579|NCT02497287|100696102|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
33218580|NCT02497287|100696102|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
33358325|NCT05593432|101198598|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
33558585|NCT01725308|101941215|FG001|Treatment Period I|Miscellaneous|0|||
33218581|NCT02497287|100696102|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
33358326|NCT05593432|101198599|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
33358327|NCT05593432|101198600|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
33358328|NCT00658333|101201045|FG000|Overall Study|Adverse Event|2|||
33558586|NCT01725308|101941216|FG002|Treatment Period I|Miscellaneous|3|||
33558587|NCT01725308|101941214|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
33558588|NCT01725308|101941215|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
33558589|NCT01725308|101941216|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
33558590|NCT01725308|101941214|FG000|Treatment Period II|Did Not Receive Drug|4|||
33558591|NCT01725308|101941215|FG001|Treatment Period II|Did Not Receive Drug|0|||
33558592|NCT01725308|101941216|FG002|Treatment Period II|Did Not Receive Drug|0|||
33558593|NCT01725308|101941214|FG000|Treatment Period II|Adverse Event|13|||
33558594|NCT01725308|101941215|FG001|Treatment Period II|Adverse Event|8|||
33558595|NCT01725308|101941216|FG002|Treatment Period II|Adverse Event|20|||
33622894|NCT01384734|102169395|FG000|Overall Study|Early termination|0|||
33622895|NCT01384734|102169396|FG001|Overall Study|Early termination|0|||
33622896|NCT01384734|102169397|FG002|Overall Study|Early termination|0|||
33622897|NCT01384734|102169398|FG003|Overall Study|Early termination|0|||
33622898|NCT01384734|102169399|FG004|Overall Study|Early termination|1|||
33622899|NCT01384734|102169395|FG000|Overall Study|Physician Decision|1|||
33622900|NCT01384734|102169396|FG001|Overall Study|Physician Decision|0|||
33622901|NCT01384734|102169397|FG002|Overall Study|Physician Decision|0|||
33622902|NCT01384734|102169398|FG003|Overall Study|Physician Decision|0|||
33622903|NCT01384734|102169399|FG004|Overall Study|Physician Decision|0|||
33622904|NCT01363700|102169406|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
33622905|NCT01363700|102169407|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
33622906|NCT01363700|102169408|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
33622907|NCT01363700|102169409|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
33622908|NCT01363700|102169410|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
33622909|NCT00717249|102169411|FG000|Overall Study|Lens Discomfort|4|||
33622910|NCT00717249|102169412|FG001|Overall Study|Lens Discomfort|1|||
33622911|NCT00717249|102169411|FG000|Overall Study|Unsatisfactory visual Response|0|||
33622912|NCT00717249|102169412|FG001|Overall Study|Unsatisfactory visual Response|2|||
33622913|NCT00717249|102169411|FG000|Overall Study|Adverse Event|4|||
33622914|NCT00717249|102169412|FG001|Overall Study|Adverse Event|2|||
33622915|NCT00717249|102169411|FG000|Overall Study|Lost to Follow-up|2|||
33622916|NCT00717249|102169412|FG001|Overall Study|Lost to Follow-up|0|||
33622917|NCT00717249|102169411|FG000|Overall Study|Withdrawal by Subject|1|||
33622918|NCT00717249|102169412|FG001|Overall Study|Withdrawal by Subject|2|||
33622919|NCT00717249|102169411|FG000|Overall Study|Pregnancy|6|||
33622920|NCT00717249|102169412|FG001|Overall Study|Pregnancy|3|||
33622921|NCT00717249|102169411|FG000|Overall Study|Protocol Violation|0|||
33622922|NCT00717249|102169412|FG001|Overall Study|Protocol Violation|2|||
33622923|NCT00717249|102169411|FG000|Overall Study|Subject became Ineligible|1|||
33622924|NCT00717249|102169412|FG001|Overall Study|Subject became Ineligible|1|||
33622925|NCT00717249|102169411|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
33622926|NCT00717249|102169412|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
33622927|NCT00717249|102169411|FG000|Overall Study|Gastric Surgery|0|||
33622928|NCT00717249|102169412|FG001|Overall Study|Gastric Surgery|1|||
33622929|NCT00717249|102169411|FG000|Overall Study|Diagnosed with Diabetes|1|||
33622930|NCT00717249|102169412|FG001|Overall Study|Diagnosed with Diabetes|0|||
33622931|NCT00717249|102169411|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
33622932|NCT00717249|102169412|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
33358329|NCT00658333|101201046|FG001|Overall Study|Adverse Event|1|||
33558596|NCT01725308|101941214|FG000|Treatment Period II|Insufficient Response|2|||
33622933|NCT00717249|102169411|FG000|Overall Study|Subject relocated|1|||
33622934|NCT00717249|102169412|FG001|Overall Study|Subject relocated|0|||
33358330|NCT02299934|101201047|FG000|Overall Study|Termination of study|13|||
33558597|NCT01725308|101941215|FG001|Treatment Period II|Insufficient Response|4|||
33558598|NCT01725308|101941216|FG002|Treatment Period II|Insufficient Response|6|||
33558599|NCT01725308|101941214|FG000|Treatment Period II|Worsening of the Target Disease|1|||
33558600|NCT01725308|101941215|FG001|Treatment Period II|Worsening of the Target Disease|4|||
33414565|NCT03387423|101409833|FG002|Overall Study|Administrative Reason|17|||
33414566|NCT03387423|101409834|FG003|Overall Study|Administrative Reason|19|||
33558601|NCT01725308|101941216|FG002|Treatment Period II|Worsening of the Target Disease|2|||
33558602|NCT01725308|101941214|FG000|Treatment Period II|Changes in the Episodes|1|||
33558603|NCT01725308|101941215|FG001|Treatment Period II|Changes in the Episodes|0|||
33558604|NCT01725308|101941216|FG002|Treatment Period II|Changes in the Episodes|5|||
33558605|NCT01725308|101941214|FG000|Treatment Period II|Withdrawal of Consent|28|||
33558606|NCT01725308|101941215|FG001|Treatment Period II|Withdrawal of Consent|2|||
33558607|NCT01725308|101941216|FG002|Treatment Period II|Withdrawal of Consent|16|||
33358331|NCT00474253|101201050|FG000|Overall Study|Withdrew consent|2|||
33622935|NCT00717249|102169411|FG000|Overall Study|Headaches|1|||
33358332|NCT00474253|101201051|FG001|Overall Study|Withdrew consent|0|||
33358333|NCT00474253|101201050|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
33358334|NCT00474253|101201051|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
33358335|NCT00474253|101201050|FG000|Overall Study|Lost to Follow-up|1|||
33358336|NCT00474253|101201051|FG001|Overall Study|Lost to Follow-up|0|||
33358337|NCT00474253|101201050|FG000|Overall Study|Discharged prior to study completion|0|||
33358338|NCT00474253|101201051|FG001|Overall Study|Discharged prior to study completion|1|||
33358339|NCT00630032|101201052|FG000|Overall Study|Death|55|||
33358340|NCT00630032|101201053|FG001|Overall Study|Death|49|||
33358341|NCT00630032|101201052|FG000|Overall Study|Withdrawal by Subject|3|||
33358342|NCT00630032|101201053|FG001|Overall Study|Withdrawal by Subject|2|||
33358343|NCT00630032|101201052|FG000|Overall Study|Lost to Follow-up|18|||
33358344|NCT00630032|101201053|FG001|Overall Study|Lost to Follow-up|31|||
33358345|NCT00630032|101201052|FG000|Overall Study|Protocol Violation|1|||
33358346|NCT00630032|101201053|FG001|Overall Study|Protocol Violation|0|||
33358347|NCT00630032|101201052|FG000|Overall Study|Patient has moved|1|||
33358348|NCT00630032|101201053|FG001|Overall Study|Patient has moved|1|||
33358349|NCT00630032|101201052|FG000|Overall Study|Disease progression|1|||
33358350|NCT00630032|101201053|FG001|Overall Study|Disease progression|1|||
33358351|NCT00630032|101201052|FG000|Overall Study|End of monitoring in US centers|11|||
33358352|NCT00630032|101201053|FG001|Overall Study|End of monitoring in US centers|11|||
33358353|NCT01024244|101201058|FG000|Overall Study|Adverse Event|1|||
33358354|NCT01024244|101201059|FG001|Overall Study|Adverse Event|2|||
33358355|NCT01024244|101201060|FG002|Overall Study|Adverse Event|0|||
33358356|NCT01024244|101201061|FG003|Overall Study|Adverse Event|1|||
33358357|NCT01024244|101201062|FG004|Overall Study|Adverse Event|2|||
33558608|NCT01725308|101941214|FG000|Treatment Period II|Lost to Follow-up|1|||
33558609|NCT01725308|101941215|FG001|Treatment Period II|Lost to Follow-up|5|||
33558610|NCT01725308|101941216|FG002|Treatment Period II|Lost to Follow-up|3|||
33558611|NCT01725308|101941214|FG000|Treatment Period II|Protocol Deviations|0|||
33558612|NCT01725308|101941215|FG001|Treatment Period II|Protocol Deviations|0|||
33558613|NCT01725308|101941216|FG002|Treatment Period II|Protocol Deviations|1|||
33558614|NCT01725308|101941214|FG000|Treatment Period II|Miscellaneous|5|||
33558615|NCT01725308|101941215|FG001|Treatment Period II|Miscellaneous|3|||
33558616|NCT01725308|101941216|FG002|Treatment Period II|Miscellaneous|7|||
33558617|NCT01698905|101941217|FG000|Overall Study|Adverse Event|4|||
33558618|NCT01698905|101941217|FG000|Overall Study|Physician Decision|2|||
33558619|NCT01698905|101941217|FG000|Overall Study|Pregnancy|1|||
33558620|NCT01698905|101941217|FG000|Overall Study|Protocol Violation|1|||
33558621|NCT01698905|101941217|FG000|Overall Study|Subject/guardian decision|2|||
33558622|NCT01698905|101941217|FG000|Overall Study|Death|1|||
33558623|NCT03878069|101941218|FG000|Overall Study|Death|0|||
33558624|NCT03878069|101941219|FG001|Overall Study|Death|1|||
33558625|NCT03878069|101941220|FG002|Overall Study|Death|0|||
33558626|NCT02226653|101941221|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
33558627|NCT02226653|101941222|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
33558628|NCT02226653|101941221|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
33622936|NCT00717249|102169412|FG001|Overall Study|Headaches|0|||
33622937|NCT02763644|102169419|FG000|Overall Study|Patient/guardian decision|1|||
33622938|NCT02763644|102169420|FG001|Overall Study|Patient/guardian decision|0|||
33622939|NCT02763644|102169419|FG000|Overall Study|Death|1|||
33622940|NCT02763644|102169420|FG001|Overall Study|Death|1|||
33622941|NCT02763644|102169419|FG000|Overall Study|Adverse Event|1|||
33622942|NCT02763644|102169420|FG001|Overall Study|Adverse Event|1|||
33622943|NCT02614729|102169421|FG000|Overall Study|Withdrawal by Subject|1|||
33622944|NCT02614729|102169422|FG001|Overall Study|Withdrawal by Subject|0|||
33622945|NCT00887549|102169423|FG000|Induction Therapy|Adverse Event|8|||
33622946|NCT00887549|102169423|FG000|Induction Therapy|Physician Decision|1|||
33622947|NCT00887549|102169423|FG000|Induction Therapy|Progressive Disease|13|||
33622948|NCT00887549|102169423|FG000|Induction Therapy|Death due to Study Disease|4|||
33622949|NCT00887549|102169423|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
33218582|NCT02497287|100696102|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
33358358|NCT01024244|101201058|FG000|Overall Study|Entry Criteria Not Met|0|||
33358359|NCT01024244|101201059|FG001|Overall Study|Entry Criteria Not Met|1|||
33358360|NCT01024244|101201060|FG002|Overall Study|Entry Criteria Not Met|0|||
33358361|NCT01024244|101201061|FG003|Overall Study|Entry Criteria Not Met|0|||
33358362|NCT01024244|101201062|FG004|Overall Study|Entry Criteria Not Met|0|||
33358363|NCT01024244|101201058|FG000|Overall Study|Lack of Efficacy|1|||
33358364|NCT01024244|101201059|FG001|Overall Study|Lack of Efficacy|0|||
33558629|NCT02226653|101941222|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
33558630|NCT02142803|101941228|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
33358365|NCT01024244|101201060|FG002|Overall Study|Lack of Efficacy|0|||
33558631|NCT02142803|101941229|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
33558632|NCT02142803|101941230|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
33558633|NCT02142803|101941231|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
33358366|NCT01024244|101201061|FG003|Overall Study|Lack of Efficacy|0|||
33358367|NCT01024244|101201062|FG004|Overall Study|Lack of Efficacy|0|||
33358368|NCT01024244|101201058|FG000|Overall Study|Protocol Violation|1|||
33358369|NCT01024244|101201059|FG001|Overall Study|Protocol Violation|0|||
33358370|NCT01024244|101201060|FG002|Overall Study|Protocol Violation|0|||
33358371|NCT01024244|101201061|FG003|Overall Study|Protocol Violation|0|||
33358372|NCT01024244|101201062|FG004|Overall Study|Protocol Violation|2|||
33358373|NCT01024244|101201058|FG000|Overall Study|Sponsor Decision|14|||
33358374|NCT01024244|101201059|FG001|Overall Study|Sponsor Decision|7|||
33358375|NCT01024244|101201060|FG002|Overall Study|Sponsor Decision|14|||
33358376|NCT01024244|101201061|FG003|Overall Study|Sponsor Decision|12|||
33358377|NCT01024244|101201062|FG004|Overall Study|Sponsor Decision|10|||
33358378|NCT01024244|101201058|FG000|Overall Study|Withdrawal by Subject|0|||
33218583|NCT02497287|100696102|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
33358379|NCT01024244|101201059|FG001|Overall Study|Withdrawal by Subject|1|||
33414567|NCT03387423|101409831|FG000|Overall Study|Revocation Consent|76|||
33622950|NCT00887549|102169423|FG000|Maintenance Therapy|Adverse Event|16|||
33622951|NCT00887549|102169423|FG000|Maintenance Therapy|Physician Decision|1|||
33622952|NCT00887549|102169423|FG000|Maintenance Therapy|Progressive Disease|25|||
33622953|NCT00887549|102169423|FG000|Maintenance Therapy|Death due to adverse event|1|||
33358380|NCT01024244|101201060|FG002|Overall Study|Withdrawal by Subject|0|||
33218584|NCT02497287|100696102|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
33218585|NCT02497287|100696102|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
33218586|NCT02497287|100696102|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
33218587|NCT02497287|100696102|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
33218588|NCT02497287|100696102|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
33218589|NCT02497287|100696102|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
33218590|NCT02497287|100696102|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
33218591|NCT02497287|100696102|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
33218592|NCT02497287|100696102|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
33218593|NCT02497287|100696102|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
33218594|NCT02497287|100696102|FG000|Follow-up Phase (4 Week)|Other|1|||
33218595|NCT04026165|100696103|FG000|Run-in Placebo Period|Enrollment Error|13|||
33218596|NCT04026165|100696104|FG001|Run-in Placebo Period|Enrollment Error|0|||
33358381|NCT01024244|101201061|FG003|Overall Study|Withdrawal by Subject|0|||
33414568|NCT03387423|101409832|FG001|Overall Study|Revocation Consent|32|||
33622954|NCT03275740|102169424|FG000|Overall Study|Adverse Event|0|||
33358382|NCT01024244|101201062|FG004|Overall Study|Withdrawal by Subject|0|||
33358383|NCT03067311|101201065|FG000|Overall Study|Lost to Follow-up|1|||
33358384|NCT03067311|101201066|FG001|Overall Study|Lost to Follow-up|1|||
33358385|NCT03067311|101201065|FG000|Overall Study|Moved away|1|||
33358386|NCT03067311|101201066|FG001|Overall Study|Moved away|1|||
33358387|NCT00844883|101201069|FG000|Overall Study|Bridged to liver transplant|3|||
33358388|NCT00844883|101201069|FG000|Overall Study|Bridged to resection|1|||
33358389|NCT03517436|101201085|FG000|Overall Study|Death|3|||
33358390|NCT03517436|101201085|FG000|Overall Study|Withdrawal by Subject|4|||
33358391|NCT03517436|101201085|FG000|Overall Study|Did not receive study valve.|1|||
33358392|NCT03019549|101201086|FG000|Washout|DId not meet genotype criteria|11|||
33358393|NCT03019549|101201086|FG000|Period 2|Adverse Event|2|||
33358394|NCT03019549|101201086|FG000|Period 2|Physician Decision|2|||
33358395|NCT03019549|101201086|FG000|Period 2|Withdrawal by Subject|1|||
33558634|NCT04641975|101941232|FG000|Overall Study|Protocol Violation|1|||
33358396|NCT01252966|101201087|FG000|Overall Study|Lost to Follow-up|16|||
33358397|NCT01252966|101201088|FG001|Overall Study|Lost to Follow-up|10|||
33358398|NCT01252966|101201087|FG000|Overall Study|Withdrawal by Subject|7|||
33358399|NCT01252966|101201088|FG001|Overall Study|Withdrawal by Subject|3|||
33358400|NCT04285723|101201089|FG000|Overall Study|Subject decision|1|||
33358401|NCT04285723|101201090|FG001|Overall Study|Subject decision|2|||
33622955|NCT03275740|102169425|FG001|Overall Study|Adverse Event|0|||
33622956|NCT03275740|102169426|FG002|Overall Study|Adverse Event|0|||
33622957|NCT03275740|102169427|FG003|Overall Study|Adverse Event|0|||
33622958|NCT03275740|102169428|FG004|Overall Study|Adverse Event|1|||
33622959|NCT03275740|102169429|FG005|Overall Study|Adverse Event|0|||
33622960|NCT03275740|102169430|FG006|Overall Study|Adverse Event|0|||
33622961|NCT03275740|102169431|FG007|Overall Study|Adverse Event|0|||
33622962|NCT03275740|102169432|FG008|Overall Study|Adverse Event|0|||
33622963|NCT03275740|102169433|FG009|Overall Study|Adverse Event|0|||
33622964|NCT03275740|102169434|FG010|Overall Study|Adverse Event|0|||
33622965|NCT03275740|102169435|FG011|Overall Study|Adverse Event|0|||
33622966|NCT03275740|102169424|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
33622967|NCT03275740|102169425|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
33622968|NCT03275740|102169426|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
33622969|NCT03275740|102169427|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
33622970|NCT03275740|102169428|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
33622971|NCT03275740|102169429|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
33622972|NCT03275740|102169430|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
33622973|NCT03275740|102169431|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
33622974|NCT03275740|102169432|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
33622975|NCT03275740|102169433|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
33622976|NCT03275740|102169434|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
33622977|NCT03275740|102169435|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
33622978|NCT03275740|102169424|FG000|Overall Study|Withdrawal by Subject|0|||
33622979|NCT03275740|102169425|FG001|Overall Study|Withdrawal by Subject|0|||
33622980|NCT03275740|102169426|FG002|Overall Study|Withdrawal by Subject|0|||
33622981|NCT03275740|102169427|FG003|Overall Study|Withdrawal by Subject|0|||
33622982|NCT03275740|102169428|FG004|Overall Study|Withdrawal by Subject|0|||
33622983|NCT03275740|102169429|FG005|Overall Study|Withdrawal by Subject|0|||
33622984|NCT03275740|102169430|FG006|Overall Study|Withdrawal by Subject|0|||
33622985|NCT03275740|102169431|FG007|Overall Study|Withdrawal by Subject|0|||
33622986|NCT03275740|102169432|FG008|Overall Study|Withdrawal by Subject|1|||
33622987|NCT03275740|102169433|FG009|Overall Study|Withdrawal by Subject|1|||
33622988|NCT03275740|102169434|FG010|Overall Study|Withdrawal by Subject|0|||
33622989|NCT03275740|102169435|FG011|Overall Study|Withdrawal by Subject|0|||
33622990|NCT00619515|102169436|FG000|Overall Study|Study Termination by IRB|73|||
33622991|NCT03914417|102169437|FG000|Overall Study|Withdrawal by Subject|2|||
33622992|NCT00154297|102169439|FG000|Overall Study|Death|5|||
33622993|NCT00154297|102169440|FG001|Overall Study|Death|2|||
33622994|NCT00154297|102169439|FG000|Overall Study|Withdrawal by Subject|0|||
33622995|NCT00154297|102169440|FG001|Overall Study|Withdrawal by Subject|5|||
33622996|NCT00154297|102169439|FG000|Overall Study|Lost to Follow-up|3|||
33622997|NCT00154297|102169440|FG001|Overall Study|Lost to Follow-up|0|||
33622998|NCT00255190|102169441|FG000|Overall Study|Adverse Event|17|||
33358402|NCT04285723|101201089|FG000|Overall Study|Physician Decision|1|||
33358403|NCT04285723|101201090|FG001|Overall Study|Physician Decision|0|||
33358404|NCT04285723|101201089|FG000|Overall Study|No efficiency|1|||
33358405|NCT04285723|101201090|FG001|Overall Study|No efficiency|0|||
33358406|NCT03455543|101201092|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
33358407|NCT03455543|101201093|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
33358408|NCT03455543|101201094|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
33358409|NCT03455543|101201092|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
33358410|NCT03455543|101201093|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
33622999|NCT00255190|102169442|FG001|Overall Study|Adverse Event|36|||
33623000|NCT00255190|102169441|FG000|Overall Study|Protocol Violation|2|||
33623001|NCT00255190|102169442|FG001|Overall Study|Protocol Violation|2|||
33623002|NCT00255190|102169441|FG000|Overall Study|Lost to Follow-up|10|||
33623003|NCT00255190|102169442|FG001|Overall Study|Lost to Follow-up|27|||
33623004|NCT00255190|102169441|FG000|Overall Study|Withdrew Consent|17|||
33414569|NCT03387423|101409833|FG002|Overall Study|Revocation Consent|3|||
33623005|NCT00255190|102169442|FG001|Overall Study|Withdrew Consent|48|||
33623006|NCT00255190|102169441|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
33623007|NCT00255190|102169442|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
33623008|NCT00255190|102169441|FG000|Overall Study|Erosive esophagitis not healed|0|||
33623009|NCT00255190|102169442|FG001|Overall Study|Erosive esophagitis not healed|20|||
33218597|NCT04026165|100696105|FG002|Run-in Placebo Period|Enrollment Error|0|||
33558635|NCT04641975|101941233|FG001|Overall Study|Protocol Violation|2|||
33358411|NCT03455543|101201094|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
33558636|NCT04641975|101941234|FG002|Overall Study|Protocol Violation|0|||
33558637|NCT04641975|101941235|FG003|Overall Study|Protocol Violation|0|||
33558638|NCT04641975|101941232|FG000|Overall Study|Adverse Event|0|||
33558639|NCT04641975|101941233|FG001|Overall Study|Adverse Event|0|||
33558640|NCT04641975|101941234|FG002|Overall Study|Adverse Event|1|||
33558641|NCT04641975|101941235|FG003|Overall Study|Adverse Event|1|||
33558642|NCT04641975|101941232|FG000|Overall Study|Withdrawal by Subject|1|||
33358412|NCT03455543|101201092|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
33358413|NCT03455543|101201093|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
33358414|NCT03455543|101201094|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
33358415|NCT03455543|101201092|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
33623010|NCT00255190|102169441|FG000|Overall Study|Various|4|||
33623011|NCT00255190|102169442|FG001|Overall Study|Various|23|||
33623012|NCT04524858|102169443|FG000|Overall Study|Adverse Event|1|||
33623013|NCT02576639|102169450|FG000|Overall Study|Withdrawal by Subject|1|||
33623014|NCT02576639|102169451|FG001|Overall Study|Withdrawal by Subject|2|||
33623015|NCT02576639|102169452|FG002|Overall Study|Withdrawal by Subject|1|||
33623016|NCT02576639|102169453|FG003|Overall Study|Withdrawal by Subject|0|||
33623017|NCT02576639|102169454|FG004|Overall Study|Withdrawal by Subject|1|||
33623018|NCT02576639|102169450|FG000|Overall Study|Adverse Event|1|||
33623019|NCT02576639|102169451|FG001|Overall Study|Adverse Event|0|||
33623020|NCT02576639|102169452|FG002|Overall Study|Adverse Event|1|||
33623021|NCT02576639|102169453|FG003|Overall Study|Adverse Event|1|||
33623022|NCT02576639|102169454|FG004|Overall Study|Adverse Event|2|||
33623023|NCT02576639|102169450|FG000|Overall Study|Physician Decision|0|||
33623024|NCT02576639|102169451|FG001|Overall Study|Physician Decision|0|||
33358416|NCT03455543|101201093|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
33358417|NCT03455543|101201094|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
33358418|NCT03455543|101201092|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
33358419|NCT03455543|101201093|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
33358420|NCT03455543|101201094|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
33358421|NCT03455543|101201092|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
33358422|NCT03455543|101201093|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
33358423|NCT03455543|101201094|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
33358424|NCT03455543|101201092|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
33358425|NCT03455543|101201093|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
33358426|NCT03455543|101201094|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
33358427|NCT03455543|101201092|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
33358428|NCT03455543|101201093|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
33358429|NCT03455543|101201094|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
33358430|NCT03455543|101201092|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
33358431|NCT03455543|101201093|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
33358432|NCT03455543|101201094|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
33358433|NCT00847561|101201097|FG000|Overall Study|Withdrawal by Subject|4|||
33358434|NCT00847561|101201098|FG001|Overall Study|Withdrawal by Subject|3|||
33358435|NCT00847561|101201097|FG000|Overall Study|Unable to schedule|9|||
33358436|NCT00847561|101201098|FG001|Overall Study|Unable to schedule|1|||
33358437|NCT01389128|101201099|FG000|Overall Study|Fetal distress|1|||
33358438|NCT01389128|101201100|FG001|Overall Study|Fetal distress|0|||
33358439|NCT01389128|101201099|FG000|Overall Study|Cervix dilation stop|1|||
33358440|NCT01389128|101201100|FG001|Overall Study|Cervix dilation stop|2|||
33358441|NCT01389128|101201099|FG000|Overall Study|Rapid labor evolution|3|||
33558643|NCT04641975|101941233|FG001|Overall Study|Withdrawal by Subject|0|||
33558644|NCT04641975|101941234|FG002|Overall Study|Withdrawal by Subject|0|||
33623025|NCT02576639|102169452|FG002|Overall Study|Physician Decision|0|||
33623026|NCT02576639|102169453|FG003|Overall Study|Physician Decision|0|||
33623027|NCT02576639|102169454|FG004|Overall Study|Physician Decision|1|||
33558645|NCT04641975|101941235|FG003|Overall Study|Withdrawal by Subject|0|||
33558646|NCT01142388|101941236|FG000|Overall Study|Lack of Efficacy|21|||
33558647|NCT01142388|101941237|FG001|Overall Study|Lack of Efficacy|31|||
33558648|NCT01142388|101941236|FG000|Overall Study|Adverse Event|9|||
33558649|NCT01142388|101941237|FG001|Overall Study|Adverse Event|5|||
33623028|NCT02905266|102169455|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
33623029|NCT02905266|102169456|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
33623030|NCT02905266|102169455|FG000|Treatment Phase Part 1|Disease Progression|6|||
33358442|NCT01389128|101201100|FG001|Overall Study|Rapid labor evolution|2|||
33358443|NCT01389128|101201099|FG000|Overall Study|Intolerance to procedure|0|||
33358444|NCT01389128|101201100|FG001|Overall Study|Intolerance to procedure|2|||
33358445|NCT04407507|101201102|FG000|Overall Study|Withdrawal by Subject|0|||
33358446|NCT04407507|101201103|FG001|Overall Study|Withdrawal by Subject|1|||
33358447|NCT00542815|101201104|FG000|Overall Study|Adverse Event|19|||
33558650|NCT01142388|101941236|FG000|Overall Study|Death|3|||
33558651|NCT01142388|101941237|FG001|Overall Study|Death|2|||
33558652|NCT01142388|101941236|FG000|Overall Study|Withdrawal by Subject|5|||
33623031|NCT02905266|102169456|FG001|Treatment Phase Part 1|Disease Progression|7|||
33623032|NCT02905266|102169455|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
33623033|NCT02905266|102169456|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
33623034|NCT02905266|102169455|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
33623035|NCT02905266|102169456|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
33623036|NCT02905266|102169455|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
33623037|NCT02905266|102169456|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
33623038|NCT02905266|102169455|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
33623039|NCT02905266|102169456|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
33623040|NCT02905266|102169455|FG000|Transition From Part 1 to Part 2|Death|0|||
33623041|NCT02905266|102169456|FG001|Transition From Part 1 to Part 2|Death|1|||
33623042|NCT02905266|102169455|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
33358448|NCT00542815|101201105|FG001|Overall Study|Adverse Event|6|||
33358449|NCT00542815|101201106|FG002|Overall Study|Adverse Event|9|||
33358450|NCT00542815|101201104|FG000|Overall Study|Death|10|||
33358451|NCT00542815|101201105|FG001|Overall Study|Death|7|||
33558653|NCT01142388|101941237|FG001|Overall Study|Withdrawal by Subject|3|||
33558654|NCT01142388|101941236|FG000|Overall Study|Alternative therapy|1|||
33558655|NCT01142388|101941237|FG001|Overall Study|Alternative therapy|0|||
33558656|NCT01142388|101941236|FG000|Overall Study|Other complications|0|||
33358452|NCT00542815|101201106|FG002|Overall Study|Death|3|||
33358453|NCT00542815|101201104|FG000|Overall Study|Lack of Efficacy|9|||
33358454|NCT00542815|101201105|FG001|Overall Study|Lack of Efficacy|2|||
33358455|NCT00542815|101201106|FG002|Overall Study|Lack of Efficacy|0|||
33358456|NCT00542815|101201104|FG000|Overall Study|Physician Decision|2|||
33558657|NCT01142388|101941237|FG001|Overall Study|Other complications|2|||
33358457|NCT00542815|101201105|FG001|Overall Study|Physician Decision|1|||
33358458|NCT00542815|101201106|FG002|Overall Study|Physician Decision|0|||
33358459|NCT00542815|101201104|FG000|Overall Study|Protocol Violation|1|||
33358460|NCT00542815|101201105|FG001|Overall Study|Protocol Violation|1|||
33558658|NCT01142388|101941236|FG000|Overall Study|Other|1|||
33558659|NCT01142388|101941237|FG001|Overall Study|Other|1|||
33358461|NCT00542815|101201106|FG002|Overall Study|Protocol Violation|2|||
33358462|NCT00542815|101201104|FG000|Overall Study|Withdrawal by Subject|41|||
33358463|NCT00542815|101201105|FG001|Overall Study|Withdrawal by Subject|5|||
33358464|NCT00542815|101201106|FG002|Overall Study|Withdrawal by Subject|8|||
33358465|NCT00542815|101201104|FG000|Overall Study|Other reasons|24|||
33358466|NCT00542815|101201105|FG001|Overall Study|Other reasons|10|||
33358467|NCT00542815|101201106|FG002|Overall Study|Other reasons|10|||
33358468|NCT01444391|101201107|FG000|Overall Study|Death|1|||
33358469|NCT01633060|101201108|FG000|Randomization Phase|Protocol deviation|1|||
33358470|NCT01633060|101201109|FG001|Randomization Phase|Protocol deviation|2|||
33358471|NCT01633060|101201108|FG000|Randomization Phase|Technical problem|0|||
33358472|NCT01633060|101201109|FG001|Randomization Phase|Technical problem|1|||
33358473|NCT01633060|101201108|FG000|Treatment Phase|Adverse Event|24|||
33358474|NCT01633060|101201109|FG001|Treatment Phase|Adverse Event|3|||
33358475|NCT01633060|101201108|FG000|Treatment Phase|Lost to Follow-up|1|||
33358476|NCT01633060|101201109|FG001|Treatment Phase|Lost to Follow-up|0|||
33358477|NCT01633060|101201108|FG000|Treatment Phase|Physician Decision|16|||
33358478|NCT01633060|101201109|FG001|Treatment Phase|Physician Decision|7|||
33358479|NCT01633060|101201108|FG000|Treatment Phase|Progressive Disease|210|||
33358480|NCT01633060|101201109|FG001|Treatment Phase|Progressive Disease|120|||
33358481|NCT01633060|101201108|FG000|Treatment Phase|Protocol Deviation|1|||
33358482|NCT01633060|101201109|FG001|Treatment Phase|Protocol Deviation|0|||
33358483|NCT01633060|101201108|FG000|Treatment Phase|Study Terminated by sponsor|7|||
33358484|NCT01633060|101201109|FG001|Treatment Phase|Study Terminated by sponsor|3|||
33358485|NCT01633060|101201108|FG000|Treatment Phase|Subject/guardian decision|25|||
33358486|NCT01633060|101201109|FG001|Treatment Phase|Subject/guardian decision|4|||
33358487|NCT01633060|101201108|FG000|Treatment Phase|Death|4|||
33358488|NCT01633060|101201109|FG001|Treatment Phase|Death|3|||
33358489|NCT01633060|101201108|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
33358490|NCT01633060|101201109|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33358491|NCT01633060|101201108|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
33358492|NCT01633060|101201109|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
33358493|NCT01633060|101201108|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
33358494|NCT01633060|101201109|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
33358495|NCT01633060|101201108|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
33358496|NCT01633060|101201109|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
33358497|NCT01633060|101201108|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
33358498|NCT01633060|101201109|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
33358499|NCT01633060|101201108|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
33358500|NCT01633060|101201109|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
33358501|NCT00231478|101201110|FG000|Overall Study|Protocol Violation|3|||
33558660|NCT01142388|101941236|FG000|Overall Study|Never started therapy|7|||
33558661|NCT01142388|101941237|FG001|Overall Study|Never started therapy|3|||
33558662|NCT04181762|101941238|FG000|Overall Study|Adverse Event|1|||
33558663|NCT04181762|101941239|FG001|Overall Study|Adverse Event|3|||
33558664|NCT04181762|101941238|FG000|Overall Study|Lost to Follow-up|1|||
33558665|NCT04181762|101941239|FG001|Overall Study|Lost to Follow-up|1|||
33558666|NCT04181762|101941238|FG000|Overall Study|Physician Decision|1|||
33558667|NCT04181762|101941239|FG001|Overall Study|Physician Decision|3|||
33558668|NCT04181762|101941238|FG000|Overall Study|Pregnancy|0|||
33558669|NCT04181762|101941239|FG001|Overall Study|Pregnancy|1|||
33558670|NCT04181762|101941238|FG000|Overall Study|Lack of Efficacy|2|||
33623043|NCT02905266|102169456|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
33358502|NCT00231478|101201111|FG001|Overall Study|Protocol Violation|2|||
33358503|NCT00231478|101201110|FG000|Overall Study|Refused Treatment|1|||
33358504|NCT00231478|101201111|FG001|Overall Study|Refused Treatment|1|||
33358505|NCT00231478|101201110|FG000|Overall Study|Withdrawal by Subject|1|||
33558671|NCT04181762|101941239|FG001|Overall Study|Lack of Efficacy|2|||
33558672|NCT04181762|101941238|FG000|Overall Study|Study terminated by sponsor|95|||
33558673|NCT04181762|101941239|FG001|Overall Study|Study terminated by sponsor|97|||
33358506|NCT00231478|101201111|FG001|Overall Study|Withdrawal by Subject|0|||
33358507|NCT00231478|101201110|FG000|Overall Study|Adverse Event|0|||
33358508|NCT00231478|101201111|FG001|Overall Study|Adverse Event|1|||
33358509|NCT00231478|101201110|FG000|Overall Study|Administrative|3|||
33358510|NCT00231478|101201111|FG001|Overall Study|Administrative|2|||
33358511|NCT02990338|101201114|FG000|Overall Study|Ongoing|30|||
33358512|NCT02990338|101201115|FG001|Overall Study|Ongoing|36|||
33358513|NCT02453841|101201116|FG000|Overall Study|Protocol Violation|1|||
33358514|NCT02453841|101201116|FG000|Overall Study|Unable to obtain blood samples|2|||
33358515|NCT00201201|101201119|FG000|Overall Study|Death|0|||
33358516|NCT00201201|101201120|FG001|Overall Study|Death|2|||
33358517|NCT00201201|101201119|FG000|Overall Study|Withdrawal by Subject|5|||
33358518|NCT00201201|101201120|FG001|Overall Study|Withdrawal by Subject|5|||
33358519|NCT01450540|101201123|FG000|Overall Study|Withdrawal by Subject|19|||
33358520|NCT01450540|101201124|FG001|Overall Study|Withdrawal by Subject|13|||
33358521|NCT01450540|101201123|FG000|Overall Study|protocol deviation|3|||
33358522|NCT01450540|101201124|FG001|Overall Study|protocol deviation|23|||
33358523|NCT00308620|101201127|FG000|Overall Study|Death|1|||
33358524|NCT00308620|101201128|FG001|Overall Study|Death|1|||
33358525|NCT00308620|101201129|FG002|Overall Study|Death|0|||
33358526|NCT00308620|101201127|FG000|Overall Study|Lost to Follow-up|0|||
33358527|NCT00308620|101201128|FG001|Overall Study|Lost to Follow-up|0|||
33358528|NCT00308620|101201129|FG002|Overall Study|Lost to Follow-up|1|||
33358529|NCT00707577|101201130|FG000|Overall Study|Withdrawal by Subject|3|||
33358530|NCT00707577|101201131|FG001|Overall Study|Withdrawal by Subject|2|||
33358531|NCT00707577|101201130|FG000|Overall Study|Lost to Follow-up|34|||
33358532|NCT00707577|101201131|FG001|Overall Study|Lost to Follow-up|25|||
33358533|NCT00707577|101201130|FG000|Overall Study|Left employment|13|||
33358534|NCT00707577|101201131|FG001|Overall Study|Left employment|10|||
33358535|NCT00707577|101201130|FG000|Overall Study|Pregnancy|4|||
33358536|NCT00707577|101201131|FG001|Overall Study|Pregnancy|1|||
33358537|NCT01499576|101201132|FG000|Overall Study|Physician Decision|12|||
33358538|NCT01499576|101201132|FG000|Overall Study|Withdrawal by Subject|9|||
33358539|NCT01137435|101201133|FG000|Overall Study|Lost to Follow-up|24|||
33358540|NCT01137435|101201133|FG000|Overall Study|Off label usage|4|||
33358541|NCT03228186|101201138|FG000|Overall Study|Patient never started treatment|1|||
33358542|NCT00500071|101201141|FG000|Screening and Washout Phase|Protocol Violation|1|||
33358543|NCT00500071|101201141|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
33358544|NCT00500071|101201141|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
33358545|NCT00500071|101201141|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
33358546|NCT00500071|101201141|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
33358547|NCT00500071|101201141|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
33358548|NCT00500071|101201141|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
33358549|NCT02088034|101201142|FG000|Overall Study|Lost to Follow-up|1|||
33358550|NCT02088034|101201143|FG001|Overall Study|Lost to Follow-up|1|||
33358551|NCT02088034|101201144|FG002|Overall Study|Lost to Follow-up|0|||
33358552|NCT02088034|101201142|FG000|Overall Study|Pregnancy|2|||
33358553|NCT02088034|101201143|FG001|Overall Study|Pregnancy|1|||
33358554|NCT02088034|101201144|FG002|Overall Study|Pregnancy|2|||
33358555|NCT02586207|101201145|FG000|Overall Study|Physician Decision|1|||
33358556|NCT02586207|101201145|FG000|Overall Study|Withdrawal by Subject|1|||
33358557|NCT01486238|101201146|FG000|Overall Study|Death|0|||
33358558|NCT01486238|101201147|FG001|Overall Study|Death|2|||
33358559|NCT01486238|101201146|FG000|Overall Study|Withdrawal by Subject|2|||
33358560|NCT01486238|101201147|FG001|Overall Study|Withdrawal by Subject|1|||
33358561|NCT01486238|101201146|FG000|Overall Study|Lost to Follow-up|0|||
33358562|NCT01486238|101201147|FG001|Overall Study|Lost to Follow-up|3|||
33358563|NCT03065530|101201153|FG000|Overall Study|Lack of Efficacy|1|||
33358564|NCT03065530|101201154|FG001|Overall Study|Lack of Efficacy|1|||
33358565|NCT03065530|101201155|FG002|Overall Study|Lack of Efficacy|0|||
33358566|NCT03065530|101201156|FG003|Overall Study|Lack of Efficacy|1|||
33358567|NCT03065530|101201153|FG000|Overall Study|Protocol Violation|1|||
33358568|NCT03065530|101201154|FG001|Overall Study|Protocol Violation|0|||
33358569|NCT03065530|101201155|FG002|Overall Study|Protocol Violation|1|||
33358570|NCT03065530|101201156|FG003|Overall Study|Protocol Violation|1|||
33358571|NCT03497689|101201159|FG000|Overall Study|Adverse Event|2|||
33358572|NCT03497689|101201159|FG000|Overall Study|Death|1|||
33358573|NCT03497689|101201159|FG000|Overall Study|Physician Decision|1|||
33358574|NCT03497689|101201159|FG000|Overall Study|Withdrawal by Subject|1|||
33358575|NCT03497689|101201159|FG000|Overall Study|Protocol Violation|2|||
33358576|NCT03443024|101201162|FG000|Overall Study|Adverse Event|2|||
33358577|NCT03443024|101201163|FG001|Overall Study|Adverse Event|4|||
33358578|NCT03443024|101201164|FG002|Overall Study|Adverse Event|3|||
33358579|NCT03443024|101201165|FG003|Overall Study|Adverse Event|1|||
33358580|NCT03443024|101201162|FG000|Overall Study|Lost to Follow-up|9|||
33358581|NCT03443024|101201163|FG001|Overall Study|Lost to Follow-up|9|||
33358582|NCT03443024|101201164|FG002|Overall Study|Lost to Follow-up|7|||
33358583|NCT03443024|101201165|FG003|Overall Study|Lost to Follow-up|5|||
33358584|NCT03443024|101201162|FG000|Overall Study|Withdrawal by Subject|8|||
33358585|NCT03443024|101201163|FG001|Overall Study|Withdrawal by Subject|15|||
33623044|NCT02905266|102169455|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
33623045|NCT02905266|102169456|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
33623046|NCT02905266|102169455|FG000|Maintenance Phase Part 2|Disease Progression|9|||
33623047|NCT02905266|102169456|FG001|Maintenance Phase Part 2|Disease Progression|2|||
33623048|NCT02905266|102169455|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
33623049|NCT02905266|102169456|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
33623050|NCT02905266|102169455|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
33623051|NCT02905266|102169456|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
33623052|NCT03369418|102169457|FG000|Overall Study|Withdrawal by Subject|3|||
33623053|NCT03369418|102169458|FG001|Overall Study|Withdrawal by Subject|3|||
33623054|NCT01601535|102169461|FG000|Phase 1|Adverse Event|1|||
33558674|NCT04181762|101941238|FG000|Overall Study|Subject decision|11|||
33558675|NCT04181762|101941239|FG001|Overall Study|Subject decision|4|||
33558676|NCT04181762|101941238|FG000|Overall Study|Death|1|||
33558677|NCT04181762|101941239|FG001|Overall Study|Death|1|||
33558678|NCT04181762|101941238|FG000|Overall Study|Protocol deviation|1|||
33558679|NCT04181762|101941239|FG001|Overall Study|Protocol deviation|0|||
33558680|NCT04181762|101941238|FG000|Overall Study|Withdrawal of informed consent|1|||
33558681|NCT04181762|101941239|FG001|Overall Study|Withdrawal of informed consent|3|||
33558682|NCT00792948|101941244|FG000|Overall Study|Adverse Event|6|||
33558683|NCT00792948|101941244|FG000|Overall Study|Death|4|||
33558684|NCT00792948|101941244|FG000|Overall Study|Withdrawal by Subject|3|||
33558685|NCT00792948|101941244|FG000|Overall Study|Ineligible|2|||
33558686|NCT00792948|101941244|FG000|Overall Study|Insurance denial - not treated|1|||
33558687|NCT00792948|101941244|FG000|Overall Study|Physician Decision|11|||
33558688|NCT00792948|101941244|FG000|Overall Study|Protocol Violation|1|||
33558689|NCT00292370|101941246|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
33558690|NCT00292370|101941247|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
33558691|NCT00292370|101941248|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
33558692|NCT00292370|101941246|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
33558693|NCT00292370|101941247|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
33558694|NCT00292370|101941248|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
33558695|NCT00292370|101941246|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
33558696|NCT00292370|101941247|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
33558697|NCT00292370|101941248|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
33558698|NCT00292370|101941246|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
33623055|NCT01601535|102169462|FG001|Phase 1|Adverse Event|0|||
33358586|NCT03443024|101201164|FG002|Overall Study|Withdrawal by Subject|9|||
33358587|NCT03443024|101201165|FG003|Overall Study|Withdrawal by Subject|23|||
33358588|NCT03443024|101201162|FG000|Overall Study|Physician Decision|1|||
33358589|NCT03443024|101201163|FG001|Overall Study|Physician Decision|2|||
33358590|NCT03443024|101201164|FG002|Overall Study|Physician Decision|0|||
33358591|NCT03443024|101201165|FG003|Overall Study|Physician Decision|1|||
33358592|NCT03443024|101201162|FG000|Overall Study|Sponsor Decision|1|||
33358593|NCT03443024|101201163|FG001|Overall Study|Sponsor Decision|1|||
33358594|NCT03443024|101201164|FG002|Overall Study|Sponsor Decision|0|||
33358595|NCT03443024|101201165|FG003|Overall Study|Sponsor Decision|0|||
33358596|NCT03443024|101201162|FG000|Overall Study|Protocol Deviation|0|||
33358597|NCT03443024|101201163|FG001|Overall Study|Protocol Deviation|0|||
33358598|NCT03443024|101201164|FG002|Overall Study|Protocol Deviation|0|||
33358599|NCT03443024|101201165|FG003|Overall Study|Protocol Deviation|2|||
33358600|NCT04538950|101201166|FG000|Overall Study|Pulmonary Issues|2|||
33358601|NCT04538950|101201166|FG000|Overall Study|illness|2|||
33358602|NCT03694522|101201167|FG000|Overall Study|Withdrawal by Subject|8|||
33358603|NCT03694522|101201168|FG001|Overall Study|Withdrawal by Subject|10|||
33358604|NCT03694522|101201167|FG000|Overall Study|Physician Decision|53|||
33358605|NCT03694522|101201168|FG001|Overall Study|Physician Decision|54|||
33358606|NCT03694522|101201167|FG000|Overall Study|Other|1|||
33414570|NCT03387423|101409834|FG003|Overall Study|Revocation Consent|5|||
33558699|NCT00292370|101941247|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
33558700|NCT00292370|101941248|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
33623056|NCT01601535|102169463|FG002|Phase 1|Adverse Event|2|||
33623057|NCT01601535|102169464|FG003|Phase 1|Adverse Event|1|||
33623058|NCT01601535|102169465|FG004|Phase 1|Adverse Event|0|||
33623059|NCT01601535|102169466|FG005|Phase 1|Adverse Event|0|||
33358607|NCT03694522|101201168|FG001|Overall Study|Other|1|||
33358608|NCT03694522|101201167|FG000|Overall Study|Lost to Follow-up|0|||
33358609|NCT03694522|101201168|FG001|Overall Study|Lost to Follow-up|1|||
33358610|NCT04332419|101201178|FG000|Overall Study|Withdrawal by Subject|1|||
33358611|NCT00624338|101201179|FG000|Overall Study|Adverse Event|14|||
33358612|NCT00624338|101201180|FG001|Overall Study|Adverse Event|14|||
33358613|NCT00624338|101201181|FG002|Overall Study|Adverse Event|18|||
33358614|NCT00624338|101201179|FG000|Overall Study|Lost to Follow-up|1|||
33558701|NCT00292370|101941246|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
33558702|NCT00292370|101941247|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
33623060|NCT01601535|102169461|FG000|Phase 1|Withdrawal by Subject|2|||
33623061|NCT01601535|102169462|FG001|Phase 1|Withdrawal by Subject|1|||
33623062|NCT01601535|102169463|FG002|Phase 1|Withdrawal by Subject|1|||
33623063|NCT01601535|102169464|FG003|Phase 1|Withdrawal by Subject|2|||
33623064|NCT01601535|102169465|FG004|Phase 1|Withdrawal by Subject|0|||
33623065|NCT01601535|102169466|FG005|Phase 1|Withdrawal by Subject|0|||
33623066|NCT01601535|102169461|FG000|Phase 1|Progressive Disease|2|||
33623067|NCT01601535|102169462|FG001|Phase 1|Progressive Disease|3|||
33623068|NCT01601535|102169463|FG002|Phase 1|Progressive Disease|2|||
33623069|NCT01601535|102169464|FG003|Phase 1|Progressive Disease|1|||
33623070|NCT01601535|102169465|FG004|Phase 1|Progressive Disease|0|||
33623071|NCT01601535|102169466|FG005|Phase 1|Progressive Disease|0|||
33623072|NCT01601535|102169461|FG000|Phase 1|Started Another Treatment|1|||
33623073|NCT01601535|102169462|FG001|Phase 1|Started Another Treatment|2|||
33623074|NCT01601535|102169463|FG002|Phase 1|Started Another Treatment|0|||
33623075|NCT01601535|102169464|FG003|Phase 1|Started Another Treatment|0|||
33414571|NCT03409328|101409835|FG000|Overall Study|Lost to Follow-up|6|||
33623076|NCT01601535|102169465|FG004|Phase 1|Started Another Treatment|0|||
33623077|NCT01601535|102169466|FG005|Phase 1|Started Another Treatment|0|||
33623078|NCT01601535|102169461|FG000|Phase 2|Adverse Event|0|||
33623079|NCT01601535|102169462|FG001|Phase 2|Adverse Event|0|||
33623080|NCT01601535|102169463|FG002|Phase 2|Adverse Event|0|||
33623081|NCT01601535|102169464|FG003|Phase 2|Adverse Event|0|||
33623082|NCT01601535|102169465|FG004|Phase 2|Adverse Event|5|||
33623083|NCT01601535|102169466|FG005|Phase 2|Adverse Event|1|||
33623084|NCT01601535|102169461|FG000|Phase 2|Withdrawal by Subject|0|||
33623085|NCT01601535|102169462|FG001|Phase 2|Withdrawal by Subject|0|||
33623086|NCT01601535|102169463|FG002|Phase 2|Withdrawal by Subject|0|||
33623087|NCT01601535|102169464|FG003|Phase 2|Withdrawal by Subject|0|||
33623088|NCT01601535|102169465|FG004|Phase 2|Withdrawal by Subject|8|||
33623089|NCT01601535|102169466|FG005|Phase 2|Withdrawal by Subject|2|||
33623090|NCT01601535|102169461|FG000|Phase 2|Progressive Disease|0|||
33623091|NCT01601535|102169462|FG001|Phase 2|Progressive Disease|0|||
33623092|NCT01601535|102169463|FG002|Phase 2|Progressive Disease|0|||
33623093|NCT01601535|102169464|FG003|Phase 2|Progressive Disease|0|||
33623094|NCT01601535|102169465|FG004|Phase 2|Progressive Disease|5|||
33623095|NCT01601535|102169466|FG005|Phase 2|Progressive Disease|7|||
33623096|NCT01601535|102169461|FG000|Phase 2|Started Another Treatment|0|||
33623097|NCT01601535|102169462|FG001|Phase 2|Started Another Treatment|0|||
33623098|NCT01601535|102169463|FG002|Phase 2|Started Another Treatment|0|||
33623099|NCT01601535|102169464|FG003|Phase 2|Started Another Treatment|0|||
33623100|NCT01601535|102169465|FG004|Phase 2|Started Another Treatment|1|||
33623101|NCT01601535|102169466|FG005|Phase 2|Started Another Treatment|2|||
33623102|NCT02913482|102169467|FG000|Overall Study|Death|0|||
33623103|NCT02913482|102169468|FG001|Overall Study|Death|2|||
33623104|NCT02913482|102169469|FG002|Overall Study|Death|2|||
33623105|NCT02913482|102169467|FG000|Overall Study|Progressive Disease|1|||
33623106|NCT02913482|102169468|FG001|Overall Study|Progressive Disease|1|||
33623107|NCT02913482|102169469|FG002|Overall Study|Progressive Disease|1|||
33623108|NCT02913482|102169467|FG000|Overall Study|Reason not specified|0|||
33623109|NCT02913482|102169468|FG001|Overall Study|Reason not specified|0|||
33623110|NCT02913482|102169469|FG002|Overall Study|Reason not specified|1|||
33623111|NCT02913482|102169467|FG000|Overall Study|Withdrawal by Subject|0|||
33623112|NCT02913482|102169468|FG001|Overall Study|Withdrawal by Subject|1|||
33623113|NCT02913482|102169469|FG002|Overall Study|Withdrawal by Subject|1|||
33558703|NCT00292370|101941248|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
33558704|NCT00292370|101941246|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
33558705|NCT00292370|101941247|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
33558706|NCT00292370|101941248|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
33558707|NCT03033576|101941249|FG000|Overall Study|Ineligible|1|||
33558708|NCT03033576|101941250|FG001|Overall Study|Ineligible|1|||
33558709|NCT03033576|101941249|FG000|Overall Study|Adverse Event|4|||
33558710|NCT03033576|101941250|FG001|Overall Study|Adverse Event|20|||
33558711|NCT03033576|101941249|FG000|Overall Study|Progression/relapse|9|||
33558712|NCT03033576|101941250|FG001|Overall Study|Progression/relapse|36|||
33558713|NCT03033576|101941249|FG000|Overall Study|Death|1|||
33558714|NCT03033576|101941250|FG001|Overall Study|Death|1|||
33558715|NCT03033576|101941249|FG000|Overall Study|Patient refusal|1|||
33558716|NCT03033576|101941250|FG001|Overall Study|Patient refusal|6|||
33558717|NCT03033576|101941249|FG000|Overall Study|Other, unspecified reasons|0|||
33558718|NCT03033576|101941250|FG001|Overall Study|Other, unspecified reasons|4|||
33558719|NCT03033576|101941249|FG000|Overall Study|Currently on protocol therapy|0|||
33558720|NCT03033576|101941250|FG001|Overall Study|Currently on protocol therapy|2|||
33558721|NCT01385995|101941251|FG000|Period 1, 2 Months|Physician Decision|1|||
33558722|NCT01385995|101941252|FG001|Period 1, 2 Months|Physician Decision|0|||
33558723|NCT02021318|101941260|FG000|Overall Study|Adverse Event|2|||
33623114|NCT03259555|102169472|FG000|Overall Study|Adverse Event|6|||
33558724|NCT02021318|101941261|FG001|Overall Study|Adverse Event|1|||
33623115|NCT03259555|102169473|FG001|Overall Study|Adverse Event|4|||
33623116|NCT03259555|102169472|FG000|Overall Study|Lack of Efficacy|6|||
33623117|NCT03259555|102169473|FG001|Overall Study|Lack of Efficacy|4|||
33623118|NCT03259555|102169472|FG000|Overall Study|Lost to Follow-up|0|||
33623119|NCT03259555|102169473|FG001|Overall Study|Lost to Follow-up|2|||
33623120|NCT03259555|102169472|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33623121|NCT03259555|102169473|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33623122|NCT03259555|102169472|FG000|Overall Study|Progressive Disease|0|||
33558725|NCT02021318|101941260|FG000|Overall Study|Death|33|||
33218598|NCT04026165|100696106|FG003|Run-in Placebo Period|Enrollment Error|0|||
33218599|NCT04026165|100696103|FG000|Run-in Placebo Period|Run-in Failure|4|||
33558726|NCT02021318|101941261|FG001|Overall Study|Death|34|||
33558727|NCT02021318|101941260|FG000|Overall Study|Lost to Follow-up|3|||
33558728|NCT02021318|101941261|FG001|Overall Study|Lost to Follow-up|3|||
33558729|NCT02021318|101941260|FG000|Overall Study|Progressive Disease|0|||
33558730|NCT02021318|101941261|FG001|Overall Study|Progressive Disease|1|||
33558731|NCT02021318|101941260|FG000|Overall Study|Withdrawal by Subject|30|||
33558732|NCT02021318|101941261|FG001|Overall Study|Withdrawal by Subject|18|||
33558733|NCT02021318|101941260|FG000|Overall Study|Physician Decision|3|||
33558734|NCT02021318|101941261|FG001|Overall Study|Physician Decision|3|||
33558735|NCT02021318|101941260|FG000|Overall Study|Miscellaneous|2|||
33558736|NCT02021318|101941261|FG001|Overall Study|Miscellaneous|3|||
33558737|NCT02761057|101941262|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
33558738|NCT02761057|101941263|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
33558739|NCT02761057|101941264|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
33558740|NCT02761057|101941265|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
33558741|NCT02761057|101941262|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
33558742|NCT02761057|101941263|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
33558743|NCT02761057|101941264|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
33558744|NCT02761057|101941265|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
33558745|NCT02761057|101941262|FG000|Overall Study|Currently On Study Treatment|0|||
33558746|NCT02761057|101941263|FG001|Overall Study|Currently On Study Treatment|3|||
33558747|NCT02761057|101941264|FG002|Overall Study|Currently On Study Treatment|0|||
33558748|NCT02761057|101941265|FG003|Overall Study|Currently On Study Treatment|0|||
33558749|NCT02761057|101941262|FG000|Overall Study|Adverse Event|11|||
33558750|NCT02761057|101941263|FG001|Overall Study|Adverse Event|9|||
33558751|NCT02761057|101941264|FG002|Overall Study|Adverse Event|5|||
33558752|NCT02761057|101941265|FG003|Overall Study|Adverse Event|3|||
33558753|NCT02761057|101941262|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
33558754|NCT02761057|101941263|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
33558755|NCT02761057|101941264|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
33558756|NCT02761057|101941265|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
33558757|NCT02761057|101941262|FG000|Overall Study|Progression/Relapse|29|||
33558758|NCT02761057|101941263|FG001|Overall Study|Progression/Relapse|27|||
33623123|NCT03259555|102169473|FG001|Overall Study|Progressive Disease|2|||
33218600|NCT04026165|100696104|FG001|Run-in Placebo Period|Run-in Failure|0|||
33414572|NCT03409328|101409836|FG001|Overall Study|Lost to Follow-up|3|||
33558759|NCT02761057|101941264|FG002|Overall Study|Progression/Relapse|20|||
33558760|NCT02761057|101941265|FG003|Overall Study|Progression/Relapse|23|||
33558761|NCT02761057|101941262|FG000|Overall Study|Death|2|||
33558762|NCT02761057|101941263|FG001|Overall Study|Death|2|||
33558763|NCT02761057|101941264|FG002|Overall Study|Death|1|||
33558764|NCT02761057|101941265|FG003|Overall Study|Death|1|||
33558765|NCT02761057|101941262|FG000|Overall Study|Other - Not Protocol Specified|2|||
33558766|NCT02761057|101941263|FG001|Overall Study|Other - Not Protocol Specified|1|||
33218601|NCT04026165|100696105|FG002|Run-in Placebo Period|Run-in Failure|0|||
33623124|NCT03259555|102169472|FG000|Overall Study|Withdrawal by Subject|19|||
33623125|NCT03259555|102169473|FG001|Overall Study|Withdrawal by Subject|16|||
33623126|NCT03259555|102169472|FG000|Overall Study|Physician Decision|1|||
33623127|NCT03259555|102169473|FG001|Overall Study|Physician Decision|2|||
33623128|NCT03259555|102169472|FG000|Overall Study|Other|1|||
33623129|NCT03259555|102169473|FG001|Overall Study|Other|0|||
33623130|NCT02260934|102169476|FG000|Overall Study|Lost to Follow-up|2|||
33623131|NCT02260934|102169477|FG001|Overall Study|Lost to Follow-up|1|||
33623132|NCT02260934|102169476|FG000|Overall Study|Withdrawal by Subject|0|||
33218602|NCT04026165|100696106|FG003|Run-in Placebo Period|Run-in Failure|0|||
33218603|NCT04026165|100696103|FG000|Run-in Placebo Period|Protocol Violation|2|||
33558767|NCT02761057|101941264|FG002|Overall Study|Other - Not Protocol Specified|2|||
33558768|NCT02761057|101941265|FG003|Overall Study|Other - Not Protocol Specified|0|||
33558769|NCT00986102|101941266|FG000|Overall Study|Lost to Follow-up|0|||
33558770|NCT00986102|101941267|FG001|Overall Study|Lost to Follow-up|1|||
33558771|NCT00986102|101941268|FG002|Overall Study|Lost to Follow-up|0|||
33558772|NCT00986102|101941269|FG003|Overall Study|Lost to Follow-up|1|||
33558773|NCT00986102|101941266|FG000|Overall Study|Withdrawal by Subject|1|||
33558774|NCT00986102|101941267|FG001|Overall Study|Withdrawal by Subject|1|||
33623133|NCT02260934|102169477|FG001|Overall Study|Withdrawal by Subject|2|||
33218604|NCT04026165|100696104|FG001|Run-in Placebo Period|Protocol Violation|0|||
33218605|NCT04026165|100696105|FG002|Run-in Placebo Period|Protocol Violation|0|||
33218606|NCT04026165|100696106|FG003|Run-in Placebo Period|Protocol Violation|0|||
33218607|NCT04026165|100696103|FG000|Run-in Placebo Period|Withdrew Consent|2|||
33218608|NCT04026165|100696104|FG001|Run-in Placebo Period|Withdrew Consent|0|||
33218609|NCT04026165|100696105|FG002|Run-in Placebo Period|Withdrew Consent|0|||
33218610|NCT04026165|100696106|FG003|Run-in Placebo Period|Withdrew Consent|0|||
33358615|NCT00624338|101201180|FG001|Overall Study|Lost to Follow-up|0|||
33358616|NCT00624338|101201181|FG002|Overall Study|Lost to Follow-up|0|||
33358617|NCT00624338|101201179|FG000|Overall Study|Lack of Efficacy|11|||
33358618|NCT00624338|101201180|FG001|Overall Study|Lack of Efficacy|3|||
33358619|NCT00624338|101201181|FG002|Overall Study|Lack of Efficacy|14|||
33358620|NCT00624338|101201179|FG000|Overall Study|Protocol Violation|3|||
33358621|NCT00624338|101201180|FG001|Overall Study|Protocol Violation|3|||
33358622|NCT00624338|101201181|FG002|Overall Study|Protocol Violation|2|||
33358623|NCT00624338|101201179|FG000|Overall Study|Death|0|||
33358624|NCT00624338|101201180|FG001|Overall Study|Death|2|||
33358625|NCT00624338|101201181|FG002|Overall Study|Death|0|||
33358626|NCT00624338|101201179|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
33358627|NCT00624338|101201180|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
33358628|NCT00624338|101201181|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
33358629|NCT00624338|101201179|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
33358630|NCT00624338|101201180|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
33358631|NCT00624338|101201181|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
33358632|NCT00624338|101201179|FG000|Overall Study|Other|15|||
33358633|NCT00624338|101201180|FG001|Overall Study|Other|5|||
33358634|NCT00624338|101201181|FG002|Overall Study|Other|9|||
33358635|NCT00624338|101201179|FG000|Overall Study|Randomized but not treated|2|||
33358636|NCT00624338|101201180|FG001|Overall Study|Randomized but not treated|1|||
33358637|NCT00624338|101201181|FG002|Overall Study|Randomized but not treated|3|||
33358638|NCT01901328|101201182|FG000|Overall Study|Lost to Follow-up|1|||
33358639|NCT01901328|101201183|FG001|Overall Study|Lost to Follow-up|0|||
33558775|NCT00986102|101941268|FG002|Overall Study|Withdrawal by Subject|0|||
33623134|NCT02260934|102169476|FG000|Overall Study|Participant Relocated|1|||
33623135|NCT02260934|102169477|FG001|Overall Study|Participant Relocated|0|||
33623136|NCT02260934|102169476|FG000|Overall Study|Site error|0|||
33623137|NCT02260934|102169477|FG001|Overall Study|Site error|1|||
33623138|NCT02919761|102169478|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
33358640|NCT01901328|101201182|FG000|Overall Study|Physician Decision|0|||
33358641|NCT01901328|101201183|FG001|Overall Study|Physician Decision|1|||
33623139|NCT02919761|102169479|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
33623140|NCT02919761|102169480|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
33358642|NCT01901328|101201182|FG000|Overall Study|Protocol Violation|1|||
33358643|NCT01901328|101201183|FG001|Overall Study|Protocol Violation|1|||
33358644|NCT01901328|101201182|FG000|Overall Study|Study Terminated by Sponsor|19|||
33558776|NCT00986102|101941269|FG003|Overall Study|Withdrawal by Subject|0|||
33623141|NCT02919761|102169478|FG000|Part 1: Open Label|Adverse Event|1|||
33358645|NCT01901328|101201183|FG001|Overall Study|Study Terminated by Sponsor|16|||
33358646|NCT01901328|101201182|FG000|Overall Study|Withdrawal by Subject|1|||
33358647|NCT01901328|101201183|FG001|Overall Study|Withdrawal by Subject|2|||
33358648|NCT01901328|101201182|FG000|Overall Study|Lack of Efficacy|0|||
33558777|NCT03596983|101941271|FG000|Overall Study|Withdrawal by Subject|3|||
33558778|NCT02268851|101941275|FG000|Overall Study|Death|0|||
33558779|NCT02268851|101941276|FG001|Overall Study|Death|0|||
33218611|NCT04026165|100696103|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
33218612|NCT04026165|100696104|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
33218613|NCT04026165|100696105|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
33218614|NCT04026165|100696106|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
33218615|NCT04026165|100696103|FG000|Run-in SEL Period|Run-in Failure|0|||
33218616|NCT04026165|100696104|FG001|Run-in SEL Period|Run-in Failure|26|||
33218617|NCT04026165|100696105|FG002|Run-in SEL Period|Run-in Failure|0|||
33218618|NCT04026165|100696106|FG003|Run-in SEL Period|Run-in Failure|0|||
33218619|NCT04026165|100696103|FG000|Run-in SEL Period|Withdrew Consent|0|||
33218620|NCT04026165|100696104|FG001|Run-in SEL Period|Withdrew Consent|10|||
33218621|NCT04026165|100696105|FG002|Run-in SEL Period|Withdrew Consent|0|||
33218622|NCT04026165|100696106|FG003|Run-in SEL Period|Withdrew Consent|0|||
33623142|NCT02919761|102169479|FG001|Part 1: Open Label|Adverse Event|0|||
33623143|NCT02919761|102169480|FG002|Part 1: Open Label|Adverse Event|0|||
33623144|NCT02919761|102169478|FG000|Part 1: Open Label|Lost to Follow-up|1|||
33623145|NCT02919761|102169479|FG001|Part 1: Open Label|Lost to Follow-up|0|||
33623146|NCT02919761|102169480|FG002|Part 1: Open Label|Lost to Follow-up|0|||
33623147|NCT02919761|102169478|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
33623148|NCT02919761|102169479|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
33623149|NCT02919761|102169480|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
33623150|NCT02919761|102169478|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
33623151|NCT02919761|102169479|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
33623152|NCT02919761|102169480|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
33623153|NCT02919761|102169478|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
33623154|NCT02919761|102169479|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
33623155|NCT02919761|102169480|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
33623156|NCT02919761|102169478|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
33623157|NCT02919761|102169479|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
33623158|NCT02919761|102169480|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
33623159|NCT02919761|102169478|FG000|Part 1: Open Label|Termination by Sponsor|1|||
33623160|NCT02919761|102169479|FG001|Part 1: Open Label|Termination by Sponsor|0|||
33623161|NCT02919761|102169480|FG002|Part 1: Open Label|Termination by Sponsor|0|||
33623162|NCT02919761|102169478|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
33623163|NCT02919761|102169479|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
33623164|NCT02919761|102169480|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
33623165|NCT02919761|102169478|FG000|Part 2: Double-blind|Adverse Event|0|||
33623166|NCT02919761|102169479|FG001|Part 2: Double-blind|Adverse Event|1|||
33623167|NCT02919761|102169480|FG002|Part 2: Double-blind|Adverse Event|0|||
33623168|NCT02919761|102169478|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
33623169|NCT02919761|102169479|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
33623170|NCT02919761|102169480|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
33623171|NCT02919761|102169478|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
33623172|NCT02919761|102169479|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
33623173|NCT02919761|102169480|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
33623174|NCT02919761|102169478|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
33623175|NCT02919761|102169479|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
33623176|NCT02919761|102169480|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
33623177|NCT02919761|102169478|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
33623178|NCT02919761|102169479|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
33623179|NCT02919761|102169480|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
33623180|NCT02919761|102169478|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
33623181|NCT02919761|102169479|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
33623182|NCT02919761|102169480|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
33623183|NCT02919761|102169478|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
33218623|NCT04026165|100696103|FG000|Run-in SEL Period|Enrollment Error|0|||
33218624|NCT04026165|100696104|FG001|Run-in SEL Period|Enrollment Error|4|||
33358649|NCT01901328|101201183|FG001|Overall Study|Lack of Efficacy|1|||
33358650|NCT01845077|101201188|FG000|Washout Period|Lost to Follow-up|0|||
33358651|NCT01845077|101201189|FG001|Washout Period|Lost to Follow-up|1|||
33358652|NCT01845077|101201190|FG002|Washout Period|Lost to Follow-up|0|||
33358653|NCT01845077|101201191|FG003|Washout Period|Lost to Follow-up|1|||
33623184|NCT02919761|102169479|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
33623185|NCT02919761|102169480|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
33623186|NCT04393493|102169481|FG000|First 4 Days of Intervention|Early improvement|5|||
33623187|NCT04393493|102169482|FG001|First 4 Days of Intervention|Early improvement|7|||
33623188|NCT02210000|102169484|FG000|Overall Study|Study Terminated|11|||
33623189|NCT02210000|102169485|FG001|Overall Study|Study Terminated|12|||
33623190|NCT02210000|102169484|FG000|Overall Study|Withdrawal by Subject|7|||
33623191|NCT02210000|102169485|FG001|Overall Study|Withdrawal by Subject|1|||
33623192|NCT02210000|102169484|FG000|Overall Study|Adverse Event|1|||
33623193|NCT02210000|102169485|FG001|Overall Study|Adverse Event|5|||
33623194|NCT02210000|102169484|FG000|Overall Study|Lost to Follow-up|0|||
33623195|NCT02210000|102169485|FG001|Overall Study|Lost to Follow-up|2|||
33218625|NCT04026165|100696105|FG002|Run-in SEL Period|Enrollment Error|0|||
33558780|NCT02268851|101941277|FG002|Overall Study|Death|0|||
33558781|NCT02268851|101941278|FG003|Overall Study|Death|1|||
33558782|NCT02268851|101941279|FG004|Overall Study|Death|2|||
33558783|NCT02268851|101941280|FG005|Overall Study|Death|1|||
33558784|NCT02268851|101941275|FG000|Overall Study|Adverse Event|0|||
33358654|NCT01845077|101201192|FG004|Washout Period|Lost to Follow-up|0|||
33218626|NCT04026165|100696106|FG003|Run-in SEL Period|Enrollment Error|0|||
33218627|NCT04026165|100696103|FG000|Run-in SEL Period|Protocol Violation|0|||
33218628|NCT04026165|100696104|FG001|Run-in SEL Period|Protocol Violation|3|||
33218629|NCT04026165|100696105|FG002|Run-in SEL Period|Protocol Violation|0|||
33218630|NCT04026165|100696106|FG003|Run-in SEL Period|Protocol Violation|0|||
33218631|NCT04026165|100696103|FG000|Run-in SEL Period|Investigator's Discretion|0|||
33218632|NCT04026165|100696104|FG001|Run-in SEL Period|Investigator's Discretion|2|||
33218633|NCT04026165|100696105|FG002|Run-in SEL Period|Investigator's Discretion|0|||
33218634|NCT04026165|100696106|FG003|Run-in SEL Period|Investigator's Discretion|0|||
33218635|NCT04026165|100696103|FG000|Run-in SEL Period|Death|0|||
33218636|NCT04026165|100696104|FG001|Run-in SEL Period|Death|1|||
33358655|NCT01845077|101201193|FG005|Washout Period|Lost to Follow-up|1|||
33358656|NCT01845077|101201188|FG000|Washout Period|Adverse Event|1|||
33358657|NCT01845077|101201189|FG001|Washout Period|Adverse Event|0|||
33358658|NCT01845077|101201190|FG002|Washout Period|Adverse Event|0|||
33358659|NCT01845077|101201191|FG003|Washout Period|Adverse Event|0|||
33358660|NCT01845077|101201192|FG004|Washout Period|Adverse Event|0|||
33358661|NCT01845077|101201193|FG005|Washout Period|Adverse Event|0|||
33558785|NCT02268851|101941276|FG001|Overall Study|Adverse Event|0|||
33558786|NCT02268851|101941277|FG002|Overall Study|Adverse Event|0|||
33558787|NCT02268851|101941278|FG003|Overall Study|Adverse Event|0|||
33558788|NCT02268851|101941279|FG004|Overall Study|Adverse Event|2|||
33558789|NCT02268851|101941280|FG005|Overall Study|Adverse Event|2|||
33558790|NCT02268851|101941275|FG000|Overall Study|Withdrawal by Subject|0|||
33558791|NCT02268851|101941276|FG001|Overall Study|Withdrawal by Subject|0|||
33558792|NCT02268851|101941277|FG002|Overall Study|Withdrawal by Subject|0|||
33558793|NCT02268851|101941278|FG003|Overall Study|Withdrawal by Subject|2|||
33558794|NCT02268851|101941279|FG004|Overall Study|Withdrawal by Subject|0|||
33558795|NCT02268851|101941280|FG005|Overall Study|Withdrawal by Subject|1|||
33558796|NCT02268851|101941275|FG000|Overall Study|Progressive Disease|1|||
33558797|NCT02268851|101941276|FG001|Overall Study|Progressive Disease|3|||
33558798|NCT02268851|101941277|FG002|Overall Study|Progressive Disease|0|||
33558799|NCT02268851|101941278|FG003|Overall Study|Progressive Disease|0|||
33558800|NCT02268851|101941279|FG004|Overall Study|Progressive Disease|1|||
33558801|NCT02268851|101941280|FG005|Overall Study|Progressive Disease|4|||
33558802|NCT02268851|101941275|FG000|Overall Study|Physician Decision|0|||
33558803|NCT02268851|101941276|FG001|Overall Study|Physician Decision|0|||
33558804|NCT02268851|101941277|FG002|Overall Study|Physician Decision|1|||
33558805|NCT02268851|101941278|FG003|Overall Study|Physician Decision|0|||
33558806|NCT02268851|101941279|FG004|Overall Study|Physician Decision|0|||
33558807|NCT02268851|101941280|FG005|Overall Study|Physician Decision|1|||
33558808|NCT02268851|101941275|FG000|Overall Study|Patient Compliance|0|||
33558809|NCT02268851|101941276|FG001|Overall Study|Patient Compliance|0|||
33558810|NCT02268851|101941277|FG002|Overall Study|Patient Compliance|0|||
33558811|NCT02268851|101941278|FG003|Overall Study|Patient Compliance|0|||
33558812|NCT02268851|101941279|FG004|Overall Study|Patient Compliance|1|||
33558813|NCT02268851|101941280|FG005|Overall Study|Patient Compliance|1|||
33558814|NCT02268851|101941275|FG000|Overall Study|Co-Morbid Condition|0|||
33558815|NCT02268851|101941276|FG001|Overall Study|Co-Morbid Condition|0|||
33358662|NCT01845077|101201188|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
33558816|NCT02268851|101941277|FG002|Overall Study|Co-Morbid Condition|0|||
33558817|NCT02268851|101941278|FG003|Overall Study|Co-Morbid Condition|0|||
33558818|NCT02268851|101941279|FG004|Overall Study|Co-Morbid Condition|1|||
33558819|NCT02268851|101941280|FG005|Overall Study|Co-Morbid Condition|1|||
33558820|NCT03048019|101941281|FG000|Overall Study|Adverse Event|1|||
33558821|NCT03048019|101941282|FG001|Overall Study|Adverse Event|0|||
33558822|NCT01927861|101941283|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
33558823|NCT01927861|101941284|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
33558824|NCT01927861|101941283|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
33558825|NCT01927861|101941284|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
33558826|NCT05206604|101941285|FG000|Overall Study|Non-compliance with study drug|0|||
33558827|NCT05206604|101941286|FG001|Overall Study|Non-compliance with study drug|0|||
33558828|NCT05206604|101941287|FG002|Overall Study|Non-compliance with study drug|0|||
33558829|NCT05206604|101941288|FG003|Overall Study|Non-compliance with study drug|0|||
33558830|NCT05206604|101941289|FG004|Overall Study|Non-compliance with study drug|0|||
33558831|NCT05206604|101941290|FG005|Overall Study|Non-compliance with study drug|1|||
33558832|NCT05206604|101941291|FG006|Overall Study|Non-compliance with study drug|0|||
33558833|NCT05206604|101941292|FG007|Overall Study|Non-compliance with study drug|0|||
33558834|NCT06048705|101941293|FG000|Overall Study|Physician Decision|1|||
33558835|NCT06048705|101941294|FG001|Overall Study|Physician Decision|0|||
33558836|NCT06048705|101941295|FG002|Overall Study|Physician Decision|0|||
33558837|NCT06048705|101941293|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
33558838|NCT06048705|101941294|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
33558839|NCT06048705|101941295|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
33558840|NCT06048705|101941293|FG000|Overall Study|Death prior to lymphodepletion|0|||
33558841|NCT06048705|101941294|FG001|Overall Study|Death prior to lymphodepletion|0|||
33558842|NCT06048705|101941295|FG002|Overall Study|Death prior to lymphodepletion|1|||
33558843|NCT00345592|101941300|FG000|Overall Study|Death|14|||
33558844|NCT00345592|101941301|FG001|Overall Study|Death|16|||
33558845|NCT00345592|101941300|FG000|Overall Study|Withdrawal by Subject|11|||
33623196|NCT02210000|102169484|FG000|Overall Study|Physician Decision|0|||
33623197|NCT02210000|102169485|FG001|Overall Study|Physician Decision|1|||
33623198|NCT00360412|102169489|FG000|Overall Study|Adverse Event|37|||
33623199|NCT00360412|102169490|FG001|Overall Study|Adverse Event|65|||
33218637|NCT04026165|100696105|FG002|Run-in SEL Period|Death|0|||
33358663|NCT01845077|101201189|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
33358664|NCT01845077|101201190|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
33623200|NCT00360412|102169489|FG000|Overall Study|Protocol Violation|2|||
33358665|NCT01845077|101201191|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
33358666|NCT01845077|101201192|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
33358667|NCT01845077|101201193|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
33358668|NCT01845077|101201188|FG000|Washout Period|Protocol Violation|0|||
33358669|NCT01845077|101201189|FG001|Washout Period|Protocol Violation|0|||
33358670|NCT01845077|101201190|FG002|Washout Period|Protocol Violation|0|||
33358671|NCT01845077|101201191|FG003|Washout Period|Protocol Violation|1|||
33358672|NCT01845077|101201192|FG004|Washout Period|Protocol Violation|1|||
33358673|NCT01845077|101201193|FG005|Washout Period|Protocol Violation|0|||
33358674|NCT00206518|101201194|FG000|Overall Study|Lack of Efficacy|6|||
33358675|NCT00206518|101201195|FG001|Overall Study|Lack of Efficacy|4|||
33358676|NCT00206518|101201194|FG000|Overall Study|Adverse Event|2|||
33358677|NCT00206518|101201195|FG001|Overall Study|Adverse Event|1|||
33358678|NCT00206518|101201194|FG000|Overall Study|Physician Decision|1|||
33358679|NCT00206518|101201195|FG001|Overall Study|Physician Decision|0|||
33358680|NCT00206518|101201194|FG000|Overall Study|Protocol Violation|1|||
33358681|NCT00206518|101201195|FG001|Overall Study|Protocol Violation|1|||
33358682|NCT02190591|101201196|FG000|Overall Study|Withdrawal by Subject|1|||
33358683|NCT02190591|101201197|FG001|Overall Study|Withdrawal by Subject|8|||
33623201|NCT00360412|102169490|FG001|Overall Study|Protocol Violation|5|||
33623202|NCT00360412|102169489|FG000|Overall Study|Patient withdrew consent|27|||
33623203|NCT00360412|102169490|FG001|Overall Study|Patient withdrew consent|52|||
33623204|NCT00360412|102169489|FG000|Overall Study|Lack of therapeutic efficacy|46|||
33623205|NCT00360412|102169490|FG001|Overall Study|Lack of therapeutic efficacy|61|||
33623206|NCT00360412|102169489|FG000|Overall Study|Physician Decision|2|||
33623207|NCT00360412|102169490|FG001|Overall Study|Physician Decision|4|||
33623208|NCT00360412|102169489|FG000|Overall Study|Other|5|||
33623209|NCT00360412|102169490|FG001|Overall Study|Other|6|||
33623210|NCT00360412|102169489|FG000|Overall Study|Study termination by Sponsor|214|||
33623211|NCT00360412|102169490|FG001|Overall Study|Study termination by Sponsor|469|||
33623212|NCT01135134|102169491|FG000|Overall Study|Adverse Event|1|||
33623213|NCT01135134|102169492|FG001|Overall Study|Adverse Event|1|||
33623214|NCT01135134|102169491|FG000|Overall Study|Did not meet protocol eligibility|1|||
33623215|NCT01135134|102169492|FG001|Overall Study|Did not meet protocol eligibility|0|||
33623216|NCT03071263|102169495|FG000|Overall Study|Adverse Event|1|||
33623217|NCT03071263|102169496|FG001|Overall Study|Adverse Event|3|||
33623218|NCT03071263|102169495|FG000|Overall Study|Withdrawal by Subject|1|||
33218638|NCT04026165|100696106|FG003|Run-in SEL Period|Death|0|||
33358684|NCT02190591|101201196|FG000|Overall Study|Protocol Violation|1|||
33358685|NCT02190591|101201197|FG001|Overall Study|Protocol Violation|0|||
33623219|NCT03071263|102169496|FG001|Overall Study|Withdrawal by Subject|3|||
33218639|NCT04026165|100696103|FG000|Randomized Period|Withdrew Consent|0|||
33358686|NCT02190591|101201196|FG000|Overall Study|did not use peanut ball as instructed|0|||
33358687|NCT02190591|101201197|FG001|Overall Study|did not use peanut ball as instructed|2|||
33358688|NCT02190591|101201196|FG000|Overall Study|face presentation so she was ineligible|0|||
33358689|NCT02190591|101201197|FG001|Overall Study|face presentation so she was ineligible|1|||
33558846|NCT00345592|101941301|FG001|Overall Study|Withdrawal by Subject|8|||
33558847|NCT04135352|101941304|FG000|Overall Study|Not treated-randomization error|0|||
33218640|NCT04026165|100696104|FG001|Randomized Period|Withdrew Consent|0|||
33218641|NCT04026165|100696105|FG002|Randomized Period|Withdrew Consent|5|||
33218642|NCT04026165|100696106|FG003|Randomized Period|Withdrew Consent|8|||
33218643|NCT04026165|100696103|FG000|Randomized Period|Death|0|||
33218644|NCT04026165|100696104|FG001|Randomized Period|Death|0|||
33218645|NCT04026165|100696105|FG002|Randomized Period|Death|5|||
33218646|NCT04026165|100696106|FG003|Randomized Period|Death|7|||
33218647|NCT04026165|100696103|FG000|Randomized Period|Investigator's Discretion|0|||
33218648|NCT04026165|100696104|FG001|Randomized Period|Investigator's Discretion|0|||
33558848|NCT04135352|101941305|FG001|Overall Study|Not treated-randomization error|0|||
33558849|NCT04135352|101941306|FG002|Overall Study|Not treated-randomization error|1|||
33558850|NCT04135352|101941307|FG003|Overall Study|Not treated-randomization error|0|||
33558851|NCT04135352|101941308|FG004|Overall Study|Not treated-randomization error|0|||
33558852|NCT04135352|101941309|FG005|Overall Study|Not treated-randomization error|0|||
33558853|NCT04135352|101941310|FG006|Overall Study|Not treated-randomization error|0|||
33558854|NCT04135352|101941311|FG007|Overall Study|Not treated-randomization error|0|||
33558855|NCT04135352|101941304|FG000|Overall Study|Withdrawal by Subject|0|||
33558856|NCT04135352|101941305|FG001|Overall Study|Withdrawal by Subject|0|||
33558857|NCT04135352|101941306|FG002|Overall Study|Withdrawal by Subject|2|||
33558858|NCT04135352|101941307|FG003|Overall Study|Withdrawal by Subject|0|||
33558859|NCT04135352|101941308|FG004|Overall Study|Withdrawal by Subject|0|||
33558860|NCT04135352|101941309|FG005|Overall Study|Withdrawal by Subject|0|||
33558861|NCT04135352|101941310|FG006|Overall Study|Withdrawal by Subject|0|||
33558862|NCT04135352|101941311|FG007|Overall Study|Withdrawal by Subject|0|||
33558863|NCT04135352|101941304|FG000|Overall Study|Sponsor Decision|0|||
33623220|NCT03071263|102169495|FG000|Overall Study|Physician Decision|1|||
33623221|NCT03071263|102169496|FG001|Overall Study|Physician Decision|0|||
33623222|NCT03071263|102169495|FG000|Overall Study|Participant moved to another city|0|||
33623223|NCT03071263|102169496|FG001|Overall Study|Participant moved to another city|1|||
33218649|NCT04026165|100696105|FG002|Randomized Period|Investigator's Discretion|2|||
33623224|NCT02336607|102169497|FG000|Overall Study|Physician Decision|1|||
33623225|NCT02336607|102169498|FG001|Overall Study|Physician Decision|4|||
33623226|NCT02336607|102169499|FG002|Overall Study|Physician Decision|3|||
33358690|NCT00196937|101201198|FG000|Overall Study|Serious Adverse Event|1|||
33358691|NCT00196937|101201199|FG001|Overall Study|Serious Adverse Event|0|||
33358692|NCT00196937|101201200|FG002|Overall Study|Serious Adverse Event|0|||
33358693|NCT00196937|101201198|FG000|Overall Study|Non-serious adverse event|1|||
33358694|NCT00196937|101201199|FG001|Overall Study|Non-serious adverse event|1|||
33358695|NCT00196937|101201200|FG002|Overall Study|Non-serious adverse event|1|||
33358696|NCT00196937|101201198|FG000|Overall Study|Withdrawal by Subject|0|||
33358697|NCT00196937|101201199|FG001|Overall Study|Withdrawal by Subject|0|||
33414573|NCT01915498|101409837|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33218650|NCT04026165|100696106|FG003|Randomized Period|Investigator's Discretion|2|||
33218651|NCT04026165|100696103|FG000|Randomized Period|Lost to Follow-up|0|||
33218652|NCT04026165|100696104|FG001|Randomized Period|Lost to Follow-up|0|||
33558864|NCT04135352|101941305|FG001|Overall Study|Sponsor Decision|0|||
33623227|NCT02336607|102169500|FG003|Overall Study|Physician Decision|15|||
33218653|NCT04026165|100696105|FG002|Randomized Period|Lost to Follow-up|2|||
33558865|NCT04135352|101941306|FG002|Overall Study|Sponsor Decision|2|||
33558866|NCT04135352|101941307|FG003|Overall Study|Sponsor Decision|5|||
33623228|NCT02336607|102169497|FG000|Overall Study|Lack of Efficacy|1|||
33218654|NCT04026165|100696106|FG003|Randomized Period|Lost to Follow-up|2|||
33218655|NCT00522626|100696107|FG000|Overall Study|Lost to Follow-up|7|||
33218656|NCT01814748|100696108|FG000|Overall Study|Lost to Follow-up|1|||
33218657|NCT01814748|100696109|FG001|Overall Study|Lost to Follow-up|2|||
33218658|NCT01814748|100696108|FG000|Overall Study|Study site terminated by sponsor|1|||
33218659|NCT01814748|100696109|FG001|Overall Study|Study site terminated by sponsor|1|||
33218660|NCT01814748|100696108|FG000|Overall Study|Withdrawal by Subject|6|||
33218661|NCT01814748|100696109|FG001|Overall Study|Withdrawal by Subject|4|||
33218662|NCT00789815|100696110|FG000|Overall Study|Protocol Violation|6|||
33218663|NCT00789815|100696111|FG001|Overall Study|Protocol Violation|1|||
33218664|NCT00789815|100696110|FG000|Overall Study|Intubation due to massive bleeding|1|||
33218665|NCT00789815|100696111|FG001|Overall Study|Intubation due to massive bleeding|0|||
33218666|NCT00335452|100696119|FG000|Overall Study|Death|156|||
33218667|NCT00335452|100696120|FG001|Overall Study|Death|144|||
33218668|NCT00335452|100696121|FG002|Overall Study|Death|158|||
33218669|NCT00335452|100696122|FG003|Overall Study|Death|129|||
33218670|NCT00335452|100696119|FG000|Overall Study|Lost to Follow-up|2|||
33218671|NCT00335452|100696120|FG001|Overall Study|Lost to Follow-up|3|||
33218672|NCT00335452|100696121|FG002|Overall Study|Lost to Follow-up|1|||
33218673|NCT00335452|100696122|FG003|Overall Study|Lost to Follow-up|2|||
33218674|NCT02623322|100696124|FG000|Overall Study|Lost to Follow-up|2|||
33218675|NCT02623322|100696125|FG001|Overall Study|Lost to Follow-up|1|||
33218676|NCT02623322|100696126|FG002|Overall Study|Lost to Follow-up|0|||
33218677|NCT00590902|100696127|FG000|Overall Study|Death|1|||
33218678|NCT05099926|100696128|FG000|Overall Study|Lost to Follow-up|1|||
33218679|NCT01783418|100696129|FG000|Overall Study|Withdrawal by Subject|1|||
33218680|NCT01783418|100696130|FG001|Overall Study|Withdrawal by Subject|0|||
33218681|NCT04274894|100696133|FG000|Overall Study|Adverse Event|7|||
33218682|NCT04274894|100696133|FG000|Overall Study|Withdrew consent|5|||
33218683|NCT04274894|100696133|FG000|Overall Study|Lost to Follow-up|9|||
33218684|NCT04274894|100696133|FG000|Overall Study|COVID-19 infection|1|||
33218685|NCT04274894|100696133|FG000|Overall Study|Other, not specified|20|||
33218686|NCT01896869|100699700|FG000|Overall Study|Withdrawal by Subject|0|||
33218687|NCT01896869|100699701|FG001|Overall Study|Withdrawal by Subject|6|||
33218688|NCT01896869|100699700|FG000|Overall Study|Lost to Follow-up|1|||
33218689|NCT01896869|100699701|FG001|Overall Study|Lost to Follow-up|0|||
33218690|NCT01922076|100699704|FG000|Overall Study|Adverse Event|0|||
33623229|NCT02336607|102169498|FG001|Overall Study|Lack of Efficacy|0|||
33623230|NCT02336607|102169499|FG002|Overall Study|Lack of Efficacy|0|||
33623231|NCT02336607|102169500|FG003|Overall Study|Lack of Efficacy|2|||
33623232|NCT02336607|102169497|FG000|Overall Study|Lost to Follow-up|2|||
33623233|NCT02336607|102169498|FG001|Overall Study|Lost to Follow-up|1|||
33623234|NCT02336607|102169499|FG002|Overall Study|Lost to Follow-up|0|||
33623235|NCT02336607|102169500|FG003|Overall Study|Lost to Follow-up|21|||
33623236|NCT02336607|102169497|FG000|Overall Study|Protocol Violation|0|||
33623237|NCT02336607|102169498|FG001|Overall Study|Protocol Violation|1|||
33623238|NCT02336607|102169499|FG002|Overall Study|Protocol Violation|1|||
33623239|NCT02336607|102169500|FG003|Overall Study|Protocol Violation|3|||
33218691|NCT01922076|100699705|FG001|Overall Study|Adverse Event|0|||
33218692|NCT01922076|100699706|FG002|Overall Study|Adverse Event|0|||
33218693|NCT01922076|100699707|FG003|Overall Study|Adverse Event|0|||
33218694|NCT01922076|100699708|FG004|Overall Study|Adverse Event|1|||
33218695|NCT01922076|100699709|FG005|Overall Study|Adverse Event|0|||
33218696|NCT01922076|100699710|FG006|Overall Study|Adverse Event|0|||
33218697|NCT01922076|100699704|FG000|Overall Study|Physician Decision|0|||
33218698|NCT01922076|100699705|FG001|Overall Study|Physician Decision|0|||
33218699|NCT01922076|100699706|FG002|Overall Study|Physician Decision|1|||
33218700|NCT01922076|100699707|FG003|Overall Study|Physician Decision|0|||
33218701|NCT01922076|100699708|FG004|Overall Study|Physician Decision|0|||
33218702|NCT01922076|100699709|FG005|Overall Study|Physician Decision|0|||
33218703|NCT01922076|100699710|FG006|Overall Study|Physician Decision|0|||
33218704|NCT01922076|100699704|FG000|Overall Study|Withdrawal by Subject|0|||
33218705|NCT01922076|100699705|FG001|Overall Study|Withdrawal by Subject|0|||
33218706|NCT01922076|100699706|FG002|Overall Study|Withdrawal by Subject|0|||
33218707|NCT01922076|100699707|FG003|Overall Study|Withdrawal by Subject|1|||
33218708|NCT01922076|100699708|FG004|Overall Study|Withdrawal by Subject|0|||
33218709|NCT01922076|100699709|FG005|Overall Study|Withdrawal by Subject|1|||
33358698|NCT00196937|101201200|FG002|Overall Study|Withdrawal by Subject|2|||
33358699|NCT00196937|101201198|FG000|Overall Study|Lost to Follow-up|4|||
33358700|NCT00196937|101201199|FG001|Overall Study|Lost to Follow-up|3|||
33358701|NCT00196937|101201200|FG002|Overall Study|Lost to Follow-up|3|||
33358702|NCT00196937|101201198|FG000|Overall Study|Other|3|||
33623240|NCT02336607|102169497|FG000|Overall Study|Adverse Event|0|||
33558867|NCT04135352|101941308|FG004|Overall Study|Sponsor Decision|1|||
33558868|NCT04135352|101941309|FG005|Overall Study|Sponsor Decision|4|||
33558869|NCT04135352|101941310|FG006|Overall Study|Sponsor Decision|0|||
33558870|NCT04135352|101941311|FG007|Overall Study|Sponsor Decision|0|||
33558871|NCT04135352|101941304|FG000|Overall Study|Physician Decision|0|||
33358703|NCT00196937|101201199|FG001|Overall Study|Other|1|||
33623241|NCT02336607|102169498|FG001|Overall Study|Adverse Event|2|||
33623242|NCT02336607|102169499|FG002|Overall Study|Adverse Event|2|||
33558872|NCT04135352|101941305|FG001|Overall Study|Physician Decision|0|||
33558873|NCT04135352|101941306|FG002|Overall Study|Physician Decision|1|||
33558874|NCT04135352|101941307|FG003|Overall Study|Physician Decision|0|||
33558875|NCT04135352|101941308|FG004|Overall Study|Physician Decision|1|||
33558876|NCT04135352|101941309|FG005|Overall Study|Physician Decision|0|||
33558877|NCT04135352|101941310|FG006|Overall Study|Physician Decision|0|||
33558878|NCT04135352|101941311|FG007|Overall Study|Physician Decision|0|||
33558879|NCT04135352|101941304|FG000|Overall Study|Death|3|||
33623243|NCT02336607|102169500|FG003|Overall Study|Adverse Event|26|||
33623244|NCT02336607|102169497|FG000|Overall Study|Withdrawal by Subject|0|||
33623245|NCT02336607|102169498|FG001|Overall Study|Withdrawal by Subject|2|||
33623246|NCT02336607|102169499|FG002|Overall Study|Withdrawal by Subject|0|||
33623247|NCT02336607|102169500|FG003|Overall Study|Withdrawal by Subject|20|||
33623248|NCT00362648|102169501|FG000|Overall Study|Adverse Event|12|||
33623249|NCT00362648|102169502|FG001|Overall Study|Adverse Event|21|||
33358704|NCT00196937|101201200|FG002|Overall Study|Other|1|||
33358705|NCT02981472|101201201|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
33358706|NCT02981472|101201202|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
33358707|NCT02981472|101201201|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
33623250|NCT00362648|102169503|FG002|Overall Study|Adverse Event|1|||
33623251|NCT00362648|102169504|FG003|Overall Study|Adverse Event|0|||
33623252|NCT00362648|102169501|FG000|Overall Study|Lost to Follow-up|62|||
33623253|NCT00362648|102169502|FG001|Overall Study|Lost to Follow-up|69|||
33623254|NCT00362648|102169503|FG002|Overall Study|Lost to Follow-up|4|||
33623255|NCT00362648|102169504|FG003|Overall Study|Lost to Follow-up|3|||
33623256|NCT00362648|102169501|FG000|Overall Study|Protocol Violation|4|||
33623257|NCT00362648|102169502|FG001|Overall Study|Protocol Violation|2|||
33358708|NCT02981472|101201202|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33218710|NCT01922076|100699710|FG006|Overall Study|Withdrawal by Subject|1|||
33218711|NCT04349280|100699711|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
33218712|NCT04349280|100699712|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
33218713|NCT04349280|100699711|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
33218714|NCT04349280|100699712|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
33358709|NCT02981472|101201201|FG000|Treatment Period|Adverse Event|6|||
33358710|NCT02981472|101201202|FG001|Treatment Period|Adverse Event|1|||
33358711|NCT02981472|101201201|FG000|Treatment Period|Participant withdrew consent|1|||
33358712|NCT02981472|101201202|FG001|Treatment Period|Participant withdrew consent|0|||
33358713|NCT02981472|101201201|FG000|Treatment Period|Lost to Follow-up|0|||
33558880|NCT04135352|101941305|FG001|Overall Study|Death|4|||
33558881|NCT04135352|101941306|FG002|Overall Study|Death|7|||
33358714|NCT02981472|101201202|FG001|Treatment Period|Lost to Follow-up|1|||
33558882|NCT04135352|101941307|FG003|Overall Study|Death|0|||
33558883|NCT04135352|101941308|FG004|Overall Study|Death|3|||
33558884|NCT04135352|101941309|FG005|Overall Study|Death|1|||
33558885|NCT04135352|101941310|FG006|Overall Study|Death|0|||
33623258|NCT00362648|102169503|FG002|Overall Study|Protocol Violation|2|||
33218715|NCT04349280|100699711|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
33218716|NCT04349280|100699712|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
33218717|NCT02403180|100699713|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
33218718|NCT02403180|100699714|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
33218719|NCT02403180|100699713|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
33218720|NCT02403180|100699714|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
33218721|NCT01089374|100699723|FG000|Overall Study|Lost to Follow-up|3|||
33218722|NCT01089374|100699724|FG001|Overall Study|Lost to Follow-up|0|||
33218723|NCT01089374|100699723|FG000|Overall Study|Withdrawal by Subject|1|||
33218724|NCT01089374|100699724|FG001|Overall Study|Withdrawal by Subject|0|||
33218725|NCT01089374|100699723|FG000|Overall Study|Study closed early - low accrual|6|||
33218726|NCT01089374|100699724|FG001|Overall Study|Study closed early - low accrual|0|||
33558886|NCT04135352|101941311|FG007|Overall Study|Death|0|||
33558887|NCT02536339|101941317|FG000|Overall Study|Death|20|||
33558888|NCT02536339|101941317|FG000|Overall Study|Withdrawal by Subject|3|||
33558889|NCT02536339|101941317|FG000|Overall Study|Lost to Follow-up|2|||
33558890|NCT02536339|101941317|FG000|Overall Study|Treatment discontinued|2|||
33558891|NCT02536339|101941317|FG000|Overall Study|Physician Decision|1|||
33558892|NCT02367040|101941318|FG000|Overall Study|Lost to Follow-up|1|||
33558893|NCT02367040|101941319|FG001|Overall Study|Lost to Follow-up|1|||
33558894|NCT02367040|101941318|FG000|Overall Study|Lack of Efficacy|1|||
33558895|NCT02367040|101941319|FG001|Overall Study|Lack of Efficacy|0|||
33558896|NCT02367040|101941318|FG000|Overall Study|Additional primary malignancy|0|||
33558897|NCT02367040|101941319|FG001|Overall Study|Additional primary malignancy|1|||
33558898|NCT02367040|101941318|FG000|Overall Study|AE not associated with clinical disease progression|114|||
33558899|NCT02367040|101941319|FG001|Overall Study|AE not associated with clinical disease progression|11|||
33558900|NCT02367040|101941318|FG000|Overall Study|AE associated with clinical disease progression|1|||
33558901|NCT02367040|101941319|FG001|Overall Study|AE associated with clinical disease progression|3|||
33558902|NCT02367040|101941318|FG000|Overall Study|Physician Decision|2|||
33558903|NCT02367040|101941319|FG001|Overall Study|Physician Decision|8|||
33558904|NCT02367040|101941318|FG000|Overall Study|Non-compliance with study drug|1|||
33558905|NCT02367040|101941319|FG001|Overall Study|Non-compliance with study drug|0|||
33558906|NCT02367040|101941318|FG000|Overall Study|Failure to meet continuation criteria|1|||
33558907|NCT02367040|101941319|FG001|Overall Study|Failure to meet continuation criteria|0|||
33558908|NCT02367040|101941318|FG000|Overall Study|Switching to other therapy|2|||
33558909|NCT02367040|101941319|FG001|Overall Study|Switching to other therapy|0|||
33558910|NCT02367040|101941318|FG000|Overall Study|Withdrawal by Subject|46|||
33558911|NCT02367040|101941319|FG001|Overall Study|Withdrawal by Subject|16|||
33558912|NCT02367040|101941318|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
33558913|NCT02367040|101941319|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
33558914|NCT02367040|101941318|FG000|Overall Study|Patient decision|39|||
33558915|NCT02367040|101941319|FG001|Overall Study|Patient decision|14|||
33558916|NCT02367040|101941318|FG000|Overall Study|Required procedure failed|1|||
33558917|NCT02367040|101941319|FG001|Overall Study|Required procedure failed|0|||
33558918|NCT02367040|101941318|FG000|Overall Study|Randomized by mistake with study treatment|1|||
33558919|NCT02367040|101941319|FG001|Overall Study|Randomized by mistake with study treatment|0|||
33558920|NCT02367040|101941318|FG000|Overall Study|Protocol Violation|1|||
33558921|NCT02367040|101941319|FG001|Overall Study|Protocol Violation|0|||
33558922|NCT02367040|101941318|FG000|Overall Study|Progressive disease - radiological progression|51|||
33558923|NCT02367040|101941319|FG001|Overall Study|Progressive disease - radiological progression|78|||
33558924|NCT02367040|101941318|FG000|Overall Study|Progressive disease - clinical progression|6|||
33558925|NCT02367040|101941319|FG001|Overall Study|Progressive disease - clinical progression|6|||
33558926|NCT02367040|101941318|FG000|Overall Study|Drug not administered|3|||
33558927|NCT02367040|101941319|FG001|Overall Study|Drug not administered|2|||
33558928|NCT02367040|101941318|FG000|Overall Study|Progressive disease|0|||
33558929|NCT02367040|101941319|FG001|Overall Study|Progressive disease|1|||
33558930|NCT02367040|101941318|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
33558931|NCT02367040|101941319|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
33558932|NCT02367040|101941318|FG000|Overall Study|Death|2|||
33558933|NCT02367040|101941319|FG001|Overall Study|Death|0|||
33558934|NCT00937937|101941320|FG000|Overall Study|Adverse Event|6|||
33558935|NCT00937937|101941320|FG000|Overall Study|Withdrawal by Subject|2|||
33558936|NCT00937937|101941320|FG000|Overall Study|Progression/relapse|61|||
33558937|NCT00937937|101941320|FG000|Overall Study|Death|1|||
33218727|NCT02054806|100699725|FG000|Overall Study|Sponsor Decision|31|||
33218728|NCT02054806|100699725|FG000|Overall Study|Withdrawal by Subject|43|||
33218729|NCT02054806|100699725|FG000|Overall Study|Protocol Violation|2|||
33218730|NCT02054806|100699725|FG000|Overall Study|Lost to Follow-up|10|||
33218731|NCT02054806|100699725|FG000|Overall Study|Death|391|||
33558938|NCT00937937|101941320|FG000|Overall Study|Other|2|||
33558939|NCT03228537|101941323|FG000|Neoadjuvant|Adverse Event|2|||
33558940|NCT03228537|101941323|FG000|Neoadjuvant|Progression/Relapse|4|||
33558941|NCT03228537|101941323|FG000|Neoadjuvant|Death|1|||
33558942|NCT03228537|101941323|FG000|Surgery|Death|1|||
33558943|NCT03228537|101941323|FG000|Surgery|Other - Not Protocol Specified|2|||
33623259|NCT00362648|102169504|FG003|Overall Study|Protocol Violation|2|||
33623260|NCT00362648|102169501|FG000|Overall Study|Withdrawal by Subject|48|||
33623261|NCT00362648|102169502|FG001|Overall Study|Withdrawal by Subject|42|||
33623262|NCT00362648|102169503|FG002|Overall Study|Withdrawal by Subject|2|||
33623263|NCT00362648|102169504|FG003|Overall Study|Withdrawal by Subject|6|||
33218732|NCT00999466|100699729|FG000|Main Part|Withdrawal by Subject|0|||
33623264|NCT00988598|102169507|FG000|Overall Study|Withdrawal by Subject|2|||
33623265|NCT00988598|102169508|FG001|Overall Study|Withdrawal by Subject|0|||
33623266|NCT00890825|102169509|FG000|Overall Study|Withdrawal by Subject|1|||
33623267|NCT00890825|102169510|FG001|Overall Study|Withdrawal by Subject|0|||
33623268|NCT00890825|102169509|FG000|Overall Study|Alive at data cut off (DCO)|13|||
33623269|NCT00890825|102169510|FG001|Overall Study|Alive at data cut off (DCO)|14|||
33623270|NCT02252146|102169511|FG000|Overall Study|Lack of Efficacy|4|||
33623271|NCT02252146|102169511|FG000|Overall Study|Entered hospice care|1|||
33623272|NCT02252146|102169511|FG000|Overall Study|Inability to travel to study site|1|||
33623273|NCT04033367|102169512|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
33623274|NCT04033367|102169513|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
33623275|NCT04033367|102169512|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
33623276|NCT04033367|102169513|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
33623277|NCT04033367|102169512|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
33623278|NCT04033367|102169513|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
33623279|NCT04033367|102169512|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
33623280|NCT04033367|102169513|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
33623281|NCT01458639|102169514|FG000|Overall Study|Physician Decision|4|||
33623282|NCT01458639|102169514|FG000|Overall Study|Equipment issue|1|||
33623283|NCT01458639|102169514|FG000|Overall Study|Inability to obtain subject blood sample|1|||
33623284|NCT03010319|102169531|FG000|Overall Study|Adverse Event|15|||
33623285|NCT03010319|102169532|FG001|Overall Study|Adverse Event|9|||
33623286|NCT03010319|102169531|FG000|Overall Study|Withdrawal by Subject|1|||
33623287|NCT03010319|102169532|FG001|Overall Study|Withdrawal by Subject|6|||
33623288|NCT03010319|102169531|FG000|Overall Study|Physician Decision|2|||
33623289|NCT03010319|102169532|FG001|Overall Study|Physician Decision|4|||
33623290|NCT03010319|102169531|FG000|Overall Study|Sponsor requested withdrawal|2|||
33623291|NCT03010319|102169532|FG001|Overall Study|Sponsor requested withdrawal|2|||
33623292|NCT03010319|102169531|FG000|Overall Study|Death|1|||
33218733|NCT00999466|100699730|FG001|Main Part|Withdrawal by Subject|0|||
33218734|NCT00999466|100699731|FG002|Main Part|Withdrawal by Subject|2|||
33358715|NCT00377962|101201203|FG000|Core Study: 0-12 Months|Adverse Event|18|||
33558944|NCT03228537|101941323|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
33558945|NCT03228537|101941323|FG000|Maintenance|Progression/Relapse|10|||
33558946|NCT02595879|101941326|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
33558947|NCT02595879|101941327|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
33558948|NCT01433978|101941331|FG000|Core Study|Adverse Event, Non-Fatal|0|||
33558949|NCT01433978|101941332|FG001|Core Study|Adverse Event, Non-Fatal|1|||
33558950|NCT01433978|101941333|FG002|Core Study|Adverse Event, Non-Fatal|0|||
33558951|NCT01433978|101941331|FG000|Core Study|Lack of Efficacy|5|||
33558952|NCT01433978|101941332|FG001|Core Study|Lack of Efficacy|1|||
33558953|NCT01433978|101941333|FG002|Core Study|Lack of Efficacy|0|||
33558954|NCT01433978|101941331|FG000|Core Study|Study Terminated by Sponsor|6|||
33558955|NCT01433978|101941332|FG001|Core Study|Study Terminated by Sponsor|9|||
33623293|NCT03010319|102169532|FG001|Overall Study|Death|0|||
33623294|NCT03010319|102169531|FG000|Overall Study|Lost to Follow-up|0|||
33623295|NCT03010319|102169532|FG001|Overall Study|Lost to Follow-up|1|||
33623296|NCT03010319|102169531|FG000|Overall Study|Other Reason|5|||
33623297|NCT03010319|102169532|FG001|Overall Study|Other Reason|7|||
33623298|NCT02800863|102169539|FG000|Overall Study|Adverse Event|14|||
33623299|NCT02800863|102169539|FG000|Overall Study|Another Device Implanted|1|||
33623300|NCT02800863|102169539|FG000|Overall Study|Device Explanted|1|||
33623301|NCT02800863|102169539|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
33623302|NCT02800863|102169539|FG000|Overall Study|Health Issues|1|||
33623303|NCT02800863|102169539|FG000|Overall Study|Insurance Denial|8|||
33623304|NCT02800863|102169539|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
33623305|NCT02800863|102169539|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
33358716|NCT00377962|101201204|FG001|Core Study: 0-12 Months|Adverse Event|2|||
33623306|NCT02800863|102169539|FG000|Overall Study|Screen Failure|1|||
33623307|NCT02800863|102169539|FG000|Overall Study|Sponsor Request|6|||
33623308|NCT02800863|102169539|FG000|Overall Study|Death|3|||
33218735|NCT00999466|100699729|FG000|Main Part|Adverse Event|0|||
33218736|NCT00999466|100699730|FG001|Main Part|Adverse Event|4|||
33623309|NCT02800863|102169539|FG000|Overall Study|Subject Implant at Another Facility|1|||
33623310|NCT02800863|102169539|FG000|Overall Study|Lost to Follow-up|26|||
33623311|NCT02800863|102169539|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
33623312|NCT02800863|102169539|FG000|Overall Study|Subject and/or Family Request|64|||
33358717|NCT00377962|101201203|FG000|Core Study: 0-12 Months|Death|3|||
33218737|NCT00999466|100699731|FG002|Main Part|Adverse Event|2|||
33558956|NCT01433978|101941333|FG002|Core Study|Study Terminated by Sponsor|0|||
33558957|NCT01433978|101941331|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
33558958|NCT01433978|101941332|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
33558959|NCT01433978|101941333|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
33558960|NCT01433978|101941331|FG000|Extension Phase|Lack of Efficacy|0|||
33558961|NCT01433978|101941332|FG001|Extension Phase|Lack of Efficacy|0|||
33558962|NCT01433978|101941333|FG002|Extension Phase|Lack of Efficacy|1|||
33558963|NCT01433978|101941331|FG000|Extension Phase|Study Terminated by Sponsor|0|||
33558964|NCT01433978|101941332|FG001|Extension Phase|Study Terminated by Sponsor|0|||
33218738|NCT00977665|100699732|FG000|Overall Study|Withdrawal by Subject|1|||
33218739|NCT00977665|100699733|FG001|Overall Study|Withdrawal by Subject|3|||
33218740|NCT00977665|100699732|FG000|Overall Study|Physician Decision|2|||
33218741|NCT00977665|100699733|FG001|Overall Study|Physician Decision|1|||
33218742|NCT00977665|100699732|FG000|Overall Study|Sponsor requested withdrawal|0|||
33218743|NCT00977665|100699733|FG001|Overall Study|Sponsor requested withdrawal|1|||
33218744|NCT00977665|100699732|FG000|Overall Study|Lost to Follow-up|1|||
33218745|NCT00977665|100699733|FG001|Overall Study|Lost to Follow-up|0|||
33218746|NCT00977665|100699732|FG000|Overall Study|Death|3|||
33218747|NCT00977665|100699733|FG001|Overall Study|Death|2|||
33218748|NCT00977665|100699732|FG000|Overall Study|Adverse Event|14|||
33218749|NCT00977665|100699733|FG001|Overall Study|Adverse Event|7|||
33218750|NCT00977665|100699732|FG000|Overall Study|Treatment failure|0|||
33218751|NCT00977665|100699733|FG001|Overall Study|Treatment failure|1|||
33218752|NCT00929162|100699734|FG000|Overall Study|Adverse Event|8|||
33218753|NCT00929162|100699735|FG001|Overall Study|Adverse Event|5|||
33218754|NCT00929162|100699734|FG000|Overall Study|Withdrawal by Subject|3|||
33218755|NCT00929162|100699735|FG001|Overall Study|Withdrawal by Subject|1|||
33218756|NCT00929162|100699734|FG000|Overall Study|Protocol Violation|32|||
33218757|NCT00929162|100699735|FG001|Overall Study|Protocol Violation|30|||
33218758|NCT00929162|100699734|FG000|Overall Study|Other termination reason|5|||
33218759|NCT00929162|100699735|FG001|Overall Study|Other termination reason|6|||
33218760|NCT02701985|100699736|FG000|Overall Study|Withdrawal by Subject|1|||
33218761|NCT02701985|100699737|FG001|Overall Study|Withdrawal by Subject|1|||
33358718|NCT00377962|101201204|FG001|Core Study: 0-12 Months|Death|0|||
33358719|NCT00377962|101201203|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
33358720|NCT00377962|101201204|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
33358721|NCT00377962|101201203|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
33358722|NCT00377962|101201204|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
33358723|NCT00377962|101201203|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
33358724|NCT00377962|101201204|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
33358725|NCT00377962|101201203|FG000|Extension Study: 12-24 Months|Death|1|||
33558965|NCT01433978|101941333|FG002|Extension Phase|Study Terminated by Sponsor|4|||
33558966|NCT04042311|101941334|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
33558967|NCT04042311|101941334|FG000|Overall Study|Unable to tolerate|4|||
33558968|NCT04042311|101941334|FG000|Overall Study|Concurrent illness|2|||
33558969|NCT04042311|101941334|FG000|Overall Study|Adverse Event|2|||
33558970|NCT04042311|101941334|FG000|Overall Study|No longer meeting inclusion criteria|2|||
33558971|NCT04042311|101941334|FG000|Overall Study|No reason given|1|||
33558972|NCT04042311|101941334|FG000|Overall Study|Withdrawal by Subject|4|||
33558973|NCT03865706|101941337|FG000|Overall Study|Death|0|||
33558974|NCT03865706|101941338|FG001|Overall Study|Death|3|||
33558975|NCT03865706|101941339|FG002|Overall Study|Death|1|||
33558976|NCT02100644|101941340|FG000|LTG Escalation Phase|Adverse Event|9|||
33358726|NCT00377962|101201204|FG001|Extension Study: 12-24 Months|Death|1|||
33358727|NCT00377962|101201203|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
33358728|NCT00377962|101201204|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
33358729|NCT00377962|101201203|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
33358730|NCT00377962|101201204|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
33623313|NCT02800863|102169539|FG000|Overall Study|Trial Failure|81|||
33358731|NCT00377962|101201203|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
33358732|NCT00377962|101201204|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
33358733|NCT02124798|101201205|FG000|Overall Study|Adverse Event|3|||
33358734|NCT02124798|101201205|FG000|Overall Study|Lost to Follow-up|1|||
33218762|NCT02701985|100699736|FG000|Overall Study|Lost to Follow-up|1|||
33218763|NCT02701985|100699737|FG001|Overall Study|Lost to Follow-up|0|||
33218764|NCT02701985|100699736|FG000|Overall Study|Death|1|||
33218765|NCT02701985|100699737|FG001|Overall Study|Death|0|||
33558977|NCT02100644|101941341|FG001|LTG Escalation Phase|Adverse Event|0|||
33218766|NCT02701985|100699736|FG000|Overall Study|Adverse Event|0|||
33218767|NCT02701985|100699737|FG001|Overall Study|Adverse Event|5|||
33218768|NCT01972529|100699752|FG000|Overall Study|Adverse Event|0|||
33218769|NCT01972529|100699753|FG001|Overall Study|Adverse Event|1|||
33218770|NCT01972529|100699754|FG002|Overall Study|Adverse Event|0|||
33218771|NCT01972529|100699755|FG003|Overall Study|Adverse Event|0|||
33558978|NCT02100644|101941342|FG002|LTG Escalation Phase|Adverse Event|0|||
33623314|NCT02800863|102169539|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
33218772|NCT01972529|100699752|FG000|Overall Study|Lost to Follow-up|1|||
33358735|NCT01926886|101201208|FG000|Overall Study|Administrative/other|1|||
33358736|NCT01926886|101201209|FG001|Overall Study|Administrative/other|0|||
33358737|NCT01926886|101201208|FG000|Overall Study|Adverse event/intercurrent illness|4|||
33358738|NCT01926886|101201209|FG001|Overall Study|Adverse event/intercurrent illness|0|||
33358739|NCT01926886|101201208|FG000|Overall Study|Disease progression/recurrence|4|||
33358740|NCT01926886|101201209|FG001|Overall Study|Disease progression/recurrence|0|||
33358741|NCT01926886|101201208|FG000|Overall Study|Withdrawal by Subject|15|||
33414574|NCT01915498|101409838|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33414575|NCT01915498|101409839|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33558979|NCT02100644|101941340|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
33558980|NCT02100644|101941341|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
33558981|NCT02100644|101941342|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
33218773|NCT01972529|100699753|FG001|Overall Study|Lost to Follow-up|0|||
33218774|NCT01972529|100699754|FG002|Overall Study|Lost to Follow-up|0|||
33218775|NCT01972529|100699755|FG003|Overall Study|Lost to Follow-up|0|||
33218776|NCT01972529|100699752|FG000|Overall Study|Participant Choice|0|||
33218777|NCT01972529|100699753|FG001|Overall Study|Participant Choice|1|||
33218778|NCT01972529|100699754|FG002|Overall Study|Participant Choice|0|||
33218779|NCT01972529|100699755|FG003|Overall Study|Participant Choice|0|||
33218780|NCT01972529|100699752|FG000|Overall Study|Withdrawl of Consent|1|||
33218781|NCT01972529|100699753|FG001|Overall Study|Withdrawl of Consent|2|||
33218782|NCT01972529|100699754|FG002|Overall Study|Withdrawl of Consent|0|||
33218783|NCT01972529|100699755|FG003|Overall Study|Withdrawl of Consent|1|||
33218784|NCT01972529|100699752|FG000|Overall Study|Other|0|||
33218785|NCT01972529|100699753|FG001|Overall Study|Other|0|||
33218786|NCT01972529|100699754|FG002|Overall Study|Other|0|||
33558982|NCT02100644|101941340|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
33558983|NCT02100644|101941341|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
33558984|NCT02100644|101941342|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
33623315|NCT02366195|102169541|FG000|Overall Study|Protocol-specified criteria|3|||
33623316|NCT02366195|102169541|FG000|Overall Study|Withdrawal by Subject|9|||
33623317|NCT02366195|102169541|FG000|Overall Study|Lost to Follow-up|1|||
33623318|NCT02366195|102169541|FG000|Overall Study|Death|41|||
33623319|NCT00961181|102169551|FG000|Overall Study|Death|2|||
33623320|NCT00961181|102169551|FG000|Overall Study|Withdrawal by Subject|2|||
33623321|NCT00961181|102169551|FG000|Overall Study|Lost to Follow-up|1|||
33623322|NCT01702558|102169563|FG000|Overall Study|Withdrawal by Subject|0|||
33623323|NCT01702558|102169564|FG001|Overall Study|Withdrawal by Subject|0|||
33623324|NCT01702558|102169565|FG002|Overall Study|Withdrawal by Subject|0|||
33623325|NCT01702558|102169566|FG003|Overall Study|Withdrawal by Subject|12|||
33558985|NCT03975647|101941343|FG000|Overall Study|Death|71|||
33558986|NCT03975647|101941344|FG001|Overall Study|Death|63|||
33558987|NCT03975647|101941343|FG000|Overall Study|Lost to Follow-up|2|||
33558988|NCT03975647|101941344|FG001|Overall Study|Lost to Follow-up|2|||
33558989|NCT03975647|101941343|FG000|Overall Study|Subject withdrawal of consent|7|||
33558990|NCT03975647|101941344|FG001|Overall Study|Subject withdrawal of consent|11|||
33558991|NCT03620981|101941345|FG000|Overall Study|Adverse Event|14|||
33558992|NCT03620981|101941346|FG001|Overall Study|Adverse Event|38|||
33558993|NCT03620981|101941347|FG002|Overall Study|Adverse Event|25|||
33558994|NCT03620981|101941345|FG000|Overall Study|Lack of Efficacy|2|||
33558995|NCT03620981|101941346|FG001|Overall Study|Lack of Efficacy|1|||
33558996|NCT03620981|101941347|FG002|Overall Study|Lack of Efficacy|1|||
33558997|NCT03620981|101941345|FG000|Overall Study|Physician Decision|7|||
33558998|NCT03620981|101941346|FG001|Overall Study|Physician Decision|4|||
33558999|NCT03620981|101941347|FG002|Overall Study|Physician Decision|4|||
33559000|NCT03620981|101941345|FG000|Overall Study|Protocol Violation|1|||
33559001|NCT03620981|101941346|FG001|Overall Study|Protocol Violation|2|||
33559002|NCT03620981|101941347|FG002|Overall Study|Protocol Violation|1|||
33623326|NCT01702558|102169567|FG004|Overall Study|Withdrawal by Subject|4|||
33218787|NCT01972529|100699755|FG003|Overall Study|Other|2|||
33218788|NCT01972529|100699752|FG000|Overall Study|Not treated|0|||
33218789|NCT01972529|100699753|FG001|Overall Study|Not treated|1|||
33218790|NCT01972529|100699754|FG002|Overall Study|Not treated|2|||
33358742|NCT01926886|101201209|FG001|Overall Study|Withdrawal by Subject|0|||
33559003|NCT03620981|101941345|FG000|Overall Study|Withdrawal by Legal Representative|2|||
33559004|NCT03620981|101941346|FG001|Overall Study|Withdrawal by Legal Representative|1|||
33559005|NCT03620981|101941347|FG002|Overall Study|Withdrawal by Legal Representative|1|||
33218791|NCT01972529|100699755|FG003|Overall Study|Not treated|1|||
33218792|NCT03172702|100699756|FG000|Overall Study|Adverse Event|9|||
33218793|NCT03172702|100699756|FG000|Overall Study|Death|2|||
33559006|NCT03620981|101941345|FG000|Overall Study|Withdrawal by Care Giver|2|||
33559007|NCT03620981|101941346|FG001|Overall Study|Withdrawal by Care Giver|0|||
33623327|NCT01702558|102169563|FG000|Overall Study|Lost to Follow-up|0|||
33623328|NCT01702558|102169564|FG001|Overall Study|Lost to Follow-up|0|||
33623329|NCT01702558|102169565|FG002|Overall Study|Lost to Follow-up|0|||
33623330|NCT01702558|102169566|FG003|Overall Study|Lost to Follow-up|3|||
33218794|NCT03172702|100699756|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
33559008|NCT03620981|101941347|FG002|Overall Study|Withdrawal by Care Giver|1|||
33559009|NCT03620981|101941345|FG000|Overall Study|Non-compliance with Study Drug|1|||
33559010|NCT03620981|101941346|FG001|Overall Study|Non-compliance with Study Drug|1|||
33559011|NCT03620981|101941347|FG002|Overall Study|Non-compliance with Study Drug|0|||
33559012|NCT00960856|101943618|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
33559013|NCT00960856|101943619|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
33559014|NCT00960856|101943620|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
33559015|NCT00960856|101943621|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
33559016|NCT00960856|101943618|FG000|Washout Period of 7 Days|Adverse Event|0|||
33559017|NCT00960856|101943619|FG001|Washout Period of 7 Days|Adverse Event|0|||
33559018|NCT00960856|101943620|FG002|Washout Period of 7 Days|Adverse Event|1|||
33559019|NCT00960856|101943621|FG003|Washout Period of 7 Days|Adverse Event|0|||
33559020|NCT04209855|101943622|FG000|Overall Study|Adverse Event|20|||
33559021|NCT04209855|101943623|FG001|Overall Study|Adverse Event|28|||
33559022|NCT04209855|101943622|FG000|Overall Study|Death|3|||
33559023|NCT04209855|101943623|FG001|Overall Study|Death|1|||
33559024|NCT04209855|101943622|FG000|Overall Study|Principal Investigator (PI) Discretion|4|||
33559025|NCT04209855|101943623|FG001|Overall Study|Principal Investigator (PI) Discretion|9|||
33559026|NCT04209855|101943622|FG000|Overall Study|Participant Withdrew Consent to Treatment|4|||
33559027|NCT04209855|101943623|FG001|Overall Study|Participant Withdrew Consent to Treatment|11|||
33559028|NCT04209855|101943622|FG000|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|4|||
33559029|NCT04209855|101943623|FG001|Overall Study|Participant Withdrew Consent to Treatment and Follow-Up|15|||
33559030|NCT04209855|101943622|FG000|Overall Study|Progressive Disease|154|||
33559031|NCT04209855|101943623|FG001|Overall Study|Progressive Disease|145|||
33559032|NCT04209855|101943622|FG000|Overall Study|Protocol Deviation|1|||
33559033|NCT04209855|101943623|FG001|Overall Study|Protocol Deviation|1|||
33559034|NCT04209855|101943622|FG000|Overall Study|Other Than Specified|5|||
33559035|NCT04209855|101943623|FG001|Overall Study|Other Than Specified|10|||
33559036|NCT03186378|101943624|FG000|Overall Study|Lost to Follow-up|1|||
33559037|NCT03186378|101943625|FG001|Overall Study|Lost to Follow-up|0|||
33559038|NCT04105725|101943626|FG000|Primary Intervention|Lost to Follow-up|0|||
33559039|NCT04105725|101943627|FG001|Primary Intervention|Lost to Follow-up|2|||
33559040|NCT04105725|101943626|FG000|Primary Intervention|Withdrawal by Subject|0|||
33559041|NCT04105725|101943627|FG001|Primary Intervention|Withdrawal by Subject|1|||
33559042|NCT01886872|101943628|FG000|Overall Study|Ineligible|7|||
33623331|NCT01702558|102169567|FG004|Overall Study|Lost to Follow-up|0|||
33623332|NCT01702558|102169563|FG000|Overall Study|Death|4|||
33623333|NCT01702558|102169564|FG001|Overall Study|Death|3|||
33623334|NCT01702558|102169565|FG002|Overall Study|Death|3|||
33623335|NCT01702558|102169566|FG003|Overall Study|Death|16|||
33623336|NCT01702558|102169567|FG004|Overall Study|Death|20|||
33358743|NCT01926886|101201208|FG000|Overall Study|Failure to return|3|||
33358744|NCT01926886|101201209|FG001|Overall Study|Failure to return|0|||
33358745|NCT01926886|101201208|FG000|Overall Study|Recurrence of disease|1|||
33358746|NCT01926886|101201209|FG001|Overall Study|Recurrence of disease|0|||
33358747|NCT01926886|101201208|FG000|Overall Study|Progression of disease|2|||
33358748|NCT01926886|101201209|FG001|Overall Study|Progression of disease|0|||
33358749|NCT01926886|101201208|FG000|Overall Study|Death|1|||
33358750|NCT01926886|101201209|FG001|Overall Study|Death|0|||
33358751|NCT01926886|101201208|FG000|Overall Study|Did not cooperate|1|||
33358752|NCT01926886|101201209|FG001|Overall Study|Did not cooperate|0|||
33358753|NCT01707147|101201210|FG000|Overall Study|Administered Trajenta prior to contract|5|||
33559043|NCT01886872|101943629|FG001|Overall Study|Ineligible|4|||
33218795|NCT03172702|100699756|FG000|Overall Study|Withdrawal by Subject|5|||
33218796|NCT03172702|100699756|FG000|Overall Study|Other|2|||
33218797|NCT00409682|100699757|FG000|Open-label Induction Period|Adverse Event|1|||
33218798|NCT00409682|100699758|FG001|Open-label Induction Period|Adverse Event|0|||
33218799|NCT00409682|100699759|FG002|Open-label Induction Period|Adverse Event|0|||
33218800|NCT00409682|100699757|FG000|Open-label Induction Period|Lack of Efficacy|1|||
33218801|NCT00409682|100699758|FG001|Open-label Induction Period|Lack of Efficacy|0|||
33218802|NCT00409682|100699759|FG002|Open-label Induction Period|Lack of Efficacy|0|||
33559044|NCT01886872|101943630|FG002|Overall Study|Ineligible|12|||
33559045|NCT01902173|101943631|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
33559046|NCT01902173|101943632|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
33559047|NCT01902173|101943633|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
33623337|NCT01702558|102169563|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
33623338|NCT01702558|102169564|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
33623339|NCT01702558|102169565|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
33218803|NCT00409682|100699757|FG000|Open-label Induction Period|Protocol Violation|1|||
33218804|NCT00409682|100699758|FG001|Open-label Induction Period|Protocol Violation|0|||
33358754|NCT01707147|101201210|FG000|Overall Study|Patients who have not taken Trajenta|1|||
33559048|NCT01902173|101943634|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
33559049|NCT01902173|101943635|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
33623340|NCT01702558|102169566|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
33218805|NCT00409682|100699759|FG002|Open-label Induction Period|Protocol Violation|0|||
33218806|NCT00409682|100699757|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
33218807|NCT00409682|100699758|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
33358755|NCT01707147|101201210|FG000|Overall Study|Follow-up failure|17|||
33559050|NCT01902173|101943636|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
33358756|NCT01707147|101201210|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
33358757|NCT00793585|101201216|FG000|Overall Study|Adverse Event|1|||
33358758|NCT00793585|101201217|FG001|Overall Study|Adverse Event|1|||
33358759|NCT00793585|101201216|FG000|Overall Study|Protocol Violation|1|||
33358760|NCT00793585|101201217|FG001|Overall Study|Protocol Violation|2|||
33358761|NCT05370157|101201224|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
33358762|NCT05370157|101201225|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
33358763|NCT05370157|101201224|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
33358764|NCT05370157|101201225|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
33358765|NCT01096667|101201228|FG000|Overall Study|Lost to Follow-up|1|||
33358766|NCT01096667|101201229|FG001|Overall Study|Lost to Follow-up|1|||
33358767|NCT01096667|101201230|FG002|Overall Study|Lost to Follow-up|1|||
33358768|NCT01096667|101201231|FG003|Overall Study|Lost to Follow-up|0|||
33358769|NCT01096667|101201232|FG004|Overall Study|Lost to Follow-up|0|||
33358770|NCT01096667|101201228|FG000|Overall Study|Withdrawal by Subject|1|||
33358771|NCT01096667|101201229|FG001|Overall Study|Withdrawal by Subject|0|||
33358772|NCT01096667|101201230|FG002|Overall Study|Withdrawal by Subject|0|||
33358773|NCT01096667|101201231|FG003|Overall Study|Withdrawal by Subject|1|||
33358774|NCT01096667|101201232|FG004|Overall Study|Withdrawal by Subject|0|||
33358775|NCT01096667|101201228|FG000|Overall Study|Reason not available|0|||
33358776|NCT01096667|101201229|FG001|Overall Study|Reason not available|1|||
33358777|NCT01096667|101201230|FG002|Overall Study|Reason not available|1|||
33358778|NCT01096667|101201231|FG003|Overall Study|Reason not available|1|||
33358779|NCT01096667|101201232|FG004|Overall Study|Reason not available|0|||
33358780|NCT01096667|101201228|FG000|Overall Study|Protocol Violation|0|||
33358781|NCT01096667|101201229|FG001|Overall Study|Protocol Violation|0|||
33358782|NCT01096667|101201230|FG002|Overall Study|Protocol Violation|0|||
33358783|NCT01096667|101201231|FG003|Overall Study|Protocol Violation|1|||
33358784|NCT01096667|101201232|FG004|Overall Study|Protocol Violation|0|||
33358785|NCT01096667|101201228|FG000|Overall Study|Not treated|1|||
33358786|NCT01096667|101201229|FG001|Overall Study|Not treated|0|||
33358787|NCT01096667|101201230|FG002|Overall Study|Not treated|0|||
33358788|NCT01096667|101201231|FG003|Overall Study|Not treated|0|||
33358789|NCT01096667|101201232|FG004|Overall Study|Not treated|0|||
33358790|NCT02707757|101201237|FG000|Overall Study|Protocol Violation|3|||
33358791|NCT02707757|101201238|FG001|Overall Study|Protocol Violation|2|||
33358792|NCT02707757|101201237|FG000|Overall Study|Withdrawal by Subject|2|||
33358793|NCT02707757|101201238|FG001|Overall Study|Withdrawal by Subject|0|||
33358794|NCT02707757|101201237|FG000|Overall Study|Death|0|||
33358795|NCT02707757|101201238|FG001|Overall Study|Death|1|||
33358796|NCT02707757|101201237|FG000|Overall Study|Adverse Event|6|||
33559051|NCT01902173|101943631|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
33559052|NCT01902173|101943632|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
33559053|NCT01902173|101943633|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
33559054|NCT01902173|101943634|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
33559055|NCT01902173|101943635|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
33559056|NCT01902173|101943636|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
33559057|NCT01902173|101943631|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
33559058|NCT01902173|101943632|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
33559059|NCT01902173|101943633|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
33559060|NCT01902173|101943634|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
33559061|NCT01902173|101943635|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
33559062|NCT01902173|101943636|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
33559063|NCT01902173|101943631|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
33559064|NCT01902173|101943632|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
33559065|NCT01902173|101943633|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
33559066|NCT01902173|101943634|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
33559067|NCT01902173|101943635|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
33358797|NCT02707757|101201238|FG001|Overall Study|Adverse Event|4|||
33358798|NCT02707757|101201237|FG000|Overall Study|Renal transplant/elective operation|1|||
33358799|NCT02707757|101201238|FG001|Overall Study|Renal transplant/elective operation|5|||
33358800|NCT01416181|101201239|FG000|Part 1|Other|10|||
33559068|NCT01902173|101943636|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
33358801|NCT01416181|101201240|FG001|Part 1|Other|24|||
33358802|NCT01416181|101201239|FG000|Part 1|Death|0|||
33358803|NCT01416181|101201240|FG001|Part 1|Death|1|||
33358804|NCT01416181|101201239|FG000|Part 1|Investigator Decision|7|||
33358805|NCT01416181|101201240|FG001|Part 1|Investigator Decision|6|||
33559069|NCT01902173|101943631|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
33559070|NCT01902173|101943632|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
33358806|NCT01416181|101201239|FG000|Part 1|Withdrawal by Subject|74|||
33358807|NCT01416181|101201240|FG001|Part 1|Withdrawal by Subject|48|||
33358808|NCT01416181|101201239|FG000|Part 1|Lack of Efficacy|16|||
33218808|NCT00409682|100699759|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
33218809|NCT00409682|100699757|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
33218810|NCT00409682|100699758|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
33218811|NCT00409682|100699759|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
33218812|NCT00409682|100699757|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
33559071|NCT01902173|101943633|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
33559072|NCT01902173|101943634|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
33559073|NCT01902173|101943635|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
33559074|NCT01902173|101943636|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
33218813|NCT00409682|100699758|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
33218814|NCT00409682|100699759|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
33218815|NCT00409682|100699757|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
33218816|NCT00409682|100699758|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
33218817|NCT00409682|100699759|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
33218818|NCT00409682|100699757|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
33218819|NCT00409682|100699758|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
33218820|NCT00409682|100699759|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
33218821|NCT00409682|100699757|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
33218822|NCT00409682|100699758|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
33218823|NCT00409682|100699759|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
33218824|NCT00409682|100699757|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
33218825|NCT00409682|100699758|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
33358809|NCT01416181|101201240|FG001|Part 1|Lack of Efficacy|8|||
33358810|NCT01416181|101201239|FG000|Part 1|Lost to Follow-up|1|||
33358811|NCT01416181|101201240|FG001|Part 1|Lost to Follow-up|1|||
33358812|NCT01416181|101201239|FG000|Part 1|Adverse Event|15|||
33358813|NCT01416181|101201240|FG001|Part 1|Adverse Event|18|||
33358814|NCT01416181|101201239|FG000|Part 1|Ongoing in Follow-Up|14|||
33358815|NCT01416181|101201240|FG001|Part 1|Ongoing in Follow-Up|8|||
33358816|NCT01416181|101201239|FG000|Part 2|Adverse Event|11|||
33358817|NCT01416181|101201240|FG001|Part 2|Adverse Event|4|||
33358818|NCT01416181|101201239|FG000|Part 2|Other|234|||
33358819|NCT01416181|101201240|FG001|Part 2|Other|267|||
33358820|NCT01416181|101201239|FG000|Part 2|Investigator Decision|6|||
33358821|NCT01416181|101201240|FG001|Part 2|Investigator Decision|7|||
33414576|NCT01915498|101409840|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
33414577|NCT01915498|101409841|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
33559075|NCT01902173|101943631|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
33559076|NCT01902173|101943632|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
33559077|NCT01902173|101943633|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
33559078|NCT01902173|101943634|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
33559079|NCT01902173|101943635|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
33559080|NCT01902173|101943636|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
33559081|NCT01902173|101943631|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
33559082|NCT01902173|101943632|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
33559083|NCT01902173|101943633|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
33559084|NCT01902173|101943634|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
33559085|NCT01902173|101943635|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
33559086|NCT01902173|101943636|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
33559087|NCT01902173|101943631|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
33559088|NCT01902173|101943632|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
33559089|NCT01902173|101943633|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
33559090|NCT01902173|101943634|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
33559091|NCT01902173|101943635|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
33559092|NCT01902173|101943636|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
33559093|NCT01902173|101943631|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
33559094|NCT01902173|101943632|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
33218826|NCT00409682|100699759|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
33218827|NCT01494584|100699760|FG000|Overall Study|Study Closed/Terminated|1|||
33218828|NCT00441090|100699761|FG000|Overall Study|Adverse Event|0|||
33218829|NCT00441090|100699762|FG001|Overall Study|Adverse Event|1|||
33218830|NCT00441090|100699763|FG002|Overall Study|Adverse Event|1|||
33358822|NCT01416181|101201239|FG000|Part 2|Withdrawal by Subject|14|||
33358823|NCT01416181|101201240|FG001|Part 2|Withdrawal by Subject|5|||
33358824|NCT01416181|101201239|FG000|Part 2|Lack of Efficacy|4|||
33358825|NCT01416181|101201240|FG001|Part 2|Lack of Efficacy|1|||
33358826|NCT01416181|101201239|FG000|Part 2|Lost to Follow-up|2|||
33358827|NCT01416181|101201240|FG001|Part 2|Lost to Follow-up|2|||
33358828|NCT00174941|101201241|FG000|Overall Study|Adverse Event|1|||
33218831|NCT00441090|100699764|FG003|Overall Study|Adverse Event|0|||
33218832|NCT00441090|100699765|FG004|Overall Study|Adverse Event|0|||
33218833|NCT00441090|100699761|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
33218834|NCT00441090|100699762|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
33218835|NCT00441090|100699763|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
33218836|NCT00441090|100699764|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
33218837|NCT00441090|100699765|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
33218838|NCT00441090|100699761|FG000|Overall Study|Withdrawal by Subject|1|||
33218839|NCT00441090|100699762|FG001|Overall Study|Withdrawal by Subject|0|||
33218840|NCT00441090|100699763|FG002|Overall Study|Withdrawal by Subject|1|||
33218841|NCT00441090|100699764|FG003|Overall Study|Withdrawal by Subject|0|||
33218842|NCT00441090|100699765|FG004|Overall Study|Withdrawal by Subject|0|||
33218843|NCT00441090|100699761|FG000|Overall Study|Lack of Efficacy|1|||
33218844|NCT00441090|100699762|FG001|Overall Study|Lack of Efficacy|0|||
33218845|NCT00441090|100699763|FG002|Overall Study|Lack of Efficacy|0|||
33218846|NCT00441090|100699764|FG003|Overall Study|Lack of Efficacy|0|||
33218847|NCT00441090|100699765|FG004|Overall Study|Lack of Efficacy|0|||
33218848|NCT03804710|100699766|FG000|Overall Study|Adverse Event|0|||
33218849|NCT03804710|100699767|FG001|Overall Study|Adverse Event|3|||
33218850|NCT03804710|100699766|FG000|Overall Study|Withdrawal by Subject|2|||
33218851|NCT03804710|100699767|FG001|Overall Study|Withdrawal by Subject|1|||
33218852|NCT03804710|100699766|FG000|Overall Study|Other|0|||
33218853|NCT03804710|100699767|FG001|Overall Study|Other|1|||
33218854|NCT01113502|100699768|FG000|Overall Study|Withdrawal by Subject|1|||
33218855|NCT01113502|100699769|FG001|Overall Study|Withdrawal by Subject|0|||
33218856|NCT01113502|100699770|FG002|Overall Study|Withdrawal by Subject|1|||
33218857|NCT01113502|100699771|FG003|Overall Study|Withdrawal by Subject|1|||
33218858|NCT01113502|100699772|FG004|Overall Study|Withdrawal by Subject|0|||
33218859|NCT01113502|100699768|FG000|Overall Study|Adverse Event|0|||
33218860|NCT01113502|100699769|FG001|Overall Study|Adverse Event|0|||
33218861|NCT01113502|100699770|FG002|Overall Study|Adverse Event|3|||
33218862|NCT01113502|100699771|FG003|Overall Study|Adverse Event|2|||
33218863|NCT01113502|100699772|FG004|Overall Study|Adverse Event|0|||
33218864|NCT03802123|100699777|FG000|Overall Study|Withdrawal by Subject|3|||
33218865|NCT03802123|100699777|FG000|Overall Study|Physician Decision|1|||
33218866|NCT03802123|100699777|FG000|Overall Study|Subject moved to hospice care|1|||
33218867|NCT03802123|100699777|FG000|Overall Study|technician error|1|||
33218868|NCT03802123|100699777|FG000|Overall Study|Death|3|||
33218869|NCT03295318|100699778|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
33218870|NCT03295318|100699779|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
33218871|NCT03295318|100699780|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
33218872|NCT03295318|100699778|FG000|Overall Study|Death|1|||
33218873|NCT03295318|100699779|FG001|Overall Study|Death|1|||
33218874|NCT03295318|100699780|FG002|Overall Study|Death|1|||
33218875|NCT03295318|100699778|FG000|Overall Study|Protocol Violation|4|||
33218876|NCT03295318|100699779|FG001|Overall Study|Protocol Violation|3|||
33218877|NCT03295318|100699780|FG002|Overall Study|Protocol Violation|3|||
33218878|NCT03295318|100699778|FG000|Overall Study|Withdrawal by Subject|0|||
33218879|NCT03295318|100699779|FG001|Overall Study|Withdrawal by Subject|0|||
33218880|NCT03295318|100699780|FG002|Overall Study|Withdrawal by Subject|1|||
33559095|NCT01902173|101943633|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
33559096|NCT01902173|101943634|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
33559097|NCT01902173|101943635|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
33559098|NCT01902173|101943636|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
33559099|NCT01902173|101943631|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
33559100|NCT01902173|101943632|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
33559101|NCT01902173|101943633|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
33559102|NCT01902173|101943634|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
33559103|NCT01902173|101943635|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
33218881|NCT03295318|100699778|FG000|Overall Study|Subject discontinued due to travel|0|||
33218882|NCT03295318|100699779|FG001|Overall Study|Subject discontinued due to travel|1|||
33218883|NCT03295318|100699780|FG002|Overall Study|Subject discontinued due to travel|0|||
33218884|NCT02089230|100699781|FG000|Overall Study|Death|0|||
33218885|NCT02089230|100699782|FG001|Overall Study|Death|0|||
33559104|NCT01902173|101943636|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
33559105|NCT01902173|101943631|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
33218886|NCT02089230|100699783|FG002|Overall Study|Death|2|||
33218887|NCT02089230|100699781|FG000|Overall Study|Seeking Alternative Therapy|0|||
33218888|NCT02089230|100699782|FG001|Overall Study|Seeking Alternative Therapy|0|||
33218889|NCT02089230|100699783|FG002|Overall Study|Seeking Alternative Therapy|4|||
33218890|NCT00289887|100699784|FG000|Overall Study|Adverse Event|3|||
33218891|NCT00289887|100699785|FG001|Overall Study|Adverse Event|3|||
33218892|NCT00289887|100699784|FG000|Overall Study|Lack of Efficacy|3|||
33218893|NCT00289887|100699785|FG001|Overall Study|Lack of Efficacy|11|||
33559106|NCT01902173|101943632|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
33358829|NCT00174941|101201242|FG001|Overall Study|Adverse Event|10|||
33358830|NCT00174941|101201243|FG002|Overall Study|Adverse Event|2|||
33559107|NCT01902173|101943633|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
33559108|NCT01902173|101943634|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
33559109|NCT01902173|101943635|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
33559110|NCT01902173|101943636|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
33358831|NCT00174941|101201244|FG003|Overall Study|Adverse Event|13|||
33358832|NCT00174941|101201241|FG000|Overall Study|Protocol Violation|0|||
33358833|NCT00174941|101201242|FG001|Overall Study|Protocol Violation|1|||
33358834|NCT00174941|101201243|FG002|Overall Study|Protocol Violation|0|||
33358835|NCT00174941|101201244|FG003|Overall Study|Protocol Violation|1|||
33358836|NCT00174941|101201241|FG000|Overall Study|Lost to Follow-up|0|||
33358837|NCT00174941|101201242|FG001|Overall Study|Lost to Follow-up|3|||
33358838|NCT00174941|101201243|FG002|Overall Study|Lost to Follow-up|2|||
33358839|NCT00174941|101201244|FG003|Overall Study|Lost to Follow-up|5|||
33358840|NCT00174941|101201241|FG000|Overall Study|Personal Reason(s)|0|||
33559111|NCT01902173|101943631|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
33559112|NCT01902173|101943632|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
33559113|NCT01902173|101943633|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
33559114|NCT01902173|101943634|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
33559115|NCT01902173|101943635|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
33559116|NCT01902173|101943636|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
33559117|NCT01902173|101943631|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
33559118|NCT01902173|101943632|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
33559119|NCT01902173|101943633|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
33559120|NCT01902173|101943634|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
33559121|NCT01902173|101943635|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
33559122|NCT01902173|101943636|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
33559123|NCT01902173|101943631|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
33559124|NCT01902173|101943632|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
33559125|NCT01902173|101943633|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
33559126|NCT01902173|101943634|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
33559127|NCT01902173|101943635|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
33559128|NCT01902173|101943636|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
33559129|NCT06399471|101943639|FG000|Overall Study|Withdrawal by Subject|1|||
33559130|NCT05652140|101943640|FG000|Overall Study|Lost to Follow-up|7|||
33559131|NCT05652140|101943641|FG001|Overall Study|Lost to Follow-up|16|||
33559132|NCT05652140|101943642|FG002|Overall Study|Lost to Follow-up|22|||
33559133|NCT05652140|101943643|FG003|Overall Study|Lost to Follow-up|31|||
33559134|NCT04157738|101943646|FG000|Overall Study|Moved out of state|0|||
33559135|NCT04157738|101943647|FG001|Overall Study|Moved out of state|2|||
33559136|NCT04157738|101943646|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
33559137|NCT04157738|101943647|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
33559138|NCT01856192|101943648|FG000|Overall Study|Adverse Event|12|||
33559139|NCT01856192|101943649|FG001|Overall Study|Adverse Event|4|||
33559140|NCT01856192|101943648|FG000|Overall Study|Alternative therapy|0|||
33559141|NCT01856192|101943649|FG001|Overall Study|Alternative therapy|3|||
33559142|NCT01856192|101943648|FG000|Overall Study|Death|3|||
33559143|NCT01856192|101943649|FG001|Overall Study|Death|5|||
33559144|NCT01856192|101943648|FG000|Overall Study|Lack of Efficacy|0|||
33358841|NCT00174941|101201242|FG001|Overall Study|Personal Reason(s)|14|||
33559145|NCT01856192|101943649|FG001|Overall Study|Lack of Efficacy|5|||
33559146|NCT01856192|101943648|FG000|Overall Study|Withdrawal by Subject|1|||
33559147|NCT01856192|101943649|FG001|Overall Study|Withdrawal by Subject|1|||
33559148|NCT01856192|101943648|FG000|Overall Study|Other diseases|1|||
33559149|NCT01856192|101943649|FG001|Overall Study|Other diseases|0|||
33559150|NCT01856192|101943648|FG000|Overall Study|Never started treatment|7|||
33559151|NCT01856192|101943649|FG001|Overall Study|Never started treatment|5|||
33559152|NCT01856192|101943648|FG000|Overall Study|Path ineligible|20|||
33559153|NCT01856192|101943649|FG001|Overall Study|Path ineligible|34|||
33559154|NCT01856192|101943648|FG000|Overall Study|Non-path ineligible|2|||
33559155|NCT01856192|101943649|FG001|Overall Study|Non-path ineligible|2|||
33358842|NCT00174941|101201243|FG002|Overall Study|Personal Reason(s)|8|||
33358843|NCT00174941|101201244|FG003|Overall Study|Personal Reason(s)|22|||
33358844|NCT00174941|101201241|FG000|Overall Study|Gout Flare|0|||
33559156|NCT01856192|101943648|FG000|Overall Study|Physician Decision|1|||
33559157|NCT01856192|101943649|FG001|Overall Study|Physician Decision|1|||
33559158|NCT01856192|101943648|FG000|Overall Study|Suspicion of progressive disease|1|||
33559159|NCT01856192|101943649|FG001|Overall Study|Suspicion of progressive disease|0|||
33559160|NCT01856192|101943648|FG000|Overall Study|Non-compliance|1|||
33559161|NCT01856192|101943649|FG001|Overall Study|Non-compliance|0|||
33559162|NCT03533491|101943650|FG000|Overall Study|Lost to Follow-up|2|||
33559163|NCT04398706|101943651|FG000|Overall Study|Adverse Event|0|||
33559164|NCT04398706|101943652|FG001|Overall Study|Adverse Event|0|||
33218894|NCT00289887|100699784|FG000|Overall Study|Lost to Follow-up|3|||
33358845|NCT00174941|101201242|FG001|Overall Study|Gout Flare|4|||
33559165|NCT04398706|101943653|FG002|Overall Study|Adverse Event|0|||
33559166|NCT04398706|101943654|FG003|Overall Study|Adverse Event|0|||
33559167|NCT04398706|101943655|FG004|Overall Study|Adverse Event|0|||
33559168|NCT04398706|101943656|FG005|Overall Study|Adverse Event|1|||
33559169|NCT04398706|101943657|FG006|Overall Study|Adverse Event|1|||
33559170|NCT04398706|101943658|FG007|Overall Study|Adverse Event|0|||
33559171|NCT04398706|101943651|FG000|Overall Study|Lost to Follow-up|0|||
33559172|NCT04398706|101943652|FG001|Overall Study|Lost to Follow-up|1|||
33559173|NCT04398706|101943653|FG002|Overall Study|Lost to Follow-up|2|||
33559174|NCT04398706|101943654|FG003|Overall Study|Lost to Follow-up|1|||
33559175|NCT04398706|101943655|FG004|Overall Study|Lost to Follow-up|6|||
33559176|NCT04398706|101943656|FG005|Overall Study|Lost to Follow-up|3|||
33559177|NCT04398706|101943657|FG006|Overall Study|Lost to Follow-up|8|||
33559178|NCT04398706|101943658|FG007|Overall Study|Lost to Follow-up|2|||
33623341|NCT01702558|102169567|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
33623342|NCT01702558|102169563|FG000|Overall Study|Study Terminated by Sponsor|0|||
33623343|NCT01702558|102169564|FG001|Overall Study|Study Terminated by Sponsor|1|||
33623344|NCT01702558|102169565|FG002|Overall Study|Study Terminated by Sponsor|0|||
33218895|NCT00289887|100699785|FG001|Overall Study|Lost to Follow-up|3|||
33218896|NCT00289887|100699784|FG000|Overall Study|Protocol Violation|3|||
33623345|NCT01702558|102169566|FG003|Overall Study|Study Terminated by Sponsor|0|||
33623346|NCT01702558|102169567|FG004|Overall Study|Study Terminated by Sponsor|1|||
33623347|NCT01702558|102169563|FG000|Overall Study|Other|0|||
33623348|NCT01702558|102169564|FG001|Overall Study|Other|0|||
33623349|NCT01702558|102169565|FG002|Overall Study|Other|0|||
33623350|NCT01702558|102169566|FG003|Overall Study|Other|16|||
33623351|NCT01702558|102169567|FG004|Overall Study|Other|17|||
33623352|NCT00764361|102169572|FG000|Overall Study|Withdrawal by Subject|2|||
33623353|NCT00764361|102169573|FG001|Overall Study|Withdrawal by Subject|3|||
33218897|NCT00289887|100699785|FG001|Overall Study|Protocol Violation|1|||
33218898|NCT00289887|100699784|FG000|Overall Study|Withdrawal by Subject|3|||
33218899|NCT00289887|100699785|FG001|Overall Study|Withdrawal by Subject|8|||
33218900|NCT00289887|100699784|FG000|Overall Study|Other|7|||
33218901|NCT00289887|100699785|FG001|Overall Study|Other|3|||
33218902|NCT00708916|100699786|FG000|Overall Study|Subject Noncompliance|2|||
33218903|NCT00708916|100699786|FG000|Overall Study|Adverse Event|2|||
33218904|NCT00549757|100699787|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
33218905|NCT00549757|100699788|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
33218906|NCT00549757|100699787|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
33218907|NCT00549757|100699788|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
33218908|NCT00549757|100699787|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
33218909|NCT00549757|100699788|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
33218910|NCT00549757|100699787|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
33218911|NCT00549757|100699788|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
33218912|NCT00549757|100699787|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
33218913|NCT00549757|100699788|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
33218914|NCT00549757|100699787|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
33218915|NCT00549757|100699788|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
33218916|NCT00549757|100699787|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
33218917|NCT00549757|100699788|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
33218918|NCT00549757|100699787|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
33218919|NCT00549757|100699788|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
33218920|NCT00549757|100699787|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
33218921|NCT00549757|100699788|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
33218922|NCT00549757|100699787|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
33218923|NCT00549757|100699788|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
33218924|NCT00549757|100699787|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
33218925|NCT00549757|100699788|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
33218926|NCT00549757|100699787|FG000|Extension Period (in Average 9 Months)|Death|143|||
33218927|NCT00549757|100699788|FG001|Extension Period (in Average 9 Months)|Death|136|||
33623354|NCT00764361|102169572|FG000|Overall Study|Adverse Event|0|||
33623355|NCT00764361|102169573|FG001|Overall Study|Adverse Event|1|||
33623356|NCT04537793|102169574|FG000|Part B (24 Weeks)|Adverse Event|0|||
33218928|NCT00549757|100699787|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
33218929|NCT00549757|100699788|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
33218930|NCT00549757|100699787|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
33218931|NCT00549757|100699788|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
33218932|NCT00549757|100699787|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
33559179|NCT04398706|101943651|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33559180|NCT04398706|101943652|FG001|Overall Study|Withdrawal by parent/guardian|2|||
33559181|NCT04398706|101943653|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33623357|NCT04537793|102169575|FG001|Part B (24 Weeks)|Adverse Event|1|||
33559182|NCT04398706|101943654|FG003|Overall Study|Withdrawal by parent/guardian|2|||
33559183|NCT04398706|101943655|FG004|Overall Study|Withdrawal by parent/guardian|19|||
33559184|NCT04398706|101943656|FG005|Overall Study|Withdrawal by parent/guardian|23|||
33559185|NCT04398706|101943657|FG006|Overall Study|Withdrawal by parent/guardian|13|||
33559186|NCT04398706|101943658|FG007|Overall Study|Withdrawal by parent/guardian|11|||
33559187|NCT04398706|101943651|FG000|Overall Study|Protocol deviation|0|||
33559188|NCT04398706|101943652|FG001|Overall Study|Protocol deviation|1|||
33559189|NCT04398706|101943653|FG002|Overall Study|Protocol deviation|0|||
33559190|NCT04398706|101943654|FG003|Overall Study|Protocol deviation|0|||
33358846|NCT00174941|101201243|FG002|Overall Study|Gout Flare|4|||
33358847|NCT00174941|101201244|FG003|Overall Study|Gout Flare|8|||
33358848|NCT00174941|101201241|FG000|Overall Study|Reason Not Specified|1|||
33358849|NCT00174941|101201242|FG001|Overall Study|Reason Not Specified|6|||
33358850|NCT00174941|101201243|FG002|Overall Study|Reason Not Specified|2|||
33358851|NCT00174941|101201244|FG003|Overall Study|Reason Not Specified|9|||
33559191|NCT04398706|101943655|FG004|Overall Study|Protocol deviation|6|||
33559192|NCT04398706|101943656|FG005|Overall Study|Protocol deviation|4|||
33218933|NCT00549757|100699788|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
33218934|NCT01733732|100699789|FG000|Overall Study|Adverse Event|1|||
33218935|NCT01733732|100699790|FG001|Overall Study|Adverse Event|0|||
33623358|NCT01794000|102169576|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
33623359|NCT01794000|102169577|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
33623360|NCT01794000|102169576|FG000|Double-Blind Phase (DBP)|Death|1|||
33623361|NCT01794000|102169577|FG001|Double-Blind Phase (DBP)|Death|2|||
33623362|NCT01794000|102169576|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
33623363|NCT01794000|102169577|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
33623364|NCT01794000|102169576|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
33623365|NCT01794000|102169577|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
33623366|NCT01794000|102169576|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
33623367|NCT01794000|102169577|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
33623368|NCT01794000|102169576|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
33623369|NCT01794000|102169577|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
33623370|NCT01794000|102169576|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
33623371|NCT01794000|102169577|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
33623372|NCT01794000|102169576|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
33623373|NCT01794000|102169577|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
33623374|NCT00550953|102169591|FG000|Overall Study|Adverse Event|4|||
33623375|NCT00550953|102169592|FG001|Overall Study|Adverse Event|3|||
33623376|NCT00550953|102169591|FG000|Overall Study|Not able to visit the site|2|||
33623377|NCT00550953|102169592|FG001|Overall Study|Not able to visit the site|3|||
33623378|NCT02730728|102169596|FG000|Overall Study|Withdrawal by Subject|0|||
33623379|NCT02730728|102169597|FG001|Overall Study|Withdrawal by Subject|1|||
33623380|NCT02730728|102169598|FG002|Overall Study|Withdrawal by Subject|0|||
33623381|NCT02730728|102169596|FG000|Overall Study|Lack of Efficacy|0|||
33623382|NCT02730728|102169597|FG001|Overall Study|Lack of Efficacy|1|||
33623383|NCT02730728|102169598|FG002|Overall Study|Lack of Efficacy|1|||
33623384|NCT01879683|102169599|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
33623385|NCT01751984|102169601|FG000|Overall Study|Adverse Event|5|||
33623386|NCT01751984|102169602|FG001|Overall Study|Adverse Event|3|||
33623387|NCT01751984|102169601|FG000|Overall Study|Withdrawal by Subject|0|||
33218936|NCT01733732|100699789|FG000|Overall Study|Did not attend all study visits|1|||
33218937|NCT01733732|100699790|FG001|Overall Study|Did not attend all study visits|0|||
33218938|NCT02027402|100699791|FG000|Overall Study|Withdrawal by Subject|4|||
33218939|NCT02027402|100699792|FG001|Overall Study|Withdrawal by Subject|1|||
33218940|NCT03595332|100699793|FG000|Overall Study|Lost to Follow-up|16|||
33218941|NCT03595332|100699794|FG001|Overall Study|Lost to Follow-up|22|||
33218942|NCT03595332|100699793|FG000|Overall Study|Unable to retrieve ID from school|0|||
33218943|NCT03595332|100699794|FG001|Overall Study|Unable to retrieve ID from school|2|||
33218944|NCT01949311|100699795|FG000|Overall Study|Lost to Follow-up|73|||
33218945|NCT01949311|100699795|FG000|Overall Study|Terminated by Sponsor|708|||
33623388|NCT01751984|102169602|FG001|Overall Study|Withdrawal by Subject|1|||
33358852|NCT01873950|101201245|FG000|Period 5|Withdrawal by Subject|0|||
33623389|NCT01751984|102169601|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
33358853|NCT01873950|101201246|FG001|Period 5|Withdrawal by Subject|0|||
33358854|NCT01873950|101201247|FG002|Period 5|Withdrawal by Subject|0|||
33358855|NCT01873950|101201248|FG003|Period 5|Withdrawal by Subject|1|||
33623390|NCT01751984|102169602|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
33218946|NCT01949311|100699795|FG000|Overall Study|Withdrawal by Subject|375|||
33358856|NCT01873950|101201249|FG004|Period 5|Withdrawal by Subject|0|||
33218947|NCT01949311|100699795|FG000|Overall Study|Lack of Efficacy|50|||
33218948|NCT01949311|100699795|FG000|Overall Study|Protocol Deviation|34|||
33559193|NCT04398706|101943657|FG006|Overall Study|Protocol deviation|6|||
33559194|NCT04398706|101943658|FG007|Overall Study|Protocol deviation|3|||
33559195|NCT03734536|101943660|FG000|Overall Study|Withdrew Consent|1|||
33559196|NCT03734536|101943661|FG001|Overall Study|Withdrew Consent|5|||
33559197|NCT03734536|101943660|FG000|Overall Study|Lost to Follow-up|10|||
33559198|NCT03734536|101943661|FG001|Overall Study|Lost to Follow-up|7|||
33559199|NCT04765384|101943662|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
33559200|NCT04765384|101943663|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
33559201|NCT04765384|101943664|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
33559202|NCT04765384|101943665|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
33559203|NCT04765384|101943666|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
33218949|NCT01949311|100699795|FG000|Overall Study|Pregnancy|20|||
33218950|NCT01949311|100699795|FG000|Overall Study|Physician Decision|9|||
33218951|NCT01949311|100699795|FG000|Overall Study|Other|4|||
33218952|NCT01949311|100699795|FG000|Overall Study|Adverse Event|107|||
33218953|NCT03255824|100699806|FG000|Overall Study|Under-sedation|2|||
33358857|NCT00858832|101201252|FG000|Overall Study|became ineligible: delivered vaginally|1|||
33559204|NCT04765384|101943667|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
33559205|NCT04765384|101943662|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
33559206|NCT04765384|101943663|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
33559207|NCT04765384|101943664|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
33559208|NCT04765384|101943665|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
33559209|NCT04765384|101943666|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
33559210|NCT04765384|101943667|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
33559211|NCT04765384|101943662|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
33559212|NCT04765384|101943663|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
33559213|NCT04765384|101943664|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
33559214|NCT04765384|101943665|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
33559215|NCT04765384|101943666|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
33559216|NCT04765384|101943667|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
33559217|NCT04765384|101943662|FG000|Post-natal: Neonates and Infants|Death|0|||
33559218|NCT04765384|101943663|FG001|Post-natal: Neonates and Infants|Death|0|||
33559219|NCT04765384|101943664|FG002|Post-natal: Neonates and Infants|Death|0|||
33218954|NCT03255824|100699807|FG001|Overall Study|Under-sedation|1|||
33218955|NCT03813238|100699810|FG000|Overall Study|Adverse Event|0|||
33218956|NCT03813238|100699811|FG001|Overall Study|Adverse Event|6|||
33218957|NCT03813238|100699810|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33218958|NCT03813238|100699811|FG001|Overall Study|Withdrawal by parent/guardian|2|||
33218959|NCT03813238|100699810|FG000|Overall Study|Lost to Follow-up|0|||
33218960|NCT03813238|100699811|FG001|Overall Study|Lost to Follow-up|1|||
33218961|NCT03813238|100699810|FG000|Overall Study|Other than specified|1|||
33218962|NCT03813238|100699811|FG001|Overall Study|Other than specified|2|||
33218963|NCT01648270|100699812|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
33218964|NCT04252742|100699815|FG000|Overall Study|Decision by sponsor|0|||
33218965|NCT04252742|100699816|FG001|Overall Study|Decision by sponsor|2|||
33218966|NCT04252742|100699815|FG000|Overall Study|Withdrawal by Subject|15|||
33218967|NCT04252742|100699816|FG001|Overall Study|Withdrawal by Subject|9|||
33218968|NCT04252742|100699815|FG000|Overall Study|Lost to Follow-up|0|||
33218969|NCT04252742|100699816|FG001|Overall Study|Lost to Follow-up|1|||
33218970|NCT05899686|100699817|FG000|Overall Study|Protocol Violation|1|||
33218971|NCT01822587|100699818|FG000|Overall Study|Lost to Follow-up|7|||
33218972|NCT01822587|100699819|FG001|Overall Study|Lost to Follow-up|9|||
33218973|NCT01822587|100699820|FG002|Overall Study|Lost to Follow-up|12|||
33218974|NCT01822587|100699818|FG000|Overall Study|Physician Decision|9|||
33218975|NCT01822587|100699819|FG001|Overall Study|Physician Decision|6|||
33218976|NCT01822587|100699820|FG002|Overall Study|Physician Decision|6|||
33218977|NCT02355028|100699821|FG000|Overall Study|Adverse Event|2|||
33218978|NCT02355028|100699822|FG001|Overall Study|Adverse Event|0|||
33218979|NCT02355028|100699821|FG000|Overall Study|Withdrawal by Subject|1|||
33218980|NCT02355028|100699822|FG001|Overall Study|Withdrawal by Subject|1|||
33218981|NCT02355028|100699821|FG000|Overall Study|Deemed ineligible after randomization|8|||
33218982|NCT02355028|100699822|FG001|Overall Study|Deemed ineligible after randomization|4|||
33218983|NCT01281202|100699823|FG000|Overall Study|Adverse Event|2|||
33218984|NCT01281202|100699824|FG001|Overall Study|Adverse Event|0|||
33218985|NCT01281202|100699823|FG000|Overall Study|Withdrawal by Subject|2|||
33218986|NCT01281202|100699824|FG001|Overall Study|Withdrawal by Subject|2|||
33218987|NCT01281202|100699823|FG000|Overall Study|Protocol Violation|11|||
33218988|NCT01281202|100699824|FG001|Overall Study|Protocol Violation|10|||
33218989|NCT01281202|100699823|FG000|Overall Study|Administrative|2|||
33218990|NCT01281202|100699824|FG001|Overall Study|Administrative|8|||
33218991|NCT01281202|100699823|FG000|Overall Study|Lost to Follow-up|11|||
33218992|NCT01281202|100699824|FG001|Overall Study|Lost to Follow-up|13|||
33218993|NCT01281202|100699823|FG000|Overall Study|Incarceration|0|||
33218994|NCT01281202|100699824|FG001|Overall Study|Incarceration|3|||
33218995|NCT00117676|100699827|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
33218996|NCT00117676|100699828|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
33218997|NCT00117676|100699827|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
33218998|NCT00117676|100699828|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
33218999|NCT00117676|100699827|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
33219000|NCT00117676|100699828|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
33219001|NCT00117676|100699827|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
33219002|NCT00117676|100699828|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
33219003|NCT00117676|100699827|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
33219004|NCT00117676|100699828|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
33219005|NCT00117676|100699827|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
33219006|NCT00117676|100699828|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
33219007|NCT00117676|100699827|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
33219008|NCT00117676|100699828|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
33219009|NCT00117676|100699827|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
33219010|NCT00117676|100699828|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
33219011|NCT00117676|100699827|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
33219012|NCT00117676|100699828|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
33219013|NCT00117676|100699827|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
33219014|NCT00117676|100699828|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
33358858|NCT00858832|101201253|FG001|Overall Study|became ineligible: delivered vaginally|0|||
33358859|NCT00858832|101201252|FG000|Overall Study|Adverse Event|0|||
33358860|NCT00858832|101201253|FG001|Overall Study|Adverse Event|1|||
33219015|NCT00117676|100699827|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
33219016|NCT00117676|100699828|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
33219017|NCT00117676|100699827|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
33219018|NCT00117676|100699828|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
33219019|NCT00117676|100699827|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
33219020|NCT00117676|100699828|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
33219021|NCT00117676|100699827|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
33219022|NCT00117676|100699828|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
33219023|NCT00117676|100699827|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
33219024|NCT00117676|100699828|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
33219025|NCT00117676|100699827|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
33219026|NCT00117676|100699828|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
33219027|NCT00117676|100699827|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
33219028|NCT00117676|100699828|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
33219029|NCT00117676|100699827|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
33219030|NCT00117676|100699828|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
33219031|NCT00117676|100699827|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
33219032|NCT00117676|100699828|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
33219033|NCT00117676|100699827|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
33219034|NCT00117676|100699828|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
33219035|NCT00117676|100699827|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
33219036|NCT00117676|100699828|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
33219037|NCT00117676|100699827|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
33219038|NCT00117676|100699828|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
33219039|NCT00117676|100699827|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
33219040|NCT00117676|100699828|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
33219041|NCT00117676|100699827|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
33219042|NCT00117676|100699828|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
33219043|NCT00117676|100699827|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
33219044|NCT00117676|100699828|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
33219045|NCT00117676|100699827|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
33219046|NCT00117676|100699828|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
33219047|NCT00117676|100699827|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
33219048|NCT00117676|100699828|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
33219049|NCT00117676|100699827|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
33219050|NCT00117676|100699828|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
33219051|NCT00117676|100699827|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
33219052|NCT00117676|100699828|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
33219053|NCT00117676|100699827|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
33219054|NCT00117676|100699828|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
33219055|NCT00117676|100699827|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
33219056|NCT00117676|100699828|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
33219057|NCT00117676|100699827|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
33219058|NCT00117676|100699828|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
33219059|NCT00117676|100699827|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
33219060|NCT00117676|100699828|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
33219061|NCT00117676|100699827|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
33219062|NCT00117676|100699828|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
33219063|NCT00117676|100699827|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
33219064|NCT00117676|100699828|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
33219065|NCT01833143|100699831|FG000|Overall Study|Not Treated|1|||
33219066|NCT02753595|100699832|FG000|Overall Study|Sponsor termination|2|||
33219067|NCT02753595|100699833|FG001|Overall Study|Sponsor termination|2|||
33219068|NCT02548455|100699834|FG000|Overall Study|Withdrawal by Subject|27|||
33219069|NCT02548455|100699834|FG000|Overall Study|Death|26|||
33219070|NCT02548455|100699834|FG000|Overall Study|Lost to Follow-up|14|||
33219071|NCT02548455|100699834|FG000|Overall Study|Visit not completed|173|||
33219072|NCT02969525|100699838|FG000|Double-Blind Period|Adverse Event|0|||
33219073|NCT02969525|100699839|FG001|Double-Blind Period|Adverse Event|0|||
33219074|NCT02969525|100699840|FG002|Double-Blind Period|Adverse Event|1|||
33219075|NCT02969525|100699841|FG003|Double-Blind Period|Adverse Event|1|||
33219076|NCT02969525|100699842|FG004|Double-Blind Period|Adverse Event|0|||
33219077|NCT02969525|100699843|FG005|Double-Blind Period|Adverse Event|0|||
33219078|NCT02969525|100699844|FG006|Double-Blind Period|Adverse Event|0|||
33219079|NCT02969525|100699845|FG007|Double-Blind Period|Adverse Event|0|||
33219080|NCT02969525|100699846|FG008|Double-Blind Period|Adverse Event|0|||
33219081|NCT02969525|100699847|FG009|Double-Blind Period|Adverse Event|0|||
33219082|NCT02969525|100699848|FG010|Double-Blind Period|Adverse Event|0|||
33219083|NCT02969525|100699849|FG011|Double-Blind Period|Adverse Event|0|||
33219084|NCT02969525|100699838|FG000|Double-Blind Period|LOW EGFR|0|||
33219085|NCT02969525|100699839|FG001|Double-Blind Period|LOW EGFR|0|||
33219086|NCT02969525|100699840|FG002|Double-Blind Period|LOW EGFR|0|||
33219087|NCT02969525|100699841|FG003|Double-Blind Period|LOW EGFR|1|||
33219088|NCT02969525|100699842|FG004|Double-Blind Period|LOW EGFR|0|||
33219089|NCT02969525|100699843|FG005|Double-Blind Period|LOW EGFR|0|||
33219090|NCT02969525|100699844|FG006|Double-Blind Period|LOW EGFR|0|||
33219091|NCT02969525|100699845|FG007|Double-Blind Period|LOW EGFR|0|||
33219092|NCT02969525|100699846|FG008|Double-Blind Period|LOW EGFR|0|||
33219093|NCT02969525|100699847|FG009|Double-Blind Period|LOW EGFR|0|||
33219094|NCT02969525|100699848|FG010|Double-Blind Period|LOW EGFR|0|||
33219095|NCT02969525|100699849|FG011|Double-Blind Period|LOW EGFR|0|||
33219096|NCT02969525|100699838|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
33219097|NCT02969525|100699839|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33219098|NCT02969525|100699840|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33219099|NCT02969525|100699841|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
33219100|NCT02969525|100699842|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33219101|NCT02969525|100699843|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33219102|NCT02969525|100699844|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33219103|NCT02969525|100699845|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33219104|NCT02969525|100699846|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33219105|NCT02969525|100699847|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33219106|NCT02969525|100699848|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33219107|NCT02969525|100699849|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
33219108|NCT02969525|100699838|FG000|Dose-Blind Period|Adverse Event|0|||
33219109|NCT02969525|100699839|FG001|Dose-Blind Period|Adverse Event|0|||
33219110|NCT02969525|100699840|FG002|Dose-Blind Period|Adverse Event|0|||
33219111|NCT02969525|100699841|FG003|Dose-Blind Period|Adverse Event|0|||
33219112|NCT02969525|100699842|FG004|Dose-Blind Period|Adverse Event|0|||
33219113|NCT02969525|100699843|FG005|Dose-Blind Period|Adverse Event|0|||
33219114|NCT02969525|100699844|FG006|Dose-Blind Period|Adverse Event|0|||
33219115|NCT02969525|100699845|FG007|Dose-Blind Period|Adverse Event|0|||
33219116|NCT02969525|100699846|FG008|Dose-Blind Period|Adverse Event|0|||
33219117|NCT02969525|100699847|FG009|Dose-Blind Period|Adverse Event|1|||
33219118|NCT02969525|100699848|FG010|Dose-Blind Period|Adverse Event|1|||
33219119|NCT02969525|100699849|FG011|Dose-Blind Period|Adverse Event|1|||
33219120|NCT02969525|100699838|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
33219121|NCT02969525|100699839|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
33219122|NCT02969525|100699840|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
33219123|NCT02969525|100699841|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
33219124|NCT02969525|100699842|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
33219125|NCT02969525|100699843|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
33219126|NCT02969525|100699844|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
33219127|NCT02969525|100699845|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
33219128|NCT02969525|100699846|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
33219129|NCT02969525|100699847|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
33219130|NCT02969525|100699848|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
33219131|NCT02969525|100699849|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
33219132|NCT02969525|100699838|FG000|Dose-Blind Period|Non-cooperating patient|0|||
33219133|NCT02969525|100699839|FG001|Dose-Blind Period|Non-cooperating patient|0|||
33219134|NCT02969525|100699840|FG002|Dose-Blind Period|Non-cooperating patient|0|||
33219135|NCT02969525|100699841|FG003|Dose-Blind Period|Non-cooperating patient|0|||
33219136|NCT02969525|100699842|FG004|Dose-Blind Period|Non-cooperating patient|0|||
33219137|NCT02969525|100699843|FG005|Dose-Blind Period|Non-cooperating patient|0|||
33219138|NCT02969525|100699844|FG006|Dose-Blind Period|Non-cooperating patient|0|||
33219139|NCT02969525|100699845|FG007|Dose-Blind Period|Non-cooperating patient|0|||
33219140|NCT02969525|100699846|FG008|Dose-Blind Period|Non-cooperating patient|0|||
33219141|NCT02969525|100699847|FG009|Dose-Blind Period|Non-cooperating patient|0|||
33219142|NCT02969525|100699848|FG010|Dose-Blind Period|Non-cooperating patient|0|||
33219143|NCT02969525|100699849|FG011|Dose-Blind Period|Non-cooperating patient|1|||
33219144|NCT02969525|100699838|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33219145|NCT02969525|100699839|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33219146|NCT02969525|100699840|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33219147|NCT02969525|100699841|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33219148|NCT02969525|100699842|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33219149|NCT02969525|100699843|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33219150|NCT02969525|100699844|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33219151|NCT02969525|100699845|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33219152|NCT02969525|100699846|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33219153|NCT02969525|100699847|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33219154|NCT02969525|100699848|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
33219155|NCT02969525|100699849|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
33219156|NCT02070484|100699853|FG000|Overall Study|Withdrawal by Subject|1|||
33219157|NCT02070484|100699854|FG001|Overall Study|Withdrawal by Subject|0|||
33219158|NCT01735201|100699860|FG000|Overall Study|Adverse Event|1|||
33219159|NCT01735201|100699861|FG001|Overall Study|Adverse Event|1|||
33219160|NCT01735201|100699862|FG002|Overall Study|Adverse Event|0|||
33219161|NCT01735201|100699863|FG003|Overall Study|Adverse Event|1|||
33219162|NCT01735201|100699864|FG004|Overall Study|Adverse Event|1|||
33219163|NCT01735201|100699865|FG005|Overall Study|Adverse Event|3|||
33219164|NCT01735201|100699866|FG006|Overall Study|Adverse Event|2|||
33219165|NCT01735201|100699867|FG007|Overall Study|Adverse Event|1|||
33219166|NCT01735201|100699860|FG000|Overall Study|Personal Reasons|1|||
33219167|NCT01735201|100699861|FG001|Overall Study|Personal Reasons|0|||
33219168|NCT01735201|100699862|FG002|Overall Study|Personal Reasons|0|||
33219169|NCT01735201|100699863|FG003|Overall Study|Personal Reasons|0|||
33219170|NCT01735201|100699864|FG004|Overall Study|Personal Reasons|0|||
33219171|NCT01735201|100699865|FG005|Overall Study|Personal Reasons|0|||
33219172|NCT01735201|100699866|FG006|Overall Study|Personal Reasons|0|||
33219173|NCT01735201|100699867|FG007|Overall Study|Personal Reasons|0|||
33219174|NCT01735201|100699860|FG000|Overall Study|Protocol Violation|1|||
33219175|NCT01735201|100699861|FG001|Overall Study|Protocol Violation|0|||
33219176|NCT01735201|100699862|FG002|Overall Study|Protocol Violation|0|||
33219177|NCT01735201|100699863|FG003|Overall Study|Protocol Violation|0|||
33219178|NCT01735201|100699864|FG004|Overall Study|Protocol Violation|0|||
33219179|NCT01735201|100699865|FG005|Overall Study|Protocol Violation|0|||
33219180|NCT01735201|100699866|FG006|Overall Study|Protocol Violation|0|||
33219181|NCT01735201|100699867|FG007|Overall Study|Protocol Violation|0|||
33219182|NCT01735201|100699860|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33219183|NCT01735201|100699861|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33219184|NCT01735201|100699862|FG002|Overall Study|Other Miscellaneous Reasons|0|||
33219185|NCT01735201|100699863|FG003|Overall Study|Other Miscellaneous Reasons|1|||
33219186|NCT01735201|100699864|FG004|Overall Study|Other Miscellaneous Reasons|0|||
33559220|NCT04765384|101943665|FG003|Post-natal: Neonates and Infants|Death|1|||
33559221|NCT04765384|101943666|FG004|Post-natal: Neonates and Infants|Death|0|||
33559222|NCT04765384|101943667|FG005|Post-natal: Neonates and Infants|Death|0|||
33559223|NCT04765384|101943662|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
33559224|NCT04765384|101943663|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
33559225|NCT04765384|101943664|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
33559226|NCT04765384|101943665|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
33559227|NCT04765384|101943666|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
33559228|NCT04765384|101943667|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
33559229|NCT04191135|101943670|FG000|Induction Treatment|Not Treated|2|||
33559230|NCT04191135|101943671|FG001|Induction Treatment|Not Treated|0|||
33559231|NCT04191135|101943672|FG002|Induction Treatment|Not Treated|0|||
33559232|NCT04191135|101943670|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
33559233|NCT04191135|101943671|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
33559234|NCT04191135|101943672|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
33559235|NCT04191135|101943670|FG000|Induction Treatment|Adverse Event|25|||
33559236|NCT04191135|101943671|FG001|Induction Treatment|Adverse Event|0|||
33559237|NCT04191135|101943672|FG002|Induction Treatment|Adverse Event|0|||
33559238|NCT04191135|101943670|FG000|Induction Treatment|Clinical Progression|8|||
33559239|NCT04191135|101943671|FG001|Induction Treatment|Clinical Progression|0|||
33559240|NCT04191135|101943672|FG002|Induction Treatment|Clinical Progression|0|||
33559241|NCT04191135|101943670|FG000|Induction Treatment|Excluded Medication|1|||
33559242|NCT04191135|101943671|FG001|Induction Treatment|Excluded Medication|0|||
33559243|NCT04191135|101943672|FG002|Induction Treatment|Excluded Medication|0|||
33559244|NCT04191135|101943670|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
33559245|NCT04191135|101943671|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
33219187|NCT01735201|100699865|FG005|Overall Study|Other Miscellaneous Reasons|2|||
33559246|NCT04191135|101943672|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
33559247|NCT04191135|101943670|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
33219188|NCT01735201|100699866|FG006|Overall Study|Other Miscellaneous Reasons|1|||
33219189|NCT01735201|100699867|FG007|Overall Study|Other Miscellaneous Reasons|1|||
33219190|NCT01323530|100699868|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
33219191|NCT01323530|100699869|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33219192|NCT01323530|100699870|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33219193|NCT01323530|100699871|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33219194|NCT01323530|100699872|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33219195|NCT01323530|100699873|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
33219196|NCT01323530|100699874|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33219197|NCT01323530|100699868|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
33219198|NCT01323530|100699869|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
33219199|NCT01323530|100699870|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
33219200|NCT01323530|100699871|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
33219201|NCT01323530|100699872|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
33219202|NCT01323530|100699873|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
33219203|NCT01323530|100699874|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
33219204|NCT01323530|100699868|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
33219205|NCT01323530|100699869|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
33219206|NCT01323530|100699870|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
33219207|NCT01323530|100699871|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
33219208|NCT01323530|100699872|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
33219209|NCT01323530|100699873|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
33219210|NCT01323530|100699874|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
33219211|NCT01323530|100699868|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
33219212|NCT01323530|100699869|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
33219213|NCT01323530|100699870|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
33219214|NCT01323530|100699871|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
33219215|NCT01323530|100699872|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
33219216|NCT01323530|100699873|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
33219217|NCT01323530|100699874|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
33219218|NCT01323530|100699868|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
33219219|NCT01323530|100699869|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
33219220|NCT01323530|100699870|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
33219221|NCT01323530|100699871|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
33219222|NCT01323530|100699872|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
33219223|NCT01323530|100699873|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
33219224|NCT01323530|100699874|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
33219225|NCT01323530|100699868|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
33219226|NCT01323530|100699869|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
33219227|NCT01323530|100699870|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
33219228|NCT01323530|100699871|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
33559248|NCT04191135|101943671|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
33219229|NCT01323530|100699872|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
33219230|NCT01323530|100699873|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
33219231|NCT01323530|100699874|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
33219232|NCT01323530|100699868|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
33219233|NCT01323530|100699869|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
33219234|NCT01323530|100699870|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
33219235|NCT01323530|100699871|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
33219236|NCT01323530|100699872|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
33219237|NCT01323530|100699873|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
33219238|NCT01323530|100699874|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
33219239|NCT01323530|100699868|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
33219240|NCT01323530|100699869|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
33219241|NCT01323530|100699870|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
33219242|NCT01323530|100699871|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
33219243|NCT01323530|100699872|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
33219244|NCT01323530|100699873|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
33219245|NCT01323530|100699874|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
33219246|NCT00734630|100699875|FG000|Overall Study|Lack of Efficacy|4|||
33219247|NCT00734630|100699876|FG001|Overall Study|Lack of Efficacy|4|||
33219248|NCT00734630|100699875|FG000|Overall Study|Withdrawal by Subject|7|||
33219249|NCT00734630|100699876|FG001|Overall Study|Withdrawal by Subject|9|||
33559249|NCT04191135|101943672|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
33219250|NCT00734630|100699875|FG000|Overall Study|Lost to Follow-up|13|||
33219251|NCT00734630|100699876|FG001|Overall Study|Lost to Follow-up|7|||
33219252|NCT00734630|100699875|FG000|Overall Study|Protocol Violation|0|||
33219253|NCT00734630|100699876|FG001|Overall Study|Protocol Violation|3|||
33219254|NCT00734630|100699875|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
33219255|NCT00734630|100699876|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
33219256|NCT00734630|100699875|FG000|Overall Study|Adverse Event|3|||
33219257|NCT00734630|100699876|FG001|Overall Study|Adverse Event|6|||
33219258|NCT00734630|100699875|FG000|Overall Study|Randomized in Error|0|||
33219259|NCT00734630|100699876|FG001|Overall Study|Randomized in Error|1|||
33219260|NCT00734630|100699875|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
33219261|NCT00734630|100699876|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
33219262|NCT00734630|100699875|FG000|Overall Study|Poor Compliance|1|||
33219263|NCT00734630|100699876|FG001|Overall Study|Poor Compliance|1|||
33219264|NCT02355743|100699882|FG000|Overall Study|Withdrawal by Subject|1|||
33219265|NCT02355743|100699882|FG000|Overall Study|Lost to Follow-up|1|||
33219266|NCT03848403|100699885|FG000|Period 2 (Day 8)|Adverse Event|1|||
33219267|NCT03848403|100699886|FG001|Period 2 (Day 8)|Adverse Event|2|||
33219268|NCT03848403|100699887|FG002|Period 2 (Day 8)|Adverse Event|2|||
33219269|NCT03848403|100699885|FG000|Period 2 (Day 8)|Physician Decision|0|||
33219270|NCT03848403|100699886|FG001|Period 2 (Day 8)|Physician Decision|1|||
33219271|NCT03848403|100699887|FG002|Period 2 (Day 8)|Physician Decision|0|||
33219272|NCT03848403|100699885|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
33219273|NCT03848403|100699886|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
33219274|NCT03848403|100699887|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
33219275|NCT01982435|100699898|FG000|Overall Study|Adverse Event|1|||
33219276|NCT01982435|100699899|FG001|Overall Study|Adverse Event|0|||
33219277|NCT03574597|100699900|FG000|Overall Study|Withdrawal by Subject|67|||
33219278|NCT03574597|100699901|FG001|Overall Study|Withdrawal by Subject|96|||
33219279|NCT03574597|100699900|FG000|Overall Study|Lost to Follow-up|192|||
33219280|NCT03574597|100699901|FG001|Overall Study|Lost to Follow-up|188|||
33219281|NCT00168038|100699908|FG000|Overall Study|Adverse Event|1|||
33219282|NCT00168038|100699908|FG000|Overall Study|Therapy failure|1|||
33219283|NCT01966003|100699911|FG000|Overall Study|Death|43|||
33219284|NCT01966003|100699912|FG001|Overall Study|Death|36|||
33219285|NCT01966003|100699911|FG000|Overall Study|Protocol Violation|6|||
33219286|NCT01966003|100699912|FG001|Overall Study|Protocol Violation|4|||
33219287|NCT01966003|100699911|FG000|Overall Study|Lost to Follow-up|4|||
33219288|NCT01966003|100699912|FG001|Overall Study|Lost to Follow-up|3|||
33219289|NCT01966003|100699911|FG000|Overall Study|Physician Decision|12|||
33219290|NCT01966003|100699912|FG001|Overall Study|Physician Decision|13|||
33219291|NCT01966003|100699911|FG000|Overall Study|Withdrawal by Subject|29|||
33219292|NCT01966003|100699912|FG001|Overall Study|Withdrawal by Subject|19|||
33219293|NCT01966003|100699911|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
33219294|NCT01966003|100699912|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
33219295|NCT01966003|100699911|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
33219296|NCT01966003|100699912|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
33219297|NCT01966003|100699911|FG000|Overall Study|Other|1|||
33219298|NCT01966003|100699912|FG001|Overall Study|Other|1|||
33219299|NCT02170025|100699913|FG000|Overall Study|Adverse Event|2|||
33219300|NCT02170025|100699914|FG001|Overall Study|Adverse Event|0|||
33219301|NCT03409666|100699925|FG000|Overall Study|Physician Decision|0|||
33219302|NCT03409666|100699926|FG001|Overall Study|Physician Decision|1|||
33219303|NCT03409666|100699925|FG000|Overall Study|Protocol Violation|0|||
33219304|NCT03409666|100699926|FG001|Overall Study|Protocol Violation|3|||
33219305|NCT02157779|100699928|FG000|Overall Study|Logistical|9|||
33219306|NCT02157779|100699929|FG001|Overall Study|Logistical|3|||
33219307|NCT02157779|100699928|FG000|Overall Study|Stopped attending, reason unknown|11|||
33219308|NCT02157779|100699929|FG001|Overall Study|Stopped attending, reason unknown|7|||
33219309|NCT02157779|100699928|FG000|Overall Study|No response to outreach after Baseline|1|||
33219310|NCT02157779|100699929|FG001|Overall Study|No response to outreach after Baseline|1|||
33358861|NCT00670111|101201254|FG000|Enrollment to One Month|Testing Failure|0|||
33358862|NCT00670111|101201255|FG001|Enrollment to One Month|Testing Failure|0|||
33219311|NCT02157779|100699928|FG000|Overall Study|Moved|1|||
33219312|NCT02157779|100699929|FG001|Overall Study|Moved|0|||
33219313|NCT02157779|100699928|FG000|Overall Study|Medical|1|||
33219314|NCT02157779|100699929|FG001|Overall Study|Medical|0|||
33219315|NCT02157779|100699928|FG000|Overall Study|Legal issue|1|||
33219316|NCT02157779|100699929|FG001|Overall Study|Legal issue|0|||
33219317|NCT01756352|100699930|FG000|Overall Study|moved away and lost to followup|1|||
33219318|NCT03419364|100699935|FG000|Overall Study|Delivery due to maternal condition|2|||
33219319|NCT03419364|100699936|FG001|Overall Study|Delivery due to maternal condition|0|||
33219320|NCT03419364|100699937|FG002|Overall Study|Delivery due to maternal condition|0|||
33219321|NCT01964326|100699943|FG000|Overall Study|Adverse Event|48|||
33219322|NCT01964326|100699943|FG000|Overall Study|Death|2|||
33219323|NCT01964326|100699943|FG000|Overall Study|Protocol Violation|4|||
33219324|NCT01964326|100699943|FG000|Overall Study|Lost to Follow-up|88|||
33219325|NCT01964326|100699943|FG000|Overall Study|Withdrawal by Subject|87|||
33219326|NCT01964326|100699943|FG000|Overall Study|Pregnancy|1|||
33219327|NCT01964326|100699943|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
33219328|NCT01964326|100699943|FG000|Overall Study|Physician Decision|55|||
33219329|NCT01964326|100699943|FG000|Overall Study|Investigator Discretion|1|||
33219330|NCT01964326|100699943|FG000|Overall Study|Other|9|||
33219331|NCT01964326|100699943|FG000|Overall Study|Did not meet eligibility criteria|1|||
33219332|NCT03224182|100699944|FG000|Overall Study|Study Drug Not Instilled|6|||
33219333|NCT03224182|100699945|FG001|Overall Study|Study Drug Not Instilled|1|||
33219334|NCT03224182|100699944|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
33219335|NCT03224182|100699945|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
33219336|NCT03224182|100699944|FG000|Overall Study|Withdrew of Consent|4|||
33219337|NCT03224182|100699945|FG001|Overall Study|Withdrew of Consent|2|||
33219338|NCT03224182|100699944|FG000|Overall Study|Investigator Decision|3|||
33219339|NCT03224182|100699945|FG001|Overall Study|Investigator Decision|1|||
33219340|NCT03224182|100699944|FG000|Overall Study|Sponsor Decision|26|||
33219341|NCT03224182|100699945|FG001|Overall Study|Sponsor Decision|12|||
33219342|NCT03224182|100699944|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
33219343|NCT03224182|100699945|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
33219344|NCT03224182|100699944|FG000|Overall Study|Lost to Follow-up|1|||
33219345|NCT03224182|100699945|FG001|Overall Study|Lost to Follow-up|0|||
33219346|NCT03224182|100699944|FG000|Overall Study|Participant Had Recurrence|11|||
33219347|NCT03224182|100699945|FG001|Overall Study|Participant Had Recurrence|5|||
33219348|NCT03224182|100699944|FG000|Overall Study|Death|0|||
33219349|NCT03224182|100699945|FG001|Overall Study|Death|1|||
33219350|NCT03224182|100699944|FG000|Overall Study|Reason not Specified|3|||
33219351|NCT03224182|100699945|FG001|Overall Study|Reason not Specified|3|||
33219352|NCT03224182|100699944|FG000|Overall Study|Other|1|||
33219353|NCT03224182|100699945|FG001|Overall Study|Other|0|||
33219354|NCT00316173|100699956|FG000|Run-in Phase|Adverse Event|1|||
33219355|NCT00316173|100699957|FG001|Run-in Phase|Adverse Event|0|||
33219356|NCT00316173|100699956|FG000|Run-in Phase|Protocol Violation|1|||
33219357|NCT00316173|100699957|FG001|Run-in Phase|Protocol Violation|0|||
33219358|NCT00316173|100699956|FG000|Run-in Phase|Study Follow-up Stopped|5|||
33219359|NCT00316173|100699957|FG001|Run-in Phase|Study Follow-up Stopped|0|||
33219360|NCT00316173|100699956|FG000|Treatment Phase|Adverse Event|0|||
33219361|NCT00316173|100699957|FG001|Treatment Phase|Adverse Event|1|||
33219362|NCT00316173|100699956|FG000|Treatment Phase|Lack of Efficacy|0|||
33219363|NCT00316173|100699957|FG001|Treatment Phase|Lack of Efficacy|3|||
33219364|NCT00316173|100699956|FG000|Treatment Phase|Lost to Follow-up|0|||
33219365|NCT00316173|100699957|FG001|Treatment Phase|Lost to Follow-up|3|||
33219366|NCT00316173|100699956|FG000|Treatment Phase|Withdrawal by Subject|0|||
33219367|NCT00316173|100699957|FG001|Treatment Phase|Withdrawal by Subject|1|||
33219368|NCT00316173|100699956|FG000|Treatment Phase|Study Follow-up Stopped|0|||
33219369|NCT00316173|100699957|FG001|Treatment Phase|Study Follow-up Stopped|34|||
33219370|NCT04493931|100699959|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
33219371|NCT04493931|100699960|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
33219372|NCT04493931|100699961|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
33219373|NCT04493931|100699962|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
33219374|NCT04493931|100699963|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
33219375|NCT04493931|100699964|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
33219376|NCT04493931|100699965|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
33219377|NCT04493931|100699959|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
33219378|NCT04493931|100699960|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
33219379|NCT04493931|100699961|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
33219380|NCT04493931|100699962|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
33219381|NCT04493931|100699963|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
33219382|NCT04493931|100699964|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
33219383|NCT04493931|100699965|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
33219384|NCT04493931|100699959|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
33358863|NCT00670111|101201256|FG002|Enrollment to One Month|Testing Failure|13|||
33358864|NCT00670111|101201254|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
33358865|NCT00670111|101201255|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
33358866|NCT00670111|101201256|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
33219385|NCT04493931|100699960|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
33219386|NCT04493931|100699961|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
33219387|NCT04493931|100699962|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
33219388|NCT04493931|100699963|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
33358867|NCT00670111|101201254|FG000|Enrollment to One Month|Physician Decision|1|||
33219389|NCT04493931|100699964|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
33219390|NCT04493931|100699965|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
33358868|NCT00670111|101201255|FG001|Enrollment to One Month|Physician Decision|0|||
33219391|NCT04493931|100699959|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
33219392|NCT04493931|100699960|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
33219393|NCT04493931|100699961|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
33219394|NCT04493931|100699962|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
33219395|NCT04493931|100699963|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
33219396|NCT04493931|100699964|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
33219397|NCT04493931|100699965|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
33219398|NCT01266850|100699967|FG000|Overall Study|Lost to Follow-up|19|||
33219399|NCT01266850|100699968|FG001|Overall Study|Lost to Follow-up|19|||
33219400|NCT01266850|100699969|FG002|Overall Study|Lost to Follow-up|13|||
33219401|NCT01266850|100699970|FG003|Overall Study|Lost to Follow-up|13|||
33219402|NCT01266850|100699971|FG004|Overall Study|Lost to Follow-up|12|||
33219403|NCT01266850|100699967|FG000|Overall Study|Withdrawal by Subject|8|||
33219404|NCT01266850|100699968|FG001|Overall Study|Withdrawal by Subject|9|||
33219405|NCT01266850|100699969|FG002|Overall Study|Withdrawal by Subject|6|||
33219406|NCT01266850|100699970|FG003|Overall Study|Withdrawal by Subject|9|||
33219407|NCT01266850|100699971|FG004|Overall Study|Withdrawal by Subject|12|||
33219408|NCT01266850|100699967|FG000|Overall Study|Physician Decision|3|||
33219409|NCT01266850|100699968|FG001|Overall Study|Physician Decision|6|||
33219410|NCT01266850|100699969|FG002|Overall Study|Physician Decision|4|||
33219411|NCT01266850|100699970|FG003|Overall Study|Physician Decision|4|||
33219412|NCT01266850|100699971|FG004|Overall Study|Physician Decision|3|||
33219413|NCT01266850|100699967|FG000|Overall Study|Protocol Violation|0|||
33219414|NCT01266850|100699968|FG001|Overall Study|Protocol Violation|1|||
33219415|NCT01266850|100699969|FG002|Overall Study|Protocol Violation|0|||
33219416|NCT01266850|100699970|FG003|Overall Study|Protocol Violation|1|||
33219417|NCT01266850|100699971|FG004|Overall Study|Protocol Violation|2|||
33219418|NCT01266850|100699967|FG000|Overall Study|Adverse Event|0|||
33219419|NCT01266850|100699968|FG001|Overall Study|Adverse Event|0|||
33219420|NCT01266850|100699969|FG002|Overall Study|Adverse Event|0|||
33219421|NCT01266850|100699970|FG003|Overall Study|Adverse Event|0|||
33219422|NCT01266850|100699971|FG004|Overall Study|Adverse Event|1|||
33219423|NCT01266850|100699967|FG000|Overall Study|Site Closure|0|||
33219424|NCT01266850|100699968|FG001|Overall Study|Site Closure|1|||
33219425|NCT01266850|100699969|FG002|Overall Study|Site Closure|1|||
33219426|NCT01266850|100699970|FG003|Overall Study|Site Closure|1|||
33219427|NCT01266850|100699971|FG004|Overall Study|Site Closure|0|||
33219428|NCT04279314|100699972|FG000|Overall Study|Adverse Event|55|||
33219429|NCT04279314|100699972|FG000|Overall Study|Withdrawal by Subject|5|||
33219430|NCT04279314|100699972|FG000|Overall Study|Lack of Efficacy|5|||
33219431|NCT04279314|100699972|FG000|Overall Study|Protocol Violation|3|||
33219432|NCT04279314|100699972|FG000|Overall Study|Other (not COVID-19 related)|2|||
33219433|NCT02658630|100699980|FG000|Overall Study|Withdrawal by Subject|4|||
33219434|NCT02606279|100699981|FG000|Overall Study|Lost to Follow-up|0|||
33358869|NCT00670111|101201256|FG002|Enrollment to One Month|Physician Decision|0|||
33358870|NCT02902809|101201259|FG000|Overall Study|Discontinuation of asthma program|28|||
33358871|NCT00479466|101201260|FG000|Overall Study|Adverse Event|5|||
33358872|NCT00479466|101201261|FG001|Overall Study|Adverse Event|1|||
33358873|NCT00479466|101201262|FG002|Overall Study|Adverse Event|0|||
33358874|NCT00479466|101201263|FG003|Overall Study|Adverse Event|1|||
33358875|NCT00479466|101201264|FG004|Overall Study|Adverse Event|2|||
33358876|NCT00479466|101201265|FG005|Overall Study|Adverse Event|0|||
33358877|NCT00479466|101201260|FG000|Overall Study|Hyperglycemia|0|||
33358878|NCT00479466|101201261|FG001|Overall Study|Hyperglycemia|0|||
33358879|NCT00479466|101201262|FG002|Overall Study|Hyperglycemia|0|||
33358880|NCT00479466|101201263|FG003|Overall Study|Hyperglycemia|0|||
33358881|NCT00479466|101201264|FG004|Overall Study|Hyperglycemia|0|||
33358882|NCT00479466|101201265|FG005|Overall Study|Hyperglycemia|1|||
33358883|NCT00479466|101201260|FG000|Overall Study|Lack of Efficacy|2|||
33358884|NCT00479466|101201261|FG001|Overall Study|Lack of Efficacy|0|||
33358885|NCT00479466|101201262|FG002|Overall Study|Lack of Efficacy|1|||
33358886|NCT00479466|101201263|FG003|Overall Study|Lack of Efficacy|0|||
33358887|NCT00479466|101201264|FG004|Overall Study|Lack of Efficacy|0|||
33358888|NCT00479466|101201265|FG005|Overall Study|Lack of Efficacy|0|||
33219435|NCT02606279|100699982|FG001|Overall Study|Lost to Follow-up|1|||
33219436|NCT00415610|100699984|FG000|Overall Study|Death|3|||
33219437|NCT00415610|100699985|FG001|Overall Study|Death|2|||
33219438|NCT00415610|100699986|FG002|Overall Study|Death|5|||
33219439|NCT04027348|100699989|FG000|Overall Study|Adverse Event|2|||
33219440|NCT00855062|100699990|FG000|Step1|Early Study Closure|5|||
33219441|NCT00855062|100699991|FG001|Step1|Early Study Closure|7|||
33219442|NCT00855062|100699990|FG000|Step1|Adverse Event|1|||
33358889|NCT00479466|101201260|FG000|Overall Study|Lost to Follow-up|0|||
33358890|NCT00479466|101201261|FG001|Overall Study|Lost to Follow-up|1|||
33358891|NCT00479466|101201262|FG002|Overall Study|Lost to Follow-up|1|||
33358892|NCT00479466|101201263|FG003|Overall Study|Lost to Follow-up|0|||
33358893|NCT00479466|101201264|FG004|Overall Study|Lost to Follow-up|2|||
33414578|NCT01915498|101409842|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33219443|NCT00855062|100699991|FG001|Step1|Adverse Event|1|||
33623391|NCT01546857|102169603|FG000|Overall Study|Withdrawal by Subject|2|||
33623392|NCT01546857|102169604|FG001|Overall Study|Withdrawal by Subject|3|||
33623393|NCT02631551|102169605|FG000|Overall Study|Adverse Event|1|||
33623394|NCT02631551|102169606|FG001|Overall Study|Adverse Event|2|||
33623395|NCT02631551|102169607|FG002|Overall Study|Adverse Event|4|||
33623396|NCT02631551|102169608|FG003|Overall Study|Adverse Event|0|||
33623397|NCT02631551|102169605|FG000|Overall Study|Lack of Efficacy|0|||
33623398|NCT02631551|102169606|FG001|Overall Study|Lack of Efficacy|0|||
33623399|NCT02631551|102169607|FG002|Overall Study|Lack of Efficacy|1|||
33219444|NCT00855062|100699990|FG000|Step1|Protocol Violation|1|||
33358894|NCT00479466|101201265|FG005|Overall Study|Lost to Follow-up|2|||
33358895|NCT00479466|101201260|FG000|Overall Study|Physician Decision|2|||
33358896|NCT00479466|101201261|FG001|Overall Study|Physician Decision|1|||
33358897|NCT00479466|101201262|FG002|Overall Study|Physician Decision|1|||
33358898|NCT00479466|101201263|FG003|Overall Study|Physician Decision|0|||
33559250|NCT04191135|101943670|FG000|Induction Treatment|Physician Decision|2|||
33559251|NCT04191135|101943671|FG001|Induction Treatment|Physician Decision|0|||
33559252|NCT04191135|101943672|FG002|Induction Treatment|Physician Decision|0|||
33559253|NCT04191135|101943670|FG000|Induction Treatment|Progressive Disease|135|||
33559254|NCT04191135|101943671|FG001|Induction Treatment|Progressive Disease|0|||
33559255|NCT04191135|101943672|FG002|Induction Treatment|Progressive Disease|0|||
33559256|NCT04191135|101943670|FG000|Induction Treatment|Protocol Violation|10|||
33559257|NCT04191135|101943671|FG001|Induction Treatment|Protocol Violation|0|||
33559258|NCT04191135|101943672|FG002|Induction Treatment|Protocol Violation|0|||
33559259|NCT04191135|101943670|FG000|Induction Treatment|Withdrawal by Subject|4|||
33559260|NCT04191135|101943671|FG001|Induction Treatment|Withdrawal by Subject|0|||
33623400|NCT02631551|102169608|FG003|Overall Study|Lack of Efficacy|0|||
33623401|NCT02631551|102169605|FG000|Overall Study|Lost to Follow-up|1|||
33219445|NCT00855062|100699991|FG001|Step1|Protocol Violation|0|||
33358899|NCT00479466|101201264|FG004|Overall Study|Physician Decision|0|||
33358900|NCT00479466|101201265|FG005|Overall Study|Physician Decision|0|||
33219446|NCT00855062|100699990|FG000|Step1|Pregnancy|1|||
33219447|NCT00855062|100699991|FG001|Step1|Pregnancy|0|||
33219448|NCT00855062|100699990|FG000|Step1|Withdrawal by Subject|2|||
33219449|NCT00855062|100699991|FG001|Step1|Withdrawal by Subject|3|||
33219450|NCT00855062|100699990|FG000|Step2|Early Study Closure|6|||
33219451|NCT00855062|100699991|FG001|Step2|Early Study Closure|2|||
33219452|NCT00855062|100699990|FG000|Step2|Adverse Event|0|||
33219453|NCT00855062|100699991|FG001|Step2|Adverse Event|3|||
33219454|NCT00855062|100699990|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
33219455|NCT00855062|100699991|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
33219456|NCT04398537|100699992|FG000|Overall Study|Physician Decision|10|||
33219457|NCT04398537|100699993|FG001|Overall Study|Physician Decision|15|||
33219458|NCT03308825|100699994|FG000|Overall Study|Lost to Follow-up|2|||
33219459|NCT03308825|100699995|FG001|Overall Study|Lost to Follow-up|2|||
33219460|NCT03308825|100699996|FG002|Overall Study|Lost to Follow-up|1|||
33219461|NCT03308825|100699997|FG003|Overall Study|Lost to Follow-up|0|||
33219462|NCT03308825|100699994|FG000|Overall Study|Protocol Violation|0|||
33219463|NCT03308825|100699995|FG001|Overall Study|Protocol Violation|2|||
33219464|NCT03308825|100699996|FG002|Overall Study|Protocol Violation|0|||
33219465|NCT03308825|100699997|FG003|Overall Study|Protocol Violation|0|||
33219466|NCT02216773|100699998|FG000|Overall Study|Disease progression|4|||
33219467|NCT02216773|100699999|FG001|Overall Study|Disease progression|2|||
33219468|NCT02216773|100699998|FG000|Overall Study|Insufficient FLRV|4|||
33219469|NCT02216773|100699999|FG001|Overall Study|Insufficient FLRV|0|||
33358901|NCT00479466|101201260|FG000|Overall Study|Pregnancy|0|||
33358902|NCT00479466|101201261|FG001|Overall Study|Pregnancy|0|||
33219470|NCT02216773|100699998|FG000|Overall Study|Abandoned|4|||
33219471|NCT02216773|100699999|FG001|Overall Study|Abandoned|3|||
33219472|NCT01505387|100700000|FG000|Overall Study|Protocol Violation|1|||
33219473|NCT01505387|100700001|FG001|Overall Study|Protocol Violation|0|||
33219474|NCT01505387|100700000|FG000|Overall Study|Withdrawal by Subject|1|||
33559261|NCT04191135|101943672|FG002|Induction Treatment|Withdrawal by Subject|0|||
33219475|NCT01505387|100700001|FG001|Overall Study|Withdrawal by Subject|1|||
33219476|NCT04179721|100700002|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
33219477|NCT04179721|100700003|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
33219478|NCT04179721|100700002|FG000|Overall Study|Lost to Follow-up|0|||
33219479|NCT04179721|100700003|FG001|Overall Study|Lost to Follow-up|1|||
33358903|NCT00479466|101201262|FG002|Overall Study|Pregnancy|0|||
33358904|NCT00479466|101201263|FG003|Overall Study|Pregnancy|0|||
33559262|NCT04191135|101943670|FG000|Randomized Treatment|Death|0|||
33623402|NCT02631551|102169606|FG001|Overall Study|Lost to Follow-up|2|||
33219480|NCT02080871|100700005|FG000|Overall Study|Death|1|||
33219481|NCT02080871|100700005|FG000|Overall Study|Lost to Follow-up|1|||
33623403|NCT02631551|102169607|FG002|Overall Study|Lost to Follow-up|0|||
33219482|NCT02178566|100700011|FG000|Overall Study|patient did not complete due to noncompliance|0|||
33559263|NCT04191135|101943671|FG001|Randomized Treatment|Death|50|||
33559264|NCT04191135|101943672|FG002|Randomized Treatment|Death|54|||
33358905|NCT00479466|101201264|FG004|Overall Study|Pregnancy|1|||
33358906|NCT00479466|101201265|FG005|Overall Study|Pregnancy|0|||
33358907|NCT00479466|101201260|FG000|Overall Study|Protocol Violation|1|||
33358908|NCT00479466|101201261|FG001|Overall Study|Protocol Violation|0|||
33358909|NCT00479466|101201262|FG002|Overall Study|Protocol Violation|0|||
33358910|NCT00479466|101201263|FG003|Overall Study|Protocol Violation|0|||
33358911|NCT00479466|101201264|FG004|Overall Study|Protocol Violation|0|||
33358912|NCT00479466|101201265|FG005|Overall Study|Protocol Violation|0|||
33358913|NCT00479466|101201260|FG000|Overall Study|Withdrawal by Subject|3|||
33358914|NCT00479466|101201261|FG001|Overall Study|Withdrawal by Subject|5|||
33358915|NCT00479466|101201262|FG002|Overall Study|Withdrawal by Subject|0|||
33358916|NCT00479466|101201263|FG003|Overall Study|Withdrawal by Subject|2|||
33358917|NCT00479466|101201264|FG004|Overall Study|Withdrawal by Subject|3|||
33358918|NCT00479466|101201265|FG005|Overall Study|Withdrawal by Subject|1|||
33219483|NCT02178566|100700012|FG001|Overall Study|patient did not complete due to noncompliance|1|||
33219484|NCT01572389|100703003|FG000|Overall Study|Death|1|||
33219485|NCT01572389|100703004|FG001|Overall Study|Death|3|||
33219486|NCT01572389|100703003|FG000|Overall Study|Withdrawal by Subject|14|||
33219487|NCT01572389|100703004|FG001|Overall Study|Withdrawal by Subject|2|||
33219488|NCT01572389|100703003|FG000|Overall Study|Lost to Follow-up|25|||
33219489|NCT01572389|100703004|FG001|Overall Study|Lost to Follow-up|14|||
33219490|NCT01572389|100703003|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
33219491|NCT01572389|100703004|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
33219492|NCT04510675|100703005|FG000|Overall Study|Withdrawal by Subject|5|||
33219493|NCT01648348|100703009|FG000|Overall Study|Cancel|1|||
33219494|NCT01648348|100703010|FG001|Overall Study|Cancel|0|||
33219495|NCT01648348|100703011|FG002|Overall Study|Cancel|0|||
33219496|NCT01648348|100703012|FG003|Overall Study|Cancel|0|||
33219497|NCT01648348|100703013|FG004|Overall Study|Cancel|3|||
33219498|NCT01648348|100703014|FG005|Overall Study|Cancel|6|||
33219499|NCT01648348|100703009|FG000|Overall Study|Replaced for MTD analysis|1|||
33219500|NCT01648348|100703010|FG001|Overall Study|Replaced for MTD analysis|0|||
33219501|NCT01648348|100703011|FG002|Overall Study|Replaced for MTD analysis|1|||
33219502|NCT01648348|100703012|FG003|Overall Study|Replaced for MTD analysis|0|||
33219503|NCT01648348|100703013|FG004|Overall Study|Replaced for MTD analysis|0|||
33219504|NCT01648348|100703014|FG005|Overall Study|Replaced for MTD analysis|0|||
33219505|NCT00677235|100703017|FG000|Overall Study|Withdrawal by Subject|1|||
33219506|NCT00677235|100703018|FG001|Overall Study|Withdrawal by Subject|1|||
33219507|NCT00677235|100703017|FG000|Overall Study|Lost to Follow-up|2|||
33219508|NCT00677235|100703018|FG001|Overall Study|Lost to Follow-up|1|||
33219509|NCT00677235|100703017|FG000|Overall Study|Death|37|||
33219510|NCT00677235|100703018|FG001|Overall Study|Death|36|||
33219511|NCT00677235|100703017|FG000|Overall Study|Adverse Experience|1|||
33219512|NCT00677235|100703018|FG001|Overall Study|Adverse Experience|0|||
33219513|NCT03420781|100703019|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
33219514|NCT03420781|100703020|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
33219515|NCT03420781|100703021|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
33219516|NCT03420781|100703022|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
33219517|NCT03420781|100703023|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
33219518|NCT03420781|100703019|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
33219519|NCT03420781|100703020|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
33358919|NCT02436239|101201266|FG000|Open-Lable Treatment Period|Adverse Event|12|||
33358920|NCT02436239|101201267|FG001|Open-Lable Treatment Period|Adverse Event|3|||
33219520|NCT03420781|100703021|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
33358921|NCT02436239|101201268|FG002|Open-Lable Treatment Period|Adverse Event|4|||
33414579|NCT01915498|101409843|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33219521|NCT03420781|100703022|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
33219522|NCT03420781|100703023|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
33219523|NCT03420781|100703019|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
33219524|NCT03420781|100703020|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
33219525|NCT03420781|100703021|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
33219526|NCT03420781|100703022|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
33219527|NCT03420781|100703023|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
33559265|NCT04191135|101943670|FG000|Randomized Treatment|Lost to Follow-up|0|||
33559266|NCT04191135|101943671|FG001|Randomized Treatment|Lost to Follow-up|0|||
33559267|NCT04191135|101943672|FG002|Randomized Treatment|Lost to Follow-up|1|||
33559268|NCT04191135|101943670|FG000|Randomized Treatment|Withdrawal by Subject|0|||
33559269|NCT04191135|101943671|FG001|Randomized Treatment|Withdrawal by Subject|2|||
33559270|NCT04191135|101943672|FG002|Randomized Treatment|Withdrawal by Subject|0|||
33559271|NCT04191135|101943670|FG000|Randomized Treatment|Ongoing in Trial|0|||
33559272|NCT04191135|101943671|FG001|Randomized Treatment|Ongoing in Trial|83|||
33559273|NCT04191135|101943672|FG002|Randomized Treatment|Ongoing in Trial|81|||
33559274|NCT01064648|101943673|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
33559275|NCT01064648|101943674|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
33559276|NCT01064648|101943675|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
33559277|NCT01064648|101943676|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
33358922|NCT02436239|101201269|FG003|Open-Lable Treatment Period|Adverse Event|2|||
33358923|NCT02436239|101201266|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
33358924|NCT02436239|101201267|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
33358925|NCT02436239|101201268|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
33358926|NCT02436239|101201269|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
33358927|NCT02436239|101201266|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
33358928|NCT02436239|101201267|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
33358929|NCT02436239|101201268|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
33358930|NCT02436239|101201269|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
33358931|NCT02436239|101201266|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
33358932|NCT02436239|101201267|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
33358933|NCT02436239|101201268|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
33358934|NCT02436239|101201269|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
33358935|NCT02436239|101201266|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
33358936|NCT02436239|101201267|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
33559278|NCT01064648|101943673|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
33559279|NCT01064648|101943674|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
33559280|NCT01064648|101943675|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
33559281|NCT01064648|101943676|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
33559282|NCT01064648|101943673|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
33559283|NCT01064648|101943674|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
33559284|NCT01064648|101943675|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
33559285|NCT01064648|101943676|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
33559286|NCT01064648|101943673|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
33559287|NCT01064648|101943674|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
33559288|NCT01064648|101943675|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
33559289|NCT01064648|101943676|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
33623404|NCT02631551|102169608|FG003|Overall Study|Lost to Follow-up|3|||
33623405|NCT02631551|102169605|FG000|Overall Study|Withdrawal by Subject|2|||
33623406|NCT02631551|102169606|FG001|Overall Study|Withdrawal by Subject|2|||
33623407|NCT02631551|102169607|FG002|Overall Study|Withdrawal by Subject|0|||
33623408|NCT02631551|102169608|FG003|Overall Study|Withdrawal by Subject|5|||
33623409|NCT02631551|102169605|FG000|Overall Study|Protocol deviation|3|||
33623410|NCT02631551|102169606|FG001|Overall Study|Protocol deviation|6|||
33623411|NCT02631551|102169607|FG002|Overall Study|Protocol deviation|3|||
33358937|NCT02436239|101201268|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
33623412|NCT02631551|102169608|FG003|Overall Study|Protocol deviation|0|||
33623413|NCT02631551|102169605|FG000|Overall Study|Non-compliance with study procedures|0|||
33358938|NCT02436239|101201269|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
33623414|NCT02631551|102169606|FG001|Overall Study|Non-compliance with study procedures|0|||
33623415|NCT02631551|102169607|FG002|Overall Study|Non-compliance with study procedures|1|||
33358939|NCT02436239|101201266|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
33358940|NCT02436239|101201267|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
33358941|NCT02436239|101201268|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
33559290|NCT01064648|101943673|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
33559291|NCT01064648|101943674|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
33559292|NCT01064648|101943675|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
33559293|NCT01064648|101943676|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
33559294|NCT01064648|101943673|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
33559295|NCT01064648|101943674|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
33559296|NCT01064648|101943675|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
33559297|NCT01064648|101943676|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
33559298|NCT01064648|101943673|FG000|Phase II|Adverse Event|0|||
33559299|NCT01064648|101943674|FG001|Phase II|Adverse Event|0|||
33559300|NCT01064648|101943675|FG002|Phase II|Adverse Event|15|||
33559301|NCT01064648|101943676|FG003|Phase II|Adverse Event|8|||
33559302|NCT01064648|101943673|FG000|Phase II|Death|0|||
33559303|NCT01064648|101943674|FG001|Phase II|Death|0|||
33559304|NCT01064648|101943675|FG002|Phase II|Death|4|||
33559305|NCT01064648|101943676|FG003|Phase II|Death|5|||
33559306|NCT01064648|101943673|FG000|Phase II|Withdrawal by Subject|0|||
33559307|NCT01064648|101943674|FG001|Phase II|Withdrawal by Subject|0|||
33559308|NCT01064648|101943675|FG002|Phase II|Withdrawal by Subject|2|||
33559309|NCT01064648|101943676|FG003|Phase II|Withdrawal by Subject|5|||
33559310|NCT01064648|101943673|FG000|Phase II|Progression|0|||
33559311|NCT01064648|101943674|FG001|Phase II|Progression|0|||
33559312|NCT01064648|101943675|FG002|Phase II|Progression|21|||
33559313|NCT01064648|101943676|FG003|Phase II|Progression|27|||
33559314|NCT01064648|101943673|FG000|Phase II|Non-protocol specified|0|||
33559315|NCT01064648|101943674|FG001|Phase II|Non-protocol specified|0|||
33559316|NCT01064648|101943675|FG002|Phase II|Non-protocol specified|5|||
33559317|NCT01064648|101943676|FG003|Phase II|Non-protocol specified|3|||
33559318|NCT01064648|101943673|FG000|Phase II|Under Review|0|||
33559319|NCT01064648|101943674|FG001|Phase II|Under Review|0|||
33559320|NCT01064648|101943675|FG002|Phase II|Under Review|2|||
33559321|NCT01064648|101943676|FG003|Phase II|Under Review|0|||
33559322|NCT06083493|101943677|FG000|Overall Study|Technical issues with the interventional device|2|||
33559323|NCT06083493|101943678|FG001|Overall Study|Technical issues with the interventional device|2|||
33559324|NCT06083493|101943677|FG000|Overall Study|Performed incorrect visual task|1|||
33559325|NCT06083493|101943678|FG001|Overall Study|Performed incorrect visual task|0|||
33559326|NCT06083493|101943677|FG000|Overall Study|Insufficient baseline performance|0|||
33559327|NCT06083493|101943678|FG001|Overall Study|Insufficient baseline performance|1|||
33559328|NCT00588770|101943679|FG000|Overall Study|Disease progression|85|||
33559329|NCT00588770|101943680|FG001|Overall Study|Disease progression|68|||
33559330|NCT00588770|101943679|FG000|Overall Study|Adverse Event|29|||
33559331|NCT00588770|101943680|FG001|Overall Study|Adverse Event|58|||
33559332|NCT00588770|101943679|FG000|Overall Study|Death|13|||
33559333|NCT00588770|101943680|FG001|Overall Study|Death|22|||
33559334|NCT00588770|101943679|FG000|Overall Study|Withdrawal by Subject|15|||
33559335|NCT00588770|101943680|FG001|Overall Study|Withdrawal by Subject|25|||
33559336|NCT00588770|101943679|FG000|Overall Study|Alternative therapy|2|||
33559337|NCT00588770|101943680|FG001|Overall Study|Alternative therapy|4|||
33559338|NCT00588770|101943679|FG000|Overall Study|Other complicating disease|3|||
33559339|NCT00588770|101943680|FG001|Overall Study|Other complicating disease|2|||
33559340|NCT00588770|101943679|FG000|Overall Study|Not start protocol therapy|0|||
33559341|NCT00588770|101943680|FG001|Overall Study|Not start protocol therapy|9|||
33559342|NCT00588770|101943679|FG000|Overall Study|Lack of Efficacy|8|||
33559343|NCT00588770|101943680|FG001|Overall Study|Lack of Efficacy|10|||
33559344|NCT00588770|101943679|FG000|Overall Study|Physician discretion|2|||
33559345|NCT00588770|101943680|FG001|Overall Study|Physician discretion|0|||
33559346|NCT00588770|101943679|FG000|Overall Study|Patient non-compliance|2|||
33559347|NCT00588770|101943680|FG001|Overall Study|Patient non-compliance|2|||
33559348|NCT05346640|101943685|FG000|Overall Study|Lack of Efficacy|2|||
33559349|NCT05346640|101943685|FG000|Overall Study|Lost to Follow-up|14|||
33559350|NCT05346640|101943685|FG000|Overall Study|Protocol Violation|4|||
33358942|NCT02436239|101201269|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
33358943|NCT02436239|101201266|FG000|Open-Lable Treatment Period|Other Reason|1|||
33559351|NCT05346640|101943685|FG000|Overall Study|Withdrawal by Subject|2|||
33559352|NCT05346640|101943685|FG000|Overall Study|Physiological Complications|3|||
33559353|NCT05346640|101943685|FG000|Overall Study|Other Reason|3|||
33559354|NCT01871727|101943687|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
33559355|NCT01871727|101943688|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
33559356|NCT01871727|101943689|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
33559357|NCT01871727|101943690|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
33559358|NCT01871727|101943691|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
33559359|NCT01871727|101943687|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
33559360|NCT01871727|101943688|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
33559361|NCT01871727|101943689|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
33559362|NCT01871727|101943690|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
33559363|NCT01871727|101943691|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
33559364|NCT01871727|101943687|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
33559365|NCT01871727|101943688|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
33559366|NCT01871727|101943689|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
33559367|NCT01871727|101943690|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
33358944|NCT02436239|101201267|FG001|Open-Lable Treatment Period|Other Reason|1|||
33358945|NCT02436239|101201268|FG002|Open-Lable Treatment Period|Other Reason|0|||
33358946|NCT02436239|101201269|FG003|Open-Lable Treatment Period|Other Reason|0|||
33358947|NCT02436239|101201266|FG000|Down-Taper Period|Withdrawal by Subject|4|||
33358948|NCT02436239|101201267|FG001|Down-Taper Period|Withdrawal by Subject|4|||
33358949|NCT02436239|101201268|FG002|Down-Taper Period|Withdrawal by Subject|1|||
33358950|NCT02436239|101201269|FG003|Down-Taper Period|Withdrawal by Subject|2|||
33358951|NCT00636818|101201276|FG000|Overall Study|Adverse Event|1|||
33358952|NCT00636818|101201276|FG000|Overall Study|Lost to Follow-up|2|||
33559368|NCT01871727|101943691|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
33559369|NCT01871727|101943687|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
33559370|NCT01871727|101943688|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
33559371|NCT01871727|101943689|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
33559372|NCT01871727|101943690|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
33559373|NCT01871727|101943691|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
33559374|NCT01871727|101943687|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
33559375|NCT01871727|101943688|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
33358953|NCT00636818|101201276|FG000|Overall Study|Entry Criteria Exclusion|3|||
33414580|NCT01915498|101409844|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33358954|NCT00636818|101201276|FG000|Overall Study|Protocol Violation|1|||
33559376|NCT01871727|101943689|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
33559377|NCT01871727|101943690|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
33559378|NCT01871727|101943691|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
33559379|NCT01871727|101943687|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
33414581|NCT01915498|101409845|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33414582|NCT01915498|101409846|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
33414583|NCT01915498|101409847|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33414584|NCT01915498|101409848|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33414585|NCT01915498|101409849|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
33559380|NCT01871727|101943688|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
33559381|NCT01871727|101943689|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
33559382|NCT01871727|101943690|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
33559383|NCT01871727|101943691|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
33559384|NCT01871727|101943687|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
33559385|NCT01871727|101943688|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
33358955|NCT00636818|101201276|FG000|Overall Study|Withdrawal by Subject|4|||
33358956|NCT00408681|101201279|FG000|Overall Study|Lack of Efficacy|2|||
33358957|NCT00408681|101201279|FG000|Overall Study|Adverse Event|7|||
33358958|NCT01938625|101201282|FG000|Overall Study|Withdrawal by Subject|0|||
33358959|NCT01938625|101201283|FG001|Overall Study|Withdrawal by Subject|1|||
33358960|NCT01938625|101201282|FG000|Overall Study|Adverse Event|0|||
33358961|NCT01938625|101201283|FG001|Overall Study|Adverse Event|1|||
33358962|NCT01208181|101201286|FG000|Part 1|Withdrawal by Subject|11|||
33358963|NCT01208181|101201287|FG001|Part 1|Withdrawal by Subject|10|||
33358964|NCT01208181|101201288|FG002|Part 1|Withdrawal by Subject|0|||
33358965|NCT01208181|101201289|FG003|Part 1|Withdrawal by Subject|0|||
33358966|NCT01208181|101201290|FG004|Part 1|Withdrawal by Subject|0|||
33358967|NCT01208181|101201286|FG000|Part 1|Technical problem|5|||
33358968|NCT01208181|101201287|FG001|Part 1|Technical problem|0|||
33358969|NCT01208181|101201288|FG002|Part 1|Technical problem|0|||
33358970|NCT01208181|101201289|FG003|Part 1|Technical problem|0|||
33358971|NCT01208181|101201290|FG004|Part 1|Technical problem|0|||
33358972|NCT01208181|101201286|FG000|Part 1|Protocol Violation|10|||
33358973|NCT01208181|101201287|FG001|Part 1|Protocol Violation|5|||
33358974|NCT01208181|101201288|FG002|Part 1|Protocol Violation|0|||
33559386|NCT01871727|101943689|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
33559387|NCT01871727|101943690|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
33559388|NCT01871727|101943691|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
33559389|NCT03760081|101943692|FG000|Overall Study|Miscellaneous|0|||
33559390|NCT03760081|101943693|FG001|Overall Study|Miscellaneous|1|||
33559391|NCT03760081|101943692|FG000|Overall Study|Progressive Disease|5|||
33559392|NCT03760081|101943693|FG001|Overall Study|Progressive Disease|10|||
33559393|NCT03760081|101943692|FG000|Overall Study|Death|1|||
33559394|NCT03760081|101943693|FG001|Overall Study|Death|1|||
33559395|NCT03921541|101943694|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
33559396|NCT03921541|101943695|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
33559397|NCT04380753|101943696|FG000|Overall Study|Participants continuing study|4|||
33559398|NCT04380753|101943696|FG000|Overall Study|Death|2|||
33559399|NCT03268499|101943697|FG000|Overall Study|Withdrawal by Subject|2|||
33559400|NCT03268499|101943698|FG001|Overall Study|Withdrawal by Subject|1|||
33559401|NCT03976375|101943699|FG000|Overall Study|Death|147|||
33559402|NCT03976375|101943700|FG001|Overall Study|Death|150|||
33559403|NCT03976375|101943701|FG002|Overall Study|Death|38|||
33559404|NCT03976375|101943699|FG000|Overall Study|Lost to Follow-up|1|||
33559405|NCT03976375|101943700|FG001|Overall Study|Lost to Follow-up|1|||
33559406|NCT03976375|101943701|FG002|Overall Study|Lost to Follow-up|1|||
33559407|NCT03976375|101943699|FG000|Overall Study|Withdrawal by Subject|4|||
33559408|NCT03976375|101943700|FG001|Overall Study|Withdrawal by Subject|9|||
33358975|NCT01208181|101201289|FG003|Part 1|Protocol Violation|0|||
33559409|NCT03976375|101943701|FG002|Overall Study|Withdrawal by Subject|4|||
33559410|NCT03976375|101943699|FG000|Overall Study|Ongoing|33|||
33559411|NCT03976375|101943700|FG001|Overall Study|Ongoing|29|||
33559412|NCT03976375|101943701|FG002|Overall Study|Ongoing|5|||
33559413|NCT00861705|101943702|FG000|Overall Study|Never Began Treatment|7|||
33559414|NCT00861705|101943703|FG001|Overall Study|Never Began Treatment|3|||
33358976|NCT01208181|101201290|FG004|Part 1|Protocol Violation|0|||
33358977|NCT01208181|101201286|FG000|Part 1|Physician Decision|4|||
33358978|NCT01208181|101201287|FG001|Part 1|Physician Decision|0|||
33358979|NCT01208181|101201288|FG002|Part 1|Physician Decision|0|||
33358980|NCT01208181|101201289|FG003|Part 1|Physician Decision|0|||
33358981|NCT01208181|101201290|FG004|Part 1|Physician Decision|0|||
33559415|NCT00861705|101943704|FG002|Overall Study|Never Began Treatment|0|||
33559416|NCT00861705|101943705|FG003|Overall Study|Never Began Treatment|1|||
33559417|NCT05626686|101943707|FG000|Overall Study|Protocol Violation|3|||
33358982|NCT01208181|101201286|FG000|Part 1|Non-compliance with study drug|1|||
33358983|NCT01208181|101201287|FG001|Part 1|Non-compliance with study drug|1|||
33358984|NCT01208181|101201288|FG002|Part 1|Non-compliance with study drug|0|||
33358985|NCT01208181|101201289|FG003|Part 1|Non-compliance with study drug|0|||
33358986|NCT01208181|101201290|FG004|Part 1|Non-compliance with study drug|0|||
33358987|NCT01208181|101201286|FG000|Part 1|Lost to Follow-up|5|||
33358988|NCT01208181|101201287|FG001|Part 1|Lost to Follow-up|3|||
33358989|NCT01208181|101201288|FG002|Part 1|Lost to Follow-up|0|||
33358990|NCT01208181|101201289|FG003|Part 1|Lost to Follow-up|0|||
33358991|NCT01208181|101201290|FG004|Part 1|Lost to Follow-up|1|||
33358992|NCT01208181|101201286|FG000|Part 1|Lack of Efficacy|37|||
33358993|NCT01208181|101201287|FG001|Part 1|Lack of Efficacy|12|||
33358994|NCT01208181|101201288|FG002|Part 1|Lack of Efficacy|0|||
33358995|NCT01208181|101201289|FG003|Part 1|Lack of Efficacy|0|||
33358996|NCT01208181|101201290|FG004|Part 1|Lack of Efficacy|17|||
33358997|NCT01208181|101201286|FG000|Part 1|Adverse Event|26|||
33358998|NCT01208181|101201287|FG001|Part 1|Adverse Event|24|||
33358999|NCT01208181|101201288|FG002|Part 1|Adverse Event|0|||
33359000|NCT01208181|101201289|FG003|Part 1|Adverse Event|0|||
33359001|NCT01208181|101201290|FG004|Part 1|Adverse Event|4|||
33359002|NCT01208181|101201286|FG000|Part 2|Adverse Event|0|||
33359003|NCT01208181|101201287|FG001|Part 2|Adverse Event|0|||
33359004|NCT01208181|101201288|FG002|Part 2|Adverse Event|6|||
33359005|NCT01208181|101201289|FG003|Part 2|Adverse Event|7|||
33359006|NCT01208181|101201290|FG004|Part 2|Adverse Event|0|||
33359007|NCT01208181|101201286|FG000|Part 2|Withdrawal by Subject|0|||
33359008|NCT01208181|101201287|FG001|Part 2|Withdrawal by Subject|0|||
33359009|NCT01208181|101201288|FG002|Part 2|Withdrawal by Subject|1|||
33359010|NCT01208181|101201289|FG003|Part 2|Withdrawal by Subject|1|||
33359011|NCT01208181|101201290|FG004|Part 2|Withdrawal by Subject|0|||
33359012|NCT01208181|101201286|FG000|Part 2|Protocol Violation|0|||
33359013|NCT01208181|101201287|FG001|Part 2|Protocol Violation|0|||
33359014|NCT01208181|101201288|FG002|Part 2|Protocol Violation|1|||
33359015|NCT01208181|101201289|FG003|Part 2|Protocol Violation|0|||
33359016|NCT01208181|101201290|FG004|Part 2|Protocol Violation|0|||
33359017|NCT01208181|101201286|FG000|Part 2|Physician Decision|0|||
33359018|NCT01208181|101201287|FG001|Part 2|Physician Decision|0|||
33359019|NCT01208181|101201288|FG002|Part 2|Physician Decision|1|||
33359020|NCT01208181|101201289|FG003|Part 2|Physician Decision|2|||
33359021|NCT01208181|101201290|FG004|Part 2|Physician Decision|0|||
33359022|NCT01208181|101201286|FG000|Part 2|Non-compliance with study drug|0|||
33359023|NCT01208181|101201287|FG001|Part 2|Non-compliance with study drug|0|||
33359024|NCT01208181|101201288|FG002|Part 2|Non-compliance with study drug|1|||
33359025|NCT01208181|101201289|FG003|Part 2|Non-compliance with study drug|1|||
33359026|NCT01208181|101201290|FG004|Part 2|Non-compliance with study drug|0|||
33359027|NCT01208181|101201286|FG000|Part 2|Lost to Follow-up|0|||
33359028|NCT01208181|101201287|FG001|Part 2|Lost to Follow-up|0|||
33359029|NCT01208181|101201288|FG002|Part 2|Lost to Follow-up|1|||
33359030|NCT01208181|101201289|FG003|Part 2|Lost to Follow-up|2|||
33359031|NCT01208181|101201290|FG004|Part 2|Lost to Follow-up|0|||
33359032|NCT01208181|101201286|FG000|Part 2|Lack of Efficacy|0|||
33359033|NCT01208181|101201287|FG001|Part 2|Lack of Efficacy|0|||
33359034|NCT01208181|101201288|FG002|Part 2|Lack of Efficacy|5|||
33359035|NCT01208181|101201289|FG003|Part 2|Lack of Efficacy|7|||
33414586|NCT01915498|101409850|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
33359036|NCT01208181|101201290|FG004|Part 2|Lack of Efficacy|0|||
33414587|NCT01915498|101409851|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
33359037|NCT00820040|101201293|FG000|Overall Study|Death|1|||
33359038|NCT00820040|101201293|FG000|Overall Study|Sponsor terminated study|1|||
33414588|NCT01915498|101409852|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
33359039|NCT00820040|101201293|FG000|Overall Study|Screen failure|1|||
33359040|NCT00849212|101201294|FG000|Overall Study|Lack of Efficacy|1|||
33359041|NCT00849212|101201294|FG000|Overall Study|Withdrawal by Subject|3|||
33359042|NCT00849212|101201294|FG000|Overall Study|Adverse Event|2|||
33359043|NCT00849212|101201294|FG000|Overall Study|Miscellaneous|1|||
33359044|NCT02489630|101201299|FG000|Overall Study|Oversedation|1|||
33359045|NCT02489630|101201300|FG001|Overall Study|Oversedation|1|||
33359046|NCT02489630|101201299|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
33359047|NCT02489630|101201300|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
33359048|NCT00069121|101201301|FG000|Overall Study|Death|286|||
33359049|NCT00069121|101201302|FG001|Overall Study|Death|242|||
33359050|NCT00069121|101201301|FG000|Overall Study|Withdrawal by Subject|18|||
33559418|NCT05626686|101943707|FG000|Overall Study|Withdrawal by Subject|3|||
33559419|NCT02446600|101943713|FG000|Overall Study|Never treated|20|||
33559420|NCT02446600|101943714|FG001|Overall Study|Never treated|2|||
33559421|NCT02446600|101943715|FG002|Overall Study|Never treated|6|||
33559422|NCT02446600|101943716|FG003|Overall Study|Never treated|0|||
33559423|NCT02446600|101943713|FG000|Overall Study|Withdrawal by Subject|19|||
33559424|NCT02446600|101943714|FG001|Overall Study|Withdrawal by Subject|5|||
33559425|NCT02446600|101943715|FG002|Overall Study|Withdrawal by Subject|17|||
33559426|NCT02446600|101943716|FG003|Overall Study|Withdrawal by Subject|0|||
33559427|NCT02446600|101943713|FG000|Overall Study|Ineligible|1|||
33559428|NCT02446600|101943714|FG001|Overall Study|Ineligible|4|||
33559429|NCT02446600|101943715|FG002|Overall Study|Ineligible|4|||
33559430|NCT02446600|101943716|FG003|Overall Study|Ineligible|1|||
33559431|NCT02446600|101943713|FG000|Overall Study|Duplicate Enrollment|0|||
33559432|NCT02446600|101943714|FG001|Overall Study|Duplicate Enrollment|1|||
33559433|NCT02446600|101943715|FG002|Overall Study|Duplicate Enrollment|0|||
33559434|NCT02446600|101943716|FG003|Overall Study|Duplicate Enrollment|0|||
33359051|NCT00069121|101201302|FG001|Overall Study|Withdrawal by Subject|20|||
33359052|NCT00069121|101201301|FG000|Overall Study|Lost to Follow-up|63|||
33559435|NCT03941860|101943717|FG000|Overall Study|Withdrawal by Subject|0|||
33559436|NCT03941860|101943718|FG001|Overall Study|Withdrawal by Subject|1|||
33559437|NCT03735498|101943720|FG000|Overall Study|Withdrawal by Subject|3|||
33559438|NCT03735498|101943720|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
33559439|NCT01708941|101943721|FG000|Overall Study|Adverse Event|4|||
33559440|NCT01708941|101943722|FG001|Overall Study|Adverse Event|6|||
33559441|NCT01708941|101943723|FG002|Overall Study|Adverse Event|1|||
33559442|NCT01708941|101943724|FG003|Overall Study|Adverse Event|0|||
33559443|NCT01708941|101943721|FG000|Overall Study|Death|1|||
33559444|NCT01708941|101943722|FG001|Overall Study|Death|1|||
33559445|NCT01708941|101943723|FG002|Overall Study|Death|2|||
33559446|NCT01708941|101943724|FG003|Overall Study|Death|14|||
33559447|NCT01708941|101943721|FG000|Overall Study|Withdrawal by Subject|1|||
33559448|NCT01708941|101943722|FG001|Overall Study|Withdrawal by Subject|0|||
33559449|NCT01708941|101943723|FG002|Overall Study|Withdrawal by Subject|3|||
33559450|NCT01708941|101943724|FG003|Overall Study|Withdrawal by Subject|4|||
33559451|NCT01708941|101943721|FG000|Overall Study|Disease progression|9|||
33559452|NCT01708941|101943722|FG001|Overall Study|Disease progression|10|||
33559453|NCT01708941|101943723|FG002|Overall Study|Disease progression|8|||
33559454|NCT01708941|101943724|FG003|Overall Study|Disease progression|0|||
33623416|NCT02631551|102169608|FG003|Overall Study|Non-compliance with study procedures|1|||
33623417|NCT02631551|102169605|FG000|Overall Study|Non-compliance with study drug|1|||
33623418|NCT02631551|102169606|FG001|Overall Study|Non-compliance with study drug|0|||
33623419|NCT02631551|102169607|FG002|Overall Study|Non-compliance with study drug|0|||
33623420|NCT02631551|102169608|FG003|Overall Study|Non-compliance with study drug|0|||
33623421|NCT02631551|102169605|FG000|Overall Study|Other, specific reasons not collected|5|||
33623422|NCT02631551|102169606|FG001|Overall Study|Other, specific reasons not collected|7|||
33623423|NCT02631551|102169607|FG002|Overall Study|Other, specific reasons not collected|2|||
33359053|NCT00069121|101201302|FG001|Overall Study|Lost to Follow-up|63|||
33623424|NCT02631551|102169608|FG003|Overall Study|Other, specific reasons not collected|2|||
33623425|NCT00721396|102169618|FG000|Overall Study|Adverse Event|4|||
33623426|NCT00721396|102169619|FG001|Overall Study|Adverse Event|7|||
33359054|NCT00947154|101204342|FG000|Overall Study|Lost to Follow-up|1|||
33359055|NCT00545818|101204349|FG000|Overall Study|Protocol Violation|1|||
33359056|NCT00545818|101204350|FG001|Overall Study|Protocol Violation|0|||
33359057|NCT00545818|101204349|FG000|Overall Study|Adverse Event|1|||
33359058|NCT00545818|101204350|FG001|Overall Study|Adverse Event|1|||
33359059|NCT00545818|101204349|FG000|Overall Study|Lost to Follow-up|1|||
33414589|NCT01915498|101409853|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
33414590|NCT01915498|101409854|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
33559455|NCT01708941|101943721|FG000|Overall Study|Alternative therapy|0|||
33559456|NCT01708941|101943722|FG001|Overall Study|Alternative therapy|0|||
33623427|NCT00721396|102169620|FG002|Overall Study|Adverse Event|2|||
33559457|NCT01708941|101943723|FG002|Overall Study|Alternative therapy|2|||
33623428|NCT00721396|102169621|FG003|Overall Study|Adverse Event|0|||
33359060|NCT00545818|101204350|FG001|Overall Study|Lost to Follow-up|6|||
33559458|NCT01708941|101943724|FG003|Overall Study|Alternative therapy|0|||
33559459|NCT01708941|101943721|FG000|Overall Study|Ineligible and never started treatment|1|||
33559460|NCT01708941|101943722|FG001|Overall Study|Ineligible and never started treatment|0|||
33559461|NCT01708941|101943723|FG002|Overall Study|Ineligible and never started treatment|1|||
33623429|NCT00721396|102169618|FG000|Overall Study|Withdrawal by Subject|12|||
33359061|NCT00964795|101204351|FG000|Overall Study|Withdrawal by Subject|79|||
33359062|NCT00964795|101204351|FG000|Overall Study|Adverse Event|12|||
33359063|NCT00964795|101204351|FG000|Overall Study|Death|14|||
33359064|NCT00964795|101204351|FG000|Overall Study|Lost to Follow-up|7|||
33559462|NCT01708941|101943724|FG003|Overall Study|Ineligible and never started treatment|0|||
33559463|NCT01708941|101943721|FG000|Overall Study|Never started treatment|2|||
33559464|NCT01708941|101943722|FG001|Overall Study|Never started treatment|1|||
33559465|NCT01708941|101943723|FG002|Overall Study|Never started treatment|0|||
33559466|NCT01708941|101943724|FG003|Overall Study|Never started treatment|0|||
33559467|NCT01708941|101943721|FG000|Overall Study|Ineligible|0|||
33559468|NCT01708941|101943722|FG001|Overall Study|Ineligible|0|||
33359065|NCT00964795|101204351|FG000|Overall Study|Termination of Study by Sponsor|169|||
33359066|NCT00964795|101204351|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
33359067|NCT00964795|101204351|FG000|Overall Study|Other|23|||
33359068|NCT00376688|101204352|FG000|Overall Study|Adverse Event|3|||
33359069|NCT00376688|101204352|FG000|Overall Study|Death|1|||
33359070|NCT00465569|101204353|FG000|Overall Study|persistent eczema during dose escalation|1|||
33559469|NCT01708941|101943723|FG002|Overall Study|Ineligible|2|||
33559470|NCT01708941|101943724|FG003|Overall Study|Ineligible|0|||
33559471|NCT03382873|101943730|FG000|Overall Study|Lost to Follow-up|9|||
33559472|NCT03382873|101943731|FG001|Overall Study|Lost to Follow-up|10|||
33559473|NCT03382873|101943730|FG000|Overall Study|Withdrawal by Subject|6|||
33559474|NCT03382873|101943731|FG001|Overall Study|Withdrawal by Subject|11|||
33559475|NCT03382873|101943730|FG000|Overall Study|Visit not completed due to pandemic|16|||
33559476|NCT03382873|101943731|FG001|Overall Study|Visit not completed due to pandemic|41|||
33559477|NCT02741193|101943733|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
33559478|NCT02741193|101943733|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
33559479|NCT01340170|101943734|FG000|Overall Study|Lost to Follow-up|2|||
33559480|NCT01340170|101943735|FG001|Overall Study|Lost to Follow-up|4|||
33559481|NCT01340170|101943736|FG002|Overall Study|Lost to Follow-up|0|||
33559482|NCT01340170|101943734|FG000|Overall Study|Implant failure|1|||
33559483|NCT01340170|101943735|FG001|Overall Study|Implant failure|3|||
33559484|NCT01340170|101943736|FG002|Overall Study|Implant failure|0|||
33559485|NCT03735979|101943737|FG000|Overall Study|Lost to Follow-up|1|||
33559486|NCT03735979|101943738|FG001|Overall Study|Lost to Follow-up|12|||
33559487|NCT03735979|101943739|FG002|Overall Study|Lost to Follow-up|14|||
33559488|NCT03735979|101943737|FG000|Overall Study|Withdrawal by Subject|1|||
33559489|NCT03735979|101943738|FG001|Overall Study|Withdrawal by Subject|5|||
33559490|NCT03735979|101943739|FG002|Overall Study|Withdrawal by Subject|2|||
33559491|NCT03735979|101943737|FG000|Overall Study|Not due to the above reasons|1|||
33359071|NCT00465569|101204354|FG001|Overall Study|persistent eczema during dose escalation|0|||
33359072|NCT01287117|101204355|FG000|Overall Study|Adverse Event|2|||
33359073|NCT01287117|101204356|FG001|Overall Study|Adverse Event|1|||
33559492|NCT03735979|101943738|FG001|Overall Study|Not due to the above reasons|0|||
33559493|NCT03735979|101943739|FG002|Overall Study|Not due to the above reasons|0|||
33559494|NCT02656173|101943741|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
33559495|NCT02656173|101943742|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
33219528|NCT03420781|100703019|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
33219529|NCT03420781|100703020|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
33219530|NCT03420781|100703021|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
33359074|NCT01287117|101204357|FG002|Overall Study|Adverse Event|1|||
33359075|NCT01287117|101204358|FG003|Overall Study|Adverse Event|1|||
33359076|NCT01287117|101204355|FG000|Overall Study|Lost to Follow-up|1|||
33559496|NCT02656173|101943741|FG000|Overall Study|Adverse Event|7|||
33623430|NCT00721396|102169619|FG001|Overall Study|Withdrawal by Subject|15|||
33359077|NCT01287117|101204356|FG001|Overall Study|Lost to Follow-up|1|||
33414591|NCT01915498|101409855|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
33359078|NCT01287117|101204357|FG002|Overall Study|Lost to Follow-up|0|||
33359079|NCT01287117|101204358|FG003|Overall Study|Lost to Follow-up|0|||
33359080|NCT01287117|101204355|FG000|Overall Study|Physician Decision|0|||
33359081|NCT01287117|101204356|FG001|Overall Study|Physician Decision|1|||
33359082|NCT01287117|101204357|FG002|Overall Study|Physician Decision|1|||
33359083|NCT01287117|101204358|FG003|Overall Study|Physician Decision|1|||
33359084|NCT01287117|101204355|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
33359085|NCT01287117|101204356|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
33359086|NCT01287117|101204357|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
33359087|NCT01287117|101204358|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
33359088|NCT01287117|101204355|FG000|Overall Study|Disease Progression|10|||
33359089|NCT01287117|101204356|FG001|Overall Study|Disease Progression|5|||
33359090|NCT01287117|101204357|FG002|Overall Study|Disease Progression|6|||
33359091|NCT01287117|101204358|FG003|Overall Study|Disease Progression|5|||
33559497|NCT02656173|101943742|FG001|Overall Study|Adverse Event|5|||
33559498|NCT02656173|101943741|FG000|Overall Study|Withdrawal by Subject|1|||
33559499|NCT02656173|101943742|FG001|Overall Study|Withdrawal by Subject|3|||
33559500|NCT02656173|101943741|FG000|Overall Study|Protocol Violation|0|||
33559501|NCT02656173|101943742|FG001|Overall Study|Protocol Violation|1|||
33559502|NCT02656173|101943741|FG000|Overall Study|Miscellaneous|2|||
33559503|NCT02656173|101943742|FG001|Overall Study|Miscellaneous|0|||
33559504|NCT03769467|101943745|FG000|Overall Study|Adverse Event|1|||
33559505|NCT03769467|101943746|FG001|Overall Study|Adverse Event|1|||
33559506|NCT03769467|101943747|FG002|Overall Study|Adverse Event|0|||
33559507|NCT03769467|101943745|FG000|Overall Study|Death|3|||
33559508|NCT03769467|101943746|FG001|Overall Study|Death|3|||
33559509|NCT03769467|101943747|FG002|Overall Study|Death|0|||
33359092|NCT00095121|101204361|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
33359093|NCT00095121|101204362|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
33559510|NCT03769467|101943745|FG000|Overall Study|Study Terminated By Sponsor|2|||
33559511|NCT03769467|101943746|FG001|Overall Study|Study Terminated By Sponsor|1|||
33559512|NCT03769467|101943747|FG002|Overall Study|Study Terminated By Sponsor|0|||
33559513|NCT03769467|101943745|FG000|Overall Study|Withdrawal by Subject|0|||
33559514|NCT03769467|101943746|FG001|Overall Study|Withdrawal by Subject|1|||
33559515|NCT03769467|101943747|FG002|Overall Study|Withdrawal by Subject|0|||
33559516|NCT02657551|101943749|FG000|Overall Study|Adverse Event|2|||
33559517|NCT02657551|101943749|FG000|Overall Study|Withdrawal by Subject|1|||
33559518|NCT02657551|101943749|FG000|Overall Study|Non-Compliance|1|||
33559519|NCT02657551|101943749|FG000|Overall Study|Progression / Relapse|4|||
33559520|NCT01840163|101943750|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
33559521|NCT01840163|101943751|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
33559522|NCT01840163|101943750|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
33559523|NCT01840163|101943751|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
33559524|NCT01840163|101943750|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
33559525|NCT01840163|101943751|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
33559526|NCT02410200|101943752|FG000|Overall Study|Adverse Event|2|||
33559527|NCT03648372|101943757|FG000|Overall Study|Withdrawal by Subject|2|||
33559528|NCT03648372|101943758|FG001|Overall Study|Withdrawal by Subject|0|||
33559529|NCT03648372|101943759|FG002|Overall Study|Withdrawal by Subject|0|||
33559530|NCT03648372|101943760|FG003|Overall Study|Withdrawal by Subject|0|||
33559531|NCT03648372|101943761|FG004|Overall Study|Withdrawal by Subject|0|||
33559532|NCT03648372|101943762|FG005|Overall Study|Withdrawal by Subject|1|||
33559533|NCT03648372|101943763|FG006|Overall Study|Withdrawal by Subject|2|||
33219531|NCT03420781|100703022|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
33559534|NCT03648372|101943764|FG007|Overall Study|Withdrawal by Subject|0|||
33559535|NCT03648372|101943765|FG008|Overall Study|Withdrawal by Subject|0|||
33559536|NCT03648372|101943766|FG009|Overall Study|Withdrawal by Subject|0|||
33559537|NCT03648372|101943767|FG010|Overall Study|Withdrawal by Subject|2|||
33559538|NCT03648372|101943768|FG011|Overall Study|Withdrawal by Subject|0|||
33559539|NCT03648372|101943769|FG012|Overall Study|Withdrawal by Subject|2|||
33559540|NCT03648372|101943770|FG013|Overall Study|Withdrawal by Subject|0|||
33559541|NCT03648372|101943771|FG014|Overall Study|Withdrawal by Subject|0|||
33219532|NCT03420781|100703023|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
33359094|NCT00095121|101204361|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
33559542|NCT03648372|101943772|FG015|Overall Study|Withdrawal by Subject|0|||
33359095|NCT00095121|101204362|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
33359096|NCT01457339|101204363|FG000|Period 3 (100 mg)|Adverse Event|0|||
33359097|NCT01457339|101204364|FG001|Period 3 (100 mg)|Adverse Event|1|||
33559543|NCT03648372|101943773|FG016|Overall Study|Withdrawal by Subject|1|||
33219533|NCT03420781|100703019|FG000|Treatment Period (40 Weeks)|Death|2|||
33359098|NCT01457339|101204363|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
33414592|NCT01915498|101409837|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33559544|NCT03648372|101943774|FG017|Overall Study|Withdrawal by Subject|0|||
33559545|NCT03648372|101943775|FG018|Overall Study|Withdrawal by Subject|0|||
33559546|NCT03648372|101943776|FG019|Overall Study|Withdrawal by Subject|0|||
33359099|NCT01457339|101204364|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
33359100|NCT01457339|101204363|FG000|Period 6 (250 mg)|Family Emergency|1|||
33359101|NCT01457339|101204364|FG001|Period 6 (250 mg)|Family Emergency|0|||
33359102|NCT01457339|101204363|FG000|Period 6 (250 mg)|Personal appointment|0|||
33359103|NCT01457339|101204364|FG001|Period 6 (250 mg)|Personal appointment|1|||
33359104|NCT00532259|101204368|FG000|Overall Study|Withdrawal by Subject|2|||
33359105|NCT00532259|101204368|FG000|Overall Study|Adverse Event|1|||
33359106|NCT00532259|101204368|FG000|Overall Study|Death|1|||
33359107|NCT00532259|101204368|FG000|Overall Study|Lack of Efficacy|21|||
33359108|NCT00532259|101204368|FG000|Overall Study|Lost to Follow-up|3|||
33359109|NCT00532259|101204368|FG000|Overall Study|Physician Decision|3|||
33559547|NCT03648372|101943777|FG020|Overall Study|Withdrawal by Subject|0|||
33559548|NCT03648372|101943757|FG000|Overall Study|Progressive Disease|2|||
33559549|NCT03648372|101943758|FG001|Overall Study|Progressive Disease|3|||
33359110|NCT00532259|101204368|FG000|Overall Study|Protocol Violation|1|||
33559550|NCT03648372|101943759|FG002|Overall Study|Progressive Disease|4|||
33559551|NCT03648372|101943760|FG003|Overall Study|Progressive Disease|3|||
33559552|NCT03648372|101943761|FG004|Overall Study|Progressive Disease|2|||
33559553|NCT03648372|101943762|FG005|Overall Study|Progressive Disease|2|||
33559554|NCT03648372|101943763|FG006|Overall Study|Progressive Disease|3|||
33559555|NCT03648372|101943764|FG007|Overall Study|Progressive Disease|3|||
33559556|NCT03648372|101943765|FG008|Overall Study|Progressive Disease|5|||
33559557|NCT03648372|101943766|FG009|Overall Study|Progressive Disease|5|||
33559558|NCT03648372|101943767|FG010|Overall Study|Progressive Disease|2|||
33559559|NCT03648372|101943768|FG011|Overall Study|Progressive Disease|3|||
33559560|NCT03648372|101943769|FG012|Overall Study|Progressive Disease|3|||
33559561|NCT03648372|101943770|FG013|Overall Study|Progressive Disease|3|||
33559562|NCT03648372|101943771|FG014|Overall Study|Progressive Disease|6|||
33559563|NCT03648372|101943772|FG015|Overall Study|Progressive Disease|0|||
33559564|NCT03648372|101943773|FG016|Overall Study|Progressive Disease|0|||
33559565|NCT03648372|101943774|FG017|Overall Study|Progressive Disease|0|||
33559566|NCT03648372|101943775|FG018|Overall Study|Progressive Disease|0|||
33559567|NCT03648372|101943776|FG019|Overall Study|Progressive Disease|0|||
33559568|NCT03648372|101943777|FG020|Overall Study|Progressive Disease|0|||
33559569|NCT03648372|101943757|FG000|Overall Study|Other|0|||
33559570|NCT03648372|101943758|FG001|Overall Study|Other|0|||
33359111|NCT02629393|101204378|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
33359112|NCT02629393|101204378|FG000|Overall Study|Physician Decision|1|||
33559571|NCT03648372|101943759|FG002|Overall Study|Other|0|||
33559572|NCT03648372|101943760|FG003|Overall Study|Other|0|||
33559573|NCT03648372|101943761|FG004|Overall Study|Other|1|||
33559574|NCT03648372|101943762|FG005|Overall Study|Other|0|||
33559575|NCT03648372|101943763|FG006|Overall Study|Other|0|||
33559576|NCT03648372|101943764|FG007|Overall Study|Other|0|||
33559577|NCT03648372|101943765|FG008|Overall Study|Other|0|||
33559578|NCT03648372|101943766|FG009|Overall Study|Other|0|||
33559579|NCT03648372|101943767|FG010|Overall Study|Other|1|||
33559580|NCT03648372|101943768|FG011|Overall Study|Other|2|||
33559581|NCT03648372|101943769|FG012|Overall Study|Other|1|||
33559582|NCT03648372|101943770|FG013|Overall Study|Other|3|||
33623431|NCT00721396|102169620|FG002|Overall Study|Withdrawal by Subject|3|||
33623432|NCT00721396|102169621|FG003|Overall Study|Withdrawal by Subject|7|||
33623433|NCT00721396|102169618|FG000|Overall Study|Lost to Follow-up|7|||
33623434|NCT00721396|102169619|FG001|Overall Study|Lost to Follow-up|9|||
33623435|NCT00721396|102169620|FG002|Overall Study|Lost to Follow-up|3|||
33623436|NCT00721396|102169621|FG003|Overall Study|Lost to Follow-up|3|||
33623437|NCT00721396|102169618|FG000|Overall Study|Protocol Violation|4|||
33623438|NCT00721396|102169619|FG001|Overall Study|Protocol Violation|3|||
33623439|NCT00721396|102169620|FG002|Overall Study|Protocol Violation|1|||
33623440|NCT00721396|102169621|FG003|Overall Study|Protocol Violation|0|||
33623441|NCT00721396|102169618|FG000|Overall Study|Inappropriate enrollment|0|||
33623442|NCT00721396|102169619|FG001|Overall Study|Inappropriate enrollment|2|||
33623443|NCT00721396|102169620|FG002|Overall Study|Inappropriate enrollment|0|||
33219534|NCT03420781|100703020|FG001|Treatment Period (40 Weeks)|Death|2|||
33559583|NCT03648372|101943771|FG014|Overall Study|Other|0|||
33559584|NCT03648372|101943772|FG015|Overall Study|Other|5|||
33559585|NCT03648372|101943773|FG016|Overall Study|Other|1|||
33623444|NCT00721396|102169621|FG003|Overall Study|Inappropriate enrollment|0|||
33623445|NCT00721396|102169618|FG000|Overall Study|Administrative reason|3|||
33623446|NCT00721396|102169619|FG001|Overall Study|Administrative reason|0|||
33559586|NCT03648372|101943774|FG017|Overall Study|Other|5|||
33559587|NCT03648372|101943775|FG018|Overall Study|Other|0|||
33559588|NCT03648372|101943776|FG019|Overall Study|Other|1|||
33559589|NCT03648372|101943777|FG020|Overall Study|Other|0|||
33559590|NCT03648372|101943757|FG000|Overall Study|Lost to Follow-up|0|||
33559591|NCT03648372|101943758|FG001|Overall Study|Lost to Follow-up|0|||
33559592|NCT03648372|101943759|FG002|Overall Study|Lost to Follow-up|0|||
33559593|NCT03648372|101943760|FG003|Overall Study|Lost to Follow-up|0|||
33559594|NCT03648372|101943761|FG004|Overall Study|Lost to Follow-up|0|||
33559595|NCT03648372|101943762|FG005|Overall Study|Lost to Follow-up|0|||
33559596|NCT03648372|101943763|FG006|Overall Study|Lost to Follow-up|0|||
33559597|NCT03648372|101943764|FG007|Overall Study|Lost to Follow-up|0|||
33559598|NCT03648372|101943765|FG008|Overall Study|Lost to Follow-up|0|||
33559599|NCT03648372|101943766|FG009|Overall Study|Lost to Follow-up|0|||
33559600|NCT03648372|101943767|FG010|Overall Study|Lost to Follow-up|0|||
33559601|NCT03648372|101943768|FG011|Overall Study|Lost to Follow-up|0|||
33559602|NCT03648372|101943769|FG012|Overall Study|Lost to Follow-up|0|||
33559603|NCT03648372|101943770|FG013|Overall Study|Lost to Follow-up|1|||
33559604|NCT03648372|101943771|FG014|Overall Study|Lost to Follow-up|0|||
33559605|NCT03648372|101943772|FG015|Overall Study|Lost to Follow-up|1|||
33559606|NCT03648372|101943773|FG016|Overall Study|Lost to Follow-up|0|||
33559607|NCT03648372|101943774|FG017|Overall Study|Lost to Follow-up|1|||
33559608|NCT03648372|101943775|FG018|Overall Study|Lost to Follow-up|0|||
33559609|NCT03648372|101943776|FG019|Overall Study|Lost to Follow-up|0|||
33559610|NCT03648372|101943777|FG020|Overall Study|Lost to Follow-up|0|||
33559611|NCT03648372|101943757|FG000|Overall Study|Start of a New Systemic Treatment|0|||
33559612|NCT03648372|101943758|FG001|Overall Study|Start of a New Systemic Treatment|0|||
33559613|NCT03648372|101943759|FG002|Overall Study|Start of a New Systemic Treatment|0|||
33559614|NCT03648372|101943760|FG003|Overall Study|Start of a New Systemic Treatment|0|||
33623447|NCT00721396|102169620|FG002|Overall Study|Administrative reason|1|||
33359113|NCT01676116|101204380|FG000|Overall Study|Withdrawal criteria|2|||
33359114|NCT01676116|101204381|FG001|Overall Study|Withdrawal criteria|14|||
33359115|NCT01676116|101204380|FG000|Overall Study|Adverse Event|1|||
33359116|NCT01676116|101204381|FG001|Overall Study|Adverse Event|2|||
33359117|NCT01676116|101204380|FG000|Overall Study|Unclassified|4|||
33359118|NCT01676116|101204381|FG001|Overall Study|Unclassified|10|||
33359119|NCT01676116|101204380|FG000|Overall Study|Protocol Violation|9|||
33359120|NCT01676116|101204381|FG001|Overall Study|Protocol Violation|3|||
33359121|NCT01325493|101204382|FG000|Overall Study|Protocol Violation|0|||
33559615|NCT03648372|101943761|FG004|Overall Study|Start of a New Systemic Treatment|0|||
33559616|NCT03648372|101943762|FG005|Overall Study|Start of a New Systemic Treatment|0|||
33559617|NCT03648372|101943763|FG006|Overall Study|Start of a New Systemic Treatment|0|||
33559618|NCT03648372|101943764|FG007|Overall Study|Start of a New Systemic Treatment|2|||
33559619|NCT03648372|101943765|FG008|Overall Study|Start of a New Systemic Treatment|0|||
33559620|NCT03648372|101943766|FG009|Overall Study|Start of a New Systemic Treatment|0|||
33559621|NCT03648372|101943767|FG010|Overall Study|Start of a New Systemic Treatment|1|||
33559622|NCT03648372|101943768|FG011|Overall Study|Start of a New Systemic Treatment|0|||
33559623|NCT03648372|101943769|FG012|Overall Study|Start of a New Systemic Treatment|0|||
33559624|NCT03648372|101943770|FG013|Overall Study|Start of a New Systemic Treatment|0|||
33559625|NCT03648372|101943771|FG014|Overall Study|Start of a New Systemic Treatment|0|||
33559626|NCT03648372|101943772|FG015|Overall Study|Start of a New Systemic Treatment|0|||
33559627|NCT03648372|101943773|FG016|Overall Study|Start of a New Systemic Treatment|0|||
33559628|NCT03648372|101943774|FG017|Overall Study|Start of a New Systemic Treatment|0|||
33559629|NCT03648372|101943775|FG018|Overall Study|Start of a New Systemic Treatment|0|||
33559630|NCT03648372|101943776|FG019|Overall Study|Start of a New Systemic Treatment|0|||
33559631|NCT03648372|101943777|FG020|Overall Study|Start of a New Systemic Treatment|0|||
33559632|NCT03745313|101943783|FG000|At 30 Days Follow-up|Death|2|||
33623448|NCT00721396|102169621|FG003|Overall Study|Administrative reason|0|||
33623449|NCT02807623|102169622|FG000|Overall Study|Lost to Follow-up|23|||
33623450|NCT02807623|102169623|FG001|Overall Study|Lost to Follow-up|18|||
33623451|NCT02807623|102169624|FG002|Overall Study|Lost to Follow-up|22|||
33623452|NCT02807623|102169622|FG000|Overall Study|Drug intolerance|0|||
33623453|NCT02807623|102169623|FG001|Overall Study|Drug intolerance|1|||
33359122|NCT01325493|101204383|FG001|Overall Study|Protocol Violation|1|||
33359123|NCT01325493|101204382|FG000|Overall Study|loss of neuromonitoring signals|0|||
33559633|NCT03745313|101943783|FG000|At 6 Months Follow-up|Death|1|||
33559634|NCT03745313|101943783|FG000|At 6 Months Follow-up|Missed Visit|1|||
33359124|NCT01325493|101204383|FG001|Overall Study|loss of neuromonitoring signals|2|||
33359125|NCT01325493|101204382|FG000|Overall Study|Allergy|1|||
33359126|NCT01325493|101204383|FG001|Overall Study|Allergy|0|||
33359127|NCT03429556|101204385|FG000|Overall Study|Lost to Follow-up|0|||
33559635|NCT03745313|101943783|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
33559636|NCT03745313|101943783|FG000|At 1 Year Follow-up|Death|2|||
33559637|NCT03745313|101943783|FG000|At 1 Year Follow-up|Missed Visit|2|||
33559638|NCT03745313|101943783|FG000|At 2 Year Follow-up|Missed Visit|1|||
33559639|NCT01844986|101943787|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
33559640|NCT01844986|101943788|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
33559641|NCT01844986|101943787|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
33559642|NCT01844986|101943788|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
33623454|NCT02807623|102169624|FG002|Overall Study|Drug intolerance|0|||
33559643|NCT01844986|101943787|FG000|Overall Study (Global Cohort)|Death|55|||
33559644|NCT01844986|101943788|FG001|Overall Study (Global Cohort)|Death|26|||
33559645|NCT01844986|101943787|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
33559646|NCT01844986|101943788|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
33559647|NCT01844986|101943787|FG000|Overall Study (China Cohort)|Death|10|||
33559648|NCT01844986|101943788|FG001|Overall Study (China Cohort)|Death|6|||
33559649|NCT01104870|101943789|FG000|Overall Study|Adverse Event|1|||
33559650|NCT01104870|101943790|FG001|Overall Study|Adverse Event|1|||
33559651|NCT01104870|101943791|FG002|Overall Study|Adverse Event|0|||
33559652|NCT01104870|101943789|FG000|Overall Study|Death|0|||
33559653|NCT01104870|101943790|FG001|Overall Study|Death|0|||
33559654|NCT01104870|101943791|FG002|Overall Study|Death|1|||
33559655|NCT01104870|101943789|FG000|Overall Study|Withdrawal by Subject|0|||
33559656|NCT01104870|101943790|FG001|Overall Study|Withdrawal by Subject|0|||
33559657|NCT01104870|101943791|FG002|Overall Study|Withdrawal by Subject|1|||
33559658|NCT03249558|101943792|FG000|Overall Study|Lost to Follow-up|2|||
33559659|NCT03249558|101943793|FG001|Overall Study|Lost to Follow-up|1|||
33559660|NCT03249558|101943794|FG002|Overall Study|Lost to Follow-up|4|||
33559661|NCT03249558|101943792|FG000|Overall Study|Physician Decision|1|||
33559662|NCT03249558|101943793|FG001|Overall Study|Physician Decision|0|||
33559663|NCT03249558|101943794|FG002|Overall Study|Physician Decision|0|||
33559664|NCT03249558|101943792|FG000|Overall Study|Withdrawal by Subject|6|||
33559665|NCT03249558|101943793|FG001|Overall Study|Withdrawal by Subject|5|||
33559666|NCT03249558|101943794|FG002|Overall Study|Withdrawal by Subject|7|||
33559667|NCT03249558|101943792|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
33559668|NCT03249558|101943793|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
33359128|NCT03429556|101204386|FG001|Overall Study|Lost to Follow-up|1|||
33559669|NCT03249558|101943794|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
33559670|NCT03249558|101943792|FG000|Overall Study|Protocol Violation|1|||
33623455|NCT02807623|102169622|FG000|Overall Study|incomplete blood draw|0|||
33359129|NCT03429556|101204387|FG002|Overall Study|Lost to Follow-up|0|||
33623456|NCT02807623|102169623|FG001|Overall Study|incomplete blood draw|2|||
33623457|NCT02807623|102169624|FG002|Overall Study|incomplete blood draw|1|||
33623458|NCT01156480|102169625|FG000|Overall Study|change in diagnosis|0|||
33623459|NCT01156480|102169626|FG001|Overall Study|change in diagnosis|1|||
33623460|NCT01623115|102169629|FG000|Overall Study|Randomized but not treated|0|||
33623461|NCT01623115|102169630|FG001|Overall Study|Randomized but not treated|1|||
33623462|NCT01623115|102169629|FG000|Overall Study|Physician Decision|1|||
33623463|NCT01623115|102169630|FG001|Overall Study|Physician Decision|0|||
33623464|NCT01623115|102169629|FG000|Overall Study|Participants moved|1|||
33623465|NCT01623115|102169630|FG001|Overall Study|Participants moved|5|||
33623466|NCT01623115|102169629|FG000|Overall Study|Adverse Event|10|||
33623467|NCT01623115|102169630|FG001|Overall Study|Adverse Event|13|||
33623468|NCT01623115|102169629|FG000|Overall Study|Poor compliance to protocol|4|||
33623469|NCT01623115|102169630|FG001|Overall Study|Poor compliance to protocol|10|||
33623470|NCT01623115|102169629|FG000|Overall Study|Consent withdrawn by participant|2|||
33623471|NCT01623115|102169630|FG001|Overall Study|Consent withdrawn by participant|6|||
33623472|NCT01623115|102169629|FG000|Overall Study|Related to study drug administration|0|||
33623473|NCT01623115|102169630|FG001|Overall Study|Related to study drug administration|2|||
33623474|NCT01623115|102169629|FG000|Overall Study|Last visit outside protocol visit window|14|||
33623475|NCT01623115|102169630|FG001|Overall Study|Last visit outside protocol visit window|26|||
33359130|NCT03429556|101204388|FG003|Overall Study|Lost to Follow-up|0|||
33559671|NCT03249558|101943793|FG001|Overall Study|Protocol Violation|1|||
33559672|NCT03249558|101943794|FG002|Overall Study|Protocol Violation|2|||
33559673|NCT02217982|101943799|FG000|Overall Study|Trial discontinued|1|||
33623476|NCT01623115|102169629|FG000|Overall Study|Site closure|1|||
33219535|NCT03420781|100703021|FG002|Treatment Period (40 Weeks)|Death|0|||
33559674|NCT02217982|101943800|FG001|Overall Study|Trial discontinued|0|||
33559675|NCT02217982|101943799|FG000|Overall Study|Adverse Event|0|||
33559676|NCT02217982|101943800|FG001|Overall Study|Adverse Event|1|||
33559677|NCT03537729|101943805|FG000|Overall Study|Death|2|||
33559678|NCT03537729|101943806|FG001|Overall Study|Death|2|||
33559679|NCT03537729|101943807|FG002|Overall Study|Death|7|||
33559680|NCT03537729|101943805|FG000|Overall Study|Withdrawal by Subject|3|||
33559681|NCT03537729|101943806|FG001|Overall Study|Withdrawal by Subject|3|||
33559682|NCT03537729|101943807|FG002|Overall Study|Withdrawal by Subject|0|||
33559683|NCT03537729|101943805|FG000|Overall Study|Subject Moved|8|||
33559684|NCT03537729|101943806|FG001|Overall Study|Subject Moved|5|||
33219536|NCT03420781|100703022|FG003|Treatment Period (40 Weeks)|Death|0|||
33219537|NCT03420781|100703023|FG004|Treatment Period (40 Weeks)|Death|0|||
33219538|NCT03420781|100703019|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
33219539|NCT03420781|100703020|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
33219540|NCT03420781|100703021|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
33219541|NCT03420781|100703022|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
33219542|NCT03420781|100703023|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
33219543|NCT03420781|100703019|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
33559685|NCT03537729|101943807|FG002|Overall Study|Subject Moved|4|||
33559686|NCT03537729|101943805|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
33559687|NCT03537729|101943806|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
33559688|NCT03537729|101943807|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
33559689|NCT03537729|101943805|FG000|Overall Study|COVID-19 Site Restrictions|11|||
33559690|NCT03537729|101943806|FG001|Overall Study|COVID-19 Site Restrictions|15|||
33559691|NCT03537729|101943807|FG002|Overall Study|COVID-19 Site Restrictions|18|||
33219544|NCT03420781|100703020|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
33219545|NCT03420781|100703021|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
33219546|NCT03420781|100703022|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
33219547|NCT03420781|100703023|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
33219548|NCT03420781|100703019|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
33219549|NCT03420781|100703020|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
33219550|NCT03420781|100703021|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
33219551|NCT03420781|100703022|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
33559692|NCT03537729|101943805|FG000|Overall Study|Decline in Health|5|||
33559693|NCT03537729|101943806|FG001|Overall Study|Decline in Health|9|||
33623477|NCT01623115|102169630|FG001|Overall Study|Site closure|7|||
33559694|NCT03537729|101943807|FG002|Overall Study|Decline in Health|4|||
33559695|NCT03537729|101943805|FG000|Overall Study|Determined Ineligible|0|||
33219552|NCT03420781|100703023|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
33219553|NCT03420781|100703019|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
33219554|NCT03420781|100703020|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
33219555|NCT03420781|100703021|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
33219556|NCT03420781|100703022|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
33219557|NCT03420781|100703023|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
33219558|NCT03420781|100703019|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
33219559|NCT03420781|100703020|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
33219560|NCT03420781|100703021|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
33219561|NCT03420781|100703022|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
33219562|NCT03420781|100703023|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
33219563|NCT03420781|100703019|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
33219564|NCT03420781|100703020|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
33219565|NCT03420781|100703021|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
33219566|NCT03420781|100703022|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
33219567|NCT03420781|100703023|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
33219568|NCT03420781|100703019|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
33219569|NCT03420781|100703020|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
33219570|NCT03420781|100703021|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
33219571|NCT03420781|100703022|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
33219572|NCT03420781|100703023|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
33219573|NCT03420781|100703019|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
33219574|NCT03420781|100703020|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
33219575|NCT03420781|100703021|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
33219576|NCT03420781|100703022|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
33219577|NCT03420781|100703023|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
33219578|NCT02612064|100703024|FG000|Overall Study|Withdrawal by Subject|1|||
33219579|NCT02612064|100703025|FG001|Overall Study|Withdrawal by Subject|1|||
33219580|NCT02612064|100703024|FG000|Overall Study|Other|0|||
33219581|NCT02612064|100703025|FG001|Overall Study|Other|2|||
33219582|NCT02719990|100703026|FG000|Overall Study|Physician Decision|2|||
33219583|NCT02719990|100703026|FG000|Overall Study|Withdrawal by Subject|2|||
33219584|NCT02719990|100703026|FG000|Overall Study|Study Terminated By Sponsor|32|||
33219585|NCT02686034|100703033|FG000|Run-In Period 1|Eligibility|12|||
33219586|NCT02686034|100703034|FG001|Run-In Period 1|Eligibility|10|||
33219587|NCT02686034|100703033|FG000|Run-In Period 1|Withdrawal by Subject|4|||
33219588|NCT02686034|100703034|FG001|Run-In Period 1|Withdrawal by Subject|3|||
33219589|NCT02686034|100703033|FG000|Run-In Period 1|Lost to Follow-up|4|||
33219590|NCT02686034|100703034|FG001|Run-In Period 1|Lost to Follow-up|4|||
33219591|NCT02686034|100703033|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
33219592|NCT02686034|100703034|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
33219593|NCT02686034|100703033|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
33219594|NCT02686034|100703034|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
33219595|NCT02686034|100703033|FG000|Randomized Controlled Period 2|Adverse Event|0|||
33219596|NCT02686034|100703034|FG001|Randomized Controlled Period 2|Adverse Event|2|||
33219597|NCT02686034|100703033|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
33219598|NCT02686034|100703034|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
33219599|NCT02686034|100703033|FG000|Open Label Period 3|Lost to Follow-up|0|||
33219600|NCT02686034|100703034|FG001|Open Label Period 3|Lost to Follow-up|1|||
33219601|NCT04108000|100703037|FG000|Overall Study|Death of patient|1|||
33219602|NCT04108000|100703038|FG001|Overall Study|Death of patient|0|||
33219603|NCT04108000|100703039|FG002|Overall Study|Death of patient|1|||
33219604|NCT04108000|100703040|FG003|Overall Study|Death of patient|0|||
33219605|NCT04108000|100703037|FG000|Overall Study|Withdrawal by Subject|2|||
33219606|NCT04108000|100703038|FG001|Overall Study|Withdrawal by Subject|2|||
33219607|NCT04108000|100703039|FG002|Overall Study|Withdrawal by Subject|0|||
33219608|NCT04108000|100703040|FG003|Overall Study|Withdrawal by Subject|0|||
33219609|NCT04108000|100703037|FG000|Overall Study|Death of surrogate partner|0|||
33219610|NCT04108000|100703038|FG001|Overall Study|Death of surrogate partner|1|||
33219611|NCT04108000|100703039|FG002|Overall Study|Death of surrogate partner|0|||
33219612|NCT04108000|100703040|FG003|Overall Study|Death of surrogate partner|1|||
33219613|NCT03286751|100703041|FG000|Washout Period 1|Withdrawal by Subject|0|||
33559696|NCT03537729|101943806|FG001|Overall Study|Determined Ineligible|0|||
33559697|NCT03537729|101943807|FG002|Overall Study|Determined Ineligible|1|||
33623478|NCT01623115|102169629|FG000|Overall Study|Death|0|||
33219614|NCT03286751|100703042|FG001|Washout Period 1|Withdrawal by Subject|0|||
33219615|NCT03286751|100703043|FG002|Washout Period 1|Withdrawal by Subject|0|||
33359131|NCT00064701|101204389|FG000|One Year Post-transplant|Did not receive study drug|7|||
33559698|NCT01386645|101943808|FG000|Overall Study|Physician Decision|0|||
33559699|NCT01386645|101943809|FG001|Overall Study|Physician Decision|0|||
33559700|NCT01386645|101943810|FG002|Overall Study|Physician Decision|1|||
33559701|NCT01386645|101943808|FG000|Overall Study|Withdrawal by Subject|0|||
33559702|NCT01386645|101943809|FG001|Overall Study|Withdrawal by Subject|1|||
33559703|NCT01386645|101943810|FG002|Overall Study|Withdrawal by Subject|1|||
33219616|NCT03286751|100703044|FG003|Washout Period 1|Withdrawal by Subject|0|||
33219617|NCT03286751|100703045|FG004|Washout Period 1|Withdrawal by Subject|1|||
33219618|NCT03286751|100703046|FG005|Washout Period 1|Withdrawal by Subject|0|||
33219619|NCT03286751|100703041|FG000|Washout Period 2|Personal Reasons|0|||
33219620|NCT03286751|100703042|FG001|Washout Period 2|Personal Reasons|1|||
33219621|NCT03286751|100703043|FG002|Washout Period 2|Personal Reasons|0|||
33219622|NCT03286751|100703044|FG003|Washout Period 2|Personal Reasons|0|||
33219623|NCT03286751|100703045|FG004|Washout Period 2|Personal Reasons|0|||
33219624|NCT03286751|100703046|FG005|Washout Period 2|Personal Reasons|0|||
33219625|NCT03286751|100703041|FG000|Washout Period 5|Adverse Event|0|||
33219626|NCT03286751|100703042|FG001|Washout Period 5|Adverse Event|0|||
33219627|NCT03286751|100703043|FG002|Washout Period 5|Adverse Event|0|||
33219628|NCT03286751|100703044|FG003|Washout Period 5|Adverse Event|0|||
33219629|NCT03286751|100703045|FG004|Washout Period 5|Adverse Event|1|||
33219630|NCT03286751|100703046|FG005|Washout Period 5|Adverse Event|0|||
33559704|NCT03359395|101943811|FG000|First Intervention A / B|Withdrawal by Subject|1|||
33559705|NCT03359395|101943812|FG001|First Intervention A / B|Withdrawal by Subject|0|||
33219631|NCT04477187|100703047|FG000|Overall Study|Lost to Follow-up|2|||
33219632|NCT02044848|100703049|FG000|Overall Study|Administrative Problems|2|||
33219633|NCT02044848|100703050|FG001|Overall Study|Administrative Problems|3|||
33219634|NCT00386022|100703053|FG000|Plus Estrogen|Lost to Follow-up|2|||
33559706|NCT03359395|101943811|FG000|First Intervention A / B|Lost to Follow-up|2|||
33559707|NCT03359395|101943812|FG001|First Intervention A / B|Lost to Follow-up|3|||
33559708|NCT03359395|101943811|FG000|Second Intervention B/A|Exclusion criteria|0|||
33559709|NCT03359395|101943812|FG001|Second Intervention B/A|Exclusion criteria|1|||
33559710|NCT03359395|101943811|FG000|Second Intervention B/A|Lost to Follow-up|3|||
33559711|NCT03359395|101943812|FG001|Second Intervention B/A|Lost to Follow-up|2|||
33559712|NCT03163264|101943813|FG000|Overall Study|Withdrawal by Subject|13|||
33559713|NCT03163264|101943814|FG001|Overall Study|Withdrawal by Subject|3|||
33559714|NCT03163264|101943815|FG002|Overall Study|Withdrawal by Subject|4|||
33559715|NCT03163264|101943816|FG003|Overall Study|Withdrawal by Subject|2|||
33559716|NCT03163264|101943813|FG000|Overall Study|Lost to Follow-up|17|||
33559717|NCT03163264|101943814|FG001|Overall Study|Lost to Follow-up|20|||
33559718|NCT03163264|101943815|FG002|Overall Study|Lost to Follow-up|0|||
33559719|NCT03163264|101943816|FG003|Overall Study|Lost to Follow-up|0|||
33559720|NCT03163264|101943813|FG000|Overall Study|Death|0|||
33559721|NCT03163264|101943814|FG001|Overall Study|Death|2|||
33559722|NCT03163264|101943815|FG002|Overall Study|Death|0|||
33559723|NCT03163264|101943816|FG003|Overall Study|Death|0|||
33559724|NCT03973489|101945972|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
33559725|NCT03973489|101945973|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
33559726|NCT03973489|101945974|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
33559727|NCT03973489|101945975|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
33559728|NCT03973489|101945976|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
33559729|NCT03973489|101945977|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
33559730|NCT03973489|101945978|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
33559731|NCT03973489|101945979|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
33559732|NCT03973489|101945972|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
33559733|NCT03973489|101945973|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
33559734|NCT03973489|101945974|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
33559735|NCT03973489|101945975|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
33559736|NCT03973489|101945976|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
33559737|NCT03973489|101945977|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
33559738|NCT03973489|101945978|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
33559739|NCT03973489|101945979|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
33559740|NCT03973489|101945972|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
33559741|NCT03973489|101945973|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
33559742|NCT03973489|101945974|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
33559743|NCT03973489|101945975|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
33559744|NCT03973489|101945976|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
33559745|NCT03973489|101945977|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
33559746|NCT03973489|101945978|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
33559747|NCT03973489|101945979|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
33559748|NCT03973489|101945972|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
33559749|NCT03973489|101945973|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
33559750|NCT03973489|101945974|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
33559751|NCT03973489|101945975|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
33559752|NCT03973489|101945976|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
33559753|NCT03973489|101945977|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
33559754|NCT03973489|101945978|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
33559755|NCT03973489|101945979|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
33559756|NCT03973489|101945972|FG000|Second Intervention (1 Day)|Adverse Event|0|||
33559757|NCT03973489|101945973|FG001|Second Intervention (1 Day)|Adverse Event|0|||
33559758|NCT03973489|101945974|FG002|Second Intervention (1 Day)|Adverse Event|0|||
33559759|NCT03973489|101945975|FG003|Second Intervention (1 Day)|Adverse Event|1|||
33559760|NCT03973489|101945976|FG004|Second Intervention (1 Day)|Adverse Event|0|||
33559761|NCT03973489|101945977|FG005|Second Intervention (1 Day)|Adverse Event|0|||
33559762|NCT03973489|101945978|FG006|Second Intervention (1 Day)|Adverse Event|0|||
33559763|NCT03973489|101945979|FG007|Second Intervention (1 Day)|Adverse Event|0|||
33559764|NCT05013905|101945980|FG000|Overall Study|Adverse Event|1|||
33559765|NCT05013905|101945980|FG000|Overall Study|Lack of Efficacy|1|||
33559766|NCT05788328|101945981|FG000|Treatment Period 4 (5 Days)|Other|1|||
33559767|NCT05788328|101945981|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
33559768|NCT03258593|101945982|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
33559769|NCT03258593|101945983|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
33559770|NCT03258593|101945984|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
33559771|NCT03258593|101945985|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
33559772|NCT03258593|101945982|FG000|Run-In Maintenance Phase|Disease progression|3|||
33559773|NCT03258593|101945983|FG001|Run-In Maintenance Phase|Disease progression|0|||
33559774|NCT03258593|101945984|FG002|Run-In Maintenance Phase|Disease progression|0|||
33559775|NCT03258593|101945985|FG003|Run-In Maintenance Phase|Disease progression|0|||
33559776|NCT03258593|101945982|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
33559777|NCT03258593|101945983|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
33559778|NCT03258593|101945984|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
33559779|NCT03258593|101945985|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
33559780|NCT03258593|101945982|FG000|Expansion Maintenance Phase|Physician Decision|0|||
33559781|NCT03258593|101945983|FG001|Expansion Maintenance Phase|Physician Decision|1|||
33559782|NCT03258593|101945984|FG002|Expansion Maintenance Phase|Physician Decision|0|||
33559783|NCT03258593|101945985|FG003|Expansion Maintenance Phase|Physician Decision|0|||
33559784|NCT02506153|101945992|FG000|Overall Study|Adverse Event|359|||
33559785|NCT02506153|101945993|FG001|Overall Study|Adverse Event|114|||
33559786|NCT02506153|101945992|FG000|Overall Study|Refused unrelated to adverse event|127|||
33559787|NCT02506153|101945993|FG001|Overall Study|Refused unrelated to adverse event|18|||
33559788|NCT02506153|101945992|FG000|Overall Study|Progression/relapse|91|||
33559789|NCT02506153|101945993|FG001|Overall Study|Progression/relapse|136|||
33559790|NCT02506153|101945992|FG000|Overall Study|Death|2|||
33559791|NCT02506153|101945993|FG001|Overall Study|Death|1|||
33559792|NCT02506153|101945992|FG000|Overall Study|Other - not protocol specified|23|||
33559793|NCT02506153|101945993|FG001|Overall Study|Other - not protocol specified|12|||
33559794|NCT02965456|101945994|FG000|Overall Study|Lost to Follow-up|40|||
33559795|NCT02965456|101945995|FG001|Overall Study|Lost to Follow-up|18|||
33559796|NCT02965456|101945994|FG000|Overall Study|Subject Request|22|||
33559797|NCT02965456|101945995|FG001|Overall Study|Subject Request|13|||
33559798|NCT02965456|101945994|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
33219635|NCT00386022|100703054|FG001|Plus Estrogen|Lost to Follow-up|0|||
33219636|NCT00386022|100703053|FG000|Plus Estrogen|Adverse Event|0|||
33559799|NCT02965456|101945995|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
33559800|NCT02965456|101945994|FG000|Overall Study|Adverse Event|3|||
33559801|NCT02965456|101945995|FG001|Overall Study|Adverse Event|0|||
33559802|NCT02965456|101945994|FG000|Overall Study|Noncompliance with Study Drug|1|||
33559803|NCT02965456|101945995|FG001|Overall Study|Noncompliance with Study Drug|1|||
33623479|NCT01623115|102169630|FG001|Overall Study|Death|4|||
33623480|NCT01623115|102169629|FG000|Overall Study|Other than specified above|0|||
33623481|NCT01623115|102169630|FG001|Overall Study|Other than specified above|3|||
33623482|NCT00296816|102169631|FG000|Overall Study|Disease Progression|37|||
33623483|NCT00296816|102169631|FG000|Overall Study|Adverse Event|18|||
33623484|NCT00296816|102169631|FG000|Overall Study|Investigator/Participant request|5|||
33623485|NCT00296816|102169631|FG000|Overall Study|Non-compliance|1|||
33559804|NCT02965456|101945994|FG000|Overall Study|Worsening Condition|0|||
33559805|NCT02965456|101945995|FG001|Overall Study|Worsening Condition|2|||
33559806|NCT02965456|101945994|FG000|Overall Study|Lack of Efficacy|1|||
33559807|NCT02965456|101945995|FG001|Overall Study|Lack of Efficacy|0|||
33559808|NCT02965456|101945994|FG000|Overall Study|Physician Decision|0|||
33559809|NCT02965456|101945995|FG001|Overall Study|Physician Decision|1|||
33559810|NCT02965456|101945994|FG000|Overall Study|Pregnancy|1|||
33559811|NCT02965456|101945995|FG001|Overall Study|Pregnancy|0|||
33559812|NCT02965456|101945994|FG000|Overall Study|Protocol Violation|0|||
33559813|NCT02965456|101945995|FG001|Overall Study|Protocol Violation|1|||
33559814|NCT02965456|101945994|FG000|Overall Study|Participant ran out of study drug|0|||
33559815|NCT02965456|101945995|FG001|Overall Study|Participant ran out of study drug|1|||
33559816|NCT02899754|101945996|FG000|Overall Study|Lost to Follow-up|7|||
33559817|NCT02899754|101945997|FG001|Overall Study|Lost to Follow-up|9|||
33559818|NCT04551053|101946002|FG000|Overall Study|Death|9|||
33559819|NCT04551053|101946003|FG001|Overall Study|Death|9|||
33623486|NCT00296816|102169631|FG000|Overall Study|Missing for end of treatment|4|||
33623487|NCT00296816|102169631|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
33623488|NCT00296816|102169631|FG000|Overall Study|Poor performance status|1|||
33559820|NCT04551053|101946002|FG000|Overall Study|Lost to Follow-up|0|||
33559821|NCT04551053|101946003|FG001|Overall Study|Lost to Follow-up|2|||
33219637|NCT00386022|100703054|FG001|Plus Estrogen|Adverse Event|1|||
33559822|NCT04551053|101946002|FG000|Overall Study|Study Terminated by Sponsor|53|||
33559823|NCT04551053|101946003|FG001|Overall Study|Study Terminated by Sponsor|63|||
33559824|NCT04551053|101946002|FG000|Overall Study|Withdrawal by Subject|12|||
33219638|NCT02048072|100703055|FG000|Overall Study|Adverse Event|3|||
33219639|NCT02048072|100703055|FG000|Overall Study|Lost to Follow-up|1|||
33219640|NCT00490282|100703057|FG000|Overall Study|Withdrawal by Subject|3|||
33219641|NCT04605978|100703058|FG000|Overall Study|Adverse Event|2|||
33219642|NCT04605978|100703059|FG001|Overall Study|Adverse Event|1|||
33219643|NCT04605978|100703058|FG000|Overall Study|Withdrawal nonmedical reason|1|||
33219644|NCT04605978|100703059|FG001|Overall Study|Withdrawal nonmedical reason|1|||
33219645|NCT00593567|100703060|FG000|Overall Study|Adverse Event|2|||
33219646|NCT00593567|100703061|FG001|Overall Study|Adverse Event|0|||
33219647|NCT00593567|100703060|FG000|Overall Study|Physician Decision|2|||
33219648|NCT00593567|100703061|FG001|Overall Study|Physician Decision|0|||
33219649|NCT00593567|100703060|FG000|Overall Study|Protocol Violation|13|||
33219650|NCT00593567|100703061|FG001|Overall Study|Protocol Violation|7|||
33219651|NCT00593567|100703060|FG000|Overall Study|Lack of Efficacy|2|||
33219652|NCT00593567|100703061|FG001|Overall Study|Lack of Efficacy|1|||
33219653|NCT00593567|100703060|FG000|Overall Study|Withdrawal by Subject|1|||
33219654|NCT00593567|100703061|FG001|Overall Study|Withdrawal by Subject|2|||
33559825|NCT04551053|101946003|FG001|Overall Study|Withdrawal by Subject|5|||
33559826|NCT04551053|101946002|FG000|Overall Study|Adverse Event|1|||
33559827|NCT04551053|101946003|FG001|Overall Study|Adverse Event|0|||
33559828|NCT04551053|101946002|FG000|Overall Study|Lack of Efficacy|2|||
33559829|NCT04551053|101946003|FG001|Overall Study|Lack of Efficacy|0|||
33559830|NCT04551053|101946002|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
33559831|NCT04551053|101946003|FG001|Overall Study|Transitioned to Rollover per Protocol|3|||
33559832|NCT04551053|101946002|FG000|Overall Study|Splenapendectomi|1|||
33559833|NCT04551053|101946003|FG001|Overall Study|Splenapendectomi|0|||
33559834|NCT04551053|101946002|FG000|Overall Study|Cytomegalovirus pneumonia|1|||
33559835|NCT04551053|101946003|FG001|Overall Study|Cytomegalovirus pneumonia|0|||
33559836|NCT04551053|101946002|FG000|Overall Study|Medical Decision|0|||
33559837|NCT04551053|101946003|FG001|Overall Study|Medical Decision|1|||
33559838|NCT04551053|101946002|FG000|Overall Study|Ongoing|6|||
33559839|NCT04551053|101946003|FG001|Overall Study|Ongoing|4|||
33559840|NCT02633527|101946004|FG000|Overall Study|Failed to meet eligibility|0|||
33559841|NCT02633527|101946005|FG001|Overall Study|Failed to meet eligibility|1|||
33559842|NCT02633527|101946006|FG002|Overall Study|Failed to meet eligibility|1|||
33559843|NCT02633527|101946007|FG003|Overall Study|Failed to meet eligibility|0|||
33559844|NCT02633527|101946008|FG004|Overall Study|Failed to meet eligibility|1|||
33559845|NCT02633527|101946004|FG000|Overall Study|Adverse Event|0|||
33559846|NCT02633527|101946005|FG001|Overall Study|Adverse Event|4|||
33559847|NCT02633527|101946006|FG002|Overall Study|Adverse Event|3|||
33559848|NCT02633527|101946007|FG003|Overall Study|Adverse Event|1|||
33559849|NCT02633527|101946008|FG004|Overall Study|Adverse Event|5|||
33559850|NCT02633527|101946004|FG000|Overall Study|Lost to Follow-up|1|||
33559851|NCT02633527|101946005|FG001|Overall Study|Lost to Follow-up|2|||
33559852|NCT02633527|101946006|FG002|Overall Study|Lost to Follow-up|5|||
33559853|NCT02633527|101946007|FG003|Overall Study|Lost to Follow-up|5|||
33559854|NCT02633527|101946008|FG004|Overall Study|Lost to Follow-up|4|||
33559855|NCT02633527|101946004|FG000|Overall Study|Withdrawal by Subject|0|||
33559856|NCT02633527|101946005|FG001|Overall Study|Withdrawal by Subject|3|||
33219655|NCT00939484|100703062|FG000|Overall Study|Progression/Relapse|8|||
33219656|NCT00939484|100703063|FG001|Overall Study|Progression/Relapse|20|||
33359132|NCT00064701|101204390|FG001|One Year Post-transplant|Did not receive study drug|12|||
33559857|NCT02633527|101946006|FG002|Overall Study|Withdrawal by Subject|5|||
33559858|NCT02633527|101946007|FG003|Overall Study|Withdrawal by Subject|4|||
33559859|NCT02633527|101946008|FG004|Overall Study|Withdrawal by Subject|4|||
33559860|NCT02633527|101946004|FG000|Overall Study|Protocol Violation|0|||
33219657|NCT00939484|100703064|FG002|Overall Study|Progression/Relapse|3|||
33219658|NCT02953938|100703069|FG000|Overall Study|Adverse Event|0|||
33219659|NCT02953938|100703070|FG001|Overall Study|Adverse Event|1|||
33219660|NCT02953938|100703069|FG000|Overall Study|Withdrawal by Subject|1|||
33559861|NCT02633527|101946005|FG001|Overall Study|Protocol Violation|1|||
33559862|NCT02633527|101946006|FG002|Overall Study|Protocol Violation|1|||
33559863|NCT02633527|101946007|FG003|Overall Study|Protocol Violation|1|||
33559864|NCT02633527|101946008|FG004|Overall Study|Protocol Violation|1|||
33559865|NCT02633527|101946004|FG000|Overall Study|Physician Decision|0|||
33219661|NCT02953938|100703070|FG001|Overall Study|Withdrawal by Subject|1|||
33219662|NCT02641392|100703071|FG000|Overall Study|Lost to Follow-up|0|||
33219663|NCT02641392|100703072|FG001|Overall Study|Lost to Follow-up|0|||
33219664|NCT02641392|100703073|FG002|Overall Study|Lost to Follow-up|2|||
33219665|NCT02641392|100703071|FG000|Overall Study|Withdrawal by Subject|0|||
33219666|NCT02641392|100703072|FG001|Overall Study|Withdrawal by Subject|0|||
33623489|NCT00296816|102169631|FG000|Overall Study|Relocation to Florida|1|||
33219667|NCT02641392|100703073|FG002|Overall Study|Withdrawal by Subject|17|||
33414593|NCT01915498|101409838|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33414594|NCT01915498|101409839|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33414595|NCT01915498|101409840|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33414596|NCT01915498|101409841|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33414597|NCT01915498|101409842|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
33414598|NCT01915498|101409843|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33414599|NCT01915498|101409844|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33414600|NCT01915498|101409845|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33414601|NCT01915498|101409846|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
33414602|NCT01915498|101409847|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33414603|NCT01915498|101409848|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33414604|NCT01915498|101409849|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33414605|NCT01915498|101409850|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
33414606|NCT01915498|101409851|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
33414607|NCT01915498|101409852|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
33414608|NCT01915498|101409853|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
33414609|NCT01915498|101409854|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
33414610|NCT01915498|101409855|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
33559866|NCT02633527|101946005|FG001|Overall Study|Physician Decision|0|||
33559867|NCT02633527|101946006|FG002|Overall Study|Physician Decision|0|||
33559868|NCT02633527|101946007|FG003|Overall Study|Physician Decision|0|||
33559869|NCT02633527|101946008|FG004|Overall Study|Physician Decision|1|||
33559870|NCT02633527|101946004|FG000|Overall Study|Administrative reason|1|||
33559871|NCT02633527|101946005|FG001|Overall Study|Administrative reason|0|||
33559872|NCT02633527|101946006|FG002|Overall Study|Administrative reason|0|||
33559873|NCT02633527|101946007|FG003|Overall Study|Administrative reason|1|||
33559874|NCT02633527|101946008|FG004|Overall Study|Administrative reason|0|||
33559875|NCT02633527|101946004|FG000|Overall Study|Multiple reasons|1|||
33559876|NCT02633527|101946005|FG001|Overall Study|Multiple reasons|0|||
33559877|NCT02633527|101946006|FG002|Overall Study|Multiple reasons|2|||
33559878|NCT02633527|101946007|FG003|Overall Study|Multiple reasons|2|||
33559879|NCT02633527|101946008|FG004|Overall Study|Multiple reasons|1|||
33559880|NCT00658814|101946017|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
33559881|NCT00658814|101946018|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
33559882|NCT00658814|101946017|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
33559883|NCT00658814|101946018|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
33559884|NCT00658814|101946017|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
33559885|NCT00658814|101946018|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
33559886|NCT00658814|101946017|FG000|Remission Induction Chemotherapy|Death|1|||
33559887|NCT00658814|101946018|FG001|Remission Induction Chemotherapy|Death|4|||
33559888|NCT00658814|101946017|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
33559889|NCT00658814|101946018|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
33559890|NCT00658814|101946017|FG000|Remission Induction Chemotherapy|Not eligible|1|||
33559891|NCT00658814|101946018|FG001|Remission Induction Chemotherapy|Not eligible|2|||
33559892|NCT00658814|101946017|FG000|Consolidation Therapy|Not protocol specified|0|||
33219668|NCT02641392|100703071|FG000|Overall Study|Adverse Event|0|||
33219669|NCT02641392|100703072|FG001|Overall Study|Adverse Event|1|||
33219670|NCT02641392|100703073|FG002|Overall Study|Adverse Event|25|||
33219671|NCT02641392|100703071|FG000|Overall Study|Study Terminated by Sponsor|4|||
33219672|NCT02641392|100703072|FG001|Overall Study|Study Terminated by Sponsor|12|||
33219673|NCT02641392|100703073|FG002|Overall Study|Study Terminated by Sponsor|144|||
33359133|NCT00064701|101204391|FG002|One Year Post-transplant|Did not receive study drug|11|||
33359134|NCT00064701|101204389|FG000|One Year Post-transplant|Adverse Event|23|||
33359135|NCT00064701|101204390|FG001|One Year Post-transplant|Adverse Event|19|||
33359136|NCT00064701|101204391|FG002|One Year Post-transplant|Adverse Event|37|||
33359137|NCT00064701|101204389|FG000|One Year Post-transplant|Rejection|0|||
33359138|NCT00064701|101204390|FG001|One Year Post-transplant|Rejection|1|||
33359139|NCT00064701|101204391|FG002|One Year Post-transplant|Rejection|16|||
33359140|NCT00064701|101204389|FG000|One Year Post-transplant|Non-compliance|4|||
33359141|NCT00064701|101204390|FG001|One Year Post-transplant|Non-compliance|2|||
33559893|NCT00658814|101946018|FG001|Consolidation Therapy|Not protocol specified|1|||
33559894|NCT00658814|101946017|FG000|Consolidation Therapy|Not eligible|2|||
33359142|NCT00064701|101204391|FG002|One Year Post-transplant|Non-compliance|5|||
33359143|NCT00064701|101204389|FG000|One Year Post-transplant|Graft Failure|3|||
33359144|NCT00064701|101204390|FG001|One Year Post-transplant|Graft Failure|2|||
33559895|NCT00658814|101946018|FG001|Consolidation Therapy|Not eligible|2|||
33559896|NCT00658814|101946017|FG000|Maintenance Therapy|Adverse Event|1|||
33559897|NCT00658814|101946018|FG001|Maintenance Therapy|Adverse Event|1|||
33559898|NCT00658814|101946017|FG000|Maintenance Therapy|Not protocol specified|1|||
33559899|NCT00658814|101946018|FG001|Maintenance Therapy|Not protocol specified|0|||
33559900|NCT00658814|101946017|FG000|Maintenance Therapy|Not eligible|1|||
33559901|NCT00658814|101946018|FG001|Maintenance Therapy|Not eligible|0|||
33219674|NCT02641392|100703071|FG000|Overall Study|Lack of Efficacy|0|||
33219675|NCT02641392|100703072|FG001|Overall Study|Lack of Efficacy|0|||
33219676|NCT02641392|100703073|FG002|Overall Study|Lack of Efficacy|101|||
33219677|NCT02641392|100703071|FG000|Overall Study|Miscellaneous|0|||
33219678|NCT02641392|100703072|FG001|Overall Study|Miscellaneous|0|||
33219679|NCT02641392|100703073|FG002|Overall Study|Miscellaneous|3|||
33219680|NCT02641392|100703071|FG000|Overall Study|Death|0|||
33219681|NCT02641392|100703072|FG001|Overall Study|Death|0|||
33219682|NCT02641392|100703073|FG002|Overall Study|Death|1|||
33219683|NCT01820559|100703076|FG000|Overall Study|Adverse Event|4|||
33219684|NCT01820559|100703077|FG001|Overall Study|Adverse Event|6|||
33219685|NCT01820559|100703078|FG002|Overall Study|Adverse Event|13|||
33623490|NCT00296816|102169631|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
33623491|NCT00296816|102169631|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
33623492|NCT00296816|102169631|FG000|Overall Study|Neuropathy/patient preference|1|||
33219686|NCT01820559|100703076|FG000|Overall Study|Withdrawal by Subject|1|||
33219687|NCT01820559|100703077|FG001|Overall Study|Withdrawal by Subject|2|||
33219688|NCT01820559|100703078|FG002|Overall Study|Withdrawal by Subject|5|||
33219689|NCT01820559|100703076|FG000|Overall Study|Protocol Violation|2|||
33219690|NCT01820559|100703077|FG001|Overall Study|Protocol Violation|1|||
33219691|NCT01820559|100703078|FG002|Overall Study|Protocol Violation|3|||
33219692|NCT01820559|100703076|FG000|Overall Study|Subject's non-compliance|1|||
33559902|NCT03581292|101946026|FG000|Overall Study|Physician Decision|9|||
33559903|NCT03581292|101946027|FG001|Overall Study|Physician Decision|5|||
33559904|NCT03581292|101946026|FG000|Overall Study|Withdrawal by Subject|3|||
33559905|NCT03581292|101946027|FG001|Overall Study|Withdrawal by Subject|0|||
33559906|NCT03581292|101946026|FG000|Overall Study|Withdrawal before Therapy Start|1|||
33559907|NCT03581292|101946027|FG001|Overall Study|Withdrawal before Therapy Start|0|||
33559908|NCT02661815|101946028|FG000|Overall Study|Withdrawal by Subject|1|||
33559909|NCT02661815|101946029|FG001|Overall Study|Withdrawal by Subject|0|||
33559910|NCT02661815|101946030|FG002|Overall Study|Withdrawal by Subject|0|||
33219693|NCT01820559|100703077|FG001|Overall Study|Subject's non-compliance|0|||
33219694|NCT01820559|100703078|FG002|Overall Study|Subject's non-compliance|2|||
33219695|NCT01820559|100703076|FG000|Overall Study|Lost to Follow-up|3|||
33219696|NCT01820559|100703077|FG001|Overall Study|Lost to Follow-up|2|||
33219697|NCT01820559|100703078|FG002|Overall Study|Lost to Follow-up|2|||
33219698|NCT01820559|100703076|FG000|Overall Study|At sponsor request|0|||
33219699|NCT01820559|100703077|FG001|Overall Study|At sponsor request|0|||
33219700|NCT01820559|100703078|FG002|Overall Study|At sponsor request|1|||
33219701|NCT01820559|100703076|FG000|Overall Study|Lack of Efficacy|3|||
33219702|NCT01820559|100703077|FG001|Overall Study|Lack of Efficacy|2|||
33219703|NCT01820559|100703078|FG002|Overall Study|Lack of Efficacy|3|||
33219704|NCT00716092|100703079|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
33219705|NCT00716092|100703080|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
33219706|NCT00716092|100703081|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
33219707|NCT03395405|100703082|FG000|Overall Study|Death|0|||
33219708|NCT03395405|100703083|FG001|Overall Study|Death|2|||
33219709|NCT03395405|100703082|FG000|Overall Study|Lost to Follow-up|0|||
33219710|NCT03395405|100703083|FG001|Overall Study|Lost to Follow-up|1|||
33219711|NCT03395405|100703082|FG000|Overall Study|Protocol Violation|0|||
33219712|NCT03395405|100703083|FG001|Overall Study|Protocol Violation|1|||
33219713|NCT03395405|100703082|FG000|Overall Study|Withdrawal by Subject|3|||
33219714|NCT03395405|100703083|FG001|Overall Study|Withdrawal by Subject|1|||
33219715|NCT03395405|100703082|FG000|Overall Study|COVID-19 Pandemic|1|||
33219716|NCT03395405|100703083|FG001|Overall Study|COVID-19 Pandemic|0|||
33219717|NCT01644734|100703084|FG000|Overall Study|Adverse Event|4|||
33219718|NCT01644734|100703084|FG000|Overall Study|Lost to Follow-up|17|||
33219719|NCT01644734|100703084|FG000|Overall Study|Reasons other than stated above|7|||
33219720|NCT01644734|100703084|FG000|Overall Study|Missing documentation|238|||
33219721|NCT05158296|100703087|FG000|Overall Study|Sponsor Decision|2|||
33219722|NCT05158296|100703088|FG001|Overall Study|Sponsor Decision|3|||
33219723|NCT05158296|100703089|FG002|Overall Study|Sponsor Decision|2|||
33219724|NCT02007434|100703090|FG000|Overall Study|Lost to Follow-up|0|||
33219725|NCT02007434|100703091|FG001|Overall Study|Lost to Follow-up|1|||
33219726|NCT02007434|100703092|FG002|Overall Study|Lost to Follow-up|0|||
33219727|NCT02007434|100703093|FG003|Overall Study|Lost to Follow-up|0|||
33219728|NCT02007434|100703094|FG004|Overall Study|Lost to Follow-up|0|||
33219729|NCT02007434|100703095|FG005|Overall Study|Lost to Follow-up|0|||
33559911|NCT02661815|101946031|FG003|Overall Study|Withdrawal by Subject|0|||
33623493|NCT00296816|102169631|FG000|Overall Study|Proteinuria|1|||
33623494|NCT00296816|102169631|FG000|Overall Study|ineligibility due to radiation treatment|1|||
33219730|NCT02007434|100703096|FG006|Overall Study|Lost to Follow-up|0|||
33219731|NCT02007434|100703097|FG007|Overall Study|Lost to Follow-up|0|||
33219732|NCT02007434|100703090|FG000|Overall Study|Non-compliance|1|||
33219733|NCT02007434|100703091|FG001|Overall Study|Non-compliance|0|||
33219734|NCT02007434|100703092|FG002|Overall Study|Non-compliance|1|||
33559912|NCT01539525|101946032|FG000|Overall Study|Lost to Follow-up|19|||
33559913|NCT01539525|101946033|FG001|Overall Study|Lost to Follow-up|12|||
33559914|NCT01539525|101946034|FG002|Overall Study|Lost to Follow-up|11|||
33219735|NCT02007434|100703093|FG003|Overall Study|Non-compliance|0|||
33219736|NCT02007434|100703094|FG004|Overall Study|Non-compliance|0|||
33219737|NCT02007434|100703095|FG005|Overall Study|Non-compliance|0|||
33219738|NCT02007434|100703096|FG006|Overall Study|Non-compliance|0|||
33219739|NCT02007434|100703097|FG007|Overall Study|Non-compliance|0|||
33219740|NCT00266825|100703102|FG000|Completed Follow-Up|Lost to Follow-up|14|||
33414611|NCT01915498|101409837|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
33559915|NCT01539525|101946032|FG000|Overall Study|Withdrawal by Subject|0|||
33559916|NCT01539525|101946033|FG001|Overall Study|Withdrawal by Subject|3|||
33559917|NCT01539525|101946034|FG002|Overall Study|Withdrawal by Subject|2|||
33559918|NCT01539525|101946032|FG000|Overall Study|Protocol Violation|1|||
33559919|NCT01539525|101946033|FG001|Overall Study|Protocol Violation|1|||
33559920|NCT01539525|101946034|FG002|Overall Study|Protocol Violation|4|||
33559921|NCT00769379|101946038|FG000|Overall Study|No follow up data mapped to Other.|3|||
33559922|NCT00769379|101946039|FG001|Overall Study|No follow up data mapped to Other.|13|||
33219741|NCT00266825|100703103|FG001|Completed Follow-Up|Lost to Follow-up|19|||
33559923|NCT04309500|101946040|FG000|Overall Study|Lost to Follow-up|1|||
33219742|NCT00266825|100703102|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
33219743|NCT00266825|100703103|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
33219744|NCT02436811|100703104|FG000|Overall Study|Lost to Follow-up|2|||
33219745|NCT02436811|100703105|FG001|Overall Study|Lost to Follow-up|9|||
33219746|NCT02436811|100703106|FG002|Overall Study|Lost to Follow-up|7|||
33219747|NCT04493216|100703114|FG000|Overall Study|Study terminated by sponsor|30|||
33219748|NCT04493216|100703115|FG001|Overall Study|Study terminated by sponsor|33|||
33219749|NCT04493216|100703116|FG002|Overall Study|Study terminated by sponsor|28|||
33219750|NCT04493216|100703117|FG003|Overall Study|Study terminated by sponsor|27|||
33219751|NCT04493216|100703114|FG000|Overall Study|Withdrawal by Subject|2|||
33219752|NCT04493216|100703115|FG001|Overall Study|Withdrawal by Subject|1|||
33219753|NCT04493216|100703116|FG002|Overall Study|Withdrawal by Subject|1|||
33219754|NCT04493216|100703117|FG003|Overall Study|Withdrawal by Subject|2|||
33219755|NCT04493216|100703114|FG000|Overall Study|Protocol Violation|1|||
33219756|NCT04493216|100703115|FG001|Overall Study|Protocol Violation|2|||
33219757|NCT04493216|100703116|FG002|Overall Study|Protocol Violation|0|||
33219758|NCT04493216|100703117|FG003|Overall Study|Protocol Violation|2|||
33559924|NCT04309500|101946041|FG001|Overall Study|Lost to Follow-up|0|||
33559925|NCT04309500|101946042|FG002|Overall Study|Lost to Follow-up|0|||
33559926|NCT04309500|101946043|FG003|Overall Study|Lost to Follow-up|0|||
33559927|NCT01674062|101946046|FG000|Overall Study|Insufficient Therapeutic Response|56|||
33559928|NCT01674062|101946047|FG001|Overall Study|Insufficient Therapeutic Response|26|||
33559929|NCT01674062|101946046|FG000|Overall Study|Other|8|||
33559930|NCT01674062|101946047|FG001|Overall Study|Other|1|||
33559931|NCT01674062|101946046|FG000|Overall Study|Adverse Event|1|||
33559932|NCT01674062|101946047|FG001|Overall Study|Adverse Event|1|||
33559933|NCT01674062|101946046|FG000|Overall Study|Death|0|||
33623495|NCT00496015|102169637|FG000|Overall Study|Other|1|||
33623496|NCT00496015|102169638|FG001|Overall Study|Other|0|||
33219759|NCT04493216|100703114|FG000|Overall Study|Physician Decision|0|||
33219760|NCT04493216|100703115|FG001|Overall Study|Physician Decision|0|||
33219761|NCT04493216|100703116|FG002|Overall Study|Physician Decision|1|||
33219762|NCT04493216|100703117|FG003|Overall Study|Physician Decision|0|||
33219763|NCT04493216|100703114|FG000|Overall Study|Lost to Follow-up|2|||
33219764|NCT04493216|100703115|FG001|Overall Study|Lost to Follow-up|1|||
33219765|NCT04493216|100703116|FG002|Overall Study|Lost to Follow-up|0|||
33219766|NCT04493216|100703117|FG003|Overall Study|Lost to Follow-up|1|||
33219767|NCT04493216|100703114|FG000|Overall Study|Adverse Event|1|||
33219768|NCT04493216|100703115|FG001|Overall Study|Adverse Event|4|||
33219769|NCT04493216|100703116|FG002|Overall Study|Adverse Event|5|||
33219770|NCT04493216|100703117|FG003|Overall Study|Adverse Event|2|||
33219771|NCT04493216|100703114|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
33219772|NCT04493216|100703115|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
33219773|NCT04493216|100703116|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
33219774|NCT04493216|100703117|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
33219775|NCT01525602|100703118|FG000|Overall Study|Adverse Event|1|||
33219776|NCT01525602|100703119|FG001|Overall Study|Adverse Event|0|||
33219777|NCT01525602|100703120|FG002|Overall Study|Adverse Event|1|||
33219778|NCT01525602|100703121|FG003|Overall Study|Adverse Event|1|||
33219779|NCT01525602|100703122|FG004|Overall Study|Adverse Event|3|||
33219780|NCT01525602|100703123|FG005|Overall Study|Adverse Event|3|||
33219781|NCT01525602|100703124|FG006|Overall Study|Adverse Event|0|||
33219782|NCT01525602|100703125|FG007|Overall Study|Adverse Event|1|||
33219783|NCT01525602|100703118|FG000|Overall Study|Disease progression|6|||
33219784|NCT01525602|100703119|FG001|Overall Study|Disease progression|3|||
33219785|NCT01525602|100703120|FG002|Overall Study|Disease progression|2|||
33219786|NCT01525602|100703121|FG003|Overall Study|Disease progression|5|||
33219787|NCT01525602|100703122|FG004|Overall Study|Disease progression|22|||
33219788|NCT01525602|100703123|FG005|Overall Study|Disease progression|2|||
33219789|NCT01525602|100703124|FG006|Overall Study|Disease progression|3|||
33219790|NCT01525602|100703125|FG007|Overall Study|Disease progression|3|||
33219791|NCT01525602|100703118|FG000|Overall Study|Clinical progression|2|||
33414612|NCT01915498|101409838|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33414613|NCT01915498|101409839|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33219792|NCT01525602|100703119|FG001|Overall Study|Clinical progression|0|||
33219793|NCT01525602|100703120|FG002|Overall Study|Clinical progression|0|||
33219794|NCT01525602|100703121|FG003|Overall Study|Clinical progression|0|||
33559934|NCT01674062|101946047|FG001|Overall Study|Death|1|||
33219795|NCT01525602|100703122|FG004|Overall Study|Clinical progression|0|||
33219796|NCT01525602|100703123|FG005|Overall Study|Clinical progression|0|||
33219797|NCT01525602|100703124|FG006|Overall Study|Clinical progression|1|||
33219798|NCT01525602|100703125|FG007|Overall Study|Clinical progression|1|||
33219799|NCT01525602|100703118|FG000|Overall Study|Non-compliance|0|||
33219800|NCT01525602|100703119|FG001|Overall Study|Non-compliance|0|||
33559935|NCT01674062|101946046|FG000|Overall Study|Programming Error|1|||
33559936|NCT01674062|101946047|FG001|Overall Study|Programming Error|0|||
33559937|NCT03247673|101946048|FG000|Overall Study|Withdrawal by Subject|1|||
33559938|NCT03247673|101946049|FG001|Overall Study|Withdrawal by Subject|0|||
33219801|NCT01525602|100703120|FG002|Overall Study|Non-compliance|0|||
33219802|NCT01525602|100703121|FG003|Overall Study|Non-compliance|0|||
33219803|NCT01525602|100703122|FG004|Overall Study|Non-compliance|1|||
33219804|NCT01525602|100703123|FG005|Overall Study|Non-compliance|0|||
33219805|NCT01525602|100703124|FG006|Overall Study|Non-compliance|0|||
33219806|NCT01525602|100703125|FG007|Overall Study|Non-compliance|0|||
33219807|NCT01525602|100703118|FG000|Overall Study|Withdrawal by Subject|0|||
33219808|NCT01525602|100703119|FG001|Overall Study|Withdrawal by Subject|0|||
33219809|NCT01525602|100703120|FG002|Overall Study|Withdrawal by Subject|0|||
33219810|NCT01525602|100703121|FG003|Overall Study|Withdrawal by Subject|0|||
33219811|NCT01525602|100703122|FG004|Overall Study|Withdrawal by Subject|3|||
33219812|NCT01525602|100703123|FG005|Overall Study|Withdrawal by Subject|1|||
33219813|NCT01525602|100703124|FG006|Overall Study|Withdrawal by Subject|0|||
33219814|NCT01525602|100703125|FG007|Overall Study|Withdrawal by Subject|1|||
33219815|NCT01525602|100703118|FG000|Overall Study|Physician Decision|0|||
33219816|NCT01525602|100703119|FG001|Overall Study|Physician Decision|0|||
33219817|NCT01525602|100703120|FG002|Overall Study|Physician Decision|0|||
33219818|NCT01525602|100703121|FG003|Overall Study|Physician Decision|0|||
33219819|NCT01525602|100703122|FG004|Overall Study|Physician Decision|3|||
33219820|NCT01525602|100703123|FG005|Overall Study|Physician Decision|0|||
33219821|NCT01525602|100703124|FG006|Overall Study|Physician Decision|1|||
33219822|NCT01525602|100703125|FG007|Overall Study|Physician Decision|0|||
33219823|NCT01525602|100703118|FG000|Overall Study|Death|0|||
33219824|NCT01525602|100703119|FG001|Overall Study|Death|0|||
33219825|NCT01525602|100703120|FG002|Overall Study|Death|0|||
33219826|NCT01525602|100703121|FG003|Overall Study|Death|0|||
33219827|NCT01525602|100703122|FG004|Overall Study|Death|1|||
33219828|NCT01525602|100703123|FG005|Overall Study|Death|1|||
33219829|NCT01525602|100703124|FG006|Overall Study|Death|0|||
33219830|NCT01525602|100703125|FG007|Overall Study|Death|0|||
33219831|NCT01525602|100703118|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
33219832|NCT01525602|100703119|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
33219833|NCT01525602|100703120|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
33219834|NCT01525602|100703121|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
33219835|NCT01525602|100703122|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
33219836|NCT01525602|100703123|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
33219837|NCT01525602|100703124|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
33219838|NCT01525602|100703125|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
33219839|NCT01197508|100703126|FG000|Overall Study|Withdrawal by Subject|8|||
33219840|NCT01197508|100703127|FG001|Overall Study|Withdrawal by Subject|7|||
33219841|NCT01197508|100703128|FG002|Overall Study|Withdrawal by Subject|15|||
33219842|NCT01197508|100703129|FG003|Overall Study|Withdrawal by Subject|4|||
33219843|NCT01197508|100703126|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
33219844|NCT01197508|100703127|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
33219845|NCT01197508|100703128|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
33219846|NCT01197508|100703129|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
33219847|NCT01197508|100703126|FG000|Overall Study|Adverse Event|10|||
33219848|NCT01197508|100703127|FG001|Overall Study|Adverse Event|13|||
33219849|NCT01197508|100703128|FG002|Overall Study|Adverse Event|23|||
33219850|NCT01197508|100703129|FG003|Overall Study|Adverse Event|3|||
33219851|NCT01197508|100703126|FG000|Overall Study|Severe non-compliance to protocol|0|||
33219852|NCT01197508|100703127|FG001|Overall Study|Severe non-compliance to protocol|3|||
33219853|NCT01197508|100703128|FG002|Overall Study|Severe non-compliance to protocol|1|||
33219854|NCT01197508|100703129|FG003|Overall Study|Severe non-compliance to protocol|3|||
33219855|NCT01197508|100703126|FG000|Overall Study|Condition under investigation worsened|1|||
33219856|NCT01197508|100703127|FG001|Overall Study|Condition under investigation worsened|1|||
33219857|NCT01197508|100703128|FG002|Overall Study|Condition under investigation worsened|1|||
33219858|NCT01197508|100703129|FG003|Overall Study|Condition under investigation worsened|1|||
33219859|NCT01197508|100703126|FG000|Overall Study|Lack of Efficacy|1|||
33414614|NCT01915498|101409840|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33414615|NCT01915498|101409841|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33414616|NCT01915498|101409842|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
33414617|NCT01915498|101409843|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33219860|NCT01197508|100703127|FG001|Overall Study|Lack of Efficacy|2|||
33219861|NCT01197508|100703128|FG002|Overall Study|Lack of Efficacy|2|||
33219862|NCT01197508|100703129|FG003|Overall Study|Lack of Efficacy|1|||
33219863|NCT01197508|100703126|FG000|Overall Study|Study-specific withdrawal criteria|0|||
33219864|NCT01197508|100703127|FG001|Overall Study|Study-specific withdrawal criteria|0|||
33219865|NCT01197508|100703128|FG002|Overall Study|Study-specific withdrawal criteria|1|||
33219866|NCT01197508|100703129|FG003|Overall Study|Study-specific withdrawal criteria|2|||
33219867|NCT01197508|100703126|FG000|Overall Study|Lost to Follow-up|1|||
33219868|NCT01197508|100703127|FG001|Overall Study|Lost to Follow-up|1|||
33219869|NCT01197508|100703128|FG002|Overall Study|Lost to Follow-up|2|||
33219870|NCT01197508|100703129|FG003|Overall Study|Lost to Follow-up|0|||
33219871|NCT01197508|100703126|FG000|Overall Study|Other|2|||
33219872|NCT01197508|100703127|FG001|Overall Study|Other|3|||
33219873|NCT01197508|100703128|FG002|Overall Study|Other|2|||
33219874|NCT01197508|100703129|FG003|Overall Study|Other|2|||
33219875|NCT01373931|100703133|FG000|Lead-in Period|Adverse Event|2|||
33219876|NCT01373931|100703134|FG001|Lead-in Period|Adverse Event|0|||
33219877|NCT01373931|100703133|FG000|Period 1|Adverse Event|2|||
33219878|NCT01373931|100703134|FG001|Period 1|Adverse Event|0|||
33559939|NCT03247673|101946050|FG002|Overall Study|Withdrawal by Subject|3|||
33559940|NCT03247673|101946048|FG000|Overall Study|Lost to Follow-up|0|||
33559941|NCT03247673|101946049|FG001|Overall Study|Lost to Follow-up|0|||
33559942|NCT03247673|101946050|FG002|Overall Study|Lost to Follow-up|1|||
33559943|NCT03238196|101946055|FG000|Overall Study|Adverse Event|3|||
33559944|NCT03238196|101946056|FG001|Overall Study|Adverse Event|0|||
33559945|NCT03238196|101946057|FG002|Overall Study|Adverse Event|2|||
33559946|NCT03238196|101946058|FG003|Overall Study|Adverse Event|2|||
33559947|NCT03238196|101946055|FG000|Overall Study|Withdrawal by Subject|4|||
33559948|NCT03238196|101946056|FG001|Overall Study|Withdrawal by Subject|1|||
33559949|NCT03238196|101946057|FG002|Overall Study|Withdrawal by Subject|1|||
33559950|NCT03238196|101946058|FG003|Overall Study|Withdrawal by Subject|0|||
33559951|NCT03238196|101946055|FG000|Overall Study|Disease progression|14|||
33559952|NCT03238196|101946056|FG001|Overall Study|Disease progression|2|||
33559953|NCT03238196|101946057|FG002|Overall Study|Disease progression|3|||
33559954|NCT03238196|101946058|FG003|Overall Study|Disease progression|2|||
33219879|NCT01373931|100703133|FG000|Period 1|Withdrawal by Subject|0|||
33219880|NCT01373931|100703134|FG001|Period 1|Withdrawal by Subject|2|||
33219881|NCT02636270|100703145|FG000|Overall Study|Adverse Event|1|||
33219882|NCT02636270|100703146|FG001|Overall Study|Adverse Event|0|||
33219883|NCT02636270|100703147|FG002|Overall Study|Adverse Event|0|||
33219884|NCT02636270|100703145|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
33219885|NCT02636270|100703146|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
33219886|NCT02636270|100703147|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
33219887|NCT00116844|100703148|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
33219888|NCT00116844|100703149|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
33219889|NCT00116844|100703148|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
33219890|NCT00116844|100703149|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
33219891|NCT00116844|100703148|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
33219892|NCT00116844|100703149|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
33219893|NCT00116844|100703148|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
33219894|NCT00116844|100703149|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
33219895|NCT00116844|100703148|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
33219896|NCT00116844|100703149|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
33219897|NCT00116844|100703148|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
33219898|NCT00116844|100703149|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
33219899|NCT00116844|100703148|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
33219900|NCT00116844|100703149|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
33219901|NCT00116844|100703148|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
33219902|NCT00116844|100703149|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
33219903|NCT00116844|100703148|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
33219904|NCT00116844|100703149|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
33219905|NCT03879408|100703150|FG000|Overall Study|Lost to Follow-up|0|||
33219906|NCT03879408|100703151|FG001|Overall Study|Lost to Follow-up|3|||
33219907|NCT03879408|100703152|FG002|Overall Study|Lost to Follow-up|2|||
33219908|NCT03879408|100703153|FG003|Overall Study|Lost to Follow-up|1|||
33219909|NCT03879408|100703154|FG004|Overall Study|Lost to Follow-up|0|||
33219910|NCT03879408|100703150|FG000|Overall Study|Withdrawal by Subject|2|||
33219911|NCT03879408|100703151|FG001|Overall Study|Withdrawal by Subject|1|||
33219912|NCT03879408|100703152|FG002|Overall Study|Withdrawal by Subject|1|||
33219913|NCT03879408|100703153|FG003|Overall Study|Withdrawal by Subject|0|||
33219914|NCT03879408|100703154|FG004|Overall Study|Withdrawal by Subject|1|||
33219915|NCT02055157|100703155|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
33219916|NCT02055157|100703156|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
33219917|NCT02055157|100703157|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
33219918|NCT02055157|100703158|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
33559955|NCT03238196|101946055|FG000|Overall Study|Still on treatment|1|||
33559956|NCT03238196|101946056|FG001|Overall Study|Still on treatment|0|||
33219919|NCT02055157|100703155|FG000|Initial 6 Months|Adverse Event|0|||
33219920|NCT02055157|100703156|FG001|Initial 6 Months|Adverse Event|0|||
33219921|NCT02055157|100703157|FG002|Initial 6 Months|Adverse Event|0|||
33219922|NCT02055157|100703158|FG003|Initial 6 Months|Adverse Event|1|||
33219923|NCT02055157|100703155|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
33559957|NCT03238196|101946057|FG002|Overall Study|Still on treatment|0|||
33559958|NCT03238196|101946058|FG003|Overall Study|Still on treatment|0|||
33219924|NCT02055157|100703156|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
33219925|NCT02055157|100703157|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
33219926|NCT02055157|100703158|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
33219927|NCT02055157|100703155|FG000|18-month Extension|Investigator decision|0|||
33219928|NCT02055157|100703156|FG001|18-month Extension|Investigator decision|1|||
33219929|NCT02055157|100703157|FG002|18-month Extension|Investigator decision|0|||
33219930|NCT02055157|100703158|FG003|18-month Extension|Investigator decision|0|||
33219931|NCT02055157|100703155|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
33559959|NCT00203242|101946059|FG000|Overall Study|Lost to Follow-up|1|||
33559960|NCT02844816|101946060|FG000|Overall Study|No protocol treatment received|5|||
33559961|NCT02844816|101946061|FG001|Overall Study|No protocol treatment received|1|||
33559962|NCT02844816|101946060|FG000|Overall Study|Ineligible|22|||
33559963|NCT02844816|101946061|FG001|Overall Study|Ineligible|15|||
33559964|NCT02844816|101946060|FG000|Overall Study|Participant refusal|5|||
33559965|NCT02844816|101946061|FG001|Overall Study|Participant refusal|5|||
33559966|NCT02844816|101946060|FG000|Overall Study|Adverse Event|5|||
33559967|NCT02844816|101946061|FG001|Overall Study|Adverse Event|4|||
33623497|NCT00496015|102169639|FG002|Overall Study|Other|0|||
33623498|NCT00496015|102169640|FG003|Overall Study|Other|1|||
33623499|NCT00496015|102169641|FG004|Overall Study|Other|0|||
33623500|NCT00990106|102169642|FG000|Overall Study|"too busy to continue"|1|||
33623501|NCT00990106|102169643|FG001|Overall Study|"too busy to continue"|2|||
33559968|NCT02844816|101946060|FG000|Overall Study|Death|0|||
33559969|NCT02844816|101946061|FG001|Overall Study|Death|1|||
33559970|NCT02844816|101946060|FG000|Overall Study|Disease progression/recurrence|50|||
33559971|NCT02844816|101946061|FG001|Overall Study|Disease progression/recurrence|24|||
33559972|NCT02844816|101946060|FG000|Overall Study|Physician Decision|1|||
33623502|NCT00990106|102169642|FG000|Overall Study|Lost to Follow-up|1|||
33623503|NCT00990106|102169643|FG001|Overall Study|Lost to Follow-up|3|||
33623504|NCT00990106|102169642|FG000|Overall Study|Withdrawal by Subject|2|||
33623505|NCT00990106|102169643|FG001|Overall Study|Withdrawal by Subject|1|||
33623506|NCT00990106|102169642|FG000|Overall Study|opted for open label prazosin|1|||
33623507|NCT00990106|102169643|FG001|Overall Study|opted for open label prazosin|1|||
33623508|NCT00990106|102169642|FG000|Overall Study|relocation/deployment|4|||
33623509|NCT00990106|102169643|FG001|Overall Study|relocation/deployment|1|||
33623510|NCT00990106|102169642|FG000|Overall Study|started exclusionary medication|0|||
33623511|NCT00990106|102169643|FG001|Overall Study|started exclusionary medication|1|||
33623512|NCT00990106|102169642|FG000|Overall Study|planned major surgery|0|||
33623513|NCT00990106|102169643|FG001|Overall Study|planned major surgery|1|||
33623514|NCT00990106|102169642|FG000|Overall Study|scheduling conflicts|0|||
33623515|NCT00990106|102169643|FG001|Overall Study|scheduling conflicts|2|||
33623516|NCT01467505|102169644|FG000|Overall Study|Adverse Event|1|||
33623517|NCT01467505|102169645|FG001|Overall Study|Adverse Event|0|||
33623518|NCT01467505|102169644|FG000|Overall Study|Withdrawal by Subject|4|||
33623519|NCT01467505|102169645|FG001|Overall Study|Withdrawal by Subject|0|||
33623520|NCT01467505|102169644|FG000|Overall Study|Study Terminated by Sponsor|28|||
33623521|NCT01467505|102169645|FG001|Overall Study|Study Terminated by Sponsor|3|||
33623522|NCT04426318|102169646|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
33623523|NCT04426318|102169647|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
33623524|NCT02055898|102172872|FG000|First Intervention (5 Days)|Physician Decision|2|||
33623525|NCT02055898|102172873|FG001|First Intervention (5 Days)|Physician Decision|0|||
33623526|NCT02055898|102172872|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
33623527|NCT02055898|102172873|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
33623528|NCT02451917|102172876|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
33623529|NCT02451917|102172877|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
33623530|NCT02451917|102172876|FG000|First Intervention (24 Weeks)|Death|0|||
33559973|NCT02844816|101946061|FG001|Overall Study|Physician Decision|1|||
33559974|NCT02025010|101946067|FG000|Overall Study|Symptomatic or radiographic progression|36|||
33559975|NCT02025010|101946067|FG000|Overall Study|Adverse Event|6|||
33559976|NCT02025010|101946067|FG000|Overall Study|Physician Decision|7|||
33623531|NCT02451917|102172877|FG001|First Intervention (24 Weeks)|Death|1|||
33623532|NCT02451917|102172876|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
33623533|NCT02451917|102172877|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
33623534|NCT01050634|102172878|FG000|Overall Study|Enrolled, but Not Treated|56|||
33623535|NCT01050634|102172878|FG000|Overall Study|Death|2|||
33623536|NCT01050634|102172878|FG000|Overall Study|Adverse Event|42|||
33623537|NCT01050634|102172878|FG000|Overall Study|Lost to Follow-up|2|||
33219932|NCT02055157|100703156|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
33559977|NCT02025010|101946067|FG000|Overall Study|Withdrawal by Subject|3|||
33559978|NCT02025010|101946067|FG000|Overall Study|Intercurrent illness|3|||
33559979|NCT02025010|101946067|FG000|Overall Study|Patients still on treatment|3|||
33559980|NCT02025010|101946067|FG000|Overall Study|Never initiate the treatment|2|||
33559981|NCT04126174|101946072|FG000|Overall Study|Lost to Follow-up|3|||
33559982|NCT04126174|101946073|FG001|Overall Study|Lost to Follow-up|3|||
33559983|NCT00101400|101946074|FG000|Survival Follow-Up|Alive|7|||
33559984|NCT02514746|101946075|FG000|Overall Study|Chronically Ill|1|||
33559985|NCT02514746|101946076|FG001|Overall Study|Chronically Ill|2|||
33559986|NCT02514746|101946075|FG000|Overall Study|Physician Decision|4|||
33559987|NCT02514746|101946076|FG001|Overall Study|Physician Decision|2|||
33559988|NCT02514746|101946075|FG000|Overall Study|Withdrawal by Subject|12|||
33219933|NCT02055157|100703157|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
33219934|NCT02055157|100703158|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
33219935|NCT00002558|100703159|FG000|Overall Study|Withdrawal by Subject|0|||
33219936|NCT00002558|100703160|FG001|Overall Study|Withdrawal by Subject|1|||
33219937|NCT03649230|100703161|FG000|Overall Study|Adverse Event|12|||
33219938|NCT03649230|100703161|FG000|Overall Study|Death|8|||
33219939|NCT03649230|100703161|FG000|Overall Study|Withdrawal by Subject|6|||
33219940|NCT03649230|100703161|FG000|Overall Study|Physician Decision|5|||
33219941|NCT03649230|100703161|FG000|Overall Study|Disease progression|5|||
33219942|NCT03649230|100703161|FG000|Overall Study|Switched to non-HEC|5|||
33219943|NCT03649230|100703161|FG000|Overall Study|Chemotherapy discontinued|4|||
33219944|NCT03649230|100703161|FG000|Overall Study|Received only 3 HEC cycles|4|||
33219945|NCT03649230|100703161|FG000|Overall Study|Screen Failure|3|||
33219946|NCT03649230|100703161|FG000|Overall Study|Patient stopped treatment|2|||
33219947|NCT03649230|100703161|FG000|Overall Study|Protocol Violation|1|||
33219948|NCT03649230|100703161|FG000|Overall Study|Non-compliance|1|||
33219949|NCT03649230|100703161|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
33219950|NCT02543658|100703162|FG000|Overall Study|Lack of Efficacy|0|||
33219951|NCT02543658|100703163|FG001|Overall Study|Lack of Efficacy|4|||
33623538|NCT01050634|102172878|FG000|Overall Study|Other|21|||
33623539|NCT01050634|102172878|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
33359145|NCT00064701|101204391|FG002|One Year Post-transplant|Graft Failure|1|||
33623540|NCT01176032|102172879|FG000|Overall Study|Adverse Event|1|||
33623541|NCT01176032|102172880|FG001|Overall Study|Adverse Event|0|||
33623542|NCT01176032|102172879|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33623543|NCT01176032|102172880|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33623544|NCT01176032|102172879|FG000|Overall Study|Protocol Violation|1|||
33623545|NCT01176032|102172880|FG001|Overall Study|Protocol Violation|0|||
33623546|NCT01176032|102172879|FG000|Overall Study|Informed consent withdrawn|3|||
33623547|NCT01176032|102172880|FG001|Overall Study|Informed consent withdrawn|0|||
33219952|NCT02192970|100703168|FG000|Overall Study|Lost to Follow-up|6|||
33219953|NCT02192970|100703169|FG001|Overall Study|Lost to Follow-up|0|||
33219954|NCT02090634|100703174|FG000|Overall Study|Lost to Follow-up|0|||
33219955|NCT02090634|100703175|FG001|Overall Study|Lost to Follow-up|1|||
33219956|NCT02090634|100703174|FG000|Overall Study|Death|0|||
33359146|NCT00064701|101204389|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
33219957|NCT02090634|100703175|FG001|Overall Study|Death|1|||
33623548|NCT01176032|102172879|FG000|Overall Study|Other|1|||
33623549|NCT01176032|102172880|FG001|Overall Study|Other|0|||
33359147|NCT00064701|101204390|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
33219958|NCT02090634|100703174|FG000|Overall Study|Protocol Violation|3|||
33219959|NCT02090634|100703175|FG001|Overall Study|Protocol Violation|1|||
33219960|NCT02090634|100703174|FG000|Overall Study|Adverse Event|2|||
33219961|NCT02090634|100703175|FG001|Overall Study|Adverse Event|0|||
33219962|NCT02428296|100703177|FG000|Overall Study|Adverse Event|7|||
33559989|NCT02514746|101946076|FG001|Overall Study|Withdrawal by Subject|10|||
33559990|NCT02514746|101946075|FG000|Overall Study|Other|5|||
33623550|NCT03535974|102172881|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
33623551|NCT03535974|102172882|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
33559991|NCT02514746|101946076|FG001|Overall Study|Other|1|||
33559992|NCT01028560|101946077|FG000|Overall Study|Lack of Efficacy|3|||
33559993|NCT01028560|101946078|FG001|Overall Study|Lack of Efficacy|6|||
33559994|NCT01028560|101946077|FG000|Overall Study|Withdrawal by Subject|7|||
33559995|NCT01028560|101946078|FG001|Overall Study|Withdrawal by Subject|12|||
33559996|NCT00089583|101946083|FG000|Overall Study|Adverse Event|0|||
33559997|NCT00089583|101946084|FG001|Overall Study|Adverse Event|3|||
33559998|NCT00089583|101946083|FG000|Overall Study|Insufficient Viral Load Response|5|||
33559999|NCT00089583|101946084|FG001|Overall Study|Insufficient Viral Load Response|5|||
33560000|NCT00089583|101946083|FG000|Overall Study|Withdrawal by Subject|0|||
33560001|NCT00089583|101946084|FG001|Overall Study|Withdrawal by Subject|4|||
33560002|NCT00089583|101946083|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
33560003|NCT00089583|101946084|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
33560004|NCT00089583|101946083|FG000|Overall Study|Participant Refused Study Medication|0|||
33560005|NCT00089583|101946084|FG001|Overall Study|Participant Refused Study Medication|2|||
33560006|NCT00089583|101946083|FG000|Overall Study|Non-Compliance|0|||
33560007|NCT00089583|101946084|FG001|Overall Study|Non-Compliance|4|||
33560008|NCT00089583|101946083|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
33560009|NCT00089583|101946084|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
33560010|NCT00089583|101946083|FG000|Overall Study|Participant Management Criteria Met|0|||
33560011|NCT00089583|101946084|FG001|Overall Study|Participant Management Criteria Met|1|||
33560012|NCT00089583|101946083|FG000|Overall Study|Reason Not Provided|0|||
33560013|NCT00089583|101946084|FG001|Overall Study|Reason Not Provided|1|||
33560014|NCT00089583|101946083|FG000|Overall Study|Protocol Violation|0|||
33560015|NCT00089583|101946084|FG001|Overall Study|Protocol Violation|3|||
33560016|NCT00089583|101946083|FG000|Overall Study|Principal Investigator Decision|0|||
33560017|NCT00089583|101946084|FG001|Overall Study|Principal Investigator Decision|10|||
33560018|NCT00089583|101946083|FG000|Overall Study|Start of Disallowed Medication|0|||
33560019|NCT00089583|101946084|FG001|Overall Study|Start of Disallowed Medication|1|||
33560020|NCT00089583|101946083|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
33560021|NCT00089583|101946084|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
33560022|NCT00089583|101946083|FG000|Overall Study|Participant Incarcerated|0|||
33560023|NCT00089583|101946084|FG001|Overall Study|Participant Incarcerated|1|||
33560024|NCT01248468|101946085|FG000|Overall Study|Administrative problem|1|||
33560025|NCT01248468|101946086|FG001|Overall Study|Administrative problem|0|||
33560026|NCT01248468|101946087|FG002|Overall Study|Administrative problem|0|||
33560027|NCT01248468|101946085|FG000|Overall Study|Lost to Follow-up|9|||
33560028|NCT01248468|101946086|FG001|Overall Study|Lost to Follow-up|12|||
33560029|NCT01248468|101946087|FG002|Overall Study|Lost to Follow-up|4|||
33560030|NCT01248468|101946085|FG000|Overall Study|Pregnancy|1|||
33560031|NCT01248468|101946086|FG001|Overall Study|Pregnancy|0|||
33560032|NCT01248468|101946087|FG002|Overall Study|Pregnancy|0|||
33560033|NCT01248468|101946085|FG000|Overall Study|Withdrawal by Subject|4|||
33560034|NCT01248468|101946086|FG001|Overall Study|Withdrawal by Subject|2|||
33560035|NCT01248468|101946087|FG002|Overall Study|Withdrawal by Subject|0|||
33560036|NCT00079781|101946092|FG000|Pre-implant Period|Withdrawal by Subject|2|||
33623552|NCT03535974|102172883|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
33623553|NCT03535974|102172881|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
33560037|NCT00079781|101946093|FG001|Pre-implant Period|Withdrawal by Subject|0|||
33560038|NCT00079781|101946094|FG002|Pre-implant Period|Withdrawal by Subject|0|||
33560039|NCT00079781|101946092|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
33560040|NCT00079781|101946093|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
33560041|NCT00079781|101946094|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
33560042|NCT00079781|101946092|FG000|Follow-up Period|Withdrawal by Subject|3|||
33560043|NCT00079781|101946093|FG001|Follow-up Period|Withdrawal by Subject|0|||
33560044|NCT00079781|101946094|FG002|Follow-up Period|Withdrawal by Subject|1|||
33560045|NCT00079781|101946092|FG000|Follow-up Period|Lost to Follow-up|1|||
33560046|NCT00079781|101946093|FG001|Follow-up Period|Lost to Follow-up|0|||
33560047|NCT00079781|101946094|FG002|Follow-up Period|Lost to Follow-up|0|||
33560048|NCT00079781|101946092|FG000|Follow-up Period|Death|0|||
33560049|NCT00079781|101946093|FG001|Follow-up Period|Death|0|||
33560050|NCT00079781|101946094|FG002|Follow-up Period|Death|1|||
33560051|NCT00289978|101946095|FG000|Overall Study|Withdrawal by Subject|31|||
33560052|NCT00289978|101946096|FG001|Overall Study|Withdrawal by Subject|17|||
33560053|NCT00289978|101946097|FG002|Overall Study|Withdrawal by Subject|28|||
33560054|NCT00289978|101946095|FG000|Overall Study|Adverse Event|22|||
33560055|NCT00289978|101946096|FG001|Overall Study|Adverse Event|13|||
33560056|NCT00289978|101946097|FG002|Overall Study|Adverse Event|18|||
33560057|NCT00289978|101946095|FG000|Overall Study|Lack of Efficacy|13|||
33560058|NCT00289978|101946096|FG001|Overall Study|Lack of Efficacy|6|||
33560059|NCT00289978|101946097|FG002|Overall Study|Lack of Efficacy|25|||
33560060|NCT00289978|101946095|FG000|Overall Study|Abnormal laboratory value(s)|20|||
33560061|NCT00289978|101946096|FG001|Overall Study|Abnormal laboratory value(s)|9|||
33560062|NCT00289978|101946097|FG002|Overall Study|Abnormal laboratory value(s)|1|||
33560063|NCT00289978|101946095|FG000|Overall Study|Lost to Follow-up|3|||
33560064|NCT00289978|101946096|FG001|Overall Study|Lost to Follow-up|5|||
33560065|NCT00289978|101946097|FG002|Overall Study|Lost to Follow-up|7|||
33560066|NCT00289978|101946095|FG000|Overall Study|Protocol Violation|5|||
33560067|NCT00289978|101946096|FG001|Overall Study|Protocol Violation|5|||
33560068|NCT00289978|101946097|FG002|Overall Study|Protocol Violation|4|||
33560069|NCT00289978|101946095|FG000|Overall Study|Abnormal test procedure result(s)|2|||
33560070|NCT00289978|101946096|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33560071|NCT00289978|101946097|FG002|Overall Study|Abnormal test procedure result(s)|1|||
33560072|NCT00289978|101946095|FG000|Overall Study|Death|1|||
33560073|NCT00289978|101946096|FG001|Overall Study|Death|0|||
33560074|NCT00289978|101946097|FG002|Overall Study|Death|2|||
33560075|NCT01796470|101946098|FG000|Overall Study|Adverse Event|4|||
33560076|NCT01796470|101946099|FG001|Overall Study|Adverse Event|2|||
33560077|NCT01796470|101946100|FG002|Overall Study|Adverse Event|2|||
33560078|NCT01796470|101946101|FG003|Overall Study|Adverse Event|1|||
33560079|NCT01796470|101946102|FG004|Overall Study|Adverse Event|3|||
33560080|NCT01796470|101946098|FG000|Overall Study|Death|2|||
33560081|NCT01796470|101946099|FG001|Overall Study|Death|0|||
33560082|NCT01796470|101946100|FG002|Overall Study|Death|0|||
33560083|NCT01796470|101946101|FG003|Overall Study|Death|0|||
33359148|NCT00064701|101204391|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
33359149|NCT00064701|101204389|FG000|One Year Post-transplant|Lost to Follow-up|1|||
33359150|NCT00064701|101204390|FG001|One Year Post-transplant|Lost to Follow-up|0|||
33359151|NCT00064701|101204391|FG002|One Year Post-transplant|Lost to Follow-up|0|||
33560084|NCT01796470|101946102|FG004|Overall Study|Death|1|||
33623554|NCT03535974|102172882|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
33623555|NCT03535974|102172883|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
33623556|NCT01400698|102172884|FG000|Overall Study|Lost to Follow-up|2|||
33623557|NCT01400698|102172885|FG001|Overall Study|Lost to Follow-up|5|||
33359152|NCT00064701|101204389|FG000|One Year Post-transplant|Converted to rapamycin|1|||
33359153|NCT00064701|101204390|FG001|One Year Post-transplant|Converted to rapamycin|0|||
33560085|NCT01796470|101946098|FG000|Overall Study|Initiated New Therapy|9|||
33560086|NCT01796470|101946099|FG001|Overall Study|Initiated New Therapy|0|||
33560087|NCT01796470|101946100|FG002|Overall Study|Initiated New Therapy|0|||
33560088|NCT01796470|101946101|FG003|Overall Study|Initiated New Therapy|0|||
33560089|NCT01796470|101946102|FG004|Overall Study|Initiated New Therapy|2|||
33560090|NCT01796470|101946098|FG000|Overall Study|Lost to Follow-up|0|||
33560091|NCT01796470|101946099|FG001|Overall Study|Lost to Follow-up|1|||
33560092|NCT01796470|101946100|FG002|Overall Study|Lost to Follow-up|0|||
33560093|NCT01796470|101946101|FG003|Overall Study|Lost to Follow-up|0|||
33560094|NCT01796470|101946102|FG004|Overall Study|Lost to Follow-up|0|||
33560095|NCT01796470|101946098|FG000|Overall Study|Physician Decision|5|||
33560096|NCT01796470|101946099|FG001|Overall Study|Physician Decision|4|||
33560097|NCT01796470|101946100|FG002|Overall Study|Physician Decision|1|||
33623558|NCT01400698|102172886|FG002|Overall Study|Lost to Follow-up|2|||
33623559|NCT01400698|102172887|FG003|Overall Study|Lost to Follow-up|1|||
33623560|NCT01400698|102172888|FG004|Overall Study|Lost to Follow-up|4|||
33623561|NCT01400698|102172889|FG005|Overall Study|Lost to Follow-up|3|||
33623562|NCT01400698|102172884|FG000|Overall Study|Withdrawal by Subject|8|||
33623563|NCT01400698|102172885|FG001|Overall Study|Withdrawal by Subject|2|||
33623564|NCT01400698|102172886|FG002|Overall Study|Withdrawal by Subject|0|||
33359154|NCT00064701|101204391|FG002|One Year Post-transplant|Converted to rapamycin|0|||
33560098|NCT01796470|101946101|FG003|Overall Study|Physician Decision|0|||
33560099|NCT01796470|101946102|FG004|Overall Study|Physician Decision|1|||
33560100|NCT01796470|101946098|FG000|Overall Study|Progressive Disease|7|||
33560101|NCT01796470|101946099|FG001|Overall Study|Progressive Disease|7|||
33359155|NCT00064701|101204389|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
33359156|NCT00064701|101204390|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
33560102|NCT01796470|101946100|FG002|Overall Study|Progressive Disease|3|||
33560103|NCT01796470|101946101|FG003|Overall Study|Progressive Disease|2|||
33560104|NCT01796470|101946102|FG004|Overall Study|Progressive Disease|0|||
33560105|NCT01796470|101946098|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
33560106|NCT01796470|101946099|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
33560107|NCT01796470|101946100|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
33623565|NCT01400698|102172887|FG003|Overall Study|Withdrawal by Subject|4|||
33623566|NCT01400698|102172888|FG004|Overall Study|Withdrawal by Subject|1|||
33623567|NCT01400698|102172889|FG005|Overall Study|Withdrawal by Subject|3|||
33623568|NCT01400698|102172884|FG000|Overall Study|Protocol Violation|0|||
33623569|NCT01400698|102172885|FG001|Overall Study|Protocol Violation|1|||
33359157|NCT00064701|101204391|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
33359158|NCT00064701|101204389|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
33359159|NCT00064701|101204390|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
33359160|NCT00064701|101204391|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
33359161|NCT00064701|101204389|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
33359162|NCT00064701|101204390|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
33359163|NCT00064701|101204391|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
33359164|NCT00064701|101204389|FG000|One Year Post-transplant|Poor absorption|0|||
33359165|NCT00064701|101204390|FG001|One Year Post-transplant|Poor absorption|1|||
33359166|NCT00064701|101204391|FG002|One Year Post-transplant|Poor absorption|0|||
33359167|NCT00064701|101204389|FG000|One Year Post-transplant|Pancreas transplant|0|||
33359168|NCT00064701|101204390|FG001|One Year Post-transplant|Pancreas transplant|0|||
33359169|NCT00064701|101204391|FG002|One Year Post-transplant|Pancreas transplant|1|||
33359170|NCT00064701|101204389|FG000|Clinical Continuation Phase|Adverse Event|12|||
33359171|NCT00064701|101204390|FG001|Clinical Continuation Phase|Adverse Event|21|||
33359172|NCT00064701|101204391|FG002|Clinical Continuation Phase|Adverse Event|14|||
33359173|NCT00064701|101204389|FG000|Clinical Continuation Phase|Non-compliance|8|||
33359174|NCT00064701|101204390|FG001|Clinical Continuation Phase|Non-compliance|6|||
33359175|NCT00064701|101204391|FG002|Clinical Continuation Phase|Non-compliance|7|||
33623570|NCT01400698|102172886|FG002|Overall Study|Protocol Violation|0|||
33623571|NCT01400698|102172887|FG003|Overall Study|Protocol Violation|0|||
33623572|NCT01400698|102172888|FG004|Overall Study|Protocol Violation|1|||
33623573|NCT01400698|102172889|FG005|Overall Study|Protocol Violation|0|||
33623574|NCT01400698|102172884|FG000|Overall Study|Non-compliance|0|||
33623575|NCT01400698|102172885|FG001|Overall Study|Non-compliance|1|||
33623576|NCT01400698|102172886|FG002|Overall Study|Non-compliance|0|||
33623577|NCT01400698|102172887|FG003|Overall Study|Non-compliance|1|||
33623578|NCT01400698|102172888|FG004|Overall Study|Non-compliance|0|||
33623579|NCT01400698|102172889|FG005|Overall Study|Non-compliance|0|||
33623580|NCT01400698|102172884|FG000|Overall Study|Adverse Event|1|||
33623581|NCT01400698|102172885|FG001|Overall Study|Adverse Event|0|||
33623582|NCT01400698|102172886|FG002|Overall Study|Adverse Event|0|||
33623583|NCT01400698|102172887|FG003|Overall Study|Adverse Event|0|||
33623584|NCT01400698|102172888|FG004|Overall Study|Adverse Event|0|||
33623585|NCT01400698|102172889|FG005|Overall Study|Adverse Event|0|||
33359176|NCT00064701|101204389|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
33359177|NCT00064701|101204390|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
33359178|NCT00064701|101204391|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
33623586|NCT01400698|102172884|FG000|Overall Study|Other|4|||
33359179|NCT00064701|101204389|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
33359180|NCT00064701|101204390|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
33560108|NCT01796470|101946101|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
33560109|NCT01796470|101946102|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
33623587|NCT01400698|102172885|FG001|Overall Study|Other|2|||
33623588|NCT01400698|102172886|FG002|Overall Study|Other|0|||
33623589|NCT01400698|102172887|FG003|Overall Study|Other|2|||
33623590|NCT01400698|102172888|FG004|Overall Study|Other|1|||
33623591|NCT01400698|102172889|FG005|Overall Study|Other|0|||
33623592|NCT03550378|102172890|FG000|Overall Study|Death|0|||
33623593|NCT03550378|102172891|FG001|Overall Study|Death|1|||
33560110|NCT01796470|101946098|FG000|Overall Study|Withdrawal by Subject|7|||
33560111|NCT01796470|101946099|FG001|Overall Study|Withdrawal by Subject|0|||
33560112|NCT01796470|101946100|FG002|Overall Study|Withdrawal by Subject|0|||
33359181|NCT00064701|101204391|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
33359182|NCT00064701|101204389|FG000|Clinical Continuation Phase|Graft Failure|5|||
33359183|NCT00064701|101204390|FG001|Clinical Continuation Phase|Graft Failure|5|||
33359184|NCT00064701|101204391|FG002|Clinical Continuation Phase|Graft Failure|2|||
33359185|NCT00064701|101204389|FG000|Clinical Continuation Phase|Rejection|1|||
33359186|NCT00064701|101204390|FG001|Clinical Continuation Phase|Rejection|2|||
33560113|NCT01796470|101946101|FG003|Overall Study|Withdrawal by Subject|0|||
33560114|NCT01796470|101946102|FG004|Overall Study|Withdrawal by Subject|1|||
33359187|NCT00064701|101204391|FG002|Clinical Continuation Phase|Rejection|2|||
33359188|NCT00064701|101204389|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
33359189|NCT00064701|101204390|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
33359190|NCT00064701|101204391|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
33359191|NCT00064701|101204389|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
33359192|NCT00064701|101204390|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
33359193|NCT00064701|101204391|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
33359194|NCT00064701|101204389|FG000|Clinical Continuation Phase|Physician Decision|1|||
33359195|NCT00064701|101204390|FG001|Clinical Continuation Phase|Physician Decision|3|||
33359196|NCT00064701|101204391|FG002|Clinical Continuation Phase|Physician Decision|0|||
33359197|NCT00064701|101204389|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
33359198|NCT00064701|101204390|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
33359199|NCT00064701|101204391|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
33359200|NCT00064701|101204389|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
33359201|NCT00064701|101204390|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
33359202|NCT00064701|101204391|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
33359203|NCT00064701|101204389|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
33359204|NCT00064701|101204390|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
33359205|NCT00064701|101204391|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
33359206|NCT00064701|101204389|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
33359207|NCT00064701|101204390|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
33560115|NCT05943990|101946104|FG000|Overall Study|Study Terminated by Sponsor|0|||
33359208|NCT00064701|101204391|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
33560116|NCT05943990|101946105|FG001|Overall Study|Study Terminated by Sponsor|0|||
33560117|NCT05943990|101946106|FG002|Overall Study|Study Terminated by Sponsor|1|||
33560118|NCT00069953|101946111|FG000|Overall Study|Protocol Violation|2|||
33560119|NCT01341990|101946112|FG000|Overall Study|Adverse Event|0|||
33560120|NCT01341990|101946113|FG001|Overall Study|Adverse Event|1|||
33560121|NCT01341990|101946112|FG000|Overall Study|Torn Study Lens|1|||
33560122|NCT01341990|101946113|FG001|Overall Study|Torn Study Lens|0|||
33560123|NCT01341990|101946112|FG000|Overall Study|Withdrawal by Subject|2|||
33560124|NCT01341990|101946113|FG001|Overall Study|Withdrawal by Subject|0|||
33560125|NCT01569763|101946116|FG000|Overall Study|Lack of Efficacy|2|||
33560126|NCT01569763|101946117|FG001|Overall Study|Lack of Efficacy|7|||
33560127|NCT01569763|101946116|FG000|Overall Study|Adverse Event|1|||
33560128|NCT01569763|101946117|FG001|Overall Study|Adverse Event|0|||
33560129|NCT03654326|101946118|FG000|Overall Study|Withdrawal by Subject|5|||
33560130|NCT03654326|101946119|FG001|Overall Study|Withdrawal by Subject|3|||
33560131|NCT03654326|101946118|FG000|Overall Study|Physician Decision|0|||
33560132|NCT03654326|101946119|FG001|Overall Study|Physician Decision|1|||
33560133|NCT03654326|101946118|FG000|Overall Study|Unable to adhere to study schedule|0|||
33560134|NCT03654326|101946119|FG001|Overall Study|Unable to adhere to study schedule|1|||
33560135|NCT03654326|101946118|FG000|Overall Study|Lost to Follow-up|1|||
33560136|NCT03654326|101946119|FG001|Overall Study|Lost to Follow-up|1|||
33560137|NCT01217047|101946120|FG000|Overall Study|Lost to Follow-up|0|||
33560138|NCT01217047|101946121|FG001|Overall Study|Lost to Follow-up|1|||
33560139|NCT01217047|101946122|FG002|Overall Study|Lost to Follow-up|0|||
33560140|NCT01887600|101946123|FG000|Overall Study|Death|39|||
33560141|NCT01887600|101946124|FG001|Overall Study|Death|16|||
33560142|NCT01887600|101946123|FG000|Overall Study|Lack of Efficacy|3|||
33560143|NCT01887600|101946124|FG001|Overall Study|Lack of Efficacy|26|||
33560144|NCT01887600|101946123|FG000|Overall Study|Lost to Follow-up|5|||
33560145|NCT01887600|101946124|FG001|Overall Study|Lost to Follow-up|1|||
33560146|NCT01887600|101946123|FG000|Overall Study|Physician Decision|7|||
33560147|NCT01887600|101946124|FG001|Overall Study|Physician Decision|8|||
33560148|NCT01887600|101946123|FG000|Overall Study|Protocol Deviation|3|||
33560149|NCT01887600|101946124|FG001|Overall Study|Protocol Deviation|0|||
33560150|NCT01887600|101946123|FG000|Overall Study|Withdrawal by Subject|58|||
33560151|NCT01887600|101946124|FG001|Overall Study|Withdrawal by Subject|52|||
33560152|NCT01887600|101946123|FG000|Overall Study|Adverse Event|21|||
33560153|NCT01887600|101946124|FG001|Overall Study|Adverse Event|9|||
33560154|NCT01887600|101946123|FG000|Overall Study|Non-compliance with study drug|3|||
33560155|NCT01887600|101946124|FG001|Overall Study|Non-compliance with study drug|0|||
33560156|NCT01887600|101946123|FG000|Overall Study|Miscellaneous|6|||
33560157|NCT01887600|101946124|FG001|Overall Study|Miscellaneous|2|||
33560158|NCT01887600|101946123|FG000|Overall Study|Progressive Disease|1|||
33560159|NCT01887600|101946124|FG001|Overall Study|Progressive Disease|0|||
33560160|NCT05071027|101946125|FG000|Overall Study|Lost to Follow-up|1|||
33560161|NCT05071027|101946126|FG001|Overall Study|Lost to Follow-up|4|||
33560162|NCT01575548|101946127|FG000|Overall Study|Adverse Event|15|||
33560163|NCT01575548|101946128|FG001|Overall Study|Adverse Event|2|||
33560164|NCT01575548|101946127|FG000|Overall Study|Disease progression|12|||
33560165|NCT01575548|101946128|FG001|Overall Study|Disease progression|25|||
33560166|NCT01575548|101946127|FG000|Overall Study|Death|1|||
33560167|NCT01575548|101946128|FG001|Overall Study|Death|0|||
33560168|NCT01575548|101946127|FG000|Overall Study|Other complicating disease|1|||
33560169|NCT01575548|101946128|FG001|Overall Study|Other complicating disease|0|||
33560170|NCT01575548|101946127|FG000|Overall Study|Withdrawal by Subject|7|||
33560171|NCT01575548|101946128|FG001|Overall Study|Withdrawal by Subject|3|||
33560172|NCT01575548|101946127|FG000|Overall Study|Noncompliance|1|||
33560173|NCT01575548|101946128|FG001|Overall Study|Noncompliance|0|||
33560174|NCT01575548|101946127|FG000|Overall Study|Anticipated surgery|0|||
33560175|NCT01575548|101946128|FG001|Overall Study|Anticipated surgery|1|||
33560176|NCT01575548|101946127|FG000|Overall Study|Never started protocol therapy|3|||
33560177|NCT01575548|101946128|FG001|Overall Study|Never started protocol therapy|2|||
33560178|NCT03193437|101946132|FG000|Overall Study|Adverse Event|4|||
33560179|NCT03193437|101946132|FG000|Overall Study|Withdrawal by Subject|2|||
33560180|NCT03193437|101946132|FG000|Overall Study|Disease Progression|2|||
33560181|NCT00421408|101946135|FG000|Overall Study|Lost to Follow-up|30|||
33560182|NCT00421408|101946136|FG001|Overall Study|Lost to Follow-up|20|||
33560183|NCT00421408|101946135|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
33560184|NCT00421408|101946136|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
33560185|NCT03810495|101946137|FG000|Overall Study|Lost to Follow-up|2|||
33560186|NCT03810495|101946137|FG000|Overall Study|Withdrawal by Subject|1|||
33560187|NCT00655356|101946140|FG000|Overall Study|Withdrawal by Subject|3|||
33359209|NCT00064701|101204389|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
33359210|NCT00064701|101204390|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
33560188|NCT00655356|101946141|FG001|Overall Study|Withdrawal by Subject|4|||
33560189|NCT00655356|101946140|FG000|Overall Study|Sponsor Request|10|||
33560190|NCT00655356|101946141|FG001|Overall Study|Sponsor Request|4|||
33560191|NCT00655356|101946140|FG000|Overall Study|Adverse Event|1|||
33560192|NCT00655356|101946141|FG001|Overall Study|Adverse Event|1|||
33560193|NCT00655356|101946140|FG000|Overall Study|Protocol Violation|2|||
33560194|NCT00655356|101946141|FG001|Overall Study|Protocol Violation|1|||
33560195|NCT00655356|101946140|FG000|Overall Study|Other Reason|1|||
33560196|NCT00655356|101946141|FG001|Overall Study|Other Reason|0|||
33560197|NCT05287685|101946142|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
33560198|NCT05287685|101946143|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
33560199|NCT05287685|101946142|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
33560200|NCT05287685|101946143|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
33560201|NCT02336555|101946144|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33560202|NCT02336555|101946145|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
33560203|NCT02336555|101946144|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
33560204|NCT02336555|101946145|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
33560205|NCT02336555|101946144|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
33560206|NCT02336555|101946145|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
33560207|NCT00692237|101946146|FG000|Overall Study|Withdrawal by Subject|1|||
33560208|NCT00692237|101946147|FG001|Overall Study|Withdrawal by Subject|3|||
33560209|NCT00692237|101946146|FG000|Overall Study|Adverse Event|0|||
33560210|NCT00692237|101946147|FG001|Overall Study|Adverse Event|1|||
33560211|NCT02502383|101946151|FG000|Overall Study|Lost to Follow-up|130|||
33560212|NCT02502383|101946152|FG001|Overall Study|Lost to Follow-up|131|||
33560213|NCT02502383|101946151|FG000|Overall Study|Withdrawal by Subject|31|||
33560214|NCT02502383|101946152|FG001|Overall Study|Withdrawal by Subject|24|||
33560215|NCT01093573|101946153|FG000|Overall Study|Physician Decision|0|||
33560216|NCT01093573|101946154|FG001|Overall Study|Physician Decision|0|||
33560217|NCT01093573|101946155|FG002|Overall Study|Physician Decision|1|||
33560218|NCT01093573|101946153|FG000|Overall Study|Insurance Denied|0|||
33560219|NCT01093573|101946154|FG001|Overall Study|Insurance Denied|0|||
33560220|NCT01093573|101946155|FG002|Overall Study|Insurance Denied|1|||
33560221|NCT02757768|101946156|FG000|Overall Study|Randomized Never Received Study Drug|3|||
33560222|NCT02757768|101946157|FG001|Overall Study|Randomized Never Received Study Drug|4|||
33560223|NCT02757768|101946156|FG000|Overall Study|Adverse Event|5|||
33560224|NCT02757768|101946157|FG001|Overall Study|Adverse Event|3|||
33560225|NCT02757768|101946156|FG000|Overall Study|Lack of Efficacy|2|||
33560226|NCT02757768|101946157|FG001|Overall Study|Lack of Efficacy|1|||
33560227|NCT02757768|101946156|FG000|Overall Study|Lost to Follow-up|1|||
33560228|NCT02757768|101946157|FG001|Overall Study|Lost to Follow-up|0|||
33560229|NCT02757768|101946156|FG000|Overall Study|Protocol Deviation|2|||
33560230|NCT02757768|101946157|FG001|Overall Study|Protocol Deviation|9|||
33560231|NCT02757768|101946156|FG000|Overall Study|Withdrawal by Subject|16|||
33560232|NCT02757768|101946157|FG001|Overall Study|Withdrawal by Subject|9|||
33560233|NCT02757768|101946156|FG000|Overall Study|Miscellaneous|4|||
33560234|NCT02757768|101946157|FG001|Overall Study|Miscellaneous|2|||
33560235|NCT02242903|101946158|FG000|Overall Study|Withdrawal by Subject|1|||
33560236|NCT02242903|101946159|FG001|Overall Study|Withdrawal by Subject|0|||
33560237|NCT02242903|101946160|FG002|Overall Study|Withdrawal by Subject|0|||
33560238|NCT02242903|101946161|FG003|Overall Study|Withdrawal by Subject|0|||
33560239|NCT02242903|101946162|FG004|Overall Study|Withdrawal by Subject|0|||
33560240|NCT02242903|101946163|FG005|Overall Study|Withdrawal by Subject|0|||
33560241|NCT02242903|101946164|FG006|Overall Study|Withdrawal by Subject|0|||
33560242|NCT03688139|101946165|FG000|Overall Study|Lost to Follow-up|2|||
33560243|NCT03688139|101946166|FG001|Overall Study|Lost to Follow-up|0|||
33560244|NCT03688139|101946165|FG000|Overall Study|Physician Decision|0|||
33560245|NCT03688139|101946166|FG001|Overall Study|Physician Decision|1|||
33560246|NCT03688139|101946165|FG000|Overall Study|Withdrawal by Subject|2|||
33560247|NCT03688139|101946166|FG001|Overall Study|Withdrawal by Subject|3|||
33560248|NCT02715856|101946176|FG000|Overall Study|Software Issues|12|||
33560249|NCT02715856|101946177|FG001|Overall Study|Software Issues|7|||
33560250|NCT02715856|101946176|FG000|Overall Study|Death|6|||
33560251|NCT02715856|101946177|FG001|Overall Study|Death|5|||
33560252|NCT02715856|101946176|FG000|Overall Study|Non- Compliant|0|||
33560253|NCT02715856|101946177|FG001|Overall Study|Non- Compliant|40|||
33560254|NCT01423084|101946180|FG000|Overall Study|Adverse Event|0|||
33560255|NCT01423084|101946181|FG001|Overall Study|Adverse Event|1|||
33560256|NCT01423084|101946180|FG000|Overall Study|Withdrawal by Subject|2|||
33560257|NCT01423084|101946181|FG001|Overall Study|Withdrawal by Subject|3|||
33560258|NCT02771145|101946182|FG000|Overall Study|Adverse Event|3|||
33560259|NCT02771145|101946182|FG000|Overall Study|Lost to Follow-up|1|||
33560260|NCT05852470|101946183|FG000|Overall Study|Withdrawal by Subject|0|||
33560261|NCT05852470|101946184|FG001|Overall Study|Withdrawal by Subject|1|||
33560262|NCT02091960|101946186|FG000|Overall Study|Death|7|||
33560263|NCT02091960|101946186|FG000|Overall Study|Withdrawal by Subject|1|||
33560264|NCT02091960|101946186|FG000|Overall Study|Miscellaneous Reasons|31|||
33560265|NCT02091960|101946186|FG000|Overall Study|On Study at Data Cut-off|12|||
33560266|NCT00395447|101948893|FG000|Overall Study|Death|37|||
33560267|NCT00395447|101948894|FG001|Overall Study|Death|32|||
33560268|NCT00395447|101948893|FG000|Overall Study|Lost to Follow-up|52|||
33560269|NCT00395447|101948894|FG001|Overall Study|Lost to Follow-up|43|||
33560270|NCT00395447|101948893|FG000|Overall Study|Withdrawal by Subject|24|||
33560271|NCT00395447|101948894|FG001|Overall Study|Withdrawal by Subject|19|||
33560272|NCT00395447|101948893|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
33560273|NCT00395447|101948894|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
33560274|NCT04223687|101948899|FG000|Overall Study|Missing primary outcome|1|||
33560275|NCT04223687|101948900|FG001|Overall Study|Missing primary outcome|0|||
33560276|NCT01272219|101948903|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
33560277|NCT01272219|101948904|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
33560278|NCT01272219|101948905|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
33560279|NCT01272219|101948906|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
33623594|NCT03901144|102172894|FG000|Overall Study|Lost to Follow-up|1|||
33623595|NCT03901144|102172895|FG001|Overall Study|Lost to Follow-up|1|||
33623596|NCT03901144|102172896|FG002|Overall Study|Lost to Follow-up|1|||
33623597|NCT03901144|102172897|FG003|Overall Study|Lost to Follow-up|1|||
33623598|NCT00628030|102172899|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
33623599|NCT00628030|102172900|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
33623600|NCT00628030|102172899|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
33623601|NCT00628030|102172900|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
33560280|NCT01272219|101948907|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
33623602|NCT00628030|102172899|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
33623603|NCT00628030|102172900|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
33219963|NCT02428296|100703177|FG000|Overall Study|Withdrawal by Subject|2|||
33219964|NCT00118716|100703185|FG000|Overall Study|Adverse Event|2|||
33560281|NCT01272219|101948908|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
33219965|NCT00118716|100703186|FG001|Overall Study|Adverse Event|7|||
33560282|NCT01272219|101948903|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
33560283|NCT01272219|101948904|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
33560284|NCT01272219|101948905|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
33623604|NCT00763386|102172901|FG000|Overall Study|Adverse Event|43|||
33359211|NCT00064701|101204391|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
33560285|NCT01272219|101948906|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
33560286|NCT01272219|101948907|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
33560287|NCT01272219|101948908|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
33560288|NCT01272219|101948903|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
33560289|NCT01272219|101948904|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
33560290|NCT01272219|101948905|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
33560291|NCT01272219|101948906|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
33560292|NCT01272219|101948907|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
33560293|NCT01272219|101948908|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
33623605|NCT00763386|102172902|FG001|Overall Study|Adverse Event|33|||
33623606|NCT00763386|102172901|FG000|Overall Study|Death|1|||
33623607|NCT00763386|102172902|FG001|Overall Study|Death|2|||
33623608|NCT00763386|102172901|FG000|Overall Study|Lost to Follow-up|3|||
33623609|NCT00763386|102172902|FG001|Overall Study|Lost to Follow-up|3|||
33623610|NCT00763386|102172901|FG000|Overall Study|Withdrawal by Subject|0|||
33623611|NCT00763386|102172902|FG001|Overall Study|Withdrawal by Subject|1|||
33623612|NCT00763386|102172901|FG000|Overall Study|CRF missing|0|||
33623613|NCT00763386|102172902|FG001|Overall Study|CRF missing|1|||
33623614|NCT00763386|102172901|FG000|Overall Study|Study Prosthesis Removed|1|||
33623615|NCT00763386|102172902|FG001|Overall Study|Study Prosthesis Removed|0|||
33623616|NCT01691794|102172903|FG000|Overall Study|Poor/Non-Compliance|1|||
33623617|NCT01691794|102172904|FG001|Overall Study|Poor/Non-Compliance|4|||
33623618|NCT01691794|102172905|FG002|Overall Study|Poor/Non-Compliance|1|||
33623619|NCT01691794|102172903|FG000|Overall Study|Death|0|||
33623620|NCT01691794|102172904|FG001|Overall Study|Death|0|||
33623621|NCT01691794|102172905|FG002|Overall Study|Death|1|||
33623622|NCT01691794|102172903|FG000|Overall Study|Lack of Efficacy|0|||
33623623|NCT01691794|102172904|FG001|Overall Study|Lack of Efficacy|7|||
33623624|NCT01691794|102172905|FG002|Overall Study|Lack of Efficacy|1|||
33623625|NCT01691794|102172903|FG000|Overall Study|Participant request to discontinue|0|||
33623626|NCT01691794|102172904|FG001|Overall Study|Participant request to discontinue|1|||
33623627|NCT01691794|102172905|FG002|Overall Study|Participant request to discontinue|0|||
33623628|NCT01691794|102172903|FG000|Overall Study|Adverse Event|0|||
33623629|NCT01691794|102172904|FG001|Overall Study|Adverse Event|1|||
33623630|NCT01691794|102172905|FG002|Overall Study|Adverse Event|1|||
33623631|NCT01691794|102172903|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
33623632|NCT01691794|102172904|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
33623633|NCT01691794|102172905|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
33623634|NCT01691794|102172903|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
33623635|NCT01691794|102172904|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
33623636|NCT01691794|102172905|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
33623637|NCT01960140|102172918|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
33623638|NCT00395746|102172919|FG000|Overall Study|Adverse Event|5|||
33623639|NCT00395746|102172920|FG001|Overall Study|Adverse Event|2|||
33623640|NCT00395746|102172921|FG002|Overall Study|Adverse Event|2|||
33623641|NCT00395746|102172919|FG000|Overall Study|Protocol Violation|0|||
33623642|NCT00395746|102172920|FG001|Overall Study|Protocol Violation|1|||
33623643|NCT00395746|102172921|FG002|Overall Study|Protocol Violation|0|||
33623644|NCT00395746|102172919|FG000|Overall Study|Lack of Efficacy|2|||
33623645|NCT00395746|102172920|FG001|Overall Study|Lack of Efficacy|0|||
33623646|NCT00395746|102172921|FG002|Overall Study|Lack of Efficacy|17|||
33623647|NCT00395746|102172919|FG000|Overall Study|Hypoglycaemia|2|||
33623648|NCT00395746|102172920|FG001|Overall Study|Hypoglycaemia|1|||
33623649|NCT00395746|102172921|FG002|Overall Study|Hypoglycaemia|0|||
33623650|NCT00395746|102172919|FG000|Overall Study|Subject decision|0|||
33623651|NCT00395746|102172920|FG001|Overall Study|Subject decision|0|||
33623652|NCT00395746|102172921|FG002|Overall Study|Subject decision|1|||
33623653|NCT00395746|102172919|FG000|Overall Study|Withdrawal of consent|0|||
33623654|NCT00395746|102172920|FG001|Overall Study|Withdrawal of consent|0|||
33623655|NCT00395746|102172921|FG002|Overall Study|Withdrawal of consent|1|||
33623656|NCT00395746|102172919|FG000|Overall Study|Difficultulty in use of device|0|||
33623657|NCT00395746|102172920|FG001|Overall Study|Difficultulty in use of device|0|||
33623658|NCT00395746|102172921|FG002|Overall Study|Difficultulty in use of device|1|||
33623659|NCT00395746|102172919|FG000|Overall Study|Unable to visit site on schedule|1|||
33623660|NCT00395746|102172920|FG001|Overall Study|Unable to visit site on schedule|0|||
33623661|NCT00395746|102172921|FG002|Overall Study|Unable to visit site on schedule|0|||
33623662|NCT00688259|102172922|FG000|Overall Study|Lost to Follow-up|2|||
33623663|NCT00688259|102172923|FG001|Overall Study|Lost to Follow-up|4|||
33623664|NCT00688259|102172922|FG000|Overall Study|Physician Decision|1|||
33623665|NCT00688259|102172923|FG001|Overall Study|Physician Decision|0|||
33560294|NCT01272219|101948903|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
33560295|NCT01272219|101948904|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
33560296|NCT01272219|101948905|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
33560297|NCT01272219|101948906|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
33560298|NCT01272219|101948907|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
33560299|NCT01272219|101948908|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
33560300|NCT01272219|101948903|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
33560301|NCT01272219|101948904|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
33560302|NCT01272219|101948905|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
33623666|NCT00688259|102172922|FG000|Overall Study|Withdrawal by Subject|2|||
33623667|NCT00688259|102172923|FG001|Overall Study|Withdrawal by Subject|0|||
33623668|NCT00688259|102172922|FG000|Overall Study|Declined Interview|2|||
33623669|NCT00688259|102172923|FG001|Overall Study|Declined Interview|3|||
33623670|NCT00688259|102172922|FG000|Overall Study|Hospitalized at Follow-up|0|||
33623671|NCT00688259|102172923|FG001|Overall Study|Hospitalized at Follow-up|1|||
33623672|NCT00443040|102172927|FG000|Overall Study|Withdrawal by Subject|1|||
33623673|NCT00443040|102172928|FG001|Overall Study|Withdrawal by Subject|0|||
33560303|NCT01272219|101948906|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
33560304|NCT01272219|101948907|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
33623674|NCT00443040|102172929|FG002|Overall Study|Withdrawal by Subject|0|||
33623675|NCT00443040|102172927|FG000|Overall Study|Converted to an open laparotomy|3|||
33623676|NCT00443040|102172928|FG001|Overall Study|Converted to an open laparotomy|0|||
33623677|NCT00443040|102172929|FG002|Overall Study|Converted to an open laparotomy|1|||
33219966|NCT00118716|100703185|FG000|Overall Study|Protocol Violation|5|||
33219967|NCT00118716|100703186|FG001|Overall Study|Protocol Violation|4|||
33219968|NCT00118716|100703185|FG000|Overall Study|Withdrawal by Subject|0|||
33219969|NCT00118716|100703186|FG001|Overall Study|Withdrawal by Subject|1|||
33219970|NCT00118716|100703185|FG000|Overall Study|Exacerbation|2|||
33219971|NCT00118716|100703186|FG001|Overall Study|Exacerbation|2|||
33219972|NCT00118716|100703185|FG000|Overall Study|Discontinued by sponsor|1|||
33219973|NCT00118716|100703186|FG001|Overall Study|Discontinued by sponsor|1|||
33219974|NCT00118716|100703185|FG000|Overall Study|Non-compliance|1|||
33219975|NCT00118716|100703186|FG001|Overall Study|Non-compliance|3|||
33219976|NCT00118716|100703185|FG000|Overall Study|misrandomized|1|||
33219977|NCT00118716|100703186|FG001|Overall Study|misrandomized|1|||
33219978|NCT00118716|100703185|FG000|Overall Study|Expired drug use|1|||
33219979|NCT00118716|100703186|FG001|Overall Study|Expired drug use|2|||
33219980|NCT00118716|100703185|FG000|Overall Study|Investigator discretion|0|||
33560305|NCT01272219|101948908|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
33560306|NCT01272219|101948903|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
33560307|NCT01272219|101948904|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
33560308|NCT01272219|101948905|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
33560309|NCT01272219|101948906|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
33560310|NCT01272219|101948907|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
33560311|NCT01272219|101948908|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
33560312|NCT01272219|101948903|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
33560313|NCT01272219|101948904|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
33560314|NCT01272219|101948905|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
33560315|NCT01272219|101948906|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
33560316|NCT01272219|101948907|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
33560317|NCT01272219|101948908|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
33623678|NCT04737278|102172933|FG000|Overall Study|Lost to Follow-up|1|||
33623679|NCT04737278|102172934|FG001|Overall Study|Lost to Follow-up|1|||
33623680|NCT04737278|102172933|FG000|Overall Study|Withdrawal by Subject|1|||
33623681|NCT04737278|102172934|FG001|Overall Study|Withdrawal by Subject|0|||
33623682|NCT04737278|102172933|FG000|Overall Study|Protocol Violation|1|||
33414618|NCT01915498|101409844|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33414619|NCT01915498|101409845|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33359212|NCT00064701|101204389|FG000|Clinical Continuation Phase|Patient opted out|0|||
33359213|NCT00064701|101204390|FG001|Clinical Continuation Phase|Patient opted out|0|||
33359214|NCT00064701|101204391|FG002|Clinical Continuation Phase|Patient opted out|1|||
33359215|NCT00814710|101204394|FG000|Overall Study|Adverse Event|1|||
33359216|NCT00814710|101204395|FG001|Overall Study|Adverse Event|0|||
33359217|NCT00814710|101204394|FG000|Overall Study|Lost to Follow-up|7|||
33359218|NCT00814710|101204395|FG001|Overall Study|Lost to Follow-up|3|||
33359219|NCT00850499|101204397|FG000|Overall Study|Adverse Event|3|||
33359220|NCT00850499|101204398|FG001|Overall Study|Adverse Event|1|||
33359221|NCT00850499|101204397|FG000|Overall Study|Lack of Efficacy|0|||
33359222|NCT00850499|101204398|FG001|Overall Study|Lack of Efficacy|1|||
33359223|NCT00852930|101204399|FG000|Overall Study|Withdrawal by Subject|1|||
33359224|NCT00852930|101204400|FG001|Overall Study|Withdrawal by Subject|1|||
33359225|NCT00852930|101204401|FG002|Overall Study|Withdrawal by Subject|1|||
33359226|NCT00852930|101204399|FG000|Overall Study|Physician Decision|0|||
33359227|NCT00852930|101204400|FG001|Overall Study|Physician Decision|0|||
33359228|NCT00852930|101204401|FG002|Overall Study|Physician Decision|1|||
33359229|NCT02786537|101204402|FG000|As Randomized|Adverse Event|0|||
33359230|NCT02786537|101204403|FG001|As Randomized|Adverse Event|11|||
33359231|NCT02786537|101204404|FG002|As Randomized|Adverse Event|0|||
33359232|NCT02786537|101204405|FG003|As Randomized|Adverse Event|4|||
33359233|NCT02786537|101204406|FG004|As Randomized|Adverse Event|6|||
33359234|NCT02786537|101204407|FG005|As Randomized|Adverse Event|2|||
33359235|NCT02786537|101204402|FG000|As Randomized|Lack of Efficacy|0|||
33359236|NCT02786537|101204403|FG001|As Randomized|Lack of Efficacy|0|||
33359237|NCT02786537|101204404|FG002|As Randomized|Lack of Efficacy|0|||
33359238|NCT02786537|101204405|FG003|As Randomized|Lack of Efficacy|1|||
33560318|NCT01272219|101948903|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
33623683|NCT04737278|102172934|FG001|Overall Study|Protocol Violation|1|||
33623684|NCT04737278|102172933|FG000|Overall Study|failure to complete questionnaire|1|||
33623685|NCT04737278|102172934|FG001|Overall Study|failure to complete questionnaire|1|||
33623686|NCT01693029|102172935|FG000|Overall Study|Withdrawal by Subject|15|||
33623687|NCT01693029|102172936|FG001|Overall Study|Withdrawal by Subject|22|||
33560319|NCT01272219|101948904|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
33560320|NCT01272219|101948905|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
33560321|NCT01272219|101948906|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
33560322|NCT01272219|101948907|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
33560323|NCT01272219|101948908|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
33560324|NCT01272219|101948903|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
33560325|NCT01272219|101948904|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
33560326|NCT01272219|101948905|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
33560327|NCT01272219|101948906|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
33623688|NCT01693029|102172935|FG000|Overall Study|Kidney transplantation|7|||
33359239|NCT02786537|101204406|FG004|As Randomized|Lack of Efficacy|0|||
33359240|NCT02786537|101204407|FG005|As Randomized|Lack of Efficacy|0|||
33359241|NCT02786537|101204402|FG000|As Randomized|Withdrawal by Subject|1|||
33359242|NCT02786537|101204403|FG001|As Randomized|Withdrawal by Subject|2|||
33414620|NCT01915498|101409846|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33623689|NCT01693029|102172936|FG001|Overall Study|Kidney transplantation|7|||
33623690|NCT01693029|102172935|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
33414621|NCT01915498|101409847|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33623691|NCT01693029|102172936|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
33623692|NCT01693029|102172935|FG000|Overall Study|Protocol Violation|6|||
33359243|NCT02786537|101204404|FG002|As Randomized|Withdrawal by Subject|0|||
33359244|NCT02786537|101204405|FG003|As Randomized|Withdrawal by Subject|1|||
33359245|NCT02786537|101204406|FG004|As Randomized|Withdrawal by Subject|1|||
33359246|NCT02786537|101204407|FG005|As Randomized|Withdrawal by Subject|0|||
33359247|NCT02786537|101204402|FG000|As Randomized|Death|0|||
33359248|NCT02786537|101204403|FG001|As Randomized|Death|2|||
33359249|NCT02786537|101204404|FG002|As Randomized|Death|0|||
33219981|NCT00118716|100703186|FG001|Overall Study|Investigator discretion|1|||
33219982|NCT02238379|100703193|FG000|Overall Study|Lost to Follow-up|1|||
33219983|NCT02238379|100703194|FG001|Overall Study|Lost to Follow-up|0|||
33219984|NCT00621543|100703197|FG000|Overall Study|Lost to Follow-up|23|||
33359250|NCT02786537|101204405|FG003|As Randomized|Death|3|||
33359251|NCT02786537|101204406|FG004|As Randomized|Death|1|||
33359252|NCT02786537|101204407|FG005|As Randomized|Death|0|||
33359253|NCT02786537|101204402|FG000|As Randomized|Non-compliance with study drug|1|||
33359254|NCT02786537|101204403|FG001|As Randomized|Non-compliance with study drug|11|||
33359255|NCT02786537|101204404|FG002|As Randomized|Non-compliance with study drug|0|||
33359256|NCT02786537|101204405|FG003|As Randomized|Non-compliance with study drug|1|||
33359257|NCT02786537|101204406|FG004|As Randomized|Non-compliance with study drug|0|||
33359258|NCT02786537|101204407|FG005|As Randomized|Non-compliance with study drug|1|||
33359259|NCT02786537|101204402|FG000|As Randomized|Lost to treatment follow-up|4|||
33359260|NCT02786537|101204403|FG001|As Randomized|Lost to treatment follow-up|32|||
33219985|NCT02946918|100703202|FG000|Overall Study|Patient unblinded himself|1|||
33359261|NCT02786537|101204404|FG002|As Randomized|Lost to treatment follow-up|0|||
33359262|NCT02786537|101204405|FG003|As Randomized|Lost to treatment follow-up|24|||
33359263|NCT02786537|101204406|FG004|As Randomized|Lost to treatment follow-up|4|||
33359264|NCT02786537|101204407|FG005|As Randomized|Lost to treatment follow-up|4|||
33359265|NCT02786537|101204402|FG000|As Randomized|Incarceration|0|||
33359266|NCT02786537|101204403|FG001|As Randomized|Incarceration|1|||
33359267|NCT02786537|101204404|FG002|As Randomized|Incarceration|0|||
33359268|NCT02786537|101204405|FG003|As Randomized|Incarceration|0|||
33359269|NCT02786537|101204406|FG004|As Randomized|Incarceration|0|||
33359270|NCT02786537|101204407|FG005|As Randomized|Incarceration|0|||
33359271|NCT02786537|101204402|FG000|As Randomized|Opiate Dependency Relapse|0|||
33359272|NCT02786537|101204403|FG001|As Randomized|Opiate Dependency Relapse|1|||
33359273|NCT02786537|101204404|FG002|As Randomized|Opiate Dependency Relapse|0|||
33359274|NCT02786537|101204405|FG003|As Randomized|Opiate Dependency Relapse|0|||
33359275|NCT02786537|101204406|FG004|As Randomized|Opiate Dependency Relapse|0|||
33359276|NCT02786537|101204407|FG005|As Randomized|Opiate Dependency Relapse|0|||
33359277|NCT02786537|101204402|FG000|As Randomized|HCV drugs stolen from pt|0|||
33359278|NCT02786537|101204403|FG001|As Randomized|HCV drugs stolen from pt|1|||
33359279|NCT02786537|101204404|FG002|As Randomized|HCV drugs stolen from pt|0|||
33359280|NCT02786537|101204405|FG003|As Randomized|HCV drugs stolen from pt|0|||
33359281|NCT02786537|101204406|FG004|As Randomized|HCV drugs stolen from pt|0|||
33359282|NCT02786537|101204407|FG005|As Randomized|HCV drugs stolen from pt|0|||
33359283|NCT02786537|101204402|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
33359284|NCT02786537|101204403|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
33560328|NCT01272219|101948907|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
33560329|NCT01272219|101948908|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
33560330|NCT01272219|101948903|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
33560331|NCT01272219|101948904|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
33623693|NCT01693029|102172936|FG001|Overall Study|Protocol Violation|7|||
33414622|NCT01915498|101409848|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33359285|NCT02786537|101204404|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
33359286|NCT02786537|101204405|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
33359287|NCT02786537|101204406|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
33359288|NCT02786537|101204407|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
33359289|NCT02786537|101204402|FG000|As Randomized|Subject lost insurance|0|||
33414623|NCT01915498|101409849|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33414624|NCT01915498|101409850|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33623694|NCT01693029|102172935|FG000|Overall Study|Change in dialysis modality|2|||
33219986|NCT02946918|100703203|FG001|Overall Study|Patient unblinded himself|0|||
33219987|NCT02946918|100703202|FG000|Overall Study|Physician Decision|0|||
33359290|NCT02786537|101204403|FG001|As Randomized|Subject lost insurance|0|||
33359291|NCT02786537|101204404|FG002|As Randomized|Subject lost insurance|0|||
33359292|NCT02786537|101204405|FG003|As Randomized|Subject lost insurance|1|||
33414625|NCT01915498|101409851|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
33623695|NCT01693029|102172936|FG001|Overall Study|Change in dialysis modality|1|||
33560332|NCT01272219|101948905|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
33560333|NCT01272219|101948906|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
33560334|NCT01272219|101948907|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
33560335|NCT01272219|101948908|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
33560336|NCT01272219|101948903|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
33560337|NCT01272219|101948904|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
33560338|NCT01272219|101948905|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
33623696|NCT01693029|102172935|FG000|Overall Study|Physician Decision|0|||
33623697|NCT01693029|102172936|FG001|Overall Study|Physician Decision|2|||
33623698|NCT01693029|102172935|FG000|Overall Study|Lost to Follow-up|0|||
33623699|NCT01693029|102172936|FG001|Overall Study|Lost to Follow-up|1|||
33623700|NCT01693029|102172935|FG000|Overall Study|Adverse Event|1|||
33623701|NCT01693029|102172936|FG001|Overall Study|Adverse Event|6|||
33623702|NCT01693029|102172935|FG000|Overall Study|Death|5|||
33623703|NCT01693029|102172936|FG001|Overall Study|Death|8|||
33623704|NCT01693029|102172935|FG000|Overall Study|Non-compliance|2|||
33623705|NCT01693029|102172936|FG001|Overall Study|Non-compliance|1|||
33623706|NCT02813889|102172938|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
33359293|NCT02786537|101204406|FG004|As Randomized|Subject lost insurance|0|||
33359294|NCT02786537|101204407|FG005|As Randomized|Subject lost insurance|0|||
33623707|NCT02813889|102172939|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
33623708|NCT00796666|102172941|FG000|Overall Study|Death|2|||
33359295|NCT02786537|101204402|FG000|As Treated|Adverse Event|0|||
33359296|NCT02786537|101204403|FG001|As Treated|Adverse Event|11|||
33359297|NCT02786537|101204404|FG002|As Treated|Adverse Event|0|||
33359298|NCT02786537|101204405|FG003|As Treated|Adverse Event|4|||
33359299|NCT02786537|101204406|FG004|As Treated|Adverse Event|6|||
33359300|NCT02786537|101204407|FG005|As Treated|Adverse Event|2|||
33359301|NCT02786537|101204402|FG000|As Treated|Death|0|||
33359302|NCT02786537|101204403|FG001|As Treated|Death|2|||
33359303|NCT02786537|101204404|FG002|As Treated|Death|0|||
33560339|NCT01272219|101948906|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
33359304|NCT02786537|101204405|FG003|As Treated|Death|3|||
33359305|NCT02786537|101204406|FG004|As Treated|Death|1|||
33359306|NCT02786537|101204407|FG005|As Treated|Death|0|||
33359307|NCT02786537|101204402|FG000|As Treated|Lack of Efficacy|0|||
33359308|NCT02786537|101204403|FG001|As Treated|Lack of Efficacy|0|||
33359309|NCT02786537|101204404|FG002|As Treated|Lack of Efficacy|0|||
33359310|NCT02786537|101204405|FG003|As Treated|Lack of Efficacy|1|||
33359311|NCT02786537|101204406|FG004|As Treated|Lack of Efficacy|0|||
33359312|NCT02786537|101204407|FG005|As Treated|Lack of Efficacy|0|||
33560340|NCT01272219|101948907|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
33560341|NCT01272219|101948908|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
33560342|NCT01272219|101948903|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
33560343|NCT01272219|101948904|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
33560344|NCT01272219|101948905|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
33560345|NCT01272219|101948906|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
33560346|NCT01272219|101948907|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
33560347|NCT01272219|101948908|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
33623709|NCT00796666|102172942|FG001|Overall Study|Death|4|||
33623710|NCT00796666|102172941|FG000|Overall Study|Withdrawal by Subject|2|||
33623711|NCT00796666|102172942|FG001|Overall Study|Withdrawal by Subject|0|||
33560348|NCT01272219|101948903|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
33560349|NCT01272219|101948904|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
33560350|NCT01272219|101948905|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
33623712|NCT00796666|102172941|FG000|Overall Study|Adverse Event|7|||
33623713|NCT00796666|102172942|FG001|Overall Study|Adverse Event|5|||
33623714|NCT00796666|102172941|FG000|Overall Study|Protocol Violation|1|||
33623715|NCT00796666|102172942|FG001|Overall Study|Protocol Violation|0|||
33623716|NCT00796666|102172941|FG000|Overall Study|Other|1|||
33623717|NCT00796666|102172942|FG001|Overall Study|Other|0|||
33623718|NCT00796666|102172941|FG000|Overall Study|Terminated by sponsor|53|||
33623719|NCT00796666|102172942|FG001|Overall Study|Terminated by sponsor|55|||
33623720|NCT00796666|102172941|FG000|Overall Study|Randomized and not treated|1|||
33623721|NCT00796666|102172942|FG001|Overall Study|Randomized and not treated|0|||
33623722|NCT01177007|102172946|FG000|Overall Study|Lost to Follow-up|2|||
33623723|NCT01177007|102172946|FG000|Overall Study|Death|4|||
33623724|NCT01177007|102172946|FG000|Overall Study|Entered hospice care|5|||
33623725|NCT01177007|102172946|FG000|Overall Study|Required additional Y90 treatment|6|||
33623726|NCT01177007|102172946|FG000|Overall Study|Change in treatment modality|21|||
33623727|NCT02038153|102172947|FG000|Overall Study|Withdrawal by Subject|1|||
33623728|NCT03649217|102172948|FG000|Overall Study|subject had severe ataxia not initially found|1|||
33623729|NCT03649217|102172948|FG000|Overall Study|subject had cognitive issues not initially found|1|||
33623730|NCT00117637|102172949|FG000|First Intervention (Period 1)|Adverse Event|11|||
33623731|NCT00117637|102172950|FG001|First Intervention (Period 1)|Adverse Event|16|||
33623732|NCT00117637|102172949|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
33623733|NCT00117637|102172950|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
33623734|NCT00117637|102172949|FG000|First Intervention (Period 1)|Protocol Violation|1|||
33623735|NCT00117637|102172950|FG001|First Intervention (Period 1)|Protocol Violation|0|||
33623736|NCT00117637|102172949|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
33623737|NCT00117637|102172950|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
33623738|NCT00117637|102172949|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
33623739|NCT00117637|102172950|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
33623740|NCT00117637|102172949|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
33623741|NCT00117637|102172950|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
33623742|NCT00117637|102172949|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
33623743|NCT00117637|102172950|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
33623744|NCT00117637|102172949|FG000|First Intervention (Period 1)|reason not reported|0|||
33623745|NCT00117637|102172950|FG001|First Intervention (Period 1)|reason not reported|1|||
33623746|NCT00117637|102172949|FG000|Second Intervention (Period 2)|Adverse Event|0|||
33623747|NCT00117637|102172950|FG001|Second Intervention (Period 2)|Adverse Event|9|||
33623748|NCT00117637|102172949|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
33623749|NCT00117637|102172950|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
33623750|NCT00117637|102172949|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
33623751|NCT00117637|102172950|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
33623752|NCT00117637|102172949|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
33623753|NCT00117637|102172950|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
33623754|NCT00117637|102172949|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
33623755|NCT00117637|102172950|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
33623756|NCT00117637|102172949|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
33623757|NCT00117637|102172950|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
33623758|NCT00117637|102172949|FG000|Second Intervention (Period 2)|reason not reported|1|||
33359313|NCT02786537|101204402|FG000|As Treated|Lost to Follow-up|4|||
33560351|NCT01272219|101948906|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
33560352|NCT01272219|101948907|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
33359314|NCT02786537|101204403|FG001|As Treated|Lost to Follow-up|32|||
33359315|NCT02786537|101204404|FG002|As Treated|Lost to Follow-up|0|||
33560353|NCT01272219|101948908|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
33560354|NCT01272219|101948903|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
33560355|NCT01272219|101948904|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
33560356|NCT01272219|101948905|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
33560357|NCT01272219|101948906|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
33560358|NCT01272219|101948907|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
33560359|NCT01272219|101948908|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
33560360|NCT01272219|101948903|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
33560361|NCT01272219|101948904|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
33560362|NCT01272219|101948905|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
33560363|NCT01272219|101948906|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
33560364|NCT01272219|101948907|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
33560365|NCT01272219|101948908|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
33560366|NCT01272219|101948903|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
33560367|NCT01272219|101948904|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
33560368|NCT01272219|101948905|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
33560369|NCT01272219|101948906|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
33560370|NCT01272219|101948907|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
33560371|NCT01272219|101948908|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
33560372|NCT05430919|101948909|FG000|Overall Study|Protocol Violation|0|||
33560373|NCT05430919|101948910|FG001|Overall Study|Protocol Violation|0|||
33560374|NCT05430919|101948911|FG002|Overall Study|Protocol Violation|1|||
33560375|NCT05430919|101948912|FG003|Overall Study|Protocol Violation|0|||
33560376|NCT05430919|101948909|FG000|Overall Study|Lost to Follow-up|0|||
33560377|NCT05430919|101948910|FG001|Overall Study|Lost to Follow-up|1|||
33560378|NCT05430919|101948911|FG002|Overall Study|Lost to Follow-up|0|||
33560379|NCT05430919|101948912|FG003|Overall Study|Lost to Follow-up|0|||
33560380|NCT05430919|101948909|FG000|Overall Study|Withdrawal by Subject|3|||
33560381|NCT05430919|101948910|FG001|Overall Study|Withdrawal by Subject|0|||
33560382|NCT05430919|101948911|FG002|Overall Study|Withdrawal by Subject|0|||
33560383|NCT05430919|101948912|FG003|Overall Study|Withdrawal by Subject|1|||
33560384|NCT01275677|101948913|FG000|Overall Study|Not at risk for recurrence.|1|||
33560385|NCT01275677|101948914|FG001|Overall Study|Not at risk for recurrence.|1|||
33560386|NCT01275677|101948913|FG000|Overall Study|No follow-up|26|||
33560387|NCT01275677|101948914|FG001|Overall Study|No follow-up|37|||
33623759|NCT00117637|102172950|FG001|Second Intervention (Period 2)|reason not reported|0|||
33560388|NCT01275677|101948913|FG000|Overall Study|No clinical follow up.|1|||
33359316|NCT02786537|101204405|FG003|As Treated|Lost to Follow-up|25|||
33560389|NCT01275677|101948914|FG001|Overall Study|No clinical follow up.|4|||
33560390|NCT01908699|101948915|FG000|Overall Study|Adverse Event|8|||
33560391|NCT01908699|101948916|FG001|Overall Study|Adverse Event|12|||
33560392|NCT01908699|101948915|FG000|Overall Study|Lack of Efficacy|2|||
33219988|NCT02946918|100703203|FG001|Overall Study|Physician Decision|2|||
33219989|NCT02946918|100703202|FG000|Overall Study|Ran out of study medication|0|||
33560393|NCT01908699|101948916|FG001|Overall Study|Lack of Efficacy|2|||
33560394|NCT01908699|101948915|FG000|Overall Study|Lost to Follow-up|2|||
33560395|NCT01908699|101948916|FG001|Overall Study|Lost to Follow-up|4|||
33560396|NCT01908699|101948915|FG000|Overall Study|Physician Decision|8|||
33560397|NCT01908699|101948916|FG001|Overall Study|Physician Decision|8|||
33560398|NCT01908699|101948915|FG000|Overall Study|Withdrawal by Subject|15|||
33219990|NCT02946918|100703203|FG001|Overall Study|Ran out of study medication|1|||
33219991|NCT01699022|100703204|FG000|Overall Study|Early discontinuation from the study|3|||
33560399|NCT01908699|101948916|FG001|Overall Study|Withdrawal by Subject|10|||
33560400|NCT01908699|101948915|FG000|Overall Study|Pregnancy|0|||
33560401|NCT01908699|101948916|FG001|Overall Study|Pregnancy|1|||
33560402|NCT01908699|101948915|FG000|Overall Study|Randomized in Error|1|||
33560403|NCT01908699|101948916|FG001|Overall Study|Randomized in Error|0|||
33560404|NCT01908699|101948915|FG000|Overall Study|Death|9|||
33560405|NCT01908699|101948916|FG001|Overall Study|Death|12|||
33560406|NCT01908699|101948915|FG000|Overall Study|Progressive Disease|30|||
33560407|NCT01908699|101948916|FG001|Overall Study|Progressive Disease|29|||
33560408|NCT04590963|101948917|FG000|Overall Study|Death|118|||
33560409|NCT04590963|101948918|FG001|Overall Study|Death|59|||
33560410|NCT04590963|101948917|FG000|Overall Study|Lost to Follow-up|1|||
33623760|NCT01962441|102172951|FG000|Randomized Period|Randomized but Never Treated|4|||
33623761|NCT01962441|102172952|FG001|Randomized Period|Randomized but Never Treated|2|||
33623762|NCT01962441|102172953|FG002|Randomized Period|Randomized but Never Treated|3|||
33623763|NCT01962441|102172951|FG000|Randomized Period|Lost to Follow-up|2|||
33623764|NCT01962441|102172952|FG001|Randomized Period|Lost to Follow-up|4|||
33219992|NCT00394355|100703205|FG000|Overall Study|Adverse Event|10|||
33623765|NCT01962441|102172953|FG002|Randomized Period|Lost to Follow-up|4|||
33623766|NCT01962441|102172951|FG000|Randomized Period|Withdrew Consent|3|||
33623767|NCT01962441|102172952|FG001|Randomized Period|Withdrew Consent|3|||
33623768|NCT01962441|102172953|FG002|Randomized Period|Withdrew Consent|2|||
33623769|NCT01962441|102172951|FG000|Randomized Period|Adverse Event|1|||
33623770|NCT01962441|102172952|FG001|Randomized Period|Adverse Event|1|||
33623771|NCT01962441|102172953|FG002|Randomized Period|Adverse Event|0|||
33623772|NCT01962441|102172951|FG000|Randomized Period|Death|0|||
33623773|NCT01962441|102172952|FG001|Randomized Period|Death|0|||
33623774|NCT01962441|102172953|FG002|Randomized Period|Death|2|||
33623775|NCT01962441|102172951|FG000|Randomized Period|Protocol Violation|0|||
33623776|NCT01962441|102172952|FG001|Randomized Period|Protocol Violation|1|||
33623777|NCT01962441|102172953|FG002|Randomized Period|Protocol Violation|0|||
33623778|NCT01962441|102172951|FG000|Retreatment Substudy|Lack of Efficacy|1|||
33219993|NCT00394355|100703206|FG001|Overall Study|Adverse Event|6|||
33219994|NCT00394355|100703207|FG002|Overall Study|Adverse Event|7|||
33219995|NCT00394355|100703208|FG003|Overall Study|Adverse Event|8|||
33219996|NCT00394355|100703205|FG000|Overall Study|Did not meet protocol eligibility|1|||
33219997|NCT00394355|100703206|FG001|Overall Study|Did not meet protocol eligibility|5|||
33219998|NCT00394355|100703207|FG002|Overall Study|Did not meet protocol eligibility|4|||
33219999|NCT00394355|100703208|FG003|Overall Study|Did not meet protocol eligibility|2|||
33220000|NCT00394355|100703205|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
33560411|NCT04590963|101948918|FG001|Overall Study|Lost to Follow-up|1|||
33560412|NCT04590963|101948917|FG000|Overall Study|Progressive disease|0|||
33560413|NCT04590963|101948918|FG001|Overall Study|Progressive disease|1|||
33623779|NCT01962441|102172952|FG001|Retreatment Substudy|Lack of Efficacy|0|||
33623780|NCT01962441|102172953|FG002|Retreatment Substudy|Lack of Efficacy|0|||
33623781|NCT01962441|102172951|FG000|Retreatment Substudy|Lost to Follow-up|1|||
33359317|NCT02786537|101204406|FG004|As Treated|Lost to Follow-up|4|||
33623782|NCT01962441|102172952|FG001|Retreatment Substudy|Lost to Follow-up|0|||
33623783|NCT01962441|102172953|FG002|Retreatment Substudy|Lost to Follow-up|0|||
33623784|NCT00667888|102172954|FG000|Overall Study|Death|1|||
33560414|NCT04590963|101948917|FG000|Overall Study|Study terminated by sponsor|103|||
33560415|NCT04590963|101948918|FG001|Overall Study|Study terminated by sponsor|50|||
33560416|NCT04590963|101948917|FG000|Overall Study|Withdrawal by Subject|15|||
33560417|NCT04590963|101948918|FG001|Overall Study|Withdrawal by Subject|8|||
33560418|NCT04590963|101948917|FG000|Overall Study|Ongoing at data cut-off|9|||
33560419|NCT04590963|101948918|FG001|Overall Study|Ongoing at data cut-off|4|||
33560420|NCT04590963|101948917|FG000|Overall Study|Screen failure|1|||
33560421|NCT04590963|101948918|FG001|Overall Study|Screen failure|0|||
33560422|NCT02940223|101948919|FG000|Overall Study|Failed Requirement|2|||
33560423|NCT02940223|101948920|FG001|Overall Study|Failed Requirement|0|||
33560424|NCT04725188|101948921|FG000|Overall Study|Death|44|||
33560425|NCT04725188|101948922|FG001|Overall Study|Death|46|||
33560426|NCT04725188|101948923|FG002|Overall Study|Death|48|||
33560427|NCT04725188|101948921|FG000|Overall Study|Lost to Follow-up|0|||
33560428|NCT04725188|101948922|FG001|Overall Study|Lost to Follow-up|0|||
33560429|NCT04725188|101948923|FG002|Overall Study|Lost to Follow-up|1|||
33560430|NCT04725188|101948921|FG000|Overall Study|Withdrawal by Subject|2|||
33560431|NCT04725188|101948922|FG001|Overall Study|Withdrawal by Subject|2|||
33560432|NCT04725188|101948923|FG002|Overall Study|Withdrawal by Subject|1|||
33560433|NCT04725188|101948921|FG000|Overall Study|Participants ongoing in the study|41|||
33560434|NCT04725188|101948922|FG001|Overall Study|Participants ongoing in the study|35|||
33560435|NCT04725188|101948923|FG002|Overall Study|Participants ongoing in the study|35|||
33560436|NCT02496156|101948924|FG000|Overall Study|Lost to Follow-up|5|||
33359318|NCT02786537|101204407|FG005|As Treated|Lost to Follow-up|4|||
33359319|NCT02786537|101204402|FG000|As Treated|Non-compliance with study drug|1|||
33359320|NCT02786537|101204403|FG001|As Treated|Non-compliance with study drug|11|||
33359321|NCT02786537|101204404|FG002|As Treated|Non-compliance with study drug|0|||
33359322|NCT02786537|101204405|FG003|As Treated|Non-compliance with study drug|1|||
33359323|NCT02786537|101204406|FG004|As Treated|Non-compliance with study drug|0|||
33359324|NCT02786537|101204407|FG005|As Treated|Non-compliance with study drug|1|||
33359325|NCT02786537|101204402|FG000|As Treated|Lost insurance|0|||
33359326|NCT02786537|101204403|FG001|As Treated|Lost insurance|0|||
33359327|NCT02786537|101204404|FG002|As Treated|Lost insurance|0|||
33359328|NCT02786537|101204405|FG003|As Treated|Lost insurance|1|||
33359329|NCT02786537|101204406|FG004|As Treated|Lost insurance|0|||
33359330|NCT02786537|101204407|FG005|As Treated|Lost insurance|0|||
33359331|NCT02786537|101204402|FG000|As Treated|Withdrawal by Subject|1|||
33359332|NCT02786537|101204403|FG001|As Treated|Withdrawal by Subject|2|||
33359333|NCT02786537|101204404|FG002|As Treated|Withdrawal by Subject|0|||
33560437|NCT02496156|101948925|FG001|Overall Study|Lost to Follow-up|0|||
33560438|NCT02496156|101948924|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
33560439|NCT02496156|101948925|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
33560440|NCT03280615|101948926|FG000|Overall Study|Lost to Follow-up|1|||
33560441|NCT03280615|101948927|FG001|Overall Study|Lost to Follow-up|2|||
33560442|NCT03280615|101948926|FG000|Overall Study|Adverse Event|1|||
33560443|NCT03280615|101948927|FG001|Overall Study|Adverse Event|1|||
33560444|NCT03280615|101948926|FG000|Overall Study|Withdrawal by Subject|2|||
33560445|NCT03280615|101948927|FG001|Overall Study|Withdrawal by Subject|2|||
33560446|NCT03378635|101948928|FG000|Overall Study|Adverse Event|1|||
33359334|NCT02786537|101204405|FG003|As Treated|Withdrawal by Subject|0|||
33359335|NCT02786537|101204406|FG004|As Treated|Withdrawal by Subject|1|||
33359336|NCT02786537|101204407|FG005|As Treated|Withdrawal by Subject|0|||
33359337|NCT02786537|101204402|FG000|As Treated|Incarceration|0|||
33359338|NCT02786537|101204403|FG001|As Treated|Incarceration|1|||
33359339|NCT02786537|101204404|FG002|As Treated|Incarceration|0|||
33359340|NCT02786537|101204405|FG003|As Treated|Incarceration|0|||
33359341|NCT02786537|101204406|FG004|As Treated|Incarceration|0|||
33359342|NCT02786537|101204407|FG005|As Treated|Incarceration|0|||
33359343|NCT02786537|101204402|FG000|As Treated|Opiate dependency relapse|0|||
33359344|NCT02786537|101204403|FG001|As Treated|Opiate dependency relapse|1|||
33359345|NCT02786537|101204404|FG002|As Treated|Opiate dependency relapse|0|||
33359346|NCT02786537|101204405|FG003|As Treated|Opiate dependency relapse|0|||
33359347|NCT02786537|101204406|FG004|As Treated|Opiate dependency relapse|0|||
33359348|NCT02786537|101204407|FG005|As Treated|Opiate dependency relapse|0|||
33359349|NCT02786537|101204402|FG000|As Treated|Drugs stolen from patient|0|||
33359350|NCT02786537|101204403|FG001|As Treated|Drugs stolen from patient|1|||
33359351|NCT02786537|101204404|FG002|As Treated|Drugs stolen from patient|0|||
33359352|NCT02786537|101204405|FG003|As Treated|Drugs stolen from patient|0|||
33359353|NCT02786537|101204406|FG004|As Treated|Drugs stolen from patient|0|||
33359354|NCT02786537|101204407|FG005|As Treated|Drugs stolen from patient|0|||
33359355|NCT02786537|101204402|FG000|As Treated|Advised to stop tx after loss of meds|0|||
33560447|NCT03378635|101948929|FG001|Overall Study|Adverse Event|0|||
33560448|NCT03378635|101948930|FG002|Overall Study|Adverse Event|0|||
33560449|NCT03378635|101948928|FG000|Overall Study|Withdrawal by Subject|1|||
33359356|NCT02786537|101204403|FG001|As Treated|Advised to stop tx after loss of meds|1|||
33359357|NCT02786537|101204404|FG002|As Treated|Advised to stop tx after loss of meds|0|||
33359358|NCT02786537|101204405|FG003|As Treated|Advised to stop tx after loss of meds|0|||
33359359|NCT02786537|101204406|FG004|As Treated|Advised to stop tx after loss of meds|0|||
33359360|NCT02786537|101204407|FG005|As Treated|Advised to stop tx after loss of meds|0|||
33560450|NCT03378635|101948929|FG001|Overall Study|Withdrawal by Subject|0|||
33560451|NCT03378635|101948930|FG002|Overall Study|Withdrawal by Subject|0|||
33560452|NCT00866775|101948931|FG000|Overall Study|Adverse Event|5|||
33560453|NCT00866775|101948932|FG001|Overall Study|Adverse Event|19|||
33359361|NCT01824602|101204408|FG000|Overall Study|Withdrawal by Subject|0|||
33359362|NCT01824602|101204409|FG001|Overall Study|Withdrawal by Subject|0|||
33359363|NCT01824602|101204410|FG002|Overall Study|Withdrawal by Subject|1|||
33359364|NCT01824602|101204411|FG003|Overall Study|Withdrawal by Subject|2|||
33359365|NCT01824602|101204408|FG000|Overall Study|Patient non-compliance|0|||
33560454|NCT00866775|101948931|FG000|Overall Study|Death|1|||
33560455|NCT00866775|101948932|FG001|Overall Study|Death|0|||
33560456|NCT00866775|101948931|FG000|Overall Study|Lost to Follow-up|0|||
33560457|NCT00866775|101948932|FG001|Overall Study|Lost to Follow-up|4|||
33560458|NCT00866775|101948931|FG000|Overall Study|Physician Decision|0|||
33560459|NCT00866775|101948932|FG001|Overall Study|Physician Decision|3|||
33560460|NCT00866775|101948931|FG000|Overall Study|Protocol Violation|3|||
33560461|NCT00866775|101948932|FG001|Overall Study|Protocol Violation|4|||
33560462|NCT00866775|101948931|FG000|Overall Study|Withdrawal by Subject|4|||
33560463|NCT00866775|101948932|FG001|Overall Study|Withdrawal by Subject|4|||
33560464|NCT00866775|101948931|FG000|Overall Study|met exit criteria|23|||
33560465|NCT00866775|101948932|FG001|Overall Study|met exit criteria|17|||
33560466|NCT00866775|101948931|FG000|Overall Study|discontinued due to communication error|0|||
33560467|NCT00866775|101948932|FG001|Overall Study|discontinued due to communication error|1|||
33560468|NCT02184442|101948939|FG000|Overall Study|Death|61|||
33560469|NCT02184442|101948940|FG001|Overall Study|Death|65|||
33560470|NCT02184442|101948939|FG000|Overall Study|Withdrawal by Subject|3|||
33560471|NCT02184442|101948940|FG001|Overall Study|Withdrawal by Subject|11|||
33560472|NCT02554474|101948943|FG000|Overall Study|Protocol Violation|1|||
33560473|NCT02554474|101948944|FG001|Overall Study|Protocol Violation|1|||
33560474|NCT02554474|101948943|FG000|Overall Study|Health issue not related to the study|1|||
33560475|NCT02554474|101948944|FG001|Overall Study|Health issue not related to the study|0|||
33560476|NCT02554474|101948943|FG000|Overall Study|Withdrawal by Subject|1|||
33560477|NCT02554474|101948944|FG001|Overall Study|Withdrawal by Subject|1|||
33560478|NCT04562090|101948945|FG000|Overall Study|Withdrawal by Subject|3|||
33560479|NCT04562090|101948946|FG001|Overall Study|Withdrawal by Subject|4|||
33560480|NCT04562090|101948945|FG000|Overall Study|Protocol Violation|2|||
33560481|NCT04562090|101948946|FG001|Overall Study|Protocol Violation|0|||
33560482|NCT04562090|101948945|FG000|Overall Study|Lack of Efficacy|0|||
33560483|NCT04562090|101948946|FG001|Overall Study|Lack of Efficacy|1|||
33560484|NCT04562090|101948945|FG000|Overall Study|Adverse Event|1|||
33560485|NCT04562090|101948946|FG001|Overall Study|Adverse Event|4|||
33560486|NCT04562090|101948945|FG000|Overall Study|Miscellaneous|0|||
33560487|NCT04562090|101948946|FG001|Overall Study|Miscellaneous|3|||
33560488|NCT00787800|101948947|FG000|Overall Study|Withdrawal by Subject|3|||
33560489|NCT00787800|101948948|FG001|Overall Study|Withdrawal by Subject|5|||
33560490|NCT00787800|101948947|FG000|Overall Study|Death|0|||
33560491|NCT00787800|101948948|FG001|Overall Study|Death|2|||
33560492|NCT00504556|101948949|FG000|Overall Study|Adverse Event|11|||
33560493|NCT00504556|101948950|FG001|Overall Study|Adverse Event|11|||
33560494|NCT00504556|101948951|FG002|Overall Study|Adverse Event|14|||
33560495|NCT00504556|101948952|FG003|Overall Study|Adverse Event|13|||
33560496|NCT00504556|101948953|FG004|Overall Study|Adverse Event|5|||
33560497|NCT00504556|101948949|FG000|Overall Study|Death|3|||
33560498|NCT00504556|101948950|FG001|Overall Study|Death|3|||
33560499|NCT00504556|101948951|FG002|Overall Study|Death|1|||
33560500|NCT00504556|101948952|FG003|Overall Study|Death|0|||
33560501|NCT00504556|101948953|FG004|Overall Study|Death|2|||
33560502|NCT00504556|101948949|FG000|Overall Study|Protocol Violation|1|||
33560503|NCT00504556|101948950|FG001|Overall Study|Protocol Violation|3|||
33560504|NCT00504556|101948951|FG002|Overall Study|Protocol Violation|2|||
33560505|NCT00504556|101948952|FG003|Overall Study|Protocol Violation|1|||
33560506|NCT00504556|101948953|FG004|Overall Study|Protocol Violation|2|||
33560507|NCT00504556|101948949|FG000|Overall Study|Lost to Follow-up|0|||
33359366|NCT01824602|101204409|FG001|Overall Study|Patient non-compliance|0|||
33359367|NCT01824602|101204410|FG002|Overall Study|Patient non-compliance|1|||
33359368|NCT01824602|101204411|FG003|Overall Study|Patient non-compliance|0|||
33359369|NCT01824602|101204408|FG000|Overall Study|Adverse Event|1|||
33560508|NCT00504556|101948950|FG001|Overall Study|Lost to Follow-up|0|||
33560509|NCT00504556|101948951|FG002|Overall Study|Lost to Follow-up|1|||
33560510|NCT00504556|101948952|FG003|Overall Study|Lost to Follow-up|1|||
33359370|NCT01824602|101204409|FG001|Overall Study|Adverse Event|0|||
33359371|NCT01824602|101204410|FG002|Overall Study|Adverse Event|2|||
33359372|NCT01824602|101204411|FG003|Overall Study|Adverse Event|2|||
33560511|NCT00504556|101948953|FG004|Overall Study|Lost to Follow-up|1|||
33560512|NCT00504556|101948949|FG000|Overall Study|Withdrawal by Subject|16|||
33560513|NCT00504556|101948950|FG001|Overall Study|Withdrawal by Subject|16|||
33560514|NCT00504556|101948951|FG002|Overall Study|Withdrawal by Subject|7|||
33560515|NCT00504556|101948952|FG003|Overall Study|Withdrawal by Subject|8|||
33560516|NCT00504556|101948953|FG004|Overall Study|Withdrawal by Subject|12|||
33560517|NCT00504556|101948949|FG000|Overall Study|administrative reasons|0|||
33560518|NCT00504556|101948950|FG001|Overall Study|administrative reasons|2|||
33560519|NCT00504556|101948951|FG002|Overall Study|administrative reasons|2|||
33560520|NCT00504556|101948952|FG003|Overall Study|administrative reasons|1|||
33560521|NCT00504556|101948953|FG004|Overall Study|administrative reasons|2|||
33560522|NCT00504556|101948949|FG000|Overall Study|did not meet entry criteria|2|||
33560523|NCT00504556|101948950|FG001|Overall Study|did not meet entry criteria|0|||
33560524|NCT00504556|101948951|FG002|Overall Study|did not meet entry criteria|1|||
33560525|NCT00504556|101948952|FG003|Overall Study|did not meet entry criteria|1|||
33560526|NCT00504556|101948953|FG004|Overall Study|did not meet entry criteria|0|||
33560527|NCT00504556|101948949|FG000|Overall Study|data monitor committee decision|0|||
33560528|NCT00504556|101948950|FG001|Overall Study|data monitor committee decision|0|||
33560529|NCT00504556|101948951|FG002|Overall Study|data monitor committee decision|0|||
33560530|NCT00504556|101948952|FG003|Overall Study|data monitor committee decision|100|||
33560531|NCT00504556|101948953|FG004|Overall Study|data monitor committee decision|0|||
33560532|NCT00504556|101948949|FG000|Overall Study|Other|2|||
33560533|NCT00504556|101948950|FG001|Overall Study|Other|2|||
33560534|NCT00504556|101948951|FG002|Overall Study|Other|2|||
33560535|NCT00504556|101948952|FG003|Overall Study|Other|3|||
33560536|NCT00504556|101948953|FG004|Overall Study|Other|0|||
33560537|NCT00504556|101948949|FG000|Overall Study|not in safety analysis set|0|||
33560538|NCT00504556|101948950|FG001|Overall Study|not in safety analysis set|1|||
33560539|NCT00504556|101948951|FG002|Overall Study|not in safety analysis set|1|||
33560540|NCT00504556|101948952|FG003|Overall Study|not in safety analysis set|0|||
33560541|NCT00504556|101948953|FG004|Overall Study|not in safety analysis set|1|||
33560542|NCT03810365|101948954|FG000|Overall Study|Lost to Follow-up|2|||
33560543|NCT03810365|101948955|FG001|Overall Study|Lost to Follow-up|2|||
33560544|NCT03810365|101948954|FG000|Overall Study|Withdrawal by Subject|4|||
33560545|NCT03810365|101948955|FG001|Overall Study|Withdrawal by Subject|5|||
33560546|NCT02365064|101948957|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
33560547|NCT02365064|101948958|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
33560548|NCT02365064|101948957|FG000|Overall Study|Withdrawal by Subject|6|||
33560549|NCT02365064|101948958|FG001|Overall Study|Withdrawal by Subject|9|||
33560550|NCT02365064|101948957|FG000|Overall Study|Treatment intolerance|2|||
33560551|NCT02365064|101948958|FG001|Overall Study|Treatment intolerance|4|||
33560552|NCT02544763|101948960|FG000|Overall Study|Adverse Event|8|||
33560553|NCT02544763|101948961|FG001|Overall Study|Adverse Event|8|||
33560554|NCT02544763|101948962|FG002|Overall Study|Adverse Event|0|||
33560555|NCT02544763|101948960|FG000|Overall Study|Withdrawn by parent/guardian|1|||
33560556|NCT02544763|101948961|FG001|Overall Study|Withdrawn by parent/guardian|1|||
33560557|NCT02544763|101948962|FG002|Overall Study|Withdrawn by parent/guardian|1|||
33560558|NCT02544763|101948960|FG000|Overall Study|Met withdrawal criteria|0|||
33560559|NCT02544763|101948961|FG001|Overall Study|Met withdrawal criteria|2|||
33560560|NCT02544763|101948962|FG002|Overall Study|Met withdrawal criteria|0|||
33560561|NCT02544763|101948960|FG000|Overall Study|Physician Decision|0|||
33560562|NCT02544763|101948961|FG001|Overall Study|Physician Decision|1|||
33560563|NCT02544763|101948962|FG002|Overall Study|Physician Decision|0|||
33560564|NCT02544763|101948960|FG000|Overall Study|Difficulties taking IMP|1|||
33560565|NCT02544763|101948961|FG001|Overall Study|Difficulties taking IMP|0|||
33560566|NCT02544763|101948962|FG002|Overall Study|Difficulties taking IMP|0|||
33560567|NCT02691494|101948963|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
33560568|NCT02691494|101948964|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
33560569|NCT02691494|101948965|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
33560570|NCT02691494|101948963|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
33560571|NCT02691494|101948964|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
33560572|NCT02691494|101948965|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
33560573|NCT02691494|101948963|FG000|Post-Treatment Follow-Up Period|Other|2|||
33560574|NCT02691494|101948964|FG001|Post-Treatment Follow-Up Period|Other|1|||
33220001|NCT00394355|100703206|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
33560575|NCT02691494|101948965|FG002|Post-Treatment Follow-Up Period|Other|1|||
33560576|NCT02691494|101948963|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
33560577|NCT02691494|101948964|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
33560578|NCT02691494|101948965|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
33220002|NCT00394355|100703207|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
33560579|NCT02691494|101948963|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
33560580|NCT02691494|101948964|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
33560581|NCT02691494|101948965|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
33560582|NCT02011542|101948966|FG000|Overall Study|Physician Decision|1|||
33560583|NCT03878602|101948970|FG000|Overall Study|cord blood donation|7|||
33560584|NCT03878602|101948971|FG001|Overall Study|cord blood donation|1|||
33560585|NCT03878602|101948970|FG000|Overall Study|incomplete data collection|2|||
33560586|NCT03878602|101948971|FG001|Overall Study|incomplete data collection|0|||
33560587|NCT01897896|101948972|FG000|Overall Study|Death|1|||
33560588|NCT01897896|101948973|FG001|Overall Study|Death|0|||
33560589|NCT01897896|101948972|FG000|Overall Study|Adverse Event|11|||
33560590|NCT01897896|101948973|FG001|Overall Study|Adverse Event|1|||
33560591|NCT01897896|101948972|FG000|Overall Study|Lost to Follow-up|1|||
33560592|NCT01897896|101948973|FG001|Overall Study|Lost to Follow-up|0|||
33560593|NCT01897896|101948972|FG000|Overall Study|Non-compliance with study drug dosing|1|||
33560594|NCT01897896|101948973|FG001|Overall Study|Non-compliance with study drug dosing|1|||
33560595|NCT01897896|101948972|FG000|Overall Study|Withdrawal by Subject|7|||
33560596|NCT01897896|101948973|FG001|Overall Study|Withdrawal by Subject|1|||
33560597|NCT01897896|101948972|FG000|Overall Study|Require drug that interfere with study|1|||
33560598|NCT01897896|101948973|FG001|Overall Study|Require drug that interfere with study|4|||
33560599|NCT01897896|101948972|FG000|Overall Study|Protocol Violation|1|||
33560600|NCT01897896|101948973|FG001|Overall Study|Protocol Violation|1|||
33560601|NCT01897896|101948972|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
33560602|NCT01897896|101948973|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
33560603|NCT01897896|101948972|FG000|Overall Study|Caregiver can no longer participate|0|||
33560604|NCT01897896|101948973|FG001|Overall Study|Caregiver can no longer participate|2|||
33560605|NCT01897896|101948972|FG000|Overall Study|Other than specified|2|||
33560606|NCT01897896|101948973|FG001|Overall Study|Other than specified|1|||
33560607|NCT01916226|101948975|FG000|Overall Study|Adverse Event|1|||
33560608|NCT01916226|101948976|FG001|Overall Study|Adverse Event|0|||
33220003|NCT00394355|100703208|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
33359373|NCT01824602|101204408|FG000|Overall Study|Treatment failure|0|||
33359374|NCT01824602|101204409|FG001|Overall Study|Treatment failure|0|||
33359375|NCT01824602|101204410|FG002|Overall Study|Treatment failure|0|||
33359376|NCT01824602|101204411|FG003|Overall Study|Treatment failure|1|||
33359377|NCT02623361|101204415|FG000|Overall Study|Protocol Violation|0|||
33359378|NCT02623361|101204416|FG001|Overall Study|Protocol Violation|1|||
33359379|NCT02623361|101204415|FG000|Overall Study|Withdrawal by Subject|0|||
33560609|NCT01916226|101948977|FG002|Overall Study|Adverse Event|1|||
33560610|NCT01916226|101948978|FG003|Overall Study|Adverse Event|1|||
33560611|NCT01916226|101948975|FG000|Overall Study|Lack of Efficacy|0|||
33560612|NCT01916226|101948976|FG001|Overall Study|Lack of Efficacy|0|||
33560613|NCT01916226|101948977|FG002|Overall Study|Lack of Efficacy|2|||
33560614|NCT01916226|101948978|FG003|Overall Study|Lack of Efficacy|1|||
33220004|NCT00394355|100703205|FG000|Overall Study|Subject withdrawal - related to drug|1|||
33359380|NCT02623361|101204416|FG001|Overall Study|Withdrawal by Subject|1|||
33560615|NCT01916226|101948975|FG000|Overall Study|Protocol Violation|0|||
33560616|NCT01916226|101948976|FG001|Overall Study|Protocol Violation|1|||
33560617|NCT01916226|101948977|FG002|Overall Study|Protocol Violation|0|||
33560618|NCT01916226|101948978|FG003|Overall Study|Protocol Violation|1|||
33359381|NCT02873221|101204420|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
33359382|NCT02873221|101204421|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
33359383|NCT02873221|101204422|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
33359384|NCT02873221|101204420|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
33359385|NCT02873221|101204421|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
33359386|NCT02873221|101204422|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
33359387|NCT02873221|101204420|FG000|Treatment Period|Protocol Violation|2|||
33359388|NCT02873221|101204421|FG001|Treatment Period|Protocol Violation|5|||
33560619|NCT01916226|101948975|FG000|Overall Study|Physician Decision|0|||
33560620|NCT01916226|101948976|FG001|Overall Study|Physician Decision|0|||
33560621|NCT01916226|101948977|FG002|Overall Study|Physician Decision|0|||
33560622|NCT01916226|101948978|FG003|Overall Study|Physician Decision|1|||
33560623|NCT00124657|101948979|FG000|Overall Study|Toxicity|0|||
33560624|NCT00124657|101948980|FG001|Overall Study|Toxicity|0|||
33560625|NCT00124657|101948981|FG002|Overall Study|Toxicity|1|||
33560626|NCT00124657|101948979|FG000|Overall Study|Non-compliance|1|||
33560627|NCT00124657|101948980|FG001|Overall Study|Non-compliance|0|||
33560628|NCT00124657|101948981|FG002|Overall Study|Non-compliance|4|||
33560629|NCT00124657|101948979|FG000|Overall Study|Progressive disease|14|||
33560630|NCT00124657|101948980|FG001|Overall Study|Progressive disease|5|||
33560631|NCT00124657|101948981|FG002|Overall Study|Progressive disease|27|||
33560632|NCT00124657|101948979|FG000|Overall Study|Intercurrent illness|1|||
33560633|NCT00124657|101948980|FG001|Overall Study|Intercurrent illness|0|||
33560634|NCT00124657|101948981|FG002|Overall Study|Intercurrent illness|0|||
33560635|NCT01608308|101948986|FG000|Overall Study|pretreatment medical and billing reasons|0|||
33560636|NCT01608308|101948987|FG001|Overall Study|pretreatment medical and billing reasons|2|||
33560637|NCT00128492|101948988|FG000|Overall Study|AE unrelated to study|2|||
33560638|NCT00128492|101948989|FG001|Overall Study|AE unrelated to study|9|||
33560639|NCT00128492|101948988|FG000|Overall Study|Study drug intolerance (AE)|2|||
33560640|NCT00128492|101948989|FG001|Overall Study|Study drug intolerance (AE)|8|||
33560641|NCT00128492|101948988|FG000|Overall Study|AE related to study|1|||
33560642|NCT00128492|101948989|FG001|Overall Study|AE related to study|4|||
33560643|NCT00128492|101948988|FG000|Overall Study|Death|1|||
33560644|NCT00128492|101948989|FG001|Overall Study|Death|0|||
33560645|NCT00128492|101948988|FG000|Overall Study|Lost to Follow-up|1|||
33560646|NCT00128492|101948989|FG001|Overall Study|Lost to Follow-up|5|||
33560647|NCT00128492|101948988|FG000|Overall Study|Noncompliance|0|||
33560648|NCT00128492|101948989|FG001|Overall Study|Noncompliance|5|||
33560649|NCT00128492|101948988|FG000|Overall Study|Personal or administrative|10|||
33560650|NCT00128492|101948989|FG001|Overall Study|Personal or administrative|22|||
33560651|NCT00128492|101948988|FG000|Overall Study|Withdrawal by Subject|3|||
33623785|NCT00667888|102172955|FG001|Overall Study|Death|1|||
33623786|NCT00667888|102172954|FG000|Overall Study|Withdrawal by Subject|6|||
33623787|NCT00667888|102172955|FG001|Overall Study|Withdrawal by Subject|3|||
33623788|NCT00667888|102172954|FG000|Overall Study|Proceed with other treatment|3|||
33623789|NCT00667888|102172955|FG001|Overall Study|Proceed with other treatment|3|||
33623790|NCT00667888|102172954|FG000|Overall Study|Ineligible after SIM|0|||
33623791|NCT00667888|102172955|FG001|Overall Study|Ineligible after SIM|2|||
33623792|NCT02719171|102172956|FG000|Overall Study|Adverse Event|1|||
33623793|NCT02719171|102172957|FG001|Overall Study|Adverse Event|2|||
33623794|NCT02719171|102172958|FG002|Overall Study|Adverse Event|0|||
33623795|NCT02719171|102172959|FG003|Overall Study|Adverse Event|0|||
33623796|NCT02719171|102172960|FG004|Overall Study|Adverse Event|2|||
33623797|NCT02719171|102172956|FG000|Overall Study|Lost to Follow-up|0|||
33220005|NCT00394355|100703206|FG001|Overall Study|Subject withdrawal - related to drug|0|||
33359389|NCT02873221|101204422|FG002|Treatment Period|Protocol Violation|8|||
33359390|NCT02873221|101204420|FG000|Treatment Period|Pregnancy|4|||
33359391|NCT02873221|101204421|FG001|Treatment Period|Pregnancy|6|||
33359392|NCT02873221|101204422|FG002|Treatment Period|Pregnancy|3|||
33359393|NCT02873221|101204420|FG000|Treatment Period|Lack of Qualifying Event|0|||
33359394|NCT02873221|101204421|FG001|Treatment Period|Lack of Qualifying Event|3|||
33359395|NCT02873221|101204422|FG002|Treatment Period|Lack of Qualifying Event|1|||
33414626|NCT01915498|101409852|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33414627|NCT01915498|101409853|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33220006|NCT00394355|100703207|FG002|Overall Study|Subject withdrawal - related to drug|0|||
33560652|NCT00128492|101948989|FG001|Overall Study|Withdrawal by Subject|5|||
33560653|NCT00128492|101948988|FG000|Overall Study|Pregnancy|0|||
33560654|NCT00128492|101948989|FG001|Overall Study|Pregnancy|1|||
33623798|NCT02719171|102172957|FG001|Overall Study|Lost to Follow-up|0|||
33623799|NCT02719171|102172958|FG002|Overall Study|Lost to Follow-up|1|||
33560655|NCT03301415|101948990|FG000|Overall Study|Lost to Follow-up|2|||
33560656|NCT03301415|101948990|FG000|Overall Study|Unable to comply with visit schedule|2|||
33560657|NCT00382863|101948991|FG000|Overall Study|Death|9|||
33560658|NCT00382863|101948992|FG001|Overall Study|Death|9|||
33560659|NCT00382863|101948991|FG000|Overall Study|Lost to Follow-up|1|||
33623800|NCT02719171|102172959|FG003|Overall Study|Lost to Follow-up|0|||
33220007|NCT00394355|100703208|FG003|Overall Study|Subject withdrawal - related to drug|0|||
33220008|NCT00394355|100703205|FG000|Overall Study|Lost to Follow-up|7|||
33220009|NCT00394355|100703206|FG001|Overall Study|Lost to Follow-up|5|||
33220010|NCT00394355|100703207|FG002|Overall Study|Lost to Follow-up|4|||
33359396|NCT02873221|101204420|FG000|Treatment Period|Withdrawal of Consent|52|||
33359397|NCT02873221|101204421|FG001|Treatment Period|Withdrawal of Consent|51|||
33359398|NCT02873221|101204422|FG002|Treatment Period|Withdrawal of Consent|41|||
33359399|NCT02873221|101204420|FG000|Treatment Period|Lack of Efficacy|0|||
33359400|NCT02873221|101204421|FG001|Treatment Period|Lack of Efficacy|17|||
33220011|NCT00394355|100703208|FG003|Overall Study|Lost to Follow-up|3|||
33220012|NCT00394355|100703205|FG000|Overall Study|Noncompliance with protocol|4|||
33220013|NCT00394355|100703206|FG001|Overall Study|Noncompliance with protocol|3|||
33220014|NCT00394355|100703207|FG002|Overall Study|Noncompliance with protocol|10|||
33220015|NCT00394355|100703208|FG003|Overall Study|Noncompliance with protocol|8|||
33220016|NCT00394355|100703205|FG000|Overall Study|Administrative|0|||
33220017|NCT00394355|100703206|FG001|Overall Study|Administrative|1|||
33220018|NCT00394355|100703207|FG002|Overall Study|Administrative|1|||
33220019|NCT00394355|100703208|FG003|Overall Study|Administrative|1|||
33220020|NCT00394355|100703205|FG000|Overall Study|Lack of Efficacy|0|||
33220021|NCT00394355|100703206|FG001|Overall Study|Lack of Efficacy|0|||
33220022|NCT00394355|100703207|FG002|Overall Study|Lack of Efficacy|2|||
33220023|NCT00394355|100703208|FG003|Overall Study|Lack of Efficacy|3|||
33220024|NCT03764072|100703209|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
33220025|NCT03764072|100703210|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
33220026|NCT03764072|100703211|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
33220027|NCT03764072|100703212|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
33220028|NCT03764072|100703213|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
33220029|NCT03764072|100703214|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
33220030|NCT03764072|100703209|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
33220031|NCT03764072|100703210|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
33220032|NCT03764072|100703211|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
33220033|NCT03764072|100703212|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
33220034|NCT03764072|100703213|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
33220035|NCT03764072|100703214|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
33220036|NCT03764072|100703209|FG000|Overall Study|Lost to Follow-up|0|||
33220037|NCT03764072|100703210|FG001|Overall Study|Lost to Follow-up|0|||
33220038|NCT03764072|100703211|FG002|Overall Study|Lost to Follow-up|0|||
33220039|NCT03764072|100703212|FG003|Overall Study|Lost to Follow-up|0|||
33220040|NCT03764072|100703213|FG004|Overall Study|Lost to Follow-up|1|||
33220041|NCT03764072|100703214|FG005|Overall Study|Lost to Follow-up|0|||
33220042|NCT02114151|100703227|FG000|Overall Study|Death|1|||
33220043|NCT02114151|100703227|FG000|Overall Study|Lost to Follow-up|1|||
33220044|NCT02114151|100703227|FG000|Overall Study|Withdrawal by Subject|5|||
33220045|NCT02124265|100703228|FG000|Overall Study|Adverse Event|1|||
33359401|NCT02873221|101204422|FG002|Treatment Period|Lack of Efficacy|12|||
33359402|NCT02873221|101204420|FG000|Treatment Period|Adverse Event|4|||
33359403|NCT02873221|101204421|FG001|Treatment Period|Adverse Event|9|||
33359404|NCT02873221|101204422|FG002|Treatment Period|Adverse Event|11|||
33560660|NCT00382863|101948992|FG001|Overall Study|Lost to Follow-up|2|||
33560661|NCT00382863|101948991|FG000|Overall Study|Withdrawal by Subject|5|||
33560662|NCT00382863|101948992|FG001|Overall Study|Withdrawal by Subject|25|||
33560663|NCT03715829|101948993|FG000|Dose Ranging Period|Adverse Event|2|||
33560664|NCT03715829|101948994|FG001|Dose Ranging Period|Adverse Event|4|||
33560665|NCT03715829|101948995|FG002|Dose Ranging Period|Adverse Event|5|||
33560666|NCT03715829|101948996|FG003|Dose Ranging Period|Adverse Event|2|||
33560667|NCT03715829|101948997|FG004|Dose Ranging Period|Adverse Event|3|||
33560668|NCT03715829|101948998|FG005|Dose Ranging Period|Adverse Event|3|||
33560669|NCT03715829|101948999|FG006|Dose Ranging Period|Adverse Event|0|||
33560670|NCT03715829|101949000|FG007|Dose Ranging Period|Adverse Event|0|||
33560671|NCT03715829|101949001|FG008|Dose Ranging Period|Adverse Event|0|||
33560672|NCT03715829|101949002|FG009|Dose Ranging Period|Adverse Event|0|||
33560673|NCT03715829|101949003|FG010|Dose Ranging Period|Adverse Event|0|||
33560674|NCT03715829|101948993|FG000|Dose Ranging Period|Lack of Efficacy|0|||
33560675|NCT03715829|101948994|FG001|Dose Ranging Period|Lack of Efficacy|1|||
33560676|NCT03715829|101948995|FG002|Dose Ranging Period|Lack of Efficacy|0|||
33560677|NCT03715829|101948996|FG003|Dose Ranging Period|Lack of Efficacy|1|||
33560678|NCT03715829|101948997|FG004|Dose Ranging Period|Lack of Efficacy|0|||
33560679|NCT03715829|101948998|FG005|Dose Ranging Period|Lack of Efficacy|0|||
33560680|NCT03715829|101948999|FG006|Dose Ranging Period|Lack of Efficacy|0|||
33560681|NCT03715829|101949000|FG007|Dose Ranging Period|Lack of Efficacy|0|||
33560682|NCT03715829|101949001|FG008|Dose Ranging Period|Lack of Efficacy|0|||
33220046|NCT02390531|100703229|FG000|Overall Study|Death|0|||
33220047|NCT02390531|100703230|FG001|Overall Study|Death|2|||
33220048|NCT02390531|100703231|FG002|Overall Study|Death|0|||
33220049|NCT02390531|100703232|FG003|Overall Study|Death|1|||
33220050|NCT02390531|100703233|FG004|Overall Study|Death|0|||
33220051|NCT02390531|100703234|FG005|Overall Study|Death|0|||
33220052|NCT02390531|100703235|FG006|Overall Study|Death|0|||
33220053|NCT02390531|100703236|FG007|Overall Study|Death|1|||
33220054|NCT02390531|100703229|FG000|Overall Study|Protocol Violation|0|||
33220055|NCT02390531|100703230|FG001|Overall Study|Protocol Violation|0|||
33220056|NCT02390531|100703231|FG002|Overall Study|Protocol Violation|0|||
33220057|NCT02390531|100703232|FG003|Overall Study|Protocol Violation|0|||
33220058|NCT02390531|100703233|FG004|Overall Study|Protocol Violation|1|||
33220059|NCT02390531|100703234|FG005|Overall Study|Protocol Violation|0|||
33220060|NCT02390531|100703235|FG006|Overall Study|Protocol Violation|2|||
33220061|NCT02390531|100703236|FG007|Overall Study|Protocol Violation|0|||
33220062|NCT02657317|100703237|FG000|Overall Study|Withdrawal by Subject|2|||
33220063|NCT02657317|100703238|FG001|Overall Study|Withdrawal by Subject|0|||
33220064|NCT02657317|100703237|FG000|Overall Study|Lost to Follow-up|3|||
33220065|NCT02657317|100703238|FG001|Overall Study|Lost to Follow-up|3|||
33220066|NCT02243280|100703244|FG000|Treated|Adverse Event|1|||
33220067|NCT02243280|100703245|FG001|Treated|Adverse Event|0|||
33220068|NCT02243280|100703246|FG002|Treated|Adverse Event|0|||
33220069|NCT02243280|100703247|FG003|Treated|Adverse Event|0|||
33220070|NCT02243280|100703248|FG004|Treated|Adverse Event|0|||
33220071|NCT02243280|100703249|FG005|Treated|Adverse Event|0|||
33220072|NCT02243280|100703250|FG006|Treated|Adverse Event|0|||
33220073|NCT02243280|100703251|FG007|Treated|Adverse Event|0|||
33220074|NCT02243280|100703252|FG008|Treated|Adverse Event|0|||
33220075|NCT02243280|100703253|FG009|Treated|Adverse Event|0|||
33220076|NCT02243280|100703254|FG010|Treated|Adverse Event|1|||
33220077|NCT02243280|100703244|FG000|Treated|Lost to Follow-up|0|||
33220078|NCT02243280|100703245|FG001|Treated|Lost to Follow-up|0|||
33220079|NCT02243280|100703246|FG002|Treated|Lost to Follow-up|0|||
33220080|NCT02243280|100703247|FG003|Treated|Lost to Follow-up|0|||
33220081|NCT02243280|100703248|FG004|Treated|Lost to Follow-up|0|||
33220082|NCT02243280|100703249|FG005|Treated|Lost to Follow-up|0|||
33220083|NCT02243280|100703250|FG006|Treated|Lost to Follow-up|0|||
33220084|NCT02243280|100703251|FG007|Treated|Lost to Follow-up|0|||
33220085|NCT02243280|100703252|FG008|Treated|Lost to Follow-up|1|||
33220086|NCT02243280|100703253|FG009|Treated|Lost to Follow-up|0|||
33220087|NCT02243280|100703254|FG010|Treated|Lost to Follow-up|2|||
33220088|NCT02272725|100703257|FG000|Overall Study|equipment malfunction|2|||
33220089|NCT02272725|100703258|FG001|Overall Study|equipment malfunction|0|||
33220090|NCT02052310|100703279|FG000|Overall Study|Death|64|||
33220091|NCT02052310|100703280|FG001|Overall Study|Death|54|||
33623801|NCT02719171|102172960|FG004|Overall Study|Lost to Follow-up|0|||
33623802|NCT02719171|102172956|FG000|Overall Study|Subject Withdrawal|0|||
33220092|NCT02052310|100703279|FG000|Overall Study|Withdrawal by Subject|37|||
33220093|NCT02052310|100703280|FG001|Overall Study|Withdrawal by Subject|49|||
33220094|NCT02052310|100703279|FG000|Overall Study|Other than specified|32|||
33220095|NCT02052310|100703280|FG001|Overall Study|Other than specified|29|||
33220096|NCT02052310|100703279|FG000|Overall Study|Adverse Event|29|||
33220097|NCT02052310|100703280|FG001|Overall Study|Adverse Event|22|||
33220098|NCT02052310|100703279|FG000|Overall Study|Kidney Transplant|23|||
33220099|NCT02052310|100703280|FG001|Overall Study|Kidney Transplant|29|||
33220100|NCT02052310|100703279|FG000|Overall Study|Physician Decision|14|||
33220101|NCT02052310|100703280|FG001|Overall Study|Physician Decision|7|||
33220102|NCT02052310|100703279|FG000|Overall Study|Lack of Efficacy|6|||
33220103|NCT02052310|100703280|FG001|Overall Study|Lack of Efficacy|1|||
33220104|NCT02052310|100703279|FG000|Overall Study|Site Terminated by Sponsor|5|||
33220105|NCT02052310|100703280|FG001|Overall Study|Site Terminated by Sponsor|13|||
33220106|NCT02052310|100703279|FG000|Overall Study|Lost to Follow-up|4|||
33220107|NCT02052310|100703280|FG001|Overall Study|Lost to Follow-up|2|||
33220108|NCT02052310|100703279|FG000|Overall Study|Protocol Violation|1|||
33220109|NCT02052310|100703280|FG001|Overall Study|Protocol Violation|6|||
33220110|NCT01287611|100703281|FG000|Overall Study|Lost to Follow-up|29|||
33220111|NCT01287611|100703282|FG001|Overall Study|Lost to Follow-up|16|||
33623803|NCT02719171|102172957|FG001|Overall Study|Subject Withdrawal|2|||
33220112|NCT01287611|100703281|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
33220113|NCT01287611|100703282|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
33220114|NCT01959425|100703283|FG000|Overall Study|Withdrawal by Subject|5|||
33220115|NCT01959425|100703284|FG001|Overall Study|Withdrawal by Subject|4|||
33220116|NCT01959425|100703283|FG000|Overall Study|Lost to Follow-up|1|||
33220117|NCT01959425|100703284|FG001|Overall Study|Lost to Follow-up|0|||
33220118|NCT01959425|100703283|FG000|Overall Study|Discontinued Subjects|6|||
33220119|NCT01959425|100703284|FG001|Overall Study|Discontinued Subjects|4|||
33220120|NCT03205371|100703288|FG000|Overall Study|Withdrawal by Subject|4|||
33220121|NCT03205371|100703289|FG001|Overall Study|Withdrawal by Subject|1|||
33220122|NCT03205371|100703290|FG002|Overall Study|Withdrawal by Subject|0|||
33220123|NCT03205371|100703291|FG003|Overall Study|Withdrawal by Subject|0|||
33220124|NCT03205371|100703292|FG004|Overall Study|Withdrawal by Subject|0|||
33220125|NCT03205371|100703293|FG005|Overall Study|Withdrawal by Subject|0|||
33220126|NCT03205371|100703294|FG006|Overall Study|Withdrawal by Subject|4|||
33220127|NCT03205371|100703295|FG007|Overall Study|Withdrawal by Subject|0|||
33220128|NCT03205371|100703296|FG008|Overall Study|Withdrawal by Subject|2|||
33220129|NCT03205371|100703297|FG009|Overall Study|Withdrawal by Subject|0|||
33220130|NCT03205371|100703298|FG010|Overall Study|Withdrawal by Subject|0|||
33220131|NCT03205371|100703299|FG011|Overall Study|Withdrawal by Subject|1|||
33220132|NCT03205371|100703288|FG000|Overall Study|Lost to Follow-up|0|||
33220133|NCT03205371|100703289|FG001|Overall Study|Lost to Follow-up|0|||
33220134|NCT03205371|100703290|FG002|Overall Study|Lost to Follow-up|0|||
33220135|NCT03205371|100703291|FG003|Overall Study|Lost to Follow-up|0|||
33220136|NCT03205371|100703292|FG004|Overall Study|Lost to Follow-up|0|||
33220137|NCT03205371|100703293|FG005|Overall Study|Lost to Follow-up|0|||
33220138|NCT03205371|100703294|FG006|Overall Study|Lost to Follow-up|5|||
33220139|NCT03205371|100703295|FG007|Overall Study|Lost to Follow-up|2|||
33220140|NCT03205371|100703296|FG008|Overall Study|Lost to Follow-up|3|||
33220141|NCT03205371|100703297|FG009|Overall Study|Lost to Follow-up|0|||
33220142|NCT03205371|100703298|FG010|Overall Study|Lost to Follow-up|0|||
33220143|NCT03205371|100703299|FG011|Overall Study|Lost to Follow-up|0|||
33220144|NCT03205371|100703288|FG000|Overall Study|Protocol Violation|0|||
33220145|NCT03205371|100703289|FG001|Overall Study|Protocol Violation|0|||
33220146|NCT03205371|100703290|FG002|Overall Study|Protocol Violation|0|||
33220147|NCT03205371|100703291|FG003|Overall Study|Protocol Violation|0|||
33220148|NCT03205371|100703292|FG004|Overall Study|Protocol Violation|0|||
33220149|NCT03205371|100703293|FG005|Overall Study|Protocol Violation|0|||
33220150|NCT03205371|100703294|FG006|Overall Study|Protocol Violation|1|||
33220151|NCT03205371|100703295|FG007|Overall Study|Protocol Violation|0|||
33220152|NCT03205371|100703296|FG008|Overall Study|Protocol Violation|0|||
33220153|NCT03205371|100703297|FG009|Overall Study|Protocol Violation|0|||
33220154|NCT03205371|100703298|FG010|Overall Study|Protocol Violation|0|||
33220155|NCT03205371|100703299|FG011|Overall Study|Protocol Violation|0|||
33220156|NCT03205371|100703288|FG000|Overall Study|Adverse Event|0|||
33220157|NCT03205371|100703289|FG001|Overall Study|Adverse Event|0|||
33220158|NCT03205371|100703290|FG002|Overall Study|Adverse Event|0|||
33220159|NCT03205371|100703291|FG003|Overall Study|Adverse Event|0|||
33220160|NCT03205371|100703292|FG004|Overall Study|Adverse Event|0|||
33220161|NCT03205371|100703293|FG005|Overall Study|Adverse Event|0|||
33220162|NCT03205371|100703294|FG006|Overall Study|Adverse Event|0|||
33220163|NCT03205371|100703295|FG007|Overall Study|Adverse Event|1|||
33220164|NCT03205371|100703296|FG008|Overall Study|Adverse Event|0|||
33220165|NCT03205371|100703297|FG009|Overall Study|Adverse Event|0|||
33220166|NCT03205371|100703298|FG010|Overall Study|Adverse Event|0|||
33220167|NCT03205371|100703299|FG011|Overall Study|Adverse Event|0|||
33220168|NCT00742079|100703302|FG000|Overall Study|Lost to Follow-up|0|||
33220169|NCT00742079|100703303|FG001|Overall Study|Lost to Follow-up|1|||
33220170|NCT00620750|100703304|FG000|Overall Study|Lost to Follow-up|25|||
33220171|NCT00295022|100703312|FG000|Overall Study|Adverse Event|1|||
33220172|NCT00295022|100703313|FG001|Overall Study|Adverse Event|1|||
33220173|NCT00295022|100703314|FG002|Overall Study|Adverse Event|2|||
33220174|NCT00295022|100703312|FG000|Overall Study|Lost to Follow-up|0|||
33220175|NCT00295022|100703313|FG001|Overall Study|Lost to Follow-up|0|||
33220176|NCT00295022|100703314|FG002|Overall Study|Lost to Follow-up|1|||
33220177|NCT00295022|100703312|FG000|Overall Study|Withdrawal by Subject|0|||
33220178|NCT00295022|100703313|FG001|Overall Study|Withdrawal by Subject|0|||
33220179|NCT00295022|100703314|FG002|Overall Study|Withdrawal by Subject|2|||
33220180|NCT00863655|100703315|FG000|Overall Study|Protocol Violation|4|||
33220181|NCT00863655|100703316|FG001|Overall Study|Protocol Violation|0|||
33220182|NCT00863655|100703315|FG000|Overall Study|Adverse Event|52|||
33220183|NCT00863655|100703316|FG001|Overall Study|Adverse Event|8|||
33220184|NCT00863655|100703315|FG000|Overall Study|Withdrawal by Subject|47|||
33220185|NCT00863655|100703316|FG001|Overall Study|Withdrawal by Subject|7|||
33220186|NCT00863655|100703315|FG000|Overall Study|Administrative problems|1|||
33220187|NCT00863655|100703316|FG001|Overall Study|Administrative problems|0|||
33560683|NCT03715829|101949002|FG009|Dose Ranging Period|Lack of Efficacy|0|||
33560684|NCT03715829|101949003|FG010|Dose Ranging Period|Lack of Efficacy|0|||
33560685|NCT03715829|101948993|FG000|Dose Ranging Period|Lost to Follow-up|2|||
33560686|NCT03715829|101948994|FG001|Dose Ranging Period|Lost to Follow-up|0|||
33560687|NCT03715829|101948995|FG002|Dose Ranging Period|Lost to Follow-up|1|||
33560688|NCT03715829|101948996|FG003|Dose Ranging Period|Lost to Follow-up|1|||
33560689|NCT03715829|101948997|FG004|Dose Ranging Period|Lost to Follow-up|1|||
33560690|NCT03715829|101948998|FG005|Dose Ranging Period|Lost to Follow-up|2|||
33220188|NCT00863655|100703315|FG000|Overall Study|Death|7|||
33220189|NCT00863655|100703316|FG001|Overall Study|Death|1|||
33220190|NCT00863655|100703315|FG000|Overall Study|New cancer therapy|5|||
33220191|NCT00863655|100703316|FG001|Overall Study|New cancer therapy|1|||
33220192|NCT00863655|100703315|FG000|Overall Study|Disease progression|364|||
33220193|NCT00863655|100703316|FG001|Overall Study|Disease progression|221|||
33220194|NCT00863655|100703315|FG000|Overall Study|Treatment completed as per protocol|5|||
33220195|NCT00863655|100703316|FG001|Overall Study|Treatment completed as per protocol|1|||
33220196|NCT02831257|100703317|FG000|Overall Study|Lack of Efficacy|3|||
33220197|NCT02831257|100703317|FG000|Overall Study|Adverse Event|2|||
33220198|NCT02831257|100703317|FG000|Overall Study|Physician Decision|1|||
33220199|NCT02831257|100703317|FG000|Overall Study|Withdrawal by Subject|6|||
33220200|NCT02287584|100703318|FG000|the Double-blind Phase|Adverse Event|17|||
33220201|NCT02287584|100703319|FG001|the Double-blind Phase|Adverse Event|17|||
33220202|NCT02287584|100703320|FG002|the Double-blind Phase|Adverse Event|12|||
33560691|NCT03715829|101948999|FG006|Dose Ranging Period|Lost to Follow-up|0|||
33560692|NCT03715829|101949000|FG007|Dose Ranging Period|Lost to Follow-up|0|||
33560693|NCT03715829|101949001|FG008|Dose Ranging Period|Lost to Follow-up|0|||
33560694|NCT03715829|101949002|FG009|Dose Ranging Period|Lost to Follow-up|0|||
33560695|NCT03715829|101949003|FG010|Dose Ranging Period|Lost to Follow-up|0|||
33560696|NCT03715829|101948993|FG000|Dose Ranging Period|Protocol Violation|0|||
33560697|NCT03715829|101948994|FG001|Dose Ranging Period|Protocol Violation|0|||
33560698|NCT03715829|101948995|FG002|Dose Ranging Period|Protocol Violation|0|||
33560699|NCT03715829|101948996|FG003|Dose Ranging Period|Protocol Violation|1|||
33560700|NCT03715829|101948997|FG004|Dose Ranging Period|Protocol Violation|0|||
33560701|NCT03715829|101948998|FG005|Dose Ranging Period|Protocol Violation|0|||
33560702|NCT03715829|101948999|FG006|Dose Ranging Period|Protocol Violation|0|||
33560703|NCT03715829|101949000|FG007|Dose Ranging Period|Protocol Violation|0|||
33560704|NCT03715829|101949001|FG008|Dose Ranging Period|Protocol Violation|0|||
33560705|NCT03715829|101949002|FG009|Dose Ranging Period|Protocol Violation|0|||
33220203|NCT02287584|100703321|FG003|the Double-blind Phase|Adverse Event|0|||
33220204|NCT02287584|100703322|FG004|the Double-blind Phase|Adverse Event|0|||
33220205|NCT02287584|100703323|FG005|the Double-blind Phase|Adverse Event|0|||
33220206|NCT02287584|100703318|FG000|the Double-blind Phase|Lack of Efficacy|18|||
33220207|NCT02287584|100703319|FG001|the Double-blind Phase|Lack of Efficacy|8|||
33220208|NCT02287584|100703320|FG002|the Double-blind Phase|Lack of Efficacy|8|||
33220209|NCT02287584|100703321|FG003|the Double-blind Phase|Lack of Efficacy|0|||
33220210|NCT02287584|100703322|FG004|the Double-blind Phase|Lack of Efficacy|0|||
33220211|NCT02287584|100703323|FG005|the Double-blind Phase|Lack of Efficacy|0|||
33220212|NCT02287584|100703318|FG000|the Double-blind Phase|Lost to Follow-up|0|||
33220213|NCT02287584|100703319|FG001|the Double-blind Phase|Lost to Follow-up|1|||
33220214|NCT02287584|100703320|FG002|the Double-blind Phase|Lost to Follow-up|1|||
33220215|NCT02287584|100703321|FG003|the Double-blind Phase|Lost to Follow-up|0|||
33220216|NCT02287584|100703322|FG004|the Double-blind Phase|Lost to Follow-up|0|||
33220217|NCT02287584|100703323|FG005|the Double-blind Phase|Lost to Follow-up|0|||
33220218|NCT02287584|100703318|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
33220219|NCT02287584|100703319|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
33220220|NCT02287584|100703320|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
33220221|NCT02287584|100703321|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
33220222|NCT02287584|100703322|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
33220223|NCT02287584|100703323|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
33220224|NCT02287584|100703318|FG000|the Double-blind Phase|Pregnancy|0|||
33220225|NCT02287584|100703319|FG001|the Double-blind Phase|Pregnancy|1|||
33220226|NCT02287584|100703320|FG002|the Double-blind Phase|Pregnancy|0|||
33220227|NCT02287584|100703321|FG003|the Double-blind Phase|Pregnancy|0|||
33220228|NCT02287584|100703322|FG004|the Double-blind Phase|Pregnancy|0|||
33220229|NCT02287584|100703323|FG005|the Double-blind Phase|Pregnancy|0|||
33220230|NCT02287584|100703318|FG000|the Double-blind Phase|Protocol Violation|0|||
33220231|NCT02287584|100703319|FG001|the Double-blind Phase|Protocol Violation|3|||
33220232|NCT02287584|100703320|FG002|the Double-blind Phase|Protocol Violation|0|||
33220233|NCT02287584|100703321|FG003|the Double-blind Phase|Protocol Violation|0|||
33220234|NCT02287584|100703322|FG004|the Double-blind Phase|Protocol Violation|0|||
33220235|NCT02287584|100703323|FG005|the Double-blind Phase|Protocol Violation|0|||
33220236|NCT02287584|100703318|FG000|the Double-blind Phase|other reasons|0|||
33220237|NCT02287584|100703319|FG001|the Double-blind Phase|other reasons|0|||
33220238|NCT02287584|100703320|FG002|the Double-blind Phase|other reasons|1|||
33220239|NCT02287584|100703321|FG003|the Double-blind Phase|other reasons|0|||
33220240|NCT02287584|100703322|FG004|the Double-blind Phase|other reasons|0|||
33220241|NCT02287584|100703323|FG005|the Double-blind Phase|other reasons|0|||
33220242|NCT02287584|100703318|FG000|the Open-label Phase|Did not receive drug|0|||
33220243|NCT02287584|100703319|FG001|the Open-label Phase|Did not receive drug|0|||
33220244|NCT02287584|100703320|FG002|the Open-label Phase|Did not receive drug|0|||
33220245|NCT02287584|100703321|FG003|the Open-label Phase|Did not receive drug|7|||
33560706|NCT03715829|101949003|FG010|Dose Ranging Period|Protocol Violation|0|||
33220246|NCT02287584|100703322|FG004|the Open-label Phase|Did not receive drug|6|||
33560707|NCT03715829|101948993|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
33220247|NCT02287584|100703323|FG005|the Open-label Phase|Did not receive drug|4|||
33220248|NCT02287584|100703318|FG000|the Open-label Phase|Adverse Event|0|||
33220249|NCT02287584|100703319|FG001|the Open-label Phase|Adverse Event|0|||
33220250|NCT02287584|100703320|FG002|the Open-label Phase|Adverse Event|0|||
33220251|NCT02287584|100703321|FG003|the Open-label Phase|Adverse Event|15|||
33220252|NCT02287584|100703322|FG004|the Open-label Phase|Adverse Event|12|||
33220253|NCT02287584|100703323|FG005|the Open-label Phase|Adverse Event|16|||
33220254|NCT02287584|100703318|FG000|the Open-label Phase|Lack of Efficacy|0|||
33220255|NCT02287584|100703319|FG001|the Open-label Phase|Lack of Efficacy|0|||
33220256|NCT02287584|100703320|FG002|the Open-label Phase|Lack of Efficacy|0|||
33220257|NCT02287584|100703321|FG003|the Open-label Phase|Lack of Efficacy|8|||
33220258|NCT02287584|100703322|FG004|the Open-label Phase|Lack of Efficacy|3|||
33220259|NCT02287584|100703323|FG005|the Open-label Phase|Lack of Efficacy|7|||
33220260|NCT02287584|100703318|FG000|the Open-label Phase|Lost to Follow-up|0|||
33220261|NCT02287584|100703319|FG001|the Open-label Phase|Lost to Follow-up|0|||
33220262|NCT02287584|100703320|FG002|the Open-label Phase|Lost to Follow-up|0|||
33220263|NCT02287584|100703321|FG003|the Open-label Phase|Lost to Follow-up|4|||
33220264|NCT02287584|100703322|FG004|the Open-label Phase|Lost to Follow-up|1|||
33220265|NCT02287584|100703323|FG005|the Open-label Phase|Lost to Follow-up|2|||
33220266|NCT02287584|100703318|FG000|the Open-label Phase|Withdrawal by Subject|0|||
33220267|NCT02287584|100703319|FG001|the Open-label Phase|Withdrawal by Subject|0|||
33220268|NCT02287584|100703320|FG002|the Open-label Phase|Withdrawal by Subject|0|||
33220269|NCT02287584|100703321|FG003|the Open-label Phase|Withdrawal by Subject|18|||
33220270|NCT02287584|100703322|FG004|the Open-label Phase|Withdrawal by Subject|29|||
33220271|NCT02287584|100703323|FG005|the Open-label Phase|Withdrawal by Subject|21|||
33220272|NCT02287584|100703318|FG000|the Open-label Phase|non-compliance|0|||
33220273|NCT02287584|100703319|FG001|the Open-label Phase|non-compliance|0|||
33220274|NCT02287584|100703320|FG002|the Open-label Phase|non-compliance|0|||
33220275|NCT02287584|100703321|FG003|the Open-label Phase|non-compliance|2|||
33220276|NCT02287584|100703322|FG004|the Open-label Phase|non-compliance|5|||
33220277|NCT02287584|100703323|FG005|the Open-label Phase|non-compliance|1|||
33220278|NCT02287584|100703318|FG000|the Open-label Phase|other reasons|0|||
33220279|NCT02287584|100703319|FG001|the Open-label Phase|other reasons|0|||
33220280|NCT02287584|100703320|FG002|the Open-label Phase|other reasons|0|||
33220281|NCT02287584|100703321|FG003|the Open-label Phase|other reasons|3|||
33220282|NCT02287584|100703322|FG004|the Open-label Phase|other reasons|6|||
33220283|NCT02287584|100703323|FG005|the Open-label Phase|other reasons|6|||
33220284|NCT01221948|100703335|FG000|Overall Study|Physician Decision|5|||
33220285|NCT01221948|100703335|FG000|Overall Study|Withdrawal by Subject|2|||
33220286|NCT01221948|100703335|FG000|Overall Study|not disclosed|2|||
33220287|NCT01221948|100703335|FG000|Overall Study|Death|1|||
33220288|NCT01221948|100703335|FG000|Overall Study|Protocol Violation|4|||
33220289|NCT03496662|100703337|FG000|Overall Study|Adverse Event|1|||
33220290|NCT03496662|100703338|FG001|Overall Study|Adverse Event|0|||
33220291|NCT03496662|100703339|FG002|Overall Study|Adverse Event|1|||
33220292|NCT03496662|100703337|FG000|Overall Study|Physician Decision|1|||
33220293|NCT03496662|100703338|FG001|Overall Study|Physician Decision|0|||
33220294|NCT03496662|100703339|FG002|Overall Study|Physician Decision|3|||
33220295|NCT03496662|100703337|FG000|Overall Study|Withdrawal by Subject|0|||
33220296|NCT03496662|100703338|FG001|Overall Study|Withdrawal by Subject|0|||
33220297|NCT03496662|100703339|FG002|Overall Study|Withdrawal by Subject|2|||
33220298|NCT03496662|100703337|FG000|Overall Study|Death|0|||
33220299|NCT03496662|100703338|FG001|Overall Study|Death|0|||
33220300|NCT03496662|100703339|FG002|Overall Study|Death|2|||
33220301|NCT03496662|100703337|FG000|Overall Study|Noncompliance|0|||
33220302|NCT03496662|100703338|FG001|Overall Study|Noncompliance|0|||
33220303|NCT03496662|100703339|FG002|Overall Study|Noncompliance|1|||
33220304|NCT00089141|100703341|FG000|Overall Study|Termination of trial|18|||
33220305|NCT00089141|100703342|FG001|Overall Study|Termination of trial|24|||
33220306|NCT01060553|100703346|FG000|Overall Study|Lost to Follow-up|3|||
33220307|NCT01060553|100703347|FG001|Overall Study|Lost to Follow-up|5|||
33220308|NCT01060553|100703346|FG000|Overall Study|Withdrawal by Subject|5|||
33220309|NCT01060553|100703347|FG001|Overall Study|Withdrawal by Subject|5|||
33220310|NCT01060553|100703346|FG000|Overall Study|Lack of Efficacy|1|||
33220311|NCT01060553|100703347|FG001|Overall Study|Lack of Efficacy|0|||
33220312|NCT01412801|100703349|FG000|Overall Study|Death|0|||
33220313|NCT01412801|100703350|FG001|Overall Study|Death|1|||
33220314|NCT01412801|100703351|FG002|Overall Study|Death|0|||
33220315|NCT01412801|100703352|FG003|Overall Study|Death|4|||
33220316|NCT01412801|100703353|FG004|Overall Study|Death|2|||
33220317|NCT01412801|100703354|FG005|Overall Study|Death|2|||
33220318|NCT01412801|100703349|FG000|Overall Study|Lost to Follow-up|1|||
33220319|NCT01412801|100703350|FG001|Overall Study|Lost to Follow-up|2|||
33220320|NCT01412801|100703351|FG002|Overall Study|Lost to Follow-up|4|||
33220321|NCT01412801|100703352|FG003|Overall Study|Lost to Follow-up|0|||
33220322|NCT01412801|100703353|FG004|Overall Study|Lost to Follow-up|1|||
33220323|NCT01412801|100703354|FG005|Overall Study|Lost to Follow-up|1|||
33220324|NCT01412801|100703349|FG000|Overall Study|Withdrawal by Subject|3|||
33359405|NCT02873221|101204420|FG000|Treatment Period|Lost to Follow-up|26|||
33220325|NCT01412801|100703350|FG001|Overall Study|Withdrawal by Subject|2|||
33220326|NCT01412801|100703351|FG002|Overall Study|Withdrawal by Subject|1|||
33220327|NCT01412801|100703352|FG003|Overall Study|Withdrawal by Subject|0|||
33220328|NCT01412801|100703353|FG004|Overall Study|Withdrawal by Subject|0|||
33220329|NCT01412801|100703354|FG005|Overall Study|Withdrawal by Subject|0|||
33220330|NCT01412801|100703349|FG000|Overall Study|Relocated to another area|0|||
33220331|NCT01412801|100703350|FG001|Overall Study|Relocated to another area|0|||
33220332|NCT01412801|100703351|FG002|Overall Study|Relocated to another area|2|||
33220333|NCT01412801|100703352|FG003|Overall Study|Relocated to another area|0|||
33220334|NCT01412801|100703353|FG004|Overall Study|Relocated to another area|0|||
33220335|NCT01412801|100703354|FG005|Overall Study|Relocated to another area|0|||
33220336|NCT04044456|100703355|FG000|Overall Study|Lost to Follow-up|4|||
33220337|NCT04044456|100703356|FG001|Overall Study|Lost to Follow-up|1|||
33220338|NCT04044456|100703355|FG000|Overall Study|Withdrawal by Subject|1|||
33220339|NCT04044456|100703356|FG001|Overall Study|Withdrawal by Subject|0|||
33220340|NCT02230956|100703359|FG000|Overall Study|Adverse Event|1|||
33220341|NCT02230956|100703360|FG001|Overall Study|Adverse Event|1|||
33220342|NCT02230956|100703361|FG002|Overall Study|Adverse Event|0|||
33220343|NCT02230956|100703359|FG000|Overall Study|Lack of Efficacy|1|||
33220344|NCT02230956|100703360|FG001|Overall Study|Lack of Efficacy|1|||
33220345|NCT02230956|100703361|FG002|Overall Study|Lack of Efficacy|1|||
33220346|NCT02230956|100703359|FG000|Overall Study|Lost to Follow-up|1|||
33220347|NCT02230956|100703360|FG001|Overall Study|Lost to Follow-up|1|||
33220348|NCT02230956|100703361|FG002|Overall Study|Lost to Follow-up|2|||
33220349|NCT02230956|100703359|FG000|Overall Study|Personal Reasons|2|||
33220350|NCT02230956|100703360|FG001|Overall Study|Personal Reasons|1|||
33220351|NCT02230956|100703361|FG002|Overall Study|Personal Reasons|1|||
33220352|NCT02230956|100703359|FG000|Overall Study|Protocol Violation|0|||
33220353|NCT02230956|100703360|FG001|Overall Study|Protocol Violation|1|||
33220354|NCT02230956|100703361|FG002|Overall Study|Protocol Violation|1|||
33220355|NCT02230956|100703359|FG000|Overall Study|Other Miscellaneous Reason|0|||
33220356|NCT02230956|100703360|FG001|Overall Study|Other Miscellaneous Reason|1|||
33220357|NCT02230956|100703361|FG002|Overall Study|Other Miscellaneous Reason|2|||
33220358|NCT03266770|100703362|FG000|Overall Study|Physician Decision|3|||
33220359|NCT03266770|100703362|FG000|Overall Study|Insufficient study supplies|1|||
33220360|NCT03266770|100703362|FG000|Overall Study|Adverse Event|1|||
33220361|NCT01127646|100703363|FG000|Overall Study|Entry Criteria Not Met|1|||
33220362|NCT01127646|100703364|FG001|Overall Study|Entry Criteria Not Met|0|||
33220363|NCT01127646|100703363|FG000|Overall Study|Protocol Violation|0|||
33220364|NCT01127646|100703364|FG001|Overall Study|Protocol Violation|1|||
33220365|NCT02274857|100703367|FG000|Overall Study|Adverse Event|1|||
33220366|NCT02274857|100703368|FG001|Overall Study|Adverse Event|0|||
33560708|NCT03715829|101948994|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
33560709|NCT03715829|101948995|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
33220367|NCT02274857|100703367|FG000|Overall Study|Death|1|||
33220368|NCT02274857|100703368|FG001|Overall Study|Death|2|||
33220369|NCT02274857|100703367|FG000|Overall Study|Lost to Follow-up|3|||
33220370|NCT02274857|100703368|FG001|Overall Study|Lost to Follow-up|0|||
33220371|NCT02274857|100703367|FG000|Overall Study|Physician Decision|2|||
33220372|NCT02274857|100703368|FG001|Overall Study|Physician Decision|0|||
33359406|NCT02873221|101204421|FG001|Treatment Period|Lost to Follow-up|30|||
33560710|NCT03715829|101948996|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
33560711|NCT03715829|101948997|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
33560712|NCT03715829|101948998|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
33560713|NCT03715829|101948999|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
33560714|NCT03715829|101949000|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
33560715|NCT03715829|101949001|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
33560716|NCT03715829|101949002|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
33560717|NCT03715829|101949003|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
33560718|NCT03715829|101948993|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33560719|NCT03715829|101948994|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33560720|NCT03715829|101948995|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
33560721|NCT03715829|101948996|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33560722|NCT03715829|101948997|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33560723|NCT03715829|101948998|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33560724|NCT03715829|101948999|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33560725|NCT03715829|101949000|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33560726|NCT03715829|101949001|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33623804|NCT02719171|102172958|FG002|Overall Study|Subject Withdrawal|2|||
33359407|NCT02873221|101204422|FG002|Treatment Period|Lost to Follow-up|26|||
33359408|NCT02873221|101204420|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
33359409|NCT02873221|101204421|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
33414628|NCT01915498|101409854|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
33220373|NCT02274857|100703367|FG000|Overall Study|Trial screen failure|0|||
33220374|NCT02274857|100703368|FG001|Overall Study|Trial screen failure|2|||
33220375|NCT02274857|100703367|FG000|Overall Study|Withdrawal by Subject|11|||
33220376|NCT02274857|100703368|FG001|Overall Study|Withdrawal by Subject|2|||
33220377|NCT02274857|100703367|FG000|Overall Study|Other|2|||
33220378|NCT02274857|100703368|FG001|Overall Study|Other|0|||
33220379|NCT02583425|100703369|FG000|Screening|Did not meet entry criteria|12|||
33560727|NCT03715829|101949002|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33560728|NCT03715829|101949003|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
33220380|NCT02583425|100703369|FG000|Baseline|Did not meet continued criteria|5|||
33220381|NCT02583425|100703369|FG000|Treatment Period|Adverse Event|1|||
33220382|NCT00552084|100703370|FG000|Overall Study|Adverse Event|2|||
33220383|NCT00552084|100703371|FG001|Overall Study|Adverse Event|3|||
33359410|NCT02873221|101204422|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
33560729|NCT03715829|101948993|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33560730|NCT03715829|101948994|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33560731|NCT03715829|101948995|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
33560732|NCT03715829|101948996|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33560733|NCT03715829|101948997|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
33560734|NCT03715829|101948998|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33560735|NCT03715829|101948999|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33560736|NCT03715829|101949000|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33560737|NCT03715829|101949001|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33560738|NCT03715829|101949002|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33560739|NCT03715829|101949003|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
33560740|NCT03715829|101948993|FG000|Dose Ranging Period|Other|0|||
33560741|NCT03715829|101948994|FG001|Dose Ranging Period|Other|0|||
33560742|NCT03715829|101948995|FG002|Dose Ranging Period|Other|2|||
33359411|NCT02873221|101204420|FG000|Safety Follow-up Period|Protocol Violation|0|||
33560743|NCT03715829|101948996|FG003|Dose Ranging Period|Other|0|||
33623805|NCT02719171|102172959|FG003|Overall Study|Subject Withdrawal|1|||
33623806|NCT02719171|102172960|FG004|Overall Study|Subject Withdrawal|0|||
33623807|NCT02719171|102172956|FG000|Overall Study|Other|0|||
33623808|NCT02719171|102172957|FG001|Overall Study|Other|0|||
33623809|NCT02719171|102172958|FG002|Overall Study|Other|0|||
33623810|NCT02719171|102172959|FG003|Overall Study|Other|1|||
33623811|NCT02719171|102172960|FG004|Overall Study|Other|0|||
33623812|NCT00292942|102172963|FG000|Overall Study|Withdrawal by Subject|0|||
33623813|NCT00292942|102172964|FG001|Overall Study|Withdrawal by Subject|0|||
33623814|NCT00292942|102172965|FG002|Overall Study|Withdrawal by Subject|1|||
33623815|NCT00292942|102172966|FG003|Overall Study|Withdrawal by Subject|0|||
33623816|NCT00292942|102172963|FG000|Overall Study|Adverse Event|0|||
33623817|NCT00292942|102172964|FG001|Overall Study|Adverse Event|0|||
33623818|NCT00292942|102172965|FG002|Overall Study|Adverse Event|0|||
33623819|NCT00292942|102172966|FG003|Overall Study|Adverse Event|1|||
33623820|NCT04864639|102172967|FG000|Overall Study|Death|1|||
33623821|NCT04864639|102172967|FG000|Overall Study|Lost to Follow-up|1|||
33623822|NCT04972786|102172968|FG000|First Intervention (1 Day)|Adverse Event|1|||
33623823|NCT04972786|102172969|FG001|First Intervention (1 Day)|Adverse Event|0|||
33623824|NCT03546621|102172974|FG000|Overall Study|Withdrawal by Subject|0|||
33623825|NCT03546621|102172975|FG001|Overall Study|Withdrawal by Subject|1|||
33623826|NCT03546621|102172976|FG002|Overall Study|Withdrawal by Subject|2|||
33623827|NCT03546621|102172977|FG003|Overall Study|Withdrawal by Subject|1|||
33623828|NCT03546621|102172974|FG000|Overall Study|Lost to Follow-up|0|||
33623829|NCT03546621|102172975|FG001|Overall Study|Lost to Follow-up|1|||
33623830|NCT03546621|102172976|FG002|Overall Study|Lost to Follow-up|0|||
33623831|NCT03546621|102172977|FG003|Overall Study|Lost to Follow-up|0|||
33623832|NCT03546621|102172974|FG000|Overall Study|Adverse Event|0|||
33623833|NCT03546621|102172975|FG001|Overall Study|Adverse Event|1|||
33623834|NCT03546621|102172976|FG002|Overall Study|Adverse Event|0|||
33623835|NCT03546621|102172977|FG003|Overall Study|Adverse Event|1|||
33623836|NCT03546621|102172974|FG000|Overall Study|Progressive disease|0|||
33623837|NCT03546621|102172975|FG001|Overall Study|Progressive disease|0|||
33623838|NCT03546621|102172976|FG002|Overall Study|Progressive disease|0|||
33623839|NCT03546621|102172977|FG003|Overall Study|Progressive disease|1|||
33220384|NCT00552084|100703370|FG000|Overall Study|Withdrawal by Subject|4|||
33220385|NCT00552084|100703371|FG001|Overall Study|Withdrawal by Subject|5|||
33220386|NCT00552084|100703370|FG000|Overall Study|Protocol Violation|1|||
33220387|NCT00552084|100703371|FG001|Overall Study|Protocol Violation|0|||
33623840|NCT03007966|102172978|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
33623841|NCT03007966|102172979|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
33623842|NCT00286442|102172980|FG000|Overall Study|Hyperglycemic Rescue|19|||
33623843|NCT00286442|102172981|FG001|Overall Study|Hyperglycemic Rescue|17|||
33623844|NCT00286442|102172982|FG002|Overall Study|Hyperglycemic Rescue|25|||
33623845|NCT00286442|102172980|FG000|Overall Study|Adverse Event|7|||
33623846|NCT00286442|102172981|FG001|Overall Study|Adverse Event|6|||
33623847|NCT00286442|102172982|FG002|Overall Study|Adverse Event|1|||
33623848|NCT00286442|102172980|FG000|Overall Study|Protocol Violation|2|||
33623849|NCT00286442|102172981|FG001|Overall Study|Protocol Violation|4|||
33623850|NCT00286442|102172982|FG002|Overall Study|Protocol Violation|2|||
33623851|NCT00286442|102172980|FG000|Overall Study|Lost to Follow-up|5|||
33623852|NCT00286442|102172981|FG001|Overall Study|Lost to Follow-up|2|||
33623853|NCT00286442|102172982|FG002|Overall Study|Lost to Follow-up|1|||
33623854|NCT00286442|102172980|FG000|Overall Study|Physician Decision|1|||
33623855|NCT00286442|102172981|FG001|Overall Study|Physician Decision|1|||
33623856|NCT00286442|102172982|FG002|Overall Study|Physician Decision|1|||
33623857|NCT00286442|102172980|FG000|Overall Study|Administrative Error|1|||
33623858|NCT00286442|102172981|FG001|Overall Study|Administrative Error|1|||
33623859|NCT00286442|102172982|FG002|Overall Study|Administrative Error|0|||
33359412|NCT02873221|101204421|FG001|Safety Follow-up Period|Protocol Violation|0|||
33359413|NCT02873221|101204422|FG002|Safety Follow-up Period|Protocol Violation|1|||
33359414|NCT02873221|101204420|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
33359415|NCT02873221|101204421|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
33560744|NCT03715829|101948997|FG004|Dose Ranging Period|Other|0|||
33560745|NCT03715829|101948998|FG005|Dose Ranging Period|Other|3|||
33560746|NCT03715829|101948999|FG006|Dose Ranging Period|Other|0|||
33560747|NCT03715829|101949000|FG007|Dose Ranging Period|Other|0|||
33560748|NCT03715829|101949001|FG008|Dose Ranging Period|Other|0|||
33560749|NCT03715829|101949002|FG009|Dose Ranging Period|Other|0|||
33359416|NCT02873221|101204422|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
33359417|NCT02873221|101204420|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
33220388|NCT00552084|100703370|FG000|Overall Study|change in anti-arrythmic drug|1|||
33359418|NCT02873221|101204421|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
33359419|NCT02873221|101204422|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
33560750|NCT03715829|101949003|FG010|Dose Ranging Period|Other|0|||
33560751|NCT03715829|101948993|FG000|Extension Period|Adverse Event|0|||
33560752|NCT03715829|101948994|FG001|Extension Period|Adverse Event|0|||
33560753|NCT03715829|101948995|FG002|Extension Period|Adverse Event|0|||
33560754|NCT03715829|101948996|FG003|Extension Period|Adverse Event|0|||
33560755|NCT03715829|101948997|FG004|Extension Period|Adverse Event|0|||
33560756|NCT03715829|101948998|FG005|Extension Period|Adverse Event|0|||
33560757|NCT03715829|101948999|FG006|Extension Period|Adverse Event|3|||
33560758|NCT03715829|101949000|FG007|Extension Period|Adverse Event|1|||
33359420|NCT01919411|101204425|FG000|Overall Study|Lost to Follow-up|2|||
33359421|NCT01919411|101204426|FG001|Overall Study|Lost to Follow-up|4|||
33359422|NCT01919411|101204425|FG000|Overall Study|Physician Decision|1|||
33359423|NCT01919411|101204426|FG001|Overall Study|Physician Decision|0|||
33359424|NCT01919411|101204425|FG000|Overall Study|Protocol Violation|2|||
33359425|NCT01919411|101204426|FG001|Overall Study|Protocol Violation|1|||
33359426|NCT05421754|101204427|FG000|Overall Study|Technical issue with sensor|1|||
33359427|NCT01450137|101204428|FG000|Up to Week 12|Adverse Event|2|||
33359428|NCT01450137|101204429|FG001|Up to Week 12|Adverse Event|1|||
33359429|NCT01450137|101204428|FG000|Up to Week 12|Withdrawal by Subject|0|||
33359430|NCT01450137|101204429|FG001|Up to Week 12|Withdrawal by Subject|2|||
33359431|NCT01450137|101204428|FG000|Week 12 to Study End|Death|0|||
33359432|NCT01450137|101204429|FG001|Week 12 to Study End|Death|1|||
33359433|NCT01450137|101204428|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
33359434|NCT01450137|101204429|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
33359435|NCT02032875|101204430|FG000|Treatment Period|Adverse Event|1|||
33359436|NCT02032875|101204431|FG001|Treatment Period|Adverse Event|0|||
33359437|NCT02032875|101204430|FG000|Treatment Period|Liver transplant, No extension needed|0|||
33359438|NCT02032875|101204431|FG001|Treatment Period|Liver transplant, No extension needed|1|||
33359439|NCT02032875|101204430|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
33359440|NCT02032875|101204431|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
33359441|NCT02032875|101204430|FG000|Follow-up Period|Death|0|||
33359442|NCT02032875|101204431|FG001|Follow-up Period|Death|1|||
33359443|NCT02032875|101204430|FG000|Follow-up Period|Virologic Relapse|3|||
33359444|NCT02032875|101204431|FG001|Follow-up Period|Virologic Relapse|10|||
33359445|NCT01821963|101204432|FG000|Overall Study|Adverse Event|1|||
33359446|NCT02104180|101204433|FG000|Overall Study|Protocol Violation|1|||
33359447|NCT02104180|101204434|FG001|Overall Study|Protocol Violation|0|||
33359448|NCT01183858|101204439|FG000|Overall Study|Death not related to Progressive Disease|5|||
33359449|NCT01183858|101204440|FG001|Overall Study|Death not related to Progressive Disease|6|||
33359450|NCT01183858|101204439|FG000|Overall Study|Adverse Event|14|||
33359451|NCT01183858|101204440|FG001|Overall Study|Adverse Event|11|||
33359452|NCT01183858|101204439|FG000|Overall Study|Investigator's Decision|0|||
33359453|NCT01183858|101204440|FG001|Overall Study|Investigator's Decision|3|||
33359454|NCT01183858|101204439|FG000|Overall Study|Insufficient Therapeutic Response|2|||
33359455|NCT01183858|101204440|FG001|Overall Study|Insufficient Therapeutic Response|0|||
33359456|NCT01183858|101204439|FG000|Overall Study|Refused Treatment|1|||
33359457|NCT01183858|101204440|FG001|Overall Study|Refused Treatment|4|||
33359458|NCT01183858|101204439|FG000|Overall Study|Withdrew Consent|4|||
33359459|NCT01183858|101204440|FG001|Overall Study|Withdrew Consent|4|||
33359460|NCT01183858|101204439|FG000|Overall Study|Discontinued Smoking|3|||
33359461|NCT01183858|101204440|FG001|Overall Study|Discontinued Smoking|1|||
33359462|NCT01183858|101204439|FG000|Overall Study|Protocol Violation|1|||
33359463|NCT01183858|101204440|FG001|Overall Study|Protocol Violation|0|||
33623860|NCT00286442|102172980|FG000|Overall Study|Withdrawal by Subject|2|||
33623861|NCT00286442|102172981|FG001|Overall Study|Withdrawal by Subject|14|||
33623862|NCT00286442|102172982|FG002|Overall Study|Withdrawal by Subject|2|||
33623863|NCT01724866|102172983|FG000|Overall Study|Adverse Event|0|||
33623864|NCT01724866|102172984|FG001|Overall Study|Adverse Event|0|||
33623865|NCT01724866|102172985|FG002|Overall Study|Adverse Event|1|||
33220389|NCT00552084|100703371|FG001|Overall Study|change in anti-arrythmic drug|1|||
33220390|NCT00031486|100706737|FG000|Overall Study|Adverse Event|1|||
33220391|NCT00031486|100706738|FG001|Overall Study|Adverse Event|0|||
33359464|NCT01183858|101204439|FG000|Overall Study|Administrative/Other|6|||
33359465|NCT01183858|101204440|FG001|Overall Study|Administrative/Other|6|||
33359466|NCT01183858|101204439|FG000|Overall Study|Progressive Disease|112|||
33359467|NCT01183858|101204440|FG001|Overall Study|Progressive Disease|115|||
33359468|NCT01183858|101204439|FG000|Overall Study|Death related to Progressive Disease|4|||
33359469|NCT01183858|101204440|FG001|Overall Study|Death related to Progressive Disease|5|||
33359470|NCT01183858|101204439|FG000|Overall Study|Lost to Follow-up|1|||
33359471|NCT01183858|101204440|FG001|Overall Study|Lost to Follow-up|1|||
33623866|NCT01724866|102172986|FG003|Overall Study|Adverse Event|1|||
33623867|NCT01724866|102172983|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
33359472|NCT01165229|101204441|FG000|Overall Study|Serious Adverse Event|456|||
33359473|NCT01165229|101204442|FG001|Overall Study|Serious Adverse Event|487|||
33359474|NCT01165229|101204441|FG000|Overall Study|Non-Serious Adverse Event|47|||
33359475|NCT01165229|101204442|FG001|Overall Study|Non-Serious Adverse Event|15|||
33359476|NCT01165229|101204441|FG000|Overall Study|Protocol Violation|6|||
33359477|NCT01165229|101204442|FG001|Overall Study|Protocol Violation|8|||
33359478|NCT01165229|101204441|FG000|Overall Study|Withdrawal by Subject|387|||
33359479|NCT01165229|101204442|FG001|Overall Study|Withdrawal by Subject|396|||
33359480|NCT01165229|101204441|FG000|Overall Study|Migrated/moved from study area|51|||
33560759|NCT03715829|101949001|FG008|Extension Period|Adverse Event|6|||
33359481|NCT01165229|101204442|FG001|Overall Study|Migrated/moved from study area|46|||
33359482|NCT01165229|101204441|FG000|Overall Study|Lost to Follow-up|123|||
33359483|NCT01165229|101204442|FG001|Overall Study|Lost to Follow-up|133|||
33359484|NCT01165229|101204441|FG000|Overall Study|Suspected HZ Episode|2|||
33359485|NCT01165229|101204442|FG001|Overall Study|Suspected HZ Episode|2|||
33359486|NCT01165229|101204441|FG000|Overall Study|No reason from the subject|108|||
33359487|NCT01165229|101204442|FG001|Overall Study|No reason from the subject|102|||
33560760|NCT03715829|101949002|FG009|Extension Period|Adverse Event|0|||
33560761|NCT03715829|101949003|FG010|Extension Period|Adverse Event|0|||
33560762|NCT03715829|101948993|FG000|Extension Period|Lack of Efficacy|0|||
33623868|NCT01724866|102172984|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
33359488|NCT01165229|101204441|FG000|Overall Study|Unknown completion status|0|||
33359489|NCT01165229|101204442|FG001|Overall Study|Unknown completion status|1|||
33359490|NCT01507246|101204443|FG000|Overall Study|Required different surgical procedures|2|||
33560763|NCT03715829|101948994|FG001|Extension Period|Lack of Efficacy|0|||
33560764|NCT03715829|101948995|FG002|Extension Period|Lack of Efficacy|0|||
33560765|NCT03715829|101948996|FG003|Extension Period|Lack of Efficacy|0|||
33560766|NCT03715829|101948997|FG004|Extension Period|Lack of Efficacy|0|||
33560767|NCT03715829|101948998|FG005|Extension Period|Lack of Efficacy|0|||
33560768|NCT03715829|101948999|FG006|Extension Period|Lack of Efficacy|1|||
33560769|NCT03715829|101949000|FG007|Extension Period|Lack of Efficacy|9|||
33560770|NCT03715829|101949001|FG008|Extension Period|Lack of Efficacy|2|||
33623869|NCT01724866|102172985|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
33623870|NCT01724866|102172986|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
33623871|NCT01724866|102172983|FG000|Overall Study|Investigator's Discretion|0|||
33560771|NCT03715829|101949002|FG009|Extension Period|Lack of Efficacy|0|||
33560772|NCT03715829|101949003|FG010|Extension Period|Lack of Efficacy|0|||
33560773|NCT03715829|101948993|FG000|Extension Period|Lost to Follow-up|0|||
33560774|NCT03715829|101948994|FG001|Extension Period|Lost to Follow-up|0|||
33560775|NCT03715829|101948995|FG002|Extension Period|Lost to Follow-up|0|||
33560776|NCT03715829|101948996|FG003|Extension Period|Lost to Follow-up|0|||
33560777|NCT03715829|101948997|FG004|Extension Period|Lost to Follow-up|0|||
33560778|NCT03715829|101948998|FG005|Extension Period|Lost to Follow-up|0|||
33560779|NCT03715829|101948999|FG006|Extension Period|Lost to Follow-up|0|||
33560780|NCT03715829|101949000|FG007|Extension Period|Lost to Follow-up|0|||
33560781|NCT03715829|101949001|FG008|Extension Period|Lost to Follow-up|2|||
33560782|NCT03715829|101949002|FG009|Extension Period|Lost to Follow-up|0|||
33560783|NCT03715829|101949003|FG010|Extension Period|Lost to Follow-up|0|||
33560784|NCT03715829|101948993|FG000|Extension Period|Protocol Violation|0|||
33359491|NCT01507246|101204444|FG001|Overall Study|Required different surgical procedures|1|||
33359492|NCT00393458|101204445|FG000|Overall Study|Adverse Event|35|||
33359493|NCT00393458|101204446|FG001|Overall Study|Adverse Event|24|||
33359494|NCT00393458|101204447|FG002|Overall Study|Adverse Event|40|||
33359495|NCT00393458|101204448|FG003|Overall Study|Adverse Event|35|||
33359496|NCT00393458|101204445|FG000|Overall Study|Subject withdrew consent|27|||
33359497|NCT00393458|101204446|FG001|Overall Study|Subject withdrew consent|40|||
33414629|NCT01915498|101409855|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
33560785|NCT03715829|101948994|FG001|Extension Period|Protocol Violation|0|||
33560786|NCT03715829|101948995|FG002|Extension Period|Protocol Violation|0|||
33359498|NCT00393458|101204447|FG002|Overall Study|Subject withdrew consent|33|||
33359499|NCT00393458|101204448|FG003|Overall Study|Subject withdrew consent|50|||
33359500|NCT00393458|101204445|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
33359501|NCT00393458|101204446|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
33359502|NCT00393458|101204447|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
33359503|NCT00393458|101204448|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
33359504|NCT00393458|101204445|FG000|Overall Study|Protocol deviation|11|||
33359505|NCT00393458|101204446|FG001|Overall Study|Protocol deviation|11|||
33359506|NCT00393458|101204447|FG002|Overall Study|Protocol deviation|11|||
33359507|NCT00393458|101204448|FG003|Overall Study|Protocol deviation|10|||
33359508|NCT00393458|101204445|FG000|Overall Study|Administrative problems|7|||
33359509|NCT00393458|101204446|FG001|Overall Study|Administrative problems|8|||
33359510|NCT00393458|101204447|FG002|Overall Study|Administrative problems|5|||
33359511|NCT00393458|101204448|FG003|Overall Study|Administrative problems|2|||
33560787|NCT03715829|101948996|FG003|Extension Period|Protocol Violation|0|||
33560788|NCT03715829|101948997|FG004|Extension Period|Protocol Violation|0|||
33560789|NCT03715829|101948998|FG005|Extension Period|Protocol Violation|0|||
33560790|NCT03715829|101948999|FG006|Extension Period|Protocol Violation|0|||
33560791|NCT03715829|101949000|FG007|Extension Period|Protocol Violation|0|||
33560792|NCT03715829|101949001|FG008|Extension Period|Protocol Violation|1|||
33220392|NCT00031486|100706737|FG000|Overall Study|Lost to Follow-up|0|||
33560793|NCT03715829|101949002|FG009|Extension Period|Protocol Violation|0|||
33560794|NCT03715829|101949003|FG010|Extension Period|Protocol Violation|0|||
33560795|NCT03715829|101948993|FG000|Extension Period|Withdrawal by Subject|0|||
33560796|NCT03715829|101948994|FG001|Extension Period|Withdrawal by Subject|0|||
33560797|NCT03715829|101948995|FG002|Extension Period|Withdrawal by Subject|0|||
33560798|NCT03715829|101948996|FG003|Extension Period|Withdrawal by Subject|0|||
33560799|NCT03715829|101948997|FG004|Extension Period|Withdrawal by Subject|0|||
33560800|NCT03715829|101948998|FG005|Extension Period|Withdrawal by Subject|0|||
33560801|NCT03715829|101948999|FG006|Extension Period|Withdrawal by Subject|3|||
33560802|NCT03715829|101949000|FG007|Extension Period|Withdrawal by Subject|3|||
33623872|NCT01724866|102172984|FG001|Overall Study|Investigator's Discretion|1|||
33623873|NCT01724866|102172985|FG002|Overall Study|Investigator's Discretion|1|||
33623874|NCT01724866|102172986|FG003|Overall Study|Investigator's Discretion|0|||
33623875|NCT01724866|102172983|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
33623876|NCT01724866|102172984|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
33623877|NCT01724866|102172985|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
33623878|NCT01724866|102172986|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
33623879|NCT01724866|102172983|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
33623880|NCT01724866|102172984|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
33220393|NCT00031486|100706738|FG001|Overall Study|Lost to Follow-up|1|||
33220394|NCT00031486|100706737|FG000|Overall Study|Withdrawal by Subject|3|||
33359512|NCT00393458|101204445|FG000|Overall Study|Lost to Follow-up|5|||
33359513|NCT00393458|101204446|FG001|Overall Study|Lost to Follow-up|6|||
33359514|NCT00393458|101204447|FG002|Overall Study|Lost to Follow-up|5|||
33359515|NCT00393458|101204448|FG003|Overall Study|Lost to Follow-up|3|||
33359516|NCT00393458|101204445|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33359517|NCT00393458|101204446|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33359518|NCT00393458|101204447|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33359519|NCT00393458|101204448|FG003|Overall Study|Abnormal laboratory value(s)|0|||
33359520|NCT00393458|101204445|FG000|Overall Study|Death|1|||
33359521|NCT00393458|101204446|FG001|Overall Study|Death|1|||
33560803|NCT03715829|101949001|FG008|Extension Period|Withdrawal by Subject|12|||
33631308|NCT03486912|102202914|FG000|Treatment Period|Lost to Follow-up|1|||
33560804|NCT03715829|101949002|FG009|Extension Period|Withdrawal by Subject|3|||
33560805|NCT03715829|101949003|FG010|Extension Period|Withdrawal by Subject|0|||
33560806|NCT03715829|101948993|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
33560807|NCT03715829|101948994|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
33560808|NCT03715829|101948995|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
33560809|NCT03715829|101948996|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
33560810|NCT03715829|101948997|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
33560811|NCT03715829|101948998|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
33560812|NCT03715829|101948999|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
33560813|NCT03715829|101949000|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
33560814|NCT03715829|101949001|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
33560815|NCT03715829|101949002|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
33560816|NCT03715829|101949003|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
33560817|NCT03715829|101948993|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
33560818|NCT03715829|101948994|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
33623881|NCT01724866|102172985|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
33623882|NCT01724866|102172986|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
33623883|NCT00216671|102172989|FG000|Overall Study|Adverse Event|4|||
33623884|NCT00216671|102172990|FG001|Overall Study|Adverse Event|9|||
33623885|NCT00216671|102172989|FG000|Overall Study|Pregnancy|0|||
33623886|NCT00216671|102172990|FG001|Overall Study|Pregnancy|1|||
33623887|NCT00216671|102172989|FG000|Overall Study|Withdrawal by Subject|4|||
33623888|NCT00216671|102172990|FG001|Overall Study|Withdrawal by Subject|2|||
33623889|NCT00216671|102172989|FG000|Overall Study|Refused Injections|3|||
33623890|NCT00216671|102172990|FG001|Overall Study|Refused Injections|13|||
33623891|NCT00216671|102172989|FG000|Overall Study|No Need to Continue Medication|1|||
33623892|NCT00216671|102172990|FG001|Overall Study|No Need to Continue Medication|1|||
33623893|NCT00216671|102172989|FG000|Overall Study|Insufficient Response|9|||
33623894|NCT00216671|102172990|FG001|Overall Study|Insufficient Response|4|||
33623895|NCT00216671|102172989|FG000|Overall Study|Lost to Follow-up|3|||
33623896|NCT00216671|102172990|FG001|Overall Study|Lost to Follow-up|5|||
33623897|NCT00216671|102172989|FG000|Overall Study|Non compliant|2|||
33623898|NCT00216671|102172990|FG001|Overall Study|Non compliant|2|||
33623899|NCT00216671|102172989|FG000|Overall Study|Ineligible|0|||
33623900|NCT00216671|102172990|FG001|Overall Study|Ineligible|2|||
33623901|NCT00216671|102172989|FG000|Overall Study|Physician Decision|1|||
33623902|NCT00216671|102172990|FG001|Overall Study|Physician Decision|1|||
33623903|NCT00216671|102172989|FG000|Overall Study|Protocol Violation|3|||
33623904|NCT00216671|102172990|FG001|Overall Study|Protocol Violation|5|||
33623905|NCT00216671|102172989|FG000|Overall Study|Relapse|1|||
33623906|NCT00216671|102172990|FG001|Overall Study|Relapse|0|||
33623907|NCT00216671|102172989|FG000|Overall Study|Investigator Illness|0|||
33623908|NCT00216671|102172990|FG001|Overall Study|Investigator Illness|1|||
33623909|NCT00216671|102172989|FG000|Overall Study|Patient Moved|0|||
33623910|NCT00216671|102172990|FG001|Overall Study|Patient Moved|1|||
33623911|NCT00216671|102172989|FG000|Overall Study|Ineligible, no efficacy data|2|||
33623912|NCT00216671|102172990|FG001|Overall Study|Ineligible, no efficacy data|2|||
33623913|NCT00216671|102172989|FG000|Overall Study|Insufficient Response Adverse Event|2|||
33623914|NCT00216671|102172990|FG001|Overall Study|Insufficient Response Adverse Event|1|||
33623915|NCT03480152|102172991|FG000|Phase I|Signed consent. Died before treatment.|1|||
33623916|NCT03480152|102172992|FG001|Phase I|Signed consent. Died before treatment.|0|||
33623917|NCT03480152|102172993|FG002|Phase I|Signed consent. Died before treatment.|0|||
33623918|NCT01300728|102172995|FG000|Overall Study|Withdrawal by Subject|1|||
33623919|NCT01300728|102172996|FG001|Overall Study|Withdrawal by Subject|1|||
33623920|NCT01300728|102172995|FG000|Overall Study|Physician Decision|1|||
33623921|NCT01300728|102172996|FG001|Overall Study|Physician Decision|0|||
33623922|NCT01421017|102173003|FG000|Overall Study|Withdrawal by Subject|2|||
33623923|NCT01421017|102173004|FG001|Overall Study|Withdrawal by Subject|0|||
33623924|NCT01421017|102173005|FG002|Overall Study|Withdrawal by Subject|0|||
33623925|NCT01421017|102173003|FG000|Overall Study|POD|0|||
33623926|NCT01421017|102173004|FG001|Overall Study|POD|6|||
33623927|NCT01421017|102173005|FG002|Overall Study|POD|3|||
33623928|NCT01046565|102173006|FG000|Overall Study|Adverse Event|2|||
33623929|NCT01046565|102173006|FG000|Overall Study|Withdrawal by Subject|7|||
33623930|NCT01247324|102173007|FG000|Overall Study|Death|6|||
33623931|NCT01247324|102173008|FG001|Overall Study|Death|10|||
33623932|NCT01247324|102173007|FG000|Overall Study|Physician Decision|2|||
33623933|NCT01247324|102173008|FG001|Overall Study|Physician Decision|3|||
33623934|NCT01247324|102173007|FG000|Overall Study|Non-compliance with study drug|3|||
33623935|NCT01247324|102173008|FG001|Overall Study|Non-compliance with study drug|0|||
33623936|NCT01247324|102173007|FG000|Overall Study|Lack of Efficacy|24|||
33623937|NCT01247324|102173008|FG001|Overall Study|Lack of Efficacy|14|||
33623938|NCT01247324|102173007|FG000|Overall Study|Non-compliance|3|||
33623939|NCT01247324|102173008|FG001|Overall Study|Non-compliance|2|||
33623940|NCT01247324|102173007|FG000|Overall Study|Pregnancy|5|||
33623941|NCT01247324|102173008|FG001|Overall Study|Pregnancy|10|||
33623942|NCT01247324|102173007|FG000|Overall Study|Protocol Violation|1|||
33623943|NCT01247324|102173008|FG001|Overall Study|Protocol Violation|1|||
33623944|NCT01247324|102173007|FG000|Overall Study|Reason not specified|42|||
33623945|NCT01247324|102173008|FG001|Overall Study|Reason not specified|32|||
33623946|NCT01247324|102173007|FG000|Overall Study|Consent withdrawn by participant|41|||
33623947|NCT01247324|102173008|FG001|Overall Study|Consent withdrawn by participant|56|||
33623948|NCT01247324|102173007|FG000|Overall Study|Adverse Event|49|||
33623949|NCT01247324|102173008|FG001|Overall Study|Adverse Event|35|||
33623950|NCT01247324|102173007|FG000|Overall Study|Lost to Follow-up|3|||
33623951|NCT01247324|102173008|FG001|Overall Study|Lost to Follow-up|6|||
33623952|NCT01247324|102173007|FG000|Overall Study|Study Terminated by Sponsor|4|||
33623953|NCT01247324|102173008|FG001|Overall Study|Study Terminated by Sponsor|1|||
33623954|NCT01247324|102173007|FG000|Overall Study|Missing|2|||
33623955|NCT01247324|102173008|FG001|Overall Study|Missing|1|||
33623956|NCT00614380|102173014|FG000|Overall Study|Adverse Event|14|||
33623957|NCT00614380|102173015|FG001|Overall Study|Adverse Event|4|||
33623958|NCT00614380|102173016|FG002|Overall Study|Adverse Event|0|||
33623959|NCT00614380|102173017|FG003|Overall Study|Adverse Event|0|||
33623960|NCT00614380|102173014|FG000|Overall Study|Lost to Follow-up|6|||
33560819|NCT03715829|101948995|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
33560820|NCT03715829|101948996|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
33560821|NCT03715829|101948997|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
33560822|NCT03715829|101948998|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
33560823|NCT03715829|101948999|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
33560824|NCT03715829|101949000|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
33560825|NCT03715829|101949001|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
33560826|NCT03715829|101949002|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
33623961|NCT00614380|102173015|FG001|Overall Study|Lost to Follow-up|1|||
33623962|NCT00614380|102173016|FG002|Overall Study|Lost to Follow-up|0|||
33623963|NCT00614380|102173017|FG003|Overall Study|Lost to Follow-up|0|||
33623964|NCT00614380|102173014|FG000|Overall Study|Non compliant with the protocol|12|||
33623965|NCT00614380|102173015|FG001|Overall Study|Non compliant with the protocol|2|||
33623966|NCT00614380|102173016|FG002|Overall Study|Non compliant with the protocol|1|||
33623967|NCT00614380|102173017|FG003|Overall Study|Non compliant with the protocol|2|||
33623968|NCT00614380|102173014|FG000|Overall Study|Consent withdrawn|3|||
33623969|NCT00614380|102173015|FG001|Overall Study|Consent withdrawn|1|||
33623970|NCT00614380|102173016|FG002|Overall Study|Consent withdrawn|0|||
33623971|NCT00614380|102173017|FG003|Overall Study|Consent withdrawn|0|||
33623972|NCT00423657|102173018|FG000|Overall Study|Withdrew consent|10|||
33623973|NCT00423657|102173019|FG001|Overall Study|Withdrew consent|8|||
33623974|NCT00423657|102173018|FG000|Overall Study|Non-compliance|0|||
33560827|NCT03715829|101949003|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
33560828|NCT03715829|101948993|FG000|Extension Period|Other|0|||
33560829|NCT03715829|101948994|FG001|Extension Period|Other|0|||
33560830|NCT03715829|101948995|FG002|Extension Period|Other|0|||
33560831|NCT03715829|101948996|FG003|Extension Period|Other|0|||
33560832|NCT03715829|101948997|FG004|Extension Period|Other|0|||
33560833|NCT03715829|101948998|FG005|Extension Period|Other|0|||
33560834|NCT03715829|101948999|FG006|Extension Period|Other|1|||
33560835|NCT03715829|101949000|FG007|Extension Period|Other|2|||
33560836|NCT03715829|101949001|FG008|Extension Period|Other|4|||
33560837|NCT03715829|101949002|FG009|Extension Period|Other|0|||
33560838|NCT03715829|101949003|FG010|Extension Period|Other|0|||
33560839|NCT01903733|101949004|FG000|Overall Study|Death|23|||
33560840|NCT01903733|101949005|FG001|Overall Study|Death|54|||
33560841|NCT01903733|101949006|FG002|Overall Study|Death|30|||
33560842|NCT01903733|101949007|FG003|Overall Study|Death|98|||
33560843|NCT01903733|101949004|FG000|Overall Study|Participant refused further follow-up|35|||
33560844|NCT01903733|101949005|FG001|Overall Study|Participant refused further follow-up|38|||
33623975|NCT00423657|102173019|FG001|Overall Study|Non-compliance|1|||
33623976|NCT00423657|102173018|FG000|Overall Study|Other|15|||
33560845|NCT01903733|101949006|FG002|Overall Study|Participant refused further follow-up|13|||
33623977|NCT00423657|102173019|FG001|Overall Study|Other|16|||
33623978|NCT00423657|102173018|FG000|Overall Study|Request of sponsor/investigator|1|||
33623979|NCT00423657|102173019|FG001|Overall Study|Request of sponsor/investigator|0|||
33560846|NCT01903733|101949007|FG003|Overall Study|Participant refused further follow-up|9|||
33560847|NCT01903733|101949004|FG000|Overall Study|Lost to Follow-up|18|||
33623980|NCT03367858|102173020|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
33623981|NCT03367858|102173021|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
33560848|NCT01903733|101949005|FG001|Overall Study|Lost to Follow-up|19|||
33560849|NCT01903733|101949006|FG002|Overall Study|Lost to Follow-up|6|||
33560850|NCT01903733|101949007|FG003|Overall Study|Lost to Follow-up|9|||
33560851|NCT01903733|101949004|FG000|Overall Study|Other|10|||
33560852|NCT01903733|101949005|FG001|Overall Study|Other|15|||
33560853|NCT01903733|101949006|FG002|Overall Study|Other|12|||
33560854|NCT01903733|101949007|FG003|Overall Study|Other|3|||
33623982|NCT03367858|102173020|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
33623983|NCT03367858|102173021|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
33623984|NCT03367858|102173020|FG000|3 Month Follow Up|Lost to Follow-up|8|||
33623985|NCT03367858|102173021|FG001|3 Month Follow Up|Lost to Follow-up|3|||
33623986|NCT03367858|102173020|FG000|3 Month Follow Up|Moved out of study area|2|||
33623987|NCT03367858|102173021|FG001|3 Month Follow Up|Moved out of study area|6|||
33623988|NCT03367858|102173020|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
33623989|NCT03367858|102173021|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
33623990|NCT03367858|102173020|FG000|3 Month Follow Up|MRI contraindication|2|||
33623991|NCT03367858|102173021|FG001|3 Month Follow Up|MRI contraindication|1|||
33623992|NCT03367858|102173020|FG000|3 Month Follow Up|Incarcerated|0|||
33623993|NCT03367858|102173021|FG001|3 Month Follow Up|Incarcerated|1|||
33623994|NCT03367858|102173020|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
33623995|NCT03367858|102173021|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
33623996|NCT03367858|102173020|FG000|6 Month Follow Up|Lost to Follow-up|5|||
33623997|NCT03367858|102173021|FG001|6 Month Follow Up|Lost to Follow-up|2|||
33623998|NCT03367858|102173020|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
33623999|NCT03367858|102173021|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
33624000|NCT03367858|102173020|FG000|12 Month Follow Up|Lost to Follow-up|3|||
33624001|NCT03367858|102173021|FG001|12 Month Follow Up|Lost to Follow-up|3|||
33624002|NCT03367858|102173020|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
33624003|NCT03367858|102173021|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
33624004|NCT01092728|102173024|FG000|Overall Study|Withdrawal by Subject|2|||
33624005|NCT01092728|102173025|FG001|Overall Study|Withdrawal by Subject|0|||
33624006|NCT01092728|102173024|FG000|Overall Study|Adverse Event|0|||
33624007|NCT01092728|102173025|FG001|Overall Study|Adverse Event|1|||
33624008|NCT01092728|102173024|FG000|Overall Study|Disease Progression|1|||
33624009|NCT01092728|102173025|FG001|Overall Study|Disease Progression|13|||
33624010|NCT01092728|102173024|FG000|Overall Study|Prohibited Concomitant Medications|1|||
33624011|NCT01092728|102173025|FG001|Overall Study|Prohibited Concomitant Medications|0|||
33624012|NCT02469623|102173026|FG000|Overall Study|Not consented for long-term follow-up|4|||
33624013|NCT02469623|102173026|FG000|Overall Study|Lost to Follow-up|4|||
33624014|NCT02469623|102173026|FG000|Overall Study|Withdrawal by Subject|2|||
33624015|NCT02469623|102173026|FG000|Overall Study|Death|3|||
33359522|NCT00393458|101204447|FG002|Overall Study|Death|5|||
33359523|NCT00393458|101204448|FG003|Overall Study|Death|5|||
33359524|NCT00393458|101204445|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33359525|NCT00393458|101204446|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33220395|NCT00031486|100706738|FG001|Overall Study|Withdrawal by Subject|2|||
33220396|NCT00031486|100706737|FG000|Overall Study|Death|0|||
33359526|NCT00393458|101204447|FG002|Overall Study|Abnormal test procedure result(s)|1|||
33359527|NCT00393458|101204448|FG003|Overall Study|Abnormal test procedure result(s)|2|||
33359528|NCT00393458|101204445|FG000|Overall Study|Subject no longer requires study drug|0|||
33560855|NCT01903733|101949004|FG000|Overall Study|Missing|2|||
33560856|NCT01903733|101949005|FG001|Overall Study|Missing|0|||
33560857|NCT01903733|101949006|FG002|Overall Study|Missing|0|||
33560858|NCT01903733|101949007|FG003|Overall Study|Missing|0|||
33560859|NCT01903733|101949004|FG000|Overall Study|Investigator request|18|||
33560860|NCT01903733|101949005|FG001|Overall Study|Investigator request|0|||
33560861|NCT01903733|101949006|FG002|Overall Study|Investigator request|0|||
33560862|NCT01903733|101949007|FG003|Overall Study|Investigator request|0|||
33560863|NCT02003898|101949014|FG000|Overall Study|Death|3|||
33560864|NCT02003898|101949014|FG000|Overall Study|Lost to Follow-up|12|||
33560865|NCT02003898|101949014|FG000|Overall Study|Withdrawal by Subject|52|||
33560866|NCT01309100|101949015|FG000|Overall Study|Protocol Violation|1|||
33560867|NCT01309100|101949015|FG000|Overall Study|Positive Slit lamp finding|1|||
33560868|NCT00392288|101949019|FG000|Overall Study|Adverse Event|17|||
33560869|NCT00392288|101949020|FG001|Overall Study|Adverse Event|7|||
33560870|NCT00392288|101949021|FG002|Overall Study|Adverse Event|8|||
33220397|NCT00031486|100706738|FG001|Overall Study|Death|3|||
33220398|NCT00031486|100706737|FG000|Overall Study|Non-compliant|0|||
33220399|NCT00031486|100706738|FG001|Overall Study|Non-compliant|4|||
33220400|NCT00031486|100706737|FG000|Overall Study|Did not meet eligibility requirement|2|||
33220401|NCT00031486|100706738|FG001|Overall Study|Did not meet eligibility requirement|1|||
33220402|NCT00031486|100706737|FG000|Overall Study|Other|1|||
33220403|NCT00031486|100706738|FG001|Overall Study|Other|1|||
33220404|NCT00733499|100706740|FG000|Pre-operative|Protocol Violation|0|||
33220405|NCT00733499|100706741|FG001|Pre-operative|Protocol Violation|1|||
33220406|NCT00733499|100706740|FG000|3 Months Follow-up|Death|1|||
33220407|NCT00733499|100706741|FG001|3 Months Follow-up|Death|2|||
33220408|NCT00733499|100706740|FG000|6 Months Follow-up|Death|0|||
33220409|NCT00733499|100706741|FG001|6 Months Follow-up|Death|2|||
33220410|NCT00733499|100706740|FG000|6 Months Follow-up|Adverse Event|0|||
33220411|NCT00733499|100706741|FG001|6 Months Follow-up|Adverse Event|1|||
33560871|NCT00392288|101949019|FG000|Overall Study|Lack of Efficacy|8|||
33560872|NCT00392288|101949020|FG001|Overall Study|Lack of Efficacy|5|||
33560873|NCT00392288|101949021|FG002|Overall Study|Lack of Efficacy|3|||
33560874|NCT00392288|101949019|FG000|Overall Study|Protocol Violation|1|||
33560875|NCT00392288|101949020|FG001|Overall Study|Protocol Violation|3|||
33560876|NCT00392288|101949021|FG002|Overall Study|Protocol Violation|1|||
33220412|NCT00733499|100706740|FG000|12 Months Follow-up|Death|2|||
33220413|NCT00733499|100706741|FG001|12 Months Follow-up|Death|1|||
33560877|NCT00392288|101949019|FG000|Overall Study|Lost to Follow-up|1|||
33560878|NCT00392288|101949020|FG001|Overall Study|Lost to Follow-up|1|||
33560879|NCT00392288|101949021|FG002|Overall Study|Lost to Follow-up|1|||
33560880|NCT00392288|101949019|FG000|Overall Study|Withdrawal by Subject|1|||
33560881|NCT00392288|101949020|FG001|Overall Study|Withdrawal by Subject|0|||
33560882|NCT00392288|101949021|FG002|Overall Study|Withdrawal by Subject|2|||
33560883|NCT00392288|101949019|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
33560884|NCT00392288|101949020|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
33560885|NCT00392288|101949021|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
33560886|NCT00392288|101949019|FG000|Overall Study|Other|3|||
33560887|NCT00392288|101949020|FG001|Overall Study|Other|4|||
33560888|NCT00392288|101949021|FG002|Overall Study|Other|1|||
33560889|NCT04821245|101949022|FG000|Overall Study|Withdrawal by Subject|3|||
33560890|NCT04821245|101949022|FG000|Overall Study|Physician Decision|1|||
33560891|NCT04821245|101949022|FG000|Overall Study|Protocol Violation|5|||
33560892|NCT00185614|101949023|FG000|Inter-treatment Period|Physician Decision|1|||
33560893|NCT00185614|101949023|FG000|Inter-treatment Period|Relapse|2|||
33560894|NCT00185614|101949023|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
33560895|NCT02529488|101949027|FG000|Overall Study|Adverse Event|1|||
33560896|NCT02529488|101949027|FG000|Overall Study|Death|3|||
33560897|NCT03111108|101949028|FG000|Overall Study|Death|0|||
33560898|NCT03111108|101949029|FG001|Overall Study|Death|1|||
33560899|NCT03111108|101949028|FG000|Overall Study|Withdrawal by Subject|1|||
33560900|NCT03111108|101949029|FG001|Overall Study|Withdrawal by Subject|0|||
33560901|NCT01546987|101949030|FG000|Overall Study|Protocol Violation|3|||
33560902|NCT01546987|101949031|FG001|Overall Study|Protocol Violation|4|||
33220414|NCT00733499|100706740|FG000|24 Months Follow-up|Death|0|||
33220415|NCT00733499|100706741|FG001|24 Months Follow-up|Death|1|||
33220416|NCT00733499|100706740|FG000|5 Year Followup|Adverse Event|2|||
33220417|NCT00733499|100706741|FG001|5 Year Followup|Adverse Event|2|||
33220418|NCT00733499|100706740|FG000|5 Year Followup|Non device related AE|0|||
33220419|NCT00733499|100706741|FG001|5 Year Followup|Non device related AE|1|||
33560903|NCT01347086|101949034|FG000|Overall Study|failed screening visit|0|||
33560904|NCT01347086|101949035|FG001|Overall Study|failed screening visit|0|||
33560905|NCT01347086|101949036|FG002|Overall Study|failed screening visit|1|||
33220420|NCT00733499|100706740|FG000|5 Year Followup|Revision of Study Implant|0|||
33220421|NCT00733499|100706741|FG001|5 Year Followup|Revision of Study Implant|1|||
33220422|NCT00733499|100706740|FG000|5 Year Followup|Lost to Follow-up|2|||
33220423|NCT00733499|100706741|FG001|5 Year Followup|Lost to Follow-up|0|||
33220424|NCT00733499|100706740|FG000|5 Year Followup|Death|13|||
33220425|NCT00733499|100706741|FG001|5 Year Followup|Death|19|||
33220426|NCT00733499|100706740|FG000|5 Year Followup|missing, unable to locate|0|||
33220427|NCT00733499|100706741|FG001|5 Year Followup|missing, unable to locate|1|||
33220428|NCT00733499|100706740|FG000|5 Year Followup|Withdrawal by Subject|4|||
33220429|NCT00733499|100706741|FG001|5 Year Followup|Withdrawal by Subject|1|||
33220430|NCT00733499|100706740|FG000|10 Year Followup|Death|9|||
33220431|NCT00733499|100706741|FG001|10 Year Followup|Death|7|||
33220432|NCT00733499|100706740|FG000|10 Year Followup|Adverse Event|3|||
33220433|NCT00733499|100706741|FG001|10 Year Followup|Adverse Event|3|||
33220434|NCT00733499|100706740|FG000|10 Year Followup|Lost to Follow-up|3|||
33220435|NCT00733499|100706741|FG001|10 Year Followup|Lost to Follow-up|2|||
33220436|NCT00733499|100706740|FG000|10 Year Followup|Withdrawal by Subject|5|||
33220437|NCT00733499|100706741|FG001|10 Year Followup|Withdrawal by Subject|5|||
33220438|NCT00733499|100706740|FG000|10 Year Followup|missing, unable to locate|0|||
33220439|NCT00733499|100706741|FG001|10 Year Followup|missing, unable to locate|2|||
33220440|NCT01065350|100706745|FG000|Overall Study|Received incorrect drug allocation|0|||
33220441|NCT01065350|100706746|FG001|Overall Study|Received incorrect drug allocation|1|||
33220442|NCT02856113|100706749|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
33220443|NCT02856113|100706750|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
33220444|NCT02856113|100706749|FG000|Overall Study|Significant Protocol Deviation|1|||
33220445|NCT02856113|100706750|FG001|Overall Study|Significant Protocol Deviation|0|||
33220446|NCT02856113|100706749|FG000|Overall Study|Lost to Follow-up|3|||
33220447|NCT02856113|100706750|FG001|Overall Study|Lost to Follow-up|5|||
33220448|NCT02856113|100706749|FG000|Overall Study|Voluntary Withdrawal|3|||
33220449|NCT02856113|100706750|FG001|Overall Study|Voluntary Withdrawal|5|||
33220450|NCT02856113|100706749|FG000|Overall Study|Pregnancy|0|||
33220451|NCT02856113|100706750|FG001|Overall Study|Pregnancy|1|||
33220452|NCT02856113|100706749|FG000|Overall Study|Principal Investigator Discretion|2|||
33220453|NCT02856113|100706750|FG001|Overall Study|Principal Investigator Discretion|1|||
33220454|NCT02856113|100706749|FG000|Overall Study|Randomized but not Treated|1|||
33220455|NCT02856113|100706750|FG001|Overall Study|Randomized but not Treated|0|||
33220456|NCT02856113|100706749|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
33220457|NCT02856113|100706750|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
33220458|NCT04082884|100706756|FG000|Overall Study|Withdrawal by Subject|1|||
33220459|NCT00827541|100706763|FG000|Overall Study|Exitus|1|||
33220460|NCT00827541|100706764|FG001|Overall Study|Exitus|8|||
33220461|NCT00827541|100706763|FG000|Overall Study|Other|1|||
33220462|NCT00827541|100706764|FG001|Overall Study|Other|3|||
33220463|NCT00827541|100706763|FG000|Overall Study|Pathogen not susceptible|1|||
33220464|NCT00827541|100706764|FG001|Overall Study|Pathogen not susceptible|0|||
33220465|NCT00827541|100706763|FG000|Overall Study|Lack of effectiveness|1|||
33220466|NCT00827541|100706764|FG001|Overall Study|Lack of effectiveness|0|||
33220467|NCT01111123|100706765|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
33220468|NCT01111123|100706766|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
33220469|NCT01111123|100706765|FG000|Maintenance Phase|Lost to Follow-up|0|||
33220470|NCT01111123|100706766|FG001|Maintenance Phase|Lost to Follow-up|2|||
33220471|NCT02940574|100706769|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
33220472|NCT02940574|100706770|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
33220473|NCT02940574|100706769|FG000|1-year Follow-up|Lost to Follow-up|3|||
33220474|NCT02940574|100706770|FG001|1-year Follow-up|Lost to Follow-up|4|||
33220475|NCT02740049|100706773|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
33220476|NCT01120249|100706774|FG000|Overall Study|No protocol treatment received|21|||
33220477|NCT01120249|100706775|FG001|Overall Study|No protocol treatment received|15|||
33220478|NCT01120249|100706774|FG000|Overall Study|Disease recurrence|107|||
33220479|NCT01120249|100706775|FG001|Overall Study|Disease recurrence|57|||
33220480|NCT01120249|100706774|FG000|Overall Study|Death|1|||
33220481|NCT01120249|100706775|FG001|Overall Study|Death|0|||
33220482|NCT01120249|100706774|FG000|Overall Study|Adverse Event|40|||
33220483|NCT01120249|100706775|FG001|Overall Study|Adverse Event|276|||
33359529|NCT00393458|101204446|FG001|Overall Study|Subject no longer requires study drug|1|||
33359530|NCT00393458|101204447|FG002|Overall Study|Subject no longer requires study drug|0|||
33359531|NCT00393458|101204448|FG003|Overall Study|Subject no longer requires study drug|0|||
33220484|NCT01120249|100706774|FG000|Overall Study|Participant refusal|34|||
33220485|NCT01120249|100706775|FG001|Overall Study|Participant refusal|42|||
33220486|NCT01120249|100706774|FG000|Overall Study|Other reasons, not protocol specified|29|||
33220487|NCT01120249|100706775|FG001|Overall Study|Other reasons, not protocol specified|22|||
33220488|NCT00766675|100706776|FG000|Overall Study|Adverse Event|16|||
33220489|NCT00766675|100706776|FG000|Overall Study|Lost to Follow-up|2|||
33220490|NCT00766675|100706776|FG000|Overall Study|Withdrawal by Subject|11|||
33359532|NCT04723537|101204449|FG000|Overall Study|Withdrawal by Subject|3|||
33220491|NCT00766675|100706776|FG000|Overall Study|Protocol Violation|8|||
33220492|NCT00766675|100706776|FG000|Overall Study|Participant took prohibited medication|1|||
33220493|NCT00766675|100706776|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
33220494|NCT00766675|100706776|FG000|Overall Study|Insufficient therapy|1|||
33220495|NCT01984697|100706777|FG000|Overall Study|Adverse Event|0|||
33220496|NCT01984697|100706778|FG001|Overall Study|Adverse Event|0|||
33220497|NCT01984697|100706779|FG002|Overall Study|Adverse Event|2|||
33220498|NCT01984697|100706780|FG003|Overall Study|Adverse Event|0|||
33220499|NCT01984697|100706781|FG004|Overall Study|Adverse Event|0|||
33220500|NCT01984697|100706777|FG000|Overall Study|Lost to Follow-up|14|||
33220501|NCT01984697|100706778|FG001|Overall Study|Lost to Follow-up|5|||
33220502|NCT01984697|100706779|FG002|Overall Study|Lost to Follow-up|10|||
33220503|NCT01984697|100706780|FG003|Overall Study|Lost to Follow-up|6|||
33220504|NCT01984697|100706781|FG004|Overall Study|Lost to Follow-up|21|||
33220505|NCT01984697|100706777|FG000|Overall Study|Physician Decision|3|||
33220506|NCT01984697|100706778|FG001|Overall Study|Physician Decision|0|||
33220507|NCT01984697|100706779|FG002|Overall Study|Physician Decision|0|||
33220508|NCT01984697|100706780|FG003|Overall Study|Physician Decision|1|||
33220509|NCT01984697|100706781|FG004|Overall Study|Physician Decision|0|||
33220510|NCT01984697|100706777|FG000|Overall Study|Protocol Violation|8|||
33220511|NCT01984697|100706778|FG001|Overall Study|Protocol Violation|5|||
33220512|NCT01984697|100706779|FG002|Overall Study|Protocol Violation|3|||
33220513|NCT01984697|100706780|FG003|Overall Study|Protocol Violation|2|||
33220514|NCT01984697|100706781|FG004|Overall Study|Protocol Violation|0|||
33220515|NCT01984697|100706777|FG000|Overall Study|Withdrawal by Subject|15|||
33220516|NCT01984697|100706778|FG001|Overall Study|Withdrawal by Subject|21|||
33220517|NCT01984697|100706779|FG002|Overall Study|Withdrawal by Subject|13|||
33220518|NCT01984697|100706780|FG003|Overall Study|Withdrawal by Subject|11|||
33220519|NCT01984697|100706781|FG004|Overall Study|Withdrawal by Subject|13|||
33220520|NCT01984697|100706777|FG000|Overall Study|Missed last follow-up visit|1|||
33220521|NCT01984697|100706778|FG001|Overall Study|Missed last follow-up visit|0|||
33560906|NCT01347086|101949037|FG003|Overall Study|failed screening visit|0|||
33560907|NCT01347086|101949038|FG004|Overall Study|failed screening visit|0|||
33220522|NCT01984697|100706779|FG002|Overall Study|Missed last follow-up visit|0|||
33560908|NCT01347086|101949039|FG005|Overall Study|failed screening visit|0|||
33560909|NCT01347086|101949040|FG006|Overall Study|failed screening visit|1|||
33560910|NCT01347086|101949041|FG007|Overall Study|failed screening visit|1|||
33560911|NCT01347086|101949042|FG008|Overall Study|failed screening visit|0|||
33560912|NCT01347086|101949043|FG009|Overall Study|failed screening visit|1|||
33560913|NCT02094885|101949047|FG000|Overall Study|Death|1|||
33220523|NCT01984697|100706780|FG003|Overall Study|Missed last follow-up visit|0|||
33220524|NCT01984697|100706781|FG004|Overall Study|Missed last follow-up visit|0|||
33220525|NCT01984697|100706777|FG000|Overall Study|Death|0|||
33220526|NCT01984697|100706778|FG001|Overall Study|Death|0|||
33414630|NCT01915498|101409837|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33560914|NCT02094885|101949048|FG001|Overall Study|Death|5|||
33220527|NCT01984697|100706779|FG002|Overall Study|Death|0|||
33220528|NCT01984697|100706780|FG003|Overall Study|Death|1|||
33220529|NCT01984697|100706781|FG004|Overall Study|Death|0|||
33359533|NCT04723537|101204450|FG001|Overall Study|Withdrawal by Subject|0|||
33359534|NCT04723537|101204451|FG002|Overall Study|Withdrawal by Subject|0|||
33359535|NCT04723537|101204449|FG000|Overall Study|Physician Decision|0|||
33359536|NCT04723537|101204450|FG001|Overall Study|Physician Decision|0|||
33560915|NCT02094885|101949047|FG000|Overall Study|Withdrawn due to age|1|||
33560916|NCT02094885|101949048|FG001|Overall Study|Withdrawn due to age|0|||
33560917|NCT04535362|101949049|FG000|Overall Study|Lost to Follow-up|3|||
33560918|NCT04535362|101949050|FG001|Overall Study|Lost to Follow-up|1|||
33560919|NCT01013870|101949051|FG000|Overall Study|Lost to Follow-up|1|||
33560920|NCT01013870|101949052|FG001|Overall Study|Lost to Follow-up|3|||
33560921|NCT00088881|101949053|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
33560922|NCT00088881|101949053|FG000|Step 1 - R-CHOP|Adverse Event|1|||
33560923|NCT00088881|101949053|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
33560924|NCT00088881|101949053|FG000|Step 1 - R-CHOP|Physician Decision|1|||
33560925|NCT00088881|101949053|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
33560926|NCT00088881|101949053|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
33560927|NCT00088881|101949053|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
33560928|NCT00215657|101949055|FG000|Overall Study|Adverse Event|5|||
33560929|NCT00215657|101949056|FG001|Overall Study|Adverse Event|1|||
33560930|NCT00215657|101949057|FG002|Overall Study|Adverse Event|3|||
33560931|NCT00215657|101949058|FG003|Overall Study|Adverse Event|0|||
33560932|NCT00215657|101949059|FG004|Overall Study|Adverse Event|3|||
33624016|NCT03431441|102173027|FG000|Overall Study|Withdrawal by Subject|2|||
33624017|NCT03431441|102173027|FG000|Overall Study|Adverse Event|2|||
33359537|NCT04723537|101204451|FG002|Overall Study|Physician Decision|1|||
33359538|NCT04723537|101204449|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
33414631|NCT01915498|101409838|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33414632|NCT01915498|101409839|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33414633|NCT01915498|101409840|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33560933|NCT00215657|101949060|FG005|Overall Study|Adverse Event|1|||
33560934|NCT00215657|101949061|FG006|Overall Study|Adverse Event|0|||
33624018|NCT03431441|102173027|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
33624019|NCT00088530|102173032|FG000|Overall Study|Progressive/Relapsed Disease|28|||
33624020|NCT00088530|102173033|FG001|Overall Study|Progressive/Relapsed Disease|39|||
33624021|NCT00088530|102173032|FG000|Overall Study|Adverse Event|15|||
33624022|NCT00088530|102173033|FG001|Overall Study|Adverse Event|9|||
33560935|NCT00215657|101949062|FG007|Overall Study|Adverse Event|3|||
33560936|NCT00215657|101949055|FG000|Overall Study|Withdrawal by Subject|6|||
33624023|NCT00088530|102173032|FG000|Overall Study|Withdrawal by Subject|2|||
33220530|NCT01984697|100706777|FG000|Overall Study|Pregnancy|2|||
33359539|NCT04723537|101204450|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
33359540|NCT04723537|101204451|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
33220531|NCT01984697|100706778|FG001|Overall Study|Pregnancy|0|||
33220532|NCT01984697|100706779|FG002|Overall Study|Pregnancy|1|||
33220533|NCT01984697|100706780|FG003|Overall Study|Pregnancy|0|||
33220534|NCT01984697|100706781|FG004|Overall Study|Pregnancy|1|||
33220535|NCT00989092|100706786|FG000|Overall Study|Physician Decision|9|||
33220536|NCT00989092|100706787|FG001|Overall Study|Physician Decision|6|||
33220537|NCT00989092|100706786|FG000|Overall Study|Adverse Event|20|||
33220538|NCT00989092|100706787|FG001|Overall Study|Adverse Event|1|||
33624024|NCT00088530|102173033|FG001|Overall Study|Withdrawal by Subject|5|||
33624025|NCT00088530|102173032|FG000|Overall Study|Lost to Follow-up|2|||
33624026|NCT00088530|102173033|FG001|Overall Study|Lost to Follow-up|0|||
33624027|NCT00088530|102173032|FG000|Overall Study|Physician Decision|2|||
33624028|NCT00088530|102173033|FG001|Overall Study|Physician Decision|0|||
33624029|NCT00088530|102173032|FG000|Overall Study|Sponsor decision|0|||
33624030|NCT00088530|102173033|FG001|Overall Study|Sponsor decision|1|||
33624031|NCT00088530|102173032|FG000|Overall Study|Patient never treated|1|||
33624032|NCT00088530|102173033|FG001|Overall Study|Patient never treated|0|||
33624033|NCT04612725|102173042|FG000|Overall Study|Adverse Event|1|||
33624034|NCT04612725|102173043|FG001|Overall Study|Adverse Event|3|||
33220539|NCT00989092|100706786|FG000|Overall Study|Chemotherapy initiated|12|||
33220540|NCT00989092|100706787|FG001|Overall Study|Chemotherapy initiated|4|||
33624035|NCT04612725|102173044|FG002|Overall Study|Adverse Event|1|||
33624036|NCT04612725|102173045|FG003|Overall Study|Adverse Event|0|||
33624037|NCT04612725|102173046|FG004|Overall Study|Adverse Event|1|||
33624038|NCT04612725|102173042|FG000|Overall Study|Lost to Follow-up|0|||
33624039|NCT04612725|102173043|FG001|Overall Study|Lost to Follow-up|1|||
33624040|NCT04612725|102173044|FG002|Overall Study|Lost to Follow-up|0|||
33624041|NCT04612725|102173045|FG003|Overall Study|Lost to Follow-up|0|||
33624042|NCT04612725|102173046|FG004|Overall Study|Lost to Follow-up|0|||
33624043|NCT04612725|102173042|FG000|Overall Study|Physician Decision|2|||
33624044|NCT04612725|102173043|FG001|Overall Study|Physician Decision|0|||
33624045|NCT04612725|102173044|FG002|Overall Study|Physician Decision|0|||
33624046|NCT04612725|102173045|FG003|Overall Study|Physician Decision|0|||
33624047|NCT04612725|102173046|FG004|Overall Study|Physician Decision|0|||
33624048|NCT04612725|102173042|FG000|Overall Study|Study terminated by sponsor|3|||
33624049|NCT04612725|102173043|FG001|Overall Study|Study terminated by sponsor|1|||
33624050|NCT04612725|102173044|FG002|Overall Study|Study terminated by sponsor|2|||
33624051|NCT04612725|102173045|FG003|Overall Study|Study terminated by sponsor|4|||
33220541|NCT00989092|100706786|FG000|Overall Study|Withdrawal by Subject|17|||
33220542|NCT00989092|100706787|FG001|Overall Study|Withdrawal by Subject|9|||
33220543|NCT00989092|100706786|FG000|Overall Study|Death|14|||
33220544|NCT00989092|100706787|FG001|Overall Study|Death|2|||
33220545|NCT00989092|100706786|FG000|Overall Study|Ineligibility determined|3|||
33624052|NCT04612725|102173046|FG004|Overall Study|Study terminated by sponsor|5|||
33624053|NCT04612725|102173042|FG000|Overall Study|Withdrawal by Subject|8|||
33624054|NCT04612725|102173043|FG001|Overall Study|Withdrawal by Subject|3|||
33624055|NCT04612725|102173044|FG002|Overall Study|Withdrawal by Subject|5|||
33624056|NCT04612725|102173045|FG003|Overall Study|Withdrawal by Subject|1|||
33624057|NCT04612725|102173046|FG004|Overall Study|Withdrawal by Subject|9|||
33220546|NCT00989092|100706787|FG001|Overall Study|Ineligibility determined|3|||
33624058|NCT04612725|102173042|FG000|Overall Study|Other|0|||
33624059|NCT04612725|102173043|FG001|Overall Study|Other|0|||
33359541|NCT02082184|101204452|FG000|Overall Study|Adverse Event|1|||
33359542|NCT02082184|101204453|FG001|Overall Study|Adverse Event|0|||
33359543|NCT02082184|101204452|FG000|Overall Study|Medical diagnosis|1|||
33359544|NCT02082184|101204453|FG001|Overall Study|Medical diagnosis|2|||
33359545|NCT02082184|101204452|FG000|Overall Study|Device associated symptoms|5|||
33359546|NCT02082184|101204453|FG001|Overall Study|Device associated symptoms|0|||
33560937|NCT00215657|101949056|FG001|Overall Study|Withdrawal by Subject|3|||
33560938|NCT00215657|101949057|FG002|Overall Study|Withdrawal by Subject|3|||
33624060|NCT04612725|102173044|FG002|Overall Study|Other|0|||
33624061|NCT04612725|102173045|FG003|Overall Study|Other|0|||
33624062|NCT04612725|102173046|FG004|Overall Study|Other|1|||
33624063|NCT00416624|102173056|FG000|Overall Study|Withdrawal by Subject|1|||
33624064|NCT00416624|102173057|FG001|Overall Study|Withdrawal by Subject|6|||
33624065|NCT00416624|102173058|FG002|Overall Study|Withdrawal by Subject|4|||
33560939|NCT00215657|101949058|FG003|Overall Study|Withdrawal by Subject|1|||
33560940|NCT00215657|101949059|FG004|Overall Study|Withdrawal by Subject|6|||
33560941|NCT00215657|101949060|FG005|Overall Study|Withdrawal by Subject|1|||
33560942|NCT00215657|101949061|FG006|Overall Study|Withdrawal by Subject|10|||
33560943|NCT00215657|101949062|FG007|Overall Study|Withdrawal by Subject|3|||
33560944|NCT00215657|101949055|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
33560945|NCT00215657|101949056|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
33560946|NCT00215657|101949057|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
33560947|NCT00215657|101949058|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
33624066|NCT00416624|102173059|FG003|Overall Study|Withdrawal by Subject|9|||
33624067|NCT00416624|102173056|FG000|Overall Study|Death|4|||
33624068|NCT00416624|102173057|FG001|Overall Study|Death|7|||
33624069|NCT00416624|102173058|FG002|Overall Study|Death|7|||
33624070|NCT00416624|102173059|FG003|Overall Study|Death|1|||
33624071|NCT00416624|102173056|FG000|Overall Study|Adverse Event|8|||
33359547|NCT02082184|101204452|FG000|Overall Study|Withdrawal by Subject|3|||
33359548|NCT02082184|101204453|FG001|Overall Study|Withdrawal by Subject|2|||
33359549|NCT02082184|101204452|FG000|Overall Study|Protocol Violation|0|||
33359550|NCT02082184|101204453|FG001|Overall Study|Protocol Violation|6|||
33359551|NCT02082184|101204452|FG000|Overall Study|Lost to Follow-up|0|||
33359552|NCT02082184|101204453|FG001|Overall Study|Lost to Follow-up|2|||
33359553|NCT02082184|101204452|FG000|Overall Study|Subject non-compliance|0|||
33359554|NCT02082184|101204453|FG001|Overall Study|Subject non-compliance|1|||
33359555|NCT01614457|101204454|FG000|Overall Study|Non-Compliance|1|||
33359556|NCT01614457|101204455|FG001|Overall Study|Non-Compliance|0|||
33359557|NCT01614457|101204454|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
33359558|NCT01614457|101204455|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
33359559|NCT01282814|101204456|FG000|First Intervention|Emesis During Dosing Interval|0|||
33359560|NCT01282814|101204457|FG001|First Intervention|Emesis During Dosing Interval|3|||
33359561|NCT01282814|101204456|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
33359562|NCT01282814|101204457|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
33359563|NCT02285010|101204458|FG000|Overall Study|not abdominal hysterectomy|2|||
33359564|NCT02285010|101204459|FG001|Overall Study|not abdominal hysterectomy|0|||
33359565|NCT02285010|101204458|FG000|Overall Study|Not spinal anesthesia|3|||
33359566|NCT02285010|101204459|FG001|Overall Study|Not spinal anesthesia|1|||
33359567|NCT02426086|101204464|FG000|Overall Study|Death|33|||
33359568|NCT02426086|101204465|FG001|Overall Study|Death|36|||
33359569|NCT02426086|101204464|FG000|Overall Study|Lost to Follow-up|2|||
33359570|NCT02426086|101204465|FG001|Overall Study|Lost to Follow-up|0|||
33359571|NCT02426086|101204464|FG000|Overall Study|Study Terminated by Sponsor|5|||
33359572|NCT02426086|101204465|FG001|Overall Study|Study Terminated by Sponsor|14|||
33359573|NCT02426086|101204464|FG000|Overall Study|Withdrawal by Subject|8|||
33359574|NCT02426086|101204465|FG001|Overall Study|Withdrawal by Subject|9|||
33359575|NCT05165394|101204468|FG000|Overall Study|Withdrawal by Subject|5|||
33359576|NCT05165394|101204469|FG001|Overall Study|Withdrawal by Subject|1|||
33359577|NCT05165394|101204468|FG000|Overall Study|Lost to Follow-up|1|||
33560948|NCT00215657|101949059|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
33624072|NCT00416624|102173057|FG001|Overall Study|Adverse Event|3|||
33624073|NCT00416624|102173058|FG002|Overall Study|Adverse Event|2|||
33624074|NCT00416624|102173059|FG003|Overall Study|Adverse Event|2|||
33624075|NCT00416624|102173056|FG000|Overall Study|Other|8|||
33624076|NCT00416624|102173057|FG001|Overall Study|Other|11|||
33624077|NCT00416624|102173058|FG002|Overall Study|Other|5|||
33624078|NCT00416624|102173059|FG003|Overall Study|Other|5|||
33359578|NCT05165394|101204469|FG001|Overall Study|Lost to Follow-up|2|||
33359579|NCT05165394|101204468|FG000|Overall Study|Other Than Specified|0|||
33359580|NCT05165394|101204469|FG001|Overall Study|Other Than Specified|1|||
33359581|NCT00519623|101204472|FG000|Overall Study|Adverse Event|1|||
33359582|NCT02400346|101204477|FG000|Overall Study|Adverse Event|24|||
33359583|NCT02400346|101204477|FG000|Overall Study|Lack of Efficacy|9|||
33359584|NCT02400346|101204477|FG000|Overall Study|Non-compliance with IMP|1|||
33359585|NCT02400346|101204477|FG000|Overall Study|Withdrawal by Subject|7|||
33359586|NCT02400346|101204477|FG000|Overall Study|Administrative or other reason(s)|2|||
33359587|NCT02400346|101204477|FG000|Overall Study|Lost to Follow-up|1|||
33359588|NCT01478347|101204483|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
33560949|NCT00215657|101949060|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
33560950|NCT00215657|101949061|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
33624079|NCT00416624|102173056|FG000|Overall Study|Cancel|1|||
33624080|NCT00416624|102173057|FG001|Overall Study|Cancel|0|||
33624081|NCT00416624|102173058|FG002|Overall Study|Cancel|0|||
33624082|NCT00416624|102173059|FG003|Overall Study|Cancel|0|||
33624083|NCT01894607|102173064|FG000|Overall Study|Ineligible|1|||
33624084|NCT02090426|102173065|FG000|Overall Study|Lost to Follow-up|12|||
33624085|NCT02090426|102173066|FG001|Overall Study|Lost to Follow-up|6|||
33624086|NCT01788566|102173067|FG000|Overall Study|Death|4|||
33624087|NCT01788566|102173067|FG000|Overall Study|Adverse Event|1|||
33624088|NCT01788566|102173067|FG000|Overall Study|Clinical Progressive Disease|3|||
33359589|NCT01478347|101204483|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
33359590|NCT01478347|101204483|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
33560951|NCT00215657|101949062|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
33560952|NCT00215657|101949055|FG000|Overall Study|Insufficient testosterone response|5|||
33560953|NCT00215657|101949056|FG001|Overall Study|Insufficient testosterone response|4|||
33560954|NCT00215657|101949057|FG002|Overall Study|Insufficient testosterone response|1|||
33624089|NCT01917747|102173073|FG000|Overall Study|Withdrawal by Subject|1|||
33624090|NCT01917747|102173074|FG001|Overall Study|Withdrawal by Subject|2|||
33624091|NCT01917747|102173073|FG000|Overall Study|Lost to Follow-up|18|||
33624092|NCT01917747|102173074|FG001|Overall Study|Lost to Follow-up|9|||
33624093|NCT00141102|102173075|FG000|Overall Study|Adverse Event|233|||
33624094|NCT00141102|102173076|FG001|Overall Study|Adverse Event|305|||
33359591|NCT01050062|101204484|FG000|Overall Study|Adverse Event|75|||
33359592|NCT01050062|101204485|FG001|Overall Study|Adverse Event|22|||
33359593|NCT01050062|101204484|FG000|Overall Study|Lost to Follow-up|83|||
33359594|NCT01050062|101204485|FG001|Overall Study|Lost to Follow-up|35|||
33359595|NCT01050062|101204484|FG000|Overall Study|Lack of Efficacy|22|||
33359596|NCT01050062|101204485|FG001|Overall Study|Lack of Efficacy|35|||
33359597|NCT01050062|101204484|FG000|Overall Study|Physician Decision|74|||
33220547|NCT00989092|100706786|FG000|Overall Study|Lost to Follow-up|6|||
33220548|NCT00989092|100706787|FG001|Overall Study|Lost to Follow-up|2|||
33359598|NCT01050062|101204485|FG001|Overall Study|Physician Decision|9|||
33359599|NCT01050062|101204484|FG000|Overall Study|Others|17|||
33359600|NCT01050062|101204485|FG001|Overall Study|Others|11|||
33359601|NCT00283712|101204486|FG000|Overall Study|Death|0|||
33359602|NCT00283712|101204487|FG001|Overall Study|Death|1|||
33359603|NCT03607682|101204488|FG000|Overall Study|Withdrawal by Subject|1|||
33359604|NCT03607682|101204488|FG000|Overall Study|Disease progression|1|||
33359605|NCT02273973|101204489|FG000|Overall Study|Adverse Event|4|||
33359606|NCT02273973|101204490|FG001|Overall Study|Adverse Event|0|||
33359607|NCT02273973|101204489|FG000|Overall Study|Withdrawal by Subject|2|||
33359608|NCT02273973|101204490|FG001|Overall Study|Withdrawal by Subject|3|||
33359609|NCT02273973|101204489|FG000|Overall Study|Death|1|||
33359610|NCT02273973|101204490|FG001|Overall Study|Death|0|||
33359611|NCT02273973|101204489|FG000|Overall Study|Non-compliance|1|||
33359612|NCT02273973|101204490|FG001|Overall Study|Non-compliance|0|||
33359613|NCT02273973|101204489|FG000|Overall Study|Protocol Violation|1|||
33359614|NCT02273973|101204490|FG001|Overall Study|Protocol Violation|0|||
33359615|NCT02273973|101204489|FG000|Overall Study|Progression of disease|0|||
33359616|NCT02273973|101204490|FG001|Overall Study|Progression of disease|2|||
33359617|NCT02273973|101204489|FG000|Overall Study|Lost to Follow-up|0|||
33359618|NCT02273973|101204490|FG001|Overall Study|Lost to Follow-up|1|||
33359619|NCT02273973|101204489|FG000|Overall Study|Physician Decision|0|||
33359620|NCT02273973|101204490|FG001|Overall Study|Physician Decision|1|||
33359621|NCT02273973|101204489|FG000|Overall Study|Reason not specified|0|||
33359622|NCT02273973|101204490|FG001|Overall Study|Reason not specified|1|||
33359623|NCT03941548|101204491|FG000|Overall Study|Adverse Event|0|||
33359624|NCT03941548|101204492|FG001|Overall Study|Adverse Event|1|||
33359625|NCT03941548|101204491|FG000|Overall Study|Lost to Follow-up|0|||
33359626|NCT03941548|101204492|FG001|Overall Study|Lost to Follow-up|1|||
33359627|NCT03941548|101204491|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
33359628|NCT03941548|101204492|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
33359629|NCT00663858|101204494|FG000|Overall Study|Adverse Event|9|||
33359630|NCT00663858|101204495|FG001|Overall Study|Adverse Event|1|||
33359631|NCT00663858|101204496|FG002|Overall Study|Adverse Event|6|||
33359632|NCT00663858|101204494|FG000|Overall Study|Lack of Efficacy|5|||
33359633|NCT00663858|101204495|FG001|Overall Study|Lack of Efficacy|1|||
33359634|NCT00663858|101204496|FG002|Overall Study|Lack of Efficacy|3|||
33359635|NCT00663858|101204494|FG000|Overall Study|Withdrawal by Subject|7|||
33359636|NCT00663858|101204495|FG001|Overall Study|Withdrawal by Subject|3|||
33359637|NCT00663858|101204496|FG002|Overall Study|Withdrawal by Subject|3|||
33359638|NCT00663858|101204494|FG000|Overall Study|Protocol Violation|5|||
33359639|NCT00663858|101204495|FG001|Overall Study|Protocol Violation|3|||
33359640|NCT00663858|101204496|FG002|Overall Study|Protocol Violation|4|||
33359641|NCT00663858|101204494|FG000|Overall Study|Other|8|||
33359642|NCT00663858|101204495|FG001|Overall Study|Other|2|||
33359643|NCT00663858|101204496|FG002|Overall Study|Other|4|||
33359644|NCT02559505|101204497|FG000|Overall Study|Lost to Follow-up|23|||
33359645|NCT02559505|101204498|FG001|Overall Study|Lost to Follow-up|20|||
33359646|NCT02559505|101204497|FG000|Overall Study|Withdrawal by Subject|4|||
33359647|NCT02559505|101204498|FG001|Overall Study|Withdrawal by Subject|2|||
33359648|NCT00091793|101204512|FG000|Overall Study|Adverse Event|1|||
33359649|NCT00091793|101204513|FG001|Overall Study|Adverse Event|2|||
33359650|NCT00091793|101204512|FG000|Overall Study|Withdrawal by Subject|10|||
33359651|NCT00091793|101204513|FG001|Overall Study|Withdrawal by Subject|15|||
33220549|NCT00989092|100706786|FG000|Overall Study|Other|3|||
33220550|NCT00989092|100706787|FG001|Overall Study|Other|1|||
33359652|NCT00091793|101204512|FG000|Overall Study|Ineligibility determined|2|||
33359653|NCT00091793|101204513|FG001|Overall Study|Ineligibility determined|0|||
33359654|NCT00091793|101204512|FG000|Overall Study|Lost to Follow-up|7|||
33359655|NCT00091793|101204513|FG001|Overall Study|Lost to Follow-up|5|||
33359656|NCT00091793|101204512|FG000|Overall Study|Noncompliance|2|||
33359657|NCT00091793|101204513|FG001|Overall Study|Noncompliance|0|||
33359658|NCT00091793|101204512|FG000|Overall Study|Other|2|||
33359659|NCT00091793|101204513|FG001|Overall Study|Other|0|||
33359660|NCT02403206|101204514|FG000|Overall Study|Lost to Follow-up|4|||
33359661|NCT02403206|101204515|FG001|Overall Study|Lost to Follow-up|3|||
33359662|NCT02403206|101204514|FG000|Overall Study|Physician Decision|2|||
33359663|NCT02403206|101204515|FG001|Overall Study|Physician Decision|0|||
33359664|NCT02403206|101204514|FG000|Overall Study|Withdrawal by Subject|3|||
33359665|NCT02403206|101204515|FG001|Overall Study|Withdrawal by Subject|3|||
33359666|NCT02403206|101204514|FG000|Overall Study|Reason not given|2|||
33359667|NCT02403206|101204515|FG001|Overall Study|Reason not given|4|||
33359668|NCT00783289|101204520|FG000|Overall Study|Protocol Violation|0|||
33359669|NCT00783289|101204521|FG001|Overall Study|Protocol Violation|1|||
33359670|NCT00783289|101204522|FG002|Overall Study|Protocol Violation|0|||
33359671|NCT00783289|101204523|FG003|Overall Study|Protocol Violation|0|||
33359672|NCT01164501|101204525|FG000|Overall Study|Not treated|2|||
33359673|NCT01164501|101204526|FG001|Overall Study|Not treated|0|||
33414634|NCT01915498|101409841|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33414635|NCT01915498|101409842|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33414636|NCT01915498|101409843|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33414637|NCT01915498|101409844|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33414638|NCT01915498|101409845|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33414639|NCT01915498|101409846|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33414640|NCT01915498|101409847|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
33414641|NCT01915498|101409848|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33414642|NCT01915498|101409849|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33414643|NCT01915498|101409850|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
33414644|NCT01915498|101409851|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33220551|NCT00989092|100706786|FG000|Overall Study|Protocol deviation|2|||
33220552|NCT00989092|100706787|FG001|Overall Study|Protocol deviation|0|||
33414645|NCT01915498|101409852|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33560955|NCT00215657|101949058|FG003|Overall Study|Insufficient testosterone response|12|||
33560956|NCT00215657|101949059|FG004|Overall Study|Insufficient testosterone response|8|||
33560957|NCT00215657|101949060|FG005|Overall Study|Insufficient testosterone response|12|||
33220553|NCT00989092|100706786|FG000|Overall Study|Erythropoietin therapy initiated|2|||
33560958|NCT00215657|101949061|FG006|Overall Study|Insufficient testosterone response|4|||
33560959|NCT00215657|101949062|FG007|Overall Study|Insufficient testosterone response|7|||
33560960|NCT00215657|101949055|FG000|Overall Study|Other|3|||
33560961|NCT00215657|101949056|FG001|Overall Study|Other|1|||
33560962|NCT00215657|101949057|FG002|Overall Study|Other|2|||
33560963|NCT00215657|101949058|FG003|Overall Study|Other|3|||
33560964|NCT00215657|101949059|FG004|Overall Study|Other|5|||
33560965|NCT00215657|101949060|FG005|Overall Study|Other|4|||
33560966|NCT00215657|101949061|FG006|Overall Study|Other|6|||
33560967|NCT00215657|101949062|FG007|Overall Study|Other|1|||
33560968|NCT00309946|101949063|FG000|Overall Study|Withdrawal by Subject|1|||
33560969|NCT03794544|101949064|FG000|Overall Study|Withdrawal by Subject|1|||
33560970|NCT03794544|101949065|FG001|Overall Study|Withdrawal by Subject|1|||
33560971|NCT03794544|101949066|FG002|Overall Study|Withdrawal by Subject|0|||
33560972|NCT03794544|101949067|FG003|Overall Study|Withdrawal by Subject|0|||
33560973|NCT03794544|101949064|FG000|Overall Study|Death|0|||
33220554|NCT00989092|100706787|FG001|Overall Study|Erythropoietin therapy initiated|0|||
33560974|NCT03794544|101949065|FG001|Overall Study|Death|0|||
33359674|NCT01164501|101204527|FG002|Overall Study|Not treated|1|||
33414646|NCT01915498|101409853|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
33414647|NCT01915498|101409854|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
33414648|NCT01915498|101409855|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
33359675|NCT01164501|101204525|FG000|Overall Study|Adverse Event|18|||
33359676|NCT01164501|101204526|FG001|Overall Study|Adverse Event|4|||
33359677|NCT01164501|101204527|FG002|Overall Study|Adverse Event|21|||
33359678|NCT01164501|101204525|FG000|Overall Study|Lack of Efficacy|0|||
33359679|NCT01164501|101204526|FG001|Overall Study|Lack of Efficacy|0|||
33359680|NCT01164501|101204527|FG002|Overall Study|Lack of Efficacy|1|||
33359681|NCT01164501|101204525|FG000|Overall Study|Non compliant with protocol|1|||
33359682|NCT01164501|101204526|FG001|Overall Study|Non compliant with protocol|1|||
33359683|NCT01164501|101204527|FG002|Overall Study|Non compliant with protocol|4|||
33359684|NCT01164501|101204525|FG000|Overall Study|Lost to Follow-up|3|||
33359685|NCT01164501|101204526|FG001|Overall Study|Lost to Follow-up|0|||
33359686|NCT01164501|101204527|FG002|Overall Study|Lost to Follow-up|3|||
33414649|NCT01915498|101409837|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
33414650|NCT01915498|101409838|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
33414651|NCT01915498|101409839|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33560975|NCT03794544|101949066|FG002|Overall Study|Death|0|||
33560976|NCT03794544|101949067|FG003|Overall Study|Death|1|||
33560977|NCT03794544|101949064|FG000|Overall Study|Lost to Follow-up|0|||
33560978|NCT03794544|101949065|FG001|Overall Study|Lost to Follow-up|1|||
33560979|NCT03794544|101949066|FG002|Overall Study|Lost to Follow-up|1|||
33359687|NCT01164501|101204525|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
33359688|NCT01164501|101204526|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
33560980|NCT03794544|101949067|FG003|Overall Study|Lost to Follow-up|0|||
33560981|NCT03794544|101949064|FG000|Overall Study|Other|0|||
33560982|NCT03794544|101949065|FG001|Overall Study|Other|1|||
33560983|NCT03794544|101949066|FG002|Overall Study|Other|0|||
33560984|NCT03794544|101949067|FG003|Overall Study|Other|0|||
33560985|NCT01027754|101949076|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
33560986|NCT01027754|101949077|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
33560987|NCT01027754|101949076|FG000|Overall Study|Withdrawal by Subject|0|||
33560988|NCT01027754|101949077|FG001|Overall Study|Withdrawal by Subject|5|||
33560989|NCT03996395|101949078|FG000|Overall Study|Lost to Follow-up|4|||
33560990|NCT03996395|101949078|FG000|Overall Study|Withdrawal by Subject|1|||
33560991|NCT03996395|101949078|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
33560992|NCT02264821|101949079|FG000|Overall Study|Protocol Violation|1|||
33560993|NCT02264821|101949080|FG001|Overall Study|Protocol Violation|3|||
33624095|NCT00141102|102173075|FG000|Overall Study|Laboratory Abnormality|9|||
33624096|NCT00141102|102173076|FG001|Overall Study|Laboratory Abnormality|33|||
33624097|NCT00141102|102173075|FG000|Overall Study|Lack of Efficacy|21|||
33624098|NCT00141102|102173076|FG001|Overall Study|Lack of Efficacy|26|||
33624099|NCT00141102|102173075|FG000|Overall Study|Lost to Follow-up|29|||
33624100|NCT00141102|102173076|FG001|Overall Study|Lost to Follow-up|32|||
33359689|NCT01164501|101204527|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
33359690|NCT01164501|101204525|FG000|Overall Study|Other reason not defined above|9|||
33359691|NCT01164501|101204526|FG001|Overall Study|Other reason not defined above|1|||
33359692|NCT01164501|101204527|FG002|Overall Study|Other reason not defined above|4|||
33359693|NCT00546351|101204537|FG000|Overall Study|Adverse Event|76|||
33359694|NCT00546351|101204537|FG000|Overall Study|Lack of Efficacy|15|||
33359695|NCT00546351|101204537|FG000|Overall Study|Withdrawal by Subject|109|||
33560994|NCT02264821|101949081|FG002|Overall Study|Protocol Violation|6|||
33560995|NCT01687595|101949084|FG000|Overall Study|Withdrawal by Subject|8|||
33624101|NCT00141102|102173075|FG000|Overall Study|Other|87|||
33624102|NCT00141102|102173076|FG001|Overall Study|Other|76|||
33624103|NCT00141102|102173075|FG000|Overall Study|Withdrawal by Subject|112|||
33624104|NCT00141102|102173076|FG001|Overall Study|Withdrawal by Subject|142|||
33624105|NCT00141102|102173075|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
33624106|NCT00141102|102173076|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
33624107|NCT00141102|102173075|FG000|Overall Study|Death|2|||
33624108|NCT00141102|102173076|FG001|Overall Study|Death|2|||
33624109|NCT00833040|102173077|FG000|Overall Study|Adverse Event|0|||
33624110|NCT00833040|102173078|FG001|Overall Study|Adverse Event|0|||
33624111|NCT00833040|102173079|FG002|Overall Study|Adverse Event|0|||
33624112|NCT00833040|102173080|FG003|Overall Study|Adverse Event|0|||
33624113|NCT00833040|102173081|FG004|Overall Study|Adverse Event|0|||
33624114|NCT00833040|102173082|FG005|Overall Study|Adverse Event|1|||
33624115|NCT00730158|102173083|FG000|Overall Study|Withdrawal by Subject|1|||
33359696|NCT00546351|101204537|FG000|Overall Study|Lost to Follow-up|9|||
33359697|NCT00546351|101204537|FG000|Overall Study|Protocol Deviation|1|||
33359698|NCT00546351|101204537|FG000|Overall Study|Unsatisfactory compliance|9|||
33359699|NCT00546351|101204537|FG000|Overall Study|Other reasons for premature termination|17|||
33560996|NCT01687595|101949085|FG001|Overall Study|Withdrawal by Subject|0|||
33560997|NCT01687595|101949084|FG000|Overall Study|Lost to Follow-up|3|||
33414652|NCT01915498|101409840|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
33624116|NCT00730158|102173084|FG001|Overall Study|Withdrawal by Subject|1|||
33624117|NCT00217425|102173098|FG000|Overall Study|Never started treatment|2|||
33624118|NCT00217425|102173098|FG000|Overall Study|Patient ineligible|5|||
33624119|NCT00217425|102173098|FG000|Overall Study|Lack of Efficacy|13|||
33624120|NCT00217425|102173098|FG000|Overall Study|Adverse Event|8|||
33624121|NCT00217425|102173098|FG000|Overall Study|Withdrawal by Subject|4|||
33624122|NCT00217425|102173098|FG000|Overall Study|Other complicating disease|1|||
33624123|NCT00217425|102173098|FG000|Overall Study|Other|4|||
33414653|NCT01915498|101409841|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33624124|NCT01392547|102173099|FG000|Overall Study|Adverse Event|2|||
33624125|NCT01392547|102173099|FG000|Overall Study|Non-compliance|2|||
33624126|NCT01392547|102173099|FG000|Overall Study|Withdrawal criteria|3|||
33624127|NCT01392547|102173099|FG000|Overall Study|Unclassified|1|||
33624128|NCT00681629|102173104|FG000|Overall Study|Study termination|4|||
33624129|NCT00681629|102173105|FG001|Overall Study|Study termination|2|||
33624130|NCT00681629|102173104|FG000|Overall Study|Adverse Event|1|||
33624131|NCT00681629|102173105|FG001|Overall Study|Adverse Event|0|||
33624132|NCT03951077|102173108|FG000|Overall Study|Adverse Event|1|||
33624133|NCT03951077|102173109|FG001|Overall Study|Adverse Event|0|||
33624134|NCT03951077|102173110|FG002|Overall Study|Adverse Event|0|||
33624135|NCT03951077|102173111|FG003|Overall Study|Adverse Event|0|||
33624136|NCT03951077|102173112|FG004|Overall Study|Adverse Event|0|||
33624137|NCT03951077|102173113|FG005|Overall Study|Adverse Event|0|||
33624138|NCT03951077|102173108|FG000|Overall Study|Withdrawal by Subject|3|||
33624139|NCT03951077|102173109|FG001|Overall Study|Withdrawal by Subject|3|||
33624140|NCT03951077|102173110|FG002|Overall Study|Withdrawal by Subject|0|||
33624141|NCT03951077|102173111|FG003|Overall Study|Withdrawal by Subject|3|||
33624142|NCT03951077|102173112|FG004|Overall Study|Withdrawal by Subject|3|||
33624143|NCT03951077|102173113|FG005|Overall Study|Withdrawal by Subject|2|||
33624144|NCT03951077|102173108|FG000|Overall Study|Lost to Follow-up|1|||
33624145|NCT03951077|102173109|FG001|Overall Study|Lost to Follow-up|1|||
33624146|NCT03951077|102173110|FG002|Overall Study|Lost to Follow-up|2|||
33624147|NCT03951077|102173111|FG003|Overall Study|Lost to Follow-up|3|||
33624148|NCT03951077|102173112|FG004|Overall Study|Lost to Follow-up|2|||
33624149|NCT03951077|102173113|FG005|Overall Study|Lost to Follow-up|3|||
33624150|NCT03951077|102173108|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
33624151|NCT03951077|102173109|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
33624152|NCT03951077|102173110|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
33624153|NCT03951077|102173111|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
33624154|NCT03951077|102173112|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
33624155|NCT03951077|102173113|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
33624156|NCT03951077|102173108|FG000|Overall Study|Other, Not Specified|12|||
33624157|NCT03951077|102173109|FG001|Overall Study|Other, Not Specified|10|||
33624158|NCT03951077|102173110|FG002|Overall Study|Other, Not Specified|10|||
33624159|NCT03951077|102173111|FG003|Overall Study|Other, Not Specified|5|||
33624160|NCT03951077|102173112|FG004|Overall Study|Other, Not Specified|9|||
33414654|NCT01915498|101409842|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33624161|NCT03951077|102173113|FG005|Overall Study|Other, Not Specified|6|||
33624162|NCT03951077|102173108|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
33624163|NCT03951077|102173109|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
33624164|NCT03951077|102173110|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
33624165|NCT03951077|102173111|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
33624166|NCT03951077|102173112|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
33624167|NCT03951077|102173113|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
33624168|NCT01020786|102173120|FG000|Induction Period|Entry Criteria Not Met|2|||
33624169|NCT01020786|102173120|FG000|Induction Period|Adverse Event|10|||
33624170|NCT01020786|102173120|FG000|Induction Period|Progressive Disease|31|||
33624171|NCT01020786|102173120|FG000|Induction Period|Investigator Decision|3|||
33624172|NCT01020786|102173120|FG000|Induction Period|Withdrawal by Subject|3|||
33624173|NCT01020786|102173120|FG000|Maintenance Period|Adverse Event|8|||
33624174|NCT01020786|102173120|FG000|Maintenance Period|Progressive Disease|43|||
33624175|NCT01020786|102173120|FG000|Maintenance Period|Withdrawal by Subject|8|||
33624176|NCT01020786|102173120|FG000|Maintenance Period|Sponsor Decision|1|||
33624177|NCT04023526|102173125|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
33624178|NCT04023526|102173126|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
33624179|NCT04023526|102173125|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
33624180|NCT04023526|102173126|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
33624181|NCT00960063|102173128|FG000|Overall Study|Adverse Event|1|||
33359700|NCT00465738|101204538|FG000|Overall Study|Lost to Follow-up|2|||
33359701|NCT00465738|101204539|FG001|Overall Study|Lost to Follow-up|0|||
33624182|NCT00960063|102173129|FG001|Overall Study|Adverse Event|0|||
33624183|NCT00960063|102173130|FG002|Overall Study|Adverse Event|0|||
33624184|NCT00960063|102173128|FG000|Overall Study|Progression of Disease|0|||
33624185|NCT00960063|102173129|FG001|Overall Study|Progression of Disease|0|||
33624186|NCT00960063|102173130|FG002|Overall Study|Progression of Disease|3|||
33624187|NCT00953667|102173131|FG000|Overall Study|Lost to Follow-up|11|||
33624188|NCT00953667|102173131|FG000|Overall Study|Physician Decision|35|||
33624189|NCT00953667|102173131|FG000|Overall Study|Withdrawal by Subject|63|||
33624190|NCT00953667|102173131|FG000|Overall Study|Adverse Event|10|||
33624191|NCT00953667|102173131|FG000|Overall Study|poor venous access,unable to draw blood|4|||
33624192|NCT03347123|102173132|FG000|Overall Study|Death|1|||
33624193|NCT03347123|102173133|FG001|Overall Study|Death|2|||
33624194|NCT03347123|102173134|FG002|Overall Study|Death|0|||
33624195|NCT03347123|102173135|FG003|Overall Study|Death|0|||
33624196|NCT03347123|102173136|FG004|Overall Study|Death|0|||
33624197|NCT03347123|102173137|FG005|Overall Study|Death|0|||
33624198|NCT03347123|102173138|FG006|Overall Study|Death|0|||
33624199|NCT03347123|102173132|FG000|Overall Study|Withdrawal by Subject|1|||
33624200|NCT03347123|102173133|FG001|Overall Study|Withdrawal by Subject|0|||
33624201|NCT03347123|102173134|FG002|Overall Study|Withdrawal by Subject|0|||
33624202|NCT03347123|102173135|FG003|Overall Study|Withdrawal by Subject|0|||
33624203|NCT03347123|102173136|FG004|Overall Study|Withdrawal by Subject|0|||
33624204|NCT03347123|102173137|FG005|Overall Study|Withdrawal by Subject|0|||
33624205|NCT03347123|102173138|FG006|Overall Study|Withdrawal by Subject|0|||
33624206|NCT03347123|102173132|FG000|Overall Study|Reason not Specified|3|||
33624207|NCT03347123|102173133|FG001|Overall Study|Reason not Specified|4|||
33624208|NCT03347123|102173134|FG002|Overall Study|Reason not Specified|0|||
33624209|NCT03347123|102173135|FG003|Overall Study|Reason not Specified|0|||
33624210|NCT03347123|102173136|FG004|Overall Study|Reason not Specified|0|||
33624211|NCT03347123|102173137|FG005|Overall Study|Reason not Specified|0|||
33624212|NCT03347123|102173138|FG006|Overall Study|Reason not Specified|0|||
33624213|NCT02960217|102173139|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
33624214|NCT02960217|102173140|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
33624215|NCT02960217|102173139|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
33624216|NCT02960217|102173140|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
33624217|NCT02960217|102173139|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
33624218|NCT02960217|102173140|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
33624219|NCT02960217|102173139|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
33624220|NCT02960217|102173140|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
33624221|NCT02960217|102173139|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
33624222|NCT02960217|102173140|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
33359702|NCT00465738|101204538|FG000|Overall Study|Adverse Event|0|||
33359703|NCT00465738|101204539|FG001|Overall Study|Adverse Event|1|||
33624223|NCT02960217|102173139|FG000|Open-Label Extension Phase|Adverse Event|1|||
33624224|NCT02960217|102173140|FG001|Open-Label Extension Phase|Adverse Event|0|||
33624225|NCT02960217|102173139|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
33359704|NCT00465738|101204538|FG000|Overall Study|Withdrawal by Subject|2|||
33359705|NCT00465738|101204539|FG001|Overall Study|Withdrawal by Subject|0|||
33624226|NCT02960217|102173140|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
33624227|NCT02960217|102173139|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
33624228|NCT02960217|102173140|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
33359706|NCT00465738|101204538|FG000|Overall Study|Other|2|||
33624229|NCT02960217|102173139|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
33624230|NCT02960217|102173140|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
33624231|NCT02675907|102173141|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
33624232|NCT02675907|102173142|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
33624233|NCT02675907|102173141|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
33624234|NCT02675907|102173142|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
33624235|NCT02675907|102173141|FG000|Study Overall|Lack of Efficacy|1|||
33624236|NCT02675907|102173142|FG001|Study Overall|Lack of Efficacy|0|||
33624237|NCT02675907|102173141|FG000|Study Overall|Withdrawal by Subject|2|||
33624238|NCT02675907|102173142|FG001|Study Overall|Withdrawal by Subject|2|||
33624239|NCT02675907|102173141|FG000|Study Overall|Lost to Follow-up|0|||
33624240|NCT02675907|102173142|FG001|Study Overall|Lost to Follow-up|2|||
33560998|NCT01687595|101949085|FG001|Overall Study|Lost to Follow-up|1|||
33560999|NCT01687595|101949084|FG000|Overall Study|Investigator's decision|1|||
33561000|NCT01687595|101949085|FG001|Overall Study|Investigator's decision|0|||
33561001|NCT01687595|101949084|FG000|Overall Study|Sponsor's decision|1|||
33561002|NCT01687595|101949085|FG001|Overall Study|Sponsor's decision|0|||
33561003|NCT01687595|101949084|FG000|Overall Study|Noncompliance|1|||
33561004|NCT01687595|101949085|FG001|Overall Study|Noncompliance|2|||
33561005|NCT01687595|101949084|FG000|Overall Study|Other than specified|56|||
33561006|NCT01687595|101949085|FG001|Overall Study|Other than specified|7|||
33561007|NCT01084135|101949086|FG000|20 Week|Physician Decision|0|||
33561008|NCT01084135|101949087|FG001|20 Week|Physician Decision|1|||
33561009|NCT05122143|101949089|FG000|Overall Study|Adverse Event|1|||
33561010|NCT05122143|101949090|FG001|Overall Study|Adverse Event|0|||
33561011|NCT05122143|101949091|FG002|Overall Study|Adverse Event|0|||
33561012|NCT05122143|101949092|FG003|Overall Study|Adverse Event|0|||
33561013|NCT05122143|101949093|FG004|Overall Study|Adverse Event|1|||
33561014|NCT05122143|101949094|FG005|Overall Study|Adverse Event|0|||
33561015|NCT05122143|101949089|FG000|Overall Study|Protocol non-compliance|0|||
33561016|NCT05122143|101949090|FG001|Overall Study|Protocol non-compliance|0|||
33561017|NCT05122143|101949091|FG002|Overall Study|Protocol non-compliance|1|||
33561018|NCT05122143|101949092|FG003|Overall Study|Protocol non-compliance|0|||
33561019|NCT05122143|101949093|FG004|Overall Study|Protocol non-compliance|0|||
33561020|NCT05122143|101949094|FG005|Overall Study|Protocol non-compliance|0|||
33561021|NCT05122143|101949089|FG000|Overall Study|Covid contact|0|||
33561022|NCT05122143|101949090|FG001|Overall Study|Covid contact|0|||
33561023|NCT05122143|101949091|FG002|Overall Study|Covid contact|0|||
33561024|NCT05122143|101949092|FG003|Overall Study|Covid contact|0|||
33561025|NCT05122143|101949093|FG004|Overall Study|Covid contact|1|||
33561026|NCT05122143|101949094|FG005|Overall Study|Covid contact|0|||
33561027|NCT00637156|101949096|FG000|Overall Study|Withdrawal by Subject|0|||
33561028|NCT00637156|101949097|FG001|Overall Study|Withdrawal by Subject|7|||
33561029|NCT00637156|101949096|FG000|Overall Study|Death|0|||
33561030|NCT00637156|101949097|FG001|Overall Study|Death|1|||
33561031|NCT00637156|101949096|FG000|Overall Study|Lost to Follow-up|10|||
33561032|NCT00637156|101949097|FG001|Overall Study|Lost to Follow-up|16|||
33561033|NCT01659151|101949099|FG000|Overall Study|Inadequate TIL growth|1|||
33561034|NCT01714063|101949120|FG000|Overall Study|Equipment malfunction|2|||
33561035|NCT00561821|101949121|FG000|Overall Study|Not treated|0|||
33561036|NCT00561821|101949122|FG001|Overall Study|Not treated|0|||
33561037|NCT00561821|101949123|FG002|Overall Study|Not treated|1|||
33561038|NCT00561821|101949124|FG003|Overall Study|Not treated|0|||
33561039|NCT00561821|101949121|FG000|Overall Study|Withdrawal by Subject|0|||
33561040|NCT00561821|101949122|FG001|Overall Study|Withdrawal by Subject|1|||
33561041|NCT00561821|101949123|FG002|Overall Study|Withdrawal by Subject|0|||
33561042|NCT00561821|101949124|FG003|Overall Study|Withdrawal by Subject|2|||
33561043|NCT00561821|101949121|FG000|Overall Study|Reasons not related to trial|2|||
33561044|NCT00561821|101949122|FG001|Overall Study|Reasons not related to trial|1|||
33561045|NCT00561821|101949123|FG002|Overall Study|Reasons not related to trial|0|||
33561046|NCT00561821|101949124|FG003|Overall Study|Reasons not related to trial|0|||
33561047|NCT00561821|101949121|FG000|Overall Study|Other (reason not specified)|1|||
33561048|NCT00561821|101949122|FG001|Overall Study|Other (reason not specified)|1|||
33561049|NCT00561821|101949123|FG002|Overall Study|Other (reason not specified)|0|||
33561050|NCT00561821|101949124|FG003|Overall Study|Other (reason not specified)|0|||
33561051|NCT00561821|101949121|FG000|Overall Study|Adverse Event|2|||
33561052|NCT00561821|101949122|FG001|Overall Study|Adverse Event|3|||
33561053|NCT00561821|101949123|FG002|Overall Study|Adverse Event|1|||
33561054|NCT00561821|101949124|FG003|Overall Study|Adverse Event|1|||
33561055|NCT02105012|101949125|FG000|Overall Study|Withdrawal by Subject|11|||
33561056|NCT02105012|101949125|FG000|Overall Study|Protocol Specified Criteria|9|||
33561057|NCT02105012|101949125|FG000|Overall Study|Lost to Follow-up|4|||
33561058|NCT02105012|101949125|FG000|Overall Study|Protocol Violation|4|||
33561059|NCT02105012|101949125|FG000|Overall Study|Physician Decision|3|||
33561060|NCT02105012|101949125|FG000|Overall Study|Adverse Event|1|||
33624241|NCT02748863|102173146|FG000|Treatment Period 1|Adverse Event|0|||
33624242|NCT02748863|102173147|FG001|Treatment Period 1|Adverse Event|1|||
33624243|NCT02748863|102173148|FG002|Treatment Period 1|Adverse Event|0|||
33624244|NCT02748863|102173149|FG003|Treatment Period 1|Adverse Event|0|||
33624245|NCT02748863|102173150|FG004|Treatment Period 1|Adverse Event|0|||
33624246|NCT02748863|102173146|FG000|Treatment Period 1|Lack of Efficacy|0|||
33624247|NCT02748863|102173147|FG001|Treatment Period 1|Lack of Efficacy|0|||
33624248|NCT02748863|102173148|FG002|Treatment Period 1|Lack of Efficacy|1|||
33624249|NCT02748863|102173149|FG003|Treatment Period 1|Lack of Efficacy|0|||
33624250|NCT02748863|102173150|FG004|Treatment Period 1|Lack of Efficacy|0|||
33624251|NCT02748863|102173146|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33624252|NCT02748863|102173147|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33624253|NCT02748863|102173148|FG002|Treatment Period 1|Withdrawal by Subject|1|||
33624254|NCT02748863|102173149|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33624255|NCT02748863|102173150|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33624256|NCT02748863|102173146|FG000|Treatment Period 2|Lost to Follow-up|2|||
33624257|NCT02748863|102173147|FG001|Treatment Period 2|Lost to Follow-up|0|||
33624258|NCT02748863|102173148|FG002|Treatment Period 2|Lost to Follow-up|0|||
33624259|NCT02748863|102173149|FG003|Treatment Period 2|Lost to Follow-up|0|||
33624260|NCT02748863|102173150|FG004|Treatment Period 2|Lost to Follow-up|0|||
33624261|NCT02748863|102173146|FG000|Treatment Period 2|Adverse Event|3|||
33624262|NCT02748863|102173147|FG001|Treatment Period 2|Adverse Event|2|||
33624263|NCT02748863|102173148|FG002|Treatment Period 2|Adverse Event|0|||
33624264|NCT02748863|102173149|FG003|Treatment Period 2|Adverse Event|2|||
33624265|NCT02748863|102173150|FG004|Treatment Period 2|Adverse Event|0|||
33624266|NCT02748863|102173146|FG000|Treatment Period 2|Lack of Efficacy|0|||
33624267|NCT02748863|102173147|FG001|Treatment Period 2|Lack of Efficacy|1|||
33624268|NCT02748863|102173148|FG002|Treatment Period 2|Lack of Efficacy|0|||
33624269|NCT02748863|102173149|FG003|Treatment Period 2|Lack of Efficacy|0|||
33624270|NCT02748863|102173150|FG004|Treatment Period 2|Lack of Efficacy|0|||
33359707|NCT00465738|101204539|FG001|Overall Study|Other|5|||
33359708|NCT00550238|101204540|FG000|Overall Study|Adverse Event|88|||
33359709|NCT00550238|101204540|FG000|Overall Study|Death|34|||
33359710|NCT00550238|101204540|FG000|Overall Study|Disease progression|46|||
33359711|NCT00550238|101204540|FG000|Overall Study|Withdrawal by Subject|167|||
33359712|NCT00550238|101204540|FG000|Overall Study|Physician Decision|31|||
33624271|NCT02748863|102173146|FG000|Treatment Period 2|Pregnancy|0|||
33624272|NCT02748863|102173147|FG001|Treatment Period 2|Pregnancy|0|||
33624273|NCT02748863|102173148|FG002|Treatment Period 2|Pregnancy|0|||
33359713|NCT00550238|101204540|FG000|Overall Study|Patient noncompliance|25|||
33220555|NCT00989092|100706786|FG000|Overall Study|Did not receive study drug|2|||
33220556|NCT00989092|100706787|FG001|Overall Study|Did not receive study drug|0|||
33220557|NCT00045708|100706788|FG000|Phase 1|early progressive disease|0|||
33220558|NCT00045708|100706789|FG001|Phase 1|early progressive disease|1|||
33220559|NCT00045708|100706790|FG002|Phase 1|early progressive disease|0|||
33220560|NCT00710606|100706791|FG000|Overall Study|Adverse Event|0|||
33220561|NCT00710606|100706792|FG001|Overall Study|Adverse Event|2|||
33220562|NCT01965938|100706793|FG000|Overall Study|Withdrawal by Subject|1|||
33220563|NCT01965938|100706794|FG001|Overall Study|Withdrawal by Subject|0|||
33220564|NCT05232864|100706795|FG000|Overall Study|Adverse Event|0|||
33220565|NCT05232864|100706796|FG001|Overall Study|Adverse Event|1|||
33220566|NCT05232864|100706795|FG000|Overall Study|Study terminated by sponsor|16|||
33220567|NCT05232864|100706796|FG001|Overall Study|Study terminated by sponsor|14|||
33220568|NCT00691938|100706797|FG000|Overall Study|QTc prolongation|1|||
33220569|NCT00691938|100706798|FG001|Overall Study|QTc prolongation|0|||
33220570|NCT00691938|100706799|FG002|Overall Study|QTc prolongation|0|||
33220571|NCT00691938|100706800|FG003|Overall Study|QTc prolongation|0|||
33220572|NCT00691938|100706801|FG004|Overall Study|QTc prolongation|0|||
33220573|NCT00691938|100706802|FG005|Overall Study|QTc prolongation|0|||
33220574|NCT00691938|100706803|FG006|Overall Study|QTc prolongation|0|||
33220575|NCT01669798|100706804|FG000|Overall Study|Physician Decision|5|||
33220576|NCT00948974|100706809|FG000|Overall Study|Lost to Follow-up|23|||
33220577|NCT00948974|100706810|FG001|Overall Study|Lost to Follow-up|20|||
33220578|NCT01058304|100706811|FG000|Overall Study|Withdrawal by Subject|8|||
33220579|NCT01058304|100706812|FG001|Overall Study|Withdrawal by Subject|5|||
33220580|NCT01058304|100706811|FG000|Overall Study|Lost to Follow-up|13|||
33220581|NCT01058304|100706812|FG001|Overall Study|Lost to Follow-up|16|||
33220582|NCT01058304|100706811|FG000|Overall Study|Developed exclusion criterion|6|||
33220583|NCT01058304|100706812|FG001|Overall Study|Developed exclusion criterion|12|||
33359714|NCT00550238|101204540|FG000|Overall Study|Lost to Follow-up|13|||
33359715|NCT00550238|101204540|FG000|Overall Study|Sponsor decision|55|||
33359716|NCT01570491|101204541|FG000|Overall Study|Lost to Follow-up|3|||
33359717|NCT01570491|101204542|FG001|Overall Study|Lost to Follow-up|1|||
33359718|NCT01570491|101204541|FG000|Overall Study|treatment: not given or discontinued|2|||
33359719|NCT01570491|101204542|FG001|Overall Study|treatment: not given or discontinued|0|||
33359720|NCT02332915|101204543|FG000|Overall Study|Moved out of region|3|||
33359721|NCT02332915|101204544|FG001|Overall Study|Moved out of region|0|||
33359722|NCT02332915|101204543|FG000|Overall Study|Unrelated illness|1|||
33359723|NCT02332915|101204544|FG001|Overall Study|Unrelated illness|1|||
33359724|NCT02332915|101204543|FG000|Overall Study|Travel distance prohibitive|0|||
33359725|NCT02332915|101204544|FG001|Overall Study|Travel distance prohibitive|1|||
33359726|NCT02332915|101204543|FG000|Overall Study|did not meet inclusion criteria|2|||
33359727|NCT02332915|101204544|FG001|Overall Study|did not meet inclusion criteria|4|||
33359728|NCT02234622|101204548|FG000|Overall Study|Withdrawal by Subject|16|||
33359729|NCT02234622|101204549|FG001|Overall Study|Withdrawal by Subject|22|||
33359730|NCT02234622|101204548|FG000|Overall Study|Lost to Follow-up|27|||
33359731|NCT02234622|101204549|FG001|Overall Study|Lost to Follow-up|14|||
33359732|NCT00753922|101204550|FG000|Overall Study|Lost to Follow-up|155|||
33359733|NCT00753922|101204551|FG001|Overall Study|Lost to Follow-up|24|||
33359734|NCT00753922|101204552|FG002|Overall Study|Lost to Follow-up|28|||
33359735|NCT00753922|101204553|FG003|Overall Study|Lost to Follow-up|5|||
33359736|NCT00753922|101204550|FG000|Overall Study|Withdrawal by Subject|9|||
33359737|NCT00753922|101204551|FG001|Overall Study|Withdrawal by Subject|11|||
33359738|NCT00753922|101204552|FG002|Overall Study|Withdrawal by Subject|4|||
33359739|NCT00753922|101204553|FG003|Overall Study|Withdrawal by Subject|2|||
33359740|NCT00753922|101204550|FG000|Overall Study|Patient Non-compliance|55|||
33359741|NCT00753922|101204551|FG001|Overall Study|Patient Non-compliance|22|||
33359742|NCT00753922|101204552|FG002|Overall Study|Patient Non-compliance|14|||
33359743|NCT00753922|101204553|FG003|Overall Study|Patient Non-compliance|11|||
33359744|NCT00753922|101204550|FG000|Overall Study|Patients Not Completing Visit|11|||
33359745|NCT00753922|101204551|FG001|Overall Study|Patients Not Completing Visit|0|||
33359746|NCT00753922|101204552|FG002|Overall Study|Patients Not Completing Visit|1|||
33359747|NCT00753922|101204553|FG003|Overall Study|Patients Not Completing Visit|0|||
33359748|NCT00753922|101204550|FG000|Overall Study|Death|2|||
33624274|NCT02748863|102173149|FG003|Treatment Period 2|Pregnancy|0|||
33624275|NCT02748863|102173150|FG004|Treatment Period 2|Pregnancy|1|||
33359749|NCT00753922|101204551|FG001|Overall Study|Death|23|||
33359750|NCT00753922|101204552|FG002|Overall Study|Death|2|||
33359751|NCT00753922|101204553|FG003|Overall Study|Death|1|||
33359752|NCT00753922|101204550|FG000|Overall Study|Discontinuation Due to Explantation|14|||
33359753|NCT00753922|101204551|FG001|Overall Study|Discontinuation Due to Explantation|14|||
33624276|NCT00551759|102173151|FG000|Overall Study|Adverse Event|7|||
33220584|NCT02227875|100706813|FG000|Overall Study|Protocol Violation|10|||
33220585|NCT02227875|100706814|FG001|Overall Study|Protocol Violation|7|||
33220586|NCT02227875|100706813|FG000|Overall Study|Other|1|||
33220587|NCT02227875|100706814|FG001|Overall Study|Other|3|||
33220588|NCT02227875|100706813|FG000|Overall Study|Physician Decision|1|||
33220589|NCT02227875|100706814|FG001|Overall Study|Physician Decision|0|||
33414655|NCT01915498|101409843|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
33414656|NCT01915498|101409844|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33414657|NCT01915498|101409845|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33414658|NCT01915498|101409846|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33414659|NCT01915498|101409847|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
33414660|NCT01915498|101409848|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33414661|NCT01915498|101409849|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
33414662|NCT01915498|101409850|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
33414663|NCT01915498|101409851|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
33414664|NCT01915498|101409852|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
33414665|NCT01915498|101409853|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
33414666|NCT01915498|101409854|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
33414667|NCT01915498|101409855|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
33414668|NCT01915498|101409837|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33414669|NCT01915498|101409838|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
33624277|NCT00551759|102173151|FG000|Overall Study|Death|5|||
33624278|NCT00551759|102173151|FG000|Overall Study|Ineligible|1|||
33624279|NCT02485691|102173152|FG000|Overall Study|Adverse Event|25|||
33624280|NCT02485691|102173153|FG001|Overall Study|Adverse Event|11|||
33624281|NCT02485691|102173152|FG000|Overall Study|Poor compliance to protocol|0|||
33624282|NCT02485691|102173153|FG001|Overall Study|Poor compliance to protocol|1|||
33624283|NCT02485691|102173152|FG000|Overall Study|Disease progression|57|||
33624284|NCT02485691|102173153|FG001|Overall Study|Disease progression|92|||
33624285|NCT02485691|102173152|FG000|Overall Study|Investigator's decision|23|||
33624286|NCT02485691|102173153|FG001|Overall Study|Investigator's decision|5|||
33220590|NCT02227875|100706813|FG000|Overall Study|Adverse Event|3|||
33220591|NCT02227875|100706814|FG001|Overall Study|Adverse Event|0|||
33220592|NCT02227875|100706813|FG000|Overall Study|Withdrawal by Subject|12|||
33220593|NCT02227875|100706814|FG001|Overall Study|Withdrawal by Subject|13|||
33220594|NCT02227875|100706813|FG000|Overall Study|Lost to Follow-up|10|||
33220595|NCT02227875|100706814|FG001|Overall Study|Lost to Follow-up|10|||
33220596|NCT00261495|100706816|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
33220597|NCT00261495|100706817|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
33220598|NCT00261495|100706816|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
33220599|NCT00261495|100706817|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
33220600|NCT00261495|100706816|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
33220601|NCT00261495|100706817|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
33220602|NCT00261495|100706816|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
33220603|NCT00261495|100706817|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
33220604|NCT00261495|100706816|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
33220605|NCT00261495|100706817|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
33220606|NCT00261495|100706816|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
33220607|NCT00261495|100706817|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
33220608|NCT00261495|100706816|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
33220609|NCT00261495|100706817|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
33220610|NCT00261495|100706816|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
33220611|NCT00261495|100706817|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
33220612|NCT00261495|100706816|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
33220613|NCT00261495|100706817|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
33220614|NCT00261495|100706816|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
33220615|NCT00261495|100706817|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
33220616|NCT00261495|100706816|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
33220617|NCT00261495|100706817|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
33220618|NCT00261495|100706816|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
33414670|NCT01915498|101409839|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
33624287|NCT02485691|102173152|FG000|Overall Study|Participant's request|13|||
33359754|NCT00753922|101204552|FG002|Overall Study|Discontinuation Due to Explantation|14|||
33624288|NCT02485691|102173153|FG001|Overall Study|Participant's request|6|||
33220619|NCT00261495|100706817|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
33220620|NCT00261495|100706816|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
33220621|NCT00261495|100706817|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
33220622|NCT00261495|100706816|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
33220623|NCT00261495|100706817|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
33220624|NCT00261495|100706816|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
33220625|NCT00261495|100706817|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
33220626|NCT00261495|100706816|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
33220627|NCT00261495|100706817|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
33220628|NCT00261495|100706816|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
33220629|NCT00261495|100706817|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
33220630|NCT00261495|100706816|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
33220631|NCT00261495|100706817|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
33561061|NCT02105012|101949125|FG000|Overall Study|Lack of Efficacy|1|||
33561062|NCT03829683|101949128|FG000|Overall Study|Lost to Follow-up|1|||
33561063|NCT03829683|101949129|FG001|Overall Study|Lost to Follow-up|0|||
33561064|NCT03829683|101949128|FG000|Overall Study|Physician Decision|3|||
33561065|NCT03829683|101949129|FG001|Overall Study|Physician Decision|1|||
33561066|NCT03829683|101949128|FG000|Overall Study|Withdrawal by Subject|0|||
33561067|NCT03829683|101949129|FG001|Overall Study|Withdrawal by Subject|1|||
33561068|NCT03829683|101949128|FG000|Overall Study|Discharge from hospital|1|||
33561069|NCT03829683|101949129|FG001|Overall Study|Discharge from hospital|0|||
33561070|NCT00449787|101949133|FG000|Overall Study|Lost to Follow-up|10|||
33561071|NCT00449787|101949134|FG001|Overall Study|Lost to Follow-up|8|||
33561072|NCT00449787|101949133|FG000|Overall Study|Did not require medication|95|||
33561073|NCT00449787|101949134|FG001|Overall Study|Did not require medication|92|||
33561074|NCT04691115|101949135|FG000|Overall Study|Withdrawal by Subject|0|||
33561075|NCT04691115|101949136|FG001|Overall Study|Withdrawal by Subject|0|||
33561076|NCT04691115|101949137|FG002|Overall Study|Withdrawal by Subject|0|||
33561077|NCT04691115|101949138|FG003|Overall Study|Withdrawal by Subject|0|||
33561078|NCT04691115|101949139|FG004|Overall Study|Withdrawal by Subject|0|||
33561079|NCT04691115|101949140|FG005|Overall Study|Withdrawal by Subject|1|||
33561080|NCT04691115|101949141|FG006|Overall Study|Withdrawal by Subject|0|||
33561081|NCT04691115|101949142|FG007|Overall Study|Withdrawal by Subject|0|||
33624289|NCT02485691|102173152|FG000|Overall Study|Other reason|8|||
33624290|NCT02485691|102173153|FG001|Overall Study|Other reason|9|||
33624291|NCT02485691|102173152|FG000|Overall Study|Randomized and not treated|3|||
33624292|NCT02485691|102173153|FG001|Overall Study|Randomized and not treated|2|||
33624293|NCT04292535|102173156|FG000|Overall Study|Withdrawal by Subject|0|||
33624294|NCT04292535|102173157|FG001|Overall Study|Withdrawal by Subject|0|||
33624295|NCT04292535|102173158|FG002|Overall Study|Withdrawal by Subject|0|||
33624296|NCT04292535|102173159|FG003|Overall Study|Withdrawal by Subject|0|||
33624297|NCT04292535|102173160|FG004|Overall Study|Withdrawal by Subject|0|||
33624298|NCT04292535|102173161|FG005|Overall Study|Withdrawal by Subject|0|||
33624299|NCT04292535|102173162|FG006|Overall Study|Withdrawal by Subject|0|||
33624300|NCT04292535|102173163|FG007|Overall Study|Withdrawal by Subject|1|||
33624301|NCT04292535|102173164|FG008|Overall Study|Withdrawal by Subject|0|||
33624302|NCT04292535|102173165|FG009|Overall Study|Withdrawal by Subject|0|||
33624303|NCT04292535|102173166|FG010|Overall Study|Withdrawal by Subject|0|||
33624304|NCT04292535|102173167|FG011|Overall Study|Withdrawal by Subject|0|||
33624305|NCT04292535|102173168|FG012|Overall Study|Withdrawal by Subject|0|||
33624306|NCT04292535|102173169|FG013|Overall Study|Withdrawal by Subject|0|||
33624307|NCT04292535|102173156|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33624308|NCT04292535|102173157|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33624309|NCT04292535|102173158|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33624310|NCT04292535|102173159|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33624311|NCT04292535|102173160|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33624312|NCT04292535|102173161|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33220632|NCT00261495|100706816|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
33220633|NCT00261495|100706817|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
33220634|NCT00261495|100706816|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
33220635|NCT00261495|100706817|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
33220636|NCT00261495|100706816|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
33561082|NCT04691115|101949143|FG008|Overall Study|Withdrawal by Subject|0|||
33624313|NCT04292535|102173162|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33624314|NCT04292535|102173163|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
33624315|NCT04292535|102173164|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33624316|NCT04292535|102173165|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33220637|NCT00261495|100706817|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
33561083|NCT04691115|101949144|FG009|Overall Study|Withdrawal by Subject|0|||
33561084|NCT04691115|101949145|FG010|Overall Study|Withdrawal by Subject|0|||
33561085|NCT04691115|101949146|FG011|Overall Study|Withdrawal by Subject|0|||
33220638|NCT00404495|100706818|FG000|Overall Study|Death|37|||
33561086|NCT04691115|101949147|FG012|Overall Study|Withdrawal by Subject|0|||
33561087|NCT04691115|101949148|FG013|Overall Study|Withdrawal by Subject|0|||
33624317|NCT04292535|102173166|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33624318|NCT04292535|102173167|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
33624319|NCT04292535|102173168|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
33624320|NCT04292535|102173169|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
33624321|NCT04292535|102173156|FG000|Overall Study|Report of Dizziness|0|||
33624322|NCT04292535|102173157|FG001|Overall Study|Report of Dizziness|0|||
33624323|NCT04292535|102173158|FG002|Overall Study|Report of Dizziness|0|||
33624324|NCT04292535|102173159|FG003|Overall Study|Report of Dizziness|0|||
33624325|NCT04292535|102173160|FG004|Overall Study|Report of Dizziness|0|||
33624326|NCT04292535|102173161|FG005|Overall Study|Report of Dizziness|0|||
33624327|NCT04292535|102173162|FG006|Overall Study|Report of Dizziness|0|||
33624328|NCT04292535|102173163|FG007|Overall Study|Report of Dizziness|0|||
33624329|NCT04292535|102173164|FG008|Overall Study|Report of Dizziness|0|||
33624330|NCT04292535|102173165|FG009|Overall Study|Report of Dizziness|0|||
33624331|NCT04292535|102173166|FG010|Overall Study|Report of Dizziness|0|||
33624332|NCT04292535|102173167|FG011|Overall Study|Report of Dizziness|0|||
33624333|NCT04292535|102173168|FG012|Overall Study|Report of Dizziness|0|||
33624334|NCT04292535|102173169|FG013|Overall Study|Report of Dizziness|1|||
33624335|NCT04292535|102173156|FG000|Overall Study|Equipment Failure|0|||
33624336|NCT04292535|102173157|FG001|Overall Study|Equipment Failure|0|||
33624337|NCT04292535|102173158|FG002|Overall Study|Equipment Failure|0|||
33624338|NCT04292535|102173159|FG003|Overall Study|Equipment Failure|0|||
33624339|NCT04292535|102173160|FG004|Overall Study|Equipment Failure|0|||
33624340|NCT04292535|102173161|FG005|Overall Study|Equipment Failure|0|||
33624341|NCT04292535|102173162|FG006|Overall Study|Equipment Failure|0|||
33624342|NCT04292535|102173163|FG007|Overall Study|Equipment Failure|0|||
33624343|NCT04292535|102173164|FG008|Overall Study|Equipment Failure|0|||
33624344|NCT04292535|102173165|FG009|Overall Study|Equipment Failure|0|||
33624345|NCT04292535|102173166|FG010|Overall Study|Equipment Failure|0|||
33624346|NCT04292535|102173167|FG011|Overall Study|Equipment Failure|1|||
33624347|NCT04292535|102173168|FG012|Overall Study|Equipment Failure|0|||
33624348|NCT04292535|102173169|FG013|Overall Study|Equipment Failure|0|||
33624349|NCT01332994|102173170|FG000|Overall Study|Adverse Event|34|||
33624350|NCT01332994|102173170|FG000|Overall Study|Death|1|||
33624351|NCT01332994|102173170|FG000|Overall Study|Lack of Efficacy|1|||
33624352|NCT01332994|102173170|FG000|Overall Study|Lost to Follow-up|4|||
33624353|NCT01332994|102173170|FG000|Overall Study|Protocol Violation|6|||
33624354|NCT01332994|102173170|FG000|Overall Study|Withdrawal by Subject|15|||
33624355|NCT01332994|102173170|FG000|Overall Study|Administrative Problem|2|||
33624356|NCT01332994|102173170|FG000|Overall Study|Other|8|||
33624357|NCT01859923|102177098|FG000|Overall Study|Adverse Event|0|||
33624358|NCT01859923|102177099|FG001|Overall Study|Adverse Event|0|||
33624359|NCT01859923|102177100|FG002|Overall Study|Adverse Event|1|||
33624360|NCT01859923|102177101|FG003|Overall Study|Adverse Event|1|||
33624361|NCT02653326|102177108|FG000|Overall Study|Lost to Follow-up|10|||
33624362|NCT02653326|102177109|FG001|Overall Study|Lost to Follow-up|7|||
33624363|NCT01307319|102177111|FG000|Overall Study|Adverse Event|2|||
33624364|NCT01307319|102177112|FG001|Overall Study|Adverse Event|2|||
33624365|NCT01307319|102177113|FG002|Overall Study|Adverse Event|1|||
33624366|NCT01307319|102177111|FG000|Overall Study|Lost to Follow-up|1|||
33220639|NCT00404495|100706819|FG001|Overall Study|Death|11|||
33624367|NCT01307319|102177112|FG001|Overall Study|Lost to Follow-up|0|||
33624368|NCT01307319|102177113|FG002|Overall Study|Lost to Follow-up|1|||
33624369|NCT01307319|102177111|FG000|Overall Study|Protocol Violation|1|||
33624370|NCT01307319|102177112|FG001|Overall Study|Protocol Violation|1|||
33624371|NCT01307319|102177113|FG002|Overall Study|Protocol Violation|0|||
33624372|NCT01307319|102177111|FG000|Overall Study|Withdrawal by Subject|0|||
33624373|NCT01307319|102177112|FG001|Overall Study|Withdrawal by Subject|1|||
33359755|NCT00753922|101204553|FG003|Overall Study|Discontinuation Due to Explantation|4|||
33414671|NCT01915498|101409840|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33414672|NCT01915498|101409841|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33414673|NCT01915498|101409842|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33414674|NCT01915498|101409843|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33414675|NCT01915498|101409844|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
33414676|NCT01915498|101409845|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
33359756|NCT01720667|101204554|FG000|Overall Study|Adverse Event|1|||
33359757|NCT01720667|101204555|FG001|Overall Study|Adverse Event|1|||
33359758|NCT01720667|101204554|FG000|Overall Study|Withdrawal by Subject|3|||
33359759|NCT01720667|101204555|FG001|Overall Study|Withdrawal by Subject|0|||
33359760|NCT01380093|101204556|FG000|Naloxone Challenge Phase|Screen failures|21|||
33359761|NCT01380093|101204557|FG001|Naloxone Challenge Phase|Screen failures|0|||
33359762|NCT01380093|101204558|FG002|Naloxone Challenge Phase|Screen failures|0|||
33359763|NCT01380093|101204559|FG003|Naloxone Challenge Phase|Screen failures|0|||
33359764|NCT01380093|101204560|FG004|Naloxone Challenge Phase|Screen failures|0|||
33359765|NCT01380093|101204561|FG005|Naloxone Challenge Phase|Screen failures|0|||
33359766|NCT01380093|101204562|FG006|Naloxone Challenge Phase|Screen failures|0|||
33414677|NCT01915498|101409846|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
33414678|NCT01915498|101409847|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33414679|NCT01915498|101409848|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
33414680|NCT01915498|101409849|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33414681|NCT01915498|101409850|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
33414682|NCT01915498|101409851|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33414683|NCT01915498|101409852|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
33414684|NCT01915498|101409853|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
33414685|NCT01915498|101409854|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
33414686|NCT01915498|101409855|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
33414687|NCT01915498|101409837|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33414688|NCT01915498|101409838|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33624374|NCT01307319|102177113|FG002|Overall Study|Withdrawal by Subject|2|||
33624375|NCT01307319|102177111|FG000|Overall Study|Other|0|||
33624376|NCT01307319|102177112|FG001|Overall Study|Other|4|||
33624377|NCT01307319|102177113|FG002|Overall Study|Other|3|||
33414689|NCT01915498|101409839|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33414690|NCT01915498|101409840|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33414691|NCT01915498|101409841|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
33414692|NCT01915498|101409842|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33414693|NCT01915498|101409843|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33414694|NCT01915498|101409844|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33414695|NCT01915498|101409845|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33414696|NCT01915498|101409846|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
33414697|NCT01915498|101409847|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33414698|NCT01915498|101409848|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33414699|NCT01915498|101409849|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33414700|NCT01915498|101409850|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33414701|NCT01915498|101409851|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33414702|NCT01915498|101409852|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33624378|NCT01814527|102177117|FG000|Overall Study|RTP greater than 30 days|6|||
33624379|NCT01814527|102177118|FG001|Overall Study|RTP greater than 30 days|1|||
33624380|NCT01290523|102177119|FG000|Overall Study|Death|3|||
33624381|NCT01141712|102177120|FG000|Overall Study|Disease progression|3|||
33624382|NCT02914639|102177121|FG000|Overall Study|Withdrawal by Subject|0|||
33624383|NCT02914639|102177122|FG001|Overall Study|Withdrawal by Subject|2|||
33624384|NCT00985673|102177125|FG000|Overall Study|Lost to Follow-up|6|||
33359767|NCT01380093|101204563|FG007|Naloxone Challenge Phase|Screen failures|0|||
33359768|NCT01380093|101204564|FG008|Naloxone Challenge Phase|Screen failures|0|||
33359769|NCT01380093|101204556|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33359770|NCT01380093|101204557|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
33359771|NCT01380093|101204558|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33359772|NCT01380093|101204559|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33359773|NCT01380093|101204560|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33359774|NCT01380093|101204561|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33359775|NCT01380093|101204562|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33359776|NCT01380093|101204563|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33359777|NCT01380093|101204564|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
33414703|NCT01915498|101409853|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33561088|NCT04875533|101949149|FG000|Overall Study|Adverse Event|6|||
33561089|NCT04875533|101949150|FG001|Overall Study|Adverse Event|4|||
33561090|NCT04875533|101949149|FG000|Overall Study|Protocol Violation|4|||
33624385|NCT00985673|102177126|FG001|Overall Study|Lost to Follow-up|7|||
33624386|NCT00985673|102177127|FG002|Overall Study|Lost to Follow-up|6|||
33624387|NCT00985673|102177128|FG003|Overall Study|Lost to Follow-up|10|||
33624388|NCT00985673|102177129|FG004|Overall Study|Lost to Follow-up|5|||
33624389|NCT00985673|102177130|FG005|Overall Study|Lost to Follow-up|3|||
33624390|NCT00985673|102177125|FG000|Overall Study|Withdrawal by Subject|0|||
33624391|NCT00985673|102177126|FG001|Overall Study|Withdrawal by Subject|4|||
33624392|NCT00985673|102177127|FG002|Overall Study|Withdrawal by Subject|5|||
33624393|NCT00985673|102177128|FG003|Overall Study|Withdrawal by Subject|2|||
33624394|NCT00985673|102177129|FG004|Overall Study|Withdrawal by Subject|2|||
33624395|NCT00985673|102177130|FG005|Overall Study|Withdrawal by Subject|3|||
33624396|NCT00985673|102177125|FG000|Overall Study|Other|1|||
33624397|NCT00985673|102177126|FG001|Overall Study|Other|0|||
33624398|NCT00985673|102177127|FG002|Overall Study|Other|1|||
33624399|NCT00985673|102177128|FG003|Overall Study|Other|0|||
33624400|NCT00985673|102177129|FG004|Overall Study|Other|1|||
33624401|NCT00985673|102177130|FG005|Overall Study|Other|0|||
33624402|NCT00791388|102177132|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
33624403|NCT00791388|102177133|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
33624404|NCT00791388|102177134|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
33624405|NCT00791388|102177135|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
33624406|NCT00791388|102177136|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
33624407|NCT00791388|102177132|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
33624408|NCT00791388|102177133|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
33624409|NCT00791388|102177134|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
33624410|NCT00791388|102177135|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
33624411|NCT00791388|102177136|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
33624412|NCT00791388|102177132|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
33624413|NCT00791388|102177133|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
33624414|NCT00791388|102177134|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
33624415|NCT00791388|102177135|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
33624416|NCT00791388|102177136|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
33624417|NCT00857285|102177138|FG000|Overall Study|Adverse Event|4|||
33624418|NCT00857285|102177139|FG001|Overall Study|Adverse Event|2|||
33624419|NCT00857285|102177138|FG000|Overall Study|Lack of Efficacy|0|||
33624420|NCT00857285|102177139|FG001|Overall Study|Lack of Efficacy|2|||
33624421|NCT00857285|102177138|FG000|Overall Study|Protocol Violation|3|||
33624422|NCT00857285|102177139|FG001|Overall Study|Protocol Violation|1|||
33624423|NCT00857285|102177138|FG000|Overall Study|Withdrawal by Subject|4|||
33624424|NCT00857285|102177139|FG001|Overall Study|Withdrawal by Subject|0|||
33624425|NCT00857285|102177138|FG000|Overall Study|Randomization criteria not met|1|||
33624426|NCT00857285|102177139|FG001|Overall Study|Randomization criteria not met|1|||
33624427|NCT00527735|102177141|FG000|Overall Study|Disease progression|47|||
33624428|NCT00527735|102177142|FG001|Overall Study|Disease progression|61|||
33624429|NCT00527735|102177143|FG002|Overall Study|Disease progression|53|||
33624430|NCT00527735|102177141|FG000|Overall Study|Death|23|||
33624431|NCT00527735|102177142|FG001|Overall Study|Death|13|||
33624432|NCT00527735|102177143|FG002|Overall Study|Death|15|||
33624433|NCT00527735|102177141|FG000|Overall Study|Completed treatment in treatment phase|14|||
33624434|NCT00527735|102177142|FG001|Overall Study|Completed treatment in treatment phase|13|||
33624435|NCT00527735|102177143|FG002|Overall Study|Completed treatment in treatment phase|18|||
33624436|NCT00527735|102177141|FG000|Overall Study|Adverse Event|10|||
33624437|NCT00527735|102177142|FG001|Overall Study|Adverse Event|6|||
33624438|NCT00527735|102177143|FG002|Overall Study|Adverse Event|7|||
33624439|NCT00527735|102177141|FG000|Overall Study|Not identified|5|||
33624440|NCT00527735|102177142|FG001|Overall Study|Not identified|5|||
33561091|NCT04875533|101949150|FG001|Overall Study|Protocol Violation|0|||
33561092|NCT04875533|101949149|FG000|Overall Study|Withdrawal by Subject|8|||
33561093|NCT04875533|101949150|FG001|Overall Study|Withdrawal by Subject|5|||
33561094|NCT04875533|101949149|FG000|Overall Study|No longer meets eligibility criteria|1|||
33561095|NCT04875533|101949150|FG001|Overall Study|No longer meets eligibility criteria|0|||
33561096|NCT04875533|101949149|FG000|Overall Study|Other|0|||
33561097|NCT04875533|101949150|FG001|Overall Study|Other|2|||
33561098|NCT00720083|101949151|FG000|Overall Study|Ineligible|1|||
33561099|NCT00720083|101949152|FG001|Overall Study|Ineligible|2|||
33624441|NCT00527735|102177143|FG002|Overall Study|Not identified|5|||
33624442|NCT00527735|102177141|FG000|Overall Study|Withdrawal by Subject|5|||
33624443|NCT00527735|102177142|FG001|Overall Study|Withdrawal by Subject|4|||
33561100|NCT03574389|101951626|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
33624444|NCT00527735|102177143|FG002|Overall Study|Withdrawal by Subject|3|||
33624445|NCT00527735|102177141|FG000|Overall Study|No longer met study criteria|2|||
33624446|NCT00527735|102177142|FG001|Overall Study|No longer met study criteria|2|||
33624447|NCT00527735|102177143|FG002|Overall Study|No longer met study criteria|1|||
33624448|NCT00527735|102177141|FG000|Overall Study|Lost to Follow-up|0|||
33624449|NCT00527735|102177142|FG001|Overall Study|Lost to Follow-up|0|||
33624450|NCT00527735|102177143|FG002|Overall Study|Lost to Follow-up|3|||
33624451|NCT00527735|102177141|FG000|Overall Study|Poor compliance or noncompliance|0|||
33624452|NCT00527735|102177142|FG001|Overall Study|Poor compliance or noncompliance|1|||
33624453|NCT00527735|102177143|FG002|Overall Study|Poor compliance or noncompliance|1|||
33624454|NCT00527735|102177141|FG000|Overall Study|Completed treatment during maintenance|2|||
33624455|NCT00527735|102177142|FG001|Overall Study|Completed treatment during maintenance|2|||
33624456|NCT00527735|102177143|FG002|Overall Study|Completed treatment during maintenance|1|||
33624457|NCT02314052|102177144|FG000|Cycle One|Adverse Event|0|||
33624458|NCT02314052|102177145|FG001|Cycle One|Adverse Event|0|||
33624459|NCT02314052|102177146|FG002|Cycle One|Adverse Event|0|||
33624460|NCT02314052|102177147|FG003|Cycle One|Adverse Event|1|||
33624461|NCT02314052|102177148|FG004|Cycle One|Adverse Event|0|||
33624462|NCT02314052|102177149|FG005|Cycle One|Adverse Event|0|||
33624463|NCT01664910|102177150|FG000|Overall Study|Adverse Event|0|||
33624464|NCT01664910|102177151|FG001|Overall Study|Adverse Event|0|||
33624465|NCT01664910|102177152|FG002|Overall Study|Adverse Event|1|||
33624466|NCT04664153|102177153|FG000|Overall Study|Lack of Efficacy|0|||
33624467|NCT04664153|102177154|FG001|Overall Study|Lack of Efficacy|0|||
33624468|NCT04664153|102177155|FG002|Overall Study|Lack of Efficacy|1|||
33624469|NCT04664153|102177156|FG003|Overall Study|Lack of Efficacy|0|||
33624470|NCT04664153|102177153|FG000|Overall Study|Physician Decision|0|||
33624471|NCT04664153|102177154|FG001|Overall Study|Physician Decision|0|||
33624472|NCT04664153|102177155|FG002|Overall Study|Physician Decision|1|||
33624473|NCT04664153|102177156|FG003|Overall Study|Physician Decision|0|||
33624474|NCT04664153|102177153|FG000|Overall Study|Withdrawal by Subject|3|||
33624475|NCT04664153|102177154|FG001|Overall Study|Withdrawal by Subject|2|||
33624476|NCT04664153|102177155|FG002|Overall Study|Withdrawal by Subject|1|||
33624477|NCT04664153|102177156|FG003|Overall Study|Withdrawal by Subject|2|||
33624478|NCT04664153|102177153|FG000|Overall Study|Other|0|||
33624479|NCT04664153|102177154|FG001|Overall Study|Other|1|||
33624480|NCT04664153|102177155|FG002|Overall Study|Other|0|||
33624481|NCT04664153|102177156|FG003|Overall Study|Other|0|||
33624482|NCT04664153|102177153|FG000|Overall Study|Adverse Event|4|||
33624483|NCT04664153|102177154|FG001|Overall Study|Adverse Event|0|||
33624484|NCT04664153|102177155|FG002|Overall Study|Adverse Event|1|||
33624485|NCT04664153|102177156|FG003|Overall Study|Adverse Event|0|||
33624486|NCT04716426|102177158|FG000|Overall Study|Vaccination|1|||
33624487|NCT04716426|102177159|FG001|Overall Study|Vaccination|1|||
33624488|NCT04716426|102177158|FG000|Overall Study|Contamination|1|||
33624489|NCT04716426|102177159|FG001|Overall Study|Contamination|0|||
33624490|NCT01903460|102177172|FG000|Overall Study|Adverse Event|0|||
33624491|NCT01903460|102177173|FG001|Overall Study|Adverse Event|0|||
33624492|NCT01903460|102177174|FG002|Overall Study|Adverse Event|0|||
33624493|NCT01903460|102177175|FG003|Overall Study|Adverse Event|1|||
33624494|NCT00922623|102177180|FG000|Overall Study|Other|4|||
33624495|NCT00922623|102177180|FG000|Overall Study|Lost to Follow-up|1|||
33624496|NCT04486235|102177183|FG000|Overall Study|Pregnancy|1|||
33624497|NCT04486235|102177184|FG001|Overall Study|Pregnancy|0|||
33624498|NCT04486235|102177183|FG000|Overall Study|Lost to Follow-up|1|||
33624499|NCT04486235|102177184|FG001|Overall Study|Lost to Follow-up|0|||
33624500|NCT01485094|102177185|FG000|Overall Study|Adverse Event|1|||
33624501|NCT01485094|102177186|FG001|Overall Study|Adverse Event|1|||
33624502|NCT01485094|102177187|FG002|Overall Study|Adverse Event|1|||
33624503|NCT01485094|102177185|FG000|Overall Study|Lost to Follow-up|1|||
33624504|NCT01485094|102177186|FG001|Overall Study|Lost to Follow-up|0|||
33624505|NCT01485094|102177187|FG002|Overall Study|Lost to Follow-up|0|||
33624506|NCT01485094|102177185|FG000|Overall Study|Withdrawal by Subject|1|||
33624507|NCT01485094|102177186|FG001|Overall Study|Withdrawal by Subject|1|||
33624508|NCT01485094|102177187|FG002|Overall Study|Withdrawal by Subject|0|||
33624509|NCT04024891|102177188|FG000|Overall Study|Pregnancy|0|||
33624510|NCT04024891|102177189|FG001|Overall Study|Pregnancy|1|||
33624511|NCT00079040|102177190|FG000|Overall Study|Withdrew before treatment|1|||
33624512|NCT00079040|102177190|FG000|Overall Study|Ineligible|1|||
33624513|NCT03016312|102177193|FG000|Overall Study|discontinued before the treatment started|0|||
33624514|NCT03016312|102177194|FG001|Overall Study|discontinued before the treatment started|1|||
33624515|NCT03016312|102177193|FG000|Overall Study|Withdrawal by Subject|37|||
33624516|NCT03016312|102177194|FG001|Overall Study|Withdrawal by Subject|44|||
33624517|NCT03016312|102177193|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
33624518|NCT03016312|102177194|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
33624519|NCT03016312|102177193|FG000|Overall Study|Physician Decision|1|||
33624520|NCT03016312|102177194|FG001|Overall Study|Physician Decision|3|||
33624521|NCT03016312|102177193|FG000|Overall Study|Lost to Follow-up|12|||
33624522|NCT03016312|102177194|FG001|Overall Study|Lost to Follow-up|12|||
33624523|NCT03016312|102177193|FG000|Overall Study|Death|210|||
33624524|NCT03016312|102177194|FG001|Overall Study|Death|184|||
33624525|NCT03016312|102177193|FG000|Overall Study|loss to contact|1|||
33624526|NCT03016312|102177194|FG001|Overall Study|loss to contact|0|||
33624527|NCT03016312|102177193|FG000|Overall Study|started a new cancer therapy|1|||
33414704|NCT01915498|101409854|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33414705|NCT01915498|101409855|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
33414706|NCT01915498|101409837|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
33414707|NCT01915498|101409838|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
33359778|NCT01380093|101204556|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
33359779|NCT01380093|101204557|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
33359780|NCT01380093|101204558|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
33359781|NCT01380093|101204559|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
33359782|NCT01380093|101204560|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
33359783|NCT01380093|101204561|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
33359784|NCT01380093|101204562|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
33359785|NCT01380093|101204563|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
33359786|NCT01380093|101204564|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
33359787|NCT01380093|101204556|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33414708|NCT01915498|101409839|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
33414709|NCT01915498|101409840|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
33414710|NCT01915498|101409841|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
33414711|NCT01915498|101409842|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
33414712|NCT01915498|101409843|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
33414713|NCT01915498|101409844|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
33561101|NCT03574389|101951627|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
33561102|NCT03574389|101951628|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
33561103|NCT03574389|101951629|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
33561104|NCT03574389|101951630|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
33561105|NCT03574389|101951631|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
33561106|NCT03574389|101951632|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
33561107|NCT03574389|101951626|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
33561108|NCT03574389|101951627|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
33561109|NCT03574389|101951628|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
33561110|NCT03574389|101951629|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
33561111|NCT03574389|101951630|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
33561112|NCT03574389|101951631|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
33561113|NCT03574389|101951632|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
33561114|NCT03574389|101951626|FG000|Vaccination Period|Other|6|||
33561115|NCT03574389|101951627|FG001|Vaccination Period|Other|0|||
33624528|NCT03016312|102177194|FG001|Overall Study|started a new cancer therapy|0|||
33624529|NCT02201524|102177197|FG000|Overall Study|Adverse Event|0|||
33624530|NCT02201524|102177198|FG001|Overall Study|Adverse Event|2|||
33624531|NCT02201524|102177199|FG002|Overall Study|Adverse Event|1|||
33624532|NCT02201524|102177200|FG003|Overall Study|Adverse Event|0|||
33624533|NCT02201524|102177197|FG000|Overall Study|Insufficient clinical response|1|||
33624534|NCT02201524|102177198|FG001|Overall Study|Insufficient clinical response|0|||
33624535|NCT02201524|102177199|FG002|Overall Study|Insufficient clinical response|0|||
33624536|NCT02201524|102177200|FG003|Overall Study|Insufficient clinical response|0|||
33359788|NCT01380093|101204557|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
33359789|NCT01380093|101204558|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33359790|NCT01380093|101204559|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33414714|NCT01915498|101409845|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
33624537|NCT02201524|102177197|FG000|Overall Study|Lost to Follow-up|0|||
33624538|NCT02201524|102177198|FG001|Overall Study|Lost to Follow-up|0|||
33624539|NCT02201524|102177199|FG002|Overall Study|Lost to Follow-up|2|||
33624540|NCT02201524|102177200|FG003|Overall Study|Lost to Follow-up|0|||
33624541|NCT02201524|102177197|FG000|Overall Study|No longer meets eligibility criteria|0|||
33624542|NCT02201524|102177198|FG001|Overall Study|No longer meets eligibility criteria|0|||
33624543|NCT02201524|102177199|FG002|Overall Study|No longer meets eligibility criteria|0|||
33624544|NCT02201524|102177200|FG003|Overall Study|No longer meets eligibility criteria|2|||
33624545|NCT02201524|102177197|FG000|Overall Study|Protocol Violation|0|||
33624546|NCT02201524|102177198|FG001|Overall Study|Protocol Violation|0|||
33624547|NCT02201524|102177199|FG002|Overall Study|Protocol Violation|0|||
33624548|NCT02201524|102177200|FG003|Overall Study|Protocol Violation|1|||
33624549|NCT02201524|102177197|FG000|Overall Study|Withdrawal by Subject|0|||
33624550|NCT02201524|102177198|FG001|Overall Study|Withdrawal by Subject|0|||
33624551|NCT02201524|102177199|FG002|Overall Study|Withdrawal by Subject|1|||
33624552|NCT02201524|102177200|FG003|Overall Study|Withdrawal by Subject|1|||
33624553|NCT02201524|102177197|FG000|Overall Study|Other|1|||
33624554|NCT02201524|102177198|FG001|Overall Study|Other|1|||
33624555|NCT02201524|102177199|FG002|Overall Study|Other|0|||
33624556|NCT02201524|102177200|FG003|Overall Study|Other|0|||
33624557|NCT00962208|102177204|FG000|Overall Study|Could not achieve good vision|9|||
33624558|NCT00962208|102177205|FG001|Overall Study|Could not achieve good vision|0|||
33624559|NCT00962208|102177204|FG000|Overall Study|Contraindicated to continue study|5|||
33359791|NCT01380093|101204560|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33359792|NCT01380093|101204561|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33359793|NCT01380093|101204562|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33359794|NCT01380093|101204563|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33359795|NCT01380093|101204564|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
33359796|NCT01380093|101204556|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
33359797|NCT01380093|101204557|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
33359798|NCT01380093|101204558|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
33359799|NCT01380093|101204559|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
33359800|NCT01380093|101204560|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
33359801|NCT01380093|101204561|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
33359802|NCT01380093|101204562|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
33359803|NCT01380093|101204563|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
33359804|NCT01380093|101204564|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
33359805|NCT01380093|101204556|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
33561116|NCT03574389|101951628|FG002|Vaccination Period|Other|0|||
33561117|NCT03574389|101951629|FG003|Vaccination Period|Other|0|||
33561118|NCT03574389|101951630|FG004|Vaccination Period|Other|0|||
33561119|NCT03574389|101951631|FG005|Vaccination Period|Other|0|||
33561120|NCT03574389|101951632|FG006|Vaccination Period|Other|0|||
33561121|NCT03574389|101951626|FG000|Vaccination Period|Adverse Event|0|||
33561122|NCT03574389|101951627|FG001|Vaccination Period|Adverse Event|1|||
33359806|NCT01380093|101204557|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
33561123|NCT03574389|101951628|FG002|Vaccination Period|Adverse Event|0|||
33561124|NCT03574389|101951629|FG003|Vaccination Period|Adverse Event|0|||
33561125|NCT03574389|101951630|FG004|Vaccination Period|Adverse Event|0|||
33561126|NCT03574389|101951631|FG005|Vaccination Period|Adverse Event|0|||
33561127|NCT03574389|101951632|FG006|Vaccination Period|Adverse Event|0|||
33561128|NCT03574389|101951626|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
33561129|NCT03574389|101951627|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
33561130|NCT03574389|101951628|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
33561131|NCT03574389|101951629|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
33561132|NCT03574389|101951630|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
33561133|NCT03574389|101951631|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
33561134|NCT03574389|101951632|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
33561135|NCT01122680|101951634|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
33561136|NCT01122680|101951635|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
33624560|NCT00962208|102177205|FG001|Overall Study|Contraindicated to continue study|1|||
33624561|NCT00962208|102177204|FG000|Overall Study|Lost to Follow-up|0|||
33624562|NCT00962208|102177205|FG001|Overall Study|Lost to Follow-up|9|||
33624563|NCT00499681|102177206|FG000|Overall Study|toxicity|0|||
33624564|NCT00499681|102177207|FG001|Overall Study|toxicity|1|||
33624565|NCT00499681|102177206|FG000|Overall Study|disease progression|0|||
33624566|NCT00499681|102177207|FG001|Overall Study|disease progression|1|||
33624567|NCT02178995|102177208|FG000|Double Blind|Adverse Event|0|||
33624568|NCT02178995|102177209|FG001|Double Blind|Adverse Event|0|||
33624569|NCT02178995|102177210|FG002|Double Blind|Adverse Event|0|||
33624570|NCT02178995|102177211|FG003|Double Blind|Adverse Event|0|||
33624571|NCT02178995|102177212|FG004|Double Blind|Adverse Event|0|||
33624572|NCT02178995|102177213|FG005|Double Blind|Adverse Event|1|||
33624573|NCT02178995|102177214|FG006|Double Blind|Adverse Event|0|||
33624574|NCT02178995|102177215|FG007|Double Blind|Adverse Event|1|||
33624575|NCT02178995|102177216|FG008|Double Blind|Adverse Event|1|||
33624576|NCT02178995|102177208|FG000|Double Blind|Lost to Follow-up|0|||
33624577|NCT02178995|102177209|FG001|Double Blind|Lost to Follow-up|1|||
33624578|NCT02178995|102177210|FG002|Double Blind|Lost to Follow-up|0|||
33561137|NCT01122680|101951636|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
33561138|NCT01122680|101951637|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
33624579|NCT02178995|102177211|FG003|Double Blind|Lost to Follow-up|0|||
33624580|NCT02178995|102177212|FG004|Double Blind|Lost to Follow-up|0|||
33624581|NCT02178995|102177213|FG005|Double Blind|Lost to Follow-up|0|||
33624582|NCT02178995|102177214|FG006|Double Blind|Lost to Follow-up|0|||
33624583|NCT02178995|102177215|FG007|Double Blind|Lost to Follow-up|1|||
33624584|NCT02178995|102177216|FG008|Double Blind|Lost to Follow-up|0|||
33220640|NCT00404495|100706818|FG000|Overall Study|Lost to Follow-up|5|||
33624585|NCT02178995|102177208|FG000|Open Label|Adverse Event|2|||
33624586|NCT02178995|102177209|FG001|Open Label|Adverse Event|0|||
33624587|NCT02178995|102177210|FG002|Open Label|Adverse Event|0|||
33624588|NCT02178995|102177211|FG003|Open Label|Adverse Event|0|||
33624589|NCT02178995|102177212|FG004|Open Label|Adverse Event|0|||
33624590|NCT02178995|102177213|FG005|Open Label|Adverse Event|0|||
33624591|NCT02178995|102177214|FG006|Open Label|Adverse Event|0|||
33624592|NCT02178995|102177215|FG007|Open Label|Adverse Event|0|||
33624593|NCT02178995|102177216|FG008|Open Label|Adverse Event|0|||
33624594|NCT03310723|102177224|FG000|Overall Study|Withdrawal by Subject|0|||
33624595|NCT03310723|102177225|FG001|Overall Study|Withdrawal by Subject|1|||
33624596|NCT03310723|102177224|FG000|Overall Study|Protocol Violation|0|||
33624597|NCT03310723|102177225|FG001|Overall Study|Protocol Violation|2|||
33624598|NCT00227721|102177228|FG000|Overall Study|On study, but never treated.|1|||
33624599|NCT02898454|102177229|FG000|Overall Study|Adverse Event|4|||
33220641|NCT00404495|100706819|FG001|Overall Study|Lost to Follow-up|0|||
33414715|NCT01915498|101409846|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
33414716|NCT01915498|101409847|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
33414717|NCT01915498|101409848|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
33561139|NCT01122680|101951634|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
33561140|NCT01122680|101951635|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
33561141|NCT01122680|101951636|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
33561142|NCT01122680|101951637|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
33561143|NCT01122680|101951634|FG000|Period 1 (4 Weeks)|Other|1|||
33414718|NCT01915498|101409849|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
33414719|NCT01915498|101409850|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
33414720|NCT01915498|101409851|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
33414721|NCT01915498|101409852|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
33414722|NCT01915498|101409853|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
33561144|NCT01122680|101951635|FG001|Period 1 (4 Weeks)|Other|1|||
33561145|NCT01122680|101951636|FG002|Period 1 (4 Weeks)|Other|0|||
33561146|NCT01122680|101951637|FG003|Period 1 (4 Weeks)|Other|0|||
33561147|NCT01122680|101951634|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
33561148|NCT01122680|101951635|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
33561149|NCT01122680|101951636|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
33624600|NCT02898454|102177230|FG001|Overall Study|Adverse Event|1|||
33624601|NCT02898454|102177231|FG002|Overall Study|Adverse Event|2|||
33624602|NCT02898454|102177229|FG000|Overall Study|Protocol Violation|1|||
33624603|NCT02898454|102177230|FG001|Overall Study|Protocol Violation|0|||
33359807|NCT01380093|101204558|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
33359808|NCT01380093|101204559|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
33359809|NCT01380093|101204560|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
33359810|NCT01380093|101204561|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
33359811|NCT01380093|101204562|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
33359812|NCT01380093|101204563|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
33359813|NCT01380093|101204564|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
33359814|NCT01380093|101204556|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
33359815|NCT01380093|101204557|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
33359816|NCT01380093|101204558|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
33359817|NCT01380093|101204559|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
33359818|NCT01380093|101204560|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
33359819|NCT01380093|101204561|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
33359820|NCT01380093|101204562|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
33359821|NCT01380093|101204563|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
33359822|NCT01380093|101204564|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
33359823|NCT01380093|101204556|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33359824|NCT01380093|101204557|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33359825|NCT01380093|101204558|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
33561150|NCT01122680|101951637|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
33561151|NCT01122680|101951634|FG000|Period 2 (4 Weeks)|Other|1|||
33624604|NCT02898454|102177231|FG002|Overall Study|Protocol Violation|1|||
33624605|NCT02898454|102177229|FG000|Overall Study|Lack of Efficacy|4|||
33414723|NCT01915498|101409854|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
33414724|NCT01915498|101409855|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
33414725|NCT01915498|101409837|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414726|NCT01915498|101409838|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414727|NCT01915498|101409839|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414728|NCT01915498|101409840|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414729|NCT01915498|101409841|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33561152|NCT01122680|101951635|FG001|Period 2 (4 Weeks)|Other|0|||
33561153|NCT01122680|101951636|FG002|Period 2 (4 Weeks)|Other|0|||
33561154|NCT01122680|101951637|FG003|Period 2 (4 Weeks)|Other|0|||
33561155|NCT01122680|101951634|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
33561156|NCT01122680|101951635|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
33561157|NCT01122680|101951636|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
33561158|NCT01122680|101951637|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
33561159|NCT01122680|101951634|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
33561160|NCT01122680|101951635|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
33561161|NCT01122680|101951636|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
33561162|NCT01122680|101951637|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
33561163|NCT00397046|101951638|FG000|Overall Study|Disease Progression|3|||
33561164|NCT00397046|101951639|FG001|Overall Study|Disease Progression|3|||
33624606|NCT02898454|102177230|FG001|Overall Study|Lack of Efficacy|1|||
33561165|NCT00397046|101951640|FG002|Overall Study|Disease Progression|10|||
33561166|NCT00397046|101951641|FG003|Overall Study|Disease Progression|5|||
33414730|NCT01915498|101409842|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414731|NCT01915498|101409843|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414732|NCT01915498|101409844|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414733|NCT01915498|101409845|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414734|NCT01915498|101409846|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33561167|NCT00855166|101951646|FG000|Overall Study|Adverse Event|0|||
33414735|NCT01915498|101409847|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
33561168|NCT00855166|101951647|FG001|Overall Study|Adverse Event|2|||
33561169|NCT00855166|101951646|FG000|Overall Study|Death|0|||
33561170|NCT00855166|101951647|FG001|Overall Study|Death|1|||
33414736|NCT01915498|101409848|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414737|NCT01915498|101409849|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414738|NCT01915498|101409850|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414739|NCT01915498|101409851|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414740|NCT01915498|101409852|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414741|NCT01915498|101409853|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414742|NCT01915498|101409854|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414743|NCT01915498|101409855|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
33414744|NCT01915498|101409837|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
33414745|NCT01915498|101409838|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
33414746|NCT01915498|101409839|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
33414747|NCT01915498|101409840|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
33414748|NCT01915498|101409841|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
33414749|NCT01915498|101409842|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
33561171|NCT00855166|101951646|FG000|Overall Study|Withdrawal by Subject|1|||
33561172|NCT00855166|101951647|FG001|Overall Study|Withdrawal by Subject|4|||
33220642|NCT00404495|100706818|FG000|Overall Study|Other|1|||
33220643|NCT00404495|100706819|FG001|Overall Study|Other|0|||
33220644|NCT00404495|100706818|FG000|Overall Study|Withdrawal by Subject|1|||
33359826|NCT01380093|101204559|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33359827|NCT01380093|101204560|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33359828|NCT01380093|101204561|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33359829|NCT01380093|101204562|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33359830|NCT01380093|101204563|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33359831|NCT01380093|101204564|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
33359832|NCT01380093|101204556|FG000|Treatment Phase: Second Intervention|Other|0|||
33359833|NCT01380093|101204557|FG001|Treatment Phase: Second Intervention|Other|0|||
33359834|NCT01380093|101204558|FG002|Treatment Phase: Second Intervention|Other|0|||
33359835|NCT01380093|101204559|FG003|Treatment Phase: Second Intervention|Other|1|||
33359836|NCT01380093|101204560|FG004|Treatment Phase: Second Intervention|Other|0|||
33359837|NCT01380093|101204561|FG005|Treatment Phase: Second Intervention|Other|0|||
33359838|NCT01380093|101204562|FG006|Treatment Phase: Second Intervention|Other|0|||
33359839|NCT01380093|101204563|FG007|Treatment Phase: Second Intervention|Other|0|||
33359840|NCT01380093|101204564|FG008|Treatment Phase: Second Intervention|Other|0|||
33359841|NCT01380093|101204556|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
33359842|NCT01380093|101204557|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
33359843|NCT01380093|101204558|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
33359844|NCT01380093|101204559|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
33359845|NCT01380093|101204560|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
33359846|NCT01380093|101204561|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
33359847|NCT01380093|101204562|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
33359848|NCT01380093|101204563|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
33359849|NCT01380093|101204564|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
33359850|NCT01380093|101204556|FG000|Treatment Phase: Third Intervention|Other|0|||
33359851|NCT01380093|101204557|FG001|Treatment Phase: Third Intervention|Other|0|||
33359852|NCT01380093|101204558|FG002|Treatment Phase: Third Intervention|Other|0|||
33359853|NCT01380093|101204559|FG003|Treatment Phase: Third Intervention|Other|0|||
33359854|NCT01380093|101204560|FG004|Treatment Phase: Third Intervention|Other|0|||
33359855|NCT01380093|101204561|FG005|Treatment Phase: Third Intervention|Other|0|||
33359856|NCT01380093|101204562|FG006|Treatment Phase: Third Intervention|Other|0|||
33359857|NCT01380093|101204563|FG007|Treatment Phase: Third Intervention|Other|0|||
33359858|NCT01380093|101204564|FG008|Treatment Phase: Third Intervention|Other|1|||
33359859|NCT02024464|101204569|FG000|Overall Study|Discontinued|5|||
33359860|NCT02024464|101204570|FG001|Overall Study|Discontinued|4|||
33359861|NCT02024464|101204569|FG000|Overall Study|Missed Visits|1|||
33359862|NCT02024464|101204570|FG001|Overall Study|Missed Visits|0|||
33359863|NCT02024464|101204569|FG000|Overall Study|Lost to Follow-up|4|||
33359864|NCT02024464|101204570|FG001|Overall Study|Lost to Follow-up|7|||
33359865|NCT04786210|101204571|FG000|Overall Study|Lost to Follow-up|2|||
33561173|NCT00855166|101951646|FG000|Overall Study|Poor/non-compliance|2|||
33561174|NCT00855166|101951647|FG001|Overall Study|Poor/non-compliance|0|||
33561175|NCT00855166|101951646|FG000|Overall Study|Administrative reasons by sponsor|1|||
33220645|NCT00404495|100706819|FG001|Overall Study|Withdrawal by Subject|0|||
33220646|NCT01875185|100706823|FG000|Overall Study|study was terminated|52|||
33359866|NCT04786210|101204571|FG000|Overall Study|Withdrawal by Subject|4|||
33359867|NCT04655586|101204576|FG000|Overall Study|Physician Decision|1|||
33359868|NCT04655586|101204577|FG001|Overall Study|Physician Decision|3|||
33359869|NCT04655586|101204578|FG002|Overall Study|Physician Decision|4|||
33359870|NCT04655586|101204576|FG000|Overall Study|Withdrawal by Subject|1|||
33359871|NCT04655586|101204577|FG001|Overall Study|Withdrawal by Subject|3|||
33414750|NCT01915498|101409843|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
33561176|NCT00855166|101951647|FG001|Overall Study|Administrative reasons by sponsor|0|||
33359872|NCT04655586|101204578|FG002|Overall Study|Withdrawal by Subject|1|||
33359873|NCT01171521|101204583|FG000|Overall Study|Lost to Follow-up|5|||
33414751|NCT01915498|101409844|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
33414752|NCT01915498|101409845|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
33414753|NCT01915498|101409846|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
33414754|NCT01915498|101409847|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
33414755|NCT01915498|101409848|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
33414756|NCT01915498|101409849|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
33414757|NCT01915498|101409850|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
33414758|NCT01915498|101409851|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
33414759|NCT01915498|101409852|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
33414760|NCT01915498|101409853|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
33414761|NCT01915498|101409854|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
33414762|NCT01915498|101409855|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
33414763|NCT01915498|101409837|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
33414764|NCT01915498|101409838|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
33414765|NCT01915498|101409839|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
33414766|NCT01915498|101409840|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
33414767|NCT01915498|101409841|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
33414768|NCT01915498|101409842|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
33414769|NCT01915498|101409843|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
33414770|NCT01915498|101409844|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
33414771|NCT01915498|101409845|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
33414772|NCT01915498|101409846|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
33414773|NCT01915498|101409847|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
33414774|NCT01915498|101409848|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
33414775|NCT01915498|101409849|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
33414776|NCT01915498|101409850|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
33359874|NCT01171521|101204583|FG000|Overall Study|screen failure|1|||
33359875|NCT03750838|101204584|FG000|Overall Study|Lost to Follow-up|10|||
33359876|NCT03750838|101204585|FG001|Overall Study|Lost to Follow-up|6|||
33359877|NCT04430348|101204592|FG000|Overall Study|Death|3|||
33359878|NCT04430348|101204593|FG001|Overall Study|Death|2|||
33359879|NCT04430348|101204594|FG002|Overall Study|Death|2|||
33359880|NCT04430348|101204595|FG003|Overall Study|Death|2|||
33359881|NCT04430348|101204596|FG004|Overall Study|Death|2|||
33359882|NCT04430348|101204597|FG005|Overall Study|Death|3|||
33359883|NCT04430348|101204592|FG000|Overall Study|Lost to Follow-up|0|||
33359884|NCT04430348|101204593|FG001|Overall Study|Lost to Follow-up|0|||
33359885|NCT04430348|101204594|FG002|Overall Study|Lost to Follow-up|0|||
33359886|NCT04430348|101204595|FG003|Overall Study|Lost to Follow-up|1|||
33359887|NCT04430348|101204596|FG004|Overall Study|Lost to Follow-up|0|||
33359888|NCT04430348|101204597|FG005|Overall Study|Lost to Follow-up|0|||
33359889|NCT04430348|101204592|FG000|Overall Study|Adverse Event|0|||
33414777|NCT01915498|101409851|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
33414778|NCT01915498|101409852|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
33414779|NCT01915498|101409853|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
33414780|NCT01915498|101409854|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
33414781|NCT01915498|101409855|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
33414782|NCT01915498|101409837|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414783|NCT01915498|101409838|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414784|NCT01915498|101409839|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33359890|NCT04430348|101204593|FG001|Overall Study|Adverse Event|0|||
33414785|NCT01915498|101409840|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33561177|NCT00855166|101951646|FG000|Overall Study|Subject no longer meets study criteria|1|||
33561178|NCT00855166|101951647|FG001|Overall Study|Subject no longer meets study criteria|1|||
33561179|NCT00773461|101951650|FG000|Overall Study|Adverse Event|1|||
33561180|NCT00773461|101951651|FG001|Overall Study|Adverse Event|3|||
33561181|NCT00773461|101951650|FG000|Overall Study|Withdrawal by Subject|4|||
33561182|NCT00773461|101951651|FG001|Overall Study|Withdrawal by Subject|1|||
33561183|NCT01903720|101951656|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
33561184|NCT01903720|101951656|FG000|Overall Study|Adverse Event|1|||
33561185|NCT01903720|101951656|FG000|Overall Study|Rescinding of informed consent|2|||
33359891|NCT04430348|101204594|FG002|Overall Study|Adverse Event|0|||
33359892|NCT04430348|101204595|FG003|Overall Study|Adverse Event|0|||
33359893|NCT04430348|101204596|FG004|Overall Study|Adverse Event|0|||
33359894|NCT04430348|101204597|FG005|Overall Study|Adverse Event|1|||
33414786|NCT01915498|101409841|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414787|NCT01915498|101409842|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414788|NCT01915498|101409843|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33561186|NCT01903720|101951656|FG000|Overall Study|Lost to Follow-up|2|||
33624607|NCT02898454|102177231|FG002|Overall Study|Lack of Efficacy|0|||
33624608|NCT02898454|102177229|FG000|Overall Study|Withdrawal by Subject|6|||
33624609|NCT02898454|102177230|FG001|Overall Study|Withdrawal by Subject|3|||
33624610|NCT02898454|102177231|FG002|Overall Study|Withdrawal by Subject|3|||
33624611|NCT02898454|102177229|FG000|Overall Study|Lost to Follow-up|1|||
33624612|NCT02898454|102177230|FG001|Overall Study|Lost to Follow-up|0|||
33624613|NCT02898454|102177231|FG002|Overall Study|Lost to Follow-up|0|||
33624614|NCT02898454|102177229|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
33624615|NCT02898454|102177230|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
33624616|NCT02898454|102177231|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
33624617|NCT02539797|102177232|FG000|Overall Study|Lost to Follow-up|0|||
33624618|NCT02539797|102177233|FG001|Overall Study|Lost to Follow-up|1|||
33624619|NCT02539797|102177234|FG002|Overall Study|Lost to Follow-up|0|||
33624620|NCT02123134|102177235|FG000|Overall Study|Withdrawal of consent|3|||
33624621|NCT02123134|102177236|FG001|Overall Study|Withdrawal of consent|2|||
33624622|NCT02123134|102177235|FG000|Overall Study|Administrative decision|0|||
33624623|NCT02123134|102177236|FG001|Overall Study|Administrative decision|1|||
33624624|NCT01420861|102177238|FG000|Overall Study|Adverse Event|2|||
33624625|NCT01420861|102177238|FG000|Overall Study|Study terminated by Sponsor|7|||
33624626|NCT01420861|102177238|FG000|Overall Study|Screen failure|7|||
33624627|NCT01420861|102177238|FG000|Overall Study|Randomized not Treated|2|||
33624628|NCT00982735|102177239|FG000|Overall Study|Lost to Follow-up|6|||
33624629|NCT00982735|102177239|FG000|Overall Study|Patient ineligible for trial|224|||
33624630|NCT01300234|102177245|FG000|Overall Study|Adverse Event|1|||
33624631|NCT01300234|102177246|FG001|Overall Study|Adverse Event|1|||
33624632|NCT01300234|102177245|FG000|Overall Study|Protocol Violation|2|||
33624633|NCT01300234|102177246|FG001|Overall Study|Protocol Violation|3|||
33624634|NCT01300234|102177245|FG000|Overall Study|Withdrawal by Subject|5|||
33624635|NCT01300234|102177246|FG001|Overall Study|Withdrawal by Subject|9|||
33624636|NCT01300234|102177245|FG000|Overall Study|Lost to Follow-up|14|||
33624637|NCT01300234|102177246|FG001|Overall Study|Lost to Follow-up|12|||
33624638|NCT01300234|102177245|FG000|Overall Study|Pregnancy|2|||
33624639|NCT01300234|102177246|FG001|Overall Study|Pregnancy|1|||
33624640|NCT01300234|102177245|FG000|Overall Study|Participant reached stopping critera|2|||
33624641|NCT01300234|102177246|FG001|Overall Study|Participant reached stopping critera|0|||
33624642|NCT01300234|102177245|FG000|Overall Study|Participant stopped medication|1|||
33624643|NCT01300234|102177246|FG001|Overall Study|Participant stopped medication|1|||
33624644|NCT01300234|102177245|FG000|Overall Study|Participant refused return to hospital|1|||
33624645|NCT01300234|102177246|FG001|Overall Study|Participant refused return to hospital|0|||
33624646|NCT03050801|102177248|FG000|Experiment 1|Lost to Follow-up|0|||
33624647|NCT03050801|102177249|FG001|Experiment 1|Lost to Follow-up|1|||
33624648|NCT03050801|102177250|FG002|Experiment 1|Lost to Follow-up|0|||
33624649|NCT03050801|102177251|FG003|Experiment 1|Lost to Follow-up|0|||
33624650|NCT03050801|102177252|FG004|Experiment 1|Lost to Follow-up|0|||
33624651|NCT03050801|102177253|FG005|Experiment 1|Lost to Follow-up|0|||
33624652|NCT03050801|102177248|FG000|Experiment 1|Physician Decision|0|||
33624653|NCT03050801|102177249|FG001|Experiment 1|Physician Decision|3|||
33624654|NCT03050801|102177250|FG002|Experiment 1|Physician Decision|0|||
33624655|NCT03050801|102177251|FG003|Experiment 1|Physician Decision|0|||
33624656|NCT03050801|102177252|FG004|Experiment 1|Physician Decision|0|||
33561187|NCT01903720|101951656|FG000|Overall Study|Treatment with alternative drug|1|||
33561188|NCT02101853|101951657|FG000|Block 1 Induction|Adverse Event|11|||
33561189|NCT02101853|101951658|FG001|Block 1 Induction|Adverse Event|0|||
33561190|NCT02101853|101951659|FG002|Block 1 Induction|Adverse Event|0|||
33561191|NCT02101853|101951660|FG003|Block 1 Induction|Adverse Event|0|||
33561192|NCT02101853|101951661|FG004|Block 1 Induction|Adverse Event|0|||
33561193|NCT02101853|101951662|FG005|Block 1 Induction|Adverse Event|0|||
33561194|NCT02101853|101951657|FG000|Block 1 Induction|Death|20|||
33561195|NCT02101853|101951658|FG001|Block 1 Induction|Death|0|||
33561196|NCT02101853|101951659|FG002|Block 1 Induction|Death|0|||
33561197|NCT02101853|101951660|FG003|Block 1 Induction|Death|0|||
33561198|NCT02101853|101951661|FG004|Block 1 Induction|Death|0|||
33561199|NCT02101853|101951662|FG005|Block 1 Induction|Death|0|||
33561200|NCT02101853|101951657|FG000|Block 1 Induction|Lack of Efficacy|6|||
33561201|NCT02101853|101951658|FG001|Block 1 Induction|Lack of Efficacy|0|||
33561202|NCT02101853|101951659|FG002|Block 1 Induction|Lack of Efficacy|0|||
33561203|NCT02101853|101951660|FG003|Block 1 Induction|Lack of Efficacy|0|||
33561204|NCT02101853|101951661|FG004|Block 1 Induction|Lack of Efficacy|0|||
33561205|NCT02101853|101951662|FG005|Block 1 Induction|Lack of Efficacy|0|||
33561206|NCT02101853|101951657|FG000|Block 1 Induction|Physician Decision|61|||
33561207|NCT02101853|101951658|FG001|Block 1 Induction|Physician Decision|0|||
33561208|NCT02101853|101951659|FG002|Block 1 Induction|Physician Decision|0|||
33624657|NCT03050801|102177253|FG005|Experiment 1|Physician Decision|0|||
33561209|NCT02101853|101951660|FG003|Block 1 Induction|Physician Decision|0|||
33561210|NCT02101853|101951661|FG004|Block 1 Induction|Physician Decision|0|||
33561211|NCT02101853|101951662|FG005|Block 1 Induction|Physician Decision|0|||
33561212|NCT02101853|101951657|FG000|Block 1 Induction|Protocol Violation|2|||
33561213|NCT02101853|101951658|FG001|Block 1 Induction|Protocol Violation|0|||
33414789|NCT01915498|101409844|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414790|NCT01915498|101409845|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414791|NCT01915498|101409846|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414792|NCT01915498|101409847|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414793|NCT01915498|101409848|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414794|NCT01915498|101409849|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414795|NCT01915498|101409850|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414796|NCT01915498|101409851|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414797|NCT01915498|101409852|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414798|NCT01915498|101409853|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414799|NCT01915498|101409854|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
33414800|NCT01915498|101409855|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
33359895|NCT04430348|101204592|FG000|Overall Study|Withdrawal by Subject|0|||
33359896|NCT04430348|101204593|FG001|Overall Study|Withdrawal by Subject|1|||
33359897|NCT04430348|101204594|FG002|Overall Study|Withdrawal by Subject|0|||
33359898|NCT04430348|101204595|FG003|Overall Study|Withdrawal by Subject|0|||
33359899|NCT04430348|101204596|FG004|Overall Study|Withdrawal by Subject|0|||
33359900|NCT04430348|101204597|FG005|Overall Study|Withdrawal by Subject|1|||
33359901|NCT04430348|101204592|FG000|Overall Study|Study Terminated by Sponsor|0|||
33359902|NCT04430348|101204593|FG001|Overall Study|Study Terminated by Sponsor|0|||
33359903|NCT04430348|101204594|FG002|Overall Study|Study Terminated by Sponsor|2|||
33359904|NCT04430348|101204595|FG003|Overall Study|Study Terminated by Sponsor|0|||
33359905|NCT04430348|101204596|FG004|Overall Study|Study Terminated by Sponsor|1|||
33359906|NCT04430348|101204597|FG005|Overall Study|Study Terminated by Sponsor|1|||
33359907|NCT00482001|101204600|FG000|Overall Study|Protocol Violation|1|||
33414801|NCT01915498|101409837|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414802|NCT01915498|101409838|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414803|NCT01915498|101409839|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33561214|NCT02101853|101951659|FG002|Block 1 Induction|Protocol Violation|0|||
33359908|NCT00482001|101204601|FG001|Overall Study|Protocol Violation|1|||
33359909|NCT01088412|101204602|FG000|Overall Study|Adverse Event|38|||
33359910|NCT01088412|101204603|FG001|Overall Study|Adverse Event|0|||
33359911|NCT01088412|101204604|FG002|Overall Study|Adverse Event|0|||
33359912|NCT01088412|101204602|FG000|Overall Study|Death|42|||
33359913|NCT01088412|101204603|FG001|Overall Study|Death|6|||
33359914|NCT01088412|101204604|FG002|Overall Study|Death|0|||
33359915|NCT01088412|101204602|FG000|Overall Study|Other Reason per Case Report Form|2089|||
33359916|NCT01088412|101204603|FG001|Overall Study|Other Reason per Case Report Form|103|||
33359917|NCT01088412|101204604|FG002|Overall Study|Other Reason per Case Report Form|9|||
33561215|NCT02101853|101951660|FG003|Block 1 Induction|Protocol Violation|0|||
33561216|NCT02101853|101951661|FG004|Block 1 Induction|Protocol Violation|0|||
33220647|NCT01875185|100706824|FG001|Overall Study|study was terminated|48|||
33220648|NCT01111838|100706832|FG000|Overall Study|Patient Ineligible|2|||
33220649|NCT01111838|100706832|FG000|Overall Study|Not Treated|3|||
33359918|NCT01088412|101204602|FG000|Overall Study|Withdrawal by Subject|1761|||
33359919|NCT01088412|101204603|FG001|Overall Study|Withdrawal by Subject|25|||
33561217|NCT02101853|101951662|FG005|Block 1 Induction|Protocol Violation|0|||
33561218|NCT02101853|101951657|FG000|Block 1 Induction|Withdrawal by Subject|65|||
33561219|NCT02101853|101951658|FG001|Block 1 Induction|Withdrawal by Subject|0|||
33561220|NCT02101853|101951659|FG002|Block 1 Induction|Withdrawal by Subject|0|||
33561221|NCT02101853|101951660|FG003|Block 1 Induction|Withdrawal by Subject|0|||
33561222|NCT02101853|101951661|FG004|Block 1 Induction|Withdrawal by Subject|0|||
33561223|NCT02101853|101951662|FG005|Block 1 Induction|Withdrawal by Subject|0|||
33561224|NCT02101853|101951657|FG000|Block 1 Induction|Ineligible|8|||
33561225|NCT02101853|101951658|FG001|Block 1 Induction|Ineligible|0|||
33561226|NCT02101853|101951659|FG002|Block 1 Induction|Ineligible|0|||
33561227|NCT02101853|101951660|FG003|Block 1 Induction|Ineligible|0|||
33561228|NCT02101853|101951661|FG004|Block 1 Induction|Ineligible|0|||
33561229|NCT02101853|101951662|FG005|Block 1 Induction|Ineligible|0|||
33561230|NCT02101853|101951657|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
33561231|NCT02101853|101951658|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
33561232|NCT02101853|101951659|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
33220650|NCT01111838|100706832|FG000|Overall Study|Clinical deterioration|1|||
33359920|NCT01088412|101204604|FG002|Overall Study|Withdrawal by Subject|1|||
33359921|NCT01088412|101204602|FG000|Overall Study|Received Another GH Product|79|||
33359922|NCT01088412|101204603|FG001|Overall Study|Received Another GH Product|0|||
33359923|NCT01088412|101204604|FG002|Overall Study|Received Another GH Product|0|||
33414804|NCT01915498|101409840|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33561233|NCT02101853|101951660|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
33561234|NCT02101853|101951661|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
33359924|NCT01088412|101204602|FG000|Overall Study|Participant Moved|601|||
33359925|NCT01088412|101204603|FG001|Overall Study|Participant Moved|21|||
33359926|NCT01088412|101204604|FG002|Overall Study|Participant Moved|2|||
33359927|NCT01088412|101204602|FG000|Overall Study|Physician Decision|1041|||
33359928|NCT01088412|101204603|FG001|Overall Study|Physician Decision|8|||
33359929|NCT01088412|101204604|FG002|Overall Study|Physician Decision|4|||
33359930|NCT01088412|101204602|FG000|Overall Study|Sponsor Decision|4467|||
33359931|NCT01088412|101204603|FG001|Overall Study|Sponsor Decision|79|||
33359932|NCT01088412|101204604|FG002|Overall Study|Sponsor Decision|23|||
33359933|NCT01088412|101204602|FG000|Overall Study|Third Party Required to Change Brand|487|||
33359934|NCT01088412|101204603|FG001|Overall Study|Third Party Required to Change Brand|0|||
33359935|NCT01088412|101204604|FG002|Overall Study|Third Party Required to Change Brand|0|||
33359936|NCT01088412|101204602|FG000|Overall Study|Lost to Follow-up|3052|||
33359937|NCT01088412|101204603|FG001|Overall Study|Lost to Follow-up|130|||
33359938|NCT01088412|101204604|FG002|Overall Study|Lost to Follow-up|11|||
33359939|NCT01088412|101204602|FG000|Overall Study|Study Summary Not Completed|4360|||
33359940|NCT01088412|101204603|FG001|Overall Study|Study Summary Not Completed|64|||
33414805|NCT01915498|101409841|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414806|NCT01915498|101409842|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414807|NCT01915498|101409843|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414808|NCT01915498|101409844|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414809|NCT01915498|101409845|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414810|NCT01915498|101409846|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414811|NCT01915498|101409847|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414812|NCT01915498|101409848|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414813|NCT01915498|101409849|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414814|NCT01915498|101409850|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414815|NCT01915498|101409851|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414816|NCT01915498|101409852|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414817|NCT01915498|101409853|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414818|NCT01915498|101409854|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
33414819|NCT01915498|101409855|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
33414820|NCT01915498|101409837|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33414821|NCT01915498|101409838|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33414822|NCT01915498|101409839|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33414823|NCT01915498|101409840|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33414824|NCT01915498|101409841|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33414825|NCT01915498|101409842|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33561235|NCT02101853|101951662|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
33561236|NCT02101853|101951657|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
33561237|NCT02101853|101951658|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33561238|NCT02101853|101951659|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33561239|NCT02101853|101951660|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33561240|NCT02101853|101951661|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33624658|NCT03050801|102177248|FG000|Experiment 1|Change of experimental design|0|||
33624659|NCT03050801|102177249|FG001|Experiment 1|Change of experimental design|3|||
33624660|NCT03050801|102177250|FG002|Experiment 1|Change of experimental design|0|||
33624661|NCT03050801|102177251|FG003|Experiment 1|Change of experimental design|0|||
33624662|NCT03050801|102177252|FG004|Experiment 1|Change of experimental design|0|||
33624663|NCT03050801|102177253|FG005|Experiment 1|Change of experimental design|0|||
33624664|NCT03050801|102177248|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
33624665|NCT03050801|102177249|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
33624666|NCT03050801|102177250|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
33624667|NCT03050801|102177251|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
33624668|NCT03050801|102177252|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
33624669|NCT03050801|102177253|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
33624670|NCT03050801|102177248|FG000|Experiment 2|Lost to Follow-up|0|||
33624671|NCT03050801|102177249|FG001|Experiment 2|Lost to Follow-up|0|||
33624672|NCT03050801|102177250|FG002|Experiment 2|Lost to Follow-up|0|||
33624673|NCT03050801|102177251|FG003|Experiment 2|Lost to Follow-up|1|||
33624674|NCT03050801|102177252|FG004|Experiment 2|Lost to Follow-up|1|||
33624675|NCT03050801|102177253|FG005|Experiment 2|Lost to Follow-up|0|||
33624676|NCT03050801|102177248|FG000|Experiment 2|Physician Decision|0|||
33624677|NCT03050801|102177249|FG001|Experiment 2|Physician Decision|0|||
33359941|NCT01088412|101204604|FG002|Overall Study|Study Summary Not Completed|22|||
33359942|NCT02424539|101204605|FG000|Overall Study|Adverse Event|0|||
33359943|NCT02424539|101204606|FG001|Overall Study|Adverse Event|0|||
33359944|NCT02424539|101204607|FG002|Overall Study|Adverse Event|1|||
33359945|NCT02424539|101204605|FG000|Overall Study|Physician Decision|0|||
33359946|NCT02424539|101204606|FG001|Overall Study|Physician Decision|0|||
33359947|NCT02424539|101204607|FG002|Overall Study|Physician Decision|1|||
33359948|NCT02424539|101204605|FG000|Overall Study|Withdrawal by Subject|3|||
33359949|NCT02424539|101204606|FG001|Overall Study|Withdrawal by Subject|1|||
33359950|NCT02424539|101204607|FG002|Overall Study|Withdrawal by Subject|0|||
33359951|NCT02424539|101204605|FG000|Overall Study|Other: Reached stopping criteria|11|||
33359952|NCT02424539|101204606|FG001|Overall Study|Other: Reached stopping criteria|7|||
33359953|NCT02424539|101204607|FG002|Overall Study|Other: Reached stopping criteria|6|||
33359954|NCT00519532|101204610|FG000|Overall Study|Adverse Event|11|||
33359955|NCT00519532|101204610|FG000|Overall Study|Withdrawal by Subject|5|||
33359956|NCT00519532|101204610|FG000|Overall Study|Lost to Follow-up|2|||
33359957|NCT02441803|101204611|FG000|Overall Study|Physician Decision|0|||
33359958|NCT02441803|101204612|FG001|Overall Study|Physician Decision|2|||
33359959|NCT02441803|101204613|FG002|Overall Study|Physician Decision|2|||
33624678|NCT03050801|102177250|FG002|Experiment 2|Physician Decision|0|||
33624679|NCT03050801|102177251|FG003|Experiment 2|Physician Decision|0|||
33624680|NCT03050801|102177252|FG004|Experiment 2|Physician Decision|1|||
33624681|NCT03050801|102177253|FG005|Experiment 2|Physician Decision|0|||
33624682|NCT03050801|102177248|FG000|Experiment 2|Pregnancy|0|||
33624683|NCT03050801|102177249|FG001|Experiment 2|Pregnancy|0|||
33624684|NCT03050801|102177250|FG002|Experiment 2|Pregnancy|0|||
33561241|NCT02101853|101951662|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33561242|NCT02101853|101951657|FG000|Post Induction Randomization|Adverse Event|0|||
33561243|NCT02101853|101951658|FG001|Post Induction Randomization|Adverse Event|3|||
33561244|NCT02101853|101951659|FG002|Post Induction Randomization|Adverse Event|8|||
33561245|NCT02101853|101951660|FG003|Post Induction Randomization|Adverse Event|4|||
33561246|NCT02101853|101951661|FG004|Post Induction Randomization|Adverse Event|4|||
33561247|NCT02101853|101951662|FG005|Post Induction Randomization|Adverse Event|0|||
33561248|NCT02101853|101951657|FG000|Post Induction Randomization|Death|0|||
33561249|NCT02101853|101951658|FG001|Post Induction Randomization|Death|9|||
33624685|NCT03050801|102177251|FG003|Experiment 2|Pregnancy|0|||
33624686|NCT03050801|102177252|FG004|Experiment 2|Pregnancy|1|||
33624687|NCT03050801|102177253|FG005|Experiment 2|Pregnancy|0|||
33624688|NCT03050801|102177248|FG000|Experiment 2|Withdrawal by Subject|0|||
33624689|NCT03050801|102177249|FG001|Experiment 2|Withdrawal by Subject|0|||
33624690|NCT03050801|102177250|FG002|Experiment 2|Withdrawal by Subject|0|||
33624691|NCT03050801|102177251|FG003|Experiment 2|Withdrawal by Subject|1|||
33624692|NCT03050801|102177252|FG004|Experiment 2|Withdrawal by Subject|0|||
33624693|NCT03050801|102177253|FG005|Experiment 2|Withdrawal by Subject|0|||
33624694|NCT03050801|102177248|FG000|Experiment 2|Poor data quality|0|||
33624695|NCT03050801|102177249|FG001|Experiment 2|Poor data quality|0|||
33624696|NCT03050801|102177250|FG002|Experiment 2|Poor data quality|0|||
33624697|NCT03050801|102177251|FG003|Experiment 2|Poor data quality|4|||
33624698|NCT03050801|102177252|FG004|Experiment 2|Poor data quality|1|||
33624699|NCT03050801|102177253|FG005|Experiment 2|Poor data quality|0|||
33624700|NCT03050801|102177248|FG000|Experiment 2|Discomfort during stimulation|0|||
33624701|NCT03050801|102177249|FG001|Experiment 2|Discomfort during stimulation|0|||
33624702|NCT03050801|102177250|FG002|Experiment 2|Discomfort during stimulation|0|||
33624703|NCT03050801|102177251|FG003|Experiment 2|Discomfort during stimulation|0|||
33624704|NCT03050801|102177252|FG004|Experiment 2|Discomfort during stimulation|0|||
33624705|NCT03050801|102177253|FG005|Experiment 2|Discomfort during stimulation|2|||
33624706|NCT02859246|102177258|FG000|Overall Study|Screen fails|3|||
33624707|NCT02859246|102177258|FG000|Overall Study|Adverse Event|1|||
33624708|NCT02859246|102177258|FG000|Overall Study|Withdrawal by Subject|1|||
33624709|NCT01121146|102177262|FG000|Overall Study|Death|17|||
33624710|NCT01121146|102177263|FG001|Overall Study|Death|15|||
33624711|NCT01121146|102177262|FG000|Overall Study|Adverse Event|2|||
33624712|NCT01121146|102177263|FG001|Overall Study|Adverse Event|11|||
33414826|NCT01915498|101409843|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33561250|NCT02101853|101951659|FG002|Post Induction Randomization|Death|2|||
33561251|NCT02101853|101951660|FG003|Post Induction Randomization|Death|2|||
33624713|NCT01121146|102177262|FG000|Overall Study|Lost to Follow-up|7|||
33624714|NCT01121146|102177263|FG001|Overall Study|Lost to Follow-up|16|||
33359960|NCT00201851|101204615|FG000|Overall Study|Lost to Follow-up|2|||
33359961|NCT00201851|101204616|FG001|Overall Study|Lost to Follow-up|1|||
33359962|NCT00201851|101204617|FG002|Overall Study|Lost to Follow-up|0|||
33359963|NCT00201851|101204615|FG000|Overall Study|Ineligible post enrollment|6|||
33359964|NCT00201851|101204616|FG001|Overall Study|Ineligible post enrollment|1|||
33561252|NCT02101853|101951661|FG004|Post Induction Randomization|Death|0|||
33624715|NCT01096316|102177264|FG000|Overall Study|Lost to Follow-up|15|||
33624716|NCT01096316|102177265|FG001|Overall Study|Lost to Follow-up|9|||
33624717|NCT00601835|102177266|FG000|Overall Study|Withdrawal by Subject|9|||
33624718|NCT00601835|102177267|FG001|Overall Study|Withdrawal by Subject|6|||
33624719|NCT00601835|102177266|FG000|Overall Study|Physician Decision|1|||
33624720|NCT00601835|102177267|FG001|Overall Study|Physician Decision|0|||
33624721|NCT00601835|102177266|FG000|Overall Study|Lost to Follow-up|37|||
33220651|NCT01111838|100706832|FG000|Overall Study|Other Complicating Disease|1|||
33220652|NCT02347657|100706835|FG000|Overall Study|Physician Decision|0|||
33220653|NCT02347657|100706836|FG001|Overall Study|Physician Decision|1|||
33220654|NCT02347657|100706835|FG000|Overall Study|Adverse Event|8|||
33220655|NCT02347657|100706836|FG001|Overall Study|Adverse Event|4|||
33220656|NCT02347657|100706835|FG000|Overall Study|Withdrawal by Subject|6|||
33220657|NCT02347657|100706836|FG001|Overall Study|Withdrawal by Subject|7|||
33220658|NCT02347657|100706835|FG000|Overall Study|Randomized but not treated|1|||
33220659|NCT02347657|100706836|FG001|Overall Study|Randomized but not treated|0|||
33220660|NCT02347657|100706835|FG000|Overall Study|Other|3|||
33220661|NCT02347657|100706836|FG001|Overall Study|Other|3|||
33220662|NCT04209725|100706837|FG000|Overall Study|Adverse Event|1|||
33220663|NCT01061333|100706838|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
33220664|NCT01061333|100706839|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
33220665|NCT01122381|100706850|FG000|Overall Study|study terminated early|0|||
33220666|NCT01122381|100706851|FG001|Overall Study|study terminated early|1|||
33220667|NCT01949870|100706856|FG000|Overall Study|Lack of Efficacy|2|||
33220668|NCT01949870|100706856|FG000|Overall Study|Adverse Event|1|||
33220669|NCT01949870|100706856|FG000|Overall Study|Study termination|1|||
33220670|NCT01949870|100706856|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
33220671|NCT03995784|100706857|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
33220672|NCT00779779|100706861|FG000|Overall Study|Adverse Event|1|||
33220673|NCT00779779|100706861|FG000|Overall Study|Protocol Violation|14|||
33220674|NCT00779779|100706861|FG000|Overall Study|Withdrawal by Subject|4|||
33220675|NCT00779779|100706861|FG000|Overall Study|Lost to Follow-up|5|||
33220676|NCT01654601|100706862|FG000|1st Administration|Withdrawal by Subject|2|||
33220677|NCT01654601|100706863|FG001|1st Administration|Withdrawal by Subject|0|||
33220678|NCT01654601|100706862|FG000|1st Administration|Protocol Violation|0|||
33220679|NCT01654601|100706863|FG001|1st Administration|Protocol Violation|2|||
33220680|NCT01654601|100706862|FG000|2nd Administration|Adverse Event|1|||
33220681|NCT01654601|100706863|FG001|2nd Administration|Adverse Event|0|||
33220682|NCT01654601|100706862|FG000|2nd Administration|Protocol Violation|0|||
33220683|NCT01654601|100706863|FG001|2nd Administration|Protocol Violation|1|||
33220684|NCT00982930|100706869|FG000|Overall Study|Adverse Event|1|||
33220685|NCT00982930|100706869|FG000|Overall Study|Withdrawal by Subject|1|||
33220686|NCT00982930|100706869|FG000|Overall Study|Administrative Problems|2|||
33220687|NCT01682213|100706870|FG000|Overall Study|Withdrawal by Subject|2|||
33220688|NCT00454571|100706871|FG000|Overall Study|Adverse Event|2|||
33220689|NCT00454571|100706872|FG001|Overall Study|Adverse Event|0|||
33359965|NCT00201851|101204617|FG002|Overall Study|Ineligible post enrollment|1|||
33359966|NCT03478683|101204618|FG000|Overall Study|Adverse Event|5|||
33359967|NCT03478683|101204619|FG001|Overall Study|Adverse Event|3|||
33359968|NCT03478683|101204618|FG000|Overall Study|Lost to Follow-up|0|||
33359969|NCT03478683|101204619|FG001|Overall Study|Lost to Follow-up|5|||
33359970|NCT03478683|101204618|FG000|Overall Study|Physician Decision|1|||
33359971|NCT03478683|101204619|FG001|Overall Study|Physician Decision|3|||
33561253|NCT02101853|101951662|FG005|Post Induction Randomization|Death|0|||
33561254|NCT02101853|101951657|FG000|Post Induction Randomization|Lack of Efficacy|0|||
33561255|NCT02101853|101951658|FG001|Post Induction Randomization|Lack of Efficacy|14|||
33561256|NCT02101853|101951659|FG002|Post Induction Randomization|Lack of Efficacy|23|||
33220690|NCT00454571|100706871|FG000|Overall Study|Physician Decision|0|||
33561257|NCT02101853|101951660|FG003|Post Induction Randomization|Lack of Efficacy|18|||
33220691|NCT00454571|100706872|FG001|Overall Study|Physician Decision|1|||
33220692|NCT00454571|100706871|FG000|Overall Study|Protocol Violation|1|||
33220693|NCT00454571|100706872|FG001|Overall Study|Protocol Violation|0|||
33359972|NCT03478683|101204618|FG000|Overall Study|Withdrawal by Subject|7|||
33359973|NCT03478683|101204619|FG001|Overall Study|Withdrawal by Subject|7|||
33359974|NCT00949650|101204620|FG000|Overall Study|Progressive disease|188|||
33359975|NCT00949650|101204621|FG001|Overall Study|Progressive disease|19|||
33359976|NCT00949650|101204620|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
33561258|NCT02101853|101951661|FG004|Post Induction Randomization|Lack of Efficacy|21|||
33561259|NCT02101853|101951662|FG005|Post Induction Randomization|Lack of Efficacy|0|||
33561260|NCT02101853|101951657|FG000|Post Induction Randomization|Physician Decision|0|||
33359977|NCT00949650|101204621|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
33359978|NCT00949650|101204620|FG000|Overall Study|Other Adverse Event (AE)|28|||
33359979|NCT00949650|101204621|FG001|Overall Study|Other Adverse Event (AE)|17|||
33561261|NCT02101853|101951658|FG001|Post Induction Randomization|Physician Decision|43|||
33220694|NCT00454571|100706871|FG000|Overall Study|Withdrawal by Subject|10|||
33220695|NCT00454571|100706872|FG001|Overall Study|Withdrawal by Subject|5|||
33220696|NCT02459262|100706873|FG000|Overall Study|Withdrawal by Subject|0|||
33220697|NCT02459262|100706874|FG001|Overall Study|Withdrawal by Subject|0|||
33220698|NCT02459262|100706875|FG002|Overall Study|Withdrawal by Subject|0|||
33220699|NCT02459262|100706876|FG003|Overall Study|Withdrawal by Subject|0|||
33220700|NCT02459262|100706877|FG004|Overall Study|Withdrawal by Subject|0|||
33220701|NCT02459262|100706878|FG005|Overall Study|Withdrawal by Subject|0|||
33220702|NCT02459262|100706879|FG006|Overall Study|Withdrawal by Subject|0|||
33359980|NCT00949650|101204620|FG000|Overall Study|Protocol Violation|1|||
33359981|NCT00949650|101204621|FG001|Overall Study|Protocol Violation|4|||
33359982|NCT00949650|101204620|FG000|Overall Study|Refusal to continue medication|7|||
33359983|NCT00949650|101204621|FG001|Overall Study|Refusal to continue medication|11|||
33359984|NCT00949650|101204620|FG000|Overall Study|Not treated|1|||
33359985|NCT00949650|101204621|FG001|Overall Study|Not treated|4|||
33359986|NCT00949650|101204620|FG000|Overall Study|Other not specified above|5|||
33414827|NCT01915498|101409844|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33414828|NCT01915498|101409845|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33414829|NCT01915498|101409846|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33561262|NCT02101853|101951659|FG002|Post Induction Randomization|Physician Decision|23|||
33359987|NCT00949650|101204621|FG001|Overall Study|Other not specified above|0|||
33359988|NCT03126227|101204622|FG000|Overall Study|Adverse Event|43|||
33359989|NCT03126227|101204623|FG001|Overall Study|Adverse Event|4|||
33359990|NCT03126227|101204622|FG000|Overall Study|Death|0|||
33359991|NCT03126227|101204623|FG001|Overall Study|Death|1|||
33359992|NCT03126227|101204622|FG000|Overall Study|Lost to Follow-up|0|||
33359993|NCT03126227|101204623|FG001|Overall Study|Lost to Follow-up|1|||
33359994|NCT03126227|101204622|FG000|Overall Study|Physician Decision|2|||
33359995|NCT03126227|101204623|FG001|Overall Study|Physician Decision|0|||
33359996|NCT03126227|101204622|FG000|Overall Study|Protocol Violation|1|||
33359997|NCT03126227|101204623|FG001|Overall Study|Protocol Violation|0|||
33359998|NCT03126227|101204622|FG000|Overall Study|Withdrawal by Subject|19|||
33359999|NCT03126227|101204623|FG001|Overall Study|Withdrawal by Subject|3|||
33360000|NCT03126227|101204622|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
33360001|NCT03126227|101204623|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
33360002|NCT03126227|101204622|FG000|Overall Study|Lack of dosing compliance|2|||
33360003|NCT03126227|101204623|FG001|Overall Study|Lack of dosing compliance|0|||
33360004|NCT03126227|101204622|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
33360005|NCT03126227|101204623|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
33360006|NCT03126227|101204622|FG000|Overall Study|Scheduling conflict|1|||
33360007|NCT03126227|101204623|FG001|Overall Study|Scheduling conflict|0|||
33360008|NCT03894540|101204624|FG000|Overall Study|Adverse Event|0|||
33360009|NCT03894540|101204625|FG001|Overall Study|Adverse Event|0|||
33360010|NCT03894540|101204626|FG002|Overall Study|Adverse Event|0|||
33360011|NCT03894540|101204627|FG003|Overall Study|Adverse Event|0|||
33561263|NCT02101853|101951660|FG003|Post Induction Randomization|Physician Decision|14|||
33360012|NCT03894540|101204628|FG004|Overall Study|Adverse Event|1|||
33360013|NCT03894540|101204629|FG005|Overall Study|Adverse Event|0|||
33360014|NCT03894540|101204624|FG000|Overall Study|Withdrawal by Subject|0|||
33360015|NCT03894540|101204625|FG001|Overall Study|Withdrawal by Subject|0|||
33360016|NCT03894540|101204626|FG002|Overall Study|Withdrawal by Subject|0|||
33360017|NCT03894540|101204627|FG003|Overall Study|Withdrawal by Subject|0|||
33360018|NCT03894540|101204628|FG004|Overall Study|Withdrawal by Subject|1|||
33360019|NCT03894540|101204629|FG005|Overall Study|Withdrawal by Subject|0|||
33360020|NCT03894540|101204624|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
33360021|NCT03894540|101204625|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
33360022|NCT03894540|101204626|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
33360023|NCT03894540|101204627|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
33360024|NCT03894540|101204628|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
33561264|NCT02101853|101951661|FG004|Post Induction Randomization|Physician Decision|14|||
33561265|NCT02101853|101951662|FG005|Post Induction Randomization|Physician Decision|0|||
33561266|NCT02101853|101951657|FG000|Post Induction Randomization|Protocol Violation|0|||
33561267|NCT02101853|101951658|FG001|Post Induction Randomization|Protocol Violation|3|||
33561268|NCT02101853|101951659|FG002|Post Induction Randomization|Protocol Violation|0|||
33561269|NCT02101853|101951660|FG003|Post Induction Randomization|Protocol Violation|0|||
33561270|NCT02101853|101951661|FG004|Post Induction Randomization|Protocol Violation|0|||
33561271|NCT02101853|101951662|FG005|Post Induction Randomization|Protocol Violation|0|||
33561272|NCT02101853|101951657|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
33561273|NCT02101853|101951658|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
33561274|NCT02101853|101951659|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
33561275|NCT02101853|101951660|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
33561276|NCT02101853|101951661|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
33561277|NCT02101853|101951662|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
33561278|NCT02101853|101951657|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33360025|NCT03894540|101204629|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
33360026|NCT03894540|101204624|FG000|Overall Study|Progressive Disease Clinical|1|||
33360027|NCT03894540|101204625|FG001|Overall Study|Progressive Disease Clinical|1|||
33360028|NCT03894540|101204626|FG002|Overall Study|Progressive Disease Clinical|0|||
33360029|NCT03894540|101204627|FG003|Overall Study|Progressive Disease Clinical|1|||
33360030|NCT03894540|101204628|FG004|Overall Study|Progressive Disease Clinical|5|||
33360031|NCT03894540|101204629|FG005|Overall Study|Progressive Disease Clinical|1|||
33360032|NCT03894540|101204624|FG000|Overall Study|Study termination by sponsor|0|||
33360033|NCT03894540|101204625|FG001|Overall Study|Study termination by sponsor|0|||
33360034|NCT03894540|101204626|FG002|Overall Study|Study termination by sponsor|0|||
33360035|NCT03894540|101204627|FG003|Overall Study|Study termination by sponsor|0|||
33360036|NCT03894540|101204628|FG004|Overall Study|Study termination by sponsor|2|||
33360037|NCT03894540|101204629|FG005|Overall Study|Study termination by sponsor|0|||
33360038|NCT03088605|101204631|FG000|Overall Study|Withdrawal by Subject|1|||
33360039|NCT03088605|101204632|FG001|Overall Study|Withdrawal by Subject|0|||
33360040|NCT00149214|101207320|FG000|Overall Study|Adverse Event|12|||
33360041|NCT00149214|101207321|FG001|Overall Study|Adverse Event|9|||
33360042|NCT00149214|101207320|FG000|Overall Study|Withdrawal by Subject|4|||
33360043|NCT00149214|101207321|FG001|Overall Study|Withdrawal by Subject|1|||
33360044|NCT00149214|101207320|FG000|Overall Study|Physician Decision|3|||
33360045|NCT00149214|101207321|FG001|Overall Study|Physician Decision|3|||
33360046|NCT00149214|101207320|FG000|Overall Study|Sponsor Decision|0|||
33360047|NCT00149214|101207321|FG001|Overall Study|Sponsor Decision|1|||
33360048|NCT00149214|101207320|FG000|Overall Study|Progressive Disease|7|||
33360049|NCT00149214|101207321|FG001|Overall Study|Progressive Disease|3|||
33360050|NCT03227861|101207323|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
33360051|NCT03227861|101207323|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
33360052|NCT03227861|101207323|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
33360053|NCT03227861|101207323|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
33220703|NCT02459262|100706880|FG007|Overall Study|Withdrawal by Subject|0|||
33360054|NCT03227861|101207323|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
33360055|NCT03227861|101207323|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
33360056|NCT03227861|101207323|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
33360057|NCT03227861|101207323|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
33360058|NCT03227861|101207323|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
33360059|NCT03227861|101207323|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
33360060|NCT00637728|101207324|FG000|Double-blind Phase|Adverse Event|1|||
33360061|NCT00637728|101207325|FG001|Double-blind Phase|Adverse Event|0|||
33360062|NCT00637728|101207326|FG002|Double-blind Phase|Adverse Event|0|||
33360063|NCT00637728|101207324|FG000|Double-blind Phase|Non-compliance|2|||
33360064|NCT00637728|101207325|FG001|Double-blind Phase|Non-compliance|0|||
33360065|NCT00637728|101207326|FG002|Double-blind Phase|Non-compliance|0|||
33360066|NCT00637728|101207324|FG000|Double-blind Phase|Study Discontinued|1|||
33360067|NCT00637728|101207325|FG001|Double-blind Phase|Study Discontinued|1|||
33360068|NCT00637728|101207326|FG002|Double-blind Phase|Study Discontinued|0|||
33360069|NCT00072189|101207327|FG000|Overall Study|Withdrawal by Subject|1|||
33360070|NCT00542828|101207334|FG000|Overall Study|Physician Decision|1|||
33360071|NCT00542828|101207334|FG000|Overall Study|Need for Prohibited Treatment|3|||
33360072|NCT00542828|101207334|FG000|Overall Study|Study Prematurely Discontinued|7|||
33360073|NCT00542828|101207334|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
33360074|NCT02767570|101207340|FG000|Overall Study|Lost to Follow-up|3|||
33360075|NCT02767570|101207341|FG001|Overall Study|Lost to Follow-up|0|||
33360076|NCT02767570|101207340|FG000|Overall Study|COVID shutdown|2|||
33360077|NCT02767570|101207341|FG001|Overall Study|COVID shutdown|5|||
33360078|NCT02767570|101207340|FG000|Overall Study|Increased pain|2|||
33360079|NCT02767570|101207341|FG001|Overall Study|Increased pain|0|||
33360080|NCT02767570|101207340|FG000|Overall Study|Withdrawal by Subject|1|||
33360081|NCT02767570|101207341|FG001|Overall Study|Withdrawal by Subject|3|||
33360082|NCT02767570|101207340|FG000|Overall Study|Unrelated medical issue|1|||
33561279|NCT02101853|101951658|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33561280|NCT02101853|101951659|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33561281|NCT02101853|101951660|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
33561282|NCT02101853|101951661|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33561283|NCT02101853|101951662|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
33220704|NCT02459262|100706881|FG008|Overall Study|Withdrawal by Subject|0|||
33360083|NCT02767570|101207341|FG001|Overall Study|Unrelated medical issue|1|||
33360084|NCT02767570|101207340|FG000|Overall Study|Received intra-articular injection|0|||
33360085|NCT02767570|101207341|FG001|Overall Study|Received intra-articular injection|1|||
33360086|NCT00447421|101207346|FG000|Overall Study|Lack of Efficacy|1|||
33360087|NCT00447421|101207346|FG000|Overall Study|Adverse Event|3|||
33360088|NCT00447421|101207346|FG000|Overall Study|Sponsor Decision|2|||
33360089|NCT02053246|101207350|FG000|Overall Study|Withdrawal by Subject|3|||
33360090|NCT02053246|101207350|FG000|Overall Study|Physician Decision|1|||
33360091|NCT01040832|101207352|FG000|Overall Study|Adverse Event|4|||
33220705|NCT02459262|100706882|FG009|Overall Study|Withdrawal by Subject|1|||
33220706|NCT02459262|100706883|FG010|Overall Study|Withdrawal by Subject|0|||
33220707|NCT00514683|100706885|FG000|Overall Study|Not treated|2|||
33220708|NCT00514683|100706886|FG001|Overall Study|Not treated|1|||
33220709|NCT00514683|100706887|FG002|Overall Study|Not treated|0|||
33220710|NCT00514683|100706888|FG003|Overall Study|Not treated|0|||
33561284|NCT02101853|101951657|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
33561285|NCT02101853|101951658|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
33561286|NCT02101853|101951659|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
33220711|NCT00514683|100706889|FG004|Overall Study|Not treated|1|||
33220712|NCT00514683|100706885|FG000|Overall Study|Adverse Event|21|||
33220713|NCT00514683|100706886|FG001|Overall Study|Adverse Event|20|||
33220714|NCT00514683|100706887|FG002|Overall Study|Adverse Event|15|||
33220715|NCT00514683|100706888|FG003|Overall Study|Adverse Event|13|||
33220716|NCT00514683|100706889|FG004|Overall Study|Adverse Event|27|||
33220717|NCT00514683|100706885|FG000|Overall Study|Protocol Violation|1|||
33220718|NCT00514683|100706886|FG001|Overall Study|Protocol Violation|1|||
33220719|NCT00514683|100706887|FG002|Overall Study|Protocol Violation|0|||
33414830|NCT01915498|101409847|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33414831|NCT01915498|101409848|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33414832|NCT01915498|101409849|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33414833|NCT01915498|101409850|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33414834|NCT01915498|101409851|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33414835|NCT01915498|101409852|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33414836|NCT01915498|101409853|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33561287|NCT02101853|101951660|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
33561288|NCT02101853|101951661|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
33561289|NCT02101853|101951662|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
33561290|NCT02101853|101951657|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
33561291|NCT02101853|101951658|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
33561292|NCT02101853|101951659|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
33561293|NCT02101853|101951660|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
33561294|NCT02101853|101951661|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
33561295|NCT02101853|101951662|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
33561296|NCT02101853|101951657|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
33220720|NCT00514683|100706888|FG003|Overall Study|Protocol Violation|1|||
33220721|NCT00514683|100706889|FG004|Overall Study|Protocol Violation|0|||
33220722|NCT00514683|100706885|FG000|Overall Study|Withdrawal by Subject|2|||
33220723|NCT00514683|100706886|FG001|Overall Study|Withdrawal by Subject|2|||
33220724|NCT00514683|100706887|FG002|Overall Study|Withdrawal by Subject|1|||
33220725|NCT00514683|100706888|FG003|Overall Study|Withdrawal by Subject|0|||
33220726|NCT00514683|100706889|FG004|Overall Study|Withdrawal by Subject|4|||
33220727|NCT00514683|100706885|FG000|Overall Study|Reason other than listed above|0|||
33220728|NCT00514683|100706886|FG001|Overall Study|Reason other than listed above|1|||
33220729|NCT00514683|100706887|FG002|Overall Study|Reason other than listed above|2|||
33561297|NCT02101853|101951658|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
33567648|NCT02723955|101973203|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33220730|NCT00514683|100706888|FG003|Overall Study|Reason other than listed above|0|||
33220731|NCT00514683|100706889|FG004|Overall Study|Reason other than listed above|1|||
33220732|NCT01666808|100706890|FG000|Overall Study|Lost to Follow-up|9|||
33220733|NCT01666808|100706891|FG001|Overall Study|Lost to Follow-up|15|||
33220734|NCT01666808|100706890|FG000|Overall Study|Withdrawal by Subject|3|||
33360092|NCT01040832|101207353|FG001|Overall Study|Adverse Event|5|||
33360093|NCT01040832|101207352|FG000|Overall Study|Death|4|||
33360094|NCT01040832|101207353|FG001|Overall Study|Death|6|||
33360095|NCT01040832|101207352|FG000|Overall Study|Withdrawal by Subject|2|||
33360096|NCT01040832|101207353|FG001|Overall Study|Withdrawal by Subject|3|||
33360097|NCT01040832|101207352|FG000|Overall Study|Progressive disease|32|||
33360098|NCT01040832|101207353|FG001|Overall Study|Progressive disease|17|||
33360099|NCT01040832|101207352|FG000|Overall Study|Symptomatic deterioration|2|||
33360100|NCT01040832|101207353|FG001|Overall Study|Symptomatic deterioration|5|||
33360101|NCT01040832|101207352|FG000|Overall Study|Other|2|||
33360102|NCT01040832|101207353|FG001|Overall Study|Other|1|||
33360103|NCT00969618|101207354|FG000|Overall Study|Adverse Event|29|||
33360104|NCT00969618|101207354|FG000|Overall Study|Entry Criteria Not Met|3|||
33360105|NCT00969618|101207354|FG000|Overall Study|Lack of Efficacy|2|||
33360106|NCT00969618|101207354|FG000|Overall Study|Lost to Follow-up|7|||
33360107|NCT00969618|101207354|FG000|Overall Study|Physician Decision|1|||
33360108|NCT00969618|101207354|FG000|Overall Study|Protocol Violation|9|||
33220735|NCT01666808|100706891|FG001|Overall Study|Withdrawal by Subject|1|||
33220736|NCT01666808|100706890|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
33360109|NCT00969618|101207354|FG000|Overall Study|Withdrawal by Subject|27|||
33220737|NCT01666808|100706891|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
33220738|NCT00658567|100706900|FG000|Overall Study|Adverse Event|5|||
33220739|NCT00658567|100706901|FG001|Overall Study|Adverse Event|2|||
33220740|NCT00658567|100706902|FG002|Overall Study|Adverse Event|3|||
33624722|NCT00601835|102177267|FG001|Overall Study|Lost to Follow-up|5|||
33624723|NCT00601835|102177266|FG000|Overall Study|Adverse Event|1|||
33624724|NCT00601835|102177267|FG001|Overall Study|Adverse Event|1|||
33624725|NCT00601835|102177266|FG000|Overall Study|Relocate|12|||
33360110|NCT00772967|101207355|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
33360111|NCT00772967|101207356|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
33360112|NCT00772967|101207357|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
33360113|NCT00772967|101207358|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
33360114|NCT00772967|101207359|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
33360115|NCT00772967|101207360|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
33360116|NCT00772967|101207355|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
33360117|NCT00772967|101207356|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
33624726|NCT00601835|102177267|FG001|Overall Study|Relocate|2|||
33624727|NCT01451723|102177276|FG000|Overall Study|study halted|6|||
33624728|NCT01451723|102177277|FG001|Overall Study|study halted|5|||
33624729|NCT02872116|102177278|FG000|Pre-Treatment|Disease Progression|0|||
33360118|NCT00772967|101207357|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
33360119|NCT00772967|101207358|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
33360120|NCT00772967|101207359|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
33360121|NCT00772967|101207360|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
33360122|NCT00772967|101207355|FG000|Crossover Treatment 3|Adverse Event|0|||
33624730|NCT02872116|102177279|FG001|Pre-Treatment|Disease Progression|1|||
33624731|NCT02872116|102177280|FG002|Pre-Treatment|Disease Progression|0|||
33624732|NCT02872116|102177278|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
33624733|NCT02872116|102177279|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
33624734|NCT02872116|102177280|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
33624735|NCT02872116|102177278|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
33624736|NCT02872116|102177279|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
33624737|NCT02872116|102177280|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
33624738|NCT02872116|102177278|FG000|Pre-Treatment|Participant withdrew consent|2|||
33624739|NCT02872116|102177279|FG001|Pre-Treatment|Participant withdrew consent|20|||
33624740|NCT02872116|102177280|FG002|Pre-Treatment|Participant withdrew consent|3|||
33624741|NCT02872116|102177278|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
33624742|NCT02872116|102177279|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
33624743|NCT02872116|102177280|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
33624744|NCT02872116|102177278|FG000|Pre-Treatment|Other reasons|1|||
33624745|NCT02872116|102177279|FG001|Pre-Treatment|Other reasons|2|||
33624746|NCT02872116|102177280|FG002|Pre-Treatment|Other reasons|2|||
33624747|NCT02872116|102177278|FG000|Treatment|Death|122|||
33624748|NCT02872116|102177279|FG001|Treatment|Death|94|||
33624749|NCT02872116|102177280|FG002|Treatment|Death|68|||
33624750|NCT02872116|102177278|FG000|Treatment|Lost to Follow-up|5|||
33624751|NCT02872116|102177279|FG001|Treatment|Lost to Follow-up|7|||
33624752|NCT02872116|102177280|FG002|Treatment|Lost to Follow-up|3|||
33624753|NCT02872116|102177278|FG000|Treatment|Participant withdrew consent|20|||
33360123|NCT00772967|101207356|FG001|Crossover Treatment 3|Adverse Event|0|||
33360124|NCT00772967|101207357|FG002|Crossover Treatment 3|Adverse Event|0|||
33360125|NCT00772967|101207358|FG003|Crossover Treatment 3|Adverse Event|0|||
33360126|NCT00772967|101207359|FG004|Crossover Treatment 3|Adverse Event|1|||
33360127|NCT00772967|101207360|FG005|Crossover Treatment 3|Adverse Event|0|||
33624754|NCT02872116|102177279|FG001|Treatment|Participant withdrew consent|40|||
33624755|NCT02872116|102177280|FG002|Treatment|Participant withdrew consent|8|||
33360128|NCT02908477|101207363|FG000|Overall Study|Withdrawal by Subject|8|||
33360129|NCT02908477|101207364|FG001|Overall Study|Withdrawal by Subject|28|||
33624756|NCT02872116|102177278|FG000|Treatment|Other reasons|12|||
33624757|NCT02872116|102177279|FG001|Treatment|Other reasons|12|||
33624758|NCT02872116|102177280|FG002|Treatment|Other reasons|5|||
33624759|NCT03634085|102177281|FG000|Overall Study|Adverse Event|1|||
33624760|NCT03634085|102177282|FG001|Overall Study|Adverse Event|0|||
33360130|NCT03952650|101207365|FG000|Overall Study|TRAVEL|0|||
33360131|NCT03952650|101207366|FG001|Overall Study|TRAVEL|4|||
33624761|NCT03634085|102177281|FG000|Overall Study|Withdrawal by Subject|0|||
33624762|NCT03634085|102177282|FG001|Overall Study|Withdrawal by Subject|2|||
33360132|NCT03952650|101207367|FG002|Overall Study|TRAVEL|0|||
33360133|NCT03952650|101207368|FG003|Overall Study|TRAVEL|4|||
33360134|NCT03952650|101207369|FG004|Overall Study|TRAVEL|0|||
33624763|NCT01217944|102177283|FG000|Overall Study|Protocol Violation|1|||
33360135|NCT03952650|101207370|FG005|Overall Study|TRAVEL|3|||
33360136|NCT03952650|101207371|FG006|Overall Study|TRAVEL|2|||
33624764|NCT01217944|102177284|FG001|Overall Study|Protocol Violation|1|||
33624765|NCT01217944|102177285|FG002|Overall Study|Protocol Violation|0|||
33624766|NCT01217944|102177283|FG000|Overall Study|Lost to Follow-up|3|||
33624767|NCT01217944|102177284|FG001|Overall Study|Lost to Follow-up|1|||
33561298|NCT02101853|101951659|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
33561299|NCT02101853|101951660|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
33561300|NCT02101853|101951661|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
33561301|NCT02101853|101951662|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
33561302|NCT02101853|101951657|FG000|Blinatumomab Salvage Therapy|Death|0|||
33561303|NCT02101853|101951658|FG001|Blinatumomab Salvage Therapy|Death|0|||
33561304|NCT02101853|101951659|FG002|Blinatumomab Salvage Therapy|Death|0|||
33561305|NCT02101853|101951660|FG003|Blinatumomab Salvage Therapy|Death|0|||
33561306|NCT02101853|101951661|FG004|Blinatumomab Salvage Therapy|Death|0|||
33561307|NCT02101853|101951662|FG005|Blinatumomab Salvage Therapy|Death|2|||
33561308|NCT02101853|101951657|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
33561309|NCT02101853|101951658|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
33561310|NCT02101853|101951659|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
33561311|NCT02101853|101951660|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
33561312|NCT02101853|101951661|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
33561313|NCT02101853|101951662|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
33561314|NCT02101853|101951657|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
33561315|NCT02101853|101951658|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
33561316|NCT02101853|101951659|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
33561317|NCT02101853|101951660|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
33561318|NCT02101853|101951661|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
33561319|NCT02101853|101951662|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
33561320|NCT02101853|101951657|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
33561321|NCT02101853|101951658|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
33561322|NCT02101853|101951659|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
33561323|NCT02101853|101951660|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
33561324|NCT02101853|101951661|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
33561325|NCT02101853|101951662|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
33360137|NCT03952650|101207365|FG000|Overall Study|Withdrawal by Subject|0|||
33360138|NCT03952650|101207366|FG001|Overall Study|Withdrawal by Subject|2|||
33360139|NCT03952650|101207367|FG002|Overall Study|Withdrawal by Subject|0|||
33360140|NCT03952650|101207368|FG003|Overall Study|Withdrawal by Subject|3|||
33360141|NCT03952650|101207369|FG004|Overall Study|Withdrawal by Subject|0|||
33360142|NCT03952650|101207370|FG005|Overall Study|Withdrawal by Subject|1|||
33360143|NCT03952650|101207371|FG006|Overall Study|Withdrawal by Subject|1|||
33360144|NCT03952650|101207365|FG000|Overall Study|Lost to Follow-up|0|||
33360145|NCT03952650|101207366|FG001|Overall Study|Lost to Follow-up|1|||
33360146|NCT03952650|101207367|FG002|Overall Study|Lost to Follow-up|0|||
33220741|NCT00658567|100706900|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
33220742|NCT00658567|100706901|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
33220743|NCT00658567|100706902|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
33220744|NCT00658567|100706900|FG000|Overall Study|Physician Decision|0|||
33220745|NCT00658567|100706901|FG001|Overall Study|Physician Decision|1|||
33220746|NCT00658567|100706902|FG002|Overall Study|Physician Decision|0|||
33220747|NCT00658567|100706900|FG000|Overall Study|At Discretion of Sponsor|1|||
33414837|NCT01915498|101409854|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
33414838|NCT01915498|101409855|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
33414839|NCT00962013|101409856|FG000|Overall Study|Did not have surgery|1|||
33414840|NCT00962013|101409856|FG000|Overall Study|Death|8|||
33220748|NCT00658567|100706901|FG001|Overall Study|At Discretion of Sponsor|1|||
33220749|NCT00658567|100706902|FG002|Overall Study|At Discretion of Sponsor|1|||
33220750|NCT01330433|100706903|FG000|Overall Study|Death|1|||
33220751|NCT01330433|100706904|FG001|Overall Study|Death|3|||
33220752|NCT01330433|100706903|FG000|Overall Study|Lost to Follow-up|1|||
33220753|NCT01330433|100706904|FG001|Overall Study|Lost to Follow-up|0|||
33220754|NCT03243422|100706907|FG000|Overall Study|Death|20|||
33220755|NCT03243422|100706908|FG001|Overall Study|Death|21|||
33220756|NCT03243422|100706907|FG000|Overall Study|Lost to Follow-up|9|||
33220757|NCT03243422|100706908|FG001|Overall Study|Lost to Follow-up|21|||
33220758|NCT03243422|100706907|FG000|Overall Study|Withdrawal by Subject|22|||
33220759|NCT03243422|100706908|FG001|Overall Study|Withdrawal by Subject|8|||
33414841|NCT00962013|101409856|FG000|Overall Study|Lost to Follow-up|12|||
33414842|NCT00962013|101409856|FG000|Overall Study|Unable/Unwilling to return|6|||
33414843|NCT00962013|101409856|FG000|Overall Study|Withdrawal by Subject|8|||
33414844|NCT00962013|101409856|FG000|Overall Study|Removal of study device|3|||
33561326|NCT01379937|101951665|FG000|Overall Study|Protocol Violation|0|||
33561327|NCT01379937|101951666|FG001|Overall Study|Protocol Violation|0|||
33561328|NCT01379937|101951667|FG002|Overall Study|Protocol Violation|0|||
33561329|NCT01379937|101951668|FG003|Overall Study|Protocol Violation|1|||
33561330|NCT01379937|101951665|FG000|Overall Study|Consent withdrawal|0|||
33561331|NCT01379937|101951666|FG001|Overall Study|Consent withdrawal|1|||
33414845|NCT00962013|101409856|FG000|Overall Study|Site Termination|24|||
33414846|NCT00962013|101409856|FG000|Overall Study|No 5 year evaluation|6|||
33414847|NCT03606109|101409857|FG000|Overall Study|Lost to Follow-up|2|||
33414848|NCT03606109|101409858|FG001|Overall Study|Lost to Follow-up|1|||
33414849|NCT04355767|101409859|FG000|Overall Study|Withdrawal by Subject|2|||
33414850|NCT04355767|101409860|FG001|Overall Study|Withdrawal by Subject|2|||
33414851|NCT04355767|101409859|FG000|Overall Study|Death|5|||
33414852|NCT04355767|101409860|FG001|Overall Study|Death|1|||
33414853|NCT02353572|101409862|FG000|Overall Study|Withdrawal by Subject|1|||
33414854|NCT02353572|101409862|FG000|Overall Study|Study terminated|2|||
33414855|NCT01901393|101409864|FG000|Overall Study|Adverse Event|1|||
33414856|NCT01901393|101409865|FG001|Overall Study|Adverse Event|0|||
33414857|NCT03075215|101409866|FG000|12-Month Primary Endpoint|Death|152|||
33414858|NCT03075215|101409866|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
33414859|NCT03075215|101409866|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
33414860|NCT03075215|101409866|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
33414861|NCT04611152|101409869|FG000|Overall Study|Adverse Event|9|||
33414862|NCT04611152|101409870|FG001|Overall Study|Adverse Event|8|||
33414863|NCT04611152|101409869|FG000|Overall Study|Non-compliance with study schedule|1|||
33414864|NCT04611152|101409870|FG001|Overall Study|Non-compliance with study schedule|3|||
33414865|NCT04611152|101409869|FG000|Overall Study|Withdrawal by Subject|5|||
33414866|NCT04611152|101409870|FG001|Overall Study|Withdrawal by Subject|6|||
33414867|NCT04611152|101409869|FG000|Overall Study|Lost to Follow-up|11|||
33561332|NCT01379937|101951667|FG002|Overall Study|Consent withdrawal|0|||
33561333|NCT01379937|101951668|FG003|Overall Study|Consent withdrawal|0|||
33561334|NCT01379937|101951665|FG000|Overall Study|Lost to Follow-up|1|||
33561335|NCT01379937|101951666|FG001|Overall Study|Lost to Follow-up|2|||
33561336|NCT01379937|101951667|FG002|Overall Study|Lost to Follow-up|2|||
33561337|NCT01379937|101951668|FG003|Overall Study|Lost to Follow-up|0|||
33624768|NCT01217944|102177285|FG002|Overall Study|Lost to Follow-up|0|||
33220760|NCT03988166|100706909|FG000|Overall Study|Lost to Follow-up|2|||
33220761|NCT03988166|100706909|FG000|Overall Study|Death|1|||
33414868|NCT04611152|101409870|FG001|Overall Study|Lost to Follow-up|2|||
33220762|NCT01370525|100706910|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
33561338|NCT04755231|101951683|FG000|Overall Study|Lost to Follow-up|5|||
33561339|NCT04755231|101951683|FG000|Overall Study|Withdrawal by Subject|5|||
33220763|NCT01370525|100706911|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
33414869|NCT00538473|101409873|FG000|Overall Study|Adverse Event|1|||
33414870|NCT00538473|101409874|FG001|Overall Study|Adverse Event|0|||
33414871|NCT01615822|101409877|FG000|Period 1|Withdrawal by Subject|0|||
33414872|NCT01615822|101409878|FG001|Period 1|Withdrawal by Subject|1|||
33414873|NCT01615822|101409879|FG002|Period 1|Withdrawal by Subject|0|||
33414874|NCT01615822|101409877|FG000|Period 1|Adverse Event|1|||
33414875|NCT01615822|101409878|FG001|Period 1|Adverse Event|1|||
33414876|NCT01615822|101409879|FG002|Period 1|Adverse Event|0|||
33360147|NCT03952650|101207368|FG003|Overall Study|Lost to Follow-up|0|||
33360148|NCT03952650|101207369|FG004|Overall Study|Lost to Follow-up|0|||
33414877|NCT01615822|101409877|FG000|Period 2|Lost to Follow-up|0|||
33414878|NCT01615822|101409878|FG001|Period 2|Lost to Follow-up|1|||
33414879|NCT01615822|101409879|FG002|Period 2|Lost to Follow-up|2|||
33561340|NCT02766478|101951684|FG000|Overall Study|Withdrawal by Subject|1|||
33561341|NCT02766478|101951685|FG001|Overall Study|Withdrawal by Subject|1|||
33561342|NCT02231580|101951688|FG000|Overall Study|Adverse Event|5|||
33561343|NCT02231580|101951689|FG001|Overall Study|Adverse Event|0|||
33561344|NCT01848457|101951691|FG000|Overall Study|Death|1|||
33561345|NCT01848457|101951692|FG001|Overall Study|Death|0|||
33561346|NCT01848457|101951693|FG002|Overall Study|Death|0|||
33561347|NCT01848457|101951694|FG003|Overall Study|Death|0|||
33561348|NCT04008069|101951695|FG000|Open-Label Period|Adverse Event|1|||
33561349|NCT04008069|101951696|FG001|Open-Label Period|Adverse Event|0|||
33561350|NCT04008069|101951697|FG002|Open-Label Period|Adverse Event|0|||
33561351|NCT04008069|101951695|FG000|Open-Label Period|Lack of Efficacy|4|||
33220764|NCT01370525|100706910|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33220765|NCT01370525|100706911|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33220766|NCT01370525|100706910|FG000|Overall Study|Adverse Event|0|||
33220767|NCT01370525|100706911|FG001|Overall Study|Adverse Event|1|||
33220768|NCT01370525|100706910|FG000|Overall Study|Protocol Violation|2|||
33220769|NCT01370525|100706911|FG001|Overall Study|Protocol Violation|1|||
33220770|NCT01370525|100706910|FG000|Overall Study|Lost to follow up|2|||
33220771|NCT01370525|100706911|FG001|Overall Study|Lost to follow up|6|||
33220772|NCT00941798|100706915|FG000|Overall Study|Withdrawal by Subject|72|||
33220773|NCT00941798|100706916|FG001|Overall Study|Withdrawal by Subject|74|||
33220774|NCT00941798|100706915|FG000|Overall Study|Adverse Event|43|||
33220775|NCT00941798|100706916|FG001|Overall Study|Adverse Event|23|||
33220776|NCT00941798|100706915|FG000|Overall Study|Lost to Follow-up|29|||
33220777|NCT00941798|100706916|FG001|Overall Study|Lost to Follow-up|23|||
33220778|NCT00941798|100706915|FG000|Overall Study|Protocol Violation|17|||
33220779|NCT00941798|100706916|FG001|Overall Study|Protocol Violation|20|||
33360149|NCT03952650|101207370|FG005|Overall Study|Lost to Follow-up|1|||
33360150|NCT03952650|101207371|FG006|Overall Study|Lost to Follow-up|1|||
33360151|NCT03952650|101207365|FG000|Overall Study|Received wrong vaccine and travelled|0|||
33360152|NCT03952650|101207366|FG001|Overall Study|Received wrong vaccine and travelled|0|||
33360153|NCT03952650|101207367|FG002|Overall Study|Received wrong vaccine and travelled|0|||
33360154|NCT03952650|101207368|FG003|Overall Study|Received wrong vaccine and travelled|0|||
33360155|NCT03952650|101207369|FG004|Overall Study|Received wrong vaccine and travelled|0|||
33360156|NCT03952650|101207370|FG005|Overall Study|Received wrong vaccine and travelled|1|||
33360157|NCT03952650|101207371|FG006|Overall Study|Received wrong vaccine and travelled|0|||
33360158|NCT03952650|101207365|FG000|Overall Study|Unable to make study visit|0|||
33360159|NCT03952650|101207366|FG001|Overall Study|Unable to make study visit|0|||
33360160|NCT03952650|101207367|FG002|Overall Study|Unable to make study visit|0|||
33360161|NCT03952650|101207368|FG003|Overall Study|Unable to make study visit|0|||
33360162|NCT03952650|101207369|FG004|Overall Study|Unable to make study visit|0|||
33360163|NCT03952650|101207370|FG005|Overall Study|Unable to make study visit|1|||
33220780|NCT00941798|100706915|FG000|Overall Study|Administrative problems|13|||
33220781|NCT00941798|100706916|FG001|Overall Study|Administrative problems|23|||
33414880|NCT01988337|101409880|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
33360164|NCT03952650|101207371|FG006|Overall Study|Unable to make study visit|0|||
33360165|NCT01520922|101207374|FG000|Treatment Phase|Physician Decision|2|||
33414881|NCT04456998|101409881|FG000|Overall Study|Adverse Event|0|||
33414882|NCT04456998|101409882|FG001|Overall Study|Adverse Event|4|||
33561352|NCT04008069|101951696|FG001|Open-Label Period|Lack of Efficacy|0|||
33561353|NCT04008069|101951697|FG002|Open-Label Period|Lack of Efficacy|0|||
33561354|NCT04008069|101951695|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
33561355|NCT04008069|101951696|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
33561356|NCT04008069|101951697|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
33561357|NCT04008069|101951695|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
33561358|NCT04008069|101951696|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
33561359|NCT04008069|101951697|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
33561360|NCT04065841|101951698|FG000|Overall Study|Adverse Event|4|||
33561361|NCT04065841|101951699|FG001|Overall Study|Adverse Event|2|||
33561362|NCT04065841|101951700|FG002|Overall Study|Adverse Event|10|||
33561363|NCT04065841|101951701|FG003|Overall Study|Adverse Event|1|||
33561364|NCT04065841|101951698|FG000|Overall Study|Lost to Follow-up|1|||
33561365|NCT04065841|101951699|FG001|Overall Study|Lost to Follow-up|2|||
33561366|NCT04065841|101951700|FG002|Overall Study|Lost to Follow-up|2|||
33561367|NCT04065841|101951701|FG003|Overall Study|Lost to Follow-up|2|||
33561368|NCT04065841|101951698|FG000|Overall Study|Physician Decision|1|||
33561369|NCT04065841|101951699|FG001|Overall Study|Physician Decision|0|||
33360166|NCT01520922|101207375|FG001|Treatment Phase|Physician Decision|1|||
33360167|NCT01520922|101207374|FG000|Treatment Phase|Progression|0|||
33360168|NCT01520922|101207375|FG001|Treatment Phase|Progression|2|||
33360169|NCT01520922|101207374|FG000|Treatment Phase|Adverse Event|3|||
33360170|NCT01520922|101207375|FG001|Treatment Phase|Adverse Event|5|||
33561370|NCT04065841|101951700|FG002|Overall Study|Physician Decision|0|||
33561371|NCT04065841|101951701|FG003|Overall Study|Physician Decision|0|||
33561372|NCT04065841|101951698|FG000|Overall Study|Protocol Violation|0|||
33561373|NCT04065841|101951699|FG001|Overall Study|Protocol Violation|1|||
33561374|NCT04065841|101951700|FG002|Overall Study|Protocol Violation|0|||
33561375|NCT04065841|101951701|FG003|Overall Study|Protocol Violation|0|||
33561376|NCT04065841|101951698|FG000|Overall Study|Study terminated by Sponsor|22|||
33220782|NCT00941798|100706915|FG000|Overall Study|Lack of Efficacy|10|||
33220783|NCT00941798|100706916|FG001|Overall Study|Lack of Efficacy|17|||
33360171|NCT01520922|101207374|FG000|Follow up|Lost to Follow-up|0|||
33360172|NCT01520922|101207375|FG001|Follow up|Lost to Follow-up|1|||
33360173|NCT01520922|101207374|FG000|Survival Follow-up|Withdrawal by Subject|1|||
33360174|NCT01520922|101207375|FG001|Survival Follow-up|Withdrawal by Subject|0|||
33360175|NCT01121406|101207376|FG000|Overall Study|Progressive disease RECIST|44|||
33360176|NCT01121406|101207377|FG001|Overall Study|Progressive disease RECIST|28|||
33360177|NCT01121406|101207376|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
33360178|NCT01121406|101207377|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
33360179|NCT01121406|101207376|FG000|Overall Study|Other AE|3|||
33360180|NCT01121406|101207377|FG001|Overall Study|Other AE|10|||
33360181|NCT01121406|101207376|FG000|Overall Study|Non-compliant with protocol|0|||
33360182|NCT01121406|101207377|FG001|Overall Study|Non-compliant with protocol|2|||
33360183|NCT01121406|101207376|FG000|Overall Study|Lost to Follow-up|0|||
33360184|NCT01121406|101207377|FG001|Overall Study|Lost to Follow-up|1|||
33360185|NCT01121406|101207376|FG000|Overall Study|Refused continuation of study med.|1|||
33360186|NCT01121406|101207377|FG001|Overall Study|Refused continuation of study med.|2|||
33360187|NCT01121406|101207376|FG000|Overall Study|Reason other than specified above|2|||
33360188|NCT01121406|101207377|FG001|Overall Study|Reason other than specified above|6|||
33360189|NCT01121406|101207376|FG000|Overall Study|Not treated|1|||
33360190|NCT01121406|101207377|FG001|Overall Study|Not treated|0|||
33360191|NCT00673673|101207379|FG000|Overall Study|Progressive disease|27|||
33360192|NCT00673673|101207379|FG000|Overall Study|Adverse Event|4|||
33360193|NCT00673673|101207379|FG000|Overall Study|Withdrawal by Subject|3|||
33360194|NCT00673673|101207379|FG000|Overall Study|Investigators' discretion|2|||
33360195|NCT00638846|101207380|FG000|Overall Study|Adverse Event|0|||
33360196|NCT00638846|101207381|FG001|Overall Study|Adverse Event|1|||
33360197|NCT00638846|101207380|FG000|Overall Study|Lost to Follow-up|3|||
33360198|NCT00638846|101207381|FG001|Overall Study|Lost to Follow-up|2|||
33360199|NCT00638846|101207380|FG000|Overall Study|lens issue|1|||
33360200|NCT00638846|101207381|FG001|Overall Study|lens issue|3|||
33360201|NCT00871858|101207382|FG000|Overall Study|Protocol Violation|3|||
33360202|NCT00871858|101207383|FG001|Overall Study|Protocol Violation|4|||
33360203|NCT00871858|101207382|FG000|Overall Study|Adverse Event|1|||
33360204|NCT00871858|101207383|FG001|Overall Study|Adverse Event|1|||
33360205|NCT00871858|101207382|FG000|Overall Study|Withdrawal by Subject|1|||
33360206|NCT00871858|101207383|FG001|Overall Study|Withdrawal by Subject|1|||
33360207|NCT00871858|101207382|FG000|Overall Study|Lost to Follow-up|0|||
33360208|NCT00871858|101207383|FG001|Overall Study|Lost to Follow-up|1|||
33360209|NCT00404768|101207384|FG000|Part A and B|Withdrawn due to labor progression|1|||
33624769|NCT01217944|102177283|FG000|Overall Study|Withdrawal by Subject|1|||
33624770|NCT01217944|102177284|FG001|Overall Study|Withdrawal by Subject|2|||
33624771|NCT01217944|102177285|FG002|Overall Study|Withdrawal by Subject|0|||
33624772|NCT01217944|102177283|FG000|Overall Study|Lack of Efficacy|1|||
33624773|NCT01217944|102177284|FG001|Overall Study|Lack of Efficacy|0|||
33624774|NCT01217944|102177285|FG002|Overall Study|Lack of Efficacy|0|||
33624775|NCT00467740|102177286|FG000|Overall Study|Adverse Event|0|||
33624776|NCT00467740|102177287|FG001|Overall Study|Adverse Event|0|||
33624777|NCT00467740|102177288|FG002|Overall Study|Adverse Event|1|||
33360210|NCT00404768|101207385|FG001|Part A and B|Withdrawn due to labor progression|0|||
33360211|NCT00404768|101207386|FG002|Part A and B|Withdrawn due to labor progression|0|||
33360212|NCT00404768|101207387|FG003|Part A and B|Withdrawn due to labor progression|0|||
33360213|NCT00404768|101207384|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
33360214|NCT00404768|101207385|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
33360215|NCT00404768|101207386|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
33360216|NCT00404768|101207387|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
33360217|NCT00404768|101207384|FG000|Part C|Adverse Event|0|||
33360218|NCT00404768|101207385|FG001|Part C|Adverse Event|0|||
33624778|NCT00467740|102177289|FG003|Overall Study|Adverse Event|0|||
33360219|NCT00404768|101207386|FG002|Part C|Adverse Event|0|||
33360220|NCT00404768|101207387|FG003|Part C|Adverse Event|3|||
33360221|NCT00404768|101207384|FG000|Part C|Lost to Follow-up|0|||
33360222|NCT00404768|101207385|FG001|Part C|Lost to Follow-up|0|||
33360223|NCT00404768|101207386|FG002|Part C|Lost to Follow-up|3|||
33360224|NCT00404768|101207387|FG003|Part C|Lost to Follow-up|1|||
33360225|NCT00404768|101207384|FG000|Part C|Withdrawal by Subject|0|||
33360226|NCT00404768|101207385|FG001|Part C|Withdrawal by Subject|0|||
33360227|NCT00404768|101207386|FG002|Part C|Withdrawal by Subject|2|||
33360228|NCT00404768|101207387|FG003|Part C|Withdrawal by Subject|1|||
33360229|NCT00404768|101207384|FG000|Part C|Early withdrawal from study medication|0|||
33360230|NCT00404768|101207385|FG001|Part C|Early withdrawal from study medication|0|||
33360231|NCT00404768|101207386|FG002|Part C|Early withdrawal from study medication|1|||
33360232|NCT00404768|101207387|FG003|Part C|Early withdrawal from study medication|0|||
33360233|NCT00404768|101207384|FG000|Part C|Participant did not respond to therapy|0|||
33360234|NCT00404768|101207385|FG001|Part C|Participant did not respond to therapy|0|||
33360235|NCT00404768|101207386|FG002|Part C|Participant did not respond to therapy|1|||
33360236|NCT00404768|101207387|FG003|Part C|Participant did not respond to therapy|1|||
33360237|NCT00404768|101207384|FG000|Part C|Physician withdrew the study medication|0|||
33360238|NCT00404768|101207385|FG001|Part C|Physician withdrew the study medication|0|||
33561377|NCT04065841|101951699|FG001|Overall Study|Study terminated by Sponsor|16|||
33561378|NCT04065841|101951700|FG002|Overall Study|Study terminated by Sponsor|28|||
33561379|NCT04065841|101951701|FG003|Overall Study|Study terminated by Sponsor|17|||
33561380|NCT04065841|101951698|FG000|Overall Study|Withdrawal by Subject|1|||
33561381|NCT04065841|101951699|FG001|Overall Study|Withdrawal by Subject|1|||
33561382|NCT04065841|101951700|FG002|Overall Study|Withdrawal by Subject|2|||
33561383|NCT04065841|101951701|FG003|Overall Study|Withdrawal by Subject|0|||
33561384|NCT01767857|101951703|FG000|Overall Study|Adverse Event|27|||
33561385|NCT01767857|101951704|FG001|Overall Study|Adverse Event|7|||
33561386|NCT01767857|101951703|FG000|Overall Study|Death|28|||
33561387|NCT01767857|101951704|FG001|Overall Study|Death|13|||
33561388|NCT01767857|101951703|FG000|Overall Study|Lack of Efficacy|299|||
33561389|NCT01767857|101951704|FG001|Overall Study|Lack of Efficacy|151|||
33561390|NCT01767857|101951703|FG000|Overall Study|Lost to Follow-up|1|||
33561391|NCT01767857|101951704|FG001|Overall Study|Lost to Follow-up|1|||
33561392|NCT01767857|101951703|FG000|Overall Study|Withdrawal by Subject|38|||
33561393|NCT01767857|101951704|FG001|Overall Study|Withdrawal by Subject|18|||
33561394|NCT01767857|101951703|FG000|Overall Study|Physician Decision|17|||
33561395|NCT01767857|101951704|FG001|Overall Study|Physician Decision|10|||
33561396|NCT01767857|101951703|FG000|Overall Study|Protocol Terminated|1|||
33561397|NCT01767857|101951704|FG001|Overall Study|Protocol Terminated|0|||
33561398|NCT01767857|101951703|FG000|Overall Study|Randomized But Never Treated|19|||
33561399|NCT01767857|101951704|FG001|Overall Study|Randomized But Never Treated|13|||
33561400|NCT01514422|101951705|FG000|Overall Study|Lost to Follow-up|1|||
33561401|NCT01517178|101951706|FG000|Period 1|Adverse Event|1|||
33561402|NCT01517178|101951707|FG001|Period 1|Adverse Event|2|||
33561403|NCT01517178|101951706|FG000|Period 1|Lack of Efficacy|0|||
33220784|NCT00941798|100706915|FG000|Overall Study|Patient's inability to use device|6|||
33561404|NCT01517178|101951707|FG001|Period 1|Lack of Efficacy|1|||
33561405|NCT01517178|101951706|FG000|Period 1|E.g. study termination|3|||
33624779|NCT00467740|102177290|FG004|Overall Study|Adverse Event|0|||
33624780|NCT00467740|102177286|FG000|Overall Study|Protocol Violation|0|||
33624781|NCT00467740|102177287|FG001|Overall Study|Protocol Violation|0|||
33624782|NCT00467740|102177288|FG002|Overall Study|Protocol Violation|1|||
33624783|NCT00467740|102177289|FG003|Overall Study|Protocol Violation|0|||
33360239|NCT00404768|101207386|FG002|Part C|Physician withdrew the study medication|1|||
33624784|NCT00467740|102177290|FG004|Overall Study|Protocol Violation|0|||
33624785|NCT00467740|102177286|FG000|Overall Study|Lost to Follow-up|0|||
33624786|NCT00467740|102177287|FG001|Overall Study|Lost to Follow-up|1|||
33624787|NCT00467740|102177288|FG002|Overall Study|Lost to Follow-up|0|||
33624788|NCT00467740|102177289|FG003|Overall Study|Lost to Follow-up|0|||
33624789|NCT00467740|102177290|FG004|Overall Study|Lost to Follow-up|0|||
33624790|NCT00467740|102177286|FG000|Overall Study|Withdrawal by Subject|1|||
33624791|NCT00467740|102177287|FG001|Overall Study|Withdrawal by Subject|1|||
33360240|NCT00404768|101207387|FG003|Part C|Physician withdrew the study medication|0|||
33360241|NCT00404768|101207384|FG000|Part C|Participant delivered baby|0|||
33360242|NCT00404768|101207385|FG001|Part C|Participant delivered baby|0|||
33624792|NCT00467740|102177288|FG002|Overall Study|Withdrawal by Subject|0|||
33624793|NCT00467740|102177289|FG003|Overall Study|Withdrawal by Subject|1|||
33624794|NCT00467740|102177290|FG004|Overall Study|Withdrawal by Subject|0|||
33624795|NCT00467740|102177286|FG000|Overall Study|Lack of Efficacy|0|||
33624796|NCT00467740|102177287|FG001|Overall Study|Lack of Efficacy|1|||
33624797|NCT00467740|102177288|FG002|Overall Study|Lack of Efficacy|0|||
33624798|NCT00467740|102177289|FG003|Overall Study|Lack of Efficacy|0|||
33624799|NCT00467740|102177290|FG004|Overall Study|Lack of Efficacy|0|||
33624800|NCT02868554|102177291|FG000|Overall Study|Lost to Follow-up|3|||
33624801|NCT02868554|102177292|FG001|Overall Study|Lost to Follow-up|0|||
33624802|NCT02868554|102177293|FG002|Overall Study|Lost to Follow-up|1|||
33624803|NCT01173601|102177294|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
33624804|NCT01173601|102177295|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33624805|NCT01173601|102177296|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33624806|NCT01173601|102177297|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33624807|NCT01173601|102177298|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33624808|NCT01173601|102177294|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
33624809|NCT01173601|102177295|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33624810|NCT01173601|102177296|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33624811|NCT01173601|102177297|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33360243|NCT00404768|101207386|FG002|Part C|Participant delivered baby|0|||
33360244|NCT00404768|101207387|FG003|Part C|Participant delivered baby|1|||
33624812|NCT01173601|102177298|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33624813|NCT01173601|102177294|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
33624814|NCT01173601|102177295|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33624815|NCT01173601|102177296|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33624816|NCT01173601|102177297|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33624817|NCT01173601|102177298|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33624818|NCT01173601|102177294|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
33624819|NCT01173601|102177295|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33624820|NCT01173601|102177296|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33624821|NCT01173601|102177297|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33624822|NCT01173601|102177298|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33360245|NCT00404768|101207384|FG000|Part C|Unsatisfactory uterine response to IP|0|||
33360246|NCT00404768|101207385|FG001|Part C|Unsatisfactory uterine response to IP|0|||
33360247|NCT00404768|101207386|FG002|Part C|Unsatisfactory uterine response to IP|0|||
33360248|NCT00404768|101207387|FG003|Part C|Unsatisfactory uterine response to IP|1|||
33624823|NCT01173601|102177294|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
33624824|NCT01173601|102177295|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33624825|NCT01173601|102177296|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33624826|NCT01173601|102177297|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33624827|NCT01173601|102177298|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33624828|NCT01173601|102177294|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
33360249|NCT00404768|101207384|FG000|Part C|Active labor|0|||
33360250|NCT00404768|101207385|FG001|Part C|Active labor|0|||
33624829|NCT01173601|102177295|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33624830|NCT01173601|102177296|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33624831|NCT01173601|102177297|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33360251|NCT00404768|101207386|FG002|Part C|Active labor|0|||
33360252|NCT00404768|101207387|FG003|Part C|Active labor|1|||
33360253|NCT00404768|101207384|FG000|Part C|Lack of Efficacy|0|||
33360254|NCT00404768|101207385|FG001|Part C|Lack of Efficacy|0|||
33360255|NCT00404768|101207386|FG002|Part C|Lack of Efficacy|0|||
33360256|NCT00404768|101207387|FG003|Part C|Lack of Efficacy|2|||
33360257|NCT00404768|101207384|FG000|Part C|Treatment failure|0|||
33360258|NCT00404768|101207385|FG001|Part C|Treatment failure|0|||
33360259|NCT00404768|101207386|FG002|Part C|Treatment failure|0|||
33360260|NCT00404768|101207387|FG003|Part C|Treatment failure|1|||
33561406|NCT01517178|101951707|FG001|Period 1|E.g. study termination|1|||
33561407|NCT01517178|101951706|FG000|Period 1|Withdrawal by Subject|0|||
33561408|NCT01517178|101951707|FG001|Period 1|Withdrawal by Subject|1|||
33561409|NCT01517178|101951706|FG000|Period 2|Adverse Event|1|||
33561410|NCT01517178|101951707|FG001|Period 2|Adverse Event|0|||
33561411|NCT01517178|101951706|FG000|Period 2|Withdrawal by Subject|3|||
33561412|NCT01517178|101951707|FG001|Period 2|Withdrawal by Subject|0|||
33561413|NCT01517178|101951706|FG000|Period 2|E.g. study termination|2|||
33561414|NCT01517178|101951707|FG001|Period 2|E.g. study termination|2|||
33561415|NCT05451329|101951708|FG000|Overall Study|Adverse Event|1|||
33561416|NCT05451329|101951709|FG001|Overall Study|Adverse Event|1|||
33561417|NCT05451329|101951710|FG002|Overall Study|Adverse Event|0|||
33561418|NCT05451329|101951708|FG000|Overall Study|Withdrawal by Subject|1|||
33561419|NCT05451329|101951709|FG001|Overall Study|Withdrawal by Subject|0|||
33561420|NCT05451329|101951710|FG002|Overall Study|Withdrawal by Subject|0|||
33561421|NCT05451329|101951708|FG000|Overall Study|Investigational Product Lot exchange|1|||
33561422|NCT05451329|101951709|FG001|Overall Study|Investigational Product Lot exchange|1|||
33561423|NCT05451329|101951710|FG002|Overall Study|Investigational Product Lot exchange|0|||
33561424|NCT02395627|101951711|FG000|Overall Study|Withdrawal by Subject|0|||
33561425|NCT02395627|101951712|FG001|Overall Study|Withdrawal by Subject|2|||
33561426|NCT02395627|101951713|FG002|Overall Study|Withdrawal by Subject|0|||
33561427|NCT02395627|101951711|FG000|Overall Study|Did not receive pembrolizumab|3|||
33561428|NCT02395627|101951712|FG001|Overall Study|Did not receive pembrolizumab|1|||
33561429|NCT02395627|101951713|FG002|Overall Study|Did not receive pembrolizumab|0|||
33561430|NCT04507269|101951719|FG000|Overall Study|Withdrawal by Subject|1|||
33561431|NCT04507269|101951720|FG001|Overall Study|Withdrawal by Subject|1|||
33561432|NCT04507269|101951721|FG002|Overall Study|Withdrawal by Subject|0|||
33561433|NCT04507269|101951722|FG003|Overall Study|Withdrawal by Subject|0|||
33561434|NCT04507269|101951723|FG004|Overall Study|Withdrawal by Subject|0|||
33561435|NCT04507269|101951724|FG005|Overall Study|Withdrawal by Subject|0|||
33561436|NCT04507269|101951719|FG000|Overall Study|Lost to Follow-up|0|||
33561437|NCT04507269|101951720|FG001|Overall Study|Lost to Follow-up|0|||
33561438|NCT04507269|101951721|FG002|Overall Study|Lost to Follow-up|0|||
33561439|NCT04507269|101951722|FG003|Overall Study|Lost to Follow-up|0|||
33561440|NCT04507269|101951723|FG004|Overall Study|Lost to Follow-up|1|||
33561441|NCT04507269|101951724|FG005|Overall Study|Lost to Follow-up|0|||
33561442|NCT00752219|101951728|FG000|Overall Study|Clinical failure|0|||
33561443|NCT00752219|101951729|FG001|Overall Study|Clinical failure|1|||
33561444|NCT00752219|101951728|FG000|Overall Study|Adverse Event|5|||
33561445|NCT00752219|101951729|FG001|Overall Study|Adverse Event|3|||
33561446|NCT00752219|101951728|FG000|Overall Study|Protocol deviation|1|||
33561447|NCT00752219|101951729|FG001|Overall Study|Protocol deviation|0|||
33561448|NCT00752219|101951728|FG000|Overall Study|Lost to Follow-up|1|||
33561449|NCT00752219|101951729|FG001|Overall Study|Lost to Follow-up|2|||
33561450|NCT00752219|101951728|FG000|Overall Study|Randomized but not treated|1|||
33561451|NCT00752219|101951729|FG001|Overall Study|Randomized but not treated|0|||
33561452|NCT00752219|101951728|FG000|Overall Study|Other|3|||
33561453|NCT00752219|101951729|FG001|Overall Study|Other|0|||
33561454|NCT00236197|101951730|FG000|Overall Study|Withdrawal by Subject|3|||
33561455|NCT00236197|101951731|FG001|Overall Study|Withdrawal by Subject|2|||
33561456|NCT00236197|101951730|FG000|Overall Study|Lost to Follow-up|1|||
33561457|NCT00236197|101951731|FG001|Overall Study|Lost to Follow-up|5|||
33561458|NCT00236197|101951730|FG000|Overall Study|Protocol Violation|0|||
33561459|NCT00236197|101951731|FG001|Overall Study|Protocol Violation|3|||
33561460|NCT00236197|101951730|FG000|Overall Study|Medication non-compliance|1|||
33414883|NCT04456998|101409881|FG000|Overall Study|Protocol Deviation|0|||
33414884|NCT04456998|101409882|FG001|Overall Study|Protocol Deviation|1|||
33414885|NCT04456998|101409881|FG000|Overall Study|Withdrawal by Subject|0|||
33561461|NCT00236197|101951731|FG001|Overall Study|Medication non-compliance|2|||
33561462|NCT00236197|101951730|FG000|Overall Study|Other|0|||
33360261|NCT00404768|101207384|FG000|Part C|Investigator discretion|0|||
33360262|NCT00404768|101207385|FG001|Part C|Investigator discretion|0|||
33360263|NCT00404768|101207386|FG002|Part C|Investigator discretion|0|||
33414886|NCT04456998|101409882|FG001|Overall Study|Withdrawal by Subject|1|||
33561463|NCT00236197|101951731|FG001|Overall Study|Other|2|||
33561464|NCT04903093|101951733|FG000|Overall Study|Withdrawal by Subject|0|||
33561465|NCT04903093|101951734|FG001|Overall Study|Withdrawal by Subject|0|||
33561466|NCT04903093|101951735|FG002|Overall Study|Withdrawal by Subject|0|||
33360264|NCT00404768|101207387|FG003|Part C|Investigator discretion|1|||
33624832|NCT01173601|102177298|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33624833|NCT01173601|102177294|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
33624834|NCT01173601|102177295|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33624835|NCT01173601|102177296|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33624836|NCT01173601|102177297|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33624837|NCT01173601|102177298|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33624838|NCT01173601|102177294|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
33624839|NCT01173601|102177295|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
33624840|NCT01173601|102177296|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
33624841|NCT01173601|102177297|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
33624842|NCT01173601|102177298|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
33624843|NCT01173601|102177294|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
33624844|NCT01173601|102177295|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
33624845|NCT01173601|102177296|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
33624846|NCT01173601|102177297|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
33624847|NCT01173601|102177298|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
33624848|NCT01173601|102177294|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
33624849|NCT01173601|102177295|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
33624850|NCT01173601|102177296|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
33624851|NCT01173601|102177297|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
33624852|NCT01173601|102177298|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
33624853|NCT01173601|102177294|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
33624854|NCT01173601|102177295|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
33624855|NCT01173601|102177296|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
33624856|NCT01173601|102177297|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
33624857|NCT01173601|102177298|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
33624858|NCT01173601|102177294|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
33624859|NCT01173601|102177295|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
33624860|NCT01173601|102177296|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
33624861|NCT01173601|102177297|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
33624862|NCT01173601|102177298|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
33624863|NCT01173601|102177294|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
33624864|NCT01173601|102177295|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
33624865|NCT01173601|102177296|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
33624866|NCT01173601|102177297|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
33624867|NCT01173601|102177298|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
33624868|NCT01173601|102177294|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
33624869|NCT01173601|102177295|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
33624870|NCT01173601|102177296|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
33624871|NCT01173601|102177297|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
33624872|NCT01173601|102177298|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
33624873|NCT01631435|102177299|FG000|Overall Study|Adverse Event|2|||
33624874|NCT01631435|102177299|FG000|Overall Study|Withdrawal by Subject|2|||
33624875|NCT01631435|102177299|FG000|Overall Study|incomplete study procedure|5|||
33624876|NCT01790594|102177300|FG000|Overall Study|Death|1|||
33624877|NCT01790594|102177301|FG001|Overall Study|Death|0|||
33624878|NCT01790594|102177302|FG002|Overall Study|Death|0|||
33624879|NCT01790594|102177300|FG000|Overall Study|Physician Decision|2|||
33624880|NCT01790594|102177301|FG001|Overall Study|Physician Decision|1|||
33624881|NCT01790594|102177302|FG002|Overall Study|Physician Decision|0|||
33360265|NCT00404768|101207384|FG000|Part C|Researcher suspended study medication|0|||
33360266|NCT00404768|101207385|FG001|Part C|Researcher suspended study medication|0|||
33360267|NCT00404768|101207386|FG002|Part C|Researcher suspended study medication|0|||
33360268|NCT00404768|101207387|FG003|Part C|Researcher suspended study medication|1|||
33360269|NCT01415440|101207388|FG000|Overall Study|Lost to Follow-up|0|||
33360270|NCT01415440|101207389|FG001|Overall Study|Lost to Follow-up|1|||
33360271|NCT01415440|101207390|FG002|Overall Study|Lost to Follow-up|2|||
33360272|NCT01415440|101207388|FG000|Overall Study|Physician Decision|3|||
33360273|NCT01415440|101207389|FG001|Overall Study|Physician Decision|0|||
33360274|NCT01415440|101207390|FG002|Overall Study|Physician Decision|0|||
33360275|NCT01415440|101207388|FG000|Overall Study|Withdrawal by Subject|1|||
33624882|NCT01790594|102177300|FG000|Overall Study|Withdrawal by Subject|2|||
33624883|NCT01790594|102177301|FG001|Overall Study|Withdrawal by Subject|0|||
33360276|NCT01415440|101207389|FG001|Overall Study|Withdrawal by Subject|0|||
33360277|NCT01415440|101207390|FG002|Overall Study|Withdrawal by Subject|0|||
33360278|NCT01359982|101207391|FG000|Overall Study|Adverse Event|2|||
33360279|NCT01359982|101207392|FG001|Overall Study|Adverse Event|0|||
33360280|NCT01359982|101207393|FG002|Overall Study|Adverse Event|0|||
33360281|NCT01359982|101207394|FG003|Overall Study|Adverse Event|1|||
33624884|NCT01790594|102177302|FG002|Overall Study|Withdrawal by Subject|0|||
33624885|NCT01790594|102177300|FG000|Overall Study|Transplant was not done|0|||
33220785|NCT00941798|100706916|FG001|Overall Study|Patient's inability to use device|1|||
33220786|NCT00941798|100706915|FG000|Overall Study|Abnormal test procedure results|3|||
33360282|NCT01359982|101207395|FG004|Overall Study|Adverse Event|0|||
33360283|NCT01359982|101207396|FG005|Overall Study|Adverse Event|0|||
33360284|NCT01359982|101207391|FG000|Overall Study|Death|1|||
33360285|NCT01359982|101207392|FG001|Overall Study|Death|0|||
33360286|NCT01359982|101207393|FG002|Overall Study|Death|0|||
33360287|NCT01359982|101207394|FG003|Overall Study|Death|0|||
33360288|NCT01359982|101207395|FG004|Overall Study|Death|0|||
33360289|NCT01359982|101207396|FG005|Overall Study|Death|0|||
33360290|NCT04419506|101207400|FG000|Overall Study|Adverse Event|0|||
33360291|NCT04419506|101207401|FG001|Overall Study|Adverse Event|10|||
33360292|NCT04419506|101207402|FG002|Overall Study|Adverse Event|0|||
33360293|NCT04419506|101207403|FG003|Overall Study|Adverse Event|3|||
33561467|NCT04903093|101951736|FG003|Overall Study|Withdrawal by Subject|1|||
33561468|NCT04903093|101951737|FG004|Overall Study|Withdrawal by Subject|0|||
33561469|NCT04903093|101951738|FG005|Overall Study|Withdrawal by Subject|0|||
33561470|NCT02451007|101951739|FG000|Overall Study|Withdrawal by Subject|4|||
33561471|NCT02451007|101951739|FG000|Overall Study|Adverse Event|1|||
33561472|NCT02451007|101951739|FG000|Overall Study|Disease Progression|2|||
33561473|NCT02489045|101951740|FG000|Overall Study|unable to collect usable data|53|||
33561474|NCT02489045|101951740|FG000|Follow-up|Lost to Follow-up|10|||
33561475|NCT00993473|101951742|FG000|Overall Study|Adverse Event|0|||
33561476|NCT00993473|101951743|FG001|Overall Study|Adverse Event|2|||
33561477|NCT00993473|101951742|FG000|Overall Study|Protocol Violation|1|||
33561478|NCT00993473|101951743|FG001|Overall Study|Protocol Violation|2|||
33561479|NCT00993473|101951742|FG000|Overall Study|Lost to Follow-up|1|||
33561480|NCT00993473|101951743|FG001|Overall Study|Lost to Follow-up|0|||
33561481|NCT00993473|101951742|FG000|Overall Study|Withdrawal by Subject|1|||
33561482|NCT00993473|101951743|FG001|Overall Study|Withdrawal by Subject|5|||
33561483|NCT00993473|101951742|FG000|Overall Study|Technical problem with CGM device|0|||
33561484|NCT00993473|101951743|FG001|Overall Study|Technical problem with CGM device|1|||
33561485|NCT00993473|101951742|FG000|Overall Study|Family event|1|||
33561486|NCT00993473|101951743|FG001|Overall Study|Family event|0|||
33561487|NCT04003389|101951744|FG000|Overall Study|Adverse Event|27|||
33561488|NCT04003389|101951745|FG001|Overall Study|Adverse Event|34|||
33561489|NCT04003389|101951746|FG002|Overall Study|Adverse Event|28|||
33561490|NCT04003389|101951744|FG000|Overall Study|Lost to Follow-up|39|||
33561491|NCT04003389|101951745|FG001|Overall Study|Lost to Follow-up|30|||
33561492|NCT04003389|101951746|FG002|Overall Study|Lost to Follow-up|33|||
33561493|NCT04003389|101951744|FG000|Overall Study|Protocol Violation|1|||
33561494|NCT04003389|101951745|FG001|Overall Study|Protocol Violation|6|||
33561495|NCT04003389|101951746|FG002|Overall Study|Protocol Violation|5|||
33561496|NCT04003389|101951744|FG000|Overall Study|Withdrawal by Subject|119|||
33561497|NCT04003389|101951745|FG001|Overall Study|Withdrawal by Subject|79|||
33561498|NCT04003389|101951746|FG002|Overall Study|Withdrawal by Subject|85|||
33561499|NCT04003389|101951744|FG000|Overall Study|Miscellaneous|14|||
33561500|NCT04003389|101951745|FG001|Overall Study|Miscellaneous|11|||
33561501|NCT04003389|101951746|FG002|Overall Study|Miscellaneous|14|||
33561502|NCT04003389|101951744|FG000|Overall Study|Participant did not receive study drug|1|||
33561503|NCT04003389|101951745|FG001|Overall Study|Participant did not receive study drug|0|||
33561504|NCT04003389|101951746|FG002|Overall Study|Participant did not receive study drug|0|||
33561505|NCT00488293|101951747|FG000|Overall Study|Lost to Follow-up|28|||
33561506|NCT00488293|101951748|FG001|Overall Study|Lost to Follow-up|25|||
33561507|NCT00488293|101951747|FG000|Overall Study|Withdrawal by Subject|5|||
33561508|NCT00488293|101951748|FG001|Overall Study|Withdrawal by Subject|3|||
33561509|NCT00488293|101951747|FG000|Overall Study|Death|2|||
33561510|NCT00488293|101951748|FG001|Overall Study|Death|1|||
33561511|NCT00488293|101951747|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
33561512|NCT00488293|101951748|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
33561513|NCT00489476|101951751|FG000|Overall Study|Lost to Follow-up|0|||
33561514|NCT00489476|101951752|FG001|Overall Study|Lost to Follow-up|1|||
33624886|NCT01790594|102177301|FG001|Overall Study|Transplant was not done|0|||
33624887|NCT01790594|102177302|FG002|Overall Study|Transplant was not done|3|||
33561515|NCT00489476|101951753|FG002|Overall Study|Lost to Follow-up|0|||
33561516|NCT00489476|101951754|FG003|Overall Study|Lost to Follow-up|0|||
33561517|NCT05069415|101951755|FG000|Overall Study|Withdrawal by Subject|2|||
33561518|NCT05069415|101951756|FG001|Overall Study|Withdrawal by Subject|0|||
33360294|NCT04419506|101207400|FG000|Overall Study|Withdrawal by Subject|0|||
33360295|NCT04419506|101207401|FG001|Overall Study|Withdrawal by Subject|0|||
33414887|NCT01843660|101409883|FG000|Overall Study|Other|30|||
33561519|NCT05069415|101951755|FG000|Overall Study|Adverse Event|2|||
33561520|NCT05069415|101951756|FG001|Overall Study|Adverse Event|0|||
33624888|NCT01790594|102177300|FG000|Overall Study|Terminated prior to week 76|0|||
33624889|NCT01790594|102177301|FG001|Overall Study|Terminated prior to week 76|2|||
33624890|NCT01790594|102177302|FG002|Overall Study|Terminated prior to week 76|0|||
33624891|NCT00660192|102177303|FG000|Overall Study|Lost to Follow-up|2|||
33624892|NCT00660192|102177304|FG001|Overall Study|Lost to Follow-up|3|||
33624893|NCT00556075|102177305|FG000|Overall Study|Lost to Follow-up|3|||
33624894|NCT00556075|102177306|FG001|Overall Study|Lost to Follow-up|0|||
33624895|NCT00556075|102177307|FG002|Overall Study|Lost to Follow-up|3|||
33624896|NCT00556075|102177305|FG000|Overall Study|Withdrawal by Subject|3|||
33624897|NCT00556075|102177306|FG001|Overall Study|Withdrawal by Subject|3|||
33624898|NCT00556075|102177307|FG002|Overall Study|Withdrawal by Subject|0|||
33624899|NCT00556075|102177305|FG000|Overall Study|Protocol Violation|1|||
33624900|NCT00556075|102177306|FG001|Overall Study|Protocol Violation|1|||
33624901|NCT00556075|102177307|FG002|Overall Study|Protocol Violation|3|||
33624902|NCT00556075|102177305|FG000|Overall Study|Not eligible|1|||
33624903|NCT00556075|102177306|FG001|Overall Study|Not eligible|1|||
33624904|NCT00556075|102177307|FG002|Overall Study|Not eligible|2|||
33624905|NCT00556075|102177305|FG000|Overall Study|Adverse Event|1|||
33624906|NCT00556075|102177306|FG001|Overall Study|Adverse Event|2|||
33624907|NCT00556075|102177307|FG002|Overall Study|Adverse Event|0|||
33624908|NCT00556075|102177305|FG000|Overall Study|Personal issues|4|||
33624909|NCT00556075|102177306|FG001|Overall Study|Personal issues|1|||
33624910|NCT00556075|102177307|FG002|Overall Study|Personal issues|0|||
33624911|NCT00556075|102177305|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
33624912|NCT00556075|102177306|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
33624913|NCT00556075|102177307|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
33624914|NCT01129622|102177308|FG000|Overall Study|Withdrawal by Subject|2|||
33624915|NCT01410890|102177309|FG000|Overall Study|Withdrawal by Subject|0|||
33624916|NCT01410890|102177310|FG001|Overall Study|Withdrawal by Subject|1|||
33624917|NCT03836625|102177311|FG000|Overall Study|Lost to Follow-up|9|||
33624918|NCT03836625|102177312|FG001|Overall Study|Lost to Follow-up|9|||
33624919|NCT03836625|102177311|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
33624920|NCT03836625|102177312|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
33624921|NCT03836625|102177311|FG000|Overall Study|Death|0|||
33624922|NCT03836625|102177312|FG001|Overall Study|Death|1|||
33624923|NCT03836625|102177311|FG000|Overall Study|Refused follow-up|0|||
33624924|NCT03836625|102177312|FG001|Overall Study|Refused follow-up|1|||
33624925|NCT01389882|102177313|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
33624926|NCT01389882|102177314|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
33624927|NCT01389882|102177313|FG000|Overall Study|Withdrawal by Subject|0|||
33624928|NCT01389882|102177314|FG001|Overall Study|Withdrawal by Subject|1|||
33624929|NCT00322881|102177315|FG000|Overall Study|Death|2|||
33624930|NCT00322881|102177315|FG000|Overall Study|Adverse Event|1|||
33624931|NCT00322881|102177315|FG000|Overall Study|Disease Progression|2|||
33624932|NCT03137992|102177316|FG000|Washout Period 1|Adverse Event|1|||
33624933|NCT03137992|102177317|FG001|Washout Period 1|Adverse Event|1|||
33624934|NCT03137992|102177318|FG002|Washout Period 1|Adverse Event|0|||
33624935|NCT03137992|102177319|FG003|Washout Period 1|Adverse Event|0|||
33624936|NCT03137992|102177320|FG004|Washout Period 1|Adverse Event|0|||
33624937|NCT03137992|102177321|FG005|Washout Period 1|Adverse Event|1|||
33624938|NCT03137992|102177316|FG000|Washout Period 1|Withdrawal by Subject|0|||
33624939|NCT03137992|102177317|FG001|Washout Period 1|Withdrawal by Subject|1|||
33624940|NCT03137992|102177318|FG002|Washout Period 1|Withdrawal by Subject|1|||
33624941|NCT03137992|102177319|FG003|Washout Period 1|Withdrawal by Subject|0|||
33624942|NCT03137992|102177320|FG004|Washout Period 1|Withdrawal by Subject|0|||
33624943|NCT03137992|102177321|FG005|Washout Period 1|Withdrawal by Subject|0|||
33624944|NCT03137992|102177316|FG000|Washout Period 1|Principal Investigator Discretion|0|||
33624945|NCT03137992|102177317|FG001|Washout Period 1|Principal Investigator Discretion|1|||
33624946|NCT03137992|102177318|FG002|Washout Period 1|Principal Investigator Discretion|0|||
33624947|NCT03137992|102177319|FG003|Washout Period 1|Principal Investigator Discretion|0|||
33624948|NCT03137992|102177320|FG004|Washout Period 1|Principal Investigator Discretion|0|||
33624949|NCT03137992|102177321|FG005|Washout Period 1|Principal Investigator Discretion|0|||
33624950|NCT03137992|102177316|FG000|Washout Period 1|COPD Exacerbation|1|||
33624951|NCT03137992|102177317|FG001|Washout Period 1|COPD Exacerbation|1|||
33624952|NCT03137992|102177318|FG002|Washout Period 1|COPD Exacerbation|1|||
33624953|NCT03137992|102177319|FG003|Washout Period 1|COPD Exacerbation|0|||
33624954|NCT03137992|102177320|FG004|Washout Period 1|COPD Exacerbation|1|||
33624955|NCT03137992|102177321|FG005|Washout Period 1|COPD Exacerbation|1|||
33624956|NCT03137992|102177316|FG000|Washout Period 1|Subject Noncompliance|1|||
33624957|NCT03137992|102177317|FG001|Washout Period 1|Subject Noncompliance|0|||
33624958|NCT03137992|102177318|FG002|Washout Period 1|Subject Noncompliance|0|||
33624959|NCT03137992|102177319|FG003|Washout Period 1|Subject Noncompliance|0|||
33624960|NCT03137992|102177320|FG004|Washout Period 1|Subject Noncompliance|1|||
33624961|NCT03137992|102177321|FG005|Washout Period 1|Subject Noncompliance|0|||
33624962|NCT03137992|102177316|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
33624963|NCT03137992|102177317|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
33624964|NCT03137992|102177318|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
33624965|NCT03137992|102177319|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
33624966|NCT03137992|102177320|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
33624967|NCT03137992|102177321|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
33624968|NCT03137992|102177316|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
33624969|NCT03137992|102177317|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
33624970|NCT03137992|102177318|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
33624971|NCT03137992|102177319|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
33624972|NCT03137992|102177320|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
33624973|NCT03137992|102177321|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
33624974|NCT03137992|102177316|FG000|Period 2 (Visit 3)|Adverse Event|0|||
33624975|NCT03137992|102177317|FG001|Period 2 (Visit 3)|Adverse Event|1|||
33624976|NCT03137992|102177318|FG002|Period 2 (Visit 3)|Adverse Event|0|||
33624977|NCT03137992|102177319|FG003|Period 2 (Visit 3)|Adverse Event|0|||
33624978|NCT03137992|102177320|FG004|Period 2 (Visit 3)|Adverse Event|0|||
33624979|NCT03137992|102177321|FG005|Period 2 (Visit 3)|Adverse Event|0|||
33624980|NCT03137992|102177316|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
33624981|NCT03137992|102177317|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
33624982|NCT03137992|102177318|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
33624983|NCT03137992|102177319|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
33624984|NCT03137992|102177320|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
33624985|NCT03137992|102177321|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
33624986|NCT03137992|102177316|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
33624987|NCT03137992|102177317|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
33624988|NCT03137992|102177318|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
33624989|NCT03137992|102177319|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
33624990|NCT03137992|102177320|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
33624991|NCT03137992|102177321|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
33360296|NCT04419506|101207402|FG002|Overall Study|Withdrawal by Subject|0|||
33360297|NCT04419506|101207403|FG003|Overall Study|Withdrawal by Subject|1|||
33360298|NCT04419506|101207400|FG000|Overall Study|poor-compliance|0|||
33360299|NCT04419506|101207401|FG001|Overall Study|poor-compliance|0|||
33360300|NCT04419506|101207402|FG002|Overall Study|poor-compliance|0|||
33360301|NCT04419506|101207403|FG003|Overall Study|poor-compliance|1|||
33360302|NCT01426386|101207404|FG000|Overall Study|Adverse Event|0|||
33360303|NCT01426386|101207405|FG001|Overall Study|Adverse Event|1|||
33360304|NCT01426386|101207406|FG002|Overall Study|Adverse Event|0|||
33360305|NCT01426386|101207407|FG003|Overall Study|Adverse Event|0|||
33360306|NCT01426386|101207408|FG004|Overall Study|Adverse Event|0|||
33360307|NCT01426386|101207409|FG005|Overall Study|Adverse Event|0|||
33360308|NCT01426386|101207404|FG000|Overall Study|Did not attend scheduled visit|1|||
33360309|NCT01426386|101207405|FG001|Overall Study|Did not attend scheduled visit|4|||
33624992|NCT03137992|102177316|FG000|Washout Period 2|COPD Exacerbation|1|||
33624993|NCT03137992|102177317|FG001|Washout Period 2|COPD Exacerbation|1|||
33624994|NCT03137992|102177318|FG002|Washout Period 2|COPD Exacerbation|0|||
33624995|NCT03137992|102177319|FG003|Washout Period 2|COPD Exacerbation|0|||
33624996|NCT03137992|102177320|FG004|Washout Period 2|COPD Exacerbation|1|||
33624997|NCT03137992|102177321|FG005|Washout Period 2|COPD Exacerbation|0|||
33624998|NCT03137992|102177316|FG000|Washout Period 2|Subject Non-compliance|0|||
33624999|NCT03137992|102177317|FG001|Washout Period 2|Subject Non-compliance|1|||
33625000|NCT03137992|102177318|FG002|Washout Period 2|Subject Non-compliance|0|||
33625001|NCT03137992|102177319|FG003|Washout Period 2|Subject Non-compliance|0|||
33625002|NCT03137992|102177320|FG004|Washout Period 2|Subject Non-compliance|0|||
33360310|NCT01426386|101207406|FG002|Overall Study|Did not attend scheduled visit|0|||
33360311|NCT01426386|101207407|FG003|Overall Study|Did not attend scheduled visit|0|||
33360312|NCT01426386|101207408|FG004|Overall Study|Did not attend scheduled visit|2|||
33360313|NCT01426386|101207409|FG005|Overall Study|Did not attend scheduled visit|1|||
33360314|NCT01426386|101207404|FG000|Overall Study|Poor response|2|||
33360315|NCT01426386|101207405|FG001|Overall Study|Poor response|1|||
33360316|NCT01426386|101207406|FG002|Overall Study|Poor response|2|||
33360317|NCT01426386|101207407|FG003|Overall Study|Poor response|0|||
33360318|NCT01426386|101207408|FG004|Overall Study|Poor response|1|||
33625003|NCT03137992|102177321|FG005|Washout Period 2|Subject Non-compliance|0|||
33625004|NCT03137992|102177316|FG000|Washout Period 2|Adverse Event|0|||
33625005|NCT03137992|102177317|FG001|Washout Period 2|Adverse Event|0|||
33625006|NCT03137992|102177318|FG002|Washout Period 2|Adverse Event|0|||
33360319|NCT01426386|101207409|FG005|Overall Study|Poor response|0|||
33625007|NCT03137992|102177319|FG003|Washout Period 2|Adverse Event|1|||
33360320|NCT01426386|101207404|FG000|Overall Study|Personal reasons|0|||
33360321|NCT01426386|101207405|FG001|Overall Study|Personal reasons|0|||
33625008|NCT03137992|102177320|FG004|Washout Period 2|Adverse Event|1|||
33625009|NCT03137992|102177321|FG005|Washout Period 2|Adverse Event|0|||
33625010|NCT03137992|102177316|FG000|Washout Period 2|Withdrawal by Subject|1|||
33360322|NCT01426386|101207406|FG002|Overall Study|Personal reasons|0|||
33360323|NCT01426386|101207407|FG003|Overall Study|Personal reasons|0|||
33360324|NCT01426386|101207408|FG004|Overall Study|Personal reasons|1|||
33360325|NCT01426386|101207409|FG005|Overall Study|Personal reasons|0|||
33360326|NCT00414440|101207410|FG000|Core Period|Withdrawal by Subject|70|||
33360327|NCT00414440|101207411|FG001|Core Period|Withdrawal by Subject|32|||
33360328|NCT00414440|101207410|FG000|Extension Period|Lost to Follow-up|44|||
33360329|NCT00414440|101207411|FG001|Extension Period|Lost to Follow-up|52|||
33360330|NCT00414440|101207410|FG000|Extension Period|Did not consent to continue follow up|61|||
33360331|NCT00414440|101207411|FG001|Extension Period|Did not consent to continue follow up|54|||
33360332|NCT00414440|101207410|FG000|Extension Period|Other|1|||
33360333|NCT00414440|101207411|FG001|Extension Period|Other|1|||
33360334|NCT00414440|101207410|FG000|Extension Period|Administrative|16|||
33360335|NCT00414440|101207411|FG001|Extension Period|Administrative|16|||
33360336|NCT00414440|101207410|FG000|Extension Period|Death|1|||
33360337|NCT00414440|101207411|FG001|Extension Period|Death|2|||
33360338|NCT00414440|101207410|FG000|Extension Period|Withdrawal by Subject|9|||
33360339|NCT00414440|101207411|FG001|Extension Period|Withdrawal by Subject|7|||
33360340|NCT00414440|101207410|FG000|Extension Period|Not included in follow up period|18|||
33360341|NCT00414440|101207411|FG001|Extension Period|Not included in follow up period|8|||
33360342|NCT01158950|101207412|FG000|1st Intervention (1 Day)|Physician Decision|1|||
33360343|NCT01158950|101207413|FG001|1st Intervention (1 Day)|Physician Decision|2|||
33360344|NCT00922935|101207417|FG000|Overall Study|Protocol Violation|0|||
33360345|NCT00922935|101207418|FG001|Overall Study|Protocol Violation|3|||
33360346|NCT00922935|101207419|FG002|Overall Study|Protocol Violation|0|||
33360347|NCT00922935|101207417|FG000|Overall Study|Physician Decision|1|||
33360348|NCT00922935|101207418|FG001|Overall Study|Physician Decision|1|||
33220787|NCT00941798|100706916|FG001|Overall Study|Abnormal test procedure results|1|||
33220788|NCT00941798|100706915|FG000|Overall Study|Abnormal laboratory values|1|||
33220789|NCT00941798|100706916|FG001|Overall Study|Abnormal laboratory values|2|||
33220790|NCT00941798|100706915|FG000|Overall Study|Death|0|||
33220791|NCT00941798|100706916|FG001|Overall Study|Death|1|||
33220792|NCT00337272|100706920|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
33220793|NCT00337272|100706921|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
33220794|NCT00337272|100706920|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
33360349|NCT00922935|101207419|FG002|Overall Study|Physician Decision|0|||
33360350|NCT00922935|101207417|FG000|Overall Study|Lost to Follow-up|0|||
33360351|NCT00922935|101207418|FG001|Overall Study|Lost to Follow-up|1|||
33360352|NCT00922935|101207419|FG002|Overall Study|Lost to Follow-up|0|||
33360353|NCT03167619|101207420|FG000|Overall Study|Death|11|||
33360354|NCT03167619|101207421|FG001|Overall Study|Death|8|||
33360355|NCT03167619|101207420|FG000|Overall Study|Withdrawal by Subject|1|||
33360356|NCT03167619|101207421|FG001|Overall Study|Withdrawal by Subject|2|||
33360357|NCT03167619|101207420|FG000|Overall Study|Physician Decision|0|||
33360358|NCT03167619|101207421|FG001|Overall Study|Physician Decision|1|||
33360359|NCT00443560|101207426|FG000|Overall Study|No intrathecal dose|58|||
33360360|NCT00443560|101207427|FG001|Overall Study|No intrathecal dose|26|||
33360361|NCT00443560|101207426|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
33360362|NCT00443560|101207427|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
33414888|NCT03273257|101409884|FG000|Overall Study|Death|0|||
33414889|NCT03273257|101409885|FG001|Overall Study|Death|1|||
33414890|NCT03273257|101409884|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
33414891|NCT03273257|101409885|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
33414892|NCT03273257|101409884|FG000|Overall Study|Study terminated|3|||
33561521|NCT00107614|101951760|FG000|Overall Study|Physician Decision|10|||
33561522|NCT00107614|101951760|FG000|Overall Study|Death|2|||
33561523|NCT00266032|101951761|FG000|Treatment|Adverse Event|42|||
33561524|NCT00266032|101951762|FG001|Treatment|Adverse Event|26|||
33561525|NCT00266032|101951763|FG002|Treatment|Adverse Event|10|||
33561526|NCT00266032|101951761|FG000|Treatment|Lost to Follow-up|19|||
33561527|NCT00266032|101951762|FG001|Treatment|Lost to Follow-up|4|||
33561528|NCT00266032|101951763|FG002|Treatment|Lost to Follow-up|2|||
33561529|NCT00266032|101951761|FG000|Treatment|Pregnancy|3|||
33561530|NCT00266032|101951762|FG001|Treatment|Pregnancy|2|||
33561531|NCT00266032|101951763|FG002|Treatment|Pregnancy|2|||
33561532|NCT00266032|101951761|FG000|Treatment|Protocol Violation|6|||
33561533|NCT00266032|101951762|FG001|Treatment|Protocol Violation|14|||
33561534|NCT00266032|101951763|FG002|Treatment|Protocol Violation|13|||
33561535|NCT00266032|101951761|FG000|Treatment|Withdrawal by Subject|28|||
33561536|NCT00266032|101951762|FG001|Treatment|Withdrawal by Subject|13|||
33561537|NCT00266032|101951763|FG002|Treatment|Withdrawal by Subject|12|||
33561538|NCT00266032|101951761|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
33561539|NCT00266032|101951762|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
33561540|NCT00266032|101951763|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
33561541|NCT00266032|101951761|FG000|Open-label Safety Extension|Adverse Event|5|||
33561542|NCT00266032|101951762|FG001|Open-label Safety Extension|Adverse Event|0|||
33561543|NCT00266032|101951763|FG002|Open-label Safety Extension|Adverse Event|4|||
33561544|NCT00266032|101951761|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
33561545|NCT00266032|101951762|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
33561546|NCT00266032|101951763|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
33561547|NCT00266032|101951761|FG000|Open-label Safety Extension|Pregnancy|4|||
33561548|NCT00266032|101951762|FG001|Open-label Safety Extension|Pregnancy|1|||
33561549|NCT00266032|101951763|FG002|Open-label Safety Extension|Pregnancy|2|||
33220795|NCT00337272|100706921|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
33561550|NCT00266032|101951761|FG000|Open-label Safety Extension|Protocol Violation|1|||
33561551|NCT00266032|101951762|FG001|Open-label Safety Extension|Protocol Violation|3|||
33414893|NCT03273257|101409885|FG001|Overall Study|Study terminated|2|||
33414894|NCT00916617|101409886|FG000|Overall Study|Adverse Event|3|||
33414895|NCT00916617|101409887|FG001|Overall Study|Adverse Event|2|||
33414896|NCT00916617|101409888|FG002|Overall Study|Adverse Event|6|||
33414897|NCT00916617|101409889|FG003|Overall Study|Adverse Event|3|||
33414898|NCT00916617|101409886|FG000|Overall Study|Withdrawal by Subject|3|||
33414899|NCT00916617|101409887|FG001|Overall Study|Withdrawal by Subject|2|||
33414900|NCT00916617|101409888|FG002|Overall Study|Withdrawal by Subject|0|||
33625011|NCT03137992|102177317|FG001|Washout Period 2|Withdrawal by Subject|0|||
33625012|NCT03137992|102177318|FG002|Washout Period 2|Withdrawal by Subject|0|||
33625013|NCT03137992|102177319|FG003|Washout Period 2|Withdrawal by Subject|0|||
33625014|NCT03137992|102177320|FG004|Washout Period 2|Withdrawal by Subject|1|||
33625015|NCT03137992|102177321|FG005|Washout Period 2|Withdrawal by Subject|0|||
33625016|NCT03137992|102177316|FG000|Washout Period 2|Sponsor Decision|0|||
33625017|NCT03137992|102177317|FG001|Washout Period 2|Sponsor Decision|0|||
33625018|NCT03137992|102177318|FG002|Washout Period 2|Sponsor Decision|0|||
33625019|NCT03137992|102177319|FG003|Washout Period 2|Sponsor Decision|0|||
33625020|NCT03137992|102177320|FG004|Washout Period 2|Sponsor Decision|0|||
33625021|NCT03137992|102177321|FG005|Washout Period 2|Sponsor Decision|1|||
33625022|NCT03137992|102177316|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
33625023|NCT03137992|102177317|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
33625024|NCT03137992|102177318|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
33625025|NCT03137992|102177319|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
33625026|NCT03137992|102177320|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
33625027|NCT03137992|102177321|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
33625028|NCT03137992|102177316|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
33625029|NCT03137992|102177317|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
33625030|NCT03137992|102177318|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
33625031|NCT03137992|102177319|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
33625032|NCT03137992|102177320|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
33625033|NCT03137992|102177321|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
33625034|NCT03137992|102177316|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
33625035|NCT03137992|102177317|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
33625036|NCT03137992|102177318|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
33625037|NCT03137992|102177319|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
33625038|NCT03137992|102177320|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
33625039|NCT03137992|102177321|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
33625040|NCT03137992|102177316|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
33625041|NCT03137992|102177317|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
33625042|NCT03137992|102177318|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
33625043|NCT03137992|102177319|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
33625044|NCT03137992|102177320|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
33625045|NCT03137992|102177321|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
33625046|NCT03137992|102177316|FG000|Part 2 (Open-label Extension)|Per study team|1|||
33625047|NCT03137992|102177317|FG001|Part 2 (Open-label Extension)|Per study team|0|||
33625048|NCT03137992|102177318|FG002|Part 2 (Open-label Extension)|Per study team|0|||
33625049|NCT03137992|102177319|FG003|Part 2 (Open-label Extension)|Per study team|0|||
33625050|NCT03137992|102177320|FG004|Part 2 (Open-label Extension)|Per study team|0|||
33625051|NCT03137992|102177321|FG005|Part 2 (Open-label Extension)|Per study team|0|||
33625052|NCT03137992|102177316|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
33625053|NCT03137992|102177317|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
33625054|NCT03137992|102177318|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
33625055|NCT03137992|102177319|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
33625056|NCT03137992|102177320|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
33625057|NCT03137992|102177321|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
33625058|NCT02721875|102177322|FG000|Overall Study|Progressive disease/relapse|1|||
33625059|NCT02721875|102177323|FG001|Overall Study|Progressive disease/relapse|0|||
33625060|NCT02349633|102177328|FG000|Overall Study|Death|0|||
33625061|NCT02349633|102177329|FG001|Overall Study|Death|1|||
33625062|NCT02349633|102177330|FG002|Overall Study|Death|0|||
33625063|NCT02349633|102177331|FG003|Overall Study|Death|0|||
33625064|NCT02349633|102177332|FG004|Overall Study|Death|0|||
33625065|NCT02349633|102177333|FG005|Overall Study|Death|1|||
33625066|NCT02349633|102177334|FG006|Overall Study|Death|1|||
33625067|NCT02349633|102177335|FG007|Overall Study|Death|1|||
33220796|NCT00337272|100706920|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
33220797|NCT00337272|100706921|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
33625068|NCT02349633|102177336|FG008|Overall Study|Death|0|||
33625069|NCT02349633|102177337|FG009|Overall Study|Death|1|||
33625070|NCT02349633|102177338|FG010|Overall Study|Death|0|||
33625071|NCT02349633|102177339|FG011|Overall Study|Death|0|||
33625072|NCT02349633|102177340|FG012|Overall Study|Death|0|||
33625073|NCT02349633|102177341|FG013|Overall Study|Death|0|||
33414901|NCT00916617|101409889|FG003|Overall Study|Withdrawal by Subject|1|||
33360363|NCT03937986|101207428|FG000|Overall Study|COVID-19 Pandemic|1|||
33561552|NCT00266032|101951763|FG002|Open-label Safety Extension|Protocol Violation|2|||
33561553|NCT00266032|101951761|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
33625074|NCT02349633|102177328|FG000|Overall Study|Withdrawal by Subject|0|||
33625075|NCT02349633|102177329|FG001|Overall Study|Withdrawal by Subject|0|||
33625076|NCT02349633|102177330|FG002|Overall Study|Withdrawal by Subject|0|||
33625077|NCT02349633|102177331|FG003|Overall Study|Withdrawal by Subject|1|||
33625078|NCT02349633|102177332|FG004|Overall Study|Withdrawal by Subject|0|||
33625079|NCT02349633|102177333|FG005|Overall Study|Withdrawal by Subject|0|||
33625080|NCT02349633|102177334|FG006|Overall Study|Withdrawal by Subject|0|||
33625081|NCT02349633|102177335|FG007|Overall Study|Withdrawal by Subject|2|||
33625082|NCT02349633|102177336|FG008|Overall Study|Withdrawal by Subject|2|||
33625083|NCT02349633|102177337|FG009|Overall Study|Withdrawal by Subject|1|||
33625084|NCT02349633|102177338|FG010|Overall Study|Withdrawal by Subject|0|||
33625085|NCT02349633|102177339|FG011|Overall Study|Withdrawal by Subject|0|||
33625086|NCT02349633|102177340|FG012|Overall Study|Withdrawal by Subject|0|||
33625087|NCT02349633|102177341|FG013|Overall Study|Withdrawal by Subject|0|||
33625088|NCT02349633|102177328|FG000|Overall Study|Withdrawal of informed consent|0|||
33625089|NCT02349633|102177329|FG001|Overall Study|Withdrawal of informed consent|0|||
33625090|NCT02349633|102177330|FG002|Overall Study|Withdrawal of informed consent|0|||
33625091|NCT02349633|102177331|FG003|Overall Study|Withdrawal of informed consent|1|||
33625092|NCT02349633|102177332|FG004|Overall Study|Withdrawal of informed consent|1|||
33625093|NCT02349633|102177333|FG005|Overall Study|Withdrawal of informed consent|0|||
33625094|NCT02349633|102177334|FG006|Overall Study|Withdrawal of informed consent|0|||
33625095|NCT02349633|102177335|FG007|Overall Study|Withdrawal of informed consent|3|||
33625096|NCT02349633|102177336|FG008|Overall Study|Withdrawal of informed consent|0|||
33625097|NCT02349633|102177337|FG009|Overall Study|Withdrawal of informed consent|0|||
33625098|NCT02349633|102177338|FG010|Overall Study|Withdrawal of informed consent|0|||
33625099|NCT02349633|102177339|FG011|Overall Study|Withdrawal of informed consent|0|||
33625100|NCT02349633|102177340|FG012|Overall Study|Withdrawal of informed consent|0|||
33625101|NCT02349633|102177341|FG013|Overall Study|Withdrawal of informed consent|0|||
33625102|NCT02349633|102177328|FG000|Overall Study|Transition to compassionate use|0|||
33625103|NCT02349633|102177329|FG001|Overall Study|Transition to compassionate use|0|||
33625104|NCT02349633|102177330|FG002|Overall Study|Transition to compassionate use|0|||
33561554|NCT00266032|101951762|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
33561555|NCT00266032|101951763|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
33561556|NCT00266032|101951761|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
33561557|NCT00266032|101951762|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
33561558|NCT00266032|101951763|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
33561559|NCT01260311|101951764|FG000|Overall Study|Adverse Event|11|||
33561560|NCT01260311|101951764|FG000|Overall Study|Lack of Efficacy|4|||
33561561|NCT01260311|101951764|FG000|Overall Study|Lost to Follow-up|25|||
33561562|NCT01260311|101951764|FG000|Overall Study|Withdrawal by Subject|6|||
33561563|NCT01260311|101951764|FG000|Overall Study|Financial Constraints|77|||
33561564|NCT01260311|101951764|FG000|Overall Study|Gone to Province|2|||
33625105|NCT02349633|102177331|FG003|Overall Study|Transition to compassionate use|0|||
33625106|NCT02349633|102177332|FG004|Overall Study|Transition to compassionate use|1|||
33625107|NCT02349633|102177333|FG005|Overall Study|Transition to compassionate use|0|||
33625108|NCT02349633|102177334|FG006|Overall Study|Transition to compassionate use|0|||
33625109|NCT02349633|102177335|FG007|Overall Study|Transition to compassionate use|3|||
33625110|NCT02349633|102177336|FG008|Overall Study|Transition to compassionate use|0|||
33625111|NCT02349633|102177337|FG009|Overall Study|Transition to compassionate use|1|||
33625112|NCT02349633|102177338|FG010|Overall Study|Transition to compassionate use|0|||
33625113|NCT02349633|102177339|FG011|Overall Study|Transition to compassionate use|0|||
33625114|NCT02349633|102177340|FG012|Overall Study|Transition to compassionate use|0|||
33625115|NCT02349633|102177341|FG013|Overall Study|Transition to compassionate use|0|||
33625116|NCT02349633|102177328|FG000|Overall Study|Early termination of survival follow-up|0|||
33414902|NCT00916617|101409886|FG000|Overall Study|Caregiver Request|3|||
33414903|NCT00916617|101409887|FG001|Overall Study|Caregiver Request|2|||
33414904|NCT00916617|101409888|FG002|Overall Study|Caregiver Request|1|||
33414905|NCT00916617|101409889|FG003|Overall Study|Caregiver Request|0|||
33414906|NCT00916617|101409886|FG000|Overall Study|Physician Decision|1|||
33561565|NCT01260311|101951764|FG000|Overall Study|Medication Stopped|1|||
33414907|NCT00916617|101409887|FG001|Overall Study|Physician Decision|1|||
33561566|NCT01260311|101951764|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
33561567|NCT03882801|101951765|FG000|Period 1|Adverse Event|0|||
33561568|NCT03882801|101951766|FG001|Period 1|Adverse Event|1|||
33561569|NCT03882801|101951765|FG000|Period 1|Non-compliance with study drug|1|||
33561570|NCT03882801|101951766|FG001|Period 1|Non-compliance with study drug|1|||
33561571|NCT03882801|101951765|FG000|Period 1|Never treated with study drug|1|||
33561572|NCT03882801|101951766|FG001|Period 1|Never treated with study drug|0|||
33561573|NCT03882801|101951765|FG000|Washout Period|Physician Decision|0|||
33561574|NCT03882801|101951766|FG001|Washout Period|Physician Decision|1|||
33561575|NCT03882801|101951765|FG000|Period 2|Non-compliance with study drug|0|||
33561576|NCT03882801|101951766|FG001|Period 2|Non-compliance with study drug|1|||
33561577|NCT00680914|101951769|FG000|Overall Study|Consent withdrawal|6|||
33561578|NCT00680914|101951770|FG001|Overall Study|Consent withdrawal|3|||
33561579|NCT00680914|101951769|FG000|Overall Study|Lost to Follow-up|4|||
33561580|NCT00680914|101951770|FG001|Overall Study|Lost to Follow-up|0|||
33561581|NCT00680914|101951769|FG000|Overall Study|serious adverse event (SAE)|0|||
33561582|NCT00680914|101951770|FG001|Overall Study|serious adverse event (SAE)|1|||
33561583|NCT00004228|101951771|FG000|Overall Study|Adverse Event|0|||
33561584|NCT00004228|101951772|FG001|Overall Study|Adverse Event|1|||
33561585|NCT00004228|101951773|FG002|Overall Study|Adverse Event|0|||
33561586|NCT00004228|101951774|FG003|Overall Study|Adverse Event|0|||
33561587|NCT00004228|101951775|FG004|Overall Study|Adverse Event|1|||
33561588|NCT00004228|101951776|FG005|Overall Study|Adverse Event|0|||
33561589|NCT00004228|101951777|FG006|Overall Study|Adverse Event|0|||
33561590|NCT00004228|101951771|FG000|Overall Study|Death|0|||
33561591|NCT00004228|101951772|FG001|Overall Study|Death|1|||
33561592|NCT00004228|101951773|FG002|Overall Study|Death|2|||
33561593|NCT00004228|101951774|FG003|Overall Study|Death|0|||
33561594|NCT00004228|101951775|FG004|Overall Study|Death|1|||
33561595|NCT00004228|101951776|FG005|Overall Study|Death|0|||
33561596|NCT00004228|101951777|FG006|Overall Study|Death|0|||
33561597|NCT00004228|101951771|FG000|Overall Study|Lack of Efficacy|1|||
33561598|NCT00004228|101951772|FG001|Overall Study|Lack of Efficacy|6|||
33625117|NCT02349633|102177329|FG001|Overall Study|Early termination of survival follow-up|0|||
33414908|NCT00916617|101409888|FG002|Overall Study|Physician Decision|0|||
33414909|NCT00916617|101409889|FG003|Overall Study|Physician Decision|0|||
33561599|NCT00004228|101951773|FG002|Overall Study|Lack of Efficacy|5|||
33561600|NCT00004228|101951774|FG003|Overall Study|Lack of Efficacy|3|||
33360364|NCT01787591|101207433|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
33360365|NCT01787591|101207434|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
33360366|NCT01787591|101207435|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
33360367|NCT01787591|101207436|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
33360368|NCT02263365|101207437|FG000|Overall Study|Physician Decision|22|||
33360369|NCT02263365|101207438|FG001|Overall Study|Physician Decision|18|||
33360370|NCT04075604|101207439|FG000|Overall Study|Adverse Event|0|||
33360371|NCT04075604|101207440|FG001|Overall Study|Adverse Event|0|||
33360372|NCT04075604|101207441|FG002|Overall Study|Adverse Event|3|||
33360373|NCT04075604|101207439|FG000|Overall Study|Participant request to discontinue study treatment|0|||
33625118|NCT02349633|102177330|FG002|Overall Study|Early termination of survival follow-up|0|||
33625119|NCT02349633|102177331|FG003|Overall Study|Early termination of survival follow-up|0|||
33360374|NCT04075604|101207440|FG001|Overall Study|Participant request to discontinue study treatment|0|||
33360375|NCT04075604|101207441|FG002|Overall Study|Participant request to discontinue study treatment|1|||
33360376|NCT04075604|101207439|FG000|Overall Study|Participant withdrew consent|0|||
33360377|NCT04075604|101207440|FG001|Overall Study|Participant withdrew consent|0|||
33360378|NCT04075604|101207441|FG002|Overall Study|Participant withdrew consent|1|||
33360379|NCT04075604|101207439|FG000|Overall Study|Other reasons|1|||
33625120|NCT02349633|102177332|FG004|Overall Study|Early termination of survival follow-up|0|||
33625121|NCT02349633|102177333|FG005|Overall Study|Early termination of survival follow-up|0|||
33625122|NCT02349633|102177334|FG006|Overall Study|Early termination of survival follow-up|0|||
33625123|NCT02349633|102177335|FG007|Overall Study|Early termination of survival follow-up|4|||
33625124|NCT02349633|102177336|FG008|Overall Study|Early termination of survival follow-up|0|||
33625125|NCT02349633|102177337|FG009|Overall Study|Early termination of survival follow-up|0|||
33625126|NCT02349633|102177338|FG010|Overall Study|Early termination of survival follow-up|0|||
33625127|NCT02349633|102177339|FG011|Overall Study|Early termination of survival follow-up|0|||
33625128|NCT02349633|102177340|FG012|Overall Study|Early termination of survival follow-up|0|||
33625129|NCT02349633|102177341|FG013|Overall Study|Early termination of survival follow-up|0|||
33625130|NCT02349633|102177328|FG000|Overall Study|Termination by sponsor|0|||
33625131|NCT02349633|102177329|FG001|Overall Study|Termination by sponsor|0|||
33625132|NCT02349633|102177330|FG002|Overall Study|Termination by sponsor|0|||
33360380|NCT04075604|101207440|FG001|Overall Study|Other reasons|0|||
33360381|NCT04075604|101207441|FG002|Overall Study|Other reasons|0|||
33360382|NCT04075604|101207439|FG000|Overall Study|Disease progression|0|||
33360383|NCT04075604|101207440|FG001|Overall Study|Disease progression|1|||
33360384|NCT04075604|101207441|FG002|Overall Study|Disease progression|0|||
33360385|NCT04075604|101207439|FG000|Overall Study|Study drug toxicity|0|||
33625133|NCT02349633|102177331|FG003|Overall Study|Termination by sponsor|0|||
33625134|NCT02349633|102177332|FG004|Overall Study|Termination by sponsor|0|||
33360386|NCT04075604|101207440|FG001|Overall Study|Study drug toxicity|5|||
33360387|NCT04075604|101207441|FG002|Overall Study|Study drug toxicity|1|||
33625135|NCT02349633|102177333|FG005|Overall Study|Termination by sponsor|0|||
33625136|NCT02349633|102177334|FG006|Overall Study|Termination by sponsor|0|||
33625137|NCT02349633|102177335|FG007|Overall Study|Termination by sponsor|1|||
33625138|NCT02349633|102177336|FG008|Overall Study|Termination by sponsor|0|||
33360388|NCT00642616|101207442|FG000|Overall Study|Adverse Event|2|||
33360389|NCT00642616|101207443|FG001|Overall Study|Adverse Event|0|||
33360390|NCT00642616|101207444|FG002|Overall Study|Adverse Event|1|||
33360391|NCT00642616|101207445|FG003|Overall Study|Adverse Event|0|||
33360392|NCT00642616|101207442|FG000|Overall Study|Study Terminated by Sponsor|7|||
33360393|NCT00642616|101207443|FG001|Overall Study|Study Terminated by Sponsor|6|||
33360394|NCT00642616|101207444|FG002|Overall Study|Study Terminated by Sponsor|4|||
33360395|NCT00642616|101207445|FG003|Overall Study|Study Terminated by Sponsor|5|||
33360396|NCT00642616|101207442|FG000|Overall Study|Withdrawal by Subject|0|||
33360397|NCT00642616|101207443|FG001|Overall Study|Withdrawal by Subject|1|||
33360398|NCT00642616|101207444|FG002|Overall Study|Withdrawal by Subject|1|||
33360399|NCT00642616|101207445|FG003|Overall Study|Withdrawal by Subject|1|||
33360400|NCT00642616|101207442|FG000|Overall Study|Protocol Violation|0|||
33360401|NCT00642616|101207443|FG001|Overall Study|Protocol Violation|0|||
33360402|NCT00642616|101207444|FG002|Overall Study|Protocol Violation|2|||
33360403|NCT00642616|101207445|FG003|Overall Study|Protocol Violation|0|||
33561601|NCT00004228|101951775|FG004|Overall Study|Lack of Efficacy|9|||
33561602|NCT00004228|101951776|FG005|Overall Study|Lack of Efficacy|8|||
33561603|NCT00004228|101951777|FG006|Overall Study|Lack of Efficacy|4|||
33561604|NCT00004228|101951771|FG000|Overall Study|Lost to Follow-up|0|||
33561605|NCT00004228|101951772|FG001|Overall Study|Lost to Follow-up|0|||
33561606|NCT00004228|101951773|FG002|Overall Study|Lost to Follow-up|1|||
33561607|NCT00004228|101951774|FG003|Overall Study|Lost to Follow-up|0|||
33561608|NCT00004228|101951775|FG004|Overall Study|Lost to Follow-up|0|||
33561609|NCT00004228|101951776|FG005|Overall Study|Lost to Follow-up|0|||
33561610|NCT00004228|101951777|FG006|Overall Study|Lost to Follow-up|0|||
33561611|NCT00004228|101951771|FG000|Overall Study|Physician Decision|1|||
33561612|NCT00004228|101951772|FG001|Overall Study|Physician Decision|0|||
33561613|NCT00004228|101951773|FG002|Overall Study|Physician Decision|3|||
33561614|NCT00004228|101951774|FG003|Overall Study|Physician Decision|2|||
33561615|NCT00004228|101951775|FG004|Overall Study|Physician Decision|1|||
33561616|NCT00004228|101951776|FG005|Overall Study|Physician Decision|1|||
33625139|NCT02349633|102177337|FG009|Overall Study|Termination by sponsor|2|||
33625140|NCT02349633|102177338|FG010|Overall Study|Termination by sponsor|0|||
33625141|NCT02349633|102177339|FG011|Overall Study|Termination by sponsor|0|||
33625142|NCT02349633|102177340|FG012|Overall Study|Termination by sponsor|0|||
33625143|NCT02349633|102177341|FG013|Overall Study|Termination by sponsor|0|||
33625144|NCT02349633|102177328|FG000|Overall Study|Other|0|||
33625145|NCT02349633|102177329|FG001|Overall Study|Other|0|||
33625146|NCT02349633|102177330|FG002|Overall Study|Other|0|||
33625147|NCT02349633|102177331|FG003|Overall Study|Other|0|||
33625148|NCT02349633|102177332|FG004|Overall Study|Other|0|||
33625149|NCT02349633|102177333|FG005|Overall Study|Other|0|||
33625150|NCT02349633|102177334|FG006|Overall Study|Other|0|||
33625151|NCT02349633|102177335|FG007|Overall Study|Other|2|||
33625152|NCT02349633|102177336|FG008|Overall Study|Other|0|||
33625153|NCT02349633|102177337|FG009|Overall Study|Other|0|||
33625154|NCT02349633|102177338|FG010|Overall Study|Other|0|||
33625155|NCT02349633|102177339|FG011|Overall Study|Other|0|||
33625156|NCT02349633|102177340|FG012|Overall Study|Other|0|||
33625157|NCT02349633|102177341|FG013|Overall Study|Other|0|||
33625158|NCT02138890|102177342|FG000|Overall Study|Adverse Event|1|||
33625159|NCT02138890|102177343|FG001|Overall Study|Adverse Event|0|||
33625160|NCT01091675|102177344|FG000|Overall Study|Adverse Event|7|||
33625161|NCT01091675|102177344|FG000|Overall Study|Lack of Efficacy|27|||
33625162|NCT02159066|102177345|FG000|Part I|Adverse Event|7|||
33625163|NCT02159066|102177346|FG001|Part I|Adverse Event|5|||
33625164|NCT02159066|102177347|FG002|Part I|Adverse Event|0|||
33625165|NCT02159066|102177348|FG003|Part I|Adverse Event|0|||
33625166|NCT02159066|102177349|FG004|Part I|Adverse Event|0|||
33625167|NCT02159066|102177350|FG005|Part I|Adverse Event|0|||
33625168|NCT02159066|102177345|FG000|Part I|Death|11|||
33625169|NCT02159066|102177346|FG001|Part I|Death|9|||
33625170|NCT02159066|102177347|FG002|Part I|Death|0|||
33625171|NCT02159066|102177348|FG003|Part I|Death|0|||
33625172|NCT02159066|102177349|FG004|Part I|Death|0|||
33625173|NCT02159066|102177350|FG005|Part I|Death|0|||
33360404|NCT00642616|101207442|FG000|Overall Study|Physician Decision|0|||
33360405|NCT00642616|101207443|FG001|Overall Study|Physician Decision|0|||
33561617|NCT00004228|101951777|FG006|Overall Study|Physician Decision|1|||
33625174|NCT02159066|102177345|FG000|Part I|Progressive Disease|37|||
33625175|NCT02159066|102177346|FG001|Part I|Progressive Disease|46|||
33220798|NCT00337272|100706920|FG000|Treatment Period|Non-compliance|1|||
33360406|NCT00642616|101207444|FG002|Overall Study|Physician Decision|1|||
33360407|NCT00642616|101207445|FG003|Overall Study|Physician Decision|1|||
33561618|NCT00004228|101951771|FG000|Overall Study|Protocol Violation|0|||
33625176|NCT02159066|102177347|FG002|Part I|Progressive Disease|0|||
33625177|NCT02159066|102177348|FG003|Part I|Progressive Disease|0|||
33360408|NCT04329949|101207448|FG000|Overall Study|Death|36|||
33360409|NCT04329949|101207448|FG000|Overall Study|Withdrawal by Subject|4|||
33360410|NCT04329949|101207448|FG000|Overall Study|Termination of study by sponsor|3|||
33360411|NCT01174784|101207449|FG000|Overall Study|Screen fails|4|||
33414910|NCT00916617|101409886|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
33414911|NCT00916617|101409887|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
33360412|NCT01753518|101207450|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
33360413|NCT01753518|101207451|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
33360414|NCT01753518|101207450|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
33414912|NCT00916617|101409888|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
33414913|NCT00916617|101409889|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
33561619|NCT00004228|101951772|FG001|Overall Study|Protocol Violation|5|||
33561620|NCT00004228|101951773|FG002|Overall Study|Protocol Violation|2|||
33561621|NCT00004228|101951774|FG003|Overall Study|Protocol Violation|1|||
33561622|NCT00004228|101951775|FG004|Overall Study|Protocol Violation|1|||
33561623|NCT00004228|101951776|FG005|Overall Study|Protocol Violation|2|||
33561624|NCT00004228|101951777|FG006|Overall Study|Protocol Violation|0|||
33561625|NCT00004228|101951771|FG000|Overall Study|Withdrawal by Subject|3|||
33561626|NCT00004228|101951772|FG001|Overall Study|Withdrawal by Subject|0|||
33561627|NCT00004228|101951773|FG002|Overall Study|Withdrawal by Subject|1|||
33561628|NCT00004228|101951774|FG003|Overall Study|Withdrawal by Subject|0|||
33561629|NCT00004228|101951775|FG004|Overall Study|Withdrawal by Subject|2|||
33561630|NCT00004228|101951776|FG005|Overall Study|Withdrawal by Subject|1|||
33360415|NCT01753518|101207451|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
33360416|NCT01753518|101207450|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
33414914|NCT00916617|101409886|FG000|Overall Study|Lost to Follow-up|2|||
33561631|NCT00004228|101951777|FG006|Overall Study|Withdrawal by Subject|2|||
33625178|NCT02159066|102177349|FG004|Part I|Progressive Disease|0|||
33625179|NCT02159066|102177350|FG005|Part I|Progressive Disease|0|||
33625180|NCT02159066|102177345|FG000|Part I|New Therapy for Study Indication|5|||
33625181|NCT02159066|102177346|FG001|Part I|New Therapy for Study Indication|4|||
33625182|NCT02159066|102177347|FG002|Part I|New Therapy for Study Indication|0|||
33625183|NCT02159066|102177348|FG003|Part I|New Therapy for Study Indication|0|||
33625184|NCT02159066|102177349|FG004|Part I|New Therapy for Study Indication|0|||
33625185|NCT02159066|102177350|FG005|Part I|New Therapy for Study Indication|0|||
33625186|NCT02159066|102177345|FG000|Part I|Termination of participants from the study|3|||
33625187|NCT02159066|102177346|FG001|Part I|Termination of participants from the study|3|||
33625188|NCT02159066|102177347|FG002|Part I|Termination of participants from the study|0|||
33625189|NCT02159066|102177348|FG003|Part I|Termination of participants from the study|0|||
33625190|NCT02159066|102177349|FG004|Part I|Termination of participants from the study|0|||
33625191|NCT02159066|102177350|FG005|Part I|Termination of participants from the study|0|||
33625192|NCT02159066|102177345|FG000|Part I|Physician Decision|2|||
33625193|NCT02159066|102177346|FG001|Part I|Physician Decision|9|||
33625194|NCT02159066|102177347|FG002|Part I|Physician Decision|0|||
33625195|NCT02159066|102177348|FG003|Part I|Physician Decision|0|||
33625196|NCT02159066|102177349|FG004|Part I|Physician Decision|0|||
33625197|NCT02159066|102177350|FG005|Part I|Physician Decision|0|||
33625198|NCT02159066|102177345|FG000|Part I|Participant/Guardian Decision|9|||
33625199|NCT02159066|102177346|FG001|Part I|Participant/Guardian Decision|3|||
33625200|NCT02159066|102177347|FG002|Part I|Participant/Guardian Decision|0|||
33625201|NCT02159066|102177348|FG003|Part I|Participant/Guardian Decision|0|||
33625202|NCT02159066|102177349|FG004|Part I|Participant/Guardian Decision|0|||
33625203|NCT02159066|102177350|FG005|Part I|Participant/Guardian Decision|0|||
33625204|NCT02159066|102177345|FG000|Part I|Missing Data|1|||
33625205|NCT02159066|102177346|FG001|Part I|Missing Data|0|||
33625206|NCT02159066|102177347|FG002|Part I|Missing Data|0|||
33625207|NCT02159066|102177348|FG003|Part I|Missing Data|0|||
33625208|NCT02159066|102177349|FG004|Part I|Missing Data|0|||
33625209|NCT02159066|102177350|FG005|Part I|Missing Data|0|||
33625210|NCT02159066|102177345|FG000|Part II|Adverse Event|0|||
33625211|NCT02159066|102177346|FG001|Part II|Adverse Event|0|||
33625212|NCT02159066|102177347|FG002|Part II|Adverse Event|1|||
33625213|NCT02159066|102177348|FG003|Part II|Adverse Event|0|||
33625214|NCT02159066|102177349|FG004|Part II|Adverse Event|1|||
33625215|NCT02159066|102177350|FG005|Part II|Adverse Event|1|||
33625216|NCT02159066|102177345|FG000|Part II|Death|0|||
33625217|NCT02159066|102177346|FG001|Part II|Death|0|||
33625218|NCT02159066|102177347|FG002|Part II|Death|1|||
33625219|NCT02159066|102177348|FG003|Part II|Death|0|||
33625220|NCT02159066|102177349|FG004|Part II|Death|2|||
33625221|NCT02159066|102177350|FG005|Part II|Death|1|||
33625222|NCT02159066|102177345|FG000|Part II|Progressive Disease|0|||
33625223|NCT02159066|102177346|FG001|Part II|Progressive Disease|0|||
33625224|NCT02159066|102177347|FG002|Part II|Progressive Disease|35|||
33625225|NCT02159066|102177348|FG003|Part II|Progressive Disease|1|||
33625226|NCT02159066|102177349|FG004|Part II|Progressive Disease|7|||
33625227|NCT02159066|102177350|FG005|Part II|Progressive Disease|4|||
33625228|NCT02159066|102177345|FG000|Part II|New Therapy for Study Indication|0|||
33625229|NCT02159066|102177346|FG001|Part II|New Therapy for Study Indication|0|||
33625230|NCT02159066|102177347|FG002|Part II|New Therapy for Study Indication|0|||
33625231|NCT02159066|102177348|FG003|Part II|New Therapy for Study Indication|0|||
33625232|NCT02159066|102177349|FG004|Part II|New Therapy for Study Indication|1|||
33625233|NCT02159066|102177350|FG005|Part II|New Therapy for Study Indication|0|||
33625234|NCT02159066|102177345|FG000|Part II|Physician Decision|0|||
33625235|NCT02159066|102177346|FG001|Part II|Physician Decision|0|||
33625236|NCT02159066|102177347|FG002|Part II|Physician Decision|1|||
33625237|NCT02159066|102177348|FG003|Part II|Physician Decision|0|||
33625238|NCT02159066|102177349|FG004|Part II|Physician Decision|0|||
33625239|NCT02159066|102177350|FG005|Part II|Physician Decision|0|||
33625240|NCT02159066|102177345|FG000|Part II|Participant/Guardian Decision|0|||
33625241|NCT02159066|102177346|FG001|Part II|Participant/Guardian Decision|0|||
33625242|NCT02159066|102177347|FG002|Part II|Participant/Guardian Decision|0|||
33625243|NCT02159066|102177348|FG003|Part II|Participant/Guardian Decision|0|||
33220799|NCT00337272|100706921|FG001|Treatment Period|Non-compliance|1|||
33220800|NCT00337272|100706920|FG000|Treatment Period|Withdrawal by Subject|0|||
33220801|NCT00337272|100706921|FG001|Treatment Period|Withdrawal by Subject|1|||
33220802|NCT00337272|100706920|FG000|Withdrawal Period|Non-compliance|0|||
33220803|NCT00337272|100706921|FG001|Withdrawal Period|Non-compliance|1|||
33220804|NCT01078155|100706924|FG000|Overall Study|Adverse Event|7|||
33220805|NCT01078155|100706924|FG000|Overall Study|Lack of Efficacy|16|||
33220806|NCT01078155|100706924|FG000|Overall Study|Participant's Decision|6|||
33220807|NCT01078155|100706924|FG000|Overall Study|Lost to Follow-up|15|||
33220808|NCT04176939|100706925|FG000|Overall Study|Adverse Event|7|||
33561632|NCT00004228|101951771|FG000|Overall Study|Other|0|||
33561633|NCT00004228|101951772|FG001|Overall Study|Other|0|||
33561634|NCT00004228|101951773|FG002|Overall Study|Other|1|||
33561635|NCT00004228|101951774|FG003|Overall Study|Other|0|||
33561636|NCT00004228|101951775|FG004|Overall Study|Other|0|||
33561637|NCT00004228|101951776|FG005|Overall Study|Other|0|||
33561638|NCT00004228|101951777|FG006|Overall Study|Other|0|||
33561639|NCT00004228|101951771|FG000|Overall Study|ineligible|4|||
33561640|NCT00004228|101951772|FG001|Overall Study|ineligible|2|||
33561641|NCT00004228|101951773|FG002|Overall Study|ineligible|4|||
33561642|NCT00004228|101951774|FG003|Overall Study|ineligible|1|||
33561643|NCT00004228|101951775|FG004|Overall Study|ineligible|1|||
33561644|NCT00004228|101951776|FG005|Overall Study|ineligible|2|||
33561645|NCT00004228|101951777|FG006|Overall Study|ineligible|5|||
33561646|NCT00903344|101951779|FG000|Overall Study|Pregnancy|2|||
33561647|NCT00903344|101951780|FG001|Overall Study|Pregnancy|3|||
33561648|NCT00903344|101951779|FG000|Overall Study|Lost to Follow-up|3|||
33561649|NCT00903344|101951780|FG001|Overall Study|Lost to Follow-up|0|||
33561650|NCT01922895|101951781|FG000|Overall Study|Death|0|||
33561651|NCT01922895|101951782|FG001|Overall Study|Death|1|||
33561652|NCT01922895|101951781|FG000|Overall Study|Withdrawal by Subject|1|||
33561653|NCT01922895|101951782|FG001|Overall Study|Withdrawal by Subject|2|||
33561654|NCT01922895|101951781|FG000|Overall Study|Lost to Follow-up|5|||
33561655|NCT01922895|101951782|FG001|Overall Study|Lost to Follow-up|11|||
33561656|NCT03791060|101951783|FG000|Overall Study|Withdrawal by Subject|1|||
33561657|NCT01557569|101951785|FG000|Overall Study|Adverse Event|2|||
33561658|NCT01557569|101951786|FG001|Overall Study|Adverse Event|0|||
33561659|NCT01557569|101951785|FG000|Overall Study|high blood pressure|0|||
33220809|NCT04176939|100706925|FG000|Overall Study|Unspecified reason|2|||
33220810|NCT04176939|100706925|FG000|Overall Study|Migrated/Moved from the study area|1|||
33561660|NCT01557569|101951786|FG001|Overall Study|high blood pressure|1|||
33561661|NCT01557569|101951785|FG000|Overall Study|Withdrawal by Subject|3|||
33561662|NCT01557569|101951786|FG001|Overall Study|Withdrawal by Subject|5|||
33561663|NCT01557569|101951785|FG000|Overall Study|noncompliance with rules of residential|0|||
33561664|NCT01557569|101951786|FG001|Overall Study|noncompliance with rules of residential|1|||
33561665|NCT00635050|101951787|FG000|Overall Study|Withdrawal by Subject|1|||
33625244|NCT02159066|102177349|FG004|Part II|Participant/Guardian Decision|2|||
33625245|NCT02159066|102177350|FG005|Part II|Participant/Guardian Decision|0|||
33625246|NCT02525471|102177353|FG000|Overall Study|Screen Failure|6|||
33625247|NCT02525471|102177353|FG000|Overall Study|Withdrawal by Subject|4|||
33625248|NCT02525471|102177353|FG000|Overall Study|Death|1|||
33625249|NCT03473236|102177356|FG000|Overall Study|Withdrawal by Subject|0|||
33625250|NCT03473236|102177357|FG001|Overall Study|Withdrawal by Subject|0|||
33625251|NCT03473236|102177358|FG002|Overall Study|Withdrawal by Subject|0|||
33625252|NCT03473236|102177359|FG003|Overall Study|Withdrawal by Subject|0|||
33625253|NCT03473236|102177360|FG004|Overall Study|Withdrawal by Subject|0|||
33625254|NCT03473236|102177361|FG005|Overall Study|Withdrawal by Subject|1|||
33625255|NCT03473236|102177362|FG006|Overall Study|Withdrawal by Subject|0|||
33625256|NCT03473236|102177363|FG007|Overall Study|Withdrawal by Subject|0|||
33625257|NCT03473236|102177364|FG008|Overall Study|Withdrawal by Subject|1|||
33625258|NCT03473236|102177365|FG009|Overall Study|Withdrawal by Subject|0|||
33625259|NCT01132807|102177368|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
33625260|NCT01132807|102177369|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
33625261|NCT01132807|102177370|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
33625262|NCT01132807|102177368|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
33625263|NCT01132807|102177369|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
33625264|NCT01132807|102177370|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
33625265|NCT01488045|102177371|FG000|Overall Study|Withdrawal by Subject|6|||
33625266|NCT01488045|102177372|FG001|Overall Study|Withdrawal by Subject|11|||
33625267|NCT01488045|102177371|FG000|Overall Study|Failure to present for colonoscopy|3|||
33625268|NCT01488045|102177372|FG001|Overall Study|Failure to present for colonoscopy|6|||
33625269|NCT01488045|102177371|FG000|Overall Study|Failure to report exclusion criteria|0|||
33625270|NCT01488045|102177372|FG001|Overall Study|Failure to report exclusion criteria|1|||
33625271|NCT00859547|102177373|FG000|Overall Study|Lost to Follow-up|1|||
33625272|NCT00859547|102177373|FG000|Overall Study|Parent withdrew consent|1|||
33625273|NCT00647296|102177374|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
33625274|NCT00647296|102177375|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
33625275|NCT00647296|102177376|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
33625276|NCT00647296|102177377|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
33625277|NCT00647296|102177374|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
33625278|NCT00647296|102177375|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
33625279|NCT00647296|102177376|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
33625280|NCT00647296|102177377|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
33625281|NCT00647296|102177374|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
33625282|NCT00647296|102177375|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
33625283|NCT00647296|102177376|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
33625284|NCT00647296|102177377|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
33625285|NCT00647296|102177374|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
33625286|NCT00647296|102177375|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
33625287|NCT00647296|102177376|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
33625288|NCT00647296|102177377|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
33625289|NCT00647296|102177374|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
33625290|NCT00647296|102177375|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
33625291|NCT00647296|102177376|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
33625292|NCT00647296|102177377|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
33625293|NCT00647296|102177374|FG000|Part 2: 4-week Placebo Washout|Death|3|||
33625294|NCT00647296|102177375|FG001|Part 2: 4-week Placebo Washout|Death|0|||
33625295|NCT00647296|102177376|FG002|Part 2: 4-week Placebo Washout|Death|0|||
33625296|NCT00647296|102177377|FG003|Part 2: 4-week Placebo Washout|Death|0|||
33625297|NCT00647296|102177374|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
33625298|NCT00647296|102177375|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
33625299|NCT00647296|102177376|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
33625300|NCT00647296|102177377|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
33625301|NCT00647296|102177374|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
33625302|NCT00647296|102177375|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
33625303|NCT00647296|102177376|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
33625304|NCT00647296|102177377|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
33625305|NCT00647296|102177374|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
33625306|NCT00647296|102177375|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
33625307|NCT00647296|102177376|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
33625308|NCT00647296|102177377|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
33625309|NCT00647296|102177374|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
33220811|NCT04176939|100706925|FG000|Overall Study|Withdrawal by Subject|4|||
33220812|NCT04176939|100706925|FG000|Overall Study|In follow-up|54|||
33414915|NCT00916617|101409887|FG001|Overall Study|Lost to Follow-up|1|||
33625310|NCT00647296|102177375|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
33625311|NCT00647296|102177376|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
33625312|NCT00647296|102177377|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
33625313|NCT00647296|102177374|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
33625314|NCT00647296|102177375|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
33625315|NCT00647296|102177376|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
33625316|NCT00647296|102177377|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
33625317|NCT01600885|102177378|FG000|First Period|Adverse Event|1|||
33625318|NCT01600885|102177379|FG001|First Period|Adverse Event|1|||
33625319|NCT01600885|102177378|FG000|First Period|moved out of area|1|||
33625320|NCT01600885|102177379|FG001|First Period|moved out of area|0|||
33625321|NCT01650558|102177380|FG000|Overall Study|Migration out of study area|61|||
33625322|NCT01650558|102177381|FG001|Overall Study|Migration out of study area|71|||
33625323|NCT01650558|102177382|FG002|Overall Study|Migration out of study area|56|||
33625324|NCT01650558|102177380|FG000|Overall Study|Lost to Follow-up|10|||
33625325|NCT01650558|102177381|FG001|Overall Study|Lost to Follow-up|13|||
33625326|NCT01650558|102177382|FG002|Overall Study|Lost to Follow-up|6|||
33625327|NCT01650558|102177380|FG000|Overall Study|Death|10|||
33625328|NCT01650558|102177381|FG001|Overall Study|Death|6|||
33625329|NCT01650558|102177382|FG002|Overall Study|Death|8|||
33625330|NCT01650558|102177380|FG000|Overall Study|Withdrawal by Subject|1|||
33625331|NCT01650558|102177381|FG001|Overall Study|Withdrawal by Subject|1|||
33360417|NCT01753518|101207451|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
33360418|NCT01753518|101207450|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
33360419|NCT01753518|101207451|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
33360420|NCT04601272|101207453|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
33360421|NCT04601272|101207454|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
33360422|NCT04601272|101207455|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
33360423|NCT01845025|101207458|FG000|Overall Study|Adverse Event|6|||
33625332|NCT01650558|102177382|FG002|Overall Study|Withdrawal by Subject|3|||
33625333|NCT01650558|102177380|FG000|Overall Study|Non-compliant participant|1|||
33625334|NCT01650558|102177381|FG001|Overall Study|Non-compliant participant|0|||
33625335|NCT01650558|102177382|FG002|Overall Study|Non-compliant participant|2|||
33625336|NCT01650558|102177380|FG000|Overall Study|Physician Decision|0|||
33625337|NCT01650558|102177381|FG001|Overall Study|Physician Decision|1|||
33625338|NCT01650558|102177382|FG002|Overall Study|Physician Decision|0|||
33625339|NCT01329263|102177384|FG000|Overall Study|Lost to Follow-up|4|||
33625340|NCT01329263|102177385|FG001|Overall Study|Lost to Follow-up|21|||
33625341|NCT01329263|102177384|FG000|Overall Study|Withdrawal by Subject|1|||
33625342|NCT01329263|102177385|FG001|Overall Study|Withdrawal by Subject|2|||
33625343|NCT01232868|102177390|FG000|Overall Study|Lost to Follow-up|2|||
33625344|NCT01232868|102177391|FG001|Overall Study|Lost to Follow-up|4|||
33625345|NCT00404651|102177392|FG000|Overall Study|Serious Adverse Event|0|||
33625346|NCT00404651|102177393|FG001|Overall Study|Serious Adverse Event|0|||
33625347|NCT00404651|102177394|FG002|Overall Study|Serious Adverse Event|2|||
33625348|NCT00404651|102177395|FG003|Overall Study|Serious Adverse Event|0|||
33625349|NCT00404651|102177392|FG000|Overall Study|Protocol Violation|10|||
33625350|NCT00404651|102177393|FG001|Overall Study|Protocol Violation|5|||
33625351|NCT00404651|102177394|FG002|Overall Study|Protocol Violation|14|||
33625352|NCT00404651|102177395|FG003|Overall Study|Protocol Violation|5|||
33360424|NCT01845025|101207459|FG001|Overall Study|Adverse Event|3|||
33360425|NCT01845025|101207458|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33360426|NCT01845025|101207459|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33360427|NCT01845025|101207458|FG000|Overall Study|Withdrawal by Subject|48|||
33561666|NCT04642079|101951794|FG000|Overall Study|Lost to Follow-up|2|||
33561667|NCT04642079|101951795|FG001|Overall Study|Lost to Follow-up|5|||
33561668|NCT04642079|101951796|FG002|Overall Study|Lost to Follow-up|2|||
33561669|NCT04642079|101951797|FG003|Overall Study|Lost to Follow-up|0|||
33561670|NCT04642079|101951794|FG000|Overall Study|Withdrawal by Subject|0|||
33561671|NCT04642079|101951795|FG001|Overall Study|Withdrawal by Subject|4|||
33561672|NCT04642079|101951796|FG002|Overall Study|Withdrawal by Subject|1|||
33561673|NCT04642079|101951797|FG003|Overall Study|Withdrawal by Subject|2|||
33561674|NCT04642079|101951794|FG000|Overall Study|Other|0|||
33561675|NCT04642079|101951795|FG001|Overall Study|Other|0|||
33561676|NCT04642079|101951796|FG002|Overall Study|Other|0|||
33561677|NCT04642079|101951797|FG003|Overall Study|Other|1|||
33561678|NCT04642079|101951794|FG000|Overall Study|No longer met eligibility criteria|1|||
33561679|NCT04642079|101951795|FG001|Overall Study|No longer met eligibility criteria|0|||
33625353|NCT00404651|102177392|FG000|Overall Study|Lost to Follow-up|15|||
33625354|NCT00404651|102177393|FG001|Overall Study|Lost to Follow-up|11|||
33625355|NCT00404651|102177394|FG002|Overall Study|Lost to Follow-up|13|||
33561680|NCT04642079|101951796|FG002|Overall Study|No longer met eligibility criteria|1|||
33625356|NCT00404651|102177395|FG003|Overall Study|Lost to Follow-up|10|||
33625357|NCT00404651|102177392|FG000|Overall Study|Withdrawal by Subject|14|||
33625358|NCT00404651|102177393|FG001|Overall Study|Withdrawal by Subject|12|||
33625359|NCT00404651|102177394|FG002|Overall Study|Withdrawal by Subject|16|||
33625360|NCT00404651|102177395|FG003|Overall Study|Withdrawal by Subject|6|||
33625361|NCT00965081|102177397|FG000|Overall Study|Adverse Event|14|||
33625362|NCT00965081|102177398|FG001|Overall Study|Adverse Event|9|||
33625363|NCT00965081|102177397|FG000|Overall Study|Lack of Efficacy|2|||
33625364|NCT00965081|102177398|FG001|Overall Study|Lack of Efficacy|5|||
33625365|NCT00965081|102177397|FG000|Overall Study|Lost to Follow-up|4|||
33625366|NCT00965081|102177398|FG001|Overall Study|Lost to Follow-up|5|||
33625367|NCT00965081|102177397|FG000|Overall Study|Physician Decision|2|||
33625368|NCT00965081|102177398|FG001|Overall Study|Physician Decision|0|||
33625369|NCT00965081|102177397|FG000|Overall Study|Protocol Violation|2|||
33625370|NCT00965081|102177398|FG001|Overall Study|Protocol Violation|5|||
33625371|NCT00965081|102177397|FG000|Overall Study|Sponsor Decision|1|||
33625372|NCT00965081|102177398|FG001|Overall Study|Sponsor Decision|0|||
33625373|NCT00965081|102177397|FG000|Overall Study|Withdrawal by Subject|4|||
33625374|NCT00965081|102177398|FG001|Overall Study|Withdrawal by Subject|7|||
33625375|NCT00965081|102177397|FG000|Overall Study|Switched to Rescue Arm|5|||
33625376|NCT00965081|102177398|FG001|Overall Study|Switched to Rescue Arm|12|||
33625377|NCT05470387|102177399|FG000|Overall Study|Protocol Violation|0|||
33625378|NCT05470387|102177400|FG001|Overall Study|Protocol Violation|3|||
33625379|NCT00687401|102177402|FG000|Overall Study|Protocol Violation|7|||
33625380|NCT00687401|102177402|FG000|Overall Study|Adverse Event|6|||
33625381|NCT00687401|102177402|FG000|Overall Study|Lack of Efficacy|6|||
33625382|NCT00687401|102177402|FG000|Overall Study|Withdrawal by Subject|4|||
33625383|NCT00687401|102177402|FG000|Overall Study|Did not return for visit|3|||
33625384|NCT00687401|102177402|FG000|Overall Study|For reasons different from those above|4|||
33625385|NCT02922725|102177403|FG000|Overall Study|Withdrawal by Subject|1|||
33625386|NCT02922725|102177404|FG001|Overall Study|Withdrawal by Subject|0|||
33625387|NCT02922725|102177405|FG002|Overall Study|Withdrawal by Subject|0|||
33625388|NCT03683173|102177410|FG000|Completed Follow-up|Unavailable|235|||
33625389|NCT03683173|102177411|FG001|Completed Follow-up|Unavailable|217|||
33625390|NCT03683173|102177410|FG000|Completed Follow-up|Refused|69|||
33625391|NCT03683173|102177411|FG001|Completed Follow-up|Refused|59|||
33625392|NCT03683173|102177410|FG000|Completed Follow-up|Disconnected phone|65|||
33625393|NCT03683173|102177411|FG001|Completed Follow-up|Disconnected phone|95|||
33625394|NCT03683173|102177410|FG000|Completed Follow-up|Health issue/deceased|10|||
33625395|NCT03683173|102177411|FG001|Completed Follow-up|Health issue/deceased|4|||
33625396|NCT03683173|102177410|FG000|Completed Follow-up|Moved away|8|||
33625397|NCT03683173|102177411|FG001|Completed Follow-up|Moved away|1|||
33625398|NCT03790111|102180735|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
33625399|NCT01216202|102180736|FG000|Overall Study|Withdrawal by Subject|8|||
33625400|NCT01216202|102180737|FG001|Overall Study|Withdrawal by Subject|0|||
33625401|NCT01216202|102180736|FG000|Overall Study|Death|0|||
33625402|NCT01216202|102180737|FG001|Overall Study|Death|2|||
33625403|NCT01216202|102180736|FG000|Overall Study|Lost to Follow-up|14|||
33625404|NCT01216202|102180737|FG001|Overall Study|Lost to Follow-up|0|||
33625405|NCT00248495|102180738|FG000|Overall Study|Withdrawal by Subject|1|||
33625406|NCT00528957|102180748|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
33625407|NCT00528957|102180749|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
33625408|NCT00528957|102180748|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
33625409|NCT00528957|102180749|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
33625410|NCT00528957|102180748|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
33625411|NCT00528957|102180749|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
33625412|NCT00528957|102180748|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
33625413|NCT00528957|102180749|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
33625414|NCT00528957|102180748|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
33625415|NCT00528957|102180749|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
33625416|NCT00528957|102180748|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
33625417|NCT00528957|102180749|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
33625418|NCT00528957|102180748|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
33625419|NCT00528957|102180749|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
33625420|NCT00528957|102180748|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
33625421|NCT00528957|102180749|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
33625422|NCT00528957|102180748|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
33625423|NCT00528957|102180749|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
33625424|NCT00528957|102180748|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
33625425|NCT00528957|102180749|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
33625426|NCT00528957|102180748|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
33625427|NCT00528957|102180749|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
33625428|NCT00528957|102180748|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
33625429|NCT00528957|102180749|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
33625430|NCT00528957|102180748|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
33625431|NCT00528957|102180749|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
33625432|NCT00528957|102180748|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
33625433|NCT00528957|102180749|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
33625434|NCT00528957|102180748|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
33625435|NCT00528957|102180749|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
33625436|NCT00528957|102180748|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
33625437|NCT00528957|102180749|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
33625438|NCT00101686|102180752|FG000|Overall Study|Progressive Disease|37|||
33220813|NCT01591382|100706926|FG000|Overall Study|Discharged Prior to Study Completion|2|||
33360428|NCT01845025|101207459|FG001|Overall Study|Withdrawal by Subject|44|||
33360429|NCT01845025|101207458|FG000|Overall Study|Lost to Follow-up|13|||
33625439|NCT00101686|102180753|FG001|Overall Study|Progressive Disease|28|||
33625440|NCT00101686|102180754|FG002|Overall Study|Progressive Disease|37|||
33625441|NCT00101686|102180755|FG003|Overall Study|Progressive Disease|38|||
33625442|NCT00101686|102180756|FG004|Overall Study|Progressive Disease|28|||
33625443|NCT00101686|102180757|FG005|Overall Study|Progressive Disease|25|||
33625444|NCT00101686|102180758|FG006|Overall Study|Progressive Disease|5|||
33625445|NCT00101686|102180759|FG007|Overall Study|Progressive Disease|7|||
33625446|NCT00101686|102180760|FG008|Overall Study|Progressive Disease|10|||
33625447|NCT00101686|102180761|FG009|Overall Study|Progressive Disease|8|||
33625448|NCT00101686|102180752|FG000|Overall Study|initiation other anti-cancer treatment|4|||
33360430|NCT01845025|101207459|FG001|Overall Study|Lost to Follow-up|13|||
33360431|NCT01845025|101207458|FG000|Overall Study|Administrative problems|8|||
33625449|NCT00101686|102180753|FG001|Overall Study|initiation other anti-cancer treatment|3|||
33625450|NCT00101686|102180754|FG002|Overall Study|initiation other anti-cancer treatment|4|||
33625451|NCT00101686|102180755|FG003|Overall Study|initiation other anti-cancer treatment|3|||
33625452|NCT00101686|102180756|FG004|Overall Study|initiation other anti-cancer treatment|1|||
33625453|NCT00101686|102180757|FG005|Overall Study|initiation other anti-cancer treatment|1|||
33625454|NCT00101686|102180758|FG006|Overall Study|initiation other anti-cancer treatment|2|||
33625455|NCT00101686|102180759|FG007|Overall Study|initiation other anti-cancer treatment|2|||
33625456|NCT00101686|102180760|FG008|Overall Study|initiation other anti-cancer treatment|3|||
33625457|NCT00101686|102180761|FG009|Overall Study|initiation other anti-cancer treatment|3|||
33360432|NCT01845025|101207459|FG001|Overall Study|Administrative problems|8|||
33360433|NCT01845025|101207458|FG000|Overall Study|Death|2|||
33360434|NCT01845025|101207459|FG001|Overall Study|Death|0|||
33360435|NCT01845025|101207458|FG000|Overall Study|Protocol deviation|3|||
33625458|NCT00101686|102180752|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
33625459|NCT00101686|102180753|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
33625460|NCT00101686|102180754|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
33625461|NCT00101686|102180755|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
33625462|NCT00101686|102180756|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
33625463|NCT00101686|102180757|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
33625464|NCT00101686|102180758|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
33625465|NCT00101686|102180759|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
33625466|NCT00101686|102180760|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
33625467|NCT00101686|102180761|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
33625468|NCT00101686|102180752|FG000|Overall Study|unacceptable toxicity|3|||
33625469|NCT00101686|102180753|FG001|Overall Study|unacceptable toxicity|9|||
33625470|NCT00101686|102180754|FG002|Overall Study|unacceptable toxicity|10|||
33625471|NCT00101686|102180755|FG003|Overall Study|unacceptable toxicity|6|||
33625472|NCT00101686|102180756|FG004|Overall Study|unacceptable toxicity|16|||
33625473|NCT00101686|102180757|FG005|Overall Study|unacceptable toxicity|10|||
33625474|NCT00101686|102180758|FG006|Overall Study|unacceptable toxicity|4|||
33625475|NCT00101686|102180759|FG007|Overall Study|unacceptable toxicity|2|||
33360436|NCT01845025|101207459|FG001|Overall Study|Protocol deviation|6|||
33360437|NCT01845025|101207458|FG000|Overall Study|Missing|1|||
33360438|NCT01845025|101207459|FG001|Overall Study|Missing|1|||
33360439|NCT04430582|101207460|FG000|Overall Study|Found to meet exclusionary criteria|1|||
33360440|NCT04430582|101207461|FG001|Overall Study|Found to meet exclusionary criteria|0|||
33360441|NCT04430582|101207460|FG000|Overall Study|Withdrawal by Subject|0|||
33360442|NCT04430582|101207461|FG001|Overall Study|Withdrawal by Subject|1|||
33360443|NCT05590403|101207463|FG000|Overall Study|Lost to Follow-up|3|||
33360444|NCT05590403|101207464|FG001|Overall Study|Lost to Follow-up|0|||
33360445|NCT05590403|101207465|FG002|Overall Study|Lost to Follow-up|2|||
33561681|NCT04642079|101951797|FG003|Overall Study|No longer met eligibility criteria|1|||
33561682|NCT00987935|101951798|FG000|Overall Study|Progressive disease|3|||
33561683|NCT00987935|101951799|FG001|Overall Study|Progressive disease|2|||
33561684|NCT00987935|101951800|FG002|Overall Study|Progressive disease|3|||
33561685|NCT00987935|101951801|FG003|Overall Study|Progressive disease|2|||
33561686|NCT00987935|101951802|FG004|Overall Study|Progressive disease|5|||
33561687|NCT00987935|101951803|FG005|Overall Study|Progressive disease|3|||
33561688|NCT00987935|101951804|FG006|Overall Study|Progressive disease|9|||
33561689|NCT00987935|101951805|FG007|Overall Study|Progressive disease|48|||
33561690|NCT00987935|101951806|FG008|Overall Study|Progressive disease|23|||
33561691|NCT00987935|101951798|FG000|Overall Study|Adverse Event|0|||
33561692|NCT00987935|101951799|FG001|Overall Study|Adverse Event|1|||
33561693|NCT00987935|101951800|FG002|Overall Study|Adverse Event|0|||
33561694|NCT00987935|101951801|FG003|Overall Study|Adverse Event|1|||
33561695|NCT00987935|101951802|FG004|Overall Study|Adverse Event|1|||
33561696|NCT00987935|101951803|FG005|Overall Study|Adverse Event|0|||
33561697|NCT00987935|101951804|FG006|Overall Study|Adverse Event|2|||
33561698|NCT00987935|101951805|FG007|Overall Study|Adverse Event|10|||
33561699|NCT00987935|101951806|FG008|Overall Study|Adverse Event|6|||
33561700|NCT00987935|101951798|FG000|Overall Study|Refused to continue taking trial med.|1|||
33561701|NCT00987935|101951799|FG001|Overall Study|Refused to continue taking trial med.|0|||
33561702|NCT00987935|101951800|FG002|Overall Study|Refused to continue taking trial med.|0|||
33561703|NCT00987935|101951801|FG003|Overall Study|Refused to continue taking trial med.|0|||
33561704|NCT00987935|101951802|FG004|Overall Study|Refused to continue taking trial med.|1|||
33561705|NCT00987935|101951803|FG005|Overall Study|Refused to continue taking trial med.|0|||
33561706|NCT00987935|101951804|FG006|Overall Study|Refused to continue taking trial med.|4|||
33561707|NCT00987935|101951805|FG007|Overall Study|Refused to continue taking trial med.|4|||
33561708|NCT00987935|101951806|FG008|Overall Study|Refused to continue taking trial med.|2|||
33561709|NCT00987935|101951798|FG000|Overall Study|Reason other than those specified above|0|||
33561710|NCT00987935|101951799|FG001|Overall Study|Reason other than those specified above|0|||
33561711|NCT00987935|101951800|FG002|Overall Study|Reason other than those specified above|0|||
33561712|NCT00987935|101951801|FG003|Overall Study|Reason other than those specified above|0|||
33561713|NCT00987935|101951802|FG004|Overall Study|Reason other than those specified above|0|||
33561714|NCT00987935|101951803|FG005|Overall Study|Reason other than those specified above|0|||
33561715|NCT00987935|101951804|FG006|Overall Study|Reason other than those specified above|0|||
33561716|NCT00987935|101951805|FG007|Overall Study|Reason other than those specified above|0|||
33561717|NCT00987935|101951806|FG008|Overall Study|Reason other than those specified above|1|||
33561718|NCT00458705|101951810|FG000|Overall Study|Adverse Event|4|||
33561719|NCT00458705|101951810|FG000|Overall Study|Not Treated|1|||
33561720|NCT00662038|101951811|FG000|Overall Study|Reason not specified|3|||
33561721|NCT00662038|101951811|FG000|Overall Study|Withdrawn consent|22|||
33561722|NCT00662038|101951811|FG000|Overall Study|Withdrawal by Subject|83|||
33561723|NCT00662038|101951811|FG000|Overall Study|Sponsor decision|1|||
33561724|NCT00662038|101951811|FG000|Overall Study|Physician Decision|19|||
33561725|NCT00662038|101951811|FG000|Overall Study|Lung transplantation|44|||
33561726|NCT00662038|101951811|FG000|Overall Study|Lost to Follow-up|1|||
33561727|NCT00662038|101951811|FG000|Overall Study|Death|95|||
33561728|NCT00662038|101951811|FG000|Overall Study|Adverse Event|358|||
33561729|NCT00662038|101951811|FG000|Overall Study|Continued treatment|5|||
33561730|NCT02757963|101951812|FG000|Overall Study|Adverse Event|3|||
33561731|NCT02757963|101951812|FG000|Overall Study|Reached Stopping Criteria|1054|||
33561732|NCT02757963|101951812|FG000|Overall Study|Lost to Follow-up|5|||
33561733|NCT02757963|101951812|FG000|Overall Study|Physician Decision|1|||
33561734|NCT02757963|101951812|FG000|Overall Study|Withdrawal by Subject|34|||
33561735|NCT01251861|101951813|FG000|Overall Study|Disease progression|6|||
33561736|NCT01251861|101951814|FG001|Overall Study|Disease progression|6|||
33561737|NCT01251861|101951813|FG000|Overall Study|Adverse Event|2|||
33561738|NCT01251861|101951814|FG001|Overall Study|Adverse Event|17|||
33561739|NCT01251861|101951813|FG000|Overall Study|Withdrawal by Subject|2|||
33561740|NCT01251861|101951814|FG001|Overall Study|Withdrawal by Subject|2|||
33561741|NCT01251861|101951813|FG000|Overall Study|Alternative therapy|1|||
33561742|NCT01251861|101951814|FG001|Overall Study|Alternative therapy|0|||
33561743|NCT01251861|101951813|FG000|Overall Study|Other complicating disease|0|||
33561744|NCT01251861|101951814|FG001|Overall Study|Other complicating disease|1|||
33360446|NCT05590403|101207466|FG003|Overall Study|Lost to Follow-up|0|||
33360447|NCT05590403|101207467|FG004|Overall Study|Lost to Follow-up|0|||
33360448|NCT05590403|101207463|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
33360449|NCT05590403|101207464|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1|||
33360450|NCT05590403|101207465|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
33360451|NCT05590403|101207466|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|1|||
33360452|NCT05590403|101207467|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|0|||
33561745|NCT01251861|101951813|FG000|Overall Study|Physician Decision|1|||
33360453|NCT02240628|101207468|FG000|Overall Study|Physician Decision|6|||
33360454|NCT02240628|101207469|FG001|Overall Study|Physician Decision|5|||
33360455|NCT00510692|101207470|FG000|Overall Study|Adverse Event|1|||
33561746|NCT01251861|101951814|FG001|Overall Study|Physician Decision|0|||
33561747|NCT01251861|101951813|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
33561748|NCT01251861|101951814|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
33561749|NCT01251861|101951813|FG000|Overall Study|Other|1|||
33561750|NCT01251861|101951814|FG001|Overall Study|Other|0|||
33561751|NCT01251861|101951813|FG000|Overall Study|Never started therapy|4|||
33561752|NCT01251861|101951814|FG001|Overall Study|Never started therapy|1|||
33561753|NCT01251861|101951813|FG000|Overall Study|Potential interaction of drugs|0|||
33561754|NCT01251861|101951814|FG001|Overall Study|Potential interaction of drugs|1|||
33561755|NCT00493285|101951815|FG000|Overall Study|Lost to Follow-up|0|||
33561756|NCT00493285|101951816|FG001|Overall Study|Lost to Follow-up|0|||
33561757|NCT00493285|101951817|FG002|Overall Study|Lost to Follow-up|0|||
33561758|NCT00493285|101951818|FG003|Overall Study|Lost to Follow-up|0|||
33561759|NCT00493285|101951819|FG004|Overall Study|Lost to Follow-up|1|||
33561760|NCT00493285|101951820|FG005|Overall Study|Lost to Follow-up|0|||
33561761|NCT00552279|101951821|FG000|Overall Study|Adverse Event|0|||
33625476|NCT00101686|102180760|FG008|Overall Study|unacceptable toxicity|1|||
33625477|NCT00101686|102180761|FG009|Overall Study|unacceptable toxicity|4|||
33625478|NCT00101686|102180752|FG000|Overall Study|Randomized but did not receive treament|1|||
33625479|NCT00101686|102180753|FG001|Overall Study|Randomized but did not receive treament|6|||
33625480|NCT00101686|102180754|FG002|Overall Study|Randomized but did not receive treament|2|||
33625481|NCT00101686|102180755|FG003|Overall Study|Randomized but did not receive treament|2|||
33625482|NCT00101686|102180756|FG004|Overall Study|Randomized but did not receive treament|2|||
33625483|NCT00101686|102180757|FG005|Overall Study|Randomized but did not receive treament|2|||
33625484|NCT00101686|102180758|FG006|Overall Study|Randomized but did not receive treament|0|||
33625485|NCT00101686|102180759|FG007|Overall Study|Randomized but did not receive treament|1|||
33625486|NCT00101686|102180760|FG008|Overall Study|Randomized but did not receive treament|0|||
33625487|NCT00101686|102180761|FG009|Overall Study|Randomized but did not receive treament|1|||
33625488|NCT00101686|102180752|FG000|Overall Study|intercurrent non-cancer related illness|0|||
33625489|NCT00101686|102180753|FG001|Overall Study|intercurrent non-cancer related illness|0|||
33625490|NCT00101686|102180754|FG002|Overall Study|intercurrent non-cancer related illness|2|||
33625491|NCT00101686|102180755|FG003|Overall Study|intercurrent non-cancer related illness|0|||
33625492|NCT00101686|102180756|FG004|Overall Study|intercurrent non-cancer related illness|1|||
33625493|NCT00101686|102180757|FG005|Overall Study|intercurrent non-cancer related illness|3|||
33625494|NCT00101686|102180758|FG006|Overall Study|intercurrent non-cancer related illness|1|||
33625495|NCT00101686|102180759|FG007|Overall Study|intercurrent non-cancer related illness|0|||
33360456|NCT00510692|101207471|FG001|Overall Study|Adverse Event|3|||
33561762|NCT00552279|101951822|FG001|Overall Study|Adverse Event|1|||
33561763|NCT00552279|101951821|FG000|Overall Study|Withdrawal by Subject|12|||
33220814|NCT01591382|100706927|FG001|Overall Study|Discharged Prior to Study Completion|1|||
33220815|NCT01591382|100706926|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
33220816|NCT01591382|100706927|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
33220817|NCT00331344|100706928|FG000|Phase I|Adverse Event|0|||
33220818|NCT00331344|100706929|FG001|Phase I|Adverse Event|0|||
33220819|NCT00331344|100706930|FG002|Phase I|Adverse Event|0|||
33220820|NCT00331344|100706931|FG003|Phase I|Adverse Event|1|||
33220821|NCT00331344|100706932|FG004|Phase I|Adverse Event|2|||
33220822|NCT00331344|100706933|FG005|Phase I|Adverse Event|2|||
33220823|NCT00331344|100706934|FG006|Phase I|Adverse Event|0|||
33220824|NCT00331344|100706935|FG007|Phase I|Adverse Event|1|||
33220825|NCT00331344|100706936|FG008|Phase I|Adverse Event|0|||
33220826|NCT00331344|100706928|FG000|Phase II|Death|0|||
33625496|NCT00101686|102180760|FG008|Overall Study|intercurrent non-cancer related illness|1|||
33625497|NCT00101686|102180761|FG009|Overall Study|intercurrent non-cancer related illness|1|||
33625498|NCT00101686|102180752|FG000|Overall Study|Physician Decision|10|||
33625499|NCT00101686|102180753|FG001|Overall Study|Physician Decision|13|||
33625500|NCT00101686|102180754|FG002|Overall Study|Physician Decision|6|||
33625501|NCT00101686|102180755|FG003|Overall Study|Physician Decision|7|||
33220827|NCT00331344|100706929|FG001|Phase II|Death|0|||
33220828|NCT00331344|100706930|FG002|Phase II|Death|0|||
33561764|NCT00552279|101951822|FG001|Overall Study|Withdrawal by Subject|1|||
33625502|NCT00101686|102180756|FG004|Overall Study|Physician Decision|8|||
33625503|NCT00101686|102180757|FG005|Overall Study|Physician Decision|9|||
33220829|NCT00331344|100706931|FG003|Phase II|Death|0|||
33220830|NCT00331344|100706932|FG004|Phase II|Death|0|||
33220831|NCT00331344|100706933|FG005|Phase II|Death|0|||
33220832|NCT00331344|100706934|FG006|Phase II|Death|0|||
33561765|NCT00552279|101951821|FG000|Overall Study|Lost to Follow-up|1|||
33561766|NCT00552279|101951822|FG001|Overall Study|Lost to Follow-up|0|||
33561767|NCT00552279|101951821|FG000|Overall Study|Other|1|||
33561768|NCT00552279|101951822|FG001|Overall Study|Other|1|||
33561769|NCT04101331|101951823|FG000|Overall Study|Adverse Event|9|||
33561770|NCT04101331|101951823|FG000|Overall Study|Disease progression|82|||
33561771|NCT04101331|101951823|FG000|Overall Study|Withdrawal by Subject|1|||
33561772|NCT04101331|101951823|FG000|Overall Study|Investigator decision|6|||
33561773|NCT04101331|101951823|FG000|Overall Study|Death|6|||
33561774|NCT04101331|101951823|FG000|Overall Study|Allogenic transplant|1|||
33561775|NCT01335685|101951825|FG000|Overall Study|Study Terminated by Sponsor|2|||
33561776|NCT01335685|101951826|FG001|Overall Study|Study Terminated by Sponsor|1|||
33561777|NCT01335685|101951827|FG002|Overall Study|Study Terminated by Sponsor|1|||
33561778|NCT01335685|101951828|FG003|Overall Study|Study Terminated by Sponsor|10|||
33561779|NCT01335685|101951829|FG004|Overall Study|Study Terminated by Sponsor|0|||
33561780|NCT01335685|101951830|FG005|Overall Study|Study Terminated by Sponsor|4|||
33561781|NCT01335685|101951831|FG006|Overall Study|Study Terminated by Sponsor|2|||
33561782|NCT01335685|101951832|FG007|Overall Study|Study Terminated by Sponsor|3|||
33561783|NCT01335685|101951825|FG000|Overall Study|Withdrawal by Subject|1|||
33561784|NCT01335685|101951826|FG001|Overall Study|Withdrawal by Subject|0|||
33561785|NCT01335685|101951827|FG002|Overall Study|Withdrawal by Subject|0|||
33561786|NCT01335685|101951828|FG003|Overall Study|Withdrawal by Subject|1|||
33561787|NCT01335685|101951829|FG004|Overall Study|Withdrawal by Subject|0|||
33561788|NCT01335685|101951830|FG005|Overall Study|Withdrawal by Subject|0|||
33561789|NCT01335685|101951831|FG006|Overall Study|Withdrawal by Subject|0|||
33561790|NCT01335685|101951832|FG007|Overall Study|Withdrawal by Subject|0|||
33561791|NCT01335685|101951825|FG000|Overall Study|Reason not Specified|0|||
33561792|NCT01335685|101951826|FG001|Overall Study|Reason not Specified|0|||
33561793|NCT01335685|101951827|FG002|Overall Study|Reason not Specified|1|||
33561794|NCT01335685|101951828|FG003|Overall Study|Reason not Specified|0|||
33561795|NCT01335685|101951829|FG004|Overall Study|Reason not Specified|0|||
33561796|NCT01335685|101951830|FG005|Overall Study|Reason not Specified|1|||
33561797|NCT01335685|101951831|FG006|Overall Study|Reason not Specified|0|||
33220833|NCT00331344|100706935|FG007|Phase II|Death|0|||
33220834|NCT00331344|100706936|FG008|Phase II|Death|4|||
33561798|NCT01335685|101951832|FG007|Overall Study|Reason not Specified|0|||
33561799|NCT01027351|101951833|FG000|Overall Study|Withdrawal by Subject|1|||
33561800|NCT01027351|101951834|FG001|Overall Study|Withdrawal by Subject|0|||
33561801|NCT01027351|101951835|FG002|Overall Study|Withdrawal by Subject|1|||
33561802|NCT01027351|101951836|FG003|Overall Study|Withdrawal by Subject|0|||
33561803|NCT01027351|101951837|FG004|Overall Study|Withdrawal by Subject|3|||
33561804|NCT01027351|101951838|FG005|Overall Study|Withdrawal by Subject|5|||
33220835|NCT00991341|100706937|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
33220836|NCT00991341|100706938|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
33220837|NCT00991341|100706937|FG000|Overall Study|Death|3|||
33220838|NCT00991341|100706938|FG001|Overall Study|Death|0|||
33561805|NCT01027351|101951833|FG000|Overall Study|Lost to Follow-up|1|||
33561806|NCT01027351|101951834|FG001|Overall Study|Lost to Follow-up|1|||
33561807|NCT01027351|101951835|FG002|Overall Study|Lost to Follow-up|0|||
33625504|NCT00101686|102180758|FG006|Overall Study|Physician Decision|5|||
33625505|NCT00101686|102180759|FG007|Overall Study|Physician Decision|5|||
33625506|NCT00101686|102180760|FG008|Overall Study|Physician Decision|1|||
33625507|NCT00101686|102180761|FG009|Overall Study|Physician Decision|1|||
33625508|NCT00101686|102180752|FG000|Overall Study|Other|1|||
33625509|NCT00101686|102180753|FG001|Overall Study|Other|4|||
33625510|NCT00101686|102180754|FG002|Overall Study|Other|1|||
33625511|NCT00101686|102180755|FG003|Overall Study|Other|6|||
33625512|NCT00101686|102180756|FG004|Overall Study|Other|2|||
33625513|NCT00101686|102180757|FG005|Overall Study|Other|12|||
33625514|NCT00101686|102180758|FG006|Overall Study|Other|1|||
33625515|NCT00101686|102180759|FG007|Overall Study|Other|5|||
33625516|NCT00101686|102180760|FG008|Overall Study|Other|3|||
33625517|NCT00101686|102180761|FG009|Overall Study|Other|3|||
33625518|NCT00101686|102180752|FG000|Overall Study|Withdrawal by Subject|9|||
33220839|NCT00991341|100706937|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
33220840|NCT00991341|100706938|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
33220841|NCT00991341|100706937|FG000|Overall Study|Physician Decision|1|||
33220842|NCT00991341|100706938|FG001|Overall Study|Physician Decision|2|||
33561808|NCT01027351|101951836|FG003|Overall Study|Lost to Follow-up|1|||
33561809|NCT01027351|101951837|FG004|Overall Study|Lost to Follow-up|6|||
33561810|NCT01027351|101951838|FG005|Overall Study|Lost to Follow-up|0|||
33561811|NCT01027351|101951833|FG000|Overall Study|Inappropriate enrollment|0|||
33561812|NCT01027351|101951834|FG001|Overall Study|Inappropriate enrollment|0|||
33561813|NCT01027351|101951835|FG002|Overall Study|Inappropriate enrollment|0|||
33561814|NCT01027351|101951836|FG003|Overall Study|Inappropriate enrollment|0|||
33561815|NCT01027351|101951837|FG004|Overall Study|Inappropriate enrollment|1|||
33561816|NCT01027351|101951838|FG005|Overall Study|Inappropriate enrollment|0|||
33561817|NCT01027351|101951833|FG000|Overall Study|Protocol Violation|1|||
33561818|NCT01027351|101951834|FG001|Overall Study|Protocol Violation|0|||
33561819|NCT01027351|101951835|FG002|Overall Study|Protocol Violation|0|||
33561820|NCT01027351|101951836|FG003|Overall Study|Protocol Violation|1|||
33561821|NCT01027351|101951837|FG004|Overall Study|Protocol Violation|1|||
33561822|NCT01027351|101951838|FG005|Overall Study|Protocol Violation|0|||
33561823|NCT01050218|101951841|FG000|Overall Study|Adverse Event|37|||
33561824|NCT01050218|101951841|FG000|Overall Study|Lack of Efficacy|8|||
33561825|NCT01050218|101951841|FG000|Overall Study|Protocol Violation|3|||
33561826|NCT01050218|101951841|FG000|Overall Study|Withdrawal by Subject|18|||
33561827|NCT01050218|101951841|FG000|Overall Study|Discontinued by sponsor|18|||
33561828|NCT01050218|101951841|FG000|Overall Study|Compliance|2|||
33561829|NCT01050218|101951841|FG000|Overall Study|Failed to return|7|||
33561830|NCT01050218|101951841|FG000|Overall Study|Serious Adverse Event|1|||
33561831|NCT01050218|101951841|FG000|Overall Study|Family emergency|1|||
33561832|NCT00563316|101951844|FG000|Overall Study|Adverse Event|2|||
33561833|NCT00563316|101951844|FG000|Overall Study|Physician Decision|1|||
33561834|NCT00563316|101951844|FG000|Overall Study|Lost to Follow-up|2|||
33561835|NCT00563316|101951844|FG000|Overall Study|Death|1|||
33561836|NCT00563316|101951844|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
33561837|NCT00563316|101951844|FG000|Overall Study|Other|1|||
33561838|NCT00050011|101951848|FG000|Overall Study|Adverse Event|41|||
33561839|NCT00050011|101951849|FG001|Overall Study|Adverse Event|46|||
33561840|NCT00050011|101951848|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33561841|NCT00050011|101951849|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33625519|NCT00101686|102180753|FG001|Overall Study|Withdrawal by Subject|8|||
33625520|NCT00101686|102180754|FG002|Overall Study|Withdrawal by Subject|6|||
33625521|NCT00101686|102180755|FG003|Overall Study|Withdrawal by Subject|8|||
33625522|NCT00101686|102180756|FG004|Overall Study|Withdrawal by Subject|8|||
33625523|NCT00101686|102180757|FG005|Overall Study|Withdrawal by Subject|7|||
33625524|NCT00101686|102180758|FG006|Overall Study|Withdrawal by Subject|7|||
33625525|NCT00101686|102180759|FG007|Overall Study|Withdrawal by Subject|7|||
33625526|NCT00101686|102180760|FG008|Overall Study|Withdrawal by Subject|8|||
33625527|NCT00101686|102180761|FG009|Overall Study|Withdrawal by Subject|9|||
33561842|NCT00050011|101951848|FG000|Overall Study|Abnormal test procedure results|0|||
33561843|NCT00050011|101951849|FG001|Overall Study|Abnormal test procedure results|1|||
33561844|NCT00050011|101951848|FG000|Overall Study|Lack of Efficacy|16|||
33220843|NCT00991341|100706937|FG000|Overall Study|Withdrawal by Subject|3|||
33625528|NCT02796677|102180765|FG000|Overall Study|Adverse Event|11|||
33625529|NCT02796677|102180766|FG001|Overall Study|Adverse Event|22|||
33625530|NCT02796677|102180767|FG002|Overall Study|Adverse Event|14|||
33220844|NCT00991341|100706938|FG001|Overall Study|Withdrawal by Subject|4|||
33220845|NCT03320018|100706956|FG000|Treatment Period|Withdrawal by Subject|1|||
33220846|NCT03320018|100706957|FG001|Treatment Period|Withdrawal by Subject|0|||
33220847|NCT03320018|100706956|FG000|Day 90 Follow up|Death|0|||
33220848|NCT03320018|100706957|FG001|Day 90 Follow up|Death|1|||
33220849|NCT00118898|100706958|FG000|Overall Study|Death|6|||
33220850|NCT00118898|100706959|FG001|Overall Study|Death|11|||
33220851|NCT00118898|100706960|FG002|Overall Study|Death|6|||
33220852|NCT00118898|100706961|FG003|Overall Study|Death|8|||
33220853|NCT00118898|100706958|FG000|Overall Study|Lost to Follow-up|26|||
33220854|NCT00118898|100706959|FG001|Overall Study|Lost to Follow-up|34|||
33220855|NCT00118898|100706960|FG002|Overall Study|Lost to Follow-up|33|||
33220856|NCT00118898|100706961|FG003|Overall Study|Lost to Follow-up|33|||
33220857|NCT00118898|100706958|FG000|Overall Study|Withdrawal by Subject|10|||
33220858|NCT00118898|100706959|FG001|Overall Study|Withdrawal by Subject|5|||
33220859|NCT00118898|100706960|FG002|Overall Study|Withdrawal by Subject|8|||
33220860|NCT00118898|100706961|FG003|Overall Study|Withdrawal by Subject|8|||
33220861|NCT00118898|100706958|FG000|Overall Study|Site Closure|33|||
33220862|NCT00118898|100706959|FG001|Overall Study|Site Closure|31|||
33220863|NCT00118898|100706960|FG002|Overall Study|Site Closure|28|||
33220864|NCT00118898|100706961|FG003|Overall Study|Site Closure|37|||
33220865|NCT00118898|100706958|FG000|Overall Study|Severe debilitation|1|||
33220866|NCT00118898|100706959|FG001|Overall Study|Severe debilitation|4|||
33220867|NCT00118898|100706960|FG002|Overall Study|Severe debilitation|6|||
33220868|NCT00118898|100706961|FG003|Overall Study|Severe debilitation|4|||
33220869|NCT00118898|100706958|FG000|Overall Study|Not compliant with requirements|11|||
33220870|NCT00118898|100706959|FG001|Overall Study|Not compliant with requirements|13|||
33220871|NCT00118898|100706960|FG002|Overall Study|Not compliant with requirements|11|||
33220872|NCT00118898|100706961|FG003|Overall Study|Not compliant with requirements|11|||
33220873|NCT00118898|100706958|FG000|Overall Study|Not able to get to clinic|34|||
33220874|NCT00118898|100706959|FG001|Overall Study|Not able to get to clinic|43|||
33220875|NCT00118898|100706960|FG002|Overall Study|Not able to get to clinic|31|||
33220876|NCT00118898|100706961|FG003|Overall Study|Not able to get to clinic|40|||
33220877|NCT00152464|100706965|FG000|Overall Study|Adverse Event|3|||
33220878|NCT00152464|100706966|FG001|Overall Study|Adverse Event|6|||
33220879|NCT00152464|100706965|FG000|Overall Study|Lost to Follow-up|8|||
33220880|NCT00152464|100706966|FG001|Overall Study|Lost to Follow-up|4|||
33220881|NCT00152464|100706965|FG000|Overall Study|Protocol Violation|3|||
33220882|NCT00152464|100706966|FG001|Overall Study|Protocol Violation|1|||
33220883|NCT00152464|100706965|FG000|Overall Study|Withdrawal by Subject|21|||
33220884|NCT00152464|100706966|FG001|Overall Study|Withdrawal by Subject|22|||
33220885|NCT00152464|100706965|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
33220886|NCT00152464|100706966|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
33220887|NCT00152464|100706965|FG000|Overall Study|Eczema deterioration|0|||
33220888|NCT00152464|100706966|FG001|Overall Study|Eczema deterioration|1|||
33220889|NCT00152464|100706965|FG000|Overall Study|Parent decision|1|||
33220890|NCT00152464|100706966|FG001|Overall Study|Parent decision|1|||
33220891|NCT00152464|100706965|FG000|Overall Study|Investigator decision|1|||
33220892|NCT00152464|100706966|FG001|Overall Study|Investigator decision|0|||
33220893|NCT00152464|100706965|FG000|Overall Study|Lack of Efficacy|1|||
33220894|NCT00152464|100706966|FG001|Overall Study|Lack of Efficacy|0|||
33220895|NCT00152464|100706965|FG000|Overall Study|Eczema poorly controlled|1|||
33220896|NCT00152464|100706966|FG001|Overall Study|Eczema poorly controlled|0|||
33220897|NCT00152464|100706965|FG000|Overall Study|Patient relocated|1|||
33220898|NCT00152464|100706966|FG001|Overall Study|Patient relocated|0|||
33360457|NCT00510692|101207470|FG000|Overall Study|Withdrawal by Subject|1|||
33360458|NCT00510692|101207471|FG001|Overall Study|Withdrawal by Subject|0|||
33561845|NCT00050011|101951849|FG001|Overall Study|Lack of Efficacy|21|||
33561846|NCT00050011|101951848|FG000|Overall Study|Participant condition no longer required|1|||
33625531|NCT02796677|102180768|FG003|Overall Study|Adverse Event|14|||
33220899|NCT03040713|100706969|FG000|Overall Study|Positive amyloid scan|3|||
33220900|NCT01077544|100706970|FG000|Overall Study|New Cancer Therapy|3|||
33220901|NCT01077544|100706971|FG001|Overall Study|New Cancer Therapy|3|||
33220902|NCT01077544|100706970|FG000|Overall Study|Adverse Event|0|||
33220903|NCT01077544|100706971|FG001|Overall Study|Adverse Event|1|||
33220904|NCT01077544|100706970|FG000|Overall Study|Disease Progression|0|||
33220905|NCT01077544|100706971|FG001|Overall Study|Disease Progression|1|||
33220906|NCT03445065|100706978|FG000|Overall Study|Withdrawal by Subject|3|||
33220907|NCT03445065|100706979|FG001|Overall Study|Withdrawal by Subject|6|||
33220908|NCT03445065|100706980|FG002|Overall Study|Withdrawal by Subject|2|||
33625532|NCT02796677|102180765|FG000|Overall Study|Protocol Violation|7|||
33220909|NCT03445065|100706981|FG003|Overall Study|Withdrawal by Subject|2|||
33220910|NCT03445065|100706978|FG000|Overall Study|Other|4|||
33220911|NCT03445065|100706979|FG001|Overall Study|Other|3|||
33220912|NCT03445065|100706980|FG002|Overall Study|Other|3|||
33220913|NCT03445065|100706981|FG003|Overall Study|Other|1|||
33220914|NCT00571701|100706987|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
33220915|NCT00571701|100706988|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
33220916|NCT00571701|100706987|FG000|First Intervention 12 Months|Death|1|||
33220917|NCT00571701|100706988|FG001|First Intervention 12 Months|Death|0|||
33220918|NCT00571701|100706987|FG000|Second Intervention 12 Months|Adverse Event|0|||
33220919|NCT00571701|100706988|FG001|Second Intervention 12 Months|Adverse Event|1|||
33220920|NCT00571701|100706987|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
33220921|NCT00571701|100706988|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
33220922|NCT00539279|100706993|FG000|Treatment|Withdrawal by Subject|10|||
33220923|NCT00539279|100706994|FG001|Treatment|Withdrawal by Subject|8|||
33625533|NCT02796677|102180766|FG001|Overall Study|Protocol Violation|5|||
33625534|NCT02796677|102180767|FG002|Overall Study|Protocol Violation|4|||
33625535|NCT02796677|102180768|FG003|Overall Study|Protocol Violation|8|||
33625536|NCT02796677|102180765|FG000|Overall Study|Lost to Follow-up|1|||
33625537|NCT02796677|102180766|FG001|Overall Study|Lost to Follow-up|5|||
33625538|NCT02796677|102180767|FG002|Overall Study|Lost to Follow-up|2|||
33625539|NCT02796677|102180768|FG003|Overall Study|Lost to Follow-up|2|||
33625540|NCT02796677|102180765|FG000|Overall Study|Lack of Efficacy|7|||
33625541|NCT02796677|102180766|FG001|Overall Study|Lack of Efficacy|9|||
33625542|NCT02796677|102180767|FG002|Overall Study|Lack of Efficacy|14|||
33625543|NCT02796677|102180768|FG003|Overall Study|Lack of Efficacy|20|||
33625544|NCT02796677|102180765|FG000|Overall Study|Withdrawal by Subject|4|||
33625545|NCT02796677|102180766|FG001|Overall Study|Withdrawal by Subject|14|||
33625546|NCT02796677|102180767|FG002|Overall Study|Withdrawal by Subject|6|||
33625547|NCT02796677|102180768|FG003|Overall Study|Withdrawal by Subject|7|||
33220924|NCT00539279|100706993|FG000|Treatment|Death|1|||
33220925|NCT00539279|100706994|FG001|Treatment|Death|0|||
33220926|NCT00539279|100706993|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
33220927|NCT00539279|100706994|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
33220928|NCT00539279|100706993|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
33625548|NCT02796677|102180765|FG000|Overall Study|Progressive disease|6|||
33220929|NCT00539279|100706994|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
33220930|NCT05168579|100707004|FG000|Overall Study|Lack of Consent|1|||
33625549|NCT02796677|102180766|FG001|Overall Study|Progressive disease|15|||
33220931|NCT05168579|100707005|FG001|Overall Study|Lack of Consent|0|||
33625550|NCT02796677|102180767|FG002|Overall Study|Progressive disease|13|||
33625551|NCT02796677|102180768|FG003|Overall Study|Progressive disease|18|||
33220932|NCT05168579|100707004|FG000|Overall Study|Conflicts with time|2|||
33220933|NCT05168579|100707005|FG001|Overall Study|Conflicts with time|0|||
33220934|NCT05168579|100707004|FG000|Overall Study|Time slots were full|3|||
33220935|NCT05168579|100707005|FG001|Overall Study|Time slots were full|0|||
33220936|NCT05168579|100707004|FG000|Overall Study|Lost to Follow-up|0|||
33220937|NCT05168579|100707005|FG001|Overall Study|Lost to Follow-up|15|||
33220938|NCT03078816|100707006|FG000|Overall Study|Withdrawal by Subject|1|||
33220939|NCT00844857|100707014|FG000|Overall Study|Adverse Event|24|||
33220940|NCT00844857|100707015|FG001|Overall Study|Adverse Event|5|||
33220941|NCT00844857|100707014|FG000|Overall Study|Sponsor Decision|1|||
33220942|NCT00844857|100707015|FG001|Overall Study|Sponsor Decision|1|||
33220943|NCT00844857|100707014|FG000|Overall Study|Physician Decision|2|||
33220944|NCT00844857|100707015|FG001|Overall Study|Physician Decision|0|||
33220945|NCT00844857|100707014|FG000|Overall Study|Parent/Caregiver Decision|6|||
33220946|NCT00844857|100707015|FG001|Overall Study|Parent/Caregiver Decision|2|||
33220947|NCT00844857|100707014|FG000|Overall Study|Withdrawal by Subject|8|||
33220948|NCT00844857|100707015|FG001|Overall Study|Withdrawal by Subject|7|||
33220949|NCT00844857|100707014|FG000|Overall Study|Protocol Violation|6|||
33220950|NCT00844857|100707015|FG001|Overall Study|Protocol Violation|0|||
33220951|NCT00844857|100707014|FG000|Overall Study|Lack of Efficacy|5|||
33220952|NCT00844857|100707015|FG001|Overall Study|Lack of Efficacy|5|||
33220953|NCT00844857|100707014|FG000|Overall Study|Clinical Relapse|0|||
33220954|NCT00844857|100707015|FG001|Overall Study|Clinical Relapse|1|||
33220955|NCT00844857|100707014|FG000|Overall Study|Entry Criteria Not Met|0|||
33220956|NCT00844857|100707015|FG001|Overall Study|Entry Criteria Not Met|1|||
33220957|NCT00844857|100707014|FG000|Overall Study|Lost to Follow-up|2|||
33220958|NCT00844857|100707015|FG001|Overall Study|Lost to Follow-up|3|||
33220959|NCT00844857|100707014|FG000|Overall Study|Did Not Take Study Drug|3|||
33220960|NCT00844857|100707015|FG001|Overall Study|Did Not Take Study Drug|1|||
33220961|NCT00844857|100707014|FG000|Overall Study|Good Clinical Practice Violations|21|||
33220962|NCT00844857|100707015|FG001|Overall Study|Good Clinical Practice Violations|11|||
33220963|NCT00790452|100707016|FG000|Overall Study|Drug supply issue|1|||
33220964|NCT00790452|100707017|FG001|Overall Study|Drug supply issue|0|||
33220965|NCT02158884|100707024|FG000|Baseline Assessment|Missed performance assessment|3|||
33220966|NCT02158884|100707024|FG000|Baseline Assessment|Missed SMFA|1|||
33220967|NCT02158884|100707024|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
33220968|NCT02158884|100707024|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
33220969|NCT02158884|100707024|FG000|6 Month Assessment|Missed SMFA|20|||
33220970|NCT02158884|100707024|FG000|12 Month Assessment|Missed SMFA|17|||
33220971|NCT01301391|100707028|FG000|Overall Study|Death|13|||
33220972|NCT01301391|100707028|FG000|Overall Study|Lost to Follow-up|3|||
33220973|NCT01301391|100707028|FG000|Overall Study|Physician Decision|2|||
33220974|NCT01301391|100707028|FG000|Overall Study|Sponsor's decision|8|||
33561847|NCT00050011|101951849|FG001|Overall Study|Participant condition no longer required|0|||
33561848|NCT00050011|101951848|FG000|Overall Study|Protocol Violation|4|||
33561849|NCT00050011|101951849|FG001|Overall Study|Protocol Violation|10|||
33561850|NCT00050011|101951848|FG000|Overall Study|Withdrawal by Subject|34|||
33561851|NCT00050011|101951849|FG001|Overall Study|Withdrawal by Subject|26|||
33561852|NCT00050011|101951848|FG000|Overall Study|Lost to Follow-up|7|||
33561853|NCT00050011|101951849|FG001|Overall Study|Lost to Follow-up|9|||
33561854|NCT00050011|101951848|FG000|Overall Study|Administrative problems|10|||
33561855|NCT00050011|101951849|FG001|Overall Study|Administrative problems|6|||
33561856|NCT00050011|101951848|FG000|Overall Study|Death|7|||
33561857|NCT00050011|101951849|FG001|Overall Study|Death|4|||
33561858|NCT00050011|101951848|FG000|Overall Study|Unknown - Reason is missing|0|||
33220975|NCT01806584|100707029|FG000|Overall Study|Adverse Event|2|||
33220976|NCT01806584|100707030|FG001|Overall Study|Adverse Event|1|||
33360459|NCT00090285|101207481|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
33360460|NCT00090285|101207482|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
33561859|NCT00050011|101951849|FG001|Overall Study|Unknown - Reason is missing|2|||
33220977|NCT01806584|100707029|FG000|Overall Study|Death|1|||
33220978|NCT01806584|100707030|FG001|Overall Study|Death|0|||
33220979|NCT01806584|100707029|FG000|Overall Study|Lost to Follow-up|0|||
33220980|NCT01806584|100707030|FG001|Overall Study|Lost to Follow-up|2|||
33220981|NCT01806584|100707029|FG000|Overall Study|Study terminated by sponsor|9|||
33220982|NCT01806584|100707030|FG001|Overall Study|Study terminated by sponsor|14|||
33360461|NCT00090285|101207483|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
33561860|NCT03004183|101951850|FG000|Overall Study|Adverse Event|7|||
33561861|NCT03004183|101951850|FG000|Overall Study|Lost to Follow-up|1|||
33561862|NCT03004183|101951850|FG000|Overall Study|Physician Decision|40|||
33561863|NCT03004183|101951850|FG000|Overall Study|Withdrawal by Subject|1|||
33561864|NCT03004183|101951850|FG000|Overall Study|COVID-19|1|||
33561865|NCT04204902|101951854|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
33561866|NCT04204902|101951855|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
33561867|NCT01421459|101951858|FG000|Overall Study|Adverse Event|6|||
33561868|NCT01421459|101951859|FG001|Overall Study|Adverse Event|10|||
33561869|NCT01421459|101951858|FG000|Overall Study|Death|1|||
33561870|NCT01421459|101951859|FG001|Overall Study|Death|1|||
33561871|NCT01421459|101951858|FG000|Overall Study|Lack of Efficacy|1|||
33561872|NCT01421459|101951859|FG001|Overall Study|Lack of Efficacy|2|||
33625552|NCT02796677|102180765|FG000|Overall Study|Reason not mentioned|2|||
33625553|NCT02796677|102180766|FG001|Overall Study|Reason not mentioned|3|||
33625554|NCT02796677|102180767|FG002|Overall Study|Reason not mentioned|0|||
33625555|NCT02796677|102180768|FG003|Overall Study|Reason not mentioned|5|||
33625556|NCT00849940|102180777|FG000|Overall Study|Physician Decision|4|||
33625557|NCT00528112|102180778|FG000|Treatment up to 3 Years|Adverse Event|313|||
33561873|NCT01421459|101951858|FG000|Overall Study|Lost to Follow-up|8|||
33561874|NCT01421459|101951859|FG001|Overall Study|Lost to Follow-up|9|||
33561875|NCT01421459|101951858|FG000|Overall Study|Physician Decision|9|||
33561876|NCT01421459|101951859|FG001|Overall Study|Physician Decision|9|||
33561877|NCT01421459|101951858|FG000|Overall Study|Protocol Violation|8|||
33561878|NCT01421459|101951859|FG001|Overall Study|Protocol Violation|5|||
33625558|NCT00528112|102180779|FG001|Treatment up to 3 Years|Adverse Event|278|||
33625559|NCT00528112|102180778|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
33625560|NCT00528112|102180779|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
33561879|NCT01421459|101951858|FG000|Overall Study|Withdrawal by Subject|12|||
33561880|NCT01421459|101951859|FG001|Overall Study|Withdrawal by Subject|16|||
33561881|NCT02595437|101951860|FG000|Triferic Via IV|Withdrawal by Subject|1|||
33561882|NCT01773889|101951861|FG000|Overall Study|lack of funding|2|||
33561883|NCT01681849|101951863|FG000|Overall Study|Protocol Violation|2|||
33561884|NCT01681849|101951864|FG001|Overall Study|Protocol Violation|0|||
33561885|NCT01681849|101951865|FG002|Overall Study|Protocol Violation|0|||
33561886|NCT01681849|101951863|FG000|Overall Study|Withdrawal by Subject|3|||
33561887|NCT01681849|101951864|FG001|Overall Study|Withdrawal by Subject|5|||
33561888|NCT01681849|101951865|FG002|Overall Study|Withdrawal by Subject|33|||
33561889|NCT01681849|101951863|FG000|Overall Study|Lost to Follow-up|3|||
33561890|NCT01681849|101951864|FG001|Overall Study|Lost to Follow-up|2|||
33561891|NCT01681849|101951865|FG002|Overall Study|Lost to Follow-up|6|||
33561892|NCT02769481|101951872|FG000|Overall Study|Protocol Violation|1|||
33561893|NCT02769481|101951873|FG001|Overall Study|Protocol Violation|0|||
33561894|NCT02769481|101951872|FG000|Overall Study|Adverse Event|3|||
33561895|NCT02769481|101951873|FG001|Overall Study|Adverse Event|6|||
33625561|NCT00528112|102180778|FG000|Treatment up to 3 Years|Protocol Violation|16|||
33625562|NCT00528112|102180779|FG001|Treatment up to 3 Years|Protocol Violation|16|||
33625563|NCT00528112|102180778|FG000|Treatment up to 3 Years|Death|0|||
33625564|NCT00528112|102180779|FG001|Treatment up to 3 Years|Death|1|||
33625565|NCT00528112|102180778|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
33625566|NCT00528112|102180779|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
33625567|NCT00528112|102180778|FG000|Treatment up to 3 Years|Pregnancy|9|||
33561896|NCT02769481|101951872|FG000|Overall Study|Entry Criteria Not Met|1|||
33561897|NCT02769481|101951873|FG001|Overall Study|Entry Criteria Not Met|2|||
33561898|NCT02769481|101951872|FG000|Overall Study|Withdrawal by Subject|14|||
33625568|NCT00528112|102180779|FG001|Treatment up to 3 Years|Pregnancy|10|||
33625569|NCT00528112|102180778|FG000|Treatment up to 3 Years|Other reasons|186|||
33625570|NCT00528112|102180779|FG001|Treatment up to 3 Years|Other reasons|186|||
33625571|NCT00528112|102180778|FG000|Extension Phase|Withdrawal by Subject|0|||
33625572|NCT00528112|102180779|FG001|Extension Phase|Withdrawal by Subject|3|||
33625573|NCT00528112|102180778|FG000|Extension Phase|Other reasons|0|||
33625574|NCT00528112|102180779|FG001|Extension Phase|Other reasons|100|||
33625575|NCT00528112|102180778|FG000|Extension Phase|Pregnancy|0|||
33625576|NCT00528112|102180779|FG001|Extension Phase|Pregnancy|3|||
33625577|NCT00528112|102180778|FG000|Extension Phase|Lost to Follow-up|0|||
33625578|NCT00528112|102180779|FG001|Extension Phase|Lost to Follow-up|12|||
33561899|NCT02769481|101951873|FG001|Overall Study|Withdrawal by Subject|16|||
33561900|NCT02769481|101951872|FG000|Overall Study|Lost to Follow-up|9|||
33561901|NCT02769481|101951873|FG001|Overall Study|Lost to Follow-up|9|||
33625579|NCT00528112|102180778|FG000|Extension Phase|Death|0|||
33625580|NCT00528112|102180779|FG001|Extension Phase|Death|1|||
33625581|NCT00528112|102180778|FG000|Extension Phase|Adverse Event|0|||
33561902|NCT02769481|101951872|FG000|Overall Study|Physician Decision|0|||
33561903|NCT02769481|101951873|FG001|Overall Study|Physician Decision|1|||
33561904|NCT02769481|101951872|FG000|Overall Study|Terminated by Sponsor|1|||
33625582|NCT00528112|102180779|FG001|Extension Phase|Adverse Event|36|||
33625583|NCT00528112|102180778|FG000|Extension Phase|Protocol Violation|0|||
33625584|NCT00528112|102180779|FG001|Extension Phase|Protocol Violation|2|||
33561905|NCT02769481|101951873|FG001|Overall Study|Terminated by Sponsor|0|||
33561906|NCT02769481|101951872|FG000|Overall Study|Death|0|||
33360462|NCT00090285|101207484|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
33360463|NCT00090285|101207485|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
33360464|NCT00090285|101207486|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
33360465|NCT00090285|101207481|FG000|Base Study Vaccination Period|Adverse Event|2|||
33360466|NCT00090285|101207482|FG001|Base Study Vaccination Period|Adverse Event|4|||
33360467|NCT00090285|101207483|FG002|Base Study Vaccination Period|Adverse Event|0|||
33360468|NCT00090285|101207484|FG003|Base Study Vaccination Period|Adverse Event|0|||
33360469|NCT00090285|101207485|FG004|Base Study Vaccination Period|Adverse Event|0|||
33360470|NCT00090285|101207486|FG005|Base Study Vaccination Period|Adverse Event|0|||
33360471|NCT00090285|101207481|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
33360472|NCT00090285|101207482|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
33360473|NCT00090285|101207483|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
33360474|NCT00090285|101207484|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
33360475|NCT00090285|101207485|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
33360476|NCT00090285|101207486|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
33360477|NCT00090285|101207481|FG000|Base Study Vaccination Period|Protocol Violation|2|||
33360478|NCT00090285|101207482|FG001|Base Study Vaccination Period|Protocol Violation|3|||
33360479|NCT00090285|101207483|FG002|Base Study Vaccination Period|Protocol Violation|0|||
33360480|NCT00090285|101207484|FG003|Base Study Vaccination Period|Protocol Violation|0|||
33360481|NCT00090285|101207485|FG004|Base Study Vaccination Period|Protocol Violation|0|||
33360482|NCT00090285|101207486|FG005|Base Study Vaccination Period|Protocol Violation|0|||
33360483|NCT00090285|101207481|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
33360484|NCT00090285|101207482|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
33360485|NCT00090285|101207483|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
33360486|NCT00090285|101207484|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
33360487|NCT00090285|101207485|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
33360488|NCT00090285|101207486|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
33360489|NCT00090285|101207481|FG000|Base Study Vaccination Period|Uncooperative|2|||
33360490|NCT00090285|101207482|FG001|Base Study Vaccination Period|Uncooperative|2|||
33360491|NCT00090285|101207483|FG002|Base Study Vaccination Period|Uncooperative|0|||
33360492|NCT00090285|101207484|FG003|Base Study Vaccination Period|Uncooperative|0|||
33360493|NCT00090285|101207485|FG004|Base Study Vaccination Period|Uncooperative|0|||
33360494|NCT00090285|101207486|FG005|Base Study Vaccination Period|Uncooperative|0|||
33360495|NCT00090285|101207481|FG000|Base Study Vaccination Period|Moved|20|||
33360496|NCT00090285|101207482|FG001|Base Study Vaccination Period|Moved|21|||
33360497|NCT00090285|101207483|FG002|Base Study Vaccination Period|Moved|0|||
33360498|NCT00090285|101207484|FG003|Base Study Vaccination Period|Moved|0|||
33360499|NCT00090285|101207485|FG004|Base Study Vaccination Period|Moved|0|||
33360500|NCT00090285|101207486|FG005|Base Study Vaccination Period|Moved|0|||
33360501|NCT00090285|101207481|FG000|Base Study Vaccination Period|Site Terminated|1|||
33360502|NCT00090285|101207482|FG001|Base Study Vaccination Period|Site Terminated|0|||
33360503|NCT00090285|101207483|FG002|Base Study Vaccination Period|Site Terminated|0|||
33360504|NCT00090285|101207484|FG003|Base Study Vaccination Period|Site Terminated|0|||
33360505|NCT00090285|101207485|FG004|Base Study Vaccination Period|Site Terminated|0|||
33360506|NCT00090285|101207486|FG005|Base Study Vaccination Period|Site Terminated|0|||
33360507|NCT00090285|101207481|FG000|Base Study Vaccination Period|Other|2|||
33360508|NCT00090285|101207482|FG001|Base Study Vaccination Period|Other|2|||
33360509|NCT00090285|101207483|FG002|Base Study Vaccination Period|Other|0|||
33360510|NCT00090285|101207484|FG003|Base Study Vaccination Period|Other|0|||
33360511|NCT00090285|101207485|FG004|Base Study Vaccination Period|Other|0|||
33360512|NCT00090285|101207486|FG005|Base Study Vaccination Period|Other|0|||
33360513|NCT00090285|101207481|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
33360514|NCT00090285|101207482|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
33360515|NCT00090285|101207483|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
33360516|NCT00090285|101207484|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
33360517|NCT00090285|101207485|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
33360518|NCT00090285|101207486|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
33360519|NCT00090285|101207481|FG000|Base Study Vaccination Period|HIV positive|1|||
33360520|NCT00090285|101207482|FG001|Base Study Vaccination Period|HIV positive|1|||
33360521|NCT00090285|101207483|FG002|Base Study Vaccination Period|HIV positive|0|||
33360522|NCT00090285|101207484|FG003|Base Study Vaccination Period|HIV positive|0|||
33360523|NCT00090285|101207485|FG004|Base Study Vaccination Period|HIV positive|0|||
33360524|NCT00090285|101207486|FG005|Base Study Vaccination Period|HIV positive|0|||
33360525|NCT00090285|101207481|FG000|Base Study Follow-up Period|Adverse Event|3|||
33360526|NCT00090285|101207482|FG001|Base Study Follow-up Period|Adverse Event|10|||
33360527|NCT00090285|101207483|FG002|Base Study Follow-up Period|Adverse Event|0|||
33561907|NCT02769481|101951873|FG001|Overall Study|Death|1|||
33625585|NCT02735239|102180780|FG000|Overall Study|Adverse Event|0|||
33360528|NCT00090285|101207484|FG003|Base Study Follow-up Period|Adverse Event|0|||
33360529|NCT00090285|101207485|FG004|Base Study Follow-up Period|Adverse Event|0|||
33625586|NCT02735239|102180781|FG001|Overall Study|Adverse Event|0|||
33625587|NCT02735239|102180782|FG002|Overall Study|Adverse Event|4|||
33625588|NCT02735239|102180783|FG003|Overall Study|Adverse Event|0|||
33625589|NCT02735239|102180784|FG004|Overall Study|Adverse Event|0|||
33625590|NCT02735239|102180785|FG005|Overall Study|Adverse Event|0|||
33625591|NCT02735239|102180780|FG000|Overall Study|Death|1|||
33625592|NCT02735239|102180781|FG001|Overall Study|Death|1|||
33625593|NCT02735239|102180782|FG002|Overall Study|Death|0|||
33625594|NCT02735239|102180783|FG003|Overall Study|Death|0|||
33625595|NCT02735239|102180784|FG004|Overall Study|Death|0|||
33625596|NCT02735239|102180785|FG005|Overall Study|Death|0|||
33625597|NCT02735239|102180780|FG000|Overall Study|Physician Decision|0|||
33625598|NCT02735239|102180781|FG001|Overall Study|Physician Decision|0|||
33625599|NCT02735239|102180782|FG002|Overall Study|Physician Decision|1|||
33625600|NCT02735239|102180783|FG003|Overall Study|Physician Decision|0|||
33625601|NCT02735239|102180784|FG004|Overall Study|Physician Decision|0|||
33625602|NCT02735239|102180785|FG005|Overall Study|Physician Decision|0|||
33625603|NCT02735239|102180780|FG000|Overall Study|Progressive disease|3|||
33625604|NCT02735239|102180781|FG001|Overall Study|Progressive disease|1|||
33625605|NCT02735239|102180782|FG002|Overall Study|Progressive disease|3|||
33625606|NCT02735239|102180783|FG003|Overall Study|Progressive disease|0|||
33625607|NCT02735239|102180784|FG004|Overall Study|Progressive disease|0|||
33625608|NCT02735239|102180785|FG005|Overall Study|Progressive disease|2|||
33625609|NCT02735239|102180780|FG000|Overall Study|Withdrawal by Subject|0|||
33625610|NCT02735239|102180781|FG001|Overall Study|Withdrawal by Subject|1|||
33625611|NCT02735239|102180782|FG002|Overall Study|Withdrawal by Subject|0|||
33625612|NCT02735239|102180783|FG003|Overall Study|Withdrawal by Subject|0|||
33625613|NCT02735239|102180784|FG004|Overall Study|Withdrawal by Subject|0|||
33625614|NCT02735239|102180785|FG005|Overall Study|Withdrawal by Subject|0|||
33625615|NCT01643668|102180786|FG000|Overall Study|Death|1|||
33625616|NCT01350999|102180787|FG000|Overall Study|Adverse Event|4|||
33625617|NCT01350999|102180788|FG001|Overall Study|Adverse Event|9|||
33625618|NCT01350999|102180789|FG002|Overall Study|Adverse Event|10|||
33625619|NCT01350999|102180787|FG000|Overall Study|Voluntary withdrawal|3|||
33625620|NCT01350999|102180788|FG001|Overall Study|Voluntary withdrawal|4|||
33625621|NCT01350999|102180789|FG002|Overall Study|Voluntary withdrawal|6|||
33625622|NCT01350999|102180787|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
33625623|NCT01350999|102180788|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
33625624|NCT01350999|102180789|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
33625625|NCT02738008|102180790|FG000|Overall Study|Study Terminated by Sponsor|1|||
33625626|NCT02738008|102180791|FG001|Overall Study|Study Terminated by Sponsor|5|||
33625627|NCT02738008|102180792|FG002|Overall Study|Study Terminated by Sponsor|3|||
33625628|NCT02738008|102180790|FG000|Overall Study|Adverse Event|0|||
33625629|NCT02738008|102180791|FG001|Overall Study|Adverse Event|1|||
33625630|NCT02738008|102180792|FG002|Overall Study|Adverse Event|2|||
33220983|NCT01806584|100707029|FG000|Overall Study|Withdrawal by Subject|1|||
33220984|NCT01806584|100707030|FG001|Overall Study|Withdrawal by Subject|1|||
33220985|NCT01806584|100707029|FG000|Overall Study|Other unspecified|1|||
33220986|NCT01806584|100707030|FG001|Overall Study|Other unspecified|0|||
33220987|NCT00420199|100707031|FG000|Overall Study|Participant no longer met study criteria|1|||
33220988|NCT00420199|100707032|FG001|Overall Study|Participant no longer met study criteria|0|||
33220989|NCT02979639|100707033|FG000|Overall Study|Withdrawal based on medical judgement|1|||
33220990|NCT02979639|100707033|FG000|Overall Study|Lost to Follow-up|8|||
33220991|NCT02979639|100707033|FG000|Overall Study|Withdrawal by Subject|3|||
33220992|NCT02979639|100707033|FG000|Overall Study|Adverse Event|2|||
33220993|NCT02839343|100707037|FG000|Overall Study|Withdrawal by Subject|3|||
33220994|NCT02839343|100707038|FG001|Overall Study|Withdrawal by Subject|1|||
33220995|NCT02839343|100707037|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
33220996|NCT02839343|100707038|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
33220997|NCT02839343|100707037|FG000|Overall Study|Adverse Event|1|||
33625631|NCT00844844|102180793|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
33625632|NCT00844844|102180793|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
33625633|NCT00844844|102180793|FG000|Extension Treatment Period|Adverse Event|2|||
33625634|NCT00844844|102180793|FG000|Post Treatment Period|Withdrawal by Subject|1|||
33220998|NCT02839343|100707038|FG001|Overall Study|Adverse Event|0|||
33625635|NCT01602224|102180797|FG000|Overall Study|Adverse Event|0|||
33625636|NCT01602224|102180798|FG001|Overall Study|Adverse Event|1|||
33625637|NCT01602224|102180799|FG002|Overall Study|Adverse Event|0|||
33625638|NCT01602224|102180797|FG000|Overall Study|Investigator Decison|1|||
33625639|NCT01602224|102180798|FG001|Overall Study|Investigator Decison|0|||
33220999|NCT01119898|100707044|FG000|Overall Study|Adverse Event|4|||
33625640|NCT01602224|102180799|FG002|Overall Study|Investigator Decison|0|||
33625641|NCT01602224|102180797|FG000|Overall Study|Lost to Follow-up|0|||
33625642|NCT01602224|102180798|FG001|Overall Study|Lost to Follow-up|0|||
33625643|NCT01602224|102180799|FG002|Overall Study|Lost to Follow-up|1|||
33625644|NCT01602224|102180797|FG000|Overall Study|Protocol Violation|0|||
33625645|NCT01602224|102180798|FG001|Overall Study|Protocol Violation|1|||
33625646|NCT01602224|102180799|FG002|Overall Study|Protocol Violation|0|||
33625647|NCT01602224|102180797|FG000|Overall Study|Sponsor Decision|2|||
33561908|NCT02769481|101951872|FG000|Overall Study|Undefined|4|||
33561909|NCT02769481|101951873|FG001|Overall Study|Undefined|1|||
33561910|NCT00912509|101951874|FG000|Overall Study|Lost to Follow-up|1|||
33360530|NCT00090285|101207486|FG005|Base Study Follow-up Period|Adverse Event|0|||
33360531|NCT00090285|101207481|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
33360532|NCT00090285|101207482|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
33360533|NCT00090285|101207483|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
33360534|NCT00090285|101207484|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
33625648|NCT01602224|102180798|FG001|Overall Study|Sponsor Decision|3|||
33625649|NCT01602224|102180799|FG002|Overall Study|Sponsor Decision|2|||
33625650|NCT01602224|102180797|FG000|Overall Study|Withdrawal by Subject|5|||
33360535|NCT00090285|101207485|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
33360536|NCT00090285|101207486|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
33360537|NCT00090285|101207481|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
33360538|NCT00090285|101207482|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
33360539|NCT00090285|101207483|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
33360540|NCT00090285|101207484|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
33360541|NCT00090285|101207485|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
33625651|NCT01602224|102180798|FG001|Overall Study|Withdrawal by Subject|3|||
33625652|NCT01602224|102180799|FG002|Overall Study|Withdrawal by Subject|3|||
33625653|NCT01329978|102180801|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
33625654|NCT01329978|102180802|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
33625655|NCT01329978|102180803|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
33625656|NCT01329978|102180804|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
33625657|NCT01329978|102180805|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
33625658|NCT01329978|102180801|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
33625659|NCT01329978|102180802|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
33360542|NCT00090285|101207486|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
33360543|NCT00090285|101207481|FG000|Base Study Follow-up Period|Moved|41|||
33360544|NCT00090285|101207482|FG001|Base Study Follow-up Period|Moved|36|||
33360545|NCT00090285|101207483|FG002|Base Study Follow-up Period|Moved|0|||
33360546|NCT00090285|101207484|FG003|Base Study Follow-up Period|Moved|0|||
33561911|NCT00912509|101951875|FG001|Overall Study|Lost to Follow-up|0|||
33561912|NCT00912509|101951874|FG000|Overall Study|Lack of Efficacy|4|||
33561913|NCT00912509|101951875|FG001|Overall Study|Lack of Efficacy|3|||
33561914|NCT01689649|101954499|FG000|Overall Study|Lack of Efficacy|3|||
33561915|NCT01689649|101954499|FG000|Overall Study|Non-compliance|11|||
33561916|NCT01689649|101954499|FG000|Overall Study|Protocol Violation|3|||
33561917|NCT01689649|101954499|FG000|Overall Study|Lost to Follow-up|5|||
33561918|NCT03773562|101954500|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
33561919|NCT03773562|101954500|FG000|Overall Study|Lost to Follow-up|10|||
33561920|NCT03773562|101954500|FG000|Overall Study|Withdrawal by Subject|1|||
33561921|NCT02837952|101954505|FG000|Overall Study|Adverse Event|0|||
33561922|NCT02837952|101954506|FG001|Overall Study|Adverse Event|1|||
33561923|NCT02837952|101954505|FG000|Overall Study|Withdrawal by Subject|4|||
33561924|NCT02837952|101954506|FG001|Overall Study|Withdrawal by Subject|5|||
33561925|NCT02837952|101954505|FG000|Overall Study|Medication Error|1|||
33561926|NCT02837952|101954506|FG001|Overall Study|Medication Error|0|||
33561927|NCT00663260|101954509|FG000|Overall Study|Lack of Efficacy|2|||
33561928|NCT00663260|101954510|FG001|Overall Study|Lack of Efficacy|0|||
33561929|NCT00663260|101954511|FG002|Overall Study|Lack of Efficacy|0|||
33561930|NCT00663260|101954509|FG000|Overall Study|Adverse Event|12|||
33561931|NCT00663260|101954510|FG001|Overall Study|Adverse Event|7|||
33561932|NCT00663260|101954511|FG002|Overall Study|Adverse Event|6|||
33561933|NCT00663260|101954509|FG000|Overall Study|Withdrawal by Subject|3|||
33561934|NCT00663260|101954510|FG001|Overall Study|Withdrawal by Subject|1|||
33561935|NCT00663260|101954511|FG002|Overall Study|Withdrawal by Subject|6|||
33561936|NCT00663260|101954509|FG000|Overall Study|Death|1|||
33561937|NCT00663260|101954510|FG001|Overall Study|Death|0|||
33561938|NCT00663260|101954511|FG002|Overall Study|Death|1|||
33561939|NCT00663260|101954509|FG000|Overall Study|Lost to Follow-up|0|||
33561940|NCT00663260|101954510|FG001|Overall Study|Lost to Follow-up|1|||
33561941|NCT00663260|101954511|FG002|Overall Study|Lost to Follow-up|0|||
33561942|NCT00663260|101954509|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
33561943|NCT00663260|101954510|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
33561944|NCT00663260|101954511|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
33561945|NCT00605657|101954512|FG000|Overall Study|Adverse Event|1|||
33561946|NCT00605657|101954512|FG000|Overall Study|Protocol Violation|1|||
33561947|NCT05333965|101954515|FG000|First Intervention|Adverse Event|0|||
33625660|NCT01329978|102180803|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
33625661|NCT01329978|102180804|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
33625662|NCT01329978|102180805|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
33625663|NCT01329978|102180801|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
33360547|NCT00090285|101207485|FG004|Base Study Follow-up Period|Moved|0|||
33360548|NCT00090285|101207486|FG005|Base Study Follow-up Period|Moved|0|||
33360549|NCT00090285|101207481|FG000|Base Study Follow-up Period|Other|2|||
33360550|NCT00090285|101207482|FG001|Base Study Follow-up Period|Other|0|||
33561948|NCT05333965|101954516|FG001|First Intervention|Adverse Event|1|||
33561949|NCT05333965|101954515|FG000|First Intervention|Withdrawal by Subject|0|||
33561950|NCT05333965|101954516|FG001|First Intervention|Withdrawal by Subject|1|||
33561951|NCT03400787|101954517|FG000|Overall Study|Lost to Follow-up|1|||
33561952|NCT03400787|101954518|FG001|Overall Study|Lost to Follow-up|0|||
33561953|NCT03400787|101954517|FG000|Overall Study|Death|1|||
33625664|NCT01329978|102180802|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
33625665|NCT01329978|102180803|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
33625666|NCT01329978|102180804|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
33561954|NCT03400787|101954518|FG001|Overall Study|Death|0|||
33561955|NCT03400787|101954517|FG000|Overall Study|Protocol Violation|0|||
33561956|NCT03400787|101954518|FG001|Overall Study|Protocol Violation|2|||
33561957|NCT03400787|101954517|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
33561958|NCT03400787|101954518|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
33561959|NCT01111552|101954519|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
33561960|NCT01111552|101954520|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33561961|NCT01111552|101954521|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33561962|NCT01111552|101954522|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33561963|NCT01111552|101954523|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33561964|NCT01111552|101954519|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
33561965|NCT01111552|101954520|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33561966|NCT01111552|101954521|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33561967|NCT01111552|101954522|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33561968|NCT01111552|101954523|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33561969|NCT01111552|101954519|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
33561970|NCT01111552|101954520|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33561971|NCT01111552|101954521|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33561972|NCT01111552|101954522|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33561973|NCT01111552|101954523|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33561974|NCT01111552|101954519|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
33561975|NCT01111552|101954520|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
33561976|NCT01111552|101954521|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
33561977|NCT01111552|101954522|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
33561978|NCT01111552|101954523|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
33561979|NCT01111552|101954519|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
33561980|NCT01111552|101954520|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
33561981|NCT01111552|101954521|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
33561982|NCT01111552|101954522|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
33561983|NCT01111552|101954523|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
33561984|NCT01111552|101954519|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
33561985|NCT01111552|101954520|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
33561986|NCT01111552|101954521|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
33625667|NCT01329978|102180805|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
33625668|NCT01329978|102180801|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
33625669|NCT01329978|102180802|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
33625670|NCT01329978|102180803|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
33625671|NCT01329978|102180804|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
33625672|NCT01329978|102180805|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
33625673|NCT01329978|102180801|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
33625674|NCT01329978|102180802|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
33625675|NCT01329978|102180803|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
33625676|NCT01329978|102180804|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
33625677|NCT01329978|102180805|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
33625678|NCT01329978|102180801|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
33625679|NCT01329978|102180802|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
33625680|NCT01329978|102180803|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
33625681|NCT01329978|102180804|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
33625682|NCT01329978|102180805|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
33360551|NCT00090285|101207483|FG002|Base Study Follow-up Period|Other|0|||
33561987|NCT01111552|101954522|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
33360552|NCT00090285|101207484|FG003|Base Study Follow-up Period|Other|0|||
33360553|NCT00090285|101207485|FG004|Base Study Follow-up Period|Other|0|||
33360554|NCT00090285|101207486|FG005|Base Study Follow-up Period|Other|0|||
33561988|NCT01111552|101954523|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
33561989|NCT01111552|101954519|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
33561990|NCT01111552|101954520|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33360555|NCT00090285|101207481|FG000|Base Study Follow-up Period|Protocol Violation|1|||
33360556|NCT00090285|101207482|FG001|Base Study Follow-up Period|Protocol Violation|0|||
33360557|NCT00090285|101207483|FG002|Base Study Follow-up Period|Protocol Violation|0|||
33360558|NCT00090285|101207484|FG003|Base Study Follow-up Period|Protocol Violation|0|||
33360559|NCT00090285|101207485|FG004|Base Study Follow-up Period|Protocol Violation|0|||
33360560|NCT00090285|101207486|FG005|Base Study Follow-up Period|Protocol Violation|0|||
33360561|NCT00090285|101207481|FG000|Base Study Follow-up Period|Uncooperative|3|||
33360562|NCT00090285|101207482|FG001|Base Study Follow-up Period|Uncooperative|4|||
33360563|NCT00090285|101207483|FG002|Base Study Follow-up Period|Uncooperative|0|||
33360564|NCT00090285|101207484|FG003|Base Study Follow-up Period|Uncooperative|0|||
33360565|NCT00090285|101207485|FG004|Base Study Follow-up Period|Uncooperative|0|||
33360566|NCT00090285|101207486|FG005|Base Study Follow-up Period|Uncooperative|0|||
33360567|NCT00090285|101207481|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
33561991|NCT01111552|101954521|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33561992|NCT01111552|101954522|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33561993|NCT01111552|101954523|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33561994|NCT01111552|101954519|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
33561995|NCT01111552|101954520|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
33561996|NCT01111552|101954521|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
33561997|NCT01111552|101954522|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
33561998|NCT01111552|101954523|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
33561999|NCT01111552|101954519|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33562000|NCT01111552|101954520|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33562001|NCT01111552|101954521|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33562002|NCT01111552|101954522|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
33562003|NCT01111552|101954523|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33562004|NCT01111552|101954519|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
33562005|NCT01111552|101954520|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
33562006|NCT01111552|101954521|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
33562007|NCT01111552|101954522|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
33562008|NCT01111552|101954523|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
33562009|NCT01111552|101954519|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
33562010|NCT01111552|101954520|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
33562011|NCT01111552|101954521|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
33562012|NCT01111552|101954522|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
33562013|NCT01111552|101954523|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
33562014|NCT01111552|101954519|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
33562015|NCT01111552|101954520|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
33562016|NCT01111552|101954521|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
33562017|NCT01111552|101954522|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
33562018|NCT01111552|101954523|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
33562019|NCT01111552|101954519|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
33562020|NCT01111552|101954520|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
33562021|NCT01111552|101954521|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
33562022|NCT01111552|101954522|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
33562023|NCT01111552|101954523|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
33562024|NCT01111552|101954519|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33562025|NCT01111552|101954520|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33562026|NCT01111552|101954521|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
33562027|NCT01111552|101954522|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33562028|NCT01111552|101954523|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33562029|NCT02254460|101954524|FG000|Overall Study|Adverse Event|1|||
33360568|NCT00090285|101207482|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
33360569|NCT00090285|101207483|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
33360570|NCT00090285|101207484|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
33360571|NCT00090285|101207485|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
33625683|NCT01329978|102180801|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
33625684|NCT01329978|102180802|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
33625685|NCT01329978|102180803|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
33625686|NCT01329978|102180804|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
33625687|NCT01329978|102180805|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
33625688|NCT00539981|102180806|FG000|Overall Study|Adverse events (AE)|3|||
33625689|NCT00539981|102180807|FG001|Overall Study|Adverse events (AE)|3|||
33625690|NCT00539981|102180806|FG000|Overall Study|Lost to Follow-up|260|||
33625691|NCT00539981|102180807|FG001|Overall Study|Lost to Follow-up|251|||
33625692|NCT00539981|102180806|FG000|Overall Study|Withdrew consent|22|||
33625693|NCT00539981|102180807|FG001|Overall Study|Withdrew consent|14|||
33625694|NCT00539981|102180806|FG000|Overall Study|Death|1|||
33625695|NCT00539981|102180807|FG001|Overall Study|Death|1|||
33625696|NCT00539981|102180806|FG000|Overall Study|Other reason-unspecified|9|||
33625697|NCT00539981|102180807|FG001|Overall Study|Other reason-unspecified|13|||
33625698|NCT02978417|102180808|FG000|Overall Study|Lost to Follow-up|2|||
33625699|NCT02978417|102180809|FG001|Overall Study|Lost to Follow-up|2|||
33625700|NCT01255423|102180810|FG000|Overall Study|Abnormal Laboratory value|3|||
33625701|NCT01255423|102180811|FG001|Overall Study|Abnormal Laboratory value|2|||
33625702|NCT01255423|102180810|FG000|Overall Study|Use of prohibited medications|0|||
33625703|NCT01255423|102180811|FG001|Overall Study|Use of prohibited medications|1|||
33625704|NCT03084796|102180814|FG000|Overall Study|Adverse Event|4|||
33625705|NCT03084796|102180815|FG001|Overall Study|Adverse Event|5|||
33625706|NCT03084796|102180816|FG002|Overall Study|Adverse Event|6|||
33625707|NCT03084796|102180817|FG003|Overall Study|Adverse Event|2|||
33625708|NCT03084796|102180818|FG004|Overall Study|Adverse Event|3|||
33625709|NCT03084796|102180819|FG005|Overall Study|Adverse Event|5|||
33625710|NCT03084796|102180814|FG000|Overall Study|Withdrawal by Subject|3|||
33625711|NCT03084796|102180815|FG001|Overall Study|Withdrawal by Subject|5|||
33625712|NCT03084796|102180816|FG002|Overall Study|Withdrawal by Subject|2|||
33625713|NCT03084796|102180817|FG003|Overall Study|Withdrawal by Subject|1|||
33625714|NCT03084796|102180818|FG004|Overall Study|Withdrawal by Subject|3|||
33625715|NCT03084796|102180819|FG005|Overall Study|Withdrawal by Subject|0|||
33625716|NCT03084796|102180814|FG000|Overall Study|Protocol Violation|0|||
33625717|NCT03084796|102180815|FG001|Overall Study|Protocol Violation|0|||
33360572|NCT00090285|101207486|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
33360573|NCT00090285|101207481|FG000|Extension 1|Adverse Event|0|||
33625718|NCT03084796|102180816|FG002|Overall Study|Protocol Violation|1|||
33625719|NCT03084796|102180817|FG003|Overall Study|Protocol Violation|0|||
33625720|NCT03084796|102180818|FG004|Overall Study|Protocol Violation|1|||
33625721|NCT03084796|102180819|FG005|Overall Study|Protocol Violation|1|||
33360574|NCT00090285|101207482|FG001|Extension 1|Adverse Event|0|||
33360575|NCT00090285|101207483|FG002|Extension 1|Adverse Event|2|||
33360576|NCT00090285|101207484|FG003|Extension 1|Adverse Event|0|||
33360577|NCT00090285|101207485|FG004|Extension 1|Adverse Event|0|||
33360578|NCT00090285|101207486|FG005|Extension 1|Adverse Event|0|||
33360579|NCT00090285|101207481|FG000|Extension 1|Lost to Follow-up|0|||
33360580|NCT00090285|101207482|FG001|Extension 1|Lost to Follow-up|0|||
33360581|NCT00090285|101207483|FG002|Extension 1|Lost to Follow-up|35|||
33360582|NCT00090285|101207484|FG003|Extension 1|Lost to Follow-up|0|||
33360583|NCT00090285|101207485|FG004|Extension 1|Lost to Follow-up|0|||
33360584|NCT00090285|101207486|FG005|Extension 1|Lost to Follow-up|0|||
33360585|NCT00090285|101207481|FG000|Extension 1|Withdrawal by Subject|0|||
33360586|NCT00090285|101207482|FG001|Extension 1|Withdrawal by Subject|0|||
33360587|NCT00090285|101207483|FG002|Extension 1|Withdrawal by Subject|13|||
33360588|NCT00090285|101207484|FG003|Extension 1|Withdrawal by Subject|1|||
33625722|NCT03084796|102180814|FG000|Overall Study|Lack of Efficacy|0|||
33625723|NCT03084796|102180815|FG001|Overall Study|Lack of Efficacy|0|||
33625724|NCT03084796|102180816|FG002|Overall Study|Lack of Efficacy|1|||
33625725|NCT03084796|102180817|FG003|Overall Study|Lack of Efficacy|0|||
33625726|NCT03084796|102180818|FG004|Overall Study|Lack of Efficacy|1|||
33625727|NCT03084796|102180819|FG005|Overall Study|Lack of Efficacy|0|||
33625728|NCT03084796|102180814|FG000|Overall Study|Lost to Follow-up|0|||
33562030|NCT02254460|101954525|FG001|Overall Study|Adverse Event|0|||
33562031|NCT01149460|101954526|FG000|Overall Study|Withdrawal by Subject|0|||
33562032|NCT01149460|101954527|FG001|Overall Study|Withdrawal by Subject|2|||
33562033|NCT01882829|101954528|FG000|Overall Study|Adverse Event|4|||
33562034|NCT01882829|101954528|FG000|Overall Study|Protocol Violation|1|||
33562035|NCT01882829|101954528|FG000|Overall Study|Withdrawal by Subject|1|||
33562036|NCT01629563|101954529|FG000|Overall Study|Adverse Event|16|||
33562037|NCT01629563|101954530|FG001|Overall Study|Adverse Event|16|||
33562038|NCT01629563|101954529|FG000|Overall Study|Death|2|||
33562039|NCT01629563|101954530|FG001|Overall Study|Death|0|||
33562040|NCT01629563|101954529|FG000|Overall Study|Lack of Efficacy|2|||
33562041|NCT01629563|101954530|FG001|Overall Study|Lack of Efficacy|3|||
33562042|NCT01629563|101954529|FG000|Overall Study|Lost to Follow-up|1|||
33562043|NCT01629563|101954530|FG001|Overall Study|Lost to Follow-up|0|||
33562044|NCT01629563|101954529|FG000|Overall Study|Pregnancy|1|||
33562045|NCT01629563|101954530|FG001|Overall Study|Pregnancy|2|||
33221000|NCT01119898|100707045|FG001|Overall Study|Adverse Event|5|||
33221001|NCT01119898|100707044|FG000|Overall Study|Withdrawal by Subject|1|||
33221002|NCT01119898|100707045|FG001|Overall Study|Withdrawal by Subject|4|||
33221003|NCT01119898|100707044|FG000|Overall Study|Lack of Efficacy|0|||
33221004|NCT01119898|100707045|FG001|Overall Study|Lack of Efficacy|2|||
33221005|NCT01119898|100707044|FG000|Overall Study|Protocol Violation|1|||
33221006|NCT01119898|100707045|FG001|Overall Study|Protocol Violation|1|||
33221007|NCT01119898|100707044|FG000|Overall Study|Medical procedure|1|||
33221008|NCT01119898|100707045|FG001|Overall Study|Medical procedure|0|||
33360589|NCT00090285|101207485|FG004|Extension 1|Withdrawal by Subject|0|||
33360590|NCT00090285|101207486|FG005|Extension 1|Withdrawal by Subject|0|||
33360591|NCT00090285|101207481|FG000|Extension 1|Other|0|||
33360592|NCT00090285|101207482|FG001|Extension 1|Other|0|||
33360593|NCT00090285|101207483|FG002|Extension 1|Other|4|||
33360594|NCT00090285|101207484|FG003|Extension 1|Other|0|||
33360595|NCT00090285|101207485|FG004|Extension 1|Other|0|||
33360596|NCT00090285|101207486|FG005|Extension 1|Other|0|||
33360597|NCT00090285|101207481|FG000|Extension 1|Moved|0|||
33360598|NCT00090285|101207482|FG001|Extension 1|Moved|0|||
33360599|NCT00090285|101207483|FG002|Extension 1|Moved|3|||
33360600|NCT00090285|101207484|FG003|Extension 1|Moved|0|||
33360601|NCT00090285|101207485|FG004|Extension 1|Moved|0|||
33360602|NCT00090285|101207486|FG005|Extension 1|Moved|0|||
33360603|NCT00090285|101207481|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
33360604|NCT00090285|101207482|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
33360605|NCT00090285|101207483|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
33360606|NCT00090285|101207484|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
33360607|NCT00090285|101207485|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
33360608|NCT00090285|101207486|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
33360609|NCT00090285|101207481|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33360610|NCT00090285|101207482|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33360611|NCT00090285|101207483|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33360612|NCT00090285|101207484|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
33360613|NCT00090285|101207485|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
33360614|NCT00090285|101207486|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
33360615|NCT00090285|101207481|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33360616|NCT00090285|101207482|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33360617|NCT00090285|101207483|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33360618|NCT00090285|101207484|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
33360619|NCT00090285|101207485|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
33360620|NCT00090285|101207486|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
33360621|NCT00090285|101207481|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
33562046|NCT01629563|101954529|FG000|Overall Study|Protocol Violation|0|||
33221009|NCT01119898|100707044|FG000|Overall Study|Randomized in error did not participate|1|||
33360622|NCT00090285|101207482|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
33360623|NCT00090285|101207483|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
33360624|NCT00090285|101207484|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
33360625|NCT00090285|101207485|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
33360626|NCT00090285|101207486|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
33360627|NCT01524289|101207487|FG000|Overall Study|Lost to Follow-up|0|||
33221010|NCT01119898|100707045|FG001|Overall Study|Randomized in error did not participate|0|||
33221011|NCT02710292|100707046|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
33221012|NCT02710292|100707047|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
33360628|NCT01524289|101207488|FG001|Overall Study|Lost to Follow-up|1|||
33360629|NCT01524289|101207487|FG000|Overall Study|Physician Decision|1|||
33360630|NCT01524289|101207488|FG001|Overall Study|Physician Decision|0|||
33360631|NCT01524289|101207487|FG000|Overall Study|Protocol Violation|5|||
33562047|NCT01629563|101954530|FG001|Overall Study|Protocol Violation|1|||
33562048|NCT01629563|101954529|FG000|Overall Study|Withdrawal by Subject|27|||
33562049|NCT01629563|101954530|FG001|Overall Study|Withdrawal by Subject|20|||
33562050|NCT01629563|101954529|FG000|Overall Study|surgery|0|||
33562051|NCT01629563|101954530|FG001|Overall Study|surgery|3|||
33562052|NCT01629563|101954529|FG000|Overall Study|Lack of return of menses|12|||
33360632|NCT01524289|101207488|FG001|Overall Study|Protocol Violation|1|||
33360633|NCT01524289|101207487|FG000|Overall Study|Withdrawal by Subject|11|||
33360634|NCT01524289|101207488|FG001|Overall Study|Withdrawal by Subject|7|||
33360635|NCT01524289|101207487|FG000|Overall Study|Adverse Event|12|||
33360636|NCT01524289|101207488|FG001|Overall Study|Adverse Event|5|||
33360637|NCT01524289|101207487|FG000|Overall Study|Did not take study medication|1|||
33360638|NCT01524289|101207488|FG001|Overall Study|Did not take study medication|0|||
33360639|NCT02532543|101207489|FG000|Overall Study|Lost to Follow-up|0|||
33360640|NCT02532543|101207490|FG001|Overall Study|Lost to Follow-up|0|||
33360641|NCT02532543|101207491|FG002|Overall Study|Lost to Follow-up|1|||
33360642|NCT02532543|101207492|FG003|Overall Study|Lost to Follow-up|0|||
33360643|NCT00095303|101207497|FG000|Main Study|Lost to Follow-up|91|||
33360644|NCT00095303|101207498|FG001|Main Study|Lost to Follow-up|87|||
33360645|NCT00095303|101207497|FG000|Follow Up Study|Lost to Follow-up|59|||
33360646|NCT00095303|101207498|FG001|Follow Up Study|Lost to Follow-up|58|||
33360647|NCT04382651|101207499|FG000|Overall Study|Death|26|||
33360648|NCT04382651|101207500|FG001|Overall Study|Death|23|||
33360649|NCT04382651|101207499|FG000|Overall Study|Lost to Follow-up|3|||
33360650|NCT04382651|101207500|FG001|Overall Study|Lost to Follow-up|4|||
33360651|NCT04382651|101207499|FG000|Overall Study|Withdrawal by Subject|2|||
33360652|NCT04382651|101207500|FG001|Overall Study|Withdrawal by Subject|0|||
33360653|NCT04382651|101207499|FG000|Overall Study|Physician Decision|0|||
33360654|NCT04382651|101207500|FG001|Overall Study|Physician Decision|1|||
33360655|NCT03671369|101207501|FG000|Overall Study|Other|1|||
33360656|NCT03671369|101207501|FG000|Overall Study|Withdrawal by Subject|289|||
33360657|NCT03671369|101207501|FG000|Overall Study|Not willing to be vaccinated|1|||
33360658|NCT00971321|101207502|FG000|Up to Month 7|Withdrawal by Subject|1|||
33360659|NCT00971321|101207503|FG001|Up to Month 7|Withdrawal by Subject|0|||
33360660|NCT00971321|101207502|FG000|Up to Month 7|Migrated/moved from study area|3|||
33360661|NCT00971321|101207503|FG001|Up to Month 7|Migrated/moved from study area|2|||
33360662|NCT00971321|101207502|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
33360663|NCT00971321|101207503|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
33360664|NCT00971321|101207502|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
33360665|NCT00971321|101207503|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
33360666|NCT00971321|101207502|FG000|Up to Month 11-12|Lost to Follow-up|1|||
33360667|NCT00971321|101207503|FG001|Up to Month 11-12|Lost to Follow-up|0|||
33360668|NCT00853905|101207504|FG000|Overall Study|Lost to Follow-up|1|||
33360669|NCT00853905|101207505|FG001|Overall Study|Lost to Follow-up|3|||
33360670|NCT00853905|101207504|FG000|Overall Study|Withdrawal by Subject|0|||
33360671|NCT00853905|101207505|FG001|Overall Study|Withdrawal by Subject|1|||
33360672|NCT00853905|101207504|FG000|Overall Study|never had surgery|1|||
33360673|NCT00853905|101207505|FG001|Overall Study|never had surgery|0|||
33360674|NCT01645930|101207509|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
33360675|NCT01645930|101207509|FG000|Overall Study|Progressive Disease|12|||
33360676|NCT01645930|101207509|FG000|Overall Study|Adverse Event|4|||
33360677|NCT01645930|101207509|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
33360678|NCT01645930|101207509|FG000|Overall Study|Withdrawal by Participant|2|||
33360679|NCT01645930|101207509|FG000|Overall Study|Reason not Defined|1|||
33360680|NCT03517722|101207510|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
33360681|NCT03517722|101207511|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
33360682|NCT03517722|101207510|FG000|Double Blind Period: Week 0-52|Death|0|||
33360683|NCT03517722|101207511|FG001|Double Blind Period: Week 0-52|Death|4|||
33360684|NCT03517722|101207510|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
33360685|NCT03517722|101207511|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
33562053|NCT01629563|101954530|FG001|Overall Study|Lack of return of menses|7|||
33562054|NCT01629563|101954529|FG000|Overall Study|Protocol Violation|0|||
33562055|NCT01629563|101954530|FG001|Overall Study|Protocol Violation|1|||
33562056|NCT03449147|101954533|FG000|52-week Treatment Period|Death|0|||
33562057|NCT03449147|101954534|FG001|52-week Treatment Period|Death|1|||
33562058|NCT03449147|101954535|FG002|52-week Treatment Period|Death|0|||
33562059|NCT03449147|101954533|FG000|52-week Treatment Period|Lost to Follow-up|6|||
33562060|NCT03449147|101954534|FG001|52-week Treatment Period|Lost to Follow-up|2|||
33360686|NCT03517722|101207510|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
33360687|NCT03517722|101207511|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
33360688|NCT03517722|101207510|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
33360689|NCT03517722|101207511|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
33360690|NCT03517722|101207510|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
33562061|NCT03449147|101954535|FG002|52-week Treatment Period|Lost to Follow-up|5|||
33360691|NCT03517722|101207511|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
33562062|NCT03449147|101954533|FG000|52-week Treatment Period|Other|0|||
33562063|NCT03449147|101954534|FG001|52-week Treatment Period|Other|1|||
33562064|NCT03449147|101954535|FG002|52-week Treatment Period|Other|2|||
33562065|NCT03449147|101954533|FG000|52-week Treatment Period|Physician Decision|1|||
33360692|NCT03517722|101207510|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
33360693|NCT03517722|101207511|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
33360694|NCT03517722|101207510|FG000|Double Blind Period: Week 0-52|Other|4|||
33360695|NCT03517722|101207511|FG001|Double Blind Period: Week 0-52|Other|3|||
33360696|NCT03517722|101207510|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
33360697|NCT03517722|101207511|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
33360698|NCT03517722|101207510|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
33360699|NCT03517722|101207511|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
33360700|NCT03517722|101207510|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
33360701|NCT03517722|101207511|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
33360702|NCT03517722|101207510|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
33360703|NCT03517722|101207511|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
33360704|NCT03517722|101207510|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
33360705|NCT03517722|101207511|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
33360706|NCT01396525|101207515|FG000|Overall Study|Withdrawal by Subject|8|||
33360707|NCT01396525|101207515|FG000|Overall Study|Death|14|||
33360708|NCT01396525|101207515|FG000|Overall Study|Lost to Follow-up|4|||
33360709|NCT00881205|101207516|FG000|Overall Study|Adverse Event|8|||
33360710|NCT00881205|101207517|FG001|Overall Study|Adverse Event|3|||
33360711|NCT00881205|101207516|FG000|Overall Study|Withdrawal by Subject|1|||
33360712|NCT00881205|101207517|FG001|Overall Study|Withdrawal by Subject|2|||
33360713|NCT00881205|101207516|FG000|Overall Study|Lost to Follow-up|0|||
33562066|NCT03449147|101954534|FG001|52-week Treatment Period|Physician Decision|0|||
33562067|NCT03449147|101954535|FG002|52-week Treatment Period|Physician Decision|3|||
33562068|NCT03449147|101954533|FG000|52-week Treatment Period|Screen Failure|1|||
33360714|NCT00881205|101207517|FG001|Overall Study|Lost to Follow-up|1|||
33360715|NCT00881205|101207516|FG000|Overall Study|Administrative problems|1|||
33360716|NCT00881205|101207517|FG001|Overall Study|Administrative problems|1|||
33360717|NCT00881205|101207516|FG000|Overall Study|Condition no longer requires drug|1|||
33360718|NCT00881205|101207517|FG001|Overall Study|Condition no longer requires drug|0|||
33360719|NCT02243176|101207518|FG000|Overall Study|Other reason|1|||
33360720|NCT02243176|101207519|FG001|Overall Study|Other reason|2|||
33360721|NCT02243176|101207518|FG000|Overall Study|protocol specified withdrawal critera|1|||
33360722|NCT02243176|101207519|FG001|Overall Study|protocol specified withdrawal critera|3|||
33360723|NCT02243176|101207518|FG000|Overall Study|Protocol Violation|2|||
33360724|NCT02243176|101207519|FG001|Overall Study|Protocol Violation|1|||
33360725|NCT02243176|101207518|FG000|Overall Study|Withdrawal by Subject|8|||
33360726|NCT02243176|101207519|FG001|Overall Study|Withdrawal by Subject|7|||
33360727|NCT02243176|101207518|FG000|Overall Study|Adverse Event|2|||
33360728|NCT02243176|101207519|FG001|Overall Study|Adverse Event|2|||
33360729|NCT03952130|101207524|FG000|Overall Study|Adverse Event|0|||
33360730|NCT03952130|101207525|FG001|Overall Study|Adverse Event|1|||
33360731|NCT03952130|101207524|FG000|Overall Study|Lost to Follow-up|1|||
33360732|NCT03952130|101207525|FG001|Overall Study|Lost to Follow-up|0|||
33360733|NCT03952130|101207524|FG000|Overall Study|Withdrawal by Subject|1|||
33360734|NCT03952130|101207525|FG001|Overall Study|Withdrawal by Subject|5|||
33360735|NCT01318902|101207526|FG000|Overall Study|Symptomatic Deterioration|0|||
33360736|NCT01318902|101207527|FG001|Overall Study|Symptomatic Deterioration|1|||
33360737|NCT01318902|101207528|FG002|Overall Study|Symptomatic Deterioration|1|||
33360738|NCT01318902|101207529|FG003|Overall Study|Symptomatic Deterioration|2|||
33360739|NCT01318902|101207526|FG000|Overall Study|Withdrawal by Patient|0|||
33360740|NCT01318902|101207527|FG001|Overall Study|Withdrawal by Patient|1|||
33562069|NCT03449147|101954534|FG001|52-week Treatment Period|Screen Failure|2|||
33562070|NCT03449147|101954535|FG002|52-week Treatment Period|Screen Failure|0|||
33562071|NCT03449147|101954533|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
33562072|NCT03449147|101954534|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
33562073|NCT03449147|101954535|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
33360741|NCT01318902|101207528|FG002|Overall Study|Withdrawal by Patient|0|||
33360742|NCT01318902|101207529|FG003|Overall Study|Withdrawal by Patient|3|||
33360743|NCT01318902|101207526|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
33562074|NCT03449147|101954533|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
33625729|NCT03084796|102180815|FG001|Overall Study|Lost to Follow-up|0|||
33360744|NCT01318902|101207527|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
33360745|NCT01318902|101207528|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
33360746|NCT01318902|101207529|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
33360747|NCT01318902|101207526|FG000|Overall Study|Adverse Event|0|||
33360748|NCT01318902|101207527|FG001|Overall Study|Adverse Event|1|||
33360749|NCT01318902|101207528|FG002|Overall Study|Adverse Event|0|||
33360750|NCT01318902|101207529|FG003|Overall Study|Adverse Event|0|||
33360751|NCT01318902|101207526|FG000|Overall Study|Terminated by Sponsor|0|||
33360752|NCT01318902|101207527|FG001|Overall Study|Terminated by Sponsor|0|||
33221013|NCT02710292|100707046|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
33221014|NCT02710292|100707047|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
33221015|NCT00736489|100707048|FG000|Period 1|Lost to Follow-up|1|||
33221016|NCT00736489|100707049|FG001|Period 1|Lost to Follow-up|0|||
33221017|NCT00736489|100707050|FG002|Period 1|Lost to Follow-up|0|||
33221018|NCT00736489|100707051|FG003|Period 1|Lost to Follow-up|0|||
33221019|NCT00736489|100707052|FG004|Period 1|Lost to Follow-up|0|||
33221020|NCT00736489|100707053|FG005|Period 1|Lost to Follow-up|0|||
33221021|NCT00736489|100707048|FG000|Period 1|Withdrawal by Subject|0|||
33221022|NCT00736489|100707049|FG001|Period 1|Withdrawal by Subject|0|||
33360753|NCT01318902|101207528|FG002|Overall Study|Terminated by Sponsor|1|||
33360754|NCT01318902|101207529|FG003|Overall Study|Terminated by Sponsor|0|||
33360755|NCT04024228|101207530|FG000|Overall Study|Adverse Event|1|||
33360756|NCT04024228|101207531|FG001|Overall Study|Adverse Event|0|||
33360757|NCT04024228|101207530|FG000|Overall Study|Protocol Deviation|0|||
33360758|NCT04024228|101207531|FG001|Overall Study|Protocol Deviation|2|||
33360759|NCT04024228|101207530|FG000|Overall Study|Withdrawal by Subject|3|||
33360760|NCT04024228|101207531|FG001|Overall Study|Withdrawal by Subject|4|||
33360761|NCT03598777|101207534|FG000|Overall Study|Study Terminated by Sponsor|3|||
33360762|NCT03598777|101207535|FG001|Overall Study|Study Terminated by Sponsor|0|||
33221023|NCT00736489|100707050|FG002|Period 1|Withdrawal by Subject|0|||
33221024|NCT00736489|100707051|FG003|Period 1|Withdrawal by Subject|0|||
33360763|NCT03598777|101207536|FG002|Overall Study|Study Terminated by Sponsor|0|||
33360764|NCT03598777|101207537|FG003|Overall Study|Study Terminated by Sponsor|0|||
33360765|NCT03598777|101207538|FG004|Overall Study|Study Terminated by Sponsor|15|||
33360766|NCT03598777|101207534|FG000|Overall Study|Withdrawal by Subject|1|||
33562075|NCT03449147|101954534|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
33562076|NCT03449147|101954535|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
33562077|NCT03449147|101954533|FG000|12-Week Off-Treatment Durability Period|Other|0|||
33562078|NCT03449147|101954534|FG001|12-Week Off-Treatment Durability Period|Other|1|||
33562079|NCT03449147|101954535|FG002|12-Week Off-Treatment Durability Period|Other|0|||
33562080|NCT02272985|101954536|FG000|Overall Study|Withdrawal by Subject|1|||
33562081|NCT02272985|101954536|FG000|Overall Study|hip fracture|1|||
33562082|NCT02272985|101954536|FG000|Overall Study|kidney transplantation|1|||
33562083|NCT01772693|101954539|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
33562084|NCT01772693|101954540|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
33562085|NCT01772693|101954539|FG000|Overall Study|Withdrawal by Subject|2|||
33562086|NCT01772693|101954540|FG001|Overall Study|Withdrawal by Subject|0|||
33221025|NCT00736489|100707052|FG004|Period 1|Withdrawal by Subject|0|||
33562087|NCT01772693|101954539|FG000|Overall Study|Alternative Treatment|2|||
33360767|NCT03598777|101207535|FG001|Overall Study|Withdrawal by Subject|1|||
33360768|NCT03598777|101207536|FG002|Overall Study|Withdrawal by Subject|0|||
33360769|NCT03598777|101207537|FG003|Overall Study|Withdrawal by Subject|0|||
33360770|NCT03598777|101207538|FG004|Overall Study|Withdrawal by Subject|0|||
33360771|NCT03598777|101207534|FG000|Overall Study|Adverse Event|1|||
33360772|NCT03598777|101207535|FG001|Overall Study|Adverse Event|0|||
33360773|NCT03598777|101207536|FG002|Overall Study|Adverse Event|0|||
33360774|NCT03598777|101207537|FG003|Overall Study|Adverse Event|0|||
33360775|NCT03598777|101207538|FG004|Overall Study|Adverse Event|0|||
33360776|NCT03598777|101207534|FG000|Overall Study|Lost to Follow-up|1|||
33360777|NCT03598777|101207535|FG001|Overall Study|Lost to Follow-up|0|||
33360778|NCT03598777|101207536|FG002|Overall Study|Lost to Follow-up|0|||
33360779|NCT03598777|101207537|FG003|Overall Study|Lost to Follow-up|0|||
33360780|NCT03598777|101207538|FG004|Overall Study|Lost to Follow-up|0|||
33360781|NCT02640612|101207541|FG000|Overall Study|Adverse Event|6|||
33360782|NCT02640612|101207542|FG001|Overall Study|Adverse Event|7|||
33360783|NCT02640612|101207543|FG002|Overall Study|Adverse Event|2|||
33360784|NCT02640612|101207541|FG000|Overall Study|Death|1|||
33360785|NCT02640612|101207542|FG001|Overall Study|Death|0|||
33360786|NCT02640612|101207543|FG002|Overall Study|Death|0|||
33360787|NCT02640612|101207541|FG000|Overall Study|Withdrawal by Subject|10|||
33360788|NCT02640612|101207542|FG001|Overall Study|Withdrawal by Subject|3|||
33360789|NCT02640612|101207543|FG002|Overall Study|Withdrawal by Subject|3|||
33360790|NCT02640612|101207541|FG000|Overall Study|Lost to Follow-up|4|||
33221026|NCT00736489|100707053|FG005|Period 1|Withdrawal by Subject|1|||
33221027|NCT02487498|100710937|FG000|Period: Period 1|Adverse Event|2|||
33221028|NCT02487498|100710938|FG001|Period: Period 1|Adverse Event|4|||
33221029|NCT02487498|100710937|FG000|Period: Period 1|Subject/guardian decision|2|||
33221030|NCT02487498|100710938|FG001|Period: Period 1|Subject/guardian decision|4|||
33360791|NCT02640612|101207542|FG001|Overall Study|Lost to Follow-up|1|||
33360792|NCT02640612|101207543|FG002|Overall Study|Lost to Follow-up|1|||
33360793|NCT02640612|101207541|FG000|Overall Study|Protocol Violation|0|||
33360794|NCT02640612|101207542|FG001|Overall Study|Protocol Violation|2|||
33360795|NCT02640612|101207543|FG002|Overall Study|Protocol Violation|0|||
33360796|NCT02640612|101207541|FG000|Overall Study|Lack of Efficacy|1|||
33360797|NCT02640612|101207542|FG001|Overall Study|Lack of Efficacy|1|||
33562088|NCT01772693|101954540|FG001|Overall Study|Alternative Treatment|0|||
33562089|NCT03647137|101954541|FG000|Overall Study|Scan Limitation|2|||
33562090|NCT03647137|101954542|FG001|Overall Study|Scan Limitation|1|||
33562091|NCT03647137|101954543|FG002|Overall Study|Scan Limitation|1|||
33562092|NCT03647137|101954544|FG003|Overall Study|Scan Limitation|2|||
33562093|NCT00908141|101954550|FG000|Overall Study|Withdrawal by Subject|0|||
33221031|NCT02487498|100710937|FG000|Period: Period 1|Lost to Follow-up|0|||
33360798|NCT02640612|101207543|FG002|Overall Study|Lack of Efficacy|0|||
33360799|NCT02128490|101207548|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
33360800|NCT02128490|101207549|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
33360801|NCT02128490|101207550|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
33360802|NCT02128490|101207551|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
33360803|NCT02128490|101207552|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
33360804|NCT02128490|101207548|FG000|Overall Study|Major Protocol Deviation|1|||
33360805|NCT02128490|101207549|FG001|Overall Study|Major Protocol Deviation|2|||
33360806|NCT02128490|101207550|FG002|Overall Study|Major Protocol Deviation|0|||
33360807|NCT02128490|101207551|FG003|Overall Study|Major Protocol Deviation|2|||
33562094|NCT00908141|101954551|FG001|Overall Study|Withdrawal by Subject|1|||
33360808|NCT02128490|101207552|FG004|Overall Study|Major Protocol Deviation|2|||
33360809|NCT02128490|101207548|FG000|Overall Study|Lost to Follow-up|0|||
33625730|NCT03084796|102180816|FG002|Overall Study|Lost to Follow-up|1|||
33625731|NCT03084796|102180817|FG003|Overall Study|Lost to Follow-up|1|||
33625732|NCT03084796|102180818|FG004|Overall Study|Lost to Follow-up|3|||
33625733|NCT03084796|102180819|FG005|Overall Study|Lost to Follow-up|1|||
33625734|NCT03084796|102180814|FG000|Overall Study|Randomization error|0|||
33360810|NCT02128490|101207549|FG001|Overall Study|Lost to Follow-up|0|||
33360811|NCT02128490|101207550|FG002|Overall Study|Lost to Follow-up|1|||
33360812|NCT02128490|101207551|FG003|Overall Study|Lost to Follow-up|1|||
33360813|NCT02128490|101207552|FG004|Overall Study|Lost to Follow-up|1|||
33360814|NCT02128490|101207548|FG000|Overall Study|Voluntary Withdrawal|3|||
33360815|NCT02128490|101207549|FG001|Overall Study|Voluntary Withdrawal|3|||
33360816|NCT02128490|101207550|FG002|Overall Study|Voluntary Withdrawal|1|||
33360817|NCT02128490|101207551|FG003|Overall Study|Voluntary Withdrawal|1|||
33360818|NCT02128490|101207552|FG004|Overall Study|Voluntary Withdrawal|2|||
33360819|NCT02128490|101207548|FG000|Overall Study|Lack of Efficacy|0|||
33360820|NCT02128490|101207549|FG001|Overall Study|Lack of Efficacy|1|||
33360821|NCT02128490|101207550|FG002|Overall Study|Lack of Efficacy|0|||
33562095|NCT02904265|101954552|FG000|Overall Study|Physician Decision|1|||
33562096|NCT02904265|101954553|FG001|Overall Study|Physician Decision|2|||
33625735|NCT03084796|102180815|FG001|Overall Study|Randomization error|0|||
33625736|NCT03084796|102180816|FG002|Overall Study|Randomization error|1|||
33625737|NCT03084796|102180817|FG003|Overall Study|Randomization error|0|||
33625738|NCT03084796|102180818|FG004|Overall Study|Randomization error|0|||
33625739|NCT03084796|102180819|FG005|Overall Study|Randomization error|0|||
33625740|NCT00659061|102180822|FG000|Overall Study|Migration due to political unrest|21|||
33625741|NCT00659061|102180823|FG001|Overall Study|Migration due to political unrest|15|||
33625742|NCT03149055|102180824|FG000|Overall Study|Not treated|4|||
33625743|NCT00475670|102180825|FG000|Overall Study|Death|0|||
33625744|NCT00475670|102180826|FG001|Overall Study|Death|1|||
33625745|NCT00475670|102180825|FG000|Overall Study|Lack of Efficacy|3|||
33625746|NCT00475670|102180826|FG001|Overall Study|Lack of Efficacy|34|||
33625747|NCT00475670|102180825|FG000|Overall Study|Refused treatment|0|||
33625748|NCT00475670|102180826|FG001|Overall Study|Refused treatment|2|||
33625749|NCT00475670|102180825|FG000|Overall Study|Failure to Return|0|||
33625750|NCT00475670|102180826|FG001|Overall Study|Failure to Return|1|||
33625751|NCT00475670|102180825|FG000|Overall Study|Other|0|||
33625752|NCT00475670|102180826|FG001|Overall Study|Other|3|||
33625753|NCT04258423|102180832|FG000|Overall Study|Study Closure|2|||
33625754|NCT04258423|102180833|FG001|Overall Study|Study Closure|2|||
33625755|NCT02519439|102180834|FG000|Overall Study|Study Termination|19|||
33625756|NCT02519439|102180834|FG000|Overall Study|Withdrawal by Subject|1|||
33625757|NCT02519439|102180834|FG000|Overall Study|Adverse Event|1|||
33625758|NCT02888106|102180837|FG000|Overall Study|Withdrawal by Subject|1|||
33625759|NCT02888106|102180838|FG001|Overall Study|Withdrawal by Subject|2|||
33221032|NCT02487498|100710938|FG001|Period: Period 1|Lost to Follow-up|2|||
33221033|NCT02487498|100710937|FG000|Period: Period 1|Lack of Efficacy|1|||
33221034|NCT02487498|100710938|FG001|Period: Period 1|Lack of Efficacy|0|||
33221035|NCT02487498|100710937|FG000|Period: Period 1|Physician Decision|0|||
33221036|NCT02487498|100710938|FG001|Period: Period 1|Physician Decision|1|||
33221037|NCT02487498|100710937|FG000|Period: Period 1|Protocol deviation|1|||
33221038|NCT02487498|100710938|FG001|Period: Period 1|Protocol deviation|0|||
33221039|NCT02487498|100710937|FG000|Period: Washout|Subject/guardian decision|0|||
33221040|NCT02487498|100710938|FG001|Period: Washout|Subject/guardian decision|5|||
33221041|NCT02487498|100710937|FG000|Period: Washout|Lack of Efficacy|1|||
33221042|NCT02487498|100710938|FG001|Period: Washout|Lack of Efficacy|1|||
33221043|NCT02487498|100710937|FG000|Period: Washout|Physician Decision|1|||
33221044|NCT02487498|100710938|FG001|Period: Washout|Physician Decision|0|||
33221045|NCT02487498|100710937|FG000|Period: Washout|Non-compliance with study treatment|0|||
33221046|NCT02487498|100710938|FG001|Period: Washout|Non-compliance with study treatment|1|||
33221047|NCT02487498|100710937|FG000|Period: Period 2|Adverse Event|2|||
33625760|NCT02888106|102180839|FG002|Overall Study|Withdrawal by Subject|0|||
33221048|NCT02487498|100710938|FG001|Period: Period 2|Adverse Event|2|||
33221049|NCT02487498|100710937|FG000|Period: Period 2|Subject/guardian decision|2|||
33221050|NCT02487498|100710938|FG001|Period: Period 2|Subject/guardian decision|1|||
33360822|NCT02128490|101207551|FG003|Overall Study|Lack of Efficacy|0|||
33360823|NCT02128490|101207552|FG004|Overall Study|Lack of Efficacy|0|||
33360824|NCT02128490|101207548|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
33414916|NCT00916617|101409888|FG002|Overall Study|Lost to Follow-up|0|||
33562097|NCT01550965|101954554|FG000|Overall Study|Adverse Event|26|||
33562098|NCT01550965|101954554|FG000|Overall Study|Withdrawal by Subject|10|||
33562099|NCT01550965|101954554|FG000|Overall Study|Lost to Follow-up|2|||
33562100|NCT01550965|101954554|FG000|Overall Study|Lack of Efficacy|59|||
33562101|NCT01550965|101954554|FG000|Overall Study|Other|13|||
33562102|NCT00803049|101954555|FG000|Overall Study|Adverse Event|21|||
33562103|NCT00803049|101954556|FG001|Overall Study|Adverse Event|33|||
33625761|NCT02888106|102180840|FG003|Overall Study|Withdrawal by Subject|1|||
33625762|NCT02888106|102180841|FG004|Overall Study|Withdrawal by Subject|0|||
33221051|NCT02487498|100710937|FG000|Period: Period 2|Lost to Follow-up|1|||
33221052|NCT02487498|100710938|FG001|Period: Period 2|Lost to Follow-up|1|||
33221053|NCT02487498|100710937|FG000|Period: Period 2|Death|0|||
33221054|NCT02487498|100710938|FG001|Period: Period 2|Death|1|||
33221055|NCT02487498|100710937|FG000|Period: Period 2|Physician Decision|1|||
33360825|NCT02128490|101207549|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
33360826|NCT02128490|101207550|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
33360827|NCT02128490|101207551|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
33360828|NCT02128490|101207552|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
33360829|NCT02128490|101207548|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33360830|NCT02128490|101207549|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33360831|NCT02128490|101207550|FG002|Overall Study|Other Miscellaneous Reasons|2|||
33414917|NCT00916617|101409889|FG003|Overall Study|Lost to Follow-up|0|||
33414918|NCT00916617|101409886|FG000|Overall Study|Lack of Efficacy|1|||
33414919|NCT00916617|101409887|FG001|Overall Study|Lack of Efficacy|0|||
33414920|NCT00916617|101409888|FG002|Overall Study|Lack of Efficacy|0|||
33414921|NCT00916617|101409889|FG003|Overall Study|Lack of Efficacy|0|||
33414922|NCT00916617|101409886|FG000|Overall Study|Other|2|||
33414923|NCT00916617|101409887|FG001|Overall Study|Other|0|||
33414924|NCT00916617|101409888|FG002|Overall Study|Other|0|||
33414925|NCT00916617|101409889|FG003|Overall Study|Other|2|||
33414926|NCT01067339|101409890|FG000|Overall Study|Withdrawal by Subject|6|||
33414927|NCT01067339|101409891|FG001|Overall Study|Withdrawal by Subject|5|||
33414928|NCT00902265|101409892|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
33414929|NCT00902265|101409892|FG000|Overall Study|Adverse Event|2|||
33414930|NCT00902265|101409892|FG000|Overall Study|Lack of Efficacy|2|||
33414931|NCT00902265|101409892|FG000|Overall Study|Protocol Violation|1|||
33414932|NCT00556166|101409901|FG000|Overall Study|Withdrawal by Subject|1|||
33414933|NCT03728257|101409903|FG000|Overall Study|Death|3|||
33414934|NCT03728257|101409904|FG001|Overall Study|Death|0|||
33414935|NCT00980460|101409909|FG000|Overall Study|Death|0|||
33414936|NCT00980460|101409910|FG001|Overall Study|Death|0|||
33414937|NCT00980460|101409911|FG002|Overall Study|Death|1|||
33414938|NCT00980460|101409912|FG003|Overall Study|Death|2|||
33414939|NCT00980460|101409913|FG004|Overall Study|Death|1|||
33562104|NCT00803049|101954557|FG002|Overall Study|Adverse Event|13|||
33562105|NCT00803049|101954558|FG003|Overall Study|Adverse Event|27|||
33562106|NCT00803049|101954555|FG000|Overall Study|Lack of Efficacy|10|||
33562107|NCT00803049|101954556|FG001|Overall Study|Lack of Efficacy|19|||
33562108|NCT00803049|101954557|FG002|Overall Study|Lack of Efficacy|6|||
33562109|NCT00803049|101954558|FG003|Overall Study|Lack of Efficacy|13|||
33562110|NCT00803049|101954555|FG000|Overall Study|Lost to Follow-up|0|||
33562111|NCT00803049|101954556|FG001|Overall Study|Lost to Follow-up|2|||
33625763|NCT02888106|102180842|FG005|Overall Study|Withdrawal by Subject|0|||
33625764|NCT02888106|102180837|FG000|Overall Study|Lost to Follow-up|1|||
33625765|NCT02888106|102180838|FG001|Overall Study|Lost to Follow-up|0|||
33625766|NCT02888106|102180839|FG002|Overall Study|Lost to Follow-up|0|||
33562112|NCT00803049|101954557|FG002|Overall Study|Lost to Follow-up|0|||
33562113|NCT00803049|101954558|FG003|Overall Study|Lost to Follow-up|3|||
33562114|NCT00803049|101954555|FG000|Overall Study|Death|2|||
33562115|NCT00803049|101954556|FG001|Overall Study|Death|1|||
33562116|NCT00803049|101954557|FG002|Overall Study|Death|0|||
33562117|NCT00803049|101954558|FG003|Overall Study|Death|2|||
33562118|NCT00803049|101954555|FG000|Overall Study|Progressive Disease|6|||
33562119|NCT00803049|101954556|FG001|Overall Study|Progressive Disease|10|||
33562120|NCT00803049|101954557|FG002|Overall Study|Progressive Disease|6|||
33562121|NCT00803049|101954558|FG003|Overall Study|Progressive Disease|6|||
33562122|NCT00803049|101954555|FG000|Overall Study|Withdrawal by Subject|19|||
33562123|NCT00803049|101954556|FG001|Overall Study|Withdrawal by Subject|43|||
33562124|NCT00803049|101954557|FG002|Overall Study|Withdrawal by Subject|16|||
33625767|NCT02888106|102180840|FG003|Overall Study|Lost to Follow-up|1|||
33625768|NCT02888106|102180841|FG004|Overall Study|Lost to Follow-up|0|||
33625769|NCT02888106|102180842|FG005|Overall Study|Lost to Follow-up|1|||
33625770|NCT02888106|102180837|FG000|Overall Study|Adverse Event|2|||
33625771|NCT02888106|102180838|FG001|Overall Study|Adverse Event|0|||
33625772|NCT02888106|102180839|FG002|Overall Study|Adverse Event|0|||
33625773|NCT02888106|102180840|FG003|Overall Study|Adverse Event|0|||
33625774|NCT02888106|102180841|FG004|Overall Study|Adverse Event|0|||
33625775|NCT02888106|102180842|FG005|Overall Study|Adverse Event|0|||
33221056|NCT02487498|100710938|FG001|Period: Period 2|Physician Decision|0|||
33221057|NCT01493687|100710939|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
33414940|NCT00980460|101409909|FG000|Overall Study|Lack of Efficacy|0|||
33414941|NCT00980460|101409910|FG001|Overall Study|Lack of Efficacy|0|||
33414942|NCT00980460|101409911|FG002|Overall Study|Lack of Efficacy|10|||
33414943|NCT00980460|101409912|FG003|Overall Study|Lack of Efficacy|6|||
33414944|NCT00980460|101409913|FG004|Overall Study|Lack of Efficacy|8|||
33562125|NCT00803049|101954558|FG003|Overall Study|Withdrawal by Subject|44|||
33360832|NCT02128490|101207551|FG003|Overall Study|Other Miscellaneous Reasons|1|||
33562126|NCT00803049|101954555|FG000|Overall Study|Protocol Violation|0|||
33562127|NCT00803049|101954556|FG001|Overall Study|Protocol Violation|1|||
33221058|NCT01493687|100710940|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
33221059|NCT01493687|100710939|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
33221060|NCT01493687|100710940|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
33221061|NCT01493687|100710939|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
33221062|NCT01493687|100710940|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
33221063|NCT01493687|100710939|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
33221064|NCT01493687|100710940|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
33221065|NCT01493687|100710939|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
33221066|NCT01493687|100710940|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
33221067|NCT01493687|100710939|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
33221068|NCT01493687|100710940|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
33221069|NCT01493687|100710939|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
33221070|NCT01493687|100710940|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
33221071|NCT01493687|100710939|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
33221072|NCT01493687|100710940|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
33221073|NCT01493687|100710939|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
33221074|NCT01493687|100710940|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
33221075|NCT01493687|100710939|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
33221076|NCT01493687|100710940|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
33360833|NCT02128490|101207552|FG004|Overall Study|Other Miscellaneous Reasons|1|||
33360834|NCT00552305|101207553|FG000|Overall Study|Adverse Event|43|||
33360835|NCT00552305|101207553|FG000|Overall Study|Lack of Efficacy|120|||
33360836|NCT00552305|101207553|FG000|Overall Study|Lost to Follow-up|4|||
33221077|NCT01493687|100710939|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
33221078|NCT01493687|100710940|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
33221079|NCT01493687|100710939|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
33221080|NCT01493687|100710940|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
33221081|NCT01493687|100710939|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
33221082|NCT01493687|100710940|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
33221083|NCT01493687|100710939|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
33221084|NCT01493687|100710940|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
33221085|NCT01493687|100710939|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
33221086|NCT01493687|100710940|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
33221087|NCT01059643|100710941|FG000|Overall Study|Adverse Event|3|||
33221088|NCT01059643|100710941|FG000|Overall Study|Withdrawal by Subject|2|||
33221089|NCT01059643|100710941|FG000|Overall Study|Physician Decision|1|||
33221090|NCT02395133|100710946|FG000|Overall Study|Adverse Event|4|||
33221091|NCT02395133|100710947|FG001|Overall Study|Adverse Event|1|||
33221092|NCT02395133|100710948|FG002|Overall Study|Adverse Event|3|||
33221093|NCT02395133|100710949|FG003|Overall Study|Adverse Event|0|||
33221094|NCT02395133|100710946|FG000|Overall Study|Lack of Efficacy|1|||
33221095|NCT02395133|100710947|FG001|Overall Study|Lack of Efficacy|0|||
33221096|NCT02395133|100710948|FG002|Overall Study|Lack of Efficacy|1|||
33221097|NCT02395133|100710949|FG003|Overall Study|Lack of Efficacy|1|||
33221098|NCT02395133|100710946|FG000|Overall Study|Protocol Violation|1|||
33221099|NCT02395133|100710947|FG001|Overall Study|Protocol Violation|1|||
33221100|NCT02395133|100710948|FG002|Overall Study|Protocol Violation|0|||
33221101|NCT02395133|100710949|FG003|Overall Study|Protocol Violation|3|||
33221102|NCT02395133|100710946|FG000|Overall Study|Lost to Follow-up|0|||
33221103|NCT02395133|100710947|FG001|Overall Study|Lost to Follow-up|1|||
33221104|NCT02395133|100710948|FG002|Overall Study|Lost to Follow-up|1|||
33221105|NCT02395133|100710949|FG003|Overall Study|Lost to Follow-up|0|||
33221106|NCT02395133|100710946|FG000|Overall Study|Pregnancy|0|||
33221107|NCT02395133|100710947|FG001|Overall Study|Pregnancy|0|||
33221108|NCT02395133|100710948|FG002|Overall Study|Pregnancy|3|||
33221109|NCT02395133|100710949|FG003|Overall Study|Pregnancy|0|||
33221110|NCT02395133|100710946|FG000|Overall Study|Consent withdrawn with no reason given|1|||
33221111|NCT02395133|100710947|FG001|Overall Study|Consent withdrawn with no reason given|3|||
33221112|NCT02395133|100710948|FG002|Overall Study|Consent withdrawn with no reason given|0|||
33221113|NCT02395133|100710949|FG003|Overall Study|Consent withdrawn with no reason given|2|||
33221114|NCT02395133|100710946|FG000|Overall Study|Consent withdrawn with personal reason|0|||
33221115|NCT02395133|100710947|FG001|Overall Study|Consent withdrawn with personal reason|1|||
33221116|NCT02395133|100710948|FG002|Overall Study|Consent withdrawn with personal reason|0|||
33221117|NCT02395133|100710949|FG003|Overall Study|Consent withdrawn with personal reason|3|||
33221118|NCT02395133|100710946|FG000|Overall Study|Sponsor decision|2|||
33221119|NCT02395133|100710947|FG001|Overall Study|Sponsor decision|0|||
33221120|NCT02395133|100710948|FG002|Overall Study|Sponsor decision|0|||
33221121|NCT02395133|100710949|FG003|Overall Study|Sponsor decision|1|||
33221122|NCT02395133|100710946|FG000|Overall Study|Other than specified above|5|||
33221123|NCT02395133|100710947|FG001|Overall Study|Other than specified above|2|||
33221124|NCT02395133|100710948|FG002|Overall Study|Other than specified above|2|||
33221125|NCT02395133|100710949|FG003|Overall Study|Other than specified above|4|||
33360837|NCT00552305|101207553|FG000|Overall Study|Protocol Violation|3|||
33360838|NCT00552305|101207553|FG000|Overall Study|Withdrawal by Subject|44|||
33360839|NCT00552305|101207553|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
33360840|NCT00552305|101207553|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
33360841|NCT00552305|101207553|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
33360842|NCT00552305|101207553|FG000|Overall Study|Unsatisfactory compliance|11|||
33360843|NCT00552305|101207553|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
33360844|NCT00552305|101207553|FG000|Overall Study|AE/Other: prohibited drug required|1|||
33360845|NCT00552305|101207553|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
33360846|NCT00552305|101207553|FG000|Overall Study|Other: Site closed|4|||
33562128|NCT00803049|101954557|FG002|Overall Study|Protocol Violation|1|||
33221126|NCT02296190|100710951|FG000|Overall Study|Lost to Follow-up|0|||
33221127|NCT02296190|100710952|FG001|Overall Study|Lost to Follow-up|0|||
33221128|NCT02296190|100710953|FG002|Overall Study|Lost to Follow-up|0|||
33360847|NCT00552305|101207553|FG000|Overall Study|Other: Personal problems|1|||
33221129|NCT02296190|100710954|FG003|Overall Study|Lost to Follow-up|0|||
33221130|NCT02296190|100710955|FG004|Overall Study|Lost to Follow-up|1|||
33360848|NCT00552305|101207553|FG000|Overall Study|Other: Unable to attend visits|1|||
33360849|NCT00552305|101207553|FG000|Overall Study|Other: Subject underwent surgery|4|||
33625776|NCT02888106|102180837|FG000|Overall Study|Withdrawal of consent|0|||
33221131|NCT02296190|100710956|FG005|Overall Study|Lost to Follow-up|0|||
33221132|NCT02296190|100710951|FG000|Overall Study|Failure to induce PSVT|6|||
33221133|NCT02296190|100710952|FG001|Overall Study|Failure to induce PSVT|10|||
33221134|NCT02296190|100710953|FG002|Overall Study|Failure to induce PSVT|5|||
33360850|NCT00552305|101207553|FG000|Overall Study|Other: Subject became pregnant|1|||
33360851|NCT00552305|101207553|FG000|Overall Study|Other: Health problems, not drug related|1|||
33360852|NCT00552305|101207553|FG000|Overall Study|Other: Subject moved from area|2|||
33625777|NCT02888106|102180838|FG001|Overall Study|Withdrawal of consent|0|||
33625778|NCT02888106|102180839|FG002|Overall Study|Withdrawal of consent|0|||
33625779|NCT02888106|102180840|FG003|Overall Study|Withdrawal of consent|0|||
33625780|NCT02888106|102180841|FG004|Overall Study|Withdrawal of consent|1|||
33625781|NCT02888106|102180842|FG005|Overall Study|Withdrawal of consent|0|||
33360853|NCT00552305|101207553|FG000|Overall Study|Other: Subject incarcerated|1|||
33360854|NCT00552305|101207553|FG000|Overall Study|Other: Subject went to rehab|1|||
33360855|NCT01716169|101207554|FG000|Overall Study|Adverse Event|1|||
33360856|NCT01716169|101207554|FG000|Overall Study|Lost to Follow-up|1|||
33360857|NCT01716169|101207554|FG000|Overall Study|Withdrawal by Subject|1|||
33360858|NCT01716169|101207554|FG000|Overall Study|inconsistent dressing application|1|||
33360859|NCT00686205|101207555|FG000|Overall Study|Protocol Violation|127|||
33360860|NCT00686205|101207556|FG001|Overall Study|Protocol Violation|0|||
33360861|NCT00686205|101207555|FG000|Overall Study|Withdrawal by Subject|2|||
33360862|NCT00686205|101207556|FG001|Overall Study|Withdrawal by Subject|0|||
33360863|NCT00686205|101207555|FG000|Overall Study|Specimen handling procedure altered|5878|||
33360864|NCT00686205|101207556|FG001|Overall Study|Specimen handling procedure altered|0|||
33360865|NCT00686205|101207555|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
33360866|NCT00686205|101207556|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
33360867|NCT04814823|101207557|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
33562129|NCT00803049|101954558|FG003|Overall Study|Protocol Violation|0|||
33562130|NCT00803049|101954555|FG000|Overall Study|Randomized and Not Treated|0|||
33562131|NCT00803049|101954556|FG001|Overall Study|Randomized and Not Treated|0|||
33562132|NCT00803049|101954557|FG002|Overall Study|Randomized and Not Treated|0|||
33360868|NCT02859415|101207562|FG000|Overall Study|Physician Decision|1|||
33562133|NCT00803049|101954558|FG003|Overall Study|Randomized and Not Treated|2|||
33562134|NCT00803049|101954555|FG000|Overall Study|Other than Specified Above|3|||
33562135|NCT00803049|101954556|FG001|Overall Study|Other than Specified Above|9|||
33562136|NCT00803049|101954557|FG002|Overall Study|Other than Specified Above|2|||
33562137|NCT00803049|101954558|FG003|Overall Study|Other than Specified Above|5|||
33562138|NCT04362254|101954561|FG000|Overall Study|Adverse Event|1|||
33562139|NCT04362254|101954561|FG000|Overall Study|Protocol Violation|1|||
33562140|NCT04362254|101954561|FG000|Overall Study|Due to early termination of the trial|10|||
33562141|NCT02402907|101954563|FG000|Overall Study|Delivered vaginally|9|||
33562142|NCT02402907|101954564|FG001|Overall Study|Delivered vaginally|3|||
33562143|NCT02402907|101954563|FG000|Overall Study|Delivered outside of Sinai|1|||
33562144|NCT02402907|101954564|FG001|Overall Study|Delivered outside of Sinai|1|||
33562145|NCT02402907|101954563|FG000|Overall Study|Lost to follow up after C-Section|10|||
33562146|NCT02402907|101954564|FG001|Overall Study|Lost to follow up after C-Section|23|||
33562147|NCT03635996|101954569|FG000|Overall Study|Study terminated by Sponsor|94|||
33562148|NCT03635996|101954569|FG000|Overall Study|Withdrawal by Subject|20|||
33562149|NCT03635996|101954569|FG000|Overall Study|Ablation|26|||
33562150|NCT03635996|101954569|FG000|Overall Study|Adverse Event|7|||
33562151|NCT03635996|101954569|FG000|Overall Study|Physician Decision|3|||
33562152|NCT03635996|101954569|FG000|Overall Study|Prohibited medication|5|||
33625782|NCT02888106|102180837|FG000|Overall Study|Pregnancy|1|||
33625783|NCT02888106|102180838|FG001|Overall Study|Pregnancy|0|||
33625784|NCT02888106|102180839|FG002|Overall Study|Pregnancy|0|||
33625785|NCT02888106|102180840|FG003|Overall Study|Pregnancy|0|||
33625786|NCT02888106|102180841|FG004|Overall Study|Pregnancy|0|||
33625787|NCT02888106|102180842|FG005|Overall Study|Pregnancy|0|||
33625788|NCT03642873|102180845|FG000|Third Intervention (1 Day)|Screen failure|0|||
33625789|NCT03642873|102180846|FG001|Third Intervention (1 Day)|Screen failure|0|||
33625790|NCT03642873|102180847|FG002|Third Intervention (1 Day)|Screen failure|0|||
33625791|NCT03642873|102180848|FG003|Third Intervention (1 Day)|Screen failure|0|||
33625792|NCT03642873|102180849|FG004|Third Intervention (1 Day)|Screen failure|1|||
33625793|NCT03642873|102180850|FG005|Third Intervention (1 Day)|Screen failure|0|||
33625794|NCT02903160|102180865|FG000|Overall Study|Adverse Event|2|||
33625795|NCT02903160|102180865|FG000|Overall Study|Death|1|||
33625796|NCT02903160|102180865|FG000|Overall Study|Lost to Follow-up|2|||
33625797|NCT02903160|102180865|FG000|Overall Study|Withdrawal by Subject|1|||
33625798|NCT02903160|102180865|FG000|Overall Study|Medical Insurance Barriers|1|||
33360869|NCT02859415|101207563|FG001|Overall Study|Physician Decision|0|||
33360870|NCT02859415|101207562|FG000|Overall Study|Off treatment due to cardiac event|0|||
33360871|NCT02859415|101207563|FG001|Overall Study|Off treatment due to cardiac event|1|||
33360872|NCT02369510|101207569|FG000|Overall Study|Spilled Medication|1|||
33360873|NCT02369510|101207570|FG001|Overall Study|Spilled Medication|2|||
33414945|NCT00980460|101409909|FG000|Overall Study|Lost to Follow-up|0|||
33562153|NCT03635996|101954569|FG000|Overall Study|Did not meet eligibility criteria|5|||
33562154|NCT03635996|101954569|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
33562155|NCT03635996|101954569|FG000|Overall Study|Protocol Violation|1|||
33562156|NCT03635996|101954569|FG000|Overall Study|Lost to Follow-up|1|||
33562157|NCT00913835|101954570|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
33562158|NCT00913835|101954571|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
33562159|NCT00913835|101954570|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
33562160|NCT00913835|101954571|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
33562161|NCT00913835|101954570|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
33562162|NCT00913835|101954571|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
33562163|NCT00913835|101954570|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
33562164|NCT00913835|101954571|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
33562165|NCT00913835|101954570|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
33562166|NCT00913835|101954571|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
33562167|NCT03726879|101954572|FG000|Overall Study|Death|11|||
33562168|NCT03726879|101954573|FG001|Overall Study|Death|13|||
33562169|NCT03726879|101954572|FG000|Overall Study|Physician Decision|0|||
33360874|NCT02369510|101207571|FG002|Overall Study|Spilled Medication|1|||
33360875|NCT02369510|101207569|FG000|Overall Study|Epidural Activation|1|||
33360876|NCT02369510|101207570|FG001|Overall Study|Epidural Activation|1|||
33360877|NCT02369510|101207571|FG002|Overall Study|Epidural Activation|5|||
33360878|NCT04101422|101207572|FG000|Overall Study|Ineligible|1|||
33360879|NCT04101422|101207573|FG001|Overall Study|Ineligible|0|||
33360880|NCT04101422|101207574|FG002|Overall Study|Ineligible|9|||
33360881|NCT04101422|101207575|FG003|Overall Study|Ineligible|0|||
33360882|NCT04101422|101207572|FG000|Overall Study|Withdrawal by Subject|0|||
33360883|NCT04101422|101207573|FG001|Overall Study|Withdrawal by Subject|0|||
33360884|NCT04101422|101207574|FG002|Overall Study|Withdrawal by Subject|1|||
33360885|NCT04101422|101207575|FG003|Overall Study|Withdrawal by Subject|0|||
33360886|NCT04101422|101207572|FG000|Overall Study|Not attending to the stimuli|0|||
33360887|NCT04101422|101207573|FG001|Overall Study|Not attending to the stimuli|0|||
33360888|NCT04101422|101207574|FG002|Overall Study|Not attending to the stimuli|4|||
33360889|NCT04101422|101207575|FG003|Overall Study|Not attending to the stimuli|0|||
33360890|NCT04101422|101207572|FG000|Overall Study|Did not download app|0|||
33360891|NCT04101422|101207573|FG001|Overall Study|Did not download app|0|||
33360892|NCT04101422|101207574|FG002|Overall Study|Did not download app|0|||
33360893|NCT04101422|101207575|FG003|Overall Study|Did not download app|17|||
33360894|NCT04101422|101207572|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
33360895|NCT04101422|101207573|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
33360896|NCT04101422|101207574|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
33562170|NCT03726879|101954573|FG001|Overall Study|Physician Decision|2|||
33562171|NCT03726879|101954572|FG000|Overall Study|Protocol Violation|0|||
33625799|NCT00644358|102180866|FG000|Overall Study|Adverse Event|124|||
33360897|NCT04101422|101207575|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
33360898|NCT01200511|101207576|FG000|Overall Study|Lost to Follow-up|3|||
33360899|NCT01200511|101207576|FG000|Overall Study|Withdrawal by Subject|1|||
33360900|NCT01200511|101207576|FG000|Overall Study|Adverse Event|1|||
33360901|NCT00667277|101207579|FG000|Overall Study|Withdrawal by Subject|2|||
33360902|NCT01887210|101207582|FG000|Overall Study|Withdrawal by Subject|1|||
33414946|NCT00980460|101409910|FG001|Overall Study|Lost to Follow-up|0|||
33414947|NCT00980460|101409911|FG002|Overall Study|Lost to Follow-up|0|||
33414948|NCT00980460|101409912|FG003|Overall Study|Lost to Follow-up|1|||
33414949|NCT00980460|101409913|FG004|Overall Study|Lost to Follow-up|0|||
33414950|NCT00980460|101409909|FG000|Overall Study|Physician Decision|0|||
33414951|NCT00980460|101409910|FG001|Overall Study|Physician Decision|0|||
33414952|NCT00980460|101409911|FG002|Overall Study|Physician Decision|11|||
33414953|NCT00980460|101409912|FG003|Overall Study|Physician Decision|5|||
33414954|NCT00980460|101409913|FG004|Overall Study|Physician Decision|3|||
33414955|NCT00980460|101409909|FG000|Overall Study|Withdrawal by Subject|0|||
33562172|NCT03726879|101954573|FG001|Overall Study|Protocol Violation|1|||
33221135|NCT02296190|100710954|FG003|Overall Study|Failure to induce PSVT|13|||
33221136|NCT02296190|100710955|FG004|Overall Study|Failure to induce PSVT|8|||
33221137|NCT02296190|100710956|FG005|Overall Study|Failure to induce PSVT|0|||
33221138|NCT02296190|100710951|FG000|Overall Study|Physician Decision|1|||
33562173|NCT03726879|101954572|FG000|Overall Study|Withdrawal by Subject|5|||
33221139|NCT02296190|100710952|FG001|Overall Study|Physician Decision|1|||
33221140|NCT02296190|100710953|FG002|Overall Study|Physician Decision|0|||
33414956|NCT00980460|101409910|FG001|Overall Study|Withdrawal by Subject|0|||
33414957|NCT00980460|101409911|FG002|Overall Study|Withdrawal by Subject|1|||
33562174|NCT03726879|101954573|FG001|Overall Study|Withdrawal by Subject|6|||
33562175|NCT03726879|101954572|FG000|Overall Study|TSH result is unstable|0|||
33562176|NCT03726879|101954573|FG001|Overall Study|TSH result is unstable|1|||
33562177|NCT03726879|101954572|FG000|Overall Study|Disease relapse|1|||
33625800|NCT00644358|102180866|FG000|Overall Study|Lost to Follow-up|105|||
33221141|NCT02296190|100710954|FG003|Overall Study|Physician Decision|1|||
33414958|NCT00980460|101409912|FG003|Overall Study|Withdrawal by Subject|0|||
33562178|NCT03726879|101954573|FG001|Overall Study|Disease relapse|0|||
33625801|NCT00644358|102180866|FG000|Overall Study|Consent Withdrawal|64|||
33625802|NCT00644358|102180866|FG000|Overall Study|Lack of Effectiveness|39|||
33625803|NCT00644358|102180866|FG000|Overall Study|Protocol Violation|5|||
33625804|NCT00644358|102180866|FG000|Overall Study|Noncompliance|14|||
33625805|NCT00644358|102180866|FG000|Overall Study|Other Unspecified|11|||
33625806|NCT00657540|102180868|FG000|Overall Study|Lost to Follow-up|1|||
33625807|NCT00657540|102180869|FG001|Overall Study|Lost to Follow-up|4|||
33221142|NCT02296190|100710955|FG004|Overall Study|Physician Decision|2|||
33221143|NCT02296190|100710956|FG005|Overall Study|Physician Decision|0|||
33221144|NCT02296190|100710951|FG000|Overall Study|Withdrawal by Subject|0|||
33221145|NCT02296190|100710952|FG001|Overall Study|Withdrawal by Subject|1|||
33221146|NCT02296190|100710953|FG002|Overall Study|Withdrawal by Subject|0|||
33221147|NCT02296190|100710954|FG003|Overall Study|Withdrawal by Subject|0|||
33221148|NCT02296190|100710955|FG004|Overall Study|Withdrawal by Subject|0|||
33625808|NCT00672555|102180870|FG000|Overall Study|Lost to Follow-up|4|||
33625809|NCT00672555|102180870|FG000|Overall Study|Did not want to answer questionnaire|2|||
33360903|NCT01887210|101207583|FG001|Overall Study|Withdrawal by Subject|3|||
33360904|NCT01887210|101207582|FG000|Overall Study|Lost to Follow-up|0|||
33360905|NCT01887210|101207583|FG001|Overall Study|Lost to Follow-up|1|||
33360906|NCT00793104|101207584|FG000|Overall Study|Lost to Follow-up|1|||
33360907|NCT01300286|101207585|FG000|Overall Study|did not get dosed|1|||
33360908|NCT03270085|101207586|FG000|Overall Study|Withdrawal by Subject|1|||
33360909|NCT03270085|101207587|FG001|Overall Study|Withdrawal by Subject|0|||
33360910|NCT02723630|101207588|FG000|Intervention Period 1|Adverse Event|1|||
33221149|NCT02296190|100710956|FG005|Overall Study|Withdrawal by Subject|0|||
33221150|NCT02296190|100710951|FG000|Overall Study|PSVT < 5 minutes|5|||
33360911|NCT02723630|101207589|FG001|Intervention Period 1|Adverse Event|0|||
33360912|NCT02723630|101207590|FG002|Intervention Period 1|Adverse Event|0|||
33414959|NCT00980460|101409913|FG004|Overall Study|Withdrawal by Subject|0|||
33414960|NCT00980460|101409909|FG000|Overall Study|Ineligible|0|||
33414961|NCT00980460|101409910|FG001|Overall Study|Ineligible|2|||
33414962|NCT00980460|101409911|FG002|Overall Study|Ineligible|3|||
33414963|NCT00980460|101409912|FG003|Overall Study|Ineligible|1|||
33414964|NCT00980460|101409913|FG004|Overall Study|Ineligible|4|||
33414965|NCT00980460|101409909|FG000|Overall Study|Refusal of further therapy|0|||
33360913|NCT02723630|101207591|FG003|Intervention Period 1|Adverse Event|0|||
33360914|NCT02723630|101207592|FG004|Intervention Period 1|Adverse Event|0|||
33360915|NCT02723630|101207593|FG005|Intervention Period 1|Adverse Event|0|||
33360916|NCT02723630|101207588|FG000|Intervention Period 3|consumption of restricted item|0|||
33360917|NCT02723630|101207589|FG001|Intervention Period 3|consumption of restricted item|1|||
33360918|NCT02723630|101207590|FG002|Intervention Period 3|consumption of restricted item|0|||
33360919|NCT02723630|101207591|FG003|Intervention Period 3|consumption of restricted item|0|||
33360920|NCT02723630|101207592|FG004|Intervention Period 3|consumption of restricted item|0|||
33360921|NCT02723630|101207593|FG005|Intervention Period 3|consumption of restricted item|0|||
33360922|NCT03103750|101207594|FG000|Overall Study|Adverse Event|1|||
33360923|NCT03103750|101207595|FG001|Overall Study|Adverse Event|0|||
33360924|NCT03103750|101207594|FG000|Overall Study|Lost to Follow-up|1|||
33360925|NCT03103750|101207595|FG001|Overall Study|Lost to Follow-up|0|||
33360926|NCT03103750|101207594|FG000|Overall Study|PET Equipment Related|2|||
33360927|NCT03103750|101207595|FG001|Overall Study|PET Equipment Related|2|||
33360928|NCT02792777|101207599|FG000|Overall Study|Withdrawal by Subject|2|||
33360929|NCT02792777|101207600|FG001|Overall Study|Withdrawal by Subject|0|||
33360930|NCT02792777|101207599|FG000|Overall Study|Recording malfunction|2|||
33360931|NCT02792777|101207600|FG001|Overall Study|Recording malfunction|0|||
33360932|NCT02792777|101207599|FG000|Overall Study|Later determined to be ineligible|2|||
33360933|NCT02792777|101207600|FG001|Overall Study|Later determined to be ineligible|0|||
33360934|NCT02792777|101207599|FG000|Overall Study|Participant interviewed twice|1|||
33360935|NCT02792777|101207600|FG001|Overall Study|Participant interviewed twice|0|||
33360936|NCT02385123|101207601|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
33414966|NCT00980460|101409910|FG001|Overall Study|Refusal of further therapy|2|||
33360937|NCT03060577|101207602|FG000|Overall Study|Withdrawal by Subject|25|||
33414967|NCT00980460|101409911|FG002|Overall Study|Refusal of further therapy|3|||
33360938|NCT03060577|101207603|FG001|Overall Study|Withdrawal by Subject|5|||
33360939|NCT03060577|101207602|FG000|Overall Study|Physician Decision|4|||
33360940|NCT03060577|101207603|FG001|Overall Study|Physician Decision|3|||
33414968|NCT00980460|101409912|FG003|Overall Study|Refusal of further therapy|2|||
33625810|NCT01339689|102180871|FG000|Overall Study|Adverse Event|1|||
33221151|NCT02296190|100710952|FG001|Overall Study|PSVT < 5 minutes|6|||
33360941|NCT03060577|101207602|FG000|Overall Study|Lost to Follow-up|3|||
33360942|NCT03060577|101207603|FG001|Overall Study|Lost to Follow-up|0|||
33414969|NCT00980460|101409913|FG004|Overall Study|Refusal of further therapy|0|||
33414970|NCT00980460|101409909|FG000|Overall Study|No therapy within 42 days of resection|0|||
33414971|NCT00980460|101409910|FG001|Overall Study|No therapy within 42 days of resection|0|||
33414972|NCT00980460|101409911|FG002|Overall Study|No therapy within 42 days of resection|3|||
33414973|NCT00980460|101409912|FG003|Overall Study|No therapy within 42 days of resection|1|||
33414974|NCT00980460|101409913|FG004|Overall Study|No therapy within 42 days of resection|0|||
33414975|NCT00980460|101409909|FG000|Overall Study|No transplant by protocol timepoints|0|||
33414976|NCT00980460|101409910|FG001|Overall Study|No transplant by protocol timepoints|0|||
33414977|NCT00980460|101409911|FG002|Overall Study|No transplant by protocol timepoints|3|||
33414978|NCT00980460|101409912|FG003|Overall Study|No transplant by protocol timepoints|0|||
33414979|NCT00980460|101409913|FG004|Overall Study|No transplant by protocol timepoints|0|||
33414980|NCT03252756|101409914|FG000|Overall Study|Protocol Violation|2|||
33414981|NCT03252756|101409915|FG001|Overall Study|Protocol Violation|4|||
33414982|NCT03252756|101409914|FG000|Overall Study|COVID-19 Pandemic|1|||
33414983|NCT03252756|101409915|FG001|Overall Study|COVID-19 Pandemic|1|||
33414984|NCT03252756|101409914|FG000|Overall Study|Study Drug Expiration|0|||
33414985|NCT03252756|101409915|FG001|Overall Study|Study Drug Expiration|1|||
33414986|NCT01265875|101409916|FG000|Overall Study|Uncooperative/unreliable|1|||
33414987|NCT03867500|101409919|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
33414988|NCT00290511|101409920|FG000|Overall Study|Adverse Event|1|||
33414989|NCT00290511|101409920|FG000|Overall Study|Death|1|||
33414990|NCT00290511|101409920|FG000|Overall Study|Physician Decision|1|||
33414991|NCT00290511|101409920|FG000|Overall Study|Withdrawal by Subject|1|||
33414992|NCT02674568|101409927|FG000|Overall Study|Withdrawal by Subject|5|||
33414993|NCT02674568|101409927|FG000|Overall Study|Death|303|||
33414994|NCT02674568|101409927|FG000|Overall Study|Physician Decision|2|||
33414995|NCT02674568|101409927|FG000|Overall Study|Lost to Follow-up|9|||
33414996|NCT02674568|101409927|FG000|Overall Study|Other, Not Specified|20|||
33414997|NCT00577031|101409928|FG000|Overall Study|Adverse Event|52|||
33414998|NCT00577031|101409928|FG000|Overall Study|Progression of disease|93|||
33414999|NCT00577031|101409928|FG000|Overall Study|Protocol Violation|5|||
33415000|NCT00577031|101409928|FG000|Overall Study|Participant withdrew consent|13|||
33415001|NCT00577031|101409928|FG000|Overall Study|Participant non-compliance|5|||
33415002|NCT00577031|101409928|FG000|Overall Study|Need for surgery|17|||
33415003|NCT00577031|101409928|FG000|Overall Study|Medical decision|14|||
33415004|NCT00577031|101409928|FG000|Overall Study|Death|6|||
33221152|NCT02296190|100710953|FG002|Overall Study|PSVT < 5 minutes|6|||
33360943|NCT03060577|101207602|FG000|Overall Study|Death|7|||
33562179|NCT03726879|101954572|FG000|Overall Study|Lost to Follow-up|3|||
33562180|NCT03726879|101954573|FG001|Overall Study|Lost to Follow-up|0|||
33562181|NCT04003142|101954574|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
33562182|NCT04003142|101954575|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
33562183|NCT04003142|101954576|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
33562184|NCT04003142|101954577|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
33562185|NCT04003142|101954578|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
33562186|NCT04003142|101954574|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
33562187|NCT04003142|101954575|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
33562188|NCT04003142|101954576|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
33562189|NCT04003142|101954577|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
33562190|NCT04003142|101954578|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
33562191|NCT04003142|101954574|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
33360944|NCT03060577|101207603|FG001|Overall Study|Death|1|||
33360945|NCT03060577|101207602|FG000|Overall Study|Adverse Event|9|||
33360946|NCT03060577|101207603|FG001|Overall Study|Adverse Event|1|||
33360947|NCT03060577|101207602|FG000|Overall Study|Inclusion/Exclusion|1|||
33360948|NCT03060577|101207603|FG001|Overall Study|Inclusion/Exclusion|0|||
33360949|NCT03060577|101207602|FG000|Overall Study|Other|8|||
33360950|NCT03060577|101207603|FG001|Overall Study|Other|2|||
33360951|NCT04334148|101207604|FG000|Overall Study|positive nasal swab at baseline|0|||
33360952|NCT04334148|101207605|FG001|Overall Study|positive nasal swab at baseline|1|||
33360953|NCT01821677|101207606|FG000|Overall Study|Adverse Event|4|||
33360954|NCT01821677|101207607|FG001|Overall Study|Adverse Event|6|||
33415005|NCT00902486|101409930|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
33415006|NCT00902486|101409931|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
33415007|NCT00902486|101409932|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
33415008|NCT00902486|101409933|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
33221153|NCT02296190|100710954|FG003|Overall Study|PSVT < 5 minutes|6|||
33415009|NCT00902486|101409934|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
33562192|NCT04003142|101954575|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
33360955|NCT01821677|101207608|FG002|Overall Study|Adverse Event|5|||
33360956|NCT01821677|101207606|FG000|Overall Study|Physician Decision|1|||
33360957|NCT01821677|101207607|FG001|Overall Study|Physician Decision|4|||
33360958|NCT01821677|101207608|FG002|Overall Study|Physician Decision|1|||
33360959|NCT01821677|101207606|FG000|Overall Study|Non-compliance|0|||
33360960|NCT01821677|101207607|FG001|Overall Study|Non-compliance|1|||
33360961|NCT01821677|101207608|FG002|Overall Study|Non-compliance|2|||
33360962|NCT01821677|101207606|FG000|Overall Study|Lost to Follow-up|2|||
33360963|NCT01821677|101207607|FG001|Overall Study|Lost to Follow-up|1|||
33360964|NCT01821677|101207608|FG002|Overall Study|Lost to Follow-up|3|||
33360965|NCT01821677|101207606|FG000|Overall Study|Protocol Violation|0|||
33360966|NCT01821677|101207607|FG001|Overall Study|Protocol Violation|0|||
33360967|NCT01821677|101207608|FG002|Overall Study|Protocol Violation|2|||
33360968|NCT01821677|101207606|FG000|Overall Study|Withdrawal by Subject|7|||
33360969|NCT01821677|101207607|FG001|Overall Study|Withdrawal by Subject|3|||
33360970|NCT01821677|101207608|FG002|Overall Study|Withdrawal by Subject|2|||
33360971|NCT01821677|101207606|FG000|Overall Study|Other|9|||
33562193|NCT04003142|101954576|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
33562194|NCT04003142|101954577|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
33562195|NCT04003142|101954578|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
33562196|NCT04003142|101954574|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
33562197|NCT04003142|101954575|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
33562198|NCT04003142|101954576|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
33562199|NCT04003142|101954577|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
33562200|NCT04003142|101954578|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
33562201|NCT04003142|101954574|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
33562202|NCT04003142|101954575|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
33562203|NCT04003142|101954576|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
33562204|NCT04003142|101954577|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
33562205|NCT04003142|101954578|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
33562206|NCT04003142|101954574|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
33562207|NCT04003142|101954575|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
33562208|NCT04003142|101954576|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
33562209|NCT04003142|101954577|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
33562210|NCT04003142|101954578|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
33562211|NCT04003142|101954574|FG000|Extension Period (40 Weeks)|Death|0|||
33562212|NCT04003142|101954575|FG001|Extension Period (40 Weeks)|Death|0|||
33562213|NCT04003142|101954576|FG002|Extension Period (40 Weeks)|Death|0|||
33562214|NCT04003142|101954577|FG003|Extension Period (40 Weeks)|Death|0|||
33562215|NCT04003142|101954578|FG004|Extension Period (40 Weeks)|Death|1|||
33562216|NCT04003142|101954574|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
33562217|NCT04003142|101954575|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
33562218|NCT04003142|101954576|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
33562219|NCT04003142|101954577|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
33562220|NCT04003142|101954578|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
33562221|NCT04003142|101954574|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
33562222|NCT04003142|101954575|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
33562223|NCT04003142|101954576|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
33562224|NCT04003142|101954577|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
33562225|NCT04003142|101954578|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
33562226|NCT04003142|101954574|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
33562227|NCT04003142|101954575|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
33562228|NCT04003142|101954576|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
33562229|NCT04003142|101954577|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
33562230|NCT04003142|101954578|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
33562231|NCT04003142|101954574|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
33562232|NCT04003142|101954575|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
33562233|NCT04003142|101954576|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
33562234|NCT04003142|101954577|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
33562235|NCT04003142|101954578|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
33562236|NCT02727699|101954579|FG000|Overall Study|Adverse Event|2|||
33562237|NCT02727699|101954580|FG001|Overall Study|Adverse Event|0|||
33562238|NCT02727699|101954579|FG000|Overall Study|Withdrawal by Subject|5|||
33360972|NCT01821677|101207607|FG001|Overall Study|Other|0|||
33360973|NCT01821677|101207608|FG002|Overall Study|Other|0|||
33562239|NCT02727699|101954580|FG001|Overall Study|Withdrawal by Subject|3|||
33562240|NCT02727699|101954579|FG000|Overall Study|Protocol Violation|0|||
33360974|NCT00144300|101210651|FG000|Overall Study|Adverse Event|18|||
33360975|NCT00144300|101210652|FG001|Overall Study|Adverse Event|16|||
33562241|NCT02727699|101954580|FG001|Overall Study|Protocol Violation|1|||
33562242|NCT02727699|101954579|FG000|Overall Study|Physician Decision|0|||
33562243|NCT02727699|101954580|FG001|Overall Study|Physician Decision|1|||
33562244|NCT02727699|101954579|FG000|Overall Study|Lost to Follow-up|1|||
33360976|NCT00144300|101210651|FG000|Overall Study|Protocol Violation|1|||
33360977|NCT00144300|101210652|FG001|Overall Study|Protocol Violation|3|||
33360978|NCT00144300|101210651|FG000|Overall Study|Lost to Follow-up|3|||
33360979|NCT00144300|101210652|FG001|Overall Study|Lost to Follow-up|0|||
33360980|NCT00144300|101210651|FG000|Overall Study|Withdrawal by Subject|6|||
33360981|NCT00144300|101210652|FG001|Overall Study|Withdrawal by Subject|6|||
33360982|NCT00144300|101210651|FG000|Overall Study|Other reason (not specified)|1|||
33360983|NCT00144300|101210652|FG001|Overall Study|Other reason (not specified)|3|||
33360984|NCT00377299|101210654|FG000|Overall Study|Lost to Follow-up|14|||
33360985|NCT00377299|101210655|FG001|Overall Study|Lost to Follow-up|19|||
33360986|NCT00377299|101210654|FG000|Overall Study|Adverse Event|0|||
33360987|NCT00377299|101210655|FG001|Overall Study|Adverse Event|1|||
33360988|NCT00377299|101210654|FG000|Overall Study|Withdrawal by Subject|5|||
33360989|NCT00377299|101210655|FG001|Overall Study|Withdrawal by Subject|4|||
33360990|NCT00875420|101210659|FG000|Overall Study|Adverse Event|0|||
33360991|NCT00875420|101210660|FG001|Overall Study|Adverse Event|1|||
33360992|NCT00875420|101210661|FG002|Overall Study|Adverse Event|1|||
33360993|NCT00875420|101210662|FG003|Overall Study|Adverse Event|0|||
33360994|NCT00875420|101210663|FG004|Overall Study|Adverse Event|0|||
33360995|NCT00875420|101210659|FG000|Overall Study|Inability to complete study procedures|1|||
33360996|NCT00875420|101210660|FG001|Overall Study|Inability to complete study procedures|0|||
33360997|NCT00875420|101210661|FG002|Overall Study|Inability to complete study procedures|1|||
33360998|NCT00875420|101210662|FG003|Overall Study|Inability to complete study procedures|1|||
33360999|NCT00875420|101210663|FG004|Overall Study|Inability to complete study procedures|1|||
33625811|NCT01339689|102180872|FG001|Overall Study|Adverse Event|2|||
33625812|NCT01339689|102180871|FG000|Overall Study|Lost to Follow-up|9|||
33625813|NCT01339689|102180872|FG001|Overall Study|Lost to Follow-up|3|||
33625814|NCT01339689|102180871|FG000|Overall Study|Withdrawal by Subject|3|||
33625815|NCT01339689|102180872|FG001|Overall Study|Withdrawal by Subject|0|||
33625816|NCT01339689|102180871|FG000|Overall Study|Noncompliance|1|||
33625817|NCT01339689|102180872|FG001|Overall Study|Noncompliance|0|||
33625818|NCT01339689|102180871|FG000|Overall Study|Relocated out of area|0|||
33625819|NCT01339689|102180872|FG001|Overall Study|Relocated out of area|1|||
33625820|NCT01339689|102180871|FG000|Overall Study|Other|2|||
33625821|NCT01339689|102180872|FG001|Overall Study|Other|2|||
33625822|NCT01339689|102180871|FG000|Overall Study|multiple reasons|1|||
33625823|NCT01339689|102180872|FG001|Overall Study|multiple reasons|1|||
33625824|NCT01945021|102180873|FG000|Overall Study|Adverse Event|1|||
33625825|NCT01945021|102180873|FG000|Overall Study|Withdrawal of consent|12|||
33625826|NCT01945021|102180873|FG000|Overall Study|Lost to Follow-up|5|||
33625827|NCT01945021|102180873|FG000|Overall Study|Death|65|||
33625828|NCT00702702|102180876|FG000|Overall Study|Study prematurely terminated|56|||
33625829|NCT00531284|102180879|FG000|Overall Study|Progressive Disease|1|||
33625830|NCT00531284|102180880|FG001|Overall Study|Progressive Disease|3|||
33625831|NCT00531284|102180881|FG002|Overall Study|Progressive Disease|5|||
33625832|NCT00531284|102180882|FG003|Overall Study|Progressive Disease|42|||
33625833|NCT00531284|102180883|FG004|Overall Study|Progressive Disease|4|||
33625834|NCT00531284|102180884|FG005|Overall Study|Progressive Disease|4|||
33625835|NCT00531284|102180885|FG006|Overall Study|Progressive Disease|3|||
33625836|NCT00531284|102180886|FG007|Overall Study|Progressive Disease|8|||
33625837|NCT00531284|102180887|FG008|Overall Study|Progressive Disease|6|||
33625838|NCT00531284|102180888|FG009|Overall Study|Progressive Disease|3|||
33625839|NCT00531284|102180889|FG010|Overall Study|Progressive Disease|3|||
33625840|NCT00531284|102180890|FG011|Overall Study|Progressive Disease|14|||
33625841|NCT00531284|102180891|FG012|Overall Study|Progressive Disease|2|||
33625842|NCT00531284|102180892|FG013|Overall Study|Progressive Disease|1|||
33625843|NCT00531284|102180893|FG014|Overall Study|Progressive Disease|2|||
33625844|NCT00531284|102180894|FG015|Overall Study|Progressive Disease|11|||
33625845|NCT00531284|102180895|FG016|Overall Study|Progressive Disease|5|||
33625846|NCT00531284|102180879|FG000|Overall Study|Adverse Event|0|||
33221154|NCT02296190|100710955|FG004|Overall Study|PSVT < 5 minutes|5|||
33625847|NCT00531284|102180880|FG001|Overall Study|Adverse Event|1|||
33221155|NCT02296190|100710956|FG005|Overall Study|PSVT < 5 minutes|0|||
33221156|NCT02296190|100710951|FG000|Overall Study|Patient was given Propofol|0|||
33221157|NCT02296190|100710952|FG001|Overall Study|Patient was given Propofol|1|||
33221158|NCT02296190|100710953|FG002|Overall Study|Patient was given Propofol|0|||
33625848|NCT00531284|102180881|FG002|Overall Study|Adverse Event|1|||
33625849|NCT00531284|102180882|FG003|Overall Study|Adverse Event|7|||
33625850|NCT00531284|102180883|FG004|Overall Study|Adverse Event|0|||
33625851|NCT00531284|102180884|FG005|Overall Study|Adverse Event|2|||
33625852|NCT00531284|102180885|FG006|Overall Study|Adverse Event|3|||
33221159|NCT02296190|100710954|FG003|Overall Study|Patient was given Propofol|1|||
33361000|NCT00875420|101210659|FG000|Overall Study|Lost to Follow-up|1|||
33361001|NCT00875420|101210660|FG001|Overall Study|Lost to Follow-up|0|||
33361002|NCT00875420|101210661|FG002|Overall Study|Lost to Follow-up|0|||
33415010|NCT00902486|101409935|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
33625853|NCT00531284|102180886|FG007|Overall Study|Adverse Event|2|||
33625854|NCT00531284|102180887|FG008|Overall Study|Adverse Event|3|||
33625855|NCT00531284|102180888|FG009|Overall Study|Adverse Event|0|||
33221160|NCT02296190|100710955|FG004|Overall Study|Patient was given Propofol|0|||
33625856|NCT00531284|102180889|FG010|Overall Study|Adverse Event|0|||
33625857|NCT00531284|102180890|FG011|Overall Study|Adverse Event|5|||
33625858|NCT00531284|102180891|FG012|Overall Study|Adverse Event|0|||
33625859|NCT00531284|102180892|FG013|Overall Study|Adverse Event|1|||
33625860|NCT00531284|102180893|FG014|Overall Study|Adverse Event|1|||
33625861|NCT00531284|102180894|FG015|Overall Study|Adverse Event|0|||
33625862|NCT00531284|102180895|FG016|Overall Study|Adverse Event|2|||
33625863|NCT00531284|102180879|FG000|Overall Study|Withdrawal by Subject|1|||
33625864|NCT00531284|102180880|FG001|Overall Study|Withdrawal by Subject|0|||
33625865|NCT00531284|102180881|FG002|Overall Study|Withdrawal by Subject|0|||
33625866|NCT00531284|102180882|FG003|Overall Study|Withdrawal by Subject|4|||
33625867|NCT00531284|102180883|FG004|Overall Study|Withdrawal by Subject|0|||
33625868|NCT00531284|102180884|FG005|Overall Study|Withdrawal by Subject|0|||
33625869|NCT00531284|102180885|FG006|Overall Study|Withdrawal by Subject|0|||
33625870|NCT00531284|102180886|FG007|Overall Study|Withdrawal by Subject|0|||
33625871|NCT00531284|102180887|FG008|Overall Study|Withdrawal by Subject|0|||
33625872|NCT00531284|102180888|FG009|Overall Study|Withdrawal by Subject|0|||
33625873|NCT00531284|102180889|FG010|Overall Study|Withdrawal by Subject|0|||
33625874|NCT00531284|102180890|FG011|Overall Study|Withdrawal by Subject|3|||
33361003|NCT00875420|101210662|FG003|Overall Study|Lost to Follow-up|0|||
33361004|NCT00875420|101210663|FG004|Overall Study|Lost to Follow-up|0|||
33625875|NCT00531284|102180891|FG012|Overall Study|Withdrawal by Subject|0|||
33625876|NCT00531284|102180892|FG013|Overall Study|Withdrawal by Subject|1|||
33625877|NCT00531284|102180893|FG014|Overall Study|Withdrawal by Subject|0|||
33625878|NCT00531284|102180894|FG015|Overall Study|Withdrawal by Subject|1|||
33625879|NCT00531284|102180895|FG016|Overall Study|Withdrawal by Subject|1|||
33625880|NCT00531284|102180879|FG000|Overall Study|Other|1|||
33625881|NCT00531284|102180880|FG001|Overall Study|Other|0|||
33625882|NCT00531284|102180881|FG002|Overall Study|Other|0|||
33625883|NCT00531284|102180882|FG003|Overall Study|Other|10|||
33625884|NCT00531284|102180883|FG004|Overall Study|Other|2|||
33625885|NCT00531284|102180884|FG005|Overall Study|Other|1|||
33625886|NCT00531284|102180885|FG006|Overall Study|Other|0|||
33625887|NCT00531284|102180886|FG007|Overall Study|Other|0|||
33625888|NCT00531284|102180887|FG008|Overall Study|Other|2|||
33625889|NCT00531284|102180888|FG009|Overall Study|Other|1|||
33625890|NCT00531284|102180889|FG010|Overall Study|Other|0|||
33625891|NCT00531284|102180890|FG011|Overall Study|Other|2|||
33625892|NCT00531284|102180891|FG012|Overall Study|Other|0|||
33625893|NCT00531284|102180892|FG013|Overall Study|Other|0|||
33625894|NCT00531284|102180893|FG014|Overall Study|Other|1|||
33625895|NCT00531284|102180894|FG015|Overall Study|Other|0|||
33625896|NCT00531284|102180895|FG016|Overall Study|Other|0|||
33625897|NCT00113841|102180896|FG000|Overall Study|Disease progression|0|||
33625898|NCT00113841|102180897|FG001|Overall Study|Disease progression|2|||
33625899|NCT00113841|102180896|FG000|Overall Study|Non-compliant|1|||
33625900|NCT00113841|102180897|FG001|Overall Study|Non-compliant|0|||
33625901|NCT02542865|102180898|FG000|Overall Study|Identified as screen failure|1|||
33625902|NCT02542865|102180899|FG001|Overall Study|Identified as screen failure|0|||
33361005|NCT00875420|101210659|FG000|Overall Study|Personal reason|0|||
33361006|NCT00875420|101210660|FG001|Overall Study|Personal reason|0|||
33361007|NCT00875420|101210661|FG002|Overall Study|Personal reason|0|||
33361008|NCT00875420|101210662|FG003|Overall Study|Personal reason|0|||
33361009|NCT00875420|101210663|FG004|Overall Study|Personal reason|1|||
33625903|NCT02542865|102180898|FG000|Overall Study|Withdrawal by Subject|16|||
33625904|NCT02542865|102180899|FG001|Overall Study|Withdrawal by Subject|0|||
33625905|NCT00683878|102180903|FG000|Overall Study|Lack of Efficacy|3|||
33625906|NCT00683878|102180904|FG001|Overall Study|Lack of Efficacy|0|||
33625907|NCT00683878|102180905|FG002|Overall Study|Lack of Efficacy|1|||
33625908|NCT00683878|102180903|FG000|Overall Study|Adverse Event|4|||
33625909|NCT00683878|102180904|FG001|Overall Study|Adverse Event|3|||
33625910|NCT00683878|102180905|FG002|Overall Study|Adverse Event|3|||
33625911|NCT00683878|102180903|FG000|Overall Study|Withdrawal by Subject|9|||
33625912|NCT00683878|102180904|FG001|Overall Study|Withdrawal by Subject|8|||
33625913|NCT00683878|102180905|FG002|Overall Study|Withdrawal by Subject|6|||
33625914|NCT00683878|102180903|FG000|Overall Study|Death|0|||
33625915|NCT00683878|102180904|FG001|Overall Study|Death|1|||
33361010|NCT00875420|101210659|FG000|Overall Study|Prohibited medication|0|||
33625916|NCT00683878|102180905|FG002|Overall Study|Death|0|||
33625917|NCT00683878|102180903|FG000|Overall Study|Lost to Follow-up|4|||
33625918|NCT00683878|102180904|FG001|Overall Study|Lost to Follow-up|2|||
33625919|NCT00683878|102180905|FG002|Overall Study|Lost to Follow-up|4|||
33625920|NCT00683878|102180903|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
33625921|NCT00683878|102180904|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
33625922|NCT00683878|102180905|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
33625923|NCT02513563|102180906|FG000|Overall Study|Death|4|||
33625924|NCT02513563|102180906|FG000|Overall Study|Withdrawal by Subject|4|||
33625925|NCT02513563|102180906|FG000|Overall Study|Physician Decision|1|||
33625926|NCT03935126|102180907|FG000|Overall Study|Study termination by sponsor|3|||
33625927|NCT00152503|102180913|FG000|Overall Study|Adverse Event|4|||
33625928|NCT01147666|102180918|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
33625929|NCT01147666|102180919|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
33625930|NCT01147666|102180920|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
33625931|NCT01147666|102180921|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33625932|NCT01147666|102180922|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33625933|NCT01147666|102180923|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33625934|NCT01147666|102180924|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33625935|NCT01147666|102180925|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33625936|NCT01147666|102180926|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33625937|NCT01147666|102180927|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33625938|NCT01147666|102180928|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33625939|NCT01147666|102180929|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33625940|NCT01147666|102180930|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
33625941|NCT01147666|102180931|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33625942|NCT01147666|102180932|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
33625943|NCT01147666|102180918|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
33625944|NCT01147666|102180919|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
33625945|NCT01147666|102180920|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
33625946|NCT01147666|102180921|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
33625947|NCT01147666|102180922|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
33625948|NCT01147666|102180923|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
33625949|NCT01147666|102180924|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
33625950|NCT01147666|102180925|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
33625951|NCT01147666|102180926|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
33625952|NCT01147666|102180927|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
33625953|NCT01147666|102180928|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
33625954|NCT01147666|102180929|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
33625955|NCT01147666|102180930|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
33625956|NCT01147666|102180931|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
33625957|NCT01147666|102180932|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
33625958|NCT01147666|102180918|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
33625959|NCT01147666|102180919|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
33625960|NCT01147666|102180920|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
33625961|NCT01147666|102180921|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
33625962|NCT01147666|102180922|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
33625963|NCT01147666|102180923|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
33625964|NCT01147666|102180924|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
33625965|NCT01147666|102180925|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
33625966|NCT01147666|102180926|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
33625967|NCT01147666|102180927|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
33625968|NCT01147666|102180928|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
33625969|NCT01147666|102180929|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
33625970|NCT01147666|102180930|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
33625971|NCT01147666|102180931|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
33625972|NCT01147666|102180932|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
33625973|NCT01147666|102180918|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
33625974|NCT01147666|102180919|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33625975|NCT01147666|102180920|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33625976|NCT01147666|102180921|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
33625977|NCT01147666|102180922|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33625978|NCT01147666|102180923|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33625979|NCT01147666|102180924|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33625980|NCT01147666|102180925|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33625981|NCT01147666|102180926|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33625982|NCT01147666|102180927|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33562245|NCT02727699|101954580|FG001|Overall Study|Lost to Follow-up|0|||
33625983|NCT01147666|102180928|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
33625984|NCT01147666|102180929|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33625985|NCT01147666|102180930|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33625986|NCT01147666|102180931|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33625987|NCT01147666|102180932|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
33625988|NCT01147666|102180918|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33625989|NCT01147666|102180919|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33625990|NCT01147666|102180920|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33625991|NCT01147666|102180921|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33625992|NCT01147666|102180922|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
33625993|NCT01147666|102180923|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
33625994|NCT01147666|102180924|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33625995|NCT01147666|102180925|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
33625996|NCT01147666|102180926|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33625997|NCT01147666|102180927|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
33625998|NCT01147666|102180928|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33625999|NCT01147666|102180929|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
33626000|NCT01147666|102180930|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33626001|NCT01147666|102180931|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
33626002|NCT01147666|102180932|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
33626003|NCT01147666|102180918|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33626004|NCT01147666|102180919|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33626005|NCT01147666|102180920|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33626006|NCT01147666|102180921|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
33626007|NCT01147666|102180922|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33626008|NCT01147666|102180923|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33626009|NCT01147666|102180924|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33626010|NCT01147666|102180925|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33626011|NCT01147666|102180926|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33626012|NCT01147666|102180927|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33626013|NCT01147666|102180928|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
33626014|NCT01147666|102180929|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33626015|NCT01147666|102180930|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33626016|NCT01147666|102180931|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33626017|NCT01147666|102180932|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
33626018|NCT01147666|102180918|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33626019|NCT01147666|102180919|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33626020|NCT01147666|102180920|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33626021|NCT01147666|102180921|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33626022|NCT01147666|102180922|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33626023|NCT01147666|102180923|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33626024|NCT01147666|102180924|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33626025|NCT01147666|102180925|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33626026|NCT01147666|102180926|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33626027|NCT01147666|102180927|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33626028|NCT01147666|102180928|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33626029|NCT01147666|102180929|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
33626030|NCT01147666|102180930|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
33626031|NCT01147666|102180931|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
33626032|NCT01147666|102180932|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
33626033|NCT01147666|102180918|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
33626034|NCT01147666|102180919|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
33626035|NCT01147666|102180920|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
33626036|NCT01147666|102180921|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
33626037|NCT01147666|102180922|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
33626038|NCT01147666|102180923|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
33626039|NCT01147666|102180924|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
33626040|NCT01147666|102180925|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
33626041|NCT01147666|102180926|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
33626042|NCT01147666|102180927|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
33626043|NCT01147666|102180928|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
33221161|NCT02296190|100710956|FG005|Overall Study|Patient was given Propofol|0|||
33221162|NCT02296190|100710951|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
33361011|NCT00875420|101210660|FG001|Overall Study|Prohibited medication|0|||
33361012|NCT00875420|101210661|FG002|Overall Study|Prohibited medication|0|||
33361013|NCT00875420|101210662|FG003|Overall Study|Prohibited medication|1|||
33626044|NCT01147666|102180929|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
33626045|NCT01147666|102180930|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
33626046|NCT01147666|102180931|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
33626047|NCT01147666|102180932|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
33626048|NCT01147666|102180918|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33626049|NCT01147666|102180919|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33626050|NCT01147666|102180920|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33626051|NCT01147666|102180921|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33626052|NCT01147666|102180922|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
33626053|NCT01147666|102180923|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
33626054|NCT01147666|102180924|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
33626055|NCT01147666|102180925|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
33626056|NCT01147666|102180926|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33626057|NCT01147666|102180927|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
33626058|NCT01147666|102180928|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33626059|NCT01147666|102180929|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33626060|NCT01147666|102180930|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
33626061|NCT01147666|102180931|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
33626062|NCT01147666|102180932|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
33626063|NCT01147666|102180918|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33626064|NCT01147666|102180919|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33626065|NCT01147666|102180920|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33626066|NCT01147666|102180921|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
33626067|NCT01147666|102180922|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33626068|NCT01147666|102180923|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33626069|NCT01147666|102180924|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33626070|NCT01147666|102180925|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33626071|NCT01147666|102180926|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33626072|NCT01147666|102180927|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33626073|NCT01147666|102180928|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33626074|NCT01147666|102180929|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33626075|NCT01147666|102180930|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33626076|NCT01147666|102180931|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33626077|NCT01147666|102180932|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
33626078|NCT01147666|102180918|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33626079|NCT01147666|102180919|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33626080|NCT01147666|102180920|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33626081|NCT01147666|102180921|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33626082|NCT01147666|102180922|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
33626083|NCT01147666|102180923|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
33626084|NCT01147666|102180924|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33626085|NCT01147666|102180925|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
33626086|NCT01147666|102180926|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33626087|NCT01147666|102180927|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
33626088|NCT01147666|102180928|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33626089|NCT01147666|102180929|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33626090|NCT01147666|102180930|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33626091|NCT01147666|102180931|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
33626092|NCT01147666|102180932|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
33626093|NCT01147666|102180918|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33626094|NCT01147666|102180919|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33626095|NCT01147666|102180920|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33626096|NCT01147666|102180921|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
33221163|NCT02296190|100710952|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
33221164|NCT02296190|100710953|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
33221165|NCT02296190|100710954|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
33221166|NCT02296190|100710955|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
33221167|NCT02296190|100710956|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
33221168|NCT02296190|100710951|FG000|Overall Study|Blood pressure <100 after sedation|0|||
33221169|NCT02296190|100710952|FG001|Overall Study|Blood pressure <100 after sedation|0|||
33221170|NCT02296190|100710953|FG002|Overall Study|Blood pressure <100 after sedation|0|||
33626097|NCT01147666|102180922|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33626098|NCT01147666|102180923|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33626099|NCT01147666|102180924|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33626100|NCT01147666|102180925|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33626101|NCT01147666|102180926|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33221171|NCT02296190|100710954|FG003|Overall Study|Blood pressure <100 after sedation|1|||
33221172|NCT02296190|100710955|FG004|Overall Study|Blood pressure <100 after sedation|0|||
33221173|NCT02296190|100710956|FG005|Overall Study|Blood pressure <100 after sedation|0|||
33221174|NCT02296190|100710951|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
33221175|NCT02296190|100710952|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
33221176|NCT02296190|100710953|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
33221177|NCT02296190|100710954|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
33221178|NCT02296190|100710955|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
33221179|NCT02296190|100710956|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
33221180|NCT02296190|100710951|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
33221181|NCT02296190|100710952|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
33221182|NCT02296190|100710953|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
33626102|NCT01147666|102180927|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33626103|NCT01147666|102180928|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
33626104|NCT01147666|102180929|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33626105|NCT01147666|102180930|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33626106|NCT01147666|102180931|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33626107|NCT01147666|102180932|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
33626108|NCT01147666|102180918|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33626109|NCT01147666|102180919|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33626110|NCT01147666|102180920|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33626111|NCT01147666|102180921|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33626112|NCT01147666|102180922|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33626113|NCT01147666|102180923|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33626114|NCT01147666|102180924|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33626115|NCT01147666|102180925|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33626116|NCT01147666|102180926|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33626117|NCT01147666|102180927|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33626118|NCT01147666|102180928|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33626119|NCT01147666|102180929|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33626120|NCT01147666|102180930|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
33626121|NCT01147666|102180931|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33626122|NCT01147666|102180932|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
33626123|NCT01147666|102180918|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33626124|NCT01147666|102180919|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33626125|NCT01147666|102180920|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33626126|NCT01147666|102180921|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33221183|NCT02296190|100710954|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
33221184|NCT02296190|100710955|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
33221185|NCT02296190|100710956|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
33221186|NCT02296190|100710951|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
33361014|NCT00875420|101210663|FG004|Overall Study|Prohibited medication|0|||
33361015|NCT00875420|101210659|FG000|Overall Study|Sponsor decision|0|||
33361016|NCT00875420|101210660|FG001|Overall Study|Sponsor decision|1|||
33562246|NCT02727699|101954579|FG000|Overall Study|Sponsor Decision|1|||
33562247|NCT02727699|101954580|FG001|Overall Study|Sponsor Decision|0|||
33562248|NCT02180867|101954581|FG000|Overall Study|Adverse Event|3|||
33562249|NCT02180867|101954582|FG001|Overall Study|Adverse Event|4|||
33562250|NCT02180867|101954583|FG002|Overall Study|Adverse Event|1|||
33562251|NCT02180867|101954584|FG003|Overall Study|Adverse Event|5|||
33562252|NCT02180867|101954585|FG004|Overall Study|Adverse Event|0|||
33562253|NCT02180867|101954586|FG005|Overall Study|Adverse Event|0|||
33562254|NCT02180867|101954587|FG006|Overall Study|Adverse Event|0|||
33562255|NCT02180867|101954581|FG000|Overall Study|Death|0|||
33562256|NCT02180867|101954582|FG001|Overall Study|Death|0|||
33562257|NCT02180867|101954583|FG002|Overall Study|Death|0|||
33562258|NCT02180867|101954584|FG003|Overall Study|Death|0|||
33626127|NCT01147666|102180922|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33626128|NCT01147666|102180923|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33626129|NCT01147666|102180924|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33626130|NCT01147666|102180925|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33221187|NCT02296190|100710952|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
33221188|NCT02296190|100710953|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
33221189|NCT02296190|100710954|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
33221190|NCT02296190|100710955|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
33221191|NCT02296190|100710956|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
33361017|NCT00875420|101210661|FG002|Overall Study|Sponsor decision|0|||
33562259|NCT02180867|101954585|FG004|Overall Study|Death|1|||
33562260|NCT02180867|101954586|FG005|Overall Study|Death|0|||
33562261|NCT02180867|101954587|FG006|Overall Study|Death|0|||
33562262|NCT02180867|101954581|FG000|Overall Study|Lack of Efficacy|0|||
33221192|NCT02296190|100710951|FG000|Overall Study|Lab result not available in time|1|||
33221193|NCT02296190|100710952|FG001|Overall Study|Lab result not available in time|0|||
33221194|NCT02296190|100710953|FG002|Overall Study|Lab result not available in time|0|||
33221195|NCT02296190|100710954|FG003|Overall Study|Lab result not available in time|0|||
33221196|NCT02296190|100710955|FG004|Overall Study|Lab result not available in time|0|||
33221197|NCT02296190|100710956|FG005|Overall Study|Lab result not available in time|0|||
33221198|NCT01693692|100710958|FG000|Overall Study|Withdrawal by Subject|12|||
33221199|NCT01693692|100710959|FG001|Overall Study|Withdrawal by Subject|10|||
33221200|NCT01693692|100710960|FG002|Overall Study|Withdrawal by Subject|11|||
33221201|NCT01693692|100710958|FG000|Overall Study|Adverse Event|7|||
33221202|NCT01693692|100710959|FG001|Overall Study|Adverse Event|14|||
33221203|NCT01693692|100710960|FG002|Overall Study|Adverse Event|9|||
33221204|NCT01693692|100710958|FG000|Overall Study|Physician Decision|0|||
33221205|NCT01693692|100710959|FG001|Overall Study|Physician Decision|0|||
33221206|NCT01693692|100710960|FG002|Overall Study|Physician Decision|1|||
33221207|NCT01693692|100710958|FG000|Overall Study|Protocol Violation|5|||
33221208|NCT01693692|100710959|FG001|Overall Study|Protocol Violation|4|||
33221209|NCT01693692|100710960|FG002|Overall Study|Protocol Violation|6|||
33221210|NCT01693692|100710958|FG000|Overall Study|Lost to Follow-up|2|||
33221211|NCT01693692|100710959|FG001|Overall Study|Lost to Follow-up|2|||
33221212|NCT01693692|100710960|FG002|Overall Study|Lost to Follow-up|3|||
33221213|NCT01693692|100710958|FG000|Overall Study|Other|4|||
33221214|NCT01693692|100710959|FG001|Overall Study|Other|4|||
33221215|NCT01693692|100710960|FG002|Overall Study|Other|6|||
33221216|NCT01690130|100710963|FG000|Overall Study|Subject have cancelled visit.|1|||
33221217|NCT01690130|100710964|FG001|Overall Study|Subject have cancelled visit.|0|||
33221218|NCT02569710|100710965|FG000|Overall Study|Adverse Event|1|||
33221219|NCT02569710|100710966|FG001|Overall Study|Adverse Event|0|||
33221220|NCT02569710|100710967|FG002|Overall Study|Adverse Event|0|||
33221221|NCT02569710|100710968|FG003|Overall Study|Adverse Event|0|||
33221222|NCT02569710|100710969|FG004|Overall Study|Adverse Event|0|||
33221223|NCT02569710|100710970|FG005|Overall Study|Adverse Event|0|||
33221224|NCT02569710|100710971|FG006|Overall Study|Adverse Event|0|||
33221225|NCT02569710|100710972|FG007|Overall Study|Adverse Event|0|||
33221226|NCT02569710|100710973|FG008|Overall Study|Adverse Event|0|||
33221227|NCT02569710|100710974|FG009|Overall Study|Adverse Event|0|||
33221228|NCT02569710|100710965|FG000|Overall Study|Lost to Follow-up|0|||
33221229|NCT02569710|100710966|FG001|Overall Study|Lost to Follow-up|0|||
33221230|NCT02569710|100710967|FG002|Overall Study|Lost to Follow-up|0|||
33221231|NCT02569710|100710968|FG003|Overall Study|Lost to Follow-up|0|||
33221232|NCT02569710|100710969|FG004|Overall Study|Lost to Follow-up|0|||
33221233|NCT02569710|100710970|FG005|Overall Study|Lost to Follow-up|0|||
33221234|NCT02569710|100710971|FG006|Overall Study|Lost to Follow-up|1|||
33221235|NCT02569710|100710972|FG007|Overall Study|Lost to Follow-up|0|||
33221236|NCT02569710|100710973|FG008|Overall Study|Lost to Follow-up|1|||
33221237|NCT02569710|100710974|FG009|Overall Study|Lost to Follow-up|0|||
33221238|NCT02569710|100710965|FG000|Overall Study|Virologic failure|0|||
33221239|NCT02569710|100710966|FG001|Overall Study|Virologic failure|0|||
33221240|NCT02569710|100710967|FG002|Overall Study|Virologic failure|0|||
33221241|NCT02569710|100710968|FG003|Overall Study|Virologic failure|0|||
33221242|NCT02569710|100710969|FG004|Overall Study|Virologic failure|1|||
33221243|NCT02569710|100710970|FG005|Overall Study|Virologic failure|0|||
33221244|NCT02569710|100710971|FG006|Overall Study|Virologic failure|1|||
33221245|NCT02569710|100710972|FG007|Overall Study|Virologic failure|0|||
33221246|NCT02569710|100710973|FG008|Overall Study|Virologic failure|0|||
33221247|NCT02569710|100710974|FG009|Overall Study|Virologic failure|0|||
33415011|NCT00902486|101409930|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
33562263|NCT02180867|101954582|FG001|Overall Study|Lack of Efficacy|2|||
33562264|NCT02180867|101954583|FG002|Overall Study|Lack of Efficacy|0|||
33562265|NCT02180867|101954584|FG003|Overall Study|Lack of Efficacy|1|||
33562266|NCT02180867|101954585|FG004|Overall Study|Lack of Efficacy|6|||
33562267|NCT02180867|101954586|FG005|Overall Study|Lack of Efficacy|0|||
33562268|NCT02180867|101954587|FG006|Overall Study|Lack of Efficacy|1|||
33562269|NCT02180867|101954581|FG000|Overall Study|Physician Decision|1|||
33221248|NCT02569710|100710965|FG000|Overall Study|Withdrawal by Subject|0|||
33221249|NCT02569710|100710966|FG001|Overall Study|Withdrawal by Subject|0|||
33221250|NCT02569710|100710967|FG002|Overall Study|Withdrawal by Subject|0|||
33221251|NCT02569710|100710968|FG003|Overall Study|Withdrawal by Subject|0|||
33221252|NCT02569710|100710969|FG004|Overall Study|Withdrawal by Subject|0|||
33221253|NCT02569710|100710970|FG005|Overall Study|Withdrawal by Subject|1|||
33221254|NCT02569710|100710971|FG006|Overall Study|Withdrawal by Subject|0|||
33221255|NCT02569710|100710972|FG007|Overall Study|Withdrawal by Subject|0|||
33221256|NCT02569710|100710973|FG008|Overall Study|Withdrawal by Subject|0|||
33221257|NCT02569710|100710974|FG009|Overall Study|Withdrawal by Subject|0|||
33221258|NCT03403426|100710978|FG000|Overall Study|Death|1|||
33562270|NCT02180867|101954582|FG001|Overall Study|Physician Decision|3|||
33562271|NCT02180867|101954583|FG002|Overall Study|Physician Decision|1|||
33562272|NCT02180867|101954584|FG003|Overall Study|Physician Decision|10|||
33221259|NCT03403426|100710978|FG000|Overall Study|Lost to Follow-up|2|||
33221260|NCT01678131|100710979|FG000|Overall Study|Adverse Event|0|||
33221261|NCT01678131|100710980|FG001|Overall Study|Adverse Event|1|||
33221262|NCT01678131|100710981|FG002|Overall Study|Adverse Event|0|||
33221263|NCT01678131|100710979|FG000|Overall Study|Withdrawal by Subject|0|||
33221264|NCT01678131|100710980|FG001|Overall Study|Withdrawal by Subject|0|||
33221265|NCT01678131|100710981|FG002|Overall Study|Withdrawal by Subject|2|||
33221266|NCT00985725|100710982|FG000|Overall Study|Adverse Event|4|||
33221267|NCT00985725|100710983|FG001|Overall Study|Adverse Event|1|||
33221268|NCT00985725|100710982|FG000|Overall Study|Protocol Violation|1|||
33221269|NCT00985725|100710983|FG001|Overall Study|Protocol Violation|3|||
33221270|NCT00985725|100710982|FG000|Overall Study|Withdrawal by Subject|4|||
33221271|NCT00985725|100710983|FG001|Overall Study|Withdrawal by Subject|4|||
33221272|NCT00985725|100710982|FG000|Overall Study|Lost to Follow-up|1|||
33221273|NCT00985725|100710983|FG001|Overall Study|Lost to Follow-up|1|||
33221274|NCT00985725|100710982|FG000|Overall Study|Lack of Efficacy|0|||
33221275|NCT00985725|100710983|FG001|Overall Study|Lack of Efficacy|1|||
33221276|NCT00985725|100710982|FG000|Overall Study|Non-compliance|1|||
33221277|NCT00985725|100710983|FG001|Overall Study|Non-compliance|2|||
33221278|NCT00985725|100710982|FG000|Overall Study|Out-of-window visits|0|||
33221279|NCT00985725|100710983|FG001|Overall Study|Out-of-window visits|1|||
33221280|NCT00387894|100710984|FG000|Overall Study|Withdrawal by Subject|1|||
33221281|NCT00615264|100710985|FG000|Overall Study|Withdrawal by Subject|17|||
33221282|NCT00615264|100710986|FG001|Overall Study|Withdrawal by Subject|19|||
33221283|NCT00615264|100710985|FG000|Overall Study|Lost to Follow-up|6|||
33221284|NCT00615264|100710986|FG001|Overall Study|Lost to Follow-up|13|||
33221285|NCT00615264|100710985|FG000|Overall Study|Adverse Event|8|||
33221286|NCT00615264|100710986|FG001|Overall Study|Adverse Event|5|||
33221287|NCT00615264|100710985|FG000|Overall Study|Death|1|||
33221288|NCT00615264|100710986|FG001|Overall Study|Death|1|||
33221289|NCT00615264|100710985|FG000|Overall Study|Protocol Violation|11|||
33221290|NCT00615264|100710986|FG001|Overall Study|Protocol Violation|7|||
33221291|NCT00615264|100710985|FG000|Overall Study|Not defined|7|||
33221292|NCT00615264|100710986|FG001|Overall Study|Not defined|4|||
33221293|NCT00615264|100710985|FG000|Overall Study|Dermal Hypersensitivity|0|||
33221294|NCT00615264|100710986|FG001|Overall Study|Dermal Hypersensitivity|3|||
33221295|NCT01376323|100710987|FG000|Overall Study|Adverse Event|1|||
33221296|NCT01376323|100710988|FG001|Overall Study|Adverse Event|0|||
33221297|NCT01376323|100710989|FG002|Overall Study|Adverse Event|0|||
33221298|NCT01376323|100710990|FG003|Overall Study|Adverse Event|2|||
33221299|NCT01376323|100710991|FG004|Overall Study|Adverse Event|0|||
33221300|NCT01376323|100710987|FG000|Overall Study|Lost to Follow-up|0|||
33221301|NCT01376323|100710988|FG001|Overall Study|Lost to Follow-up|0|||
33221302|NCT01376323|100710989|FG002|Overall Study|Lost to Follow-up|0|||
33221303|NCT01376323|100710990|FG003|Overall Study|Lost to Follow-up|2|||
33221304|NCT01376323|100710991|FG004|Overall Study|Lost to Follow-up|0|||
33221305|NCT01376323|100710987|FG000|Overall Study|Physician Decision|1|||
33221306|NCT01376323|100710988|FG001|Overall Study|Physician Decision|0|||
33221307|NCT01376323|100710989|FG002|Overall Study|Physician Decision|2|||
33221308|NCT01376323|100710990|FG003|Overall Study|Physician Decision|1|||
33221309|NCT01376323|100710991|FG004|Overall Study|Physician Decision|1|||
33221310|NCT01376323|100710987|FG000|Overall Study|Withdrawal by Subject|0|||
33221311|NCT01376323|100710988|FG001|Overall Study|Withdrawal by Subject|1|||
33221312|NCT01376323|100710989|FG002|Overall Study|Withdrawal by Subject|1|||
33221313|NCT01376323|100710990|FG003|Overall Study|Withdrawal by Subject|0|||
33221314|NCT01376323|100710991|FG004|Overall Study|Withdrawal by Subject|0|||
33221315|NCT00674570|100710995|FG000|Overall Study|Withdrawal by Subject|0|||
33221316|NCT00674570|100710996|FG001|Overall Study|Withdrawal by Subject|2|||
33221317|NCT00674570|100710997|FG002|Overall Study|Withdrawal by Subject|0|||
33221318|NCT04247282|100710998|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
33221319|NCT04247282|100710999|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
33221320|NCT04247282|100711000|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
33221321|NCT04247282|100711001|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
33221322|NCT04247282|100710998|FG000|Overall Study|Refused further treatment|0|||
33221323|NCT04247282|100710999|FG001|Overall Study|Refused further treatment|1|||
33221324|NCT04247282|100711000|FG002|Overall Study|Refused further treatment|0|||
33221325|NCT04247282|100711001|FG003|Overall Study|Refused further treatment|0|||
33221326|NCT00085202|100711004|FG000|Overall Study|Still on therapy|2|||
33221327|NCT00085202|100711005|FG001|Overall Study|Still on therapy|0|||
33221328|NCT00085202|100711004|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
33221329|NCT00085202|100711005|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
33221330|NCT00085202|100711004|FG000|Overall Study|Excessive toxicity|6|||
33626131|NCT01147666|102180926|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33221331|NCT00085202|100711005|FG001|Overall Study|Excessive toxicity|5|||
33221332|NCT00085202|100711004|FG000|Overall Study|Non-specified|3|||
33221333|NCT00085202|100711005|FG001|Overall Study|Non-specified|5|||
33361018|NCT00875420|101210662|FG003|Overall Study|Sponsor decision|0|||
33221334|NCT00085202|100711004|FG000|Overall Study|Withdrawal by Subject|2|||
33221335|NCT00085202|100711005|FG001|Overall Study|Withdrawal by Subject|1|||
33221336|NCT00085202|100711004|FG000|Overall Study|Physician Decision|4|||
33221337|NCT00085202|100711005|FG001|Overall Study|Physician Decision|1|||
33221338|NCT00085202|100711004|FG000|Overall Study|Progressive disease|1|||
33221339|NCT00085202|100711005|FG001|Overall Study|Progressive disease|11|||
33221340|NCT00895622|100711012|FG000|Overall Study|Protocol Violation|5|||
33221341|NCT00895622|100711013|FG001|Overall Study|Protocol Violation|4|||
33221342|NCT00895622|100711014|FG002|Overall Study|Protocol Violation|4|||
33221343|NCT01424930|100711015|FG000|Overall Study|Adverse Event|0|||
33221344|NCT01424930|100711016|FG001|Overall Study|Adverse Event|1|||
33221345|NCT01424930|100711015|FG000|Overall Study|Death|1|||
33221346|NCT01424930|100711016|FG001|Overall Study|Death|0|||
33221347|NCT01424930|100711015|FG000|Overall Study|Progressive Disease|3|||
33221348|NCT01424930|100711016|FG001|Overall Study|Progressive Disease|6|||
33221349|NCT01424930|100711015|FG000|Overall Study|Screen Failure|0|||
33221350|NCT01424930|100711016|FG001|Overall Study|Screen Failure|1|||
33361019|NCT00875420|101210663|FG004|Overall Study|Sponsor decision|0|||
33361020|NCT00875420|101210659|FG000|Overall Study|Withdrawal by Subject|0|||
33562273|NCT02180867|101954585|FG004|Overall Study|Physician Decision|9|||
33562274|NCT02180867|101954586|FG005|Overall Study|Physician Decision|3|||
33562275|NCT02180867|101954587|FG006|Overall Study|Physician Decision|4|||
33562276|NCT02180867|101954581|FG000|Overall Study|Withdrawal by Subject|0|||
33562277|NCT02180867|101954582|FG001|Overall Study|Withdrawal by Subject|0|||
33562278|NCT02180867|101954583|FG002|Overall Study|Withdrawal by Subject|0|||
33562279|NCT02180867|101954584|FG003|Overall Study|Withdrawal by Subject|1|||
33562280|NCT02180867|101954585|FG004|Overall Study|Withdrawal by Subject|1|||
33562281|NCT02180867|101954586|FG005|Overall Study|Withdrawal by Subject|0|||
33562282|NCT02180867|101954587|FG006|Overall Study|Withdrawal by Subject|0|||
33562283|NCT02180867|101954581|FG000|Overall Study|Ineligible|1|||
33562284|NCT02180867|101954582|FG001|Overall Study|Ineligible|2|||
33361021|NCT00875420|101210660|FG001|Overall Study|Withdrawal by Subject|0|||
33361022|NCT00875420|101210661|FG002|Overall Study|Withdrawal by Subject|1|||
33361023|NCT00875420|101210662|FG003|Overall Study|Withdrawal by Subject|0|||
33361024|NCT00875420|101210663|FG004|Overall Study|Withdrawal by Subject|0|||
33361025|NCT03825042|101210667|FG000|Overall Study|Adverse Event|1|||
33361026|NCT03825042|101210668|FG001|Overall Study|Adverse Event|0|||
33361027|NCT03825042|101210667|FG000|Overall Study|Withdrawal by Subject|1|||
33361028|NCT03825042|101210668|FG001|Overall Study|Withdrawal by Subject|0|||
33361029|NCT01416610|101210669|FG000|Overall Study|Adverse Event|4|||
33361030|NCT01416610|101210669|FG000|Overall Study|Adverse Event -Patient decision|3|||
33361031|NCT01416610|101210669|FG000|Overall Study|Lack of Efficacy|4|||
33361032|NCT01416610|101210669|FG000|Overall Study|No reason given|5|||
33361033|NCT01416610|101210669|FG000|Overall Study|Withdrawal by Subject|13|||
33361034|NCT01416610|101210669|FG000|Overall Study|Lost to Follow-up|7|||
33415012|NCT00902486|101409931|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
33415013|NCT00902486|101409932|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
33415014|NCT00902486|101409933|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
33415015|NCT00902486|101409934|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
33562285|NCT02180867|101954583|FG002|Overall Study|Ineligible|0|||
33562286|NCT02180867|101954584|FG003|Overall Study|Ineligible|3|||
33562287|NCT02180867|101954585|FG004|Overall Study|Ineligible|5|||
33562288|NCT02180867|101954586|FG005|Overall Study|Ineligible|0|||
33562289|NCT02180867|101954587|FG006|Overall Study|Ineligible|0|||
33562290|NCT02180867|101954581|FG000|Overall Study|Repeat Eligibility Studies|0|||
33562291|NCT02180867|101954582|FG001|Overall Study|Repeat Eligibility Studies|0|||
33221351|NCT01424930|100711015|FG000|Overall Study|Reason not specified|0|||
33221352|NCT01424930|100711016|FG001|Overall Study|Reason not specified|6|||
33562292|NCT02180867|101954583|FG002|Overall Study|Repeat Eligibility Studies|0|||
33221353|NCT00508261|100711017|FG000|Overall Study|Other|0|||
33221354|NCT00508261|100711018|FG001|Overall Study|Other|1|||
33361035|NCT01416610|101210669|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
33361036|NCT03976401|101210670|FG000|Overall Study|Adverse Event|2|||
33562293|NCT02180867|101954584|FG003|Overall Study|Repeat Eligibility Studies|0|||
33562294|NCT02180867|101954585|FG004|Overall Study|Repeat Eligibility Studies|1|||
33562295|NCT02180867|101954586|FG005|Overall Study|Repeat Eligibility Studies|0|||
33562296|NCT02180867|101954587|FG006|Overall Study|Repeat Eligibility Studies|0|||
33221355|NCT00508261|100711019|FG002|Overall Study|Other|1|||
33221356|NCT00508261|100711020|FG003|Overall Study|Other|0|||
33221357|NCT00508261|100711017|FG000|Overall Study|Serious Adverse Event|0|||
33221358|NCT00508261|100711018|FG001|Overall Study|Serious Adverse Event|1|||
33221359|NCT00508261|100711019|FG002|Overall Study|Serious Adverse Event|0|||
33221360|NCT00508261|100711020|FG003|Overall Study|Serious Adverse Event|0|||
33562297|NCT02180867|101954581|FG000|Overall Study|Refusal of further protocol therapy|1|||
33562298|NCT02180867|101954582|FG001|Overall Study|Refusal of further protocol therapy|0|||
33221361|NCT00508261|100711017|FG000|Overall Study|Withdrawal by Subject|3|||
33221362|NCT00508261|100711018|FG001|Overall Study|Withdrawal by Subject|4|||
33221363|NCT00508261|100711019|FG002|Overall Study|Withdrawal by Subject|4|||
33221364|NCT00508261|100711020|FG003|Overall Study|Withdrawal by Subject|0|||
33221365|NCT00508261|100711017|FG000|Overall Study|Migrated/ moved from study area|0|||
33221366|NCT00508261|100711018|FG001|Overall Study|Migrated/ moved from study area|1|||
33221367|NCT00508261|100711019|FG002|Overall Study|Migrated/ moved from study area|0|||
33221368|NCT00508261|100711020|FG003|Overall Study|Migrated/ moved from study area|0|||
33221369|NCT00508261|100711017|FG000|Overall Study|Lost to Follow-up|0|||
33221370|NCT00508261|100711018|FG001|Overall Study|Lost to Follow-up|1|||
33221371|NCT00508261|100711019|FG002|Overall Study|Lost to Follow-up|1|||
33221372|NCT00508261|100711020|FG003|Overall Study|Lost to Follow-up|1|||
33221373|NCT00962247|100711023|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
33361037|NCT03976401|101210671|FG001|Overall Study|Adverse Event|0|||
33361038|NCT03976401|101210672|FG002|Overall Study|Adverse Event|4|||
33361039|NCT03976401|101210673|FG003|Overall Study|Adverse Event|1|||
33361040|NCT03976401|101210674|FG004|Overall Study|Adverse Event|1|||
33361041|NCT03976401|101210675|FG005|Overall Study|Adverse Event|0|||
33361042|NCT03976401|101210670|FG000|Overall Study|Withdrawal by Subject|0|||
33361043|NCT03976401|101210671|FG001|Overall Study|Withdrawal by Subject|1|||
33361044|NCT03976401|101210672|FG002|Overall Study|Withdrawal by Subject|0|||
33361045|NCT03976401|101210673|FG003|Overall Study|Withdrawal by Subject|0|||
33361046|NCT03976401|101210674|FG004|Overall Study|Withdrawal by Subject|0|||
33361047|NCT03976401|101210675|FG005|Overall Study|Withdrawal by Subject|1|||
33361048|NCT03976401|101210670|FG000|Overall Study|Physician Decision|0|||
33361049|NCT03976401|101210671|FG001|Overall Study|Physician Decision|0|||
33361050|NCT03976401|101210672|FG002|Overall Study|Physician Decision|1|||
33562299|NCT02180867|101954583|FG002|Overall Study|Refusal of further protocol therapy|2|||
33562300|NCT02180867|101954584|FG003|Overall Study|Refusal of further protocol therapy|6|||
33562301|NCT02180867|101954585|FG004|Overall Study|Refusal of further protocol therapy|4|||
33562302|NCT02180867|101954586|FG005|Overall Study|Refusal of further protocol therapy|0|||
33562303|NCT02180867|101954587|FG006|Overall Study|Refusal of further protocol therapy|0|||
33562304|NCT03160573|101954589|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
33562305|NCT03160573|101954590|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
33562306|NCT03160573|101954591|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
33562307|NCT03160573|101954592|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
33562308|NCT03633058|101954593|FG000|Overall Study|Adverse Event|0|||
33562309|NCT03633058|101954594|FG001|Overall Study|Adverse Event|0|||
33562310|NCT03633058|101954595|FG002|Overall Study|Adverse Event|1|||
33562311|NCT03633058|101954596|FG003|Overall Study|Adverse Event|0|||
33562312|NCT01791205|101954597|FG000|Phase II|Lack of Efficacy|6|||
33562313|NCT01791205|101954598|FG001|Phase II|Lack of Efficacy|0|||
33562314|NCT01791205|101954597|FG000|Phase II|Adverse Event|2|||
33562315|NCT01791205|101954598|FG001|Phase II|Adverse Event|0|||
33562316|NCT01791205|101954597|FG000|Phase II|Safety|1|||
33562317|NCT01791205|101954598|FG001|Phase II|Safety|0|||
33562318|NCT01791205|101954597|FG000|Phase II|Lost to Follow-up|1|||
33562319|NCT01791205|101954598|FG001|Phase II|Lost to Follow-up|0|||
33562320|NCT01791205|101954597|FG000|Phase II|Remission of disease|1|||
33562321|NCT01791205|101954598|FG001|Phase II|Remission of disease|0|||
33562322|NCT01791205|101954597|FG000|Phase II|Physician's decision|1|||
33562323|NCT01791205|101954598|FG001|Phase II|Physician's decision|0|||
33221374|NCT00962247|100711023|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
33221375|NCT00429663|100711025|FG000|Overall Study|Lost to Follow-up|24|||
33361051|NCT03976401|101210673|FG003|Overall Study|Physician Decision|0|||
33562324|NCT01213251|101954603|FG000|Overall Study|Death|2|||
33562325|NCT01213251|101954604|FG001|Overall Study|Death|1|||
33562326|NCT01213251|101954605|FG002|Overall Study|Death|2|||
33562327|NCT01213251|101954603|FG000|Overall Study|Exit|3|||
33562328|NCT01213251|101954604|FG001|Overall Study|Exit|2|||
33361052|NCT03976401|101210674|FG004|Overall Study|Physician Decision|0|||
33562329|NCT01213251|101954605|FG002|Overall Study|Exit|8|||
33221376|NCT00429663|100711026|FG001|Overall Study|Lost to Follow-up|31|||
33221377|NCT00429663|100711025|FG000|Overall Study|Physician Decision|6|||
33221378|NCT00429663|100711026|FG001|Overall Study|Physician Decision|3|||
33562330|NCT01213251|101954603|FG000|Overall Study|Protocol Violation|1|||
33562331|NCT01213251|101954604|FG001|Overall Study|Protocol Violation|1|||
33562332|NCT01213251|101954605|FG002|Overall Study|Protocol Violation|0|||
33361053|NCT03976401|101210675|FG005|Overall Study|Physician Decision|0|||
33361054|NCT03976401|101210670|FG000|Overall Study|Lost to Follow-up|1|||
33562333|NCT01213251|101954603|FG000|Overall Study|Missed 18-Month Follow-up|0|||
33361055|NCT03976401|101210671|FG001|Overall Study|Lost to Follow-up|2|||
33361056|NCT03976401|101210672|FG002|Overall Study|Lost to Follow-up|0|||
33361057|NCT03976401|101210673|FG003|Overall Study|Lost to Follow-up|0|||
33361058|NCT03976401|101210674|FG004|Overall Study|Lost to Follow-up|0|||
33361059|NCT03976401|101210675|FG005|Overall Study|Lost to Follow-up|0|||
33361060|NCT03976401|101210670|FG000|Overall Study|Protocol Violation|0|||
33361061|NCT03976401|101210671|FG001|Overall Study|Protocol Violation|1|||
33361062|NCT03976401|101210672|FG002|Overall Study|Protocol Violation|0|||
33361063|NCT03976401|101210673|FG003|Overall Study|Protocol Violation|0|||
33361064|NCT03976401|101210674|FG004|Overall Study|Protocol Violation|0|||
33361065|NCT03976401|101210675|FG005|Overall Study|Protocol Violation|0|||
33361066|NCT03976401|101210670|FG000|Overall Study|Withdrew Consent|0|||
33361067|NCT03976401|101210671|FG001|Overall Study|Withdrew Consent|0|||
33361068|NCT03976401|101210672|FG002|Overall Study|Withdrew Consent|0|||
33361069|NCT03976401|101210673|FG003|Overall Study|Withdrew Consent|1|||
33361070|NCT03976401|101210674|FG004|Overall Study|Withdrew Consent|0|||
33361071|NCT03976401|101210675|FG005|Overall Study|Withdrew Consent|0|||
33361072|NCT05253807|101210680|FG000|Overall Study|Death|1|||
33361073|NCT05253807|101210681|FG001|Overall Study|Death|4|||
33361074|NCT05253807|101210680|FG000|Overall Study|Withdrawal by Subject|1|||
33361075|NCT05253807|101210681|FG001|Overall Study|Withdrawal by Subject|0|||
33361076|NCT05253807|101210680|FG000|Overall Study|Study Terminated by Sponsor|1|||
33361077|NCT05253807|101210681|FG001|Overall Study|Study Terminated by Sponsor|1|||
33361078|NCT02955186|101210685|FG000|Overall Study|Withdrawal by Subject|6|||
33361079|NCT02955186|101210686|FG001|Overall Study|Withdrawal by Subject|2|||
33361080|NCT02955186|101210685|FG000|Overall Study|Protocol Violation|1|||
33361081|NCT02955186|101210686|FG001|Overall Study|Protocol Violation|0|||
33361082|NCT00893789|101210687|FG000|Overall Study|Withdrawal by Subject|3|||
33361083|NCT00893789|101210688|FG001|Overall Study|Withdrawal by Subject|1|||
33361084|NCT00893789|101210689|FG002|Overall Study|Withdrawal by Subject|3|||
33361085|NCT00893789|101210690|FG003|Overall Study|Withdrawal by Subject|1|||
33361086|NCT00893789|101210687|FG000|Overall Study|Noncompliance With Study Drug|1|||
33361087|NCT00893789|101210688|FG001|Overall Study|Noncompliance With Study Drug|0|||
33361088|NCT00893789|101210689|FG002|Overall Study|Noncompliance With Study Drug|1|||
33562334|NCT01213251|101954604|FG001|Overall Study|Missed 18-Month Follow-up|0|||
33562335|NCT01213251|101954605|FG002|Overall Study|Missed 18-Month Follow-up|1|||
33562336|NCT00480025|101954606|FG000|Overall Study|Protocol Violation|12|||
33562337|NCT00480025|101954607|FG001|Overall Study|Protocol Violation|7|||
33562338|NCT00480025|101954606|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
33562339|NCT00480025|101954607|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
33562340|NCT00480025|101954606|FG000|Overall Study|Disease Progression / Recurrence|449|||
33562341|NCT00480025|101954607|FG001|Overall Study|Disease Progression / Recurrence|224|||
33562342|NCT00480025|101954606|FG000|Overall Study|Adverse Event|44|||
33562343|NCT00480025|101954607|FG001|Overall Study|Adverse Event|12|||
33562344|NCT00480025|101954606|FG000|Overall Study|Other|70|||
33562345|NCT00480025|101954607|FG001|Overall Study|Other|29|||
33562346|NCT00480025|101954606|FG000|Overall Study|SAE including intercurrent illness|76|||
33562347|NCT00480025|101954607|FG001|Overall Study|SAE including intercurrent illness|42|||
33562348|NCT00595075|101954608|FG000|Overall Study|Withdrawal by Subject|1|||
33562349|NCT00595075|101954609|FG001|Overall Study|Withdrawal by Subject|0|||
33562350|NCT04985682|101954611|FG000|Overall Study|Withdrawal by Subject|1|||
33562351|NCT00489359|101954612|FG000|Overall Study|Death|0|||
33562352|NCT00489359|101954613|FG001|Overall Study|Death|2|||
33562353|NCT00489359|101954612|FG000|Overall Study|Progressive Disease|5|||
33562354|NCT00489359|101954613|FG001|Overall Study|Progressive Disease|6|||
33221379|NCT00429663|100711025|FG000|Overall Study|Withdrawal by Subject|2|||
33221380|NCT00429663|100711026|FG001|Overall Study|Withdrawal by Subject|5|||
33562355|NCT00489359|101954612|FG000|Overall Study|Lost to Follow-up|1|||
33562356|NCT00489359|101954613|FG001|Overall Study|Lost to Follow-up|0|||
33562357|NCT00489359|101954612|FG000|Overall Study|Withdrawal by Subject|1|||
33562358|NCT00489359|101954613|FG001|Overall Study|Withdrawal by Subject|5|||
33361089|NCT00893789|101210690|FG003|Overall Study|Noncompliance With Study Drug|2|||
33361090|NCT00893789|101210687|FG000|Overall Study|Noncompliance With Study Procedures|1|||
33361091|NCT00893789|101210688|FG001|Overall Study|Noncompliance With Study Procedures|0|||
33361092|NCT00893789|101210689|FG002|Overall Study|Noncompliance With Study Procedures|0|||
33361093|NCT00893789|101210690|FG003|Overall Study|Noncompliance With Study Procedures|0|||
33361094|NCT00893789|101210687|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
33361095|NCT00893789|101210688|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
33562359|NCT00489359|101954612|FG000|Overall Study|Adverse Event|0|||
33562360|NCT00489359|101954613|FG001|Overall Study|Adverse Event|16|||
33562361|NCT02067156|101954614|FG000|Overall Study|Lost to Follow-up|4|||
33626132|NCT01147666|102180927|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33626133|NCT01147666|102180928|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33626134|NCT01147666|102180929|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33626135|NCT01147666|102180930|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
33221381|NCT00429663|100711025|FG000|Overall Study|Death|4|||
33221382|NCT00429663|100711026|FG001|Overall Study|Death|0|||
33221383|NCT00263328|100711030|FG000|Overall Study|Death|0|||
33562362|NCT04115293|101954615|FG000|Overall Study|Adverse Event|0|||
33562363|NCT04115293|101954616|FG001|Overall Study|Adverse Event|2|||
33562364|NCT04115293|101954615|FG000|Overall Study|Withdrawal by Subject|2|||
33562365|NCT04115293|101954616|FG001|Overall Study|Withdrawal by Subject|1|||
33562366|NCT04115293|101954615|FG000|Overall Study|Physician Decision|1|||
33562367|NCT04115293|101954616|FG001|Overall Study|Physician Decision|0|||
33221384|NCT00263328|100711031|FG001|Overall Study|Death|0|||
33221385|NCT00263328|100711032|FG002|Overall Study|Death|1|||
33221386|NCT00263328|100711030|FG000|Overall Study|Lost to Follow-up|1|||
33361096|NCT00893789|101210689|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
33361097|NCT00893789|101210690|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
33361098|NCT00893789|101210687|FG000|Overall Study|Adverse Event|0|||
33562368|NCT04115293|101954615|FG000|Overall Study|Death|1|||
33562369|NCT04115293|101954616|FG001|Overall Study|Death|1|||
33562370|NCT02799043|101954617|FG000|Overall Study|Adverse Event|0|||
33562371|NCT02799043|101954618|FG001|Overall Study|Adverse Event|1|||
33562372|NCT02799043|101954617|FG000|Overall Study|Death|1|||
33562373|NCT02799043|101954618|FG001|Overall Study|Death|1|||
33626136|NCT01147666|102180931|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
33626137|NCT01147666|102180932|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
33626138|NCT00883779|102180933|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
33626139|NCT00883779|102180934|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
33626140|NCT00883779|102180933|FG000|Primary Study Treatment Phase|Disease progression|75|||
33626141|NCT00883779|102180934|FG001|Primary Study Treatment Phase|Disease progression|59|||
33626142|NCT00883779|102180933|FG000|Primary Study Treatment Phase|Adverse Event|16|||
33626143|NCT00883779|102180934|FG001|Primary Study Treatment Phase|Adverse Event|16|||
33626144|NCT00883779|102180933|FG000|Primary Study Treatment Phase|Death|2|||
33626145|NCT00883779|102180934|FG001|Primary Study Treatment Phase|Death|3|||
33626146|NCT00883779|102180933|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
33626147|NCT00883779|102180934|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
33221387|NCT00263328|100711031|FG001|Overall Study|Lost to Follow-up|1|||
33221388|NCT00263328|100711032|FG002|Overall Study|Lost to Follow-up|0|||
33562374|NCT02799043|101954617|FG000|Overall Study|Lost to Follow-up|3|||
33562375|NCT02799043|101954618|FG001|Overall Study|Lost to Follow-up|6|||
33562376|NCT02799043|101954617|FG000|Overall Study|Withdrawal by Subject|4|||
33562377|NCT02799043|101954618|FG001|Overall Study|Withdrawal by Subject|4|||
33361099|NCT00893789|101210688|FG001|Overall Study|Adverse Event|2|||
33361100|NCT00893789|101210689|FG002|Overall Study|Adverse Event|1|||
33361101|NCT00893789|101210690|FG003|Overall Study|Adverse Event|5|||
33361102|NCT00893789|101210687|FG000|Overall Study|Protocol Violation|0|||
33361103|NCT00893789|101210688|FG001|Overall Study|Protocol Violation|1|||
33361104|NCT00893789|101210689|FG002|Overall Study|Protocol Violation|1|||
33361105|NCT00893789|101210690|FG003|Overall Study|Protocol Violation|4|||
33361106|NCT00893789|101210687|FG000|Overall Study|Lost to Follow-up|0|||
33361107|NCT00893789|101210688|FG001|Overall Study|Lost to Follow-up|0|||
33361108|NCT00893789|101210689|FG002|Overall Study|Lost to Follow-up|0|||
33361109|NCT00893789|101210690|FG003|Overall Study|Lost to Follow-up|1|||
33361110|NCT03334214|101210696|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
33361111|NCT03334214|101210697|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
33361112|NCT03334214|101210696|FG000|Overall Study|Withdrawal by Subject|0|||
33361113|NCT03334214|101210697|FG001|Overall Study|Withdrawal by Subject|1|||
33361114|NCT03334214|101210696|FG000|Overall Study|Other|1|||
33361115|NCT03334214|101210697|FG001|Overall Study|Other|0|||
33361116|NCT02658656|101210703|FG000|Screening|Failed eligibility criteria|0|||
33361117|NCT02658656|101210704|FG001|Screening|Failed eligibility criteria|0|||
33361118|NCT02658656|101210705|FG002|Screening|Failed eligibility criteria|263|||
33361119|NCT02658656|101210703|FG000|Randomization|Withdrawal by Subject|8|||
33361120|NCT02658656|101210704|FG001|Randomization|Withdrawal by Subject|7|||
33361121|NCT02658656|101210705|FG002|Randomization|Withdrawal by Subject|0|||
33361122|NCT02658656|101210703|FG000|Randomization|Lost to Follow-up|1|||
33361123|NCT02658656|101210704|FG001|Randomization|Lost to Follow-up|3|||
33361124|NCT02658656|101210705|FG002|Randomization|Lost to Follow-up|0|||
33361125|NCT02658656|101210703|FG000|Randomization|Adverse Event|4|||
33361126|NCT02658656|101210704|FG001|Randomization|Adverse Event|0|||
33361127|NCT02658656|101210705|FG002|Randomization|Adverse Event|0|||
33361128|NCT02658656|101210703|FG000|Randomization|Administrative Termination|3|||
33361129|NCT02658656|101210704|FG001|Randomization|Administrative Termination|1|||
33361130|NCT02658656|101210705|FG002|Randomization|Administrative Termination|0|||
33361131|NCT02658656|101210703|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
33361132|NCT02658656|101210704|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
33361133|NCT02658656|101210705|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
33361134|NCT02658656|101210703|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
33562378|NCT02799043|101954617|FG000|Overall Study|Moved to different country|0|||
33562379|NCT02799043|101954618|FG001|Overall Study|Moved to different country|1|||
33562380|NCT02799043|101954617|FG000|Overall Study|Trial Screen Failure|1|||
33626148|NCT00883779|102180933|FG000|Primary Study Treatment Phase|Other|3|||
33626149|NCT00883779|102180934|FG001|Primary Study Treatment Phase|Other|0|||
33626150|NCT00883779|102180933|FG000|Post-Study Treatment Phase|Adverse Event|2|||
33626151|NCT00883779|102180934|FG001|Post-Study Treatment Phase|Adverse Event|3|||
33626152|NCT00883779|102180933|FG000|Post-Study Treatment Phase|Death|1|||
33626153|NCT00883779|102180934|FG001|Post-Study Treatment Phase|Death|3|||
33626154|NCT00883779|102180933|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
33626155|NCT00883779|102180934|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
33626156|NCT00883779|102180933|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
33626157|NCT00883779|102180934|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
33626158|NCT00883779|102180933|FG000|Post-Study Treatment Phase|Disease progression|103|||
33626159|NCT00883779|102180934|FG001|Post-Study Treatment Phase|Disease progression|122|||
33626160|NCT00883779|102180933|FG000|Post-Study Treatment Phase|Other|3|||
33626161|NCT00883779|102180934|FG001|Post-Study Treatment Phase|Other|0|||
33626162|NCT00883779|102180933|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
33626163|NCT00883779|102180934|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
33626164|NCT00883779|102180933|FG000|Off-study Phase|Death|185|||
33626165|NCT00883779|102180934|FG001|Off-study Phase|Death|174|||
33626166|NCT00883779|102180933|FG000|Off-study Phase|Refused treatment|1|||
33626167|NCT00883779|102180934|FG001|Off-study Phase|Refused treatment|1|||
33626168|NCT00883779|102180933|FG000|Off-study Phase|Failure to return|5|||
33626169|NCT00883779|102180934|FG001|Off-study Phase|Failure to return|6|||
33626170|NCT00883779|102180933|FG000|Off-study Phase|Other|18|||
33626171|NCT00883779|102180934|FG001|Off-study Phase|Other|21|||
33361135|NCT02658656|101210704|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
33562381|NCT02799043|101954618|FG001|Overall Study|Trial Screen Failure|0|||
33562382|NCT02799043|101954617|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
33562383|NCT02799043|101954618|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
33562384|NCT03941093|101954619|FG000|Overall Study|Protocol Violation|0|||
33562385|NCT03941093|101954620|FG001|Overall Study|Protocol Violation|1|||
33562386|NCT03941093|101954619|FG000|Overall Study|Withdrawal by Subject|9|||
33562387|NCT03941093|101954620|FG001|Overall Study|Withdrawal by Subject|6|||
33562388|NCT03460704|101954632|FG000|Overall Study|Withdrawal by Subject|11|||
33626172|NCT02920892|102180935|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
33626173|NCT02920892|102180936|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
33626174|NCT02920892|102180937|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
33361136|NCT02658656|101210705|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
33361137|NCT02658656|101210703|FG000|Randomization|Not eligible for Randomization|1|||
33361138|NCT02658656|101210704|FG001|Randomization|Not eligible for Randomization|0|||
33361139|NCT02658656|101210705|FG002|Randomization|Not eligible for Randomization|0|||
33361140|NCT02658656|101210703|FG000|Randomization|Protocol Violation|1|||
33361141|NCT02658656|101210704|FG001|Randomization|Protocol Violation|0|||
33361142|NCT02658656|101210705|FG002|Randomization|Protocol Violation|0|||
33361143|NCT02660580|101210713|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
33361144|NCT02660580|101210714|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
33361145|NCT02660580|101210715|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
33361146|NCT02660580|101210716|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
33415016|NCT00902486|101409935|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
33626175|NCT02920892|102180935|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
33626176|NCT02920892|102180936|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
33626177|NCT02920892|102180937|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
33626178|NCT02920892|102180935|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
33626179|NCT02920892|102180936|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
33626180|NCT02920892|102180937|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
33626181|NCT02920892|102180935|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
33626182|NCT02920892|102180936|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
33626183|NCT02920892|102180937|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
33626184|NCT02920892|102180935|FG000|Placebo-Controlled Period|Physician Decision|0|||
33626185|NCT02920892|102180936|FG001|Placebo-Controlled Period|Physician Decision|0|||
33626186|NCT02920892|102180937|FG002|Placebo-Controlled Period|Physician Decision|1|||
33626187|NCT02920892|102180935|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
33626188|NCT02920892|102180936|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
33626189|NCT02920892|102180937|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
33626190|NCT02920892|102180935|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
33626191|NCT02920892|102180936|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
33626192|NCT02920892|102180937|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
33626193|NCT02920892|102180935|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
33626194|NCT02920892|102180936|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
33626195|NCT02920892|102180937|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
33626196|NCT03798717|102180938|FG000|Overall Study|Failed Screening|0|||
33626197|NCT03798717|102180939|FG001|Overall Study|Failed Screening|0|||
33626198|NCT03798717|102180940|FG002|Overall Study|Failed Screening|0|||
33626199|NCT03798717|102180941|FG003|Overall Study|Failed Screening|0|||
33626200|NCT03798717|102180942|FG004|Overall Study|Failed Screening|0|||
33626201|NCT03798717|102180943|FG005|Overall Study|Failed Screening|1|||
33626202|NCT03798717|102180938|FG000|Overall Study|Physician Decision|1|||
33626203|NCT03798717|102180939|FG001|Overall Study|Physician Decision|0|||
33626204|NCT03798717|102180940|FG002|Overall Study|Physician Decision|1|||
33626205|NCT03798717|102180941|FG003|Overall Study|Physician Decision|0|||
33626206|NCT03798717|102180942|FG004|Overall Study|Physician Decision|0|||
33626207|NCT03798717|102180943|FG005|Overall Study|Physician Decision|0|||
33626208|NCT03798717|102180938|FG000|Overall Study|Withdrawal by Subject|0|||
33626209|NCT03798717|102180939|FG001|Overall Study|Withdrawal by Subject|0|||
33626210|NCT03798717|102180940|FG002|Overall Study|Withdrawal by Subject|0|||
33626211|NCT03798717|102180941|FG003|Overall Study|Withdrawal by Subject|1|||
33626212|NCT03798717|102180942|FG004|Overall Study|Withdrawal by Subject|0|||
33626213|NCT03798717|102180943|FG005|Overall Study|Withdrawal by Subject|0|||
33626214|NCT03798717|102180938|FG000|Overall Study|Lost to Follow-up|1|||
33626215|NCT03798717|102180939|FG001|Overall Study|Lost to Follow-up|0|||
33626216|NCT03798717|102180940|FG002|Overall Study|Lost to Follow-up|0|||
33626217|NCT03798717|102180941|FG003|Overall Study|Lost to Follow-up|1|||
33626218|NCT03798717|102180942|FG004|Overall Study|Lost to Follow-up|0|||
33626219|NCT03798717|102180943|FG005|Overall Study|Lost to Follow-up|0|||
33626220|NCT03798717|102180938|FG000|Overall Study|Adverse Event|0|||
33626221|NCT03798717|102180939|FG001|Overall Study|Adverse Event|1|||
33626222|NCT03798717|102180940|FG002|Overall Study|Adverse Event|0|||
33626223|NCT03798717|102180941|FG003|Overall Study|Adverse Event|0|||
33626224|NCT03798717|102180942|FG004|Overall Study|Adverse Event|0|||
33626225|NCT03798717|102180943|FG005|Overall Study|Adverse Event|0|||
33626226|NCT03798717|102180938|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
33415017|NCT00902486|101409930|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
33626227|NCT03798717|102180939|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
33626228|NCT03798717|102180940|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
33626229|NCT03798717|102180941|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
33626230|NCT03798717|102180942|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
33626231|NCT03798717|102180943|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
33626232|NCT03186209|102180944|FG000|Overall Study|Withdrawal by Subject|11|||
33626233|NCT03186209|102180945|FG001|Overall Study|Withdrawal by Subject|22|||
33626234|NCT03186209|102180944|FG000|Overall Study|Pregnancy|1|||
33361147|NCT02660580|101210717|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
33361148|NCT02660580|101210713|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
33626235|NCT03186209|102180945|FG001|Overall Study|Pregnancy|0|||
33626236|NCT03186209|102180944|FG000|Overall Study|Adverse Event|4|||
33626237|NCT03186209|102180945|FG001|Overall Study|Adverse Event|0|||
33626238|NCT03186209|102180944|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
33626239|NCT03186209|102180945|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
33626240|NCT03186209|102180944|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
33626241|NCT03186209|102180945|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
33626242|NCT03186209|102180944|FG000|Overall Study|Fail to meet randomization criteria|0|||
33626243|NCT03186209|102180945|FG001|Overall Study|Fail to meet randomization criteria|1|||
33626244|NCT03186209|102180944|FG000|Overall Study|Lost to Follow-up|0|||
33626245|NCT03186209|102180945|FG001|Overall Study|Lost to Follow-up|1|||
33626246|NCT03605667|102180946|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
33626247|NCT03605667|102180947|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
33626248|NCT03605667|102180946|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
33626249|NCT03605667|102180947|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
33626250|NCT03605667|102180946|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
33626251|NCT03605667|102180947|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
33626252|NCT03605667|102180946|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
33626253|NCT03605667|102180947|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
33626254|NCT03605667|102180946|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
33626255|NCT03605667|102180947|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
33626256|NCT03605667|102180946|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
33626257|NCT03605667|102180947|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
33626258|NCT03605667|102180946|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
33626259|NCT03605667|102180947|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
33626260|NCT03605667|102180946|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
33626261|NCT03605667|102180947|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
33626262|NCT03605667|102180946|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
33626263|NCT03605667|102180947|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
33626264|NCT03605667|102180946|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
33626265|NCT03605667|102180947|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
33626266|NCT03605667|102180946|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
33626267|NCT03605667|102180947|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
33626268|NCT03605667|102180946|FG000|OLE Phase (48 Weeks)|Other|6|||
33626269|NCT03605667|102180947|FG001|OLE Phase (48 Weeks)|Other|8|||
33361149|NCT02660580|101210714|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
33361150|NCT02660580|101210715|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
33361151|NCT02660580|101210716|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
33361152|NCT02660580|101210717|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
33361153|NCT02660580|101210713|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
33361154|NCT02660580|101210714|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
33361155|NCT02660580|101210715|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
33361156|NCT02660580|101210716|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
33361157|NCT02660580|101210717|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
33361158|NCT02660580|101210713|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
33361159|NCT02660580|101210714|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
33361160|NCT02660580|101210715|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
33626270|NCT03605667|102180946|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
33626271|NCT03605667|102180947|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
33626272|NCT03605667|102180946|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
33626273|NCT03605667|102180947|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
33626274|NCT03605667|102180946|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
33626275|NCT03605667|102180947|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
33626276|NCT03605667|102180946|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
33626277|NCT03605667|102180947|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
33626278|NCT03605667|102180946|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
33626279|NCT03605667|102180947|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
33626280|NCT03605667|102180946|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
33626281|NCT03605667|102180947|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
33626282|NCT03605667|102180946|FG000|OLE Phase (48 Weeks)|Death|0|||
33626283|NCT03605667|102180947|FG001|OLE Phase (48 Weeks)|Death|2|||
33626284|NCT03605667|102180946|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
33626285|NCT03605667|102180947|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
33626286|NCT00960375|102180951|FG000|Overall Study|Lost to Follow-up|20|||
33626287|NCT00960375|102180952|FG001|Overall Study|Lost to Follow-up|22|||
33626288|NCT00321789|102180954|FG000|Overall Study|Lost to Follow-up|4|||
33626289|NCT00321789|102180955|FG001|Overall Study|Lost to Follow-up|7|||
33626290|NCT00321789|102180954|FG000|Overall Study|Withdrawal by Subject|6|||
33626291|NCT00321789|102180955|FG001|Overall Study|Withdrawal by Subject|6|||
33626292|NCT00321789|102180954|FG000|Overall Study|Protocol Violation|5|||
33626293|NCT00321789|102180955|FG001|Overall Study|Protocol Violation|3|||
33626294|NCT00419393|102180958|FG000|Overall Study|Adverse Event|5|||
33626295|NCT00419393|102180958|FG000|Overall Study|Protocol Violation|5|||
33626296|NCT00419393|102180958|FG000|Overall Study|Withdrawal by Subject|7|||
33626297|NCT00419393|102180958|FG000|Overall Study|Other: Sponsor request|3|||
33361161|NCT02660580|101210716|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
33361162|NCT02660580|101210717|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
33361163|NCT02660580|101210713|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
33361164|NCT02660580|101210714|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
33361165|NCT02660580|101210715|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
33361166|NCT02660580|101210716|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
33626298|NCT00419393|102180958|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
33626299|NCT00419393|102180958|FG000|Overall Study|Other: Site closure|1|||
33626300|NCT00419393|102180958|FG000|Overall Study|Other: Other health problems|1|||
33626301|NCT00419393|102180958|FG000|Overall Study|Other: Investigator decision|1|||
33626302|NCT01506271|102180959|FG000|Overall Study|Progressive disease|0|||
33626303|NCT01506271|102180960|FG001|Overall Study|Progressive disease|1|||
33626304|NCT01506271|102180961|FG002|Overall Study|Progressive disease|0|||
33626305|NCT01506271|102180959|FG000|Overall Study|Protocol Violation|3|||
33626306|NCT01506271|102180960|FG001|Overall Study|Protocol Violation|1|||
33626307|NCT01506271|102180961|FG002|Overall Study|Protocol Violation|0|||
33626308|NCT01506271|102180959|FG000|Overall Study|Death|0|||
33626309|NCT01506271|102180960|FG001|Overall Study|Death|1|||
33626310|NCT01506271|102180961|FG002|Overall Study|Death|0|||
33626311|NCT01506271|102180959|FG000|Overall Study|Adverse Event|0|||
33626312|NCT01506271|102180960|FG001|Overall Study|Adverse Event|2|||
33626313|NCT01506271|102180961|FG002|Overall Study|Adverse Event|0|||
33626314|NCT01506271|102180959|FG000|Overall Study|Insufficient supply of study drug|1|||
33361167|NCT02660580|101210717|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
33626315|NCT01506271|102180960|FG001|Overall Study|Insufficient supply of study drug|0|||
33626316|NCT01506271|102180961|FG002|Overall Study|Insufficient supply of study drug|0|||
33626317|NCT01506271|102180959|FG000|Overall Study|Withdrawal by Subject|0|||
33626318|NCT01506271|102180960|FG001|Overall Study|Withdrawal by Subject|1|||
33626319|NCT01506271|102180961|FG002|Overall Study|Withdrawal by Subject|1|||
33626320|NCT01506271|102180959|FG000|Overall Study|Lost to Follow-up|0|||
33626321|NCT01506271|102180960|FG001|Overall Study|Lost to Follow-up|1|||
33626322|NCT01506271|102180961|FG002|Overall Study|Lost to Follow-up|2|||
33626323|NCT00657046|102180964|FG000|Overall Study|Adverse Event|1|||
33626324|NCT00657046|102180965|FG001|Overall Study|Adverse Event|1|||
33626325|NCT00657046|102180966|FG002|Overall Study|Adverse Event|0|||
33626326|NCT00657046|102180964|FG000|Overall Study|Protocol Violation|2|||
33361168|NCT02660580|101210713|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
33626327|NCT00657046|102180965|FG001|Overall Study|Protocol Violation|2|||
33626328|NCT00657046|102180966|FG002|Overall Study|Protocol Violation|0|||
33626329|NCT00657046|102180964|FG000|Overall Study|Withdrawal by Subject|1|||
33626330|NCT00657046|102180965|FG001|Overall Study|Withdrawal by Subject|0|||
33626331|NCT00657046|102180966|FG002|Overall Study|Withdrawal by Subject|0|||
33626332|NCT00657046|102180964|FG000|Overall Study|Death|0|||
33626333|NCT00657046|102180965|FG001|Overall Study|Death|0|||
33361169|NCT02660580|101210714|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
33626334|NCT00657046|102180966|FG002|Overall Study|Death|1|||
33626335|NCT00657046|102180964|FG000|Overall Study|Surgery|0|||
33626336|NCT00657046|102180965|FG001|Overall Study|Surgery|0|||
33626337|NCT00657046|102180966|FG002|Overall Study|Surgery|1|||
33626338|NCT00614575|102180967|FG000|Overall Study|Adverse Event|106|||
33626339|NCT00614575|102180967|FG000|Overall Study|Lost to Follow-up|55|||
33626340|NCT00614575|102180967|FG000|Overall Study|Lack of Efficacy|14|||
33626341|NCT00614575|102180967|FG000|Overall Study|Withdrawal by Subject|6|||
33626342|NCT00614575|102180967|FG000|Overall Study|Death|3|||
33626343|NCT00614575|102180967|FG000|Overall Study|Physician Decision|2|||
33626344|NCT00614575|102180967|FG000|Overall Study|No data were collected.|18|||
33626345|NCT00614575|102180967|FG000|Overall Study|Irregularly enrolled patients|23|||
33626346|NCT00614575|102180967|FG000|Overall Study|No treatment|1|||
33626347|NCT01884077|102180970|FG000|Overall Study|screen fail|0|||
33626348|NCT01884077|102180971|FG001|Overall Study|screen fail|2|||
33626349|NCT01884077|102180970|FG000|Overall Study|canceled surgery|2|||
33626350|NCT01884077|102180971|FG001|Overall Study|canceled surgery|0|||
33626351|NCT01884077|102180970|FG000|Overall Study|Lost to Follow-up|0|||
33626352|NCT01884077|102180971|FG001|Overall Study|Lost to Follow-up|4|||
33626353|NCT01884077|102180970|FG000|Overall Study|study closed|6|||
33626354|NCT01884077|102180971|FG001|Overall Study|study closed|4|||
33626355|NCT03309878|102180975|FG000|Overall Study|Adverse Event|1|||
33626356|NCT03309878|102180976|FG001|Overall Study|Adverse Event|0|||
33626357|NCT03309878|102180977|FG002|Overall Study|Adverse Event|0|||
33626358|NCT03309878|102180978|FG003|Overall Study|Adverse Event|0|||
33626359|NCT03309878|102180975|FG000|Overall Study|Did not maintain eligibility|2|||
33626360|NCT03309878|102180976|FG001|Overall Study|Did not maintain eligibility|1|||
33626361|NCT03309878|102180977|FG002|Overall Study|Did not maintain eligibility|0|||
33626362|NCT03309878|102180978|FG003|Overall Study|Did not maintain eligibility|0|||
33626363|NCT03309878|102180975|FG000|Overall Study|Withdrawal by Subject|0|||
33626364|NCT03309878|102180976|FG001|Overall Study|Withdrawal by Subject|1|||
33626365|NCT03309878|102180977|FG002|Overall Study|Withdrawal by Subject|0|||
33626366|NCT03309878|102180978|FG003|Overall Study|Withdrawal by Subject|0|||
33626367|NCT00468299|102180979|FG000|Overall Study|Withdrawal by Subject|0|||
33626368|NCT00468299|102180980|FG001|Overall Study|Withdrawal by Subject|1|||
33626369|NCT00333775|102180981|FG000|Overall Study|Death|144|||
33626370|NCT00333775|102180982|FG001|Overall Study|Death|149|||
33361170|NCT02660580|101210715|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
33361171|NCT02660580|101210716|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
33361172|NCT02660580|101210717|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
33361173|NCT02660580|101210713|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
33361174|NCT02660580|101210714|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
33626371|NCT00333775|102180983|FG002|Overall Study|Death|143|||
33626372|NCT00333775|102180981|FG000|Overall Study|In Follow-up When Study Stopped|87|||
33626373|NCT00333775|102180982|FG001|Overall Study|In Follow-up When Study Stopped|92|||
33626374|NCT00333775|102180983|FG002|Overall Study|In Follow-up When Study Stopped|96|||
33626375|NCT00333775|102180981|FG000|Overall Study|Lost to Follow-up|10|||
33626376|NCT00333775|102180982|FG001|Overall Study|Lost to Follow-up|7|||
33626377|NCT00333775|102180983|FG002|Overall Study|Lost to Follow-up|8|||
33626378|NCT02422498|102180984|FG000|Overall Study|Inevaluable|4|||
33626379|NCT00265564|102180988|FG000|Overall Study|Lost to Follow-up|5|||
33626380|NCT00265564|102180989|FG001|Overall Study|Lost to Follow-up|7|||
33626381|NCT00265564|102180988|FG000|Overall Study|met exclusion criteria|5|||
33626382|NCT00265564|102180989|FG001|Overall Study|met exclusion criteria|2|||
33626383|NCT01033240|102180990|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
33626384|NCT01033240|102180991|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
33626385|NCT01033240|102180992|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
33626386|NCT01033240|102180990|FG000|Overall Study|Death|2|||
33626387|NCT01033240|102180991|FG001|Overall Study|Death|0|||
33626388|NCT01033240|102180992|FG002|Overall Study|Death|0|||
33626389|NCT01033240|102180990|FG000|Overall Study|Withdrew Consent|2|||
33626390|NCT01033240|102180991|FG001|Overall Study|Withdrew Consent|9|||
33626391|NCT01033240|102180992|FG002|Overall Study|Withdrew Consent|2|||
33626392|NCT01033240|102180990|FG000|Overall Study|Disease Progression|35|||
33626393|NCT01033240|102180991|FG001|Overall Study|Disease Progression|32|||
33626394|NCT01033240|102180992|FG002|Overall Study|Disease Progression|41|||
33626395|NCT01033240|102180990|FG000|Overall Study|Investigator Discretion|0|||
33626396|NCT01033240|102180991|FG001|Overall Study|Investigator Discretion|0|||
33626397|NCT01033240|102180992|FG002|Overall Study|Investigator Discretion|2|||
33361175|NCT02660580|101210715|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
33626398|NCT01033240|102180990|FG000|Overall Study|Other|0|||
33626399|NCT01033240|102180991|FG001|Overall Study|Other|1|||
33626400|NCT01033240|102180992|FG002|Overall Study|Other|2|||
33626401|NCT00866177|102180993|FG000|Overall Study|Withdrawal by Subject|1|||
33626402|NCT00866177|102180993|FG000|Overall Study|Not Treated|151|||
33626403|NCT03057496|102180996|FG000|Overall Study|Withdrawal by Subject|8|||
33626404|NCT03057496|102180996|FG000|Overall Study|Lost to Follow-up|5|||
33626405|NCT03057496|102180996|FG000|Overall Study|Did not use device during home trial|3|||
33626406|NCT03057496|102180996|FG000|Overall Study|Device failure|2|||
33626407|NCT03905096|102181000|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
33626408|NCT03905096|102181001|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
33626409|NCT01277744|102181002|FG000|Overall Study|Physician Decision|2|||
33626410|NCT00561652|102181003|FG000|Overall Study|Withdrawal by Subject|0|||
33361176|NCT02660580|101210716|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
33361177|NCT02660580|101210717|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
33361178|NCT02660580|101210713|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
33361179|NCT02660580|101210714|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
33361180|NCT02660580|101210715|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
33361181|NCT02660580|101210716|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
33361182|NCT02660580|101210717|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
33361183|NCT02660580|101210713|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
33361184|NCT02660580|101210714|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
33361185|NCT02660580|101210715|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
33361186|NCT02660580|101210716|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
33361187|NCT02660580|101210717|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
33361188|NCT02660580|101210713|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
33361189|NCT02660580|101210714|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
33361190|NCT02660580|101210715|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
33361191|NCT02660580|101210716|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
33361192|NCT02660580|101210717|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
33361193|NCT02660580|101210713|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
33361194|NCT02660580|101210714|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
33361195|NCT02660580|101210715|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
33361196|NCT02660580|101210716|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
33361197|NCT02660580|101210717|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
33361198|NCT02660580|101210713|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
33626411|NCT00561652|102181004|FG001|Overall Study|Withdrawal by Subject|1|||
33626412|NCT01746368|102181014|FG000|Overall Study|Lost to Follow-up|2|||
33626413|NCT01746368|102181015|FG001|Overall Study|Lost to Follow-up|0|||
33626414|NCT01746368|102181014|FG000|Overall Study|Withdrawal by Subject|0|||
33626415|NCT01746368|102181015|FG001|Overall Study|Withdrawal by Subject|1|||
33626416|NCT02520726|102181016|FG000|Overall Study|Lost to Follow-up|3|||
33626417|NCT02520726|102181017|FG001|Overall Study|Lost to Follow-up|2|||
33626418|NCT00918385|102181018|FG000|Monotherapy|Adverse Event|1|||
33626419|NCT00918385|102181019|FG001|Monotherapy|Adverse Event|6|||
33626420|NCT00918385|102181018|FG000|Monotherapy|Complicating illness|1|||
33626421|NCT00918385|102181019|FG001|Monotherapy|Complicating illness|0|||
33626422|NCT00918385|102181018|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
33361199|NCT02660580|101210714|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
33361200|NCT02660580|101210715|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
33361201|NCT02660580|101210716|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
33361202|NCT02660580|101210717|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
33361203|NCT02660580|101210713|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
33361204|NCT02660580|101210714|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
33626423|NCT00918385|102181019|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
33626424|NCT00918385|102181018|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
33626425|NCT00918385|102181019|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
33626426|NCT00918385|102181018|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
33626427|NCT00918385|102181019|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
33626428|NCT00918385|102181018|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
33626429|NCT00918385|102181019|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
33626430|NCT00447226|102181020|FG000|12-Week Open-label Phase|Adverse Event|0|||
33626431|NCT00447226|102181021|FG001|12-Week Open-label Phase|Adverse Event|3|||
33626432|NCT00447226|102181020|FG000|12-Week Open-label Phase|Protocol Violation|0|||
33626433|NCT00447226|102181021|FG001|12-Week Open-label Phase|Protocol Violation|1|||
33626434|NCT00447226|102181020|FG000|12-Week Open-label Phase|Disease Progression|0|||
33626435|NCT00447226|102181021|FG001|12-Week Open-label Phase|Disease Progression|20|||
33626436|NCT00447226|102181020|FG000|12-Week Open-label Phase|Physician Decision|0|||
33626437|NCT00447226|102181021|FG001|12-Week Open-label Phase|Physician Decision|1|||
33626438|NCT00447226|102181020|FG000|Double-blind Phase|Disease Progression|4|||
33626439|NCT00447226|102181021|FG001|Double-blind Phase|Disease Progression|3|||
33626440|NCT01342913|102181026|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
33626441|NCT01342913|102181027|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33626442|NCT01342913|102181028|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33626443|NCT01342913|102181026|FG000|2-week Run-in Period|Physician Decision|6|||
33626444|NCT01342913|102181027|FG001|2-week Run-in Period|Physician Decision|0|||
33626445|NCT01342913|102181028|FG002|2-week Run-in Period|Physician Decision|0|||
33626446|NCT01342913|102181026|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
33361205|NCT02660580|101210715|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
33361206|NCT02660580|101210716|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
33626447|NCT01342913|102181027|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
33626448|NCT01342913|102181028|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
33626449|NCT01342913|102181026|FG000|2-week Run-in Period|Adverse Event|2|||
33626450|NCT01342913|102181027|FG001|2-week Run-in Period|Adverse Event|0|||
33626451|NCT01342913|102181028|FG002|2-week Run-in Period|Adverse Event|0|||
33626452|NCT01342913|102181026|FG000|2-week Run-in Period|Protocol Violation|5|||
33626453|NCT01342913|102181027|FG001|2-week Run-in Period|Protocol Violation|0|||
33626454|NCT01342913|102181028|FG002|2-week Run-in Period|Protocol Violation|0|||
33626455|NCT01342913|102181026|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
33626456|NCT01342913|102181027|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
33626457|NCT01342913|102181028|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
33626458|NCT01342913|102181026|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33626459|NCT01342913|102181027|FG001|Double-Blind Treatment Period|Adverse Event|3|||
33626460|NCT01342913|102181028|FG002|Double-Blind Treatment Period|Adverse Event|6|||
33626461|NCT01342913|102181026|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
33626462|NCT01342913|102181027|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
33626463|NCT01342913|102181028|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
33626464|NCT01342913|102181026|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
33626465|NCT01342913|102181027|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
33626466|NCT01342913|102181028|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
33626467|NCT01342913|102181026|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33221389|NCT00263328|100711030|FG000|Overall Study|Withdrawal by Subject|3|||
33361207|NCT02660580|101210717|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
33361208|NCT03575468|101210720|FG000|Overall Study|Withdrawal by Subject|3|||
33361209|NCT03575468|101210721|FG001|Overall Study|Withdrawal by Subject|0|||
33361210|NCT03575468|101210720|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
33361211|NCT03575468|101210721|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
33361212|NCT03575468|101210720|FG000|Overall Study|Lost to Follow-up|13|||
33361213|NCT03575468|101210721|FG001|Overall Study|Lost to Follow-up|17|||
33361214|NCT01713348|101210722|FG000|Overall Study|Withdrawal by Subject|3|||
33361215|NCT01713348|101210723|FG001|Overall Study|Withdrawal by Subject|2|||
33361216|NCT01713348|101210724|FG002|Overall Study|Withdrawal by Subject|2|||
33626468|NCT01342913|102181027|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
33626469|NCT01342913|102181028|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
33361217|NCT01713348|101210725|FG003|Overall Study|Withdrawal by Subject|0|||
33626470|NCT01342913|102181026|FG000|Double-Blind Treatment Period|Physician Decision|0|||
33221390|NCT00263328|100711031|FG001|Overall Study|Withdrawal by Subject|0|||
33221391|NCT00263328|100711032|FG002|Overall Study|Withdrawal by Subject|1|||
33361218|NCT01713348|101210722|FG000|Overall Study|Lost to Follow-up|1|||
33361219|NCT01713348|101210723|FG001|Overall Study|Lost to Follow-up|0|||
33361220|NCT01713348|101210724|FG002|Overall Study|Lost to Follow-up|0|||
33361221|NCT01713348|101210725|FG003|Overall Study|Lost to Follow-up|0|||
33361222|NCT01541254|101210727|FG000|Overall Study|Withdrawal by Subject|1|||
33361223|NCT01541254|101210727|FG000|Overall Study|excluded - metal allergy|1|||
33361224|NCT01541254|101210727|FG000|Overall Study|enrolled after study closed|1|||
33361225|NCT01541254|101210727|FG000|Overall Study|GI bleed prior to procedure|1|||
33562389|NCT03460704|101954633|FG001|Overall Study|Withdrawal by Subject|14|||
33221392|NCT00263328|100711030|FG000|Overall Study|Other|3|||
33221393|NCT00263328|100711031|FG001|Overall Study|Other|0|||
33221394|NCT00263328|100711032|FG002|Overall Study|Other|1|||
33221395|NCT00263328|100711030|FG000|Overall Study|Adverse Event|1|||
33221396|NCT00263328|100711031|FG001|Overall Study|Adverse Event|1|||
33221397|NCT00263328|100711032|FG002|Overall Study|Adverse Event|4|||
33221398|NCT01242748|100711033|FG000|Overall Study|Adverse Event|10|||
33221399|NCT01242748|100711034|FG001|Overall Study|Adverse Event|5|||
33221400|NCT01242748|100711033|FG000|Overall Study|Lost to Follow-up|6|||
33221401|NCT01242748|100711034|FG001|Overall Study|Lost to Follow-up|2|||
33221402|NCT01242748|100711033|FG000|Overall Study|Physician Decision|3|||
33361226|NCT01541254|101210727|FG000|Overall Study|stent not required|1|||
33562390|NCT03460704|101954632|FG000|Overall Study|Study terminated by the Sponsor|29|||
33562391|NCT03460704|101954633|FG001|Overall Study|Study terminated by the Sponsor|19|||
33562392|NCT03460704|101954632|FG000|Overall Study|Adverse Event|10|||
33562393|NCT03460704|101954633|FG001|Overall Study|Adverse Event|5|||
33562394|NCT03460704|101954632|FG000|Overall Study|Death|3|||
33562395|NCT03460704|101954633|FG001|Overall Study|Death|2|||
33562396|NCT03460704|101954632|FG000|Overall Study|Non-Compliance with Study Drug|3|||
33562397|NCT03460704|101954633|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33562398|NCT03460704|101954632|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33562399|NCT03460704|101954633|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
33562400|NCT03460704|101954632|FG000|Overall Study|Other|2|||
33562401|NCT03460704|101954633|FG001|Overall Study|Other|1|||
33562402|NCT01877278|101954634|FG000|Overall Study|Lost to Follow-up|3|||
33562403|NCT01877278|101954635|FG001|Overall Study|Lost to Follow-up|3|||
33562404|NCT01487161|101954639|FG000|Overall Study|Adverse Event|1|||
33562405|NCT01487161|101954640|FG001|Overall Study|Adverse Event|0|||
33562406|NCT01487161|101954641|FG002|Overall Study|Adverse Event|0|||
33562407|NCT01487161|101954642|FG003|Overall Study|Adverse Event|0|||
33562408|NCT01487161|101954639|FG000|Overall Study|Withdrawal by Subject|1|||
33562409|NCT01487161|101954640|FG001|Overall Study|Withdrawal by Subject|1|||
33562410|NCT01487161|101954641|FG002|Overall Study|Withdrawal by Subject|1|||
33562411|NCT01487161|101954642|FG003|Overall Study|Withdrawal by Subject|2|||
33626471|NCT01342913|102181027|FG001|Double-Blind Treatment Period|Physician Decision|2|||
33361227|NCT01541254|101210727|FG000|Overall Study|alternate stent used|1|||
33361228|NCT00652093|101210734|FG000|Overall Study|Withdrawal by Subject|0|||
33562412|NCT01487161|101954639|FG000|Overall Study|missing data|0|||
33221403|NCT01242748|100711034|FG001|Overall Study|Physician Decision|2|||
33221404|NCT01242748|100711033|FG000|Overall Study|Protocol Violation|1|||
33221405|NCT01242748|100711034|FG001|Overall Study|Protocol Violation|0|||
33221406|NCT01242748|100711033|FG000|Overall Study|Withdrawal by Subject|10|||
33221407|NCT01242748|100711034|FG001|Overall Study|Withdrawal by Subject|2|||
33221408|NCT01242748|100711033|FG000|Overall Study|Miscellaneous reasons|8|||
33221409|NCT01242748|100711034|FG001|Overall Study|Miscellaneous reasons|3|||
33626472|NCT01342913|102181028|FG002|Double-Blind Treatment Period|Physician Decision|0|||
33626473|NCT01342913|102181026|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33626474|NCT01342913|102181027|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
33626475|NCT01342913|102181028|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
33626476|NCT00689390|102181030|FG000|Overall Study|Adverse Event|19|||
33626477|NCT00689390|102181031|FG001|Overall Study|Adverse Event|0|||
33626478|NCT00689390|102181030|FG000|Overall Study|Lost to Follow-up|179|||
33221410|NCT02010632|100711038|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
33415018|NCT00902486|101409931|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
33415019|NCT00902486|101409932|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
33415020|NCT00902486|101409933|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
33415021|NCT00902486|101409934|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
33415022|NCT00902486|101409935|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
33415023|NCT00902486|101409930|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
33562413|NCT01487161|101954640|FG001|Overall Study|missing data|1|||
33562414|NCT01487161|101954641|FG002|Overall Study|missing data|0|||
33562415|NCT01487161|101954642|FG003|Overall Study|missing data|0|||
33562416|NCT01793129|101954643|FG000|Overall Study|Lost to Follow-up|3|||
33562417|NCT01793129|101954644|FG001|Overall Study|Lost to Follow-up|7|||
33562418|NCT01793129|101954643|FG000|Overall Study|Withdrawal by Subject|0|||
33562419|NCT01793129|101954644|FG001|Overall Study|Withdrawal by Subject|2|||
33562420|NCT02420314|101954653|FG000|Overall Study|Withdrawal by Subject|1|||
33562421|NCT02420314|101954653|FG000|Overall Study|Protocol Violation|1|||
33562422|NCT01592747|101954654|FG000|Overall Study|Loss of Therapeutic Response|107|||
33562423|NCT01592747|101954655|FG001|Overall Study|Loss of Therapeutic Response|108|||
33562424|NCT01592747|101954656|FG002|Overall Study|Loss of Therapeutic Response|100|||
33562425|NCT01592747|101954654|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
33562426|NCT01592747|101954655|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
33562427|NCT01592747|101954656|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
33562428|NCT01592747|101954654|FG000|Overall Study|Adverse Event|1|||
33562429|NCT01592747|101954655|FG001|Overall Study|Adverse Event|0|||
33562430|NCT01592747|101954656|FG002|Overall Study|Adverse Event|0|||
33562431|NCT01592747|101954654|FG000|Overall Study|Protocol Violation|4|||
33562432|NCT01592747|101954655|FG001|Overall Study|Protocol Violation|0|||
33562433|NCT01592747|101954656|FG002|Overall Study|Protocol Violation|4|||
33562434|NCT01592747|101954654|FG000|Overall Study|Lack of Efficacy|0|||
33562435|NCT01592747|101954655|FG001|Overall Study|Lack of Efficacy|1|||
33562436|NCT01592747|101954656|FG002|Overall Study|Lack of Efficacy|0|||
33562437|NCT01592747|101954654|FG000|Overall Study|Withdrawal by Subject|2|||
33562438|NCT01592747|101954655|FG001|Overall Study|Withdrawal by Subject|0|||
33562439|NCT01592747|101954656|FG002|Overall Study|Withdrawal by Subject|2|||
33562440|NCT01592747|101954654|FG000|Overall Study|Lost to Follow-up|1|||
33562441|NCT01592747|101954655|FG001|Overall Study|Lost to Follow-up|0|||
33562442|NCT01592747|101954656|FG002|Overall Study|Lost to Follow-up|1|||
33562443|NCT01592747|101954654|FG000|Overall Study|Other Reasons|1|||
33562444|NCT01592747|101954655|FG001|Overall Study|Other Reasons|1|||
33562445|NCT01592747|101954656|FG002|Overall Study|Other Reasons|0|||
33562446|NCT02933151|101954657|FG000|Overall Study|Lost to Follow-up|19|||
33562447|NCT02933151|101954658|FG001|Overall Study|Lost to Follow-up|18|||
33562448|NCT02933151|101954657|FG000|Overall Study|Death|1732|||
33562449|NCT02933151|101954658|FG001|Overall Study|Death|1827|||
33562450|NCT02933151|101954657|FG000|Overall Study|Transplant|210|||
33562451|NCT02933151|101954658|FG001|Overall Study|Transplant|278|||
33562452|NCT02933151|101954657|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
33562453|NCT02933151|101954658|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
33562454|NCT02933151|101954657|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
33562455|NCT02933151|101954658|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
33562456|NCT02933151|101954657|FG000|Overall Study|Recovered Kidney Function|47|||
33562457|NCT02933151|101954658|FG001|Overall Study|Recovered Kidney Function|29|||
33562458|NCT05185453|101954659|FG000|Overall Study|Lost to Follow-up|13|||
33562459|NCT05185453|101954660|FG001|Overall Study|Lost to Follow-up|3|||
33562460|NCT02698787|101954661|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
33626479|NCT00689390|102181031|FG001|Overall Study|Lost to Follow-up|7|||
33626480|NCT00689390|102181030|FG000|Overall Study|Withdrawal by Subject|117|||
33626481|NCT00689390|102181031|FG001|Overall Study|Withdrawal by Subject|3|||
33415024|NCT00902486|101409931|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
33562461|NCT02698787|101954662|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
33562462|NCT02093520|101954665|FG000|Overall Study|Not treated|6|||
33562463|NCT02093520|101954666|FG001|Overall Study|Not treated|22|||
33562464|NCT03253627|101954667|FG000|Overall Study|Lost to Follow-up|1|||
33562465|NCT03253627|101954668|FG001|Overall Study|Lost to Follow-up|2|||
33562466|NCT03253627|101954667|FG000|Overall Study|Withdrawal by Subject|0|||
33361229|NCT00652093|101210735|FG001|Overall Study|Withdrawal by Subject|0|||
33361230|NCT00652093|101210736|FG002|Overall Study|Withdrawal by Subject|1|||
33361231|NCT00652093|101210737|FG003|Overall Study|Withdrawal by Subject|0|||
33361232|NCT00652093|101210738|FG004|Overall Study|Withdrawal by Subject|1|||
33361233|NCT00652093|101210739|FG005|Overall Study|Withdrawal by Subject|0|||
33361234|NCT00652093|101210734|FG000|Overall Study|Physician Decision|0|||
33361235|NCT00652093|101210735|FG001|Overall Study|Physician Decision|0|||
33361236|NCT00652093|101210736|FG002|Overall Study|Physician Decision|0|||
33361237|NCT00652093|101210737|FG003|Overall Study|Physician Decision|0|||
33361238|NCT00652093|101210738|FG004|Overall Study|Physician Decision|1|||
33361239|NCT00652093|101210739|FG005|Overall Study|Physician Decision|0|||
33361240|NCT01364467|101210751|FG000|Overall Study|Lost to Follow-up|1|||
33361241|NCT01364467|101210752|FG001|Overall Study|Lost to Follow-up|2|||
33361242|NCT01770353|101210758|FG000|Overall Study|Progressive disease|2|||
33361243|NCT01770353|101210759|FG001|Overall Study|Progressive disease|1|||
33361244|NCT01770353|101210758|FG000|Overall Study|Adverse Event|0|||
33361245|NCT01770353|101210759|FG001|Overall Study|Adverse Event|1|||
33361246|NCT01770353|101210758|FG000|Overall Study|Protocol Violation|1|||
33361247|NCT01770353|101210759|FG001|Overall Study|Protocol Violation|0|||
33361248|NCT01770353|101210758|FG000|Overall Study|Physician Decision|0|||
33361249|NCT01770353|101210759|FG001|Overall Study|Physician Decision|3|||
33361250|NCT01770353|101210758|FG000|Overall Study|Clinical deterioration|3|||
33361251|NCT01770353|101210759|FG001|Overall Study|Clinical deterioration|6|||
33361252|NCT01770353|101210758|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
33361253|NCT01770353|101210759|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
33361254|NCT01458340|101210762|FG000|Overall Study|Adverse Event|5|||
33361255|NCT01458340|101210763|FG001|Overall Study|Adverse Event|4|||
33361256|NCT01458340|101210764|FG002|Overall Study|Adverse Event|2|||
33361257|NCT01458340|101210762|FG000|Overall Study|Lost to Follow-up|3|||
33361258|NCT01458340|101210763|FG001|Overall Study|Lost to Follow-up|3|||
33361259|NCT01458340|101210764|FG002|Overall Study|Lost to Follow-up|10|||
33361260|NCT01458340|101210762|FG000|Overall Study|Miscellaneous|0|||
33361261|NCT01458340|101210763|FG001|Overall Study|Miscellaneous|1|||
33361262|NCT01458340|101210764|FG002|Overall Study|Miscellaneous|0|||
33361263|NCT01458340|101210762|FG000|Overall Study|Physician Decision|1|||
33361264|NCT01458340|101210763|FG001|Overall Study|Physician Decision|1|||
33361265|NCT01458340|101210764|FG002|Overall Study|Physician Decision|2|||
33361266|NCT01458340|101210762|FG000|Overall Study|Protocol Violation|6|||
33361267|NCT01458340|101210763|FG001|Overall Study|Protocol Violation|6|||
33361268|NCT01458340|101210764|FG002|Overall Study|Protocol Violation|5|||
33361269|NCT01458340|101210762|FG000|Overall Study|Withdrawal by Subject|12|||
33361270|NCT01458340|101210763|FG001|Overall Study|Withdrawal by Subject|6|||
33361271|NCT01458340|101210764|FG002|Overall Study|Withdrawal by Subject|4|||
33361272|NCT00538733|101210765|FG000|Overall Study|Adverse Event|8|||
33361273|NCT00538733|101210765|FG000|Overall Study|Death|1|||
33361274|NCT00538733|101210765|FG000|Overall Study|declined to participate|2|||
33562467|NCT03253627|101954668|FG001|Overall Study|Withdrawal by Subject|2|||
33562468|NCT03253627|101954667|FG000|Overall Study|Inability to complete MRI|1|||
33562469|NCT03253627|101954668|FG001|Overall Study|Inability to complete MRI|0|||
33562470|NCT02412436|101954669|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
33562471|NCT02412436|101954669|FG000|Overall Study|Lost to Follow-up|6|||
33562472|NCT02412436|101954669|FG000|Overall Study|Unable to get to clinic|3|||
33562473|NCT02412436|101954669|FG000|Overall Study|Death|1|||
33562474|NCT02412436|101954669|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
33562475|NCT05805150|101954670|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
33562476|NCT05805150|101954671|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
33562477|NCT01767987|101954676|FG000|Overall Study|Physician Decision|4|||
33562478|NCT01767987|101954677|FG001|Overall Study|Physician Decision|1|||
33562479|NCT03518060|101954680|FG000|Overall Study|Death|1|||
33562480|NCT03518060|101954680|FG000|Overall Study|Poor adherence|1|||
33562481|NCT03518060|101954680|FG000|Overall Study|Withdrawal of informed consent|2|||
33562482|NCT03518060|101954680|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
33562483|NCT03518060|101954680|FG000|Overall Study|Physician Decision|7|||
33562484|NCT03518060|101954680|FG000|Overall Study|Adverse drug reactions|23|||
33562485|NCT03518060|101954680|FG000|Overall Study|Withdrawal by Subject|25|||
33562486|NCT03518060|101954680|FG000|Overall Study|Lost to Follow-up|13|||
33562487|NCT03766906|101954683|FG000|Overall Study|Withdrawal by Subject|6|||
33562488|NCT03934684|101954684|FG000|Overall Study|Participants continuing in study|11|||
33562489|NCT03934684|101954685|FG001|Overall Study|Participants continuing in study|4|||
33361275|NCT00538733|101210765|FG000|Overall Study|still on therapy|1|||
33361276|NCT03705494|101210766|FG000|Overall Study|Lost to Follow-up|2|||
33361277|NCT03705494|101210767|FG001|Overall Study|Lost to Follow-up|1|||
33361278|NCT03705494|101210766|FG000|Overall Study|Withdrawal by Subject|5|||
33361279|NCT03705494|101210767|FG001|Overall Study|Withdrawal by Subject|2|||
33361280|NCT02732912|101210779|FG000|Overall Study|Discharged before night|2|||
33361281|NCT02732912|101210780|FG001|Overall Study|Discharged before night|6|||
33361282|NCT02732912|101210779|FG000|Overall Study|Incomplete completion of questionnaire|2|||
33562490|NCT03934684|101954684|FG000|Overall Study|Discontinuation of carfilzomib|20|||
33562491|NCT03934684|101954685|FG001|Overall Study|Discontinuation of carfilzomib|30|||
33562492|NCT03934684|101954684|FG000|Overall Study|Death|2|||
33562493|NCT03934684|101954685|FG001|Overall Study|Death|2|||
33562494|NCT03934684|101954684|FG000|Overall Study|Lost to Follow-up|2|||
33562495|NCT03934684|101954685|FG001|Overall Study|Lost to Follow-up|5|||
33562496|NCT03934684|101954684|FG000|Overall Study|Withdrawal by Subject|7|||
33221411|NCT02010632|100711039|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
33221412|NCT00685945|100711040|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
33361283|NCT02732912|101210780|FG001|Overall Study|Incomplete completion of questionnaire|3|||
33361284|NCT02732912|101210779|FG000|Overall Study|No outcome; discharged or refused|6|||
33361285|NCT02732912|101210780|FG001|Overall Study|No outcome; discharged or refused|9|||
33361286|NCT04651777|101210781|FG000|Overall Study|Adverse Event|1|||
33361287|NCT04651777|101210781|FG000|Overall Study|Withdrawal by Subject|2|||
33361288|NCT01326962|101210782|FG000|Overall Study|Adverse Event|1|||
33361289|NCT01326962|101210782|FG000|Overall Study|Withdrawal by Subject|1|||
33361290|NCT01326962|101210782|FG000|Overall Study|Lost to Follow-up|3|||
33361291|NCT01326962|101210782|FG000|Overall Study|Other|2|||
33361292|NCT02725177|101210783|FG000|Overall Study|Physician Decision|4|||
33361293|NCT02725177|101210783|FG000|Overall Study|Adverse Event|1|||
33361294|NCT01736683|101210784|FG000|Overall Study|Disease Relapse|0|||
33361295|NCT01736683|101210785|FG001|Overall Study|Disease Relapse|0|||
33562497|NCT03934684|101954685|FG001|Overall Study|Withdrawal by Subject|8|||
33562498|NCT01197300|101954686|FG000|Overall Study|Lost to Follow-up|0|||
33562499|NCT01197300|101954687|FG001|Overall Study|Lost to Follow-up|1|||
33562500|NCT01197300|101954686|FG000|Overall Study|Protocol Violation|0|||
33562501|NCT01197300|101954687|FG001|Overall Study|Protocol Violation|1|||
33562502|NCT03627468|101954688|FG000|Overall Study|Adverse Event|5|||
33562503|NCT03627468|101954689|FG001|Overall Study|Adverse Event|33|||
33562504|NCT03627468|101954688|FG000|Overall Study|Withdrawal by Subject|13|||
33562505|NCT03627468|101954689|FG001|Overall Study|Withdrawal by Subject|23|||
33562506|NCT03627468|101954688|FG000|Overall Study|Physician Decision|1|||
33562507|NCT03627468|101954689|FG001|Overall Study|Physician Decision|0|||
33562508|NCT03627468|101954688|FG000|Overall Study|Protocol Violation|0|||
33562509|NCT03627468|101954689|FG001|Overall Study|Protocol Violation|2|||
33626482|NCT00689390|102181030|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
33626483|NCT00689390|102181031|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
33562510|NCT03627468|101954688|FG000|Overall Study|Lost to Follow-up|10|||
33562511|NCT03627468|101954689|FG001|Overall Study|Lost to Follow-up|16|||
33562512|NCT03627468|101954688|FG000|Overall Study|Death|1|||
33626484|NCT00689390|102181030|FG000|Overall Study|Non-Compliance With Protocol|21|||
33626485|NCT00689390|102181031|FG001|Overall Study|Non-Compliance With Protocol|0|||
33626486|NCT00689390|102181030|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
33626487|NCT00689390|102181031|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
33626488|NCT00689390|102181030|FG000|Overall Study|Administrative|37|||
33361296|NCT01736683|101210786|FG002|Overall Study|Disease Relapse|2|||
33361297|NCT01736683|101210787|FG003|Overall Study|Disease Relapse|1|||
33626489|NCT00689390|102181031|FG001|Overall Study|Administrative|0|||
33626490|NCT02694744|102181032|FG000|Overall Study|Adverse Event|2|||
33626491|NCT02694744|102181033|FG001|Overall Study|Adverse Event|1|||
33626492|NCT02694744|102181032|FG000|Overall Study|Withdrawal by Subject|2|||
33562513|NCT03627468|101954689|FG001|Overall Study|Death|0|||
33562514|NCT03627468|101954688|FG000|Overall Study|Pregnancy|1|||
33562515|NCT03627468|101954689|FG001|Overall Study|Pregnancy|1|||
33562516|NCT03627468|101954688|FG000|Overall Study|Lack of Efficacy|0|||
33562517|NCT03627468|101954689|FG001|Overall Study|Lack of Efficacy|2|||
33562518|NCT03627468|101954688|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
33562519|NCT03627468|101954689|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
33562520|NCT01428713|101954690|FG000|Overall Study|Non-compliance|2|||
33562521|NCT01428713|101954691|FG001|Overall Study|Non-compliance|2|||
33562522|NCT01428713|101954690|FG000|Overall Study|Withdrawal by Subject|1|||
33562523|NCT01428713|101954691|FG001|Overall Study|Withdrawal by Subject|1|||
33562524|NCT01428713|101954690|FG000|Overall Study|Adverse Event|0|||
33626493|NCT02694744|102181033|FG001|Overall Study|Withdrawal by Subject|1|||
33626494|NCT02694744|102181032|FG000|Overall Study|Physician Decision|1|||
33626495|NCT02694744|102181033|FG001|Overall Study|Physician Decision|2|||
33221413|NCT02160314|100711048|FG000|Overall Study|Adverse Event|0|||
33221414|NCT02160314|100711049|FG001|Overall Study|Adverse Event|6|||
33221415|NCT02160314|100711048|FG000|Overall Study|Protocol Violation|0|||
33361298|NCT01736683|101210788|FG004|Overall Study|Disease Relapse|0|||
33361299|NCT01736683|101210784|FG000|Overall Study|Adverse Event|0|||
33562525|NCT01428713|101954691|FG001|Overall Study|Adverse Event|2|||
33562526|NCT01475825|101954696|FG000|Overall Study|Adverse Event|41|||
33562527|NCT01475825|101954697|FG001|Overall Study|Adverse Event|15|||
33626496|NCT02694744|102181032|FG000|Overall Study|Lost to Follow-up|1|||
33626497|NCT02694744|102181033|FG001|Overall Study|Lost to Follow-up|0|||
33626498|NCT02694744|102181032|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
33626499|NCT02694744|102181033|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
33626500|NCT01308736|102181034|FG000|Overall Study|Did not attend a single session|6|||
33626501|NCT01308736|102181035|FG001|Overall Study|Did not attend a single session|5|||
33626502|NCT00317473|102181036|FG000|Overall Study|Withdrawal by Subject|2|||
33626503|NCT00317473|102181037|FG001|Overall Study|Withdrawal by Subject|1|||
33626504|NCT00317473|102181038|FG002|Overall Study|Withdrawal by Subject|2|||
33626505|NCT00317473|102181039|FG003|Overall Study|Withdrawal by Subject|1|||
33626506|NCT00317473|102181040|FG004|Overall Study|Withdrawal by Subject|3|||
33626507|NCT00317473|102181041|FG005|Overall Study|Withdrawal by Subject|1|||
33626508|NCT00317473|102181036|FG000|Overall Study|Relocation|1|||
33626509|NCT00317473|102181037|FG001|Overall Study|Relocation|0|||
33626510|NCT00317473|102181038|FG002|Overall Study|Relocation|1|||
33626511|NCT00317473|102181039|FG003|Overall Study|Relocation|1|||
33626512|NCT00317473|102181040|FG004|Overall Study|Relocation|5|||
33626513|NCT00317473|102181041|FG005|Overall Study|Relocation|2|||
33626514|NCT00317473|102181036|FG000|Overall Study|Death|1|||
33626515|NCT00317473|102181037|FG001|Overall Study|Death|0|||
33626516|NCT00317473|102181038|FG002|Overall Study|Death|0|||
33626517|NCT00317473|102181039|FG003|Overall Study|Death|0|||
33626518|NCT00317473|102181040|FG004|Overall Study|Death|0|||
33626519|NCT00317473|102181041|FG005|Overall Study|Death|0|||
33626520|NCT00317473|102181036|FG000|Overall Study|Other|0|||
33626521|NCT00317473|102181037|FG001|Overall Study|Other|2|||
33626522|NCT00317473|102181038|FG002|Overall Study|Other|0|||
33626523|NCT00317473|102181039|FG003|Overall Study|Other|0|||
33626524|NCT00317473|102181040|FG004|Overall Study|Other|0|||
33626525|NCT00317473|102181041|FG005|Overall Study|Other|0|||
33626526|NCT01478971|102181042|FG000|Standard of Care Period|Adverse Event|1|||
33626527|NCT01478971|102181042|FG000|Standard of Care Period|Withdrawal by Subject|3|||
33626528|NCT01478971|102181042|FG000|Standard of Care Period|Death|8|||
33626529|NCT01478971|102181042|FG000|Standard of Care Period|Lost to Follow-up|9|||
33626530|NCT01478971|102181042|FG000|Standard of Care Period|Other|4|||
33626531|NCT01478971|102181042|FG000|Peginesatide Treatment Period|Adverse Event|1|||
33626532|NCT01478971|102181042|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
33626533|NCT01478971|102181042|FG000|Peginesatide Treatment Period|Death|4|||
33626534|NCT01478971|102181042|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
33626535|NCT01478971|102181042|FG000|Peginesatide Treatment Period|Other|4|||
33626536|NCT00855959|102181043|FG000|Overall Study|Adverse Event|2|||
33626537|NCT00855959|102181043|FG000|Overall Study|Lost to Follow-up|2|||
33626538|NCT00855959|102181043|FG000|Overall Study|Withdrawal by Subject|3|||
33562528|NCT01475825|101954698|FG002|Overall Study|Adverse Event|27|||
33626539|NCT00855959|102181043|FG000|Overall Study|Pregnancy|1|||
33562529|NCT01475825|101954699|FG003|Overall Study|Adverse Event|11|||
33626540|NCT00855959|102181043|FG000|Overall Study|Incorrect enrolment|1|||
33221416|NCT02160314|100711049|FG001|Overall Study|Protocol Violation|4|||
33361300|NCT01736683|101210785|FG001|Overall Study|Adverse Event|2|||
33626541|NCT04349072|102181044|FG000|Randomization Period|Found ineligible post enrollment|0|||
33626542|NCT04349072|102181045|FG001|Randomization Period|Found ineligible post enrollment|1|||
33626543|NCT04349072|102181044|FG000|Treatment Period|Permanent Stopping Criteria Met|0|||
33221417|NCT02160314|100711048|FG000|Overall Study|Withdrawal by Subject|1|||
33221418|NCT02160314|100711049|FG001|Overall Study|Withdrawal by Subject|2|||
33221419|NCT02160314|100711048|FG000|Overall Study|Lost to Follow-up|0|||
33221420|NCT02160314|100711049|FG001|Overall Study|Lost to Follow-up|1|||
33361301|NCT01736683|101210786|FG002|Overall Study|Adverse Event|2|||
33562530|NCT01475825|101954696|FG000|Overall Study|Death|1|||
33626544|NCT04349072|102181045|FG001|Treatment Period|Permanent Stopping Criteria Met|2|||
33626545|NCT04349072|102181044|FG000|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|3|||
33626546|NCT04349072|102181045|FG001|Treatment Period|Proceeding With Septal Reduction Therapy (SRT)|5|||
33626547|NCT04349072|102181044|FG000|Treatment Period|Physician Decision|0|||
33626548|NCT04349072|102181045|FG001|Treatment Period|Physician Decision|1|||
33626549|NCT04349072|102181044|FG000|Treatment Period|Protocol Violation|0|||
33626550|NCT04349072|102181045|FG001|Treatment Period|Protocol Violation|1|||
33626551|NCT04349072|102181044|FG000|Treatment Period|Withdrawal by Subject|1|||
33626552|NCT04349072|102181045|FG001|Treatment Period|Withdrawal by Subject|1|||
33626553|NCT00453154|102181046|FG000|Double BIind Maintenance|Adverse Event|0|||
33626554|NCT00453154|102181047|FG001|Double BIind Maintenance|Adverse Event|0|||
33626555|NCT00453154|102181048|FG002|Double BIind Maintenance|Adverse Event|3|||
33626556|NCT00453154|102181049|FG003|Double BIind Maintenance|Adverse Event|12|||
33626557|NCT00453154|102181046|FG000|Double BIind Maintenance|Death|0|||
33626558|NCT00453154|102181047|FG001|Double BIind Maintenance|Death|0|||
33626559|NCT00453154|102181048|FG002|Double BIind Maintenance|Death|2|||
33626560|NCT00453154|102181049|FG003|Double BIind Maintenance|Death|1|||
33626561|NCT00453154|102181046|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
33626562|NCT00453154|102181047|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
33626563|NCT00453154|102181048|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
33221421|NCT02036645|100711050|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33361302|NCT01736683|101210787|FG003|Overall Study|Adverse Event|3|||
33361303|NCT01736683|101210788|FG004|Overall Study|Adverse Event|2|||
33361304|NCT01736683|101210784|FG000|Overall Study|Withdrawal by Subject|0|||
33361305|NCT01736683|101210785|FG001|Overall Study|Withdrawal by Subject|0|||
33361306|NCT01736683|101210786|FG002|Overall Study|Withdrawal by Subject|3|||
33361307|NCT01736683|101210787|FG003|Overall Study|Withdrawal by Subject|1|||
33361308|NCT01736683|101210788|FG004|Overall Study|Withdrawal by Subject|1|||
33361309|NCT01736683|101210784|FG000|Overall Study|Lack of Therapeutic Effect|7|||
33361310|NCT01736683|101210785|FG001|Overall Study|Lack of Therapeutic Effect|4|||
33361311|NCT01736683|101210786|FG002|Overall Study|Lack of Therapeutic Effect|13|||
33361312|NCT01736683|101210787|FG003|Overall Study|Lack of Therapeutic Effect|20|||
33361313|NCT01736683|101210788|FG004|Overall Study|Lack of Therapeutic Effect|1|||
33361314|NCT01736683|101210784|FG000|Overall Study|Progressive Disease|0|||
33562531|NCT01475825|101954697|FG001|Overall Study|Death|0|||
33562532|NCT01475825|101954698|FG002|Overall Study|Death|1|||
33562533|NCT01475825|101954699|FG003|Overall Study|Death|0|||
33562534|NCT01475825|101954696|FG000|Overall Study|Lack of Efficacy|0|||
33562535|NCT01475825|101954697|FG001|Overall Study|Lack of Efficacy|0|||
33361315|NCT01736683|101210785|FG001|Overall Study|Progressive Disease|0|||
33361316|NCT01736683|101210786|FG002|Overall Study|Progressive Disease|0|||
33562536|NCT01475825|101954698|FG002|Overall Study|Lack of Efficacy|1|||
33562537|NCT01475825|101954699|FG003|Overall Study|Lack of Efficacy|0|||
33562538|NCT01475825|101954696|FG000|Overall Study|Lost to Follow-up|0|||
33562539|NCT01475825|101954697|FG001|Overall Study|Lost to Follow-up|0|||
33562540|NCT01475825|101954698|FG002|Overall Study|Lost to Follow-up|3|||
33562541|NCT01475825|101954699|FG003|Overall Study|Lost to Follow-up|1|||
33562542|NCT01475825|101954696|FG000|Overall Study|Non-compliance with Study Drug|1|||
33562543|NCT01475825|101954697|FG001|Overall Study|Non-compliance with Study Drug|2|||
33562544|NCT01475825|101954698|FG002|Overall Study|Non-compliance with Study Drug|4|||
33562545|NCT01475825|101954699|FG003|Overall Study|Non-compliance with Study Drug|0|||
33562546|NCT01475825|101954696|FG000|Overall Study|Other: Not available|0|||
33562547|NCT01475825|101954697|FG001|Overall Study|Other: Not available|0|||
33562548|NCT01475825|101954698|FG002|Overall Study|Other: Not available|2|||
33562549|NCT01475825|101954699|FG003|Overall Study|Other: Not available|0|||
33562550|NCT01475825|101954696|FG000|Overall Study|Protocol Violation|1|||
33562551|NCT01475825|101954697|FG001|Overall Study|Protocol Violation|0|||
33562552|NCT01475825|101954698|FG002|Overall Study|Protocol Violation|0|||
33562553|NCT01475825|101954699|FG003|Overall Study|Protocol Violation|0|||
33562554|NCT01475825|101954696|FG000|Overall Study|Physician Decision|0|||
33562555|NCT01475825|101954697|FG001|Overall Study|Physician Decision|1|||
33562556|NCT01475825|101954698|FG002|Overall Study|Physician Decision|0|||
33562557|NCT01475825|101954699|FG003|Overall Study|Physician Decision|0|||
33562558|NCT01475825|101954696|FG000|Overall Study|Withdrawal by Subject|8|||
33562559|NCT01475825|101954697|FG001|Overall Study|Withdrawal by Subject|3|||
33562560|NCT01475825|101954698|FG002|Overall Study|Withdrawal by Subject|11|||
33562561|NCT01475825|101954699|FG003|Overall Study|Withdrawal by Subject|7|||
33361317|NCT01736683|101210787|FG003|Overall Study|Progressive Disease|1|||
33361318|NCT01736683|101210788|FG004|Overall Study|Progressive Disease|0|||
33361319|NCT01736683|101210784|FG000|Overall Study|Other|0|||
33562562|NCT01475825|101954696|FG000|Overall Study|Did not enter OLC|15|||
33562563|NCT01475825|101954697|FG001|Overall Study|Did not enter OLC|11|||
33562564|NCT01475825|101954698|FG002|Overall Study|Did not enter OLC|15|||
33562565|NCT01475825|101954699|FG003|Overall Study|Did not enter OLC|11|||
33562566|NCT01946880|101954700|FG000|Overall Study|Lost to Follow-up|1|||
33626564|NCT00453154|102181049|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
33562567|NCT01946880|101954701|FG001|Overall Study|Lost to Follow-up|0|||
33562568|NCT01946880|101954700|FG000|Overall Study|Physician Decision|1|||
33562569|NCT01946880|101954701|FG001|Overall Study|Physician Decision|1|||
33562570|NCT01946880|101954700|FG000|Overall Study|Withdrawal by Subject|3|||
33562571|NCT01946880|101954701|FG001|Overall Study|Withdrawal by Subject|2|||
33562572|NCT01946880|101954700|FG000|Overall Study|Met Primary Endpoint|1|||
33626565|NCT00453154|102181046|FG000|Double BIind Maintenance|Progression|0|||
33626566|NCT00453154|102181047|FG001|Double BIind Maintenance|Progression|0|||
33626567|NCT00453154|102181048|FG002|Double BIind Maintenance|Progression|29|||
33626568|NCT00453154|102181049|FG003|Double BIind Maintenance|Progression|26|||
33626569|NCT00453154|102181046|FG000|Double BIind Maintenance|Medical Issues|0|||
33626570|NCT00453154|102181047|FG001|Double BIind Maintenance|Medical Issues|0|||
33626571|NCT00453154|102181048|FG002|Double BIind Maintenance|Medical Issues|3|||
33626572|NCT00453154|102181049|FG003|Double BIind Maintenance|Medical Issues|1|||
33626573|NCT00453154|102181046|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
33626574|NCT00453154|102181047|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
33626575|NCT00453154|102181048|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
33626576|NCT00453154|102181049|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
33626577|NCT03812380|102181050|FG000|Overall Study|Protocol Violation|3|||
33626578|NCT03812380|102181051|FG001|Overall Study|Protocol Violation|3|||
33626579|NCT03812380|102181050|FG000|Overall Study|Withdrawal by Subject|5|||
33626580|NCT03812380|102181051|FG001|Overall Study|Withdrawal by Subject|4|||
33626581|NCT03812380|102181050|FG000|Overall Study|Early termination of study|14|||
33626582|NCT03812380|102181051|FG001|Overall Study|Early termination of study|14|||
33626583|NCT01018030|102181053|FG000|Overall Study|Adverse Event|10|||
33626584|NCT01018030|102181054|FG001|Overall Study|Adverse Event|5|||
33626585|NCT01018030|102181055|FG002|Overall Study|Adverse Event|5|||
33626586|NCT01018030|102181053|FG000|Overall Study|Withdrawal by Subject|2|||
33626587|NCT01018030|102181054|FG001|Overall Study|Withdrawal by Subject|2|||
33626588|NCT01018030|102181055|FG002|Overall Study|Withdrawal by Subject|4|||
33626589|NCT01018030|102181053|FG000|Overall Study|Lost to Follow-up|2|||
33626590|NCT01018030|102181054|FG001|Overall Study|Lost to Follow-up|0|||
33626591|NCT01018030|102181055|FG002|Overall Study|Lost to Follow-up|3|||
33626592|NCT01018030|102181053|FG000|Overall Study|Protocol Violation|2|||
33626593|NCT01018030|102181054|FG001|Overall Study|Protocol Violation|1|||
33626594|NCT01018030|102181055|FG002|Overall Study|Protocol Violation|0|||
33626595|NCT01018030|102181053|FG000|Overall Study|Physician Decision|1|||
33626596|NCT01018030|102181054|FG001|Overall Study|Physician Decision|0|||
33626597|NCT01018030|102181055|FG002|Overall Study|Physician Decision|1|||
33626598|NCT01018030|102181053|FG000|Overall Study|Lack of Efficacy|1|||
33626599|NCT01018030|102181054|FG001|Overall Study|Lack of Efficacy|0|||
33626600|NCT01018030|102181055|FG002|Overall Study|Lack of Efficacy|0|||
33626601|NCT01018030|102181053|FG000|Overall Study|Did Not Receive Study Drug|1|||
33626602|NCT01018030|102181054|FG001|Overall Study|Did Not Receive Study Drug|3|||
33626603|NCT01018030|102181055|FG002|Overall Study|Did Not Receive Study Drug|0|||
33626604|NCT03224130|102181056|FG000|Overall Study|consent issue|0|||
33626605|NCT03224130|102181057|FG001|Overall Study|consent issue|1|||
33626606|NCT00057863|102181058|FG000|Overall Study|Death|1|||
33626607|NCT00057863|102181058|FG000|Overall Study|Withdrawal by Subject|2|||
33626608|NCT02407223|102181059|FG000|Overall Study|Adverse Event|1|||
33626609|NCT02407223|102181060|FG001|Overall Study|Adverse Event|0|||
33626610|NCT02407223|102181061|FG002|Overall Study|Adverse Event|1|||
33626611|NCT02407223|102181059|FG000|Overall Study|Lack of Efficacy|6|||
33626612|NCT02407223|102181060|FG001|Overall Study|Lack of Efficacy|6|||
33626613|NCT02407223|102181061|FG002|Overall Study|Lack of Efficacy|4|||
33626614|NCT02407223|102181059|FG000|Overall Study|Lost to Follow-up|1|||
33626615|NCT02407223|102181060|FG001|Overall Study|Lost to Follow-up|0|||
33626616|NCT02407223|102181061|FG002|Overall Study|Lost to Follow-up|2|||
33626617|NCT02407223|102181059|FG000|Overall Study|Withdrawal by Subject|2|||
33626618|NCT02407223|102181060|FG001|Overall Study|Withdrawal by Subject|4|||
33626619|NCT02407223|102181061|FG002|Overall Study|Withdrawal by Subject|4|||
33626620|NCT02407223|102181059|FG000|Overall Study|Study Terminated by Sponsor|77|||
33626621|NCT02407223|102181060|FG001|Overall Study|Study Terminated by Sponsor|80|||
33626622|NCT02407223|102181061|FG002|Overall Study|Study Terminated by Sponsor|86|||
33626623|NCT02407223|102181059|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
33626624|NCT02407223|102181060|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
33626625|NCT02407223|102181061|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
33361320|NCT01736683|101210785|FG001|Overall Study|Other|0|||
33626626|NCT02407223|102181059|FG000|Overall Study|Other|29|||
33626627|NCT02407223|102181060|FG001|Overall Study|Other|27|||
33626628|NCT02407223|102181061|FG002|Overall Study|Other|25|||
33361321|NCT01736683|101210786|FG002|Overall Study|Other|1|||
33361322|NCT01736683|101210787|FG003|Overall Study|Other|9|||
33626629|NCT04590014|102181066|FG000|Overall Study|Withdrawal by Subject|1|||
33626630|NCT04590014|102181067|FG001|Overall Study|Withdrawal by Subject|0|||
33626631|NCT00474955|102181068|FG000|Overall Study|Adverse Event|2|||
33626632|NCT00474955|102181068|FG000|Overall Study|Drug unavailability|1|||
33626633|NCT00474955|102181068|FG000|Overall Study|Personal reasons|5|||
33626634|NCT00981149|102181070|FG000|Overall Study|Lost to Follow-up|1|||
33626635|NCT00981149|102181071|FG001|Overall Study|Lost to Follow-up|2|||
33361323|NCT01736683|101210788|FG004|Overall Study|Other|1|||
33361324|NCT01589094|101210789|FG000|Overall Study|Did not receive treatment|2|||
33626636|NCT00981149|102181070|FG000|Overall Study|Withdrawal by Subject|1|||
33626637|NCT00981149|102181071|FG001|Overall Study|Withdrawal by Subject|1|||
33626638|NCT02753946|102181072|FG000|Overall Study|Adverse Event|7|||
33626639|NCT02753946|102181073|FG001|Overall Study|Adverse Event|6|||
33626640|NCT02753946|102181072|FG000|Overall Study|Withdrawal by Subject|6|||
33626641|NCT02753946|102181073|FG001|Overall Study|Withdrawal by Subject|1|||
33626642|NCT02753946|102181072|FG000|Overall Study|Lack of Efficacy|1|||
33626643|NCT02753946|102181073|FG001|Overall Study|Lack of Efficacy|0|||
33626644|NCT02753946|102181072|FG000|Overall Study|Physician Decision|0|||
33626645|NCT02753946|102181073|FG001|Overall Study|Physician Decision|2|||
33626646|NCT01731912|102184366|FG000|Overall Study|noncompliance|2|||
33626647|NCT01582061|102184375|FG000|Overall Study|Lack of Efficacy|3|||
33626648|NCT01582061|102184376|FG001|Overall Study|Lack of Efficacy|23|||
33361325|NCT01056107|101210794|FG000|Overall Study|Withdrawal by Subject|0|||
33415025|NCT00902486|101409932|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
33562573|NCT01946880|101954701|FG001|Overall Study|Met Primary Endpoint|0|||
33562574|NCT01946880|101954700|FG000|Overall Study|Personal and Family Issues|1|||
33562575|NCT01946880|101954701|FG001|Overall Study|Personal and Family Issues|0|||
33562576|NCT05130281|101954702|FG000|Overall Study|Withdrawal by Subject|0|||
33562577|NCT05130281|101954703|FG001|Overall Study|Withdrawal by Subject|0|||
33562578|NCT05130281|101954704|FG002|Overall Study|Withdrawal by Subject|1|||
33562579|NCT02076009|101954705|FG000|Overall Study|Death|172|||
33562580|NCT02076009|101954706|FG001|Overall Study|Death|153|||
33562581|NCT02076009|101954705|FG000|Overall Study|Withdrawal by Subject|16|||
33562582|NCT02076009|101954706|FG001|Overall Study|Withdrawal by Subject|12|||
33562583|NCT02076009|101954705|FG000|Overall Study|Lost to Follow-up|4|||
33562584|NCT02076009|101954706|FG001|Overall Study|Lost to Follow-up|2|||
33562585|NCT02076009|101954705|FG000|Overall Study|Progressive Disease|1|||
33562586|NCT02076009|101954706|FG001|Overall Study|Progressive Disease|0|||
33562587|NCT02076009|101954705|FG000|Overall Study|Physician Decision|0|||
33562588|NCT02076009|101954706|FG001|Overall Study|Physician Decision|1|||
33626649|NCT01582061|102184375|FG000|Overall Study|Adverse Event|12|||
33626650|NCT01582061|102184376|FG001|Overall Study|Adverse Event|8|||
33626651|NCT01582061|102184375|FG000|Overall Study|Withdrawal by Subject|10|||
33562589|NCT02076009|101954705|FG000|Overall Study|End of data collection|90|||
33361326|NCT01056107|101210795|FG001|Overall Study|Withdrawal by Subject|1|||
33361327|NCT01056107|101210796|FG002|Overall Study|Withdrawal by Subject|3|||
33361328|NCT01056107|101210797|FG003|Overall Study|Withdrawal by Subject|0|||
33361329|NCT02614794|101210798|FG000|Overall Study|Death|258|||
33361330|NCT02614794|101210799|FG001|Overall Study|Death|151|||
33361331|NCT02614794|101210798|FG000|Overall Study|Study closure by Sponsor|119|||
33361332|NCT02614794|101210799|FG001|Overall Study|Study closure by Sponsor|45|||
33361333|NCT02614794|101210798|FG000|Overall Study|Withdrawal by Subject|24|||
33361334|NCT02614794|101210799|FG001|Overall Study|Withdrawal by Subject|5|||
33361335|NCT02614794|101210798|FG000|Overall Study|Lost to Follow-up|7|||
33361336|NCT02614794|101210799|FG001|Overall Study|Lost to Follow-up|0|||
33361337|NCT02614794|101210798|FG000|Overall Study|Physician Decision|1|||
33361338|NCT02614794|101210799|FG001|Overall Study|Physician Decision|1|||
33361339|NCT02614794|101210798|FG000|Overall Study|Hospital closure|1|||
33361340|NCT02614794|101210799|FG001|Overall Study|Hospital closure|0|||
33361341|NCT00003641|101210800|FG000|Overall Study|Withdrawal by Subject|0|||
33361342|NCT00003641|101210801|FG001|Overall Study|Withdrawal by Subject|100|||
33361343|NCT00003641|101210800|FG000|Overall Study|Adverse Event|0|||
33361344|NCT00003641|101210801|FG001|Overall Study|Adverse Event|38|||
33361345|NCT00003641|101210800|FG000|Overall Study|Disease progression|0|||
33361346|NCT00003641|101210801|FG001|Overall Study|Disease progression|2|||
33361347|NCT00003641|101210800|FG000|Overall Study|Unknown/missing|0|||
33361348|NCT00003641|101210801|FG001|Overall Study|Unknown/missing|22|||
33361349|NCT00003641|101210800|FG000|Overall Study|Should not receive interferon therapy|2|||
33361350|NCT00003641|101210801|FG001|Overall Study|Should not receive interferon therapy|0|||
33361351|NCT00003641|101210800|FG000|Overall Study|Never started interferon|567|||
33361352|NCT00003641|101210801|FG001|Overall Study|Never started interferon|12|||
33361353|NCT01348919|101210802|FG000|Overall Study|Adverse Event|3|||
33361354|NCT01348919|101210803|FG001|Overall Study|Adverse Event|1|||
33361355|NCT01348919|101210804|FG002|Overall Study|Adverse Event|0|||
33361356|NCT01348919|101210802|FG000|Overall Study|Withdrawal by Subject|0|||
33361357|NCT01348919|101210803|FG001|Overall Study|Withdrawal by Subject|1|||
33361358|NCT01348919|101210804|FG002|Overall Study|Withdrawal by Subject|0|||
33562590|NCT02076009|101954706|FG001|Overall Study|End of data collection|118|||
33562591|NCT02462057|101954707|FG000|Overall Study|Left Vitality|32|||
33562592|NCT02462057|101954708|FG001|Overall Study|Left Vitality|27|||
33562593|NCT02462057|101954709|FG002|Overall Study|Left Vitality|23|||
33562594|NCT02462057|101954710|FG003|Overall Study|Left Vitality|35|||
33562595|NCT02462057|101954711|FG004|Overall Study|Left Vitality|33|||
33562596|NCT02462057|101954707|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
33562597|NCT02462057|101954708|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
33562598|NCT02462057|101954709|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
33562599|NCT02462057|101954710|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
33562600|NCT02462057|101954711|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
33562601|NCT03338790|101954726|FG000|Overall Study|Disease Progression|65|||
33562602|NCT03338790|101954727|FG001|Overall Study|Disease Progression|43|||
33562603|NCT03338790|101954728|FG002|Overall Study|Disease Progression|50|||
33562604|NCT03338790|101954729|FG003|Overall Study|Disease Progression|37|||
33562605|NCT03338790|101954726|FG000|Overall Study|Study Drug Toxicity|9|||
33562606|NCT03338790|101954727|FG001|Overall Study|Study Drug Toxicity|8|||
33361359|NCT01348919|101210802|FG000|Overall Study|Disease progression|0|||
33361360|NCT01348919|101210803|FG001|Overall Study|Disease progression|1|||
33361361|NCT01348919|101210804|FG002|Overall Study|Disease progression|1|||
33361362|NCT02333331|101210809|FG000|Overall Study|Adverse Event|1|||
33361363|NCT02333331|101210810|FG001|Overall Study|Adverse Event|0|||
33361364|NCT02333331|101210811|FG002|Overall Study|Adverse Event|4|||
33361365|NCT02333331|101210812|FG003|Overall Study|Adverse Event|1|||
33361366|NCT02333331|101210809|FG000|Overall Study|Death|0|||
33562607|NCT03338790|101954728|FG002|Overall Study|Study Drug Toxicity|15|||
33562608|NCT03338790|101954729|FG003|Overall Study|Study Drug Toxicity|0|||
33562609|NCT03338790|101954726|FG000|Overall Study|Death|1|||
33562610|NCT03338790|101954727|FG001|Overall Study|Death|1|||
33361367|NCT02333331|101210810|FG001|Overall Study|Death|0|||
33361368|NCT02333331|101210811|FG002|Overall Study|Death|2|||
33361369|NCT02333331|101210812|FG003|Overall Study|Death|0|||
33361370|NCT02333331|101210809|FG000|Overall Study|Lost to Follow-up|0|||
33361371|NCT02333331|101210810|FG001|Overall Study|Lost to Follow-up|0|||
33361372|NCT02333331|101210811|FG002|Overall Study|Lost to Follow-up|1|||
33361373|NCT02333331|101210812|FG003|Overall Study|Lost to Follow-up|0|||
33361374|NCT02333331|101210809|FG000|Overall Study|Physician Decision|0|||
33361375|NCT02333331|101210810|FG001|Overall Study|Physician Decision|1|||
33562611|NCT03338790|101954728|FG002|Overall Study|Death|1|||
33626652|NCT01582061|102184376|FG001|Overall Study|Withdrawal by Subject|4|||
33626653|NCT01582061|102184375|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33626654|NCT01582061|102184376|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33626655|NCT01582061|102184375|FG000|Overall Study|Death|0|||
33626656|NCT01582061|102184376|FG001|Overall Study|Death|1|||
33626657|NCT01582061|102184375|FG000|Overall Study|condition no longer requires study drug|1|||
33562612|NCT03338790|101954729|FG003|Overall Study|Death|0|||
33562613|NCT03338790|101954726|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
33562614|NCT03338790|101954727|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
33562615|NCT03338790|101954728|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
33562616|NCT03338790|101954729|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
33562617|NCT03338790|101954726|FG000|Overall Study|Participant request to discontinue study treatment|3|||
33562618|NCT03338790|101954727|FG001|Overall Study|Participant request to discontinue study treatment|3|||
33562619|NCT03338790|101954728|FG002|Overall Study|Participant request to discontinue study treatment|2|||
33562620|NCT03338790|101954729|FG003|Overall Study|Participant request to discontinue study treatment|1|||
33562621|NCT03338790|101954726|FG000|Overall Study|Poor/non-compliance|0|||
33562622|NCT03338790|101954727|FG001|Overall Study|Poor/non-compliance|1|||
33562623|NCT03338790|101954728|FG002|Overall Study|Poor/non-compliance|0|||
33562624|NCT03338790|101954729|FG003|Overall Study|Poor/non-compliance|0|||
33562625|NCT03338790|101954726|FG000|Overall Study|Participant withdrew consent|1|||
33562626|NCT03338790|101954727|FG001|Overall Study|Participant withdrew consent|0|||
33562627|NCT03338790|101954728|FG002|Overall Study|Participant withdrew consent|1|||
33562628|NCT03338790|101954729|FG003|Overall Study|Participant withdrew consent|1|||
33562629|NCT03338790|101954726|FG000|Overall Study|Other reasons|0|||
33562630|NCT03338790|101954727|FG001|Overall Study|Other reasons|5|||
33562631|NCT03338790|101954728|FG002|Overall Study|Other reasons|0|||
33562632|NCT03338790|101954729|FG003|Overall Study|Other reasons|2|||
33562633|NCT03338790|101954726|FG000|Overall Study|Not reported|0|||
33562634|NCT03338790|101954727|FG001|Overall Study|Not reported|0|||
33562635|NCT03338790|101954728|FG002|Overall Study|Not reported|1|||
33562636|NCT03338790|101954729|FG003|Overall Study|Not reported|0|||
33562637|NCT03338790|101954726|FG000|Overall Study|Completed treatment period|1|||
33562638|NCT03338790|101954727|FG001|Overall Study|Completed treatment period|2|||
33562639|NCT03338790|101954728|FG002|Overall Study|Completed treatment period|0|||
33562640|NCT03338790|101954729|FG003|Overall Study|Completed treatment period|0|||
33562641|NCT01346592|101954751|FG000|Overall Study|Lost to Follow-up|62|||
33562642|NCT01346592|101954752|FG001|Overall Study|Lost to Follow-up|29|||
33562643|NCT01346592|101954753|FG002|Overall Study|Lost to Follow-up|29|||
33562644|NCT01346592|101954751|FG000|Overall Study|Protocol Violation|2|||
33562645|NCT01346592|101954752|FG001|Overall Study|Protocol Violation|1|||
33562646|NCT01346592|101954753|FG002|Overall Study|Protocol Violation|0|||
33562647|NCT01346592|101954751|FG000|Overall Study|Death|1|||
33562648|NCT01346592|101954752|FG001|Overall Study|Death|3|||
33562649|NCT01346592|101954753|FG002|Overall Study|Death|4|||
33562650|NCT01346592|101954751|FG000|Overall Study|Adverse Event|0|||
33626658|NCT01582061|102184376|FG001|Overall Study|condition no longer requires study drug|0|||
33562651|NCT01346592|101954752|FG001|Overall Study|Adverse Event|1|||
33361376|NCT02333331|101210811|FG002|Overall Study|Physician Decision|0|||
33361377|NCT02333331|101210812|FG003|Overall Study|Physician Decision|0|||
33562652|NCT01346592|101954753|FG002|Overall Study|Adverse Event|0|||
33562653|NCT01346592|101954751|FG000|Overall Study|Withdrawal by Subject|77|||
33562654|NCT01346592|101954752|FG001|Overall Study|Withdrawal by Subject|51|||
33626659|NCT01582061|102184375|FG000|Overall Study|Lost to Follow-up|1|||
33361378|NCT02333331|101210809|FG000|Overall Study|Protocol Deviation|0|||
33562655|NCT01346592|101954753|FG002|Overall Study|Withdrawal by Subject|38|||
33562656|NCT01346592|101954751|FG000|Overall Study|Inappropriate enrollment|3|||
33562657|NCT01346592|101954752|FG001|Overall Study|Inappropriate enrollment|1|||
33562658|NCT01346592|101954753|FG002|Overall Study|Inappropriate enrollment|1|||
33562659|NCT01346592|101954751|FG000|Overall Study|Administrative reason|1|||
33562660|NCT01346592|101954752|FG001|Overall Study|Administrative reason|0|||
33562661|NCT01346592|101954753|FG002|Overall Study|Administrative reason|0|||
33562662|NCT01346592|101954751|FG000|Overall Study|Unable to Classify|7|||
33562663|NCT01346592|101954752|FG001|Overall Study|Unable to Classify|3|||
33626660|NCT01582061|102184376|FG001|Overall Study|Lost to Follow-up|0|||
33626661|NCT02831764|102184377|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
33626662|NCT02831764|102184378|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
33626663|NCT02831764|102184379|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
33626664|NCT02831764|102184380|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
33626665|NCT02831764|102184381|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
33221422|NCT02036645|100711051|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33626666|NCT02831764|102184377|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
33626667|NCT02831764|102184378|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
33626668|NCT02831764|102184379|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
33626669|NCT02831764|102184380|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
33626670|NCT02831764|102184381|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
33626671|NCT02831764|102184377|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
33626672|NCT02831764|102184378|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
33626673|NCT02831764|102184379|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
33626674|NCT02831764|102184380|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
33626675|NCT02831764|102184381|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
33626676|NCT02831764|102184377|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
33626677|NCT02831764|102184378|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
33626678|NCT02831764|102184379|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
33626679|NCT02831764|102184380|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
33626680|NCT02831764|102184381|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
33626681|NCT02831764|102184377|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
33626682|NCT02831764|102184378|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
33626683|NCT02831764|102184379|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
33626684|NCT02831764|102184380|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
33626685|NCT02831764|102184381|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
33626686|NCT02831764|102184377|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
33626687|NCT02831764|102184378|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
33626688|NCT02831764|102184379|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
33626689|NCT02831764|102184380|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
33626690|NCT02831764|102184381|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
33626691|NCT02831764|102184377|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
33626692|NCT02831764|102184378|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
33626693|NCT02831764|102184379|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
33626694|NCT02831764|102184380|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
33626695|NCT02831764|102184381|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
33626696|NCT02831764|102184377|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
33221423|NCT02036645|100711052|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33221424|NCT02036645|100711053|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33562664|NCT01346592|101954753|FG002|Overall Study|Unable to Classify|6|||
33361379|NCT02333331|101210810|FG001|Overall Study|Protocol Deviation|3|||
33361380|NCT02333331|101210811|FG002|Overall Study|Protocol Deviation|2|||
33562665|NCT01697501|101954754|FG000|Overall Study|Protocol Violation|2|||
33562666|NCT03523585|101954761|FG000|Overall Study|Progressive Disease|174|||
33562667|NCT03523585|101954762|FG001|Overall Study|Progressive Disease|64|||
33562668|NCT03523585|101954763|FG002|Overall Study|Progressive Disease|77|||
33562669|NCT03523585|101954761|FG000|Overall Study|Adverse Event|74|||
33626697|NCT02831764|102184378|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
33626698|NCT02831764|102184379|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
33221425|NCT02036645|100711054|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33221426|NCT02036645|100711055|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33562670|NCT03523585|101954762|FG001|Overall Study|Adverse Event|5|||
33562671|NCT03523585|101954763|FG002|Overall Study|Adverse Event|9|||
33562672|NCT03523585|101954761|FG000|Overall Study|Withdrawal by Subject|30|||
33562673|NCT03523585|101954762|FG001|Overall Study|Withdrawal by Subject|11|||
33562674|NCT03523585|101954763|FG002|Overall Study|Withdrawal by Subject|6|||
33562675|NCT03523585|101954761|FG000|Overall Study|Clinical Progression|23|||
33562676|NCT03523585|101954762|FG001|Overall Study|Clinical Progression|5|||
33562677|NCT03523585|101954763|FG002|Overall Study|Clinical Progression|10|||
33562678|NCT03523585|101954761|FG000|Overall Study|Death|4|||
33626699|NCT02831764|102184380|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
33562679|NCT03523585|101954762|FG001|Overall Study|Death|0|||
33562680|NCT03523585|101954763|FG002|Overall Study|Death|1|||
33562681|NCT03523585|101954761|FG000|Overall Study|Physician Decision|2|||
33562682|NCT03523585|101954762|FG001|Overall Study|Physician Decision|1|||
33562683|NCT03523585|101954763|FG002|Overall Study|Physician Decision|0|||
33562684|NCT03523585|101954761|FG000|Overall Study|Lost to Follow-up|1|||
33562685|NCT03523585|101954762|FG001|Overall Study|Lost to Follow-up|0|||
33562686|NCT03523585|101954763|FG002|Overall Study|Lost to Follow-up|0|||
33562687|NCT03523585|101954761|FG000|Overall Study|Miscellaneous|1|||
33562688|NCT03523585|101954762|FG001|Overall Study|Miscellaneous|0|||
33562689|NCT03523585|101954763|FG002|Overall Study|Miscellaneous|0|||
33562690|NCT03523585|101954761|FG000|Overall Study|Protocol Deviation|1|||
33562691|NCT03523585|101954762|FG001|Overall Study|Protocol Deviation|0|||
33626700|NCT02831764|102184381|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
33626701|NCT02831764|102184377|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
33626702|NCT02831764|102184378|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
33626703|NCT02831764|102184379|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
33221427|NCT02036645|100711056|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
33221428|NCT02036645|100711057|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33361381|NCT02333331|101210812|FG003|Overall Study|Protocol Deviation|1|||
33361382|NCT02333331|101210809|FG000|Overall Study|Patient/Guardian Decision|1|||
33562692|NCT03523585|101954763|FG002|Overall Study|Protocol Deviation|1|||
33562693|NCT03523585|101954761|FG000|Overall Study|Randomized But Not Treated|2|||
33626704|NCT02831764|102184380|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
33626705|NCT02831764|102184381|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
33626706|NCT02831764|102184377|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
33626707|NCT02831764|102184378|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
33626708|NCT02831764|102184379|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
33626709|NCT02831764|102184380|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
33626710|NCT02831764|102184381|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
33626711|NCT02831764|102184377|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
33626712|NCT02831764|102184378|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
33626713|NCT02831764|102184379|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
33626714|NCT02831764|102184380|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
33626715|NCT02831764|102184381|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
33626716|NCT02831764|102184377|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
33626717|NCT02831764|102184378|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
33626718|NCT02831764|102184379|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
33626719|NCT02831764|102184380|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
33626720|NCT02831764|102184381|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
33626721|NCT02831764|102184377|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
33562694|NCT03523585|101954762|FG001|Overall Study|Randomized But Not Treated|4|||
33562695|NCT03523585|101954763|FG002|Overall Study|Randomized But Not Treated|3|||
33562696|NCT04629521|101954769|FG000|Overall Study|Death|1|||
33562697|NCT04629521|101954769|FG000|Overall Study|Lost to Follow-up|3|||
33562698|NCT04629521|101954769|FG000|Overall Study|Subject withdrew consent|3|||
33221429|NCT02036645|100711058|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33221430|NCT02036645|100711059|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33221431|NCT02036645|100711060|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33221432|NCT02036645|100711061|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
33221433|NCT02036645|100711050|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33221434|NCT02036645|100711051|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33221435|NCT02036645|100711052|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33221436|NCT02036645|100711053|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
33221437|NCT02036645|100711054|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33221438|NCT02036645|100711055|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33221439|NCT02036645|100711056|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33221440|NCT02036645|100711057|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33221441|NCT02036645|100711058|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33221442|NCT02036645|100711059|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33221443|NCT02036645|100711060|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33221444|NCT02036645|100711061|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
33221445|NCT00180479|100711070|FG000|Overall Study|Death|4|||
33221446|NCT00180479|100711071|FG001|Overall Study|Death|2|||
33221447|NCT00180479|100711070|FG000|Overall Study|Lost to Follow-up|9|||
33221448|NCT00180479|100711071|FG001|Overall Study|Lost to Follow-up|7|||
33221449|NCT00180479|100711070|FG000|Overall Study|Withdrawal by Subject|3|||
33221450|NCT00180479|100711071|FG001|Overall Study|Withdrawal by Subject|3|||
33221451|NCT00180479|100711070|FG000|Overall Study|Informed consent not signed|0|||
33221452|NCT00180479|100711071|FG001|Overall Study|Informed consent not signed|1|||
33221453|NCT00110890|100711072|FG000|Overall Study|Adverse Event|30|||
33221454|NCT00110890|100711073|FG001|Overall Study|Adverse Event|7|||
33221455|NCT00110890|100711072|FG000|Overall Study|Death|16|||
33221456|NCT00110890|100711073|FG001|Overall Study|Death|9|||
33221457|NCT00110890|100711072|FG000|Overall Study|Lost to Follow-up|3|||
33221458|NCT00110890|100711073|FG001|Overall Study|Lost to Follow-up|1|||
33221459|NCT00110890|100711072|FG000|Overall Study|Physician Decision|4|||
33221460|NCT00110890|100711073|FG001|Overall Study|Physician Decision|5|||
33221461|NCT00110890|100711072|FG000|Overall Study|Withdrawal by Subject|17|||
33562699|NCT04629521|101954769|FG000|Overall Study|Enrolled in error|1|||
33562700|NCT01299961|101954770|FG000|Overall Study|Adverse Event|3|||
33562701|NCT01299961|101954770|FG000|Overall Study|Lack of Efficacy|2|||
33562702|NCT01299961|101954770|FG000|Overall Study|Lost to Follow-up|1|||
33562703|NCT02743221|101956870|FG000|Overall Study|Progressive disease|29|||
33562704|NCT02743221|101956871|FG001|Overall Study|Progressive disease|38|||
33562705|NCT02743221|101956870|FG000|Overall Study|Adverse Event|17|||
33562706|NCT02743221|101956871|FG001|Overall Study|Adverse Event|14|||
33562707|NCT02743221|101956870|FG000|Overall Study|non medical reason|8|||
33562708|NCT02743221|101956871|FG001|Overall Study|non medical reason|2|||
33562709|NCT02743221|101956870|FG000|Overall Study|Physician Decision|2|||
33562710|NCT02743221|101956871|FG001|Overall Study|Physician Decision|5|||
33562711|NCT02743221|101956870|FG000|Overall Study|Patient not eligible, not treated|0|||
33562712|NCT02743221|101956871|FG001|Overall Study|Patient not eligible, not treated|1|||
33562713|NCT02150863|101956872|FG000|Overall Study|Lost to Follow-up|0|||
33562714|NCT02150863|101956873|FG001|Overall Study|Lost to Follow-up|1|||
33562715|NCT02150863|101956874|FG002|Overall Study|Lost to Follow-up|0|||
33562716|NCT01892189|101956875|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
33562717|NCT01892189|101956876|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
33562718|NCT01892189|101956877|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
33562719|NCT01892189|101956878|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
33562720|NCT01892189|101956879|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
33221462|NCT00110890|100711073|FG001|Overall Study|Withdrawal by Subject|5|||
33221463|NCT00110890|100711072|FG000|Overall Study|Protocol Deviation|1|||
33221464|NCT00110890|100711073|FG001|Overall Study|Protocol Deviation|0|||
33221465|NCT00110890|100711072|FG000|Overall Study|Noncompliance|10|||
33562721|NCT01892189|101956880|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
33562722|NCT01892189|101956881|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
33562723|NCT01892189|101956882|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
33562724|NCT01892189|101956883|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
33562725|NCT01892189|101956875|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33415026|NCT00902486|101409933|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
33415027|NCT00902486|101409934|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
33415028|NCT00902486|101409935|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
33562726|NCT01892189|101956876|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33562727|NCT01892189|101956877|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
33562728|NCT01892189|101956878|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
33562729|NCT01892189|101956879|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33562730|NCT01892189|101956880|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33562731|NCT01892189|101956881|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
33562732|NCT01892189|101956882|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33562733|NCT01892189|101956883|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
33562734|NCT01892189|101956875|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33562735|NCT01892189|101956876|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33562736|NCT01892189|101956877|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33562737|NCT01892189|101956878|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33562738|NCT01892189|101956879|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33562739|NCT01892189|101956880|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
33562740|NCT01892189|101956881|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33562741|NCT01892189|101956882|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33562742|NCT01892189|101956883|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
33562743|NCT04193176|101956885|FG000|Overall Study|Withdrawal by Subject|6|||
33562744|NCT04193176|101956886|FG001|Overall Study|Withdrawal by Subject|10|||
33562745|NCT03984188|101956889|FG000|Overall Study|Death|2|||
33562746|NCT03984188|101956890|FG001|Overall Study|Death|4|||
33562747|NCT03984188|101956889|FG000|Overall Study|Physician Decision|0|||
33562748|NCT03984188|101956890|FG001|Overall Study|Physician Decision|2|||
33562749|NCT03984188|101956889|FG000|Overall Study|Lost to Follow-up|3|||
33562750|NCT03984188|101956890|FG001|Overall Study|Lost to Follow-up|2|||
33562751|NCT03984188|101956889|FG000|Overall Study|Withdrawal by Subject|6|||
33415029|NCT00902486|101409930|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
33415030|NCT00902486|101409931|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
33415031|NCT00902486|101409932|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
33415032|NCT00902486|101409933|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
33562752|NCT03984188|101956890|FG001|Overall Study|Withdrawal by Subject|0|||
33562753|NCT02904096|101956892|FG000|Overall Study|Adverse Event|1|||
33562754|NCT02904096|101956893|FG001|Overall Study|Adverse Event|0|||
33562755|NCT02904096|101956892|FG000|Overall Study|Withdrawal by Subject|4|||
33562756|NCT02904096|101956893|FG001|Overall Study|Withdrawal by Subject|3|||
33562757|NCT02904096|101956892|FG000|Overall Study|Lost to Follow-up|10|||
33562758|NCT02904096|101956893|FG001|Overall Study|Lost to Follow-up|17|||
33562759|NCT02904096|101956892|FG000|Overall Study|Non-compliant|3|||
33562760|NCT02904096|101956893|FG001|Overall Study|Non-compliant|1|||
33562761|NCT02904096|101956892|FG000|Overall Study|Sponsor instructed|1|||
33562762|NCT02904096|101956893|FG001|Overall Study|Sponsor instructed|0|||
33562763|NCT04620668|101956894|FG000|Overall Study|Withdrawal by Subject|2|||
33562764|NCT04620668|101956895|FG001|Overall Study|Withdrawal by Subject|0|||
33562765|NCT04620668|101956894|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
33415033|NCT00902486|101409934|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
33562766|NCT04620668|101956895|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
33562767|NCT04620668|101956894|FG000|Overall Study|Removed before analysis: missing data|2|||
33562768|NCT04620668|101956895|FG001|Overall Study|Removed before analysis: missing data|0|||
33562769|NCT04620668|101956894|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
33221466|NCT00110890|100711073|FG001|Overall Study|Noncompliance|0|||
33562770|NCT04620668|101956895|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
33562771|NCT04620668|101956894|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
33562772|NCT04620668|101956895|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
33562773|NCT02244957|101956896|FG000|Overall Study|Lack of Efficacy|1|||
33562774|NCT02244957|101956897|FG001|Overall Study|Lack of Efficacy|0|||
33415034|NCT00902486|101409935|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
33415035|NCT00902486|101409930|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
33415036|NCT00902486|101409931|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
33415037|NCT00902486|101409932|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
33415038|NCT00902486|101409933|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
33626722|NCT02831764|102184378|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
33626723|NCT02831764|102184379|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
33626724|NCT02831764|102184380|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
33626725|NCT02831764|102184381|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
33626726|NCT02831764|102184377|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
33626727|NCT02831764|102184378|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
33626728|NCT02831764|102184379|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
33626729|NCT02831764|102184380|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
33626730|NCT02831764|102184381|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
33626731|NCT02831764|102184377|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
33361383|NCT02333331|101210810|FG001|Overall Study|Patient/Guardian Decision|2|||
33361384|NCT02333331|101210811|FG002|Overall Study|Patient/Guardian Decision|9|||
33361385|NCT02333331|101210812|FG003|Overall Study|Patient/Guardian Decision|1|||
33361386|NCT00641147|101210817|FG000|Completed 4 Months.|Physician Decision|1|||
33361387|NCT00641147|101210818|FG001|Completed 4 Months.|Physician Decision|0|||
33361388|NCT00641147|101210817|FG000|Completed 4 Months.|Adverse Event|1|||
33361389|NCT00641147|101210818|FG001|Completed 4 Months.|Adverse Event|0|||
33361390|NCT00641147|101210817|FG000|Completed 8 Months.|Physician Decision|2|||
33361391|NCT00641147|101210818|FG001|Completed 8 Months.|Physician Decision|1|||
33361392|NCT00641147|101210817|FG000|Completed 8 Months.|non compliance|1|||
33361393|NCT00641147|101210818|FG001|Completed 8 Months.|non compliance|0|||
33361394|NCT00641147|101210817|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
33361395|NCT00641147|101210818|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
33361396|NCT00641147|101210817|FG000|Completed 12 Months.|Physician Decision|1|||
33361397|NCT00641147|101210818|FG001|Completed 12 Months.|Physician Decision|1|||
33361398|NCT00641147|101210817|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
33361399|NCT00641147|101210818|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
33361400|NCT00641147|101210817|FG000|Completed 16 Months.|Physician Decision|1|||
33361401|NCT00641147|101210818|FG001|Completed 16 Months.|Physician Decision|0|||
33361402|NCT00641147|101210817|FG000|Completed 16 Months.|Lost to Follow-up|1|||
33361403|NCT00641147|101210818|FG001|Completed 16 Months.|Lost to Follow-up|0|||
33361404|NCT00258154|101210821|FG000|Overall Study|Adverse Event|1|||
33415039|NCT00902486|101409934|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
33361405|NCT00258154|101210822|FG001|Overall Study|Adverse Event|0|||
33415040|NCT00902486|101409935|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
33415041|NCT00902486|101409930|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
33415042|NCT00902486|101409931|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
33415043|NCT00902486|101409932|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
33415044|NCT00902486|101409933|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
33415045|NCT00902486|101409934|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
33415046|NCT00902486|101409935|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
33415047|NCT00902486|101409930|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
33415048|NCT00902486|101409931|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
33415049|NCT00902486|101409932|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
33415050|NCT00902486|101409933|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
33562775|NCT00456365|101956899|FG000|Overall Study|Lost to Follow-up|1|||
33361406|NCT00258154|101210821|FG000|Overall Study|Lost to Follow-up|0|||
33361407|NCT00258154|101210822|FG001|Overall Study|Lost to Follow-up|1|||
33361408|NCT00258154|101210821|FG000|Overall Study|Protocol Violation|2|||
33361409|NCT00258154|101210822|FG001|Overall Study|Protocol Violation|1|||
33562776|NCT00456365|101956900|FG001|Overall Study|Lost to Follow-up|3|||
33562777|NCT00456365|101956899|FG000|Overall Study|Withdrawal by Subject|4|||
33562778|NCT00456365|101956900|FG001|Overall Study|Withdrawal by Subject|7|||
33562779|NCT00456365|101956899|FG000|Overall Study|Pregnancy|1|||
33562780|NCT00456365|101956900|FG001|Overall Study|Pregnancy|1|||
33361410|NCT00258154|101210821|FG000|Overall Study|Withdrawal by Subject|3|||
33361411|NCT00258154|101210822|FG001|Overall Study|Withdrawal by Subject|4|||
33361412|NCT00258154|101210821|FG000|Overall Study|Patient Moved|3|||
33361413|NCT00258154|101210822|FG001|Overall Study|Patient Moved|1|||
33415051|NCT00902486|101409934|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
33415052|NCT00902486|101409935|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
33415053|NCT00902486|101409930|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
33415054|NCT00902486|101409931|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
33562781|NCT00456365|101956899|FG000|Overall Study|oncologic diagnosis|1|||
33562782|NCT00456365|101956900|FG001|Overall Study|oncologic diagnosis|1|||
33562783|NCT05486065|101956901|FG000|Overall Study|Withdrawal by Subject|1|||
33562784|NCT05486065|101956902|FG001|Overall Study|Withdrawal by Subject|5|||
33562785|NCT05486065|101956903|FG002|Overall Study|Withdrawal by Subject|4|||
33562786|NCT05486065|101956904|FG003|Overall Study|Withdrawal by Subject|3|||
33562787|NCT05486065|101956901|FG000|Overall Study|Lost to Follow-up|4|||
33562788|NCT05486065|101956902|FG001|Overall Study|Lost to Follow-up|2|||
33562789|NCT05486065|101956903|FG002|Overall Study|Lost to Follow-up|2|||
33562790|NCT05486065|101956904|FG003|Overall Study|Lost to Follow-up|2|||
33562791|NCT05486065|101956901|FG000|Overall Study|Physician Decision|0|||
33562792|NCT05486065|101956902|FG001|Overall Study|Physician Decision|1|||
33562793|NCT05486065|101956903|FG002|Overall Study|Physician Decision|1|||
33562794|NCT05486065|101956904|FG003|Overall Study|Physician Decision|0|||
33562795|NCT05486065|101956901|FG000|Overall Study|Failure to meet randomization criteria|0|||
33562796|NCT05486065|101956902|FG001|Overall Study|Failure to meet randomization criteria|0|||
33562797|NCT05486065|101956903|FG002|Overall Study|Failure to meet randomization criteria|0|||
33562798|NCT05486065|101956904|FG003|Overall Study|Failure to meet randomization criteria|1|||
33562799|NCT00661687|101956905|FG000|Overall Study|Study related symptoms and complaints|5|||
33562800|NCT00661687|101956905|FG000|Overall Study|Positive slit lamp findings|4|||
33562801|NCT00661687|101956905|FG000|Overall Study|Inability to maintain wearing schedule|3|||
33562802|NCT00661687|101956905|FG000|Overall Study|Physician Decision|1|||
33361414|NCT00621023|101210825|FG000|Overall Study|Death|5|||
33361415|NCT00621023|101210825|FG000|Overall Study|Follow up discontinued|1|||
33361416|NCT02031146|101210829|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
33626732|NCT02831764|102184378|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
33626733|NCT02831764|102184379|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
33626734|NCT02831764|102184380|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
33626735|NCT02831764|102184381|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
33626736|NCT02831764|102184377|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33626737|NCT02831764|102184378|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33626738|NCT02831764|102184379|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33626739|NCT02831764|102184380|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
33626740|NCT02831764|102184381|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
33626741|NCT02831764|102184377|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33626742|NCT02831764|102184378|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33626743|NCT02831764|102184379|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33626744|NCT02831764|102184380|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
33626745|NCT02831764|102184381|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
33626746|NCT02831764|102184377|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33626747|NCT02831764|102184378|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33626748|NCT02831764|102184379|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33626749|NCT02831764|102184380|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
33361417|NCT02031146|101210830|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
33361418|NCT02031146|101210831|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
33361419|NCT02031146|101210832|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
33361420|NCT02031146|101210833|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
33361421|NCT02031146|101210834|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
33361422|NCT02031146|101210835|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
33361423|NCT01161524|101210836|FG000|Core Study (23 Weeks)|Adverse Event|3|||
33361424|NCT01161524|101210837|FG001|Core Study (23 Weeks)|Adverse Event|0|||
33361425|NCT01161524|101210838|FG002|Core Study (23 Weeks)|Adverse Event|0|||
33361426|NCT01161524|101210836|FG000|Core Study (23 Weeks)|Other|1|||
33361427|NCT01161524|101210837|FG001|Core Study (23 Weeks)|Other|0|||
33361428|NCT01161524|101210838|FG002|Core Study (23 Weeks)|Other|0|||
33361429|NCT01161524|101210836|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
33361430|NCT01161524|101210837|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
33361431|NCT01161524|101210838|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
33361432|NCT01161524|101210836|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
33361433|NCT01161524|101210837|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
33361434|NCT01161524|101210838|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
33361435|NCT01161524|101210836|FG000|Core Study (23 Weeks)|Subject Choice|3|||
33361436|NCT01161524|101210837|FG001|Core Study (23 Weeks)|Subject Choice|2|||
33361437|NCT01161524|101210838|FG002|Core Study (23 Weeks)|Subject Choice|0|||
33361438|NCT01161524|101210836|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
33361439|NCT01161524|101210837|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
33361440|NCT01161524|101210838|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
33361441|NCT01161524|101210836|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
33361442|NCT01161524|101210837|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
33361443|NCT01161524|101210838|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
33361444|NCT01161524|101210836|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
33361445|NCT01161524|101210837|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
33361446|NCT01161524|101210838|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
33361447|NCT01161524|101210836|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
33361448|NCT01161524|101210837|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
33361449|NCT01161524|101210838|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
33361450|NCT01161524|101210836|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
33361451|NCT01161524|101210837|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
33361452|NCT01161524|101210838|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
33361453|NCT02522481|101210839|FG000|Overall Study|discontinued|1|||
33361454|NCT02522481|101210839|FG000|Overall Study|Not dosed|2|||
33361455|NCT01743027|101210840|FG000|Overall Study|Adverse Event|2|||
33361456|NCT01743027|101210841|FG001|Overall Study|Adverse Event|0|||
33361457|NCT01743027|101210842|FG002|Overall Study|Adverse Event|0|||
33626750|NCT02831764|102184381|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
33626751|NCT02831764|102184377|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33361458|NCT01743027|101210843|FG003|Overall Study|Adverse Event|0|||
33361459|NCT01743027|101210840|FG000|Overall Study|Lost to Follow-up|0|||
33361460|NCT01743027|101210841|FG001|Overall Study|Lost to Follow-up|0|||
33626752|NCT02831764|102184378|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33626753|NCT02831764|102184379|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33626754|NCT02831764|102184380|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
33626755|NCT02831764|102184381|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
33626756|NCT02587221|102184385|FG000|Overall Study|Adverse Event|3|||
33626757|NCT02587221|102184386|FG001|Overall Study|Adverse Event|3|||
33626758|NCT02587221|102184385|FG000|Overall Study|Death|33|||
33626759|NCT02587221|102184386|FG001|Overall Study|Death|34|||
33626760|NCT02587221|102184385|FG000|Overall Study|Withdrawal by Subject|66|||
33626761|NCT02587221|102184386|FG001|Overall Study|Withdrawal by Subject|61|||
33626762|NCT02587221|102184385|FG000|Overall Study|Lost to Follow-up|21|||
33626763|NCT02587221|102184386|FG001|Overall Study|Lost to Follow-up|19|||
33626764|NCT02587221|102184385|FG000|Overall Study|Protocol Violation|6|||
33626765|NCT02587221|102184386|FG001|Overall Study|Protocol Violation|5|||
33626766|NCT02587221|102184385|FG000|Overall Study|Other Reason or Unspecified|2|||
33626767|NCT02587221|102184386|FG001|Overall Study|Other Reason or Unspecified|1|||
33361461|NCT01743027|101210842|FG002|Overall Study|Lost to Follow-up|2|||
33361462|NCT01743027|101210843|FG003|Overall Study|Lost to Follow-up|0|||
33361463|NCT01743027|101210840|FG000|Overall Study|Progressive Disease|1|||
33361464|NCT01743027|101210841|FG001|Overall Study|Progressive Disease|4|||
33361465|NCT01743027|101210842|FG002|Overall Study|Progressive Disease|3|||
33361466|NCT01743027|101210843|FG003|Overall Study|Progressive Disease|0|||
33361467|NCT01743027|101210840|FG000|Overall Study|Protocol Violation|1|||
33626768|NCT00948064|102184387|FG000|Phase I|No treatment received|1|||
33361468|NCT01743027|101210841|FG001|Overall Study|Protocol Violation|1|||
33626769|NCT00948064|102184388|FG001|Phase I|No treatment received|0|||
33626770|NCT00948064|102184389|FG002|Phase I|No treatment received|0|||
33626771|NCT00948064|102184387|FG000|Phase II|Physician Decision|0|||
33626772|NCT00948064|102184388|FG001|Phase II|Physician Decision|0|||
33626773|NCT00948064|102184389|FG002|Phase II|Physician Decision|1|||
33626774|NCT00948064|102184387|FG000|Phase II|Withdrawal by Subject|0|||
33626775|NCT00948064|102184388|FG001|Phase II|Withdrawal by Subject|1|||
33626776|NCT00948064|102184389|FG002|Phase II|Withdrawal by Subject|0|||
33626777|NCT00713609|102184390|FG000|Overall Study|Adverse Event|2|||
33361469|NCT01743027|101210842|FG002|Overall Study|Protocol Violation|1|||
33562803|NCT00661687|101956905|FG000|Overall Study|Adverse Event|2|||
33562804|NCT01730729|101956906|FG000|Overall Study|Adverse Event|1|||
33562805|NCT01730729|101956906|FG000|Overall Study|Death|1|||
33562806|NCT01730729|101956906|FG000|Overall Study|Progressive Disease|12|||
33562807|NCT03464461|101956910|FG000|Overall Study|exclusionary medication given ,|1|||
33562808|NCT03464461|101956911|FG001|Overall Study|exclusionary medication given ,|2|||
33562809|NCT03464461|101956912|FG002|Overall Study|exclusionary medication given ,|0|||
33562810|NCT03464461|101956910|FG000|Overall Study|Physician Decision|0|||
33562811|NCT03464461|101956911|FG001|Overall Study|Physician Decision|1|||
33562812|NCT03464461|101956912|FG002|Overall Study|Physician Decision|0|||
33562813|NCT04909801|101956915|FG000|Overall Study|Lack of Efficacy|2|||
33562814|NCT04909801|101956916|FG001|Overall Study|Lack of Efficacy|1|||
33562815|NCT04909801|101956915|FG000|Overall Study|Adverse Event|1|||
33562816|NCT04909801|101956916|FG001|Overall Study|Adverse Event|2|||
33562817|NCT04909801|101956915|FG000|Overall Study|Participant request to discontinue study treatment|1|||
33562818|NCT04909801|101956916|FG001|Overall Study|Participant request to discontinue study treatment|2|||
33562819|NCT04909801|101956915|FG000|Overall Study|Withdrawal by Subject|2|||
33562820|NCT04909801|101956916|FG001|Overall Study|Withdrawal by Subject|1|||
33562821|NCT04909801|101956915|FG000|Overall Study|other reasons|1|||
33562822|NCT04909801|101956916|FG001|Overall Study|other reasons|1|||
33562823|NCT01959919|101956919|FG000|Overall Study|Did not meet the eligibility criteria|2|||
33562824|NCT02363283|101956920|FG000|Overall Study|Withdrawal by Subject|1|||
33562825|NCT02363283|101956920|FG000|Overall Study|Not eligible due to transaminitis|1|||
33626778|NCT00713609|102184391|FG001|Overall Study|Adverse Event|0|||
33626779|NCT00713609|102184392|FG002|Overall Study|Adverse Event|2|||
33626780|NCT00713609|102184393|FG003|Overall Study|Adverse Event|2|||
33626781|NCT00713609|102184394|FG004|Overall Study|Adverse Event|3|||
33626782|NCT00713609|102184395|FG005|Overall Study|Adverse Event|1|||
33361470|NCT01743027|101210843|FG003|Overall Study|Protocol Violation|0|||
33626783|NCT00713609|102184390|FG000|Overall Study|Lost to Follow-up|5|||
33562826|NCT04439357|101956925|FG000|Overall Study|Disease Progression|4|||
33626784|NCT00713609|102184391|FG001|Overall Study|Lost to Follow-up|7|||
33626785|NCT00713609|102184392|FG002|Overall Study|Lost to Follow-up|5|||
33562827|NCT02579759|101956926|FG000|Overall Study|Protocol Violation|2|||
33562828|NCT02579759|101956927|FG001|Overall Study|Protocol Violation|0|||
33562829|NCT02579759|101956928|FG002|Overall Study|Protocol Violation|0|||
33626786|NCT00713609|102184393|FG003|Overall Study|Lost to Follow-up|5|||
33626787|NCT00713609|102184394|FG004|Overall Study|Lost to Follow-up|7|||
33626788|NCT00713609|102184395|FG005|Overall Study|Lost to Follow-up|0|||
33626789|NCT00713609|102184390|FG000|Overall Study|Lack of Efficacy|1|||
33626790|NCT00713609|102184391|FG001|Overall Study|Lack of Efficacy|3|||
33626791|NCT00713609|102184392|FG002|Overall Study|Lack of Efficacy|0|||
33626792|NCT00713609|102184393|FG003|Overall Study|Lack of Efficacy|0|||
33626793|NCT00713609|102184394|FG004|Overall Study|Lack of Efficacy|1|||
33626794|NCT00713609|102184395|FG005|Overall Study|Lack of Efficacy|0|||
33626795|NCT00713609|102184390|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
33626796|NCT00713609|102184391|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
33626797|NCT00713609|102184392|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
33626798|NCT00713609|102184393|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
33626799|NCT00713609|102184394|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
33626800|NCT00713609|102184395|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
33626801|NCT00713609|102184390|FG000|Overall Study|Withdrawal by Subject|6|||
33626802|NCT00713609|102184391|FG001|Overall Study|Withdrawal by Subject|1|||
33626803|NCT00713609|102184392|FG002|Overall Study|Withdrawal by Subject|5|||
33626804|NCT00713609|102184393|FG003|Overall Study|Withdrawal by Subject|1|||
33626805|NCT00713609|102184394|FG004|Overall Study|Withdrawal by Subject|5|||
33626806|NCT00713609|102184395|FG005|Overall Study|Withdrawal by Subject|7|||
33626807|NCT00713609|102184390|FG000|Overall Study|Protocol Violation|6|||
33626808|NCT00713609|102184391|FG001|Overall Study|Protocol Violation|3|||
33626809|NCT00713609|102184392|FG002|Overall Study|Protocol Violation|1|||
33626810|NCT00713609|102184393|FG003|Overall Study|Protocol Violation|1|||
33626811|NCT00713609|102184394|FG004|Overall Study|Protocol Violation|2|||
33626812|NCT00713609|102184395|FG005|Overall Study|Protocol Violation|0|||
33626813|NCT04999839|102184399|FG000|Overall Study|Adverse Event|1|||
33626814|NCT04999839|102184400|FG001|Overall Study|Adverse Event|1|||
33626815|NCT04999839|102184401|FG002|Overall Study|Adverse Event|1|||
33626816|NCT04999839|102184402|FG003|Overall Study|Adverse Event|1|||
33626817|NCT04999839|102184403|FG004|Overall Study|Adverse Event|1|||
33626818|NCT04999839|102184399|FG000|Overall Study|Lost to Follow-up|2|||
33626819|NCT04999839|102184400|FG001|Overall Study|Lost to Follow-up|0|||
33626820|NCT04999839|102184401|FG002|Overall Study|Lost to Follow-up|2|||
33626821|NCT04999839|102184402|FG003|Overall Study|Lost to Follow-up|4|||
33626822|NCT04999839|102184403|FG004|Overall Study|Lost to Follow-up|1|||
33626823|NCT04999839|102184399|FG000|Overall Study|Withdrawal by Subject|6|||
33626824|NCT04999839|102184400|FG001|Overall Study|Withdrawal by Subject|5|||
33626825|NCT04999839|102184401|FG002|Overall Study|Withdrawal by Subject|3|||
33626826|NCT04999839|102184402|FG003|Overall Study|Withdrawal by Subject|2|||
33361471|NCT01743027|101210840|FG000|Overall Study|Withdrawal by Subject|1|||
33361472|NCT01743027|101210841|FG001|Overall Study|Withdrawal by Subject|0|||
33361473|NCT01743027|101210842|FG002|Overall Study|Withdrawal by Subject|3|||
33361474|NCT01743027|101210843|FG003|Overall Study|Withdrawal by Subject|1|||
33361475|NCT03518840|101210845|FG000|Overall Study|Lost to Follow-up|6|||
33361476|NCT01933672|101210846|FG000|Metformin Run-in Period|Adverse Event|1|||
33361477|NCT01933672|101210847|FG001|Metformin Run-in Period|Adverse Event|0|||
33361478|NCT01933672|101210848|FG002|Metformin Run-in Period|Adverse Event|0|||
33361479|NCT01933672|101210849|FG003|Metformin Run-in Period|Adverse Event|0|||
33361480|NCT01933672|101210850|FG004|Metformin Run-in Period|Adverse Event|0|||
33361481|NCT01933672|101210851|FG005|Metformin Run-in Period|Adverse Event|0|||
33361482|NCT01933672|101210852|FG006|Metformin Run-in Period|Adverse Event|0|||
33361483|NCT01933672|101210846|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
33361484|NCT01933672|101210847|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
33361485|NCT01933672|101210848|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
33361486|NCT01933672|101210849|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
33361487|NCT01933672|101210850|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
33361488|NCT01933672|101210851|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
33415055|NCT00902486|101409932|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
33415056|NCT00902486|101409933|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
33626827|NCT04999839|102184403|FG004|Overall Study|Withdrawal by Subject|2|||
33626828|NCT04999839|102184399|FG000|Overall Study|Lack of Efficacy|0|||
33626829|NCT04999839|102184400|FG001|Overall Study|Lack of Efficacy|1|||
33626830|NCT04999839|102184401|FG002|Overall Study|Lack of Efficacy|0|||
33626831|NCT04999839|102184402|FG003|Overall Study|Lack of Efficacy|0|||
33361489|NCT01933672|101210852|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
33626832|NCT04999839|102184403|FG004|Overall Study|Lack of Efficacy|0|||
33221467|NCT00110890|100711072|FG000|Overall Study|Kidney Transplant|16|||
33626833|NCT04999839|102184399|FG000|Overall Study|Physician Decision|0|||
33626834|NCT04999839|102184400|FG001|Overall Study|Physician Decision|0|||
33626835|NCT04999839|102184401|FG002|Overall Study|Physician Decision|0|||
33626836|NCT04999839|102184402|FG003|Overall Study|Physician Decision|0|||
33626837|NCT04999839|102184403|FG004|Overall Study|Physician Decision|1|||
33626838|NCT04999839|102184399|FG000|Overall Study|Sponsor request|0|||
33626839|NCT04999839|102184400|FG001|Overall Study|Sponsor request|1|||
33626840|NCT04999839|102184401|FG002|Overall Study|Sponsor request|0|||
33626841|NCT04999839|102184402|FG003|Overall Study|Sponsor request|0|||
33361490|NCT01933672|101210846|FG000|Metformin Run-in Period|Other|5|||
33361491|NCT01933672|101210847|FG001|Metformin Run-in Period|Other|0|||
33562830|NCT02579759|101956926|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
33562831|NCT02579759|101956927|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
33562832|NCT02579759|101956928|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
33562833|NCT02579759|101956926|FG000|Overall Study|BfArM hold|13|||
33562834|NCT02579759|101956927|FG001|Overall Study|BfArM hold|12|||
33562835|NCT02579759|101956928|FG002|Overall Study|BfArM hold|12|||
33562836|NCT02579759|101956926|FG000|Overall Study|Sponsor stopped Dose 2|0|||
33562837|NCT02579759|101956927|FG001|Overall Study|Sponsor stopped Dose 2|41|||
33562838|NCT02579759|101956928|FG002|Overall Study|Sponsor stopped Dose 2|0|||
33562839|NCT02579759|101956926|FG000|Overall Study|Non compliance|0|||
33562840|NCT02579759|101956927|FG001|Overall Study|Non compliance|1|||
33562841|NCT02579759|101956928|FG002|Overall Study|Non compliance|0|||
33562842|NCT02579759|101956926|FG000|Overall Study|Pregnancy|0|||
33562843|NCT02579759|101956927|FG001|Overall Study|Pregnancy|1|||
33562844|NCT02579759|101956928|FG002|Overall Study|Pregnancy|0|||
33562845|NCT02579759|101956926|FG000|Overall Study|Inclusion/exclusion criteria|0|||
33562846|NCT02579759|101956927|FG001|Overall Study|Inclusion/exclusion criteria|0|||
33562847|NCT02579759|101956928|FG002|Overall Study|Inclusion/exclusion criteria|1|||
33562848|NCT02579759|101956926|FG000|Overall Study|Adverse Event|4|||
33562849|NCT02579759|101956927|FG001|Overall Study|Adverse Event|3|||
33562850|NCT02579759|101956928|FG002|Overall Study|Adverse Event|1|||
33562851|NCT02579759|101956926|FG000|Overall Study|Withdrawal by Subject|3|||
33562852|NCT02579759|101956927|FG001|Overall Study|Withdrawal by Subject|3|||
33562853|NCT02579759|101956928|FG002|Overall Study|Withdrawal by Subject|5|||
33562854|NCT02579759|101956926|FG000|Overall Study|Lost to Follow-up|2|||
33562855|NCT02579759|101956927|FG001|Overall Study|Lost to Follow-up|2|||
33562856|NCT02579759|101956928|FG002|Overall Study|Lost to Follow-up|2|||
33562857|NCT02202577|101956929|FG000|Overall Study|Lost to Follow-up|6|||
33562858|NCT02202577|101956930|FG001|Overall Study|Lost to Follow-up|16|||
33562859|NCT02202577|101956929|FG000|Overall Study|Protocol Violation|7|||
33562860|NCT02202577|101956930|FG001|Overall Study|Protocol Violation|3|||
33562861|NCT02180672|101956935|FG000|Overall Study|Lost to Follow-up|5|||
33562862|NCT02180672|101956936|FG001|Overall Study|Lost to Follow-up|7|||
33562863|NCT01903863|101956942|FG000|Overall Study|Physician Decision|2|||
33562864|NCT01903863|101956943|FG001|Overall Study|Physician Decision|0|||
33562865|NCT00836901|101956947|FG000|First Intervention|Withdrawal by Subject|1|||
33562866|NCT00836901|101956948|FG001|First Intervention|Withdrawal by Subject|0|||
33562867|NCT00468546|101956949|FG000|Week 24 Analysis|Lack of Efficacy|83|||
33562868|NCT00468546|101956950|FG001|Week 24 Analysis|Lack of Efficacy|37|||
33562869|NCT00468546|101956949|FG000|Week 24 Analysis|Refused treatment|5|||
33562870|NCT00468546|101956950|FG001|Week 24 Analysis|Refused treatment|5|||
33562871|NCT00468546|101956949|FG000|Week 24 Analysis|Adverse Event|1|||
33562872|NCT00468546|101956950|FG001|Week 24 Analysis|Adverse Event|8|||
33562873|NCT00468546|101956949|FG000|Week 24 Analysis|Failure to return|3|||
33562874|NCT00468546|101956950|FG001|Week 24 Analysis|Failure to return|4|||
33562875|NCT00468546|101956949|FG000|Week 24 Analysis|Rescue therapy|2|||
33562876|NCT00468546|101956950|FG001|Week 24 Analysis|Rescue therapy|0|||
33562877|NCT00468546|101956949|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
33562878|NCT00468546|101956950|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
33562879|NCT00468546|101956949|FG000|Week 24 Analysis|Due to clinical hold|1|||
33562880|NCT00468546|101956950|FG001|Week 24 Analysis|Due to clinical hold|0|||
33562881|NCT00468546|101956949|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
33562882|NCT00468546|101956950|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
33361492|NCT01933672|101210848|FG002|Metformin Run-in Period|Other|0|||
33361493|NCT01933672|101210849|FG003|Metformin Run-in Period|Other|0|||
33361494|NCT01933672|101210850|FG004|Metformin Run-in Period|Other|0|||
33361495|NCT01933672|101210851|FG005|Metformin Run-in Period|Other|0|||
33361496|NCT01933672|101210852|FG006|Metformin Run-in Period|Other|0|||
33361497|NCT01933672|101210846|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33361498|NCT01933672|101210847|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33361499|NCT01933672|101210848|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33562883|NCT00468546|101956949|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
33562884|NCT00468546|101956950|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
33562885|NCT00468546|101956949|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
33562886|NCT00468546|101956950|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
33562887|NCT00468546|101956949|FG000|Week 24 to Week 104 Analysis|Death|1|||
33562888|NCT00468546|101956950|FG001|Week 24 to Week 104 Analysis|Death|0|||
33562889|NCT00468546|101956949|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
33562890|NCT00468546|101956950|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
33562891|NCT00468546|101956949|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
33562892|NCT00468546|101956950|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
33562893|NCT00468546|101956949|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
33562894|NCT00468546|101956950|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
33562895|NCT00468546|101956949|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
33626842|NCT04999839|102184403|FG004|Overall Study|Sponsor request|0|||
33626843|NCT04999839|102184399|FG000|Overall Study|Other|0|||
33626844|NCT04999839|102184400|FG001|Overall Study|Other|0|||
33626845|NCT04999839|102184401|FG002|Overall Study|Other|1|||
33626846|NCT04999839|102184402|FG003|Overall Study|Other|0|||
33626847|NCT04999839|102184403|FG004|Overall Study|Other|0|||
33626848|NCT00399516|102184404|FG000|Overall Study|Lost to Follow-up|2|||
33626849|NCT01808196|102184405|FG000|Overall Study|Lost to Follow-up|1|||
33626850|NCT01045460|102184409|FG000|Overall Study|Physician Decision|3|||
33626851|NCT01045460|102184410|FG001|Overall Study|Physician Decision|2|||
33626852|NCT01045460|102184409|FG000|Overall Study|Lost to Follow-up|0|||
33626853|NCT01045460|102184410|FG001|Overall Study|Lost to Follow-up|1|||
33626854|NCT01045460|102184409|FG000|Overall Study|Lack of Efficacy|3|||
33626855|NCT01045460|102184410|FG001|Overall Study|Lack of Efficacy|0|||
33626856|NCT01469221|102184411|FG000|Double Blind Phase|Protocol Violation|1|||
33626857|NCT01469221|102184412|FG001|Double Blind Phase|Protocol Violation|0|||
33626858|NCT01469221|102184413|FG002|Double Blind Phase|Protocol Violation|0|||
33626859|NCT01469221|102184411|FG000|Double Blind Phase|Physician Decision|1|||
33626860|NCT01469221|102184412|FG001|Double Blind Phase|Physician Decision|1|||
33626861|NCT01469221|102184413|FG002|Double Blind Phase|Physician Decision|0|||
33626862|NCT01469221|102184411|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
33626863|NCT01469221|102184412|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
33626864|NCT01469221|102184413|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
33626865|NCT00668148|102184417|FG000|Overall Study|Adverse Event|5|||
33626866|NCT00668148|102184417|FG000|Overall Study|Subject Non-compliance|1|||
33626867|NCT00668148|102184417|FG000|Overall Study|Progressive Disease Before Treatment|2|||
33626868|NCT00668148|102184417|FG000|Overall Study|Withdrawal of Consent|2|||
33626869|NCT01791244|102184422|FG000|Overall Study|Adverse Event|5|||
33626870|NCT01791244|102184423|FG001|Overall Study|Adverse Event|7|||
33626871|NCT01791244|102184422|FG000|Overall Study|Insufficient clinical response|10|||
33626872|NCT01791244|102184423|FG001|Overall Study|Insufficient clinical response|10|||
33626873|NCT01791244|102184422|FG000|Overall Study|Laboratory Abnormality|0|||
33626874|NCT01791244|102184423|FG001|Overall Study|Laboratory Abnormality|1|||
33626875|NCT03206216|102184426|FG000|Overall Study|Withdrawal by Subject|0|||
33626876|NCT03206216|102184427|FG001|Overall Study|Withdrawal by Subject|1|||
33626877|NCT02322281|102184428|FG000|Overall Study|Progressive Disease|42|||
33626878|NCT02322281|102184429|FG001|Overall Study|Progressive Disease|14|||
33626879|NCT02322281|102184430|FG002|Overall Study|Progressive Disease|49|||
33626880|NCT02322281|102184428|FG000|Overall Study|Adverse Event|3|||
33626881|NCT02322281|102184429|FG001|Overall Study|Adverse Event|4|||
33626882|NCT02322281|102184430|FG002|Overall Study|Adverse Event|6|||
33626883|NCT02322281|102184428|FG000|Overall Study|Death|3|||
33626884|NCT02322281|102184429|FG001|Overall Study|Death|3|||
33626885|NCT02322281|102184430|FG002|Overall Study|Death|3|||
33626886|NCT02322281|102184428|FG000|Overall Study|Withdrawal by Subject|1|||
33626887|NCT02322281|102184429|FG001|Overall Study|Withdrawal by Subject|1|||
33626888|NCT02322281|102184430|FG002|Overall Study|Withdrawal by Subject|6|||
33626889|NCT02322281|102184428|FG000|Overall Study|Physician Decision|2|||
33626890|NCT02322281|102184429|FG001|Overall Study|Physician Decision|0|||
33626891|NCT02322281|102184430|FG002|Overall Study|Physician Decision|5|||
33626892|NCT02322281|102184428|FG000|Overall Study|Study Terminated by Sponsor|2|||
33626893|NCT02322281|102184429|FG001|Overall Study|Study Terminated by Sponsor|0|||
33626894|NCT02322281|102184430|FG002|Overall Study|Study Terminated by Sponsor|0|||
33626895|NCT02322281|102184428|FG000|Overall Study|Missing|0|||
33626896|NCT02322281|102184429|FG001|Overall Study|Missing|0|||
33626897|NCT02322281|102184430|FG002|Overall Study|Missing|1|||
33626898|NCT02322281|102184428|FG000|Overall Study|Miscellaneous|0|||
33626899|NCT02322281|102184429|FG001|Overall Study|Miscellaneous|0|||
33626900|NCT02322281|102184430|FG002|Overall Study|Miscellaneous|4|||
33626901|NCT02656017|102184431|FG000|Overall Study|Study burden|3|||
33626902|NCT02656017|102184432|FG001|Overall Study|Study burden|3|||
33221468|NCT00110890|100711073|FG001|Overall Study|Kidney Transplant|12|||
33626903|NCT02656017|102184431|FG000|Overall Study|Adverse Event|2|||
33626904|NCT02656017|102184432|FG001|Overall Study|Adverse Event|1|||
33626905|NCT02656017|102184431|FG000|Overall Study|Unable/unwilling to take study medication|2|||
33626906|NCT02656017|102184432|FG001|Overall Study|Unable/unwilling to take study medication|1|||
33626907|NCT02656017|102184431|FG000|Overall Study|Began Tolvaptan|1|||
33626908|NCT02656017|102184432|FG001|Overall Study|Began Tolvaptan|1|||
33626909|NCT02656017|102184431|FG000|Overall Study|Withdrawal by Subject|1|||
33626910|NCT02656017|102184432|FG001|Overall Study|Withdrawal by Subject|0|||
33626911|NCT00510835|102184433|FG000|Overall Study|Withdrawal by Subject|6|||
33626912|NCT00510835|102184434|FG001|Overall Study|Withdrawal by Subject|2|||
33626913|NCT00510835|102184435|FG002|Overall Study|Withdrawal by Subject|2|||
33626914|NCT01428258|102184436|FG000|Intervention 1|Withdrawal by Subject|2|||
33626915|NCT01428258|102184437|FG001|Intervention 1|Withdrawal by Subject|0|||
33626916|NCT00499486|102184440|FG000|Overall Study|Withdrawal by Subject|16|||
33626917|NCT01620060|102184441|FG000|Overall Study|Adverse Event|9|||
33626918|NCT01620060|102184441|FG000|Overall Study|Protocol Violation|1|||
33626919|NCT01620060|102184441|FG000|Overall Study|Withdrawal by Subject|1|||
33626920|NCT01620060|102184441|FG000|Overall Study|Did not comply with Study Produre|1|||
33626921|NCT01620060|102184441|FG000|Overall Study|Family emergency|1|||
33221469|NCT00110890|100711072|FG000|Overall Study|Invest. Product Commercially Available|217|||
33221470|NCT00110890|100711073|FG001|Overall Study|Invest. Product Commercially Available|110|||
33626922|NCT01620060|102184441|FG000|Overall Study|Per Sponsor Decision|2|||
33626923|NCT02269124|102184442|FG000|Overall Study|Lost to Follow-up|1|||
33626924|NCT02269124|102184443|FG001|Overall Study|Lost to Follow-up|0|||
33626925|NCT02269124|102184442|FG000|Overall Study|Withdrawal by Subject|0|||
33626926|NCT02269124|102184443|FG001|Overall Study|Withdrawal by Subject|2|||
33626927|NCT01777308|102184445|FG000|Overall Study|Withdrawal by Subject|5|||
33626928|NCT01777308|102184446|FG001|Overall Study|Withdrawal by Subject|1|||
33626929|NCT01777308|102184445|FG000|Overall Study|Migrated/moved from study area|1|||
33626930|NCT01777308|102184446|FG001|Overall Study|Migrated/moved from study area|0|||
33626931|NCT01777308|102184445|FG000|Overall Study|Lost to Follow-up|7|||
33626932|NCT01777308|102184446|FG001|Overall Study|Lost to Follow-up|2|||
33626933|NCT01777308|102184445|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
33626934|NCT01777308|102184446|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
33626935|NCT01069484|102184447|FG000|Overall Study|Death-in-near-family|1|||
33626936|NCT01069484|102184448|FG001|Overall Study|Death-in-near-family|0|||
33626937|NCT01069484|102184447|FG000|Overall Study|No specific reason|8|||
33626938|NCT01069484|102184448|FG001|Overall Study|No specific reason|2|||
33626939|NCT01069484|102184447|FG000|Overall Study|Illness mother or child|3|||
33626940|NCT01069484|102184448|FG001|Overall Study|Illness mother or child|1|||
33626941|NCT01702844|102184449|FG000|Overall Study|Adverse Event|9|||
33221471|NCT00110890|100711072|FG000|Overall Study|Other|34|||
33221472|NCT00110890|100711073|FG001|Overall Study|Other|23|||
33221473|NCT00110890|100711072|FG000|Overall Study|Ineligibility determined|3|||
33221474|NCT00110890|100711073|FG001|Overall Study|Ineligibility determined|0|||
33221475|NCT00110890|100711072|FG000|Overall Study|Requirement for alternative therapy|0|||
33221476|NCT00110890|100711073|FG001|Overall Study|Requirement for alternative therapy|1|||
33221477|NCT00110890|100711072|FG000|Overall Study|Disease progression|0|||
33221478|NCT00110890|100711073|FG001|Overall Study|Disease progression|1|||
33221479|NCT00110890|100711072|FG000|Overall Study|Parathyroidectomy|0|||
33221480|NCT00110890|100711073|FG001|Overall Study|Parathyroidectomy|1|||
33221481|NCT00110890|100711072|FG000|Overall Study|Did not enter follow-up phase|10|||
33221482|NCT00110890|100711073|FG001|Overall Study|Did not enter follow-up phase|4|||
33221483|NCT04425902|100711074|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
33221484|NCT02901626|100711075|FG000|Overall Study|Lost to Follow-up|1|||
33221485|NCT02901626|100711076|FG001|Overall Study|Lost to Follow-up|1|||
33221486|NCT04524598|100711077|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
33221487|NCT04524598|100711078|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
33221488|NCT04524598|100711079|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
33221489|NCT04524598|100711080|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
33221490|NCT04524598|100711081|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
33221491|NCT04524598|100711077|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
33221492|NCT04524598|100711078|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
33221493|NCT04524598|100711079|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
33361500|NCT01933672|101210849|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33361501|NCT01933672|101210850|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
33626942|NCT01702844|102184449|FG000|Overall Study|Death|1|||
33626943|NCT01702844|102184449|FG000|Overall Study|Withdrawal by Subject|3|||
33626944|NCT01702844|102184449|FG000|Overall Study|Physician Decision|6|||
33626945|NCT02051764|102184450|FG000|Overall Study|Study terminated by sponsor|0|||
33626946|NCT02051764|102184451|FG001|Overall Study|Study terminated by sponsor|7|||
33221494|NCT04524598|100711080|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
33626947|NCT03760029|102184452|FG000|Overall Study|Death|1|||
33626948|NCT03760029|102184453|FG001|Overall Study|Death|0|||
33626949|NCT03760029|102184454|FG002|Overall Study|Death|0|||
33626950|NCT03760029|102184452|FG000|Overall Study|Lost to Follow-up|0|||
33626951|NCT03760029|102184453|FG001|Overall Study|Lost to Follow-up|2|||
33626952|NCT03760029|102184454|FG002|Overall Study|Lost to Follow-up|1|||
33626953|NCT03760029|102184452|FG000|Overall Study|Withdrawal by Subject|1|||
33626954|NCT03760029|102184453|FG001|Overall Study|Withdrawal by Subject|4|||
33626955|NCT03760029|102184454|FG002|Overall Study|Withdrawal by Subject|1|||
33221495|NCT04524598|100711081|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
33221496|NCT04524598|100711077|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
33221497|NCT04524598|100711078|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
33221498|NCT04524598|100711079|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
33221499|NCT04524598|100711080|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
33221500|NCT04524598|100711081|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
33221501|NCT04524598|100711077|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
33221502|NCT04524598|100711078|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
33221503|NCT04524598|100711079|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
33221504|NCT04524598|100711080|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
33221505|NCT04524598|100711081|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
33221506|NCT04524598|100711077|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
33221507|NCT04524598|100711078|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
33221508|NCT04524598|100711079|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
33221509|NCT04524598|100711080|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
33221510|NCT04524598|100711081|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
33221511|NCT04524598|100711077|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
33221512|NCT04524598|100711078|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
33221513|NCT04524598|100711079|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
33221514|NCT04524598|100711080|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
33221515|NCT04524598|100711081|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
33221516|NCT04524598|100711077|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
33221517|NCT04524598|100711078|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
33221518|NCT04524598|100711079|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
33221519|NCT04524598|100711080|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
33221520|NCT04524598|100711081|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
33221521|NCT02237508|100711082|FG000|Overall Study|Withdrawal by Subject|0|||
33221522|NCT02237508|100711083|FG001|Overall Study|Withdrawal by Subject|2|||
33221523|NCT02237508|100711084|FG002|Overall Study|Withdrawal by Subject|0|||
33361502|NCT01933672|101210851|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33562896|NCT00468546|101956950|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
33562897|NCT00468546|101956949|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
33562898|NCT00468546|101956950|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
33562899|NCT00468546|101956949|FG000|Week 24 to Week 104 Analysis|Other|17|||
33562900|NCT00468546|101956950|FG001|Week 24 to Week 104 Analysis|Other|14|||
33562901|NCT02913326|101956951|FG000|Overall Study|Reason not listed|0|||
33562902|NCT02913326|101956952|FG001|Overall Study|Reason not listed|1|||
33562903|NCT02913326|101956951|FG000|Overall Study|Lost to Follow-up|0|||
33562904|NCT02913326|101956952|FG001|Overall Study|Lost to Follow-up|1|||
33562905|NCT02913326|101956951|FG000|Overall Study|Adverse Event|1|||
33562906|NCT02913326|101956952|FG001|Overall Study|Adverse Event|0|||
33562907|NCT01044459|101956954|FG000|Overall Study|Withdrawal by Subject|21|||
33562908|NCT01044459|101956955|FG001|Overall Study|Withdrawal by Subject|28|||
33562909|NCT01044459|101956954|FG000|Overall Study|Terminated by Sponsor|22|||
33562910|NCT01044459|101956955|FG001|Overall Study|Terminated by Sponsor|21|||
33562911|NCT01044459|101956954|FG000|Overall Study|Adverse Event|22|||
33562912|NCT01044459|101956955|FG001|Overall Study|Adverse Event|20|||
33562913|NCT01044459|101956954|FG000|Overall Study|Lack of Efficacy|23|||
33626956|NCT03760029|102184452|FG000|Overall Study|Withdrawal by parent/guardian|4|||
33626957|NCT03760029|102184453|FG001|Overall Study|Withdrawal by parent/guardian|4|||
33626958|NCT03760029|102184454|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33562914|NCT01044459|101956955|FG001|Overall Study|Lack of Efficacy|12|||
33562915|NCT01044459|101956954|FG000|Overall Study|Protocol Violation|11|||
33562916|NCT01044459|101956955|FG001|Overall Study|Protocol Violation|16|||
33562917|NCT01044459|101956954|FG000|Overall Study|Other Reason|7|||
33562918|NCT01044459|101956955|FG001|Overall Study|Other Reason|14|||
33562919|NCT01044459|101956954|FG000|Overall Study|COPD exacerbation|9|||
33562920|NCT01044459|101956955|FG001|Overall Study|COPD exacerbation|8|||
33626959|NCT03760029|102184452|FG000|Overall Study|Other|2|||
33626960|NCT03760029|102184453|FG001|Overall Study|Other|1|||
33626961|NCT03760029|102184454|FG002|Overall Study|Other|0|||
33562921|NCT01044459|101956954|FG000|Overall Study|Lost to Follow-up|18|||
33562922|NCT01044459|101956955|FG001|Overall Study|Lost to Follow-up|12|||
33562923|NCT02038647|101956956|FG000|Overall Study|Progressive Disease|50|||
33562924|NCT02038647|101956957|FG001|Overall Study|Progressive Disease|59|||
33562925|NCT02038647|101956956|FG000|Overall Study|Adverse Event|18|||
33562926|NCT02038647|101956957|FG001|Overall Study|Adverse Event|10|||
33562927|NCT02038647|101956956|FG000|Overall Study|Symptomatic Deterioration|7|||
33562928|NCT02038647|101956957|FG001|Overall Study|Symptomatic Deterioration|7|||
33562929|NCT02038647|101956956|FG000|Overall Study|Withdrawal by Subject|5|||
33562930|NCT02038647|101956957|FG001|Overall Study|Withdrawal by Subject|2|||
33562931|NCT02038647|101956956|FG000|Overall Study|Not Reported|0|||
33562932|NCT02038647|101956957|FG001|Overall Study|Not Reported|1|||
33562933|NCT02038647|101956956|FG000|Overall Study|Ongoing at Datacut|9|||
33562934|NCT02038647|101956957|FG001|Overall Study|Ongoing at Datacut|10|||
33562935|NCT00003907|101956958|FG000|Overall Study|Adverse Event|2|||
33562936|NCT00003907|101956959|FG001|Overall Study|Adverse Event|11|||
33562937|NCT00003907|101956958|FG000|Overall Study|Death|2|||
33562938|NCT00003907|101956959|FG001|Overall Study|Death|0|||
33562939|NCT00003907|101956958|FG000|Overall Study|Withdrawal by Subject|1|||
33562940|NCT00003907|101956959|FG001|Overall Study|Withdrawal by Subject|3|||
33562941|NCT00003907|101956958|FG000|Overall Study|Progressive disease|4|||
33562942|NCT00003907|101956959|FG001|Overall Study|Progressive disease|4|||
33562943|NCT00003907|101956958|FG000|Overall Study|Complicating disease|1|||
33562944|NCT00003907|101956959|FG001|Overall Study|Complicating disease|0|||
33562945|NCT00003907|101956958|FG000|Overall Study|Other|1|||
33562946|NCT00003907|101956959|FG001|Overall Study|Other|3|||
33562947|NCT00003907|101956958|FG000|Overall Study|ineligible or not treated|2|||
33562948|NCT00003907|101956959|FG001|Overall Study|ineligible or not treated|2|||
33562949|NCT05252702|101956960|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
33562950|NCT05252702|101956960|FG000|Overall Study|Death|16|||
33221524|NCT02237508|100711085|FG003|Overall Study|Withdrawal by Subject|1|||
33221525|NCT02237508|100711086|FG004|Overall Study|Withdrawal by Subject|0|||
33221526|NCT02237508|100711087|FG005|Overall Study|Withdrawal by Subject|1|||
33562951|NCT05252702|101956960|FG000|Overall Study|System explant|5|||
33562952|NCT05252702|101956960|FG000|Overall Study|Lost to Follow-up|1|||
33562953|NCT05252702|101956960|FG000|Overall Study|Withdrawn by investigator|1|||
33221527|NCT02237508|100711088|FG006|Overall Study|Withdrawal by Subject|1|||
33221528|NCT02237508|100711089|FG007|Overall Study|Withdrawal by Subject|0|||
33562954|NCT05252702|101956960|FG000|Overall Study|Visit not due|306|||
33562955|NCT05252702|101956960|FG000|Overall Study|Visit within window but not completed|92|||
33562956|NCT05252702|101956960|FG000|Overall Study|Unsuccessful implant|1|||
33562957|NCT03211858|101956963|FG000|Overall Study|Adverse Event|8|||
33562958|NCT03211858|101956964|FG001|Overall Study|Adverse Event|6|||
33562959|NCT03211858|101956963|FG000|Overall Study|Lack of Efficacy|0|||
33562960|NCT03211858|101956964|FG001|Overall Study|Lack of Efficacy|4|||
33626962|NCT03623243|102184458|FG000|Overall Study|Adverse Event|15|||
33626963|NCT03623243|102184458|FG000|Overall Study|Guardian Decision|1|||
33626964|NCT03623243|102184458|FG000|Overall Study|New Therapy for Study Indication|1|||
33626965|NCT03623243|102184458|FG000|Overall Study|Protocol Deviation|3|||
33626966|NCT03623243|102184458|FG000|Overall Study|Physician Decision|4|||
33221529|NCT02237508|100711090|FG008|Overall Study|Withdrawal by Subject|1|||
33361503|NCT01933672|101210852|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33361504|NCT01933672|101210846|FG000|First Intervention Period (12-16 Days)|Other|0|||
33562961|NCT03211858|101956963|FG000|Overall Study|Poor compliance to protocol|6|||
33562962|NCT03211858|101956964|FG001|Overall Study|Poor compliance to protocol|2|||
33562963|NCT03211858|101956963|FG000|Overall Study|Non-serious Hypoglycemia|1|||
33562964|NCT03211858|101956964|FG001|Overall Study|Non-serious Hypoglycemia|0|||
33562965|NCT03211858|101956963|FG000|Overall Study|Other than specified above|22|||
33562966|NCT03211858|101956964|FG001|Overall Study|Other than specified above|21|||
33562967|NCT00814983|101956968|FG000|Overall Study|Screen failure|1|||
33562968|NCT00814983|101956969|FG001|Overall Study|Screen failure|0|||
33562969|NCT00814983|101956968|FG000|Overall Study|Withdrawal by Subject|1|||
33562970|NCT00814983|101956969|FG001|Overall Study|Withdrawal by Subject|0|||
33562971|NCT00814983|101956968|FG000|Overall Study|Graft failure|1|||
33562972|NCT00814983|101956969|FG001|Overall Study|Graft failure|0|||
33562973|NCT03411044|101956970|FG000|Overall Study|Death|30|||
33562974|NCT03411044|101956970|FG000|Overall Study|Withdrawal by Subject|48|||
33562975|NCT03411044|101956970|FG000|Overall Study|Lost to Follow-up|78|||
33562976|NCT03411044|101956970|FG000|Overall Study|Adverse Event|30|||
33562977|NCT03411044|101956970|FG000|Overall Study|Missing status|4|||
33562978|NCT04349098|101956974|FG000|Overall Study|Death|16|||
33562979|NCT04349098|101956975|FG001|Overall Study|Death|8|||
33562980|NCT04349098|101956974|FG000|Overall Study|Lost to Follow-up|11|||
33562981|NCT04349098|101956975|FG001|Overall Study|Lost to Follow-up|8|||
33562982|NCT04349098|101956974|FG000|Overall Study|Withdrawal by Subject|8|||
33562983|NCT04349098|101956975|FG001|Overall Study|Withdrawal by Subject|5|||
33562984|NCT04349098|101956974|FG000|Overall Study|Other|3|||
33562985|NCT04349098|101956975|FG001|Overall Study|Other|5|||
33562986|NCT03579719|101956979|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
33562987|NCT02088554|101956984|FG000|Overall Study|Exited before procedure|130|||
33562988|NCT02088554|101956984|FG000|Overall Study|Attempted but not implanted|31|||
33562989|NCT02088554|101956984|FG000|Overall Study|Implant not attempted|19|||
33562990|NCT02088554|101956984|FG000|Overall Study|Pending next visit|532|||
33562991|NCT02088554|101956984|FG000|Overall Study|Death|170|||
33562992|NCT02088554|101956984|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
33562993|NCT02088554|101956984|FG000|Overall Study|Lost to Follow-up|23|||
33562994|NCT02088554|101956984|FG000|Overall Study|Explanted|32|||
33562995|NCT02088554|101956984|FG000|Overall Study|Any other reason not covered by previous categories|11|||
33562996|NCT01443026|101956994|FG000|Overall Study|Physician Decision|1|||
33562997|NCT01443026|101956995|FG001|Overall Study|Physician Decision|0|||
33562998|NCT01443026|101956994|FG000|Overall Study|Death|0|||
33562999|NCT01443026|101956995|FG001|Overall Study|Death|1|||
33563000|NCT01443026|101956994|FG000|Overall Study|Withdrawal by Subject|0|||
33563001|NCT01443026|101956995|FG001|Overall Study|Withdrawal by Subject|3|||
33563002|NCT01443026|101956994|FG000|Overall Study|Lost to Follow-up|2|||
33563003|NCT01443026|101956995|FG001|Overall Study|Lost to Follow-up|1|||
33563004|NCT01472185|101956996|FG000|Overall Study|Randomized but Not Treated|0|||
33221530|NCT02237508|100711091|FG009|Overall Study|Withdrawal by Subject|0|||
33563005|NCT01472185|101956997|FG001|Overall Study|Randomized but Not Treated|1|||
33626967|NCT03623243|102184458|FG000|Overall Study|Patient Decision|15|||
33221531|NCT02237508|100711082|FG000|Overall Study|Physician Decision|0|||
33563006|NCT01472185|101956996|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
33563007|NCT01472185|101956997|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
33563008|NCT01472185|101956996|FG000|Overall Study|Hyperglycemia|5|||
33563009|NCT01472185|101956997|FG001|Overall Study|Hyperglycemia|2|||
33563010|NCT01472185|101956996|FG000|Overall Study|Investigator's Discretion|3|||
33563011|NCT01472185|101956997|FG001|Overall Study|Investigator's Discretion|1|||
33563012|NCT01472185|101956996|FG000|Overall Study|Lost to Follow-up|4|||
33563013|NCT01472185|101956997|FG001|Overall Study|Lost to Follow-up|1|||
33563014|NCT01472185|101956996|FG000|Overall Study|Protocol Violation|5|||
33563015|NCT01472185|101956997|FG001|Overall Study|Protocol Violation|1|||
33626968|NCT01405768|102184459|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
33563016|NCT01472185|101956996|FG000|Overall Study|Subject Noncompliance|8|||
33563017|NCT01472185|101956997|FG001|Overall Study|Subject Noncompliance|15|||
33563018|NCT01472185|101956996|FG000|Overall Study|Subject Withdrew Consent|6|||
33563019|NCT01472185|101956997|FG001|Overall Study|Subject Withdrew Consent|3|||
33563020|NCT02776735|101957000|FG000|Overall Study|Adverse Event|0|||
33563021|NCT02776735|101957001|FG001|Overall Study|Adverse Event|0|||
33563022|NCT02776735|101957002|FG002|Overall Study|Adverse Event|0|||
33563023|NCT02776735|101957003|FG003|Overall Study|Adverse Event|1|||
33221532|NCT02237508|100711083|FG001|Overall Study|Physician Decision|1|||
33221533|NCT02237508|100711084|FG002|Overall Study|Physician Decision|0|||
33221534|NCT02237508|100711085|FG003|Overall Study|Physician Decision|0|||
33221535|NCT02237508|100711086|FG004|Overall Study|Physician Decision|0|||
33221536|NCT02237508|100711087|FG005|Overall Study|Physician Decision|0|||
33221537|NCT02237508|100711088|FG006|Overall Study|Physician Decision|0|||
33563024|NCT02776735|101957004|FG004|Overall Study|Adverse Event|0|||
33563025|NCT02776735|101957005|FG005|Overall Study|Adverse Event|1|||
33221538|NCT02237508|100711089|FG007|Overall Study|Physician Decision|0|||
33563026|NCT02776735|101957000|FG000|Overall Study|Lost to Follow-up|0|||
33221539|NCT02237508|100711090|FG008|Overall Study|Physician Decision|0|||
33221540|NCT02237508|100711091|FG009|Overall Study|Physician Decision|0|||
33221541|NCT02237508|100711082|FG000|Overall Study|Protocol Violation|0|||
33221542|NCT02237508|100711083|FG001|Overall Study|Protocol Violation|0|||
33221543|NCT02237508|100711084|FG002|Overall Study|Protocol Violation|1|||
33221544|NCT02237508|100711085|FG003|Overall Study|Protocol Violation|0|||
33221545|NCT02237508|100711086|FG004|Overall Study|Protocol Violation|0|||
33221546|NCT02237508|100711087|FG005|Overall Study|Protocol Violation|0|||
33221547|NCT02237508|100711088|FG006|Overall Study|Protocol Violation|0|||
33221548|NCT02237508|100711089|FG007|Overall Study|Protocol Violation|0|||
33221549|NCT02237508|100711090|FG008|Overall Study|Protocol Violation|0|||
33221550|NCT02237508|100711091|FG009|Overall Study|Protocol Violation|0|||
33563027|NCT02776735|101957001|FG001|Overall Study|Lost to Follow-up|0|||
33563028|NCT02776735|101957002|FG002|Overall Study|Lost to Follow-up|0|||
33563029|NCT02776735|101957003|FG003|Overall Study|Lost to Follow-up|1|||
33563030|NCT02776735|101957004|FG004|Overall Study|Lost to Follow-up|0|||
33563031|NCT02776735|101957005|FG005|Overall Study|Lost to Follow-up|0|||
33563032|NCT02776735|101957000|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33563033|NCT02776735|101957001|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33563034|NCT02776735|101957002|FG002|Overall Study|Withdrawal by parent/guardian|2|||
33563035|NCT02776735|101957003|FG003|Overall Study|Withdrawal by parent/guardian|2|||
33563036|NCT02776735|101957004|FG004|Overall Study|Withdrawal by parent/guardian|0|||
33563037|NCT02776735|101957005|FG005|Overall Study|Withdrawal by parent/guardian|0|||
33563038|NCT02776735|101957000|FG000|Overall Study|Withdrawal by Subject|1|||
33563039|NCT02776735|101957001|FG001|Overall Study|Withdrawal by Subject|0|||
33563040|NCT02776735|101957002|FG002|Overall Study|Withdrawal by Subject|0|||
33563041|NCT02776735|101957003|FG003|Overall Study|Withdrawal by Subject|0|||
33563042|NCT02776735|101957004|FG004|Overall Study|Withdrawal by Subject|0|||
33563043|NCT02776735|101957005|FG005|Overall Study|Withdrawal by Subject|1|||
33563044|NCT02776735|101957000|FG000|Overall Study|Other|0|||
33563045|NCT02776735|101957001|FG001|Overall Study|Other|0|||
33563046|NCT02776735|101957002|FG002|Overall Study|Other|3|||
33563047|NCT02776735|101957003|FG003|Overall Study|Other|0|||
33563048|NCT02776735|101957004|FG004|Overall Study|Other|0|||
33563049|NCT02776735|101957005|FG005|Overall Study|Other|0|||
33563050|NCT03443401|101957006|FG000|Overall Study|Lost to Follow-up|13|||
33563051|NCT03443401|101957006|FG000|Overall Study|Influential outlier|1|||
33563052|NCT02607722|101957007|FG000|Overall Study|No data reliability|1|||
33563053|NCT02607722|101957007|FG000|Overall Study|no patient visit|18|||
33563054|NCT02607722|101957007|FG000|Overall Study|missing info in CRF|13|||
33563055|NCT02607722|101957007|FG000|Overall Study|Withdrawal by Subject|616|||
33563056|NCT02607722|101957007|FG000|Overall Study|Lost to Follow-up|312|||
33221551|NCT01931735|100711094|FG000|Randomized Phase|Lost to Follow-up|2|||
33221552|NCT01931735|100711095|FG001|Randomized Phase|Lost to Follow-up|2|||
33221553|NCT01931735|100711096|FG002|Randomized Phase|Lost to Follow-up|5|||
33221554|NCT01931735|100711097|FG003|Randomized Phase|Lost to Follow-up|0|||
33221555|NCT01931735|100711094|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
33221556|NCT01931735|100711095|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
33563057|NCT02607722|101957007|FG000|Overall Study|Improved|22|||
33563058|NCT02607722|101957007|FG000|Overall Study|Lack of Efficacy|316|||
33563059|NCT02607722|101957007|FG000|Overall Study|Adverse Event|2553|||
33563060|NCT02607722|101957007|FG000|Overall Study|Not treated|1|||
33563061|NCT02607722|101957007|FG000|Overall Study|No CRF collected|138|||
33563062|NCT02607722|101957007|FG000|Overall Study|without CRF|4225|||
33563063|NCT02607722|101957007|FG000|Overall Study|Physician Decision|367|||
33563064|NCT04976855|101957008|FG000|Part I|Withdrawal by Subject|0|||
33563065|NCT04976855|101957009|FG001|Part I|Withdrawal by Subject|1|||
33563066|NCT04976855|101957010|FG002|Part I|Withdrawal by Subject|0|||
33563067|NCT04976855|101957011|FG003|Part I|Withdrawal by Subject|0|||
33563068|NCT04976855|101957012|FG004|Part I|Withdrawal by Subject|0|||
33563069|NCT04976855|101957013|FG005|Part I|Withdrawal by Subject|0|||
33221557|NCT01931735|100711096|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
33221558|NCT01931735|100711097|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
33221559|NCT01931735|100711094|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
33221560|NCT01931735|100711095|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
33221561|NCT01931735|100711096|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
33221562|NCT01931735|100711097|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
33361505|NCT01933672|101210847|FG001|First Intervention Period (12-16 Days)|Other|0|||
33361506|NCT01933672|101210848|FG002|First Intervention Period (12-16 Days)|Other|1|||
33361507|NCT01933672|101210849|FG003|First Intervention Period (12-16 Days)|Other|0|||
33361508|NCT01933672|101210850|FG004|First Intervention Period (12-16 Days)|Other|0|||
33361509|NCT01933672|101210851|FG005|First Intervention Period (12-16 Days)|Other|1|||
33361510|NCT01933672|101210852|FG006|First Intervention Period (12-16 Days)|Other|0|||
33361511|NCT01933672|101210846|FG000|Second Intervention Period (12-16 Days)|Other|0|||
33361512|NCT01933672|101210847|FG001|Second Intervention Period (12-16 Days)|Other|1|||
33361513|NCT01933672|101210848|FG002|Second Intervention Period (12-16 Days)|Other|1|||
33361514|NCT01933672|101210849|FG003|Second Intervention Period (12-16 Days)|Other|0|||
33361515|NCT01933672|101210850|FG004|Second Intervention Period (12-16 Days)|Other|0|||
33361516|NCT01933672|101210851|FG005|Second Intervention Period (12-16 Days)|Other|0|||
33361517|NCT01933672|101210852|FG006|Second Intervention Period (12-16 Days)|Other|0|||
33361518|NCT01933672|101210846|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33361519|NCT01933672|101210847|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33221563|NCT00508404|100711102|FG000|Overall Study|Ongoing at Data Cut-off|12|||
33221564|NCT00508404|100711102|FG000|Overall Study|Adverse Event|2|||
33361520|NCT01933672|101210848|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33361521|NCT01933672|101210849|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
33361522|NCT01933672|101210850|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33361523|NCT01933672|101210851|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33361524|NCT01933672|101210852|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
33361525|NCT01933672|101210846|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
33361526|NCT01933672|101210847|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
33361527|NCT01933672|101210848|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
33563070|NCT04976855|101957014|FG006|Part I|Withdrawal by Subject|0|||
33563071|NCT04976855|101957008|FG000|Part II|Adverse Event|0|||
33563072|NCT04976855|101957009|FG001|Part II|Adverse Event|0|||
33563073|NCT04976855|101957010|FG002|Part II|Adverse Event|0|||
33563074|NCT04976855|101957011|FG003|Part II|Adverse Event|1|||
33563075|NCT04976855|101957012|FG004|Part II|Adverse Event|0|||
33563076|NCT04976855|101957013|FG005|Part II|Adverse Event|0|||
33626969|NCT01405768|102184460|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
33626970|NCT02552966|102184464|FG000|Overall Study|Lost to Follow-up|2|||
33626971|NCT02552966|102184464|FG000|Overall Study|Withdrawal by Subject|3|||
33626972|NCT01927497|102184465|FG000|Overall Study|Death|0|||
33626973|NCT01927497|102184466|FG001|Overall Study|Death|1|||
33626974|NCT01927497|102184465|FG000|Overall Study|Protocol Violation|2|||
33221565|NCT00508404|100711102|FG000|Overall Study|Death|16|||
33221566|NCT00508404|100711102|FG000|Overall Study|Physician Decision|2|||
33221567|NCT00508404|100711102|FG000|Overall Study|Withdrawal by Subject|3|||
33221568|NCT00508404|100711102|FG000|Overall Study|Protocol-specified Criteria|2|||
33221569|NCT00508404|100711102|FG000|Overall Study|Lost to Follow-up|2|||
33221570|NCT00508404|100711102|FG000|Overall Study|Other - Not Specified|3|||
33626975|NCT01927497|102184466|FG001|Overall Study|Protocol Violation|0|||
33626976|NCT03449758|102184467|FG000|Overall Study|Major protocol deviation|1|||
33626977|NCT03449758|102184467|FG000|Overall Study|Treatment inefficacy|5|||
33626978|NCT03449758|102184467|FG000|Overall Study|Adverse Event|9|||
33626979|NCT03449758|102184467|FG000|Overall Study|Consent withdrawal|1|||
33626980|NCT03449758|102184467|FG000|Overall Study|Other unspecified reason|3|||
33626981|NCT03811340|102184468|FG000|Overall Study|subjects did not complete the survey.|90|||
33221571|NCT00437645|100711103|FG000|Overall Study|Adverse Event|15|||
33361528|NCT01933672|101210849|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
33563077|NCT04976855|101957014|FG006|Part II|Adverse Event|0|||
33563078|NCT04976855|101957008|FG000|Part II|Withdrawal by Subject|0|||
33563079|NCT04976855|101957009|FG001|Part II|Withdrawal by Subject|0|||
33221572|NCT00437645|100711104|FG001|Overall Study|Adverse Event|84|||
33361529|NCT01933672|101210850|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
33361530|NCT01933672|101210851|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
33563080|NCT04976855|101957010|FG002|Part II|Withdrawal by Subject|0|||
33563081|NCT04976855|101957011|FG003|Part II|Withdrawal by Subject|0|||
33563082|NCT04976855|101957012|FG004|Part II|Withdrawal by Subject|1|||
33563083|NCT04976855|101957013|FG005|Part II|Withdrawal by Subject|0|||
33563084|NCT04976855|101957014|FG006|Part II|Withdrawal by Subject|0|||
33563085|NCT04976855|101957008|FG000|Part II|Lost to Follow-up|0|||
33626982|NCT02193776|102184470|FG000|Overall Study|Consent withdrawn|1|||
33626983|NCT02193776|102184471|FG001|Overall Study|Consent withdrawn|0|||
33626984|NCT02193776|102184472|FG002|Overall Study|Consent withdrawn|0|||
33626985|NCT02193776|102184473|FG003|Overall Study|Consent withdrawn|0|||
33626986|NCT02193776|102184470|FG000|Overall Study|Failure to comply with protocol|0|||
33361531|NCT01933672|101210852|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
33626987|NCT02193776|102184471|FG001|Overall Study|Failure to comply with protocol|1|||
33626988|NCT02193776|102184472|FG002|Overall Study|Failure to comply with protocol|0|||
33626989|NCT02193776|102184473|FG003|Overall Study|Failure to comply with protocol|0|||
33626990|NCT02193776|102184470|FG000|Overall Study|Investigator/Sponsor decision|1|||
33626991|NCT02193776|102184471|FG001|Overall Study|Investigator/Sponsor decision|1|||
33626992|NCT02193776|102184472|FG002|Overall Study|Investigator/Sponsor decision|0|||
33626993|NCT02193776|102184473|FG003|Overall Study|Investigator/Sponsor decision|0|||
33626994|NCT02193776|102184470|FG000|Overall Study|Death|1|||
33626995|NCT02193776|102184471|FG001|Overall Study|Death|0|||
33626996|NCT02193776|102184472|FG002|Overall Study|Death|0|||
33626997|NCT02193776|102184473|FG003|Overall Study|Death|0|||
33626998|NCT02193776|102184470|FG000|Overall Study|Adverse event/Specific toxicity|5|||
33626999|NCT02193776|102184471|FG001|Overall Study|Adverse event/Specific toxicity|5|||
33627000|NCT02193776|102184472|FG002|Overall Study|Adverse event/Specific toxicity|2|||
33627001|NCT02193776|102184473|FG003|Overall Study|Adverse event/Specific toxicity|2|||
33627002|NCT01005251|102184474|FG000|Overall Study|Withdrawal by Subject|2|||
33627003|NCT01005251|102184475|FG001|Overall Study|Withdrawal by Subject|5|||
33627004|NCT01005251|102184476|FG002|Overall Study|Withdrawal by Subject|3|||
33563086|NCT04976855|101957009|FG001|Part II|Lost to Follow-up|0|||
33563087|NCT04976855|101957010|FG002|Part II|Lost to Follow-up|0|||
33563088|NCT04976855|101957011|FG003|Part II|Lost to Follow-up|0|||
33563089|NCT04976855|101957012|FG004|Part II|Lost to Follow-up|0|||
33563090|NCT04976855|101957013|FG005|Part II|Lost to Follow-up|1|||
33563091|NCT04976855|101957014|FG006|Part II|Lost to Follow-up|0|||
33563092|NCT04918771|101957015|FG000|Overall Study|Withdrawal by Subject|4|||
33563093|NCT04918771|101957016|FG001|Overall Study|Withdrawal by Subject|5|||
33627005|NCT01005251|102184477|FG003|Overall Study|Withdrawal by Subject|4|||
33627006|NCT01005251|102184478|FG004|Overall Study|Withdrawal by Subject|9|||
33627007|NCT01005251|102184474|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
33563094|NCT04918771|101957015|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
33627008|NCT01005251|102184475|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33627009|NCT01005251|102184476|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
33627010|NCT01005251|102184477|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
33627011|NCT01005251|102184478|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
33627012|NCT01005251|102184474|FG000|Overall Study|Adverse Event|2|||
33627013|NCT01005251|102184475|FG001|Overall Study|Adverse Event|6|||
33627014|NCT01005251|102184476|FG002|Overall Study|Adverse Event|8|||
33361532|NCT00035815|101210854|FG000|Overall Study|Withdrawal by Subject|17|||
33361533|NCT00035815|101210855|FG001|Overall Study|Withdrawal by Subject|11|||
33361534|NCT01172288|101210856|FG000|Overall Study|Adverse Event|1|||
33361535|NCT01172288|101210857|FG001|Overall Study|Adverse Event|0|||
33361536|NCT01172288|101210856|FG000|Overall Study|Protocol Violation|0|||
33361537|NCT01172288|101210857|FG001|Overall Study|Protocol Violation|1|||
33361538|NCT02795156|101210860|FG000|Overall Study|Progressive Disease|22|||
33361539|NCT02795156|101210861|FG001|Overall Study|Progressive Disease|7|||
33361540|NCT02795156|101210862|FG002|Overall Study|Progressive Disease|34|||
33361541|NCT02795156|101210863|FG003|Overall Study|Progressive Disease|7|||
33361542|NCT02795156|101210860|FG000|Overall Study|Adverse Event|13|||
33361543|NCT02795156|101210861|FG001|Overall Study|Adverse Event|2|||
33361544|NCT02795156|101210862|FG002|Overall Study|Adverse Event|3|||
33361545|NCT02795156|101210863|FG003|Overall Study|Adverse Event|2|||
33563095|NCT04918771|101957016|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
33563096|NCT05654181|101957017|FG000|Overall Study|Adverse Event|1|||
33563097|NCT05654181|101957018|FG001|Overall Study|Adverse Event|0|||
33627015|NCT01005251|102184477|FG003|Overall Study|Adverse Event|5|||
33627016|NCT01005251|102184478|FG004|Overall Study|Adverse Event|4|||
33627017|NCT01005251|102184474|FG000|Overall Study|Protocol Violation|1|||
33627018|NCT01005251|102184475|FG001|Overall Study|Protocol Violation|0|||
33627019|NCT01005251|102184476|FG002|Overall Study|Protocol Violation|0|||
33221573|NCT00437645|100711103|FG000|Overall Study|Withdrawal by Subject|10|||
33221574|NCT00437645|100711104|FG001|Overall Study|Withdrawal by Subject|22|||
33221575|NCT00437645|100711103|FG000|Overall Study|Protocol Violation|3|||
33221576|NCT00437645|100711104|FG001|Overall Study|Protocol Violation|3|||
33361546|NCT02795156|101210860|FG000|Overall Study|Death|1|||
33361547|NCT02795156|101210861|FG001|Overall Study|Death|1|||
33563098|NCT05654181|101957019|FG002|Overall Study|Adverse Event|0|||
33361548|NCT02795156|101210862|FG002|Overall Study|Death|1|||
33361549|NCT02795156|101210863|FG003|Overall Study|Death|0|||
33563099|NCT05654181|101957020|FG003|Overall Study|Adverse Event|0|||
33563100|NCT05654181|101957021|FG004|Overall Study|Adverse Event|0|||
33563101|NCT05654181|101957022|FG005|Overall Study|Adverse Event|0|||
33627020|NCT01005251|102184477|FG003|Overall Study|Protocol Violation|0|||
33221577|NCT00437645|100711103|FG000|Overall Study|Lost to Follow-up|2|||
33361550|NCT02795156|101210860|FG000|Overall Study|Physician Decision|1|||
33563102|NCT05654181|101957023|FG006|Overall Study|Adverse Event|0|||
33563103|NCT05654181|101957024|FG007|Overall Study|Adverse Event|1|||
33361551|NCT02795156|101210861|FG001|Overall Study|Physician Decision|0|||
33361552|NCT02795156|101210862|FG002|Overall Study|Physician Decision|1|||
33361553|NCT02795156|101210863|FG003|Overall Study|Physician Decision|0|||
33361554|NCT02795156|101210860|FG000|Overall Study|Withdrawal by Subject|2|||
33361555|NCT02795156|101210861|FG001|Overall Study|Withdrawal by Subject|0|||
33361556|NCT02795156|101210862|FG002|Overall Study|Withdrawal by Subject|3|||
33361557|NCT02795156|101210863|FG003|Overall Study|Withdrawal by Subject|0|||
33361558|NCT02492711|101210871|FG000|Overall Study|Adverse Event|9|||
33415057|NCT00902486|101409934|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
33415058|NCT00902486|101409935|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
33415059|NCT00902486|101409930|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
33415060|NCT00902486|101409931|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
33415061|NCT00902486|101409932|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
33415062|NCT00902486|101409933|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
33415063|NCT00902486|101409934|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
33415064|NCT00902486|101409935|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
33415065|NCT00902486|101409930|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
33415066|NCT00902486|101409931|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
33415067|NCT00902486|101409932|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
33415068|NCT00902486|101409933|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
33415069|NCT00902486|101409934|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
33415070|NCT00902486|101409935|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
33415071|NCT00592007|101409936|FG000|Overall Study|Withdrawal by Subject|1|||
33415072|NCT00592007|101409936|FG000|Overall Study|patient ineligible (out of lab range)|1|||
33415073|NCT00183170|101409940|FG000|First Intervention|Did not complete study|1|||
33415074|NCT00183170|101409941|FG001|First Intervention|Did not complete study|0|||
33415075|NCT00183170|101409940|FG000|First Intervention|Did not meet targeted BrAC|1|||
33415076|NCT00183170|101409941|FG001|First Intervention|Did not meet targeted BrAC|0|||
33415077|NCT00183170|101409940|FG000|Washout 1 Week|Did not complete study|6|||
33415078|NCT00183170|101409941|FG001|Washout 1 Week|Did not complete study|8|||
33415079|NCT00183170|101409940|FG000|Second Intervention|Did not complete study|1|||
33415080|NCT00183170|101409941|FG001|Second Intervention|Did not complete study|0|||
33415081|NCT00183170|101409940|FG000|Second Intervention|Did not meet targeted BrAC|0|||
33415082|NCT00183170|101409941|FG001|Second Intervention|Did not meet targeted BrAC|2|||
33415083|NCT00299546|101409942|FG000|Overall Study|Death|3|||
33415084|NCT00299546|101409943|FG001|Overall Study|Death|2|||
33415085|NCT00299546|101409944|FG002|Overall Study|Death|0|||
33415086|NCT00299546|101409942|FG000|Overall Study|Lost to Follow-up|2|||
33415087|NCT00299546|101409943|FG001|Overall Study|Lost to Follow-up|2|||
33415088|NCT00299546|101409944|FG002|Overall Study|Lost to Follow-up|5|||
33415089|NCT00299546|101409942|FG000|Overall Study|Adverse Event|37|||
33415090|NCT00299546|101409943|FG001|Overall Study|Adverse Event|22|||
33563104|NCT05654181|101957025|FG008|Overall Study|Adverse Event|0|||
33563105|NCT05654181|101957026|FG009|Overall Study|Adverse Event|0|||
33563106|NCT05654181|101957017|FG000|Overall Study|Withdrawal by Subject|0|||
33563107|NCT05654181|101957018|FG001|Overall Study|Withdrawal by Subject|0|||
33563108|NCT05654181|101957019|FG002|Overall Study|Withdrawal by Subject|0|||
33563109|NCT05654181|101957020|FG003|Overall Study|Withdrawal by Subject|0|||
33563110|NCT05654181|101957021|FG004|Overall Study|Withdrawal by Subject|0|||
33563111|NCT05654181|101957022|FG005|Overall Study|Withdrawal by Subject|0|||
33563112|NCT05654181|101957023|FG006|Overall Study|Withdrawal by Subject|0|||
33563113|NCT05654181|101957024|FG007|Overall Study|Withdrawal by Subject|1|||
33563114|NCT05654181|101957025|FG008|Overall Study|Withdrawal by Subject|0|||
33563115|NCT05654181|101957026|FG009|Overall Study|Withdrawal by Subject|0|||
33563116|NCT05654181|101957017|FG000|Overall Study|Other|0|||
33563117|NCT05654181|101957018|FG001|Overall Study|Other|0|||
33563118|NCT05654181|101957019|FG002|Overall Study|Other|0|||
33563119|NCT05654181|101957020|FG003|Overall Study|Other|0|||
33563120|NCT05654181|101957021|FG004|Overall Study|Other|1|||
33563121|NCT05654181|101957022|FG005|Overall Study|Other|1|||
33221578|NCT00437645|100711104|FG001|Overall Study|Lost to Follow-up|3|||
33361559|NCT02492711|101210872|FG001|Overall Study|Adverse Event|9|||
33361560|NCT02492711|101210873|FG002|Overall Study|Adverse Event|2|||
33361561|NCT02492711|101210871|FG000|Overall Study|Death|3|||
33361562|NCT02492711|101210872|FG001|Overall Study|Death|3|||
33415091|NCT00299546|101409944|FG002|Overall Study|Adverse Event|27|||
33415092|NCT00299546|101409942|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
33415093|NCT00299546|101409943|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
33415094|NCT00299546|101409944|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
33563122|NCT05654181|101957023|FG006|Overall Study|Other|0|||
33627021|NCT01005251|102184478|FG004|Overall Study|Protocol Violation|2|||
33563123|NCT05654181|101957024|FG007|Overall Study|Other|0|||
33563124|NCT05654181|101957025|FG008|Overall Study|Other|0|||
33563125|NCT05654181|101957026|FG009|Overall Study|Other|0|||
33563126|NCT01813357|101957028|FG000|Overall Study|Lost to Follow-up|5|||
33415095|NCT00299546|101409942|FG000|Overall Study|Other|24|||
33415096|NCT00299546|101409943|FG001|Overall Study|Other|26|||
33415097|NCT00299546|101409944|FG002|Overall Study|Other|19|||
33415098|NCT00299546|101409942|FG000|Overall Study|Not treated|0|||
33415099|NCT00299546|101409943|FG001|Overall Study|Not treated|1|||
33415100|NCT00299546|101409944|FG002|Overall Study|Not treated|1|||
33415101|NCT00440193|101409945|FG000|Treatment Period|Adverse Event|74|||
33415102|NCT00440193|101409946|FG001|Treatment Period|Adverse Event|67|||
33415103|NCT00440193|101409945|FG000|Treatment Period|Death|19|||
33415104|NCT00440193|101409946|FG001|Treatment Period|Death|22|||
33415105|NCT00440193|101409945|FG000|Treatment Period|Lack of Efficacy|0|||
33415106|NCT00440193|101409946|FG001|Treatment Period|Lack of Efficacy|1|||
33415107|NCT00440193|101409945|FG000|Treatment Period|Lost to Follow-up|12|||
33415108|NCT00440193|101409946|FG001|Treatment Period|Lost to Follow-up|18|||
33415109|NCT00440193|101409945|FG000|Treatment Period|Physician Decision|3|||
33415110|NCT00440193|101409946|FG001|Treatment Period|Physician Decision|6|||
33415111|NCT00440193|101409945|FG000|Treatment Period|Protocol Violation|16|||
33415112|NCT00440193|101409946|FG001|Treatment Period|Protocol Violation|19|||
33415113|NCT00440193|101409945|FG000|Treatment Period|Withdrawal by Subject|36|||
33415114|NCT00440193|101409946|FG001|Treatment Period|Withdrawal by Subject|77|||
33361563|NCT02492711|101210873|FG002|Overall Study|Death|0|||
33361564|NCT02492711|101210871|FG000|Overall Study|Withdrawal by Subject|10|||
33415115|NCT00440193|101409945|FG000|Treatment Period|Clinical endpoint reached|28|||
33415116|NCT00440193|101409946|FG001|Treatment Period|Clinical endpoint reached|25|||
33415117|NCT00440193|101409945|FG000|Treatment Period|Study terminated by sponsor|102|||
33415118|NCT00440193|101409946|FG001|Treatment Period|Study terminated by sponsor|94|||
33415119|NCT00440193|101409945|FG000|Treatment Period|Protocol driven decision point|2|||
33415120|NCT00440193|101409946|FG001|Treatment Period|Protocol driven decision point|2|||
33415121|NCT00440193|101409945|FG000|Treatment Period|Switch to commercial drug|0|||
33415122|NCT00440193|101409946|FG001|Treatment Period|Switch to commercial drug|2|||
33415123|NCT00440193|101409945|FG000|Treatment Period|Technical problems|1|||
33415124|NCT00440193|101409946|FG001|Treatment Period|Technical problems|1|||
33361565|NCT02492711|101210872|FG001|Overall Study|Withdrawal by Subject|16|||
33361566|NCT02492711|101210873|FG002|Overall Study|Withdrawal by Subject|5|||
33361567|NCT02492711|101210871|FG000|Overall Study|Physician Decision|10|||
33361568|NCT02492711|101210872|FG001|Overall Study|Physician Decision|6|||
33361569|NCT02492711|101210873|FG002|Overall Study|Physician Decision|4|||
33361570|NCT02492711|101210871|FG000|Overall Study|Lost to Follow-up|0|||
33415125|NCT00440193|101409945|FG000|Treatment Period|Participant convenience|5|||
33415126|NCT00440193|101409946|FG001|Treatment Period|Participant convenience|2|||
33563127|NCT01813357|101957029|FG001|Overall Study|Lost to Follow-up|6|||
33563128|NCT00619918|101957034|FG000|Overall Study|Withdrawal by Subject|4|||
33563129|NCT00619918|101957035|FG001|Overall Study|Withdrawal by Subject|3|||
33563130|NCT00619918|101957034|FG000|Overall Study|Physician Decision|2|||
33563131|NCT00619918|101957035|FG001|Overall Study|Physician Decision|4|||
33563132|NCT00619918|101957034|FG000|Overall Study|Transfer to outside facility|3|||
33563133|NCT00619918|101957035|FG001|Overall Study|Transfer to outside facility|3|||
33563134|NCT00619918|101957034|FG000|Overall Study|Left before receiving first dose|7|||
33563135|NCT00619918|101957035|FG001|Overall Study|Left before receiving first dose|6|||
33563136|NCT00619918|101957034|FG000|Overall Study|ICU admission|4|||
33563137|NCT00619918|101957035|FG001|Overall Study|ICU admission|6|||
33563138|NCT01308788|101957036|FG000|2-year Treatment|medication change by treating physician|4|||
33563139|NCT01308788|101957037|FG001|2-year Treatment|medication change by treating physician|11|||
33563140|NCT02951819|101957040|FG000|Overall Study|Death|9|||
33563141|NCT02951819|101957041|FG001|Overall Study|Death|7|||
33563142|NCT02951819|101957040|FG000|Overall Study|Withdrawal by Subject|3|||
33563143|NCT02951819|101957041|FG001|Overall Study|Withdrawal by Subject|0|||
33563144|NCT02951819|101957040|FG000|Overall Study|Adverse Event|1|||
33563145|NCT02951819|101957041|FG001|Overall Study|Adverse Event|0|||
33563146|NCT02951819|101957040|FG000|Overall Study|Lack of Efficacy|4|||
33627022|NCT01005251|102184474|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
33627023|NCT01005251|102184475|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
33361571|NCT02492711|101210872|FG001|Overall Study|Lost to Follow-up|0|||
33361572|NCT02492711|101210873|FG002|Overall Study|Lost to Follow-up|1|||
33361573|NCT02492711|101210871|FG000|Overall Study|study treatment delay|2|||
33361574|NCT02492711|101210872|FG001|Overall Study|study treatment delay|1|||
33415127|NCT00440193|101409945|FG000|Treatment Period|Participant did not receive treatment|7|||
33415128|NCT00440193|101409946|FG001|Treatment Period|Participant did not receive treatment|13|||
33415129|NCT00440193|101409945|FG000|Treatment Period|Site closed by investigator|0|||
33415130|NCT00440193|101409946|FG001|Treatment Period|Site closed by investigator|2|||
33415131|NCT00440193|101409945|FG000|Observational Period|Adverse Event|2|||
33415132|NCT00440193|101409946|FG001|Observational Period|Adverse Event|2|||
33415133|NCT00440193|101409945|FG000|Observational Period|Death|15|||
33415134|NCT00440193|101409946|FG001|Observational Period|Death|20|||
33563147|NCT02951819|101957041|FG001|Overall Study|Lack of Efficacy|0|||
33563148|NCT02951819|101957040|FG000|Overall Study|Lost to Follow-up|1|||
33563149|NCT02951819|101957041|FG001|Overall Study|Lost to Follow-up|0|||
33627024|NCT01005251|102184476|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
33627025|NCT01005251|102184477|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
33627026|NCT01005251|102184478|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
33627027|NCT01005251|102184474|FG000|Overall Study|Lost to Follow-up|1|||
33627028|NCT01005251|102184475|FG001|Overall Study|Lost to Follow-up|4|||
33627029|NCT01005251|102184476|FG002|Overall Study|Lost to Follow-up|2|||
33627030|NCT01005251|102184477|FG003|Overall Study|Lost to Follow-up|0|||
33627031|NCT01005251|102184478|FG004|Overall Study|Lost to Follow-up|0|||
33361575|NCT02492711|101210873|FG002|Overall Study|study treatment delay|0|||
33627032|NCT01005251|102184474|FG000|Overall Study|Physician Decision|0|||
33627033|NCT01005251|102184475|FG001|Overall Study|Physician Decision|0|||
33627034|NCT01005251|102184476|FG002|Overall Study|Physician Decision|0|||
33627035|NCT01005251|102184477|FG003|Overall Study|Physician Decision|0|||
33627036|NCT01005251|102184478|FG004|Overall Study|Physician Decision|2|||
33627037|NCT01005251|102184474|FG000|Overall Study|Patient moved|1|||
33627038|NCT01005251|102184475|FG001|Overall Study|Patient moved|0|||
33627039|NCT01005251|102184476|FG002|Overall Study|Patient moved|0|||
33627040|NCT01005251|102184477|FG003|Overall Study|Patient moved|0|||
33627041|NCT01005251|102184478|FG004|Overall Study|Patient moved|0|||
33361576|NCT02492711|101210871|FG000|Overall Study|change in chemotherapy|0|||
33361577|NCT02492711|101210872|FG001|Overall Study|change in chemotherapy|1|||
33361578|NCT02492711|101210873|FG002|Overall Study|change in chemotherapy|0|||
33361579|NCT02492711|101210871|FG000|Overall Study|never treated|2|||
33361580|NCT02492711|101210872|FG001|Overall Study|never treated|4|||
33361581|NCT02492711|101210873|FG002|Overall Study|never treated|0|||
33361582|NCT02492711|101210871|FG000|Overall Study|Other|0|||
33361583|NCT02492711|101210872|FG001|Overall Study|Other|0|||
33361584|NCT02492711|101210873|FG002|Overall Study|Other|1|||
33361585|NCT01927562|101210879|FG000|Overall Study|Lost to Follow-up|30|||
33361586|NCT01927562|101210879|FG000|Overall Study|Withdrawal by Subject|3|||
33361587|NCT01927562|101210879|FG000|Overall Study|Physician Decision|5|||
33361588|NCT02675517|101210881|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
33361589|NCT02675517|101210881|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
33361590|NCT01632878|101210887|FG000|Screening|Physician Decision|268|||
33361591|NCT01632878|101210887|FG000|Treatment|Lost to Follow-up|41|||
33361592|NCT01632878|101210887|FG000|Treatment|Withdrawal by Subject|36|||
33361593|NCT01632878|101210887|FG000|Treatment|Physician Decision|34|||
33361594|NCT01632878|101210887|FG000|Treatment|missing information|4|||
33361595|NCT01632878|101210887|FG000|Treatment|no information on study completion|43|||
33361596|NCT00984659|101210894|FG000|2-week Run-in Period|Adverse Event|8|||
33361597|NCT00984659|101210895|FG001|2-week Run-in Period|Adverse Event|0|||
33361598|NCT00984659|101210896|FG002|2-week Run-in Period|Adverse Event|0|||
33361599|NCT00984659|101210897|FG003|2-week Run-in Period|Adverse Event|0|||
33361600|NCT00984659|101210894|FG000|2-week Run-in Period|Protocol Violation|5|||
33361601|NCT00984659|101210895|FG001|2-week Run-in Period|Protocol Violation|0|||
33361602|NCT00984659|101210896|FG002|2-week Run-in Period|Protocol Violation|0|||
33361603|NCT00984659|101210897|FG003|2-week Run-in Period|Protocol Violation|0|||
33361604|NCT00984659|101210894|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
33415135|NCT00440193|101409945|FG000|Observational Period|Lost to Follow-up|12|||
33415136|NCT00440193|101409946|FG001|Observational Period|Lost to Follow-up|8|||
33415137|NCT00440193|101409945|FG000|Observational Period|Protocol Violation|1|||
33563150|NCT02951819|101957040|FG000|Overall Study|Progressive Disease|1|||
33563151|NCT02951819|101957041|FG001|Overall Study|Progressive Disease|0|||
33563152|NCT02951819|101957040|FG000|Overall Study|Other|9|||
33563153|NCT02951819|101957041|FG001|Overall Study|Other|0|||
33563154|NCT01491919|101957042|FG000|Overall Study|Insufficient PK sampling|1|||
33563155|NCT01491919|101957043|FG001|Overall Study|Insufficient PK sampling|2|||
33563156|NCT01491919|101957044|FG002|Overall Study|Insufficient PK sampling|1|||
33563157|NCT03735121|101957058|FG000|Overall Study|Death|3|||
33563158|NCT03735121|101957059|FG001|Overall Study|Death|6|||
33627042|NCT01005251|102184474|FG000|Overall Study|Wrong drug dispensed|0|||
33627043|NCT01005251|102184475|FG001|Overall Study|Wrong drug dispensed|1|||
33627044|NCT01005251|102184476|FG002|Overall Study|Wrong drug dispensed|0|||
33627045|NCT01005251|102184477|FG003|Overall Study|Wrong drug dispensed|0|||
33563159|NCT03735121|101957060|FG002|Overall Study|Death|8|||
33627046|NCT01005251|102184478|FG004|Overall Study|Wrong drug dispensed|0|||
33627047|NCT01005251|102184474|FG000|Overall Study|Randomized in error|0|||
33627048|NCT01005251|102184475|FG001|Overall Study|Randomized in error|0|||
33627049|NCT01005251|102184476|FG002|Overall Study|Randomized in error|1|||
33627050|NCT01005251|102184477|FG003|Overall Study|Randomized in error|1|||
33627051|NCT01005251|102184478|FG004|Overall Study|Randomized in error|0|||
33361605|NCT00984659|101210895|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
33361606|NCT00984659|101210896|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
33415138|NCT00440193|101409946|FG001|Observational Period|Protocol Violation|0|||
33563160|NCT03735121|101957061|FG003|Overall Study|Death|37|||
33563161|NCT03735121|101957062|FG004|Overall Study|Death|86|||
33563162|NCT03735121|101957058|FG000|Overall Study|Withdrawal by Subject|1|||
33415139|NCT00440193|101409945|FG000|Observational Period|Withdrawal by Subject|11|||
33415140|NCT00440193|101409946|FG001|Observational Period|Withdrawal by Subject|8|||
33415141|NCT00440193|101409945|FG000|Observational Period|Physician Decision|1|||
33415142|NCT00440193|101409946|FG001|Observational Period|Physician Decision|0|||
33415143|NCT00440193|101409945|FG000|Observational Period|Clinical endpoint reached|1|||
33415144|NCT00440193|101409946|FG001|Observational Period|Clinical endpoint reached|0|||
33415145|NCT00440193|101409945|FG000|Observational Period|Participant convenience|2|||
33415146|NCT00440193|101409946|FG001|Observational Period|Participant convenience|0|||
33415147|NCT01165424|101409949|FG000|Overall Study|Clinical adverse experiences|1|||
33415148|NCT01165424|101409949|FG000|Overall Study|Laboratory adverse experiences|1|||
33415149|NCT01165424|101409949|FG000|Overall Study|Did not meet entry criteria|1|||
33415150|NCT01165424|101409949|FG000|Overall Study|Participant moved (relocated)|1|||
33415151|NCT04139642|101409952|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
33415152|NCT04139642|101409953|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
33415153|NCT02181634|101409958|FG000|Overall Study|Lack of Efficacy|33|||
33415154|NCT02181634|101409958|FG000|Overall Study|Adverse Event|17|||
33415155|NCT02181634|101409958|FG000|Overall Study|Physician Decision|8|||
33415156|NCT02181634|101409958|FG000|Overall Study|Withdrawal by Subject|5|||
33415157|NCT02181634|101409958|FG000|Overall Study|Death|2|||
33415158|NCT02181634|101409958|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
33415159|NCT02181634|101409958|FG000|Overall Study|Ineligible|1|||
33415160|NCT02181634|101409958|FG000|Overall Study|Max number of dose reduction|1|||
33415161|NCT02181634|101409958|FG000|Overall Study|Symptomatic progression|1|||
33415162|NCT02181634|101409958|FG000|Overall Study|Patient opted to proceed to surgery|1|||
33563163|NCT03735121|101957059|FG001|Overall Study|Withdrawal by Subject|1|||
33563164|NCT03735121|101957060|FG002|Overall Study|Withdrawal by Subject|3|||
33563165|NCT03735121|101957061|FG003|Overall Study|Withdrawal by Subject|4|||
33563166|NCT03735121|101957062|FG004|Overall Study|Withdrawal by Subject|2|||
33361607|NCT00984659|101210897|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
33361608|NCT00984659|101210894|FG000|2-week Run-in Period|Lost to Follow-up|3|||
33361609|NCT00984659|101210895|FG001|2-week Run-in Period|Lost to Follow-up|0|||
33361610|NCT00984659|101210896|FG002|2-week Run-in Period|Lost to Follow-up|0|||
33361611|NCT00984659|101210897|FG003|2-week Run-in Period|Lost to Follow-up|0|||
33361612|NCT00984659|101210894|FG000|2-week Run-in Period|Physician Decision|10|||
33361613|NCT00984659|101210895|FG001|2-week Run-in Period|Physician Decision|0|||
33361614|NCT00984659|101210896|FG002|2-week Run-in Period|Physician Decision|0|||
33361615|NCT00984659|101210897|FG003|2-week Run-in Period|Physician Decision|0|||
33361616|NCT00984659|101210894|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
33361617|NCT00984659|101210895|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
33361618|NCT00984659|101210896|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
33361619|NCT00984659|101210897|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
33361620|NCT00984659|101210894|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
33361621|NCT00984659|101210895|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
33361622|NCT00984659|101210896|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
33361623|NCT00984659|101210897|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
33361624|NCT00984659|101210894|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
33563167|NCT03735121|101957058|FG000|Overall Study|Progressive Disease|0|||
33563168|NCT03735121|101957059|FG001|Overall Study|Progressive Disease|0|||
33563169|NCT03735121|101957060|FG002|Overall Study|Progressive Disease|1|||
33563170|NCT03735121|101957061|FG003|Overall Study|Progressive Disease|0|||
33563171|NCT03735121|101957062|FG004|Overall Study|Progressive Disease|0|||
33563172|NCT03735121|101957058|FG000|Overall Study|Lost to Follow-up|0|||
33563173|NCT03735121|101957059|FG001|Overall Study|Lost to Follow-up|0|||
33563174|NCT03735121|101957060|FG002|Overall Study|Lost to Follow-up|0|||
33563175|NCT03735121|101957061|FG003|Overall Study|Lost to Follow-up|0|||
33563176|NCT03735121|101957062|FG004|Overall Study|Lost to Follow-up|1|||
33563177|NCT03735121|101957058|FG000|Overall Study|Ongoing|3|||
33563178|NCT03735121|101957059|FG001|Overall Study|Ongoing|3|||
33563179|NCT03735121|101957060|FG002|Overall Study|Ongoing|26|||
33563180|NCT03735121|101957061|FG003|Overall Study|Ongoing|83|||
33563181|NCT03735121|101957062|FG004|Overall Study|Ongoing|158|||
33563182|NCT00267488|101957066|FG000|Overall Study|Sponsor Terminated Study|9|||
33563183|NCT00267488|101957066|FG000|Overall Study|Protocol Violation|1|||
33627052|NCT01005251|102184474|FG000|Overall Study|Lack of Efficacy|0|||
33221579|NCT00437645|100711103|FG000|Overall Study|Administrative problems|2|||
33361625|NCT00984659|101210895|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
33415163|NCT00359073|101409959|FG000|Overall Study|Withdrawal by Subject|1|||
33415164|NCT00359073|101409960|FG001|Overall Study|Withdrawal by Subject|1|||
33415165|NCT00359073|101409959|FG000|Overall Study|Eligibility criteria no longer met|3|||
33415166|NCT00359073|101409960|FG001|Overall Study|Eligibility criteria no longer met|0|||
33415167|NCT00359073|101409959|FG000|Overall Study|developed RV16 antibody|0|||
33415168|NCT00359073|101409960|FG001|Overall Study|developed RV16 antibody|1|||
33563184|NCT00267488|101957066|FG000|Overall Study|Other (Disease Progression)|1|||
33563185|NCT00944645|101957067|FG000|Period 2|Adverse Event|1|||
33361626|NCT00984659|101210896|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
33361627|NCT00984659|101210897|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
33361628|NCT00984659|101210894|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
33361629|NCT00984659|101210895|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
33361630|NCT00984659|101210896|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
33361631|NCT00984659|101210897|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
33361632|NCT00984659|101210894|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
33415169|NCT02985515|101409961|FG000|Olfaction Testing|Lost to Follow-up|0|||
33415170|NCT02985515|101409962|FG001|Olfaction Testing|Lost to Follow-up|5|||
33415171|NCT02985515|101409961|FG000|Olfaction Testing|Protocol Violation|0|||
33415172|NCT02985515|101409962|FG001|Olfaction Testing|Protocol Violation|3|||
33415173|NCT02152631|101409963|FG000|Overall Study|Adverse Event|32|||
33415174|NCT02152631|101409964|FG001|Overall Study|Adverse Event|4|||
33415175|NCT02152631|101409963|FG000|Overall Study|Withdrawal by Subject|13|||
33415176|NCT02152631|101409964|FG001|Overall Study|Withdrawal by Subject|16|||
33415177|NCT02152631|101409963|FG000|Overall Study|Noncompliance with study drug|1|||
33415178|NCT02152631|101409964|FG001|Overall Study|Noncompliance with study drug|0|||
33415179|NCT02152631|101409963|FG000|Overall Study|Physician Decision|1|||
33415180|NCT02152631|101409964|FG001|Overall Study|Physician Decision|2|||
33415181|NCT02152631|101409963|FG000|Overall Study|Lost to Follow-up|0|||
33415182|NCT02152631|101409964|FG001|Overall Study|Lost to Follow-up|1|||
33415183|NCT02152631|101409963|FG000|Overall Study|On Treatment|19|||
33415184|NCT02152631|101409964|FG001|Overall Study|On Treatment|3|||
33415185|NCT03151707|101409968|FG000|Overall Study|Lost to Follow-up|6|||
33415186|NCT02508649|101409969|FG000|Overall Study|Withdrawal by Subject|4|||
33563186|NCT00944645|101957068|FG001|Period 2|Adverse Event|0|||
33563187|NCT00944645|101957067|FG000|Period 2|Lost to Follow-up|0|||
33563188|NCT00944645|101957068|FG001|Period 2|Lost to Follow-up|3|||
33563189|NCT00944645|101957067|FG000|Period 2|Withdrawal by Subject|7|||
33563190|NCT00944645|101957068|FG001|Period 2|Withdrawal by Subject|6|||
33563191|NCT02609503|101957071|FG000|Overall Study|Adverse Event|1|||
33563192|NCT02609503|101957071|FG000|Overall Study|Death|1|||
33563193|NCT02609503|101957071|FG000|Overall Study|Withdrawal by Subject|1|||
33563194|NCT02609503|101957071|FG000|Overall Study|Disease progression|1|||
33563195|NCT00911157|101957072|FG000|Overall Study|Adverse Event|4|||
33563196|NCT00911157|101957073|FG001|Overall Study|Adverse Event|1|||
33563197|NCT00911157|101957072|FG000|Overall Study|Withdrawal by Subject|1|||
33563198|NCT00911157|101957073|FG001|Overall Study|Withdrawal by Subject|1|||
33563199|NCT00911157|101957072|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
33563200|NCT00911157|101957073|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
33563201|NCT00911157|101957072|FG000|Overall Study|Need to treat for lung cancer|1|||
33563202|NCT00911157|101957073|FG001|Overall Study|Need to treat for lung cancer|0|||
33563203|NCT03510715|101957074|FG000|Overall Study|Adverse Event|1|||
33563204|NCT03510715|101957075|FG001|Overall Study|Adverse Event|0|||
33563205|NCT02457793|101957076|FG000|Overall Study|Reason not specified|0|||
33563206|NCT02457793|101957077|FG001|Overall Study|Reason not specified|0|||
33563207|NCT02457793|101957078|FG002|Overall Study|Reason not specified|0|||
33563208|NCT02457793|101957079|FG003|Overall Study|Reason not specified|1|||
33563209|NCT02457793|101957080|FG004|Overall Study|Reason not specified|1|||
33563210|NCT02457793|101957081|FG005|Overall Study|Reason not specified|1|||
33563211|NCT02457793|101957076|FG000|Overall Study|Withdrawal by Subject|0|||
33563212|NCT02457793|101957077|FG001|Overall Study|Withdrawal by Subject|4|||
33563213|NCT02457793|101957078|FG002|Overall Study|Withdrawal by Subject|2|||
33563214|NCT02457793|101957079|FG003|Overall Study|Withdrawal by Subject|2|||
33563215|NCT02457793|101957080|FG004|Overall Study|Withdrawal by Subject|2|||
33563216|NCT02457793|101957081|FG005|Overall Study|Withdrawal by Subject|2|||
33627053|NCT01005251|102184475|FG001|Overall Study|Lack of Efficacy|0|||
33415187|NCT02508649|101409970|FG001|Overall Study|Withdrawal by Subject|6|||
33415188|NCT02508649|101409971|FG002|Overall Study|Withdrawal by Subject|5|||
33415189|NCT02508649|101409972|FG003|Overall Study|Withdrawal by Subject|6|||
33415190|NCT02508649|101409969|FG000|Overall Study|Investigator withdrew the subject|1|||
33415191|NCT02508649|101409970|FG001|Overall Study|Investigator withdrew the subject|2|||
33415192|NCT02508649|101409971|FG002|Overall Study|Investigator withdrew the subject|1|||
33415193|NCT02508649|101409972|FG003|Overall Study|Investigator withdrew the subject|0|||
33415194|NCT02508649|101409969|FG000|Overall Study|Post randomization screening failure|12|||
33415195|NCT02508649|101409970|FG001|Overall Study|Post randomization screening failure|4|||
33563217|NCT02457793|101957076|FG000|Overall Study|Adverse Event|0|||
33563218|NCT02457793|101957077|FG001|Overall Study|Adverse Event|0|||
33563219|NCT02457793|101957078|FG002|Overall Study|Adverse Event|0|||
33563220|NCT02457793|101957079|FG003|Overall Study|Adverse Event|1|||
33563221|NCT02457793|101957080|FG004|Overall Study|Adverse Event|0|||
33563222|NCT02457793|101957081|FG005|Overall Study|Adverse Event|0|||
33563223|NCT02457793|101957076|FG000|Overall Study|Physician Decision|1|||
33563224|NCT02457793|101957077|FG001|Overall Study|Physician Decision|0|||
33563225|NCT02457793|101957078|FG002|Overall Study|Physician Decision|1|||
33563226|NCT02457793|101957079|FG003|Overall Study|Physician Decision|1|||
33361633|NCT00984659|101210895|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
33361634|NCT00984659|101210896|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
33361635|NCT00984659|101210897|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
33361636|NCT00984659|101210894|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
33361637|NCT00984659|101210895|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
33361638|NCT00984659|101210896|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
33361639|NCT00984659|101210897|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
33361640|NCT00984659|101210894|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33361641|NCT00984659|101210895|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
33361642|NCT00984659|101210896|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
33361643|NCT00984659|101210897|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
33361644|NCT02873715|101210898|FG000|Overall Study|Lost to Follow-up|84|||
33361645|NCT02873715|101210899|FG001|Overall Study|Lost to Follow-up|94|||
33361646|NCT02873715|101210898|FG000|Overall Study|Withdrawal by Subject|7|||
33361647|NCT02873715|101210899|FG001|Overall Study|Withdrawal by Subject|26|||
33361648|NCT03241173|101210900|FG000|Overall Study|Death|3|||
33361649|NCT03241173|101210901|FG001|Overall Study|Death|2|||
33361650|NCT03241173|101210902|FG002|Overall Study|Death|4|||
33361651|NCT03241173|101210903|FG003|Overall Study|Death|4|||
33361652|NCT03241173|101210904|FG004|Overall Study|Death|2|||
33361653|NCT03241173|101210905|FG005|Overall Study|Death|2|||
33361654|NCT03241173|101210906|FG006|Overall Study|Death|3|||
33361655|NCT03241173|101210907|FG007|Overall Study|Death|1|||
33361656|NCT03241173|101210908|FG008|Overall Study|Death|0|||
33361657|NCT03241173|101210909|FG009|Overall Study|Death|5|||
33361658|NCT03241173|101210910|FG010|Overall Study|Death|4|||
33361659|NCT03241173|101210911|FG011|Overall Study|Death|3|||
33361660|NCT03241173|101210912|FG012|Overall Study|Death|0|||
33361661|NCT03241173|101210913|FG013|Overall Study|Death|0|||
33361662|NCT03241173|101210914|FG014|Overall Study|Death|0|||
33361663|NCT03241173|101210900|FG000|Overall Study|Withdrawal by Subject|0|||
33361664|NCT03241173|101210901|FG001|Overall Study|Withdrawal by Subject|0|||
33361665|NCT03241173|101210902|FG002|Overall Study|Withdrawal by Subject|1|||
33361666|NCT03241173|101210903|FG003|Overall Study|Withdrawal by Subject|0|||
33361667|NCT03241173|101210904|FG004|Overall Study|Withdrawal by Subject|0|||
33361668|NCT03241173|101210905|FG005|Overall Study|Withdrawal by Subject|1|||
33361669|NCT03241173|101210906|FG006|Overall Study|Withdrawal by Subject|0|||
33361670|NCT03241173|101210907|FG007|Overall Study|Withdrawal by Subject|0|||
33361671|NCT03241173|101210908|FG008|Overall Study|Withdrawal by Subject|0|||
33361672|NCT03241173|101210909|FG009|Overall Study|Withdrawal by Subject|0|||
33361673|NCT03241173|101210910|FG010|Overall Study|Withdrawal by Subject|0|||
33361674|NCT03241173|101210911|FG011|Overall Study|Withdrawal by Subject|0|||
33361675|NCT03241173|101210912|FG012|Overall Study|Withdrawal by Subject|0|||
33361676|NCT03241173|101210913|FG013|Overall Study|Withdrawal by Subject|0|||
33361677|NCT03241173|101210914|FG014|Overall Study|Withdrawal by Subject|0|||
33361678|NCT03241173|101210900|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
33361679|NCT03241173|101210901|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
33361680|NCT03241173|101210902|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
33361681|NCT03241173|101210903|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
33361682|NCT03241173|101210904|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
33361683|NCT03241173|101210905|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
33361684|NCT03241173|101210906|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
33361685|NCT03241173|101210907|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
33361686|NCT03241173|101210908|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
33361687|NCT03241173|101210909|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
33361688|NCT03241173|101210910|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
33361689|NCT03241173|101210911|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
33361690|NCT03241173|101210912|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
33361691|NCT03241173|101210913|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
33361692|NCT03241173|101210914|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
33563227|NCT02457793|101957080|FG004|Overall Study|Physician Decision|1|||
33563228|NCT02457793|101957081|FG005|Overall Study|Physician Decision|3|||
33361693|NCT03241173|101210900|FG000|Overall Study|Lost to Follow-up|0|||
33361694|NCT03241173|101210901|FG001|Overall Study|Lost to Follow-up|0|||
33361695|NCT03241173|101210902|FG002|Overall Study|Lost to Follow-up|0|||
33361696|NCT03241173|101210903|FG003|Overall Study|Lost to Follow-up|0|||
33361697|NCT03241173|101210904|FG004|Overall Study|Lost to Follow-up|1|||
33563229|NCT02144337|101957083|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
33361698|NCT03241173|101210905|FG005|Overall Study|Lost to Follow-up|0|||
33361699|NCT03241173|101210906|FG006|Overall Study|Lost to Follow-up|0|||
33361700|NCT03241173|101210907|FG007|Overall Study|Lost to Follow-up|0|||
33361701|NCT03241173|101210908|FG008|Overall Study|Lost to Follow-up|0|||
33361702|NCT03241173|101210909|FG009|Overall Study|Lost to Follow-up|1|||
33361703|NCT03241173|101210910|FG010|Overall Study|Lost to Follow-up|0|||
33361704|NCT03241173|101210911|FG011|Overall Study|Lost to Follow-up|0|||
33361705|NCT03241173|101210912|FG012|Overall Study|Lost to Follow-up|0|||
33361706|NCT03241173|101210913|FG013|Overall Study|Lost to Follow-up|0|||
33361707|NCT03241173|101210914|FG014|Overall Study|Lost to Follow-up|0|||
33361708|NCT02345161|101210915|FG000|Overall Study|Withdrawal by Subject|25|||
33361709|NCT02345161|101210916|FG001|Overall Study|Withdrawal by Subject|33|||
33361710|NCT02345161|101210915|FG000|Overall Study|Adverse Event|16|||
33361711|NCT02345161|101210916|FG001|Overall Study|Adverse Event|19|||
33361712|NCT02345161|101210915|FG000|Overall Study|Physician Decision|4|||
33361713|NCT02345161|101210916|FG001|Overall Study|Physician Decision|4|||
33361714|NCT02345161|101210915|FG000|Overall Study|Lost to Follow-up|0|||
33361715|NCT02345161|101210916|FG001|Overall Study|Lost to Follow-up|1|||
33361716|NCT01334125|101210917|FG000|Overall Study|Lost to Follow-up|3|||
33361717|NCT01334125|101210918|FG001|Overall Study|Lost to Follow-up|3|||
33361718|NCT00312377|101210919|FG000|Overall Study|Death|403|||
33361719|NCT00312377|101210920|FG001|Overall Study|Death|418|||
33361720|NCT00312377|101210919|FG000|Overall Study|Withdrawal by Subject|23|||
33361721|NCT00312377|101210920|FG001|Overall Study|Withdrawal by Subject|30|||
33361722|NCT00312377|101210919|FG000|Overall Study|Lost to Follow-up|9|||
33361723|NCT00312377|101210920|FG001|Overall Study|Lost to Follow-up|12|||
33361724|NCT00312377|101210919|FG000|Overall Study|Non-compliance|0|||
33361725|NCT00312377|101210920|FG001|Overall Study|Non-compliance|2|||
33361726|NCT00312377|101210919|FG000|Overall Study|Randomised but never received treatment|6|||
33361727|NCT00312377|101210920|FG001|Overall Study|Randomised but never received treatment|6|||
33361728|NCT00312377|101210919|FG000|Overall Study|Discontinue treatment survival follow up|202|||
33361729|NCT00312377|101210920|FG001|Overall Study|Discontinue treatment survival follow up|200|||
33361730|NCT00312377|101210919|FG000|Overall Study|Site ended participation in study|1|||
33361731|NCT00312377|101210920|FG001|Overall Study|Site ended participation in study|0|||
33361732|NCT00265941|101210933|FG000|Overall Study|Protocol Violation|22|||
33361733|NCT00265941|101210934|FG001|Overall Study|Protocol Violation|25|||
33361734|NCT00265941|101210933|FG000|Overall Study|Lost to Follow-up|1|||
33361735|NCT00265941|101210934|FG001|Overall Study|Lost to Follow-up|1|||
33361736|NCT02517515|101210939|FG000|Overall Study|Adverse Event|0|||
33361737|NCT02517515|101210940|FG001|Overall Study|Adverse Event|1|||
33361738|NCT02517515|101210939|FG000|Overall Study|Withdrew Consent|0|||
33361739|NCT02517515|101210940|FG001|Overall Study|Withdrew Consent|1|||
33627054|NCT01005251|102184476|FG002|Overall Study|Lack of Efficacy|1|||
33627055|NCT01005251|102184477|FG003|Overall Study|Lack of Efficacy|1|||
33627056|NCT01005251|102184478|FG004|Overall Study|Lack of Efficacy|0|||
33627057|NCT01009060|102184480|FG000|Overall Study|Adverse Event|1|||
33361740|NCT02517515|101210939|FG000|Overall Study|Lost to Follow-up|1|||
33627058|NCT01009060|102184481|FG001|Overall Study|Adverse Event|2|||
33627059|NCT01009060|102184480|FG000|Overall Study|Protocol Violation|0|||
33627060|NCT01009060|102184481|FG001|Overall Study|Protocol Violation|1|||
33361741|NCT02517515|101210940|FG001|Overall Study|Lost to Follow-up|0|||
33361742|NCT02517515|101210939|FG000|Overall Study|Other|1|||
33361743|NCT02517515|101210940|FG001|Overall Study|Other|0|||
33361744|NCT04530825|101210949|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
33361745|NCT04530825|101210950|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
33361746|NCT04530825|101210951|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
33415196|NCT02508649|101409971|FG002|Overall Study|Post randomization screening failure|9|||
33415197|NCT02508649|101409972|FG003|Overall Study|Post randomization screening failure|3|||
33361747|NCT04530825|101210952|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
33627061|NCT01009060|102184480|FG000|Overall Study|Lost to Follow-up|1|||
33627062|NCT01009060|102184481|FG001|Overall Study|Lost to Follow-up|0|||
33361748|NCT04530825|101210949|FG000|Overall Study|Did not complete follow-up|3|||
33627063|NCT01009060|102184480|FG000|Overall Study|Physician Decision|1|||
33361749|NCT04530825|101210950|FG001|Overall Study|Did not complete follow-up|0|||
33361750|NCT04530825|101210951|FG002|Overall Study|Did not complete follow-up|0|||
33361751|NCT04530825|101210952|FG003|Overall Study|Did not complete follow-up|0|||
33361752|NCT01330381|101214228|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
33627064|NCT01009060|102184481|FG001|Overall Study|Physician Decision|1|||
33627065|NCT01009060|102184480|FG000|Overall Study|Withdrawal by Subject|1|||
33361753|NCT01330381|101214229|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
33361754|NCT01330381|101214230|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
33361755|NCT01330381|101214228|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
33361756|NCT01330381|101214229|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
33361757|NCT01330381|101214230|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
33361758|NCT01330381|101214228|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
33361759|NCT01330381|101214229|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
33361760|NCT01330381|101214230|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
33361761|NCT01330381|101214228|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
33361762|NCT01330381|101214229|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
33361763|NCT01330381|101214230|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
33361764|NCT01330381|101214228|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
33361765|NCT01330381|101214229|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
33361766|NCT01330381|101214230|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
33361767|NCT01330381|101214228|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
33361768|NCT01330381|101214229|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
33361769|NCT01330381|101214230|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
33361770|NCT01330381|101214228|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
33361771|NCT01330381|101214229|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
33361772|NCT01330381|101214230|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
33361773|NCT01330381|101214228|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
33361774|NCT01330381|101214229|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
33361775|NCT01330381|101214230|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
33361776|NCT01330381|101214228|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
33361777|NCT01330381|101214229|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
33361778|NCT01330381|101214230|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
33361779|NCT01330381|101214228|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
33361780|NCT01330381|101214229|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
33361781|NCT01330381|101214230|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
33361782|NCT01269125|101214233|FG000|Overall Study|Adverse Event|3|||
33361783|NCT01269125|101214234|FG001|Overall Study|Adverse Event|5|||
33361784|NCT01269125|101214235|FG002|Overall Study|Adverse Event|0|||
33361785|NCT01269125|101214233|FG000|Overall Study|Lost to Follow-up|4|||
33361786|NCT01269125|101214234|FG001|Overall Study|Lost to Follow-up|0|||
33361787|NCT01269125|101214235|FG002|Overall Study|Lost to Follow-up|0|||
33361788|NCT01009463|101214238|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
33361789|NCT01009463|101214239|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33361790|NCT01009463|101214240|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33361791|NCT01009463|101214241|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33361792|NCT01009463|101214242|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
33361793|NCT01009463|101214238|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
33361794|NCT01009463|101214239|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
33361795|NCT01009463|101214240|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
33361796|NCT01009463|101214241|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
33361797|NCT01009463|101214242|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
33361798|NCT01009463|101214238|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
33361799|NCT01009463|101214239|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33361800|NCT01009463|101214240|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33361801|NCT01009463|101214241|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33361802|NCT01009463|101214242|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
33361803|NCT01009463|101214238|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
33361804|NCT01009463|101214239|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
33361805|NCT01009463|101214240|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
33361806|NCT01009463|101214241|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
33361807|NCT01009463|101214242|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
33361808|NCT01009463|101214238|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
33361809|NCT01009463|101214239|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33415198|NCT02508649|101409969|FG000|Overall Study|Lost to Follow-up|1|||
33627066|NCT01009060|102184481|FG001|Overall Study|Withdrawal by Subject|1|||
33627067|NCT02559622|102184500|FG000|Overall Study|Progressive disease|0|||
33627068|NCT02559622|102184501|FG001|Overall Study|Progressive disease|1|||
33627069|NCT02559622|102184502|FG002|Overall Study|Progressive disease|0|||
33361810|NCT01009463|101214240|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33415199|NCT02508649|101409970|FG001|Overall Study|Lost to Follow-up|1|||
33415200|NCT02508649|101409971|FG002|Overall Study|Lost to Follow-up|0|||
33415201|NCT02508649|101409972|FG003|Overall Study|Lost to Follow-up|1|||
33627070|NCT02559622|102184503|FG003|Overall Study|Progressive disease|0|||
33627071|NCT02559622|102184500|FG000|Overall Study|Adverse Event|0|||
33627072|NCT02559622|102184501|FG001|Overall Study|Adverse Event|2|||
33627073|NCT02559622|102184502|FG002|Overall Study|Adverse Event|2|||
33361811|NCT01009463|101214241|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33361812|NCT01009463|101214242|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
33361813|NCT01009463|101214238|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
33361814|NCT01009463|101214239|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
33361815|NCT01009463|101214240|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
33627074|NCT02559622|102184503|FG003|Overall Study|Adverse Event|2|||
33627075|NCT02559622|102184500|FG000|Overall Study|Patient/guardian decision|1|||
33361816|NCT01009463|101214241|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
33361817|NCT01009463|101214242|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
33361818|NCT01009463|101214238|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
33361819|NCT01009463|101214239|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
33361820|NCT01009463|101214240|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
33361821|NCT01009463|101214241|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
33361822|NCT01009463|101214242|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
33361823|NCT01009463|101214238|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
33361824|NCT01009463|101214239|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
33361825|NCT01009463|101214240|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
33361826|NCT01009463|101214241|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
33361827|NCT01009463|101214242|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
33361828|NCT01009463|101214238|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
33415202|NCT00320801|101409973|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
33563230|NCT02144337|101957084|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
33563231|NCT02144337|101957083|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
33563232|NCT02144337|101957084|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
33563233|NCT02144337|101957083|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
33627076|NCT02559622|102184501|FG001|Overall Study|Patient/guardian decision|2|||
33627077|NCT02559622|102184502|FG002|Overall Study|Patient/guardian decision|0|||
33627078|NCT02559622|102184503|FG003|Overall Study|Patient/guardian decision|1|||
33627079|NCT02648204|102184504|FG000|Overall Study|Withdrawal by Subject|12|||
33627080|NCT02648204|102184505|FG001|Overall Study|Withdrawal by Subject|8|||
33627081|NCT02648204|102184506|FG002|Overall Study|Withdrawal by Subject|2|||
33627082|NCT02648204|102184507|FG003|Overall Study|Withdrawal by Subject|6|||
33627083|NCT02648204|102184504|FG000|Overall Study|Lost to Follow-up|5|||
33627084|NCT02648204|102184505|FG001|Overall Study|Lost to Follow-up|8|||
33361829|NCT01009463|101214239|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
33361830|NCT01009463|101214240|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
33415203|NCT00320801|101409974|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
33563234|NCT02144337|101957084|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
33563235|NCT02144337|101957083|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
33563236|NCT02144337|101957084|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
33563237|NCT02144337|101957083|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
33563238|NCT02144337|101957084|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
33563239|NCT02414841|101957085|FG000|Overall Study|Withdrawal by Subject|7|||
33563240|NCT02414841|101957086|FG001|Overall Study|Withdrawal by Subject|5|||
33563241|NCT02414841|101957085|FG000|Overall Study|Lost to Follow-up|13|||
33563242|NCT02414841|101957086|FG001|Overall Study|Lost to Follow-up|6|||
33563243|NCT02414841|101957085|FG000|Overall Study|Death|17|||
33563244|NCT02414841|101957086|FG001|Overall Study|Death|14|||
33563245|NCT02414841|101957085|FG000|Overall Study|Received a Kidney Transplant|13|||
33563246|NCT02414841|101957086|FG001|Overall Study|Received a Kidney Transplant|4|||
33563247|NCT02414841|101957085|FG000|Overall Study|Randomized But Not Treated|6|||
33627085|NCT02648204|102184506|FG002|Overall Study|Lost to Follow-up|4|||
33627086|NCT02648204|102184507|FG003|Overall Study|Lost to Follow-up|6|||
33361831|NCT01009463|101214241|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
33415204|NCT00320801|101409975|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
33563248|NCT02414841|101957086|FG001|Overall Study|Randomized But Not Treated|4|||
33563249|NCT01416831|101959420|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
33627087|NCT02648204|102184504|FG000|Overall Study|Missing follow-up information|4|||
33627088|NCT02648204|102184505|FG001|Overall Study|Missing follow-up information|4|||
33627089|NCT02648204|102184506|FG002|Overall Study|Missing follow-up information|4|||
33361832|NCT01009463|101214242|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
33361833|NCT01009463|101214238|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
33361834|NCT01009463|101214239|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
33361835|NCT01009463|101214240|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
33361836|NCT01009463|101214241|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
33361837|NCT01009463|101214242|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
33361838|NCT01009463|101214238|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
33361839|NCT01009463|101214239|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
33361840|NCT01009463|101214240|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
33361841|NCT01009463|101214241|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
33361842|NCT01009463|101214242|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
33361843|NCT01009463|101214238|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33361844|NCT01009463|101214239|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
33361845|NCT01009463|101214240|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
33361846|NCT01009463|101214241|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
33361847|NCT01009463|101214242|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
33361848|NCT01009463|101214238|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
33361849|NCT01009463|101214239|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
33361850|NCT01009463|101214240|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
33361851|NCT01009463|101214241|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
33361852|NCT01009463|101214242|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
33361853|NCT01618656|101214243|FG000|Overall Study|Withdrawal by Subject|7|||
33361854|NCT01618656|101214244|FG001|Overall Study|Withdrawal by Subject|3|||
33361855|NCT01618656|101214243|FG000|Overall Study|Physician Decision|1|||
33361856|NCT01618656|101214244|FG001|Overall Study|Physician Decision|1|||
33361857|NCT01855789|101214248|FG000|1) Baseline up to Week 24|Adverse Event|37|||
33361858|NCT01855789|101214249|FG001|1) Baseline up to Week 24|Adverse Event|0|||
33361859|NCT01855789|101214250|FG002|1) Baseline up to Week 24|Adverse Event|0|||
33361860|NCT01855789|101214251|FG003|1) Baseline up to Week 24|Adverse Event|0|||
33361861|NCT01855789|101214248|FG000|1) Baseline up to Week 24|Death|2|||
33361862|NCT01855789|101214249|FG001|1) Baseline up to Week 24|Death|0|||
33361863|NCT01855789|101214250|FG002|1) Baseline up to Week 24|Death|0|||
33361864|NCT01855789|101214251|FG003|1) Baseline up to Week 24|Death|0|||
33361865|NCT01855789|101214248|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
33361866|NCT01855789|101214249|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
33361867|NCT01855789|101214250|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
33415205|NCT00320801|101409976|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
33563250|NCT01416831|101959421|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
33563251|NCT00322218|101959423|FG000|Overall Study|Death|3|||
33563252|NCT00322218|101959424|FG001|Overall Study|Death|6|||
33563253|NCT01586910|101959425|FG000|Overall Study|Death|4|||
33563254|NCT01586910|101959426|FG001|Overall Study|Death|4|||
33563255|NCT01586910|101959425|FG000|Overall Study|Withdrawal by Subject|6|||
33563256|NCT01586910|101959426|FG001|Overall Study|Withdrawal by Subject|43|||
33563257|NCT01586910|101959425|FG000|Overall Study|Physician withdrew Subject|5|||
33563258|NCT01586910|101959426|FG001|Overall Study|Physician withdrew Subject|24|||
33563259|NCT04650893|101959427|FG000|Overall Study|Lost to Follow-up|11|||
33563260|NCT04650893|101959428|FG001|Overall Study|Lost to Follow-up|10|||
33563261|NCT04650893|101959429|FG002|Overall Study|Lost to Follow-up|11|||
33563262|NCT03093415|101959430|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
33563263|NCT03093415|101959431|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
33563264|NCT03093415|101959432|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
33563265|NCT03093415|101959430|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
33563266|NCT03093415|101959431|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
33563267|NCT03093415|101959432|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
33563268|NCT03093415|101959430|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
33563269|NCT03093415|101959431|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
33563270|NCT03093415|101959432|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
33563271|NCT03093415|101959430|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
33563272|NCT03093415|101959431|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
33563273|NCT03093415|101959432|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
33361868|NCT01855789|101214251|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
33361869|NCT01855789|101214248|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
33361870|NCT01855789|101214249|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
33563274|NCT03093415|101959430|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
33627090|NCT02648204|102184507|FG003|Overall Study|Missing follow-up information|2|||
33627091|NCT02648204|102184504|FG000|Overall Study|Death|1|||
33627092|NCT02648204|102184505|FG001|Overall Study|Death|1|||
33221580|NCT00437645|100711104|FG001|Overall Study|Administrative problems|1|||
33221581|NCT00437645|100711103|FG000|Overall Study|Lack of Efficacy|2|||
33221582|NCT00437645|100711104|FG001|Overall Study|Lack of Efficacy|1|||
33221583|NCT00437645|100711103|FG000|Overall Study|Condition no longer requires study drug|1|||
33221584|NCT00437645|100711104|FG001|Overall Study|Condition no longer requires study drug|1|||
33221585|NCT00112580|100711109|FG000|Overall Study|Adverse Event|1|||
33221586|NCT00112580|100711110|FG001|Overall Study|Adverse Event|2|||
33221587|NCT00112580|100711109|FG000|Overall Study|Disease progression|5|||
33361871|NCT01855789|101214250|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
33361872|NCT01855789|101214251|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
33361873|NCT01855789|101214248|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
33361874|NCT01855789|101214249|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
33361875|NCT01855789|101214250|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
33361876|NCT01855789|101214251|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
33221588|NCT00112580|100711110|FG001|Overall Study|Disease progression|16|||
33221589|NCT00112580|100711109|FG000|Overall Study|Participant withdrew consent|2|||
33221590|NCT00112580|100711110|FG001|Overall Study|Participant withdrew consent|1|||
33221591|NCT02312856|100711111|FG000|Overall Study|Death|1|||
33361877|NCT01855789|101214248|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
33361878|NCT01855789|101214249|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
33361879|NCT01855789|101214250|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
33415206|NCT00320801|101409973|FG000|Open-label Run-in Period|Adverse Event|33|||
33563275|NCT03093415|101959431|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
33563276|NCT03093415|101959432|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
33563277|NCT03093415|101959430|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
33221592|NCT02312856|100711111|FG000|Overall Study|Lost to Follow-up|3|||
33563278|NCT03093415|101959431|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
33563279|NCT03093415|101959432|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
33563280|NCT03093415|101959430|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
33563281|NCT03093415|101959431|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
33221593|NCT02799784|100711112|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
33221594|NCT02799784|100711113|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
33221595|NCT02799784|100711112|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
33221596|NCT02799784|100711113|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
33221597|NCT02799784|100711112|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
33221598|NCT02799784|100711113|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
33221599|NCT02799784|100711112|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
33221600|NCT02799784|100711113|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
33221601|NCT02799784|100711112|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
33221602|NCT02799784|100711113|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
33221603|NCT02799784|100711112|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
33221604|NCT02799784|100711113|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
33221605|NCT00321048|100711114|FG000|Overall Study|Withdrawal by Subject|6|||
33221606|NCT00321048|100711115|FG001|Overall Study|Withdrawal by Subject|8|||
33221607|NCT01621880|100711116|FG000|Overall Study|Adverse Event|5|||
33221608|NCT01621880|100711117|FG001|Overall Study|Adverse Event|1|||
33563282|NCT03093415|101959432|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
33563283|NCT03093415|101959430|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
33563284|NCT03093415|101959431|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
33563285|NCT03093415|101959432|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
33563286|NCT03093415|101959430|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
33563287|NCT03093415|101959431|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
33627093|NCT02648204|102184506|FG002|Overall Study|Death|2|||
33627094|NCT02648204|102184507|FG003|Overall Study|Death|2|||
33627095|NCT02648204|102184504|FG000|Overall Study|Adverse Event|0|||
33627096|NCT02648204|102184505|FG001|Overall Study|Adverse Event|0|||
33627097|NCT02648204|102184506|FG002|Overall Study|Adverse Event|1|||
33627098|NCT02648204|102184507|FG003|Overall Study|Adverse Event|0|||
33627099|NCT05135871|102184508|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
33221609|NCT01621880|100711116|FG000|Overall Study|Withdrawal by Subject|5|||
33627100|NCT05135871|102184509|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
33221610|NCT01621880|100711117|FG001|Overall Study|Withdrawal by Subject|4|||
33221611|NCT00652938|100711120|FG000|Overall Study|Adverse Event|1|||
33415207|NCT00320801|101409974|FG001|Open-label Run-in Period|Adverse Event|0|||
33415208|NCT00320801|101409975|FG002|Open-label Run-in Period|Adverse Event|0|||
33361880|NCT01855789|101214251|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
33361881|NCT01855789|101214248|FG000|1) Baseline up to Week 24|Physician Decision|4|||
33361882|NCT01855789|101214249|FG001|1) Baseline up to Week 24|Physician Decision|0|||
33361883|NCT01855789|101214250|FG002|1) Baseline up to Week 24|Physician Decision|0|||
33361884|NCT01855789|101214251|FG003|1) Baseline up to Week 24|Physician Decision|0|||
33361885|NCT01855789|101214248|FG000|1) Baseline up to Week 24|Pregnancy|1|||
33361886|NCT01855789|101214249|FG001|1) Baseline up to Week 24|Pregnancy|0|||
33361887|NCT01855789|101214250|FG002|1) Baseline up to Week 24|Pregnancy|0|||
33415209|NCT00320801|101409976|FG003|Open-label Run-in Period|Adverse Event|0|||
33415210|NCT00320801|101409973|FG000|Open-label Run-in Period|Administrative|10|||
33415211|NCT00320801|101409974|FG001|Open-label Run-in Period|Administrative|0|||
33415212|NCT00320801|101409975|FG002|Open-label Run-in Period|Administrative|0|||
33415213|NCT00320801|101409976|FG003|Open-label Run-in Period|Administrative|0|||
33415214|NCT00320801|101409973|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
33415215|NCT00320801|101409974|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
33415216|NCT00320801|101409975|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
33415217|NCT00320801|101409976|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
33415218|NCT00320801|101409973|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
33415219|NCT00320801|101409974|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
33415220|NCT00320801|101409975|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
33415221|NCT00320801|101409976|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
33415222|NCT00320801|101409973|FG000|Open-label Run-in Period|Did not qualify|1|||
33415223|NCT00320801|101409974|FG001|Open-label Run-in Period|Did not qualify|0|||
33221612|NCT00652938|100711121|FG001|Overall Study|Adverse Event|0|||
33221613|NCT00652938|100711122|FG002|Overall Study|Adverse Event|2|||
33221614|NCT00652938|100711120|FG000|Overall Study|Withdrawal by Subject|0|||
33221615|NCT00652938|100711121|FG001|Overall Study|Withdrawal by Subject|6|||
33415224|NCT00320801|101409975|FG002|Open-label Run-in Period|Did not qualify|0|||
33415225|NCT00320801|101409976|FG003|Open-label Run-in Period|Did not qualify|0|||
33415226|NCT00320801|101409973|FG000|Double-blind Phase|Withdrawal by Subject|0|||
33563288|NCT03093415|101959432|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
33221616|NCT00652938|100711122|FG002|Overall Study|Withdrawal by Subject|1|||
33361888|NCT01855789|101214251|FG003|1) Baseline up to Week 24|Pregnancy|0|||
33361889|NCT01855789|101214248|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
33415227|NCT00320801|101409974|FG001|Double-blind Phase|Withdrawal by Subject|0|||
33563289|NCT03093415|101959430|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
33221617|NCT00652938|100711120|FG000|Overall Study|Lost to Follow-up|0|||
33415228|NCT00320801|101409975|FG002|Double-blind Phase|Withdrawal by Subject|1|||
33221618|NCT00652938|100711121|FG001|Overall Study|Lost to Follow-up|0|||
33221619|NCT00652938|100711122|FG002|Overall Study|Lost to Follow-up|2|||
33221620|NCT00652938|100711120|FG000|Overall Study|fear of blood sampling|0|||
33221621|NCT00652938|100711121|FG001|Overall Study|fear of blood sampling|1|||
33221622|NCT00652938|100711122|FG002|Overall Study|fear of blood sampling|0|||
33221623|NCT02487472|100711123|FG000|Overall Study|Did not complete telephonic interviews|9|||
33221624|NCT02487472|100711123|FG000|Overall Study|Other|2|||
33221625|NCT03928028|100711124|FG000|Overall Study|Physician Decision|9|||
33221626|NCT03928028|100711125|FG001|Overall Study|Physician Decision|6|||
33221627|NCT03928028|100711126|FG002|Overall Study|Physician Decision|3|||
33221628|NCT03928028|100711124|FG000|Overall Study|Withdrawal by Subject|12|||
33221629|NCT03928028|100711125|FG001|Overall Study|Withdrawal by Subject|3|||
33221630|NCT03928028|100711126|FG002|Overall Study|Withdrawal by Subject|3|||
33221631|NCT01224925|100711127|FG000|Overall Study|Lost to Follow-up|3|||
33221632|NCT01224925|100711128|FG001|Overall Study|Lost to Follow-up|2|||
33221633|NCT02404389|100711129|FG000|Overall Study|Adverse Event|1|||
33221634|NCT02404389|100711130|FG001|Overall Study|Adverse Event|0|||
33221635|NCT02404389|100711131|FG002|Overall Study|Adverse Event|1|||
33221636|NCT02404389|100711132|FG003|Overall Study|Adverse Event|0|||
33221637|NCT02404389|100711133|FG004|Overall Study|Adverse Event|2|||
33221638|NCT02404389|100711129|FG000|Overall Study|Subject/guardian decision|1|||
33221639|NCT02404389|100711130|FG001|Overall Study|Subject/guardian decision|0|||
33221640|NCT02404389|100711131|FG002|Overall Study|Subject/guardian decision|0|||
33221641|NCT02404389|100711132|FG003|Overall Study|Subject/guardian decision|1|||
33221642|NCT02404389|100711133|FG004|Overall Study|Subject/guardian decision|1|||
33221643|NCT01330316|100711134|FG000|Overall Study|Adverse Event|2|||
33221644|NCT01330316|100711135|FG001|Overall Study|Adverse Event|2|||
33221645|NCT01330316|100711134|FG000|Overall Study|Lack of Efficacy|0|||
33221646|NCT01330316|100711135|FG001|Overall Study|Lack of Efficacy|10|||
33221647|NCT01330316|100711134|FG000|Overall Study|Lost to Follow-up|0|||
33221648|NCT01330316|100711135|FG001|Overall Study|Lost to Follow-up|1|||
33563290|NCT03093415|101959431|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
33563291|NCT03093415|101959432|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
33221649|NCT01330316|100711134|FG000|Overall Study|Withdrawal by Subject|0|||
33221650|NCT01330316|100711135|FG001|Overall Study|Withdrawal by Subject|1|||
33221651|NCT01330316|100711134|FG000|Overall Study|other than above|0|||
33361890|NCT01855789|101214249|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
33361891|NCT01855789|101214250|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
33361892|NCT01855789|101214251|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
33563292|NCT03093415|101959430|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
33563293|NCT03093415|101959431|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
33221652|NCT01330316|100711135|FG001|Overall Study|other than above|1|||
33221653|NCT02127372|100711137|FG000|Overall Study|Withdrawal by Subject|1|||
33361893|NCT01855789|101214248|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
33361894|NCT01855789|101214249|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
33361895|NCT01855789|101214250|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
33361896|NCT01855789|101214251|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
33563294|NCT03093415|101959432|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
33563295|NCT02302222|101959433|FG000|Overall Study|Physician Decision|0|||
33221654|NCT02127372|100711138|FG001|Overall Study|Withdrawal by Subject|0|||
33221655|NCT01435655|100711139|FG000|Overall Study|Death|2|||
33221656|NCT01435655|100711139|FG000|Overall Study|Other|1|||
33221657|NCT01368900|100711146|FG000|Overall Study|Lost to Follow-up|7|||
33221658|NCT01538472|100711151|FG000|Overall Study|Disease Progression|3|||
33221659|NCT01538472|100711151|FG000|Overall Study|Death|1|||
33221660|NCT00570674|100711162|FG000|Overall Study|Withdrawal by Subject|0|||
33221661|NCT00570674|100711163|FG001|Overall Study|Withdrawal by Subject|0|||
33221662|NCT00570674|100711164|FG002|Overall Study|Withdrawal by Subject|1|||
33221663|NCT00570674|100711165|FG003|Overall Study|Withdrawal by Subject|0|||
33563296|NCT02302222|101959434|FG001|Overall Study|Physician Decision|4|||
33221664|NCT00570674|100711166|FG004|Overall Study|Withdrawal by Subject|0|||
33221665|NCT00570674|100711167|FG005|Overall Study|Withdrawal by Subject|0|||
33221666|NCT00570674|100711168|FG006|Overall Study|Withdrawal by Subject|0|||
33221667|NCT00946296|100711169|FG000|Overall Study|Physician Decision|3|||
33221668|NCT00946296|100711170|FG001|Overall Study|Physician Decision|0|||
33221669|NCT02634788|100711171|FG000|Overall Study|Adverse Event|0|||
33221670|NCT02634788|100711172|FG001|Overall Study|Adverse Event|8|||
33221671|NCT02634788|100711173|FG002|Overall Study|Adverse Event|3|||
33221672|NCT02634788|100711174|FG003|Overall Study|Adverse Event|1|||
33221673|NCT02634788|100711171|FG000|Overall Study|Lack of Efficacy|4|||
33221674|NCT02634788|100711172|FG001|Overall Study|Lack of Efficacy|0|||
33221675|NCT02634788|100711173|FG002|Overall Study|Lack of Efficacy|1|||
33221676|NCT02634788|100711174|FG003|Overall Study|Lack of Efficacy|4|||
33221677|NCT02634788|100711171|FG000|Overall Study|Lost to Follow-up|0|||
33221678|NCT02634788|100711172|FG001|Overall Study|Lost to Follow-up|1|||
33221679|NCT02634788|100711173|FG002|Overall Study|Lost to Follow-up|0|||
33221680|NCT02634788|100711174|FG003|Overall Study|Lost to Follow-up|0|||
33221681|NCT02634788|100711171|FG000|Overall Study|Withdrawal by Subject|0|||
33221682|NCT02634788|100711172|FG001|Overall Study|Withdrawal by Subject|1|||
33221683|NCT02634788|100711173|FG002|Overall Study|Withdrawal by Subject|1|||
33221684|NCT02634788|100711174|FG003|Overall Study|Withdrawal by Subject|0|||
33221685|NCT02228395|100711175|FG000|First Intervention Period|No longer willing to participate|1|||
33221686|NCT02228395|100711176|FG001|First Intervention Period|No longer willing to participate|0|||
33221687|NCT02228395|100711177|FG002|First Intervention Period|No longer willing to participate|0|||
33221688|NCT02228395|100711175|FG000|First Intervention Period|Unable to comply with study dates|0|||
33221689|NCT02228395|100711176|FG001|First Intervention Period|Unable to comply with study dates|1|||
33221690|NCT02228395|100711177|FG002|First Intervention Period|Unable to comply with study dates|1|||
33221691|NCT01337674|100711178|FG000|Treatment Period 1|Adverse Event|0|||
33221692|NCT01337674|100711179|FG001|Treatment Period 1|Adverse Event|1|||
33221693|NCT01337674|100711180|FG002|Treatment Period 1|Adverse Event|0|||
33221694|NCT01337674|100711181|FG003|Treatment Period 1|Adverse Event|0|||
33221695|NCT01337674|100711178|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
33221696|NCT01337674|100711179|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
33221697|NCT01337674|100711180|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
33221698|NCT01337674|100711181|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
33221699|NCT01337674|100711178|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33221700|NCT01337674|100711179|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33221701|NCT01337674|100711180|FG002|Treatment Period 2|Withdrawal by Subject|1|||
33221702|NCT01337674|100711181|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33221703|NCT02978443|100711182|FG000|Overall Study|Withdrawal by Subject|1|||
33221704|NCT02978443|100711182|FG000|Overall Study|Adverse Event|3|||
33221705|NCT02978443|100711182|FG000|Overall Study|Disease Progression on study|6|||
33221706|NCT02978443|100711182|FG000|Overall Study|Death|1|||
33221707|NCT02978443|100711182|FG000|Overall Study|Physician Decision|1|||
33221708|NCT02978443|100711182|FG000|Overall Study|Switch to alternative therapy|1|||
33221709|NCT02978443|100711182|FG000|Overall Study|Refused further treatment|1|||
33221710|NCT00499863|100711185|FG000|Overall Study|Lack of Efficacy|21|||
33221711|NCT00499863|100711186|FG001|Overall Study|Lack of Efficacy|27|||
33221712|NCT00499863|100711185|FG000|Overall Study|Protocol Violation|12|||
33221713|NCT00499863|100711186|FG001|Overall Study|Protocol Violation|7|||
33221714|NCT00499863|100711185|FG000|Overall Study|Withdrawal by Subject|6|||
33221715|NCT00499863|100711186|FG001|Overall Study|Withdrawal by Subject|4|||
33221716|NCT00499863|100711185|FG000|Overall Study|Adverse Event|8|||
33221717|NCT00499863|100711186|FG001|Overall Study|Adverse Event|2|||
33221718|NCT00499863|100711185|FG000|Overall Study|Sponsor decision|2|||
33221719|NCT00499863|100711186|FG001|Overall Study|Sponsor decision|2|||
33221720|NCT00499863|100711185|FG000|Overall Study|Lost to Follow-up|1|||
33221721|NCT00499863|100711186|FG001|Overall Study|Lost to Follow-up|1|||
33221722|NCT02472652|100711187|FG000|Overall Study|Lost to Follow-up|1|||
33221723|NCT02073097|100711188|FG000|Overall Study|Adverse Event|0|||
33563297|NCT02302222|101959433|FG000|Overall Study|Lost to Follow-up|1|||
33563298|NCT02302222|101959434|FG001|Overall Study|Lost to Follow-up|0|||
33221724|NCT02073097|100711189|FG001|Overall Study|Adverse Event|0|||
33221725|NCT02073097|100711190|FG002|Overall Study|Adverse Event|0|||
33221726|NCT02073097|100711191|FG003|Overall Study|Adverse Event|0|||
33221727|NCT02073097|100711192|FG004|Overall Study|Adverse Event|0|||
33221728|NCT02073097|100711193|FG005|Overall Study|Adverse Event|0|||
33221729|NCT02073097|100711194|FG006|Overall Study|Adverse Event|0|||
33221730|NCT02073097|100711195|FG007|Overall Study|Adverse Event|2|||
33221731|NCT02073097|100711188|FG000|Overall Study|Withdrawal by Subject|0|||
33221732|NCT02073097|100711189|FG001|Overall Study|Withdrawal by Subject|0|||
33221733|NCT02073097|100711190|FG002|Overall Study|Withdrawal by Subject|0|||
33221734|NCT02073097|100711191|FG003|Overall Study|Withdrawal by Subject|0|||
33221735|NCT02073097|100711192|FG004|Overall Study|Withdrawal by Subject|0|||
33221736|NCT02073097|100711193|FG005|Overall Study|Withdrawal by Subject|0|||
33221737|NCT02073097|100711194|FG006|Overall Study|Withdrawal by Subject|0|||
33221738|NCT02073097|100711195|FG007|Overall Study|Withdrawal by Subject|2|||
33221739|NCT02073097|100711188|FG000|Overall Study|Death|0|||
33221740|NCT02073097|100711189|FG001|Overall Study|Death|0|||
33221741|NCT02073097|100711190|FG002|Overall Study|Death|0|||
33221742|NCT02073097|100711191|FG003|Overall Study|Death|0|||
33221743|NCT02073097|100711192|FG004|Overall Study|Death|0|||
33221744|NCT02073097|100711193|FG005|Overall Study|Death|0|||
33221745|NCT02073097|100711194|FG006|Overall Study|Death|0|||
33221746|NCT02073097|100711195|FG007|Overall Study|Death|1|||
33221747|NCT02073097|100711188|FG000|Overall Study|Physician Decision|0|||
33221748|NCT02073097|100711189|FG001|Overall Study|Physician Decision|0|||
33221749|NCT02073097|100711190|FG002|Overall Study|Physician Decision|0|||
33221750|NCT02073097|100711191|FG003|Overall Study|Physician Decision|0|||
33221751|NCT02073097|100711192|FG004|Overall Study|Physician Decision|0|||
33221752|NCT02073097|100711193|FG005|Overall Study|Physician Decision|0|||
33221753|NCT02073097|100711194|FG006|Overall Study|Physician Decision|0|||
33221754|NCT02073097|100711195|FG007|Overall Study|Physician Decision|1|||
33221755|NCT01778556|100711196|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
33221756|NCT01778556|100711197|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
33221757|NCT01778556|100711196|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
33221758|NCT01778556|100711197|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
33221759|NCT01778556|100711196|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
33221760|NCT01778556|100711197|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
33221761|NCT01778556|100711196|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
33221762|NCT01778556|100711197|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
33221763|NCT02417064|100711206|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
33221764|NCT02417064|100711207|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
33221765|NCT02417064|100711208|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
33221766|NCT02417064|100711206|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
33221767|NCT02417064|100711207|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
33221768|NCT02417064|100711208|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
33221769|NCT02417064|100711206|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
33221770|NCT02417064|100711207|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
33221771|NCT02417064|100711208|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
33221772|NCT02417064|100711206|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
33221773|NCT02417064|100711207|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
33221774|NCT02417064|100711208|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
33221775|NCT02417064|100711206|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
33361897|NCT01855789|101214248|FG000|1) Baseline up to Week 24|Other|4|||
33361898|NCT01855789|101214249|FG001|1) Baseline up to Week 24|Other|0|||
33361899|NCT01855789|101214250|FG002|1) Baseline up to Week 24|Other|0|||
33361900|NCT01855789|101214251|FG003|1) Baseline up to Week 24|Other|0|||
33361901|NCT01855789|101214248|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
33361902|NCT01855789|101214249|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
33361903|NCT01855789|101214250|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
33361904|NCT01855789|101214251|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
33361905|NCT01855789|101214248|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
33361906|NCT01855789|101214249|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
33361907|NCT01855789|101214250|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
33361908|NCT01855789|101214251|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
33361909|NCT01855789|101214248|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
33361910|NCT01855789|101214249|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
33361911|NCT01855789|101214250|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
33361912|NCT01855789|101214251|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
33361913|NCT01855789|101214248|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
33361914|NCT01855789|101214249|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
33361915|NCT01855789|101214250|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
33361916|NCT01855789|101214251|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
33361917|NCT01855789|101214248|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
33221776|NCT02417064|100711207|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
33221777|NCT02417064|100711208|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
33221778|NCT02417064|100711206|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
33221779|NCT02417064|100711207|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
33221780|NCT02417064|100711208|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
33415229|NCT00320801|101409976|FG003|Double-blind Phase|Withdrawal by Subject|0|||
33415230|NCT00320801|101409973|FG000|Double-blind Phase|Adverse Event|0|||
33415231|NCT00320801|101409974|FG001|Double-blind Phase|Adverse Event|2|||
33415232|NCT00320801|101409975|FG002|Double-blind Phase|Adverse Event|8|||
33415233|NCT00320801|101409976|FG003|Double-blind Phase|Adverse Event|0|||
33415234|NCT00320801|101409973|FG000|Double-blind Phase|Administrative|0|||
33415235|NCT00320801|101409974|FG001|Double-blind Phase|Administrative|0|||
33415236|NCT00320801|101409975|FG002|Double-blind Phase|Administrative|4|||
33415237|NCT00320801|101409976|FG003|Double-blind Phase|Administrative|0|||
33415238|NCT00320801|101409973|FG000|Double-blind Phase|Lack of Efficacy|0|||
33415239|NCT00320801|101409974|FG001|Double-blind Phase|Lack of Efficacy|9|||
33415240|NCT00320801|101409975|FG002|Double-blind Phase|Lack of Efficacy|1|||
33415241|NCT00320801|101409976|FG003|Double-blind Phase|Lack of Efficacy|0|||
33415242|NCT00320801|101409973|FG000|Extension Phase|Withdrawal by Subject|0|||
33415243|NCT00320801|101409974|FG001|Extension Phase|Withdrawal by Subject|0|||
33415244|NCT00320801|101409975|FG002|Extension Phase|Withdrawal by Subject|0|||
33415245|NCT00320801|101409976|FG003|Extension Phase|Withdrawal by Subject|6|||
33415246|NCT00320801|101409973|FG000|Extension Phase|Adverse Event|0|||
33415247|NCT00320801|101409974|FG001|Extension Phase|Adverse Event|0|||
33415248|NCT00320801|101409975|FG002|Extension Phase|Adverse Event|0|||
33415249|NCT00320801|101409976|FG003|Extension Phase|Adverse Event|8|||
33415250|NCT00320801|101409973|FG000|Extension Phase|Administrative|0|||
33415251|NCT00320801|101409974|FG001|Extension Phase|Administrative|0|||
33415252|NCT00320801|101409975|FG002|Extension Phase|Administrative|0|||
33415253|NCT00320801|101409976|FG003|Extension Phase|Administrative|29|||
33415254|NCT00320801|101409973|FG000|Extension Phase|Lack of Efficacy|0|||
33415255|NCT00320801|101409974|FG001|Extension Phase|Lack of Efficacy|0|||
33415256|NCT00320801|101409975|FG002|Extension Phase|Lack of Efficacy|0|||
33415257|NCT00320801|101409976|FG003|Extension Phase|Lack of Efficacy|2|||
33415258|NCT00320801|101409973|FG000|Extension Phase|Lost to Follow-up|0|||
33415259|NCT00320801|101409974|FG001|Extension Phase|Lost to Follow-up|0|||
33415260|NCT00320801|101409975|FG002|Extension Phase|Lost to Follow-up|0|||
33415261|NCT00320801|101409976|FG003|Extension Phase|Lost to Follow-up|3|||
33415262|NCT00563706|101409977|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
33415263|NCT00563706|101409978|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
33415264|NCT00563706|101409979|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
33415265|NCT00563706|101409980|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
33415266|NCT00563706|101409981|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
33563299|NCT02302222|101959433|FG000|Overall Study|Treatment discontinued before day 5|0|||
33627101|NCT05135871|102184510|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
33627102|NCT05135871|102184511|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
33627103|NCT00001959|102184512|FG000|Overall Study|newly diagnosed colon cancer|1|||
33627104|NCT00001959|102184512|FG000|Overall Study|disabling sedation|1|||
33627105|NCT00001959|102184512|FG000|Overall Study|non-compliance|1|||
33627106|NCT00231777|102184515|FG000|Overall Study|Lost to Follow-up|3|||
33627107|NCT00231777|102184516|FG001|Overall Study|Lost to Follow-up|0|||
33627108|NCT00231777|102184515|FG000|Overall Study|Other|3|||
33627109|NCT00231777|102184516|FG001|Overall Study|Other|2|||
33627110|NCT02240485|102184517|FG000|3 Months Post-admission|Lost to Follow-up|1|||
33627111|NCT02240485|102184518|FG001|3 Months Post-admission|Lost to Follow-up|5|||
33627112|NCT02240485|102184517|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
33627113|NCT02240485|102184518|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
33627114|NCT02240485|102184517|FG000|9 Months Post-admission|Lost to Follow-up|3|||
33627115|NCT02240485|102184518|FG001|9 Months Post-admission|Lost to Follow-up|1|||
33627116|NCT02240485|102184517|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
33627117|NCT02240485|102184518|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
33627118|NCT02240485|102184517|FG000|18 Months Post-admission|Lost to Follow-up|1|||
33627119|NCT02240485|102184518|FG001|18 Months Post-admission|Lost to Follow-up|1|||
33627120|NCT02240485|102184517|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
33627121|NCT02240485|102184518|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
33627122|NCT00112736|102184519|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
33627123|NCT00112736|102184520|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
33627124|NCT03557970|102184524|FG000|Overall Study|Study closure|1|||
33627125|NCT03557970|102184525|FG001|Overall Study|Study closure|0|||
33415267|NCT00563706|101409982|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
33563300|NCT02302222|101959434|FG001|Overall Study|Treatment discontinued before day 5|1|||
33563301|NCT02302222|101959433|FG000|Overall Study|Withdrawn prior to any treatment|0|||
33563302|NCT02302222|101959434|FG001|Overall Study|Withdrawn prior to any treatment|1|||
33563303|NCT05543174|101959435|FG000|Overall Study|Ongoing|7|||
33563304|NCT03412591|101959436|FG000|Overall Study|Withdrawal by Subject|1|||
33563305|NCT03412591|101959437|FG001|Overall Study|Withdrawal by Subject|8|||
33563306|NCT03412591|101959436|FG000|Overall Study|Adverse Event|0|||
33563307|NCT03412591|101959437|FG001|Overall Study|Adverse Event|1|||
33627126|NCT03557970|102184524|FG000|Overall Study|Physician Decision|0|||
33415268|NCT00563706|101409983|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
33627127|NCT03557970|102184525|FG001|Overall Study|Physician Decision|1|||
33415269|NCT00563706|101409984|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
33627128|NCT03557970|102184524|FG000|Overall Study|Death|0|||
33627129|NCT03557970|102184525|FG001|Overall Study|Death|1|||
33627130|NCT03212326|102184532|FG000|Overall Study|Physician Decision|4|||
33627131|NCT04247347|102184533|FG000|Overall Study|Withdrawal by Subject|2|||
33627132|NCT04247347|102184534|FG001|Overall Study|Withdrawal by Subject|3|||
33627133|NCT04247347|102184535|FG002|Overall Study|Withdrawal by Subject|3|||
33627134|NCT04247347|102184533|FG000|Overall Study|Lost to Follow-up|1|||
33627135|NCT04247347|102184534|FG001|Overall Study|Lost to Follow-up|1|||
33627136|NCT04247347|102184535|FG002|Overall Study|Lost to Follow-up|1|||
33627137|NCT01576341|102184536|FG000|Overall Study|Withdrawal by Subject|24|||
33627138|NCT01576341|102184536|FG000|Overall Study|Adverse Event|10|||
33361918|NCT01855789|101214249|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
33361919|NCT01855789|101214250|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
33361920|NCT01855789|101214251|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
33361921|NCT01855789|101214248|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
33361922|NCT01855789|101214249|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
33361923|NCT01855789|101214250|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
33361924|NCT01855789|101214251|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
33361925|NCT01855789|101214248|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
33361926|NCT01855789|101214249|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
33361927|NCT01855789|101214250|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
33361928|NCT01855789|101214251|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
33361929|NCT01855789|101214248|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
33361930|NCT01855789|101214249|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
33361931|NCT01855789|101214250|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
33361932|NCT01855789|101214251|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
33361933|NCT01855789|101214248|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
33361934|NCT01855789|101214249|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
33361935|NCT01855789|101214250|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
33361936|NCT01855789|101214251|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
33361937|NCT01855789|101214248|FG000|2) Week 24 up to End of Study|Other|0|||
33361938|NCT01855789|101214249|FG001|2) Week 24 up to End of Study|Other|0|||
33361939|NCT01855789|101214250|FG002|2) Week 24 up to End of Study|Other|0|||
33361940|NCT01855789|101214251|FG003|2) Week 24 up to End of Study|Other|1|||
33361941|NCT00955110|101214254|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
33361942|NCT00955110|101214254|FG000|Treatment Phase|Adverse Event|2|||
33361943|NCT00955110|101214254|FG000|Treatment Phase|Administrative reasons|2|||
33627139|NCT01576341|102184536|FG000|Overall Study|Death|21|||
33627140|NCT01576341|102184536|FG000|Overall Study|Physician Decision|2|||
33361944|NCT00955110|101214254|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
33361945|NCT00955110|101214254|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
33361946|NCT04799782|101214255|FG000|Washout|Physician Decision|2|||
33627141|NCT01576341|102184536|FG000|Overall Study|Lost to Follow-up|2|||
33361947|NCT04799782|101214256|FG001|Washout|Physician Decision|0|||
33361948|NCT04799782|101214255|FG000|Washout|Withdrawal by Subject|0|||
33361949|NCT04799782|101214256|FG001|Washout|Withdrawal by Subject|2|||
33627142|NCT01576341|102184536|FG000|Overall Study|Kidney transplantation|10|||
33627143|NCT01576341|102184536|FG000|Overall Study|Protocol Violation|12|||
33627144|NCT01576341|102184536|FG000|Overall Study|Other|12|||
33627145|NCT01519323|102184537|FG000|Overall Study|Death|3|||
33627146|NCT01519323|102184538|FG001|Overall Study|Death|2|||
33627147|NCT01519323|102184537|FG000|Overall Study|Study terminated by sponsor|0|||
33627148|NCT01519323|102184538|FG001|Overall Study|Study terminated by sponsor|1|||
33627149|NCT04801420|102184548|FG000|Overall Study|Other|1|||
33627150|NCT04801420|102184549|FG001|Overall Study|Other|2|||
33627151|NCT04801420|102184550|FG002|Overall Study|Other|1|||
33627152|NCT04801420|102184548|FG000|Overall Study|Lost to Follow-up|7|||
33627153|NCT04801420|102184549|FG001|Overall Study|Lost to Follow-up|9|||
33627154|NCT04801420|102184550|FG002|Overall Study|Lost to Follow-up|10|||
33627155|NCT04801420|102184548|FG000|Overall Study|Moved from study area|0|||
33627156|NCT04801420|102184549|FG001|Overall Study|Moved from study area|1|||
33627157|NCT04801420|102184550|FG002|Overall Study|Moved from study area|1|||
33627158|NCT04801420|102184548|FG000|Overall Study|Withdrawal by Subject|5|||
33627159|NCT04801420|102184549|FG001|Overall Study|Withdrawal by Subject|1|||
33627160|NCT04801420|102184550|FG002|Overall Study|Withdrawal by Subject|4|||
33627161|NCT04801420|102184548|FG000|Overall Study|Individual stopping criteria reached|0|||
33627162|NCT04801420|102184549|FG001|Overall Study|Individual stopping criteria reached|1|||
33627163|NCT04801420|102184550|FG002|Overall Study|Individual stopping criteria reached|0|||
33627164|NCT04801420|102184548|FG000|Overall Study|Ongoing in the study|195|||
33627165|NCT04801420|102184549|FG001|Overall Study|Ongoing in the study|195|||
33627166|NCT04801420|102184550|FG002|Overall Study|Ongoing in the study|192|||
33361950|NCT04799782|101214255|FG000|Washout|Lost to Follow-up|0|||
33361951|NCT04799782|101214256|FG001|Washout|Lost to Follow-up|1|||
33361952|NCT00425438|101214257|FG000|Overall Study|Termination by Sponsor|25|||
33361953|NCT00425438|101214258|FG001|Overall Study|Termination by Sponsor|27|||
33627167|NCT03617172|102184551|FG000|Overall Study|Lost to Follow-up|1|||
33627168|NCT03617172|102184552|FG001|Overall Study|Lost to Follow-up|0|||
33627169|NCT00388349|102184557|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
33627170|NCT00388349|102184558|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
33627171|NCT01535040|102184561|FG000|Overall Study|Physician Decision|0|||
33627172|NCT01535040|102184562|FG001|Overall Study|Physician Decision|1|||
33627173|NCT01535040|102184561|FG000|Overall Study|Withdrawal by Subject|13|||
33627174|NCT01535040|102184562|FG001|Overall Study|Withdrawal by Subject|10|||
33627175|NCT01535040|102184561|FG000|Overall Study|Never Started|9|||
33627176|NCT01535040|102184562|FG001|Overall Study|Never Started|4|||
33627177|NCT01535040|102184561|FG000|Overall Study|Toxicity|7|||
33627178|NCT01535040|102184562|FG001|Overall Study|Toxicity|5|||
33627179|NCT01535040|102184561|FG000|Overall Study|Multiple Reasons|1|||
33627180|NCT01535040|102184562|FG001|Overall Study|Multiple Reasons|1|||
33627181|NCT02336282|102184563|FG000|Overall Study|Unrelated illness|1|||
33627182|NCT02336282|102184563|FG000|Overall Study|Uncomfortable with technology|1|||
33627183|NCT02336282|102184563|FG000|Overall Study|Lost to Follow-up|1|||
33627184|NCT02336282|102184563|FG000|Overall Study|Not enough time to complete sessions|2|||
33361954|NCT03494725|101214260|FG000|Overall Study|Withdrawal by Subject|0|||
33361955|NCT03494725|101214261|FG001|Overall Study|Withdrawal by Subject|2|||
33415270|NCT00563706|101409985|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
33361956|NCT03494725|101214260|FG000|Overall Study|Antibiotic use|1|||
33627185|NCT01743469|102184566|FG000|Active Treatment Phase|Adverse Event|10|||
33627186|NCT01743469|102184567|FG001|Active Treatment Phase|Adverse Event|5|||
33627187|NCT01743469|102184568|FG002|Active Treatment Phase|Adverse Event|8|||
33627188|NCT01743469|102184569|FG003|Active Treatment Phase|Adverse Event|1|||
33627189|NCT01743469|102184566|FG000|Active Treatment Phase|Disease Progression|40|||
33627190|NCT01743469|102184567|FG001|Active Treatment Phase|Disease Progression|47|||
33627191|NCT01743469|102184568|FG002|Active Treatment Phase|Disease Progression|30|||
33627192|NCT01743469|102184569|FG003|Active Treatment Phase|Disease Progression|20|||
33627193|NCT01743469|102184566|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
33627194|NCT01743469|102184567|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
33627195|NCT01743469|102184568|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
33627196|NCT01743469|102184569|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
33627197|NCT01743469|102184566|FG000|Active Treatment Phase|Missing|1|||
33627198|NCT01743469|102184567|FG001|Active Treatment Phase|Missing|0|||
33627199|NCT01743469|102184568|FG002|Active Treatment Phase|Missing|0|||
33627200|NCT01743469|102184569|FG003|Active Treatment Phase|Missing|0|||
33627201|NCT01743469|102184566|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
33627202|NCT01743469|102184567|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
33627203|NCT01743469|102184568|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
33627204|NCT01743469|102184569|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
33627205|NCT01743469|102184566|FG000|Follow-up Period - Post-Treatment|Death|43|||
33627206|NCT01743469|102184567|FG001|Follow-up Period - Post-Treatment|Death|47|||
33627207|NCT01743469|102184568|FG002|Follow-up Period - Post-Treatment|Death|22|||
33627208|NCT01743469|102184569|FG003|Follow-up Period - Post-Treatment|Death|16|||
33627209|NCT01743469|102184566|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
33627210|NCT01743469|102184567|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
33627211|NCT01743469|102184568|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
33627212|NCT01743469|102184569|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
33627213|NCT00189540|102184570|FG000|Overall Study|Withdrawal by Subject|3|||
33627214|NCT00189540|102184571|FG001|Overall Study|Withdrawal by Subject|0|||
33627215|NCT00189540|102184570|FG000|Overall Study|Death|4|||
33627216|NCT00189540|102184571|FG001|Overall Study|Death|1|||
33627217|NCT03416868|102184573|FG000|Overall Study|Withdrawal by Subject|2|||
33627218|NCT03416868|102184573|FG000|Overall Study|Lost to Follow-up|1|||
33627219|NCT01755234|102184574|FG000|Overall Study|Lost to Follow-up|11|||
33627220|NCT01755234|102184575|FG001|Overall Study|Lost to Follow-up|6|||
33627221|NCT01755234|102184574|FG000|Overall Study|Change in surgical case|2|||
33627222|NCT01755234|102184575|FG001|Overall Study|Change in surgical case|1|||
33627223|NCT01755234|102184574|FG000|Overall Study|case cancelled|1|||
33627224|NCT01755234|102184575|FG001|Overall Study|case cancelled|0|||
33627225|NCT01755234|102184574|FG000|Overall Study|Withdrawal by Subject|0|||
33627226|NCT01755234|102184575|FG001|Overall Study|Withdrawal by Subject|1|||
33627227|NCT01755234|102184574|FG000|Overall Study|unblinded|1|||
33627228|NCT01755234|102184575|FG001|Overall Study|unblinded|0|||
33361957|NCT03494725|101214261|FG001|Overall Study|Antibiotic use|0|||
33563308|NCT04347538|101959438|FG000|Overall Study|Lost to Follow-up|4|||
33563309|NCT04347538|101959439|FG001|Overall Study|Lost to Follow-up|5|||
33563310|NCT04347538|101959440|FG002|Overall Study|Lost to Follow-up|7|||
33563311|NCT02034565|101959442|FG000|Overall Study|Adverse Event|1|||
33563312|NCT02034565|101959443|FG001|Overall Study|Adverse Event|0|||
33563313|NCT02624687|101959446|FG000|Overall Study|Withdrawal by Subject|1|||
33563314|NCT02624687|101959447|FG001|Overall Study|Withdrawal by Subject|1|||
33563315|NCT02624687|101959446|FG000|Overall Study|medical leave from work|0|||
33563316|NCT02624687|101959447|FG001|Overall Study|medical leave from work|1|||
33563317|NCT02367885|101959450|FG000|Overall Study|Lost to Follow-up|1|||
33563318|NCT02367885|101959451|FG001|Overall Study|Lost to Follow-up|0|||
33563319|NCT02367885|101959452|FG002|Overall Study|Lost to Follow-up|0|||
33563320|NCT02367885|101959450|FG000|Overall Study|Withdrawal by Subject|1|||
33563321|NCT02367885|101959451|FG001|Overall Study|Withdrawal by Subject|0|||
33563322|NCT02367885|101959452|FG002|Overall Study|Withdrawal by Subject|0|||
33563323|NCT01450631|101959453|FG000|Overall Study|Lost to Follow-up|2|||
33563324|NCT01450631|101959454|FG001|Overall Study|Lost to Follow-up|4|||
33563325|NCT01450631|101959453|FG000|Overall Study|Withdrawal by Subject|1|||
33563326|NCT01450631|101959454|FG001|Overall Study|Withdrawal by Subject|0|||
33563327|NCT06582732|101959458|FG000|Initial Study Period|Adverse Event|0|||
33563328|NCT06582732|101959459|FG001|Initial Study Period|Adverse Event|0|||
33563329|NCT06582732|101959460|FG002|Initial Study Period|Adverse Event|0|||
33563330|NCT06582732|101959461|FG003|Initial Study Period|Adverse Event|2|||
33563331|NCT06582732|101959462|FG004|Initial Study Period|Adverse Event|0|||
33563332|NCT06582732|101959463|FG005|Initial Study Period|Adverse Event|0|||
33627229|NCT02174731|102184578|FG000|Overall Study|Participant decision|67|||
33627230|NCT02174731|102184579|FG001|Overall Study|Participant decision|64|||
33627231|NCT02174731|102184578|FG000|Overall Study|Incorrect enrolment before randomization|0|||
33627232|NCT02174731|102184579|FG001|Overall Study|Incorrect enrolment before randomization|1|||
33627233|NCT02174731|102184578|FG000|Overall Study|Missing|2|||
33627234|NCT02174731|102184579|FG001|Overall Study|Missing|0|||
33627235|NCT00097500|102184580|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
33627236|NCT00097500|102184581|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
33627237|NCT00097500|102184580|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
33627238|NCT00097500|102184581|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
33627239|NCT00097500|102184580|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
33627240|NCT00097500|102184581|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
33627241|NCT00097500|102184580|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
33627242|NCT00097500|102184581|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
33627243|NCT00097500|102184580|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
33627244|NCT00097500|102184581|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
33627245|NCT00097500|102184580|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
33627246|NCT00097500|102184581|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
33361958|NCT03396471|101214263|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
33361959|NCT03396471|101214263|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
33361960|NCT03396471|101214263|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
33361961|NCT03396471|101214263|FG000|Study Treatment - Up to 22 Months|Death|2|||
33361962|NCT03396471|101214263|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
33361963|NCT03396471|101214263|FG000|Follow up - Up to 2 Years|Death|9|||
33361964|NCT03396471|101214263|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
33361965|NCT03396471|101214263|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
33361966|NCT03396471|101214263|FG000|Follow up - Up to 2 Years|study terminated|1|||
33361967|NCT03396471|101214263|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
33361968|NCT03396471|101214263|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
33361969|NCT01849848|101214264|FG000|Overall Study|Physician Decision|1|||
33361970|NCT01849848|101214264|FG000|Overall Study|Progression of the primary disease|3|||
33361971|NCT00570739|101214265|FG000|Overall Study|Adverse Event|8|||
33361972|NCT00570739|101214266|FG001|Overall Study|Adverse Event|6|||
33361973|NCT00570739|101214267|FG002|Overall Study|Adverse Event|2|||
33361974|NCT00570739|101214268|FG003|Overall Study|Adverse Event|2|||
33361975|NCT00570739|101214265|FG000|Overall Study|Lost to Follow-up|4|||
33361976|NCT00570739|101214266|FG001|Overall Study|Lost to Follow-up|5|||
33563333|NCT06582732|101959464|FG006|Initial Study Period|Adverse Event|0|||
33563334|NCT06582732|101959458|FG000|Initial Study Period|Death|1|||
33563335|NCT06582732|101959459|FG001|Initial Study Period|Death|0|||
33563336|NCT06582732|101959460|FG002|Initial Study Period|Death|0|||
33563337|NCT06582732|101959461|FG003|Initial Study Period|Death|0|||
33563338|NCT06582732|101959462|FG004|Initial Study Period|Death|1|||
33563339|NCT06582732|101959463|FG005|Initial Study Period|Death|0|||
33221781|NCT02417064|100711206|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
33221782|NCT02417064|100711207|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
33361977|NCT00570739|101214267|FG002|Overall Study|Lost to Follow-up|4|||
33361978|NCT00570739|101214268|FG003|Overall Study|Lost to Follow-up|1|||
33361979|NCT00570739|101214265|FG000|Overall Study|Physician Decision|1|||
33361980|NCT00570739|101214266|FG001|Overall Study|Physician Decision|1|||
33361981|NCT00570739|101214267|FG002|Overall Study|Physician Decision|0|||
33361982|NCT00570739|101214268|FG003|Overall Study|Physician Decision|0|||
33361983|NCT00570739|101214265|FG000|Overall Study|Withdrawal by Subject|7|||
33361984|NCT00570739|101214266|FG001|Overall Study|Withdrawal by Subject|7|||
33361985|NCT00570739|101214267|FG002|Overall Study|Withdrawal by Subject|3|||
33361986|NCT00570739|101214268|FG003|Overall Study|Withdrawal by Subject|5|||
33361987|NCT00570739|101214265|FG000|Overall Study|Required restricted medication|0|||
33361988|NCT00570739|101214266|FG001|Overall Study|Required restricted medication|0|||
33361989|NCT00570739|101214267|FG002|Overall Study|Required restricted medication|1|||
33361990|NCT00570739|101214268|FG003|Overall Study|Required restricted medication|0|||
33361991|NCT00570739|101214265|FG000|Overall Study|Met discontinuation criteria|1|||
33361992|NCT00570739|101214266|FG001|Overall Study|Met discontinuation criteria|0|||
33361993|NCT00570739|101214267|FG002|Overall Study|Met discontinuation criteria|1|||
33361994|NCT00570739|101214268|FG003|Overall Study|Met discontinuation criteria|1|||
33361995|NCT00570739|101214265|FG000|Overall Study|Other|0|||
33361996|NCT00570739|101214266|FG001|Overall Study|Other|2|||
33361997|NCT00570739|101214267|FG002|Overall Study|Other|5|||
33361998|NCT00570739|101214268|FG003|Overall Study|Other|3|||
33361999|NCT00933335|101214270|FG000|Overall Study|Lost to Follow-up|1|||
33362000|NCT00933335|101214271|FG001|Overall Study|Lost to Follow-up|3|||
33563340|NCT06582732|101959464|FG006|Initial Study Period|Death|0|||
33362001|NCT00933335|101214270|FG000|Overall Study|Withdrawal by Subject|0|||
33563341|NCT06582732|101959458|FG000|Initial Study Period|Lost to Follow-up|0|||
33563342|NCT06582732|101959459|FG001|Initial Study Period|Lost to Follow-up|0|||
33221783|NCT02417064|100711208|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
33221784|NCT02417064|100711206|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
33362002|NCT00933335|101214271|FG001|Overall Study|Withdrawal by Subject|1|||
33362003|NCT00933335|101214270|FG000|Overall Study|Progressive Disease|0|||
33627247|NCT00097500|102184580|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
33627248|NCT00097500|102184581|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
33627249|NCT03095651|102184582|FG000|Overall Study|Lost to Follow-up|1|||
33627250|NCT03095651|102184583|FG001|Overall Study|Lost to Follow-up|1|||
33627251|NCT03095651|102184584|FG002|Overall Study|Lost to Follow-up|0|||
33627252|NCT03095651|102184585|FG003|Overall Study|Lost to Follow-up|1|||
33627253|NCT03095651|102184586|FG004|Overall Study|Lost to Follow-up|0|||
33627254|NCT03095651|102184587|FG005|Overall Study|Lost to Follow-up|0|||
33627255|NCT03095651|102184588|FG006|Overall Study|Lost to Follow-up|0|||
33627256|NCT03095651|102184589|FG007|Overall Study|Lost to Follow-up|0|||
33627257|NCT03095651|102184582|FG000|Overall Study|Withdrawal by Subject|0|||
33627258|NCT03095651|102184583|FG001|Overall Study|Withdrawal by Subject|0|||
33627259|NCT03095651|102184584|FG002|Overall Study|Withdrawal by Subject|0|||
33627260|NCT03095651|102184585|FG003|Overall Study|Withdrawal by Subject|0|||
33627261|NCT03095651|102184586|FG004|Overall Study|Withdrawal by Subject|0|||
33627262|NCT03095651|102184587|FG005|Overall Study|Withdrawal by Subject|1|||
33627263|NCT03095651|102184588|FG006|Overall Study|Withdrawal by Subject|0|||
33627264|NCT03095651|102184589|FG007|Overall Study|Withdrawal by Subject|0|||
33627265|NCT01476722|102184591|FG000|Overall Study|Adverse Event|1|||
33627266|NCT03040141|102184595|FG000|Overall Study|Death|1|||
33627267|NCT03040141|102184596|FG001|Overall Study|Death|2|||
33627268|NCT03040141|102184597|FG002|Overall Study|Death|3|||
33627269|NCT03040141|102184595|FG000|Overall Study|Withdrawal by Subject|3|||
33627270|NCT03040141|102184596|FG001|Overall Study|Withdrawal by Subject|1|||
33627271|NCT03040141|102184597|FG002|Overall Study|Withdrawal by Subject|1|||
33627272|NCT03040141|102184595|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
33627273|NCT03040141|102184596|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
33627274|NCT03040141|102184597|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
33627275|NCT03040141|102184595|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
33627276|NCT03040141|102184596|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
33627277|NCT03040141|102184597|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
33627278|NCT03305666|102184599|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
33627279|NCT03305666|102184600|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
33627280|NCT01285401|102184604|FG000|Overall Study|Prematurely withdrawn from the study|17|||
33627281|NCT01285401|102184605|FG001|Overall Study|Prematurely withdrawn from the study|29|||
33627282|NCT00997035|102184606|FG000|3-week Followup Visit|Lost to Follow-up|9|||
33627283|NCT00997035|102184607|FG001|3-week Followup Visit|Lost to Follow-up|6|||
33627284|NCT00997035|102184606|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
33627285|NCT00997035|102184607|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
33627286|NCT02973100|102184608|FG000|Overall Study|Adverse Event|1|||
33627287|NCT02973100|102184609|FG001|Overall Study|Adverse Event|2|||
33627288|NCT02973100|102184610|FG002|Overall Study|Adverse Event|1|||
33362004|NCT00933335|101214271|FG001|Overall Study|Progressive Disease|11|||
33627289|NCT02973100|102184611|FG003|Overall Study|Adverse Event|2|||
33627290|NCT02973100|102184608|FG000|Overall Study|Lost to Follow-up|3|||
33627291|NCT02973100|102184609|FG001|Overall Study|Lost to Follow-up|1|||
33627292|NCT02973100|102184610|FG002|Overall Study|Lost to Follow-up|1|||
33627293|NCT02973100|102184611|FG003|Overall Study|Lost to Follow-up|0|||
33627294|NCT02973100|102184608|FG000|Overall Study|Withdrawal by Subject|3|||
33627295|NCT02973100|102184609|FG001|Overall Study|Withdrawal by Subject|5|||
33627296|NCT02973100|102184610|FG002|Overall Study|Withdrawal by Subject|1|||
33627297|NCT02973100|102184611|FG003|Overall Study|Withdrawal by Subject|4|||
33627298|NCT02973100|102184608|FG000|Overall Study|Notification of change in address|0|||
33627299|NCT02973100|102184609|FG001|Overall Study|Notification of change in address|0|||
33627300|NCT02973100|102184610|FG002|Overall Study|Notification of change in address|0|||
33627301|NCT02973100|102184611|FG003|Overall Study|Notification of change in address|1|||
33627302|NCT02973100|102184608|FG000|Overall Study|Failed to attend Safety followup period|0|||
33627303|NCT02973100|102184609|FG001|Overall Study|Failed to attend Safety followup period|0|||
33627304|NCT02973100|102184610|FG002|Overall Study|Failed to attend Safety followup period|1|||
33627305|NCT02973100|102184611|FG003|Overall Study|Failed to attend Safety followup period|0|||
33627306|NCT04439136|102184612|FG000|Overall Study|Ineligible|1|||
33627307|NCT04439136|102184612|FG000|Overall Study|Never Started Treatment|2|||
33627308|NCT04439136|102184612|FG000|Overall Study|Adverse Event|4|||
33627309|NCT04439136|102184612|FG000|Overall Study|Death|3|||
33627310|NCT04439136|102184612|FG000|Overall Study|Disease Progression|27|||
33627311|NCT04439136|102184612|FG000|Overall Study|Alternative Therapy|1|||
33627312|NCT04439136|102184612|FG000|Overall Study|Increased Tumor Burden|1|||
33627313|NCT04439136|102184612|FG000|Overall Study|Symptomatic Detrioration|1|||
33627314|NCT01419769|102184613|FG000|Overall Study|Did not receive the AXIOS stent|3|||
33627315|NCT01419769|102184613|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
33627316|NCT00768989|102184614|FG000|Prior to Week 24|Withdrawal by Subject|1|||
33627317|NCT00768989|102184615|FG001|Prior to Week 24|Withdrawal by Subject|0|||
33627318|NCT00768989|102184614|FG000|Prior to Week 24|Adverse Event|3|||
33627319|NCT00768989|102184615|FG001|Prior to Week 24|Adverse Event|0|||
33627320|NCT00768989|102184614|FG000|Prior to Week 24|Lost to Follow-up|0|||
33627321|NCT00768989|102184615|FG001|Prior to Week 24|Lost to Follow-up|1|||
33627322|NCT00768989|102184614|FG000|Prior to Week 24|Protocol Violation|0|||
33627323|NCT00768989|102184615|FG001|Prior to Week 24|Protocol Violation|2|||
33627324|NCT00768989|102184614|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
33627325|NCT00768989|102184615|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
33627326|NCT00768989|102184614|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
33627327|NCT00768989|102184615|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
33627328|NCT00768989|102184614|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
33627329|NCT00768989|102184615|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
33627330|NCT00768989|102184614|FG000|On or After Week 36|Lack of Efficacy|1|||
33627331|NCT00768989|102184615|FG001|On or After Week 36|Lack of Efficacy|0|||
33627332|NCT00768989|102184614|FG000|On or After Week 36|Adverse Event|0|||
33627333|NCT00768989|102184615|FG001|On or After Week 36|Adverse Event|1|||
33627334|NCT00768989|102184614|FG000|On or After Week 36|Lost to Follow-up|1|||
33627335|NCT00768989|102184615|FG001|On or After Week 36|Lost to Follow-up|0|||
33627336|NCT00768989|102184614|FG000|On or After Week 36|Poor Compliance|1|||
33627337|NCT00768989|102184615|FG001|On or After Week 36|Poor Compliance|0|||
33627338|NCT00768989|102184614|FG000|On or After Week 36|Protocol Violation|1|||
33627339|NCT00768989|102184615|FG001|On or After Week 36|Protocol Violation|0|||
33627340|NCT00768989|102184614|FG000|On or After Week 36|Did not attend termination visit|2|||
33627341|NCT00768989|102184615|FG001|On or After Week 36|Did not attend termination visit|0|||
33627342|NCT00768989|102184614|FG000|On or After Week 36|Sponsor Termination|45|||
33627343|NCT00768989|102184615|FG001|On or After Week 36|Sponsor Termination|26|||
33627344|NCT03600909|102184618|FG000|Overall Study|Not treated|0|||
33627345|NCT03600909|102184619|FG001|Overall Study|Not treated|3|||
33627346|NCT03600909|102184620|FG002|Overall Study|Not treated|0|||
33627347|NCT03922581|102184621|FG000|Overall Study|Lost to Follow-up|20|||
33627348|NCT03922581|102184622|FG001|Overall Study|Lost to Follow-up|9|||
33627349|NCT03922581|102184621|FG000|Overall Study|Physician Decision|1|||
33362005|NCT00933335|101214270|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
33362006|NCT00933335|101214271|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
33627350|NCT03922581|102184622|FG001|Overall Study|Physician Decision|1|||
33627351|NCT03922581|102184621|FG000|Overall Study|Withdrawal by Subject|1|||
33362007|NCT00933335|101214270|FG000|Overall Study|Co-morbid Illness|1|||
33415271|NCT00563706|101409977|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
33627352|NCT03922581|102184622|FG001|Overall Study|Withdrawal by Subject|0|||
33627353|NCT02016781|102184623|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
33627354|NCT02016781|102184624|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
33627355|NCT02016781|102184623|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
33627356|NCT02016781|102184624|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
33627357|NCT02016781|102184623|FG000|Final Database Lock|Withdrawal by Subject|2|||
33627358|NCT02016781|102184624|FG001|Final Database Lock|Withdrawal by Subject|1|||
33221785|NCT02417064|100711207|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
33221786|NCT02417064|100711208|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
33221787|NCT02417064|100711206|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
33221788|NCT02417064|100711207|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
33362008|NCT00933335|101214271|FG001|Overall Study|Co-morbid Illness|0|||
33362009|NCT02114203|101214272|FG000|Overall Study|Adverse Event|0|||
33221789|NCT02417064|100711208|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
33221790|NCT02417064|100711206|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
33221791|NCT02417064|100711207|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
33221792|NCT02417064|100711208|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
33221793|NCT02417064|100711206|FG000|Follow-up Phase (24 Weeks)|Other|2|||
33221794|NCT02417064|100711207|FG001|Follow-up Phase (24 Weeks)|Other|2|||
33362010|NCT02114203|101214273|FG001|Overall Study|Adverse Event|1|||
33362011|NCT02114203|101214274|FG002|Overall Study|Adverse Event|0|||
33362012|NCT02114203|101214272|FG000|Overall Study|Withdrawal by Subject|0|||
33362013|NCT02114203|101214273|FG001|Overall Study|Withdrawal by Subject|1|||
33362014|NCT02114203|101214274|FG002|Overall Study|Withdrawal by Subject|0|||
33362015|NCT02903511|101214275|FG000|Overall Study|Withdrawal by Subject|1|||
33362016|NCT02903511|101214276|FG001|Overall Study|Withdrawal by Subject|0|||
33362017|NCT02903511|101214275|FG000|Overall Study|Lost to Follow-up|3|||
33563343|NCT06582732|101959460|FG002|Initial Study Period|Lost to Follow-up|2|||
33563344|NCT06582732|101959461|FG003|Initial Study Period|Lost to Follow-up|0|||
33563345|NCT06582732|101959462|FG004|Initial Study Period|Lost to Follow-up|0|||
33563346|NCT06582732|101959463|FG005|Initial Study Period|Lost to Follow-up|0|||
33563347|NCT06582732|101959464|FG006|Initial Study Period|Lost to Follow-up|0|||
33563348|NCT06582732|101959458|FG000|Initial Study Period|Withdrawal by Subject|0|||
33563349|NCT06582732|101959459|FG001|Initial Study Period|Withdrawal by Subject|1|||
33563350|NCT06582732|101959460|FG002|Initial Study Period|Withdrawal by Subject|0|||
33563351|NCT06582732|101959461|FG003|Initial Study Period|Withdrawal by Subject|1|||
33563352|NCT06582732|101959462|FG004|Initial Study Period|Withdrawal by Subject|3|||
33563353|NCT06582732|101959463|FG005|Initial Study Period|Withdrawal by Subject|1|||
33563354|NCT06582732|101959464|FG006|Initial Study Period|Withdrawal by Subject|2|||
33563355|NCT06582732|101959458|FG000|Initial Study Period|Moved Away|0|||
33563356|NCT06582732|101959459|FG001|Initial Study Period|Moved Away|0|||
33563357|NCT06582732|101959460|FG002|Initial Study Period|Moved Away|0|||
33563358|NCT06582732|101959461|FG003|Initial Study Period|Moved Away|0|||
33563359|NCT06582732|101959462|FG004|Initial Study Period|Moved Away|1|||
33563360|NCT06582732|101959463|FG005|Initial Study Period|Moved Away|0|||
33563361|NCT06582732|101959464|FG006|Initial Study Period|Moved Away|0|||
33563362|NCT05535972|101959465|FG000|Overall Study|Withdrawal by Subject|31|||
33563363|NCT05535972|101959465|FG000|Overall Study|Lost to Follow-up|5|||
33563364|NCT05535972|101959465|FG000|Overall Study|Adverse Event|6|||
33563365|NCT05535972|101959465|FG000|Overall Study|Protocol Deviation|2|||
33563366|NCT03777020|101959466|FG000|Overall Study|Withdrawal by Subject|4|||
33563367|NCT03777020|101959467|FG001|Overall Study|Withdrawal by Subject|4|||
33563368|NCT03777020|101959466|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
33563369|NCT03777020|101959467|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
33563370|NCT02255656|101959468|FG000|Overall Study|Adverse Event|11|||
33221795|NCT02417064|100711208|FG002|Follow-up Phase (24 Weeks)|Other|3|||
33563371|NCT02255656|101959468|FG000|Overall Study|Poor compliance to protocol|3|||
33563372|NCT02255656|101959468|FG000|Overall Study|Lost to Follow-up|30|||
33362018|NCT02903511|101214276|FG001|Overall Study|Lost to Follow-up|2|||
33362019|NCT00942708|101214280|FG000|Overall Study|Withdrawal by Subject|1|||
33221796|NCT00662857|100711224|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
33221797|NCT00662857|100711225|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
33221798|NCT00662857|100711224|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
33362020|NCT00501852|101214281|FG000|Overall Study|Adverse Event|3|||
33627359|NCT02016781|102184623|FG000|Final Database Lock|Lost to Follow-up|11|||
33627360|NCT02016781|102184624|FG001|Final Database Lock|Lost to Follow-up|4|||
33627361|NCT02016781|102184623|FG000|Final Database Lock|Missing data|0|||
33627362|NCT02016781|102184624|FG001|Final Database Lock|Missing data|3|||
33627363|NCT02021565|102184625|FG000|Baseline Through Intervention|Death|0|||
33627364|NCT02021565|102184626|FG001|Baseline Through Intervention|Death|1|||
33221799|NCT00662857|100711225|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
33362021|NCT00501852|101214281|FG000|Overall Study|Withdrawal by Subject|2|||
33362022|NCT02089737|101214282|FG000|Overall Study|Survey form not completed|5|||
33362023|NCT02089737|101214282|FG000|Overall Study|Not treated|1|||
33627365|NCT02021565|102184625|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
33627366|NCT02021565|102184626|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
33627367|NCT02021565|102184625|FG000|Baseline Through Intervention|Protocol Violation|0|||
33627368|NCT02021565|102184626|FG001|Baseline Through Intervention|Protocol Violation|7|||
33627369|NCT02021565|102184625|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
33627370|NCT02021565|102184626|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
33627371|NCT02021565|102184625|FG000|3-month Follow-up|Death|3|||
33627372|NCT02021565|102184626|FG001|3-month Follow-up|Death|0|||
33627373|NCT02021565|102184625|FG000|3-month Follow-up|Withdrawal by Subject|4|||
33627374|NCT02021565|102184626|FG001|3-month Follow-up|Withdrawal by Subject|0|||
33627375|NCT02021565|102184625|FG000|3-month Follow-up|Protocol Violation|3|||
33627376|NCT02021565|102184626|FG001|3-month Follow-up|Protocol Violation|2|||
33627377|NCT00651924|102184627|FG000|Overall Study|Withdrawal by PI|0|||
33627378|NCT00651924|102184628|FG001|Overall Study|Withdrawal by PI|2|||
33627379|NCT00651924|102184627|FG000|Overall Study|Withdrawal by Subject|0|||
33627380|NCT00651924|102184628|FG001|Overall Study|Withdrawal by Subject|5|||
33627381|NCT01415882|102184632|FG000|Overall Study|Ineligible|1|||
33627382|NCT01415882|102184633|FG001|Overall Study|Ineligible|0|||
33627383|NCT01415882|102184634|FG002|Overall Study|Ineligible|0|||
33627384|NCT01415882|102184635|FG003|Overall Study|Ineligible|3|||
33627385|NCT01415882|102184636|FG004|Overall Study|Ineligible|0|||
33627386|NCT01415882|102184632|FG000|Overall Study|Withdrawal by Subject|0|||
33627387|NCT01415882|102184633|FG001|Overall Study|Withdrawal by Subject|1|||
33627388|NCT01415882|102184634|FG002|Overall Study|Withdrawal by Subject|0|||
33627389|NCT01415882|102184635|FG003|Overall Study|Withdrawal by Subject|1|||
33627390|NCT01415882|102184636|FG004|Overall Study|Withdrawal by Subject|0|||
33627391|NCT00473434|102187611|FG000|Overall Study|Physician Decision|3|||
33627392|NCT00473434|102187611|FG000|Overall Study|Withdrawal by Subject|9|||
33627393|NCT00473434|102187611|FG000|Overall Study|Compliance|3|||
33362024|NCT01089725|101214285|FG000|Overall Study|Adverse Event|1|||
33362025|NCT01089725|101214286|FG001|Overall Study|Adverse Event|1|||
33362026|NCT01089725|101214287|FG002|Overall Study|Adverse Event|0|||
33362027|NCT01089725|101214288|FG003|Overall Study|Adverse Event|0|||
33362028|NCT01089725|101214289|FG004|Overall Study|Adverse Event|2|||
33362029|NCT01089725|101214285|FG000|Overall Study|Lack of Efficacy|4|||
33362030|NCT01089725|101214286|FG001|Overall Study|Lack of Efficacy|3|||
33362031|NCT01089725|101214287|FG002|Overall Study|Lack of Efficacy|1|||
33362032|NCT01089725|101214288|FG003|Overall Study|Lack of Efficacy|0|||
33362033|NCT01089725|101214289|FG004|Overall Study|Lack of Efficacy|4|||
33362034|NCT01089725|101214285|FG000|Overall Study|Lost to Follow-up|2|||
33362035|NCT01089725|101214286|FG001|Overall Study|Lost to Follow-up|2|||
33362036|NCT01089725|101214287|FG002|Overall Study|Lost to Follow-up|0|||
33362037|NCT01089725|101214288|FG003|Overall Study|Lost to Follow-up|3|||
33362038|NCT01089725|101214289|FG004|Overall Study|Lost to Follow-up|0|||
33362039|NCT01089725|101214285|FG000|Overall Study|Protocol Violation|0|||
33362040|NCT01089725|101214286|FG001|Overall Study|Protocol Violation|0|||
33362041|NCT01089725|101214287|FG002|Overall Study|Protocol Violation|1|||
33362042|NCT01089725|101214288|FG003|Overall Study|Protocol Violation|1|||
33362043|NCT01089725|101214289|FG004|Overall Study|Protocol Violation|0|||
33362044|NCT01089725|101214285|FG000|Overall Study|Withdrawal by Subject|5|||
33362045|NCT01089725|101214286|FG001|Overall Study|Withdrawal by Subject|5|||
33362046|NCT01089725|101214287|FG002|Overall Study|Withdrawal by Subject|4|||
33627394|NCT00473434|102187611|FG000|Overall Study|Lack of Efficacy|3|||
33627395|NCT00473434|102187611|FG000|Overall Study|Adverse Event|3|||
33627396|NCT00473434|102187611|FG000|Overall Study|Patient was selling medication to others|1|||
33627397|NCT00473434|102187611|FG000|Overall Study|Safety evaluation|1|||
33627398|NCT00473434|102187611|FG000|Overall Study|Reason not specified|6|||
33221800|NCT00662857|100711224|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
33221801|NCT00662857|100711225|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
33627399|NCT00473434|102187611|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
33627400|NCT00473434|102187611|FG000|Overall Study|Switching to trial medication|1|||
33627401|NCT00473434|102187611|FG000|Overall Study|No longer required|1|||
33627402|NCT02399215|102187612|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
33627403|NCT02399215|102187612|FG000|Overall Study|Withdrawal by Subject|1|||
33362047|NCT01089725|101214288|FG003|Overall Study|Withdrawal by Subject|5|||
33362048|NCT01089725|101214289|FG004|Overall Study|Withdrawal by Subject|4|||
33362049|NCT01089725|101214285|FG000|Overall Study|Study Terminated by Sponsor|51|||
33415272|NCT00563706|101409978|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
33362050|NCT01089725|101214286|FG001|Overall Study|Study Terminated by Sponsor|56|||
33362051|NCT01089725|101214287|FG002|Overall Study|Study Terminated by Sponsor|53|||
33415273|NCT00563706|101409979|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
33415274|NCT00563706|101409980|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
33415275|NCT00563706|101409981|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
33415276|NCT00563706|101409982|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
33415277|NCT00563706|101409983|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
33415278|NCT00563706|101409984|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
33415279|NCT00563706|101409985|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
33415280|NCT00563706|101409977|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
33415281|NCT00563706|101409978|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
33415282|NCT00563706|101409979|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
33415283|NCT00563706|101409980|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
33415284|NCT00563706|101409981|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
33415285|NCT00563706|101409982|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
33415286|NCT00563706|101409983|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
33415287|NCT00563706|101409984|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
33415288|NCT00563706|101409985|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
33415289|NCT00563706|101409977|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
33415290|NCT00563706|101409978|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
33415291|NCT00563706|101409979|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
33415292|NCT00563706|101409980|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
33415293|NCT00563706|101409981|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
33627404|NCT03582215|102187619|FG000|Overall Study|Adverse Event|1|||
33627405|NCT03582215|102187620|FG001|Overall Study|Adverse Event|0|||
33627406|NCT03582215|102187621|FG002|Overall Study|Adverse Event|0|||
33362052|NCT01089725|101214288|FG003|Overall Study|Study Terminated by Sponsor|68|||
33362053|NCT01089725|101214289|FG004|Overall Study|Study Terminated by Sponsor|68|||
33362054|NCT01089725|101214285|FG000|Overall Study|Randomized, but not treated|0|||
33415294|NCT00563706|101409982|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
33415295|NCT00563706|101409983|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
33415296|NCT00563706|101409984|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
33415297|NCT00563706|101409985|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
33415298|NCT00563706|101409977|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
33415299|NCT00563706|101409978|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
33415300|NCT00563706|101409979|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
33415301|NCT00563706|101409980|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
33415302|NCT00563706|101409981|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
33415303|NCT00563706|101409982|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
33415304|NCT00563706|101409983|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
33415305|NCT00563706|101409984|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
33362055|NCT01089725|101214286|FG001|Overall Study|Randomized, but not treated|1|||
33362056|NCT01089725|101214287|FG002|Overall Study|Randomized, but not treated|2|||
33362057|NCT01089725|101214288|FG003|Overall Study|Randomized, but not treated|1|||
33362058|NCT01089725|101214289|FG004|Overall Study|Randomized, but not treated|2|||
33415306|NCT00563706|101409985|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
33415307|NCT04936334|101409988|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
33415308|NCT04993339|101409989|FG000|Overall Study|Lost to Follow-up|0|||
33415309|NCT04993339|101409990|FG001|Overall Study|Lost to Follow-up|1|||
33415310|NCT04993339|101409989|FG000|Overall Study|no MRI scan|3|||
33415311|NCT04993339|101409990|FG001|Overall Study|no MRI scan|1|||
33362059|NCT01089725|101214285|FG000|Overall Study|Other|3|||
33362060|NCT01089725|101214286|FG001|Overall Study|Other|0|||
33362061|NCT01089725|101214287|FG002|Overall Study|Other|0|||
33362062|NCT01089725|101214288|FG003|Overall Study|Other|1|||
33362063|NCT01089725|101214289|FG004|Overall Study|Other|0|||
33362064|NCT01903434|101214296|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
33362065|NCT01903434|101214297|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
33415312|NCT03099265|101409991|FG000|Overall Study|Adverse Event|1|||
33362066|NCT01903434|101214296|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
33362067|NCT01903434|101214297|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
33362068|NCT00306891|101214298|FG000|Part A|Withdrawal by Subject|1|||
33362069|NCT00306891|101214299|FG001|Part A|Withdrawal by Subject|1|||
33362070|NCT00306891|101214300|FG002|Part A|Withdrawal by Subject|0|||
33415313|NCT00054275|101409992|FG000|Overall Study|Withdrawal by Subject|4|||
33415314|NCT00054275|101409992|FG000|Overall Study|Adverse Event|5|||
33415315|NCT00054275|101409992|FG000|Overall Study|Progressive disease in cycle 1|1|||
33415316|NCT00054275|101409992|FG000|Overall Study|Physician Decision|1|||
33415317|NCT01728376|101409995|FG000|Overall Study|Adverse Event|1|||
33415318|NCT01728376|101409996|FG001|Overall Study|Adverse Event|1|||
33415319|NCT01728376|101409997|FG002|Overall Study|Adverse Event|1|||
33415320|NCT01728376|101409998|FG003|Overall Study|Adverse Event|1|||
33415321|NCT01728376|101409999|FG004|Overall Study|Adverse Event|1|||
33415322|NCT01728376|101410000|FG005|Overall Study|Adverse Event|0|||
33415323|NCT01728376|101409995|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
33415324|NCT01728376|101409996|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
33415325|NCT01728376|101409997|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
33415326|NCT01728376|101409998|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
33415327|NCT01728376|101409999|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
33415328|NCT01728376|101410000|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
33415329|NCT01728376|101409995|FG000|Overall Study|No relevant bacteria|2|||
33415330|NCT01728376|101409996|FG001|Overall Study|No relevant bacteria|0|||
33415331|NCT01728376|101409997|FG002|Overall Study|No relevant bacteria|0|||
33415332|NCT01728376|101409998|FG003|Overall Study|No relevant bacteria|0|||
33415333|NCT01728376|101409999|FG004|Overall Study|No relevant bacteria|1|||
33415334|NCT01728376|101410000|FG005|Overall Study|No relevant bacteria|1|||
33415335|NCT01728376|101409995|FG000|Overall Study|Did not receive treatment|0|||
33415336|NCT01728376|101409996|FG001|Overall Study|Did not receive treatment|1|||
33415337|NCT01728376|101409997|FG002|Overall Study|Did not receive treatment|0|||
33415338|NCT01728376|101409998|FG003|Overall Study|Did not receive treatment|0|||
33415339|NCT01728376|101409999|FG004|Overall Study|Did not receive treatment|0|||
33415340|NCT01728376|101410000|FG005|Overall Study|Did not receive treatment|0|||
33362071|NCT00306891|101214301|FG003|Part A|Withdrawal by Subject|0|||
33362072|NCT00306891|101214298|FG000|Part A|Condition under investigation worsened|2|||
33415341|NCT01728376|101409995|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
33415342|NCT01728376|101409996|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
33563373|NCT02255656|101959468|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
33563374|NCT02255656|101959468|FG000|Overall Study|Other|126|||
33362073|NCT00306891|101214299|FG001|Part A|Condition under investigation worsened|2|||
33563375|NCT05788991|101959472|FG000|Overall Study|Not treated with study medication|1|||
33362074|NCT00306891|101214300|FG002|Part A|Condition under investigation worsened|0|||
33362075|NCT00306891|101214301|FG003|Part A|Condition under investigation worsened|0|||
33362076|NCT00306891|101214298|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
33563376|NCT05788991|101959473|FG001|Overall Study|Not treated with study medication|3|||
33563377|NCT05788991|101959472|FG000|Overall Study|Withdrawal by Subject|1|||
33563378|NCT05788991|101959473|FG001|Overall Study|Withdrawal by Subject|0|||
33563379|NCT05788991|101959472|FG000|Overall Study|Lack of Efficacy|0|||
33563380|NCT05788991|101959473|FG001|Overall Study|Lack of Efficacy|1|||
33563381|NCT05788991|101959472|FG000|Overall Study|Protocol Violation|1|||
33563382|NCT05788991|101959473|FG001|Overall Study|Protocol Violation|2|||
33563383|NCT02298946|101959474|FG000|Overall Study|Did not receive treatment|2|||
33563384|NCT02298946|101959475|FG001|Overall Study|Did not receive treatment|0|||
33563385|NCT02298946|101959474|FG000|Overall Study|Unevaluable|2|||
33563386|NCT02298946|101959475|FG001|Overall Study|Unevaluable|1|||
33563387|NCT01854775|101959476|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
33563388|NCT01854775|101959477|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
33563389|NCT01854775|101959478|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
33563390|NCT01854775|101959476|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
33563391|NCT01854775|101959477|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
33563392|NCT01854775|101959478|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
33563393|NCT01854775|101959476|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
33563394|NCT01854775|101959477|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
33563395|NCT01854775|101959478|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
33563396|NCT01854775|101959476|FG000|Extension Phase|Pregnancy|3|||
33563397|NCT01854775|101959477|FG001|Extension Phase|Pregnancy|0|||
33563398|NCT01854775|101959478|FG002|Extension Phase|Pregnancy|0|||
33563399|NCT01854775|101959476|FG000|Extension Phase|Investigator's Discretion|1|||
33563400|NCT01854775|101959477|FG001|Extension Phase|Investigator's Discretion|0|||
33563401|NCT01854775|101959478|FG002|Extension Phase|Investigator's Discretion|0|||
33563402|NCT01854775|101959476|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
33563403|NCT01854775|101959477|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
33563404|NCT01854775|101959478|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
33563405|NCT01854775|101959476|FG000|Extension Phase|Lost to Follow-up|2|||
33563406|NCT01854775|101959477|FG001|Extension Phase|Lost to Follow-up|0|||
33563407|NCT01854775|101959478|FG002|Extension Phase|Lost to Follow-up|0|||
33563408|NCT01854775|101959476|FG000|Extension Phase|Still on Study|32|||
33362077|NCT00306891|101214299|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
33362078|NCT00306891|101214300|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
33362079|NCT00306891|101214301|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
33415343|NCT01728376|101409997|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
33415344|NCT01728376|101409998|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
33415345|NCT01728376|101409999|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
33362080|NCT00306891|101214298|FG000|Part A|Partial bowel obstruction|1|||
33362081|NCT00306891|101214299|FG001|Part A|Partial bowel obstruction|0|||
33362082|NCT00306891|101214300|FG002|Part A|Partial bowel obstruction|0|||
33362083|NCT00306891|101214301|FG003|Part A|Partial bowel obstruction|0|||
33362084|NCT00306891|101214298|FG000|Part A|Reaccumul. of ascites following drainage|0|||
33362085|NCT00306891|101214299|FG001|Part A|Reaccumul. of ascites following drainage|1|||
33362086|NCT00306891|101214300|FG002|Part A|Reaccumul. of ascites following drainage|0|||
33362087|NCT00306891|101214301|FG003|Part A|Reaccumul. of ascites following drainage|0|||
33362088|NCT00306891|101214298|FG000|Part A|Suspicion of second malignancy|0|||
33415346|NCT01728376|101410000|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
33415347|NCT04854421|101410007|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
33415348|NCT04854421|101410008|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
33415349|NCT01266642|101410013|FG000|Overall Study|Protocol Violation|0|||
33415350|NCT01266642|101410014|FG001|Overall Study|Protocol Violation|1|||
33415351|NCT05378269|101410015|FG000|Overall Study|Protocol Violation|1|||
33415352|NCT05378269|101410016|FG001|Overall Study|Protocol Violation|0|||
33415353|NCT05378269|101410017|FG002|Overall Study|Protocol Violation|2|||
33415354|NCT05378269|101410018|FG003|Overall Study|Protocol Violation|0|||
33415355|NCT05378269|101410019|FG004|Overall Study|Protocol Violation|0|||
33415356|NCT02395536|101410020|FG000|Overall Study|Lost to Follow-up|4|||
33415357|NCT02395536|101410021|FG001|Overall Study|Lost to Follow-up|4|||
33415358|NCT02395536|101410020|FG000|Overall Study|Death|2|||
33415359|NCT02395536|101410021|FG001|Overall Study|Death|0|||
33415360|NCT02395536|101410020|FG000|Overall Study|Physician Decision|4|||
33415361|NCT02395536|101410021|FG001|Overall Study|Physician Decision|6|||
33415362|NCT02395536|101410020|FG000|Overall Study|Withdrawal by Subject|9|||
33415363|NCT02395536|101410021|FG001|Overall Study|Withdrawal by Subject|17|||
33415364|NCT02395536|101410020|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
33415365|NCT02395536|101410021|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
33415366|NCT02395536|101410020|FG000|Overall Study|Insurance issue|0|||
33415367|NCT02395536|101410021|FG001|Overall Study|Insurance issue|1|||
33415368|NCT03224234|101410032|FG000|Main Study|Lost to Follow-up|5|||
33415369|NCT03224234|101410033|FG001|Main Study|Lost to Follow-up|5|||
33415370|NCT00669110|101410035|FG000|Overall Study|Adverse Event|4|||
33627407|NCT03582215|102187622|FG003|Overall Study|Adverse Event|0|||
33627408|NCT03582215|102187623|FG004|Overall Study|Adverse Event|0|||
33415371|NCT00669110|101410036|FG001|Overall Study|Adverse Event|3|||
33415372|NCT00669110|101410035|FG000|Overall Study|Caregiver request|3|||
33415373|NCT00669110|101410036|FG001|Overall Study|Caregiver request|2|||
33415374|NCT00669110|101410035|FG000|Overall Study|Physician Decision|0|||
33415375|NCT00669110|101410036|FG001|Overall Study|Physician Decision|1|||
33415376|NCT00669110|101410035|FG000|Overall Study|Lost to Follow-up|1|||
33415377|NCT00669110|101410036|FG001|Overall Study|Lost to Follow-up|0|||
33415378|NCT00669110|101410035|FG000|Overall Study|Protocol Violation|0|||
33415379|NCT00669110|101410036|FG001|Overall Study|Protocol Violation|5|||
33415380|NCT00669110|101410035|FG000|Overall Study|Withdrawal by Subject|0|||
33415381|NCT00669110|101410036|FG001|Overall Study|Withdrawal by Subject|2|||
33563409|NCT01854775|101959477|FG001|Extension Phase|Still on Study|47|||
33563410|NCT01854775|101959478|FG002|Extension Phase|Still on Study|18|||
33563411|NCT03977155|101959481|FG000|Overall Study|Adverse Event|3|||
33563412|NCT03977155|101959482|FG001|Overall Study|Adverse Event|0|||
33563413|NCT03977155|101959483|FG002|Overall Study|Adverse Event|0|||
33563414|NCT03977155|101959481|FG000|Overall Study|Lost to Follow-up|0|||
33563415|NCT03977155|101959482|FG001|Overall Study|Lost to Follow-up|1|||
33563416|NCT03977155|101959483|FG002|Overall Study|Lost to Follow-up|0|||
33563417|NCT03977155|101959481|FG000|Overall Study|Withdrawal by Subject|1|||
33563418|NCT03977155|101959482|FG001|Overall Study|Withdrawal by Subject|1|||
33563419|NCT03977155|101959483|FG002|Overall Study|Withdrawal by Subject|2|||
33563420|NCT03977155|101959481|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
33563421|NCT03977155|101959482|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
33563422|NCT03977155|101959483|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
33563423|NCT03906071|101959484|FG000|Overall Study|Death|180|||
33563424|NCT03906071|101959485|FG001|Overall Study|Death|185|||
33627409|NCT03582215|102187624|FG005|Overall Study|Adverse Event|0|||
33563425|NCT03906071|101959484|FG000|Overall Study|Lost to Follow-up|3|||
33627410|NCT03582215|102187625|FG006|Overall Study|Adverse Event|2|||
33563426|NCT03906071|101959485|FG001|Overall Study|Lost to Follow-up|3|||
33563427|NCT03906071|101959484|FG000|Overall Study|Withdrawal by Subject|15|||
33627411|NCT03582215|102187626|FG007|Overall Study|Adverse Event|2|||
33362089|NCT00306891|101214299|FG001|Part A|Suspicion of second malignancy|1|||
33415382|NCT00557830|101410039|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
33415383|NCT00557830|101410040|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
33415384|NCT00557830|101410041|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
33362090|NCT00306891|101214300|FG002|Part A|Suspicion of second malignancy|0|||
33362091|NCT00306891|101214301|FG003|Part A|Suspicion of second malignancy|0|||
33415385|NCT00557830|101410039|FG000|Screening Treatment Phase|Adverse Event|2|||
33563428|NCT03906071|101959485|FG001|Overall Study|Withdrawal by Subject|27|||
33627412|NCT02723773|102187632|FG000|Overall Study|Adverse Event|934|||
33627413|NCT02723773|102187633|FG001|Overall Study|Adverse Event|3|||
33627414|NCT02723773|102187634|FG002|Overall Study|Adverse Event|1|||
33627415|NCT02723773|102187635|FG003|Overall Study|Adverse Event|9|||
33627416|NCT02723773|102187632|FG000|Overall Study|Protocol Violation|1|||
33627417|NCT02723773|102187633|FG001|Overall Study|Protocol Violation|0|||
33627418|NCT02723773|102187634|FG002|Overall Study|Protocol Violation|0|||
33627419|NCT02723773|102187635|FG003|Overall Study|Protocol Violation|0|||
33627420|NCT02723773|102187632|FG000|Overall Study|Withdrawal by Subject|360|||
33627421|NCT02723773|102187633|FG001|Overall Study|Withdrawal by Subject|5|||
33627422|NCT02723773|102187634|FG002|Overall Study|Withdrawal by Subject|6|||
33627423|NCT02723773|102187635|FG003|Overall Study|Withdrawal by Subject|10|||
33627424|NCT02723773|102187632|FG000|Overall Study|Migrated/moved from study area|37|||
33627425|NCT02723773|102187633|FG001|Overall Study|Migrated/moved from study area|0|||
33627426|NCT02723773|102187634|FG002|Overall Study|Migrated/moved from study area|0|||
33627427|NCT02723773|102187635|FG003|Overall Study|Migrated/moved from study area|1|||
33627428|NCT02723773|102187632|FG000|Overall Study|Lost to Follow-up|198|||
33627429|NCT02723773|102187633|FG001|Overall Study|Lost to Follow-up|0|||
33627430|NCT02723773|102187634|FG002|Overall Study|Lost to Follow-up|0|||
33627431|NCT02723773|102187635|FG003|Overall Study|Lost to Follow-up|0|||
33627432|NCT02723773|102187632|FG000|Overall Study|Other|189|||
33627433|NCT02723773|102187633|FG001|Overall Study|Other|1|||
33627434|NCT02723773|102187634|FG002|Overall Study|Other|2|||
33627435|NCT02723773|102187635|FG003|Overall Study|Other|2|||
33627436|NCT00642356|102187636|FG000|Overall Study|Adverse Event|1|||
33627437|NCT00642356|102187637|FG001|Overall Study|Adverse Event|0|||
33627438|NCT00642356|102187636|FG000|Overall Study|Protocol Violation|0|||
33627439|NCT00642356|102187637|FG001|Overall Study|Protocol Violation|3|||
33627440|NCT00642356|102187636|FG000|Overall Study|Lack of Efficacy|1|||
33627441|NCT00642356|102187637|FG001|Overall Study|Lack of Efficacy|0|||
33627442|NCT00472108|102187638|FG000|Overall Study|Lost to Follow-up|0|||
33627443|NCT00472108|102187639|FG001|Overall Study|Lost to Follow-up|1|||
33627444|NCT04388111|102187640|FG000|Overall Study|Lost to Follow-up|5|||
33627445|NCT04388111|102187641|FG001|Overall Study|Lost to Follow-up|3|||
33627446|NCT04388111|102187640|FG000|Overall Study|Adverse Event|1|||
33627447|NCT04388111|102187641|FG001|Overall Study|Adverse Event|1|||
33627448|NCT04388111|102187640|FG000|Overall Study|Protocol Violation|2|||
33627449|NCT04388111|102187641|FG001|Overall Study|Protocol Violation|4|||
33627450|NCT04388111|102187640|FG000|Overall Study|Withdrawal by Subject|1|||
33627451|NCT04388111|102187641|FG001|Overall Study|Withdrawal by Subject|0|||
33627452|NCT01611792|102187644|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
33627453|NCT01611792|102187645|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
33627454|NCT01611792|102187644|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
33627455|NCT01611792|102187645|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
33627456|NCT01188772|102187647|FG000|Overall Study|Randomized but Not Treated|0|||
33627457|NCT01188772|102187648|FG001|Overall Study|Randomized but Not Treated|1|||
33627458|NCT01188772|102187649|FG002|Overall Study|Randomized but Not Treated|0|||
33627459|NCT01188772|102187650|FG003|Overall Study|Randomized but Not Treated|0|||
33627460|NCT01188772|102187647|FG000|Overall Study|Adverse Event|0|||
33627461|NCT01188772|102187648|FG001|Overall Study|Adverse Event|1|||
33627462|NCT01188772|102187649|FG002|Overall Study|Adverse Event|2|||
33627463|NCT01188772|102187650|FG003|Overall Study|Adverse Event|0|||
33627464|NCT01188772|102187647|FG000|Overall Study|Lost to Follow-up|4|||
33627465|NCT01188772|102187648|FG001|Overall Study|Lost to Follow-up|1|||
33627466|NCT01188772|102187649|FG002|Overall Study|Lost to Follow-up|1|||
33627467|NCT01188772|102187650|FG003|Overall Study|Lost to Follow-up|1|||
33627468|NCT01188772|102187647|FG000|Overall Study|Non-responder|0|||
33563429|NCT03906071|101959484|FG000|Overall Study|Other|2|||
33627469|NCT01188772|102187648|FG001|Overall Study|Non-responder|0|||
33627470|NCT01188772|102187649|FG002|Overall Study|Non-responder|3|||
33627471|NCT01188772|102187650|FG003|Overall Study|Non-responder|0|||
33627472|NCT01188772|102187647|FG000|Overall Study|Physician Decision|0|||
33627473|NCT01188772|102187648|FG001|Overall Study|Physician Decision|0|||
33627474|NCT01188772|102187649|FG002|Overall Study|Physician Decision|1|||
33627475|NCT01188772|102187650|FG003|Overall Study|Physician Decision|0|||
33627476|NCT01188772|102187647|FG000|Overall Study|Terminated by Sponsor|0|||
33627477|NCT01188772|102187648|FG001|Overall Study|Terminated by Sponsor|0|||
33627478|NCT01188772|102187649|FG002|Overall Study|Terminated by Sponsor|1|||
33627479|NCT01188772|102187650|FG003|Overall Study|Terminated by Sponsor|0|||
33627480|NCT01188772|102187647|FG000|Overall Study|Treatment Failure|0|||
33627481|NCT01188772|102187648|FG001|Overall Study|Treatment Failure|0|||
33627482|NCT01188772|102187649|FG002|Overall Study|Treatment Failure|1|||
33627483|NCT01188772|102187650|FG003|Overall Study|Treatment Failure|0|||
33627484|NCT01188772|102187647|FG000|Overall Study|Virologic Failure|1|||
33627485|NCT01188772|102187648|FG001|Overall Study|Virologic Failure|0|||
33627486|NCT01188772|102187649|FG002|Overall Study|Virologic Failure|0|||
33627487|NCT01188772|102187650|FG003|Overall Study|Virologic Failure|0|||
33627488|NCT01188772|102187647|FG000|Overall Study|Withdrawal by Subject|0|||
33627489|NCT01188772|102187648|FG001|Overall Study|Withdrawal by Subject|0|||
33627490|NCT01188772|102187649|FG002|Overall Study|Withdrawal by Subject|2|||
33627491|NCT01188772|102187650|FG003|Overall Study|Withdrawal by Subject|0|||
33627492|NCT00591006|102187651|FG000|Overall Study|Withdrawal by Subject|0|||
33627493|NCT00591006|102187652|FG001|Overall Study|Withdrawal by Subject|0|||
33627494|NCT00591006|102187653|FG002|Overall Study|Withdrawal by Subject|0|||
33627495|NCT00591006|102187654|FG003|Overall Study|Withdrawal by Subject|0|||
33627496|NCT00591006|102187655|FG004|Overall Study|Withdrawal by Subject|0|||
33627497|NCT00591006|102187656|FG005|Overall Study|Withdrawal by Subject|0|||
33627498|NCT00591006|102187657|FG006|Overall Study|Withdrawal by Subject|0|||
33627499|NCT00591006|102187658|FG007|Overall Study|Withdrawal by Subject|0|||
33627500|NCT00591006|102187659|FG008|Overall Study|Withdrawal by Subject|0|||
33627501|NCT00591006|102187660|FG009|Overall Study|Withdrawal by Subject|0|||
33627502|NCT00591006|102187661|FG010|Overall Study|Withdrawal by Subject|0|||
33627503|NCT00591006|102187662|FG011|Overall Study|Withdrawal by Subject|0|||
33627504|NCT00591006|102187663|FG012|Overall Study|Withdrawal by Subject|0|||
33627505|NCT00591006|102187664|FG013|Overall Study|Withdrawal by Subject|0|||
33627506|NCT00591006|102187665|FG014|Overall Study|Withdrawal by Subject|0|||
33627507|NCT00591006|102187666|FG015|Overall Study|Withdrawal by Subject|1|||
33627508|NCT00591006|102187667|FG016|Overall Study|Withdrawal by Subject|0|||
33627509|NCT00591006|102187668|FG017|Overall Study|Withdrawal by Subject|0|||
33627510|NCT00591006|102187669|FG018|Overall Study|Withdrawal by Subject|0|||
33627511|NCT00591006|102187670|FG019|Overall Study|Withdrawal by Subject|0|||
33627512|NCT00591006|102187671|FG020|Overall Study|Withdrawal by Subject|0|||
33627513|NCT00591006|102187672|FG021|Overall Study|Withdrawal by Subject|0|||
33627514|NCT00591006|102187673|FG022|Overall Study|Withdrawal by Subject|0|||
33627515|NCT00591006|102187674|FG023|Overall Study|Withdrawal by Subject|1|||
33627516|NCT00591006|102187651|FG000|Overall Study|Adverse Event|0|||
33627517|NCT00591006|102187652|FG001|Overall Study|Adverse Event|0|||
33627518|NCT00591006|102187653|FG002|Overall Study|Adverse Event|0|||
33627519|NCT00591006|102187654|FG003|Overall Study|Adverse Event|0|||
33627520|NCT00591006|102187655|FG004|Overall Study|Adverse Event|0|||
33627521|NCT00591006|102187656|FG005|Overall Study|Adverse Event|0|||
33627522|NCT00591006|102187657|FG006|Overall Study|Adverse Event|0|||
33627523|NCT00591006|102187658|FG007|Overall Study|Adverse Event|0|||
33627524|NCT00591006|102187659|FG008|Overall Study|Adverse Event|0|||
33627525|NCT00591006|102187660|FG009|Overall Study|Adverse Event|0|||
33627526|NCT00591006|102187661|FG010|Overall Study|Adverse Event|0|||
33627527|NCT00591006|102187662|FG011|Overall Study|Adverse Event|0|||
33627528|NCT00591006|102187663|FG012|Overall Study|Adverse Event|0|||
33627529|NCT00591006|102187664|FG013|Overall Study|Adverse Event|0|||
33627530|NCT00591006|102187665|FG014|Overall Study|Adverse Event|0|||
33627531|NCT00591006|102187666|FG015|Overall Study|Adverse Event|0|||
33627532|NCT00591006|102187667|FG016|Overall Study|Adverse Event|0|||
33627533|NCT00591006|102187668|FG017|Overall Study|Adverse Event|0|||
33627534|NCT00591006|102187669|FG018|Overall Study|Adverse Event|0|||
33627535|NCT00591006|102187670|FG019|Overall Study|Adverse Event|0|||
33627536|NCT00591006|102187671|FG020|Overall Study|Adverse Event|0|||
33627537|NCT00591006|102187672|FG021|Overall Study|Adverse Event|0|||
33627538|NCT00591006|102187673|FG022|Overall Study|Adverse Event|1|||
33627539|NCT00591006|102187674|FG023|Overall Study|Adverse Event|0|||
33627540|NCT00141453|102187675|FG000|Overall Study|Protocol Violation|6|||
33627541|NCT00141453|102187676|FG001|Overall Study|Protocol Violation|5|||
33627542|NCT03115359|102187679|FG000|Overall Study|Withdrawal by Subject|29|||
33627543|NCT03115359|102187680|FG001|Overall Study|Withdrawal by Subject|39|||
33627544|NCT03115359|102187679|FG000|Overall Study|Scheduling conflict|25|||
33627545|NCT03115359|102187680|FG001|Overall Study|Scheduling conflict|23|||
33627546|NCT03115359|102187679|FG000|Overall Study|Personal reasons including health|12|||
33627547|NCT03115359|102187680|FG001|Overall Study|Personal reasons including health|9|||
33627548|NCT03115359|102187679|FG000|Overall Study|Transportation barriers|3|||
33627549|NCT03115359|102187680|FG001|Overall Study|Transportation barriers|0|||
33627550|NCT03115359|102187679|FG000|Overall Study|No longer interested|5|||
33627551|NCT03115359|102187680|FG001|Overall Study|No longer interested|4|||
33627552|NCT03115359|102187679|FG000|Overall Study|No reason provided|45|||
33627553|NCT03115359|102187680|FG001|Overall Study|No reason provided|47|||
33627554|NCT01517750|102187684|FG000|Overall Study|Lost to Follow-up|1|||
33627555|NCT01517750|102187685|FG001|Overall Study|Lost to Follow-up|2|||
33627556|NCT01517750|102187686|FG002|Overall Study|Lost to Follow-up|4|||
33627557|NCT01517750|102187687|FG003|Overall Study|Lost to Follow-up|1|||
33627558|NCT00346216|102187688|FG000|Overall Study|Other|181|||
33627559|NCT00346216|102187689|FG001|Overall Study|Other|231|||
33627560|NCT00346216|102187690|FG002|Overall Study|Other|205|||
33627561|NCT00346216|102187688|FG000|Overall Study|No longer willing to participate|600|||
33627562|NCT00346216|102187689|FG001|Overall Study|No longer willing to participate|606|||
33627563|NCT00346216|102187690|FG002|Overall Study|No longer willing to participate|585|||
33627564|NCT00346216|102187688|FG000|Overall Study|Withdrawal by Subject|661|||
33627565|NCT00346216|102187689|FG001|Overall Study|Withdrawal by Subject|692|||
33627566|NCT00346216|102187690|FG002|Overall Study|Withdrawal by Subject|651|||
33627567|NCT00346216|102187688|FG000|Overall Study|Lost to Follow-up|611|||
33627568|NCT00346216|102187689|FG001|Overall Study|Lost to Follow-up|588|||
33627569|NCT00346216|102187690|FG002|Overall Study|Lost to Follow-up|542|||
33627570|NCT00346216|102187688|FG000|Overall Study|Physician Decision|80|||
33627571|NCT00346216|102187689|FG001|Overall Study|Physician Decision|76|||
33627572|NCT00346216|102187690|FG002|Overall Study|Physician Decision|59|||
33627573|NCT00346216|102187688|FG000|Overall Study|Does not meet entrance criteria|13|||
33627574|NCT00346216|102187689|FG001|Overall Study|Does not meet entrance criteria|10|||
33627575|NCT00346216|102187690|FG002|Overall Study|Does not meet entrance criteria|8|||
33627576|NCT00346216|102187688|FG000|Overall Study|Death|189|||
33627577|NCT00346216|102187689|FG001|Overall Study|Death|192|||
33627578|NCT00346216|102187690|FG002|Overall Study|Death|228|||
33221802|NCT04062448|100711226|FG000|Overall Study|Lost to Follow-up|1|||
33221803|NCT04062448|100711226|FG000|Overall Study|Withdrawal by Subject|2|||
33627579|NCT00346216|102187688|FG000|Overall Study|Study terminated by sponsor|11|||
33627580|NCT00346216|102187689|FG001|Overall Study|Study terminated by sponsor|4|||
33627581|NCT00346216|102187690|FG002|Overall Study|Study terminated by sponsor|8|||
33627582|NCT00346216|102187688|FG000|Overall Study|Missing Subject Summary Status|62|||
33627583|NCT00346216|102187689|FG001|Overall Study|Missing Subject Summary Status|61|||
33627584|NCT00346216|102187690|FG002|Overall Study|Missing Subject Summary Status|62|||
33627585|NCT04233801|102187691|FG000|Overall Study|Other than listed|0|||
33627586|NCT04233801|102187692|FG001|Overall Study|Other than listed|0|||
33627587|NCT04233801|102187693|FG002|Overall Study|Other than listed|1|||
33627588|NCT04233801|102187691|FG000|Overall Study|Withdrawal by Subject|0|||
33627589|NCT04233801|102187692|FG001|Overall Study|Withdrawal by Subject|2|||
33627590|NCT04233801|102187693|FG002|Overall Study|Withdrawal by Subject|3|||
33627591|NCT01381016|102187697|FG000|Overall Study|Lost to Follow-up|1|||
33627592|NCT01381016|102187698|FG001|Overall Study|Lost to Follow-up|1|||
33627593|NCT01381016|102187697|FG000|Overall Study|Screen Failure|2|||
33627594|NCT01381016|102187698|FG001|Overall Study|Screen Failure|2|||
33627595|NCT01381016|102187697|FG000|Overall Study|Withdrawal by Subject|0|||
33627596|NCT01381016|102187698|FG001|Overall Study|Withdrawal by Subject|1|||
33627597|NCT01381016|102187697|FG000|Overall Study|Physician Decision|0|||
33627598|NCT01381016|102187698|FG001|Overall Study|Physician Decision|2|||
33627599|NCT02738801|102187699|FG000|Overall Study|Adverse Event|1|||
33627600|NCT02738801|102187700|FG001|Overall Study|Adverse Event|1|||
33627601|NCT02738801|102187699|FG000|Overall Study|Withdrawal by Subject|0|||
33627602|NCT02738801|102187700|FG001|Overall Study|Withdrawal by Subject|1|||
33627603|NCT03287791|102187703|FG000|Overall Study|Insufficient Therapeutic Response|0|||
33627604|NCT03287791|102187704|FG001|Overall Study|Insufficient Therapeutic Response|0|||
33627605|NCT03287791|102187705|FG002|Overall Study|Insufficient Therapeutic Response|1|||
33627606|NCT03287791|102187703|FG000|Overall Study|Adverse Event|0|||
33627607|NCT03287791|102187704|FG001|Overall Study|Adverse Event|4|||
33627608|NCT03287791|102187705|FG002|Overall Study|Adverse Event|3|||
33627609|NCT03287791|102187703|FG000|Overall Study|Withdrawal by Subject|12|||
33627610|NCT03287791|102187704|FG001|Overall Study|Withdrawal by Subject|12|||
33627611|NCT03287791|102187705|FG002|Overall Study|Withdrawal by Subject|17|||
33627612|NCT03287791|102187703|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
33627613|NCT03287791|102187704|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
33627614|NCT03287791|102187705|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
33627615|NCT03287791|102187703|FG000|Overall Study|Lost to Follow-up|8|||
33627616|NCT03287791|102187704|FG001|Overall Study|Lost to Follow-up|14|||
33362092|NCT00306891|101214298|FG000|Part A|QTC interval outwith elig. criteria|1|||
33362093|NCT00306891|101214299|FG001|Part A|QTC interval outwith elig. criteria|0|||
33362094|NCT00306891|101214300|FG002|Part A|QTC interval outwith elig. criteria|0|||
33362095|NCT00306891|101214301|FG003|Part A|QTC interval outwith elig. criteria|0|||
33362096|NCT00306891|101214298|FG000|Part B|Death|0|||
33362097|NCT00306891|101214299|FG001|Part B|Death|0|||
33362098|NCT00306891|101214300|FG002|Part B|Death|1|||
33362099|NCT00306891|101214301|FG003|Part B|Death|2|||
33362100|NCT00306891|101214298|FG000|Part B|Adverse Event|0|||
33362101|NCT00306891|101214299|FG001|Part B|Adverse Event|0|||
33563430|NCT03906071|101959485|FG001|Overall Study|Other|1|||
33563431|NCT03345550|101959490|FG000|Overall Study|Withdrawal by Subject|1|||
33563432|NCT03345550|101959491|FG001|Overall Study|Withdrawal by Subject|0|||
33563433|NCT03345550|101959490|FG000|Overall Study|Lost to Follow-up|4|||
33563434|NCT03345550|101959491|FG001|Overall Study|Lost to Follow-up|5|||
33563435|NCT02113878|101959492|FG000|Overall Study|Adverse Event|1|||
33563436|NCT02113878|101959493|FG001|Overall Study|Adverse Event|0|||
33563437|NCT02113878|101959492|FG000|Overall Study|Withdrawal by Subject|1|||
33563438|NCT02113878|101959493|FG001|Overall Study|Withdrawal by Subject|0|||
33563439|NCT02113878|101959492|FG000|Overall Study|patient non-compliance|1|||
33563440|NCT02113878|101959493|FG001|Overall Study|patient non-compliance|0|||
33563441|NCT00847730|101959494|FG000|Overall Study|Multiple interruptions in therapy|8|||
33563442|NCT01400412|101959500|FG000|Overall Study|Lost to Follow-up|4|||
33563443|NCT01400412|101959501|FG001|Overall Study|Lost to Follow-up|7|||
33563444|NCT01400412|101959500|FG000|Overall Study|Withdrawal by Subject|3|||
33563445|NCT01400412|101959501|FG001|Overall Study|Withdrawal by Subject|4|||
33563446|NCT01400412|101959500|FG000|Overall Study|Unable to complete|3|||
33563447|NCT01400412|101959501|FG001|Overall Study|Unable to complete|3|||
33563448|NCT01400412|101959500|FG000|Overall Study|Never started study treatment|0|||
33563449|NCT01400412|101959501|FG001|Overall Study|Never started study treatment|3|||
33563450|NCT03766399|101959503|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563451|NCT03766399|101959504|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563452|NCT03766399|101959505|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563453|NCT03766399|101959506|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563454|NCT03766399|101959507|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563455|NCT03766399|101959508|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563456|NCT03766399|101959509|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563457|NCT03766399|101959510|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563458|NCT03766399|101959511|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563459|NCT03766399|101959512|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563460|NCT03766399|101959513|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563461|NCT03766399|101959514|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563462|NCT03766399|101959515|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563463|NCT03766399|101959516|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
33563464|NCT03766399|101959517|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563465|NCT03766399|101959518|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563466|NCT03766399|101959519|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563467|NCT03766399|101959520|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
33563468|NCT03312543|101959521|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
33563469|NCT03312543|101959522|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
33563470|NCT03312543|101959521|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
33563471|NCT03312543|101959522|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
33563472|NCT03312543|101959521|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
33563473|NCT03312543|101959522|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
33563474|NCT03312543|101959521|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
33563475|NCT03312543|101959522|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
33563476|NCT03312543|101959521|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
33563477|NCT03312543|101959522|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
33563478|NCT03312543|101959521|FG000|Regression (Week 12 to Week 24)|Death|0|||
33627617|NCT03287791|102187705|FG002|Overall Study|Lost to Follow-up|11|||
33627618|NCT03287791|102187703|FG000|Overall Study|Protocol Violation|7|||
33627619|NCT03287791|102187704|FG001|Overall Study|Protocol Violation|2|||
33563479|NCT03312543|101959522|FG001|Regression (Week 12 to Week 24)|Death|1|||
33627620|NCT03287791|102187705|FG002|Overall Study|Protocol Violation|1|||
33627621|NCT03287791|102187703|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
33362102|NCT00306891|101214300|FG002|Part B|Adverse Event|5|||
33563480|NCT00265122|101959526|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
33563481|NCT00265122|101959527|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
33627622|NCT03287791|102187704|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
33362103|NCT00306891|101214301|FG003|Part B|Adverse Event|5|||
33362104|NCT00306891|101214298|FG000|Part B|Withdrawal by Subject|0|||
33362105|NCT00306891|101214299|FG001|Part B|Withdrawal by Subject|0|||
33627623|NCT03287791|102187705|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
33362106|NCT00306891|101214300|FG002|Part B|Withdrawal by Subject|3|||
33362107|NCT00306891|101214301|FG003|Part B|Withdrawal by Subject|1|||
33362108|NCT00306891|101214298|FG000|Part B|Condition under investigation worsened|0|||
33362109|NCT00306891|101214299|FG001|Part B|Condition under investigation worsened|0|||
33362110|NCT00306891|101214300|FG002|Part B|Condition under investigation worsened|2|||
33563482|NCT00265122|101959528|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
33563483|NCT00265122|101959529|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
33563484|NCT00265122|101959530|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
33563485|NCT00265122|101959531|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
33563486|NCT00265122|101959526|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
33563487|NCT00265122|101959527|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
33563488|NCT00265122|101959528|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
33563489|NCT00265122|101959529|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
33563490|NCT00265122|101959530|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
33563491|NCT00265122|101959531|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
33563492|NCT00265122|101959526|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
33563493|NCT00265122|101959527|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
33563494|NCT00265122|101959528|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
33563495|NCT00265122|101959529|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
33563496|NCT00265122|101959530|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
33563497|NCT00265122|101959531|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
33563498|NCT00265122|101959526|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
33563499|NCT00265122|101959527|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
33563500|NCT00265122|101959528|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
33563501|NCT00265122|101959529|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
33563502|NCT00265122|101959530|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
33563503|NCT00265122|101959531|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
33563504|NCT00265122|101959526|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
33563505|NCT00265122|101959527|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
33563506|NCT00265122|101959528|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
33563507|NCT00265122|101959529|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
33563508|NCT00265122|101959530|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
33563509|NCT00265122|101959531|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
33563510|NCT00265122|101959526|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
33563511|NCT00265122|101959527|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
33563512|NCT00265122|101959528|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
33563513|NCT00265122|101959529|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
33563514|NCT00265122|101959530|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
33563515|NCT00265122|101959531|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
33563516|NCT01832038|101959534|FG000|Overall Study|Death|5|||
33563517|NCT01832038|101959534|FG000|Overall Study|Adverse Event|50|||
33563518|NCT01832038|101959534|FG000|Overall Study|Lack of Efficacy|81|||
33563519|NCT01832038|101959534|FG000|Overall Study|Protocol Violation|7|||
33563520|NCT01832038|101959534|FG000|Overall Study|Lost to Follow-up|10|||
33627624|NCT03287791|102187703|FG000|Overall Study|Too much time between 2 visits|0|||
33627625|NCT03287791|102187704|FG001|Overall Study|Too much time between 2 visits|1|||
33627626|NCT03287791|102187705|FG002|Overall Study|Too much time between 2 visits|0|||
33627627|NCT03287791|102187703|FG000|Overall Study|Non-compliance|0|||
33627628|NCT03287791|102187704|FG001|Overall Study|Non-compliance|1|||
33627629|NCT03287791|102187705|FG002|Overall Study|Non-compliance|0|||
33627630|NCT03287791|102187703|FG000|Overall Study|Did not meet inclusion criteria|1|||
33627631|NCT03287791|102187704|FG001|Overall Study|Did not meet inclusion criteria|0|||
33627632|NCT03287791|102187705|FG002|Overall Study|Did not meet inclusion criteria|0|||
33627633|NCT04423718|102187706|FG000|Overall Study|Adverse Event|6|||
33627634|NCT04423718|102187707|FG001|Overall Study|Adverse Event|2|||
33627635|NCT04423718|102187708|FG002|Overall Study|Adverse Event|5|||
33627636|NCT04423718|102187706|FG000|Overall Study|Physician Decision|1|||
33627637|NCT04423718|102187707|FG001|Overall Study|Physician Decision|4|||
33627638|NCT04423718|102187708|FG002|Overall Study|Physician Decision|1|||
33627639|NCT04423718|102187706|FG000|Overall Study|Protocol Violation|0|||
33627640|NCT04423718|102187707|FG001|Overall Study|Protocol Violation|1|||
33627641|NCT04423718|102187708|FG002|Overall Study|Protocol Violation|1|||
33627642|NCT04423718|102187706|FG000|Overall Study|Lost to Follow-up|1|||
33627643|NCT04423718|102187707|FG001|Overall Study|Lost to Follow-up|1|||
33627644|NCT04423718|102187708|FG002|Overall Study|Lost to Follow-up|2|||
33627645|NCT04423718|102187706|FG000|Overall Study|Lack of Efficacy|2|||
33627646|NCT04423718|102187707|FG001|Overall Study|Lack of Efficacy|0|||
33627647|NCT04423718|102187708|FG002|Overall Study|Lack of Efficacy|0|||
33362111|NCT00306891|101214301|FG003|Part B|Condition under investigation worsened|8|||
33362112|NCT00306891|101214298|FG000|Part B|Development of study specific disc crit.|0|||
33362113|NCT00306891|101214299|FG001|Part B|Development of study specific disc crit.|0|||
33362114|NCT00306891|101214300|FG002|Part B|Development of study specific disc crit.|0|||
33563521|NCT01832038|101959534|FG000|Overall Study|Withdrawal by Subject|49|||
33563522|NCT01832038|101959534|FG000|Overall Study|Visit non-compliance|2|||
33563523|NCT01832038|101959534|FG000|Overall Study|Subject refused to return visit|2|||
33563524|NCT01832038|101959534|FG000|Overall Study|Not convenient to come back to site|2|||
33563525|NCT01832038|101959534|FG000|Overall Study|Participant was asked to quit|5|||
33563526|NCT01832038|101959534|FG000|Overall Study|Back home|1|||
33563527|NCT01832038|101959534|FG000|Overall Study|Pregnancy|1|||
33563528|NCT01832038|101959534|FG000|Overall Study|Low compliance|3|||
33563529|NCT01832038|101959534|FG000|Overall Study|Prohibit procedure|2|||
33563530|NCT01832038|101959534|FG000|Overall Study|Not possible to visit the hospital|1|||
33563531|NCT01832038|101959534|FG000|Overall Study|Changes of implementation system|3|||
33563532|NCT01832038|101959534|FG000|Overall Study|Plan to pregnancy|7|||
33563533|NCT01832038|101959534|FG000|Overall Study|Bad mood and has suicidal thought|1|||
33563534|NCT01832038|101959534|FG000|Overall Study|Prohibited concomitant medication|1|||
33563535|NCT01832038|101959534|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
33563536|NCT01832038|101959534|FG000|Overall Study|Subject considered the efficacy was poor|1|||
33563537|NCT02402647|101959535|FG000|Overall Study|Lost to Follow-up|13|||
33563538|NCT02402647|101959536|FG001|Overall Study|Lost to Follow-up|7|||
33563539|NCT02402647|101959535|FG000|Overall Study|Protocol Violation|1|||
33563540|NCT02402647|101959536|FG001|Overall Study|Protocol Violation|1|||
33563541|NCT02402647|101959535|FG000|Overall Study|scheduled and timed out|2|||
33563542|NCT02402647|101959536|FG001|Overall Study|scheduled and timed out|1|||
33563543|NCT02402647|101959535|FG000|Overall Study|medical illness|2|||
33563544|NCT02402647|101959536|FG001|Overall Study|medical illness|4|||
33563545|NCT02402647|101959535|FG000|Overall Study|Moved|2|||
33563546|NCT02402647|101959536|FG001|Overall Study|Moved|0|||
33563547|NCT02402647|101959535|FG000|Overall Study|loved one illness|1|||
33563548|NCT02402647|101959536|FG001|Overall Study|loved one illness|0|||
33563549|NCT02402647|101959535|FG000|Overall Study|deceased preexisting condition|2|||
33563550|NCT02402647|101959536|FG001|Overall Study|deceased preexisting condition|0|||
33563551|NCT02402647|101959535|FG000|Overall Study|Other|2|||
33563552|NCT02402647|101959536|FG001|Overall Study|Other|1|||
33563553|NCT02971137|101959538|FG000|Overall Study|Lost to Follow-up|44|||
33563554|NCT02971137|101959539|FG001|Overall Study|Lost to Follow-up|56|||
33563555|NCT00959049|101959540|FG000|Overall Study|Adverse Event|1|||
33563556|NCT00959049|101959541|FG001|Overall Study|Adverse Event|0|||
33563557|NCT00959049|101959542|FG002|Overall Study|Adverse Event|0|||
33563558|NCT00959049|101959543|FG003|Overall Study|Adverse Event|0|||
33362115|NCT00306891|101214301|FG003|Part B|Development of study specific disc crit.|1|||
33362116|NCT01522651|101214302|FG000|Overall Study|Adverse Event|3|||
33362117|NCT01522651|101214303|FG001|Overall Study|Adverse Event|4|||
33415386|NCT00557830|101410040|FG001|Screening Treatment Phase|Adverse Event|0|||
33415387|NCT00557830|101410041|FG002|Screening Treatment Phase|Adverse Event|0|||
33563559|NCT00959049|101959544|FG004|Overall Study|Adverse Event|0|||
33627648|NCT04423718|102187706|FG000|Overall Study|Withdrawal by Subject|6|||
33563560|NCT00959049|101959545|FG005|Overall Study|Adverse Event|0|||
33563561|NCT00959049|101959540|FG000|Overall Study|Lost to Follow-up|17|||
33221804|NCT05056870|100711227|FG000|Period 1|Site COVID-19 Related|3|||
33221805|NCT05056870|100711228|FG001|Period 1|Site COVID-19 Related|3|||
33221806|NCT05056870|100711227|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
33221807|NCT05056870|100711228|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
33221808|NCT05056870|100711227|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
33221809|NCT05056870|100711228|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
33221810|NCT05056870|100711227|FG000|Period 2|COVID-19 Related|1|||
33221811|NCT05056870|100711228|FG001|Period 2|COVID-19 Related|0|||
33221812|NCT05056870|100711227|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
33221813|NCT05056870|100711228|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
33221814|NCT04539821|100711229|FG000|Overall Study|Withdrawal by Subject|2|||
33221815|NCT04539821|100711229|FG000|Overall Study|continued care with their physician|20|||
33221816|NCT04539821|100711229|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
33221817|NCT03002610|100711233|FG000|Overall Study|Withdrawal by Subject|6|||
33221818|NCT03002610|100711234|FG001|Overall Study|Withdrawal by Subject|25|||
33221819|NCT03002610|100711235|FG002|Overall Study|Withdrawal by Subject|13|||
33221820|NCT01489189|100711236|FG000|Overall Study|Withdrawal by Subject|20|||
33221821|NCT01489189|100711237|FG001|Overall Study|Withdrawal by Subject|23|||
33221822|NCT01489189|100711236|FG000|Overall Study|Death|10|||
33221823|NCT01489189|100711237|FG001|Overall Study|Death|8|||
33221824|NCT01489189|100711236|FG000|Overall Study|Missed Visit|1|||
33221825|NCT01489189|100711237|FG001|Overall Study|Missed Visit|4|||
33221826|NCT00886639|100711238|FG000|Overall Study|acute exacerbation|14|||
33221827|NCT00886639|100711238|FG000|Overall Study|non-compliance|2|||
33221828|NCT02207725|100711240|FG000|Overall Study|Did Not Receive Treatment|0|||
33221829|NCT02207725|100711241|FG001|Overall Study|Did Not Receive Treatment|1|||
33221830|NCT02207725|100711242|FG002|Overall Study|Did Not Receive Treatment|1|||
33221831|NCT02207725|100711243|FG003|Overall Study|Did Not Receive Treatment|1|||
33221832|NCT01553318|100711244|FG000|Overall Study|Protocol Violation|3|||
33221833|NCT01553318|100711245|FG001|Overall Study|Protocol Violation|2|||
33221834|NCT03520400|100711248|FG000|Overall Study|Physician Decision|15|||
33221835|NCT03520400|100711249|FG001|Overall Study|Physician Decision|7|||
33221836|NCT01392300|100711251|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
33221837|NCT01392300|100711252|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
33221838|NCT01392300|100711253|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
33221839|NCT01392300|100711251|FG000|Main Period (MP)|Withdrawal by Subject|5|||
33221840|NCT01392300|100711252|FG001|Main Period (MP)|Withdrawal by Subject|1|||
33221841|NCT01392300|100711253|FG002|Main Period (MP)|Withdrawal by Subject|0|||
33221842|NCT01392300|100711251|FG000|Main Period (MP)|Lost to Follow-up|3|||
33221843|NCT01392300|100711252|FG001|Main Period (MP)|Lost to Follow-up|3|||
33221844|NCT01392300|100711253|FG002|Main Period (MP)|Lost to Follow-up|0|||
33221845|NCT01392300|100711251|FG000|Main Period (MP)|Non-compliance|1|||
33221846|NCT01392300|100711252|FG001|Main Period (MP)|Non-compliance|0|||
33221847|NCT01392300|100711253|FG002|Main Period (MP)|Non-compliance|0|||
33221848|NCT01392300|100711251|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
33221849|NCT01392300|100711252|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
33221850|NCT01392300|100711253|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
33221851|NCT01392300|100711251|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
33221852|NCT01392300|100711252|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
33221853|NCT01392300|100711253|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
33221854|NCT01392300|100711251|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
33221855|NCT01392300|100711252|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
33362118|NCT01522651|101214304|FG002|Overall Study|Adverse Event|4|||
33563562|NCT00959049|101959541|FG001|Overall Study|Lost to Follow-up|5|||
33563563|NCT00959049|101959542|FG002|Overall Study|Lost to Follow-up|1|||
33563564|NCT00959049|101959543|FG003|Overall Study|Lost to Follow-up|10|||
33563565|NCT00959049|101959544|FG004|Overall Study|Lost to Follow-up|9|||
33563566|NCT00959049|101959545|FG005|Overall Study|Lost to Follow-up|1|||
33563567|NCT00959049|101959540|FG000|Overall Study|Contraindicated medication|0|||
33563568|NCT00959049|101959541|FG001|Overall Study|Contraindicated medication|0|||
33563569|NCT00959049|101959542|FG002|Overall Study|Contraindicated medication|0|||
33563570|NCT00959049|101959543|FG003|Overall Study|Contraindicated medication|1|||
33221856|NCT01392300|100711253|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
33221857|NCT01392300|100711251|FG000|Open Label Extension (OLEX) Period|Death|0|||
33221858|NCT01392300|100711252|FG001|Open Label Extension (OLEX) Period|Death|0|||
33221859|NCT01392300|100711253|FG002|Open Label Extension (OLEX) Period|Death|4|||
33221860|NCT01392300|100711251|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
33221861|NCT01392300|100711252|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
33221862|NCT01392300|100711253|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
33221863|NCT01392300|100711251|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
33221864|NCT01392300|100711252|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
33563571|NCT00959049|101959544|FG004|Overall Study|Contraindicated medication|0|||
33563572|NCT00959049|101959545|FG005|Overall Study|Contraindicated medication|0|||
33221865|NCT01392300|100711253|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
33221866|NCT01392300|100711251|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
33221867|NCT01392300|100711252|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
33221868|NCT01392300|100711253|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
33221869|NCT01662063|100711254|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
33221870|NCT01662063|100711255|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
33221871|NCT01662063|100711256|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
33221872|NCT01662063|100711254|FG000|Overall Study|Lack of Efficacy|1|||
33221873|NCT01662063|100711255|FG001|Overall Study|Lack of Efficacy|6|||
33221874|NCT01662063|100711256|FG002|Overall Study|Lack of Efficacy|0|||
33221875|NCT01662063|100711254|FG000|Overall Study|Lost to Follow-up|0|||
33221876|NCT01662063|100711255|FG001|Overall Study|Lost to Follow-up|4|||
33221877|NCT01662063|100711256|FG002|Overall Study|Lost to Follow-up|0|||
33221878|NCT01662063|100711254|FG000|Overall Study|Protocol Violation|1|||
33221879|NCT01662063|100711255|FG001|Overall Study|Protocol Violation|0|||
33221880|NCT01662063|100711256|FG002|Overall Study|Protocol Violation|0|||
33221881|NCT01662063|100711254|FG000|Overall Study|Withdrawal by Subject|2|||
33221882|NCT01662063|100711255|FG001|Overall Study|Withdrawal by Subject|4|||
33221883|NCT01662063|100711256|FG002|Overall Study|Withdrawal by Subject|1|||
33221884|NCT01662063|100711254|FG000|Overall Study|Physician Decision|0|||
33221885|NCT01662063|100711255|FG001|Overall Study|Physician Decision|2|||
33221886|NCT01662063|100711256|FG002|Overall Study|Physician Decision|0|||
33221887|NCT01662063|100711254|FG000|Overall Study|Other|0|||
33221888|NCT01662063|100711255|FG001|Overall Study|Other|1|||
33221889|NCT01662063|100711256|FG002|Overall Study|Other|0|||
33221890|NCT00058422|100711258|FG000|Overall Study|Not treated|2|||
33221891|NCT05597722|100711259|FG000|Overall Study|Study was terminated|6|||
33221892|NCT05597722|100711260|FG001|Overall Study|Study was terminated|1|||
33221893|NCT01786330|100711261|FG000|Overall Study|Withdrawal by Subject|0|||
33221894|NCT01786330|100711262|FG001|Overall Study|Withdrawal by Subject|1|||
33221895|NCT01786330|100711261|FG000|Overall Study|Lost to Follow-up|0|||
33221896|NCT01786330|100711262|FG001|Overall Study|Lost to Follow-up|1|||
33221897|NCT01786330|100711261|FG000|Overall Study|Excluded intraoperatively|0|||
33221898|NCT01786330|100711262|FG001|Overall Study|Excluded intraoperatively|1|||
33221899|NCT01786330|100711261|FG000|Overall Study|Protocol Violation|1|||
33221900|NCT01786330|100711262|FG001|Overall Study|Protocol Violation|0|||
33221901|NCT04080752|100711263|FG000|Overall Study|Adverse Event|2|||
33221902|NCT04080752|100711264|FG001|Overall Study|Adverse Event|3|||
33221903|NCT04080752|100711263|FG000|Overall Study|Lack of Efficacy|1|||
33221904|NCT04080752|100711264|FG001|Overall Study|Lack of Efficacy|0|||
33221905|NCT04080752|100711263|FG000|Overall Study|Lost to Follow-up|1|||
33362119|NCT01522651|101214305|FG003|Overall Study|Adverse Event|5|||
33563573|NCT00959049|101959540|FG000|Overall Study|Withdrawal by Subject|0|||
33563574|NCT00959049|101959541|FG001|Overall Study|Withdrawal by Subject|2|||
33563575|NCT00959049|101959542|FG002|Overall Study|Withdrawal by Subject|0|||
33563576|NCT00959049|101959543|FG003|Overall Study|Withdrawal by Subject|0|||
33563577|NCT00959049|101959544|FG004|Overall Study|Withdrawal by Subject|0|||
33563578|NCT00959049|101959545|FG005|Overall Study|Withdrawal by Subject|0|||
33563579|NCT04034927|101959546|FG000|Overall Study|Adverse Event|4|||
33563580|NCT04034927|101959547|FG001|Overall Study|Adverse Event|9|||
33563581|NCT04034927|101959546|FG000|Overall Study|Death|0|||
33563582|NCT04034927|101959547|FG001|Overall Study|Death|1|||
33362120|NCT01522651|101214306|FG004|Overall Study|Adverse Event|4|||
33362121|NCT01522651|101214302|FG000|Overall Study|Cardioversion|1|||
33362122|NCT01522651|101214303|FG001|Overall Study|Cardioversion|0|||
33362123|NCT01522651|101214304|FG002|Overall Study|Cardioversion|0|||
33362124|NCT01522651|101214305|FG003|Overall Study|Cardioversion|0|||
33362125|NCT01522651|101214306|FG004|Overall Study|Cardioversion|0|||
33362126|NCT01522651|101214302|FG000|Overall Study|Device Malfunction|0|||
33362127|NCT01522651|101214303|FG001|Overall Study|Device Malfunction|1|||
33362128|NCT01522651|101214304|FG002|Overall Study|Device Malfunction|0|||
33362129|NCT01522651|101214305|FG003|Overall Study|Device Malfunction|0|||
33563583|NCT04034927|101959546|FG000|Overall Study|Withdrawal by Subject|0|||
33563584|NCT04034927|101959547|FG001|Overall Study|Withdrawal by Subject|3|||
33221906|NCT04080752|100711264|FG001|Overall Study|Lost to Follow-up|0|||
33221907|NCT04080752|100711263|FG000|Overall Study|Pregnancy|0|||
33221908|NCT04080752|100711264|FG001|Overall Study|Pregnancy|1|||
33221909|NCT04080752|100711263|FG000|Overall Study|Withdrawal by Subject|7|||
33221910|NCT04080752|100711264|FG001|Overall Study|Withdrawal by Subject|0|||
33221911|NCT04080752|100711263|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33221912|NCT04080752|100711264|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33221913|NCT04080752|100711263|FG000|Overall Study|Other|2|||
33221914|NCT04080752|100711264|FG001|Overall Study|Other|1|||
33362130|NCT01522651|101214306|FG004|Overall Study|Device Malfunction|0|||
33362131|NCT01522651|101214302|FG000|Overall Study|Investigator's Discretion|0|||
33362132|NCT01522651|101214303|FG001|Overall Study|Investigator's Discretion|1|||
33563585|NCT04034927|101959546|FG000|Overall Study|Still on Treatment|2|||
33563586|NCT04034927|101959547|FG001|Overall Study|Still on Treatment|1|||
33415388|NCT00557830|101410039|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
33415389|NCT00557830|101410040|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
33415390|NCT00557830|101410041|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
33415391|NCT04278872|101410042|FG000|Overall Study|Adverse Event|1|||
33415392|NCT04278872|101410043|FG001|Overall Study|Adverse Event|0|||
33415393|NCT04278872|101410042|FG000|Overall Study|Protocol Violation|0|||
33415394|NCT04278872|101410043|FG001|Overall Study|Protocol Violation|1|||
33415395|NCT04278872|101410042|FG000|Overall Study|Study Termination|2|||
33415396|NCT04278872|101410043|FG001|Overall Study|Study Termination|0|||
33415397|NCT02181673|101410046|FG000|Up to Week 24|Adverse Event|2|||
33415398|NCT02181673|101410047|FG001|Up to Week 24|Adverse Event|0|||
33415399|NCT02181673|101410048|FG002|Up to Week 24|Adverse Event|3|||
33415400|NCT02181673|101410046|FG000|Up to Week 24|Death|1|||
33415401|NCT02181673|101410047|FG001|Up to Week 24|Death|0|||
33415402|NCT02181673|101410048|FG002|Up to Week 24|Death|0|||
33415403|NCT02181673|101410046|FG000|Up to Week 24|Lack of Efficacy|1|||
33415404|NCT02181673|101410047|FG001|Up to Week 24|Lack of Efficacy|0|||
33415405|NCT02181673|101410048|FG002|Up to Week 24|Lack of Efficacy|0|||
33415406|NCT02181673|101410046|FG000|Up to Week 24|Lost to Follow-up|1|||
33415407|NCT02181673|101410047|FG001|Up to Week 24|Lost to Follow-up|0|||
33415408|NCT02181673|101410048|FG002|Up to Week 24|Lost to Follow-up|0|||
33415409|NCT02181673|101410046|FG000|Up to Week 24|Physician Decision|0|||
33415410|NCT02181673|101410047|FG001|Up to Week 24|Physician Decision|0|||
33415411|NCT02181673|101410048|FG002|Up to Week 24|Physician Decision|3|||
33415412|NCT02181673|101410046|FG000|Up to Week 24|Withdrawal by Subject|10|||
33415413|NCT02181673|101410047|FG001|Up to Week 24|Withdrawal by Subject|0|||
33415414|NCT02181673|101410048|FG002|Up to Week 24|Withdrawal by Subject|1|||
33415415|NCT02181673|101410046|FG000|Up to Week 24|Other|2|||
33415416|NCT02181673|101410047|FG001|Up to Week 24|Other|0|||
33415417|NCT02181673|101410048|FG002|Up to Week 24|Other|3|||
33415418|NCT02181673|101410046|FG000|Up to Week 24|Randomized not Treated|0|||
33415419|NCT02181673|101410047|FG001|Up to Week 24|Randomized not Treated|0|||
33362133|NCT01522651|101214304|FG002|Overall Study|Investigator's Discretion|0|||
33362134|NCT01522651|101214305|FG003|Overall Study|Investigator's Discretion|0|||
33362135|NCT01522651|101214306|FG004|Overall Study|Investigator's Discretion|0|||
33362136|NCT01522651|101214302|FG000|Overall Study|Protocol Violation|3|||
33362137|NCT01522651|101214303|FG001|Overall Study|Protocol Violation|0|||
33362138|NCT01522651|101214304|FG002|Overall Study|Protocol Violation|0|||
33362139|NCT01522651|101214305|FG003|Overall Study|Protocol Violation|0|||
33362140|NCT01522651|101214306|FG004|Overall Study|Protocol Violation|0|||
33362141|NCT01522651|101214302|FG000|Overall Study|Reason Not Specified|0|||
33415420|NCT02181673|101410048|FG002|Up to Week 24|Randomized not Treated|1|||
33415421|NCT02181673|101410046|FG000|Week 24-Week 60|Adverse Event|0|||
33415422|NCT02181673|101410047|FG001|Week 24-Week 60|Adverse Event|4|||
33415423|NCT02181673|101410048|FG002|Week 24-Week 60|Adverse Event|10|||
33415424|NCT02181673|101410046|FG000|Week 24-Week 60|Other|0|||
33415425|NCT02181673|101410047|FG001|Week 24-Week 60|Other|2|||
33415426|NCT02181673|101410048|FG002|Week 24-Week 60|Other|1|||
33415427|NCT02181673|101410046|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
33415428|NCT02181673|101410047|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
33415429|NCT02181673|101410048|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
33415430|NCT02181673|101410046|FG000|Week 24-Week 60|Pregnancy|0|||
33415431|NCT02181673|101410047|FG001|Week 24-Week 60|Pregnancy|0|||
33415432|NCT02181673|101410048|FG002|Week 24-Week 60|Pregnancy|1|||
33415433|NCT02181673|101410046|FG000|Week 24-Week 60|Lack of Efficacy|0|||
33415434|NCT02181673|101410047|FG001|Week 24-Week 60|Lack of Efficacy|0|||
33415435|NCT02181673|101410048|FG002|Week 24-Week 60|Lack of Efficacy|1|||
33415436|NCT02181673|101410046|FG000|Week 24-Week 60|Lost to Follow-up|0|||
33415437|NCT02181673|101410047|FG001|Week 24-Week 60|Lost to Follow-up|0|||
33415438|NCT02181673|101410048|FG002|Week 24-Week 60|Lost to Follow-up|1|||
33415439|NCT02181673|101410046|FG000|Week 24-Week 60|Physician Decision|0|||
33415440|NCT02181673|101410047|FG001|Week 24-Week 60|Physician Decision|0|||
33415441|NCT02181673|101410048|FG002|Week 24-Week 60|Physician Decision|1|||
33362142|NCT01522651|101214303|FG001|Overall Study|Reason Not Specified|0|||
33362143|NCT01522651|101214304|FG002|Overall Study|Reason Not Specified|0|||
33362144|NCT01522651|101214305|FG003|Overall Study|Reason Not Specified|1|||
33415442|NCT04362761|101410050|FG000|Part A (48 Weeks)|Adverse Event|2|||
33415443|NCT04362761|101410050|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
33415444|NCT04362761|101410050|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
33415445|NCT04362761|101410050|FG000|Part A (48 Weeks)|Other|5|||
33415446|NCT04362761|101410050|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
33415447|NCT04362761|101410050|FG000|Part B (86 Weeks)|Other|4|||
33415448|NCT04512976|101410051|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
33415449|NCT04512976|101410052|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
33415450|NCT04512976|101410053|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
33415451|NCT04512976|101410054|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
33415452|NCT04512976|101410055|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
33627649|NCT04423718|102187707|FG001|Overall Study|Withdrawal by Subject|8|||
33627650|NCT04423718|102187708|FG002|Overall Study|Withdrawal by Subject|14|||
33362145|NCT01522651|101214306|FG004|Overall Study|Reason Not Specified|0|||
33362146|NCT01522651|101214302|FG000|Overall Study|Participant Non-Compliance|1|||
33362147|NCT01522651|101214303|FG001|Overall Study|Participant Non-Compliance|0|||
33362148|NCT01522651|101214304|FG002|Overall Study|Participant Non-Compliance|0|||
33362149|NCT01522651|101214305|FG003|Overall Study|Participant Non-Compliance|0|||
33362150|NCT01522651|101214306|FG004|Overall Study|Participant Non-Compliance|0|||
33362151|NCT01522651|101214302|FG000|Overall Study|Withdrew Consent|1|||
33362152|NCT01522651|101214303|FG001|Overall Study|Withdrew Consent|1|||
33362153|NCT01522651|101214304|FG002|Overall Study|Withdrew Consent|0|||
33362154|NCT01522651|101214305|FG003|Overall Study|Withdrew Consent|1|||
33362155|NCT01522651|101214306|FG004|Overall Study|Withdrew Consent|1|||
33362156|NCT01522651|101214302|FG000|Overall Study|Randomized but Never Treated|0|||
33362157|NCT01522651|101214303|FG001|Overall Study|Randomized but Never Treated|1|||
33362158|NCT01522651|101214304|FG002|Overall Study|Randomized but Never Treated|0|||
33362159|NCT01522651|101214305|FG003|Overall Study|Randomized but Never Treated|1|||
33362160|NCT01522651|101214306|FG004|Overall Study|Randomized but Never Treated|1|||
33362161|NCT01001494|101214318|FG000|Overall Study|Adverse Event|8|||
33362162|NCT01001494|101214319|FG001|Overall Study|Adverse Event|4|||
33362163|NCT01001494|101214320|FG002|Overall Study|Adverse Event|6|||
33362164|NCT01001494|101214318|FG000|Overall Study|Protocol Violation|0|||
33362165|NCT01001494|101214319|FG001|Overall Study|Protocol Violation|1|||
33362166|NCT01001494|101214320|FG002|Overall Study|Protocol Violation|1|||
33362167|NCT01001494|101214318|FG000|Overall Study|Lost to Follow-up|2|||
33362168|NCT01001494|101214319|FG001|Overall Study|Lost to Follow-up|0|||
33362169|NCT01001494|101214320|FG002|Overall Study|Lost to Follow-up|1|||
33362170|NCT01001494|101214318|FG000|Overall Study|Withdrawal by Subject|9|||
33362171|NCT01001494|101214319|FG001|Overall Study|Withdrawal by Subject|7|||
33362172|NCT01001494|101214320|FG002|Overall Study|Withdrawal by Subject|17|||
33362173|NCT01001494|101214318|FG000|Overall Study|COPD exacerbation|3|||
33362174|NCT01001494|101214319|FG001|Overall Study|COPD exacerbation|4|||
33362175|NCT01001494|101214320|FG002|Overall Study|COPD exacerbation|5|||
33362176|NCT01001494|101214318|FG000|Overall Study|Lack of Efficacy|2|||
33362177|NCT01001494|101214319|FG001|Overall Study|Lack of Efficacy|0|||
33362178|NCT01001494|101214320|FG002|Overall Study|Lack of Efficacy|8|||
33362179|NCT01001494|101214318|FG000|Overall Study|Other|0|||
33362180|NCT01001494|101214319|FG001|Overall Study|Other|1|||
33362181|NCT01001494|101214320|FG002|Overall Study|Other|3|||
33362182|NCT02413255|101214321|FG000|Overall Study|Voluntary Withdrawal|0|||
33362183|NCT02413255|101214322|FG001|Overall Study|Voluntary Withdrawal|0|||
33362184|NCT02413255|101214323|FG002|Overall Study|Voluntary Withdrawal|0|||
33362185|NCT02413255|101214324|FG003|Overall Study|Voluntary Withdrawal|0|||
33362186|NCT02413255|101214325|FG004|Overall Study|Voluntary Withdrawal|0|||
33362187|NCT02413255|101214326|FG005|Overall Study|Voluntary Withdrawal|0|||
33362188|NCT02413255|101214327|FG006|Overall Study|Voluntary Withdrawal|0|||
33362189|NCT02413255|101214328|FG007|Overall Study|Voluntary Withdrawal|0|||
33362190|NCT02413255|101214329|FG008|Overall Study|Voluntary Withdrawal|0|||
33362191|NCT02413255|101214330|FG009|Overall Study|Voluntary Withdrawal|0|||
33362192|NCT02413255|101214331|FG010|Overall Study|Voluntary Withdrawal|0|||
33362193|NCT02413255|101214332|FG011|Overall Study|Voluntary Withdrawal|0|||
33362194|NCT02413255|101214333|FG012|Overall Study|Voluntary Withdrawal|0|||
33362195|NCT02413255|101214334|FG013|Overall Study|Voluntary Withdrawal|0|||
33362196|NCT02413255|101214335|FG014|Overall Study|Voluntary Withdrawal|1|||
33362197|NCT02413255|101214336|FG015|Overall Study|Voluntary Withdrawal|0|||
33362198|NCT02413255|101214337|FG016|Overall Study|Voluntary Withdrawal|0|||
33362199|NCT02342171|101214339|FG000|Overall Study|Death|4|||
33362200|NCT02342171|101214340|FG001|Overall Study|Death|87|||
33362201|NCT02342171|101214339|FG000|Overall Study|Received favipiravir|10|||
33362202|NCT02342171|101214340|FG001|Overall Study|Received favipiravir|0|||
33362203|NCT02342171|101214339|FG000|Overall Study|Missing cycle treshold value|1|||
33362204|NCT02342171|101214340|FG001|Overall Study|Missing cycle treshold value|0|||
33415453|NCT04512976|101410056|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
33627651|NCT04423718|102187706|FG000|Overall Study|Death|5|||
33627652|NCT04423718|102187707|FG001|Overall Study|Death|3|||
33627653|NCT04423718|102187708|FG002|Overall Study|Death|2|||
33362205|NCT02342171|101214339|FG000|Overall Study|Unknown outcome|0|||
33362206|NCT02342171|101214340|FG001|Overall Study|Unknown outcome|1|||
33362207|NCT02342171|101214339|FG000|Overall Study|Missing age data|0|||
33362208|NCT02342171|101214340|FG001|Overall Study|Missing age data|1|||
33627654|NCT04423718|102187706|FG000|Overall Study|COVID-19 pandemic|2|||
33362209|NCT02760602|101214341|FG000|Overall Study|Withdrawal by Subject|1|||
33362210|NCT02760602|101214342|FG001|Overall Study|Withdrawal by Subject|0|||
33362211|NCT02760602|101214341|FG000|Overall Study|Terminated by sponsor|12|||
33362212|NCT02760602|101214342|FG001|Overall Study|Terminated by sponsor|13|||
33362213|NCT01041573|101214343|FG000|Overall Study|Withdrawal by Subject|2|||
33627655|NCT04423718|102187707|FG001|Overall Study|COVID-19 pandemic|2|||
33627656|NCT04423718|102187708|FG002|Overall Study|COVID-19 pandemic|2|||
33415454|NCT03205163|101410061|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
33415455|NCT03205163|101410062|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
33415456|NCT00891527|101410063|FG000|Overall Study|Withdrawal by Subject|2|||
33415457|NCT05279807|101410064|FG000|Overall Study|Withdrawal by Subject|1|||
33627657|NCT04423718|102187706|FG000|Overall Study|Other|6|||
33627658|NCT04423718|102187707|FG001|Overall Study|Other|2|||
33627659|NCT04423718|102187708|FG002|Overall Study|Other|2|||
33563587|NCT04034927|101959546|FG000|Overall Study|Other|1|||
33563588|NCT04034927|101959547|FG001|Overall Study|Other|1|||
33627660|NCT04423718|102187706|FG000|Overall Study|Unknown if completed study treatment until Week 60|3|||
33627661|NCT04423718|102187707|FG001|Overall Study|Unknown if completed study treatment until Week 60|3|||
33627662|NCT04423718|102187708|FG002|Overall Study|Unknown if completed study treatment until Week 60|1|||
33627663|NCT03253393|102187709|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
33627664|NCT03253393|102187710|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
33627665|NCT03253393|102187711|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
33627666|NCT00445549|102187712|FG000|Overall Study|progressive disease|12|||
33627667|NCT02782676|102187714|FG000|Overall Study|Lost to Follow-up|0|||
33627668|NCT02782676|102187715|FG001|Overall Study|Lost to Follow-up|1|||
33627669|NCT01706458|102187716|FG000|Overall Study|Physician Decision|3|||
33627670|NCT01706458|102187717|FG001|Overall Study|Physician Decision|4|||
33627671|NCT01921205|102187718|FG000|Overall Study|Adverse Event|12|||
33627672|NCT01921205|102187719|FG001|Overall Study|Adverse Event|7|||
33627673|NCT01921205|102187718|FG000|Overall Study|Lack of Efficacy|1|||
33221915|NCT04710927|100711265|FG000|Overall Study|Lost to Follow-up|7|||
33362214|NCT01041573|101214344|FG001|Overall Study|Withdrawal by Subject|5|||
33362215|NCT01041573|101214345|FG002|Overall Study|Withdrawal by Subject|2|||
33362216|NCT01041573|101214346|FG003|Overall Study|Withdrawal by Subject|0|||
33362217|NCT01041573|101214343|FG000|Overall Study|Death|1|||
33362218|NCT01041573|101214344|FG001|Overall Study|Death|0|||
33362219|NCT01041573|101214345|FG002|Overall Study|Death|0|||
33362220|NCT01041573|101214346|FG003|Overall Study|Death|0|||
33362221|NCT01041573|101214343|FG000|Overall Study|Lost to Follow-up|0|||
33362222|NCT01041573|101214344|FG001|Overall Study|Lost to Follow-up|1|||
33362223|NCT01041573|101214345|FG002|Overall Study|Lost to Follow-up|2|||
33362224|NCT01041573|101214346|FG003|Overall Study|Lost to Follow-up|1|||
33362225|NCT01041573|101214343|FG000|Overall Study|Adverse Event|0|||
33362226|NCT01041573|101214344|FG001|Overall Study|Adverse Event|2|||
33362227|NCT01041573|101214345|FG002|Overall Study|Adverse Event|0|||
33362228|NCT01041573|101214346|FG003|Overall Study|Adverse Event|0|||
33362229|NCT01041573|101214343|FG000|Overall Study|relocation|1|||
33362230|NCT01041573|101214344|FG001|Overall Study|relocation|4|||
33362231|NCT01041573|101214345|FG002|Overall Study|relocation|3|||
33362232|NCT01041573|101214346|FG003|Overall Study|relocation|1|||
33362233|NCT01041573|101214343|FG000|Overall Study|further blood extraction|0|||
33563589|NCT02014103|101959548|FG000|Overall Study|Protocol Violation|7|||
33563590|NCT02014103|101959549|FG001|Overall Study|Protocol Violation|7|||
33563591|NCT02014103|101959548|FG000|Overall Study|Adverse Event|1|||
33563592|NCT02014103|101959549|FG001|Overall Study|Adverse Event|0|||
33563593|NCT02014103|101959548|FG000|Overall Study|Lost venous access|1|||
33563594|NCT02014103|101959549|FG001|Overall Study|Lost venous access|0|||
33563595|NCT02014103|101959548|FG000|Overall Study|Withdrawal by Subject|0|||
33362234|NCT01041573|101214344|FG001|Overall Study|further blood extraction|1|||
33415458|NCT05279807|101410065|FG001|Overall Study|Withdrawal by Subject|0|||
33563596|NCT02014103|101959549|FG001|Overall Study|Withdrawal by Subject|2|||
33627674|NCT01921205|102187719|FG001|Overall Study|Lack of Efficacy|0|||
33627675|NCT01921205|102187718|FG000|Overall Study|Protocol Violation|1|||
33221916|NCT04710927|100711266|FG001|Overall Study|Lost to Follow-up|6|||
33221917|NCT04710927|100711267|FG002|Overall Study|Lost to Follow-up|5|||
33221918|NCT03576768|100711268|FG000|Overall Study|Lost to Follow-up|3|||
33221919|NCT03576768|100711269|FG001|Overall Study|Lost to Follow-up|3|||
33221920|NCT03576768|100711270|FG002|Overall Study|Lost to Follow-up|0|||
33221921|NCT03576768|100711271|FG003|Overall Study|Lost to Follow-up|0|||
33221922|NCT00521144|100711272|FG000|Overall Study|Not Treated|0|||
33221923|NCT00521144|100711273|FG001|Overall Study|Not Treated|0|||
33221924|NCT00521144|100711274|FG002|Overall Study|Not Treated|0|||
33221925|NCT00521144|100711275|FG003|Overall Study|Not Treated|1|||
33221926|NCT00521144|100711276|FG004|Overall Study|Not Treated|0|||
33415459|NCT05279807|101410064|FG000|Overall Study|Adverse Event|0|||
33415460|NCT05279807|101410065|FG001|Overall Study|Adverse Event|1|||
33415461|NCT05279807|101410064|FG000|Overall Study|Laboratory Abnormal Results|1|||
33415462|NCT05279807|101410065|FG001|Overall Study|Laboratory Abnormal Results|0|||
33415463|NCT04484805|101410066|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
33563597|NCT05375929|101959550|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
33563598|NCT05375929|101959551|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
33627676|NCT01921205|102187719|FG001|Overall Study|Protocol Violation|3|||
33415464|NCT04484805|101410067|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
33415465|NCT04484805|101410066|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
33415466|NCT04484805|101410067|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
33415467|NCT01125358|101410068|FG000|Overall Study|Adverse Event|3|||
33415468|NCT01125358|101410069|FG001|Overall Study|Adverse Event|0|||
33563599|NCT05375929|101959552|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
33563600|NCT05375929|101959553|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
33563601|NCT05375929|101959550|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
33563602|NCT05375929|101959551|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
33563603|NCT05375929|101959552|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
33563604|NCT05375929|101959553|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
33563605|NCT05375929|101959550|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
33563606|NCT05375929|101959551|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
33563607|NCT05375929|101959552|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
33563608|NCT05375929|101959553|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
33563609|NCT05375929|101959550|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
33563610|NCT05375929|101959551|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
33563611|NCT05375929|101959552|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
33563612|NCT05375929|101959553|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
33563613|NCT05375929|101959550|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
33563614|NCT05375929|101959551|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
33563615|NCT05375929|101959552|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
33563616|NCT05375929|101959553|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
33563617|NCT05375929|101959550|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
33563618|NCT05375929|101959551|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
33563619|NCT05375929|101959552|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
33563620|NCT05375929|101959553|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
33563621|NCT05375929|101959550|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
33563622|NCT05375929|101959551|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
33563623|NCT05375929|101959552|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
33563624|NCT05375929|101959553|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
33563625|NCT05375929|101959550|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
33563626|NCT05375929|101959551|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
33563627|NCT05375929|101959552|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
33563628|NCT05375929|101959553|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
33563629|NCT05375929|101959550|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
33563630|NCT05375929|101959551|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
33563631|NCT05375929|101959552|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
33563632|NCT05375929|101959553|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
33627677|NCT01921205|102187718|FG000|Overall Study|Lost to Follow-up|1|||
33221927|NCT00521144|100711272|FG000|Overall Study|Adverse Event|0|||
33221928|NCT00521144|100711273|FG001|Overall Study|Adverse Event|1|||
33221929|NCT00521144|100711274|FG002|Overall Study|Adverse Event|0|||
33362235|NCT01041573|101214345|FG002|Overall Study|further blood extraction|0|||
33221930|NCT00521144|100711275|FG003|Overall Study|Adverse Event|0|||
33221931|NCT00521144|100711276|FG004|Overall Study|Adverse Event|1|||
33221932|NCT00521144|100711272|FG000|Overall Study|Progressive Disease|4|||
33221933|NCT00521144|100711273|FG001|Overall Study|Progressive Disease|2|||
33362236|NCT01041573|101214346|FG003|Overall Study|further blood extraction|0|||
33627678|NCT01921205|102187719|FG001|Overall Study|Lost to Follow-up|1|||
33627679|NCT01921205|102187718|FG000|Overall Study|Withdrawal by Subject|6|||
33627680|NCT01921205|102187719|FG001|Overall Study|Withdrawal by Subject|5|||
33627681|NCT01921205|102187718|FG000|Overall Study|Use Of Prohibited Medication|0|||
33563633|NCT05375929|101959550|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
33563634|NCT05375929|101959551|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
33563635|NCT05375929|101959552|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
33563636|NCT05375929|101959553|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
33563637|NCT00112385|101959562|FG000|Overall Study|Lost to Follow-up|1|||
33563638|NCT00112385|101959563|FG001|Overall Study|Lost to Follow-up|0|||
33563639|NCT00112385|101959562|FG000|Overall Study|Withdrawal by Subject|0|||
33563640|NCT00112385|101959563|FG001|Overall Study|Withdrawal by Subject|1|||
33563641|NCT00979407|101959570|FG000|Overall Study|Withdrawal by Subject|3|||
33563642|NCT00979407|101959571|FG001|Overall Study|Withdrawal by Subject|4|||
33563643|NCT00979407|101959570|FG000|Overall Study|Lost to Follow-up|3|||
33563644|NCT00979407|101959571|FG001|Overall Study|Lost to Follow-up|3|||
33563645|NCT03436732|101959572|FG000|Overall Study|Not treated-enrolled in different study|1|||
33563646|NCT03436732|101959573|FG001|Overall Study|Not treated-enrolled in different study|0|||
33563647|NCT03436732|101959572|FG000|Overall Study|Off study after cycle 1|1|||
33563648|NCT03436732|101959573|FG001|Overall Study|Off study after cycle 1|0|||
33563649|NCT03436732|101959572|FG000|Overall Study|Adverse Event|2|||
33563650|NCT03436732|101959573|FG001|Overall Study|Adverse Event|0|||
33563651|NCT03436732|101959572|FG000|Overall Study|Death|0|||
33563652|NCT03436732|101959573|FG001|Overall Study|Death|1|||
33563653|NCT02936323|101959578|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
33563654|NCT02936323|101959579|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
33563655|NCT02936323|101959580|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
33563656|NCT02936323|101959581|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
33563657|NCT02936323|101959582|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
33563658|NCT02936323|101959583|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
33563659|NCT02936323|101959584|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
33563660|NCT02936323|101959585|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
33563661|NCT02936323|101959586|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
33563662|NCT02936323|101959587|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
33563663|NCT02936323|101959578|FG000|Phase 1 Dose Escalation|Death|2|||
33563664|NCT02936323|101959579|FG001|Phase 1 Dose Escalation|Death|1|||
33627682|NCT01921205|102187719|FG001|Overall Study|Use Of Prohibited Medication|1|||
33563665|NCT02936323|101959580|FG002|Phase 1 Dose Escalation|Death|3|||
33563666|NCT02936323|101959581|FG003|Phase 1 Dose Escalation|Death|1|||
33563667|NCT02936323|101959582|FG004|Phase 1 Dose Escalation|Death|2|||
33563668|NCT02936323|101959583|FG005|Phase 1 Dose Escalation|Death|3|||
33563669|NCT02936323|101959584|FG006|Phase 1 Dose Escalation|Death|3|||
33563670|NCT02936323|101959585|FG007|Phase 1 Dose Escalation|Death|0|||
33563671|NCT02936323|101959586|FG008|Phase 1 Dose Escalation|Death|0|||
33563672|NCT02936323|101959587|FG009|Phase 1 Dose Escalation|Death|0|||
33563673|NCT02936323|101959578|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33563674|NCT02936323|101959579|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33415469|NCT01125358|101410070|FG002|Overall Study|Adverse Event|0|||
33415470|NCT01125358|101410071|FG003|Overall Study|Adverse Event|2|||
33415471|NCT01125358|101410068|FG000|Overall Study|Perceived Lack of Efficacy|6|||
33415472|NCT01125358|101410069|FG001|Overall Study|Perceived Lack of Efficacy|3|||
33415473|NCT01125358|101410070|FG002|Overall Study|Perceived Lack of Efficacy|7|||
33415474|NCT01125358|101410071|FG003|Overall Study|Perceived Lack of Efficacy|4|||
33415475|NCT01125358|101410068|FG000|Overall Study|Protocol Violation|1|||
33415476|NCT01125358|101410069|FG001|Overall Study|Protocol Violation|0|||
33415477|NCT01125358|101410070|FG002|Overall Study|Protocol Violation|0|||
33415478|NCT01125358|101410071|FG003|Overall Study|Protocol Violation|0|||
33415479|NCT01125358|101410068|FG000|Overall Study|Sponsor Decision|0|||
33415480|NCT01125358|101410069|FG001|Overall Study|Sponsor Decision|0|||
33415481|NCT01125358|101410070|FG002|Overall Study|Sponsor Decision|1|||
33563675|NCT02936323|101959580|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33563676|NCT02936323|101959581|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33563677|NCT02936323|101959582|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33627683|NCT01921205|102187718|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
33415482|NCT01125358|101410071|FG003|Overall Study|Sponsor Decision|1|||
33415483|NCT01125358|101410068|FG000|Overall Study|Withdrawal by Subject|2|||
33415484|NCT01125358|101410069|FG001|Overall Study|Withdrawal by Subject|1|||
33415485|NCT01125358|101410070|FG002|Overall Study|Withdrawal by Subject|1|||
33415486|NCT01125358|101410071|FG003|Overall Study|Withdrawal by Subject|1|||
33415487|NCT04341727|101410076|FG000|Overall Study|Withdrawal by Subject|0|||
33415488|NCT04341727|101410077|FG001|Overall Study|Withdrawal by Subject|0|||
33415489|NCT04341727|101410078|FG002|Overall Study|Withdrawal by Subject|1|||
33627684|NCT01921205|102187719|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
33627685|NCT01921205|102187718|FG000|Overall Study|Non Compliance Of The Parent|0|||
33627686|NCT01921205|102187719|FG001|Overall Study|Non Compliance Of The Parent|1|||
33627687|NCT01921205|102187718|FG000|Overall Study|Non Compliance Of Child|0|||
33627688|NCT01921205|102187719|FG001|Overall Study|Non Compliance Of Child|1|||
33627689|NCT04002960|102187721|FG000|Overall Study|Withdrawn prior to Completion|2|||
33627690|NCT00308139|102187722|FG000|Overall Study|Adverse Event|20|||
33415490|NCT04341727|101410079|FG003|Overall Study|Withdrawal by Subject|0|||
33415491|NCT04341727|101410076|FG000|Overall Study|Lost to Follow-up|0|||
33221934|NCT00521144|100711274|FG002|Overall Study|Progressive Disease|2|||
33415492|NCT04341727|101410077|FG001|Overall Study|Lost to Follow-up|0|||
33415493|NCT04341727|101410078|FG002|Overall Study|Lost to Follow-up|0|||
33415494|NCT04341727|101410079|FG003|Overall Study|Lost to Follow-up|1|||
33563678|NCT02936323|101959583|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
33563679|NCT02936323|101959584|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33627691|NCT00308139|102187723|FG001|Overall Study|Adverse Event|14|||
33627692|NCT00308139|102187722|FG000|Overall Study|Lost to Follow-up|13|||
33415495|NCT00558831|101410080|FG000|Overall Study|Lost to Follow-up|1|||
33415496|NCT04342390|101410081|FG000|Overall Study|Lost to Follow-up|3|||
33415497|NCT04342390|101410082|FG001|Overall Study|Lost to Follow-up|0|||
33627693|NCT00308139|102187723|FG001|Overall Study|Lost to Follow-up|8|||
33627694|NCT00308139|102187722|FG000|Overall Study|Protocol Violation|3|||
33627695|NCT00308139|102187723|FG001|Overall Study|Protocol Violation|2|||
33627696|NCT00308139|102187722|FG000|Overall Study|Withdrawal of Consent|40|||
33627697|NCT00308139|102187723|FG001|Overall Study|Withdrawal of Consent|42|||
33627698|NCT00308139|102187722|FG000|Overall Study|Investigator Decision|11|||
33627699|NCT00308139|102187723|FG001|Overall Study|Investigator Decision|10|||
33627700|NCT00308139|102187722|FG000|Overall Study|Loss of Glucose Control|5|||
33627701|NCT00308139|102187723|FG001|Overall Study|Loss of Glucose Control|7|||
33627702|NCT00308139|102187722|FG000|Overall Study|Administrative|1|||
33627703|NCT00308139|102187723|FG001|Overall Study|Administrative|4|||
33627704|NCT00308139|102187722|FG000|Overall Study|Other|1|||
33627705|NCT00308139|102187723|FG001|Overall Study|Other|0|||
33627706|NCT00772538|102187726|FG000|Overall Study|Adverse Event|6|||
33627707|NCT00772538|102187727|FG001|Overall Study|Adverse Event|6|||
33627708|NCT00772538|102187726|FG000|Overall Study|Protocol Violation|3|||
33627709|NCT00772538|102187727|FG001|Overall Study|Protocol Violation|3|||
33627710|NCT00772538|102187726|FG000|Overall Study|Lost to Follow-up|1|||
33627711|NCT00772538|102187727|FG001|Overall Study|Lost to Follow-up|1|||
33627712|NCT00772538|102187726|FG000|Overall Study|Withdrawal by Subject|3|||
33627713|NCT00772538|102187727|FG001|Overall Study|Withdrawal by Subject|8|||
33627714|NCT00772538|102187726|FG000|Overall Study|Lack of Efficacy|0|||
33627715|NCT00772538|102187727|FG001|Overall Study|Lack of Efficacy|1|||
33627716|NCT00772538|102187726|FG000|Overall Study|Other|7|||
33627717|NCT00772538|102187727|FG001|Overall Study|Other|7|||
33627718|NCT00524485|102187728|FG000|Overall Study|Withdrawal by Subject|5|||
33627719|NCT03532542|102187731|FG000|Overall Study|Death|1|||
33627720|NCT03532542|102187732|FG001|Overall Study|Death|0|||
33627721|NCT03532542|102187731|FG000|Overall Study|Study Terminated by Sponsor|41|||
33362237|NCT01041573|101214343|FG000|Overall Study|positive to anti-HCV|1|||
33362238|NCT01041573|101214344|FG001|Overall Study|positive to anti-HCV|0|||
33362239|NCT01041573|101214345|FG002|Overall Study|positive to anti-HCV|0|||
33362240|NCT01041573|101214346|FG003|Overall Study|positive to anti-HCV|0|||
33362241|NCT00945191|101214347|FG000|Overall Study|Did not achieve a complete response|18|||
33362242|NCT00945191|101214347|FG000|Overall Study|Participant relocated to another state|1|||
33362243|NCT00945191|101214347|FG000|Overall Study|Disease progression|3|||
33362244|NCT00945191|101214347|FG000|Overall Study|Serious adverse event or adverse event|1|||
33362245|NCT00945191|101214347|FG000|Overall Study|Investigator's discretion|1|||
33362246|NCT01749735|101214348|FG000|Overall Study|Withdrawal by Subject|1|||
33362247|NCT01749735|101214349|FG001|Overall Study|Withdrawal by Subject|0|||
33362248|NCT05372315|101214360|FG000|Overall Study|Withdrawal by Subject|1|||
33362249|NCT05372315|101214361|FG001|Overall Study|Withdrawal by Subject|0|||
33362250|NCT01769404|101214362|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
33627722|NCT03532542|102187732|FG001|Overall Study|Study Terminated by Sponsor|65|||
33627723|NCT03532542|102187731|FG000|Overall Study|Withdrawal by Subject|6|||
33627724|NCT03532542|102187732|FG001|Overall Study|Withdrawal by Subject|5|||
33627725|NCT00083889|102187737|FG000|Overall Study|Adverse Event|76|||
33627726|NCT00083889|102187738|FG001|Overall Study|Adverse Event|86|||
33627727|NCT00083889|102187737|FG000|Overall Study|Protocol Violation|2|||
33627728|NCT00083889|102187738|FG001|Overall Study|Protocol Violation|2|||
33627729|NCT00083889|102187737|FG000|Overall Study|Withdrawal by Subject|22|||
33627730|NCT00083889|102187738|FG001|Overall Study|Withdrawal by Subject|24|||
33627731|NCT00083889|102187737|FG000|Overall Study|Lack of Efficacy|240|||
33627732|NCT00083889|102187738|FG001|Overall Study|Lack of Efficacy|219|||
33627733|NCT00083889|102187737|FG000|Overall Study|Decision of sponsor|32|||
33627734|NCT00083889|102187738|FG001|Overall Study|Decision of sponsor|4|||
33627735|NCT00083889|102187737|FG000|Overall Study|Randomized: did not take study drug|0|||
33627736|NCT00083889|102187738|FG001|Overall Study|Randomized: did not take study drug|15|||
33627737|NCT00083889|102187737|FG000|Overall Study|Completed on marketed sunitinub|3|||
33627738|NCT00083889|102187738|FG001|Overall Study|Completed on marketed sunitinub|0|||
33627739|NCT00083889|102187737|FG000|Overall Study|Crossover to SU011248|0|||
33221935|NCT00521144|100711275|FG003|Overall Study|Progressive Disease|0|||
33362251|NCT01769404|101214363|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
33362252|NCT01769404|101214362|FG000|Treatment Period 1|Withdrawal by Subject|3|||
33362253|NCT01769404|101214363|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33362254|NCT01769404|101214362|FG000|Treatment Period 1|Sponsor decision|1|||
33362255|NCT01769404|101214363|FG001|Treatment Period 1|Sponsor decision|0|||
33362256|NCT01769404|101214362|FG000|Treatment Period 2|Sponsor decision|7|||
33627740|NCT00083889|102187738|FG001|Overall Study|Crossover to SU011248|25|||
33627741|NCT00740220|102187739|FG000|Overall Study|screen failures (non-COPD patients)|9|||
33627742|NCT01539759|102187740|FG000|Overall Study|Lost to Follow-up|6|||
33627743|NCT01539759|102187741|FG001|Overall Study|Lost to Follow-up|8|||
33627744|NCT03309020|102187743|FG000|Overall Study|Death|1|||
33627745|NCT03309020|102187744|FG001|Overall Study|Death|0|||
33627746|NCT03309020|102187743|FG000|Overall Study|Did not undergo surgery|2|||
33627747|NCT03309020|102187744|FG001|Overall Study|Did not undergo surgery|1|||
33627748|NCT04050553|102187745|FG000|Period 1|Physician Decision|2|||
33627749|NCT04050553|102187746|FG001|Period 1|Physician Decision|2|||
33627750|NCT04050553|102187745|FG000|Period 1|Adverse Event|1|||
33627751|NCT04050553|102187746|FG001|Period 1|Adverse Event|1|||
33627752|NCT04050553|102187745|FG000|Period 1|Withdrawal by Subject|0|||
33627753|NCT04050553|102187746|FG001|Period 1|Withdrawal by Subject|1|||
33627754|NCT04050553|102187745|FG000|Wash-out|Adverse Event|0|||
33627755|NCT04050553|102187746|FG001|Wash-out|Adverse Event|1|||
33627756|NCT04050553|102187745|FG000|Wash-out|Withdrawal by Subject|0|||
33627757|NCT04050553|102187746|FG001|Wash-out|Withdrawal by Subject|1|||
33627758|NCT03353675|102187747|FG000|Overall Study|Adverse Event|4|||
33627759|NCT03337308|102187748|FG000|Overall Study|Adverse Event|2|||
33627760|NCT03337308|102187749|FG001|Overall Study|Adverse Event|3|||
33627761|NCT03337308|102187750|FG002|Overall Study|Adverse Event|3|||
33627762|NCT03337308|102187751|FG003|Overall Study|Adverse Event|1|||
33627763|NCT03337308|102187748|FG000|Overall Study|Lost to Follow-up|1|||
33627764|NCT03337308|102187749|FG001|Overall Study|Lost to Follow-up|2|||
33627765|NCT03337308|102187750|FG002|Overall Study|Lost to Follow-up|0|||
33627766|NCT03337308|102187751|FG003|Overall Study|Lost to Follow-up|0|||
33627767|NCT03337308|102187748|FG000|Overall Study|Withdrawal by Subject|2|||
33627768|NCT03337308|102187749|FG001|Overall Study|Withdrawal by Subject|1|||
33627769|NCT03337308|102187750|FG002|Overall Study|Withdrawal by Subject|2|||
33627770|NCT03337308|102187751|FG003|Overall Study|Withdrawal by Subject|1|||
33627771|NCT03337308|102187748|FG000|Overall Study|Protocol Violation|0|||
33627772|NCT03337308|102187749|FG001|Overall Study|Protocol Violation|1|||
33627773|NCT03337308|102187750|FG002|Overall Study|Protocol Violation|0|||
33627774|NCT03337308|102187751|FG003|Overall Study|Protocol Violation|0|||
33627775|NCT03597347|102187752|FG000|Overall Study|Withdrawal by Subject|1|||
33627776|NCT03597347|102187753|FG001|Overall Study|Withdrawal by Subject|1|||
33627777|NCT03597347|102187754|FG002|Overall Study|Withdrawal by Subject|0|||
33627778|NCT03597347|102187752|FG000|Overall Study|Withdrawal due to Covid-19|3|||
33627779|NCT03597347|102187753|FG001|Overall Study|Withdrawal due to Covid-19|0|||
33627780|NCT03597347|102187754|FG002|Overall Study|Withdrawal due to Covid-19|0|||
33627781|NCT03597347|102187752|FG000|Overall Study|Sponsor decision to terminate study|3|||
33627782|NCT03597347|102187753|FG001|Overall Study|Sponsor decision to terminate study|2|||
33627783|NCT03597347|102187754|FG002|Overall Study|Sponsor decision to terminate study|4|||
33627784|NCT03192176|102187757|FG000|Overall Study|Adverse Event|1|||
33627785|NCT03192176|102187758|FG001|Overall Study|Adverse Event|0|||
33627786|NCT03192176|102187759|FG002|Overall Study|Adverse Event|4|||
33627787|NCT03192176|102187760|FG003|Overall Study|Adverse Event|5|||
33627788|NCT03192176|102187761|FG004|Overall Study|Adverse Event|3|||
33627789|NCT03192176|102187762|FG005|Overall Study|Adverse Event|2|||
33627790|NCT03192176|102187763|FG006|Overall Study|Adverse Event|3|||
33627791|NCT03192176|102187764|FG007|Overall Study|Adverse Event|3|||
33627792|NCT03192176|102187757|FG000|Overall Study|Lost to Follow-up|0|||
33627793|NCT03192176|102187758|FG001|Overall Study|Lost to Follow-up|0|||
33627794|NCT03192176|102187759|FG002|Overall Study|Lost to Follow-up|1|||
33415498|NCT00276458|101410083|FG000|Overall Study|Adverse Event|0|||
33415499|NCT00276458|101410084|FG001|Overall Study|Adverse Event|2|||
33415500|NCT00276458|101410083|FG000|Overall Study|Lost to Follow-up|2|||
33415501|NCT00276458|101410084|FG001|Overall Study|Lost to Follow-up|2|||
33415502|NCT00276458|101410083|FG000|Overall Study|Protocol Violation|4|||
33415503|NCT00276458|101410084|FG001|Overall Study|Protocol Violation|3|||
33415504|NCT01600755|101410085|FG000|Overall Study|Withdrawal by Subject|6|||
33415505|NCT02875340|101410086|FG000|Overall Study|Death|2|||
33415506|NCT02875340|101410086|FG000|Overall Study|Withdrawal by Subject|2|||
33415507|NCT02875340|101410086|FG000|Overall Study|Physician Decision|3|||
33415508|NCT02875340|101410086|FG000|Overall Study|Adverse Event|1|||
33415509|NCT01513759|101410090|FG000|Overall Study|Protocol Violation|4|||
33415510|NCT01513759|101410090|FG000|Overall Study|Death during catheter placement|1|||
33415511|NCT01819467|101410091|FG000|Overall Study|Physician Decision|20|||
33415512|NCT01819467|101410092|FG001|Overall Study|Physician Decision|9|||
33415513|NCT01803464|101413030|FG000|Overall Study|Incomplete data|0|||
33415514|NCT01803464|101413031|FG001|Overall Study|Incomplete data|0|||
33627795|NCT03192176|102187760|FG003|Overall Study|Lost to Follow-up|2|||
33627796|NCT03192176|102187761|FG004|Overall Study|Lost to Follow-up|3|||
33415515|NCT01803464|101413032|FG002|Overall Study|Incomplete data|4|||
33627797|NCT03192176|102187762|FG005|Overall Study|Lost to Follow-up|1|||
33415516|NCT01803464|101413033|FG003|Overall Study|Incomplete data|0|||
33415517|NCT01803464|101413030|FG000|Overall Study|Withdrawal by Subject|1|||
33627798|NCT03192176|102187763|FG006|Overall Study|Lost to Follow-up|1|||
33627799|NCT03192176|102187764|FG007|Overall Study|Lost to Follow-up|1|||
33627800|NCT03192176|102187757|FG000|Overall Study|Physician Decision|1|||
33415518|NCT01803464|101413031|FG001|Overall Study|Withdrawal by Subject|0|||
33627801|NCT03192176|102187758|FG001|Overall Study|Physician Decision|0|||
33627802|NCT03192176|102187759|FG002|Overall Study|Physician Decision|0|||
33627803|NCT03192176|102187760|FG003|Overall Study|Physician Decision|0|||
33627804|NCT03192176|102187761|FG004|Overall Study|Physician Decision|0|||
33415519|NCT01803464|101413032|FG002|Overall Study|Withdrawal by Subject|0|||
33627805|NCT03192176|102187762|FG005|Overall Study|Physician Decision|2|||
33627806|NCT03192176|102187763|FG006|Overall Study|Physician Decision|1|||
33415520|NCT01803464|101413033|FG003|Overall Study|Withdrawal by Subject|0|||
33415521|NCT04881448|101413034|FG000|Overall Study|Study cancelled by sponsor|220|||
33415522|NCT04881448|101413034|FG000|Overall Study|Withdrawal by Subject|2|||
33415523|NCT04881448|101413034|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
33415524|NCT00391092|101413040|FG000|Overall Study|Death|78|||
33415525|NCT00391092|101413041|FG001|Overall Study|Death|81|||
33415526|NCT00391092|101413040|FG000|Overall Study|Lost to Follow-up|13|||
33415527|NCT00391092|101413041|FG001|Overall Study|Lost to Follow-up|18|||
33415528|NCT00391092|101413040|FG000|Overall Study|Alive on treatment|29|||
33415529|NCT00391092|101413041|FG001|Overall Study|Alive on treatment|33|||
33415530|NCT00391092|101413040|FG000|Overall Study|Alive in follow-up|88|||
33415531|NCT00391092|101413041|FG001|Overall Study|Alive in follow-up|84|||
33415532|NCT00646282|101413042|FG000|Overall Study|Protocol terminated|4|||
33415533|NCT00646282|101413043|FG001|Overall Study|Protocol terminated|4|||
33415534|NCT04639310|101413044|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
33563680|NCT02936323|101959585|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33563681|NCT02936323|101959586|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33563682|NCT02936323|101959587|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
33563683|NCT02936323|101959578|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
33627807|NCT03192176|102187764|FG007|Overall Study|Physician Decision|0|||
33627808|NCT03192176|102187757|FG000|Overall Study|Protocol Deviation|1|||
33627809|NCT03192176|102187758|FG001|Overall Study|Protocol Deviation|1|||
33627810|NCT03192176|102187759|FG002|Overall Study|Protocol Deviation|0|||
33627811|NCT03192176|102187760|FG003|Overall Study|Protocol Deviation|0|||
33627812|NCT03192176|102187761|FG004|Overall Study|Protocol Deviation|2|||
33627813|NCT03192176|102187762|FG005|Overall Study|Protocol Deviation|0|||
33627814|NCT03192176|102187763|FG006|Overall Study|Protocol Deviation|0|||
33627815|NCT03192176|102187764|FG007|Overall Study|Protocol Deviation|0|||
33627816|NCT03192176|102187757|FG000|Overall Study|Withdrawal by Subject|3|||
33627817|NCT03192176|102187758|FG001|Overall Study|Withdrawal by Subject|4|||
33627818|NCT03192176|102187759|FG002|Overall Study|Withdrawal by Subject|0|||
33627819|NCT03192176|102187760|FG003|Overall Study|Withdrawal by Subject|4|||
33627820|NCT03192176|102187761|FG004|Overall Study|Withdrawal by Subject|3|||
33627821|NCT03192176|102187762|FG005|Overall Study|Withdrawal by Subject|4|||
33627822|NCT03192176|102187763|FG006|Overall Study|Withdrawal by Subject|4|||
33627823|NCT03192176|102187764|FG007|Overall Study|Withdrawal by Subject|2|||
33627824|NCT03192176|102187757|FG000|Overall Study|Miscellaneous|1|||
33627825|NCT03192176|102187758|FG001|Overall Study|Miscellaneous|0|||
33627826|NCT03192176|102187759|FG002|Overall Study|Miscellaneous|1|||
33627827|NCT03192176|102187760|FG003|Overall Study|Miscellaneous|1|||
33627828|NCT03192176|102187761|FG004|Overall Study|Miscellaneous|1|||
33627829|NCT03192176|102187762|FG005|Overall Study|Miscellaneous|2|||
33627830|NCT03192176|102187763|FG006|Overall Study|Miscellaneous|0|||
33627831|NCT03192176|102187764|FG007|Overall Study|Miscellaneous|1|||
33627832|NCT05280717|102187765|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
33627833|NCT05280717|102187766|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
33563684|NCT02936323|101959579|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
33627834|NCT05280717|102187767|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
33627835|NCT05280717|102187768|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
33627836|NCT05280717|102187769|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
33627837|NCT05280717|102187770|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
33627838|NCT05280717|102187771|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
33627839|NCT05280717|102187765|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
33627840|NCT05280717|102187766|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
33627841|NCT05280717|102187767|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
33627842|NCT05280717|102187768|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
33627843|NCT05280717|102187769|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
33563685|NCT02936323|101959580|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
33563686|NCT02936323|101959581|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
33563687|NCT02936323|101959582|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
33627844|NCT05280717|102187770|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
33415535|NCT04639310|101413045|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
33415536|NCT02918318|101413048|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
33627845|NCT05280717|102187771|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
33627846|NCT05280717|102187765|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
33627847|NCT05280717|102187766|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
33415537|NCT02918318|101413049|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
33415538|NCT02918318|101413050|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
33415539|NCT02918318|101413051|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
33627848|NCT05280717|102187767|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
33627849|NCT05280717|102187768|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
33627850|NCT05280717|102187769|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
33627851|NCT05280717|102187770|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
33627852|NCT05280717|102187771|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
33627853|NCT05280717|102187765|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
33627854|NCT05280717|102187766|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
33627855|NCT05280717|102187767|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
33627856|NCT05280717|102187768|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
33627857|NCT05280717|102187769|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
33627858|NCT05280717|102187770|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
33627859|NCT05280717|102187771|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
33627860|NCT05280717|102187765|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
33627861|NCT05280717|102187766|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
33627862|NCT05280717|102187767|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
33627863|NCT05280717|102187768|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
33627864|NCT05280717|102187769|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
33627865|NCT05280717|102187770|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
33627866|NCT05280717|102187771|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
33627867|NCT05280717|102187765|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
33627868|NCT05280717|102187766|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
33563688|NCT02936323|101959583|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
33563689|NCT02936323|101959584|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
33627869|NCT05280717|102187767|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
33627870|NCT05280717|102187768|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
33627871|NCT05280717|102187769|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
33627872|NCT05280717|102187770|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
33627873|NCT05280717|102187771|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
33627874|NCT00449696|102187786|FG000|Overall Study|Other Treatment Required|6|||
33627875|NCT00449696|102187787|FG001|Overall Study|Other Treatment Required|1|||
33627876|NCT00449696|102187786|FG000|Overall Study|Withdrawal by Subject|5|||
33627877|NCT00449696|102187787|FG001|Overall Study|Withdrawal by Subject|5|||
33627878|NCT00449696|102187786|FG000|Overall Study|Lost to Follow-up|2|||
33627879|NCT00449696|102187787|FG001|Overall Study|Lost to Follow-up|3|||
33627880|NCT00449696|102187786|FG000|Overall Study|Others|7|||
33627881|NCT00449696|102187787|FG001|Overall Study|Others|0|||
33627882|NCT02384551|102187788|FG000|Overall Study|Lost to Follow-up|13|||
33627883|NCT02384551|102187789|FG001|Overall Study|Lost to Follow-up|14|||
33627884|NCT02384551|102187790|FG002|Overall Study|Lost to Follow-up|14|||
33627885|NCT02384551|102187791|FG003|Overall Study|Lost to Follow-up|14|||
33627886|NCT06308822|102187792|FG000|Overall Study|Mutation Status Not Confirmed|17|||
33627887|NCT06308822|102187792|FG000|Overall Study|Adverse Event|1|||
33627888|NCT06308822|102187792|FG000|Overall Study|Death|5|||
33627889|NCT06308822|102187792|FG000|Overall Study|Disease progression|8|||
33627890|NCT06308822|102187792|FG000|Overall Study|Withdrawal by Subject|1|||
33627891|NCT06308822|102187792|FG000|Overall Study|Physician Decision|3|||
33627892|NCT04349891|102187795|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
33627893|NCT04349891|102187796|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
33627894|NCT04349891|102187795|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
33627895|NCT04349891|102187796|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
33627896|NCT04349891|102187795|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
33627897|NCT04349891|102187796|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
33627898|NCT04349891|102187795|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
33627899|NCT04349891|102187796|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
33627900|NCT02994108|102187801|FG000|Intervention Messages|Withdrawal by Subject|2|||
33627901|NCT02994108|102187802|FG001|Intervention Messages|Withdrawal by Subject|0|||
33627902|NCT02994108|102187801|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
33563690|NCT02936323|101959585|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
33563691|NCT02936323|101959586|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
33563692|NCT02936323|101959587|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
33563693|NCT02936323|101959578|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
33563694|NCT02936323|101959579|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
33627903|NCT02994108|102187802|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
33627904|NCT02994108|102187801|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
33627905|NCT02994108|102187802|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
33627906|NCT02994108|102187801|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
33627907|NCT02994108|102187802|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
33627908|NCT01453049|102187803|FG000|Overall Study|Protocol Violation|2|||
33627909|NCT01453049|102187804|FG001|Overall Study|Protocol Violation|5|||
33627910|NCT01453049|102187803|FG000|Overall Study|Lost to Follow-up|2|||
33362257|NCT01769404|101214363|FG001|Treatment Period 2|Sponsor decision|0|||
33362258|NCT05635838|101214364|FG000|16-Week DBVC Period|Adverse Event|2|||
33362259|NCT05635838|101214365|FG001|16-Week DBVC Period|Adverse Event|0|||
33362260|NCT05635838|101214366|FG002|16-Week DBVC Period|Adverse Event|0|||
33362261|NCT05635838|101214367|FG003|16-Week DBVC Period|Adverse Event|0|||
33362262|NCT05635838|101214364|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
33362263|NCT05635838|101214365|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
33362264|NCT05635838|101214366|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
33362265|NCT05635838|101214367|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
33362266|NCT05635838|101214364|FG000|16-Week DBVC Period|Physician Decision|0|||
33362267|NCT05635838|101214365|FG001|16-Week DBVC Period|Physician Decision|1|||
33362268|NCT05635838|101214366|FG002|16-Week DBVC Period|Physician Decision|0|||
33362269|NCT05635838|101214367|FG003|16-Week DBVC Period|Physician Decision|0|||
33362270|NCT05635838|101214364|FG000|16-Week DBVC Period|Protocol Violation|1|||
33362271|NCT05635838|101214365|FG001|16-Week DBVC Period|Protocol Violation|0|||
33362272|NCT05635838|101214366|FG002|16-Week DBVC Period|Protocol Violation|0|||
33362273|NCT05635838|101214367|FG003|16-Week DBVC Period|Protocol Violation|0|||
33362274|NCT05635838|101214364|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
33362275|NCT05635838|101214365|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
33362276|NCT05635838|101214366|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
33362277|NCT05635838|101214367|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
33362278|NCT05635838|101214364|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
33362279|NCT05635838|101214365|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
33362280|NCT05635838|101214366|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
33362281|NCT05635838|101214367|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
33362282|NCT05635838|101214364|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
33362283|NCT05635838|101214365|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
33362284|NCT05635838|101214366|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
33362285|NCT05635838|101214367|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
33362286|NCT05635838|101214364|FG000|16-Week OLE Period|Adverse Event|0|||
33362287|NCT05635838|101214365|FG001|16-Week OLE Period|Adverse Event|0|||
33362288|NCT05635838|101214366|FG002|16-Week OLE Period|Adverse Event|0|||
33362289|NCT05635838|101214367|FG003|16-Week OLE Period|Adverse Event|2|||
33362290|NCT05635838|101214364|FG000|16-Week OLE Period|Lost to Follow-up|0|||
33362291|NCT05635838|101214365|FG001|16-Week OLE Period|Lost to Follow-up|0|||
33362292|NCT05635838|101214366|FG002|16-Week OLE Period|Lost to Follow-up|1|||
33362293|NCT05635838|101214367|FG003|16-Week OLE Period|Lost to Follow-up|3|||
33362294|NCT05635838|101214364|FG000|16-Week OLE Period|Physician Decision|0|||
33362295|NCT05635838|101214365|FG001|16-Week OLE Period|Physician Decision|0|||
33362296|NCT05635838|101214366|FG002|16-Week OLE Period|Physician Decision|0|||
33362297|NCT05635838|101214367|FG003|16-Week OLE Period|Physician Decision|1|||
33362298|NCT05635838|101214364|FG000|16-Week OLE Period|Protocol Violation|0|||
33362299|NCT05635838|101214365|FG001|16-Week OLE Period|Protocol Violation|0|||
33362300|NCT05635838|101214366|FG002|16-Week OLE Period|Protocol Violation|1|||
33362301|NCT05635838|101214367|FG003|16-Week OLE Period|Protocol Violation|1|||
33362302|NCT05635838|101214364|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
33362303|NCT05635838|101214365|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
33362304|NCT05635838|101214366|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
33362305|NCT05635838|101214367|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
33362306|NCT05635838|101214364|FG000|16-Week OLE Period|Pregnancy|0|||
33362307|NCT05635838|101214365|FG001|16-Week OLE Period|Pregnancy|0|||
33362308|NCT05635838|101214366|FG002|16-Week OLE Period|Pregnancy|1|||
33627911|NCT01453049|102187804|FG001|Overall Study|Lost to Follow-up|1|||
33627912|NCT01453049|102187803|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
33627913|NCT01453049|102187804|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
33627914|NCT01453049|102187803|FG000|Overall Study|Withdrawal by Subject|1|||
33627915|NCT01453049|102187804|FG001|Overall Study|Withdrawal by Subject|0|||
33627916|NCT01453049|102187803|FG000|Overall Study|Randomized in Error|1|||
33362309|NCT05635838|101214367|FG003|16-Week OLE Period|Pregnancy|0|||
33362310|NCT01853228|101214368|FG000|Phase 1|Lack of Efficacy|8|||
33627917|NCT01453049|102187804|FG001|Overall Study|Randomized in Error|0|||
33221936|NCT00521144|100711276|FG004|Overall Study|Progressive Disease|6|||
33221937|NCT00105235|100711280|FG000|Overall Study|Death|4|||
33362311|NCT01853228|101214369|FG001|Phase 1|Lack of Efficacy|0|||
33362312|NCT01853228|101214368|FG000|Phase 1|Other|1|||
33362313|NCT01853228|101214369|FG001|Phase 1|Other|0|||
33362314|NCT01853228|101214368|FG000|Phase 2|Physician Decision|0|||
33362315|NCT01853228|101214369|FG001|Phase 2|Physician Decision|1|||
33362316|NCT01853228|101214368|FG000|Phase 2|Proceed To Transplant|0|||
33627918|NCT01690052|102187805|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
33627919|NCT01690052|102187806|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
33362317|NCT01853228|101214369|FG001|Phase 2|Proceed To Transplant|3|||
33362318|NCT01853228|101214368|FG000|Phase 2|Lack of Efficacy|0|||
33563695|NCT02936323|101959580|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
33563696|NCT02936323|101959581|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
33563697|NCT02936323|101959582|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
33563698|NCT02936323|101959583|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
33563699|NCT02936323|101959584|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
33563700|NCT02936323|101959585|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
33563701|NCT02936323|101959586|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
33563702|NCT02936323|101959587|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
33563703|NCT02936323|101959578|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33563704|NCT02936323|101959579|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33563705|NCT02936323|101959580|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33563706|NCT02936323|101959581|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33563707|NCT02936323|101959582|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33563708|NCT02936323|101959583|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33563709|NCT02936323|101959584|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33563710|NCT02936323|101959585|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
33563711|NCT02936323|101959586|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
33563712|NCT02936323|101959587|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
33563713|NCT02936323|101959578|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33563714|NCT02936323|101959579|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33563715|NCT02936323|101959580|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33563716|NCT02936323|101959581|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33563717|NCT02936323|101959582|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33563718|NCT02936323|101959583|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33563719|NCT02936323|101959584|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33563720|NCT02936323|101959585|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33563721|NCT02936323|101959586|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
33563722|NCT02936323|101959587|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
33563723|NCT02936323|101959578|FG000|Phase 2a Dose Expansion|Death|0|||
33563724|NCT02936323|101959579|FG001|Phase 2a Dose Expansion|Death|0|||
33563725|NCT02936323|101959580|FG002|Phase 2a Dose Expansion|Death|0|||
33563726|NCT02936323|101959581|FG003|Phase 2a Dose Expansion|Death|0|||
33563727|NCT02936323|101959582|FG004|Phase 2a Dose Expansion|Death|0|||
33563728|NCT02936323|101959583|FG005|Phase 2a Dose Expansion|Death|0|||
33563729|NCT02936323|101959584|FG006|Phase 2a Dose Expansion|Death|0|||
33563730|NCT02936323|101959585|FG007|Phase 2a Dose Expansion|Death|4|||
33563731|NCT02936323|101959586|FG008|Phase 2a Dose Expansion|Death|8|||
33563732|NCT02936323|101959587|FG009|Phase 2a Dose Expansion|Death|10|||
33563733|NCT01817777|101959588|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
33563734|NCT01817777|101959589|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
33563735|NCT01817777|101959590|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
33563736|NCT01817777|101959588|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
33563737|NCT01817777|101959589|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
33563738|NCT01817777|101959590|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
33563739|NCT01817777|101959588|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
33563740|NCT01817777|101959589|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
33563741|NCT01817777|101959590|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
33563742|NCT01817777|101959588|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
33563743|NCT01817777|101959589|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
33563744|NCT01817777|101959590|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
33563745|NCT01817777|101959588|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
33563746|NCT01817777|101959589|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
33563747|NCT01817777|101959590|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
33563748|NCT03709472|101959593|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
33563749|NCT03709472|101959594|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
33563750|NCT03709472|101959593|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
33563751|NCT03709472|101959594|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
33563752|NCT00721110|101959597|FG000|Overall Study|Ultram use|1|||
33563753|NCT00721110|101959598|FG001|Overall Study|Ultram use|0|||
33563754|NCT00721110|101959599|FG002|Overall Study|Ultram use|0|||
33563755|NCT00721110|101959600|FG003|Overall Study|Ultram use|0|||
33563756|NCT00721110|101959597|FG000|Overall Study|vertical incision|0|||
33563757|NCT00721110|101959598|FG001|Overall Study|vertical incision|0|||
33563758|NCT00721110|101959599|FG002|Overall Study|vertical incision|1|||
33563759|NCT00721110|101959600|FG003|Overall Study|vertical incision|0|||
33563760|NCT02960893|101959601|FG000|Randomization Phase (8-week)|Adverse Event|5|||
33563761|NCT02960893|101959602|FG001|Randomization Phase (8-week)|Adverse Event|0|||
33563762|NCT02960893|101959601|FG000|Randomization Phase (8-week)|Withdrawal by Subject|2|||
33563763|NCT02960893|101959602|FG001|Randomization Phase (8-week)|Withdrawal by Subject|1|||
33362319|NCT01853228|101214369|FG001|Phase 2|Lack of Efficacy|4|||
33627920|NCT02343263|102187810|FG000|Overall Study|Physician Decision|5|||
33627921|NCT02343263|102187811|FG001|Overall Study|Physician Decision|3|||
33627922|NCT02343263|102187812|FG002|Overall Study|Physician Decision|1|||
33627923|NCT02285855|102187813|FG000|Overall Study|Withdrawal by Subject|2|||
33627924|NCT02285855|102187814|FG001|Overall Study|Withdrawal by Subject|1|||
33362320|NCT03090737|101214376|FG000|Overall Study|Other reasons|1|||
33362321|NCT03090737|101214376|FG000|Overall Study|Completed treatment as per protocol|17|||
33362322|NCT03090737|101214376|FG000|Overall Study|Maximum clinical benefit|2|||
33362323|NCT03090737|101214376|FG000|Overall Study|Adverse event unrelated to study drug|7|||
33362324|NCT03090737|101214376|FG000|Overall Study|Study drug toxicity|4|||
33362325|NCT03090737|101214376|FG000|Overall Study|Disease progression|98|||
33362326|NCT02224846|101214377|FG000|Period 1 (Month 3)|Adverse Event|2|||
33362327|NCT02224846|101214378|FG001|Period 1 (Month 3)|Adverse Event|1|||
33627925|NCT02636699|102187815|FG000|Overall Study|Adverse Event|4|||
33627926|NCT02636699|102187816|FG001|Overall Study|Adverse Event|0|||
33627927|NCT02636699|102187815|FG000|Overall Study|Lost to Follow-up|3|||
33627928|NCT02636699|102187816|FG001|Overall Study|Lost to Follow-up|3|||
33627929|NCT02636699|102187815|FG000|Overall Study|Non-compliance with the investigational product (IP)|2|||
33627930|NCT02636699|102187816|FG001|Overall Study|Non-compliance with the investigational product (IP)|0|||
33627931|NCT02636699|102187815|FG000|Overall Study|Physician Decision|0|||
33627932|NCT02636699|102187816|FG001|Overall Study|Physician Decision|1|||
33627933|NCT02636699|102187815|FG000|Overall Study|Withdrawal by Subject|13|||
33627934|NCT02636699|102187816|FG001|Overall Study|Withdrawal by Subject|6|||
33627935|NCT02636699|102187815|FG000|Overall Study|Other|3|||
33627936|NCT02636699|102187816|FG001|Overall Study|Other|1|||
33627937|NCT04124939|102187817|FG000|Overall Study|Lost to Follow-up|1|||
33627938|NCT04124939|102187818|FG001|Overall Study|Lost to Follow-up|3|||
33627939|NCT00001832|102187823|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
33627940|NCT00001832|102187824|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
33627941|NCT00001832|102187825|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
33627942|NCT00001832|102187826|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
33627943|NCT00001832|102187827|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
33627944|NCT00001832|102187828|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
33627945|NCT00001832|102187829|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
33627946|NCT00001832|102187830|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
33627947|NCT00001832|102187831|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
33627948|NCT00001832|102187832|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
33627949|NCT00001832|102187833|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
33627950|NCT00001832|102187834|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
33627951|NCT00001832|102187835|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
33627952|NCT00001832|102187836|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
33627953|NCT00001832|102187837|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
33362328|NCT02224846|101214377|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
33362329|NCT02224846|101214378|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
33362330|NCT02224846|101214377|FG000|Period 1 (Month 3)|Protocol Violation|4|||
33362331|NCT02224846|101214378|FG001|Period 1 (Month 3)|Protocol Violation|8|||
33563764|NCT02960893|101959601|FG000|Randomization Phase (8-week)|Reason Not Specified|0|||
33563765|NCT02960893|101959602|FG001|Randomization Phase (8-week)|Reason Not Specified|1|||
33563766|NCT02960893|101959601|FG000|Extension Phase (48-week)|Adverse Event|2|||
33563767|NCT02960893|101959602|FG001|Extension Phase (48-week)|Adverse Event|3|||
33563768|NCT02960893|101959601|FG000|Extension Phase (48-week)|Withdrawal by Subject|8|||
33563769|NCT02960893|101959602|FG001|Extension Phase (48-week)|Withdrawal by Subject|8|||
33563770|NCT02960893|101959601|FG000|Extension Phase (48-week)|Other Reason|2|||
33563771|NCT02960893|101959602|FG001|Extension Phase (48-week)|Other Reason|1|||
33563772|NCT02960893|101959601|FG000|Extension Phase (48-week)|Lost to Follow-up|1|||
33563773|NCT02960893|101959602|FG001|Extension Phase (48-week)|Lost to Follow-up|1|||
33563774|NCT02960893|101959601|FG000|Extension Phase (48-week)|Sponsors Decision|1|||
33563775|NCT02960893|101959602|FG001|Extension Phase (48-week)|Sponsors Decision|0|||
33563776|NCT03439072|101959603|FG000|Overall Study|Withdrawal by Subject|2|||
33563777|NCT03439072|101959604|FG001|Overall Study|Withdrawal by Subject|3|||
33221938|NCT00105235|100711280|FG000|Overall Study|Physician Decision|1|||
33362332|NCT02224846|101214377|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
33362333|NCT02224846|101214378|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
33221939|NCT00105235|100711280|FG000|Overall Study|Withdrawal by Subject|2|||
33362334|NCT02224846|101214377|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
33563778|NCT03439072|101959603|FG000|Overall Study|Physician Decision|0|||
33563779|NCT03439072|101959604|FG001|Overall Study|Physician Decision|1|||
33221940|NCT01224158|100711281|FG000|Overall Study|Withdrawal by Subject|1|||
33563780|NCT03502200|101959610|FG000|Overall Study|Adverse Event|1|||
33563781|NCT03502200|101959611|FG001|Overall Study|Adverse Event|0|||
33362335|NCT02224846|101214378|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
33362336|NCT02224846|101214377|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
33362337|NCT02224846|101214378|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
33362338|NCT02224846|101214377|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
33362339|NCT02224846|101214378|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
33362340|NCT02224846|101214377|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
33362341|NCT02224846|101214378|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
33362342|NCT02224846|101214377|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
33362343|NCT02224846|101214378|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
33362344|NCT02224846|101214377|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
33362345|NCT02224846|101214378|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
33362346|NCT02224846|101214377|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
33362347|NCT02224846|101214378|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
33362348|NCT02224846|101214377|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
33362349|NCT02224846|101214378|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
33362350|NCT02224846|101214377|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
33362351|NCT02224846|101214378|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
33362352|NCT02224846|101214377|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
33362353|NCT02224846|101214378|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
33362354|NCT02224846|101214377|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
33362355|NCT02224846|101214378|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
33362356|NCT02224846|101214377|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
33362357|NCT02224846|101214378|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
33362358|NCT02224846|101214377|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
33362359|NCT02224846|101214378|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
33362360|NCT04498910|101214379|FG000|Overall Study|Lost to Follow-up|0|||
33362361|NCT04498910|101214380|FG001|Overall Study|Lost to Follow-up|1|||
33362362|NCT04498910|101214379|FG000|Overall Study|Withdrawal by Subject|2|||
33362363|NCT04498910|101214380|FG001|Overall Study|Withdrawal by Subject|1|||
33362364|NCT04498910|101214379|FG000|Overall Study|Adverse Event|1|||
33362365|NCT04498910|101214380|FG001|Overall Study|Adverse Event|0|||
33362366|NCT04579393|101214382|FG000|Overall Study|Withdrawal by Subject|2|||
33362367|NCT04579393|101214383|FG001|Overall Study|Withdrawal by Subject|2|||
33362368|NCT04579393|101214382|FG000|Overall Study|Death|1|||
33362369|NCT04579393|101214383|FG001|Overall Study|Death|3|||
33362370|NCT02021812|101214384|FG000|Overall Study|Death|8|||
33362371|NCT02021812|101214384|FG000|Overall Study|Withdrawal by Subject|3|||
33362372|NCT02021812|101214384|FG000|Overall Study|Lost to Follow-up|2|||
33362373|NCT02021812|101214384|FG000|Overall Study|Refuse to return, COVD 19|2|||
33362374|NCT04083222|101214385|FG000|Overall Study|Voluntary Withdrawal|0|||
33362375|NCT04083222|101214386|FG001|Overall Study|Voluntary Withdrawal|1|||
33362376|NCT04083222|101214385|FG000|Overall Study|Reason not Specified|0|||
33362377|NCT04083222|101214386|FG001|Overall Study|Reason not Specified|1|||
33362378|NCT04021862|101214389|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
33362379|NCT04021862|101214390|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
33362380|NCT04021862|101214391|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
33362381|NCT04021862|101214392|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
33362382|NCT04021862|101214393|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
33362383|NCT04021862|101214394|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
33362384|NCT04021862|101214389|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
33362385|NCT04021862|101214390|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
33362386|NCT04021862|101214391|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
33362387|NCT04021862|101214392|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
33362388|NCT04021862|101214393|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
33362389|NCT04021862|101214394|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
33362390|NCT04021862|101214389|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
33362391|NCT04021862|101214390|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
33362392|NCT04021862|101214391|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
33362393|NCT04021862|101214392|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
33362394|NCT04021862|101214393|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
33362395|NCT04021862|101214394|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
33362396|NCT04021862|101214389|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
33362397|NCT04021862|101214390|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
33362398|NCT04021862|101214391|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
33362399|NCT04021862|101214392|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
33362400|NCT04021862|101214393|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
33362401|NCT04021862|101214394|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
33362402|NCT04021862|101214389|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
33362403|NCT04021862|101214390|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
33362404|NCT04021862|101214391|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
33362405|NCT04021862|101214392|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
33362406|NCT04021862|101214393|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
33362407|NCT04021862|101214394|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
33362408|NCT02117050|101214395|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
33362409|NCT03700892|101214398|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
33362410|NCT03700892|101214399|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
33362411|NCT03700892|101214400|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
33362412|NCT03000452|101214401|FG000|Treatment Period|Death|1|||
33362413|NCT03000452|101214401|FG000|Treatment Period|Progressive Disease (PD)|14|||
33362414|NCT03000452|101214401|FG000|Treatment Period|Physician Decision|1|||
33362415|NCT03000452|101214401|FG000|Treatment Period|Miscellaneous|2|||
33362416|NCT03000452|101214401|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
33362417|NCT03000452|101214401|FG000|Follow-Up Period|Death|3|||
33362418|NCT03000452|101214401|FG000|Follow-Up Period|Withdrawal by Subject|3|||
33362419|NCT02269319|101214402|FG000|Overall Study|Lost to Follow-up|4|||
33362420|NCT02269319|101214403|FG001|Overall Study|Lost to Follow-up|3|||
33362421|NCT02269319|101214402|FG000|Overall Study|Adverse Event|0|||
33362422|NCT02269319|101214403|FG001|Overall Study|Adverse Event|1|||
33362423|NCT02269319|101214402|FG000|Overall Study|Instructions not followed|1|||
33362424|NCT02269319|101214403|FG001|Overall Study|Instructions not followed|0|||
33362425|NCT00970294|101214404|FG000|Overall Study|Physician Decision|4|||
33362426|NCT00970294|101214404|FG000|Overall Study|Withdrawal by Subject|1|||
33362427|NCT00231062|101214405|FG000|Overall Study|Physician Decision|6|||
33362428|NCT00573131|101214407|FG000|Overall Study|Withdrawal by Subject|10|||
33362429|NCT00573131|101214408|FG001|Overall Study|Withdrawal by Subject|8|||
33362430|NCT00492921|101214409|FG000|Overall Study|Death|1|||
33362431|NCT00492921|101214410|FG001|Overall Study|Death|0|||
33362432|NCT00492921|101214411|FG002|Overall Study|Death|1|||
33362433|NCT00779038|101214413|FG000|Overall Study|Study Prematurely Terminated|13|||
33362434|NCT03366844|101214414|FG000|Overall Study|Physician Decision|1|||
33362435|NCT03366844|101214414|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
33362436|NCT00537940|101214415|FG000|Overall Study|Adverse Event|20|||
33362437|NCT00537940|101214416|FG001|Overall Study|Adverse Event|19|||
33362438|NCT00537940|101214415|FG000|Overall Study|Lack of Efficacy|8|||
33362439|NCT00537940|101214416|FG001|Overall Study|Lack of Efficacy|16|||
33362440|NCT00537940|101214415|FG000|Overall Study|Lost to Follow-up|23|||
33362441|NCT00537940|101214416|FG001|Overall Study|Lost to Follow-up|29|||
33362442|NCT00537940|101214415|FG000|Overall Study|Withdrawal by Subject|113|||
33362443|NCT00537940|101214416|FG001|Overall Study|Withdrawal by Subject|95|||
33362444|NCT00537940|101214415|FG000|Overall Study|Protocol Violation|6|||
33362445|NCT00537940|101214416|FG001|Overall Study|Protocol Violation|4|||
33362446|NCT00537940|101214415|FG000|Overall Study|Pregnancy|1|||
33362447|NCT00537940|101214416|FG001|Overall Study|Pregnancy|1|||
33362448|NCT00537940|101214415|FG000|Overall Study|Study terminated by sponsor|2|||
33362449|NCT00537940|101214416|FG001|Overall Study|Study terminated by sponsor|3|||
33563782|NCT03502200|101959610|FG000|Overall Study|Lost to Follow-up|36|||
33563783|NCT03502200|101959611|FG001|Overall Study|Lost to Follow-up|38|||
33362450|NCT00537940|101214415|FG000|Overall Study|Other|10|||
33362451|NCT00537940|101214416|FG001|Overall Study|Other|12|||
33362452|NCT00537745|101214417|FG000|Overall Study|Did not meet eligibility criteria|2|||
33362453|NCT00537745|101214417|FG000|Overall Study|Withdrawal by Subject|2|||
33362454|NCT00537745|101214417|FG000|Overall Study|Subject unable to provide Interlock info|1|||
33362455|NCT02973815|101214418|FG000|Post Intervention|Death|1|||
33362456|NCT02973815|101214419|FG001|Post Intervention|Death|0|||
33362457|NCT02973815|101214418|FG000|Post Intervention|Lost to Follow-up|7|||
33362458|NCT02973815|101214419|FG001|Post Intervention|Lost to Follow-up|24|||
33362459|NCT02973815|101214418|FG000|Follow-up|Lost to Follow-up|2|||
33362460|NCT02973815|101214419|FG001|Follow-up|Lost to Follow-up|0|||
33362461|NCT02698423|101214420|FG000|Overall Study|Lost to Follow-up|19|||
33362462|NCT02698423|101214421|FG001|Overall Study|Lost to Follow-up|24|||
33362463|NCT01408537|101214422|FG000|Overall Study|Withdrawal by Subject|2|||
33362464|NCT01408537|101214422|FG000|Overall Study|Protocol Violation|3|||
33362465|NCT01408537|101214422|FG000|Overall Study|Lost to Follow-up|3|||
33362466|NCT01645280|101214425|FG000|Overall Study|Death|0|||
33362467|NCT01645280|101214426|FG001|Overall Study|Death|1|||
33362468|NCT01645280|101214427|FG002|Overall Study|Death|0|||
33362469|NCT01645280|101214428|FG003|Overall Study|Death|0|||
33563784|NCT03502200|101959610|FG000|Overall Study|Study Team Decision|1|||
33563785|NCT03502200|101959611|FG001|Overall Study|Study Team Decision|1|||
33563786|NCT03502200|101959610|FG000|Overall Study|Withdrawal by Subject|5|||
33563787|NCT03502200|101959611|FG001|Overall Study|Withdrawal by Subject|7|||
33362470|NCT01645280|101214429|FG004|Overall Study|Death|0|||
33362471|NCT01645280|101214425|FG000|Overall Study|Withdrawal by Subject|4|||
33362472|NCT01645280|101214426|FG001|Overall Study|Withdrawal by Subject|0|||
33362473|NCT01645280|101214427|FG002|Overall Study|Withdrawal by Subject|2|||
33362474|NCT01645280|101214428|FG003|Overall Study|Withdrawal by Subject|4|||
33362475|NCT01645280|101214429|FG004|Overall Study|Withdrawal by Subject|5|||
33362476|NCT01645280|101214425|FG000|Overall Study|Lost to Follow-up|0|||
33362477|NCT01645280|101214426|FG001|Overall Study|Lost to Follow-up|0|||
33563788|NCT03502200|101959610|FG000|Overall Study|Death|0|||
33362478|NCT01645280|101214427|FG002|Overall Study|Lost to Follow-up|0|||
33362479|NCT01645280|101214428|FG003|Overall Study|Lost to Follow-up|2|||
33362480|NCT01645280|101214429|FG004|Overall Study|Lost to Follow-up|1|||
33362481|NCT01645280|101214425|FG000|Overall Study|Other|1|||
33362482|NCT01645280|101214426|FG001|Overall Study|Other|1|||
33362483|NCT01645280|101214427|FG002|Overall Study|Other|2|||
33362484|NCT01645280|101214428|FG003|Overall Study|Other|0|||
33362485|NCT01645280|101214429|FG004|Overall Study|Other|0|||
33362486|NCT01645280|101214425|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
33362487|NCT01645280|101214426|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
33362488|NCT01645280|101214427|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
33362489|NCT01645280|101214428|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
33362490|NCT01645280|101214429|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
33362491|NCT02961764|101214431|FG000|Overall Study|Protocol Violation|0|||
33362492|NCT02961764|101214432|FG001|Overall Study|Protocol Violation|1|||
33362493|NCT02961764|101214431|FG000|Overall Study|Death|2|||
33415540|NCT02918318|101413052|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
33362494|NCT02961764|101214432|FG001|Overall Study|Death|0|||
33362495|NCT02961764|101214431|FG000|Overall Study|Lost to Follow-up|35|||
33362496|NCT02961764|101214432|FG001|Overall Study|Lost to Follow-up|24|||
33415541|NCT02918318|101413048|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
33362497|NCT02961764|101214431|FG000|Overall Study|Withdrawal by Subject|2|||
33362498|NCT02961764|101214432|FG001|Overall Study|Withdrawal by Subject|0|||
33362499|NCT00487279|101214433|FG000|Overall Study|Death|1|||
33362500|NCT00487279|101214434|FG001|Overall Study|Death|0|||
33362501|NCT00487279|101214433|FG000|Overall Study|Withdrawal by Subject|0|||
33415542|NCT02918318|101413049|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
33415543|NCT02918318|101413050|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
33415544|NCT02918318|101413051|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
33415545|NCT02918318|101413052|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
33415546|NCT02918318|101413048|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
33563789|NCT03502200|101959611|FG001|Overall Study|Death|2|||
33563790|NCT04818229|101959612|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
33563791|NCT04818229|101959613|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
33563792|NCT04818229|101959614|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
33563793|NCT04818229|101959612|FG000|Overall Study|Adverse Event|3|||
33563794|NCT04818229|101959613|FG001|Overall Study|Adverse Event|1|||
33563795|NCT04818229|101959614|FG002|Overall Study|Adverse Event|1|||
33563796|NCT04818229|101959612|FG000|Overall Study|Withdrawal by Subject|0|||
33563797|NCT04818229|101959613|FG001|Overall Study|Withdrawal by Subject|0|||
33563798|NCT04818229|101959614|FG002|Overall Study|Withdrawal by Subject|2|||
33563799|NCT04818229|101959612|FG000|Overall Study|Lost to Follow-up|0|||
33563800|NCT04818229|101959613|FG001|Overall Study|Lost to Follow-up|0|||
33563801|NCT04818229|101959614|FG002|Overall Study|Lost to Follow-up|1|||
33563802|NCT02781558|101959615|FG000|Overall Study|Lost to Follow-up|2|||
33563803|NCT02781558|101959616|FG001|Overall Study|Lost to Follow-up|2|||
33627954|NCT00001832|102187823|FG000|Treatment Period|Death during treatment|0|||
33627955|NCT00001832|102187824|FG001|Treatment Period|Death during treatment|0|||
33627956|NCT00001832|102187825|FG002|Treatment Period|Death during treatment|0|||
33627957|NCT00001832|102187826|FG003|Treatment Period|Death during treatment|0|||
33627958|NCT00001832|102187827|FG004|Treatment Period|Death during treatment|0|||
33627959|NCT00001832|102187828|FG005|Treatment Period|Death during treatment|1|||
33627960|NCT00001832|102187829|FG006|Treatment Period|Death during treatment|0|||
33627961|NCT00001832|102187830|FG007|Treatment Period|Death during treatment|0|||
33627962|NCT00001832|102187831|FG008|Treatment Period|Death during treatment|0|||
33627963|NCT00001832|102187832|FG009|Treatment Period|Death during treatment|0|||
33627964|NCT00001832|102187833|FG010|Treatment Period|Death during treatment|0|||
33627965|NCT00001832|102187834|FG011|Treatment Period|Death during treatment|0|||
33627966|NCT00001832|102187835|FG012|Treatment Period|Death during treatment|0|||
33627967|NCT00001832|102187836|FG013|Treatment Period|Death during treatment|0|||
33627968|NCT00001832|102187837|FG014|Treatment Period|Death during treatment|0|||
33627969|NCT00001832|102187823|FG000|Treatment Period|Not treated|0|||
33627970|NCT00001832|102187824|FG001|Treatment Period|Not treated|0|||
33627971|NCT00001832|102187825|FG002|Treatment Period|Not treated|0|||
33627972|NCT00001832|102187826|FG003|Treatment Period|Not treated|0|||
33362502|NCT00487279|101214434|FG001|Overall Study|Withdrawal by Subject|2|||
33415547|NCT02918318|101413049|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
33415548|NCT02918318|101413050|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
33563804|NCT02781558|101959615|FG000|Overall Study|Adverse Event|1|||
33563805|NCT02781558|101959616|FG001|Overall Study|Adverse Event|0|||
33627973|NCT00001832|102187827|FG004|Treatment Period|Not treated|0|||
33627974|NCT00001832|102187828|FG005|Treatment Period|Not treated|0|||
33627975|NCT00001832|102187829|FG006|Treatment Period|Not treated|0|||
33362503|NCT00857246|101214439|FG000|Induction Regimen|Adverse Event|1|||
33362504|NCT00857246|101214439|FG000|Induction Regimen|disease-related complications|1|||
33362505|NCT00857246|101214439|FG000|Induction Regimen|Withdrawal by Subject|1|||
33563806|NCT01500135|101959625|FG000|Overall Study|Withdrawal of Consent|4|||
33563807|NCT01500135|101959626|FG001|Overall Study|Withdrawal of Consent|0|||
33563808|NCT01500135|101959625|FG000|Overall Study|Lost to Follow-up|6|||
33563809|NCT01500135|101959626|FG001|Overall Study|Lost to Follow-up|4|||
33563810|NCT01500135|101959625|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
33563811|NCT01500135|101959626|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
33563812|NCT01500135|101959625|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
33563813|NCT01500135|101959626|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
33563814|NCT01500135|101959625|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
33563815|NCT01500135|101959626|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
33563816|NCT01500135|101959625|FG000|Overall Study|Participant was a Safety Concern|1|||
33563817|NCT01500135|101959626|FG001|Overall Study|Participant was a Safety Concern|0|||
33563818|NCT01500135|101959625|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
33627976|NCT00001832|102187830|FG007|Treatment Period|Not treated|1|||
33627977|NCT00001832|102187831|FG008|Treatment Period|Not treated|0|||
33627978|NCT00001832|102187832|FG009|Treatment Period|Not treated|0|||
33627979|NCT00001832|102187833|FG010|Treatment Period|Not treated|0|||
33627980|NCT00001832|102187834|FG011|Treatment Period|Not treated|0|||
33563819|NCT01500135|101959626|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
33563820|NCT04573881|101959627|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
33563821|NCT04629196|101959632|FG000|Overall Study|Subject discontinued study drug|1|||
33563822|NCT04629196|101959633|FG001|Overall Study|Subject discontinued study drug|0|||
33221941|NCT01224158|100711282|FG001|Overall Study|Withdrawal by Subject|0|||
33221942|NCT02173054|100711283|FG000|Overall Study|lack of compliance|1|||
33221943|NCT02173054|100711284|FG001|Overall Study|lack of compliance|0|||
33221944|NCT02173054|100711285|FG002|Overall Study|lack of compliance|0|||
33221945|NCT02173054|100711283|FG000|Overall Study|Withdrawal by Subject|0|||
33221946|NCT02173054|100711284|FG001|Overall Study|Withdrawal by Subject|0|||
33221947|NCT02173054|100711285|FG002|Overall Study|Withdrawal by Subject|1|||
33221948|NCT00800202|100711286|FG000|Overall Study|Adverse Event|7|||
33221949|NCT00800202|100711287|FG001|Overall Study|Adverse Event|6|||
33221950|NCT00800202|100711286|FG000|Overall Study|Death|1|||
33221951|NCT00800202|100711287|FG001|Overall Study|Death|0|||
33221952|NCT00800202|100711286|FG000|Overall Study|Other|5|||
33221953|NCT00800202|100711287|FG001|Overall Study|Other|0|||
33221954|NCT00800202|100711286|FG000|Overall Study|Disease Progression|54|||
33221955|NCT00800202|100711287|FG001|Overall Study|Disease Progression|18|||
33221956|NCT04810221|100715630|FG000|Overall Study|Physician Decision|3|||
33221957|NCT00682643|100715633|FG000|Overall Study|Adverse Event|12|||
33221958|NCT00682643|100715634|FG001|Overall Study|Adverse Event|23|||
33563823|NCT04629196|101959632|FG000|Overall Study|Subject study drug dosing increased|1|||
33221959|NCT00682643|100715633|FG000|Overall Study|Lack of Efficacy|2|||
33221960|NCT00682643|100715634|FG001|Overall Study|Lack of Efficacy|0|||
33221961|NCT00682643|100715633|FG000|Overall Study|Protocol Violation|38|||
33221962|NCT00682643|100715634|FG001|Overall Study|Protocol Violation|76|||
33627981|NCT00001832|102187835|FG012|Treatment Period|Not treated|0|||
33221963|NCT00682643|100715633|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
33221964|NCT00682643|100715634|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
33221965|NCT00682643|100715633|FG000|Overall Study|Lost to Follow-up|1|||
33627982|NCT00001832|102187836|FG013|Treatment Period|Not treated|0|||
33221966|NCT00682643|100715634|FG001|Overall Study|Lost to Follow-up|6|||
33221967|NCT00682643|100715633|FG000|Overall Study|Physician Decision|2|||
33221968|NCT00682643|100715634|FG001|Overall Study|Physician Decision|6|||
33221969|NCT00682643|100715633|FG000|Overall Study|Withdrawal by Subject|19|||
33221970|NCT00682643|100715634|FG001|Overall Study|Withdrawal by Subject|53|||
33221971|NCT00682643|100715633|FG000|Overall Study|Did Not Receive Study Drug|1|||
33221972|NCT00682643|100715634|FG001|Overall Study|Did Not Receive Study Drug|1|||
33221973|NCT04899245|100715637|FG000|Overall Study|Withdrawal by Subject|3|||
33415549|NCT02918318|101413051|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
33415550|NCT02918318|101413052|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
33415551|NCT02918318|101413048|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
33415552|NCT02918318|101413049|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
33563824|NCT04629196|101959633|FG001|Overall Study|Subject study drug dosing increased|1|||
33563825|NCT04629196|101959632|FG000|Overall Study|Withdrawal by Subject|1|||
33627983|NCT00001832|102187837|FG014|Treatment Period|Not treated|0|||
33563826|NCT04629196|101959633|FG001|Overall Study|Withdrawal by Subject|2|||
33627984|NCT04481243|102187838|FG000|Overall Study|Withdrawal by Subject|4|||
33221974|NCT04899245|100715638|FG001|Overall Study|Withdrawal by Subject|5|||
33221975|NCT04899245|100715639|FG002|Overall Study|Withdrawal by Subject|2|||
33221976|NCT04899245|100715637|FG000|Overall Study|No longer eligible - Left staff position|0|||
33221977|NCT04899245|100715638|FG001|Overall Study|No longer eligible - Left staff position|0|||
33221978|NCT04899245|100715639|FG002|Overall Study|No longer eligible - Left staff position|1|||
33221979|NCT04899245|100715637|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
33221980|NCT04899245|100715638|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
33563827|NCT05418426|101959634|FG000|Overall Study|Adverse Event|0|||
33627985|NCT03253679|102187839|FG000|Overall Study|Screen Failure|1|||
33221981|NCT04899245|100715639|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
33221982|NCT04899245|100715637|FG000|Overall Study|No longer eligible - Moved away from area|2|||
33221983|NCT04899245|100715638|FG001|Overall Study|No longer eligible - Moved away from area|2|||
33221984|NCT04899245|100715639|FG002|Overall Study|No longer eligible - Moved away from area|0|||
33221985|NCT02316769|100715640|FG000|Overall Study|Physician Decision|1|||
33221986|NCT02316769|100715641|FG001|Overall Study|Physician Decision|0|||
33221987|NCT02316769|100715640|FG000|Overall Study|Withdrawal by Subject|1|||
33221988|NCT02316769|100715641|FG001|Overall Study|Withdrawal by Subject|0|||
33221989|NCT03988634|100715642|FG000|Double-Blind|Adverse Event|4|||
33221990|NCT03988634|100715643|FG001|Double-Blind|Adverse Event|0|||
33221991|NCT03988634|100715644|FG002|Double-Blind|Adverse Event|0|||
33221992|NCT03988634|100715642|FG000|Double-Blind|Death|18|||
33563828|NCT05418426|101959635|FG001|Overall Study|Adverse Event|1|||
33563829|NCT05418426|101959636|FG002|Overall Study|Adverse Event|0|||
33563830|NCT05418426|101959634|FG000|Overall Study|Withdrawal by Subject|0|||
33563831|NCT05418426|101959635|FG001|Overall Study|Withdrawal by Subject|1|||
33563832|NCT05418426|101959636|FG002|Overall Study|Withdrawal by Subject|0|||
33563833|NCT05418426|101959634|FG000|Overall Study|Protocol Violation|0|||
33627986|NCT01172535|102187840|FG000|Overall Study|Death|3|||
33627987|NCT01172535|102187840|FG000|Overall Study|Withdrawal by Subject|2|||
33221993|NCT03988634|100715643|FG001|Double-Blind|Death|26|||
33221994|NCT03988634|100715644|FG002|Double-Blind|Death|0|||
33221995|NCT03988634|100715642|FG000|Double-Blind|Lost to Follow-up|6|||
33563834|NCT05418426|101959635|FG001|Overall Study|Protocol Violation|0|||
33563835|NCT05418426|101959636|FG002|Overall Study|Protocol Violation|1|||
33563836|NCT05852340|101959643|FG000|Period 5|Not completing the meal|0|||
33563837|NCT05852340|101959644|FG001|Period 5|Not completing the meal|1|||
33563838|NCT05852340|101959645|FG002|Period 5|Not completing the meal|0|||
33563839|NCT05852340|101959646|FG003|Period 5|Not completing the meal|0|||
33563840|NCT05852340|101959643|FG000|Period 5|Adverse Event|0|||
33563841|NCT05852340|101959644|FG001|Period 5|Adverse Event|0|||
33563842|NCT05852340|101959645|FG002|Period 5|Adverse Event|0|||
33563843|NCT05852340|101959646|FG003|Period 5|Adverse Event|1|||
33563844|NCT01904279|101961844|FG000|Overall Study|Lack of Efficacy|2|||
33563845|NCT01904279|101961845|FG001|Overall Study|Lack of Efficacy|3|||
33563846|NCT01904279|101961844|FG000|Overall Study|Withdrawal by Subject|1|||
33563847|NCT01904279|101961845|FG001|Overall Study|Withdrawal by Subject|0|||
33563848|NCT00581919|101961848|FG000|Overall Study|Adverse Event|8|||
33563849|NCT00581919|101961848|FG000|Overall Study|Death|1|||
33563850|NCT00581919|101961848|FG000|Overall Study|Disease Progression|10|||
33563851|NCT00581919|101961848|FG000|Overall Study|Physician Decision|1|||
33563852|NCT00581919|101961848|FG000|Overall Study|Other Complicating Disease|1|||
33563853|NCT00581919|101961848|FG000|Overall Study|Started Non-Protocol Therapy|2|||
33563854|NCT00581919|101961848|FG000|Overall Study|Withdrawal by Subject|1|||
33563855|NCT01381679|101961849|FG000|Overall Study|Adverse Event|3|||
33563856|NCT01381679|101961849|FG000|Overall Study|Lost to Follow-up|885|||
33627988|NCT01172535|102187840|FG000|Overall Study|Lost to Follow-up|1|||
33627989|NCT01172535|102187840|FG000|Overall Study|Ineligible at study entry|1|||
33627990|NCT01172535|102187840|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
33627991|NCT01323582|102187842|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
33627992|NCT01323582|102187843|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
33627993|NCT01323582|102187842|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
33627994|NCT01323582|102187843|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
33627995|NCT01323582|102187842|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
33627996|NCT01323582|102187843|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
33627997|NCT04869982|102187844|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
33627998|NCT04869982|102187845|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
33627999|NCT04869982|102187844|FG000|Overall Study|Migrated / moved from the study area|1|||
33221996|NCT03988634|100715643|FG001|Double-Blind|Lost to Follow-up|7|||
33221997|NCT03988634|100715644|FG002|Double-Blind|Lost to Follow-up|0|||
33221998|NCT03988634|100715642|FG000|Double-Blind|Physician Decision|9|||
33563857|NCT03163667|101961854|FG000|Overall Study|Death|15|||
33563858|NCT03163667|101961855|FG001|Overall Study|Death|27|||
33563859|NCT03163667|101961854|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
33563860|NCT03163667|101961855|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
33563861|NCT00530257|101961858|FG000|Overall Study|Lost to Follow-up|1|||
33563862|NCT05715827|101961859|FG000|Overall Study|Physician Decision|0|||
33563863|NCT05715827|101961860|FG001|Overall Study|Physician Decision|1|||
33563864|NCT05715827|101961859|FG000|Overall Study|console communication error|0|||
33221999|NCT03988634|100715643|FG001|Double-Blind|Physician Decision|5|||
33222000|NCT03988634|100715644|FG002|Double-Blind|Physician Decision|0|||
33222001|NCT03988634|100715642|FG000|Double-Blind|Subject decision|24|||
33563865|NCT05715827|101961860|FG001|Overall Study|console communication error|1|||
33563866|NCT02679274|101961862|FG000|Overall Study|Withdrawal by Subject|1|||
33563867|NCT02679274|101961863|FG001|Overall Study|Withdrawal by Subject|0|||
33415553|NCT02918318|101413050|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
33415554|NCT02918318|101413051|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
33415555|NCT02918318|101413052|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
33415556|NCT02918318|101413048|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
33415557|NCT02918318|101413049|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
33415558|NCT02918318|101413050|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
33415559|NCT02918318|101413051|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
33415560|NCT02918318|101413052|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
33415561|NCT02918318|101413048|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
33415562|NCT02918318|101413049|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
33415563|NCT02918318|101413050|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
33415564|NCT02918318|101413051|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
33415565|NCT02918318|101413052|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
33415566|NCT02918318|101413048|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
33415567|NCT02918318|101413049|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
33415568|NCT02918318|101413050|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
33415569|NCT02918318|101413051|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
33415570|NCT02918318|101413052|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
33415571|NCT02918318|101413048|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
33415572|NCT02918318|101413049|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
33415573|NCT02918318|101413050|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
33415574|NCT02918318|101413051|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
33415575|NCT02918318|101413052|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
33628000|NCT04869982|102187845|FG001|Overall Study|Migrated / moved from the study area|1|||
33628001|NCT04869982|102187844|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
33628002|NCT04869982|102187845|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
33628003|NCT04869982|102187844|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
33628004|NCT04869982|102187845|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
33222002|NCT03988634|100715643|FG001|Double-Blind|Subject decision|13|||
33222003|NCT03988634|100715644|FG002|Double-Blind|Subject decision|0|||
33222004|NCT03988634|100715642|FG000|Open-Label|Adverse Event|0|||
33222005|NCT03988634|100715643|FG001|Open-Label|Adverse Event|0|||
33222006|NCT03988634|100715644|FG002|Open-Label|Adverse Event|7|||
33362506|NCT00857246|101214439|FG000|Surgery (Curative)|disease progression|6|||
33362507|NCT00857246|101214439|FG000|ChemoRT|Withdrawal by Subject|1|||
33362508|NCT00857246|101214439|FG000|ChemoRT|Adverse Event|2|||
33362509|NCT01342640|101214442|FG000|Overall Study|Adverse Event|3|||
33362510|NCT01342640|101214442|FG000|Overall Study|Protocol Violation|16|||
33362511|NCT01342640|101214442|FG000|Overall Study|Lost to Follow-up|21|||
33362512|NCT01342640|101214442|FG000|Overall Study|Other|1|||
33362513|NCT01276847|101214443|FG000|Overall Study|Withdrawal by Subject|1|||
33362514|NCT01276847|101214444|FG001|Overall Study|Withdrawal by Subject|0|||
33362515|NCT01276847|101214445|FG002|Overall Study|Withdrawal by Subject|0|||
33362516|NCT01084252|101214446|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
33563868|NCT00855335|101961864|FG000|Overall Study|Lost to Follow-up|0|||
33563869|NCT00855335|101961865|FG001|Overall Study|Lost to Follow-up|0|||
33563870|NCT00855335|101961866|FG002|Overall Study|Lost to Follow-up|3|||
33563871|NCT00855335|101961867|FG003|Overall Study|Lost to Follow-up|1|||
33563872|NCT00855335|101961868|FG004|Overall Study|Lost to Follow-up|0|||
33563873|NCT00855335|101961864|FG000|Overall Study|Withdrawal by Subject|0|||
33563874|NCT00855335|101961865|FG001|Overall Study|Withdrawal by Subject|0|||
33563875|NCT00855335|101961866|FG002|Overall Study|Withdrawal by Subject|0|||
33563876|NCT00855335|101961867|FG003|Overall Study|Withdrawal by Subject|1|||
33563877|NCT00855335|101961868|FG004|Overall Study|Withdrawal by Subject|0|||
33563878|NCT00855335|101961864|FG000|Overall Study|Adverse Event|2|||
33563879|NCT00855335|101961865|FG001|Overall Study|Adverse Event|0|||
33628005|NCT04869982|102187844|FG000|Overall Study|Solicited adverse event|2|||
33628006|NCT04869982|102187845|FG001|Overall Study|Solicited adverse event|1|||
33628007|NCT01393158|102187846|FG000|Overall Study|Adverse Event|1|||
33628008|NCT01393158|102187847|FG001|Overall Study|Adverse Event|0|||
33628009|NCT03261336|102187848|FG000|Overall Study|Adverse Event|1|||
33628010|NCT03318549|102187849|FG000|Overall Study|Withdrawal by Subject|5|||
33628011|NCT03318549|102187850|FG001|Overall Study|Withdrawal by Subject|19|||
33628012|NCT03318549|102187851|FG002|Overall Study|Withdrawal by Subject|2|||
33628013|NCT03318549|102187852|FG003|Overall Study|Withdrawal by Subject|0|||
33628014|NCT03318549|102187853|FG004|Overall Study|Withdrawal by Subject|0|||
33628015|NCT03318549|102187854|FG005|Overall Study|Withdrawal by Subject|0|||
33563880|NCT00855335|101961866|FG002|Overall Study|Adverse Event|0|||
33628016|NCT03318549|102187855|FG006|Overall Study|Withdrawal by Subject|0|||
33628017|NCT03318549|102187849|FG000|Overall Study|Physician Decision|0|||
33362517|NCT01084252|101214447|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
33362518|NCT01084252|101214448|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
33628018|NCT03318549|102187850|FG001|Overall Study|Physician Decision|4|||
33628019|NCT03318549|102187851|FG002|Overall Study|Physician Decision|1|||
33628020|NCT03318549|102187852|FG003|Overall Study|Physician Decision|0|||
33362519|NCT01084252|101214449|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
33362520|NCT01084252|101214450|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
33362521|NCT01084252|101214451|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
33362522|NCT01084252|101214452|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
33362523|NCT01084252|101214453|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
33362524|NCT01084252|101214454|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
33362525|NCT01084252|101214455|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
33362526|NCT01084252|101214456|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
33362527|NCT01084252|101214457|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
33362528|NCT01084252|101214458|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
33362529|NCT01084252|101214459|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
33362530|NCT00336492|101214460|FG000|Overall Study|Adverse Event|4|||
33362531|NCT00336492|101214461|FG001|Overall Study|Adverse Event|3|||
33362532|NCT00336492|101214462|FG002|Overall Study|Adverse Event|6|||
33563881|NCT00855335|101961867|FG003|Overall Study|Adverse Event|0|||
33563882|NCT00855335|101961868|FG004|Overall Study|Adverse Event|0|||
33563883|NCT00855335|101961864|FG000|Overall Study|Physician Decision|1|||
33563884|NCT00855335|101961865|FG001|Overall Study|Physician Decision|1|||
33563885|NCT00855335|101961866|FG002|Overall Study|Physician Decision|0|||
33362533|NCT00336492|101214460|FG000|Overall Study|Lack of Efficacy|6|||
33362534|NCT00336492|101214461|FG001|Overall Study|Lack of Efficacy|1|||
33362535|NCT00336492|101214462|FG002|Overall Study|Lack of Efficacy|4|||
33362536|NCT00336492|101214460|FG000|Overall Study|Other|5|||
33362537|NCT00336492|101214461|FG001|Overall Study|Other|0|||
33362538|NCT00336492|101214462|FG002|Overall Study|Other|1|||
33362539|NCT00117338|101214467|FG000|Overall Study|Adverse Event|0|||
33362540|NCT00117338|101214468|FG001|Overall Study|Adverse Event|1|||
33362541|NCT00117338|101214467|FG000|Overall Study|Protocol Violation|3|||
33362542|NCT00117338|101214468|FG001|Overall Study|Protocol Violation|2|||
33362543|NCT00117338|101214467|FG000|Overall Study|Withdrawal by Subject|1|||
33362544|NCT00117338|101214468|FG001|Overall Study|Withdrawal by Subject|0|||
33362545|NCT00117338|101214467|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
33362546|NCT00117338|101214468|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
33362547|NCT00117338|101214467|FG000|Overall Study|Lack of Efficacy|0|||
33362548|NCT00117338|101214468|FG001|Overall Study|Lack of Efficacy|1|||
33362549|NCT00128206|101214469|FG000|Overall Study|Lost to Follow-up|137|||
33362550|NCT00128206|101214470|FG001|Overall Study|Lost to Follow-up|118|||
33362551|NCT00128206|101214469|FG000|Overall Study|Adverse Event|0|||
33362552|NCT00128206|101214470|FG001|Overall Study|Adverse Event|2|||
33362553|NCT00728416|101214471|FG000|Overall Study|Adverse Event|1|||
33362554|NCT00728416|101214472|FG001|Overall Study|Adverse Event|1|||
33362555|NCT00728416|101214471|FG000|Overall Study|Treatment Failure|0|||
33362556|NCT00728416|101214472|FG001|Overall Study|Treatment Failure|1|||
33563886|NCT00855335|101961867|FG003|Overall Study|Physician Decision|0|||
33563887|NCT00855335|101961868|FG004|Overall Study|Physician Decision|0|||
33563888|NCT00855335|101961864|FG000|Overall Study|Other|2|||
33563889|NCT00855335|101961865|FG001|Overall Study|Other|1|||
33628021|NCT03318549|102187853|FG004|Overall Study|Physician Decision|0|||
33628022|NCT03318549|102187854|FG005|Overall Study|Physician Decision|0|||
33628023|NCT03318549|102187855|FG006|Overall Study|Physician Decision|0|||
33628024|NCT03318549|102187849|FG000|Overall Study|Lost to Follow-up|0|||
33628025|NCT03318549|102187850|FG001|Overall Study|Lost to Follow-up|3|||
33628026|NCT03318549|102187851|FG002|Overall Study|Lost to Follow-up|3|||
33628027|NCT03318549|102187852|FG003|Overall Study|Lost to Follow-up|0|||
33628028|NCT03318549|102187853|FG004|Overall Study|Lost to Follow-up|0|||
33628029|NCT03318549|102187854|FG005|Overall Study|Lost to Follow-up|0|||
33628030|NCT03318549|102187855|FG006|Overall Study|Lost to Follow-up|0|||
33628031|NCT03289208|102187856|FG000|Overall Study|Adverse Event|1|||
33628032|NCT03289208|102187857|FG001|Overall Study|Adverse Event|0|||
33628033|NCT03289208|102187858|FG002|Overall Study|Adverse Event|0|||
33628034|NCT00686777|102187859|FG000|Overall Study|Adverse Event|2|||
33628035|NCT00686777|102187859|FG000|Overall Study|Pregnancy|1|||
33563890|NCT00855335|101961866|FG002|Overall Study|Other|2|||
33563891|NCT00855335|101961867|FG003|Overall Study|Other|5|||
33563892|NCT00855335|101961868|FG004|Overall Study|Other|1|||
33563893|NCT04280783|101961869|FG000|Overall Study|Family issues unrelated to the study.|1|||
33628036|NCT00686777|102187859|FG000|Overall Study|Withdrawal by Subject|2|||
33628037|NCT00686777|102187859|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
33628038|NCT00686777|102187859|FG000|Overall Study|No Visit|1|||
33628039|NCT00739401|102187860|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
33628040|NCT00739401|102187860|FG000|Overall Study|Death|3|||
33362557|NCT00728416|101214471|FG000|Overall Study|Withdrawal by Subject|1|||
33362558|NCT00728416|101214472|FG001|Overall Study|Withdrawal by Subject|0|||
33563894|NCT04280783|101961870|FG001|Overall Study|Family issues unrelated to the study.|0|||
33628041|NCT00739401|102187860|FG000|Overall Study|Withdrawal by Subject|4|||
33362559|NCT01899144|101214482|FG000|Treatment Period 2|Other|1|||
33362560|NCT01899144|101214482|FG000|Treatment Period 3|Other|2|||
33362561|NCT01899144|101214482|FG000|Treatment Period 5|Other|1|||
33362562|NCT04983901|101214483|FG000|Overall Study|Death|1|||
33362563|NCT04983901|101214484|FG001|Overall Study|Death|4|||
33362564|NCT04983901|101214483|FG000|Overall Study|Lost to Follow-up|3|||
33362565|NCT04983901|101214484|FG001|Overall Study|Lost to Follow-up|0|||
33362566|NCT04983901|101214483|FG000|Overall Study|Protocol Violation|1|||
33362567|NCT04983901|101214484|FG001|Overall Study|Protocol Violation|0|||
33362568|NCT04983901|101214483|FG000|Overall Study|Withdrawal by Subject|1|||
33362569|NCT04983901|101214484|FG001|Overall Study|Withdrawal by Subject|2|||
33362570|NCT00564629|101214485|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
33362571|NCT00564629|101214486|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
33362572|NCT00923091|101214487|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
33362573|NCT00923091|101214488|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
33362574|NCT00923091|101214489|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
33362575|NCT00923091|101214490|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
33362576|NCT00923091|101214491|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
33362577|NCT00923091|101214492|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
33362578|NCT00923091|101214493|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
33362579|NCT00923091|101214494|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
33362580|NCT00923091|101214495|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
33362581|NCT00923091|101214496|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
33362582|NCT00923091|101214497|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
33362583|NCT00923091|101214498|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
33362584|NCT00923091|101214499|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
33362585|NCT00923091|101214487|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
33362586|NCT00923091|101214488|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
33362587|NCT00923091|101214489|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
33362588|NCT00923091|101214490|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
33362589|NCT00923091|101214491|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
33362590|NCT00923091|101214492|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
33362591|NCT00923091|101214493|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
33362592|NCT00923091|101214494|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
33362593|NCT00923091|101214495|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
33362594|NCT00923091|101214496|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
33362595|NCT00923091|101214497|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
33362596|NCT00923091|101214498|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
33362597|NCT00923091|101214499|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
33362598|NCT00923091|101214487|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
33362599|NCT00923091|101214488|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
33362600|NCT00923091|101214489|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
33362601|NCT00923091|101214490|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
33362602|NCT00923091|101214491|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
33362603|NCT00923091|101214492|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
33362604|NCT00923091|101214493|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
33362605|NCT00923091|101214494|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
33362606|NCT00923091|101214495|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
33362607|NCT00923091|101214496|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
33362608|NCT00923091|101214497|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
33362609|NCT00923091|101214498|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
33362610|NCT00923091|101214499|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
33362611|NCT00923091|101214487|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33362612|NCT00923091|101214488|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33362613|NCT00923091|101214489|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33362614|NCT00923091|101214490|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33362615|NCT00923091|101214491|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33362616|NCT00923091|101214492|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
33362617|NCT00923091|101214493|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33362618|NCT00923091|101214494|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33362619|NCT00923091|101214495|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33628042|NCT02140047|102187862|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33628043|NCT02140047|102187863|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33628044|NCT02140047|102187864|FG002|Overall Study|Withdrawal by parent/guardian|0|||
33628045|NCT01908426|102187865|FG000|Overall Study|Adverse Event|98|||
33628046|NCT01908426|102187866|FG001|Overall Study|Adverse Event|11|||
33628047|NCT01908426|102187865|FG000|Overall Study|Clinical Deterioration|72|||
33222007|NCT03988634|100715642|FG000|Open-Label|Physician Decision|0|||
33415576|NCT02918318|101413048|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
33415577|NCT02918318|101413049|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
33415578|NCT02918318|101413050|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
33415579|NCT02918318|101413051|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
33415580|NCT02918318|101413052|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
33415581|NCT02918318|101413048|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
33415582|NCT02918318|101413049|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
33415583|NCT02918318|101413050|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
33415584|NCT02918318|101413051|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
33415585|NCT02918318|101413052|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
33415586|NCT02918318|101413048|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
33415587|NCT02918318|101413049|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
33415588|NCT02918318|101413050|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
33415589|NCT02918318|101413051|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
33415590|NCT02918318|101413052|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
33415591|NCT02918318|101413048|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
33415592|NCT02918318|101413049|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
33415593|NCT02918318|101413050|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
33415594|NCT02918318|101413051|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
33362620|NCT00923091|101214496|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33415595|NCT02918318|101413052|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
33415596|NCT00391118|101413059|FG000|Overall Study|Adverse Event|3|||
33415597|NCT00391118|101413060|FG001|Overall Study|Adverse Event|10|||
33415598|NCT00391118|101413061|FG002|Overall Study|Adverse Event|7|||
33415599|NCT00391118|101413059|FG000|Overall Study|Lost to Follow-up|0|||
33415600|NCT00391118|101413060|FG001|Overall Study|Lost to Follow-up|2|||
33415601|NCT00391118|101413061|FG002|Overall Study|Lost to Follow-up|3|||
33415602|NCT00391118|101413059|FG000|Overall Study|Withdrawal by Subject|0|||
33415603|NCT00391118|101413060|FG001|Overall Study|Withdrawal by Subject|9|||
33415604|NCT00391118|101413061|FG002|Overall Study|Withdrawal by Subject|1|||
33415605|NCT00391118|101413059|FG000|Overall Study|Death|0|||
33415606|NCT00391118|101413060|FG001|Overall Study|Death|1|||
33415607|NCT00391118|101413061|FG002|Overall Study|Death|0|||
33415608|NCT00391118|101413059|FG000|Overall Study|Physician Decision|0|||
33563895|NCT04280783|101961869|FG000|Overall Study|Withdrawal by Subject|0|||
33563896|NCT04280783|101961870|FG001|Overall Study|Withdrawal by Subject|1|||
33563897|NCT02321514|101961872|FG000|Overall Study|Death|15|||
33563898|NCT02321514|101961872|FG000|Overall Study|Missed Visit|7|||
33222008|NCT03988634|100715643|FG001|Open-Label|Physician Decision|0|||
33222009|NCT03988634|100715644|FG002|Open-Label|Physician Decision|1|||
33222010|NCT03988634|100715642|FG000|Open-Label|Technical problems|0|||
33362621|NCT00923091|101214497|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33362622|NCT00923091|101214498|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33362623|NCT00923091|101214499|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
33362624|NCT00923091|101214487|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33362625|NCT00923091|101214488|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
33362626|NCT00923091|101214489|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33362627|NCT00923091|101214490|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
33362628|NCT00923091|101214491|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33362629|NCT00923091|101214492|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
33362630|NCT00923091|101214493|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33362631|NCT00923091|101214494|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33362632|NCT00923091|101214495|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33362633|NCT00923091|101214496|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33563899|NCT02321514|101961872|FG000|Overall Study|Study Exit|3|||
33563900|NCT01380080|101961874|FG000|Overall Study|Death|36|||
33563901|NCT01380080|101961875|FG001|Overall Study|Death|44|||
33563902|NCT01380080|101961874|FG000|Overall Study|Site is closing|28|||
33563903|NCT01380080|101961875|FG001|Overall Study|Site is closing|31|||
33563904|NCT01380080|101961874|FG000|Overall Study|Not able to get to clinic|7|||
33563905|NCT01380080|101961875|FG001|Overall Study|Not able to get to clinic|1|||
33563906|NCT01380080|101961874|FG000|Overall Study|Not willing to adhere to requirements|6|||
33563907|NCT01380080|101961875|FG001|Overall Study|Not willing to adhere to requirements|2|||
33222011|NCT03988634|100715643|FG001|Open-Label|Technical problems|0|||
33362634|NCT00923091|101214497|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33362635|NCT00923091|101214498|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33415609|NCT00391118|101413060|FG001|Overall Study|Physician Decision|3|||
33415610|NCT00391118|101413061|FG002|Overall Study|Physician Decision|0|||
33415611|NCT00391118|101413059|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
33415612|NCT00391118|101413060|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
33415613|NCT00391118|101413061|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
33563908|NCT01380080|101961874|FG000|Overall Study|Withdrawal by Subject|5|||
33222012|NCT03988634|100715644|FG002|Open-Label|Technical problems|1|||
33628048|NCT01908426|102187866|FG001|Overall Study|Clinical Deterioration|38|||
33628049|NCT01908426|102187865|FG000|Overall Study|Lack of Efficacy|3|||
33628050|NCT01908426|102187866|FG001|Overall Study|Lack of Efficacy|0|||
33628051|NCT01908426|102187865|FG000|Overall Study|Lost to Follow-up|0|||
33628052|NCT01908426|102187866|FG001|Overall Study|Lost to Follow-up|1|||
33362636|NCT00923091|101214499|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
33362637|NCT00923091|101214487|FG000|Period III (Single-Blind)|Adverse Event|5|||
33362638|NCT00923091|101214488|FG001|Period III (Single-Blind)|Adverse Event|0|||
33362639|NCT00923091|101214489|FG002|Period III (Single-Blind)|Adverse Event|0|||
33362640|NCT00923091|101214490|FG003|Period III (Single-Blind)|Adverse Event|0|||
33362641|NCT00923091|101214491|FG004|Period III (Single-Blind)|Adverse Event|0|||
33362642|NCT00923091|101214492|FG005|Period III (Single-Blind)|Adverse Event|0|||
33362643|NCT00923091|101214493|FG006|Period III (Single-Blind)|Adverse Event|0|||
33362644|NCT00923091|101214494|FG007|Period III (Single-Blind)|Adverse Event|0|||
33362645|NCT00923091|101214495|FG008|Period III (Single-Blind)|Adverse Event|0|||
33362646|NCT00923091|101214496|FG009|Period III (Single-Blind)|Adverse Event|0|||
33563909|NCT01380080|101961875|FG001|Overall Study|Withdrawal by Subject|2|||
33362647|NCT00923091|101214497|FG010|Period III (Single-Blind)|Adverse Event|0|||
33362648|NCT00923091|101214498|FG011|Period III (Single-Blind)|Adverse Event|0|||
33362649|NCT00923091|101214499|FG012|Period III (Single-Blind)|Adverse Event|0|||
33362650|NCT00923091|101214487|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
33362651|NCT00923091|101214488|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
33362652|NCT00923091|101214489|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
33362653|NCT00923091|101214490|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
33362654|NCT00923091|101214491|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
33362655|NCT00923091|101214492|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
33362656|NCT00923091|101214493|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
33362657|NCT00923091|101214494|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
33362658|NCT00923091|101214495|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
33362659|NCT00923091|101214496|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
33362660|NCT00923091|101214497|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
33362661|NCT00923091|101214498|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
33362662|NCT00923091|101214499|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
33362663|NCT00923091|101214487|FG000|Period III (Single-Blind)|Protocol Violation|3|||
33362664|NCT00923091|101214488|FG001|Period III (Single-Blind)|Protocol Violation|0|||
33362665|NCT00923091|101214489|FG002|Period III (Single-Blind)|Protocol Violation|0|||
33362666|NCT00923091|101214490|FG003|Period III (Single-Blind)|Protocol Violation|0|||
33362667|NCT00923091|101214491|FG004|Period III (Single-Blind)|Protocol Violation|0|||
33362668|NCT00923091|101214492|FG005|Period III (Single-Blind)|Protocol Violation|0|||
33362669|NCT00923091|101214493|FG006|Period III (Single-Blind)|Protocol Violation|0|||
33362670|NCT00923091|101214494|FG007|Period III (Single-Blind)|Protocol Violation|0|||
33362671|NCT00923091|101214495|FG008|Period III (Single-Blind)|Protocol Violation|0|||
33362672|NCT00923091|101214496|FG009|Period III (Single-Blind)|Protocol Violation|0|||
33362673|NCT00923091|101214497|FG010|Period III (Single-Blind)|Protocol Violation|0|||
33362674|NCT00923091|101214498|FG011|Period III (Single-Blind)|Protocol Violation|0|||
33362675|NCT00923091|101214499|FG012|Period III (Single-Blind)|Protocol Violation|0|||
33362676|NCT00923091|101214487|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
33362677|NCT00923091|101214488|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
33362678|NCT00923091|101214489|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
33362679|NCT00923091|101214490|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
33362680|NCT00923091|101214491|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
33362681|NCT00923091|101214492|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
33362682|NCT00923091|101214493|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
33362683|NCT00923091|101214494|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
33362684|NCT00923091|101214495|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
33362685|NCT00923091|101214496|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
33415614|NCT00391118|101413059|FG000|Overall Study|Progressive Disease|7|||
33563910|NCT01380080|101961874|FG000|Overall Study|Lost to Follow-up|3|||
33563911|NCT01380080|101961875|FG001|Overall Study|Lost to Follow-up|3|||
33563912|NCT03847519|101961876|FG000|Overall Study|Death|5|||
33563913|NCT03847519|101961877|FG001|Overall Study|Death|8|||
33563914|NCT03847519|101961878|FG002|Overall Study|Death|1|||
33563915|NCT03847519|101961876|FG000|Overall Study|Lost to Follow-up|1|||
33563916|NCT03847519|101961877|FG001|Overall Study|Lost to Follow-up|2|||
33563917|NCT03847519|101961878|FG002|Overall Study|Lost to Follow-up|0|||
33563918|NCT03847519|101961876|FG000|Overall Study|Study Terminated by Sponsor|0|||
33563919|NCT03847519|101961877|FG001|Overall Study|Study Terminated by Sponsor|3|||
33563920|NCT03847519|101961878|FG002|Overall Study|Study Terminated by Sponsor|2|||
33563921|NCT05473715|101961879|FG000|Overall Study|Trial terminate|2|||
33563922|NCT05473715|101961880|FG001|Overall Study|Trial terminate|1|||
33563923|NCT00605189|101961881|FG000|Overall Study|Adverse Event|1|||
33415615|NCT00391118|101413060|FG001|Overall Study|Progressive Disease|26|||
33415616|NCT00391118|101413061|FG002|Overall Study|Progressive Disease|43|||
33415617|NCT00391118|101413059|FG000|Overall Study|Sponsor Decision|0|||
33415618|NCT00391118|101413060|FG001|Overall Study|Sponsor Decision|1|||
33415619|NCT00391118|101413061|FG002|Overall Study|Sponsor Decision|3|||
33415620|NCT00391118|101413059|FG000|Overall Study|Protocol Violation|1|||
33415621|NCT00391118|101413060|FG001|Overall Study|Protocol Violation|0|||
33415622|NCT00391118|101413061|FG002|Overall Study|Protocol Violation|0|||
33415623|NCT03083639|101413063|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
33415624|NCT03083639|101413064|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
33415625|NCT03083639|101413063|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
33415626|NCT03083639|101413064|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
33415627|NCT02453282|101413065|FG000|Overall Study|Death|275|||
33222013|NCT02835339|100715649|FG000|Overall Study|Did not receive allocated intervention|13|||
33222014|NCT02835339|100715650|FG001|Overall Study|Did not receive allocated intervention|16|||
33415628|NCT02453282|101413066|FG001|Overall Study|Death|277|||
33415629|NCT02453282|101413067|FG002|Overall Study|Death|296|||
33415630|NCT02453282|101413065|FG000|Overall Study|Lost to Follow-up|1|||
33415631|NCT02453282|101413066|FG001|Overall Study|Lost to Follow-up|0|||
33415632|NCT02453282|101413067|FG002|Overall Study|Lost to Follow-up|2|||
33415633|NCT02453282|101413065|FG000|Overall Study|Withdrawal by Subject|12|||
33415634|NCT02453282|101413066|FG001|Overall Study|Withdrawal by Subject|10|||
33415635|NCT02453282|101413067|FG002|Overall Study|Withdrawal by Subject|11|||
33415636|NCT02453282|101413065|FG000|Overall Study|Participants ongoing at data cut-off|85|||
33415637|NCT02453282|101413066|FG001|Overall Study|Participants ongoing at data cut-off|84|||
33415638|NCT02453282|101413067|FG002|Overall Study|Participants ongoing at data cut-off|62|||
33415639|NCT02453282|101413065|FG000|Overall Study|Other|1|||
33415640|NCT02453282|101413066|FG001|Overall Study|Other|1|||
33362686|NCT00923091|101214497|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
33362687|NCT00923091|101214498|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
33362688|NCT00923091|101214499|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
33362689|NCT00923091|101214487|FG000|Period IV (Double-Blind)|Adverse Event|2|||
33362690|NCT00923091|101214488|FG001|Period IV (Double-Blind)|Adverse Event|0|||
33362691|NCT00923091|101214489|FG002|Period IV (Double-Blind)|Adverse Event|0|||
33415641|NCT02453282|101413067|FG002|Overall Study|Other|1|||
33415642|NCT03466060|101413068|FG000|Period 1|Test Lens Damage|0|||
33415643|NCT03466060|101413069|FG001|Period 1|Test Lens Damage|2|||
33563924|NCT00605189|101961882|FG001|Overall Study|Adverse Event|0|||
33563925|NCT00605189|101961883|FG002|Overall Study|Adverse Event|0|||
33362692|NCT00923091|101214490|FG003|Period IV (Double-Blind)|Adverse Event|0|||
33362693|NCT00923091|101214491|FG004|Period IV (Double-Blind)|Adverse Event|0|||
33362694|NCT00923091|101214492|FG005|Period IV (Double-Blind)|Adverse Event|0|||
33362695|NCT00923091|101214493|FG006|Period IV (Double-Blind)|Adverse Event|0|||
33362696|NCT00923091|101214494|FG007|Period IV (Double-Blind)|Adverse Event|0|||
33362697|NCT00923091|101214495|FG008|Period IV (Double-Blind)|Adverse Event|0|||
33362698|NCT00923091|101214496|FG009|Period IV (Double-Blind)|Adverse Event|0|||
33563926|NCT00605189|101961881|FG000|Overall Study|Other|2|||
33563927|NCT00605189|101961882|FG001|Overall Study|Other|2|||
33563928|NCT00605189|101961883|FG002|Overall Study|Other|0|||
33563929|NCT02730169|101961884|FG000|Overall Study|Protocol Violation|1|||
33563930|NCT02730169|101961885|FG001|Overall Study|Protocol Violation|0|||
33563931|NCT02730169|101961886|FG002|Overall Study|Protocol Violation|0|||
33563932|NCT02730169|101961887|FG003|Overall Study|Protocol Violation|1|||
33563933|NCT02730169|101961884|FG000|Overall Study|Adverse Event|2|||
33563934|NCT02730169|101961885|FG001|Overall Study|Adverse Event|3|||
33628053|NCT01908426|102187865|FG000|Overall Study|Physician Decision|3|||
33628054|NCT01908426|102187866|FG001|Overall Study|Physician Decision|3|||
33628055|NCT01908426|102187865|FG000|Overall Study|Withdrawal by Subject|11|||
33628056|NCT01908426|102187866|FG001|Overall Study|Withdrawal by Subject|6|||
33628057|NCT01908426|102187865|FG000|Overall Study|Progressive Disease|206|||
33628058|NCT01908426|102187866|FG001|Overall Study|Progressive Disease|152|||
33628059|NCT01908426|102187865|FG000|Overall Study|Protocol Violation|1|||
33628060|NCT01908426|102187866|FG001|Overall Study|Protocol Violation|0|||
33628061|NCT01908426|102187865|FG000|Overall Study|No Study Treatment Given|3|||
33628062|NCT01908426|102187866|FG001|Overall Study|No Study Treatment Given|0|||
33628063|NCT00774046|102187867|FG000|Screening|Not eligible|56|||
33222015|NCT05178121|100715651|FG000|Overall Study|Other|4|||
33362699|NCT00923091|101214497|FG010|Period IV (Double-Blind)|Adverse Event|0|||
33415644|NCT03466060|101413070|FG002|Period 1|Test Lens Damage|0|||
33415645|NCT03466060|101413071|FG003|Period 1|Test Lens Damage|0|||
33415646|NCT03466060|101413072|FG004|Period 1|Test Lens Damage|0|||
33415647|NCT03466060|101413073|FG005|Period 1|Test Lens Damage|0|||
33415648|NCT03466060|101413068|FG000|Period 1|Withdrawal by Subject|0|||
33415649|NCT03466060|101413069|FG001|Period 1|Withdrawal by Subject|0|||
33415650|NCT03466060|101413070|FG002|Period 1|Withdrawal by Subject|2|||
33563935|NCT02730169|101961886|FG002|Overall Study|Adverse Event|3|||
33628064|NCT00774046|102187867|FG000|Enrollment|Desired other therapy/refused|28|||
33628065|NCT00774046|102187867|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
33563936|NCT02730169|101961887|FG003|Overall Study|Adverse Event|0|||
33563937|NCT02730169|101961884|FG000|Overall Study|Adverse Event of Special Interest|0|||
33563938|NCT02730169|101961885|FG001|Overall Study|Adverse Event of Special Interest|1|||
33563939|NCT02730169|101961886|FG002|Overall Study|Adverse Event of Special Interest|2|||
33563940|NCT02730169|101961887|FG003|Overall Study|Adverse Event of Special Interest|0|||
33563941|NCT02730169|101961884|FG000|Overall Study|Withdrawal by Subject|6|||
33563942|NCT02730169|101961885|FG001|Overall Study|Withdrawal by Subject|11|||
33563943|NCT02730169|101961886|FG002|Overall Study|Withdrawal by Subject|6|||
33563944|NCT02730169|101961887|FG003|Overall Study|Withdrawal by Subject|8|||
33563945|NCT02730169|101961884|FG000|Overall Study|Lost to Follow-up|5|||
33563946|NCT02730169|101961885|FG001|Overall Study|Lost to Follow-up|6|||
33563947|NCT02730169|101961886|FG002|Overall Study|Lost to Follow-up|5|||
33563948|NCT02730169|101961887|FG003|Overall Study|Lost to Follow-up|6|||
33563949|NCT02730169|101961884|FG000|Overall Study|Other|0|||
33563950|NCT02730169|101961885|FG001|Overall Study|Other|0|||
33563951|NCT02730169|101961886|FG002|Overall Study|Other|1|||
33628066|NCT03253796|102187869|FG000|Period 1: Run-In|Adverse Event|4|||
33628067|NCT03253796|102187870|FG001|Period 1: Run-In|Adverse Event|0|||
33628068|NCT03253796|102187871|FG002|Period 1: Run-In|Adverse Event|0|||
33628069|NCT03253796|102187872|FG003|Period 1: Run-In|Adverse Event|0|||
33628070|NCT03253796|102187873|FG004|Period 1: Run-In|Adverse Event|0|||
33628071|NCT03253796|102187869|FG000|Period 1: Run-In|Lack of Efficacy|1|||
33628072|NCT03253796|102187870|FG001|Period 1: Run-In|Lack of Efficacy|0|||
33628073|NCT03253796|102187871|FG002|Period 1: Run-In|Lack of Efficacy|0|||
33628074|NCT03253796|102187872|FG003|Period 1: Run-In|Lack of Efficacy|0|||
33628075|NCT03253796|102187873|FG004|Period 1: Run-In|Lack of Efficacy|0|||
33628076|NCT03253796|102187869|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
33628077|NCT03253796|102187870|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
33628078|NCT03253796|102187871|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
33628079|NCT03253796|102187872|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
33628080|NCT03253796|102187873|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
33628081|NCT03253796|102187869|FG000|Period 1: Run-In|Protocol Violation|5|||
33628082|NCT03253796|102187870|FG001|Period 1: Run-In|Protocol Violation|0|||
33628083|NCT03253796|102187871|FG002|Period 1: Run-In|Protocol Violation|0|||
33628084|NCT03253796|102187872|FG003|Period 1: Run-In|Protocol Violation|0|||
33628085|NCT03253796|102187873|FG004|Period 1: Run-In|Protocol Violation|0|||
33628086|NCT03253796|102187869|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
33628087|NCT03253796|102187870|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
33628088|NCT03253796|102187871|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
33628089|NCT03253796|102187872|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
33628090|NCT03253796|102187873|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
33628091|NCT03253796|102187869|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
33628092|NCT03253796|102187870|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
33628093|NCT03253796|102187871|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
33628094|NCT03253796|102187872|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
33628095|NCT03253796|102187873|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
33628096|NCT03253796|102187869|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
33628097|NCT03253796|102187870|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
33628098|NCT03253796|102187871|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
33628099|NCT03253796|102187872|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
33628100|NCT03253796|102187873|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
33628101|NCT03253796|102187869|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
33628102|NCT03253796|102187870|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
33628103|NCT03253796|102187871|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
33628104|NCT03253796|102187872|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
33628105|NCT03253796|102187873|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
33628106|NCT03253796|102187869|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
33628107|NCT03253796|102187870|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
33628108|NCT03253796|102187871|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
33628109|NCT03253796|102187872|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
33628110|NCT03253796|102187873|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
33628111|NCT03253796|102187869|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
33628112|NCT03253796|102187870|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
33563952|NCT02730169|101961887|FG003|Overall Study|Other|1|||
33563953|NCT02457546|101961888|FG000|Overall Study|Other reasons|4|||
33563954|NCT02457546|101961889|FG001|Overall Study|Other reasons|1|||
33563955|NCT02457546|101961888|FG000|Overall Study|Refused to complete study/procedures|1|||
33563956|NCT02457546|101961889|FG001|Overall Study|Refused to complete study/procedures|1|||
33631309|NCT03486912|102202915|FG001|Treatment Period|Lost to Follow-up|0|||
33563957|NCT02457546|101961888|FG000|Overall Study|Lost to Follow-up|4|||
33563958|NCT02457546|101961889|FG001|Overall Study|Lost to Follow-up|1|||
33628113|NCT03253796|102187871|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
33628114|NCT03253796|102187872|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
33628115|NCT03253796|102187873|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
33628116|NCT03253796|102187869|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
33628117|NCT03253796|102187870|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
33628118|NCT03253796|102187871|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
33628119|NCT03253796|102187872|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
33628120|NCT03253796|102187873|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
33628121|NCT02163902|102187874|FG000|Overall Study|Subject's Request|3|||
33628122|NCT02163902|102187875|FG001|Overall Study|Subject's Request|4|||
33628123|NCT02163902|102187874|FG000|Overall Study|Lost to Follow-up|6|||
33628124|NCT02163902|102187875|FG001|Overall Study|Lost to Follow-up|7|||
33222016|NCT05178121|100715651|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
33222017|NCT01987817|100715652|FG000|Overall Study|Adverse Event|4|||
33222018|NCT01987817|100715653|FG001|Overall Study|Adverse Event|0|||
33628125|NCT02163902|102187874|FG000|Overall Study|Administrative Decision|2|||
33628126|NCT02163902|102187875|FG001|Overall Study|Administrative Decision|2|||
33628127|NCT03452540|102187880|FG000|Overall Study|Adverse Event|1|||
33628128|NCT03452540|102187880|FG000|Overall Study|Withdrawal by Subject|1|||
33628129|NCT03452540|102187880|FG000|Overall Study|Other SAE and AE|2|||
33628130|NCT03259230|102187881|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
33628131|NCT03259230|102187882|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
33628132|NCT02313766|102187883|FG000|Overall Study|surgery cancelled|1|||
33628133|NCT02313766|102187884|FG001|Overall Study|surgery cancelled|0|||
33628134|NCT02313766|102187885|FG002|Overall Study|surgery cancelled|0|||
33628135|NCT02313766|102187883|FG000|Overall Study|Lost to Follow-up|0|||
33628136|NCT02313766|102187884|FG001|Overall Study|Lost to Follow-up|2|||
33628137|NCT02313766|102187885|FG002|Overall Study|Lost to Follow-up|0|||
33628138|NCT02313766|102187883|FG000|Overall Study|Adverse Event|0|||
33628139|NCT02313766|102187884|FG001|Overall Study|Adverse Event|1|||
33628140|NCT02313766|102187885|FG002|Overall Study|Adverse Event|0|||
33628141|NCT00525512|102187903|FG000|Double-Blind Phase|Adverse Event|48|||
33628142|NCT00525512|102187904|FG001|Double-Blind Phase|Adverse Event|28|||
33628143|NCT00525512|102187905|FG002|Double-Blind Phase|Adverse Event|0|||
33628144|NCT00525512|102187906|FG003|Double-Blind Phase|Adverse Event|0|||
33628145|NCT00525512|102187903|FG000|Double-Blind Phase|Protocol Violation|3|||
33628146|NCT00525512|102187904|FG001|Double-Blind Phase|Protocol Violation|1|||
33628147|NCT00525512|102187905|FG002|Double-Blind Phase|Protocol Violation|0|||
33628148|NCT00525512|102187906|FG003|Double-Blind Phase|Protocol Violation|0|||
33628149|NCT00525512|102187903|FG000|Double-Blind Phase|Lost to Follow-up|3|||
33628150|NCT00525512|102187904|FG001|Double-Blind Phase|Lost to Follow-up|7|||
33222019|NCT01987817|100715652|FG000|Overall Study|Withdrawal by Subject|1|||
33628151|NCT00525512|102187905|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33628152|NCT00525512|102187906|FG003|Double-Blind Phase|Lost to Follow-up|0|||
33628153|NCT00525512|102187903|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
33628154|NCT00525512|102187904|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
33628155|NCT00525512|102187905|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
33628156|NCT00525512|102187906|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
33628157|NCT00525512|102187903|FG000|Double-Blind Phase|Lack of Efficacy|13|||
33628158|NCT00525512|102187904|FG001|Double-Blind Phase|Lack of Efficacy|5|||
33628159|NCT00525512|102187905|FG002|Double-Blind Phase|Lack of Efficacy|0|||
33628160|NCT00525512|102187906|FG003|Double-Blind Phase|Lack of Efficacy|0|||
33628161|NCT00525512|102187903|FG000|Double-Blind Phase|Other reason (not specified)|12|||
33628162|NCT00525512|102187904|FG001|Double-Blind Phase|Other reason (not specified)|13|||
33628163|NCT00525512|102187905|FG002|Double-Blind Phase|Other reason (not specified)|0|||
33628164|NCT00525512|102187906|FG003|Double-Blind Phase|Other reason (not specified)|0|||
33628165|NCT00525512|102187903|FG000|Open-Label Phase|Adverse Event|0|||
33628166|NCT00525512|102187904|FG001|Open-Label Phase|Adverse Event|0|||
33628167|NCT00525512|102187905|FG002|Open-Label Phase|Adverse Event|1|||
33628168|NCT00525512|102187906|FG003|Open-Label Phase|Adverse Event|0|||
33628169|NCT00525512|102187903|FG000|Open-Label Phase|Lost to Follow-up|0|||
33628170|NCT00525512|102187904|FG001|Open-Label Phase|Lost to Follow-up|0|||
33628171|NCT00525512|102187905|FG002|Open-Label Phase|Lost to Follow-up|1|||
33628172|NCT00525512|102187906|FG003|Open-Label Phase|Lost to Follow-up|0|||
33628173|NCT00525512|102187903|FG000|Open-Label Phase|Other reason (not specified)|0|||
33628174|NCT00525512|102187904|FG001|Open-Label Phase|Other reason (not specified)|0|||
33628175|NCT00525512|102187905|FG002|Open-Label Phase|Other reason (not specified)|4|||
33628176|NCT00525512|102187906|FG003|Open-Label Phase|Other reason (not specified)|5|||
33628177|NCT03804528|102191065|FG000|Overall Study|Time Commitment|18|||
33628178|NCT03804528|102191065|FG000|Overall Study|Health Reasons|5|||
33628179|NCT04551989|102191067|FG000|Overall Study|Adverse Event|4|||
33628180|NCT04551989|102191067|FG000|Overall Study|Protocol Violation|3|||
33628181|NCT04551989|102191067|FG000|Overall Study|Lost to Follow-up|1|||
33628182|NCT04551989|102191067|FG000|Overall Study|Physician Decision|3|||
33628183|NCT00383552|102191068|FG000|Overall Study|Adverse Event|7|||
33628184|NCT00383552|102191069|FG001|Overall Study|Adverse Event|6|||
33628185|NCT00383552|102191070|FG002|Overall Study|Adverse Event|9|||
33628186|NCT00383552|102191071|FG003|Overall Study|Adverse Event|6|||
33628187|NCT00383552|102191068|FG000|Overall Study|Lack of Efficacy|4|||
33628188|NCT00383552|102191069|FG001|Overall Study|Lack of Efficacy|13|||
33628189|NCT00383552|102191070|FG002|Overall Study|Lack of Efficacy|29|||
33628190|NCT00383552|102191071|FG003|Overall Study|Lack of Efficacy|42|||
33628191|NCT00383552|102191068|FG000|Overall Study|Lost to Follow-up|0|||
33563959|NCT02457546|101961888|FG000|Overall Study|Adverse Event|0|||
33563960|NCT02457546|101961889|FG001|Overall Study|Adverse Event|1|||
33563961|NCT03427619|101961901|FG000|Overall Study|Physician Decision|3|||
33563962|NCT03427619|101961901|FG000|Overall Study|Withdrawal by Subject|4|||
33563963|NCT03427619|101961901|FG000|Overall Study|Lost to Follow-up|5|||
33563964|NCT03427619|101961901|FG000|Overall Study|Administrative|4|||
33563965|NCT03427619|101961901|FG000|Overall Study|Other|2|||
33563966|NCT03427619|101961901|FG000|Overall Study|Unknown or Missing Completion Status|48|||
33563967|NCT03599713|101961905|FG000|Overall Study|Death|26|||
33563968|NCT03599713|101961906|FG001|Overall Study|Death|3|||
33563969|NCT03599713|101961905|FG000|Overall Study|Withdrawal by Subject|6|||
33563970|NCT03599713|101961906|FG001|Overall Study|Withdrawal by Subject|0|||
33563971|NCT03599713|101961905|FG000|Overall Study|Ongoing|69|||
33563972|NCT03599713|101961906|FG001|Overall Study|Ongoing|3|||
33563973|NCT03913130|101961909|FG000|Overall Study|Sponsor Decision|1|||
33563974|NCT01926509|101961910|FG000|Overall Study|vital sign met discontinuation criteria|1|||
33563975|NCT01926509|101961911|FG001|Overall Study|vital sign met discontinuation criteria|0|||
33563976|NCT01926509|101961912|FG002|Overall Study|vital sign met discontinuation criteria|0|||
33628192|NCT00383552|102191069|FG001|Overall Study|Lost to Follow-up|1|||
33628193|NCT00383552|102191070|FG002|Overall Study|Lost to Follow-up|5|||
33628194|NCT00383552|102191071|FG003|Overall Study|Lost to Follow-up|1|||
33628195|NCT00383552|102191068|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
33362700|NCT00923091|101214498|FG011|Period IV (Double-Blind)|Adverse Event|0|||
33362701|NCT00923091|101214499|FG012|Period IV (Double-Blind)|Adverse Event|0|||
33362702|NCT00923091|101214487|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33362703|NCT00923091|101214488|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
33362704|NCT00923091|101214489|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33563977|NCT01926509|101961913|FG003|Overall Study|vital sign met discontinuation criteria|0|||
33563978|NCT02507934|101961914|FG000|Overall Study|Lost to Follow-up|2|||
33628196|NCT00383552|102191069|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
33628197|NCT00383552|102191070|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
33563979|NCT02507934|101961915|FG001|Overall Study|Lost to Follow-up|0|||
33628198|NCT00383552|102191071|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
33628199|NCT00383552|102191068|FG000|Overall Study|Did not wish to continue (related)|1|||
33628200|NCT00383552|102191069|FG001|Overall Study|Did not wish to continue (related)|0|||
33628201|NCT00383552|102191070|FG002|Overall Study|Did not wish to continue (related)|2|||
33628202|NCT00383552|102191071|FG003|Overall Study|Did not wish to continue (related)|3|||
33628203|NCT00383552|102191068|FG000|Overall Study|Noncompliance with the protocol|11|||
33628204|NCT00383552|102191069|FG001|Overall Study|Noncompliance with the protocol|6|||
33628205|NCT00383552|102191070|FG002|Overall Study|Noncompliance with the protocol|8|||
33628206|NCT00383552|102191071|FG003|Overall Study|Noncompliance with the protocol|10|||
33628207|NCT00383552|102191068|FG000|Overall Study|Did not meet protocol eligibility|8|||
33362705|NCT00923091|101214490|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33628208|NCT00383552|102191069|FG001|Overall Study|Did not meet protocol eligibility|6|||
33628209|NCT00383552|102191070|FG002|Overall Study|Did not meet protocol eligibility|2|||
33628210|NCT00383552|102191071|FG003|Overall Study|Did not meet protocol eligibility|3|||
33628211|NCT00383552|102191068|FG000|Overall Study|Administrative|1|||
33628212|NCT00383552|102191069|FG001|Overall Study|Administrative|0|||
33628213|NCT00383552|102191070|FG002|Overall Study|Administrative|1|||
33628214|NCT00383552|102191071|FG003|Overall Study|Administrative|1|||
33628215|NCT04201431|102191072|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
33628216|NCT04201431|102191073|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
33628217|NCT04201431|102191074|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
33628218|NCT00280917|102191079|FG000|Overall Study|Adverse Event|1|||
33628219|NCT00280917|102191080|FG001|Overall Study|Adverse Event|1|||
33628220|NCT00280917|102191081|FG002|Overall Study|Adverse Event|4|||
33628221|NCT00280917|102191082|FG003|Overall Study|Adverse Event|1|||
33628222|NCT00280917|102191079|FG000|Overall Study|Change Therapy|1|||
33628223|NCT00280917|102191080|FG001|Overall Study|Change Therapy|2|||
33628224|NCT00280917|102191081|FG002|Overall Study|Change Therapy|0|||
33628225|NCT00280917|102191082|FG003|Overall Study|Change Therapy|0|||
33628226|NCT00280917|102191079|FG000|Overall Study|Withdrawal by Subject|0|||
33628227|NCT00280917|102191080|FG001|Overall Study|Withdrawal by Subject|2|||
33628228|NCT00280917|102191081|FG002|Overall Study|Withdrawal by Subject|0|||
33628229|NCT00280917|102191082|FG003|Overall Study|Withdrawal by Subject|1|||
33628230|NCT00280917|102191079|FG000|Overall Study|Noncompliance|0|||
33628231|NCT00280917|102191080|FG001|Overall Study|Noncompliance|1|||
33628232|NCT00280917|102191081|FG002|Overall Study|Noncompliance|2|||
33628233|NCT00280917|102191082|FG003|Overall Study|Noncompliance|0|||
33628234|NCT00770653|102191084|FG000|Overall Study|Adverse Event|13|||
33628235|NCT00770653|102191085|FG001|Overall Study|Adverse Event|5|||
33628236|NCT00770653|102191084|FG000|Overall Study|Protocol Violation|8|||
33628237|NCT00770653|102191085|FG001|Overall Study|Protocol Violation|6|||
33628238|NCT00770653|102191084|FG000|Overall Study|Withdrawal by Subject|4|||
33628239|NCT00770653|102191085|FG001|Overall Study|Withdrawal by Subject|7|||
33628240|NCT00770653|102191084|FG000|Overall Study|Lack of Compliance|1|||
33628241|NCT00770653|102191085|FG001|Overall Study|Lack of Compliance|4|||
33628242|NCT00770653|102191084|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
33628243|NCT00770653|102191085|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
33628244|NCT00770653|102191084|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
33628245|NCT00770653|102191085|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
33628246|NCT00770653|102191084|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
33628247|NCT00770653|102191085|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
33628248|NCT00770653|102191084|FG000|Overall Study|Lost to Follow-up|1|||
33415651|NCT03466060|101413071|FG003|Period 1|Withdrawal by Subject|0|||
33628249|NCT00770653|102191085|FG001|Overall Study|Lost to Follow-up|2|||
33563980|NCT02507934|101961914|FG000|Overall Study|Withdrawal by Subject|2|||
33563981|NCT02507934|101961915|FG001|Overall Study|Withdrawal by Subject|0|||
33563982|NCT01356940|101961916|FG000|First Intervention (28 Days)|Adverse Event|1|||
33563983|NCT01356940|101961917|FG001|First Intervention (28 Days)|Adverse Event|0|||
33563984|NCT01356940|101961916|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
33563985|NCT01356940|101961917|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
33563986|NCT03274466|101961918|FG000|Overall Study|Withdrawal by Subject|7|||
33563987|NCT03274466|101961919|FG001|Overall Study|Withdrawal by Subject|3|||
33563988|NCT03274466|101961918|FG000|Overall Study|Protocol Specified Withdrawal|5|||
33563989|NCT03274466|101961919|FG001|Overall Study|Protocol Specified Withdrawal|11|||
33563990|NCT03274466|101961918|FG000|Overall Study|Lost to Follow-up|5|||
33563991|NCT03274466|101961919|FG001|Overall Study|Lost to Follow-up|7|||
33563992|NCT03274466|101961918|FG000|Overall Study|Subject Non-compliance|0|||
33563993|NCT03274466|101961919|FG001|Overall Study|Subject Non-compliance|1|||
33563994|NCT03274466|101961918|FG000|Overall Study|Adverse Event|3|||
33563995|NCT03274466|101961919|FG001|Overall Study|Adverse Event|3|||
33563996|NCT03274466|101961918|FG000|Overall Study|Physician Decision|0|||
33563997|NCT03274466|101961919|FG001|Overall Study|Physician Decision|1|||
33563998|NCT03274466|101961918|FG000|Overall Study|Protocol Violation|3|||
33563999|NCT03274466|101961919|FG001|Overall Study|Protocol Violation|3|||
33564000|NCT01557244|101961920|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
33564001|NCT01557244|101961921|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
33564002|NCT01557244|101961922|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
33564003|NCT01557244|101961923|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
33564004|NCT01557244|101961924|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
33564005|NCT01557244|101961925|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
33564006|NCT01557244|101961926|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
33564007|NCT01557244|101961920|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
33564008|NCT01557244|101961921|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
33564009|NCT01557244|101961922|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
33564010|NCT01557244|101961923|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
33564011|NCT01557244|101961924|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
33564012|NCT01557244|101961925|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
33564013|NCT01557244|101961926|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
33564014|NCT01557244|101961920|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
33564015|NCT01557244|101961921|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
33564016|NCT01557244|101961922|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
33564017|NCT01557244|101961923|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
33564018|NCT01557244|101961924|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
33564019|NCT01557244|101961925|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
33564020|NCT01557244|101961926|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
33564021|NCT01557244|101961920|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
33564022|NCT01557244|101961921|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
33564023|NCT01557244|101961922|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
33564024|NCT01557244|101961923|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
33564025|NCT01557244|101961924|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
33564026|NCT01557244|101961925|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
33564027|NCT01557244|101961926|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
33564028|NCT01557244|101961920|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
33564029|NCT01557244|101961921|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
33564030|NCT01557244|101961922|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
33564031|NCT01557244|101961923|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
33564032|NCT01557244|101961924|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
33564033|NCT01557244|101961925|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
33628250|NCT00770653|102191084|FG000|Overall Study|Physician Decision|1|||
33564034|NCT01557244|101961926|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
33564035|NCT01557244|101961920|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
33564036|NCT01557244|101961921|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
33564037|NCT01557244|101961922|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
33628251|NCT00770653|102191085|FG001|Overall Study|Physician Decision|0|||
33628252|NCT00387881|102191088|FG000|Overall Study|Lost to Follow-up|23|||
33628253|NCT00387881|102191089|FG001|Overall Study|Lost to Follow-up|23|||
33628254|NCT00387881|102191088|FG000|Overall Study|Protocol Violation|2|||
33628255|NCT00387881|102191089|FG001|Overall Study|Protocol Violation|12|||
33628256|NCT00387881|102191088|FG000|Overall Study|Withdrawal by Subject|15|||
33628257|NCT00387881|102191089|FG001|Overall Study|Withdrawal by Subject|18|||
33628258|NCT00387881|102191088|FG000|Overall Study|Sponsor terminated Study|0|||
33628259|NCT00387881|102191089|FG001|Overall Study|Sponsor terminated Study|1|||
33628260|NCT00387881|102191088|FG000|Overall Study|Not eligible|6|||
33628261|NCT00387881|102191089|FG001|Overall Study|Not eligible|7|||
33628262|NCT00387881|102191088|FG000|Overall Study|No opportunity to treat headache|32|||
33628263|NCT00387881|102191089|FG001|Overall Study|No opportunity to treat headache|34|||
33628264|NCT00387881|102191088|FG000|Overall Study|Not otherwise specified|11|||
33628265|NCT00387881|102191089|FG001|Overall Study|Not otherwise specified|7|||
33628266|NCT02544321|102191092|FG000|Overall Study|Withdrawal by Subject|1|||
33628267|NCT02544321|102191093|FG001|Overall Study|Withdrawal by Subject|2|||
33628268|NCT02544321|102191092|FG000|Overall Study|Adverse Event|1|||
33628269|NCT02544321|102191093|FG001|Overall Study|Adverse Event|1|||
33628270|NCT02544321|102191092|FG000|Overall Study|Protocol Violation|0|||
33628271|NCT02544321|102191093|FG001|Overall Study|Protocol Violation|1|||
33628272|NCT00474812|102191094|FG000|Overall Study|Withdrawal by Subject|5|||
33628273|NCT00474812|102191094|FG000|Overall Study|No Initiation of treatment|2|||
33628274|NCT00107653|102191095|FG000|Overall Study|Adverse Event|24|||
33628275|NCT00107653|102191096|FG001|Overall Study|Adverse Event|43|||
33628276|NCT00107653|102191095|FG000|Overall Study|Insufficient Therapeutic Response|25|||
33628277|NCT00107653|102191096|FG001|Overall Study|Insufficient Therapeutic Response|11|||
33628278|NCT00107653|102191095|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
33628279|NCT00107653|102191096|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
33628280|NCT00107653|102191095|FG000|Overall Study|Protocol Violation|1|||
33628281|NCT00107653|102191096|FG001|Overall Study|Protocol Violation|0|||
33628282|NCT00107653|102191095|FG000|Overall Study|Withdrawal by Subject|12|||
33628283|NCT00107653|102191096|FG001|Overall Study|Withdrawal by Subject|13|||
33628284|NCT00107653|102191095|FG000|Overall Study|Lost to Follow-up|13|||
33628285|NCT00107653|102191096|FG001|Overall Study|Lost to Follow-up|5|||
33628286|NCT00107653|102191095|FG000|Overall Study|Administrative Reasons|3|||
33628287|NCT00107653|102191096|FG001|Overall Study|Administrative Reasons|3|||
33628288|NCT03724942|102191097|FG000|Overall Study|Adverse Event|20|||
33628289|NCT03724942|102191098|FG001|Overall Study|Adverse Event|14|||
33628290|NCT03724942|102191097|FG000|Overall Study|Lack of Efficacy|0|||
33628291|NCT03724942|102191098|FG001|Overall Study|Lack of Efficacy|1|||
33628292|NCT03724942|102191097|FG000|Overall Study|Physician Decision|5|||
33628293|NCT03724942|102191098|FG001|Overall Study|Physician Decision|2|||
33628294|NCT03724942|102191097|FG000|Overall Study|Protocol Violation|1|||
33628295|NCT03724942|102191098|FG001|Overall Study|Protocol Violation|0|||
33628296|NCT03724942|102191097|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
33222020|NCT01987817|100715653|FG001|Overall Study|Withdrawal by Subject|1|||
33362706|NCT00923091|101214491|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33362707|NCT00923091|101214492|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33362708|NCT00923091|101214493|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33362709|NCT00923091|101214494|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33362710|NCT00923091|101214495|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33362711|NCT00923091|101214496|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33362712|NCT00923091|101214497|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33362713|NCT00923091|101214498|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33362714|NCT00923091|101214499|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
33362715|NCT00923091|101214487|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
33362716|NCT00923091|101214488|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
33362717|NCT00923091|101214489|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
33362718|NCT00923091|101214490|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
33362719|NCT00923091|101214491|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
33362720|NCT00923091|101214492|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
33362721|NCT00923091|101214493|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
33362722|NCT00923091|101214494|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
33628297|NCT03724942|102191098|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
33628298|NCT03724942|102191097|FG000|Overall Study|Withdrawal by Legal Representative|3|||
33628299|NCT03724942|102191098|FG001|Overall Study|Withdrawal by Legal Representative|0|||
33628300|NCT03562195|102191099|FG000|Overall Study|Adverse Event|0|||
33628301|NCT03562195|102191100|FG001|Overall Study|Adverse Event|6|||
33628302|NCT03562195|102191099|FG000|Overall Study|Lack of Efficacy|0|||
33628303|NCT03562195|102191100|FG001|Overall Study|Lack of Efficacy|5|||
33362723|NCT00923091|101214495|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
33415652|NCT03466060|101413072|FG004|Period 1|Withdrawal by Subject|0|||
33628304|NCT03562195|102191099|FG000|Overall Study|Protocol Violation|0|||
33222021|NCT01987817|100715652|FG000|Overall Study|Physician Decision|1|||
33415653|NCT03466060|101413073|FG005|Period 1|Withdrawal by Subject|0|||
33415654|NCT03466060|101413068|FG000|Period 1|Lost to Follow-up|0|||
33415655|NCT03466060|101413069|FG001|Period 1|Lost to Follow-up|0|||
33415656|NCT03466060|101413070|FG002|Period 1|Lost to Follow-up|0|||
33415657|NCT03466060|101413071|FG003|Period 1|Lost to Follow-up|1|||
33415658|NCT03466060|101413072|FG004|Period 1|Lost to Follow-up|0|||
33222022|NCT01987817|100715653|FG001|Overall Study|Physician Decision|0|||
33222023|NCT01114204|100715656|FG000|Overall Study|Adverse Event|3|||
33222024|NCT01114204|100715657|FG001|Overall Study|Adverse Event|2|||
33222025|NCT01114204|100715656|FG000|Overall Study|Lost to Follow-up|1|||
33222026|NCT01114204|100715657|FG001|Overall Study|Lost to Follow-up|0|||
33222027|NCT01114204|100715656|FG000|Overall Study|Withdrawal by Subject|10|||
33222028|NCT01114204|100715657|FG001|Overall Study|Withdrawal by Subject|6|||
33415659|NCT03466060|101413073|FG005|Period 1|Lost to Follow-up|0|||
33415660|NCT03466060|101413068|FG000|Period 1|Grade 2 Conjunctivitis|0|||
33415661|NCT03466060|101413069|FG001|Period 1|Grade 2 Conjunctivitis|0|||
33415662|NCT03466060|101413070|FG002|Period 1|Grade 2 Conjunctivitis|1|||
33222029|NCT01114204|100715656|FG000|Overall Study|Death|1|||
33222030|NCT01114204|100715657|FG001|Overall Study|Death|0|||
33222031|NCT01114204|100715656|FG000|Overall Study|Other-Personal reasons|2|||
33222032|NCT01114204|100715657|FG001|Overall Study|Other-Personal reasons|0|||
33222033|NCT01114204|100715656|FG000|Overall Study|Other-Medical monitor request|1|||
33222034|NCT01114204|100715657|FG001|Overall Study|Other-Medical monitor request|0|||
33222035|NCT01114204|100715656|FG000|Overall Study|Other-Participant request|2|||
33222036|NCT01114204|100715657|FG001|Overall Study|Other-Participant request|0|||
33222037|NCT01114204|100715656|FG000|Overall Study|Other-Protocol Violation|1|||
33222038|NCT01114204|100715657|FG001|Overall Study|Other-Protocol Violation|0|||
33222039|NCT02569437|100715658|FG000|Overall Study|Lost to Follow-up|12|||
33222040|NCT02569437|100715659|FG001|Overall Study|Lost to Follow-up|14|||
33222041|NCT01279343|100715662|FG000|Overall Study|Did not receive treatment|2|||
33222042|NCT01279343|100715663|FG001|Overall Study|Did not receive treatment|6|||
33222043|NCT03642938|100715665|FG000|Overall Study|Withdrawal by Subject|0|||
33222044|NCT03642938|100715666|FG001|Overall Study|Withdrawal by Subject|0|||
33222045|NCT03642938|100715667|FG002|Overall Study|Withdrawal by Subject|0|||
33222046|NCT03642938|100715668|FG003|Overall Study|Withdrawal by Subject|1|||
33222047|NCT04098406|100715669|FG000|Overall Study|Adverse Event|2|||
33222048|NCT04098406|100715670|FG001|Overall Study|Adverse Event|1|||
33222049|NCT04098406|100715669|FG000|Overall Study|Withdrawal by Subject|1|||
33222050|NCT04098406|100715670|FG001|Overall Study|Withdrawal by Subject|0|||
33222051|NCT03587142|100715671|FG000|Overall Study|Lost to Follow-up|5|||
33222052|NCT03587142|100715672|FG001|Overall Study|Lost to Follow-up|3|||
33222053|NCT03587142|100715671|FG000|Overall Study|Did not complete the f4 visit|3|||
33222054|NCT03587142|100715672|FG001|Overall Study|Did not complete the f4 visit|7|||
33222055|NCT01892345|100715673|FG000|Overall Study|Adverse Event|0|||
33222056|NCT01892345|100715674|FG001|Overall Study|Adverse Event|2|||
33222057|NCT01892345|100715673|FG000|Overall Study|Death|1|||
33222058|NCT01892345|100715674|FG001|Overall Study|Death|0|||
33415663|NCT03466060|101413071|FG003|Period 1|Grade 2 Conjunctivitis|0|||
33415664|NCT03466060|101413072|FG004|Period 1|Grade 2 Conjunctivitis|0|||
33415665|NCT03466060|101413073|FG005|Period 1|Grade 2 Conjunctivitis|0|||
33362724|NCT00923091|101214496|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
33362725|NCT00923091|101214497|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
33362726|NCT00923091|101214498|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
33362727|NCT00923091|101214499|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
33362728|NCT00923091|101214487|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
33362729|NCT00923091|101214488|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
33362730|NCT00923091|101214489|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
33362731|NCT00923091|101214490|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
33415666|NCT03466060|101413068|FG000|Period 2|Lens Handling Difficulties|0|||
33415667|NCT03466060|101413069|FG001|Period 2|Lens Handling Difficulties|0|||
33415668|NCT03466060|101413070|FG002|Period 2|Lens Handling Difficulties|1|||
33628305|NCT03562195|102191100|FG001|Overall Study|Protocol Violation|1|||
33628306|NCT03562195|102191099|FG000|Overall Study|Lost to Follow-up|0|||
33415669|NCT03466060|101413071|FG003|Period 2|Lens Handling Difficulties|0|||
33415670|NCT03466060|101413072|FG004|Period 2|Lens Handling Difficulties|0|||
33222059|NCT01892345|100715673|FG000|Overall Study|Lost to Follow-up|3|||
33222060|NCT01892345|100715674|FG001|Overall Study|Lost to Follow-up|0|||
33222061|NCT01892345|100715673|FG000|Overall Study|Withdrawal by Subject|12|||
33222062|NCT01892345|100715674|FG001|Overall Study|Withdrawal by Subject|1|||
33222063|NCT00659490|100715675|FG000|Overall Study|Lost to Follow-up|2|||
33222064|NCT00659490|100715676|FG001|Overall Study|Lost to Follow-up|0|||
33222065|NCT00659490|100715677|FG002|Overall Study|Lost to Follow-up|1|||
33222066|NCT00746096|100715680|FG000|Overall Study|Adverse Event|1|||
33222067|NCT00746096|100715681|FG001|Overall Study|Adverse Event|0|||
33222068|NCT00746096|100715680|FG000|Overall Study|Withdrawal by Subject|5|||
33222069|NCT00746096|100715681|FG001|Overall Study|Withdrawal by Subject|1|||
33415671|NCT03466060|101413073|FG005|Period 2|Lens Handling Difficulties|0|||
33222070|NCT00746096|100715680|FG000|Overall Study|Lost to Follow-up|2|||
33628307|NCT03562195|102191100|FG001|Overall Study|Lost to Follow-up|1|||
33564038|NCT01557244|101961923|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
33564039|NCT01557244|101961924|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
33564040|NCT01557244|101961925|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
33564041|NCT01557244|101961926|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
33564042|NCT01557244|101961920|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
33564043|NCT01557244|101961921|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
33564044|NCT01557244|101961922|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
33564045|NCT01557244|101961923|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
33564046|NCT01557244|101961924|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
33564047|NCT01557244|101961925|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
33564048|NCT01557244|101961926|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
33564049|NCT01557244|101961920|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
33628308|NCT03562195|102191099|FG000|Overall Study|Physician Decision|1|||
33628309|NCT03562195|102191100|FG001|Overall Study|Physician Decision|0|||
33628310|NCT03562195|102191099|FG000|Overall Study|Withdrawal by Subject|3|||
33628311|NCT03562195|102191100|FG001|Overall Study|Withdrawal by Subject|0|||
33628312|NCT00758771|102191107|FG000|Overall Study|Withdrawal by Subject|1|||
33628313|NCT00758771|102191108|FG001|Overall Study|Withdrawal by Subject|1|||
33628314|NCT00758771|102191107|FG000|Overall Study|Did not meet eligibility criteria|2|||
33628315|NCT00758771|102191108|FG001|Overall Study|Did not meet eligibility criteria|4|||
33628316|NCT00231816|102191109|FG000|Overall Study|Adverse Event|1|||
33628317|NCT00231816|102191110|FG001|Overall Study|Adverse Event|0|||
33628318|NCT00231816|102191109|FG000|Overall Study|Lost to Follow-up|8|||
33628319|NCT00231816|102191110|FG001|Overall Study|Lost to Follow-up|5|||
33628320|NCT00231816|102191109|FG000|Overall Study|Protocol Violation|2|||
33628321|NCT00231816|102191110|FG001|Overall Study|Protocol Violation|3|||
33628322|NCT00231816|102191109|FG000|Overall Study|Withdrawal by Subject|3|||
33628323|NCT00231816|102191110|FG001|Overall Study|Withdrawal by Subject|3|||
33628324|NCT00231816|102191109|FG000|Overall Study|Other|2|||
33628325|NCT00231816|102191110|FG001|Overall Study|Other|1|||
33628326|NCT01064440|102191111|FG000|Overall Study|Lost to Follow-up|1|||
33628327|NCT01064440|102191112|FG001|Overall Study|Lost to Follow-up|1|||
33628328|NCT01064440|102191113|FG002|Overall Study|Lost to Follow-up|1|||
33628329|NCT01064440|102191111|FG000|Overall Study|Non-compliance|0|||
33628330|NCT01064440|102191112|FG001|Overall Study|Non-compliance|1|||
33628331|NCT01064440|102191113|FG002|Overall Study|Non-compliance|0|||
33628332|NCT01064440|102191111|FG000|Overall Study|Death|1|||
33628333|NCT01064440|102191112|FG001|Overall Study|Death|0|||
33628334|NCT01064440|102191113|FG002|Overall Study|Death|1|||
33628335|NCT01064440|102191111|FG000|Overall Study|Withdrawal by Subject|0|||
33628336|NCT01064440|102191112|FG001|Overall Study|Withdrawal by Subject|1|||
33628337|NCT01064440|102191113|FG002|Overall Study|Withdrawal by Subject|1|||
33628338|NCT01064440|102191111|FG000|Overall Study|Other: amputation|1|||
33628339|NCT01064440|102191112|FG001|Overall Study|Other: amputation|0|||
33628340|NCT01064440|102191113|FG002|Overall Study|Other: amputation|0|||
33628341|NCT03001557|102191114|FG000|Core Phase|Randomized but not treated|0|||
33628342|NCT03001557|102191115|FG001|Core Phase|Randomized but not treated|0|||
33628343|NCT03001557|102191116|FG002|Core Phase|Randomized but not treated|1|||
33628344|NCT03001557|102191117|FG003|Core Phase|Randomized but not treated|0|||
33628345|NCT03001557|102191118|FG004|Core Phase|Randomized but not treated|0|||
33415672|NCT04969263|101413077|FG000|Overall Study|Death|1|||
33628346|NCT03001557|102191119|FG005|Core Phase|Randomized but not treated|0|||
33628347|NCT03001557|102191120|FG006|Core Phase|Randomized but not treated|0|||
33222071|NCT00746096|100715681|FG001|Overall Study|Lost to Follow-up|1|||
33222072|NCT00746096|100715680|FG000|Overall Study|Protocol Violation|1|||
33222073|NCT00746096|100715681|FG001|Overall Study|Protocol Violation|0|||
33222074|NCT00746096|100715680|FG000|Overall Study|No study drug treatment|1|||
33222075|NCT00746096|100715681|FG001|Overall Study|No study drug treatment|1|||
33222076|NCT00847405|100715682|FG000|First Intervention|Adverse Event|0|||
33222077|NCT00847405|100715683|FG001|First Intervention|Adverse Event|1|||
33222078|NCT00847405|100715682|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
33222079|NCT00847405|100715683|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
33222080|NCT05292534|100715687|FG000|Overall Study|Protocol Violation|3|||
33222081|NCT05292534|100715688|FG001|Overall Study|Protocol Violation|4|||
33222082|NCT05292534|100715687|FG000|Overall Study|Withdrawal by Subject|0|||
33222083|NCT05292534|100715688|FG001|Overall Study|Withdrawal by Subject|1|||
33222084|NCT03108157|100715689|FG000|Overall Study|Protocol Violation|15|||
33222085|NCT03108157|100715690|FG001|Overall Study|Protocol Violation|4|||
33222086|NCT01750879|100715691|FG000|Overall Study|Adverse Event|8|||
33222087|NCT01750879|100715692|FG001|Overall Study|Adverse Event|0|||
33222088|NCT01750879|100715691|FG000|Overall Study|Lack of Efficacy|1|||
33222089|NCT01750879|100715692|FG001|Overall Study|Lack of Efficacy|0|||
33222090|NCT01750879|100715691|FG000|Overall Study|Withdrawal by Subject|1|||
33222091|NCT01750879|100715692|FG001|Overall Study|Withdrawal by Subject|0|||
33222092|NCT01750879|100715691|FG000|Overall Study|Did not complete per protocol|0|||
33222093|NCT01750879|100715692|FG001|Overall Study|Did not complete per protocol|3|||
33222094|NCT03299686|100715694|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
33222095|NCT03299686|100715695|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
33222096|NCT03299686|100715694|FG000|Treatment Epoch|Physician Decision|1|||
33222097|NCT03299686|100715695|FG001|Treatment Epoch|Physician Decision|0|||
33222098|NCT03299686|100715694|FG000|Treatment Epoch|Adverse Event|8|||
33222099|NCT03299686|100715695|FG001|Treatment Epoch|Adverse Event|4|||
33222100|NCT03299686|100715694|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
33222101|NCT03299686|100715695|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
33222102|NCT01780935|100715696|FG000|Overall Study|Admin problems due to early termination|321|||
33222103|NCT01780935|100715697|FG001|Overall Study|Admin problems due to early termination|309|||
33222104|NCT01780935|100715696|FG000|Overall Study|Adverse Event|2|||
33222105|NCT01780935|100715697|FG001|Overall Study|Adverse Event|4|||
33222106|NCT01780935|100715696|FG000|Overall Study|Death|1|||
33222107|NCT01780935|100715697|FG001|Overall Study|Death|6|||
33628348|NCT03001557|102191121|FG007|Core Phase|Randomized but not treated|0|||
33628349|NCT03001557|102191114|FG000|Extension Phase|Adverse Event|0|||
33628350|NCT03001557|102191115|FG001|Extension Phase|Adverse Event|0|||
33628351|NCT03001557|102191116|FG002|Extension Phase|Adverse Event|0|||
33628352|NCT03001557|102191117|FG003|Extension Phase|Adverse Event|0|||
33628353|NCT03001557|102191118|FG004|Extension Phase|Adverse Event|0|||
33628354|NCT03001557|102191119|FG005|Extension Phase|Adverse Event|2|||
33628355|NCT03001557|102191120|FG006|Extension Phase|Adverse Event|0|||
33628356|NCT03001557|102191121|FG007|Extension Phase|Adverse Event|0|||
33628357|NCT03001557|102191114|FG000|Extension Phase|Withdrawal by Subject|0|||
33628358|NCT03001557|102191115|FG001|Extension Phase|Withdrawal by Subject|0|||
33628359|NCT03001557|102191116|FG002|Extension Phase|Withdrawal by Subject|0|||
33628360|NCT03001557|102191117|FG003|Extension Phase|Withdrawal by Subject|0|||
33628361|NCT03001557|102191118|FG004|Extension Phase|Withdrawal by Subject|0|||
33628362|NCT03001557|102191119|FG005|Extension Phase|Withdrawal by Subject|1|||
33564050|NCT01557244|101961921|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
33564051|NCT01557244|101961922|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
33564052|NCT01557244|101961923|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
33564053|NCT01557244|101961924|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
33564054|NCT01557244|101961925|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
33564055|NCT01557244|101961926|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
33564056|NCT01557244|101961920|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
33564057|NCT01557244|101961921|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
33564058|NCT01557244|101961922|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
33564059|NCT01557244|101961923|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
33564060|NCT01557244|101961924|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
33564061|NCT01557244|101961925|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
33564062|NCT01557244|101961926|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
33564063|NCT01557244|101961920|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
33564064|NCT01557244|101961921|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
33222108|NCT01780935|100715696|FG000|Overall Study|Lost to Follow-up|2|||
33222109|NCT01780935|100715697|FG001|Overall Study|Lost to Follow-up|6|||
33222110|NCT01780935|100715696|FG000|Overall Study|Physician Decision|1|||
33628363|NCT03001557|102191120|FG006|Extension Phase|Withdrawal by Subject|5|||
33628364|NCT03001557|102191121|FG007|Extension Phase|Withdrawal by Subject|2|||
33222111|NCT01780935|100715697|FG001|Overall Study|Physician Decision|1|||
33222112|NCT01780935|100715696|FG000|Overall Study|Protocol deviation|0|||
33222113|NCT01780935|100715697|FG001|Overall Study|Protocol deviation|1|||
33564065|NCT01557244|101961922|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
33628365|NCT03001557|102191114|FG000|Extension Phase|Lost to Follow-up|0|||
33222114|NCT01780935|100715696|FG000|Overall Study|Patient withdrew consent|8|||
33222115|NCT01780935|100715697|FG001|Overall Study|Patient withdrew consent|9|||
33222116|NCT00595504|100715698|FG000|Overall Study|Withdrawal by Subject|1|||
33222117|NCT00595504|100715699|FG001|Overall Study|Withdrawal by Subject|3|||
33222118|NCT00595504|100715698|FG000|Overall Study|Physician Decision|1|||
33222119|NCT00595504|100715699|FG001|Overall Study|Physician Decision|0|||
33222120|NCT01691521|100715700|FG000|Overall Study|Adverse Event|4|||
33222121|NCT01691521|100715701|FG001|Overall Study|Adverse Event|0|||
33222122|NCT01691521|100715702|FG002|Overall Study|Adverse Event|1|||
33222123|NCT01691521|100715700|FG000|Overall Study|Lack of Efficacy|1|||
33222124|NCT01691521|100715701|FG001|Overall Study|Lack of Efficacy|1|||
33222125|NCT01691521|100715702|FG002|Overall Study|Lack of Efficacy|2|||
33222126|NCT01691521|100715700|FG000|Overall Study|Protocol Violation|0|||
33222127|NCT01691521|100715701|FG001|Overall Study|Protocol Violation|3|||
33564066|NCT01557244|101961923|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
33564067|NCT01557244|101961924|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
33564068|NCT01557244|101961925|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
33564069|NCT01557244|101961926|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
33564070|NCT01557244|101961920|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
33564071|NCT01557244|101961921|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
33564072|NCT01557244|101961922|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
33564073|NCT01557244|101961923|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
33564074|NCT01557244|101961924|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
33564075|NCT01557244|101961925|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
33564076|NCT01557244|101961926|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
33564077|NCT01557244|101961920|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
33564078|NCT01557244|101961921|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
33564079|NCT01557244|101961922|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
33564080|NCT01557244|101961923|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
33564081|NCT01557244|101961924|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
33564082|NCT01557244|101961925|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
33564083|NCT01557244|101961926|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
33564084|NCT02276040|101961929|FG000|Overall Study|Physician Decision|15|||
33564085|NCT03900650|101961932|FG000|Overall Study|Withdrawal by Subject|1|||
33564086|NCT03900650|101961933|FG001|Overall Study|Withdrawal by Subject|1|||
33564087|NCT03900650|101961934|FG002|Overall Study|Withdrawal by Subject|0|||
33564088|NCT03900650|101961935|FG003|Overall Study|Withdrawal by Subject|0|||
33564089|NCT03900650|101961932|FG000|Overall Study|Withdrawn by staff|1|||
33564090|NCT03900650|101961933|FG001|Overall Study|Withdrawn by staff|0|||
33564091|NCT03900650|101961934|FG002|Overall Study|Withdrawn by staff|0|||
33564092|NCT03900650|101961935|FG003|Overall Study|Withdrawn by staff|0|||
33564093|NCT02249949|101961942|FG000|Overall Study|Cancelled prior to treatment|2|||
33564094|NCT01435356|101961949|FG000|Overall Study|Adverse Event|2|||
33564095|NCT01435356|101961950|FG001|Overall Study|Adverse Event|0|||
33564096|NCT01435356|101961949|FG000|Overall Study|Disease progression/recurrence|17|||
33564097|NCT01435356|101961950|FG001|Overall Study|Disease progression/recurrence|10|||
33564098|NCT01435356|101961949|FG000|Overall Study|Protocol Violation|0|||
33222128|NCT01691521|100715702|FG002|Overall Study|Protocol Violation|0|||
33222129|NCT01691521|100715700|FG000|Overall Study|Lost to Follow-up|0|||
33222130|NCT01691521|100715701|FG001|Overall Study|Lost to Follow-up|2|||
33222131|NCT01691521|100715702|FG002|Overall Study|Lost to Follow-up|2|||
33222132|NCT01691521|100715700|FG000|Overall Study|Physician Decision|2|||
33222133|NCT01691521|100715701|FG001|Overall Study|Physician Decision|1|||
33222134|NCT01691521|100715702|FG002|Overall Study|Physician Decision|0|||
33222135|NCT01691521|100715700|FG000|Overall Study|Withdrawal by Subject|5|||
33222136|NCT01691521|100715701|FG001|Overall Study|Withdrawal by Subject|9|||
33222137|NCT01691521|100715702|FG002|Overall Study|Withdrawal by Subject|4|||
33415673|NCT04969263|101413077|FG000|Overall Study|Lost to Follow-up|2|||
33564099|NCT01435356|101961950|FG001|Overall Study|Protocol Violation|1|||
33564100|NCT01435356|101961949|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
33564101|NCT01435356|101961950|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
33564102|NCT01435356|101961949|FG000|Overall Study|Withdrawal by Subject|1|||
33564103|NCT01435356|101961950|FG001|Overall Study|Withdrawal by Subject|1|||
33564104|NCT01435356|101961949|FG000|Overall Study|Facial palsy|1|||
33564105|NCT01435356|101961950|FG001|Overall Study|Facial palsy|0|||
33628366|NCT03001557|102191115|FG001|Extension Phase|Lost to Follow-up|0|||
33222138|NCT01564368|100715706|FG000|Overall Study|Ineligible|18|||
33222139|NCT01564368|100715706|FG000|Overall Study|Not Randomized in Parent study|116|||
33222140|NCT01564368|100715706|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
33564106|NCT01435356|101961949|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
33564107|NCT01435356|101961950|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
33564108|NCT01435356|101961949|FG000|Overall Study|Physician Decision|1|||
33564109|NCT01435356|101961950|FG001|Overall Study|Physician Decision|0|||
33564110|NCT01435356|101961949|FG000|Overall Study|Patient decision|3|||
33564111|NCT01435356|101961950|FG001|Overall Study|Patient decision|0|||
33564112|NCT01435356|101961949|FG000|Overall Study|Patient moved to another city|1|||
33564113|NCT01435356|101961950|FG001|Overall Study|Patient moved to another city|1|||
33564114|NCT03701074|101961954|FG000|Overall Study|Physician Decision|1|||
33564115|NCT03701074|101961955|FG001|Overall Study|Physician Decision|0|||
33564116|NCT01166646|101961956|FG000|Overall Study|Protocol Violation|0|||
33564117|NCT01166646|101961957|FG001|Overall Study|Protocol Violation|1|||
33564118|NCT01166646|101961956|FG000|Overall Study|Adverse Event|1|||
33564119|NCT01166646|101961957|FG001|Overall Study|Adverse Event|0|||
33564120|NCT02185768|101961960|FG000|Overall Study|Patients were not treated|2|||
33564121|NCT03757715|101961963|FG000|Overall Study|Lost to Follow-up|4|||
33564122|NCT03757715|101961964|FG001|Overall Study|Lost to Follow-up|9|||
33564123|NCT03757715|101961963|FG000|Overall Study|Withdrawal by Subject|1|||
33564124|NCT03757715|101961964|FG001|Overall Study|Withdrawal by Subject|1|||
33564125|NCT04893811|101961965|FG000|Vaccination Phase|Death|1|||
33564126|NCT04893811|101961966|FG001|Vaccination Phase|Death|0|||
33564127|NCT04893811|101961965|FG000|Vaccination Phase|Lost to Follow-up|1|||
33564128|NCT04893811|101961966|FG001|Vaccination Phase|Lost to Follow-up|1|||
33564129|NCT04893811|101961965|FG000|Vaccination Phase|Protocol Violation|2|||
33564130|NCT04893811|101961966|FG001|Vaccination Phase|Protocol Violation|0|||
33564131|NCT04893811|101961965|FG000|Vaccination Phase|Withdrawal by Subject|2|||
33564132|NCT04893811|101961966|FG001|Vaccination Phase|Withdrawal by Subject|1|||
33564133|NCT04893811|101961965|FG000|Vaccination Phase|Other|0|||
33564134|NCT04893811|101961966|FG001|Vaccination Phase|Other|1|||
33564135|NCT04893811|101961965|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
33564136|NCT04893811|101961966|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
33564137|NCT04893811|101961965|FG000|Follow-up Phase|Lost to Follow-up|0|||
33564138|NCT04893811|101961966|FG001|Follow-up Phase|Lost to Follow-up|1|||
33564139|NCT03312114|101961967|FG000|Overall Study|All the five enrolled dropped out of the|5|||
33564140|NCT04938427|101961974|FG000|Overall Study|Adverse Event|5|||
33564141|NCT04938427|101961975|FG001|Overall Study|Adverse Event|19|||
33564142|NCT04938427|101961974|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
33564143|NCT04938427|101961975|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33564144|NCT04938427|101961974|FG000|Overall Study|Withdrawal by Subject|1|||
33564145|NCT04938427|101961975|FG001|Overall Study|Withdrawal by Subject|0|||
33564146|NCT04938427|101961974|FG000|Overall Study|Reason Not Specified|2|||
33564147|NCT04938427|101961975|FG001|Overall Study|Reason Not Specified|1|||
33564148|NCT03034044|101961976|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
33564149|NCT02097225|101961979|FG000|Dose Level 4|Adverse Event|0|||
33564150|NCT02097225|101961980|FG001|Dose Level 4|Adverse Event|0|||
33564151|NCT02097225|101961981|FG002|Dose Level 4|Adverse Event|0|||
33564152|NCT02097225|101961982|FG003|Dose Level 4|Adverse Event|0|||
33564153|NCT02097225|101961983|FG004|Dose Level 4|Adverse Event|1|||
33564154|NCT03559556|101961984|FG000|Overall Study|Withdrawal by Subject|1|||
33564155|NCT00085735|101961999|FG000|Overall Study|Adverse Event|1|||
33564156|NCT00085735|101962000|FG001|Overall Study|Adverse Event|0|||
33564157|NCT00085735|101962001|FG002|Overall Study|Adverse Event|0|||
33564158|NCT00085735|101962002|FG003|Overall Study|Adverse Event|0|||
33628367|NCT03001557|102191116|FG002|Extension Phase|Lost to Follow-up|0|||
33628368|NCT03001557|102191117|FG003|Extension Phase|Lost to Follow-up|0|||
33628369|NCT03001557|102191118|FG004|Extension Phase|Lost to Follow-up|0|||
33628370|NCT03001557|102191119|FG005|Extension Phase|Lost to Follow-up|0|||
33628371|NCT03001557|102191120|FG006|Extension Phase|Lost to Follow-up|2|||
33628372|NCT03001557|102191121|FG007|Extension Phase|Lost to Follow-up|1|||
33628373|NCT03001557|102191114|FG000|Extension Phase|Administrative Reason|0|||
33628374|NCT03001557|102191115|FG001|Extension Phase|Administrative Reason|0|||
33628375|NCT03001557|102191116|FG002|Extension Phase|Administrative Reason|0|||
33628376|NCT03001557|102191117|FG003|Extension Phase|Administrative Reason|0|||
33222141|NCT01564368|100715706|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
33222142|NCT01191840|100715716|FG000|Overall Study|withdrew consent|2|||
33415674|NCT04969263|101413077|FG000|Overall Study|Withdrawal by Subject|5|||
33564159|NCT00085735|101962003|FG004|Overall Study|Adverse Event|0|||
33628377|NCT03001557|102191118|FG004|Extension Phase|Administrative Reason|0|||
33564160|NCT00085735|101962004|FG005|Overall Study|Adverse Event|0|||
33564161|NCT00085735|101961999|FG000|Overall Study|Lack of Efficacy|2|||
33564162|NCT00085735|101962000|FG001|Overall Study|Lack of Efficacy|4|||
33564163|NCT00085735|101962001|FG002|Overall Study|Lack of Efficacy|6|||
33222143|NCT01191840|100715717|FG001|Overall Study|withdrew consent|1|||
33222144|NCT01191840|100715716|FG000|Overall Study|Subject discontinued treatment|1|||
33222145|NCT01191840|100715717|FG001|Overall Study|Subject discontinued treatment|2|||
33564164|NCT00085735|101962002|FG003|Overall Study|Lack of Efficacy|3|||
33564165|NCT00085735|101962003|FG004|Overall Study|Lack of Efficacy|4|||
33222146|NCT01191840|100715716|FG000|Overall Study|Lost to Follow-up|4|||
33222147|NCT01191840|100715717|FG001|Overall Study|Lost to Follow-up|6|||
33564166|NCT00085735|101962004|FG005|Overall Study|Lack of Efficacy|3|||
33564167|NCT00085735|101961999|FG000|Overall Study|Lost to Follow-up|0|||
33564168|NCT00085735|101962000|FG001|Overall Study|Lost to Follow-up|1|||
33564169|NCT00085735|101962001|FG002|Overall Study|Lost to Follow-up|0|||
33564170|NCT00085735|101962002|FG003|Overall Study|Lost to Follow-up|0|||
33564171|NCT00085735|101962003|FG004|Overall Study|Lost to Follow-up|1|||
33564172|NCT00085735|101962004|FG005|Overall Study|Lost to Follow-up|0|||
33564173|NCT00085735|101961999|FG000|Overall Study|Physician Decision|2|||
33564174|NCT00085735|101962000|FG001|Overall Study|Physician Decision|3|||
33564175|NCT00085735|101962001|FG002|Overall Study|Physician Decision|2|||
33564176|NCT00085735|101962002|FG003|Overall Study|Physician Decision|3|||
33564177|NCT00085735|101962003|FG004|Overall Study|Physician Decision|11|||
33564178|NCT00085735|101962004|FG005|Overall Study|Physician Decision|8|||
33564179|NCT00085735|101961999|FG000|Overall Study|Protocol Violation|1|||
33564180|NCT00085735|101962000|FG001|Overall Study|Protocol Violation|0|||
33564181|NCT00085735|101962001|FG002|Overall Study|Protocol Violation|0|||
33564182|NCT00085735|101962002|FG003|Overall Study|Protocol Violation|0|||
33564183|NCT00085735|101962003|FG004|Overall Study|Protocol Violation|0|||
33564184|NCT00085735|101962004|FG005|Overall Study|Protocol Violation|0|||
33564185|NCT00085735|101961999|FG000|Overall Study|Withdrawal by Subject|1|||
33564186|NCT00085735|101962000|FG001|Overall Study|Withdrawal by Subject|0|||
33564187|NCT00085735|101962001|FG002|Overall Study|Withdrawal by Subject|4|||
33564188|NCT00085735|101962002|FG003|Overall Study|Withdrawal by Subject|5|||
33564189|NCT00085735|101962003|FG004|Overall Study|Withdrawal by Subject|7|||
33564190|NCT00085735|101962004|FG005|Overall Study|Withdrawal by Subject|8|||
33564191|NCT00085735|101961999|FG000|Overall Study|Patient ineligible|1|||
33564192|NCT00085735|101962000|FG001|Overall Study|Patient ineligible|0|||
33564193|NCT00085735|101962001|FG002|Overall Study|Patient ineligible|3|||
33628378|NCT03001557|102191119|FG005|Extension Phase|Administrative Reason|1|||
33628379|NCT03001557|102191120|FG006|Extension Phase|Administrative Reason|3|||
33628380|NCT03001557|102191121|FG007|Extension Phase|Administrative Reason|3|||
33628381|NCT03001557|102191114|FG000|Extension Phase|Loss of caregiver|0|||
33628382|NCT03001557|102191115|FG001|Extension Phase|Loss of caregiver|0|||
33628383|NCT03001557|102191116|FG002|Extension Phase|Loss of caregiver|0|||
33628384|NCT03001557|102191117|FG003|Extension Phase|Loss of caregiver|0|||
33628385|NCT03001557|102191118|FG004|Extension Phase|Loss of caregiver|0|||
33628386|NCT03001557|102191119|FG005|Extension Phase|Loss of caregiver|0|||
33628387|NCT03001557|102191120|FG006|Extension Phase|Loss of caregiver|1|||
33628388|NCT03001557|102191121|FG007|Extension Phase|Loss of caregiver|0|||
33415675|NCT04969263|101413077|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
33564194|NCT00085735|101962002|FG003|Overall Study|Patient ineligible|7|||
33564195|NCT00085735|101962003|FG004|Overall Study|Patient ineligible|17|||
33222148|NCT01191840|100715716|FG000|Overall Study|Non Staph Infection|4|||
33415676|NCT02723786|101413078|FG000|Overall Study|Lost to Follow-up|1|||
33628389|NCT03001557|102191114|FG000|Extension Phase|Others|0|||
33628390|NCT03001557|102191115|FG001|Extension Phase|Others|0|||
33628391|NCT03001557|102191116|FG002|Extension Phase|Others|0|||
33564196|NCT00085735|101962004|FG005|Overall Study|Patient ineligible|8|||
33628392|NCT03001557|102191117|FG003|Extension Phase|Others|0|||
33564197|NCT00085735|101961999|FG000|Overall Study|Excess residual disease|2|||
33564198|NCT00085735|101962000|FG001|Overall Study|Excess residual disease|2|||
33564199|NCT00085735|101962001|FG002|Overall Study|Excess residual disease|1|||
33564200|NCT00085735|101962002|FG003|Overall Study|Excess residual disease|1|||
33564201|NCT00085735|101962003|FG004|Overall Study|Excess residual disease|1|||
33564202|NCT00085735|101962004|FG005|Overall Study|Excess residual disease|4|||
33564203|NCT00085735|101961999|FG000|Overall Study|Reason not documented|1|||
33564204|NCT00085735|101962000|FG001|Overall Study|Reason not documented|0|||
33564205|NCT00085735|101962001|FG002|Overall Study|Reason not documented|1|||
33564206|NCT00085735|101962002|FG003|Overall Study|Reason not documented|0|||
33564207|NCT00085735|101962003|FG004|Overall Study|Reason not documented|1|||
33564208|NCT00085735|101962004|FG005|Overall Study|Reason not documented|0|||
33564209|NCT00085735|101961999|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
33564210|NCT00085735|101962000|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
33564211|NCT00085735|101962001|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
33564212|NCT00085735|101962002|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
33564213|NCT00085735|101962003|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
33564214|NCT00085735|101962004|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
33564215|NCT00830336|101962008|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
33564216|NCT00830336|101962009|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
33564217|NCT00511199|101962013|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
33564218|NCT00511199|101962014|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
33564219|NCT00511199|101962013|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
33564220|NCT00511199|101962014|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
33564221|NCT00511199|101962013|FG000|Overall Study|Withdrawal of Informed Consent|19|||
33564222|NCT00511199|101962014|FG001|Overall Study|Withdrawal of Informed Consent|4|||
33564223|NCT00511199|101962013|FG000|Overall Study|Pregnancy|6|||
33564224|NCT00511199|101962014|FG001|Overall Study|Pregnancy|3|||
33564225|NCT00511199|101962013|FG000|Overall Study|Pregnancy Wish|16|||
33564226|NCT00511199|101962014|FG001|Overall Study|Pregnancy Wish|8|||
33564227|NCT00511199|101962013|FG000|Overall Study|Lost to Follow-up|40|||
33564228|NCT00511199|101962014|FG001|Overall Study|Lost to Follow-up|17|||
33564229|NCT00511199|101962013|FG000|Overall Study|Other Reason|78|||
33564230|NCT00511199|101962014|FG001|Overall Study|Other Reason|37|||
33564231|NCT04770285|101962015|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
33564232|NCT04770285|101962016|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
33564233|NCT04770285|101962015|FG000|Overall Study|Lack of Efficacy|0|||
33564234|NCT04770285|101962016|FG001|Overall Study|Lack of Efficacy|1|||
33564235|NCT04770285|101962015|FG000|Overall Study|Lost to Follow-up|11|||
33564236|NCT04770285|101962016|FG001|Overall Study|Lost to Follow-up|8|||
33564237|NCT04770285|101962015|FG000|Overall Study|Protocol Deviation|6|||
33564238|NCT04770285|101962016|FG001|Overall Study|Protocol Deviation|6|||
33415677|NCT02866695|101413082|FG000|Overall Study|Adverse Event|1|||
33415678|NCT02866695|101413082|FG000|Overall Study|Lost to Follow-up|1|||
33564239|NCT04770285|101962015|FG000|Overall Study|Technical Problem|0|||
33564240|NCT04770285|101962016|FG001|Overall Study|Technical Problem|1|||
33564241|NCT04770285|101962015|FG000|Overall Study|Withdrawal by Subject|9|||
33564242|NCT04770285|101962016|FG001|Overall Study|Withdrawal by Subject|8|||
33564243|NCT04770285|101962015|FG000|Overall Study|Reason Not Specified|0|||
33564244|NCT04770285|101962016|FG001|Overall Study|Reason Not Specified|1|||
33564245|NCT06351371|101962018|FG000|Overall Study|Mutation Status Not Confirmed|9|||
33628393|NCT03001557|102191118|FG004|Extension Phase|Others|0|||
33628394|NCT03001557|102191119|FG005|Extension Phase|Others|1|||
33628395|NCT03001557|102191120|FG006|Extension Phase|Others|3|||
33628396|NCT03001557|102191121|FG007|Extension Phase|Others|0|||
33628397|NCT00625131|102191127|FG000|Overall Study|Lost to Follow-up|3|||
33628398|NCT00625131|102191128|FG001|Overall Study|Lost to Follow-up|2|||
33628399|NCT00625131|102191129|FG002|Overall Study|Lost to Follow-up|0|||
33628400|NCT00625131|102191127|FG000|Overall Study|Withdrawal by Subject|1|||
33628401|NCT00625131|102191128|FG001|Overall Study|Withdrawal by Subject|0|||
33628402|NCT00625131|102191129|FG002|Overall Study|Withdrawal by Subject|5|||
33628403|NCT04890652|102191133|FG000|Overall Study|Withdrawal by Subject|2|||
33628404|NCT02927301|102191134|FG000|Overall Study|Death|39|||
33628405|NCT02927301|102191134|FG000|Overall Study|Lost to Follow-up|8|||
33628406|NCT02927301|102191134|FG000|Overall Study|Physician Decision|2|||
33628407|NCT02927301|102191134|FG000|Overall Study|Withdrawal by Subject|12|||
33628408|NCT02927301|102191134|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
33628409|NCT01075243|102191136|FG000|Overall Study|Lost to Follow-up|5|||
33628410|NCT01075243|102191137|FG001|Overall Study|Lost to Follow-up|2|||
33222149|NCT01191840|100715717|FG001|Overall Study|Non Staph Infection|3|||
33222150|NCT01191840|100715716|FG000|Overall Study|ineligible at enrollment|1|||
33564246|NCT06351371|101962018|FG000|Overall Study|Ineligible|1|||
33564247|NCT06351371|101962018|FG000|Overall Study|Adverse Event|4|||
33564248|NCT06351371|101962018|FG000|Overall Study|Death|1|||
33564249|NCT06351371|101962018|FG000|Overall Study|Disease progression|14|||
33564250|NCT06351371|101962018|FG000|Overall Study|Withdrawal by Subject|3|||
33564251|NCT06351371|101962018|FG000|Overall Study|Physician Decision|3|||
33564252|NCT00432965|101962019|FG000|Overall Study|Lost to Follow-up|22|||
33564253|NCT00432965|101962020|FG001|Overall Study|Lost to Follow-up|19|||
33564254|NCT00432965|101962019|FG000|Overall Study|Withdrawal by Subject|13|||
33564255|NCT00432965|101962020|FG001|Overall Study|Withdrawal by Subject|13|||
33564256|NCT00432965|101962019|FG000|Overall Study|Physician Decision|14|||
33564257|NCT00432965|101962020|FG001|Overall Study|Physician Decision|13|||
33564258|NCT00432965|101962019|FG000|Overall Study|Lack of Efficacy|8|||
33564259|NCT00432965|101962020|FG001|Overall Study|Lack of Efficacy|13|||
33564260|NCT00432965|101962019|FG000|Overall Study|Non-compliance|7|||
33564261|NCT00432965|101962020|FG001|Overall Study|Non-compliance|0|||
33564262|NCT00432965|101962019|FG000|Overall Study|Adverse Event|22|||
33564263|NCT00432965|101962020|FG001|Overall Study|Adverse Event|19|||
33564264|NCT00432965|101962019|FG000|Overall Study|Death|3|||
33564265|NCT00432965|101962020|FG001|Overall Study|Death|4|||
33564266|NCT00432965|101962019|FG000|Overall Study|Exclusionary Methods|1|||
33564267|NCT00432965|101962020|FG001|Overall Study|Exclusionary Methods|2|||
33564268|NCT00432965|101962019|FG000|Overall Study|Incomplete Data|4|||
33564269|NCT00432965|101962020|FG001|Overall Study|Incomplete Data|3|||
33564270|NCT02251041|101962021|FG000|Overall Study|Did not receive intervention|15|||
33564271|NCT02251041|101962022|FG001|Overall Study|Did not receive intervention|4|||
33564272|NCT01969058|101962026|FG000|Overall Study|Withdrawal by Subject|2|||
33564273|NCT01969058|101962027|FG001|Overall Study|Withdrawal by Subject|0|||
33564274|NCT01969058|101962026|FG000|Overall Study|Adverse Event|1|||
33564275|NCT01969058|101962027|FG001|Overall Study|Adverse Event|0|||
33564276|NCT03189719|101962035|FG000|Overall Study|Death|325|||
33564277|NCT03189719|101962036|FG001|Overall Study|Death|361|||
33564278|NCT03189719|101962035|FG000|Overall Study|Physician Decision|1|||
33564279|NCT03189719|101962036|FG001|Overall Study|Physician Decision|0|||
33564280|NCT03189719|101962035|FG000|Overall Study|Sponsor Decision|40|||
33564281|NCT03189719|101962036|FG001|Overall Study|Sponsor Decision|12|||
33564282|NCT03189719|101962035|FG000|Overall Study|Withdrawal by Subject|7|||
33564283|NCT03189719|101962036|FG001|Overall Study|Withdrawal by Subject|3|||
33564284|NCT04134936|101962039|FG000|Overall Study|Adverse Event|3|||
33564285|NCT04134936|101962040|FG001|Overall Study|Adverse Event|2|||
33564286|NCT04134936|101962039|FG000|Overall Study|Withdrawal by Subject|2|||
33564287|NCT04134936|101962040|FG001|Overall Study|Withdrawal by Subject|3|||
33564288|NCT04134936|101962039|FG000|Overall Study|Physician Decision|0|||
33564289|NCT04134936|101962040|FG001|Overall Study|Physician Decision|1|||
33564290|NCT04134936|101962039|FG000|Overall Study|Progressive disease, joined another trial|1|||
33564291|NCT04134936|101962040|FG001|Overall Study|Progressive disease, joined another trial|0|||
33564292|NCT04134936|101962039|FG000|Overall Study|Progressive disease|1|||
33564293|NCT04134936|101962040|FG001|Overall Study|Progressive disease|0|||
33564294|NCT00833703|101962041|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
33628411|NCT01075243|102191138|FG002|Overall Study|Lost to Follow-up|0|||
33628412|NCT01075243|102191136|FG000|Overall Study|Withdrawal by Subject|1|||
33628413|NCT01075243|102191137|FG001|Overall Study|Withdrawal by Subject|1|||
33628414|NCT01075243|102191138|FG002|Overall Study|Withdrawal by Subject|0|||
33564295|NCT00833703|101962042|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
33564296|NCT04144517|101962043|FG000|Overall Study|Physician Decision|0|||
33628415|NCT03655132|102191143|FG000|Overall Study|Lost to Follow-up|2|||
33628416|NCT03655132|102191144|FG001|Overall Study|Lost to Follow-up|1|||
33628417|NCT03655132|102191143|FG000|Overall Study|Withdrawal by Subject|0|||
33628418|NCT03655132|102191144|FG001|Overall Study|Withdrawal by Subject|1|||
33628419|NCT03655132|102191143|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
33628420|NCT03655132|102191144|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
33628421|NCT04196686|102191145|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
33628422|NCT04196686|102191146|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
33628423|NCT01358877|102191147|FG000|Overall Study|Death|80|||
33628424|NCT01358877|102191148|FG001|Overall Study|Death|89|||
33628425|NCT01358877|102191147|FG000|Overall Study|Ongoing follow-up for post-recurrence|87|||
33628426|NCT01358877|102191148|FG001|Overall Study|Ongoing follow-up for post-recurrence|108|||
33628427|NCT01358877|102191147|FG000|Overall Study|Ongoing follow-up for IDFS event|2084|||
33628428|NCT01358877|102191148|FG001|Overall Study|Ongoing follow-up for IDFS event|2073|||
33628429|NCT01358877|102191147|FG000|Overall Study|Ongoing follow-up for overall survival|7|||
33628430|NCT01358877|102191148|FG001|Overall Study|Ongoing follow-up for overall survival|5|||
33628431|NCT01358877|102191147|FG000|Overall Study|Other|142|||
33628432|NCT01358877|102191148|FG001|Overall Study|Other|129|||
33628433|NCT04516746|102191149|FG000|Overall Study|Randomized but not Treated|51|||
33628434|NCT04516746|102191150|FG001|Overall Study|Randomized but not Treated|19|||
33628435|NCT04516746|102191149|FG000|Overall Study|Adverse Event|0|||
33628436|NCT04516746|102191150|FG001|Overall Study|Adverse Event|1|||
33628437|NCT04516746|102191149|FG000|Overall Study|Death|62|||
33628438|NCT04516746|102191150|FG001|Overall Study|Death|32|||
33628439|NCT04516746|102191149|FG000|Overall Study|Lost to Follow-up|3431|||
33628440|NCT04516746|102191150|FG001|Overall Study|Lost to Follow-up|1831|||
33628441|NCT04516746|102191149|FG000|Overall Study|Withdrawal by Subject|1946|||
33628442|NCT04516746|102191150|FG001|Overall Study|Withdrawal by Subject|1696|||
33628443|NCT04516746|102191149|FG000|Overall Study|Physician Decision|10|||
33628444|NCT04516746|102191150|FG001|Overall Study|Physician Decision|8|||
33628445|NCT04516746|102191149|FG000|Overall Study|Other|35|||
33628446|NCT04516746|102191150|FG001|Overall Study|Other|16|||
33628447|NCT00517296|102191151|FG000|Overall Study|Withdrawal by Subject|1|||
33628448|NCT00517296|102191152|FG001|Overall Study|Withdrawal by Subject|0|||
33628449|NCT01045967|102191155|FG000|Second Intervention|Protocol Violation|0|||
33628450|NCT01045967|102191156|FG001|Second Intervention|Protocol Violation|1|||
33628451|NCT01089504|102191157|FG000|Overall Study|Lost to Follow-up|1|||
33628452|NCT01089504|102191158|FG001|Overall Study|Lost to Follow-up|1|||
33628453|NCT01089504|102191157|FG000|Overall Study|Withdrawal by Subject|2|||
33628454|NCT01089504|102191158|FG001|Overall Study|Withdrawal by Subject|0|||
33628455|NCT00979901|102191159|FG000|Overall Study|Adverse Event|1|||
33628456|NCT00979901|102191160|FG001|Overall Study|Adverse Event|3|||
33628457|NCT00979901|102191161|FG002|Overall Study|Adverse Event|9|||
33628458|NCT00979901|102191162|FG003|Overall Study|Adverse Event|2|||
33628459|NCT00979901|102191159|FG000|Overall Study|Lack of Efficacy|8|||
33628460|NCT00979901|102191160|FG001|Overall Study|Lack of Efficacy|4|||
33628461|NCT00979901|102191161|FG002|Overall Study|Lack of Efficacy|9|||
33628462|NCT00979901|102191162|FG003|Overall Study|Lack of Efficacy|0|||
33628463|NCT00979901|102191159|FG000|Overall Study|Lost to Follow-up|1|||
33628464|NCT00979901|102191160|FG001|Overall Study|Lost to Follow-up|1|||
33628465|NCT00979901|102191161|FG002|Overall Study|Lost to Follow-up|2|||
33628466|NCT00979901|102191162|FG003|Overall Study|Lost to Follow-up|0|||
33628467|NCT00979901|102191159|FG000|Overall Study|Protocol Violation|2|||
33628468|NCT00979901|102191160|FG001|Overall Study|Protocol Violation|2|||
33628469|NCT00979901|102191161|FG002|Overall Study|Protocol Violation|7|||
33628470|NCT00979901|102191162|FG003|Overall Study|Protocol Violation|1|||
33628471|NCT00979901|102191159|FG000|Overall Study|Withdrawal by Subject|2|||
33628472|NCT00979901|102191160|FG001|Overall Study|Withdrawal by Subject|1|||
33628473|NCT00979901|102191161|FG002|Overall Study|Withdrawal by Subject|1|||
33628474|NCT00979901|102191162|FG003|Overall Study|Withdrawal by Subject|1|||
33628475|NCT00979901|102191159|FG000|Overall Study|Noncompliance|1|||
33628476|NCT00979901|102191160|FG001|Overall Study|Noncompliance|0|||
33628477|NCT00979901|102191161|FG002|Overall Study|Noncompliance|0|||
33628478|NCT00979901|102191162|FG003|Overall Study|Noncompliance|0|||
33628479|NCT00979901|102191159|FG000|Overall Study|out-of-state|1|||
33628480|NCT00979901|102191160|FG001|Overall Study|out-of-state|0|||
33628481|NCT00979901|102191161|FG002|Overall Study|out-of-state|0|||
33628482|NCT00979901|102191162|FG003|Overall Study|out-of-state|0|||
33628483|NCT00979901|102191159|FG000|Overall Study|vacation|1|||
33628484|NCT00979901|102191160|FG001|Overall Study|vacation|0|||
33628485|NCT00979901|102191161|FG002|Overall Study|vacation|0|||
33628486|NCT00979901|102191162|FG003|Overall Study|vacation|0|||
33628487|NCT00979901|102191159|FG000|Overall Study|elevated lab values pre-randomization|1|||
33628488|NCT00979901|102191160|FG001|Overall Study|elevated lab values pre-randomization|0|||
33628489|NCT00979901|102191161|FG002|Overall Study|elevated lab values pre-randomization|0|||
33628490|NCT00979901|102191162|FG003|Overall Study|elevated lab values pre-randomization|0|||
33628491|NCT00979901|102191159|FG000|Overall Study|Discontinued in Error|0|||
33628492|NCT00979901|102191160|FG001|Overall Study|Discontinued in Error|1|||
33628493|NCT00979901|102191161|FG002|Overall Study|Discontinued in Error|0|||
33628494|NCT00979901|102191162|FG003|Overall Study|Discontinued in Error|0|||
33628495|NCT00979901|102191159|FG000|Overall Study|Left Country|0|||
33628496|NCT00979901|102191160|FG001|Overall Study|Left Country|0|||
33628497|NCT00979901|102191161|FG002|Overall Study|Left Country|1|||
33628498|NCT00979901|102191162|FG003|Overall Study|Left Country|0|||
33628499|NCT00979901|102191159|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
33628500|NCT00979901|102191160|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
33628501|NCT00979901|102191161|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
33628502|NCT00979901|102191162|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
33628503|NCT03585660|102191165|FG000|Overall Study|operator error|1|||
33628504|NCT03585660|102191165|FG000|Overall Study|technical error|2|||
33628505|NCT03585660|102191165|FG000|Overall Study|hip prosthesis|2|||
33628506|NCT03585660|102191165|FG000|Overall Study|did not undergo biopsy|8|||
33628507|NCT03585660|102191165|FG000|Overall Study|scanner problem|2|||
33628508|NCT00360230|102191166|FG000|Overall Study|Withdrawal by Subject|1|||
33628509|NCT00360230|102191167|FG001|Overall Study|Withdrawal by Subject|1|||
33628510|NCT00360230|102191168|FG002|Overall Study|Withdrawal by Subject|0|||
33628511|NCT00360230|102191169|FG003|Overall Study|Withdrawal by Subject|1|||
33628512|NCT00360230|102191170|FG004|Overall Study|Withdrawal by Subject|1|||
33628513|NCT00360230|102191171|FG005|Overall Study|Withdrawal by Subject|1|||
33628514|NCT00360230|102191172|FG006|Overall Study|Withdrawal by Subject|0|||
33628515|NCT00360230|102191166|FG000|Overall Study|Migrated|4|||
33628516|NCT00360230|102191167|FG001|Overall Study|Migrated|1|||
33628517|NCT00360230|102191168|FG002|Overall Study|Migrated|3|||
33628518|NCT00360230|102191169|FG003|Overall Study|Migrated|1|||
33628519|NCT00360230|102191170|FG004|Overall Study|Migrated|4|||
33628520|NCT00360230|102191171|FG005|Overall Study|Migrated|1|||
33628521|NCT00360230|102191172|FG006|Overall Study|Migrated|1|||
33628522|NCT00360230|102191166|FG000|Overall Study|Other|1|||
33628523|NCT00360230|102191167|FG001|Overall Study|Other|0|||
33628524|NCT00360230|102191168|FG002|Overall Study|Other|0|||
33628525|NCT00360230|102191169|FG003|Overall Study|Other|0|||
33628526|NCT00360230|102191170|FG004|Overall Study|Other|0|||
33628527|NCT00360230|102191171|FG005|Overall Study|Other|0|||
33628528|NCT00360230|102191172|FG006|Overall Study|Other|0|||
33628529|NCT00360230|102191166|FG000|Overall Study|Protocol Violation|0|||
33628530|NCT00360230|102191167|FG001|Overall Study|Protocol Violation|0|||
33628531|NCT00360230|102191168|FG002|Overall Study|Protocol Violation|0|||
33628532|NCT00360230|102191169|FG003|Overall Study|Protocol Violation|0|||
33628533|NCT00360230|102191170|FG004|Overall Study|Protocol Violation|0|||
33628534|NCT00360230|102191171|FG005|Overall Study|Protocol Violation|1|||
33628535|NCT00360230|102191172|FG006|Overall Study|Protocol Violation|0|||
33628536|NCT00360230|102191166|FG000|Overall Study|Death|0|||
33628537|NCT00360230|102191167|FG001|Overall Study|Death|1|||
33628538|NCT00360230|102191168|FG002|Overall Study|Death|0|||
33628539|NCT00360230|102191169|FG003|Overall Study|Death|0|||
33628540|NCT00360230|102191170|FG004|Overall Study|Death|0|||
33628541|NCT00360230|102191171|FG005|Overall Study|Death|1|||
33628542|NCT00360230|102191172|FG006|Overall Study|Death|1|||
33628543|NCT00894803|102191173|FG000|Overall Study|Death|20|||
33628544|NCT00894803|102191174|FG001|Overall Study|Death|4|||
33628545|NCT00894803|102191173|FG000|Overall Study|Lost to Follow-up|0|||
33628546|NCT00894803|102191174|FG001|Overall Study|Lost to Follow-up|1|||
33628547|NCT05498649|102191175|FG000|Overall Study|Lost to Follow-up|1|||
33628548|NCT02421172|102191176|FG000|Period 1|Adverse Event|1|||
33628549|NCT02421172|102191177|FG001|Period 1|Adverse Event|0|||
33628550|NCT02421172|102191178|FG002|Period 1|Adverse Event|0|||
33628551|NCT02421172|102191179|FG003|Period 1|Adverse Event|0|||
33628552|NCT02421172|102191180|FG004|Period 1|Adverse Event|0|||
33628553|NCT02421172|102191176|FG000|Period 1|Lost to Follow-up|3|||
33628554|NCT02421172|102191177|FG001|Period 1|Lost to Follow-up|1|||
33628555|NCT02421172|102191178|FG002|Period 1|Lost to Follow-up|0|||
33222151|NCT01191840|100715717|FG001|Overall Study|ineligible at enrollment|0|||
33628556|NCT02421172|102191179|FG003|Period 1|Lost to Follow-up|0|||
33628557|NCT02421172|102191180|FG004|Period 1|Lost to Follow-up|0|||
33628558|NCT02421172|102191176|FG000|Period 1|Patient/guardian decision|0|||
33628559|NCT02421172|102191177|FG001|Period 1|Patient/guardian decision|1|||
33628560|NCT02421172|102191178|FG002|Period 1|Patient/guardian decision|0|||
33628561|NCT02421172|102191179|FG003|Period 1|Patient/guardian decision|0|||
33628562|NCT02421172|102191180|FG004|Period 1|Patient/guardian decision|0|||
33628563|NCT02421172|102191176|FG000|Period 2|Adverse Event|0|||
33628564|NCT02421172|102191177|FG001|Period 2|Adverse Event|0|||
33628565|NCT02421172|102191178|FG002|Period 2|Adverse Event|4|||
33628566|NCT02421172|102191179|FG003|Period 2|Adverse Event|0|||
33628567|NCT02421172|102191180|FG004|Period 2|Adverse Event|0|||
33628568|NCT02421172|102191176|FG000|Period 2|Lost to Follow-up|0|||
33628569|NCT02421172|102191177|FG001|Period 2|Lost to Follow-up|0|||
33628570|NCT02421172|102191178|FG002|Period 2|Lost to Follow-up|0|||
33628571|NCT02421172|102191179|FG003|Period 2|Lost to Follow-up|1|||
33628572|NCT02421172|102191180|FG004|Period 2|Lost to Follow-up|0|||
33628573|NCT02421172|102191176|FG000|Period 2|Patient/guardian decision|0|||
33628574|NCT02421172|102191177|FG001|Period 2|Patient/guardian decision|0|||
33628575|NCT02421172|102191178|FG002|Period 2|Patient/guardian decision|3|||
33628576|NCT02421172|102191179|FG003|Period 2|Patient/guardian decision|2|||
33628577|NCT02421172|102191180|FG004|Period 2|Patient/guardian decision|1|||
33628578|NCT04842747|102191181|FG000|Overall Study|Withdrawal by Subject|6|||
33628579|NCT04842747|102191182|FG001|Overall Study|Withdrawal by Subject|2|||
33628580|NCT04842747|102191181|FG000|Overall Study|Lost to Follow-up|1|||
33628581|NCT04842747|102191182|FG001|Overall Study|Lost to Follow-up|2|||
33628582|NCT04842747|102191181|FG000|Overall Study|Physician Decision|1|||
33628583|NCT04842747|102191182|FG001|Overall Study|Physician Decision|0|||
33628584|NCT04842747|102191181|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
33628585|NCT04842747|102191182|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
33628586|NCT00436332|102191184|FG000|Overall Study|Adverse Event|9|||
33628587|NCT00436332|102191184|FG000|Overall Study|Withdrawal by Subject|2|||
33628588|NCT00436332|102191184|FG000|Overall Study|Progression|59|||
33628589|NCT00436332|102191184|FG000|Overall Study|Death|2|||
33628590|NCT00436332|102191184|FG000|Overall Study|Not Protocol Specified|6|||
33628591|NCT00436332|102191184|FG000|Overall Study|Ineligible|2|||
33628592|NCT00436332|102191184|FG000|Overall Study|Never Received Treatment|3|||
33628593|NCT01349959|102191185|FG000|Overall Study|Adverse Event|7|||
33628594|NCT03740048|102191191|FG000|Overall Study|Withdrawal by Subject|1|||
33628595|NCT03740048|102191192|FG001|Overall Study|Withdrawal by Subject|1|||
33628596|NCT03740048|102191191|FG000|Overall Study|Death|1|||
33628597|NCT03740048|102191192|FG001|Overall Study|Death|6|||
33628598|NCT03740048|102191191|FG000|Overall Study|Switched to thrice-weekly HD|2|||
33628599|NCT03740048|102191192|FG001|Overall Study|Switched to thrice-weekly HD|0|||
33628600|NCT03740048|102191191|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
33628601|NCT03740048|102191192|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
33628602|NCT03740048|102191191|FG000|Overall Study|Lost to Follow-up|0|||
33628603|NCT03740048|102191192|FG001|Overall Study|Lost to Follow-up|1|||
33628604|NCT03740048|102191191|FG000|Overall Study|Non-compliance with HD|0|||
33628605|NCT03740048|102191192|FG001|Overall Study|Non-compliance with HD|1|||
33628606|NCT02234843|102191193|FG000|Overall Study|Death|1|||
33628607|NCT02234843|102191194|FG001|Overall Study|Death|0|||
33628608|NCT02234843|102191195|FG002|Overall Study|Death|0|||
33628609|NCT02234843|102191196|FG003|Overall Study|Death|0|||
33628610|NCT02234843|102191197|FG004|Overall Study|Death|0|||
33628611|NCT02234843|102191198|FG005|Overall Study|Death|0|||
33628612|NCT02234843|102191199|FG006|Overall Study|Death|0|||
33628613|NCT02234843|102191200|FG007|Overall Study|Death|0|||
33628614|NCT02234843|102191201|FG008|Overall Study|Death|0|||
33628615|NCT02234843|102191202|FG009|Overall Study|Death|0|||
33628616|NCT02234843|102191193|FG000|Overall Study|Protocol Violation|1|||
33628617|NCT02234843|102191194|FG001|Overall Study|Protocol Violation|0|||
33628618|NCT02234843|102191195|FG002|Overall Study|Protocol Violation|1|||
33628619|NCT02234843|102191196|FG003|Overall Study|Protocol Violation|0|||
33628620|NCT02234843|102191197|FG004|Overall Study|Protocol Violation|0|||
33628621|NCT02234843|102191198|FG005|Overall Study|Protocol Violation|0|||
33628622|NCT02234843|102191199|FG006|Overall Study|Protocol Violation|0|||
33628623|NCT02234843|102191200|FG007|Overall Study|Protocol Violation|0|||
33628624|NCT02234843|102191201|FG008|Overall Study|Protocol Violation|0|||
33628625|NCT02234843|102191202|FG009|Overall Study|Protocol Violation|0|||
33628626|NCT02234843|102191193|FG000|Overall Study|Efficacy outcome reached|2|||
33628627|NCT02234843|102191194|FG001|Overall Study|Efficacy outcome reached|0|||
33628628|NCT02234843|102191195|FG002|Overall Study|Efficacy outcome reached|0|||
33628629|NCT02234843|102191196|FG003|Overall Study|Efficacy outcome reached|0|||
33628630|NCT02234843|102191197|FG004|Overall Study|Efficacy outcome reached|0|||
33628631|NCT02234843|102191198|FG005|Overall Study|Efficacy outcome reached|2|||
33628632|NCT02234843|102191199|FG006|Overall Study|Efficacy outcome reached|0|||
33628633|NCT02234843|102191200|FG007|Overall Study|Efficacy outcome reached|0|||
33628634|NCT02234843|102191201|FG008|Overall Study|Efficacy outcome reached|0|||
33628635|NCT02234843|102191202|FG009|Overall Study|Efficacy outcome reached|0|||
33628636|NCT02234843|102191193|FG000|Overall Study|Patient convenience|2|||
33628637|NCT02234843|102191194|FG001|Overall Study|Patient convenience|0|||
33628638|NCT02234843|102191195|FG002|Overall Study|Patient convenience|0|||
33628639|NCT02234843|102191196|FG003|Overall Study|Patient convenience|0|||
33628640|NCT02234843|102191197|FG004|Overall Study|Patient convenience|0|||
33628641|NCT02234843|102191198|FG005|Overall Study|Patient convenience|1|||
33628642|NCT02234843|102191199|FG006|Overall Study|Patient convenience|0|||
33628643|NCT02234843|102191200|FG007|Overall Study|Patient convenience|0|||
33628644|NCT02234843|102191201|FG008|Overall Study|Patient convenience|0|||
33628645|NCT02234843|102191202|FG009|Overall Study|Patient convenience|0|||
33628646|NCT02234843|102191193|FG000|Overall Study|Withdrawal by Subject|5|||
33628647|NCT02234843|102191194|FG001|Overall Study|Withdrawal by Subject|1|||
33628648|NCT02234843|102191195|FG002|Overall Study|Withdrawal by Subject|1|||
33628649|NCT02234843|102191196|FG003|Overall Study|Withdrawal by Subject|0|||
33628650|NCT02234843|102191197|FG004|Overall Study|Withdrawal by Subject|0|||
33628651|NCT02234843|102191198|FG005|Overall Study|Withdrawal by Subject|7|||
33628652|NCT02234843|102191199|FG006|Overall Study|Withdrawal by Subject|0|||
33628653|NCT02234843|102191200|FG007|Overall Study|Withdrawal by Subject|0|||
33628654|NCT02234843|102191201|FG008|Overall Study|Withdrawal by Subject|0|||
33628655|NCT02234843|102191202|FG009|Overall Study|Withdrawal by Subject|0|||
33628656|NCT02234843|102191193|FG000|Overall Study|Recovery|1|||
33628657|NCT02234843|102191194|FG001|Overall Study|Recovery|0|||
33628658|NCT02234843|102191195|FG002|Overall Study|Recovery|0|||
33628659|NCT02234843|102191196|FG003|Overall Study|Recovery|0|||
33628660|NCT02234843|102191197|FG004|Overall Study|Recovery|0|||
33628661|NCT02234843|102191198|FG005|Overall Study|Recovery|0|||
33628662|NCT02234843|102191199|FG006|Overall Study|Recovery|0|||
33628663|NCT02234843|102191200|FG007|Overall Study|Recovery|0|||
33628664|NCT02234843|102191201|FG008|Overall Study|Recovery|0|||
33628665|NCT02234843|102191202|FG009|Overall Study|Recovery|0|||
33628666|NCT02234843|102191193|FG000|Overall Study|Other|0|||
33628667|NCT02234843|102191194|FG001|Overall Study|Other|2|||
33628668|NCT02234843|102191195|FG002|Overall Study|Other|0|||
33628669|NCT02234843|102191196|FG003|Overall Study|Other|1|||
33628670|NCT02234843|102191197|FG004|Overall Study|Other|0|||
33628671|NCT02234843|102191198|FG005|Overall Study|Other|1|||
33628672|NCT02234843|102191199|FG006|Overall Study|Other|0|||
33628673|NCT02234843|102191200|FG007|Overall Study|Other|1|||
33628674|NCT02234843|102191201|FG008|Overall Study|Other|0|||
33628675|NCT02234843|102191202|FG009|Overall Study|Other|0|||
33628676|NCT02234843|102191193|FG000|Overall Study|Physician Decision|4|||
33628677|NCT02234843|102191194|FG001|Overall Study|Physician Decision|1|||
33628678|NCT02234843|102191195|FG002|Overall Study|Physician Decision|0|||
33628679|NCT02234843|102191196|FG003|Overall Study|Physician Decision|1|||
33628680|NCT02234843|102191197|FG004|Overall Study|Physician Decision|0|||
33628681|NCT02234843|102191198|FG005|Overall Study|Physician Decision|0|||
33628682|NCT02234843|102191199|FG006|Overall Study|Physician Decision|0|||
33628683|NCT02234843|102191200|FG007|Overall Study|Physician Decision|1|||
33628684|NCT02234843|102191201|FG008|Overall Study|Physician Decision|0|||
33628685|NCT02234843|102191202|FG009|Overall Study|Physician Decision|0|||
33628686|NCT02234843|102191193|FG000|Overall Study|Adverse Event|5|||
33628687|NCT02234843|102191194|FG001|Overall Study|Adverse Event|1|||
33628688|NCT02234843|102191195|FG002|Overall Study|Adverse Event|1|||
33628689|NCT02234843|102191196|FG003|Overall Study|Adverse Event|3|||
33628690|NCT02234843|102191197|FG004|Overall Study|Adverse Event|2|||
33628691|NCT02234843|102191198|FG005|Overall Study|Adverse Event|1|||
33628692|NCT02234843|102191199|FG006|Overall Study|Adverse Event|0|||
33628693|NCT02234843|102191200|FG007|Overall Study|Adverse Event|0|||
33628694|NCT02234843|102191201|FG008|Overall Study|Adverse Event|1|||
33628695|NCT02234843|102191202|FG009|Overall Study|Adverse Event|0|||
33628696|NCT02234843|102191193|FG000|Overall Study|Non-compliance with study drug|1|||
33628697|NCT02234843|102191194|FG001|Overall Study|Non-compliance with study drug|0|||
33628698|NCT02234843|102191195|FG002|Overall Study|Non-compliance with study drug|0|||
33628699|NCT02234843|102191196|FG003|Overall Study|Non-compliance with study drug|0|||
33628700|NCT02234843|102191197|FG004|Overall Study|Non-compliance with study drug|0|||
33628701|NCT02234843|102191198|FG005|Overall Study|Non-compliance with study drug|1|||
33628702|NCT02234843|102191199|FG006|Overall Study|Non-compliance with study drug|1|||
33628703|NCT02234843|102191200|FG007|Overall Study|Non-compliance with study drug|0|||
33628704|NCT02234843|102191201|FG008|Overall Study|Non-compliance with study drug|0|||
33628705|NCT02234843|102191202|FG009|Overall Study|Non-compliance with study drug|0|||
33628706|NCT02234843|102191193|FG000|Overall Study|Lost to Follow-up|0|||
33628707|NCT02234843|102191194|FG001|Overall Study|Lost to Follow-up|1|||
33628708|NCT02234843|102191195|FG002|Overall Study|Lost to Follow-up|0|||
33628709|NCT02234843|102191196|FG003|Overall Study|Lost to Follow-up|0|||
33628710|NCT02234843|102191197|FG004|Overall Study|Lost to Follow-up|0|||
33628711|NCT02234843|102191198|FG005|Overall Study|Lost to Follow-up|0|||
33628712|NCT02234843|102191199|FG006|Overall Study|Lost to Follow-up|1|||
33628713|NCT02234843|102191200|FG007|Overall Study|Lost to Follow-up|0|||
33628714|NCT02234843|102191201|FG008|Overall Study|Lost to Follow-up|0|||
33362732|NCT00923091|101214491|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
33628715|NCT02234843|102191202|FG009|Overall Study|Lost to Follow-up|0|||
33628716|NCT02426580|102191206|FG000|Overall Study|Death|2|||
33628717|NCT02426580|102191207|FG001|Overall Study|Death|2|||
33628718|NCT02426580|102191206|FG000|Overall Study|Lost to Follow-up|0|||
33628719|NCT02426580|102191207|FG001|Overall Study|Lost to Follow-up|9|||
33628720|NCT02426580|102191206|FG000|Overall Study|transfer to hemodialysis|5|||
33628721|NCT02426580|102191207|FG001|Overall Study|transfer to hemodialysis|5|||
33628722|NCT02426580|102191206|FG000|Overall Study|Kidney transplant|3|||
33628723|NCT02426580|102191207|FG001|Overall Study|Kidney transplant|0|||
33628724|NCT02426580|102191206|FG000|Overall Study|Allergic to egg white|1|||
33628725|NCT02426580|102191207|FG001|Overall Study|Allergic to egg white|0|||
33628726|NCT03341299|102191208|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
33628727|NCT03341299|102191209|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
33628728|NCT03341299|102191210|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
33628729|NCT03341299|102191211|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
33628730|NCT00928486|102191212|FG000|Overall Study|Adverse Event|2|||
33628731|NCT00928486|102191212|FG000|Overall Study|Disease Progression|7|||
33628732|NCT00928486|102191212|FG000|Overall Study|Withdrawal by Subject|1|||
33628733|NCT01446159|102191213|FG000|Overall Study|Withdrawal by Subject|1|||
33628734|NCT01446159|102191214|FG001|Overall Study|Withdrawal by Subject|0|||
33628735|NCT01446159|102191215|FG002|Overall Study|Withdrawal by Subject|14|||
33628736|NCT01446159|102191216|FG003|Overall Study|Withdrawal by Subject|11|||
33628737|NCT01446159|102191213|FG000|Overall Study|Lost to Follow-up|0|||
33628738|NCT01446159|102191214|FG001|Overall Study|Lost to Follow-up|0|||
33628739|NCT01446159|102191215|FG002|Overall Study|Lost to Follow-up|1|||
33628740|NCT01446159|102191216|FG003|Overall Study|Lost to Follow-up|2|||
33628741|NCT01446159|102191213|FG000|Overall Study|Death|2|||
33628742|NCT01446159|102191214|FG001|Overall Study|Death|3|||
33628743|NCT01446159|102191215|FG002|Overall Study|Death|43|||
33628744|NCT01446159|102191216|FG003|Overall Study|Death|36|||
33628745|NCT01446159|102191213|FG000|Overall Study|Other|0|||
33628746|NCT01446159|102191214|FG001|Overall Study|Other|0|||
33628747|NCT01446159|102191215|FG002|Overall Study|Other|13|||
33628748|NCT01446159|102191216|FG003|Overall Study|Other|13|||
33628749|NCT00981656|102191217|FG000|Overall Study|Protocol Violation|1|||
33628750|NCT00981656|102191217|FG000|Overall Study|Did not start protocol treatment|2|||
33628751|NCT04011540|102191218|FG000|Overall Study|Lost to Follow-up|9|||
33628752|NCT04011540|102191219|FG001|Overall Study|Lost to Follow-up|6|||
33628753|NCT03768414|102191220|FG000|Overall Study|Adverse Event or side effects|72|||
33628754|NCT03768414|102191221|FG001|Overall Study|Adverse Event or side effects|28|||
33628755|NCT03768414|102191220|FG000|Overall Study|Refusal unrelated to adverse event|33|||
33628756|NCT03768414|102191221|FG001|Overall Study|Refusal unrelated to adverse event|33|||
33628757|NCT03768414|102191220|FG000|Overall Study|Progression/relapse|132|||
33628758|NCT03768414|102191221|FG001|Overall Study|Progression/relapse|60|||
33628759|NCT03768414|102191220|FG000|Overall Study|Death|9|||
33628760|NCT03768414|102191221|FG001|Overall Study|Death|6|||
33628761|NCT03768414|102191220|FG000|Overall Study|Other - not protocol specified|45|||
33628762|NCT03768414|102191221|FG001|Overall Study|Other - not protocol specified|18|||
33628763|NCT03768414|102191220|FG000|Overall Study|Reason under review|3|||
33628764|NCT03768414|102191221|FG001|Overall Study|Reason under review|2|||
33628765|NCT00617734|102191222|FG000|Overall Study|Withdrew Consent|2|||
33628766|NCT00617734|102191223|FG001|Overall Study|Withdrew Consent|0|||
33628767|NCT00617734|102191222|FG000|Overall Study|Adverse Event|4|||
33628768|NCT00617734|102191223|FG001|Overall Study|Adverse Event|1|||
33628769|NCT00617734|102191222|FG000|Overall Study|Protocol Violation|1|||
33628770|NCT00617734|102191223|FG001|Overall Study|Protocol Violation|0|||
33628771|NCT00617734|102191222|FG000|Overall Study|Found Ineligible After Randomization|1|||
33628772|NCT00617734|102191223|FG001|Overall Study|Found Ineligible After Randomization|4|||
33628773|NCT00617734|102191222|FG000|Overall Study|Lost to Follow-up|0|||
33628774|NCT00617734|102191223|FG001|Overall Study|Lost to Follow-up|1|||
33628775|NCT02903914|102191224|FG000|Overall Study|Adverse Event|0|||
33628776|NCT02903914|102191225|FG001|Overall Study|Adverse Event|0|||
33628777|NCT02903914|102191226|FG002|Overall Study|Adverse Event|1|||
33628778|NCT02903914|102191227|FG003|Overall Study|Adverse Event|0|||
33628779|NCT02903914|102191228|FG004|Overall Study|Adverse Event|0|||
33628780|NCT02903914|102191229|FG005|Overall Study|Adverse Event|0|||
33628781|NCT02903914|102191230|FG006|Overall Study|Adverse Event|2|||
33628782|NCT02903914|102191231|FG007|Overall Study|Adverse Event|0|||
33628783|NCT02903914|102191224|FG000|Overall Study|Withdrawal by Subject|3|||
33628784|NCT02903914|102191225|FG001|Overall Study|Withdrawal by Subject|1|||
33628785|NCT02903914|102191226|FG002|Overall Study|Withdrawal by Subject|28|||
33628786|NCT02903914|102191227|FG003|Overall Study|Withdrawal by Subject|0|||
33628787|NCT02903914|102191228|FG004|Overall Study|Withdrawal by Subject|1|||
33628788|NCT02903914|102191229|FG005|Overall Study|Withdrawal by Subject|2|||
33628789|NCT02903914|102191230|FG006|Overall Study|Withdrawal by Subject|12|||
33628790|NCT02903914|102191231|FG007|Overall Study|Withdrawal by Subject|0|||
33628791|NCT02903914|102191224|FG000|Overall Study|Progressive Disease|1|||
33362733|NCT00923091|101214492|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
33362734|NCT00923091|101214493|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
33362735|NCT00923091|101214494|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
33628792|NCT02903914|102191225|FG001|Overall Study|Progressive Disease|0|||
33628793|NCT02903914|102191226|FG002|Overall Study|Progressive Disease|4|||
33628794|NCT02903914|102191227|FG003|Overall Study|Progressive Disease|0|||
33628795|NCT02903914|102191228|FG004|Overall Study|Progressive Disease|0|||
33628796|NCT02903914|102191229|FG005|Overall Study|Progressive Disease|0|||
33628797|NCT02903914|102191230|FG006|Overall Study|Progressive Disease|2|||
33628798|NCT02903914|102191231|FG007|Overall Study|Progressive Disease|0|||
33628799|NCT02903914|102191224|FG000|Overall Study|Death|0|||
33628800|NCT02903914|102191225|FG001|Overall Study|Death|0|||
33628801|NCT02903914|102191226|FG002|Overall Study|Death|9|||
33628802|NCT02903914|102191227|FG003|Overall Study|Death|0|||
33628803|NCT02903914|102191228|FG004|Overall Study|Death|1|||
33628804|NCT02903914|102191229|FG005|Overall Study|Death|3|||
33628805|NCT02903914|102191230|FG006|Overall Study|Death|24|||
33628806|NCT02903914|102191231|FG007|Overall Study|Death|2|||
33628807|NCT02903914|102191224|FG000|Overall Study|Lost to Follow-up|0|||
33628808|NCT02903914|102191225|FG001|Overall Study|Lost to Follow-up|1|||
33628809|NCT02903914|102191226|FG002|Overall Study|Lost to Follow-up|0|||
33628810|NCT02903914|102191227|FG003|Overall Study|Lost to Follow-up|0|||
33628811|NCT02903914|102191228|FG004|Overall Study|Lost to Follow-up|2|||
33628812|NCT02903914|102191229|FG005|Overall Study|Lost to Follow-up|0|||
33628813|NCT02903914|102191230|FG006|Overall Study|Lost to Follow-up|1|||
33628814|NCT02903914|102191231|FG007|Overall Study|Lost to Follow-up|0|||
33628815|NCT02903914|102191224|FG000|Overall Study|Physician Decision|0|||
33628816|NCT02903914|102191225|FG001|Overall Study|Physician Decision|0|||
33628817|NCT02903914|102191226|FG002|Overall Study|Physician Decision|1|||
33628818|NCT02903914|102191227|FG003|Overall Study|Physician Decision|0|||
33628819|NCT02903914|102191228|FG004|Overall Study|Physician Decision|0|||
33628820|NCT02903914|102191229|FG005|Overall Study|Physician Decision|0|||
33628821|NCT02903914|102191230|FG006|Overall Study|Physician Decision|1|||
33628822|NCT02903914|102191231|FG007|Overall Study|Physician Decision|0|||
33628823|NCT02903914|102191224|FG000|Overall Study|Symptomatic Deterioration|0|||
33628824|NCT02903914|102191225|FG001|Overall Study|Symptomatic Deterioration|0|||
33628825|NCT02903914|102191226|FG002|Overall Study|Symptomatic Deterioration|1|||
33628826|NCT02903914|102191227|FG003|Overall Study|Symptomatic Deterioration|0|||
33628827|NCT02903914|102191228|FG004|Overall Study|Symptomatic Deterioration|0|||
33628828|NCT02903914|102191229|FG005|Overall Study|Symptomatic Deterioration|0|||
33628829|NCT02903914|102191230|FG006|Overall Study|Symptomatic Deterioration|0|||
33628830|NCT02903914|102191231|FG007|Overall Study|Symptomatic Deterioration|0|||
33628831|NCT02903914|102191224|FG000|Overall Study|New Cancer Therapy|2|||
33628832|NCT02903914|102191225|FG001|Overall Study|New Cancer Therapy|2|||
33628833|NCT02903914|102191226|FG002|Overall Study|New Cancer Therapy|21|||
33628834|NCT02903914|102191227|FG003|Overall Study|New Cancer Therapy|4|||
33628835|NCT02903914|102191228|FG004|Overall Study|New Cancer Therapy|3|||
33628836|NCT02903914|102191229|FG005|Overall Study|New Cancer Therapy|6|||
33628837|NCT02903914|102191230|FG006|Overall Study|New Cancer Therapy|56|||
33628838|NCT02903914|102191231|FG007|Overall Study|New Cancer Therapy|3|||
33628839|NCT02903914|102191224|FG000|Overall Study|Didn't Return to Site|1|||
33628840|NCT02903914|102191225|FG001|Overall Study|Didn't Return to Site|0|||
33628841|NCT02903914|102191226|FG002|Overall Study|Didn't Return to Site|1|||
33628842|NCT02903914|102191227|FG003|Overall Study|Didn't Return to Site|1|||
33628843|NCT02903914|102191228|FG004|Overall Study|Didn't Return to Site|0|||
33628844|NCT02903914|102191229|FG005|Overall Study|Didn't Return to Site|0|||
33628845|NCT02903914|102191230|FG006|Overall Study|Didn't Return to Site|2|||
33628846|NCT02903914|102191231|FG007|Overall Study|Didn't Return to Site|0|||
33628847|NCT02903914|102191224|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
33628848|NCT02903914|102191225|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
33628849|NCT02903914|102191226|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
33628850|NCT02903914|102191227|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
33628851|NCT02903914|102191228|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
33628852|NCT02903914|102191229|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
33628853|NCT02903914|102191230|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
33628854|NCT02903914|102191231|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
33628855|NCT02903914|102191224|FG000|Overall Study|Follow-up Did Not Occur|0|||
33415679|NCT01591499|101413085|FG000|Baseline Visit|Withdrawal by Subject|0|||
33415680|NCT01591499|101413086|FG001|Baseline Visit|Withdrawal by Subject|2|||
33415681|NCT01591499|101413087|FG002|Baseline Visit|Withdrawal by Subject|0|||
33415682|NCT01591499|101413088|FG003|Baseline Visit|Withdrawal by Subject|2|||
33415683|NCT01591499|101413085|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
33415684|NCT01591499|101413086|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
33415685|NCT01591499|101413087|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
33415686|NCT01591499|101413088|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
33415687|NCT01591499|101413085|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
33415688|NCT01591499|101413086|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
33415689|NCT01591499|101413087|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
33415690|NCT01591499|101413088|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
33415691|NCT02610842|101413089|FG000|Overall Study|Lost to Follow-up|5|||
33415692|NCT02545868|101413091|FG000|Overall Study|Lack of Efficacy|1|||
33628856|NCT02903914|102191225|FG001|Overall Study|Follow-up Did Not Occur|1|||
33628857|NCT02903914|102191226|FG002|Overall Study|Follow-up Did Not Occur|1|||
33628858|NCT02903914|102191227|FG003|Overall Study|Follow-up Did Not Occur|0|||
33628859|NCT02903914|102191228|FG004|Overall Study|Follow-up Did Not Occur|2|||
33628860|NCT02903914|102191229|FG005|Overall Study|Follow-up Did Not Occur|0|||
33628861|NCT02903914|102191230|FG006|Overall Study|Follow-up Did Not Occur|8|||
33628862|NCT02903914|102191231|FG007|Overall Study|Follow-up Did Not Occur|0|||
33628863|NCT02903914|102191224|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
33628864|NCT02903914|102191225|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
33628865|NCT02903914|102191226|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
33628866|NCT02903914|102191227|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
33628867|NCT02903914|102191228|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
33564297|NCT04144517|101962044|FG001|Overall Study|Physician Decision|1|||
33564298|NCT04144517|101962043|FG000|Overall Study|Other|2|||
33564299|NCT04144517|101962044|FG001|Overall Study|Other|2|||
33564300|NCT04144517|101962043|FG000|Overall Study|Death|6|||
33628868|NCT02903914|102191229|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
33628869|NCT02903914|102191230|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
33628870|NCT02903914|102191231|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
33628871|NCT02903914|102191224|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
33628872|NCT02903914|102191225|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
33628873|NCT02903914|102191226|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
33628874|NCT02903914|102191227|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
33628875|NCT02903914|102191228|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
33628876|NCT02903914|102191229|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
33628877|NCT02903914|102191230|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
33628878|NCT02903914|102191231|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
33628879|NCT02903914|102191224|FG000|Overall Study|Clinical Disease Progression|0|||
33628880|NCT02903914|102191225|FG001|Overall Study|Clinical Disease Progression|0|||
33628881|NCT02903914|102191226|FG002|Overall Study|Clinical Disease Progression|2|||
33628882|NCT02903914|102191227|FG003|Overall Study|Clinical Disease Progression|0|||
33628883|NCT02903914|102191228|FG004|Overall Study|Clinical Disease Progression|0|||
33628884|NCT02903914|102191229|FG005|Overall Study|Clinical Disease Progression|0|||
33628885|NCT02903914|102191230|FG006|Overall Study|Clinical Disease Progression|0|||
33628886|NCT02903914|102191231|FG007|Overall Study|Clinical Disease Progression|0|||
33628887|NCT02903914|102191224|FG000|Overall Study|Completed Follow-up Period|0|||
33628888|NCT02903914|102191225|FG001|Overall Study|Completed Follow-up Period|0|||
33628889|NCT02903914|102191226|FG002|Overall Study|Completed Follow-up Period|6|||
33564301|NCT04144517|101962044|FG001|Overall Study|Death|3|||
33564302|NCT04035486|101962050|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
33628890|NCT02903914|102191227|FG003|Overall Study|Completed Follow-up Period|2|||
33628891|NCT02903914|102191228|FG004|Overall Study|Completed Follow-up Period|1|||
33362736|NCT00923091|101214495|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
33362737|NCT00923091|101214496|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
33362738|NCT00923091|101214497|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
33362739|NCT00923091|101214498|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
33628892|NCT02903914|102191229|FG005|Overall Study|Completed Follow-up Period|0|||
33628893|NCT02903914|102191230|FG006|Overall Study|Completed Follow-up Period|9|||
33628894|NCT02903914|102191231|FG007|Overall Study|Completed Follow-up Period|1|||
33628895|NCT02903914|102191224|FG000|Overall Study|Taken off Treatment per Protocol|0|||
33628896|NCT02903914|102191225|FG001|Overall Study|Taken off Treatment per Protocol|0|||
33628897|NCT02903914|102191226|FG002|Overall Study|Taken off Treatment per Protocol|0|||
33628898|NCT02903914|102191227|FG003|Overall Study|Taken off Treatment per Protocol|0|||
33628899|NCT02903914|102191228|FG004|Overall Study|Taken off Treatment per Protocol|0|||
33628900|NCT02903914|102191229|FG005|Overall Study|Taken off Treatment per Protocol|1|||
33628901|NCT02903914|102191230|FG006|Overall Study|Taken off Treatment per Protocol|0|||
33628902|NCT02903914|102191231|FG007|Overall Study|Taken off Treatment per Protocol|0|||
33362740|NCT00923091|101214499|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
33362741|NCT00923091|101214487|FG000|Period V (Double -Blind)|Protocol Violation|0|||
33362742|NCT00923091|101214488|FG001|Period V (Double -Blind)|Protocol Violation|0|||
33362743|NCT00923091|101214489|FG002|Period V (Double -Blind)|Protocol Violation|0|||
33362744|NCT00923091|101214490|FG003|Period V (Double -Blind)|Protocol Violation|0|||
33564303|NCT04035486|101962051|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
33564304|NCT04035486|101962052|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
33564305|NCT04035486|101962053|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
33564306|NCT04035486|101962050|FG000|Overall Study|Death|6|||
33564307|NCT04035486|101962051|FG001|Overall Study|Death|3|||
33564308|NCT04035486|101962052|FG002|Overall Study|Death|70|||
33564309|NCT04035486|101962053|FG003|Overall Study|Death|77|||
33564310|NCT04035486|101962050|FG000|Overall Study|Screen Failure|0|||
33564311|NCT04035486|101962051|FG001|Overall Study|Screen Failure|0|||
33564312|NCT04035486|101962052|FG002|Overall Study|Screen Failure|1|||
33564313|NCT04035486|101962053|FG003|Overall Study|Screen Failure|1|||
33564314|NCT04035486|101962050|FG000|Overall Study|Withdrawal by Subject|1|||
33564315|NCT04035486|101962051|FG001|Overall Study|Withdrawal by Subject|1|||
33564316|NCT04035486|101962052|FG002|Overall Study|Withdrawal by Subject|11|||
33564317|NCT04035486|101962053|FG003|Overall Study|Withdrawal by Subject|9|||
33564318|NCT00835042|101962057|FG000|First Intervention|Withdrawal by Subject|3|||
33628903|NCT02903914|102191224|FG000|Overall Study|Refused Further Treatment/Contact|0|||
33628904|NCT02903914|102191225|FG001|Overall Study|Refused Further Treatment/Contact|0|||
33415693|NCT02545868|101413092|FG001|Overall Study|Lack of Efficacy|1|||
33564319|NCT00835042|101962058|FG001|First Intervention|Withdrawal by Subject|0|||
33564320|NCT00835042|101962057|FG000|First Intervention|Adverse Event|1|||
33564321|NCT00835042|101962058|FG001|First Intervention|Adverse Event|2|||
33628905|NCT02903914|102191226|FG002|Overall Study|Refused Further Treatment/Contact|0|||
33628906|NCT02903914|102191227|FG003|Overall Study|Refused Further Treatment/Contact|0|||
33628907|NCT02903914|102191228|FG004|Overall Study|Refused Further Treatment/Contact|0|||
33628908|NCT02903914|102191229|FG005|Overall Study|Refused Further Treatment/Contact|0|||
33628909|NCT02903914|102191230|FG006|Overall Study|Refused Further Treatment/Contact|1|||
33628910|NCT02903914|102191231|FG007|Overall Study|Refused Further Treatment/Contact|0|||
33628911|NCT02903914|102191224|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
33628912|NCT02903914|102191225|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
33628913|NCT02903914|102191226|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
33628914|NCT02903914|102191227|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
33628915|NCT02903914|102191228|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
33628916|NCT02903914|102191229|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
33628917|NCT02903914|102191230|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
33628918|NCT02903914|102191231|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
33628919|NCT04663321|102191232|FG000|Overall Study|Study terminated by Sponsor|2|||
33628920|NCT04663321|102191233|FG001|Overall Study|Study terminated by Sponsor|1|||
33628921|NCT04663321|102191234|FG002|Overall Study|Study terminated by Sponsor|2|||
33628922|NCT04663321|102191232|FG000|Overall Study|Withdrawal by Subject|10|||
33628923|NCT04663321|102191233|FG001|Overall Study|Withdrawal by Subject|3|||
33628924|NCT04663321|102191234|FG002|Overall Study|Withdrawal by Subject|2|||
33628925|NCT04663321|102191232|FG000|Overall Study|Not provided|0|||
33628926|NCT04663321|102191233|FG001|Overall Study|Not provided|0|||
33628927|NCT04663321|102191234|FG002|Overall Study|Not provided|1|||
33628928|NCT05789745|102191235|FG000|Overall Study|Withdrawal by Subject|0|||
33628929|NCT05789745|102191236|FG001|Overall Study|Withdrawal by Subject|0|||
33628930|NCT05789745|102191237|FG002|Overall Study|Withdrawal by Subject|0|||
33628931|NCT05789745|102191238|FG003|Overall Study|Withdrawal by Subject|0|||
33628932|NCT05789745|102191239|FG004|Overall Study|Withdrawal by Subject|1|||
33628933|NCT04819945|102191240|FG000|Overall Study|Lost to Follow-up|1|||
33628934|NCT04685798|102191241|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
33628935|NCT00771914|102191242|FG000|Overall Study|Physician Decision|0|||
33628936|NCT00771914|102191243|FG001|Overall Study|Physician Decision|0|||
33222152|NCT01191840|100715716|FG000|Overall Study|IRB approval lapse|0|||
33222153|NCT01191840|100715717|FG001|Overall Study|IRB approval lapse|2|||
33564322|NCT00835042|101962057|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
33564323|NCT00835042|101962058|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
33564324|NCT02284893|101962061|FG000|26 Week (Short Term)|Adverse Event|1|||
33564325|NCT02284893|101962062|FG001|26 Week (Short Term)|Adverse Event|9|||
33564326|NCT02284893|101962061|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
33564327|NCT02284893|101962062|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
33564328|NCT02284893|101962061|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
33564329|NCT02284893|101962062|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
33564330|NCT02284893|101962061|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
33564331|NCT02284893|101962062|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
33564332|NCT02284893|101962061|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
33564333|NCT02284893|101962062|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
33362745|NCT00923091|101214491|FG004|Period V (Double -Blind)|Protocol Violation|0|||
33362746|NCT00923091|101214492|FG005|Period V (Double -Blind)|Protocol Violation|0|||
33222154|NCT01191840|100715716|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
33362747|NCT00923091|101214493|FG006|Period V (Double -Blind)|Protocol Violation|0|||
33362748|NCT00923091|101214494|FG007|Period V (Double -Blind)|Protocol Violation|0|||
33362749|NCT00923091|101214495|FG008|Period V (Double -Blind)|Protocol Violation|0|||
33362750|NCT00923091|101214496|FG009|Period V (Double -Blind)|Protocol Violation|0|||
33415694|NCT02545868|101413093|FG002|Overall Study|Lack of Efficacy|0|||
33564334|NCT02284893|101962061|FG000|26 Week (Short Term)|Other|1|||
33628937|NCT00771914|102191244|FG002|Overall Study|Physician Decision|0|||
33628938|NCT00771914|102191245|FG003|Overall Study|Physician Decision|1|||
33628939|NCT00771914|102191242|FG000|Overall Study|Lost to Follow-up|0|||
33628940|NCT00771914|102191243|FG001|Overall Study|Lost to Follow-up|0|||
33628941|NCT00771914|102191244|FG002|Overall Study|Lost to Follow-up|0|||
33628942|NCT00771914|102191245|FG003|Overall Study|Lost to Follow-up|1|||
33628943|NCT01346358|102191246|FG000|Overall Study|Withdrawal by Subject|1|||
33362751|NCT00923091|101214497|FG010|Period V (Double -Blind)|Protocol Violation|0|||
33362752|NCT00923091|101214498|FG011|Period V (Double -Blind)|Protocol Violation|0|||
33362753|NCT00923091|101214499|FG012|Period V (Double -Blind)|Protocol Violation|1|||
33415695|NCT02545868|101413091|FG000|Overall Study|Lost to Follow-up|1|||
33415696|NCT02545868|101413092|FG001|Overall Study|Lost to Follow-up|5|||
33415697|NCT02545868|101413093|FG002|Overall Study|Lost to Follow-up|1|||
33415698|NCT02545868|101413091|FG000|Overall Study|Non-compliance|1|||
33415699|NCT02545868|101413092|FG001|Overall Study|Non-compliance|1|||
33415700|NCT02545868|101413093|FG002|Overall Study|Non-compliance|1|||
33564335|NCT02284893|101962062|FG001|26 Week (Short Term)|Other|1|||
33564336|NCT02284893|101962061|FG000|52 Week (Long Term)|Adverse Event|3|||
33564337|NCT02284893|101962062|FG001|52 Week (Long Term)|Adverse Event|1|||
33362754|NCT00923091|101214487|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
33362755|NCT00923091|101214488|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
33362756|NCT00923091|101214489|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
33362757|NCT00923091|101214490|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
33362758|NCT00923091|101214491|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
33362759|NCT00923091|101214492|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
33362760|NCT00923091|101214493|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
33362761|NCT00923091|101214494|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
33362762|NCT00923091|101214495|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
33362763|NCT00923091|101214496|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
33362764|NCT00923091|101214497|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
33362765|NCT00923091|101214498|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
33362766|NCT00923091|101214499|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
33415701|NCT02545868|101413091|FG000|Overall Study|Treatment change|21|||
33415702|NCT02545868|101413092|FG001|Overall Study|Treatment change|19|||
33415703|NCT02545868|101413093|FG002|Overall Study|Treatment change|22|||
33564338|NCT02284893|101962061|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
33564339|NCT02284893|101962062|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
33564340|NCT02284893|101962061|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
33564341|NCT02284893|101962062|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
33564342|NCT02284893|101962061|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
33564343|NCT02284893|101962062|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
33564344|NCT02284893|101962061|FG000|52 Week (Long Term)|Non-Compliance|2|||
33564345|NCT02284893|101962062|FG001|52 Week (Long Term)|Non-Compliance|3|||
33564346|NCT00086515|101962063|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
33564347|NCT00086515|101962064|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
33564348|NCT00086515|101962063|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
33564349|NCT00086515|101962064|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
33564350|NCT00086515|101962063|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
33564351|NCT00086515|101962064|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
33564352|NCT00086515|101962063|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
33564353|NCT00086515|101962064|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
33564354|NCT00086515|101962063|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
33564355|NCT00086515|101962064|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
33564356|NCT00086515|101962063|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
33564357|NCT00086515|101962064|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
33564358|NCT00086515|101962063|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
33564359|NCT00086515|101962064|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
33564360|NCT00086515|101962063|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
33564361|NCT00086515|101962064|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
33564362|NCT00086515|101962063|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
33564363|NCT00086515|101962064|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
33564364|NCT00086515|101962063|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
33564365|NCT00086515|101962064|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
33564366|NCT00086515|101962063|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
33628944|NCT01346358|102191247|FG001|Overall Study|Withdrawal by Subject|0|||
33564367|NCT00086515|101962064|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
33564368|NCT00086515|101962063|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
33564369|NCT00086515|101962064|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
33564370|NCT00086515|101962063|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
33415704|NCT02545868|101413091|FG000|Overall Study|Physician Decision|1|||
33564371|NCT00086515|101962064|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
33564372|NCT00086515|101962063|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
33564373|NCT00086515|101962064|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
33564374|NCT00086515|101962063|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
33628945|NCT01346358|102191248|FG002|Overall Study|Withdrawal by Subject|1|||
33362767|NCT00923091|101214487|FG000|Period VI (Open-Label)|Adverse Event|17|||
33362768|NCT00923091|101214488|FG001|Period VI (Open-Label)|Adverse Event|0|||
33564375|NCT00086515|101962064|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
33628946|NCT01346358|102191249|FG003|Overall Study|Withdrawal by Subject|1|||
33628947|NCT01346358|102191250|FG004|Overall Study|Withdrawal by Subject|0|||
33628948|NCT01346358|102191251|FG005|Overall Study|Withdrawal by Subject|2|||
33628949|NCT01346358|102191252|FG006|Overall Study|Withdrawal by Subject|1|||
33628950|NCT01346358|102191253|FG007|Overall Study|Withdrawal by Subject|1|||
33628951|NCT01346358|102191254|FG008|Overall Study|Withdrawal by Subject|1|||
33628952|NCT01346358|102191246|FG000|Overall Study|Adverse Event|1|||
33628953|NCT01346358|102191247|FG001|Overall Study|Adverse Event|0|||
33628954|NCT01346358|102191248|FG002|Overall Study|Adverse Event|0|||
33628955|NCT01346358|102191249|FG003|Overall Study|Adverse Event|0|||
33628956|NCT01346358|102191250|FG004|Overall Study|Adverse Event|1|||
33628957|NCT01346358|102191251|FG005|Overall Study|Adverse Event|0|||
33628958|NCT01346358|102191252|FG006|Overall Study|Adverse Event|0|||
33628959|NCT01346358|102191253|FG007|Overall Study|Adverse Event|0|||
33628960|NCT01346358|102191254|FG008|Overall Study|Adverse Event|1|||
33628961|NCT01346358|102191246|FG000|Overall Study|Non-Compliance|0|||
33628962|NCT01346358|102191247|FG001|Overall Study|Non-Compliance|0|||
33628963|NCT01346358|102191248|FG002|Overall Study|Non-Compliance|0|||
33628964|NCT01346358|102191249|FG003|Overall Study|Non-Compliance|0|||
33628965|NCT01346358|102191250|FG004|Overall Study|Non-Compliance|0|||
33628966|NCT01346358|102191251|FG005|Overall Study|Non-Compliance|0|||
33628967|NCT01346358|102191252|FG006|Overall Study|Non-Compliance|0|||
33628968|NCT01346358|102191253|FG007|Overall Study|Non-Compliance|2|||
33628969|NCT01346358|102191254|FG008|Overall Study|Non-Compliance|0|||
33628970|NCT01346358|102191246|FG000|Overall Study|Physician Decision|0|||
33628971|NCT01346358|102191247|FG001|Overall Study|Physician Decision|1|||
33628972|NCT01346358|102191248|FG002|Overall Study|Physician Decision|0|||
33628973|NCT01346358|102191249|FG003|Overall Study|Physician Decision|0|||
33628974|NCT01346358|102191250|FG004|Overall Study|Physician Decision|0|||
33628975|NCT01346358|102191251|FG005|Overall Study|Physician Decision|0|||
33628976|NCT01346358|102191252|FG006|Overall Study|Physician Decision|0|||
33628977|NCT01346358|102191253|FG007|Overall Study|Physician Decision|1|||
33628978|NCT01346358|102191254|FG008|Overall Study|Physician Decision|1|||
33628979|NCT00784563|102191256|FG000|Years 1 & 2|Withdrawal by Subject|3|||
33628980|NCT00784563|102191257|FG001|Years 1 & 2|Withdrawal by Subject|2|||
33628981|NCT00784563|102191258|FG002|Years 1 & 2|Withdrawal by Subject|0|||
33628982|NCT00784563|102191256|FG000|Years 1 & 2|Adverse Event|0|||
33628983|NCT00784563|102191257|FG001|Years 1 & 2|Adverse Event|3|||
33628984|NCT00784563|102191258|FG002|Years 1 & 2|Adverse Event|0|||
33628985|NCT00784563|102191256|FG000|Year 3|Withdrawal by Subject|0|||
33628986|NCT00784563|102191257|FG001|Year 3|Withdrawal by Subject|0|||
33628987|NCT00784563|102191258|FG002|Year 3|Withdrawal by Subject|2|||
33628988|NCT00784563|102191256|FG000|Year 3|Adverse Event|0|||
33628989|NCT00784563|102191257|FG001|Year 3|Adverse Event|0|||
33628990|NCT00784563|102191258|FG002|Year 3|Adverse Event|1|||
33628991|NCT03043313|102191259|FG000|Overall Study|Withdrawal by Subject|5|||
33628992|NCT03043313|102191260|FG001|Overall Study|Withdrawal by Subject|1|||
33628993|NCT03043313|102191261|FG002|Overall Study|Withdrawal by Subject|1|||
33628994|NCT03043313|102191259|FG000|Overall Study|Lost to Follow-up|1|||
33628995|NCT03043313|102191260|FG001|Overall Study|Lost to Follow-up|1|||
33628996|NCT03043313|102191261|FG002|Overall Study|Lost to Follow-up|0|||
33628997|NCT03043313|102191259|FG000|Overall Study|Death|28|||
33628998|NCT03043313|102191260|FG001|Overall Study|Death|26|||
33628999|NCT03043313|102191261|FG002|Overall Study|Death|17|||
33629000|NCT03043313|102191259|FG000|Overall Study|Participation terminated by sponsor|11|||
33629001|NCT03043313|102191260|FG001|Overall Study|Participation terminated by sponsor|13|||
33629002|NCT03043313|102191261|FG002|Overall Study|Participation terminated by sponsor|13|||
33629003|NCT00168844|102191262|FG000|Overall Study|Adverse Event|31|||
33629004|NCT00168844|102191263|FG001|Overall Study|Adverse Event|32|||
33629005|NCT00168844|102191264|FG002|Overall Study|Adverse Event|48|||
33629006|NCT00168844|102191262|FG000|Overall Study|Lost to Follow-up|4|||
33415705|NCT02545868|101413092|FG001|Overall Study|Physician Decision|1|||
33629007|NCT00168844|102191263|FG001|Overall Study|Lost to Follow-up|5|||
33629008|NCT00168844|102191264|FG002|Overall Study|Lost to Follow-up|11|||
33629009|NCT00168844|102191262|FG000|Overall Study|Withdrawal by Subject|12|||
33629010|NCT00168844|102191263|FG001|Overall Study|Withdrawal by Subject|9|||
33629011|NCT00168844|102191264|FG002|Overall Study|Withdrawal by Subject|19|||
33629012|NCT00168844|102191262|FG000|Overall Study|Protocol Violation|2|||
33629013|NCT00168844|102191263|FG001|Overall Study|Protocol Violation|2|||
33629014|NCT00168844|102191264|FG002|Overall Study|Protocol Violation|4|||
33629015|NCT00168844|102191262|FG000|Overall Study|Other|6|||
33629016|NCT00168844|102191263|FG001|Overall Study|Other|7|||
33629017|NCT00168844|102191264|FG002|Overall Study|Other|9|||
33629018|NCT01231984|102191268|FG000|Study Period 1|Withdrawal by Subject|0|||
33629019|NCT01231984|102191269|FG001|Study Period 1|Withdrawal by Subject|0|||
33629020|NCT01231984|102191270|FG002|Study Period 1|Withdrawal by Subject|0|||
33629021|NCT01231984|102191271|FG003|Study Period 1|Withdrawal by Subject|1|||
33629022|NCT01231984|102191268|FG000|Study Period 1|Lost to Follow-up|1|||
33629023|NCT01231984|102191269|FG001|Study Period 1|Lost to Follow-up|1|||
33629024|NCT01231984|102191270|FG002|Study Period 1|Lost to Follow-up|1|||
33629025|NCT01231984|102191271|FG003|Study Period 1|Lost to Follow-up|0|||
33629026|NCT01231984|102191268|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
33629027|NCT01231984|102191269|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
33629028|NCT01231984|102191270|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
33629029|NCT01231984|102191271|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
33629030|NCT01231984|102191268|FG000|Study Period 1|Screen Failure|0|||
33415706|NCT02545868|101413093|FG002|Overall Study|Physician Decision|1|||
33415707|NCT02545868|101413091|FG000|Overall Study|Withdrawal by Subject|6|||
33362769|NCT00923091|101214489|FG002|Period VI (Open-Label)|Adverse Event|4|||
33362770|NCT00923091|101214490|FG003|Period VI (Open-Label)|Adverse Event|1|||
33362771|NCT00923091|101214491|FG004|Period VI (Open-Label)|Adverse Event|1|||
33362772|NCT00923091|101214492|FG005|Period VI (Open-Label)|Adverse Event|0|||
33629031|NCT01231984|102191269|FG001|Study Period 1|Screen Failure|0|||
33629032|NCT01231984|102191270|FG002|Study Period 1|Screen Failure|0|||
33222155|NCT01191840|100715717|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
33222156|NCT01191840|100715716|FG000|Overall Study|Withdrawal by Subject|2|||
33222157|NCT01191840|100715717|FG001|Overall Study|Withdrawal by Subject|0|||
33362773|NCT00923091|101214493|FG006|Period VI (Open-Label)|Adverse Event|0|||
33362774|NCT00923091|101214494|FG007|Period VI (Open-Label)|Adverse Event|0|||
33362775|NCT00923091|101214495|FG008|Period VI (Open-Label)|Adverse Event|0|||
33362776|NCT00923091|101214496|FG009|Period VI (Open-Label)|Adverse Event|0|||
33362777|NCT00923091|101214497|FG010|Period VI (Open-Label)|Adverse Event|0|||
33362778|NCT00923091|101214498|FG011|Period VI (Open-Label)|Adverse Event|0|||
33362779|NCT00923091|101214499|FG012|Period VI (Open-Label)|Adverse Event|0|||
33362780|NCT00923091|101214487|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
33415708|NCT02545868|101413092|FG001|Overall Study|Withdrawal by Subject|7|||
33415709|NCT02545868|101413093|FG002|Overall Study|Withdrawal by Subject|9|||
33415710|NCT03130777|101413094|FG000|Overall Study|Death|0|||
33415711|NCT03130777|101413095|FG001|Overall Study|Death|1|||
33415712|NCT03130777|101413094|FG000|Overall Study|Did not meet eligibility criteria|1|||
33415713|NCT03130777|101413095|FG001|Overall Study|Did not meet eligibility criteria|0|||
33415714|NCT03914469|101413098|FG000|Overall Study|Lost to Follow-up|1|||
33415715|NCT03914469|101413099|FG001|Overall Study|Lost to Follow-up|4|||
33415716|NCT00816166|101413100|FG000|Overall Study|Lost to Follow-up|6|||
33415717|NCT00816166|101413101|FG001|Overall Study|Lost to Follow-up|10|||
33415718|NCT00816166|101413100|FG000|Overall Study|Death|4|||
33415719|NCT00816166|101413101|FG001|Overall Study|Death|2|||
33415720|NCT03252015|101413107|FG000|Overall Study|Withdrawal by Subject|0|||
33415721|NCT03252015|101413108|FG001|Overall Study|Withdrawal by Subject|1|||
33415722|NCT03252015|101413109|FG002|Overall Study|Withdrawal by Subject|1|||
33415723|NCT03252015|101413110|FG003|Overall Study|Withdrawal by Subject|0|||
33415724|NCT03252015|101413107|FG000|Overall Study|Adverse Event|1|||
33415725|NCT03252015|101413108|FG001|Overall Study|Adverse Event|0|||
33415726|NCT03252015|101413109|FG002|Overall Study|Adverse Event|0|||
33415727|NCT03252015|101413110|FG003|Overall Study|Adverse Event|1|||
33415728|NCT02666768|101413111|FG000|Overall Study|Withdrawal by Subject|4|||
33415729|NCT00110084|101413115|FG000|Overall Study|Adverse Event|9|||
33415730|NCT00110084|101413115|FG000|Overall Study|Death|1|||
33415731|NCT00110084|101413115|FG000|Overall Study|Patient Refusal|10|||
33415732|NCT00110084|101413115|FG000|Overall Study|Alternate Therapy|5|||
33415733|NCT00110084|101413115|FG000|Overall Study|Intercurrent Illness|1|||
33415734|NCT00110084|101413115|FG000|Overall Study|Other|2|||
33564376|NCT00086515|101962063|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
33564377|NCT00086515|101962064|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
33564378|NCT00086515|101962063|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
33564379|NCT00086515|101962064|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
33564380|NCT00086515|101962063|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
33564381|NCT00086515|101962064|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
33564382|NCT00086515|101962063|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
33564383|NCT00086515|101962064|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
33564384|NCT00086515|101962063|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
33629033|NCT01231984|102191271|FG003|Study Period 1|Screen Failure|1|||
33222158|NCT00758459|100715718|FG000|Overall Study|Adverse Event|3|||
33415735|NCT02332655|101413116|FG000|Overall Study|Lack of Efficacy|1|||
33415736|NCT00244881|101413118|FG000|Overall Study|Withdrawal by Subject|3|||
33415737|NCT03683719|101413131|FG000|Overall Study|Lack of Efficacy|1|||
33629034|NCT01231984|102191268|FG000|Study Period 1|Non-compliance with study requirements|5|||
33362781|NCT00923091|101214488|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
33362782|NCT00923091|101214489|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
33362783|NCT00923091|101214490|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
33415738|NCT03683719|101413132|FG001|Overall Study|Lack of Efficacy|3|||
33415739|NCT03683719|101413133|FG002|Overall Study|Lack of Efficacy|4|||
33415740|NCT03683719|101413134|FG003|Overall Study|Lack of Efficacy|0|||
33415741|NCT03683719|101413135|FG004|Overall Study|Lack of Efficacy|4|||
33415742|NCT03683719|101413131|FG000|Overall Study|Adverse Event|6|||
33564385|NCT00086515|101962064|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
33564386|NCT00086515|101962063|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
33564387|NCT00086515|101962064|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
33564388|NCT00086515|101962063|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
33564389|NCT00086515|101962064|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
33629035|NCT01231984|102191269|FG001|Study Period 1|Non-compliance with study requirements|0|||
33629036|NCT01231984|102191270|FG002|Study Period 1|Non-compliance with study requirements|2|||
33362784|NCT00923091|101214491|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
33362785|NCT00923091|101214492|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
33362786|NCT00923091|101214493|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
33362787|NCT00923091|101214494|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
33362788|NCT00923091|101214495|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
33362789|NCT00923091|101214496|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
33362790|NCT00923091|101214497|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
33362791|NCT00923091|101214498|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
33362792|NCT00923091|101214499|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
33362793|NCT00923091|101214487|FG000|Period VI (Open-Label)|Protocol Violation|6|||
33362794|NCT00923091|101214488|FG001|Period VI (Open-Label)|Protocol Violation|1|||
33362795|NCT00923091|101214489|FG002|Period VI (Open-Label)|Protocol Violation|3|||
33362796|NCT00923091|101214490|FG003|Period VI (Open-Label)|Protocol Violation|1|||
33362797|NCT00923091|101214491|FG004|Period VI (Open-Label)|Protocol Violation|4|||
33362798|NCT00923091|101214492|FG005|Period VI (Open-Label)|Protocol Violation|0|||
33362799|NCT00923091|101214493|FG006|Period VI (Open-Label)|Protocol Violation|0|||
33362800|NCT00923091|101214494|FG007|Period VI (Open-Label)|Protocol Violation|0|||
33362801|NCT00923091|101214495|FG008|Period VI (Open-Label)|Protocol Violation|0|||
33362802|NCT00923091|101214496|FG009|Period VI (Open-Label)|Protocol Violation|0|||
33362803|NCT00923091|101214497|FG010|Period VI (Open-Label)|Protocol Violation|0|||
33362804|NCT00923091|101214498|FG011|Period VI (Open-Label)|Protocol Violation|0|||
33362805|NCT00923091|101214499|FG012|Period VI (Open-Label)|Protocol Violation|0|||
33362806|NCT00923091|101214487|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
33362807|NCT00923091|101214488|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
33362808|NCT00923091|101214489|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
33362809|NCT00923091|101214490|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
33362810|NCT00923091|101214491|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
33362811|NCT00923091|101214492|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
33362812|NCT00923091|101214493|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
33362813|NCT00923091|101214494|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
33362814|NCT00923091|101214495|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
33362815|NCT00923091|101214496|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
33362816|NCT00923091|101214497|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
33362817|NCT00923091|101214498|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
33362818|NCT00923091|101214499|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
33362819|NCT00923091|101214487|FG000|Period VI (Open-Label)|Other Reason|0|||
33362820|NCT00923091|101214488|FG001|Period VI (Open-Label)|Other Reason|0|||
33362821|NCT00923091|101214489|FG002|Period VI (Open-Label)|Other Reason|0|||
33362822|NCT00923091|101214490|FG003|Period VI (Open-Label)|Other Reason|1|||
33362823|NCT00923091|101214491|FG004|Period VI (Open-Label)|Other Reason|1|||
33362824|NCT00923091|101214492|FG005|Period VI (Open-Label)|Other Reason|0|||
33362825|NCT00923091|101214493|FG006|Period VI (Open-Label)|Other Reason|0|||
33362826|NCT00923091|101214494|FG007|Period VI (Open-Label)|Other Reason|0|||
33362827|NCT00923091|101214495|FG008|Period VI (Open-Label)|Other Reason|0|||
33362828|NCT00923091|101214496|FG009|Period VI (Open-Label)|Other Reason|0|||
33362829|NCT00923091|101214497|FG010|Period VI (Open-Label)|Other Reason|0|||
33362830|NCT00923091|101214498|FG011|Period VI (Open-Label)|Other Reason|0|||
33362831|NCT00923091|101214499|FG012|Period VI (Open-Label)|Other Reason|0|||
33362832|NCT01507545|101214505|FG000|Overall Study|Withdrawal by Subject|6|||
33362833|NCT01507545|101214506|FG001|Overall Study|Withdrawal by Subject|2|||
33415743|NCT03683719|101413132|FG001|Overall Study|Adverse Event|6|||
33564390|NCT00086515|101962063|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
33564391|NCT00086515|101962064|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
33564392|NCT00086515|101962063|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
33564393|NCT00086515|101962064|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
33564394|NCT00086515|101962063|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
33564395|NCT00086515|101962064|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
33564396|NCT00086515|101962063|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
33564397|NCT00086515|101962064|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
33222159|NCT00758459|100715719|FG001|Overall Study|Adverse Event|2|||
33362834|NCT01507545|101214505|FG000|Overall Study|Lost to Follow-up|1|||
33362835|NCT01507545|101214506|FG001|Overall Study|Lost to Follow-up|0|||
33362836|NCT01507545|101214505|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
33362837|NCT01507545|101214506|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
33362838|NCT01507545|101214505|FG000|Overall Study|Progressive disease|60|||
33362839|NCT01507545|101214506|FG001|Overall Study|Progressive disease|27|||
33564398|NCT00086515|101962063|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
33415744|NCT03683719|101413133|FG002|Overall Study|Adverse Event|0|||
33415745|NCT03683719|101413134|FG003|Overall Study|Adverse Event|1|||
33415746|NCT03683719|101413135|FG004|Overall Study|Adverse Event|3|||
33415747|NCT03683719|101413131|FG000|Overall Study|Withdrawal by Subject|4|||
33415748|NCT03683719|101413132|FG001|Overall Study|Withdrawal by Subject|4|||
33415749|NCT03683719|101413133|FG002|Overall Study|Withdrawal by Subject|3|||
33415750|NCT03683719|101413134|FG003|Overall Study|Withdrawal by Subject|5|||
33415751|NCT03683719|101413135|FG004|Overall Study|Withdrawal by Subject|5|||
33415752|NCT03683719|101413131|FG000|Overall Study|Lost to Follow-up|1|||
33564399|NCT00086515|101962064|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
33564400|NCT00086515|101962063|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
33564401|NCT00086515|101962064|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
33564402|NCT00086515|101962063|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
33564403|NCT00086515|101962064|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
33564404|NCT00086515|101962063|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
33564405|NCT00086515|101962064|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
33415753|NCT03683719|101413132|FG001|Overall Study|Lost to Follow-up|0|||
33415754|NCT03683719|101413133|FG002|Overall Study|Lost to Follow-up|0|||
33415755|NCT03683719|101413134|FG003|Overall Study|Lost to Follow-up|1|||
33415756|NCT03683719|101413135|FG004|Overall Study|Lost to Follow-up|1|||
33415757|NCT03683719|101413131|FG000|Overall Study|Other personal reasons|0|||
33564406|NCT00086515|101962063|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
33564407|NCT00086515|101962064|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
33564408|NCT03331354|101962065|FG000|Overall Study|Withdrawal by Subject|1|||
33564409|NCT03331354|101962066|FG001|Overall Study|Withdrawal by Subject|3|||
33564410|NCT03331354|101962065|FG000|Overall Study|Lost to Follow-up|3|||
33564411|NCT03331354|101962066|FG001|Overall Study|Lost to Follow-up|3|||
33564412|NCT03331354|101962065|FG000|Overall Study|Found employment before initiated active intervention|0|||
33564413|NCT03331354|101962066|FG001|Overall Study|Found employment before initiated active intervention|4|||
33564414|NCT00500331|101962070|FG000|Overall Study|Adverse Event|0|||
33564415|NCT00500331|101962071|FG001|Overall Study|Adverse Event|2|||
33564416|NCT00500331|101962072|FG002|Overall Study|Adverse Event|0|||
33629037|NCT01231984|102191271|FG003|Study Period 1|Non-compliance with study requirements|1|||
33362840|NCT01507545|101214505|FG000|Overall Study|Other|6|||
33362841|NCT01507545|101214506|FG001|Overall Study|Other|4|||
33362842|NCT00872898|101214508|FG000|Part Two - Double Blind|Adverse Event|4|||
33362843|NCT00872898|101214509|FG001|Part Two - Double Blind|Adverse Event|3|||
33362844|NCT00872898|101214508|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
33362845|NCT00872898|101214509|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
33362846|NCT00872898|101214508|FG000|Part Two - Double Blind|Protocol Violation|1|||
33362847|NCT00872898|101214509|FG001|Part Two - Double Blind|Protocol Violation|0|||
33362848|NCT00872898|101214508|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
33362849|NCT00872898|101214509|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
33362850|NCT00872898|101214508|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
33362851|NCT00872898|101214509|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
33362852|NCT00872898|101214508|FG000|Part Two - Double Blind|Other reasons|2|||
33362853|NCT00872898|101214509|FG001|Part Two - Double Blind|Other reasons|0|||
33362854|NCT00455858|101214513|FG000|Overall Study|Lost to Follow-up|2|||
33362855|NCT00455858|101214513|FG000|Overall Study|Protocol Violation|1|||
33362856|NCT00455858|101214513|FG000|Overall Study|Lack of Efficacy|1|||
33362857|NCT00455858|101214513|FG000|Overall Study|Well controlled FPG without insulin|1|||
33362858|NCT00455858|101214513|FG000|Overall Study|Withdrawal|1|||
33362859|NCT00375934|101214514|FG000|Overall Study|Adverse Event|1|||
33362860|NCT00375934|101214515|FG001|Overall Study|Adverse Event|1|||
33362861|NCT00375934|101214514|FG000|Overall Study|Withdrawal by Subject|2|||
33362862|NCT00375934|101214515|FG001|Overall Study|Withdrawal by Subject|2|||
33362863|NCT00375934|101214514|FG000|Overall Study|Lack of Efficacy|0|||
33362864|NCT00375934|101214515|FG001|Overall Study|Lack of Efficacy|2|||
33362865|NCT00375934|101214514|FG000|Overall Study|Physician Decision|0|||
33362866|NCT00375934|101214515|FG001|Overall Study|Physician Decision|1|||
33415758|NCT03683719|101413132|FG001|Overall Study|Other personal reasons|0|||
33415759|NCT03683719|101413133|FG002|Overall Study|Other personal reasons|1|||
33362867|NCT04283461|101214516|FG000|Overall Study|Enrolled in separate trial|0|||
33362868|NCT04283461|101214517|FG001|Overall Study|Enrolled in separate trial|0|||
33415760|NCT03683719|101413134|FG003|Overall Study|Other personal reasons|0|||
33362869|NCT04283461|101214518|FG002|Overall Study|Enrolled in separate trial|8|||
33362870|NCT04283461|101214519|FG003|Overall Study|Enrolled in separate trial|13|||
33362871|NCT04283461|101214520|FG004|Overall Study|Enrolled in separate trial|12|||
33362872|NCT04283461|101214521|FG005|Overall Study|Enrolled in separate trial|0|||
33362873|NCT04283461|101214522|FG006|Overall Study|Enrolled in separate trial|0|||
33362874|NCT04283461|101214523|FG007|Overall Study|Enrolled in separate trial|8|||
33415761|NCT03683719|101413135|FG004|Overall Study|Other personal reasons|1|||
33415762|NCT03972709|101413138|FG000|Overall Study|Withdrawal by Subject|18|||
33415763|NCT03972709|101413139|FG001|Overall Study|Withdrawal by Subject|7|||
33564417|NCT00500331|101962073|FG003|Overall Study|Adverse Event|1|||
33564418|NCT00500331|101962074|FG004|Overall Study|Adverse Event|2|||
33564419|NCT00500331|101962075|FG005|Overall Study|Adverse Event|2|||
33629038|NCT01231984|102191268|FG000|Study Period 1|Protocol Violation|3|||
33629039|NCT01231984|102191269|FG001|Study Period 1|Protocol Violation|4|||
33629040|NCT01231984|102191270|FG002|Study Period 1|Protocol Violation|2|||
33629041|NCT01231984|102191271|FG003|Study Period 1|Protocol Violation|3|||
33362875|NCT04283461|101214524|FG008|Overall Study|Enrolled in separate trial|0|||
33362876|NCT04283461|101214525|FG009|Overall Study|Enrolled in separate trial|0|||
33564420|NCT00500331|101962076|FG006|Overall Study|Adverse Event|0|||
33564421|NCT00500331|101962070|FG000|Overall Study|Lost to Follow-up|1|||
33564422|NCT00500331|101962071|FG001|Overall Study|Lost to Follow-up|1|||
33564423|NCT00500331|101962072|FG002|Overall Study|Lost to Follow-up|1|||
33564424|NCT00500331|101962073|FG003|Overall Study|Lost to Follow-up|2|||
33564425|NCT00500331|101962074|FG004|Overall Study|Lost to Follow-up|1|||
33564426|NCT00500331|101962075|FG005|Overall Study|Lost to Follow-up|0|||
33564427|NCT00500331|101962076|FG006|Overall Study|Lost to Follow-up|0|||
33564428|NCT00500331|101962070|FG000|Overall Study|Protocol Violation|3|||
33564429|NCT00500331|101962071|FG001|Overall Study|Protocol Violation|1|||
33564430|NCT00500331|101962072|FG002|Overall Study|Protocol Violation|1|||
33564431|NCT00500331|101962073|FG003|Overall Study|Protocol Violation|0|||
33564432|NCT00500331|101962074|FG004|Overall Study|Protocol Violation|1|||
33564433|NCT00500331|101962075|FG005|Overall Study|Protocol Violation|1|||
33564434|NCT00500331|101962076|FG006|Overall Study|Protocol Violation|1|||
33629042|NCT01231984|102191268|FG000|Study Period 1|Adverse Event|1|||
33629043|NCT01231984|102191269|FG001|Study Period 1|Adverse Event|0|||
33362877|NCT04283461|101214526|FG010|Overall Study|Enrolled in separate trial|0|||
33362878|NCT04283461|101214527|FG011|Overall Study|Enrolled in separate trial|7|||
33362879|NCT04283461|101214528|FG012|Overall Study|Enrolled in separate trial|0|||
33362880|NCT03849560|101214529|FG000|Overall Study|Withdrawal by Subject|1|||
33362881|NCT03849560|101214530|FG001|Overall Study|Withdrawal by Subject|0|||
33362882|NCT03849560|101214531|FG002|Overall Study|Withdrawal by Subject|0|||
33362883|NCT02714205|101214534|FG000|Overall Study|Cannot tolerate medication|1|||
33362884|NCT02714205|101214535|FG001|Overall Study|Cannot tolerate medication|0|||
33362885|NCT02714205|101214534|FG000|Overall Study|Adverse Event|2|||
33362886|NCT02714205|101214535|FG001|Overall Study|Adverse Event|0|||
33362887|NCT02714205|101214534|FG000|Overall Study|Too busy|1|||
33362888|NCT02714205|101214535|FG001|Overall Study|Too busy|0|||
33362889|NCT02714205|101214534|FG000|Overall Study|Incomplete outcome data|0|||
33362890|NCT02714205|101214535|FG001|Overall Study|Incomplete outcome data|1|||
33362891|NCT03184701|101214536|FG000|Overall Study|Death|3|||
33362892|NCT03184701|101214536|FG000|Overall Study|Physician Decision|3|||
33362893|NCT03184701|101214536|FG000|Overall Study|Withdrawal by Subject|6|||
33362894|NCT03184701|101214536|FG000|Overall Study|Lost to Follow-up|5|||
33362895|NCT04770155|101214540|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
33362896|NCT04770155|101214541|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
33362897|NCT04770155|101214542|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
33362898|NCT04770155|101214543|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
33362899|NCT04770155|101214544|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
33362900|NCT04770155|101214545|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
33362901|NCT04770155|101214546|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
33362902|NCT04770155|101214547|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
33362903|NCT02717546|101217308|FG000|Overall Study|Lost to Follow-up|12|||
33362904|NCT01635933|101217309|FG000|Overall Study|Adverse Event|1|||
33362905|NCT01635933|101217310|FG001|Overall Study|Adverse Event|0|||
33564435|NCT00500331|101962070|FG000|Overall Study|Withdrawal by Subject|4|||
33362906|NCT01635933|101217309|FG000|Overall Study|Lost to Follow-up|0|||
33362907|NCT01635933|101217310|FG001|Overall Study|Lost to Follow-up|5|||
33362908|NCT01635933|101217309|FG000|Overall Study|Subject decision|1|||
33362909|NCT01635933|101217310|FG001|Overall Study|Subject decision|1|||
33362910|NCT01635933|101217309|FG000|Overall Study|Noncompliance|0|||
33362911|NCT01635933|101217310|FG001|Overall Study|Noncompliance|1|||
33362912|NCT01635933|101217309|FG000|Overall Study|No longer had transportation|0|||
33564436|NCT00500331|101962071|FG001|Overall Study|Withdrawal by Subject|0|||
33629044|NCT01231984|102191270|FG002|Study Period 1|Adverse Event|0|||
33629045|NCT01231984|102191271|FG003|Study Period 1|Adverse Event|0|||
33362913|NCT01635933|101217310|FG001|Overall Study|No longer had transportation|1|||
33362914|NCT03133481|101217311|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
33564437|NCT00500331|101962072|FG002|Overall Study|Withdrawal by Subject|1|||
33564438|NCT00500331|101962073|FG003|Overall Study|Withdrawal by Subject|5|||
33564439|NCT00500331|101962074|FG004|Overall Study|Withdrawal by Subject|0|||
33564440|NCT00500331|101962075|FG005|Overall Study|Withdrawal by Subject|1|||
33629046|NCT01231984|102191268|FG000|Study Period 1|Other|0|||
33362915|NCT03133481|101217312|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
33362916|NCT00866294|101217313|FG000|Overall Study|Adverse Event|12|||
33415764|NCT03972709|101413140|FG002|Overall Study|Withdrawal by Subject|14|||
33415765|NCT03972709|101413138|FG000|Overall Study|Study Terminated by Sponsor|48|||
33415766|NCT03972709|101413139|FG001|Overall Study|Study Terminated by Sponsor|25|||
33415767|NCT03972709|101413140|FG002|Overall Study|Study Terminated by Sponsor|50|||
33415768|NCT03972709|101413138|FG000|Overall Study|Physician Decision|1|||
33415769|NCT03972709|101413139|FG001|Overall Study|Physician Decision|0|||
33415770|NCT03972709|101413140|FG002|Overall Study|Physician Decision|0|||
33415771|NCT03972709|101413138|FG000|Overall Study|COVID-19|0|||
33415772|NCT03972709|101413139|FG001|Overall Study|COVID-19|1|||
33415773|NCT03972709|101413140|FG002|Overall Study|COVID-19|1|||
33415774|NCT03972709|101413138|FG000|Overall Study|Lost to Follow-up|6|||
33415775|NCT03972709|101413139|FG001|Overall Study|Lost to Follow-up|1|||
33415776|NCT03972709|101413140|FG002|Overall Study|Lost to Follow-up|2|||
33415777|NCT03972709|101413138|FG000|Overall Study|Death|5|||
33415778|NCT03972709|101413139|FG001|Overall Study|Death|1|||
33415779|NCT03972709|101413140|FG002|Overall Study|Death|4|||
33415780|NCT03972709|101413138|FG000|Overall Study|Adverse Event|3|||
33415781|NCT03972709|101413139|FG001|Overall Study|Adverse Event|1|||
33415782|NCT03972709|101413140|FG002|Overall Study|Adverse Event|4|||
33415783|NCT03972709|101413138|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
33415784|NCT03972709|101413139|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
33415785|NCT03972709|101413140|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
33415786|NCT03972709|101413138|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
33564441|NCT00500331|101962076|FG006|Overall Study|Withdrawal by Subject|1|||
33564442|NCT00500331|101962070|FG000|Overall Study|Lack of Efficacy|3|||
33362917|NCT00866294|101217314|FG001|Overall Study|Adverse Event|13|||
33362918|NCT00866294|101217315|FG002|Overall Study|Adverse Event|9|||
33362919|NCT00866294|101217313|FG000|Overall Study|Lack of Efficacy|7|||
33362920|NCT00866294|101217314|FG001|Overall Study|Lack of Efficacy|1|||
33362921|NCT00866294|101217315|FG002|Overall Study|Lack of Efficacy|0|||
33362922|NCT00866294|101217313|FG000|Overall Study|Protocol Violation|2|||
33362923|NCT00866294|101217314|FG001|Overall Study|Protocol Violation|0|||
33362924|NCT00866294|101217315|FG002|Overall Study|Protocol Violation|0|||
33362925|NCT00866294|101217313|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
33362926|NCT00866294|101217314|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33362927|NCT00866294|101217315|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33362928|NCT00866294|101217313|FG000|Overall Study|Lost to Follow-up|1|||
33415787|NCT03972709|101413139|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
33564443|NCT00500331|101962071|FG001|Overall Study|Lack of Efficacy|1|||
33564444|NCT00500331|101962072|FG002|Overall Study|Lack of Efficacy|0|||
33564445|NCT00500331|101962073|FG003|Overall Study|Lack of Efficacy|0|||
33564446|NCT00500331|101962074|FG004|Overall Study|Lack of Efficacy|0|||
33564447|NCT00500331|101962075|FG005|Overall Study|Lack of Efficacy|0|||
33564448|NCT00500331|101962076|FG006|Overall Study|Lack of Efficacy|0|||
33564449|NCT00500331|101962070|FG000|Overall Study|Liver function test abnormality|0|||
33564450|NCT00500331|101962071|FG001|Overall Study|Liver function test abnormality|0|||
33564451|NCT00500331|101962072|FG002|Overall Study|Liver function test abnormality|1|||
33564452|NCT00500331|101962073|FG003|Overall Study|Liver function test abnormality|0|||
33564453|NCT00500331|101962074|FG004|Overall Study|Liver function test abnormality|0|||
33564454|NCT00500331|101962075|FG005|Overall Study|Liver function test abnormality|0|||
33564455|NCT00500331|101962076|FG006|Overall Study|Liver function test abnormality|0|||
33564456|NCT00500331|101962070|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
33564457|NCT00500331|101962071|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
33564458|NCT00500331|101962072|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
33564459|NCT00500331|101962073|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
33629047|NCT01231984|102191269|FG001|Study Period 1|Other|0|||
33362929|NCT00866294|101217314|FG001|Overall Study|Lost to Follow-up|3|||
33362930|NCT00866294|101217315|FG002|Overall Study|Lost to Follow-up|0|||
33362931|NCT00866294|101217313|FG000|Overall Study|Physician Decision|6|||
33362932|NCT00866294|101217314|FG001|Overall Study|Physician Decision|2|||
33362933|NCT00866294|101217315|FG002|Overall Study|Physician Decision|1|||
33362934|NCT02613572|101217316|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
33362935|NCT02613572|101217317|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
33362936|NCT02613572|101217318|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
33362937|NCT02613572|101217316|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
33415788|NCT03972709|101413140|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
33415789|NCT03972709|101413138|FG000|Overall Study|Subject Unable to be Contacted|0|||
33415790|NCT03972709|101413139|FG001|Overall Study|Subject Unable to be Contacted|1|||
33564460|NCT00500331|101962074|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
33564461|NCT00500331|101962075|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
33564462|NCT00500331|101962076|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
33629048|NCT01231984|102191270|FG002|Study Period 1|Other|0|||
33564463|NCT00500331|101962070|FG000|Overall Study|Didn't return for continuation of study|1|||
33564464|NCT00500331|101962071|FG001|Overall Study|Didn't return for continuation of study|0|||
33629049|NCT01231984|102191271|FG003|Study Period 1|Other|1|||
33564465|NCT00500331|101962072|FG002|Overall Study|Didn't return for continuation of study|0|||
33564466|NCT00500331|101962073|FG003|Overall Study|Didn't return for continuation of study|0|||
33564467|NCT00500331|101962074|FG004|Overall Study|Didn't return for continuation of study|0|||
33629050|NCT01231984|102191268|FG000|Study Period 2|Withdrawal by Subject|1|||
33629051|NCT01231984|102191269|FG001|Study Period 2|Withdrawal by Subject|1|||
33629052|NCT01231984|102191270|FG002|Study Period 2|Withdrawal by Subject|0|||
33629053|NCT01231984|102191271|FG003|Study Period 2|Withdrawal by Subject|0|||
33629054|NCT01231984|102191268|FG000|Study Period 2|Lost to Follow-up|1|||
33629055|NCT01231984|102191269|FG001|Study Period 2|Lost to Follow-up|0|||
33629056|NCT01231984|102191270|FG002|Study Period 2|Lost to Follow-up|0|||
33629057|NCT01231984|102191271|FG003|Study Period 2|Lost to Follow-up|3|||
33629058|NCT01231984|102191268|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
33415791|NCT03972709|101413140|FG002|Overall Study|Subject Unable to be Contacted|0|||
33415792|NCT03972709|101413138|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
33415793|NCT03972709|101413139|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
33415794|NCT03972709|101413140|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
33415795|NCT03972709|101413138|FG000|Overall Study|Subject Moved|0|||
33415796|NCT03972709|101413139|FG001|Overall Study|Subject Moved|1|||
33415797|NCT03972709|101413140|FG002|Overall Study|Subject Moved|0|||
33415798|NCT03972709|101413138|FG000|Overall Study|Missed Study Visits|1|||
33415799|NCT03972709|101413139|FG001|Overall Study|Missed Study Visits|0|||
33415800|NCT03972709|101413140|FG002|Overall Study|Missed Study Visits|0|||
33415801|NCT00665366|101413141|FG000|Overall Study|Lack of Efficacy|11|||
33415802|NCT00665366|101413142|FG001|Overall Study|Lack of Efficacy|10|||
33415803|NCT00665366|101413141|FG000|Overall Study|Adverse Event|25|||
33415804|NCT00665366|101413142|FG001|Overall Study|Adverse Event|23|||
33415805|NCT00665366|101413141|FG000|Overall Study|Withdrawal by Subject|11|||
33415806|NCT00665366|101413142|FG001|Overall Study|Withdrawal by Subject|14|||
33415807|NCT00665366|101413141|FG000|Overall Study|Lost to Follow-up|3|||
33415808|NCT00665366|101413142|FG001|Overall Study|Lost to Follow-up|5|||
33415809|NCT00665366|101413141|FG000|Overall Study|Poor compliance/noncompliance|3|||
33415810|NCT00665366|101413142|FG001|Overall Study|Poor compliance/noncompliance|5|||
33415811|NCT00665366|101413141|FG000|Overall Study|Pregnancy|1|||
33415812|NCT00665366|101413142|FG001|Overall Study|Pregnancy|0|||
33415813|NCT00665366|101413141|FG000|Overall Study|No longer meets study criteria|0|||
33415814|NCT00665366|101413142|FG001|Overall Study|No longer meets study criteria|1|||
33415815|NCT00665366|101413141|FG000|Overall Study|Other reasons|4|||
33564468|NCT00500331|101962075|FG005|Overall Study|Didn't return for continuation of study|0|||
33564469|NCT00500331|101962076|FG006|Overall Study|Didn't return for continuation of study|0|||
33564470|NCT00500331|101962070|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
33564471|NCT00500331|101962071|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
33564472|NCT00500331|101962072|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
33564473|NCT00500331|101962073|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
33564474|NCT00500331|101962074|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
33564475|NCT00500331|101962075|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
33564476|NCT00500331|101962076|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
33564477|NCT00500331|101962070|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
33564478|NCT00500331|101962071|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
33564479|NCT00500331|101962072|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
33564480|NCT00500331|101962073|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
33564481|NCT00500331|101962074|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
33629059|NCT01231984|102191269|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
33629060|NCT01231984|102191270|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
33629061|NCT01231984|102191271|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
33629062|NCT01667900|102191272|FG000|Part B|Death|0|||
33222160|NCT00758459|100715718|FG000|Overall Study|Protocol Violation|0|||
33415816|NCT00665366|101413142|FG001|Overall Study|Other reasons|1|||
33415817|NCT00242567|101413143|FG000|Overall Study|Adverse Event|70|||
33415818|NCT00242567|101413144|FG001|Overall Study|Adverse Event|43|||
33415819|NCT00242567|101413143|FG000|Overall Study|Disease Progression|17|||
33564482|NCT00500331|101962075|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
33629063|NCT01667900|102191273|FG001|Part B|Death|0|||
33629064|NCT01667900|102191274|FG002|Part B|Death|0|||
33415820|NCT00242567|101413144|FG001|Overall Study|Disease Progression|22|||
33564483|NCT00500331|101962076|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
33629065|NCT01667900|102191275|FG003|Part B|Death|0|||
33629066|NCT01667900|102191276|FG004|Part B|Death|0|||
33415821|NCT00242567|101413143|FG000|Overall Study|Symptomatic deterioration|9|||
33415822|NCT00242567|101413144|FG001|Overall Study|Symptomatic deterioration|3|||
33415823|NCT00242567|101413143|FG000|Overall Study|Lack of Efficacy|2|||
33415824|NCT00242567|101413144|FG001|Overall Study|Lack of Efficacy|2|||
33564484|NCT00500331|101962070|FG000|Overall Study|Participant was randomized by mistake|1|||
33564485|NCT00500331|101962071|FG001|Overall Study|Participant was randomized by mistake|0|||
33564486|NCT00500331|101962072|FG002|Overall Study|Participant was randomized by mistake|0|||
33564487|NCT00500331|101962073|FG003|Overall Study|Participant was randomized by mistake|0|||
33564488|NCT00500331|101962074|FG004|Overall Study|Participant was randomized by mistake|0|||
33564489|NCT00500331|101962075|FG005|Overall Study|Participant was randomized by mistake|0|||
33564490|NCT00500331|101962076|FG006|Overall Study|Participant was randomized by mistake|0|||
33564491|NCT00500331|101962070|FG000|Overall Study|Diabetologist nurse in the study|0|||
33564492|NCT00500331|101962071|FG001|Overall Study|Diabetologist nurse in the study|0|||
33564493|NCT00500331|101962072|FG002|Overall Study|Diabetologist nurse in the study|1|||
33564494|NCT00500331|101962073|FG003|Overall Study|Diabetologist nurse in the study|0|||
33564495|NCT00500331|101962074|FG004|Overall Study|Diabetologist nurse in the study|0|||
33564496|NCT00500331|101962075|FG005|Overall Study|Diabetologist nurse in the study|0|||
33564497|NCT00500331|101962076|FG006|Overall Study|Diabetologist nurse in the study|0|||
33629067|NCT01667900|102191277|FG005|Part B|Death|0|||
33629068|NCT01667900|102191278|FG006|Part B|Death|0|||
33629069|NCT01667900|102191279|FG007|Part B|Death|0|||
33629070|NCT01667900|102191280|FG008|Part B|Death|0|||
33629071|NCT01667900|102191281|FG009|Part B|Death|0|||
33629072|NCT01667900|102191282|FG010|Part B|Death|0|||
33629073|NCT01667900|102191283|FG011|Part B|Death|0|||
33629074|NCT01667900|102191284|FG012|Part B|Death|0|||
33629075|NCT01667900|102191285|FG013|Part B|Death|0|||
33629076|NCT01667900|102191286|FG014|Part B|Death|0|||
33629077|NCT01667900|102191287|FG015|Part B|Death|0|||
33629078|NCT01667900|102191288|FG016|Part B|Death|1|||
33629079|NCT01667900|102191289|FG017|Part B|Death|0|||
33629080|NCT01667900|102191290|FG018|Part B|Death|0|||
33629081|NCT01667900|102191291|FG019|Part B|Death|0|||
33629082|NCT00703014|102191292|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
33629083|NCT00703014|102191293|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
33629084|NCT00703014|102191294|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
33629085|NCT00703014|102191295|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
33629086|NCT00703014|102191292|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
33629087|NCT00703014|102191293|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
33629088|NCT00703014|102191294|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
33629089|NCT00703014|102191295|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
33629090|NCT05236270|102191296|FG000|Overall Study|Lost to Follow-up|3|||
33629091|NCT05236270|102191297|FG001|Overall Study|Lost to Follow-up|2|||
33629092|NCT05236270|102191298|FG002|Overall Study|Lost to Follow-up|0|||
33629093|NCT05236270|102191299|FG003|Overall Study|Lost to Follow-up|0|||
33629094|NCT05236270|102191300|FG004|Overall Study|Lost to Follow-up|2|||
33629095|NCT05236270|102191301|FG005|Overall Study|Lost to Follow-up|0|||
33629096|NCT05236270|102191302|FG006|Overall Study|Lost to Follow-up|1|||
33629097|NCT05236270|102191303|FG007|Overall Study|Lost to Follow-up|3|||
33629098|NCT00865345|102191306|FG000|Overall Study|Withdrawal by Subject|2|||
33629099|NCT03291067|102191307|FG000|Overall Study|Adverse Event|0|||
33629100|NCT03291067|102191308|FG001|Overall Study|Adverse Event|2|||
33629101|NCT03291067|102191309|FG002|Overall Study|Adverse Event|17|||
33629102|NCT03291067|102191310|FG003|Overall Study|Adverse Event|3|||
33629103|NCT03291067|102191307|FG000|Overall Study|Lost to Follow-up|2|||
33629104|NCT03291067|102191308|FG001|Overall Study|Lost to Follow-up|1|||
33629105|NCT03291067|102191309|FG002|Overall Study|Lost to Follow-up|0|||
33629106|NCT03291067|102191310|FG003|Overall Study|Lost to Follow-up|1|||
33629107|NCT03291067|102191307|FG000|Overall Study|Physician Decision|0|||
33629108|NCT03291067|102191308|FG001|Overall Study|Physician Decision|0|||
33629109|NCT03291067|102191309|FG002|Overall Study|Physician Decision|1|||
33629110|NCT03291067|102191310|FG003|Overall Study|Physician Decision|0|||
33629111|NCT03291067|102191307|FG000|Overall Study|Protocol Violation|5|||
33629112|NCT03291067|102191308|FG001|Overall Study|Protocol Violation|3|||
33629113|NCT03291067|102191309|FG002|Overall Study|Protocol Violation|4|||
33629114|NCT03291067|102191310|FG003|Overall Study|Protocol Violation|2|||
33629115|NCT03291067|102191307|FG000|Overall Study|Withdrawal by Subject|3|||
33629116|NCT03291067|102191308|FG001|Overall Study|Withdrawal by Subject|4|||
33629117|NCT03291067|102191309|FG002|Overall Study|Withdrawal by Subject|7|||
33629118|NCT03291067|102191310|FG003|Overall Study|Withdrawal by Subject|5|||
33629119|NCT03291067|102191307|FG000|Overall Study|Other|0|||
33629120|NCT03291067|102191308|FG001|Overall Study|Other|4|||
33629121|NCT03291067|102191309|FG002|Overall Study|Other|4|||
33629122|NCT03291067|102191310|FG003|Overall Study|Other|6|||
33629123|NCT00781768|102191312|FG000|Overall Study|Not transplanted.|0|||
33629124|NCT00781768|102191313|FG001|Overall Study|Not transplanted.|2|||
33629125|NCT00481832|102191314|FG000|Enrollment|Physician Decision|8|||
33415825|NCT00242567|101413143|FG000|Overall Study|Lost to Follow-up|9|||
33222161|NCT00758459|100715719|FG001|Overall Study|Protocol Violation|1|||
33222162|NCT00758459|100715718|FG000|Overall Study|Withdrawal by Subject|0|||
33222163|NCT00758459|100715719|FG001|Overall Study|Withdrawal by Subject|1|||
33564498|NCT00500331|101962070|FG000|Overall Study|State ban of biological samples export|0|||
33564499|NCT00500331|101962071|FG001|Overall Study|State ban of biological samples export|0|||
33222164|NCT01226511|100715720|FG000|Acute Treatment Period|Adverse Event|7|||
33222165|NCT01226511|100715721|FG001|Acute Treatment Period|Adverse Event|6|||
33564500|NCT00500331|101962072|FG002|Overall Study|State ban of biological samples export|0|||
33564501|NCT00500331|101962073|FG003|Overall Study|State ban of biological samples export|1|||
33564502|NCT00500331|101962074|FG004|Overall Study|State ban of biological samples export|0|||
33564503|NCT00500331|101962075|FG005|Overall Study|State ban of biological samples export|0|||
33564504|NCT00500331|101962076|FG006|Overall Study|State ban of biological samples export|0|||
33564505|NCT00500331|101962070|FG000|Overall Study|Protocol violated|0|||
33564506|NCT00500331|101962071|FG001|Overall Study|Protocol violated|0|||
33564507|NCT00500331|101962072|FG002|Overall Study|Protocol violated|0|||
33564508|NCT00500331|101962073|FG003|Overall Study|Protocol violated|1|||
33564509|NCT00500331|101962074|FG004|Overall Study|Protocol violated|0|||
33564510|NCT00500331|101962075|FG005|Overall Study|Protocol violated|0|||
33564511|NCT00500331|101962076|FG006|Overall Study|Protocol violated|0|||
33564512|NCT05309291|101962079|FG000|Overall Study|Adverse Event|0|||
33564513|NCT05309291|101962080|FG001|Overall Study|Adverse Event|1|||
33564514|NCT00835354|101964618|FG000|First Intervention|Adverse Event|0|||
33564515|NCT00835354|101964619|FG001|First Intervention|Adverse Event|1|||
33564516|NCT04116489|101964623|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
33564517|NCT04116489|101964623|FG000|Overall Study|Withdrawal by Subject|1|||
33564518|NCT00980798|101964624|FG000|Overall Study|Adverse Event|7|||
33564519|NCT00980798|101964625|FG001|Overall Study|Adverse Event|36|||
33564520|NCT00980798|101964624|FG000|Overall Study|Lack of Efficacy|16|||
33564521|NCT00980798|101964625|FG001|Overall Study|Lack of Efficacy|5|||
33564522|NCT00980798|101964624|FG000|Overall Study|Lost to Follow-up|0|||
33564523|NCT00980798|101964625|FG001|Overall Study|Lost to Follow-up|1|||
33564524|NCT00980798|101964624|FG000|Overall Study|Physician Decision|2|||
33564525|NCT00980798|101964625|FG001|Overall Study|Physician Decision|1|||
33564526|NCT00980798|101964624|FG000|Overall Study|Withdrawal by Subject|8|||
33564527|NCT00980798|101964625|FG001|Overall Study|Withdrawal by Subject|11|||
33564528|NCT00980798|101964624|FG000|Overall Study|Other|0|||
33564529|NCT00980798|101964625|FG001|Overall Study|Other|1|||
33564530|NCT00879398|101964626|FG000|Overall Study|Visit Stop|399|||
33564531|NCT00879398|101964626|FG000|Overall Study|Lack of Efficacy|64|||
33564532|NCT00879398|101964626|FG000|Overall Study|Adverse Event|41|||
33564533|NCT00879398|101964626|FG000|Overall Study|Other Reasons|171|||
33564534|NCT01889251|101964627|FG000|Overall Study|Adverse Event|1|||
33564535|NCT01889251|101964628|FG001|Overall Study|Adverse Event|0|||
33564536|NCT03379870|101964629|FG000|Overall Study|Lost to Follow-up|1|||
33564537|NCT03379870|101964630|FG001|Overall Study|Lost to Follow-up|0|||
33564538|NCT03379870|101964629|FG000|Overall Study|Protocol Violation|1|||
33564539|NCT03379870|101964630|FG001|Overall Study|Protocol Violation|1|||
33564540|NCT02721732|101964636|FG000|Overall Study|Adverse Event|2|||
33564541|NCT02721732|101964637|FG001|Overall Study|Adverse Event|0|||
33564542|NCT02721732|101964638|FG002|Overall Study|Adverse Event|2|||
33564543|NCT02721732|101964639|FG003|Overall Study|Adverse Event|0|||
33564544|NCT02721732|101964640|FG004|Overall Study|Adverse Event|1|||
33564545|NCT02721732|101964641|FG005|Overall Study|Adverse Event|0|||
33564546|NCT02721732|101964642|FG006|Overall Study|Adverse Event|1|||
33564547|NCT02721732|101964643|FG007|Overall Study|Adverse Event|0|||
33564548|NCT02721732|101964644|FG008|Overall Study|Adverse Event|1|||
33564549|NCT02721732|101964645|FG009|Overall Study|Adverse Event|1|||
33564550|NCT02721732|101964636|FG000|Overall Study|Death|0|||
33564551|NCT02721732|101964637|FG001|Overall Study|Death|0|||
33564552|NCT02721732|101964638|FG002|Overall Study|Death|0|||
33564553|NCT02721732|101964639|FG003|Overall Study|Death|0|||
33564554|NCT02721732|101964640|FG004|Overall Study|Death|1|||
33564555|NCT02721732|101964641|FG005|Overall Study|Death|0|||
33564556|NCT02721732|101964642|FG006|Overall Study|Death|1|||
33222166|NCT01226511|100715720|FG000|Acute Treatment Period|Lack of Efficacy|2|||
33564557|NCT02721732|101964643|FG007|Overall Study|Death|0|||
33564558|NCT02721732|101964644|FG008|Overall Study|Death|0|||
33564559|NCT02721732|101964645|FG009|Overall Study|Death|1|||
33564560|NCT02721732|101964636|FG000|Overall Study|Lack of Efficacy|12|||
33564561|NCT02721732|101964637|FG001|Overall Study|Lack of Efficacy|11|||
33415826|NCT00242567|101413144|FG001|Overall Study|Lost to Follow-up|19|||
33564562|NCT02721732|101964638|FG002|Overall Study|Lack of Efficacy|18|||
33564563|NCT02721732|101964639|FG003|Overall Study|Lack of Efficacy|5|||
33564564|NCT02721732|101964640|FG004|Overall Study|Lack of Efficacy|21|||
33564565|NCT02721732|101964641|FG005|Overall Study|Lack of Efficacy|2|||
33564566|NCT02721732|101964642|FG006|Overall Study|Lack of Efficacy|8|||
33564567|NCT02721732|101964643|FG007|Overall Study|Lack of Efficacy|11|||
33564568|NCT02721732|101964644|FG008|Overall Study|Lack of Efficacy|10|||
33564569|NCT02721732|101964645|FG009|Overall Study|Lack of Efficacy|20|||
33222167|NCT01226511|100715721|FG001|Acute Treatment Period|Lack of Efficacy|1|||
33629126|NCT00481832|102191314|FG000|Enrollment|Unable to collect enough stem cells|2|||
33629127|NCT00481832|102191314|FG000|Inter-transplant Period|Adverse Event|4|||
33629128|NCT00481832|102191314|FG000|Inter-transplant Period|Death|3|||
33629129|NCT00481832|102191314|FG000|Inter-transplant Period|Physician Decision|4|||
33629130|NCT00481832|102191314|FG000|Inter-transplant Period|Disease relapse|11|||
33629131|NCT00481832|102191314|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
33629132|NCT00301808|102191315|FG000|Overall Study|Adverse Event|5|||
33629133|NCT00301808|102191315|FG000|Overall Study|Death|3|||
33629134|NCT00301808|102191315|FG000|Overall Study|Lack of Efficacy|4|||
33222168|NCT01226511|100715720|FG000|Acute Treatment Period|Lost to Follow-up|3|||
33564570|NCT02721732|101964636|FG000|Overall Study|Physician Decision|0|||
33564571|NCT02721732|101964637|FG001|Overall Study|Physician Decision|0|||
33564572|NCT02721732|101964638|FG002|Overall Study|Physician Decision|1|||
33564573|NCT02721732|101964639|FG003|Overall Study|Physician Decision|0|||
33564574|NCT02721732|101964640|FG004|Overall Study|Physician Decision|0|||
33564575|NCT02721732|101964641|FG005|Overall Study|Physician Decision|0|||
33564576|NCT02721732|101964642|FG006|Overall Study|Physician Decision|0|||
33564577|NCT02721732|101964643|FG007|Overall Study|Physician Decision|0|||
33564578|NCT02721732|101964644|FG008|Overall Study|Physician Decision|0|||
33564579|NCT02721732|101964645|FG009|Overall Study|Physician Decision|0|||
33564580|NCT02721732|101964636|FG000|Overall Study|Withdrawal by Subject|1|||
33564581|NCT02721732|101964637|FG001|Overall Study|Withdrawal by Subject|0|||
33564582|NCT02721732|101964638|FG002|Overall Study|Withdrawal by Subject|0|||
33564583|NCT02721732|101964639|FG003|Overall Study|Withdrawal by Subject|0|||
33564584|NCT02721732|101964640|FG004|Overall Study|Withdrawal by Subject|3|||
33564585|NCT02721732|101964641|FG005|Overall Study|Withdrawal by Subject|0|||
33564586|NCT02721732|101964642|FG006|Overall Study|Withdrawal by Subject|1|||
33564587|NCT02721732|101964643|FG007|Overall Study|Withdrawal by Subject|1|||
33564588|NCT02721732|101964644|FG008|Overall Study|Withdrawal by Subject|0|||
33564589|NCT02721732|101964645|FG009|Overall Study|Withdrawal by Subject|1|||
33564590|NCT02721732|101964636|FG000|Overall Study|Participant Choice|1|||
33564591|NCT02721732|101964637|FG001|Overall Study|Participant Choice|0|||
33564592|NCT02721732|101964638|FG002|Overall Study|Participant Choice|0|||
33564593|NCT02721732|101964639|FG003|Overall Study|Participant Choice|0|||
33564594|NCT02721732|101964640|FG004|Overall Study|Participant Choice|0|||
33564595|NCT02721732|101964641|FG005|Overall Study|Participant Choice|0|||
33564596|NCT02721732|101964642|FG006|Overall Study|Participant Choice|0|||
33564597|NCT02721732|101964643|FG007|Overall Study|Participant Choice|0|||
33564598|NCT02721732|101964644|FG008|Overall Study|Participant Choice|0|||
33564599|NCT02721732|101964645|FG009|Overall Study|Participant Choice|1|||
33564600|NCT02721732|101964636|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
33564601|NCT02721732|101964637|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
33564602|NCT02721732|101964638|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
33564603|NCT02721732|101964639|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
33564604|NCT02721732|101964640|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
33564605|NCT02721732|101964641|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
33564606|NCT02721732|101964642|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
33564607|NCT02721732|101964643|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
33564608|NCT02721732|101964644|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
33564609|NCT02721732|101964645|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
33564610|NCT02721732|101964636|FG000|Overall Study|Progression and withdrew consent|1|||
33564611|NCT02721732|101964637|FG001|Overall Study|Progression and withdrew consent|1|||
33564612|NCT02721732|101964638|FG002|Overall Study|Progression and withdrew consent|0|||
33564613|NCT02721732|101964639|FG003|Overall Study|Progression and withdrew consent|0|||
33564614|NCT02721732|101964640|FG004|Overall Study|Progression and withdrew consent|0|||
33564615|NCT02721732|101964641|FG005|Overall Study|Progression and withdrew consent|0|||
33564616|NCT02721732|101964642|FG006|Overall Study|Progression and withdrew consent|0|||
33564617|NCT02721732|101964643|FG007|Overall Study|Progression and withdrew consent|0|||
33564618|NCT02721732|101964644|FG008|Overall Study|Progression and withdrew consent|0|||
33564619|NCT02721732|101964645|FG009|Overall Study|Progression and withdrew consent|1|||
33629135|NCT05473026|102191316|FG000|Overall Study|Lost to Follow-up|5|||
33629136|NCT05473026|102191317|FG001|Overall Study|Lost to Follow-up|2|||
33629137|NCT03919773|102191324|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
33222169|NCT01226511|100715721|FG001|Acute Treatment Period|Lost to Follow-up|6|||
33564620|NCT02721732|101964636|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
33564621|NCT02721732|101964637|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
33564622|NCT02721732|101964638|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
33564623|NCT02721732|101964639|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
33564624|NCT02721732|101964640|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
33362938|NCT02613572|101217317|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
33362939|NCT02613572|101217318|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
33362940|NCT01494038|101217319|FG000|Overall Study|Protocol Violation|1|||
33362941|NCT01494038|101217320|FG001|Overall Study|Protocol Violation|1|||
33362942|NCT01494038|101217319|FG000|Overall Study|Lost to Follow-up|18|||
33362943|NCT01494038|101217320|FG001|Overall Study|Lost to Follow-up|20|||
33362944|NCT01494038|101217319|FG000|Overall Study|Withdrawal by Subject|44|||
33362945|NCT01494038|101217320|FG001|Overall Study|Withdrawal by Subject|34|||
33362946|NCT01494038|101217319|FG000|Overall Study|Not able to get to clinic|21|||
33362947|NCT01494038|101217320|FG001|Overall Study|Not able to get to clinic|15|||
33362948|NCT01494038|101217319|FG000|Overall Study|Not willing to adhere to reqs|2|||
33362949|NCT01494038|101217320|FG001|Overall Study|Not willing to adhere to reqs|9|||
33362950|NCT01494038|101217319|FG000|Overall Study|Death|2|||
33362951|NCT01494038|101217320|FG001|Overall Study|Death|4|||
33362952|NCT02749721|101217326|FG000|Screening|Withdrawal by Subject|1|||
33362953|NCT02749721|101217326|FG000|Screening|Lost to Follow-up|2|||
33362954|NCT02749721|101217326|FG000|Screening|Protocol Violation|3|||
33362955|NCT02749721|101217326|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
33362956|NCT02749721|101217326|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
33415827|NCT00242567|101413143|FG000|Overall Study|Withdrawal by Subject|33|||
33415828|NCT00242567|101413144|FG001|Overall Study|Withdrawal by Subject|28|||
33415829|NCT00242567|101413143|FG000|Overall Study|Protocol Violation|12|||
33415830|NCT00242567|101413144|FG001|Overall Study|Protocol Violation|12|||
33415831|NCT00242567|101413143|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
33415832|NCT00242567|101413144|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
33415833|NCT00242567|101413143|FG000|Overall Study|Other|14|||
33415834|NCT00242567|101413144|FG001|Overall Study|Other|9|||
33415835|NCT02860039|101413145|FG000|Overall Study|Death|4|||
33415836|NCT02860039|101413146|FG001|Overall Study|Death|0|||
33415837|NCT02860039|101413145|FG000|Overall Study|Lost to Follow-up|2|||
33415838|NCT02860039|101413146|FG001|Overall Study|Lost to Follow-up|2|||
33415839|NCT02860039|101413145|FG000|Overall Study|Protocol Violation|3|||
33415840|NCT02860039|101413146|FG001|Overall Study|Protocol Violation|1|||
33415841|NCT02860039|101413145|FG000|Overall Study|Withdrawal by Subject|1|||
33415842|NCT02860039|101413146|FG001|Overall Study|Withdrawal by Subject|0|||
33415843|NCT02860039|101413145|FG000|Overall Study|Not otherwise eligible|1|||
33415844|NCT02860039|101413146|FG001|Overall Study|Not otherwise eligible|1|||
33415845|NCT00890409|101413147|FG000|Overall Study|Lost to Follow-up|20|||
33415846|NCT00890409|101413148|FG001|Overall Study|Lost to Follow-up|21|||
33415847|NCT01607398|101413149|FG000|Overall Study|Adverse Event|0|||
33564625|NCT02721732|101964641|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
33564626|NCT02721732|101964642|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
33564627|NCT02721732|101964643|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
33564628|NCT02721732|101964644|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
33564629|NCT02721732|101964645|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
33564630|NCT02135133|101964646|FG000|Overall Study|Adverse Event|10|||
33564631|NCT02135133|101964646|FG000|Overall Study|regulatory mandate|5|||
33564632|NCT00137449|101964647|FG000|Overall Study|Disease Progression|8|||
33564633|NCT00137449|101964648|FG001|Overall Study|Disease Progression|13|||
33564634|NCT00137449|101964647|FG000|Overall Study|Death|4|||
33564635|NCT00137449|101964648|FG001|Overall Study|Death|3|||
33564636|NCT00137449|101964647|FG000|Overall Study|Adverse Event|3|||
33564637|NCT00137449|101964648|FG001|Overall Study|Adverse Event|1|||
33564638|NCT00137449|101964647|FG000|Overall Study|Withdrawal by Subject|1|||
33564639|NCT00137449|101964648|FG001|Overall Study|Withdrawal by Subject|1|||
33564640|NCT00522379|101964649|FG000|Overall Study|Adverse Event|12|||
33564641|NCT00522379|101964650|FG001|Overall Study|Adverse Event|15|||
33564642|NCT00522379|101964651|FG002|Overall Study|Adverse Event|12|||
33564643|NCT00522379|101964652|FG003|Overall Study|Adverse Event|5|||
33564644|NCT00522379|101964653|FG004|Overall Study|Adverse Event|17|||
33564645|NCT00522379|101964649|FG000|Overall Study|Lack of Efficacy|3|||
33564646|NCT00522379|101964650|FG001|Overall Study|Lack of Efficacy|0|||
33564647|NCT00522379|101964651|FG002|Overall Study|Lack of Efficacy|2|||
33564648|NCT00522379|101964652|FG003|Overall Study|Lack of Efficacy|2|||
33362957|NCT03461289|101217327|FG000|Overall Study|Death|1|||
33415848|NCT01607398|101413150|FG001|Overall Study|Adverse Event|2|||
33415849|NCT01607398|101413149|FG000|Overall Study|Severe COPD|2|||
33415850|NCT01607398|101413150|FG001|Overall Study|Severe COPD|0|||
33415851|NCT03901352|101413153|FG000|Double-blind Phase|Adverse Event|6|||
33415852|NCT03901352|101413154|FG001|Double-blind Phase|Adverse Event|4|||
33415853|NCT03901352|101413153|FG000|Double-blind Phase|Death|1|||
33564649|NCT00522379|101964653|FG004|Overall Study|Lack of Efficacy|7|||
33564650|NCT00522379|101964649|FG000|Overall Study|Withdrawal by Subject|2|||
33362958|NCT02116972|101217328|FG000|Overall Study|Adverse Event|4|||
33415854|NCT03901352|101413154|FG001|Double-blind Phase|Death|0|||
33415855|NCT03901352|101413153|FG000|Double-blind Phase|Lack of Efficacy|0|||
33415856|NCT03901352|101413154|FG001|Double-blind Phase|Lack of Efficacy|1|||
33564651|NCT00522379|101964650|FG001|Overall Study|Withdrawal by Subject|3|||
33564652|NCT00522379|101964651|FG002|Overall Study|Withdrawal by Subject|1|||
33564653|NCT00522379|101964652|FG003|Overall Study|Withdrawal by Subject|2|||
33564654|NCT00522379|101964653|FG004|Overall Study|Withdrawal by Subject|0|||
33564655|NCT00522379|101964649|FG000|Overall Study|Protocol Violation|1|||
33564656|NCT00522379|101964650|FG001|Overall Study|Protocol Violation|1|||
33564657|NCT00522379|101964651|FG002|Overall Study|Protocol Violation|2|||
33564658|NCT00522379|101964652|FG003|Overall Study|Protocol Violation|0|||
33564659|NCT00522379|101964653|FG004|Overall Study|Protocol Violation|0|||
33564660|NCT00522379|101964649|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
33564661|NCT00522379|101964650|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
33564662|NCT00522379|101964651|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
33564663|NCT00522379|101964652|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
33564664|NCT00522379|101964653|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
33564665|NCT00522379|101964649|FG000|Overall Study|Lost to Follow-up|1|||
33564666|NCT00522379|101964650|FG001|Overall Study|Lost to Follow-up|0|||
33564667|NCT00522379|101964651|FG002|Overall Study|Lost to Follow-up|4|||
33564668|NCT00522379|101964652|FG003|Overall Study|Lost to Follow-up|2|||
33564669|NCT00522379|101964653|FG004|Overall Study|Lost to Follow-up|2|||
33564670|NCT00522379|101964649|FG000|Overall Study|Randomization error|0|||
33564671|NCT00522379|101964650|FG001|Overall Study|Randomization error|0|||
33564672|NCT00522379|101964651|FG002|Overall Study|Randomization error|0|||
33564673|NCT00522379|101964652|FG003|Overall Study|Randomization error|0|||
33564674|NCT00522379|101964653|FG004|Overall Study|Randomization error|1|||
33564675|NCT00522379|101964649|FG000|Overall Study|Dispensing error|1|||
33564676|NCT00522379|101964650|FG001|Overall Study|Dispensing error|0|||
33564677|NCT00522379|101964651|FG002|Overall Study|Dispensing error|0|||
33564678|NCT00522379|101964652|FG003|Overall Study|Dispensing error|1|||
33564679|NCT00522379|101964653|FG004|Overall Study|Dispensing error|0|||
33564680|NCT00522379|101964649|FG000|Overall Study|Subject Moved|1|||
33564681|NCT00522379|101964650|FG001|Overall Study|Subject Moved|1|||
33564682|NCT00522379|101964651|FG002|Overall Study|Subject Moved|0|||
33564683|NCT00522379|101964652|FG003|Overall Study|Subject Moved|0|||
33564684|NCT00522379|101964653|FG004|Overall Study|Subject Moved|0|||
33564685|NCT00522379|101964649|FG000|Overall Study|Sponsor Request|0|||
33564686|NCT00522379|101964650|FG001|Overall Study|Sponsor Request|1|||
33564687|NCT00522379|101964651|FG002|Overall Study|Sponsor Request|0|||
33564688|NCT00522379|101964652|FG003|Overall Study|Sponsor Request|0|||
33564689|NCT00522379|101964653|FG004|Overall Study|Sponsor Request|0|||
33564690|NCT00522379|101964649|FG000|Overall Study|Family Problem|0|||
33564691|NCT00522379|101964650|FG001|Overall Study|Family Problem|0|||
33564692|NCT00522379|101964651|FG002|Overall Study|Family Problem|1|||
33564693|NCT00522379|101964652|FG003|Overall Study|Family Problem|0|||
33564694|NCT00522379|101964653|FG004|Overall Study|Family Problem|0|||
33564695|NCT00522379|101964649|FG000|Overall Study|Site Closed|0|||
33564696|NCT00522379|101964650|FG001|Overall Study|Site Closed|0|||
33564697|NCT00522379|101964651|FG002|Overall Study|Site Closed|0|||
33564698|NCT00522379|101964652|FG003|Overall Study|Site Closed|1|||
33564699|NCT00522379|101964653|FG004|Overall Study|Site Closed|0|||
33564700|NCT00522379|101964649|FG000|Overall Study|Subject Withdrawal|0|||
33564701|NCT00522379|101964650|FG001|Overall Study|Subject Withdrawal|0|||
33564702|NCT00522379|101964651|FG002|Overall Study|Subject Withdrawal|0|||
33564703|NCT00522379|101964652|FG003|Overall Study|Subject Withdrawal|1|||
33564704|NCT00522379|101964653|FG004|Overall Study|Subject Withdrawal|0|||
33564705|NCT05810597|101964654|FG000|Period 1|Adverse Event|2|||
33564706|NCT05810597|101964655|FG001|Period 1|Adverse Event|0|||
33564707|NCT05810597|101964654|FG000|Period 1|Physician Decision|1|||
33564708|NCT05810597|101964655|FG001|Period 1|Physician Decision|0|||
33564709|NCT05360784|101964656|FG000|Overall Study|Discontinued|25|||
33564710|NCT05360784|101964657|FG001|Overall Study|Discontinued|11|||
33564711|NCT01587196|101964660|FG000|Overall Study|Lost to Follow-up|50|||
33564712|NCT01587196|101964660|FG000|Overall Study|Withdrawal by Subject|4|||
33564713|NCT03537508|101964677|FG000|Overall Study|Adverse Event|2|||
33564714|NCT03537508|101964678|FG001|Overall Study|Adverse Event|1|||
33629138|NCT03919773|102191325|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
33629139|NCT03919773|102191324|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
33629140|NCT03919773|102191325|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
33564715|NCT03537508|101964677|FG000|Overall Study|Protocol Violation|65|||
33564716|NCT03537508|101964678|FG001|Overall Study|Protocol Violation|48|||
33564717|NCT03537508|101964677|FG000|Overall Study|Lost to Follow-up|86|||
33564718|NCT03537508|101964678|FG001|Overall Study|Lost to Follow-up|60|||
33629141|NCT01844765|102191326|FG000|Overall Study|Adverse Event|6|||
33564719|NCT03537508|101964677|FG000|Overall Study|Withdrawal by parent/guardian|263|||
33564720|NCT03537508|101964678|FG001|Overall Study|Withdrawal by parent/guardian|149|||
33564721|NCT01394185|101964679|FG000|Overall Study|Withdrawal by Subject|2|||
33564722|NCT01394185|101964680|FG001|Overall Study|Withdrawal by Subject|0|||
33564723|NCT01394185|101964681|FG002|Overall Study|Withdrawal by Subject|0|||
33564724|NCT01394185|101964682|FG003|Overall Study|Withdrawal by Subject|0|||
33564725|NCT01394185|101964683|FG004|Overall Study|Withdrawal by Subject|1|||
33564726|NCT01394185|101964684|FG005|Overall Study|Withdrawal by Subject|0|||
33564727|NCT01394185|101964679|FG000|Overall Study|Change in protocol|3|||
33564728|NCT01394185|101964680|FG001|Overall Study|Change in protocol|0|||
33564729|NCT01394185|101964681|FG002|Overall Study|Change in protocol|0|||
33564730|NCT01394185|101964682|FG003|Overall Study|Change in protocol|0|||
33564731|NCT01394185|101964683|FG004|Overall Study|Change in protocol|3|||
33564732|NCT01394185|101964684|FG005|Overall Study|Change in protocol|0|||
33564733|NCT01394185|101964679|FG000|Overall Study|Protocol Violation|1|||
33564734|NCT01394185|101964680|FG001|Overall Study|Protocol Violation|0|||
33564735|NCT01394185|101964681|FG002|Overall Study|Protocol Violation|0|||
33222170|NCT01226511|100715720|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
33222171|NCT01226511|100715721|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
33222172|NCT01226511|100715720|FG000|Acute Treatment Period|Protocol Violation|5|||
33222173|NCT01226511|100715721|FG001|Acute Treatment Period|Protocol Violation|5|||
33222174|NCT01226511|100715720|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
33222175|NCT01226511|100715721|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
33222176|NCT01226511|100715720|FG000|Extension Treatment Period|Adverse Event|8|||
33222177|NCT01226511|100715721|FG001|Extension Treatment Period|Adverse Event|8|||
33222178|NCT01226511|100715720|FG000|Extension Treatment Period|Lack of Efficacy|3|||
33222179|NCT01226511|100715721|FG001|Extension Treatment Period|Lack of Efficacy|2|||
33222180|NCT01226511|100715720|FG000|Extension Treatment Period|Lost to Follow-up|4|||
33222181|NCT01226511|100715721|FG001|Extension Treatment Period|Lost to Follow-up|3|||
33222182|NCT01226511|100715720|FG000|Extension Treatment Period|Protocol Violation|2|||
33222183|NCT01226511|100715721|FG001|Extension Treatment Period|Protocol Violation|2|||
33222184|NCT01226511|100715720|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
33222185|NCT01226511|100715721|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
33222186|NCT01226511|100715720|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
33222187|NCT01226511|100715721|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
33222188|NCT01226511|100715720|FG000|Extension Treatment Period|Sponsor Decision|1|||
33222189|NCT01226511|100715721|FG001|Extension Treatment Period|Sponsor Decision|1|||
33222190|NCT01226511|100715720|FG000|Taper Period|Adverse Event|1|||
33222191|NCT01226511|100715721|FG001|Taper Period|Adverse Event|0|||
33222192|NCT01226511|100715720|FG000|Taper Period|Lost to Follow-up|2|||
33222193|NCT01226511|100715721|FG001|Taper Period|Lost to Follow-up|2|||
33222194|NCT01226511|100715720|FG000|Taper Period|Protocol Violation|1|||
33222195|NCT01226511|100715721|FG001|Taper Period|Protocol Violation|0|||
33222196|NCT01226511|100715720|FG000|Taper Period|Parent/Caregiver Decision|1|||
33222197|NCT01226511|100715721|FG001|Taper Period|Parent/Caregiver Decision|1|||
33222198|NCT01986881|100715722|FG000|Overall Study|Death|228|||
33222199|NCT01986881|100715723|FG001|Overall Study|Death|233|||
33222200|NCT01986881|100715724|FG002|Overall Study|Death|247|||
33222201|NCT01986881|100715722|FG000|Overall Study|Lost to Follow-up|51|||
33564736|NCT01394185|101964682|FG003|Overall Study|Protocol Violation|1|||
33222202|NCT01986881|100715723|FG001|Overall Study|Lost to Follow-up|44|||
33222203|NCT01986881|100715724|FG002|Overall Study|Lost to Follow-up|55|||
33222204|NCT01986881|100715722|FG000|Overall Study|Physician Decision|7|||
33222205|NCT01986881|100715723|FG001|Overall Study|Physician Decision|4|||
33222206|NCT01986881|100715724|FG002|Overall Study|Physician Decision|6|||
33222207|NCT01986881|100715722|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
33222208|NCT01986881|100715723|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
33222209|NCT01986881|100715724|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
33222210|NCT01986881|100715722|FG000|Overall Study|Withdrawal by Subject|41|||
33222211|NCT01986881|100715723|FG001|Overall Study|Withdrawal by Subject|60|||
33222212|NCT01986881|100715724|FG002|Overall Study|Withdrawal by Subject|45|||
33222213|NCT01986881|100715722|FG000|Overall Study|Subject Moved|0|||
33222214|NCT01986881|100715723|FG001|Overall Study|Subject Moved|1|||
33222215|NCT01986881|100715724|FG002|Overall Study|Subject Moved|0|||
33222216|NCT01986881|100715722|FG000|Overall Study|Other|1|||
33222217|NCT01986881|100715723|FG001|Overall Study|Other|2|||
33222218|NCT01986881|100715724|FG002|Overall Study|Other|2|||
33222219|NCT04766086|100715732|FG000|Overall Study|Lost to Follow-up|3|||
33222220|NCT04766086|100715733|FG001|Overall Study|Lost to Follow-up|5|||
33222221|NCT04766086|100715734|FG002|Overall Study|Lost to Follow-up|3|||
33564737|NCT01394185|101964683|FG004|Overall Study|Protocol Violation|0|||
33222222|NCT04766086|100715732|FG000|Overall Study|Withdrawal by Subject|1|||
33564738|NCT01394185|101964684|FG005|Overall Study|Protocol Violation|1|||
33222223|NCT04766086|100715733|FG001|Overall Study|Withdrawal by Subject|1|||
33564739|NCT01355627|101964692|FG000|Overall Study|Request By the Patient to Discontinue|5|||
33222224|NCT04766086|100715734|FG002|Overall Study|Withdrawal by Subject|2|||
33222225|NCT04766086|100715732|FG000|Overall Study|Other|0|||
33222226|NCT04766086|100715733|FG001|Overall Study|Other|0|||
33222227|NCT04766086|100715734|FG002|Overall Study|Other|1|||
33222228|NCT04382924|100715735|FG000|Overall Study|Death|2|||
33222229|NCT04382924|100715736|FG001|Overall Study|Death|5|||
33222230|NCT04382924|100715737|FG002|Overall Study|Death|4|||
33222231|NCT04382924|100715735|FG000|Overall Study|Protocol Violation|0|||
33222232|NCT04382924|100715736|FG001|Overall Study|Protocol Violation|1|||
33629142|NCT01844765|102191327|FG001|Overall Study|Adverse Event|8|||
33564740|NCT01355627|101964693|FG001|Overall Study|Request By the Patient to Discontinue|7|||
33564741|NCT01355627|101964692|FG000|Overall Study|Lost to Follow-up|8|||
33564742|NCT01355627|101964693|FG001|Overall Study|Lost to Follow-up|7|||
33564743|NCT01355627|101964692|FG000|Overall Study|Fatal Adverse Event|19|||
33564744|NCT01355627|101964693|FG001|Overall Study|Fatal Adverse Event|23|||
33564745|NCT01355627|101964692|FG000|Overall Study|Other|1|||
33564746|NCT01355627|101964693|FG001|Overall Study|Other|1|||
33564747|NCT04756531|101964696|FG000|Overall Study|Adverse Event|0|||
33564748|NCT04756531|101964697|FG001|Overall Study|Adverse Event|0|||
33564749|NCT04756531|101964698|FG002|Overall Study|Adverse Event|0|||
33564750|NCT04756531|101964699|FG003|Overall Study|Adverse Event|0|||
33564751|NCT04756531|101964700|FG004|Overall Study|Adverse Event|1|||
33564752|NCT04756531|101964701|FG005|Overall Study|Adverse Event|0|||
33564753|NCT04756531|101964702|FG006|Overall Study|Adverse Event|0|||
33564754|NCT04756531|101964703|FG007|Overall Study|Adverse Event|0|||
33564755|NCT04756531|101964704|FG008|Overall Study|Adverse Event|0|||
33564756|NCT04756531|101964705|FG009|Overall Study|Adverse Event|0|||
33564757|NCT04756531|101964706|FG010|Overall Study|Adverse Event|0|||
33564758|NCT04756531|101964707|FG011|Overall Study|Adverse Event|0|||
33564759|NCT04756531|101964708|FG012|Overall Study|Adverse Event|0|||
33564760|NCT04756531|101964709|FG013|Overall Study|Adverse Event|0|||
33564761|NCT04756531|101964710|FG014|Overall Study|Adverse Event|0|||
33564762|NCT04756531|101964711|FG015|Overall Study|Adverse Event|0|||
33564763|NCT04756531|101964712|FG016|Overall Study|Adverse Event|0|||
33564764|NCT04756531|101964713|FG017|Overall Study|Adverse Event|0|||
33564765|NCT04756531|101964696|FG000|Overall Study|Withdrawal by Subject|0|||
33564766|NCT04756531|101964697|FG001|Overall Study|Withdrawal by Subject|0|||
33564767|NCT04756531|101964698|FG002|Overall Study|Withdrawal by Subject|0|||
33564768|NCT04756531|101964699|FG003|Overall Study|Withdrawal by Subject|0|||
33564769|NCT04756531|101964700|FG004|Overall Study|Withdrawal by Subject|0|||
33564770|NCT04756531|101964701|FG005|Overall Study|Withdrawal by Subject|0|||
33222233|NCT04382924|100715737|FG002|Overall Study|Protocol Violation|1|||
33564771|NCT04756531|101964702|FG006|Overall Study|Withdrawal by Subject|1|||
33564772|NCT04756531|101964703|FG007|Overall Study|Withdrawal by Subject|0|||
33564773|NCT04756531|101964704|FG008|Overall Study|Withdrawal by Subject|0|||
33564774|NCT04756531|101964705|FG009|Overall Study|Withdrawal by Subject|0|||
33564775|NCT04756531|101964706|FG010|Overall Study|Withdrawal by Subject|0|||
33564776|NCT04756531|101964707|FG011|Overall Study|Withdrawal by Subject|0|||
33564777|NCT04756531|101964708|FG012|Overall Study|Withdrawal by Subject|0|||
33564778|NCT04756531|101964709|FG013|Overall Study|Withdrawal by Subject|0|||
33564779|NCT04756531|101964710|FG014|Overall Study|Withdrawal by Subject|0|||
33564780|NCT04756531|101964711|FG015|Overall Study|Withdrawal by Subject|0|||
33564781|NCT04756531|101964712|FG016|Overall Study|Withdrawal by Subject|0|||
33629143|NCT01844765|102191326|FG000|Overall Study|Withdrawal by Subject|2|||
33222234|NCT04382924|100715735|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
33222235|NCT04382924|100715736|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
33222236|NCT04382924|100715737|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
33222237|NCT04382924|100715735|FG000|Overall Study|Withdrawal by Subject|6|||
33222238|NCT04382924|100715736|FG001|Overall Study|Withdrawal by Subject|3|||
33222239|NCT04382924|100715737|FG002|Overall Study|Withdrawal by Subject|6|||
33222240|NCT04860518|100715742|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
33222241|NCT04860518|100715743|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
33222242|NCT01436201|100715744|FG000|Overall Study|Adverse Event|2|||
33222243|NCT01436201|100715744|FG000|Overall Study|Withdrawal by Subject|1|||
33222244|NCT01436201|100715744|FG000|Overall Study|Protocol Violation|1|||
33222245|NCT02130284|100715745|FG000|Overall Study|Withdrawal by Subject|3|||
33222246|NCT02130284|100715745|FG000|Overall Study|Subject Withdrew Consent|1|||
33222247|NCT02130284|100715745|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
33222248|NCT02130284|100715745|FG000|Overall Study|Subject was screened as backup for study|3|||
33222249|NCT02130284|100715745|FG000|Overall Study|Screen Failure|1|||
33222250|NCT00384059|100715747|FG000|Infant Series|Not consented|2|||
33222251|NCT00384059|100715748|FG001|Infant Series|Not consented|6|||
33222252|NCT00384059|100715747|FG000|Infant Series|Withdrawal by Subject|2|||
33222253|NCT00384059|100715748|FG001|Infant Series|Withdrawal by Subject|2|||
33222254|NCT00384059|100715747|FG000|Infant Series|Adverse Event|1|||
33222255|NCT00384059|100715748|FG001|Infant Series|Adverse Event|2|||
33222256|NCT00384059|100715747|FG000|Infant Series|Protocol Violation|1|||
33629144|NCT01844765|102191327|FG001|Overall Study|Withdrawal by Subject|3|||
33222257|NCT00384059|100715748|FG001|Infant Series|Protocol Violation|2|||
33222258|NCT00384059|100715747|FG000|Infant Series|Lost to Follow-up|0|||
33564782|NCT04756531|101964713|FG017|Overall Study|Withdrawal by Subject|0|||
33564783|NCT02758626|101964717|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
33564784|NCT02758626|101964718|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
33222259|NCT00384059|100715748|FG001|Infant Series|Lost to Follow-up|1|||
33222260|NCT00384059|100715747|FG000|After Infant Series|Protocol Violation|2|||
33564785|NCT02758626|101964717|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
33362959|NCT02116972|101217329|FG001|Overall Study|Adverse Event|4|||
33564786|NCT02758626|101964718|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
33564787|NCT02758626|101964717|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
33564788|NCT02758626|101964718|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
33564789|NCT02758626|101964717|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
33564790|NCT02758626|101964718|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
33564791|NCT03802396|101964721|FG000|Overall Study|Withdrawal by Subject|2|||
33564792|NCT03802396|101964722|FG001|Overall Study|Withdrawal by Subject|0|||
33564793|NCT03802396|101964721|FG000|Overall Study|Surgery Cancelled|1|||
33564794|NCT03802396|101964722|FG001|Overall Study|Surgery Cancelled|0|||
33564795|NCT00492050|101964723|FG000|Overall Study|Adverse Event|1|||
33564796|NCT00492050|101964723|FG000|Overall Study|Lack of Efficacy|1|||
33564797|NCT00492050|101964723|FG000|Overall Study|Withdrawal by Subject|3|||
33564798|NCT00492050|101964723|FG000|Overall Study|Unable to collect SCT|2|||
33564799|NCT00492050|101964723|FG000|Overall Study|Progressive Disease|2|||
33564800|NCT02989857|101964730|FG000|Randomization Phase|Not Treated|3|||
33564801|NCT02989857|101964731|FG001|Randomization Phase|Not Treated|2|||
33362960|NCT02116972|101217330|FG002|Overall Study|Adverse Event|1|||
33362961|NCT02116972|101217328|FG000|Overall Study|Withdrawal by Subject|1|||
33362962|NCT02116972|101217329|FG001|Overall Study|Withdrawal by Subject|1|||
33362963|NCT02116972|101217330|FG002|Overall Study|Withdrawal by Subject|5|||
33362964|NCT02116972|101217328|FG000|Overall Study|Protocol Violation|1|||
33362965|NCT02116972|101217329|FG001|Overall Study|Protocol Violation|0|||
33362966|NCT02116972|101217330|FG002|Overall Study|Protocol Violation|1|||
33362967|NCT02116972|101217328|FG000|Overall Study|Lost to Follow-up|4|||
33362968|NCT02116972|101217329|FG001|Overall Study|Lost to Follow-up|3|||
33362969|NCT02116972|101217330|FG002|Overall Study|Lost to Follow-up|1|||
33362970|NCT02116972|101217328|FG000|Overall Study|Lack of Efficacy|6|||
33362971|NCT02116972|101217329|FG001|Overall Study|Lack of Efficacy|6|||
33362972|NCT02116972|101217330|FG002|Overall Study|Lack of Efficacy|5|||
33362973|NCT02116972|101217328|FG000|Overall Study|scheduling conflicts and relocation|3|||
33362974|NCT02116972|101217329|FG001|Overall Study|scheduling conflicts and relocation|3|||
33362975|NCT02116972|101217330|FG002|Overall Study|scheduling conflicts and relocation|6|||
33362976|NCT03635190|101217331|FG000|Overall Study|Lost to Follow-up|4|||
33362977|NCT03635190|101217331|FG000|Overall Study|Death|3|||
33362978|NCT03635190|101217331|FG000|Overall Study|Withdrawal by Subject|1|||
33362979|NCT03635190|101217331|FG000|Overall Study|Patient moved and did not return for follow up|1|||
33415857|NCT03901352|101413153|FG000|Double-blind Phase|Protocol Violation|0|||
33415858|NCT03901352|101413154|FG001|Double-blind Phase|Protocol Violation|1|||
33415859|NCT03901352|101413153|FG000|Double-blind Phase|Withdrawal by Subject|10|||
33564802|NCT02989857|101964732|FG002|Randomization Phase|Not Treated|0|||
33564803|NCT02801578|101964733|FG000|Overall Study|Adverse Event|2|||
33564804|NCT00381641|101964743|FG000|Overall Study|Withdrawal by Subject|0|||
33564805|NCT00381641|101964744|FG001|Overall Study|Withdrawal by Subject|2|||
33564806|NCT04197583|101964747|FG000|Overall Study|Study Stent Replacement|34|||
33564807|NCT04197583|101964748|FG001|Overall Study|Study Stent Replacement|8|||
33564808|NCT04197583|101964747|FG000|Overall Study|Lost to Follow-up|14|||
33564809|NCT04197583|101964748|FG001|Overall Study|Lost to Follow-up|3|||
33564810|NCT04197583|101964747|FG000|Overall Study|Death|3|||
33564811|NCT04197583|101964748|FG001|Overall Study|Death|0|||
33564812|NCT04197583|101964747|FG000|Overall Study|Physician Decision|1|||
33564813|NCT04197583|101964748|FG001|Overall Study|Physician Decision|0|||
33564814|NCT04197583|101964747|FG000|Overall Study|Withdrawal by Subject|1|||
33564815|NCT04197583|101964748|FG001|Overall Study|Withdrawal by Subject|1|||
33564816|NCT04197583|101964747|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
33564817|NCT04197583|101964748|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
33415860|NCT03901352|101413154|FG001|Double-blind Phase|Withdrawal by Subject|8|||
33415861|NCT03901352|101413153|FG000|Open-label Extension Phase|Adverse Event|24|||
33415862|NCT03901352|101413154|FG001|Open-label Extension Phase|Adverse Event|0|||
33415863|NCT03901352|101413153|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
33564818|NCT04197583|101964747|FG000|Overall Study|Screen Failure|0|||
33564819|NCT04197583|101964748|FG001|Overall Study|Screen Failure|20|||
33415864|NCT03901352|101413154|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
33415865|NCT03901352|101413153|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
33415866|NCT03901352|101413154|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
33564820|NCT00023595|101964751|FG000|5 Year Follow up|Lost to Follow-up|2|||
33564821|NCT00023595|101964752|FG001|5 Year Follow up|Lost to Follow-up|2|||
33564822|NCT00023595|101964753|FG002|5 Year Follow up|Lost to Follow-up|1|||
33564823|NCT00023595|101964754|FG003|5 Year Follow up|Lost to Follow-up|7|||
33362980|NCT01118143|101217337|FG000|Overall Study|Withdrawal by Subject|2|||
33415867|NCT03901352|101413153|FG000|Open-label Extension Phase|Other|1|||
33415868|NCT03901352|101413154|FG001|Open-label Extension Phase|Other|0|||
33564824|NCT00023595|101964755|FG004|5 Year Follow up|Lost to Follow-up|3|||
33564825|NCT00023595|101964751|FG000|10 Year Follow up|Lost to Follow-up|12|||
33564826|NCT00023595|101964752|FG001|10 Year Follow up|Lost to Follow-up|10|||
33564827|NCT00023595|101964753|FG002|10 Year Follow up|Lost to Follow-up|3|||
33564828|NCT00023595|101964754|FG003|10 Year Follow up|Lost to Follow-up|0|||
33564829|NCT00023595|101964755|FG004|10 Year Follow up|Lost to Follow-up|0|||
33564830|NCT01969409|101964756|FG000|Overall Study|Death|2|||
33415869|NCT00769132|101413157|FG000|Period 1|Adverse Event|1|||
33415870|NCT00769132|101413158|FG001|Period 1|Adverse Event|0|||
33415871|NCT00769132|101413159|FG002|Period 1|Adverse Event|0|||
33415872|NCT00769132|101413160|FG003|Period 1|Adverse Event|1|||
33564831|NCT01969409|101964757|FG001|Overall Study|Death|2|||
33564832|NCT01969409|101964756|FG000|Overall Study|Transplant|1|||
33564833|NCT01969409|101964757|FG001|Overall Study|Transplant|1|||
33222261|NCT00384059|100715748|FG001|After Infant Series|Protocol Violation|3|||
33222262|NCT00384059|100715747|FG000|After Infant Series|Withdrawal by Subject|2|||
33222263|NCT00384059|100715748|FG001|After Infant Series|Withdrawal by Subject|2|||
33222264|NCT00384059|100715747|FG000|After Infant Series|Failed to Return|0|||
33362981|NCT01118143|101217338|FG001|Overall Study|Withdrawal by Subject|5|||
33415873|NCT00769132|101413157|FG000|Period 2|Withdrawal by Subject|0|||
33415874|NCT00769132|101413158|FG001|Period 2|Withdrawal by Subject|0|||
33415875|NCT00769132|101413159|FG002|Period 2|Withdrawal by Subject|0|||
33415876|NCT00769132|101413160|FG003|Period 2|Withdrawal by Subject|1|||
33415877|NCT00769132|101413157|FG000|Period 3|Withdrawal by Subject|1|||
33415878|NCT00769132|101413158|FG001|Period 3|Withdrawal by Subject|0|||
33415879|NCT00769132|101413159|FG002|Period 3|Withdrawal by Subject|0|||
33415880|NCT00769132|101413160|FG003|Period 3|Withdrawal by Subject|0|||
33415881|NCT00769132|101413157|FG000|Period 4|Withdrawal by Subject|0|||
33415882|NCT00769132|101413158|FG001|Period 4|Withdrawal by Subject|1|||
33415883|NCT00769132|101413159|FG002|Period 4|Withdrawal by Subject|0|||
33415884|NCT00769132|101413160|FG003|Period 4|Withdrawal by Subject|0|||
33362982|NCT02465034|101217339|FG000|Overall Study|Withdrawal by Subject|1|||
33362983|NCT02465034|101217340|FG001|Overall Study|Withdrawal by Subject|1|||
33362984|NCT02465034|101217339|FG000|Overall Study|Screen fail|2|||
33362985|NCT02465034|101217340|FG001|Overall Study|Screen fail|0|||
33362986|NCT02465034|101217339|FG000|Overall Study|Could not be scheduled for study visit|0|||
33362987|NCT02465034|101217340|FG001|Overall Study|Could not be scheduled for study visit|5|||
33362988|NCT00891657|101217342|FG000|Overall Study|Withdrawal by Subject|1|||
33362989|NCT00891657|101217343|FG001|Overall Study|Withdrawal by Subject|1|||
33362990|NCT00537823|101217348|FG000|Overall Study|Adverse Event|2|||
33362991|NCT00537823|101217349|FG001|Overall Study|Adverse Event|0|||
33362992|NCT03176966|101217353|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
33362993|NCT03176966|101217354|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
33362994|NCT03176966|101217353|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
33362995|NCT03176966|101217354|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
33362996|NCT03176966|101217353|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
33362997|NCT03176966|101217354|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
33362998|NCT03176966|101217353|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
33362999|NCT03176966|101217354|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
33363000|NCT03176966|101217353|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
33363001|NCT03176966|101217354|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
33363002|NCT03176966|101217353|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
33363003|NCT03176966|101217354|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
33363004|NCT03176966|101217353|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
33363005|NCT03176966|101217354|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
33363006|NCT00685178|101217358|FG000|Overall Study|Adverse Event|1|||
33363007|NCT00685178|101217359|FG001|Overall Study|Adverse Event|5|||
33363008|NCT00685178|101217360|FG002|Overall Study|Adverse Event|2|||
33363009|NCT00685178|101217361|FG003|Overall Study|Adverse Event|4|||
33363010|NCT00685178|101217358|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
33363011|NCT00685178|101217359|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
33363012|NCT00685178|101217360|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
33363013|NCT00685178|101217361|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
33363014|NCT00685178|101217358|FG000|Overall Study|voluntary study discharge|4|||
33363015|NCT00685178|101217359|FG001|Overall Study|voluntary study discharge|5|||
33363016|NCT00685178|101217360|FG002|Overall Study|voluntary study discharge|1|||
33363017|NCT00685178|101217361|FG003|Overall Study|voluntary study discharge|1|||
33363018|NCT00685178|101217358|FG000|Overall Study|incarcerated|1|||
33363019|NCT00685178|101217359|FG001|Overall Study|incarcerated|3|||
33564834|NCT01969409|101964756|FG000|Overall Study|Withdrawal by Subject|0|||
33564835|NCT01969409|101964757|FG001|Overall Study|Withdrawal by Subject|1|||
33363020|NCT00685178|101217360|FG002|Overall Study|incarcerated|7|||
33415885|NCT01371006|101413161|FG000|Overall Study|Adverse Event|1|||
33415886|NCT01371006|101413162|FG001|Overall Study|Adverse Event|0|||
33415887|NCT04285983|101413169|FG000|Overall Study|Protocol Violation|6|||
33415888|NCT04935931|101413170|FG000|Overall Study|Withdrawal by Subject|1|||
33629145|NCT01844765|102191326|FG000|Overall Study|Disease progression|1|||
33222265|NCT00384059|100715748|FG001|After Infant Series|Failed to Return|2|||
33222266|NCT00384059|100715747|FG000|After Infant Series|Adverse Event|0|||
33222267|NCT00384059|100715748|FG001|After Infant Series|Adverse Event|1|||
33222268|NCT00384059|100715747|FG000|After Infant Series|Physician Decision|0|||
33222269|NCT00384059|100715748|FG001|After Infant Series|Physician Decision|1|||
33222270|NCT00384059|100715747|FG000|After Infant Series|Lost to Follow-up|0|||
33222271|NCT00384059|100715748|FG001|After Infant Series|Lost to Follow-up|1|||
33222272|NCT00384059|100715747|FG000|Toddler Dose|Lost to Follow-up|1|||
33222273|NCT00384059|100715748|FG001|Toddler Dose|Lost to Follow-up|1|||
33222274|NCT00384059|100715747|FG000|Toddler Dose|Failed to return|0|||
33222275|NCT00384059|100715748|FG001|Toddler Dose|Failed to return|1|||
33222276|NCT02277743|100715750|FG000|Overall Study|Protocol Violation|1|||
33222277|NCT02277743|100715751|FG001|Overall Study|Protocol Violation|1|||
33222278|NCT02277743|100715752|FG002|Overall Study|Protocol Violation|1|||
33222279|NCT02277743|100715750|FG000|Overall Study|Adverse Event|10|||
33222280|NCT02277743|100715751|FG001|Overall Study|Adverse Event|6|||
33222281|NCT02277743|100715752|FG002|Overall Study|Adverse Event|6|||
33222282|NCT02277743|100715750|FG000|Overall Study|Lack of Efficacy|11|||
33222283|NCT02277743|100715751|FG001|Overall Study|Lack of Efficacy|4|||
33222284|NCT02277743|100715752|FG002|Overall Study|Lack of Efficacy|3|||
33222285|NCT02277743|100715750|FG000|Overall Study|Other than specified above|18|||
33222286|NCT02277743|100715751|FG001|Overall Study|Other than specified above|5|||
33222287|NCT02277743|100715752|FG002|Overall Study|Other than specified above|16|||
33222288|NCT00117156|100715762|FG000|Overall Study|Adverse Event|9|||
33222289|NCT00117156|100715762|FG000|Overall Study|Physician Decision|1|||
33222290|NCT00117156|100715762|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
33222291|NCT02755597|100715763|FG000|Overall Study|Withdrew consent|27|||
33222292|NCT02755597|100715764|FG001|Overall Study|Withdrew consent|11|||
33222293|NCT02755597|100715763|FG000|Overall Study|Lost to Follow-up|1|||
33222294|NCT02755597|100715764|FG001|Overall Study|Lost to Follow-up|0|||
33222295|NCT02755597|100715763|FG000|Overall Study|Death|78|||
33222296|NCT02755597|100715764|FG001|Overall Study|Death|36|||
33222297|NCT02755597|100715763|FG000|Overall Study|Study terminated by Sponsor|67|||
33222298|NCT02755597|100715764|FG001|Overall Study|Study terminated by Sponsor|47|||
33222299|NCT02755597|100715763|FG000|Overall Study|Other, not specified|20|||
33222300|NCT02755597|100715764|FG001|Overall Study|Other, not specified|3|||
33222301|NCT02755597|100715763|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
33222302|NCT02755597|100715764|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
33222303|NCT00638235|100715767|FG000|Overall Study|Lost to Follow-up|31|||
33222304|NCT00638235|100715768|FG001|Overall Study|Lost to Follow-up|3|||
33415889|NCT03353415|101413171|FG000|Masked CGM Wear|Lost to Follow-up|2|||
33415890|NCT03353415|101413171|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
33415891|NCT01360021|101413174|FG000|Overall Study|Eligibility criteria + other|2|||
33415892|NCT01360021|101413175|FG001|Overall Study|Eligibility criteria + other|1|||
33415893|NCT01360021|101413176|FG002|Overall Study|Eligibility criteria + other|1|||
33415894|NCT01360021|101413174|FG000|Overall Study|Protocol Violation|0|||
33415895|NCT01360021|101413175|FG001|Overall Study|Protocol Violation|0|||
33415896|NCT01360021|101413176|FG002|Overall Study|Protocol Violation|1|||
33415897|NCT01360021|101413174|FG000|Overall Study|Withdrawal by Subject|4|||
33415898|NCT01360021|101413175|FG001|Overall Study|Withdrawal by Subject|0|||
33415899|NCT01360021|101413176|FG002|Overall Study|Withdrawal by Subject|2|||
33415900|NCT01360021|101413174|FG000|Overall Study|Adverse Event|2|||
33564836|NCT01405196|101964758|FG000|Overall Study|Study Terminated by Sponsor|0|||
33564837|NCT01405196|101964759|FG001|Overall Study|Study Terminated by Sponsor|0|||
33564838|NCT01405196|101964760|FG002|Overall Study|Study Terminated by Sponsor|9|||
33564839|NCT01405196|101964761|FG003|Overall Study|Study Terminated by Sponsor|0|||
33564840|NCT01405196|101964758|FG000|Overall Study|Other|2|||
33564841|NCT01405196|101964759|FG001|Overall Study|Other|2|||
33564842|NCT01405196|101964760|FG002|Overall Study|Other|5|||
33564843|NCT01405196|101964761|FG003|Overall Study|Other|0|||
33564844|NCT01405196|101964758|FG000|Overall Study|Withdrawal by Subject|4|||
33564845|NCT01405196|101964759|FG001|Overall Study|Withdrawal by Subject|6|||
33564846|NCT01405196|101964760|FG002|Overall Study|Withdrawal by Subject|3|||
33415901|NCT01360021|101413175|FG001|Overall Study|Adverse Event|3|||
33415902|NCT01360021|101413176|FG002|Overall Study|Adverse Event|3|||
33222305|NCT00638235|100715769|FG002|Overall Study|Lost to Follow-up|18|||
33415903|NCT01260194|101413179|FG000|Overall Study|Withdrawal of Consent|1|||
33564847|NCT01405196|101964761|FG003|Overall Study|Withdrawal by Subject|6|||
33564848|NCT01405196|101964758|FG000|Overall Study|Adverse Event|2|||
33222306|NCT00638235|100715770|FG003|Overall Study|Lost to Follow-up|10|||
33222307|NCT00638235|100715771|FG004|Overall Study|Lost to Follow-up|13|||
33222308|NCT00638235|100715772|FG005|Overall Study|Lost to Follow-up|26|||
33222309|NCT00638235|100715773|FG006|Overall Study|Lost to Follow-up|0|||
33222310|NCT00638235|100715774|FG007|Overall Study|Lost to Follow-up|1|||
33222311|NCT00638235|100715775|FG008|Overall Study|Lost to Follow-up|18|||
33222312|NCT01520402|100715777|FG000|Overall Study|Withdrawal by Subject|2|||
33222313|NCT01520402|100715777|FG000|Overall Study|Physician Decision|3|||
33564849|NCT01405196|101964759|FG001|Overall Study|Adverse Event|2|||
33222314|NCT00612534|100715778|FG000|Overall Study|Adverse Event|0|||
33222315|NCT00612534|100715779|FG001|Overall Study|Adverse Event|4|||
33415904|NCT01023815|101413180|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
33415905|NCT01023815|101413181|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
33415906|NCT01023815|101413182|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
33415907|NCT01023815|101413183|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
33415908|NCT01023815|101413180|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
33415909|NCT01023815|101413181|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
33415910|NCT01023815|101413182|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
33415911|NCT01023815|101413183|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
33415912|NCT01023815|101413180|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
33415913|NCT01023815|101413181|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
33415914|NCT01023815|101413182|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
33415915|NCT01023815|101413183|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
33415916|NCT01023815|101413180|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
33415917|NCT01023815|101413181|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
33415918|NCT01023815|101413182|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
33415919|NCT01023815|101413183|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
33415920|NCT01023815|101413180|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
33415921|NCT01023815|101413181|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
33415922|NCT01023815|101413182|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
33415923|NCT01023815|101413183|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
33415924|NCT04798027|101413184|FG000|Overall Study|Protocol Violation|0|||
33564850|NCT01405196|101964760|FG002|Overall Study|Adverse Event|0|||
33564851|NCT01405196|101964761|FG003|Overall Study|Adverse Event|2|||
33564852|NCT01405196|101964758|FG000|Overall Study|Death|1|||
33564853|NCT01405196|101964759|FG001|Overall Study|Death|0|||
33564854|NCT01405196|101964760|FG002|Overall Study|Death|3|||
33564855|NCT01405196|101964761|FG003|Overall Study|Death|0|||
33564856|NCT01405196|101964758|FG000|Overall Study|Lost to Follow-up|2|||
33564857|NCT01405196|101964759|FG001|Overall Study|Lost to Follow-up|2|||
33564858|NCT01405196|101964760|FG002|Overall Study|Lost to Follow-up|3|||
33222316|NCT00612534|100715780|FG002|Overall Study|Adverse Event|2|||
33222317|NCT00612534|100715781|FG003|Overall Study|Adverse Event|1|||
33222318|NCT00612534|100715778|FG000|Overall Study|Lack of Efficacy|13|||
33222319|NCT00612534|100715779|FG001|Overall Study|Lack of Efficacy|12|||
33222320|NCT00612534|100715780|FG002|Overall Study|Lack of Efficacy|5|||
33222321|NCT00612534|100715781|FG003|Overall Study|Lack of Efficacy|16|||
33222322|NCT00612534|100715778|FG000|Overall Study|Other Reason|0|||
33222323|NCT00612534|100715779|FG001|Overall Study|Other Reason|1|||
33222324|NCT00612534|100715780|FG002|Overall Study|Other Reason|0|||
33222325|NCT00612534|100715781|FG003|Overall Study|Other Reason|0|||
33222326|NCT00943306|100715782|FG000|Overall Study|Physician Decision|1|||
33222327|NCT00943306|100715782|FG000|Overall Study|Death|1|||
33222328|NCT00943306|100715782|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
33222329|NCT01521884|100715783|FG000|Overall Study|Non Responders|10|||
33222330|NCT01521884|100715783|FG000|Overall Study|Adverse Event|5|||
33222331|NCT01521884|100715783|FG000|Overall Study|Pregnancy|1|||
33222332|NCT01521884|100715783|FG000|Overall Study|Withdrawal by Subject|1|||
33222333|NCT01521884|100715783|FG000|Overall Study|Physician Decision|2|||
33222334|NCT01521884|100715783|FG000|Overall Study|Protocol Violation|3|||
33564859|NCT01405196|101964761|FG003|Overall Study|Lost to Follow-up|1|||
33564860|NCT03440411|101964762|FG000|Overall Study|Adverse Event|0|||
33564861|NCT03440411|101964763|FG001|Overall Study|Adverse Event|0|||
33564862|NCT03440411|101964764|FG002|Overall Study|Adverse Event|1|||
33564863|NCT03440411|101964765|FG003|Overall Study|Adverse Event|0|||
33564864|NCT03440411|101964762|FG000|Overall Study|PD|2|||
33564865|NCT03440411|101964763|FG001|Overall Study|PD|1|||
33564866|NCT03440411|101964764|FG002|Overall Study|PD|1|||
33564867|NCT03440411|101964765|FG003|Overall Study|PD|1|||
33564868|NCT03440411|101964762|FG000|Overall Study|Withdrawal by Subject|1|||
33564869|NCT03440411|101964763|FG001|Overall Study|Withdrawal by Subject|0|||
33629146|NCT01844765|102191327|FG001|Overall Study|Disease progression|0|||
33222335|NCT01521884|100715783|FG000|Overall Study|Participant non-eligible|1|||
33564870|NCT03440411|101964764|FG002|Overall Study|Withdrawal by Subject|0|||
33222336|NCT01521884|100715783|FG000|Overall Study|Lost to Follow-up|4|||
33222337|NCT02323646|100715784|FG000|Treatment Course 1|Adverse Event|1|||
33222338|NCT02323646|100715785|FG001|Treatment Course 1|Adverse Event|0|||
33222339|NCT02323646|100715786|FG002|Treatment Course 1|Adverse Event|1|||
33222340|NCT02323646|100715784|FG000|Treatment Course 1|Heavy Bleeding|1|||
33222341|NCT02323646|100715785|FG001|Treatment Course 1|Heavy Bleeding|1|||
33222342|NCT02323646|100715786|FG002|Treatment Course 1|Heavy Bleeding|0|||
33564871|NCT03440411|101964765|FG003|Overall Study|Withdrawal by Subject|0|||
33564872|NCT03440411|101964762|FG000|Overall Study|Closed study by sponsor|0|||
33564873|NCT03440411|101964763|FG001|Overall Study|Closed study by sponsor|0|||
33564874|NCT03440411|101964764|FG002|Overall Study|Closed study by sponsor|0|||
33629147|NCT01844765|102191326|FG000|Overall Study|Administrative problems|3|||
33415925|NCT04798027|101413185|FG001|Overall Study|Protocol Violation|0|||
33415926|NCT04798027|101413186|FG002|Overall Study|Protocol Violation|0|||
33415927|NCT04798027|101413187|FG003|Overall Study|Protocol Violation|0|||
33415928|NCT04798027|101413188|FG004|Overall Study|Protocol Violation|1|||
33415929|NCT04798027|101413189|FG005|Overall Study|Protocol Violation|0|||
33415930|NCT04798027|101413190|FG006|Overall Study|Protocol Violation|0|||
33415931|NCT04798027|101413191|FG007|Overall Study|Protocol Violation|1|||
33415932|NCT04798027|101413192|FG008|Overall Study|Protocol Violation|0|||
33415933|NCT04798027|101413184|FG000|Overall Study|Withdrawal by Subject|1|||
33222343|NCT02323646|100715784|FG000|Treatment Course 1|Lost to Follow-up|1|||
33415934|NCT04798027|101413185|FG001|Overall Study|Withdrawal by Subject|0|||
33415935|NCT04798027|101413186|FG002|Overall Study|Withdrawal by Subject|1|||
33415936|NCT04798027|101413187|FG003|Overall Study|Withdrawal by Subject|1|||
33415937|NCT04798027|101413188|FG004|Overall Study|Withdrawal by Subject|1|||
33415938|NCT04798027|101413189|FG005|Overall Study|Withdrawal by Subject|1|||
33415939|NCT04798027|101413190|FG006|Overall Study|Withdrawal by Subject|3|||
33415940|NCT04798027|101413191|FG007|Overall Study|Withdrawal by Subject|2|||
33415941|NCT04798027|101413192|FG008|Overall Study|Withdrawal by Subject|2|||
33415942|NCT04798027|101413184|FG000|Overall Study|Lost to Follow-up|1|||
33415943|NCT04798027|101413185|FG001|Overall Study|Lost to Follow-up|3|||
33564875|NCT03440411|101964765|FG003|Overall Study|Closed study by sponsor|1|||
33564876|NCT01554904|101964766|FG000|Overall Study|Withdrawal by Subject|3|||
33564877|NCT01554904|101964766|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
33564878|NCT00835172|101964770|FG000|Washout|Protocol Violation|0|||
33564879|NCT00835172|101964771|FG001|Washout|Protocol Violation|1|||
33564880|NCT02496000|101964775|FG000|Overall Study|Withdrawal by Subject|1|||
33564881|NCT02496000|101964776|FG001|Overall Study|Withdrawal by Subject|2|||
33415944|NCT04798027|101413186|FG002|Overall Study|Lost to Follow-up|0|||
33415945|NCT04798027|101413187|FG003|Overall Study|Lost to Follow-up|0|||
33415946|NCT04798027|101413188|FG004|Overall Study|Lost to Follow-up|0|||
33415947|NCT04798027|101413189|FG005|Overall Study|Lost to Follow-up|1|||
33415948|NCT04798027|101413190|FG006|Overall Study|Lost to Follow-up|0|||
33415949|NCT04798027|101413191|FG007|Overall Study|Lost to Follow-up|0|||
33415950|NCT04798027|101413192|FG008|Overall Study|Lost to Follow-up|1|||
33415951|NCT04798027|101413184|FG000|Overall Study|Withdrawal by Sponsor|8|||
33415952|NCT04798027|101413185|FG001|Overall Study|Withdrawal by Sponsor|22|||
33415953|NCT04798027|101413186|FG002|Overall Study|Withdrawal by Sponsor|9|||
33415954|NCT04798027|101413187|FG003|Overall Study|Withdrawal by Sponsor|26|||
33415955|NCT04798027|101413188|FG004|Overall Study|Withdrawal by Sponsor|24|||
33415956|NCT04798027|101413189|FG005|Overall Study|Withdrawal by Sponsor|11|||
33415957|NCT04798027|101413190|FG006|Overall Study|Withdrawal by Sponsor|25|||
33415958|NCT04798027|101413191|FG007|Overall Study|Withdrawal by Sponsor|26|||
33415959|NCT04798027|101413192|FG008|Overall Study|Withdrawal by Sponsor|11|||
33415960|NCT03690206|101413193|FG000|Overall Study|Withdrawal by Subject|2|||
33415961|NCT03690206|101413194|FG001|Overall Study|Withdrawal by Subject|0|||
33415962|NCT03690206|101413195|FG002|Overall Study|Withdrawal by Subject|0|||
33415963|NCT03690206|101413193|FG000|Overall Study|ICF withdrawal|2|||
33415964|NCT03690206|101413194|FG001|Overall Study|ICF withdrawal|0|||
33415965|NCT03690206|101413195|FG002|Overall Study|ICF withdrawal|0|||
33415966|NCT01833897|101413196|FG000|Overall Study|Lack of Efficacy|1|||
33415967|NCT00463385|101413197|FG000|Overall Study|Other|4|||
33415968|NCT00463385|101413198|FG001|Overall Study|Other|3|||
33415969|NCT00463385|101413199|FG002|Overall Study|Other|6|||
33564882|NCT02496000|101964777|FG002|Overall Study|Withdrawal by Subject|0|||
33415970|NCT00463385|101413200|FG003|Overall Study|Other|4|||
33415971|NCT00463385|101413197|FG000|Overall Study|Adverse Event|5|||
33415972|NCT00463385|101413198|FG001|Overall Study|Adverse Event|8|||
33415973|NCT00463385|101413199|FG002|Overall Study|Adverse Event|4|||
33415974|NCT00463385|101413200|FG003|Overall Study|Adverse Event|2|||
33415975|NCT00463385|101413197|FG000|Overall Study|Lack of Efficacy|6|||
33415976|NCT00463385|101413198|FG001|Overall Study|Lack of Efficacy|6|||
33415977|NCT00463385|101413199|FG002|Overall Study|Lack of Efficacy|7|||
33415978|NCT00463385|101413200|FG003|Overall Study|Lack of Efficacy|9|||
33415979|NCT00463385|101413197|FG000|Overall Study|Withdrawal by Subject|3|||
33415980|NCT00463385|101413198|FG001|Overall Study|Withdrawal by Subject|3|||
33415981|NCT00463385|101413199|FG002|Overall Study|Withdrawal by Subject|3|||
33415982|NCT00463385|101413200|FG003|Overall Study|Withdrawal by Subject|4|||
33222344|NCT02323646|100715785|FG001|Treatment Course 1|Lost to Follow-up|0|||
33415983|NCT00463385|101413197|FG000|Overall Study|Lost to Follow-up|0|||
33415984|NCT00463385|101413198|FG001|Overall Study|Lost to Follow-up|0|||
33415985|NCT00463385|101413199|FG002|Overall Study|Lost to Follow-up|0|||
33564883|NCT02496000|101964775|FG000|Overall Study|Lost to Follow-up|1|||
33564884|NCT02496000|101964776|FG001|Overall Study|Lost to Follow-up|0|||
33564885|NCT02496000|101964777|FG002|Overall Study|Lost to Follow-up|1|||
33564886|NCT02496000|101964775|FG000|Overall Study|Protocol Violation|0|||
33564887|NCT02496000|101964776|FG001|Overall Study|Protocol Violation|0|||
33564888|NCT02496000|101964777|FG002|Overall Study|Protocol Violation|1|||
33564889|NCT02496000|101964775|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
33564890|NCT02496000|101964776|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
33564891|NCT02496000|101964777|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
33564892|NCT02496000|101964775|FG000|Overall Study|undetermined|0|||
33564893|NCT02496000|101964776|FG001|Overall Study|undetermined|1|||
33564894|NCT02496000|101964777|FG002|Overall Study|undetermined|0|||
33564895|NCT03332056|101964780|FG000|Overall Study|Incomplete questionnaires|8|||
33564896|NCT03332056|101964781|FG001|Overall Study|Incomplete questionnaires|9|||
33564897|NCT03332056|101964780|FG000|Overall Study|Passed stone prior to surgery date|1|||
33564898|NCT03332056|101964781|FG001|Overall Study|Passed stone prior to surgery date|0|||
33564899|NCT03332056|101964780|FG000|Overall Study|Did not require a ureteral stent|0|||
33564900|NCT03332056|101964781|FG001|Overall Study|Did not require a ureteral stent|1|||
33564901|NCT01344226|101964782|FG000|Overall Study|Protocol Violation|2|||
33564902|NCT01344226|101964782|FG000|Overall Study|Withdrawal by Subject|3|||
33564903|NCT01344226|101964782|FG000|Overall Study|Lack of Efficacy|3|||
33564904|NCT01506726|101964783|FG000|Overall Study|Adverse Event|1|||
33564905|NCT01506726|101964784|FG001|Overall Study|Adverse Event|2|||
33564906|NCT00642759|101964785|FG000|Overall Study|Protocol Violation|1|||
33564907|NCT00539500|101964786|FG000|Overall Study|Disease Progression|1|||
33564908|NCT00539500|101964786|FG000|Overall Study|Lost to Follow-up|2|||
33564909|NCT00443456|101964787|FG000|Overall Study|Adverse Event|16|||
33564910|NCT00443456|101964787|FG000|Overall Study|Move|1|||
33564911|NCT00443456|101964787|FG000|Overall Study|Withdrawal by Subject|1|||
33564912|NCT02971163|101964788|FG000|Overall Study|Lost to Follow-up|4|||
33564913|NCT02971163|101964789|FG001|Overall Study|Lost to Follow-up|2|||
33564914|NCT02706392|101964790|FG000|Overall Study|Death|1|||
33564915|NCT02706392|101964791|FG001|Overall Study|Death|0|||
33564916|NCT02706392|101964792|FG002|Overall Study|Death|2|||
33564917|NCT02706392|101964793|FG003|Overall Study|Death|2|||
33564918|NCT02706392|101964794|FG004|Overall Study|Death|5|||
33564919|NCT02706392|101964795|FG005|Overall Study|Death|2|||
33564920|NCT01649869|101964796|FG000|Overall Study|Family member illness|1|||
33564921|NCT01649869|101964797|FG001|Overall Study|Family member illness|0|||
33564922|NCT01649869|101964796|FG000|Overall Study|Required treatment outside protocol|1|||
33564923|NCT01649869|101964797|FG001|Overall Study|Required treatment outside protocol|0|||
33564924|NCT01649869|101964796|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
33564925|NCT01649869|101964797|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
33564926|NCT00553254|101964801|FG000|Overall Study|Death|3|||
33564927|NCT00553254|101964802|FG001|Overall Study|Death|6|||
33564928|NCT00553254|101964803|FG002|Overall Study|Death|25|||
33564929|NCT00553254|101964801|FG000|Overall Study|Lost to Follow-up|0|||
33564930|NCT00553254|101964802|FG001|Overall Study|Lost to Follow-up|0|||
33564931|NCT00553254|101964803|FG002|Overall Study|Lost to Follow-up|2|||
33564932|NCT00553254|101964801|FG000|Overall Study|Withdrawal by Subject|2|||
33222345|NCT02323646|100715786|FG002|Treatment Course 1|Lost to Follow-up|2|||
33415986|NCT00463385|101413200|FG003|Overall Study|Lost to Follow-up|1|||
33564933|NCT00553254|101964802|FG001|Overall Study|Withdrawal by Subject|0|||
33564934|NCT00553254|101964803|FG002|Overall Study|Withdrawal by Subject|2|||
33564935|NCT00553254|101964801|FG000|Overall Study|Study terminated by Sponsor|0|||
33564936|NCT00553254|101964802|FG001|Overall Study|Study terminated by Sponsor|0|||
33564937|NCT00553254|101964803|FG002|Overall Study|Study terminated by Sponsor|1|||
33564938|NCT00553254|101964801|FG000|Overall Study|Other|1|||
33564939|NCT00553254|101964802|FG001|Overall Study|Other|0|||
33415987|NCT00463385|101413197|FG000|Overall Study|Death|2|||
33629148|NCT01844765|102191327|FG001|Overall Study|Administrative problems|4|||
33415988|NCT00463385|101413198|FG001|Overall Study|Death|1|||
33564940|NCT00553254|101964803|FG002|Overall Study|Other|13|||
33415989|NCT00463385|101413199|FG002|Overall Study|Death|2|||
33415990|NCT00463385|101413200|FG003|Overall Study|Death|0|||
33415991|NCT00463385|101413197|FG000|Overall Study|Missing|2|||
33415992|NCT00463385|101413198|FG001|Overall Study|Missing|0|||
33415993|NCT00463385|101413199|FG002|Overall Study|Missing|0|||
33415994|NCT00463385|101413200|FG003|Overall Study|Missing|2|||
33415995|NCT00463385|101413197|FG000|Overall Study|1 participant received commercial drug|0|||
33415996|NCT00463385|101413198|FG001|Overall Study|1 participant received commercial drug|1|||
33415997|NCT00463385|101413199|FG002|Overall Study|1 participant received commercial drug|0|||
33415998|NCT00463385|101413200|FG003|Overall Study|1 participant received commercial drug|0|||
33415999|NCT00491322|101413201|FG000|Overall Study|Protocol Violation|1|||
33416000|NCT00491322|101413202|FG001|Overall Study|Protocol Violation|0|||
33416001|NCT00491322|101413201|FG000|Overall Study|Pregnancy|0|||
33416002|NCT00491322|101413202|FG001|Overall Study|Pregnancy|1|||
33416003|NCT02392559|101413203|FG000|Overall Study|Withdrawal by Subject|0|||
33564941|NCT04100018|101964808|FG000|Pre-Treatment Period|Not Reported|0|||
33564942|NCT04100018|101964809|FG001|Pre-Treatment Period|Not Reported|4|||
33564943|NCT04100018|101964808|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
33564944|NCT04100018|101964809|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
33564945|NCT04100018|101964808|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
33564946|NCT04100018|101964809|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
33564947|NCT04100018|101964808|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
33564948|NCT04100018|101964809|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
33564949|NCT04100018|101964808|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
33564950|NCT04100018|101964809|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
33564951|NCT04100018|101964808|FG000|Treatment Period|Ongoing Treatment as of clinical cut off date|58|||
33564952|NCT04100018|101964809|FG001|Treatment Period|Ongoing Treatment as of clinical cut off date|52|||
33564953|NCT04100018|101964808|FG000|Treatment Period|Other Reason|18|||
33564954|NCT04100018|101964809|FG001|Treatment Period|Other Reason|29|||
33564955|NCT04100018|101964808|FG000|Treatment Period|Completed treatment as per protocol|0|||
33564956|NCT04100018|101964809|FG001|Treatment Period|Completed treatment as per protocol|1|||
33564957|NCT04100018|101964808|FG000|Treatment Period|Maximum clinical benefit|3|||
33564958|NCT04100018|101964809|FG001|Treatment Period|Maximum clinical benefit|0|||
33564959|NCT04100018|101964808|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
33564960|NCT04100018|101964809|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
33564961|NCT04100018|101964808|FG000|Treatment Period|Study drug toxicity|67|||
33564962|NCT04100018|101964809|FG001|Treatment Period|Study drug toxicity|28|||
33564963|NCT04100018|101964808|FG000|Treatment Period|Disease Progression|269|||
33564964|NCT04100018|101964809|FG001|Treatment Period|Disease Progression|318|||
33564965|NCT04100018|101964808|FG000|Treatment Period|Administrative reasons by sponsor|1|||
33564966|NCT04100018|101964809|FG001|Treatment Period|Administrative reasons by sponsor|1|||
33564967|NCT04100018|101964808|FG000|Treatment Period|Poor/Non-Compliance|1|||
33564968|NCT04100018|101964809|FG001|Treatment Period|Poor/Non-Compliance|0|||
33564969|NCT04100018|101964808|FG000|Treatment Period|Lost to Follow-up|2|||
33416004|NCT02392559|101413204|FG001|Overall Study|Withdrawal by Subject|1|||
33416005|NCT00390572|101413205|FG000|Overall Study|Lost to Follow-up|8|||
33564970|NCT04100018|101964809|FG001|Treatment Period|Lost to Follow-up|2|||
33564971|NCT04100018|101964808|FG000|Treatment Period|Death|14|||
33564972|NCT04100018|101964809|FG001|Treatment Period|Death|11|||
33416006|NCT00390572|101413206|FG001|Overall Study|Lost to Follow-up|4|||
33416007|NCT00390572|101413205|FG000|Overall Study|health condition|0|||
33564973|NCT04100018|101964808|FG000|Treatment Period|Participant withdrew consent|8|||
33564974|NCT04100018|101964809|FG001|Treatment Period|Participant withdrew consent|10|||
33564975|NCT04100018|101964808|FG000|Treatment Period|Participant request to discontinue study treatment|32|||
33564976|NCT04100018|101964809|FG001|Treatment Period|Participant request to discontinue study treatment|31|||
33564977|NCT04100018|101964808|FG000|Treatment Period|Adverse Event|12|||
33564978|NCT04100018|101964809|FG001|Treatment Period|Adverse Event|6|||
33564979|NCT04100018|101964808|FG000|Treatment Period|Lack of Efficacy|4|||
33564980|NCT04100018|101964809|FG001|Treatment Period|Lack of Efficacy|2|||
33363021|NCT00685178|101217361|FG003|Overall Study|incarcerated|0|||
33363022|NCT00685178|101217358|FG000|Overall Study|administrative (disciplinary) discharge|0|||
33363023|NCT00685178|101217359|FG001|Overall Study|administrative (disciplinary) discharge|1|||
33629149|NCT01844765|102191326|FG000|Overall Study|Protocol deviation|2|||
33363024|NCT00685178|101217360|FG002|Overall Study|administrative (disciplinary) discharge|0|||
33629150|NCT01844765|102191327|FG001|Overall Study|Protocol deviation|0|||
33564981|NCT02592863|101964810|FG000|Overall Study|Withdrawal by Subject|2|||
33564982|NCT02592863|101964811|FG001|Overall Study|Withdrawal by Subject|2|||
33564983|NCT02592863|101964810|FG000|Overall Study|Lost to Follow-up|1|||
33564984|NCT02592863|101964811|FG001|Overall Study|Lost to Follow-up|1|||
33564985|NCT00939185|101964812|FG000|Overall Study|Adverse Event|3|||
33564986|NCT00939185|101964812|FG000|Overall Study|Lack of Efficacy|1|||
33564987|NCT00939185|101964812|FG000|Overall Study|Lost to Follow-up|6|||
33363025|NCT00685178|101217361|FG003|Overall Study|administrative (disciplinary) discharge|2|||
33363026|NCT00685178|101217358|FG000|Overall Study|Pregnancy|0|||
33363027|NCT00685178|101217359|FG001|Overall Study|Pregnancy|0|||
33363028|NCT00685178|101217360|FG002|Overall Study|Pregnancy|0|||
33363029|NCT00685178|101217361|FG003|Overall Study|Pregnancy|1|||
33363030|NCT04773041|101217362|FG000|Overall Study|Unable to data match|1|||
33363031|NCT04773041|101217363|FG001|Overall Study|Unable to data match|0|||
33363032|NCT04773041|101217364|FG002|Overall Study|Unable to data match|0|||
33363033|NCT01713036|101217367|FG000|Overall Study|Death|1|||
33363034|NCT03237845|101217380|FG000|Overall Study|Adverse Event|0|||
33363035|NCT03237845|101217381|FG001|Overall Study|Adverse Event|1|||
33363036|NCT03237845|101217380|FG000|Overall Study|Lost to Follow-up|13|||
33363037|NCT03237845|101217381|FG001|Overall Study|Lost to Follow-up|10|||
33363038|NCT03237845|101217380|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
33363039|NCT03237845|101217381|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
33363040|NCT03237845|101217380|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
33363041|NCT03237845|101217381|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
33363042|NCT03237845|101217380|FG000|Overall Study|Physician Decision|1|||
33363043|NCT03237845|101217381|FG001|Overall Study|Physician Decision|2|||
33363044|NCT03237845|101217380|FG000|Overall Study|Pregnancy|1|||
33564988|NCT00939185|101964812|FG000|Overall Study|Other|3|||
33564989|NCT00939185|101964812|FG000|Overall Study|Withdrawal by Subject|2|||
33564990|NCT00939185|101964812|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
33564991|NCT00835367|101964814|FG000|Washout|Adverse Event|2|||
33564992|NCT00835367|101964815|FG001|Washout|Adverse Event|0|||
33564993|NCT00835367|101964814|FG000|Washout|Withdrawal by Subject|1|||
33564994|NCT00835367|101964815|FG001|Washout|Withdrawal by Subject|0|||
33564995|NCT00835367|101964814|FG000|Second Intervention|Adverse Event|1|||
33564996|NCT00835367|101964815|FG001|Second Intervention|Adverse Event|1|||
33564997|NCT03131479|101964818|FG000|Overall Study|Adverse Event|0|||
33564998|NCT03131479|101964819|FG001|Overall Study|Adverse Event|0|||
33564999|NCT03131479|101964820|FG002|Overall Study|Adverse Event|1|||
33565000|NCT03131479|101964821|FG003|Overall Study|Adverse Event|1|||
33565001|NCT03131479|101964822|FG004|Overall Study|Adverse Event|0|||
33565002|NCT03131479|101964818|FG000|Overall Study|Subject/Guardian Decision|0|||
33565003|NCT03131479|101964819|FG001|Overall Study|Subject/Guardian Decision|0|||
33565004|NCT03131479|101964820|FG002|Overall Study|Subject/Guardian Decision|0|||
33565005|NCT03131479|101964821|FG003|Overall Study|Subject/Guardian Decision|1|||
33565006|NCT03131479|101964822|FG004|Overall Study|Subject/Guardian Decision|0|||
33565007|NCT03456076|101964828|FG000|Overall Study|Withdrawal by Subject|5|||
33565008|NCT03456076|101964829|FG001|Overall Study|Withdrawal by Subject|9|||
33565009|NCT03456076|101964828|FG000|Overall Study|Protocol deviation|0|||
33363045|NCT03237845|101217381|FG001|Overall Study|Pregnancy|0|||
33363046|NCT03237845|101217380|FG000|Overall Study|Protocol Deviation|0|||
33565010|NCT03456076|101964829|FG001|Overall Study|Protocol deviation|1|||
33565011|NCT03456076|101964828|FG000|Overall Study|Lost to Follow-up|0|||
33565012|NCT03456076|101964829|FG001|Overall Study|Lost to Follow-up|1|||
33363047|NCT03237845|101217381|FG001|Overall Study|Protocol Deviation|1|||
33363048|NCT03237845|101217380|FG000|Overall Study|Technical Problems|8|||
33363049|NCT03237845|101217381|FG001|Overall Study|Technical Problems|1|||
33363050|NCT03237845|101217380|FG000|Overall Study|Withdrawal by Subject|3|||
33363051|NCT03237845|101217381|FG001|Overall Study|Withdrawal by Subject|3|||
33565013|NCT03456076|101964828|FG000|Overall Study|Death|2|||
33565014|NCT03456076|101964829|FG001|Overall Study|Death|5|||
33565015|NCT03456076|101964828|FG000|Overall Study|Study ongoing|123|||
33565016|NCT03456076|101964829|FG001|Overall Study|Study ongoing|111|||
33629151|NCT01844765|102191326|FG000|Overall Study|Untreated|1|||
33222346|NCT02323646|100715784|FG000|Treatment Course 1|Withdrawal by Subject|0|||
33222347|NCT02323646|100715785|FG001|Treatment Course 1|Withdrawal by Subject|2|||
33222348|NCT02323646|100715786|FG002|Treatment Course 1|Withdrawal by Subject|0|||
33222349|NCT02323646|100715784|FG000|Treatment Course 2|Adverse Event|1|||
33222350|NCT02323646|100715785|FG001|Treatment Course 2|Adverse Event|0|||
33222351|NCT02323646|100715786|FG002|Treatment Course 2|Adverse Event|1|||
33222352|NCT02323646|100715784|FG000|Treatment Course 2|Lost to Follow-up|0|||
33222353|NCT02323646|100715785|FG001|Treatment Course 2|Lost to Follow-up|0|||
33222354|NCT02323646|100715786|FG002|Treatment Course 2|Lost to Follow-up|1|||
33222355|NCT02323646|100715784|FG000|Treatment Course 2|Non-compliance|0|||
33222356|NCT02323646|100715785|FG001|Treatment Course 2|Non-compliance|1|||
33222357|NCT02323646|100715786|FG002|Treatment Course 2|Non-compliance|1|||
33222358|NCT03021668|100715787|FG000|Overall Study|Physician Decision|0|||
33565017|NCT02022202|101964830|FG000|Overall Study|Withdrawal by Subject|2|||
33565018|NCT02022202|101964830|FG000|Overall Study|Disease Progression|3|||
33222359|NCT03021668|100715788|FG001|Overall Study|Physician Decision|1|||
33222360|NCT02736825|100715789|FG000|Overall Study|Lost to Follow-up|10|||
33565019|NCT02022202|101964830|FG000|Overall Study|Desire go to immediately to surgery|3|||
33565020|NCT05752487|101964837|FG000|Overall Study|Randomized, not treated|9|||
33565021|NCT05752487|101964837|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
33222361|NCT02736825|100715790|FG001|Overall Study|Lost to Follow-up|11|||
33222362|NCT02736825|100715789|FG000|Overall Study|Early Termination|0|||
33222363|NCT02736825|100715790|FG001|Overall Study|Early Termination|1|||
33565022|NCT05752487|101964837|FG000|Overall Study|Withdrawal by Subject|2|||
33565023|NCT05752487|101964837|FG000|Overall Study|Ongoing|137|||
33565024|NCT03384966|101964838|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
33565025|NCT03384966|101964839|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
33222364|NCT00215540|100715791|FG000|Overall Study|Withdrew from study medication|1|||
33222365|NCT00215540|100715792|FG001|Overall Study|Withdrew from study medication|0|||
33222366|NCT00215540|100715793|FG002|Overall Study|Withdrew from study medication|0|||
33222367|NCT03745222|100715795|FG000|Overall Study|Withdrawal by Subject|0|||
33222368|NCT03745222|100715796|FG001|Overall Study|Withdrawal by Subject|1|||
33222369|NCT03745222|100715797|FG002|Overall Study|Withdrawal by Subject|0|||
33222370|NCT00312702|100715798|FG000|Immunization Phase|Lost to Follow-up|0|||
33222371|NCT00312702|100715799|FG001|Immunization Phase|Lost to Follow-up|1|||
33222372|NCT00312702|100715800|FG002|Immunization Phase|Lost to Follow-up|0|||
33222373|NCT01518946|100715801|FG000|Open-label Phase|Other|4|||
33222374|NCT01518946|100715802|FG001|Open-label Phase|Other|0|||
33222375|NCT01518946|100715803|FG002|Open-label Phase|Other|0|||
33222376|NCT01518946|100715801|FG000|Randomized Phase (First Intervention)|Other|0|||
33222377|NCT01518946|100715802|FG001|Randomized Phase (First Intervention)|Other|1|||
33222378|NCT01518946|100715803|FG002|Randomized Phase (First Intervention)|Other|0|||
33222379|NCT02535364|100715804|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
33222380|NCT02535364|100715804|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
33222381|NCT02535364|100715804|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
33222382|NCT02535364|100715804|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
33222383|NCT02535364|100715804|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
33222384|NCT02535364|100715804|FG000|Part B Screening|Death|2|||
33222385|NCT02535364|100715804|FG000|Part B Screening|Physician Decision|1|||
33222386|NCT02535364|100715804|FG000|Part B Screening|Withdrawal by Subject|1|||
33222387|NCT02535364|100715804|FG000|Part B Screening|Adverse Event|1|||
33222388|NCT02535364|100715804|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
33222389|NCT02535364|100715804|FG000|Study Treatment|Death|1|||
33222390|NCT02535364|100715804|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
33222391|NCT02535364|100715804|FG000|12-Month Follow-up Period|Disease progression|22|||
33363052|NCT03237845|101217380|FG000|Overall Study|Other Reasons|4|||
33363053|NCT03237845|101217381|FG001|Overall Study|Other Reasons|0|||
33565026|NCT03384966|101964840|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
33565027|NCT03384966|101964838|FG000|Follow-up Period|Adverse Event|1|||
33565028|NCT03384966|101964839|FG001|Follow-up Period|Adverse Event|0|||
33565029|NCT03384966|101964840|FG002|Follow-up Period|Adverse Event|0|||
33565030|NCT00321932|101964841|FG000|Overall Study|Death|3|||
33565031|NCT00321932|101964842|FG001|Overall Study|Death|6|||
33565032|NCT00321932|101964841|FG000|Overall Study|Withdrawal by Subject|3|||
33222392|NCT02535364|100715804|FG000|12-Month Follow-up Period|Death|5|||
33222393|NCT02535364|100715804|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
33222394|NCT02535364|100715804|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
33222395|NCT02535364|100715804|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
33222396|NCT01337986|100715807|FG000|Overall Study|Adverse Event|2|||
33222397|NCT01337986|100715808|FG001|Overall Study|Adverse Event|2|||
33222398|NCT01337986|100715807|FG000|Overall Study|Lost to Follow-up|1|||
33222399|NCT01337986|100715808|FG001|Overall Study|Lost to Follow-up|0|||
33222400|NCT01337986|100715807|FG000|Overall Study|Protocol Violation|0|||
33222401|NCT01337986|100715808|FG001|Overall Study|Protocol Violation|3|||
33222402|NCT02613221|100715809|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
33222403|NCT02613221|100715809|FG000|Overall Study|Adverse Event|2|||
33222404|NCT02613221|100715809|FG000|Overall Study|Voluntary Discontinuation|1|||
33222405|NCT02613221|100715809|FG000|Overall Study|Delayed Treatment|1|||
33222406|NCT02613221|100715809|FG000|Overall Study|Enrolled but Not Treated|1|||
33222407|NCT03633929|100715810|FG000|Overall Study|Lost to Follow-up|1|||
33222408|NCT03633929|100715810|FG000|Overall Study|Did not login to software. Did not participate|3|||
33222409|NCT00708435|100715811|FG000|Overall Study|Death / Serious Adverse Event|10|||
33222410|NCT00708435|100715812|FG001|Overall Study|Death / Serious Adverse Event|5|||
33222411|NCT00708435|100715811|FG000|Overall Study|Lost to Follow-up|9|||
33222412|NCT00708435|100715812|FG001|Overall Study|Lost to Follow-up|4|||
33222413|NCT00708435|100715811|FG000|Overall Study|Withdrawal by Subject|3|||
33222414|NCT00708435|100715812|FG001|Overall Study|Withdrawal by Subject|7|||
33565033|NCT00321932|101964842|FG001|Overall Study|Withdrawal by Subject|6|||
33565034|NCT00321932|101964841|FG000|Overall Study|Early relapse|2|||
33565035|NCT00321932|101964842|FG001|Overall Study|Early relapse|8|||
33565036|NCT00321932|101964841|FG000|Overall Study|Missing data|2|||
33565037|NCT00321932|101964842|FG001|Overall Study|Missing data|1|||
33565038|NCT02697448|101964845|FG000|Overall Study|Protocol Violation|2|||
33565039|NCT02697448|101964846|FG001|Overall Study|Protocol Violation|4|||
33565040|NCT02697448|101964845|FG000|Overall Study|Clinical concerns during ablation|1|||
33565041|NCT02697448|101964846|FG001|Overall Study|Clinical concerns during ablation|1|||
33565042|NCT02697448|101964845|FG000|Overall Study|No data collected|2|||
33565043|NCT02697448|101964846|FG001|Overall Study|No data collected|0|||
33565044|NCT01422382|101964847|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
33565045|NCT00071032|101964848|FG000|Overall Study|Lost to Follow-up|1|||
33565046|NCT00071032|101964849|FG001|Overall Study|Lost to Follow-up|1|||
33565047|NCT00071032|101964848|FG000|Overall Study|Withdrawal by Subject|8|||
33565048|NCT00071032|101964849|FG001|Overall Study|Withdrawal by Subject|6|||
33565049|NCT00071032|101964848|FG000|Overall Study|Missing Primary Outcome|0|||
33565050|NCT00071032|101964849|FG001|Overall Study|Missing Primary Outcome|1|||
33565051|NCT05878067|101967381|FG000|Overall Study|Lost to Follow-up|2|||
33565052|NCT03636022|101967382|FG000|Overall Study|Withdrawal by Subject|1|||
33565053|NCT03636022|101967383|FG001|Overall Study|Withdrawal by Subject|3|||
33565054|NCT01661595|101967386|FG000|Phase 1: Week 0-4|Adverse Event|1|||
33565055|NCT01661595|101967387|FG001|Phase 1: Week 0-4|Adverse Event|0|||
33565056|NCT01661595|101967388|FG002|Phase 1: Week 0-4|Adverse Event|0|||
33565057|NCT01661595|101967389|FG003|Phase 1: Week 0-4|Adverse Event|0|||
33565058|NCT01661595|101967386|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
33565059|NCT01661595|101967387|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
33565060|NCT01661595|101967388|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
33565061|NCT01661595|101967389|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
33565062|NCT01651208|101967390|FG000|Overall Study|Lost to Follow-up|14|||
33565063|NCT01651208|101967391|FG001|Overall Study|Lost to Follow-up|16|||
33565064|NCT01437189|101967395|FG000|Overall Study|Adverse Event|3|||
33565065|NCT01437189|101967395|FG000|Overall Study|Lack of Efficacy|4|||
33565066|NCT01437189|101967395|FG000|Overall Study|Withdrawal by Subject|8|||
33565067|NCT02489279|101967396|FG000|Overall Study|Lost to Follow-up|12|||
33565068|NCT02489279|101967397|FG001|Overall Study|Lost to Follow-up|10|||
33565069|NCT01702298|101967398|FG000|Overall Study|Withdrawal by Subject|1|||
33565070|NCT03770286|101967407|FG000|Overall Study|Lost to Follow-up|6|||
33565071|NCT03770286|101967408|FG001|Overall Study|Lost to Follow-up|4|||
33565072|NCT03770286|101967409|FG002|Overall Study|Lost to Follow-up|3|||
33565073|NCT03770286|101967407|FG000|Overall Study|Protocol Violation|1|||
33222415|NCT00708435|100715811|FG000|Overall Study|Adverse Event|1|||
33565074|NCT03770286|101967408|FG001|Overall Study|Protocol Violation|0|||
33565075|NCT03770286|101967409|FG002|Overall Study|Protocol Violation|2|||
33565076|NCT02921256|101967410|FG000|Arm 1a v. Arm II|Adverse Event|6|||
33565077|NCT02921256|101967411|FG001|Arm 1a v. Arm II|Adverse Event|15|||
33565078|NCT02921256|101967412|FG002|Arm 1a v. Arm II|Adverse Event|0|||
33565079|NCT02921256|101967410|FG000|Arm 1a v. Arm II|Death|0|||
33565080|NCT02921256|101967411|FG001|Arm 1a v. Arm II|Death|2|||
33565081|NCT02921256|101967412|FG002|Arm 1a v. Arm II|Death|0|||
33565082|NCT02921256|101967410|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
33565083|NCT02921256|101967411|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
33565084|NCT02921256|101967412|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
33222416|NCT00708435|100715812|FG001|Overall Study|Adverse Event|0|||
33222417|NCT00708435|100715811|FG000|Overall Study|Protocol Violation|0|||
33222418|NCT00708435|100715812|FG001|Overall Study|Protocol Violation|1|||
33222419|NCT00708435|100715811|FG000|Overall Study|Intervention by primary care physician|1|||
33222420|NCT00708435|100715812|FG001|Overall Study|Intervention by primary care physician|0|||
33565085|NCT02921256|101967410|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
33565086|NCT02921256|101967411|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
33565087|NCT02921256|101967412|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
33565088|NCT02921256|101967410|FG000|Arm 1a v. Arm II|Physician Decision|1|||
33565089|NCT02921256|101967411|FG001|Arm 1a v. Arm II|Physician Decision|1|||
33565090|NCT02921256|101967412|FG002|Arm 1a v. Arm II|Physician Decision|0|||
33565091|NCT02921256|101967410|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
33565092|NCT02921256|101967411|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
33565093|NCT02921256|101967412|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
33565094|NCT02921256|101967410|FG000|Arm Ib v Arm III|Adverse Event|9|||
33565095|NCT02921256|101967411|FG001|Arm Ib v Arm III|Adverse Event|0|||
33565096|NCT02921256|101967412|FG002|Arm Ib v Arm III|Adverse Event|4|||
33565097|NCT02921256|101967410|FG000|Arm Ib v Arm III|Death|1|||
33565098|NCT02921256|101967411|FG001|Arm Ib v Arm III|Death|0|||
33565099|NCT02921256|101967412|FG002|Arm Ib v Arm III|Death|1|||
33565100|NCT02921256|101967410|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
33565101|NCT02921256|101967411|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
33565102|NCT02921256|101967412|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
33565103|NCT02921256|101967410|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
33222421|NCT00708435|100715811|FG000|Overall Study|Refused hospitalization|1|||
33222422|NCT00708435|100715812|FG001|Overall Study|Refused hospitalization|0|||
33222423|NCT01755702|100715815|FG000|Wash Out Period I|Other Reason|3|||
33565104|NCT02921256|101967411|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
33565105|NCT02921256|101967412|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
33565106|NCT02921256|101967410|FG000|Arm Ib v Arm III|Physician Decision|4|||
33565107|NCT02921256|101967411|FG001|Arm Ib v Arm III|Physician Decision|0|||
33565108|NCT02921256|101967412|FG002|Arm Ib v Arm III|Physician Decision|1|||
33565109|NCT02921256|101967410|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
33222424|NCT01755702|100715815|FG000|Washout Period II|Other Reason|5|||
33222425|NCT04128293|100715819|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
33222426|NCT04128293|100715820|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
33222427|NCT04128293|100715821|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
33222428|NCT04128293|100715822|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
33222429|NCT00524030|100715827|FG000|Overall Study|Lack of Efficacy|10|||
33222430|NCT00524030|100715828|FG001|Overall Study|Lack of Efficacy|24|||
33222431|NCT00524030|100715827|FG000|Overall Study|Lost to Follow-up|0|||
33222432|NCT00524030|100715828|FG001|Overall Study|Lost to Follow-up|2|||
33222433|NCT00524030|100715827|FG000|Overall Study|Withdrawal by Subject|3|||
33222434|NCT00524030|100715828|FG001|Overall Study|Withdrawal by Subject|8|||
33222435|NCT00524030|100715827|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
33222436|NCT00524030|100715828|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
33222437|NCT00524030|100715827|FG000|Overall Study|Protocol Violation|0|||
33222438|NCT00524030|100715828|FG001|Overall Study|Protocol Violation|1|||
33222439|NCT00524030|100715827|FG000|Overall Study|Pregnancy|1|||
33222440|NCT00524030|100715828|FG001|Overall Study|Pregnancy|0|||
33222441|NCT00524030|100715827|FG000|Overall Study|Adverse Event|3|||
33222442|NCT00524030|100715828|FG001|Overall Study|Adverse Event|21|||
33222443|NCT00524030|100715827|FG000|Overall Study|Death|0|||
33222444|NCT00524030|100715828|FG001|Overall Study|Death|1|||
33222445|NCT01712009|100715833|FG000|Overall Study|Withdrawal by Subject|24|||
33222446|NCT01712009|100715834|FG001|Overall Study|Withdrawal by Subject|15|||
33222447|NCT01712009|100715835|FG002|Overall Study|Withdrawal by Subject|8|||
33222448|NCT01712009|100715833|FG000|Overall Study|Lost to Follow-up|2|||
33222449|NCT01712009|100715834|FG001|Overall Study|Lost to Follow-up|0|||
33222450|NCT01712009|100715835|FG002|Overall Study|Lost to Follow-up|1|||
33222451|NCT01712009|100715833|FG000|Overall Study|Decision by Sponsor|12|||
33222452|NCT01712009|100715834|FG001|Overall Study|Decision by Sponsor|14|||
33222453|NCT01712009|100715835|FG002|Overall Study|Decision by Sponsor|12|||
33222454|NCT02991482|100715836|FG000|Overall Study|Disease progression|56|||
33222455|NCT02991482|100715837|FG001|Overall Study|Disease progression|47|||
33222456|NCT02991482|100715836|FG000|Overall Study|Death|4|||
33222457|NCT02991482|100715837|FG001|Overall Study|Death|4|||
33222458|NCT02991482|100715836|FG000|Overall Study|Adverse Event|1|||
33222459|NCT02991482|100715837|FG001|Overall Study|Adverse Event|6|||
33222460|NCT02991482|100715836|FG000|Overall Study|Patient decision|1|||
33565110|NCT02921256|101967411|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
33565111|NCT02921256|101967412|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
33565112|NCT03078868|101967413|FG000|Overall Study|Physician Decision|3|||
33565113|NCT00835549|101967414|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
33565114|NCT00835549|101967415|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
33222461|NCT02991482|100715837|FG001|Overall Study|Patient decision|1|||
33222462|NCT02991482|100715836|FG000|Overall Study|Physician Decision|0|||
33565115|NCT03559530|101967420|FG000|Overall Study|non-location of medical records|44|||
33222463|NCT02991482|100715837|FG001|Overall Study|Physician Decision|6|||
33222464|NCT02991482|100715836|FG000|Overall Study|Clinical deterioration|1|||
33222465|NCT02991482|100715837|FG001|Overall Study|Clinical deterioration|0|||
33363054|NCT01184989|101217382|FG000|Overall Study|Adverse Event|11|||
33222466|NCT02991482|100715836|FG000|Overall Study|Patient feeling too unwell|1|||
33222467|NCT02991482|100715837|FG001|Overall Study|Patient feeling too unwell|0|||
33222468|NCT02991482|100715836|FG000|Overall Study|Worsening of performance status|0|||
33565116|NCT03559530|101967421|FG001|Overall Study|non-location of medical records|0|||
33565117|NCT03559530|101967420|FG000|Overall Study|culture results not considered for treat|29|||
33629152|NCT01844765|102191327|FG001|Overall Study|Untreated|0|||
33222469|NCT02991482|100715837|FG001|Overall Study|Worsening of performance status|1|||
33363055|NCT01184989|101217382|FG000|Overall Study|Withdrawal by Subject|1|||
33565118|NCT03559530|101967421|FG001|Overall Study|culture results not considered for treat|0|||
33565119|NCT03559530|101967420|FG000|Overall Study|duplicate cases|8|||
33565120|NCT03559530|101967421|FG001|Overall Study|duplicate cases|0|||
33565121|NCT03559530|101967420|FG000|Overall Study|other species of Acinetobacte|7|||
33565122|NCT03559530|101967421|FG001|Overall Study|other species of Acinetobacte|0|||
33565123|NCT03559530|101967420|FG000|Overall Study|contamination / colonization|3|||
33565124|NCT03559530|101967421|FG001|Overall Study|contamination / colonization|0|||
33565125|NCT03880019|101967424|FG000|Overall Study|Competing disease|1|||
33565126|NCT00323622|101967425|FG000|Overall Study|Other|30|||
33565127|NCT00323622|101967426|FG001|Overall Study|Other|91|||
33565128|NCT00323622|101967427|FG002|Overall Study|Other|4|||
33565129|NCT00323622|101967428|FG003|Overall Study|Other|12|||
33565130|NCT00323622|101967429|FG004|Overall Study|Other|32|||
33565131|NCT00323622|101967430|FG005|Overall Study|Other|74|||
33565132|NCT00323622|101967431|FG006|Overall Study|Other|5|||
33565133|NCT00323622|101967432|FG007|Overall Study|Other|13|||
33565134|NCT00323622|101967425|FG000|Overall Study|Death|1|||
33565135|NCT00323622|101967426|FG001|Overall Study|Death|1|||
33565136|NCT00323622|101967427|FG002|Overall Study|Death|0|||
33565137|NCT00323622|101967428|FG003|Overall Study|Death|0|||
33565138|NCT00323622|101967429|FG004|Overall Study|Death|7|||
33565139|NCT00323622|101967430|FG005|Overall Study|Death|0|||
33565140|NCT00323622|101967431|FG006|Overall Study|Death|0|||
33565141|NCT00323622|101967432|FG007|Overall Study|Death|2|||
33565142|NCT02657343|101967434|FG000|Overall Study|Death|0|||
33565143|NCT02657343|101967435|FG001|Overall Study|Death|2|||
33565144|NCT02657343|101967436|FG002|Overall Study|Death|0|||
33565145|NCT02657343|101967437|FG003|Overall Study|Death|0|||
33565146|NCT02657343|101967438|FG004|Overall Study|Death|0|||
33565147|NCT02657343|101967439|FG005|Overall Study|Death|0|||
33565148|NCT02657343|101967434|FG000|Overall Study|Patient went to hospice|1|||
33565149|NCT02657343|101967435|FG001|Overall Study|Patient went to hospice|0|||
33565150|NCT02657343|101967436|FG002|Overall Study|Patient went to hospice|0|||
33565151|NCT02657343|101967437|FG003|Overall Study|Patient went to hospice|0|||
33565152|NCT02657343|101967438|FG004|Overall Study|Patient went to hospice|0|||
33565153|NCT02657343|101967439|FG005|Overall Study|Patient went to hospice|0|||
33565154|NCT02657343|101967434|FG000|Overall Study|Withdrawal by Subject|0|||
33565155|NCT02657343|101967435|FG001|Overall Study|Withdrawal by Subject|0|||
33565156|NCT02657343|101967436|FG002|Overall Study|Withdrawal by Subject|0|||
33565157|NCT02657343|101967437|FG003|Overall Study|Withdrawal by Subject|0|||
33565158|NCT02657343|101967438|FG004|Overall Study|Withdrawal by Subject|1|||
33565159|NCT02657343|101967439|FG005|Overall Study|Withdrawal by Subject|0|||
33565160|NCT03729609|101967440|FG000|Overall Study|Protocol Violation|1|||
33565161|NCT04724837|101967441|FG000|Overall Study|Other|4|||
33565162|NCT04724837|101967442|FG001|Overall Study|Other|16|||
33565163|NCT04724837|101967443|FG002|Overall Study|Other|0|||
33565164|NCT04724837|101967441|FG000|Overall Study|Withdrawal by Subject|2|||
33565165|NCT04724837|101967442|FG001|Overall Study|Withdrawal by Subject|9|||
33565166|NCT04724837|101967443|FG002|Overall Study|Withdrawal by Subject|9|||
33565167|NCT04724837|101967441|FG000|Overall Study|Adverse Event|2|||
33565168|NCT04724837|101967442|FG001|Overall Study|Adverse Event|7|||
33565169|NCT04724837|101967443|FG002|Overall Study|Adverse Event|4|||
33565170|NCT04724837|101967441|FG000|Overall Study|Lost to Follow-up|0|||
33565171|NCT04724837|101967442|FG001|Overall Study|Lost to Follow-up|1|||
33565172|NCT04724837|101967443|FG002|Overall Study|Lost to Follow-up|3|||
33565173|NCT04724837|101967441|FG000|Overall Study|Physician Decision|1|||
33565174|NCT04724837|101967442|FG001|Overall Study|Physician Decision|2|||
33565175|NCT04724837|101967443|FG002|Overall Study|Physician Decision|0|||
33565176|NCT04724837|101967441|FG000|Overall Study|Death|0|||
33565177|NCT04724837|101967442|FG001|Overall Study|Death|0|||
33565178|NCT04724837|101967443|FG002|Overall Study|Death|1|||
33565179|NCT04724837|101967441|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
33565180|NCT04724837|101967442|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
33565181|NCT04724837|101967443|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
33565182|NCT04724837|101967441|FG000|Overall Study|Study Terminated by Sponsor|0|||
33565183|NCT04724837|101967442|FG001|Overall Study|Study Terminated by Sponsor|1|||
33565184|NCT04724837|101967443|FG002|Overall Study|Study Terminated by Sponsor|0|||
33565185|NCT00668642|101967444|FG000|First Off-cycle|Cancer progression|1|||
33565186|NCT00668642|101967445|FG001|First Off-cycle|Cancer progression|0|||
33565187|NCT00668642|101967444|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
33565188|NCT00668642|101967445|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
33565189|NCT03896581|101967446|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
33565190|NCT03896581|101967447|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
33565191|NCT03896581|101967446|FG000|Overall Study|Withdrawal by Subject|4|||
33565192|NCT03896581|101967447|FG001|Overall Study|Withdrawal by Subject|1|||
33565193|NCT03896581|101967446|FG000|Overall Study|Lost to Follow-up|1|||
33565194|NCT03896581|101967447|FG001|Overall Study|Lost to Follow-up|0|||
33565195|NCT03896581|101967446|FG000|Overall Study|Lack of Efficacy|2|||
33565196|NCT03896581|101967447|FG001|Overall Study|Lack of Efficacy|1|||
33222470|NCT02991482|100715836|FG000|Overall Study|Death prior to study drug initiation|1|||
33222471|NCT02991482|100715837|FG001|Overall Study|Death prior to study drug initiation|0|||
33222472|NCT02991482|100715836|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
33222473|NCT02991482|100715837|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
33222474|NCT01787097|100715838|FG000|Overall Study|Withdrawal by Subject|1|||
33222475|NCT01787097|100715839|FG001|Overall Study|Withdrawal by Subject|0|||
33222476|NCT01787097|100715840|FG002|Overall Study|Withdrawal by Subject|0|||
33222477|NCT01787097|100715841|FG003|Overall Study|Withdrawal by Subject|0|||
33222478|NCT03122119|100715842|FG000|Overall Study|Did not meet eligibility critria|1|||
33222479|NCT00998400|100715843|FG000|Overall Study|Lack of interest/motivation|1|||
33222480|NCT00998400|100715844|FG001|Overall Study|Lack of interest/motivation|2|||
33222481|NCT00998400|100715843|FG000|Overall Study|Logistical problems|1|||
33222482|NCT00998400|100715844|FG001|Overall Study|Logistical problems|0|||
33222483|NCT00695786|100715847|FG000|Overall Study|Adverse Event|0|||
33222484|NCT00695786|100715848|FG001|Overall Study|Adverse Event|3|||
33222485|NCT00695786|100715849|FG002|Overall Study|Adverse Event|4|||
33222486|NCT00695786|100715850|FG003|Overall Study|Adverse Event|2|||
33222487|NCT00695786|100715847|FG000|Overall Study|Lost to Follow-up|0|||
33222488|NCT00695786|100715848|FG001|Overall Study|Lost to Follow-up|5|||
33565197|NCT03896581|101967446|FG000|Overall Study|Adverse event, non-fatal|0|||
33565198|NCT03896581|101967447|FG001|Overall Study|Adverse event, non-fatal|2|||
33565199|NCT01542788|101967448|FG000|Overall Study|Randomized but Not Treated|2|||
33565200|NCT01542788|101967449|FG001|Overall Study|Randomized but Not Treated|0|||
33565201|NCT01542788|101967448|FG000|Overall Study|Lack of Efficacy|41|||
33565202|NCT01542788|101967449|FG001|Overall Study|Lack of Efficacy|71|||
33565203|NCT01542788|101967448|FG000|Overall Study|Lost to Follow-up|5|||
33565204|NCT01542788|101967449|FG001|Overall Study|Lost to Follow-up|0|||
33565205|NCT01542788|101967448|FG000|Overall Study|Death|3|||
33565206|NCT01542788|101967449|FG001|Overall Study|Death|0|||
33565207|NCT01542788|101967448|FG000|Overall Study|Protocol Violation|2|||
33565208|NCT01542788|101967449|FG001|Overall Study|Protocol Violation|0|||
33565209|NCT01542788|101967448|FG000|Overall Study|Physician Decision|1|||
33565210|NCT01542788|101967449|FG001|Overall Study|Physician Decision|0|||
33565211|NCT01542788|101967448|FG000|Overall Study|Withdrawal by Subject|1|||
33565212|NCT01542788|101967449|FG001|Overall Study|Withdrawal by Subject|0|||
33565213|NCT03524157|101967450|FG000|Overall Study|cytology not readable|0|||
33565214|NCT03524157|101967451|FG001|Overall Study|cytology not readable|0|||
33565215|NCT03524157|101967452|FG002|Overall Study|cytology not readable|1|||
33565216|NCT00329420|101967453|FG000|Re-induction Phase|Lack of Efficacy|0|||
33565217|NCT00329420|101967454|FG001|Re-induction Phase|Lack of Efficacy|1|||
33222489|NCT00695786|100715849|FG002|Overall Study|Lost to Follow-up|1|||
33222490|NCT00695786|100715850|FG003|Overall Study|Lost to Follow-up|1|||
33222491|NCT00695786|100715847|FG000|Overall Study|Withdrawal by Subject|0|||
33222492|NCT00695786|100715848|FG001|Overall Study|Withdrawal by Subject|4|||
33565218|NCT00329420|101967455|FG002|Re-induction Phase|Lack of Efficacy|0|||
33565219|NCT00329420|101967453|FG000|Re-induction Phase|Withdrawal of Consent|0|||
33565220|NCT00329420|101967454|FG001|Re-induction Phase|Withdrawal of Consent|0|||
33565221|NCT00329420|101967455|FG002|Re-induction Phase|Withdrawal of Consent|1|||
33565222|NCT00329420|101967453|FG000|Re-induction Phase|Did not respond to re-induction|6|||
33565223|NCT00329420|101967454|FG001|Re-induction Phase|Did not respond to re-induction|5|||
33565224|NCT00329420|101967455|FG002|Re-induction Phase|Did not respond to re-induction|7|||
33565225|NCT00329420|101967453|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
33565226|NCT00329420|101967454|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
33565227|NCT00329420|101967455|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
33565228|NCT00329420|101967453|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
33565229|NCT00329420|101967454|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
33565230|NCT00329420|101967455|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
33565231|NCT00329420|101967453|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
33565232|NCT00329420|101967454|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
33565233|NCT00329420|101967455|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
33222493|NCT00695786|100715849|FG002|Overall Study|Withdrawal by Subject|3|||
33565234|NCT03685149|101967457|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
33565235|NCT03685149|101967458|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
33222494|NCT00695786|100715850|FG003|Overall Study|Withdrawal by Subject|1|||
33222495|NCT00695786|100715847|FG000|Overall Study|Deemed Ineligible|1|||
33222496|NCT00695786|100715848|FG001|Overall Study|Deemed Ineligible|0|||
33222497|NCT00695786|100715849|FG002|Overall Study|Deemed Ineligible|0|||
33565236|NCT03685149|101967457|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
33565237|NCT03685149|101967458|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
33222498|NCT00695786|100715850|FG003|Overall Study|Deemed Ineligible|0|||
33565238|NCT03685149|101967457|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
33565239|NCT03685149|101967458|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
33565240|NCT01313676|101967459|FG000|Overall Study|Adverse Event|395|||
33565241|NCT01313676|101967460|FG001|Overall Study|Adverse Event|365|||
33565242|NCT01313676|101967461|FG002|Overall Study|Adverse Event|372|||
33565243|NCT01313676|101967462|FG003|Overall Study|Adverse Event|333|||
33565244|NCT01313676|101967459|FG000|Overall Study|Lack of Efficacy|98|||
33565245|NCT01313676|101967460|FG001|Overall Study|Lack of Efficacy|90|||
33565246|NCT01313676|101967461|FG002|Overall Study|Lack of Efficacy|65|||
33565247|NCT01313676|101967462|FG003|Overall Study|Lack of Efficacy|46|||
33222499|NCT00695786|100715847|FG000|Overall Study|Lack of Efficacy|0|||
33222500|NCT00695786|100715848|FG001|Overall Study|Lack of Efficacy|0|||
33222501|NCT00695786|100715849|FG002|Overall Study|Lack of Efficacy|0|||
33222502|NCT00695786|100715850|FG003|Overall Study|Lack of Efficacy|4|||
33222503|NCT02178059|100715851|FG000|Washout|Physician Decision|1|||
33222504|NCT02178059|100715852|FG001|Washout|Physician Decision|0|||
33222505|NCT03391765|100715857|FG000|Overall Study|Adverse Event|2|||
33222506|NCT03391765|100715858|FG001|Overall Study|Adverse Event|0|||
33222507|NCT03391765|100715859|FG002|Overall Study|Adverse Event|0|||
33222508|NCT03391765|100715860|FG003|Overall Study|Adverse Event|2|||
33222509|NCT03391765|100715857|FG000|Overall Study|Withdrew consent|5|||
33222510|NCT03391765|100715858|FG001|Overall Study|Withdrew consent|7|||
33222511|NCT03391765|100715859|FG002|Overall Study|Withdrew consent|2|||
33222512|NCT03391765|100715860|FG003|Overall Study|Withdrew consent|5|||
33222513|NCT03391765|100715857|FG000|Overall Study|Other, not specified|44|||
33222514|NCT03391765|100715858|FG001|Overall Study|Other, not specified|38|||
33222515|NCT03391765|100715859|FG002|Overall Study|Other, not specified|21|||
33222516|NCT03391765|100715860|FG003|Overall Study|Other, not specified|16|||
33222517|NCT02240108|100715861|FG000|Overall Study|Other than specified|8|||
33222518|NCT02240108|100715862|FG001|Overall Study|Other than specified|6|||
33222519|NCT02240108|100715861|FG000|Overall Study|Adverse Event|1|||
33222520|NCT02240108|100715862|FG001|Overall Study|Adverse Event|9|||
33222521|NCT02240108|100715861|FG000|Overall Study|Pregnancy|1|||
33222522|NCT02240108|100715862|FG001|Overall Study|Pregnancy|0|||
33222523|NCT02240108|100715861|FG000|Overall Study|Withdrawal by Subject|4|||
33222524|NCT02240108|100715862|FG001|Overall Study|Withdrawal by Subject|9|||
33222525|NCT02240108|100715861|FG000|Overall Study|StudyTerminated by Sponsor|0|||
33222526|NCT02240108|100715862|FG001|Overall Study|StudyTerminated by Sponsor|1|||
33222527|NCT02668016|100715863|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
33222528|NCT02668016|100715863|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
33222529|NCT02668016|100715863|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
33222530|NCT02668016|100715863|FG000|Month 4|Withdrawal due to severe symptoms|1|||
33222531|NCT02668016|100715863|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
33222532|NCT02668016|100715863|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
33222533|NCT02668016|100715863|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
33222534|NCT02668016|100715863|FG000|Month 6|Withdrawal due to severe symptoms|2|||
33222535|NCT02668016|100715863|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
33222536|NCT02668016|100715863|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
33222537|NCT02668016|100715863|FG000|Month 8|Withdrawal due to severe symptoms|1|||
33222538|NCT02668016|100715863|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
33222539|NCT02668016|100715863|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
33222540|NCT02668016|100715863|FG000|Month 10|Withdrawal due to severe symptoms|1|||
33222541|NCT02668016|100715863|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
33222542|NCT02857426|100715864|FG000|Overall Study|Disease progression|34|||
33222543|NCT02857426|100715865|FG001|Overall Study|Disease progression|13|||
33222544|NCT02857426|100715864|FG000|Overall Study|Study drug toxicity|4|||
33222545|NCT02857426|100715865|FG001|Overall Study|Study drug toxicity|1|||
33222546|NCT02857426|100715864|FG000|Overall Study|Death|1|||
33222547|NCT02857426|100715865|FG001|Overall Study|Death|0|||
33222548|NCT02857426|100715864|FG000|Overall Study|Adverse event unrelated to study drug|6|||
33222549|NCT02857426|100715865|FG001|Overall Study|Adverse event unrelated to study drug|2|||
33222550|NCT02857426|100715864|FG000|Overall Study|Participant withdrew consent|1|||
33363056|NCT01663740|101217384|FG000|Overall Study|Lost to Follow-up|1|||
33565248|NCT01313676|101967459|FG000|Overall Study|Protocol Violation|37|||
33565249|NCT01313676|101967460|FG001|Overall Study|Protocol Violation|44|||
33565250|NCT01313676|101967461|FG002|Overall Study|Protocol Violation|46|||
33565251|NCT01313676|101967462|FG003|Overall Study|Protocol Violation|44|||
33222551|NCT02857426|100715865|FG001|Overall Study|Participant withdrew consent|1|||
33222552|NCT02857426|100715864|FG000|Overall Study|Maximum clinical benefit|1|||
33222553|NCT02857426|100715865|FG001|Overall Study|Maximum clinical benefit|0|||
33222554|NCT02857426|100715864|FG000|Overall Study|Completed treatment|0|||
33222555|NCT02857426|100715865|FG001|Overall Study|Completed treatment|2|||
33222556|NCT03916744|100715866|FG000|Overall Study|Withdrawal by Subject|0|||
33222557|NCT03916744|100715867|FG001|Overall Study|Withdrawal by Subject|1|||
33222558|NCT03916744|100715868|FG002|Overall Study|Withdrawal by Subject|2|||
33222559|NCT00622180|100715869|FG000|Overall Study|Lost to Follow-up|1|||
33222560|NCT00622180|100715870|FG001|Overall Study|Lost to Follow-up|2|||
33222561|NCT01919970|100715871|FG000|Overall Study|Withdrawal by Subject|3|||
33222562|NCT01919970|100715872|FG001|Overall Study|Withdrawal by Subject|0|||
33222563|NCT00642902|100715877|FG000|Overall Study|Adverse Event|0|||
33222564|NCT00642902|100715878|FG001|Overall Study|Adverse Event|1|||
33222565|NCT00642902|100715879|FG002|Overall Study|Adverse Event|3|||
33222566|NCT00642902|100715880|FG003|Overall Study|Adverse Event|1|||
33222567|NCT00642902|100715877|FG000|Overall Study|Lost to Follow-up|1|||
33222568|NCT00642902|100715878|FG001|Overall Study|Lost to Follow-up|1|||
33222569|NCT00642902|100715879|FG002|Overall Study|Lost to Follow-up|0|||
33222570|NCT00642902|100715880|FG003|Overall Study|Lost to Follow-up|0|||
33222571|NCT00642902|100715877|FG000|Overall Study|Lack of Efficacy|0|||
33222572|NCT00642902|100715878|FG001|Overall Study|Lack of Efficacy|3|||
33222573|NCT00642902|100715879|FG002|Overall Study|Lack of Efficacy|3|||
33222574|NCT00642902|100715880|FG003|Overall Study|Lack of Efficacy|0|||
33222575|NCT00642902|100715877|FG000|Overall Study|Death|1|||
33222576|NCT00642902|100715878|FG001|Overall Study|Death|0|||
33222577|NCT00642902|100715879|FG002|Overall Study|Death|0|||
33222578|NCT00642902|100715880|FG003|Overall Study|Death|0|||
33222579|NCT00642902|100715877|FG000|Overall Study|Premature termination of clinical trial|37|||
33222580|NCT00642902|100715878|FG001|Overall Study|Premature termination of clinical trial|32|||
33222581|NCT00642902|100715879|FG002|Overall Study|Premature termination of clinical trial|35|||
33222582|NCT00642902|100715880|FG003|Overall Study|Premature termination of clinical trial|35|||
33222583|NCT00642902|100715877|FG000|Overall Study|Randomized, but not treated|0|||
33222584|NCT00642902|100715878|FG001|Overall Study|Randomized, but not treated|0|||
33222585|NCT00642902|100715879|FG002|Overall Study|Randomized, but not treated|1|||
33222586|NCT00642902|100715880|FG003|Overall Study|Randomized, but not treated|0|||
33222587|NCT00642902|100715877|FG000|Overall Study|Other|1|||
33222588|NCT00642902|100715878|FG001|Overall Study|Other|5|||
33222589|NCT00642902|100715879|FG002|Overall Study|Other|1|||
33222590|NCT00642902|100715880|FG003|Overall Study|Other|4|||
33222591|NCT01807650|100715881|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
33222592|NCT01807650|100715881|FG000|Overall Study|Adverse Event|5|||
33222593|NCT01807650|100715881|FG000|Overall Study|Other|2|||
33222594|NCT02691182|100715884|FG000|Overall Study|Withdrawal by Subject|4|||
33222595|NCT02691182|100715885|FG001|Overall Study|Withdrawal by Subject|7|||
33222596|NCT02691182|100715886|FG002|Overall Study|Withdrawal by Subject|6|||
33222597|NCT02691182|100715887|FG003|Overall Study|Withdrawal by Subject|8|||
33222598|NCT02691182|100715884|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
33565252|NCT01313676|101967459|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
33565253|NCT01313676|101967460|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
33565254|NCT01313676|101967461|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
33565255|NCT01313676|101967462|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
33565256|NCT01313676|101967459|FG000|Overall Study|Study Closed/terminated|7|||
33565257|NCT01313676|101967460|FG001|Overall Study|Study Closed/terminated|6|||
33565258|NCT01313676|101967461|FG002|Overall Study|Study Closed/terminated|9|||
33565259|NCT01313676|101967462|FG003|Overall Study|Study Closed/terminated|9|||
33222599|NCT02691182|100715885|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
33222600|NCT02691182|100715886|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
33222601|NCT02691182|100715887|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
33222602|NCT02691182|100715884|FG000|Overall Study|Lost to Follow-up|8|||
33222603|NCT02691182|100715885|FG001|Overall Study|Lost to Follow-up|33|||
33222604|NCT02691182|100715886|FG002|Overall Study|Lost to Follow-up|19|||
33222605|NCT02691182|100715887|FG003|Overall Study|Lost to Follow-up|22|||
33222606|NCT02691182|100715884|FG000|Overall Study|Adverse Event|3|||
33222607|NCT02691182|100715885|FG001|Overall Study|Adverse Event|10|||
33222608|NCT02691182|100715886|FG002|Overall Study|Adverse Event|10|||
33222609|NCT02691182|100715887|FG003|Overall Study|Adverse Event|11|||
33222610|NCT02691182|100715884|FG000|Overall Study|Physician Decision|3|||
33222611|NCT02691182|100715885|FG001|Overall Study|Physician Decision|7|||
33222612|NCT02691182|100715886|FG002|Overall Study|Physician Decision|14|||
33222613|NCT02691182|100715887|FG003|Overall Study|Physician Decision|8|||
33222614|NCT02691182|100715884|FG000|Overall Study|Lack of Efficacy|0|||
33222615|NCT02691182|100715885|FG001|Overall Study|Lack of Efficacy|0|||
33565260|NCT01313676|101967459|FG000|Overall Study|Lost to Follow-up|0|||
33565261|NCT01313676|101967460|FG001|Overall Study|Lost to Follow-up|0|||
33565262|NCT01313676|101967461|FG002|Overall Study|Lost to Follow-up|1|||
33222616|NCT02691182|100715886|FG002|Overall Study|Lack of Efficacy|0|||
33222617|NCT02691182|100715887|FG003|Overall Study|Lack of Efficacy|4|||
33222618|NCT02691182|100715884|FG000|Overall Study|Protocol Violation|2|||
33222619|NCT02691182|100715885|FG001|Overall Study|Protocol Violation|6|||
33222620|NCT02691182|100715886|FG002|Overall Study|Protocol Violation|6|||
33222621|NCT02691182|100715887|FG003|Overall Study|Protocol Violation|8|||
33222622|NCT02691182|100715884|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
33222623|NCT02691182|100715885|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
33222624|NCT02691182|100715886|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
33363057|NCT01663740|101217385|FG001|Overall Study|Lost to Follow-up|4|||
33222625|NCT02691182|100715887|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
33222626|NCT02691182|100715884|FG000|Overall Study|Missing|0|||
33222627|NCT02691182|100715885|FG001|Overall Study|Missing|5|||
33222628|NCT02691182|100715886|FG002|Overall Study|Missing|1|||
33222629|NCT02691182|100715887|FG003|Overall Study|Missing|5|||
33222630|NCT05096208|100715889|FG000|Overall Study|Lost to Follow-up|3|||
33222631|NCT05096208|100715890|FG001|Overall Study|Lost to Follow-up|5|||
33363058|NCT01663740|101217384|FG000|Overall Study|Other|9|||
33363059|NCT01663740|101217385|FG001|Overall Study|Other|2|||
33565263|NCT01313676|101967462|FG003|Overall Study|Lost to Follow-up|0|||
33565264|NCT01313676|101967459|FG000|Overall Study|Physician Decision|53|||
33565265|NCT01313676|101967460|FG001|Overall Study|Physician Decision|64|||
33565266|NCT01313676|101967461|FG002|Overall Study|Physician Decision|62|||
33565267|NCT01313676|101967462|FG003|Overall Study|Physician Decision|48|||
33565268|NCT01313676|101967459|FG000|Overall Study|Decision by Participant or Proxy|643|||
33565269|NCT01313676|101967460|FG001|Overall Study|Decision by Participant or Proxy|527|||
33565270|NCT01313676|101967461|FG002|Overall Study|Decision by Participant or Proxy|515|||
33565271|NCT01313676|101967462|FG003|Overall Study|Decision by Participant or Proxy|492|||
33565272|NCT01313676|101967459|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
33565273|NCT01313676|101967460|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
33565274|NCT01313676|101967461|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
33565275|NCT01313676|101967462|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
33565276|NCT01313676|101967459|FG000|Overall Study|Investigator Site Closed|12|||
33565277|NCT01313676|101967460|FG001|Overall Study|Investigator Site Closed|11|||
33565278|NCT01313676|101967461|FG002|Overall Study|Investigator Site Closed|15|||
33565279|NCT01313676|101967462|FG003|Overall Study|Investigator Site Closed|10|||
33565280|NCT01313676|101967459|FG000|Overall Study|Missing|1|||
33565281|NCT01313676|101967460|FG001|Overall Study|Missing|1|||
33565282|NCT01313676|101967461|FG002|Overall Study|Missing|1|||
33565283|NCT01313676|101967462|FG003|Overall Study|Missing|0|||
33565284|NCT00480532|101967463|FG000|Overall Study|Withdrawal by Subject|2|||
33565285|NCT00480532|101967464|FG001|Overall Study|Withdrawal by Subject|4|||
33565286|NCT00480532|101967465|FG002|Overall Study|Withdrawal by Subject|3|||
33565287|NCT00480532|101967466|FG003|Overall Study|Withdrawal by Subject|1|||
33565288|NCT00480532|101967463|FG000|Overall Study|Protocol Violation|0|||
33565289|NCT00480532|101967464|FG001|Overall Study|Protocol Violation|0|||
33565290|NCT00480532|101967465|FG002|Overall Study|Protocol Violation|1|||
33565291|NCT00480532|101967466|FG003|Overall Study|Protocol Violation|0|||
33565292|NCT02314923|101967467|FG000|Overall Study|Death|0|||
33565293|NCT02314923|101967468|FG001|Overall Study|Death|0|||
33363060|NCT01663740|101217384|FG000|Overall Study|Inclusion/Exclusion not met|1|||
33363061|NCT01663740|101217385|FG001|Overall Study|Inclusion/Exclusion not met|0|||
33363062|NCT01663740|101217384|FG000|Overall Study|Death|0|||
33363063|NCT01663740|101217385|FG001|Overall Study|Death|1|||
33363064|NCT01663740|101217384|FG000|Overall Study|Withdrawal by Subject|2|||
33363065|NCT01663740|101217385|FG001|Overall Study|Withdrawal by Subject|1|||
33363066|NCT01663740|101217384|FG000|Overall Study|No end of study status|3|||
33363067|NCT01663740|101217385|FG001|Overall Study|No end of study status|0|||
33363068|NCT01277289|101217386|FG000|Overall Study|fragile vein|1|||
33363069|NCT01277289|101217387|FG001|Overall Study|fragile vein|0|||
33363070|NCT01277289|101217386|FG000|Overall Study|Physician Decision|1|||
33363071|NCT01277289|101217387|FG001|Overall Study|Physician Decision|0|||
33363072|NCT01277289|101217386|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
33363073|NCT01277289|101217387|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
33222632|NCT05096208|100715891|FG002|Overall Study|Lost to Follow-up|5|||
33363074|NCT01277289|101217386|FG000|Overall Study|Protocol Violation|1|||
33565294|NCT02314923|101967469|FG002|Overall Study|Death|0|||
33565295|NCT02314923|101967470|FG003|Overall Study|Death|1|||
33565296|NCT02314923|101967471|FG004|Overall Study|Death|0|||
33565297|NCT02314923|101967472|FG005|Overall Study|Death|0|||
33565298|NCT02314923|101967473|FG006|Overall Study|Death|0|||
33565299|NCT02314923|101967474|FG007|Overall Study|Death|0|||
33565300|NCT02314923|101967475|FG008|Overall Study|Death|0|||
33565301|NCT02314923|101967476|FG009|Overall Study|Death|0|||
33363075|NCT01277289|101217387|FG001|Overall Study|Protocol Violation|1|||
33565302|NCT02314923|101967467|FG000|Overall Study|Lost to Follow-up|2|||
33565303|NCT02314923|101967468|FG001|Overall Study|Lost to Follow-up|3|||
33565304|NCT02314923|101967469|FG002|Overall Study|Lost to Follow-up|1|||
33565305|NCT02314923|101967470|FG003|Overall Study|Lost to Follow-up|0|||
33565306|NCT02314923|101967471|FG004|Overall Study|Lost to Follow-up|0|||
33565307|NCT02314923|101967472|FG005|Overall Study|Lost to Follow-up|0|||
33565308|NCT02314923|101967473|FG006|Overall Study|Lost to Follow-up|3|||
33565309|NCT02314923|101967474|FG007|Overall Study|Lost to Follow-up|4|||
33222633|NCT05096208|100715892|FG003|Overall Study|Lost to Follow-up|2|||
33222634|NCT05096208|100715889|FG000|Overall Study|Withdrawal by Subject|0|||
33363076|NCT01277289|101217386|FG000|Overall Study|Adverse Event|2|||
33565310|NCT02314923|101967475|FG008|Overall Study|Lost to Follow-up|2|||
33565311|NCT02314923|101967476|FG009|Overall Study|Lost to Follow-up|0|||
33565312|NCT02314923|101967467|FG000|Overall Study|Withdrawal by Subject|0|||
33565313|NCT02314923|101967468|FG001|Overall Study|Withdrawal by Subject|0|||
33565314|NCT02314923|101967469|FG002|Overall Study|Withdrawal by Subject|1|||
33565315|NCT02314923|101967470|FG003|Overall Study|Withdrawal by Subject|0|||
33565316|NCT02314923|101967471|FG004|Overall Study|Withdrawal by Subject|1|||
33565317|NCT02314923|101967472|FG005|Overall Study|Withdrawal by Subject|0|||
33363077|NCT01277289|101217387|FG001|Overall Study|Adverse Event|1|||
33363078|NCT01277289|101217386|FG000|Overall Study|consent withdrawn|1|||
33363079|NCT01277289|101217387|FG001|Overall Study|consent withdrawn|1|||
33363080|NCT01277289|101217386|FG000|Overall Study|premature closure of the study|4|||
33363081|NCT01277289|101217387|FG001|Overall Study|premature closure of the study|2|||
33363082|NCT02795767|101217388|FG000|Overall Study|Received Commercial Emicizumab|1|||
33363083|NCT02795767|101217389|FG001|Overall Study|Received Commercial Emicizumab|0|||
33363084|NCT02795767|101217390|FG002|Overall Study|Received Commercial Emicizumab|0|||
33363085|NCT01188798|101217391|FG000|Overall Study|Death|0|||
33363086|NCT01188798|101217392|FG001|Overall Study|Death|1|||
33363087|NCT01188798|101217391|FG000|Overall Study|Required additional transplant|1|||
33363088|NCT01188798|101217392|FG001|Overall Study|Required additional transplant|1|||
33363089|NCT01188798|101217391|FG000|Overall Study|Protocol closure|1|||
33363090|NCT01188798|101217392|FG001|Overall Study|Protocol closure|1|||
33363091|NCT00399802|101217393|FG000|Overall Study|Adverse Event|0|||
33363092|NCT00399802|101217394|FG001|Overall Study|Adverse Event|2|||
33363093|NCT00399802|101217393|FG000|Overall Study|Participant discontinued by mistake|0|||
33363094|NCT00399802|101217394|FG001|Overall Study|Participant discontinued by mistake|1|||
33363095|NCT01952015|101217395|FG000|Induction|Protocol Violation|1|||
33363096|NCT01952015|101217395|FG000|Maintenance|Adverse Event|2|||
33363097|NCT01952015|101217395|FG000|Treatment Period 3|Physician Decision|9|||
33363098|NCT04172831|101217396|FG000|Overall Study|Adverse Event|21|||
33363099|NCT04172831|101217397|FG001|Overall Study|Adverse Event|9|||
33363100|NCT04172831|101217396|FG000|Overall Study|Lack of Efficacy|2|||
33363101|NCT04172831|101217397|FG001|Overall Study|Lack of Efficacy|8|||
33363102|NCT04172831|101217396|FG000|Overall Study|Physician Decision|0|||
33363103|NCT04172831|101217397|FG001|Overall Study|Physician Decision|1|||
33363104|NCT04172831|101217396|FG000|Overall Study|Withdrawal by Subject|12|||
33565318|NCT02314923|101967473|FG006|Overall Study|Withdrawal by Subject|1|||
33565319|NCT02314923|101967474|FG007|Overall Study|Withdrawal by Subject|0|||
33565320|NCT02314923|101967475|FG008|Overall Study|Withdrawal by Subject|0|||
33565321|NCT02314923|101967476|FG009|Overall Study|Withdrawal by Subject|0|||
33565322|NCT02314923|101967467|FG000|Overall Study|Physician Decision|0|||
33565323|NCT02314923|101967468|FG001|Overall Study|Physician Decision|1|||
33565324|NCT02314923|101967469|FG002|Overall Study|Physician Decision|0|||
33565325|NCT02314923|101967470|FG003|Overall Study|Physician Decision|0|||
33565326|NCT02314923|101967471|FG004|Overall Study|Physician Decision|0|||
33565327|NCT02314923|101967472|FG005|Overall Study|Physician Decision|0|||
33565328|NCT02314923|101967473|FG006|Overall Study|Physician Decision|0|||
33565329|NCT02314923|101967474|FG007|Overall Study|Physician Decision|0|||
33565330|NCT02314923|101967475|FG008|Overall Study|Physician Decision|0|||
33565331|NCT02314923|101967476|FG009|Overall Study|Physician Decision|0|||
33565332|NCT02314923|101967467|FG000|Overall Study|Participant unavailable|0|||
33565333|NCT02314923|101967468|FG001|Overall Study|Participant unavailable|0|||
33565334|NCT02314923|101967469|FG002|Overall Study|Participant unavailable|0|||
33565335|NCT02314923|101967470|FG003|Overall Study|Participant unavailable|0|||
33565336|NCT02314923|101967471|FG004|Overall Study|Participant unavailable|0|||
33565337|NCT02314923|101967472|FG005|Overall Study|Participant unavailable|1|||
33565338|NCT02314923|101967473|FG006|Overall Study|Participant unavailable|0|||
33565339|NCT02314923|101967474|FG007|Overall Study|Participant unavailable|0|||
33565340|NCT02314923|101967475|FG008|Overall Study|Participant unavailable|0|||
33565341|NCT02314923|101967476|FG009|Overall Study|Participant unavailable|0|||
33565342|NCT02314923|101967467|FG000|Overall Study|Screen failure|0|||
33565343|NCT02314923|101967468|FG001|Overall Study|Screen failure|0|||
33565344|NCT02314923|101967469|FG002|Overall Study|Screen failure|0|||
33565345|NCT02314923|101967470|FG003|Overall Study|Screen failure|0|||
33565346|NCT02314923|101967471|FG004|Overall Study|Screen failure|0|||
33565347|NCT02314923|101967472|FG005|Overall Study|Screen failure|0|||
33565348|NCT02314923|101967473|FG006|Overall Study|Screen failure|1|||
33565349|NCT02314923|101967474|FG007|Overall Study|Screen failure|0|||
33565350|NCT02314923|101967475|FG008|Overall Study|Screen failure|0|||
33565351|NCT02314923|101967476|FG009|Overall Study|Screen failure|0|||
33565352|NCT02314923|101967467|FG000|Overall Study|Participant relocation|1|||
33565353|NCT02314923|101967468|FG001|Overall Study|Participant relocation|0|||
33363105|NCT04172831|101217397|FG001|Overall Study|Withdrawal by Subject|11|||
33363106|NCT04172831|101217396|FG000|Overall Study|Lost to Follow-up|4|||
33363107|NCT04172831|101217397|FG001|Overall Study|Lost to Follow-up|9|||
33363108|NCT04172831|101217396|FG000|Overall Study|COVID-19 related crisis|3|||
33363109|NCT04172831|101217397|FG001|Overall Study|COVID-19 related crisis|3|||
33363110|NCT04172831|101217396|FG000|Overall Study|Subject non-compliance|1|||
33416008|NCT00390572|101413206|FG001|Overall Study|health condition|1|||
33565354|NCT02314923|101967469|FG002|Overall Study|Participant relocation|0|||
33565355|NCT02314923|101967470|FG003|Overall Study|Participant relocation|0|||
33565356|NCT02314923|101967471|FG004|Overall Study|Participant relocation|0|||
33565357|NCT02314923|101967472|FG005|Overall Study|Participant relocation|0|||
33565358|NCT02314923|101967473|FG006|Overall Study|Participant relocation|0|||
33565359|NCT02314923|101967474|FG007|Overall Study|Participant relocation|1|||
33565360|NCT02314923|101967475|FG008|Overall Study|Participant relocation|0|||
33565361|NCT02314923|101967476|FG009|Overall Study|Participant relocation|0|||
33565362|NCT00526799|101967479|FG000|Overall Study|Withdrawal by Subject|1|||
33565363|NCT00526799|101967480|FG001|Overall Study|Withdrawal by Subject|0|||
33565364|NCT00526799|101967479|FG000|Overall Study|Intercurrent Complicating Disease|0|||
33565365|NCT00526799|101967480|FG001|Overall Study|Intercurrent Complicating Disease|1|||
33565366|NCT00815633|101967481|FG000|Overall Study|study terminated|1|||
33565367|NCT05837481|101967483|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
33565368|NCT05837481|101967484|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
33565369|NCT03738228|101967489|FG000|Overall Study|Never received study treatment|2|||
33565370|NCT03738228|101967490|FG001|Overall Study|Never received study treatment|2|||
33565371|NCT04581395|101967501|FG000|Overall Study|Protocol Violation|4|||
33565372|NCT04581395|101967502|FG001|Overall Study|Protocol Violation|3|||
33565373|NCT04581395|101967503|FG002|Overall Study|Protocol Violation|2|||
33565374|NCT04581395|101967501|FG000|Overall Study|Physician Decision|0|||
33565375|NCT04581395|101967502|FG001|Overall Study|Physician Decision|1|||
33565376|NCT04581395|101967503|FG002|Overall Study|Physician Decision|0|||
33565377|NCT01979185|101967506|FG000|Period 2|Other|0|||
33565378|NCT01979185|101967507|FG001|Period 2|Other|1|||
33565379|NCT00095576|101967508|FG000|Overall Study|Adverse Event|5|||
33565380|NCT00095576|101967509|FG001|Overall Study|Adverse Event|3|||
33565381|NCT00095576|101967508|FG000|Overall Study|Lost to Follow-up|233|||
33565382|NCT00095576|101967509|FG001|Overall Study|Lost to Follow-up|229|||
33565383|NCT00095576|101967508|FG000|Overall Study|Protocol Violation|1|||
33565384|NCT00095576|101967509|FG001|Overall Study|Protocol Violation|0|||
33565385|NCT00095576|101967508|FG000|Overall Study|Withdrawal by Subject|34|||
33565386|NCT00095576|101967509|FG001|Overall Study|Withdrawal by Subject|47|||
33565387|NCT00095576|101967508|FG000|Overall Study|Option to switch to a rollover study|1097|||
33565388|NCT00095576|101967509|FG001|Overall Study|Option to switch to a rollover study|1099|||
33565389|NCT00095576|101967508|FG000|Overall Study|Site terminated|75|||
33565390|NCT00095576|101967509|FG001|Overall Study|Site terminated|67|||
33565391|NCT00095576|101967508|FG000|Overall Study|Subject moved|30|||
33363111|NCT04172831|101217397|FG001|Overall Study|Subject non-compliance|1|||
33363112|NCT04172831|101217396|FG000|Overall Study|Family emergency|1|||
33363113|NCT04172831|101217397|FG001|Overall Study|Family emergency|0|||
33363114|NCT01266148|101217398|FG000|Overall Study|Adverse Event|2|||
33363115|NCT01266148|101217399|FG001|Overall Study|Adverse Event|0|||
33363116|NCT01266148|101217398|FG000|Overall Study|Ongoing rejection|1|||
33363117|NCT01266148|101217399|FG001|Overall Study|Ongoing rejection|0|||
33363118|NCT01266148|101217398|FG000|Overall Study|2 2R rejections|1|||
33363119|NCT01266148|101217399|FG001|Overall Study|2 2R rejections|0|||
33363120|NCT01266148|101217398|FG000|Overall Study|Death|2|||
33363121|NCT01266148|101217399|FG001|Overall Study|Death|3|||
33363122|NCT01266148|101217398|FG000|Overall Study|missing mGFR value + AE|1|||
33363123|NCT01266148|101217399|FG001|Overall Study|missing mGFR value + AE|0|||
33363124|NCT00778999|101217400|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
33363125|NCT00778999|101217401|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
33363126|NCT00778999|101217400|FG000|Overall Study|Did not receive recFSH|14|||
33363127|NCT00778999|101217401|FG001|Overall Study|Did not receive recFSH|20|||
33363128|NCT00576693|101217406|FG000|Overall Study|Lost to Follow-up|7|||
33363129|NCT00576693|101217407|FG001|Overall Study|Lost to Follow-up|11|||
33565392|NCT00095576|101967509|FG001|Overall Study|Subject moved|36|||
33565393|NCT03232567|101967510|FG000|Overall Study|Withdrawal by Subject|0|||
33565394|NCT03232567|101967511|FG001|Overall Study|Withdrawal by Subject|1|||
33565395|NCT03232567|101967512|FG002|Overall Study|Withdrawal by Subject|0|||
33565396|NCT03232567|101967513|FG003|Overall Study|Withdrawal by Subject|0|||
33565397|NCT03552029|101967514|FG000|Overall Study|Death|3|||
33565398|NCT03552029|101967515|FG001|Overall Study|Death|0|||
33565399|NCT03552029|101967514|FG000|Overall Study|Adverse Event|1|||
33363130|NCT00576693|101217406|FG000|Overall Study|Withdrawal by Subject|3|||
33363131|NCT00576693|101217407|FG001|Overall Study|Withdrawal by Subject|13|||
33363132|NCT00882713|101217408|FG000|Overall Study|Adverse Event|2|||
33363133|NCT00882713|101217408|FG000|Overall Study|Death|3|||
33363134|NCT00882713|101217408|FG000|Overall Study|Administrative reasons|4|||
33565400|NCT03552029|101967515|FG001|Overall Study|Adverse Event|0|||
33565401|NCT03552029|101967514|FG000|Overall Study|Lack of Efficacy|0|||
33565402|NCT03552029|101967515|FG001|Overall Study|Lack of Efficacy|2|||
33565403|NCT03552029|101967514|FG000|Overall Study|Physician Decision|0|||
33565404|NCT03552029|101967515|FG001|Overall Study|Physician Decision|1|||
33565405|NCT03552029|101967514|FG000|Overall Study|Study terminated by Sponsor|0|||
33629153|NCT00468169|102191328|FG000|Overall Study|Withdrawal by Subject|1|||
33363135|NCT00882713|101217408|FG000|Overall Study|refused treatment/withdrew consent|4|||
33565406|NCT03552029|101967515|FG001|Overall Study|Study terminated by Sponsor|1|||
33363136|NCT00882713|101217408|FG000|Overall Study|Blood transfusion|2|||
33363137|NCT00882713|101217408|FG000|Overall Study|Insufficient therapeutic response|3|||
33363138|NCT00882713|101217408|FG000|Overall Study|Failure to return|2|||
33363139|NCT00882713|101217408|FG000|Overall Study|Other - Reasons|2|||
33363140|NCT02504892|101217409|FG000|Overall Study|Adverse event-pneumonitis|2|||
33363141|NCT01650779|101217410|FG000|Overall Study|Withdrawal by Subject|1|||
33565407|NCT03552029|101967514|FG000|Overall Study|Other|0|||
33565408|NCT03552029|101967515|FG001|Overall Study|Other|2|||
33565409|NCT01052779|101967516|FG000|Overall Study|Adverse Event|1|||
33565410|NCT01052779|101967517|FG001|Overall Study|Adverse Event|4|||
33565411|NCT01052779|101967516|FG000|Overall Study|Withdrawal by Subject|1|||
33565412|NCT01052779|101967517|FG001|Overall Study|Withdrawal by Subject|2|||
33565413|NCT01052779|101967516|FG000|Overall Study|Other-Protocol Violation|1|||
33565414|NCT01052779|101967517|FG001|Overall Study|Other-Protocol Violation|1|||
33565415|NCT01052779|101967516|FG000|Overall Study|Other-Surgery|0|||
33565416|NCT01052779|101967517|FG001|Overall Study|Other-Surgery|2|||
33363142|NCT00418886|101217415|FG000|Overall Study|discontinue treatment survival follow up|90|||
33565417|NCT01052779|101967516|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
33565418|NCT01052779|101967517|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
33565419|NCT00618787|101967520|FG000|Overall Study|Adverse Event|0|||
33565420|NCT00618787|101967521|FG001|Overall Study|Adverse Event|1|||
33565421|NCT00618787|101967520|FG000|Overall Study|Withdrawal by Subject|2|||
33565422|NCT00618787|101967521|FG001|Overall Study|Withdrawal by Subject|1|||
33565423|NCT00618787|101967520|FG000|Overall Study|Lost to Follow-up|1|||
33565424|NCT00618787|101967521|FG001|Overall Study|Lost to Follow-up|0|||
33565425|NCT00505687|101967522|FG000|Overall Study|Important protocol violation|2|||
33565426|NCT00505687|101967522|FG000|Overall Study|Lack of Efficacy|15|||
33565427|NCT00505687|101967522|FG000|Overall Study|Adverse Event|48|||
33565428|NCT00505687|101967522|FG000|Overall Study|Subject withdrew consent|15|||
33565429|NCT00505687|101967522|FG000|Overall Study|Lost to Follow-up|1|||
33565430|NCT00505687|101967522|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
33565431|NCT00505687|101967522|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
33565432|NCT00505687|101967522|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
33565433|NCT00505687|101967522|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
33565434|NCT00505687|101967522|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
33565435|NCT00505687|101967522|FG000|Overall Study|Other: Disease Progression|1|||
33565436|NCT00505687|101967522|FG000|Overall Study|Other: As Per Sponsor|8|||
33565437|NCT01107496|101967523|FG000|Overall Study|Adverse Event|1|||
33565438|NCT01107496|101967524|FG001|Overall Study|Adverse Event|0|||
33565439|NCT01107496|101967523|FG000|Overall Study|Lack of Efficacy|1|||
33565440|NCT01107496|101967524|FG001|Overall Study|Lack of Efficacy|0|||
33565441|NCT01107496|101967523|FG000|Overall Study|Protocol Violation|0|||
33565442|NCT01107496|101967524|FG001|Overall Study|Protocol Violation|1|||
33565443|NCT01107496|101967523|FG000|Overall Study|Lost to Follow-up|0|||
33565444|NCT01107496|101967524|FG001|Overall Study|Lost to Follow-up|1|||
33565445|NCT04617860|101967531|FG000|Overall Study|Adverse Event|0|||
33565446|NCT04617860|101967532|FG001|Overall Study|Adverse Event|2|||
33565447|NCT04617860|101967533|FG002|Overall Study|Adverse Event|2|||
33565448|NCT04617860|101967531|FG000|Overall Study|Withdrawal by Subject|0|||
33565449|NCT04617860|101967532|FG001|Overall Study|Withdrawal by Subject|0|||
33565450|NCT04617860|101967533|FG002|Overall Study|Withdrawal by Subject|2|||
33565451|NCT04617860|101967531|FG000|Overall Study|Physician Decision|0|||
33565452|NCT04617860|101967532|FG001|Overall Study|Physician Decision|1|||
33565453|NCT04617860|101967533|FG002|Overall Study|Physician Decision|0|||
33565454|NCT04617860|101967531|FG000|Overall Study|Sponsor Decision|0|||
33565455|NCT04617860|101967532|FG001|Overall Study|Sponsor Decision|3|||
33629154|NCT00468169|102191329|FG001|Overall Study|Withdrawal by Subject|0|||
33629155|NCT04617782|102191333|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
33629156|NCT04617782|102191333|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
33629157|NCT04617782|102191333|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
33629158|NCT04617782|102191333|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
33363143|NCT00418886|101217416|FG001|Overall Study|discontinue treatment survival follow up|91|||
33363144|NCT00418886|101217415|FG000|Overall Study|Death|122|||
33363145|NCT00418886|101217416|FG001|Overall Study|Death|147|||
33565456|NCT04617860|101967533|FG002|Overall Study|Sponsor Decision|1|||
33565457|NCT04617860|101967531|FG000|Overall Study|Termination of Study by Sponsor|8|||
33565458|NCT04617860|101967532|FG001|Overall Study|Termination of Study by Sponsor|4|||
33565459|NCT04617860|101967533|FG002|Overall Study|Termination of Study by Sponsor|13|||
33363146|NCT00418886|101217415|FG000|Overall Study|Withdrawal by Subject|9|||
33565460|NCT05014919|101967536|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
33565461|NCT05014919|101967537|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
33565462|NCT05014919|101967538|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
33565463|NCT05014919|101967536|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
33565464|NCT05014919|101967537|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
33565465|NCT05014919|101967538|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
33565466|NCT05014919|101967536|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
33565467|NCT05014919|101967537|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
33629159|NCT04617782|102191333|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
33629160|NCT04617782|102191333|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
33629161|NCT03182374|102191334|FG000|Overall Study|Lost to Follow-up|3|||
33629162|NCT03182374|102191335|FG001|Overall Study|Lost to Follow-up|2|||
33629163|NCT03182374|102191334|FG000|Overall Study|Lack of Efficacy|8|||
33222635|NCT05096208|100715890|FG001|Overall Study|Withdrawal by Subject|1|||
33363147|NCT00418886|101217416|FG001|Overall Study|Withdrawal by Subject|10|||
33363148|NCT00418886|101217415|FG000|Overall Study|Lost to Follow-up|4|||
33363149|NCT00418886|101217416|FG001|Overall Study|Lost to Follow-up|6|||
33363150|NCT00418886|101217415|FG000|Overall Study|withdrawn due to other reason|1|||
33363151|NCT00418886|101217416|FG001|Overall Study|withdrawn due to other reason|0|||
33363152|NCT00418886|101217415|FG000|Overall Study|randomised but no treatment received|0|||
33363153|NCT00418886|101217416|FG001|Overall Study|randomised but no treatment received|1|||
33363154|NCT04542291|101217419|FG000|Overall Study|Adverse Event|1|||
33363155|NCT04542291|101217419|FG000|Overall Study|Physician Decision|2|||
33565468|NCT05014919|101967538|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
33565469|NCT05014919|101967536|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
33565470|NCT05014919|101967537|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
33565471|NCT05014919|101967538|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
33565472|NCT05014919|101967536|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
33565473|NCT05014919|101967537|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
33565474|NCT05014919|101967538|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
33565475|NCT05014919|101967536|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
33565476|NCT05014919|101967537|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
33565477|NCT05014919|101967538|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
33565478|NCT05014919|101967536|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
33565479|NCT05014919|101967537|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
33565480|NCT05014919|101967538|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
33565481|NCT05014919|101967536|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
33565482|NCT05014919|101967537|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
33565483|NCT05014919|101967538|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
33565484|NCT00113373|101967539|FG000|Overall Study|Ineligible: wrong primary|1|||
33565485|NCT00113373|101967539|FG000|Overall Study|Ineligible: second primary|1|||
33565486|NCT00113373|101967539|FG000|Overall Study|Never Treated|1|||
33565487|NCT00363298|101967540|FG000|First Study Week|Lack of Efficacy|6|||
33565488|NCT00363298|101967541|FG001|First Study Week|Lack of Efficacy|5|||
33565489|NCT00363298|101967540|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
33565490|NCT00363298|101967541|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
33565491|NCT01073293|101967542|FG000|Overall Study|Lost to Follow-up|0|||
33565492|NCT01073293|101967543|FG001|Overall Study|Lost to Follow-up|1|||
33565493|NCT01073293|101967542|FG000|Overall Study|Withdrawal by Subject|5|||
33565494|NCT01073293|101967543|FG001|Overall Study|Withdrawal by Subject|10|||
33565495|NCT03242434|101967544|FG000|Overall Study|Death|0|||
33565496|NCT03242434|101967545|FG001|Overall Study|Death|2|||
33565497|NCT00437073|101967549|FG000|Overall Study|Sponsor Terminated Study|1|||
33565498|NCT00437073|101967550|FG001|Overall Study|Sponsor Terminated Study|0|||
33565499|NCT00437073|101967549|FG000|Overall Study|Physician Decision|0|||
33565500|NCT00437073|101967550|FG001|Overall Study|Physician Decision|1|||
33565501|NCT02526290|101967551|FG000|Overall Study|Adverse Event|3|||
33565502|NCT02526290|101967551|FG000|Overall Study|Withdrawal by Subject|4|||
33565503|NCT02526290|101967551|FG000|Overall Study|Physician Decision|1|||
33565504|NCT01148771|101967552|FG000|Washout Period|Withdrawal by Subject|0|||
33565505|NCT01148771|101967553|FG001|Washout Period|Withdrawal by Subject|1|||
33565506|NCT01230060|101967555|FG000|Overall Study|Withdrawal by Subject|1|||
33565507|NCT00105066|101967558|FG000|Overall Study|Adverse Event|2|||
33565508|NCT00105066|101967559|FG001|Overall Study|Adverse Event|5|||
33565509|NCT00652834|101967560|FG000|Overall Study|Withdrawal by Subject|3|||
33565510|NCT00652834|101967560|FG000|Overall Study|Lost to Follow-up|2|||
33565511|NCT03289039|101967561|FG000|Overall Study|Withdrawal by Subject|0|||
33565512|NCT03289039|101967562|FG001|Overall Study|Withdrawal by Subject|1|||
33565513|NCT03289039|101967561|FG000|Overall Study|Became ineligible prior to treatment start|0|||
33565514|NCT03289039|101967562|FG001|Overall Study|Became ineligible prior to treatment start|1|||
33222636|NCT05096208|100715891|FG002|Overall Study|Withdrawal by Subject|2|||
33363156|NCT01070303|101217420|FG000|Overall Study|Adverse Event|39|||
33565515|NCT03289039|101967561|FG000|Overall Study|progressed before treatment start|1|||
33565516|NCT03289039|101967562|FG001|Overall Study|progressed before treatment start|0|||
33629164|NCT03182374|102191335|FG001|Overall Study|Lack of Efficacy|14|||
33363157|NCT01070303|101217420|FG000|Overall Study|Withdrawal by Subject|20|||
33565517|NCT00104884|101967563|FG000|Overall Study|Disease progression|4|||
33565518|NCT03257657|101967564|FG000|Overall Study|Lost to Follow-up|0|||
33565519|NCT03257657|101967565|FG001|Overall Study|Lost to Follow-up|3|||
33565520|NCT03257657|101967564|FG000|Overall Study|Withdrawn|0|||
33565521|NCT03257657|101967565|FG001|Overall Study|Withdrawn|1|||
33565522|NCT03257657|101967564|FG000|Overall Study|Noted not eligible right after enrolled|0|||
33565523|NCT03257657|101967565|FG001|Overall Study|Noted not eligible right after enrolled|1|||
33565524|NCT04576455|101967566|FG000|Overall Study|Ongoing in the Study|122|||
33565525|NCT04576455|101967567|FG001|Overall Study|Ongoing in the Study|135|||
33565526|NCT04576455|101967566|FG000|Overall Study|Death|18|||
33565527|NCT04576455|101967567|FG001|Overall Study|Death|12|||
33565528|NCT04576455|101967566|FG000|Overall Study|Lost to Follow-up|1|||
33629165|NCT03182374|102191334|FG000|Overall Study|Withdrawal by Subject|1|||
33629166|NCT03182374|102191335|FG001|Overall Study|Withdrawal by Subject|1|||
33629167|NCT03182374|102191334|FG000|Overall Study|exit for non-compliance|1|||
33222637|NCT05096208|100715892|FG003|Overall Study|Withdrawal by Subject|3|||
33222638|NCT05096208|100715889|FG000|Overall Study|No longer met eligibility criteria|1|||
33222639|NCT05096208|100715890|FG001|Overall Study|No longer met eligibility criteria|0|||
33629168|NCT03182374|102191335|FG001|Overall Study|exit for non-compliance|1|||
33629169|NCT03182374|102191334|FG000|Overall Study|one subject was randomized but not treated|1|||
33629170|NCT03182374|102191335|FG001|Overall Study|one subject was randomized but not treated|0|||
33629171|NCT03182374|102191334|FG000|Overall Study|Other reasons|0|||
33629172|NCT03182374|102191335|FG001|Overall Study|Other reasons|3|||
33629173|NCT02219464|102191338|FG000|Overall Study|Withdrawal by Subject|1|||
33629174|NCT02219464|102191339|FG001|Overall Study|Withdrawal by Subject|0|||
33629175|NCT02219464|102191338|FG000|Overall Study|case cancelled|1|||
33629176|NCT02219464|102191339|FG001|Overall Study|case cancelled|0|||
33565529|NCT04576455|101967567|FG001|Overall Study|Lost to Follow-up|0|||
33629177|NCT02219464|102191338|FG000|Overall Study|catheter malfunction|1|||
33629178|NCT02219464|102191339|FG001|Overall Study|catheter malfunction|0|||
33565530|NCT04576455|101967566|FG000|Overall Study|Withdrawal by Subject|10|||
33629179|NCT05482308|102191340|FG000|Overall Study|Withdrawal by Subject|1|||
33629180|NCT05482308|102191341|FG001|Overall Study|Withdrawal by Subject|0|||
33629181|NCT05482308|102191340|FG000|Overall Study|No longer meets eligibility criteria|0|||
33222640|NCT05096208|100715891|FG002|Overall Study|No longer met eligibility criteria|0|||
33363158|NCT01070303|101217420|FG000|Overall Study|Lost to Follow-up|9|||
33363159|NCT01070303|101217420|FG000|Overall Study|Protocol Violation|0|||
33363160|NCT01070303|101217420|FG000|Overall Study|Lack of Efficacy|2|||
33363161|NCT01070303|101217420|FG000|Overall Study|Administrative Reason|1|||
33222641|NCT05096208|100715892|FG003|Overall Study|No longer met eligibility criteria|0|||
33222642|NCT05096208|100715889|FG000|Overall Study|Other|0|||
33222643|NCT05096208|100715890|FG001|Overall Study|Other|0|||
33222644|NCT05096208|100715891|FG002|Overall Study|Other|1|||
33629182|NCT05482308|102191341|FG001|Overall Study|No longer meets eligibility criteria|1|||
33629183|NCT00005906|102191345|FG000|Overall Study|Lack of Efficacy|3|||
33629184|NCT00671658|102191349|FG000|Overall Study|Physician Decision|5|||
33629185|NCT01924845|102191355|FG000|Overall Study|Adverse Event|3|||
33629186|NCT01924845|102191355|FG000|Overall Study|Withdrawal by Subject|2|||
33629187|NCT01924845|102191355|FG000|Overall Study|Protocol Violation|1|||
33629188|NCT04416204|102191357|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
33629189|NCT04416204|102191358|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
33629190|NCT04416204|102191359|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
33629191|NCT04416204|102191360|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
33629192|NCT01710345|102191366|FG000|Overall Study|Adverse Event|0|||
33629193|NCT01710345|102191367|FG001|Overall Study|Adverse Event|2|||
33629194|NCT01710345|102191368|FG002|Overall Study|Adverse Event|0|||
33629195|NCT01710345|102191366|FG000|Overall Study|Lack of Efficacy|2|||
33629196|NCT01710345|102191367|FG001|Overall Study|Lack of Efficacy|3|||
33629197|NCT01710345|102191368|FG002|Overall Study|Lack of Efficacy|1|||
33629198|NCT01710345|102191366|FG000|Overall Study|Drug Dosing Error|1|||
33629199|NCT01710345|102191367|FG001|Overall Study|Drug Dosing Error|0|||
33629200|NCT01710345|102191368|FG002|Overall Study|Drug Dosing Error|0|||
33629201|NCT01766050|102191369|FG000|Overall Study|Adverse Event|1|||
33629202|NCT01766050|102191369|FG000|Overall Study|Lost to Follow-up|1|||
33629203|NCT01766050|102191369|FG000|Overall Study|Withdrawal by Subject|2|||
33629204|NCT03737123|102194204|FG000|Study Treatment|Adverse Event|2|||
33629205|NCT03737123|102194205|FG001|Study Treatment|Adverse Event|0|||
33629206|NCT03737123|102194204|FG000|Study Treatment|Disease Progression|2|||
33629207|NCT03737123|102194205|FG001|Study Treatment|Disease Progression|0|||
33629208|NCT03737123|102194204|FG000|Study Treatment|Withdrawal by Subject|2|||
33629209|NCT03737123|102194205|FG001|Study Treatment|Withdrawal by Subject|0|||
33629210|NCT03737123|102194204|FG000|Follow up|Death|1|||
33629211|NCT03737123|102194205|FG001|Follow up|Death|0|||
33629212|NCT03737123|102194204|FG000|Follow up|Withdrawal by Subject|1|||
33629213|NCT03737123|102194205|FG001|Follow up|Withdrawal by Subject|0|||
33629214|NCT03737123|102194204|FG000|Follow up|Termination of study|4|||
33629215|NCT03737123|102194205|FG001|Follow up|Termination of study|0|||
33629216|NCT04366349|102194206|FG000|Overall Study|Withdrawal by Subject|1|||
33629217|NCT04366349|102194207|FG001|Overall Study|Withdrawal by Subject|0|||
33629218|NCT04366349|102194208|FG002|Overall Study|Withdrawal by Subject|0|||
33629219|NCT04366349|102194209|FG003|Overall Study|Withdrawal by Subject|0|||
33629220|NCT04366349|102194210|FG004|Overall Study|Withdrawal by Subject|0|||
33629221|NCT04366349|102194211|FG005|Overall Study|Withdrawal by Subject|0|||
33629222|NCT00062439|102194212|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
33629223|NCT00062439|102194212|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
33629224|NCT00062439|102194212|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
33629225|NCT00062439|102194212|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
33629226|NCT00062439|102194212|FG000|Post Chemoradiation Assessment|Death|1|||
33629227|NCT00062439|102194212|FG000|Post Chemoradiation Assessment|Disease progression|2|||
33629228|NCT00062439|102194212|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
33629229|NCT00062439|102194212|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
33629230|NCT00062439|102194212|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
33629231|NCT00062439|102194212|FG000|Surgery|Physician Decision|4|||
33629232|NCT00062439|102194212|FG000|Surgery|Death|1|||
33629233|NCT00062439|102194212|FG000|Surgery|Adverse Event|2|||
33629234|NCT00062439|102194212|FG000|Consolidation Chemotherapy|Adverse Event|2|||
33629235|NCT04949191|102194213|FG000|Overall Study|Non-compliance with Study Drug|1|||
33629236|NCT04949191|102194214|FG001|Overall Study|Non-compliance with Study Drug|0|||
33629237|NCT04949191|102194215|FG002|Overall Study|Non-compliance with Study Drug|0|||
33629238|NCT04949191|102194216|FG003|Overall Study|Non-compliance with Study Drug|0|||
33629239|NCT04949191|102194213|FG000|Overall Study|Progressive Disease|0|||
33629240|NCT04949191|102194214|FG001|Overall Study|Progressive Disease|1|||
33629241|NCT04949191|102194215|FG002|Overall Study|Progressive Disease|0|||
33629242|NCT04949191|102194216|FG003|Overall Study|Progressive Disease|0|||
33629243|NCT04949191|102194213|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
33629244|NCT04949191|102194214|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
33629245|NCT04949191|102194215|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
33629246|NCT04949191|102194216|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
33629247|NCT04949191|102194213|FG000|Overall Study|Sponsor Terminated Study|0|||
33629248|NCT04949191|102194214|FG001|Overall Study|Sponsor Terminated Study|0|||
33629249|NCT04949191|102194215|FG002|Overall Study|Sponsor Terminated Study|1|||
33629250|NCT04949191|102194216|FG003|Overall Study|Sponsor Terminated Study|1|||
33629251|NCT00837434|102194217|FG000|Overall Study|Physician Decision|3|||
33629252|NCT00837434|102194218|FG001|Overall Study|Physician Decision|0|||
33629253|NCT00837434|102194217|FG000|Overall Study|Lost to Follow-up|1|||
33629254|NCT00837434|102194218|FG001|Overall Study|Lost to Follow-up|1|||
33629255|NCT00837434|102194217|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
33629256|NCT00837434|102194218|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
33629257|NCT00837434|102194217|FG000|Overall Study|Noncompliant|2|||
33222645|NCT05096208|100715892|FG003|Overall Study|Other|0|||
33222646|NCT03954743|100715895|FG000|Overall Study|Adverse Event|1|||
33222647|NCT03954743|100715896|FG001|Overall Study|Adverse Event|0|||
33363162|NCT01070303|101217420|FG000|Overall Study|Other|18|||
33363163|NCT00611130|101217421|FG000|Overall Study|Lost to Follow-up|25|||
33363164|NCT00611130|101217422|FG001|Overall Study|Lost to Follow-up|29|||
33363165|NCT00611130|101217421|FG000|Overall Study|Protocol noncompliance|7|||
33363166|NCT00611130|101217422|FG001|Overall Study|Protocol noncompliance|6|||
33363167|NCT00611130|101217421|FG000|Overall Study|Withdrawal by Subject|6|||
33363168|NCT00611130|101217422|FG001|Overall Study|Withdrawal by Subject|5|||
33363169|NCT00611130|101217421|FG000|Overall Study|Other|5|||
33363170|NCT00611130|101217422|FG001|Overall Study|Other|4|||
33416009|NCT01017731|101413209|FG000|Overall Study|Lost to Follow-up|2|||
33565531|NCT04576455|101967567|FG001|Overall Study|Withdrawal by Subject|5|||
33565532|NCT04704193|101967568|FG000|Overall Study|Withdrawal by Subject|1|||
33565533|NCT01088906|101967571|FG000|Overall Study|Inclusion error|1|||
33565534|NCT01088906|101967571|FG000|Overall Study|Did not receive study treatment|3|||
33565535|NCT01088906|101967571|FG000|Overall Study|Missing data|1|||
33565536|NCT02038036|101967572|FG000|Core Study|Adverse Event|7|||
33565537|NCT02038036|101967573|FG001|Core Study|Adverse Event|7|||
33565538|NCT02038036|101967572|FG000|Core Study|Death|1|||
33565539|NCT02038036|101967573|FG001|Core Study|Death|1|||
33565540|NCT02038036|101967572|FG000|Core Study|Disease progression|2|||
33565541|NCT02038036|101967573|FG001|Core Study|Disease progression|2|||
33565542|NCT02038036|101967572|FG000|Core Study|Lost to Follow-up|0|||
33565543|NCT02038036|101967573|FG001|Core Study|Lost to Follow-up|1|||
33565544|NCT02038036|101967572|FG000|Core Study|Physician Decision|2|||
33565545|NCT02038036|101967573|FG001|Core Study|Physician Decision|1|||
33565546|NCT02038036|101967572|FG000|Core Study|Subject/guardian decision|0|||
33565547|NCT02038036|101967573|FG001|Core Study|Subject/guardian decision|1|||
33565548|NCT02038036|101967572|FG000|Core Study|Withdrawal by Subject|3|||
33565549|NCT02038036|101967573|FG001|Core Study|Withdrawal by Subject|1|||
33565550|NCT02038036|101967572|FG000|Crossover Period|Withdrawal by Subject|0|||
33565551|NCT02038036|101967573|FG001|Crossover Period|Withdrawal by Subject|3|||
33565552|NCT02038036|101967572|FG000|Crossover Period|Adverse Event|0|||
33565553|NCT02038036|101967573|FG001|Crossover Period|Adverse Event|9|||
33565554|NCT02038036|101967572|FG000|Crossover Period|Death|0|||
33565555|NCT02038036|101967573|FG001|Crossover Period|Death|2|||
33565556|NCT02038036|101967572|FG000|Crossover Period|Disease progression|0|||
33565557|NCT02038036|101967573|FG001|Crossover Period|Disease progression|3|||
33565558|NCT02038036|101967572|FG000|Crossover Period|Lost to Follow-up|0|||
33565559|NCT02038036|101967573|FG001|Crossover Period|Lost to Follow-up|1|||
33565560|NCT02038036|101967572|FG000|Crossover Period|Physician Decision|0|||
33565561|NCT02038036|101967573|FG001|Crossover Period|Physician Decision|2|||
33565562|NCT02853136|101967575|FG000|Wash-out|Adverse Event|0|||
33565563|NCT02853136|101967576|FG001|Wash-out|Adverse Event|0|||
33565564|NCT02853136|101967577|FG002|Wash-out|Adverse Event|0|||
33629258|NCT00837434|102194218|FG001|Overall Study|Noncompliant|0|||
33629259|NCT00837434|102194217|FG000|Overall Study|Baseline assessments not done in time|1|||
33629260|NCT00837434|102194218|FG001|Overall Study|Baseline assessments not done in time|0|||
33629261|NCT00837434|102194217|FG000|Overall Study|Unable to obtain study drug|1|||
33629262|NCT00837434|102194218|FG001|Overall Study|Unable to obtain study drug|0|||
33629263|NCT04235140|102194224|FG000|Overall Study|Adverse Event|2|||
33629264|NCT04235140|102194224|FG000|Overall Study|Lost to Follow-up|1|||
33629265|NCT04235140|102194224|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
33629266|NCT04235140|102194224|FG000|Overall Study|Commercial drug is available for participants|7|||
33629267|NCT00918281|102194227|FG000|Overall Study|Physician Decision|29|||
33629268|NCT03466658|102194228|FG000|Overall Study|Withdrawal by Subject|3|||
33629269|NCT02529852|102194232|FG000|Overall Study|Withdrawal by Subject|2|||
33629270|NCT03346434|102194241|FG000|Overall Study|Randomized in Error|0|||
33629271|NCT03346434|102194242|FG001|Overall Study|Randomized in Error|0|||
33629272|NCT03346434|102194243|FG002|Overall Study|Randomized in Error|0|||
33629273|NCT03346434|102194244|FG003|Overall Study|Randomized in Error|0|||
33629274|NCT03346434|102194245|FG004|Overall Study|Randomized in Error|1|||
33629275|NCT03346434|102194246|FG005|Overall Study|Randomized in Error|0|||
33629276|NCT03346434|102194241|FG000|Overall Study|Withdrawal by Subject|0|||
33629277|NCT03346434|102194242|FG001|Overall Study|Withdrawal by Subject|0|||
33222648|NCT03954743|100715895|FG000|Overall Study|Lost to Follow-up|6|||
33363171|NCT00611130|101217421|FG000|Overall Study|Incarceration|3|||
33363172|NCT00611130|101217422|FG001|Overall Study|Incarceration|2|||
33363173|NCT00611130|101217421|FG000|Overall Study|Administrative|1|||
33565565|NCT02853136|101967578|FG003|Wash-out|Adverse Event|1|||
33565566|NCT02367456|101967580|FG000|Overall Study|Death|8|||
33565567|NCT02367456|101967581|FG001|Overall Study|Death|24|||
33565568|NCT02367456|101967582|FG002|Overall Study|Death|17|||
33565569|NCT02367456|101967580|FG000|Overall Study|Lost to Follow-up|1|||
33565570|NCT02367456|101967581|FG001|Overall Study|Lost to Follow-up|3|||
33565571|NCT02367456|101967582|FG002|Overall Study|Lost to Follow-up|1|||
33565572|NCT02367456|101967580|FG000|Overall Study|Other reason|3|||
33416010|NCT01017731|101413209|FG000|Overall Study|Withdrawal by Subject|3|||
33416011|NCT01017731|101413209|FG000|Overall Study|Physician Decision|2|||
33416012|NCT01017731|101413209|FG000|Overall Study|Adverse Event|1|||
33416013|NCT01525407|101413214|FG000|Overall Study|Change in recipient treatment plan|2|||
33416014|NCT01525407|101413215|FG001|Overall Study|Change in recipient treatment plan|2|||
33416015|NCT01525407|101413214|FG000|Overall Study|Withdrawal by Subject|0|||
33416016|NCT01525407|101413215|FG001|Overall Study|Withdrawal by Subject|1|||
33416017|NCT01525407|101413214|FG000|Overall Study|Transplant was delayed|0|||
33416018|NCT01525407|101413215|FG001|Overall Study|Transplant was delayed|1|||
33416019|NCT01525407|101413214|FG000|Overall Study|Delay in Transplant|1|||
33416020|NCT01525407|101413215|FG001|Overall Study|Delay in Transplant|0|||
33416021|NCT01965431|101413218|FG000|Overall Study|Adverse Event|0|||
33416022|NCT01965431|101413219|FG001|Overall Study|Adverse Event|1|||
33416023|NCT01965431|101413220|FG002|Overall Study|Adverse Event|0|||
33416024|NCT01965431|101413221|FG003|Overall Study|Adverse Event|0|||
33416025|NCT01965431|101413222|FG004|Overall Study|Adverse Event|0|||
33416026|NCT01965431|101413223|FG005|Overall Study|Adverse Event|0|||
33416027|NCT01965431|101413218|FG000|Overall Study|Other than stated above|6|||
33416028|NCT01965431|101413219|FG001|Overall Study|Other than stated above|5|||
33416029|NCT01965431|101413220|FG002|Overall Study|Other than stated above|6|||
33416030|NCT01965431|101413221|FG003|Overall Study|Other than stated above|6|||
33416031|NCT01965431|101413222|FG004|Overall Study|Other than stated above|6|||
33416032|NCT01965431|101413223|FG005|Overall Study|Other than stated above|6|||
33416033|NCT02662556|101413224|FG000|Overall Study|Adverse Event|4|||
33416034|NCT02662556|101413224|FG000|Overall Study|Lack of Efficacy|4|||
33416035|NCT04764669|101413225|FG000|Overall Study|Adverse Event|1|||
33416036|NCT04764669|101413226|FG001|Overall Study|Adverse Event|0|||
33416037|NCT04764669|101413227|FG002|Overall Study|Adverse Event|1|||
33416038|NCT04764669|101413228|FG003|Overall Study|Adverse Event|0|||
33416039|NCT04764669|101413225|FG000|Overall Study|Subject Choice|0|||
33416040|NCT04764669|101413226|FG001|Overall Study|Subject Choice|0|||
33416041|NCT04764669|101413227|FG002|Overall Study|Subject Choice|1|||
33416042|NCT04764669|101413228|FG003|Overall Study|Subject Choice|0|||
33416043|NCT04764669|101413225|FG000|Overall Study|Withdrawal by Subject|2|||
33565573|NCT02367456|101967581|FG001|Overall Study|Other reason|3|||
33565574|NCT02367456|101967582|FG002|Overall Study|Other reason|9|||
33565575|NCT02367456|101967580|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
33565576|NCT02367456|101967581|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
33565577|NCT02367456|101967582|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
33565578|NCT04110145|101967583|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
33565579|NCT04110145|101967584|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
33565580|NCT04110145|101967585|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
33565581|NCT04110145|101967586|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
33565582|NCT04110145|101967587|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
33565583|NCT00836706|101967591|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
33222649|NCT03954743|100715896|FG001|Overall Study|Lost to Follow-up|4|||
33222650|NCT03954743|100715895|FG000|Overall Study|Protocol Violation|1|||
33222651|NCT03954743|100715896|FG001|Overall Study|Protocol Violation|0|||
33222652|NCT03954743|100715895|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
33416044|NCT04764669|101413226|FG001|Overall Study|Withdrawal by Subject|0|||
33416045|NCT04764669|101413227|FG002|Overall Study|Withdrawal by Subject|0|||
33416046|NCT04764669|101413228|FG003|Overall Study|Withdrawal by Subject|0|||
33416047|NCT03889197|101413232|FG000|Overall Study|Withdrawal by Subject|1|||
33416048|NCT03889197|101413233|FG001|Overall Study|Withdrawal by Subject|0|||
33416049|NCT03889197|101413232|FG000|Overall Study|Physician Decision|0|||
33416050|NCT03889197|101413233|FG001|Overall Study|Physician Decision|1|||
33416051|NCT03889197|101413232|FG000|Overall Study|met exclusion criteria|0|||
33416052|NCT03889197|101413233|FG001|Overall Study|met exclusion criteria|1|||
33416053|NCT03889197|101413232|FG000|Overall Study|Protocol Violation|1|||
33416054|NCT03889197|101413233|FG001|Overall Study|Protocol Violation|0|||
33416055|NCT05458895|101413236|FG000|Overall Study|Withdrawal by Subject|8|||
33629278|NCT03346434|102194243|FG002|Overall Study|Withdrawal by Subject|1|||
33416056|NCT05458895|101413236|FG000|Overall Study|Lost to Follow-up|17|||
33222653|NCT03954743|100715896|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
33416057|NCT05458895|101413236|FG000|Overall Study|Pregnancy|2|||
33629279|NCT03346434|102194244|FG003|Overall Study|Withdrawal by Subject|0|||
33629280|NCT03346434|102194245|FG004|Overall Study|Withdrawal by Subject|1|||
33629281|NCT03346434|102194246|FG005|Overall Study|Withdrawal by Subject|0|||
33629282|NCT03346434|102194241|FG000|Overall Study|Lost to Follow-up|0|||
33629283|NCT03346434|102194242|FG001|Overall Study|Lost to Follow-up|0|||
33629284|NCT03346434|102194243|FG002|Overall Study|Lost to Follow-up|0|||
33629285|NCT03346434|102194244|FG003|Overall Study|Lost to Follow-up|0|||
33629286|NCT03346434|102194245|FG004|Overall Study|Lost to Follow-up|1|||
33629287|NCT03346434|102194246|FG005|Overall Study|Lost to Follow-up|1|||
33629288|NCT03346434|102194241|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
33629289|NCT03346434|102194242|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
33629290|NCT03346434|102194243|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
33629291|NCT03346434|102194244|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
33629292|NCT03346434|102194245|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
33629293|NCT03346434|102194246|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
33629294|NCT03489863|102194247|FG000|Overall Study|Withdrawal by Subject|0|||
33629295|NCT03489863|102194248|FG001|Overall Study|Withdrawal by Subject|1|||
33629296|NCT05196828|102194249|FG000|Overall Study|Withdrawal by Subject|2|||
33222654|NCT03954743|100715895|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
33565584|NCT00836706|101967592|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
33565585|NCT04164901|101967593|FG000|Overall Study|Withdrawal by Subject|4|||
33565586|NCT04164901|101967594|FG001|Overall Study|Withdrawal by Subject|4|||
33565587|NCT02495883|101967595|FG000|Overall Study|Excessive head motion|1|||
33565588|NCT02495883|101967596|FG001|Overall Study|Excessive head motion|0|||
33565589|NCT03639935|101967597|FG000|Overall Study|Death|3|||
33565590|NCT03639935|101967597|FG000|Overall Study|Adverse Event|1|||
33565591|NCT02943473|101967602|FG000|Overall Study|enrolled but not dosed|1|||
33565592|NCT02943473|101967602|FG000|Overall Study|screen failure|1|||
33565593|NCT02943473|101967602|FG000|Overall Study|Physician Decision|4|||
33565594|NCT00404248|101967603|FG000|Overall Study|pts declining status|0|||
33565595|NCT00404248|101967604|FG001|Overall Study|pts declining status|1|||
33565596|NCT00404248|101967605|FG002|Overall Study|pts declining status|0|||
33565597|NCT00404248|101967606|FG003|Overall Study|pts declining status|0|||
33565598|NCT00404248|101967607|FG004|Overall Study|pts declining status|0|||
33565599|NCT00404248|101967608|FG005|Overall Study|pts declining status|0|||
33565600|NCT00404248|101967609|FG006|Overall Study|pts declining status|0|||
33565601|NCT00404248|101967610|FG007|Overall Study|pts declining status|0|||
33565602|NCT00404248|101967611|FG008|Overall Study|pts declining status|0|||
33565603|NCT01051661|101967612|FG000|Overall Study|Adverse Event|1|||
33565604|NCT01051661|101967613|FG001|Overall Study|Adverse Event|1|||
33565605|NCT01051661|101967614|FG002|Overall Study|Adverse Event|1|||
33565606|NCT01051661|101967615|FG003|Overall Study|Adverse Event|1|||
33565607|NCT01051661|101967616|FG004|Overall Study|Adverse Event|0|||
33565608|NCT01051661|101967617|FG005|Overall Study|Adverse Event|0|||
33565609|NCT01051661|101967612|FG000|Overall Study|Lost to Follow-up|13|||
33565610|NCT01051661|101967613|FG001|Overall Study|Lost to Follow-up|22|||
33565611|NCT01051661|101967614|FG002|Overall Study|Lost to Follow-up|15|||
33565612|NCT01051661|101967615|FG003|Overall Study|Lost to Follow-up|17|||
33565613|NCT01051661|101967616|FG004|Overall Study|Lost to Follow-up|10|||
33565614|NCT01051661|101967617|FG005|Overall Study|Lost to Follow-up|24|||
33565615|NCT01051661|101967612|FG000|Overall Study|Migrated/moved from study area|1|||
33565616|NCT01051661|101967613|FG001|Overall Study|Migrated/moved from study area|6|||
33565617|NCT01051661|101967614|FG002|Overall Study|Migrated/moved from study area|6|||
33565618|NCT01051661|101967615|FG003|Overall Study|Migrated/moved from study area|8|||
33565619|NCT01051661|101967616|FG004|Overall Study|Migrated/moved from study area|7|||
33565620|NCT01051661|101967617|FG005|Overall Study|Migrated/moved from study area|3|||
33565621|NCT01051661|101967612|FG000|Overall Study|Refused blood sampling|0|||
33565622|NCT01051661|101967613|FG001|Overall Study|Refused blood sampling|0|||
33565623|NCT01051661|101967614|FG002|Overall Study|Refused blood sampling|0|||
33565624|NCT01051661|101967615|FG003|Overall Study|Refused blood sampling|0|||
33565625|NCT01051661|101967616|FG004|Overall Study|Refused blood sampling|0|||
33565626|NCT01051661|101967617|FG005|Overall Study|Refused blood sampling|1|||
33565627|NCT01051661|101967612|FG000|Overall Study|Data not reliable|1|||
33565628|NCT01051661|101967613|FG001|Overall Study|Data not reliable|0|||
33565629|NCT01051661|101967614|FG002|Overall Study|Data not reliable|0|||
33565630|NCT01051661|101967615|FG003|Overall Study|Data not reliable|0|||
33565631|NCT01051661|101967616|FG004|Overall Study|Data not reliable|0|||
33565632|NCT01051661|101967617|FG005|Overall Study|Data not reliable|1|||
33565633|NCT01051661|101967612|FG000|Overall Study|Unable to attend visit(s)|2|||
33416058|NCT05458895|101413236|FG000|Overall Study|Withdrawal by Study Team|1|||
33416059|NCT02780115|101413243|FG000|Overall Study|Withdrawal by Subject|0|||
33416060|NCT02780115|101413244|FG001|Overall Study|Withdrawal by Subject|1|||
33416061|NCT02780115|101413245|FG002|Overall Study|Withdrawal by Subject|1|||
33416062|NCT02780115|101413246|FG003|Overall Study|Withdrawal by Subject|0|||
33416063|NCT02780115|101413247|FG004|Overall Study|Withdrawal by Subject|0|||
33416064|NCT02780115|101413243|FG000|Overall Study|Adverse Event|0|||
33416065|NCT02780115|101413244|FG001|Overall Study|Adverse Event|0|||
33416066|NCT02780115|101413245|FG002|Overall Study|Adverse Event|0|||
33416067|NCT02780115|101413246|FG003|Overall Study|Adverse Event|1|||
33416068|NCT02780115|101413247|FG004|Overall Study|Adverse Event|1|||
33416069|NCT03359473|101413248|FG000|Overall Study|Adverse Event|0|||
33416070|NCT03359473|101413249|FG001|Overall Study|Adverse Event|2|||
33416071|NCT03359473|101413250|FG002|Overall Study|Adverse Event|5|||
33416072|NCT03359473|101413251|FG003|Overall Study|Adverse Event|3|||
33416073|NCT03359473|101413248|FG000|Overall Study|Lost to Follow-up|0|||
33416074|NCT03359473|101413249|FG001|Overall Study|Lost to Follow-up|1|||
33416075|NCT03359473|101413250|FG002|Overall Study|Lost to Follow-up|0|||
33416076|NCT03359473|101413251|FG003|Overall Study|Lost to Follow-up|0|||
33416077|NCT03359473|101413248|FG000|Overall Study|Physician Decision|0|||
33416078|NCT03359473|101413249|FG001|Overall Study|Physician Decision|1|||
33416079|NCT03359473|101413250|FG002|Overall Study|Physician Decision|0|||
33416080|NCT03359473|101413251|FG003|Overall Study|Physician Decision|1|||
33416081|NCT03359473|101413248|FG000|Overall Study|Withdrawal by Subject|1|||
33416082|NCT03359473|101413249|FG001|Overall Study|Withdrawal by Subject|2|||
33416083|NCT03359473|101413250|FG002|Overall Study|Withdrawal by Subject|1|||
33416084|NCT03359473|101413251|FG003|Overall Study|Withdrawal by Subject|0|||
33416085|NCT03359473|101413248|FG000|Overall Study|Protocol-defined stopping criteria|1|||
33416086|NCT03359473|101413249|FG001|Overall Study|Protocol-defined stopping criteria|0|||
33416087|NCT03359473|101413250|FG002|Overall Study|Protocol-defined stopping criteria|0|||
33416088|NCT03359473|101413251|FG003|Overall Study|Protocol-defined stopping criteria|1|||
33416089|NCT01311505|101413252|FG000|First Intervention Period|Protocol Violation|0|||
33416090|NCT01311505|101413253|FG001|First Intervention Period|Protocol Violation|1|||
33416091|NCT01876082|101413254|FG000|Overall Study|Withdrawal by Subject|0|||
33416092|NCT01876082|101413255|FG001|Overall Study|Withdrawal by Subject|2|||
33416093|NCT01876082|101413254|FG000|Overall Study|Protocol Violation|1|||
33416094|NCT01876082|101413255|FG001|Overall Study|Protocol Violation|0|||
33565634|NCT01051661|101967613|FG001|Overall Study|Unable to attend visit(s)|4|||
33565635|NCT01051661|101967614|FG002|Overall Study|Unable to attend visit(s)|2|||
33565636|NCT01051661|101967615|FG003|Overall Study|Unable to attend visit(s)|1|||
33565637|NCT01051661|101967616|FG004|Overall Study|Unable to attend visit(s)|3|||
33565638|NCT01051661|101967617|FG005|Overall Study|Unable to attend visit(s)|2|||
33565639|NCT01051661|101967612|FG000|Overall Study|Consent not received from both parents|0|||
33565640|NCT01051661|101967613|FG001|Overall Study|Consent not received from both parents|0|||
33565641|NCT01051661|101967614|FG002|Overall Study|Consent not received from both parents|0|||
33565642|NCT01051661|101967615|FG003|Overall Study|Consent not received from both parents|0|||
33565643|NCT01051661|101967616|FG004|Overall Study|Consent not received from both parents|0|||
33565644|NCT01051661|101967617|FG005|Overall Study|Consent not received from both parents|1|||
33565645|NCT01051661|101967612|FG000|Overall Study|Failure to comply with protocol|0|||
33565646|NCT01051661|101967613|FG001|Overall Study|Failure to comply with protocol|0|||
33565647|NCT01051661|101967614|FG002|Overall Study|Failure to comply with protocol|2|||
33565648|NCT01051661|101967615|FG003|Overall Study|Failure to comply with protocol|0|||
33565649|NCT01051661|101967616|FG004|Overall Study|Failure to comply with protocol|0|||
33565650|NCT01051661|101967617|FG005|Overall Study|Failure to comply with protocol|0|||
33565651|NCT01051661|101967612|FG000|Overall Study|Subject lost legal representation|0|||
33565652|NCT01051661|101967613|FG001|Overall Study|Subject lost legal representation|0|||
33565653|NCT01051661|101967614|FG002|Overall Study|Subject lost legal representation|0|||
33565654|NCT01051661|101967615|FG003|Overall Study|Subject lost legal representation|0|||
33565655|NCT01051661|101967616|FG004|Overall Study|Subject lost legal representation|1|||
33565656|NCT01051661|101967617|FG005|Overall Study|Subject lost legal representation|0|||
33416095|NCT01876082|101413254|FG000|Overall Study|Adverse Event|1|||
33416096|NCT01876082|101413255|FG001|Overall Study|Adverse Event|1|||
33416097|NCT01876082|101413254|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
33416098|NCT01876082|101413255|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
33416099|NCT02216214|101413256|FG000|Overall Study|Randomized Never Received Study Drug|1|||
33416100|NCT02216214|101413257|FG001|Overall Study|Randomized Never Received Study Drug|0|||
33565657|NCT01051661|101967612|FG000|Overall Study|Protocol Violation|0|||
33565658|NCT01051661|101967613|FG001|Overall Study|Protocol Violation|0|||
33416101|NCT02216214|101413256|FG000|Overall Study|Adverse Event|10|||
33416102|NCT02216214|101413257|FG001|Overall Study|Adverse Event|8|||
33416103|NCT02216214|101413256|FG000|Overall Study|Lack of Efficacy|2|||
33416104|NCT02216214|101413257|FG001|Overall Study|Lack of Efficacy|2|||
33416105|NCT02216214|101413256|FG000|Overall Study|Lost to Follow-up|3|||
33416106|NCT02216214|101413257|FG001|Overall Study|Lost to Follow-up|2|||
33629297|NCT05196828|102194250|FG001|Overall Study|Withdrawal by Subject|0|||
33629298|NCT05196828|102194249|FG000|Overall Study|Lost to Follow-up|0|||
33629299|NCT05196828|102194250|FG001|Overall Study|Lost to Follow-up|4|||
33629300|NCT05196828|102194249|FG000|Overall Study|Adverse Event|1|||
33629301|NCT05196828|102194250|FG001|Overall Study|Adverse Event|0|||
33629302|NCT05121766|102194258|FG000|Overall Study|Covid reinfection|3|||
33629303|NCT05121766|102194259|FG001|Overall Study|Covid reinfection|0|||
33629304|NCT05121766|102194258|FG000|Overall Study|Withdrawal by Subject|3|||
33629305|NCT05121766|102194259|FG001|Overall Study|Withdrawal by Subject|1|||
33629306|NCT05121766|102194258|FG000|Overall Study|Adverse Event|2|||
33629307|NCT05121766|102194259|FG001|Overall Study|Adverse Event|4|||
33629308|NCT05121766|102194258|FG000|Overall Study|Lost to Follow-up|0|||
33629309|NCT05121766|102194259|FG001|Overall Study|Lost to Follow-up|1|||
33629310|NCT00074711|102194260|FG000|Overall Study|Withdrawal by Subject|1|||
33629311|NCT00074711|102194261|FG001|Overall Study|Withdrawal by Subject|1|||
33629312|NCT00074711|102194260|FG000|Overall Study|Lost to Follow-up|10|||
33629313|NCT00074711|102194261|FG001|Overall Study|Lost to Follow-up|8|||
33629314|NCT00074711|102194260|FG000|Overall Study|Participant stopped study drug|4|||
33565659|NCT01051661|101967614|FG002|Overall Study|Protocol Violation|0|||
33565660|NCT01051661|101967615|FG003|Overall Study|Protocol Violation|1|||
33565661|NCT01051661|101967616|FG004|Overall Study|Protocol Violation|2|||
33565662|NCT01051661|101967617|FG005|Overall Study|Protocol Violation|1|||
33565663|NCT01051661|101967612|FG000|Overall Study|Withdrawal by Subject|16|||
33565664|NCT01051661|101967613|FG001|Overall Study|Withdrawal by Subject|30|||
33565665|NCT01051661|101967614|FG002|Overall Study|Withdrawal by Subject|13|||
33565666|NCT01051661|101967615|FG003|Overall Study|Withdrawal by Subject|28|||
33565667|NCT01051661|101967616|FG004|Overall Study|Withdrawal by Subject|12|||
33565668|NCT01051661|101967617|FG005|Overall Study|Withdrawal by Subject|34|||
33565669|NCT02374255|101967620|FG000|Overall Study|Withdrawal by Subject|2|||
33565670|NCT02374255|101967621|FG001|Overall Study|Withdrawal by Subject|0|||
33565671|NCT02374255|101967622|FG002|Overall Study|Withdrawal by Subject|0|||
33565672|NCT02374255|101967623|FG003|Overall Study|Withdrawal by Subject|0|||
33565673|NCT01537432|101967626|FG000|Overall Study|Lost to Follow-up|3|||
33565674|NCT01537432|101967627|FG001|Overall Study|Lost to Follow-up|1|||
33565675|NCT01537432|101967626|FG000|Overall Study|Withdrawal by Subject|0|||
33565676|NCT01537432|101967627|FG001|Overall Study|Withdrawal by Subject|1|||
33565677|NCT01537432|101967626|FG000|Overall Study|Administrative problems|1|||
33565678|NCT01537432|101967627|FG001|Overall Study|Administrative problems|0|||
33565679|NCT01537432|101967626|FG000|Overall Study|Adverse Event|1|||
33565680|NCT01537432|101967627|FG001|Overall Study|Adverse Event|0|||
33565681|NCT01537432|101967626|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33565682|NCT01537432|101967627|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33565683|NCT00770679|101967631|FG000|Overall Study|Lost to Follow-up|3|||
33565684|NCT00770679|101967631|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
33565685|NCT03423979|101967632|FG000|Overall Study|Death|1|||
33565686|NCT02997202|101967633|FG000|Overall Study|Miscellaneous|2|||
33565687|NCT02997202|101967634|FG001|Overall Study|Miscellaneous|2|||
33565688|NCT02997202|101967633|FG000|Overall Study|Withdrawal by Subject|8|||
33565689|NCT02997202|101967634|FG001|Overall Study|Withdrawal by Subject|12|||
33565690|NCT02997202|101967633|FG000|Overall Study|Lost to Follow-up|5|||
33565691|NCT02997202|101967634|FG001|Overall Study|Lost to Follow-up|3|||
33565692|NCT02997202|101967633|FG000|Overall Study|Death|41|||
33565693|NCT02997202|101967634|FG001|Overall Study|Death|45|||
33565694|NCT01085214|101967635|FG000|Overall Study|Alternate treatment required|1|||
33565695|NCT02263547|101967636|FG000|Overall Study|Adverse Event|1|||
33565696|NCT02263547|101967636|FG000|Overall Study|Lost to Follow-up|2|||
33565697|NCT02296125|101970449|FG000|Overall Study|Withdrawal by Subject|18|||
33565698|NCT02296125|101970450|FG001|Overall Study|Withdrawal by Subject|8|||
33565699|NCT02296125|101970451|FG002|Overall Study|Withdrawal by Subject|6|||
33565700|NCT02296125|101970452|FG003|Overall Study|Withdrawal by Subject|2|||
33565701|NCT02296125|101970449|FG000|Overall Study|Adverse Event|41|||
33565702|NCT02296125|101970450|FG001|Overall Study|Adverse Event|52|||
33565703|NCT02296125|101970451|FG002|Overall Study|Adverse Event|9|||
33565704|NCT02296125|101970452|FG003|Overall Study|Adverse Event|4|||
33565705|NCT02296125|101970449|FG000|Overall Study|Severe non-compliance to protocol|0|||
33565706|NCT02296125|101970450|FG001|Overall Study|Severe non-compliance to protocol|1|||
33565707|NCT02296125|101970451|FG002|Overall Study|Severe non-compliance to protocol|0|||
33565708|NCT02296125|101970452|FG003|Overall Study|Severe non-compliance to protocol|0|||
33565709|NCT02296125|101970449|FG000|Overall Study|Condition under investigation worsened|153|||
33629315|NCT00074711|102194261|FG001|Overall Study|Participant stopped study drug|6|||
33222655|NCT03954743|100715896|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33629316|NCT05362487|102194262|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
33629317|NCT01352117|102194265|FG000|Overall Study|Death|15|||
33629318|NCT01352117|102194266|FG001|Overall Study|Death|16|||
33565710|NCT02296125|101970450|FG001|Overall Study|Condition under investigation worsened|199|||
33565711|NCT02296125|101970451|FG002|Overall Study|Condition under investigation worsened|39|||
33629319|NCT01352117|102194265|FG000|Overall Study|Withdrawal by Subject|1|||
33629320|NCT01352117|102194266|FG001|Overall Study|Withdrawal by Subject|0|||
33629321|NCT01352117|102194265|FG000|Overall Study|Lost to Follow-up|2|||
33629322|NCT01352117|102194266|FG001|Overall Study|Lost to Follow-up|7|||
33363174|NCT00611130|101217422|FG001|Overall Study|Administrative|1|||
33363175|NCT00611130|101217421|FG000|Overall Study|Adverse Event|1|||
33363176|NCT00611130|101217422|FG001|Overall Study|Adverse Event|0|||
33363177|NCT00611130|101217421|FG000|Overall Study|Death|1|||
33363178|NCT00611130|101217422|FG001|Overall Study|Death|0|||
33363179|NCT00092547|101217429|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
33363180|NCT00092547|101217430|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
33363181|NCT00092547|101217431|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
33363182|NCT00092547|101217429|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
33363183|NCT00092547|101217430|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
33363184|NCT00092547|101217431|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
33363185|NCT00092547|101217429|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
33363186|NCT00092547|101217430|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
33363187|NCT00092547|101217431|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
33363188|NCT00092547|101217429|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
33363189|NCT00092547|101217430|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
33363190|NCT00092547|101217431|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
33363191|NCT00092547|101217429|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
33629323|NCT01352117|102194265|FG000|Overall Study|Non-adherent to study requirements|1|||
33629324|NCT01352117|102194266|FG001|Overall Study|Non-adherent to study requirements|1|||
33629325|NCT01352117|102194265|FG000|Overall Study|Did not initiate study treatment|1|||
33629326|NCT01352117|102194266|FG001|Overall Study|Did not initiate study treatment|0|||
33629327|NCT01352117|102194265|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
33629328|NCT01352117|102194266|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
33629329|NCT02412306|102194267|FG000|Overall Study|Lost to Follow-up|0|||
33629330|NCT02412306|102194268|FG001|Overall Study|Lost to Follow-up|1|||
33629331|NCT02412306|102194269|FG002|Overall Study|Lost to Follow-up|0|||
33629332|NCT02412306|102194270|FG003|Overall Study|Lost to Follow-up|0|||
33629333|NCT02412306|102194271|FG004|Overall Study|Lost to Follow-up|0|||
33629334|NCT02412306|102194267|FG000|Overall Study|Withdrawal by Subject|0|||
33629335|NCT02412306|102194268|FG001|Overall Study|Withdrawal by Subject|0|||
33629336|NCT02412306|102194269|FG002|Overall Study|Withdrawal by Subject|1|||
33629337|NCT02412306|102194270|FG003|Overall Study|Withdrawal by Subject|0|||
33629338|NCT02412306|102194271|FG004|Overall Study|Withdrawal by Subject|0|||
33629339|NCT02412306|102194267|FG000|Overall Study|Death|5|||
33629340|NCT02412306|102194268|FG001|Overall Study|Death|7|||
33629341|NCT02412306|102194269|FG002|Overall Study|Death|15|||
33629342|NCT02412306|102194270|FG003|Overall Study|Death|0|||
33629343|NCT02412306|102194271|FG004|Overall Study|Death|2|||
33363192|NCT00092547|101217430|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
33629344|NCT04906499|102194272|FG000|Overall Study|Lack of time|1|||
33629345|NCT03839940|102194275|FG000|Overall Study|Withdrawal by Subject|3|||
33629346|NCT03839940|102194276|FG001|Overall Study|Withdrawal by Subject|0|||
33222656|NCT04043962|100715900|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
33222657|NCT04043962|100715900|FG000|Post-Treatment|Withdrawal by Subject|5|||
33222658|NCT04043962|100715900|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
33222659|NCT00514943|100715903|FG000|Stage 1|Progressive disease|4|||
33222660|NCT00514943|100715904|FG001|Stage 1|Progressive disease|8|||
33222661|NCT00514943|100715903|FG000|Stage 1|Other Adverse Event|16|||
33222662|NCT00514943|100715904|FG001|Stage 1|Other Adverse Event|6|||
33222663|NCT00514943|100715903|FG000|Stage 1|Not treated|1|||
33363193|NCT00092547|101217431|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
33629347|NCT03839940|102194275|FG000|Overall Study|Protocol Violation|0|||
33629348|NCT03839940|102194276|FG001|Overall Study|Protocol Violation|1|||
33629349|NCT03839940|102194275|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
33629350|NCT03839940|102194276|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
33629351|NCT00762359|102194280|FG000|Overall Study|Adverse Event|20|||
33629352|NCT00762359|102194281|FG001|Overall Study|Adverse Event|23|||
33629353|NCT00762359|102194280|FG000|Overall Study|Protocol Violation|21|||
33629354|NCT00762359|102194281|FG001|Overall Study|Protocol Violation|13|||
33629355|NCT00762359|102194280|FG000|Overall Study|Withdrawal by Subject|13|||
33629356|NCT00762359|102194281|FG001|Overall Study|Withdrawal by Subject|10|||
33629357|NCT00762359|102194280|FG000|Overall Study|Lack of Efficacy|0|||
33629358|NCT00762359|102194281|FG001|Overall Study|Lack of Efficacy|4|||
33629359|NCT00762359|102194280|FG000|Overall Study|Institution closed|2|||
33629360|NCT00762359|102194281|FG001|Overall Study|Institution closed|3|||
33629361|NCT00762359|102194280|FG000|Overall Study|Physician Decision|2|||
33629362|NCT00762359|102194281|FG001|Overall Study|Physician Decision|3|||
33629363|NCT00762359|102194280|FG000|Overall Study|Removal|0|||
33222664|NCT00514943|100715904|FG001|Stage 1|Not treated|2|||
33222665|NCT00514943|100715903|FG000|Stage 1|Patient refused to continue study meds|8|||
33629364|NCT00762359|102194281|FG001|Overall Study|Removal|1|||
33629365|NCT00762359|102194280|FG000|Overall Study|Withdrew consent|1|||
33629366|NCT00762359|102194281|FG001|Overall Study|Withdrew consent|0|||
33629367|NCT00377520|102194305|FG000|Overall Study|Ineligible (Prior radiation)|1|||
33629368|NCT01126749|102194306|FG000|Phase 1b|Other|0|||
33629369|NCT01126749|102194307|FG001|Phase 1b|Other|1|||
33363194|NCT00092547|101217429|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
33363195|NCT00092547|101217430|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
33363196|NCT00092547|101217431|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
33363197|NCT00092547|101217429|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
33363198|NCT00092547|101217430|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
33363199|NCT00092547|101217431|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
33363200|NCT00092547|101217429|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
33363201|NCT00092547|101217430|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
33363202|NCT00092547|101217431|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
33363203|NCT00092547|101217429|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
33363204|NCT00092547|101217430|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
33565712|NCT02296125|101970452|FG003|Overall Study|Condition under investigation worsened|56|||
33565713|NCT02296125|101970449|FG000|Overall Study|Any reason not specifically recorded|6|||
33565714|NCT02296125|101970450|FG001|Overall Study|Any reason not specifically recorded|4|||
33565715|NCT02296125|101970451|FG002|Overall Study|Any reason not specifically recorded|2|||
33565716|NCT02296125|101970452|FG003|Overall Study|Any reason not specifically recorded|0|||
33565717|NCT00567502|101970454|FG000|Overall Study|Lost to Follow-up|91|||
33565718|NCT00567502|101970455|FG001|Overall Study|Lost to Follow-up|14|||
33565719|NCT00567502|101970456|FG002|Overall Study|Lost to Follow-up|351|||
33565720|NCT00567502|101970457|FG003|Overall Study|Lost to Follow-up|2|||
33565721|NCT00567502|101970454|FG000|Overall Study|Death|65|||
33565722|NCT00567502|101970455|FG001|Overall Study|Death|16|||
33565723|NCT00567502|101970456|FG002|Overall Study|Death|360|||
33565724|NCT00567502|101970457|FG003|Overall Study|Death|5|||
33565725|NCT00567502|101970454|FG000|Overall Study|Other|64|||
33565726|NCT00567502|101970455|FG001|Overall Study|Other|2|||
33565727|NCT00567502|101970456|FG002|Overall Study|Other|134|||
33565728|NCT00567502|101970457|FG003|Overall Study|Other|6|||
33565729|NCT00567502|101970454|FG000|Overall Study|Participant request|12|||
33565730|NCT00567502|101970455|FG001|Overall Study|Participant request|1|||
33565731|NCT00567502|101970456|FG002|Overall Study|Participant request|33|||
33565732|NCT00567502|101970457|FG003|Overall Study|Participant request|1|||
33565733|NCT00567502|101970454|FG000|Overall Study|Sponsor request|9|||
33565734|NCT00567502|101970455|FG001|Overall Study|Sponsor request|0|||
33565735|NCT00567502|101970456|FG002|Overall Study|Sponsor request|30|||
33565736|NCT00567502|101970457|FG003|Overall Study|Sponsor request|1|||
33565737|NCT00567502|101970454|FG000|Overall Study|Never Initiated Treatment|0|||
33565738|NCT00567502|101970455|FG001|Overall Study|Never Initiated Treatment|0|||
33565739|NCT00567502|101970456|FG002|Overall Study|Never Initiated Treatment|0|||
33565740|NCT00567502|101970457|FG003|Overall Study|Never Initiated Treatment|72|||
33565741|NCT04129398|101970458|FG000|Overall Study|Physician Decision|2|||
33565742|NCT00209131|101970459|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
33565743|NCT00209131|101970460|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
33565744|NCT00863304|101970461|FG000|Overall Study|Adverse Event|10|||
33565745|NCT00863304|101970462|FG001|Overall Study|Adverse Event|4|||
33565746|NCT00863304|101970463|FG002|Overall Study|Adverse Event|14|||
33565747|NCT00863304|101970464|FG003|Overall Study|Adverse Event|16|||
33565748|NCT00863304|101970461|FG000|Overall Study|Lost to Follow-up|1|||
33565749|NCT00863304|101970462|FG001|Overall Study|Lost to Follow-up|5|||
33565750|NCT00863304|101970463|FG002|Overall Study|Lost to Follow-up|4|||
33565751|NCT00863304|101970464|FG003|Overall Study|Lost to Follow-up|2|||
33565752|NCT00863304|101970461|FG000|Overall Study|Lack of Efficacy|57|||
33565753|NCT00863304|101970462|FG001|Overall Study|Lack of Efficacy|26|||
33565754|NCT00863304|101970463|FG002|Overall Study|Lack of Efficacy|30|||
33565755|NCT00863304|101970464|FG003|Overall Study|Lack of Efficacy|28|||
33565756|NCT00863304|101970461|FG000|Overall Study|Withdrawal by Subject|19|||
33565757|NCT00863304|101970462|FG001|Overall Study|Withdrawal by Subject|14|||
33629370|NCT01126749|102194308|FG002|Phase 1b|Other|0|||
33629371|NCT01126749|102194309|FG003|Phase 1b|Other|0|||
33629372|NCT01126749|102194306|FG000|Phase 1b|Withdrawal by Subject|0|||
33629373|NCT01126749|102194307|FG001|Phase 1b|Withdrawal by Subject|1|||
33629374|NCT01126749|102194308|FG002|Phase 1b|Withdrawal by Subject|0|||
33363205|NCT00092547|101217431|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
33363206|NCT00092547|101217429|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
33565758|NCT00863304|101970463|FG002|Overall Study|Withdrawal by Subject|20|||
33565759|NCT00863304|101970464|FG003|Overall Study|Withdrawal by Subject|18|||
33565760|NCT00863304|101970461|FG000|Overall Study|Other|1|||
33565761|NCT00863304|101970462|FG001|Overall Study|Other|0|||
33565762|NCT00863304|101970463|FG002|Overall Study|Other|0|||
33565763|NCT00863304|101970464|FG003|Overall Study|Other|1|||
33416107|NCT02216214|101413256|FG000|Overall Study|Protocol Violation|4|||
33416108|NCT02216214|101413257|FG001|Overall Study|Protocol Violation|2|||
33416109|NCT02216214|101413256|FG000|Overall Study|Withdrawal by Subject|22|||
33416110|NCT02216214|101413257|FG001|Overall Study|Withdrawal by Subject|20|||
33416111|NCT02216214|101413256|FG000|Overall Study|Study Terminated By Sponsor|0|||
33416112|NCT02216214|101413257|FG001|Overall Study|Study Terminated By Sponsor|1|||
33222666|NCT00514943|100715904|FG001|Stage 1|Patient refused to continue study meds|3|||
33222667|NCT00514943|100715903|FG000|Stage 1|Other than stated above|1|||
33222668|NCT00514943|100715904|FG001|Stage 1|Other than stated above|7|||
33222669|NCT00514943|100715903|FG000|Stage 2|Progressive disease|27|||
33222670|NCT00514943|100715904|FG001|Stage 2|Progressive disease|24|||
33222671|NCT00514943|100715903|FG000|Stage 2|Other Adverse Event|3|||
33222672|NCT00514943|100715904|FG001|Stage 2|Other Adverse Event|10|||
33222673|NCT00514943|100715903|FG000|Stage 2|Patient refused to continue study meds|2|||
33222674|NCT00514943|100715904|FG001|Stage 2|Patient refused to continue study meds|0|||
33222675|NCT00514943|100715903|FG000|Stage 2|Other than stated above|0|||
33222676|NCT00514943|100715904|FG001|Stage 2|Other than stated above|2|||
33222677|NCT00768430|100715912|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
33222678|NCT00768430|100715913|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
33222679|NCT01396317|100715914|FG000|Overall Study|Adverse Event|1|||
33222680|NCT01396317|100715915|FG001|Overall Study|Adverse Event|0|||
33222681|NCT00782496|100715916|FG000|Overall Study|Lost to Follow-up|14|||
33416113|NCT02216214|101413256|FG000|Overall Study|Miscellaneous|1|||
33363207|NCT00092547|101217430|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
33363208|NCT00092547|101217431|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
33363209|NCT00092547|101217429|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
33363210|NCT00092547|101217430|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
33363211|NCT00092547|101217431|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
33363212|NCT00092547|101217429|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
33363213|NCT00092547|101217430|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
33363214|NCT00092547|101217431|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
33363215|NCT00092547|101217429|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
33363216|NCT00092547|101217430|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
33363217|NCT00092547|101217431|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
33363218|NCT00092547|101217429|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
33363219|NCT00092547|101217430|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
33363220|NCT00092547|101217431|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
33363221|NCT00092547|101217429|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
33363222|NCT00092547|101217430|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
33363223|NCT00092547|101217431|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
33416114|NCT02216214|101413257|FG001|Overall Study|Miscellaneous|1|||
33363224|NCT00092547|101217429|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
33363225|NCT00092547|101217430|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
33363226|NCT00092547|101217431|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
33363227|NCT00092547|101217429|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
33363228|NCT00092547|101217430|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
33363229|NCT00092547|101217431|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
33363230|NCT00092547|101217429|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
33363231|NCT00092547|101217430|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
33363232|NCT00092547|101217431|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
33363233|NCT00092547|101217429|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
33363234|NCT00092547|101217430|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
33363235|NCT00092547|101217431|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
33416115|NCT02886494|101413266|FG000|Overall Study|Adverse Event|1|||
33416116|NCT02886494|101413267|FG001|Overall Study|Adverse Event|0|||
33416117|NCT02886494|101413266|FG000|Overall Study|Withdrawal by Subject|12|||
33416118|NCT02886494|101413267|FG001|Overall Study|Withdrawal by Subject|3|||
33565764|NCT00863304|101970461|FG000|Overall Study|Protocol Violation|2|||
33565765|NCT00863304|101970462|FG001|Overall Study|Protocol Violation|6|||
33565766|NCT00863304|101970463|FG002|Overall Study|Protocol Violation|2|||
33565767|NCT00863304|101970464|FG003|Overall Study|Protocol Violation|0|||
33565768|NCT00863304|101970461|FG000|Overall Study|Randomized, but not Treated|3|||
33565769|NCT00863304|101970462|FG001|Overall Study|Randomized, but not Treated|1|||
33565770|NCT00863304|101970463|FG002|Overall Study|Randomized, but not Treated|4|||
33565771|NCT00863304|101970464|FG003|Overall Study|Randomized, but not Treated|1|||
33565772|NCT00863304|101970461|FG000|Overall Study|Entered extension study|101|||
33565773|NCT00863304|101970462|FG001|Overall Study|Entered extension study|129|||
33565774|NCT00863304|101970463|FG002|Overall Study|Entered extension study|113|||
33222682|NCT00782496|100715917|FG001|Overall Study|Lost to Follow-up|15|||
33222683|NCT02799472|100715921|FG000|Overall Study|Withdrawal by Subject|2|||
33222684|NCT02799472|100715922|FG001|Overall Study|Withdrawal by Subject|4|||
33222685|NCT02799472|100715921|FG000|Overall Study|Lack of Efficacy|2|||
33416119|NCT02886494|101413266|FG000|Overall Study|Protocol Violation|4|||
33416120|NCT02886494|101413267|FG001|Overall Study|Protocol Violation|1|||
33629375|NCT01126749|102194309|FG003|Phase 1b|Withdrawal by Subject|0|||
33629376|NCT01126749|102194306|FG000|Phase 1b|Death|3|||
33629377|NCT01126749|102194307|FG001|Phase 1b|Death|4|||
33629378|NCT01126749|102194308|FG002|Phase 1b|Death|0|||
33629379|NCT01126749|102194309|FG003|Phase 1b|Death|0|||
33629380|NCT01126749|102194306|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
33629381|NCT01126749|102194307|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
33629382|NCT01126749|102194308|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
33629383|NCT01126749|102194309|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
33629384|NCT01126749|102194306|FG000|Phase 2|Study Termination by Sponsor|0|||
33629385|NCT01126749|102194307|FG001|Phase 2|Study Termination by Sponsor|0|||
33629386|NCT01126749|102194308|FG002|Phase 2|Study Termination by Sponsor|12|||
33629387|NCT01126749|102194309|FG003|Phase 2|Study Termination by Sponsor|6|||
33629388|NCT01126749|102194306|FG000|Phase 2|Other|0|||
33629389|NCT01126749|102194307|FG001|Phase 2|Other|0|||
33629390|NCT01126749|102194308|FG002|Phase 2|Other|4|||
33629391|NCT01126749|102194309|FG003|Phase 2|Other|2|||
33629392|NCT01126749|102194306|FG000|Phase 2|Withdrawal by Subject|0|||
33629393|NCT01126749|102194307|FG001|Phase 2|Withdrawal by Subject|0|||
33629394|NCT01126749|102194308|FG002|Phase 2|Withdrawal by Subject|0|||
33629395|NCT01126749|102194309|FG003|Phase 2|Withdrawal by Subject|2|||
33629396|NCT01126749|102194306|FG000|Phase 2|Lost to Follow-up|0|||
33629397|NCT01126749|102194307|FG001|Phase 2|Lost to Follow-up|0|||
33629398|NCT01126749|102194308|FG002|Phase 2|Lost to Follow-up|0|||
33629399|NCT01126749|102194309|FG003|Phase 2|Lost to Follow-up|1|||
33629400|NCT01126749|102194306|FG000|Phase 2|Death|0|||
33629401|NCT01126749|102194307|FG001|Phase 2|Death|0|||
33629402|NCT01126749|102194308|FG002|Phase 2|Death|22|||
33629403|NCT01126749|102194309|FG003|Phase 2|Death|22|||
33629404|NCT01126749|102194306|FG000|Phase 2|Adverse Event|0|||
33629405|NCT01126749|102194307|FG001|Phase 2|Adverse Event|0|||
33629406|NCT01126749|102194308|FG002|Phase 2|Adverse Event|0|||
33629407|NCT01126749|102194309|FG003|Phase 2|Adverse Event|1|||
33629408|NCT04564846|102194314|FG000|Overall Study|Withdrawal by Subject|2|||
33629409|NCT04564846|102194315|FG001|Overall Study|Withdrawal by Subject|1|||
33629410|NCT04564846|102194314|FG000|Overall Study|Physician Decision|0|||
33629411|NCT04564846|102194315|FG001|Overall Study|Physician Decision|1|||
33629412|NCT04564846|102194314|FG000|Overall Study|Lost to Follow-up|0|||
33629413|NCT04564846|102194315|FG001|Overall Study|Lost to Follow-up|1|||
33629414|NCT04564846|102194314|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
33629415|NCT04564846|102194315|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
33416121|NCT01414062|101413268|FG000|Overall Study|Lost to Follow-up|3|||
33416122|NCT01414062|101413269|FG001|Overall Study|Lost to Follow-up|2|||
33416123|NCT01414062|101413268|FG000|Overall Study|Left Country|1|||
33416124|NCT01414062|101413269|FG001|Overall Study|Left Country|1|||
33629416|NCT04564846|102194314|FG000|Overall Study|Subject non-compliance|1|||
33629417|NCT04564846|102194315|FG001|Overall Study|Subject non-compliance|0|||
33629418|NCT03744312|102194316|FG000|Overall Study|Withdrawal by Subject|0|||
33629419|NCT03744312|102194317|FG001|Overall Study|Withdrawal by Subject|1|||
33629420|NCT03744312|102194316|FG000|Overall Study|Screen fail|0|||
33629421|NCT03744312|102194317|FG001|Overall Study|Screen fail|1|||
33629422|NCT03040999|102194318|FG000|Overall Study|Lost to Follow-up|1|||
33629423|NCT03040999|102194319|FG001|Overall Study|Lost to Follow-up|0|||
33629424|NCT03040999|102194318|FG000|Overall Study|Withdrawal by Subject|7|||
33629425|NCT03040999|102194319|FG001|Overall Study|Withdrawal by Subject|12|||
33629426|NCT03040999|102194318|FG000|Overall Study|Death|128|||
33629427|NCT03040999|102194319|FG001|Overall Study|Death|138|||
33629428|NCT03040999|102194318|FG000|Overall Study|Participants Ongoing in Trial|266|||
33629429|NCT03040999|102194319|FG001|Overall Study|Participants Ongoing in Trial|252|||
33629430|NCT00005780|102194329|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
33416125|NCT01414062|101413268|FG000|Overall Study|Family Disapproval|1|||
33416126|NCT01414062|101413269|FG001|Overall Study|Family Disapproval|0|||
33416127|NCT01414062|101413268|FG000|Overall Study|Withdrawal by Subject|0|||
33416128|NCT01414062|101413269|FG001|Overall Study|Withdrawal by Subject|1|||
33416129|NCT00602927|101413273|FG000|Period 1: 13 Days|Protocol Violation|2|||
33416130|NCT00602927|101413274|FG001|Period 1: 13 Days|Protocol Violation|4|||
33416131|NCT00602927|101413273|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
33416132|NCT00602927|101413274|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
33416133|NCT00602927|101413273|FG000|Period 1: 13 Days|Time|1|||
33416134|NCT00602927|101413274|FG001|Period 1: 13 Days|Time|0|||
33416135|NCT00602927|101413273|FG000|Period 1: 13 Days|Claustrophobia|0|||
33416136|NCT00602927|101413274|FG001|Period 1: 13 Days|Claustrophobia|1|||
33363236|NCT00092547|101217429|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
33416137|NCT00602927|101413273|FG000|Period 2: 14 Days|Protocol Violation|0|||
33416138|NCT00602927|101413274|FG001|Period 2: 14 Days|Protocol Violation|2|||
33416139|NCT00602927|101413273|FG000|Period 3: 13 Days|Protocol Violation|0|||
33416140|NCT00602927|101413274|FG001|Period 3: 13 Days|Protocol Violation|1|||
33416141|NCT00602927|101413273|FG000|Period 3: 13 Days|MRI data quality|2|||
33416142|NCT00602927|101413274|FG001|Period 3: 13 Days|MRI data quality|2|||
33416143|NCT00532779|101413275|FG000|Overall Study|Adverse Event|122|||
33416144|NCT00532779|101413276|FG001|Overall Study|Adverse Event|112|||
33416145|NCT00532779|101413277|FG002|Overall Study|Adverse Event|56|||
33416146|NCT00532779|101413275|FG000|Overall Study|Lost to Follow-up|76|||
33416147|NCT00532779|101413276|FG001|Overall Study|Lost to Follow-up|65|||
33416148|NCT00532779|101413277|FG002|Overall Study|Lost to Follow-up|66|||
33416149|NCT00532779|101413275|FG000|Overall Study|Withdrawal by Subject|63|||
33416150|NCT00532779|101413276|FG001|Overall Study|Withdrawal by Subject|60|||
33416151|NCT00532779|101413277|FG002|Overall Study|Withdrawal by Subject|90|||
33416152|NCT00532779|101413275|FG000|Overall Study|Lack of Efficacy|12|||
33416153|NCT00532779|101413276|FG001|Overall Study|Lack of Efficacy|12|||
33416154|NCT00532779|101413277|FG002|Overall Study|Lack of Efficacy|40|||
33416155|NCT00532779|101413275|FG000|Overall Study|Protocol Violation|5|||
33416156|NCT00532779|101413276|FG001|Overall Study|Protocol Violation|9|||
33416157|NCT00532779|101413277|FG002|Overall Study|Protocol Violation|7|||
33416158|NCT00532779|101413275|FG000|Overall Study|Pregnancy|2|||
33416159|NCT00532779|101413276|FG001|Overall Study|Pregnancy|5|||
33416160|NCT00532779|101413277|FG002|Overall Study|Pregnancy|3|||
33416161|NCT00532779|101413275|FG000|Overall Study|Death|0|||
33416162|NCT00532779|101413276|FG001|Overall Study|Death|1|||
33416163|NCT00532779|101413277|FG002|Overall Study|Death|0|||
33416164|NCT00532779|101413275|FG000|Overall Study|Drug noncompliance, moved, other|14|||
33363237|NCT00092547|101217430|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
33363238|NCT00092547|101217431|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
33363239|NCT00092547|101217429|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
33363240|NCT00092547|101217430|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
33363241|NCT00092547|101217431|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
33363242|NCT02138110|101217439|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
33363243|NCT02138110|101217439|FG000|Overall Scaffold Implantation|Death|3|||
33363244|NCT01597193|101217440|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
33416165|NCT00532779|101413276|FG001|Overall Study|Drug noncompliance, moved, other|23|||
33363245|NCT01597193|101217441|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
33363246|NCT01597193|101217442|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
33416166|NCT00532779|101413277|FG002|Overall Study|Drug noncompliance, moved, other|29|||
33416167|NCT00713830|101413280|FG000|Overall Study|Adverse Event|23|||
33416168|NCT00713830|101413281|FG001|Overall Study|Adverse Event|71|||
33416169|NCT00713830|101413280|FG000|Overall Study|Lack of Efficacy|24|||
33416170|NCT00713830|101413281|FG001|Overall Study|Lack of Efficacy|16|||
33416171|NCT00713830|101413280|FG000|Overall Study|Lost to Follow-up|2|||
33416172|NCT00713830|101413281|FG001|Overall Study|Lost to Follow-up|9|||
33416173|NCT00713830|101413280|FG000|Overall Study|Withdrawal by Subject|13|||
33416174|NCT00713830|101413281|FG001|Overall Study|Withdrawal by Subject|23|||
33416175|NCT00713830|101413280|FG000|Overall Study|Poor Compliance to Protocol|7|||
33416176|NCT00713830|101413281|FG001|Overall Study|Poor Compliance to Protocol|14|||
33416177|NCT00713830|101413280|FG000|Overall Study|Familial and Personal Reasons|9|||
33416178|NCT00713830|101413281|FG001|Overall Study|Familial and Personal Reasons|34|||
33416179|NCT00713830|101413280|FG000|Overall Study|Sponsor Decision|4|||
33416180|NCT00713830|101413281|FG001|Overall Study|Sponsor Decision|10|||
33416181|NCT00447265|101413284|FG000|Overall Study|Physician Decision|1|||
33416182|NCT00447265|101413285|FG001|Overall Study|Physician Decision|0|||
33629431|NCT02182895|102194333|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
33629432|NCT02182895|102194334|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
33629433|NCT02060721|102194335|FG000|Overall Study|Lost to Follow-up|1|||
33363247|NCT01597193|101217443|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
33363248|NCT01597193|101217444|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
33363249|NCT01597193|101217445|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
33363250|NCT01597193|101217446|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
33363251|NCT01597193|101217440|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
33363252|NCT01597193|101217441|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
33363253|NCT01597193|101217442|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
33363254|NCT01597193|101217443|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
33363255|NCT01597193|101217444|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
33363256|NCT01597193|101217445|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
33363257|NCT01597193|101217446|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
33363258|NCT01597193|101217440|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
33363259|NCT01597193|101217441|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
33363260|NCT01597193|101217442|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
33363261|NCT01597193|101217443|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
33363262|NCT01597193|101217444|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
33629434|NCT02060721|102194335|FG000|Overall Study|Physician Decision|2|||
33629435|NCT02060721|102194335|FG000|Overall Study|Death|14|||
33629436|NCT02060721|102194335|FG000|Overall Study|Withdrawal by Subject|2|||
33629437|NCT02060721|102194335|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
33629438|NCT01097668|102194336|FG000|Overall Study|Withdrawal by Subject|1|||
33629439|NCT01097668|102194337|FG001|Overall Study|Withdrawal by Subject|2|||
33363263|NCT01597193|101217445|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
33363264|NCT01597193|101217446|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
33363265|NCT01597193|101217440|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
33363266|NCT01597193|101217441|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
33363267|NCT01597193|101217442|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
33363268|NCT01597193|101217443|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
33363269|NCT01597193|101217444|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
33363270|NCT01597193|101217445|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
33363271|NCT01597193|101217446|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
33363272|NCT01597193|101217440|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
33363273|NCT01597193|101217441|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
33363274|NCT01597193|101217442|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
33363275|NCT01597193|101217443|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
33363276|NCT01597193|101217444|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
33363277|NCT01597193|101217445|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
33363278|NCT01597193|101217446|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
33629440|NCT01097668|102194336|FG000|Overall Study|Lost to Follow-up|1|||
33629441|NCT01097668|102194337|FG001|Overall Study|Lost to Follow-up|0|||
33629442|NCT04924062|102194343|FG000|Overall Study|Death|49|||
33629443|NCT04924062|102194344|FG001|Overall Study|Death|63|||
33629444|NCT04924062|102194343|FG000|Overall Study|Participant On-going|26|||
33629445|NCT04924062|102194344|FG001|Overall Study|Participant On-going|20|||
33629446|NCT02246530|102194345|FG000|Overall Study|Lost to Follow-up|4|||
33629447|NCT02246530|102194346|FG001|Overall Study|Lost to Follow-up|0|||
33222686|NCT02799472|100715922|FG001|Overall Study|Lack of Efficacy|0|||
33222687|NCT02799472|100715921|FG000|Overall Study|Lost to Follow-up|0|||
33363279|NCT00593112|101217447|FG000|Overall Study|Scan Anxiety|3|||
33363280|NCT00593112|101217448|FG001|Overall Study|Scan Anxiety|0|||
33363281|NCT00593112|101217447|FG000|Overall Study|Abnormal Scan|1|||
33629448|NCT00764699|102194349|FG000|Overall Study|PI left and study terminated|3|||
33363282|NCT00593112|101217448|FG001|Overall Study|Abnormal Scan|0|||
33363283|NCT00593112|101217447|FG000|Overall Study|Unreadable Scan|1|||
33363284|NCT00593112|101217448|FG001|Overall Study|Unreadable Scan|0|||
33416183|NCT00337727|101413286|FG000|Overall Study|Adverse Event|5|||
33416184|NCT00337727|101413287|FG001|Overall Study|Adverse Event|3|||
33629449|NCT05064735|102194350|FG000|Overall Study|Withdrawal by Subject|7|||
33629450|NCT05064735|102194351|FG001|Overall Study|Withdrawal by Subject|8|||
33222688|NCT02799472|100715922|FG001|Overall Study|Lost to Follow-up|1|||
33222689|NCT03092375|100715923|FG000|Overall Study|Lack of Efficacy|0|||
33629451|NCT05064735|102194350|FG000|Overall Study|Lost to Follow-up|7|||
33629452|NCT05064735|102194351|FG001|Overall Study|Lost to Follow-up|2|||
33629453|NCT05064735|102194350|FG000|Overall Study|Physician Decision|2|||
33629454|NCT05064735|102194351|FG001|Overall Study|Physician Decision|1|||
33629455|NCT05064735|102194350|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
33629456|NCT05064735|102194351|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
33629457|NCT05064735|102194350|FG000|Overall Study|Site Closure|7|||
33629458|NCT05064735|102194351|FG001|Overall Study|Site Closure|2|||
33629459|NCT04079296|102194352|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
33629460|NCT04079296|102194353|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
33629461|NCT04079296|102194354|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
33629462|NCT04079296|102194355|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
33629463|NCT04079296|102194356|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
33629464|NCT04079296|102194352|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
33363285|NCT00593112|101217447|FG000|Overall Study|Withdrawal by Subject|5|||
33363286|NCT00593112|101217448|FG001|Overall Study|Withdrawal by Subject|0|||
33363287|NCT03704051|101217449|FG000|Overall Study|Withdrawal by Subject|4|||
33363288|NCT03704051|101217450|FG001|Overall Study|Withdrawal by Subject|0|||
33363289|NCT00450866|101217453|FG000|Overall Study|Adverse Event|0|||
33363290|NCT00450866|101217454|FG001|Overall Study|Adverse Event|1|||
33363291|NCT00450866|101217453|FG000|Overall Study|Withdrawal by Subject|5|||
33363292|NCT00450866|101217454|FG001|Overall Study|Withdrawal by Subject|2|||
33363293|NCT00450866|101217453|FG000|Overall Study|Death|1|||
33363294|NCT00450866|101217454|FG001|Overall Study|Death|0|||
33363295|NCT00450866|101217453|FG000|Overall Study|Physician Decision|1|||
33363296|NCT00450866|101217454|FG001|Overall Study|Physician Decision|0|||
33363297|NCT00909090|101217455|FG000|Overall Study|Lost to Follow-up|17|||
33363298|NCT00909090|101217456|FG001|Overall Study|Lost to Follow-up|17|||
33363299|NCT00916721|101217457|FG000|Overall Study|Lost to Follow-up|0|||
33363300|NCT00916721|101217458|FG001|Overall Study|Lost to Follow-up|1|||
33363301|NCT00916721|101217457|FG000|Overall Study|Adverse Event|6|||
33629465|NCT04079296|102194353|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
33629466|NCT04079296|102194354|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
33629467|NCT04079296|102194355|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
33629468|NCT04079296|102194356|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
33629469|NCT04079296|102194352|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
33629470|NCT04079296|102194353|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
33629471|NCT04079296|102194354|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
33629472|NCT04079296|102194355|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
33629473|NCT04079296|102194356|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
33629474|NCT04079296|102194352|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
33629475|NCT04079296|102194353|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
33629476|NCT04079296|102194354|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
33629477|NCT04079296|102194355|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
33629478|NCT04079296|102194356|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
33629479|NCT04079296|102194352|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
33629480|NCT04079296|102194353|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
33629481|NCT04079296|102194354|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
33629482|NCT04079296|102194355|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
33629483|NCT04079296|102194356|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
33629484|NCT04079296|102194352|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
33363302|NCT00916721|101217458|FG001|Overall Study|Adverse Event|3|||
33363303|NCT00916721|101217457|FG000|Overall Study|Withdrawal by Subject|2|||
33629485|NCT04079296|102194353|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
33629486|NCT04079296|102194354|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
33629487|NCT04079296|102194355|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
33629488|NCT04079296|102194356|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
33629489|NCT04079296|102194352|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
33629490|NCT04079296|102194353|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
33363304|NCT00916721|101217458|FG001|Overall Study|Withdrawal by Subject|2|||
33363305|NCT00916721|101217457|FG000|Overall Study|Protocol Violation|2|||
33363306|NCT00916721|101217458|FG001|Overall Study|Protocol Violation|4|||
33416185|NCT00337727|101413286|FG000|Overall Study|Lost to Follow-up|5|||
33629491|NCT04079296|102194354|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
33629492|NCT04079296|102194355|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
33629493|NCT04079296|102194356|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
33629494|NCT04079296|102194352|FG000|Dose Expansion Phase (168 Days)|Death|0|||
33629495|NCT04079296|102194353|FG001|Dose Expansion Phase (168 Days)|Death|0|||
33629496|NCT04079296|102194354|FG002|Dose Expansion Phase (168 Days)|Death|0|||
33629497|NCT04079296|102194355|FG003|Dose Expansion Phase (168 Days)|Death|1|||
33629498|NCT04079296|102194356|FG004|Dose Expansion Phase (168 Days)|Death|0|||
33629499|NCT02358473|102194361|FG000|Overall Study|Disease Progession|6|||
33629500|NCT02358473|102194361|FG000|Overall Study|Adverse Event|3|||
33629501|NCT02358473|102194361|FG000|Overall Study|Withdrawal by Subject|2|||
33629502|NCT02358473|102194361|FG000|Overall Study|Physician Decision|2|||
33629503|NCT00262860|102194362|FG000|Overall Study|Adverse Event|2|||
33629504|NCT01169103|102194365|FG000|Overall Study|Lost to Follow-up|3|||
33629505|NCT01169103|102194366|FG001|Overall Study|Lost to Follow-up|3|||
33629506|NCT01169103|102194365|FG000|Overall Study|Withdrawal by Subject|3|||
33629507|NCT01169103|102194366|FG001|Overall Study|Withdrawal by Subject|1|||
33629508|NCT04739982|102194368|FG000|Overall Study|Lost to Follow-up|176|||
33629509|NCT04739982|102194369|FG001|Overall Study|Lost to Follow-up|65|||
33629510|NCT04739982|102194368|FG000|Overall Study|Withdrawal by Subject|19|||
33629511|NCT04739982|102194369|FG001|Overall Study|Withdrawal by Subject|0|||
33222690|NCT03092375|100715924|FG001|Overall Study|Lack of Efficacy|1|||
33222691|NCT03092375|100715925|FG002|Overall Study|Lack of Efficacy|1|||
33222692|NCT03092375|100715926|FG003|Overall Study|Lack of Efficacy|0|||
33565775|NCT00863304|101970464|FG003|Overall Study|Entered extension study|125|||
33565776|NCT03391882|101970465|FG000|Study Overall|Adverse Event|3|||
33565777|NCT03391882|101970466|FG001|Study Overall|Adverse Event|6|||
33565778|NCT03391882|101970467|FG002|Study Overall|Adverse Event|1|||
33565779|NCT03391882|101970468|FG003|Study Overall|Adverse Event|1|||
33565780|NCT03391882|101970469|FG004|Study Overall|Adverse Event|3|||
33565781|NCT03391882|101970470|FG005|Study Overall|Adverse Event|1|||
33565782|NCT03391882|101970465|FG000|Study Overall|Lack of Efficacy|13|||
33565783|NCT03391882|101970466|FG001|Study Overall|Lack of Efficacy|9|||
33565784|NCT03391882|101970467|FG002|Study Overall|Lack of Efficacy|0|||
33565785|NCT03391882|101970468|FG003|Study Overall|Lack of Efficacy|0|||
33565786|NCT03391882|101970469|FG004|Study Overall|Lack of Efficacy|0|||
33565787|NCT03391882|101970470|FG005|Study Overall|Lack of Efficacy|0|||
33565788|NCT03391882|101970465|FG000|Study Overall|Withdrawal by Subject|3|||
33565789|NCT03391882|101970466|FG001|Study Overall|Withdrawal by Subject|3|||
33565790|NCT03391882|101970467|FG002|Study Overall|Withdrawal by Subject|2|||
33565791|NCT03391882|101970468|FG003|Study Overall|Withdrawal by Subject|2|||
33565792|NCT03391882|101970469|FG004|Study Overall|Withdrawal by Subject|1|||
33565793|NCT03391882|101970470|FG005|Study Overall|Withdrawal by Subject|3|||
33565794|NCT03391882|101970465|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
33565795|NCT03391882|101970466|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
33565796|NCT03391882|101970467|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
33565797|NCT03391882|101970468|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
33565798|NCT03391882|101970469|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
33565799|NCT03391882|101970470|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
33565800|NCT03391882|101970465|FG000|Study Overall|Protocol Violation|1|||
33565801|NCT03391882|101970466|FG001|Study Overall|Protocol Violation|0|||
33565802|NCT03391882|101970467|FG002|Study Overall|Protocol Violation|0|||
33565803|NCT03391882|101970468|FG003|Study Overall|Protocol Violation|0|||
33565804|NCT03391882|101970469|FG004|Study Overall|Protocol Violation|0|||
33565805|NCT03391882|101970470|FG005|Study Overall|Protocol Violation|0|||
33565806|NCT03391882|101970465|FG000|Part A - Titration Phase|Adverse Event|3|||
33565807|NCT03391882|101970466|FG001|Part A - Titration Phase|Adverse Event|6|||
33565808|NCT03391882|101970467|FG002|Part A - Titration Phase|Adverse Event|0|||
33565809|NCT03391882|101970468|FG003|Part A - Titration Phase|Adverse Event|0|||
33565810|NCT03391882|101970469|FG004|Part A - Titration Phase|Adverse Event|0|||
33565811|NCT03391882|101970470|FG005|Part A - Titration Phase|Adverse Event|0|||
33565812|NCT03391882|101970465|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
33565813|NCT03391882|101970466|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
33565814|NCT03391882|101970467|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
33565815|NCT03391882|101970468|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
33565816|NCT03391882|101970469|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
33565817|NCT03391882|101970470|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
33629512|NCT04739982|102194368|FG000|Overall Study|Protocol Violation|0|||
33629513|NCT04739982|102194369|FG001|Overall Study|Protocol Violation|5|||
33629514|NCT03796728|102194370|FG000|Overall Study|Lost to Follow-up|8|||
33629515|NCT03796728|102194370|FG000|Overall Study|Reason not Specified|16|||
33629516|NCT02731638|102194371|FG000|Overall Study|Lost to Follow-up|6|||
33629517|NCT02731638|102194372|FG001|Overall Study|Lost to Follow-up|9|||
33629518|NCT00980954|102194373|FG000|Overall Study|Protocol Violation|9|||
33565818|NCT03391882|101970465|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
33565819|NCT03391882|101970466|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
33629519|NCT00980954|102194374|FG001|Overall Study|Protocol Violation|15|||
33222693|NCT01995539|100715927|FG000|Overall Study|Screening Failure|1|||
33363307|NCT03321929|101217459|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
33363308|NCT01056523|101217460|FG000|Overall Study|Death|1|||
33363309|NCT01056523|101217461|FG001|Overall Study|Death|0|||
33363310|NCT01056523|101217462|FG002|Overall Study|Death|2|||
33565820|NCT03391882|101970467|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
33565821|NCT03391882|101970468|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
33565822|NCT03391882|101970469|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
33565823|NCT03391882|101970470|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
33565824|NCT03391882|101970465|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
33565825|NCT03391882|101970466|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
33565826|NCT03391882|101970467|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
33565827|NCT03391882|101970468|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
33565828|NCT03391882|101970469|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
33565829|NCT03391882|101970470|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
33565830|NCT03391882|101970465|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
33565831|NCT03391882|101970466|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
33565832|NCT03391882|101970467|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
33565833|NCT03391882|101970468|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
33565834|NCT03391882|101970469|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
33565835|NCT03391882|101970470|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
33565836|NCT03391882|101970465|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
33565837|NCT03391882|101970466|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
33565838|NCT03391882|101970467|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
33565839|NCT03391882|101970468|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
33565840|NCT03391882|101970469|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
33565841|NCT03391882|101970470|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
33565842|NCT03391882|101970465|FG000|Part B - Treatment Phase|Adverse Event|0|||
33565843|NCT03391882|101970466|FG001|Part B - Treatment Phase|Adverse Event|0|||
33565844|NCT03391882|101970467|FG002|Part B - Treatment Phase|Adverse Event|1|||
33565845|NCT03391882|101970468|FG003|Part B - Treatment Phase|Adverse Event|1|||
33565846|NCT03391882|101970469|FG004|Part B - Treatment Phase|Adverse Event|3|||
33565847|NCT03391882|101970470|FG005|Part B - Treatment Phase|Adverse Event|1|||
33565848|NCT03391882|101970465|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
33565849|NCT03391882|101970466|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
33565850|NCT03391882|101970467|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
33565851|NCT03391882|101970468|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
33565852|NCT03391882|101970469|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
33565853|NCT03391882|101970470|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
33565854|NCT04237584|101970472|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
33565855|NCT04237584|101970473|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
33565856|NCT04237584|101970474|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
33565857|NCT04237584|101970475|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
33565858|NCT04237584|101970472|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
33565859|NCT04237584|101970473|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
33565860|NCT04237584|101970474|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
33565861|NCT04237584|101970475|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
33565862|NCT04237584|101970472|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
33565863|NCT04237584|101970473|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
33565864|NCT04237584|101970474|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
33565865|NCT04237584|101970475|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
33565866|NCT04237584|101970472|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
33565867|NCT04237584|101970473|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
33565868|NCT04237584|101970474|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
33565869|NCT04237584|101970475|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
33565870|NCT04237584|101970472|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
33565871|NCT04237584|101970473|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
33565872|NCT04237584|101970474|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
33565873|NCT04237584|101970475|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
33565874|NCT02457065|101970478|FG000|Overall Study|Lost to Follow-up|9|||
33363311|NCT01056523|101217463|FG003|Overall Study|Death|3|||
33363312|NCT01056523|101217464|FG004|Overall Study|Death|0|||
33363313|NCT01056523|101217465|FG005|Overall Study|Death|0|||
33629520|NCT04097678|102194375|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
33629521|NCT04097678|102194376|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
33629522|NCT00435409|102194377|FG000|Overall Study|Protocol Violation|1|||
33629523|NCT00435409|102194378|FG001|Overall Study|Protocol Violation|2|||
33629524|NCT00435409|102194379|FG002|Overall Study|Protocol Violation|0|||
33629525|NCT00435409|102194377|FG000|Overall Study|Lost to Follow-up|1|||
33629526|NCT00435409|102194378|FG001|Overall Study|Lost to Follow-up|2|||
33629527|NCT00435409|102194379|FG002|Overall Study|Lost to Follow-up|0|||
33629528|NCT00435409|102194377|FG000|Overall Study|Death|8|||
33629529|NCT00435409|102194378|FG001|Overall Study|Death|6|||
33629530|NCT00435409|102194379|FG002|Overall Study|Death|6|||
33629531|NCT00435409|102194377|FG000|Overall Study|Objective progression or relapse|158|||
33629532|NCT00435409|102194378|FG001|Overall Study|Objective progression or relapse|93|||
33363314|NCT01056523|101217466|FG006|Overall Study|Death|1|||
33363315|NCT05111249|101217467|FG000|Overall Study|Lost to Follow-up|0|||
33363316|NCT05111249|101217468|FG001|Overall Study|Lost to Follow-up|2|||
33629533|NCT00435409|102194379|FG002|Overall Study|Objective progression or relapse|58|||
33629534|NCT00435409|102194377|FG000|Overall Study|Global deterioration of health status|0|||
33629535|NCT00435409|102194378|FG001|Overall Study|Global deterioration of health status|0|||
33629536|NCT00435409|102194379|FG002|Overall Study|Global deterioration of health status|4|||
33629537|NCT00435409|102194377|FG000|Overall Study|Withdrawal by Subject|8|||
33629538|NCT00435409|102194378|FG001|Overall Study|Withdrawal by Subject|7|||
33629539|NCT00435409|102194379|FG002|Overall Study|Withdrawal by Subject|1|||
33629540|NCT00435409|102194377|FG000|Overall Study|Other|45|||
33363317|NCT05111249|101217467|FG000|Overall Study|Physician Decision|0|||
33363318|NCT05111249|101217468|FG001|Overall Study|Physician Decision|1|||
33363319|NCT05111249|101217467|FG000|Overall Study|Participant decision|1|||
33363320|NCT05111249|101217468|FG001|Overall Study|Participant decision|5|||
33629541|NCT00435409|102194378|FG001|Overall Study|Other|30|||
33629542|NCT00435409|102194379|FG002|Overall Study|Other|1|||
33629543|NCT00435409|102194377|FG000|Overall Study|Adverse Event|0|||
33629544|NCT00435409|102194378|FG001|Overall Study|Adverse Event|0|||
33629545|NCT00435409|102194379|FG002|Overall Study|Adverse Event|8|||
33629546|NCT00435409|102194377|FG000|Overall Study|Sponsor decision|0|||
33629547|NCT00435409|102194378|FG001|Overall Study|Sponsor decision|3|||
33629548|NCT00435409|102194379|FG002|Overall Study|Sponsor decision|0|||
33629549|NCT03633396|102194381|FG000|Overall Study|Withdrawal by Subject|4|||
33629550|NCT03633396|102194382|FG001|Overall Study|Withdrawal by Subject|4|||
33629551|NCT03633396|102194381|FG000|Overall Study|Adverse Event|1|||
33629552|NCT03633396|102194382|FG001|Overall Study|Adverse Event|1|||
33629553|NCT03633396|102194381|FG000|Overall Study|Lack of Efficacy|1|||
33629554|NCT03633396|102194382|FG001|Overall Study|Lack of Efficacy|0|||
33629555|NCT03633396|102194381|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
33629556|NCT03633396|102194382|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
33629557|NCT00976274|102194383|FG000|Overall Study|Lost to Follow-up|5|||
33629558|NCT00976274|102194384|FG001|Overall Study|Lost to Follow-up|5|||
33629559|NCT00976274|102194383|FG000|Overall Study|Withdrawal by Subject|1|||
33629560|NCT00976274|102194384|FG001|Overall Study|Withdrawal by Subject|1|||
33629561|NCT00976274|102194383|FG000|Overall Study|Physician Decision|1|||
33629562|NCT00976274|102194384|FG001|Overall Study|Physician Decision|2|||
33629563|NCT03985761|102194391|FG000|Overall Study|Withdrawal by Subject|2|||
33629564|NCT03985761|102194392|FG001|Overall Study|Withdrawal by Subject|3|||
33629565|NCT00627393|102194396|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
33629566|NCT00627393|102194397|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
33629567|NCT00627393|102194396|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
33629568|NCT00627393|102194397|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
33222694|NCT01995539|100715927|FG000|Overall Study|Withdrawal by Investigator|15|||
33222695|NCT01995539|100715927|FG000|Overall Study|Withdrawal by Subject|11|||
33222696|NCT01995539|100715927|FG000|Overall Study|Lost to Follow-up|5|||
33222697|NCT01995539|100715927|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
33363321|NCT01712438|101217469|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
33363322|NCT01712438|101217469|FG000|Overall Study|Ongoing ITI treatment|6|||
33363323|NCT01712438|101217469|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
33363324|NCT01712438|101217469|FG000|Overall Study|Prematurely Discontinued|25|||
33629569|NCT00627393|102194396|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
33629570|NCT00627393|102194397|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
33629571|NCT00627393|102194396|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
33629572|NCT00627393|102194397|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
33629573|NCT03858049|102194398|FG000|Overall Study|Adverse Event|16|||
33629574|NCT03858049|102194399|FG001|Overall Study|Adverse Event|9|||
33629575|NCT03858049|102194398|FG000|Overall Study|Other|1|||
33629576|NCT03858049|102194399|FG001|Overall Study|Other|1|||
33629577|NCT03157830|102194400|FG000|Overall Study|Lost to Follow-up|1|||
33363325|NCT03988751|101217472|FG000|Overall Study|Withdrawal by Subject|1|||
33222698|NCT03131960|100715928|FG000|Overall Study|Adverse Event|0|||
33416186|NCT00337727|101413287|FG001|Overall Study|Lost to Follow-up|4|||
33416187|NCT00337727|101413286|FG000|Overall Study|Physician Decision|1|||
33416188|NCT00337727|101413287|FG001|Overall Study|Physician Decision|0|||
33416189|NCT00337727|101413286|FG000|Overall Study|Protocol Violation|4|||
33416190|NCT00337727|101413287|FG001|Overall Study|Protocol Violation|0|||
33416191|NCT00337727|101413286|FG000|Overall Study|Withdrawal by Subject|3|||
33416192|NCT00337727|101413287|FG001|Overall Study|Withdrawal by Subject|5|||
33416193|NCT00903409|101413293|FG000|Overall Study|Adverse Event|11|||
33416194|NCT00903409|101413294|FG001|Overall Study|Adverse Event|9|||
33416195|NCT00903409|101413293|FG000|Overall Study|Non-compliance with Protocol|1|||
33416196|NCT00903409|101413294|FG001|Overall Study|Non-compliance with Protocol|1|||
33416197|NCT00903409|101413293|FG000|Overall Study|Laboratory Abnormality|2|||
33565875|NCT02457065|101970479|FG001|Overall Study|Lost to Follow-up|11|||
33565876|NCT02082977|101970485|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
33565877|NCT02082977|101970486|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
33565878|NCT02082977|101970487|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
33565879|NCT02082977|101970488|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
33565880|NCT02082977|101970489|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
33565881|NCT02082977|101970490|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
33565882|NCT02082977|101970491|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
33565883|NCT02082977|101970492|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
33565884|NCT02082977|101970493|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
33565885|NCT02082977|101970494|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
33565886|NCT02082977|101970485|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33565887|NCT02082977|101970486|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33565888|NCT02082977|101970487|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33565889|NCT02082977|101970488|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33565890|NCT02082977|101970489|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33565891|NCT02082977|101970490|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33565892|NCT02082977|101970491|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33629578|NCT03157830|102194400|FG000|Overall Study|Withdrawal by Subject|1|||
33629579|NCT02558894|102194401|FG000|Overall Study|Death; any cause, entire study duration|28|||
33565893|NCT02082977|101970492|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
33565894|NCT02082977|101970493|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33565895|NCT02082977|101970494|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
33565896|NCT02082977|101970485|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33565897|NCT02082977|101970486|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33565898|NCT02082977|101970487|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33565899|NCT02082977|101970488|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33565900|NCT02082977|101970489|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33565901|NCT02082977|101970490|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
33565902|NCT02082977|101970491|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33565903|NCT02082977|101970492|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33565904|NCT02082977|101970493|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33565905|NCT02082977|101970494|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
33565906|NCT02082977|101970485|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
33565907|NCT02082977|101970486|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
33565908|NCT02082977|101970487|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
33565909|NCT02082977|101970488|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
33565910|NCT02082977|101970489|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
33565911|NCT02082977|101970490|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
33565912|NCT02082977|101970491|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
33565913|NCT02082977|101970492|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
33565914|NCT02082977|101970493|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
33565915|NCT02082977|101970494|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
33565916|NCT02082977|101970485|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33565917|NCT02082977|101970486|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33565918|NCT02082977|101970487|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33565919|NCT02082977|101970488|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33565920|NCT02082977|101970489|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33565921|NCT02082977|101970490|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33565922|NCT02082977|101970491|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33565923|NCT02082977|101970492|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
33565924|NCT02082977|101970493|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33629580|NCT02558894|102194402|FG001|Overall Study|Death; any cause, entire study duration|31|||
33629581|NCT02558894|102194401|FG000|Overall Study|Withdrawal by Subject|2|||
33629582|NCT02558894|102194402|FG001|Overall Study|Withdrawal by Subject|1|||
33629583|NCT02558894|102194401|FG000|Overall Study|Closure of Part A|2|||
33629584|NCT02558894|102194402|FG001|Overall Study|Closure of Part A|1|||
33629585|NCT00882440|102194403|FG000|Overall Study|Adverse Event|2|||
33222699|NCT03131960|100715929|FG001|Overall Study|Adverse Event|1|||
33222700|NCT00106184|100715935|FG000|Overall Study|Withdrawal by Subject|3|||
33222701|NCT00106184|100715936|FG001|Overall Study|Withdrawal by Subject|2|||
33222702|NCT01490125|100715937|FG000|Period I|Adverse Event|4|||
33222703|NCT01490125|100715938|FG001|Period I|Adverse Event|1|||
33363326|NCT03988751|101217473|FG001|Overall Study|Withdrawal by Subject|0|||
33363327|NCT03988751|101217472|FG000|Overall Study|Protocol Violation|0|||
33363328|NCT03988751|101217473|FG001|Overall Study|Protocol Violation|1|||
33363329|NCT02168946|101217476|FG000|Overall Study|Adverse Event|8|||
33363330|NCT02168946|101217477|FG001|Overall Study|Adverse Event|5|||
33363331|NCT02168946|101217476|FG000|Overall Study|Lost to Follow-up|3|||
33629586|NCT00882440|102194404|FG001|Overall Study|Adverse Event|2|||
33629587|NCT00882440|102194405|FG002|Overall Study|Adverse Event|2|||
33629588|NCT00882440|102194406|FG003|Overall Study|Adverse Event|1|||
33629589|NCT00882440|102194407|FG004|Overall Study|Adverse Event|1|||
33629590|NCT00882440|102194408|FG005|Overall Study|Adverse Event|4|||
33629591|NCT00882440|102194409|FG006|Overall Study|Adverse Event|2|||
33629592|NCT00882440|102194403|FG000|Overall Study|Lack of Efficacy|3|||
33629593|NCT00882440|102194404|FG001|Overall Study|Lack of Efficacy|5|||
33629594|NCT00882440|102194405|FG002|Overall Study|Lack of Efficacy|2|||
33629595|NCT00882440|102194406|FG003|Overall Study|Lack of Efficacy|0|||
33629596|NCT00882440|102194407|FG004|Overall Study|Lack of Efficacy|0|||
33629597|NCT00882440|102194408|FG005|Overall Study|Lack of Efficacy|3|||
33629598|NCT00882440|102194409|FG006|Overall Study|Lack of Efficacy|0|||
33629599|NCT00882440|102194403|FG000|Overall Study|Lost to Follow-up|2|||
33629600|NCT00882440|102194404|FG001|Overall Study|Lost to Follow-up|0|||
33629601|NCT00882440|102194405|FG002|Overall Study|Lost to Follow-up|1|||
33629602|NCT00882440|102194406|FG003|Overall Study|Lost to Follow-up|1|||
33629603|NCT00882440|102194407|FG004|Overall Study|Lost to Follow-up|1|||
33629604|NCT00882440|102194408|FG005|Overall Study|Lost to Follow-up|0|||
33629605|NCT00882440|102194409|FG006|Overall Study|Lost to Follow-up|1|||
33629606|NCT00882440|102194403|FG000|Overall Study|Protocol Violation|0|||
33629607|NCT00882440|102194404|FG001|Overall Study|Protocol Violation|0|||
33629608|NCT00882440|102194405|FG002|Overall Study|Protocol Violation|1|||
33629609|NCT00882440|102194406|FG003|Overall Study|Protocol Violation|1|||
33629610|NCT00882440|102194407|FG004|Overall Study|Protocol Violation|1|||
33629611|NCT00882440|102194408|FG005|Overall Study|Protocol Violation|0|||
33629612|NCT00882440|102194409|FG006|Overall Study|Protocol Violation|0|||
33629613|NCT00882440|102194403|FG000|Overall Study|Withdrawal by Subject|2|||
33629614|NCT00882440|102194404|FG001|Overall Study|Withdrawal by Subject|1|||
33629615|NCT00882440|102194405|FG002|Overall Study|Withdrawal by Subject|1|||
33629616|NCT00882440|102194406|FG003|Overall Study|Withdrawal by Subject|0|||
33629617|NCT00882440|102194407|FG004|Overall Study|Withdrawal by Subject|6|||
33629618|NCT00882440|102194408|FG005|Overall Study|Withdrawal by Subject|0|||
33629619|NCT00882440|102194409|FG006|Overall Study|Withdrawal by Subject|1|||
33629620|NCT00882440|102194403|FG000|Overall Study|Patient Uncooperative|2|||
33629621|NCT00882440|102194404|FG001|Overall Study|Patient Uncooperative|0|||
33629622|NCT00882440|102194405|FG002|Overall Study|Patient Uncooperative|0|||
33629623|NCT00882440|102194406|FG003|Overall Study|Patient Uncooperative|0|||
33629624|NCT00882440|102194407|FG004|Overall Study|Patient Uncooperative|1|||
33629625|NCT00882440|102194408|FG005|Overall Study|Patient Uncooperative|0|||
33629626|NCT00882440|102194409|FG006|Overall Study|Patient Uncooperative|0|||
33629627|NCT04698343|102194410|FG000|Overall Study|Withdrawal by Subject|6|||
33629628|NCT04698343|102194410|FG000|Overall Study|Physician Decision|2|||
33629629|NCT04698343|102194410|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
33629630|NCT04698343|102194410|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
33629631|NCT04698343|102194410|FG000|Overall Study|Personal reasons|3|||
33629632|NCT04698343|102194410|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
33629633|NCT03924622|102194411|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
33629634|NCT03924622|102194412|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
33629635|NCT03924622|102194413|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
33629636|NCT03924622|102194414|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
33629637|NCT03924622|102194415|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
33629638|NCT03924622|102194416|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
33629639|NCT03770260|102194421|FG000|Overall Study|Disease progression|0|||
33629640|NCT03770260|102194422|FG001|Overall Study|Disease progression|1|||
33629641|NCT03770260|102194423|FG002|Overall Study|Disease progression|0|||
33629642|NCT03770260|102194424|FG003|Overall Study|Disease progression|0|||
33629643|NCT02647281|102194429|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33222704|NCT01490125|100715939|FG002|Period I|Adverse Event|1|||
33363332|NCT02168946|101217477|FG001|Overall Study|Lost to Follow-up|0|||
33222705|NCT01490125|100715940|FG003|Period I|Adverse Event|3|||
33629644|NCT02647281|102194430|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33629645|NCT02647281|102194431|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33222706|NCT01490125|100715941|FG004|Period I|Adverse Event|2|||
33222707|NCT01490125|100715942|FG005|Period I|Adverse Event|4|||
33222708|NCT01490125|100715937|FG000|Period I|Protocol Violation|1|||
33222709|NCT01490125|100715938|FG001|Period I|Protocol Violation|1|||
33222710|NCT01490125|100715939|FG002|Period I|Protocol Violation|1|||
33222711|NCT01490125|100715940|FG003|Period I|Protocol Violation|1|||
33222712|NCT01490125|100715941|FG004|Period I|Protocol Violation|0|||
33222713|NCT01490125|100715942|FG005|Period I|Protocol Violation|0|||
33363333|NCT02168946|101217476|FG000|Overall Study|Subject unable to come back for visits|1|||
33363334|NCT02168946|101217477|FG001|Overall Study|Subject unable to come back for visits|0|||
33629646|NCT02647281|102194432|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33629647|NCT02647281|102194433|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33629648|NCT02647281|102194434|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33629649|NCT02647281|102194435|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33629650|NCT02647281|102194436|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
33629651|NCT02647281|102194437|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
33629652|NCT05083351|102194442|FG000|Overall Study|Adverse Event|3|||
33629653|NCT05083351|102194442|FG000|Overall Study|Did not meet data inclusion criteria|8|||
33629654|NCT05083351|102194442|FG000|Overall Study|Did not meet eligibility criteria|19|||
33629655|NCT05083351|102194442|FG000|Overall Study|Study Staff Decision|19|||
33629656|NCT03661723|102194443|FG000|Overall Study|Disease Progression|4|||
33629657|NCT03661723|102194444|FG001|Overall Study|Disease Progression|24|||
33629658|NCT03661723|102194445|FG002|Overall Study|Disease Progression|4|||
33629659|NCT03661723|102194446|FG003|Overall Study|Disease Progression|19|||
33629660|NCT03661723|102194443|FG000|Overall Study|Withdrawal by Subject|1|||
33629661|NCT03661723|102194444|FG001|Overall Study|Withdrawal by Subject|0|||
33629662|NCT03661723|102194445|FG002|Overall Study|Withdrawal by Subject|2|||
33629663|NCT03661723|102194446|FG003|Overall Study|Withdrawal by Subject|4|||
33363335|NCT03634072|101217479|FG000|Overall Study|Early termination of overall study|1|||
33363336|NCT03634072|101217480|FG001|Overall Study|Early termination of overall study|0|||
33629664|NCT03661723|102194443|FG000|Overall Study|Physician Decision|1|||
33629665|NCT03661723|102194444|FG001|Overall Study|Physician Decision|0|||
33629666|NCT03661723|102194445|FG002|Overall Study|Physician Decision|0|||
33629667|NCT03661723|102194446|FG003|Overall Study|Physician Decision|0|||
33629668|NCT03661723|102194443|FG000|Overall Study|Clinical Deterioration|0|||
33629669|NCT03661723|102194444|FG001|Overall Study|Clinical Deterioration|0|||
33629670|NCT03661723|102194445|FG002|Overall Study|Clinical Deterioration|0|||
33629671|NCT03661723|102194446|FG003|Overall Study|Clinical Deterioration|1|||
33629672|NCT03096834|102194447|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
33629673|NCT03096834|102194448|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
33629674|NCT03096834|102194449|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
33629675|NCT03096834|102194450|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
33629676|NCT03096834|102194447|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
33629677|NCT03096834|102194448|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
33629678|NCT03096834|102194449|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
33629679|NCT03096834|102194450|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
33629680|NCT03096834|102194447|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
33629681|NCT03096834|102194448|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
33629682|NCT03096834|102194449|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
33629683|NCT03096834|102194450|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
33629684|NCT03096834|102194447|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
33629685|NCT03096834|102194448|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
33629686|NCT03096834|102194449|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
33629687|NCT03096834|102194450|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
33629688|NCT03096834|102194447|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
33629689|NCT03096834|102194448|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
33629690|NCT03096834|102194449|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
33629691|NCT03096834|102194450|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
33629692|NCT03096834|102194447|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
33222714|NCT01490125|100715937|FG000|Period I|Withdrawal by Subject|1|||
33222715|NCT01490125|100715938|FG001|Period I|Withdrawal by Subject|3|||
33222716|NCT01490125|100715939|FG002|Period I|Withdrawal by Subject|2|||
33363337|NCT02601001|101217482|FG000|Dosing Period 2|Adverse Event|0|||
33363338|NCT02601001|101217483|FG001|Dosing Period 2|Adverse Event|0|||
33363339|NCT02601001|101217484|FG002|Dosing Period 2|Adverse Event|0|||
33363340|NCT02601001|101217485|FG003|Dosing Period 2|Adverse Event|0|||
33363341|NCT02601001|101217486|FG004|Dosing Period 2|Adverse Event|0|||
33629693|NCT03096834|102194448|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
33629694|NCT03096834|102194449|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
33629695|NCT03096834|102194450|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
33629696|NCT03096834|102194447|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
33629697|NCT03096834|102194448|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
33629698|NCT03096834|102194449|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
33629699|NCT03096834|102194450|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
33629700|NCT03096834|102194447|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
33629701|NCT03096834|102194448|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
33629702|NCT03096834|102194449|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
33629703|NCT03096834|102194450|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
33629704|NCT03096834|102194447|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
33629705|NCT03096834|102194448|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
33629706|NCT03096834|102194449|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
33629707|NCT03096834|102194450|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
33629708|NCT03096834|102194447|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
33629709|NCT03096834|102194448|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
33629710|NCT03096834|102194449|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
33629711|NCT03096834|102194450|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
33629712|NCT03096834|102194447|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
33629713|NCT03096834|102194448|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
33629714|NCT03096834|102194449|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
33629715|NCT03096834|102194450|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
33629716|NCT03096834|102194447|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
33629717|NCT03096834|102194448|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
33629718|NCT03096834|102194449|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
33629719|NCT03096834|102194450|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
33629720|NCT03525444|102194451|FG000|Overall Study|Adverse Event|0|||
33629721|NCT03525444|102194452|FG001|Overall Study|Adverse Event|1|||
33629722|NCT03525444|102194451|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
33629723|NCT03525444|102194452|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
33629724|NCT03525444|102194451|FG000|Overall Study|Other|0|||
33629725|NCT03525444|102194452|FG001|Overall Study|Other|1|||
33222717|NCT01490125|100715940|FG003|Period I|Withdrawal by Subject|1|||
33222718|NCT01490125|100715941|FG004|Period I|Withdrawal by Subject|2|||
33629726|NCT02340026|102194453|FG000|Treatment Phase|Withdrawal by Subject|2|||
33629727|NCT02340026|102194454|FG001|Treatment Phase|Withdrawal by Subject|2|||
33222719|NCT01490125|100715942|FG005|Period I|Withdrawal by Subject|1|||
33363342|NCT02601001|101217487|FG005|Dosing Period 2|Adverse Event|0|||
33629728|NCT02340026|102194453|FG000|Follow-up Phase|Lost to Follow-up|1|||
33629729|NCT02340026|102194454|FG001|Follow-up Phase|Lost to Follow-up|0|||
33629730|NCT01680341|102194455|FG000|Overall Study|Adverse Event|3|||
33629731|NCT01680341|102194456|FG001|Overall Study|Adverse Event|2|||
33222720|NCT01490125|100715937|FG000|Period II|Adverse Event|2|||
33565925|NCT02082977|101970494|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
33565926|NCT00581100|101970498|FG000|Overall Study|Death|1|||
33565927|NCT00581100|101970499|FG001|Overall Study|Death|0|||
33565928|NCT00581100|101970498|FG000|Overall Study|Adverse Event|2|||
33565929|NCT00581100|101970499|FG001|Overall Study|Adverse Event|1|||
33565930|NCT00581100|101970498|FG000|Overall Study|Withdrawal by Subject|1|||
33565931|NCT00581100|101970499|FG001|Overall Study|Withdrawal by Subject|4|||
33629732|NCT01680341|102194455|FG000|Overall Study|Unclassified|18|||
33629733|NCT01680341|102194456|FG001|Overall Study|Unclassified|15|||
33629734|NCT03589859|102194457|FG000|Overall Study|Withdrawal by Subject|0|||
33565932|NCT00581100|101970498|FG000|Overall Study|Other|3|||
33565933|NCT00581100|101970499|FG001|Overall Study|Other|0|||
33565934|NCT03204812|101970500|FG000|Overall Study|Adverse Event|3|||
33565935|NCT05166902|101970501|FG000|First Intervention|Lost to Follow-up|0|||
33565936|NCT05166902|101970502|FG001|First Intervention|Lost to Follow-up|1|||
33565937|NCT03468998|101970511|FG000|Overall Study|Withdrawal by Subject|1|||
33565938|NCT03468998|101970512|FG001|Overall Study|Withdrawal by Subject|1|||
33565939|NCT03468998|101970513|FG002|Overall Study|Withdrawal by Subject|0|||
33565940|NCT03468998|101970514|FG003|Overall Study|Withdrawal by Subject|4|||
33565941|NCT03468998|101970515|FG004|Overall Study|Withdrawal by Subject|1|||
33565942|NCT03468998|101970516|FG005|Overall Study|Withdrawal by Subject|0|||
33565943|NCT05270863|101970524|FG000|Visit 2 First Intervention|Randomization error|0|||
33565944|NCT05270863|101970525|FG001|Visit 2 First Intervention|Randomization error|0|||
33565945|NCT05270863|101970526|FG002|Visit 2 First Intervention|Randomization error|0|||
33629735|NCT03589859|102194458|FG001|Overall Study|Withdrawal by Subject|6|||
33629736|NCT03267277|102194459|FG000|Overall Study|Withdrawal by Subject|1|||
33629737|NCT05137041|102194467|FG000|Overall Study|Lost to Follow-up|1|||
33629738|NCT05137041|102194468|FG001|Overall Study|Lost to Follow-up|1|||
33629739|NCT05137041|102194467|FG000|Overall Study|Withdrawal by Subject|0|||
33629740|NCT05137041|102194468|FG001|Overall Study|Withdrawal by Subject|2|||
33629741|NCT05137041|102194467|FG000|Overall Study|Reason not Specified|0|||
33629742|NCT05137041|102194468|FG001|Overall Study|Reason not Specified|1|||
33629743|NCT01052493|102194470|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
33629744|NCT01052493|102194471|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
33629745|NCT01052493|102194472|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
33629746|NCT00179621|102194473|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
33629747|NCT00179621|102194474|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
33363343|NCT02601001|101217488|FG006|Dosing Period 2|Adverse Event|1|||
33363344|NCT03515538|101217489|FG000|Overall Study|Lack of Efficacy|2|||
33363345|NCT03515538|101217490|FG001|Overall Study|Lack of Efficacy|0|||
33363346|NCT03515538|101217491|FG002|Overall Study|Lack of Efficacy|2|||
33363347|NCT03515538|101217492|FG003|Overall Study|Lack of Efficacy|0|||
33363348|NCT03515538|101217489|FG000|Overall Study|Death|0|||
33363349|NCT03515538|101217490|FG001|Overall Study|Death|0|||
33363350|NCT03515538|101217491|FG002|Overall Study|Death|1|||
33363351|NCT03515538|101217492|FG003|Overall Study|Death|0|||
33363352|NCT03515538|101217489|FG000|Overall Study|Protocol Violation|0|||
33363353|NCT03515538|101217490|FG001|Overall Study|Protocol Violation|0|||
33363354|NCT03515538|101217491|FG002|Overall Study|Protocol Violation|0|||
33363355|NCT03515538|101217492|FG003|Overall Study|Protocol Violation|1|||
33363356|NCT03515538|101217489|FG000|Overall Study|Screen failure (baseline dropout)|0|||
33363357|NCT03515538|101217490|FG001|Overall Study|Screen failure (baseline dropout)|1|||
33363358|NCT03515538|101217491|FG002|Overall Study|Screen failure (baseline dropout)|0|||
33363359|NCT03515538|101217492|FG003|Overall Study|Screen failure (baseline dropout)|0|||
33363360|NCT03515538|101217489|FG000|Overall Study|Withdrawal by Subject|2|||
33363361|NCT03515538|101217490|FG001|Overall Study|Withdrawal by Subject|2|||
33363362|NCT03515538|101217491|FG002|Overall Study|Withdrawal by Subject|1|||
33363363|NCT03515538|101217492|FG003|Overall Study|Withdrawal by Subject|3|||
33363364|NCT03515538|101217489|FG000|Overall Study|Physician Decision|1|||
33363365|NCT03515538|101217490|FG001|Overall Study|Physician Decision|0|||
33363366|NCT03515538|101217491|FG002|Overall Study|Physician Decision|0|||
33363367|NCT03515538|101217492|FG003|Overall Study|Physician Decision|1|||
33363368|NCT01013883|101217495|FG000|Overall Study|Lost to Follow-up|2|||
33363369|NCT01013883|101217496|FG001|Overall Study|Lost to Follow-up|2|||
33363370|NCT00374907|101217497|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
33363371|NCT00374907|101217498|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
33363372|NCT00374907|101217497|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
33363373|NCT00374907|101217498|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
33363374|NCT00374907|101217497|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
33363375|NCT00374907|101217498|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
33363376|NCT00374907|101217497|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
33416198|NCT00903409|101413294|FG001|Overall Study|Laboratory Abnormality|0|||
33565946|NCT05270863|101970527|FG003|Visit 2 First Intervention|Randomization error|1|||
33629748|NCT00179621|102194475|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
33629749|NCT00179621|102194476|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
33629750|NCT00179621|102194473|FG000|Double-Blind Period|Adverse Event|2|||
33629751|NCT00179621|102194474|FG001|Double-Blind Period|Adverse Event|7|||
33629752|NCT00179621|102194475|FG002|Double-Blind Period|Adverse Event|4|||
33629753|NCT00179621|102194476|FG003|Double-Blind Period|Adverse Event|0|||
33629754|NCT00179621|102194473|FG000|Double-Blind Period|Withdrawal by Subject|2|||
33629755|NCT00179621|102194474|FG001|Double-Blind Period|Withdrawal by Subject|1|||
33629756|NCT00179621|102194475|FG002|Double-Blind Period|Withdrawal by Subject|3|||
33629757|NCT00179621|102194476|FG003|Double-Blind Period|Withdrawal by Subject|0|||
33363377|NCT00374907|101217498|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
33363378|NCT00374907|101217497|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
33363379|NCT00374907|101217498|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
33363380|NCT00184054|101217499|FG000|Overall Study|Adverse Event|1|||
33363381|NCT00098345|101217500|FG000|Overall Study|Adverse Event|7|||
33363382|NCT00098345|101217500|FG000|Overall Study|Withdrawal by Subject|2|||
33363383|NCT00098345|101217500|FG000|Overall Study|progression|4|||
33363384|NCT00091390|101217501|FG000|Overall Study|Protocol Violation|1|||
33363385|NCT00091390|101217501|FG000|Overall Study|No protocol treatment|3|||
33363386|NCT02983292|101217502|FG000|Overall Study|Participant unwell & cannot travel|2|||
33363387|NCT02983292|101217502|FG000|Overall Study|Lost to Follow-up|3|||
33363388|NCT02983292|101217502|FG000|Overall Study|Participant withdrew consent|2|||
33363389|NCT02983292|101217502|FG000|Overall Study|Revision|7|||
33363390|NCT02983292|101217502|FG000|Overall Study|Death|1|||
33363391|NCT02983292|101217502|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
33363392|NCT02983292|101217502|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
33363393|NCT02983292|101217502|FG000|Overall Study|Participant relocation|1|||
33363394|NCT03964415|101217504|FG000|Overall Study|Sponsor's decision|1563|||
33363395|NCT03964415|101217505|FG001|Overall Study|Sponsor's decision|1528|||
33363396|NCT03964415|101217504|FG000|Overall Study|Lost to Follow-up|139|||
33363397|NCT03964415|101217505|FG001|Overall Study|Lost to Follow-up|146|||
33363398|NCT03964415|101217504|FG000|Overall Study|Withdrawal by Subject|68|||
33363399|NCT03964415|101217505|FG001|Overall Study|Withdrawal by Subject|72|||
33363400|NCT03964415|101217504|FG000|Overall Study|Physician Decision|34|||
33363401|NCT03964415|101217505|FG001|Overall Study|Physician Decision|48|||
33363402|NCT03964415|101217504|FG000|Overall Study|Adverse Event|3|||
33363403|NCT03964415|101217505|FG001|Overall Study|Adverse Event|0|||
33363404|NCT03964415|101217504|FG000|Overall Study|Death|4|||
33363405|NCT03964415|101217505|FG001|Overall Study|Death|6|||
33363406|NCT03964415|101217504|FG000|Overall Study|Protocol Violation|1|||
33363407|NCT03964415|101217505|FG001|Overall Study|Protocol Violation|4|||
33363408|NCT03964415|101217504|FG000|Overall Study|Other|35|||
33363409|NCT03964415|101217505|FG001|Overall Study|Other|38|||
33363410|NCT03964415|101217504|FG000|Overall Study|Randomized but not treated|6|||
33363411|NCT03964415|101217505|FG001|Overall Study|Randomized but not treated|7|||
33363412|NCT00227877|101217506|FG000|Pre-visit Assessment|Technical difficulties|7|||
33363413|NCT00227877|101217507|FG001|Pre-visit Assessment|Technical difficulties|3|||
33363414|NCT00227877|101217508|FG002|Pre-visit Assessment|Technical difficulties|0|||
33363415|NCT00227877|101217509|FG003|Pre-visit Assessment|Technical difficulties|0|||
33363416|NCT00227877|101217506|FG000|Post-visit Checklist|Lost to Follow-up|24|||
33363417|NCT00227877|101217507|FG001|Post-visit Checklist|Lost to Follow-up|13|||
33363418|NCT00227877|101217508|FG002|Post-visit Checklist|Lost to Follow-up|1|||
33363419|NCT00227877|101217509|FG003|Post-visit Checklist|Lost to Follow-up|0|||
33363420|NCT00227877|101217506|FG000|3-months Follow-up|Completed late|135|||
33363421|NCT00227877|101217507|FG001|3-months Follow-up|Completed late|128|||
33363422|NCT00227877|101217508|FG002|3-months Follow-up|Completed late|34|||
33629758|NCT00179621|102194473|FG000|Double-Blind Period|Death|0|||
33629759|NCT00179621|102194474|FG001|Double-Blind Period|Death|1|||
33629760|NCT00179621|102194475|FG002|Double-Blind Period|Death|2|||
33629761|NCT00179621|102194476|FG003|Double-Blind Period|Death|0|||
33629762|NCT00179621|102194473|FG000|Double-Blind Period|Protocol Violation|1|||
33629763|NCT00179621|102194474|FG001|Double-Blind Period|Protocol Violation|0|||
33363423|NCT00227877|101217509|FG003|3-months Follow-up|Completed late|8|||
33363424|NCT00227877|101217506|FG000|3-months Follow-up|Lost to Follow-up|178|||
33363425|NCT00227877|101217507|FG001|3-months Follow-up|Lost to Follow-up|139|||
33363426|NCT00227877|101217508|FG002|3-months Follow-up|Lost to Follow-up|18|||
33363427|NCT00227877|101217509|FG003|3-months Follow-up|Lost to Follow-up|13|||
33363428|NCT00227877|101217506|FG000|12-months Follow-up|Completed late|78|||
33363429|NCT00227877|101217507|FG001|12-months Follow-up|Completed late|74|||
33363430|NCT00227877|101217508|FG002|12-months Follow-up|Completed late|1|||
33363431|NCT00227877|101217509|FG003|12-months Follow-up|Completed late|0|||
33363432|NCT00227877|101217506|FG000|12-months Follow-up|Lost to Follow-up|232|||
33363433|NCT00227877|101217507|FG001|12-months Follow-up|Lost to Follow-up|189|||
33363434|NCT00227877|101217508|FG002|12-months Follow-up|Lost to Follow-up|30|||
33363435|NCT00227877|101217509|FG003|12-months Follow-up|Lost to Follow-up|26|||
33629764|NCT00179621|102194475|FG002|Double-Blind Period|Protocol Violation|0|||
33629765|NCT00179621|102194476|FG003|Double-Blind Period|Protocol Violation|0|||
33629766|NCT00179621|102194473|FG000|Double-Blind Period|Other|0|||
33629767|NCT00179621|102194474|FG001|Double-Blind Period|Other|2|||
33629768|NCT00179621|102194475|FG002|Double-Blind Period|Other|2|||
33629769|NCT00179621|102194476|FG003|Double-Blind Period|Other|0|||
33629770|NCT00179621|102194473|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
33629771|NCT00179621|102194474|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
33629772|NCT00179621|102194475|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
33629773|NCT00179621|102194476|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
33629774|NCT00179621|102194473|FG000|Open-Label Period|Adverse Event|0|||
33629775|NCT00179621|102194474|FG001|Open-Label Period|Adverse Event|6|||
33629776|NCT00179621|102194475|FG002|Open-Label Period|Adverse Event|5|||
33629777|NCT00179621|102194476|FG003|Open-Label Period|Adverse Event|6|||
33629778|NCT00179621|102194473|FG000|Open-Label Period|Withdrawal by Subject|0|||
33629779|NCT00179621|102194474|FG001|Open-Label Period|Withdrawal by Subject|2|||
33629780|NCT00179621|102194475|FG002|Open-Label Period|Withdrawal by Subject|2|||
33629781|NCT00179621|102194476|FG003|Open-Label Period|Withdrawal by Subject|2|||
33629782|NCT00179621|102194473|FG000|Open-Label Period|Death|0|||
33629783|NCT00179621|102194474|FG001|Open-Label Period|Death|0|||
33629784|NCT00179621|102194475|FG002|Open-Label Period|Death|1|||
33629785|NCT00179621|102194476|FG003|Open-Label Period|Death|2|||
33629786|NCT00179621|102194473|FG000|Open-Label Period|Other|0|||
33629787|NCT00179621|102194474|FG001|Open-Label Period|Other|1|||
33629788|NCT00179621|102194475|FG002|Open-Label Period|Other|1|||
33629789|NCT00179621|102194476|FG003|Open-Label Period|Other|2|||
33629790|NCT00667628|102194487|FG000|Overall Study|Lost to Follow-up|1|||
33629791|NCT00667628|102194488|FG001|Overall Study|Lost to Follow-up|0|||
33629792|NCT00667628|102194487|FG000|Overall Study|Death|6|||
33629793|NCT00667628|102194488|FG001|Overall Study|Death|6|||
33629794|NCT00667628|102194487|FG000|Overall Study|Investigator Considers in Best Interest|1|||
33629795|NCT00667628|102194488|FG001|Overall Study|Investigator Considers in Best Interest|0|||
33629796|NCT00667628|102194487|FG000|Overall Study|Sponsor Terminated Study|17|||
33629797|NCT00667628|102194488|FG001|Overall Study|Sponsor Terminated Study|21|||
33629798|NCT00644423|102194495|FG000|Overall Study|Lost to Follow-up|1|||
33629799|NCT00644423|102194496|FG001|Overall Study|Lost to Follow-up|1|||
33629800|NCT01383928|102194497|FG000|Overall Study|Initiation of ASCT|2|||
33629801|NCT01383928|102194498|FG001|Overall Study|Initiation of ASCT|1|||
33629802|NCT01383928|102194499|FG002|Overall Study|Initiation of ASCT|18|||
33629803|NCT01383928|102194497|FG000|Overall Study|Adverse Event|1|||
33629804|NCT01383928|102194498|FG001|Overall Study|Adverse Event|2|||
33629805|NCT01383928|102194499|FG002|Overall Study|Adverse Event|8|||
33629806|NCT01383928|102194497|FG000|Overall Study|Other|1|||
33629807|NCT01383928|102194498|FG001|Overall Study|Other|3|||
33629808|NCT01383928|102194499|FG002|Overall Study|Other|4|||
33629809|NCT01383928|102194497|FG000|Overall Study|Progressive Disease|1|||
33629810|NCT01383928|102194498|FG001|Overall Study|Progressive Disease|1|||
33629811|NCT01383928|102194499|FG002|Overall Study|Progressive Disease|5|||
33629812|NCT01383928|102194497|FG000|Overall Study|Withdrawal by Subject|0|||
33629813|NCT01383928|102194498|FG001|Overall Study|Withdrawal by Subject|0|||
33629814|NCT01383928|102194499|FG002|Overall Study|Withdrawal by Subject|4|||
33629815|NCT01383928|102194497|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
33629816|NCT01383928|102194498|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
33629817|NCT01383928|102194499|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
33629818|NCT04484961|102194502|FG000|Overall Study|Lost to Follow-up|9|||
33629819|NCT04484961|102194503|FG001|Overall Study|Lost to Follow-up|9|||
33629820|NCT03379818|102197585|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
33629821|NCT03379818|102197586|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
33629822|NCT03379818|102197585|FG000|Overall Study|Withdrawal by Subject|2|||
33629823|NCT03379818|102197586|FG001|Overall Study|Withdrawal by Subject|3|||
33629824|NCT03379818|102197585|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
33629825|NCT03379818|102197586|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
33629826|NCT01751061|102197588|FG000|Overall Study|Death|1|||
33629827|NCT01751061|102197589|FG001|Overall Study|Death|0|||
33629828|NCT01751061|102197588|FG000|Overall Study|patient death|5|||
33629829|NCT01751061|102197589|FG001|Overall Study|patient death|0|||
33629830|NCT01751061|102197588|FG000|Overall Study|Lost to Follow-up|40|||
33629831|NCT01751061|102197589|FG001|Overall Study|Lost to Follow-up|25|||
33629832|NCT01751061|102197588|FG000|Overall Study|patient regained decisional capacity|4|||
33629833|NCT01751061|102197589|FG001|Overall Study|patient regained decisional capacity|8|||
33629834|NCT01751061|102197588|FG000|Overall Study|Withdrawal by Subject|4|||
33629835|NCT01751061|102197589|FG001|Overall Study|Withdrawal by Subject|1|||
33629836|NCT01751061|102197588|FG000|Overall Study|Physician Decision|2|||
33629837|NCT01751061|102197589|FG001|Overall Study|Physician Decision|0|||
33629838|NCT03379675|102197590|FG000|Overall Study|Lost to Follow-up|0|||
33629839|NCT03379675|102197591|FG001|Overall Study|Lost to Follow-up|1|||
33629840|NCT03379675|102197592|FG002|Overall Study|Lost to Follow-up|0|||
33629841|NCT03379675|102197590|FG000|Overall Study|Adverse Event|2|||
33629842|NCT03379675|102197591|FG001|Overall Study|Adverse Event|0|||
33629843|NCT03379675|102197592|FG002|Overall Study|Adverse Event|0|||
33629844|NCT03379675|102197590|FG000|Overall Study|Withdrawal by Subject|2|||
33629845|NCT03379675|102197591|FG001|Overall Study|Withdrawal by Subject|1|||
33629846|NCT03379675|102197592|FG002|Overall Study|Withdrawal by Subject|2|||
33629847|NCT04026113|102197595|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
33629848|NCT04026113|102197596|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
33629849|NCT04026113|102197597|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
33629850|NCT04026113|102197598|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
33629851|NCT04026113|102197595|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
33629852|NCT04026113|102197596|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
33565947|NCT05270863|101970528|FG004|Visit 2 First Intervention|Randomization error|0|||
33363436|NCT03216265|101217512|FG000|Overall Study|Adverse Event|2|||
33629853|NCT04026113|102197597|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
33363437|NCT03216265|101217513|FG001|Overall Study|Adverse Event|0|||
33629854|NCT04026113|102197598|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
33629855|NCT04026113|102197595|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
33629856|NCT04026113|102197596|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
33629857|NCT04026113|102197597|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
33629858|NCT04026113|102197598|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
33629859|NCT04026113|102197595|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
33629860|NCT04026113|102197596|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
33629861|NCT04026113|102197597|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
33629862|NCT04026113|102197598|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
33629863|NCT04026113|102197595|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
33629864|NCT04026113|102197596|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
33629865|NCT04026113|102197597|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
33629866|NCT04026113|102197598|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
33629867|NCT04026113|102197595|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
33629868|NCT04026113|102197596|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
33629869|NCT04026113|102197597|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
33565948|NCT05270863|101970529|FG005|Visit 2 First Intervention|Randomization error|0|||
33565949|NCT05270863|101970524|FG000|First Washout|Withdrawal by Subject|0|||
33565950|NCT05270863|101970525|FG001|First Washout|Withdrawal by Subject|0|||
33565951|NCT05270863|101970526|FG002|First Washout|Withdrawal by Subject|0|||
33565952|NCT05270863|101970527|FG003|First Washout|Withdrawal by Subject|0|||
33565953|NCT05270863|101970528|FG004|First Washout|Withdrawal by Subject|1|||
33565954|NCT05270863|101970529|FG005|First Washout|Withdrawal by Subject|1|||
33565955|NCT05270863|101970524|FG000|First Washout|Lost to Follow-up|0|||
33565956|NCT05270863|101970525|FG001|First Washout|Lost to Follow-up|0|||
33565957|NCT05270863|101970526|FG002|First Washout|Lost to Follow-up|0|||
33565958|NCT05270863|101970527|FG003|First Washout|Lost to Follow-up|0|||
33565959|NCT05270863|101970528|FG004|First Washout|Lost to Follow-up|0|||
33565960|NCT05270863|101970529|FG005|First Washout|Lost to Follow-up|1|||
33565961|NCT05270863|101970524|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
33565962|NCT05270863|101970525|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
33565963|NCT05270863|101970526|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
33565964|NCT05270863|101970527|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
33565965|NCT05270863|101970528|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
33565966|NCT05270863|101970529|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
33565967|NCT05270863|101970524|FG000|Second Washout|Withdrawal by Subject|1|||
33565968|NCT05270863|101970525|FG001|Second Washout|Withdrawal by Subject|1|||
33565969|NCT05270863|101970526|FG002|Second Washout|Withdrawal by Subject|0|||
33565970|NCT05270863|101970527|FG003|Second Washout|Withdrawal by Subject|0|||
33565971|NCT05270863|101970528|FG004|Second Washout|Withdrawal by Subject|0|||
33565972|NCT05270863|101970529|FG005|Second Washout|Withdrawal by Subject|0|||
33565973|NCT05270863|101970524|FG000|Second Washout|Lost to Follow-up|0|||
33565974|NCT05270863|101970525|FG001|Second Washout|Lost to Follow-up|0|||
33565975|NCT05270863|101970526|FG002|Second Washout|Lost to Follow-up|0|||
33565976|NCT05270863|101970527|FG003|Second Washout|Lost to Follow-up|1|||
33565977|NCT05270863|101970528|FG004|Second Washout|Lost to Follow-up|0|||
33565978|NCT05270863|101970529|FG005|Second Washout|Lost to Follow-up|0|||
33565979|NCT01344356|101970530|FG000|Overall Study|Physician Decision|0|||
33565980|NCT01344356|101970531|FG001|Overall Study|Physician Decision|3|||
33565981|NCT01344356|101970530|FG000|Overall Study|Lost to Follow-up|0|||
33565982|NCT01344356|101970531|FG001|Overall Study|Lost to Follow-up|6|||
33565983|NCT02096354|101970535|FG000|Overall Study|Physician Decision|4|||
33565984|NCT02096354|101970536|FG001|Overall Study|Physician Decision|5|||
33565985|NCT02096354|101970537|FG002|Overall Study|Physician Decision|0|||
33565986|NCT02096354|101970535|FG000|Overall Study|Withdrawal by Subject|3|||
33565987|NCT02096354|101970536|FG001|Overall Study|Withdrawal by Subject|1|||
33565988|NCT02096354|101970537|FG002|Overall Study|Withdrawal by Subject|0|||
33565989|NCT02096354|101970535|FG000|Overall Study|Adverse Event|7|||
33629870|NCT04026113|102197598|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
33629871|NCT04026113|102197595|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
33629872|NCT04026113|102197596|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
33629873|NCT04026113|102197597|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
33629874|NCT04026113|102197598|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
33629875|NCT04026113|102197595|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
33629876|NCT04026113|102197596|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
33629877|NCT04026113|102197597|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
33629878|NCT04026113|102197598|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
33629879|NCT04026113|102197595|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
33629880|NCT04026113|102197596|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
33629881|NCT04026113|102197597|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
33629882|NCT04026113|102197598|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
33629883|NCT01451606|102197599|FG000|Overall Study|Withdrawal by Subject|4|||
33629884|NCT01451606|102197600|FG001|Overall Study|Withdrawal by Subject|3|||
33629885|NCT03041038|102197602|FG000|Overall Study|Withdrawal by Subject|4|||
33629886|NCT03041038|102197603|FG001|Overall Study|Withdrawal by Subject|0|||
33629887|NCT03041038|102197602|FG000|Overall Study|Lost to Follow-up|1|||
33629888|NCT03041038|102197603|FG001|Overall Study|Lost to Follow-up|1|||
33629889|NCT03041038|102197602|FG000|Overall Study|Protocol Violation|1|||
33629890|NCT03041038|102197603|FG001|Overall Study|Protocol Violation|1|||
33629891|NCT04529083|102197604|FG000|Overall Study|Withdrawal by Subject|3|||
33363438|NCT03216265|101217514|FG002|Overall Study|Adverse Event|2|||
33363439|NCT03216265|101217512|FG000|Overall Study|Lost to Follow-up|0|||
33363440|NCT03216265|101217513|FG001|Overall Study|Lost to Follow-up|1|||
33363441|NCT03216265|101217514|FG002|Overall Study|Lost to Follow-up|0|||
33363442|NCT03216265|101217512|FG000|Overall Study|Withdrawal by Subject|0|||
33629892|NCT03497676|102197605|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
33363443|NCT03216265|101217513|FG001|Overall Study|Withdrawal by Subject|0|||
33363444|NCT03216265|101217514|FG002|Overall Study|Withdrawal by Subject|1|||
33363445|NCT04275310|101217519|FG000|Overall Study|Non-randomized due to running out of funding|4|||
33363446|NCT04275310|101217520|FG001|Overall Study|Non-randomized due to running out of funding|0|||
33363447|NCT04222725|101217521|FG000|Overall Study|Adverse Event|0|||
33363448|NCT04222725|101217522|FG001|Overall Study|Adverse Event|1|||
33363449|NCT04222725|101217523|FG002|Overall Study|Adverse Event|0|||
33363450|NCT04222725|101217524|FG003|Overall Study|Adverse Event|0|||
33363451|NCT03238248|101217529|FG000|Overall Study|Death|5|||
33363452|NCT03238248|101217529|FG000|Overall Study|Withdrawal by Subject|7|||
33363453|NCT03238248|101217529|FG000|Overall Study|Participant proceeding to transplant|10|||
33363454|NCT03238248|101217529|FG000|Overall Study|Lack of Efficacy|4|||
33363455|NCT03238248|101217529|FG000|Overall Study|Physician Decision|3|||
33363456|NCT03238248|101217529|FG000|Overall Study|Transitioning to another study|1|||
33363457|NCT03238248|101217529|FG000|Overall Study|No longer benefiting|1|||
33363458|NCT03238248|101217529|FG000|Overall Study|Other complicating disease|1|||
33363459|NCT03238248|101217529|FG000|Overall Study|Adverse Event|5|||
33222721|NCT01490125|100715938|FG001|Period II|Adverse Event|3|||
33222722|NCT01490125|100715939|FG002|Period II|Adverse Event|2|||
33222723|NCT01490125|100715940|FG003|Period II|Adverse Event|2|||
33222724|NCT01490125|100715941|FG004|Period II|Adverse Event|4|||
33363460|NCT03238248|101217529|FG000|Overall Study|Disease progression|26|||
33363461|NCT03238248|101217529|FG000|Overall Study|N/A participant is still on treatment|1|||
33363462|NCT03238248|101217529|FG000|Overall Study|Decline in condition|1|||
33363463|NCT03238248|101217529|FG000|Overall Study|Alternative therapy|2|||
33363464|NCT01797432|101217532|FG000|Overall Study|Lost to Follow-up|1|||
33629893|NCT03497676|102197606|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
33222725|NCT01490125|100715942|FG005|Period II|Adverse Event|2|||
33222726|NCT01490125|100715937|FG000|Period II|Protocol Violation|0|||
33222727|NCT01490125|100715938|FG001|Period II|Protocol Violation|0|||
33222728|NCT01490125|100715939|FG002|Period II|Protocol Violation|1|||
33222729|NCT01490125|100715940|FG003|Period II|Protocol Violation|1|||
33222730|NCT01490125|100715941|FG004|Period II|Protocol Violation|0|||
33222731|NCT01490125|100715942|FG005|Period II|Protocol Violation|0|||
33222732|NCT01490125|100715937|FG000|Period II|Lost to Follow-up|0|||
33222733|NCT01490125|100715938|FG001|Period II|Lost to Follow-up|1|||
33222734|NCT01490125|100715939|FG002|Period II|Lost to Follow-up|0|||
33222735|NCT01490125|100715940|FG003|Period II|Lost to Follow-up|0|||
33222736|NCT01490125|100715941|FG004|Period II|Lost to Follow-up|0|||
33222737|NCT01490125|100715942|FG005|Period II|Lost to Follow-up|0|||
33222738|NCT01490125|100715937|FG000|Period II|Withdrawal by Subject|1|||
33222739|NCT01490125|100715938|FG001|Period II|Withdrawal by Subject|0|||
33222740|NCT01490125|100715939|FG002|Period II|Withdrawal by Subject|0|||
33363465|NCT01797432|101217532|FG000|Overall Study|Adverse Event|1|||
33363466|NCT01797432|101217532|FG000|Overall Study|Withdrawal by Subject|1|||
33363467|NCT01797432|101217532|FG000|Overall Study|lived too far from study site|1|||
33363468|NCT01863758|101217533|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
33363469|NCT01863758|101217533|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
33363470|NCT02203838|101217536|FG000|Overall Study|Lack of Efficacy|7|||
33363471|NCT02203838|101217537|FG001|Overall Study|Lack of Efficacy|0|||
33629894|NCT03497676|102197607|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
33629895|NCT03497676|102197608|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
33629896|NCT03497676|102197605|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
33629897|NCT03497676|102197606|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
33629898|NCT03497676|102197607|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
33629899|NCT03497676|102197608|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
33629900|NCT03497676|102197605|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
33629901|NCT03497676|102197606|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
33629902|NCT03497676|102197607|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
33629903|NCT03497676|102197608|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
33629904|NCT03497676|102197605|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
33629905|NCT03497676|102197606|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
33629906|NCT03497676|102197607|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
33629907|NCT03497676|102197608|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
33629908|NCT03497676|102197605|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
33629909|NCT03497676|102197606|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
33629910|NCT03497676|102197607|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
33629911|NCT03497676|102197608|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
33629912|NCT03497676|102197605|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
33629913|NCT03497676|102197606|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
33629914|NCT03497676|102197607|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
33629915|NCT03497676|102197608|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
33629916|NCT03497676|102197605|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
33629917|NCT03497676|102197606|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
33629918|NCT03497676|102197607|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
33629919|NCT03497676|102197608|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
33629920|NCT03497676|102197605|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
33629921|NCT03497676|102197606|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
33629922|NCT03497676|102197607|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
33629923|NCT03497676|102197608|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
33629924|NCT04672239|102197609|FG000|Week 2 Survey|Failed survey check items|1|||
33629925|NCT04672239|102197610|FG001|Week 2 Survey|Failed survey check items|2|||
33629926|NCT04672239|102197611|FG002|Week 2 Survey|Failed survey check items|3|||
33629927|NCT04672239|102197609|FG000|Week 2 Survey|Partially completed survey|7|||
33629928|NCT04672239|102197610|FG001|Week 2 Survey|Partially completed survey|1|||
33629929|NCT04672239|102197611|FG002|Week 2 Survey|Partially completed survey|4|||
33629930|NCT04672239|102197609|FG000|Week 2 Survey|Withdrawal by Subject|0|||
33629931|NCT04672239|102197610|FG001|Week 2 Survey|Withdrawal by Subject|1|||
33629932|NCT04672239|102197611|FG002|Week 2 Survey|Withdrawal by Subject|0|||
33629933|NCT04672239|102197609|FG000|Week 2 Survey|Lost to Follow-up|3|||
33629934|NCT04672239|102197610|FG001|Week 2 Survey|Lost to Follow-up|2|||
33629935|NCT04672239|102197611|FG002|Week 2 Survey|Lost to Follow-up|5|||
33629936|NCT04672239|102197609|FG000|Week 6 Survey|Failed survey check items|2|||
33629937|NCT04672239|102197610|FG001|Week 6 Survey|Failed survey check items|2|||
33629938|NCT04672239|102197611|FG002|Week 6 Survey|Failed survey check items|2|||
33363472|NCT02203838|101217538|FG002|Overall Study|Lack of Efficacy|1|||
33222741|NCT01490125|100715940|FG003|Period II|Withdrawal by Subject|0|||
33222742|NCT01490125|100715941|FG004|Period II|Withdrawal by Subject|0|||
33222743|NCT01490125|100715942|FG005|Period II|Withdrawal by Subject|0|||
33363473|NCT02203838|101217539|FG003|Overall Study|Lack of Efficacy|1|||
33363474|NCT02203838|101217536|FG000|Overall Study|Adverse Event|46|||
33363475|NCT02203838|101217537|FG001|Overall Study|Adverse Event|6|||
33363476|NCT02203838|101217538|FG002|Overall Study|Adverse Event|3|||
33363477|NCT02203838|101217539|FG003|Overall Study|Adverse Event|2|||
33363478|NCT02203838|101217536|FG000|Overall Study|Lost to Follow-up|39|||
33363479|NCT02203838|101217537|FG001|Overall Study|Lost to Follow-up|3|||
33363480|NCT02203838|101217538|FG002|Overall Study|Lost to Follow-up|2|||
33222744|NCT01490125|100715937|FG000|Period III|Adverse Event|3|||
33222745|NCT01490125|100715938|FG001|Period III|Adverse Event|1|||
33222746|NCT01490125|100715939|FG002|Period III|Adverse Event|0|||
33222747|NCT01490125|100715940|FG003|Period III|Adverse Event|1|||
33222748|NCT01490125|100715941|FG004|Period III|Adverse Event|0|||
33222749|NCT01490125|100715942|FG005|Period III|Adverse Event|0|||
33222750|NCT01490125|100715937|FG000|Period III|Death|0|||
33222751|NCT01490125|100715938|FG001|Period III|Death|0|||
33222752|NCT01490125|100715939|FG002|Period III|Death|0|||
33222753|NCT01490125|100715940|FG003|Period III|Death|1|||
33363481|NCT02203838|101217539|FG003|Overall Study|Lost to Follow-up|1|||
33565990|NCT02096354|101970536|FG001|Overall Study|Adverse Event|4|||
33565991|NCT02096354|101970537|FG002|Overall Study|Adverse Event|0|||
33565992|NCT02096354|101970535|FG000|Overall Study|Ineligible|0|||
33565993|NCT02096354|101970536|FG001|Overall Study|Ineligible|0|||
33565994|NCT02096354|101970537|FG002|Overall Study|Ineligible|11|||
33565995|NCT04016714|101970540|FG000|Overall Study|Death|1|||
33565996|NCT04016714|101970541|FG001|Overall Study|Death|0|||
33565997|NCT04016714|101970540|FG000|Overall Study|Lost to Follow-up|3|||
33565998|NCT04016714|101970541|FG001|Overall Study|Lost to Follow-up|1|||
33565999|NCT04016714|101970540|FG000|Overall Study|Physician Decision|3|||
33566000|NCT04016714|101970541|FG001|Overall Study|Physician Decision|3|||
33566001|NCT04016714|101970540|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
33566002|NCT04016714|101970541|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
33566003|NCT03309202|101970542|FG000|Overall Study|Lost to Follow-up|1|||
33566004|NCT03309202|101970543|FG001|Overall Study|Lost to Follow-up|0|||
33566005|NCT03309202|101970544|FG002|Overall Study|Lost to Follow-up|0|||
33566006|NCT03309202|101970545|FG003|Overall Study|Lost to Follow-up|0|||
33566007|NCT00734032|101970553|FG000|Overall Study|Adverse Event|0|||
33566008|NCT00734032|101970554|FG001|Overall Study|Adverse Event|1|||
33566009|NCT00734032|101970555|FG002|Overall Study|Adverse Event|0|||
33566010|NCT00734032|101970556|FG003|Overall Study|Adverse Event|0|||
33566011|NCT03931330|101970557|FG000|Overall Study|Physician Decision|1|||
33566012|NCT02836249|101970558|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
33566013|NCT02836249|101970559|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
33566014|NCT02836249|101970560|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
33566015|NCT02836249|101970561|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
33566016|NCT02836249|101970558|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
33566017|NCT02836249|101970559|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
33566018|NCT02836249|101970560|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
33566019|NCT02836249|101970561|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
33566020|NCT02836249|101970558|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
33566021|NCT02836249|101970559|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
33566022|NCT02836249|101970560|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
33566023|NCT02836249|101970561|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
33566024|NCT02836249|101970558|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33566025|NCT02836249|101970559|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
33566026|NCT02836249|101970560|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33566027|NCT02836249|101970561|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33566028|NCT02836249|101970558|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
33566029|NCT02836249|101970559|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
33566030|NCT02836249|101970560|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
33566031|NCT02836249|101970561|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
33566032|NCT02836249|101970558|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
33566033|NCT02836249|101970559|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
33566034|NCT02836249|101970560|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
33566035|NCT02836249|101970561|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
33566036|NCT02836249|101970558|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
33566037|NCT02836249|101970559|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
33629939|NCT04672239|102197609|FG000|Week 6 Survey|Partially completed survey|3|||
33566038|NCT02836249|101970560|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
33566039|NCT02836249|101970561|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
33222754|NCT01490125|100715941|FG004|Period III|Death|0|||
33222755|NCT01490125|100715942|FG005|Period III|Death|0|||
33222756|NCT01490125|100715937|FG000|Period III|Lack of Efficacy|0|||
33222757|NCT01490125|100715938|FG001|Period III|Lack of Efficacy|0|||
33363482|NCT02203838|101217536|FG000|Overall Study|Protocol Violation|7|||
33363483|NCT02203838|101217537|FG001|Overall Study|Protocol Violation|3|||
33363484|NCT02203838|101217538|FG002|Overall Study|Protocol Violation|0|||
33222758|NCT01490125|100715939|FG002|Period III|Lack of Efficacy|0|||
33222759|NCT01490125|100715940|FG003|Period III|Lack of Efficacy|0|||
33222760|NCT01490125|100715941|FG004|Period III|Lack of Efficacy|1|||
33222761|NCT01490125|100715942|FG005|Period III|Lack of Efficacy|0|||
33222762|NCT00459342|100715943|FG000|Overall Study|Not eligible|1|||
33222763|NCT02277990|100715944|FG000|Overall Study|Death|170|||
33566040|NCT02836249|101970558|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
33566041|NCT02836249|101970559|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
33566042|NCT02836249|101970560|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
33566043|NCT02836249|101970561|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
33629940|NCT04672239|102197610|FG001|Week 6 Survey|Partially completed survey|3|||
33629941|NCT04672239|102197611|FG002|Week 6 Survey|Partially completed survey|2|||
33629942|NCT04672239|102197609|FG000|Week 6 Survey|Withdrawal by Subject|1|||
33629943|NCT04672239|102197610|FG001|Week 6 Survey|Withdrawal by Subject|1|||
33629944|NCT04672239|102197611|FG002|Week 6 Survey|Withdrawal by Subject|1|||
33629945|NCT04672239|102197609|FG000|Week 6 Survey|Withdrawn by PI|0|||
33629946|NCT04672239|102197610|FG001|Week 6 Survey|Withdrawn by PI|1|||
33629947|NCT04672239|102197611|FG002|Week 6 Survey|Withdrawn by PI|0|||
33629948|NCT04672239|102197609|FG000|Week 6 Survey|Lost to Follow-up|12|||
33629949|NCT04672239|102197610|FG001|Week 6 Survey|Lost to Follow-up|2|||
33629950|NCT04672239|102197611|FG002|Week 6 Survey|Lost to Follow-up|5|||
33629951|NCT04672239|102197609|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
33629952|NCT04672239|102197610|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
33629953|NCT04672239|102197611|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
33629954|NCT04672239|102197609|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
33629955|NCT04672239|102197610|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
33629956|NCT04672239|102197611|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
33629957|NCT04672239|102197609|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
33629958|NCT04672239|102197610|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
33629959|NCT04672239|102197611|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
33629960|NCT04672239|102197609|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
33629961|NCT04672239|102197610|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
33629962|NCT04672239|102197611|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
33629963|NCT04672239|102197609|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
33629964|NCT04672239|102197610|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
33629965|NCT04672239|102197611|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
33629966|NCT04672239|102197609|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
33629967|NCT04672239|102197610|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
33629968|NCT04672239|102197611|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
33629969|NCT04672239|102197609|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
33629970|NCT04672239|102197610|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
33629971|NCT04672239|102197611|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
33629972|NCT00771758|102197620|FG000|Overall Study|Adverse Event|2|||
33629973|NCT00771758|102197621|FG001|Overall Study|Adverse Event|8|||
33566044|NCT02836249|101970558|FG000|Open-Label TAF Treatment Phase|Death|0|||
33566045|NCT02836249|101970559|FG001|Open-Label TAF Treatment Phase|Death|0|||
33566046|NCT02836249|101970560|FG002|Open-Label TAF Treatment Phase|Death|1|||
33566047|NCT02836249|101970561|FG003|Open-Label TAF Treatment Phase|Death|0|||
33566048|NCT02836249|101970558|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
33566049|NCT02836249|101970559|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
33566050|NCT02836249|101970560|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
33566051|NCT02836249|101970561|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
33566052|NCT02836249|101970558|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
33566053|NCT02836249|101970559|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
33566054|NCT02836249|101970560|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
33566055|NCT02836249|101970561|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
33566056|NCT00936936|101970568|FG000|Overall Study|Adverse Event|7|||
33629974|NCT00771758|102197622|FG002|Overall Study|Adverse Event|1|||
33629975|NCT00771758|102197620|FG000|Overall Study|Lack of Efficacy|0|||
33629976|NCT00771758|102197621|FG001|Overall Study|Lack of Efficacy|2|||
33629977|NCT00771758|102197622|FG002|Overall Study|Lack of Efficacy|1|||
33222764|NCT02277990|100715945|FG001|Overall Study|Death|188|||
33222765|NCT02277990|100715944|FG000|Overall Study|Withdrawal by Subject|64|||
33416199|NCT00903409|101413293|FG000|Overall Study|Withdrawal by Subject|8|||
33416200|NCT00903409|101413294|FG001|Overall Study|Withdrawal by Subject|8|||
33416201|NCT00903409|101413293|FG000|Overall Study|Other|2|||
33416202|NCT00903409|101413294|FG001|Overall Study|Other|3|||
33416203|NCT00903409|101413293|FG000|Overall Study|Lost to Follow-up|2|||
33416204|NCT00903409|101413294|FG001|Overall Study|Lost to Follow-up|6|||
33416205|NCT00518011|101413295|FG000|Overall Study|Death|1|||
33416206|NCT00518011|101413296|FG001|Overall Study|Death|1|||
33416207|NCT00518011|101413295|FG000|Overall Study|Adverse Event|2|||
33416208|NCT00518011|101413296|FG001|Overall Study|Adverse Event|3|||
33416209|NCT00518011|101413295|FG000|Overall Study|Disease Progression|2|||
33416210|NCT00518011|101413296|FG001|Overall Study|Disease Progression|2|||
33416211|NCT00518011|101413295|FG000|Overall Study|Other Reasons|3|||
33416212|NCT00518011|101413296|FG001|Overall Study|Other Reasons|2|||
33416213|NCT00518011|101413295|FG000|Overall Study|Withdrawal by Subject|1|||
33416214|NCT00518011|101413296|FG001|Overall Study|Withdrawal by Subject|0|||
33566057|NCT00936936|101970569|FG001|Overall Study|Adverse Event|1|||
33566058|NCT00936936|101970568|FG000|Overall Study|Disease Progression|2|||
33566059|NCT00936936|101970569|FG001|Overall Study|Disease Progression|2|||
33566060|NCT00936936|101970568|FG000|Overall Study|Unrelated|3|||
33566061|NCT00936936|101970569|FG001|Overall Study|Unrelated|1|||
33566062|NCT02919618|101970570|FG000|Overall Study|Death|1|||
33566063|NCT01585025|101970571|FG000|Overall Study|Withdrawal by Subject|0|||
33566064|NCT01585025|101970572|FG001|Overall Study|Withdrawal by Subject|3|||
33566065|NCT01585025|101970573|FG002|Overall Study|Withdrawal by Subject|4|||
33566066|NCT00867035|101970574|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
33629978|NCT00771758|102197620|FG000|Overall Study|Lost to Follow-up|1|||
33629979|NCT00771758|102197621|FG001|Overall Study|Lost to Follow-up|0|||
33629980|NCT00771758|102197622|FG002|Overall Study|Lost to Follow-up|0|||
33629981|NCT00771758|102197620|FG000|Overall Study|Protocol Violation|1|||
33566067|NCT00867035|101970575|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
33566068|NCT00867035|101970574|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
33566069|NCT00867035|101970575|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
33566070|NCT02439957|101970576|FG000|Overall Study|Study Terminated|3|||
33566071|NCT02439957|101970577|FG001|Overall Study|Study Terminated|3|||
33566072|NCT02278003|101970578|FG000|Overall Study|Withdrawal by Subject|11|||
33566073|NCT02278003|101970579|FG001|Overall Study|Withdrawal by Subject|0|||
33566074|NCT02278003|101970578|FG000|Overall Study|Not Treated|1|||
33566075|NCT02278003|101970579|FG001|Overall Study|Not Treated|0|||
33566076|NCT02278003|101970578|FG000|Overall Study|Recognition task improperly completed|7|||
33566077|NCT02278003|101970579|FG001|Overall Study|Recognition task improperly completed|0|||
33566078|NCT00619866|101970580|FG000|Weeks 1 - 12|Adverse Event|0|||
33566079|NCT00619866|101970581|FG001|Weeks 1 - 12|Adverse Event|1|||
33566080|NCT00619866|101970582|FG002|Weeks 1 - 12|Adverse Event|2|||
33566081|NCT00619866|101970583|FG003|Weeks 1 - 12|Adverse Event|0|||
33566082|NCT00619866|101970584|FG004|Weeks 1 - 12|Adverse Event|0|||
33566083|NCT00619866|101970580|FG000|Weeks 1 - 12|Non-compliance|0|||
33629982|NCT00771758|102197621|FG001|Overall Study|Protocol Violation|0|||
33629983|NCT00771758|102197622|FG002|Overall Study|Protocol Violation|0|||
33629984|NCT00771758|102197620|FG000|Overall Study|Withdrawal by Subject|1|||
33629985|NCT00771758|102197621|FG001|Overall Study|Withdrawal by Subject|0|||
33629986|NCT00771758|102197622|FG002|Overall Study|Withdrawal by Subject|0|||
33629987|NCT00771758|102197620|FG000|Overall Study|Other|3|||
33629988|NCT00771758|102197621|FG001|Overall Study|Other|2|||
33629989|NCT00771758|102197622|FG002|Overall Study|Other|0|||
33629990|NCT00383786|102197623|FG000|Overall Study|Protocol Violation|2|||
33629991|NCT00383786|102197624|FG001|Overall Study|Protocol Violation|6|||
33629992|NCT00383786|102197623|FG000|Overall Study|Withdrawal by Subject|2|||
33566084|NCT00619866|101970581|FG001|Weeks 1 - 12|Non-compliance|0|||
33629993|NCT00383786|102197624|FG001|Overall Study|Withdrawal by Subject|5|||
33629994|NCT00383786|102197623|FG000|Overall Study|Physician Decision|0|||
33629995|NCT00383786|102197624|FG001|Overall Study|Physician Decision|1|||
33629996|NCT01436149|102197627|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
33222766|NCT02277990|100715945|FG001|Overall Study|Withdrawal by Subject|53|||
33566085|NCT00619866|101970582|FG002|Weeks 1 - 12|Non-compliance|1|||
33629997|NCT01436149|102197628|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
33566086|NCT00619866|101970583|FG003|Weeks 1 - 12|Non-compliance|0|||
33566087|NCT00619866|101970584|FG004|Weeks 1 - 12|Non-compliance|0|||
33566088|NCT00619866|101970580|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
33566089|NCT00619866|101970581|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
33629998|NCT01436149|102197629|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
33416215|NCT02815540|101413298|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
33629999|NCT01436149|102197627|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
33630000|NCT01436149|102197628|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
33416216|NCT04469465|101413304|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
33416217|NCT04469465|101413305|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
33416218|NCT04469465|101413304|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
33416219|NCT04469465|101413305|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
33222767|NCT02277990|100715944|FG000|Overall Study|Physician Decision|40|||
33222768|NCT02277990|100715945|FG001|Overall Study|Physician Decision|34|||
33222769|NCT02277990|100715944|FG000|Overall Study|Lost to Follow-up|66|||
33222770|NCT02277990|100715945|FG001|Overall Study|Lost to Follow-up|69|||
33222771|NCT02277990|100715944|FG000|Overall Study|Had other reason|26|||
33222772|NCT02277990|100715945|FG001|Overall Study|Had other reason|32|||
33222773|NCT01264380|100718684|FG000|Period C|Disease Progression|0|||
33222774|NCT01264380|100718685|FG001|Period C|Disease Progression|0|||
33222775|NCT01264380|100718686|FG002|Period C|Disease Progression|4|||
33222776|NCT01264380|100718684|FG000|Period C|Death|0|||
33222777|NCT01264380|100718685|FG001|Period C|Death|0|||
33222778|NCT01264380|100718686|FG002|Period C|Death|2|||
33222779|NCT01264380|100718684|FG000|Period C|Follow-up for survival status|0|||
33222780|NCT01264380|100718685|FG001|Period C|Follow-up for survival status|0|||
33222781|NCT01264380|100718686|FG002|Period C|Follow-up for survival status|6|||
33222782|NCT01264380|100718684|FG000|Period C|Withdrawal by Subject|0|||
33222783|NCT01264380|100718685|FG001|Period C|Withdrawal by Subject|0|||
33222784|NCT01264380|100718686|FG002|Period C|Withdrawal by Subject|1|||
33222785|NCT01264380|100718684|FG000|Period C|Adverse Event|0|||
33222786|NCT01264380|100718685|FG001|Period C|Adverse Event|0|||
33222787|NCT01264380|100718686|FG002|Period C|Adverse Event|1|||
33222788|NCT02768662|100718690|FG000|Overall Study|Adverse Event|1|||
33222789|NCT02768662|100718690|FG000|Overall Study|Lost to Follow-up|4|||
33222790|NCT02768662|100718690|FG000|Overall Study|Withdrawal by Subject|3|||
33222791|NCT02768662|100718690|FG000|Overall Study|Study terminated by Sponsor|78|||
33222792|NCT01657266|100718691|FG000|Overall Study|Lost to Follow-up|2|||
33222793|NCT01657266|100718692|FG001|Overall Study|Lost to Follow-up|2|||
33222794|NCT01657266|100718691|FG000|Overall Study|Adverse Event|2|||
33222795|NCT01657266|100718692|FG001|Overall Study|Adverse Event|3|||
33222796|NCT03573908|100718700|FG000|Treatment Period|Adverse Event|4|||
33222797|NCT03573908|100718701|FG001|Treatment Period|Adverse Event|9|||
33222798|NCT03573908|100718702|FG002|Treatment Period|Adverse Event|0|||
33222799|NCT03573908|100718703|FG003|Treatment Period|Adverse Event|0|||
33222800|NCT03573908|100718704|FG004|Treatment Period|Adverse Event|0|||
33222801|NCT03573908|100718700|FG000|Treatment Period|Protocol Violation|1|||
33222802|NCT03573908|100718701|FG001|Treatment Period|Protocol Violation|0|||
33222803|NCT03573908|100718702|FG002|Treatment Period|Protocol Violation|0|||
33222804|NCT03573908|100718703|FG003|Treatment Period|Protocol Violation|0|||
33222805|NCT03573908|100718704|FG004|Treatment Period|Protocol Violation|0|||
33222806|NCT03573908|100718700|FG000|Treatment Period|Withdrawal by Subject|7|||
33222807|NCT03573908|100718701|FG001|Treatment Period|Withdrawal by Subject|5|||
33222808|NCT03573908|100718702|FG002|Treatment Period|Withdrawal by Subject|0|||
33222809|NCT03573908|100718703|FG003|Treatment Period|Withdrawal by Subject|0|||
33222810|NCT03573908|100718704|FG004|Treatment Period|Withdrawal by Subject|0|||
33222811|NCT03573908|100718700|FG000|Treatment Period|Lost to Follow-up|7|||
33222812|NCT03573908|100718701|FG001|Treatment Period|Lost to Follow-up|6|||
33222813|NCT03573908|100718702|FG002|Treatment Period|Lost to Follow-up|0|||
33222814|NCT03573908|100718703|FG003|Treatment Period|Lost to Follow-up|0|||
33222815|NCT03573908|100718704|FG004|Treatment Period|Lost to Follow-up|0|||
33222816|NCT03573908|100718700|FG000|Treatment Period|Pregnancy|1|||
33222817|NCT03573908|100718701|FG001|Treatment Period|Pregnancy|0|||
33222818|NCT03573908|100718702|FG002|Treatment Period|Pregnancy|0|||
33222819|NCT03573908|100718703|FG003|Treatment Period|Pregnancy|0|||
33222820|NCT03573908|100718704|FG004|Treatment Period|Pregnancy|0|||
33222821|NCT03573908|100718700|FG000|Treatment Period|Other, Not Specified|4|||
33222822|NCT03573908|100718701|FG001|Treatment Period|Other, Not Specified|6|||
33222823|NCT03573908|100718702|FG002|Treatment Period|Other, Not Specified|0|||
33363485|NCT02203838|101217539|FG003|Overall Study|Protocol Violation|0|||
33363486|NCT02203838|101217536|FG000|Overall Study|Withdrawal by Subject|83|||
33363487|NCT02203838|101217537|FG001|Overall Study|Withdrawal by Subject|10|||
33363488|NCT02203838|101217538|FG002|Overall Study|Withdrawal by Subject|8|||
33363489|NCT02203838|101217539|FG003|Overall Study|Withdrawal by Subject|11|||
33363490|NCT02203838|101217536|FG000|Overall Study|Physician Decision|27|||
33363491|NCT02203838|101217537|FG001|Overall Study|Physician Decision|0|||
33222824|NCT03573908|100718703|FG003|Treatment Period|Other, Not Specified|0|||
33222825|NCT03573908|100718704|FG004|Treatment Period|Other, Not Specified|0|||
33222826|NCT03573908|100718700|FG000|Randomized Withdrawal Period|Adverse Event|0|||
33222827|NCT03573908|100718701|FG001|Randomized Withdrawal Period|Adverse Event|0|||
33222828|NCT03573908|100718702|FG002|Randomized Withdrawal Period|Adverse Event|3|||
33222829|NCT03573908|100718703|FG003|Randomized Withdrawal Period|Adverse Event|0|||
33222830|NCT03573908|100718704|FG004|Randomized Withdrawal Period|Adverse Event|0|||
33222831|NCT03573908|100718700|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33222832|NCT03573908|100718701|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33222833|NCT03573908|100718702|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33222834|NCT03573908|100718703|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
33363492|NCT02203838|101217538|FG002|Overall Study|Physician Decision|2|||
33363493|NCT02203838|101217539|FG003|Overall Study|Physician Decision|3|||
33222835|NCT03573908|100718704|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
33222836|NCT03573908|100718700|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
33222837|NCT03573908|100718701|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
33222838|NCT03573908|100718702|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
33222839|NCT03573908|100718703|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
33222840|NCT03573908|100718704|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
33222841|NCT03573908|100718700|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
33222842|NCT03573908|100718701|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
33416220|NCT04469465|101413304|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
33416221|NCT04469465|101413305|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
33416222|NCT04469465|101413304|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
33222843|NCT03573908|100718702|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
33222844|NCT03573908|100718703|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
33222845|NCT03573908|100718704|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
33222846|NCT02301156|100718711|FG000|Overall Study|Adverse Event|13|||
33416223|NCT04469465|101413305|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
33416224|NCT04469465|101413304|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
33416225|NCT04469465|101413305|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
33222847|NCT02301156|100718712|FG001|Overall Study|Adverse Event|14|||
33222848|NCT02301156|100718711|FG000|Overall Study|Death|1|||
33222849|NCT02301156|100718712|FG001|Overall Study|Death|5|||
33222850|NCT02301156|100718711|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
33222851|NCT02301156|100718712|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
33222852|NCT02301156|100718711|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
33222853|NCT02301156|100718712|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
33222854|NCT02301156|100718711|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
33222855|NCT02301156|100718712|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
33222856|NCT02301156|100718711|FG000|Overall Study|Reason not Specified|6|||
33222857|NCT02301156|100718712|FG001|Overall Study|Reason not Specified|3|||
33222858|NCT00903786|100718713|FG000|Overall Study|Physician Decision|6|||
33222859|NCT00903786|100718713|FG000|Overall Study|Lack of Efficacy|5|||
33222860|NCT00903786|100718713|FG000|Overall Study|Reason other than lack of efficacy|4|||
33222861|NCT04074590|100718714|FG000|Overall Study|Adverse Event|1|||
33222862|NCT04074590|100718715|FG001|Overall Study|Adverse Event|0|||
33222863|NCT04074590|100718714|FG000|Overall Study|Physician Decision|1|||
33222864|NCT04074590|100718715|FG001|Overall Study|Physician Decision|0|||
33222865|NCT04074590|100718714|FG000|Overall Study|Withdrawal by Subject|2|||
33222866|NCT04074590|100718715|FG001|Overall Study|Withdrawal by Subject|0|||
33222867|NCT03124199|100718716|FG000|Overall Study|Lost to Follow-up|4|||
33222868|NCT02228967|100718717|FG000|Overall Study|Lost to Follow-up|146|||
33222869|NCT02228967|100718718|FG001|Overall Study|Lost to Follow-up|142|||
33222870|NCT02228967|100718717|FG000|Overall Study|Withdrawal by Subject|13|||
33222871|NCT02228967|100718718|FG001|Overall Study|Withdrawal by Subject|18|||
33222872|NCT01807156|100718720|FG000|Overall Study|Physician Decision|1|||
33222873|NCT00245102|100718721|FG000|Overall Study|Not Treated|1|||
33222874|NCT00245102|100718722|FG001|Overall Study|Not Treated|0|||
33222875|NCT00245102|100718723|FG002|Overall Study|Not Treated|1|||
33222876|NCT00245102|100718724|FG003|Overall Study|Not Treated|0|||
33222877|NCT00245102|100718725|FG004|Overall Study|Not Treated|0|||
33222878|NCT00245102|100718726|FG005|Overall Study|Not Treated|0|||
33222879|NCT00245102|100718721|FG000|Overall Study|Protocol Violation|1|||
33222880|NCT00245102|100718722|FG001|Overall Study|Protocol Violation|0|||
33222881|NCT00245102|100718723|FG002|Overall Study|Protocol Violation|0|||
33222882|NCT00245102|100718724|FG003|Overall Study|Protocol Violation|0|||
33416226|NCT04469465|101413304|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
33416227|NCT04469465|101413305|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
33416228|NCT04469465|101413304|FG000|Long-Term Extension (LTE)|Death|0|||
33416229|NCT04469465|101413305|FG001|Long-Term Extension (LTE)|Death|1|||
33416230|NCT04469465|101413304|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
33416231|NCT04469465|101413305|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
33416232|NCT03701516|101413308|FG000|Period 1|Lost to Follow-up|0|||
33416233|NCT03701516|101413309|FG001|Period 1|Lost to Follow-up|1|||
33416234|NCT03701516|101413308|FG000|Period 1|Adverse Event|0|||
33416235|NCT03701516|101413309|FG001|Period 1|Adverse Event|2|||
33566090|NCT00619866|101970582|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
33566091|NCT00619866|101970583|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
33566092|NCT00619866|101970584|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
33222883|NCT00245102|100718725|FG004|Overall Study|Protocol Violation|0|||
33416236|NCT03701516|101413308|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
33222884|NCT00245102|100718726|FG005|Overall Study|Protocol Violation|0|||
33222885|NCT00245102|100718721|FG000|Overall Study|Death|0|||
33222886|NCT00245102|100718722|FG001|Overall Study|Death|0|||
33222887|NCT00245102|100718723|FG002|Overall Study|Death|0|||
33222888|NCT00245102|100718724|FG003|Overall Study|Death|1|||
33222889|NCT00245102|100718725|FG004|Overall Study|Death|0|||
33363494|NCT02203838|101217536|FG000|Overall Study|Other|1|||
33363495|NCT02203838|101217537|FG001|Overall Study|Other|0|||
33363496|NCT02203838|101217538|FG002|Overall Study|Other|0|||
33363497|NCT02203838|101217539|FG003|Overall Study|Other|0|||
33363498|NCT02616029|101217540|FG000|Overall Study|Adverse Event|1|||
33363499|NCT02616029|101217541|FG001|Overall Study|Adverse Event|0|||
33363500|NCT02616029|101217540|FG000|Overall Study|Death|0|||
33363501|NCT02616029|101217541|FG001|Overall Study|Death|1|||
33363502|NCT02616029|101217540|FG000|Overall Study|Protocol Violation|1|||
33363503|NCT02616029|101217541|FG001|Overall Study|Protocol Violation|0|||
33363504|NCT02616029|101217540|FG000|Overall Study|Withdrew Consent|1|||
33363505|NCT02616029|101217541|FG001|Overall Study|Withdrew Consent|0|||
33363506|NCT02616029|101217540|FG000|Overall Study|Enrolled and Never Treated|1|||
33363507|NCT02616029|101217541|FG001|Overall Study|Enrolled and Never Treated|1|||
33363508|NCT01696877|101217542|FG000|Overall Study|Adverse Event|0|||
33363509|NCT01696877|101217543|FG001|Overall Study|Adverse Event|1|||
33363510|NCT00443430|101217544|FG000|Overall Study|Lack of Efficacy|3|||
33363511|NCT00443430|101217545|FG001|Overall Study|Lack of Efficacy|3|||
33363512|NCT00443430|101217544|FG000|Overall Study|Adverse Event|1|||
33363513|NCT00443430|101217545|FG001|Overall Study|Adverse Event|1|||
33363514|NCT00719810|101217550|FG000|Overall Study|Adverse Event|0|||
33363515|NCT00719810|101217551|FG001|Overall Study|Adverse Event|2|||
33363516|NCT00719810|101217552|FG002|Overall Study|Adverse Event|3|||
33363517|NCT00719810|101217550|FG000|Overall Study|Lost to Follow-up|2|||
33363518|NCT00719810|101217551|FG001|Overall Study|Lost to Follow-up|0|||
33363519|NCT00719810|101217552|FG002|Overall Study|Lost to Follow-up|3|||
33363520|NCT00719810|101217550|FG000|Overall Study|Physician Decision|0|||
33363521|NCT00719810|101217551|FG001|Overall Study|Physician Decision|1|||
33363522|NCT00719810|101217552|FG002|Overall Study|Physician Decision|0|||
33363523|NCT00719810|101217550|FG000|Overall Study|Withdrawal by Subject|1|||
33363524|NCT00719810|101217551|FG001|Overall Study|Withdrawal by Subject|1|||
33363525|NCT00719810|101217552|FG002|Overall Study|Withdrawal by Subject|2|||
33363526|NCT02037919|101217553|FG000|Overall Study|Lost to Follow-up|30|||
33363527|NCT02037919|101217554|FG001|Overall Study|Lost to Follow-up|45|||
33363528|NCT01022853|101217555|FG000|Overall Study|Progressive disease|2|||
33363529|NCT01022853|101217556|FG001|Overall Study|Progressive disease|3|||
33363530|NCT01022853|101217557|FG002|Overall Study|Progressive disease|11|||
33363531|NCT01022853|101217558|FG003|Overall Study|Progressive disease|7|||
33363532|NCT01022853|101217559|FG004|Overall Study|Progressive disease|1|||
33363533|NCT01022853|101217555|FG000|Overall Study|Dose-limiting toxicity|0|||
33363534|NCT01022853|101217556|FG001|Overall Study|Dose-limiting toxicity|0|||
33363535|NCT01022853|101217557|FG002|Overall Study|Dose-limiting toxicity|0|||
33363536|NCT01022853|101217558|FG003|Overall Study|Dose-limiting toxicity|0|||
33363537|NCT01022853|101217559|FG004|Overall Study|Dose-limiting toxicity|1|||
33363538|NCT01022853|101217555|FG000|Overall Study|Withdrawal by Subject|0|||
33363539|NCT01022853|101217556|FG001|Overall Study|Withdrawal by Subject|1|||
33363540|NCT01022853|101217557|FG002|Overall Study|Withdrawal by Subject|1|||
33363541|NCT01022853|101217558|FG003|Overall Study|Withdrawal by Subject|1|||
33363542|NCT01022853|101217559|FG004|Overall Study|Withdrawal by Subject|0|||
33363543|NCT01022853|101217555|FG000|Overall Study|Other not stated above|1|||
33363544|NCT01022853|101217556|FG001|Overall Study|Other not stated above|0|||
33363545|NCT01022853|101217557|FG002|Overall Study|Other not stated above|1|||
33363546|NCT01022853|101217558|FG003|Overall Study|Other not stated above|0|||
33363547|NCT01022853|101217559|FG004|Overall Study|Other not stated above|0|||
33363548|NCT01780389|101217560|FG000|Overall Study|Adverse Event|1|||
33363549|NCT02749370|101217563|FG000|Overall Study|Withdrawal by Subject|11|||
33566093|NCT00619866|101970580|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
33363550|NCT02749370|101217563|FG000|Overall Study|Lost to Follow-up|3|||
33363551|NCT00734929|101217566|FG000|Overall Study|Lost to Follow-up|1|||
33363552|NCT00734929|101217567|FG001|Overall Study|Lost to Follow-up|2|||
33363553|NCT00734929|101217566|FG000|Overall Study|No intervention/ screen fail|5|||
33363554|NCT00734929|101217567|FG001|Overall Study|No intervention/ screen fail|3|||
33363555|NCT03280550|101217570|FG000|Overall Study|Withdrawal by Subject|2|||
33363556|NCT03280550|101217571|FG001|Overall Study|Withdrawal by Subject|2|||
33363557|NCT03280550|101217570|FG000|Overall Study|Physician Decision|0|||
33363558|NCT03280550|101217571|FG001|Overall Study|Physician Decision|1|||
33363559|NCT03199911|101217572|FG000|Overall Study|Lost to Follow-up|5|||
33363560|NCT03199911|101217573|FG001|Overall Study|Lost to Follow-up|5|||
33363561|NCT03199911|101217572|FG000|Overall Study|Did not proceed with surgery|2|||
33363562|NCT03199911|101217573|FG001|Overall Study|Did not proceed with surgery|1|||
33363563|NCT00790296|101217580|FG000|Overall Study|Did not meet study eligibility criteria|1|||
33363564|NCT00790296|101217581|FG001|Overall Study|Did not meet study eligibility criteria|1|||
33566094|NCT00619866|101970581|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
33566095|NCT00619866|101970582|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
33363565|NCT00790296|101217580|FG000|Overall Study|Adverse Event|0|||
33363566|NCT00790296|101217581|FG001|Overall Study|Adverse Event|1|||
33363567|NCT00394914|101220328|FG000|Treatment Period|Adverse Event|0|||
33363568|NCT00394914|101220329|FG001|Treatment Period|Adverse Event|3|||
33363569|NCT00394914|101220330|FG002|Treatment Period|Adverse Event|1|||
33416237|NCT03701516|101413309|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
33416238|NCT03701516|101413308|FG000|Period 1|Non Compliance to Protocol|2|||
33416239|NCT03701516|101413309|FG001|Period 1|Non Compliance to Protocol|1|||
33416240|NCT03701516|101413308|FG000|Period 1|Withdrawal by Subject|0|||
33416241|NCT03701516|101413309|FG001|Period 1|Withdrawal by Subject|1|||
33416242|NCT03701516|101413308|FG000|Period 2|failed to meet all eligibility creiteria|1|||
33416243|NCT03701516|101413309|FG001|Period 2|failed to meet all eligibility creiteria|0|||
33416244|NCT03701516|101413308|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
33416245|NCT03701516|101413309|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
33416246|NCT00396318|101413310|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
33416247|NCT00742859|101416040|FG000|Overall Study|Adverse Event|5|||
33416248|NCT00742859|101416041|FG001|Overall Study|Adverse Event|6|||
33416249|NCT00742859|101416042|FG002|Overall Study|Adverse Event|3|||
33416250|NCT00742859|101416043|FG003|Overall Study|Adverse Event|1|||
33416251|NCT00742859|101416040|FG000|Overall Study|Death|1|||
33416252|NCT00742859|101416041|FG001|Overall Study|Death|0|||
33416253|NCT00742859|101416042|FG002|Overall Study|Death|0|||
33416254|NCT00742859|101416043|FG003|Overall Study|Death|1|||
33416255|NCT00742859|101416040|FG000|Overall Study|Physician Decision|1|||
33416256|NCT00742859|101416041|FG001|Overall Study|Physician Decision|2|||
33416257|NCT00742859|101416042|FG002|Overall Study|Physician Decision|0|||
33416258|NCT00742859|101416043|FG003|Overall Study|Physician Decision|0|||
33416259|NCT00742859|101416040|FG000|Overall Study|Withdrawal by Subject|4|||
33416260|NCT00742859|101416041|FG001|Overall Study|Withdrawal by Subject|2|||
33416261|NCT00742859|101416042|FG002|Overall Study|Withdrawal by Subject|4|||
33416262|NCT00742859|101416043|FG003|Overall Study|Withdrawal by Subject|1|||
33416263|NCT00742859|101416040|FG000|Overall Study|Endpoint|0|||
33416264|NCT00742859|101416041|FG001|Overall Study|Endpoint|1|||
33416265|NCT00742859|101416042|FG002|Overall Study|Endpoint|1|||
33416266|NCT00742859|101416043|FG003|Overall Study|Endpoint|2|||
33416267|NCT00742859|101416040|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
33416268|NCT00742859|101416041|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
33566096|NCT00619866|101970583|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
33566097|NCT00619866|101970584|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
33566098|NCT00619866|101970580|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
33363570|NCT00394914|101220328|FG000|Treatment Period|Lost to Follow-up|0|||
33363571|NCT00394914|101220329|FG001|Treatment Period|Lost to Follow-up|1|||
33363572|NCT00394914|101220330|FG002|Treatment Period|Lost to Follow-up|0|||
33363573|NCT00394914|101220328|FG000|Treatment Period|Withdrawal by Subject|0|||
33363574|NCT00394914|101220329|FG001|Treatment Period|Withdrawal by Subject|2|||
33363575|NCT00394914|101220330|FG002|Treatment Period|Withdrawal by Subject|2|||
33363576|NCT00394914|101220328|FG000|Treatment Period|Noncompliance with protocol|0|||
33363577|NCT00394914|101220329|FG001|Treatment Period|Noncompliance with protocol|3|||
33363578|NCT00394914|101220330|FG002|Treatment Period|Noncompliance with protocol|2|||
33363579|NCT00394914|101220328|FG000|Treatment Period|Did not meet protocol eligibility|0|||
33363580|NCT00394914|101220329|FG001|Treatment Period|Did not meet protocol eligibility|1|||
33363581|NCT00394914|101220330|FG002|Treatment Period|Did not meet protocol eligibility|1|||
33363582|NCT00803244|101220331|FG000|Overall Study|Adverse Event|1|||
33363583|NCT00803244|101220332|FG001|Overall Study|Adverse Event|2|||
33363584|NCT00803244|101220331|FG000|Overall Study|Withdrawal by Subject|2|||
33363585|NCT00803244|101220332|FG001|Overall Study|Withdrawal by Subject|3|||
33363586|NCT00803244|101220331|FG000|Overall Study|Any other reason not above-mentioned|4|||
33363587|NCT00803244|101220332|FG001|Overall Study|Any other reason not above-mentioned|10|||
33363588|NCT02119104|101220337|FG000|Overall Study|Protocol Violation|16|||
33363589|NCT01595646|101220338|FG000|Overall Study|Withdrawal by Subject|1|||
33363590|NCT01595646|101220339|FG001|Overall Study|Withdrawal by Subject|0|||
33363591|NCT01595646|101220340|FG002|Overall Study|Withdrawal by Subject|0|||
33363592|NCT02574312|101220349|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
33363593|NCT02574312|101220350|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
33363594|NCT01371838|101220353|FG000|Overall Study|Withdrawal by Subject|27|||
33363595|NCT01371838|101220354|FG001|Overall Study|Withdrawal by Subject|33|||
33363596|NCT01371838|101220353|FG000|Overall Study|Lost to Follow-up|10|||
33363597|NCT01371838|101220354|FG001|Overall Study|Lost to Follow-up|20|||
33416269|NCT00742859|101416042|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
33416270|NCT00742859|101416043|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
33416271|NCT00742859|101416040|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
33222890|NCT00245102|100718726|FG005|Overall Study|Death|0|||
33222891|NCT00245102|100718721|FG000|Overall Study|Adverse Event|4|||
33363598|NCT01371838|101220353|FG000|Overall Study|Death|3|||
33416272|NCT00742859|101416041|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
33416273|NCT00742859|101416042|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
33416274|NCT00742859|101416043|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
33416275|NCT00742859|101416040|FG000|Overall Study|Sponsor request patient out of town|0|||
33416276|NCT00742859|101416041|FG001|Overall Study|Sponsor request patient out of town|0|||
33416277|NCT00742859|101416042|FG002|Overall Study|Sponsor request patient out of town|1|||
33363599|NCT01371838|101220354|FG001|Overall Study|Death|4|||
33363600|NCT01371838|101220353|FG000|Overall Study|Protocol Violation|3|||
33363601|NCT01371838|101220354|FG001|Overall Study|Protocol Violation|0|||
33363602|NCT01371838|101220353|FG000|Overall Study|Investigator Decision|3|||
33363603|NCT01371838|101220354|FG001|Overall Study|Investigator Decision|8|||
33363604|NCT01371838|101220353|FG000|Overall Study|Last follow-up visit not conducted|2|||
33416278|NCT00742859|101416043|FG003|Overall Study|Sponsor request patient out of town|1|||
33416279|NCT00742859|101416040|FG000|Overall Study|Site error|0|||
33416280|NCT00742859|101416041|FG001|Overall Study|Site error|0|||
33416281|NCT00742859|101416042|FG002|Overall Study|Site error|1|||
33416282|NCT00742859|101416043|FG003|Overall Study|Site error|1|||
33416283|NCT00447694|101416047|FG000|Overall Study|Adverse Event|2|||
33566099|NCT00619866|101970581|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
33566100|NCT00619866|101970582|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
33566101|NCT00619866|101970583|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
33566102|NCT00619866|101970584|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
33566103|NCT00619866|101970580|FG000|Weeks 1 - 12|Sponsor Decision|0|||
33566104|NCT00619866|101970581|FG001|Weeks 1 - 12|Sponsor Decision|1|||
33566105|NCT00619866|101970582|FG002|Weeks 1 - 12|Sponsor Decision|0|||
33566106|NCT00619866|101970583|FG003|Weeks 1 - 12|Sponsor Decision|0|||
33566107|NCT00619866|101970584|FG004|Weeks 1 - 12|Sponsor Decision|0|||
33630001|NCT01436149|102197629|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
33630002|NCT01436149|102197627|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
33630003|NCT01436149|102197628|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
33630004|NCT01436149|102197629|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
33630005|NCT01436149|102197627|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
33363605|NCT01371838|101220354|FG001|Overall Study|Last follow-up visit not conducted|0|||
33363606|NCT01371838|101220353|FG000|Overall Study|Lack of therapeutic response|0|||
33363607|NCT01371838|101220354|FG001|Overall Study|Lack of therapeutic response|1|||
33363608|NCT01371838|101220353|FG000|Overall Study|Surgery|1|||
33363609|NCT01371838|101220354|FG001|Overall Study|Surgery|0|||
33363610|NCT01518699|101220355|FG000|Period 2|Protocol Violation|1|||
33363611|NCT01518699|101220356|FG001|Period 2|Protocol Violation|1|||
33363612|NCT01518699|101220357|FG002|Period 2|Protocol Violation|0|||
33363613|NCT01518699|101220358|FG003|Period 2|Protocol Violation|0|||
33363614|NCT01518699|101220359|FG004|Period 2|Protocol Violation|0|||
33363615|NCT01518699|101220360|FG005|Period 2|Protocol Violation|0|||
33363616|NCT01518699|101220355|FG000|Period 2|Lost to Follow-up|0|||
33363617|NCT01518699|101220356|FG001|Period 2|Lost to Follow-up|1|||
33363618|NCT01518699|101220357|FG002|Period 2|Lost to Follow-up|0|||
33363619|NCT01518699|101220358|FG003|Period 2|Lost to Follow-up|0|||
33363620|NCT01518699|101220359|FG004|Period 2|Lost to Follow-up|0|||
33363621|NCT01518699|101220360|FG005|Period 2|Lost to Follow-up|0|||
33363622|NCT01518699|101220355|FG000|Period 2|Adverse Event|1|||
33630006|NCT01436149|102197628|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
33630007|NCT01436149|102197629|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
33630008|NCT01436149|102197627|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
33630009|NCT01436149|102197628|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
33630010|NCT01436149|102197629|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
33630011|NCT01436149|102197627|FG000|Antidepressant Lead-in Phase|Other|119|||
33630012|NCT01436149|102197628|FG001|Antidepressant Lead-in Phase|Other|0|||
33363623|NCT01518699|101220356|FG001|Period 2|Adverse Event|0|||
33363624|NCT01518699|101220357|FG002|Period 2|Adverse Event|0|||
33363625|NCT01518699|101220358|FG003|Period 2|Adverse Event|0|||
33630013|NCT01436149|102197629|FG002|Antidepressant Lead-in Phase|Other|0|||
33630014|NCT01436149|102197627|FG000|Randomized Phase|Adverse Event|9|||
33630015|NCT01436149|102197628|FG001|Randomized Phase|Adverse Event|10|||
33630016|NCT01436149|102197629|FG002|Randomized Phase|Adverse Event|11|||
33630017|NCT01436149|102197627|FG000|Randomized Phase|Protocol Violation|4|||
33630018|NCT01436149|102197628|FG001|Randomized Phase|Protocol Violation|5|||
33630019|NCT01436149|102197629|FG002|Randomized Phase|Protocol Violation|0|||
33630020|NCT01436149|102197627|FG000|Randomized Phase|Withdrawal by Subject|16|||
33630021|NCT01436149|102197628|FG001|Randomized Phase|Withdrawal by Subject|10|||
33630022|NCT01436149|102197629|FG002|Randomized Phase|Withdrawal by Subject|10|||
33630023|NCT01436149|102197627|FG000|Randomized Phase|Lost to Follow-up|34|||
33630024|NCT01436149|102197628|FG001|Randomized Phase|Lost to Follow-up|5|||
33363626|NCT01518699|101220359|FG004|Period 2|Adverse Event|0|||
33566108|NCT00619866|101970580|FG000|Weeks 13 - 24|Adverse Event|0|||
33630025|NCT01436149|102197629|FG002|Randomized Phase|Lost to Follow-up|6|||
33363627|NCT01518699|101220360|FG005|Period 2|Adverse Event|0|||
33363628|NCT00914628|101220361|FG000|Overall Study|Death|35|||
33363629|NCT00914628|101220362|FG001|Overall Study|Death|17|||
33363630|NCT00914628|101220361|FG000|Overall Study|Medical decision|4|||
33363631|NCT00914628|101220362|FG001|Overall Study|Medical decision|0|||
33416284|NCT00447694|101416047|FG000|Overall Study|Abnormal laboratory value|1|||
33363632|NCT00914628|101220361|FG000|Overall Study|Protocol Violation|1|||
33363633|NCT00914628|101220362|FG001|Overall Study|Protocol Violation|0|||
33566109|NCT00619866|101970581|FG001|Weeks 13 - 24|Adverse Event|0|||
33222892|NCT00245102|100718722|FG001|Overall Study|Adverse Event|2|||
33222893|NCT00245102|100718723|FG002|Overall Study|Adverse Event|5|||
33222894|NCT00245102|100718724|FG003|Overall Study|Adverse Event|1|||
33222895|NCT00245102|100718725|FG004|Overall Study|Adverse Event|0|||
33222896|NCT00245102|100718726|FG005|Overall Study|Adverse Event|2|||
33222897|NCT00245102|100718721|FG000|Overall Study|Decline in performance|0|||
33222898|NCT00245102|100718722|FG001|Overall Study|Decline in performance|2|||
33222899|NCT00245102|100718723|FG002|Overall Study|Decline in performance|0|||
33222900|NCT00245102|100718724|FG003|Overall Study|Decline in performance|1|||
33222901|NCT00245102|100718725|FG004|Overall Study|Decline in performance|0|||
33222902|NCT00245102|100718726|FG005|Overall Study|Decline in performance|2|||
33222903|NCT00245102|100718721|FG000|Overall Study|Participant needed surgery|0|||
33222904|NCT00245102|100718722|FG001|Overall Study|Participant needed surgery|0|||
33222905|NCT00245102|100718723|FG002|Overall Study|Participant needed surgery|1|||
33222906|NCT00245102|100718724|FG003|Overall Study|Participant needed surgery|0|||
33222907|NCT00245102|100718725|FG004|Overall Study|Participant needed surgery|0|||
33222908|NCT00245102|100718726|FG005|Overall Study|Participant needed surgery|0|||
33222909|NCT00245102|100718721|FG000|Overall Study|Clinical progression|1|||
33222910|NCT00245102|100718722|FG001|Overall Study|Clinical progression|0|||
33222911|NCT00245102|100718723|FG002|Overall Study|Clinical progression|0|||
33222912|NCT00245102|100718724|FG003|Overall Study|Clinical progression|0|||
33222913|NCT00245102|100718725|FG004|Overall Study|Clinical progression|0|||
33222914|NCT00245102|100718726|FG005|Overall Study|Clinical progression|0|||
33222915|NCT03333915|100718729|FG000|Overall Study|Lost to Follow-up|0|||
33222916|NCT03333915|100718730|FG001|Overall Study|Lost to Follow-up|0|||
33222917|NCT03333915|100718731|FG002|Overall Study|Lost to Follow-up|1|||
33222918|NCT03333915|100718732|FG003|Overall Study|Lost to Follow-up|0|||
33222919|NCT03333915|100718733|FG004|Overall Study|Lost to Follow-up|0|||
33222920|NCT03333915|100718729|FG000|Overall Study|Disease Progression|0|||
33222921|NCT03333915|100718730|FG001|Overall Study|Disease Progression|1|||
33566110|NCT00619866|101970582|FG002|Weeks 13 - 24|Adverse Event|2|||
33566111|NCT00619866|101970583|FG003|Weeks 13 - 24|Adverse Event|1|||
33630026|NCT01436149|102197627|FG000|Randomized Phase|Lack of Efficacy|0|||
33630027|NCT01436149|102197628|FG001|Randomized Phase|Lack of Efficacy|0|||
33630028|NCT01436149|102197629|FG002|Randomized Phase|Lack of Efficacy|1|||
33630029|NCT01436149|102197627|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
33630030|NCT01436149|102197628|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
33630031|NCT01436149|102197629|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
33630032|NCT01436149|102197627|FG000|Randomized Phase|Other|12|||
33630033|NCT01436149|102197628|FG001|Randomized Phase|Other|5|||
33630034|NCT01436149|102197629|FG002|Randomized Phase|Other|11|||
33630035|NCT02365649|102197630|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33630036|NCT02365649|102197631|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33630037|NCT02365649|102197632|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33630038|NCT02365649|102197633|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
33630039|NCT02365649|102197634|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33630040|NCT02365649|102197635|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33566112|NCT00619866|101970584|FG004|Weeks 13 - 24|Adverse Event|0|||
33566113|NCT00619866|101970580|FG000|Weeks 13 - 24|Protocol Deviation|0|||
33566114|NCT00619866|101970581|FG001|Weeks 13 - 24|Protocol Deviation|0|||
33566115|NCT00619866|101970582|FG002|Weeks 13 - 24|Protocol Deviation|0|||
33566116|NCT00619866|101970583|FG003|Weeks 13 - 24|Protocol Deviation|1|||
33566117|NCT00619866|101970584|FG004|Weeks 13 - 24|Protocol Deviation|0|||
33566118|NCT00619866|101970580|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
33566119|NCT00619866|101970581|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
33566120|NCT00619866|101970582|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
33566121|NCT00619866|101970583|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
33566122|NCT00619866|101970584|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
33566123|NCT00619866|101970580|FG000|Weeks 13 - 24|Non-compliance|0|||
33566124|NCT00619866|101970581|FG001|Weeks 13 - 24|Non-compliance|1|||
33222922|NCT03333915|100718731|FG002|Overall Study|Disease Progression|0|||
33222923|NCT03333915|100718732|FG003|Overall Study|Disease Progression|0|||
33222924|NCT03333915|100718733|FG004|Overall Study|Disease Progression|0|||
33222925|NCT03333915|100718729|FG000|Overall Study|Death|0|||
33566125|NCT00619866|101970582|FG002|Weeks 13 - 24|Non-compliance|1|||
33566126|NCT00619866|101970583|FG003|Weeks 13 - 24|Non-compliance|0|||
33566127|NCT00619866|101970584|FG004|Weeks 13 - 24|Non-compliance|0|||
33630041|NCT02365649|102197636|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33222926|NCT03333915|100718730|FG001|Overall Study|Death|0|||
33222927|NCT03333915|100718731|FG002|Overall Study|Death|0|||
33222928|NCT03333915|100718732|FG003|Overall Study|Death|37|||
33222929|NCT03333915|100718733|FG004|Overall Study|Death|18|||
33222930|NCT03333915|100718729|FG000|Overall Study|Sponsor's Decision|0|||
33222931|NCT03333915|100718730|FG001|Overall Study|Sponsor's Decision|0|||
33222932|NCT03333915|100718731|FG002|Overall Study|Sponsor's Decision|0|||
33222933|NCT03333915|100718732|FG003|Overall Study|Sponsor's Decision|48|||
33222934|NCT03333915|100718733|FG004|Overall Study|Sponsor's Decision|4|||
33630042|NCT02365649|102197637|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33630043|NCT02365649|102197638|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33630044|NCT02365649|102197639|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
33630045|NCT02365649|102197630|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
33630046|NCT02365649|102197631|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
33630047|NCT02365649|102197632|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
33630048|NCT02365649|102197633|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
33630049|NCT02365649|102197634|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
33630050|NCT02365649|102197635|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
33630051|NCT02365649|102197636|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
33630052|NCT02365649|102197637|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
33630053|NCT02365649|102197638|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
33630054|NCT02365649|102197639|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
33630055|NCT02365649|102197630|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
33630056|NCT02365649|102197631|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
33566128|NCT00619866|101970580|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
33566129|NCT00619866|101970581|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
33566130|NCT00619866|101970582|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
33566131|NCT00619866|101970583|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
33363634|NCT00914628|101220361|FG000|Overall Study|Lack of Efficacy|1|||
33363635|NCT00914628|101220362|FG001|Overall Study|Lack of Efficacy|0|||
33363636|NCT00914628|101220361|FG000|Overall Study|non-randomized|1|||
33363637|NCT00914628|101220362|FG001|Overall Study|non-randomized|0|||
33363638|NCT00914628|101220361|FG000|Overall Study|Relapse|1|||
33363639|NCT00914628|101220362|FG001|Overall Study|Relapse|2|||
33363640|NCT00914628|101220361|FG000|Overall Study|Study terminated by Sponsor|14|||
33363641|NCT00914628|101220362|FG001|Overall Study|Study terminated by Sponsor|8|||
33630057|NCT02365649|102197632|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
33630058|NCT02365649|102197633|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
33630059|NCT02365649|102197634|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
33630060|NCT02365649|102197635|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
33630061|NCT02365649|102197636|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
33630062|NCT02365649|102197637|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
33630063|NCT02365649|102197638|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
33630064|NCT02365649|102197639|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
33630065|NCT02365649|102197630|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
33630066|NCT02365649|102197631|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
33630067|NCT02365649|102197632|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
33630068|NCT02365649|102197633|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
33630069|NCT02365649|102197634|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
33630070|NCT02365649|102197635|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
33630071|NCT02365649|102197636|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
33630072|NCT02365649|102197637|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
33630073|NCT02365649|102197638|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
33630074|NCT02365649|102197639|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
33630075|NCT02365649|102197630|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
33630076|NCT02365649|102197631|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
33363642|NCT00914628|101220361|FG000|Overall Study|Patients who did not receive a single dose|7|||
33566132|NCT00619866|101970584|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
33566133|NCT03033784|101970591|FG000|Overall Study|Anxiety related to MRI scanner|0|||
33566134|NCT03033784|101970592|FG001|Overall Study|Anxiety related to MRI scanner|1|||
33566135|NCT03033784|101970593|FG002|Overall Study|Anxiety related to MRI scanner|0|||
33566136|NCT03033784|101970594|FG003|Overall Study|Anxiety related to MRI scanner|0|||
33566137|NCT03033784|101970595|FG004|Overall Study|Anxiety related to MRI scanner|0|||
33566138|NCT03033784|101970596|FG005|Overall Study|Anxiety related to MRI scanner|0|||
33566139|NCT03033784|101970597|FG006|Overall Study|Anxiety related to MRI scanner|0|||
33566140|NCT03033784|101970598|FG007|Overall Study|Anxiety related to MRI scanner|0|||
33566141|NCT03033784|101970599|FG008|Overall Study|Anxiety related to MRI scanner|0|||
33566142|NCT03033784|101970600|FG009|Overall Study|Anxiety related to MRI scanner|0|||
33566143|NCT03033784|101970601|FG010|Overall Study|Anxiety related to MRI scanner|0|||
33566144|NCT03033784|101970602|FG011|Overall Study|Anxiety related to MRI scanner|0|||
33566145|NCT03033784|101970603|FG012|Overall Study|Anxiety related to MRI scanner|0|||
33630077|NCT02365649|102197632|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
33630078|NCT02365649|102197633|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
33630079|NCT02365649|102197634|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
33363643|NCT00914628|101220362|FG001|Overall Study|Patients who did not receive a single dose|1|||
33363644|NCT01260181|101220363|FG000|Overall Study|Decision of Investigator|1|||
33566146|NCT03033784|101970591|FG000|Overall Study|Withdrawal by Subject|0|||
33566147|NCT03033784|101970592|FG001|Overall Study|Withdrawal by Subject|0|||
33566148|NCT03033784|101970593|FG002|Overall Study|Withdrawal by Subject|0|||
33363645|NCT00401973|101220366|FG000|Overall Study|Adverse Event|2|||
33630080|NCT02365649|102197635|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
33630081|NCT02365649|102197636|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
33630082|NCT02365649|102197637|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
33630083|NCT02365649|102197638|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
33630084|NCT02365649|102197639|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
33630085|NCT02365649|102197630|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
33630086|NCT02365649|102197631|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
33630087|NCT02365649|102197632|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
33630088|NCT02365649|102197633|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
33630089|NCT02365649|102197634|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
33630090|NCT02365649|102197635|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
33630091|NCT02365649|102197636|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
33630092|NCT02365649|102197637|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
33630093|NCT02365649|102197638|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
33630094|NCT02365649|102197639|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
33630095|NCT02365649|102197630|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33630096|NCT02365649|102197631|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33630097|NCT02365649|102197632|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
33630098|NCT02365649|102197633|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33630099|NCT02365649|102197634|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33630100|NCT02365649|102197635|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33630101|NCT02365649|102197636|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33630102|NCT02365649|102197637|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33222935|NCT03333915|100718729|FG000|Overall Study|Withdrawal by Subject|0|||
33222936|NCT03333915|100718730|FG001|Overall Study|Withdrawal by Subject|0|||
33222937|NCT03333915|100718731|FG002|Overall Study|Withdrawal by Subject|0|||
33222938|NCT03333915|100718732|FG003|Overall Study|Withdrawal by Subject|5|||
33222939|NCT03333915|100718733|FG004|Overall Study|Withdrawal by Subject|1|||
33222940|NCT01859793|100718734|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
33222941|NCT01859793|100718735|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
33363646|NCT00401973|101220367|FG001|Overall Study|Adverse Event|8|||
33363647|NCT00401973|101220368|FG002|Overall Study|Adverse Event|4|||
33363648|NCT00401973|101220366|FG000|Overall Study|Clinical Relapse|0|||
33363649|NCT00401973|101220367|FG001|Overall Study|Clinical Relapse|1|||
33363650|NCT00401973|101220368|FG002|Overall Study|Clinical Relapse|1|||
33363651|NCT00401973|101220366|FG000|Overall Study|Lack of Efficacy|0|||
33363652|NCT00401973|101220367|FG001|Overall Study|Lack of Efficacy|0|||
33363653|NCT00401973|101220368|FG002|Overall Study|Lack of Efficacy|3|||
33363654|NCT00401973|101220366|FG000|Overall Study|Lost to Follow-up|2|||
33363655|NCT00401973|101220367|FG001|Overall Study|Lost to Follow-up|2|||
33363656|NCT00401973|101220368|FG002|Overall Study|Lost to Follow-up|2|||
33363657|NCT00401973|101220366|FG000|Overall Study|Physician Decision|2|||
33363658|NCT00401973|101220367|FG001|Overall Study|Physician Decision|0|||
33363659|NCT00401973|101220368|FG002|Overall Study|Physician Decision|1|||
33363660|NCT00401973|101220366|FG000|Overall Study|Protocol Violation|1|||
33363661|NCT00401973|101220367|FG001|Overall Study|Protocol Violation|2|||
33363662|NCT00401973|101220368|FG002|Overall Study|Protocol Violation|3|||
33363663|NCT00401973|101220366|FG000|Overall Study|Sponsor Decision|0|||
33363664|NCT00401973|101220367|FG001|Overall Study|Sponsor Decision|1|||
33363665|NCT00401973|101220368|FG002|Overall Study|Sponsor Decision|0|||
33363666|NCT00401973|101220366|FG000|Overall Study|Withdrawal by Subject|4|||
33363667|NCT00401973|101220367|FG001|Overall Study|Withdrawal by Subject|12|||
33363668|NCT00401973|101220368|FG002|Overall Study|Withdrawal by Subject|9|||
33363669|NCT00590681|101220371|FG000|Overall Study|Withdrawal by Subject|7|||
33363670|NCT00590681|101220371|FG000|Overall Study|Adverse Event|8|||
33363671|NCT00590681|101220371|FG000|Overall Study|Death|3|||
33363672|NCT00590681|101220371|FG000|Overall Study|Lost to Follow-up|1|||
33566149|NCT03033784|101970594|FG003|Overall Study|Withdrawal by Subject|0|||
33566150|NCT03033784|101970595|FG004|Overall Study|Withdrawal by Subject|0|||
33566151|NCT03033784|101970596|FG005|Overall Study|Withdrawal by Subject|0|||
33566152|NCT03033784|101970597|FG006|Overall Study|Withdrawal by Subject|0|||
33566153|NCT03033784|101970598|FG007|Overall Study|Withdrawal by Subject|0|||
33566154|NCT03033784|101970599|FG008|Overall Study|Withdrawal by Subject|0|||
33566155|NCT03033784|101970600|FG009|Overall Study|Withdrawal by Subject|0|||
33566156|NCT03033784|101970601|FG010|Overall Study|Withdrawal by Subject|0|||
33566157|NCT03033784|101970602|FG011|Overall Study|Withdrawal by Subject|0|||
33566158|NCT03033784|101970603|FG012|Overall Study|Withdrawal by Subject|2|||
33566159|NCT03322566|101970607|FG000|Overall Study|Death|34|||
33566160|NCT03322566|101970608|FG001|Overall Study|Death|35|||
33566161|NCT03322566|101970609|FG002|Overall Study|Death|23|||
33566162|NCT03322566|101970607|FG000|Overall Study|Physician Decision|6|||
33222942|NCT01859793|100718734|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
33222943|NCT01859793|100718735|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
33222944|NCT01859793|100718734|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
33222945|NCT01859793|100718735|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
33222946|NCT01859793|100718734|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
33222947|NCT01859793|100718735|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
33222948|NCT00838682|100718736|FG000|Overall Study|Lost to Follow-up|21|||
33222949|NCT00838682|100718737|FG001|Overall Study|Lost to Follow-up|14|||
33222950|NCT00838682|100718736|FG000|Overall Study|detection of exclusion criteria|4|||
33222951|NCT00838682|100718737|FG001|Overall Study|detection of exclusion criteria|3|||
33222952|NCT00838682|100718736|FG000|Overall Study|Protocol Violation|0|||
33222953|NCT00838682|100718737|FG001|Overall Study|Protocol Violation|1|||
33363673|NCT00590681|101220371|FG000|Overall Study|disease progression|1|||
33363674|NCT00849693|101220372|FG000|Acute Treatment Phase|Adverse Event|12|||
33363675|NCT00849693|101220373|FG001|Acute Treatment Phase|Adverse Event|7|||
33363676|NCT00849693|101220374|FG002|Acute Treatment Phase|Adverse Event|6|||
33363677|NCT00849693|101220375|FG003|Acute Treatment Phase|Adverse Event|4|||
33363678|NCT00849693|101220372|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
33363679|NCT00849693|101220373|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
33363680|NCT00849693|101220374|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
33363681|NCT00849693|101220375|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
33363682|NCT00849693|101220372|FG000|Acute Treatment Phase|Protocol Violation|1|||
33363683|NCT00849693|101220373|FG001|Acute Treatment Phase|Protocol Violation|5|||
33363684|NCT00849693|101220374|FG002|Acute Treatment Phase|Protocol Violation|2|||
33363685|NCT00849693|101220375|FG003|Acute Treatment Phase|Protocol Violation|6|||
33363686|NCT00849693|101220372|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
33566163|NCT03322566|101970608|FG001|Overall Study|Physician Decision|7|||
33566164|NCT03322566|101970609|FG002|Overall Study|Physician Decision|2|||
33566165|NCT03322566|101970607|FG000|Overall Study|Withdrawal by Subject|4|||
33566166|NCT03322566|101970608|FG001|Overall Study|Withdrawal by Subject|3|||
33363687|NCT00849693|101220373|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
33566167|NCT03322566|101970609|FG002|Overall Study|Withdrawal by Subject|6|||
33566168|NCT03322566|101970607|FG000|Overall Study|Lost to Follow-up|0|||
33566169|NCT03322566|101970608|FG001|Overall Study|Lost to Follow-up|0|||
33566170|NCT03322566|101970609|FG002|Overall Study|Lost to Follow-up|1|||
33566171|NCT03322566|101970607|FG000|Overall Study|Study terminated by sponsor|1|||
33566172|NCT03322566|101970608|FG001|Overall Study|Study terminated by sponsor|0|||
33566173|NCT03322566|101970609|FG002|Overall Study|Study terminated by sponsor|1|||
33566174|NCT04890509|101970610|FG000|Overall Study|Death|4|||
33566175|NCT04890509|101970611|FG001|Overall Study|Death|4|||
33566176|NCT03014089|101970612|FG000|Overall Study|Withdrawal by Subject|0|||
33566177|NCT03014089|101970613|FG001|Overall Study|Withdrawal by Subject|1|||
33566178|NCT03014089|101970614|FG002|Overall Study|Withdrawal by Subject|1|||
33566179|NCT03014089|101970615|FG003|Overall Study|Withdrawal by Subject|1|||
33566180|NCT03014089|101970612|FG000|Overall Study|Lost to Follow-up|1|||
33566181|NCT03014089|101970613|FG001|Overall Study|Lost to Follow-up|0|||
33566182|NCT03014089|101970614|FG002|Overall Study|Lost to Follow-up|0|||
33566183|NCT03014089|101970615|FG003|Overall Study|Lost to Follow-up|0|||
33566184|NCT03014089|101970612|FG000|Overall Study|Adverse Event|1|||
33566185|NCT03014089|101970613|FG001|Overall Study|Adverse Event|0|||
33566186|NCT03014089|101970614|FG002|Overall Study|Adverse Event|1|||
33566187|NCT03014089|101970615|FG003|Overall Study|Adverse Event|0|||
33566188|NCT00478257|101970616|FG000|Overall Study|Withdrawal by Subject|8|||
33566189|NCT00478257|101970617|FG001|Overall Study|Withdrawal by Subject|3|||
33566190|NCT04507204|101970620|FG000|Overall Study|Adverse Event|8|||
33566191|NCT04507204|101970621|FG001|Overall Study|Adverse Event|13|||
33363688|NCT00849693|101220374|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
33566192|NCT04507204|101970620|FG000|Overall Study|Death|0|||
33566193|NCT04507204|101970621|FG001|Overall Study|Death|1|||
33566194|NCT04507204|101970620|FG000|Overall Study|Lost to Follow-up|15|||
33566195|NCT04507204|101970621|FG001|Overall Study|Lost to Follow-up|14|||
33566196|NCT04507204|101970620|FG000|Overall Study|Poor Compliance with Protocol|2|||
33222954|NCT00838682|100718736|FG000|Overall Study|Withdrawal by Subject|0|||
33222955|NCT00838682|100718737|FG001|Overall Study|Withdrawal by Subject|1|||
33630103|NCT02365649|102197638|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33630104|NCT02365649|102197639|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
33363689|NCT00849693|101220375|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
33363690|NCT00849693|101220372|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
33363691|NCT00849693|101220373|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
33363692|NCT00849693|101220374|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
33566197|NCT04507204|101970621|FG001|Overall Study|Poor Compliance with Protocol|4|||
33566198|NCT04507204|101970620|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
33566199|NCT04507204|101970621|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
33566200|NCT04507204|101970620|FG000|Overall Study|Withdrawal of Patient Consent|21|||
33566201|NCT04507204|101970621|FG001|Overall Study|Withdrawal of Patient Consent|13|||
33566202|NCT00754572|101970622|FG000|Overall Study|Adverse Event|19|||
33566203|NCT00754572|101970622|FG000|Overall Study|Other|39|||
33566204|NCT00754572|101970622|FG000|Overall Study|Protocol Violation|3|||
33566205|NCT00754572|101970622|FG000|Overall Study|Withdrawal by Subject|3|||
33566206|NCT00754572|101970622|FG000|Overall Study|Lack of Efficacy|2|||
33566207|NCT00754572|101970622|FG000|Overall Study|Death|1|||
33566208|NCT00754572|101970622|FG000|Overall Study|Administrative Reason|3|||
33566209|NCT00754572|101970622|FG000|Overall Study|Lost to Follow-up|1|||
33566210|NCT01188967|101970623|FG000|Overall Study|Withdrawal by Subject|1|||
33566211|NCT01188967|101970624|FG001|Overall Study|Withdrawal by Subject|1|||
33566212|NCT01188967|101970623|FG000|Overall Study|Physician Decision|1|||
33566213|NCT01188967|101970624|FG001|Overall Study|Physician Decision|1|||
33566214|NCT01188967|101970623|FG000|Overall Study|Lost to Follow-up|3|||
33566215|NCT01188967|101970624|FG001|Overall Study|Lost to Follow-up|2|||
33566216|NCT00645658|101970625|FG000|Overall Study|Withdrawal by Subject|1|||
33566217|NCT00645658|101970626|FG001|Overall Study|Withdrawal by Subject|0|||
33566218|NCT00645658|101970625|FG000|Overall Study|Did not complete all assesments|0|||
33566219|NCT00645658|101970626|FG001|Overall Study|Did not complete all assesments|2|||
33566220|NCT03773484|101970627|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
33566221|NCT03110562|101970643|FG000|Initial Treatment Period|Disease Progression|1|||
33566222|NCT03110562|101970644|FG001|Initial Treatment Period|Disease Progression|1|||
33566223|NCT03110562|101970645|FG002|Initial Treatment Period|Disease Progression|0|||
33566224|NCT03110562|101970646|FG003|Initial Treatment Period|Disease Progression|0|||
33566225|NCT03110562|101970643|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
33566226|NCT03110562|101970644|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
33566227|NCT03110562|101970645|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
33566228|NCT03110562|101970646|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
33566229|NCT03110562|101970643|FG000|Initial Treatment Period|Adverse Event|1|||
33566230|NCT03110562|101970644|FG001|Initial Treatment Period|Adverse Event|0|||
33566231|NCT03110562|101970645|FG002|Initial Treatment Period|Adverse Event|0|||
33566232|NCT03110562|101970646|FG003|Initial Treatment Period|Adverse Event|0|||
33566233|NCT03110562|101970643|FG000|Initial Treatment Period|Death|74|||
33566234|NCT03110562|101970644|FG001|Initial Treatment Period|Death|82|||
33566235|NCT03110562|101970645|FG002|Initial Treatment Period|Death|0|||
33566236|NCT03110562|101970646|FG003|Initial Treatment Period|Death|0|||
33566237|NCT03110562|101970643|FG000|Initial Treatment Period|Lost to Follow-up|13|||
33566238|NCT03110562|101970644|FG001|Initial Treatment Period|Lost to Follow-up|8|||
33566239|NCT03110562|101970645|FG002|Initial Treatment Period|Lost to Follow-up|0|||
33566240|NCT03110562|101970646|FG003|Initial Treatment Period|Lost to Follow-up|0|||
33566241|NCT03110562|101970643|FG000|Initial Treatment Period|Protocol Deviation|1|||
33566242|NCT03110562|101970644|FG001|Initial Treatment Period|Protocol Deviation|0|||
33566243|NCT03110562|101970645|FG002|Initial Treatment Period|Protocol Deviation|0|||
33566244|NCT03110562|101970646|FG003|Initial Treatment Period|Protocol Deviation|0|||
33566245|NCT03110562|101970643|FG000|Initial Treatment Period|Physician Decision|2|||
33566246|NCT03110562|101970644|FG001|Initial Treatment Period|Physician Decision|1|||
33566247|NCT03110562|101970645|FG002|Initial Treatment Period|Physician Decision|0|||
33566248|NCT03110562|101970646|FG003|Initial Treatment Period|Physician Decision|0|||
33566249|NCT03110562|101970643|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
33566250|NCT03110562|101970644|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
33566251|NCT03110562|101970645|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
33566252|NCT03110562|101970646|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
33566253|NCT03110562|101970643|FG000|Initial Treatment Period|Other|5|||
33566254|NCT03110562|101970644|FG001|Initial Treatment Period|Other|4|||
33630105|NCT02365649|102197630|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33566255|NCT03110562|101970645|FG002|Initial Treatment Period|Other|0|||
33566256|NCT03110562|101970646|FG003|Initial Treatment Period|Other|0|||
33566257|NCT03110562|101970643|FG000|Initial Treatment Period|Randomized but never treated|0|||
33566258|NCT03110562|101970644|FG001|Initial Treatment Period|Randomized but never treated|3|||
33566259|NCT03110562|101970645|FG002|Initial Treatment Period|Randomized but never treated|0|||
33363693|NCT00849693|101220375|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
33363694|NCT00849693|101220372|FG000|Acute Treatment Phase|Physician Decision|2|||
33363695|NCT00849693|101220373|FG001|Acute Treatment Phase|Physician Decision|1|||
33363696|NCT00849693|101220374|FG002|Acute Treatment Phase|Physician Decision|2|||
33363697|NCT00849693|101220375|FG003|Acute Treatment Phase|Physician Decision|1|||
33363698|NCT00849693|101220372|FG000|Acute Treatment Phase|Sponsor decision|0|||
33363699|NCT00849693|101220373|FG001|Acute Treatment Phase|Sponsor decision|0|||
33363700|NCT00849693|101220374|FG002|Acute Treatment Phase|Sponsor decision|1|||
33363701|NCT00849693|101220375|FG003|Acute Treatment Phase|Sponsor decision|0|||
33363702|NCT00849693|101220372|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
33363703|NCT00849693|101220373|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
33363704|NCT00849693|101220374|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
33363705|NCT00849693|101220375|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
33363706|NCT00849693|101220372|FG000|Extension Phase|Adverse Event|4|||
33222956|NCT01498822|100718738|FG000|Overall Study|Protocol Violation|8|||
33222957|NCT01498822|100718739|FG001|Overall Study|Protocol Violation|4|||
33630106|NCT02365649|102197631|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33630107|NCT02365649|102197632|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33630108|NCT02365649|102197633|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33630109|NCT02365649|102197634|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33630110|NCT02365649|102197635|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33630111|NCT02365649|102197636|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
33630112|NCT02365649|102197637|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33630113|NCT02365649|102197638|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33630114|NCT02365649|102197639|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
33630115|NCT02365649|102197630|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
33630116|NCT02365649|102197631|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
33630117|NCT02365649|102197632|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
33630118|NCT02365649|102197633|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
33630119|NCT02365649|102197634|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
33630120|NCT02365649|102197635|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
33630121|NCT02365649|102197636|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
33630122|NCT02365649|102197637|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
33630123|NCT02365649|102197638|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
33630124|NCT02365649|102197639|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
33630125|NCT02365649|102197630|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
33630126|NCT02365649|102197631|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
33630127|NCT02365649|102197632|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
33630128|NCT02365649|102197633|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
33630129|NCT02365649|102197634|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
33630130|NCT02365649|102197635|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
33630131|NCT02365649|102197636|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
33630132|NCT02365649|102197637|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
33630133|NCT02365649|102197638|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
33630134|NCT02365649|102197639|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
33630135|NCT02365649|102197630|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
33222958|NCT01498822|100718738|FG000|Overall Study|Other Reason|5|||
33363707|NCT00849693|101220373|FG001|Extension Phase|Adverse Event|6|||
33566260|NCT03110562|101970646|FG003|Initial Treatment Period|Randomized but never treated|0|||
33566261|NCT03110562|101970643|FG000|Crossover Period|Disease Progression|0|||
33566262|NCT03110562|101970644|FG001|Crossover Period|Disease Progression|0|||
33566263|NCT03110562|101970645|FG002|Crossover Period|Disease Progression|1|||
33566264|NCT03110562|101970646|FG003|Crossover Period|Disease Progression|0|||
33566265|NCT03110562|101970643|FG000|Crossover Period|Withdrawal by Subject|0|||
33566266|NCT03110562|101970644|FG001|Crossover Period|Withdrawal by Subject|0|||
33566267|NCT03110562|101970645|FG002|Crossover Period|Withdrawal by Subject|8|||
33566268|NCT03110562|101970646|FG003|Crossover Period|Withdrawal by Subject|6|||
33566269|NCT03110562|101970643|FG000|Crossover Period|Death|0|||
33566270|NCT03110562|101970644|FG001|Crossover Period|Death|0|||
33566271|NCT03110562|101970645|FG002|Crossover Period|Death|37|||
33566272|NCT03110562|101970646|FG003|Crossover Period|Death|3|||
33566273|NCT03110562|101970643|FG000|Crossover Period|Lost to Follow-up|0|||
33566274|NCT03110562|101970644|FG001|Crossover Period|Lost to Follow-up|0|||
33566275|NCT03110562|101970645|FG002|Crossover Period|Lost to Follow-up|0|||
33566276|NCT03110562|101970646|FG003|Crossover Period|Lost to Follow-up|1|||
33566277|NCT03110562|101970643|FG000|Crossover Period|Other|0|||
33566278|NCT03110562|101970644|FG001|Crossover Period|Other|0|||
33566279|NCT03110562|101970645|FG002|Crossover Period|Other|1|||
33566280|NCT03110562|101970646|FG003|Crossover Period|Other|1|||
33566281|NCT03110562|101970643|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
33566282|NCT03110562|101970644|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
33222959|NCT01498822|100718739|FG001|Overall Study|Other Reason|2|||
33630136|NCT02365649|102197631|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
33630137|NCT02365649|102197632|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
33630138|NCT02365649|102197633|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
33630139|NCT02365649|102197634|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
33630140|NCT02365649|102197635|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
33630141|NCT02365649|102197636|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
33630142|NCT02365649|102197637|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
33566283|NCT03110562|101970645|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
33566284|NCT03110562|101970646|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
33566285|NCT00129974|101970647|FG000|Overall Study|Other|1|||
33566286|NCT01358734|101970648|FG000|Overall Study|Adverse Event|4|||
33566287|NCT01358734|101970649|FG001|Overall Study|Adverse Event|7|||
33566288|NCT01358734|101970650|FG002|Overall Study|Adverse Event|3|||
33566289|NCT01358734|101970648|FG000|Overall Study|Lack of Efficacy|0|||
33566290|NCT01358734|101970649|FG001|Overall Study|Lack of Efficacy|1|||
33566291|NCT01358734|101970650|FG002|Overall Study|Lack of Efficacy|3|||
33566292|NCT01358734|101970648|FG000|Overall Study|Withdrawal by Subject|1|||
33630143|NCT02365649|102197638|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
33566293|NCT01358734|101970649|FG001|Overall Study|Withdrawal by Subject|6|||
33566294|NCT01358734|101970650|FG002|Overall Study|Withdrawal by Subject|3|||
33566295|NCT01358734|101970648|FG000|Overall Study|Death|3|||
33566296|NCT01358734|101970649|FG001|Overall Study|Death|7|||
33566297|NCT01358734|101970650|FG002|Overall Study|Death|2|||
33566298|NCT01358734|101970648|FG000|Overall Study|Progressive Disease|5|||
33566299|NCT01358734|101970649|FG001|Overall Study|Progressive Disease|13|||
33566300|NCT01358734|101970650|FG002|Overall Study|Progressive Disease|16|||
33566301|NCT01358734|101970648|FG000|Overall Study|Non-compliance with study drug|0|||
33566302|NCT01358734|101970649|FG001|Overall Study|Non-compliance with study drug|0|||
33566303|NCT01358734|101970650|FG002|Overall Study|Non-compliance with study drug|1|||
33566304|NCT01358734|101970648|FG000|Overall Study|Other|2|||
33566305|NCT01358734|101970649|FG001|Overall Study|Other|5|||
33566306|NCT01358734|101970650|FG002|Overall Study|Other|4|||
33566307|NCT01358734|101970648|FG000|Overall Study|Protocol Violation|0|||
33566308|NCT01358734|101970649|FG001|Overall Study|Protocol Violation|0|||
33566309|NCT01358734|101970650|FG002|Overall Study|Protocol Violation|2|||
33566310|NCT01911260|101970651|FG000|Supplementation Period|transference or evasion of school|7|||
33566311|NCT01911260|101970652|FG001|Supplementation Period|transference or evasion of school|9|||
33566312|NCT01911260|101970653|FG002|Supplementation Period|transference or evasion of school|7|||
33566313|NCT01911260|101970654|FG003|Supplementation Period|transference or evasion of school|6|||
33566314|NCT01911260|101970651|FG000|Supplementation Period|Adverse Event|2|||
33566315|NCT01911260|101970652|FG001|Supplementation Period|Adverse Event|0|||
33566316|NCT01911260|101970653|FG002|Supplementation Period|Adverse Event|1|||
33566317|NCT01911260|101970654|FG003|Supplementation Period|Adverse Event|0|||
33566318|NCT01911260|101970651|FG000|Supplementation Period|refused to receive supplement|1|||
33566319|NCT01911260|101970652|FG001|Supplementation Period|refused to receive supplement|0|||
33566320|NCT01911260|101970653|FG002|Supplementation Period|refused to receive supplement|1|||
33566321|NCT01911260|101970654|FG003|Supplementation Period|refused to receive supplement|0|||
33630144|NCT02365649|102197639|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
33630145|NCT02365649|102197630|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33630146|NCT02365649|102197631|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33222960|NCT01498822|100718738|FG000|Overall Study|Lack of Efficacy|7|||
33222961|NCT01498822|100718739|FG001|Overall Study|Lack of Efficacy|2|||
33222962|NCT01498822|100718738|FG000|Overall Study|AE, non-serious non-fatal|8|||
33222963|NCT01498822|100718739|FG001|Overall Study|AE, non-serious non-fatal|17|||
33222964|NCT01498822|100718738|FG000|Overall Study|SAE, non-fatal|2|||
33222965|NCT01498822|100718739|FG001|Overall Study|SAE, non-fatal|2|||
33222966|NCT01498822|100718738|FG000|Overall Study|Adverse Event, serious fatal|1|||
33222967|NCT01498822|100718739|FG001|Overall Study|Adverse Event, serious fatal|1|||
33222968|NCT01498822|100718738|FG000|Overall Study|Withdrawal by Subject|15|||
33222969|NCT01498822|100718739|FG001|Overall Study|Withdrawal by Subject|25|||
33222970|NCT01498822|100718738|FG000|Overall Study|Lost to Follow-up|8|||
33222971|NCT01498822|100718739|FG001|Overall Study|Lost to Follow-up|3|||
33222972|NCT00509236|100718740|FG000|Overall Study|Adverse Event|7|||
33566322|NCT01911260|101970651|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
33566323|NCT01911260|101970652|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
33566324|NCT01911260|101970653|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
33630147|NCT02365649|102197632|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33630148|NCT02365649|102197633|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33630149|NCT02365649|102197634|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33630150|NCT02365649|102197635|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33630151|NCT02365649|102197636|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
33630152|NCT02365649|102197637|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33630153|NCT02365649|102197638|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
33630154|NCT02365649|102197639|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
33630155|NCT02101775|102197644|FG000|Overall Study|Adverse Event|4|||
33630156|NCT02101775|102197645|FG001|Overall Study|Adverse Event|0|||
33630157|NCT02101775|102197646|FG002|Overall Study|Adverse Event|0|||
33630158|NCT02101775|102197644|FG000|Overall Study|Admission to Hospital|0|||
33630159|NCT02101775|102197645|FG001|Overall Study|Admission to Hospital|1|||
33630160|NCT02101775|102197646|FG002|Overall Study|Admission to Hospital|0|||
33630161|NCT03534804|102197658|FG000|Overall Study|Withdrawal by Subject|1|||
33363708|NCT00849693|101220374|FG002|Extension Phase|Adverse Event|3|||
33416285|NCT00447694|101416047|FG000|Overall Study|Abnormal test procedure result|1|||
33416286|NCT00447694|101416047|FG000|Overall Study|Withdrawal by Subject|2|||
33416287|NCT00265239|101416051|FG000|Overall Study|Adverse Event|2|||
33416288|NCT00265239|101416052|FG001|Overall Study|Adverse Event|1|||
33416289|NCT02007512|101416055|FG000|Double Blind Treatment Period|Adverse Event|4|||
33566325|NCT01911260|101970654|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
33566326|NCT01911260|101970651|FG000|Follow-up Period|transference or evasion of school|13|||
33566327|NCT01911260|101970652|FG001|Follow-up Period|transference or evasion of school|20|||
33566328|NCT01911260|101970653|FG002|Follow-up Period|transference or evasion of school|15|||
33566329|NCT01911260|101970654|FG003|Follow-up Period|transference or evasion of school|12|||
33363709|NCT00849693|101220375|FG003|Extension Phase|Adverse Event|7|||
33363710|NCT00849693|101220372|FG000|Extension Phase|Lost to Follow-up|7|||
33363711|NCT00849693|101220373|FG001|Extension Phase|Lost to Follow-up|5|||
33363712|NCT00849693|101220374|FG002|Extension Phase|Lost to Follow-up|6|||
33416290|NCT02007512|101416056|FG001|Double Blind Treatment Period|Adverse Event|2|||
33416291|NCT02007512|101416057|FG002|Double Blind Treatment Period|Adverse Event|6|||
33416292|NCT02007512|101416058|FG003|Double Blind Treatment Period|Adverse Event|2|||
33416293|NCT02007512|101416055|FG000|Double Blind Treatment Period|Death|1|||
33416294|NCT02007512|101416056|FG001|Double Blind Treatment Period|Death|0|||
33416295|NCT02007512|101416057|FG002|Double Blind Treatment Period|Death|0|||
33416296|NCT02007512|101416058|FG003|Double Blind Treatment Period|Death|0|||
33416297|NCT02007512|101416055|FG000|Double Blind Treatment Period|Disease progression|44|||
33416298|NCT02007512|101416056|FG001|Double Blind Treatment Period|Disease progression|49|||
33416299|NCT02007512|101416057|FG002|Double Blind Treatment Period|Disease progression|45|||
33566330|NCT01285102|101970660|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
33566331|NCT01107886|101970674|FG000|Overall Study|Lost to Follow-up|15|||
33566332|NCT01107886|101970675|FG001|Overall Study|Lost to Follow-up|13|||
33630162|NCT02018562|102197665|FG000|Overall Study|Withdrawal by Subject|2|||
33630163|NCT02018562|102197666|FG001|Overall Study|Withdrawal by Subject|0|||
33630164|NCT02018562|102197665|FG000|Overall Study|Discharged prior to study completion|1|||
33416300|NCT02007512|101416058|FG003|Double Blind Treatment Period|Disease progression|51|||
33416301|NCT02007512|101416055|FG000|Double Blind Treatment Period|Withdrawal by Subject|4|||
33630165|NCT02018562|102197666|FG001|Overall Study|Discharged prior to study completion|0|||
33630166|NCT04583280|102197669|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
33630167|NCT04583280|102197670|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
33630168|NCT05194124|102197671|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
33630169|NCT05194124|102197672|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
33630170|NCT05194124|102197673|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
33630171|NCT05194124|102197674|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
33630172|NCT05194124|102197675|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
33630173|NCT05194124|102197676|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
33222973|NCT00509236|100718741|FG001|Overall Study|Adverse Event|9|||
33363713|NCT00849693|101220375|FG003|Extension Phase|Lost to Follow-up|6|||
33416302|NCT02007512|101416056|FG001|Double Blind Treatment Period|Withdrawal by Subject|2|||
33416303|NCT02007512|101416057|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
33416304|NCT02007512|101416058|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
33566333|NCT01107886|101970674|FG000|Overall Study|Withdrawal by Subject|180|||
33566334|NCT01107886|101970675|FG001|Overall Study|Withdrawal by Subject|196|||
33630174|NCT05194124|102197677|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
33363714|NCT00849693|101220372|FG000|Extension Phase|Protocol Violation|0|||
33363715|NCT00849693|101220373|FG001|Extension Phase|Protocol Violation|3|||
33363716|NCT00849693|101220374|FG002|Extension Phase|Protocol Violation|2|||
33566335|NCT01107886|101970674|FG000|Overall Study|Administrative withdrawal of consent|7|||
33222974|NCT00509236|100718740|FG000|Overall Study|Withdrawal by Subject|5|||
33222975|NCT00509236|100718741|FG001|Overall Study|Withdrawal by Subject|10|||
33222976|NCT00509236|100718740|FG000|Overall Study|Protocol Violation|3|||
33222977|NCT00509236|100718741|FG001|Overall Study|Protocol Violation|0|||
33222978|NCT00509236|100718740|FG000|Overall Study|Excluded Medication|1|||
33222979|NCT00509236|100718741|FG001|Overall Study|Excluded Medication|1|||
33222980|NCT00509236|100718740|FG000|Overall Study|Scheduled Kidney Transplant|1|||
33222981|NCT00509236|100718741|FG001|Overall Study|Scheduled Kidney Transplant|0|||
33222982|NCT01889186|100718743|FG000|Overall Study|Adverse event- not related to progression|18|||
33222983|NCT01889186|100718744|FG001|Overall Study|Adverse event- not related to progression|5|||
33222984|NCT01889186|100718743|FG000|Overall Study|Adverse event- related to progression|7|||
33222985|NCT01889186|100718744|FG001|Overall Study|Adverse event- related to progression|2|||
33222986|NCT01889186|100718743|FG000|Overall Study|COVID-19 logistical restrictions|1|||
33222987|NCT01889186|100718744|FG001|Overall Study|COVID-19 logistical restrictions|0|||
33222988|NCT01889186|100718743|FG000|Overall Study|Investigator request|1|||
33222989|NCT01889186|100718744|FG001|Overall Study|Investigator request|1|||
33222990|NCT01889186|100718743|FG000|Overall Study|Progressive disease- Richter's|12|||
33222991|NCT01889186|100718744|FG001|Overall Study|Progressive disease- Richter's|7|||
33222992|NCT01889186|100718743|FG000|Overall Study|Progressive disease per protocol|46|||
33222993|NCT01889186|100718744|FG001|Overall Study|Progressive disease per protocol|17|||
33222994|NCT01889186|100718743|FG000|Overall Study|Stem cell transplant|2|||
33222995|NCT01889186|100718744|FG001|Overall Study|Stem cell transplant|1|||
33222996|NCT01889186|100718743|FG000|Overall Study|Withdrew consent|2|||
33222997|NCT01889186|100718744|FG001|Overall Study|Withdrew consent|3|||
33222998|NCT01889186|100718743|FG000|Overall Study|Other, not specified|18|||
33222999|NCT01889186|100718744|FG001|Overall Study|Other, not specified|15|||
33223000|NCT00738101|100718745|FG000|Overall Study|Physician Decision|5|||
33223001|NCT00738101|100718745|FG000|Overall Study|Death|1|||
33223002|NCT00738101|100718745|FG000|Overall Study|Repeat enrollment|1|||
33223003|NCT01453348|100718746|FG000|Overall Study|Death|0|||
33223004|NCT01453348|100718747|FG001|Overall Study|Death|0|||
33223005|NCT01453348|100718748|FG002|Overall Study|Death|1|||
33223006|NCT01453348|100718746|FG000|Overall Study|Withdrawal by Subject|0|||
33223007|NCT01453348|100718747|FG001|Overall Study|Withdrawal by Subject|1|||
33223008|NCT01453348|100718748|FG002|Overall Study|Withdrawal by Subject|0|||
33223009|NCT01453348|100718746|FG000|Overall Study|Protocol Violation|1|||
33223010|NCT01453348|100718747|FG001|Overall Study|Protocol Violation|0|||
33223011|NCT01453348|100718748|FG002|Overall Study|Protocol Violation|0|||
33223012|NCT00676130|100718749|FG000|Overall Study|Lost to Follow-up|0|||
33223013|NCT00676130|100718750|FG001|Overall Study|Lost to Follow-up|1|||
33223014|NCT00676130|100718749|FG000|Overall Study|Found ineligible|3|||
33223015|NCT00676130|100718750|FG001|Overall Study|Found ineligible|2|||
33223016|NCT00676130|100718749|FG000|Overall Study|Withdrawal by Subject|0|||
33223017|NCT00676130|100718750|FG001|Overall Study|Withdrawal by Subject|1|||
33223018|NCT00116272|100718751|FG000|Overall Study|Lost to Follow-up|11|||
33223019|NCT00116272|100718752|FG001|Overall Study|Lost to Follow-up|6|||
33223020|NCT02217280|100718766|FG000|Overall Study|Withdrawal by Subject|2|||
33223021|NCT02217280|100718766|FG000|Overall Study|Post-consent sceen fail|2|||
33223022|NCT04555096|100718767|FG000|Overall Study|Death|4|||
33363717|NCT00849693|101220375|FG003|Extension Phase|Protocol Violation|3|||
33363718|NCT00849693|101220372|FG000|Extension Phase|Withdrawal by Subject|6|||
33363719|NCT00849693|101220373|FG001|Extension Phase|Withdrawal by Subject|9|||
33363720|NCT00849693|101220374|FG002|Extension Phase|Withdrawal by Subject|10|||
33363721|NCT00849693|101220375|FG003|Extension Phase|Withdrawal by Subject|15|||
33363722|NCT00849693|101220372|FG000|Extension Phase|Parent or caregiver decision|9|||
33363723|NCT00849693|101220373|FG001|Extension Phase|Parent or caregiver decision|4|||
33363724|NCT00849693|101220374|FG002|Extension Phase|Parent or caregiver decision|10|||
33363725|NCT00849693|101220375|FG003|Extension Phase|Parent or caregiver decision|5|||
33416305|NCT02007512|101416055|FG000|Double Blind Treatment Period|Protocol Violation|0|||
33416306|NCT02007512|101416056|FG001|Double Blind Treatment Period|Protocol Violation|0|||
33566336|NCT01107886|101970675|FG001|Overall Study|Administrative withdrawal of consent|5|||
33566337|NCT00659425|101970686|FG000|Overall Study|Disease progression|1|||
33566338|NCT00659425|101970687|FG001|Overall Study|Disease progression|0|||
33223023|NCT04555096|100718768|FG001|Overall Study|Death|4|||
33223024|NCT04555096|100718767|FG000|Overall Study|Withdrawal by Subject|1|||
33223025|NCT04555096|100718768|FG001|Overall Study|Withdrawal by Subject|0|||
33223026|NCT04555096|100718767|FG000|Overall Study|Other|0|||
33223027|NCT04555096|100718768|FG001|Overall Study|Other|1|||
33363726|NCT00849693|101220372|FG000|Extension Phase|Physician Decision|1|||
33363727|NCT00849693|101220373|FG001|Extension Phase|Physician Decision|1|||
33223028|NCT00643123|100718772|FG000|Overall Study|Lost to Follow-up|4|||
33223029|NCT00643123|100718773|FG001|Overall Study|Lost to Follow-up|0|||
33223030|NCT00643123|100718772|FG000|Overall Study|Withdrawal by Subject|1|||
33223031|NCT00643123|100718773|FG001|Overall Study|Withdrawal by Subject|1|||
33223032|NCT01201811|100718774|FG000|Overall Study|Adverse Event|6|||
33223033|NCT01201811|100718774|FG000|Overall Study|Disease progression|3|||
33630175|NCT05194124|102197678|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
33630176|NCT05194124|102197679|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
33630177|NCT05194124|102197680|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
33630178|NCT05194124|102197671|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
33630179|NCT05194124|102197672|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
33630180|NCT05194124|102197673|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
33630181|NCT05194124|102197674|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
33223034|NCT01201811|100718774|FG000|Overall Study|Withdrawal by Subject|3|||
33223035|NCT01201811|100718774|FG000|Overall Study|Death|4|||
33223036|NCT01201811|100718774|FG000|Overall Study|Treatment Failure|2|||
33223037|NCT01201811|100718774|FG000|Overall Study|Physician Decision|1|||
33223038|NCT01013792|100718777|FG000|Overall Study|Study suspended|2|||
33223039|NCT01013792|100718778|FG001|Overall Study|Study suspended|1|||
33223040|NCT01013792|100718777|FG000|Overall Study|Adverse Event|0|||
33223041|NCT01013792|100718778|FG001|Overall Study|Adverse Event|3|||
33223042|NCT01013792|100718777|FG000|Overall Study|Lost to Follow-up|0|||
33223043|NCT01013792|100718778|FG001|Overall Study|Lost to Follow-up|1|||
33223044|NCT03237858|100718779|FG000|Overall Study|Death|19|||
33223045|NCT03237858|100718779|FG000|Overall Study|Withdrawal by Subject|37|||
33223046|NCT01555164|100718783|FG000|Overall Study|Adverse Event|5|||
33223047|NCT01555164|100718784|FG001|Overall Study|Adverse Event|7|||
33223048|NCT01555164|100718783|FG000|Overall Study|Hyperglycemia|0|||
33223049|NCT01555164|100718784|FG001|Overall Study|Hyperglycemia|1|||
33223050|NCT01555164|100718783|FG000|Overall Study|Investigator's Discretion|2|||
33223051|NCT01555164|100718784|FG001|Overall Study|Investigator's Discretion|2|||
33223052|NCT01555164|100718783|FG000|Overall Study|Lost to Follow-up|4|||
33223053|NCT01555164|100718784|FG001|Overall Study|Lost to Follow-up|3|||
33223054|NCT01555164|100718783|FG000|Overall Study|Protocol Violation|9|||
33223055|NCT01555164|100718784|FG001|Overall Study|Protocol Violation|5|||
33223056|NCT01555164|100718783|FG000|Overall Study|Subject Non-compliance|14|||
33223057|NCT01555164|100718784|FG001|Overall Study|Subject Non-compliance|6|||
33223058|NCT01555164|100718783|FG000|Overall Study|Subject Withdrew Consent|6|||
33223059|NCT01555164|100718784|FG001|Overall Study|Subject Withdrew Consent|11|||
33223060|NCT01301274|100718785|FG000|Overall Study|Physician Decision|2|||
33223061|NCT01301274|100718786|FG001|Overall Study|Physician Decision|1|||
33223062|NCT03300570|100718787|FG000|Overall Study|Adverse Event|0|||
33223063|NCT03300570|100718788|FG001|Overall Study|Adverse Event|1|||
33223064|NCT03300570|100718787|FG000|Overall Study|Withdrawal by Subject|1|||
33223065|NCT03300570|100718788|FG001|Overall Study|Withdrawal by Subject|0|||
33223066|NCT03300570|100718787|FG000|Overall Study|Inadequate bowel prep|1|||
33223067|NCT03300570|100718788|FG001|Overall Study|Inadequate bowel prep|0|||
33223068|NCT03287414|100718789|FG000|Treatment Epoch|Adverse Event|0|||
33223069|NCT03287414|100718790|FG001|Treatment Epoch|Adverse Event|1|||
33223070|NCT03287414|100718789|FG000|Treatment Epoch|Study terminated by sponsor|2|||
33223071|NCT03287414|100718790|FG001|Treatment Epoch|Study terminated by sponsor|2|||
33223072|NCT03287414|100718789|FG000|Treatment Epoch|Subject/Guardian decision|4|||
33363728|NCT00849693|101220374|FG002|Extension Phase|Physician Decision|2|||
33363729|NCT00849693|101220375|FG003|Extension Phase|Physician Decision|0|||
33363730|NCT00849693|101220372|FG000|Extension Phase|Sponsor decision|1|||
33363731|NCT00849693|101220373|FG001|Extension Phase|Sponsor decision|0|||
33363732|NCT00849693|101220374|FG002|Extension Phase|Sponsor decision|0|||
33363733|NCT00849693|101220375|FG003|Extension Phase|Sponsor decision|1|||
33363734|NCT00849693|101220372|FG000|Extension Phase|Lack of Efficacy|2|||
33363735|NCT00849693|101220373|FG001|Extension Phase|Lack of Efficacy|2|||
33363736|NCT00849693|101220374|FG002|Extension Phase|Lack of Efficacy|2|||
33363737|NCT00849693|101220375|FG003|Extension Phase|Lack of Efficacy|1|||
33363738|NCT00839098|101220376|FG000|Overall Study|Withdrawal by Subject|2|||
33363739|NCT00839098|101220377|FG001|Overall Study|Withdrawal by Subject|1|||
33363740|NCT00839098|101220378|FG002|Overall Study|Withdrawal by Subject|7|||
33363741|NCT03242759|101220379|FG000|Overall Study|Adverse Event|5|||
33363742|NCT03242759|101220380|FG001|Overall Study|Adverse Event|1|||
33363743|NCT03242759|101220379|FG000|Overall Study|Withdrawal by Subject|4|||
33363744|NCT03242759|101220380|FG001|Overall Study|Withdrawal by Subject|3|||
33363745|NCT03242759|101220379|FG000|Overall Study|Lost to Follow-up|3|||
33363746|NCT03242759|101220380|FG001|Overall Study|Lost to Follow-up|1|||
33363747|NCT03242759|101220379|FG000|Overall Study|Administrative problems|1|||
33416307|NCT02007512|101416057|FG002|Double Blind Treatment Period|Protocol Violation|0|||
33416308|NCT02007512|101416058|FG003|Double Blind Treatment Period|Protocol Violation|1|||
33363748|NCT03242759|101220380|FG001|Overall Study|Administrative problems|1|||
33363749|NCT03242759|101220379|FG000|Overall Study|Death|22|||
33363750|NCT03242759|101220380|FG001|Overall Study|Death|0|||
33363751|NCT03242759|101220379|FG000|Overall Study|Change visit schedule|0|||
33363752|NCT03242759|101220380|FG001|Overall Study|Change visit schedule|1|||
33223073|NCT03287414|100718790|FG001|Treatment Epoch|Subject/Guardian decision|0|||
33223074|NCT03287414|100718789|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
33363753|NCT01651260|101220381|FG000|Overall Study|unable to apply product|3|||
33416309|NCT02007512|101416055|FG000|Double Blind Treatment Period|Other|0|||
33363754|NCT02100657|101220384|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
33363755|NCT02100657|101220385|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
33363756|NCT02100657|101220386|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
33363757|NCT02100657|101220384|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
33223075|NCT03287414|100718790|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
33223076|NCT03287414|100718789|FG000|Treatment Epoch|Withdrawal by Subject|1|||
33223077|NCT03287414|100718790|FG001|Treatment Epoch|Withdrawal by Subject|0|||
33223078|NCT03287414|100718789|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
33223079|NCT03287414|100718790|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
33223080|NCT03287414|100718789|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
33223081|NCT03287414|100718790|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
33363758|NCT02100657|101220385|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
33630182|NCT05194124|102197675|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
33630183|NCT05194124|102197676|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
33363759|NCT02100657|101220386|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
33363760|NCT02100657|101220384|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
33363761|NCT02100657|101220385|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
33363762|NCT02100657|101220386|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
33363763|NCT02100657|101220384|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
33363764|NCT02100657|101220385|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
33363765|NCT02100657|101220386|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
33363766|NCT02100657|101220384|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
33363767|NCT02100657|101220385|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
33363768|NCT02100657|101220386|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
33363769|NCT02100657|101220384|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
33363770|NCT02100657|101220385|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
33363771|NCT02100657|101220386|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
33363772|NCT02100657|101220384|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
33363773|NCT02100657|101220385|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
33363774|NCT02100657|101220386|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
33363775|NCT02100657|101220384|FG000|Cohort 3: Dose Level 3|Death|0|||
33363776|NCT02100657|101220385|FG001|Cohort 3: Dose Level 3|Death|0|||
33363777|NCT02100657|101220386|FG002|Cohort 3: Dose Level 3|Death|1|||
33363778|NCT02100657|101220384|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
33363779|NCT02100657|101220385|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
33363780|NCT02100657|101220386|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
33363781|NCT02100657|101220384|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
33363782|NCT02100657|101220385|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
33363783|NCT02100657|101220386|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
33363784|NCT02100657|101220384|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
33363785|NCT02100657|101220385|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
33363786|NCT02100657|101220386|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
33363787|NCT02100657|101220384|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
33363788|NCT02100657|101220385|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
33363789|NCT02100657|101220386|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
33363790|NCT02100657|101220384|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
33363791|NCT02100657|101220385|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
33363792|NCT02100657|101220386|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
33363793|NCT01469052|101220389|FG000|Overall Study|Adverse Event|2|||
33363794|NCT01469052|101220390|FG001|Overall Study|Adverse Event|3|||
33363795|NCT01469052|101220391|FG002|Overall Study|Adverse Event|0|||
33363796|NCT01469052|101220392|FG003|Overall Study|Adverse Event|2|||
33363797|NCT01469052|101220393|FG004|Overall Study|Adverse Event|0|||
33363798|NCT01469052|101220394|FG005|Overall Study|Adverse Event|1|||
33363799|NCT01469052|101220389|FG000|Overall Study|Progressive disease|3|||
33363800|NCT01469052|101220390|FG001|Overall Study|Progressive disease|0|||
33363801|NCT01469052|101220391|FG002|Overall Study|Progressive disease|5|||
33363802|NCT01469052|101220392|FG003|Overall Study|Progressive disease|3|||
33363803|NCT01469052|101220393|FG004|Overall Study|Progressive disease|7|||
33363804|NCT01469052|101220394|FG005|Overall Study|Progressive disease|2|||
33363805|NCT01469052|101220389|FG000|Overall Study|Lack of Efficacy|0|||
33363806|NCT01469052|101220390|FG001|Overall Study|Lack of Efficacy|0|||
33363807|NCT01469052|101220391|FG002|Overall Study|Lack of Efficacy|0|||
33363808|NCT01469052|101220392|FG003|Overall Study|Lack of Efficacy|0|||
33363809|NCT01469052|101220393|FG004|Overall Study|Lack of Efficacy|0|||
33363810|NCT01469052|101220394|FG005|Overall Study|Lack of Efficacy|2|||
33363811|NCT01469052|101220389|FG000|Overall Study|Moved to rollover protocol|1|||
33363812|NCT01469052|101220390|FG001|Overall Study|Moved to rollover protocol|0|||
33630184|NCT05194124|102197677|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
33630185|NCT05194124|102197678|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
33630186|NCT05194124|102197679|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
33630187|NCT05194124|102197680|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
33630188|NCT03773978|102197681|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
33363813|NCT01469052|101220391|FG002|Overall Study|Moved to rollover protocol|1|||
33363814|NCT01469052|101220392|FG003|Overall Study|Moved to rollover protocol|0|||
33630189|NCT03773978|102197682|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
33630190|NCT03773978|102197681|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
33363815|NCT01469052|101220393|FG004|Overall Study|Moved to rollover protocol|0|||
33363816|NCT01469052|101220394|FG005|Overall Study|Moved to rollover protocol|1|||
33363817|NCT01469052|101220389|FG000|Overall Study|Other|0|||
33363818|NCT01469052|101220390|FG001|Overall Study|Other|1|||
33363819|NCT01469052|101220391|FG002|Overall Study|Other|0|||
33363820|NCT01469052|101220392|FG003|Overall Study|Other|0|||
33363821|NCT01469052|101220393|FG004|Overall Study|Other|1|||
33630191|NCT03773978|102197682|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
33630192|NCT03773978|102197681|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
33630193|NCT03773978|102197682|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
33630194|NCT03773978|102197681|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
33630195|NCT03773978|102197682|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
33630196|NCT03773978|102197681|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
33630197|NCT03773978|102197682|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
33630198|NCT03773978|102197681|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
33630199|NCT03773978|102197682|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
33223082|NCT01802437|100718794|FG000|Overall Study|Lost to Follow-up|1|||
33363822|NCT01469052|101220394|FG005|Overall Study|Other|0|||
33363823|NCT00149825|101220398|FG000|Overall Study|Intolerance to medication side effects|1|||
33363824|NCT00149825|101220399|FG001|Overall Study|Intolerance to medication side effects|2|||
33363825|NCT00149825|101220398|FG000|Overall Study|Time commitments|2|||
33363826|NCT00149825|101220399|FG001|Overall Study|Time commitments|1|||
33363827|NCT00149825|101220398|FG000|Overall Study|Not liking insomnia therapy|1|||
33363828|NCT00149825|101220399|FG001|Overall Study|Not liking insomnia therapy|0|||
33363829|NCT00149825|101220398|FG000|Overall Study|Other|1|||
33363830|NCT00149825|101220399|FG001|Overall Study|Other|0|||
33363831|NCT02606877|101220400|FG000|Overall Study|Adverse Event|3|||
33363832|NCT02606877|101220401|FG001|Overall Study|Adverse Event|0|||
33363833|NCT02606877|101220400|FG000|Overall Study|Non-compliance with protocol|0|||
33363834|NCT02606877|101220401|FG001|Overall Study|Non-compliance with protocol|1|||
33363835|NCT02606877|101220400|FG000|Overall Study|Other than listed above|1|||
33363836|NCT02606877|101220401|FG001|Overall Study|Other than listed above|0|||
33363837|NCT02940886|101220402|FG000|Overall Study|Adverse Event|7|||
33223083|NCT01802437|100718795|FG001|Overall Study|Lost to Follow-up|0|||
33223084|NCT01802437|100718794|FG000|Overall Study|Withdrawal by Subject|3|||
33363838|NCT02940886|101220403|FG001|Overall Study|Adverse Event|3|||
33566339|NCT00659425|101970688|FG002|Overall Study|Disease progression|0|||
33566340|NCT00659425|101970689|FG003|Overall Study|Disease progression|1|||
33566341|NCT00659425|101970690|FG004|Overall Study|Disease progression|0|||
33566342|NCT00659425|101970691|FG005|Overall Study|Disease progression|2|||
33566343|NCT00659425|101970692|FG006|Overall Study|Disease progression|4|||
33566344|NCT00659425|101970693|FG007|Overall Study|Disease progression|3|||
33566345|NCT00659425|101970694|FG008|Overall Study|Disease progression|5|||
33566346|NCT00659425|101970695|FG009|Overall Study|Disease progression|3|||
33566347|NCT00659425|101970686|FG000|Overall Study|Death|0|||
33223085|NCT01802437|100718795|FG001|Overall Study|Withdrawal by Subject|4|||
33363839|NCT02940886|101220402|FG000|Overall Study|Protocol Violation|0|||
33363840|NCT02940886|101220403|FG001|Overall Study|Protocol Violation|2|||
33363841|NCT02940886|101220402|FG000|Overall Study|Withdrawal by Subject|28|||
33566348|NCT00659425|101970687|FG001|Overall Study|Death|0|||
33566349|NCT00659425|101970688|FG002|Overall Study|Death|0|||
33566350|NCT00659425|101970689|FG003|Overall Study|Death|1|||
33223086|NCT02093663|100718796|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
33223087|NCT02093663|100718797|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
33223088|NCT02093663|100718798|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
33223089|NCT02093663|100718799|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
33223090|NCT02093663|100718800|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
33223091|NCT02093663|100718796|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
33223092|NCT02093663|100718797|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33223093|NCT02093663|100718798|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33566351|NCT00659425|101970690|FG004|Overall Study|Death|0|||
33566352|NCT00659425|101970691|FG005|Overall Study|Death|0|||
33223094|NCT02093663|100718799|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33363842|NCT02940886|101220403|FG001|Overall Study|Withdrawal by Subject|20|||
33363843|NCT02940886|101220402|FG000|Overall Study|Death|1|||
33566353|NCT00659425|101970692|FG006|Overall Study|Death|1|||
33566354|NCT00659425|101970693|FG007|Overall Study|Death|0|||
33566355|NCT00659425|101970694|FG008|Overall Study|Death|0|||
33566356|NCT00659425|101970695|FG009|Overall Study|Death|0|||
33566357|NCT00659425|101970686|FG000|Overall Study|Adverse Event|0|||
33566358|NCT00659425|101970687|FG001|Overall Study|Adverse Event|0|||
33566359|NCT00659425|101970688|FG002|Overall Study|Adverse Event|0|||
33566360|NCT00659425|101970689|FG003|Overall Study|Adverse Event|0|||
33566361|NCT00659425|101970690|FG004|Overall Study|Adverse Event|0|||
33566362|NCT00659425|101970691|FG005|Overall Study|Adverse Event|1|||
33566363|NCT00659425|101970692|FG006|Overall Study|Adverse Event|0|||
33566364|NCT00659425|101970693|FG007|Overall Study|Adverse Event|3|||
33363844|NCT02940886|101220403|FG001|Overall Study|Death|0|||
33363845|NCT02940886|101220402|FG000|Overall Study|Lack of Efficacy|1|||
33363846|NCT02940886|101220403|FG001|Overall Study|Lack of Efficacy|0|||
33363847|NCT02940886|101220402|FG000|Overall Study|Lost to Follow-up|49|||
33363848|NCT02940886|101220403|FG001|Overall Study|Lost to Follow-up|21|||
33363849|NCT02940886|101220402|FG000|Overall Study|Physician Decision|9|||
33363850|NCT02940886|101220403|FG001|Overall Study|Physician Decision|4|||
33363851|NCT02940886|101220402|FG000|Overall Study|Sponsor decision|0|||
33363852|NCT02940886|101220403|FG001|Overall Study|Sponsor decision|1|||
33363853|NCT02940886|101220402|FG000|Overall Study|No treatment|7|||
33363854|NCT02940886|101220403|FG001|Overall Study|No treatment|2|||
33363855|NCT02940886|101220402|FG000|Overall Study|Enrolment error|0|||
33363856|NCT02940886|101220403|FG001|Overall Study|Enrolment error|1|||
33363857|NCT04003155|101220405|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
33363858|NCT04003155|101220406|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
33363859|NCT04003155|101220407|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
33363860|NCT04003155|101220408|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
33363861|NCT04003155|101220409|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
33363862|NCT04003155|101220405|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
33363863|NCT04003155|101220406|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
33363864|NCT04003155|101220407|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
33363865|NCT04003155|101220408|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
33363866|NCT04003155|101220409|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
33363867|NCT04003155|101220405|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
33363868|NCT04003155|101220406|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
33363869|NCT04003155|101220407|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
33363870|NCT04003155|101220408|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
33363871|NCT04003155|101220409|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
33363872|NCT04003155|101220405|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
33363873|NCT04003155|101220406|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
33363874|NCT04003155|101220407|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
33363875|NCT04003155|101220408|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
33363876|NCT04003155|101220409|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
33363877|NCT04003155|101220405|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
33363878|NCT04003155|101220406|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
33363879|NCT04003155|101220407|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
33363880|NCT04003155|101220408|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
33363881|NCT04003155|101220409|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
33363882|NCT04003155|101220405|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
33363883|NCT04003155|101220406|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
33566365|NCT00659425|101970694|FG008|Overall Study|Adverse Event|1|||
33630200|NCT03773978|102197681|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
33566366|NCT00659425|101970695|FG009|Overall Study|Adverse Event|4|||
33566367|NCT00659425|101970686|FG000|Overall Study|Investigator Discretion|0|||
33566368|NCT00659425|101970687|FG001|Overall Study|Investigator Discretion|0|||
33363884|NCT04003155|101220407|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
33363885|NCT04003155|101220408|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
33363886|NCT04003155|101220409|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
33566369|NCT00659425|101970688|FG002|Overall Study|Investigator Discretion|0|||
33630201|NCT03773978|102197682|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
33630202|NCT03773978|102197681|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
33630203|NCT03773978|102197682|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
33630204|NCT03773978|102197681|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
33630205|NCT03773978|102197682|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
33630206|NCT03773978|102197681|FG000|DBW Period|Adverse Event|2|||
33630207|NCT03773978|102197682|FG001|DBW Period|Adverse Event|2|||
33630208|NCT03773978|102197681|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
33630209|NCT03773978|102197682|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
33630210|NCT03773978|102197681|FG000|DBW Period|Withdrawal by Subject|2|||
33630211|NCT03773978|102197682|FG001|DBW Period|Withdrawal by Subject|1|||
33630212|NCT03773978|102197681|FG000|DBW Period|Due to epidemic or pandemic|5|||
33630213|NCT03773978|102197682|FG001|DBW Period|Due to epidemic or pandemic|6|||
33630214|NCT03773978|102197681|FG000|DBW Period|Study team decision|1|||
33630215|NCT03773978|102197682|FG001|DBW Period|Study team decision|0|||
33363887|NCT04003155|101220405|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
33363888|NCT04003155|101220406|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
33363889|NCT04003155|101220407|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
33363890|NCT04003155|101220408|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
33363891|NCT04003155|101220409|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
33363892|NCT04003155|101220405|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
33363893|NCT04003155|101220406|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
33363894|NCT04003155|101220407|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
33363895|NCT04003155|101220408|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
33363896|NCT04003155|101220409|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
33363897|NCT04003155|101220405|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
33363898|NCT04003155|101220406|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
33363899|NCT04003155|101220407|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
33363900|NCT04003155|101220408|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
33363901|NCT04003155|101220409|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
33566370|NCT00659425|101970689|FG003|Overall Study|Investigator Discretion|0|||
33566371|NCT00659425|101970690|FG004|Overall Study|Investigator Discretion|0|||
33566372|NCT00659425|101970691|FG005|Overall Study|Investigator Discretion|1|||
33566373|NCT00659425|101970692|FG006|Overall Study|Investigator Discretion|0|||
33566374|NCT00659425|101970693|FG007|Overall Study|Investigator Discretion|3|||
33566375|NCT00659425|101970694|FG008|Overall Study|Investigator Discretion|0|||
33566376|NCT00659425|101970695|FG009|Overall Study|Investigator Discretion|0|||
33566377|NCT00659425|101970686|FG000|Overall Study|Other|0|||
33566378|NCT00659425|101970687|FG001|Overall Study|Other|1|||
33566379|NCT00659425|101970688|FG002|Overall Study|Other|1|||
33566380|NCT00659425|101970689|FG003|Overall Study|Other|2|||
33566381|NCT00659425|101970690|FG004|Overall Study|Other|4|||
33566382|NCT00659425|101970691|FG005|Overall Study|Other|0|||
33566383|NCT00659425|101970692|FG006|Overall Study|Other|3|||
33566384|NCT00659425|101970693|FG007|Overall Study|Other|2|||
33566385|NCT00659425|101970694|FG008|Overall Study|Other|0|||
33566386|NCT00659425|101970695|FG009|Overall Study|Other|6|||
33566387|NCT00160563|101970700|FG000|Overall Study|Adverse Event|1|||
33566388|NCT00160563|101970701|FG001|Overall Study|Adverse Event|1|||
33566389|NCT00160563|101970702|FG002|Overall Study|Adverse Event|1|||
33566390|NCT00160563|101970700|FG000|Overall Study|Lost to Follow-up|1|||
33566391|NCT00160563|101970701|FG001|Overall Study|Lost to Follow-up|1|||
33566392|NCT00160563|101970702|FG002|Overall Study|Lost to Follow-up|2|||
33566393|NCT00160563|101970700|FG000|Overall Study|Protocol Violation|0|||
33566394|NCT00160563|101970701|FG001|Overall Study|Protocol Violation|0|||
33566395|NCT00160563|101970702|FG002|Overall Study|Protocol Violation|3|||
33630216|NCT00537394|102197690|FG000|First Year of Follow-up|Death|7|||
33363902|NCT00081289|101220410|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
33566396|NCT00160563|101970700|FG000|Overall Study|Withdrawal by Subject|1|||
33566397|NCT00160563|101970701|FG001|Overall Study|Withdrawal by Subject|2|||
33566398|NCT00160563|101970702|FG002|Overall Study|Withdrawal by Subject|3|||
33566399|NCT00160563|101970700|FG000|Overall Study|Other (listed in the study report)|48|||
33630217|NCT00537394|102197691|FG001|First Year of Follow-up|Death|0|||
33630218|NCT00537394|102197692|FG002|First Year of Follow-up|Death|0|||
33630219|NCT00537394|102197690|FG000|First Year of Follow-up|Severe debilitation|1|||
33630220|NCT00537394|102197691|FG001|First Year of Follow-up|Severe debilitation|0|||
33630221|NCT00537394|102197692|FG002|First Year of Follow-up|Severe debilitation|1|||
33630222|NCT00537394|102197690|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
33630223|NCT00537394|102197691|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
33630224|NCT00537394|102197692|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
33630225|NCT00537394|102197690|FG000|First Year of Follow-up|Lost to Follow-up|1|||
33630226|NCT00537394|102197691|FG001|First Year of Follow-up|Lost to Follow-up|5|||
33630227|NCT00537394|102197692|FG002|First Year of Follow-up|Lost to Follow-up|1|||
33630228|NCT00537394|102197690|FG000|2nd Year of Follow-up|Death|4|||
33630229|NCT00537394|102197691|FG001|2nd Year of Follow-up|Death|1|||
33630230|NCT00537394|102197692|FG002|2nd Year of Follow-up|Death|2|||
33630231|NCT00537394|102197690|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
33630232|NCT00537394|102197691|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
33630233|NCT00537394|102197692|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
33630234|NCT00537394|102197690|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
33630235|NCT00537394|102197691|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
33630236|NCT00537394|102197692|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
33630237|NCT00537394|102197690|FG000|2nd Year of Follow-up|Clinic site closure|1|||
33630238|NCT00537394|102197691|FG001|2nd Year of Follow-up|Clinic site closure|0|||
33630239|NCT00537394|102197692|FG002|2nd Year of Follow-up|Clinic site closure|0|||
33630240|NCT03409796|102197693|FG000|Overall Study|Adverse Event|2|||
33630241|NCT03409796|102197694|FG001|Overall Study|Adverse Event|0|||
33630242|NCT03409796|102197693|FG000|Overall Study|Other|0|||
33630243|NCT03409796|102197694|FG001|Overall Study|Other|1|||
33630244|NCT00374140|102197695|FG000|Overall Study|Lost to Follow-up|1|||
33630245|NCT00374140|102197695|FG000|Overall Study|Protocol Violation|1|||
33630246|NCT02814916|102197700|FG000|Overall Study|Withdrawal of consent|0|||
33630247|NCT02814916|102197701|FG001|Overall Study|Withdrawal of consent|2|||
33630248|NCT02814916|102197702|FG002|Overall Study|Withdrawal of consent|0|||
33630249|NCT02814916|102197700|FG000|Overall Study|Lost to Follow-up|0|||
33630250|NCT02814916|102197701|FG001|Overall Study|Lost to Follow-up|1|||
33630251|NCT02814916|102197702|FG002|Overall Study|Lost to Follow-up|0|||
33630252|NCT02814916|102197700|FG000|Overall Study|Other, not specified|0|||
33630253|NCT02814916|102197701|FG001|Overall Study|Other, not specified|1|||
33630254|NCT02814916|102197702|FG002|Overall Study|Other, not specified|0|||
33630255|NCT05291520|102197710|FG000|Overall Study|Lost to Follow-up|0|||
33630256|NCT05291520|102197711|FG001|Overall Study|Lost to Follow-up|0|||
33630257|NCT05291520|102197712|FG002|Overall Study|Lost to Follow-up|1|||
33630258|NCT03284710|102197714|FG000|Overall Study|Withdrawal by Subject|1|||
33630259|NCT03284710|102197715|FG001|Overall Study|Withdrawal by Subject|0|||
33630260|NCT03284710|102197716|FG002|Overall Study|Withdrawal by Subject|1|||
33630261|NCT03284710|102197717|FG003|Overall Study|Withdrawal by Subject|6|||
33363903|NCT00081289|101220411|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
33630262|NCT03284710|102197714|FG000|Overall Study|Lost to Follow-up|3|||
33630263|NCT03284710|102197715|FG001|Overall Study|Lost to Follow-up|3|||
33630264|NCT03284710|102197716|FG002|Overall Study|Lost to Follow-up|1|||
33630265|NCT03284710|102197717|FG003|Overall Study|Lost to Follow-up|0|||
33630266|NCT03284710|102197714|FG000|Overall Study|Physician Decision|1|||
33630267|NCT03284710|102197715|FG001|Overall Study|Physician Decision|0|||
33630268|NCT03284710|102197716|FG002|Overall Study|Physician Decision|0|||
33630269|NCT03284710|102197717|FG003|Overall Study|Physician Decision|0|||
33630270|NCT03284710|102197714|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
33630271|NCT03284710|102197715|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
33630272|NCT03284710|102197716|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
33630273|NCT03284710|102197717|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
33630274|NCT03284710|102197714|FG000|Overall Study|HIV Infection|0|||
33630275|NCT03284710|102197715|FG001|Overall Study|HIV Infection|2|||
33630276|NCT03284710|102197716|FG002|Overall Study|HIV Infection|2|||
33630277|NCT03284710|102197717|FG003|Overall Study|HIV Infection|1|||
33630278|NCT04607668|102197718|FG000|Overall Study|Death|49|||
33630279|NCT04607668|102197719|FG001|Overall Study|Death|26|||
33630280|NCT04607668|102197718|FG000|Overall Study|Lost to Follow-up|3|||
33630281|NCT04607668|102197719|FG001|Overall Study|Lost to Follow-up|4|||
33630282|NCT04607668|102197718|FG000|Overall Study|Study terminated by Sponsor|92|||
33630283|NCT04607668|102197719|FG001|Overall Study|Study terminated by Sponsor|114|||
33630284|NCT04607668|102197718|FG000|Overall Study|Withdrawal by Subject|12|||
33630285|NCT04607668|102197719|FG001|Overall Study|Withdrawal by Subject|11|||
33630286|NCT04607668|102197718|FG000|Overall Study|Other, unspecified|8|||
33630287|NCT04607668|102197719|FG001|Overall Study|Other, unspecified|7|||
33630288|NCT02953652|102197720|FG000|Overall Study|Adverse Event|18|||
33630289|NCT02953652|102197720|FG000|Overall Study|Withdrawal by Subject|6|||
33630290|NCT02953652|102197720|FG000|Overall Study|Protocol Violation|1|||
33630291|NCT02953652|102197720|FG000|Overall Study|Disease Progression|27|||
33630292|NCT03547518|102197721|FG000|Overall Study|Lost to Follow-up|2|||
33630293|NCT03547518|102197722|FG001|Overall Study|Lost to Follow-up|0|||
33630294|NCT03019406|102197725|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
33630295|NCT03019406|102197726|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
33630296|NCT03019406|102197727|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
33630297|NCT03019406|102197728|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
33630298|NCT03035032|102197729|FG000|Overall Study|Adverse Event|2|||
33630299|NCT03035032|102197729|FG000|Overall Study|Death|9|||
33630300|NCT03035032|102197729|FG000|Overall Study|Lost to Follow-up|1|||
33630301|NCT03035032|102197729|FG000|Overall Study|Progressive Disease|22|||
33630302|NCT03035032|102197729|FG000|Overall Study|Protocol Violation|2|||
33630303|NCT03035032|102197729|FG000|Overall Study|Withdrawal by Subject|2|||
33630304|NCT03035032|102197729|FG000|Overall Study|Physician Decision|5|||
33630305|NCT04607005|102197730|FG000|Overall Study|Adverse Event|0|||
33630306|NCT04607005|102197731|FG001|Overall Study|Adverse Event|1|||
33630307|NCT04607005|102197730|FG000|Overall Study|Lack of Efficacy|1|||
33630308|NCT04607005|102197731|FG001|Overall Study|Lack of Efficacy|6|||
33630309|NCT04607005|102197730|FG000|Overall Study|Withdrawal by Subject|4|||
33630310|NCT04607005|102197731|FG001|Overall Study|Withdrawal by Subject|9|||
33630311|NCT04607005|102197730|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
33630312|NCT04607005|102197731|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
33630313|NCT03474588|102197732|FG000|Overall Study|Withdrawal by Subject|4|||
33630314|NCT03474588|102197733|FG001|Overall Study|Withdrawal by Subject|3|||
33630315|NCT03474588|102197732|FG000|Overall Study|Death|0|||
33630316|NCT03474588|102197733|FG001|Overall Study|Death|1|||
33630317|NCT05472090|102197734|FG000|Overall Study|Adverse Event|2|||
33630318|NCT05472090|102197735|FG001|Overall Study|Adverse Event|3|||
33630319|NCT05472090|102197734|FG000|Overall Study|Lack of Efficacy|1|||
33630320|NCT05472090|102197735|FG001|Overall Study|Lack of Efficacy|0|||
33630321|NCT05472090|102197734|FG000|Overall Study|Physician Decision|1|||
33630322|NCT05472090|102197735|FG001|Overall Study|Physician Decision|0|||
33630323|NCT05472090|102197734|FG000|Overall Study|Withdrawal by Subject|2|||
33630324|NCT05472090|102197735|FG001|Overall Study|Withdrawal by Subject|0|||
33630325|NCT05472090|102197734|FG000|Overall Study|Lost to Follow-up|0|||
33630326|NCT05472090|102197735|FG001|Overall Study|Lost to Follow-up|3|||
33630327|NCT05526716|102197739|FG000|Overall Study|Death|1|||
33630328|NCT05526716|102197740|FG001|Overall Study|Death|2|||
33223095|NCT02093663|100718800|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33223096|NCT02093663|100718796|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
33223097|NCT02093663|100718797|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
33223098|NCT02093663|100718798|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
33223099|NCT02093663|100718799|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
33223100|NCT02093663|100718800|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
33223101|NCT02093663|100718796|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
33223102|NCT02093663|100718797|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
33223103|NCT02093663|100718798|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
33223104|NCT02093663|100718799|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
33223105|NCT02093663|100718800|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
33223106|NCT02093663|100718796|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33223107|NCT02093663|100718797|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33223108|NCT02093663|100718798|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
33223109|NCT02093663|100718799|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33223110|NCT02093663|100718800|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
33223111|NCT02093663|100718796|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
33223112|NCT02093663|100718797|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
33223113|NCT02093663|100718798|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
33223114|NCT02093663|100718799|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
33223115|NCT02093663|100718800|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
33223116|NCT02093663|100718796|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
33223117|NCT02093663|100718797|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
33223118|NCT02093663|100718798|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
33223119|NCT02093663|100718799|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
33223120|NCT02093663|100718800|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
33223121|NCT02093663|100718796|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
33223122|NCT02093663|100718797|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
33223123|NCT02093663|100718798|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
33223124|NCT02093663|100718799|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
33223125|NCT02093663|100718800|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
33223126|NCT02093663|100718796|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
33223127|NCT02093663|100718797|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
33223128|NCT02093663|100718798|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
33223129|NCT02093663|100718799|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
33223130|NCT02093663|100718800|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
33223131|NCT01125722|100718801|FG000|Overall Study|Withdrawal by Subject|2|||
33223132|NCT01125722|100718802|FG001|Overall Study|Withdrawal by Subject|1|||
33223133|NCT01125722|100718801|FG000|Overall Study|Lost to Follow-up|1|||
33223134|NCT01125722|100718802|FG001|Overall Study|Lost to Follow-up|0|||
33223135|NCT02313909|100718803|FG000|Overall Study|Consent withdrawn by participant|33|||
33223136|NCT02313909|100718804|FG001|Overall Study|Consent withdrawn by participant|33|||
33223137|NCT02313909|100718803|FG000|Overall Study|Lost to Follow-up|24|||
33223138|NCT02313909|100718804|FG001|Overall Study|Lost to Follow-up|17|||
33223139|NCT03976466|100718806|FG000|Overall Study|Lost to Follow-up|1|||
33223140|NCT03976466|100718807|FG001|Overall Study|Lost to Follow-up|3|||
33223141|NCT00855595|100718808|FG000|Overall Study|Withdrawal by Subject|1|||
33223142|NCT00855595|100718809|FG001|Overall Study|Withdrawal by Subject|2|||
33223143|NCT00855595|100718808|FG000|Overall Study|Lost to Follow-up|3|||
33223144|NCT00855595|100718809|FG001|Overall Study|Lost to Follow-up|3|||
33223145|NCT00855595|100718808|FG000|Overall Study|Adverse Event|1|||
33223146|NCT00855595|100718809|FG001|Overall Study|Adverse Event|1|||
33223147|NCT00855595|100718808|FG000|Overall Study|patient moved out of state|1|||
33223148|NCT00855595|100718809|FG001|Overall Study|patient moved out of state|0|||
33223149|NCT00855595|100718808|FG000|Overall Study|patient left country|0|||
33223150|NCT00855595|100718809|FG001|Overall Study|patient left country|1|||
33223151|NCT01852058|100718810|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
33223152|NCT01852058|100718811|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33223153|NCT01852058|100718812|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33630329|NCT05526716|102197739|FG000|Overall Study|Lost to Follow-up|17|||
33630330|NCT05526716|102197740|FG001|Overall Study|Lost to Follow-up|15|||
33630331|NCT05526716|102197739|FG000|Overall Study|Physician Decision|0|||
33223154|NCT01852058|100718813|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33223155|NCT01852058|100718814|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33223156|NCT01852058|100718815|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33416310|NCT02007512|101416056|FG001|Double Blind Treatment Period|Other|0|||
33416311|NCT02007512|101416057|FG002|Double Blind Treatment Period|Other|1|||
33630332|NCT05526716|102197740|FG001|Overall Study|Physician Decision|1|||
33630333|NCT05526716|102197739|FG000|Overall Study|Randomized by mistake without study treatment|0|||
33223157|NCT01852058|100718816|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33630334|NCT05526716|102197740|FG001|Overall Study|Randomized by mistake without study treatment|1|||
33223158|NCT01852058|100718817|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33223159|NCT01852058|100718818|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33223160|NCT01852058|100718819|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33223161|NCT01852058|100718820|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33223162|NCT01852058|100718821|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
33223163|NCT01852058|100718810|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33223164|NCT01852058|100718811|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33223165|NCT01852058|100718812|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33223166|NCT01852058|100718813|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33223167|NCT01852058|100718814|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
33223168|NCT01852058|100718815|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33223169|NCT01852058|100718816|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33223170|NCT01852058|100718817|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33223171|NCT01852058|100718818|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33223172|NCT01852058|100718819|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33223173|NCT01852058|100718820|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33223174|NCT01852058|100718821|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
33223175|NCT01852058|100718810|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33223176|NCT01852058|100718811|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33223177|NCT01852058|100718812|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33223178|NCT01852058|100718813|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33223179|NCT01852058|100718814|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
33223180|NCT01852058|100718815|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
33223181|NCT01852058|100718816|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33223182|NCT01852058|100718817|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33223183|NCT01852058|100718818|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33223184|NCT01852058|100718819|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33630335|NCT05526716|102197739|FG000|Overall Study|Withdrawal by Subject|12|||
33630336|NCT05526716|102197740|FG001|Overall Study|Withdrawal by Subject|12|||
33630337|NCT05526716|102197739|FG000|Overall Study|Not reported|0|||
33630338|NCT05526716|102197740|FG001|Overall Study|Not reported|2|||
33630339|NCT00878501|102197751|FG000|Overall Study|Adverse Event|11|||
33630340|NCT00878501|102197752|FG001|Overall Study|Adverse Event|3|||
33630341|NCT00878501|102197753|FG002|Overall Study|Adverse Event|3|||
33630342|NCT00878501|102197751|FG000|Overall Study|Lack of Efficacy|2|||
33630343|NCT00878501|102197752|FG001|Overall Study|Lack of Efficacy|1|||
33630344|NCT00878501|102197753|FG002|Overall Study|Lack of Efficacy|0|||
33630345|NCT00878501|102197751|FG000|Overall Study|Withdrawal by Subject|2|||
33630346|NCT00878501|102197752|FG001|Overall Study|Withdrawal by Subject|1|||
33630347|NCT00878501|102197753|FG002|Overall Study|Withdrawal by Subject|2|||
33630348|NCT00878501|102197751|FG000|Overall Study|Protocol Violation|0|||
33630349|NCT00878501|102197752|FG001|Overall Study|Protocol Violation|0|||
33630350|NCT00878501|102197753|FG002|Overall Study|Protocol Violation|1|||
33630351|NCT00878501|102197751|FG000|Overall Study|Incorrect enrolment|1|||
33630352|NCT00878501|102197752|FG001|Overall Study|Incorrect enrolment|2|||
33630353|NCT00878501|102197753|FG002|Overall Study|Incorrect enrolment|0|||
33630354|NCT00878501|102197751|FG000|Overall Study|Intake of prohibited concom. medication|0|||
33630355|NCT00878501|102197752|FG001|Overall Study|Intake of prohibited concom. medication|0|||
33630356|NCT00878501|102197753|FG002|Overall Study|Intake of prohibited concom. medication|1|||
33630357|NCT00878501|102197751|FG000|Overall Study|Mis-randomisation of patient|1|||
33630358|NCT00878501|102197752|FG001|Overall Study|Mis-randomisation of patient|0|||
33630359|NCT00878501|102197753|FG002|Overall Study|Mis-randomisation of patient|0|||
33630360|NCT00878501|102197751|FG000|Overall Study|Administrative|0|||
33630361|NCT00878501|102197752|FG001|Overall Study|Administrative|0|||
33630362|NCT00878501|102197753|FG002|Overall Study|Administrative|1|||
33630363|NCT02218372|102197754|FG000|Overall Study|Adverse Event|1|||
33630364|NCT02218372|102197755|FG001|Overall Study|Adverse Event|1|||
33630365|NCT02218372|102197754|FG000|Overall Study|Miscellaneous|2|||
33630366|NCT02218372|102197755|FG001|Overall Study|Miscellaneous|1|||
33630367|NCT02218372|102197754|FG000|Overall Study|Randomized but did not receive treatment|2|||
33630368|NCT02218372|102197755|FG001|Overall Study|Randomized but did not receive treatment|3|||
33630369|NCT02218372|102197754|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33630370|NCT02218372|102197755|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33630371|NCT00984256|102197756|FG000|Overall Study|Withdrawal by Subject|0|||
33630372|NCT00984256|102197757|FG001|Overall Study|Withdrawal by Subject|1|||
33630373|NCT02004236|102197759|FG000|Overall Study|Lack of Efficacy|0|||
33223185|NCT01852058|100718820|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33630374|NCT02004236|102197760|FG001|Overall Study|Lack of Efficacy|0|||
33630375|NCT02004236|102197761|FG002|Overall Study|Lack of Efficacy|16|||
33223186|NCT01852058|100718821|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
33223187|NCT01852058|100718810|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33223188|NCT01852058|100718811|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33223189|NCT01852058|100718812|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33223190|NCT01852058|100718813|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33223191|NCT01852058|100718814|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
33416312|NCT02007512|101416058|FG003|Double Blind Treatment Period|Other|2|||
33416313|NCT02007512|101416055|FG000|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10|||
33416314|NCT02007512|101416056|FG001|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11|||
33416315|NCT02007512|101416057|FG002|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5|||
33416316|NCT02007512|101416058|FG003|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1|||
33416317|NCT02007512|101416055|FG000|Open Label Treatment Period|Adverse Event|0|||
33416318|NCT02007512|101416056|FG001|Open Label Treatment Period|Adverse Event|1|||
33416319|NCT02007512|101416057|FG002|Open Label Treatment Period|Adverse Event|0|||
33416320|NCT02007512|101416058|FG003|Open Label Treatment Period|Adverse Event|0|||
33416321|NCT02007512|101416055|FG000|Open Label Treatment Period|Other|0|||
33416322|NCT02007512|101416056|FG001|Open Label Treatment Period|Other|0|||
33416323|NCT02007512|101416057|FG002|Open Label Treatment Period|Other|0|||
33416324|NCT02007512|101416058|FG003|Open Label Treatment Period|Other|1|||
33416325|NCT02007512|101416055|FG000|Open Label Treatment Period|Disease progression|0|||
33416326|NCT02007512|101416056|FG001|Open Label Treatment Period|Disease progression|17|||
33416327|NCT02007512|101416057|FG002|Open Label Treatment Period|Disease progression|0|||
33416328|NCT02007512|101416058|FG003|Open Label Treatment Period|Disease progression|11|||
33416329|NCT02007512|101416055|FG000|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
33416330|NCT02007512|101416056|FG001|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3|||
33416331|NCT02007512|101416057|FG002|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
33630376|NCT05138653|102197762|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
33223192|NCT01852058|100718815|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33223193|NCT01852058|100718816|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33363904|NCT00081289|101220410|FG000|Overall Study|Ineligible / no protocol treatment|3|||
33363905|NCT00081289|101220411|FG001|Overall Study|Ineligible / no protocol treatment|4|||
33363906|NCT01422304|101220418|FG000|Overall Study|Adverse Event|0|||
33363907|NCT01422304|101220419|FG001|Overall Study|Adverse Event|1|||
33363908|NCT01422304|101220418|FG000|Overall Study|Lost to Follow-up|14|||
33363909|NCT01422304|101220419|FG001|Overall Study|Lost to Follow-up|20|||
33363910|NCT01422304|101220418|FG000|Overall Study|Never Entered Follow-up|2|||
33363911|NCT01422304|101220419|FG001|Overall Study|Never Entered Follow-up|1|||
33363912|NCT01422304|101220418|FG000|Overall Study|Protocol Violation|1|||
33363913|NCT01422304|101220419|FG001|Overall Study|Protocol Violation|0|||
33363914|NCT01422304|101220418|FG000|Overall Study|Withdrawal by Subject|4|||
33363915|NCT01422304|101220419|FG001|Overall Study|Withdrawal by Subject|2|||
33363916|NCT01422304|101220418|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
33363917|NCT01422304|101220419|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
33363918|NCT01422304|101220418|FG000|Overall Study|Not Treated|3|||
33363919|NCT01422304|101220419|FG001|Overall Study|Not Treated|11|||
33363920|NCT00053846|101220424|FG000|Overall Study|Changed mind|8|||
33363921|NCT00053846|101220425|FG001|Overall Study|Changed mind|13|||
33363922|NCT00053846|101220424|FG000|Overall Study|Became too ill|8|||
33363923|NCT00053846|101220425|FG001|Overall Study|Became too ill|7|||
33363924|NCT00053846|101220424|FG000|Overall Study|Expired|5|||
33363925|NCT00053846|101220425|FG001|Overall Study|Expired|0|||
33363926|NCT00053846|101220424|FG000|Overall Study|Became ineligible|3|||
33363927|NCT00053846|101220425|FG001|Overall Study|Became ineligible|1|||
33363928|NCT00053846|101220424|FG000|Overall Study|Did not return data|1|||
33363929|NCT00053846|101220425|FG001|Overall Study|Did not return data|2|||
33363930|NCT00053846|101220424|FG000|Overall Study|Quit due to side effects|1|||
33363931|NCT00053846|101220425|FG001|Overall Study|Quit due to side effects|3|||
33363932|NCT00053846|101220424|FG000|Overall Study|Pills too large|0|||
33363933|NCT00053846|101220425|FG001|Overall Study|Pills too large|1|||
33363934|NCT00744055|101220426|FG000|Overall Study|Withdrawal by Subject|6|||
33363935|NCT00744055|101220427|FG001|Overall Study|Withdrawal by Subject|9|||
33363936|NCT00744055|101220426|FG000|Overall Study|Lack of Efficacy|0|||
33363937|NCT00744055|101220427|FG001|Overall Study|Lack of Efficacy|1|||
33363938|NCT00744055|101220426|FG000|Overall Study|Physician Decision|0|||
33363939|NCT00744055|101220427|FG001|Overall Study|Physician Decision|2|||
33363940|NCT00744055|101220426|FG000|Overall Study|Protocol Violation|1|||
33363941|NCT00744055|101220427|FG001|Overall Study|Protocol Violation|1|||
33363942|NCT00744055|101220426|FG000|Overall Study|Lost to Follow-up|0|||
33363943|NCT00744055|101220427|FG001|Overall Study|Lost to Follow-up|1|||
33363944|NCT02746679|101220430|FG000|Overall Study|Lost to Follow-up|4|||
33363945|NCT02746679|101220431|FG001|Overall Study|Lost to Follow-up|6|||
33363946|NCT05372575|101220432|FG000|Overall Study|Protocol Violation|7|||
33363947|NCT05372575|101220433|FG001|Overall Study|Protocol Violation|16|||
33416332|NCT02007512|101416058|FG003|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0|||
33416333|NCT04736576|101416061|FG000|Overall Study|Progressive disease|3|||
33416334|NCT04736576|101416062|FG001|Overall Study|Progressive disease|1|||
33630377|NCT05138653|102197763|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33630378|NCT05138653|102197764|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33630379|NCT05138653|102197765|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33223194|NCT01852058|100718817|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33416335|NCT04736576|101416061|FG000|Overall Study|Death|1|||
33416336|NCT04736576|101416062|FG001|Overall Study|Death|0|||
33416337|NCT03022799|101416064|FG000|Overall Study|Adverse Event|0|||
33363948|NCT00234104|101220439|FG000|Overall Study|Adverse Event|4|||
33363949|NCT00234104|101220440|FG001|Overall Study|Adverse Event|0|||
33363950|NCT00234104|101220441|FG002|Overall Study|Adverse Event|3|||
33363951|NCT00234104|101220442|FG003|Overall Study|Adverse Event|5|||
33363952|NCT00234104|101220439|FG000|Overall Study|Protocol Violation|0|||
33363953|NCT00234104|101220440|FG001|Overall Study|Protocol Violation|0|||
33363954|NCT00234104|101220441|FG002|Overall Study|Protocol Violation|0|||
33416338|NCT03022799|101416065|FG001|Overall Study|Adverse Event|0|||
33416339|NCT03022799|101416066|FG002|Overall Study|Adverse Event|0|||
33416340|NCT03022799|101416067|FG003|Overall Study|Adverse Event|0|||
33416341|NCT03022799|101416068|FG004|Overall Study|Adverse Event|0|||
33416342|NCT03022799|101416069|FG005|Overall Study|Adverse Event|0|||
33416343|NCT03022799|101416070|FG006|Overall Study|Adverse Event|0|||
33416344|NCT03022799|101416071|FG007|Overall Study|Adverse Event|0|||
33416345|NCT03022799|101416072|FG008|Overall Study|Adverse Event|0|||
33416346|NCT03022799|101416073|FG009|Overall Study|Adverse Event|1|||
33416347|NCT03022799|101416074|FG010|Overall Study|Adverse Event|1|||
33416348|NCT03022799|101416075|FG011|Overall Study|Adverse Event|0|||
33416349|NCT03022799|101416076|FG012|Overall Study|Adverse Event|0|||
33566400|NCT00160563|101970701|FG001|Overall Study|Other (listed in the study report)|40|||
33566401|NCT00160563|101970702|FG002|Overall Study|Other (listed in the study report)|81|||
33566402|NCT00160563|101970700|FG000|Overall Study|Missing reason|0|||
33566403|NCT00160563|101970701|FG001|Overall Study|Missing reason|1|||
33566404|NCT00160563|101970702|FG002|Overall Study|Missing reason|0|||
33566405|NCT00425555|101970713|FG000|Overall Study|Withdrawal by Subject|11|||
33566406|NCT00425555|101970714|FG001|Overall Study|Withdrawal by Subject|8|||
33566407|NCT00425555|101970713|FG000|Overall Study|Lost to Follow-up|0|||
33566408|NCT00425555|101970714|FG001|Overall Study|Lost to Follow-up|1|||
33566409|NCT00425555|101970713|FG000|Overall Study|Administrative problems|3|||
33566410|NCT00425555|101970714|FG001|Overall Study|Administrative problems|0|||
33566411|NCT00425555|101970713|FG000|Overall Study|Death|1|||
33566412|NCT00425555|101970714|FG001|Overall Study|Death|2|||
33566413|NCT00425555|101970713|FG000|Overall Study|New cancer therapy|2|||
33363955|NCT00234104|101220442|FG003|Overall Study|Protocol Violation|1|||
33363956|NCT00234104|101220439|FG000|Overall Study|Physician Decision|0|||
33566414|NCT00425555|101970714|FG001|Overall Study|New cancer therapy|1|||
33566415|NCT00425555|101970713|FG000|Overall Study|Disease progression|36|||
33566416|NCT00425555|101970714|FG001|Overall Study|Disease progression|33|||
33223195|NCT01852058|100718818|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33223196|NCT01852058|100718819|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33223197|NCT01852058|100718820|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33223198|NCT01852058|100718821|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
33223199|NCT01852058|100718810|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33223200|NCT01852058|100718811|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33223201|NCT01852058|100718812|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33223202|NCT01852058|100718813|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33223203|NCT01852058|100718814|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
33363957|NCT00234104|101220440|FG001|Overall Study|Physician Decision|1|||
33416350|NCT03862807|101416078|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
33416351|NCT00537056|101416080|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
33416352|NCT01870921|101416081|FG000|Overall Study|Subject decision|80|||
33416353|NCT01870921|101416081|FG000|Overall Study|Severe non-compliance to protocol|7|||
33416354|NCT01870921|101416081|FG000|Overall Study|Subject Lost to Follow up|2|||
33416355|NCT01870921|101416081|FG000|Overall Study|Other|1|||
33416356|NCT03505606|101416082|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
33416357|NCT03505606|101416083|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
33416358|NCT03505606|101416084|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
33363958|NCT00234104|101220441|FG002|Overall Study|Physician Decision|2|||
33416359|NCT03505606|101416082|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
33416360|NCT03505606|101416083|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
33566417|NCT00425555|101970713|FG000|Overall Study|Adverse Event|25|||
33566418|NCT00425555|101970714|FG001|Overall Study|Adverse Event|15|||
33566419|NCT00425555|101970713|FG000|Overall Study|Protocol Violation|1|||
33416361|NCT03505606|101416084|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
33416362|NCT03505606|101416082|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
33416363|NCT03505606|101416083|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
33416364|NCT03505606|101416084|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
33416365|NCT03505606|101416082|FG000|Overall Study|Poor compliance with refractive correction|0|||
33223204|NCT01852058|100718815|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
33223205|NCT01852058|100718816|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33223206|NCT01852058|100718817|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33223207|NCT01852058|100718818|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33223208|NCT01852058|100718819|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33223209|NCT01852058|100718820|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33416366|NCT03505606|101416083|FG001|Overall Study|Poor compliance with refractive correction|0|||
33416367|NCT03505606|101416084|FG002|Overall Study|Poor compliance with refractive correction|1|||
33416368|NCT03505606|101416082|FG000|Overall Study|Insufficient anisometropia|0|||
33363959|NCT00234104|101220442|FG003|Overall Study|Physician Decision|2|||
33363960|NCT02399475|101220443|FG000|Overall Study|Physician Decision|1|||
33363961|NCT02399475|101220444|FG001|Overall Study|Physician Decision|0|||
33363962|NCT01052012|101220449|FG000|Overall Study|Not treated|2|||
33363963|NCT01052012|101220450|FG001|Overall Study|Not treated|5|||
33363964|NCT01052012|101220451|FG002|Overall Study|Not treated|0|||
33363965|NCT01052012|101220452|FG003|Overall Study|Not treated|0|||
33363966|NCT01052012|101220453|FG004|Overall Study|Not treated|11|||
33363967|NCT01052012|101220454|FG005|Overall Study|Not treated|8|||
33363968|NCT01052012|101220449|FG000|Overall Study|Adverse Event|1|||
33363969|NCT01052012|101220450|FG001|Overall Study|Adverse Event|0|||
33363970|NCT01052012|101220451|FG002|Overall Study|Adverse Event|0|||
33363971|NCT01052012|101220452|FG003|Overall Study|Adverse Event|1|||
33416369|NCT03505606|101416083|FG001|Overall Study|Insufficient anisometropia|0|||
33416370|NCT03505606|101416084|FG002|Overall Study|Insufficient anisometropia|2|||
33416371|NCT03505606|101416082|FG000|Overall Study|Ectopia Lentis|0|||
33416372|NCT03505606|101416083|FG001|Overall Study|Ectopia Lentis|0|||
33416373|NCT03505606|101416084|FG002|Overall Study|Ectopia Lentis|1|||
33416374|NCT03505606|101416082|FG000|Overall Study|alternation of amblyopic eye|0|||
33416375|NCT03505606|101416083|FG001|Overall Study|alternation of amblyopic eye|1|||
33416376|NCT03505606|101416084|FG002|Overall Study|alternation of amblyopic eye|0|||
33416377|NCT01523301|101416085|FG000|Overall Study|Adverse Event|25|||
33416378|NCT01523301|101416086|FG001|Overall Study|Adverse Event|16|||
33416379|NCT01523301|101416085|FG000|Overall Study|Lack of Efficacy|0|||
33416380|NCT01523301|101416086|FG001|Overall Study|Lack of Efficacy|2|||
33416381|NCT01523301|101416085|FG000|Overall Study|Protocol Violation|3|||
33416382|NCT01523301|101416086|FG001|Overall Study|Protocol Violation|4|||
33416383|NCT01523301|101416085|FG000|Overall Study|Lost to Follow-up|1|||
33416384|NCT01523301|101416086|FG001|Overall Study|Lost to Follow-up|0|||
33416385|NCT01523301|101416085|FG000|Overall Study|Withdrawal by Subject|6|||
33416386|NCT01523301|101416086|FG001|Overall Study|Withdrawal by Subject|8|||
33416387|NCT01523301|101416085|FG000|Overall Study|Other Reason|0|||
33416388|NCT01523301|101416086|FG001|Overall Study|Other Reason|2|||
33416389|NCT05013749|101416089|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
33416390|NCT05013749|101416090|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
33416391|NCT05013749|101416089|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
33416392|NCT05013749|101416090|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
33416393|NCT00564486|101416091|FG000|Overall Study|Adverse Event|0|||
33416394|NCT00564486|101416092|FG001|Overall Study|Adverse Event|1|||
33416395|NCT00564486|101416093|FG002|Overall Study|Adverse Event|0|||
33416396|NCT00564486|101416094|FG003|Overall Study|Adverse Event|0|||
33416397|NCT00564486|101416091|FG000|Overall Study|Withdrawal by Subject|4|||
33416398|NCT00564486|101416092|FG001|Overall Study|Withdrawal by Subject|0|||
33416399|NCT00564486|101416093|FG002|Overall Study|Withdrawal by Subject|0|||
33223210|NCT01852058|100718821|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
33223211|NCT01852058|100718810|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33416400|NCT00564486|101416094|FG003|Overall Study|Withdrawal by Subject|5|||
33416401|NCT00564486|101416091|FG000|Overall Study|Subject refused to have blood drawn|0|||
33416402|NCT00564486|101416092|FG001|Overall Study|Subject refused to have blood drawn|0|||
33416403|NCT00564486|101416093|FG002|Overall Study|Subject refused to have blood drawn|1|||
33416404|NCT00564486|101416094|FG003|Overall Study|Subject refused to have blood drawn|0|||
33416405|NCT00564486|101416091|FG000|Overall Study|Lost to Follow-up|3|||
33416406|NCT00564486|101416092|FG001|Overall Study|Lost to Follow-up|0|||
33416407|NCT00564486|101416093|FG002|Overall Study|Lost to Follow-up|2|||
33416408|NCT00564486|101416094|FG003|Overall Study|Lost to Follow-up|2|||
33416409|NCT04527549|101416096|FG000|Overall Study|Withdrawal by Subject|1|||
33416410|NCT04527549|101416097|FG001|Overall Study|Withdrawal by Subject|1|||
33363972|NCT01052012|101220453|FG004|Overall Study|Adverse Event|0|||
33363973|NCT01052012|101220454|FG005|Overall Study|Adverse Event|0|||
33416411|NCT00138658|101416100|FG000|Overall Study|Adverse Event|23|||
33416412|NCT00138658|101416100|FG000|Overall Study|Death|1|||
33416413|NCT00138658|101416100|FG000|Overall Study|Disease Progression|21|||
33416414|NCT00138658|101416100|FG000|Overall Study|Physician Decision|11|||
33416415|NCT00138658|101416100|FG000|Overall Study|Withdrawal by Subject|5|||
33363974|NCT01052012|101220449|FG000|Overall Study|Lost to Follow-up|0|||
33630380|NCT05138653|102197766|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33630381|NCT05138653|102197767|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33416416|NCT03033069|101416103|FG000|Overall Study|Adverse Event|6|||
33416417|NCT03033069|101416104|FG001|Overall Study|Adverse Event|7|||
33416418|NCT03033069|101416105|FG002|Overall Study|Adverse Event|4|||
33416419|NCT03033069|101416106|FG003|Overall Study|Adverse Event|6|||
33416420|NCT03033069|101416103|FG000|Overall Study|Lack of Efficacy|0|||
33363975|NCT01052012|101220450|FG001|Overall Study|Lost to Follow-up|0|||
33363976|NCT01052012|101220451|FG002|Overall Study|Lost to Follow-up|0|||
33363977|NCT01052012|101220452|FG003|Overall Study|Lost to Follow-up|0|||
33363978|NCT01052012|101220453|FG004|Overall Study|Lost to Follow-up|1|||
33363979|NCT01052012|101220454|FG005|Overall Study|Lost to Follow-up|0|||
33363980|NCT01052012|101220449|FG000|Overall Study|Withdrawal by Subject|1|||
33363981|NCT01052012|101220450|FG001|Overall Study|Withdrawal by Subject|1|||
33363982|NCT01052012|101220451|FG002|Overall Study|Withdrawal by Subject|0|||
33363983|NCT01052012|101220452|FG003|Overall Study|Withdrawal by Subject|0|||
33363984|NCT01052012|101220453|FG004|Overall Study|Withdrawal by Subject|3|||
33363985|NCT01052012|101220454|FG005|Overall Study|Withdrawal by Subject|1|||
33223212|NCT01852058|100718811|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33363986|NCT01052012|101220449|FG000|Overall Study|Physician Decision|0|||
33363987|NCT01052012|101220450|FG001|Overall Study|Physician Decision|0|||
33363988|NCT01052012|101220451|FG002|Overall Study|Physician Decision|0|||
33363989|NCT01052012|101220452|FG003|Overall Study|Physician Decision|0|||
33363990|NCT01052012|101220453|FG004|Overall Study|Physician Decision|0|||
33363991|NCT01052012|101220454|FG005|Overall Study|Physician Decision|1|||
33363992|NCT01052012|101220449|FG000|Overall Study|Other|0|||
33363993|NCT01052012|101220450|FG001|Overall Study|Other|0|||
33363994|NCT01052012|101220451|FG002|Overall Study|Other|0|||
33223213|NCT01852058|100718812|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33223214|NCT01852058|100718813|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
33416421|NCT03033069|101416104|FG001|Overall Study|Lack of Efficacy|0|||
33416422|NCT03033069|101416105|FG002|Overall Study|Lack of Efficacy|1|||
33416423|NCT03033069|101416106|FG003|Overall Study|Lack of Efficacy|0|||
33416424|NCT03033069|101416103|FG000|Overall Study|Lost to Follow-up|6|||
33416425|NCT03033069|101416104|FG001|Overall Study|Lost to Follow-up|5|||
33416426|NCT03033069|101416105|FG002|Overall Study|Lost to Follow-up|5|||
33416427|NCT03033069|101416106|FG003|Overall Study|Lost to Follow-up|6|||
33416428|NCT03033069|101416103|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33416429|NCT03033069|101416104|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33630382|NCT05138653|102197768|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33630383|NCT05138653|102197769|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33630384|NCT05138653|102197770|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33630385|NCT05138653|102197771|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33630386|NCT05138653|102197772|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33630387|NCT05138653|102197773|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33223215|NCT01852058|100718814|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33363995|NCT01052012|101220452|FG003|Overall Study|Other|0|||
33363996|NCT01052012|101220453|FG004|Overall Study|Other|1|||
33416430|NCT03033069|101416105|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33416431|NCT03033069|101416106|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33416432|NCT03033069|101416103|FG000|Overall Study|Protocol Deviation|0|||
33416433|NCT03033069|101416104|FG001|Overall Study|Protocol Deviation|1|||
33416434|NCT03033069|101416105|FG002|Overall Study|Protocol Deviation|0|||
33416435|NCT03033069|101416106|FG003|Overall Study|Protocol Deviation|0|||
33630388|NCT05138653|102197774|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33363997|NCT01052012|101220454|FG005|Overall Study|Other|0|||
33363998|NCT01272180|101220455|FG000|Overall Study|Adverse Event|0|||
33416436|NCT03033069|101416103|FG000|Overall Study|Withdrawal by Subject|10|||
33363999|NCT01272180|101220456|FG001|Overall Study|Adverse Event|0|||
33364000|NCT01272180|101220457|FG002|Overall Study|Adverse Event|1|||
33364001|NCT01272180|101220458|FG003|Overall Study|Adverse Event|0|||
33416437|NCT03033069|101416104|FG001|Overall Study|Withdrawal by Subject|10|||
33566420|NCT00425555|101970714|FG001|Overall Study|Protocol Violation|0|||
33364002|NCT01272180|101220455|FG000|Overall Study|Withdrawal by Subject|2|||
33364003|NCT01272180|101220456|FG001|Overall Study|Withdrawal by Subject|6|||
33364004|NCT01272180|101220457|FG002|Overall Study|Withdrawal by Subject|3|||
33364005|NCT01272180|101220458|FG003|Overall Study|Withdrawal by Subject|2|||
33630389|NCT05138653|102197775|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33630390|NCT05138653|102197776|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33630391|NCT05138653|102197777|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
33630392|NCT05138653|102197762|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
33630393|NCT05138653|102197763|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
33630394|NCT05138653|102197764|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
33630395|NCT05138653|102197765|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
33630396|NCT05138653|102197766|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
33630397|NCT05138653|102197767|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
33630398|NCT05138653|102197768|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
33630399|NCT05138653|102197769|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
33630400|NCT05138653|102197770|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
33630401|NCT05138653|102197771|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
33630402|NCT05138653|102197772|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
33630403|NCT05138653|102197773|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
33630404|NCT05138653|102197774|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
33630405|NCT05138653|102197775|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
33630406|NCT05138653|102197776|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
33630407|NCT05138653|102197777|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
33630408|NCT05138653|102197762|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
33630409|NCT05138653|102197763|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
33630410|NCT05138653|102197764|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
33630411|NCT05138653|102197765|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
33630412|NCT05138653|102197766|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
33630413|NCT05138653|102197767|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
33630414|NCT05138653|102197768|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
33364006|NCT01272180|101220455|FG000|Overall Study|Lost to Follow-up|15|||
33364007|NCT01272180|101220456|FG001|Overall Study|Lost to Follow-up|14|||
33364008|NCT01272180|101220457|FG002|Overall Study|Lost to Follow-up|8|||
33364009|NCT01272180|101220458|FG003|Overall Study|Lost to Follow-up|10|||
33364010|NCT01272180|101220455|FG000|Overall Study|Inappropriate enrollment|0|||
33364011|NCT01272180|101220456|FG001|Overall Study|Inappropriate enrollment|0|||
33364012|NCT01272180|101220457|FG002|Overall Study|Inappropriate enrollment|1|||
33364013|NCT01272180|101220458|FG003|Overall Study|Inappropriate enrollment|1|||
33364014|NCT01272180|101220455|FG000|Overall Study|Protocol Violation|0|||
33364015|NCT01272180|101220456|FG001|Overall Study|Protocol Violation|1|||
33364016|NCT01272180|101220457|FG002|Overall Study|Protocol Violation|0|||
33364017|NCT01272180|101220458|FG003|Overall Study|Protocol Violation|1|||
33364018|NCT01126619|101220459|FG000|Overall Study|Not eligible for the study|2|||
33630415|NCT05138653|102197769|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
33630416|NCT05138653|102197770|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
33630417|NCT05138653|102197771|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
33630418|NCT05138653|102197772|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
33630419|NCT05138653|102197773|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
33630420|NCT05138653|102197774|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
33630421|NCT05138653|102197775|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
33630422|NCT05138653|102197776|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
33630423|NCT05138653|102197777|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
33630424|NCT05138653|102197762|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33630425|NCT05138653|102197763|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33630426|NCT05138653|102197764|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33630427|NCT05138653|102197765|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33630428|NCT05138653|102197766|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33630429|NCT05138653|102197767|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33630430|NCT05138653|102197768|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
33630431|NCT05138653|102197769|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33630432|NCT05138653|102197770|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33630433|NCT05138653|102197771|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33630434|NCT05138653|102197772|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33364019|NCT01126619|101220459|FG000|Overall Study|Investigator decision|4|||
33364020|NCT01126619|101220459|FG000|Overall Study|Serious adverse event|1|||
33364021|NCT01126619|101220459|FG000|Overall Study|Withdrawal by Subject|9|||
33364022|NCT01126619|101220459|FG000|Overall Study|Non-compliance|1|||
33364023|NCT01004146|101220460|FG000|Overall Study|Withdrawal by Subject|4|||
33364024|NCT01004146|101220461|FG001|Overall Study|Withdrawal by Subject|5|||
33630435|NCT05138653|102197773|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33630436|NCT05138653|102197774|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33630437|NCT05138653|102197775|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33630438|NCT05138653|102197776|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33364025|NCT00514449|101220462|FG000|Overall Study|Withdrawal by Subject|1|||
33364026|NCT00514449|101220463|FG001|Overall Study|Withdrawal by Subject|2|||
33364027|NCT00514449|101220462|FG000|Overall Study|Protocol Violation|1|||
33364028|NCT00514449|101220463|FG001|Overall Study|Protocol Violation|2|||
33364029|NCT00514449|101220462|FG000|Overall Study|Lost to Follow-up|1|||
33364030|NCT00514449|101220463|FG001|Overall Study|Lost to Follow-up|0|||
33364031|NCT01781026|101220466|FG000|Overall Study|Lack of Efficacy|2|||
33364032|NCT01062399|101220467|FG000|Overall Study|Protocol Violation|0|||
33364033|NCT01062399|101220468|FG001|Overall Study|Protocol Violation|1|||
33364034|NCT01062399|101220469|FG002|Overall Study|Protocol Violation|0|||
33364035|NCT01062399|101220470|FG003|Overall Study|Protocol Violation|6|||
33364036|NCT01062399|101220471|FG004|Overall Study|Protocol Violation|4|||
33364037|NCT01302041|101220472|FG000|Overall Study|Death|5|||
33364038|NCT01302041|101220472|FG000|Overall Study|Withdrawal by Subject|4|||
33364039|NCT01302041|101220472|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
33364040|NCT01302041|101220472|FG000|Overall Study|Other-Miscellaneous Reason|2|||
33364041|NCT04973228|101220473|FG000|Overall Study|Adverse Event|2|||
33364042|NCT04973228|101220474|FG001|Overall Study|Adverse Event|3|||
33364043|NCT04973228|101220473|FG000|Overall Study|Lack of Efficacy|1|||
33364044|NCT04973228|101220474|FG001|Overall Study|Lack of Efficacy|3|||
33364045|NCT04973228|101220473|FG000|Overall Study|Lost to Follow-up|12|||
33364046|NCT04973228|101220474|FG001|Overall Study|Lost to Follow-up|4|||
33364047|NCT04973228|101220473|FG000|Overall Study|Withdrawal by Subject|11|||
33364048|NCT04973228|101220474|FG001|Overall Study|Withdrawal by Subject|4|||
33364049|NCT04973228|101220473|FG000|Overall Study|Did not tolerate application|1|||
33364050|NCT04973228|101220474|FG001|Overall Study|Did not tolerate application|0|||
33364051|NCT04973228|101220473|FG000|Overall Study|Wanted to early terminate and use own product|0|||
33364052|NCT04973228|101220474|FG001|Overall Study|Wanted to early terminate and use own product|1|||
33364053|NCT04973228|101220473|FG000|Overall Study|Missed visits due to new work schedule|1|||
33364054|NCT04973228|101220474|FG001|Overall Study|Missed visits due to new work schedule|0|||
33364055|NCT00469014|101220477|FG000|Initial Phase Randomization|Disease Progression|0|||
33364056|NCT00469014|101220478|FG001|Initial Phase Randomization|Disease Progression|1|||
33364057|NCT00469014|101220479|FG002|Initial Phase Randomization|Disease Progression|1|||
33364058|NCT00469014|101220480|FG003|Initial Phase Randomization|Disease Progression|0|||
33364059|NCT00469014|101220477|FG000|Initial Phase Randomization|No Response|1|||
33364060|NCT00469014|101220478|FG001|Initial Phase Randomization|No Response|0|||
33364061|NCT00469014|101220479|FG002|Initial Phase Randomization|No Response|0|||
33364062|NCT00469014|101220480|FG003|Initial Phase Randomization|No Response|1|||
33416438|NCT03033069|101416105|FG002|Overall Study|Withdrawal by Subject|11|||
33416439|NCT03033069|101416106|FG003|Overall Study|Withdrawal by Subject|6|||
33416440|NCT03033069|101416103|FG000|Overall Study|Withdrawal By Caregiver|1|||
33416441|NCT03033069|101416104|FG001|Overall Study|Withdrawal By Caregiver|0|||
33364063|NCT00469014|101220477|FG000|Adaptive Randomization|Not Evaluable|1|||
33364064|NCT00469014|101220478|FG001|Adaptive Randomization|Not Evaluable|0|||
33416442|NCT03033069|101416105|FG002|Overall Study|Withdrawal By Caregiver|0|||
33630439|NCT05138653|102197777|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
33416443|NCT03033069|101416106|FG003|Overall Study|Withdrawal By Caregiver|0|||
33630440|NCT05138653|102197762|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
33630441|NCT05138653|102197763|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
33630442|NCT05138653|102197764|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
33630443|NCT05138653|102197765|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
33630444|NCT05138653|102197766|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
33630445|NCT05138653|102197767|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
33630446|NCT05138653|102197768|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
33630447|NCT05138653|102197769|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
33630448|NCT05138653|102197770|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
33630449|NCT05138653|102197771|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
33364065|NCT00469014|101220479|FG002|Adaptive Randomization|Not Evaluable|0|||
33364066|NCT00469014|101220480|FG003|Adaptive Randomization|Not Evaluable|1|||
33364067|NCT00469014|101220477|FG000|Adaptive Randomization|No Response|0|||
33364068|NCT00469014|101220478|FG001|Adaptive Randomization|No Response|1|||
33364069|NCT00469014|101220479|FG002|Adaptive Randomization|No Response|0|||
33364070|NCT00469014|101220480|FG003|Adaptive Randomization|No Response|0|||
33364071|NCT00469014|101220477|FG000|Adaptive Randomization|Death|0|||
33364072|NCT00469014|101220478|FG001|Adaptive Randomization|Death|0|||
33416444|NCT03033069|101416103|FG000|Overall Study|Reason not Specified|0|||
33416445|NCT03033069|101416104|FG001|Overall Study|Reason not Specified|1|||
33364073|NCT00469014|101220479|FG002|Adaptive Randomization|Death|1|||
33364074|NCT00469014|101220480|FG003|Adaptive Randomization|Death|0|||
33364075|NCT01894516|101220482|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
33364076|NCT01894516|101220483|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
33364077|NCT01894516|101220484|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
33364078|NCT01894516|101220485|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
33364079|NCT01894516|101220482|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
33364080|NCT01894516|101220483|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33364081|NCT01894516|101220484|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33364082|NCT01894516|101220485|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
33364083|NCT01894516|101220482|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
33364084|NCT01894516|101220483|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
33364085|NCT01894516|101220484|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
33364086|NCT01894516|101220485|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
33364087|NCT01894516|101220482|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
33364088|NCT01894516|101220483|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
33364089|NCT01894516|101220484|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
33416446|NCT03033069|101416105|FG002|Overall Study|Reason not Specified|0|||
33416447|NCT03033069|101416106|FG003|Overall Study|Reason not Specified|1|||
33416448|NCT03387735|101416108|FG000|Overall Study|Lost to Follow-up|4|||
33416449|NCT03387735|101416109|FG001|Overall Study|Lost to Follow-up|8|||
33416450|NCT03387735|101416108|FG000|Overall Study|Death|4|||
33416451|NCT03387735|101416109|FG001|Overall Study|Death|8|||
33416452|NCT00806416|101416119|FG000|Period 1 - Part I|Adverse Event|0|||
33416453|NCT00806416|101416120|FG001|Period 1 - Part I|Adverse Event|1|||
33416454|NCT00806416|101416121|FG002|Period 1 - Part I|Adverse Event|0|||
33416455|NCT00806416|101416122|FG003|Period 1 - Part I|Adverse Event|0|||
33416456|NCT00806416|101416119|FG000|Period 1 - Part I|Lost to Follow-up|0|||
33416457|NCT00806416|101416120|FG001|Period 1 - Part I|Lost to Follow-up|2|||
33416458|NCT00806416|101416121|FG002|Period 1 - Part I|Lost to Follow-up|0|||
33416459|NCT00806416|101416122|FG003|Period 1 - Part I|Lost to Follow-up|0|||
33416460|NCT00806416|101416119|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
33416461|NCT00806416|101416120|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
33416462|NCT00806416|101416121|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
33416463|NCT00806416|101416122|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
33416464|NCT00806416|101416119|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
33416465|NCT00806416|101416120|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
33416466|NCT00806416|101416121|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
33416467|NCT00806416|101416122|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
33416468|NCT02086968|101416125|FG000|Overall Study|Adverse Event|1|||
33416469|NCT02086968|101416126|FG001|Overall Study|Adverse Event|5|||
33416470|NCT02086968|101416125|FG000|Overall Study|Lost to Follow-up|2|||
33416471|NCT02086968|101416126|FG001|Overall Study|Lost to Follow-up|3|||
33416472|NCT02086968|101416125|FG000|Overall Study|Study drug received outside protocol|0|||
33416473|NCT02086968|101416126|FG001|Overall Study|Study drug received outside protocol|1|||
33416474|NCT02086968|101416125|FG000|Overall Study|Physician Decision|4|||
33566421|NCT02014376|101970718|FG000|Overall Study|Adverse Event|1|||
33566422|NCT02014376|101970719|FG001|Overall Study|Adverse Event|1|||
33566423|NCT02014376|101970720|FG002|Overall Study|Adverse Event|0|||
33223216|NCT01852058|100718815|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33416475|NCT02086968|101416126|FG001|Overall Study|Physician Decision|0|||
33416476|NCT02086968|101416125|FG000|Overall Study|Withdrawal by Subject|1|||
33416477|NCT02086968|101416126|FG001|Overall Study|Withdrawal by Subject|4|||
33416478|NCT02998645|101416127|FG000|Treatment Period 1|Adverse Event|6|||
33416479|NCT02998645|101416127|FG000|Treatment Period 1|Death|5|||
33416480|NCT02998645|101416127|FG000|Treatment Period 1|Technical Problems|4|||
33416481|NCT02998645|101416127|FG000|Treatment Period 1|Lack of Efficacy|2|||
33416482|NCT02998645|101416127|FG000|Treatment Period 1|Progressive disease|1|||
33364090|NCT01894516|101220485|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
33364091|NCT01894516|101220482|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
33364092|NCT01894516|101220483|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
33364093|NCT01894516|101220484|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
33364094|NCT01894516|101220485|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
33364095|NCT01894516|101220482|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
33364096|NCT01894516|101220483|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
33364097|NCT01894516|101220484|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
33364098|NCT01894516|101220485|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
33364099|NCT01894516|101220482|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
33364100|NCT01894516|101220483|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
33364101|NCT01894516|101220484|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
33364102|NCT01894516|101220485|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
33364103|NCT01894516|101220482|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
33364104|NCT01894516|101220483|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
33364105|NCT01894516|101220484|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
33630450|NCT05138653|102197772|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
33630451|NCT05138653|102197773|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
33630452|NCT05138653|102197774|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
33630453|NCT05138653|102197775|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
33630454|NCT05138653|102197776|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
33630455|NCT05138653|102197777|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
33630456|NCT05138653|102197762|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33630457|NCT05138653|102197763|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33630458|NCT05138653|102197764|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33364106|NCT01894516|101220485|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
33364107|NCT03918642|101220486|FG000|Overall Study|Lost to Follow-up|12|||
33364108|NCT03918642|101220487|FG001|Overall Study|Lost to Follow-up|10|||
33364109|NCT04329923|101220488|FG000|Overall Study|Withdrawal by Subject|1|||
33364110|NCT04329923|101220489|FG001|Overall Study|Withdrawal by Subject|4|||
33364111|NCT04329923|101220490|FG002|Overall Study|Withdrawal by Subject|1|||
33364112|NCT04329923|101220491|FG003|Overall Study|Withdrawal by Subject|1|||
33364113|NCT04329923|101220492|FG004|Overall Study|Withdrawal by Subject|1|||
33364114|NCT04329923|101220493|FG005|Overall Study|Withdrawal by Subject|1|||
33364115|NCT04329923|101220488|FG000|Overall Study|early termination of study|0|||
33364116|NCT04329923|101220489|FG001|Overall Study|early termination of study|0|||
33364117|NCT04329923|101220490|FG002|Overall Study|early termination of study|0|||
33364118|NCT04329923|101220491|FG003|Overall Study|early termination of study|0|||
33364119|NCT04329923|101220492|FG004|Overall Study|early termination of study|1|||
33364120|NCT04329923|101220493|FG005|Overall Study|early termination of study|2|||
33364121|NCT04329923|101220488|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
33364122|NCT04329923|101220489|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
33364123|NCT04329923|101220490|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
33364124|NCT04329923|101220491|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
33566424|NCT02014376|101970718|FG000|Overall Study|Lost to Follow-up|2|||
33566425|NCT02014376|101970719|FG001|Overall Study|Lost to Follow-up|0|||
33566426|NCT02014376|101970720|FG002|Overall Study|Lost to Follow-up|0|||
33566427|NCT02191618|101970721|FG000|Overall Study|Withdrawal by Subject|3|||
33566428|NCT02191618|101970721|FG000|Overall Study|Missed Visit|4|||
33566429|NCT00654355|101970722|FG000|Overall Study|Lost to Follow-up|2|||
33566430|NCT00654355|101970723|FG001|Overall Study|Lost to Follow-up|2|||
33566431|NCT03802916|101970724|FG000|Overall Study|Adverse Event|0|||
33566432|NCT03802916|101970725|FG001|Overall Study|Adverse Event|1|||
33566433|NCT03802916|101970724|FG000|Overall Study|Withdrawal by Subject|0|||
33566434|NCT03802916|101970725|FG001|Overall Study|Withdrawal by Subject|1|||
33566435|NCT03814044|101970726|FG000|Overall Study|Protocol deviation|1|||
33566436|NCT00542178|101970727|FG000|Overall Study|did not complete year 4 follow-up|75|||
33566437|NCT00542178|101970728|FG001|Overall Study|did not complete year 4 follow-up|80|||
33566438|NCT00542178|101970729|FG002|Overall Study|did not complete year 4 follow-up|74|||
33566439|NCT00542178|101970730|FG003|Overall Study|did not complete year 4 follow-up|62|||
33566440|NCT00542178|101970731|FG004|Overall Study|did not complete year 4 follow-up|64|||
33566441|NCT00542178|101970732|FG005|Overall Study|did not complete year 4 follow-up|89|||
33566442|NCT00542178|101970733|FG006|Overall Study|did not complete year 4 follow-up|87|||
33566443|NCT00542178|101970734|FG007|Overall Study|did not complete year 4 follow-up|85|||
33364125|NCT04329923|101220492|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
33364126|NCT04329923|101220493|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
33364127|NCT00739297|101220498|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
33364128|NCT00739297|101220499|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
33364129|NCT00739297|101220500|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
33566444|NCT00867334|101970735|FG000|Overall Study|Withdrawal by Subject|0|||
33566445|NCT00867334|101970736|FG001|Overall Study|Withdrawal by Subject|1|||
33364130|NCT00739297|101220501|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
33364131|NCT00739297|101220502|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
33364132|NCT00739297|101220503|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
33364133|NCT00739297|101220504|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
33364134|NCT00739297|101220498|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
33364135|NCT00739297|101220499|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
33364136|NCT00739297|101220500|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
33364137|NCT00739297|101220501|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
33364138|NCT00739297|101220502|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
33364139|NCT00739297|101220503|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
33364140|NCT00739297|101220504|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
33364141|NCT02495077|101220505|FG000|Overall Study|Adverse Event|0|||
33364142|NCT02495077|101220506|FG001|Overall Study|Adverse Event|1|||
33364143|NCT02495077|101220507|FG002|Overall Study|Adverse Event|1|||
33364144|NCT02495077|101220508|FG003|Overall Study|Adverse Event|0|||
33364145|NCT02495077|101220505|FG000|Overall Study|Death|3|||
33364146|NCT02495077|101220506|FG001|Overall Study|Death|5|||
33364147|NCT02495077|101220507|FG002|Overall Study|Death|0|||
33364148|NCT02495077|101220508|FG003|Overall Study|Death|0|||
33364149|NCT02495077|101220505|FG000|Overall Study|Lost to Follow-up|6|||
33364150|NCT02495077|101220506|FG001|Overall Study|Lost to Follow-up|4|||
33364151|NCT02495077|101220507|FG002|Overall Study|Lost to Follow-up|0|||
33364152|NCT02495077|101220508|FG003|Overall Study|Lost to Follow-up|0|||
33364153|NCT02495077|101220505|FG000|Overall Study|Physician Decision|2|||
33364154|NCT02495077|101220506|FG001|Overall Study|Physician Decision|1|||
33364155|NCT02495077|101220507|FG002|Overall Study|Physician Decision|4|||
33364156|NCT02495077|101220508|FG003|Overall Study|Physician Decision|0|||
33364157|NCT02495077|101220505|FG000|Overall Study|Protocol Violation|0|||
33364158|NCT02495077|101220506|FG001|Overall Study|Protocol Violation|1|||
33364159|NCT02495077|101220507|FG002|Overall Study|Protocol Violation|0|||
33364160|NCT02495077|101220508|FG003|Overall Study|Protocol Violation|0|||
33364161|NCT02495077|101220505|FG000|Overall Study|Screen Failure|0|||
33364162|NCT02495077|101220506|FG001|Overall Study|Screen Failure|0|||
33630459|NCT05138653|102197765|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33630460|NCT05138653|102197766|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33630461|NCT05138653|102197767|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33630462|NCT05138653|102197768|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33630463|NCT05138653|102197769|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33630464|NCT05138653|102197770|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33630465|NCT05138653|102197771|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33630466|NCT05138653|102197772|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33630467|NCT05138653|102197773|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33630468|NCT05138653|102197774|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33630469|NCT05138653|102197775|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33630470|NCT05138653|102197776|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
33416483|NCT02998645|101416127|FG000|Treatment Period 1|Subject/guardian decision|1|||
33630471|NCT05138653|102197777|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
33364163|NCT02495077|101220507|FG002|Overall Study|Screen Failure|0|||
33364164|NCT02495077|101220508|FG003|Overall Study|Screen Failure|48|||
33364165|NCT02495077|101220505|FG000|Overall Study|Withdrawal by Subject|7|||
33364166|NCT02495077|101220506|FG001|Overall Study|Withdrawal by Subject|7|||
33364167|NCT02495077|101220507|FG002|Overall Study|Withdrawal by Subject|7|||
33364168|NCT02495077|101220508|FG003|Overall Study|Withdrawal by Subject|0|||
33364169|NCT02495077|101220505|FG000|Overall Study|Covid-19 research restrictions|1|||
33364170|NCT02495077|101220506|FG001|Overall Study|Covid-19 research restrictions|0|||
33364171|NCT02495077|101220507|FG002|Overall Study|Covid-19 research restrictions|0|||
33364172|NCT02495077|101220508|FG003|Overall Study|Covid-19 research restrictions|0|||
33364173|NCT02495077|101220505|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
33630472|NCT05138653|102197762|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33630473|NCT05138653|102197763|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33630474|NCT05138653|102197764|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33630475|NCT05138653|102197765|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33630476|NCT05138653|102197766|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33630477|NCT05138653|102197767|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33630478|NCT05138653|102197768|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33416484|NCT02998645|101416127|FG000|Treatment Period 2|Lack of Efficacy|5|||
33416485|NCT02998645|101416127|FG000|Treatment Period 2|Adverse Event|2|||
33416486|NCT02998645|101416127|FG000|Treatment Period 2|Progressive disease|2|||
33416487|NCT02998645|101416127|FG000|Treatment Period 2|Physician Decision|1|||
33416488|NCT00518531|101416131|FG000|Treatment Period 1|Adverse Event|5|||
33416489|NCT00518531|101416132|FG001|Treatment Period 1|Adverse Event|0|||
33630479|NCT05138653|102197769|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33630480|NCT05138653|102197770|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33630481|NCT05138653|102197771|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33416490|NCT00518531|101416131|FG000|Treatment Period 1|Lost to Follow-up|5|||
33416491|NCT00518531|101416132|FG001|Treatment Period 1|Lost to Follow-up|3|||
33416492|NCT00518531|101416131|FG000|Treatment Period 1|Physician Decision|1|||
33416493|NCT00518531|101416132|FG001|Treatment Period 1|Physician Decision|0|||
33416494|NCT00518531|101416131|FG000|Treatment Period 1|Protocol Violation|2|||
33364174|NCT02495077|101220506|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
33364175|NCT02495077|101220507|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
33364176|NCT02495077|101220508|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
33364177|NCT02495077|101220505|FG000|Overall Study|Incarcerated|0|||
33364178|NCT02495077|101220506|FG001|Overall Study|Incarcerated|1|||
33364179|NCT02495077|101220507|FG002|Overall Study|Incarcerated|0|||
33364180|NCT02495077|101220508|FG003|Overall Study|Incarcerated|0|||
33364181|NCT02495077|101220505|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
33364182|NCT02495077|101220506|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
33416495|NCT00518531|101416132|FG001|Treatment Period 1|Protocol Violation|0|||
33416496|NCT00518531|101416131|FG000|Treatment Period 1|Withdrawal by Subject|4|||
33416497|NCT00518531|101416132|FG001|Treatment Period 1|Withdrawal by Subject|6|||
33416498|NCT00518531|101416131|FG000|Treatment Period 1|Early crossover|1|||
33416499|NCT00518531|101416132|FG001|Treatment Period 1|Early crossover|3|||
33364183|NCT02495077|101220507|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
33364184|NCT02495077|101220508|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
33364185|NCT02495077|101220505|FG000|Overall Study|Timing of transplant and randomization|0|||
33364186|NCT02495077|101220506|FG001|Overall Study|Timing of transplant and randomization|0|||
33364187|NCT02495077|101220507|FG002|Overall Study|Timing of transplant and randomization|5|||
33364188|NCT02495077|101220508|FG003|Overall Study|Timing of transplant and randomization|0|||
33364189|NCT00430781|101220513|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
33364190|NCT00430781|101220514|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
33364191|NCT00430781|101220515|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
33364192|NCT00430781|101220513|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
33364193|NCT00430781|101220514|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
33364194|NCT00430781|101220515|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
33364195|NCT00430781|101220513|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
33416500|NCT00518531|101416131|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33416501|NCT00518531|101416132|FG001|Treatment Period 2|Withdrawal by Subject|8|||
33416502|NCT00518531|101416131|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
33416503|NCT00518531|101416132|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
33416504|NCT00518531|101416131|FG000|Treatment Period 2|Adverse Event|1|||
33416505|NCT00518531|101416132|FG001|Treatment Period 2|Adverse Event|7|||
33223217|NCT01852058|100718816|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33223218|NCT01852058|100718817|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33223219|NCT01852058|100718818|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33223220|NCT01852058|100718819|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33223221|NCT01852058|100718820|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33223222|NCT01852058|100718821|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
33223223|NCT01852058|100718810|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33223224|NCT01852058|100718811|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33223225|NCT01852058|100718812|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33223226|NCT01852058|100718813|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33223227|NCT01852058|100718814|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
33223228|NCT01852058|100718815|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
33223229|NCT01852058|100718816|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33416506|NCT00518531|101416131|FG000|Treatment Period 2|Protocol-specified criteria|0|||
33416507|NCT00518531|101416132|FG001|Treatment Period 2|Protocol-specified criteria|1|||
33416508|NCT00518531|101416131|FG000|Treatment Period 2|Non-compliance|1|||
33416509|NCT00518531|101416132|FG001|Treatment Period 2|Non-compliance|2|||
33416510|NCT02594384|101416139|FG000|Overall Study|Disease Progression|3|||
33416511|NCT02594384|101416140|FG001|Overall Study|Disease Progression|7|||
33416512|NCT02594384|101416141|FG002|Overall Study|Disease Progression|0|||
33416513|NCT02594384|101416142|FG003|Overall Study|Disease Progression|2|||
33416514|NCT02594384|101416143|FG004|Overall Study|Disease Progression|2|||
33416515|NCT02594384|101416144|FG005|Overall Study|Disease Progression|12|||
33416516|NCT02594384|101416145|FG006|Overall Study|Disease Progression|5|||
33416517|NCT02594384|101416146|FG007|Overall Study|Disease Progression|5|||
33416518|NCT02594384|101416139|FG000|Overall Study|Adverse Event|0|||
33416519|NCT02594384|101416140|FG001|Overall Study|Adverse Event|1|||
33416520|NCT02594384|101416141|FG002|Overall Study|Adverse Event|4|||
33416521|NCT02594384|101416142|FG003|Overall Study|Adverse Event|1|||
33416522|NCT02594384|101416143|FG004|Overall Study|Adverse Event|0|||
33416523|NCT02594384|101416144|FG005|Overall Study|Adverse Event|6|||
33566446|NCT00867334|101970735|FG000|Overall Study|Withdrawal by Subject|1|||
33566447|NCT00867334|101970736|FG001|Overall Study|Withdrawal by Subject|0|||
33566448|NCT00867334|101970735|FG000|Overall Study|Withdrawal by Subject|1|||
33566449|NCT00867334|101970736|FG001|Overall Study|Withdrawal by Subject|0|||
33566450|NCT04992273|101970747|FG000|Overall Study|Lost to Follow-up|0|||
33416524|NCT02594384|101416145|FG006|Overall Study|Adverse Event|1|||
33416525|NCT02594384|101416146|FG007|Overall Study|Adverse Event|1|||
33416526|NCT02594384|101416139|FG000|Overall Study|Withdrawal by Subject|0|||
33566451|NCT04992273|101970748|FG001|Overall Study|Lost to Follow-up|1|||
33566452|NCT02157610|101970749|FG000|Overall Study|Death|4|||
33566453|NCT02157610|101970750|FG001|Overall Study|Death|4|||
33416527|NCT02594384|101416140|FG001|Overall Study|Withdrawal by Subject|0|||
33416528|NCT02594384|101416141|FG002|Overall Study|Withdrawal by Subject|0|||
33416529|NCT02594384|101416142|FG003|Overall Study|Withdrawal by Subject|1|||
33416530|NCT02594384|101416143|FG004|Overall Study|Withdrawal by Subject|0|||
33416531|NCT02594384|101416144|FG005|Overall Study|Withdrawal by Subject|0|||
33416532|NCT02594384|101416145|FG006|Overall Study|Withdrawal by Subject|0|||
33416533|NCT02594384|101416146|FG007|Overall Study|Withdrawal by Subject|1|||
33416534|NCT02594384|101416139|FG000|Overall Study|Physician Decision|0|||
33416535|NCT02594384|101416140|FG001|Overall Study|Physician Decision|0|||
33416536|NCT02594384|101416141|FG002|Overall Study|Physician Decision|0|||
33416537|NCT02594384|101416142|FG003|Overall Study|Physician Decision|0|||
33416538|NCT02594384|101416143|FG004|Overall Study|Physician Decision|0|||
33416539|NCT02594384|101416144|FG005|Overall Study|Physician Decision|1|||
33416540|NCT02594384|101416145|FG006|Overall Study|Physician Decision|2|||
33416541|NCT02594384|101416146|FG007|Overall Study|Physician Decision|0|||
33416542|NCT02594384|101416139|FG000|Overall Study|Progressive Leukocytosis|0|||
33416543|NCT02594384|101416140|FG001|Overall Study|Progressive Leukocytosis|0|||
33566454|NCT05293717|101970752|FG000|Overall Study|Physician Decision|1|||
33416544|NCT02594384|101416141|FG002|Overall Study|Progressive Leukocytosis|1|||
33416545|NCT02594384|101416142|FG003|Overall Study|Progressive Leukocytosis|0|||
33416546|NCT02594384|101416143|FG004|Overall Study|Progressive Leukocytosis|0|||
33416547|NCT02594384|101416144|FG005|Overall Study|Progressive Leukocytosis|0|||
33566455|NCT04540367|101970753|FG000|Overall Study|Withdrawal by Subject|0|||
33416548|NCT02594384|101416145|FG006|Overall Study|Progressive Leukocytosis|0|||
33566456|NCT04540367|101970754|FG001|Overall Study|Withdrawal by Subject|0|||
33416549|NCT02594384|101416146|FG007|Overall Study|Progressive Leukocytosis|0|||
33566457|NCT04540367|101970755|FG002|Overall Study|Withdrawal by Subject|0|||
33566458|NCT04540367|101970756|FG003|Overall Study|Withdrawal by Subject|2|||
33416550|NCT02594384|101416139|FG000|Overall Study|Lack of Efficacy|0|||
33223230|NCT01852058|100718817|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33223231|NCT01852058|100718818|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33364196|NCT00430781|101220514|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
33223232|NCT01852058|100718819|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33223233|NCT01852058|100718820|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33223234|NCT01852058|100718821|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
33223235|NCT01852058|100718810|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33223236|NCT01852058|100718811|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33223237|NCT01852058|100718812|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33223238|NCT01852058|100718813|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33223239|NCT01852058|100718814|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33223240|NCT01852058|100718815|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33223241|NCT01852058|100718816|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33223242|NCT01852058|100718817|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
33223243|NCT01852058|100718818|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33223244|NCT01852058|100718819|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33223245|NCT01852058|100718820|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33223246|NCT01852058|100718821|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
33223247|NCT01852058|100718810|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33223248|NCT01852058|100718811|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33223249|NCT01852058|100718812|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33223250|NCT01852058|100718813|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33223251|NCT01852058|100718814|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33223252|NCT01852058|100718815|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33223253|NCT01852058|100718816|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33223254|NCT01852058|100718817|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33223255|NCT01852058|100718818|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
33223256|NCT01852058|100718819|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33223257|NCT01852058|100718820|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33223258|NCT01852058|100718821|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
33223259|NCT03502616|100718822|FG000|Up to Week 16|Withdrawal by Subject|1|||
33223260|NCT03502616|100718823|FG001|Up to Week 16|Withdrawal by Subject|2|||
33223261|NCT03502616|100718822|FG000|Up to Week 16|Lost to Follow-up|0|||
33223262|NCT03502616|100718823|FG001|Up to Week 16|Lost to Follow-up|1|||
33223263|NCT03502616|100718822|FG000|Up to Week 16|Randomized, but not treated|1|||
33223264|NCT03502616|100718823|FG001|Up to Week 16|Randomized, but not treated|0|||
33566459|NCT04540367|101970753|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
33566460|NCT04540367|101970754|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
33566461|NCT04540367|101970755|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
33223265|NCT03502616|100718822|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
33223266|NCT03502616|100718823|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
33223267|NCT03502616|100718822|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
33223268|NCT03502616|100718823|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
33223269|NCT01529008|100718830|FG000|Bone Marrow Harvesting|Physician Decision|1|||
33416551|NCT02594384|101416140|FG001|Overall Study|Lack of Efficacy|0|||
33416552|NCT02594384|101416141|FG002|Overall Study|Lack of Efficacy|0|||
33223270|NCT01529008|100718831|FG001|Bone Marrow Harvesting|Physician Decision|1|||
33223271|NCT01529008|100718830|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
33223272|NCT01529008|100718831|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
33223273|NCT01529008|100718830|FG000|Treatment|Adverse Event|6|||
33223274|NCT01529008|100718831|FG001|Treatment|Adverse Event|0|||
33223275|NCT01529008|100718830|FG000|Treatment|Other|3|||
33223276|NCT01529008|100718831|FG001|Treatment|Other|1|||
33223277|NCT01529008|100718830|FG000|Efficacy Analysis|Protocol Violation|2|||
33223278|NCT01529008|100718831|FG001|Efficacy Analysis|Protocol Violation|0|||
33223279|NCT01529008|100718830|FG000|Efficacy Analysis|Physician Decision|0|||
33223280|NCT01529008|100718831|FG001|Efficacy Analysis|Physician Decision|1|||
33223281|NCT01529008|100718830|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
33364197|NCT00430781|101220515|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
33364198|NCT00430781|101220513|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
33364199|NCT00430781|101220514|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
33364200|NCT00430781|101220515|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
33364201|NCT00430781|101220513|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
33364202|NCT00430781|101220514|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
33364203|NCT00430781|101220515|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
33364204|NCT00430781|101220513|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
33364205|NCT00430781|101220514|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
33364206|NCT00430781|101220515|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
33364207|NCT00430781|101220513|FG000|Interim Analysis; 11 February 2008|Death|0|||
33364208|NCT00430781|101220514|FG001|Interim Analysis; 11 February 2008|Death|1|||
33364209|NCT00430781|101220515|FG002|Interim Analysis; 11 February 2008|Death|0|||
33364210|NCT00430781|101220513|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
33416553|NCT02594384|101416142|FG003|Overall Study|Lack of Efficacy|0|||
33416554|NCT02594384|101416143|FG004|Overall Study|Lack of Efficacy|1|||
33364211|NCT00430781|101220514|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
33364212|NCT00430781|101220515|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
33364213|NCT00430781|101220513|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
33364214|NCT00430781|101220514|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
33364215|NCT00430781|101220515|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
33364216|NCT00430781|101220513|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
33364217|NCT00430781|101220514|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
33364218|NCT00430781|101220515|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
33364219|NCT00430781|101220513|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
33364220|NCT00430781|101220514|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
33364221|NCT00430781|101220515|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
33364222|NCT00430781|101220513|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
33364223|NCT00430781|101220514|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
33364224|NCT00430781|101220515|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
33364225|NCT00430781|101220513|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
33364226|NCT00430781|101220514|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
33364227|NCT00430781|101220515|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
33416555|NCT02594384|101416144|FG005|Overall Study|Lack of Efficacy|0|||
33416556|NCT02594384|101416145|FG006|Overall Study|Lack of Efficacy|0|||
33566462|NCT04540367|101970756|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
33566463|NCT04540367|101970753|FG000|Overall Study|Adverse Event|0|||
33223282|NCT01529008|100718831|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
33223283|NCT02309112|100718842|FG000|Overall Study|Withdrawal by Subject|1|||
33223284|NCT02309112|100718843|FG001|Overall Study|Withdrawal by Subject|0|||
33223285|NCT02309112|100718844|FG002|Overall Study|Withdrawal by Subject|1|||
33223286|NCT02309112|100718842|FG000|Overall Study|Lost to Follow-up|0|||
33566464|NCT04540367|101970754|FG001|Overall Study|Adverse Event|0|||
33566465|NCT04540367|101970755|FG002|Overall Study|Adverse Event|1|||
33566466|NCT04540367|101970756|FG003|Overall Study|Adverse Event|1|||
33566467|NCT02371889|101970758|FG000|Overall Study|Adverse medication effect|11|||
33566468|NCT02371889|101970759|FG001|Overall Study|Adverse medication effect|2|||
33566469|NCT02371889|101970758|FG000|Overall Study|Lost to Follow-up|6|||
33566470|NCT02371889|101970759|FG001|Overall Study|Lost to Follow-up|5|||
33566471|NCT02371889|101970758|FG000|Overall Study|Personal time constraints|2|||
33566472|NCT02371889|101970759|FG001|Overall Study|Personal time constraints|4|||
33364228|NCT00430781|101220513|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
33364229|NCT00430781|101220514|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
33364230|NCT00430781|101220515|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
33364231|NCT00430781|101220513|FG000|Final Analysis; 31 July 2008|Other|0|||
33364232|NCT00430781|101220514|FG001|Final Analysis; 31 July 2008|Other|1|||
33364233|NCT00430781|101220515|FG002|Final Analysis; 31 July 2008|Other|0|||
33364234|NCT00430781|101220513|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
33364235|NCT00430781|101220514|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
33364236|NCT00430781|101220515|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
33364237|NCT00430781|101220513|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
33364238|NCT00430781|101220514|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
33416557|NCT02594384|101416146|FG007|Overall Study|Lack of Efficacy|0|||
33416558|NCT02594384|101416139|FG000|Overall Study|Substantial noncompliance|0|||
33416559|NCT02594384|101416140|FG001|Overall Study|Substantial noncompliance|0|||
33416560|NCT02594384|101416141|FG002|Overall Study|Substantial noncompliance|0|||
33416561|NCT02594384|101416142|FG003|Overall Study|Substantial noncompliance|0|||
33416562|NCT02594384|101416143|FG004|Overall Study|Substantial noncompliance|0|||
33416563|NCT02594384|101416144|FG005|Overall Study|Substantial noncompliance|0|||
33416564|NCT02594384|101416145|FG006|Overall Study|Substantial noncompliance|1|||
33416565|NCT02594384|101416146|FG007|Overall Study|Substantial noncompliance|0|||
33416566|NCT00057330|101416147|FG000|Overall Study|Adverse Event|9|||
33416567|NCT00057330|101416148|FG001|Overall Study|Adverse Event|12|||
33416568|NCT00057330|101416147|FG000|Overall Study|Death|1|||
33416569|NCT00057330|101416148|FG001|Overall Study|Death|0|||
33416570|NCT00057330|101416147|FG000|Overall Study|Protocol Violation|1|||
33416571|NCT00057330|101416148|FG001|Overall Study|Protocol Violation|1|||
33416572|NCT00057330|101416147|FG000|Overall Study|Withdrawal by Subject|115|||
33416573|NCT00057330|101416148|FG001|Overall Study|Withdrawal by Subject|84|||
33566473|NCT02371889|101970758|FG000|Overall Study|Lack of Efficacy|0|||
33566474|NCT02371889|101970759|FG001|Overall Study|Lack of Efficacy|2|||
33566475|NCT02371889|101970758|FG000|Overall Study|Relapse|0|||
33566476|NCT02371889|101970759|FG001|Overall Study|Relapse|1|||
33566477|NCT00967499|101970760|FG000|Overall Study|Adverse Event|0|||
33566478|NCT00967499|101970761|FG001|Overall Study|Adverse Event|1|||
33566479|NCT00967499|101970760|FG000|Overall Study|Protocol Violation|1|||
33566480|NCT00967499|101970761|FG001|Overall Study|Protocol Violation|0|||
33566481|NCT00967499|101970760|FG000|Overall Study|Sponsor Decision|1|||
33566482|NCT00967499|101970761|FG001|Overall Study|Sponsor Decision|0|||
33566483|NCT00967499|101970760|FG000|Overall Study|Randomized but not treated|63|||
33566484|NCT00967499|101970761|FG001|Overall Study|Randomized but not treated|59|||
33566485|NCT00889005|101970762|FG000|Overall Study|Lost to Follow-up|4|||
33566486|NCT00889005|101970763|FG001|Overall Study|Lost to Follow-up|2|||
33566487|NCT00889005|101970762|FG000|Overall Study|Withdrawal by Subject|4|||
33566488|NCT00889005|101970763|FG001|Overall Study|Withdrawal by Subject|0|||
33566489|NCT00654732|101970764|FG000|Overall Study|Adverse Event|4|||
33566490|NCT00654732|101970765|FG001|Overall Study|Adverse Event|6|||
33566491|NCT03032484|101970766|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
33566492|NCT03032484|101970767|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
33566493|NCT03032484|101970766|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
33566494|NCT03032484|101970767|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
33566495|NCT03341936|101970768|FG000|Overall Study|Ineligible|1|||
33566496|NCT03341936|101970768|FG000|Overall Study|Disease Progression|2|||
33630482|NCT05138653|102197772|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33223287|NCT02309112|100718843|FG001|Overall Study|Lost to Follow-up|1|||
33223288|NCT02309112|100718844|FG002|Overall Study|Lost to Follow-up|0|||
33223289|NCT01480596|100718845|FG000|Overall Study|Adverse Event|3|||
33223290|NCT01480596|100718846|FG001|Overall Study|Adverse Event|0|||
33223291|NCT01480596|100718845|FG000|Overall Study|MG exacerbation or change in medication|2|||
33223292|NCT01480596|100718846|FG001|Overall Study|MG exacerbation or change in medication|2|||
33223293|NCT03439189|100718847|FG000|Overall Study|Protocol Violation|19|||
33223294|NCT03439189|100718847|FG000|Overall Study|Lack of Efficacy|63|||
33223295|NCT03929562|100718848|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
33223296|NCT03929562|100718849|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
33223297|NCT03929562|100718848|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
33223298|NCT03929562|100718849|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
33223299|NCT03929562|100718848|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
33223300|NCT03929562|100718849|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
33223301|NCT01960725|100718853|FG000|Overall Study|Lost to Follow-up|4|||
33223302|NCT01960725|100718854|FG001|Overall Study|Lost to Follow-up|3|||
33223303|NCT01960725|100718853|FG000|Overall Study|Withdrawal by Subject|1|||
33416574|NCT00057330|101416147|FG000|Overall Study|Lost to Follow-up|745|||
33416575|NCT00057330|101416148|FG001|Overall Study|Lost to Follow-up|617|||
33566497|NCT03341936|101970768|FG000|Overall Study|Withdrew Consent|4|||
33566498|NCT03341936|101970768|FG000|Overall Study|Non-Compliance|1|||
33566499|NCT03341936|101970768|FG000|Overall Study|Physician Decision|1|||
33566500|NCT03341936|101970768|FG000|Overall Study|Withdrawal by Subject|1|||
33416576|NCT00057330|101416147|FG000|Overall Study|Physician Decision|1|||
33416577|NCT00057330|101416148|FG001|Overall Study|Physician Decision|0|||
33416578|NCT00057330|101416147|FG000|Overall Study|Other|260|||
33416579|NCT00057330|101416148|FG001|Overall Study|Other|206|||
33416580|NCT02949219|101416149|FG000|Overall Study|Withdrawal by Subject|1|||
33416581|NCT01268683|101416152|FG000|Overall Study|Lost to Follow-up|1|||
33416582|NCT01268683|101416152|FG000|Overall Study|Death|1|||
33416583|NCT02325401|101416157|FG000|Overall Study|Withdrawal by Subject|0|||
33416584|NCT02325401|101416158|FG001|Overall Study|Withdrawal by Subject|1|||
33416585|NCT02325401|101416159|FG002|Overall Study|Withdrawal by Subject|1|||
33416586|NCT04854707|101416165|FG000|Overall Study|Lack of Efficacy|78|||
33416587|NCT04854707|101416166|FG001|Overall Study|Lack of Efficacy|59|||
33416588|NCT04854707|101416167|FG002|Overall Study|Lack of Efficacy|30|||
33416589|NCT03255226|101416168|FG000|Overall Study|Adverse Event|2|||
33416590|NCT03255226|101416168|FG000|Overall Study|Physician Decision|3|||
33416591|NCT03255226|101416168|FG000|Overall Study|Withdrawal by Subject|1|||
33416592|NCT03255226|101416168|FG000|Overall Study|Serum or blood sodium increased|4|||
33416593|NCT03255226|101416168|FG000|Overall Study|Serum or blood potassium increased|4|||
33364239|NCT00430781|101220515|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
33364240|NCT00430781|101220513|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
33364241|NCT00430781|101220514|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
33364242|NCT00430781|101220515|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
33416594|NCT01071083|101416169|FG000|Overall Study|Adverse Event|1|||
33364243|NCT00430781|101220513|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
33364244|NCT00430781|101220514|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
33364245|NCT00430781|101220515|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
33364246|NCT00430781|101220513|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
33364247|NCT00430781|101220514|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
33364248|NCT00430781|101220515|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
33364249|NCT00430781|101220513|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
33364250|NCT00430781|101220514|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
33364251|NCT00430781|101220515|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
33364252|NCT00430781|101220513|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
33364253|NCT00430781|101220514|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
33364254|NCT00430781|101220515|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
33364255|NCT00616239|101220516|FG000|Overall Study|Withdrawal by Subject|2|||
33364256|NCT03090191|101220517|FG000|Overall Study|Adverse Event|90|||
33364257|NCT03090191|101220518|FG001|Overall Study|Adverse Event|72|||
33364258|NCT03090191|101220517|FG000|Overall Study|Death|365|||
33364259|NCT03090191|101220518|FG001|Overall Study|Death|358|||
33364260|NCT03090191|101220517|FG000|Overall Study|Lost to Follow-up|382|||
33364261|NCT03090191|101220518|FG001|Overall Study|Lost to Follow-up|394|||
33364262|NCT03090191|101220517|FG000|Overall Study|Physician Decision|77|||
33364263|NCT03090191|101220518|FG001|Overall Study|Physician Decision|66|||
33364264|NCT03090191|101220517|FG000|Overall Study|Protocol Violation|43|||
33364265|NCT03090191|101220518|FG001|Overall Study|Protocol Violation|52|||
33364266|NCT03090191|101220517|FG000|Overall Study|Withdrawal by Subject|2160|||
33364267|NCT03090191|101220518|FG001|Overall Study|Withdrawal by Subject|2133|||
33364268|NCT03090191|101220517|FG000|Overall Study|Site terminated|7|||
33364269|NCT03090191|101220518|FG001|Overall Study|Site terminated|8|||
33364270|NCT03090191|101220517|FG000|Overall Study|Other|66|||
33364271|NCT03090191|101220518|FG001|Overall Study|Other|60|||
33364272|NCT03090191|101220517|FG000|Overall Study|Withdrawn before any study vaccination|43|||
33364273|NCT03090191|101220518|FG001|Overall Study|Withdrawn before any study vaccination|52|||
33364274|NCT00530712|101220520|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
33364275|NCT00530712|101220520|FG000|30 Day Follow-up Visit|Missed Visit|5|||
33364276|NCT00530712|101220520|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
33416595|NCT01071083|101416170|FG001|Overall Study|Adverse Event|0|||
33416596|NCT01071083|101416171|FG002|Overall Study|Adverse Event|1|||
33416597|NCT01071083|101416172|FG003|Overall Study|Adverse Event|0|||
33416598|NCT01071083|101416173|FG004|Overall Study|Adverse Event|1|||
33416599|NCT01071083|101416169|FG000|Overall Study|Withdrawal by Subject|3|||
33416600|NCT01071083|101416170|FG001|Overall Study|Withdrawal by Subject|0|||
33630483|NCT05138653|102197773|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33364277|NCT00530712|101220520|FG000|6 Month Follow-up Visit|Missed Visit|3|||
33364278|NCT00530712|101220520|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
33364279|NCT00530712|101220520|FG000|6 Month Follow-up Visit|Death|2|||
33364280|NCT00530712|101220520|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
33364281|NCT00530712|101220520|FG000|12 Month Follow-up Visit|Missed Visit|3|||
33364282|NCT00530712|101220520|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
33416601|NCT01071083|101416171|FG002|Overall Study|Withdrawal by Subject|2|||
33416602|NCT01071083|101416172|FG003|Overall Study|Withdrawal by Subject|0|||
33416603|NCT01071083|101416173|FG004|Overall Study|Withdrawal by Subject|3|||
33416604|NCT01071083|101416169|FG000|Overall Study|Physician Decision|1|||
33416605|NCT01071083|101416170|FG001|Overall Study|Physician Decision|0|||
33630484|NCT05138653|102197774|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33630485|NCT05138653|102197775|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
33630486|NCT05138653|102197776|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33630487|NCT05138653|102197777|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
33630488|NCT02521285|102197778|FG000|Overall Study|Lost to Follow-up|1|||
33630489|NCT02521285|102197779|FG001|Overall Study|Lost to Follow-up|1|||
33630490|NCT02521285|102197778|FG000|Overall Study|Withdrawal by Subject|1|||
33630491|NCT02521285|102197779|FG001|Overall Study|Withdrawal by Subject|1|||
33630492|NCT02521285|102197778|FG000|Overall Study|Adverse Event|0|||
33630493|NCT02521285|102197779|FG001|Overall Study|Adverse Event|1|||
33630494|NCT03524612|102197781|FG000|Overall Study|Lack of Efficacy|10|||
33630495|NCT03524612|102197781|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
33630496|NCT03524612|102197781|FG000|Overall Study|Adverse Event|10|||
33630497|NCT03524612|102197781|FG000|Overall Study|Withdrawal by Subject|7|||
33630498|NCT03524612|102197781|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
33364283|NCT00530712|101220520|FG000|12 Month Follow-up Visit|Death|9|||
33364284|NCT00370149|101220521|FG000|Overall Study|Physician Decision|16|||
33364285|NCT00370149|101220522|FG001|Overall Study|Physician Decision|16|||
33364286|NCT00370149|101220521|FG000|Overall Study|Protocol Violation|1|||
33364287|NCT00370149|101220522|FG001|Overall Study|Protocol Violation|0|||
33364288|NCT00370149|101220521|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
33364289|NCT00370149|101220522|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
33364290|NCT00370149|101220521|FG000|Overall Study|Pre-existing infection|0|||
33364291|NCT00370149|101220522|FG001|Overall Study|Pre-existing infection|1|||
33364292|NCT00370149|101220521|FG000|Overall Study|Antibiotic coated dressing placed|0|||
33364293|NCT00370149|101220522|FG001|Overall Study|Antibiotic coated dressing placed|1|||
33364294|NCT00942877|101220523|FG000|Overall Study|Refused further treatment|1|||
33364295|NCT00942877|101220524|FG001|Overall Study|Refused further treatment|1|||
33364296|NCT00942877|101220523|FG000|Overall Study|Patient was not treated|1|||
33364297|NCT00942877|101220524|FG001|Overall Study|Patient was not treated|0|||
33364298|NCT00942877|101220523|FG000|Overall Study|Adverse Event|1|||
33364299|NCT00942877|101220524|FG001|Overall Study|Adverse Event|0|||
33364300|NCT00942877|101220523|FG000|Overall Study|Progressive disease|42|||
33364301|NCT00942877|101220524|FG001|Overall Study|Progressive disease|3|||
33364302|NCT02225223|101220525|FG000|Overall Study|Death|10|||
33364303|NCT02225223|101220526|FG001|Overall Study|Death|1|||
33364304|NCT02225223|101220525|FG000|Overall Study|Lost to Follow-up|5|||
33364305|NCT02225223|101220526|FG001|Overall Study|Lost to Follow-up|0|||
33364306|NCT02225223|101220525|FG000|Overall Study|Other|1|||
33364307|NCT02225223|101220526|FG001|Overall Study|Other|2|||
33364308|NCT02225223|101220525|FG000|Overall Study|Physician Decision|1|||
33364309|NCT02225223|101220526|FG001|Overall Study|Physician Decision|0|||
33364310|NCT02225223|101220525|FG000|Overall Study|Withdrawal by Subject|2|||
33364311|NCT02225223|101220526|FG001|Overall Study|Withdrawal by Subject|2|||
33364312|NCT04156646|101220529|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
33364313|NCT04156646|101220530|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
33364314|NCT03290300|101220531|FG000|Overall Study|Lost to Follow-up|3|||
33364315|NCT02046564|101220532|FG000|Overall Study|Adverse Event|6|||
33416606|NCT01071083|101416171|FG002|Overall Study|Physician Decision|0|||
33630499|NCT03524612|102197781|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
33630500|NCT03524612|102197781|FG000|Overall Study|New therapy for study indication|6|||
33223304|NCT01960725|100718854|FG001|Overall Study|Withdrawal by Subject|0|||
33630501|NCT03524612|102197781|FG000|Overall Study|Death|3|||
33630502|NCT03524612|102197781|FG000|Overall Study|Lost to Follow-up|2|||
33364316|NCT02046564|101220533|FG001|Overall Study|Adverse Event|3|||
33364317|NCT02046564|101220532|FG000|Overall Study|Physician Decision|0|||
33364318|NCT02046564|101220533|FG001|Overall Study|Physician Decision|1|||
33364319|NCT02046564|101220532|FG000|Overall Study|Protocol Violation|3|||
33364320|NCT02046564|101220533|FG001|Overall Study|Protocol Violation|1|||
33364321|NCT02046564|101220532|FG000|Overall Study|Withdrawal by Subject|4|||
33364322|NCT02046564|101220533|FG001|Overall Study|Withdrawal by Subject|10|||
33364323|NCT02046564|101220532|FG000|Overall Study|Subject met withdrawal criteria|2|||
33630503|NCT03524612|102197781|FG000|Overall Study|Protocol Violation|1|||
33364324|NCT02046564|101220533|FG001|Overall Study|Subject met withdrawal criteria|5|||
33630504|NCT04065048|102197783|FG000|Overall Study|Withdrawal by Subject|1|||
33630505|NCT04065048|102197784|FG001|Overall Study|Withdrawal by Subject|2|||
33416607|NCT01071083|101416172|FG003|Overall Study|Physician Decision|1|||
33416608|NCT01071083|101416173|FG004|Overall Study|Physician Decision|1|||
33416609|NCT01071083|101416169|FG000|Overall Study|Early Rescue|1|||
33416610|NCT01071083|101416170|FG001|Overall Study|Early Rescue|0|||
33566501|NCT03341936|101970768|FG000|Overall Study|Other|1|||
33566502|NCT03038087|101970769|FG000|Overall Study|lost data|1|||
33364325|NCT00723840|101220534|FG000|Overall Study|Lost to Follow-up|2|||
33364326|NCT00723840|101220534|FG000|Overall Study|Failure to return|18|||
33364327|NCT00723840|101220534|FG000|Overall Study|Withdrawal by Subject|55|||
33364328|NCT00723840|101220534|FG000|Overall Study|Serious Adverse Events|3|||
33364329|NCT00723840|101220534|FG000|Overall Study|Other Medical Event|2|||
33364330|NCT00723840|101220534|FG000|Overall Study|Unspecified reason|2|||
33364331|NCT02927171|101220535|FG000|Overall Study|Lost to Follow-up|0|||
33364332|NCT02927171|101220536|FG001|Overall Study|Lost to Follow-up|1|||
33364333|NCT00791128|101220537|FG000|Overall Study|Adverse Event|4|||
33364334|NCT00791128|101220537|FG000|Overall Study|Device migration|2|||
33364335|NCT00791128|101220537|FG000|Overall Study|non-compliance by subject|2|||
33364336|NCT00791128|101220537|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
33364337|NCT01221233|101220540|FG000|Overall Study|Withdrawal by Subject|3|||
33364338|NCT01221233|101220541|FG001|Overall Study|Withdrawal by Subject|1|||
33364339|NCT05032157|101220542|FG000|Overall Study|Adverse Event|12|||
33364340|NCT05032157|101220543|FG001|Overall Study|Adverse Event|7|||
33364341|NCT05032157|101220542|FG000|Overall Study|Pregnancy|0|||
33364342|NCT05032157|101220543|FG001|Overall Study|Pregnancy|2|||
33364343|NCT05032157|101220542|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33364344|NCT05032157|101220543|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
33364345|NCT05032157|101220542|FG000|Overall Study|Protocol Deviation|8|||
33364346|NCT05032157|101220543|FG001|Overall Study|Protocol Deviation|4|||
33364347|NCT05032157|101220542|FG000|Overall Study|Lost to Follow-up|1|||
33364348|NCT05032157|101220543|FG001|Overall Study|Lost to Follow-up|3|||
33364349|NCT05032157|101220542|FG000|Overall Study|Physician Decision|7|||
33364350|NCT05032157|101220543|FG001|Overall Study|Physician Decision|2|||
33364351|NCT05032157|101220542|FG000|Overall Study|Patient Decision|38|||
33364352|NCT05032157|101220543|FG001|Overall Study|Patient Decision|19|||
33364353|NCT04952389|101220549|FG000|Overall Study|Withdrawal by Subject|8|||
33364354|NCT04952389|101220550|FG001|Overall Study|Withdrawal by Subject|4|||
33364355|NCT01978912|101220553|FG000|Overall Study|Adverse Event|0|||
33364356|NCT01978912|101220554|FG001|Overall Study|Adverse Event|1|||
33364357|NCT01978912|101220555|FG002|Overall Study|Adverse Event|0|||
33364358|NCT01978912|101220556|FG003|Overall Study|Adverse Event|0|||
33364359|NCT01978912|101220553|FG000|Overall Study|Lost to Follow-up|1|||
33364360|NCT01978912|101220554|FG001|Overall Study|Lost to Follow-up|1|||
33364361|NCT01978912|101220555|FG002|Overall Study|Lost to Follow-up|0|||
33364362|NCT01978912|101220556|FG003|Overall Study|Lost to Follow-up|1|||
33364363|NCT01978912|101220553|FG000|Overall Study|Withdrawal by Subject|1|||
33416611|NCT01071083|101416171|FG002|Overall Study|Early Rescue|0|||
33416612|NCT01071083|101416172|FG003|Overall Study|Early Rescue|0|||
33416613|NCT01071083|101416173|FG004|Overall Study|Early Rescue|1|||
33416614|NCT01071083|101416169|FG000|Overall Study|Subject Moved|0|||
33566503|NCT00982280|101970771|FG000|Observation Period|Not eligible to be dosed|19|||
33566504|NCT00982280|101970771|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
33566505|NCT00982280|101970771|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
33566506|NCT00982280|101970771|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
33566507|NCT00982280|101970771|FG000|Maintenance Period|Adverse Event|1|||
33416615|NCT01071083|101416170|FG001|Overall Study|Subject Moved|1|||
33416616|NCT01071083|101416171|FG002|Overall Study|Subject Moved|0|||
33416617|NCT01071083|101416172|FG003|Overall Study|Subject Moved|0|||
33416618|NCT01071083|101416173|FG004|Overall Study|Subject Moved|0|||
33364364|NCT01978912|101220554|FG001|Overall Study|Withdrawal by Subject|0|||
33364365|NCT01978912|101220555|FG002|Overall Study|Withdrawal by Subject|2|||
33364366|NCT01978912|101220556|FG003|Overall Study|Withdrawal by Subject|2|||
33364367|NCT01978912|101220553|FG000|Overall Study|Lumbar Surgery|1|||
33364368|NCT01978912|101220554|FG001|Overall Study|Lumbar Surgery|0|||
33364369|NCT01978912|101220555|FG002|Overall Study|Lumbar Surgery|1|||
33364370|NCT01978912|101220556|FG003|Overall Study|Lumbar Surgery|0|||
33416619|NCT01071083|101416169|FG000|Overall Study|Images Not Usable (Motion)|0|||
33566508|NCT04339062|101970777|FG000|Overall Study|Death|0|||
33630506|NCT04065048|102197785|FG002|Overall Study|Withdrawal by Subject|1|||
33630507|NCT04065048|102197786|FG003|Overall Study|Withdrawal by Subject|1|||
33630508|NCT04065048|102197783|FG000|Overall Study|Adverse Event|1|||
33630509|NCT04065048|102197784|FG001|Overall Study|Adverse Event|0|||
33630510|NCT04065048|102197785|FG002|Overall Study|Adverse Event|1|||
33630511|NCT04065048|102197786|FG003|Overall Study|Adverse Event|0|||
33630512|NCT01584232|102197788|FG000|Overall Study|Adverse Event|3|||
33630513|NCT01584232|102197789|FG001|Overall Study|Adverse Event|1|||
33630514|NCT01584232|102197788|FG000|Overall Study|Withdrawal by Subject|2|||
33630515|NCT01584232|102197789|FG001|Overall Study|Withdrawal by Subject|1|||
33630516|NCT01584232|102197788|FG000|Overall Study|Physician Decision|2|||
33416620|NCT01071083|101416170|FG001|Overall Study|Images Not Usable (Motion)|1|||
33630517|NCT01584232|102197789|FG001|Overall Study|Physician Decision|1|||
33630518|NCT01584232|102197788|FG000|Overall Study|Lost to Follow-up|1|||
33630519|NCT01584232|102197789|FG001|Overall Study|Lost to Follow-up|0|||
33630520|NCT03629886|102197793|FG000|Overall Study|Migrated / moved from the study area|0|||
33630521|NCT03629886|102197794|FG001|Overall Study|Migrated / moved from the study area|55|||
33630522|NCT03629886|102197793|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
33630523|NCT03629886|102197794|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
33630524|NCT03629886|102197793|FG000|Overall Study|Study vaccine not administrated|0|||
33630525|NCT03629886|102197794|FG001|Overall Study|Study vaccine not administrated|3|||
33630526|NCT03629886|102197793|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
33630527|NCT03629886|102197794|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
33630528|NCT03629886|102197793|FG000|Overall Study|Refused vaccination step of the study|0|||
33630529|NCT03629886|102197794|FG001|Overall Study|Refused vaccination step of the study|44|||
33630530|NCT01339832|102197795|FG000|Overall Study|Lost to Follow-up|3|||
33630531|NCT01339832|102197795|FG000|Overall Study|Death|11|||
33630532|NCT01614249|102197804|FG000|Overall Study|Lost to Follow-up|11|||
33630533|NCT01614249|102197805|FG001|Overall Study|Lost to Follow-up|23|||
33630534|NCT02183675|102197812|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
33630535|NCT02183675|102197813|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
33630536|NCT02183675|102197814|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
33630537|NCT02183675|102197815|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
33630538|NCT02183675|102197816|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
33630539|NCT02183675|102197817|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
33630540|NCT02891174|102197818|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
33630541|NCT02891174|102197819|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
33630542|NCT02891174|102197818|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
33630543|NCT02891174|102197819|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
33630544|NCT02891174|102197818|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
33630545|NCT02891174|102197819|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
33630546|NCT02891174|102197818|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
33630547|NCT02891174|102197819|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
33630548|NCT02891174|102197818|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
33630549|NCT02891174|102197819|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
33630550|NCT02891174|102197818|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
33630551|NCT02891174|102197819|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
33630552|NCT02891174|102197818|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
33630553|NCT02891174|102197819|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
33416621|NCT01071083|101416171|FG002|Overall Study|Images Not Usable (Motion)|0|||
33630554|NCT02163538|102197821|FG000|Overall Study|Protocol Violation|1|||
33630555|NCT02163538|102197822|FG001|Overall Study|Protocol Violation|0|||
33630556|NCT02163538|102197821|FG000|Overall Study|Physician Decision|0|||
33630557|NCT02163538|102197822|FG001|Overall Study|Physician Decision|1|||
33630558|NCT00633477|102197823|FG000|Overall Study|Death|1|||
33630559|NCT00633477|102197824|FG001|Overall Study|Death|0|||
33630560|NCT00633477|102197823|FG000|Overall Study|Randomized but not treated|1|||
33630561|NCT00633477|102197824|FG001|Overall Study|Randomized but not treated|0|||
33630562|NCT03915717|102197825|FG000|Overall Study|EchoMark Not Implanted|6|||
33630563|NCT04742556|102197828|FG000|Overall Study|Withdrawal by Subject|0|||
33223305|NCT01960725|100718853|FG000|Overall Study|unable to obtain blood sample|1|||
33223306|NCT01960725|100718854|FG001|Overall Study|unable to obtain blood sample|2|||
33223307|NCT01036022|100718855|FG000|Overall Study|Adverse Event|1|||
33223308|NCT01036022|100718856|FG001|Overall Study|Adverse Event|3|||
33223309|NCT01036022|100718857|FG002|Overall Study|Adverse Event|2|||
33223310|NCT01036022|100718858|FG003|Overall Study|Adverse Event|1|||
33223311|NCT01036022|100718859|FG004|Overall Study|Adverse Event|0|||
33223312|NCT01036022|100718860|FG005|Overall Study|Adverse Event|2|||
33223313|NCT01036022|100718855|FG000|Overall Study|Lack of Efficacy|1|||
33223314|NCT01036022|100718856|FG001|Overall Study|Lack of Efficacy|1|||
33223315|NCT01036022|100718857|FG002|Overall Study|Lack of Efficacy|1|||
33223316|NCT01036022|100718858|FG003|Overall Study|Lack of Efficacy|0|||
33223317|NCT01036022|100718859|FG004|Overall Study|Lack of Efficacy|1|||
33223318|NCT01036022|100718860|FG005|Overall Study|Lack of Efficacy|1|||
33223319|NCT01036022|100718855|FG000|Overall Study|Physician Decision|0|||
33223320|NCT01036022|100718856|FG001|Overall Study|Physician Decision|0|||
33223321|NCT01036022|100718857|FG002|Overall Study|Physician Decision|1|||
33223322|NCT01036022|100718858|FG003|Overall Study|Physician Decision|0|||
33223323|NCT01036022|100718859|FG004|Overall Study|Physician Decision|0|||
33223324|NCT01036022|100718860|FG005|Overall Study|Physician Decision|0|||
33223325|NCT01036022|100718855|FG000|Overall Study|Withdrawal by Subject|0|||
33223326|NCT01036022|100718856|FG001|Overall Study|Withdrawal by Subject|0|||
33223327|NCT01036022|100718857|FG002|Overall Study|Withdrawal by Subject|0|||
33223328|NCT01036022|100718858|FG003|Overall Study|Withdrawal by Subject|1|||
33223329|NCT01036022|100718859|FG004|Overall Study|Withdrawal by Subject|2|||
33223330|NCT01036022|100718860|FG005|Overall Study|Withdrawal by Subject|0|||
33630564|NCT04742556|102197829|FG001|Overall Study|Withdrawal by Subject|1|||
33223331|NCT00840801|100718868|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
33223332|NCT00840801|100718869|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
33223333|NCT00840801|100718870|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
33223334|NCT00840801|100718868|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
33223335|NCT00840801|100718869|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
33223336|NCT00840801|100718870|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
33223337|NCT00840801|100718868|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
33223338|NCT00840801|100718869|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
33223339|NCT00840801|100718870|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
33223340|NCT00840801|100718868|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
33223341|NCT00840801|100718869|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
33223342|NCT00840801|100718870|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
33223343|NCT03315130|100718871|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
33223344|NCT03315130|100718872|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
33223345|NCT03315130|100718873|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
33223346|NCT03315130|100718874|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
33223347|NCT03315130|100718871|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
33223348|NCT03315130|100718872|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
33223349|NCT03315130|100718873|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
33223350|NCT03315130|100718874|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
33223351|NCT03315130|100718871|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
33223352|NCT03315130|100718872|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
33223353|NCT03315130|100718873|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
33223354|NCT03315130|100718874|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
33223355|NCT03315130|100718871|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
33223356|NCT03315130|100718872|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
33223357|NCT03315130|100718873|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
33223358|NCT03315130|100718874|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
33223359|NCT03315130|100718871|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
33223360|NCT03315130|100718872|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
33223361|NCT03315130|100718873|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
33223362|NCT03315130|100718874|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
33223363|NCT03315130|100718871|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
33364371|NCT01978912|101220553|FG000|Overall Study|Intradiscal Steroid Injection|0|||
33364372|NCT01978912|101220554|FG001|Overall Study|Intradiscal Steroid Injection|1|||
33364373|NCT01978912|101220555|FG002|Overall Study|Intradiscal Steroid Injection|0|||
33364374|NCT01978912|101220556|FG003|Overall Study|Intradiscal Steroid Injection|0|||
33364375|NCT01413178|101220557|FG000|Overall Study|Toxicity|1|||
33364376|NCT01413178|101220558|FG001|Overall Study|Toxicity|0|||
33416622|NCT01071083|101416172|FG003|Overall Study|Images Not Usable (Motion)|0|||
33416623|NCT01071083|101416173|FG004|Overall Study|Images Not Usable (Motion)|0|||
33223364|NCT03315130|100718872|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
33223365|NCT03315130|100718873|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
33223366|NCT03315130|100718874|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
33223367|NCT00185640|100718878|FG000|Overall Study|Not Eligible|4|||
33223368|NCT00185640|100718878|FG000|Overall Study|Withdrawal by Subject|3|||
33223369|NCT00185640|100718878|FG000|Overall Study|Death|138|||
33223370|NCT01830595|100718885|FG000|First Period|Withdrawal by Subject|1|||
33223371|NCT01830595|100718886|FG001|First Period|Withdrawal by Subject|3|||
33223372|NCT01830595|100718885|FG000|Washout|Withdrawal by Subject|2|||
33223373|NCT01830595|100718886|FG001|Washout|Withdrawal by Subject|2|||
33223374|NCT03585296|100718887|FG000|Overall Study|Adverse Event|1|||
33223375|NCT03585296|100718887|FG000|Overall Study|Lost to Follow-up|2|||
33223376|NCT03585296|100718887|FG000|Overall Study|Withdrawal by Subject|2|||
33223377|NCT00246337|100718888|FG000|Overall Study|Lost to Follow-up|3|||
33223378|NCT00246337|100718889|FG001|Overall Study|Lost to Follow-up|0|||
33223379|NCT00246337|100718890|FG002|Overall Study|Lost to Follow-up|0|||
33223380|NCT00246337|100718891|FG003|Overall Study|Lost to Follow-up|0|||
33223381|NCT00246337|100718892|FG004|Overall Study|Lost to Follow-up|2|||
33223382|NCT00246337|100718893|FG005|Overall Study|Lost to Follow-up|2|||
33223383|NCT00246337|100718894|FG006|Overall Study|Lost to Follow-up|1|||
33223384|NCT00246337|100718895|FG007|Overall Study|Lost to Follow-up|2|||
33223385|NCT00246337|100718896|FG008|Overall Study|Lost to Follow-up|0|||
33223386|NCT00246337|100718888|FG000|Overall Study|Protocol Violation|1|||
33223387|NCT00246337|100718889|FG001|Overall Study|Protocol Violation|0|||
33223388|NCT00246337|100718890|FG002|Overall Study|Protocol Violation|0|||
33223389|NCT00246337|100718891|FG003|Overall Study|Protocol Violation|0|||
33223390|NCT00246337|100718892|FG004|Overall Study|Protocol Violation|1|||
33223391|NCT00246337|100718893|FG005|Overall Study|Protocol Violation|0|||
33223392|NCT00246337|100718894|FG006|Overall Study|Protocol Violation|1|||
33223393|NCT00246337|100718895|FG007|Overall Study|Protocol Violation|1|||
33223394|NCT00246337|100718896|FG008|Overall Study|Protocol Violation|0|||
33223395|NCT00246337|100718888|FG000|Overall Study|Withdrawal by Subject|2|||
33223396|NCT00246337|100718889|FG001|Overall Study|Withdrawal by Subject|0|||
33223397|NCT00246337|100718890|FG002|Overall Study|Withdrawal by Subject|0|||
33223398|NCT00246337|100718891|FG003|Overall Study|Withdrawal by Subject|0|||
33223399|NCT00246337|100718892|FG004|Overall Study|Withdrawal by Subject|0|||
33223400|NCT00246337|100718893|FG005|Overall Study|Withdrawal by Subject|0|||
33223401|NCT00246337|100718894|FG006|Overall Study|Withdrawal by Subject|1|||
33223402|NCT00246337|100718895|FG007|Overall Study|Withdrawal by Subject|1|||
33223403|NCT00246337|100718896|FG008|Overall Study|Withdrawal by Subject|0|||
33223404|NCT00246337|100718888|FG000|Overall Study|Lack of Qualifying Event|8|||
33223405|NCT00246337|100718889|FG001|Overall Study|Lack of Qualifying Event|2|||
33223406|NCT00246337|100718890|FG002|Overall Study|Lack of Qualifying Event|1|||
33223407|NCT00246337|100718891|FG003|Overall Study|Lack of Qualifying Event|1|||
33223408|NCT00246337|100718892|FG004|Overall Study|Lack of Qualifying Event|1|||
33223409|NCT00246337|100718893|FG005|Overall Study|Lack of Qualifying Event|3|||
33223410|NCT00246337|100718894|FG006|Overall Study|Lack of Qualifying Event|3|||
33223411|NCT00246337|100718895|FG007|Overall Study|Lack of Qualifying Event|2|||
33223412|NCT00246337|100718896|FG008|Overall Study|Lack of Qualifying Event|5|||
33223413|NCT00246337|100718888|FG000|Overall Study|Site Terminated|10|||
33223414|NCT00246337|100718889|FG001|Overall Study|Site Terminated|0|||
33223415|NCT00246337|100718890|FG002|Overall Study|Site Terminated|0|||
33223416|NCT00246337|100718891|FG003|Overall Study|Site Terminated|0|||
33223417|NCT00246337|100718892|FG004|Overall Study|Site Terminated|0|||
33223418|NCT00246337|100718893|FG005|Overall Study|Site Terminated|7|||
33223419|NCT00246337|100718894|FG006|Overall Study|Site Terminated|1|||
33630565|NCT04742556|102197830|FG002|Overall Study|Withdrawal by Subject|0|||
33630566|NCT04742556|102197828|FG000|Overall Study|Adverse Event|0|||
33630567|NCT04742556|102197829|FG001|Overall Study|Adverse Event|0|||
33630568|NCT04742556|102197830|FG002|Overall Study|Adverse Event|2|||
33630569|NCT04742556|102197828|FG000|Overall Study|Clinical disease progression|0|||
33223420|NCT00246337|100718895|FG007|Overall Study|Site Terminated|6|||
33223421|NCT00246337|100718896|FG008|Overall Study|Site Terminated|2|||
33223422|NCT00246337|100718888|FG000|Overall Study|Abnormal baseline lab values|7|||
33223423|NCT00246337|100718889|FG001|Overall Study|Abnormal baseline lab values|0|||
33223424|NCT00246337|100718890|FG002|Overall Study|Abnormal baseline lab values|2|||
33223425|NCT00246337|100718891|FG003|Overall Study|Abnormal baseline lab values|0|||
33223426|NCT00246337|100718892|FG004|Overall Study|Abnormal baseline lab values|0|||
33223427|NCT00246337|100718893|FG005|Overall Study|Abnormal baseline lab values|2|||
33223428|NCT00246337|100718894|FG006|Overall Study|Abnormal baseline lab values|2|||
33223429|NCT00246337|100718895|FG007|Overall Study|Abnormal baseline lab values|0|||
33223430|NCT00246337|100718896|FG008|Overall Study|Abnormal baseline lab values|4|||
33223431|NCT00246337|100718888|FG000|Overall Study|Overwhelmed|0|||
33223432|NCT00246337|100718889|FG001|Overall Study|Overwhelmed|0|||
33223433|NCT00246337|100718890|FG002|Overall Study|Overwhelmed|0|||
33223434|NCT00246337|100718891|FG003|Overall Study|Overwhelmed|0|||
33223435|NCT00246337|100718892|FG004|Overall Study|Overwhelmed|0|||
33630570|NCT04742556|102197829|FG001|Overall Study|Clinical disease progression|1|||
33630571|NCT04742556|102197830|FG002|Overall Study|Clinical disease progression|2|||
33630572|NCT04742556|102197828|FG000|Overall Study|Objective disease progression|3|||
33630573|NCT04742556|102197829|FG001|Overall Study|Objective disease progression|2|||
33630574|NCT04742556|102197830|FG002|Overall Study|Objective disease progression|4|||
33631310|NCT03486912|102202916|FG002|Treatment Period|Lost to Follow-up|0|||
33631311|NCT03486912|102202917|FG003|Treatment Period|Lost to Follow-up|2|||
33631312|NCT02177123|102202924|FG000|Overall Study|Lost to Follow-up|6|||
33631313|NCT02177123|102202924|FG000|Overall Study|Withdrawal by Subject|4|||
33364377|NCT01413178|101220557|FG000|Overall Study|Ineligible|0|||
33631314|NCT02177123|102202924|FG000|Overall Study|Adverse Event|4|||
33223436|NCT00246337|100718893|FG005|Overall Study|Overwhelmed|1|||
33364378|NCT01413178|101220558|FG001|Overall Study|Ineligible|2|||
33364379|NCT01512368|101220559|FG000|Overall Study|Protocol Violation|3|||
33631315|NCT02177123|102202924|FG000|Overall Study|Physician Decision|3|||
33364380|NCT02760407|101220564|FG000|Overall Study|Death|2|||
33630575|NCT05712460|102200360|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
33630576|NCT05712460|102200361|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
33630577|NCT05712460|102200362|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
33630578|NCT05712460|102200363|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
33630579|NCT05712460|102200364|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
33630580|NCT05712460|102200365|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
33630581|NCT05712460|102200366|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
33630582|NCT05712460|102200367|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
33630583|NCT05712460|102200368|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
33630584|NCT05712460|102200369|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
33630585|NCT05712460|102200370|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
33630586|NCT05712460|102200371|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
33630587|NCT01838395|102200375|FG000|Overall Study|Withdrawal by Subject|0|||
33630588|NCT01838395|102200376|FG001|Overall Study|Withdrawal by Subject|0|||
33630589|NCT01838395|102200377|FG002|Overall Study|Withdrawal by Subject|0|||
33630590|NCT01838395|102200378|FG003|Overall Study|Withdrawal by Subject|0|||
33630591|NCT01838395|102200379|FG004|Overall Study|Withdrawal by Subject|1|||
33630592|NCT01838395|102200380|FG005|Overall Study|Withdrawal by Subject|0|||
33630593|NCT01838395|102200375|FG000|Overall Study|Death|0|||
33630594|NCT01838395|102200376|FG001|Overall Study|Death|0|||
33630595|NCT01838395|102200377|FG002|Overall Study|Death|1|||
33630596|NCT01838395|102200378|FG003|Overall Study|Death|0|||
33630597|NCT01838395|102200379|FG004|Overall Study|Death|0|||
33630598|NCT01838395|102200380|FG005|Overall Study|Death|0|||
33630599|NCT01838395|102200375|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
33630600|NCT01838395|102200376|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
33630601|NCT01838395|102200377|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
33630602|NCT01838395|102200378|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
33364381|NCT02760407|101220565|FG001|Overall Study|Death|3|||
33364382|NCT02760407|101220566|FG002|Overall Study|Death|1|||
33223437|NCT00246337|100718894|FG006|Overall Study|Overwhelmed|0|||
33223438|NCT00246337|100718895|FG007|Overall Study|Overwhelmed|0|||
33223439|NCT00246337|100718896|FG008|Overall Study|Overwhelmed|0|||
33364383|NCT02760407|101220567|FG003|Overall Study|Death|1|||
33364384|NCT02760407|101220564|FG000|Overall Study|Lost to Follow-up|1|||
33364385|NCT02760407|101220565|FG001|Overall Study|Lost to Follow-up|7|||
33364386|NCT02760407|101220566|FG002|Overall Study|Lost to Follow-up|4|||
33364387|NCT02760407|101220567|FG003|Overall Study|Lost to Follow-up|6|||
33630603|NCT01838395|102200379|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
33630604|NCT01838395|102200380|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
33630605|NCT01690143|102200381|FG000|Overall Study|Withdrawal by Subject|1|||
33630606|NCT04750824|102200382|FG000|Overall Study|Toxicity/intolerability|3|||
33223440|NCT00246337|100718888|FG000|Overall Study|Protocol Violator|1|||
33416624|NCT01071083|101416169|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
33223441|NCT00246337|100718889|FG001|Overall Study|Protocol Violator|0|||
33364388|NCT02760407|101220564|FG000|Overall Study|Withdrawal by Subject|25|||
33364389|NCT02760407|101220565|FG001|Overall Study|Withdrawal by Subject|31|||
33630607|NCT04750824|102200383|FG001|Overall Study|Toxicity/intolerability|1|||
33630608|NCT04750824|102200382|FG000|Overall Study|Death|1|||
33630609|NCT04750824|102200383|FG001|Overall Study|Death|3|||
33630610|NCT04750824|102200382|FG000|Overall Study|Scheduled duration of therapy complete|1|||
33630611|NCT04750824|102200383|FG001|Overall Study|Scheduled duration of therapy complete|9|||
33630612|NCT04750824|102200382|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
33630613|NCT04750824|102200383|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
33630614|NCT04913610|102200386|FG000|Randomized Participants|Did Not Receive Treatment|0|||
33364390|NCT02760407|101220566|FG002|Overall Study|Withdrawal by Subject|37|||
33364391|NCT02760407|101220567|FG003|Overall Study|Withdrawal by Subject|25|||
33364392|NCT02760407|101220564|FG000|Overall Study|Violation of Eligibility criteria|0|||
33364393|NCT02760407|101220565|FG001|Overall Study|Violation of Eligibility criteria|0|||
33364394|NCT02760407|101220566|FG002|Overall Study|Violation of Eligibility criteria|1|||
33364395|NCT02760407|101220567|FG003|Overall Study|Violation of Eligibility criteria|1|||
33364396|NCT02760407|101220564|FG000|Overall Study|Personal reasons|0|||
33364397|NCT02760407|101220565|FG001|Overall Study|Personal reasons|0|||
33364398|NCT02760407|101220566|FG002|Overall Study|Personal reasons|0|||
33364399|NCT02760407|101220567|FG003|Overall Study|Personal reasons|1|||
33364400|NCT02760407|101220564|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
33364401|NCT02760407|101220565|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
33364402|NCT02760407|101220566|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
33364403|NCT02760407|101220567|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
33364404|NCT02760407|101220564|FG000|Overall Study|Use of prohibited Medication|0|||
33364405|NCT02760407|101220565|FG001|Overall Study|Use of prohibited Medication|0|||
33364406|NCT02760407|101220566|FG002|Overall Study|Use of prohibited Medication|1|||
33364407|NCT02760407|101220567|FG003|Overall Study|Use of prohibited Medication|0|||
33566509|NCT04339062|101970778|FG001|Overall Study|Death|1|||
33566510|NCT03132467|101970779|FG000|Overall Study|Adverse Event|2|||
33566511|NCT03132467|101970779|FG000|Overall Study|Withdrawal by Subject|2|||
33566512|NCT01992757|101970780|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
33566513|NCT00573768|101972993|FG000|Overall Study|Adverse Event|1|||
33566514|NCT00573768|101972994|FG001|Overall Study|Adverse Event|1|||
33566515|NCT00573768|101972995|FG002|Overall Study|Adverse Event|2|||
33566516|NCT00573768|101972993|FG000|Overall Study|Protocol Violation|1|||
33566517|NCT00573768|101972994|FG001|Overall Study|Protocol Violation|0|||
33566518|NCT00573768|101972995|FG002|Overall Study|Protocol Violation|1|||
33566519|NCT00573768|101972993|FG000|Overall Study|Withdrawal by Subject|0|||
33566520|NCT00573768|101972994|FG001|Overall Study|Withdrawal by Subject|1|||
33566521|NCT00573768|101972995|FG002|Overall Study|Withdrawal by Subject|0|||
33566522|NCT00573768|101972993|FG000|Overall Study|Lost to Follow-up|0|||
33566523|NCT00573768|101972994|FG001|Overall Study|Lost to Follow-up|0|||
33566524|NCT00573768|101972995|FG002|Overall Study|Lost to Follow-up|1|||
33566525|NCT01538199|101972996|FG000|Overall Study|Lost to Follow-up|1|||
33566526|NCT01538199|101972997|FG001|Overall Study|Lost to Follow-up|2|||
33566527|NCT01538199|101972998|FG002|Overall Study|Lost to Follow-up|1|||
33566528|NCT01538199|101972999|FG003|Overall Study|Lost to Follow-up|0|||
33566529|NCT01538199|101972996|FG000|Overall Study|participant did not have time|1|||
33566530|NCT01538199|101972997|FG001|Overall Study|participant did not have time|0|||
33566531|NCT01538199|101972998|FG002|Overall Study|participant did not have time|0|||
33566532|NCT01538199|101972999|FG003|Overall Study|participant did not have time|2|||
33566533|NCT01538199|101972996|FG000|Overall Study|Lack of Efficacy|0|||
33566534|NCT01538199|101972997|FG001|Overall Study|Lack of Efficacy|1|||
33566535|NCT01538199|101972998|FG002|Overall Study|Lack of Efficacy|0|||
33566536|NCT01538199|101972999|FG003|Overall Study|Lack of Efficacy|0|||
33566537|NCT03514134|101973002|FG000|Overall Study|Lost to Follow-up|0|||
33566538|NCT03514134|101973003|FG001|Overall Study|Lost to Follow-up|1|||
33566539|NCT04023487|101973006|FG000|Overall Study|Lost to Follow-up|5|||
33566540|NCT04023487|101973007|FG001|Overall Study|Lost to Follow-up|4|||
33566541|NCT04023487|101973006|FG000|Overall Study|Pregnancy|1|||
33566542|NCT04023487|101973007|FG001|Overall Study|Pregnancy|2|||
33566543|NCT04023487|101973006|FG000|Overall Study|Withdrawal by Subject|4|||
33566544|NCT04023487|101973007|FG001|Overall Study|Withdrawal by Subject|5|||
33566545|NCT04023487|101973006|FG000|Overall Study|Partially completed testing|8|||
33566546|NCT04023487|101973007|FG001|Overall Study|Partially completed testing|4|||
33566547|NCT03360344|101973008|FG000|Overall Study|Withdrawal by Subject|0|||
33566548|NCT03360344|101973009|FG001|Overall Study|Withdrawal by Subject|1|||
33566549|NCT03360344|101973010|FG002|Overall Study|Withdrawal by Subject|1|||
33566550|NCT00183248|101973014|FG000|Overall Study|Lost to Follow-up|0|||
33566551|NCT00183248|101973015|FG001|Overall Study|Lost to Follow-up|1|||
33566552|NCT00183248|101973014|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
33566553|NCT00183248|101973015|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
33566554|NCT00347269|101973016|FG000|Overall Study|Lost to Follow-up|74|||
33630615|NCT04913610|102200387|FG001|Randomized Participants|Did Not Receive Treatment|0|||
33630616|NCT04913610|102200388|FG002|Randomized Participants|Did Not Receive Treatment|1|||
33630617|NCT04913610|102200389|FG003|Randomized Participants|Did Not Receive Treatment|1|||
33630618|NCT04913610|102200390|FG004|Randomized Participants|Did Not Receive Treatment|0|||
33630619|NCT04913610|102200386|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
33630620|NCT04913610|102200387|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
33630621|NCT04913610|102200388|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
33630622|NCT04913610|102200389|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
33630623|NCT04913610|102200390|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
33416625|NCT01071083|101416170|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
33416626|NCT01071083|101416171|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
33416627|NCT01071083|101416172|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
33416628|NCT01071083|101416173|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
33416629|NCT01071083|101416169|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
33416630|NCT01071083|101416170|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
33416631|NCT01071083|101416171|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
33416632|NCT01071083|101416172|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
33416633|NCT01071083|101416173|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
33416634|NCT01071083|101416169|FG000|Overall Study|Subject Refused to Continue|1|||
33416635|NCT01071083|101416170|FG001|Overall Study|Subject Refused to Continue|0|||
33416636|NCT01071083|101416171|FG002|Overall Study|Subject Refused to Continue|0|||
33416637|NCT01071083|101416172|FG003|Overall Study|Subject Refused to Continue|0|||
33630624|NCT05131165|102200391|FG000|Overall Study|Death|1|||
33630625|NCT05131165|102200392|FG001|Overall Study|Death|1|||
33630626|NCT05131165|102200393|FG002|Overall Study|Death|0|||
33630627|NCT05131165|102200391|FG000|Overall Study|Lost to Follow-up|2|||
33630628|NCT05131165|102200392|FG001|Overall Study|Lost to Follow-up|2|||
33630629|NCT05131165|102200393|FG002|Overall Study|Lost to Follow-up|5|||
33630630|NCT05131165|102200391|FG000|Overall Study|Transferred out of clinic|1|||
33630631|NCT05131165|102200392|FG001|Overall Study|Transferred out of clinic|0|||
33630632|NCT05131165|102200393|FG002|Overall Study|Transferred out of clinic|3|||
33630633|NCT05131165|102200391|FG000|Overall Study|Dropped out|1|||
33630634|NCT05131165|102200392|FG001|Overall Study|Dropped out|2|||
33630635|NCT05131165|102200393|FG002|Overall Study|Dropped out|0|||
33630636|NCT05131204|102200394|FG000|Overall Study|Sponsor request|2|||
33630637|NCT05131204|102200395|FG001|Overall Study|Sponsor request|1|||
33630638|NCT04575155|102200396|FG000|2 Month|Withdrawal by Subject|1|||
33630639|NCT04575155|102200397|FG001|2 Month|Withdrawal by Subject|1|||
33630640|NCT04575155|102200396|FG000|2 Month|Lost to Follow-up|5|||
33630641|NCT04575155|102200397|FG001|2 Month|Lost to Follow-up|3|||
33630642|NCT04575155|102200396|FG000|2 Month|Ineligible|1|||
33630643|NCT04575155|102200397|FG001|2 Month|Ineligible|0|||
33630644|NCT03624881|102200400|FG000|Overall Study|Screen Failure|14|||
33630645|NCT03624881|102200401|FG001|Overall Study|Screen Failure|0|||
33630646|NCT03624881|102200400|FG000|Overall Study|No Catheter Inserted|6|||
33630647|NCT03624881|102200401|FG001|Overall Study|No Catheter Inserted|1|||
33223442|NCT00246337|100718890|FG002|Overall Study|Protocol Violator|0|||
33416638|NCT01071083|101416173|FG004|Overall Study|Subject Refused to Continue|0|||
33416639|NCT00798707|101416179|FG000|Overall Study|Adverse Event|6|||
33416640|NCT00798707|101416180|FG001|Overall Study|Adverse Event|8|||
33630648|NCT03624881|102200400|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
33416641|NCT00798707|101416181|FG002|Overall Study|Adverse Event|8|||
33416642|NCT00798707|101416179|FG000|Overall Study|Failed to return|2|||
33630649|NCT03624881|102200401|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
33416643|NCT00798707|101416180|FG001|Overall Study|Failed to return|2|||
33416644|NCT00798707|101416181|FG002|Overall Study|Failed to return|0|||
33630650|NCT03624881|102200400|FG000|Overall Study|Death|2|||
33630651|NCT03624881|102200401|FG001|Overall Study|Death|0|||
33630652|NCT03624881|102200400|FG000|Overall Study|Lost to Follow-up|10|||
33630653|NCT03624881|102200401|FG001|Overall Study|Lost to Follow-up|4|||
33630654|NCT03624881|102200400|FG000|Overall Study|Withdrawal by Subject|12|||
33630655|NCT03624881|102200401|FG001|Overall Study|Withdrawal by Subject|1|||
33630656|NCT03748823|102200402|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
33630657|NCT03748823|102200403|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
33223443|NCT00246337|100718891|FG003|Overall Study|Protocol Violator|0|||
33630658|NCT03748823|102200402|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
33630659|NCT03748823|102200403|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
33630660|NCT03748823|102200402|FG000|Extension Period|Withdrawal by Subject|9|||
33630661|NCT03748823|102200403|FG001|Extension Period|Withdrawal by Subject|12|||
33630662|NCT03748823|102200402|FG000|Extension Period|Death|2|||
33630663|NCT03748823|102200403|FG001|Extension Period|Death|2|||
33630664|NCT03748823|102200402|FG000|Extension Period|Other than Specified|0|||
33630665|NCT03748823|102200403|FG001|Extension Period|Other than Specified|1|||
33630666|NCT03748823|102200402|FG000|Extension Period|Protocol Violation|1|||
33630667|NCT03748823|102200403|FG001|Extension Period|Protocol Violation|0|||
33630668|NCT03748823|102200402|FG000|Extension Period|Lost to Follow-up|0|||
33630669|NCT03748823|102200403|FG001|Extension Period|Lost to Follow-up|1|||
33630670|NCT03748823|102200402|FG000|Extension Period|Lack of Efficacy|0|||
33364408|NCT02760407|101220564|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
33364409|NCT02760407|101220565|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
33364410|NCT02760407|101220566|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
33364411|NCT02760407|101220567|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
33364412|NCT02760407|101220564|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
33364413|NCT02760407|101220565|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
33364414|NCT02760407|101220566|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
33364415|NCT02760407|101220567|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
33364416|NCT02760407|101220564|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
33364417|NCT02760407|101220565|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
33364418|NCT02760407|101220566|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
33364419|NCT02760407|101220567|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
33364420|NCT02760407|101220564|FG000|Overall Study|Inadequately Enrolled|0|||
33364421|NCT02760407|101220565|FG001|Overall Study|Inadequately Enrolled|0|||
33223444|NCT00246337|100718892|FG004|Overall Study|Protocol Violator|0|||
33223445|NCT00246337|100718893|FG005|Overall Study|Protocol Violator|0|||
33223446|NCT00246337|100718894|FG006|Overall Study|Protocol Violator|0|||
33364422|NCT02760407|101220566|FG002|Overall Study|Inadequately Enrolled|0|||
33364423|NCT02760407|101220567|FG003|Overall Study|Inadequately Enrolled|1|||
33364424|NCT02760407|101220564|FG000|Overall Study|Withdrawal By PI's Decision|0|||
33364425|NCT02760407|101220565|FG001|Overall Study|Withdrawal By PI's Decision|1|||
33416645|NCT00798707|101416179|FG000|Overall Study|Investigator|0|||
33416646|NCT00798707|101416180|FG001|Overall Study|Investigator|1|||
33416647|NCT00798707|101416181|FG002|Overall Study|Investigator|2|||
33416648|NCT00798707|101416179|FG000|Overall Study|Lack of Efficacy|2|||
33416649|NCT00798707|101416180|FG001|Overall Study|Lack of Efficacy|2|||
33416650|NCT00798707|101416181|FG002|Overall Study|Lack of Efficacy|1|||
33630671|NCT03748823|102200403|FG001|Extension Period|Lack of Efficacy|1|||
33630672|NCT03748823|102200402|FG000|Extension Period|Physician Decision|1|||
33630673|NCT03748823|102200403|FG001|Extension Period|Physician Decision|2|||
33630674|NCT02173769|102200406|FG000|Overall Study|Protocol Violation|4|||
33630675|NCT00948246|102200409|FG000|Overall Study|Lost to Follow-up|11|||
33630676|NCT00948246|102200409|FG000|Overall Study|Adverse Event|11|||
33630677|NCT00948246|102200409|FG000|Overall Study|Death|1|||
33630678|NCT00948246|102200409|FG000|Overall Study|Withdrawal by Subject|1|||
33630679|NCT05430854|102200410|FG000|Overall Study|Trial terminated by Sponsor|39|||
33630680|NCT05430854|102200411|FG001|Overall Study|Trial terminated by Sponsor|50|||
33223447|NCT00246337|100718895|FG007|Overall Study|Protocol Violator|0|||
33630681|NCT05430854|102200412|FG002|Overall Study|Trial terminated by Sponsor|46|||
33416651|NCT00798707|101416179|FG000|Overall Study|Lost to Follow-up|5|||
33416652|NCT00798707|101416180|FG001|Overall Study|Lost to Follow-up|6|||
33416653|NCT00798707|101416181|FG002|Overall Study|Lost to Follow-up|6|||
33630682|NCT05430854|102200410|FG000|Overall Study|Withdrawal by Subject|0|||
33630683|NCT05430854|102200411|FG001|Overall Study|Withdrawal by Subject|3|||
33630684|NCT05430854|102200412|FG002|Overall Study|Withdrawal by Subject|0|||
33630685|NCT04571944|102200414|FG000|Overall Study|Death|1|||
33630686|NCT04571944|102200415|FG001|Overall Study|Death|0|||
33630687|NCT04571944|102200414|FG000|Overall Study|Withdrawal by Subject|3|||
33630688|NCT04571944|102200415|FG001|Overall Study|Withdrawal by Subject|0|||
33566555|NCT00347269|101973017|FG001|Overall Study|Lost to Follow-up|65|||
33566556|NCT00347269|101973016|FG000|Overall Study|Withdrawal by Subject|18|||
33566557|NCT00347269|101973017|FG001|Overall Study|Withdrawal by Subject|38|||
33566558|NCT00347269|101973016|FG000|Overall Study|Death|2|||
33566559|NCT00347269|101973017|FG001|Overall Study|Death|3|||
33566560|NCT00829244|101973018|FG000|Overall Study|Adverse Event|1|||
33566561|NCT00829244|101973019|FG001|Overall Study|Adverse Event|3|||
33566562|NCT00829244|101973018|FG000|Overall Study|Protocol Violation|1|||
33566563|NCT00829244|101973019|FG001|Overall Study|Protocol Violation|0|||
33630689|NCT04571944|102200414|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
33630690|NCT04571944|102200415|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
33630691|NCT02702492|102200420|FG000|Overall Study|Disease progression|3|||
33566564|NCT00829244|101973018|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
33566565|NCT00829244|101973019|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
33566566|NCT00829244|101973018|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
33566567|NCT00829244|101973019|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
33566568|NCT00829244|101973018|FG000|Overall Study|No fertilization|2|||
33566569|NCT00829244|101973019|FG001|Overall Study|No fertilization|2|||
33566570|NCT00829244|101973018|FG000|Overall Study|All embryos discarded|0|||
33566571|NCT00829244|101973019|FG001|Overall Study|All embryos discarded|3|||
33566572|NCT00829244|101973018|FG000|Overall Study|No embryo cleavage|0|||
33566573|NCT00829244|101973019|FG001|Overall Study|No embryo cleavage|2|||
33566574|NCT01432444|101973022|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
33566575|NCT01432444|101973023|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
33566576|NCT01432444|101973024|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
33566577|NCT01432444|101973022|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
33566578|NCT01432444|101973023|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
33566579|NCT01432444|101973024|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
33566580|NCT01432444|101973022|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
33566581|NCT01432444|101973023|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
33566582|NCT01432444|101973024|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
33566583|NCT01432444|101973022|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
33566584|NCT01432444|101973023|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
33566585|NCT01432444|101973024|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
33566586|NCT01432444|101973022|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
33630692|NCT02702492|102200421|FG001|Overall Study|Disease progression|3|||
33630693|NCT02702492|102200422|FG002|Overall Study|Disease progression|2|||
33630694|NCT02702492|102200423|FG003|Overall Study|Disease progression|4|||
33630695|NCT02702492|102200424|FG004|Overall Study|Disease progression|4|||
33630696|NCT02702492|102200425|FG005|Overall Study|Disease progression|1|||
33630697|NCT02702492|102200426|FG006|Overall Study|Disease progression|2|||
33630698|NCT02702492|102200427|FG007|Overall Study|Disease progression|8|||
33630699|NCT02702492|102200428|FG008|Overall Study|Disease progression|5|||
33630700|NCT02702492|102200429|FG009|Overall Study|Disease progression|1|||
33630701|NCT02702492|102200430|FG010|Overall Study|Disease progression|0|||
33630702|NCT02702492|102200431|FG011|Overall Study|Disease progression|3|||
33630703|NCT02702492|102200432|FG012|Overall Study|Disease progression|2|||
33630704|NCT02702492|102200420|FG000|Overall Study|Clinical progression|0|||
33630705|NCT02702492|102200421|FG001|Overall Study|Clinical progression|0|||
33630706|NCT02702492|102200422|FG002|Overall Study|Clinical progression|2|||
33630707|NCT02702492|102200423|FG003|Overall Study|Clinical progression|1|||
33630708|NCT02702492|102200424|FG004|Overall Study|Clinical progression|0|||
33630709|NCT02702492|102200425|FG005|Overall Study|Clinical progression|2|||
33630710|NCT02702492|102200426|FG006|Overall Study|Clinical progression|1|||
33630711|NCT02702492|102200427|FG007|Overall Study|Clinical progression|4|||
33630712|NCT02702492|102200428|FG008|Overall Study|Clinical progression|0|||
33630713|NCT02702492|102200429|FG009|Overall Study|Clinical progression|0|||
33630714|NCT02702492|102200430|FG010|Overall Study|Clinical progression|1|||
33630715|NCT02702492|102200431|FG011|Overall Study|Clinical progression|2|||
33630716|NCT02702492|102200432|FG012|Overall Study|Clinical progression|0|||
33630717|NCT02702492|102200420|FG000|Overall Study|Adverse Event|0|||
33630718|NCT02702492|102200421|FG001|Overall Study|Adverse Event|0|||
33630719|NCT02702492|102200422|FG002|Overall Study|Adverse Event|1|||
33630720|NCT02702492|102200423|FG003|Overall Study|Adverse Event|2|||
33630721|NCT02702492|102200424|FG004|Overall Study|Adverse Event|1|||
33630722|NCT02702492|102200425|FG005|Overall Study|Adverse Event|0|||
33223448|NCT00246337|100718896|FG008|Overall Study|Protocol Violator|0|||
33630723|NCT02702492|102200426|FG006|Overall Study|Adverse Event|1|||
33630724|NCT02702492|102200427|FG007|Overall Study|Adverse Event|0|||
33630725|NCT02702492|102200428|FG008|Overall Study|Adverse Event|2|||
33630726|NCT02702492|102200429|FG009|Overall Study|Adverse Event|0|||
33630727|NCT02702492|102200430|FG010|Overall Study|Adverse Event|0|||
33630728|NCT02702492|102200431|FG011|Overall Study|Adverse Event|0|||
33630729|NCT02702492|102200432|FG012|Overall Study|Adverse Event|1|||
33223449|NCT00246337|100718888|FG000|Overall Study|Reported as completing trial in error|0|||
33223450|NCT00246337|100718889|FG001|Overall Study|Reported as completing trial in error|0|||
33223451|NCT00246337|100718890|FG002|Overall Study|Reported as completing trial in error|0|||
33364426|NCT02760407|101220566|FG002|Overall Study|Withdrawal By PI's Decision|0|||
33364427|NCT02760407|101220567|FG003|Overall Study|Withdrawal By PI's Decision|0|||
33364428|NCT02760407|101220564|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
33364429|NCT02760407|101220565|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
33364430|NCT02760407|101220566|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
33416654|NCT00798707|101416179|FG000|Overall Study|Other|0|||
33566587|NCT01432444|101973023|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
33566588|NCT01432444|101973024|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
33566589|NCT01432444|101973022|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
33630730|NCT02702492|102200420|FG000|Overall Study|Other|0|||
33630731|NCT02702492|102200421|FG001|Overall Study|Other|0|||
33630732|NCT02702492|102200422|FG002|Overall Study|Other|0|||
33630733|NCT02702492|102200423|FG003|Overall Study|Other|0|||
33630734|NCT02702492|102200424|FG004|Overall Study|Other|0|||
33630735|NCT02702492|102200425|FG005|Overall Study|Other|0|||
33630736|NCT02702492|102200426|FG006|Overall Study|Other|0|||
33630737|NCT02702492|102200427|FG007|Overall Study|Other|0|||
33630738|NCT02702492|102200428|FG008|Overall Study|Other|0|||
33364431|NCT02760407|101220567|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
33416655|NCT00798707|101416180|FG001|Overall Study|Other|1|||
33630739|NCT02702492|102200429|FG009|Overall Study|Other|0|||
33630740|NCT02702492|102200430|FG010|Overall Study|Other|0|||
33630741|NCT02702492|102200431|FG011|Overall Study|Other|0|||
33630742|NCT02702492|102200432|FG012|Overall Study|Other|1|||
33630743|NCT05652010|102200436|FG000|First Intervention|Withdrawal by Subject|0|||
33416656|NCT00798707|101416181|FG002|Overall Study|Other|0|||
33416657|NCT00798707|101416179|FG000|Overall Study|Protocol Violation|4|||
33416658|NCT00798707|101416180|FG001|Overall Study|Protocol Violation|0|||
33416659|NCT00798707|101416181|FG002|Overall Study|Protocol Violation|2|||
33416660|NCT00798707|101416179|FG000|Overall Study|Withdrawal by Subject|3|||
33416661|NCT00798707|101416180|FG001|Overall Study|Withdrawal by Subject|8|||
33566590|NCT01432444|101973023|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
33566591|NCT01432444|101973024|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
33566592|NCT01432444|101973022|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
33566593|NCT01432444|101973023|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
33566594|NCT01432444|101973024|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
33566595|NCT01432444|101973022|FG000|Treatment Phase|Lost to Follow-up|0|||
33566596|NCT01432444|101973023|FG001|Treatment Phase|Lost to Follow-up|33|||
33566597|NCT01432444|101973024|FG002|Treatment Phase|Lost to Follow-up|0|||
33566598|NCT01432444|101973022|FG000|Treatment Phase|Adverse Event|0|||
33630744|NCT05652010|102200437|FG001|First Intervention|Withdrawal by Subject|1|||
33630745|NCT05652010|102200436|FG000|Second Intervention|Withdrawal by Subject|1|||
33630746|NCT05652010|102200437|FG001|Second Intervention|Withdrawal by Subject|0|||
33630747|NCT01903356|102200438|FG000|Overall Study|Lost to Follow-up|7|||
33630748|NCT01903356|102200438|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
33223452|NCT00246337|100718891|FG003|Overall Study|Reported as completing trial in error|0|||
33223453|NCT00246337|100718892|FG004|Overall Study|Reported as completing trial in error|0|||
33223454|NCT00246337|100718893|FG005|Overall Study|Reported as completing trial in error|0|||
33223455|NCT00246337|100718894|FG006|Overall Study|Reported as completing trial in error|0|||
33223456|NCT00246337|100718895|FG007|Overall Study|Reported as completing trial in error|1|||
33223457|NCT00246337|100718896|FG008|Overall Study|Reported as completing trial in error|0|||
33223458|NCT03324880|100718897|FG000|Overall Study|Adverse Event|0|||
33223459|NCT03324880|100718898|FG001|Overall Study|Adverse Event|2|||
33223460|NCT03324880|100718897|FG000|Overall Study|Withdrawal by Subject|2|||
33223461|NCT03324880|100718898|FG001|Overall Study|Withdrawal by Subject|2|||
33223462|NCT03324880|100718897|FG000|Overall Study|Lost to Follow-up|0|||
33223463|NCT03324880|100718898|FG001|Overall Study|Lost to Follow-up|1|||
33223464|NCT03324880|100718897|FG000|Overall Study|Product Recall|0|||
33223465|NCT03324880|100718898|FG001|Overall Study|Product Recall|1|||
33223466|NCT03518125|100718899|FG000|Overall Study|Lost to Follow-up|0|||
33630749|NCT01903356|102200438|FG000|Overall Study|Violated the dosage and administration|3|||
33630750|NCT05635461|102200440|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
33630751|NCT05635461|102200441|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
33223467|NCT03518125|100718900|FG001|Overall Study|Lost to Follow-up|2|||
33223468|NCT03518125|100718901|FG002|Overall Study|Lost to Follow-up|0|||
33223469|NCT03518125|100718902|FG003|Overall Study|Lost to Follow-up|0|||
33223470|NCT03518125|100718903|FG004|Overall Study|Lost to Follow-up|3|||
33223471|NCT03518125|100718904|FG005|Overall Study|Lost to Follow-up|5|||
33223472|NCT03518125|100718899|FG000|Overall Study|Physician Decision|0|||
33223473|NCT03518125|100718900|FG001|Overall Study|Physician Decision|1|||
33223474|NCT03518125|100718901|FG002|Overall Study|Physician Decision|0|||
33223475|NCT03518125|100718902|FG003|Overall Study|Physician Decision|0|||
33223476|NCT03518125|100718903|FG004|Overall Study|Physician Decision|0|||
33223477|NCT03518125|100718904|FG005|Overall Study|Physician Decision|0|||
33223478|NCT03518125|100718899|FG000|Overall Study|Withdrawal by Subject|1|||
33223479|NCT03518125|100718900|FG001|Overall Study|Withdrawal by Subject|1|||
33223480|NCT03518125|100718901|FG002|Overall Study|Withdrawal by Subject|0|||
33223481|NCT03518125|100718902|FG003|Overall Study|Withdrawal by Subject|1|||
33223482|NCT03518125|100718903|FG004|Overall Study|Withdrawal by Subject|1|||
33223483|NCT03518125|100718904|FG005|Overall Study|Withdrawal by Subject|3|||
33223484|NCT03518125|100718899|FG000|Overall Study|Missed Day 394 Visit|1|||
33223485|NCT03518125|100718900|FG001|Overall Study|Missed Day 394 Visit|0|||
33223486|NCT03518125|100718901|FG002|Overall Study|Missed Day 394 Visit|0|||
33223487|NCT03518125|100718902|FG003|Overall Study|Missed Day 394 Visit|0|||
33223488|NCT03518125|100718903|FG004|Overall Study|Missed Day 394 Visit|0|||
33223489|NCT03518125|100718904|FG005|Overall Study|Missed Day 394 Visit|0|||
33223490|NCT03474549|100718905|FG000|Overall Study|Death|31|||
33223491|NCT03474549|100718905|FG000|Overall Study|Lost to Follow-up|4|||
33223492|NCT03474549|100718905|FG000|Overall Study|Withdrawal by Subject|2|||
33223493|NCT01395823|100718907|FG000|Overall Study|Death|4|||
33223494|NCT01395823|100718908|FG001|Overall Study|Death|4|||
33223495|NCT01395823|100718907|FG000|Overall Study|Physician Decision|3|||
33223496|NCT01395823|100718908|FG001|Overall Study|Physician Decision|1|||
33223497|NCT01395823|100718907|FG000|Overall Study|Lost to Follow-up|1|||
33223498|NCT01395823|100718908|FG001|Overall Study|Lost to Follow-up|0|||
33223499|NCT01395823|100718907|FG000|Overall Study|Transplant|1|||
33223500|NCT01395823|100718908|FG001|Overall Study|Transplant|0|||
33223501|NCT01395823|100718907|FG000|Overall Study|GI symptoms|1|||
33223502|NCT01395823|100718908|FG001|Overall Study|GI symptoms|0|||
33223503|NCT01395823|100718907|FG000|Overall Study|Withdrawal by Subject|5|||
33223504|NCT01395823|100718908|FG001|Overall Study|Withdrawal by Subject|4|||
33630752|NCT05635461|102200442|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
33223505|NCT00990340|100718909|FG000|First 14-day Treatment|Not Compliant|2|||
33223506|NCT00990340|100718910|FG001|First 14-day Treatment|Not Compliant|1|||
33223507|NCT00990340|100718909|FG000|First 14-day Treatment|Lost to Follow-up|2|||
33223508|NCT00990340|100718910|FG001|First 14-day Treatment|Lost to Follow-up|1|||
33223509|NCT00990340|100718909|FG000|First 14-day Treatment|Protocol Violation|2|||
33223510|NCT00990340|100718910|FG001|First 14-day Treatment|Protocol Violation|2|||
33630753|NCT05635461|102200443|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
33630754|NCT05635461|102200444|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
33223511|NCT00118092|100718912|FG000|Overall Study|Withdrawal by Subject|1|||
33223512|NCT00118092|100718912|FG000|Overall Study|Protocol Violation|1|||
33223513|NCT00691132|100718913|FG000|Overall Study|Adverse Event|2|||
33223514|NCT00691132|100718914|FG001|Overall Study|Adverse Event|3|||
33223515|NCT00691132|100718913|FG000|Overall Study|Withdrawal by Subject|10|||
33223516|NCT00691132|100718914|FG001|Overall Study|Withdrawal by Subject|10|||
33223517|NCT04067401|100718915|FG000|Overall Study|Withdrawal by Subject|7|||
33223518|NCT04067401|100718916|FG001|Overall Study|Withdrawal by Subject|0|||
33223519|NCT04067401|100718915|FG000|Overall Study|no data provided|1|||
33223520|NCT04067401|100718916|FG001|Overall Study|no data provided|0|||
33223521|NCT02259517|100718917|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
33566599|NCT01432444|101973023|FG001|Treatment Phase|Adverse Event|37|||
33223522|NCT02259517|100718918|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
33223523|NCT02259517|100718919|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
33223524|NCT02259517|100718917|FG000|Overall Study|Withdrawal by Subject|0|||
33223525|NCT02259517|100718918|FG001|Overall Study|Withdrawal by Subject|0|||
33223526|NCT02259517|100718919|FG002|Overall Study|Withdrawal by Subject|3|||
33223527|NCT02293395|100718920|FG000|Overall Study|Lost to Follow-up|1|||
33223528|NCT02293395|100718921|FG001|Overall Study|Lost to Follow-up|0|||
33223529|NCT02293395|100718920|FG000|Overall Study|Withdrawal by Subject|8|||
33223530|NCT02293395|100718921|FG001|Overall Study|Withdrawal by Subject|7|||
33223531|NCT01782872|100718922|FG000|Overall Study|Protocol Violation|0|||
33223532|NCT01782872|100718923|FG001|Overall Study|Protocol Violation|0|||
33223533|NCT01782872|100718924|FG002|Overall Study|Protocol Violation|0|||
33223534|NCT01782872|100718925|FG003|Overall Study|Protocol Violation|1|||
33223535|NCT01782872|100718922|FG000|Overall Study|Withdrawal by Subject|0|||
33223536|NCT01782872|100718923|FG001|Overall Study|Withdrawal by Subject|1|||
33223537|NCT01782872|100718924|FG002|Overall Study|Withdrawal by Subject|0|||
33223538|NCT01782872|100718925|FG003|Overall Study|Withdrawal by Subject|0|||
33223539|NCT04934722|100718927|FG000|Overall Study|Death|4|||
33223540|NCT04934722|100718928|FG001|Overall Study|Death|3|||
33223541|NCT04934722|100718927|FG000|Overall Study|Participants Ongoing|88|||
33223542|NCT04934722|100718928|FG001|Overall Study|Participants Ongoing|91|||
33223543|NCT03188120|100718929|FG000|Overall Study|Adverse Event|4|||
33223544|NCT03188120|100718929|FG000|Overall Study|Insufficient Effectiveness|8|||
33223545|NCT03188120|100718929|FG000|Overall Study|Improved|12|||
33223546|NCT03188120|100718929|FG000|Overall Study|Lost to Follow-up|7|||
33223547|NCT03188120|100718929|FG000|Overall Study|Other than specified|3|||
33223548|NCT03188120|100718929|FG000|Overall Study|No visit after the first visit|13|||
33223549|NCT02923739|100718930|FG000|Overall Study|Withdrawal by Subject|2|||
33223550|NCT02923739|100718931|FG001|Overall Study|Withdrawal by Subject|0|||
33223551|NCT02923739|100718932|FG002|Overall Study|Withdrawal by Subject|0|||
33223552|NCT02923739|100718933|FG003|Overall Study|Withdrawal by Subject|0|||
33223553|NCT02923739|100718930|FG000|Overall Study|Failed Screening|3|||
33223554|NCT02923739|100718931|FG001|Overall Study|Failed Screening|0|||
33223555|NCT02923739|100718932|FG002|Overall Study|Failed Screening|0|||
33223556|NCT02923739|100718933|FG003|Overall Study|Failed Screening|0|||
33223557|NCT02243202|100718934|FG000|Overall Study|Adverse Event|5|||
33223558|NCT02243202|100718935|FG001|Overall Study|Adverse Event|6|||
33223559|NCT02243202|100718936|FG002|Overall Study|Adverse Event|10|||
33364432|NCT02760407|101220564|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
33364433|NCT02760407|101220565|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
33416662|NCT00798707|101416181|FG002|Overall Study|Withdrawal by Subject|2|||
33416663|NCT00798707|101416179|FG000|Overall Study|Randomized not treated|4|||
33416664|NCT00798707|101416180|FG001|Overall Study|Randomized not treated|5|||
33416665|NCT00798707|101416181|FG002|Overall Study|Randomized not treated|1|||
33416666|NCT00203892|101416188|FG000|Overall Study|Physician Decision|1|||
33630755|NCT05635461|102200445|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
33630756|NCT05635461|102200440|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
33364434|NCT02760407|101220566|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
33364435|NCT02760407|101220567|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
33364436|NCT02760407|101220564|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
33364437|NCT02760407|101220565|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
33364438|NCT02760407|101220566|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
33364971|NCT04760314|101223690|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33416667|NCT00203892|101416189|FG001|Overall Study|Physician Decision|2|||
33416668|NCT00203892|101416190|FG002|Overall Study|Physician Decision|0|||
33416669|NCT00203892|101416188|FG000|Overall Study|Death|1|||
33416670|NCT00203892|101416189|FG001|Overall Study|Death|0|||
33416671|NCT00203892|101416190|FG002|Overall Study|Death|0|||
33416672|NCT05037409|101416191|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
33416673|NCT05037409|101416192|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
33566600|NCT01432444|101973024|FG002|Treatment Phase|Adverse Event|0|||
33223560|NCT02243202|100718937|FG003|Overall Study|Adverse Event|4|||
33223561|NCT02243202|100718934|FG000|Overall Study|Lost to Follow-up|9|||
33223562|NCT02243202|100718935|FG001|Overall Study|Lost to Follow-up|9|||
33223563|NCT02243202|100718936|FG002|Overall Study|Lost to Follow-up|14|||
33223564|NCT02243202|100718937|FG003|Overall Study|Lost to Follow-up|11|||
33223565|NCT02243202|100718934|FG000|Overall Study|Protocol Violation|3|||
33223566|NCT02243202|100718935|FG001|Overall Study|Protocol Violation|1|||
33223567|NCT02243202|100718936|FG002|Overall Study|Protocol Violation|2|||
33223568|NCT02243202|100718937|FG003|Overall Study|Protocol Violation|1|||
33223569|NCT02243202|100718934|FG000|Overall Study|Withdrawal by Subject|7|||
33223570|NCT02243202|100718935|FG001|Overall Study|Withdrawal by Subject|6|||
33223571|NCT02243202|100718936|FG002|Overall Study|Withdrawal by Subject|4|||
33223572|NCT02243202|100718937|FG003|Overall Study|Withdrawal by Subject|4|||
33223573|NCT02243202|100718934|FG000|Overall Study|Other|1|||
33223574|NCT02243202|100718935|FG001|Overall Study|Other|3|||
33223575|NCT02243202|100718936|FG002|Overall Study|Other|1|||
33223576|NCT02243202|100718937|FG003|Overall Study|Other|2|||
33223577|NCT02243202|100718934|FG000|Overall Study|Randomized but not received treatment|0|||
33223578|NCT02243202|100718935|FG001|Overall Study|Randomized but not received treatment|0|||
33223579|NCT02243202|100718936|FG002|Overall Study|Randomized but not received treatment|0|||
33223580|NCT02243202|100718937|FG003|Overall Study|Randomized but not received treatment|1|||
33223581|NCT02669095|100718938|FG000|Overall Study|Adverse Event|1|||
33223582|NCT02669095|100718939|FG001|Overall Study|Adverse Event|0|||
33223583|NCT02669095|100718938|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
33223584|NCT02669095|100718939|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
33223585|NCT02669095|100718938|FG000|Overall Study|Torn Lens|0|||
33223586|NCT02669095|100718939|FG001|Overall Study|Torn Lens|1|||
33223587|NCT02669095|100718938|FG000|Overall Study|Visit 5 assessments not completed|0|||
33364439|NCT02760407|101220567|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
33416674|NCT05037409|101416193|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
33416675|NCT01500434|101416194|FG000|Overall Study|Death|1|||
33416676|NCT01500434|101416194|FG000|Overall Study|Withdrawal by Subject|1|||
33416677|NCT01500434|101416194|FG000|Overall Study|Missed 12-month follow-up|5|||
33416678|NCT02058368|101416196|FG000|Overall Study|Adverse Event|15|||
33416679|NCT02058368|101416197|FG001|Overall Study|Adverse Event|20|||
33416680|NCT02058368|101416196|FG000|Overall Study|Lack of Efficacy|0|||
33630757|NCT05635461|102200441|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
33630758|NCT05635461|102200442|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
33630759|NCT05635461|102200443|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
33630760|NCT05635461|102200444|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
33630761|NCT05635461|102200445|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
33630762|NCT05635461|102200440|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
33630763|NCT05635461|102200441|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
33416681|NCT02058368|101416197|FG001|Overall Study|Lack of Efficacy|1|||
33416682|NCT02058368|101416196|FG000|Overall Study|Protocol Violation|0|||
33416683|NCT02058368|101416197|FG001|Overall Study|Protocol Violation|4|||
33416684|NCT02058368|101416196|FG000|Overall Study|Lost to Follow-up|2|||
33416685|NCT02058368|101416197|FG001|Overall Study|Lost to Follow-up|0|||
33416686|NCT02058368|101416196|FG000|Overall Study|Physician Decision|2|||
33630764|NCT05635461|102200442|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
33630765|NCT05635461|102200443|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
33630766|NCT05635461|102200444|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
33630767|NCT05635461|102200445|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
33630768|NCT03959423|102200451|FG000|Overall Study|Withdrawal by Subject|2|||
33630769|NCT03959423|102200452|FG001|Overall Study|Withdrawal by Subject|3|||
33630770|NCT03959423|102200451|FG000|Overall Study|Physician Decision|0|||
33630771|NCT03959423|102200452|FG001|Overall Study|Physician Decision|1|||
33630772|NCT03959423|102200451|FG000|Overall Study|Lost to Follow-up|1|||
33630773|NCT03959423|102200452|FG001|Overall Study|Lost to Follow-up|0|||
33630774|NCT03959423|102200451|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
33630775|NCT03959423|102200452|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33630776|NCT03164616|102200453|FG000|Overall Study|Death|250|||
33630777|NCT03164616|102200454|FG001|Overall Study|Death|264|||
33630778|NCT03164616|102200455|FG002|Overall Study|Death|279|||
33630779|NCT03164616|102200453|FG000|Overall Study|Lost to Follow-up|2|||
33630780|NCT03164616|102200454|FG001|Overall Study|Lost to Follow-up|2|||
33630781|NCT03164616|102200455|FG002|Overall Study|Lost to Follow-up|2|||
33630782|NCT03164616|102200453|FG000|Overall Study|Withdrawal by Subject|6|||
33630783|NCT03164616|102200454|FG001|Overall Study|Withdrawal by Subject|7|||
33630784|NCT03164616|102200455|FG002|Overall Study|Withdrawal by Subject|16|||
33630785|NCT05468814|102200456|FG000|Overall Study|Lost to Follow-up|5|||
33630786|NCT05468814|102200457|FG001|Overall Study|Lost to Follow-up|6|||
33630787|NCT00392327|102200458|FG000|Overall Study|Death|1|||
33630788|NCT00392327|102200459|FG001|Overall Study|Death|0|||
33630789|NCT00392327|102200460|FG002|Overall Study|Death|1|||
33630790|NCT00392327|102200461|FG003|Overall Study|Death|0|||
33223588|NCT02669095|100718939|FG001|Overall Study|Visit 5 assessments not completed|1|||
33223589|NCT00224770|100718940|FG000|Overall Study|Lost to Follow-up|4|||
33223590|NCT00224770|100718941|FG001|Overall Study|Lost to Follow-up|2|||
33416687|NCT02058368|101416197|FG001|Overall Study|Physician Decision|3|||
33416688|NCT02058368|101416196|FG000|Overall Study|Withdrawal by Subject|22|||
33416689|NCT02058368|101416197|FG001|Overall Study|Withdrawal by Subject|26|||
33416690|NCT03231709|101416198|FG000|Treatment Period 1|Reason not Specified|0|||
33416691|NCT03231709|101416199|FG001|Treatment Period 1|Reason not Specified|1|||
33416692|NCT03231709|101416198|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
33416693|NCT03231709|101416199|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
33416694|NCT01777191|101416200|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
33416695|NCT01777191|101416201|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
33416696|NCT01777191|101416200|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
33416697|NCT01777191|101416201|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
33416698|NCT01777191|101416200|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
33416699|NCT01777191|101416201|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
33630791|NCT00392327|102200462|FG004|Overall Study|Death|0|||
33630792|NCT00392327|102200463|FG005|Overall Study|Death|0|||
33630793|NCT00392327|102200464|FG006|Overall Study|Death|0|||
33630794|NCT00392327|102200465|FG007|Overall Study|Death|0|||
33630795|NCT00392327|102200458|FG000|Overall Study|Lack of Efficacy|8|||
33630796|NCT00392327|102200459|FG001|Overall Study|Lack of Efficacy|8|||
33630797|NCT00392327|102200460|FG002|Overall Study|Lack of Efficacy|9|||
33630798|NCT00392327|102200461|FG003|Overall Study|Lack of Efficacy|6|||
33630799|NCT00392327|102200462|FG004|Overall Study|Lack of Efficacy|3|||
33630800|NCT00392327|102200463|FG005|Overall Study|Lack of Efficacy|3|||
33630801|NCT00392327|102200464|FG006|Overall Study|Lack of Efficacy|3|||
33630802|NCT00392327|102200465|FG007|Overall Study|Lack of Efficacy|3|||
33630803|NCT00392327|102200458|FG000|Overall Study|Physician Decision|3|||
33630804|NCT00392327|102200459|FG001|Overall Study|Physician Decision|5|||
33630805|NCT00392327|102200460|FG002|Overall Study|Physician Decision|2|||
33630806|NCT00392327|102200461|FG003|Overall Study|Physician Decision|2|||
33630807|NCT00392327|102200462|FG004|Overall Study|Physician Decision|0|||
33630808|NCT00392327|102200463|FG005|Overall Study|Physician Decision|1|||
33630809|NCT00392327|102200464|FG006|Overall Study|Physician Decision|5|||
33630810|NCT00392327|102200465|FG007|Overall Study|Physician Decision|3|||
33630811|NCT00392327|102200458|FG000|Overall Study|Protocol Violation|0|||
33416700|NCT01777191|101416200|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
33416701|NCT01777191|101416201|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
33416702|NCT01777191|101416200|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
33416703|NCT01777191|101416201|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
33416704|NCT01777191|101416200|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
33416705|NCT01777191|101416201|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
33416706|NCT01777191|101416200|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
33416707|NCT01777191|101416201|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
33566601|NCT01432444|101973022|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
33566602|NCT01432444|101973023|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
33566603|NCT01432444|101973024|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
33566604|NCT01432444|101973022|FG000|Treatment Phase|Physician Decision|0|||
33566605|NCT01432444|101973023|FG001|Treatment Phase|Physician Decision|5|||
33566606|NCT01432444|101973024|FG002|Treatment Phase|Physician Decision|0|||
33566607|NCT01432444|101973022|FG000|Treatment Phase|Withdrawal by Subject|0|||
33223591|NCT00224770|100718942|FG002|Overall Study|Lost to Follow-up|0|||
33223592|NCT00717314|100718943|FG000|Overall Study|Adverse Event|3|||
33223593|NCT00717314|100718944|FG001|Overall Study|Adverse Event|2|||
33223594|NCT00717314|100718943|FG000|Overall Study|Protocol Violation|1|||
33416708|NCT01777191|101416200|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
33416709|NCT01777191|101416201|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
33416710|NCT01777191|101416200|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
33416711|NCT01777191|101416201|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
33566608|NCT01432444|101973023|FG001|Treatment Phase|Withdrawal by Subject|41|||
33566609|NCT01432444|101973024|FG002|Treatment Phase|Withdrawal by Subject|0|||
33566610|NCT01432444|101973022|FG000|Treatment Phase|Protocol Deviation|0|||
33566611|NCT01432444|101973023|FG001|Treatment Phase|Protocol Deviation|3|||
33630812|NCT00392327|102200459|FG001|Overall Study|Protocol Violation|0|||
33630813|NCT00392327|102200460|FG002|Overall Study|Protocol Violation|1|||
33630814|NCT00392327|102200461|FG003|Overall Study|Protocol Violation|0|||
33223595|NCT00717314|100718944|FG001|Overall Study|Protocol Violation|0|||
33630815|NCT00392327|102200462|FG004|Overall Study|Protocol Violation|0|||
33630816|NCT00392327|102200463|FG005|Overall Study|Protocol Violation|0|||
33630817|NCT00392327|102200464|FG006|Overall Study|Protocol Violation|0|||
33630818|NCT00392327|102200465|FG007|Overall Study|Protocol Violation|0|||
33630819|NCT00392327|102200458|FG000|Overall Study|Withdrawal by Subject|3|||
33630820|NCT00392327|102200459|FG001|Overall Study|Withdrawal by Subject|2|||
33630821|NCT00392327|102200460|FG002|Overall Study|Withdrawal by Subject|4|||
33630822|NCT00392327|102200461|FG003|Overall Study|Withdrawal by Subject|6|||
33630823|NCT00392327|102200462|FG004|Overall Study|Withdrawal by Subject|0|||
33630824|NCT00392327|102200463|FG005|Overall Study|Withdrawal by Subject|1|||
33630825|NCT00392327|102200464|FG006|Overall Study|Withdrawal by Subject|1|||
33630826|NCT00392327|102200465|FG007|Overall Study|Withdrawal by Subject|5|||
33630827|NCT00392327|102200458|FG000|Overall Study|Ineligible|0|||
33630828|NCT00392327|102200459|FG001|Overall Study|Ineligible|4|||
33630829|NCT00392327|102200460|FG002|Overall Study|Ineligible|3|||
33630830|NCT00392327|102200461|FG003|Overall Study|Ineligible|2|||
33630831|NCT00392327|102200462|FG004|Overall Study|Ineligible|0|||
33630832|NCT00392327|102200463|FG005|Overall Study|Ineligible|0|||
33630833|NCT00392327|102200464|FG006|Overall Study|Ineligible|0|||
33630834|NCT00392327|102200465|FG007|Overall Study|Ineligible|0|||
33630835|NCT02432703|102200469|FG000|Overall Study|Adverse Event|1|||
33630836|NCT02432703|102200470|FG001|Overall Study|Adverse Event|4|||
33630837|NCT02432703|102200469|FG000|Overall Study|Lack of Efficacy|1|||
33630838|NCT02432703|102200470|FG001|Overall Study|Lack of Efficacy|0|||
33630839|NCT02432703|102200469|FG000|Overall Study|Lost to Follow-up|5|||
33630840|NCT02432703|102200470|FG001|Overall Study|Lost to Follow-up|3|||
33630841|NCT02432703|102200469|FG000|Overall Study|Withdrawal by Subject|9|||
33630842|NCT02432703|102200470|FG001|Overall Study|Withdrawal by Subject|6|||
33630843|NCT02432703|102200469|FG000|Overall Study|Other|6|||
33630844|NCT02432703|102200470|FG001|Overall Study|Other|5|||
33630845|NCT05720897|102200471|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
33630846|NCT05720897|102200472|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
33630847|NCT03009058|102200477|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
33416712|NCT01777191|101416200|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
33416713|NCT01777191|101416201|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
33416714|NCT01777191|101416200|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
33416715|NCT01777191|101416201|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
33416716|NCT00297882|101416209|FG000|Day 14|Lack of Efficacy|12|||
33416717|NCT00297882|101416210|FG001|Day 14|Lack of Efficacy|49|||
33416718|NCT00297882|101416209|FG000|Day 28|Lost to Follow-up|13|||
33416719|NCT00297882|101416210|FG001|Day 28|Lost to Follow-up|23|||
33416720|NCT00297882|101416209|FG000|Day 28|Lack of Efficacy|3|||
33416721|NCT00297882|101416210|FG001|Day 28|Lack of Efficacy|0|||
33416722|NCT01977625|101416211|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
33566612|NCT01432444|101973024|FG002|Treatment Phase|Protocol Deviation|0|||
33566613|NCT01432444|101973022|FG000|Treatment Phase|Lack of Efficacy|0|||
33566614|NCT01432444|101973023|FG001|Treatment Phase|Lack of Efficacy|10|||
33566615|NCT01432444|101973024|FG002|Treatment Phase|Lack of Efficacy|0|||
33566616|NCT01432444|101973022|FG000|Extension Phase|Lost to Follow-up|0|||
33566617|NCT01432444|101973023|FG001|Extension Phase|Lost to Follow-up|0|||
33566618|NCT01432444|101973024|FG002|Extension Phase|Lost to Follow-up|17|||
33566619|NCT01432444|101973022|FG000|Extension Phase|Adverse Event|0|||
33566620|NCT01432444|101973023|FG001|Extension Phase|Adverse Event|0|||
33566621|NCT01432444|101973024|FG002|Extension Phase|Adverse Event|10|||
33566622|NCT01432444|101973022|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
33566623|NCT01432444|101973023|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
33566624|NCT01432444|101973024|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
33566625|NCT01432444|101973022|FG000|Extension Phase|Met Withdrawal Criteria|0|||
33566626|NCT01432444|101973023|FG001|Extension Phase|Met Withdrawal Criteria|0|||
33566627|NCT01432444|101973024|FG002|Extension Phase|Met Withdrawal Criteria|144|||
33566628|NCT01432444|101973022|FG000|Extension Phase|Physician Decision|0|||
33566629|NCT01432444|101973023|FG001|Extension Phase|Physician Decision|0|||
33566630|NCT01432444|101973024|FG002|Extension Phase|Physician Decision|1|||
33566631|NCT01432444|101973022|FG000|Extension Phase|Withdrawal by Subject|0|||
33566632|NCT01432444|101973023|FG001|Extension Phase|Withdrawal by Subject|0|||
33566633|NCT01432444|101973024|FG002|Extension Phase|Withdrawal by Subject|13|||
33566634|NCT00759395|101973028|FG000|Overall Study|Adverse Event|1|||
33566635|NCT00759395|101973029|FG001|Overall Study|Adverse Event|0|||
33630848|NCT00521079|102200478|FG000|Overall Study|Adverse Event|7|||
33630849|NCT00521079|102200479|FG001|Overall Study|Adverse Event|1|||
33630850|NCT00521079|102200478|FG000|Overall Study|Lost to Follow-up|2|||
33630851|NCT00521079|102200479|FG001|Overall Study|Lost to Follow-up|1|||
33630852|NCT00521079|102200478|FG000|Overall Study|Withdrawal by Subject|5|||
33566636|NCT00759395|101973028|FG000|Overall Study|Withdrawal by Subject|1|||
33630853|NCT00521079|102200479|FG001|Overall Study|Withdrawal by Subject|3|||
33364440|NCT02760407|101220564|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
33364441|NCT02760407|101220565|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
33566637|NCT00759395|101973029|FG001|Overall Study|Withdrawal by Subject|0|||
33566638|NCT00759395|101973028|FG000|Overall Study|Lack of Efficacy|0|||
33566639|NCT00759395|101973029|FG001|Overall Study|Lack of Efficacy|2|||
33566640|NCT01514357|101973033|FG000|Overall Study|Screen failure|2|||
33566641|NCT01514357|101973034|FG001|Overall Study|Screen failure|0|||
33566642|NCT01514357|101973033|FG000|Overall Study|Withdrawal by Subject|2|||
33566643|NCT01514357|101973034|FG001|Overall Study|Withdrawal by Subject|0|||
33566644|NCT00829868|101973035|FG000|Washout|Physician Decision|1|||
33566645|NCT00829868|101973036|FG001|Washout|Physician Decision|0|||
33566646|NCT01362790|101973037|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
33566647|NCT01362790|101973038|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
33566648|NCT01362790|101973039|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
33630854|NCT04500158|102200480|FG000|Overall Study|Physician Decision|17|||
33630855|NCT04500158|102200481|FG001|Overall Study|Physician Decision|11|||
33630856|NCT02177695|102200482|FG000|ITT Analysis|Ineligible|5|||
33630857|NCT02177695|102200483|FG001|ITT Analysis|Ineligible|5|||
33630858|NCT02177695|102200482|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
33630859|NCT02177695|102200483|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
33630860|NCT02177695|102200482|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
33630861|NCT02177695|102200483|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
33630862|NCT02177695|102200482|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
33364442|NCT02760407|101220566|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
33364443|NCT02760407|101220567|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
33364444|NCT02760407|101220564|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
33364445|NCT02760407|101220565|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
33364446|NCT02760407|101220566|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
33364447|NCT02760407|101220567|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
33364448|NCT02760407|101220564|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
33364449|NCT02760407|101220565|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
33364450|NCT02760407|101220566|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
33364451|NCT02760407|101220567|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
33364452|NCT02760407|101220564|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
33364453|NCT02760407|101220565|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
33364454|NCT02760407|101220566|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
33364455|NCT02760407|101220567|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
33364456|NCT02760407|101220564|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
33364457|NCT02760407|101220565|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
33364458|NCT02760407|101220566|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
33364459|NCT02760407|101220567|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
33630863|NCT02177695|102200483|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
33630864|NCT04218240|102200484|FG000|Overall Study|Withdrawal by Subject|6|||
33630865|NCT04218240|102200485|FG001|Overall Study|Withdrawal by Subject|0|||
33630866|NCT04218240|102200484|FG000|Overall Study|Lack of Efficacy|24|||
33630867|NCT04218240|102200485|FG001|Overall Study|Lack of Efficacy|19|||
33630868|NCT04218240|102200484|FG000|Overall Study|Physician Decision|0|||
33630869|NCT04218240|102200485|FG001|Overall Study|Physician Decision|1|||
33630870|NCT04218240|102200484|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
33630871|NCT04218240|102200485|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
33630872|NCT02476617|102200487|FG000|Overall Study|Adverse Event|1|||
33630873|NCT02476617|102200487|FG000|Overall Study|Lost to Follow-up|1|||
33364460|NCT02760407|101220564|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
33364461|NCT02760407|101220565|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
33364462|NCT02760407|101220566|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
33364463|NCT02760407|101220567|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
33364464|NCT00751101|101220568|FG000|Overall Study|Withdrawal by Subject|1|||
33364465|NCT00751101|101220569|FG001|Overall Study|Withdrawal by Subject|0|||
33364466|NCT00751101|101220568|FG000|Overall Study|No HFS / Never Started Patch/|0|||
33364467|NCT00751101|101220569|FG001|Overall Study|No HFS / Never Started Patch/|4|||
33364468|NCT00751101|101220568|FG000|Overall Study|Never began capecitabine|1|||
33566649|NCT01362790|101973040|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
33630874|NCT02718898|102200490|FG000|Blinded Treatment Period|Adverse Event|5|||
33630875|NCT02718898|102200491|FG001|Blinded Treatment Period|Adverse Event|1|||
33630876|NCT02718898|102200492|FG002|Blinded Treatment Period|Adverse Event|0|||
33364469|NCT00751101|101220569|FG001|Overall Study|Never began capecitabine|0|||
33630877|NCT02718898|102200493|FG003|Blinded Treatment Period|Adverse Event|0|||
33630878|NCT02718898|102200494|FG004|Blinded Treatment Period|Adverse Event|0|||
33630879|NCT02718898|102200495|FG005|Blinded Treatment Period|Adverse Event|0|||
33630880|NCT02718898|102200496|FG006|Blinded Treatment Period|Adverse Event|0|||
33630881|NCT02718898|102200490|FG000|Blinded Treatment Period|Physician Decision|1|||
33364470|NCT00751101|101220568|FG000|Overall Study|Physician Decision|0|||
33364471|NCT00751101|101220569|FG001|Overall Study|Physician Decision|1|||
33364472|NCT00751881|101220573|FG000|Core Treatment Period|Not treated|1|||
33364473|NCT00751881|101220574|FG001|Core Treatment Period|Not treated|1|||
33364474|NCT00751881|101220575|FG002|Core Treatment Period|Not treated|2|||
33364475|NCT00751881|101220573|FG000|Core Treatment Period|Adverse Event|26|||
33364476|NCT00751881|101220574|FG001|Core Treatment Period|Adverse Event|54|||
33364477|NCT00751881|101220575|FG002|Core Treatment Period|Adverse Event|58|||
33364478|NCT00751881|101220573|FG000|Core Treatment Period|Lack of Efficacy|37|||
33630882|NCT02718898|102200491|FG001|Blinded Treatment Period|Physician Decision|0|||
33630883|NCT02718898|102200492|FG002|Blinded Treatment Period|Physician Decision|0|||
33630884|NCT02718898|102200493|FG003|Blinded Treatment Period|Physician Decision|0|||
33630885|NCT02718898|102200494|FG004|Blinded Treatment Period|Physician Decision|0|||
33630886|NCT02718898|102200495|FG005|Blinded Treatment Period|Physician Decision|0|||
33630887|NCT02718898|102200496|FG006|Blinded Treatment Period|Physician Decision|0|||
33630888|NCT02718898|102200490|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
33630889|NCT02718898|102200491|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
33630890|NCT02718898|102200492|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
33630891|NCT02718898|102200493|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
33630892|NCT02718898|102200494|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
33630893|NCT02718898|102200495|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
33630894|NCT02718898|102200496|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
33630895|NCT02718898|102200490|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
33630896|NCT02718898|102200491|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
33364479|NCT00751881|101220574|FG001|Core Treatment Period|Lack of Efficacy|30|||
33364480|NCT00751881|101220575|FG002|Core Treatment Period|Lack of Efficacy|20|||
33364481|NCT00751881|101220573|FG000|Core Treatment Period|Poor compliance to protocol|15|||
33364482|NCT00751881|101220574|FG001|Core Treatment Period|Poor compliance to protocol|3|||
33364483|NCT00751881|101220575|FG002|Core Treatment Period|Poor compliance to protocol|4|||
33364484|NCT00751881|101220573|FG000|Core Treatment Period|Lost to Follow-up|6|||
33364485|NCT00751881|101220574|FG001|Core Treatment Period|Lost to Follow-up|4|||
33364486|NCT00751881|101220575|FG002|Core Treatment Period|Lost to Follow-up|3|||
33364487|NCT00751881|101220573|FG000|Core Treatment Period|Other: protocol deviation|3|||
33364488|NCT00751881|101220574|FG001|Core Treatment Period|Other: protocol deviation|3|||
33364489|NCT00751881|101220575|FG002|Core Treatment Period|Other: protocol deviation|7|||
33364490|NCT00751881|101220573|FG000|Core Treatment Period|Other: wish to parent|5|||
33364491|NCT00751881|101220574|FG001|Core Treatment Period|Other: wish to parent|7|||
33416723|NCT01977625|101416212|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
33416724|NCT01977625|101416211|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
33416725|NCT01977625|101416212|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
33416726|NCT01856257|101416216|FG000|Overall Study|Death|2|||
33416727|NCT01856257|101416217|FG001|Overall Study|Death|0|||
33416728|NCT01856257|101416218|FG002|Overall Study|Death|0|||
33416729|NCT01856257|101416219|FG003|Overall Study|Death|0|||
33416730|NCT01856257|101416216|FG000|Overall Study|Physician Decision|0|||
33416731|NCT01856257|101416217|FG001|Overall Study|Physician Decision|0|||
33416732|NCT01856257|101416218|FG002|Overall Study|Physician Decision|0|||
33416733|NCT01856257|101416219|FG003|Overall Study|Physician Decision|1|||
33416734|NCT01856257|101416216|FG000|Overall Study|Withdrawal by Subject|1|||
33416735|NCT01856257|101416217|FG001|Overall Study|Withdrawal by Subject|1|||
33416736|NCT01856257|101416218|FG002|Overall Study|Withdrawal by Subject|0|||
33416737|NCT01856257|101416219|FG003|Overall Study|Withdrawal by Subject|0|||
33416738|NCT01856257|101416216|FG000|Overall Study|Donor complication|0|||
33416739|NCT01856257|101416217|FG001|Overall Study|Donor complication|0|||
33416740|NCT01856257|101416218|FG002|Overall Study|Donor complication|0|||
33416741|NCT01856257|101416219|FG003|Overall Study|Donor complication|1|||
33416742|NCT04980391|101416220|FG000|Overall Study|Death|0|||
33416743|NCT04980391|101416221|FG001|Overall Study|Death|0|||
33416744|NCT04980391|101416222|FG002|Overall Study|Death|1|||
33416745|NCT04980391|101416223|FG003|Overall Study|Death|1|||
33416746|NCT04980391|101416220|FG000|Overall Study|Lost to Follow-up|3|||
33416747|NCT04980391|101416221|FG001|Overall Study|Lost to Follow-up|3|||
33416748|NCT04980391|101416222|FG002|Overall Study|Lost to Follow-up|2|||
33630897|NCT02718898|102200492|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
33364492|NCT00751881|101220575|FG002|Core Treatment Period|Other: wish to parent|4|||
33416749|NCT04980391|101416223|FG003|Overall Study|Lost to Follow-up|3|||
33416750|NCT04980391|101416220|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
33416751|NCT04980391|101416221|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
33630898|NCT02718898|102200493|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
33364493|NCT00751881|101220573|FG000|Core Treatment Period|Other: personal/family constraints|6|||
33364494|NCT00751881|101220574|FG001|Core Treatment Period|Other: personal/family constraints|7|||
33364495|NCT00751881|101220575|FG002|Core Treatment Period|Other: personal/family constraints|10|||
33630899|NCT02718898|102200494|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
33630900|NCT02718898|102200495|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
33630901|NCT02718898|102200496|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
33630902|NCT02718898|102200490|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
33630903|NCT02718898|102200491|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
33630904|NCT02718898|102200492|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
33630905|NCT02718898|102200493|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
33630906|NCT02718898|102200494|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
33630907|NCT02718898|102200495|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
33630908|NCT02718898|102200496|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
33630909|NCT02718898|102200490|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
33630910|NCT02718898|102200491|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
33630911|NCT02718898|102200492|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
33630912|NCT02718898|102200493|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
33364496|NCT00751881|101220573|FG000|Core Treatment Period|Other: MS treatment change|6|||
33364497|NCT00751881|101220574|FG001|Core Treatment Period|Other: MS treatment change|4|||
33364498|NCT00751881|101220575|FG002|Core Treatment Period|Other: MS treatment change|4|||
33364499|NCT00751881|101220573|FG000|Core Treatment Period|Other: tolerability complaints|2|||
33364500|NCT00751881|101220574|FG001|Core Treatment Period|Other: tolerability complaints|0|||
33364501|NCT00751881|101220575|FG002|Core Treatment Period|Other: tolerability complaints|0|||
33364502|NCT00751881|101220573|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
33364503|NCT00751881|101220574|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
33364504|NCT00751881|101220575|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
33364505|NCT00751881|101220573|FG000|Extension Study Period|Adverse Event|18|||
33364506|NCT00751881|101220574|FG001|Extension Study Period|Adverse Event|20|||
33364507|NCT00751881|101220575|FG002|Extension Study Period|Adverse Event|21|||
33364508|NCT00751881|101220573|FG000|Extension Study Period|Lack of Efficacy|14|||
33364509|NCT00751881|101220574|FG001|Extension Study Period|Lack of Efficacy|10|||
33364510|NCT00751881|101220575|FG002|Extension Study Period|Lack of Efficacy|20|||
33364511|NCT00751881|101220573|FG000|Extension Study Period|Lost to Follow-up|4|||
33416752|NCT04980391|101416222|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
33566650|NCT01362790|101973041|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
33566651|NCT01362790|101973042|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
33566652|NCT01362790|101973043|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
33566653|NCT01362790|101973037|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
33566654|NCT01362790|101973038|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
33566655|NCT01362790|101973039|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
33566656|NCT01362790|101973040|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
33566657|NCT01362790|101973041|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
33566658|NCT01362790|101973042|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
33566659|NCT01362790|101973043|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
33566660|NCT01362790|101973037|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
33566661|NCT01362790|101973038|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
33566662|NCT01362790|101973039|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
33566663|NCT01362790|101973040|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
33566664|NCT01362790|101973041|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
33566665|NCT01362790|101973042|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
33566666|NCT01362790|101973043|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
33566667|NCT01362790|101973037|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
33566668|NCT01362790|101973038|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
33566669|NCT01362790|101973039|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
33566670|NCT01362790|101973040|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
33566671|NCT01362790|101973041|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
33566672|NCT01362790|101973042|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
33566673|NCT01362790|101973043|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
33566674|NCT01362790|101973037|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
33566675|NCT01362790|101973038|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
33566676|NCT01362790|101973039|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
33566677|NCT01362790|101973040|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
33630913|NCT02718898|102200494|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
33630914|NCT02718898|102200495|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
33630915|NCT02718898|102200496|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
33416753|NCT04980391|101416223|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
33416754|NCT04980391|101416220|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33566678|NCT01362790|101973041|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
33566679|NCT01362790|101973042|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
33566680|NCT01362790|101973043|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
33566681|NCT01362790|101973037|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
33566682|NCT01362790|101973038|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
33566683|NCT01362790|101973039|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
33630916|NCT02718898|102200490|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33630917|NCT02718898|102200491|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33416755|NCT04980391|101416221|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33416756|NCT04980391|101416222|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
33416757|NCT04980391|101416223|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33416758|NCT04980391|101416220|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
33416759|NCT04980391|101416221|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
33416760|NCT04980391|101416222|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
33416761|NCT04980391|101416223|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
33416762|NCT02204449|101416224|FG000|Overall Study|Lost to Follow-up|7|||
33364512|NCT00751881|101220574|FG001|Extension Study Period|Lost to Follow-up|9|||
33364513|NCT00751881|101220575|FG002|Extension Study Period|Lost to Follow-up|6|||
33364514|NCT00751881|101220573|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
33364515|NCT00751881|101220574|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
33364516|NCT00751881|101220575|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
33364517|NCT00751881|101220573|FG000|Extension Study Period|Other than specified above|26|||
33364518|NCT00751881|101220574|FG001|Extension Study Period|Other than specified above|30|||
33364519|NCT00751881|101220575|FG002|Extension Study Period|Other than specified above|18|||
33566684|NCT01362790|101973040|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
33566685|NCT01362790|101973041|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
33223596|NCT00717314|100718943|FG000|Overall Study|Lost to Follow-up|1|||
33566686|NCT01362790|101973042|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
33566687|NCT01362790|101973043|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
33566688|NCT01362790|101973037|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
33566689|NCT01362790|101973038|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
33566690|NCT01362790|101973039|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
33566691|NCT01362790|101973040|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
33566692|NCT01362790|101973041|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
33566693|NCT01362790|101973042|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
33566694|NCT01362790|101973043|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
33566695|NCT01362790|101973037|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
33566696|NCT01362790|101973038|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
33566697|NCT01362790|101973039|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
33566698|NCT01362790|101973040|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
33566699|NCT01362790|101973041|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
33566700|NCT01362790|101973042|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
33566701|NCT01362790|101973043|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
33566702|NCT01362790|101973037|FG000|Pilot Phase & Phase 2|Death on study|0|||
33566703|NCT01362790|101973038|FG001|Pilot Phase & Phase 2|Death on study|0|||
33566704|NCT01362790|101973039|FG002|Pilot Phase & Phase 2|Death on study|0|||
33566705|NCT01362790|101973040|FG003|Pilot Phase & Phase 2|Death on study|1|||
33566706|NCT01362790|101973041|FG004|Pilot Phase & Phase 2|Death on study|0|||
33566707|NCT01362790|101973042|FG005|Pilot Phase & Phase 2|Death on study|0|||
33566708|NCT01362790|101973043|FG006|Pilot Phase & Phase 2|Death on study|0|||
33566709|NCT01362790|101973037|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
33566710|NCT01362790|101973038|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
33566711|NCT01362790|101973039|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
33566712|NCT01362790|101973040|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
33566713|NCT01362790|101973041|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
33566714|NCT01362790|101973042|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
33566715|NCT01362790|101973043|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
33566716|NCT01362790|101973037|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
33566717|NCT01362790|101973038|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
33566718|NCT01362790|101973039|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
33566719|NCT01362790|101973040|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
33566720|NCT01362790|101973041|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
33566721|NCT01362790|101973042|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
33566722|NCT01362790|101973043|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
33566723|NCT01362790|101973037|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
33566724|NCT01362790|101973038|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
33566725|NCT01362790|101973039|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
33566726|NCT01362790|101973040|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
33566727|NCT01362790|101973041|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
33364520|NCT00546819|101220576|FG000|Overall Study|Adverse Event|2|||
33364521|NCT00546819|101220577|FG001|Overall Study|Adverse Event|3|||
33364522|NCT00546819|101220576|FG000|Overall Study|Lost to Follow-up|2|||
33364523|NCT00546819|101220577|FG001|Overall Study|Lost to Follow-up|1|||
33364524|NCT00546819|101220576|FG000|Overall Study|Withdrawal by Subject|4|||
33364525|NCT00546819|101220577|FG001|Overall Study|Withdrawal by Subject|2|||
33364526|NCT03472534|101220578|FG000|Overall Study|Withdrawal by Subject|9|||
33364527|NCT03472534|101220578|FG000|Overall Study|Adverse Event|2|||
33364528|NCT00224107|101220584|FG000|Overall Study|Adverse Event|20|||
33364529|NCT00224107|101220585|FG001|Overall Study|Adverse Event|6|||
33364530|NCT00224107|101220584|FG000|Overall Study|Protocol Violation|2|||
33364531|NCT00224107|101220585|FG001|Overall Study|Protocol Violation|3|||
33364532|NCT00224107|101220584|FG000|Overall Study|Withdrawal by Subject|1|||
33630918|NCT02718898|102200492|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
33364533|NCT00224107|101220585|FG001|Overall Study|Withdrawal by Subject|4|||
33364534|NCT00224107|101220584|FG000|Overall Study|Lack of Efficacy|2|||
33364535|NCT00224107|101220585|FG001|Overall Study|Lack of Efficacy|0|||
33223597|NCT00717314|100718944|FG001|Overall Study|Lost to Follow-up|5|||
33364536|NCT00224107|101220584|FG000|Overall Study|Lost to Follow-up|4|||
33416763|NCT02204449|101416225|FG001|Overall Study|Lost to Follow-up|9|||
33416764|NCT02204449|101416224|FG000|Overall Study|Death|0|||
33416765|NCT02204449|101416225|FG001|Overall Study|Death|1|||
33416766|NCT02204449|101416224|FG000|Overall Study|Withdrawal by Subject|0|||
33416767|NCT02204449|101416225|FG001|Overall Study|Withdrawal by Subject|1|||
33416768|NCT01244516|101416226|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
33416769|NCT01244516|101416227|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
33416770|NCT01244516|101416228|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
33416771|NCT01244516|101416226|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
33416772|NCT01244516|101416227|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
33416773|NCT01244516|101416228|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
33630919|NCT02718898|102200493|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
33630920|NCT02718898|102200494|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33630921|NCT02718898|102200495|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33630922|NCT02718898|102200496|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33630923|NCT02718898|102200490|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
33630924|NCT02718898|102200491|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
33630925|NCT02718898|102200492|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
33630926|NCT02718898|102200493|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
33630927|NCT02718898|102200494|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
33630928|NCT02718898|102200495|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
33630929|NCT02718898|102200496|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
33630930|NCT02718898|102200490|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
33630931|NCT02718898|102200491|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
33630932|NCT02718898|102200492|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
33630933|NCT02718898|102200493|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
33364537|NCT00224107|101220585|FG001|Overall Study|Lost to Follow-up|0|||
33364538|NCT00224107|101220584|FG000|Overall Study|Physician Decision|1|||
33364539|NCT00224107|101220585|FG001|Overall Study|Physician Decision|0|||
33416774|NCT01244516|101416226|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
33416775|NCT01244516|101416227|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
33416776|NCT01244516|101416228|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
33416777|NCT01244516|101416226|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
33416778|NCT01244516|101416227|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
33416779|NCT01244516|101416228|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
33566728|NCT01362790|101973042|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
33566729|NCT01362790|101973043|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
33566730|NCT01948427|101973045|FG000|Overall Study|Serious Adverse Event|3|||
33566731|NCT01948427|101973046|FG001|Overall Study|Serious Adverse Event|0|||
33566732|NCT01948427|101973047|FG002|Overall Study|Serious Adverse Event|0|||
33566733|NCT01948427|101973048|FG003|Overall Study|Serious Adverse Event|0|||
33566734|NCT01948427|101973049|FG004|Overall Study|Serious Adverse Event|1|||
33566735|NCT01948427|101973045|FG000|Overall Study|Investigator Request|0|||
33566736|NCT01948427|101973046|FG001|Overall Study|Investigator Request|8|||
33566737|NCT01948427|101973047|FG002|Overall Study|Investigator Request|0|||
33630934|NCT02718898|102200494|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
33630935|NCT02718898|102200495|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
33630936|NCT02718898|102200496|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
33630937|NCT02718898|102200490|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
33364540|NCT00224107|101220584|FG000|Overall Study|Other|1|||
33364541|NCT00224107|101220585|FG001|Overall Study|Other|1|||
33364542|NCT01544595|101220586|FG000|Status at Week 68|Adverse Event|3|||
33364543|NCT01544595|101220587|FG001|Status at Week 68|Adverse Event|2|||
33364544|NCT01544595|101220588|FG002|Status at Week 68|Adverse Event|1|||
33364545|NCT01544595|101220589|FG003|Status at Week 68|Adverse Event|0|||
33364546|NCT01544595|101220590|FG004|Status at Week 68|Adverse Event|0|||
33364547|NCT01544595|101220591|FG005|Status at Week 68|Adverse Event|0|||
33364548|NCT01544595|101220586|FG000|Status at Week 68|Lack of Efficacy|1|||
33364549|NCT01544595|101220587|FG001|Status at Week 68|Lack of Efficacy|0|||
33364550|NCT01544595|101220588|FG002|Status at Week 68|Lack of Efficacy|0|||
33364551|NCT01544595|101220589|FG003|Status at Week 68|Lack of Efficacy|0|||
33364552|NCT01544595|101220590|FG004|Status at Week 68|Lack of Efficacy|0|||
33364553|NCT01544595|101220591|FG005|Status at Week 68|Lack of Efficacy|0|||
33364554|NCT01544595|101220586|FG000|Status at Week 68|Lost to Follow-up|1|||
33364555|NCT01544595|101220587|FG001|Status at Week 68|Lost to Follow-up|1|||
33364556|NCT01544595|101220588|FG002|Status at Week 68|Lost to Follow-up|0|||
33364557|NCT01544595|101220589|FG003|Status at Week 68|Lost to Follow-up|0|||
33566738|NCT01948427|101973048|FG003|Overall Study|Investigator Request|0|||
33566739|NCT01948427|101973049|FG004|Overall Study|Investigator Request|6|||
33566740|NCT01948427|101973045|FG000|Overall Study|Lost to Follow-up|1|||
33566741|NCT01948427|101973046|FG001|Overall Study|Lost to Follow-up|0|||
33566742|NCT01948427|101973047|FG002|Overall Study|Lost to Follow-up|0|||
33566743|NCT01948427|101973048|FG003|Overall Study|Lost to Follow-up|0|||
33566744|NCT01948427|101973049|FG004|Overall Study|Lost to Follow-up|4|||
33566745|NCT01948427|101973045|FG000|Overall Study|Withdrawal by Subject|2|||
33566746|NCT01948427|101973046|FG001|Overall Study|Withdrawal by Subject|0|||
33566747|NCT01948427|101973047|FG002|Overall Study|Withdrawal by Subject|0|||
33566748|NCT01948427|101973048|FG003|Overall Study|Withdrawal by Subject|0|||
33566749|NCT01948427|101973049|FG004|Overall Study|Withdrawal by Subject|1|||
33566750|NCT01948427|101973045|FG000|Overall Study|Other, Not Specified|1|||
33566751|NCT01948427|101973046|FG001|Overall Study|Other, Not Specified|9|||
33566752|NCT01948427|101973047|FG002|Overall Study|Other, Not Specified|0|||
33566753|NCT01948427|101973048|FG003|Overall Study|Other, Not Specified|0|||
33566754|NCT01948427|101973049|FG004|Overall Study|Other, Not Specified|2|||
33566755|NCT00337168|101973052|FG000|Overall Study|Death|5|||
33566756|NCT00337168|101973052|FG000|Overall Study|Not protocol specified|2|||
33566757|NCT00337168|101973052|FG000|Overall Study|Did not start therapy|1|||
33566758|NCT00779909|101973059|FG000|Overall Study|Lost to Follow-up|1|||
33566759|NCT00779909|101973060|FG001|Overall Study|Lost to Follow-up|0|||
33566760|NCT00779909|101973061|FG002|Overall Study|Lost to Follow-up|0|||
33566761|NCT00779909|101973062|FG003|Overall Study|Lost to Follow-up|1|||
33566762|NCT00779909|101973059|FG000|Overall Study|Withdrawal by Subject|0|||
33566763|NCT00779909|101973060|FG001|Overall Study|Withdrawal by Subject|1|||
33566764|NCT00779909|101973061|FG002|Overall Study|Withdrawal by Subject|0|||
33566765|NCT00779909|101973062|FG003|Overall Study|Withdrawal by Subject|0|||
33566766|NCT02796651|101973063|FG000|Overall Study|Adverse Event|6|||
33566767|NCT02796651|101973063|FG000|Overall Study|Lost to Follow-up|1|||
33566768|NCT02796651|101973063|FG000|Overall Study|Withdrawal by Subject|4|||
33566769|NCT02796651|101973063|FG000|Overall Study|Protocol Violation|4|||
33566770|NCT02796651|101973063|FG000|Overall Study|Lack of Efficacy|1|||
33566771|NCT02796651|101973063|FG000|Overall Study|Other|10|||
33566772|NCT00829998|101973064|FG000|Washout|Adverse Event|0|||
33566773|NCT00829998|101973065|FG001|Washout|Adverse Event|1|||
33566774|NCT03038620|101973066|FG000|Overall Study|Lost to Follow-up|18|||
33566775|NCT03038620|101973067|FG001|Overall Study|Lost to Follow-up|23|||
33566776|NCT03038620|101973066|FG000|Overall Study|Withdrawal by Subject|0|||
33566777|NCT03038620|101973067|FG001|Overall Study|Withdrawal by Subject|15|||
33566778|NCT03038620|101973066|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
33566779|NCT03038620|101973067|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
33566780|NCT04282148|101973068|FG000|Overall Study|Death|1|||
33566781|NCT04282148|101973068|FG000|Overall Study|Withdrawal by Subject|1|||
33566782|NCT04282148|101973068|FG000|Overall Study|Physician Decision|1|||
33566783|NCT01217892|101973071|FG000|Overall Study|Adverse Event|1|||
33566784|NCT01217892|101973072|FG001|Overall Study|Adverse Event|1|||
33566785|NCT01217892|101973073|FG002|Overall Study|Adverse Event|1|||
33566786|NCT01217892|101973074|FG003|Overall Study|Adverse Event|0|||
33566787|NCT01217892|101973071|FG000|Overall Study|Withdrawal by Subject|0|||
33566788|NCT01217892|101973072|FG001|Overall Study|Withdrawal by Subject|2|||
33364558|NCT01544595|101220590|FG004|Status at Week 68|Lost to Follow-up|0|||
33364559|NCT01544595|101220591|FG005|Status at Week 68|Lost to Follow-up|0|||
33364560|NCT01544595|101220586|FG000|Status at Week 68|Non-compliance with study treatment|1|||
33566789|NCT01217892|101973073|FG002|Overall Study|Withdrawal by Subject|1|||
33364561|NCT01544595|101220587|FG001|Status at Week 68|Non-compliance with study treatment|0|||
33630938|NCT02718898|102200491|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
33630939|NCT02718898|102200492|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
33630940|NCT02718898|102200493|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
33630941|NCT02718898|102200494|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
33630942|NCT02718898|102200495|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
33630943|NCT02718898|102200496|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
33630944|NCT02718898|102200490|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
33630945|NCT02718898|102200491|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
33630946|NCT02718898|102200492|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
33630947|NCT02718898|102200493|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
33630948|NCT02718898|102200494|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
33630949|NCT02718898|102200495|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
33630950|NCT02718898|102200496|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
33630951|NCT02718898|102200490|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
33630952|NCT02718898|102200491|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
33630953|NCT02718898|102200492|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
33630954|NCT02718898|102200493|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
33630955|NCT02718898|102200494|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
33630956|NCT02718898|102200495|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
33630957|NCT02718898|102200496|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
33630958|NCT02718898|102200490|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33630959|NCT02718898|102200491|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33630960|NCT02718898|102200492|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33630961|NCT02718898|102200493|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33630962|NCT02718898|102200494|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33630963|NCT02718898|102200495|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
33630964|NCT02718898|102200496|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
33630965|NCT01345240|102200499|FG000|Overall Study|Adverse Event|3|||
33630966|NCT01345240|102200500|FG001|Overall Study|Adverse Event|5|||
33630967|NCT01345240|102200501|FG002|Overall Study|Adverse Event|4|||
33630968|NCT01345240|102200502|FG003|Overall Study|Adverse Event|2|||
33630969|NCT01345240|102200503|FG004|Overall Study|Adverse Event|1|||
33630970|NCT01345240|102200499|FG000|Overall Study|Lost to Follow-up|8|||
33630971|NCT01345240|102200500|FG001|Overall Study|Lost to Follow-up|9|||
33630972|NCT01345240|102200501|FG002|Overall Study|Lost to Follow-up|14|||
33630973|NCT01345240|102200502|FG003|Overall Study|Lost to Follow-up|7|||
33630974|NCT01345240|102200503|FG004|Overall Study|Lost to Follow-up|9|||
33630975|NCT03598036|102200504|FG000|Overall Study|Withdrawal by Subject|1|||
33630976|NCT03598036|102200505|FG001|Overall Study|Withdrawal by Subject|0|||
33630977|NCT00829426|102200506|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
33364562|NCT01544595|101220588|FG002|Status at Week 68|Non-compliance with study treatment|0|||
33364563|NCT01544595|101220589|FG003|Status at Week 68|Non-compliance with study treatment|1|||
33364564|NCT01544595|101220590|FG004|Status at Week 68|Non-compliance with study treatment|0|||
33364565|NCT01544595|101220591|FG005|Status at Week 68|Non-compliance with study treatment|0|||
33630978|NCT00829426|102200507|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
33630979|NCT01419236|102200510|FG000|Overall Study|Adverse Event|1|||
33630980|NCT01419236|102200511|FG001|Overall Study|Adverse Event|0|||
33223598|NCT00717314|100718943|FG000|Overall Study|Withdrawal by Subject|1|||
33566790|NCT01217892|101973074|FG003|Overall Study|Withdrawal by Subject|0|||
33566791|NCT01217892|101973071|FG000|Overall Study|Lab value|1|||
33566792|NCT01217892|101973072|FG001|Overall Study|Lab value|0|||
33566793|NCT01217892|101973073|FG002|Overall Study|Lab value|1|||
33566794|NCT01217892|101973074|FG003|Overall Study|Lab value|0|||
33566795|NCT01217892|101973071|FG000|Overall Study|Subject no longer meets study criteria|5|||
33566796|NCT01217892|101973072|FG001|Overall Study|Subject no longer meets study criteria|2|||
33566797|NCT01217892|101973073|FG002|Overall Study|Subject no longer meets study criteria|4|||
33566798|NCT01217892|101973074|FG003|Overall Study|Subject no longer meets study criteria|8|||
33566799|NCT01217892|101973071|FG000|Overall Study|Incorrect enrollment|0|||
33566800|NCT01217892|101973072|FG001|Overall Study|Incorrect enrollment|1|||
33566801|NCT01217892|101973073|FG002|Overall Study|Incorrect enrollment|1|||
33566802|NCT01217892|101973074|FG003|Overall Study|Incorrect enrollment|0|||
33566803|NCT01217892|101973071|FG000|Overall Study|Poor/Non-Compliance|0|||
33566804|NCT01217892|101973072|FG001|Overall Study|Poor/Non-Compliance|0|||
33566805|NCT01217892|101973073|FG002|Overall Study|Poor/Non-Compliance|1|||
33566806|NCT01217892|101973074|FG003|Overall Study|Poor/Non-Compliance|0|||
33566807|NCT00643279|101973075|FG000|Overall Study|Death|13|||
33566808|NCT00643279|101973076|FG001|Overall Study|Death|11|||
33566809|NCT00643279|101973075|FG000|Overall Study|Withdrawal by Subject|3|||
33566810|NCT00643279|101973076|FG001|Overall Study|Withdrawal by Subject|0|||
33566811|NCT00643279|101973075|FG000|Overall Study|Lost to Follow-up|0|||
33566812|NCT00643279|101973076|FG001|Overall Study|Lost to Follow-up|1|||
33566813|NCT00643279|101973075|FG000|Overall Study|Physician Decision|0|||
33566814|NCT00643279|101973076|FG001|Overall Study|Physician Decision|1|||
33566815|NCT00565747|101973080|FG000|Overall Study|No embryo transfer|67|||
33566816|NCT00565747|101973081|FG001|Overall Study|No embryo transfer|73|||
33566817|NCT03787615|101973084|FG000|Overall Study|Withdrawal by Subject|2|||
33566818|NCT03787615|101973084|FG000|Overall Study|Lost to Follow-up|2|||
33566819|NCT05305651|101973085|FG000|Overall Study|Death|1|||
33566820|NCT05305651|101973085|FG000|Overall Study|Withdrawal by Subject|4|||
33566821|NCT05305651|101973085|FG000|Overall Study|Lost to Follow-up|4|||
33566822|NCT00397540|101973087|FG000|Overall Study|short follow-up duration < 12 months|1|||
33566823|NCT00397540|101973088|FG001|Overall Study|short follow-up duration < 12 months|0|||
33566824|NCT01156844|101973089|FG000|Overall Study|Adverse Event|0|||
33566825|NCT01156844|101973090|FG001|Overall Study|Adverse Event|0|||
33566826|NCT01156844|101973091|FG002|Overall Study|Adverse Event|1|||
33566827|NCT01156844|101973092|FG003|Overall Study|Adverse Event|1|||
33566828|NCT01156844|101973089|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33566829|NCT01156844|101973090|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33566830|NCT01156844|101973091|FG002|Overall Study|Abnormal test procedure result(s)|2|||
33566831|NCT01156844|101973092|FG003|Overall Study|Abnormal test procedure result(s)|2|||
33566832|NCT01156844|101973089|FG000|Overall Study|Withdrawal by Subject|0|||
33566833|NCT01156844|101973090|FG001|Overall Study|Withdrawal by Subject|0|||
33566834|NCT01156844|101973091|FG002|Overall Study|Withdrawal by Subject|2|||
33566835|NCT01156844|101973092|FG003|Overall Study|Withdrawal by Subject|2|||
33566836|NCT01156844|101973089|FG000|Overall Study|Lost to Follow-up|0|||
33566837|NCT01156844|101973090|FG001|Overall Study|Lost to Follow-up|0|||
33566838|NCT01156844|101973091|FG002|Overall Study|Lost to Follow-up|1|||
33566839|NCT01156844|101973092|FG003|Overall Study|Lost to Follow-up|0|||
33566840|NCT01156844|101973089|FG000|Overall Study|Administrative problems|0|||
33566841|NCT01156844|101973090|FG001|Overall Study|Administrative problems|1|||
33566842|NCT01156844|101973091|FG002|Overall Study|Administrative problems|0|||
33566843|NCT01156844|101973092|FG003|Overall Study|Administrative problems|1|||
33223599|NCT00717314|100718944|FG001|Overall Study|Withdrawal by Subject|3|||
33566844|NCT01156844|101973089|FG000|Overall Study|Protocol deviation|2|||
33566845|NCT01156844|101973090|FG001|Overall Study|Protocol deviation|0|||
33223600|NCT03010462|100718945|FG000|Overall Study|Withdrawal by Subject|3|||
33566846|NCT01156844|101973091|FG002|Overall Study|Protocol deviation|0|||
33566847|NCT01156844|101973092|FG003|Overall Study|Protocol deviation|0|||
33566848|NCT01174563|101973093|FG000|Overall Study|Progressive Disease|45|||
33566849|NCT01174563|101973093|FG000|Overall Study|Death|5|||
33566850|NCT01174563|101973093|FG000|Overall Study|Investigator's Discretion|5|||
33566851|NCT01174563|101973093|FG000|Overall Study|Participant Withdrew Consent|3|||
33566852|NCT01174563|101973093|FG000|Overall Study|Rash Adverse Event|1|||
33364566|NCT01544595|101220586|FG000|Status at Week 68|Protocol Violation|2|||
33364567|NCT01544595|101220587|FG001|Status at Week 68|Protocol Violation|0|||
33364568|NCT01544595|101220588|FG002|Status at Week 68|Protocol Violation|1|||
33364569|NCT01544595|101220589|FG003|Status at Week 68|Protocol Violation|1|||
33364570|NCT01544595|101220590|FG004|Status at Week 68|Protocol Violation|0|||
33364571|NCT01544595|101220591|FG005|Status at Week 68|Protocol Violation|0|||
33364572|NCT01544595|101220586|FG000|Status at Week 68|Technical problems|1|||
33364573|NCT01544595|101220587|FG001|Status at Week 68|Technical problems|0|||
33364574|NCT01544595|101220588|FG002|Status at Week 68|Technical problems|0|||
33364575|NCT01544595|101220589|FG003|Status at Week 68|Technical problems|1|||
33364576|NCT01544595|101220590|FG004|Status at Week 68|Technical problems|0|||
33364577|NCT01544595|101220591|FG005|Status at Week 68|Technical problems|0|||
33364578|NCT01544595|101220586|FG000|Status at Week 68|Withdrawal by Subject|0|||
33364579|NCT01544595|101220587|FG001|Status at Week 68|Withdrawal by Subject|1|||
33364580|NCT01544595|101220588|FG002|Status at Week 68|Withdrawal by Subject|1|||
33364581|NCT01544595|101220589|FG003|Status at Week 68|Withdrawal by Subject|2|||
33364582|NCT01544595|101220590|FG004|Status at Week 68|Withdrawal by Subject|0|||
33364583|NCT01544595|101220591|FG005|Status at Week 68|Withdrawal by Subject|0|||
33364584|NCT01544595|101220586|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
33364585|NCT01544595|101220587|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
33364586|NCT01544595|101220588|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
33364587|NCT01544595|101220589|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
33364588|NCT01544595|101220590|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
33364589|NCT01544595|101220591|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
33364590|NCT01544595|101220586|FG000|Status at Week 156|Withdrawal by Subject|9|||
33364591|NCT01544595|101220587|FG001|Status at Week 156|Withdrawal by Subject|10|||
33364592|NCT01544595|101220588|FG002|Status at Week 156|Withdrawal by Subject|4|||
33364593|NCT01544595|101220589|FG003|Status at Week 156|Withdrawal by Subject|9|||
33566853|NCT01174563|101973093|FG000|Overall Study|Sponsor's decision|1|||
33566854|NCT02090764|101973110|FG000|Overall Study|Adverse Event|1|||
33566855|NCT02090764|101973111|FG001|Overall Study|Adverse Event|3|||
33566856|NCT02090764|101973110|FG000|Overall Study|Lack of Efficacy|0|||
33566857|NCT02090764|101973111|FG001|Overall Study|Lack of Efficacy|13|||
33566858|NCT02090764|101973110|FG000|Overall Study|Withdrawal by Subject|2|||
33566859|NCT02090764|101973111|FG001|Overall Study|Withdrawal by Subject|1|||
33566860|NCT02090764|101973110|FG000|Overall Study|Intercurrent illness and other|1|||
33566861|NCT02090764|101973111|FG001|Overall Study|Intercurrent illness and other|1|||
33566862|NCT02090764|101973110|FG000|Overall Study|Lost to Follow-up|2|||
33566863|NCT02090764|101973111|FG001|Overall Study|Lost to Follow-up|2|||
33566864|NCT02014467|101973116|FG000|Overall Study|Adverse Event|4|||
33566865|NCT02014467|101973117|FG001|Overall Study|Adverse Event|0|||
33566866|NCT02014467|101973116|FG000|Overall Study|Protocol Violation|3|||
33566867|NCT02014467|101973117|FG001|Overall Study|Protocol Violation|0|||
33566868|NCT02014467|101973116|FG000|Overall Study|Physician Decision|2|||
33566869|NCT02014467|101973117|FG001|Overall Study|Physician Decision|3|||
33566870|NCT02014467|101973116|FG000|Overall Study|Withdrawal by Subject|16|||
33566871|NCT02014467|101973117|FG001|Overall Study|Withdrawal by Subject|4|||
33566872|NCT03682367|101973118|FG000|Overall Study|Protocol Violation|2|||
33566873|NCT03682367|101973119|FG001|Overall Study|Protocol Violation|1|||
33566874|NCT03682367|101973118|FG000|Overall Study|Closed Study Early|0|||
33566875|NCT03682367|101973119|FG001|Overall Study|Closed Study Early|3|||
33566876|NCT01853280|101973120|FG000|Overall Study|Lack of Efficacy|2|||
33566877|NCT01853280|101973121|FG001|Overall Study|Lack of Efficacy|2|||
33566878|NCT01853280|101973120|FG000|Overall Study|Lost to Follow-up|0|||
33566879|NCT01853280|101973121|FG001|Overall Study|Lost to Follow-up|1|||
33566880|NCT01853280|101973120|FG000|Overall Study|Physician Decision|0|||
33566881|NCT01853280|101973121|FG001|Overall Study|Physician Decision|1|||
33566882|NCT01853280|101973120|FG000|Overall Study|Withdrawal by Subject|0|||
33566883|NCT01853280|101973121|FG001|Overall Study|Withdrawal by Subject|1|||
33566884|NCT01853280|101973120|FG000|Overall Study|Ineligible|0|||
33566885|NCT01853280|101973121|FG001|Overall Study|Ineligible|1|||
33566886|NCT04486716|101973124|FG000|Overall Study|Subject decision|6|||
33566887|NCT04486716|101973124|FG000|Overall Study|Adverse Event|5|||
33566888|NCT04486716|101973124|FG000|Overall Study|Lost to Follow-up|1|||
33566889|NCT04486716|101973124|FG000|Overall Study|Physician Decision|1|||
33566890|NCT04486716|101973124|FG000|Overall Study|Enrolled subjects not treated|9|||
33566891|NCT03271151|101973125|FG000|Overall Study|Lost to Follow-up|1|||
33364594|NCT01544595|101220590|FG004|Status at Week 156|Withdrawal by Subject|20|||
33364595|NCT01544595|101220591|FG005|Status at Week 156|Withdrawal by Subject|6|||
33364596|NCT01544595|101220586|FG000|Status at Week 156|Adverse Event|9|||
33364597|NCT01544595|101220587|FG001|Status at Week 156|Adverse Event|11|||
33364598|NCT01544595|101220588|FG002|Status at Week 156|Adverse Event|1|||
33566892|NCT03271151|101973126|FG001|Overall Study|Lost to Follow-up|3|||
33630981|NCT01419236|102200510|FG000|Overall Study|Lack of Efficacy|0|||
33630982|NCT01419236|102200511|FG001|Overall Study|Lack of Efficacy|1|||
33630983|NCT01419236|102200510|FG000|Overall Study|Lost to Follow-up|1|||
33630984|NCT01419236|102200511|FG001|Overall Study|Lost to Follow-up|0|||
33630985|NCT01419236|102200510|FG000|Overall Study|Physician Decision|1|||
33630986|NCT01419236|102200511|FG001|Overall Study|Physician Decision|0|||
33630987|NCT01419236|102200510|FG000|Overall Study|Withdrawal by Subject|1|||
33630988|NCT01419236|102200511|FG001|Overall Study|Withdrawal by Subject|4|||
33630989|NCT01419236|102200510|FG000|Overall Study|Entry Criteria Not Met|1|||
33630990|NCT01419236|102200511|FG001|Overall Study|Entry Criteria Not Met|0|||
33630991|NCT01864018|102200512|FG000|Overall Study|Ineligible|3|||
33630992|NCT01864018|102200513|FG001|Overall Study|Ineligible|1|||
33630993|NCT04038359|102200514|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
33630994|NCT04038359|102200515|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
33630995|NCT04038359|102200514|FG000|Overall Study|Death|8|||
33630996|NCT04038359|102200515|FG001|Overall Study|Death|7|||
33630997|NCT04038359|102200514|FG000|Overall Study|Lost to Follow-up|3|||
33630998|NCT04038359|102200515|FG001|Overall Study|Lost to Follow-up|0|||
33630999|NCT04038359|102200514|FG000|Overall Study|Participant Moved|1|||
33416780|NCT01244516|101416226|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
33416781|NCT01244516|101416227|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
33566893|NCT03271151|101973125|FG000|Overall Study|Withdrawal by Subject|1|||
33566894|NCT03271151|101973126|FG001|Overall Study|Withdrawal by Subject|0|||
33566895|NCT04439253|101973127|FG000|Overall Study|Adverse Event|1|||
33566896|NCT04439253|101973127|FG000|Overall Study|Disease progression|2|||
33566897|NCT04439253|101973127|FG000|Overall Study|Complicating disease|1|||
33566898|NCT03433339|101973134|FG000|Overall Study|Lost to Follow-up|2|||
33566899|NCT03433339|101973135|FG001|Overall Study|Lost to Follow-up|0|||
33566900|NCT03433339|101973134|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
33566901|NCT03433339|101973135|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
33566902|NCT03433339|101973134|FG000|Overall Study|Withdrawal by Subject|0|||
33566903|NCT03433339|101973135|FG001|Overall Study|Withdrawal by Subject|2|||
33566904|NCT03370276|101973136|FG000|Overall Study|Death|0|||
33566905|NCT03370276|101973137|FG001|Overall Study|Death|2|||
33566906|NCT03370276|101973138|FG002|Overall Study|Death|5|||
33566907|NCT03189524|101973140|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
33566908|NCT03189524|101973141|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
33566909|NCT03189524|101973142|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
33566910|NCT03189524|101973140|FG000|Overall Study|Death|2|||
33566911|NCT03189524|101973141|FG001|Overall Study|Death|2|||
33566912|NCT03189524|101973142|FG002|Overall Study|Death|1|||
33566913|NCT03189524|101973140|FG000|Overall Study|Lost to Follow-up|1|||
33566914|NCT03189524|101973141|FG001|Overall Study|Lost to Follow-up|0|||
33566915|NCT03189524|101973142|FG002|Overall Study|Lost to Follow-up|8|||
33566916|NCT03189524|101973140|FG000|Overall Study|Withdrawal by Subject|1|||
33566917|NCT03189524|101973141|FG001|Overall Study|Withdrawal by Subject|1|||
33566918|NCT03189524|101973142|FG002|Overall Study|Withdrawal by Subject|3|||
33566919|NCT03189524|101973140|FG000|Overall Study|Progressive Disease|0|||
33566920|NCT03189524|101973141|FG001|Overall Study|Progressive Disease|2|||
33566921|NCT03189524|101973142|FG002|Overall Study|Progressive Disease|0|||
33566922|NCT02143414|101973144|FG000|Induction|Adverse Event|1|||
33566923|NCT02143414|101973145|FG001|Induction|Adverse Event|2|||
33566924|NCT02143414|101973144|FG000|Induction|Death|1|||
33566925|NCT02143414|101973145|FG001|Induction|Death|2|||
33566926|NCT02143414|101973144|FG000|Induction|Patient refusal|1|||
33566927|NCT02143414|101973145|FG001|Induction|Patient refusal|1|||
33566928|NCT02143414|101973144|FG000|Induction|Refractory|1|||
33566929|NCT02143414|101973145|FG001|Induction|Refractory|0|||
33566930|NCT02143414|101973144|FG000|Induction|Began alternative treatment|1|||
33566931|NCT02143414|101973145|FG001|Induction|Began alternative treatment|0|||
33566932|NCT02143414|101973144|FG000|Induction|Ineligible for postremission|5|||
33416782|NCT01244516|101416228|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
33566933|NCT02143414|101973145|FG001|Induction|Ineligible for postremission|1|||
33566934|NCT02143414|101973144|FG000|Post-remission|Adverse Event|0|||
33566935|NCT02143414|101973145|FG001|Post-remission|Adverse Event|2|||
33566936|NCT02143414|101973144|FG000|Post-remission|Disease progression/relapse|5|||
33566937|NCT02143414|101973145|FG001|Post-remission|Disease progression/relapse|0|||
33566938|NCT02143414|101973144|FG000|Maintenance|Adverse Event|4|||
33566939|NCT02143414|101973145|FG001|Maintenance|Adverse Event|6|||
33631000|NCT04038359|102200515|FG001|Overall Study|Participant Moved|0|||
33631001|NCT04038359|102200514|FG000|Overall Study|Withdrawal by Subject|4|||
33566940|NCT02143414|101973144|FG000|Maintenance|Disease progression/relapse|3|||
33566941|NCT02143414|101973145|FG001|Maintenance|Disease progression/relapse|2|||
33631002|NCT04038359|102200515|FG001|Overall Study|Withdrawal by Subject|3|||
33631003|NCT04038359|102200514|FG000|Overall Study|Physician Decision|3|||
33631004|NCT04038359|102200515|FG001|Overall Study|Physician Decision|2|||
33566942|NCT02143414|101973144|FG000|Maintenance|Patient refusal|2|||
33566943|NCT02143414|101973145|FG001|Maintenance|Patient refusal|1|||
33566944|NCT02143414|101973144|FG000|Maintenance|Physician Decision|1|||
33566945|NCT02143414|101973145|FG001|Maintenance|Physician Decision|0|||
33566946|NCT02143414|101973144|FG000|Maintenance|Death|0|||
33566947|NCT02143414|101973145|FG001|Maintenance|Death|1|||
33566948|NCT02143414|101973144|FG000|Maintenance|On protocol treatment|0|||
33566949|NCT02143414|101973145|FG001|Maintenance|On protocol treatment|6|||
33566950|NCT04743973|101973154|FG000|Overall Study|Withdrawal by Subject|5|||
33566951|NCT05034952|101973157|FG000|Overall Study|Adverse Event|1|||
33566952|NCT05034952|101973158|FG001|Overall Study|Adverse Event|0|||
33566953|NCT05034952|101973159|FG002|Overall Study|Adverse Event|0|||
33566954|NCT05034952|101973160|FG003|Overall Study|Adverse Event|0|||
33566955|NCT05034952|101973157|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
33566956|NCT05034952|101973158|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
33566957|NCT05034952|101973159|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
33566958|NCT05034952|101973160|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
33566959|NCT05034952|101973157|FG000|Overall Study|Lost to Follow-up|1|||
33566960|NCT05034952|101973158|FG001|Overall Study|Lost to Follow-up|4|||
33566961|NCT05034952|101973159|FG002|Overall Study|Lost to Follow-up|3|||
33566962|NCT05034952|101973160|FG003|Overall Study|Lost to Follow-up|3|||
33566963|NCT05034952|101973157|FG000|Overall Study|Other|0|||
33566964|NCT05034952|101973158|FG001|Overall Study|Other|0|||
33566965|NCT05034952|101973159|FG002|Overall Study|Other|0|||
33566966|NCT05034952|101973160|FG003|Overall Study|Other|1|||
33566967|NCT03896503|101973161|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
33566968|NCT03896503|101973162|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
33566969|NCT03896503|101973163|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
33566970|NCT03896503|101973164|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
33566971|NCT03896503|101973165|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
33566972|NCT03896503|101973166|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
33566973|NCT03896503|101973167|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
33566974|NCT03896503|101973168|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
33566975|NCT03896503|101973161|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
33566976|NCT03896503|101973162|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
33566977|NCT03896503|101973163|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
33566978|NCT03896503|101973164|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
33566979|NCT03896503|101973165|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
33566980|NCT03896503|101973166|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
33566981|NCT03896503|101973167|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
33566982|NCT03896503|101973168|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
33566983|NCT03896503|101973161|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
33566984|NCT03896503|101973162|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
33566985|NCT03896503|101973163|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
33566986|NCT03896503|101973164|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
33566987|NCT03896503|101973165|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
33566988|NCT03896503|101973166|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
33566989|NCT03896503|101973167|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
33566990|NCT03896503|101973168|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
33566991|NCT03896503|101973161|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
33566992|NCT03896503|101973162|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
33566993|NCT03896503|101973163|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
33566994|NCT03896503|101973164|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
33566995|NCT03896503|101973165|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
33566996|NCT03896503|101973166|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
33566997|NCT03896503|101973167|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
33566998|NCT03896503|101973168|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
33566999|NCT03896503|101973161|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
33567000|NCT03896503|101973162|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
33567001|NCT03896503|101973163|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
33567002|NCT03896503|101973164|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
33567003|NCT03896503|101973165|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
33567004|NCT03896503|101973166|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
33631005|NCT04038359|102200514|FG000|Overall Study|Adverse Event|0|||
33223601|NCT03010462|100718946|FG001|Overall Study|Withdrawal by Subject|1|||
33364599|NCT01544595|101220589|FG003|Status at Week 156|Adverse Event|3|||
33223602|NCT04359771|100718947|FG000|Overall Study|Lack of Efficacy|2|||
33223603|NCT04359771|100718948|FG001|Overall Study|Lack of Efficacy|2|||
33223604|NCT00949715|100718949|FG000|Overall Study|Physician Decision|1|||
33223605|NCT00949715|100718950|FG001|Overall Study|Physician Decision|0|||
33223606|NCT00949715|100718949|FG000|Overall Study|Lost to Follow-up|1|||
33223607|NCT00949715|100718950|FG001|Overall Study|Lost to Follow-up|0|||
33364600|NCT01544595|101220590|FG004|Status at Week 156|Adverse Event|4|||
33364601|NCT01544595|101220591|FG005|Status at Week 156|Adverse Event|2|||
33223608|NCT00949715|100718949|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
33223609|NCT00949715|100718950|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
33223610|NCT03145766|100718951|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
33223611|NCT03145766|100718952|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
33223612|NCT03145766|100718953|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
33223613|NCT03145766|100718954|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
33223614|NCT03145766|100718955|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
33223615|NCT03145766|100718951|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
33223616|NCT03145766|100718952|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
33223617|NCT03145766|100718953|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
33223618|NCT03145766|100718954|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
33223619|NCT03145766|100718955|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
33223620|NCT03145766|100718951|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
33223621|NCT03145766|100718952|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
33223622|NCT03145766|100718953|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
33223623|NCT03145766|100718954|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
33223624|NCT03145766|100718955|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
33223625|NCT03145766|100718951|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
33567005|NCT03896503|101973167|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
33567006|NCT03896503|101973168|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
33567007|NCT03896503|101973161|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
33567008|NCT03896503|101973162|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
33567009|NCT03896503|101973163|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
33567010|NCT03896503|101973164|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
33567011|NCT03896503|101973165|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
33223626|NCT03145766|100718952|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
33223627|NCT03145766|100718953|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
33223628|NCT03145766|100718954|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
33223629|NCT03145766|100718955|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
33364602|NCT01544595|101220586|FG000|Status at Week 156|Lost to Follow-up|4|||
33567012|NCT03896503|101973166|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
33567013|NCT03896503|101973167|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
33567014|NCT03896503|101973168|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
33567015|NCT03896503|101973161|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
33567016|NCT03896503|101973162|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
33567017|NCT03896503|101973163|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
33567018|NCT03896503|101973164|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
33567019|NCT03896503|101973165|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
33567020|NCT03896503|101973166|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
33567021|NCT03896503|101973167|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
33567022|NCT03896503|101973168|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
33567023|NCT03896503|101973161|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
33567024|NCT03896503|101973162|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
33567025|NCT03896503|101973163|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
33567026|NCT03896503|101973164|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
33567027|NCT03896503|101973165|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
33567028|NCT03896503|101973166|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
33567029|NCT03896503|101973167|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
33631006|NCT04038359|102200515|FG001|Overall Study|Adverse Event|2|||
33223630|NCT03145766|100718951|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
33223631|NCT03145766|100718952|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
33223632|NCT03145766|100718953|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
33364603|NCT01544595|101220587|FG001|Status at Week 156|Lost to Follow-up|4|||
33364604|NCT01544595|101220588|FG002|Status at Week 156|Lost to Follow-up|0|||
33364605|NCT01544595|101220589|FG003|Status at Week 156|Lost to Follow-up|1|||
33223633|NCT03145766|100718954|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
33223634|NCT03145766|100718955|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
33223635|NCT03145766|100718951|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
33223636|NCT03145766|100718952|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
33223637|NCT03145766|100718953|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
33223638|NCT03145766|100718954|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
33223639|NCT03145766|100718955|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
33223640|NCT03145766|100718951|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
33223641|NCT03145766|100718952|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
33223642|NCT03145766|100718953|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
33223643|NCT03145766|100718954|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
33223644|NCT03145766|100718955|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
33223645|NCT00985985|100718956|FG000|Overall Study|Adverse Event|4|||
33223646|NCT00985985|100718957|FG001|Overall Study|Adverse Event|2|||
33223647|NCT00985985|100718958|FG002|Overall Study|Adverse Event|2|||
33223648|NCT00985985|100718959|FG003|Overall Study|Adverse Event|2|||
33223649|NCT00985985|100718956|FG000|Overall Study|Lost to Follow-up|4|||
33223650|NCT00985985|100718957|FG001|Overall Study|Lost to Follow-up|11|||
33223651|NCT00985985|100718958|FG002|Overall Study|Lost to Follow-up|2|||
33223652|NCT00985985|100718959|FG003|Overall Study|Lost to Follow-up|3|||
33223653|NCT00985985|100718956|FG000|Overall Study|Protocol Violation|1|||
33223654|NCT00985985|100718957|FG001|Overall Study|Protocol Violation|2|||
33223655|NCT00985985|100718958|FG002|Overall Study|Protocol Violation|0|||
33223656|NCT00985985|100718959|FG003|Overall Study|Protocol Violation|1|||
33223657|NCT00985985|100718956|FG000|Overall Study|Lack of Efficacy|5|||
33223658|NCT00985985|100718957|FG001|Overall Study|Lack of Efficacy|6|||
33223659|NCT00985985|100718958|FG002|Overall Study|Lack of Efficacy|1|||
33223660|NCT00985985|100718959|FG003|Overall Study|Lack of Efficacy|3|||
33223661|NCT00985985|100718956|FG000|Overall Study|Withdrawal by Subject|4|||
33223662|NCT00985985|100718957|FG001|Overall Study|Withdrawal by Subject|2|||
33223663|NCT00985985|100718958|FG002|Overall Study|Withdrawal by Subject|2|||
33223664|NCT00985985|100718959|FG003|Overall Study|Withdrawal by Subject|2|||
33223665|NCT00985985|100718956|FG000|Overall Study|Other Reason|6|||
33223666|NCT00985985|100718957|FG001|Overall Study|Other Reason|1|||
33223667|NCT00985985|100718958|FG002|Overall Study|Other Reason|4|||
33223668|NCT00985985|100718959|FG003|Overall Study|Other Reason|2|||
33223669|NCT01959347|100718961|FG000|Overall Study|Protocol Violation|9|||
33223670|NCT01959347|100718962|FG001|Overall Study|Protocol Violation|7|||
33223671|NCT02552238|100718965|FG000|Overall Study|Withdrawal by Subject|2|||
33223672|NCT02552238|100718965|FG000|Overall Study|Adverse Event|2|||
33223673|NCT00661661|100718968|FG000|Overall Study|Adverse Event|99|||
33223674|NCT00661661|100718969|FG001|Overall Study|Adverse Event|24|||
33223675|NCT00661661|100718968|FG000|Overall Study|Lack of Efficacy|3|||
33223676|NCT00661661|100718969|FG001|Overall Study|Lack of Efficacy|2|||
33223677|NCT00661661|100718968|FG000|Overall Study|Lost to Follow-up|0|||
33223678|NCT00661661|100718969|FG001|Overall Study|Lost to Follow-up|1|||
33223679|NCT00661661|100718968|FG000|Overall Study|Withdrawal by Subject|15|||
33223680|NCT00661661|100718969|FG001|Overall Study|Withdrawal by Subject|5|||
33223681|NCT00661661|100718968|FG000|Overall Study|Other|22|||
33223682|NCT00661661|100718969|FG001|Overall Study|Other|7|||
33223683|NCT00661661|100718968|FG000|Overall Study|Not assigned treatment|1|||
33223684|NCT00661661|100718969|FG001|Overall Study|Not assigned treatment|0|||
33223685|NCT01722162|100718972|FG000|Overall Study|Withdrawal by Subject|1|||
33223686|NCT01722162|100718973|FG001|Overall Study|Withdrawal by Subject|1|||
33223687|NCT01722162|100718972|FG000|Overall Study|Found ineligible|1|||
33631007|NCT04038359|102200514|FG000|Overall Study|Progressive Disease|0|||
33631008|NCT04038359|102200515|FG001|Overall Study|Progressive Disease|1|||
33223688|NCT01722162|100718973|FG001|Overall Study|Found ineligible|0|||
33631009|NCT02250326|102200516|FG000|Treatment|Death|1|||
33223689|NCT01722162|100718972|FG000|Overall Study|Unrelated to study adverse event|2|||
33223690|NCT01722162|100718973|FG001|Overall Study|Unrelated to study adverse event|2|||
33223691|NCT01722162|100718972|FG000|Overall Study|Adverse Event|1|||
33223692|NCT01722162|100718973|FG001|Overall Study|Adverse Event|1|||
33223693|NCT01722162|100718972|FG000|Overall Study|Insurance denial post enrollment|0|||
33223694|NCT01722162|100718973|FG001|Overall Study|Insurance denial post enrollment|1|||
33223695|NCT01722162|100718972|FG000|Overall Study|Noncompliance|0|||
33223696|NCT01722162|100718973|FG001|Overall Study|Noncompliance|1|||
33223697|NCT00069784|100718978|FG000|Overall Study|Adverse Event|105|||
33631010|NCT02250326|102200517|FG001|Treatment|Death|13|||
33631011|NCT02250326|102200518|FG002|Treatment|Death|2|||
33223698|NCT00069784|100718979|FG001|Overall Study|Adverse Event|0|||
33223699|NCT00069784|100718978|FG000|Overall Study|Withdrawal by Subject|1090|||
33223700|NCT00069784|100718979|FG001|Overall Study|Withdrawal by Subject|0|||
33223701|NCT00069784|100718978|FG000|Overall Study|Other|17|||
33223702|NCT00069784|100718979|FG001|Overall Study|Other|0|||
33223703|NCT04836858|100718980|FG000|Overall Study|Adverse Event|0|||
33223704|NCT04836858|100718981|FG001|Overall Study|Adverse Event|0|||
33223705|NCT04836858|100718982|FG002|Overall Study|Adverse Event|0|||
33223706|NCT04836858|100718983|FG003|Overall Study|Adverse Event|1|||
33223707|NCT04836858|100718980|FG000|Overall Study|Lost to Follow-up|1|||
33223708|NCT04836858|100718981|FG001|Overall Study|Lost to Follow-up|0|||
33223709|NCT04836858|100718982|FG002|Overall Study|Lost to Follow-up|0|||
33223710|NCT04836858|100718983|FG003|Overall Study|Lost to Follow-up|0|||
33223711|NCT04836858|100718980|FG000|Overall Study|Subject/Guardian decision|3|||
33223712|NCT04836858|100718981|FG001|Overall Study|Subject/Guardian decision|0|||
33223713|NCT04836858|100718982|FG002|Overall Study|Subject/Guardian decision|0|||
33223714|NCT04836858|100718983|FG003|Overall Study|Subject/Guardian decision|1|||
33223715|NCT04836858|100718980|FG000|Overall Study|Randomized but not treated|4|||
33223716|NCT04836858|100718981|FG001|Overall Study|Randomized but not treated|0|||
33223717|NCT04836858|100718982|FG002|Overall Study|Randomized but not treated|0|||
33223718|NCT04836858|100718983|FG003|Overall Study|Randomized but not treated|0|||
33223719|NCT04858802|100718984|FG000|Overall Study|Lost to Follow-up|1|||
33223720|NCT04858802|100718985|FG001|Overall Study|Lost to Follow-up|1|||
33223721|NCT04858802|100718984|FG000|Overall Study|Withdrawal by Subject|1|||
33223722|NCT04858802|100718985|FG001|Overall Study|Withdrawal by Subject|1|||
33223723|NCT01800201|100721599|FG000|Overall Study|Withdrawal by Subject|2|||
33223724|NCT01800201|100721600|FG001|Overall Study|Withdrawal by Subject|0|||
33223725|NCT01800201|100721599|FG000|Overall Study|patient privacy concerns|1|||
33223726|NCT01800201|100721600|FG001|Overall Study|patient privacy concerns|1|||
33223727|NCT01800201|100721599|FG000|Overall Study|did not want to use device|0|||
33223728|NCT01800201|100721600|FG001|Overall Study|did not want to use device|1|||
33223729|NCT01800201|100721599|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
33223730|NCT01800201|100721600|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
33223731|NCT03138733|100721601|FG000|Overall Study|Death|17|||
33223732|NCT03138733|100721602|FG001|Overall Study|Death|18|||
33223733|NCT03138733|100721601|FG000|Overall Study|Withdrawal by Subject|11|||
33223734|NCT03138733|100721602|FG001|Overall Study|Withdrawal by Subject|6|||
33223735|NCT03138733|100721601|FG000|Overall Study|Lost to Follow-up|3|||
33223736|NCT03138733|100721602|FG001|Overall Study|Lost to Follow-up|2|||
33223737|NCT03138733|100721601|FG000|Overall Study|Adverse Event|1|||
33223738|NCT03138733|100721602|FG001|Overall Study|Adverse Event|0|||
33223739|NCT03138733|100721601|FG000|Overall Study|Protocol Violation|1|||
33223740|NCT03138733|100721602|FG001|Overall Study|Protocol Violation|3|||
33223741|NCT03138733|100721601|FG000|Overall Study|Administrative or logistical reason|1|||
33223742|NCT03138733|100721602|FG001|Overall Study|Administrative or logistical reason|0|||
33223743|NCT03138733|100721601|FG000|Overall Study|The patient was transferred to another hospital|1|||
33223744|NCT03138733|100721602|FG001|Overall Study|The patient was transferred to another hospital|0|||
33223745|NCT05375955|100721603|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
33223746|NCT05375955|100721604|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
33223747|NCT05375955|100721605|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
33223748|NCT05375955|100721606|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
33223749|NCT05375955|100721607|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
33223750|NCT05375955|100721608|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
33416783|NCT01244516|101416226|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
33223751|NCT05375955|100721609|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
33416784|NCT01244516|101416227|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
33416785|NCT01244516|101416228|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
33416786|NCT01244516|101416226|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
33631012|NCT02250326|102200516|FG000|Treatment|Adverse Event|8|||
33223752|NCT05375955|100721603|FG000|Treatment (12 Weeks)|Physician Decision|4|||
33223753|NCT05375955|100721604|FG001|Treatment (12 Weeks)|Physician Decision|1|||
33223754|NCT05375955|100721605|FG002|Treatment (12 Weeks)|Physician Decision|3|||
33223755|NCT05375955|100721606|FG003|Treatment (12 Weeks)|Physician Decision|0|||
33223756|NCT05375955|100721607|FG004|Treatment (12 Weeks)|Physician Decision|0|||
33223757|NCT05375955|100721608|FG005|Treatment (12 Weeks)|Physician Decision|1|||
33223758|NCT05375955|100721609|FG006|Treatment (12 Weeks)|Physician Decision|0|||
33223759|NCT05375955|100721603|FG000|Treatment (12 Weeks)|Other|0|||
33223760|NCT05375955|100721604|FG001|Treatment (12 Weeks)|Other|1|||
33223761|NCT05375955|100721605|FG002|Treatment (12 Weeks)|Other|0|||
33223762|NCT05375955|100721606|FG003|Treatment (12 Weeks)|Other|0|||
33223763|NCT05375955|100721607|FG004|Treatment (12 Weeks)|Other|0|||
33416787|NCT01244516|101416227|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
33223764|NCT05375955|100721608|FG005|Treatment (12 Weeks)|Other|0|||
33223765|NCT05375955|100721609|FG006|Treatment (12 Weeks)|Other|0|||
33223766|NCT05375955|100721603|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
33416788|NCT01244516|101416228|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
33416789|NCT05083559|101416229|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
33223767|NCT05375955|100721604|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
33223768|NCT05375955|100721605|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
33223769|NCT05375955|100721606|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
33223770|NCT05375955|100721607|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
33416790|NCT05083559|101416230|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
33416791|NCT05083559|101416229|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
33416792|NCT05083559|101416230|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
33416793|NCT05083559|101416229|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
33416794|NCT05083559|101416230|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
33416795|NCT00819091|101416231|FG000|Overall Study|Adverse Event|3|||
33416796|NCT00819091|101416232|FG001|Overall Study|Adverse Event|5|||
33416797|NCT00819091|101416231|FG000|Overall Study|Protocol Violation|0|||
33416798|NCT00819091|101416232|FG001|Overall Study|Protocol Violation|1|||
33416799|NCT00819091|101416231|FG000|Overall Study|Lost to Follow-up|2|||
33416800|NCT00819091|101416232|FG001|Overall Study|Lost to Follow-up|0|||
33416801|NCT00819091|101416231|FG000|Overall Study|Withdrawal by Subject|1|||
33416802|NCT00819091|101416232|FG001|Overall Study|Withdrawal by Subject|2|||
33416803|NCT00819091|101416231|FG000|Overall Study|Other|1|||
33416804|NCT00819091|101416232|FG001|Overall Study|Other|2|||
33416805|NCT04797637|101416233|FG000|Overall Study|Lost to Follow-up|23|||
33416806|NCT04797637|101416234|FG001|Overall Study|Lost to Follow-up|32|||
33416807|NCT04797637|101416233|FG000|Overall Study|Withdrawal by Subject|0|||
33416808|NCT04797637|101416234|FG001|Overall Study|Withdrawal by Subject|1|||
33416809|NCT02704130|101416235|FG000|Overall Study|Physician Decision|5|||
33416810|NCT02704130|101416236|FG001|Overall Study|Physician Decision|3|||
33416811|NCT03020966|101416237|FG000|Overall Study|Withdrawal by Subject|2|||
33416812|NCT03020966|101416238|FG001|Overall Study|Withdrawal by Subject|0|||
33416813|NCT02487979|101416244|FG000|Overall Study|Physician Decision|2|||
33416814|NCT02487979|101416244|FG000|Overall Study|Withdrawal by Subject|2|||
33223771|NCT05375955|100721608|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
33223772|NCT05375955|100721609|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
33223773|NCT05375955|100721603|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
33223774|NCT05375955|100721604|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
33223775|NCT05375955|100721605|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
33223776|NCT05375955|100721606|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
33223777|NCT05375955|100721607|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
33223778|NCT05375955|100721608|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
33223779|NCT05375955|100721609|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
33223780|NCT05375955|100721603|FG000|Treatment (12 Weeks)|Pregnancy|0|||
33223781|NCT05375955|100721604|FG001|Treatment (12 Weeks)|Pregnancy|0|||
33223782|NCT05375955|100721605|FG002|Treatment (12 Weeks)|Pregnancy|1|||
33223783|NCT05375955|100721606|FG003|Treatment (12 Weeks)|Pregnancy|0|||
33223784|NCT05375955|100721607|FG004|Treatment (12 Weeks)|Pregnancy|0|||
33223785|NCT05375955|100721608|FG005|Treatment (12 Weeks)|Pregnancy|0|||
33223786|NCT05375955|100721609|FG006|Treatment (12 Weeks)|Pregnancy|0|||
33223787|NCT05375955|100721603|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
33223788|NCT05375955|100721604|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
33223789|NCT05375955|100721605|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
33223790|NCT05375955|100721606|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
33223791|NCT05375955|100721607|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
33223792|NCT05375955|100721608|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
33223793|NCT05375955|100721609|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
33223794|NCT05375955|100721603|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
33223795|NCT05375955|100721604|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
33416815|NCT02487979|101416244|FG000|Overall Study|Progressive Disease|17|||
33416816|NCT04578548|101416250|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
33416817|NCT04578548|101416251|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
33416818|NCT04578548|101416250|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
33416819|NCT04578548|101416251|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
33416820|NCT04578548|101416250|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
33567030|NCT03896503|101973168|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
33567031|NCT03896503|101973161|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
33567032|NCT03896503|101973162|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
33567033|NCT03896503|101973163|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
33567034|NCT03896503|101973164|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
33567035|NCT03896503|101973165|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
33567036|NCT03896503|101973166|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
33567037|NCT03896503|101973167|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
33567038|NCT03896503|101973168|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
33631013|NCT02250326|102200517|FG001|Treatment|Adverse Event|8|||
33223796|NCT05375955|100721605|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
33223797|NCT05375955|100721606|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
33223798|NCT05375955|100721607|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
33416821|NCT04578548|101416251|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
33631014|NCT02250326|102200518|FG002|Treatment|Adverse Event|9|||
33631015|NCT02250326|102200516|FG000|Treatment|Progressive Disease|42|||
33631016|NCT02250326|102200517|FG001|Treatment|Progressive Disease|40|||
33631017|NCT02250326|102200518|FG002|Treatment|Progressive Disease|47|||
33631018|NCT02250326|102200516|FG000|Treatment|Symptomatic Deterioration|9|||
33631019|NCT02250326|102200517|FG001|Treatment|Symptomatic Deterioration|4|||
33631020|NCT02250326|102200518|FG002|Treatment|Symptomatic Deterioration|10|||
33631021|NCT02250326|102200516|FG000|Treatment|Withdrawal by Subject|11|||
33631022|NCT02250326|102200517|FG001|Treatment|Withdrawal by Subject|6|||
33631023|NCT02250326|102200518|FG002|Treatment|Withdrawal by Subject|4|||
33631024|NCT02250326|102200516|FG000|Treatment|Other reasons|8|||
33631025|NCT02250326|102200517|FG001|Treatment|Other reasons|7|||
33631026|NCT02250326|102200518|FG002|Treatment|Other reasons|7|||
33631027|NCT02250326|102200516|FG000|Extension Period|Progressive Disease|0|||
33631028|NCT02250326|102200517|FG001|Extension Period|Progressive Disease|2|||
33631029|NCT02250326|102200518|FG002|Extension Period|Progressive Disease|0|||
33631030|NCT02250326|102200516|FG000|Extension Period|Withdrawal by Subject|0|||
33631031|NCT02250326|102200517|FG001|Extension Period|Withdrawal by Subject|1|||
33631032|NCT02250326|102200518|FG002|Extension Period|Withdrawal by Subject|0|||
33631033|NCT02250326|102200516|FG000|Extension Period|Withdrawal by investigator|0|||
33631034|NCT02250326|102200517|FG001|Extension Period|Withdrawal by investigator|1|||
33631035|NCT02250326|102200518|FG002|Extension Period|Withdrawal by investigator|0|||
33631036|NCT02546609|102200519|FG000|Overall Study|Withdrawal by Subject|0|||
33631037|NCT02546609|102200520|FG001|Overall Study|Withdrawal by Subject|1|||
33631038|NCT02546609|102200521|FG002|Overall Study|Withdrawal by Subject|2|||
33631039|NCT02546609|102200519|FG000|Overall Study|Adverse Event|0|||
33364606|NCT01544595|101220590|FG004|Status at Week 156|Lost to Follow-up|4|||
33364607|NCT01544595|101220591|FG005|Status at Week 156|Lost to Follow-up|1|||
33631040|NCT02546609|102200520|FG001|Overall Study|Adverse Event|6|||
33631041|NCT02546609|102200521|FG002|Overall Study|Adverse Event|1|||
33631042|NCT02546609|102200519|FG000|Overall Study|Protocol Violation|0|||
33631043|NCT02546609|102200520|FG001|Overall Study|Protocol Violation|1|||
33631044|NCT02546609|102200521|FG002|Overall Study|Protocol Violation|1|||
33631045|NCT02546609|102200519|FG000|Overall Study|Lost to Follow-up|2|||
33631046|NCT02546609|102200520|FG001|Overall Study|Lost to Follow-up|3|||
33631047|NCT02546609|102200521|FG002|Overall Study|Lost to Follow-up|1|||
33631048|NCT02546609|102200519|FG000|Overall Study|travel or work schedule restriction|0|||
33631049|NCT02546609|102200520|FG001|Overall Study|travel or work schedule restriction|0|||
33631050|NCT02546609|102200521|FG002|Overall Study|travel or work schedule restriction|2|||
33631051|NCT00079417|102200522|FG000|Overall Study|Physician Decision|2|||
33364608|NCT01544595|101220586|FG000|Status at Week 156|Non-compliance with study treatement|0|||
33364609|NCT01544595|101220587|FG001|Status at Week 156|Non-compliance with study treatement|1|||
33364610|NCT01544595|101220588|FG002|Status at Week 156|Non-compliance with study treatement|0|||
33364611|NCT01544595|101220589|FG003|Status at Week 156|Non-compliance with study treatement|1|||
33364612|NCT01544595|101220590|FG004|Status at Week 156|Non-compliance with study treatement|0|||
33364613|NCT01544595|101220591|FG005|Status at Week 156|Non-compliance with study treatement|1|||
33364614|NCT01544595|101220586|FG000|Status at Week 156|Physician Decision|0|||
33364615|NCT01544595|101220587|FG001|Status at Week 156|Physician Decision|3|||
33364616|NCT01544595|101220588|FG002|Status at Week 156|Physician Decision|1|||
33364617|NCT01544595|101220589|FG003|Status at Week 156|Physician Decision|0|||
33364618|NCT01544595|101220590|FG004|Status at Week 156|Physician Decision|0|||
33364619|NCT01544595|101220591|FG005|Status at Week 156|Physician Decision|0|||
33364620|NCT01544595|101220586|FG000|Status at Week 156|Pregnancy|2|||
33364621|NCT01544595|101220587|FG001|Status at Week 156|Pregnancy|3|||
33364622|NCT01544595|101220588|FG002|Status at Week 156|Pregnancy|0|||
33364623|NCT01544595|101220589|FG003|Status at Week 156|Pregnancy|0|||
33364624|NCT01544595|101220590|FG004|Status at Week 156|Pregnancy|0|||
33364625|NCT01544595|101220591|FG005|Status at Week 156|Pregnancy|0|||
33364626|NCT01544595|101220586|FG000|Status at Week 156|Protocol Violation|3|||
33364627|NCT01544595|101220587|FG001|Status at Week 156|Protocol Violation|1|||
33364628|NCT01544595|101220588|FG002|Status at Week 156|Protocol Violation|2|||
33631052|NCT00079417|102200522|FG000|Overall Study|Ineligible|7|||
33631053|NCT04659044|102200527|FG000|Induction|Physician Decision|1|||
33631054|NCT04659044|102200527|FG000|Induction|Adverse Event|2|||
33631055|NCT02085460|102200530|FG000|Overall Study|Adverse Event|2|||
33631056|NCT02085460|102200531|FG001|Overall Study|Adverse Event|2|||
33364629|NCT01544595|101220589|FG003|Status at Week 156|Protocol Violation|2|||
33631057|NCT02085460|102200532|FG002|Overall Study|Adverse Event|1|||
33631058|NCT02085460|102200530|FG000|Overall Study|Physician Decision|1|||
33631059|NCT02085460|102200531|FG001|Overall Study|Physician Decision|1|||
33631060|NCT02085460|102200532|FG002|Overall Study|Physician Decision|2|||
33631061|NCT02085460|102200530|FG000|Overall Study|Withdrawal by Subject|11|||
33364630|NCT01544595|101220590|FG004|Status at Week 156|Protocol Violation|0|||
33364631|NCT01544595|101220591|FG005|Status at Week 156|Protocol Violation|0|||
33364632|NCT01544595|101220586|FG000|Status at Week 156|Technical problems|3|||
33364633|NCT01544595|101220587|FG001|Status at Week 156|Technical problems|1|||
33364634|NCT01544595|101220588|FG002|Status at Week 156|Technical problems|0|||
33567039|NCT03896503|101973161|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
33567040|NCT03896503|101973162|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
33567041|NCT03896503|101973163|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
33567042|NCT03896503|101973164|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
33567043|NCT03896503|101973165|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
33567044|NCT03896503|101973166|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
33567045|NCT03896503|101973167|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
33567046|NCT03896503|101973168|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
33631062|NCT02085460|102200531|FG001|Overall Study|Withdrawal by Subject|5|||
33223799|NCT05375955|100721608|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
33223800|NCT05375955|100721609|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
33223801|NCT05375955|100721603|FG000|Follow-up (up to 5 Weeks)|Other|0|||
33223802|NCT05375955|100721604|FG001|Follow-up (up to 5 Weeks)|Other|1|||
33223803|NCT05375955|100721605|FG002|Follow-up (up to 5 Weeks)|Other|0|||
33223804|NCT05375955|100721606|FG003|Follow-up (up to 5 Weeks)|Other|0|||
33223805|NCT05375955|100721607|FG004|Follow-up (up to 5 Weeks)|Other|0|||
33223806|NCT05375955|100721608|FG005|Follow-up (up to 5 Weeks)|Other|0|||
33223807|NCT05375955|100721609|FG006|Follow-up (up to 5 Weeks)|Other|0|||
33223808|NCT05375955|100721603|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
33223809|NCT05375955|100721604|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
33223810|NCT05375955|100721605|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
33223811|NCT05375955|100721606|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
33223812|NCT05375955|100721607|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
33223813|NCT05375955|100721608|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
33223814|NCT05375955|100721609|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
33223815|NCT05375955|100721603|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
33223816|NCT05375955|100721604|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
33364635|NCT01544595|101220589|FG003|Status at Week 156|Technical problems|1|||
33364636|NCT01544595|101220590|FG004|Status at Week 156|Technical problems|0|||
33364637|NCT01544595|101220591|FG005|Status at Week 156|Technical problems|0|||
33364638|NCT01544595|101220586|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
33364639|NCT01544595|101220587|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
33364640|NCT01544595|101220588|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
33364641|NCT01544595|101220589|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
33364642|NCT01544595|101220590|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
33364643|NCT01544595|101220591|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
33364644|NCT01544595|101220586|FG000|Status at Week 156|Lack of Efficacy|1|||
33364645|NCT01544595|101220587|FG001|Status at Week 156|Lack of Efficacy|0|||
33364646|NCT01544595|101220588|FG002|Status at Week 156|Lack of Efficacy|1|||
33364647|NCT01544595|101220589|FG003|Status at Week 156|Lack of Efficacy|4|||
33364648|NCT01544595|101220590|FG004|Status at Week 156|Lack of Efficacy|10|||
33364649|NCT01544595|101220591|FG005|Status at Week 156|Lack of Efficacy|5|||
33364650|NCT05468086|101220592|FG000|Overall Study|Withdrawal by Subject|3|||
33364651|NCT05468086|101220592|FG000|Overall Study|Subject was found ineligible after consent|1|||
33364652|NCT01283581|101220594|FG000|Overall Study|Lost to Follow-up|8|||
33364653|NCT01283581|101220595|FG001|Overall Study|Lost to Follow-up|6|||
33364654|NCT01283581|101220596|FG002|Overall Study|Lost to Follow-up|8|||
33364655|NCT01283581|101220594|FG000|Overall Study|Withdrawal by Subject|2|||
33364656|NCT01283581|101220595|FG001|Overall Study|Withdrawal by Subject|5|||
33364657|NCT01283581|101220596|FG002|Overall Study|Withdrawal by Subject|2|||
33364658|NCT01283581|101220594|FG000|Overall Study|Adverse Event|1|||
33364659|NCT01283581|101220595|FG001|Overall Study|Adverse Event|1|||
33364660|NCT01283581|101220596|FG002|Overall Study|Adverse Event|4|||
33364661|NCT01283581|101220594|FG000|Overall Study|Physician Decision|0|||
33364662|NCT01283581|101220595|FG001|Overall Study|Physician Decision|1|||
33364663|NCT01283581|101220596|FG002|Overall Study|Physician Decision|2|||
33364664|NCT01283581|101220594|FG000|Overall Study|Protocol Violation|0|||
33364665|NCT01283581|101220595|FG001|Overall Study|Protocol Violation|1|||
33364666|NCT01283581|101220596|FG002|Overall Study|Protocol Violation|2|||
33364667|NCT01283581|101220594|FG000|Overall Study|Noncompliance|1|||
33364668|NCT01283581|101220595|FG001|Overall Study|Noncompliance|0|||
33364669|NCT01283581|101220596|FG002|Overall Study|Noncompliance|0|||
33364670|NCT01283581|101220594|FG000|Overall Study|Investigator unblinded|0|||
33364671|NCT01283581|101220595|FG001|Overall Study|Investigator unblinded|0|||
33364672|NCT01283581|101220596|FG002|Overall Study|Investigator unblinded|1|||
33364673|NCT01283581|101220594|FG000|Overall Study|"Early termination"|0|||
33364674|NCT01283581|101220595|FG001|Overall Study|"Early termination"|0|||
33364675|NCT01283581|101220596|FG002|Overall Study|"Early termination"|1|||
33364676|NCT01678807|101220601|FG000|Overall Study|Adverse Event|4|||
33364677|NCT01678807|101220602|FG001|Overall Study|Adverse Event|4|||
33223817|NCT05375955|100721605|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
33223818|NCT05375955|100721606|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
33223819|NCT05375955|100721607|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
33223820|NCT05375955|100721608|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
33223821|NCT05375955|100721609|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
33223822|NCT02234063|100721617|FG000|Overall Study|Lost to Follow-up|235|||
33223823|NCT02234063|100721618|FG001|Overall Study|Lost to Follow-up|42|||
33223824|NCT02234063|100721617|FG000|Overall Study|Withdrawal by Subject|20|||
33223825|NCT02234063|100721618|FG001|Overall Study|Withdrawal by Subject|1|||
33223826|NCT01785563|100721619|FG000|Overall Study|Physician Decision|10|||
33223827|NCT01785563|100721619|FG000|Overall Study|Withdrawal by Subject|1|||
33223828|NCT01785563|100721619|FG000|Overall Study|Protocol Violation|2|||
33223829|NCT05061537|100721620|FG000|Treatment Phase|Progressive disease|0|||
33223830|NCT05061537|100721621|FG001|Treatment Phase|Progressive disease|1|||
33223831|NCT05061537|100721622|FG002|Treatment Phase|Progressive disease|2|||
33223832|NCT05061537|100721623|FG003|Treatment Phase|Progressive disease|0|||
33223833|NCT05061537|100721624|FG004|Treatment Phase|Progressive disease|0|||
33223834|NCT05061537|100721620|FG000|Treatment Phase|Adverse Event|0|||
33223835|NCT05061537|100721621|FG001|Treatment Phase|Adverse Event|0|||
33223836|NCT05061537|100721622|FG002|Treatment Phase|Adverse Event|2|||
33223837|NCT05061537|100721623|FG003|Treatment Phase|Adverse Event|0|||
33223838|NCT05061537|100721624|FG004|Treatment Phase|Adverse Event|0|||
33223839|NCT05061537|100721620|FG000|Treatment Phase|Global deterioration of health status|0|||
33223840|NCT05061537|100721621|FG001|Treatment Phase|Global deterioration of health status|1|||
33223841|NCT05061537|100721622|FG002|Treatment Phase|Global deterioration of health status|0|||
33223842|NCT05061537|100721623|FG003|Treatment Phase|Global deterioration of health status|0|||
33223843|NCT05061537|100721624|FG004|Treatment Phase|Global deterioration of health status|0|||
33223844|NCT05061537|100721620|FG000|Follow up|Other|2|||
33223845|NCT05061537|100721621|FG001|Follow up|Other|0|||
33223846|NCT05061537|100721622|FG002|Follow up|Other|2|||
33223847|NCT05061537|100721623|FG003|Follow up|Other|0|||
33223848|NCT05061537|100721624|FG004|Follow up|Other|0|||
33223849|NCT05061537|100721620|FG000|Follow up|Study terminated by sponsor|0|||
33223850|NCT05061537|100721621|FG001|Follow up|Study terminated by sponsor|0|||
33223851|NCT05061537|100721622|FG002|Follow up|Study terminated by sponsor|2|||
33567047|NCT03896503|101973161|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
33223852|NCT05061537|100721623|FG003|Follow up|Study terminated by sponsor|0|||
33223853|NCT05061537|100721624|FG004|Follow up|Study terminated by sponsor|0|||
33223854|NCT05061537|100721620|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
33223855|NCT05061537|100721621|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
33364678|NCT01678807|101220603|FG002|Overall Study|Adverse Event|0|||
33364679|NCT01678807|101220601|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
33364680|NCT01678807|101220602|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
33364681|NCT01678807|101220603|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
33364682|NCT01558089|101220604|FG000|Overall Study|Adverse Event|1|||
33364683|NCT01558089|101220604|FG000|Overall Study|Lack of Efficacy|1|||
33364684|NCT01558089|101220604|FG000|Overall Study|Lost to Follow-up|5|||
33364685|NCT01558089|101220604|FG000|Overall Study|Withdrawal by Subject|6|||
33364686|NCT00784784|101220610|FG000|Overall Study|Withdrawal by Subject|2|||
33364687|NCT00784784|101220611|FG001|Overall Study|Withdrawal by Subject|2|||
33364688|NCT03141307|101220612|FG000|In-Hospital|Withdrawal by Subject|0|||
33364689|NCT03141307|101220613|FG001|In-Hospital|Withdrawal by Subject|2|||
33364690|NCT03141307|101220612|FG000|In-Hospital|Protocol Violation|4|||
33364691|NCT03141307|101220613|FG001|In-Hospital|Protocol Violation|0|||
33364692|NCT03141307|101220612|FG000|Follow-Up|Lost to Follow-up|97|||
33364693|NCT03141307|101220613|FG001|Follow-Up|Lost to Follow-up|54|||
33364694|NCT03662334|101223575|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
33364695|NCT03662334|101223576|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
33364696|NCT01302769|101223579|FG000|Overall Study|Lost to Follow-up|1|||
33364697|NCT01302769|101223580|FG001|Overall Study|Lost to Follow-up|1|||
33364698|NCT00829166|101223585|FG000|Overall Study|Death|305|||
33364699|NCT00829166|101223586|FG001|Overall Study|Death|333|||
33364700|NCT00829166|101223585|FG000|Overall Study|Lost to Follow-up|5|||
33364701|NCT00829166|101223586|FG001|Overall Study|Lost to Follow-up|4|||
33364702|NCT00829166|101223585|FG000|Overall Study|Physician's Decision|4|||
33364703|NCT00829166|101223586|FG001|Overall Study|Physician's Decision|3|||
33364704|NCT00829166|101223585|FG000|Overall Study|Subject's Decision|41|||
33364705|NCT00829166|101223586|FG001|Overall Study|Subject's Decision|55|||
33364706|NCT00829166|101223585|FG000|Overall Study|Sponsor's Decision|137|||
33364707|NCT00829166|101223586|FG001|Overall Study|Sponsor's Decision|98|||
33364708|NCT00829166|101223585|FG000|Overall Study|Reason Not Specified|3|||
33223856|NCT05061537|100721622|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
33223857|NCT05061537|100721623|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
33223858|NCT05061537|100721624|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
33364709|NCT00829166|101223586|FG001|Overall Study|Reason Not Specified|3|||
33223859|NCT05061537|100721620|FG000|Long-term Follow-up|Death|0|||
33223860|NCT05061537|100721621|FG001|Long-term Follow-up|Death|1|||
33223861|NCT05061537|100721622|FG002|Long-term Follow-up|Death|0|||
33416822|NCT04578548|101416250|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
33416823|NCT04578548|101416251|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
33416824|NCT04578548|101416250|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
33416825|NCT04578548|101416251|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
33416826|NCT04578548|101416250|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
33416827|NCT04578548|101416251|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
33416828|NCT04635631|101416253|FG000|Overall Study|Adverse Event|1|||
33416829|NCT04635631|101416253|FG000|Overall Study|Progressive disease|13|||
33416830|NCT04635631|101416253|FG000|Overall Study|Withdrawal by Subject|1|||
33416831|NCT05144477|101416254|FG000|Overall Study|Withdrawal by Subject|1|||
33416832|NCT05144477|101416255|FG001|Overall Study|Withdrawal by Subject|1|||
33416833|NCT04311411|101416265|FG000|Overall Study|Adverse Event|2|||
33416834|NCT04311411|101416266|FG001|Overall Study|Adverse Event|3|||
33416835|NCT04311411|101416267|FG002|Overall Study|Adverse Event|2|||
33416836|NCT04311411|101416265|FG000|Overall Study|Withdrawal by Subject|3|||
33416837|NCT04311411|101416266|FG001|Overall Study|Withdrawal by Subject|3|||
33416838|NCT04311411|101416267|FG002|Overall Study|Withdrawal by Subject|0|||
33416839|NCT03069365|101416268|FG000|Overall Study|Adverse Event|1|||
33416840|NCT00503035|101416269|FG000|Overall Study|Lost to Follow-up|2|||
33416841|NCT00503035|101416269|FG000|Overall Study|Physician Decision|3|||
33416842|NCT00503035|101416269|FG000|Overall Study|Ineligible|15|||
33416843|NCT00424632|101416281|FG000|Overall Study|Death|0|||
33416844|NCT00424632|101416282|FG001|Overall Study|Death|0|||
33416845|NCT00424632|101416283|FG002|Overall Study|Death|0|||
33631063|NCT02085460|102200532|FG002|Overall Study|Withdrawal by Subject|7|||
33631064|NCT02420717|102200533|FG000|Overall Study|Did not receive all study medication|2|||
33223862|NCT05061537|100721623|FG003|Long-term Follow-up|Death|0|||
33223863|NCT05061537|100721624|FG004|Long-term Follow-up|Death|0|||
33416846|NCT00424632|101416284|FG003|Overall Study|Death|0|||
33416847|NCT00424632|101416285|FG004|Overall Study|Death|0|||
33416848|NCT00424632|101416286|FG005|Overall Study|Death|2|||
33416849|NCT00424632|101416287|FG006|Overall Study|Death|0|||
33416850|NCT00424632|101416288|FG007|Overall Study|Death|0|||
33416851|NCT00424632|101416289|FG008|Overall Study|Death|0|||
33416852|NCT00424632|101416290|FG009|Overall Study|Death|0|||
33416853|NCT00424632|101416281|FG000|Overall Study|Adverse Event|0|||
33416854|NCT00424632|101416282|FG001|Overall Study|Adverse Event|0|||
33416855|NCT00424632|101416283|FG002|Overall Study|Adverse Event|0|||
33567048|NCT03896503|101973162|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
33567049|NCT03896503|101973163|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
33567050|NCT03896503|101973164|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
33567051|NCT03896503|101973165|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
33567052|NCT03896503|101973166|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
33567053|NCT03896503|101973167|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
33567054|NCT03896503|101973168|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
33567055|NCT02723955|101973169|FG000|Escalation Phase|Death|1|||
33567056|NCT02723955|101973170|FG001|Escalation Phase|Death|1|||
33567057|NCT02723955|101973171|FG002|Escalation Phase|Death|2|||
33567058|NCT02723955|101973172|FG003|Escalation Phase|Death|7|||
33567059|NCT02723955|101973173|FG004|Escalation Phase|Death|18|||
33567060|NCT02723955|101973174|FG005|Escalation Phase|Death|17|||
33567061|NCT02723955|101973175|FG006|Escalation Phase|Death|11|||
33567062|NCT02723955|101973176|FG007|Escalation Phase|Death|21|||
33567063|NCT02723955|101973177|FG008|Escalation Phase|Death|3|||
33567064|NCT02723955|101973178|FG009|Escalation Phase|Death|0|||
33567065|NCT02723955|101973179|FG010|Escalation Phase|Death|0|||
33567066|NCT02723955|101973180|FG011|Escalation Phase|Death|0|||
33567067|NCT02723955|101973181|FG012|Escalation Phase|Death|2|||
33567068|NCT02723955|101973182|FG013|Escalation Phase|Death|4|||
33567069|NCT02723955|101973183|FG014|Escalation Phase|Death|5|||
33567070|NCT02723955|101973184|FG015|Escalation Phase|Death|6|||
33567071|NCT02723955|101973185|FG016|Escalation Phase|Death|6|||
33567072|NCT02723955|101973186|FG017|Escalation Phase|Death|7|||
33567073|NCT02723955|101973187|FG018|Escalation Phase|Death|1|||
33567074|NCT02723955|101973188|FG019|Escalation Phase|Death|3|||
33567075|NCT02723955|101973189|FG020|Escalation Phase|Death|13|||
33567076|NCT02723955|101973190|FG021|Escalation Phase|Death|3|||
33567077|NCT02723955|101973191|FG022|Escalation Phase|Death|2|||
33631065|NCT02420717|102200534|FG001|Overall Study|Did not receive all study medication|0|||
33223864|NCT01483937|100721630|FG000|Overall Study|Withdrawal by Subject|4|||
33567078|NCT02723955|101973192|FG023|Escalation Phase|Death|4|||
33567079|NCT02723955|101973193|FG024|Escalation Phase|Death|31|||
33416856|NCT00424632|101416284|FG003|Overall Study|Adverse Event|0|||
33416857|NCT00424632|101416285|FG004|Overall Study|Adverse Event|0|||
33416858|NCT00424632|101416286|FG005|Overall Study|Adverse Event|0|||
33416859|NCT00424632|101416287|FG006|Overall Study|Adverse Event|0|||
33416860|NCT00424632|101416288|FG007|Overall Study|Adverse Event|0|||
33416861|NCT00424632|101416289|FG008|Overall Study|Adverse Event|3|||
33416862|NCT00424632|101416290|FG009|Overall Study|Adverse Event|2|||
33416863|NCT00424632|101416281|FG000|Overall Study|Global deterioration of health status|0|||
33416864|NCT00424632|101416282|FG001|Overall Study|Global deterioration of health status|0|||
33416865|NCT00424632|101416283|FG002|Overall Study|Global deterioration of health status|0|||
33416866|NCT00424632|101416284|FG003|Overall Study|Global deterioration of health status|1|||
33416867|NCT00424632|101416285|FG004|Overall Study|Global deterioration of health status|1|||
33631066|NCT02420717|102200535|FG002|Overall Study|Did not receive all study medication|0|||
33631067|NCT00129402|102200536|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
33416868|NCT00424632|101416286|FG005|Overall Study|Global deterioration of health status|0|||
33416869|NCT00424632|101416287|FG006|Overall Study|Global deterioration of health status|0|||
33416870|NCT00424632|101416288|FG007|Overall Study|Global deterioration of health status|0|||
33416871|NCT00424632|101416289|FG008|Overall Study|Global deterioration of health status|0|||
33631068|NCT00129402|102200537|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
33631069|NCT00129402|102200538|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
33631070|NCT00129402|102200539|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
33631071|NCT00129402|102200540|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
33631072|NCT00129402|102200541|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
33631073|NCT00129402|102200542|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
33631074|NCT00129402|102200536|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
33631075|NCT00129402|102200537|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
33631076|NCT00129402|102200538|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
33631077|NCT00129402|102200539|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
33631078|NCT00129402|102200540|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
33416872|NCT00424632|101416290|FG009|Overall Study|Global deterioration of health status|0|||
33416873|NCT00424632|101416281|FG000|Overall Study|Objective progression or relapse|1|||
33416874|NCT00424632|101416282|FG001|Overall Study|Objective progression or relapse|1|||
33416875|NCT00424632|101416283|FG002|Overall Study|Objective progression or relapse|1|||
33416876|NCT00424632|101416284|FG003|Overall Study|Objective progression or relapse|2|||
33416877|NCT00424632|101416285|FG004|Overall Study|Objective progression or relapse|2|||
33416878|NCT00424632|101416286|FG005|Overall Study|Objective progression or relapse|13|||
33416879|NCT00424632|101416287|FG006|Overall Study|Objective progression or relapse|7|||
33416880|NCT00424632|101416288|FG007|Overall Study|Objective progression or relapse|3|||
33416881|NCT00424632|101416289|FG008|Overall Study|Objective progression or relapse|12|||
33416882|NCT00424632|101416290|FG009|Overall Study|Objective progression or relapse|4|||
33416883|NCT00424632|101416281|FG000|Overall Study|Other|0|||
33416884|NCT00424632|101416282|FG001|Overall Study|Other|0|||
33416885|NCT00424632|101416283|FG002|Overall Study|Other|0|||
33416886|NCT00424632|101416284|FG003|Overall Study|Other|1|||
33416887|NCT00424632|101416285|FG004|Overall Study|Other|0|||
33416888|NCT00424632|101416286|FG005|Overall Study|Other|0|||
33416889|NCT00424632|101416287|FG006|Overall Study|Other|0|||
33416890|NCT00424632|101416288|FG007|Overall Study|Other|0|||
33416891|NCT00424632|101416289|FG008|Overall Study|Other|1|||
33416892|NCT00424632|101416290|FG009|Overall Study|Other|0|||
33416893|NCT02525627|101416291|FG000|Overall Study|Revision|1|||
33416894|NCT02525627|101416292|FG001|Overall Study|Revision|1|||
33416895|NCT02525627|101416291|FG000|Overall Study|Withdrawal by Subject|1|||
33416896|NCT02525627|101416292|FG001|Overall Study|Withdrawal by Subject|2|||
33416897|NCT02525627|101416291|FG000|Overall Study|Death|1|||
33416898|NCT02525627|101416292|FG001|Overall Study|Death|0|||
33416899|NCT02525627|101416291|FG000|Overall Study|Site terminated|11|||
33416900|NCT02525627|101416292|FG001|Overall Study|Site terminated|10|||
33416901|NCT03747939|101416295|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
33416902|NCT03747939|101416296|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
33416903|NCT03747939|101416297|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
33416904|NCT03747939|101416298|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
33416905|NCT03747939|101416295|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
33416906|NCT03747939|101416296|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
33416907|NCT03747939|101416297|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
33416908|NCT03747939|101416298|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
33416909|NCT03747939|101416295|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
33416910|NCT03747939|101416296|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
33416911|NCT03747939|101416297|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
33416912|NCT03747939|101416298|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
33416913|NCT03747939|101416295|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
33416914|NCT03747939|101416296|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
33567080|NCT02723955|101973194|FG025|Escalation Phase|Death|7|||
33631079|NCT00129402|102200541|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
33631080|NCT00129402|102200542|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
33631081|NCT00129402|102200536|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
33631082|NCT00129402|102200537|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
33631083|NCT00129402|102200538|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
33416915|NCT03747939|101416297|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
33416916|NCT03747939|101416298|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
33416917|NCT03747939|101416295|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
33416918|NCT03747939|101416296|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
33416919|NCT03747939|101416297|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
33416920|NCT03747939|101416298|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
33567081|NCT02723955|101973195|FG026|Escalation Phase|Death|13|||
33567082|NCT02723955|101973196|FG027|Escalation Phase|Death|0|||
33567083|NCT02723955|101973197|FG028|Escalation Phase|Death|1|||
33567084|NCT02723955|101973198|FG029|Escalation Phase|Death|0|||
33223865|NCT01483937|100721631|FG001|Overall Study|Withdrawal by Subject|3|||
33223866|NCT00909428|100721632|FG000|Overall Study|Lost to Follow-up|13|||
33223867|NCT00909428|100721633|FG001|Overall Study|Lost to Follow-up|10|||
33223868|NCT00909428|100721634|FG002|Overall Study|Lost to Follow-up|9|||
33223869|NCT04503096|100721635|FG000|Overall Study|Withdrawal by Subject|3|||
33223870|NCT00641719|100721636|FG000|Overall Study|Lack of Efficacy|1|||
33223871|NCT00641719|100721637|FG001|Overall Study|Lack of Efficacy|2|||
33223872|NCT00641719|100721636|FG000|Overall Study|Adverse Event|24|||
33223873|NCT00641719|100721637|FG001|Overall Study|Adverse Event|29|||
33223874|NCT00641719|100721636|FG000|Overall Study|Withdrawal by Subject|4|||
33223875|NCT00641719|100721637|FG001|Overall Study|Withdrawal by Subject|4|||
33223876|NCT00641719|100721636|FG000|Overall Study|Reason Not Specified|1|||
33223877|NCT00641719|100721637|FG001|Overall Study|Reason Not Specified|2|||
33223878|NCT05050578|100721642|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
33223879|NCT05050578|100721643|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
33223880|NCT05050578|100721642|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
33223881|NCT05050578|100721643|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
33223882|NCT05050578|100721642|FG000|Period 2, 30 Days|Protocol Violation|0|||
33223883|NCT05050578|100721643|FG001|Period 2, 30 Days|Protocol Violation|1|||
33223884|NCT00755222|100721648|FG000|Overall Study|Withdrawal by Subject|4|||
33223885|NCT00755222|100721649|FG001|Overall Study|Withdrawal by Subject|2|||
33364710|NCT00001259|101223587|FG000|Study 2|Adverse Event|0|||
33364711|NCT00001259|101223588|FG001|Study 2|Adverse Event|0|||
33567085|NCT02723955|101973199|FG030|Escalation Phase|Death|0|||
33567086|NCT02723955|101973200|FG031|Escalation Phase|Death|0|||
33567087|NCT02723955|101973201|FG032|Escalation Phase|Death|0|||
33567088|NCT02723955|101973202|FG033|Escalation Phase|Death|0|||
33567089|NCT02723955|101973203|FG034|Escalation Phase|Death|0|||
33567090|NCT02723955|101973204|FG035|Escalation Phase|Death|0|||
33567091|NCT02723955|101973205|FG036|Escalation Phase|Death|0|||
33567092|NCT02723955|101973206|FG037|Escalation Phase|Death|0|||
33567093|NCT02723955|101973207|FG038|Escalation Phase|Death|0|||
33567094|NCT02723955|101973208|FG039|Escalation Phase|Death|0|||
33567095|NCT02723955|101973209|FG040|Escalation Phase|Death|0|||
33567096|NCT02723955|101973210|FG041|Escalation Phase|Death|0|||
33567097|NCT02723955|101973211|FG042|Escalation Phase|Death|0|||
33567098|NCT02723955|101973169|FG000|Escalation Phase|Lost to Follow-up|0|||
33631084|NCT00129402|102200539|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
33631085|NCT00129402|102200540|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
33631086|NCT00129402|102200541|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
33631087|NCT00129402|102200542|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
33631088|NCT00129402|102200536|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
33631089|NCT00129402|102200537|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
33631090|NCT00129402|102200538|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
33223886|NCT00755222|100721648|FG000|Overall Study|Adverse Event|2|||
33223887|NCT00755222|100721649|FG001|Overall Study|Adverse Event|0|||
33364712|NCT00001259|101223589|FG002|Study 2|Adverse Event|0|||
33364713|NCT00001259|101223590|FG003|Study 2|Adverse Event|0|||
33364714|NCT00001259|101223591|FG004|Study 2|Adverse Event|2|||
33364715|NCT00001259|101223592|FG005|Study 2|Adverse Event|0|||
33364716|NCT00001259|101223593|FG006|Study 2|Adverse Event|0|||
33567099|NCT02723955|101973170|FG001|Escalation Phase|Lost to Follow-up|0|||
33567100|NCT02723955|101973171|FG002|Escalation Phase|Lost to Follow-up|0|||
33567101|NCT02723955|101973172|FG003|Escalation Phase|Lost to Follow-up|0|||
33364717|NCT02144220|101223596|FG000|Overall Study|technology incompatibility|9|||
33364718|NCT02144220|101223596|FG000|Overall Study|Lack of Efficacy|4|||
33364719|NCT02144220|101223596|FG000|Overall Study|Physician Decision|3|||
33567102|NCT02723955|101973173|FG004|Escalation Phase|Lost to Follow-up|0|||
33364720|NCT02144220|101223596|FG000|Overall Study|Withdrawal by Subject|2|||
33364721|NCT02144220|101223596|FG000|Overall Study|Protocol Violation|1|||
33567103|NCT02723955|101973174|FG005|Escalation Phase|Lost to Follow-up|2|||
33567104|NCT02723955|101973175|FG006|Escalation Phase|Lost to Follow-up|1|||
33567105|NCT02723955|101973176|FG007|Escalation Phase|Lost to Follow-up|1|||
33567106|NCT02723955|101973177|FG008|Escalation Phase|Lost to Follow-up|1|||
33567107|NCT02723955|101973178|FG009|Escalation Phase|Lost to Follow-up|0|||
33567108|NCT02723955|101973179|FG010|Escalation Phase|Lost to Follow-up|0|||
33567109|NCT02723955|101973180|FG011|Escalation Phase|Lost to Follow-up|0|||
33567110|NCT02723955|101973181|FG012|Escalation Phase|Lost to Follow-up|1|||
33567111|NCT02723955|101973182|FG013|Escalation Phase|Lost to Follow-up|0|||
33567112|NCT02723955|101973183|FG014|Escalation Phase|Lost to Follow-up|0|||
33567113|NCT02723955|101973184|FG015|Escalation Phase|Lost to Follow-up|0|||
33567114|NCT02723955|101973185|FG016|Escalation Phase|Lost to Follow-up|1|||
33567115|NCT02723955|101973186|FG017|Escalation Phase|Lost to Follow-up|2|||
33567116|NCT02723955|101973187|FG018|Escalation Phase|Lost to Follow-up|0|||
33567117|NCT02723955|101973188|FG019|Escalation Phase|Lost to Follow-up|1|||
33567118|NCT02723955|101973189|FG020|Escalation Phase|Lost to Follow-up|2|||
33567119|NCT02723955|101973190|FG021|Escalation Phase|Lost to Follow-up|1|||
33567120|NCT02723955|101973191|FG022|Escalation Phase|Lost to Follow-up|0|||
33567121|NCT02723955|101973192|FG023|Escalation Phase|Lost to Follow-up|0|||
33567122|NCT02723955|101973193|FG024|Escalation Phase|Lost to Follow-up|1|||
33567123|NCT02723955|101973194|FG025|Escalation Phase|Lost to Follow-up|1|||
33567124|NCT02723955|101973195|FG026|Escalation Phase|Lost to Follow-up|3|||
33567125|NCT02723955|101973196|FG027|Escalation Phase|Lost to Follow-up|0|||
33567126|NCT02723955|101973197|FG028|Escalation Phase|Lost to Follow-up|1|||
33567127|NCT02723955|101973198|FG029|Escalation Phase|Lost to Follow-up|0|||
33567128|NCT02723955|101973199|FG030|Escalation Phase|Lost to Follow-up|0|||
33567129|NCT02723955|101973200|FG031|Escalation Phase|Lost to Follow-up|0|||
33567130|NCT02723955|101973201|FG032|Escalation Phase|Lost to Follow-up|0|||
33567131|NCT02723955|101973202|FG033|Escalation Phase|Lost to Follow-up|0|||
33567132|NCT02723955|101973203|FG034|Escalation Phase|Lost to Follow-up|0|||
33567133|NCT02723955|101973204|FG035|Escalation Phase|Lost to Follow-up|0|||
33567134|NCT02723955|101973205|FG036|Escalation Phase|Lost to Follow-up|0|||
33567135|NCT02723955|101973206|FG037|Escalation Phase|Lost to Follow-up|0|||
33567136|NCT02723955|101973207|FG038|Escalation Phase|Lost to Follow-up|0|||
33567137|NCT02723955|101973208|FG039|Escalation Phase|Lost to Follow-up|0|||
33567138|NCT02723955|101973209|FG040|Escalation Phase|Lost to Follow-up|0|||
33567139|NCT02723955|101973210|FG041|Escalation Phase|Lost to Follow-up|0|||
33567140|NCT02723955|101973211|FG042|Escalation Phase|Lost to Follow-up|0|||
33567141|NCT02723955|101973169|FG000|Escalation Phase|Physician Decision|0|||
33567142|NCT02723955|101973170|FG001|Escalation Phase|Physician Decision|0|||
33567143|NCT02723955|101973171|FG002|Escalation Phase|Physician Decision|0|||
33567144|NCT02723955|101973172|FG003|Escalation Phase|Physician Decision|0|||
33567145|NCT02723955|101973173|FG004|Escalation Phase|Physician Decision|0|||
33567146|NCT02723955|101973174|FG005|Escalation Phase|Physician Decision|2|||
33567147|NCT02723955|101973175|FG006|Escalation Phase|Physician Decision|0|||
33567148|NCT02723955|101973176|FG007|Escalation Phase|Physician Decision|0|||
33567149|NCT02723955|101973177|FG008|Escalation Phase|Physician Decision|0|||
33567150|NCT02723955|101973178|FG009|Escalation Phase|Physician Decision|0|||
33567151|NCT02723955|101973179|FG010|Escalation Phase|Physician Decision|0|||
33567152|NCT02723955|101973180|FG011|Escalation Phase|Physician Decision|0|||
33364722|NCT00417612|101223604|FG000|Overall Study|Errant diagnosis|0|||
33567153|NCT02723955|101973181|FG012|Escalation Phase|Physician Decision|0|||
33567154|NCT02723955|101973182|FG013|Escalation Phase|Physician Decision|0|||
33567155|NCT02723955|101973183|FG014|Escalation Phase|Physician Decision|0|||
33567156|NCT02723955|101973184|FG015|Escalation Phase|Physician Decision|0|||
33223888|NCT00755222|100721648|FG000|Overall Study|Protocol Violation|2|||
33223889|NCT00755222|100721649|FG001|Overall Study|Protocol Violation|0|||
33223890|NCT02563002|100721650|FG000|Overall Study|Death|72|||
33223891|NCT02563002|100721651|FG001|Overall Study|Death|87|||
33223892|NCT02563002|100721650|FG000|Overall Study|Lost to Follow-up|5|||
33223893|NCT02563002|100721651|FG001|Overall Study|Lost to Follow-up|0|||
33223894|NCT02563002|100721650|FG000|Overall Study|Physician Decision|0|||
33223895|NCT02563002|100721651|FG001|Overall Study|Physician Decision|2|||
33223896|NCT02563002|100721650|FG000|Overall Study|Withdrawal by Subject|2|||
33223897|NCT02563002|100721651|FG001|Overall Study|Withdrawal by Subject|10|||
33223898|NCT02563002|100721650|FG000|Overall Study|Sponsor decision|74|||
33223899|NCT02563002|100721651|FG001|Overall Study|Sponsor decision|55|||
33223900|NCT03966053|100721658|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
33223901|NCT00265330|100721659|FG000|Overall Study|Adverse Event|41|||
33223902|NCT00265330|100721659|FG000|Overall Study|Lost to Follow-up|8|||
33223903|NCT00265330|100721659|FG000|Overall Study|Withdrawal by Subject|34|||
33223904|NCT00265330|100721659|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
33223905|NCT00265330|100721659|FG000|Overall Study|Lack of Efficacy|4|||
33223906|NCT00265330|100721659|FG000|Overall Study|Family Scheduling Conflicts|1|||
33223907|NCT00265330|100721659|FG000|Overall Study|Began Taking Formulary Geodon|1|||
33223908|NCT00265330|100721659|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
33223909|NCT00265330|100721659|FG000|Overall Study|Site Closed by Sponsor|1|||
33223910|NCT00265330|100721659|FG000|Overall Study|Principal Investigators Request|1|||
33223911|NCT00265330|100721659|FG000|Overall Study|Withdrew Consent|1|||
33223912|NCT00265330|100721659|FG000|Overall Study|Protocol Violation|1|||
33223913|NCT01106430|100721660|FG000|Overall Study|Adverse Event|8|||
33223914|NCT01106430|100721661|FG001|Overall Study|Adverse Event|10|||
33223915|NCT01106430|100721660|FG000|Overall Study|Lack of Efficacy|2|||
33223916|NCT01106430|100721661|FG001|Overall Study|Lack of Efficacy|13|||
33223917|NCT01106430|100721660|FG000|Overall Study|Lost to Follow-up|5|||
33223918|NCT01106430|100721661|FG001|Overall Study|Lost to Follow-up|1|||
33364723|NCT00417612|101223605|FG001|Overall Study|Errant diagnosis|1|||
33364724|NCT00417612|101223604|FG000|Overall Study|Adverse Event|2|||
33364725|NCT00417612|101223605|FG001|Overall Study|Adverse Event|0|||
33364726|NCT00417612|101223604|FG000|Overall Study|Protocol Violation|0|||
33364727|NCT00417612|101223605|FG001|Overall Study|Protocol Violation|2|||
33567157|NCT02723955|101973185|FG016|Escalation Phase|Physician Decision|0|||
33567158|NCT02723955|101973186|FG017|Escalation Phase|Physician Decision|0|||
33567159|NCT02723955|101973187|FG018|Escalation Phase|Physician Decision|0|||
33567160|NCT02723955|101973188|FG019|Escalation Phase|Physician Decision|0|||
33567161|NCT02723955|101973189|FG020|Escalation Phase|Physician Decision|0|||
33567162|NCT02723955|101973190|FG021|Escalation Phase|Physician Decision|0|||
33567163|NCT02723955|101973191|FG022|Escalation Phase|Physician Decision|0|||
33567164|NCT02723955|101973192|FG023|Escalation Phase|Physician Decision|0|||
33567165|NCT02723955|101973193|FG024|Escalation Phase|Physician Decision|0|||
33567166|NCT02723955|101973194|FG025|Escalation Phase|Physician Decision|0|||
33567167|NCT02723955|101973195|FG026|Escalation Phase|Physician Decision|2|||
33567168|NCT02723955|101973196|FG027|Escalation Phase|Physician Decision|0|||
33567169|NCT02723955|101973197|FG028|Escalation Phase|Physician Decision|0|||
33567170|NCT02723955|101973198|FG029|Escalation Phase|Physician Decision|0|||
33567171|NCT02723955|101973199|FG030|Escalation Phase|Physician Decision|0|||
33567172|NCT02723955|101973200|FG031|Escalation Phase|Physician Decision|0|||
33567173|NCT02723955|101973201|FG032|Escalation Phase|Physician Decision|0|||
33567174|NCT02723955|101973202|FG033|Escalation Phase|Physician Decision|0|||
33567175|NCT02723955|101973203|FG034|Escalation Phase|Physician Decision|0|||
33567176|NCT02723955|101973204|FG035|Escalation Phase|Physician Decision|0|||
33567177|NCT02723955|101973205|FG036|Escalation Phase|Physician Decision|0|||
33567178|NCT02723955|101973206|FG037|Escalation Phase|Physician Decision|0|||
33567179|NCT02723955|101973207|FG038|Escalation Phase|Physician Decision|0|||
33567180|NCT02723955|101973208|FG039|Escalation Phase|Physician Decision|0|||
33567181|NCT02723955|101973209|FG040|Escalation Phase|Physician Decision|0|||
33567182|NCT02723955|101973210|FG041|Escalation Phase|Physician Decision|0|||
33567183|NCT02723955|101973211|FG042|Escalation Phase|Physician Decision|0|||
33567184|NCT02723955|101973169|FG000|Escalation Phase|Withdrawal by Subject|0|||
33567185|NCT02723955|101973170|FG001|Escalation Phase|Withdrawal by Subject|0|||
33567186|NCT02723955|101973171|FG002|Escalation Phase|Withdrawal by Subject|0|||
33567187|NCT02723955|101973172|FG003|Escalation Phase|Withdrawal by Subject|0|||
33567188|NCT02723955|101973173|FG004|Escalation Phase|Withdrawal by Subject|1|||
33567189|NCT02723955|101973174|FG005|Escalation Phase|Withdrawal by Subject|1|||
33567190|NCT02723955|101973175|FG006|Escalation Phase|Withdrawal by Subject|1|||
33567191|NCT02723955|101973176|FG007|Escalation Phase|Withdrawal by Subject|1|||
33567192|NCT02723955|101973177|FG008|Escalation Phase|Withdrawal by Subject|0|||
33567193|NCT02723955|101973178|FG009|Escalation Phase|Withdrawal by Subject|0|||
33567194|NCT02723955|101973179|FG010|Escalation Phase|Withdrawal by Subject|0|||
33567195|NCT02723955|101973180|FG011|Escalation Phase|Withdrawal by Subject|0|||
33567196|NCT02723955|101973181|FG012|Escalation Phase|Withdrawal by Subject|1|||
33567197|NCT02723955|101973182|FG013|Escalation Phase|Withdrawal by Subject|0|||
33567198|NCT02723955|101973183|FG014|Escalation Phase|Withdrawal by Subject|0|||
33567199|NCT02723955|101973184|FG015|Escalation Phase|Withdrawal by Subject|0|||
33567200|NCT02723955|101973185|FG016|Escalation Phase|Withdrawal by Subject|1|||
33567201|NCT02723955|101973186|FG017|Escalation Phase|Withdrawal by Subject|0|||
33567202|NCT02723955|101973187|FG018|Escalation Phase|Withdrawal by Subject|0|||
33567203|NCT02723955|101973188|FG019|Escalation Phase|Withdrawal by Subject|0|||
33631091|NCT00129402|102200539|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
33631092|NCT00129402|102200540|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
33631093|NCT00129402|102200541|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
33631094|NCT00129402|102200542|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
33631095|NCT00129402|102200536|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
33631096|NCT00129402|102200537|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
33631097|NCT00129402|102200538|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
33631098|NCT00129402|102200539|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
33631099|NCT00129402|102200540|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
33631100|NCT00129402|102200541|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
33631101|NCT00129402|102200542|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
33631102|NCT00129402|102200536|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
33631103|NCT00129402|102200537|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
33631104|NCT00129402|102200538|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
33567204|NCT02723955|101973189|FG020|Escalation Phase|Withdrawal by Subject|0|||
33567205|NCT02723955|101973190|FG021|Escalation Phase|Withdrawal by Subject|0|||
33364728|NCT00417612|101223604|FG000|Overall Study|Lost to Follow-up|1|||
33567206|NCT02723955|101973191|FG022|Escalation Phase|Withdrawal by Subject|0|||
33567207|NCT02723955|101973192|FG023|Escalation Phase|Withdrawal by Subject|2|||
33364729|NCT00417612|101223605|FG001|Overall Study|Lost to Follow-up|0|||
33364730|NCT01721369|101223606|FG000|Overall Study|Not initial etiological diagnosis|12|||
33416921|NCT03747939|101416295|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
33416922|NCT03747939|101416296|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
33416923|NCT03747939|101416297|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
33416924|NCT03747939|101416298|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
33416925|NCT03747939|101416295|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
33416926|NCT03747939|101416296|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
33364731|NCT00719732|101223607|FG000|Overall Study|Lost to Follow-up|20|||
33364732|NCT00719732|101223607|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
33364733|NCT00719732|101223607|FG000|Overall Study|Illness not associated with device|1|||
33364734|NCT03880227|101223608|FG000|First Visit|Withdrawal by Subject|1|||
33364735|NCT03880227|101223609|FG001|First Visit|Withdrawal by Subject|0|||
33364736|NCT03880227|101223610|FG002|First Visit|Withdrawal by Subject|0|||
33364737|NCT03880227|101223611|FG003|First Visit|Withdrawal by Subject|0|||
33364738|NCT03880227|101223608|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
33364739|NCT03880227|101223609|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
33364740|NCT03880227|101223610|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
33364741|NCT03880227|101223611|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
33364742|NCT03880227|101223608|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
33416927|NCT03747939|101416297|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
33416928|NCT03747939|101416298|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
33416929|NCT03747939|101416295|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
33416930|NCT03747939|101416296|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
33416931|NCT03747939|101416297|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
33416932|NCT03747939|101416298|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
33416933|NCT03747939|101416295|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
33416934|NCT03747939|101416296|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
33416935|NCT03747939|101416297|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
33416936|NCT03747939|101416298|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
33416937|NCT03747939|101416295|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
33416938|NCT03747939|101416296|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
33416939|NCT03747939|101416297|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
33416940|NCT03747939|101416298|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
33567208|NCT02723955|101973193|FG024|Escalation Phase|Withdrawal by Subject|0|||
33567209|NCT02723955|101973194|FG025|Escalation Phase|Withdrawal by Subject|1|||
33567210|NCT02723955|101973195|FG026|Escalation Phase|Withdrawal by Subject|0|||
33567211|NCT02723955|101973196|FG027|Escalation Phase|Withdrawal by Subject|0|||
33567212|NCT02723955|101973197|FG028|Escalation Phase|Withdrawal by Subject|1|||
33567213|NCT02723955|101973198|FG029|Escalation Phase|Withdrawal by Subject|0|||
33567214|NCT02723955|101973199|FG030|Escalation Phase|Withdrawal by Subject|0|||
33567215|NCT02723955|101973200|FG031|Escalation Phase|Withdrawal by Subject|0|||
33567216|NCT02723955|101973201|FG032|Escalation Phase|Withdrawal by Subject|0|||
33567217|NCT02723955|101973202|FG033|Escalation Phase|Withdrawal by Subject|0|||
33567218|NCT02723955|101973203|FG034|Escalation Phase|Withdrawal by Subject|0|||
33567219|NCT02723955|101973204|FG035|Escalation Phase|Withdrawal by Subject|0|||
33567220|NCT02723955|101973205|FG036|Escalation Phase|Withdrawal by Subject|0|||
33567221|NCT02723955|101973206|FG037|Escalation Phase|Withdrawal by Subject|0|||
33567222|NCT02723955|101973207|FG038|Escalation Phase|Withdrawal by Subject|0|||
33567223|NCT02723955|101973208|FG039|Escalation Phase|Withdrawal by Subject|0|||
33567224|NCT02723955|101973209|FG040|Escalation Phase|Withdrawal by Subject|0|||
33567225|NCT02723955|101973210|FG041|Escalation Phase|Withdrawal by Subject|0|||
33567226|NCT02723955|101973211|FG042|Escalation Phase|Withdrawal by Subject|0|||
33567227|NCT02723955|101973169|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567228|NCT02723955|101973170|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567229|NCT02723955|101973171|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567230|NCT02723955|101973172|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567231|NCT02723955|101973173|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
33567232|NCT02723955|101973174|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
33567233|NCT02723955|101973175|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
33567234|NCT02723955|101973176|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
33567235|NCT02723955|101973177|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
33364743|NCT03880227|101223609|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
33364744|NCT03880227|101223610|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
33364745|NCT03880227|101223611|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
33364746|NCT03880227|101223608|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
33364747|NCT03880227|101223609|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
33364748|NCT03880227|101223610|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
33364749|NCT03880227|101223611|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
33631105|NCT00129402|102200539|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
33631106|NCT00129402|102200540|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
33631107|NCT00129402|102200541|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
33364750|NCT00500149|101223614|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
33416941|NCT03747939|101416295|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
33416942|NCT03747939|101416296|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
33416943|NCT03747939|101416297|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
33416944|NCT03747939|101416298|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
33416945|NCT03747939|101416295|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
33416946|NCT03747939|101416296|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
33416947|NCT03747939|101416297|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
33631108|NCT00129402|102200542|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
33631109|NCT00129402|102200536|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
33631110|NCT00129402|102200537|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
33223919|NCT01106430|100721660|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
33223920|NCT01106430|100721661|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
33364751|NCT00500149|101223615|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
33364752|NCT00500149|101223614|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
33364753|NCT00500149|101223615|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
33364754|NCT00500149|101223614|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
33364755|NCT00500149|101223615|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
33364756|NCT00500149|101223614|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
33364757|NCT00500149|101223615|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
33364758|NCT00500149|101223614|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
33364759|NCT00500149|101223615|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
33364760|NCT00500149|101223614|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
33364761|NCT00500149|101223615|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
33416948|NCT03747939|101416298|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
33416949|NCT03747939|101416295|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
33567236|NCT02723955|101973178|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567237|NCT02723955|101973179|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567238|NCT02723955|101973180|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567239|NCT02723955|101973181|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567240|NCT02723955|101973182|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567241|NCT02723955|101973183|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567242|NCT02723955|101973184|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567243|NCT02723955|101973185|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567244|NCT02723955|101973186|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567245|NCT02723955|101973187|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567246|NCT02723955|101973188|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567247|NCT02723955|101973189|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567248|NCT02723955|101973190|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567249|NCT02723955|101973191|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567250|NCT02723955|101973192|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567251|NCT02723955|101973193|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567252|NCT02723955|101973194|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567253|NCT02723955|101973195|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567254|NCT02723955|101973196|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567255|NCT02723955|101973197|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567256|NCT02723955|101973198|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33364762|NCT00500149|101223614|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
33364763|NCT00500149|101223615|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
33364764|NCT02239094|101223618|FG000|Overall Study|Withdrawal by Subject|1|||
33364765|NCT02239094|101223618|FG000|Overall Study|Remitted before started|1|||
33364766|NCT02213198|101223623|FG000|Baseline|No show for intake|7|||
33364767|NCT02213198|101223624|FG001|Baseline|No show for intake|9|||
33364768|NCT02213198|101223623|FG000|Baseline|Withdrawal by Subject|34|||
33364769|NCT02213198|101223624|FG001|Baseline|Withdrawal by Subject|11|||
33416950|NCT03747939|101416296|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
33416951|NCT03747939|101416297|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
33416952|NCT03747939|101416298|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
33416953|NCT03747939|101416295|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
33416954|NCT03747939|101416296|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
33416955|NCT03747939|101416297|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
33416956|NCT03747939|101416298|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
33416957|NCT00555399|101420150|FG000|Overall Study|Withdrawal by Subject|0|||
33416958|NCT00555399|101420151|FG001|Overall Study|Withdrawal by Subject|0|||
33416959|NCT00555399|101420152|FG002|Overall Study|Withdrawal by Subject|1|||
33416960|NCT00555399|101420153|FG003|Overall Study|Withdrawal by Subject|0|||
33416961|NCT00555399|101420154|FG004|Overall Study|Withdrawal by Subject|0|||
33416962|NCT00555399|101420155|FG005|Overall Study|Withdrawal by Subject|0|||
33631111|NCT00129402|102200538|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
33416963|NCT00555399|101420156|FG006|Overall Study|Withdrawal by Subject|0|||
33416964|NCT00555399|101420157|FG007|Overall Study|Withdrawal by Subject|0|||
33416965|NCT00555399|101420158|FG008|Overall Study|Withdrawal by Subject|0|||
33416966|NCT00555399|101420159|FG009|Overall Study|Withdrawal by Subject|0|||
33416967|NCT00555399|101420160|FG010|Overall Study|Withdrawal by Subject|0|||
33416968|NCT00555399|101420161|FG011|Overall Study|Withdrawal by Subject|1|||
33416969|NCT00555399|101420150|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
33416970|NCT00555399|101420151|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
33416971|NCT00555399|101420152|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
33416972|NCT00555399|101420153|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
33416973|NCT00555399|101420154|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
33416974|NCT00555399|101420155|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
33416975|NCT00555399|101420156|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
33416976|NCT00555399|101420157|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
33416977|NCT00555399|101420158|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
33416978|NCT00555399|101420159|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
33416979|NCT00555399|101420160|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
33416980|NCT00555399|101420161|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
33416981|NCT03332212|101420162|FG000|Overall Study|Not treated|0|||
33416982|NCT03332212|101420163|FG001|Overall Study|Not treated|1|||
33416983|NCT03332212|101420164|FG002|Overall Study|Not treated|0|||
33416984|NCT03332212|101420165|FG003|Overall Study|Not treated|0|||
33416985|NCT03332212|101420162|FG000|Overall Study|Adverse Event|0|||
33416986|NCT03332212|101420163|FG001|Overall Study|Adverse Event|0|||
33416987|NCT03332212|101420164|FG002|Overall Study|Adverse Event|0|||
33416988|NCT03332212|101420165|FG003|Overall Study|Adverse Event|1|||
33416989|NCT03332212|101420162|FG000|Overall Study|worsening of disease under study|1|||
33416990|NCT03332212|101420163|FG001|Overall Study|worsening of disease under study|1|||
33567257|NCT02723955|101973199|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567258|NCT02723955|101973200|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567259|NCT02723955|101973201|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567260|NCT02723955|101973202|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567261|NCT02723955|101973203|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567262|NCT02723955|101973204|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567263|NCT02723955|101973205|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567264|NCT02723955|101973206|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567265|NCT02723955|101973207|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567266|NCT02723955|101973208|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567267|NCT02723955|101973209|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567268|NCT02723955|101973210|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567269|NCT02723955|101973211|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
33567270|NCT02723955|101973169|FG000|Escalation Phase|Site Closed|0|||
33567271|NCT02723955|101973170|FG001|Escalation Phase|Site Closed|0|||
33567272|NCT02723955|101973171|FG002|Escalation Phase|Site Closed|0|||
33567273|NCT02723955|101973172|FG003|Escalation Phase|Site Closed|0|||
33567274|NCT02723955|101973173|FG004|Escalation Phase|Site Closed|0|||
33567275|NCT02723955|101973174|FG005|Escalation Phase|Site Closed|0|||
33567276|NCT02723955|101973175|FG006|Escalation Phase|Site Closed|0|||
33416991|NCT03332212|101420164|FG002|Overall Study|worsening of disease under study|0|||
33416992|NCT03332212|101420165|FG003|Overall Study|worsening of disease under study|0|||
33416993|NCT01215955|101420166|FG000|Overall Study|Adverse Event|1|||
33416994|NCT01215955|101420167|FG001|Overall Study|Adverse Event|4|||
33416995|NCT01215955|101420168|FG002|Overall Study|Adverse Event|2|||
33416996|NCT01215955|101420169|FG003|Overall Study|Adverse Event|3|||
33416997|NCT01215955|101420166|FG000|Overall Study|Death|2|||
33416998|NCT01215955|101420167|FG001|Overall Study|Death|0|||
33416999|NCT01215955|101420168|FG002|Overall Study|Death|1|||
33417000|NCT01215955|101420169|FG003|Overall Study|Death|3|||
33417001|NCT01215955|101420166|FG000|Overall Study|Entry Criteria Not Met|1|||
33417002|NCT01215955|101420167|FG001|Overall Study|Entry Criteria Not Met|3|||
33417003|NCT01215955|101420168|FG002|Overall Study|Entry Criteria Not Met|4|||
33417004|NCT01215955|101420169|FG003|Overall Study|Entry Criteria Not Met|7|||
33417005|NCT01215955|101420166|FG000|Overall Study|Lack of Efficacy|1|||
33417006|NCT01215955|101420167|FG001|Overall Study|Lack of Efficacy|2|||
33417007|NCT01215955|101420168|FG002|Overall Study|Lack of Efficacy|1|||
33417008|NCT01215955|101420169|FG003|Overall Study|Lack of Efficacy|0|||
33417009|NCT01215955|101420166|FG000|Overall Study|Lost to Follow-up|4|||
33417010|NCT01215955|101420167|FG001|Overall Study|Lost to Follow-up|4|||
33417011|NCT01215955|101420168|FG002|Overall Study|Lost to Follow-up|8|||
33417012|NCT01215955|101420169|FG003|Overall Study|Lost to Follow-up|9|||
33417013|NCT01215955|101420166|FG000|Overall Study|Physician Decision|4|||
33417014|NCT01215955|101420167|FG001|Overall Study|Physician Decision|10|||
33417015|NCT01215955|101420168|FG002|Overall Study|Physician Decision|8|||
33417016|NCT01215955|101420169|FG003|Overall Study|Physician Decision|11|||
33417017|NCT01215955|101420166|FG000|Overall Study|Protocol Violation|17|||
33417018|NCT01215955|101420167|FG001|Overall Study|Protocol Violation|13|||
33417019|NCT01215955|101420168|FG002|Overall Study|Protocol Violation|8|||
33417020|NCT01215955|101420169|FG003|Overall Study|Protocol Violation|8|||
33417021|NCT01215955|101420166|FG000|Overall Study|Sponsor Decision|1|||
33417022|NCT01215955|101420167|FG001|Overall Study|Sponsor Decision|2|||
33417023|NCT01215955|101420168|FG002|Overall Study|Sponsor Decision|0|||
33417024|NCT01215955|101420169|FG003|Overall Study|Sponsor Decision|1|||
33417025|NCT01215955|101420166|FG000|Overall Study|Withdrawal by Subject|14|||
33417026|NCT01215955|101420167|FG001|Overall Study|Withdrawal by Subject|15|||
33417027|NCT01215955|101420168|FG002|Overall Study|Withdrawal by Subject|13|||
33417028|NCT01215955|101420169|FG003|Overall Study|Withdrawal by Subject|9|||
33417029|NCT01215955|101420166|FG000|Overall Study|Quality Issues|0|||
33417030|NCT01215955|101420167|FG001|Overall Study|Quality Issues|0|||
33417031|NCT01215955|101420168|FG002|Overall Study|Quality Issues|3|||
33567277|NCT02723955|101973176|FG007|Escalation Phase|Site Closed|0|||
33567278|NCT02723955|101973177|FG008|Escalation Phase|Site Closed|0|||
33567279|NCT02723955|101973178|FG009|Escalation Phase|Site Closed|0|||
33567280|NCT02723955|101973179|FG010|Escalation Phase|Site Closed|0|||
33567281|NCT02723955|101973180|FG011|Escalation Phase|Site Closed|0|||
33567282|NCT02723955|101973181|FG012|Escalation Phase|Site Closed|0|||
33567283|NCT02723955|101973182|FG013|Escalation Phase|Site Closed|0|||
33567284|NCT02723955|101973183|FG014|Escalation Phase|Site Closed|0|||
33364770|NCT02213198|101223623|FG000|Baseline|transferred out of clinic|7|||
33364771|NCT02213198|101223624|FG001|Baseline|transferred out of clinic|9|||
33364772|NCT02213198|101223623|FG000|Baseline|Lost to Follow-up|40|||
33364773|NCT02213198|101223624|FG001|Baseline|Lost to Follow-up|21|||
33364774|NCT02213198|101223623|FG000|Baseline|incarcerated,violent|0|||
33364775|NCT02213198|101223624|FG001|Baseline|incarcerated,violent|1|||
33364776|NCT02213198|101223623|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
33364777|NCT02213198|101223624|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
33364778|NCT02213198|101223623|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
33364779|NCT02213198|101223624|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
33364780|NCT02213198|101223623|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
33364781|NCT02213198|101223624|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
33417032|NCT01215955|101420169|FG003|Overall Study|Quality Issues|2|||
33417033|NCT02641730|101420170|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
33417034|NCT02641730|101420171|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33417035|NCT02641730|101420172|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33417036|NCT02641730|101420173|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
33417037|NCT02641730|101420174|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
33567285|NCT02723955|101973184|FG015|Escalation Phase|Site Closed|1|||
33364782|NCT02213198|101223623|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
33364783|NCT02213198|101223624|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
33364784|NCT02213198|101223623|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
33364785|NCT02213198|101223624|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
33364786|NCT02213198|101223623|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
33417038|NCT02641730|101420170|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
33417039|NCT02641730|101420171|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
33417040|NCT02641730|101420172|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
33417041|NCT02641730|101420173|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
33567286|NCT02723955|101973185|FG016|Escalation Phase|Site Closed|0|||
33567287|NCT02723955|101973186|FG017|Escalation Phase|Site Closed|2|||
33223921|NCT01106430|100721660|FG000|Overall Study|Moved Out Of State|0|||
33223922|NCT01106430|100721661|FG001|Overall Study|Moved Out Of State|1|||
33223923|NCT01106430|100721660|FG000|Overall Study|Refused To Take Medication|0|||
33364787|NCT02213198|101223624|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
33364788|NCT02948777|101223625|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
33364789|NCT01024465|101223629|FG000|Overall Study|Adverse Event|2|||
33364790|NCT01024465|101223629|FG000|Overall Study|Physician Decision|1|||
33364791|NCT04493619|101223631|FG000|Overall Study|Death|4|||
33364792|NCT04493619|101223632|FG001|Overall Study|Death|3|||
33364793|NCT04493619|101223633|FG002|Overall Study|Death|3|||
33364794|NCT04493619|101223634|FG003|Overall Study|Death|4|||
33364795|NCT04493619|101223631|FG000|Overall Study|Study discontinued early|10|||
33364796|NCT04493619|101223632|FG001|Overall Study|Study discontinued early|0|||
33364797|NCT04493619|101223633|FG002|Overall Study|Study discontinued early|4|||
33364798|NCT04493619|101223634|FG003|Overall Study|Study discontinued early|8|||
33364799|NCT04493619|101223631|FG000|Overall Study|Lost to Follow-up|0|||
33364800|NCT04493619|101223632|FG001|Overall Study|Lost to Follow-up|0|||
33364801|NCT04493619|101223633|FG002|Overall Study|Lost to Follow-up|0|||
33567288|NCT02723955|101973187|FG018|Escalation Phase|Site Closed|0|||
33567289|NCT02723955|101973188|FG019|Escalation Phase|Site Closed|0|||
33567290|NCT02723955|101973189|FG020|Escalation Phase|Site Closed|1|||
33567291|NCT02723955|101973190|FG021|Escalation Phase|Site Closed|0|||
33567292|NCT02723955|101973191|FG022|Escalation Phase|Site Closed|0|||
33567293|NCT02723955|101973192|FG023|Escalation Phase|Site Closed|0|||
33567294|NCT02723955|101973193|FG024|Escalation Phase|Site Closed|3|||
33567295|NCT02723955|101973194|FG025|Escalation Phase|Site Closed|1|||
33567296|NCT02723955|101973195|FG026|Escalation Phase|Site Closed|3|||
33567297|NCT02723955|101973196|FG027|Escalation Phase|Site Closed|1|||
33567298|NCT02723955|101973197|FG028|Escalation Phase|Site Closed|1|||
33567299|NCT02723955|101973198|FG029|Escalation Phase|Site Closed|0|||
33567300|NCT02723955|101973199|FG030|Escalation Phase|Site Closed|0|||
33567301|NCT02723955|101973200|FG031|Escalation Phase|Site Closed|0|||
33567302|NCT02723955|101973201|FG032|Escalation Phase|Site Closed|0|||
33567303|NCT02723955|101973202|FG033|Escalation Phase|Site Closed|0|||
33567304|NCT02723955|101973203|FG034|Escalation Phase|Site Closed|0|||
33567305|NCT02723955|101973204|FG035|Escalation Phase|Site Closed|0|||
33567306|NCT02723955|101973205|FG036|Escalation Phase|Site Closed|0|||
33567307|NCT02723955|101973206|FG037|Escalation Phase|Site Closed|0|||
33567308|NCT02723955|101973207|FG038|Escalation Phase|Site Closed|0|||
33567309|NCT02723955|101973208|FG039|Escalation Phase|Site Closed|0|||
33567310|NCT02723955|101973209|FG040|Escalation Phase|Site Closed|0|||
33567311|NCT02723955|101973210|FG041|Escalation Phase|Site Closed|0|||
33567312|NCT02723955|101973211|FG042|Escalation Phase|Site Closed|0|||
33567313|NCT02723955|101973169|FG000|Expansion Phase|Death|0|||
33567314|NCT02723955|101973170|FG001|Expansion Phase|Death|0|||
33567315|NCT02723955|101973171|FG002|Expansion Phase|Death|0|||
33567316|NCT02723955|101973172|FG003|Expansion Phase|Death|0|||
33567317|NCT02723955|101973173|FG004|Expansion Phase|Death|0|||
33567318|NCT02723955|101973174|FG005|Expansion Phase|Death|0|||
33567319|NCT02723955|101973175|FG006|Expansion Phase|Death|0|||
33567320|NCT02723955|101973176|FG007|Expansion Phase|Death|0|||
33567321|NCT02723955|101973177|FG008|Expansion Phase|Death|0|||
33567322|NCT02723955|101973178|FG009|Expansion Phase|Death|25|||
33567323|NCT02723955|101973179|FG010|Expansion Phase|Death|69|||
33567324|NCT02723955|101973180|FG011|Expansion Phase|Death|48|||
33567325|NCT02723955|101973181|FG012|Expansion Phase|Death|0|||
33567326|NCT02723955|101973182|FG013|Expansion Phase|Death|0|||
33567327|NCT02723955|101973183|FG014|Expansion Phase|Death|0|||
33567328|NCT02723955|101973184|FG015|Expansion Phase|Death|0|||
33567329|NCT02723955|101973185|FG016|Expansion Phase|Death|0|||
33223924|NCT01106430|100721661|FG001|Overall Study|Refused To Take Medication|1|||
33223925|NCT01106430|100721660|FG000|Overall Study|Noncompliance|0|||
33223926|NCT01106430|100721661|FG001|Overall Study|Noncompliance|1|||
33364802|NCT04493619|101223634|FG003|Overall Study|Lost to Follow-up|1|||
33364803|NCT00064662|101223635|FG000|Overall Study|Death|1|||
33364804|NCT00064662|101223636|FG001|Overall Study|Death|1|||
33364805|NCT00064662|101223635|FG000|Overall Study|Lost to Follow-up|57|||
33364806|NCT00064662|101223636|FG001|Overall Study|Lost to Follow-up|44|||
33364807|NCT00064662|101223635|FG000|Overall Study|Withdrawal by Subject|14|||
33417042|NCT02641730|101420174|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
33567330|NCT02723955|101973186|FG017|Expansion Phase|Death|0|||
33567331|NCT02723955|101973187|FG018|Expansion Phase|Death|0|||
33567332|NCT02723955|101973188|FG019|Expansion Phase|Death|0|||
33567333|NCT02723955|101973189|FG020|Expansion Phase|Death|0|||
33567334|NCT02723955|101973190|FG021|Expansion Phase|Death|0|||
33567335|NCT02723955|101973191|FG022|Expansion Phase|Death|0|||
33567336|NCT02723955|101973192|FG023|Expansion Phase|Death|0|||
33567337|NCT02723955|101973193|FG024|Expansion Phase|Death|0|||
33567338|NCT02723955|101973194|FG025|Expansion Phase|Death|0|||
33567339|NCT02723955|101973195|FG026|Expansion Phase|Death|0|||
33567340|NCT02723955|101973196|FG027|Expansion Phase|Death|0|||
33567341|NCT02723955|101973197|FG028|Expansion Phase|Death|0|||
33567342|NCT02723955|101973198|FG029|Expansion Phase|Death|12|||
33417043|NCT02641730|101420170|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
33417044|NCT02641730|101420171|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
33417045|NCT02641730|101420172|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
33417046|NCT02641730|101420173|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
33417047|NCT02641730|101420174|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
33417048|NCT02641730|101420170|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
33417049|NCT02641730|101420171|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
33417050|NCT02641730|101420172|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
33417051|NCT02641730|101420173|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
33417052|NCT02641730|101420174|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
33417053|NCT02641730|101420170|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
33417054|NCT02641730|101420171|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
33567343|NCT02723955|101973199|FG030|Expansion Phase|Death|202|||
33631112|NCT00129402|102200539|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
33223927|NCT01106430|100721660|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
33223928|NCT01106430|100721661|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
33223929|NCT01106430|100721660|FG000|Overall Study|Previous Use Of Marijuana|1|||
33223930|NCT01106430|100721661|FG001|Overall Study|Previous Use Of Marijuana|0|||
33223931|NCT01106430|100721660|FG000|Overall Study|Protocol Violation|7|||
33223932|NCT01106430|100721661|FG001|Overall Study|Protocol Violation|2|||
33223933|NCT01106430|100721660|FG000|Overall Study|Withdrawal by Subject|8|||
33223934|NCT01106430|100721661|FG001|Overall Study|Withdrawal by Subject|4|||
33223935|NCT03682705|100721665|FG000|Overall Study|Adverse Event|1|||
33223936|NCT03682705|100721666|FG001|Overall Study|Adverse Event|1|||
33223937|NCT03682705|100721667|FG002|Overall Study|Adverse Event|1|||
33223938|NCT03682705|100721668|FG003|Overall Study|Adverse Event|0|||
33223939|NCT03682705|100721669|FG004|Overall Study|Adverse Event|1|||
33223940|NCT03682705|100721670|FG005|Overall Study|Adverse Event|1|||
33223941|NCT03682705|100721665|FG000|Overall Study|Withdrawal by Subject|1|||
33223942|NCT03682705|100721666|FG001|Overall Study|Withdrawal by Subject|3|||
33223943|NCT03682705|100721667|FG002|Overall Study|Withdrawal by Subject|2|||
33223944|NCT03682705|100721668|FG003|Overall Study|Withdrawal by Subject|4|||
33223945|NCT03682705|100721669|FG004|Overall Study|Withdrawal by Subject|0|||
33567344|NCT02723955|101973200|FG031|Expansion Phase|Death|31|||
33567345|NCT02723955|101973201|FG032|Expansion Phase|Death|17|||
33567346|NCT02723955|101973202|FG033|Expansion Phase|Death|2|||
33567347|NCT02723955|101973203|FG034|Expansion Phase|Death|3|||
33567348|NCT02723955|101973204|FG035|Expansion Phase|Death|3|||
33567349|NCT02723955|101973205|FG036|Expansion Phase|Death|1|||
33567350|NCT02723955|101973206|FG037|Expansion Phase|Death|0|||
33567351|NCT02723955|101973207|FG038|Expansion Phase|Death|0|||
33223946|NCT03682705|100721670|FG005|Overall Study|Withdrawal by Subject|1|||
33223947|NCT03682705|100721665|FG000|Overall Study|Other, not specified|0|||
33364808|NCT00064662|101223636|FG001|Overall Study|Withdrawal by Subject|14|||
33567352|NCT02723955|101973208|FG039|Expansion Phase|Death|0|||
33567353|NCT02723955|101973209|FG040|Expansion Phase|Death|0|||
33567354|NCT02723955|101973210|FG041|Expansion Phase|Death|0|||
33364809|NCT00064662|101223635|FG000|Overall Study|Administratively withdrawn|2|||
33364810|NCT00064662|101223636|FG001|Overall Study|Administratively withdrawn|2|||
33364811|NCT02413398|101223648|FG000|Overall Study|Lost to Follow-up|2|||
33567355|NCT02723955|101973211|FG042|Expansion Phase|Death|0|||
33223948|NCT03682705|100721666|FG001|Overall Study|Other, not specified|0|||
33223949|NCT03682705|100721667|FG002|Overall Study|Other, not specified|0|||
33364812|NCT02413398|101223649|FG001|Overall Study|Lost to Follow-up|4|||
33364813|NCT02413398|101223648|FG000|Overall Study|Withdrawal by Subject|1|||
33364814|NCT02413398|101223649|FG001|Overall Study|Withdrawal by Subject|1|||
33364815|NCT02413398|101223648|FG000|Overall Study|Other Eligibility criteria|1|||
33364816|NCT02413398|101223649|FG001|Overall Study|Other Eligibility criteria|2|||
33364817|NCT01588197|101223652|FG000|Overall Study|Lack of Efficacy|0|||
33364818|NCT01588197|101223653|FG001|Overall Study|Lack of Efficacy|1|||
33364819|NCT01588197|101223652|FG000|Overall Study|No MRI|1|||
33364820|NCT01588197|101223653|FG001|Overall Study|No MRI|0|||
33364821|NCT01095250|101223654|FG000|Overall Study|administrative reasons|8|||
33364822|NCT01095250|101223655|FG001|Overall Study|administrative reasons|10|||
33567356|NCT02723955|101973169|FG000|Expansion Phase|Lost to Follow-up|0|||
33567357|NCT02723955|101973170|FG001|Expansion Phase|Lost to Follow-up|0|||
33567358|NCT02723955|101973171|FG002|Expansion Phase|Lost to Follow-up|0|||
33223950|NCT03682705|100721668|FG003|Overall Study|Other, not specified|1|||
33364823|NCT01095250|101223656|FG002|Overall Study|administrative reasons|7|||
33364824|NCT01095250|101223657|FG003|Overall Study|administrative reasons|5|||
33567359|NCT02723955|101973172|FG003|Expansion Phase|Lost to Follow-up|0|||
33223951|NCT03682705|100721669|FG004|Overall Study|Other, not specified|2|||
33223952|NCT03682705|100721670|FG005|Overall Study|Other, not specified|0|||
33364825|NCT01095250|101223654|FG000|Overall Study|Withdrawal by Subject|0|||
33567360|NCT02723955|101973173|FG004|Expansion Phase|Lost to Follow-up|0|||
33364826|NCT01095250|101223655|FG001|Overall Study|Withdrawal by Subject|0|||
33364827|NCT01095250|101223656|FG002|Overall Study|Withdrawal by Subject|1|||
33417055|NCT02641730|101420172|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
33567361|NCT02723955|101973174|FG005|Expansion Phase|Lost to Follow-up|0|||
33567362|NCT02723955|101973175|FG006|Expansion Phase|Lost to Follow-up|0|||
33223953|NCT03682705|100721665|FG000|Overall Study|Lost to Follow-up|0|||
33223954|NCT03682705|100721666|FG001|Overall Study|Lost to Follow-up|0|||
33223955|NCT03682705|100721667|FG002|Overall Study|Lost to Follow-up|0|||
33223956|NCT03682705|100721668|FG003|Overall Study|Lost to Follow-up|0|||
33223957|NCT03682705|100721669|FG004|Overall Study|Lost to Follow-up|3|||
33223958|NCT03682705|100721670|FG005|Overall Study|Lost to Follow-up|0|||
33223959|NCT01446796|100721684|FG000|Overall Study|Withdrawal by Subject|1|||
33223960|NCT01446796|100721685|FG001|Overall Study|Withdrawal by Subject|0|||
33223961|NCT01492686|100721686|FG000|Double-blind Phase|Adverse Event|0|||
33223962|NCT01492686|100721687|FG001|Double-blind Phase|Adverse Event|2|||
33223963|NCT01492686|100721686|FG000|Double-blind Phase|Physician Decision|0|||
33223964|NCT01492686|100721687|FG001|Double-blind Phase|Physician Decision|1|||
33223965|NCT01492686|100721686|FG000|Double-blind Phase|Withdrawal by Subject|0|||
33223966|NCT01492686|100721687|FG001|Double-blind Phase|Withdrawal by Subject|2|||
33223967|NCT01492686|100721686|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
33223968|NCT01492686|100721687|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
33223969|NCT01492686|100721686|FG000|Open-label Phase|Adverse Event|1|||
33223970|NCT01492686|100721687|FG001|Open-label Phase|Adverse Event|2|||
33223971|NCT01492686|100721686|FG000|Open-label Phase|Physician Decision|1|||
33223972|NCT01492686|100721687|FG001|Open-label Phase|Physician Decision|0|||
33223973|NCT01492686|100721686|FG000|Open-label Phase|Withdrawal by Subject|6|||
33223974|NCT01492686|100721687|FG001|Open-label Phase|Withdrawal by Subject|7|||
33567363|NCT02723955|101973176|FG007|Expansion Phase|Lost to Follow-up|0|||
33567364|NCT02723955|101973177|FG008|Expansion Phase|Lost to Follow-up|0|||
33567365|NCT02723955|101973178|FG009|Expansion Phase|Lost to Follow-up|0|||
33567366|NCT02723955|101973179|FG010|Expansion Phase|Lost to Follow-up|4|||
33223975|NCT01492686|100721686|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
33223976|NCT01492686|100721687|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
33223977|NCT02832622|100721688|FG000|Overall Study|MPP not programmed|1259|||
33223978|NCT02832622|100721688|FG000|Overall Study|Withdrawal by Subject|123|||
33364828|NCT01095250|101223657|FG003|Overall Study|Withdrawal by Subject|0|||
33567367|NCT02723955|101973180|FG011|Expansion Phase|Lost to Follow-up|1|||
33567368|NCT02723955|101973181|FG012|Expansion Phase|Lost to Follow-up|0|||
33567369|NCT02723955|101973182|FG013|Expansion Phase|Lost to Follow-up|0|||
33567370|NCT02723955|101973183|FG014|Expansion Phase|Lost to Follow-up|0|||
33567371|NCT02723955|101973184|FG015|Expansion Phase|Lost to Follow-up|0|||
33567372|NCT02723955|101973185|FG016|Expansion Phase|Lost to Follow-up|0|||
33567373|NCT02723955|101973186|FG017|Expansion Phase|Lost to Follow-up|0|||
33567374|NCT02723955|101973187|FG018|Expansion Phase|Lost to Follow-up|0|||
33567375|NCT02723955|101973188|FG019|Expansion Phase|Lost to Follow-up|0|||
33567376|NCT02723955|101973189|FG020|Expansion Phase|Lost to Follow-up|0|||
33567377|NCT02723955|101973190|FG021|Expansion Phase|Lost to Follow-up|0|||
33567378|NCT02723955|101973191|FG022|Expansion Phase|Lost to Follow-up|0|||
33567379|NCT02723955|101973192|FG023|Expansion Phase|Lost to Follow-up|0|||
33567380|NCT02723955|101973193|FG024|Expansion Phase|Lost to Follow-up|0|||
33567381|NCT02723955|101973194|FG025|Expansion Phase|Lost to Follow-up|0|||
33567382|NCT02723955|101973195|FG026|Expansion Phase|Lost to Follow-up|0|||
33567383|NCT02723955|101973196|FG027|Expansion Phase|Lost to Follow-up|0|||
33364829|NCT02075255|101223658|FG000|Overall Study|Study specific withdrawal criteria|0|||
33364830|NCT02075255|101223659|FG001|Overall Study|Study specific withdrawal criteria|1|||
33364831|NCT02075255|101223660|FG002|Overall Study|Study specific withdrawal criteria|1|||
33364832|NCT02075255|101223658|FG000|Overall Study|Withdrawal by Subject|4|||
33364833|NCT02075255|101223659|FG001|Overall Study|Withdrawal by Subject|1|||
33364834|NCT02075255|101223660|FG002|Overall Study|Withdrawal by Subject|0|||
33364835|NCT02075255|101223658|FG000|Overall Study|Lost to Follow-up|0|||
33364836|NCT02075255|101223659|FG001|Overall Study|Lost to Follow-up|0|||
33364837|NCT02075255|101223660|FG002|Overall Study|Lost to Follow-up|1|||
33364838|NCT02075255|101223658|FG000|Overall Study|Adverse Event|0|||
33364839|NCT02075255|101223659|FG001|Overall Study|Adverse Event|0|||
33364840|NCT02075255|101223660|FG002|Overall Study|Adverse Event|1|||
33364841|NCT02075255|101223658|FG000|Overall Study|Death|0|||
33417056|NCT02641730|101420173|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
33567384|NCT02723955|101973197|FG028|Expansion Phase|Lost to Follow-up|0|||
33223979|NCT02832622|100721688|FG000|Overall Study|Death|119|||
33364842|NCT02075255|101223659|FG001|Overall Study|Death|2|||
33567385|NCT02723955|101973198|FG029|Expansion Phase|Lost to Follow-up|1|||
33567386|NCT02723955|101973199|FG030|Expansion Phase|Lost to Follow-up|19|||
33567387|NCT02723955|101973200|FG031|Expansion Phase|Lost to Follow-up|2|||
33567388|NCT02723955|101973201|FG032|Expansion Phase|Lost to Follow-up|1|||
33223980|NCT02832622|100721688|FG000|Overall Study|Unsuccessful CRT implant|93|||
33223981|NCT02832622|100721688|FG000|Overall Study|Lost to Follow-up|45|||
33223982|NCT02832622|100721688|FG000|Overall Study|Patient non-compliance|42|||
33567389|NCT02723955|101973202|FG033|Expansion Phase|Lost to Follow-up|0|||
33223983|NCT02832622|100721688|FG000|Overall Study|Withdrawal by other reasons|25|||
33567390|NCT02723955|101973203|FG034|Expansion Phase|Lost to Follow-up|0|||
33417057|NCT02641730|101420174|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
33417058|NCT02641730|101420170|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
33567391|NCT02723955|101973204|FG035|Expansion Phase|Lost to Follow-up|0|||
33567392|NCT02723955|101973205|FG036|Expansion Phase|Lost to Follow-up|0|||
33567393|NCT02723955|101973206|FG037|Expansion Phase|Lost to Follow-up|0|||
33567394|NCT02723955|101973207|FG038|Expansion Phase|Lost to Follow-up|0|||
33567395|NCT02723955|101973208|FG039|Expansion Phase|Lost to Follow-up|0|||
33567396|NCT02723955|101973209|FG040|Expansion Phase|Lost to Follow-up|0|||
33567397|NCT02723955|101973210|FG041|Expansion Phase|Lost to Follow-up|0|||
33567398|NCT02723955|101973211|FG042|Expansion Phase|Lost to Follow-up|0|||
33567399|NCT02723955|101973169|FG000|Expansion Phase|Physician Decision|0|||
33223984|NCT02832622|100721688|FG000|Overall Study|System explant|24|||
33223985|NCT02832622|100721688|FG000|Overall Study|Physician Decision|6|||
33223986|NCT01933880|100721690|FG000|Overall Study|Withdrawal by Subject|5|||
33223987|NCT01933880|100721691|FG001|Overall Study|Withdrawal by Subject|0|||
33223988|NCT01933880|100721690|FG000|Overall Study|Lack of Efficacy|1|||
33223989|NCT01933880|100721691|FG001|Overall Study|Lack of Efficacy|0|||
33223990|NCT01933880|100721690|FG000|Overall Study|Concomitant medication Interference|0|||
33223991|NCT01933880|100721691|FG001|Overall Study|Concomitant medication Interference|1|||
33223992|NCT01933880|100721690|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
33223993|NCT01933880|100721691|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
33223994|NCT01933880|100721690|FG000|Overall Study|Other|4|||
33223995|NCT01933880|100721691|FG001|Overall Study|Other|0|||
33223996|NCT01933880|100721690|FG000|Overall Study|Protocol Violation|1|||
33567400|NCT02723955|101973170|FG001|Expansion Phase|Physician Decision|0|||
33567401|NCT02723955|101973171|FG002|Expansion Phase|Physician Decision|0|||
33567402|NCT02723955|101973172|FG003|Expansion Phase|Physician Decision|0|||
33567403|NCT02723955|101973173|FG004|Expansion Phase|Physician Decision|0|||
33567404|NCT02723955|101973174|FG005|Expansion Phase|Physician Decision|0|||
33567405|NCT02723955|101973175|FG006|Expansion Phase|Physician Decision|0|||
33567406|NCT02723955|101973176|FG007|Expansion Phase|Physician Decision|0|||
33567407|NCT02723955|101973177|FG008|Expansion Phase|Physician Decision|0|||
33567408|NCT02723955|101973178|FG009|Expansion Phase|Physician Decision|0|||
33567409|NCT02723955|101973179|FG010|Expansion Phase|Physician Decision|0|||
33567410|NCT02723955|101973180|FG011|Expansion Phase|Physician Decision|0|||
33567411|NCT02723955|101973181|FG012|Expansion Phase|Physician Decision|0|||
33567412|NCT02723955|101973182|FG013|Expansion Phase|Physician Decision|0|||
33567413|NCT02723955|101973183|FG014|Expansion Phase|Physician Decision|0|||
33567414|NCT02723955|101973184|FG015|Expansion Phase|Physician Decision|0|||
33567415|NCT02723955|101973185|FG016|Expansion Phase|Physician Decision|0|||
33567416|NCT02723955|101973186|FG017|Expansion Phase|Physician Decision|0|||
33567417|NCT02723955|101973187|FG018|Expansion Phase|Physician Decision|0|||
33567418|NCT02723955|101973188|FG019|Expansion Phase|Physician Decision|0|||
33567419|NCT02723955|101973189|FG020|Expansion Phase|Physician Decision|0|||
33567420|NCT02723955|101973190|FG021|Expansion Phase|Physician Decision|0|||
33567421|NCT02723955|101973191|FG022|Expansion Phase|Physician Decision|0|||
33567422|NCT02723955|101973192|FG023|Expansion Phase|Physician Decision|0|||
33567423|NCT02723955|101973193|FG024|Expansion Phase|Physician Decision|0|||
33567424|NCT02723955|101973194|FG025|Expansion Phase|Physician Decision|0|||
33567425|NCT02723955|101973195|FG026|Expansion Phase|Physician Decision|0|||
33567426|NCT02723955|101973196|FG027|Expansion Phase|Physician Decision|0|||
33567427|NCT02723955|101973197|FG028|Expansion Phase|Physician Decision|0|||
33567428|NCT02723955|101973198|FG029|Expansion Phase|Physician Decision|0|||
33567429|NCT02723955|101973199|FG030|Expansion Phase|Physician Decision|1|||
33567430|NCT02723955|101973200|FG031|Expansion Phase|Physician Decision|1|||
33567431|NCT02723955|101973201|FG032|Expansion Phase|Physician Decision|0|||
33567432|NCT02723955|101973202|FG033|Expansion Phase|Physician Decision|0|||
33567433|NCT02723955|101973203|FG034|Expansion Phase|Physician Decision|0|||
33567434|NCT02723955|101973204|FG035|Expansion Phase|Physician Decision|0|||
33567435|NCT02723955|101973205|FG036|Expansion Phase|Physician Decision|0|||
33567436|NCT02723955|101973206|FG037|Expansion Phase|Physician Decision|0|||
33567437|NCT02723955|101973207|FG038|Expansion Phase|Physician Decision|0|||
33567438|NCT02723955|101973208|FG039|Expansion Phase|Physician Decision|0|||
33223997|NCT01933880|100721691|FG001|Overall Study|Protocol Violation|0|||
33567439|NCT02723955|101973209|FG040|Expansion Phase|Physician Decision|0|||
33567440|NCT02723955|101973210|FG041|Expansion Phase|Physician Decision|0|||
33567441|NCT02723955|101973211|FG042|Expansion Phase|Physician Decision|0|||
33567442|NCT02723955|101973169|FG000|Expansion Phase|Withdrawal by Subject|0|||
33567443|NCT02723955|101973170|FG001|Expansion Phase|Withdrawal by Subject|0|||
33567444|NCT02723955|101973171|FG002|Expansion Phase|Withdrawal by Subject|0|||
33567445|NCT02723955|101973172|FG003|Expansion Phase|Withdrawal by Subject|0|||
33567446|NCT02723955|101973173|FG004|Expansion Phase|Withdrawal by Subject|0|||
33567447|NCT02723955|101973174|FG005|Expansion Phase|Withdrawal by Subject|0|||
33567448|NCT02723955|101973175|FG006|Expansion Phase|Withdrawal by Subject|0|||
33567449|NCT02723955|101973176|FG007|Expansion Phase|Withdrawal by Subject|0|||
33567450|NCT02723955|101973177|FG008|Expansion Phase|Withdrawal by Subject|0|||
33567451|NCT02723955|101973178|FG009|Expansion Phase|Withdrawal by Subject|2|||
33567452|NCT02723955|101973179|FG010|Expansion Phase|Withdrawal by Subject|1|||
33567453|NCT02723955|101973180|FG011|Expansion Phase|Withdrawal by Subject|0|||
33567454|NCT02723955|101973181|FG012|Expansion Phase|Withdrawal by Subject|0|||
33567455|NCT02723955|101973182|FG013|Expansion Phase|Withdrawal by Subject|0|||
33567456|NCT02723955|101973183|FG014|Expansion Phase|Withdrawal by Subject|0|||
33567457|NCT02723955|101973184|FG015|Expansion Phase|Withdrawal by Subject|0|||
33567458|NCT02723955|101973185|FG016|Expansion Phase|Withdrawal by Subject|0|||
33567459|NCT02723955|101973186|FG017|Expansion Phase|Withdrawal by Subject|0|||
33567460|NCT02723955|101973187|FG018|Expansion Phase|Withdrawal by Subject|0|||
33567461|NCT02723955|101973188|FG019|Expansion Phase|Withdrawal by Subject|0|||
33567462|NCT02723955|101973189|FG020|Expansion Phase|Withdrawal by Subject|0|||
33567463|NCT02723955|101973190|FG021|Expansion Phase|Withdrawal by Subject|0|||
33567464|NCT02723955|101973191|FG022|Expansion Phase|Withdrawal by Subject|0|||
33567465|NCT02723955|101973192|FG023|Expansion Phase|Withdrawal by Subject|0|||
33567466|NCT02723955|101973193|FG024|Expansion Phase|Withdrawal by Subject|0|||
33567467|NCT02723955|101973194|FG025|Expansion Phase|Withdrawal by Subject|0|||
33567468|NCT02723955|101973195|FG026|Expansion Phase|Withdrawal by Subject|0|||
33567469|NCT02723955|101973196|FG027|Expansion Phase|Withdrawal by Subject|0|||
33567470|NCT02723955|101973197|FG028|Expansion Phase|Withdrawal by Subject|0|||
33567471|NCT02723955|101973198|FG029|Expansion Phase|Withdrawal by Subject|0|||
33567472|NCT02723955|101973199|FG030|Expansion Phase|Withdrawal by Subject|8|||
33567473|NCT02723955|101973200|FG031|Expansion Phase|Withdrawal by Subject|4|||
33567474|NCT02723955|101973201|FG032|Expansion Phase|Withdrawal by Subject|0|||
33567475|NCT02723955|101973202|FG033|Expansion Phase|Withdrawal by Subject|0|||
33567476|NCT02723955|101973203|FG034|Expansion Phase|Withdrawal by Subject|0|||
33567477|NCT02723955|101973204|FG035|Expansion Phase|Withdrawal by Subject|1|||
33567478|NCT02723955|101973205|FG036|Expansion Phase|Withdrawal by Subject|0|||
33567479|NCT02723955|101973206|FG037|Expansion Phase|Withdrawal by Subject|0|||
33567480|NCT02723955|101973207|FG038|Expansion Phase|Withdrawal by Subject|0|||
33567481|NCT02723955|101973208|FG039|Expansion Phase|Withdrawal by Subject|0|||
33567482|NCT02723955|101973209|FG040|Expansion Phase|Withdrawal by Subject|0|||
33567483|NCT02723955|101973210|FG041|Expansion Phase|Withdrawal by Subject|0|||
33567484|NCT02723955|101973211|FG042|Expansion Phase|Withdrawal by Subject|0|||
33567485|NCT02723955|101973169|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567486|NCT02723955|101973170|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567487|NCT02723955|101973171|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567488|NCT02723955|101973172|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567489|NCT02723955|101973173|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567490|NCT02723955|101973174|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567491|NCT02723955|101973175|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567492|NCT02723955|101973176|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567493|NCT02723955|101973177|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567494|NCT02723955|101973178|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
33567495|NCT02723955|101973179|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
33567496|NCT02723955|101973180|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
33567497|NCT02723955|101973181|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33223998|NCT03021486|100721695|FG000|Overall Study|Withdrawal by Subject|1|||
33223999|NCT03021486|100721696|FG001|Overall Study|Withdrawal by Subject|1|||
33224000|NCT03021486|100721697|FG002|Overall Study|Withdrawal by Subject|3|||
33224001|NCT03021486|100721695|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
33224002|NCT03021486|100721696|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
33224003|NCT03021486|100721697|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
33224004|NCT02421666|100721698|FG000|6-month Follow-up|Lost to Follow-up|8|||
33224005|NCT02421666|100721699|FG001|6-month Follow-up|Lost to Follow-up|7|||
33224006|NCT02421666|100721698|FG000|6-month Follow-up|Withdrawal by Subject|5|||
33224007|NCT02421666|100721699|FG001|6-month Follow-up|Withdrawal by Subject|6|||
33224008|NCT02421666|100721698|FG000|12-month Follow-up|Lost to Follow-up|5|||
33224009|NCT02421666|100721699|FG001|12-month Follow-up|Lost to Follow-up|5|||
33224010|NCT02421666|100721698|FG000|12-month Follow-up|Withdrawal by Subject|6|||
33224011|NCT02421666|100721699|FG001|12-month Follow-up|Withdrawal by Subject|11|||
33224012|NCT03072238|100721700|FG000|Overall Study|Withdrawal by Subject|30|||
33567498|NCT02723955|101973182|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567499|NCT02723955|101973183|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33417059|NCT02641730|101420171|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
33417060|NCT02641730|101420172|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
33417061|NCT02641730|101420173|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
33417062|NCT02641730|101420174|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
33417063|NCT04732728|101420175|FG000|Overall Study|Death|12|||
33417064|NCT04732728|101420175|FG000|Overall Study|Withdrawn|136|||
33417065|NCT00595127|101420176|FG000|Overall Study|Death|6|||
33417066|NCT00595127|101420176|FG000|Overall Study|Relapsed|3|||
33417067|NCT00595127|101420176|FG000|Overall Study|joined another trial|1|||
33417068|NCT02032823|101420177|FG000|Overall Study|Death|75|||
33417069|NCT02032823|101420178|FG001|Overall Study|Death|109|||
33417070|NCT02032823|101420177|FG000|Overall Study|Lost to Follow-up|18|||
33417071|NCT02032823|101420178|FG001|Overall Study|Lost to Follow-up|17|||
33417072|NCT02032823|101420177|FG000|Overall Study|Withdrawal by Subject|70|||
33417073|NCT02032823|101420178|FG001|Overall Study|Withdrawal by Subject|53|||
33417074|NCT02032823|101420177|FG000|Overall Study|Ongoing study at data cut-off|755|||
33417075|NCT02032823|101420178|FG001|Overall Study|Ongoing study at data cut-off|731|||
33417076|NCT02032823|101420177|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
33417077|NCT02032823|101420178|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
33417078|NCT03664024|101420179|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
33417079|NCT03664024|101420179|FG000|Overall Study|Lost to Follow-up|2|||
33417080|NCT03664024|101420179|FG000|Overall Study|Withdrawal by Subject|2|||
33417081|NCT03664024|101420179|FG000|Overall Study|Death|80|||
33417082|NCT03286426|101420189|FG000|Overall Study|Physician Decision|3|||
33417083|NCT01548573|101420190|FG000|Overall Study|Death|3|||
33417084|NCT01548573|101420190|FG000|Overall Study|Withdrawal by Subject|2|||
33417085|NCT01788163|101420191|FG000|Overall Study|Other|53|||
33417086|NCT01788163|101420192|FG001|Overall Study|Other|0|||
33567500|NCT02723955|101973184|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567501|NCT02723955|101973185|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567502|NCT02723955|101973186|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567503|NCT02723955|101973187|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567504|NCT02723955|101973188|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567505|NCT02723955|101973189|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567506|NCT02723955|101973190|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567507|NCT02723955|101973191|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567508|NCT02723955|101973192|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567509|NCT02723955|101973193|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567510|NCT02723955|101973194|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567511|NCT02723955|101973195|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567512|NCT02723955|101973196|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567513|NCT02723955|101973197|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567514|NCT02723955|101973198|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567515|NCT02723955|101973199|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
33567516|NCT02723955|101973200|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33417087|NCT01788163|101420193|FG002|Overall Study|Other|0|||
33417088|NCT01788163|101420194|FG003|Overall Study|Other|0|||
33417089|NCT01788163|101420195|FG004|Overall Study|Other|0|||
33417090|NCT01788163|101420196|FG005|Overall Study|Other|7|||
33417091|NCT01788163|101420197|FG006|Overall Study|Other|1|||
33364843|NCT02075255|101223660|FG002|Overall Study|Death|0|||
33631113|NCT00129402|102200540|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
33631114|NCT00129402|102200541|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
33631115|NCT00129402|102200542|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
33631116|NCT00129402|102200536|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
33631117|NCT00129402|102200537|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
33631118|NCT00129402|102200538|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
33631119|NCT00129402|102200539|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
33631120|NCT00129402|102200540|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
33631121|NCT00129402|102200541|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
33631122|NCT00129402|102200542|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
33631123|NCT00129402|102200536|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
33631124|NCT00129402|102200537|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
33631125|NCT00129402|102200538|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
33631126|NCT00129402|102200539|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
33631127|NCT00129402|102200540|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
33631128|NCT00129402|102200541|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
33631129|NCT00129402|102200542|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
33631130|NCT00129402|102200536|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
33631131|NCT00129402|102200537|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
33631132|NCT00129402|102200538|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
33631133|NCT00129402|102200539|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
33631134|NCT00129402|102200540|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
33631135|NCT00129402|102200541|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
33631136|NCT00129402|102200542|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
33631137|NCT00129402|102200536|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
33631138|NCT00129402|102200537|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
33631139|NCT00129402|102200538|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
33631140|NCT00129402|102200539|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
33631141|NCT00129402|102200540|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
33631142|NCT00129402|102200541|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
33631143|NCT00129402|102200542|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
33631144|NCT00129402|102200536|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
33631145|NCT00129402|102200537|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
33631146|NCT00129402|102200538|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
33631147|NCT00129402|102200539|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
33631148|NCT00129402|102200540|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
33631149|NCT00129402|102200541|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
33631150|NCT00129402|102200542|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
33631151|NCT00129402|102200536|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
33631152|NCT00129402|102200537|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
33631153|NCT00129402|102200538|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
33631154|NCT00129402|102200539|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
33631155|NCT00129402|102200540|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
33631156|NCT00129402|102200541|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
33631157|NCT00129402|102200542|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
33631158|NCT01149096|102200543|FG000|Overall Study|Lost to Follow-up|0|||
33631159|NCT01149096|102200544|FG001|Overall Study|Lost to Follow-up|1|||
33631160|NCT03204188|102200546|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
33364844|NCT01518192|101223661|FG000|Overall Study|Lost to Follow-up|29|||
33364845|NCT01518192|101223662|FG001|Overall Study|Lost to Follow-up|26|||
33364846|NCT01518192|101223663|FG002|Overall Study|Lost to Follow-up|35|||
33364847|NCT01254604|101223664|FG000|Overall Study|Lost to Follow-up|1|||
33364848|NCT01254604|101223665|FG001|Overall Study|Lost to Follow-up|1|||
33364849|NCT01254604|101223664|FG000|Overall Study|Protocol Violation|2|||
33364850|NCT01254604|101223665|FG001|Overall Study|Protocol Violation|2|||
33364851|NCT01254604|101223664|FG000|Overall Study|Withdrawal by Subject|2|||
33364852|NCT01254604|101223665|FG001|Overall Study|Withdrawal by Subject|4|||
33364853|NCT01254604|101223664|FG000|Overall Study|Adverse Event|3|||
33224013|NCT03072238|100721701|FG001|Overall Study|Withdrawal by Subject|51|||
33364854|NCT01254604|101223665|FG001|Overall Study|Adverse Event|2|||
33364855|NCT01943539|101223666|FG000|Overall Study|Non-compliance with at-home intervention|4|||
33224014|NCT03072238|100721700|FG000|Overall Study|Lost to Follow-up|7|||
33224015|NCT03072238|100721701|FG001|Overall Study|Lost to Follow-up|4|||
33364856|NCT01943539|101223667|FG001|Overall Study|Non-compliance with at-home intervention|0|||
33364857|NCT04705597|101223668|FG000|Overall Study|Death|16|||
33631161|NCT03204188|102200546|FG000|Immunotherapy Phase (1 Year)|Death|1|||
33631162|NCT03204188|102200546|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
33631163|NCT03204188|102200546|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
33631164|NCT04408989|102200548|FG000|Overall Study|Lost to Follow-up|0|||
33631165|NCT04408989|102200549|FG001|Overall Study|Lost to Follow-up|0|||
33631166|NCT04408989|102200550|FG002|Overall Study|Lost to Follow-up|1|||
33631167|NCT04408989|102200548|FG000|Overall Study|Withdrawal by Subject|0|||
33631168|NCT04408989|102200549|FG001|Overall Study|Withdrawal by Subject|0|||
33224016|NCT03072238|100721700|FG000|Overall Study|Physician Decision|1|||
33224017|NCT03072238|100721701|FG001|Overall Study|Physician Decision|3|||
33224018|NCT03072238|100721700|FG000|Overall Study|Death|139|||
33224019|NCT03072238|100721701|FG001|Overall Study|Death|121|||
33224020|NCT03072238|100721700|FG000|Overall Study|Other|0|||
33224021|NCT03072238|100721701|FG001|Overall Study|Other|1|||
33224022|NCT03072238|100721700|FG000|Overall Study|Ongoing on study|377|||
33224023|NCT03072238|100721701|FG001|Overall Study|Ongoing on study|367|||
33224024|NCT01598298|100721702|FG000|Overall Study|Not eligible|5|||
33224025|NCT01598298|100721703|FG001|Overall Study|Not eligible|5|||
33224026|NCT01598298|100721702|FG000|Overall Study|Adverse Event|21|||
33224027|NCT01598298|100721703|FG001|Overall Study|Adverse Event|19|||
33224028|NCT01598298|100721702|FG000|Overall Study|Progression/relapse|0|||
33224029|NCT01598298|100721703|FG001|Overall Study|Progression/relapse|2|||
33224030|NCT01598298|100721702|FG000|Overall Study|Withdrawal by Subject|10|||
33224031|NCT01598298|100721703|FG001|Overall Study|Withdrawal by Subject|15|||
33224032|NCT01598298|100721702|FG000|Overall Study|Other reason (not protocol specified)|4|||
33224033|NCT01598298|100721703|FG001|Overall Study|Other reason (not protocol specified)|0|||
33224034|NCT02532179|100721704|FG000|Overall Study|Lost to Follow-up|1|||
33224035|NCT02532179|100721704|FG000|Overall Study|Pregnancy|1|||
33224036|NCT02532179|100721704|FG000|Overall Study|Subject received depot steroid injection|1|||
33224037|NCT00909480|100721706|FG000|Overall Study|Adverse Event|5|||
33224038|NCT00909480|100721707|FG001|Overall Study|Adverse Event|3|||
33224039|NCT00909480|100721706|FG000|Overall Study|Protocol Violation|6|||
33224040|NCT00909480|100721707|FG001|Overall Study|Protocol Violation|8|||
33224041|NCT00909480|100721706|FG000|Overall Study|Withdrawal criteria|9|||
33224042|NCT00909480|100721707|FG001|Overall Study|Withdrawal criteria|11|||
33224043|NCT00909480|100721706|FG000|Overall Study|Unclassified|18|||
33224044|NCT00909480|100721707|FG001|Overall Study|Unclassified|19|||
33224045|NCT01203930|100721719|FG000|Overall Study|Disease Progression|0|||
33224046|NCT01203930|100721720|FG001|Overall Study|Disease Progression|4|||
33224047|NCT01203930|100721719|FG000|Overall Study|Death|3|||
33224048|NCT01203930|100721720|FG001|Overall Study|Death|1|||
33224049|NCT01203930|100721719|FG000|Overall Study|Withdrew Consent|1|||
33224050|NCT01203930|100721720|FG001|Overall Study|Withdrew Consent|10|||
33224051|NCT01203930|100721719|FG000|Overall Study|Investigator Request|0|||
33224052|NCT01203930|100721720|FG001|Overall Study|Investigator Request|8|||
33224053|NCT01203930|100721719|FG000|Overall Study|Study Terminated by Sponsor|0|||
33224054|NCT01203930|100721720|FG001|Overall Study|Study Terminated by Sponsor|12|||
33631169|NCT04408989|102200550|FG002|Overall Study|Withdrawal by Subject|2|||
33631170|NCT03361137|102200551|FG000|Overall Study|Reason not specified|1|||
33631171|NCT03361137|102200552|FG001|Overall Study|Reason not specified|0|||
33631172|NCT03361137|102200553|FG002|Overall Study|Reason not specified|0|||
33631173|NCT03361137|102200554|FG003|Overall Study|Reason not specified|0|||
33224055|NCT01203930|100721719|FG000|Overall Study|Poor tolerance of study drug|0|||
33224056|NCT01203930|100721720|FG001|Overall Study|Poor tolerance of study drug|1|||
33224057|NCT01203930|100721719|FG000|Overall Study|Adverse Event|17|||
33224058|NCT01203930|100721720|FG001|Overall Study|Adverse Event|5|||
33224059|NCT01874145|100721723|FG000|Core Period|Non-compliance|1|||
33224060|NCT01874145|100721724|FG001|Core Period|Non-compliance|0|||
33224061|NCT01874145|100721723|FG000|Core Period|Protocol Violation|1|||
33224062|NCT01874145|100721724|FG001|Core Period|Protocol Violation|1|||
33224063|NCT01874145|100721723|FG000|Core Period|Physician Decision|1|||
33224064|NCT01874145|100721724|FG001|Core Period|Physician Decision|1|||
33224065|NCT01874145|100721723|FG000|Core Period|Adverse Event|0|||
33224066|NCT01874145|100721724|FG001|Core Period|Adverse Event|1|||
33417092|NCT01788163|101420198|FG007|Overall Study|Other|48|||
33224067|NCT01874145|100721723|FG000|Core Period|Withdrawal by Subject|0|||
33364858|NCT04705597|101223669|FG001|Overall Study|Death|9|||
33631174|NCT03361137|102200555|FG004|Overall Study|Reason not specified|0|||
33631175|NCT03389477|102200556|FG000|Step 1|Withdrawal by Subject|1|||
33631176|NCT03389477|102200557|FG001|Step 1|Withdrawal by Subject|0|||
33631177|NCT03389477|102200556|FG000|Step 2|Withdrawal by Subject|1|||
33631178|NCT03389477|102200557|FG001|Step 2|Withdrawal by Subject|2|||
33631179|NCT03389477|102200556|FG000|Step 2|Disease progression|1|||
33631180|NCT03389477|102200557|FG001|Step 2|Disease progression|0|||
33631181|NCT03389477|102200556|FG000|Step 2|Death|0|||
33631182|NCT03389477|102200557|FG001|Step 2|Death|1|||
33631183|NCT03389477|102200556|FG000|Step 2|Poor performance status and nutrition|0|||
33631184|NCT03389477|102200557|FG001|Step 2|Poor performance status and nutrition|1|||
33631185|NCT03389477|102200556|FG000|Step 3|Withdrawal after 3 cycles|0|||
33631186|NCT03389477|102200557|FG001|Step 3|Withdrawal after 3 cycles|1|||
33631187|NCT03389477|102200556|FG000|Step 3|Still receiving active treatment|4|||
33631188|NCT03389477|102200557|FG001|Step 3|Still receiving active treatment|0|||
33631189|NCT03389477|102200556|FG000|Step 3|Progressive disease after 2 cycles|1|||
33631190|NCT03389477|102200557|FG001|Step 3|Progressive disease after 2 cycles|0|||
33631191|NCT02741128|102200558|FG000|Overall Study|Protocol Violation|4|||
33631192|NCT02741128|102200559|FG001|Overall Study|Protocol Violation|1|||
33631193|NCT02741128|102200558|FG000|Overall Study|Withdrawal by Subject|2|||
33631194|NCT02741128|102200559|FG001|Overall Study|Withdrawal by Subject|0|||
33631195|NCT02741128|102200558|FG000|Overall Study|Lost to Follow-up|1|||
33224068|NCT01874145|100721724|FG001|Core Period|Withdrawal by Subject|4|||
33224069|NCT01874145|100721723|FG000|Extension Period|Adverse Event|3|||
33417093|NCT01788163|101420199|FG008|Overall Study|Other|15|||
33631196|NCT02741128|102200559|FG001|Overall Study|Lost to Follow-up|0|||
33631197|NCT01506596|102200560|FG000|Overall Study|ineligible pathology|1|||
33631198|NCT01251965|102200561|FG000|Overall Study|Participant/physician decision|1|||
33631199|NCT01251965|102200562|FG001|Overall Study|Participant/physician decision|2|||
33631200|NCT01251965|102200563|FG002|Overall Study|Participant/physician decision|0|||
33631201|NCT01251965|102200561|FG000|Overall Study|Death|0|||
33631202|NCT01251965|102200562|FG001|Overall Study|Death|0|||
33631203|NCT01251965|102200563|FG002|Overall Study|Death|11|||
33631204|NCT04244253|102200570|FG000|Overall Study|Adverse Event|2|||
33631205|NCT04244253|102200571|FG001|Overall Study|Adverse Event|2|||
33631206|NCT04244253|102200572|FG002|Overall Study|Adverse Event|4|||
33631207|NCT04244253|102200570|FG000|Overall Study|Protocol Violation|1|||
33631208|NCT04244253|102200571|FG001|Overall Study|Protocol Violation|2|||
33631209|NCT04244253|102200572|FG002|Overall Study|Protocol Violation|1|||
33631210|NCT04244253|102200570|FG000|Overall Study|Withdrawal by Subject|0|||
33631211|NCT04244253|102200571|FG001|Overall Study|Withdrawal by Subject|1|||
33631212|NCT04244253|102200572|FG002|Overall Study|Withdrawal by Subject|6|||
33631213|NCT04244253|102200570|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33631214|NCT04244253|102200571|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33631215|NCT04244253|102200572|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33631216|NCT04338321|102200581|FG000|Overall Study|Adverse Event|4|||
33631217|NCT04338321|102200582|FG001|Overall Study|Adverse Event|10|||
33567517|NCT02723955|101973201|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567518|NCT02723955|101973202|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567519|NCT02723955|101973203|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567520|NCT02723955|101973204|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567521|NCT02723955|101973205|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567522|NCT02723955|101973206|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567523|NCT02723955|101973207|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33631218|NCT04338321|102200581|FG000|Overall Study|Death|1|||
33631219|NCT04338321|102200582|FG001|Overall Study|Death|1|||
33631220|NCT04338321|102200581|FG000|Overall Study|Lost to Follow-up|4|||
33631221|NCT04338321|102200582|FG001|Overall Study|Lost to Follow-up|9|||
33631222|NCT04338321|102200581|FG000|Overall Study|Withdrawal by Subject|45|||
33631223|NCT04338321|102200582|FG001|Overall Study|Withdrawal by Subject|69|||
33631224|NCT04338321|102200581|FG000|Overall Study|Physician Decision|5|||
33631225|NCT04338321|102200582|FG001|Overall Study|Physician Decision|9|||
33631226|NCT04338321|102200581|FG000|Overall Study|Other|3|||
33631227|NCT04338321|102200582|FG001|Overall Study|Other|10|||
33631228|NCT04515771|102200586|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
33631229|NCT04515771|102200587|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
33224070|NCT01874145|100721724|FG001|Extension Period|Adverse Event|2|||
33224071|NCT01874145|100721723|FG000|Extension Period|Withdrawal by Subject|2|||
33224072|NCT01874145|100721724|FG001|Extension Period|Withdrawal by Subject|1|||
33224073|NCT01874145|100721723|FG000|Extension Period|Lost to Follow-up|1|||
33224074|NCT01874145|100721724|FG001|Extension Period|Lost to Follow-up|1|||
33224075|NCT01728792|100721726|FG000|Overall Study|Withdrawal of Consent|1|||
33224076|NCT01728792|100721727|FG001|Overall Study|Withdrawal of Consent|1|||
33224077|NCT01728792|100721728|FG002|Overall Study|Withdrawal of Consent|0|||
33224078|NCT01728792|100721729|FG003|Overall Study|Withdrawal of Consent|1|||
33224079|NCT01728792|100721730|FG004|Overall Study|Withdrawal of Consent|0|||
33224080|NCT01728792|100721726|FG000|Overall Study|Lost to Follow-up|2|||
33224081|NCT01728792|100721727|FG001|Overall Study|Lost to Follow-up|1|||
33224082|NCT01728792|100721728|FG002|Overall Study|Lost to Follow-up|4|||
33224083|NCT01728792|100721729|FG003|Overall Study|Lost to Follow-up|2|||
33224084|NCT01728792|100721730|FG004|Overall Study|Lost to Follow-up|0|||
33224085|NCT02944656|100721731|FG000|Overall Study|No longer eligible|3|||
33224086|NCT02944656|100721732|FG001|Overall Study|No longer eligible|0|||
33224087|NCT02944656|100721731|FG000|Overall Study|Lost to Follow-up|7|||
33224088|NCT02944656|100721732|FG001|Overall Study|Lost to Follow-up|10|||
33224089|NCT01364597|100721733|FG000|Overall Study|Adverse Event|4|||
33224090|NCT01364597|100721734|FG001|Overall Study|Adverse Event|5|||
33224091|NCT01364597|100721735|FG002|Overall Study|Adverse Event|16|||
33224092|NCT01364597|100721736|FG003|Overall Study|Adverse Event|7|||
33224093|NCT01364597|100721733|FG000|Overall Study|Lack of Efficacy|4|||
33224094|NCT01364597|100721734|FG001|Overall Study|Lack of Efficacy|4|||
33224095|NCT01364597|100721735|FG002|Overall Study|Lack of Efficacy|23|||
33224096|NCT01364597|100721736|FG003|Overall Study|Lack of Efficacy|8|||
33224097|NCT01364597|100721733|FG000|Overall Study|Protocol Violation|0|||
33224098|NCT01364597|100721734|FG001|Overall Study|Protocol Violation|0|||
33224099|NCT01364597|100721735|FG002|Overall Study|Protocol Violation|2|||
33224100|NCT01364597|100721736|FG003|Overall Study|Protocol Violation|0|||
33224101|NCT01364597|100721733|FG000|Overall Study|Lost to Follow-up|0|||
33224102|NCT01364597|100721734|FG001|Overall Study|Lost to Follow-up|0|||
33224103|NCT01364597|100721735|FG002|Overall Study|Lost to Follow-up|5|||
33224104|NCT01364597|100721736|FG003|Overall Study|Lost to Follow-up|3|||
33224105|NCT01364597|100721733|FG000|Overall Study|Withdrawal by Subject|4|||
33224106|NCT01364597|100721734|FG001|Overall Study|Withdrawal by Subject|1|||
33224107|NCT01364597|100721735|FG002|Overall Study|Withdrawal by Subject|18|||
33224108|NCT01364597|100721736|FG003|Overall Study|Withdrawal by Subject|6|||
33224109|NCT01364597|100721733|FG000|Overall Study|Non compliance|1|||
33224110|NCT01364597|100721734|FG001|Overall Study|Non compliance|0|||
33224111|NCT01364597|100721735|FG002|Overall Study|Non compliance|1|||
33224112|NCT01364597|100721736|FG003|Overall Study|Non compliance|0|||
33224113|NCT01364597|100721733|FG000|Overall Study|Lack of compliance|1|||
33224114|NCT01364597|100721734|FG001|Overall Study|Lack of compliance|0|||
33224115|NCT01364597|100721735|FG002|Overall Study|Lack of compliance|0|||
33224116|NCT01364597|100721736|FG003|Overall Study|Lack of compliance|0|||
33224117|NCT01364597|100721733|FG000|Overall Study|End of treatment epilepsy|1|||
33224118|NCT01364597|100721734|FG001|Overall Study|End of treatment epilepsy|0|||
33224119|NCT01364597|100721735|FG002|Overall Study|End of treatment epilepsy|0|||
33224120|NCT01364597|100721736|FG003|Overall Study|End of treatment epilepsy|0|||
33224121|NCT01364597|100721733|FG000|Overall Study|No Seizures|1|||
33224122|NCT01364597|100721734|FG001|Overall Study|No Seizures|0|||
33224123|NCT01364597|100721735|FG002|Overall Study|No Seizures|0|||
33224124|NCT01364597|100721736|FG003|Overall Study|No Seizures|0|||
33224125|NCT01364597|100721733|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
33224126|NCT01364597|100721734|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
33224127|NCT01364597|100721735|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
33224128|NCT01364597|100721736|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
33224129|NCT01364597|100721733|FG000|Overall Study|Cure|1|||
33224130|NCT01364597|100721734|FG001|Overall Study|Cure|0|||
33224131|NCT01364597|100721735|FG002|Overall Study|Cure|0|||
33224132|NCT01364597|100721736|FG003|Overall Study|Cure|0|||
33224133|NCT01364597|100721733|FG000|Overall Study|Patient was moving|0|||
33364859|NCT04705597|101223668|FG000|Overall Study|Lost to Follow-up|1|||
33364860|NCT04705597|101223669|FG001|Overall Study|Lost to Follow-up|0|||
33364861|NCT04705597|101223668|FG000|Overall Study|Withdrawal by Subject|1|||
33364862|NCT04705597|101223669|FG001|Overall Study|Withdrawal by Subject|2|||
33364863|NCT00726323|101223670|FG000|Overall Study|Withdrawal by Subject|3|||
33224134|NCT01364597|100721734|FG001|Overall Study|Patient was moving|1|||
33224135|NCT01364597|100721735|FG002|Overall Study|Patient was moving|0|||
33224136|NCT01364597|100721736|FG003|Overall Study|Patient was moving|0|||
33224137|NCT01364597|100721733|FG000|Overall Study|Seizures resolved|0|||
33224138|NCT01364597|100721734|FG001|Overall Study|Seizures resolved|0|||
33224139|NCT01364597|100721735|FG002|Overall Study|Seizures resolved|1|||
33224140|NCT01364597|100721736|FG003|Overall Study|Seizures resolved|0|||
33224141|NCT01364597|100721733|FG000|Overall Study|Patient became seizure-free after surgery|0|||
33224142|NCT01364597|100721734|FG001|Overall Study|Patient became seizure-free after surgery|0|||
33364864|NCT00726323|101223671|FG001|Overall Study|Withdrawal by Subject|1|||
33224143|NCT01364597|100721735|FG002|Overall Study|Patient became seizure-free after surgery|1|||
33224144|NCT01364597|100721736|FG003|Overall Study|Patient became seizure-free after surgery|0|||
33224145|NCT01364597|100721733|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
33224146|NCT01364597|100721734|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
33224147|NCT01364597|100721735|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
33224148|NCT01364597|100721736|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
33224149|NCT01364597|100721733|FG000|Overall Study|Patient cured from Epilepsy|0|||
33224150|NCT01364597|100721734|FG001|Overall Study|Patient cured from Epilepsy|0|||
33224151|NCT01364597|100721735|FG002|Overall Study|Patient cured from Epilepsy|1|||
33417094|NCT01788163|101420191|FG000|Overall Study|Withdrawal by Subject|2|||
33417095|NCT01788163|101420192|FG001|Overall Study|Withdrawal by Subject|0|||
33224152|NCT01364597|100721736|FG003|Overall Study|Patient cured from Epilepsy|0|||
33224153|NCT01364597|100721733|FG000|Overall Study|Investigator decision|0|||
33224154|NCT01364597|100721734|FG001|Overall Study|Investigator decision|0|||
33224155|NCT01364597|100721735|FG002|Overall Study|Investigator decision|1|||
33224156|NCT01364597|100721736|FG003|Overall Study|Investigator decision|0|||
33224157|NCT01364597|100721733|FG000|Overall Study|Sponsor recommended discontinuation|0|||
33224158|NCT01364597|100721734|FG001|Overall Study|Sponsor recommended discontinuation|0|||
33224159|NCT01364597|100721735|FG002|Overall Study|Sponsor recommended discontinuation|0|||
33224160|NCT01364597|100721736|FG003|Overall Study|Sponsor recommended discontinuation|1|||
33224161|NCT01364597|100721733|FG000|Overall Study|Parents went abroad with the patient|0|||
33224162|NCT01364597|100721734|FG001|Overall Study|Parents went abroad with the patient|0|||
33224163|NCT01364597|100721735|FG002|Overall Study|Parents went abroad with the patient|1|||
33224164|NCT01364597|100721736|FG003|Overall Study|Parents went abroad with the patient|0|||
33224165|NCT01364597|100721733|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
33224166|NCT01364597|100721734|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
33224167|NCT01364597|100721735|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
33224168|NCT01364597|100721736|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
33224169|NCT01364597|100721733|FG000|Overall Study|BRV administration dropout|0|||
33224170|NCT01364597|100721734|FG001|Overall Study|BRV administration dropout|0|||
33224171|NCT01364597|100721735|FG002|Overall Study|BRV administration dropout|1|||
33224172|NCT01364597|100721736|FG003|Overall Study|BRV administration dropout|0|||
33224173|NCT01364597|100721733|FG000|Overall Study|Dropout|0|||
33224174|NCT01364597|100721734|FG001|Overall Study|Dropout|0|||
33224175|NCT01364597|100721735|FG002|Overall Study|Dropout|3|||
33224176|NCT01364597|100721736|FG003|Overall Study|Dropout|1|||
33224177|NCT01364597|100721733|FG000|Overall Study|Unreliable subject|0|||
33224178|NCT01364597|100721734|FG001|Overall Study|Unreliable subject|0|||
33224179|NCT01364597|100721735|FG002|Overall Study|Unreliable subject|0|||
33224180|NCT01364597|100721736|FG003|Overall Study|Unreliable subject|1|||
33224181|NCT01364597|100721733|FG000|Overall Study|Other|0|||
33224182|NCT01364597|100721734|FG001|Overall Study|Other|0|||
33224183|NCT01364597|100721735|FG002|Overall Study|Other|0|||
33224184|NCT01364597|100721736|FG003|Overall Study|Other|1|||
33224185|NCT01576367|100721741|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33224186|NCT01576367|100721741|FG000|Overall Study|Moved to commercial use after 6 months|1|||
33224187|NCT05340751|100721742|FG000|Overall Study|Physician Decision|3|||
33224188|NCT03391960|100721743|FG000|Overall Study|Protocol Violation|0|||
33224189|NCT03391960|100721744|FG001|Overall Study|Protocol Violation|0|||
33224190|NCT00954733|100721745|FG000|Overall Study|blood gas machine did not work|1|||
33417096|NCT01788163|101420193|FG002|Overall Study|Withdrawal by Subject|0|||
33417097|NCT01788163|101420194|FG003|Overall Study|Withdrawal by Subject|0|||
33224191|NCT00255346|100721746|FG000|Overall Study|Adverse Event|1|||
33224192|NCT00255346|100721747|FG001|Overall Study|Adverse Event|0|||
33224193|NCT00255346|100721748|FG002|Overall Study|Adverse Event|0|||
33224194|NCT00255346|100721749|FG003|Overall Study|Adverse Event|0|||
33224195|NCT00255346|100721750|FG004|Overall Study|Adverse Event|0|||
33224196|NCT00457639|100721751|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
33224197|NCT00457639|100721752|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
33224198|NCT00457639|100721751|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
33224199|NCT00457639|100721752|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
33224200|NCT00457639|100721751|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
33631230|NCT04515771|102200586|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
33224201|NCT00457639|100721752|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
33224202|NCT04146896|100721753|FG000|Overall Study|Adverse Event|5|||
33224203|NCT04146896|100721754|FG001|Overall Study|Adverse Event|8|||
33417098|NCT01788163|101420195|FG004|Overall Study|Withdrawal by Subject|0|||
33417099|NCT01788163|101420196|FG005|Overall Study|Withdrawal by Subject|0|||
33567524|NCT02723955|101973208|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567525|NCT02723955|101973209|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33417100|NCT01788163|101420197|FG006|Overall Study|Withdrawal by Subject|0|||
33417101|NCT01788163|101420198|FG007|Overall Study|Withdrawal by Subject|0|||
33417102|NCT01788163|101420199|FG008|Overall Study|Withdrawal by Subject|1|||
33417103|NCT00185731|101420204|FG000|Overall Study|Withdrawal by Subject|1|||
33417104|NCT00185731|101420204|FG000|Overall Study|Not Eligible|1|||
33417105|NCT01306968|101420205|FG000|Overall Study|Lost to Follow-up|1|||
33417106|NCT01306968|101420206|FG001|Overall Study|Lost to Follow-up|1|||
33417107|NCT01306968|101420207|FG002|Overall Study|Lost to Follow-up|0|||
33417108|NCT01306968|101420208|FG003|Overall Study|Lost to Follow-up|0|||
33417109|NCT01306968|101420205|FG000|Overall Study|Physician Decision|0|||
33417110|NCT01306968|101420206|FG001|Overall Study|Physician Decision|1|||
33417111|NCT01306968|101420207|FG002|Overall Study|Physician Decision|0|||
33417112|NCT01306968|101420208|FG003|Overall Study|Physician Decision|0|||
33417113|NCT01306968|101420205|FG000|Overall Study|Relocated and left active duty|0|||
33417114|NCT01306968|101420206|FG001|Overall Study|Relocated and left active duty|1|||
33417115|NCT01306968|101420207|FG002|Overall Study|Relocated and left active duty|1|||
33417116|NCT01306968|101420208|FG003|Overall Study|Relocated and left active duty|1|||
33417117|NCT01306968|101420205|FG000|Overall Study|Withdrew - time commitment|0|||
33417118|NCT01306968|101420206|FG001|Overall Study|Withdrew - time commitment|0|||
33417119|NCT01306968|101420207|FG002|Overall Study|Withdrew - time commitment|0|||
33417120|NCT01306968|101420208|FG003|Overall Study|Withdrew - time commitment|2|||
33417121|NCT01306968|101420205|FG000|Overall Study|Withdrew over privacy concerns|0|||
33417122|NCT01306968|101420206|FG001|Overall Study|Withdrew over privacy concerns|0|||
33417123|NCT01306968|101420207|FG002|Overall Study|Withdrew over privacy concerns|0|||
33417124|NCT01306968|101420208|FG003|Overall Study|Withdrew over privacy concerns|1|||
33417125|NCT01817764|101420209|FG000|Overall Study|Adverse Event|7|||
33417126|NCT01817764|101420210|FG001|Overall Study|Adverse Event|10|||
33417127|NCT01817764|101420209|FG000|Overall Study|Lack of Efficacy|9|||
33417128|NCT01817764|101420210|FG001|Overall Study|Lack of Efficacy|7|||
33417129|NCT01817764|101420209|FG000|Overall Study|Protocol Violation|7|||
33417130|NCT01817764|101420210|FG001|Overall Study|Protocol Violation|5|||
33417131|NCT01817764|101420209|FG000|Overall Study|Lost to Follow-up|1|||
33417132|NCT01817764|101420210|FG001|Overall Study|Lost to Follow-up|4|||
33417133|NCT01817764|101420209|FG000|Overall Study|Withdrawal by Subject|10|||
33417134|NCT01817764|101420210|FG001|Overall Study|Withdrawal by Subject|12|||
33417135|NCT02531698|101420211|FG000|Overall Study|Adverse Event|2|||
33417136|NCT02531698|101420212|FG001|Overall Study|Adverse Event|1|||
33417137|NCT02531698|101420211|FG000|Overall Study|Withdrawal by Subject|6|||
33224204|NCT04146896|100721753|FG000|Overall Study|Lack of Efficacy|3|||
33224205|NCT04146896|100721754|FG001|Overall Study|Lack of Efficacy|2|||
33224206|NCT04146896|100721753|FG000|Overall Study|Lost to Follow-up|0|||
33224207|NCT04146896|100721754|FG001|Overall Study|Lost to Follow-up|1|||
33224208|NCT04146896|100721753|FG000|Overall Study|Non-compliance|5|||
33224209|NCT04146896|100721754|FG001|Overall Study|Non-compliance|4|||
33417138|NCT02531698|101420212|FG001|Overall Study|Withdrawal by Subject|1|||
33567526|NCT02723955|101973210|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567527|NCT02723955|101973211|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
33567528|NCT02723955|101973169|FG000|Expansion Phase|Site Closed|0|||
33567529|NCT02723955|101973170|FG001|Expansion Phase|Site Closed|0|||
33567530|NCT02723955|101973171|FG002|Expansion Phase|Site Closed|0|||
33567531|NCT02723955|101973172|FG003|Expansion Phase|Site Closed|0|||
33567532|NCT02723955|101973173|FG004|Expansion Phase|Site Closed|0|||
33224210|NCT04146896|100721753|FG000|Overall Study|Withdrawal by Subject|3|||
33224211|NCT04146896|100721754|FG001|Overall Study|Withdrawal by Subject|5|||
33567533|NCT02723955|101973174|FG005|Expansion Phase|Site Closed|0|||
33567534|NCT02723955|101973175|FG006|Expansion Phase|Site Closed|0|||
33567535|NCT02723955|101973176|FG007|Expansion Phase|Site Closed|0|||
33567536|NCT02723955|101973177|FG008|Expansion Phase|Site Closed|0|||
33567537|NCT02723955|101973178|FG009|Expansion Phase|Site Closed|1|||
33567538|NCT02723955|101973179|FG010|Expansion Phase|Site Closed|2|||
33567539|NCT02723955|101973180|FG011|Expansion Phase|Site Closed|6|||
33224212|NCT04146896|100721753|FG000|Overall Study|Randomized in error|1|||
33224213|NCT04146896|100721754|FG001|Overall Study|Randomized in error|2|||
33224214|NCT03489057|100721755|FG000|Overall Study|Lost to Follow-up|16|||
33224215|NCT03489057|100721756|FG001|Overall Study|Lost to Follow-up|16|||
33417139|NCT02531698|101420211|FG000|Overall Study|Protocol Violation|2|||
33417140|NCT02531698|101420212|FG001|Overall Study|Protocol Violation|0|||
33417141|NCT02531698|101420211|FG000|Overall Study|Lost to Follow-up|1|||
33417142|NCT02531698|101420212|FG001|Overall Study|Lost to Follow-up|0|||
33417143|NCT00720304|101420215|FG000|Overall Study|Withdrawal by Subject|14|||
33417144|NCT00720304|101420216|FG001|Overall Study|Withdrawal by Subject|1|||
33417145|NCT00720304|101420215|FG000|Overall Study|Death|1|||
33417146|NCT00720304|101420216|FG001|Overall Study|Death|0|||
33417147|NCT00720304|101420215|FG000|Overall Study|Physician Decision|5|||
33417148|NCT00720304|101420216|FG001|Overall Study|Physician Decision|2|||
33417149|NCT00720304|101420215|FG000|Overall Study|Adverse Event|3|||
33567540|NCT02723955|101973181|FG012|Expansion Phase|Site Closed|0|||
33567541|NCT02723955|101973182|FG013|Expansion Phase|Site Closed|0|||
33567542|NCT02723955|101973183|FG014|Expansion Phase|Site Closed|0|||
33567543|NCT02723955|101973184|FG015|Expansion Phase|Site Closed|0|||
33567544|NCT02723955|101973185|FG016|Expansion Phase|Site Closed|0|||
33567545|NCT02723955|101973186|FG017|Expansion Phase|Site Closed|0|||
33567546|NCT02723955|101973187|FG018|Expansion Phase|Site Closed|0|||
33631231|NCT04515771|102200587|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
33631232|NCT04515771|102200586|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
33631233|NCT04515771|102200587|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
33631234|NCT05176314|102200590|FG000|Overall Study|Lost to Follow-up|2|||
33631235|NCT05176314|102200590|FG000|Overall Study|Physician Decision|1|||
33631236|NCT05176314|102200590|FG000|Overall Study|Adverse Event|1|||
33631237|NCT01527149|102200593|FG000|Overall Study|Death|2|||
33631238|NCT04825574|102200594|FG000|Overall Study|Commercial treatment became available|1|||
33631239|NCT04825574|102200594|FG000|Overall Study|Disease progression|1|||
33631240|NCT04613362|102200597|FG000|3 Month Follow-up|Lost to Follow-up|1|||
33631241|NCT04613362|102200598|FG001|3 Month Follow-up|Lost to Follow-up|2|||
33631242|NCT04613362|102200597|FG000|6 Month Follow-up|Lost to Follow-up|0|||
33631243|NCT04613362|102200598|FG001|6 Month Follow-up|Lost to Follow-up|1|||
33631244|NCT02205736|102202889|FG000|Overall Study|Lost to Follow-up|106|||
33631245|NCT00687596|102202893|FG000|Overall Study|Adverse Event (AE)|10|||
33567547|NCT02723955|101973188|FG019|Expansion Phase|Site Closed|0|||
33567548|NCT02723955|101973189|FG020|Expansion Phase|Site Closed|0|||
33567549|NCT02723955|101973190|FG021|Expansion Phase|Site Closed|0|||
33567550|NCT02723955|101973191|FG022|Expansion Phase|Site Closed|0|||
33567551|NCT02723955|101973192|FG023|Expansion Phase|Site Closed|0|||
33567552|NCT02723955|101973193|FG024|Expansion Phase|Site Closed|0|||
33567553|NCT02723955|101973194|FG025|Expansion Phase|Site Closed|0|||
33567554|NCT02723955|101973195|FG026|Expansion Phase|Site Closed|0|||
33567555|NCT02723955|101973196|FG027|Expansion Phase|Site Closed|0|||
33567556|NCT02723955|101973197|FG028|Expansion Phase|Site Closed|0|||
33567557|NCT02723955|101973198|FG029|Expansion Phase|Site Closed|0|||
33567558|NCT02723955|101973199|FG030|Expansion Phase|Site Closed|8|||
33567559|NCT02723955|101973200|FG031|Expansion Phase|Site Closed|4|||
33567560|NCT02723955|101973201|FG032|Expansion Phase|Site Closed|2|||
33567561|NCT02723955|101973202|FG033|Expansion Phase|Site Closed|2|||
33567562|NCT02723955|101973203|FG034|Expansion Phase|Site Closed|0|||
33567563|NCT02723955|101973204|FG035|Expansion Phase|Site Closed|0|||
33567564|NCT02723955|101973205|FG036|Expansion Phase|Site Closed|0|||
33567565|NCT02723955|101973206|FG037|Expansion Phase|Site Closed|0|||
33567566|NCT02723955|101973207|FG038|Expansion Phase|Site Closed|0|||
33567567|NCT02723955|101973208|FG039|Expansion Phase|Site Closed|0|||
33567568|NCT02723955|101973209|FG040|Expansion Phase|Site Closed|0|||
33631246|NCT00687596|102202894|FG001|Overall Study|Adverse Event (AE)|3|||
33631247|NCT00687596|102202893|FG000|Overall Study|Radiological Disease Progression|6|||
33631248|NCT00687596|102202894|FG001|Overall Study|Radiological Disease Progression|2|||
33631249|NCT00687596|102202893|FG000|Overall Study|Clinical Disease Progression|1|||
33631250|NCT00687596|102202894|FG001|Overall Study|Clinical Disease Progression|3|||
33631251|NCT00687596|102202893|FG000|Overall Study|Investigator Discretion|3|||
33631252|NCT00687596|102202894|FG001|Overall Study|Investigator Discretion|1|||
33631253|NCT00687596|102202893|FG000|Overall Study|Sponsor Terminated Study|6|||
33224216|NCT03489057|100721757|FG002|Overall Study|Lost to Follow-up|14|||
33224217|NCT03489057|100721758|FG003|Overall Study|Lost to Follow-up|14|||
33567569|NCT02723955|101973210|FG041|Expansion Phase|Site Closed|0|||
33567570|NCT02723955|101973211|FG042|Expansion Phase|Site Closed|0|||
33567571|NCT02723955|101973169|FG000|Crossover/ Re-treatment Phase|Death|0|||
33567572|NCT02723955|101973170|FG001|Crossover/ Re-treatment Phase|Death|0|||
33567573|NCT02723955|101973171|FG002|Crossover/ Re-treatment Phase|Death|0|||
33567574|NCT02723955|101973172|FG003|Crossover/ Re-treatment Phase|Death|0|||
33631254|NCT00687596|102202894|FG001|Overall Study|Sponsor Terminated Study|17|||
33631255|NCT04606134|102202895|FG000|Overall Study|Adverse Event|0|||
33631256|NCT04606134|102202896|FG001|Overall Study|Adverse Event|1|||
33224218|NCT03489057|100721755|FG000|Overall Study|Withdrawal by Subject|12|||
33364865|NCT00726323|101223670|FG000|Overall Study|Physician Decision|1|||
33417150|NCT00720304|101420216|FG001|Overall Study|Adverse Event|1|||
33631257|NCT01231906|102202897|FG000|Overall Study|Lack of Efficacy|75|||
33364866|NCT00726323|101223671|FG001|Overall Study|Physician Decision|0|||
33567575|NCT02723955|101973173|FG004|Crossover/ Re-treatment Phase|Death|0|||
33567576|NCT02723955|101973174|FG005|Crossover/ Re-treatment Phase|Death|0|||
33567577|NCT02723955|101973175|FG006|Crossover/ Re-treatment Phase|Death|0|||
33567649|NCT02723955|101973204|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567650|NCT02723955|101973205|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567651|NCT02723955|101973206|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567652|NCT02723955|101973207|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567653|NCT02723955|101973208|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
33567654|NCT02723955|101973209|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567655|NCT02723955|101973210|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567656|NCT02723955|101973211|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
33567657|NCT02723955|101973169|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567658|NCT02723955|101973170|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567659|NCT02723955|101973171|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567660|NCT02723955|101973172|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567661|NCT02723955|101973173|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567662|NCT02723955|101973174|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567663|NCT02723955|101973175|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567664|NCT02723955|101973176|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567665|NCT02723955|101973177|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567666|NCT02723955|101973178|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567667|NCT02723955|101973179|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567668|NCT02723955|101973180|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567669|NCT02723955|101973181|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567670|NCT02723955|101973182|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567671|NCT02723955|101973183|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567672|NCT02723955|101973184|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567673|NCT02723955|101973185|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567674|NCT02723955|101973186|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567675|NCT02723955|101973187|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567676|NCT02723955|101973188|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567677|NCT02723955|101973189|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567678|NCT02723955|101973190|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567679|NCT02723955|101973191|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
33224385|NCT05044325|100721816|FG005|Part A:Treatment Period 1|Physician Decision|0|||
33224386|NCT05044325|100721817|FG006|Part A:Treatment Period 1|Physician Decision|1|||
33224387|NCT05044325|100721818|FG007|Part A:Treatment Period 1|Physician Decision|0|||
33224388|NCT05044325|100721819|FG008|Part A:Treatment Period 1|Physician Decision|0|||
33224389|NCT05044325|100721820|FG009|Part A:Treatment Period 1|Physician Decision|0|||
33224390|NCT05044325|100721811|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
33224391|NCT05044325|100721812|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
33224392|NCT05044325|100721813|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
33224393|NCT05044325|100721814|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
33224394|NCT05044325|100721815|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
33224395|NCT05044325|100721816|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
33224396|NCT05044325|100721817|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
33224397|NCT05044325|100721818|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
33224398|NCT05044325|100721819|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
33224399|NCT05044325|100721820|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
33224400|NCT05044325|100721811|FG000|Part A:Treatment Period 2|Adverse Event|0|||
33224401|NCT05044325|100721812|FG001|Part A:Treatment Period 2|Adverse Event|1|||
33224402|NCT05044325|100721813|FG002|Part A:Treatment Period 2|Adverse Event|0|||
33224403|NCT05044325|100721814|FG003|Part A:Treatment Period 2|Adverse Event|0|||
33224404|NCT05044325|100721815|FG004|Part A:Treatment Period 2|Adverse Event|1|||
33224405|NCT05044325|100721816|FG005|Part A:Treatment Period 2|Adverse Event|1|||
33224406|NCT05044325|100721817|FG006|Part A:Treatment Period 2|Adverse Event|0|||
33224407|NCT05044325|100721818|FG007|Part A:Treatment Period 2|Adverse Event|0|||
33224408|NCT05044325|100721819|FG008|Part A:Treatment Period 2|Adverse Event|0|||
33224409|NCT05044325|100721820|FG009|Part A:Treatment Period 2|Adverse Event|0|||
33224410|NCT05044325|100721811|FG000|Part A:Treatment Period 2|Physician Decision|0|||
33224411|NCT05044325|100721812|FG001|Part A:Treatment Period 2|Physician Decision|0|||
33224412|NCT05044325|100721813|FG002|Part A:Treatment Period 2|Physician Decision|0|||
33224413|NCT05044325|100721814|FG003|Part A:Treatment Period 2|Physician Decision|0|||
33224414|NCT05044325|100721815|FG004|Part A:Treatment Period 2|Physician Decision|0|||
33224415|NCT05044325|100721816|FG005|Part A:Treatment Period 2|Physician Decision|1|||
33224416|NCT05044325|100721817|FG006|Part A:Treatment Period 2|Physician Decision|0|||
33224417|NCT05044325|100721818|FG007|Part A:Treatment Period 2|Physician Decision|0|||
33224418|NCT05044325|100721819|FG008|Part A:Treatment Period 2|Physician Decision|0|||
33224419|NCT05044325|100721820|FG009|Part A:Treatment Period 2|Physician Decision|0|||
33224420|NCT05044325|100721811|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
33489715|NCT02899962|101686772|FG000|Open-label Phase|Adverse Event|2|||
33567680|NCT02723955|101973192|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567681|NCT02723955|101973193|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567682|NCT02723955|101973194|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
33417270|NCT05004181|101420251|FG001|Overall Study|Withdrawal of consent|0|||
33417271|NCT05004181|101420252|FG002|Overall Study|Withdrawal of consent|1|||
33417272|NCT05004181|101420253|FG003|Overall Study|Withdrawal of consent|3|||
33417273|NCT05004181|101420254|FG004|Overall Study|Withdrawal of consent|3|||
33417274|NCT05004181|101420255|FG005|Overall Study|Withdrawal of consent|0|||
33417275|NCT05004181|101420256|FG006|Overall Study|Withdrawal of consent|30|||
33417276|NCT05004181|101420257|FG007|Overall Study|Withdrawal of consent|9|||
33417277|NCT05004181|101420258|FG008|Overall Study|Withdrawal of consent|3|||
33567683|NCT02723955|101973195|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567684|NCT02723955|101973196|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567685|NCT02723955|101973197|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567686|NCT02723955|101973198|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567687|NCT02723955|101973199|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567688|NCT02723955|101973200|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567689|NCT02723955|101973201|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567690|NCT02723955|101973202|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567691|NCT02723955|101973203|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567692|NCT02723955|101973204|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567693|NCT02723955|101973205|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567694|NCT02723955|101973206|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567695|NCT02723955|101973207|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
33567696|NCT02723955|101973208|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
33567697|NCT02723955|101973209|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567698|NCT02723955|101973210|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
33567699|NCT02723955|101973211|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
33567700|NCT02723955|101973169|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
33567701|NCT02723955|101973170|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
33567702|NCT02723955|101973171|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
33567703|NCT02723955|101973172|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
33567704|NCT02723955|101973173|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
33567705|NCT02723955|101973174|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
33567706|NCT02723955|101973175|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
33567707|NCT02723955|101973176|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
33567708|NCT02723955|101973177|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
33567709|NCT02723955|101973178|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
33567710|NCT02723955|101973179|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
33567711|NCT02723955|101973180|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
33567712|NCT02723955|101973181|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
33567713|NCT02723955|101973182|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
33567714|NCT02723955|101973183|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
33567715|NCT02723955|101973184|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
33567716|NCT02723955|101973185|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
33567717|NCT02723955|101973186|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
33567718|NCT02723955|101973187|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
33567719|NCT02723955|101973188|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
33567720|NCT02723955|101973189|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
33567721|NCT02723955|101973190|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
33567722|NCT02723955|101973191|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
33567723|NCT02723955|101973192|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
33567724|NCT02723955|101973193|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
33567725|NCT02723955|101973194|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
33567726|NCT02723955|101973195|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
33567727|NCT02723955|101973196|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
33567728|NCT02723955|101973197|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
33567729|NCT02723955|101973198|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
33567730|NCT02723955|101973199|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
33567731|NCT02723955|101973200|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
33567732|NCT02723955|101973201|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
33567733|NCT02723955|101973202|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
33567734|NCT02723955|101973203|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
33567735|NCT02723955|101973204|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
33567736|NCT02723955|101973205|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
33567737|NCT02723955|101973206|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
33567738|NCT02723955|101973207|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
33567739|NCT02723955|101973208|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
33567740|NCT02723955|101973209|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
33567741|NCT02723955|101973210|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
33567742|NCT02723955|101973211|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
33567743|NCT04038957|101973212|FG000|Overall Study|Withdrawal by Subject|1|||
33567744|NCT04038957|101973212|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
33567745|NCT01744782|101974773|FG000|Overall Study|Death|1|||
33567746|NCT00601900|101974780|FG000|Overall Study|Withdrawal by Subject|0|||
33567747|NCT00601900|101974781|FG001|Overall Study|Withdrawal by Subject|3|||
33567748|NCT03056040|101974782|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
33567749|NCT03056040|101974783|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
33567750|NCT03056040|101974782|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
33567751|NCT03056040|101974783|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
33567752|NCT03056040|101974782|FG000|Primary Evaluation Period|Pregnancy|0|||
33567753|NCT03056040|101974783|FG001|Primary Evaluation Period|Pregnancy|1|||
33567754|NCT03056040|101974782|FG000|Primary Evaluation Period|Randomized, not treated|1|||
33567755|NCT03056040|101974783|FG001|Primary Evaluation Period|Randomized, not treated|1|||
33567756|NCT03056040|101974782|FG000|Extension Period|Physician Decision|3|||
33567757|NCT03056040|101974783|FG001|Extension Period|Physician Decision|3|||
33567758|NCT03056040|101974782|FG000|Extension Period|Lost to Follow-up|0|||
33567759|NCT03056040|101974783|FG001|Extension Period|Lost to Follow-up|1|||
33567760|NCT03056040|101974782|FG000|Extension Period|Death|0|||
33567761|NCT03056040|101974783|FG001|Extension Period|Death|3|||
33567762|NCT03056040|101974782|FG000|Extension Period|Withdrawal by Subject|1|||
33567763|NCT03056040|101974783|FG001|Extension Period|Withdrawal by Subject|0|||
33567764|NCT00334815|101974784|FG000|Overall Study|Adverse Event|3|||
33567765|NCT00334815|101974785|FG001|Overall Study|Adverse Event|2|||
33567766|NCT00334815|101974784|FG000|Overall Study|Death|0|||
33567767|NCT00334815|101974785|FG001|Overall Study|Death|2|||
33567768|NCT00334815|101974784|FG000|Overall Study|Progression|1|||
33567769|NCT00334815|101974785|FG001|Overall Study|Progression|0|||
33567770|NCT00334815|101974784|FG000|Overall Study|ineligible|1|||
33567771|NCT00334815|101974785|FG001|Overall Study|ineligible|1|||
33567772|NCT00334815|101974784|FG000|Overall Study|patient refused treatment|0|||
33567773|NCT00334815|101974785|FG001|Overall Study|patient refused treatment|1|||
33567774|NCT00334815|101974784|FG000|Overall Study|Physician Decision|2|||
33567775|NCT00334815|101974785|FG001|Overall Study|Physician Decision|4|||
33567776|NCT04256941|101974786|FG000|Overall Study|Withdrawal by Subject|0|||
33567777|NCT04256941|101974787|FG001|Overall Study|Withdrawal by Subject|1|||
33567778|NCT04256941|101974786|FG000|Overall Study|Death|1|||
33567779|NCT04256941|101974787|FG001|Overall Study|Death|0|||
33567780|NCT04256941|101974786|FG000|Overall Study|Disease Progession|0|||
33567781|NCT04256941|101974787|FG001|Overall Study|Disease Progession|2|||
33567782|NCT02325154|101974790|FG000|Overall Study|Physician Decision|1|||
33567783|NCT04083235|101974791|FG000|Overall Study|Death|252|||
33567784|NCT04083235|101974792|FG001|Overall Study|Death|277|||
33567785|NCT04083235|101974791|FG000|Overall Study|Withdrawal by Subject|13|||
33567786|NCT04083235|101974792|FG001|Overall Study|Withdrawal by Subject|17|||
33567787|NCT04083235|101974791|FG000|Overall Study|Lost to Follow-up|1|||
33567788|NCT04083235|101974792|FG001|Overall Study|Lost to Follow-up|1|||
33567789|NCT04083235|101974791|FG000|Overall Study|Does not meet entry criteria|1|||
33567790|NCT04083235|101974792|FG001|Overall Study|Does not meet entry criteria|0|||
33567791|NCT04083235|101974791|FG000|Overall Study|Did not receive treatment|13|||
33567792|NCT04083235|101974792|FG001|Overall Study|Did not receive treatment|8|||
33567793|NCT04083235|101974791|FG000|Overall Study|Ongoing at the time of DCO|44|||
33567794|NCT04083235|101974792|FG001|Overall Study|Ongoing at the time of DCO|7|||
33567795|NCT02023866|101974793|FG000|Overall Study|Non-compliance|2|||
33567796|NCT02023866|101974793|FG000|Overall Study|Adverse Event|3|||
33567797|NCT02023866|101974793|FG000|Overall Study|Withdrawal by Subject|1|||
33567798|NCT04802967|101974794|FG000|Part B|Withdrawal by Subject|0|||
33567799|NCT04802967|101974795|FG001|Part B|Withdrawal by Subject|0|||
33567800|NCT04802967|101974796|FG002|Part B|Withdrawal by Subject|0|||
33567801|NCT04802967|101974797|FG003|Part B|Withdrawal by Subject|0|||
33567802|NCT04802967|101974798|FG004|Part B|Withdrawal by Subject|0|||
33567803|NCT04802967|101974799|FG005|Part B|Withdrawal by Subject|1|||
33567804|NCT04802967|101974800|FG006|Part B|Withdrawal by Subject|0|||
33567805|NCT04802967|101974801|FG007|Part B|Withdrawal by Subject|0|||
33567806|NCT04802967|101974802|FG008|Part B|Withdrawal by Subject|0|||
33567807|NCT04802967|101974803|FG009|Part B|Withdrawal by Subject|0|||
33567808|NCT04150718|101974804|FG000|Overall Study|Withdrawal by Subject|2|||
33567809|NCT04150718|101974805|FG001|Overall Study|Withdrawal by Subject|7|||
33567810|NCT04150718|101974806|FG002|Overall Study|Withdrawal by Subject|1|||
33567811|NCT04150718|101974804|FG000|Overall Study|Lost to Follow-up|1|||
33567812|NCT04150718|101974805|FG001|Overall Study|Lost to Follow-up|2|||
33567813|NCT04150718|101974806|FG002|Overall Study|Lost to Follow-up|0|||
33567814|NCT04150718|101974804|FG000|Overall Study|Ineligible|1|||
33567815|NCT04150718|101974805|FG001|Overall Study|Ineligible|0|||
33567816|NCT04150718|101974806|FG002|Overall Study|Ineligible|10|||
33567817|NCT01784068|101974807|FG000|NTCS Phase|Adverse Event|5|||
33567818|NCT01784068|101974808|FG001|NTCS Phase|Adverse Event|0|||
33567819|NCT01784068|101974807|FG000|NTCS Phase|Physician Decision|2|||
33567820|NCT01784068|101974808|FG001|NTCS Phase|Physician Decision|0|||
33567821|NCT01784068|101974807|FG000|NTCS Phase|Patient/guardian decision|3|||
33567822|NCT01784068|101974808|FG001|NTCS Phase|Patient/guardian decision|0|||
33567823|NCT01784068|101974807|FG000|NTCS Phase|Death|2|||
33567824|NCT01784068|101974808|FG001|NTCS Phase|Death|0|||
33224421|NCT05044325|100721812|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
33224422|NCT05044325|100721813|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
33417278|NCT05004181|101420259|FG009|Overall Study|Withdrawal of consent|2|||
33224423|NCT05044325|100721814|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
33224424|NCT05044325|100721815|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
33224425|NCT05044325|100721816|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
33224426|NCT05044325|100721817|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
33224427|NCT05044325|100721818|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
33224428|NCT05044325|100721819|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
33224429|NCT05044325|100721820|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
33224430|NCT00709059|100721821|FG000|Overall Study|Lost to Follow-up|34|||
33224431|NCT00709059|100721821|FG000|Overall Study|Withdrawal by Subject|19|||
33224432|NCT00709059|100721821|FG000|Overall Study|Physician Decision|7|||
33224433|NCT00709059|100721821|FG000|Overall Study|Disease complication|3|||
33224434|NCT00709059|100721821|FG000|Overall Study|Side effects|20|||
33224435|NCT00709059|100721821|FG000|Overall Study|Serious side effects|11|||
33417279|NCT05004181|101420260|FG010|Overall Study|Withdrawal of consent|5|||
33567825|NCT01784068|101974807|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
33567826|NCT01784068|101974808|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
33567827|NCT01784068|101974807|FG000|TFR Phase|Physician Decision|0|||
33567828|NCT01784068|101974808|FG001|TFR Phase|Physician Decision|1|||
33567829|NCT01784068|101974807|FG000|TFR Phase|Patient/guardian decision|0|||
33567830|NCT01784068|101974808|FG001|TFR Phase|Patient/guardian decision|3|||
33567831|NCT01784068|101974807|FG000|TFR Phase|Death|0|||
33567832|NCT01784068|101974808|FG001|TFR Phase|Death|1|||
33567833|NCT01784068|101974807|FG000|TFR Phase|Lack of Efficacy|0|||
33567834|NCT01784068|101974808|FG001|TFR Phase|Lack of Efficacy|88|||
33567835|NCT02965716|101974809|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
33567836|NCT02965716|101974810|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
33567837|NCT02965716|101974809|FG000|Overall Study|Progression/Relapse|8|||
33567838|NCT02965716|101974810|FG001|Overall Study|Progression/Relapse|16|||
33567839|NCT02965716|101974809|FG000|Overall Study|Death|1|||
33567840|NCT02965716|101974810|FG001|Overall Study|Death|0|||
33567841|NCT02965716|101974809|FG000|Overall Study|Not Protocol Specified|1|||
33567842|NCT02965716|101974810|FG001|Overall Study|Not Protocol Specified|3|||
33567843|NCT03090152|101974812|FG000|Overall Study|Withdrawal by Subject|0|||
33567844|NCT03090152|101974813|FG001|Overall Study|Withdrawal by Subject|2|||
33567845|NCT03090152|101974814|FG002|Overall Study|Withdrawal by Subject|1|||
33567846|NCT03090152|101974812|FG000|Overall Study|Surgery Canceled|1|||
33567847|NCT03090152|101974813|FG001|Overall Study|Surgery Canceled|0|||
33567848|NCT03090152|101974814|FG002|Overall Study|Surgery Canceled|0|||
33567849|NCT03090152|101974812|FG000|Overall Study|Epidural catheter could not be placed|0|||
33567850|NCT03090152|101974813|FG001|Overall Study|Epidural catheter could not be placed|2|||
33567851|NCT03090152|101974814|FG002|Overall Study|Epidural catheter could not be placed|0|||
33567852|NCT00408005|101974816|FG000|Induction|Adverse Event|19|||
33567853|NCT00408005|101974817|FG001|Induction|Adverse Event|3|||
33567854|NCT00408005|101974818|FG002|Induction|Adverse Event|0|||
33567855|NCT00408005|101974819|FG003|Induction|Adverse Event|0|||
33567856|NCT00408005|101974820|FG004|Induction|Adverse Event|0|||
33567857|NCT00408005|101974821|FG005|Induction|Adverse Event|0|||
33567858|NCT00408005|101974822|FG006|Induction|Adverse Event|0|||
33567859|NCT00408005|101974823|FG007|Induction|Adverse Event|0|||
33567860|NCT00408005|101974816|FG000|Induction|Death|6|||
33567861|NCT00408005|101974817|FG001|Induction|Death|0|||
33567862|NCT00408005|101974818|FG002|Induction|Death|0|||
33567863|NCT00408005|101974819|FG003|Induction|Death|0|||
33567864|NCT00408005|101974820|FG004|Induction|Death|0|||
33567865|NCT00408005|101974821|FG005|Induction|Death|0|||
33567866|NCT00408005|101974822|FG006|Induction|Death|0|||
33567867|NCT00408005|101974823|FG007|Induction|Death|0|||
33567868|NCT00408005|101974816|FG000|Induction|Physician Decision|83|||
33567869|NCT00408005|101974817|FG001|Induction|Physician Decision|9|||
33567870|NCT00408005|101974818|FG002|Induction|Physician Decision|0|||
33567871|NCT00408005|101974819|FG003|Induction|Physician Decision|0|||
33567872|NCT00408005|101974820|FG004|Induction|Physician Decision|0|||
33567873|NCT00408005|101974821|FG005|Induction|Physician Decision|0|||
33567874|NCT00408005|101974822|FG006|Induction|Physician Decision|0|||
33567875|NCT00408005|101974823|FG007|Induction|Physician Decision|0|||
33567876|NCT00408005|101974816|FG000|Induction|Withdrawal by Subject|2|||
33567877|NCT00408005|101974817|FG001|Induction|Withdrawal by Subject|4|||
33567878|NCT00408005|101974818|FG002|Induction|Withdrawal by Subject|0|||
33567879|NCT00408005|101974819|FG003|Induction|Withdrawal by Subject|0|||
33567880|NCT00408005|101974820|FG004|Induction|Withdrawal by Subject|0|||
33567881|NCT00408005|101974821|FG005|Induction|Withdrawal by Subject|0|||
33567882|NCT00408005|101974822|FG006|Induction|Withdrawal by Subject|0|||
33417280|NCT05004181|101420261|FG011|Overall Study|Withdrawal of consent|1|||
33417281|NCT05004181|101420250|FG000|Overall Study|Lost to Follow-up|2|||
33417282|NCT05004181|101420251|FG001|Overall Study|Lost to Follow-up|4|||
33567883|NCT00408005|101974823|FG007|Induction|Withdrawal by Subject|0|||
33567884|NCT00408005|101974816|FG000|Induction|Ineligible|33|||
33567885|NCT00408005|101974817|FG001|Induction|Ineligible|14|||
33567886|NCT00408005|101974818|FG002|Induction|Ineligible|0|||
33364972|NCT04760314|101223691|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33364973|NCT04760314|101223692|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
33364974|NCT04760314|101223693|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33364975|NCT04760314|101223694|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
33364976|NCT04760314|101223695|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
33364977|NCT04760314|101223696|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33417283|NCT05004181|101420252|FG002|Overall Study|Lost to Follow-up|2|||
33567887|NCT00408005|101974819|FG003|Induction|Ineligible|0|||
33567888|NCT00408005|101974820|FG004|Induction|Ineligible|0|||
33567889|NCT00408005|101974821|FG005|Induction|Ineligible|0|||
33567890|NCT00408005|101974822|FG006|Induction|Ineligible|0|||
33567891|NCT00408005|101974823|FG007|Induction|Ineligible|0|||
33567892|NCT00408005|101974816|FG000|Induction|Refusal of Further Protocol Therapy|225|||
33567893|NCT00408005|101974817|FG001|Induction|Refusal of Further Protocol Therapy|44|||
33567894|NCT00408005|101974818|FG002|Induction|Refusal of Further Protocol Therapy|0|||
33224436|NCT03303469|100721824|FG000|Overall Study|Lost to Follow-up|2|||
33224437|NCT03704584|100721825|FG000|Overall Study|Withdrawal by Subject|1|||
33224438|NCT03704584|100721826|FG001|Overall Study|Withdrawal by Subject|0|||
33224439|NCT01352585|100721827|FG000|Overall Study|Adverse Event|2|||
33224440|NCT01352585|100721828|FG001|Overall Study|Adverse Event|1|||
33224441|NCT01352585|100721827|FG000|Overall Study|Lost to Follow-up|1|||
33224442|NCT01352585|100721828|FG001|Overall Study|Lost to Follow-up|0|||
33224443|NCT01352585|100721827|FG000|Overall Study|Other|5|||
33224444|NCT01352585|100721828|FG001|Overall Study|Other|2|||
33224445|NCT02002884|100721831|FG000|Main Period (MP)|Other|0|||
33224446|NCT02002884|100721832|FG001|Main Period (MP)|Other|3|||
33224447|NCT02002884|100721833|FG002|Main Period (MP)|Other|3|||
33224448|NCT02002884|100721834|FG003|Main Period (MP)|Other|0|||
33224449|NCT02002884|100721831|FG000|Main Period (MP)|Adverse Event|0|||
33224450|NCT02002884|100721832|FG001|Main Period (MP)|Adverse Event|1|||
33224451|NCT02002884|100721833|FG002|Main Period (MP)|Adverse Event|1|||
33224452|NCT02002884|100721834|FG003|Main Period (MP)|Adverse Event|0|||
33224453|NCT02002884|100721831|FG000|Main Period (MP)|Withdrawal by Subject|6|||
33224454|NCT02002884|100721832|FG001|Main Period (MP)|Withdrawal by Subject|2|||
33224455|NCT02002884|100721833|FG002|Main Period (MP)|Withdrawal by Subject|2|||
33224456|NCT02002884|100721834|FG003|Main Period (MP)|Withdrawal by Subject|0|||
33567895|NCT00408005|101974819|FG003|Induction|Refusal of Further Protocol Therapy|0|||
33567896|NCT00408005|101974820|FG004|Induction|Refusal of Further Protocol Therapy|0|||
33567897|NCT00408005|101974821|FG005|Induction|Refusal of Further Protocol Therapy|0|||
33567898|NCT00408005|101974822|FG006|Induction|Refusal of Further Protocol Therapy|0|||
33567899|NCT00408005|101974823|FG007|Induction|Refusal of Further Protocol Therapy|0|||
33567900|NCT00408005|101974816|FG000|Induction|Entered another COG therapeutic protocol|4|||
33567901|NCT00408005|101974817|FG001|Induction|Entered another COG therapeutic protocol|0|||
33567902|NCT00408005|101974818|FG002|Induction|Entered another COG therapeutic protocol|0|||
33567903|NCT00408005|101974819|FG003|Induction|Entered another COG therapeutic protocol|0|||
33567904|NCT00408005|101974820|FG004|Induction|Entered another COG therapeutic protocol|0|||
33567905|NCT00408005|101974821|FG005|Induction|Entered another COG therapeutic protocol|0|||
33567906|NCT00408005|101974822|FG006|Induction|Entered another COG therapeutic protocol|0|||
33567907|NCT00408005|101974823|FG007|Induction|Entered another COG therapeutic protocol|0|||
33567908|NCT00408005|101974816|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
33567909|NCT00408005|101974817|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
33567910|NCT00408005|101974818|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
33567911|NCT00408005|101974819|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
33567912|NCT00408005|101974820|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
33567913|NCT00408005|101974821|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
33567914|NCT00408005|101974822|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
33567915|NCT00408005|101974823|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
33567916|NCT00408005|101974816|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
33567917|NCT00408005|101974817|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
33567918|NCT00408005|101974818|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
33567919|NCT00408005|101974819|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
33567920|NCT00408005|101974820|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
33567921|NCT00408005|101974821|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
33567922|NCT00408005|101974822|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
33567923|NCT00408005|101974823|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
33567924|NCT00408005|101974816|FG000|Induction|Progressive Disease|0|||
33567925|NCT00408005|101974817|FG001|Induction|Progressive Disease|1|||
33567926|NCT00408005|101974818|FG002|Induction|Progressive Disease|0|||
33567927|NCT00408005|101974819|FG003|Induction|Progressive Disease|0|||
33567928|NCT00408005|101974820|FG004|Induction|Progressive Disease|0|||
33567929|NCT00408005|101974821|FG005|Induction|Progressive Disease|0|||
33224457|NCT02002884|100721831|FG000|Main Period (MP)|Lost to Follow-up|0|||
33567930|NCT00408005|101974822|FG006|Induction|Progressive Disease|0|||
33567931|NCT00408005|101974823|FG007|Induction|Progressive Disease|0|||
33567932|NCT00408005|101974816|FG000|Induction|Inevaluable|18|||
33567933|NCT00408005|101974817|FG001|Induction|Inevaluable|14|||
33567934|NCT00408005|101974818|FG002|Induction|Inevaluable|0|||
33567935|NCT00408005|101974819|FG003|Induction|Inevaluable|0|||
33567936|NCT00408005|101974820|FG004|Induction|Inevaluable|0|||
33567937|NCT00408005|101974821|FG005|Induction|Inevaluable|0|||
33224458|NCT02002884|100721832|FG001|Main Period (MP)|Lost to Follow-up|0|||
33224459|NCT02002884|100721833|FG002|Main Period (MP)|Lost to Follow-up|2|||
33224460|NCT02002884|100721834|FG003|Main Period (MP)|Lost to Follow-up|0|||
33224461|NCT02002884|100721831|FG000|Open-Label Extension Period (OLEX)|Other|0|||
33224462|NCT02002884|100721832|FG001|Open-Label Extension Period (OLEX)|Other|0|||
33567938|NCT00408005|101974822|FG006|Induction|Inevaluable|0|||
33567939|NCT00408005|101974823|FG007|Induction|Inevaluable|0|||
33567940|NCT00408005|101974816|FG000|Induction|Failed to Complete Randomization|3|||
33224463|NCT02002884|100721833|FG002|Open-Label Extension Period (OLEX)|Other|0|||
33224464|NCT02002884|100721834|FG003|Open-Label Extension Period (OLEX)|Other|24|||
33224465|NCT02002884|100721831|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
33224466|NCT02002884|100721832|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
33224467|NCT02002884|100721833|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
33224468|NCT02002884|100721834|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
33224469|NCT02002884|100721831|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
33224470|NCT02002884|100721832|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
33224471|NCT02002884|100721833|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
33224472|NCT02002884|100721834|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
33224473|NCT02002884|100721831|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
33224474|NCT02002884|100721832|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
33224475|NCT02002884|100721833|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
33224476|NCT02002884|100721834|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
33224477|NCT02002884|100721831|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
33224478|NCT02002884|100721832|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
33567941|NCT00408005|101974817|FG001|Induction|Failed to Complete Randomization|2|||
33567942|NCT00408005|101974818|FG002|Induction|Failed to Complete Randomization|0|||
33224479|NCT02002884|100721833|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
33224480|NCT02002884|100721834|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
33224481|NCT02801669|100721836|FG000|Overall Study|Death|66|||
33224482|NCT02801669|100721837|FG001|Overall Study|Death|69|||
33224483|NCT02801669|100721836|FG000|Overall Study|Withdrawal by Subject|81|||
33224484|NCT02801669|100721837|FG001|Overall Study|Withdrawal by Subject|77|||
33224485|NCT02801669|100721836|FG000|Overall Study|Other|4|||
33224486|NCT02801669|100721837|FG001|Overall Study|Other|6|||
33224487|NCT01320943|100721840|FG000|Overall Study|Lost to Follow-up|1|||
33224488|NCT01320943|100721841|FG001|Overall Study|Lost to Follow-up|0|||
33224489|NCT01320943|100721840|FG000|Overall Study|Physician Decision|0|||
33224490|NCT01320943|100721841|FG001|Overall Study|Physician Decision|1|||
33224491|NCT01320943|100721840|FG000|Overall Study|Randomized but not Treated|0|||
33224492|NCT01320943|100721841|FG001|Overall Study|Randomized but not Treated|1|||
33224493|NCT02013388|100721843|FG000|Overall Study|work emergency|1|||
33224494|NCT02013388|100721844|FG001|Overall Study|work emergency|0|||
33224495|NCT02013388|100721845|FG002|Overall Study|work emergency|0|||
33224496|NCT02013388|100721846|FG003|Overall Study|work emergency|0|||
33224497|NCT02013388|100721847|FG004|Overall Study|work emergency|1|||
33224498|NCT02013388|100721848|FG005|Overall Study|work emergency|0|||
33224499|NCT02013388|100721849|FG006|Overall Study|work emergency|0|||
33224500|NCT02013388|100721850|FG007|Overall Study|work emergency|0|||
33224501|NCT02364180|100721851|FG000|Overall Study|Screen Fail|1|||
33224502|NCT04006925|100721852|FG000|Overall Study|Side effects|2|||
33224503|NCT04006925|100721853|FG001|Overall Study|Side effects|0|||
33224504|NCT02110732|100724829|FG000|Overall Study|Physician Decision|5|||
33224505|NCT02110732|100724830|FG001|Overall Study|Physician Decision|2|||
33224506|NCT02110732|100724829|FG000|Overall Study|Lost to Follow-up|1|||
33224507|NCT02110732|100724830|FG001|Overall Study|Lost to Follow-up|1|||
33224508|NCT03012061|100724831|FG000|Overall Study|Withdrawal by Subject|1|||
33224509|NCT03012061|100724832|FG001|Overall Study|Withdrawal by Subject|5|||
33224510|NCT03012061|100724833|FG002|Overall Study|Withdrawal by Subject|4|||
33224511|NCT03012061|100724831|FG000|Overall Study|Investigator Site Closed|1|||
33224512|NCT03012061|100724832|FG001|Overall Study|Investigator Site Closed|2|||
33224513|NCT03012061|100724833|FG002|Overall Study|Investigator Site Closed|0|||
33224514|NCT03012061|100724831|FG000|Overall Study|Lost to Follow-up|2|||
33224515|NCT03012061|100724832|FG001|Overall Study|Lost to Follow-up|1|||
33224516|NCT03012061|100724833|FG002|Overall Study|Lost to Follow-up|0|||
33224517|NCT03012061|100724831|FG000|Overall Study|Study closed/ Terminated|0|||
33567943|NCT00408005|101974819|FG003|Induction|Failed to Complete Randomization|0|||
33567944|NCT00408005|101974820|FG004|Induction|Failed to Complete Randomization|0|||
33567945|NCT00408005|101974821|FG005|Induction|Failed to Complete Randomization|0|||
33567946|NCT00408005|101974822|FG006|Induction|Failed to Complete Randomization|0|||
33567947|NCT00408005|101974823|FG007|Induction|Failed to Complete Randomization|0|||
33567948|NCT00408005|101974816|FG000|Induction|Protocol Deviation|3|||
33567949|NCT00408005|101974817|FG001|Induction|Protocol Deviation|1|||
33567950|NCT00408005|101974818|FG002|Induction|Protocol Deviation|0|||
33567951|NCT00408005|101974819|FG003|Induction|Protocol Deviation|0|||
33567952|NCT00408005|101974820|FG004|Induction|Protocol Deviation|0|||
33567953|NCT00408005|101974821|FG005|Induction|Protocol Deviation|0|||
33567954|NCT00408005|101974822|FG006|Induction|Protocol Deviation|0|||
33224518|NCT03012061|100724832|FG001|Overall Study|Study closed/ Terminated|0|||
33224519|NCT03012061|100724833|FG002|Overall Study|Study closed/ Terminated|1|||
33224520|NCT03012061|100724831|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
33224521|NCT03012061|100724832|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
33224522|NCT03012061|100724833|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
33224523|NCT03012061|100724831|FG000|Overall Study|Protocol Violation|0|||
33224524|NCT03012061|100724832|FG001|Overall Study|Protocol Violation|0|||
33417284|NCT05004181|101420253|FG003|Overall Study|Lost to Follow-up|3|||
33224525|NCT03012061|100724833|FG002|Overall Study|Protocol Violation|2|||
33224526|NCT03012061|100724831|FG000|Overall Study|Lack of Efficacy|0|||
33224527|NCT03012061|100724832|FG001|Overall Study|Lack of Efficacy|1|||
33224528|NCT03012061|100724833|FG002|Overall Study|Lack of Efficacy|0|||
33224529|NCT03012061|100724831|FG000|Overall Study|Adverse Event|2|||
33224530|NCT03012061|100724832|FG001|Overall Study|Adverse Event|0|||
33224531|NCT03012061|100724833|FG002|Overall Study|Adverse Event|0|||
33224532|NCT01871558|100724834|FG000|Overall Study|Other reason|0|||
33224533|NCT01871558|100724835|FG001|Overall Study|Other reason|1|||
33224534|NCT01871558|100724834|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
33224535|NCT01871558|100724835|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
33224536|NCT01871558|100724834|FG000|Overall Study|Withdrawal by Subject|2|||
33224537|NCT01871558|100724835|FG001|Overall Study|Withdrawal by Subject|0|||
33224538|NCT01845974|100724840|FG000|Overall Study|screen failure|1|||
33224539|NCT01845974|100724841|FG001|Overall Study|screen failure|0|||
33224540|NCT01407354|100724844|FG000|First Intervention|Withdrawal by Subject|0|||
33224541|NCT01407354|100724845|FG001|First Intervention|Withdrawal by Subject|2|||
33224542|NCT01407354|100724844|FG000|First Intervention|Adverse Event|1|||
33224543|NCT01407354|100724845|FG001|First Intervention|Adverse Event|0|||
33224544|NCT01407354|100724844|FG000|First Intervention|Physician Decision|1|||
33224545|NCT01407354|100724845|FG001|First Intervention|Physician Decision|0|||
33224546|NCT01781390|100724855|FG000|Overall Study|Withdrawal of Consent|0|||
33224547|NCT01781390|100724856|FG001|Overall Study|Withdrawal of Consent|3|||
33224548|NCT01781390|100724857|FG002|Overall Study|Withdrawal of Consent|1|||
33224549|NCT01781390|100724855|FG000|Overall Study|Lost to Follow-up|1|||
33224550|NCT01781390|100724856|FG001|Overall Study|Lost to Follow-up|1|||
33224551|NCT01781390|100724857|FG002|Overall Study|Lost to Follow-up|1|||
33224552|NCT01781390|100724855|FG000|Overall Study|Adverse Event|1|||
33224553|NCT01781390|100724856|FG001|Overall Study|Adverse Event|2|||
33224554|NCT01781390|100724857|FG002|Overall Study|Adverse Event|1|||
33224555|NCT01781390|100724855|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
33224556|NCT01781390|100724856|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
33224557|NCT01781390|100724857|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
33224558|NCT03713021|100724859|FG000|Overall Study|Did not have CT sim scan available|6|||
33224559|NCT03713021|100724859|FG000|Overall Study|Not eligible|4|||
33224560|NCT03713021|100724859|FG000|Overall Study|Issues with TraceIT markers|5|||
33224561|NCT00576732|100724861|FG000|DOUBLE BLIND|Adverse Event|0|||
33224562|NCT00576732|100724862|FG001|DOUBLE BLIND|Adverse Event|0|||
33224563|NCT00576732|100724863|FG002|DOUBLE BLIND|Adverse Event|1|||
33224564|NCT00576732|100724864|FG003|DOUBLE BLIND|Adverse Event|0|||
33224565|NCT00576732|100724865|FG004|DOUBLE BLIND|Adverse Event|0|||
33224566|NCT00576732|100724866|FG005|DOUBLE BLIND|Adverse Event|0|||
33224567|NCT00576732|100724861|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
33224568|NCT00576732|100724862|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
33224569|NCT00576732|100724863|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
33224570|NCT00576732|100724864|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
33224571|NCT00576732|100724865|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
33224572|NCT00576732|100724866|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
33224573|NCT00576732|100724861|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
33224574|NCT00576732|100724862|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
33224575|NCT00576732|100724863|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
33224576|NCT00576732|100724864|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
33224577|NCT00576732|100724865|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
33417285|NCT05004181|101420254|FG004|Overall Study|Lost to Follow-up|5|||
33417286|NCT05004181|101420255|FG005|Overall Study|Lost to Follow-up|2|||
33417287|NCT05004181|101420256|FG006|Overall Study|Lost to Follow-up|15|||
33417288|NCT05004181|101420257|FG007|Overall Study|Lost to Follow-up|12|||
33417289|NCT05004181|101420258|FG008|Overall Study|Lost to Follow-up|38|||
33417290|NCT05004181|101420259|FG009|Overall Study|Lost to Follow-up|6|||
33417291|NCT05004181|101420260|FG010|Overall Study|Lost to Follow-up|6|||
33417292|NCT05004181|101420261|FG011|Overall Study|Lost to Follow-up|0|||
33417293|NCT05004181|101420250|FG000|Overall Study|Death|0|||
33224578|NCT00576732|100724866|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
33224579|NCT00576732|100724861|FG000|DOUBLE BLIND|OTHER|0|||
33224580|NCT00576732|100724862|FG001|DOUBLE BLIND|OTHER|2|||
33224581|NCT00576732|100724863|FG002|DOUBLE BLIND|OTHER|1|||
33417294|NCT05004181|101420251|FG001|Overall Study|Death|0|||
33417295|NCT05004181|101420252|FG002|Overall Study|Death|0|||
33567955|NCT00408005|101974823|FG007|Induction|Protocol Deviation|0|||
33567956|NCT00408005|101974816|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
33567957|NCT00408005|101974817|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
33567958|NCT00408005|101974818|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
33567959|NCT00408005|101974819|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
33567960|NCT00408005|101974820|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
33224582|NCT00576732|100724864|FG003|DOUBLE BLIND|OTHER|0|||
33224583|NCT00576732|100724865|FG004|DOUBLE BLIND|OTHER|0|||
33364978|NCT04760314|101223697|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33364979|NCT04760314|101223698|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33364980|NCT04760314|101223699|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
33224584|NCT00576732|100724866|FG005|DOUBLE BLIND|OTHER|0|||
33224585|NCT00576732|100724861|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
33224586|NCT00576732|100724862|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
33224587|NCT00576732|100724863|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
33224588|NCT00576732|100724864|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
33224589|NCT00576732|100724865|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
33224590|NCT00576732|100724866|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
33224591|NCT00576732|100724861|FG000|DOUBLE BLIND|Protocol Violation|1|||
33224592|NCT00576732|100724862|FG001|DOUBLE BLIND|Protocol Violation|0|||
33224593|NCT00576732|100724863|FG002|DOUBLE BLIND|Protocol Violation|0|||
33224594|NCT00576732|100724864|FG003|DOUBLE BLIND|Protocol Violation|0|||
33224595|NCT00576732|100724865|FG004|DOUBLE BLIND|Protocol Violation|0|||
33224596|NCT00576732|100724866|FG005|DOUBLE BLIND|Protocol Violation|0|||
33224597|NCT00576732|100724861|FG000|OPEN LABEL|Adverse Event|0|||
33224598|NCT00576732|100724862|FG001|OPEN LABEL|Adverse Event|0|||
33224599|NCT00576732|100724863|FG002|OPEN LABEL|Adverse Event|0|||
33224600|NCT00576732|100724864|FG003|OPEN LABEL|Adverse Event|4|||
33224601|NCT00576732|100724865|FG004|OPEN LABEL|Adverse Event|0|||
33224602|NCT00576732|100724866|FG005|OPEN LABEL|Adverse Event|1|||
33224603|NCT00576732|100724861|FG000|OPEN LABEL|Lost to Follow-up|0|||
33224604|NCT00576732|100724862|FG001|OPEN LABEL|Lost to Follow-up|0|||
33364981|NCT04760314|101223689|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33364982|NCT04760314|101223690|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33364983|NCT04760314|101223691|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33364984|NCT04760314|101223692|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33364985|NCT04760314|101223693|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
33364986|NCT04760314|101223694|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33364987|NCT04760314|101223695|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33364988|NCT04760314|101223696|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33364989|NCT04760314|101223697|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33364990|NCT04760314|101223698|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33364991|NCT04760314|101223699|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
33364992|NCT04760314|101223689|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
33364993|NCT04760314|101223690|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
33364994|NCT04760314|101223691|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
33364995|NCT04760314|101223692|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
33364996|NCT04760314|101223693|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
33364997|NCT04760314|101223694|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
33364998|NCT04760314|101223695|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
33364999|NCT04760314|101223696|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
33365000|NCT04760314|101223697|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
33365001|NCT04760314|101223698|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
33365002|NCT04760314|101223699|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
33365003|NCT04760314|101223689|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33365004|NCT04760314|101223690|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33365005|NCT04760314|101223691|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33365006|NCT04760314|101223692|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33365007|NCT04760314|101223693|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33417296|NCT05004181|101420253|FG003|Overall Study|Death|0|||
33417297|NCT05004181|101420254|FG004|Overall Study|Death|0|||
33567961|NCT00408005|101974821|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
33567962|NCT00408005|101974822|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
33365008|NCT04760314|101223694|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33365009|NCT04760314|101223695|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33417298|NCT05004181|101420255|FG005|Overall Study|Death|0|||
33567963|NCT00408005|101974823|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
33567964|NCT00408005|101974816|FG000|Induction|Recurrent leukemia|1|||
33224605|NCT00576732|100724863|FG002|OPEN LABEL|Lost to Follow-up|0|||
33224606|NCT00576732|100724864|FG003|OPEN LABEL|Lost to Follow-up|2|||
33224607|NCT00576732|100724865|FG004|OPEN LABEL|Lost to Follow-up|1|||
33224608|NCT00576732|100724866|FG005|OPEN LABEL|Lost to Follow-up|1|||
33224609|NCT00576732|100724861|FG000|OPEN LABEL|Withdrawal by Subject|0|||
33224610|NCT00576732|100724862|FG001|OPEN LABEL|Withdrawal by Subject|0|||
33224611|NCT00576732|100724863|FG002|OPEN LABEL|Withdrawal by Subject|0|||
33224612|NCT00576732|100724864|FG003|OPEN LABEL|Withdrawal by Subject|1|||
33567965|NCT00408005|101974817|FG001|Induction|Recurrent leukemia|0|||
33567966|NCT00408005|101974818|FG002|Induction|Recurrent leukemia|0|||
33567967|NCT00408005|101974819|FG003|Induction|Recurrent leukemia|0|||
33567968|NCT00408005|101974820|FG004|Induction|Recurrent leukemia|0|||
33567969|NCT00408005|101974821|FG005|Induction|Recurrent leukemia|0|||
33567970|NCT00408005|101974822|FG006|Induction|Recurrent leukemia|0|||
33567971|NCT00408005|101974823|FG007|Induction|Recurrent leukemia|0|||
33567972|NCT00408005|101974816|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
33567973|NCT00408005|101974817|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
33567974|NCT00408005|101974818|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
33567975|NCT00408005|101974819|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
33567976|NCT00408005|101974820|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
33224613|NCT00576732|100724865|FG004|OPEN LABEL|Withdrawal by Subject|0|||
33224614|NCT00576732|100724866|FG005|OPEN LABEL|Withdrawal by Subject|1|||
33224615|NCT00576732|100724861|FG000|OPEN LABEL|OTHER|0|||
33224616|NCT00576732|100724862|FG001|OPEN LABEL|OTHER|0|||
33224617|NCT00576732|100724863|FG002|OPEN LABEL|OTHER|0|||
33224618|NCT00576732|100724864|FG003|OPEN LABEL|OTHER|0|||
33224619|NCT00576732|100724865|FG004|OPEN LABEL|OTHER|0|||
33224620|NCT00576732|100724866|FG005|OPEN LABEL|OTHER|2|||
33224621|NCT00576732|100724861|FG000|OPEN LABEL|Lack of Efficacy|0|||
33224622|NCT00576732|100724862|FG001|OPEN LABEL|Lack of Efficacy|0|||
33224623|NCT00576732|100724863|FG002|OPEN LABEL|Lack of Efficacy|0|||
33224624|NCT00576732|100724864|FG003|OPEN LABEL|Lack of Efficacy|2|||
33224625|NCT00576732|100724865|FG004|OPEN LABEL|Lack of Efficacy|2|||
33224626|NCT00576732|100724866|FG005|OPEN LABEL|Lack of Efficacy|3|||
33224627|NCT00576732|100724861|FG000|OPEN LABEL|Protocol Violation|0|||
33224628|NCT00576732|100724862|FG001|OPEN LABEL|Protocol Violation|0|||
33224629|NCT00576732|100724863|FG002|OPEN LABEL|Protocol Violation|0|||
33224630|NCT00576732|100724864|FG003|OPEN LABEL|Protocol Violation|2|||
33224631|NCT00576732|100724865|FG004|OPEN LABEL|Protocol Violation|1|||
33224632|NCT00576732|100724866|FG005|OPEN LABEL|Protocol Violation|0|||
33224633|NCT02696902|100724867|FG000|Overall Study|Lost to Follow-up|0|||
33224634|NCT02696902|100724868|FG001|Overall Study|Lost to Follow-up|1|||
33224635|NCT02696902|100724869|FG002|Overall Study|Lost to Follow-up|1|||
33224636|NCT02696902|100724867|FG000|Overall Study|Withdrawal by Subject|0|||
33224637|NCT02696902|100724868|FG001|Overall Study|Withdrawal by Subject|0|||
33224638|NCT02696902|100724869|FG002|Overall Study|Withdrawal by Subject|1|||
33224639|NCT02696902|100724867|FG000|Overall Study|Death|19|||
33365010|NCT04760314|101223696|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
33365011|NCT04760314|101223697|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33365012|NCT04760314|101223698|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
33365013|NCT04760314|101223699|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
33365014|NCT04760314|101223689|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33365015|NCT04760314|101223690|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33365016|NCT04760314|101223691|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33365017|NCT04760314|101223692|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33365018|NCT04760314|101223693|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33365019|NCT04760314|101223694|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33365020|NCT04760314|101223695|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33365021|NCT04760314|101223696|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
33365022|NCT04760314|101223697|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
33365023|NCT04760314|101223698|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
33365024|NCT04760314|101223699|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33365025|NCT04760314|101223689|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33365026|NCT04760314|101223690|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33365027|NCT04760314|101223691|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33365028|NCT04760314|101223692|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33365029|NCT04760314|101223693|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33365030|NCT04760314|101223694|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33365031|NCT04760314|101223695|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33365032|NCT04760314|101223696|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
33365033|NCT04760314|101223697|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33365034|NCT04760314|101223698|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33365035|NCT04760314|101223699|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33365036|NCT04760314|101223689|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
33365037|NCT04760314|101223690|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
33365038|NCT04760314|101223691|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
33567977|NCT00408005|101974821|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
33224640|NCT02696902|100724868|FG001|Overall Study|Death|3|||
33224641|NCT02696902|100724869|FG002|Overall Study|Death|24|||
33224642|NCT02696902|100724867|FG000|Overall Study|Participant not fit post-randomization|0|||
33224643|NCT02696902|100724868|FG001|Overall Study|Participant not fit post-randomization|0|||
33417299|NCT05004181|101420256|FG006|Overall Study|Death|1|||
33417300|NCT05004181|101420257|FG007|Overall Study|Death|0|||
33417301|NCT05004181|101420258|FG008|Overall Study|Death|2|||
33417302|NCT05004181|101420259|FG009|Overall Study|Death|0|||
33417303|NCT05004181|101420260|FG010|Overall Study|Death|0|||
33417304|NCT05004181|101420261|FG011|Overall Study|Death|0|||
33417305|NCT05004181|101420250|FG000|Overall Study|Physician Decision|0|||
33417306|NCT05004181|101420251|FG001|Overall Study|Physician Decision|0|||
33417307|NCT05004181|101420252|FG002|Overall Study|Physician Decision|0|||
33417308|NCT05004181|101420253|FG003|Overall Study|Physician Decision|0|||
33567978|NCT00408005|101974822|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
33567979|NCT00408005|101974823|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
33567980|NCT00408005|101974816|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
33567981|NCT00408005|101974817|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
33567982|NCT00408005|101974818|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
33224644|NCT02696902|100724869|FG002|Overall Study|Participant not fit post-randomization|1|||
33224645|NCT02696902|100724867|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
33567983|NCT00408005|101974819|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
33567984|NCT00408005|101974820|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
33567985|NCT00408005|101974821|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
33567986|NCT00408005|101974822|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
33567987|NCT00408005|101974823|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
33567988|NCT00408005|101974816|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
33567989|NCT00408005|101974817|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
33567990|NCT00408005|101974818|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
33567991|NCT00408005|101974819|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
33567992|NCT00408005|101974820|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
33567993|NCT00408005|101974821|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
33567994|NCT00408005|101974822|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
33567995|NCT00408005|101974823|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
33567996|NCT00408005|101974816|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
33567997|NCT00408005|101974817|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
33567998|NCT00408005|101974818|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
33567999|NCT00408005|101974819|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
33568000|NCT00408005|101974820|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
33568001|NCT00408005|101974821|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
33568002|NCT00408005|101974822|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
33568003|NCT00408005|101974823|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
33568004|NCT00408005|101974816|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
33568005|NCT00408005|101974817|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
33568006|NCT00408005|101974818|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
33568007|NCT00408005|101974819|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
33568008|NCT00408005|101974820|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
33568009|NCT00408005|101974821|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
33568010|NCT00408005|101974822|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
33568011|NCT00408005|101974823|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
33568012|NCT00408005|101974816|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
33568013|NCT00408005|101974817|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
33568014|NCT00408005|101974818|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
33568015|NCT00408005|101974819|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
33568016|NCT00408005|101974820|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
33568017|NCT00408005|101974821|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
33568018|NCT00408005|101974822|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
33224646|NCT02696902|100724868|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
33224647|NCT02696902|100724869|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
33224648|NCT02696902|100724867|FG000|Overall Study|Principal investigator's decision|1|||
33224649|NCT02696902|100724868|FG001|Overall Study|Principal investigator's decision|0|||
33224650|NCT02696902|100724869|FG002|Overall Study|Principal investigator's decision|0|||
33417309|NCT05004181|101420254|FG004|Overall Study|Physician Decision|0|||
33417310|NCT05004181|101420255|FG005|Overall Study|Physician Decision|0|||
33224651|NCT02696902|100724867|FG000|Overall Study|Sponsor's decision|1|||
33417311|NCT05004181|101420256|FG006|Overall Study|Physician Decision|2|||
33417312|NCT05004181|101420257|FG007|Overall Study|Physician Decision|0|||
33417313|NCT05004181|101420258|FG008|Overall Study|Physician Decision|7|||
33417314|NCT05004181|101420259|FG009|Overall Study|Physician Decision|0|||
33568019|NCT00408005|101974823|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
33568020|NCT00408005|101974816|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
33224652|NCT02696902|100724868|FG001|Overall Study|Sponsor's decision|0|||
33365039|NCT04760314|101223692|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
33365040|NCT04760314|101223693|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
33365041|NCT04760314|101223694|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
33631316|NCT02177123|102202924|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
33224653|NCT02696902|100724869|FG002|Overall Study|Sponsor's decision|0|||
33224654|NCT02696902|100724867|FG000|Overall Study|Transferred to other hospital|1|||
33224655|NCT02696902|100724868|FG001|Overall Study|Transferred to other hospital|0|||
33224656|NCT02696902|100724869|FG002|Overall Study|Transferred to other hospital|0|||
33365042|NCT04760314|101223695|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
33365043|NCT04760314|101223696|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
33365044|NCT04760314|101223697|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
33365045|NCT04760314|101223698|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
33365046|NCT04760314|101223699|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
33365047|NCT00592358|101223700|FG000|Overall Study|Withdrawal by Subject|2|||
33365048|NCT00592358|101223700|FG000|Overall Study|Adverse Event|1|||
33365049|NCT00592358|101223700|FG000|Overall Study|Lack of Efficacy|2|||
33365050|NCT00592358|101223700|FG000|Overall Study|Inability to swallow pills|1|||
33365051|NCT01486316|101223701|FG000|Overall Study|Device explanted with/without re-implant|3|||
33365052|NCT01486316|101223702|FG001|Overall Study|Device explanted with/without re-implant|2|||
33365053|NCT01486316|101223703|FG002|Overall Study|Device explanted with/without re-implant|0|||
33365054|NCT01486316|101223704|FG003|Overall Study|Device explanted with/without re-implant|2|||
33568021|NCT00408005|101974817|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
33568022|NCT00408005|101974818|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
33568023|NCT00408005|101974819|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
33568024|NCT00408005|101974820|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
33568025|NCT00408005|101974821|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
33568026|NCT00408005|101974822|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
33568027|NCT00408005|101974823|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
33568028|NCT00408005|101974816|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
33568029|NCT00408005|101974817|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
33568030|NCT00408005|101974818|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
33568031|NCT00408005|101974819|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
33568032|NCT00408005|101974820|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
33568033|NCT00408005|101974821|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
33568034|NCT00408005|101974822|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
33568035|NCT00408005|101974823|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
33568036|NCT00408005|101974816|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
33568037|NCT00408005|101974817|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
33568038|NCT00408005|101974818|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
33568039|NCT00408005|101974819|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
33568040|NCT00408005|101974820|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
33568041|NCT00408005|101974821|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
33568042|NCT00408005|101974822|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
33568043|NCT00408005|101974823|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
33568044|NCT00408005|101974816|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
33365055|NCT01486316|101223701|FG000|Overall Study|Not meeting eligibility criteria|0|||
33365056|NCT01486316|101223702|FG001|Overall Study|Not meeting eligibility criteria|0|||
33365057|NCT01486316|101223703|FG002|Overall Study|Not meeting eligibility criteria|1|||
33365058|NCT01486316|101223704|FG003|Overall Study|Not meeting eligibility criteria|0|||
33365059|NCT01486316|101223701|FG000|Overall Study|Withdrawal by Subject|1|||
33365060|NCT01486316|101223702|FG001|Overall Study|Withdrawal by Subject|0|||
33365061|NCT01486316|101223703|FG002|Overall Study|Withdrawal by Subject|3|||
33365062|NCT01486316|101223704|FG003|Overall Study|Withdrawal by Subject|0|||
33365063|NCT01486316|101223701|FG000|Overall Study|Physician Decision|0|||
33365064|NCT01486316|101223702|FG001|Overall Study|Physician Decision|0|||
33365065|NCT01486316|101223703|FG002|Overall Study|Physician Decision|1|||
33365066|NCT01486316|101223704|FG003|Overall Study|Physician Decision|0|||
33365067|NCT01486316|101223701|FG000|Overall Study|Death|0|||
33365068|NCT01486316|101223702|FG001|Overall Study|Death|1|||
33365069|NCT01486316|101223703|FG002|Overall Study|Death|0|||
33365070|NCT01486316|101223704|FG003|Overall Study|Death|0|||
33365071|NCT02874794|101223712|FG000|Overall Study|Physician Decision|3|||
33365072|NCT02874794|101223713|FG001|Overall Study|Physician Decision|2|||
33365073|NCT02874794|101223712|FG000|Overall Study|Withdrawal by Subject|2|||
33365074|NCT02874794|101223713|FG001|Overall Study|Withdrawal by Subject|8|||
33365075|NCT02874794|101223712|FG000|Overall Study|Death|2|||
33365076|NCT02874794|101223713|FG001|Overall Study|Death|1|||
33365077|NCT01751646|101223714|FG000|Overall Study|Lost to Follow-up|5|||
33365078|NCT01751646|101223715|FG001|Overall Study|Lost to Follow-up|1|||
33365079|NCT01751646|101223714|FG000|Overall Study|Withdrawal by Subject|0|||
33365080|NCT01751646|101223715|FG001|Overall Study|Withdrawal by Subject|4|||
33568045|NCT00408005|101974817|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
33568046|NCT00408005|101974818|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
33568047|NCT00408005|101974819|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
33568048|NCT00408005|101974820|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
33568049|NCT00408005|101974821|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
33568050|NCT00408005|101974822|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
33568051|NCT00408005|101974823|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
33568052|NCT00408005|101974816|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
33568053|NCT00408005|101974817|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
33568054|NCT00408005|101974818|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
33568055|NCT00408005|101974819|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
33568056|NCT00408005|101974820|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
33568057|NCT00408005|101974821|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
33568058|NCT00408005|101974822|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
33568059|NCT00408005|101974823|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
33568060|NCT00408005|101974816|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
33568061|NCT00408005|101974817|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
33568062|NCT00408005|101974818|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
33568063|NCT00408005|101974819|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
33568064|NCT00408005|101974820|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
33568065|NCT00408005|101974821|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
33568066|NCT00408005|101974822|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
33568067|NCT00408005|101974823|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
33568068|NCT00408005|101974816|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
33568069|NCT00408005|101974817|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
33568070|NCT00408005|101974818|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
33568071|NCT00408005|101974819|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
33568072|NCT00408005|101974820|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
33568073|NCT00408005|101974821|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
33568074|NCT00408005|101974822|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
33568075|NCT00408005|101974823|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
33568076|NCT00408005|101974816|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
33224657|NCT01460160|100724870|FG000|Treatment Phase|Lack of Efficacy|3|||
33224658|NCT01460160|100724870|FG000|Treatment Phase|Study Drug Toxicity|2|||
33417315|NCT05004181|101420260|FG010|Overall Study|Physician Decision|0|||
33568077|NCT00408005|101974817|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
33224659|NCT01460160|100724870|FG000|Treatment Phase|Adverse Event|8|||
33224660|NCT01460160|100724870|FG000|Treatment Phase|Withdrawal by Subject|4|||
33365081|NCT01751646|101223714|FG000|Overall Study|Starting hormone therapy|1|||
33365082|NCT01751646|101223715|FG001|Overall Study|Starting hormone therapy|0|||
33417316|NCT05004181|101420261|FG011|Overall Study|Physician Decision|0|||
33568078|NCT00408005|101974818|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
33568079|NCT00408005|101974819|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
33568080|NCT00408005|101974820|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
33568081|NCT00408005|101974821|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
33568082|NCT00408005|101974822|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
33568083|NCT00408005|101974823|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
33568084|NCT06136897|101974824|FG000|Overall Study|Ineligible|3|||
33568085|NCT06136897|101974824|FG000|Overall Study|Mutation status not confirmed|7|||
33568086|NCT06136897|101974824|FG000|Overall Study|Adverse Event|2|||
33568087|NCT06136897|101974824|FG000|Overall Study|Death|1|||
33568088|NCT06136897|101974824|FG000|Overall Study|Disease progression|18|||
33568089|NCT06136897|101974824|FG000|Overall Study|Other complicating disease|1|||
33224661|NCT01460160|100724870|FG000|Treatment Phase|Death|2|||
33224662|NCT01460160|100724870|FG000|Treatment Phase|Other reasons|9|||
33224663|NCT01460160|100724870|FG000|Follow-up Phase|Withdrawal by Subject|4|||
33224664|NCT01460160|100724870|FG000|Follow-up Phase|Death|14|||
33224665|NCT01460160|100724870|FG000|Follow-up Phase|Lost to Follow-up|7|||
33224666|NCT01460160|100724870|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
33224667|NCT01460160|100724870|FG000|Follow-up Phase|Other and not reported reasons|5|||
33224668|NCT01364922|100724874|FG000|Open-label (OL) Period|Adverse Event|7|||
33224669|NCT01364922|100724875|FG001|Open-label (OL) Period|Adverse Event|0|||
33417317|NCT05004181|101420250|FG000|Overall Study|Withdrawal by Subject|2|||
33417318|NCT05004181|101420251|FG001|Overall Study|Withdrawal by Subject|3|||
33417319|NCT05004181|101420252|FG002|Overall Study|Withdrawal by Subject|2|||
33417320|NCT05004181|101420253|FG003|Overall Study|Withdrawal by Subject|2|||
33417321|NCT05004181|101420254|FG004|Overall Study|Withdrawal by Subject|4|||
33417322|NCT05004181|101420255|FG005|Overall Study|Withdrawal by Subject|2|||
33417323|NCT05004181|101420256|FG006|Overall Study|Withdrawal by Subject|4|||
33417324|NCT05004181|101420257|FG007|Overall Study|Withdrawal by Subject|22|||
33417325|NCT05004181|101420258|FG008|Overall Study|Withdrawal by Subject|8|||
33417326|NCT05004181|101420259|FG009|Overall Study|Withdrawal by Subject|1|||
33417327|NCT05004181|101420260|FG010|Overall Study|Withdrawal by Subject|3|||
33417328|NCT05004181|101420261|FG011|Overall Study|Withdrawal by Subject|2|||
33417329|NCT05004181|101420250|FG000|Overall Study|Protocol Violation|2|||
33417330|NCT05004181|101420251|FG001|Overall Study|Protocol Violation|3|||
33417331|NCT05004181|101420252|FG002|Overall Study|Protocol Violation|0|||
33417332|NCT05004181|101420253|FG003|Overall Study|Protocol Violation|0|||
33417333|NCT05004181|101420254|FG004|Overall Study|Protocol Violation|1|||
33417334|NCT05004181|101420255|FG005|Overall Study|Protocol Violation|0|||
33224670|NCT01364922|100724876|FG002|Open-label (OL) Period|Adverse Event|0|||
33365083|NCT01751646|101223714|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
33365084|NCT01751646|101223715|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
33365085|NCT01751646|101223714|FG000|Overall Study|Inadvertent enrollment|1|||
33417335|NCT05004181|101420256|FG006|Overall Study|Protocol Violation|16|||
33417336|NCT05004181|101420257|FG007|Overall Study|Protocol Violation|18|||
33365086|NCT01751646|101223715|FG001|Overall Study|Inadvertent enrollment|1|||
33365087|NCT01751646|101223714|FG000|Overall Study|Moved out of the area|1|||
33365088|NCT01751646|101223715|FG001|Overall Study|Moved out of the area|5|||
33365089|NCT01751646|101223714|FG000|Overall Study|Inability to attend required visits|0|||
33365090|NCT01751646|101223715|FG001|Overall Study|Inability to attend required visits|1|||
33365091|NCT01751646|101223714|FG000|Overall Study|Off study due to multiple obligations|0|||
33365092|NCT01751646|101223715|FG001|Overall Study|Off study due to multiple obligations|1|||
33365093|NCT01751646|101223714|FG000|Overall Study|Fails to comply with study requirements|0|||
33365094|NCT01751646|101223715|FG001|Overall Study|Fails to comply with study requirements|1|||
33365095|NCT01751646|101223714|FG000|Overall Study|Childcare issues|1|||
33365096|NCT01751646|101223715|FG001|Overall Study|Childcare issues|1|||
33365097|NCT02401256|101223718|FG000|Overall Study|Adverse Event|5|||
33417337|NCT05004181|101420258|FG008|Overall Study|Protocol Violation|2|||
33417338|NCT05004181|101420259|FG009|Overall Study|Protocol Violation|2|||
33417339|NCT05004181|101420260|FG010|Overall Study|Protocol Violation|2|||
33417340|NCT05004181|101420261|FG011|Overall Study|Protocol Violation|1|||
33417341|NCT05004181|101420250|FG000|Overall Study|Not further specified|1|||
33417342|NCT05004181|101420251|FG001|Overall Study|Not further specified|0|||
33365098|NCT02401256|101223718|FG000|Overall Study|Withdrawal by Subject|12|||
33365099|NCT02839746|101223719|FG000|Overall Study|Not met selection criteria|12|||
33365100|NCT03043365|101223721|FG000|Weeks 0 to Week 8|Adverse Event|1|||
33365101|NCT03043365|101223722|FG001|Weeks 0 to Week 8|Adverse Event|3|||
33365102|NCT03043365|101223721|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
33365103|NCT03043365|101223722|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
33365104|NCT03043365|101223721|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
33365105|NCT03043365|101223722|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
33365106|NCT00886821|101223723|FG000|Stage 2|Adverse Event|0|||
33365107|NCT00886821|101223724|FG001|Stage 2|Adverse Event|0|||
33365108|NCT00886821|101223725|FG002|Stage 2|Adverse Event|0|||
33417343|NCT05004181|101420252|FG002|Overall Study|Not further specified|0|||
33417344|NCT05004181|101420253|FG003|Overall Study|Not further specified|0|||
33417345|NCT05004181|101420254|FG004|Overall Study|Not further specified|0|||
33417346|NCT05004181|101420255|FG005|Overall Study|Not further specified|0|||
33417347|NCT05004181|101420256|FG006|Overall Study|Not further specified|1|||
33417348|NCT05004181|101420257|FG007|Overall Study|Not further specified|0|||
33365109|NCT00886821|101223726|FG003|Stage 2|Adverse Event|0|||
33417349|NCT05004181|101420258|FG008|Overall Study|Not further specified|2|||
33417350|NCT05004181|101420259|FG009|Overall Study|Not further specified|1|||
33417351|NCT05004181|101420260|FG010|Overall Study|Not further specified|0|||
33417352|NCT05004181|101420261|FG011|Overall Study|Not further specified|1|||
33417353|NCT03425331|101420262|FG000|Overall Study|Withdrawal by Subject|1|||
33417354|NCT03425331|101420262|FG000|Overall Study|Death|1|||
33417355|NCT03425331|101420262|FG000|Overall Study|Adverse Event|1|||
33417356|NCT03425331|101420262|FG000|Overall Study|Disease Progression|2|||
33417357|NCT01345058|101420263|FG000|Overall Study|Withdrawal by Subject|1|||
33417358|NCT01345058|101420264|FG001|Overall Study|Withdrawal by Subject|0|||
33417359|NCT01345058|101420263|FG000|Overall Study|Participant Reported Increase in Events|1|||
33224671|NCT01364922|100724874|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
33224672|NCT01364922|100724875|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
33224673|NCT01364922|100724876|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
33365110|NCT00886821|101223727|FG004|Stage 2|Adverse Event|0|||
33224674|NCT01364922|100724874|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
33224675|NCT01364922|100724875|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
33224676|NCT01364922|100724876|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
33224677|NCT01364922|100724874|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
33365111|NCT00886821|101223728|FG005|Stage 2|Adverse Event|0|||
33224678|NCT01364922|100724875|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
33224679|NCT01364922|100724876|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
33224680|NCT01364922|100724874|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
33224681|NCT01364922|100724875|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
33224682|NCT01364922|100724876|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
33224683|NCT01364922|100724874|FG000|Open-label (OL) Period|Other, Unspecified|1|||
33224684|NCT01364922|100724875|FG001|Open-label (OL) Period|Other, Unspecified|0|||
33224685|NCT01364922|100724876|FG002|Open-label (OL) Period|Other, Unspecified|0|||
33224686|NCT01364922|100724874|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
33224687|NCT01364922|100724875|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
33224688|NCT01364922|100724876|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
33224689|NCT01364922|100724874|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
33224690|NCT01364922|100724875|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
33224691|NCT01364922|100724876|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
33224692|NCT01364922|100724874|FG000|Double-Blind (DB) Period|Adverse Event|0|||
33224693|NCT01364922|100724875|FG001|Double-Blind (DB) Period|Adverse Event|0|||
33224694|NCT01364922|100724876|FG002|Double-Blind (DB) Period|Adverse Event|1|||
33224695|NCT01364922|100724874|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
33224696|NCT01364922|100724875|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
33224697|NCT01364922|100724876|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
33365112|NCT00886821|101223729|FG006|Stage 2|Adverse Event|0|||
33365113|NCT00886821|101223730|FG007|Stage 2|Adverse Event|0|||
33365114|NCT00886821|101223731|FG008|Stage 2|Adverse Event|0|||
33365115|NCT00886821|101223732|FG009|Stage 2|Adverse Event|0|||
33365116|NCT00886821|101223733|FG010|Stage 2|Adverse Event|0|||
33365117|NCT00886821|101223734|FG011|Stage 2|Adverse Event|1|||
33365118|NCT00886821|101223735|FG012|Stage 2|Adverse Event|3|||
33365119|NCT00886821|101223736|FG013|Stage 2|Adverse Event|0|||
33365120|NCT00886821|101223723|FG000|Stage 2|Lost to Follow-up|0|||
33365121|NCT00886821|101223724|FG001|Stage 2|Lost to Follow-up|0|||
33365122|NCT00886821|101223725|FG002|Stage 2|Lost to Follow-up|0|||
33224698|NCT00405639|100724881|FG000|Overall Study|Withdrawal by Subject|1|||
33224699|NCT00405639|100724882|FG001|Overall Study|Withdrawal by Subject|0|||
33224700|NCT00405639|100724881|FG000|Overall Study|Adverse Event|1|||
33365123|NCT00886821|101223726|FG003|Stage 2|Lost to Follow-up|0|||
33224701|NCT00405639|100724882|FG001|Overall Study|Adverse Event|0|||
33224702|NCT00405639|100724881|FG000|Overall Study|Seizure prior to receiving BNP|1|||
33224703|NCT00405639|100724882|FG001|Overall Study|Seizure prior to receiving BNP|0|||
33224704|NCT00067990|100724883|FG000|Overall Study|Death|5|||
33224705|NCT00067990|100724884|FG001|Overall Study|Death|7|||
33224706|NCT00067990|100724883|FG000|Overall Study|ESRD, Non IF/TA|1|||
33224707|NCT00067990|100724884|FG001|Overall Study|ESRD, Non IF/TA|3|||
33224708|NCT00067990|100724883|FG000|Overall Study|Withdrawal by Subject|4|||
33224709|NCT00067990|100724884|FG001|Overall Study|Withdrawal by Subject|12|||
33224710|NCT03443713|100724885|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
33224711|NCT03443713|100724886|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
33224712|NCT03443713|100724887|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
33224713|NCT00550550|100724889|FG000|Overall Study|Adverse Event|13|||
33224714|NCT00550550|100724890|FG001|Overall Study|Adverse Event|5|||
33224715|NCT00550550|100724889|FG000|Overall Study|Treatment Failure|0|||
33224716|NCT00550550|100724890|FG001|Overall Study|Treatment Failure|1|||
33224717|NCT00550550|100724889|FG000|Overall Study|Lost to Follow-up|4|||
33224718|NCT00550550|100724890|FG001|Overall Study|Lost to Follow-up|0|||
33224719|NCT00550550|100724889|FG000|Overall Study|Withdrawal by Subject|10|||
33224720|NCT00550550|100724890|FG001|Overall Study|Withdrawal by Subject|8|||
33417360|NCT01345058|101420264|FG001|Overall Study|Participant Reported Increase in Events|0|||
33417361|NCT01345058|101420263|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
33224721|NCT00550550|100724889|FG000|Overall Study|Protocol Violation|5|||
33224722|NCT00550550|100724890|FG001|Overall Study|Protocol Violation|14|||
33417362|NCT01345058|101420264|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
33568090|NCT06136897|101974824|FG000|Overall Study|Withdrawal by Subject|1|||
33568091|NCT06136897|101974824|FG000|Overall Study|Still on treatment|1|||
33568092|NCT06136897|101974824|FG000|Overall Study|Lost to Follow-up|1|||
33568093|NCT00977574|101974825|FG000|Overall Study|Never Treated|4|||
33568094|NCT00977574|101974826|FG001|Overall Study|Never Treated|2|||
33568095|NCT00977574|101974827|FG002|Overall Study|Never Treated|4|||
33417363|NCT01345058|101420263|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
33417364|NCT01345058|101420264|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
33417365|NCT01345058|101420263|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
33417366|NCT01345058|101420264|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
33417367|NCT03123120|101420267|FG000|Overall Study|Lost to Follow-up|0|||
33417368|NCT03123120|101420268|FG001|Overall Study|Lost to Follow-up|1|||
33417369|NCT03123120|101420267|FG000|Overall Study|Withdrawal by Subject|0|||
33417370|NCT03123120|101420268|FG001|Overall Study|Withdrawal by Subject|1|||
33417371|NCT00605839|101420271|FG000|Overall Study|Protocol Violation|1|||
33417372|NCT00605839|101420272|FG001|Overall Study|Protocol Violation|0|||
33417373|NCT00605839|101420273|FG002|Overall Study|Protocol Violation|0|||
33417374|NCT00865306|101420274|FG000|Controlled Trial|Lost to Follow-up|1|||
33417375|NCT00865306|101420275|FG001|Controlled Trial|Lost to Follow-up|1|||
33224723|NCT00550550|100724889|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
33224724|NCT00550550|100724890|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
33224725|NCT00550550|100724889|FG000|Overall Study|Randomized But Not Treated|1|||
33224726|NCT00550550|100724890|FG001|Overall Study|Randomized But Not Treated|0|||
33365124|NCT00886821|101223727|FG004|Stage 2|Lost to Follow-up|0|||
33417376|NCT00865306|101420274|FG000|Controlled Trial|Difficulty commuting|2|||
33568096|NCT03575897|101974828|FG000|Overall Study|Lost to Follow-up|12|||
33224727|NCT04152343|100724891|FG000|Overall Study|Transplanted|5|||
33224728|NCT04152343|100724891|FG000|Overall Study|Death|20|||
33417377|NCT00865306|101420275|FG001|Controlled Trial|Difficulty commuting|0|||
33417378|NCT00865306|101420274|FG000|Controlled Trial|Improved btw baseline and first session|1|||
33224729|NCT04152343|100724891|FG000|Overall Study|Lost to Follow-up|3|||
33224730|NCT01382602|100724892|FG000|Overall Study|Protocol Violation|0|||
33224731|NCT01382602|100724893|FG001|Overall Study|Protocol Violation|3|||
33568097|NCT03575897|101974829|FG001|Overall Study|Lost to Follow-up|13|||
33568098|NCT04749615|101974830|FG000|Overall Study|Lost to Follow-up|6|||
33568099|NCT04749615|101974831|FG001|Overall Study|Lost to Follow-up|10|||
33568100|NCT02936752|101974832|FG000|Overall Study|Death|2|||
33568101|NCT02936752|101974833|FG001|Overall Study|Death|1|||
33568102|NCT02936752|101974832|FG000|Overall Study|Physician Decision|4|||
33568103|NCT02936752|101974833|FG001|Overall Study|Physician Decision|0|||
33568104|NCT02936752|101974832|FG000|Overall Study|Withdrawal by Subject|0|||
33568105|NCT02936752|101974833|FG001|Overall Study|Withdrawal by Subject|2|||
33568106|NCT05308004|101974834|FG000|Overall Study|Not seen by Palliative Care NP|0|||
33568107|NCT05308004|101974835|FG001|Overall Study|Not seen by Palliative Care NP|1|||
33568108|NCT03557697|101974836|FG000|Overall Study|Withdrawal by Subject|2|||
33568109|NCT03557697|101974837|FG001|Overall Study|Withdrawal by Subject|4|||
33568110|NCT05104476|101974838|FG000|Overall Study|Randomized But Not Treated|1|||
33568111|NCT05104476|101974839|FG001|Overall Study|Randomized But Not Treated|2|||
33568112|NCT05104476|101974838|FG000|Overall Study|Adverse Event|2|||
33568113|NCT05104476|101974839|FG001|Overall Study|Adverse Event|2|||
33568114|NCT05104476|101974838|FG000|Overall Study|Withdrawal by Subject|3|||
33568115|NCT05104476|101974839|FG001|Overall Study|Withdrawal by Subject|3|||
33568116|NCT05104476|101974838|FG000|Overall Study|Other Than Specified|0|||
33568117|NCT05104476|101974839|FG001|Overall Study|Other Than Specified|3|||
33568118|NCT03106779|101974840|FG000|Overall Study|Lack of Efficacy|33|||
33568119|NCT03106779|101974841|FG001|Overall Study|Lack of Efficacy|24|||
33568120|NCT03106779|101974840|FG000|Overall Study|Adverse Event|8|||
33568121|NCT03106779|101974841|FG001|Overall Study|Adverse Event|16|||
33568122|NCT03106779|101974840|FG000|Overall Study|Physician Decision|10|||
33568123|NCT03106779|101974841|FG001|Overall Study|Physician Decision|6|||
33568124|NCT03106779|101974840|FG000|Overall Study|Patient/guardian decision|4|||
33568125|NCT03106779|101974841|FG001|Overall Study|Patient/guardian decision|3|||
33568126|NCT03106779|101974840|FG000|Overall Study|Progressive disease|1|||
33568127|NCT03106779|101974841|FG001|Overall Study|Progressive disease|3|||
33568128|NCT03106779|101974840|FG000|Overall Study|Lost to Follow-up|1|||
33568129|NCT03106779|101974841|FG001|Overall Study|Lost to Follow-up|2|||
33568130|NCT03106779|101974840|FG000|Overall Study|Death|1|||
33568131|NCT03106779|101974841|FG001|Overall Study|Death|0|||
33568132|NCT03106779|101974840|FG000|Overall Study|Protocol Violation|1|||
33568133|NCT03106779|101974841|FG001|Overall Study|Protocol Violation|0|||
33568134|NCT03106779|101974840|FG000|Overall Study|Not treated|1|||
33224732|NCT01382602|100724892|FG000|Overall Study|Withdrawal by Subject|0|||
33417379|NCT00865306|101420275|FG001|Controlled Trial|Improved btw baseline and first session|0|||
33417380|NCT00865306|101420274|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
33417381|NCT00865306|101420275|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
33417382|NCT00865306|101420274|FG000|Controlled Trial|Withdrawal by Subject|0|||
33365125|NCT00886821|101223728|FG005|Stage 2|Lost to Follow-up|0|||
33365126|NCT00886821|101223729|FG006|Stage 2|Lost to Follow-up|0|||
33365127|NCT00886821|101223730|FG007|Stage 2|Lost to Follow-up|0|||
33365128|NCT00886821|101223731|FG008|Stage 2|Lost to Follow-up|0|||
33365129|NCT00886821|101223732|FG009|Stage 2|Lost to Follow-up|0|||
33365130|NCT00886821|101223733|FG010|Stage 2|Lost to Follow-up|0|||
33365131|NCT00886821|101223734|FG011|Stage 2|Lost to Follow-up|0|||
33365132|NCT00886821|101223735|FG012|Stage 2|Lost to Follow-up|2|||
33365133|NCT00886821|101223736|FG013|Stage 2|Lost to Follow-up|1|||
33365134|NCT01797783|101223737|FG000|Overall Study|Adverse Event|1|||
33365135|NCT01797783|101223738|FG001|Overall Study|Adverse Event|1|||
33365136|NCT01797783|101223737|FG000|Overall Study|Withdrawal by Subject|1|||
33365137|NCT01797783|101223738|FG001|Overall Study|Withdrawal by Subject|0|||
33365138|NCT00309777|101223740|FG000|Overall Study|Adverse Event|13|||
33365139|NCT00309777|101223741|FG001|Overall Study|Adverse Event|2|||
33365140|NCT00309777|101223742|FG002|Overall Study|Adverse Event|8|||
33365141|NCT00309777|101223743|FG003|Overall Study|Adverse Event|1|||
33365142|NCT00309777|101223740|FG000|Overall Study|Protocol Violation|4|||
33365143|NCT00309777|101223741|FG001|Overall Study|Protocol Violation|1|||
33365144|NCT00309777|101223742|FG002|Overall Study|Protocol Violation|3|||
33417383|NCT00865306|101420275|FG001|Controlled Trial|Withdrawal by Subject|1|||
33417384|NCT06371079|101420276|FG000|Overall Study|Missing data|88|||
33417385|NCT06371079|101420277|FG001|Overall Study|Missing data|247|||
33417386|NCT03256526|101420279|FG000|Overall Study|Adverse Event|1|||
33631317|NCT02177123|102202924|FG000|Overall Study|Excluded for medical reasons|2|||
33365145|NCT00309777|101223743|FG003|Overall Study|Protocol Violation|1|||
33365146|NCT00309777|101223740|FG000|Overall Study|Withdrawal by Subject|6|||
33365147|NCT00309777|101223741|FG001|Overall Study|Withdrawal by Subject|5|||
33365148|NCT00309777|101223742|FG002|Overall Study|Withdrawal by Subject|7|||
33365149|NCT00309777|101223743|FG003|Overall Study|Withdrawal by Subject|2|||
33365150|NCT00309777|101223740|FG000|Overall Study|Lost to Follow-up|0|||
33417387|NCT03256526|101420280|FG001|Overall Study|Adverse Event|0|||
33417388|NCT03256526|101420281|FG002|Overall Study|Adverse Event|1|||
33417389|NCT03256526|101420279|FG000|Overall Study|Lost to Follow-up|1|||
33365151|NCT00309777|101223741|FG001|Overall Study|Lost to Follow-up|0|||
33365152|NCT00309777|101223742|FG002|Overall Study|Lost to Follow-up|1|||
33365153|NCT00309777|101223743|FG003|Overall Study|Lost to Follow-up|0|||
33365154|NCT00309777|101223740|FG000|Overall Study|Death|0|||
33365155|NCT00309777|101223741|FG001|Overall Study|Death|1|||
33365156|NCT00309777|101223742|FG002|Overall Study|Death|0|||
33365157|NCT00309777|101223743|FG003|Overall Study|Death|0|||
33568135|NCT03106779|101974841|FG001|Overall Study|Not treated|0|||
33568136|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
33568137|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
33631318|NCT02177123|102202924|FG000|Overall Study|Death|1|||
33417390|NCT03256526|101420280|FG001|Overall Study|Lost to Follow-up|0|||
33568138|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
33568139|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
33568140|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
33365158|NCT00864227|101223751|FG000|Overall Study|Withdrawal by Subject|1|||
33365159|NCT00864227|101223751|FG000|Overall Study|Disease Relapse/Progression|3|||
33365160|NCT02209597|101223756|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
33631319|NCT02177123|102202924|FG000|Overall Study|Other|1|||
33417391|NCT03256526|101420281|FG002|Overall Study|Lost to Follow-up|2|||
33568141|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
33568142|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
33568143|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
33568144|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
33568145|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
33568146|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
33568147|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
33568148|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
33224733|NCT01382602|100724893|FG001|Overall Study|Withdrawal by Subject|1|||
33224734|NCT00980005|100724894|FG000|Overall Study|Withdrawal by Subject|6|||
33568149|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
33568150|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
33568151|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
33568152|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
33568153|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
33568154|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
33568155|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
33568156|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
33568157|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
33568158|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
33568159|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
33568160|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
33568161|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
33224735|NCT00980005|100724895|FG001|Overall Study|Withdrawal by Subject|17|||
33224736|NCT00980005|100724894|FG000|Overall Study|Lost to Follow-up|37|||
33224737|NCT00980005|100724895|FG001|Overall Study|Lost to Follow-up|43|||
33224738|NCT00980005|100724894|FG000|Overall Study|Other|4|||
33224739|NCT00980005|100724895|FG001|Overall Study|Other|3|||
33224740|NCT00462670|100724896|FG000|Overall Study|Adverse Event|3|||
33224741|NCT00462670|100724897|FG001|Overall Study|Adverse Event|5|||
33224742|NCT00462670|100724896|FG000|Overall Study|Lack of Efficacy|1|||
33224743|NCT00462670|100724897|FG001|Overall Study|Lack of Efficacy|0|||
33568162|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
33568163|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
33224744|NCT00462670|100724896|FG000|Overall Study|Protocol Violation|1|||
33224745|NCT00462670|100724897|FG001|Overall Study|Protocol Violation|0|||
33224746|NCT00462670|100724896|FG000|Overall Study|Resolution of signs and symptoms|0|||
33224747|NCT00462670|100724897|FG001|Overall Study|Resolution of signs and symptoms|2|||
33224748|NCT03610737|100724902|FG000|Overall Study|Withdrawal by Subject|1|||
33224749|NCT03610737|100724903|FG001|Overall Study|Withdrawal by Subject|5|||
33568164|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
33568165|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
33568166|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
33568167|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
33568168|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
33568169|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
33568170|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
33568171|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
33568172|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
33224750|NCT03610737|100724902|FG000|Overall Study|Death|1|||
33417392|NCT01610284|101420282|FG000|Randomization Phase|Adverse Event|1|||
33417393|NCT01610284|101420283|FG001|Randomization Phase|Adverse Event|0|||
33417394|NCT01610284|101420282|FG000|Randomization Phase|Physician Decision|1|||
33417395|NCT01610284|101420283|FG001|Randomization Phase|Physician Decision|1|||
33417396|NCT01610284|101420282|FG000|Randomization Phase|Death|0|||
33417397|NCT01610284|101420283|FG001|Randomization Phase|Death|1|||
33417398|NCT01610284|101420282|FG000|Treatment Phase|Adverse Event|80|||
33568173|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
33568174|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
33568175|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
33568176|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
33568177|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
33568178|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
33568179|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
33568180|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
33568181|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
33568182|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
33568183|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
33568184|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
33568185|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
33568186|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
33568187|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
33568188|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
33568189|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
33568190|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
33568191|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
33568192|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
33568193|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
33568194|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
33568195|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
33568196|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
33568197|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
33568198|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
33568199|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
33568200|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
33568201|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
33568202|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
33568203|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
33568204|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
33568205|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
33568206|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
33568207|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
33568208|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
33417399|NCT01610284|101420283|FG001|Treatment Phase|Adverse Event|12|||
33417400|NCT01610284|101420282|FG000|Treatment Phase|Lost to Follow-up|1|||
33568209|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
33568210|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
33568211|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
33568212|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
33568213|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
33568214|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
33568215|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
33568216|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
33568217|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
33568218|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
33568219|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
33568220|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
33417401|NCT01610284|101420283|FG001|Treatment Phase|Lost to Follow-up|0|||
33417402|NCT01610284|101420282|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
33417403|NCT01610284|101420283|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
33417404|NCT01610284|101420282|FG000|Treatment Phase|Physician Decision|27|||
33417405|NCT01610284|101420283|FG001|Treatment Phase|Physician Decision|24|||
33417406|NCT01610284|101420282|FG000|Treatment Phase|Progressive Disease|377|||
33417407|NCT01610284|101420283|FG001|Treatment Phase|Progressive Disease|486|||
33417408|NCT01610284|101420282|FG000|Treatment Phase|Protocol Deviation|2|||
33417409|NCT01610284|101420283|FG001|Treatment Phase|Protocol Deviation|3|||
33417410|NCT01610284|101420282|FG000|Treatment Phase|Study terminated by Sponsor|18|||
33417411|NCT01610284|101420283|FG001|Treatment Phase|Study terminated by Sponsor|15|||
33417412|NCT01610284|101420282|FG000|Treatment Phase|Subject/Guardian Decision|55|||
33417413|NCT01610284|101420283|FG001|Treatment Phase|Subject/Guardian Decision|23|||
33417414|NCT01610284|101420282|FG000|Treatment Phase|Death|6|||
33417415|NCT01610284|101420283|FG001|Treatment Phase|Death|5|||
33417416|NCT01610284|101420282|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
33417417|NCT01610284|101420283|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33417418|NCT01610284|101420282|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
33417419|NCT01610284|101420283|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
33417420|NCT01610284|101420282|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
33568221|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
33568222|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
33568223|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
33568224|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
33568225|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
33568226|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
33568227|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
33568228|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
33568229|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
33568230|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
33568231|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
33568232|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
33568233|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
33568234|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
33568235|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
33568236|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
33568237|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
33568238|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
33568239|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
33568240|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
33568241|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
33568242|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
33417421|NCT01610284|101420283|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
33417422|NCT01610284|101420282|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
33417423|NCT01610284|101420283|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
33417424|NCT01610284|101420282|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
33417425|NCT01610284|101420283|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
33224751|NCT03610737|100724903|FG001|Overall Study|Death|0|||
33224752|NCT03610737|100724902|FG000|Overall Study|Not treated|5|||
33224753|NCT03610737|100724903|FG001|Overall Study|Not treated|2|||
33568243|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
33568244|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
33568245|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
33568246|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
33568247|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
33568248|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
33568249|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
33568250|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
33568251|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
33568252|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
33568253|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
33568254|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
33568255|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
33568256|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
33568257|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
33568258|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
33568259|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
33568260|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
33568261|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
33568262|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
33568263|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
33568264|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
33568265|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
33568266|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
33568267|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
33568268|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
33568269|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
33568270|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
33568271|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
33568272|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
33568273|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
33568274|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
33568275|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
33568276|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
33568277|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
33568278|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
33568279|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
33568280|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
33568281|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
33568282|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
33568283|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
33568284|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
33568285|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
33568286|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
33568287|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
33568288|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
33568289|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
33568290|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
33568291|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
33568292|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
33568293|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
33568294|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
33568295|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
33568296|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
33568297|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
33568298|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
33568299|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
33568300|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
33568301|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
33224754|NCT03610737|100724902|FG000|Overall Study|Missed Visit|1|||
33224755|NCT03610737|100724903|FG001|Overall Study|Missed Visit|2|||
33489716|NCT02899962|101686773|FG001|Open-label Phase|Adverse Event|0|||
33224756|NCT01377480|100724906|FG000|Overall Study|Protocol Violation|0|||
33568302|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
33568303|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
33568304|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
33568305|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
33568306|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
33568307|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
33568308|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
33568309|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
33568310|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
33568311|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
33568312|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
33568313|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
33568314|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
33568315|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
33568316|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
33568317|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
33568318|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
33568319|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
33568320|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
33568321|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
33568322|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
33568323|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
33568324|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
33568325|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
33568326|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
33568327|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
33568328|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
33568329|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
33568330|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
33568331|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
33568332|NCT04033445|101974842|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
33568333|NCT04033445|101974843|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
33568334|NCT04033445|101974844|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
33568335|NCT04033445|101974845|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
33568336|NCT04033445|101974846|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
33568337|NCT04033445|101974847|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
33568338|NCT04033445|101974848|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
33568339|NCT04033445|101974849|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
33568340|NCT04033445|101974850|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
33631320|NCT02177123|102202924|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
33631321|NCT04227899|102202925|FG000|Overall Study|Withdrawal by Subject|6|||
33631322|NCT04227899|102202926|FG001|Overall Study|Withdrawal by Subject|3|||
33631323|NCT04227899|102202925|FG000|Overall Study|Death|12|||
33631324|NCT04227899|102202926|FG001|Overall Study|Death|6|||
33631325|NCT04227899|102202925|FG000|Overall Study|Lost to Follow-up|2|||
33631326|NCT04227899|102202926|FG001|Overall Study|Lost to Follow-up|1|||
33631327|NCT02374450|102202927|FG000|Overall Study|Protocol Violation|0|||
33631328|NCT02374450|102202928|FG001|Overall Study|Protocol Violation|1|||
33631329|NCT02374450|102202929|FG002|Overall Study|Protocol Violation|0|||
33631330|NCT02374450|102202927|FG000|Overall Study|Withdrawal by Subject|91|||
33631331|NCT02374450|102202928|FG001|Overall Study|Withdrawal by Subject|110|||
33631332|NCT02374450|102202929|FG002|Overall Study|Withdrawal by Subject|4|||
33631333|NCT02374450|102202927|FG000|Overall Study|Lost to Follow-up|168|||
33631334|NCT02374450|102202928|FG001|Overall Study|Lost to Follow-up|194|||
33631335|NCT02374450|102202929|FG002|Overall Study|Lost to Follow-up|138|||
33631336|NCT02374450|102202927|FG000|Overall Study|Death|173|||
33631337|NCT02374450|102202928|FG001|Overall Study|Death|185|||
33631338|NCT02374450|102202929|FG002|Overall Study|Death|81|||
33631339|NCT02374450|102202927|FG000|Overall Study|Migrated from the study area|538|||
33631340|NCT02374450|102202928|FG001|Overall Study|Migrated from the study area|648|||
33631341|NCT02374450|102202929|FG002|Overall Study|Migrated from the study area|181|||
33631342|NCT02374450|102202927|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
33631343|NCT02374450|102202928|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
33631344|NCT02374450|102202929|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
33489717|NCT02899962|101686774|FG002|Open-label Phase|Adverse Event|0|||
33224757|NCT01377480|100724907|FG001|Overall Study|Protocol Violation|0|||
33224758|NCT01377480|100724908|FG002|Overall Study|Protocol Violation|0|||
33224759|NCT01377480|100724909|FG003|Overall Study|Protocol Violation|4|||
33224760|NCT01377480|100724906|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
33224761|NCT01377480|100724907|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
33224762|NCT01377480|100724908|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
33224763|NCT01377480|100724909|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
33224764|NCT01377480|100724906|FG000|Overall Study|Withdrawal by Subject|0|||
33224765|NCT01377480|100724907|FG001|Overall Study|Withdrawal by Subject|0|||
33224766|NCT01377480|100724908|FG002|Overall Study|Withdrawal by Subject|1|||
33224767|NCT01377480|100724909|FG003|Overall Study|Withdrawal by Subject|0|||
33224768|NCT01377480|100724906|FG000|Overall Study|Serious adverse event|0|||
33417426|NCT01610284|101420282|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
33568341|NCT04033445|101974851|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
33568342|NCT04033445|101974852|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
33568343|NCT04033445|101974853|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
33224769|NCT01377480|100724907|FG001|Overall Study|Serious adverse event|0|||
33224770|NCT01377480|100724908|FG002|Overall Study|Serious adverse event|1|||
33224771|NCT01377480|100724909|FG003|Overall Study|Serious adverse event|1|||
33568344|NCT04033445|101974854|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
33568345|NCT04033445|101974855|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
33568346|NCT04033445|101974842|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
33568347|NCT04033445|101974843|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
33568348|NCT04033445|101974844|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
33568349|NCT04033445|101974845|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
33568350|NCT04033445|101974846|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
33568351|NCT04033445|101974847|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
33568352|NCT04033445|101974848|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
33568353|NCT04033445|101974849|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
33568354|NCT04033445|101974850|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
33568355|NCT04033445|101974851|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
33568356|NCT04033445|101974852|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
33568357|NCT04033445|101974853|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
33568358|NCT04033445|101974854|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
33568359|NCT04033445|101974855|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
33631345|NCT02374450|102202927|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
33224772|NCT01377480|100724906|FG000|Overall Study|Other|0|||
33224773|NCT01377480|100724907|FG001|Overall Study|Other|0|||
33224774|NCT01377480|100724908|FG002|Overall Study|Other|7|||
33224775|NCT01377480|100724909|FG003|Overall Study|Other|6|||
33224776|NCT00591864|100724910|FG000|Overall Study|Incomplete Imaging|5|||
33224777|NCT00510458|100724921|FG000|Overall Study|5 year not evaluable/missed|21|||
33224778|NCT00510458|100724921|FG000|Overall Study|Death|1|||
33224779|NCT00510458|100724921|FG000|Overall Study|Terminated|14|||
33224780|NCT00510458|100724921|FG000|Overall Study|Lost to Follow-up|6|||
33224781|NCT00510458|100724921|FG000|Overall Study|Withdrawal by Subject|3|||
33224782|NCT00510458|100724921|FG000|Overall Study|Revision|2|||
33224783|NCT01641926|100724923|FG000|Overall Study|Adverse Event|5|||
33224784|NCT01641926|100724924|FG001|Overall Study|Adverse Event|2|||
33224785|NCT01641926|100724925|FG002|Overall Study|Adverse Event|3|||
33224786|NCT01641926|100724926|FG003|Overall Study|Adverse Event|1|||
33224787|NCT01641926|100724923|FG000|Overall Study|Lost to Follow-up|2|||
33224788|NCT01641926|100724924|FG001|Overall Study|Lost to Follow-up|2|||
33224789|NCT01641926|100724925|FG002|Overall Study|Lost to Follow-up|1|||
33224790|NCT01641926|100724926|FG003|Overall Study|Lost to Follow-up|0|||
33224791|NCT01641926|100724923|FG000|Overall Study|Physician Decision|6|||
33224792|NCT01641926|100724924|FG001|Overall Study|Physician Decision|5|||
33224793|NCT01641926|100724925|FG002|Overall Study|Physician Decision|0|||
33224794|NCT01641926|100724926|FG003|Overall Study|Physician Decision|1|||
33224795|NCT01641926|100724923|FG000|Overall Study|Protocol Violation|1|||
33224796|NCT01641926|100724924|FG001|Overall Study|Protocol Violation|0|||
33631346|NCT02374450|102202928|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
33631347|NCT02374450|102202929|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
33631348|NCT02374450|102202927|FG000|Overall Study|Other|0|||
33631349|NCT02374450|102202928|FG001|Overall Study|Other|21|||
33631350|NCT02374450|102202929|FG002|Overall Study|Other|79|||
33631351|NCT02852655|102202930|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
33631352|NCT02852655|102202931|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
33631353|NCT02852655|102202932|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
33631354|NCT02852655|102202930|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
33631355|NCT02852655|102202931|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
33631356|NCT02852655|102202932|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
33631357|NCT02852655|102202930|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
33631358|NCT02852655|102202931|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
33631359|NCT02852655|102202932|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
33631360|NCT02852655|102202930|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
33631361|NCT02852655|102202931|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
33631362|NCT02852655|102202932|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
33631363|NCT02852655|102202930|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
33631364|NCT02852655|102202931|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
33631365|NCT02852655|102202932|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
33224797|NCT01641926|100724925|FG002|Overall Study|Protocol Violation|0|||
33224798|NCT01641926|100724926|FG003|Overall Study|Protocol Violation|1|||
33224799|NCT01641926|100724923|FG000|Overall Study|Withdrawal by Subject|13|||
33224800|NCT01641926|100724924|FG001|Overall Study|Withdrawal by Subject|5|||
33224801|NCT01641926|100724925|FG002|Overall Study|Withdrawal by Subject|6|||
33224802|NCT01641926|100724926|FG003|Overall Study|Withdrawal by Subject|1|||
33224803|NCT01641926|100724923|FG000|Overall Study|Not Treated|1|||
33224804|NCT01641926|100724924|FG001|Overall Study|Not Treated|1|||
33224805|NCT01641926|100724925|FG002|Overall Study|Not Treated|1|||
33224806|NCT01641926|100724926|FG003|Overall Study|Not Treated|0|||
33224807|NCT00100932|100724927|FG000|Overall Study|Adverse Event|11|||
33224808|NCT00100932|100724928|FG001|Overall Study|Adverse Event|2|||
33224809|NCT00100932|100724927|FG000|Overall Study|Withdrawal by Subject|6|||
33224810|NCT00100932|100724928|FG001|Overall Study|Withdrawal by Subject|0|||
33224811|NCT00100932|100724927|FG000|Overall Study|Progressive Disease|44|||
33224812|NCT00100932|100724928|FG001|Overall Study|Progressive Disease|18|||
33224813|NCT00100932|100724927|FG000|Overall Study|Physician Decision|7|||
33224814|NCT00100932|100724928|FG001|Overall Study|Physician Decision|5|||
33224815|NCT00100932|100724927|FG000|Overall Study|Other|5|||
33224816|NCT00100932|100724928|FG001|Overall Study|Other|2|||
33224817|NCT03541044|100724929|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
33224818|NCT03541044|100724930|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
33224819|NCT03541044|100724929|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
33224820|NCT03541044|100724930|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
33224821|NCT01650519|100724933|FG000|Overall Study|Withdrawal by Subject|1|||
33224822|NCT01650519|100724934|FG001|Overall Study|Withdrawal by Subject|0|||
33224823|NCT00787319|100724938|FG000|Overall Study|Lost to Follow-up|2|||
33224824|NCT00787319|100724938|FG000|Overall Study|Withdrawal by Subject|15|||
33224825|NCT00787319|100724938|FG000|Overall Study|Adverse Event|3|||
33224826|NCT00787319|100724938|FG000|Overall Study|Objective progression or relapse|30|||
33224827|NCT00787319|100724938|FG000|Overall Study|Lack of Efficacy|1|||
33224828|NCT00787319|100724938|FG000|Overall Study|Budget exhausted/exceeded|1|||
33224829|NCT00787319|100724938|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
33224830|NCT00787319|100724938|FG000|Overall Study|No health insurance reimbursement|2|||
33224831|NCT00787319|100724938|FG000|Overall Study|Stabilized disease findings|3|||
33224832|NCT00787319|100724938|FG000|Overall Study|Inactive disease|5|||
33224833|NCT01153269|100724939|FG000|Overall Study|Withdrawal by Subject|1|||
33224834|NCT01153269|100724939|FG000|Overall Study|Antiretroviral therapy break|1|||
33224835|NCT02821819|100724940|FG000|Overall Study|Protocol Violation|1|||
33224836|NCT01289418|100724941|FG000|Day 8 Survey|email address invalid|283|||
33224837|NCT01289418|100724941|FG000|Day 8 Survey|participants did not complete the survey|1935|||
33224838|NCT01289418|100724941|FG000|Day 29 Survey|email address invalid|283|||
33224839|NCT01289418|100724941|FG000|Day 29 Survey|participants did not complete the survey|2185|||
33224840|NCT01336634|100724968|FG000|Overall Study|Study closed/terminated|5|||
33224841|NCT01336634|100724969|FG001|Overall Study|Study closed/terminated|6|||
33224842|NCT01336634|100724970|FG002|Overall Study|Study closed/terminated|6|||
33224843|NCT01336634|100724968|FG000|Overall Study|Lost to Follow-up|2|||
33224844|NCT01336634|100724969|FG001|Overall Study|Lost to Follow-up|1|||
33224845|NCT01336634|100724970|FG002|Overall Study|Lost to Follow-up|1|||
33224846|NCT01336634|100724968|FG000|Overall Study|Physician Decision|1|||
33224847|NCT01336634|100724969|FG001|Overall Study|Physician Decision|1|||
33224848|NCT01336634|100724970|FG002|Overall Study|Physician Decision|0|||
33224849|NCT01336634|100724968|FG000|Overall Study|Withdrawal by Subject|6|||
33224850|NCT01336634|100724969|FG001|Overall Study|Withdrawal by Subject|0|||
33224851|NCT01336634|100724970|FG002|Overall Study|Withdrawal by Subject|2|||
33224852|NCT02736968|100724971|FG000|Overall Study|Lost to Follow-up|0|||
33224853|NCT02736968|100724972|FG001|Overall Study|Lost to Follow-up|0|||
33224854|NCT02736968|100724973|FG002|Overall Study|Lost to Follow-up|0|||
33224855|NCT02736968|100724974|FG003|Overall Study|Lost to Follow-up|0|||
33224856|NCT02736968|100724975|FG004|Overall Study|Lost to Follow-up|0|||
33224857|NCT02736968|100724976|FG005|Overall Study|Lost to Follow-up|0|||
33365161|NCT02209597|101223756|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
33365162|NCT02209597|101223756|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
33365163|NCT02209597|101223756|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
33365164|NCT00592501|101223762|FG000|Overall Study|Withdrawal by Subject|1|||
33365165|NCT00592501|101223762|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
33365166|NCT04370028|101223763|FG000|Overall Study|Withdrawal by Subject|695|||
33365167|NCT04370028|101223763|FG000|Overall Study|Protocol Violation|9|||
33365168|NCT04370028|101223763|FG000|Overall Study|Adverse Event|3|||
33365169|NCT00151411|101223764|FG000|Overall Study|Lost to Follow-up|15|||
33365170|NCT00151411|101223765|FG001|Overall Study|Lost to Follow-up|19|||
33365171|NCT00151411|101223764|FG000|Overall Study|Withdrawal by Subject|12|||
33365172|NCT00151411|101223765|FG001|Overall Study|Withdrawal by Subject|20|||
33365173|NCT00151411|101223764|FG000|Overall Study|Adverse Event|6|||
33224858|NCT02736968|100724977|FG006|Overall Study|Lost to Follow-up|5|||
33224859|NCT02736968|100724978|FG007|Overall Study|Lost to Follow-up|2|||
33224860|NCT02736968|100724971|FG000|Overall Study|COVID-19 Pandemic|0|||
33224861|NCT02736968|100724972|FG001|Overall Study|COVID-19 Pandemic|0|||
33224862|NCT02736968|100724973|FG002|Overall Study|COVID-19 Pandemic|0|||
33224863|NCT02736968|100724974|FG003|Overall Study|COVID-19 Pandemic|0|||
33224864|NCT02736968|100724975|FG004|Overall Study|COVID-19 Pandemic|0|||
33224865|NCT02736968|100724976|FG005|Overall Study|COVID-19 Pandemic|0|||
33224866|NCT02736968|100724977|FG006|Overall Study|COVID-19 Pandemic|2|||
33224867|NCT02736968|100724978|FG007|Overall Study|COVID-19 Pandemic|0|||
33224868|NCT02736968|100724971|FG000|Overall Study|Withdrawal by Subject|0|||
33224869|NCT02736968|100724972|FG001|Overall Study|Withdrawal by Subject|0|||
33631366|NCT02852655|102202930|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
33631367|NCT02852655|102202931|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
33224870|NCT02736968|100724973|FG002|Overall Study|Withdrawal by Subject|0|||
33224871|NCT02736968|100724974|FG003|Overall Study|Withdrawal by Subject|0|||
33224872|NCT02736968|100724975|FG004|Overall Study|Withdrawal by Subject|0|||
33224873|NCT02736968|100724976|FG005|Overall Study|Withdrawal by Subject|0|||
33224874|NCT02736968|100724977|FG006|Overall Study|Withdrawal by Subject|1|||
33224875|NCT02736968|100724978|FG007|Overall Study|Withdrawal by Subject|0|||
33224876|NCT03559218|100724982|FG000|Overall Study|Withdrawal by Subject|1|||
33224877|NCT03559218|100724983|FG001|Overall Study|Withdrawal by Subject|0|||
33224878|NCT00094328|100724990|FG000|Overall Study|Lost to Follow-up|1|||
33224879|NCT00861614|100724991|FG000|Overall Study|Disease Progression|182|||
33224880|NCT00861614|100724992|FG001|Overall Study|Disease Progression|263|||
33224881|NCT00861614|100724991|FG000|Overall Study|Study Drug Toxicity|79|||
33224882|NCT00861614|100724992|FG001|Overall Study|Study Drug Toxicity|6|||
33631368|NCT02852655|102202932|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
33631369|NCT02852655|102202930|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
33631370|NCT02852655|102202931|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
33631371|NCT02852655|102202932|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
33631372|NCT02852655|102202930|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
33631373|NCT02852655|102202931|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
33631374|NCT02852655|102202932|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
33631375|NCT02852655|102202930|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
33631376|NCT02852655|102202931|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
33631377|NCT02852655|102202932|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
33631378|NCT03818256|102202933|FG000|Overall Study|Withdrawal by Subject|2|||
33631379|NCT03818256|102202934|FG001|Overall Study|Withdrawal by Subject|2|||
33224883|NCT00861614|100724991|FG000|Overall Study|Death|32|||
33224884|NCT00861614|100724992|FG001|Overall Study|Death|19|||
33417427|NCT01610284|101420283|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
33417428|NCT02181842|101420284|FG000|Overall Study|Case Report Forms Uncollected|2|||
33417429|NCT01741259|101420289|FG000|Overall Study|Protocol Violation|6|||
33631380|NCT03818256|102202933|FG000|Overall Study|Adverse Event|3|||
33631381|NCT03818256|102202934|FG001|Overall Study|Adverse Event|1|||
33631382|NCT03818256|102202933|FG000|Overall Study|Lost to Follow-up|0|||
33224885|NCT00861614|100724991|FG000|Overall Study|Adverse Event|27|||
33224886|NCT00861614|100724992|FG001|Overall Study|Adverse Event|23|||
33224887|NCT00861614|100724991|FG000|Overall Study|Withdrawal by Subject|34|||
33631383|NCT03818256|102202934|FG001|Overall Study|Lost to Follow-up|5|||
33631384|NCT03818256|102202933|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
33631385|NCT03818256|102202934|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
33631386|NCT03818256|102202933|FG000|Overall Study|Not reporting for scheduled visits|1|||
33631387|NCT03818256|102202934|FG001|Overall Study|Not reporting for scheduled visits|0|||
33631388|NCT03818256|102202933|FG000|Overall Study|Non-compliant with investigational product|1|||
33631389|NCT03818256|102202934|FG001|Overall Study|Non-compliant with investigational product|0|||
33631390|NCT00581308|102202935|FG000|Pre Discharge|Lost to Follow-up|1|||
33631391|NCT00581308|102202935|FG000|Pre Discharge|Device Removed|1|||
33631392|NCT00581308|102202935|FG000|Month 1|Lost to Follow-up|3|||
33631393|NCT00581308|102202935|FG000|Month 1|Withdrawal by Subject|2|||
33631394|NCT00581308|102202935|FG000|Month 1|Device Removed|2|||
33631395|NCT00581308|102202935|FG000|Month 1|Uknown|1|||
33631396|NCT00581308|102202935|FG000|Month 6|Lost to Follow-up|1|||
33631397|NCT00581308|102202935|FG000|Month 6|Withdrawal by Subject|2|||
33631398|NCT00581308|102202935|FG000|Month 12|Death|1|||
33631399|NCT00581308|102202935|FG000|Month 12|Lost to Follow-up|14|||
33631400|NCT00581308|102202935|FG000|Month 12|Withdrawal by Subject|3|||
33631401|NCT00581308|102202935|FG000|Month 12|Device Removed|1|||
33631402|NCT00581308|102202935|FG000|Month 12|Other|1|||
33631403|NCT04629508|102202936|FG000|Overall Study|Adverse Event|1|||
33631404|NCT04629508|102202936|FG000|Overall Study|Death|2|||
33631405|NCT04629508|102202936|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
33631406|NCT05417438|102202937|FG000|Overall Study|Withdrawal by Subject|3|||
33631407|NCT03675126|102202946|FG000|Overall Study|Study Terminated by Sponsor|9|||
33224888|NCT00861614|100724992|FG001|Overall Study|Withdrawal by Subject|35|||
33224889|NCT00861614|100724991|FG000|Overall Study|Other|17|||
33224890|NCT00861614|100724992|FG001|Overall Study|Other|22|||
33224891|NCT03183388|100724993|FG000|Overall Study|Lost to Follow-up|3|||
33568360|NCT04033445|101974842|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
33568361|NCT04033445|101974843|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
33568362|NCT04033445|101974844|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
33568363|NCT04033445|101974845|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
33568364|NCT04033445|101974846|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
33568365|NCT04033445|101974847|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
33568366|NCT04033445|101974848|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
33568367|NCT04033445|101974849|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
33568368|NCT04033445|101974850|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
33568369|NCT04033445|101974851|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
33568370|NCT04033445|101974852|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
33568371|NCT04033445|101974853|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
33568372|NCT04033445|101974854|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
33568373|NCT04033445|101974855|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
33568374|NCT04033445|101974842|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
33568375|NCT04033445|101974843|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
33568376|NCT04033445|101974844|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
33568377|NCT04033445|101974845|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
33568378|NCT04033445|101974846|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
33568379|NCT04033445|101974847|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
33568380|NCT04033445|101974848|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
33568381|NCT04033445|101974849|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
33568382|NCT04033445|101974850|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
33568383|NCT04033445|101974851|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
33568384|NCT04033445|101974852|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
33568385|NCT04033445|101974853|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
33568386|NCT04033445|101974854|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
33568387|NCT04033445|101974855|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
33568388|NCT04033445|101974842|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
33568389|NCT04033445|101974843|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
33568390|NCT04033445|101974844|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
33568391|NCT04033445|101974845|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
33568392|NCT04033445|101974846|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
33631408|NCT03675126|102202946|FG000|Overall Study|Death|2|||
33631409|NCT03675126|102202946|FG000|Overall Study|Withdrawal by Subject|4|||
33631410|NCT03199976|102202947|FG000|Overall Study|Lack of Efficacy|3|||
33631411|NCT03199976|102202948|FG001|Overall Study|Lack of Efficacy|6|||
33631412|NCT03199976|102202949|FG002|Overall Study|Lack of Efficacy|13|||
33631413|NCT03199976|102202947|FG000|Overall Study|Withdrawal by Subject|1|||
33631414|NCT03199976|102202948|FG001|Overall Study|Withdrawal by Subject|0|||
33631415|NCT03199976|102202949|FG002|Overall Study|Withdrawal by Subject|0|||
33224892|NCT03183388|100724994|FG001|Overall Study|Lost to Follow-up|5|||
33224893|NCT03183388|100724993|FG000|Overall Study|Physician Decision|1|||
33631416|NCT03199976|102202947|FG000|Overall Study|Lost to Follow-up|0|||
33631417|NCT03199976|102202948|FG001|Overall Study|Lost to Follow-up|1|||
33631418|NCT03199976|102202949|FG002|Overall Study|Lost to Follow-up|1|||
33631419|NCT01607957|102202957|FG000|Overall Study|Not treated|1|||
33631420|NCT01607957|102202958|FG001|Overall Study|Not treated|1|||
33631421|NCT01607957|102202957|FG000|Overall Study|Death|367|||
33631422|NCT01607957|102202958|FG001|Overall Study|Death|211|||
33631423|NCT01607957|102202957|FG000|Overall Study|Lost to Follow-up|3|||
33631424|NCT01607957|102202958|FG001|Overall Study|Lost to Follow-up|3|||
33631425|NCT01607957|102202957|FG000|Overall Study|Participant refusal|1|||
33631426|NCT01607957|102202958|FG001|Overall Study|Participant refusal|0|||
33631427|NCT04199351|102202960|FG000|Overall Study|Decision by sponsor|0|||
33631428|NCT04199351|102202961|FG001|Overall Study|Decision by sponsor|0|||
33631429|NCT04199351|102202962|FG002|Overall Study|Decision by sponsor|0|||
33631430|NCT04199351|102202963|FG003|Overall Study|Decision by sponsor|2|||
33631431|NCT04199351|102202964|FG004|Overall Study|Decision by sponsor|0|||
33631432|NCT04199351|102202965|FG005|Overall Study|Decision by sponsor|0|||
33631433|NCT04199351|102202966|FG006|Overall Study|Decision by sponsor|0|||
33631434|NCT04199351|102202967|FG007|Overall Study|Decision by sponsor|0|||
33631435|NCT04199351|102202968|FG008|Overall Study|Decision by sponsor|0|||
33631436|NCT04199351|102202969|FG009|Overall Study|Decision by sponsor|6|||
33631437|NCT04199351|102202960|FG000|Overall Study|Lost to Follow-up|0|||
33631438|NCT04199351|102202961|FG001|Overall Study|Lost to Follow-up|0|||
33631439|NCT04199351|102202962|FG002|Overall Study|Lost to Follow-up|1|||
33631440|NCT04199351|102202963|FG003|Overall Study|Lost to Follow-up|0|||
33631441|NCT04199351|102202964|FG004|Overall Study|Lost to Follow-up|0|||
33631442|NCT04199351|102202965|FG005|Overall Study|Lost to Follow-up|1|||
33631443|NCT04199351|102202966|FG006|Overall Study|Lost to Follow-up|0|||
33631444|NCT04199351|102202967|FG007|Overall Study|Lost to Follow-up|0|||
33631445|NCT04199351|102202968|FG008|Overall Study|Lost to Follow-up|0|||
33631446|NCT04199351|102202969|FG009|Overall Study|Lost to Follow-up|0|||
33631447|NCT04199351|102202960|FG000|Overall Study|Withdrawal by Subject|0|||
33631448|NCT04199351|102202961|FG001|Overall Study|Withdrawal by Subject|1|||
33631449|NCT04199351|102202962|FG002|Overall Study|Withdrawal by Subject|0|||
33631450|NCT04199351|102202963|FG003|Overall Study|Withdrawal by Subject|0|||
33631451|NCT04199351|102202964|FG004|Overall Study|Withdrawal by Subject|1|||
33631452|NCT04199351|102202965|FG005|Overall Study|Withdrawal by Subject|4|||
33631453|NCT04199351|102202966|FG006|Overall Study|Withdrawal by Subject|2|||
33631454|NCT04199351|102202967|FG007|Overall Study|Withdrawal by Subject|0|||
33631455|NCT04199351|102202968|FG008|Overall Study|Withdrawal by Subject|3|||
33631456|NCT04199351|102202969|FG009|Overall Study|Withdrawal by Subject|0|||
33631457|NCT03995368|102202983|FG000|Overall Study|Lost to Follow-up|1|||
33631458|NCT03995368|102202984|FG001|Overall Study|Lost to Follow-up|4|||
33631459|NCT03995368|102202985|FG002|Overall Study|Lost to Follow-up|1|||
33631460|NCT03995368|102202983|FG000|Overall Study|Did not meet inclusion criteria|1|||
33631461|NCT03995368|102202984|FG001|Overall Study|Did not meet inclusion criteria|6|||
33631462|NCT03995368|102202985|FG002|Overall Study|Did not meet inclusion criteria|3|||
33631463|NCT03995368|102202983|FG000|Overall Study|Withdrawal by Subject|0|||
33631464|NCT03995368|102202984|FG001|Overall Study|Withdrawal by Subject|1|||
33631465|NCT03995368|102202985|FG002|Overall Study|Withdrawal by Subject|1|||
33631466|NCT02864394|102202987|FG000|Overall Study|Death|184|||
33631467|NCT02864394|102202988|FG001|Overall Study|Death|189|||
33631468|NCT02864394|102202987|FG000|Overall Study|Lost to Follow-up|0|||
33631469|NCT02864394|102202988|FG001|Overall Study|Lost to Follow-up|2|||
33631470|NCT02864394|102202987|FG000|Overall Study|Sponsor Decision|26|||
33631471|NCT02864394|102202988|FG001|Overall Study|Sponsor Decision|11|||
33631472|NCT02864394|102202987|FG000|Overall Study|Withdrawal by Subject|3|||
33631473|NCT02864394|102202988|FG001|Overall Study|Withdrawal by Subject|10|||
33631474|NCT01280903|102202989|FG000|Overall Study|Lost to Follow-up|23|||
33631475|NCT01280903|102202990|FG001|Overall Study|Lost to Follow-up|16|||
33631476|NCT02946580|102202991|FG000|Overall Study|Withdrawal by Subject|1|||
33631477|NCT02946580|102202992|FG001|Overall Study|Withdrawal by Subject|2|||
33631478|NCT02946580|102202991|FG000|Overall Study|Adverse Event|0|||
33631479|NCT02946580|102202992|FG001|Overall Study|Adverse Event|2|||
33631480|NCT02946580|102202991|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
33631481|NCT02946580|102202992|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
33631482|NCT04905134|102202998|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
33631483|NCT04905134|102202998|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
33631484|NCT03882021|102202999|FG000|Enrollment|Procedure aborted/cancelled|2|||
33631485|NCT03882021|102202999|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
33631486|NCT03882021|102202999|FG000|Enrollment to 3-Month|Death|1|||
33631487|NCT03882021|102202999|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
33631488|NCT03882021|102202999|FG000|Enrollment to 3-Month|Missed Visit|4|||
33631489|NCT03882021|102202999|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
33631490|NCT03882021|102202999|FG000|6-Month to 12-Month Visit|Death|1|||
33631491|NCT03882021|102202999|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
33631492|NCT03755934|102203000|FG000|Overall Study|Adverse Event|4|||
33631493|NCT03755934|102203001|FG001|Overall Study|Adverse Event|1|||
33417430|NCT01741259|101420290|FG001|Overall Study|Protocol Violation|4|||
33417431|NCT01741259|101420289|FG000|Overall Study|Withdrawal by Subject|0|||
33417432|NCT01741259|101420290|FG001|Overall Study|Withdrawal by Subject|2|||
33417433|NCT01447628|101420293|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
33417434|NCT01447628|101420294|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
33417435|NCT01447628|101420295|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
33417436|NCT01447628|101420296|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
33417437|NCT05981365|101420297|FG000|Period 1|Adverse Event|1|||
33417438|NCT05981365|101420298|FG001|Period 1|Adverse Event|0|||
33417439|NCT03533608|101420299|FG000|Overall Study|Withdrawal by Subject|3|||
33417440|NCT03533608|101420299|FG000|Overall Study|Physician Decision|2|||
33417441|NCT04136626|101420304|FG000|Treatment Phase|Withdrawal by Subject|1|||
33417442|NCT04136626|101420305|FG001|Treatment Phase|Withdrawal by Subject|9|||
33417443|NCT04136626|101420304|FG000|Treatment Phase|Adverse Event|1|||
33417444|NCT04136626|101420305|FG001|Treatment Phase|Adverse Event|0|||
33417445|NCT04136626|101420304|FG000|Treatment Phase|Lost to Follow-up|1|||
33417446|NCT04136626|101420305|FG001|Treatment Phase|Lost to Follow-up|5|||
33417447|NCT04136626|101420304|FG000|12-month Follow-up|Lost to Follow-up|8|||
33417448|NCT04136626|101420305|FG001|12-month Follow-up|Lost to Follow-up|7|||
33417449|NCT02362646|101420306|FG000|Overall Study|Death|15|||
33417450|NCT02362646|101420307|FG001|Overall Study|Death|8|||
33417451|NCT02362646|101420306|FG000|Overall Study|Withdrawal by Subject|2|||
33417452|NCT02362646|101420307|FG001|Overall Study|Withdrawal by Subject|2|||
33417453|NCT02362646|101420306|FG000|Overall Study|received transplant|21|||
33417454|NCT02362646|101420307|FG001|Overall Study|received transplant|14|||
33631494|NCT03755934|102203002|FG002|Overall Study|Adverse Event|1|||
33631495|NCT03755934|102203003|FG003|Overall Study|Adverse Event|3|||
33631496|NCT03755934|102203000|FG000|Overall Study|Physician Decision|2|||
33631497|NCT03755934|102203001|FG001|Overall Study|Physician Decision|0|||
33631498|NCT03755934|102203002|FG002|Overall Study|Physician Decision|0|||
33631499|NCT03755934|102203003|FG003|Overall Study|Physician Decision|1|||
33631500|NCT03755934|102203000|FG000|Overall Study|Withdrawal by Subject|5|||
33631501|NCT03755934|102203001|FG001|Overall Study|Withdrawal by Subject|0|||
33631502|NCT03755934|102203002|FG002|Overall Study|Withdrawal by Subject|0|||
33631503|NCT03755934|102203003|FG003|Overall Study|Withdrawal by Subject|1|||
33631504|NCT03755934|102203000|FG000|Overall Study|Other|3|||
33631505|NCT03755934|102203001|FG001|Overall Study|Other|1|||
33631506|NCT03755934|102203002|FG002|Overall Study|Other|3|||
33631507|NCT03755934|102203003|FG003|Overall Study|Other|1|||
33631508|NCT01652235|102203004|FG000|Overall Study|Death|9|||
33631509|NCT01652235|102203004|FG000|Overall Study|Lost to Follow-up|5|||
33631510|NCT01652235|102203004|FG000|Overall Study|Withdrawal by Subject|2|||
33631511|NCT02484391|102203005|FG000|Overall Study|Lack of Efficacy|15|||
33631512|NCT02484391|102203006|FG001|Overall Study|Lack of Efficacy|14|||
33631513|NCT02484391|102203007|FG002|Overall Study|Lack of Efficacy|3|||
33631514|NCT02484391|102203005|FG000|Overall Study|Lost to Follow-up|0|||
33631515|NCT02484391|102203006|FG001|Overall Study|Lost to Follow-up|0|||
33631516|NCT02484391|102203007|FG002|Overall Study|Lost to Follow-up|2|||
33631517|NCT02484391|102203005|FG000|Overall Study|Physician Decision|1|||
33631518|NCT02484391|102203006|FG001|Overall Study|Physician Decision|3|||
33631519|NCT02484391|102203007|FG002|Overall Study|Physician Decision|0|||
33631520|NCT02484391|102203005|FG000|Overall Study|Went to Transplant|5|||
33631521|NCT02484391|102203006|FG001|Overall Study|Went to Transplant|3|||
33631522|NCT02484391|102203007|FG002|Overall Study|Went to Transplant|2|||
33631523|NCT00412984|102203008|FG000|Overall Study|Death|331|||
33631524|NCT00412984|102203009|FG001|Overall Study|Death|349|||
33631525|NCT00412984|102203008|FG000|Overall Study|Adverse Event|679|||
33631526|NCT00412984|102203009|FG001|Overall Study|Adverse Event|738|||
33631527|NCT00412984|102203008|FG000|Overall Study|Withdrawal by Subject|921|||
33631528|NCT00412984|102203009|FG001|Overall Study|Withdrawal by Subject|989|||
33631529|NCT00412984|102203008|FG000|Overall Study|Lost to Follow-up|51|||
33631530|NCT00412984|102203009|FG001|Overall Study|Lost to Follow-up|39|||
33631531|NCT00412984|102203008|FG000|Overall Study|Poor/Noncompliance|57|||
33631532|NCT00412984|102203009|FG001|Overall Study|Poor/Noncompliance|77|||
33631533|NCT00412984|102203008|FG000|Overall Study|Pregnancy|1|||
33631534|NCT00412984|102203009|FG001|Overall Study|Pregnancy|0|||
33631535|NCT00412984|102203008|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
33631536|NCT00412984|102203009|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
33631537|NCT00412984|102203008|FG000|Overall Study|Administrative Reason by Sponsor|11|||
33631538|NCT00412984|102203009|FG001|Overall Study|Administrative Reason by Sponsor|8|||
33631539|NCT00412984|102203008|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
33631540|NCT00412984|102203009|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
33224894|NCT03183388|100724994|FG001|Overall Study|Physician Decision|4|||
33631541|NCT00412984|102203008|FG000|Overall Study|Other Reason|80|||
33631542|NCT00412984|102203009|FG001|Overall Study|Other Reason|92|||
33631543|NCT00412984|102203008|FG000|Overall Study|Not Reported|11|||
33224895|NCT03183388|100724993|FG000|Overall Study|Withdrawal by Subject|4|||
33631544|NCT00412984|102203009|FG001|Overall Study|Not Reported|12|||
33631545|NCT01210313|102203012|FG000|Overall Study|Withdrawal by Subject|3|||
33631546|NCT01210313|102203012|FG000|Overall Study|Adverse Event|2|||
33631547|NCT01210313|102203012|FG000|Overall Study|Distant recurrence|4|||
33631548|NCT01210313|102203012|FG000|Overall Study|Non-compliance|7|||
33631549|NCT03173560|102203013|FG000|Overall Study|Ongoing on Treatment|38|||
33365174|NCT00151411|101223765|FG001|Overall Study|Adverse Event|0|||
33365175|NCT00151411|101223764|FG000|Overall Study|Pregnancy|0|||
33365176|NCT00151411|101223765|FG001|Overall Study|Pregnancy|4|||
33365177|NCT02160977|101223766|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
33365178|NCT02160977|101223767|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
33365179|NCT02160977|101223766|FG000|Three Months After Surgery|Lost to Follow-up|0|||
33365180|NCT02160977|101223767|FG001|Three Months After Surgery|Lost to Follow-up|2|||
33365181|NCT02160977|101223766|FG000|Six Months After Surgery|Lost to Follow-up|2|||
33365182|NCT02160977|101223767|FG001|Six Months After Surgery|Lost to Follow-up|1|||
33365183|NCT01873742|101223768|FG000|Overall Study|Lost to Follow-up|68|||
33568393|NCT04033445|101974847|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
33568394|NCT04033445|101974848|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
33568395|NCT04033445|101974849|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
33568396|NCT04033445|101974850|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
33568397|NCT04033445|101974851|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
33568398|NCT04033445|101974852|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
33417455|NCT01216319|101420311|FG000|Overall Study|Lost to Follow-up|2|||
33417456|NCT01216319|101420311|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
33568399|NCT04033445|101974853|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
33568400|NCT04033445|101974854|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
33568401|NCT04033445|101974855|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
33568402|NCT04033445|101974842|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
33568403|NCT04033445|101974843|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
33568404|NCT04033445|101974844|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
33568405|NCT04033445|101974845|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
33568406|NCT04033445|101974846|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
33568407|NCT04033445|101974847|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
33568408|NCT04033445|101974848|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
33568409|NCT04033445|101974849|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
33568410|NCT04033445|101974850|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
33568411|NCT04033445|101974851|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
33568412|NCT04033445|101974852|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
33568413|NCT04033445|101974853|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
33568414|NCT04033445|101974854|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
33568415|NCT04033445|101974855|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
33568416|NCT04033445|101974842|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
33631550|NCT03173560|102203014|FG001|Overall Study|Ongoing on Treatment|50|||
33631551|NCT03173560|102203013|FG000|Overall Study|Ongoing Survival Follow-up|56|||
33631552|NCT03173560|102203014|FG001|Overall Study|Ongoing Survival Follow-up|57|||
33631553|NCT03173560|102203013|FG000|Overall Study|Lost to Follow-up|1|||
33631554|NCT03173560|102203014|FG001|Overall Study|Lost to Follow-up|4|||
33631555|NCT03173560|102203013|FG000|Overall Study|Withdrawal by Subject|10|||
33631556|NCT03173560|102203014|FG001|Overall Study|Withdrawal by Subject|5|||
33631557|NCT03173560|102203013|FG000|Overall Study|Other|0|||
33631558|NCT03173560|102203014|FG001|Overall Study|Other|1|||
33631559|NCT05543265|102203015|FG000|Overall Study|Lost to Follow-up|3|||
33631560|NCT05543265|102203016|FG001|Overall Study|Lost to Follow-up|3|||
33631561|NCT05543265|102203015|FG000|Overall Study|Withdrawal by Subject|0|||
33631562|NCT05543265|102203016|FG001|Overall Study|Withdrawal by Subject|1|||
33631563|NCT05058365|102203017|FG000|Overall Study|Migration|1|||
33631564|NCT05058365|102203018|FG001|Overall Study|Migration|1|||
33631565|NCT03043794|102203019|FG000|Overall Study|Lost to Follow-up|1|||
33631566|NCT00734149|102203023|FG000|Overall Study|Withdrawal by Subject|1|||
33631567|NCT04179175|102203024|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
33631568|NCT04179175|102203025|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
33631569|NCT04179175|102203026|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
33631570|NCT04179175|102203027|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
33631571|NCT04179175|102203028|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
33631572|NCT04179175|102203029|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
33631573|NCT04179175|102203024|FG000|Overall Study|Adverse Event|5|||
33631574|NCT04179175|102203025|FG001|Overall Study|Adverse Event|3|||
33631575|NCT04179175|102203026|FG002|Overall Study|Adverse Event|3|||
33631576|NCT04179175|102203027|FG003|Overall Study|Adverse Event|4|||
33417457|NCT01299272|101420314|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
33631577|NCT04179175|102203028|FG004|Overall Study|Adverse Event|6|||
33568417|NCT04033445|101974843|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
33568418|NCT04033445|101974844|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
33568419|NCT04033445|101974845|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
33568420|NCT04033445|101974846|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
33568421|NCT04033445|101974847|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
33568422|NCT04033445|101974848|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
33568423|NCT04033445|101974849|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
33568424|NCT04033445|101974850|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
33568425|NCT04033445|101974851|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
33224896|NCT03183388|100724994|FG001|Overall Study|Withdrawal by Subject|1|||
33224897|NCT03183388|100724993|FG000|Overall Study|Moved|1|||
33224898|NCT03183388|100724994|FG001|Overall Study|Moved|0|||
33224899|NCT03183388|100724993|FG000|Overall Study|Met Exclusion Criteria|2|||
33224900|NCT03183388|100724994|FG001|Overall Study|Met Exclusion Criteria|2|||
33224901|NCT03183388|100724993|FG000|Overall Study|COVID Pandemic Related|2|||
33224902|NCT03183388|100724994|FG001|Overall Study|COVID Pandemic Related|4|||
33224903|NCT01350505|100724995|FG000|Overall Study|Lost to Follow-up|4|||
33224904|NCT01642602|100724996|FG000|Overall Study|Adverse Event|2|||
33224905|NCT02914314|100724997|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
33417458|NCT01299272|101420315|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
33568426|NCT04033445|101974852|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
33568427|NCT04033445|101974853|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
33568428|NCT04033445|101974854|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
33568429|NCT04033445|101974855|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
33568430|NCT04033445|101974842|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
33568431|NCT04033445|101974843|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
33568432|NCT04033445|101974844|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
33568433|NCT04033445|101974845|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
33568434|NCT04033445|101974846|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
33568435|NCT04033445|101974847|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
33568436|NCT04033445|101974848|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
33224906|NCT02914314|100724998|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
33417459|NCT01299272|101420316|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
33631578|NCT04179175|102203029|FG005|Overall Study|Adverse Event|6|||
33631579|NCT04179175|102203024|FG000|Overall Study|Lack of Efficacy|5|||
33631580|NCT04179175|102203025|FG001|Overall Study|Lack of Efficacy|1|||
33631581|NCT04179175|102203026|FG002|Overall Study|Lack of Efficacy|3|||
33631582|NCT04179175|102203027|FG003|Overall Study|Lack of Efficacy|2|||
33631583|NCT04179175|102203028|FG004|Overall Study|Lack of Efficacy|18|||
33631584|NCT04179175|102203029|FG005|Overall Study|Lack of Efficacy|7|||
33631585|NCT04179175|102203024|FG000|Overall Study|Lost to Follow-up|5|||
33631586|NCT04179175|102203025|FG001|Overall Study|Lost to Follow-up|3|||
33631587|NCT04179175|102203026|FG002|Overall Study|Lost to Follow-up|2|||
33631588|NCT04179175|102203027|FG003|Overall Study|Lost to Follow-up|2|||
33631589|NCT04179175|102203028|FG004|Overall Study|Lost to Follow-up|4|||
33631590|NCT04179175|102203029|FG005|Overall Study|Lost to Follow-up|5|||
33631591|NCT04179175|102203024|FG000|Overall Study|Physician Decision|2|||
33631592|NCT04179175|102203025|FG001|Overall Study|Physician Decision|0|||
33631593|NCT04179175|102203026|FG002|Overall Study|Physician Decision|2|||
33631594|NCT04179175|102203027|FG003|Overall Study|Physician Decision|3|||
33631595|NCT04179175|102203028|FG004|Overall Study|Physician Decision|1|||
33631596|NCT04179175|102203029|FG005|Overall Study|Physician Decision|1|||
33631597|NCT04179175|102203024|FG000|Overall Study|Pregnancy|3|||
33631598|NCT04179175|102203025|FG001|Overall Study|Pregnancy|0|||
33631599|NCT04179175|102203026|FG002|Overall Study|Pregnancy|3|||
33631600|NCT04179175|102203027|FG003|Overall Study|Pregnancy|0|||
33631601|NCT04179175|102203028|FG004|Overall Study|Pregnancy|1|||
33631602|NCT04179175|102203029|FG005|Overall Study|Pregnancy|2|||
33631603|NCT04179175|102203024|FG000|Overall Study|Withdrawal by Subject|22|||
33631604|NCT04179175|102203025|FG001|Overall Study|Withdrawal by Subject|10|||
33631605|NCT04179175|102203026|FG002|Overall Study|Withdrawal by Subject|12|||
33631606|NCT04179175|102203027|FG003|Overall Study|Withdrawal by Subject|8|||
33631607|NCT04179175|102203028|FG004|Overall Study|Withdrawal by Subject|23|||
33631608|NCT04179175|102203029|FG005|Overall Study|Withdrawal by Subject|31|||
33631609|NCT04179175|102203024|FG000|Overall Study|Technical problems|0|||
33631610|NCT04179175|102203025|FG001|Overall Study|Technical problems|0|||
33631611|NCT04179175|102203026|FG002|Overall Study|Technical problems|1|||
33631612|NCT04179175|102203027|FG003|Overall Study|Technical problems|1|||
33631613|NCT04179175|102203028|FG004|Overall Study|Technical problems|0|||
33631614|NCT04179175|102203029|FG005|Overall Study|Technical problems|0|||
33631615|NCT01263769|102203030|FG000|Overall Study|Non-Compliant with treatment|1|||
33631616|NCT00626106|102203034|FG000|Overall Study|Withdrawal by Subject|2|||
33631617|NCT00626106|102203035|FG001|Overall Study|Withdrawal by Subject|1|||
33631618|NCT00626106|102203034|FG000|Overall Study|Lost to Follow-up|1|||
33631619|NCT00626106|102203035|FG001|Overall Study|Lost to Follow-up|4|||
33631620|NCT00626106|102203034|FG000|Overall Study|Death|64|||
33631621|NCT00626106|102203035|FG001|Overall Study|Death|19|||
33631622|NCT00400179|102203049|FG000|Overall Study|Adverse Event|2|||
33631623|NCT00400179|102203050|FG001|Overall Study|Adverse Event|2|||
33631624|NCT00400179|102203049|FG000|Overall Study|Death|1|||
33631625|NCT00400179|102203050|FG001|Overall Study|Death|2|||
33631626|NCT00400179|102203049|FG000|Overall Study|Withdrew Consent|1|||
33631627|NCT00400179|102203050|FG001|Overall Study|Withdrew Consent|5|||
33631628|NCT00400179|102203049|FG000|Overall Study|Disease progression|1|||
33631629|NCT00400179|102203050|FG001|Overall Study|Disease progression|1|||
33631630|NCT00400179|102203049|FG000|Overall Study|Intercurrent illness|0|||
33631631|NCT00400179|102203050|FG001|Overall Study|Intercurrent illness|1|||
33631632|NCT00400179|102203049|FG000|Overall Study|Investigator judgment|0|||
33631633|NCT00400179|102203050|FG001|Overall Study|Investigator judgment|1|||
33631634|NCT00400179|102203049|FG000|Overall Study|Randomization error/patient ineligible|1|||
33631635|NCT00400179|102203050|FG001|Overall Study|Randomization error/patient ineligible|6|||
33631636|NCT04576988|102203051|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
33631637|NCT04576988|102203052|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
33631638|NCT04576988|102203051|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
33631639|NCT04576988|102203052|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
33417460|NCT01299272|101420317|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
33417461|NCT01299272|101420314|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
33417462|NCT01299272|101420315|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
33631640|NCT04576988|102203051|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
33631641|NCT04576988|102203052|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
33631642|NCT04576988|102203051|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
33631643|NCT04576988|102203052|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
33631644|NCT04576988|102203051|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
33631645|NCT04576988|102203052|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
33631646|NCT04576988|102203051|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
33631647|NCT04576988|102203052|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
33631648|NCT04576988|102203051|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
33631649|NCT04576988|102203052|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
33631650|NCT04576988|102203051|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
33224907|NCT02914314|100724999|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
33224908|NCT02914314|100725000|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
33224909|NCT02914314|100724997|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
33224910|NCT02914314|100724998|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
33224911|NCT02914314|100724999|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
33224912|NCT02914314|100725000|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
33224913|NCT02914314|100724997|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
33224914|NCT02914314|100724998|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
33224915|NCT02914314|100724999|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
33224916|NCT02914314|100725000|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
33224917|NCT02914314|100724997|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
33224918|NCT02914314|100724998|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
33224919|NCT02914314|100724999|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
33224920|NCT02914314|100725000|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
33224921|NCT02914314|100724997|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
33224922|NCT02914314|100724998|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
33224923|NCT02914314|100724999|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
33224924|NCT02914314|100725000|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
33224925|NCT00003511|100725001|FG000|Overall Study|Not evaluable|4|||
33224926|NCT01119768|100725002|FG000|Treatment Period|Lack of Efficacy|18|||
33224927|NCT01119768|100725003|FG001|Treatment Period|Lack of Efficacy|25|||
33224928|NCT00171873|100725004|FG000|Overall Study|Withdrawal by Subject|4|||
33224929|NCT00171873|100725005|FG001|Overall Study|Withdrawal by Subject|2|||
33224930|NCT00171873|100725004|FG000|Overall Study|Adverse Event|5|||
33224931|NCT00171873|100725005|FG001|Overall Study|Adverse Event|0|||
33417463|NCT01299272|101420316|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
33417464|NCT01299272|101420317|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
33417465|NCT01299272|101420314|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
33631651|NCT04576988|102203052|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
33631652|NCT04576988|102203051|FG000|Long Term Double Blind (LTDB)|Death|2|||
33631653|NCT04576988|102203052|FG001|Long Term Double Blind (LTDB)|Death|1|||
33631654|NCT04576988|102203051|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
33631655|NCT04576988|102203052|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
33631656|NCT04966013|102203062|FG000|Overall Study|Withdrawal by Subject|0|||
33631657|NCT04966013|102203063|FG001|Overall Study|Withdrawal by Subject|2|||
33631658|NCT04966013|102203064|FG002|Overall Study|Withdrawal by Subject|1|||
33631659|NCT04966013|102203062|FG000|Overall Study|Adverse Event|2|||
33631660|NCT04966013|102203063|FG001|Overall Study|Adverse Event|1|||
33631661|NCT04966013|102203064|FG002|Overall Study|Adverse Event|1|||
33631662|NCT02052778|102203065|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
33631663|NCT02052778|102203066|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
33631664|NCT02052778|102203067|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
33631665|NCT02052778|102203068|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
33631666|NCT02052778|102203069|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
33631667|NCT02052778|102203070|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
33631668|NCT02052778|102203071|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
33631669|NCT02052778|102203072|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
33631670|NCT02052778|102203073|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
33631671|NCT02052778|102203074|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
33631672|NCT02052778|102203075|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
33631673|NCT02052778|102203076|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
33631674|NCT02052778|102203077|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
33631675|NCT02052778|102203078|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
33631676|NCT02052778|102203079|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
33631677|NCT02052778|102203080|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
33631678|NCT02052778|102203081|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
33631679|NCT02052778|102203082|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
33631680|NCT02052778|102203083|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
33631681|NCT02052778|102203084|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
33631682|NCT02052778|102203085|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
33631683|NCT02052778|102203086|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
33631684|NCT02052778|102203087|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
33631685|NCT02052778|102203065|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
33631686|NCT02052778|102203066|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
33631687|NCT02052778|102203067|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
33631688|NCT02052778|102203068|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
33631689|NCT02052778|102203069|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
33631690|NCT02052778|102203070|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
33631691|NCT02052778|102203071|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
33631692|NCT02052778|102203072|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
33631693|NCT02052778|102203073|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
33631694|NCT02052778|102203074|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
33631695|NCT02052778|102203075|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
33631696|NCT02052778|102203076|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
33631697|NCT02052778|102203077|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
33631698|NCT02052778|102203078|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
33631699|NCT02052778|102203079|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
33631700|NCT02052778|102203080|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
33631701|NCT02052778|102203081|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
33631702|NCT02052778|102203082|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
33631703|NCT02052778|102203083|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
33631704|NCT02052778|102203084|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
33631705|NCT02052778|102203085|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
33631706|NCT02052778|102203086|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
33631707|NCT02052778|102203087|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
33631708|NCT02052778|102203065|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33224932|NCT00171873|100725004|FG000|Overall Study|Switched to Octreotide|0|||
33224933|NCT00171873|100725005|FG001|Overall Study|Switched to Octreotide|1|||
33224934|NCT02496767|100725010|FG000|Open-label Lead-in Phase|Adverse Event|176|||
33224935|NCT02496767|100725011|FG001|Open-label Lead-in Phase|Adverse Event|0|||
33224936|NCT02496767|100725012|FG002|Open-label Lead-in Phase|Adverse Event|0|||
33224937|NCT02496767|100725013|FG003|Open-label Lead-in Phase|Adverse Event|0|||
33224938|NCT02496767|100725014|FG004|Open-label Lead-in Phase|Adverse Event|0|||
33631709|NCT02052778|102203066|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631710|NCT02052778|102203067|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631711|NCT02052778|102203068|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631712|NCT02052778|102203069|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631713|NCT02052778|102203070|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631714|NCT02052778|102203071|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631715|NCT02052778|102203072|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631716|NCT02052778|102203073|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631717|NCT02052778|102203074|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631718|NCT02052778|102203075|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631719|NCT02052778|102203076|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631720|NCT02052778|102203077|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631721|NCT02052778|102203078|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
33631722|NCT02052778|102203079|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631723|NCT02052778|102203080|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631724|NCT02052778|102203081|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631725|NCT02052778|102203082|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631726|NCT02052778|102203083|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631727|NCT02052778|102203084|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631728|NCT02052778|102203085|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631729|NCT02052778|102203086|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631730|NCT02052778|102203087|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
33631731|NCT02052778|102203065|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
33631732|NCT02052778|102203066|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
33631733|NCT02052778|102203067|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
33631734|NCT02052778|102203068|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
33631735|NCT02052778|102203069|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
33631736|NCT02052778|102203070|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
33631737|NCT02052778|102203071|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
33631738|NCT02052778|102203072|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
33631739|NCT02052778|102203073|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
33631740|NCT02052778|102203074|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
33631741|NCT02052778|102203075|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
33631742|NCT02052778|102203076|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
33631743|NCT02052778|102203077|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
33631744|NCT02052778|102203078|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
33631745|NCT02052778|102203079|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
33631746|NCT02052778|102203080|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
33631747|NCT02052778|102203081|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
33631748|NCT02052778|102203082|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
33631749|NCT02052778|102203083|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
33631750|NCT02052778|102203084|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
33631751|NCT02052778|102203085|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
33631752|NCT02052778|102203086|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
33631753|NCT02052778|102203087|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
33631754|NCT02052778|102203065|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631755|NCT02052778|102203066|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631756|NCT02052778|102203067|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631757|NCT02052778|102203068|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631758|NCT02052778|102203069|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631759|NCT02052778|102203070|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631760|NCT02052778|102203071|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631761|NCT02052778|102203072|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631762|NCT02052778|102203073|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
33631763|NCT02052778|102203074|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33224939|NCT02496767|100725015|FG005|Open-label Lead-in Phase|Adverse Event|0|||
33224940|NCT02496767|100725016|FG006|Open-label Lead-in Phase|Adverse Event|0|||
33224941|NCT02496767|100725017|FG007|Open-label Lead-in Phase|Adverse Event|0|||
33224942|NCT02496767|100725010|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
33224943|NCT02496767|100725011|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
33224944|NCT02496767|100725012|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
33568437|NCT04033445|101974849|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
33224945|NCT02496767|100725013|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
33224946|NCT02496767|100725014|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
33224947|NCT02496767|100725015|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
33224948|NCT02496767|100725016|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
33224949|NCT02496767|100725017|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
33224950|NCT02496767|100725010|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
33224951|NCT02496767|100725011|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
33224952|NCT02496767|100725012|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
33224953|NCT02496767|100725013|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
33224954|NCT02496767|100725014|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
33224955|NCT02496767|100725015|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
33224956|NCT02496767|100725016|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
33224957|NCT02496767|100725017|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
33224958|NCT02496767|100725010|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
33224959|NCT02496767|100725011|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
33224960|NCT02496767|100725012|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
33224961|NCT02496767|100725013|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
33224962|NCT02496767|100725014|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
33224963|NCT02496767|100725015|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
33224964|NCT02496767|100725016|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
33224965|NCT02496767|100725017|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
33224966|NCT02496767|100725010|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
33224967|NCT02496767|100725011|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
33224968|NCT02496767|100725012|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
33224969|NCT02496767|100725013|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
33631764|NCT02052778|102203075|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631765|NCT02052778|102203076|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631766|NCT02052778|102203077|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631767|NCT02052778|102203078|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
33631768|NCT02052778|102203079|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631769|NCT02052778|102203080|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631770|NCT02052778|102203081|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631771|NCT02052778|102203082|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33224970|NCT02496767|100725014|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
33224971|NCT02496767|100725015|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
33224972|NCT02496767|100725016|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
33224973|NCT02496767|100725017|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
33224974|NCT02496767|100725010|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
33224975|NCT02496767|100725011|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
33224976|NCT02496767|100725012|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
33224977|NCT02496767|100725013|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
33224978|NCT02496767|100725014|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
33224979|NCT02496767|100725015|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
33224980|NCT02496767|100725016|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
33224981|NCT02496767|100725017|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
33224982|NCT02496767|100725010|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
33224983|NCT02496767|100725011|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
33224984|NCT02496767|100725012|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
33224985|NCT02496767|100725013|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
33224986|NCT02496767|100725014|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
33224987|NCT02496767|100725015|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
33224988|NCT02496767|100725016|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
33224989|NCT02496767|100725017|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
33224990|NCT02496767|100725010|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33224991|NCT02496767|100725011|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
33224992|NCT02496767|100725012|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
33224993|NCT02496767|100725013|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
33224994|NCT02496767|100725014|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
33224995|NCT02496767|100725015|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33224996|NCT02496767|100725016|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33224997|NCT02496767|100725017|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33224998|NCT02496767|100725010|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
33224999|NCT02496767|100725011|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
33225000|NCT02496767|100725012|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
33225001|NCT02496767|100725013|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
33225002|NCT02496767|100725014|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
33225003|NCT02496767|100725015|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
33225004|NCT02496767|100725016|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
33225005|NCT02496767|100725017|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
33225006|NCT02496767|100725010|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33225007|NCT02496767|100725011|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
33225008|NCT02496767|100725012|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33225009|NCT02496767|100725013|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
33225010|NCT02496767|100725014|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
33225011|NCT02496767|100725015|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33225012|NCT02496767|100725016|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33225013|NCT02496767|100725017|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33225014|NCT02496767|100725010|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
33225015|NCT02496767|100725011|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
33225016|NCT02496767|100725012|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
33225017|NCT02496767|100725013|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
33225018|NCT02496767|100725014|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
33225019|NCT02496767|100725015|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
33225020|NCT02496767|100725016|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
33225021|NCT02496767|100725017|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
33225022|NCT02496767|100725010|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
33225023|NCT02496767|100725011|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
33225024|NCT02496767|100725012|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
33225025|NCT02496767|100725013|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
33225026|NCT02496767|100725014|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
33225027|NCT02496767|100725015|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
33225028|NCT02496767|100725016|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
33225029|NCT02496767|100725017|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
33225030|NCT02496767|100725010|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
33225031|NCT02496767|100725011|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
33225032|NCT02496767|100725012|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
33225033|NCT02496767|100725013|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
33225034|NCT02496767|100725014|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
33225035|NCT02496767|100725015|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
33225036|NCT02496767|100725016|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
33225037|NCT02496767|100725017|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
33225038|NCT02496767|100725010|FG000|Double-blind, Withdrawal Phase|Death|0|||
33225039|NCT02496767|100725011|FG001|Double-blind, Withdrawal Phase|Death|0|||
33225040|NCT02496767|100725012|FG002|Double-blind, Withdrawal Phase|Death|0|||
33225041|NCT02496767|100725013|FG003|Double-blind, Withdrawal Phase|Death|0|||
33225042|NCT02496767|100725014|FG004|Double-blind, Withdrawal Phase|Death|0|||
33225043|NCT02496767|100725015|FG005|Double-blind, Withdrawal Phase|Death|0|||
33225044|NCT02496767|100725016|FG006|Double-blind, Withdrawal Phase|Death|1|||
33225045|NCT02496767|100725017|FG007|Double-blind, Withdrawal Phase|Death|2|||
33225046|NCT02496767|100725010|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
33225047|NCT02496767|100725011|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
33225048|NCT02496767|100725012|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
33225049|NCT02496767|100725013|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
33225050|NCT02496767|100725014|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
33225051|NCT02496767|100725015|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
33225052|NCT02496767|100725016|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
33225053|NCT02496767|100725017|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
33225054|NCT01338012|100725024|FG000|Overall Study|Death|4|||
33225055|NCT01338012|100725024|FG000|Overall Study|Study terminated|4|||
33225056|NCT01862796|100725025|FG000|Overall Study|Prohibited medications|0|||
33225057|NCT01862796|100725026|FG001|Overall Study|Prohibited medications|0|||
33225058|NCT01862796|100725027|FG002|Overall Study|Prohibited medications|1|||
33225059|NCT04599101|100725028|FG000|Overall Study|Lost to Follow-up|5|||
33225060|NCT04599101|100725029|FG001|Overall Study|Lost to Follow-up|5|||
33225061|NCT04399356|100725030|FG000|Overall Study|Lost to Follow-up|1|||
33225062|NCT04399356|100725031|FG001|Overall Study|Lost to Follow-up|1|||
33225063|NCT04399356|100725030|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
33225064|NCT04399356|100725031|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
33225065|NCT04399356|100725030|FG000|Overall Study|Withdrawal by Subject|1|||
33225066|NCT04399356|100725031|FG001|Overall Study|Withdrawal by Subject|0|||
33225067|NCT01872910|100725032|FG000|Overall Study|Lost to Follow-up|2|||
33225068|NCT01872910|100725033|FG001|Overall Study|Lost to Follow-up|0|||
33225069|NCT01872910|100725034|FG002|Overall Study|Lost to Follow-up|2|||
33225070|NCT01872910|100725035|FG003|Overall Study|Lost to Follow-up|0|||
33225071|NCT01872910|100725036|FG004|Overall Study|Lost to Follow-up|0|||
33225072|NCT01872910|100725037|FG005|Overall Study|Lost to Follow-up|0|||
33225073|NCT01054573|100725039|FG000|Overall Study|Adverse Event|1|||
33225074|NCT01054573|100725040|FG001|Overall Study|Adverse Event|0|||
33225075|NCT01054573|100725041|FG002|Overall Study|Adverse Event|1|||
33225076|NCT01054573|100725042|FG003|Overall Study|Adverse Event|1|||
33225077|NCT01054573|100725039|FG000|Overall Study|Lost to Follow-up|0|||
33225078|NCT01054573|100725040|FG001|Overall Study|Lost to Follow-up|2|||
33225079|NCT01054573|100725041|FG002|Overall Study|Lost to Follow-up|0|||
33225080|NCT01054573|100725042|FG003|Overall Study|Lost to Follow-up|0|||
33225081|NCT01054573|100725039|FG000|Overall Study|Withdrawal by Subject|0|||
33225082|NCT01054573|100725040|FG001|Overall Study|Withdrawal by Subject|2|||
33225083|NCT01054573|100725041|FG002|Overall Study|Withdrawal by Subject|2|||
33225084|NCT01054573|100725042|FG003|Overall Study|Withdrawal by Subject|1|||
33631772|NCT02052778|102203083|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33225085|NCT02567825|100725043|FG000|Overall Study|No follow-up post-randomization|5|||
33225086|NCT02567825|100725044|FG001|Overall Study|No follow-up post-randomization|1|||
33225087|NCT02567825|100725043|FG000|Overall Study|Follow-up less than 23 months|16|||
33225088|NCT02567825|100725044|FG001|Overall Study|Follow-up less than 23 months|20|||
33225089|NCT03176238|100725048|FG000|Overall Study|Unacceptable AEs|15|||
33225090|NCT03176238|100725049|FG001|Overall Study|Unacceptable AEs|8|||
33225091|NCT03176238|100725048|FG000|Overall Study|Abnormal lab value(s)|2|||
33365184|NCT01873742|101223769|FG001|Overall Study|Lost to Follow-up|76|||
33225092|NCT03176238|100725049|FG001|Overall Study|Abnormal lab value(s)|0|||
33225093|NCT03176238|100725048|FG000|Overall Study|Inter-current illness|0|||
33225094|NCT03176238|100725049|FG001|Overall Study|Inter-current illness|1|||
33225095|NCT03176238|100725048|FG000|Overall Study|Consent withdrawal|14|||
33225096|NCT03176238|100725049|FG001|Overall Study|Consent withdrawal|2|||
33225097|NCT03176238|100725048|FG000|Overall Study|Lost to Follow-up|3|||
33225098|NCT03176238|100725049|FG001|Overall Study|Lost to Follow-up|0|||
33225099|NCT03176238|100725048|FG000|Overall Study|Administrative problems|1|||
33225100|NCT03176238|100725049|FG001|Overall Study|Administrative problems|0|||
33225101|NCT03176238|100725048|FG000|Overall Study|Death|3|||
33225102|NCT03176238|100725049|FG001|Overall Study|Death|0|||
33225103|NCT03176238|100725048|FG000|Overall Study|Disease Progression|133|||
33225104|NCT03176238|100725049|FG001|Overall Study|Disease Progression|22|||
33225105|NCT03176238|100725048|FG000|Overall Study|Tx duration completed per EAP|0|||
33225106|NCT03176238|100725049|FG001|Overall Study|Tx duration completed per EAP|1|||
33225107|NCT03176238|100725048|FG000|Overall Study|Patient is switched to commercial drug|16|||
33225108|NCT03176238|100725049|FG001|Overall Study|Patient is switched to commercial drug|1|||
33225109|NCT03176238|100725048|FG000|Overall Study|Protocol Violation|1|||
33225110|NCT03176238|100725049|FG001|Overall Study|Protocol Violation|0|||
33225111|NCT03176238|100725048|FG000|Overall Study|Changes in the patient's condition|2|||
33225112|NCT03176238|100725049|FG001|Overall Study|Changes in the patient's condition|1|||
33225113|NCT03176238|100725048|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
33225114|NCT03176238|100725049|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
33225115|NCT03673462|100725051|FG000|Overall Study|Adverse Event|11|||
33225116|NCT03673462|100725052|FG001|Overall Study|Adverse Event|1|||
33225117|NCT03673462|100725051|FG000|Overall Study|Protocol Violation|25|||
33225118|NCT03673462|100725052|FG001|Overall Study|Protocol Violation|11|||
33225119|NCT03673462|100725051|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
33225120|NCT03673462|100725052|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
33225121|NCT03673462|100725051|FG000|Overall Study|Lost to Follow-up|102|||
33225122|NCT03673462|100725052|FG001|Overall Study|Lost to Follow-up|19|||
33225123|NCT02759185|100725054|FG000|Stage 1|Adverse Event|0|||
33631773|NCT02052778|102203084|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631774|NCT02052778|102203085|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631775|NCT02052778|102203086|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631776|NCT02052778|102203087|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
33631777|NCT02052778|102203065|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631778|NCT02052778|102203066|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631779|NCT02052778|102203067|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631780|NCT02052778|102203068|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631781|NCT02052778|102203069|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631782|NCT02052778|102203070|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
33225124|NCT02759185|100725055|FG001|Stage 1|Adverse Event|1|||
33365185|NCT00641043|101223770|FG000|Overall Study|Adverse Event|6|||
33225125|NCT02759185|100725056|FG002|Stage 1|Adverse Event|3|||
33225126|NCT02759185|100725057|FG003|Stage 1|Adverse Event|0|||
33225127|NCT02759185|100725058|FG004|Stage 1|Adverse Event|0|||
33225128|NCT02759185|100725059|FG005|Stage 1|Adverse Event|0|||
33631783|NCT02052778|102203071|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631784|NCT02052778|102203072|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33225129|NCT02759185|100725060|FG006|Stage 1|Adverse Event|0|||
33225130|NCT02759185|100725054|FG000|Stage 1|Withdrawal by Subject|1|||
33225131|NCT02759185|100725055|FG001|Stage 1|Withdrawal by Subject|0|||
33225132|NCT02759185|100725056|FG002|Stage 1|Withdrawal by Subject|0|||
33631785|NCT02052778|102203073|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631786|NCT02052778|102203074|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631787|NCT02052778|102203075|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33225133|NCT02759185|100725057|FG003|Stage 1|Withdrawal by Subject|0|||
33225134|NCT02759185|100725058|FG004|Stage 1|Withdrawal by Subject|0|||
33225135|NCT02759185|100725059|FG005|Stage 1|Withdrawal by Subject|0|||
33225136|NCT02759185|100725060|FG006|Stage 1|Withdrawal by Subject|0|||
33225137|NCT02759185|100725054|FG000|Stage 2|Adverse Event|0|||
33225138|NCT02759185|100725055|FG001|Stage 2|Adverse Event|0|||
33225139|NCT02759185|100725056|FG002|Stage 2|Adverse Event|0|||
33225140|NCT02759185|100725057|FG003|Stage 2|Adverse Event|0|||
33225141|NCT02759185|100725058|FG004|Stage 2|Adverse Event|1|||
33225142|NCT02759185|100725059|FG005|Stage 2|Adverse Event|2|||
33225143|NCT02759185|100725060|FG006|Stage 2|Adverse Event|0|||
33225144|NCT02759185|100725054|FG000|Stage 2|Withdrawal by Subject|0|||
33225145|NCT02759185|100725055|FG001|Stage 2|Withdrawal by Subject|0|||
33225146|NCT02759185|100725056|FG002|Stage 2|Withdrawal by Subject|0|||
33225147|NCT02759185|100725057|FG003|Stage 2|Withdrawal by Subject|0|||
33225148|NCT02759185|100725058|FG004|Stage 2|Withdrawal by Subject|1|||
33225149|NCT02759185|100725059|FG005|Stage 2|Withdrawal by Subject|1|||
33225150|NCT02759185|100725060|FG006|Stage 2|Withdrawal by Subject|1|||
33225151|NCT00949884|100725061|FG000|Overall Study|Adverse Event|14|||
33225152|NCT00949884|100725062|FG001|Overall Study|Adverse Event|3|||
33225153|NCT00949884|100725063|FG002|Overall Study|Adverse Event|12|||
33225154|NCT00949884|100725061|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
33225155|NCT00949884|100725062|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
33225156|NCT00949884|100725063|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
33225157|NCT00949884|100725061|FG000|Overall Study|Lost to Follow-up|7|||
33225158|NCT00949884|100725062|FG001|Overall Study|Lost to Follow-up|5|||
33225159|NCT00949884|100725063|FG002|Overall Study|Lost to Follow-up|5|||
33225160|NCT00949884|100725061|FG000|Overall Study|Physician Decision|5|||
33225161|NCT00949884|100725062|FG001|Overall Study|Physician Decision|0|||
33225162|NCT00949884|100725063|FG002|Overall Study|Physician Decision|6|||
33225163|NCT00949884|100725061|FG000|Overall Study|Treatment non-compliance|5|||
33225164|NCT00949884|100725062|FG001|Overall Study|Treatment non-compliance|0|||
33225165|NCT00949884|100725063|FG002|Overall Study|Treatment non-compliance|8|||
33225166|NCT00949884|100725061|FG000|Overall Study|Withdrawal by Subject|13|||
33225167|NCT00949884|100725062|FG001|Overall Study|Withdrawal by Subject|4|||
33225168|NCT00949884|100725063|FG002|Overall Study|Withdrawal by Subject|16|||
33225169|NCT00949884|100725061|FG000|Overall Study|Lack of Efficacy|4|||
33225170|NCT00949884|100725062|FG001|Overall Study|Lack of Efficacy|2|||
33225171|NCT00949884|100725063|FG002|Overall Study|Lack of Efficacy|7|||
33225172|NCT00949884|100725061|FG000|Overall Study|Study terminated by sponsor|0|||
33568438|NCT04033445|101974850|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
33568439|NCT04033445|101974851|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
33568440|NCT04033445|101974852|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
33568441|NCT04033445|101974853|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
33568442|NCT04033445|101974854|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
33568443|NCT04033445|101974855|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
33568444|NCT04033445|101974842|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
33568445|NCT04033445|101974843|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
33568446|NCT04033445|101974844|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
33568447|NCT04033445|101974845|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
33568448|NCT04033445|101974846|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
33568449|NCT04033445|101974847|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
33568450|NCT04033445|101974848|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
33568451|NCT04033445|101974849|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
33568452|NCT04033445|101974850|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
33568453|NCT04033445|101974851|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
33568454|NCT04033445|101974852|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
33225173|NCT00949884|100725062|FG001|Overall Study|Study terminated by sponsor|0|||
33568455|NCT04033445|101974853|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
33568456|NCT04033445|101974854|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
33568457|NCT04033445|101974855|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
33568458|NCT03038672|101974856|FG000|Initial Treatment|Unacceptable chemistry|0|||
33568459|NCT03038672|101974857|FG001|Initial Treatment|Unacceptable chemistry|1|||
33568460|NCT03038672|101974856|FG000|Initial Treatment|Progression prior to treatment|1|||
33568461|NCT03038672|101974857|FG001|Initial Treatment|Progression prior to treatment|0|||
33568462|NCT03038672|101974856|FG000|Initial Treatment|No treatment per protocol|1|||
33568463|NCT03038672|101974857|FG001|Initial Treatment|No treatment per protocol|0|||
33568464|NCT04439266|101974858|FG000|Overall Study|Ineligible|1|||
33568465|NCT04439266|101974858|FG000|Overall Study|Adverse Event|1|||
33568466|NCT04439266|101974858|FG000|Overall Study|Death|1|||
33568467|NCT04439266|101974858|FG000|Overall Study|Disease progression|1|||
33568468|NCT04439266|101974858|FG000|Overall Study|Still on treatment|1|||
33568469|NCT05730335|101974859|FG000|Overall Study|Continuing in ongoing study|58|||
33568470|NCT05730335|101974859|FG000|Overall Study|Withdrawal by Subject|1|||
33568471|NCT05870865|101974860|FG000|Randomized|Did not receive study treatment|2|||
33568472|NCT05870865|101974861|FG001|Randomized|Did not receive study treatment|4|||
33568473|NCT05870865|101974862|FG002|Randomized|Did not receive study treatment|4|||
33568474|NCT05870865|101974863|FG003|Randomized|Did not receive study treatment|3|||
33568475|NCT05870865|101974860|FG000|Treatment Period|Adverse Event|1|||
33568476|NCT05870865|101974861|FG001|Treatment Period|Adverse Event|1|||
33568477|NCT05870865|101974862|FG002|Treatment Period|Adverse Event|1|||
33568478|NCT05870865|101974863|FG003|Treatment Period|Adverse Event|1|||
33568479|NCT05870865|101974860|FG000|Treatment Period|Lost to Follow-up|0|||
33568480|NCT05870865|101974861|FG001|Treatment Period|Lost to Follow-up|1|||
33568481|NCT05870865|101974862|FG002|Treatment Period|Lost to Follow-up|2|||
33568482|NCT05870865|101974863|FG003|Treatment Period|Lost to Follow-up|0|||
33568483|NCT05870865|101974860|FG000|Treatment Period|Protocol Violation|0|||
33568484|NCT05870865|101974861|FG001|Treatment Period|Protocol Violation|0|||
33568485|NCT05870865|101974862|FG002|Treatment Period|Protocol Violation|0|||
33568486|NCT05870865|101974863|FG003|Treatment Period|Protocol Violation|1|||
33568487|NCT05870865|101974860|FG000|Treatment Period|Withdrawal by Subject|0|||
33568488|NCT05870865|101974861|FG001|Treatment Period|Withdrawal by Subject|1|||
33568489|NCT05870865|101974862|FG002|Treatment Period|Withdrawal by Subject|1|||
33568490|NCT05870865|101974863|FG003|Treatment Period|Withdrawal by Subject|1|||
33568491|NCT02052882|101974879|FG000|Overall Study|Not treated|11|||
33568492|NCT02052882|101974879|FG000|Overall Study|Protocol Violation|1|||
33568493|NCT02052882|101974879|FG000|Overall Study|Inadequate testing|1|||
33568494|NCT02828358|101974880|FG000|Overall Study|Physician Decision|7|||
33568495|NCT02828358|101974881|FG001|Overall Study|Physician Decision|1|||
33631788|NCT02052778|102203076|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631789|NCT02052778|102203077|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
33631790|NCT02052778|102203078|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631791|NCT02052778|102203079|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631792|NCT02052778|102203080|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631793|NCT02052778|102203081|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631794|NCT02052778|102203082|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631795|NCT02052778|102203083|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631796|NCT02052778|102203084|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631797|NCT02052778|102203085|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631798|NCT02052778|102203086|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631799|NCT02052778|102203087|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
33631800|NCT02052778|102203065|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33631801|NCT02052778|102203066|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33631802|NCT02052778|102203067|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33631803|NCT02052778|102203068|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33568496|NCT02828358|101974880|FG000|Overall Study|Treatment Failure|6|||
33568497|NCT02828358|101974881|FG001|Overall Study|Treatment Failure|0|||
33568498|NCT02828358|101974880|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
33568499|NCT02828358|101974881|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
33568500|NCT02828358|101974880|FG000|Overall Study|Refusal of further protocol therapy|2|||
33568501|NCT02828358|101974881|FG001|Overall Study|Refusal of further protocol therapy|0|||
33568502|NCT02828358|101974880|FG000|Overall Study|Relapse|25|||
33568503|NCT02828358|101974881|FG001|Overall Study|Relapse|0|||
33631804|NCT02052778|102203069|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33568504|NCT02828358|101974880|FG000|Overall Study|Still on therapy|5|||
33568505|NCT02828358|101974881|FG001|Overall Study|Still on therapy|0|||
33568506|NCT02626533|101974882|FG000|Overall Study|Protocol Violation|14|||
33568507|NCT02626533|101974882|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
33568508|NCT02626533|101974882|FG000|Overall Study|Withdrawal by Subject|1|||
33568509|NCT04117347|101974885|FG000|Overall Study|Adverse Event|0|||
33568510|NCT04117347|101974886|FG001|Overall Study|Adverse Event|0|||
33568511|NCT04117347|101974887|FG002|Overall Study|Adverse Event|1|||
33568512|NCT04117347|101974885|FG000|Overall Study|No time for study|0|||
33568513|NCT04117347|101974886|FG001|Overall Study|No time for study|2|||
33568514|NCT04117347|101974887|FG002|Overall Study|No time for study|0|||
33568515|NCT04117347|101974885|FG000|Overall Study|Family emergency|1|||
33631805|NCT02052778|102203070|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33631806|NCT02052778|102203071|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33631807|NCT02052778|102203072|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33365186|NCT00641043|101223771|FG001|Overall Study|Adverse Event|4|||
33365187|NCT00641043|101223770|FG000|Overall Study|Protocol Violation|2|||
33365188|NCT00641043|101223771|FG001|Overall Study|Protocol Violation|3|||
33365189|NCT00641043|101223770|FG000|Overall Study|Lost to Follow-up|3|||
33365190|NCT00641043|101223771|FG001|Overall Study|Lost to Follow-up|2|||
33365191|NCT00641043|101223770|FG000|Overall Study|Withdrawal by Subject|4|||
33365192|NCT00641043|101223771|FG001|Overall Study|Withdrawal by Subject|4|||
33631808|NCT02052778|102203073|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33631809|NCT02052778|102203074|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33631810|NCT02052778|102203075|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33631811|NCT02052778|102203076|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33631812|NCT02052778|102203077|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33631813|NCT02052778|102203078|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33631814|NCT02052778|102203079|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
33631815|NCT02052778|102203080|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
33631816|NCT02052778|102203081|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
33631817|NCT02052778|102203082|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
33631818|NCT02052778|102203083|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
33631819|NCT02052778|102203084|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
33631820|NCT02052778|102203085|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
33631821|NCT02052778|102203086|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
33631822|NCT02052778|102203087|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
33631823|NCT02052778|102203065|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33631824|NCT02052778|102203066|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33631825|NCT02052778|102203067|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33631826|NCT02052778|102203068|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33631827|NCT02052778|102203069|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33631828|NCT02052778|102203070|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33631829|NCT02052778|102203071|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33631830|NCT02052778|102203072|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33631831|NCT02052778|102203073|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33631832|NCT02052778|102203074|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33631833|NCT02052778|102203075|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33365193|NCT00641043|101223770|FG000|Overall Study|Other incl. lack of efficacy|4|||
33365194|NCT00641043|101223771|FG001|Overall Study|Other incl. lack of efficacy|2|||
33365195|NCT01319929|101223772|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
33417466|NCT01299272|101420315|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
33568516|NCT04117347|101974886|FG001|Overall Study|Family emergency|0|||
33568517|NCT04117347|101974887|FG002|Overall Study|Family emergency|0|||
33568518|NCT00843882|101974888|FG000|Step 1|Lack of Efficacy|14|||
33568519|NCT00843882|101974889|FG001|Step 1|Lack of Efficacy|10|||
33365196|NCT01319929|101223773|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
33365197|NCT01319929|101223772|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
33568520|NCT00843882|101974890|FG002|Step 1|Lack of Efficacy|21|||
33365198|NCT01319929|101223773|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
33631834|NCT02052778|102203076|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33365199|NCT01319929|101223772|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
33365200|NCT01319929|101223773|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
33365201|NCT01319929|101223772|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
33365202|NCT01319929|101223773|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
33365203|NCT01319929|101223772|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
33365204|NCT01319929|101223773|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
33365205|NCT02345434|101223776|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
33365206|NCT02345434|101223777|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
33365207|NCT02296840|101223782|FG000|Overall Study|Adverse Event|1|||
33365208|NCT02296840|101223783|FG001|Overall Study|Adverse Event|1|||
33365209|NCT02296840|101223782|FG000|Overall Study|Protocol Violation|2|||
33365210|NCT02296840|101223783|FG001|Overall Study|Protocol Violation|1|||
33417467|NCT01299272|101420316|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
33417468|NCT01299272|101420317|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
33417469|NCT01299272|101420314|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
33417470|NCT01299272|101420315|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
33417471|NCT01299272|101420316|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
33417472|NCT01299272|101420317|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
33417473|NCT01299272|101420314|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
33417474|NCT01299272|101420315|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
33417475|NCT01299272|101420316|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
33417476|NCT01299272|101420317|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
33417477|NCT01299272|101420314|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
33417478|NCT01299272|101420315|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
33417479|NCT01299272|101420316|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
33225174|NCT00949884|100725063|FG002|Overall Study|Study terminated by sponsor|1|||
33417480|NCT01299272|101420317|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
33417481|NCT01299272|101420314|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
33417482|NCT01299272|101420315|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
33417483|NCT01299272|101420316|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
33417484|NCT01299272|101420317|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
33417485|NCT01299272|101420314|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
33417486|NCT01299272|101420315|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
33417487|NCT01299272|101420316|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
33417488|NCT01299272|101420317|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
33417489|NCT01299272|101420314|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
33417490|NCT01299272|101420315|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
33417491|NCT01299272|101420316|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
33417492|NCT01299272|101420317|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
33417493|NCT01299272|101420314|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
33417494|NCT01299272|101420315|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
33417495|NCT01299272|101420316|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
33417496|NCT01299272|101420317|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
33417497|NCT01299272|101420314|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
33568521|NCT00843882|101974888|FG000|Step 1|Adverse Event|8|||
33568522|NCT00843882|101974889|FG001|Step 1|Adverse Event|17|||
33568523|NCT00843882|101974890|FG002|Step 1|Adverse Event|20|||
33568524|NCT00843882|101974888|FG000|Step 1|Death|1|||
33225175|NCT00113360|100725066|FG000|Overall Study|Adverse Event|3|||
33365211|NCT02296840|101223782|FG000|Overall Study|Lost to Follow-up|6|||
33568525|NCT00843882|101974889|FG001|Step 1|Death|2|||
33568526|NCT00843882|101974890|FG002|Step 1|Death|4|||
33568527|NCT00843882|101974888|FG000|Step 1|Withdrawal by Subject|6|||
33568528|NCT00843882|101974889|FG001|Step 1|Withdrawal by Subject|12|||
33365212|NCT02296840|101223783|FG001|Overall Study|Lost to Follow-up|17|||
33365213|NCT02275026|101223784|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
33365214|NCT02275026|101223784|FG000|Overall Study|Withdrawal by Subject|4|||
33365215|NCT02275026|101223784|FG000|Overall Study|Ineligible due to medical history|13|||
33365216|NCT02275026|101223784|FG000|Overall Study|MRI malfunction precluded testing|1|||
33365217|NCT02275026|101223784|FG000|Overall Study|Ineligible after MRI findings|1|||
33365218|NCT02275026|101223784|FG000|Overall Study|Lost to Follow-up|2|||
33365219|NCT02275026|101223784|FG000|Overall Study|Scanner failure|1|||
33365220|NCT01208662|101223785|FG000|Induction and Consolidation|Disease Progression|23|||
33365221|NCT01208662|101223786|FG001|Induction and Consolidation|Disease Progression|13|||
33365222|NCT01208662|101223787|FG002|Induction and Consolidation|Disease Progression|0|||
33365223|NCT01208662|101223785|FG000|Induction and Consolidation|Adverse Event|16|||
33365224|NCT01208662|101223786|FG001|Induction and Consolidation|Adverse Event|18|||
33365225|NCT01208662|101223787|FG002|Induction and Consolidation|Adverse Event|2|||
33365226|NCT01208662|101223785|FG000|Induction and Consolidation|MD or Participant Decision|16|||
33365227|NCT01208662|101223786|FG001|Induction and Consolidation|MD or Participant Decision|34|||
33365228|NCT01208662|101223787|FG002|Induction and Consolidation|MD or Participant Decision|4|||
33365229|NCT01208662|101223785|FG000|Induction and Consolidation|Death|1|||
33365230|NCT01208662|101223786|FG001|Induction and Consolidation|Death|3|||
33365231|NCT01208662|101223787|FG002|Induction and Consolidation|Death|1|||
33417498|NCT01299272|101420315|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
33417499|NCT01299272|101420316|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
33417500|NCT01299272|101420317|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
33417501|NCT01299272|101420314|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
33365232|NCT01208662|101223785|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
33365233|NCT01208662|101223786|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
33417502|NCT01299272|101420315|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
33417503|NCT01299272|101420316|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
33417504|NCT01299272|101420317|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
33417505|NCT01299272|101420314|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
33417506|NCT01299272|101420315|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
33568529|NCT00843882|101974890|FG002|Step 1|Withdrawal by Subject|9|||
33568530|NCT00843882|101974888|FG000|Step 1|Physician Decision|0|||
33365234|NCT01208662|101223787|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
33568531|NCT00843882|101974889|FG001|Step 1|Physician Decision|5|||
33568532|NCT00843882|101974890|FG002|Step 1|Physician Decision|1|||
33365235|NCT01208662|101223785|FG000|Maintenance|Disease Progression|156|||
33631835|NCT02052778|102203077|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33631836|NCT02052778|102203078|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33631837|NCT02052778|102203079|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
33631838|NCT02052778|102203080|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
33631839|NCT02052778|102203081|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33631840|NCT02052778|102203082|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
33631841|NCT02052778|102203083|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
33631842|NCT02052778|102203084|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
33631843|NCT02052778|102203085|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
33631844|NCT02052778|102203086|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
33631845|NCT02052778|102203087|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
33631846|NCT02052778|102203065|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631847|NCT02052778|102203066|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631848|NCT02052778|102203067|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631849|NCT02052778|102203068|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631850|NCT02052778|102203069|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631851|NCT02052778|102203070|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631852|NCT02052778|102203071|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631853|NCT02052778|102203072|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631854|NCT02052778|102203073|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631855|NCT02052778|102203074|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631856|NCT02052778|102203075|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631857|NCT02052778|102203076|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631858|NCT02052778|102203077|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631859|NCT02052778|102203078|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631860|NCT02052778|102203079|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
33631861|NCT02052778|102203080|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
33631862|NCT02052778|102203081|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
33631863|NCT02052778|102203082|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631864|NCT02052778|102203083|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
33631865|NCT02052778|102203084|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
33631866|NCT02052778|102203085|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631867|NCT02052778|102203086|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631868|NCT02052778|102203087|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
33631869|NCT02052778|102203065|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631870|NCT02052778|102203066|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631871|NCT02052778|102203067|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631872|NCT02052778|102203068|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631873|NCT02052778|102203069|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631874|NCT02052778|102203070|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631875|NCT02052778|102203071|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631876|NCT02052778|102203072|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631877|NCT02052778|102203073|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631878|NCT02052778|102203074|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631879|NCT02052778|102203075|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631880|NCT02052778|102203076|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631881|NCT02052778|102203077|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631882|NCT02052778|102203078|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631883|NCT02052778|102203079|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
33631884|NCT02052778|102203080|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
33631885|NCT02052778|102203081|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631886|NCT02052778|102203082|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631887|NCT02052778|102203083|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631888|NCT02052778|102203084|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631889|NCT02052778|102203085|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631890|NCT02052778|102203086|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631891|NCT02052778|102203087|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
33631892|NCT02052778|102203065|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631893|NCT02052778|102203066|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631894|NCT02052778|102203067|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631895|NCT02052778|102203068|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631896|NCT02052778|102203069|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33568533|NCT00843882|101974888|FG000|Step 1|Patient and physician's decision|0|||
33568534|NCT00843882|101974889|FG001|Step 1|Patient and physician's decision|0|||
33568535|NCT00843882|101974890|FG002|Step 1|Patient and physician's decision|1|||
33568536|NCT00843882|101974888|FG000|Step 1|Other complicating disease|1|||
33568537|NCT00843882|101974889|FG001|Step 1|Other complicating disease|3|||
33568538|NCT00843882|101974890|FG002|Step 1|Other complicating disease|4|||
33568539|NCT00843882|101974888|FG000|Step 1|Alternative therapy|0|||
33568540|NCT00843882|101974889|FG001|Step 1|Alternative therapy|1|||
33568541|NCT00843882|101974890|FG002|Step 1|Alternative therapy|1|||
33568542|NCT00843882|101974888|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
33568543|NCT00843882|101974889|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
33568544|NCT00843882|101974890|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
33568545|NCT00843882|101974888|FG000|Step 1|Off treatment reason unknown|0|||
33568546|NCT00843882|101974889|FG001|Step 1|Off treatment reason unknown|1|||
33568547|NCT00843882|101974890|FG002|Step 1|Off treatment reason unknown|4|||
33568548|NCT00843882|101974888|FG000|Step 1|Never started treatment|2|||
33568549|NCT00843882|101974889|FG001|Step 1|Never started treatment|0|||
33568550|NCT00843882|101974890|FG002|Step 1|Never started treatment|0|||
33568551|NCT00843882|101974888|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
33568552|NCT00843882|101974889|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
33568553|NCT00843882|101974890|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
33568554|NCT00843882|101974888|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
33568555|NCT00843882|101974889|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
33568556|NCT00843882|101974890|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
33568557|NCT00843882|101974888|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
33568558|NCT00843882|101974889|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
33568559|NCT00843882|101974890|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
33568560|NCT00843882|101974888|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
33225176|NCT00113360|100725066|FG000|Overall Study|Subject required surgery|1|||
33568561|NCT00843882|101974889|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
33568562|NCT00843882|101974890|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
33568563|NCT00843882|101974888|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
33568564|NCT00843882|101974889|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
33568565|NCT00843882|101974890|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
33568566|NCT00843882|101974888|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
33568567|NCT00843882|101974889|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
33568568|NCT00843882|101974890|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
33568569|NCT00843882|101974888|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
33568570|NCT00843882|101974889|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
33568571|NCT00843882|101974890|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
33568572|NCT00644228|101974891|FG000|Randomization & Eligibility|Ineligible|31|||
33568573|NCT00644228|101974892|FG001|Randomization & Eligibility|Ineligible|21|||
33568574|NCT00644228|101974891|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
33568575|NCT00644228|101974892|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
33568576|NCT00644228|101974891|FG000|Randomization & Eligibility|Invalid Consent|0|||
33568577|NCT00644228|101974892|FG001|Randomization & Eligibility|Invalid Consent|1|||
33568578|NCT00644228|101974891|FG000|Induction Therapy|Adverse Event|22|||
33568579|NCT00644228|101974892|FG001|Induction Therapy|Adverse Event|55|||
33568580|NCT00644228|101974891|FG000|Induction Therapy|Withdrawal by Subject|10|||
33568581|NCT00644228|101974892|FG001|Induction Therapy|Withdrawal by Subject|3|||
33568582|NCT00644228|101974891|FG000|Induction Therapy|Progression/Relapse|24|||
33568583|NCT00644228|101974892|FG001|Induction Therapy|Progression/Relapse|12|||
33568584|NCT00644228|101974891|FG000|Induction Therapy|Death|3|||
33568585|NCT00644228|101974892|FG001|Induction Therapy|Death|7|||
33631897|NCT02052778|102203070|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631898|NCT02052778|102203071|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631899|NCT02052778|102203072|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631900|NCT02052778|102203073|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631901|NCT02052778|102203074|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631902|NCT02052778|102203075|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631903|NCT02052778|102203076|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631904|NCT02052778|102203077|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631905|NCT02052778|102203078|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631906|NCT02052778|102203079|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
33631907|NCT02052778|102203080|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
33631908|NCT02052778|102203081|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631909|NCT02052778|102203082|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631910|NCT02052778|102203083|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631911|NCT02052778|102203084|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
33631912|NCT02052778|102203085|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631913|NCT02052778|102203086|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631914|NCT02052778|102203087|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
33631915|NCT02052778|102203065|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
33225177|NCT00113360|100725066|FG000|Overall Study|Did not meet eligibility criteria|3|||
33225178|NCT01857622|100725067|FG000|Overall Study|Adverse Event|5|||
33225179|NCT01857622|100725068|FG001|Overall Study|Adverse Event|0|||
33225180|NCT01857622|100725069|FG002|Overall Study|Adverse Event|2|||
33365236|NCT01208662|101223786|FG001|Maintenance|Disease Progression|102|||
33365237|NCT01208662|101223787|FG002|Maintenance|Disease Progression|0|||
33365238|NCT01208662|101223785|FG000|Maintenance|Adverse Event|12|||
33568586|NCT00644228|101974891|FG000|Induction Therapy|Not Protocol-Specified|24|||
33568587|NCT00644228|101974892|FG001|Induction Therapy|Not Protocol-Specified|28|||
33568588|NCT00644228|101974891|FG000|Maintenance|Adverse Event|27|||
33568589|NCT00644228|101974892|FG001|Maintenance|Adverse Event|31|||
33568590|NCT00644228|101974891|FG000|Maintenance|Withdrawal by Subject|6|||
33631916|NCT02052778|102203066|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
33225181|NCT01857622|100725067|FG000|Overall Study|Physician Decision|1|||
33568591|NCT00644228|101974892|FG001|Maintenance|Withdrawal by Subject|4|||
33568592|NCT00644228|101974891|FG000|Maintenance|Progression/Relapse|67|||
33568593|NCT00644228|101974892|FG001|Maintenance|Progression/Relapse|42|||
33568594|NCT00644228|101974891|FG000|Maintenance|Death|3|||
33568595|NCT00644228|101974892|FG001|Maintenance|Death|3|||
33568596|NCT00644228|101974891|FG000|Maintenance|Not Protocol-Specified|14|||
33568597|NCT00644228|101974892|FG001|Maintenance|Not Protocol-Specified|15|||
33568598|NCT00644228|101974891|FG000|Maintenance|On Treatment|26|||
33568599|NCT00644228|101974892|FG001|Maintenance|On Treatment|40|||
33568600|NCT02115282|101974893|FG000|Overall Study|Disease progression during treatment|216|||
33568601|NCT02115282|101974894|FG001|Overall Study|Disease progression during treatment|229|||
33568602|NCT02115282|101974893|FG000|Overall Study|Adverse Event|49|||
33568603|NCT02115282|101974894|FG001|Overall Study|Adverse Event|23|||
33568604|NCT02115282|101974893|FG000|Overall Study|Death|1|||
33568605|NCT02115282|101974894|FG001|Overall Study|Death|3|||
33225182|NCT01857622|100725068|FG001|Overall Study|Physician Decision|0|||
33225183|NCT01857622|100725069|FG002|Overall Study|Physician Decision|0|||
33225184|NCT01857622|100725067|FG000|Overall Study|Protocol Violation|4|||
33225185|NCT01857622|100725068|FG001|Overall Study|Protocol Violation|1|||
33225186|NCT01857622|100725069|FG002|Overall Study|Protocol Violation|0|||
33225187|NCT01857622|100725067|FG000|Overall Study|Withdrawal by Subject|1|||
33225188|NCT01857622|100725068|FG001|Overall Study|Withdrawal by Subject|0|||
33225189|NCT01857622|100725069|FG002|Overall Study|Withdrawal by Subject|0|||
33225190|NCT02306122|100725072|FG000|Initial Physician Randomization|Physician Decision|0|||
33225191|NCT02306122|100725073|FG001|Initial Physician Randomization|Physician Decision|0|||
33225192|NCT02306122|100725074|FG002|Initial Physician Randomization|Physician Decision|0|||
33225193|NCT02306122|100725075|FG003|Initial Physician Randomization|Physician Decision|0|||
33225194|NCT02306122|100725076|FG004|Initial Physician Randomization|Physician Decision|0|||
33225195|NCT02306122|100725077|FG005|Initial Physician Randomization|Physician Decision|0|||
33225196|NCT02306122|100725078|FG006|Initial Physician Randomization|Physician Decision|0|||
33225197|NCT02306122|100725079|FG007|Initial Physician Randomization|Physician Decision|0|||
33225198|NCT02306122|100725080|FG008|Initial Physician Randomization|Physician Decision|1|||
33225199|NCT02306122|100725081|FG009|Initial Physician Randomization|Physician Decision|0|||
33225200|NCT02306122|100725082|FG010|Initial Physician Randomization|Physician Decision|0|||
33225201|NCT03565068|100725083|FG000|Overall Study|Protocol Violation|0|||
33225202|NCT03565068|100725084|FG001|Overall Study|Protocol Violation|0|||
33225203|NCT03565068|100725085|FG002|Overall Study|Protocol Violation|0|||
33225204|NCT03565068|100725086|FG003|Overall Study|Protocol Violation|0|||
33225205|NCT03565068|100725087|FG004|Overall Study|Protocol Violation|1|||
33225206|NCT03565068|100725088|FG005|Overall Study|Protocol Violation|0|||
33225207|NCT03565068|100725089|FG006|Overall Study|Protocol Violation|0|||
33225208|NCT03565068|100725090|FG007|Overall Study|Protocol Violation|1|||
33225209|NCT03565068|100725091|FG008|Overall Study|Protocol Violation|0|||
33365239|NCT01208662|101223786|FG001|Maintenance|Adverse Event|28|||
33365240|NCT01208662|101223787|FG002|Maintenance|Adverse Event|0|||
33365241|NCT01208662|101223785|FG000|Maintenance|MD or Participant Decision|24|||
33365242|NCT01208662|101223786|FG001|Maintenance|MD or Participant Decision|36|||
33365243|NCT01208662|101223787|FG002|Maintenance|MD or Participant Decision|0|||
33365244|NCT01208662|101223785|FG000|Maintenance|Death|0|||
33365245|NCT01208662|101223786|FG001|Maintenance|Death|3|||
33365246|NCT01208662|101223787|FG002|Maintenance|Death|0|||
33365247|NCT01208662|101223785|FG000|Maintenance|Discontinued for other reasons|21|||
33365248|NCT01208662|101223786|FG001|Maintenance|Discontinued for other reasons|31|||
33365249|NCT01208662|101223787|FG002|Maintenance|Discontinued for other reasons|0|||
33365250|NCT01208662|101223785|FG000|Maintenance|Still on Treatment|78|||
33365251|NCT01208662|101223786|FG001|Maintenance|Still on Treatment|89|||
33365252|NCT01208662|101223787|FG002|Maintenance|Still on Treatment|0|||
33365253|NCT02062151|101223788|FG000|Overall Study|screen failure|1|||
33365254|NCT02747043|101223791|FG000|Overall Study|Other|1|||
33365255|NCT02747043|101223792|FG001|Overall Study|Other|1|||
33568606|NCT02115282|101974893|FG000|Overall Study|Alternative therapy|1|||
33568607|NCT02115282|101974894|FG001|Overall Study|Alternative therapy|1|||
33568608|NCT02115282|101974893|FG000|Overall Study|Complicating disease|0|||
33568609|NCT02115282|101974894|FG001|Overall Study|Complicating disease|3|||
33568610|NCT02115282|101974893|FG000|Overall Study|Withdrawal by Subject|12|||
33568611|NCT02115282|101974894|FG001|Overall Study|Withdrawal by Subject|10|||
33568612|NCT02115282|101974893|FG000|Overall Study|Symptomatic progression/deterioration|7|||
33568613|NCT02115282|101974894|FG001|Overall Study|Symptomatic progression/deterioration|18|||
33568614|NCT02115282|101974893|FG000|Overall Study|Non-compliance|5|||
33568615|NCT02115282|101974894|FG001|Overall Study|Non-compliance|1|||
33568616|NCT02115282|101974893|FG000|Overall Study|Protocol Violation|2|||
33225210|NCT03565068|100725083|FG000|Overall Study|Sponsor decision|0|||
33225211|NCT03565068|100725084|FG001|Overall Study|Sponsor decision|0|||
33225212|NCT03565068|100725085|FG002|Overall Study|Sponsor decision|0|||
33225213|NCT03565068|100725086|FG003|Overall Study|Sponsor decision|0|||
33365256|NCT02747043|101223791|FG000|Overall Study|Adverse Event|3|||
33365257|NCT02747043|101223792|FG001|Overall Study|Adverse Event|1|||
33365258|NCT02747043|101223791|FG000|Overall Study|Withdrawal by Subject|1|||
33225214|NCT03565068|100725087|FG004|Overall Study|Sponsor decision|1|||
33225215|NCT03565068|100725088|FG005|Overall Study|Sponsor decision|1|||
33225216|NCT03565068|100725089|FG006|Overall Study|Sponsor decision|0|||
33225217|NCT03565068|100725090|FG007|Overall Study|Sponsor decision|0|||
33225218|NCT03565068|100725091|FG008|Overall Study|Sponsor decision|0|||
33568617|NCT02115282|101974894|FG001|Overall Study|Protocol Violation|2|||
33225219|NCT03565068|100725083|FG000|Overall Study|Withdrawal by Subject|0|||
33225220|NCT03565068|100725084|FG001|Overall Study|Withdrawal by Subject|0|||
33225221|NCT03565068|100725085|FG002|Overall Study|Withdrawal by Subject|1|||
33225222|NCT03565068|100725086|FG003|Overall Study|Withdrawal by Subject|0|||
33225223|NCT03565068|100725087|FG004|Overall Study|Withdrawal by Subject|2|||
33225224|NCT03565068|100725088|FG005|Overall Study|Withdrawal by Subject|0|||
33225225|NCT03565068|100725089|FG006|Overall Study|Withdrawal by Subject|1|||
33225226|NCT03565068|100725090|FG007|Overall Study|Withdrawal by Subject|5|||
33225227|NCT03565068|100725091|FG008|Overall Study|Withdrawal by Subject|1|||
33225228|NCT03565068|100725083|FG000|Overall Study|Physician Decision|0|||
33225229|NCT03565068|100725084|FG001|Overall Study|Physician Decision|0|||
33225230|NCT03565068|100725085|FG002|Overall Study|Physician Decision|0|||
33225231|NCT03565068|100725086|FG003|Overall Study|Physician Decision|0|||
33225232|NCT03565068|100725087|FG004|Overall Study|Physician Decision|0|||
33225233|NCT03565068|100725088|FG005|Overall Study|Physician Decision|0|||
33225234|NCT03565068|100725089|FG006|Overall Study|Physician Decision|0|||
33225235|NCT03565068|100725090|FG007|Overall Study|Physician Decision|1|||
33225236|NCT03565068|100725091|FG008|Overall Study|Physician Decision|0|||
33225237|NCT03565068|100725083|FG000|Overall Study|Lost to Follow-up|0|||
33225238|NCT03565068|100725084|FG001|Overall Study|Lost to Follow-up|0|||
33225239|NCT03565068|100725085|FG002|Overall Study|Lost to Follow-up|0|||
33225240|NCT03565068|100725086|FG003|Overall Study|Lost to Follow-up|0|||
33225241|NCT03565068|100725087|FG004|Overall Study|Lost to Follow-up|0|||
33568618|NCT02115282|101974893|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
33568619|NCT02115282|101974894|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
33568620|NCT02115282|101974893|FG000|Overall Study|Not start protocol therapy|9|||
33568621|NCT02115282|101974894|FG001|Overall Study|Not start protocol therapy|10|||
33225242|NCT03565068|100725088|FG005|Overall Study|Lost to Follow-up|0|||
33225243|NCT03565068|100725089|FG006|Overall Study|Lost to Follow-up|0|||
33225244|NCT03565068|100725090|FG007|Overall Study|Lost to Follow-up|1|||
33225245|NCT03565068|100725091|FG008|Overall Study|Lost to Follow-up|0|||
33225246|NCT04615182|100725096|FG000|Overall Study|Re-transplanted|2|||
33225247|NCT04615182|100725096|FG000|Overall Study|Protocol Violation|6|||
33225248|NCT04615182|100725096|FG000|Overall Study|Death|6|||
33365259|NCT02747043|101223792|FG001|Overall Study|Withdrawal by Subject|1|||
33365260|NCT02747043|101223791|FG000|Overall Study|Physician Decision|1|||
33225249|NCT04615182|100725096|FG000|Overall Study|Death and protocol violation|1|||
33225250|NCT04704154|100725097|FG000|Overall Study|Adverse Event|2|||
33225251|NCT04704154|100725098|FG001|Overall Study|Adverse Event|1|||
33225252|NCT04704154|100725099|FG002|Overall Study|Adverse Event|3|||
33225253|NCT04704154|100725100|FG003|Overall Study|Adverse Event|2|||
33365261|NCT02747043|101223792|FG001|Overall Study|Physician Decision|1|||
33365262|NCT02747043|101223791|FG000|Overall Study|Protocol Violation|0|||
33365263|NCT02747043|101223792|FG001|Overall Study|Protocol Violation|1|||
33365264|NCT02747043|101223791|FG000|Overall Study|Disease progression|4|||
33568622|NCT04971109|101974895|FG000|Overall Study|Adverse Event|4|||
33568623|NCT04971109|101974896|FG001|Overall Study|Adverse Event|3|||
33568624|NCT04971109|101974895|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
33225254|NCT04704154|100725101|FG004|Overall Study|Adverse Event|3|||
33225255|NCT04704154|100725102|FG005|Overall Study|Adverse Event|0|||
33225256|NCT04704154|100725097|FG000|Overall Study|Death|3|||
33225257|NCT04704154|100725098|FG001|Overall Study|Death|0|||
33225258|NCT04704154|100725099|FG002|Overall Study|Death|0|||
33225259|NCT04704154|100725100|FG003|Overall Study|Death|0|||
33365265|NCT02747043|101223792|FG001|Overall Study|Disease progression|0|||
33568625|NCT04971109|101974896|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
33225260|NCT04704154|100725101|FG004|Overall Study|Death|3|||
33225261|NCT04704154|100725102|FG005|Overall Study|Death|0|||
33225262|NCT04704154|100725097|FG000|Overall Study|Physician Decision|1|||
33365266|NCT01936649|101223799|FG000|Overall Study|Withdrawal by Subject|4|||
33568626|NCT04971109|101974895|FG000|Overall Study|Lost to Follow-up|8|||
33568627|NCT04971109|101974896|FG001|Overall Study|Lost to Follow-up|2|||
33568628|NCT04971109|101974895|FG000|Overall Study|Physician Decision|5|||
33568629|NCT04971109|101974896|FG001|Overall Study|Physician Decision|0|||
33568630|NCT04971109|101974895|FG000|Overall Study|Protocol Violation|0|||
33225263|NCT04704154|100725098|FG001|Overall Study|Physician Decision|0|||
33225264|NCT04704154|100725099|FG002|Overall Study|Physician Decision|0|||
33225265|NCT04704154|100725100|FG003|Overall Study|Physician Decision|0|||
33225266|NCT04704154|100725101|FG004|Overall Study|Physician Decision|1|||
33225267|NCT04704154|100725102|FG005|Overall Study|Physician Decision|0|||
33225268|NCT04704154|100725097|FG000|Overall Study|Participant Decision|1|||
33225269|NCT04704154|100725098|FG001|Overall Study|Participant Decision|1|||
33225270|NCT04704154|100725099|FG002|Overall Study|Participant Decision|0|||
33225271|NCT04704154|100725100|FG003|Overall Study|Participant Decision|0|||
33225272|NCT04704154|100725101|FG004|Overall Study|Participant Decision|0|||
33225273|NCT04704154|100725102|FG005|Overall Study|Participant Decision|0|||
33225274|NCT04704154|100725097|FG000|Overall Study|Progressive Disease|16|||
33225275|NCT04704154|100725098|FG001|Overall Study|Progressive Disease|17|||
33225276|NCT04704154|100725099|FG002|Overall Study|Progressive Disease|20|||
33568631|NCT04971109|101974896|FG001|Overall Study|Protocol Violation|1|||
33568632|NCT04971109|101974895|FG000|Overall Study|Withdrawal by Subject|18|||
33568633|NCT04971109|101974896|FG001|Overall Study|Withdrawal by Subject|3|||
33568634|NCT04971109|101974895|FG000|Overall Study|Subject was randomized in error|1|||
33568635|NCT04971109|101974896|FG001|Overall Study|Subject was randomized in error|0|||
33568636|NCT02286089|101974899|FG000|Overall Study|Ongoing in Study|1|||
33568637|NCT02286089|101974900|FG001|Overall Study|Ongoing in Study|1|||
33568638|NCT02286089|101974901|FG002|Overall Study|Ongoing in Study|4|||
33568639|NCT02286089|101974902|FG003|Overall Study|Ongoing in Study|10|||
33568640|NCT02286089|101974899|FG000|Overall Study|Withdrawal by Subject|0|||
33568641|NCT02286089|101974900|FG001|Overall Study|Withdrawal by Subject|0|||
33568642|NCT02286089|101974901|FG002|Overall Study|Withdrawal by Subject|2|||
33568643|NCT02286089|101974902|FG003|Overall Study|Withdrawal by Subject|2|||
33568644|NCT02473445|101974903|FG000|Overall Study|Withdrawal by Subject|2|||
33568645|NCT02473445|101974903|FG000|Overall Study|Sponsor Decision|20|||
33568646|NCT03988621|101974906|FG000|Overall Study|Lost to Follow-up|16|||
33225277|NCT04704154|100725100|FG003|Overall Study|Progressive Disease|18|||
33225278|NCT04704154|100725101|FG004|Overall Study|Progressive Disease|36|||
33225279|NCT04704154|100725102|FG005|Overall Study|Progressive Disease|30|||
33225280|NCT04704154|100725097|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
33225281|NCT04704154|100725098|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
33225282|NCT04704154|100725099|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
33225283|NCT04704154|100725100|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
33225284|NCT04704154|100725101|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
33568647|NCT03988621|101974907|FG001|Overall Study|Lost to Follow-up|17|||
33568648|NCT03988621|101974906|FG000|Overall Study|Withdrawal by Subject|14|||
33568649|NCT03988621|101974907|FG001|Overall Study|Withdrawal by Subject|7|||
33365267|NCT01936649|101223799|FG000|Overall Study|Physician Decision|2|||
33365268|NCT01936649|101223799|FG000|Overall Study|Protocol Violation|2|||
33365269|NCT01936649|101223799|FG000|Overall Study|Other than specified above|5|||
33365270|NCT02421120|101223800|FG000|Overall Study|Adverse Event|1|||
33365271|NCT03303339|101223801|FG000|Overall Study|Death|2|||
33365272|NCT03303339|101223802|FG001|Overall Study|Death|2|||
33365273|NCT03303339|101223803|FG002|Overall Study|Death|2|||
33365274|NCT03303339|101223804|FG003|Overall Study|Death|1|||
33365275|NCT03303339|101223805|FG004|Overall Study|Death|4|||
33417507|NCT01299272|101420316|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
33417508|NCT01299272|101420317|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
33225285|NCT04704154|100725102|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
33225286|NCT04207840|100725103|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
33225287|NCT04207840|100725104|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
33225288|NCT04207840|100725105|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
33417509|NCT01299272|101420314|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
33417510|NCT01299272|101420315|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
33417511|NCT01299272|101420316|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
33417512|NCT01299272|101420317|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
33365276|NCT03303339|101223806|FG005|Overall Study|Death|2|||
33365277|NCT03303339|101223807|FG006|Overall Study|Death|2|||
33365278|NCT03303339|101223808|FG007|Overall Study|Death|2|||
33365279|NCT03303339|101223809|FG008|Overall Study|Death|3|||
33365280|NCT03303339|101223810|FG009|Overall Study|Death|3|||
33417513|NCT01299272|101420314|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
33417514|NCT01299272|101420315|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
33417515|NCT01299272|101420316|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
33417516|NCT01299272|101420317|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
33417517|NCT01299272|101420314|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
33417518|NCT01299272|101420315|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
33417519|NCT01299272|101420316|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
33417520|NCT01299272|101420317|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
33417521|NCT01299272|101420314|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
33417522|NCT01299272|101420315|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
33417523|NCT01299272|101420316|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
33225289|NCT04207840|100725103|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
33417524|NCT01299272|101420317|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
33417525|NCT01299272|101420314|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
33568650|NCT03988621|101974906|FG000|Overall Study|Patient Lost to Follow Up|15|||
33631917|NCT02052778|102203067|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
33631918|NCT02052778|102203068|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
33631919|NCT02052778|102203069|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
33631920|NCT02052778|102203070|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
33631921|NCT02052778|102203071|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
33631922|NCT02052778|102203072|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
33225290|NCT04207840|100725104|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
33225291|NCT04207840|100725105|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
33568651|NCT03988621|101974907|FG001|Overall Study|Patient Lost to Follow Up|15|||
33568652|NCT03988621|101974906|FG000|Overall Study|Patient death|1|||
33568653|NCT03988621|101974907|FG001|Overall Study|Patient death|5|||
33568654|NCT03484819|101974908|FG000|Overall Study|Death|2|||
33568655|NCT03484819|101974908|FG000|Overall Study|Adverse Event|2|||
33568656|NCT03484819|101974908|FG000|Overall Study|Physician Decision|1|||
33568657|NCT03484819|101974908|FG000|Overall Study|Withdrawal by Subject|2|||
33568658|NCT03484819|101974908|FG000|Overall Study|Disease Progression|4|||
33568659|NCT03484819|101974908|FG000|Overall Study|Complicating Condition|1|||
33568660|NCT04526665|101974909|FG000|Overall Study|Withdrawal by Subject|6|||
33568661|NCT04526665|101974910|FG001|Overall Study|Withdrawal by Subject|3|||
33568662|NCT04526665|101974909|FG000|Overall Study|Adverse Event|4|||
33568663|NCT04526665|101974910|FG001|Overall Study|Adverse Event|1|||
33568664|NCT04526665|101974909|FG000|Overall Study|Physician Decision|2|||
33568665|NCT04526665|101974910|FG001|Overall Study|Physician Decision|2|||
33568666|NCT04526665|101974909|FG000|Overall Study|Death|2|||
33568667|NCT04526665|101974910|FG001|Overall Study|Death|0|||
33568668|NCT04526665|101974909|FG000|Overall Study|Other|0|||
33568669|NCT04526665|101974910|FG001|Overall Study|Other|1|||
33631923|NCT02052778|102203073|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
33631924|NCT02052778|102203074|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
33365281|NCT03303339|101223811|FG010|Overall Study|Death|4|||
33365282|NCT03303339|101223812|FG011|Overall Study|Death|24|||
33365283|NCT03303339|101223801|FG000|Overall Study|Study Terminated by Sponsor|0|||
33365284|NCT03303339|101223802|FG001|Overall Study|Study Terminated by Sponsor|0|||
33365285|NCT03303339|101223803|FG002|Overall Study|Study Terminated by Sponsor|0|||
33631925|NCT02052778|102203075|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
33631926|NCT02052778|102203076|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
33568670|NCT05347485|101974911|FG000|Overall Study|Death|14|||
33568671|NCT05347485|101974911|FG000|Overall Study|Lost to Follow-up|2|||
33631927|NCT02052778|102203077|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
33631928|NCT02052778|102203078|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
33631929|NCT02052778|102203079|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
33631930|NCT02052778|102203080|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
33631931|NCT02052778|102203081|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
33631932|NCT02052778|102203082|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
33631933|NCT02052778|102203083|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
33631934|NCT02052778|102203084|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
33225292|NCT02343003|100725107|FG000|Overall Study|Withdrawal by Subject|9|||
33417526|NCT01299272|101420315|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
33417527|NCT01299272|101420316|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
33417528|NCT01299272|101420317|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
33417529|NCT01299272|101420314|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
33417530|NCT01299272|101420315|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
33417531|NCT01299272|101420316|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
33568672|NCT05347485|101974911|FG000|Overall Study|Withdrawal by Subject|13|||
33568673|NCT05347485|101974911|FG000|Overall Study|Progressive Disease|1|||
33568674|NCT05347485|101974911|FG000|Overall Study|Study Terminated by Sponsor|49|||
33631935|NCT02052778|102203085|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
33631936|NCT02052778|102203086|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
33631937|NCT02052778|102203087|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
33631938|NCT02052778|102203065|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631939|NCT02052778|102203066|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631940|NCT02052778|102203067|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631941|NCT02052778|102203068|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631942|NCT02052778|102203069|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631943|NCT02052778|102203070|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631944|NCT02052778|102203071|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631945|NCT02052778|102203072|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631946|NCT02052778|102203073|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631947|NCT02052778|102203074|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631948|NCT02052778|102203075|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631949|NCT02052778|102203076|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631950|NCT02052778|102203077|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631951|NCT02052778|102203078|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631952|NCT02052778|102203079|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
33631953|NCT02052778|102203080|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
33631954|NCT02052778|102203081|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
33631955|NCT02052778|102203082|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631956|NCT02052778|102203083|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
33631957|NCT02052778|102203084|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631958|NCT02052778|102203085|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631959|NCT02052778|102203086|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631960|NCT02052778|102203087|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
33631961|NCT02052778|102203065|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631962|NCT02052778|102203066|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631963|NCT02052778|102203067|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631964|NCT02052778|102203068|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631965|NCT02052778|102203069|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631966|NCT02052778|102203070|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631967|NCT02052778|102203071|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631968|NCT02052778|102203072|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631969|NCT02052778|102203073|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33365286|NCT03303339|101223804|FG003|Overall Study|Study Terminated by Sponsor|0|||
33365287|NCT03303339|101223805|FG004|Overall Study|Study Terminated by Sponsor|0|||
33365288|NCT03303339|101223806|FG005|Overall Study|Study Terminated by Sponsor|0|||
33365289|NCT03303339|101223807|FG006|Overall Study|Study Terminated by Sponsor|0|||
33365290|NCT03303339|101223808|FG007|Overall Study|Study Terminated by Sponsor|0|||
33365291|NCT03303339|101223809|FG008|Overall Study|Study Terminated by Sponsor|1|||
33365292|NCT03303339|101223810|FG009|Overall Study|Study Terminated by Sponsor|0|||
33365293|NCT03303339|101223811|FG010|Overall Study|Study Terminated by Sponsor|1|||
33365294|NCT03303339|101223812|FG011|Overall Study|Study Terminated by Sponsor|1|||
33365295|NCT03303339|101223801|FG000|Overall Study|Withdrawal by Subject|1|||
33365296|NCT03303339|101223802|FG001|Overall Study|Withdrawal by Subject|0|||
33365297|NCT03303339|101223803|FG002|Overall Study|Withdrawal by Subject|0|||
33631970|NCT02052778|102203074|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631971|NCT02052778|102203075|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631972|NCT02052778|102203076|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631973|NCT02052778|102203077|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631974|NCT02052778|102203078|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631975|NCT02052778|102203079|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631976|NCT02052778|102203080|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631977|NCT02052778|102203081|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631978|NCT02052778|102203082|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33417532|NCT01299272|101420317|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
33417533|NCT01299272|101420314|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
33631979|NCT02052778|102203083|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33225293|NCT02343003|100725108|FG001|Overall Study|Withdrawal by Subject|4|||
33417534|NCT01299272|101420315|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
33417535|NCT01299272|101420316|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
33417536|NCT01299272|101420317|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
33417537|NCT01299272|101420314|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
33417538|NCT01299272|101420315|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
33417539|NCT01299272|101420316|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
33417540|NCT01299272|101420317|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
33417541|NCT01299272|101420314|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
33417542|NCT01299272|101420315|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
33417543|NCT01299272|101420316|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
33417544|NCT01299272|101420317|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
33417545|NCT01299272|101420314|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
33417546|NCT01299272|101420315|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
33417547|NCT01299272|101420316|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
33417548|NCT01299272|101420317|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
33417549|NCT01299272|101420314|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
33417550|NCT01299272|101420315|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
33417551|NCT01299272|101420316|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
33417552|NCT01299272|101420317|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
33417553|NCT01299272|101420314|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
33417554|NCT01299272|101420315|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
33417555|NCT01299272|101420316|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
33417556|NCT01299272|101420317|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
33417557|NCT03926728|101420318|FG000|Overall Study|Withdrawal by Subject|0|||
33417558|NCT03926728|101420319|FG001|Overall Study|Withdrawal by Subject|1|||
33417559|NCT03926728|101420320|FG002|Overall Study|Withdrawal by Subject|1|||
33417560|NCT03926728|101420321|FG003|Overall Study|Withdrawal by Subject|0|||
33417561|NCT03926728|101420322|FG004|Overall Study|Withdrawal by Subject|0|||
33417562|NCT03926728|101420323|FG005|Overall Study|Withdrawal by Subject|1|||
33417563|NCT03926728|101420324|FG006|Overall Study|Withdrawal by Subject|1|||
33417564|NCT03926728|101420325|FG007|Overall Study|Withdrawal by Subject|0|||
33417565|NCT03926728|101420326|FG008|Overall Study|Withdrawal by Subject|0|||
33417566|NCT03926728|101420327|FG009|Overall Study|Withdrawal by Subject|1|||
33568675|NCT05347485|101974911|FG000|Overall Study|Other|1|||
33568676|NCT05347485|101974911|FG000|Overall Study|Enrolled (consented) but not treated|4|||
33568677|NCT05347485|101974911|FG000|Overall Study|Disease Relapse|2|||
33568678|NCT05281562|101974913|FG000|Overall Study|Ineligible patient|1|||
33568679|NCT05281562|101974914|FG001|Overall Study|Ineligible patient|0|||
33568680|NCT00324805|101974917|FG000|Overall Study|Adverse Event|62|||
33568681|NCT00324805|101974918|FG001|Overall Study|Adverse Event|203|||
33631980|NCT02052778|102203084|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33225294|NCT02343003|100725107|FG000|Overall Study|Lost to Follow-up|5|||
33417567|NCT03926728|101420328|FG010|Overall Study|Withdrawal by Subject|0|||
33417568|NCT03926728|101420329|FG011|Overall Study|Withdrawal by Subject|0|||
33568682|NCT00324805|101974917|FG000|Overall Study|Progression|7|||
33631981|NCT02052778|102203085|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33225295|NCT02343003|100725108|FG001|Overall Study|Lost to Follow-up|1|||
33225296|NCT02343003|100725107|FG000|Overall Study|Protocol Violation|1|||
33225297|NCT02343003|100725108|FG001|Overall Study|Protocol Violation|0|||
33225298|NCT02343003|100725107|FG000|Overall Study|Death|0|||
33225299|NCT02343003|100725108|FG001|Overall Study|Death|1|||
33225300|NCT02343003|100725107|FG000|Overall Study|exclusion criteria met|1|||
33225301|NCT02343003|100725108|FG001|Overall Study|exclusion criteria met|1|||
33225302|NCT02343003|100725107|FG000|Overall Study|terminated by sponsor|2|||
33225303|NCT02343003|100725108|FG001|Overall Study|terminated by sponsor|0|||
33225304|NCT00553501|100725115|FG000|Overall Study|Adverse Event|2|||
33417569|NCT03751124|101420330|FG000|Overall Study|Adverse Event|4|||
33225305|NCT00553501|100725115|FG000|Overall Study|Death|1|||
33417570|NCT03751124|101420331|FG001|Overall Study|Adverse Event|3|||
33417571|NCT03751124|101420330|FG000|Overall Study|Protocol Deviation|0|||
33417572|NCT03751124|101420331|FG001|Overall Study|Protocol Deviation|1|||
33417573|NCT03751124|101420330|FG000|Overall Study|Lost to Follow-up|6|||
33417574|NCT03751124|101420331|FG001|Overall Study|Lost to Follow-up|4|||
33417575|NCT03751124|101420330|FG000|Overall Study|Withdrawal by Subject|6|||
33417576|NCT03751124|101420331|FG001|Overall Study|Withdrawal by Subject|8|||
33417577|NCT03751124|101420330|FG000|Overall Study|Lack of Efficacy|1|||
33417578|NCT03751124|101420331|FG001|Overall Study|Lack of Efficacy|1|||
33417579|NCT03751124|101420330|FG000|Overall Study|Pregnancy|0|||
33568683|NCT00324805|101974918|FG001|Overall Study|Progression|35|||
33568684|NCT00324805|101974917|FG000|Overall Study|Withdrawal by Subject|51|||
33225306|NCT00553501|100725115|FG000|Overall Study|Progression|1|||
33225307|NCT02276066|100725118|FG000|Overall Study|Lost to Follow-up|21|||
33225308|NCT02276066|100725119|FG001|Overall Study|Lost to Follow-up|11|||
33225309|NCT03485911|100725122|FG000|Part 1|Perceived lack of efficacy|1|||
33225310|NCT03485911|100725123|FG001|Part 1|Perceived lack of efficacy|1|||
33225311|NCT03485911|100725124|FG002|Part 1|Perceived lack of efficacy|2|||
33225312|NCT03485911|100725125|FG003|Part 1|Perceived lack of efficacy|0|||
33225313|NCT03485911|100725122|FG000|Part 1|Subject withdrew consent|0|||
33225314|NCT03485911|100725123|FG001|Part 1|Subject withdrew consent|1|||
33225315|NCT03485911|100725124|FG002|Part 1|Subject withdrew consent|0|||
33225316|NCT03485911|100725125|FG003|Part 1|Subject withdrew consent|1|||
33225317|NCT03485911|100725122|FG000|Part 1|Lab abnormalities/AEs|3|||
33225318|NCT03485911|100725123|FG001|Part 1|Lab abnormalities/AEs|1|||
33225319|NCT03485911|100725124|FG002|Part 1|Lab abnormalities/AEs|1|||
33225320|NCT03485911|100725125|FG003|Part 1|Lab abnormalities/AEs|0|||
33225321|NCT03485911|100725122|FG000|Part 1|Withdrew Consent prior to dosing|0|||
33225322|NCT03485911|100725123|FG001|Part 1|Withdrew Consent prior to dosing|0|||
33225323|NCT03485911|100725124|FG002|Part 1|Withdrew Consent prior to dosing|0|||
33225324|NCT03485911|100725125|FG003|Part 1|Withdrew Consent prior to dosing|1|||
33225325|NCT03485911|100725122|FG000|Part 1|Other NOS|0|||
33225326|NCT03485911|100725123|FG001|Part 1|Other NOS|0|||
33225327|NCT03485911|100725124|FG002|Part 1|Other NOS|0|||
33225328|NCT03485911|100725125|FG003|Part 1|Other NOS|1|||
33225329|NCT03485911|100725122|FG000|Part 2|Perceived lack of efficacy|5|||
33225330|NCT03485911|100725123|FG001|Part 2|Perceived lack of efficacy|3|||
33225331|NCT03485911|100725124|FG002|Part 2|Perceived lack of efficacy|0|||
33225332|NCT03485911|100725125|FG003|Part 2|Perceived lack of efficacy|2|||
33225333|NCT03485911|100725122|FG000|Part 2|Subject withdrew consent|1|||
33225334|NCT03485911|100725123|FG001|Part 2|Subject withdrew consent|0|||
33225335|NCT03485911|100725124|FG002|Part 2|Subject withdrew consent|2|||
33225336|NCT03485911|100725125|FG003|Part 2|Subject withdrew consent|1|||
33225337|NCT03485911|100725122|FG000|Part 2|Lab abnormalities/AEs|1|||
33225338|NCT03485911|100725123|FG001|Part 2|Lab abnormalities/AEs|2|||
33568685|NCT00324805|101974918|FG001|Overall Study|Withdrawal by Subject|174|||
33568686|NCT00324805|101974917|FG000|Overall Study|Death|6|||
33568687|NCT00324805|101974918|FG001|Overall Study|Death|9|||
33568688|NCT00324805|101974917|FG000|Overall Study|Alternative therapy|4|||
33568689|NCT00324805|101974918|FG001|Overall Study|Alternative therapy|8|||
33568690|NCT00324805|101974917|FG000|Overall Study|Other complicating disease|1|||
33568691|NCT00324805|101974918|FG001|Overall Study|Other complicating disease|9|||
33568692|NCT00324805|101974917|FG000|Overall Study|Other reasons|7|||
33568693|NCT00324805|101974918|FG001|Overall Study|Other reasons|26|||
33568694|NCT00324805|101974917|FG000|Overall Study|Other|0|||
33568695|NCT00324805|101974918|FG001|Overall Study|Other|2|||
33568696|NCT00324805|101974917|FG000|Overall Study|Did not start therapy|12|||
33568697|NCT00324805|101974918|FG001|Overall Study|Did not start therapy|17|||
33568698|NCT01928394|101974921|FG000|Treatment Period|Disease progression|17|||
33568699|NCT01928394|101974922|FG001|Treatment Period|Disease progression|2|||
33225339|NCT03485911|100725124|FG002|Part 2|Lab abnormalities/AEs|0|||
33225340|NCT03485911|100725125|FG003|Part 2|Lab abnormalities/AEs|0|||
33225341|NCT03485911|100725122|FG000|Part 2|Other NOS|0|||
33225342|NCT03485911|100725123|FG001|Part 2|Other NOS|1|||
33417580|NCT03751124|101420331|FG001|Overall Study|Pregnancy|1|||
33417581|NCT03751124|101420330|FG000|Overall Study|Other|9|||
33568700|NCT01928394|101974923|FG002|Treatment Period|Disease progression|12|||
33568701|NCT01928394|101974924|FG003|Treatment Period|Disease progression|48|||
33568702|NCT01928394|101974925|FG004|Treatment Period|Disease progression|3|||
33568703|NCT01928394|101974926|FG005|Treatment Period|Disease progression|25|||
33568704|NCT01928394|101974927|FG006|Treatment Period|Disease progression|38|||
33225343|NCT03485911|100725124|FG002|Part 2|Other NOS|0|||
33225344|NCT03485911|100725125|FG003|Part 2|Other NOS|0|||
33225345|NCT03485911|100725122|FG000|Part 2|Intercurrent illness/new medical condition|1|||
33225346|NCT03485911|100725123|FG001|Part 2|Intercurrent illness/new medical condition|0|||
33225347|NCT03485911|100725124|FG002|Part 2|Intercurrent illness/new medical condition|0|||
33225348|NCT03485911|100725125|FG003|Part 2|Intercurrent illness/new medical condition|0|||
33225349|NCT03485911|100725122|FG000|Part 2|Investigator judgement|1|||
33225350|NCT03485911|100725123|FG001|Part 2|Investigator judgement|0|||
33225351|NCT03485911|100725124|FG002|Part 2|Investigator judgement|0|||
33225352|NCT03485911|100725125|FG003|Part 2|Investigator judgement|0|||
33365298|NCT03303339|101223804|FG003|Overall Study|Withdrawal by Subject|0|||
33417582|NCT03751124|101420331|FG001|Overall Study|Other|9|||
33417583|NCT03751124|101420330|FG000|Overall Study|Participants who did not receive any study drug|0|||
33417584|NCT03751124|101420331|FG001|Overall Study|Participants who did not receive any study drug|1|||
33417585|NCT01186744|101420334|FG000|Overall Study|Lack of Efficacy|156|||
33631982|NCT02052778|102203086|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
33631983|NCT02052778|102203087|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
33365299|NCT03303339|101223805|FG004|Overall Study|Withdrawal by Subject|0|||
33365300|NCT03303339|101223806|FG005|Overall Study|Withdrawal by Subject|1|||
33365301|NCT03303339|101223807|FG006|Overall Study|Withdrawal by Subject|1|||
33365302|NCT03303339|101223808|FG007|Overall Study|Withdrawal by Subject|0|||
33365303|NCT03303339|101223809|FG008|Overall Study|Withdrawal by Subject|0|||
33365304|NCT03303339|101223810|FG009|Overall Study|Withdrawal by Subject|0|||
33417586|NCT01186744|101420335|FG001|Overall Study|Lack of Efficacy|99|||
33417587|NCT01186744|101420336|FG002|Overall Study|Lack of Efficacy|0|||
33417588|NCT01186744|101420337|FG003|Overall Study|Lack of Efficacy|2|||
33631984|NCT02052778|102203065|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33631985|NCT02052778|102203066|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33631986|NCT02052778|102203067|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33417589|NCT01186744|101420338|FG004|Overall Study|Lack of Efficacy|2|||
33631987|NCT02052778|102203068|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33631988|NCT02052778|102203069|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33631989|NCT02052778|102203070|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33631990|NCT02052778|102203071|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33631991|NCT02052778|102203072|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33631992|NCT02052778|102203073|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33631993|NCT02052778|102203074|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33631994|NCT02052778|102203075|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33631995|NCT02052778|102203076|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33631996|NCT02052778|102203077|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33631997|NCT02052778|102203078|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33631998|NCT02052778|102203079|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33631999|NCT02052778|102203080|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33632000|NCT02052778|102203081|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33568705|NCT01928394|101974928|FG007|Treatment Period|Disease progression|16|||
33568706|NCT01928394|101974929|FG008|Treatment Period|Disease progression|3|||
33568707|NCT01928394|101974930|FG009|Treatment Period|Disease progression|11|||
33568708|NCT01928394|101974931|FG010|Treatment Period|Disease progression|22|||
33568709|NCT01928394|101974932|FG011|Treatment Period|Disease progression|73|||
33568710|NCT01928394|101974933|FG012|Treatment Period|Disease progression|38|||
33568711|NCT01928394|101974934|FG013|Treatment Period|Disease progression|118|||
33568712|NCT01928394|101974935|FG014|Treatment Period|Disease progression|59|||
33568713|NCT01928394|101974936|FG015|Treatment Period|Disease progression|1|||
33568714|NCT01928394|101974937|FG016|Treatment Period|Disease progression|43|||
33568715|NCT01928394|101974938|FG017|Treatment Period|Disease progression|56|||
33568716|NCT01928394|101974939|FG018|Treatment Period|Disease progression|50|||
33568717|NCT01928394|101974940|FG019|Treatment Period|Disease progression|71|||
33568718|NCT01928394|101974941|FG020|Treatment Period|Disease progression|30|||
33568719|NCT01928394|101974942|FG021|Treatment Period|Disease progression|31|||
33568720|NCT01928394|101974943|FG022|Treatment Period|Disease progression|31|||
33632001|NCT02052778|102203082|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33632002|NCT02052778|102203083|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33632003|NCT02052778|102203084|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33568721|NCT01928394|101974921|FG000|Treatment Period|Study drug toxicity|1|||
33365305|NCT03303339|101223811|FG010|Overall Study|Withdrawal by Subject|0|||
33568722|NCT01928394|101974922|FG001|Treatment Period|Study drug toxicity|1|||
33568723|NCT01928394|101974923|FG002|Treatment Period|Study drug toxicity|3|||
33568724|NCT01928394|101974924|FG003|Treatment Period|Study drug toxicity|3|||
33365306|NCT03303339|101223812|FG011|Overall Study|Withdrawal by Subject|2|||
33632004|NCT02052778|102203085|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33632005|NCT02052778|102203086|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
33632006|NCT02052778|102203087|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
33632007|NCT02052778|102203065|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632008|NCT02052778|102203066|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632009|NCT02052778|102203067|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632010|NCT02052778|102203068|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632011|NCT02052778|102203069|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632012|NCT02052778|102203070|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632013|NCT02052778|102203071|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632014|NCT02052778|102203072|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632015|NCT02052778|102203073|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632016|NCT02052778|102203074|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632017|NCT02052778|102203075|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632018|NCT02052778|102203076|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632019|NCT02052778|102203077|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632020|NCT02052778|102203078|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632021|NCT02052778|102203079|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632022|NCT02052778|102203080|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632023|NCT02052778|102203081|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632024|NCT02052778|102203082|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632025|NCT02052778|102203083|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632026|NCT02052778|102203084|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632027|NCT02052778|102203085|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632028|NCT02052778|102203086|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
33632029|NCT02052778|102203087|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
33632030|NCT02052778|102203065|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632031|NCT02052778|102203066|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632032|NCT02052778|102203067|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632033|NCT02052778|102203068|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632034|NCT02052778|102203069|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632035|NCT02052778|102203070|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632036|NCT02052778|102203071|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632037|NCT02052778|102203072|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632038|NCT02052778|102203073|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632039|NCT02052778|102203074|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632040|NCT02052778|102203075|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632041|NCT02052778|102203076|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632042|NCT02052778|102203077|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632043|NCT02052778|102203078|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632044|NCT02052778|102203079|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632045|NCT02052778|102203080|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632046|NCT02052778|102203081|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632047|NCT02052778|102203082|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632048|NCT02052778|102203083|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632049|NCT02052778|102203084|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632050|NCT02052778|102203085|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632051|NCT02052778|102203086|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
33632052|NCT02052778|102203087|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
33632053|NCT02052778|102203065|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632054|NCT02052778|102203066|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632055|NCT02052778|102203067|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632056|NCT02052778|102203068|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632057|NCT02052778|102203069|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632058|NCT02052778|102203070|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632059|NCT02052778|102203071|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632060|NCT02052778|102203072|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632061|NCT02052778|102203073|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632062|NCT02052778|102203074|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632063|NCT02052778|102203075|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33365307|NCT03303339|101223801|FG000|Overall Study|Physician Decision|0|||
33365308|NCT03303339|101223802|FG001|Overall Study|Physician Decision|0|||
33365309|NCT03303339|101223803|FG002|Overall Study|Physician Decision|0|||
33225353|NCT03485911|100725122|FG000|Part 3|Perceived lack of efficacy|2|||
33225354|NCT03485911|100725123|FG001|Part 3|Perceived lack of efficacy|2|||
33225355|NCT03485911|100725124|FG002|Part 3|Perceived lack of efficacy|2|||
33225356|NCT03485911|100725125|FG003|Part 3|Perceived lack of efficacy|0|||
33225357|NCT03485911|100725122|FG000|Part 3|Subject withdrew consent|1|||
33225358|NCT03485911|100725123|FG001|Part 3|Subject withdrew consent|4|||
33225359|NCT03485911|100725124|FG002|Part 3|Subject withdrew consent|0|||
33225360|NCT03485911|100725125|FG003|Part 3|Subject withdrew consent|1|||
33225361|NCT03485911|100725122|FG000|Part 3|Lab abnormalities/AEs|1|||
33225362|NCT03485911|100725123|FG001|Part 3|Lab abnormalities/AEs|1|||
33225363|NCT03485911|100725124|FG002|Part 3|Lab abnormalities/AEs|0|||
33225364|NCT03485911|100725125|FG003|Part 3|Lab abnormalities/AEs|2|||
33225365|NCT03485911|100725122|FG000|Part 3|Other NOS|1|||
33225366|NCT03485911|100725123|FG001|Part 3|Other NOS|1|||
33225367|NCT03485911|100725124|FG002|Part 3|Other NOS|0|||
33225368|NCT03485911|100725125|FG003|Part 3|Other NOS|0|||
33225369|NCT03485911|100725122|FG000|Part 3|Intercurrent illness/new medical condition|0|||
33225370|NCT03485911|100725123|FG001|Part 3|Intercurrent illness/new medical condition|1|||
33225371|NCT03485911|100725124|FG002|Part 3|Intercurrent illness/new medical condition|1|||
33225372|NCT03485911|100725125|FG003|Part 3|Intercurrent illness/new medical condition|0|||
33225373|NCT03485911|100725122|FG000|Part 3|Sponsor discontinuation|1|||
33225374|NCT03485911|100725123|FG001|Part 3|Sponsor discontinuation|0|||
33225375|NCT03485911|100725124|FG002|Part 3|Sponsor discontinuation|0|||
33225376|NCT03485911|100725125|FG003|Part 3|Sponsor discontinuation|0|||
33225377|NCT03485911|100725122|FG000|Part 3|Berotralstat provided by alternative means|13|||
33225378|NCT03485911|100725123|FG001|Part 3|Berotralstat provided by alternative means|13|||
33632064|NCT02052778|102203076|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632065|NCT02052778|102203077|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632066|NCT02052778|102203078|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632067|NCT02052778|102203079|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632068|NCT02052778|102203080|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632069|NCT02052778|102203081|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632070|NCT02052778|102203082|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632071|NCT02052778|102203083|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632072|NCT02052778|102203084|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632073|NCT02052778|102203085|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632074|NCT02052778|102203086|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
33632075|NCT02052778|102203087|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
33632076|NCT02052778|102203065|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
33632077|NCT02052778|102203066|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
33632078|NCT02052778|102203067|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
33632079|NCT02052778|102203068|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
33632080|NCT02052778|102203069|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
33632081|NCT02052778|102203070|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
33365310|NCT03303339|101223804|FG003|Overall Study|Physician Decision|0|||
33365311|NCT03303339|101223805|FG004|Overall Study|Physician Decision|1|||
33365312|NCT03303339|101223806|FG005|Overall Study|Physician Decision|0|||
33365313|NCT03303339|101223807|FG006|Overall Study|Physician Decision|0|||
33365314|NCT03303339|101223808|FG007|Overall Study|Physician Decision|0|||
33365315|NCT03303339|101223809|FG008|Overall Study|Physician Decision|0|||
33365316|NCT03303339|101223810|FG009|Overall Study|Physician Decision|0|||
33365317|NCT03303339|101223811|FG010|Overall Study|Physician Decision|0|||
33365318|NCT03303339|101223812|FG011|Overall Study|Physician Decision|0|||
33365319|NCT03303339|101223801|FG000|Overall Study|Safety/Non-compliance|0|||
33365320|NCT03303339|101223802|FG001|Overall Study|Safety/Non-compliance|0|||
33365321|NCT03303339|101223803|FG002|Overall Study|Safety/Non-compliance|0|||
33417590|NCT01186744|101420339|FG005|Overall Study|Lack of Efficacy|5|||
33417591|NCT01186744|101420334|FG000|Overall Study|Protocol Violation|1|||
33417592|NCT01186744|101420335|FG001|Overall Study|Protocol Violation|2|||
33632082|NCT02052778|102203071|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
33632083|NCT02052778|102203072|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
33365322|NCT03303339|101223804|FG003|Overall Study|Safety/Non-compliance|0|||
33365323|NCT03303339|101223805|FG004|Overall Study|Safety/Non-compliance|0|||
33365324|NCT03303339|101223806|FG005|Overall Study|Safety/Non-compliance|0|||
33365325|NCT03303339|101223807|FG006|Overall Study|Safety/Non-compliance|0|||
33365326|NCT03303339|101223808|FG007|Overall Study|Safety/Non-compliance|0|||
33365327|NCT03303339|101223809|FG008|Overall Study|Safety/Non-compliance|0|||
33365328|NCT03303339|101223810|FG009|Overall Study|Safety/Non-compliance|0|||
33365329|NCT03303339|101223811|FG010|Overall Study|Safety/Non-compliance|0|||
33365330|NCT03303339|101223812|FG011|Overall Study|Safety/Non-compliance|1|||
33365331|NCT00426751|101223818|FG000|Overall Study|Adverse Event|8|||
33365332|NCT00426751|101223819|FG001|Overall Study|Adverse Event|1|||
33365333|NCT00426751|101223818|FG000|Overall Study|Lost to Follow-up|7|||
33365334|NCT00426751|101223819|FG001|Overall Study|Lost to Follow-up|6|||
33365335|NCT00426751|101223818|FG000|Overall Study|Consent Withdrawn|0|||
33365336|NCT00426751|101223819|FG001|Overall Study|Consent Withdrawn|1|||
33365337|NCT00426751|101223818|FG000|Overall Study|Other Reasons|7|||
33365338|NCT00426751|101223819|FG001|Overall Study|Other Reasons|12|||
33365339|NCT00515463|101223824|FG000|Overall Study|Physician Decision|4|||
33365340|NCT00515463|101223825|FG001|Overall Study|Physician Decision|2|||
33365341|NCT00515463|101223824|FG000|Overall Study|Adverse Event|1|||
33365342|NCT00515463|101223825|FG001|Overall Study|Adverse Event|2|||
33365343|NCT00515463|101223824|FG000|Overall Study|Withdrawal by Subject|3|||
33365344|NCT00515463|101223825|FG001|Overall Study|Withdrawal by Subject|4|||
33365345|NCT00515463|101223824|FG000|Overall Study|Lost to Follow-up|6|||
33365346|NCT00515463|101223825|FG001|Overall Study|Lost to Follow-up|5|||
33365347|NCT00515463|101223824|FG000|Overall Study|Other|0|||
33365348|NCT00515463|101223825|FG001|Overall Study|Other|1|||
33365349|NCT03894904|101223826|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
33365350|NCT03894904|101223827|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
33365351|NCT03894904|101223826|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
33365352|NCT03894904|101223827|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
33365353|NCT01214616|101223828|FG000|Overall Study|Progressive disease|2|||
33365354|NCT01214616|101223829|FG001|Overall Study|Progressive disease|2|||
33365355|NCT01214616|101223830|FG002|Overall Study|Progressive disease|2|||
33365356|NCT01214616|101223831|FG003|Overall Study|Progressive disease|4|||
33365357|NCT01214616|101223828|FG000|Overall Study|Dose limiting toxicity|0|||
33365358|NCT01214616|101223829|FG001|Overall Study|Dose limiting toxicity|2|||
33365359|NCT01214616|101223830|FG002|Overall Study|Dose limiting toxicity|0|||
33417593|NCT01186744|101420336|FG002|Overall Study|Protocol Violation|0|||
33417594|NCT01186744|101420337|FG003|Overall Study|Protocol Violation|1|||
33417595|NCT01186744|101420338|FG004|Overall Study|Protocol Violation|1|||
33417596|NCT01186744|101420339|FG005|Overall Study|Protocol Violation|2|||
33417597|NCT01186744|101420334|FG000|Overall Study|Lost to Follow-up|15|||
33417598|NCT01186744|101420335|FG001|Overall Study|Lost to Follow-up|16|||
33417599|NCT01186744|101420336|FG002|Overall Study|Lost to Follow-up|2|||
33417600|NCT01186744|101420337|FG003|Overall Study|Lost to Follow-up|1|||
33417601|NCT01186744|101420338|FG004|Overall Study|Lost to Follow-up|1|||
33417602|NCT01186744|101420339|FG005|Overall Study|Lost to Follow-up|4|||
33417603|NCT01186744|101420334|FG000|Overall Study|Screen failure|1|||
33417604|NCT01186744|101420335|FG001|Overall Study|Screen failure|1|||
33417605|NCT01186744|101420336|FG002|Overall Study|Screen failure|0|||
33417606|NCT01186744|101420337|FG003|Overall Study|Screen failure|1|||
33417607|NCT01186744|101420338|FG004|Overall Study|Screen failure|0|||
33417608|NCT01186744|101420339|FG005|Overall Study|Screen failure|0|||
33417609|NCT01186744|101420334|FG000|Overall Study|Withdrawal by Subject|14|||
33417610|NCT01186744|101420335|FG001|Overall Study|Withdrawal by Subject|10|||
33417611|NCT01186744|101420336|FG002|Overall Study|Withdrawal by Subject|2|||
33417612|NCT01186744|101420337|FG003|Overall Study|Withdrawal by Subject|5|||
33417613|NCT01186744|101420338|FG004|Overall Study|Withdrawal by Subject|0|||
33417614|NCT01186744|101420339|FG005|Overall Study|Withdrawal by Subject|6|||
33417615|NCT01186744|101420334|FG000|Overall Study|Study terminated by Sponsor|1|||
33417616|NCT01186744|101420335|FG001|Overall Study|Study terminated by Sponsor|0|||
33417617|NCT01186744|101420336|FG002|Overall Study|Study terminated by Sponsor|0|||
33417618|NCT01186744|101420337|FG003|Overall Study|Study terminated by Sponsor|0|||
33417619|NCT01186744|101420338|FG004|Overall Study|Study terminated by Sponsor|0|||
33417620|NCT01186744|101420339|FG005|Overall Study|Study terminated by Sponsor|0|||
33417621|NCT01186744|101420334|FG000|Overall Study|Other|9|||
33417622|NCT01186744|101420335|FG001|Overall Study|Other|10|||
33417623|NCT01186744|101420336|FG002|Overall Study|Other|1|||
33417624|NCT01186744|101420337|FG003|Overall Study|Other|2|||
33417625|NCT01186744|101420338|FG004|Overall Study|Other|1|||
33417626|NCT01186744|101420339|FG005|Overall Study|Other|5|||
33365360|NCT01214616|101223831|FG003|Overall Study|Dose limiting toxicity|0|||
33365361|NCT01214616|101223828|FG000|Overall Study|Other adverse events|0|||
33365362|NCT01214616|101223829|FG001|Overall Study|Other adverse events|1|||
33365363|NCT01214616|101223830|FG002|Overall Study|Other adverse events|1|||
33365364|NCT01214616|101223831|FG003|Overall Study|Other adverse events|1|||
33417627|NCT01186744|101420334|FG000|Overall Study|Adverse Event|10|||
33417628|NCT01186744|101420335|FG001|Overall Study|Adverse Event|14|||
33417629|NCT01186744|101420336|FG002|Overall Study|Adverse Event|1|||
33417630|NCT01186744|101420337|FG003|Overall Study|Adverse Event|0|||
33365365|NCT01214616|101223828|FG000|Overall Study|Withdrawal by Subject|1|||
33365366|NCT01214616|101223829|FG001|Overall Study|Withdrawal by Subject|0|||
33365367|NCT01214616|101223830|FG002|Overall Study|Withdrawal by Subject|0|||
33365368|NCT01214616|101223831|FG003|Overall Study|Withdrawal by Subject|1|||
33365369|NCT02335450|101223833|FG000|Overall Study|Pregnancy|1|||
33365370|NCT02546856|101223834|FG000|4 Months Evaluation|Death|2|||
33365371|NCT02546856|101223835|FG001|4 Months Evaluation|Death|3|||
33225379|NCT03485911|100725124|FG002|Part 3|Berotralstat provided by alternative means|7|||
33365372|NCT02546856|101223834|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
33365373|NCT02546856|101223835|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
33365374|NCT02546856|101223834|FG000|4 Months Evaluation|Lost to Follow-up|3|||
33225380|NCT03485911|100725125|FG003|Part 3|Berotralstat provided by alternative means|7|||
33225381|NCT02002182|100725128|FG000|Overall Study|Withdraw from study|3|||
33225382|NCT02002182|100725129|FG001|Overall Study|Withdraw from study|1|||
33225383|NCT02002182|100725128|FG000|Overall Study|Health Reasons|1|||
33225384|NCT02002182|100725129|FG001|Overall Study|Health Reasons|0|||
33225385|NCT02002182|100725128|FG000|Overall Study|Death|1|||
33225386|NCT02002182|100725129|FG001|Overall Study|Death|0|||
33225387|NCT03749447|100725130|FG000|Overall Study|Adverse Event|11|||
33225388|NCT03749447|100725131|FG001|Overall Study|Adverse Event|3|||
33225389|NCT03749447|100725130|FG000|Overall Study|Death|1|||
33225390|NCT03749447|100725131|FG001|Overall Study|Death|1|||
33225391|NCT03749447|100725130|FG000|Overall Study|Lost to Follow-up|2|||
33225392|NCT03749447|100725131|FG001|Overall Study|Lost to Follow-up|2|||
33225393|NCT03749447|100725130|FG000|Overall Study|Reason Not Specified|0|||
33225394|NCT03749447|100725131|FG001|Overall Study|Reason Not Specified|3|||
33225395|NCT03749447|100725130|FG000|Overall Study|Physician Decision|4|||
33225396|NCT03749447|100725131|FG001|Overall Study|Physician Decision|3|||
33225397|NCT03749447|100725130|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
33365375|NCT02546856|101223835|FG001|4 Months Evaluation|Lost to Follow-up|3|||
33225398|NCT03749447|100725131|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
33225399|NCT03749447|100725130|FG000|Overall Study|Study Terminated By Sponsor|112|||
33225400|NCT03749447|100725131|FG001|Overall Study|Study Terminated By Sponsor|105|||
33225401|NCT03749447|100725130|FG000|Overall Study|Withdrawal by Subject|12|||
33225402|NCT03749447|100725131|FG001|Overall Study|Withdrawal by Subject|6|||
33568725|NCT01928394|101974925|FG004|Treatment Period|Study drug toxicity|0|||
33568726|NCT01928394|101974926|FG005|Treatment Period|Study drug toxicity|9|||
33568727|NCT01928394|101974927|FG006|Treatment Period|Study drug toxicity|7|||
33568728|NCT01928394|101974928|FG007|Treatment Period|Study drug toxicity|1|||
33632084|NCT02052778|102203073|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
33632085|NCT02052778|102203074|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
33632086|NCT02052778|102203075|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
33632087|NCT02052778|102203076|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
33568729|NCT01928394|101974929|FG008|Treatment Period|Study drug toxicity|0|||
33568730|NCT01928394|101974930|FG009|Treatment Period|Study drug toxicity|5|||
33568731|NCT01928394|101974931|FG010|Treatment Period|Study drug toxicity|2|||
33568732|NCT01928394|101974932|FG011|Treatment Period|Study drug toxicity|3|||
33568733|NCT01928394|101974933|FG012|Treatment Period|Study drug toxicity|7|||
33568734|NCT01928394|101974934|FG013|Treatment Period|Study drug toxicity|5|||
33568735|NCT01928394|101974935|FG014|Treatment Period|Study drug toxicity|12|||
33568736|NCT01928394|101974936|FG015|Treatment Period|Study drug toxicity|0|||
33568737|NCT01928394|101974937|FG016|Treatment Period|Study drug toxicity|3|||
33568738|NCT01928394|101974938|FG017|Treatment Period|Study drug toxicity|3|||
33568739|NCT01928394|101974939|FG018|Treatment Period|Study drug toxicity|12|||
33568740|NCT01928394|101974940|FG019|Treatment Period|Study drug toxicity|15|||
33568741|NCT01928394|101974941|FG020|Treatment Period|Study drug toxicity|4|||
33568742|NCT01928394|101974942|FG021|Treatment Period|Study drug toxicity|7|||
33568743|NCT01928394|101974943|FG022|Treatment Period|Study drug toxicity|4|||
33568744|NCT01928394|101974921|FG000|Treatment Period|AE unrelated to study drug|0|||
33568745|NCT01928394|101974922|FG001|Treatment Period|AE unrelated to study drug|0|||
33568746|NCT01928394|101974923|FG002|Treatment Period|AE unrelated to study drug|2|||
33568747|NCT01928394|101974924|FG003|Treatment Period|AE unrelated to study drug|3|||
33568748|NCT01928394|101974925|FG004|Treatment Period|AE unrelated to study drug|0|||
33568749|NCT01928394|101974926|FG005|Treatment Period|AE unrelated to study drug|5|||
33568750|NCT01928394|101974927|FG006|Treatment Period|AE unrelated to study drug|1|||
33568751|NCT01928394|101974928|FG007|Treatment Period|AE unrelated to study drug|0|||
33568752|NCT01928394|101974929|FG008|Treatment Period|AE unrelated to study drug|0|||
33568753|NCT01928394|101974930|FG009|Treatment Period|AE unrelated to study drug|2|||
33568754|NCT01928394|101974931|FG010|Treatment Period|AE unrelated to study drug|0|||
33568755|NCT01928394|101974932|FG011|Treatment Period|AE unrelated to study drug|12|||
33568756|NCT01928394|101974933|FG012|Treatment Period|AE unrelated to study drug|6|||
33568757|NCT01928394|101974934|FG013|Treatment Period|AE unrelated to study drug|13|||
33568758|NCT01928394|101974935|FG014|Treatment Period|AE unrelated to study drug|6|||
33568759|NCT01928394|101974936|FG015|Treatment Period|AE unrelated to study drug|1|||
33568760|NCT01928394|101974937|FG016|Treatment Period|AE unrelated to study drug|1|||
33568761|NCT01928394|101974938|FG017|Treatment Period|AE unrelated to study drug|6|||
33632088|NCT02052778|102203077|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
33632089|NCT02052778|102203078|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
33632090|NCT02052778|102203079|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
33632091|NCT02052778|102203080|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
33225403|NCT03749447|100725130|FG000|Overall Study|Non-compliance With Study Drug|0|||
33568762|NCT01928394|101974939|FG018|Treatment Period|AE unrelated to study drug|3|||
33568763|NCT01928394|101974940|FG019|Treatment Period|AE unrelated to study drug|5|||
33568764|NCT01928394|101974941|FG020|Treatment Period|AE unrelated to study drug|1|||
33568765|NCT01928394|101974942|FG021|Treatment Period|AE unrelated to study drug|1|||
33568766|NCT01928394|101974943|FG022|Treatment Period|AE unrelated to study drug|0|||
33568767|NCT01928394|101974921|FG000|Treatment Period|Participant request to stop therapy|0|||
33568768|NCT01928394|101974922|FG001|Treatment Period|Participant request to stop therapy|0|||
33568769|NCT01928394|101974923|FG002|Treatment Period|Participant request to stop therapy|0|||
33568770|NCT01928394|101974924|FG003|Treatment Period|Participant request to stop therapy|0|||
33568771|NCT01928394|101974925|FG004|Treatment Period|Participant request to stop therapy|0|||
33568772|NCT01928394|101974926|FG005|Treatment Period|Participant request to stop therapy|3|||
33568773|NCT01928394|101974927|FG006|Treatment Period|Participant request to stop therapy|3|||
33568774|NCT01928394|101974928|FG007|Treatment Period|Participant request to stop therapy|0|||
33568775|NCT01928394|101974929|FG008|Treatment Period|Participant request to stop therapy|0|||
33568776|NCT01928394|101974930|FG009|Treatment Period|Participant request to stop therapy|0|||
33568777|NCT01928394|101974931|FG010|Treatment Period|Participant request to stop therapy|3|||
33417631|NCT01186744|101420338|FG004|Overall Study|Adverse Event|1|||
33568778|NCT01928394|101974932|FG011|Treatment Period|Participant request to stop therapy|2|||
33417632|NCT01186744|101420339|FG005|Overall Study|Adverse Event|4|||
33225404|NCT03749447|100725131|FG001|Overall Study|Non-compliance With Study Drug|1|||
33225405|NCT03214081|100725132|FG000|Overall Study|Case Report Forms Uncollected|9|||
33225406|NCT03214081|100725132|FG000|Overall Study|Protocol Deviation|54|||
33225407|NCT03635489|100725133|FG000|Overall Study|Death|19|||
33225408|NCT03635489|100725134|FG001|Overall Study|Death|13|||
33225409|NCT03635489|100725133|FG000|Overall Study|Lost to Follow-up|1|||
33225410|NCT03635489|100725134|FG001|Overall Study|Lost to Follow-up|2|||
33225411|NCT03635489|100725133|FG000|Overall Study|Withdrawal by Subject|1|||
33225412|NCT03635489|100725134|FG001|Overall Study|Withdrawal by Subject|2|||
33225413|NCT03635489|100725133|FG000|Overall Study|Study Ended by Sponsor|28|||
33225414|NCT03635489|100725134|FG001|Overall Study|Study Ended by Sponsor|34|||
33225415|NCT04707196|100725136|FG000|Overall Study|Withdrawal by Subject|9|||
33225416|NCT04707196|100725137|FG001|Overall Study|Withdrawal by Subject|6|||
33225417|NCT04707196|100725136|FG000|Overall Study|Lost to Follow-up|1|||
33225418|NCT04707196|100725137|FG001|Overall Study|Lost to Follow-up|0|||
33225419|NCT04707196|100725136|FG000|Overall Study|Protocol Violation|4|||
33225420|NCT04707196|100725137|FG001|Overall Study|Protocol Violation|1|||
33225421|NCT04707196|100725136|FG000|Overall Study|Adverse Event|2|||
33225422|NCT04707196|100725137|FG001|Overall Study|Adverse Event|2|||
33225423|NCT04707196|100725136|FG000|Overall Study|Death|3|||
33225424|NCT04707196|100725137|FG001|Overall Study|Death|1|||
33225425|NCT04707196|100725136|FG000|Overall Study|Non-compliance with study drug|1|||
33225426|NCT04707196|100725137|FG001|Overall Study|Non-compliance with study drug|0|||
33225427|NCT04707196|100725136|FG000|Overall Study|Progressive disease|9|||
33225428|NCT04707196|100725137|FG001|Overall Study|Progressive disease|10|||
33225429|NCT01336621|100725138|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
33225430|NCT01336621|100725138|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
33225431|NCT01336621|100725138|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
33365376|NCT02546856|101223834|FG000|4 Months Evaluation|Physician Decision|3|||
33365377|NCT02546856|101223835|FG001|4 Months Evaluation|Physician Decision|0|||
33365378|NCT02546856|101223834|FG000|4 Months Evaluation|Working or living abroad|5|||
33365379|NCT02546856|101223835|FG001|4 Months Evaluation|Working or living abroad|1|||
33365380|NCT02546856|101223834|FG000|4 Months Evaluation|reasons not due to titration|4|||
33365381|NCT02546856|101223835|FG001|4 Months Evaluation|reasons not due to titration|1|||
33365382|NCT02546856|101223834|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
33365383|NCT02546856|101223835|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
33365384|NCT02546856|101223834|FG000|6 Months Evaluation|Death|1|||
33365385|NCT02546856|101223835|FG001|6 Months Evaluation|Death|1|||
33568779|NCT01928394|101974933|FG012|Treatment Period|Participant request to stop therapy|1|||
33568780|NCT01928394|101974934|FG013|Treatment Period|Participant request to stop therapy|2|||
33568781|NCT01928394|101974935|FG014|Treatment Period|Participant request to stop therapy|4|||
33568782|NCT01928394|101974936|FG015|Treatment Period|Participant request to stop therapy|0|||
33568783|NCT01928394|101974937|FG016|Treatment Period|Participant request to stop therapy|1|||
33568784|NCT01928394|101974938|FG017|Treatment Period|Participant request to stop therapy|3|||
33568785|NCT01928394|101974939|FG018|Treatment Period|Participant request to stop therapy|1|||
33568786|NCT01928394|101974940|FG019|Treatment Period|Participant request to stop therapy|1|||
33568787|NCT01928394|101974941|FG020|Treatment Period|Participant request to stop therapy|3|||
33632092|NCT02052778|102203081|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
33225432|NCT01336621|100725138|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
33225433|NCT01336621|100725138|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
33225434|NCT01336621|100725138|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
33225435|NCT01336621|100725138|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
33365386|NCT02546856|101223834|FG000|6 Months Evaluation|Lost to Follow-up|1|||
33225436|NCT01336621|100725138|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
33225437|NCT01336621|100725138|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
33225438|NCT01336621|100725138|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
33225439|NCT01336621|100725138|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
33225440|NCT01336621|100725138|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
33225441|NCT01336621|100725138|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
33225442|NCT01336621|100725138|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
33632093|NCT02052778|102203082|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
33225443|NCT03757234|100725139|FG000|Overall Study|Adverse Event|0|||
33225444|NCT03757234|100725140|FG001|Overall Study|Adverse Event|0|||
33225445|NCT03757234|100725141|FG002|Overall Study|Adverse Event|0|||
33225446|NCT03757234|100725142|FG003|Overall Study|Adverse Event|0|||
33225447|NCT03757234|100725143|FG004|Overall Study|Adverse Event|1|||
33225448|NCT03757234|100725139|FG000|Overall Study|Lost to Follow-up|1|||
33225449|NCT03757234|100725140|FG001|Overall Study|Lost to Follow-up|0|||
33225450|NCT03757234|100725141|FG002|Overall Study|Lost to Follow-up|0|||
33225451|NCT03757234|100725142|FG003|Overall Study|Lost to Follow-up|0|||
33225452|NCT03757234|100725143|FG004|Overall Study|Lost to Follow-up|1|||
33225453|NCT03757234|100725139|FG000|Overall Study|Withdrawal by Subject|1|||
33225454|NCT03757234|100725140|FG001|Overall Study|Withdrawal by Subject|1|||
33225455|NCT03757234|100725141|FG002|Overall Study|Withdrawal by Subject|0|||
33225456|NCT03757234|100725142|FG003|Overall Study|Withdrawal by Subject|1|||
33225457|NCT03757234|100725143|FG004|Overall Study|Withdrawal by Subject|2|||
33225458|NCT03757234|100725139|FG000|Overall Study|Other|1|||
33225459|NCT03757234|100725140|FG001|Overall Study|Other|1|||
33225460|NCT03757234|100725141|FG002|Overall Study|Other|0|||
33225461|NCT03757234|100725142|FG003|Overall Study|Other|0|||
33225462|NCT03757234|100725143|FG004|Overall Study|Other|0|||
33225463|NCT01370005|100725150|FG000|Overall Study|Not treated|1|||
33225464|NCT01370005|100725151|FG001|Overall Study|Not treated|0|||
33225465|NCT01370005|100725152|FG002|Overall Study|Not treated|0|||
33225466|NCT01370005|100725150|FG000|Overall Study|Adverse Event|5|||
33225467|NCT01370005|100725151|FG001|Overall Study|Adverse Event|5|||
33225468|NCT01370005|100725152|FG002|Overall Study|Adverse Event|6|||
33225469|NCT01370005|100725150|FG000|Overall Study|Lack of Efficacy|1|||
33225470|NCT01370005|100725151|FG001|Overall Study|Lack of Efficacy|0|||
33225471|NCT01370005|100725152|FG002|Overall Study|Lack of Efficacy|0|||
33225472|NCT01370005|100725150|FG000|Overall Study|Non compliant with protocol|0|||
33225473|NCT01370005|100725151|FG001|Overall Study|Non compliant with protocol|1|||
33225474|NCT01370005|100725152|FG002|Overall Study|Non compliant with protocol|2|||
33225475|NCT01370005|100725150|FG000|Overall Study|Lost to Follow-up|1|||
33225476|NCT01370005|100725151|FG001|Overall Study|Lost to Follow-up|1|||
33225477|NCT01370005|100725152|FG002|Overall Study|Lost to Follow-up|1|||
33225478|NCT01370005|100725150|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
33225479|NCT01370005|100725151|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
33225480|NCT01370005|100725152|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
33225481|NCT01370005|100725150|FG000|Overall Study|Other reason not defined above|3|||
33225482|NCT01370005|100725151|FG001|Overall Study|Other reason not defined above|0|||
33225483|NCT01370005|100725152|FG002|Overall Study|Other reason not defined above|2|||
33225484|NCT01148862|100725153|FG000|Second Intervention|Withdrawal by Subject|0|||
33225485|NCT01148862|100725154|FG001|Second Intervention|Withdrawal by Subject|2|||
33225486|NCT01287520|100728426|FG000|Overall Study|Adverse Event|2|||
33568788|NCT01928394|101974942|FG021|Treatment Period|Participant request to stop therapy|1|||
33568789|NCT01928394|101974943|FG022|Treatment Period|Participant request to stop therapy|3|||
33568790|NCT01928394|101974921|FG000|Treatment Period|Participant withdrew consent|0|||
33568791|NCT01928394|101974922|FG001|Treatment Period|Participant withdrew consent|0|||
33568792|NCT01928394|101974923|FG002|Treatment Period|Participant withdrew consent|1|||
33568793|NCT01928394|101974924|FG003|Treatment Period|Participant withdrew consent|1|||
33568794|NCT01928394|101974925|FG004|Treatment Period|Participant withdrew consent|0|||
33568795|NCT01928394|101974926|FG005|Treatment Period|Participant withdrew consent|1|||
33632094|NCT02052778|102203083|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
33632095|NCT02052778|102203084|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
33632096|NCT02052778|102203085|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
33225487|NCT01287520|100728427|FG001|Overall Study|Adverse Event|2|||
33225488|NCT01287520|100728428|FG002|Overall Study|Adverse Event|2|||
33225489|NCT01287520|100728429|FG003|Overall Study|Adverse Event|1|||
33225490|NCT01287520|100728430|FG004|Overall Study|Adverse Event|1|||
33225491|NCT01287520|100728431|FG005|Overall Study|Adverse Event|2|||
33632097|NCT02052778|102203086|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
33632098|NCT02052778|102203087|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
33225492|NCT01287520|100728432|FG006|Overall Study|Adverse Event|0|||
33225493|NCT01287520|100728433|FG007|Overall Study|Adverse Event|2|||
33225494|NCT01287520|100728434|FG008|Overall Study|Adverse Event|0|||
33225495|NCT01287520|100728426|FG000|Overall Study|Physician Decision|1|||
33225496|NCT01287520|100728427|FG001|Overall Study|Physician Decision|1|||
33568796|NCT01928394|101974927|FG006|Treatment Period|Participant withdrew consent|0|||
33225497|NCT01287520|100728428|FG002|Overall Study|Physician Decision|2|||
33225498|NCT01287520|100728429|FG003|Overall Study|Physician Decision|0|||
33225499|NCT01287520|100728430|FG004|Overall Study|Physician Decision|1|||
33365387|NCT02546856|101223835|FG001|6 Months Evaluation|Lost to Follow-up|1|||
33365388|NCT02546856|101223834|FG000|6 Months Evaluation|Working or living abroad|6|||
33365389|NCT02546856|101223835|FG001|6 Months Evaluation|Working or living abroad|4|||
33365390|NCT02546856|101223834|FG000|6 Months Evaluation|reasons not due to titration|0|||
33632099|NCT02052778|102203065|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632100|NCT02052778|102203066|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632101|NCT02052778|102203067|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
33225500|NCT01287520|100728431|FG005|Overall Study|Physician Decision|1|||
33365391|NCT02546856|101223835|FG001|6 Months Evaluation|reasons not due to titration|1|||
33365392|NCT03135028|101223836|FG000|Overall Study|Death|6|||
33365393|NCT03135028|101223836|FG000|Overall Study|Study Terminated by Sponsor|2|||
33365394|NCT03135028|101223836|FG000|Overall Study|Withdrew Consent|1|||
33365395|NCT02190435|101223838|FG000|Overall Study|First 12 patients were lead-ins|12|||
33365396|NCT02190435|101223839|FG001|Overall Study|First 12 patients were lead-ins|0|||
33365397|NCT02190435|101223838|FG000|Overall Study|3 consented screen fails|3|||
33365398|NCT02190435|101223839|FG001|Overall Study|3 consented screen fails|0|||
33365399|NCT00328198|101223840|FG000|Treatment|Adverse Event|21|||
33365400|NCT00328198|101223840|FG000|Treatment|Death|1|||
33365401|NCT00328198|101223840|FG000|Treatment|Physician Decision|5|||
33365402|NCT00328198|101223840|FG000|Treatment|Withdrawal by Subject|5|||
33365403|NCT00328198|101223840|FG000|Treatment|Evidence of disease progression|2|||
33365404|NCT00328198|101223840|FG000|Treatment|Non-compliance|1|||
33365405|NCT00328198|101223840|FG000|Treatment|Confirmed complete response, MRD -|3|||
33365406|NCT00328198|101223840|FG000|Follow-up|Lost to Follow-up|4|||
33365407|NCT00328198|101223840|FG000|Follow-up|Death|31|||
33365408|NCT00992446|101227126|FG000|Overall Study|Disease Progression|1|||
33365409|NCT00992446|101227126|FG000|Overall Study|Withdrawal by Subject|2|||
33365410|NCT00992446|101227126|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
33365411|NCT03010423|101227127|FG000|Overall Study|Study termination|8|||
33365412|NCT00436215|101227128|FG000|Overall Study|Refused further treatment|3|||
33365413|NCT00436215|101227128|FG000|Overall Study|Small bowel obstruction|1|||
33365414|NCT00085540|101227129|FG000|Overall Study|Withdrawal by Subject|0|||
33365415|NCT00085540|101227130|FG001|Overall Study|Withdrawal by Subject|1|||
33365416|NCT00085540|101227129|FG000|Overall Study|Protocol Violation|0|||
33365417|NCT00085540|101227130|FG001|Overall Study|Protocol Violation|1|||
33365418|NCT00524745|101227134|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
33365419|NCT00524745|101227135|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
33365420|NCT00524745|101227136|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
33365421|NCT00524745|101227137|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
33365422|NCT05243550|101227138|FG000|Overall Study|Ongoing in the Study|171|||
33365423|NCT05243550|101227138|FG000|Overall Study|Withdrawal by Subject|10|||
33365424|NCT05243550|101227138|FG000|Overall Study|Lost to Follow-up|7|||
33365425|NCT05243550|101227138|FG000|Overall Study|Adverse Event|3|||
33365426|NCT05243550|101227138|FG000|Overall Study|Noncompliance|1|||
33365427|NCT05243550|101227138|FG000|Overall Study|Physician Decision|1|||
33365428|NCT05243550|101227138|FG000|Overall Study|Other Reason|4|||
33365429|NCT00907478|101227139|FG000|Overall Study|Ineligibility determined|0|||
33365430|NCT00907478|101227140|FG001|Overall Study|Ineligibility determined|0|||
33365431|NCT00907478|101227141|FG002|Overall Study|Ineligibility determined|1|||
33365432|NCT00907478|101227139|FG000|Overall Study|Noncompliance|0|||
33365433|NCT00907478|101227140|FG001|Overall Study|Noncompliance|0|||
33365434|NCT00907478|101227141|FG002|Overall Study|Noncompliance|1|||
33365435|NCT00907478|101227139|FG000|Overall Study|Adverse Event|3|||
33365436|NCT00907478|101227140|FG001|Overall Study|Adverse Event|1|||
33365437|NCT00907478|101227141|FG002|Overall Study|Adverse Event|2|||
33365438|NCT00907478|101227139|FG000|Overall Study|Withdrawal by Subject|8|||
33365439|NCT00907478|101227140|FG001|Overall Study|Withdrawal by Subject|9|||
33365440|NCT00907478|101227141|FG002|Overall Study|Withdrawal by Subject|6|||
33365441|NCT00907478|101227139|FG000|Overall Study|Requirement for alternative therapy|1|||
33365442|NCT00907478|101227140|FG001|Overall Study|Requirement for alternative therapy|2|||
33365443|NCT00907478|101227141|FG002|Overall Study|Requirement for alternative therapy|3|||
33225501|NCT01287520|100728432|FG006|Overall Study|Physician Decision|0|||
33225502|NCT01287520|100728433|FG007|Overall Study|Physician Decision|1|||
33365444|NCT00907478|101227139|FG000|Overall Study|Physician Decision|2|||
33365445|NCT00907478|101227140|FG001|Overall Study|Physician Decision|0|||
33225503|NCT01287520|100728434|FG008|Overall Study|Physician Decision|0|||
33365446|NCT00907478|101227141|FG002|Overall Study|Physician Decision|3|||
33365447|NCT00907478|101227139|FG000|Overall Study|Death|4|||
33365448|NCT00907478|101227140|FG001|Overall Study|Death|2|||
33225504|NCT01287520|100728426|FG000|Overall Study|Progressive disease|0|||
33365449|NCT00907478|101227141|FG002|Overall Study|Death|1|||
33365450|NCT00907478|101227139|FG000|Overall Study|Protocol-specified criteria|5|||
33365451|NCT00907478|101227140|FG001|Overall Study|Protocol-specified criteria|2|||
33365452|NCT00907478|101227141|FG002|Overall Study|Protocol-specified criteria|3|||
33225505|NCT01287520|100728427|FG001|Overall Study|Progressive disease|4|||
33225506|NCT01287520|100728428|FG002|Overall Study|Progressive disease|1|||
33225507|NCT01287520|100728429|FG003|Overall Study|Progressive disease|6|||
33225508|NCT01287520|100728430|FG004|Overall Study|Progressive disease|1|||
33225509|NCT01287520|100728431|FG005|Overall Study|Progressive disease|0|||
33225510|NCT01287520|100728432|FG006|Overall Study|Progressive disease|2|||
33225511|NCT01287520|100728433|FG007|Overall Study|Progressive disease|2|||
33225512|NCT01287520|100728434|FG008|Overall Study|Progressive disease|4|||
33365453|NCT00907478|101227139|FG000|Overall Study|Pregnancy|0|||
33568797|NCT01928394|101974928|FG007|Treatment Period|Participant withdrew consent|1|||
33568798|NCT01928394|101974929|FG008|Treatment Period|Participant withdrew consent|0|||
33568799|NCT01928394|101974930|FG009|Treatment Period|Participant withdrew consent|0|||
33568800|NCT01928394|101974931|FG010|Treatment Period|Participant withdrew consent|1|||
33568801|NCT01928394|101974932|FG011|Treatment Period|Participant withdrew consent|1|||
33568802|NCT01928394|101974933|FG012|Treatment Period|Participant withdrew consent|1|||
33568803|NCT01928394|101974934|FG013|Treatment Period|Participant withdrew consent|0|||
33568804|NCT01928394|101974935|FG014|Treatment Period|Participant withdrew consent|2|||
33568805|NCT01928394|101974936|FG015|Treatment Period|Participant withdrew consent|0|||
33568806|NCT01928394|101974937|FG016|Treatment Period|Participant withdrew consent|2|||
33365454|NCT00907478|101227140|FG001|Overall Study|Pregnancy|1|||
33632102|NCT02052778|102203068|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632103|NCT02052778|102203069|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632104|NCT02052778|102203070|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632105|NCT02052778|102203071|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
33365455|NCT00907478|101227141|FG002|Overall Study|Pregnancy|1|||
33632106|NCT02052778|102203072|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
33365456|NCT00907478|101227139|FG000|Overall Study|Lost to Follow-up|1|||
33365457|NCT00907478|101227140|FG001|Overall Study|Lost to Follow-up|0|||
33365458|NCT00907478|101227141|FG002|Overall Study|Lost to Follow-up|0|||
33365459|NCT00907478|101227139|FG000|Overall Study|Other|3|||
33365460|NCT00907478|101227140|FG001|Overall Study|Other|0|||
33365461|NCT00907478|101227141|FG002|Overall Study|Other|1|||
33365462|NCT01988012|101227142|FG000|Overall Study|Adverse Event|5|||
33365463|NCT01988012|101227142|FG000|Overall Study|Insufficient Therapeutic Response|3|||
33365464|NCT01988012|101227142|FG000|Overall Study|Patient Withdrawal of Consent|4|||
33365465|NCT01988012|101227142|FG000|Overall Study|Lost to Follow-up|1|||
33365466|NCT01988012|101227142|FG000|Overall Study|Physician Decision|1|||
33365467|NCT01988012|101227142|FG000|Overall Study|Protocol Violation|1|||
33365468|NCT04333433|101227146|FG000|Overall Study|Withdrawal by Subject|6|||
33365469|NCT04333433|101227147|FG001|Overall Study|Withdrawal by Subject|3|||
33365470|NCT04333433|101227146|FG000|Overall Study|Death|3|||
33365471|NCT04333433|101227147|FG001|Overall Study|Death|0|||
33365472|NCT04333433|101227146|FG000|Overall Study|Lost to Follow-up|6|||
33365473|NCT04333433|101227147|FG001|Overall Study|Lost to Follow-up|1|||
33365474|NCT04333433|101227146|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
33365475|NCT04333433|101227147|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
33365476|NCT00273858|101227148|FG000|Overall Study|Not completed 24 month observation time|334|||
33365477|NCT00273858|101227148|FG000|Overall Study|Lost to Follow-up|101|||
33365478|NCT00273858|101227148|FG000|Overall Study|Withdrawal by Subject|21|||
33365479|NCT00273858|101227148|FG000|Overall Study|Adverse Event|81|||
33568807|NCT01928394|101974938|FG017|Treatment Period|Participant withdrew consent|1|||
33568808|NCT01928394|101974939|FG018|Treatment Period|Participant withdrew consent|1|||
33568809|NCT01928394|101974940|FG019|Treatment Period|Participant withdrew consent|1|||
33568810|NCT01928394|101974941|FG020|Treatment Period|Participant withdrew consent|0|||
33568811|NCT01928394|101974942|FG021|Treatment Period|Participant withdrew consent|2|||
33568812|NCT01928394|101974943|FG022|Treatment Period|Participant withdrew consent|0|||
33568813|NCT01928394|101974921|FG000|Treatment Period|Poor/non-compliance|0|||
33568814|NCT01928394|101974922|FG001|Treatment Period|Poor/non-compliance|0|||
33568815|NCT01928394|101974923|FG002|Treatment Period|Poor/non-compliance|0|||
33568816|NCT01928394|101974924|FG003|Treatment Period|Poor/non-compliance|1|||
33632107|NCT02052778|102203073|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
33568817|NCT01928394|101974925|FG004|Treatment Period|Poor/non-compliance|0|||
33568818|NCT01928394|101974926|FG005|Treatment Period|Poor/non-compliance|0|||
33632108|NCT02052778|102203074|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
33225513|NCT01287520|100728426|FG000|Overall Study|Withdrawal by Subject|0|||
33365480|NCT02538666|101227151|FG000|Pre-Treatment|Disease progression|1|||
33365481|NCT02538666|101227152|FG001|Pre-Treatment|Disease progression|0|||
33568819|NCT01928394|101974927|FG006|Treatment Period|Poor/non-compliance|0|||
33632109|NCT02052778|102203075|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632110|NCT02052778|102203076|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632111|NCT02052778|102203077|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632112|NCT02052778|102203078|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632113|NCT02052778|102203079|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632114|NCT02052778|102203080|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632115|NCT02052778|102203081|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632116|NCT02052778|102203082|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
33417633|NCT01186744|101420334|FG000|Overall Study|Death|1|||
33417634|NCT01186744|101420335|FG001|Overall Study|Death|0|||
33632117|NCT02052778|102203083|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632118|NCT02052778|102203084|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632119|NCT02052778|102203085|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
33365482|NCT02538666|101227153|FG002|Pre-Treatment|Disease progression|0|||
33365483|NCT02538666|101227151|FG000|Pre-Treatment|no longer meets study criteria|1|||
33365484|NCT02538666|101227152|FG001|Pre-Treatment|no longer meets study criteria|0|||
33365485|NCT02538666|101227153|FG002|Pre-Treatment|no longer meets study criteria|0|||
33365486|NCT02538666|101227151|FG000|Pre-Treatment|Withdrew Consent|0|||
33365487|NCT02538666|101227152|FG001|Pre-Treatment|Withdrew Consent|1|||
33365488|NCT02538666|101227153|FG002|Pre-Treatment|Withdrew Consent|1|||
33365489|NCT02538666|101227151|FG000|Treatment|Disease progression|270|||
33365490|NCT02538666|101227152|FG001|Treatment|Disease progression|227|||
33365491|NCT02538666|101227153|FG002|Treatment|Disease progression|165|||
33365492|NCT02538666|101227151|FG000|Treatment|Study drug toxicity|1|||
33365493|NCT02538666|101227152|FG001|Treatment|Study drug toxicity|29|||
33365494|NCT02538666|101227153|FG002|Treatment|Study drug toxicity|92|||
33365495|NCT02538666|101227151|FG000|Treatment|Death|0|||
33365496|NCT02538666|101227152|FG001|Treatment|Death|2|||
33365497|NCT02538666|101227153|FG002|Treatment|Death|3|||
33365498|NCT02538666|101227151|FG000|Treatment|Adverse event unrelated to study drug|8|||
33365499|NCT02538666|101227152|FG001|Treatment|Adverse event unrelated to study drug|10|||
33365500|NCT02538666|101227153|FG002|Treatment|Adverse event unrelated to study drug|15|||
33365501|NCT02538666|101227151|FG000|Treatment|Participant request to discontinue study treatment|3|||
33365502|NCT02538666|101227152|FG001|Treatment|Participant request to discontinue study treatment|6|||
33365503|NCT02538666|101227153|FG002|Treatment|Participant request to discontinue study treatment|11|||
33365504|NCT02538666|101227151|FG000|Treatment|Participant withdrew consent|2|||
33365505|NCT02538666|101227152|FG001|Treatment|Participant withdrew consent|5|||
33365506|NCT02538666|101227153|FG002|Treatment|Participant withdrew consent|3|||
33365507|NCT02538666|101227151|FG000|Treatment|Lost to Follow-up|0|||
33365508|NCT02538666|101227152|FG001|Treatment|Lost to Follow-up|1|||
33365509|NCT02538666|101227153|FG002|Treatment|Lost to Follow-up|1|||
33365510|NCT02538666|101227151|FG000|Treatment|Maximum clinical benefit|4|||
33365511|NCT02538666|101227152|FG001|Treatment|Maximum clinical benefit|3|||
33365512|NCT02538666|101227153|FG002|Treatment|Maximum clinical benefit|4|||
33365513|NCT02538666|101227151|FG000|Treatment|Poor/non-compliance|0|||
33365514|NCT02538666|101227152|FG001|Treatment|Poor/non-compliance|1|||
33365515|NCT02538666|101227153|FG002|Treatment|Poor/non-compliance|0|||
33365516|NCT02538666|101227151|FG000|Treatment|Participant no longer meets study criteria|0|||
33365517|NCT02538666|101227152|FG001|Treatment|Participant no longer meets study criteria|2|||
33365518|NCT02538666|101227153|FG002|Treatment|Participant no longer meets study criteria|0|||
33365519|NCT02538666|101227151|FG000|Treatment|Administrative reason by sponsor|0|||
33365520|NCT02538666|101227152|FG001|Treatment|Administrative reason by sponsor|0|||
33365521|NCT02538666|101227153|FG002|Treatment|Administrative reason by sponsor|1|||
33365522|NCT02538666|101227151|FG000|Treatment|Other reasons|8|||
33365523|NCT02538666|101227152|FG001|Treatment|Other reasons|15|||
33365524|NCT02538666|101227153|FG002|Treatment|Other reasons|5|||
33365525|NCT02538666|101227151|FG000|Treatment|Not reported|2|||
33365526|NCT02538666|101227152|FG001|Treatment|Not reported|2|||
33365527|NCT02538666|101227153|FG002|Treatment|Not reported|2|||
33365528|NCT00798967|101227154|FG000|Overall Study|Adverse Event|2|||
33365529|NCT00798967|101227155|FG001|Overall Study|Adverse Event|3|||
33365530|NCT00798967|101227154|FG000|Overall Study|Withdrawal by Subject|0|||
33365531|NCT00798967|101227155|FG001|Overall Study|Withdrawal by Subject|1|||
33365532|NCT00798967|101227154|FG000|Overall Study|Physician Decision|1|||
33365533|NCT00798967|101227155|FG001|Overall Study|Physician Decision|0|||
33365534|NCT00798967|101227154|FG000|Overall Study|Randomized in error by site|1|||
33365535|NCT00798967|101227155|FG001|Overall Study|Randomized in error by site|0|||
33365536|NCT01594476|101227156|FG000|Overall Study|Protocol Violation|1|||
33365537|NCT01594476|101227157|FG001|Overall Study|Protocol Violation|3|||
33365538|NCT04238663|101227159|FG000|Overall Study|Lost to Follow-up|0|||
33365539|NCT04238663|101227160|FG001|Overall Study|Lost to Follow-up|1|||
33365540|NCT04238663|101227161|FG002|Overall Study|Lost to Follow-up|0|||
33365541|NCT02284906|101227162|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33632120|NCT02052778|102203086|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
33632121|NCT02052778|102203087|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
33632122|NCT04245111|102203088|FG000|Overall Study|Lost to Follow-up|5|||
33632123|NCT04245111|102203089|FG001|Overall Study|Lost to Follow-up|1|||
33632124|NCT04245111|102203090|FG002|Overall Study|Lost to Follow-up|1|||
33632125|NCT03264404|102203091|FG000|Overall Study|Death|2|||
33632126|NCT03264404|102203091|FG000|Overall Study|Physician Decision|1|||
33632127|NCT03264404|102203091|FG000|Overall Study|Disease Progression|28|||
33417635|NCT01186744|101420336|FG002|Overall Study|Death|0|||
33417636|NCT01186744|101420337|FG003|Overall Study|Death|0|||
33417637|NCT01186744|101420338|FG004|Overall Study|Death|0|||
33417638|NCT01186744|101420339|FG005|Overall Study|Death|0|||
33417639|NCT01126359|101420340|FG000|First Intervention (20-minutes)|Physician Decision|0|||
33417640|NCT01126359|101420341|FG001|First Intervention (20-minutes)|Physician Decision|1|||
33417641|NCT03594175|101420342|FG000|Overall Study|Not treated|8|||
33417642|NCT03594175|101420343|FG001|Overall Study|Not treated|1|||
33417643|NCT03594175|101420344|FG002|Overall Study|Not treated|5|||
33417644|NCT03594175|101420342|FG000|Overall Study|Adverse Event|3|||
33417645|NCT03594175|101420343|FG001|Overall Study|Adverse Event|0|||
33417646|NCT03594175|101420344|FG002|Overall Study|Adverse Event|0|||
33417647|NCT03594175|101420342|FG000|Overall Study|Withdrawal by Subject|3|||
33417648|NCT03594175|101420343|FG001|Overall Study|Withdrawal by Subject|0|||
33417649|NCT03594175|101420344|FG002|Overall Study|Withdrawal by Subject|0|||
33417650|NCT03594175|101420342|FG000|Overall Study|Protocol Violation|2|||
33417651|NCT03594175|101420343|FG001|Overall Study|Protocol Violation|2|||
33568820|NCT01928394|101974928|FG007|Treatment Period|Poor/non-compliance|0|||
33568821|NCT01928394|101974929|FG008|Treatment Period|Poor/non-compliance|0|||
33568822|NCT01928394|101974930|FG009|Treatment Period|Poor/non-compliance|0|||
33568823|NCT01928394|101974931|FG010|Treatment Period|Poor/non-compliance|0|||
33568824|NCT01928394|101974932|FG011|Treatment Period|Poor/non-compliance|0|||
33568825|NCT01928394|101974933|FG012|Treatment Period|Poor/non-compliance|1|||
33568826|NCT01928394|101974934|FG013|Treatment Period|Poor/non-compliance|0|||
33632128|NCT03264404|102203091|FG000|Overall Study|Adverse Event|1|||
33632129|NCT03264404|102203091|FG000|Overall Study|Off study prior to treatment|2|||
33632130|NCT01502293|102203092|FG000|Overall Study|Progressive Disease|20|||
33632131|NCT01502293|102203093|FG001|Overall Study|Progressive Disease|12|||
33632132|NCT01502293|102203094|FG002|Overall Study|Progressive Disease|2|||
33632133|NCT01502293|102203092|FG000|Overall Study|Withdrawal by Subject|3|||
33632134|NCT01502293|102203093|FG001|Overall Study|Withdrawal by Subject|3|||
33225514|NCT01287520|100728427|FG001|Overall Study|Withdrawal by Subject|0|||
33417652|NCT03594175|101420344|FG002|Overall Study|Protocol Violation|2|||
33417653|NCT02787785|101420345|FG000|Overall Study|Death|3|||
33568827|NCT01928394|101974935|FG014|Treatment Period|Poor/non-compliance|1|||
33568828|NCT01928394|101974936|FG015|Treatment Period|Poor/non-compliance|0|||
33568829|NCT01928394|101974937|FG016|Treatment Period|Poor/non-compliance|0|||
33568830|NCT01928394|101974938|FG017|Treatment Period|Poor/non-compliance|1|||
33568831|NCT01928394|101974939|FG018|Treatment Period|Poor/non-compliance|0|||
33568832|NCT01928394|101974940|FG019|Treatment Period|Poor/non-compliance|1|||
33568833|NCT01928394|101974941|FG020|Treatment Period|Poor/non-compliance|0|||
33568834|NCT01928394|101974942|FG021|Treatment Period|Poor/non-compliance|0|||
33568835|NCT01928394|101974943|FG022|Treatment Period|Poor/non-compliance|0|||
33568836|NCT01928394|101974921|FG000|Treatment Period|other reason|0|||
33568837|NCT01928394|101974922|FG001|Treatment Period|other reason|0|||
33568838|NCT01928394|101974923|FG002|Treatment Period|other reason|0|||
33568839|NCT01928394|101974924|FG003|Treatment Period|other reason|0|||
33568840|NCT01928394|101974925|FG004|Treatment Period|other reason|0|||
33568841|NCT01928394|101974926|FG005|Treatment Period|other reason|0|||
33568842|NCT01928394|101974927|FG006|Treatment Period|other reason|0|||
33568843|NCT01928394|101974928|FG007|Treatment Period|other reason|0|||
33568844|NCT01928394|101974929|FG008|Treatment Period|other reason|0|||
33568845|NCT01928394|101974930|FG009|Treatment Period|other reason|0|||
33568846|NCT01928394|101974931|FG010|Treatment Period|other reason|1|||
33568847|NCT01928394|101974932|FG011|Treatment Period|other reason|1|||
33568848|NCT01928394|101974933|FG012|Treatment Period|other reason|1|||
33568849|NCT01928394|101974934|FG013|Treatment Period|other reason|0|||
33568850|NCT01928394|101974935|FG014|Treatment Period|other reason|1|||
33632135|NCT01502293|102203094|FG002|Overall Study|Withdrawal by Subject|1|||
33417654|NCT02787785|101420346|FG001|Overall Study|Death|4|||
33417655|NCT02787785|101420345|FG000|Overall Study|Lost to Follow-up|1|||
33568851|NCT01928394|101974936|FG015|Treatment Period|other reason|0|||
33568852|NCT01928394|101974937|FG016|Treatment Period|other reason|0|||
33568853|NCT01928394|101974938|FG017|Treatment Period|other reason|0|||
33632136|NCT01502293|102203092|FG000|Overall Study|Adverse Event|0|||
33632137|NCT01502293|102203093|FG001|Overall Study|Adverse Event|2|||
33632138|NCT01502293|102203094|FG002|Overall Study|Adverse Event|0|||
33417656|NCT02787785|101420346|FG001|Overall Study|Lost to Follow-up|1|||
33417657|NCT02787785|101420345|FG000|Overall Study|Withdrawal by Subject|0|||
33568854|NCT01928394|101974939|FG018|Treatment Period|other reason|2|||
33568855|NCT01928394|101974940|FG019|Treatment Period|other reason|2|||
33568856|NCT01928394|101974941|FG020|Treatment Period|other reason|0|||
33568857|NCT01928394|101974942|FG021|Treatment Period|other reason|0|||
33568858|NCT01928394|101974943|FG022|Treatment Period|other reason|0|||
33568859|NCT01928394|101974921|FG000|Treatment Period|Maximum clinical benefit|0|||
33568860|NCT01928394|101974922|FG001|Treatment Period|Maximum clinical benefit|0|||
33568861|NCT01928394|101974923|FG002|Treatment Period|Maximum clinical benefit|0|||
33568862|NCT01928394|101974924|FG003|Treatment Period|Maximum clinical benefit|0|||
33568863|NCT01928394|101974925|FG004|Treatment Period|Maximum clinical benefit|0|||
33568864|NCT01928394|101974926|FG005|Treatment Period|Maximum clinical benefit|0|||
33568865|NCT01928394|101974927|FG006|Treatment Period|Maximum clinical benefit|0|||
33225515|NCT01287520|100728428|FG002|Overall Study|Withdrawal by Subject|0|||
33225516|NCT01287520|100728429|FG003|Overall Study|Withdrawal by Subject|0|||
33225517|NCT01287520|100728430|FG004|Overall Study|Withdrawal by Subject|0|||
33365542|NCT02284906|101227163|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
33365543|NCT02284906|101227164|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
33365544|NCT02284906|101227162|FG000|Overall Study|Major Protocol Deviation|0|||
33365545|NCT02284906|101227163|FG001|Overall Study|Major Protocol Deviation|1|||
33365546|NCT02284906|101227164|FG002|Overall Study|Major Protocol Deviation|0|||
33365547|NCT02284906|101227162|FG000|Overall Study|Voluntary Withdrawal|2|||
33365548|NCT02284906|101227163|FG001|Overall Study|Voluntary Withdrawal|4|||
33365549|NCT02284906|101227164|FG002|Overall Study|Voluntary Withdrawal|5|||
33365550|NCT02284906|101227162|FG000|Overall Study|Study Termination|0|||
33365551|NCT02284906|101227163|FG001|Overall Study|Study Termination|11|||
33568866|NCT01928394|101974928|FG007|Treatment Period|Maximum clinical benefit|0|||
33365552|NCT02284906|101227164|FG002|Overall Study|Study Termination|14|||
33365553|NCT02284906|101227162|FG000|Overall Study|Reason not Specified|1|||
33365554|NCT02284906|101227163|FG001|Overall Study|Reason not Specified|1|||
33365555|NCT02284906|101227164|FG002|Overall Study|Reason not Specified|0|||
33225518|NCT01287520|100728431|FG005|Overall Study|Withdrawal by Subject|1|||
33225519|NCT01287520|100728432|FG006|Overall Study|Withdrawal by Subject|0|||
33225520|NCT01287520|100728433|FG007|Overall Study|Withdrawal by Subject|0|||
33225521|NCT01287520|100728434|FG008|Overall Study|Withdrawal by Subject|1|||
33225522|NCT04525547|100728441|FG000|Overall Study|Not treated with Ofev|2|||
33225523|NCT04525547|100728441|FG000|Overall Study|Off-label use|2|||
33225524|NCT04525547|100728441|FG000|Overall Study|Lost to Follow-up|1|||
33225525|NCT04534114|100728444|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
33225526|NCT04534114|100728445|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
33225527|NCT04534114|100728446|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
33225528|NCT04534114|100728447|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
33225529|NCT04534114|100728444|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
33225530|NCT04534114|100728445|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
33225531|NCT04534114|100728446|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
33225532|NCT04534114|100728447|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
33225533|NCT04534114|100728444|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
33225534|NCT04534114|100728445|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
33225535|NCT04534114|100728446|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
33225536|NCT04534114|100728447|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
33225537|NCT04534114|100728444|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
33225538|NCT04534114|100728445|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
33225539|NCT04534114|100728446|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
33225540|NCT04534114|100728447|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
33225541|NCT04534114|100728444|FG000|Main Treatment Period|Physician Decision|0|||
33225542|NCT04534114|100728445|FG001|Main Treatment Period|Physician Decision|0|||
33225543|NCT04534114|100728446|FG002|Main Treatment Period|Physician Decision|0|||
33225544|NCT04534114|100728447|FG003|Main Treatment Period|Physician Decision|1|||
33225545|NCT04534114|100728444|FG000|Main Treatment Period|Death|1|||
33225546|NCT04534114|100728445|FG001|Main Treatment Period|Death|0|||
33417658|NCT02787785|101420346|FG001|Overall Study|Withdrawal by Subject|5|||
33417659|NCT04101721|101420347|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
33417660|NCT04101721|101420348|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
33417661|NCT04101721|101420347|FG000|Overall Study|Death|0|||
33417662|NCT04101721|101420348|FG001|Overall Study|Death|1|||
33417663|NCT04101721|101420347|FG000|Overall Study|Lost to Follow-up|0|||
33417664|NCT04101721|101420348|FG001|Overall Study|Lost to Follow-up|3|||
33417665|NCT00996918|101420351|FG000|Overall Study|Lack of Efficacy|1|||
33417666|NCT00996918|101420352|FG001|Overall Study|Lack of Efficacy|1|||
33417667|NCT00996918|101420353|FG002|Overall Study|Lack of Efficacy|2|||
33417668|NCT00996918|101420354|FG003|Overall Study|Lack of Efficacy|2|||
33417669|NCT00996918|101420355|FG004|Overall Study|Lack of Efficacy|0|||
33417670|NCT00996918|101420351|FG000|Overall Study|Adverse Event|2|||
33417671|NCT00996918|101420352|FG001|Overall Study|Adverse Event|5|||
33417672|NCT00996918|101420353|FG002|Overall Study|Adverse Event|2|||
33417673|NCT00996918|101420354|FG003|Overall Study|Adverse Event|6|||
33417674|NCT00996918|101420355|FG004|Overall Study|Adverse Event|0|||
33417675|NCT00996918|101420351|FG000|Overall Study|Withdrawal by Subject|1|||
33417676|NCT00996918|101420352|FG001|Overall Study|Withdrawal by Subject|4|||
33417677|NCT00996918|101420353|FG002|Overall Study|Withdrawal by Subject|3|||
33417678|NCT00996918|101420354|FG003|Overall Study|Withdrawal by Subject|3|||
33417679|NCT00996918|101420355|FG004|Overall Study|Withdrawal by Subject|2|||
33417680|NCT00996918|101420351|FG000|Overall Study|Physician Decision|1|||
33417681|NCT00996918|101420352|FG001|Overall Study|Physician Decision|0|||
33417682|NCT00996918|101420353|FG002|Overall Study|Physician Decision|0|||
33417683|NCT00996918|101420354|FG003|Overall Study|Physician Decision|0|||
33417684|NCT00996918|101420355|FG004|Overall Study|Physician Decision|0|||
33417685|NCT00996918|101420351|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
33417686|NCT00996918|101420352|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
33417687|NCT00996918|101420353|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
33225547|NCT04534114|100728446|FG002|Main Treatment Period|Death|0|||
33225548|NCT04534114|100728447|FG003|Main Treatment Period|Death|1|||
33225549|NCT04534114|100728444|FG000|Main Treatment Period|Other reason|1|||
33365556|NCT00958568|101227166|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
33417688|NCT00996918|101420354|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
33417689|NCT00996918|101420355|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
33417690|NCT00996918|101420351|FG000|Overall Study|Loss of Caregiver|0|||
33417691|NCT00996918|101420352|FG001|Overall Study|Loss of Caregiver|1|||
33417692|NCT00996918|101420353|FG002|Overall Study|Loss of Caregiver|0|||
33417693|NCT00996918|101420354|FG003|Overall Study|Loss of Caregiver|0|||
33417694|NCT00996918|101420355|FG004|Overall Study|Loss of Caregiver|0|||
33417695|NCT00996918|101420351|FG000|Overall Study|Other|3|||
33417696|NCT00996918|101420352|FG001|Overall Study|Other|1|||
33417697|NCT00996918|101420353|FG002|Overall Study|Other|0|||
33417698|NCT00996918|101420354|FG003|Overall Study|Other|0|||
33417699|NCT00996918|101420355|FG004|Overall Study|Other|0|||
33365557|NCT00958568|101227167|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
33365558|NCT00958568|101227168|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
33365559|NCT00958568|101227169|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
33365560|NCT00958568|101227166|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
33365561|NCT00958568|101227167|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
33365562|NCT00958568|101227168|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
33365563|NCT00958568|101227169|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
33365564|NCT00958568|101227166|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
33365565|NCT00958568|101227167|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
33365566|NCT00958568|101227168|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
33365567|NCT00958568|101227169|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
33365568|NCT00958568|101227166|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
33365569|NCT00958568|101227167|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
33365570|NCT00958568|101227168|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
33365571|NCT00958568|101227169|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
33365572|NCT00958568|101227166|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
33365573|NCT00958568|101227167|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
33365574|NCT00958568|101227168|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
33568867|NCT01928394|101974929|FG008|Treatment Period|Maximum clinical benefit|0|||
33568868|NCT01928394|101974930|FG009|Treatment Period|Maximum clinical benefit|0|||
33568869|NCT01928394|101974931|FG010|Treatment Period|Maximum clinical benefit|1|||
33568870|NCT01928394|101974932|FG011|Treatment Period|Maximum clinical benefit|1|||
33568871|NCT01928394|101974933|FG012|Treatment Period|Maximum clinical benefit|0|||
33568872|NCT01928394|101974934|FG013|Treatment Period|Maximum clinical benefit|0|||
33568873|NCT01928394|101974935|FG014|Treatment Period|Maximum clinical benefit|1|||
33568874|NCT01928394|101974936|FG015|Treatment Period|Maximum clinical benefit|0|||
33568875|NCT01928394|101974937|FG016|Treatment Period|Maximum clinical benefit|0|||
33568876|NCT01928394|101974938|FG017|Treatment Period|Maximum clinical benefit|1|||
33568877|NCT01928394|101974939|FG018|Treatment Period|Maximum clinical benefit|1|||
33568878|NCT01928394|101974940|FG019|Treatment Period|Maximum clinical benefit|0|||
33568879|NCT01928394|101974941|FG020|Treatment Period|Maximum clinical benefit|2|||
33568880|NCT01928394|101974942|FG021|Treatment Period|Maximum clinical benefit|0|||
33568881|NCT01928394|101974943|FG022|Treatment Period|Maximum clinical benefit|0|||
33568882|NCT01928394|101974921|FG000|Treatment Period|Lost to Follow-up|0|||
33568883|NCT01928394|101974922|FG001|Treatment Period|Lost to Follow-up|0|||
33568884|NCT01928394|101974923|FG002|Treatment Period|Lost to Follow-up|0|||
33568885|NCT01928394|101974924|FG003|Treatment Period|Lost to Follow-up|0|||
33568886|NCT01928394|101974925|FG004|Treatment Period|Lost to Follow-up|0|||
33568887|NCT01928394|101974926|FG005|Treatment Period|Lost to Follow-up|0|||
33568888|NCT01928394|101974927|FG006|Treatment Period|Lost to Follow-up|0|||
33568889|NCT01928394|101974928|FG007|Treatment Period|Lost to Follow-up|0|||
33568890|NCT01928394|101974929|FG008|Treatment Period|Lost to Follow-up|0|||
33568891|NCT01928394|101974930|FG009|Treatment Period|Lost to Follow-up|0|||
33568892|NCT01928394|101974931|FG010|Treatment Period|Lost to Follow-up|0|||
33568893|NCT01928394|101974932|FG011|Treatment Period|Lost to Follow-up|0|||
33568894|NCT01928394|101974933|FG012|Treatment Period|Lost to Follow-up|0|||
33568895|NCT01928394|101974934|FG013|Treatment Period|Lost to Follow-up|0|||
33568896|NCT01928394|101974935|FG014|Treatment Period|Lost to Follow-up|0|||
33568897|NCT01928394|101974936|FG015|Treatment Period|Lost to Follow-up|0|||
33568898|NCT01928394|101974937|FG016|Treatment Period|Lost to Follow-up|0|||
33568899|NCT01928394|101974938|FG017|Treatment Period|Lost to Follow-up|0|||
33568900|NCT01928394|101974939|FG018|Treatment Period|Lost to Follow-up|0|||
33568901|NCT01928394|101974940|FG019|Treatment Period|Lost to Follow-up|0|||
33568902|NCT01928394|101974941|FG020|Treatment Period|Lost to Follow-up|0|||
33568903|NCT01928394|101974942|FG021|Treatment Period|Lost to Follow-up|0|||
33568904|NCT01928394|101974943|FG022|Treatment Period|Lost to Follow-up|1|||
33568905|NCT01928394|101974921|FG000|Treatment Period|Death|0|||
33568906|NCT01928394|101974922|FG001|Treatment Period|Death|0|||
33568907|NCT01928394|101974923|FG002|Treatment Period|Death|0|||
33568908|NCT01928394|101974924|FG003|Treatment Period|Death|0|||
33568909|NCT01928394|101974925|FG004|Treatment Period|Death|0|||
33568910|NCT01928394|101974926|FG005|Treatment Period|Death|0|||
33568911|NCT01928394|101974927|FG006|Treatment Period|Death|0|||
33568912|NCT01928394|101974928|FG007|Treatment Period|Death|0|||
33568913|NCT01928394|101974929|FG008|Treatment Period|Death|0|||
33568914|NCT01928394|101974930|FG009|Treatment Period|Death|0|||
33568915|NCT01928394|101974931|FG010|Treatment Period|Death|0|||
33568916|NCT01928394|101974932|FG011|Treatment Period|Death|0|||
33632139|NCT01502293|102203092|FG000|Overall Study|Reason Not Specified|2|||
33568917|NCT01928394|101974933|FG012|Treatment Period|Death|0|||
33568918|NCT01928394|101974934|FG013|Treatment Period|Death|1|||
33568919|NCT01928394|101974935|FG014|Treatment Period|Death|2|||
33568920|NCT01928394|101974936|FG015|Treatment Period|Death|0|||
33568921|NCT01928394|101974937|FG016|Treatment Period|Death|0|||
33568922|NCT01928394|101974938|FG017|Treatment Period|Death|0|||
33568923|NCT01928394|101974939|FG018|Treatment Period|Death|0|||
33225550|NCT04534114|100728445|FG001|Main Treatment Period|Other reason|1|||
33225551|NCT04534114|100728446|FG002|Main Treatment Period|Other reason|0|||
33225552|NCT04534114|100728447|FG003|Main Treatment Period|Other reason|0|||
33225553|NCT04534114|100728444|FG000|Main Treatment Period|Participant decision|1|||
33225554|NCT04534114|100728445|FG001|Main Treatment Period|Participant decision|3|||
33417700|NCT04816877|101420356|FG000|Overall Study|Withdrawal by Subject|1|||
33417701|NCT04816877|101420357|FG001|Overall Study|Withdrawal by Subject|0|||
33568924|NCT01928394|101974940|FG019|Treatment Period|Death|0|||
33568925|NCT01928394|101974941|FG020|Treatment Period|Death|0|||
33417702|NCT03330847|101420363|FG000|Overall Study|Patients ongoing study|62|||
33225555|NCT04534114|100728446|FG002|Main Treatment Period|Participant decision|3|||
33225556|NCT04534114|100728447|FG003|Main Treatment Period|Participant decision|1|||
33225557|NCT04534114|100728444|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
33225558|NCT04534114|100728445|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
33225559|NCT04534114|100728446|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
33225560|NCT04534114|100728447|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
33225561|NCT04534114|100728444|FG000|Main Treatment Period|Adverse Event|4|||
33225562|NCT04534114|100728445|FG001|Main Treatment Period|Adverse Event|2|||
33225563|NCT04534114|100728446|FG002|Main Treatment Period|Adverse Event|1|||
33225564|NCT04534114|100728447|FG003|Main Treatment Period|Adverse Event|2|||
33225565|NCT04534114|100728444|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
33225566|NCT04534114|100728445|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
33225567|NCT04534114|100728446|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
33417703|NCT03330847|101420364|FG001|Overall Study|Patients ongoing study|65|||
33417704|NCT03330847|101420365|FG002|Overall Study|Patients ongoing study|15|||
33568926|NCT01928394|101974942|FG021|Treatment Period|Death|0|||
33568927|NCT01928394|101974943|FG022|Treatment Period|Death|0|||
33568928|NCT01928394|101974921|FG000|Follow-up Period|Participant withdrew consent|3|||
33568929|NCT01928394|101974922|FG001|Follow-up Period|Participant withdrew consent|0|||
33568930|NCT01928394|101974923|FG002|Follow-up Period|Participant withdrew consent|1|||
33568931|NCT01928394|101974924|FG003|Follow-up Period|Participant withdrew consent|4|||
33568932|NCT01928394|101974925|FG004|Follow-up Period|Participant withdrew consent|0|||
33568933|NCT01928394|101974926|FG005|Follow-up Period|Participant withdrew consent|2|||
33568934|NCT01928394|101974927|FG006|Follow-up Period|Participant withdrew consent|5|||
33632140|NCT01502293|102203093|FG001|Overall Study|Reason Not Specified|0|||
33632141|NCT01502293|102203094|FG002|Overall Study|Reason Not Specified|0|||
33632142|NCT01502293|102203092|FG000|Overall Study|Physician Decision|0|||
33632143|NCT01502293|102203093|FG001|Overall Study|Physician Decision|0|||
33632144|NCT01502293|102203094|FG002|Overall Study|Physician Decision|1|||
33632145|NCT02435212|102203098|FG000|Core Phase|Adverse Event|8|||
33632146|NCT02435212|102203099|FG001|Core Phase|Adverse Event|5|||
33632147|NCT02435212|102203098|FG000|Core Phase|Withdrawal by Subject|3|||
33632148|NCT02435212|102203099|FG001|Core Phase|Withdrawal by Subject|0|||
33632149|NCT02435212|102203098|FG000|Core Phase|Withdrawal by parent/guardian|9|||
33632150|NCT02435212|102203099|FG001|Core Phase|Withdrawal by parent/guardian|4|||
33632151|NCT02435212|102203098|FG000|Core Phase|Protocol Violation|1|||
33632152|NCT02435212|102203099|FG001|Core Phase|Protocol Violation|2|||
33632153|NCT02435212|102203098|FG000|Core Phase|Physician Decision|3|||
33632154|NCT02435212|102203099|FG001|Core Phase|Physician Decision|0|||
33632155|NCT02435212|102203098|FG000|Core Phase|Lost to Follow-up|0|||
33632156|NCT02435212|102203099|FG001|Core Phase|Lost to Follow-up|1|||
33632157|NCT02435212|102203098|FG000|Core Phase|Lack of Efficacy|0|||
33632158|NCT02435212|102203099|FG001|Core Phase|Lack of Efficacy|1|||
33632159|NCT02435212|102203098|FG000|Core Phase|Recovery|1|||
33632160|NCT02435212|102203099|FG001|Core Phase|Recovery|0|||
33632161|NCT02435212|102203098|FG000|Optional Extension Phase|Adverse Event|3|||
33632162|NCT02435212|102203099|FG001|Optional Extension Phase|Adverse Event|9|||
33417705|NCT03927989|101420366|FG000|Overall Study|Withdrawal by Subject|0|||
33568935|NCT01928394|101974928|FG007|Follow-up Period|Participant withdrew consent|1|||
33632163|NCT02435212|102203098|FG000|Optional Extension Phase|Physician Decision|6|||
33632164|NCT02435212|102203099|FG001|Optional Extension Phase|Physician Decision|8|||
33568936|NCT01928394|101974929|FG008|Follow-up Period|Participant withdrew consent|0|||
33568937|NCT01928394|101974930|FG009|Follow-up Period|Participant withdrew consent|0|||
33568938|NCT01928394|101974931|FG010|Follow-up Period|Participant withdrew consent|5|||
33568939|NCT01928394|101974932|FG011|Follow-up Period|Participant withdrew consent|8|||
33225568|NCT04534114|100728447|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
33225569|NCT04534114|100728444|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
33225570|NCT04534114|100728445|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
33225571|NCT04534114|100728446|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
33225572|NCT04534114|100728447|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
33225573|NCT04534114|100728444|FG000|Extension Treatment Period|Other reason|0|||
33225574|NCT04534114|100728445|FG001|Extension Treatment Period|Other reason|1|||
33225575|NCT04534114|100728446|FG002|Extension Treatment Period|Other reason|0|||
33225576|NCT04534114|100728447|FG003|Extension Treatment Period|Other reason|0|||
33225577|NCT04534114|100728444|FG000|Extension Treatment Period|Death|0|||
33225578|NCT04534114|100728445|FG001|Extension Treatment Period|Death|0|||
33225579|NCT04534114|100728446|FG002|Extension Treatment Period|Death|1|||
33568940|NCT01928394|101974933|FG012|Follow-up Period|Participant withdrew consent|2|||
33568941|NCT01928394|101974934|FG013|Follow-up Period|Participant withdrew consent|12|||
33568942|NCT01928394|101974935|FG014|Follow-up Period|Participant withdrew consent|7|||
33568943|NCT01928394|101974936|FG015|Follow-up Period|Participant withdrew consent|0|||
33568944|NCT01928394|101974937|FG016|Follow-up Period|Participant withdrew consent|5|||
33568945|NCT01928394|101974938|FG017|Follow-up Period|Participant withdrew consent|3|||
33568946|NCT01928394|101974939|FG018|Follow-up Period|Participant withdrew consent|2|||
33568947|NCT01928394|101974940|FG019|Follow-up Period|Participant withdrew consent|7|||
33568948|NCT01928394|101974941|FG020|Follow-up Period|Participant withdrew consent|4|||
33568949|NCT01928394|101974942|FG021|Follow-up Period|Participant withdrew consent|6|||
33568950|NCT01928394|101974943|FG022|Follow-up Period|Participant withdrew consent|2|||
33568951|NCT01928394|101974921|FG000|Follow-up Period|Death|0|||
33632165|NCT02435212|102203098|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
33632166|NCT02435212|102203099|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
33225580|NCT04534114|100728447|FG003|Extension Treatment Period|Death|2|||
33225581|NCT04534114|100728444|FG000|Extension Treatment Period|Adverse Event|0|||
33225582|NCT04534114|100728445|FG001|Extension Treatment Period|Adverse Event|1|||
33568952|NCT01928394|101974922|FG001|Follow-up Period|Death|0|||
33632167|NCT02435212|102203098|FG000|Optional Extension Phase|Lack of Efficacy|2|||
33632168|NCT02435212|102203099|FG001|Optional Extension Phase|Lack of Efficacy|3|||
33632169|NCT02435212|102203098|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
33632170|NCT02435212|102203099|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
33632171|NCT02435212|102203098|FG000|Optional Extension Phase|Protocol Violation|0|||
33632172|NCT02435212|102203099|FG001|Optional Extension Phase|Protocol Violation|1|||
33632173|NCT02435212|102203098|FG000|Optional Extension Phase|Recovery|1|||
33632174|NCT02435212|102203099|FG001|Optional Extension Phase|Recovery|1|||
33632175|NCT02435212|102203098|FG000|Optional Extension Phase|Death|1|||
33632176|NCT02435212|102203099|FG001|Optional Extension Phase|Death|0|||
33632177|NCT02435212|102203098|FG000|Optional Extension Phase|Technical problems|2|||
33632178|NCT02435212|102203099|FG001|Optional Extension Phase|Technical problems|0|||
33632179|NCT03453164|102203114|FG000|Overall Study|Lack of Efficacy|16|||
33632180|NCT03453164|102203114|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
33632181|NCT01775501|102203115|FG000|Overall Study|Discontinued prior to treatment|1|||
33632182|NCT05615922|102203117|FG000|Overall Study|Lost to Follow-up|1|||
33632183|NCT03668873|102203118|FG000|Overall Study|Lost to Follow-up|6|||
33632184|NCT03668873|102203119|FG001|Overall Study|Lost to Follow-up|3|||
33632185|NCT02006472|102203120|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
33632186|NCT02006472|102203121|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
33632187|NCT02006472|102203122|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
33225583|NCT04534114|100728446|FG002|Extension Treatment Period|Adverse Event|0|||
33365575|NCT00958568|101227169|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
33568953|NCT01928394|101974923|FG002|Follow-up Period|Death|2|||
33632188|NCT02006472|102203123|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
33632189|NCT02006472|102203124|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
33632190|NCT02006472|102203120|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
33225584|NCT04534114|100728447|FG003|Extension Treatment Period|Adverse Event|1|||
33225585|NCT04534114|100728444|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
33225586|NCT04534114|100728445|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
33225587|NCT04534114|100728446|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
33225588|NCT04534114|100728447|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
33225589|NCT01861522|100728448|FG000|Overall Study|Adverse Event|1|||
33225590|NCT01861522|100728449|FG001|Overall Study|Adverse Event|0|||
33225591|NCT01861522|100728448|FG000|Overall Study|Withdrawal by Subject|2|||
33225592|NCT01861522|100728449|FG001|Overall Study|Withdrawal by Subject|0|||
33225593|NCT00770432|100728450|FG000|Overall Study|Other|4|||
33225594|NCT00770432|100728451|FG001|Overall Study|Other|6|||
33225595|NCT00770432|100728450|FG000|Overall Study|Non-compliance|0|||
33225596|NCT00770432|100728451|FG001|Overall Study|Non-compliance|1|||
33225597|NCT04631705|100728452|FG000|Overall Study|Withdrawal by Subject|0|||
33225598|NCT04631705|100728453|FG001|Overall Study|Withdrawal by Subject|0|||
33225599|NCT04631705|100728454|FG002|Overall Study|Withdrawal by Subject|0|||
33225600|NCT04631705|100728455|FG003|Overall Study|Withdrawal by Subject|0|||
33225601|NCT04631705|100728456|FG004|Overall Study|Withdrawal by Subject|0|||
33225602|NCT04631705|100728457|FG005|Overall Study|Withdrawal by Subject|0|||
33225603|NCT04631705|100728458|FG006|Overall Study|Withdrawal by Subject|1|||
33225604|NCT04631705|100728459|FG007|Overall Study|Withdrawal by Subject|0|||
33225605|NCT04631705|100728460|FG008|Overall Study|Withdrawal by Subject|0|||
33225606|NCT01164228|100728462|FG000|Overall Study|Progression|24|||
33225607|NCT01164228|100728463|FG001|Overall Study|Progression|25|||
33225608|NCT01164228|100728462|FG000|Overall Study|Adverse Event|13|||
33225609|NCT01164228|100728463|FG001|Overall Study|Adverse Event|7|||
33225610|NCT01164228|100728462|FG000|Overall Study|Death|1|||
33225611|NCT01164228|100728463|FG001|Overall Study|Death|1|||
33225612|NCT01164228|100728462|FG000|Overall Study|Withdrawal by Subject|2|||
33225613|NCT01164228|100728463|FG001|Overall Study|Withdrawal by Subject|0|||
33225614|NCT01164228|100728462|FG000|Overall Study|Physician Decision|1|||
33225615|NCT01164228|100728463|FG001|Overall Study|Physician Decision|2|||
33225616|NCT01164228|100728462|FG000|Overall Study|Symptomatic deterioration|1|||
33365576|NCT00958568|101227166|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
33365577|NCT00958568|101227167|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
33365578|NCT00958568|101227168|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
33568954|NCT01928394|101974924|FG003|Follow-up Period|Death|6|||
33568955|NCT01928394|101974925|FG004|Follow-up Period|Death|0|||
33568956|NCT01928394|101974926|FG005|Follow-up Period|Death|6|||
33568957|NCT01928394|101974927|FG006|Follow-up Period|Death|6|||
33568958|NCT01928394|101974928|FG007|Follow-up Period|Death|2|||
33568959|NCT01928394|101974929|FG008|Follow-up Period|Death|1|||
33568960|NCT01928394|101974930|FG009|Follow-up Period|Death|2|||
33568961|NCT01928394|101974931|FG010|Follow-up Period|Death|4|||
33568962|NCT01928394|101974932|FG011|Follow-up Period|Death|12|||
33568963|NCT01928394|101974933|FG012|Follow-up Period|Death|11|||
33568964|NCT01928394|101974934|FG013|Follow-up Period|Death|25|||
33568965|NCT01928394|101974935|FG014|Follow-up Period|Death|18|||
33568966|NCT01928394|101974936|FG015|Follow-up Period|Death|0|||
33568967|NCT01928394|101974937|FG016|Follow-up Period|Death|6|||
33568968|NCT01928394|101974938|FG017|Follow-up Period|Death|5|||
33568969|NCT01928394|101974939|FG018|Follow-up Period|Death|13|||
33568970|NCT01928394|101974940|FG019|Follow-up Period|Death|13|||
33568971|NCT01928394|101974941|FG020|Follow-up Period|Death|5|||
33568972|NCT01928394|101974942|FG021|Follow-up Period|Death|3|||
33568973|NCT01928394|101974943|FG022|Follow-up Period|Death|2|||
33568974|NCT01928394|101974921|FG000|Follow-up Period|other reason|0|||
33568975|NCT01928394|101974922|FG001|Follow-up Period|other reason|0|||
33568976|NCT01928394|101974923|FG002|Follow-up Period|other reason|0|||
33568977|NCT01928394|101974924|FG003|Follow-up Period|other reason|0|||
33568978|NCT01928394|101974925|FG004|Follow-up Period|other reason|0|||
33568979|NCT01928394|101974926|FG005|Follow-up Period|other reason|0|||
33568980|NCT01928394|101974927|FG006|Follow-up Period|other reason|1|||
33568981|NCT01928394|101974928|FG007|Follow-up Period|other reason|3|||
33568982|NCT01928394|101974929|FG008|Follow-up Period|other reason|0|||
33568983|NCT01928394|101974930|FG009|Follow-up Period|other reason|0|||
33568984|NCT01928394|101974931|FG010|Follow-up Period|other reason|2|||
33568985|NCT01928394|101974932|FG011|Follow-up Period|other reason|1|||
33568986|NCT01928394|101974933|FG012|Follow-up Period|other reason|0|||
33568987|NCT01928394|101974934|FG013|Follow-up Period|other reason|1|||
33568988|NCT01928394|101974935|FG014|Follow-up Period|other reason|4|||
33568989|NCT01928394|101974936|FG015|Follow-up Period|other reason|0|||
33568990|NCT01928394|101974937|FG016|Follow-up Period|other reason|2|||
33568991|NCT01928394|101974938|FG017|Follow-up Period|other reason|0|||
33568992|NCT01928394|101974939|FG018|Follow-up Period|other reason|1|||
33568993|NCT01928394|101974940|FG019|Follow-up Period|other reason|1|||
33568994|NCT01928394|101974941|FG020|Follow-up Period|other reason|0|||
33568995|NCT01928394|101974942|FG021|Follow-up Period|other reason|0|||
33568996|NCT01928394|101974943|FG022|Follow-up Period|other reason|1|||
33568997|NCT01928394|101974921|FG000|Follow-up Period|Lost to Follow-up|0|||
33568998|NCT01928394|101974922|FG001|Follow-up Period|Lost to Follow-up|0|||
33225617|NCT01164228|100728463|FG001|Overall Study|Symptomatic deterioration|0|||
33568999|NCT01928394|101974923|FG002|Follow-up Period|Lost to Follow-up|0|||
33569000|NCT01928394|101974924|FG003|Follow-up Period|Lost to Follow-up|0|||
33569001|NCT01928394|101974925|FG004|Follow-up Period|Lost to Follow-up|0|||
33569002|NCT01928394|101974926|FG005|Follow-up Period|Lost to Follow-up|0|||
33225618|NCT01164228|100728462|FG000|Overall Study|Never started treatment|1|||
33225619|NCT01164228|100728463|FG001|Overall Study|Never started treatment|3|||
33365579|NCT00958568|101227169|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
33569003|NCT01928394|101974927|FG006|Follow-up Period|Lost to Follow-up|0|||
33569004|NCT01928394|101974928|FG007|Follow-up Period|Lost to Follow-up|0|||
33569005|NCT01928394|101974929|FG008|Follow-up Period|Lost to Follow-up|0|||
33569006|NCT01928394|101974930|FG009|Follow-up Period|Lost to Follow-up|0|||
33569007|NCT01928394|101974931|FG010|Follow-up Period|Lost to Follow-up|0|||
33225620|NCT01164228|100728462|FG000|Overall Study|Ineligible|1|||
33569008|NCT01928394|101974932|FG011|Follow-up Period|Lost to Follow-up|1|||
33225621|NCT01164228|100728463|FG001|Overall Study|Ineligible|0|||
33225622|NCT02204579|100728464|FG000|Overall Study|Screen failures|2|||
33225623|NCT02180438|100728468|FG000|Overall Study|Lost to Follow-up|1|||
33225624|NCT00792103|100728471|FG000|Overall Study|Enrolled, not treated|15|||
33225625|NCT00792103|100728471|FG000|Overall Study|Lost to Follow-up|17|||
33225626|NCT00792103|100728471|FG000|Overall Study|Adverse Event|25|||
33225627|NCT00792103|100728471|FG000|Overall Study|Withdrawal by Subject|52|||
33225628|NCT00792103|100728471|FG000|Overall Study|Protocol Violation|10|||
33225629|NCT00792103|100728471|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
33225630|NCT00337662|100728472|FG000|Study Period II|Lost to Follow-up|0|||
33225631|NCT00337662|100728473|FG001|Study Period II|Lost to Follow-up|0|||
33225632|NCT00337662|100728474|FG002|Study Period II|Lost to Follow-up|0|||
33225633|NCT00337662|100728475|FG003|Study Period II|Lost to Follow-up|35|||
33225634|NCT00337662|100728472|FG000|Study Period II|Withdrawal by Subject|0|||
33225635|NCT00337662|100728473|FG001|Study Period II|Withdrawal by Subject|0|||
33225636|NCT00337662|100728474|FG002|Study Period II|Withdrawal by Subject|0|||
33225637|NCT00337662|100728475|FG003|Study Period II|Withdrawal by Subject|20|||
33225638|NCT00337662|100728472|FG000|Study Period II|Adverse Event|0|||
33225639|NCT00337662|100728473|FG001|Study Period II|Adverse Event|0|||
33225640|NCT00337662|100728474|FG002|Study Period II|Adverse Event|0|||
33225641|NCT00337662|100728475|FG003|Study Period II|Adverse Event|16|||
33225642|NCT00337662|100728472|FG000|Study Period II|Physician Decision|0|||
33225643|NCT00337662|100728473|FG001|Study Period II|Physician Decision|0|||
33225644|NCT00337662|100728474|FG002|Study Period II|Physician Decision|0|||
33225645|NCT00337662|100728475|FG003|Study Period II|Physician Decision|13|||
33225646|NCT00337662|100728472|FG000|Study Period II|Entry Criteria Not Met|0|||
33225647|NCT00337662|100728473|FG001|Study Period II|Entry Criteria Not Met|0|||
33225648|NCT00337662|100728474|FG002|Study Period II|Entry Criteria Not Met|0|||
33225649|NCT00337662|100728475|FG003|Study Period II|Entry Criteria Not Met|6|||
33225650|NCT00337662|100728472|FG000|Study Period II|Protocol Violation|0|||
33225651|NCT00337662|100728473|FG001|Study Period II|Protocol Violation|0|||
33225652|NCT00337662|100728474|FG002|Study Period II|Protocol Violation|0|||
33225653|NCT00337662|100728475|FG003|Study Period II|Protocol Violation|6|||
33225654|NCT00337662|100728472|FG000|Study Period II|Lack of Efficacy|0|||
33225655|NCT00337662|100728473|FG001|Study Period II|Lack of Efficacy|0|||
33225656|NCT00337662|100728474|FG002|Study Period II|Lack of Efficacy|0|||
33225657|NCT00337662|100728475|FG003|Study Period II|Lack of Efficacy|7|||
33225658|NCT00337662|100728472|FG000|Study Period II|Sponsor Decision|0|||
33225659|NCT00337662|100728473|FG001|Study Period II|Sponsor Decision|0|||
33225660|NCT00337662|100728474|FG002|Study Period II|Sponsor Decision|0|||
33225661|NCT00337662|100728475|FG003|Study Period II|Sponsor Decision|2|||
33225662|NCT00337662|100728472|FG000|Study Period II|Parent/Caregiver Decision|0|||
33225663|NCT00337662|100728473|FG001|Study Period II|Parent/Caregiver Decision|0|||
33225664|NCT00337662|100728474|FG002|Study Period II|Parent/Caregiver Decision|0|||
33225665|NCT00337662|100728475|FG003|Study Period II|Parent/Caregiver Decision|1|||
33225666|NCT00337662|100728472|FG000|Study Period III|Lost to Follow-up|14|||
33225667|NCT00337662|100728473|FG001|Study Period III|Lost to Follow-up|16|||
33225668|NCT00337662|100728474|FG002|Study Period III|Lost to Follow-up|14|||
33225669|NCT00337662|100728475|FG003|Study Period III|Lost to Follow-up|0|||
33225670|NCT00337662|100728472|FG000|Study Period III|Withdrawal by Subject|18|||
33225671|NCT00337662|100728473|FG001|Study Period III|Withdrawal by Subject|14|||
33225672|NCT00337662|100728474|FG002|Study Period III|Withdrawal by Subject|12|||
33225673|NCT00337662|100728475|FG003|Study Period III|Withdrawal by Subject|0|||
33225674|NCT00337662|100728472|FG000|Study Period III|Adverse Event|9|||
33225675|NCT00337662|100728473|FG001|Study Period III|Adverse Event|10|||
33225676|NCT00337662|100728474|FG002|Study Period III|Adverse Event|8|||
33225677|NCT00337662|100728475|FG003|Study Period III|Adverse Event|0|||
33225678|NCT00337662|100728472|FG000|Study Period III|Protocol Violation|3|||
33225679|NCT00337662|100728473|FG001|Study Period III|Protocol Violation|8|||
33225680|NCT00337662|100728474|FG002|Study Period III|Protocol Violation|2|||
33225681|NCT00337662|100728475|FG003|Study Period III|Protocol Violation|0|||
33225682|NCT00337662|100728472|FG000|Study Period III|Physician Decision|6|||
33225683|NCT00337662|100728473|FG001|Study Period III|Physician Decision|5|||
33225684|NCT00337662|100728474|FG002|Study Period III|Physician Decision|0|||
33225685|NCT00337662|100728475|FG003|Study Period III|Physician Decision|0|||
33225686|NCT00337662|100728472|FG000|Study Period III|Entry Criteria Not Met|4|||
33225687|NCT00337662|100728473|FG001|Study Period III|Entry Criteria Not Met|1|||
33569009|NCT01928394|101974933|FG012|Follow-up Period|Lost to Follow-up|1|||
33225688|NCT00337662|100728474|FG002|Study Period III|Entry Criteria Not Met|3|||
33225689|NCT00337662|100728475|FG003|Study Period III|Entry Criteria Not Met|0|||
33225690|NCT00337662|100728472|FG000|Study Period III|Lack of Efficacy|4|||
33225691|NCT00337662|100728473|FG001|Study Period III|Lack of Efficacy|4|||
33225692|NCT00337662|100728474|FG002|Study Period III|Lack of Efficacy|2|||
33225693|NCT00337662|100728475|FG003|Study Period III|Lack of Efficacy|0|||
33225694|NCT00337662|100728472|FG000|Study Period III|Parent/Caregiver Decision|0|||
33225695|NCT00337662|100728473|FG001|Study Period III|Parent/Caregiver Decision|0|||
33225696|NCT00337662|100728474|FG002|Study Period III|Parent/Caregiver Decision|2|||
33569010|NCT01928394|101974934|FG013|Follow-up Period|Lost to Follow-up|0|||
33225697|NCT00337662|100728475|FG003|Study Period III|Parent/Caregiver Decision|0|||
33225698|NCT00337662|100728472|FG000|Study Period III|Sponsor Decision|1|||
33225699|NCT00337662|100728473|FG001|Study Period III|Sponsor Decision|0|||
33365580|NCT00958568|101227166|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
33365581|NCT00958568|101227167|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
33365582|NCT00958568|101227168|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
33569011|NCT01928394|101974935|FG014|Follow-up Period|Lost to Follow-up|1|||
33569012|NCT01928394|101974936|FG015|Follow-up Period|Lost to Follow-up|0|||
33569013|NCT01928394|101974937|FG016|Follow-up Period|Lost to Follow-up|1|||
33569014|NCT01928394|101974938|FG017|Follow-up Period|Lost to Follow-up|0|||
33569015|NCT01928394|101974939|FG018|Follow-up Period|Lost to Follow-up|0|||
33569016|NCT01928394|101974940|FG019|Follow-up Period|Lost to Follow-up|0|||
33569017|NCT01928394|101974941|FG020|Follow-up Period|Lost to Follow-up|0|||
33569018|NCT01928394|101974942|FG021|Follow-up Period|Lost to Follow-up|0|||
33569019|NCT01928394|101974943|FG022|Follow-up Period|Lost to Follow-up|1|||
33569020|NCT02460458|101974944|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
33569021|NCT02460458|101974944|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
33569022|NCT02460458|101974944|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
33569023|NCT02460458|101974944|FG000|First Prospective Phase|Lost to Follow-up|84|||
33569024|NCT02460458|101974944|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
33569025|NCT01733316|101974945|FG000|RP103 Phase|Non-compliance|1|||
33569026|NCT01733316|101974945|FG000|Long Term Extension Phase|Adverse Event|1|||
33569027|NCT01733316|101974945|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
33569028|NCT01733316|101974945|FG000|Long Term Extension Phase|Sponsor Decision|2|||
33632191|NCT02006472|102203121|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
33632192|NCT02006472|102203122|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
33632193|NCT02006472|102203123|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
33632194|NCT02006472|102203124|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
33632195|NCT02006472|102203120|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
33632196|NCT02006472|102203121|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
33632197|NCT02006472|102203122|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
33632198|NCT02006472|102203123|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
33632199|NCT02006472|102203124|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
33632200|NCT02006472|102203120|FG000|Period 1 (Through Week 26)|Other|1|||
33632201|NCT02006472|102203121|FG001|Period 1 (Through Week 26)|Other|5|||
33632202|NCT02006472|102203122|FG002|Period 1 (Through Week 26)|Other|0|||
33632203|NCT02006472|102203123|FG003|Period 1 (Through Week 26)|Other|2|||
33225700|NCT00337662|100728474|FG002|Study Period III|Sponsor Decision|1|||
33225701|NCT00337662|100728475|FG003|Study Period III|Sponsor Decision|0|||
33225702|NCT00337662|100728472|FG000|Study Period III|Clinical Relapse|1|||
33225703|NCT00337662|100728473|FG001|Study Period III|Clinical Relapse|0|||
33225704|NCT00337662|100728474|FG002|Study Period III|Clinical Relapse|0|||
33225705|NCT00337662|100728475|FG003|Study Period III|Clinical Relapse|0|||
33225706|NCT02798211|100728478|FG000|Period 1|Adverse Event|1|||
33225707|NCT02798211|100728479|FG001|Period 1|Adverse Event|1|||
33225708|NCT02798211|100728480|FG002|Period 1|Adverse Event|0|||
33225709|NCT02798211|100728481|FG003|Period 1|Adverse Event|0|||
33225710|NCT02798211|100728482|FG004|Period 1|Adverse Event|0|||
33225711|NCT02798211|100728483|FG005|Period 1|Adverse Event|0|||
33225712|NCT02798211|100728478|FG000|Period 1|Lost to Follow-up|2|||
33225713|NCT02798211|100728479|FG001|Period 1|Lost to Follow-up|1|||
33225714|NCT02798211|100728480|FG002|Period 1|Lost to Follow-up|0|||
33225715|NCT02798211|100728481|FG003|Period 1|Lost to Follow-up|0|||
33225716|NCT02798211|100728482|FG004|Period 1|Lost to Follow-up|0|||
33225717|NCT02798211|100728483|FG005|Period 1|Lost to Follow-up|0|||
33225718|NCT02798211|100728478|FG000|Period 1|Protocol Violation|0|||
33225719|NCT02798211|100728479|FG001|Period 1|Protocol Violation|0|||
33225720|NCT02798211|100728480|FG002|Period 1|Protocol Violation|2|||
33225721|NCT02798211|100728481|FG003|Period 1|Protocol Violation|0|||
33225722|NCT02798211|100728482|FG004|Period 1|Protocol Violation|0|||
33225723|NCT02798211|100728483|FG005|Period 1|Protocol Violation|0|||
33225724|NCT02798211|100728478|FG000|Period 1|Withdrawal by Subject|1|||
33225725|NCT02798211|100728479|FG001|Period 1|Withdrawal by Subject|1|||
33225726|NCT02798211|100728480|FG002|Period 1|Withdrawal by Subject|0|||
33225727|NCT02798211|100728481|FG003|Period 1|Withdrawal by Subject|0|||
33225728|NCT02798211|100728482|FG004|Period 1|Withdrawal by Subject|0|||
33225729|NCT02798211|100728483|FG005|Period 1|Withdrawal by Subject|0|||
33225730|NCT02798211|100728478|FG000|Period 1|Death|0|||
33225731|NCT02798211|100728479|FG001|Period 1|Death|0|||
33225732|NCT02798211|100728480|FG002|Period 1|Death|1|||
33225733|NCT02798211|100728481|FG003|Period 1|Death|0|||
33225734|NCT02798211|100728482|FG004|Period 1|Death|0|||
33225735|NCT02798211|100728483|FG005|Period 1|Death|0|||
33225736|NCT02798211|100728478|FG000|Period 1|Withdrawal of Informed Consent|2|||
33225737|NCT02798211|100728479|FG001|Period 1|Withdrawal of Informed Consent|7|||
33225738|NCT02798211|100728480|FG002|Period 1|Withdrawal of Informed Consent|3|||
33225739|NCT02798211|100728481|FG003|Period 1|Withdrawal of Informed Consent|0|||
33225740|NCT02798211|100728482|FG004|Period 1|Withdrawal of Informed Consent|0|||
33225741|NCT02798211|100728483|FG005|Period 1|Withdrawal of Informed Consent|0|||
33225742|NCT02798211|100728478|FG000|Period 2|Withdrawal by Subject|2|||
33225743|NCT02798211|100728479|FG001|Period 2|Withdrawal by Subject|0|||
33225744|NCT02798211|100728480|FG002|Period 2|Withdrawal by Subject|0|||
33225745|NCT02798211|100728481|FG003|Period 2|Withdrawal by Subject|0|||
33225746|NCT02798211|100728482|FG004|Period 2|Withdrawal by Subject|2|||
33225747|NCT02798211|100728483|FG005|Period 2|Withdrawal by Subject|2|||
33225748|NCT02798211|100728478|FG000|Period 2|Adverse Event|5|||
33225749|NCT02798211|100728479|FG001|Period 2|Adverse Event|0|||
33225750|NCT02798211|100728480|FG002|Period 2|Adverse Event|0|||
33225751|NCT02798211|100728481|FG003|Period 2|Adverse Event|0|||
33225752|NCT02798211|100728482|FG004|Period 2|Adverse Event|1|||
33225753|NCT02798211|100728483|FG005|Period 2|Adverse Event|0|||
33225754|NCT02798211|100728478|FG000|Period 2|Lack of Efficacy|1|||
33225755|NCT02798211|100728479|FG001|Period 2|Lack of Efficacy|0|||
33225756|NCT02798211|100728480|FG002|Period 2|Lack of Efficacy|0|||
33225757|NCT02798211|100728481|FG003|Period 2|Lack of Efficacy|1|||
33225758|NCT02798211|100728482|FG004|Period 2|Lack of Efficacy|0|||
33225759|NCT02798211|100728483|FG005|Period 2|Lack of Efficacy|1|||
33225760|NCT02798211|100728478|FG000|Period 2|Lost to Follow-up|3|||
33225761|NCT02798211|100728479|FG001|Period 2|Lost to Follow-up|0|||
33225762|NCT02798211|100728480|FG002|Period 2|Lost to Follow-up|0|||
33225763|NCT02798211|100728481|FG003|Period 2|Lost to Follow-up|0|||
33225764|NCT02798211|100728482|FG004|Period 2|Lost to Follow-up|2|||
33225765|NCT02798211|100728483|FG005|Period 2|Lost to Follow-up|0|||
33225766|NCT02798211|100728478|FG000|Period 2|Physician Decision|1|||
33225767|NCT02798211|100728479|FG001|Period 2|Physician Decision|0|||
33225768|NCT02798211|100728480|FG002|Period 2|Physician Decision|0|||
33225769|NCT02798211|100728481|FG003|Period 2|Physician Decision|1|||
33225770|NCT02798211|100728482|FG004|Period 2|Physician Decision|1|||
33225771|NCT02798211|100728483|FG005|Period 2|Physician Decision|0|||
33225772|NCT02798211|100728478|FG000|Period 2|Pregnancy|0|||
33225773|NCT02798211|100728479|FG001|Period 2|Pregnancy|0|||
33225774|NCT02798211|100728480|FG002|Period 2|Pregnancy|0|||
33225775|NCT02798211|100728481|FG003|Period 2|Pregnancy|2|||
33225776|NCT02798211|100728482|FG004|Period 2|Pregnancy|0|||
33225777|NCT02798211|100728483|FG005|Period 2|Pregnancy|0|||
33225778|NCT02798211|100728478|FG000|Period 2|Technical problems|1|||
33225779|NCT02798211|100728479|FG001|Period 2|Technical problems|0|||
33225780|NCT02798211|100728480|FG002|Period 2|Technical problems|0|||
33225781|NCT02798211|100728481|FG003|Period 2|Technical problems|1|||
33225782|NCT02798211|100728482|FG004|Period 2|Technical problems|0|||
33225783|NCT02798211|100728483|FG005|Period 2|Technical problems|0|||
33225784|NCT02798211|100728478|FG000|Period 2|Withdrawal of Informed Consent|1|||
33225785|NCT02798211|100728479|FG001|Period 2|Withdrawal of Informed Consent|0|||
33225786|NCT02798211|100728480|FG002|Period 2|Withdrawal of Informed Consent|0|||
33225787|NCT02798211|100728481|FG003|Period 2|Withdrawal of Informed Consent|2|||
33225788|NCT02798211|100728482|FG004|Period 2|Withdrawal of Informed Consent|2|||
33225789|NCT02798211|100728483|FG005|Period 2|Withdrawal of Informed Consent|3|||
33225790|NCT02508532|100728484|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33225791|NCT02508532|100728485|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33225792|NCT02508532|100728486|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33225793|NCT02508532|100728487|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33225794|NCT02508532|100728488|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33225795|NCT02508532|100728489|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33225796|NCT02508532|100728490|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
33225797|NCT02508532|100728491|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33225798|NCT02508532|100728492|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
33225799|NCT02508532|100728484|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
33225800|NCT02508532|100728485|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
33225801|NCT02508532|100728486|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
33225802|NCT02508532|100728487|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
33225803|NCT02508532|100728488|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
33225804|NCT02508532|100728489|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
33225805|NCT02508532|100728490|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
33225806|NCT02508532|100728491|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
33225807|NCT02508532|100728492|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
33225808|NCT02508532|100728484|FG000|Part 2 - Treatment|Disease Progression|0|||
33225809|NCT02508532|100728485|FG001|Part 2 - Treatment|Disease Progression|0|||
33225810|NCT02508532|100728486|FG002|Part 2 - Treatment|Disease Progression|0|||
33225811|NCT02508532|100728487|FG003|Part 2 - Treatment|Disease Progression|0|||
33225812|NCT02508532|100728488|FG004|Part 2 - Treatment|Disease Progression|0|||
33225813|NCT02508532|100728489|FG005|Part 2 - Treatment|Disease Progression|0|||
33225814|NCT02508532|100728490|FG006|Part 2 - Treatment|Disease Progression|0|||
33225815|NCT02508532|100728491|FG007|Part 2 - Treatment|Disease Progression|0|||
33225816|NCT02508532|100728492|FG008|Part 2 - Treatment|Disease Progression|118|||
33225817|NCT02508532|100728484|FG000|Part 2 - Treatment|Adverse Event|0|||
33225818|NCT02508532|100728485|FG001|Part 2 - Treatment|Adverse Event|0|||
33225819|NCT02508532|100728486|FG002|Part 2 - Treatment|Adverse Event|0|||
33225820|NCT02508532|100728487|FG003|Part 2 - Treatment|Adverse Event|0|||
33225821|NCT02508532|100728488|FG004|Part 2 - Treatment|Adverse Event|0|||
33225822|NCT02508532|100728489|FG005|Part 2 - Treatment|Adverse Event|0|||
33225823|NCT02508532|100728490|FG006|Part 2 - Treatment|Adverse Event|0|||
33225824|NCT02508532|100728491|FG007|Part 2 - Treatment|Adverse Event|0|||
33225825|NCT02508532|100728492|FG008|Part 2 - Treatment|Adverse Event|49|||
33225826|NCT02508532|100728484|FG000|Part 2 - Treatment|Physician Decision|0|||
33225827|NCT02508532|100728485|FG001|Part 2 - Treatment|Physician Decision|0|||
33225828|NCT02508532|100728486|FG002|Part 2 - Treatment|Physician Decision|0|||
33225829|NCT02508532|100728487|FG003|Part 2 - Treatment|Physician Decision|0|||
33225830|NCT02508532|100728488|FG004|Part 2 - Treatment|Physician Decision|0|||
33225831|NCT02508532|100728489|FG005|Part 2 - Treatment|Physician Decision|0|||
33225832|NCT02508532|100728490|FG006|Part 2 - Treatment|Physician Decision|0|||
33225833|NCT02508532|100728491|FG007|Part 2 - Treatment|Physician Decision|0|||
33225834|NCT02508532|100728492|FG008|Part 2 - Treatment|Physician Decision|12|||
33225835|NCT02508532|100728484|FG000|Part 2 - Treatment|Administrative|0|||
33225836|NCT02508532|100728485|FG001|Part 2 - Treatment|Administrative|0|||
33225837|NCT02508532|100728486|FG002|Part 2 - Treatment|Administrative|0|||
33225838|NCT02508532|100728487|FG003|Part 2 - Treatment|Administrative|0|||
33225839|NCT02508532|100728488|FG004|Part 2 - Treatment|Administrative|0|||
33225840|NCT02508532|100728489|FG005|Part 2 - Treatment|Administrative|0|||
33225841|NCT02508532|100728490|FG006|Part 2 - Treatment|Administrative|0|||
33225842|NCT02508532|100728491|FG007|Part 2 - Treatment|Administrative|0|||
33225843|NCT02508532|100728492|FG008|Part 2 - Treatment|Administrative|3|||
33225844|NCT02508532|100728484|FG000|Part 2 - Treatment|Sponsor Decision|0|||
33225845|NCT02508532|100728485|FG001|Part 2 - Treatment|Sponsor Decision|0|||
33569029|NCT01197378|101974950|FG000|Overall Study|Adverse Event|3|||
33632204|NCT02006472|102203124|FG004|Period 1 (Through Week 26)|Other|3|||
33225846|NCT02508532|100728486|FG002|Part 2 - Treatment|Sponsor Decision|0|||
33225847|NCT02508532|100728487|FG003|Part 2 - Treatment|Sponsor Decision|0|||
33225848|NCT02508532|100728488|FG004|Part 2 - Treatment|Sponsor Decision|0|||
33225849|NCT02508532|100728489|FG005|Part 2 - Treatment|Sponsor Decision|0|||
33225850|NCT02508532|100728490|FG006|Part 2 - Treatment|Sponsor Decision|0|||
33225851|NCT02508532|100728491|FG007|Part 2 - Treatment|Sponsor Decision|0|||
33225852|NCT02508532|100728492|FG008|Part 2 - Treatment|Sponsor Decision|28|||
33225853|NCT02508532|100728484|FG000|Part 2 - Treatment|Death|0|||
33225854|NCT02508532|100728485|FG001|Part 2 - Treatment|Death|0|||
33225855|NCT02508532|100728486|FG002|Part 2 - Treatment|Death|0|||
33225856|NCT02508532|100728487|FG003|Part 2 - Treatment|Death|0|||
33225857|NCT02508532|100728488|FG004|Part 2 - Treatment|Death|0|||
33225858|NCT02508532|100728489|FG005|Part 2 - Treatment|Death|0|||
33225859|NCT02508532|100728490|FG006|Part 2 - Treatment|Death|0|||
33225860|NCT02508532|100728491|FG007|Part 2 - Treatment|Death|0|||
33225861|NCT02508532|100728492|FG008|Part 2 - Treatment|Death|1|||
33225862|NCT02508532|100728484|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
33225863|NCT02508532|100728485|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
33225864|NCT02508532|100728486|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
33225865|NCT02508532|100728487|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
33225866|NCT02508532|100728488|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
33225867|NCT02508532|100728489|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
33225868|NCT02508532|100728490|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
33225869|NCT02508532|100728491|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
33225870|NCT02508532|100728492|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
33225871|NCT02508532|100728484|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
33225872|NCT02508532|100728485|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
33225873|NCT02508532|100728486|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
33225874|NCT02508532|100728487|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
33225875|NCT02508532|100728488|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
33225876|NCT02508532|100728489|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
33225877|NCT02508532|100728490|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
33225878|NCT02508532|100728491|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
33225879|NCT02508532|100728492|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
33225880|NCT02508532|100728484|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
33225881|NCT02508532|100728485|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
33225882|NCT02508532|100728486|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
33225883|NCT02508532|100728487|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
33225884|NCT02508532|100728488|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
33225885|NCT02508532|100728489|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
33225886|NCT02508532|100728490|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
33225887|NCT02508532|100728491|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
33225888|NCT02508532|100728492|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
33225889|NCT02508532|100728484|FG000|Part 1 and Part 2 End of Study|Death|0|||
33225890|NCT02508532|100728485|FG001|Part 1 and Part 2 End of Study|Death|4|||
33225891|NCT02508532|100728486|FG002|Part 1 and Part 2 End of Study|Death|2|||
33225892|NCT02508532|100728487|FG003|Part 1 and Part 2 End of Study|Death|4|||
33225893|NCT02508532|100728488|FG004|Part 1 and Part 2 End of Study|Death|3|||
33225894|NCT02508532|100728489|FG005|Part 1 and Part 2 End of Study|Death|0|||
33225895|NCT02508532|100728490|FG006|Part 1 and Part 2 End of Study|Death|0|||
33225896|NCT02508532|100728491|FG007|Part 1 and Part 2 End of Study|Death|1|||
33225897|NCT02508532|100728492|FG008|Part 1 and Part 2 End of Study|Death|111|||
33225898|NCT02508532|100728484|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
33225899|NCT02508532|100728485|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
33225900|NCT02508532|100728486|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
33225901|NCT02508532|100728487|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
33225902|NCT02508532|100728488|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
33225903|NCT02508532|100728489|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
33225904|NCT02508532|100728490|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
33225905|NCT02508532|100728491|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
33225906|NCT02508532|100728492|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
33225907|NCT02508532|100728484|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33225908|NCT02508532|100728485|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33225909|NCT02508532|100728486|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33225910|NCT02508532|100728487|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33225911|NCT02508532|100728488|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33417706|NCT03927989|101420367|FG001|Overall Study|Withdrawal by Subject|1|||
33417707|NCT03457727|101420368|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
33569030|NCT01197378|101974950|FG000|Overall Study|Withdrawal by Subject|1|||
33225912|NCT02508532|100728489|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33225913|NCT02508532|100728490|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33225914|NCT02508532|100728491|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
33225915|NCT02508532|100728492|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
33225916|NCT02508532|100728484|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
33225917|NCT02508532|100728485|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
33225918|NCT02508532|100728486|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
33569031|NCT01197378|101974950|FG000|Overall Study|Physician Decision|1|||
33569032|NCT01197378|101974950|FG000|Overall Study|Other|2|||
33569033|NCT00098475|101974951|FG000|Step 1|Progressive disease|33|||
33569034|NCT00098475|101974952|FG001|Step 1|Progressive disease|35|||
33569035|NCT00098475|101974953|FG002|Step 1|Progressive disease|2|||
33569036|NCT00098475|101974954|FG003|Step 1|Progressive disease|1|||
33225919|NCT02508532|100728487|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
33225920|NCT02508532|100728488|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
33225921|NCT02508532|100728489|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
33225922|NCT02508532|100728490|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
33225923|NCT02508532|100728491|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
33225924|NCT02508532|100728492|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
33225925|NCT02508532|100728484|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33225926|NCT02508532|100728485|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33225927|NCT02508532|100728486|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33225928|NCT02508532|100728487|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33225929|NCT02508532|100728488|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33225930|NCT02508532|100728489|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33225931|NCT02508532|100728490|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33225932|NCT02508532|100728491|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
33225933|NCT02508532|100728492|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
33225934|NCT02508532|100728484|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
33225935|NCT02508532|100728485|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
33225936|NCT02508532|100728486|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
33225937|NCT02508532|100728487|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
33225938|NCT02508532|100728488|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
33225939|NCT02508532|100728489|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
33225940|NCT02508532|100728490|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
33225941|NCT02508532|100728491|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
33225942|NCT02508532|100728492|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
33569037|NCT00098475|101974951|FG000|Step 1|Adverse Event|56|||
33569038|NCT00098475|101974952|FG001|Step 1|Adverse Event|37|||
33569039|NCT00098475|101974953|FG002|Step 1|Adverse Event|0|||
33569040|NCT00098475|101974954|FG003|Step 1|Adverse Event|1|||
33417708|NCT03457727|101420369|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
33569041|NCT00098475|101974951|FG000|Step 1|Death|8|||
33569042|NCT00098475|101974952|FG001|Step 1|Death|5|||
33569043|NCT00098475|101974953|FG002|Step 1|Death|0|||
33569044|NCT00098475|101974954|FG003|Step 1|Death|1|||
33569045|NCT00098475|101974951|FG000|Step 1|Withdrawal by Subject|14|||
33569046|NCT00098475|101974952|FG001|Step 1|Withdrawal by Subject|11|||
33569047|NCT00098475|101974953|FG002|Step 1|Withdrawal by Subject|0|||
33569048|NCT00098475|101974954|FG003|Step 1|Withdrawal by Subject|0|||
33569049|NCT00098475|101974951|FG000|Step 1|Physician Decision|5|||
33569050|NCT00098475|101974952|FG001|Step 1|Physician Decision|2|||
33569051|NCT00098475|101974953|FG002|Step 1|Physician Decision|0|||
33569052|NCT00098475|101974954|FG003|Step 1|Physician Decision|0|||
33569053|NCT00098475|101974951|FG000|Step 1|Alternative therapy|31|||
33569054|NCT00098475|101974952|FG001|Step 1|Alternative therapy|43|||
33569055|NCT00098475|101974953|FG002|Step 1|Alternative therapy|1|||
33569056|NCT00098475|101974954|FG003|Step 1|Alternative therapy|0|||
33569057|NCT00098475|101974951|FG000|Step 1|Other disease|2|||
33569058|NCT00098475|101974952|FG001|Step 1|Other disease|1|||
33225943|NCT02460263|100728493|FG000|Transition Period|Withdrawal by Subject|1|||
33225944|NCT02460263|100728493|FG000|Transition Period|Death|1|||
33225945|NCT01215357|100728494|FG000|Overall Study|Withdrawal by Subject|3|||
33225946|NCT01215357|100728494|FG000|Overall Study|Protocol Violation|9|||
33225947|NCT04887948|100728495|FG000|Overall Study|Death|1|||
33417709|NCT03457727|101420370|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
33569059|NCT00098475|101974953|FG002|Step 1|Other disease|1|||
33569060|NCT00098475|101974954|FG003|Step 1|Other disease|0|||
33569061|NCT00098475|101974951|FG000|Step 1|Never started treatment|0|||
33569062|NCT00098475|101974952|FG001|Step 1|Never started treatment|2|||
33569063|NCT00098475|101974953|FG002|Step 1|Never started treatment|0|||
33569064|NCT00098475|101974954|FG003|Step 1|Never started treatment|0|||
33569065|NCT00098475|101974951|FG000|Step 1|Still on treatment as of this analysis|14|||
33569066|NCT00098475|101974952|FG001|Step 1|Still on treatment as of this analysis|27|||
33569067|NCT00098475|101974953|FG002|Step 1|Still on treatment as of this analysis|0|||
33569068|NCT00098475|101974954|FG003|Step 1|Still on treatment as of this analysis|0|||
33569069|NCT00098475|101974951|FG000|Step 1|Knee surgery|1|||
33569070|NCT00098475|101974952|FG001|Step 1|Knee surgery|0|||
33569071|NCT00098475|101974953|FG002|Step 1|Knee surgery|0|||
33569072|NCT00098475|101974954|FG003|Step 1|Knee surgery|0|||
33569073|NCT00098475|101974951|FG000|Step 1|Complications|1|||
33225948|NCT04887948|100728496|FG001|Overall Study|Death|0|||
33225949|NCT04887948|100728497|FG002|Overall Study|Death|0|||
33225950|NCT04887948|100728495|FG000|Overall Study|Lost to Follow-up|1|||
33225951|NCT04887948|100728496|FG001|Overall Study|Lost to Follow-up|0|||
33225952|NCT04887948|100728497|FG002|Overall Study|Lost to Follow-up|3|||
33225953|NCT04887948|100728495|FG000|Overall Study|Physician Decision|0|||
33225954|NCT04887948|100728496|FG001|Overall Study|Physician Decision|4|||
33225955|NCT04887948|100728497|FG002|Overall Study|Physician Decision|1|||
33225956|NCT04887948|100728495|FG000|Overall Study|Protocol Violation|1|||
33225957|NCT04887948|100728496|FG001|Overall Study|Protocol Violation|1|||
33225958|NCT04887948|100728497|FG002|Overall Study|Protocol Violation|0|||
33225959|NCT04887948|100728495|FG000|Overall Study|Withdrawal by Subject|0|||
33225960|NCT04887948|100728496|FG001|Overall Study|Withdrawal by Subject|6|||
33225961|NCT04887948|100728497|FG002|Overall Study|Withdrawal by Subject|1|||
33225962|NCT04887948|100728495|FG000|Overall Study|No longer met eligibility criteria|1|||
33225963|NCT04887948|100728496|FG001|Overall Study|No longer met eligibility criteria|2|||
33225964|NCT04887948|100728497|FG002|Overall Study|No longer met eligibility criteria|1|||
33225965|NCT04887948|100728495|FG000|Overall Study|Other|2|||
33225966|NCT04887948|100728496|FG001|Overall Study|Other|1|||
33225967|NCT04887948|100728497|FG002|Overall Study|Other|1|||
33225968|NCT02254408|100728498|FG000|Overall Study|Randomized But Not Treated|1|||
33225969|NCT02254408|100728499|FG001|Overall Study|Randomized But Not Treated|3|||
33225970|NCT02254408|100728498|FG000|Overall Study|Adverse Event|1|||
33225971|NCT02254408|100728499|FG001|Overall Study|Adverse Event|0|||
33225972|NCT02254408|100728498|FG000|Overall Study|Death|2|||
33225973|NCT02254408|100728499|FG001|Overall Study|Death|3|||
33225974|NCT02254408|100728498|FG000|Overall Study|Investigator's Discretion|0|||
33225975|NCT02254408|100728499|FG001|Overall Study|Investigator's Discretion|1|||
33225976|NCT02254408|100728498|FG000|Overall Study|Withdrawal by Subject|3|||
33225977|NCT02254408|100728499|FG001|Overall Study|Withdrawal by Subject|3|||
33225978|NCT02254408|100728498|FG000|Overall Study|Lost to Follow-up|1|||
33225979|NCT02254408|100728499|FG001|Overall Study|Lost to Follow-up|0|||
33225980|NCT01964521|100728500|FG000|Overall Study|Lost to Follow-up|4|||
33225981|NCT01975220|100728504|FG000|Test Period 1|Not treated|0|||
33225982|NCT01975220|100728505|FG001|Test Period 1|Not treated|1|||
33225983|NCT01975220|100728506|FG002|Test Period 1|Not treated|0|||
33225984|NCT01975220|100728507|FG003|Test Period 1|Not treated|0|||
33225985|NCT01975220|100728508|FG004|Test Period 1|Not treated|0|||
33225986|NCT01975220|100728509|FG005|Test Period 1|Not treated|0|||
33225987|NCT02213328|100728510|FG000|Overall Study|Withdrawal by Subject|10|||
33225988|NCT02213328|100728510|FG000|Overall Study|Physician Decision|2|||
33225989|NCT02213328|100728510|FG000|Overall Study|Lost to Follow-up|16|||
33225990|NCT00876460|100728514|FG000|Combination Therapy Phase|Progressive disease|2|||
33225991|NCT00876460|100728515|FG001|Combination Therapy Phase|Progressive disease|3|||
33225992|NCT00876460|100728516|FG002|Combination Therapy Phase|Progressive disease|3|||
33225993|NCT00876460|100728517|FG003|Combination Therapy Phase|Progressive disease|3|||
33225994|NCT00876460|100728518|FG004|Combination Therapy Phase|Progressive disease|3|||
33225995|NCT00876460|100728519|FG005|Combination Therapy Phase|Progressive disease|1|||
33225996|NCT00876460|100728520|FG006|Combination Therapy Phase|Progressive disease|1|||
33225997|NCT00876460|100728521|FG007|Combination Therapy Phase|Progressive disease|1|||
33225998|NCT00876460|100728514|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
33225999|NCT00876460|100728515|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
33226000|NCT00876460|100728516|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
33226001|NCT00876460|100728517|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
33226002|NCT00876460|100728518|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
33226003|NCT00876460|100728519|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
33226004|NCT00876460|100728520|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
33226005|NCT00876460|100728521|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
33226006|NCT00876460|100728514|FG000|Combination Therapy Phase|Adverse Event|0|||
33226007|NCT00876460|100728515|FG001|Combination Therapy Phase|Adverse Event|2|||
33226008|NCT00876460|100728516|FG002|Combination Therapy Phase|Adverse Event|0|||
33226009|NCT00876460|100728517|FG003|Combination Therapy Phase|Adverse Event|2|||
33226010|NCT00876460|100728518|FG004|Combination Therapy Phase|Adverse Event|2|||
33226011|NCT00876460|100728519|FG005|Combination Therapy Phase|Adverse Event|0|||
33226012|NCT00876460|100728520|FG006|Combination Therapy Phase|Adverse Event|3|||
33226013|NCT00876460|100728521|FG007|Combination Therapy Phase|Adverse Event|2|||
33226014|NCT00876460|100728514|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
33226015|NCT00876460|100728515|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
33226016|NCT00876460|100728516|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
33226017|NCT00876460|100728517|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
33226018|NCT00876460|100728518|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
33226019|NCT00876460|100728519|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
33417710|NCT03457727|101420371|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
33417711|NCT03526679|101420372|FG000|Overall Study|still under treatment|2|||
33417712|NCT03494816|101420373|FG000|Overall Study|Protocol Violation|2|||
33417713|NCT03494816|101420373|FG000|Overall Study|Physician Decision|2|||
33417714|NCT03494816|101420373|FG000|Overall Study|Did not start trial treatment|1|||
33417715|NCT03494816|101420373|FG000|Overall Study|Adverse Event|1|||
33417716|NCT03993288|101420377|FG000|Overall Study|Lost to Follow-up|2|||
33417717|NCT03993288|101420378|FG001|Overall Study|Lost to Follow-up|1|||
33417718|NCT03993288|101420377|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
33417719|NCT03993288|101420378|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
33417720|NCT03993288|101420377|FG000|Overall Study|wrong randomization|0|||
33417721|NCT03993288|101420378|FG001|Overall Study|wrong randomization|1|||
33417722|NCT03993288|101420377|FG000|Overall Study|improper enrollment|0|||
33417723|NCT03993288|101420378|FG001|Overall Study|improper enrollment|1|||
33417724|NCT03993288|101420377|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
33417725|NCT03993288|101420378|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
33417726|NCT03993288|101420377|FG000|Overall Study|developed SAE|2|||
33417727|NCT03993288|101420378|FG001|Overall Study|developed SAE|0|||
33417728|NCT03993288|101420377|FG000|Overall Study|consent withdrawal|1|||
33417729|NCT03993288|101420378|FG001|Overall Study|consent withdrawal|0|||
33417730|NCT03993288|101420377|FG000|Overall Study|did not follow the treatment schedule|1|||
33417731|NCT03993288|101420378|FG001|Overall Study|did not follow the treatment schedule|0|||
33417732|NCT03993288|101420377|FG000|Overall Study|did not follow the treatment regimen|1|||
33417733|NCT03993288|101420378|FG001|Overall Study|did not follow the treatment regimen|0|||
33417734|NCT03993288|101420377|FG000|Overall Study|Adverse Event|1|||
33417735|NCT03993288|101420378|FG001|Overall Study|Adverse Event|0|||
33417736|NCT03993288|101420377|FG000|Overall Study|Withdrawal by Subject|1|||
33417737|NCT03993288|101420378|FG001|Overall Study|Withdrawal by Subject|1|||
33417738|NCT03992456|101420379|FG000|Overall Study|Withdrawal by Subject|1|||
33417739|NCT03992456|101420380|FG001|Overall Study|Withdrawal by Subject|0|||
33417740|NCT03992456|101420379|FG000|Overall Study|Disease progression|4|||
33417741|NCT03992456|101420380|FG001|Overall Study|Disease progression|5|||
33417742|NCT03992456|101420379|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
33417743|NCT03992456|101420380|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
33417744|NCT00929201|101420381|FG000|Period 1|Withdrawal by Subject|0|||
33226020|NCT00876460|100728520|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
33226021|NCT00876460|100728521|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
33226022|NCT00876460|100728514|FG000|Combination Therapy Phase|Other reason not defined above|0|||
33226023|NCT00876460|100728515|FG001|Combination Therapy Phase|Other reason not defined above|0|||
33226024|NCT00876460|100728516|FG002|Combination Therapy Phase|Other reason not defined above|0|||
33226025|NCT00876460|100728517|FG003|Combination Therapy Phase|Other reason not defined above|0|||
33226026|NCT00876460|100728518|FG004|Combination Therapy Phase|Other reason not defined above|0|||
33226027|NCT00876460|100728519|FG005|Combination Therapy Phase|Other reason not defined above|0|||
33226028|NCT00876460|100728520|FG006|Combination Therapy Phase|Other reason not defined above|1|||
33226029|NCT00876460|100728521|FG007|Combination Therapy Phase|Other reason not defined above|2|||
33226030|NCT00876460|100728514|FG000|Combination Therapy Phase|Not treated|0|||
33226031|NCT00876460|100728515|FG001|Combination Therapy Phase|Not treated|0|||
33226032|NCT00876460|100728516|FG002|Combination Therapy Phase|Not treated|0|||
33226033|NCT00876460|100728517|FG003|Combination Therapy Phase|Not treated|0|||
33226034|NCT00876460|100728518|FG004|Combination Therapy Phase|Not treated|0|||
33226035|NCT00876460|100728519|FG005|Combination Therapy Phase|Not treated|0|||
33226036|NCT00876460|100728520|FG006|Combination Therapy Phase|Not treated|1|||
33226037|NCT00876460|100728521|FG007|Combination Therapy Phase|Not treated|0|||
33226038|NCT00876460|100728514|FG000|Mono Therapy Phase|Progressive disease|0|||
33226039|NCT00876460|100728515|FG001|Mono Therapy Phase|Progressive disease|0|||
33226040|NCT00876460|100728516|FG002|Mono Therapy Phase|Progressive disease|0|||
33226041|NCT00876460|100728517|FG003|Mono Therapy Phase|Progressive disease|0|||
33226042|NCT00876460|100728518|FG004|Mono Therapy Phase|Progressive disease|2|||
33226043|NCT00876460|100728519|FG005|Mono Therapy Phase|Progressive disease|0|||
33226044|NCT00876460|100728520|FG006|Mono Therapy Phase|Progressive disease|1|||
33226045|NCT00876460|100728521|FG007|Mono Therapy Phase|Progressive disease|3|||
33226046|NCT00876460|100728514|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
33226047|NCT00876460|100728515|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
33417745|NCT00929201|101420382|FG001|Period 1|Withdrawal by Subject|1|||
33417746|NCT00398632|101420383|FG000|Overall Study|Withdrawal by Subject|1|||
33417747|NCT00398632|101420383|FG000|Overall Study|Lack of Efficacy|1|||
33417748|NCT00424515|101420384|FG000|Overall Study|Progressive Disease|10|||
33417749|NCT00424515|101420385|FG001|Overall Study|Progressive Disease|11|||
33226048|NCT00876460|100728516|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
33226049|NCT00876460|100728517|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
33226050|NCT00876460|100728518|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
33226051|NCT00876460|100728519|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
33226052|NCT00876460|100728520|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
33226053|NCT00876460|100728521|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
33632205|NCT02006472|102203120|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
33632206|NCT02006472|102203121|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
33226054|NCT00876460|100728514|FG000|Mono Therapy Phase|Adverse Event|0|||
33226055|NCT00876460|100728515|FG001|Mono Therapy Phase|Adverse Event|0|||
33226056|NCT00876460|100728516|FG002|Mono Therapy Phase|Adverse Event|0|||
33226057|NCT00876460|100728517|FG003|Mono Therapy Phase|Adverse Event|1|||
33226058|NCT00876460|100728518|FG004|Mono Therapy Phase|Adverse Event|0|||
33226059|NCT00876460|100728519|FG005|Mono Therapy Phase|Adverse Event|0|||
33226060|NCT00876460|100728520|FG006|Mono Therapy Phase|Adverse Event|0|||
33226061|NCT00876460|100728521|FG007|Mono Therapy Phase|Adverse Event|0|||
33226062|NCT04244396|100728523|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
33226063|NCT04244396|100728523|FG000|Overall Study|Withdrawal by Subject|2|||
33226064|NCT04244396|100728523|FG000|Overall Study|Study termination|37|||
33365583|NCT00958568|101227169|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
33365584|NCT00958568|101227166|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
33365585|NCT00958568|101227167|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
33365586|NCT00958568|101227168|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
33632207|NCT02006472|102203122|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
33632208|NCT02006472|102203123|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
33632209|NCT02006472|102203124|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
33632210|NCT02006472|102203120|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
33632211|NCT02006472|102203121|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
33632212|NCT02006472|102203122|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
33632213|NCT02006472|102203123|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
33632214|NCT02006472|102203124|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
33632215|NCT02006472|102203120|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
33632216|NCT02006472|102203121|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
33632217|NCT02006472|102203122|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
33632218|NCT02006472|102203123|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
33632219|NCT02006472|102203124|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
33632220|NCT02006472|102203120|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
33632221|NCT02006472|102203121|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
33365587|NCT00958568|101227169|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
33365588|NCT00958568|101227166|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
33417750|NCT00424515|101420384|FG000|Overall Study|Adverse Event|0|||
33417751|NCT00424515|101420385|FG001|Overall Study|Adverse Event|1|||
33569074|NCT00098475|101974952|FG001|Step 1|Complications|0|||
33569075|NCT00098475|101974953|FG002|Step 1|Complications|0|||
33569076|NCT00098475|101974954|FG003|Step 1|Complications|0|||
33569077|NCT00098475|101974951|FG000|Step 1|Cannot comply due to other tx|0|||
33569078|NCT00098475|101974952|FG001|Step 1|Cannot comply due to other tx|1|||
33569079|NCT00098475|101974953|FG002|Step 1|Cannot comply due to other tx|0|||
33569080|NCT00098475|101974954|FG003|Step 1|Cannot comply due to other tx|0|||
33569081|NCT00098475|101974951|FG000|Step 1|Both patient and physician's decision|2|||
33569082|NCT00098475|101974952|FG001|Step 1|Both patient and physician's decision|1|||
33569083|NCT00098475|101974953|FG002|Step 1|Both patient and physician's decision|0|||
33569084|NCT00098475|101974954|FG003|Step 1|Both patient and physician's decision|0|||
33569085|NCT00098475|101974951|FG000|Step 1|Incorrect disease assessment|2|||
33569086|NCT00098475|101974952|FG001|Step 1|Incorrect disease assessment|0|||
33569087|NCT00098475|101974953|FG002|Step 1|Incorrect disease assessment|0|||
33569088|NCT00098475|101974954|FG003|Step 1|Incorrect disease assessment|0|||
33226065|NCT03311230|100728524|FG000|Overall Study|Withdrawal by Subject|1|||
33226066|NCT03311230|100728525|FG001|Overall Study|Withdrawal by Subject|4|||
33417752|NCT00424515|101420384|FG000|Overall Study|Intercurrent Illness|0|||
33417753|NCT00424515|101420385|FG001|Overall Study|Intercurrent Illness|1|||
33417754|NCT00424515|101420384|FG000|Overall Study|Withdrawal by Subject|1|||
33417755|NCT00424515|101420385|FG001|Overall Study|Withdrawal by Subject|0|||
33417756|NCT02050373|101420386|FG000|Overall Study|Adverse Event|4|||
33417757|NCT02050373|101420387|FG001|Overall Study|Adverse Event|7|||
33417758|NCT02050373|101420386|FG000|Overall Study|Death|3|||
33417759|NCT02050373|101420387|FG001|Overall Study|Death|3|||
33569089|NCT00098475|101974951|FG000|Step 1|Off treatment for > specified timeframe|1|||
33569090|NCT00098475|101974952|FG001|Step 1|Off treatment for > specified timeframe|1|||
33569091|NCT00098475|101974953|FG002|Step 1|Off treatment for > specified timeframe|0|||
33632222|NCT02006472|102203122|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
33632223|NCT02006472|102203123|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
33226067|NCT03311230|100728526|FG002|Overall Study|Withdrawal by Subject|2|||
33365589|NCT00958568|101227167|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
33417760|NCT01342367|101420398|FG000|Overall Study|Death|1|||
33632224|NCT02006472|102203124|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
33632225|NCT02006472|102203120|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
33226068|NCT03311230|100728527|FG003|Overall Study|Withdrawal by Subject|7|||
33226069|NCT03311230|100728524|FG000|Overall Study|Unrelated injury|0|||
33226070|NCT03311230|100728525|FG001|Overall Study|Unrelated injury|1|||
33365590|NCT00958568|101227168|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
33365591|NCT00958568|101227169|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
33365592|NCT00958568|101227166|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
33365593|NCT00958568|101227167|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
33365594|NCT00958568|101227168|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
33365595|NCT00958568|101227169|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
33365596|NCT00958568|101227166|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
33365597|NCT00958568|101227167|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
33365598|NCT00958568|101227168|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
33365599|NCT00958568|101227169|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
33365600|NCT00958568|101227166|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
33365601|NCT00958568|101227167|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
33365602|NCT00958568|101227168|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
33365603|NCT00958568|101227169|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
33365604|NCT00958568|101227166|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
33365605|NCT00958568|101227167|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
33365606|NCT00958568|101227168|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
33365607|NCT00958568|101227169|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
33365608|NCT00958568|101227166|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
33365609|NCT00958568|101227167|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
33365610|NCT00958568|101227168|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
33365611|NCT00958568|101227169|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
33365612|NCT00958568|101227166|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
33365613|NCT00958568|101227167|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
33569092|NCT00098475|101974954|FG003|Step 1|Off treatment for > specified timeframe|0|||
33569093|NCT00098475|101974951|FG000|Step 1|Declining performance status|0|||
33569094|NCT00098475|101974952|FG001|Step 1|Declining performance status|1|||
33569095|NCT00098475|101974953|FG002|Step 1|Declining performance status|0|||
33569096|NCT00098475|101974954|FG003|Step 1|Declining performance status|0|||
33569097|NCT00098475|101974951|FG000|Step 1|Insurance issue|0|||
33569098|NCT00098475|101974952|FG001|Step 1|Insurance issue|1|||
33569099|NCT00098475|101974953|FG002|Step 1|Insurance issue|0|||
33569100|NCT00098475|101974954|FG003|Step 1|Insurance issue|0|||
33569101|NCT00098475|101974951|FG000|Step 1|Rising paraprotein|0|||
33569102|NCT00098475|101974952|FG001|Step 1|Rising paraprotein|1|||
33569103|NCT00098475|101974953|FG002|Step 1|Rising paraprotein|0|||
33569104|NCT00098475|101974954|FG003|Step 1|Rising paraprotein|0|||
33569105|NCT00098475|101974951|FG000|Step 1|Referred to other physicians|0|||
33569106|NCT00098475|101974952|FG001|Step 1|Referred to other physicians|1|||
33569107|NCT00098475|101974953|FG002|Step 1|Referred to other physicians|0|||
33569108|NCT00098475|101974954|FG003|Step 1|Referred to other physicians|0|||
33569109|NCT00098475|101974951|FG000|Step 1|Criteria to continue treatment not met|0|||
33569110|NCT00098475|101974952|FG001|Step 1|Criteria to continue treatment not met|1|||
33569111|NCT00098475|101974953|FG002|Step 1|Criteria to continue treatment not met|0|||
33569112|NCT00098475|101974954|FG003|Step 1|Criteria to continue treatment not met|0|||
33569113|NCT00098475|101974951|FG000|Step 1|Misinterpretation of lab data|0|||
33226071|NCT03311230|100728526|FG002|Overall Study|Unrelated injury|0|||
33569114|NCT00098475|101974952|FG001|Step 1|Misinterpretation of lab data|1|||
33569115|NCT00098475|101974953|FG002|Step 1|Misinterpretation of lab data|0|||
33569116|NCT00098475|101974954|FG003|Step 1|Misinterpretation of lab data|0|||
33569117|NCT00098475|101974951|FG000|Step 1|Patient fell with fracture|1|||
33569118|NCT00098475|101974952|FG001|Step 1|Patient fell with fracture|0|||
33569119|NCT00098475|101974953|FG002|Step 1|Patient fell with fracture|0|||
33569120|NCT00098475|101974954|FG003|Step 1|Patient fell with fracture|0|||
33569121|NCT00098475|101974951|FG000|Step 1|Not documented|0|||
33569122|NCT00098475|101974952|FG001|Step 1|Not documented|1|||
33365614|NCT00958568|101227168|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
33365615|NCT00958568|101227169|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
33365616|NCT00958568|101227166|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
33569123|NCT00098475|101974953|FG002|Step 1|Not documented|0|||
33569124|NCT00098475|101974954|FG003|Step 1|Not documented|0|||
33569125|NCT00098475|101974951|FG000|Step 2|Disease progression|1|||
33569126|NCT00098475|101974952|FG001|Step 2|Disease progression|4|||
33569127|NCT00098475|101974953|FG002|Step 2|Disease progression|0|||
33569128|NCT00098475|101974954|FG003|Step 2|Disease progression|0|||
33632226|NCT02006472|102203121|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
33632227|NCT02006472|102203122|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
33632228|NCT02006472|102203123|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
33632229|NCT02006472|102203124|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
33569129|NCT00098475|101974951|FG000|Step 2|Adverse Event|2|||
33632230|NCT02006472|102203120|FG000|Period 2 (Through Week 52)|Other|0|||
33632231|NCT02006472|102203121|FG001|Period 2 (Through Week 52)|Other|1|||
33632232|NCT02006472|102203122|FG002|Period 2 (Through Week 52)|Other|0|||
33632233|NCT02006472|102203123|FG003|Period 2 (Through Week 52)|Other|1|||
33226072|NCT03311230|100728527|FG003|Overall Study|Unrelated injury|0|||
33226073|NCT00856661|100728528|FG000|Overall Study|Death|15|||
33569130|NCT00098475|101974952|FG001|Step 2|Adverse Event|0|||
33632234|NCT02006472|102203124|FG004|Period 2 (Through Week 52)|Other|0|||
33365617|NCT00958568|101227167|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
33569131|NCT00098475|101974953|FG002|Step 2|Adverse Event|0|||
33226074|NCT00856661|100728529|FG001|Overall Study|Death|18|||
33569132|NCT00098475|101974954|FG003|Step 2|Adverse Event|0|||
33632235|NCT02006472|102203120|FG000|Period 2 (Through Week 52)|Not treated|0|||
33569133|NCT00098475|101974951|FG000|Step 2|Withdrawal by Subject|0|||
33569134|NCT00098475|101974952|FG001|Step 2|Withdrawal by Subject|2|||
33569135|NCT00098475|101974953|FG002|Step 2|Withdrawal by Subject|0|||
33569136|NCT00098475|101974954|FG003|Step 2|Withdrawal by Subject|0|||
33569137|NCT00098475|101974951|FG000|Step 2|Physician Decision|0|||
33569138|NCT00098475|101974952|FG001|Step 2|Physician Decision|1|||
33569139|NCT00098475|101974953|FG002|Step 2|Physician Decision|0|||
33569140|NCT00098475|101974954|FG003|Step 2|Physician Decision|0|||
33632236|NCT02006472|102203121|FG001|Period 2 (Through Week 52)|Not treated|0|||
33632237|NCT02006472|102203122|FG002|Period 2 (Through Week 52)|Not treated|2|||
33632238|NCT02006472|102203123|FG003|Period 2 (Through Week 52)|Not treated|0|||
33632239|NCT02006472|102203124|FG004|Period 2 (Through Week 52)|Not treated|0|||
33632240|NCT02006472|102203120|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
33226075|NCT00856661|100728528|FG000|Overall Study|Protocol Violation|2|||
33569141|NCT00098475|101974951|FG000|Step 2|Alternative therapy|1|||
33569142|NCT00098475|101974952|FG001|Step 2|Alternative therapy|2|||
33569143|NCT00098475|101974953|FG002|Step 2|Alternative therapy|0|||
33569144|NCT00098475|101974954|FG003|Step 2|Alternative therapy|0|||
33569145|NCT00098475|101974951|FG000|Step 2|Never started treatment|1|||
33569146|NCT00098475|101974952|FG001|Step 2|Never started treatment|1|||
33569147|NCT00098475|101974953|FG002|Step 2|Never started treatment|0|||
33569148|NCT00098475|101974954|FG003|Step 2|Never started treatment|0|||
33569149|NCT02709161|101974955|FG000|Overall Study|Withdrawal by Subject|1|||
33569150|NCT02709161|101974956|FG001|Overall Study|Withdrawal by Subject|0|||
33569151|NCT02466971|101974957|FG000|Overall Study|eligible and never treated|14|||
33569152|NCT02466971|101974958|FG001|Overall Study|eligible and never treated|20|||
33632241|NCT02006472|102203121|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
33632242|NCT02006472|102203122|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
33632243|NCT02006472|102203123|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
33632244|NCT02006472|102203124|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
33632245|NCT02006472|102203120|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
33632246|NCT02006472|102203121|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
33632247|NCT02006472|102203122|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
33632248|NCT02006472|102203123|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
33632249|NCT02006472|102203124|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
33632250|NCT03221556|102203129|FG000|Allocation|post-randomization exclusion|0|||
33632251|NCT03221556|102203130|FG001|Allocation|post-randomization exclusion|1|||
33632252|NCT03221556|102203129|FG000|Follow-Up|Withdrawal by Subject|0|||
33226076|NCT00856661|100728529|FG001|Overall Study|Protocol Violation|1|||
33569153|NCT02466971|101974957|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
33632253|NCT03221556|102203130|FG001|Follow-Up|Withdrawal by Subject|1|||
33632254|NCT00248625|102203131|FG000|Overall Study|Withdrawal by Subject|0|||
33226077|NCT00856661|100728528|FG000|Overall Study|Withdrawal by Subject|1|||
33365618|NCT00958568|101227168|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
33569154|NCT02466971|101974958|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
33569155|NCT02466971|101974957|FG000|Overall Study|ineligible and treated|1|||
33632255|NCT00248625|102203132|FG001|Overall Study|Withdrawal by Subject|2|||
33632256|NCT01285557|102203135|FG000|Overall Study|Death|173|||
33632257|NCT01285557|102203136|FG001|Overall Study|Death|90|||
33417761|NCT01342367|101420399|FG001|Overall Study|Death|0|||
33417762|NCT01342367|101420398|FG000|Overall Study|Withdrawal by Subject|1|||
33417763|NCT01342367|101420399|FG001|Overall Study|Withdrawal by Subject|2|||
33417764|NCT01612780|101420402|FG000|Overall Study|Treatment not completed|1|||
33417765|NCT01612780|101420402|FG000|Overall Study|Withdrawal by Subject|5|||
33569156|NCT02466971|101974958|FG001|Overall Study|ineligible and treated|0|||
33569157|NCT02466971|101974957|FG000|Overall Study|ineligible and never treated|0|||
33569158|NCT02466971|101974958|FG001|Overall Study|ineligible and never treated|1|||
33569159|NCT03314454|101974965|FG000|Overall Study|Protocol Violation|1|||
33226078|NCT00856661|100728529|FG001|Overall Study|Withdrawal by Subject|2|||
33569160|NCT02573493|101978194|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
33569161|NCT02573493|101978195|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
33569162|NCT02573493|101978196|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
33569163|NCT02573493|101978197|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
33569164|NCT05601544|101978199|FG000|Phase 2 Period 1|Adverse Event|0|||
33226079|NCT00856661|100728528|FG000|Overall Study|Lost to Follow-up|1|||
33226080|NCT00856661|100728529|FG001|Overall Study|Lost to Follow-up|3|||
33226081|NCT00856661|100728528|FG000|Overall Study|Physician Judgement|8|||
33226082|NCT00856661|100728529|FG001|Overall Study|Physician Judgement|5|||
33226083|NCT02716038|100728530|FG000|Overall Study|Not evaluable|1|||
33226084|NCT02716038|100728530|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
33226085|NCT02716038|100728530|FG000|Overall Study|Unresectable|3|||
33226086|NCT00728962|100728531|FG000|Implant Placement Surgery|Adverse Event|8|||
33226087|NCT00728962|100728531|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
33226088|NCT00728962|100728531|FG000|Implant Placement Surgery|Protocol Violation|1|||
33226089|NCT00728962|100728531|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
33226090|NCT00728962|100728531|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
33226091|NCT01576718|100728532|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
33226092|NCT01576718|100728533|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33226093|NCT01576718|100728534|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33226094|NCT01576718|100728535|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33226095|NCT01576718|100728536|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33226096|NCT01576718|100728537|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33226097|NCT01576718|100728538|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
33226098|NCT01576718|100728532|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
33226099|NCT01576718|100728533|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33226100|NCT01576718|100728534|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33226101|NCT01576718|100728535|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33226102|NCT01576718|100728536|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33226103|NCT01576718|100728537|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33226104|NCT01576718|100728538|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
33226105|NCT01576718|100728532|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
33226106|NCT01576718|100728533|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33226107|NCT01576718|100728534|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33226108|NCT01576718|100728535|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33226109|NCT01576718|100728536|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33226110|NCT01576718|100728537|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33226111|NCT01576718|100728538|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
33226112|NCT01576718|100728532|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
33226113|NCT01576718|100728533|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33226114|NCT01576718|100728534|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33226115|NCT01576718|100728535|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33226116|NCT01576718|100728536|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33226117|NCT01576718|100728537|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33226118|NCT01576718|100728538|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
33226119|NCT01576718|100728532|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
33226120|NCT01576718|100728533|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33226121|NCT01576718|100728534|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33226122|NCT01576718|100728535|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33226123|NCT01576718|100728536|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33226124|NCT01576718|100728537|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33226125|NCT01576718|100728538|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
33226126|NCT01576718|100728532|FG000|Treatment Period|Adverse Event|0|||
33226127|NCT01576718|100728533|FG001|Treatment Period|Adverse Event|1|||
33417766|NCT01556165|101420407|FG000|Overall Study|Adverse Event|5|||
33417767|NCT01556165|101420408|FG001|Overall Study|Adverse Event|3|||
33417768|NCT01556165|101420407|FG000|Overall Study|Protocol Violation|0|||
33226128|NCT01576718|100728534|FG002|Treatment Period|Adverse Event|1|||
33226129|NCT01576718|100728535|FG003|Treatment Period|Adverse Event|1|||
33226130|NCT01576718|100728536|FG004|Treatment Period|Adverse Event|1|||
33226131|NCT01576718|100728537|FG005|Treatment Period|Adverse Event|1|||
33632258|NCT01285557|102203135|FG000|Overall Study|Lost to Follow-up|6|||
33569165|NCT05601544|101978200|FG001|Phase 2 Period 1|Adverse Event|1|||
33569166|NCT05601544|101978201|FG002|Phase 2 Period 1|Adverse Event|0|||
33569167|NCT05601544|101978202|FG003|Phase 2 Period 1|Adverse Event|0|||
33569168|NCT05601544|101978203|FG004|Phase 2 Period 1|Adverse Event|0|||
33569169|NCT05601544|101978204|FG005|Phase 2 Period 1|Adverse Event|0|||
33569170|NCT05646355|101978205|FG000|Overall Study|Lost to Follow-up|1|||
33569171|NCT05646355|101978206|FG001|Overall Study|Lost to Follow-up|0|||
33569172|NCT05646355|101978205|FG000|Overall Study|translated materials not available for pilot|2|||
33569173|NCT05646355|101978206|FG001|Overall Study|translated materials not available for pilot|0|||
33569174|NCT05646355|101978205|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
33569175|NCT05646355|101978206|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
33569176|NCT02867592|101978207|FG000|Overall Study|Adverse Event|3|||
33569177|NCT02867592|101978208|FG001|Overall Study|Adverse Event|0|||
33569178|NCT02867592|101978209|FG002|Overall Study|Adverse Event|2|||
33569179|NCT02867592|101978210|FG003|Overall Study|Adverse Event|1|||
33569180|NCT02867592|101978211|FG004|Overall Study|Adverse Event|1|||
33569181|NCT02867592|101978212|FG005|Overall Study|Adverse Event|5|||
33632259|NCT01285557|102203136|FG001|Overall Study|Lost to Follow-up|2|||
33632260|NCT01285557|102203135|FG000|Overall Study|Withdrew Consent|6|||
33632261|NCT01285557|102203136|FG001|Overall Study|Withdrew Consent|1|||
33632262|NCT01285557|102203135|FG000|Overall Study|Sponsor Study Termination|23|||
33632263|NCT01285557|102203136|FG001|Overall Study|Sponsor Study Termination|13|||
33632264|NCT01285557|102203135|FG000|Overall Study|Randomized but not treated|1|||
33632265|NCT01285557|102203136|FG001|Overall Study|Randomized but not treated|1|||
33632266|NCT01285557|102203135|FG000|Overall Study|Study follow-up ongoing|28|||
33632267|NCT01285557|102203136|FG001|Overall Study|Study follow-up ongoing|14|||
33632268|NCT01285557|102203135|FG000|Overall Study|Sponsor Decision|2|||
33632269|NCT01285557|102203136|FG001|Overall Study|Sponsor Decision|1|||
33632270|NCT03532451|102203137|FG000|Overall Study|Withdrawal by Subject|0|||
33632271|NCT03532451|102203138|FG001|Overall Study|Withdrawal by Subject|1|||
33632272|NCT03532451|102203137|FG000|Overall Study|Did not undergo surgery|1|||
33632273|NCT03532451|102203138|FG001|Overall Study|Did not undergo surgery|1|||
33632274|NCT04531176|102203139|FG000|Overall Study|Study was stopped early|24|||
33632275|NCT04531176|102203140|FG001|Overall Study|Study was stopped early|26|||
33632276|NCT04531176|102203141|FG002|Overall Study|Study was stopped early|24|||
33632277|NCT03459079|102203142|FG000|Overall Study|Adverse Event|4|||
33632278|NCT03459079|102203143|FG001|Overall Study|Adverse Event|2|||
33632279|NCT03459079|102203144|FG002|Overall Study|Adverse Event|0|||
33632280|NCT03459079|102203142|FG000|Overall Study|Withdrawal by Subject|2|||
33632281|NCT03459079|102203143|FG001|Overall Study|Withdrawal by Subject|2|||
33632282|NCT03459079|102203144|FG002|Overall Study|Withdrawal by Subject|0|||
33632283|NCT01292486|102205906|FG000|Overall Study|Protocol Violation|2|||
33632284|NCT01292486|102205906|FG000|Overall Study|Did not meet screening criteria|2|||
33632285|NCT01292486|102205906|FG000|Overall Study|Adverse Event|1|||
33632286|NCT01292486|102205906|FG000|Overall Study|Physician Decision|1|||
33632287|NCT00632229|102205907|FG000|Overall Study|Adverse Event|6|||
33632288|NCT00632229|102205908|FG001|Overall Study|Adverse Event|0|||
33569182|NCT02867592|101978207|FG000|Overall Study|Death|0|||
33569183|NCT02867592|101978208|FG001|Overall Study|Death|0|||
33569184|NCT02867592|101978209|FG002|Overall Study|Death|0|||
33569185|NCT02867592|101978210|FG003|Overall Study|Death|1|||
33569186|NCT02867592|101978211|FG004|Overall Study|Death|0|||
33569187|NCT02867592|101978212|FG005|Overall Study|Death|1|||
33569188|NCT02867592|101978207|FG000|Overall Study|Lack of Efficacy|8|||
33569189|NCT02867592|101978208|FG001|Overall Study|Lack of Efficacy|10|||
33569190|NCT02867592|101978209|FG002|Overall Study|Lack of Efficacy|8|||
33569191|NCT02867592|101978210|FG003|Overall Study|Lack of Efficacy|8|||
33569192|NCT02867592|101978211|FG004|Overall Study|Lack of Efficacy|12|||
33632289|NCT00632229|102205907|FG000|Overall Study|Lost to Follow-up|0|||
33632290|NCT00632229|102205908|FG001|Overall Study|Lost to Follow-up|3|||
33632291|NCT00632229|102205907|FG000|Overall Study|Lack of Efficacy|0|||
33632292|NCT00632229|102205908|FG001|Overall Study|Lack of Efficacy|2|||
33569193|NCT02867592|101978212|FG005|Overall Study|Lack of Efficacy|17|||
33569194|NCT02867592|101978207|FG000|Overall Study|Physician Decision|1|||
33569195|NCT02867592|101978208|FG001|Overall Study|Physician Decision|2|||
33569196|NCT02867592|101978209|FG002|Overall Study|Physician Decision|2|||
33569197|NCT02867592|101978210|FG003|Overall Study|Physician Decision|0|||
33226132|NCT01576718|100728538|FG006|Treatment Period|Adverse Event|0|||
33226133|NCT01576718|100728532|FG000|Treatment Period|Withdrawal by Subject|0|||
33226134|NCT01576718|100728533|FG001|Treatment Period|Withdrawal by Subject|1|||
33226135|NCT01576718|100728534|FG002|Treatment Period|Withdrawal by Subject|1|||
33226136|NCT01576718|100728535|FG003|Treatment Period|Withdrawal by Subject|0|||
33226137|NCT01576718|100728536|FG004|Treatment Period|Withdrawal by Subject|2|||
33226138|NCT01576718|100728537|FG005|Treatment Period|Withdrawal by Subject|4|||
33226139|NCT01576718|100728538|FG006|Treatment Period|Withdrawal by Subject|2|||
33226140|NCT01576718|100728532|FG000|Treatment Period|Physician Decision|0|||
33226141|NCT01576718|100728533|FG001|Treatment Period|Physician Decision|1|||
33226142|NCT01576718|100728534|FG002|Treatment Period|Physician Decision|1|||
33226143|NCT01576718|100728535|FG003|Treatment Period|Physician Decision|1|||
33226144|NCT01576718|100728536|FG004|Treatment Period|Physician Decision|1|||
33226145|NCT01576718|100728537|FG005|Treatment Period|Physician Decision|0|||
33569198|NCT02867592|101978211|FG004|Overall Study|Physician Decision|5|||
33569199|NCT02867592|101978212|FG005|Overall Study|Physician Decision|1|||
33569200|NCT02867592|101978207|FG000|Overall Study|Protocol Violation|0|||
33569201|NCT02867592|101978208|FG001|Overall Study|Protocol Violation|0|||
33569202|NCT02867592|101978209|FG002|Overall Study|Protocol Violation|0|||
33569203|NCT02867592|101978210|FG003|Overall Study|Protocol Violation|0|||
33569204|NCT02867592|101978211|FG004|Overall Study|Protocol Violation|1|||
33569205|NCT02867592|101978212|FG005|Overall Study|Protocol Violation|1|||
33569206|NCT02867592|101978207|FG000|Overall Study|Withdrawal by Subject|0|||
33569207|NCT02867592|101978208|FG001|Overall Study|Withdrawal by Subject|1|||
33569208|NCT02867592|101978209|FG002|Overall Study|Withdrawal by Subject|0|||
33569209|NCT02867592|101978210|FG003|Overall Study|Withdrawal by Subject|1|||
33569210|NCT02867592|101978211|FG004|Overall Study|Withdrawal by Subject|3|||
33569211|NCT02867592|101978212|FG005|Overall Study|Withdrawal by Subject|3|||
33569212|NCT02867592|101978207|FG000|Overall Study|Ineligible|1|||
33569213|NCT02867592|101978208|FG001|Overall Study|Ineligible|1|||
33569214|NCT02867592|101978209|FG002|Overall Study|Ineligible|0|||
33569215|NCT02867592|101978210|FG003|Overall Study|Ineligible|0|||
33569216|NCT02867592|101978211|FG004|Overall Study|Ineligible|2|||
33569217|NCT02867592|101978212|FG005|Overall Study|Ineligible|0|||
33569218|NCT02867592|101978207|FG000|Overall Study|No Treatment|1|||
33632293|NCT00632229|102205907|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
33632294|NCT00632229|102205908|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
33226146|NCT01576718|100728538|FG006|Treatment Period|Physician Decision|0|||
33226147|NCT01576718|100728532|FG000|Treatment Period|Protocol Violation|0|||
33226148|NCT01576718|100728533|FG001|Treatment Period|Protocol Violation|5|||
33569219|NCT02867592|101978208|FG001|Overall Study|No Treatment|0|||
33569220|NCT02867592|101978209|FG002|Overall Study|No Treatment|0|||
33569221|NCT02867592|101978210|FG003|Overall Study|No Treatment|0|||
33569222|NCT02867592|101978211|FG004|Overall Study|No Treatment|0|||
33569223|NCT02867592|101978212|FG005|Overall Study|No Treatment|0|||
33226149|NCT01576718|100728534|FG002|Treatment Period|Protocol Violation|4|||
33569224|NCT02867592|101978207|FG000|Overall Study|Still on Therapy|0|||
33226150|NCT01576718|100728535|FG003|Treatment Period|Protocol Violation|10|||
33569225|NCT02867592|101978208|FG001|Overall Study|Still on Therapy|0|||
33569226|NCT02867592|101978209|FG002|Overall Study|Still on Therapy|0|||
33569227|NCT02867592|101978210|FG003|Overall Study|Still on Therapy|0|||
33569228|NCT02867592|101978211|FG004|Overall Study|Still on Therapy|1|||
33569229|NCT02867592|101978212|FG005|Overall Study|Still on Therapy|0|||
33569230|NCT02867592|101978207|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
33569231|NCT02867592|101978208|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
33569232|NCT02867592|101978209|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
33569233|NCT02867592|101978210|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
33569234|NCT02867592|101978211|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
33569235|NCT02867592|101978212|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
33365619|NCT00958568|101227169|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
33365620|NCT00958568|101227166|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
33365621|NCT00958568|101227167|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
33365622|NCT00958568|101227168|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
33365623|NCT00958568|101227169|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
33365624|NCT00958568|101227166|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
33365625|NCT00958568|101227167|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
33365626|NCT00958568|101227168|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
33365627|NCT00958568|101227169|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
33365628|NCT00958568|101227166|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
33365629|NCT00958568|101227167|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
33365630|NCT00958568|101227168|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
33365631|NCT00958568|101227169|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
33365632|NCT00958568|101227166|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
33365633|NCT00958568|101227167|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
33365634|NCT00958568|101227168|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
33417769|NCT01556165|101420408|FG001|Overall Study|Protocol Violation|3|||
33417770|NCT01556165|101420407|FG000|Overall Study|Withdrawal of Consent|7|||
33417771|NCT01556165|101420408|FG001|Overall Study|Withdrawal of Consent|1|||
33417772|NCT01102972|101420411|FG000|Overall Study|Adverse Event|8|||
33417773|NCT01102972|101420412|FG001|Overall Study|Adverse Event|2|||
33417774|NCT01102972|101420411|FG000|Overall Study|Lack of Efficacy|2|||
33417775|NCT01102972|101420412|FG001|Overall Study|Lack of Efficacy|1|||
33417776|NCT01102972|101420411|FG000|Overall Study|Protocol Violation|1|||
33417777|NCT01102972|101420412|FG001|Overall Study|Protocol Violation|0|||
33417778|NCT01102972|101420411|FG000|Overall Study|Lost to Follow-up|10|||
33417779|NCT01102972|101420412|FG001|Overall Study|Lost to Follow-up|5|||
33417780|NCT01102972|101420411|FG000|Overall Study|Investigator Discretion|2|||
33417781|NCT01102972|101420412|FG001|Overall Study|Investigator Discretion|0|||
33417782|NCT01102972|101420411|FG000|Overall Study|Withdrawal by Subject|6|||
33417783|NCT01102972|101420412|FG001|Overall Study|Withdrawal by Subject|6|||
33417784|NCT02617446|101420413|FG000|Overall Study|Withdrawal by Subject|0|||
33417785|NCT02617446|101420414|FG001|Overall Study|Withdrawal by Subject|2|||
33417786|NCT02617446|101420415|FG002|Overall Study|Withdrawal by Subject|0|||
33417787|NCT02617446|101420413|FG000|Overall Study|Adverse Event|1|||
33417788|NCT02617446|101420414|FG001|Overall Study|Adverse Event|0|||
33417789|NCT02617446|101420415|FG002|Overall Study|Adverse Event|5|||
33417790|NCT02617446|101420413|FG000|Overall Study|Lost to Follow-up|3|||
33417791|NCT02617446|101420414|FG001|Overall Study|Lost to Follow-up|0|||
33417792|NCT02617446|101420415|FG002|Overall Study|Lost to Follow-up|0|||
33417793|NCT02617446|101420413|FG000|Overall Study|Death|0|||
33417794|NCT02617446|101420414|FG001|Overall Study|Death|0|||
33417795|NCT02617446|101420415|FG002|Overall Study|Death|2|||
33417796|NCT04930536|101422243|FG000|Overall Study|Adverse Event|1|||
33417797|NCT04930536|101422244|FG001|Overall Study|Adverse Event|0|||
33417798|NCT04930536|101422243|FG000|Overall Study|Disease Progression|2|||
33417799|NCT04930536|101422244|FG001|Overall Study|Disease Progression|0|||
33417800|NCT04930536|101422243|FG000|Overall Study|Patient Decision|4|||
33417801|NCT04930536|101422244|FG001|Overall Study|Patient Decision|2|||
33417802|NCT04930536|101422243|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
33417803|NCT04930536|101422244|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
33417804|NCT02118896|101422247|FG000|Overall Study|Death|4|||
33417805|NCT02118896|101422248|FG001|Overall Study|Death|0|||
33417806|NCT02118896|101422249|FG002|Overall Study|Death|4|||
33417807|NCT02118896|101422250|FG003|Overall Study|Death|6|||
33417808|NCT02118896|101422251|FG004|Overall Study|Death|3|||
33417809|NCT02118896|101422252|FG005|Overall Study|Death|1|||
33417810|NCT02118896|101422253|FG006|Overall Study|Death|0|||
33417811|NCT02118896|101422254|FG007|Overall Study|Death|0|||
33417812|NCT02118896|101422255|FG008|Overall Study|Death|0|||
33417813|NCT02118896|101422256|FG009|Overall Study|Death|0|||
33417814|NCT02118896|101422247|FG000|Overall Study|Adverse Event|5|||
33417815|NCT02118896|101422248|FG001|Overall Study|Adverse Event|4|||
33569236|NCT02867592|101978207|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
33569237|NCT02867592|101978208|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
33569238|NCT02867592|101978209|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
33569239|NCT02867592|101978210|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
33569240|NCT02867592|101978211|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
33569241|NCT02867592|101978212|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
33569242|NCT03478956|101978213|FG000|Randomized Treatment Period|Adverse Event|1|||
33569243|NCT03478956|101978214|FG001|Randomized Treatment Period|Adverse Event|0|||
33569244|NCT03478956|101978215|FG002|Randomized Treatment Period|Adverse Event|0|||
33569245|NCT03478956|101978216|FG003|Randomized Treatment Period|Adverse Event|0|||
33569246|NCT03478956|101978213|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
33569247|NCT03478956|101978214|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
33569248|NCT03478956|101978215|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
33569249|NCT03478956|101978216|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
33569250|NCT03478956|101978213|FG000|Open Label Extension Period|Adverse Event|0|||
33569251|NCT03478956|101978214|FG001|Open Label Extension Period|Adverse Event|0|||
33569252|NCT03478956|101978215|FG002|Open Label Extension Period|Adverse Event|4|||
33569253|NCT03478956|101978216|FG003|Open Label Extension Period|Adverse Event|0|||
33569254|NCT03478956|101978213|FG000|Open Label Extension Period|Lack of Efficacy|0|||
33569255|NCT03478956|101978214|FG001|Open Label Extension Period|Lack of Efficacy|0|||
33569256|NCT03478956|101978215|FG002|Open Label Extension Period|Lack of Efficacy|8|||
33569257|NCT03478956|101978216|FG003|Open Label Extension Period|Lack of Efficacy|0|||
33569258|NCT03478956|101978213|FG000|Open Label Extension Period|Reason Not Provided|0|||
33569259|NCT03478956|101978214|FG001|Open Label Extension Period|Reason Not Provided|0|||
33569260|NCT03478956|101978215|FG002|Open Label Extension Period|Reason Not Provided|1|||
33569261|NCT03478956|101978216|FG003|Open Label Extension Period|Reason Not Provided|0|||
33569262|NCT03478956|101978213|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
33569263|NCT03478956|101978214|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
33569264|NCT03478956|101978215|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
33569265|NCT03478956|101978216|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
33569266|NCT03478956|101978213|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
33569267|NCT03478956|101978214|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
33569268|NCT03478956|101978215|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
33569269|NCT03478956|101978216|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
33569270|NCT03478956|101978213|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
33569271|NCT03478956|101978214|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
33569272|NCT03478956|101978215|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
33569273|NCT03478956|101978216|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
33226151|NCT01576718|100728536|FG004|Treatment Period|Protocol Violation|6|||
33226152|NCT01576718|100728537|FG005|Treatment Period|Protocol Violation|8|||
33569274|NCT03926130|101978217|FG000|Overall Study|Adverse Event|9|||
33569275|NCT03926130|101978218|FG001|Overall Study|Adverse Event|11|||
33569276|NCT03926130|101978219|FG002|Overall Study|Adverse Event|2|||
33569277|NCT03926130|101978220|FG003|Overall Study|Adverse Event|0|||
33569278|NCT03926130|101978217|FG000|Overall Study|Death|2|||
33569279|NCT03926130|101978218|FG001|Overall Study|Death|0|||
33569280|NCT03926130|101978219|FG002|Overall Study|Death|1|||
33569281|NCT03926130|101978220|FG003|Overall Study|Death|0|||
33569282|NCT03926130|101978217|FG000|Overall Study|Lack of Efficacy|14|||
33569283|NCT03926130|101978218|FG001|Overall Study|Lack of Efficacy|11|||
33569284|NCT03926130|101978219|FG002|Overall Study|Lack of Efficacy|7|||
33569285|NCT03926130|101978220|FG003|Overall Study|Lack of Efficacy|1|||
33569286|NCT03926130|101978217|FG000|Overall Study|Lost to Follow-up|0|||
33569287|NCT03926130|101978218|FG001|Overall Study|Lost to Follow-up|7|||
33569288|NCT03926130|101978219|FG002|Overall Study|Lost to Follow-up|1|||
33569289|NCT03926130|101978220|FG003|Overall Study|Lost to Follow-up|0|||
33226153|NCT01576718|100728538|FG006|Treatment Period|Protocol Violation|12|||
33226154|NCT01576718|100728532|FG000|Treatment Period|Sponsor request|0|||
33365635|NCT00958568|101227169|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
33365636|NCT00958568|101227166|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
33365637|NCT00958568|101227167|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
33569290|NCT03926130|101978217|FG000|Overall Study|As Reported by Investigator|2|||
33226155|NCT01576718|100728533|FG001|Treatment Period|Sponsor request|1|||
33569291|NCT03926130|101978218|FG001|Overall Study|As Reported by Investigator|6|||
33569292|NCT03926130|101978219|FG002|Overall Study|As Reported by Investigator|6|||
33569293|NCT03926130|101978220|FG003|Overall Study|As Reported by Investigator|0|||
33226156|NCT01576718|100728534|FG002|Treatment Period|Sponsor request|0|||
33226157|NCT01576718|100728535|FG003|Treatment Period|Sponsor request|0|||
33569294|NCT03926130|101978217|FG000|Overall Study|Physician Decision|3|||
33569295|NCT03926130|101978218|FG001|Overall Study|Physician Decision|2|||
33569296|NCT03926130|101978219|FG002|Overall Study|Physician Decision|1|||
33569297|NCT03926130|101978220|FG003|Overall Study|Physician Decision|0|||
33569298|NCT03926130|101978217|FG000|Overall Study|Pregnancy|2|||
33569299|NCT03926130|101978218|FG001|Overall Study|Pregnancy|2|||
33569300|NCT03926130|101978219|FG002|Overall Study|Pregnancy|1|||
33569301|NCT03926130|101978220|FG003|Overall Study|Pregnancy|0|||
33569302|NCT03926130|101978217|FG000|Overall Study|Withdrawal by Subject|20|||
33569303|NCT03926130|101978218|FG001|Overall Study|Withdrawal by Subject|28|||
33569304|NCT03926130|101978219|FG002|Overall Study|Withdrawal by Subject|18|||
33569305|NCT03926130|101978220|FG003|Overall Study|Withdrawal by Subject|1|||
33569306|NCT03926130|101978217|FG000|Overall Study|Non-Compliance|1|||
33569307|NCT03926130|101978218|FG001|Overall Study|Non-Compliance|1|||
33569308|NCT03926130|101978219|FG002|Overall Study|Non-Compliance|0|||
33569309|NCT03926130|101978220|FG003|Overall Study|Non-Compliance|0|||
33226158|NCT01576718|100728536|FG004|Treatment Period|Sponsor request|0|||
33226159|NCT01576718|100728537|FG005|Treatment Period|Sponsor request|1|||
33569310|NCT03926130|101978217|FG000|Overall Study|Disposition Not Captured|0|||
33569311|NCT03926130|101978218|FG001|Overall Study|Disposition Not Captured|2|||
33569312|NCT03926130|101978219|FG002|Overall Study|Disposition Not Captured|1|||
33569313|NCT03926130|101978220|FG003|Overall Study|Disposition Not Captured|0|||
33569314|NCT04089865|101978221|FG000|Overall Study|Withdrawal by Subject|2|||
33569315|NCT04089865|101978222|FG001|Overall Study|Withdrawal by Subject|2|||
33226160|NCT01576718|100728538|FG006|Treatment Period|Sponsor request|0|||
33226161|NCT01576718|100728532|FG000|Treatment Period|Met stopping criteria|0|||
33417816|NCT02118896|101422249|FG002|Overall Study|Adverse Event|4|||
33569316|NCT04089865|101978223|FG002|Overall Study|Withdrawal by Subject|7|||
33569317|NCT04089865|101978224|FG003|Overall Study|Withdrawal by Subject|2|||
33569318|NCT04660539|101978225|FG000|Overall Study|Adverse Event|10|||
33569319|NCT04660539|101978225|FG000|Overall Study|Lack of Efficacy|4|||
33569320|NCT04660539|101978225|FG000|Overall Study|Lost to Follow-up|5|||
33569321|NCT04660539|101978225|FG000|Overall Study|Non-Compliance With Study Drug|3|||
33569322|NCT04660539|101978225|FG000|Overall Study|Reason not Specified|12|||
33569323|NCT04660539|101978225|FG000|Overall Study|Pregnancy|2|||
33569324|NCT04660539|101978225|FG000|Overall Study|Protocol Violation|2|||
33569325|NCT04660539|101978225|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
33569326|NCT04660539|101978225|FG000|Overall Study|Withdrawal by Subject|21|||
33569327|NCT04025554|101978226|FG000|Overall Study|Adverse Event|3|||
33569328|NCT03299049|101978229|FG000|Overall Study|On-going|486|||
33569329|NCT03299049|101978230|FG001|Overall Study|On-going|481|||
33569330|NCT03299049|101978229|FG000|Overall Study|Withdrawal by Subject|6|||
33569331|NCT03299049|101978230|FG001|Overall Study|Withdrawal by Subject|21|||
33569332|NCT03299049|101978229|FG000|Overall Study|Physician Decision|5|||
33569333|NCT03299049|101978230|FG001|Overall Study|Physician Decision|1|||
33569334|NCT03299049|101978229|FG000|Overall Study|Lost to Follow-up|2|||
33569335|NCT03299049|101978230|FG001|Overall Study|Lost to Follow-up|0|||
33569336|NCT03299049|101978229|FG000|Overall Study|Pregnancy|1|||
33569337|NCT03299049|101978230|FG001|Overall Study|Pregnancy|3|||
33632295|NCT01394016|102205909|FG000|Overall Study|Progressive Disease|2|||
33632296|NCT01394016|102205910|FG001|Overall Study|Progressive Disease|0|||
33632297|NCT01394016|102205911|FG002|Overall Study|Progressive Disease|0|||
33569338|NCT03299049|101978229|FG000|Overall Study|Protocol Violation|1|||
33569339|NCT03299049|101978230|FG001|Overall Study|Protocol Violation|1|||
33569340|NCT03299049|101978229|FG000|Overall Study|Lack of Efficacy|9|||
33632298|NCT01394016|102205912|FG003|Overall Study|Progressive Disease|0|||
33417817|NCT02118896|101422250|FG003|Overall Study|Adverse Event|5|||
33569341|NCT03299049|101978230|FG001|Overall Study|Lack of Efficacy|3|||
33569342|NCT03299049|101978229|FG000|Overall Study|Adverse Event|12|||
33569343|NCT03299049|101978230|FG001|Overall Study|Adverse Event|13|||
33569344|NCT00980538|101978231|FG000|Overall Study|Lost to Follow-up|20|||
33569345|NCT00980538|101978231|FG000|Overall Study|Sponsor's Decision|4|||
33569346|NCT00980538|101978231|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
33569347|NCT00980538|101978231|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
33569348|NCT00980538|101978231|FG000|Overall Study|Switch to Commercially Available Medication|25|||
33569349|NCT00980538|101978231|FG000|Overall Study|Participant Non-Compliant|9|||
33569350|NCT00980538|101978231|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
33569351|NCT00980538|101978231|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
33569352|NCT00980538|101978231|FG000|Overall Study|Other|60|||
33569353|NCT00980538|101978231|FG000|Overall Study|Other|1|||
33569354|NCT02958865|101978234|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33569355|NCT02958865|101978235|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
33569356|NCT02958865|101978236|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33569357|NCT02958865|101978237|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
33226162|NCT01576718|100728533|FG001|Treatment Period|Met stopping criteria|16|||
33226163|NCT01576718|100728534|FG002|Treatment Period|Met stopping criteria|13|||
33226164|NCT01576718|100728535|FG003|Treatment Period|Met stopping criteria|19|||
33226165|NCT01576718|100728536|FG004|Treatment Period|Met stopping criteria|16|||
33226166|NCT01576718|100728537|FG005|Treatment Period|Met stopping criteria|33|||
33226167|NCT01576718|100728538|FG006|Treatment Period|Met stopping criteria|15|||
33226168|NCT01576718|100728532|FG000|Treatment Period|Lost to Follow-up|0|||
33226169|NCT01576718|100728533|FG001|Treatment Period|Lost to Follow-up|0|||
33226170|NCT01576718|100728534|FG002|Treatment Period|Lost to Follow-up|0|||
33226171|NCT01576718|100728535|FG003|Treatment Period|Lost to Follow-up|0|||
33569358|NCT02958865|101978238|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
33569359|NCT02958865|101978239|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
33569360|NCT02958865|101978240|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
33569361|NCT02958865|101978241|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33569362|NCT02958865|101978242|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33569363|NCT02958865|101978243|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33569364|NCT02958865|101978244|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33569365|NCT02958865|101978245|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33569366|NCT02958865|101978246|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33569367|NCT02958865|101978247|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33569368|NCT02958865|101978248|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33569369|NCT02958865|101978249|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
33569370|NCT02958865|101978234|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
33569371|NCT02958865|101978235|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
33569372|NCT02958865|101978236|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
33569373|NCT02958865|101978237|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
33569374|NCT02958865|101978238|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
33569375|NCT02958865|101978239|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
33569376|NCT02958865|101978240|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
33569377|NCT02958865|101978241|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
33569378|NCT02958865|101978242|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
33569379|NCT02958865|101978243|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
33569380|NCT02958865|101978244|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
33226172|NCT01576718|100728536|FG004|Treatment Period|Lost to Follow-up|1|||
33226173|NCT01576718|100728537|FG005|Treatment Period|Lost to Follow-up|0|||
33226174|NCT01576718|100728538|FG006|Treatment Period|Lost to Follow-up|0|||
33226175|NCT01576718|100728532|FG000|Treatment Period|Noncompliance to study medication|0|||
33226176|NCT01576718|100728533|FG001|Treatment Period|Noncompliance to study medication|0|||
33226177|NCT01576718|100728534|FG002|Treatment Period|Noncompliance to study medication|0|||
33226178|NCT01576718|100728535|FG003|Treatment Period|Noncompliance to study medication|0|||
33226179|NCT01576718|100728536|FG004|Treatment Period|Noncompliance to study medication|0|||
33569381|NCT02958865|101978245|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
33569382|NCT02958865|101978246|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
33569383|NCT02958865|101978247|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
33569384|NCT02958865|101978248|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
33569385|NCT02958865|101978249|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
33569386|NCT02958865|101978234|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
33569387|NCT02958865|101978235|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
33569388|NCT02958865|101978236|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33569389|NCT02958865|101978237|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33569390|NCT02958865|101978238|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33569391|NCT02958865|101978239|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33226180|NCT01576718|100728537|FG005|Treatment Period|Noncompliance to study medication|1|||
33226181|NCT01576718|100728538|FG006|Treatment Period|Noncompliance to study medication|1|||
33226182|NCT02066402|100728539|FG000|Overall Study|Adverse Event|1|||
33226183|NCT02066402|100728540|FG001|Overall Study|Adverse Event|2|||
33226184|NCT02066402|100728539|FG000|Overall Study|Lost to Follow-up|11|||
33226185|NCT02066402|100728540|FG001|Overall Study|Lost to Follow-up|8|||
33226186|NCT02066402|100728539|FG000|Overall Study|Withdrawal by Subject|14|||
33226187|NCT02066402|100728540|FG001|Overall Study|Withdrawal by Subject|11|||
33226188|NCT02066402|100728539|FG000|Overall Study|Progressive disease-clinical progression|0|||
33226189|NCT02066402|100728540|FG001|Overall Study|Progressive disease-clinical progression|1|||
33226190|NCT02066402|100728539|FG000|Overall Study|Protocol driven decision point|0|||
33226191|NCT02066402|100728540|FG001|Overall Study|Protocol driven decision point|1|||
33226192|NCT03528174|100728544|FG000|Overall Study|Adverse Event|1|||
33226193|NCT03528174|100728544|FG000|Overall Study|sensors dislodged|1|||
33226194|NCT02424591|100728561|FG000|Overall Study|Protocol Violation|2|||
33226195|NCT02424591|100728562|FG001|Overall Study|Protocol Violation|3|||
33226196|NCT00041756|100728563|FG000|Overall Study|Adverse Event|4|||
33417818|NCT02118896|101422251|FG004|Overall Study|Adverse Event|5|||
33417819|NCT02118896|101422252|FG005|Overall Study|Adverse Event|9|||
33226197|NCT00041756|100728564|FG001|Overall Study|Adverse Event|10|||
33226198|NCT00041756|100728565|FG002|Overall Study|Adverse Event|6|||
33226199|NCT00041756|100728566|FG003|Overall Study|Adverse Event|11|||
33226200|NCT00041756|100728567|FG004|Overall Study|Adverse Event|34|||
33226201|NCT00041756|100728563|FG000|Overall Study|Protocol Violation|1|||
33226202|NCT00041756|100728564|FG001|Overall Study|Protocol Violation|1|||
33226203|NCT00041756|100728565|FG002|Overall Study|Protocol Violation|2|||
33226204|NCT00041756|100728566|FG003|Overall Study|Protocol Violation|2|||
33226205|NCT00041756|100728567|FG004|Overall Study|Protocol Violation|1|||
33226206|NCT00041756|100728563|FG000|Overall Study|Withdrawal by Subject|3|||
33226207|NCT00041756|100728564|FG001|Overall Study|Withdrawal by Subject|3|||
33226208|NCT00041756|100728565|FG002|Overall Study|Withdrawal by Subject|4|||
33226209|NCT00041756|100728566|FG003|Overall Study|Withdrawal by Subject|2|||
33226210|NCT00041756|100728567|FG004|Overall Study|Withdrawal by Subject|3|||
33226211|NCT00041756|100728563|FG000|Overall Study|Lost to Follow-up|0|||
33226212|NCT00041756|100728564|FG001|Overall Study|Lost to Follow-up|1|||
33226213|NCT00041756|100728565|FG002|Overall Study|Lost to Follow-up|0|||
33226214|NCT00041756|100728566|FG003|Overall Study|Lost to Follow-up|1|||
33226215|NCT00041756|100728567|FG004|Overall Study|Lost to Follow-up|0|||
33226216|NCT00041756|100728563|FG000|Overall Study|Unable to meet protocol criteria|0|||
33226217|NCT00041756|100728564|FG001|Overall Study|Unable to meet protocol criteria|0|||
33226218|NCT00041756|100728565|FG002|Overall Study|Unable to meet protocol criteria|1|||
33226219|NCT00041756|100728566|FG003|Overall Study|Unable to meet protocol criteria|0|||
33365638|NCT00958568|101227168|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
33365639|NCT00958568|101227169|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
33365640|NCT00958568|101227166|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
33365641|NCT00958568|101227167|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
33365642|NCT00958568|101227168|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
33365643|NCT00958568|101227169|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
33365644|NCT00958568|101227166|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
33365645|NCT00958568|101227167|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
33365646|NCT00958568|101227168|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
33365647|NCT00958568|101227169|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
33365648|NCT00958568|101227166|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
33365649|NCT00958568|101227167|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
33365650|NCT00958568|101227168|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
33365651|NCT00958568|101227169|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
33365652|NCT00958568|101227166|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
33365653|NCT00958568|101227167|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
33365654|NCT00958568|101227168|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
33365655|NCT00958568|101227169|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
33365656|NCT00958568|101227166|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
33417820|NCT02118896|101422253|FG006|Overall Study|Adverse Event|1|||
33417821|NCT02118896|101422254|FG007|Overall Study|Adverse Event|1|||
33417822|NCT02118896|101422255|FG008|Overall Study|Adverse Event|4|||
33417823|NCT02118896|101422256|FG009|Overall Study|Adverse Event|0|||
33226220|NCT00041756|100728567|FG004|Overall Study|Unable to meet protocol criteria|1|||
33226221|NCT00041756|100728563|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
33226222|NCT00041756|100728564|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
33226223|NCT00041756|100728565|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
33226224|NCT00041756|100728566|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
33226225|NCT00041756|100728567|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
33226226|NCT03203694|100728568|FG000|Overall Study|Withdrawal by Subject|2|||
33226227|NCT03203694|100728569|FG001|Overall Study|Withdrawal by Subject|0|||
33226228|NCT03203694|100728570|FG002|Overall Study|Withdrawal by Subject|0|||
33226229|NCT03203694|100728571|FG003|Overall Study|Withdrawal by Subject|0|||
33226230|NCT03203694|100728572|FG004|Overall Study|Withdrawal by Subject|0|||
33226231|NCT03203694|100728573|FG005|Overall Study|Withdrawal by Subject|0|||
33226232|NCT01372605|100728574|FG000|Overall Study|Death|1|||
33226233|NCT01372605|100728575|FG001|Overall Study|Death|2|||
33226234|NCT01372605|100728574|FG000|Overall Study|Lost to Follow-up|2|||
33226235|NCT01372605|100728575|FG001|Overall Study|Lost to Follow-up|1|||
33226236|NCT01372605|100728574|FG000|Overall Study|Withdrawal by Subject|4|||
33226237|NCT01372605|100728575|FG001|Overall Study|Withdrawal by Subject|7|||
33226238|NCT01372605|100728574|FG000|Overall Study|Moved|3|||
33226239|NCT01372605|100728575|FG001|Overall Study|Moved|0|||
33226240|NCT01372605|100728574|FG000|Overall Study|Changed medical home|2|||
33226241|NCT01372605|100728575|FG001|Overall Study|Changed medical home|0|||
33226242|NCT02087501|100728576|FG000|Overall Study|Death|7|||
33226243|NCT02087501|100728576|FG000|Overall Study|Open repair of aneurysm|1|||
33226244|NCT02087501|100728576|FG000|Overall Study|Lost to Follow-up|2|||
33226245|NCT04461795|100728581|FG000|Overall Study|Lost to Follow-up|2|||
33226246|NCT04461795|100728581|FG000|Overall Study|Withdrawal by Subject|2|||
33226247|NCT04461795|100728581|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
33226248|NCT01686581|100728582|FG000|Overall Study|Side-effects or Health Problems|15|||
33226249|NCT01686581|100728582|FG000|Overall Study|Lack of Efficacy|90|||
33226250|NCT01686581|100728582|FG000|Overall Study|Participant Concerned about Risks|6|||
33226251|NCT01686581|100728582|FG000|Overall Study|Thinks Injections Too Painful|8|||
33226252|NCT01686581|100728582|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
33226253|NCT01686581|100728582|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
33226254|NCT01686581|100728582|FG000|Overall Study|Thinks it is Inconvenient|17|||
33226255|NCT01686581|100728582|FG000|Overall Study|Other Miscellaneous Reasons|36|||
33226256|NCT01686581|100728582|FG000|Overall Study|Reason Missing|1|||
33226257|NCT01351025|100728585|FG000|Week 0 - 20|Lost to Follow-up|2|||
33226258|NCT01351025|100728586|FG001|Week 0 - 20|Lost to Follow-up|1|||
33226259|NCT01351025|100728585|FG000|Week 0 - 20|Withdrawal by Subject|1|||
33226260|NCT01351025|100728586|FG001|Week 0 - 20|Withdrawal by Subject|0|||
33226261|NCT01351025|100728585|FG000|Week 24 - 44|Lost to Follow-up|0|||
33226262|NCT01351025|100728586|FG001|Week 24 - 44|Lost to Follow-up|2|||
33226263|NCT01351025|100728585|FG000|Week 24 - 44|Site closed|0|||
33226264|NCT01351025|100728586|FG001|Week 24 - 44|Site closed|1|||
33226265|NCT01351025|100728585|FG000|Week 24 - 44|unable to get to clinic|1|||
33226266|NCT01351025|100728586|FG001|Week 24 - 44|unable to get to clinic|1|||
33226267|NCT04318093|100728587|FG000|Overall Study|Adverse Event|2|||
33226268|NCT04318093|100728588|FG001|Overall Study|Adverse Event|2|||
33226269|NCT04318093|100728587|FG000|Overall Study|Participant withdrew consent|1|||
33226270|NCT04318093|100728588|FG001|Overall Study|Participant withdrew consent|0|||
33226271|NCT04318093|100728587|FG000|Overall Study|Other reasons|0|||
33226272|NCT04318093|100728588|FG001|Overall Study|Other reasons|1|||
33226273|NCT00365378|100728593|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
33226274|NCT00365378|100728594|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
33226275|NCT00365378|100728595|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
33226276|NCT00365378|100728593|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
33226277|NCT00365378|100728594|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
33226278|NCT00365378|100728595|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
33226279|NCT00365378|100728593|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
33226280|NCT00365378|100728594|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
33226281|NCT00365378|100728595|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
33226282|NCT00365378|100728593|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
33226283|NCT00365378|100728594|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
33226284|NCT00365378|100728595|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
33226285|NCT00365378|100728593|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
33226286|NCT00365378|100728594|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
33226287|NCT00365378|100728595|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
33226288|NCT00365378|100728593|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
33226289|NCT00365378|100728594|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
33226290|NCT00365378|100728595|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
33226291|NCT00365378|100728593|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
33226292|NCT00365378|100728594|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
33226293|NCT00365378|100728595|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
33226294|NCT00365378|100728593|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
33226295|NCT00365378|100728594|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
33226296|NCT00365378|100728595|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
33226297|NCT00365378|100728593|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
33226298|NCT00365378|100728594|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
33226299|NCT00365378|100728595|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
33226300|NCT00365378|100728593|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
33226301|NCT00365378|100728594|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
33226302|NCT00365378|100728595|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
33226303|NCT00365378|100728593|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
33226304|NCT00365378|100728594|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
33226305|NCT00365378|100728595|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
33226306|NCT00365378|100728593|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
33226307|NCT00365378|100728594|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
33226308|NCT00365378|100728595|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
33417824|NCT02118896|101422247|FG000|Overall Study|Consent withdrawn|2|||
33417825|NCT02118896|101422248|FG001|Overall Study|Consent withdrawn|0|||
33417826|NCT02118896|101422249|FG002|Overall Study|Consent withdrawn|3|||
33417827|NCT02118896|101422250|FG003|Overall Study|Consent withdrawn|4|||
33417828|NCT02118896|101422251|FG004|Overall Study|Consent withdrawn|1|||
33417829|NCT02118896|101422252|FG005|Overall Study|Consent withdrawn|4|||
33569392|NCT02958865|101978240|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33226309|NCT00365378|100728593|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
33365657|NCT00958568|101227167|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
33365658|NCT00958568|101227168|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
33365659|NCT00958568|101227169|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
33365660|NCT00958568|101227166|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
33365661|NCT00958568|101227167|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
33226310|NCT00365378|100728594|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
33226311|NCT00365378|100728595|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
33226312|NCT00365378|100728593|FG000|Extension|Adverse Event|0|||
33365662|NCT00958568|101227168|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
33365663|NCT00958568|101227169|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
33569393|NCT02958865|101978241|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33226313|NCT00365378|100728594|FG001|Extension|Adverse Event|0|||
33226314|NCT00365378|100728595|FG002|Extension|Adverse Event|1|||
33226315|NCT00365378|100728593|FG000|Extension|Moved|0|||
33226316|NCT00365378|100728594|FG001|Extension|Moved|0|||
33226317|NCT00365378|100728595|FG002|Extension|Moved|8|||
33226318|NCT00365378|100728593|FG000|Extension|Lost to Follow-up|0|||
33226319|NCT00365378|100728594|FG001|Extension|Lost to Follow-up|0|||
33226320|NCT00365378|100728595|FG002|Extension|Lost to Follow-up|57|||
33226321|NCT00365378|100728593|FG000|Extension|Protocol Violation|0|||
33226322|NCT00365378|100728594|FG001|Extension|Protocol Violation|0|||
33226323|NCT00365378|100728595|FG002|Extension|Protocol Violation|2|||
33226324|NCT00365378|100728593|FG000|Extension|Withdrawal by Subject|0|||
33226325|NCT00365378|100728594|FG001|Extension|Withdrawal by Subject|0|||
33226326|NCT00365378|100728595|FG002|Extension|Withdrawal by Subject|98|||
33226327|NCT00365378|100728593|FG000|Extension|Other|0|||
33226328|NCT00365378|100728594|FG001|Extension|Other|0|||
33226329|NCT00365378|100728595|FG002|Extension|Other|31|||
33226330|NCT02344537|100728596|FG000|Overall Study|Protocol Violation|1|||
33226331|NCT02344537|100728597|FG001|Overall Study|Protocol Violation|1|||
33226332|NCT02344537|100728596|FG000|Overall Study|Subject started another treatment after wk 6|1|||
33226333|NCT02344537|100728597|FG001|Overall Study|Subject started another treatment after wk 6|0|||
33226334|NCT02344537|100728596|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
33226335|NCT02344537|100728597|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
33226336|NCT04035200|100728598|FG000|Overall Study|Lost to Follow-up|0|||
33226337|NCT04035200|100728599|FG001|Overall Study|Lost to Follow-up|1|||
33569394|NCT02958865|101978242|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33569395|NCT02958865|101978243|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33569396|NCT02958865|101978244|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33569397|NCT02958865|101978245|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33569398|NCT02958865|101978246|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33569399|NCT02958865|101978247|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33569400|NCT02958865|101978248|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33632299|NCT01394016|102205913|FG004|Overall Study|Progressive Disease|0|||
33632300|NCT01394016|102205914|FG005|Overall Study|Progressive Disease|0|||
33632301|NCT01394016|102205915|FG006|Overall Study|Progressive Disease|0|||
33632302|NCT01394016|102205916|FG007|Overall Study|Progressive Disease|0|||
33632303|NCT01394016|102205917|FG008|Overall Study|Progressive Disease|0|||
33632304|NCT01394016|102205918|FG009|Overall Study|Progressive Disease|0|||
33632305|NCT01394016|102205919|FG010|Overall Study|Progressive Disease|0|||
33632306|NCT01394016|102205920|FG011|Overall Study|Progressive Disease|0|||
33632307|NCT01394016|102205921|FG012|Overall Study|Progressive Disease|0|||
33632308|NCT01394016|102205922|FG013|Overall Study|Progressive Disease|0|||
33632309|NCT01394016|102205923|FG014|Overall Study|Progressive Disease|0|||
33632310|NCT01394016|102205924|FG015|Overall Study|Progressive Disease|0|||
33632311|NCT01394016|102205925|FG016|Overall Study|Progressive Disease|0|||
33632312|NCT01394016|102205926|FG017|Overall Study|Progressive Disease|0|||
33632313|NCT01394016|102205927|FG018|Overall Study|Progressive Disease|0|||
33632314|NCT01394016|102205909|FG000|Overall Study|Withdrawal by Subject|0|||
33632315|NCT01394016|102205910|FG001|Overall Study|Withdrawal by Subject|0|||
33632316|NCT01394016|102205911|FG002|Overall Study|Withdrawal by Subject|0|||
33632317|NCT01394016|102205912|FG003|Overall Study|Withdrawal by Subject|0|||
33632318|NCT01394016|102205913|FG004|Overall Study|Withdrawal by Subject|0|||
33632319|NCT01394016|102205914|FG005|Overall Study|Withdrawal by Subject|0|||
33632320|NCT01394016|102205915|FG006|Overall Study|Withdrawal by Subject|0|||
33632321|NCT01394016|102205916|FG007|Overall Study|Withdrawal by Subject|1|||
33226338|NCT04035200|100728600|FG002|Overall Study|Lost to Follow-up|0|||
33365664|NCT00958568|101227166|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
33365665|NCT00958568|101227167|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
33365666|NCT00958568|101227168|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
33365667|NCT00958568|101227169|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
33365668|NCT00958568|101227166|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
33365669|NCT00958568|101227167|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
33365670|NCT00958568|101227168|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
33365671|NCT00958568|101227169|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
33365672|NCT01753115|101227170|FG000|Overall Study|Lost to Follow-up|3|||
33365673|NCT01753115|101227171|FG001|Overall Study|Lost to Follow-up|6|||
33365674|NCT01753115|101227172|FG002|Overall Study|Lost to Follow-up|8|||
33365675|NCT01753115|101227170|FG000|Overall Study|Withdrawal by Subject|6|||
33365676|NCT01753115|101227171|FG001|Overall Study|Withdrawal by Subject|5|||
33569401|NCT02958865|101978249|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
33569402|NCT02958865|101978234|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
33569403|NCT02958865|101978235|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33569404|NCT02958865|101978236|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
33569405|NCT02958865|101978237|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
33569406|NCT02958865|101978238|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
33569407|NCT02958865|101978239|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
33569408|NCT02958865|101978240|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
33569409|NCT02958865|101978241|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33569410|NCT02958865|101978242|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33569411|NCT02958865|101978243|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33569412|NCT02958865|101978244|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33569413|NCT02958865|101978245|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33569414|NCT02958865|101978246|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33569415|NCT02958865|101978247|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33569416|NCT02958865|101978248|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33569417|NCT02958865|101978249|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33569418|NCT02958865|101978234|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33569419|NCT02958865|101978235|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33569420|NCT02958865|101978236|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33569421|NCT02958865|101978237|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
33569422|NCT02958865|101978238|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33569423|NCT02958865|101978239|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33569424|NCT02958865|101978240|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
33569425|NCT02958865|101978241|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33569426|NCT02958865|101978242|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33569427|NCT02958865|101978243|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33569428|NCT02958865|101978244|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33632322|NCT01394016|102205917|FG008|Overall Study|Withdrawal by Subject|1|||
33632323|NCT01394016|102205918|FG009|Overall Study|Withdrawal by Subject|1|||
33365677|NCT01753115|101227172|FG002|Overall Study|Withdrawal by Subject|6|||
33632324|NCT01394016|102205919|FG010|Overall Study|Withdrawal by Subject|4|||
33632325|NCT01394016|102205920|FG011|Overall Study|Withdrawal by Subject|0|||
33632326|NCT01394016|102205921|FG012|Overall Study|Withdrawal by Subject|0|||
33632327|NCT01394016|102205922|FG013|Overall Study|Withdrawal by Subject|3|||
33365678|NCT01753115|101227170|FG000|Overall Study|Subject non-compliant|3|||
33365679|NCT01753115|101227171|FG001|Overall Study|Subject non-compliant|3|||
33365680|NCT01753115|101227172|FG002|Overall Study|Subject non-compliant|0|||
33365681|NCT01753115|101227170|FG000|Overall Study|Used excluded drug|0|||
33365682|NCT01753115|101227171|FG001|Overall Study|Used excluded drug|1|||
33365683|NCT01753115|101227172|FG002|Overall Study|Used excluded drug|0|||
33365684|NCT02926573|101227182|FG000|Overall Study|Nausea|1|||
33365685|NCT02926573|101227183|FG001|Overall Study|Nausea|0|||
33365686|NCT02926573|101227182|FG000|Overall Study|Remain intubated|2|||
33417830|NCT02118896|101422253|FG006|Overall Study|Consent withdrawn|0|||
33417831|NCT02118896|101422254|FG007|Overall Study|Consent withdrawn|0|||
33226339|NCT04035200|100728598|FG000|Overall Study|Withdrawal by Subject|1|||
33226340|NCT04035200|100728599|FG001|Overall Study|Withdrawal by Subject|4|||
33226341|NCT04035200|100728600|FG002|Overall Study|Withdrawal by Subject|4|||
33226342|NCT04035200|100728598|FG000|Overall Study|COVID-19|1|||
33226343|NCT04035200|100728599|FG001|Overall Study|COVID-19|0|||
33226344|NCT04035200|100728600|FG002|Overall Study|COVID-19|0|||
33226345|NCT04035200|100728598|FG000|Overall Study|Early Termination|0|||
33226346|NCT04035200|100728599|FG001|Overall Study|Early Termination|1|||
33226347|NCT04035200|100728600|FG002|Overall Study|Early Termination|0|||
33226348|NCT04035200|100728598|FG000|Overall Study|Non-compliance|0|||
33226349|NCT04035200|100728599|FG001|Overall Study|Non-compliance|1|||
33226350|NCT04035200|100728600|FG002|Overall Study|Non-compliance|0|||
33226351|NCT00284141|100728601|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
33226352|NCT00284141|100728601|FG000|Overall Study|Adverse Event|19|||
33226353|NCT00284141|100728601|FG000|Overall Study|Participant's request|9|||
33226354|NCT00284141|100728601|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
33226355|NCT00284141|100728601|FG000|Overall Study|Clinical deterioration / death|2|||
33226356|NCT00284141|100728601|FG000|Overall Study|General decline|1|||
33226357|NCT00284141|100728601|FG000|Overall Study|Pneumonia|1|||
33226358|NCT00284141|100728601|FG000|Overall Study|Did not take study medication|2|||
33226359|NCT00284141|100728601|FG000|Overall Study|Ongoing treatment|2|||
33226360|NCT05674890|100728604|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
33226361|NCT05674890|100728605|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
33226362|NCT05674890|100728604|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
33226363|NCT05674890|100728605|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
33226364|NCT05674890|100728604|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
33226365|NCT05674890|100728605|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
33226366|NCT04170686|100728606|FG000|Screening|Physician Decision|12|||
33226367|NCT04170686|100728607|FG001|Screening|Physician Decision|13|||
33226368|NCT04170686|100728606|FG000|Randomization and Treatment|Lost to Follow-up|26|||
33226369|NCT04170686|100728607|FG001|Randomization and Treatment|Lost to Follow-up|15|||
33226370|NCT04954586|100728608|FG000|Overall Study|Withdrawal by Subject|5|||
33226371|NCT02041923|100728620|FG000|Overall Study|Lost to Follow-up|26|||
33226372|NCT02041923|100728621|FG001|Overall Study|Lost to Follow-up|30|||
33226373|NCT03328143|100728622|FG000|Overall Study|Declined|3|||
33226374|NCT03328143|100728622|FG000|Overall Study|Required increased sedation|4|||
33226375|NCT03328143|100728622|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
33226376|NCT03328143|100728622|FG000|Overall Study|Surgery cancelled|1|||
33226377|NCT00744263|100728623|FG000|Overall Study|Death|3006|||
33226378|NCT00744263|100728624|FG001|Overall Study|Death|3005|||
33226379|NCT00744263|100728623|FG000|Overall Study|Lost to Follow-up|2038|||
33417832|NCT02118896|101422255|FG008|Overall Study|Consent withdrawn|0|||
33417833|NCT02118896|101422256|FG009|Overall Study|Consent withdrawn|0|||
33569429|NCT02958865|101978245|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33569430|NCT02958865|101978246|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33569431|NCT02958865|101978247|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33569432|NCT02958865|101978248|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33569433|NCT02958865|101978249|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
33569434|NCT02958865|101978234|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33569435|NCT02958865|101978235|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33569436|NCT02958865|101978236|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
33569437|NCT02958865|101978237|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33569438|NCT02958865|101978238|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33569439|NCT02958865|101978239|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33226380|NCT00744263|100728624|FG001|Overall Study|Lost to Follow-up|2135|||
33226381|NCT00744263|100728623|FG000|Overall Study|Withdrawal by Subject|166|||
33226382|NCT00744263|100728624|FG001|Overall Study|Withdrawal by Subject|150|||
33226383|NCT00744263|100728623|FG000|Overall Study|Physician Decision|20|||
33226384|NCT00744263|100728624|FG001|Overall Study|Physician Decision|23|||
33365687|NCT02926573|101227183|FG001|Overall Study|Remain intubated|2|||
33365688|NCT02926573|101227182|FG000|Overall Study|Change in surgery plan|3|||
33365689|NCT02926573|101227183|FG001|Overall Study|Change in surgery plan|1|||
33365690|NCT02926573|101227182|FG000|Overall Study|Change to outpatient status|5|||
33365691|NCT02926573|101227183|FG001|Overall Study|Change to outpatient status|1|||
33365692|NCT02926573|101227182|FG000|Overall Study|Withdrawal by Subject|0|||
33365693|NCT02926573|101227183|FG001|Overall Study|Withdrawal by Subject|2|||
33365694|NCT02926573|101227182|FG000|Overall Study|Return to operating room|0|||
33365695|NCT02926573|101227183|FG001|Overall Study|Return to operating room|2|||
33417834|NCT02118896|101422247|FG000|Overall Study|Non-compliance|2|||
33417835|NCT02118896|101422248|FG001|Overall Study|Non-compliance|1|||
33417836|NCT02118896|101422249|FG002|Overall Study|Non-compliance|1|||
33417837|NCT02118896|101422250|FG003|Overall Study|Non-compliance|5|||
33417838|NCT02118896|101422251|FG004|Overall Study|Non-compliance|0|||
33226385|NCT00744263|100728623|FG000|Overall Study|Protocol Violation|3|||
33226386|NCT00744263|100728624|FG001|Overall Study|Protocol Violation|5|||
33417839|NCT02118896|101422252|FG005|Overall Study|Non-compliance|1|||
33417840|NCT02118896|101422253|FG006|Overall Study|Non-compliance|0|||
33417841|NCT02118896|101422254|FG007|Overall Study|Non-compliance|1|||
33417842|NCT02118896|101422255|FG008|Overall Study|Non-compliance|0|||
33417843|NCT02118896|101422256|FG009|Overall Study|Non-compliance|0|||
33417844|NCT02118896|101422247|FG000|Overall Study|Pregnancy|1|||
33417845|NCT02118896|101422248|FG001|Overall Study|Pregnancy|1|||
33417846|NCT02118896|101422249|FG002|Overall Study|Pregnancy|0|||
33417847|NCT02118896|101422250|FG003|Overall Study|Pregnancy|0|||
33417848|NCT02118896|101422251|FG004|Overall Study|Pregnancy|1|||
33417849|NCT02118896|101422252|FG005|Overall Study|Pregnancy|3|||
33417850|NCT02118896|101422253|FG006|Overall Study|Pregnancy|1|||
33417851|NCT02118896|101422254|FG007|Overall Study|Pregnancy|0|||
33417852|NCT02118896|101422255|FG008|Overall Study|Pregnancy|0|||
33417853|NCT02118896|101422256|FG009|Overall Study|Pregnancy|0|||
33417854|NCT02118896|101422247|FG000|Overall Study|Lost to Follow-up|1|||
33417855|NCT02118896|101422248|FG001|Overall Study|Lost to Follow-up|2|||
33417856|NCT02118896|101422249|FG002|Overall Study|Lost to Follow-up|1|||
33417857|NCT02118896|101422250|FG003|Overall Study|Lost to Follow-up|0|||
33417858|NCT02118896|101422251|FG004|Overall Study|Lost to Follow-up|2|||
33417859|NCT02118896|101422252|FG005|Overall Study|Lost to Follow-up|1|||
33417860|NCT02118896|101422253|FG006|Overall Study|Lost to Follow-up|0|||
33417861|NCT02118896|101422254|FG007|Overall Study|Lost to Follow-up|0|||
33417862|NCT02118896|101422255|FG008|Overall Study|Lost to Follow-up|0|||
33417863|NCT02118896|101422256|FG009|Overall Study|Lost to Follow-up|0|||
33417864|NCT02118896|101422247|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
33417865|NCT02118896|101422248|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
33417866|NCT02118896|101422249|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
33417867|NCT02118896|101422250|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
33417868|NCT02118896|101422251|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
33417869|NCT02118896|101422252|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
33417870|NCT02118896|101422253|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
33417871|NCT02118896|101422254|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
33417872|NCT02118896|101422255|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
33417873|NCT02118896|101422256|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
33417874|NCT02118896|101422247|FG000|Overall Study|Prohibited medication|0|||
33417875|NCT02118896|101422248|FG001|Overall Study|Prohibited medication|0|||
33417876|NCT02118896|101422249|FG002|Overall Study|Prohibited medication|0|||
33417877|NCT02118896|101422250|FG003|Overall Study|Prohibited medication|0|||
33417878|NCT02118896|101422251|FG004|Overall Study|Prohibited medication|1|||
33417879|NCT02118896|101422252|FG005|Overall Study|Prohibited medication|3|||
33417880|NCT02118896|101422253|FG006|Overall Study|Prohibited medication|0|||
33417881|NCT02118896|101422254|FG007|Overall Study|Prohibited medication|0|||
33417882|NCT02118896|101422255|FG008|Overall Study|Prohibited medication|0|||
33417883|NCT02118896|101422256|FG009|Overall Study|Prohibited medication|0|||
33417884|NCT02118896|101422247|FG000|Overall Study|Miscellaneous|1|||
33569440|NCT02958865|101978240|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33226387|NCT00744263|100728623|FG000|Overall Study|Adverse Event|1|||
33365696|NCT02926573|101227182|FG000|Overall Study|Delirium|0|||
33417885|NCT02118896|101422248|FG001|Overall Study|Miscellaneous|2|||
33417886|NCT02118896|101422249|FG002|Overall Study|Miscellaneous|0|||
33417887|NCT02118896|101422250|FG003|Overall Study|Miscellaneous|2|||
33417888|NCT02118896|101422251|FG004|Overall Study|Miscellaneous|0|||
33417889|NCT02118896|101422252|FG005|Overall Study|Miscellaneous|4|||
33417890|NCT02118896|101422253|FG006|Overall Study|Miscellaneous|0|||
33417891|NCT02118896|101422254|FG007|Overall Study|Miscellaneous|0|||
33417892|NCT02118896|101422255|FG008|Overall Study|Miscellaneous|0|||
33417893|NCT02118896|101422256|FG009|Overall Study|Miscellaneous|0|||
33417894|NCT05604521|101422257|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
33226388|NCT00744263|100728624|FG001|Overall Study|Adverse Event|0|||
33226389|NCT00744263|100728623|FG000|Overall Study|Other|2|||
33365697|NCT02926573|101227183|FG001|Overall Study|Delirium|1|||
33417895|NCT05604521|101422258|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
33632328|NCT01394016|102205923|FG014|Overall Study|Withdrawal by Subject|1|||
33632329|NCT01394016|102205924|FG015|Overall Study|Withdrawal by Subject|3|||
33632330|NCT01394016|102205925|FG016|Overall Study|Withdrawal by Subject|1|||
33632331|NCT01394016|102205926|FG017|Overall Study|Withdrawal by Subject|1|||
33632332|NCT01394016|102205927|FG018|Overall Study|Withdrawal by Subject|2|||
33632333|NCT01394016|102205909|FG000|Overall Study|Adverse Event|0|||
33632334|NCT01394016|102205910|FG001|Overall Study|Adverse Event|0|||
33632335|NCT01394016|102205911|FG002|Overall Study|Adverse Event|0|||
33632336|NCT01394016|102205912|FG003|Overall Study|Adverse Event|0|||
33632337|NCT01394016|102205913|FG004|Overall Study|Adverse Event|0|||
33632338|NCT01394016|102205914|FG005|Overall Study|Adverse Event|0|||
33632339|NCT01394016|102205915|FG006|Overall Study|Adverse Event|0|||
33632340|NCT01394016|102205916|FG007|Overall Study|Adverse Event|0|||
33632341|NCT01394016|102205917|FG008|Overall Study|Adverse Event|0|||
33632342|NCT01394016|102205918|FG009|Overall Study|Adverse Event|1|||
33632343|NCT01394016|102205919|FG010|Overall Study|Adverse Event|0|||
33569441|NCT02958865|101978241|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33569442|NCT02958865|101978242|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33569443|NCT02958865|101978243|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33569444|NCT02958865|101978244|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33569445|NCT02958865|101978245|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33569446|NCT02958865|101978246|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33569447|NCT02958865|101978247|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33569448|NCT02958865|101978248|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33569449|NCT02958865|101978249|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
33569450|NCT02958865|101978234|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
33569451|NCT02958865|101978235|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
33569452|NCT02958865|101978236|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
33569453|NCT02958865|101978237|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33569454|NCT02958865|101978238|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33569455|NCT02958865|101978239|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33569456|NCT02958865|101978240|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33569457|NCT02958865|101978241|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33365698|NCT02834403|101227186|FG000|Overall Study|Physician Decision|2|||
33365699|NCT02834403|101227187|FG001|Overall Study|Physician Decision|1|||
33365700|NCT02834403|101227188|FG002|Overall Study|Physician Decision|2|||
33365701|NCT02834403|101227189|FG003|Overall Study|Physician Decision|1|||
33365702|NCT02834403|101227190|FG004|Overall Study|Physician Decision|1|||
33365703|NCT02834403|101227191|FG005|Overall Study|Physician Decision|2|||
33365704|NCT02834403|101227192|FG006|Overall Study|Physician Decision|12|||
33365705|NCT02834403|101227186|FG000|Overall Study|Adverse Event|0|||
33365706|NCT02834403|101227187|FG001|Overall Study|Adverse Event|0|||
33365707|NCT02834403|101227188|FG002|Overall Study|Adverse Event|0|||
33365708|NCT02834403|101227189|FG003|Overall Study|Adverse Event|0|||
33365709|NCT02834403|101227190|FG004|Overall Study|Adverse Event|1|||
33365710|NCT02834403|101227191|FG005|Overall Study|Adverse Event|1|||
33365711|NCT02834403|101227192|FG006|Overall Study|Adverse Event|3|||
33365712|NCT02834403|101227186|FG000|Overall Study|Withdrawal by Subject|0|||
33365713|NCT02834403|101227187|FG001|Overall Study|Withdrawal by Subject|1|||
33365714|NCT02834403|101227188|FG002|Overall Study|Withdrawal by Subject|0|||
33365715|NCT02834403|101227189|FG003|Overall Study|Withdrawal by Subject|0|||
33365716|NCT02834403|101227190|FG004|Overall Study|Withdrawal by Subject|1|||
33365717|NCT02834403|101227191|FG005|Overall Study|Withdrawal by Subject|0|||
33365718|NCT02834403|101227192|FG006|Overall Study|Withdrawal by Subject|0|||
33365719|NCT02834403|101227186|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
33569458|NCT02958865|101978242|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33569459|NCT02958865|101978243|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33569460|NCT02958865|101978244|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33569461|NCT02958865|101978245|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33569462|NCT02958865|101978246|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33569463|NCT02958865|101978247|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33632344|NCT01394016|102205920|FG011|Overall Study|Adverse Event|0|||
33632345|NCT01394016|102205921|FG012|Overall Study|Adverse Event|0|||
33632346|NCT01394016|102205922|FG013|Overall Study|Adverse Event|0|||
33632347|NCT01394016|102205923|FG014|Overall Study|Adverse Event|0|||
33632348|NCT01394016|102205924|FG015|Overall Study|Adverse Event|0|||
33632349|NCT01394016|102205925|FG016|Overall Study|Adverse Event|1|||
33365720|NCT02834403|101227187|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
33365721|NCT02834403|101227188|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
33365722|NCT02834403|101227189|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
33365723|NCT02834403|101227190|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
33417896|NCT05604521|101422257|FG000|Overall Study|Adverse Event|1|||
33569464|NCT02958865|101978248|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33569465|NCT02958865|101978249|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33569466|NCT02958865|101978234|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
33365724|NCT02834403|101227191|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
33365725|NCT02834403|101227192|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
33365726|NCT01070550|101227193|FG000|Overall Study|Adverse Event|43|||
33365727|NCT01070550|101227194|FG001|Overall Study|Adverse Event|1|||
33365728|NCT01070550|101227195|FG002|Overall Study|Adverse Event|3|||
33365729|NCT01070550|101227196|FG003|Overall Study|Adverse Event|0|||
33365730|NCT01070550|101227197|FG004|Overall Study|Adverse Event|0|||
33365731|NCT01070550|101227198|FG005|Overall Study|Adverse Event|0|||
33365732|NCT01070550|101227193|FG000|Overall Study|Death|20|||
33365733|NCT01070550|101227194|FG001|Overall Study|Death|4|||
33365734|NCT01070550|101227195|FG002|Overall Study|Death|3|||
33569467|NCT02958865|101978235|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
33569468|NCT02958865|101978236|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
33569469|NCT02958865|101978237|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
33632350|NCT01394016|102205926|FG017|Overall Study|Adverse Event|1|||
33632351|NCT01394016|102205927|FG018|Overall Study|Adverse Event|0|||
33632352|NCT01394016|102205909|FG000|Overall Study|Sponsor Decision|0|||
33632353|NCT01394016|102205910|FG001|Overall Study|Sponsor Decision|0|||
33632354|NCT01394016|102205911|FG002|Overall Study|Sponsor Decision|0|||
33632355|NCT01394016|102205912|FG003|Overall Study|Sponsor Decision|0|||
33632356|NCT01394016|102205913|FG004|Overall Study|Sponsor Decision|0|||
33632357|NCT01394016|102205914|FG005|Overall Study|Sponsor Decision|0|||
33632358|NCT01394016|102205915|FG006|Overall Study|Sponsor Decision|0|||
33632359|NCT01394016|102205916|FG007|Overall Study|Sponsor Decision|0|||
33632360|NCT01394016|102205917|FG008|Overall Study|Sponsor Decision|0|||
33632361|NCT01394016|102205918|FG009|Overall Study|Sponsor Decision|0|||
33632362|NCT01394016|102205919|FG010|Overall Study|Sponsor Decision|0|||
33632363|NCT01394016|102205920|FG011|Overall Study|Sponsor Decision|0|||
33632364|NCT01394016|102205921|FG012|Overall Study|Sponsor Decision|1|||
33632365|NCT01394016|102205922|FG013|Overall Study|Sponsor Decision|0|||
33632366|NCT01394016|102205923|FG014|Overall Study|Sponsor Decision|0|||
33632367|NCT01394016|102205924|FG015|Overall Study|Sponsor Decision|0|||
33632368|NCT01394016|102205925|FG016|Overall Study|Sponsor Decision|0|||
33632369|NCT01394016|102205926|FG017|Overall Study|Sponsor Decision|0|||
33632370|NCT01394016|102205927|FG018|Overall Study|Sponsor Decision|0|||
33632371|NCT01394016|102205909|FG000|Overall Study|Lost to Follow-up|0|||
33632372|NCT01394016|102205910|FG001|Overall Study|Lost to Follow-up|0|||
33632373|NCT01394016|102205911|FG002|Overall Study|Lost to Follow-up|0|||
33632374|NCT01394016|102205912|FG003|Overall Study|Lost to Follow-up|0|||
33569470|NCT02958865|101978238|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
33569471|NCT02958865|101978239|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
33569472|NCT02958865|101978240|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
33569473|NCT02958865|101978241|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
33569474|NCT02958865|101978242|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
33569475|NCT02958865|101978243|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
33569476|NCT02958865|101978244|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
33569477|NCT02958865|101978245|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
33569478|NCT02958865|101978246|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
33569479|NCT02958865|101978247|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
33569480|NCT02958865|101978248|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
33569481|NCT02958865|101978249|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
33569482|NCT02958865|101978234|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33569483|NCT02958865|101978235|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33569484|NCT02958865|101978236|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33569485|NCT02958865|101978237|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33569486|NCT02958865|101978238|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
33569487|NCT02958865|101978239|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33569488|NCT02958865|101978240|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33632375|NCT01394016|102205913|FG004|Overall Study|Lost to Follow-up|0|||
33632376|NCT01394016|102205914|FG005|Overall Study|Lost to Follow-up|0|||
33632377|NCT01394016|102205915|FG006|Overall Study|Lost to Follow-up|0|||
33632378|NCT01394016|102205916|FG007|Overall Study|Lost to Follow-up|0|||
33632379|NCT01394016|102205917|FG008|Overall Study|Lost to Follow-up|0|||
33632380|NCT01394016|102205918|FG009|Overall Study|Lost to Follow-up|0|||
33632381|NCT01394016|102205919|FG010|Overall Study|Lost to Follow-up|0|||
33365735|NCT01070550|101227196|FG003|Overall Study|Death|0|||
33365736|NCT01070550|101227197|FG004|Overall Study|Death|0|||
33365737|NCT01070550|101227198|FG005|Overall Study|Death|0|||
33569489|NCT02958865|101978241|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33569490|NCT02958865|101978242|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33632382|NCT01394016|102205920|FG011|Overall Study|Lost to Follow-up|0|||
33632383|NCT01394016|102205921|FG012|Overall Study|Lost to Follow-up|0|||
33417897|NCT05604521|101422258|FG001|Overall Study|Adverse Event|0|||
33417898|NCT00414011|101422262|FG000|Overall Study|Physician Decision|3|||
33417899|NCT00414011|101422262|FG000|Overall Study|Withdrawal by Subject|2|||
33417900|NCT04682639|101422264|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
33569491|NCT02958865|101978243|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33569492|NCT02958865|101978244|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33569493|NCT02958865|101978245|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33569494|NCT02958865|101978246|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33569495|NCT02958865|101978247|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33569496|NCT02958865|101978248|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33569497|NCT02958865|101978249|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33569498|NCT02958865|101978234|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33569499|NCT02958865|101978235|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33569500|NCT02958865|101978236|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33569501|NCT02958865|101978237|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33569502|NCT02958865|101978238|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33569503|NCT02958865|101978239|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33569504|NCT02958865|101978240|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33569505|NCT02958865|101978241|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
33569506|NCT02958865|101978242|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
33569507|NCT02958865|101978243|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
33569508|NCT02958865|101978244|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
33569509|NCT02958865|101978245|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
33569510|NCT02958865|101978246|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
33569511|NCT02958865|101978247|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
33569512|NCT02958865|101978248|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
33569513|NCT02958865|101978249|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
33569514|NCT02958865|101978234|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33569515|NCT02958865|101978235|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33569516|NCT02958865|101978236|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33569517|NCT02958865|101978237|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33569518|NCT02958865|101978238|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33569519|NCT02958865|101978239|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33569520|NCT02958865|101978240|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33569521|NCT02958865|101978241|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33569522|NCT02958865|101978242|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
33569523|NCT02958865|101978243|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
33569524|NCT02958865|101978244|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33569525|NCT02958865|101978245|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
33569526|NCT02958865|101978246|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33569527|NCT02958865|101978247|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
33569528|NCT02958865|101978248|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
33569529|NCT02958865|101978249|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
33569530|NCT02958865|101978234|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33569531|NCT02958865|101978235|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33569532|NCT02958865|101978236|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33569533|NCT02958865|101978237|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33569534|NCT02958865|101978238|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33569535|NCT02958865|101978239|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33569536|NCT02958865|101978240|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33569537|NCT02958865|101978241|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33569538|NCT02958865|101978242|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33569539|NCT02958865|101978243|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
33569540|NCT02958865|101978244|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33569541|NCT02958865|101978245|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33417901|NCT04682639|101422265|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
33569542|NCT02958865|101978246|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33569543|NCT02958865|101978247|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33569544|NCT02958865|101978248|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
33569545|NCT02958865|101978249|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
33632384|NCT01394016|102205922|FG013|Overall Study|Lost to Follow-up|0|||
33226390|NCT00744263|100728624|FG001|Overall Study|Other|2|||
33226391|NCT02961374|100728627|FG000|Overall Study|Adverse Event|4|||
33417902|NCT04682639|101422266|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
33569546|NCT02958865|101978234|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33569547|NCT02958865|101978235|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33569548|NCT02958865|101978236|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33569549|NCT02958865|101978237|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33569550|NCT02958865|101978238|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33569551|NCT02958865|101978239|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33365738|NCT01070550|101227193|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
33365739|NCT01070550|101227194|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
33365740|NCT01070550|101227195|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
33365741|NCT01070550|101227196|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
33365742|NCT01070550|101227197|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
33365743|NCT01070550|101227198|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
33365744|NCT01070550|101227193|FG000|Overall Study|Early termination|3|||
33569552|NCT02958865|101978240|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33569553|NCT02958865|101978241|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33569554|NCT02958865|101978242|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33569555|NCT02958865|101978243|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33569556|NCT02958865|101978244|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
33569557|NCT02958865|101978245|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
33569558|NCT02958865|101978246|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
33569559|NCT02958865|101978247|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
33569560|NCT02958865|101978248|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
33569561|NCT02958865|101978249|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
33569562|NCT02958865|101978234|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
33569563|NCT02958865|101978235|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
33569564|NCT02958865|101978236|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
33226392|NCT01734434|100728630|FG000|Overall Study|Death Infant|3|||
33226393|NCT01734434|100728631|FG001|Overall Study|Death Infant|1|||
33226394|NCT01734434|100728632|FG002|Overall Study|Death Infant|17|||
33226395|NCT01734434|100728633|FG003|Overall Study|Death Infant|5|||
33226396|NCT01734434|100728630|FG000|Overall Study|Lost to Follow-up|2|||
33226397|NCT01734434|100728631|FG001|Overall Study|Lost to Follow-up|9|||
33226398|NCT01734434|100728632|FG002|Overall Study|Lost to Follow-up|67|||
33226399|NCT01734434|100728633|FG003|Overall Study|Lost to Follow-up|11|||
33226400|NCT01734434|100728630|FG000|Overall Study|No Live Birth|1|||
33226401|NCT01734434|100728631|FG001|Overall Study|No Live Birth|2|||
33569565|NCT02958865|101978237|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
33569566|NCT02958865|101978238|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
33569567|NCT02958865|101978239|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
33569568|NCT02958865|101978240|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
33569569|NCT02958865|101978241|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
33569570|NCT02958865|101978242|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
33226402|NCT01734434|100728632|FG002|Overall Study|No Live Birth|32|||
33226403|NCT01734434|100728633|FG003|Overall Study|No Live Birth|6|||
33226404|NCT01734434|100728630|FG000|Overall Study|Withdrawal by Subject|4|||
33226405|NCT01734434|100728631|FG001|Overall Study|Withdrawal by Subject|0|||
33226406|NCT01734434|100728632|FG002|Overall Study|Withdrawal by Subject|8|||
33226407|NCT01734434|100728633|FG003|Overall Study|Withdrawal by Subject|1|||
33365745|NCT01070550|101227194|FG001|Overall Study|Early termination|0|||
33569571|NCT02958865|101978243|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
33569572|NCT02958865|101978244|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
33569573|NCT02958865|101978245|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
33569574|NCT02958865|101978246|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
33569575|NCT02958865|101978247|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
33632385|NCT01394016|102205923|FG014|Overall Study|Lost to Follow-up|0|||
33632386|NCT01394016|102205924|FG015|Overall Study|Lost to Follow-up|0|||
33632387|NCT01394016|102205925|FG016|Overall Study|Lost to Follow-up|0|||
33226408|NCT01734434|100728630|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
33226409|NCT01734434|100728631|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
33632388|NCT01394016|102205926|FG017|Overall Study|Lost to Follow-up|0|||
33632389|NCT01394016|102205927|FG018|Overall Study|Lost to Follow-up|1|||
33632390|NCT01474317|102205941|FG000|Overall Study|Adverse Event|1|||
33632391|NCT01474317|102205941|FG000|Overall Study|Subject ineligible for study|1|||
33632392|NCT04583618|102205944|FG000|Overall Study|Adverse Event|0|||
33632393|NCT04583618|102205945|FG001|Overall Study|Adverse Event|0|||
33632394|NCT04583618|102205946|FG002|Overall Study|Adverse Event|1|||
33632395|NCT04583618|102205947|FG003|Overall Study|Adverse Event|0|||
33632396|NCT04583618|102205948|FG004|Overall Study|Adverse Event|0|||
33632397|NCT04583618|102205944|FG000|Overall Study|Protocol deviation|1|||
33632398|NCT04583618|102205945|FG001|Overall Study|Protocol deviation|1|||
33632399|NCT04583618|102205946|FG002|Overall Study|Protocol deviation|1|||
33632400|NCT04583618|102205947|FG003|Overall Study|Protocol deviation|0|||
33226410|NCT01734434|100728632|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
33226411|NCT01734434|100728633|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
33226412|NCT01734434|100728630|FG000|Overall Study|Subject Not Reachable|0|||
33226413|NCT01734434|100728631|FG001|Overall Study|Subject Not Reachable|0|||
33226414|NCT01734434|100728632|FG002|Overall Study|Subject Not Reachable|1|||
33632401|NCT04583618|102205948|FG004|Overall Study|Protocol deviation|0|||
33226415|NCT01734434|100728633|FG003|Overall Study|Subject Not Reachable|0|||
33632402|NCT04583618|102205944|FG000|Overall Study|Withdrawal by Subject|2|||
33417903|NCT04682639|101422267|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
33417904|NCT04682639|101422268|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
33417905|NCT04682639|101422264|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
33569576|NCT02958865|101978248|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
33569577|NCT02958865|101978249|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
33569578|NCT02958865|101978234|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569579|NCT02958865|101978235|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569580|NCT02958865|101978236|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569581|NCT02958865|101978237|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569582|NCT02958865|101978238|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569583|NCT02958865|101978239|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569584|NCT02958865|101978240|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569585|NCT02958865|101978241|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569586|NCT02958865|101978242|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569587|NCT02958865|101978243|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569588|NCT02958865|101978244|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569589|NCT02958865|101978245|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569590|NCT02958865|101978246|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569591|NCT02958865|101978247|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
33569592|NCT02958865|101978248|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569593|NCT02958865|101978249|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
33569594|NCT02958865|101978234|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33569595|NCT02958865|101978235|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33632403|NCT04583618|102205945|FG001|Overall Study|Withdrawal by Subject|1|||
33632404|NCT04583618|102205946|FG002|Overall Study|Withdrawal by Subject|3|||
33417906|NCT04682639|101422265|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
33417907|NCT04682639|101422266|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
33417908|NCT04682639|101422267|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33417909|NCT04682639|101422268|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33417910|NCT04682639|101422264|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
33569596|NCT02958865|101978236|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33569597|NCT02958865|101978237|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33569598|NCT02958865|101978238|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33417911|NCT04682639|101422265|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
33226416|NCT01734434|100728630|FG000|Overall Study|Treatment Defaulter|0|||
33226417|NCT01734434|100728631|FG001|Overall Study|Treatment Defaulter|0|||
33226418|NCT01734434|100728632|FG002|Overall Study|Treatment Defaulter|1|||
33226419|NCT01734434|100728633|FG003|Overall Study|Treatment Defaulter|0|||
33226420|NCT01734434|100728630|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
33226421|NCT01734434|100728631|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
33226422|NCT01734434|100728632|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
33226423|NCT01734434|100728633|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
33226424|NCT01734434|100728630|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
33226425|NCT01734434|100728631|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
33226426|NCT01734434|100728632|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
33226427|NCT01734434|100728633|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
33226428|NCT01083641|100728634|FG000|Overall Study|Withdrawal by Subject|2|||
33226429|NCT02966002|100728635|FG000|Overall Study|Withdrawal by Subject|2|||
33226430|NCT02966002|100728635|FG000|Overall Study|Adverse Event|1|||
33417912|NCT04682639|101422266|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33417913|NCT04682639|101422267|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33226431|NCT02966002|100728635|FG000|Overall Study|Lost to Follow-up|1|||
33226432|NCT00622713|100728638|FG000|Overall Study|Adverse Event|35|||
33226433|NCT00622713|100728638|FG000|Overall Study|Administrative problems|4|||
33632405|NCT04583618|102205947|FG003|Overall Study|Withdrawal by Subject|1|||
33632406|NCT04583618|102205948|FG004|Overall Study|Withdrawal by Subject|1|||
33632407|NCT04583618|102205944|FG000|Overall Study|Lost to Follow-up|0|||
33417914|NCT04682639|101422268|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33417915|NCT04682639|101422264|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
33569599|NCT02958865|101978239|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33569600|NCT02958865|101978240|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33569601|NCT02958865|101978241|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33569602|NCT02958865|101978242|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33569603|NCT02958865|101978243|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33569604|NCT02958865|101978244|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33569605|NCT02958865|101978245|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33569606|NCT02958865|101978246|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33569607|NCT02958865|101978247|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
33569608|NCT02958865|101978248|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33569609|NCT02958865|101978249|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
33569610|NCT02958865|101978234|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569611|NCT02958865|101978235|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569612|NCT02958865|101978236|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569613|NCT02958865|101978237|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569614|NCT02958865|101978238|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569615|NCT02958865|101978239|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569616|NCT02958865|101978240|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569617|NCT02958865|101978241|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569618|NCT02958865|101978242|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569619|NCT02958865|101978243|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
33569620|NCT02958865|101978244|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569621|NCT02958865|101978245|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569622|NCT02958865|101978246|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569623|NCT02958865|101978247|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569624|NCT02958865|101978248|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569625|NCT02958865|101978249|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
33569626|NCT02415556|101978250|FG000|Overall Study|Adverse Event|3|||
33365746|NCT01070550|101227195|FG002|Overall Study|Early termination|0|||
33632408|NCT04583618|102205945|FG001|Overall Study|Lost to Follow-up|1|||
33632409|NCT04583618|102205946|FG002|Overall Study|Lost to Follow-up|3|||
33632410|NCT04583618|102205947|FG003|Overall Study|Lost to Follow-up|1|||
33632411|NCT04583618|102205948|FG004|Overall Study|Lost to Follow-up|1|||
33632412|NCT04272242|102205949|FG000|Overall Study|Withdrawal by Subject|3|||
33632413|NCT04272242|102205949|FG000|Overall Study|Lost to Follow-up|1|||
33632414|NCT04272242|102205949|FG000|Overall Study|Adverse Event|1|||
33632415|NCT04163341|102205955|FG000|Overall Study|Withdrawal by Subject|2|||
33632416|NCT04163341|102205956|FG001|Overall Study|Withdrawal by Subject|0|||
33632417|NCT04163341|102205955|FG000|Overall Study|Lost to Follow-up|3|||
33632418|NCT04163341|102205956|FG001|Overall Study|Lost to Follow-up|4|||
33632419|NCT01056822|102205957|FG000|Overall Study|Adverse Event|0|||
33632420|NCT01056822|102205958|FG001|Overall Study|Adverse Event|1|||
33632421|NCT01056822|102205957|FG000|Overall Study|Protocol Violation|6|||
33632422|NCT01056822|102205958|FG001|Overall Study|Protocol Violation|5|||
33632423|NCT01056822|102205957|FG000|Overall Study|Withdrawal by Subject|1|||
33632424|NCT01056822|102205958|FG001|Overall Study|Withdrawal by Subject|1|||
33632425|NCT01056822|102205957|FG000|Overall Study|Lost to Follow-up|1|||
33632426|NCT01056822|102205958|FG001|Overall Study|Lost to Follow-up|0|||
33569627|NCT02415556|101978251|FG001|Overall Study|Adverse Event|4|||
33569628|NCT02415556|101978252|FG002|Overall Study|Adverse Event|2|||
33632427|NCT05082857|102205959|FG000|Overall Study|participants relocated and could not continue|2|||
33632428|NCT05082857|102205960|FG001|Overall Study|participants relocated and could not continue|1|||
33632429|NCT05082857|102205959|FG000|Overall Study|Lost to Follow-up|1|||
33632430|NCT05082857|102205960|FG001|Overall Study|Lost to Follow-up|3|||
33569629|NCT02415556|101978253|FG003|Overall Study|Adverse Event|4|||
33569630|NCT02415556|101978250|FG000|Overall Study|Lost to Follow-up|4|||
33569631|NCT02415556|101978251|FG001|Overall Study|Lost to Follow-up|5|||
33569632|NCT02415556|101978252|FG002|Overall Study|Lost to Follow-up|4|||
33569633|NCT02415556|101978253|FG003|Overall Study|Lost to Follow-up|1|||
33569634|NCT02415556|101978250|FG000|Overall Study|Withdrawal by Subject|13|||
33632431|NCT04825678|102205961|FG000|Overall Study|Decision by Sponsor|2|||
33632432|NCT04825678|102205962|FG001|Overall Study|Decision by Sponsor|3|||
33632433|NCT04825678|102205961|FG000|Overall Study|Withdrawal of Consent From Study|7|||
33632434|NCT04825678|102205962|FG001|Overall Study|Withdrawal of Consent From Study|9|||
33632435|NCT04825678|102205961|FG000|Overall Study|Lost to Follow-up|3|||
33632436|NCT04825678|102205962|FG001|Overall Study|Lost to Follow-up|4|||
33632437|NCT04825678|102205961|FG000|Overall Study|Never Received Investigational Product|1|||
33632438|NCT04825678|102205962|FG001|Overall Study|Never Received Investigational Product|1|||
33365747|NCT01070550|101227196|FG003|Overall Study|Early termination|0|||
33365748|NCT01070550|101227197|FG004|Overall Study|Early termination|0|||
33632439|NCT04914364|102205963|FG000|Overall Study|No longer eligible for study|1|||
33365749|NCT01070550|101227198|FG005|Overall Study|Early termination|0|||
33569635|NCT02415556|101978251|FG001|Overall Study|Withdrawal by Subject|4|||
33569636|NCT02415556|101978252|FG002|Overall Study|Withdrawal by Subject|14|||
33569637|NCT02415556|101978253|FG003|Overall Study|Withdrawal by Subject|12|||
33632440|NCT04914364|102205963|FG000|Overall Study|Lost to Follow-up|2|||
33632441|NCT01074970|102205967|FG000|Overall Study|Never Treated|0|||
33632442|NCT01074970|102205968|FG001|Overall Study|Never Treated|0|||
33632443|NCT01074970|102205969|FG002|Overall Study|Never Treated|8|||
33632444|NCT01074970|102205970|FG003|Overall Study|Never Treated|1|||
33632445|NCT01074970|102205967|FG000|Overall Study|Adverse Event|1|||
33632446|NCT01074970|102205968|FG001|Overall Study|Adverse Event|0|||
33632447|NCT01074970|102205969|FG002|Overall Study|Adverse Event|4|||
33632448|NCT01074970|102205970|FG003|Overall Study|Adverse Event|3|||
33632449|NCT01074970|102205967|FG000|Overall Study|Disease progression during treatment|3|||
33632450|NCT01074970|102205968|FG001|Overall Study|Disease progression during treatment|1|||
33632451|NCT01074970|102205969|FG002|Overall Study|Disease progression during treatment|2|||
33632452|NCT01074970|102205970|FG003|Overall Study|Disease progression during treatment|9|||
33632453|NCT01074970|102205967|FG000|Overall Study|Lost to Follow-up|0|||
33632454|NCT01074970|102205968|FG001|Overall Study|Lost to Follow-up|0|||
33632455|NCT01074970|102205969|FG002|Overall Study|Lost to Follow-up|1|||
33632456|NCT01074970|102205970|FG003|Overall Study|Lost to Follow-up|0|||
33632457|NCT01074970|102205967|FG000|Overall Study|Withdrawal by Subject|0|||
33632458|NCT01074970|102205968|FG001|Overall Study|Withdrawal by Subject|0|||
33632459|NCT01074970|102205969|FG002|Overall Study|Withdrawal by Subject|6|||
33632460|NCT01074970|102205970|FG003|Overall Study|Withdrawal by Subject|4|||
33632461|NCT00904969|102205973|FG000|Overall Study|Lost to Follow-up|4|||
33632462|NCT00904969|102205973|FG000|Overall Study|Withdrawal by Subject|3|||
33632463|NCT00904969|102205973|FG000|Overall Study|Additional Treatments|11|||
33632464|NCT00904969|102205973|FG000|Overall Study|Case Aborted; Subject Exited|1|||
33632465|NCT02681523|102205975|FG000|Overall Study|Adverse Event|1|||
33632466|NCT02681523|102205975|FG000|Overall Study|Patient Non-compliance|1|||
33632467|NCT05228470|102205983|FG000|Overall Study|Death|6|||
33632468|NCT05228470|102205984|FG001|Overall Study|Death|11|||
33632469|NCT05228470|102205983|FG000|Overall Study|Withdrawal by Subject|1|||
33569638|NCT02415556|101978250|FG000|Overall Study|Physician Decision|1|||
33569639|NCT02415556|101978251|FG001|Overall Study|Physician Decision|3|||
33569640|NCT02415556|101978252|FG002|Overall Study|Physician Decision|1|||
33569641|NCT02415556|101978253|FG003|Overall Study|Physician Decision|2|||
33569642|NCT02415556|101978250|FG000|Overall Study|Censored - study completion|4|||
33569643|NCT02415556|101978251|FG001|Overall Study|Censored - study completion|5|||
33569644|NCT02415556|101978252|FG002|Overall Study|Censored - study completion|1|||
33569645|NCT02415556|101978253|FG003|Overall Study|Censored - study completion|0|||
33569646|NCT02415556|101978250|FG000|Overall Study|Family-related issues|0|||
33569647|NCT02415556|101978251|FG001|Overall Study|Family-related issues|0|||
33569648|NCT02415556|101978252|FG002|Overall Study|Family-related issues|0|||
33569649|NCT02415556|101978253|FG003|Overall Study|Family-related issues|1|||
33569650|NCT00856557|101978254|FG000|Overall Study|No patients with contextual flags|12|||
33569651|NCT00856557|101978255|FG001|Overall Study|No patients with contextual flags|16|||
33569652|NCT02216526|101978256|FG000|Overall Study|Adverse Event|1|||
33569653|NCT02216526|101978257|FG001|Overall Study|Adverse Event|1|||
33569654|NCT02216526|101978258|FG002|Overall Study|Adverse Event|0|||
33569655|NCT02216526|101978256|FG000|Overall Study|Death|0|||
33569656|NCT02216526|101978257|FG001|Overall Study|Death|1|||
33569657|NCT02216526|101978258|FG002|Overall Study|Death|3|||
33569658|NCT02216526|101978256|FG000|Overall Study|Protocol Violation|2|||
33569659|NCT02216526|101978257|FG001|Overall Study|Protocol Violation|0|||
33569660|NCT02216526|101978258|FG002|Overall Study|Protocol Violation|2|||
33569661|NCT02216526|101978256|FG000|Overall Study|Hospitalization|2|||
33569662|NCT02216526|101978257|FG001|Overall Study|Hospitalization|1|||
33569663|NCT02216526|101978258|FG002|Overall Study|Hospitalization|3|||
33569664|NCT01722669|101978261|FG000|Overall Study|Withdrawal by Subject|0|||
33569665|NCT01722669|101978262|FG001|Overall Study|Withdrawal by Subject|0|||
33569666|NCT01722669|101978263|FG002|Overall Study|Withdrawal by Subject|0|||
33569667|NCT01722669|101978264|FG003|Overall Study|Withdrawal by Subject|0|||
33569668|NCT01722669|101978265|FG004|Overall Study|Withdrawal by Subject|0|||
33569669|NCT01722669|101978266|FG005|Overall Study|Withdrawal by Subject|2|||
33569670|NCT03485157|101978270|FG000|Double Blind Phase|Lost to Follow-up|4|||
33569671|NCT03485157|101978271|FG001|Double Blind Phase|Lost to Follow-up|4|||
33569672|NCT03485157|101978270|FG000|Double Blind Phase|Adverse Event|2|||
33569673|NCT03485157|101978271|FG001|Double Blind Phase|Adverse Event|1|||
33569674|NCT03485157|101978270|FG000|Double Blind Phase|Withdrawal by Subject|6|||
33569675|NCT03485157|101978271|FG001|Double Blind Phase|Withdrawal by Subject|9|||
33569676|NCT03485157|101978270|FG000|Double Blind Phase|Removal by PI|3|||
33569677|NCT03485157|101978271|FG001|Double Blind Phase|Removal by PI|7|||
33569678|NCT03485157|101978270|FG000|Open Label Phase|Lost to Follow-up|1|||
33569679|NCT03485157|101978271|FG001|Open Label Phase|Lost to Follow-up|2|||
33569680|NCT03485157|101978270|FG000|Open Label Phase|Adverse Event|0|||
33569681|NCT03485157|101978271|FG001|Open Label Phase|Adverse Event|1|||
33569682|NCT03485157|101978270|FG000|Open Label Phase|Withdrawal by Subject|1|||
33569683|NCT03485157|101978271|FG001|Open Label Phase|Withdrawal by Subject|2|||
33569684|NCT03485157|101978270|FG000|Open Label Phase|Removal by PI|2|||
33569685|NCT03485157|101978271|FG001|Open Label Phase|Removal by PI|0|||
33569686|NCT00622726|101978272|FG000|March, 2008 to August, 2010|Death|5|||
33569687|NCT00622726|101978273|FG001|March, 2008 to August, 2010|Death|2|||
33632470|NCT05228470|102205984|FG001|Overall Study|Withdrawal by Subject|8|||
33632471|NCT05228470|102205983|FG000|Overall Study|Ongoing|1|||
33632472|NCT05228470|102205984|FG001|Overall Study|Ongoing|11|||
33632473|NCT03558737|102205985|FG000|Overall Study|Death|1|||
33632474|NCT03558737|102205986|FG001|Overall Study|Death|1|||
33632475|NCT02783690|102205987|FG000|Overall Study|Withdrawal by Subject|3|||
33632476|NCT02783690|102205988|FG001|Overall Study|Withdrawal by Subject|3|||
33226434|NCT00622713|100728638|FG000|Overall Study|Withdrawal by Subject|11|||
33417916|NCT04682639|101422265|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
33569688|NCT00622726|101978272|FG000|August, 2010 to April, 2013|Death|1|||
33569689|NCT00622726|101978273|FG001|August, 2010 to April, 2013|Death|5|||
33632477|NCT03988400|102205993|FG000|Overall Study|Adverse Event|1|||
33226435|NCT00622713|100728638|FG000|Overall Study|Lost to Follow-up|5|||
33569690|NCT00862940|101978274|FG000|Overall Study|Adverse Event|15|||
33569691|NCT00862940|101978275|FG001|Overall Study|Adverse Event|12|||
33569692|NCT00862940|101978274|FG000|Overall Study|Lack of Efficacy|1|||
33569693|NCT00862940|101978275|FG001|Overall Study|Lack of Efficacy|3|||
33569694|NCT00862940|101978274|FG000|Overall Study|Protocol Violation|2|||
33569695|NCT00862940|101978275|FG001|Overall Study|Protocol Violation|5|||
33569696|NCT00862940|101978274|FG000|Overall Study|Withdrawal by Subject|4|||
33226436|NCT00622713|100728638|FG000|Overall Study|Death|2|||
33569697|NCT00862940|101978275|FG001|Overall Study|Withdrawal by Subject|6|||
33569698|NCT00862940|101978274|FG000|Overall Study|Non-compliance|4|||
33569699|NCT00862940|101978275|FG001|Overall Study|Non-compliance|0|||
33569700|NCT00862940|101978274|FG000|Overall Study|Lost to Follow-up|0|||
33632478|NCT03988400|102205994|FG001|Overall Study|Adverse Event|0|||
33632479|NCT03988400|102205993|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
33632480|NCT03988400|102205994|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
33632481|NCT03988400|102205993|FG000|Overall Study|Lost to Follow-up|0|||
33226437|NCT00622713|100728638|FG000|Overall Study|Subject no longer required study drug|1|||
33226438|NCT00622713|100728638|FG000|Overall Study|Did not meet eligibility criteria|1|||
33226439|NCT01782742|100728639|FG000|Double-blind Treatment Phase|Adverse Event|1|||
33226440|NCT01782742|100728640|FG001|Double-blind Treatment Phase|Adverse Event|0|||
33226441|NCT03724396|100728641|FG000|Overall Study|Lost to Follow-up|1|||
33226442|NCT03724396|100728642|FG001|Overall Study|Lost to Follow-up|1|||
33226443|NCT03724396|100728641|FG000|Overall Study|Withdrawal by Subject|1|||
33226444|NCT03724396|100728642|FG001|Overall Study|Withdrawal by Subject|0|||
33226445|NCT01396395|100728643|FG000|Overall Study|Withdrawal by Subject|10|||
33226446|NCT01396395|100728644|FG001|Overall Study|Withdrawal by Subject|12|||
33226447|NCT01396395|100728643|FG000|Overall Study|Protocol Violation|3|||
33226448|NCT01396395|100728644|FG001|Overall Study|Protocol Violation|1|||
33569701|NCT00862940|101978275|FG001|Overall Study|Lost to Follow-up|1|||
33569702|NCT00862940|101978274|FG000|Overall Study|Administrative or other reason(s)|4|||
33569703|NCT00862940|101978275|FG001|Overall Study|Administrative or other reason(s)|3|||
33569704|NCT03386773|101978278|FG000|Overall Study|Lost to Follow-up|24|||
33569705|NCT03386773|101978279|FG001|Overall Study|Lost to Follow-up|33|||
33569706|NCT03386773|101978278|FG000|Overall Study|Withdrawal by Subject|3|||
33569707|NCT03386773|101978279|FG001|Overall Study|Withdrawal by Subject|2|||
33632482|NCT03988400|102205994|FG001|Overall Study|Lost to Follow-up|1|||
33632483|NCT04179500|102205995|FG000|Treatment|Withdrawal by Subject|1|||
33632484|NCT04179500|102205995|FG000|Treatment|Adverse Event|2|||
33632485|NCT04179500|102205995|FG000|Treatment|pyrazinamide resistance|1|||
33632486|NCT04109547|102205996|FG000|Overall Study|Withdrawal by Subject|3|||
33632487|NCT04109547|102205997|FG001|Overall Study|Withdrawal by Subject|2|||
33632488|NCT04109547|102205998|FG002|Overall Study|Withdrawal by Subject|6|||
33632489|NCT04109547|102205999|FG003|Overall Study|Withdrawal by Subject|6|||
33632490|NCT04109547|102205996|FG000|Overall Study|Lost to Follow-up|0|||
33632491|NCT04109547|102205997|FG001|Overall Study|Lost to Follow-up|0|||
33632492|NCT04109547|102205998|FG002|Overall Study|Lost to Follow-up|0|||
33632493|NCT04109547|102205999|FG003|Overall Study|Lost to Follow-up|1|||
33632494|NCT04109547|102205996|FG000|Overall Study|Physician Decision|1|||
33632495|NCT04109547|102205997|FG001|Overall Study|Physician Decision|2|||
33632496|NCT04109547|102205998|FG002|Overall Study|Physician Decision|0|||
33632497|NCT04109547|102205999|FG003|Overall Study|Physician Decision|0|||
33632498|NCT03104868|102206002|FG000|6 Week Follow up|Lost to Follow-up|5|||
33632499|NCT03104868|102206003|FG001|6 Week Follow up|Lost to Follow-up|8|||
33632500|NCT03104868|102206002|FG000|6 Week Follow up|Death|1|||
33632501|NCT03104868|102206003|FG001|6 Week Follow up|Death|1|||
33632502|NCT03104868|102206002|FG000|6 Week Follow up|Withdrawal by Subject|7|||
33632503|NCT03104868|102206003|FG001|6 Week Follow up|Withdrawal by Subject|6|||
33632504|NCT03104868|102206002|FG000|6 Week Follow up|Completed Later Timepoint|24|||
33632505|NCT03104868|102206003|FG001|6 Week Follow up|Completed Later Timepoint|22|||
33632506|NCT03104868|102206002|FG000|6 Month Follow up|Lost to Follow-up|2|||
33632507|NCT03104868|102206003|FG001|6 Month Follow up|Lost to Follow-up|2|||
33632508|NCT03104868|102206002|FG000|6 Month Follow up|Death|0|||
33632509|NCT03104868|102206003|FG001|6 Month Follow up|Death|1|||
33632510|NCT03104868|102206002|FG000|6 Month Follow up|Completed Later Timepoint|22|||
33632511|NCT03104868|102206003|FG001|6 Month Follow up|Completed Later Timepoint|32|||
33632512|NCT03104868|102206002|FG000|12 Month Follow up|Lost to Follow-up|1|||
33632513|NCT03104868|102206003|FG001|12 Month Follow up|Lost to Follow-up|2|||
33226449|NCT01396395|100728643|FG000|Overall Study|Adverse Event|10|||
33226450|NCT01396395|100728644|FG001|Overall Study|Adverse Event|2|||
33226451|NCT01396395|100728643|FG000|Overall Study|Lost to Follow-up|17|||
33226452|NCT01396395|100728644|FG001|Overall Study|Lost to Follow-up|11|||
33569708|NCT05538728|101978288|FG000|Overall Study|Withdrawal by Subject|1|||
33569709|NCT05538728|101978289|FG001|Overall Study|Withdrawal by Subject|1|||
33632514|NCT03104868|102206002|FG000|12 Month Follow up|Death|0|||
33632515|NCT03104868|102206003|FG001|12 Month Follow up|Death|1|||
33226453|NCT01396395|100728643|FG000|Overall Study|Other|0|||
33226454|NCT01396395|100728644|FG001|Overall Study|Other|1|||
33226455|NCT02387996|100728645|FG000|Overall Study|Disease Progression|167|||
33569710|NCT02448381|101978290|FG000|Overall Study|Adverse Event|2|||
33569711|NCT02448381|101978291|FG001|Overall Study|Adverse Event|0|||
33569712|NCT02448381|101978290|FG000|Overall Study|Lost to Follow-up|16|||
33569713|NCT02448381|101978291|FG001|Overall Study|Lost to Follow-up|9|||
33569714|NCT02448381|101978290|FG000|Overall Study|Physician Decision|1|||
33632516|NCT03104868|102206002|FG000|12 Month Follow up|Withdrawal by Subject|0|||
33632517|NCT03104868|102206003|FG001|12 Month Follow up|Withdrawal by Subject|3|||
33632518|NCT03104868|102206002|FG000|12 Month Follow up|Completed Later Timepoint|32|||
33632519|NCT03104868|102206003|FG001|12 Month Follow up|Completed Later Timepoint|29|||
33632520|NCT03104868|102206002|FG000|18 Month Follow up|Lost to Follow-up|7|||
33632521|NCT03104868|102206003|FG001|18 Month Follow up|Lost to Follow-up|11|||
33632522|NCT03104868|102206002|FG000|18 Month Follow up|Death|2|||
33632523|NCT03104868|102206003|FG001|18 Month Follow up|Death|1|||
33632524|NCT03104868|102206002|FG000|18 Month Follow up|Withdrawal by Subject|1|||
33226456|NCT02387996|100728645|FG000|Overall Study|Study Drug Toxicity|31|||
33226457|NCT02387996|100728645|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
33226458|NCT02387996|100728645|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
33226459|NCT02387996|100728645|FG000|Overall Study|Subject Withdrew Consent|5|||
33226460|NCT02387996|100728645|FG000|Overall Study|Lost to Follow-up|1|||
33226461|NCT02387996|100728645|FG000|Overall Study|Poor/Non-Compliance|1|||
33226462|NCT02387996|100728645|FG000|Overall Study|Other Reasons|5|||
33226463|NCT02387996|100728645|FG000|Overall Study|Death|1|||
33226464|NCT03185832|100728648|FG000|Overall Study|Death|9|||
33226465|NCT03185832|100728649|FG001|Overall Study|Death|14|||
33226466|NCT03185832|100728650|FG002|Overall Study|Death|9|||
33226467|NCT03185832|100728651|FG003|Overall Study|Death|7|||
33226468|NCT03185832|100728648|FG000|Overall Study|Withdrawn - vital status available|0|||
33226469|NCT03185832|100728649|FG001|Overall Study|Withdrawn - vital status available|1|||
33226470|NCT03185832|100728650|FG002|Overall Study|Withdrawn - vital status available|1|||
33226471|NCT03185832|100728651|FG003|Overall Study|Withdrawn - vital status available|4|||
33226472|NCT00659984|100728663|FG000|Overall Study|Adverse Event|1|||
33226473|NCT03342053|100728668|FG000|Overall Study|Adverse Event|2|||
33226474|NCT03342053|100728669|FG001|Overall Study|Adverse Event|0|||
33226475|NCT03342053|100728668|FG000|Overall Study|Withdrawal by Subject|0|||
33226476|NCT03342053|100728669|FG001|Overall Study|Withdrawal by Subject|1|||
33226477|NCT00874432|100728670|FG000|Overall Study|Withdrawal by Subject|1|||
33226478|NCT00874432|100728671|FG001|Overall Study|Withdrawal by Subject|0|||
33226479|NCT00874432|100728672|FG002|Overall Study|Withdrawal by Subject|0|||
33226480|NCT00874432|100728673|FG003|Overall Study|Withdrawal by Subject|0|||
33226481|NCT00874432|100728670|FG000|Overall Study|Physician Decision|1|||
33226482|NCT00874432|100728671|FG001|Overall Study|Physician Decision|0|||
33226483|NCT00874432|100728672|FG002|Overall Study|Physician Decision|0|||
33226484|NCT00874432|100728673|FG003|Overall Study|Physician Decision|0|||
33226485|NCT00874432|100728670|FG000|Overall Study|Other|1|||
33226486|NCT00874432|100728671|FG001|Overall Study|Other|2|||
33226487|NCT00874432|100728672|FG002|Overall Study|Other|8|||
33226488|NCT00874432|100728673|FG003|Overall Study|Other|3|||
33226489|NCT01547299|100728674|FG000|Overall Study|Withdrawal by Subject|2|||
33226490|NCT01547299|100728675|FG001|Overall Study|Withdrawal by Subject|2|||
33226491|NCT04399551|100728678|FG000|Overall Study|Adverse Event|15|||
33226492|NCT04399551|100728678|FG000|Overall Study|Withdrawal by Subject|6|||
33226493|NCT04399551|100728678|FG000|Overall Study|Physician Decision|3|||
33226494|NCT04399551|100728678|FG000|Overall Study|Lost to Follow-up|2|||
33226495|NCT04399551|100728678|FG000|Overall Study|Protocol Deviation|2|||
33226496|NCT01078662|100728679|FG000|Overall Study|Death|41|||
33226497|NCT01078662|100728680|FG001|Overall Study|Death|103|||
33226498|NCT01078662|100728681|FG002|Overall Study|Death|18|||
33226499|NCT01078662|100728682|FG003|Overall Study|Death|5|||
33226500|NCT01078662|100728683|FG004|Overall Study|Death|8|||
33226501|NCT01078662|100728679|FG000|Overall Study|Patients reached data cut-off|12|||
33226502|NCT01078662|100728680|FG001|Overall Study|Patients reached data cut-off|53|||
33226503|NCT01078662|100728681|FG002|Overall Study|Patients reached data cut-off|2|||
33226504|NCT01078662|100728682|FG003|Overall Study|Patients reached data cut-off|2|||
33226505|NCT01078662|100728683|FG004|Overall Study|Patients reached data cut-off|3|||
33226506|NCT01078662|100728679|FG000|Overall Study|Withdrawal by Subject|4|||
33226507|NCT01078662|100728680|FG001|Overall Study|Withdrawal by Subject|11|||
33226508|NCT01078662|100728681|FG002|Overall Study|Withdrawal by Subject|1|||
33226509|NCT01078662|100728682|FG003|Overall Study|Withdrawal by Subject|0|||
33226510|NCT01078662|100728683|FG004|Overall Study|Withdrawal by Subject|0|||
33226511|NCT01078662|100728679|FG000|Overall Study|Protocol Violation|0|||
33226512|NCT01078662|100728680|FG001|Overall Study|Protocol Violation|1|||
33226513|NCT01078662|100728681|FG002|Overall Study|Protocol Violation|0|||
33226514|NCT01078662|100728682|FG003|Overall Study|Protocol Violation|0|||
33226515|NCT01078662|100728683|FG004|Overall Study|Protocol Violation|0|||
33226516|NCT01078662|100728679|FG000|Overall Study|Lost to Follow-up|1|||
33226517|NCT01078662|100728680|FG001|Overall Study|Lost to Follow-up|0|||
33226518|NCT01078662|100728681|FG002|Overall Study|Lost to Follow-up|0|||
33226519|NCT01078662|100728682|FG003|Overall Study|Lost to Follow-up|0|||
33226520|NCT01078662|100728683|FG004|Overall Study|Lost to Follow-up|0|||
33226521|NCT02006121|100728686|FG000|Double Blind Phase|Adverse Event|6|||
33365750|NCT01070550|101227193|FG000|Overall Study|Failed to return|450|||
33365751|NCT01070550|101227194|FG001|Overall Study|Failed to return|33|||
33365752|NCT01070550|101227195|FG002|Overall Study|Failed to return|144|||
33365753|NCT01070550|101227196|FG003|Overall Study|Failed to return|40|||
33365754|NCT01070550|101227197|FG004|Overall Study|Failed to return|1|||
33365755|NCT01070550|101227198|FG005|Overall Study|Failed to return|2|||
33365756|NCT01070550|101227193|FG000|Overall Study|Incomplete treatment|2|||
33365757|NCT01070550|101227194|FG001|Overall Study|Incomplete treatment|0|||
33417917|NCT04682639|101422266|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
33417918|NCT04682639|101422267|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
33417919|NCT04682639|101422268|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
33417920|NCT04682639|101422264|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
33569715|NCT02448381|101978291|FG001|Overall Study|Physician Decision|1|||
33569716|NCT02448381|101978290|FG000|Overall Study|Pregnancy|1|||
33365758|NCT01070550|101227195|FG002|Overall Study|Incomplete treatment|0|||
33365759|NCT01070550|101227196|FG003|Overall Study|Incomplete treatment|0|||
33365760|NCT01070550|101227197|FG004|Overall Study|Incomplete treatment|0|||
33365761|NCT01070550|101227198|FG005|Overall Study|Incomplete treatment|0|||
33365762|NCT01070550|101227193|FG000|Overall Study|Lab test not done|22|||
33365763|NCT01070550|101227194|FG001|Overall Study|Lab test not done|3|||
33365764|NCT01070550|101227195|FG002|Overall Study|Lab test not done|4|||
33365765|NCT01070550|101227196|FG003|Overall Study|Lab test not done|1|||
33365766|NCT01070550|101227197|FG004|Overall Study|Lab test not done|0|||
33365767|NCT01070550|101227198|FG005|Overall Study|Lab test not done|1|||
33365768|NCT01070550|101227193|FG000|Overall Study|Lack of Efficacy|65|||
33365769|NCT01070550|101227194|FG001|Overall Study|Lack of Efficacy|1|||
33365770|NCT01070550|101227195|FG002|Overall Study|Lack of Efficacy|5|||
33365771|NCT01070550|101227196|FG003|Overall Study|Lack of Efficacy|5|||
33365772|NCT01070550|101227197|FG004|Overall Study|Lack of Efficacy|0|||
33365773|NCT01070550|101227198|FG005|Overall Study|Lack of Efficacy|1|||
33365774|NCT01070550|101227193|FG000|Overall Study|Miscellaneous|12|||
33365775|NCT01070550|101227194|FG001|Overall Study|Miscellaneous|2|||
33365776|NCT01070550|101227195|FG002|Overall Study|Miscellaneous|3|||
33365777|NCT01070550|101227196|FG003|Overall Study|Miscellaneous|1|||
33365778|NCT01070550|101227197|FG004|Overall Study|Miscellaneous|0|||
33365779|NCT01070550|101227198|FG005|Overall Study|Miscellaneous|0|||
33417921|NCT04682639|101422265|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
33569717|NCT02448381|101978291|FG001|Overall Study|Pregnancy|0|||
33569718|NCT02448381|101978290|FG000|Overall Study|Withdrawal by Subject|13|||
33569719|NCT02448381|101978291|FG001|Overall Study|Withdrawal by Subject|9|||
33569720|NCT02448381|101978290|FG000|Overall Study|Noncompliance with Study Procedures|2|||
33569721|NCT02448381|101978291|FG001|Overall Study|Noncompliance with Study Procedures|0|||
33569722|NCT04123704|101978294|FG000|Overall Study|Disease progression|2|||
33569723|NCT00666263|101978296|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
33569724|NCT00666263|101978297|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
33569725|NCT00666263|101978296|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
33569726|NCT00666263|101978297|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
33632525|NCT03104868|102206003|FG001|18 Month Follow up|Withdrawal by Subject|2|||
33632526|NCT03104868|102206002|FG000|18 Month Follow up|Graft Loss|1|||
33226522|NCT02006121|100728687|FG001|Double Blind Phase|Adverse Event|0|||
33226523|NCT02006121|100728686|FG000|Double Blind Phase|Lack of Efficacy|1|||
33365780|NCT01070550|101227193|FG000|Overall Study|New treatment started|3|||
33365781|NCT01070550|101227194|FG001|Overall Study|New treatment started|1|||
33365782|NCT01070550|101227195|FG002|Overall Study|New treatment started|0|||
33365783|NCT01070550|101227196|FG003|Overall Study|New treatment started|2|||
33365784|NCT01070550|101227197|FG004|Overall Study|New treatment started|0|||
33365785|NCT01070550|101227198|FG005|Overall Study|New treatment started|0|||
33365786|NCT01070550|101227193|FG000|Overall Study|Non-responders|493|||
33365787|NCT01070550|101227194|FG001|Overall Study|Non-responders|4|||
33365788|NCT01070550|101227195|FG002|Overall Study|Non-responders|21|||
33365789|NCT01070550|101227196|FG003|Overall Study|Non-responders|20|||
33226524|NCT02006121|100728687|FG001|Double Blind Phase|Lack of Efficacy|16|||
33226525|NCT02006121|100728686|FG000|Double Blind Phase|Withdrawal by Subject|3|||
33226526|NCT02006121|100728687|FG001|Double Blind Phase|Withdrawal by Subject|4|||
33226527|NCT02006121|100728686|FG000|Double Blind Phase|Non-compliance with study drug|1|||
33417922|NCT04682639|101422266|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
33417923|NCT04682639|101422267|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
33226528|NCT02006121|100728687|FG001|Double Blind Phase|Non-compliance with study drug|3|||
33226529|NCT02006121|100728686|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
33226530|NCT02006121|100728687|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
33226531|NCT02006121|100728686|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
33226532|NCT02006121|100728687|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
33226533|NCT02006121|100728686|FG000|Open Label Phase|Adverse Event|15|||
33226534|NCT02006121|100728687|FG001|Open Label Phase|Adverse Event|0|||
33226535|NCT02006121|100728686|FG000|Open Label Phase|Lack of Efficacy|2|||
33226536|NCT02006121|100728687|FG001|Open Label Phase|Lack of Efficacy|0|||
33226537|NCT02006121|100728686|FG000|Open Label Phase|Protocol Violation|2|||
33226538|NCT02006121|100728687|FG001|Open Label Phase|Protocol Violation|0|||
33226539|NCT02006121|100728686|FG000|Open Label Phase|Withdrawal by Subject|3|||
33226540|NCT02006121|100728687|FG001|Open Label Phase|Withdrawal by Subject|0|||
33226541|NCT02006121|100728686|FG000|Open Label Phase|Non-compliance with study drug|3|||
33226542|NCT02006121|100728687|FG001|Open Label Phase|Non-compliance with study drug|0|||
33365790|NCT01070550|101227197|FG004|Overall Study|Non-responders|0|||
33365791|NCT01070550|101227198|FG005|Overall Study|Non-responders|2|||
33365792|NCT01070550|101227193|FG000|Overall Study|Not categorized|33|||
33365793|NCT01070550|101227194|FG001|Overall Study|Not categorized|2|||
33365794|NCT01070550|101227195|FG002|Overall Study|Not categorized|6|||
33365795|NCT01070550|101227196|FG003|Overall Study|Not categorized|1|||
33365796|NCT01070550|101227197|FG004|Overall Study|Not categorized|0|||
33365797|NCT01070550|101227198|FG005|Overall Study|Not categorized|1|||
33365798|NCT01070550|101227193|FG000|Overall Study|Protocol Violation|15|||
33365799|NCT01070550|101227194|FG001|Overall Study|Protocol Violation|1|||
33365800|NCT01070550|101227195|FG002|Overall Study|Protocol Violation|1|||
33365801|NCT01070550|101227196|FG003|Overall Study|Protocol Violation|1|||
33365802|NCT01070550|101227197|FG004|Overall Study|Protocol Violation|0|||
33365803|NCT01070550|101227198|FG005|Overall Study|Protocol Violation|0|||
33365804|NCT01070550|101227193|FG000|Overall Study|Relapse|44|||
33365805|NCT01070550|101227194|FG001|Overall Study|Relapse|5|||
33365806|NCT01070550|101227195|FG002|Overall Study|Relapse|14|||
33365807|NCT01070550|101227196|FG003|Overall Study|Relapse|4|||
33365808|NCT01070550|101227197|FG004|Overall Study|Relapse|0|||
33365809|NCT01070550|101227198|FG005|Overall Study|Relapse|0|||
33365810|NCT01070550|101227193|FG000|Overall Study|Result not available|3|||
33365811|NCT01070550|101227194|FG001|Overall Study|Result not available|1|||
33365812|NCT01070550|101227195|FG002|Overall Study|Result not available|3|||
33365813|NCT01070550|101227196|FG003|Overall Study|Result not available|0|||
33365814|NCT01070550|101227197|FG004|Overall Study|Result not available|0|||
33365815|NCT01070550|101227198|FG005|Overall Study|Result not available|0|||
33365816|NCT01070550|101227193|FG000|Overall Study|Screen failure|1|||
33365817|NCT01070550|101227194|FG001|Overall Study|Screen failure|0|||
33365818|NCT01070550|101227195|FG002|Overall Study|Screen failure|0|||
33365819|NCT01070550|101227196|FG003|Overall Study|Screen failure|0|||
33365820|NCT01070550|101227197|FG004|Overall Study|Screen failure|0|||
33365821|NCT01070550|101227198|FG005|Overall Study|Screen failure|0|||
33365822|NCT01070550|101227193|FG000|Overall Study|Sponsor decision|1|||
33365823|NCT01070550|101227194|FG001|Overall Study|Sponsor decision|0|||
33365824|NCT01070550|101227195|FG002|Overall Study|Sponsor decision|0|||
33365825|NCT01070550|101227196|FG003|Overall Study|Sponsor decision|0|||
33365826|NCT01070550|101227197|FG004|Overall Study|Sponsor decision|0|||
33365827|NCT01070550|101227198|FG005|Overall Study|Sponsor decision|0|||
33365828|NCT01070550|101227193|FG000|Overall Study|Treatment duration shortened|1|||
33365829|NCT01070550|101227194|FG001|Overall Study|Treatment duration shortened|0|||
33365830|NCT01070550|101227195|FG002|Overall Study|Treatment duration shortened|0|||
33365831|NCT01070550|101227196|FG003|Overall Study|Treatment duration shortened|0|||
33365832|NCT01070550|101227197|FG004|Overall Study|Treatment duration shortened|0|||
33365833|NCT01070550|101227198|FG005|Overall Study|Treatment duration shortened|0|||
33365834|NCT01070550|101227193|FG000|Overall Study|Treatment interrupted|7|||
33365835|NCT01070550|101227194|FG001|Overall Study|Treatment interrupted|0|||
33365836|NCT01070550|101227195|FG002|Overall Study|Treatment interrupted|1|||
33365837|NCT01070550|101227196|FG003|Overall Study|Treatment interrupted|1|||
33365838|NCT01070550|101227197|FG004|Overall Study|Treatment interrupted|0|||
33365839|NCT01070550|101227198|FG005|Overall Study|Treatment interrupted|0|||
33365840|NCT01070550|101227193|FG000|Overall Study|Treatment not started|14|||
33365841|NCT01070550|101227194|FG001|Overall Study|Treatment not started|2|||
33417924|NCT04682639|101422268|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
33417925|NCT04682639|101422264|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
33417926|NCT04682639|101422265|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
33632527|NCT03104868|102206003|FG001|18 Month Follow up|Graft Loss|1|||
33632528|NCT03104868|102206002|FG000|18 Month Follow up|Completed Later Timepoint|19|||
33632529|NCT03104868|102206003|FG001|18 Month Follow up|Completed Later Timepoint|20|||
33632530|NCT03104868|102206002|FG000|24 Month Follow up|Lost to Follow-up|15|||
33632531|NCT03104868|102206003|FG001|24 Month Follow up|Lost to Follow-up|16|||
33632532|NCT03104868|102206002|FG000|24 Month Follow up|Death|3|||
33632533|NCT03104868|102206003|FG001|24 Month Follow up|Death|2|||
33632534|NCT03104868|102206002|FG000|24 Month Follow up|Withdrawal by Subject|1|||
33632535|NCT03104868|102206003|FG001|24 Month Follow up|Withdrawal by Subject|0|||
33632536|NCT03104868|102206002|FG000|24 Month Follow up|Graft Loss|2|||
33632537|NCT03104868|102206003|FG001|24 Month Follow up|Graft Loss|0|||
33632538|NCT05523089|102206004|FG000|Overall Study|Withdrawal by Subject|1|||
33632539|NCT05523089|102206005|FG001|Overall Study|Withdrawal by Subject|0|||
33632540|NCT05523089|102206006|FG002|Overall Study|Withdrawal by Subject|0|||
33632541|NCT05523089|102206004|FG000|Overall Study|Lost to Follow-up|1|||
33569727|NCT00666263|101978296|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
33569728|NCT00666263|101978297|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
33569729|NCT00954447|101978298|FG000|Overall Study|Adverse Event|33|||
33569730|NCT00954447|101978299|FG001|Overall Study|Adverse Event|25|||
33569731|NCT00954447|101978298|FG000|Overall Study|Lack of Efficacy|17|||
33569732|NCT00954447|101978299|FG001|Overall Study|Lack of Efficacy|3|||
33569733|NCT00954447|101978298|FG000|Overall Study|Protocol Violation|5|||
33569734|NCT00954447|101978299|FG001|Overall Study|Protocol Violation|7|||
33569735|NCT00954447|101978298|FG000|Overall Study|Lost to Follow-up|8|||
33569736|NCT00954447|101978299|FG001|Overall Study|Lost to Follow-up|14|||
33569737|NCT00954447|101978298|FG000|Overall Study|Withdrawal by Subject|26|||
33569738|NCT00954447|101978299|FG001|Overall Study|Withdrawal by Subject|21|||
33569739|NCT00954447|101978298|FG000|Overall Study|Other|21|||
33569740|NCT00954447|101978299|FG001|Overall Study|Other|18|||
33632542|NCT05523089|102206005|FG001|Overall Study|Lost to Follow-up|0|||
33632543|NCT05523089|102206006|FG002|Overall Study|Lost to Follow-up|0|||
33632544|NCT02230410|102206007|FG000|Overall Study|Screen Failure|3|||
33632545|NCT01772472|102206010|FG000|Overall Study|Death|56|||
33632546|NCT01772472|102206011|FG001|Overall Study|Death|42|||
33632547|NCT01772472|102206010|FG000|Overall Study|Physician Decision|1|||
33632548|NCT01772472|102206011|FG001|Overall Study|Physician Decision|3|||
33632549|NCT01772472|102206010|FG000|Overall Study|Other|5|||
33226543|NCT01160484|100728688|FG000|Overall Study|Lack of Efficacy|9|||
33226544|NCT01160484|100728688|FG000|Overall Study|Adverse Event|6|||
33226545|NCT01160484|100728688|FG000|Overall Study|Withdrawal by Subject|2|||
33226546|NCT01160484|100728688|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
33226547|NCT02322814|100728692|FG000|Overall Study|Death|7|||
33226548|NCT02322814|100728693|FG001|Overall Study|Death|29|||
33226549|NCT02322814|100728694|FG002|Overall Study|Death|32|||
33226550|NCT02322814|100728695|FG003|Overall Study|Death|23|||
33365842|NCT01070550|101227195|FG002|Overall Study|Treatment not started|4|||
33365843|NCT01070550|101227196|FG003|Overall Study|Treatment not started|0|||
33365844|NCT01070550|101227197|FG004|Overall Study|Treatment not started|0|||
33365845|NCT01070550|101227198|FG005|Overall Study|Treatment not started|0|||
33365846|NCT01070550|101227193|FG000|Overall Study|Treatment restarted|0|||
33365847|NCT01070550|101227194|FG001|Overall Study|Treatment restarted|1|||
33365848|NCT01070550|101227195|FG002|Overall Study|Treatment restarted|0|||
33365849|NCT01070550|101227196|FG003|Overall Study|Treatment restarted|0|||
33365850|NCT01070550|101227197|FG004|Overall Study|Treatment restarted|0|||
33365851|NCT01070550|101227198|FG005|Overall Study|Treatment restarted|0|||
33365852|NCT01070550|101227193|FG000|Overall Study|Treatment stopped|3|||
33365853|NCT01070550|101227194|FG001|Overall Study|Treatment stopped|0|||
33417927|NCT04682639|101422266|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
33569741|NCT01696643|101978302|FG000|Overall Study|Adverse Event|15|||
33569742|NCT01696643|101978303|FG001|Overall Study|Adverse Event|7|||
33226551|NCT02322814|100728696|FG004|Overall Study|Death|14|||
33226552|NCT02322814|100728692|FG000|Overall Study|Lost to Follow-up|1|||
33365854|NCT01070550|101227195|FG002|Overall Study|Treatment stopped|0|||
33365855|NCT01070550|101227196|FG003|Overall Study|Treatment stopped|0|||
33365856|NCT01070550|101227197|FG004|Overall Study|Treatment stopped|0|||
33569743|NCT01696643|101978302|FG000|Overall Study|Death|1|||
33569744|NCT01696643|101978303|FG001|Overall Study|Death|2|||
33569745|NCT01696643|101978302|FG000|Overall Study|Lack of Efficacy|3|||
33365857|NCT01070550|101227198|FG005|Overall Study|Treatment stopped|0|||
33632550|NCT01772472|102206011|FG001|Overall Study|Other|5|||
33632551|NCT01772472|102206010|FG000|Overall Study|Lost to Follow-up|12|||
33632552|NCT01772472|102206011|FG001|Overall Study|Lost to Follow-up|8|||
33632553|NCT01772472|102206010|FG000|Overall Study|Withdrawal by Subject|72|||
33632554|NCT01772472|102206011|FG001|Overall Study|Withdrawal by Subject|50|||
33632555|NCT01772472|102206010|FG000|Overall Study|Ongoing|597|||
33632556|NCT01772472|102206011|FG001|Overall Study|Ongoing|635|||
33365858|NCT01070550|101227193|FG000|Overall Study|Treatment unavailable|1|||
33365859|NCT01070550|101227194|FG001|Overall Study|Treatment unavailable|0|||
33365860|NCT01070550|101227195|FG002|Overall Study|Treatment unavailable|0|||
33365861|NCT01070550|101227196|FG003|Overall Study|Treatment unavailable|0|||
33365862|NCT01070550|101227197|FG004|Overall Study|Treatment unavailable|0|||
33365863|NCT01070550|101227198|FG005|Overall Study|Treatment unavailable|0|||
33365864|NCT01070550|101227193|FG000|Overall Study|Treatment was stopped early|7|||
33365865|NCT01070550|101227194|FG001|Overall Study|Treatment was stopped early|0|||
33365866|NCT01070550|101227195|FG002|Overall Study|Treatment was stopped early|0|||
33365867|NCT01070550|101227196|FG003|Overall Study|Treatment was stopped early|0|||
33365868|NCT01070550|101227197|FG004|Overall Study|Treatment was stopped early|0|||
33365869|NCT01070550|101227198|FG005|Overall Study|Treatment was stopped early|0|||
33365870|NCT01070550|101227193|FG000|Overall Study|Other|5|||
33365871|NCT01070550|101227194|FG001|Overall Study|Other|0|||
33365872|NCT01070550|101227195|FG002|Overall Study|Other|0|||
33365873|NCT01070550|101227196|FG003|Overall Study|Other|1|||
33365874|NCT01070550|101227197|FG004|Overall Study|Other|0|||
33365875|NCT01070550|101227198|FG005|Overall Study|Other|0|||
33365876|NCT01070550|101227193|FG000|Overall Study|Withdrawal by Subject|35|||
33365877|NCT01070550|101227194|FG001|Overall Study|Withdrawal by Subject|0|||
33365878|NCT01070550|101227195|FG002|Overall Study|Withdrawal by Subject|3|||
33365879|NCT01070550|101227196|FG003|Overall Study|Withdrawal by Subject|0|||
33365880|NCT01070550|101227197|FG004|Overall Study|Withdrawal by Subject|0|||
33365881|NCT01070550|101227198|FG005|Overall Study|Withdrawal by Subject|0|||
33365882|NCT02241512|101227199|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
33365883|NCT02241512|101227200|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
33365884|NCT00931892|101227201|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
33365885|NCT00931892|101227202|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
33365886|NCT01165203|101227203|FG000|Active Phase|Serious Adverse Event|1|||
33365887|NCT01165203|101227204|FG001|Active Phase|Serious Adverse Event|0|||
33365888|NCT01165203|101227203|FG000|Active Phase|Withdrawal by Subject|2|||
33365889|NCT01165203|101227204|FG001|Active Phase|Withdrawal by Subject|1|||
33365890|NCT01165203|101227203|FG000|Active Phase|Migrated/moved from study area|0|||
33365891|NCT01165203|101227204|FG001|Active Phase|Migrated/moved from study area|1|||
33365892|NCT01165203|101227203|FG000|Active Phase|Lost to Follow-up|2|||
33365893|NCT01165203|101227204|FG001|Active Phase|Lost to Follow-up|0|||
33365894|NCT01165203|101227203|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
33365895|NCT01165203|101227204|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
33365896|NCT01165203|101227203|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
33365897|NCT01165203|101227204|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
33365898|NCT01165203|101227203|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
33365899|NCT01165203|101227204|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
33365900|NCT01165203|101227203|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
33365901|NCT01165203|101227204|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
33365902|NCT01165203|101227203|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
33365903|NCT01165203|101227204|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
33365904|NCT01671488|101227206|FG000|Overall Study|Withdrawal by Subject|1|||
33365905|NCT01629667|101227207|FG000|Overall Study|Lost to Follow-up|0|||
33365906|NCT01629667|101227208|FG001|Overall Study|Lost to Follow-up|1|||
33365907|NCT01629667|101227209|FG002|Overall Study|Lost to Follow-up|1|||
33365908|NCT01629667|101227207|FG000|Overall Study|Withdrawal by Subject|31|||
33365909|NCT01629667|101227208|FG001|Overall Study|Withdrawal by Subject|20|||
33417928|NCT04682639|101422267|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
33417929|NCT04682639|101422268|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
33417930|NCT04682639|101422264|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
33417931|NCT04682639|101422265|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
33417932|NCT04682639|101422266|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
33417933|NCT04682639|101422267|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
33417934|NCT04682639|101422268|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
33417935|NCT04682639|101422264|FG000|OLE Period (28 Weeks)|Other|1|||
33417936|NCT04682639|101422265|FG001|OLE Period (28 Weeks)|Other|2|||
33417937|NCT04682639|101422266|FG002|OLE Period (28 Weeks)|Other|0|||
33417938|NCT04682639|101422267|FG003|OLE Period (28 Weeks)|Other|0|||
33417939|NCT04682639|101422268|FG004|OLE Period (28 Weeks)|Other|1|||
33417940|NCT04682639|101422264|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
33417941|NCT04682639|101422265|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
33417942|NCT04682639|101422266|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
33365910|NCT01629667|101227209|FG002|Overall Study|Withdrawal by Subject|28|||
33365911|NCT01629667|101227207|FG000|Overall Study|Death|1|||
33365912|NCT01629667|101227208|FG001|Overall Study|Death|5|||
33632557|NCT04780061|102206014|FG000|Overall Study|Withdrawal by Subject|5|||
33365913|NCT01629667|101227209|FG002|Overall Study|Death|3|||
33417943|NCT04682639|101422267|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
33417944|NCT04682639|101422268|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
33365914|NCT01629667|101227207|FG000|Overall Study|Randomized, not treated|2|||
33365915|NCT01629667|101227208|FG001|Overall Study|Randomized, not treated|1|||
33365916|NCT01629667|101227209|FG002|Overall Study|Randomized, not treated|0|||
33365917|NCT01629667|101227207|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
33365918|NCT01629667|101227208|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
33365919|NCT01629667|101227209|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
33365920|NCT01629667|101227207|FG000|Overall Study|Requiring lung transplant|2|||
33365921|NCT01629667|101227208|FG001|Overall Study|Requiring lung transplant|1|||
33365922|NCT01629667|101227209|FG002|Overall Study|Requiring lung transplant|3|||
33365923|NCT01629667|101227207|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
33365924|NCT01629667|101227208|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
33365925|NCT01629667|101227209|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
33365926|NCT01629667|101227207|FG000|Overall Study|Started other medicine|1|||
33365927|NCT01629667|101227208|FG001|Overall Study|Started other medicine|0|||
33365928|NCT01629667|101227209|FG002|Overall Study|Started other medicine|1|||
33365929|NCT01629667|101227207|FG000|Overall Study|Site error in safety follow-up|0|||
33365930|NCT01629667|101227208|FG001|Overall Study|Site error in safety follow-up|0|||
33365931|NCT01629667|101227209|FG002|Overall Study|Site error in safety follow-up|1|||
33365932|NCT01629667|101227207|FG000|Overall Study|Enrolled in another clinical study|0|||
33365933|NCT01629667|101227208|FG001|Overall Study|Enrolled in another clinical study|1|||
33365934|NCT01629667|101227209|FG002|Overall Study|Enrolled in another clinical study|0|||
33365935|NCT01629667|101227207|FG000|Overall Study|Code break|1|||
33365936|NCT01629667|101227208|FG001|Overall Study|Code break|0|||
33365937|NCT01629667|101227209|FG002|Overall Study|Code break|0|||
33365938|NCT01765764|101227214|FG000|Treatment Period|Adverse Event|1|||
33365939|NCT01765764|101227215|FG001|Treatment Period|Adverse Event|2|||
33365940|NCT01765764|101227216|FG002|Treatment Period|Adverse Event|1|||
33365941|NCT01765764|101227214|FG000|Treatment Period|Lost to Follow-up|0|||
33365942|NCT01765764|101227215|FG001|Treatment Period|Lost to Follow-up|3|||
33365943|NCT01765764|101227216|FG002|Treatment Period|Lost to Follow-up|2|||
33365944|NCT01765764|101227214|FG000|Treatment Period|Personal Reasons|1|||
33365945|NCT01765764|101227215|FG001|Treatment Period|Personal Reasons|2|||
33365946|NCT01765764|101227216|FG002|Treatment Period|Personal Reasons|1|||
33365947|NCT01765764|101227214|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
33365948|NCT01765764|101227215|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
33365949|NCT01765764|101227216|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
33365950|NCT01312428|101227220|FG000|Overall Study|Study Termination|3|||
33365951|NCT01312428|101227221|FG001|Overall Study|Study Termination|4|||
33365952|NCT01327339|101227222|FG000|Overall Study|Protocol Violation|8|||
33365953|NCT01323673|101227229|FG000|Overall Study|Adverse Event|0|||
33365954|NCT01323673|101227230|FG001|Overall Study|Adverse Event|1|||
33365955|NCT01323673|101227229|FG000|Overall Study|Lost to Follow-up|0|||
33365956|NCT01323673|101227230|FG001|Overall Study|Lost to Follow-up|1|||
33365957|NCT01323673|101227229|FG000|Overall Study|Protocol Violation|1|||
33365958|NCT01323673|101227230|FG001|Overall Study|Protocol Violation|0|||
33365959|NCT01323673|101227229|FG000|Overall Study|Withdrawal by Subject|2|||
33365960|NCT01323673|101227230|FG001|Overall Study|Withdrawal by Subject|3|||
33365961|NCT00515008|101227237|FG000|Overall Study|Lost to Follow-up|1|||
33365962|NCT00515008|101227238|FG001|Overall Study|Lost to Follow-up|0|||
33365963|NCT00515008|101227237|FG000|Overall Study|Declined|0|||
33365964|NCT00515008|101227238|FG001|Overall Study|Declined|3|||
33365965|NCT00515008|101227237|FG000|Overall Study|Left the Boston Area|1|||
33365966|NCT00515008|101227238|FG001|Overall Study|Left the Boston Area|1|||
33365967|NCT00515008|101227237|FG000|Overall Study|Scheduling conflict|1|||
33365968|NCT00515008|101227238|FG001|Overall Study|Scheduling conflict|0|||
33365969|NCT03692910|101227239|FG000|Overall Study|Lost to Follow-up|4|||
33365970|NCT03692910|101227240|FG001|Overall Study|Lost to Follow-up|0|||
33365971|NCT03692910|101227241|FG002|Overall Study|Lost to Follow-up|0|||
33417945|NCT04682639|101422264|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
33417946|NCT04682639|101422265|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
33365972|NCT03692910|101227239|FG000|Overall Study|Withdrawal by Subject|2|||
33365973|NCT03692910|101227240|FG001|Overall Study|Withdrawal by Subject|0|||
33365974|NCT03692910|101227241|FG002|Overall Study|Withdrawal by Subject|0|||
33365975|NCT00504166|101227244|FG000|Overall Study|Adverse Event|1|||
33365976|NCT00504166|101227245|FG001|Overall Study|Adverse Event|4|||
33365977|NCT00504166|101227244|FG000|Overall Study|Withdrawal by Subject|3|||
33417947|NCT04682639|101422266|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
33365978|NCT00504166|101227245|FG001|Overall Study|Withdrawal by Subject|6|||
33365979|NCT00504166|101227244|FG000|Overall Study|Physician Decision|1|||
33365980|NCT00504166|101227245|FG001|Overall Study|Physician Decision|1|||
33365981|NCT00504166|101227244|FG000|Overall Study|Lost to Follow-up|1|||
33365982|NCT00504166|101227245|FG001|Overall Study|Lost to Follow-up|3|||
33365983|NCT00783705|101227246|FG000|Overall Study|Adverse Event|2|||
33365984|NCT00783705|101227247|FG001|Overall Study|Adverse Event|0|||
33569746|NCT01696643|101978303|FG001|Overall Study|Lack of Efficacy|0|||
33569747|NCT01696643|101978302|FG000|Overall Study|Lost to Follow-up|67|||
33226553|NCT02322814|100728693|FG001|Overall Study|Lost to Follow-up|3|||
33417948|NCT04682639|101422267|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
33417949|NCT04682639|101422268|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
33417950|NCT04682639|101422264|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
33365985|NCT00783705|101227246|FG000|Overall Study|Withdrawal by Subject|3|||
33365986|NCT00783705|101227247|FG001|Overall Study|Withdrawal by Subject|2|||
33417951|NCT04682639|101422265|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
33417952|NCT04682639|101422266|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
33417953|NCT04682639|101422267|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
33417954|NCT04682639|101422268|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
33417955|NCT04682639|101422264|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
33417956|NCT04682639|101422265|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
33417957|NCT04682639|101422266|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
33417958|NCT04682639|101422267|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
33417959|NCT04682639|101422268|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
33417960|NCT05354206|101422270|FG000|Overall Study|Withdrawal by Subject|1|||
33417961|NCT05354206|101422271|FG001|Overall Study|Withdrawal by Subject|0|||
33417962|NCT01211613|101422272|FG000|Overall Study|Lost to Follow-up|2|||
33417963|NCT01211613|101422273|FG001|Overall Study|Lost to Follow-up|2|||
33417964|NCT01211613|101422274|FG002|Overall Study|Lost to Follow-up|2|||
33417965|NCT01211613|101422272|FG000|Overall Study|Withdrawal by Subject|1|||
33417966|NCT01211613|101422273|FG001|Overall Study|Withdrawal by Subject|0|||
33569748|NCT01696643|101978303|FG001|Overall Study|Lost to Follow-up|67|||
33365987|NCT00783705|101227246|FG000|Overall Study|Lost to Follow-up|1|||
33365988|NCT00783705|101227247|FG001|Overall Study|Lost to Follow-up|3|||
33365989|NCT03153111|101227250|FG000|Overall Study|Death|2|||
33365990|NCT03153111|101227251|FG001|Overall Study|Death|5|||
33365991|NCT03153111|101227250|FG000|Overall Study|Lost to Follow-up|1|||
33365992|NCT03153111|101227251|FG001|Overall Study|Lost to Follow-up|0|||
33365993|NCT03153111|101227250|FG000|Overall Study|Physician Decision|5|||
33365994|NCT03153111|101227251|FG001|Overall Study|Physician Decision|1|||
33365995|NCT03153111|101227250|FG000|Overall Study|Withdrawal by Subject|3|||
33365996|NCT03153111|101227251|FG001|Overall Study|Withdrawal by Subject|3|||
33365997|NCT01703819|101227252|FG000|Overall Study|Adverse Event|0|||
33365998|NCT01703819|101227253|FG001|Overall Study|Adverse Event|1|||
33365999|NCT01703819|101227252|FG000|Overall Study|Withdrawal by Subject|0|||
33366000|NCT01703819|101227253|FG001|Overall Study|Withdrawal by Subject|1|||
33366001|NCT01096550|101227255|FG000|Overall Study|discontinued site|10|||
33366002|NCT01096550|101227256|FG001|Overall Study|discontinued site|11|||
33366003|NCT01096550|101227255|FG000|Overall Study|non-regular treatment track at clinic|1|||
33366004|NCT01096550|101227256|FG001|Overall Study|non-regular treatment track at clinic|1|||
33366005|NCT01096550|101227255|FG000|Overall Study|clinic readmission|1|||
33366006|NCT01096550|101227256|FG001|Overall Study|clinic readmission|1|||
33366007|NCT01096550|101227255|FG000|Overall Study|Withdrawal by Subject|0|||
33366008|NCT01096550|101227256|FG001|Overall Study|Withdrawal by Subject|1|||
33366009|NCT01096550|101227255|FG000|Overall Study|non-African American participant|13|||
33366010|NCT01096550|101227256|FG001|Overall Study|non-African American participant|6|||
33366011|NCT01096550|101227255|FG000|Overall Study|Lost to Follow-up|12|||
33366012|NCT01096550|101227256|FG001|Overall Study|Lost to Follow-up|9|||
33366013|NCT04003636|101227257|FG000|Overall Study|Death|409|||
33366014|NCT04003636|101227258|FG001|Overall Study|Death|443|||
33366015|NCT04003636|101227257|FG000|Overall Study|Lost to Follow-up|0|||
33366016|NCT04003636|101227258|FG001|Overall Study|Lost to Follow-up|1|||
33366017|NCT04003636|101227257|FG000|Overall Study|Withdrawal by Subject|5|||
33366018|NCT04003636|101227258|FG001|Overall Study|Withdrawal by Subject|2|||
33366019|NCT04003636|101227257|FG000|Overall Study|Participant On-going|119|||
33366020|NCT04003636|101227258|FG001|Overall Study|Participant On-going|90|||
33366021|NCT00084682|101227262|FG000|Overall Study|Withdrawal by Subject|1|||
33569749|NCT01696643|101978302|FG000|Overall Study|Physician Decision|3|||
33569750|NCT01696643|101978303|FG001|Overall Study|Physician Decision|2|||
33569751|NCT01696643|101978302|FG000|Overall Study|Pregnancy|0|||
33569752|NCT01696643|101978303|FG001|Overall Study|Pregnancy|1|||
33366022|NCT01306058|101227269|FG000|Overall Study|Death|1|||
33366023|NCT01306058|101227269|FG000|Overall Study|Enrolled but did not get treatment|1|||
33366024|NCT00365976|101227270|FG000|Overall Study|Withdrawal by Subject|1|||
33569753|NCT01696643|101978302|FG000|Overall Study|Protocol Violation|7|||
33569754|NCT01696643|101978303|FG001|Overall Study|Protocol Violation|7|||
33366025|NCT00365976|101227271|FG001|Overall Study|Withdrawal by Subject|5|||
33366026|NCT01666444|101227272|FG000|Overall Study|Did not initiate treatment|2|||
33366027|NCT01666444|101227273|FG001|Overall Study|Did not initiate treatment|1|||
33417967|NCT01211613|101422274|FG002|Overall Study|Withdrawal by Subject|0|||
33417968|NCT00630994|101422275|FG000|Overall Study|Adverse Event|1|||
33417969|NCT00630994|101422275|FG000|Overall Study|Disease Progression|1|||
33417970|NCT00630994|101422275|FG000|Overall Study|Lack of Efficacy|1|||
33569755|NCT01696643|101978302|FG000|Overall Study|Study Terminated by Sponsor|286|||
33366028|NCT03510663|101227274|FG000|Overall Study|Withdrawal by Subject|0|||
33366029|NCT03510663|101227275|FG001|Overall Study|Withdrawal by Subject|1|||
33366030|NCT03510663|101227276|FG002|Overall Study|Withdrawal by Subject|0|||
33366031|NCT03510663|101227277|FG003|Overall Study|Withdrawal by Subject|0|||
33366032|NCT03510663|101227278|FG004|Overall Study|Withdrawal by Subject|0|||
33366033|NCT03510663|101227279|FG005|Overall Study|Withdrawal by Subject|0|||
33366034|NCT03510663|101227280|FG006|Overall Study|Withdrawal by Subject|0|||
33366035|NCT03510663|101227281|FG007|Overall Study|Withdrawal by Subject|0|||
33366036|NCT05094154|101227286|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
33366037|NCT05094154|101227287|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
33366038|NCT05094154|101227286|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
33366039|NCT05094154|101227287|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
33366040|NCT02229864|101227288|FG000|Overall Study|Death|2|||
33366041|NCT02229864|101227288|FG000|Overall Study|Lost to Follow-up|1|||
33366042|NCT01214434|101227290|FG000|Overall Study|Withdrawal by Subject|1|||
33366043|NCT01214434|101227291|FG001|Overall Study|Withdrawal by Subject|0|||
33366044|NCT01214434|101227290|FG000|Overall Study|Lost to Follow-up|2|||
33366045|NCT01214434|101227291|FG001|Overall Study|Lost to Follow-up|2|||
33366046|NCT01214434|101227290|FG000|Overall Study|Site error|1|||
33366047|NCT01214434|101227291|FG001|Overall Study|Site error|0|||
33366048|NCT02416908|101227292|FG000|Dose Escalation Phase|Adverse Event|0|||
33366049|NCT02416908|101227293|FG001|Dose Escalation Phase|Adverse Event|0|||
33366050|NCT02416908|101227294|FG002|Dose Escalation Phase|Adverse Event|3|||
33366051|NCT02416908|101227295|FG003|Dose Escalation Phase|Adverse Event|0|||
33366052|NCT02416908|101227292|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
33366053|NCT02416908|101227293|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
33366054|NCT02416908|101227294|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
33366055|NCT02416908|101227295|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
33366056|NCT02052960|101227296|FG000|Overall Study|Adverse Event|19|||
33366057|NCT02052960|101227297|FG001|Overall Study|Adverse Event|17|||
33366058|NCT02052960|101227296|FG000|Overall Study|Protocol Violation|4|||
33366059|NCT02052960|101227297|FG001|Overall Study|Protocol Violation|3|||
33366060|NCT02052960|101227296|FG000|Overall Study|Withdrawal by Subject|6|||
33366061|NCT02052960|101227297|FG001|Overall Study|Withdrawal by Subject|11|||
33366062|NCT02052960|101227296|FG000|Overall Study|Other|25|||
33366063|NCT02052960|101227297|FG001|Overall Study|Other|15|||
33366064|NCT00634543|101227300|FG000|Overall Study|Other|1|||
33366065|NCT00634543|101227301|FG001|Overall Study|Other|2|||
33366066|NCT00634543|101227300|FG000|Overall Study|Protocol Violation|3|||
33366067|NCT00634543|101227301|FG001|Overall Study|Protocol Violation|3|||
33366068|NCT00634543|101227300|FG000|Overall Study|Adverse Event|11|||
33366069|NCT00634543|101227301|FG001|Overall Study|Adverse Event|11|||
33366070|NCT00634543|101227300|FG000|Overall Study|Withdrawal by Subject|4|||
33366071|NCT00634543|101227301|FG001|Overall Study|Withdrawal by Subject|4|||
33366072|NCT00634543|101227300|FG000|Overall Study|Lost to Follow-up|0|||
33366073|NCT00634543|101227301|FG001|Overall Study|Lost to Follow-up|1|||
33366074|NCT02084134|101227302|FG000|Overall Study|Protocol Violation|4|||
33366075|NCT02084134|101227303|FG001|Overall Study|Protocol Violation|2|||
33366076|NCT02084134|101227302|FG000|Overall Study|Death|0|||
33366077|NCT02084134|101227303|FG001|Overall Study|Death|1|||
33366078|NCT02508701|101227304|FG000|Overall Study|Lost to Follow-up|9|||
33366079|NCT02508701|101227305|FG001|Overall Study|Lost to Follow-up|5|||
33366080|NCT02508701|101227306|FG002|Overall Study|Lost to Follow-up|5|||
33366081|NCT02508701|101227307|FG003|Overall Study|Lost to Follow-up|3|||
33366082|NCT02341014|101227308|FG000|Overall Study|Adverse Event|0|||
33366083|NCT02341014|101227309|FG001|Overall Study|Adverse Event|1|||
33366084|NCT02341014|101227310|FG002|Overall Study|Adverse Event|0|||
33366085|NCT02341014|101227311|FG003|Overall Study|Adverse Event|0|||
33366086|NCT02341014|101227312|FG004|Overall Study|Adverse Event|2|||
33366087|NCT03191396|101227313|FG000|Overall Study|Lost to Follow-up|0|||
33366088|NCT03191396|101227314|FG001|Overall Study|Lost to Follow-up|3|||
33366089|NCT03191396|101227313|FG000|Overall Study|Withdrawal by Subject|3|||
33366090|NCT03191396|101227314|FG001|Overall Study|Withdrawal by Subject|2|||
33366091|NCT00700752|101227322|FG000|First Intervention|Withdrawal by Subject|0|||
33366092|NCT00700752|101227323|FG001|First Intervention|Withdrawal by Subject|2|||
33366093|NCT02650284|101227324|FG000|Overall Study|Lost to Follow-up|3|||
33366094|NCT02650284|101227325|FG001|Overall Study|Lost to Follow-up|3|||
33366095|NCT02650284|101227324|FG000|Overall Study|Consent incorrectly taken|0|||
33366096|NCT02650284|101227325|FG001|Overall Study|Consent incorrectly taken|1|||
33366097|NCT02807454|101227326|FG000|Overall Study|Adverse Event|1|||
33366098|NCT02807454|101227327|FG001|Overall Study|Adverse Event|0|||
33366099|NCT02807454|101227326|FG000|Overall Study|Withdrawal by Subject|0|||
33366100|NCT02807454|101227327|FG001|Overall Study|Withdrawal by Subject|1|||
33366101|NCT02807454|101227326|FG000|Overall Study|Progressive Disease|30|||
33366102|NCT02807454|101227327|FG001|Overall Study|Progressive Disease|3|||
33366103|NCT02807454|101227326|FG000|Overall Study|Other Reasons|1|||
33366104|NCT02807454|101227327|FG001|Overall Study|Other Reasons|1|||
33366105|NCT01097616|101227330|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
33366106|NCT01097616|101227331|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
33366107|NCT01097616|101227332|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
33366108|NCT01097616|101227333|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33366109|NCT01097616|101227334|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33366110|NCT01097616|101227335|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33366111|NCT01097616|101227336|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33366112|NCT01097616|101227337|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
33366113|NCT01097616|101227330|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
33366114|NCT01097616|101227331|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
33366115|NCT01097616|101227332|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
33366116|NCT01097616|101227333|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33366117|NCT01097616|101227334|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33366118|NCT01097616|101227335|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33366119|NCT01097616|101227336|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33366120|NCT01097616|101227337|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
33366121|NCT01097616|101227330|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
33366122|NCT01097616|101227331|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
33366123|NCT01097616|101227332|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
33226554|NCT02322814|100728694|FG002|Overall Study|Lost to Follow-up|3|||
33366124|NCT01097616|101227333|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33366125|NCT01097616|101227334|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33366126|NCT01097616|101227335|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33366127|NCT01097616|101227336|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33366128|NCT01097616|101227337|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
33366129|NCT01097616|101227330|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
33366130|NCT01097616|101227331|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
33366131|NCT01097616|101227332|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33366132|NCT01097616|101227333|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33366133|NCT01097616|101227334|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33366134|NCT01097616|101227335|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33366135|NCT01097616|101227336|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33366136|NCT01097616|101227337|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
33366137|NCT01097616|101227330|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
33366138|NCT01097616|101227331|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
33366139|NCT01097616|101227332|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
33366140|NCT01097616|101227333|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33366141|NCT01097616|101227334|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33366142|NCT01097616|101227335|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33366143|NCT01097616|101227336|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33632558|NCT04780061|102206015|FG001|Overall Study|Withdrawal by Subject|8|||
33366144|NCT01097616|101227337|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
33366145|NCT01097616|101227330|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
33632559|NCT04780061|102206014|FG000|Overall Study|Adverse Event|2|||
33226555|NCT02322814|100728695|FG003|Overall Study|Lost to Follow-up|1|||
33417971|NCT00630994|101422275|FG000|Overall Study|Other|1|||
33417972|NCT02856282|101422276|FG000|Overall Study|Withdrawal by Subject|1|||
33417973|NCT02864953|101422277|FG000|Overall Study|Adverse Event|22|||
33417974|NCT02864953|101422278|FG001|Overall Study|Adverse Event|19|||
33417975|NCT02864953|101422277|FG000|Overall Study|Withdrawal by Subject|1|||
33417976|NCT02864953|101422278|FG001|Overall Study|Withdrawal by Subject|0|||
33417977|NCT02864953|101422277|FG000|Overall Study|Physician Decision|4|||
33417978|NCT02864953|101422278|FG001|Overall Study|Physician Decision|2|||
33417979|NCT02864953|101422277|FG000|Overall Study|Death|3|||
33417980|NCT02864953|101422278|FG001|Overall Study|Death|13|||
33417981|NCT02864953|101422277|FG000|Overall Study|Reason not specified|14|||
33417982|NCT02864953|101422278|FG001|Overall Study|Reason not specified|12|||
33417983|NCT02864953|101422277|FG000|Overall Study|Withdrew Prior to Dosing|9|||
33417984|NCT02864953|101422278|FG001|Overall Study|Withdrew Prior to Dosing|8|||
33417985|NCT00455923|101422279|FG000|Overall Study|Pregnancy|0|||
33417986|NCT00455923|101422280|FG001|Overall Study|Pregnancy|2|||
33417987|NCT00455923|101422279|FG000|Overall Study|Other|3|||
33417988|NCT00455923|101422280|FG001|Overall Study|Other|1|||
33417989|NCT03976076|101422281|FG000|Overall Study|Withdrawal by Subject|2|||
33417990|NCT03981614|101422282|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
33417991|NCT03981614|101422283|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
33417992|NCT03981614|101422284|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
33417993|NCT03047031|101422285|FG000|Overall Study|Other than listed|1|||
33569756|NCT01696643|101978303|FG001|Overall Study|Study Terminated by Sponsor|294|||
33569757|NCT01696643|101978302|FG000|Overall Study|Withdrawal by Subject|142|||
33569758|NCT01696643|101978303|FG001|Overall Study|Withdrawal by Subject|149|||
33569759|NCT01696643|101978302|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
33366146|NCT01097616|101227331|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
33366147|NCT01097616|101227332|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
33366148|NCT01097616|101227333|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
33366149|NCT01097616|101227334|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
33366150|NCT01097616|101227335|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
33366151|NCT01097616|101227336|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
33366152|NCT01097616|101227337|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
33366153|NCT01097616|101227330|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
33366154|NCT01097616|101227331|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
33366155|NCT01097616|101227332|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33366156|NCT01097616|101227333|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33366157|NCT01097616|101227334|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33366158|NCT01097616|101227335|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33366159|NCT01097616|101227336|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33366160|NCT01097616|101227337|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
33366161|NCT01097616|101227330|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33366162|NCT01097616|101227331|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33366163|NCT01097616|101227332|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
33366164|NCT01097616|101227333|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33366165|NCT01097616|101227334|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33366166|NCT01097616|101227335|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33366167|NCT01097616|101227336|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33366168|NCT01097616|101227337|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
33366169|NCT01097616|101227330|FG000|Optional DB EXT Phase|Adverse Event|0|||
33366170|NCT01097616|101227331|FG001|Optional DB EXT Phase|Adverse Event|7|||
33366171|NCT01097616|101227332|FG002|Optional DB EXT Phase|Adverse Event|2|||
33366172|NCT01097616|101227333|FG003|Optional DB EXT Phase|Adverse Event|0|||
33366173|NCT01097616|101227334|FG004|Optional DB EXT Phase|Adverse Event|0|||
33366174|NCT01097616|101227335|FG005|Optional DB EXT Phase|Adverse Event|0|||
33366175|NCT01097616|101227336|FG006|Optional DB EXT Phase|Adverse Event|0|||
33366176|NCT01097616|101227337|FG007|Optional DB EXT Phase|Adverse Event|0|||
33366177|NCT01097616|101227330|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
33366178|NCT01097616|101227331|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
33366179|NCT01097616|101227332|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
33366180|NCT01097616|101227333|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
33366181|NCT01097616|101227334|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
33366182|NCT01097616|101227335|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
33366183|NCT01097616|101227336|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
33417994|NCT03047031|101422286|FG001|Overall Study|Other than listed|0|||
33417995|NCT03047031|101422287|FG002|Overall Study|Other than listed|0|||
33417996|NCT03047031|101422285|FG000|Overall Study|Lost to Follow-up|4|||
33632560|NCT04780061|102206015|FG001|Overall Study|Adverse Event|2|||
33417997|NCT03047031|101422286|FG001|Overall Study|Lost to Follow-up|0|||
33417998|NCT03047031|101422287|FG002|Overall Study|Lost to Follow-up|0|||
33632561|NCT04780061|102206014|FG000|Overall Study|Lost to Follow-up|1|||
33226556|NCT02322814|100728696|FG004|Overall Study|Lost to Follow-up|0|||
33226557|NCT02322814|100728692|FG000|Overall Study|Various Reasons|2|||
33569760|NCT01696643|101978303|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
33569761|NCT01696643|101978302|FG000|Overall Study|Site Error|2|||
33569762|NCT01696643|101978303|FG001|Overall Study|Site Error|1|||
33569763|NCT01696643|101978302|FG000|Overall Study|Participant Incarcerated|0|||
33569764|NCT01696643|101978303|FG001|Overall Study|Participant Incarcerated|1|||
33569765|NCT01696643|101978302|FG000|Overall Study|Medical Monitor Decision|0|||
33569766|NCT01696643|101978303|FG001|Overall Study|Medical Monitor Decision|2|||
33569767|NCT01696643|101978302|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
33569768|NCT01696643|101978303|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
33569769|NCT00518180|101978304|FG000|Overall Study|Withdrawal by Subject|29|||
33569770|NCT00518180|101978305|FG001|Overall Study|Withdrawal by Subject|30|||
33569771|NCT00518180|101978306|FG002|Overall Study|Withdrawal by Subject|42|||
33569772|NCT00518180|101978304|FG000|Overall Study|Lost to Follow-up|30|||
33569773|NCT00518180|101978305|FG001|Overall Study|Lost to Follow-up|28|||
33569774|NCT00518180|101978306|FG002|Overall Study|Lost to Follow-up|34|||
33569775|NCT00518180|101978304|FG000|Overall Study|Administrative reason|0|||
33569776|NCT00518180|101978305|FG001|Overall Study|Administrative reason|2|||
33569777|NCT00518180|101978306|FG002|Overall Study|Administrative reason|2|||
33569778|NCT00518180|101978304|FG000|Overall Study|Protocol Violation|5|||
33569779|NCT00518180|101978305|FG001|Overall Study|Protocol Violation|7|||
33569780|NCT00518180|101978306|FG002|Overall Study|Protocol Violation|4|||
33632562|NCT04780061|102206015|FG001|Overall Study|Lost to Follow-up|5|||
33632563|NCT03317405|102206016|FG000|Overall Study|Withdrawal by Subject|1|||
33632564|NCT03317405|102206017|FG001|Overall Study|Withdrawal by Subject|0|||
33632565|NCT03317405|102206018|FG002|Overall Study|Withdrawal by Subject|0|||
33632566|NCT03317405|102206016|FG000|Overall Study|Physician Decision|0|||
33632567|NCT03317405|102206017|FG001|Overall Study|Physician Decision|0|||
33632568|NCT03317405|102206018|FG002|Overall Study|Physician Decision|1|||
33632569|NCT03317405|102206016|FG000|Overall Study|Surgery Rescheduled|0|||
33632570|NCT03317405|102206017|FG001|Overall Study|Surgery Rescheduled|1|||
33632571|NCT03317405|102206018|FG002|Overall Study|Surgery Rescheduled|0|||
33632572|NCT01473134|102206019|FG000|Overall Study|Lost to Follow-up|21|||
33632573|NCT01473134|102206020|FG001|Overall Study|Lost to Follow-up|13|||
33632574|NCT01473134|102206019|FG000|Overall Study|Protocol Violation|32|||
33632575|NCT01473134|102206020|FG001|Overall Study|Protocol Violation|19|||
33632576|NCT01473134|102206019|FG000|Overall Study|Withdrawal by Subject|1|||
33632577|NCT01473134|102206020|FG001|Overall Study|Withdrawal by Subject|2|||
33632578|NCT01473134|102206019|FG000|Overall Study|Death|0|||
33632579|NCT01473134|102206020|FG001|Overall Study|Death|1|||
33632580|NCT01473134|102206019|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
33632581|NCT01473134|102206020|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
33632582|NCT03119259|102206021|FG000|Overall Study|Withdrawn as no longer eligible|1|||
33226558|NCT02322814|100728693|FG001|Overall Study|Various Reasons|0|||
33226559|NCT02322814|100728694|FG002|Overall Study|Various Reasons|1|||
33226560|NCT02322814|100728695|FG003|Overall Study|Various Reasons|1|||
33226561|NCT02322814|100728696|FG004|Overall Study|Various Reasons|0|||
33226562|NCT02322814|100728692|FG000|Overall Study|Progressive Disease|0|||
33226563|NCT02322814|100728693|FG001|Overall Study|Progressive Disease|0|||
33569781|NCT00518180|101978304|FG000|Overall Study|Unable to classify|0|||
33226564|NCT02322814|100728694|FG002|Overall Study|Progressive Disease|0|||
33226565|NCT02322814|100728695|FG003|Overall Study|Progressive Disease|1|||
33226566|NCT02322814|100728696|FG004|Overall Study|Progressive Disease|1|||
33226567|NCT02322814|100728692|FG000|Overall Study|Protocol Violation|1|||
33226568|NCT02322814|100728693|FG001|Overall Study|Protocol Violation|0|||
33226569|NCT02322814|100728694|FG002|Overall Study|Protocol Violation|0|||
33226570|NCT02322814|100728695|FG003|Overall Study|Protocol Violation|0|||
33226571|NCT02322814|100728696|FG004|Overall Study|Protocol Violation|0|||
33226572|NCT02322814|100728692|FG000|Overall Study|Study Terminated by Sponsor|0|||
33226573|NCT02322814|100728693|FG001|Overall Study|Study Terminated by Sponsor|7|||
33226574|NCT02322814|100728694|FG002|Overall Study|Study Terminated by Sponsor|9|||
33226575|NCT02322814|100728695|FG003|Overall Study|Study Terminated by Sponsor|5|||
33226576|NCT02322814|100728696|FG004|Overall Study|Study Terminated by Sponsor|13|||
33226577|NCT02322814|100728692|FG000|Overall Study|Withdrawal by Subject|5|||
33226578|NCT02322814|100728693|FG001|Overall Study|Withdrawal by Subject|4|||
33226579|NCT02322814|100728694|FG002|Overall Study|Withdrawal by Subject|2|||
33226580|NCT02322814|100728695|FG003|Overall Study|Withdrawal by Subject|1|||
33226581|NCT02322814|100728696|FG004|Overall Study|Withdrawal by Subject|3|||
33226582|NCT03579290|100728697|FG000|Overall Study|Lost to Follow-up|9|||
33226583|NCT02601937|100728700|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
33632583|NCT03119259|102206022|FG001|Overall Study|Withdrawn as no longer eligible|0|||
33632584|NCT03119259|102206021|FG000|Overall Study|Withdrawal by Subject|4|||
33226584|NCT02601937|100728701|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
33569782|NCT00518180|101978305|FG001|Overall Study|Unable to classify|2|||
33569783|NCT00518180|101978306|FG002|Overall Study|Unable to classify|0|||
33569784|NCT00518180|101978304|FG000|Overall Study|Adverse Event|1|||
33632585|NCT03119259|102206022|FG001|Overall Study|Withdrawal by Subject|2|||
33632586|NCT03119259|102206021|FG000|Overall Study|Lost to Follow-up|0|||
33569785|NCT00518180|101978305|FG001|Overall Study|Adverse Event|0|||
33569786|NCT00518180|101978306|FG002|Overall Study|Adverse Event|0|||
33569787|NCT00833690|101978311|FG000|Overall Study|Withdrawal by Subject|1|||
33569788|NCT00833690|101978312|FG001|Overall Study|Withdrawal by Subject|0|||
33569789|NCT00833690|101978313|FG002|Overall Study|Withdrawal by Subject|0|||
33569790|NCT00833690|101978311|FG000|Overall Study|Discontinued study drug|3|||
33569791|NCT00833690|101978312|FG001|Overall Study|Discontinued study drug|2|||
33632587|NCT03119259|102206022|FG001|Overall Study|Lost to Follow-up|1|||
33632588|NCT00107198|102206028|FG000|Overall Study|Lack of Efficacy|28|||
33632589|NCT00107198|102206028|FG000|Overall Study|Lost to Follow-up|12|||
33632590|NCT00107198|102206028|FG000|Overall Study|Protocol Violation|1|||
33632591|NCT00107198|102206028|FG000|Overall Study|Withdrawal by Subject|6|||
33632592|NCT00107198|102206028|FG000|Overall Study|Ineligible|5|||
33632593|NCT01967238|102206029|FG000|Overall Study|Adverse Event|1|||
33632594|NCT01967238|102206030|FG001|Overall Study|Adverse Event|1|||
33632595|NCT01967238|102206031|FG002|Overall Study|Adverse Event|0|||
33226585|NCT02601937|100728702|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
33226586|NCT02601937|100728703|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
33632596|NCT01967238|102206029|FG000|Overall Study|Lost to Follow-up|1|||
33632597|NCT01967238|102206030|FG001|Overall Study|Lost to Follow-up|0|||
33632598|NCT01967238|102206031|FG002|Overall Study|Lost to Follow-up|1|||
33632599|NCT01967238|102206029|FG000|Overall Study|Withdrawal by Subject|0|||
33569792|NCT00833690|101978313|FG002|Overall Study|Discontinued study drug|0|||
33569793|NCT02735200|101978318|FG000|Overall Study|Lost to Follow-up|0|||
33569794|NCT02735200|101978319|FG001|Overall Study|Lost to Follow-up|5|||
33569795|NCT02735200|101978318|FG000|Overall Study|Withdrawal by Subject|8|||
33569796|NCT02735200|101978319|FG001|Overall Study|Withdrawal by Subject|0|||
33569797|NCT00557440|101978320|FG000|Treatment Period 1|Adverse Event|0|||
33569798|NCT00557440|101978321|FG001|Treatment Period 1|Adverse Event|0|||
33569799|NCT00557440|101978322|FG002|Treatment Period 1|Adverse Event|1|||
33569800|NCT01602484|101978323|FG000|Overall Study|Airway issues unrelated to study|0|||
33569801|NCT01602484|101978324|FG001|Overall Study|Airway issues unrelated to study|1|||
33569802|NCT00688740|101978325|FG000|Overall Study|Adverse Event|45|||
33569803|NCT00688740|101978326|FG001|Overall Study|Adverse Event|8|||
33632600|NCT01967238|102206030|FG001|Overall Study|Withdrawal by Subject|0|||
33632601|NCT01967238|102206031|FG002|Overall Study|Withdrawal by Subject|1|||
33632602|NCT00453206|102206033|FG000|Overall Study|Death|1|||
33632603|NCT02443688|102206034|FG000|Overall Study|Adverse Event|2|||
33632604|NCT02443688|102206035|FG001|Overall Study|Adverse Event|3|||
33569804|NCT00688740|101978325|FG000|Overall Study|Death|2|||
33569805|NCT00688740|101978326|FG001|Overall Study|Death|2|||
33569806|NCT00688740|101978325|FG000|Overall Study|Lost to Follow-up|0|||
33226587|NCT02601937|100728704|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
33569807|NCT00688740|101978326|FG001|Overall Study|Lost to Follow-up|1|||
33226588|NCT02601937|100728705|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
33226589|NCT02601937|100728706|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
33569808|NCT00688740|101978325|FG000|Overall Study|Consent Withdrawn|17|||
33569809|NCT00688740|101978326|FG001|Overall Study|Consent Withdrawn|17|||
33632605|NCT02443688|102206036|FG002|Overall Study|Adverse Event|2|||
33226590|NCT02601937|100728707|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
33226591|NCT02601937|100728708|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
33226592|NCT02601937|100728709|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
33226593|NCT02601937|100728710|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
33226594|NCT02601937|100728700|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
33226595|NCT02601937|100728701|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
33226596|NCT02601937|100728702|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
33417999|NCT03047031|101422285|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
33418000|NCT03047031|101422286|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
33418001|NCT03047031|101422287|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
33418002|NCT03047031|101422285|FG000|Overall Study|Adverse Event|1|||
33418003|NCT03047031|101422286|FG001|Overall Study|Adverse Event|0|||
33418004|NCT03047031|101422287|FG002|Overall Study|Adverse Event|0|||
33418005|NCT03047031|101422285|FG000|Overall Study|Withdrawal by Subject|2|||
33418006|NCT03047031|101422286|FG001|Overall Study|Withdrawal by Subject|0|||
33418007|NCT03047031|101422287|FG002|Overall Study|Withdrawal by Subject|0|||
33418008|NCT03047031|101422285|FG000|Overall Study|Change to other medication|2|||
33418009|NCT03047031|101422286|FG001|Overall Study|Change to other medication|0|||
33418010|NCT03047031|101422287|FG002|Overall Study|Change to other medication|0|||
33418011|NCT03047031|101422285|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
33226597|NCT02601937|100728703|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
33226598|NCT02601937|100728704|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
33226599|NCT02601937|100728705|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
33226600|NCT02601937|100728706|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
33226601|NCT02601937|100728707|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
33226602|NCT02601937|100728708|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
33226603|NCT02601937|100728709|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
33226604|NCT02601937|100728710|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
33226605|NCT02601937|100728700|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
33226606|NCT02601937|100728701|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
33226607|NCT02601937|100728702|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
33226608|NCT02601937|100728703|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
33226609|NCT02601937|100728704|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
33226610|NCT02601937|100728705|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
33226611|NCT02601937|100728706|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
33226612|NCT02601937|100728707|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
33226613|NCT02601937|100728708|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
33226614|NCT02601937|100728709|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
33226615|NCT02601937|100728710|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
33226616|NCT02601937|100728700|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
33226617|NCT02601937|100728701|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
33226618|NCT02601937|100728702|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
33226619|NCT02601937|100728703|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
33226620|NCT02601937|100728704|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
33226621|NCT02601937|100728705|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
33226622|NCT02601937|100728706|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
33418012|NCT03047031|101422286|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
33418013|NCT03047031|101422287|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
33418014|NCT04489888|101422288|FG000|Overall Study|Death|61|||
33569810|NCT00688740|101978325|FG000|Overall Study|Breast Cancer Relapse|1|||
33569811|NCT00688740|101978326|FG001|Overall Study|Breast Cancer Relapse|4|||
33632606|NCT02443688|102206034|FG000|Overall Study|Lost to Follow-up|1|||
33569812|NCT00688740|101978325|FG000|Overall Study|Violation of Inclusion Criteria|1|||
33569813|NCT00688740|101978326|FG001|Overall Study|Violation of Inclusion Criteria|3|||
33569814|NCT03058952|101978330|FG000|Overall Study|Adverse Event|1|||
33569815|NCT03058952|101978331|FG001|Overall Study|Adverse Event|0|||
33569816|NCT03058952|101978330|FG000|Overall Study|Lost to Follow-up|15|||
33569817|NCT03058952|101978331|FG001|Overall Study|Lost to Follow-up|15|||
33569818|NCT03058952|101978330|FG000|Overall Study|Withdrawal by Subject|7|||
33569819|NCT03058952|101978331|FG001|Overall Study|Withdrawal by Subject|11|||
33569820|NCT01972659|101978335|FG000|Overall Study|Protocol Violation|2|||
33569821|NCT01972659|101978336|FG001|Overall Study|Protocol Violation|2|||
33569822|NCT01972659|101978335|FG000|Overall Study|problems realted to acceleromyograph|2|||
33569823|NCT01972659|101978336|FG001|Overall Study|problems realted to acceleromyograph|1|||
33569824|NCT03895372|101978339|FG000|Investigational Treatment Period|Adverse Event|1|||
33569825|NCT03895372|101978340|FG001|Investigational Treatment Period|Adverse Event|0|||
33569826|NCT03895372|101978341|FG002|Investigational Treatment Period|Adverse Event|0|||
33632607|NCT02443688|102206035|FG001|Overall Study|Lost to Follow-up|0|||
33632608|NCT02443688|102206036|FG002|Overall Study|Lost to Follow-up|0|||
33632609|NCT02443688|102206034|FG000|Overall Study|Physician Decision|3|||
33569827|NCT03895372|101978342|FG003|Investigational Treatment Period|Adverse Event|0|||
33569828|NCT03895372|101978343|FG004|Investigational Treatment Period|Adverse Event|0|||
33569829|NCT03895372|101978344|FG005|Investigational Treatment Period|Adverse Event|0|||
33569830|NCT03895372|101978345|FG006|Investigational Treatment Period|Adverse Event|4|||
33632610|NCT02443688|102206035|FG001|Overall Study|Physician Decision|0|||
33632611|NCT02443688|102206036|FG002|Overall Study|Physician Decision|1|||
33632612|NCT02443688|102206034|FG000|Overall Study|Pregnancy|0|||
33632613|NCT02443688|102206035|FG001|Overall Study|Pregnancy|0|||
33366184|NCT01097616|101227337|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
33418015|NCT04489888|101422288|FG000|Overall Study|Participant On-going|40|||
33418016|NCT00953927|101422290|FG000|Overall Study|Lost to Follow-up|61|||
33418017|NCT00953927|101422291|FG001|Overall Study|Lost to Follow-up|65|||
33418018|NCT00953927|101422290|FG000|Overall Study|Withdrawal by Subject|36|||
33418019|NCT00953927|101422291|FG001|Overall Study|Withdrawal by Subject|25|||
33418020|NCT00953927|101422290|FG000|Overall Study|Death|7|||
33418021|NCT00953927|101422291|FG001|Overall Study|Death|4|||
33418022|NCT00953927|101422290|FG000|Overall Study|Other study discontinuation|1|||
33418023|NCT00953927|101422291|FG001|Overall Study|Other study discontinuation|1|||
33418024|NCT03273712|101422292|FG000|Overall Study|Death|5|||
33418025|NCT03273712|101422292|FG000|Overall Study|Adverse Event|1|||
33632614|NCT02443688|102206036|FG002|Overall Study|Pregnancy|1|||
33632615|NCT02443688|102206034|FG000|Overall Study|Withdrawal by Subject|3|||
33632616|NCT02443688|102206035|FG001|Overall Study|Withdrawal by Subject|3|||
33632617|NCT02443688|102206036|FG002|Overall Study|Withdrawal by Subject|4|||
33366185|NCT01097616|101227330|FG000|Optional DB EXT Phase|Protocol Violation|0|||
33366186|NCT01097616|101227331|FG001|Optional DB EXT Phase|Protocol Violation|2|||
33366187|NCT01097616|101227332|FG002|Optional DB EXT Phase|Protocol Violation|3|||
33366188|NCT01097616|101227333|FG003|Optional DB EXT Phase|Protocol Violation|0|||
33366189|NCT01097616|101227334|FG004|Optional DB EXT Phase|Protocol Violation|0|||
33366190|NCT01097616|101227335|FG005|Optional DB EXT Phase|Protocol Violation|0|||
33366191|NCT01097616|101227336|FG006|Optional DB EXT Phase|Protocol Violation|0|||
33366192|NCT01097616|101227337|FG007|Optional DB EXT Phase|Protocol Violation|0|||
33366193|NCT01097616|101227330|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
33366194|NCT01097616|101227331|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
33366195|NCT01097616|101227332|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
33366196|NCT01097616|101227333|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
33366197|NCT01097616|101227334|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
33366198|NCT01097616|101227335|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
33366199|NCT01097616|101227336|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
33366200|NCT01097616|101227337|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
33366201|NCT01097616|101227330|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
33418026|NCT03273712|101422292|FG000|Overall Study|Disease Progression|1|||
33418027|NCT03891875|101422293|FG000|Overall Study|Withdrawal by Subject|20|||
33632618|NCT02443688|102206034|FG000|Overall Study|Non-compliance with study drug|1|||
33418028|NCT03891875|101422294|FG001|Overall Study|Withdrawal by Subject|3|||
33418029|NCT03891875|101422293|FG000|Overall Study|Adverse Event|10|||
33569831|NCT03895372|101978346|FG007|Investigational Treatment Period|Adverse Event|3|||
33569832|NCT03895372|101978339|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
33632619|NCT02443688|102206035|FG001|Overall Study|Non-compliance with study drug|2|||
33632620|NCT02443688|102206036|FG002|Overall Study|Non-compliance with study drug|4|||
33366202|NCT01097616|101227331|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
33632621|NCT02443688|102206034|FG000|Overall Study|Sponsor Request|2|||
33632622|NCT02443688|102206035|FG001|Overall Study|Sponsor Request|1|||
33632623|NCT02443688|102206036|FG002|Overall Study|Sponsor Request|0|||
33632624|NCT00541658|102206037|FG000|Overall Study|Adverse Event|28|||
33418030|NCT03891875|101422294|FG001|Overall Study|Adverse Event|4|||
33418031|NCT03891875|101422293|FG000|Overall Study|Physician Decision|1|||
33418032|NCT03891875|101422294|FG001|Overall Study|Physician Decision|1|||
33418033|NCT03891875|101422293|FG000|Overall Study|Protocol Violation|1|||
33418034|NCT03891875|101422294|FG001|Overall Study|Protocol Violation|0|||
33418035|NCT03891875|101422293|FG000|Overall Study|Lost to Follow-up|1|||
33418036|NCT03891875|101422294|FG001|Overall Study|Lost to Follow-up|0|||
33418037|NCT03891875|101422293|FG000|Overall Study|COVID-19 infection|1|||
33418038|NCT03891875|101422294|FG001|Overall Study|COVID-19 infection|0|||
33418039|NCT02842086|101422295|FG000|Overall Study|Randomized but Never Treated|6|||
33418040|NCT02842086|101422296|FG001|Overall Study|Randomized but Never Treated|6|||
33418041|NCT02842086|101422295|FG000|Overall Study|Still in Double-Blind Phase|7|||
33632625|NCT00541658|102206038|FG001|Overall Study|Adverse Event|37|||
33632626|NCT00541658|102206039|FG002|Overall Study|Adverse Event|25|||
33632627|NCT00541658|102206037|FG000|Overall Study|Physician Decision|0|||
33632628|NCT00541658|102206038|FG001|Overall Study|Physician Decision|0|||
33632629|NCT00541658|102206039|FG002|Overall Study|Physician Decision|4|||
33632630|NCT00541658|102206037|FG000|Overall Study|Lost to Follow-up|3|||
33632631|NCT00541658|102206038|FG001|Overall Study|Lost to Follow-up|3|||
33632632|NCT00541658|102206039|FG002|Overall Study|Lost to Follow-up|6|||
33632633|NCT00541658|102206037|FG000|Overall Study|Protocol Violation|0|||
33632634|NCT00541658|102206038|FG001|Overall Study|Protocol Violation|1|||
33632635|NCT00541658|102206039|FG002|Overall Study|Protocol Violation|1|||
33632636|NCT00541658|102206037|FG000|Overall Study|Withdrawal by Subject|28|||
33632637|NCT00541658|102206038|FG001|Overall Study|Withdrawal by Subject|32|||
33632638|NCT00541658|102206039|FG002|Overall Study|Withdrawal by Subject|32|||
33632639|NCT00541658|102206037|FG000|Overall Study|Took No Study Drug|1|||
33632640|NCT00541658|102206038|FG001|Overall Study|Took No Study Drug|0|||
33366203|NCT01097616|101227332|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
33366204|NCT01097616|101227333|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
33366205|NCT01097616|101227334|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
33366206|NCT01097616|101227335|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
33366207|NCT01097616|101227336|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
33366208|NCT01097616|101227337|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
33366209|NCT01097616|101227330|FG000|Optional DB EXT Phase|Physician Decision|1|||
33366210|NCT01097616|101227331|FG001|Optional DB EXT Phase|Physician Decision|0|||
33366211|NCT01097616|101227332|FG002|Optional DB EXT Phase|Physician Decision|0|||
33366212|NCT01097616|101227333|FG003|Optional DB EXT Phase|Physician Decision|0|||
33366213|NCT01097616|101227334|FG004|Optional DB EXT Phase|Physician Decision|0|||
33366214|NCT01097616|101227335|FG005|Optional DB EXT Phase|Physician Decision|0|||
33366215|NCT01097616|101227336|FG006|Optional DB EXT Phase|Physician Decision|0|||
33366216|NCT01097616|101227337|FG007|Optional DB EXT Phase|Physician Decision|0|||
33366217|NCT01097616|101227330|FG000|DB RO Phase|Adverse Event|0|||
33366218|NCT01097616|101227331|FG001|DB RO Phase|Adverse Event|0|||
33366219|NCT01097616|101227332|FG002|DB RO Phase|Adverse Event|0|||
33366220|NCT01097616|101227333|FG003|DB RO Phase|Adverse Event|0|||
33366221|NCT01097616|101227334|FG004|DB RO Phase|Adverse Event|0|||
33366222|NCT01097616|101227335|FG005|DB RO Phase|Adverse Event|0|||
33366223|NCT01097616|101227336|FG006|DB RO Phase|Adverse Event|1|||
33366224|NCT01097616|101227337|FG007|DB RO Phase|Adverse Event|0|||
33366225|NCT01097616|101227330|FG000|DB RO Phase|Withdrawal by Subject|0|||
33366226|NCT01097616|101227331|FG001|DB RO Phase|Withdrawal by Subject|0|||
33366227|NCT01097616|101227332|FG002|DB RO Phase|Withdrawal by Subject|0|||
33366228|NCT01097616|101227333|FG003|DB RO Phase|Withdrawal by Subject|0|||
33366229|NCT01097616|101227334|FG004|DB RO Phase|Withdrawal by Subject|0|||
33366230|NCT01097616|101227335|FG005|DB RO Phase|Withdrawal by Subject|1|||
33366231|NCT01097616|101227336|FG006|DB RO Phase|Withdrawal by Subject|0|||
33366232|NCT01097616|101227337|FG007|DB RO Phase|Withdrawal by Subject|0|||
33366233|NCT01097616|101227330|FG000|DB RO Phase|Lost to Follow-up|0|||
33366234|NCT01097616|101227331|FG001|DB RO Phase|Lost to Follow-up|0|||
33418042|NCT02842086|101422296|FG001|Overall Study|Still in Double-Blind Phase|3|||
33418043|NCT02842086|101422295|FG000|Overall Study|Adverse Event|18|||
33418044|NCT02842086|101422296|FG001|Overall Study|Adverse Event|20|||
33418045|NCT02842086|101422295|FG000|Overall Study|Death|3|||
33418046|NCT02842086|101422296|FG001|Overall Study|Death|3|||
33632641|NCT00541658|102206039|FG002|Overall Study|Took No Study Drug|0|||
33632642|NCT01527370|102206040|FG000|Overall Study|Withdrawal by Subject|4|||
33632643|NCT01527370|102206040|FG000|Overall Study|Physician Decision|1|||
33632644|NCT01527370|102206040|FG000|Overall Study|Death|1|||
33366235|NCT01097616|101227332|FG002|DB RO Phase|Lost to Follow-up|0|||
33366236|NCT01097616|101227333|FG003|DB RO Phase|Lost to Follow-up|1|||
33366237|NCT01097616|101227334|FG004|DB RO Phase|Lost to Follow-up|1|||
33366238|NCT01097616|101227335|FG005|DB RO Phase|Lost to Follow-up|0|||
33418047|NCT02842086|101422295|FG000|Overall Study|Investigator's Discretion|9|||
33418048|NCT02842086|101422296|FG001|Overall Study|Investigator's Discretion|13|||
33632645|NCT02954536|102206046|FG000|Overall Study|Adverse Event|2|||
33418049|NCT02842086|101422295|FG000|Overall Study|Non-Compliance with Study Drug|9|||
33418050|NCT02842086|101422296|FG001|Overall Study|Non-Compliance with Study Drug|8|||
33418051|NCT02842086|101422295|FG000|Overall Study|Protocol Violation|8|||
33418052|NCT02842086|101422296|FG001|Overall Study|Protocol Violation|4|||
33418053|NCT02842086|101422295|FG000|Overall Study|Withdrew Consent|205|||
33418054|NCT02842086|101422296|FG001|Overall Study|Withdrew Consent|194|||
33418055|NCT02842086|101422295|FG000|Overall Study|Lost to Follow-up|274|||
33418056|NCT02842086|101422296|FG001|Overall Study|Lost to Follow-up|236|||
33418057|NCT02842086|101422295|FG000|Overall Study|HIV-1 Infection|5|||
33418058|NCT02842086|101422296|FG001|Overall Study|HIV-1 Infection|6|||
33418059|NCT04840901|101422297|FG000|Overall Study|Lost to Follow-up|3|||
33418060|NCT04840901|101422298|FG001|Overall Study|Lost to Follow-up|1|||
33418061|NCT04840901|101422297|FG000|Overall Study|Moved|1|||
33418062|NCT04840901|101422298|FG001|Overall Study|Moved|0|||
33418063|NCT04840901|101422297|FG000|Overall Study|Unable to comply with study schedule|0|||
33418064|NCT04840901|101422298|FG001|Overall Study|Unable to comply with study schedule|1|||
33418065|NCT04840901|101422297|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
33418066|NCT04840901|101422298|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
33418067|NCT03125915|101422301|FG000|1 Month Follow up|Lost to Follow-up|3|||
33418068|NCT03125915|101422302|FG001|1 Month Follow up|Lost to Follow-up|3|||
33418069|NCT03125915|101422303|FG002|1 Month Follow up|Lost to Follow-up|2|||
33418070|NCT03125915|101422304|FG003|1 Month Follow up|Lost to Follow-up|3|||
33418071|NCT03125915|101422301|FG000|3 Month Follow-up|Lost to Follow-up|6|||
33418072|NCT03125915|101422302|FG001|3 Month Follow-up|Lost to Follow-up|4|||
33418073|NCT03125915|101422303|FG002|3 Month Follow-up|Lost to Follow-up|4|||
33418074|NCT03125915|101422304|FG003|3 Month Follow-up|Lost to Follow-up|2|||
33418075|NCT03125915|101422301|FG000|6 Month Follow-up|Lost to Follow-up|7|||
33418076|NCT03125915|101422302|FG001|6 Month Follow-up|Lost to Follow-up|3|||
33418077|NCT03125915|101422303|FG002|6 Month Follow-up|Lost to Follow-up|6|||
33418078|NCT03125915|101422304|FG003|6 Month Follow-up|Lost to Follow-up|3|||
33418079|NCT02587325|101422305|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
33418080|NCT02587325|101422306|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
33418081|NCT02587325|101422307|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
33418082|NCT02587325|101422308|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
33418083|NCT02587325|101422309|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
33418084|NCT02587325|101422305|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
33418085|NCT02587325|101422306|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
33418086|NCT02587325|101422307|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
33418087|NCT02587325|101422308|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
33418088|NCT02587325|101422309|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
33418089|NCT02587325|101422305|FG000|32-Week Optional Extension Part|Adverse Event|0|||
33418090|NCT02587325|101422306|FG001|32-Week Optional Extension Part|Adverse Event|0|||
33418091|NCT02587325|101422307|FG002|32-Week Optional Extension Part|Adverse Event|1|||
33418092|NCT02587325|101422308|FG003|32-Week Optional Extension Part|Adverse Event|0|||
33418093|NCT02587325|101422309|FG004|32-Week Optional Extension Part|Adverse Event|0|||
33418094|NCT02587325|101422305|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
33418095|NCT02587325|101422306|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
33418096|NCT02587325|101422307|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
33418097|NCT02587325|101422308|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
33418098|NCT02587325|101422309|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
33418099|NCT00826176|101422310|FG000|Overall Study|Lost to Follow-up|1|||
33569833|NCT03895372|101978340|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
33569834|NCT03895372|101978341|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
33569835|NCT03895372|101978342|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
33569836|NCT03895372|101978343|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
33569837|NCT03895372|101978344|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
33569838|NCT03895372|101978345|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
33569839|NCT03895372|101978346|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
33569840|NCT03895372|101978339|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
33569841|NCT03895372|101978340|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
33569842|NCT03895372|101978341|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
33569843|NCT03895372|101978342|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
33569844|NCT03895372|101978343|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
33569845|NCT03895372|101978344|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
33632646|NCT02954536|102206046|FG000|Overall Study|Death|12|||
33632647|NCT00456846|102206047|FG000|Overall Study|Adverse Event|2|||
33632648|NCT00456846|102206048|FG001|Overall Study|Adverse Event|15|||
33418100|NCT00826176|101422311|FG001|Overall Study|Lost to Follow-up|0|||
33418101|NCT00826176|101422310|FG000|Overall Study|Subject Withdrew Consent|3|||
33569846|NCT03895372|101978345|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
33632649|NCT00456846|102206047|FG000|Overall Study|Physician Decision|11|||
33418102|NCT00826176|101422311|FG001|Overall Study|Subject Withdrew Consent|0|||
33418103|NCT00826176|101422310|FG000|Overall Study|Administrative|9|||
33569847|NCT03895372|101978346|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
33569848|NCT03895372|101978339|FG000|Investigational Treatment Period|Other|0|||
33569849|NCT03895372|101978340|FG001|Investigational Treatment Period|Other|0|||
33569850|NCT03895372|101978341|FG002|Investigational Treatment Period|Other|0|||
33569851|NCT03895372|101978342|FG003|Investigational Treatment Period|Other|0|||
33632650|NCT00456846|102206048|FG001|Overall Study|Physician Decision|6|||
33632651|NCT00456846|102206047|FG000|Overall Study|Protocol Deviation|2|||
33632652|NCT00456846|102206048|FG001|Overall Study|Protocol Deviation|0|||
33632653|NCT00456846|102206047|FG000|Overall Study|Participant Discretion|1|||
33632654|NCT00456846|102206048|FG001|Overall Study|Participant Discretion|5|||
33632655|NCT00456846|102206047|FG000|Overall Study|Other|0|||
33632656|NCT00456846|102206048|FG001|Overall Study|Other|2|||
33632657|NCT03777982|102206054|FG000|Overall Study|Physician Decision|0|||
33632658|NCT03777982|102206055|FG001|Overall Study|Physician Decision|1|||
33632659|NCT03962491|102206056|FG000|Overall Study|Lost to Follow-up|4|||
33632660|NCT03962491|102206057|FG001|Overall Study|Lost to Follow-up|5|||
33632661|NCT03467750|102206059|FG000|Overall Study|Surgery canceled|1|||
33632662|NCT03467750|102206060|FG001|Overall Study|Surgery canceled|0|||
33632663|NCT03467750|102206059|FG000|Overall Study|Protocol Violation|1|||
33226623|NCT02601937|100728707|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
33226624|NCT02601937|100728708|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
33226625|NCT02601937|100728709|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
33226626|NCT02601937|100728710|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
33226627|NCT02601937|100728700|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
33226628|NCT02601937|100728701|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
33226629|NCT02601937|100728702|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
33226630|NCT02601937|100728703|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
33226631|NCT02601937|100728704|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
33226632|NCT02601937|100728705|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
33226633|NCT02601937|100728706|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
33226634|NCT02601937|100728707|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
33226635|NCT02601937|100728708|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
33226636|NCT02601937|100728709|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
33226637|NCT02601937|100728710|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
33226638|NCT02601937|100728700|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
33226639|NCT02601937|100728701|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
33226640|NCT02601937|100728702|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
33226641|NCT02601937|100728703|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
33286407|NCT00092521|100943971|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
33366239|NCT01097616|101227336|FG006|DB RO Phase|Lost to Follow-up|0|||
33366240|NCT01097616|101227337|FG007|DB RO Phase|Lost to Follow-up|1|||
33366241|NCT01097616|101227330|FG000|DB RO Phase|Not Treated in RO|0|||
33366242|NCT01097616|101227331|FG001|DB RO Phase|Not Treated in RO|0|||
33366243|NCT01097616|101227332|FG002|DB RO Phase|Not Treated in RO|0|||
33366244|NCT01097616|101227333|FG003|DB RO Phase|Not Treated in RO|0|||
33366245|NCT01097616|101227334|FG004|DB RO Phase|Not Treated in RO|0|||
33569852|NCT03895372|101978343|FG004|Investigational Treatment Period|Other|0|||
33569853|NCT03895372|101978344|FG005|Investigational Treatment Period|Other|1|||
33569854|NCT03895372|101978345|FG006|Investigational Treatment Period|Other|0|||
33569855|NCT03895372|101978346|FG007|Investigational Treatment Period|Other|2|||
33569856|NCT03895372|101978339|FG000|Investigational Treatment Period|Protocol Violation|0|||
33569857|NCT03895372|101978340|FG001|Investigational Treatment Period|Protocol Violation|0|||
33569858|NCT03895372|101978341|FG002|Investigational Treatment Period|Protocol Violation|0|||
33569859|NCT03895372|101978342|FG003|Investigational Treatment Period|Protocol Violation|1|||
33569860|NCT03895372|101978343|FG004|Investigational Treatment Period|Protocol Violation|0|||
33569861|NCT03895372|101978344|FG005|Investigational Treatment Period|Protocol Violation|0|||
33569862|NCT03895372|101978345|FG006|Investigational Treatment Period|Protocol Violation|0|||
33569863|NCT03895372|101978346|FG007|Investigational Treatment Period|Protocol Violation|0|||
33569864|NCT03895372|101978339|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
33632664|NCT03467750|102206060|FG001|Overall Study|Protocol Violation|1|||
33632665|NCT03467750|102206059|FG000|Overall Study|Withdrawal by Subject|0|||
33632666|NCT03467750|102206060|FG001|Overall Study|Withdrawal by Subject|1|||
33366246|NCT01097616|101227335|FG005|DB RO Phase|Not Treated in RO|1|||
33366247|NCT01097616|101227336|FG006|DB RO Phase|Not Treated in RO|0|||
33366248|NCT01097616|101227337|FG007|DB RO Phase|Not Treated in RO|0|||
33366249|NCT02050048|101227339|FG000|Overall Study|Lost to Follow-up|0|||
33569865|NCT03895372|101978340|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
33632667|NCT04385277|102206061|FG000|Overall Study|Physician Decision|2|||
33632668|NCT04385277|102206061|FG000|Overall Study|Ineligible|1|||
33632669|NCT04385277|102206061|FG000|Overall Study|Patient/Parent Refusal|2|||
33632670|NCT03435211|102206071|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
33632671|NCT04298697|102206074|FG000|Overall Study|Lost to Follow-up|5|||
33632672|NCT04298697|102206075|FG001|Overall Study|Lost to Follow-up|5|||
33632673|NCT04298697|102206076|FG002|Overall Study|Lost to Follow-up|1|||
33632674|NCT04298697|102206077|FG003|Overall Study|Lost to Follow-up|0|||
33632675|NCT04298697|102206074|FG000|Overall Study|Withdrawal by Subject|0|||
33632676|NCT04298697|102206075|FG001|Overall Study|Withdrawal by Subject|3|||
33632677|NCT04298697|102206076|FG002|Overall Study|Withdrawal by Subject|2|||
33632678|NCT04298697|102206077|FG003|Overall Study|Withdrawal by Subject|3|||
33632679|NCT04929249|102206084|FG000|Overall Study|Adverse Event|2|||
33632680|NCT04929249|102206085|FG001|Overall Study|Adverse Event|1|||
33632681|NCT04929249|102206084|FG000|Overall Study|Death|2|||
33569866|NCT03895372|101978341|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
33569867|NCT03895372|101978342|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
33569868|NCT03895372|101978343|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
33569869|NCT03895372|101978344|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
33418104|NCT00826176|101422311|FG001|Overall Study|Administrative|0|||
33418105|NCT01346501|101422312|FG000|Overall Study|Initiated Other Biological Agents|3|||
33418106|NCT01346501|101422313|FG001|Overall Study|Initiated Other Biological Agents|1|||
33418107|NCT01346501|101422312|FG000|Overall Study|Other|8|||
33418108|NCT01346501|101422313|FG001|Overall Study|Other|12|||
33418109|NCT00797316|101422314|FG000|Overall Study|Administrative problems|1|||
33418110|NCT00797316|101422315|FG001|Overall Study|Administrative problems|0|||
33418111|NCT00797316|101422314|FG000|Overall Study|Adverse Event|5|||
33418112|NCT00797316|101422315|FG001|Overall Study|Adverse Event|3|||
33418113|NCT00797316|101422314|FG000|Overall Study|Lost to Follow-up|4|||
33418114|NCT00797316|101422315|FG001|Overall Study|Lost to Follow-up|8|||
33418115|NCT00797316|101422314|FG000|Overall Study|Protocol Deviation|1|||
33418116|NCT00797316|101422315|FG001|Overall Study|Protocol Deviation|2|||
33418117|NCT00797316|101422314|FG000|Overall Study|Patient withdrew consent|12|||
33418118|NCT00797316|101422315|FG001|Overall Study|Patient withdrew consent|6|||
33418119|NCT00797316|101422314|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33418120|NCT00797316|101422315|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
33418121|NCT00567996|101422320|FG000|Overall Study|Adverse Event|18|||
33418122|NCT00567996|101422321|FG001|Overall Study|Adverse Event|16|||
33418123|NCT00567996|101422322|FG002|Overall Study|Adverse Event|13|||
33418124|NCT00567996|101422320|FG000|Overall Study|Protocol Deviation|9|||
33418125|NCT00567996|101422321|FG001|Overall Study|Protocol Deviation|11|||
33418126|NCT00567996|101422322|FG002|Overall Study|Protocol Deviation|13|||
33418127|NCT00567996|101422320|FG000|Overall Study|Withdrawal by Subject|8|||
33418128|NCT00567996|101422321|FG001|Overall Study|Withdrawal by Subject|12|||
33418129|NCT00567996|101422322|FG002|Overall Study|Withdrawal by Subject|22|||
33418130|NCT00567996|101422320|FG000|Overall Study|Abnormal Lab value(s)|2|||
33418131|NCT00567996|101422321|FG001|Overall Study|Abnormal Lab value(s)|1|||
33418132|NCT00567996|101422322|FG002|Overall Study|Abnormal Lab value(s)|2|||
33418133|NCT00567996|101422320|FG000|Overall Study|Abnormal test procedure result(s)|2|||
33418134|NCT00567996|101422321|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33418135|NCT00567996|101422322|FG002|Overall Study|Abnormal test procedure result(s)|1|||
33418136|NCT00567996|101422320|FG000|Overall Study|Lost to Follow-up|2|||
33418137|NCT00567996|101422321|FG001|Overall Study|Lost to Follow-up|5|||
33418138|NCT00567996|101422322|FG002|Overall Study|Lost to Follow-up|2|||
33418139|NCT00567996|101422320|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33418140|NCT00567996|101422321|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33418141|NCT00567996|101422322|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
33569870|NCT03895372|101978345|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
33569871|NCT03895372|101978346|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
33569872|NCT03895372|101978339|FG000|Extension Treatment Period|Adverse Event|0|||
33569873|NCT03895372|101978340|FG001|Extension Treatment Period|Adverse Event|1|||
33569874|NCT03895372|101978341|FG002|Extension Treatment Period|Adverse Event|0|||
33569875|NCT03895372|101978342|FG003|Extension Treatment Period|Adverse Event|1|||
33569876|NCT03895372|101978343|FG004|Extension Treatment Period|Adverse Event|0|||
33569877|NCT03895372|101978344|FG005|Extension Treatment Period|Adverse Event|0|||
33569878|NCT03895372|101978345|FG006|Extension Treatment Period|Adverse Event|3|||
33632682|NCT04929249|102206085|FG001|Overall Study|Death|1|||
33632683|NCT04929249|102206084|FG000|Overall Study|Lost to Follow-up|3|||
33418142|NCT00567996|101422320|FG000|Overall Study|Administrative problems|1|||
33418143|NCT00567996|101422321|FG001|Overall Study|Administrative problems|1|||
33418144|NCT00567996|101422322|FG002|Overall Study|Administrative problems|0|||
33418145|NCT00567996|101422320|FG000|Overall Study|Death|1|||
33569879|NCT03895372|101978346|FG007|Extension Treatment Period|Adverse Event|3|||
33418146|NCT00567996|101422321|FG001|Overall Study|Death|0|||
33418147|NCT00567996|101422322|FG002|Overall Study|Death|2|||
33418148|NCT00567996|101422320|FG000|Overall Study|Patient's inability to use the device|0|||
33418149|NCT00567996|101422321|FG001|Overall Study|Patient's inability to use the device|1|||
33418150|NCT00567996|101422322|FG002|Overall Study|Patient's inability to use the device|0|||
33226642|NCT02601937|100728704|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
33418151|NCT00928135|101422332|FG000|Overall Study|Withdrawal by Subject|1|||
33418152|NCT00928135|101422333|FG001|Overall Study|Withdrawal by Subject|0|||
33632684|NCT04929249|102206085|FG001|Overall Study|Lost to Follow-up|11|||
33632685|NCT04929249|102206084|FG000|Overall Study|Technical problems|0|||
33632686|NCT04929249|102206085|FG001|Overall Study|Technical problems|1|||
33632687|NCT04929249|102206084|FG000|Overall Study|Subject decision|6|||
33632688|NCT04929249|102206085|FG001|Overall Study|Subject decision|8|||
33632689|NCT04929249|102206084|FG000|Overall Study|Withdrew consent|0|||
33632690|NCT04929249|102206085|FG001|Overall Study|Withdrew consent|8|||
33632691|NCT03815929|102206086|FG000|Overall Study|Lost to Follow-up|2|||
33632692|NCT03815929|102206087|FG001|Overall Study|Lost to Follow-up|1|||
33632693|NCT03815929|102206088|FG002|Overall Study|Lost to Follow-up|0|||
33632694|NCT03815929|102206086|FG000|Overall Study|Physician Decision|2|||
33632695|NCT03815929|102206087|FG001|Overall Study|Physician Decision|2|||
33632696|NCT03815929|102206088|FG002|Overall Study|Physician Decision|0|||
33632697|NCT03815929|102206086|FG000|Overall Study|Withdrawal by Subject|0|||
33632698|NCT03815929|102206087|FG001|Overall Study|Withdrawal by Subject|0|||
33632699|NCT03815929|102206088|FG002|Overall Study|Withdrawal by Subject|1|||
33632700|NCT03521570|102206095|FG000|Overall Study|Not eligible|11|||
33632701|NCT00966654|102206096|FG000|Overall Study|Study was terminated,PI left institution|12|||
33632702|NCT02991768|102206097|FG000|Overall Study|Physician Decision|4|||
33632703|NCT02514083|102206100|FG000|Overall Study|Adverse Event|1|||
33632704|NCT05249582|102206101|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
33632705|NCT05249582|102206102|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
33569880|NCT03895372|101978339|FG000|Extension Treatment Period|Other|1|||
33569881|NCT03895372|101978340|FG001|Extension Treatment Period|Other|3|||
33569882|NCT03895372|101978341|FG002|Extension Treatment Period|Other|0|||
33569883|NCT03895372|101978342|FG003|Extension Treatment Period|Other|0|||
33569884|NCT03895372|101978343|FG004|Extension Treatment Period|Other|1|||
33226643|NCT02601937|100728705|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
33226644|NCT02601937|100728706|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
33226645|NCT02601937|100728707|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
33569885|NCT03895372|101978344|FG005|Extension Treatment Period|Other|0|||
33226646|NCT02601937|100728708|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
33366250|NCT02050048|101227340|FG001|Overall Study|Lost to Follow-up|1|||
33569886|NCT03895372|101978345|FG006|Extension Treatment Period|Other|0|||
33226647|NCT02601937|100728709|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
33569887|NCT03895372|101978346|FG007|Extension Treatment Period|Other|2|||
33569888|NCT03895372|101978339|FG000|Extension Treatment Period|Pregnancy|0|||
33569889|NCT03895372|101978340|FG001|Extension Treatment Period|Pregnancy|0|||
33569890|NCT03895372|101978341|FG002|Extension Treatment Period|Pregnancy|0|||
33569891|NCT03895372|101978342|FG003|Extension Treatment Period|Pregnancy|0|||
33569892|NCT03895372|101978343|FG004|Extension Treatment Period|Pregnancy|1|||
33569893|NCT03895372|101978344|FG005|Extension Treatment Period|Pregnancy|0|||
33569894|NCT03895372|101978345|FG006|Extension Treatment Period|Pregnancy|0|||
33569895|NCT03895372|101978346|FG007|Extension Treatment Period|Pregnancy|0|||
33569896|NCT03895372|101978339|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
33569897|NCT03895372|101978340|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
33569898|NCT03895372|101978341|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
33569899|NCT03895372|101978342|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
33569900|NCT03895372|101978343|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
33569901|NCT03895372|101978344|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
33569902|NCT03895372|101978345|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
33569903|NCT03895372|101978346|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
33569904|NCT01121757|101978351|FG000|First Drug|Death|1|||
33569905|NCT01121757|101978352|FG001|First Drug|Death|0|||
33569906|NCT01121757|101978351|FG000|First Drug|Disease Progression|0|||
33569907|NCT01121757|101978352|FG001|First Drug|Disease Progression|2|||
33569908|NCT01121757|101978351|FG000|Combination|Physician Decision|0|||
33569909|NCT01121757|101978352|FG001|Combination|Physician Decision|1|||
33569910|NCT01121757|101978351|FG000|Combination|Disease Progression|2|||
33569911|NCT01121757|101978352|FG001|Combination|Disease Progression|0|||
33569912|NCT02037529|101978357|FG000|Overall Study|Withdrawal by Subject|1|||
33569913|NCT02037529|101978358|FG001|Overall Study|Withdrawal by Subject|3|||
33569914|NCT02037529|101978357|FG000|Overall Study|Adverse Event|0|||
33569915|NCT02037529|101978358|FG001|Overall Study|Adverse Event|1|||
33569916|NCT01936831|101978359|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33569917|NCT01936831|101978360|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33569918|NCT01936831|101978361|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33569919|NCT01936831|101978362|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33569920|NCT01936831|101978363|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33569921|NCT01936831|101978364|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
33226648|NCT02601937|100728710|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
33366251|NCT02050048|101227339|FG000|Overall Study|Death|1|||
33366252|NCT02050048|101227340|FG001|Overall Study|Death|0|||
33569922|NCT01936831|101978365|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33569923|NCT01936831|101978366|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33569924|NCT01936831|101978367|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
33569925|NCT04466891|101978368|FG000|Overall Study|Death|52|||
33569926|NCT04466891|101978369|FG001|Overall Study|Death|5|||
33569927|NCT04466891|101978368|FG000|Overall Study|Withdrawal by Subject|8|||
33366253|NCT02050048|101227339|FG000|Overall Study|Ineligible after ERCP|4|||
33366254|NCT02050048|101227340|FG001|Overall Study|Ineligible after ERCP|1|||
33569928|NCT04466891|101978369|FG001|Overall Study|Withdrawal by Subject|1|||
33569929|NCT04388826|101978370|FG000|Overall Study|Lost to Follow-up|3|||
33569930|NCT04388826|101978371|FG001|Overall Study|Lost to Follow-up|2|||
33569931|NCT04388826|101978370|FG000|Overall Study|Adverse Event|1|||
33569932|NCT04388826|101978371|FG001|Overall Study|Adverse Event|0|||
33569933|NCT01047540|101978378|FG000|Overall Study|Protocol Violation|1|||
33569934|NCT01047540|101978379|FG001|Overall Study|Protocol Violation|0|||
33569935|NCT01047540|101978380|FG002|Overall Study|Protocol Violation|0|||
33366255|NCT02232516|101227341|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
33569936|NCT01047540|101978381|FG003|Overall Study|Protocol Violation|0|||
33569937|NCT01047540|101978382|FG004|Overall Study|Protocol Violation|0|||
33569938|NCT01047540|101978378|FG000|Overall Study|Lost to Follow-up|1|||
33569939|NCT01047540|101978379|FG001|Overall Study|Lost to Follow-up|0|||
33569940|NCT01047540|101978380|FG002|Overall Study|Lost to Follow-up|0|||
33569941|NCT01047540|101978381|FG003|Overall Study|Lost to Follow-up|0|||
33569942|NCT01047540|101978382|FG004|Overall Study|Lost to Follow-up|0|||
33569943|NCT01047540|101978378|FG000|Overall Study|Withdrawal by Subject|1|||
33569944|NCT01047540|101978379|FG001|Overall Study|Withdrawal by Subject|0|||
33569945|NCT01047540|101978380|FG002|Overall Study|Withdrawal by Subject|3|||
33569946|NCT01047540|101978381|FG003|Overall Study|Withdrawal by Subject|0|||
33569947|NCT01047540|101978382|FG004|Overall Study|Withdrawal by Subject|1|||
33569948|NCT01047540|101978378|FG000|Overall Study|Pregnancy|1|||
33569949|NCT01047540|101978379|FG001|Overall Study|Pregnancy|0|||
33569950|NCT01047540|101978380|FG002|Overall Study|Pregnancy|0|||
33226649|NCT02601937|100728700|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
33569951|NCT01047540|101978381|FG003|Overall Study|Pregnancy|0|||
33569952|NCT01047540|101978382|FG004|Overall Study|Pregnancy|0|||
33569953|NCT01047540|101978378|FG000|Overall Study|Adverse Event|1|||
33569954|NCT01047540|101978379|FG001|Overall Study|Adverse Event|0|||
33569955|NCT01047540|101978380|FG002|Overall Study|Adverse Event|0|||
33569956|NCT01047540|101978381|FG003|Overall Study|Adverse Event|0|||
33569957|NCT01047540|101978382|FG004|Overall Study|Adverse Event|0|||
33569958|NCT02743962|101978383|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
33569959|NCT02743962|101978384|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
33632706|NCT05249582|102206101|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
33632707|NCT05249582|102206102|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
33226650|NCT02601937|100728701|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
33226651|NCT02601937|100728702|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
33226652|NCT02601937|100728703|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
33226653|NCT02601937|100728704|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
33226654|NCT02601937|100728705|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
33226655|NCT02601937|100728706|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
33226656|NCT02601937|100728707|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
33226657|NCT02601937|100728708|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
33226658|NCT02601937|100728709|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
33226659|NCT02601937|100728710|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
33226660|NCT02601937|100728700|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
33226661|NCT02601937|100728701|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
33226662|NCT02601937|100728702|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
33226663|NCT02601937|100728703|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
33226664|NCT02601937|100728704|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
33226665|NCT02601937|100728705|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
33366256|NCT02232516|101227341|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
33226666|NCT02601937|100728706|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
33569960|NCT01998477|101978387|FG000|Overall Study|Lost to Follow-up|4|||
33569961|NCT01998477|101978388|FG001|Overall Study|Lost to Follow-up|5|||
33569962|NCT01998477|101978387|FG000|Overall Study|Withdrawal by Subject|6|||
33569963|NCT01998477|101978388|FG001|Overall Study|Withdrawal by Subject|0|||
33569964|NCT01404234|101978389|FG000|Overall Study|Withdrawal by Subject|2|||
33569965|NCT00851084|101978390|FG000|Overall Study|Randomized but not treated|1|||
33569966|NCT00851084|101978391|FG001|Overall Study|Randomized but not treated|0|||
33569967|NCT00851084|101978390|FG000|Overall Study|Adverse Event|26|||
33569968|NCT00851084|101978391|FG001|Overall Study|Adverse Event|36|||
33569969|NCT00851084|101978390|FG000|Overall Study|Disease progression|52|||
33569970|NCT00851084|101978391|FG001|Overall Study|Disease progression|47|||
33569971|NCT00851084|101978390|FG000|Overall Study|Poor compliance to protocol|1|||
33569972|NCT00851084|101978391|FG001|Overall Study|Poor compliance to protocol|1|||
33569973|NCT00851084|101978390|FG000|Overall Study|Physician Decision|13|||
33632708|NCT05249582|102206101|FG000|Overall Study|Declined to use virtual reality headset|1|||
33632709|NCT05249582|102206102|FG001|Overall Study|Declined to use virtual reality headset|0|||
33632710|NCT03094416|102206107|FG000|Run-in|Screening failure|8|||
33632711|NCT03094416|102206107|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
33632712|NCT03094416|102206107|FG000|Run-in|Withdrawal by Subject|3|||
33632713|NCT03094416|102206107|FG000|Treatment Period|Withdrawal by Subject|2|||
33632714|NCT02903771|102206112|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
33632715|NCT02903771|102206113|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
33632716|NCT02903771|102206114|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
33632717|NCT02903771|102206115|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
33632718|NCT02903771|102206116|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
33632719|NCT02903771|102206117|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
33632720|NCT02903771|102206118|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
33632721|NCT02903771|102206112|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
33632722|NCT02903771|102206113|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
33632723|NCT02903771|102206114|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
33632724|NCT02903771|102206115|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
33632725|NCT02903771|102206116|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
33632726|NCT02903771|102206117|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
33632727|NCT02903771|102206118|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
33632728|NCT02903771|102206112|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
33226667|NCT02601937|100728707|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
33226668|NCT02601937|100728708|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
33226669|NCT02601937|100728709|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
33226670|NCT02601937|100728710|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
33226671|NCT02601937|100728700|FG000|Period 2: Dose Expansion Cohort|Other|0|||
33226672|NCT02601937|100728701|FG001|Period 2: Dose Expansion Cohort|Other|0|||
33226673|NCT02601937|100728702|FG002|Period 2: Dose Expansion Cohort|Other|0|||
33226674|NCT02601937|100728703|FG003|Period 2: Dose Expansion Cohort|Other|0|||
33226675|NCT02601937|100728704|FG004|Period 2: Dose Expansion Cohort|Other|0|||
33226676|NCT02601937|100728705|FG005|Period 2: Dose Expansion Cohort|Other|0|||
33226677|NCT02601937|100728706|FG006|Period 2: Dose Expansion Cohort|Other|0|||
33226678|NCT02601937|100728707|FG007|Period 2: Dose Expansion Cohort|Other|0|||
33226679|NCT02601937|100728708|FG008|Period 2: Dose Expansion Cohort|Other|2|||
33226680|NCT02601937|100728709|FG009|Period 2: Dose Expansion Cohort|Other|2|||
33226681|NCT02601937|100728710|FG010|Period 2: Dose Expansion Cohort|Other|0|||
33226682|NCT02601937|100728700|FG000|Period 2: Dose Expansion Cohort|Death|0|||
33226683|NCT02601937|100728701|FG001|Period 2: Dose Expansion Cohort|Death|0|||
33226684|NCT02601937|100728702|FG002|Period 2: Dose Expansion Cohort|Death|0|||
33226685|NCT02601937|100728703|FG003|Period 2: Dose Expansion Cohort|Death|0|||
33226686|NCT02601937|100728704|FG004|Period 2: Dose Expansion Cohort|Death|0|||
33226687|NCT02601937|100728705|FG005|Period 2: Dose Expansion Cohort|Death|0|||
33226688|NCT02601937|100728706|FG006|Period 2: Dose Expansion Cohort|Death|0|||
33226689|NCT02601937|100728707|FG007|Period 2: Dose Expansion Cohort|Death|0|||
33226690|NCT02601937|100728708|FG008|Period 2: Dose Expansion Cohort|Death|1|||
33226691|NCT02601937|100728709|FG009|Period 2: Dose Expansion Cohort|Death|0|||
33569974|NCT00851084|101978391|FG001|Overall Study|Physician Decision|14|||
33632729|NCT02903771|102206113|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
33632730|NCT02903771|102206114|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
33632731|NCT02903771|102206115|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
33226692|NCT02601937|100728710|FG010|Period 2: Dose Expansion Cohort|Death|0|||
33632732|NCT02903771|102206116|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
33226693|NCT02912468|100728712|FG000|Overall Study|Adverse Event|3|||
33226694|NCT02912468|100728713|FG001|Overall Study|Adverse Event|2|||
33226695|NCT02912468|100728712|FG000|Overall Study|Withdrawal by Subject|6|||
33569975|NCT00851084|101978390|FG000|Overall Study|Consent withdrawn|0|||
33226696|NCT02912468|100728713|FG001|Overall Study|Withdrawal by Subject|2|||
33226697|NCT02912468|100728712|FG000|Overall Study|Randomized and not treated|0|||
33226698|NCT02912468|100728713|FG001|Overall Study|Randomized and not treated|1|||
33569976|NCT00851084|101978391|FG001|Overall Study|Consent withdrawn|2|||
33569977|NCT00851084|101978390|FG000|Overall Study|Withdrawal by Subject|11|||
33569978|NCT00851084|101978391|FG001|Overall Study|Withdrawal by Subject|12|||
33569979|NCT00851084|101978390|FG000|Overall Study|Metastatic surgery|6|||
33569980|NCT00851084|101978391|FG001|Overall Study|Metastatic surgery|6|||
33569981|NCT00851084|101978390|FG000|Overall Study|Other|7|||
33569982|NCT00851084|101978391|FG001|Overall Study|Other|1|||
33569983|NCT03674281|101978392|FG000|Overall Study|screen failure|2|||
33569984|NCT03674281|101978393|FG001|Overall Study|screen failure|0|||
33569985|NCT03674281|101978394|FG002|Overall Study|screen failure|0|||
33569986|NCT03674281|101978392|FG000|Overall Study|Withdrawal by Subject|1|||
33569987|NCT03674281|101978393|FG001|Overall Study|Withdrawal by Subject|3|||
33569988|NCT03674281|101978394|FG002|Overall Study|Withdrawal by Subject|3|||
33569989|NCT00567580|101978395|FG000|Overall Study|Protocol Violation|28|||
33569990|NCT00567580|101978396|FG001|Overall Study|Protocol Violation|24|||
33569991|NCT00567580|101978397|FG002|Overall Study|Protocol Violation|24|||
33569992|NCT02467270|101978398|FG000|Overall Study|Participants Never Treated|0|||
33569993|NCT02467270|101978399|FG001|Overall Study|Participants Never Treated|1|||
33569994|NCT02467270|101978400|FG002|Overall Study|Participants Never Treated|0|||
33569995|NCT02467270|101978398|FG000|Overall Study|Ongoing|50|||
33569996|NCT02467270|101978399|FG001|Overall Study|Ongoing|41|||
33569997|NCT02467270|101978400|FG002|Overall Study|Ongoing|43|||
33569998|NCT02467270|101978398|FG000|Overall Study|Adverse Event|16|||
33569999|NCT02467270|101978399|FG001|Overall Study|Adverse Event|15|||
33570000|NCT02467270|101978400|FG002|Overall Study|Adverse Event|14|||
33570001|NCT02467270|101978398|FG000|Overall Study|Progressive Disease|7|||
33570002|NCT02467270|101978399|FG001|Overall Study|Progressive Disease|7|||
33570003|NCT02467270|101978400|FG002|Overall Study|Progressive Disease|4|||
33570004|NCT02467270|101978398|FG000|Overall Study|Death|2|||
33570005|NCT02467270|101978399|FG001|Overall Study|Death|0|||
33570006|NCT02467270|101978400|FG002|Overall Study|Death|2|||
33570007|NCT02467270|101978398|FG000|Overall Study|Lack of Efficacy|12|||
33570008|NCT02467270|101978399|FG001|Overall Study|Lack of Efficacy|18|||
33570009|NCT02467270|101978400|FG002|Overall Study|Lack of Efficacy|23|||
33366257|NCT02232516|101227341|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
33366258|NCT02232516|101227341|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
33366259|NCT02232516|101227341|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
33366260|NCT02232516|101227341|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
33418153|NCT00902278|101422334|FG000|Overall Study|Physician Decision|1|||
33418154|NCT00902278|101422335|FG001|Overall Study|Physician Decision|0|||
33418155|NCT00902278|101422336|FG002|Overall Study|Physician Decision|2|||
33418156|NCT00902278|101422337|FG003|Overall Study|Physician Decision|0|||
33570010|NCT02467270|101978398|FG000|Overall Study|Non-compliance With Study Drug|0|||
33570011|NCT02467270|101978399|FG001|Overall Study|Non-compliance With Study Drug|2|||
33570012|NCT02467270|101978400|FG002|Overall Study|Non-compliance With Study Drug|1|||
33570013|NCT02467270|101978398|FG000|Overall Study|Lost to Follow-up|2|||
33570014|NCT02467270|101978399|FG001|Overall Study|Lost to Follow-up|1|||
33570015|NCT02467270|101978400|FG002|Overall Study|Lost to Follow-up|0|||
33366261|NCT02232516|101227341|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
33366262|NCT02232516|101227341|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
33366263|NCT02232516|101227341|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
33366264|NCT02232516|101227341|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
33366265|NCT02232516|101227341|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
33366266|NCT02232516|101227341|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
33366267|NCT02232516|101227341|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
33366268|NCT02232516|101227341|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
33366269|NCT02232516|101227341|FG000|Survival Follow-up|Death|15|||
33366270|NCT02232516|101227341|FG000|Survival Follow-up|Withdrawal by Subject|3|||
33366271|NCT02232516|101227341|FG000|Survival Follow-up|Lost to Follow-up|1|||
33366272|NCT02232516|101227341|FG000|Survival Follow-up|Still in follow-up|5|||
33366273|NCT01582282|101227342|FG000|Overall Study|Adverse Event|1|||
33366274|NCT01582282|101227343|FG001|Overall Study|Adverse Event|1|||
33366275|NCT01582282|101227344|FG002|Overall Study|Adverse Event|0|||
33366276|NCT01582282|101227342|FG000|Overall Study|Lost to Follow-up|1|||
33366277|NCT01582282|101227343|FG001|Overall Study|Lost to Follow-up|0|||
33366278|NCT01582282|101227344|FG002|Overall Study|Lost to Follow-up|0|||
33366279|NCT01582282|101227342|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
33366280|NCT01582282|101227343|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
33366281|NCT01582282|101227344|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
33366282|NCT02092389|101227347|FG000|Overall Study|Adverse Event|1|||
33366283|NCT02092389|101227347|FG000|Overall Study|Other|5|||
33366284|NCT00486226|101227350|FG000|Overall Study|Death|3|||
33366285|NCT00486226|101227350|FG000|Overall Study|Adverse Event|1|||
33366286|NCT00486226|101227350|FG000|Overall Study|Withdrawal by Subject|1|||
33366287|NCT00486226|101227350|FG000|Overall Study|Lost to Follow-up|8|||
33570016|NCT02467270|101978398|FG000|Overall Study|Pregnancy|0|||
33570017|NCT02467270|101978399|FG001|Overall Study|Pregnancy|1|||
33570018|NCT02467270|101978400|FG002|Overall Study|Pregnancy|0|||
33418157|NCT00902278|101422338|FG004|Overall Study|Physician Decision|1|||
33418158|NCT00902278|101422334|FG000|Overall Study|Lost to Follow-up|3|||
33418159|NCT00902278|101422335|FG001|Overall Study|Lost to Follow-up|2|||
33570019|NCT02467270|101978398|FG000|Overall Study|Physician Decision|0|||
33570020|NCT02467270|101978399|FG001|Overall Study|Physician Decision|4|||
33570021|NCT02467270|101978400|FG002|Overall Study|Physician Decision|1|||
33570022|NCT02467270|101978398|FG000|Overall Study|Withdrawal by Subject|4|||
33570023|NCT02467270|101978399|FG001|Overall Study|Withdrawal by Subject|3|||
33570024|NCT02467270|101978400|FG002|Overall Study|Withdrawal by Subject|5|||
33570025|NCT02467270|101978398|FG000|Overall Study|Reason not Specified|1|||
33570026|NCT02467270|101978399|FG001|Overall Study|Reason not Specified|2|||
33570027|NCT02467270|101978400|FG002|Overall Study|Reason not Specified|1|||
33570028|NCT03663582|101978401|FG000|Overall Study|Physician Decision|1|||
33570029|NCT02106832|101978402|FG000|Overall Study|Adverse Event|1|||
33570030|NCT02106832|101978403|FG001|Overall Study|Adverse Event|2|||
33632733|NCT02903771|102206117|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
33632734|NCT02903771|102206118|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
33632735|NCT02903771|102206112|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
33418160|NCT00902278|101422336|FG002|Overall Study|Lost to Follow-up|3|||
33226699|NCT00603265|100728716|FG000|Overall Study|Adverse Event|2|||
33418161|NCT00902278|101422337|FG003|Overall Study|Lost to Follow-up|0|||
33418162|NCT00902278|101422338|FG004|Overall Study|Lost to Follow-up|1|||
33418163|NCT05899218|101422339|FG000|Overall Study|Lost to Follow-up|2|||
33418164|NCT05899218|101422340|FG001|Overall Study|Lost to Follow-up|2|||
33418165|NCT05899218|101422339|FG000|Overall Study|deemed ineligible out of country|1|||
33418166|NCT05899218|101422340|FG001|Overall Study|deemed ineligible out of country|0|||
33418167|NCT01257737|101422341|FG000|Overall Study|Lost to Follow-up|1|||
33418168|NCT01257737|101422342|FG001|Overall Study|Lost to Follow-up|2|||
33418169|NCT01257737|101422341|FG000|Overall Study|Liver transplant|1|||
33418170|NCT01257737|101422342|FG001|Overall Study|Liver transplant|0|||
33418171|NCT01257737|101422341|FG000|Overall Study|Relocation out of the country|0|||
33418172|NCT01257737|101422342|FG001|Overall Study|Relocation out of the country|1|||
33418173|NCT01257737|101422341|FG000|Overall Study|Withdrew from study|0|||
33418174|NCT01257737|101422342|FG001|Overall Study|Withdrew from study|1|||
33418175|NCT02748616|101422350|FG000|Overall Study|Lost to Follow-up|1|||
33418176|NCT02748616|101422350|FG000|Overall Study|Withdrawal by Subject|2|||
33418177|NCT02748616|101422350|FG000|Overall Study|Physician Decision|2|||
33418178|NCT02748616|101422350|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
33418179|NCT02076113|101422351|FG000|Overall Study|Lost to Follow-up|4|||
33418180|NCT02076113|101422352|FG001|Overall Study|Lost to Follow-up|1|||
33418181|NCT02076113|101422351|FG000|Overall Study|Withdrawal by Subject|2|||
33418182|NCT02076113|101422352|FG001|Overall Study|Withdrawal by Subject|3|||
33418183|NCT02076113|101422351|FG000|Overall Study|Death|1|||
33418184|NCT02076113|101422352|FG001|Overall Study|Death|3|||
33418185|NCT05789420|101422353|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
33418186|NCT05789420|101422353|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
33632736|NCT02903771|102206113|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
33632737|NCT02903771|102206114|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
33632738|NCT02903771|102206115|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
33632739|NCT02903771|102206116|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
33632740|NCT02903771|102206117|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
33632741|NCT02903771|102206118|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
33632742|NCT02903771|102206112|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
33632743|NCT02903771|102206113|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
33632744|NCT02903771|102206114|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
33632745|NCT02903771|102206115|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
33632746|NCT02903771|102206116|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
33632747|NCT02903771|102206117|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
33632748|NCT02903771|102206118|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
33632749|NCT02903771|102206112|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
33632750|NCT02903771|102206113|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
33632751|NCT02903771|102206114|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
33632752|NCT02903771|102206115|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
33632753|NCT02903771|102206116|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
33632754|NCT02903771|102206117|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
33632755|NCT02903771|102206118|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
33632756|NCT02903771|102206112|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
33632757|NCT02903771|102206113|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
33632758|NCT02903771|102206114|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
33632759|NCT02903771|102206115|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
33632760|NCT02903771|102206116|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
33632761|NCT02903771|102206117|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
33632762|NCT02903771|102206118|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
33632763|NCT02903771|102206112|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
33632764|NCT02903771|102206113|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
33632765|NCT02903771|102206114|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
33632766|NCT02903771|102206115|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
33632767|NCT02903771|102206116|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
33632768|NCT02903771|102206117|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
33632769|NCT02903771|102206118|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
33632770|NCT02903771|102206112|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
33632771|NCT02903771|102206113|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
33632772|NCT02903771|102206114|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
33632773|NCT02903771|102206115|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
33632774|NCT02903771|102206116|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
33632775|NCT02903771|102206117|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
33632776|NCT02903771|102206118|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
33632777|NCT02903771|102206112|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
33632778|NCT02903771|102206113|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
33632779|NCT02903771|102206114|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
33632780|NCT02903771|102206115|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
33632781|NCT02903771|102206116|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
33632782|NCT02903771|102206117|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
33632783|NCT02903771|102206118|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
33632784|NCT02903771|102206112|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
33632785|NCT02903771|102206113|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
33632786|NCT02903771|102206114|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
33632787|NCT02903771|102206115|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
33632788|NCT02903771|102206116|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
33632789|NCT02903771|102206117|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
33632790|NCT02903771|102206118|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
33632791|NCT04532528|102206120|FG000|Overall Study|Adverse Event|12|||
33632792|NCT04532528|102206121|FG001|Overall Study|Adverse Event|17|||
33632793|NCT04532528|102206120|FG000|Overall Study|Withdrawal of consent|16|||
33632794|NCT04532528|102206121|FG001|Overall Study|Withdrawal of consent|17|||
33632795|NCT04532528|102206120|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
33632796|NCT04532528|102206121|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
33632797|NCT04532528|102206120|FG000|Overall Study|Lost to Follow-up|69|||
33632798|NCT04532528|102206121|FG001|Overall Study|Lost to Follow-up|68|||
33632799|NCT04532528|102206120|FG000|Overall Study|Administrative problems|12|||
33632800|NCT04532528|102206121|FG001|Overall Study|Administrative problems|14|||
33632801|NCT04532528|102206120|FG000|Overall Study|Death|3|||
33632802|NCT04532528|102206121|FG001|Overall Study|Death|3|||
33632803|NCT04532528|102206120|FG000|Overall Study|Other|38|||
33632804|NCT04532528|102206121|FG001|Overall Study|Other|46|||
33632805|NCT02081677|102206123|FG000|Overall Study|Adverse Event|0|||
33632806|NCT02081677|102206124|FG001|Overall Study|Adverse Event|0|||
33632807|NCT02081677|102206125|FG002|Overall Study|Adverse Event|1|||
33632808|NCT02081677|102206126|FG003|Overall Study|Adverse Event|0|||
33632809|NCT02081677|102206123|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33632810|NCT02081677|102206124|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33570031|NCT02106832|101978404|FG002|Overall Study|Adverse Event|3|||
33570032|NCT02106832|101978405|FG003|Overall Study|Adverse Event|0|||
33570033|NCT02106832|101978402|FG000|Overall Study|Death|4|||
33570034|NCT02106832|101978403|FG001|Overall Study|Death|4|||
33570035|NCT02106832|101978404|FG002|Overall Study|Death|1|||
33570036|NCT02106832|101978405|FG003|Overall Study|Death|4|||
33570037|NCT02106832|101978402|FG000|Overall Study|Deterioration of general conditions|0|||
33570038|NCT02106832|101978403|FG001|Overall Study|Deterioration of general conditions|0|||
33570039|NCT02106832|101978404|FG002|Overall Study|Deterioration of general conditions|1|||
33570040|NCT02106832|101978405|FG003|Overall Study|Deterioration of general conditions|0|||
33570041|NCT02106832|101978402|FG000|Overall Study|Lost to Follow-up|0|||
33570042|NCT02106832|101978403|FG001|Overall Study|Lost to Follow-up|1|||
33570043|NCT02106832|101978404|FG002|Overall Study|Lost to Follow-up|1|||
33570044|NCT02106832|101978405|FG003|Overall Study|Lost to Follow-up|3|||
33570045|NCT02106832|101978402|FG000|Overall Study|Physician Decision|1|||
33632811|NCT02081677|102206125|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
33570046|NCT02106832|101978403|FG001|Overall Study|Physician Decision|0|||
33632812|NCT02081677|102206126|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
33632813|NCT02081677|102206123|FG000|Overall Study|Not comfortable with lens care system|1|||
33570047|NCT02106832|101978404|FG002|Overall Study|Physician Decision|0|||
33570048|NCT02106832|101978405|FG003|Overall Study|Physician Decision|0|||
33570049|NCT02106832|101978402|FG000|Overall Study|Protocol Violation|0|||
33570050|NCT02106832|101978403|FG001|Overall Study|Protocol Violation|0|||
33570051|NCT02106832|101978404|FG002|Overall Study|Protocol Violation|0|||
33570052|NCT02106832|101978405|FG003|Overall Study|Protocol Violation|1|||
33570053|NCT02106832|101978402|FG000|Overall Study|Withdrawal by Subject|17|||
33570054|NCT02106832|101978403|FG001|Overall Study|Withdrawal by Subject|17|||
33570055|NCT02106832|101978404|FG002|Overall Study|Withdrawal by Subject|10|||
33570056|NCT02106832|101978405|FG003|Overall Study|Withdrawal by Subject|7|||
33570057|NCT02106832|101978402|FG000|Overall Study|Technical problems|0|||
33418187|NCT04440163|101422354|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
33418188|NCT04440163|101422355|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
33418189|NCT04440163|101422356|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
33570058|NCT02106832|101978403|FG001|Overall Study|Technical problems|1|||
33570059|NCT02106832|101978404|FG002|Overall Study|Technical problems|0|||
33570060|NCT02106832|101978405|FG003|Overall Study|Technical problems|0|||
33418190|NCT04440163|101422357|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
33418191|NCT04440163|101422358|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
33418192|NCT04440163|101422359|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
33632814|NCT02081677|102206124|FG001|Overall Study|Not comfortable with lens care system|0|||
33632815|NCT02081677|102206125|FG002|Overall Study|Not comfortable with lens care system|0|||
33632816|NCT02081677|102206126|FG003|Overall Study|Not comfortable with lens care system|0|||
33632817|NCT02081677|102206123|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
33632818|NCT02081677|102206124|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
33632819|NCT02081677|102206125|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
33632820|NCT02081677|102206126|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
33632821|NCT04639245|102206127|FG000|Overall Study|Death|1|||
33632822|NCT01521117|102208597|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
33632823|NCT01521117|102208598|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
33632824|NCT01521117|102208597|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
33632825|NCT01521117|102208598|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
33632826|NCT01521117|102208597|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
33632827|NCT01521117|102208598|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
33632828|NCT03448406|102208605|FG000|Overall Study|Noncompliance of scheduled visits|1|||
33632829|NCT03448406|102208606|FG001|Overall Study|Noncompliance of scheduled visits|2|||
33632830|NCT03448406|102208605|FG000|Overall Study|Withdrawal by Subject|1|||
33632831|NCT03448406|102208606|FG001|Overall Study|Withdrawal by Subject|2|||
33632832|NCT03448406|102208605|FG000|Overall Study|Protocol Violation|1|||
33632833|NCT03448406|102208606|FG001|Overall Study|Protocol Violation|0|||
33632834|NCT03448406|102208605|FG000|Overall Study|Adverse Event|8|||
33632835|NCT03448406|102208606|FG001|Overall Study|Adverse Event|9|||
33418193|NCT04440163|101422360|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
33418194|NCT04440163|101422361|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
33570061|NCT04380142|101978406|FG000|LD/CD Stabilization Period|Adverse Event|3|||
33570062|NCT04380142|101978407|FG001|LD/CD Stabilization Period|Adverse Event|0|||
33632836|NCT05408429|102208607|FG000|Overall Study|Lost to Follow-up|1|||
33632837|NCT05408429|102208608|FG001|Overall Study|Lost to Follow-up|1|||
33632838|NCT05408429|102208609|FG002|Overall Study|Lost to Follow-up|0|||
33632839|NCT05408429|102208607|FG000|Overall Study|Withdrawal by Subject|5|||
33632840|NCT05408429|102208608|FG001|Overall Study|Withdrawal by Subject|0|||
33632841|NCT05408429|102208609|FG002|Overall Study|Withdrawal by Subject|1|||
33632842|NCT02796170|102208618|FG000|Overall Study|Lost to Follow-up|3|||
33632843|NCT02796170|102208619|FG001|Overall Study|Lost to Follow-up|0|||
33632844|NCT02002598|102208620|FG000|Dose Level 1|Withdrawal by Subject|1|||
33632845|NCT02002598|102208621|FG001|Dose Level 1|Withdrawal by Subject|0|||
33632846|NCT02002598|102208622|FG002|Dose Level 1|Withdrawal by Subject|0|||
33632847|NCT02002598|102208623|FG003|Dose Level 1|Withdrawal by Subject|0|||
33632848|NCT02002598|102208624|FG004|Dose Level 1|Withdrawal by Subject|0|||
33632849|NCT04558125|102208625|FG000|Overall Study|Death|1|||
33632850|NCT02638220|102208626|FG000|Overall Study|Lost to Follow-up|6|||
33632851|NCT02638220|102208626|FG000|Overall Study|Withdrawal by Subject|3|||
33632852|NCT02638220|102208626|FG000|Overall Study|Physician Decision|1|||
33632853|NCT02638220|102208626|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
33366288|NCT00718861|101227356|FG000|Overall Study|Withdrawal by Subject|15|||
33570063|NCT04380142|101978408|FG002|LD/CD Stabilization Period|Adverse Event|0|||
33570064|NCT04380142|101978406|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
33570065|NCT04380142|101978407|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
33570066|NCT04380142|101978408|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
33570067|NCT04380142|101978406|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
33570068|NCT04380142|101978407|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
33570069|NCT04380142|101978408|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
33632854|NCT03363841|102208629|FG000|Overall Study|Adverse Event|1|||
33632855|NCT03363841|102208629|FG000|Overall Study|Withdrawal by Subject|1|||
33632856|NCT03363841|102208629|FG000|Overall Study|Death|7|||
33632857|NCT03363841|102208629|FG000|Overall Study|Physician Decision|1|||
33632858|NCT02694185|102208632|FG000|Overall Study|Withdrawal by Subject|45|||
33632859|NCT02694185|102208633|FG001|Overall Study|Withdrawal by Subject|0|||
33632860|NCT00791934|102208636|FG000|Overall Study|Withdrawal by Subject|2|||
33632861|NCT00791934|102208636|FG000|Overall Study|Did not consent for extended follow-up|13|||
33632862|NCT02603146|102208637|FG000|Overall Study|Lost to Follow-up|5|||
33632863|NCT02603146|102208638|FG001|Overall Study|Lost to Follow-up|6|||
33366289|NCT00718861|101227357|FG001|Overall Study|Withdrawal by Subject|10|||
33366290|NCT00718861|101227356|FG000|Overall Study|Adverse Event|2|||
33366291|NCT00718861|101227357|FG001|Overall Study|Adverse Event|1|||
33226700|NCT00603265|100728717|FG001|Overall Study|Adverse Event|11|||
33570070|NCT04380142|101978406|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
33570071|NCT04380142|101978407|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
33570072|NCT04380142|101978408|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
33570073|NCT04380142|101978406|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
33570074|NCT04380142|101978407|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
33570075|NCT04380142|101978408|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
33570076|NCT04380142|101978406|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
33570077|NCT04380142|101978407|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
33570078|NCT04380142|101978408|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
33570079|NCT04380142|101978406|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33570080|NCT04380142|101978407|FG001|Double-Blind Treatment Period|Adverse Event|1|||
33570081|NCT04380142|101978408|FG002|Double-Blind Treatment Period|Adverse Event|14|||
33570082|NCT04380142|101978406|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
33570083|NCT04380142|101978407|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
33570084|NCT04380142|101978408|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
33570085|NCT04380142|101978406|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
33570086|NCT04380142|101978407|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
33226701|NCT00603265|100728718|FG002|Overall Study|Adverse Event|1|||
33226702|NCT00603265|100728716|FG000|Overall Study|Withdrawal by Subject|1|||
33226703|NCT00603265|100728717|FG001|Overall Study|Withdrawal by Subject|2|||
33226704|NCT00603265|100728718|FG002|Overall Study|Withdrawal by Subject|1|||
33226705|NCT00603265|100728716|FG000|Overall Study|Lack of Efficacy|3|||
33226706|NCT00603265|100728717|FG001|Overall Study|Lack of Efficacy|0|||
33226707|NCT00603265|100728718|FG002|Overall Study|Lack of Efficacy|3|||
33226708|NCT00603265|100728716|FG000|Overall Study|Lost to Follow-up|0|||
33226709|NCT00603265|100728717|FG001|Overall Study|Lost to Follow-up|1|||
33226710|NCT00603265|100728718|FG002|Overall Study|Lost to Follow-up|0|||
33226711|NCT00603265|100728716|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
33226712|NCT00603265|100728717|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
33226713|NCT00603265|100728718|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
33226714|NCT00603265|100728716|FG000|Overall Study|Participant Left Country, No Responses|0|||
33226715|NCT00603265|100728717|FG001|Overall Study|Participant Left Country, No Responses|1|||
33226716|NCT00603265|100728718|FG002|Overall Study|Participant Left Country, No Responses|0|||
33226717|NCT00603265|100728716|FG000|Overall Study|Protocol Violation|1|||
33226718|NCT00603265|100728717|FG001|Overall Study|Protocol Violation|0|||
33226719|NCT00603265|100728718|FG002|Overall Study|Protocol Violation|0|||
33226720|NCT00944658|100728719|FG000|Treatment 12 Weeks|Adverse Event|0|||
33226721|NCT00944658|100728720|FG001|Treatment 12 Weeks|Adverse Event|2|||
33226722|NCT01674621|100728721|FG000|Overall Study|Adverse Event|3|||
33226723|NCT01674621|100728722|FG001|Overall Study|Adverse Event|2|||
33226724|NCT01674621|100728723|FG002|Overall Study|Adverse Event|5|||
33226725|NCT01674621|100728724|FG003|Overall Study|Adverse Event|5|||
33226726|NCT01674621|100728725|FG004|Overall Study|Adverse Event|1|||
33226727|NCT01674621|100728721|FG000|Overall Study|Inability to Complete Study Procedures|0|||
33418195|NCT04440163|101422354|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
33418196|NCT04440163|101422355|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
33418197|NCT04440163|101422356|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
33418198|NCT04440163|101422357|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
33418199|NCT04440163|101422358|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
33418200|NCT04440163|101422359|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
33418201|NCT04440163|101422360|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
33418202|NCT04440163|101422361|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
33226728|NCT01674621|100728722|FG001|Overall Study|Inability to Complete Study Procedures|0|||
33226729|NCT01674621|100728723|FG002|Overall Study|Inability to Complete Study Procedures|0|||
33226730|NCT01674621|100728724|FG003|Overall Study|Inability to Complete Study Procedures|0|||
33226731|NCT01674621|100728725|FG004|Overall Study|Inability to Complete Study Procedures|2|||
33226732|NCT01674621|100728721|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
33226733|NCT01674621|100728722|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
33226734|NCT01674621|100728723|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
33226735|NCT01674621|100728724|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
33226736|NCT01674621|100728725|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
33226737|NCT01674621|100728721|FG000|Overall Study|Withdrawal by Subject|2|||
33226738|NCT01674621|100728722|FG001|Overall Study|Withdrawal by Subject|5|||
33226739|NCT01674621|100728723|FG002|Overall Study|Withdrawal by Subject|2|||
33226740|NCT01674621|100728724|FG003|Overall Study|Withdrawal by Subject|0|||
33226741|NCT01674621|100728725|FG004|Overall Study|Withdrawal by Subject|1|||
33226742|NCT01674621|100728721|FG000|Overall Study|Other than specified|0|||
33226743|NCT01674621|100728722|FG001|Overall Study|Other than specified|1|||
33226744|NCT01674621|100728723|FG002|Overall Study|Other than specified|0|||
33226745|NCT01674621|100728724|FG003|Overall Study|Other than specified|0|||
33226746|NCT01674621|100728725|FG004|Overall Study|Other than specified|2|||
33226747|NCT01161472|100728728|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
33226748|NCT01161472|100728729|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
33226749|NCT01161472|100728730|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
33418203|NCT04440163|101422354|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
33570087|NCT04380142|101978408|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
33570088|NCT04380142|101978406|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
33570089|NCT04380142|101978407|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
33570090|NCT04380142|101978408|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
33632864|NCT02603146|102208637|FG000|Overall Study|Withdrawal by Subject|8|||
33226750|NCT01161472|100728731|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
33226751|NCT01216163|100728732|FG000|Overall Study|Withdrawal by Subject|1|||
33226752|NCT01216163|100728733|FG001|Overall Study|Withdrawal by Subject|1|||
33418204|NCT04440163|101422355|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
33418205|NCT04440163|101422356|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
33632865|NCT02603146|102208638|FG001|Overall Study|Withdrawal by Subject|10|||
33632866|NCT02603146|102208637|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
33632867|NCT02603146|102208638|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
33632868|NCT02603146|102208637|FG000|Overall Study|Participant moved|2|||
33632869|NCT02603146|102208638|FG001|Overall Study|Participant moved|0|||
33632870|NCT02603146|102208637|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
33632871|NCT02603146|102208638|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
33632872|NCT01194830|102208639|FG000|Overall Study|Adverse Event|3|||
33632873|NCT01194830|102208640|FG001|Overall Study|Adverse Event|2|||
33632874|NCT01194830|102208639|FG000|Overall Study|Protocol Violation|5|||
33632875|NCT01194830|102208640|FG001|Overall Study|Protocol Violation|4|||
33632876|NCT01194830|102208639|FG000|Overall Study|Lost to Follow-up|9|||
33632877|NCT01194830|102208640|FG001|Overall Study|Lost to Follow-up|7|||
33632878|NCT01194830|102208639|FG000|Overall Study|Withdrawal by Subject|2|||
33632879|NCT01194830|102208640|FG001|Overall Study|Withdrawal by Subject|1|||
33632880|NCT01194830|102208639|FG000|Overall Study|Lack of Efficacy|1|||
33632881|NCT01194830|102208640|FG001|Overall Study|Lack of Efficacy|1|||
33632882|NCT01194830|102208639|FG000|Overall Study|Non-compliance issues|4|||
33632883|NCT01194830|102208640|FG001|Overall Study|Non-compliance issues|4|||
33632884|NCT01194830|102208639|FG000|Overall Study|Other Reason|12|||
33632885|NCT01194830|102208640|FG001|Overall Study|Other Reason|8|||
33632886|NCT00087152|102208641|FG000|Overall Study|Ineligible|6|||
33632887|NCT01648751|102208647|FG000|Overall Study|Withdrawal by Subject|2|||
33632888|NCT01648751|102208648|FG001|Overall Study|Withdrawal by Subject|3|||
33632889|NCT00687193|102208650|FG000|Overall Study|Adverse Event|0|||
33632890|NCT00687193|102208651|FG001|Overall Study|Adverse Event|1|||
33632891|NCT00687193|102208652|FG002|Overall Study|Adverse Event|2|||
33632892|NCT00687193|102208653|FG003|Overall Study|Adverse Event|3|||
33632893|NCT00687193|102208654|FG004|Overall Study|Adverse Event|0|||
33632894|NCT00687193|102208655|FG005|Overall Study|Adverse Event|2|||
33632895|NCT00687193|102208650|FG000|Overall Study|Lack of Efficacy|1|||
33632896|NCT00687193|102208651|FG001|Overall Study|Lack of Efficacy|1|||
33632897|NCT00687193|102208652|FG002|Overall Study|Lack of Efficacy|0|||
33632898|NCT00687193|102208653|FG003|Overall Study|Lack of Efficacy|0|||
33632899|NCT00687193|102208654|FG004|Overall Study|Lack of Efficacy|0|||
33632900|NCT00687193|102208655|FG005|Overall Study|Lack of Efficacy|2|||
33632901|NCT00687193|102208650|FG000|Overall Study|Protocol Violation|1|||
33632902|NCT00687193|102208651|FG001|Overall Study|Protocol Violation|2|||
33632903|NCT00687193|102208652|FG002|Overall Study|Protocol Violation|0|||
33632904|NCT00687193|102208653|FG003|Overall Study|Protocol Violation|1|||
33632905|NCT00687193|102208654|FG004|Overall Study|Protocol Violation|2|||
33632906|NCT00687193|102208655|FG005|Overall Study|Protocol Violation|0|||
33632907|NCT03205423|102208656|FG000|Overall Study|Personal|1|||
33632908|NCT03205423|102208657|FG001|Overall Study|Personal|1|||
33632909|NCT03205423|102208656|FG000|Overall Study|Physician Decision|0|||
33632910|NCT03205423|102208657|FG001|Overall Study|Physician Decision|2|||
33226753|NCT01216163|100728734|FG002|Overall Study|Withdrawal by Subject|0|||
33226754|NCT02118337|100728735|FG000|Overall Study|Other|1|||
33632911|NCT03955146|102208672|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
33632912|NCT03955146|102208673|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
33632913|NCT03955146|102208674|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
33632914|NCT03955146|102208675|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
33632915|NCT03955146|102208672|FG000|DB Period (48 Weeks)|Adverse Event|2|||
33632916|NCT03955146|102208673|FG001|DB Period (48 Weeks)|Adverse Event|5|||
33632917|NCT03955146|102208674|FG002|DB Period (48 Weeks)|Adverse Event|1|||
33632918|NCT03955146|102208675|FG003|DB Period (48 Weeks)|Adverse Event|2|||
33632919|NCT03955146|102208672|FG000|DB Period (48 Weeks)|Death|13|||
33632920|NCT03955146|102208673|FG001|DB Period (48 Weeks)|Death|17|||
33632921|NCT03955146|102208674|FG002|DB Period (48 Weeks)|Death|1|||
33226755|NCT02118337|100728736|FG001|Overall Study|Other|0|||
33226756|NCT02118337|100728737|FG002|Overall Study|Other|0|||
33226757|NCT02118337|100728738|FG003|Overall Study|Other|0|||
33226758|NCT02118337|100728739|FG004|Overall Study|Other|2|||
33226759|NCT02118337|100728740|FG005|Overall Study|Other|3|||
33226760|NCT02118337|100728741|FG006|Overall Study|Other|1|||
33226761|NCT02118337|100728742|FG007|Overall Study|Other|28|||
33226762|NCT02118337|100728743|FG008|Overall Study|Other|15|||
33226763|NCT02118337|100728735|FG000|Overall Study|Lost to Follow-up|0|||
33226764|NCT02118337|100728736|FG001|Overall Study|Lost to Follow-up|0|||
33226765|NCT02118337|100728737|FG002|Overall Study|Lost to Follow-up|0|||
33226766|NCT02118337|100728738|FG003|Overall Study|Lost to Follow-up|0|||
33226767|NCT02118337|100728739|FG004|Overall Study|Lost to Follow-up|0|||
33226768|NCT02118337|100728740|FG005|Overall Study|Lost to Follow-up|0|||
33226769|NCT02118337|100728741|FG006|Overall Study|Lost to Follow-up|0|||
33226770|NCT02118337|100728742|FG007|Overall Study|Lost to Follow-up|1|||
33226771|NCT02118337|100728743|FG008|Overall Study|Lost to Follow-up|0|||
33226772|NCT02118337|100728735|FG000|Overall Study|Withdrawal by Subject|1|||
33226773|NCT02118337|100728736|FG001|Overall Study|Withdrawal by Subject|3|||
33226774|NCT02118337|100728737|FG002|Overall Study|Withdrawal by Subject|2|||
33226775|NCT02118337|100728738|FG003|Overall Study|Withdrawal by Subject|1|||
33226776|NCT02118337|100728739|FG004|Overall Study|Withdrawal by Subject|2|||
33226777|NCT02118337|100728740|FG005|Overall Study|Withdrawal by Subject|2|||
33226778|NCT02118337|100728741|FG006|Overall Study|Withdrawal by Subject|1|||
33226779|NCT02118337|100728742|FG007|Overall Study|Withdrawal by Subject|4|||
33226780|NCT02118337|100728743|FG008|Overall Study|Withdrawal by Subject|2|||
33226781|NCT02118337|100728735|FG000|Overall Study|Death|2|||
33226782|NCT02118337|100728736|FG001|Overall Study|Death|2|||
33226783|NCT02118337|100728737|FG002|Overall Study|Death|1|||
33226784|NCT02118337|100728738|FG003|Overall Study|Death|2|||
33226785|NCT02118337|100728739|FG004|Overall Study|Death|5|||
33570091|NCT04380142|101978406|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
33226786|NCT02118337|100728740|FG005|Overall Study|Death|1|||
33226787|NCT02118337|100728741|FG006|Overall Study|Death|2|||
33226788|NCT02118337|100728742|FG007|Overall Study|Death|9|||
33226789|NCT02118337|100728743|FG008|Overall Study|Death|4|||
33226790|NCT02026232|100728744|FG000|Overall Study|incomplete visit/missing data|3|||
33226791|NCT02026232|100728745|FG001|Overall Study|incomplete visit/missing data|2|||
33226792|NCT04395183|100728751|FG000|Overall Study|Withdrawal by Subject|1|||
33226793|NCT04395183|100728752|FG001|Overall Study|Withdrawal by Subject|0|||
33226794|NCT04395183|100728753|FG002|Overall Study|Withdrawal by Subject|2|||
33226795|NCT04395183|100728754|FG003|Overall Study|Withdrawal by Subject|2|||
33226796|NCT05822921|100728756|FG000|Overall Study|Lost to Follow-up|1|||
33226797|NCT05822921|100728757|FG001|Overall Study|Lost to Follow-up|1|||
33226798|NCT01121484|100728762|FG000|Overall Study|Adverse Event|12|||
33226799|NCT01121484|100728763|FG001|Overall Study|Adverse Event|5|||
33226800|NCT01121484|100728762|FG000|Overall Study|Lack of Efficacy|3|||
33226801|NCT01121484|100728763|FG001|Overall Study|Lack of Efficacy|11|||
33226802|NCT01121484|100728762|FG000|Overall Study|Lost to Follow-up|5|||
33226803|NCT01121484|100728763|FG001|Overall Study|Lost to Follow-up|9|||
33226804|NCT01121484|100728762|FG000|Overall Study|Physician Decision|0|||
33226805|NCT01121484|100728763|FG001|Overall Study|Physician Decision|3|||
33226806|NCT01121484|100728762|FG000|Overall Study|Protocol Violation|1|||
33226807|NCT01121484|100728763|FG001|Overall Study|Protocol Violation|0|||
33226808|NCT01121484|100728762|FG000|Overall Study|Withdrawal by Subject|8|||
33226809|NCT01121484|100728763|FG001|Overall Study|Withdrawal by Subject|7|||
33226810|NCT01121484|100728762|FG000|Overall Study|Discontinuation of study by sponsor|0|||
33226811|NCT01121484|100728763|FG001|Overall Study|Discontinuation of study by sponsor|1|||
33226812|NCT01121484|100728762|FG000|Overall Study|Other|3|||
33226813|NCT01121484|100728763|FG001|Overall Study|Other|3|||
33226814|NCT01121484|100728762|FG000|Overall Study|Randomized, not treated|1|||
33226815|NCT01121484|100728763|FG001|Overall Study|Randomized, not treated|4|||
33226816|NCT02086552|100728764|FG000|Overall Study|Withdrawal by Subject|1|||
33226817|NCT00669903|100728769|FG000|Overall Study|Adverse Event|0|||
33226818|NCT00669903|100728770|FG001|Overall Study|Adverse Event|1|||
33226819|NCT00669903|100728771|FG002|Overall Study|Adverse Event|3|||
33226820|NCT00669903|100728772|FG003|Overall Study|Adverse Event|1|||
33226821|NCT00669903|100728769|FG000|Overall Study|Withdrawal by Subject|0|||
33226822|NCT00669903|100728770|FG001|Overall Study|Withdrawal by Subject|2|||
33226823|NCT00669903|100728771|FG002|Overall Study|Withdrawal by Subject|2|||
33226824|NCT00669903|100728772|FG003|Overall Study|Withdrawal by Subject|2|||
33226825|NCT00669903|100728769|FG000|Overall Study|Lost to Follow-up|1|||
33226826|NCT00669903|100728770|FG001|Overall Study|Lost to Follow-up|1|||
33226827|NCT00669903|100728771|FG002|Overall Study|Lost to Follow-up|0|||
33226828|NCT00669903|100728772|FG003|Overall Study|Lost to Follow-up|1|||
33226829|NCT00669903|100728769|FG000|Overall Study|Protocol Violation|0|||
33226830|NCT00669903|100728770|FG001|Overall Study|Protocol Violation|1|||
33226831|NCT00669903|100728771|FG002|Overall Study|Protocol Violation|0|||
33632922|NCT03955146|102208675|FG003|DB Period (48 Weeks)|Death|0|||
33226832|NCT00669903|100728772|FG003|Overall Study|Protocol Violation|0|||
33226833|NCT04404478|100732125|FG000|Overall Study|Withdrawal by Subject|1|||
33226834|NCT04404478|100732126|FG001|Overall Study|Withdrawal by Subject|3|||
33226835|NCT00803101|100732134|FG000|Overall Study|Death / Serious Adverse Event|4|||
33226836|NCT00803101|100732135|FG001|Overall Study|Death / Serious Adverse Event|6|||
33226837|NCT00803101|100732134|FG000|Overall Study|Withdrawal by Subject|6|||
33226838|NCT00803101|100732135|FG001|Overall Study|Withdrawal by Subject|4|||
33226839|NCT00803101|100732134|FG000|Overall Study|Lost to Follow-up|2|||
33226840|NCT00803101|100732135|FG001|Overall Study|Lost to Follow-up|2|||
33226841|NCT00803101|100732134|FG000|Overall Study|Protocol Violation|1|||
33226842|NCT00803101|100732135|FG001|Overall Study|Protocol Violation|7|||
33226843|NCT00803101|100732134|FG000|Overall Study|Surgery finished outside protocol window|1|||
33226844|NCT00803101|100732135|FG001|Overall Study|Surgery finished outside protocol window|1|||
33226845|NCT00803101|100732134|FG000|Overall Study|Patient died outside SAE report period|1|||
33226846|NCT00803101|100732135|FG001|Overall Study|Patient died outside SAE report period|0|||
33226847|NCT00803101|100732134|FG000|Overall Study|Patient did not attend scheduled visit|2|||
33226848|NCT00803101|100732135|FG001|Overall Study|Patient did not attend scheduled visit|1|||
33226849|NCT00803101|100732134|FG000|Overall Study|Patient did not have surgery|1|||
33226850|NCT00803101|100732135|FG001|Overall Study|Patient did not have surgery|1|||
33226851|NCT00744328|100732136|FG000|Overall Study|Lost to Follow-up|2|||
33226852|NCT00744328|100732137|FG001|Overall Study|Lost to Follow-up|5|||
33226853|NCT00744328|100732138|FG002|Overall Study|Lost to Follow-up|3|||
33226854|NCT00744328|100732136|FG000|Overall Study|Withdrawal by Subject|5|||
33226855|NCT00744328|100732137|FG001|Overall Study|Withdrawal by Subject|3|||
33226856|NCT00744328|100732138|FG002|Overall Study|Withdrawal by Subject|4|||
33226857|NCT00744328|100732136|FG000|Overall Study|Found ineligible after randomization|0|||
33570092|NCT04380142|101978407|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
33570093|NCT04380142|101978408|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
33570094|NCT04380142|101978406|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
33570095|NCT04380142|101978407|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
33570096|NCT04380142|101978408|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
33570097|NCT01959932|101978415|FG000|Overall Study|Withdrawal by Subject|1|||
33570098|NCT01959932|101978416|FG001|Overall Study|Withdrawal by Subject|0|||
33570099|NCT01959932|101978417|FG002|Overall Study|Withdrawal by Subject|0|||
33570100|NCT01567722|101978420|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
33570101|NCT01567722|101978421|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
33570102|NCT01567722|101978422|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
33570103|NCT01567722|101978420|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
33570104|NCT01567722|101978421|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
33570105|NCT01567722|101978422|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
33570106|NCT01567722|101978420|FG000|Overall Study|Protocol closure by the OCG|2|||
33570107|NCT01567722|101978421|FG001|Overall Study|Protocol closure by the OCG|0|||
33570108|NCT01567722|101978422|FG002|Overall Study|Protocol closure by the OCG|0|||
33570109|NCT01567722|101978420|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
33570110|NCT01567722|101978421|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
33570111|NCT01567722|101978422|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
33570112|NCT02757430|101978424|FG000|Overall Study|Physician Decision|6|||
33570113|NCT02757430|101978424|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
33570114|NCT02757430|101978424|FG000|Overall Study|No informed consent|1|||
33570115|NCT02757430|101978424|FG000|Overall Study|No procedure performed|2|||
33570116|NCT00789555|101978433|FG000|Overall Study|Protocol Amendment|78|||
33570117|NCT00789555|101978434|FG001|Overall Study|Protocol Amendment|76|||
33570118|NCT00789555|101978435|FG002|Overall Study|Protocol Amendment|80|||
33570119|NCT00789555|101978433|FG000|Overall Study|Adverse Event|17|||
33570120|NCT00789555|101978434|FG001|Overall Study|Adverse Event|7|||
33570121|NCT00789555|101978435|FG002|Overall Study|Adverse Event|10|||
33570122|NCT00789555|101978433|FG000|Overall Study|Lost to Follow-up|9|||
33570123|NCT00789555|101978434|FG001|Overall Study|Lost to Follow-up|10|||
33570124|NCT00789555|101978435|FG002|Overall Study|Lost to Follow-up|18|||
33570125|NCT00789555|101978433|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
33570126|NCT00789555|101978434|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
33570127|NCT00789555|101978435|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
33570128|NCT00789555|101978433|FG000|Overall Study|Treatment failure|11|||
33570129|NCT00789555|101978434|FG001|Overall Study|Treatment failure|8|||
33570130|NCT00789555|101978435|FG002|Overall Study|Treatment failure|12|||
33570131|NCT00789555|101978433|FG000|Overall Study|Protocol Violation|6|||
33226858|NCT00744328|100732137|FG001|Overall Study|Found ineligible after randomization|0|||
33226859|NCT00744328|100732138|FG002|Overall Study|Found ineligible after randomization|1|||
33226860|NCT02392611|100732140|FG000|Overall Study|Adverse Event|0|||
33226861|NCT02392611|100732141|FG001|Overall Study|Adverse Event|0|||
33226862|NCT02392611|100732142|FG002|Overall Study|Adverse Event|0|||
33570132|NCT00789555|101978434|FG001|Overall Study|Protocol Violation|9|||
33570133|NCT00789555|101978435|FG002|Overall Study|Protocol Violation|13|||
33570134|NCT02552225|101978436|FG000|Overall Study|Withdrawal by Subject|1|||
33570135|NCT02552225|101978437|FG001|Overall Study|Withdrawal by Subject|0|||
33570136|NCT02724839|101978438|FG000|Overall Study|Withdrawal by Subject|1|||
33570137|NCT02724839|101978439|FG001|Overall Study|Withdrawal by Subject|1|||
33570138|NCT02724839|101978440|FG002|Overall Study|Withdrawal by Subject|0|||
33570139|NCT02724839|101978438|FG000|Overall Study|Lost to Follow-up|0|||
33570140|NCT02724839|101978439|FG001|Overall Study|Lost to Follow-up|3|||
33570141|NCT02724839|101978440|FG002|Overall Study|Lost to Follow-up|2|||
33570142|NCT02724839|101978438|FG000|Overall Study|Physician Decision|0|||
33570143|NCT02724839|101978439|FG001|Overall Study|Physician Decision|0|||
33226863|NCT02392611|100732143|FG003|Overall Study|Adverse Event|1|||
33226864|NCT02392611|100732144|FG004|Overall Study|Adverse Event|0|||
33226865|NCT02392611|100732145|FG005|Overall Study|Adverse Event|0|||
33226866|NCT02392611|100732146|FG006|Overall Study|Adverse Event|0|||
33226867|NCT02392611|100732147|FG007|Overall Study|Adverse Event|0|||
33366292|NCT00718861|101227356|FG000|Overall Study|Lost to Follow-up|2|||
33366293|NCT00718861|101227357|FG001|Overall Study|Lost to Follow-up|1|||
33366294|NCT00718861|101227356|FG000|Overall Study|Administrative Problems|1|||
33366295|NCT00718861|101227357|FG001|Overall Study|Administrative Problems|1|||
33366296|NCT00718861|101227356|FG000|Overall Study|Death|1|||
33366297|NCT00718861|101227357|FG001|Overall Study|Death|5|||
33366298|NCT00520676|101227362|FG000|Overall Study|Death|84|||
33366299|NCT00520676|101227363|FG001|Overall Study|Death|81|||
33366300|NCT00520676|101227362|FG000|Overall Study|Lost to Follow-up|6|||
33366301|NCT00520676|101227363|FG001|Overall Study|Lost to Follow-up|10|||
33226868|NCT02392611|100732148|FG008|Overall Study|Adverse Event|0|||
33226869|NCT02392611|100732140|FG000|Overall Study|Progressive disease|0|||
33226870|NCT02392611|100732141|FG001|Overall Study|Progressive disease|0|||
33226871|NCT02392611|100732142|FG002|Overall Study|Progressive disease|0|||
33226872|NCT02392611|100732143|FG003|Overall Study|Progressive disease|2|||
33226873|NCT02392611|100732144|FG004|Overall Study|Progressive disease|1|||
33226874|NCT02392611|100732145|FG005|Overall Study|Progressive disease|0|||
33226875|NCT02392611|100732146|FG006|Overall Study|Progressive disease|0|||
33226876|NCT02392611|100732147|FG007|Overall Study|Progressive disease|0|||
33226877|NCT02392611|100732148|FG008|Overall Study|Progressive disease|0|||
33226878|NCT02392611|100732140|FG000|Overall Study|Death|1|||
33226879|NCT02392611|100732141|FG001|Overall Study|Death|0|||
33226880|NCT02392611|100732142|FG002|Overall Study|Death|0|||
33226881|NCT02392611|100732143|FG003|Overall Study|Death|0|||
33226882|NCT02392611|100732144|FG004|Overall Study|Death|0|||
33226883|NCT02392611|100732145|FG005|Overall Study|Death|1|||
33226884|NCT02392611|100732146|FG006|Overall Study|Death|0|||
33226885|NCT02392611|100732147|FG007|Overall Study|Death|0|||
33226886|NCT02392611|100732148|FG008|Overall Study|Death|0|||
33226887|NCT02392611|100732140|FG000|Overall Study|Withdrawal by Subject|0|||
33226888|NCT02392611|100732141|FG001|Overall Study|Withdrawal by Subject|0|||
33226889|NCT02392611|100732142|FG002|Overall Study|Withdrawal by Subject|0|||
33226890|NCT02392611|100732143|FG003|Overall Study|Withdrawal by Subject|1|||
33226891|NCT02392611|100732144|FG004|Overall Study|Withdrawal by Subject|0|||
33226892|NCT02392611|100732145|FG005|Overall Study|Withdrawal by Subject|0|||
33226893|NCT02392611|100732146|FG006|Overall Study|Withdrawal by Subject|0|||
33226894|NCT02392611|100732147|FG007|Overall Study|Withdrawal by Subject|0|||
33226895|NCT02392611|100732148|FG008|Overall Study|Withdrawal by Subject|0|||
33226896|NCT02392611|100732140|FG000|Overall Study|Lost to Follow-up|0|||
33226897|NCT02392611|100732141|FG001|Overall Study|Lost to Follow-up|0|||
33226898|NCT02392611|100732142|FG002|Overall Study|Lost to Follow-up|0|||
33226899|NCT02392611|100732143|FG003|Overall Study|Lost to Follow-up|0|||
33226900|NCT02392611|100732144|FG004|Overall Study|Lost to Follow-up|0|||
33226901|NCT02392611|100732145|FG005|Overall Study|Lost to Follow-up|0|||
33226902|NCT02392611|100732146|FG006|Overall Study|Lost to Follow-up|1|||
33226903|NCT02392611|100732147|FG007|Overall Study|Lost to Follow-up|0|||
33418206|NCT04440163|101422357|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
33418207|NCT04440163|101422358|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
33418208|NCT04440163|101422359|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
33226904|NCT02392611|100732148|FG008|Overall Study|Lost to Follow-up|0|||
33226905|NCT02392611|100732140|FG000|Overall Study|Enrolled, not treated|0|||
33226906|NCT02392611|100732141|FG001|Overall Study|Enrolled, not treated|0|||
33226907|NCT02392611|100732142|FG002|Overall Study|Enrolled, not treated|0|||
33418209|NCT04440163|101422360|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
33418210|NCT04440163|101422361|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
33570144|NCT02724839|101978440|FG002|Overall Study|Physician Decision|3|||
33570145|NCT03707821|101978441|FG000|Overall Study|Protocol Violation|0|||
33226908|NCT02392611|100732143|FG003|Overall Study|Enrolled, not treated|2|||
33226909|NCT02392611|100732144|FG004|Overall Study|Enrolled, not treated|0|||
33366302|NCT00520676|101227362|FG000|Overall Study|Physician Decision|4|||
33366303|NCT00520676|101227363|FG001|Overall Study|Physician Decision|1|||
33226910|NCT02392611|100732145|FG005|Overall Study|Enrolled, not treated|0|||
33226911|NCT02392611|100732146|FG006|Overall Study|Enrolled, not treated|0|||
33226912|NCT02392611|100732147|FG007|Overall Study|Enrolled, not treated|0|||
33226913|NCT02392611|100732148|FG008|Overall Study|Enrolled, not treated|0|||
33226914|NCT00988221|100732153|FG000|Part I|Adverse Event|0|||
33226915|NCT00988221|100732154|FG001|Part I|Adverse Event|1|||
33226916|NCT00988221|100732155|FG002|Part I|Adverse Event|2|||
33418211|NCT04440163|101422354|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
33418212|NCT04440163|101422355|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
33418213|NCT04440163|101422356|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
33418214|NCT04440163|101422357|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
33418215|NCT04440163|101422358|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
33366304|NCT00520676|101227362|FG000|Overall Study|Withdrawal by Subject|7|||
33366305|NCT00520676|101227363|FG001|Overall Study|Withdrawal by Subject|11|||
33366306|NCT02612077|101227364|FG000|Overall Study|Adverse Event|3|||
33366307|NCT02612077|101227364|FG000|Overall Study|Withdrawal by Subject|9|||
33366308|NCT02612077|101227364|FG000|Overall Study|Protocol Violation|28|||
33366309|NCT02612077|101227364|FG000|Overall Study|Lost to Follow-up|20|||
33366310|NCT02612077|101227364|FG000|Overall Study|Death|377|||
33366311|NCT02612077|101227364|FG000|Overall Study|Moved or Changed Medical Team|23|||
33366312|NCT02612077|101227364|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
33366313|NCT02612077|101227364|FG000|Overall Study|Disease Progression|3|||
33366314|NCT02612077|101227364|FG000|Overall Study|Unknown reason|2|||
33366315|NCT03502707|101227366|FG000|Overall Study|Adverse Event|0|||
33366316|NCT03502707|101227367|FG001|Overall Study|Adverse Event|0|||
33366317|NCT03502707|101227368|FG002|Overall Study|Adverse Event|0|||
33366318|NCT03502707|101227369|FG003|Overall Study|Adverse Event|0|||
33366319|NCT03502707|101227370|FG004|Overall Study|Adverse Event|0|||
33226917|NCT00988221|100732156|FG003|Part I|Adverse Event|0|||
33226918|NCT00988221|100732153|FG000|Part I|Insufficient Therapeutic Response|4|||
33366320|NCT03502707|101227371|FG005|Overall Study|Adverse Event|0|||
33366321|NCT03502707|101227372|FG006|Overall Study|Adverse Event|0|||
33418216|NCT04440163|101422359|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
33418217|NCT04440163|101422360|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
33418218|NCT04440163|101422361|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
33418219|NCT04440163|101422354|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
33226919|NCT00988221|100732154|FG001|Part I|Insufficient Therapeutic Response|6|||
33226920|NCT00988221|100732155|FG002|Part I|Insufficient Therapeutic Response|5|||
33366322|NCT03502707|101227373|FG007|Overall Study|Adverse Event|0|||
33366323|NCT03502707|101227374|FG008|Overall Study|Adverse Event|0|||
33366324|NCT03502707|101227375|FG009|Overall Study|Adverse Event|0|||
33226921|NCT00988221|100732156|FG003|Part I|Insufficient Therapeutic Response|0|||
33226922|NCT00988221|100732153|FG000|Part I|Refused Treatment|0|||
33226923|NCT00988221|100732154|FG001|Part I|Refused Treatment|2|||
33226924|NCT00988221|100732155|FG002|Part I|Refused Treatment|1|||
33226925|NCT00988221|100732156|FG003|Part I|Refused Treatment|0|||
33226926|NCT00988221|100732153|FG000|Part I|Lost to Follow-up|0|||
33226927|NCT00988221|100732154|FG001|Part I|Lost to Follow-up|1|||
33226928|NCT00988221|100732155|FG002|Part I|Lost to Follow-up|0|||
33226929|NCT00988221|100732156|FG003|Part I|Lost to Follow-up|0|||
33226930|NCT00988221|100732153|FG000|Part II|Adverse Event|1|||
33226931|NCT00988221|100732154|FG001|Part II|Adverse Event|0|||
33226932|NCT00988221|100732155|FG002|Part II|Adverse Event|0|||
33226933|NCT00988221|100732156|FG003|Part II|Adverse Event|1|||
33226934|NCT00988221|100732153|FG000|Part II|Withdrawal by Subject|0|||
33226935|NCT00988221|100732154|FG001|Part II|Withdrawal by Subject|0|||
33226936|NCT00988221|100732155|FG002|Part II|Withdrawal by Subject|2|||
33226937|NCT00988221|100732156|FG003|Part II|Withdrawal by Subject|2|||
33226938|NCT00988221|100732153|FG000|Part II|Reason not Specified|0|||
33226939|NCT00988221|100732154|FG001|Part II|Reason not Specified|0|||
33226940|NCT00988221|100732155|FG002|Part II|Reason not Specified|1|||
33226941|NCT00988221|100732156|FG003|Part II|Reason not Specified|0|||
33226942|NCT00988221|100732153|FG000|Part III|Adverse Event|1|||
33226943|NCT00988221|100732154|FG001|Part III|Adverse Event|0|||
33226944|NCT00988221|100732155|FG002|Part III|Adverse Event|1|||
33226945|NCT00988221|100732156|FG003|Part III|Adverse Event|0|||
33226946|NCT00988221|100732153|FG000|Part III|Insufficient Therapeutic Response|0|||
33226947|NCT00988221|100732154|FG001|Part III|Insufficient Therapeutic Response|1|||
33226948|NCT00988221|100732155|FG002|Part III|Insufficient Therapeutic Response|1|||
33226949|NCT00988221|100732156|FG003|Part III|Insufficient Therapeutic Response|0|||
33226950|NCT00988221|100732153|FG000|Part III|Refused Treatment|0|||
33226951|NCT00988221|100732154|FG001|Part III|Refused Treatment|0|||
33226952|NCT00988221|100732155|FG002|Part III|Refused Treatment|1|||
33226953|NCT00988221|100732156|FG003|Part III|Refused Treatment|0|||
33226954|NCT01462162|100732160|FG000|Overall Study|Adverse Event|5|||
33226955|NCT01462162|100732160|FG000|Overall Study|Lack of Efficacy|4|||
33226956|NCT01462162|100732160|FG000|Overall Study|Abnormal laboratory parameters|1|||
33226957|NCT01462162|100732160|FG000|Overall Study|Other|2|||
33226958|NCT00105586|100732165|FG000|Overall Study|Adverse Event|4|||
33226959|NCT00105586|100732166|FG001|Overall Study|Adverse Event|3|||
33226960|NCT00105586|100732165|FG000|Overall Study|Physician Decision|13|||
33226961|NCT00105586|100732166|FG001|Overall Study|Physician Decision|13|||
33226962|NCT03097861|100732174|FG000|Overall Study|Adverse Event|3|||
33226963|NCT03097861|100732175|FG001|Overall Study|Adverse Event|8|||
33226964|NCT03097861|100732176|FG002|Overall Study|Adverse Event|4|||
33226965|NCT03097861|100732174|FG000|Overall Study|Investigator Decision|0|||
33226966|NCT03097861|100732175|FG001|Overall Study|Investigator Decision|1|||
33226967|NCT03097861|100732176|FG002|Overall Study|Investigator Decision|0|||
33366325|NCT03502707|101227376|FG010|Overall Study|Adverse Event|0|||
33366326|NCT03502707|101227377|FG011|Overall Study|Adverse Event|0|||
33366327|NCT03502707|101227378|FG012|Overall Study|Adverse Event|0|||
33366328|NCT03502707|101227379|FG013|Overall Study|Adverse Event|0|||
33366329|NCT03502707|101227380|FG014|Overall Study|Adverse Event|0|||
33366330|NCT03502707|101227381|FG015|Overall Study|Adverse Event|1|||
33366331|NCT03502707|101227382|FG016|Overall Study|Adverse Event|5|||
33366332|NCT03502707|101227383|FG017|Overall Study|Adverse Event|0|||
33366333|NCT03502707|101227366|FG000|Overall Study|Death|0|||
33418220|NCT04440163|101422355|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
33418221|NCT04440163|101422356|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
33226968|NCT03097861|100732174|FG000|Overall Study|Lost to Follow-up|0|||
33226969|NCT03097861|100732175|FG001|Overall Study|Lost to Follow-up|7|||
33226970|NCT03097861|100732176|FG002|Overall Study|Lost to Follow-up|1|||
33226971|NCT03097861|100732174|FG000|Overall Study|Withdrawal by Subject|1|||
33226972|NCT03097861|100732175|FG001|Overall Study|Withdrawal by Subject|5|||
33226973|NCT03097861|100732176|FG002|Overall Study|Withdrawal by Subject|3|||
33570146|NCT03707821|101978442|FG001|Overall Study|Protocol Violation|1|||
33226974|NCT03097861|100732174|FG000|Overall Study|Reason not provided|3|||
33226975|NCT03097861|100732175|FG001|Overall Study|Reason not provided|1|||
33226976|NCT03097861|100732176|FG002|Overall Study|Reason not provided|1|||
33226977|NCT02176421|100732182|FG000|Overall Study|Lost to Follow-up|4|||
33366334|NCT03502707|101227367|FG001|Overall Study|Death|0|||
33366335|NCT03502707|101227368|FG002|Overall Study|Death|0|||
33226978|NCT02176421|100732182|FG000|Overall Study|Adverse Event|1|||
33226979|NCT00633932|100732183|FG000|Overall Study|Adverse Event|1|||
33226980|NCT00633932|100732184|FG001|Overall Study|Adverse Event|3|||
33226981|NCT00633932|100732185|FG002|Overall Study|Adverse Event|4|||
33226982|NCT00633932|100732183|FG000|Overall Study|Withdrawal by Subject|3|||
33226983|NCT00633932|100732184|FG001|Overall Study|Withdrawal by Subject|9|||
33226984|NCT00633932|100732185|FG002|Overall Study|Withdrawal by Subject|1|||
33226985|NCT00633932|100732183|FG000|Overall Study|Lost to Follow-up|1|||
33226986|NCT00633932|100732184|FG001|Overall Study|Lost to Follow-up|0|||
33226987|NCT00633932|100732185|FG002|Overall Study|Lost to Follow-up|2|||
33226988|NCT00633932|100732183|FG000|Overall Study|Protocol Violation|5|||
33226989|NCT00633932|100732184|FG001|Overall Study|Protocol Violation|2|||
33226990|NCT00633932|100732185|FG002|Overall Study|Protocol Violation|3|||
33226991|NCT00633932|100732183|FG000|Overall Study|Physician Decision|0|||
33570147|NCT03707821|101978441|FG000|Overall Study|Unsatisfactory Visual Response|1|||
33570148|NCT03707821|101978442|FG001|Overall Study|Unsatisfactory Visual Response|0|||
33570149|NCT03707821|101978441|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
33570150|NCT03707821|101978442|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
33570151|NCT03342560|101978443|FG000|Overall Study|Lost to Follow-up|2|||
33366336|NCT03502707|101227369|FG003|Overall Study|Death|1|||
33366337|NCT03502707|101227370|FG004|Overall Study|Death|0|||
33366338|NCT03502707|101227371|FG005|Overall Study|Death|0|||
33366339|NCT03502707|101227372|FG006|Overall Study|Death|0|||
33366340|NCT03502707|101227373|FG007|Overall Study|Death|0|||
33366341|NCT03502707|101227374|FG008|Overall Study|Death|1|||
33366342|NCT03502707|101227375|FG009|Overall Study|Death|1|||
33366343|NCT03502707|101227376|FG010|Overall Study|Death|0|||
33366344|NCT03502707|101227377|FG011|Overall Study|Death|0|||
33366345|NCT03502707|101227378|FG012|Overall Study|Death|1|||
33366346|NCT03502707|101227379|FG013|Overall Study|Death|0|||
33366347|NCT03502707|101227380|FG014|Overall Study|Death|0|||
33632923|NCT03955146|102208672|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
33632924|NCT03955146|102208673|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
33570152|NCT02437318|101978444|FG000|Overall Study|Progressive disease|173|||
33366348|NCT03502707|101227381|FG015|Overall Study|Death|1|||
33366349|NCT03502707|101227382|FG016|Overall Study|Death|0|||
33366350|NCT03502707|101227383|FG017|Overall Study|Death|0|||
33366351|NCT03502707|101227366|FG000|Overall Study|Lost to Follow-up|0|||
33570153|NCT02437318|101978445|FG001|Overall Study|Progressive disease|208|||
33570154|NCT02437318|101978444|FG000|Overall Study|Subject/guardian decision|22|||
33570155|NCT02437318|101978445|FG001|Overall Study|Subject/guardian decision|10|||
33570156|NCT02437318|101978444|FG000|Overall Study|Physician Decision|11|||
33570157|NCT02437318|101978445|FG001|Overall Study|Physician Decision|10|||
33632925|NCT03955146|102208674|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
33632926|NCT03955146|102208675|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
33570158|NCT02437318|101978444|FG000|Overall Study|Adverse Event|14|||
33570159|NCT02437318|101978445|FG001|Overall Study|Adverse Event|3|||
33226992|NCT00633932|100732184|FG001|Overall Study|Physician Decision|0|||
33226993|NCT00633932|100732185|FG002|Overall Study|Physician Decision|1|||
33226994|NCT00633932|100732183|FG000|Overall Study|Doctor's judgement|1|||
33226995|NCT00633932|100732184|FG001|Overall Study|Doctor's judgement|0|||
33226996|NCT00633932|100732185|FG002|Overall Study|Doctor's judgement|0|||
33226997|NCT00633932|100732183|FG000|Overall Study|Moved Away|1|||
33226998|NCT00633932|100732184|FG001|Overall Study|Moved Away|0|||
33226999|NCT00633932|100732185|FG002|Overall Study|Moved Away|0|||
33227000|NCT01108458|100732187|FG000|Overall Study|Withdrawal by Subject|1|||
33227001|NCT02998021|100732191|FG000|Overall Study|Withdrawal by Subject|3|||
33227002|NCT02998021|100732192|FG001|Overall Study|Withdrawal by Subject|1|||
33227003|NCT02998021|100732191|FG000|Overall Study|unsafe home|0|||
33227004|NCT02998021|100732192|FG001|Overall Study|unsafe home|1|||
33227005|NCT00114634|100732195|FG000|Overall Study|failure to return forms|3|||
33227006|NCT04844918|100732199|FG000|Overall Study|Adverse Event|7|||
33227007|NCT04844918|100732200|FG001|Overall Study|Adverse Event|8|||
33227008|NCT04844918|100732201|FG002|Overall Study|Adverse Event|5|||
33227009|NCT04844918|100732199|FG000|Overall Study|Physician Decision|0|||
33227010|NCT04844918|100732200|FG001|Overall Study|Physician Decision|1|||
33227011|NCT04844918|100732201|FG002|Overall Study|Physician Decision|0|||
33227012|NCT04844918|100732199|FG000|Overall Study|Withdrawal by Subject|6|||
33227013|NCT04844918|100732200|FG001|Overall Study|Withdrawal by Subject|3|||
33366352|NCT03502707|101227367|FG001|Overall Study|Lost to Follow-up|0|||
33366353|NCT03502707|101227368|FG002|Overall Study|Lost to Follow-up|0|||
33366354|NCT03502707|101227369|FG003|Overall Study|Lost to Follow-up|0|||
33570160|NCT02437318|101978444|FG000|Overall Study|Death|4|||
33570161|NCT02437318|101978445|FG001|Overall Study|Death|4|||
33570162|NCT02437318|101978444|FG000|Overall Study|Protocol Violation|5|||
33227014|NCT04844918|100732201|FG002|Overall Study|Withdrawal by Subject|3|||
33227015|NCT04844918|100732199|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
33227016|NCT04844918|100732200|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
33366355|NCT03502707|101227370|FG004|Overall Study|Lost to Follow-up|0|||
33366356|NCT03502707|101227371|FG005|Overall Study|Lost to Follow-up|0|||
33227017|NCT04844918|100732201|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
33227018|NCT04488003|100732209|FG000|Assessed for Eligibility|Screen Failure|24|||
33227019|NCT04488003|100732210|FG001|Assessed for Eligibility|Screen Failure|0|||
33227020|NCT04488003|100732211|FG002|Assessed for Eligibility|Screen Failure|0|||
33227021|NCT04488003|100732209|FG000|Assessed for Eligibility|Adverse Event|1|||
33227022|NCT04488003|100732210|FG001|Assessed for Eligibility|Adverse Event|0|||
33227023|NCT04488003|100732211|FG002|Assessed for Eligibility|Adverse Event|0|||
33227024|NCT04488003|100732209|FG000|Assessed for Eligibility|Death|1|||
33227025|NCT04488003|100732210|FG001|Assessed for Eligibility|Death|0|||
33227026|NCT04488003|100732211|FG002|Assessed for Eligibility|Death|0|||
33227027|NCT04488003|100732209|FG000|Assessed for Eligibility|Physician Decision|1|||
33227028|NCT04488003|100732210|FG001|Assessed for Eligibility|Physician Decision|0|||
33570163|NCT02437318|101978445|FG001|Overall Study|Protocol Violation|6|||
33570164|NCT02437318|101978444|FG000|Overall Study|Untreated|0|||
33570165|NCT02437318|101978445|FG001|Overall Study|Untreated|1|||
33570166|NCT00928668|101978446|FG000|Overall Study|Adverse Event|1|||
33570167|NCT00928668|101978447|FG001|Overall Study|Adverse Event|0|||
33570168|NCT00928668|101978448|FG002|Overall Study|Adverse Event|0|||
33570169|NCT00928668|101978449|FG003|Overall Study|Adverse Event|0|||
33570170|NCT00928668|101978450|FG004|Overall Study|Adverse Event|0|||
33570171|NCT00928668|101978446|FG000|Overall Study|Protocol Violation|0|||
33570172|NCT00928668|101978447|FG001|Overall Study|Protocol Violation|0|||
33570173|NCT00928668|101978448|FG002|Overall Study|Protocol Violation|0|||
33570174|NCT00928668|101978449|FG003|Overall Study|Protocol Violation|0|||
33570175|NCT00928668|101978450|FG004|Overall Study|Protocol Violation|1|||
33227029|NCT04488003|100732211|FG002|Assessed for Eligibility|Physician Decision|0|||
33227030|NCT04488003|100732209|FG000|Allocated to Treatment|Progressive Disease|51|||
33227031|NCT04488003|100732210|FG001|Allocated to Treatment|Progressive Disease|0|||
33227032|NCT04488003|100732211|FG002|Allocated to Treatment|Progressive Disease|0|||
33227033|NCT04488003|100732209|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
33227034|NCT04488003|100732210|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
33227035|NCT04488003|100732211|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
33227036|NCT04488003|100732209|FG000|Allocated to Treatment|Adverse Event|6|||
33227037|NCT04488003|100732210|FG001|Allocated to Treatment|Adverse Event|0|||
33227038|NCT04488003|100732211|FG002|Allocated to Treatment|Adverse Event|0|||
33227039|NCT04488003|100732209|FG000|Allocated to Treatment|Other|5|||
33227040|NCT04488003|100732210|FG001|Allocated to Treatment|Other|0|||
33227041|NCT04488003|100732211|FG002|Allocated to Treatment|Other|0|||
33227042|NCT04488003|100732209|FG000|Allocated to Treatment|Physician Decision|4|||
33227043|NCT04488003|100732210|FG001|Allocated to Treatment|Physician Decision|0|||
33227044|NCT04488003|100732211|FG002|Allocated to Treatment|Physician Decision|0|||
33227045|NCT04488003|100732209|FG000|Allocated to Treatment|Death|4|||
33227046|NCT04488003|100732210|FG001|Allocated to Treatment|Death|0|||
33227047|NCT04488003|100732211|FG002|Allocated to Treatment|Death|0|||
33227048|NCT02914184|100732212|FG000|Overall Study|Lost to Follow-up|7|||
33227049|NCT02914184|100732213|FG001|Overall Study|Lost to Follow-up|10|||
33227050|NCT02914184|100732214|FG002|Overall Study|Lost to Follow-up|8|||
33227051|NCT02914184|100732215|FG003|Overall Study|Lost to Follow-up|7|||
33227052|NCT02914184|100732212|FG000|Overall Study|Withdrawal by Subject|4|||
33227053|NCT02914184|100732213|FG001|Overall Study|Withdrawal by Subject|2|||
33227054|NCT02914184|100732214|FG002|Overall Study|Withdrawal by Subject|7|||
33227055|NCT02914184|100732215|FG003|Overall Study|Withdrawal by Subject|3|||
33227056|NCT02914184|100732212|FG000|Overall Study|Other|1|||
33227057|NCT02914184|100732213|FG001|Overall Study|Other|0|||
33227058|NCT02914184|100732214|FG002|Overall Study|Other|0|||
33227059|NCT02914184|100732215|FG003|Overall Study|Other|0|||
33227060|NCT02914184|100732212|FG000|Overall Study|Migrated/moved from the study area|2|||
33227061|NCT02914184|100732213|FG001|Overall Study|Migrated/moved from the study area|1|||
33227062|NCT02914184|100732214|FG002|Overall Study|Migrated/moved from the study area|2|||
33227063|NCT02914184|100732215|FG003|Overall Study|Migrated/moved from the study area|1|||
33570176|NCT00928668|101978446|FG000|Overall Study|Withdrawal by Subject|0|||
33227064|NCT03002038|100732216|FG000|Overall Study|Adverse Event|3|||
33227065|NCT03002038|100732217|FG001|Overall Study|Adverse Event|1|||
33570177|NCT00928668|101978447|FG001|Overall Study|Withdrawal by Subject|1|||
33227066|NCT03002038|100732216|FG000|Overall Study|Withdrawal by Subject|8|||
33227067|NCT03002038|100732217|FG001|Overall Study|Withdrawal by Subject|4|||
33227068|NCT03002038|100732216|FG000|Overall Study|Immigration to another region|0|||
33227069|NCT03002038|100732217|FG001|Overall Study|Immigration to another region|2|||
33570178|NCT00928668|101978448|FG002|Overall Study|Withdrawal by Subject|1|||
33570179|NCT00928668|101978449|FG003|Overall Study|Withdrawal by Subject|0|||
33570180|NCT00928668|101978450|FG004|Overall Study|Withdrawal by Subject|0|||
33227070|NCT03101241|100732218|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
33227071|NCT03101241|100732219|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
33418222|NCT04440163|101422357|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
33570181|NCT00928668|101978446|FG000|Overall Study|Other reasons not listed above|0|||
33570182|NCT00928668|101978447|FG001|Overall Study|Other reasons not listed above|0|||
33227072|NCT03101241|100732218|FG000|Overall Study|Participant withdrew consent|3|||
33227073|NCT03101241|100732219|FG001|Overall Study|Participant withdrew consent|1|||
33227074|NCT03101241|100732218|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
33227075|NCT03101241|100732219|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
33227076|NCT03101241|100732218|FG000|Overall Study|Lost to Follow-up|2|||
33227077|NCT03101241|100732219|FG001|Overall Study|Lost to Follow-up|0|||
33227078|NCT03101241|100732218|FG000|Overall Study|Lack of Efficacy|0|||
33227079|NCT03101241|100732219|FG001|Overall Study|Lack of Efficacy|1|||
33227080|NCT03101241|100732218|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
33227081|NCT03101241|100732219|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
33227082|NCT01090310|100732220|FG000|Core Study|Adverse Event|2|||
33227083|NCT01090310|100732221|FG001|Core Study|Adverse Event|2|||
33227084|NCT01090310|100732222|FG002|Core Study|Adverse Event|1|||
33227085|NCT01090310|100732223|FG003|Core Study|Adverse Event|1|||
33227086|NCT01090310|100732220|FG000|Core Study|Subject withdrew consent|0|||
33227087|NCT01090310|100732221|FG001|Core Study|Subject withdrew consent|3|||
33227088|NCT01090310|100732222|FG002|Core Study|Subject withdrew consent|1|||
33227089|NCT01090310|100732223|FG003|Core Study|Subject withdrew consent|1|||
33227090|NCT01090310|100732220|FG000|Core Study|Abnormal test procedure result|0|||
33227091|NCT01090310|100732221|FG001|Core Study|Abnormal test procedure result|0|||
33227092|NCT01090310|100732222|FG002|Core Study|Abnormal test procedure result|1|||
33227093|NCT01090310|100732223|FG003|Core Study|Abnormal test procedure result|0|||
33227094|NCT01090310|100732220|FG000|Core Study|Administrative reasons|5|||
33227095|NCT01090310|100732221|FG001|Core Study|Administrative reasons|6|||
33227096|NCT01090310|100732222|FG002|Core Study|Administrative reasons|4|||
33227097|NCT01090310|100732223|FG003|Core Study|Administrative reasons|4|||
33227098|NCT01090310|100732220|FG000|Core Study|Protocol deviation|1|||
33227099|NCT01090310|100732221|FG001|Core Study|Protocol deviation|0|||
33227100|NCT01090310|100732222|FG002|Core Study|Protocol deviation|0|||
33227101|NCT01090310|100732223|FG003|Core Study|Protocol deviation|1|||
33227102|NCT01090310|100732220|FG000|Extension Study|Aministrative problems|13|||
33227103|NCT01090310|100732221|FG001|Extension Study|Aministrative problems|15|||
33227104|NCT01090310|100732222|FG002|Extension Study|Aministrative problems|14|||
33227105|NCT01090310|100732223|FG003|Extension Study|Aministrative problems|18|||
33227106|NCT01090310|100732220|FG000|Extension Study|Adverse Event|0|||
33227107|NCT01090310|100732221|FG001|Extension Study|Adverse Event|0|||
33227108|NCT01090310|100732222|FG002|Extension Study|Adverse Event|0|||
33227109|NCT01090310|100732223|FG003|Extension Study|Adverse Event|1|||
33227110|NCT01090310|100732220|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
33227111|NCT01090310|100732221|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
33227112|NCT01090310|100732222|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
33227113|NCT01090310|100732223|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
33227114|NCT01090310|100732220|FG000|Extension Study|Subject withdrew consent|0|||
33227115|NCT01090310|100732221|FG001|Extension Study|Subject withdrew consent|1|||
33227116|NCT01090310|100732222|FG002|Extension Study|Subject withdrew consent|0|||
33227117|NCT01090310|100732223|FG003|Extension Study|Subject withdrew consent|0|||
33227118|NCT02714868|100732224|FG000|Overall Study|Withdrawal by Subject|3|||
33227119|NCT02714868|100732225|FG001|Overall Study|Withdrawal by Subject|0|||
33227120|NCT02714868|100732224|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
33227121|NCT02714868|100732225|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
33227122|NCT02714868|100732224|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
33227123|NCT02714868|100732225|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
33227124|NCT01735396|100732226|FG000|Overall Study|not evaluable|1|||
33227125|NCT00402337|100732229|FG000|Overall Study|Adverse Event|0|||
33227126|NCT00402337|100732230|FG001|Overall Study|Adverse Event|2|||
33227127|NCT00402337|100732231|FG002|Overall Study|Adverse Event|2|||
33227128|NCT00402337|100732232|FG003|Overall Study|Adverse Event|3|||
33227129|NCT00402337|100732233|FG004|Overall Study|Adverse Event|2|||
33227130|NCT00402337|100732229|FG000|Overall Study|Noncompliance|0|||
33227131|NCT00402337|100732230|FG001|Overall Study|Noncompliance|0|||
33418223|NCT04440163|101422358|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
33632927|NCT03955146|102208672|FG000|DB Period (48 Weeks)|Disease Progression|2|||
33632928|NCT03955146|102208673|FG001|DB Period (48 Weeks)|Disease Progression|0|||
33418224|NCT04440163|101422359|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
33632929|NCT03955146|102208674|FG002|DB Period (48 Weeks)|Disease Progression|0|||
33227132|NCT00402337|100732231|FG002|Overall Study|Noncompliance|0|||
33227133|NCT00402337|100732232|FG003|Overall Study|Noncompliance|0|||
33227134|NCT00402337|100732233|FG004|Overall Study|Noncompliance|2|||
33227135|NCT00402337|100732229|FG000|Overall Study|Withdrawal by Subject|5|||
33227136|NCT00402337|100732230|FG001|Overall Study|Withdrawal by Subject|3|||
33227137|NCT00402337|100732231|FG002|Overall Study|Withdrawal by Subject|1|||
33227138|NCT00402337|100732232|FG003|Overall Study|Withdrawal by Subject|6|||
33227139|NCT00402337|100732233|FG004|Overall Study|Withdrawal by Subject|4|||
33227140|NCT00402337|100732229|FG000|Overall Study|Lost to Follow-up|0|||
33227141|NCT00402337|100732230|FG001|Overall Study|Lost to Follow-up|0|||
33227142|NCT00402337|100732231|FG002|Overall Study|Lost to Follow-up|1|||
33227143|NCT00402337|100732232|FG003|Overall Study|Lost to Follow-up|2|||
33227144|NCT00402337|100732233|FG004|Overall Study|Lost to Follow-up|0|||
33227145|NCT00402337|100732229|FG000|Overall Study|Physician Decision|0|||
33227146|NCT00402337|100732230|FG001|Overall Study|Physician Decision|0|||
33227147|NCT00402337|100732231|FG002|Overall Study|Physician Decision|0|||
33227148|NCT00402337|100732232|FG003|Overall Study|Physician Decision|1|||
33227149|NCT00402337|100732233|FG004|Overall Study|Physician Decision|0|||
33227150|NCT00402337|100732229|FG000|Overall Study|Other Reason|0|||
33227151|NCT00402337|100732230|FG001|Overall Study|Other Reason|1|||
33227152|NCT00402337|100732231|FG002|Overall Study|Other Reason|0|||
33227153|NCT00402337|100732232|FG003|Overall Study|Other Reason|0|||
33227154|NCT00402337|100732233|FG004|Overall Study|Other Reason|0|||
33227155|NCT00720902|100732238|FG000|Overall Study|Withdrawal by Subject|1|||
33227156|NCT00720902|100732239|FG001|Overall Study|Withdrawal by Subject|0|||
33227157|NCT00720902|100732238|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
33227158|NCT00720902|100732239|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
33227159|NCT01659658|100732243|FG000|Overall Study|Withdrawal by Patient|18|||
33227160|NCT01659658|100732244|FG001|Overall Study|Withdrawal by Patient|4|||
33227161|NCT01659658|100732245|FG002|Overall Study|Withdrawal by Patient|2|||
33227162|NCT01659658|100732246|FG003|Overall Study|Withdrawal by Patient|0|||
33227163|NCT01659658|100732247|FG004|Overall Study|Withdrawal by Patient|11|||
33227164|NCT01659658|100732243|FG000|Overall Study|Study Terminated by Sponsor|9|||
33227165|NCT01659658|100732244|FG001|Overall Study|Study Terminated by Sponsor|7|||
33227166|NCT01659658|100732245|FG002|Overall Study|Study Terminated by Sponsor|0|||
33227167|NCT01659658|100732246|FG003|Overall Study|Study Terminated by Sponsor|1|||
33227168|NCT01659658|100732247|FG004|Overall Study|Study Terminated by Sponsor|4|||
33227169|NCT01659658|100732243|FG000|Overall Study|Reason not Specified|61|||
33227170|NCT01659658|100732244|FG001|Overall Study|Reason not Specified|15|||
33227171|NCT01659658|100732245|FG002|Overall Study|Reason not Specified|8|||
33227172|NCT01659658|100732246|FG003|Overall Study|Reason not Specified|1|||
33227173|NCT01659658|100732247|FG004|Overall Study|Reason not Specified|34|||
33227174|NCT01659658|100732243|FG000|Overall Study|Lost to Follow-up|2|||
33632930|NCT03955146|102208675|FG003|DB Period (48 Weeks)|Disease Progression|0|||
33632931|NCT03955146|102208672|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
33632932|NCT03955146|102208673|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
33632933|NCT03955146|102208674|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
33632934|NCT03955146|102208675|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
33227175|NCT01659658|100732244|FG001|Overall Study|Lost to Follow-up|0|||
33227176|NCT01659658|100732245|FG002|Overall Study|Lost to Follow-up|0|||
33227177|NCT01659658|100732246|FG003|Overall Study|Lost to Follow-up|0|||
33227178|NCT01659658|100732247|FG004|Overall Study|Lost to Follow-up|0|||
33227179|NCT01567865|100732248|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
33227180|NCT01567865|100732249|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
33227181|NCT01567865|100732250|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
33227182|NCT01567865|100732251|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
33227183|NCT01567865|100732248|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
33227184|NCT01567865|100732249|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
33227185|NCT01567865|100732250|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
33227186|NCT01567865|100732251|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
33227187|NCT00926003|100732254|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
33227188|NCT00926003|100732255|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
33227189|NCT00926003|100732256|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
33227190|NCT00926003|100732254|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
33227191|NCT00926003|100732255|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
33227192|NCT00926003|100732256|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
33227193|NCT00920621|100732264|FG000|Overall Study|Lost to Follow-up|16|||
33227194|NCT00920621|100732265|FG001|Overall Study|Lost to Follow-up|17|||
33227195|NCT00920621|100732266|FG002|Overall Study|Lost to Follow-up|19|||
33227196|NCT00920621|100732267|FG003|Overall Study|Lost to Follow-up|21|||
33227197|NCT00920621|100732264|FG000|Overall Study|Fetal/neonatal deaths|16|||
33227198|NCT00920621|100732265|FG001|Overall Study|Fetal/neonatal deaths|14|||
33227199|NCT00920621|100732266|FG002|Overall Study|Fetal/neonatal deaths|16|||
33227200|NCT00920621|100732267|FG003|Overall Study|Fetal/neonatal deaths|14|||
33227201|NCT00920621|100732264|FG000|Overall Study|Blood sample not collected|22|||
33227202|NCT00920621|100732265|FG001|Overall Study|Blood sample not collected|14|||
33227203|NCT00920621|100732266|FG002|Overall Study|Blood sample not collected|0|||
33632935|NCT03955146|102208672|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
33227204|NCT00920621|100732267|FG003|Overall Study|Blood sample not collected|0|||
33227205|NCT03820323|100732268|FG000|Overall Study|Lost to Follow-up|2|||
33227206|NCT03820323|100732269|FG001|Overall Study|Lost to Follow-up|1|||
33227207|NCT03820323|100732268|FG000|Overall Study|Missed 12-month visit|22|||
33227208|NCT03820323|100732269|FG001|Overall Study|Missed 12-month visit|14|||
33227209|NCT03820323|100732268|FG000|Overall Study|Death|2|||
33227210|NCT03820323|100732269|FG001|Overall Study|Death|1|||
33227211|NCT03820323|100732268|FG000|Overall Study|Transferred out|13|||
33227212|NCT03820323|100732269|FG001|Overall Study|Transferred out|11|||
33227213|NCT03820323|100732268|FG000|Overall Study|Terminated|0|||
33227214|NCT03820323|100732269|FG001|Overall Study|Terminated|3|||
33227215|NCT03820323|100732268|FG000|Overall Study|Withdrawal by Subject|1|||
33227216|NCT03820323|100732269|FG001|Overall Study|Withdrawal by Subject|6|||
33227217|NCT02459093|100732270|FG000|Overall Study|Protocol Violation|6|||
33227218|NCT02459093|100732271|FG001|Overall Study|Protocol Violation|11|||
33227219|NCT02459093|100732270|FG000|Overall Study|Lost to Follow-up|6|||
33227220|NCT02459093|100732271|FG001|Overall Study|Lost to Follow-up|7|||
33227221|NCT02044458|100732272|FG000|Overall Study|Protocol Violation|3|||
33227222|NCT02044458|100732273|FG001|Overall Study|Protocol Violation|8|||
33227223|NCT04277455|100732276|FG000|Overall Study|Lost to Follow-up|1|||
33227224|NCT00860067|100732277|FG000|Overall Study|Lost to Follow-up|46|||
33227225|NCT00860067|100732278|FG001|Overall Study|Lost to Follow-up|9|||
33227226|NCT00860067|100732279|FG002|Overall Study|Lost to Follow-up|9|||
33227227|NCT00860067|100732277|FG000|Overall Study|Withdrawal by Subject|4|||
33227228|NCT00860067|100732278|FG001|Overall Study|Withdrawal by Subject|0|||
33227229|NCT00860067|100732279|FG002|Overall Study|Withdrawal by Subject|0|||
33227230|NCT00860067|100732277|FG000|Overall Study|Pregnancy|1|||
33227231|NCT00860067|100732278|FG001|Overall Study|Pregnancy|0|||
33227232|NCT00860067|100732279|FG002|Overall Study|Pregnancy|0|||
33227233|NCT03066622|100732280|FG000|Overall Study|Lost to Follow-up|24|||
33227234|NCT03066622|100732281|FG001|Overall Study|Lost to Follow-up|25|||
33227235|NCT03066622|100732280|FG000|Overall Study|Withdrawal by Subject|2|||
33227236|NCT03066622|100732281|FG001|Overall Study|Withdrawal by Subject|1|||
33227237|NCT01540565|100732282|FG000|Overall Study|Ineligible|2|||
33227238|NCT04522180|100732283|FG000|Overall Study|Investigator judgement|3|||
33227239|NCT04522180|100732284|FG001|Overall Study|Investigator judgement|4|||
33227240|NCT04522180|100732283|FG000|Overall Study|Voluntary withdrawal|1|||
33227241|NCT04522180|100732284|FG001|Overall Study|Voluntary withdrawal|0|||
33227242|NCT04522180|100732283|FG000|Overall Study|Pregnancy|0|||
33227243|NCT04522180|100732284|FG001|Overall Study|Pregnancy|1|||
33227244|NCT04522180|100732283|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
33227245|NCT04522180|100732284|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
33227246|NCT04522180|100732283|FG000|Overall Study|Reason not specified|8|||
33227247|NCT04522180|100732284|FG001|Overall Study|Reason not specified|5|||
33227248|NCT02748694|100732288|FG000|Overall Study|Voluntary Withdrawal|0|||
33227249|NCT02748694|100732289|FG001|Overall Study|Voluntary Withdrawal|0|||
33227250|NCT02748694|100732290|FG002|Overall Study|Voluntary Withdrawal|0|||
33227251|NCT02748694|100732291|FG003|Overall Study|Voluntary Withdrawal|0|||
33227252|NCT02748694|100732292|FG004|Overall Study|Voluntary Withdrawal|0|||
33227253|NCT02748694|100732293|FG005|Overall Study|Voluntary Withdrawal|0|||
33366357|NCT03502707|101227372|FG006|Overall Study|Lost to Follow-up|0|||
33366358|NCT03502707|101227373|FG007|Overall Study|Lost to Follow-up|5|||
33632936|NCT03955146|102208673|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
33227254|NCT02748694|100732294|FG006|Overall Study|Voluntary Withdrawal|0|||
33632937|NCT03955146|102208674|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
33227255|NCT02748694|100732295|FG007|Overall Study|Voluntary Withdrawal|0|||
33227256|NCT02748694|100732296|FG008|Overall Study|Voluntary Withdrawal|0|||
33227257|NCT02748694|100732297|FG009|Overall Study|Voluntary Withdrawal|0|||
33227258|NCT02748694|100732298|FG010|Overall Study|Voluntary Withdrawal|0|||
33227259|NCT02748694|100732299|FG011|Overall Study|Voluntary Withdrawal|0|||
33227260|NCT02748694|100732300|FG012|Overall Study|Voluntary Withdrawal|0|||
33227261|NCT02748694|100732301|FG013|Overall Study|Voluntary Withdrawal|0|||
33227262|NCT02748694|100732302|FG014|Overall Study|Voluntary Withdrawal|2|||
33227263|NCT03592277|100732304|FG000|Overall Study|Withdrawal by Subject|6|||
33227264|NCT03592277|100732305|FG001|Overall Study|Withdrawal by Subject|8|||
33227265|NCT02917941|100732306|FG000|Treatment Period|Adverse Event|11|||
33227266|NCT02917941|100732306|FG000|Treatment Period|Progressive Disease|11|||
33227267|NCT02917941|100732306|FG000|Treatment Period|Reason not Specified|2|||
33227268|NCT02917941|100732306|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
33227269|NCT02917941|100732306|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
33227270|NCT02306265|100732307|FG000|Overall Study|Withdrawal by Subject|1|||
33227271|NCT03107377|100732308|FG000|Overall Study|Adverse Event|3|||
33227272|NCT03107377|100732309|FG001|Overall Study|Adverse Event|3|||
33227273|NCT03107377|100732308|FG000|Overall Study|Protocol Violation|9|||
33227274|NCT03107377|100732309|FG001|Overall Study|Protocol Violation|12|||
33227275|NCT03107377|100732308|FG000|Overall Study|Physician Decision|3|||
33227276|NCT03107377|100732309|FG001|Overall Study|Physician Decision|6|||
33227277|NCT03107377|100732308|FG000|Overall Study|Pregnancy|7|||
33227278|NCT03107377|100732309|FG001|Overall Study|Pregnancy|7|||
33227279|NCT03107377|100732308|FG000|Overall Study|Withdrawal by Subject|16|||
33227280|NCT03107377|100732309|FG001|Overall Study|Withdrawal by Subject|22|||
33227281|NCT03107377|100732308|FG000|Overall Study|Lost to Follow-up|37|||
33227282|NCT03107377|100732309|FG001|Overall Study|Lost to Follow-up|34|||
33227283|NCT03107377|100732308|FG000|Overall Study|Other reason not specified|16|||
33227284|NCT03107377|100732309|FG001|Overall Study|Other reason not specified|15|||
33227285|NCT03872388|100732310|FG000|Overall Study|Disease Progression|0|||
33227286|NCT03872388|100732311|FG001|Overall Study|Disease Progression|0|||
33227287|NCT03872388|100732312|FG002|Overall Study|Disease Progression|0|||
33227288|NCT03872388|100732313|FG003|Overall Study|Disease Progression|0|||
33227289|NCT03872388|100732314|FG004|Overall Study|Disease Progression|0|||
33227290|NCT03872388|100732315|FG005|Overall Study|Disease Progression|0|||
33227291|NCT03872388|100732316|FG006|Overall Study|Disease Progression|1|||
33227292|NCT03872388|100732317|FG007|Overall Study|Disease Progression|1|||
33227293|NCT01725386|100732318|FG000|Overall Study|Death|84|||
33227294|NCT01725386|100732319|FG001|Overall Study|Death|40|||
33227295|NCT01725386|100732318|FG000|Overall Study|Lost to Follow-up|81|||
33227296|NCT01725386|100732319|FG001|Overall Study|Lost to Follow-up|6|||
33227297|NCT01725386|100732318|FG000|Overall Study|Withdrawal by Subject|10|||
33227298|NCT01725386|100732319|FG001|Overall Study|Withdrawal by Subject|0|||
33227299|NCT04145037|100732320|FG000|Overall Study|Study terminated|2|||
33227300|NCT04145037|100732321|FG001|Overall Study|Study terminated|0|||
33227301|NCT04145037|100732320|FG000|Overall Study|Withdrawal by Subject|1|||
33227302|NCT04145037|100732321|FG001|Overall Study|Withdrawal by Subject|0|||
33227303|NCT04145037|100732320|FG000|Overall Study|Lost to Follow-up|1|||
33227304|NCT04145037|100732321|FG001|Overall Study|Lost to Follow-up|0|||
33227305|NCT00301080|100732324|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
33227306|NCT00301080|100732325|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
33227307|NCT00301080|100732326|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
33227308|NCT00301080|100732327|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
33227309|NCT00301080|100732328|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
33227310|NCT03980184|100732329|FG000|Overall Study|Dropped out before treatment|2|||
33227311|NCT03980184|100732330|FG001|Overall Study|Dropped out before treatment|2|||
33227312|NCT03980184|100732329|FG000|Overall Study|Lost to Follow-up|11|||
33227313|NCT03980184|100732330|FG001|Overall Study|Lost to Follow-up|13|||
33227314|NCT02924389|100732331|FG000|Overall Study|Lost to Follow-up|1|||
33227315|NCT02924389|100732332|FG001|Overall Study|Lost to Follow-up|0|||
33227316|NCT02924389|100732331|FG000|Overall Study|Physician Decision|2|||
33227317|NCT02924389|100732332|FG001|Overall Study|Physician Decision|0|||
33227318|NCT02924389|100732331|FG000|Overall Study|Withdrawal by Subject|3|||
33227319|NCT02924389|100732332|FG001|Overall Study|Withdrawal by Subject|0|||
33227320|NCT02924389|100732331|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
33227321|NCT02924389|100732332|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
33227322|NCT01350141|100732333|FG000|Overall Study|Lost to Follow-up|1|||
33227323|NCT01350141|100732334|FG001|Overall Study|Lost to Follow-up|0|||
33227324|NCT01350141|100732335|FG002|Overall Study|Lost to Follow-up|1|||
33227325|NCT01350141|100732333|FG000|Overall Study|Withdrawal by Subject|1|||
33227326|NCT01350141|100732334|FG001|Overall Study|Withdrawal by Subject|0|||
33227327|NCT01350141|100732335|FG002|Overall Study|Withdrawal by Subject|0|||
33227328|NCT01350141|100732333|FG000|Overall Study|Randomized but not treated|1|||
33227329|NCT01350141|100732334|FG001|Overall Study|Randomized but not treated|0|||
33227330|NCT01350141|100732335|FG002|Overall Study|Randomized but not treated|0|||
33227331|NCT00525265|100732336|FG000|Overall Study|Protocol Violation|1|||
33227332|NCT00525265|100732337|FG001|Overall Study|Protocol Violation|0|||
33227333|NCT02823964|100732341|FG000|Overall Study|Adverse Event|2|||
33227334|NCT02823964|100732341|FG000|Overall Study|Physician Decision|1|||
33227335|NCT02823964|100732341|FG000|Overall Study|Lack of Efficacy|1|||
33227336|NCT02823964|100732341|FG000|Overall Study|Withdrawal by Subject|1|||
33227337|NCT01737996|100732342|FG000|Overall Study|Adverse Event|0|||
33227338|NCT01737996|100732343|FG001|Overall Study|Adverse Event|1|||
33227339|NCT01737996|100732344|FG002|Overall Study|Adverse Event|1|||
33227340|NCT01737996|100732342|FG000|Overall Study|Withdrawal by Subject|0|||
33227341|NCT01737996|100732343|FG001|Overall Study|Withdrawal by Subject|0|||
33227342|NCT01737996|100732344|FG002|Overall Study|Withdrawal by Subject|1|||
33227343|NCT00192023|100732345|FG000|Period III - Double-Blind|Adverse Event|3|||
33227344|NCT00192023|100732346|FG001|Period III - Double-Blind|Adverse Event|0|||
33227345|NCT00192023|100732345|FG000|Period III - Double-Blind|Physician Decision|2|||
33227346|NCT00192023|100732346|FG001|Period III - Double-Blind|Physician Decision|0|||
33227347|NCT00192023|100732345|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
33227348|NCT00192023|100732346|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
33227349|NCT00192023|100732345|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
33227350|NCT00192023|100732346|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
33227351|NCT00192023|100732345|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
33227352|NCT00192023|100732346|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
33227353|NCT00192023|100732345|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
33227354|NCT00192023|100732346|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
33227355|NCT00192023|100732345|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
33227356|NCT00192023|100732346|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
33227357|NCT00192023|100732345|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
33227358|NCT00192023|100732346|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
33227359|NCT00192023|100732345|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
33227360|NCT00192023|100732346|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
33227361|NCT00192023|100732345|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
33227362|NCT00192023|100732346|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
33227363|NCT00369681|100732349|FG000|Overall Study|Death|1|||
33227364|NCT02948959|100732350|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
33227365|NCT02948959|100732351|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
33227366|NCT02948959|100732350|FG000|52 Weeks Treatment Period|Adverse Event|2|||
33227367|NCT02948959|100732351|FG001|52 Weeks Treatment Period|Adverse Event|5|||
33227368|NCT02948959|100732350|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
33227369|NCT02948959|100732351|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
33227370|NCT02948959|100732350|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
33227371|NCT02948959|100732351|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
33227372|NCT02948959|100732350|FG000|52 Weeks Treatment Period|Randomized by error|0|||
33227373|NCT02948959|100732351|FG001|52 Weeks Treatment Period|Randomized by error|5|||
33227374|NCT02948959|100732350|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
33227375|NCT02948959|100732351|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
33227376|NCT02948959|100732350|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
33227377|NCT02948959|100732351|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
33227378|NCT02948959|100732350|FG000|52 Weeks Treatment Period|Change of residence location|0|||
33227379|NCT02948959|100732351|FG001|52 Weeks Treatment Period|Change of residence location|1|||
33227380|NCT02948959|100732350|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
33227381|NCT02948959|100732351|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
33227382|NCT02948959|100732350|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
33227383|NCT02948959|100732351|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
33227384|NCT02948959|100732350|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
33227385|NCT02948959|100732351|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
33227386|NCT02948959|100732350|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
33227387|NCT02948959|100732351|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
33227388|NCT02948959|100732350|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
33227389|NCT02948959|100732351|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
33227390|NCT02948959|100732350|FG000|12 Weeks Follow-up Period|Study site closure|1|||
33227391|NCT02948959|100732351|FG001|12 Weeks Follow-up Period|Study site closure|0|||
33227392|NCT01993017|100732354|FG000|Overall Study|Death|23|||
33227393|NCT01993017|100732355|FG001|Overall Study|Death|26|||
33227394|NCT01993017|100732356|FG002|Overall Study|Death|18|||
33227395|NCT01993017|100732354|FG000|Overall Study|Could not be contacted|43|||
33632938|NCT03955146|102208675|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
33632939|NCT03955146|102208672|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
33632940|NCT03955146|102208673|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
33227396|NCT01993017|100732355|FG001|Overall Study|Could not be contacted|42|||
33227397|NCT01993017|100732356|FG002|Overall Study|Could not be contacted|38|||
33227398|NCT01993017|100732354|FG000|Overall Study|Dropped out|19|||
33632941|NCT03955146|102208674|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
33632942|NCT03955146|102208675|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
33227399|NCT01993017|100732355|FG001|Overall Study|Dropped out|6|||
33227400|NCT01993017|100732356|FG002|Overall Study|Dropped out|11|||
33227401|NCT01993017|100732354|FG000|Overall Study|Other reasons|17|||
33227402|NCT01993017|100732355|FG001|Overall Study|Other reasons|11|||
33632943|NCT03955146|102208672|FG000|DB Period (48 Weeks)|Participant Decision|9|||
33227403|NCT01993017|100732356|FG002|Overall Study|Other reasons|7|||
33227404|NCT01993017|100732354|FG000|Overall Study|Ineligible after randomization|4|||
33227405|NCT01993017|100732355|FG001|Overall Study|Ineligible after randomization|5|||
33227406|NCT01993017|100732356|FG002|Overall Study|Ineligible after randomization|5|||
33227407|NCT02291432|100732375|FG000|Overall Study|Withdrawal by Subject|2|||
33227408|NCT01062763|100732379|FG000|Overall Study|Adverse Event|3|||
33227409|NCT01062763|100732380|FG001|Overall Study|Adverse Event|4|||
33227410|NCT01834222|100732381|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
33227411|NCT00879996|100732382|FG000|Overall Study|Lost to Follow-up|7|||
33227412|NCT00879996|100732383|FG001|Overall Study|Lost to Follow-up|6|||
33570183|NCT00928668|101978448|FG002|Overall Study|Other reasons not listed above|0|||
33570184|NCT00928668|101978449|FG003|Overall Study|Other reasons not listed above|1|||
33570185|NCT00928668|101978450|FG004|Overall Study|Other reasons not listed above|0|||
33570186|NCT00415636|101978453|FG000|Overall Study|Symptomatic deterioration|1|||
33570187|NCT00415636|101978454|FG001|Overall Study|Symptomatic deterioration|0|||
33570188|NCT00415636|101978455|FG002|Overall Study|Symptomatic deterioration|1|||
33227413|NCT00879996|100732382|FG000|Overall Study|non-compliance|6|||
33227414|NCT00879996|100732383|FG001|Overall Study|non-compliance|4|||
33227415|NCT00879996|100732382|FG000|Overall Study|Physician Decision|1|||
33227416|NCT00879996|100732383|FG001|Overall Study|Physician Decision|2|||
33227417|NCT00879996|100732382|FG000|Overall Study|psychiatric problem|0|||
33227418|NCT00879996|100732383|FG001|Overall Study|psychiatric problem|1|||
33227419|NCT00879996|100732382|FG000|Overall Study|put on parole|1|||
33227420|NCT00879996|100732383|FG001|Overall Study|put on parole|0|||
33227421|NCT01616771|100732384|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
33227422|NCT01103960|100732385|FG000|Overall Study|Adverse Event|2|||
33227423|NCT01103960|100732386|FG001|Overall Study|Adverse Event|1|||
33227424|NCT01103960|100732385|FG000|Overall Study|Withdrawal by Subject|2|||
33227425|NCT01103960|100732386|FG001|Overall Study|Withdrawal by Subject|1|||
33227426|NCT01103960|100732385|FG000|Overall Study|Other|1|||
33227427|NCT01103960|100732386|FG001|Overall Study|Other|0|||
33227428|NCT02904902|100732387|FG000|Overall Study|Withdrawal by Subject|1|||
33227429|NCT01014975|100732390|FG000|Overall Study|Withdrawal by Subject|1|||
33227430|NCT01014975|100732391|FG001|Overall Study|Withdrawal by Subject|0|||
33227431|NCT01014975|100732392|FG002|Overall Study|Withdrawal by Subject|1|||
33227432|NCT01014975|100732390|FG000|Overall Study|Death|3|||
33570189|NCT00415636|101978456|FG003|Overall Study|Symptomatic deterioration|2|||
33570190|NCT00415636|101978457|FG004|Overall Study|Symptomatic deterioration|0|||
33570191|NCT00415636|101978458|FG005|Overall Study|Symptomatic deterioration|1|||
33570192|NCT00415636|101978453|FG000|Overall Study|Adverse Event|0|||
33570193|NCT00415636|101978454|FG001|Overall Study|Adverse Event|0|||
33570194|NCT00415636|101978455|FG002|Overall Study|Adverse Event|0|||
33570195|NCT00415636|101978456|FG003|Overall Study|Adverse Event|1|||
33570196|NCT00415636|101978457|FG004|Overall Study|Adverse Event|1|||
33570197|NCT00415636|101978458|FG005|Overall Study|Adverse Event|0|||
33570198|NCT00415636|101978453|FG000|Overall Study|Withdrawal by Subject|0|||
33570199|NCT00415636|101978454|FG001|Overall Study|Withdrawal by Subject|0|||
33570200|NCT00415636|101978455|FG002|Overall Study|Withdrawal by Subject|0|||
33570201|NCT00415636|101978456|FG003|Overall Study|Withdrawal by Subject|0|||
33570202|NCT00415636|101978457|FG004|Overall Study|Withdrawal by Subject|1|||
33570203|NCT00415636|101978458|FG005|Overall Study|Withdrawal by Subject|0|||
33632944|NCT03955146|102208673|FG001|DB Period (48 Weeks)|Participant Decision|12|||
33632945|NCT03955146|102208674|FG002|DB Period (48 Weeks)|Participant Decision|1|||
33227433|NCT01014975|100732391|FG001|Overall Study|Death|3|||
33227434|NCT01014975|100732392|FG002|Overall Study|Death|4|||
33227435|NCT01014975|100732390|FG000|Overall Study|Lost to Follow-up|0|||
33366359|NCT03502707|101227374|FG008|Overall Study|Lost to Follow-up|0|||
33366360|NCT03502707|101227375|FG009|Overall Study|Lost to Follow-up|2|||
33366361|NCT03502707|101227376|FG010|Overall Study|Lost to Follow-up|1|||
33366362|NCT03502707|101227377|FG011|Overall Study|Lost to Follow-up|2|||
33366363|NCT03502707|101227378|FG012|Overall Study|Lost to Follow-up|1|||
33366364|NCT03502707|101227379|FG013|Overall Study|Lost to Follow-up|1|||
33366365|NCT03502707|101227380|FG014|Overall Study|Lost to Follow-up|0|||
33366366|NCT03502707|101227381|FG015|Overall Study|Lost to Follow-up|4|||
33366367|NCT03502707|101227382|FG016|Overall Study|Lost to Follow-up|9|||
33366368|NCT03502707|101227383|FG017|Overall Study|Lost to Follow-up|2|||
33366369|NCT03502707|101227366|FG000|Overall Study|Physician Decision|0|||
33366370|NCT03502707|101227367|FG001|Overall Study|Physician Decision|0|||
33418225|NCT04440163|101422360|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
33227436|NCT01014975|100732391|FG001|Overall Study|Lost to Follow-up|0|||
33227437|NCT01014975|100732392|FG002|Overall Study|Lost to Follow-up|1|||
33227438|NCT01118455|100732393|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
33227439|NCT01118455|100732394|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
33366371|NCT03502707|101227368|FG002|Overall Study|Physician Decision|0|||
33570204|NCT00415636|101978453|FG000|Overall Study|Disease progression|0|||
33570205|NCT00415636|101978454|FG001|Overall Study|Disease progression|0|||
33570206|NCT00415636|101978455|FG002|Overall Study|Disease progression|0|||
33570207|NCT00415636|101978456|FG003|Overall Study|Disease progression|3|||
33570208|NCT00415636|101978457|FG004|Overall Study|Disease progression|0|||
33570209|NCT00415636|101978458|FG005|Overall Study|Disease progression|1|||
33570210|NCT00419744|101978459|FG000|Overall Study|Adverse Event|39|||
33570211|NCT00419744|101978460|FG001|Overall Study|Adverse Event|40|||
33570212|NCT00419744|101978461|FG002|Overall Study|Adverse Event|50|||
33570213|NCT00419744|101978459|FG000|Overall Study|Withdrawal by Subject|45|||
33570214|NCT00419744|101978460|FG001|Overall Study|Withdrawal by Subject|49|||
33570215|NCT00419744|101978461|FG002|Overall Study|Withdrawal by Subject|52|||
33632946|NCT03955146|102208675|FG003|DB Period (48 Weeks)|Participant Decision|1|||
33632947|NCT03955146|102208672|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
33632948|NCT03955146|102208673|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
33632949|NCT03955146|102208674|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
33632950|NCT03955146|102208675|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
33632951|NCT03955146|102208672|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
33632952|NCT03955146|102208673|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
33227440|NCT02035332|100732396|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
33227441|NCT01965158|100732397|FG000|Overall Study|Adverse Event|14|||
33227442|NCT01965158|100732398|FG001|Overall Study|Adverse Event|5|||
33227443|NCT01965158|100732397|FG000|Overall Study|Withdrawal by Subject|16|||
33227444|NCT01965158|100732398|FG001|Overall Study|Withdrawal by Subject|24|||
33227445|NCT01965158|100732397|FG000|Overall Study|Lost to Follow-up|7|||
33227446|NCT01965158|100732398|FG001|Overall Study|Lost to Follow-up|5|||
33227447|NCT01965158|100732397|FG000|Overall Study|Protocol Violation|1|||
33227448|NCT01965158|100732398|FG001|Overall Study|Protocol Violation|1|||
33227449|NCT01965158|100732397|FG000|Overall Study|Other - Miscellaneous|3|||
33227450|NCT01965158|100732398|FG001|Overall Study|Other - Miscellaneous|0|||
33227451|NCT04741802|100732408|FG000|Overall Study|Death|1|||
33227452|NCT04741802|100732408|FG000|Overall Study|Lost to Follow-up|11|||
33227453|NCT03469349|100732410|FG000|Overall Study|Withdrawal by Subject|1|||
33227454|NCT03469349|100732411|FG001|Overall Study|Withdrawal by Subject|3|||
33227455|NCT03469349|100732410|FG000|Overall Study|Progressive Disease|0|||
33227456|NCT03469349|100732411|FG001|Overall Study|Progressive Disease|1|||
33227457|NCT03469349|100732410|FG000|Overall Study|Lost to Follow-up|2|||
33227458|NCT03469349|100732411|FG001|Overall Study|Lost to Follow-up|2|||
33227459|NCT03469349|100732410|FG000|Overall Study|Adverse Event|2|||
33227460|NCT03469349|100732411|FG001|Overall Study|Adverse Event|4|||
33227461|NCT01777321|100732412|FG000|Overall Study|Withdrawal by Subject|0|||
33227462|NCT01777321|100732413|FG001|Overall Study|Withdrawal by Subject|1|||
33227463|NCT01008475|100732414|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
33227464|NCT01008475|100732415|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
33227465|NCT01008475|100732416|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
33227466|NCT01008475|100732417|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
33227467|NCT01008475|100732418|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
33227468|NCT01008475|100732419|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
33227469|NCT01008475|100732420|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
33227470|NCT00399763|100732421|FG000|Overall Study|Lost to Follow-up|2|||
33227471|NCT00399763|100732422|FG001|Overall Study|Lost to Follow-up|3|||
33227472|NCT00152009|100732425|FG000|Overall Study|Adverse Event|9|||
33227473|NCT00152009|100732426|FG001|Overall Study|Adverse Event|13|||
33227474|NCT00152009|100732427|FG002|Overall Study|Adverse Event|20|||
33227475|NCT00152009|100732428|FG003|Overall Study|Adverse Event|1|||
33227476|NCT00152009|100732425|FG000|Overall Study|Protocol Violation|3|||
33227477|NCT00152009|100732426|FG001|Overall Study|Protocol Violation|0|||
33227478|NCT00152009|100732427|FG002|Overall Study|Protocol Violation|0|||
33227479|NCT00152009|100732428|FG003|Overall Study|Protocol Violation|1|||
33227480|NCT00152009|100732425|FG000|Overall Study|Withdrawal by Subject|2|||
33227481|NCT00152009|100732426|FG001|Overall Study|Withdrawal by Subject|3|||
33227482|NCT00152009|100732427|FG002|Overall Study|Withdrawal by Subject|4|||
33227483|NCT00152009|100732428|FG003|Overall Study|Withdrawal by Subject|9|||
33366372|NCT03502707|101227369|FG003|Overall Study|Physician Decision|0|||
33366373|NCT03502707|101227370|FG004|Overall Study|Physician Decision|0|||
33366374|NCT03502707|101227371|FG005|Overall Study|Physician Decision|0|||
33366375|NCT03502707|101227372|FG006|Overall Study|Physician Decision|0|||
33366376|NCT03502707|101227373|FG007|Overall Study|Physician Decision|0|||
33366377|NCT03502707|101227374|FG008|Overall Study|Physician Decision|2|||
33366378|NCT03502707|101227375|FG009|Overall Study|Physician Decision|1|||
33366379|NCT03502707|101227376|FG010|Overall Study|Physician Decision|0|||
33366380|NCT03502707|101227377|FG011|Overall Study|Physician Decision|0|||
33366381|NCT03502707|101227378|FG012|Overall Study|Physician Decision|0|||
33366382|NCT03502707|101227379|FG013|Overall Study|Physician Decision|0|||
33366383|NCT03502707|101227380|FG014|Overall Study|Physician Decision|1|||
33366384|NCT03502707|101227381|FG015|Overall Study|Physician Decision|3|||
33570216|NCT00419744|101978459|FG000|Overall Study|Lost to Follow-up|8|||
33632953|NCT03955146|102208674|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
33227484|NCT00152009|100732425|FG000|Overall Study|Lost to Follow-up|2|||
33366385|NCT03502707|101227382|FG016|Overall Study|Physician Decision|0|||
33570217|NCT00419744|101978460|FG001|Overall Study|Lost to Follow-up|10|||
33227485|NCT00152009|100732426|FG001|Overall Study|Lost to Follow-up|4|||
33227486|NCT00152009|100732427|FG002|Overall Study|Lost to Follow-up|3|||
33227487|NCT00152009|100732428|FG003|Overall Study|Lost to Follow-up|3|||
33227488|NCT00152009|100732425|FG000|Overall Study|Lack of Efficacy|8|||
33227489|NCT00152009|100732426|FG001|Overall Study|Lack of Efficacy|6|||
33227490|NCT00152009|100732427|FG002|Overall Study|Lack of Efficacy|7|||
33227491|NCT00152009|100732428|FG003|Overall Study|Lack of Efficacy|15|||
33227492|NCT00152009|100732425|FG000|Overall Study|ECG abnormalities|2|||
33227493|NCT00152009|100732426|FG001|Overall Study|ECG abnormalities|2|||
33227494|NCT00152009|100732427|FG002|Overall Study|ECG abnormalities|2|||
33227495|NCT00152009|100732428|FG003|Overall Study|ECG abnormalities|1|||
33227496|NCT00152009|100732425|FG000|Overall Study|Sponsor's decision|3|||
33570218|NCT00419744|101978461|FG002|Overall Study|Lost to Follow-up|6|||
33570219|NCT00419744|101978459|FG000|Overall Study|Protocol Violation|4|||
33570220|NCT00419744|101978460|FG001|Overall Study|Protocol Violation|7|||
33570221|NCT00419744|101978461|FG002|Overall Study|Protocol Violation|8|||
33570222|NCT00419744|101978459|FG000|Overall Study|Randomized in error|9|||
33570223|NCT00419744|101978460|FG001|Overall Study|Randomized in error|6|||
33570224|NCT00419744|101978461|FG002|Overall Study|Randomized in error|7|||
33227497|NCT00152009|100732426|FG001|Overall Study|Sponsor's decision|3|||
33227498|NCT00152009|100732427|FG002|Overall Study|Sponsor's decision|1|||
33227499|NCT00152009|100732428|FG003|Overall Study|Sponsor's decision|3|||
33227500|NCT04000594|100732429|FG000|Overall Study|Withdrawal by Subject|1|||
33227501|NCT04000594|100732430|FG001|Overall Study|Withdrawal by Subject|0|||
33570225|NCT00419744|101978459|FG000|Overall Study|Moving out of state|2|||
33570226|NCT00419744|101978460|FG001|Overall Study|Moving out of state|0|||
33570227|NCT00419744|101978461|FG002|Overall Study|Moving out of state|1|||
33570228|NCT00419744|101978459|FG000|Overall Study|Physician Decision|10|||
33570229|NCT00419744|101978460|FG001|Overall Study|Physician Decision|5|||
33570230|NCT00419744|101978461|FG002|Overall Study|Physician Decision|6|||
33570231|NCT00419744|101978459|FG000|Overall Study|Spirometry mouthpiece issues|0|||
33570232|NCT00419744|101978460|FG001|Overall Study|Spirometry mouthpiece issues|1|||
33570233|NCT00419744|101978461|FG002|Overall Study|Spirometry mouthpiece issues|2|||
33570234|NCT00419744|101978459|FG000|Overall Study|Incorrect medication kit dispensed|0|||
33570235|NCT00419744|101978460|FG001|Overall Study|Incorrect medication kit dispensed|0|||
33570236|NCT00419744|101978461|FG002|Overall Study|Incorrect medication kit dispensed|1|||
33570237|NCT04064905|101978462|FG000|Overall Study|Lost to Follow-up|0|||
33570238|NCT04064905|101978463|FG001|Overall Study|Lost to Follow-up|3|||
33570239|NCT04064905|101978464|FG002|Overall Study|Lost to Follow-up|1|||
33570240|NCT04064905|101978465|FG003|Overall Study|Lost to Follow-up|4|||
33570241|NCT04064905|101978466|FG004|Overall Study|Lost to Follow-up|2|||
33570242|NCT01463033|101978467|FG000|Overall Study|Lost to Follow-up|4|||
33570243|NCT01463033|101978468|FG001|Overall Study|Lost to Follow-up|4|||
33570244|NCT01463033|101978467|FG000|Overall Study|Death|3|||
33570245|NCT01463033|101978468|FG001|Overall Study|Death|2|||
33570246|NCT01153516|101978469|FG000|Overall Study|Both subjects refused surgery|2|||
33570247|NCT01153516|101978470|FG001|Overall Study|Both subjects refused surgery|0|||
33570248|NCT02327169|101978471|FG000|Overall Study|Progressive Disease|1|||
33570249|NCT02327169|101978472|FG001|Overall Study|Progressive Disease|3|||
33570250|NCT02327169|101978473|FG002|Overall Study|Progressive Disease|4|||
33570251|NCT02327169|101978474|FG003|Overall Study|Progressive Disease|3|||
33570252|NCT02327169|101978475|FG004|Overall Study|Progressive Disease|4|||
33570253|NCT02327169|101978476|FG005|Overall Study|Progressive Disease|3|||
33570254|NCT02327169|101978477|FG006|Overall Study|Progressive Disease|3|||
33570255|NCT02327169|101978478|FG007|Overall Study|Progressive Disease|3|||
33570256|NCT02327169|101978479|FG008|Overall Study|Progressive Disease|4|||
33570257|NCT02327169|101978480|FG009|Overall Study|Progressive Disease|4|||
33570258|NCT02327169|101978481|FG010|Overall Study|Progressive Disease|4|||
33570259|NCT02327169|101978482|FG011|Overall Study|Progressive Disease|3|||
33570260|NCT02327169|101978483|FG012|Overall Study|Progressive Disease|1|||
33570261|NCT02327169|101978484|FG013|Overall Study|Progressive Disease|3|||
33570262|NCT02327169|101978485|FG014|Overall Study|Progressive Disease|3|||
33570263|NCT02327169|101978471|FG000|Overall Study|Adverse Event|2|||
33570264|NCT02327169|101978472|FG001|Overall Study|Adverse Event|0|||
33570265|NCT02327169|101978473|FG002|Overall Study|Adverse Event|1|||
33570266|NCT02327169|101978474|FG003|Overall Study|Adverse Event|0|||
33570267|NCT02327169|101978475|FG004|Overall Study|Adverse Event|1|||
33570268|NCT02327169|101978476|FG005|Overall Study|Adverse Event|0|||
33570269|NCT02327169|101978477|FG006|Overall Study|Adverse Event|0|||
33570270|NCT02327169|101978478|FG007|Overall Study|Adverse Event|0|||
33570271|NCT02327169|101978479|FG008|Overall Study|Adverse Event|0|||
33570272|NCT02327169|101978480|FG009|Overall Study|Adverse Event|2|||
33570273|NCT02327169|101978481|FG010|Overall Study|Adverse Event|0|||
33570274|NCT02327169|101978482|FG011|Overall Study|Adverse Event|3|||
33227502|NCT04000594|100732431|FG002|Overall Study|Withdrawal by Subject|0|||
33227503|NCT00621296|100732432|FG000|Overall Study|Adverse Event|2|||
33570275|NCT02327169|101978483|FG012|Overall Study|Adverse Event|0|||
33570276|NCT02327169|101978484|FG013|Overall Study|Adverse Event|2|||
33570277|NCT02327169|101978485|FG014|Overall Study|Adverse Event|1|||
33570278|NCT02327169|101978471|FG000|Overall Study|Symptomatic Deterioration|0|||
33632954|NCT03955146|102208675|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
33632955|NCT03955146|102208672|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
33632956|NCT03955146|102208673|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
33632957|NCT03955146|102208674|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
33632958|NCT03955146|102208675|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
33632959|NCT03955146|102208672|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
33570279|NCT02327169|101978472|FG001|Overall Study|Symptomatic Deterioration|0|||
33570280|NCT02327169|101978473|FG002|Overall Study|Symptomatic Deterioration|1|||
33570281|NCT02327169|101978474|FG003|Overall Study|Symptomatic Deterioration|0|||
33570282|NCT02327169|101978475|FG004|Overall Study|Symptomatic Deterioration|1|||
33570283|NCT02327169|101978476|FG005|Overall Study|Symptomatic Deterioration|1|||
33570284|NCT02327169|101978477|FG006|Overall Study|Symptomatic Deterioration|0|||
33570285|NCT02327169|101978478|FG007|Overall Study|Symptomatic Deterioration|0|||
33570286|NCT02327169|101978479|FG008|Overall Study|Symptomatic Deterioration|2|||
33570287|NCT02327169|101978480|FG009|Overall Study|Symptomatic Deterioration|1|||
33570288|NCT02327169|101978481|FG010|Overall Study|Symptomatic Deterioration|0|||
33570289|NCT02327169|101978482|FG011|Overall Study|Symptomatic Deterioration|0|||
33570290|NCT02327169|101978483|FG012|Overall Study|Symptomatic Deterioration|0|||
33632960|NCT03955146|102208673|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
33632961|NCT03955146|102208674|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
33632962|NCT03955146|102208675|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
33632963|NCT03955146|102208672|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
33632964|NCT03955146|102208673|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
33632965|NCT03955146|102208674|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
33632966|NCT03955146|102208675|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
33632967|NCT03955146|102208672|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
33632968|NCT03955146|102208673|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
33632969|NCT03955146|102208674|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
33632970|NCT03955146|102208675|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
33632971|NCT03955146|102208672|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
33366386|NCT03502707|101227383|FG017|Overall Study|Physician Decision|0|||
33632972|NCT03955146|102208673|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
33632973|NCT03955146|102208674|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
33632974|NCT03955146|102208675|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
33632975|NCT03955146|102208672|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
33632976|NCT03955146|102208673|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
33632977|NCT03955146|102208674|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
33632978|NCT03955146|102208675|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
33632979|NCT03955146|102208672|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
33632980|NCT03955146|102208673|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
33632981|NCT03955146|102208674|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
33632982|NCT03955146|102208675|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
33632983|NCT03955146|102208672|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
33632984|NCT03955146|102208673|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
33632985|NCT03955146|102208674|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
33632986|NCT03955146|102208675|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
33632987|NCT03955146|102208672|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
33632988|NCT03955146|102208673|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
33632989|NCT03955146|102208674|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
33632990|NCT03955146|102208675|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
33632991|NCT03312231|102208676|FG000|Overall Study|Lost to Follow-up|2|||
33632992|NCT03312231|102208677|FG001|Overall Study|Lost to Follow-up|6|||
33632993|NCT03312231|102208678|FG002|Overall Study|Lost to Follow-up|1|||
33632994|NCT03312231|102208679|FG003|Overall Study|Lost to Follow-up|3|||
33632995|NCT03312231|102208680|FG004|Overall Study|Lost to Follow-up|1|||
33632996|NCT03312231|102208676|FG000|Overall Study|Withdrawal by Subject|0|||
33632997|NCT03312231|102208677|FG001|Overall Study|Withdrawal by Subject|3|||
33632998|NCT03312231|102208678|FG002|Overall Study|Withdrawal by Subject|1|||
33632999|NCT03312231|102208679|FG003|Overall Study|Withdrawal by Subject|0|||
33633000|NCT03312231|102208680|FG004|Overall Study|Withdrawal by Subject|0|||
33633001|NCT03312231|102208676|FG000|Overall Study|Death|0|||
33366387|NCT03502707|101227366|FG000|Overall Study|Protocol Violation|0|||
33366388|NCT03502707|101227367|FG001|Overall Study|Protocol Violation|0|||
33366389|NCT03502707|101227368|FG002|Overall Study|Protocol Violation|0|||
33570291|NCT02327169|101978484|FG013|Overall Study|Symptomatic Deterioration|2|||
33570292|NCT02327169|101978485|FG014|Overall Study|Symptomatic Deterioration|1|||
33570293|NCT02327169|101978471|FG000|Overall Study|Reason Not Specified|0|||
33633002|NCT03312231|102208677|FG001|Overall Study|Death|1|||
33633003|NCT03312231|102208678|FG002|Overall Study|Death|1|||
33366390|NCT03502707|101227369|FG003|Overall Study|Protocol Violation|0|||
33366391|NCT03502707|101227370|FG004|Overall Study|Protocol Violation|0|||
33633004|NCT03312231|102208679|FG003|Overall Study|Death|0|||
33633005|NCT03312231|102208680|FG004|Overall Study|Death|0|||
33633006|NCT03312231|102208676|FG000|Overall Study|Study Vaccination not Received|1|||
33633007|NCT03312231|102208677|FG001|Overall Study|Study Vaccination not Received|1|||
33633008|NCT03312231|102208678|FG002|Overall Study|Study Vaccination not Received|1|||
33633009|NCT03312231|102208679|FG003|Overall Study|Study Vaccination not Received|0|||
33633010|NCT03312231|102208680|FG004|Overall Study|Study Vaccination not Received|0|||
33633011|NCT01761877|102208684|FG000|Overall Study|Adverse Event|7|||
33633012|NCT01761877|102208685|FG001|Overall Study|Adverse Event|0|||
33633013|NCT01761877|102208684|FG000|Overall Study|Withdrawal by Subject|6|||
33633014|NCT01761877|102208685|FG001|Overall Study|Withdrawal by Subject|4|||
33633015|NCT01761877|102208684|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
33633016|NCT01761877|102208685|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
33633017|NCT01761877|102208684|FG000|Overall Study|Death|0|||
33633018|NCT01761877|102208685|FG001|Overall Study|Death|1|||
33633019|NCT01761877|102208684|FG000|Overall Study|MRI intolerant|1|||
33633020|NCT01761877|102208685|FG001|Overall Study|MRI intolerant|6|||
33633021|NCT00926237|102208686|FG000|Overall Study|Withdrawal by Subject|2|||
33633022|NCT00926237|102208687|FG001|Overall Study|Withdrawal by Subject|1|||
33633023|NCT05232682|102208690|FG000|Overall Study|Lost to Follow-up|2|||
33633024|NCT01033019|102208693|FG000|Overall Study|Withdrawal by Subject|1|||
33633025|NCT01033019|102208694|FG001|Overall Study|Withdrawal by Subject|0|||
33633026|NCT02388269|102208696|FG000|Overall Study|Adverse Event|2|||
33633027|NCT02388269|102208697|FG001|Overall Study|Adverse Event|0|||
33633028|NCT02388269|102208698|FG002|Overall Study|Adverse Event|0|||
33633029|NCT02388269|102208696|FG000|Overall Study|Withdrawal by Subject|1|||
33633030|NCT02388269|102208697|FG001|Overall Study|Withdrawal by Subject|2|||
33633031|NCT02388269|102208698|FG002|Overall Study|Withdrawal by Subject|0|||
33633032|NCT02388269|102208696|FG000|Overall Study|less than 50% stimulations|1|||
33633033|NCT02388269|102208697|FG001|Overall Study|less than 50% stimulations|0|||
33633034|NCT02388269|102208698|FG002|Overall Study|less than 50% stimulations|0|||
33633035|NCT02388269|102208696|FG000|Overall Study|no diary data|3|||
33633036|NCT02388269|102208697|FG001|Overall Study|no diary data|0|||
33633037|NCT02388269|102208698|FG002|Overall Study|no diary data|0|||
33633038|NCT02388269|102208696|FG000|Overall Study|Protocol Violation|2|||
33633039|NCT02388269|102208697|FG001|Overall Study|Protocol Violation|0|||
33633040|NCT02388269|102208698|FG002|Overall Study|Protocol Violation|0|||
33633041|NCT02388269|102208696|FG000|Overall Study|Screen Failure|0|||
33633042|NCT02388269|102208697|FG001|Overall Study|Screen Failure|0|||
33633043|NCT02388269|102208698|FG002|Overall Study|Screen Failure|10|||
33633044|NCT00751296|102208704|FG000|Overall Study|Adverse Event|2|||
33633045|NCT04106557|102208705|FG000|Overall Study|Physician Decision|0|||
33633046|NCT04106557|102208706|FG001|Overall Study|Physician Decision|1|||
33633047|NCT04106557|102208707|FG002|Overall Study|Physician Decision|0|||
33633048|NCT04106557|102208705|FG000|Overall Study|Protocol Violation|0|||
33633049|NCT04106557|102208706|FG001|Overall Study|Protocol Violation|1|||
33633050|NCT04106557|102208707|FG002|Overall Study|Protocol Violation|0|||
33633051|NCT04973449|102208708|FG000|Overall Study|Withdrawal by Subject|3|||
33633052|NCT04973449|102208709|FG001|Overall Study|Withdrawal by Subject|3|||
33633053|NCT04973449|102208710|FG002|Overall Study|Withdrawal by Subject|2|||
33633054|NCT04973449|102208711|FG003|Overall Study|Withdrawal by Subject|5|||
33633055|NCT04973449|102208712|FG004|Overall Study|Withdrawal by Subject|5|||
33633056|NCT04973449|102208713|FG005|Overall Study|Withdrawal by Subject|4|||
33633057|NCT04973449|102208714|FG006|Overall Study|Withdrawal by Subject|7|||
33633058|NCT04973449|102208715|FG007|Overall Study|Withdrawal by Subject|5|||
33633059|NCT04973449|102208708|FG000|Overall Study|Lost to Follow-up|15|||
33633060|NCT04973449|102208709|FG001|Overall Study|Lost to Follow-up|16|||
33633061|NCT04973449|102208710|FG002|Overall Study|Lost to Follow-up|16|||
33633062|NCT04973449|102208711|FG003|Overall Study|Lost to Follow-up|13|||
33633063|NCT04973449|102208712|FG004|Overall Study|Lost to Follow-up|5|||
33633064|NCT04973449|102208713|FG005|Overall Study|Lost to Follow-up|6|||
33633065|NCT04973449|102208714|FG006|Overall Study|Lost to Follow-up|10|||
33633066|NCT04973449|102208715|FG007|Overall Study|Lost to Follow-up|6|||
33633067|NCT04973449|102208708|FG000|Overall Study|Death|1|||
33633068|NCT04973449|102208709|FG001|Overall Study|Death|0|||
33633069|NCT04973449|102208710|FG002|Overall Study|Death|0|||
33633070|NCT04973449|102208711|FG003|Overall Study|Death|0|||
33633071|NCT04973449|102208712|FG004|Overall Study|Death|0|||
33633072|NCT04973449|102208713|FG005|Overall Study|Death|1|||
33633073|NCT04973449|102208714|FG006|Overall Study|Death|0|||
33633074|NCT04973449|102208715|FG007|Overall Study|Death|0|||
33633075|NCT04973449|102208708|FG000|Overall Study|Other|1|||
33633076|NCT04973449|102208709|FG001|Overall Study|Other|1|||
33227504|NCT00621296|100732432|FG000|Overall Study|Lack of Efficacy|1|||
33633077|NCT04973449|102208710|FG002|Overall Study|Other|2|||
33633078|NCT04973449|102208711|FG003|Overall Study|Other|1|||
33633079|NCT04973449|102208712|FG004|Overall Study|Other|4|||
33633080|NCT04973449|102208713|FG005|Overall Study|Other|0|||
33633081|NCT04973449|102208714|FG006|Overall Study|Other|2|||
33633082|NCT04973449|102208715|FG007|Overall Study|Other|2|||
33633083|NCT01710501|102208723|FG000|Overall Study|Lost to Follow-up|2|||
33633084|NCT01710501|102208724|FG001|Overall Study|Lost to Follow-up|0|||
33633085|NCT01710501|102208725|FG002|Overall Study|Lost to Follow-up|0|||
33633086|NCT01285323|102208731|FG000|Overall Study|Adverse Event|9|||
33633087|NCT01285323|102208732|FG001|Overall Study|Adverse Event|8|||
33633088|NCT01285323|102208731|FG000|Overall Study|Lack of Efficacy|4|||
33633089|NCT01285323|102208732|FG001|Overall Study|Lack of Efficacy|2|||
33570294|NCT02327169|101978472|FG001|Overall Study|Reason Not Specified|0|||
33570295|NCT02327169|101978473|FG002|Overall Study|Reason Not Specified|1|||
33570296|NCT02327169|101978474|FG003|Overall Study|Reason Not Specified|0|||
33570297|NCT02327169|101978475|FG004|Overall Study|Reason Not Specified|0|||
33570298|NCT02327169|101978476|FG005|Overall Study|Reason Not Specified|0|||
33570299|NCT02327169|101978477|FG006|Overall Study|Reason Not Specified|0|||
33570300|NCT02327169|101978478|FG007|Overall Study|Reason Not Specified|0|||
33570301|NCT02327169|101978479|FG008|Overall Study|Reason Not Specified|0|||
33570302|NCT02327169|101978480|FG009|Overall Study|Reason Not Specified|1|||
33570303|NCT02327169|101978481|FG010|Overall Study|Reason Not Specified|2|||
33570304|NCT02327169|101978482|FG011|Overall Study|Reason Not Specified|1|||
33570305|NCT02327169|101978483|FG012|Overall Study|Reason Not Specified|0|||
33570306|NCT02327169|101978484|FG013|Overall Study|Reason Not Specified|0|||
33570307|NCT02327169|101978485|FG014|Overall Study|Reason Not Specified|2|||
33570308|NCT02327169|101978471|FG000|Overall Study|Withdrawal by Subject|1|||
33570309|NCT02327169|101978472|FG001|Overall Study|Withdrawal by Subject|0|||
33570310|NCT02327169|101978473|FG002|Overall Study|Withdrawal by Subject|0|||
33570311|NCT02327169|101978474|FG003|Overall Study|Withdrawal by Subject|0|||
33570312|NCT02327169|101978475|FG004|Overall Study|Withdrawal by Subject|1|||
33570313|NCT02327169|101978476|FG005|Overall Study|Withdrawal by Subject|0|||
33570314|NCT02327169|101978477|FG006|Overall Study|Withdrawal by Subject|0|||
33570315|NCT02327169|101978478|FG007|Overall Study|Withdrawal by Subject|1|||
33570316|NCT02327169|101978479|FG008|Overall Study|Withdrawal by Subject|0|||
33570317|NCT02327169|101978480|FG009|Overall Study|Withdrawal by Subject|0|||
33570318|NCT02327169|101978481|FG010|Overall Study|Withdrawal by Subject|0|||
33227505|NCT00621296|100732432|FG000|Overall Study|Physician Decision|7|||
33633090|NCT01285323|102208731|FG000|Overall Study|Withdrawal by Subject|15|||
33633091|NCT01285323|102208732|FG001|Overall Study|Withdrawal by Subject|11|||
33570319|NCT02327169|101978482|FG011|Overall Study|Withdrawal by Subject|0|||
33570320|NCT02327169|101978483|FG012|Overall Study|Withdrawal by Subject|0|||
33633092|NCT01285323|102208731|FG000|Overall Study|Protocol Violation|1|||
33633093|NCT01285323|102208732|FG001|Overall Study|Protocol Violation|2|||
33633094|NCT01285323|102208731|FG000|Overall Study|Non-compliance with study procedures|2|||
33633095|NCT01285323|102208732|FG001|Overall Study|Non-compliance with study procedures|3|||
33633096|NCT01285323|102208731|FG000|Overall Study|Lost to Follow-up|1|||
33633097|NCT01285323|102208732|FG001|Overall Study|Lost to Follow-up|1|||
33633098|NCT01285323|102208731|FG000|Overall Study|Other|1|||
33633099|NCT01285323|102208732|FG001|Overall Study|Other|3|||
33633100|NCT05316597|102208733|FG000|First Session|Withdrawal by Subject|0|||
33633101|NCT05316597|102208734|FG001|First Session|Withdrawal by Subject|1|||
33633102|NCT05316597|102208733|FG000|Washout Period|Lost to Follow-up|1|||
33633103|NCT05316597|102208734|FG001|Washout Period|Lost to Follow-up|2|||
33227506|NCT00621296|100732432|FG000|Overall Study|Unmatch Criteria|1|||
33570321|NCT02327169|101978484|FG013|Overall Study|Withdrawal by Subject|0|||
33570322|NCT02327169|101978485|FG014|Overall Study|Withdrawal by Subject|3|||
33570323|NCT02327169|101978471|FG000|Overall Study|Lost to Follow-up|0|||
33570324|NCT02327169|101978472|FG001|Overall Study|Lost to Follow-up|0|||
33570325|NCT02327169|101978473|FG002|Overall Study|Lost to Follow-up|0|||
33570326|NCT02327169|101978474|FG003|Overall Study|Lost to Follow-up|0|||
33570327|NCT02327169|101978475|FG004|Overall Study|Lost to Follow-up|1|||
33570328|NCT02327169|101978476|FG005|Overall Study|Lost to Follow-up|0|||
33570329|NCT02327169|101978477|FG006|Overall Study|Lost to Follow-up|0|||
33570330|NCT02327169|101978478|FG007|Overall Study|Lost to Follow-up|0|||
33570331|NCT02327169|101978479|FG008|Overall Study|Lost to Follow-up|0|||
33570332|NCT02327169|101978480|FG009|Overall Study|Lost to Follow-up|0|||
33570333|NCT02327169|101978481|FG010|Overall Study|Lost to Follow-up|0|||
33633104|NCT05316597|102208733|FG000|Washout Period|Physician Decision|1|||
33633105|NCT05316597|102208734|FG001|Washout Period|Physician Decision|1|||
33570334|NCT02327169|101978482|FG011|Overall Study|Lost to Follow-up|0|||
33570335|NCT02327169|101978483|FG012|Overall Study|Lost to Follow-up|0|||
33570336|NCT02327169|101978484|FG013|Overall Study|Lost to Follow-up|0|||
33570337|NCT02327169|101978485|FG014|Overall Study|Lost to Follow-up|0|||
33570338|NCT02006927|101978490|FG000|Overall Study|Adverse Event|2|||
33570339|NCT02006927|101978490|FG000|Overall Study|Withdrawal by Subject|1|||
33633106|NCT05316597|102208733|FG000|Washout Period|Excluded before second session|1|||
33633107|NCT05316597|102208734|FG001|Washout Period|Excluded before second session|1|||
33570340|NCT01155050|101978492|FG000|Overall Study|Lost to Follow-up|15|||
33570341|NCT01155050|101978493|FG001|Overall Study|Lost to Follow-up|20|||
33570342|NCT01155050|101978494|FG002|Overall Study|Lost to Follow-up|19|||
33570343|NCT01155050|101978495|FG003|Overall Study|Lost to Follow-up|22|||
33570344|NCT04436744|101982492|FG000|Overall Study|Adverse Event|1|||
33570345|NCT04436744|101982493|FG001|Overall Study|Adverse Event|1|||
33633108|NCT05316597|102208733|FG000|Washout Period|Withdrawal by Subject|0|||
33633109|NCT05316597|102208734|FG001|Washout Period|Withdrawal by Subject|4|||
33633110|NCT03103542|102208748|FG000|Overall Study|Physician Decision|2|||
33633111|NCT03103542|102208748|FG000|Overall Study|Adverse Event|2|||
33633112|NCT03103542|102208748|FG000|Overall Study|Other|2|||
33570346|NCT04436744|101982492|FG000|Overall Study|Death|1|||
33570347|NCT04436744|101982493|FG001|Overall Study|Death|0|||
33570348|NCT04436744|101982492|FG000|Overall Study|Lost to Follow-up|0|||
33570349|NCT04436744|101982493|FG001|Overall Study|Lost to Follow-up|2|||
33570350|NCT04436744|101982492|FG000|Overall Study|Physician Decision|0|||
33570351|NCT04436744|101982493|FG001|Overall Study|Physician Decision|1|||
33570352|NCT04436744|101982492|FG000|Overall Study|Progressive Disease|0|||
33570353|NCT04436744|101982493|FG001|Overall Study|Progressive Disease|4|||
33570354|NCT04436744|101982492|FG000|Overall Study|Protocol Deviation|1|||
33570355|NCT04436744|101982493|FG001|Overall Study|Protocol Deviation|1|||
33570356|NCT04436744|101982492|FG000|Overall Study|Withdrawal by Subject|1|||
33570357|NCT04436744|101982493|FG001|Overall Study|Withdrawal by Subject|2|||
33570358|NCT02133573|101982496|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
33570359|NCT02133573|101982497|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
33570360|NCT02133573|101982496|FG000|Overall Study|Child Deaths|3|||
33570361|NCT02133573|101982497|FG001|Overall Study|Child Deaths|5|||
33570362|NCT02133573|101982496|FG000|Overall Study|Child Declined Follow Ups|2|||
33570363|NCT02133573|101982497|FG001|Overall Study|Child Declined Follow Ups|1|||
33570364|NCT02133573|101982496|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
33570365|NCT02133573|101982497|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
33633113|NCT03103542|102208748|FG000|Overall Study|Withdrawal by Subject|1|||
33633114|NCT03175367|102208750|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
33633115|NCT03175367|102208751|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
33633116|NCT03175367|102208752|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
33633117|NCT03175367|102208753|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
33633118|NCT03175367|102208754|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
33633119|NCT03175367|102208755|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
33633120|NCT03175367|102208756|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
33633121|NCT03175367|102208750|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
33633122|NCT03175367|102208751|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
33633123|NCT03175367|102208752|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
33633124|NCT03175367|102208753|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
33633125|NCT03175367|102208754|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
33633126|NCT03175367|102208755|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
33633127|NCT03175367|102208756|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
33633128|NCT03175367|102208750|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
33570366|NCT01693367|101982500|FG000|Overall Study|Withdrawal by Subject|1|||
33570367|NCT01693367|101982501|FG001|Overall Study|Withdrawal by Subject|1|||
33570368|NCT01693367|101982500|FG000|Overall Study|Physician Decision|0|||
33570369|NCT01693367|101982501|FG001|Overall Study|Physician Decision|1|||
33570370|NCT01150357|101982504|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
33570371|NCT01150357|101982505|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
33418226|NCT04440163|101422361|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
33633129|NCT03175367|102208751|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
33633130|NCT03175367|102208752|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
33633131|NCT03175367|102208753|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
33633132|NCT03175367|102208754|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
33633133|NCT03175367|102208755|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
33633134|NCT03175367|102208756|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
33570372|NCT01150357|101982506|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
33570373|NCT01150357|101982504|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
33570374|NCT01150357|101982505|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
33570375|NCT01150357|101982506|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
33570376|NCT01150357|101982504|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
33570377|NCT01150357|101982505|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
33570378|NCT01150357|101982506|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
33570379|NCT01150357|101982504|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
33570380|NCT01150357|101982505|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
33570381|NCT01150357|101982506|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
33570382|NCT01150357|101982504|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
33570383|NCT01150357|101982505|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
33570384|NCT01150357|101982506|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
33570385|NCT01150357|101982504|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
33570386|NCT01150357|101982505|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
33570387|NCT01150357|101982506|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
33570388|NCT01150357|101982504|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
33570389|NCT01150357|101982505|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
33570390|NCT01150357|101982506|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
33570391|NCT01170663|101982507|FG000|Overall Study|Lost to Follow-up|3|||
33633135|NCT03175367|102208750|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
33633136|NCT03175367|102208751|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
33633137|NCT03175367|102208752|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
33633138|NCT03175367|102208753|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
33633139|NCT03175367|102208754|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
33570392|NCT01170663|101982508|FG001|Overall Study|Lost to Follow-up|9|||
33633140|NCT03175367|102208755|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
33633141|NCT03175367|102208756|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
33633142|NCT03175367|102208750|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33633143|NCT03175367|102208751|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33633144|NCT03175367|102208752|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
33633145|NCT03175367|102208753|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33633146|NCT03175367|102208754|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
33633147|NCT03175367|102208755|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33633148|NCT03175367|102208756|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33633149|NCT03175367|102208750|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
33633150|NCT03175367|102208751|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
33633151|NCT03175367|102208752|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
33633152|NCT03175367|102208753|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
33633153|NCT03175367|102208754|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
33227507|NCT00621296|100732432|FG000|Overall Study|Stopping Criteria|3|||
33227508|NCT03560245|100732434|FG000|Overall Study|Withdrawal by Subject|3|||
33227509|NCT03560245|100732435|FG001|Overall Study|Withdrawal by Subject|2|||
33418227|NCT04440163|101422354|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
33418228|NCT04440163|101422355|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
33418229|NCT04440163|101422356|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
33418230|NCT04440163|101422357|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
33418231|NCT04440163|101422358|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
33418232|NCT04440163|101422359|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
33418233|NCT04440163|101422360|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
33418234|NCT04440163|101422361|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
33418235|NCT04440163|101422354|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
33418236|NCT04440163|101422355|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
33418237|NCT04440163|101422356|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
33418238|NCT04440163|101422357|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
33418239|NCT04440163|101422358|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
33418240|NCT04440163|101422359|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
33418241|NCT04440163|101422360|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
33418242|NCT04440163|101422361|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
33418243|NCT04440163|101422354|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
33418244|NCT04440163|101422355|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
33633154|NCT03175367|102208755|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
33633155|NCT03175367|102208756|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
33633156|NCT03175367|102208750|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33633157|NCT03175367|102208751|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33633158|NCT03175367|102208752|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33633159|NCT03175367|102208753|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33633160|NCT03175367|102208754|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
33633161|NCT03175367|102208755|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
33633162|NCT03175367|102208756|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
33633163|NCT01600326|102208760|FG000|Overall Study|Lost to Follow-up|1|||
33633164|NCT01600326|102208761|FG001|Overall Study|Lost to Follow-up|1|||
33570393|NCT01170663|101982507|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
33570394|NCT01170663|101982508|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
33570395|NCT04103450|101982509|FG000|Overall Study|Adverse Event|4|||
33570396|NCT04103450|101982510|FG001|Overall Study|Adverse Event|2|||
33570397|NCT04103450|101982509|FG000|Overall Study|Lack of Efficacy|3|||
33570398|NCT04103450|101982510|FG001|Overall Study|Lack of Efficacy|0|||
33570399|NCT04103450|101982509|FG000|Overall Study|Withdrawal by Subject|5|||
33570400|NCT04103450|101982510|FG001|Overall Study|Withdrawal by Subject|3|||
33570401|NCT04103450|101982509|FG000|Overall Study|Lost to Follow-up|1|||
33570402|NCT04103450|101982510|FG001|Overall Study|Lost to Follow-up|2|||
33570403|NCT04103450|101982509|FG000|Overall Study|Physician Decision|1|||
33570404|NCT04103450|101982510|FG001|Overall Study|Physician Decision|2|||
33570405|NCT04103450|101982509|FG000|Overall Study|Protocol Violation|1|||
33633165|NCT04945733|102208762|FG000|Overall Study|Physician Decision|1|||
33633166|NCT04945733|102208763|FG001|Overall Study|Physician Decision|3|||
33633167|NCT04945733|102208764|FG002|Overall Study|Physician Decision|0|||
33366392|NCT03502707|101227371|FG005|Overall Study|Protocol Violation|0|||
33570406|NCT04103450|101982510|FG001|Overall Study|Protocol Violation|0|||
33570407|NCT04103450|101982509|FG000|Overall Study|Other|1|||
33366393|NCT03502707|101227372|FG006|Overall Study|Protocol Violation|0|||
33366394|NCT03502707|101227373|FG007|Overall Study|Protocol Violation|0|||
33366395|NCT03502707|101227374|FG008|Overall Study|Protocol Violation|0|||
33570408|NCT04103450|101982510|FG001|Overall Study|Other|1|||
33570409|NCT01055028|101982514|FG000|Screening|Screen Failure|1|||
33633168|NCT04945733|102208762|FG000|Overall Study|Withdrawal by Subject|3|||
33570410|NCT01055028|101982515|FG001|Screening|Screen Failure|1|||
33570411|NCT01055028|101982514|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
33633169|NCT04945733|102208763|FG001|Overall Study|Withdrawal by Subject|3|||
33633170|NCT04945733|102208764|FG002|Overall Study|Withdrawal by Subject|0|||
33633171|NCT00870740|102208769|FG000|Overall Study|Adverse Event|2|||
33633172|NCT00870740|102208770|FG001|Overall Study|Adverse Event|1|||
33633173|NCT00870740|102208771|FG002|Overall Study|Adverse Event|3|||
33366396|NCT03502707|101227375|FG009|Overall Study|Protocol Violation|0|||
33570412|NCT01055028|101982515|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
33570413|NCT01055028|101982514|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
33570414|NCT01055028|101982515|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
33633174|NCT00870740|102208772|FG003|Overall Study|Adverse Event|2|||
33227510|NCT03560245|100732434|FG000|Overall Study|Adverse Event|1|||
33227511|NCT03560245|100732435|FG001|Overall Study|Adverse Event|1|||
33227512|NCT03560245|100732434|FG000|Overall Study|Protocol Violation|1|||
33227513|NCT03560245|100732435|FG001|Overall Study|Protocol Violation|0|||
33227514|NCT03560245|100732434|FG000|Overall Study|Death|0|||
33227515|NCT03560245|100732435|FG001|Overall Study|Death|1|||
33227516|NCT03560245|100732434|FG000|Overall Study|Lost to Follow-up|0|||
33227517|NCT03560245|100732435|FG001|Overall Study|Lost to Follow-up|1|||
33227518|NCT03560245|100732434|FG000|Overall Study|Physician Decision|0|||
33227519|NCT03560245|100732435|FG001|Overall Study|Physician Decision|1|||
33227520|NCT03560245|100732434|FG000|Overall Study|Other|0|||
33227521|NCT03560245|100732435|FG001|Overall Study|Other|1|||
33227522|NCT00960752|100732436|FG000|Overall Study|Adverse Event|0|||
33227523|NCT00960752|100732437|FG001|Overall Study|Adverse Event|0|||
33227524|NCT00960752|100732438|FG002|Overall Study|Adverse Event|1|||
33227525|NCT00960752|100732436|FG000|Overall Study|Progression|0|||
33227526|NCT00960752|100732437|FG001|Overall Study|Progression|0|||
33227527|NCT00960752|100732438|FG002|Overall Study|Progression|1|||
33227528|NCT01032044|100732441|FG000|Overall Study|Protocol Violation|14|||
33227529|NCT01032044|100732442|FG001|Overall Study|Protocol Violation|8|||
33227530|NCT01032044|100732441|FG000|Overall Study|Adverse Event|0|||
33227531|NCT01032044|100732442|FG001|Overall Study|Adverse Event|1|||
33227532|NCT01032044|100732441|FG000|Overall Study|Lost to Follow-up|11|||
33227533|NCT01032044|100732442|FG001|Overall Study|Lost to Follow-up|11|||
33227534|NCT02091739|100732443|FG000|MP: 16 Weeks|Adverse Event|1|||
33227535|NCT02091739|100732444|FG001|MP: 16 Weeks|Adverse Event|1|||
33227536|NCT02091739|100732445|FG002|MP: 16 Weeks|Adverse Event|1|||
33227537|NCT02091739|100732446|FG003|MP: 16 Weeks|Adverse Event|0|||
33227538|NCT02091739|100732447|FG004|MP: 16 Weeks|Adverse Event|0|||
33227539|NCT02091739|100732443|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
33227540|NCT02091739|100732444|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
33227541|NCT02091739|100732445|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
33227542|NCT02091739|100732446|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
33227543|NCT02091739|100732447|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
33227544|NCT02091739|100732443|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
33227545|NCT02091739|100732444|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
33227546|NCT02091739|100732445|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
33227547|NCT02091739|100732446|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
33227548|NCT02091739|100732447|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
33227549|NCT02091739|100732443|FG000|EP: 48 Weeks|Other|0|||
33227550|NCT02091739|100732444|FG001|EP: 48 Weeks|Other|0|||
33227551|NCT02091739|100732445|FG002|EP: 48 Weeks|Other|0|||
33227552|NCT02091739|100732446|FG003|EP: 48 Weeks|Other|1|||
33227553|NCT02091739|100732447|FG004|EP: 48 Weeks|Other|0|||
33227554|NCT02091739|100732443|FG000|EP: 48 Weeks|Death|0|||
33227555|NCT02091739|100732444|FG001|EP: 48 Weeks|Death|0|||
33227556|NCT02091739|100732445|FG002|EP: 48 Weeks|Death|0|||
33227557|NCT02091739|100732446|FG003|EP: 48 Weeks|Death|3|||
33227558|NCT02091739|100732447|FG004|EP: 48 Weeks|Death|2|||
33227559|NCT02091739|100732443|FG000|EP: 48 Weeks|Adverse Event|0|||
33227560|NCT02091739|100732444|FG001|EP: 48 Weeks|Adverse Event|0|||
33227561|NCT02091739|100732445|FG002|EP: 48 Weeks|Adverse Event|0|||
33227562|NCT02091739|100732446|FG003|EP: 48 Weeks|Adverse Event|2|||
33227563|NCT02091739|100732447|FG004|EP: 48 Weeks|Adverse Event|6|||
33227564|NCT02091739|100732443|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
33227565|NCT02091739|100732444|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
33227566|NCT02091739|100732445|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
33227567|NCT02091739|100732446|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
33227568|NCT02091739|100732447|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
33227569|NCT04772053|100732448|FG000|Overall Study|Physician Decision|2|||
33227570|NCT04772053|100732448|FG000|Overall Study|Withdrawal by Subject|3|||
33227571|NCT04772053|100732448|FG000|Overall Study|Study Terminated by Sponsor|1|||
33227572|NCT02875834|100732450|FG000|Open-label Phase|Withdrawal by Subject|3|||
33227573|NCT02875834|100732451|FG001|Open-label Phase|Withdrawal by Subject|0|||
33227574|NCT02875834|100732452|FG002|Open-label Phase|Withdrawal by Subject|0|||
33227575|NCT02875834|100732453|FG003|Open-label Phase|Withdrawal by Subject|0|||
33227576|NCT02875834|100732450|FG000|Open-label Phase|(Not collected)|4|||
33227577|NCT02875834|100732451|FG001|Open-label Phase|(Not collected)|0|||
33227578|NCT02875834|100732452|FG002|Open-label Phase|(Not collected)|0|||
33227579|NCT02875834|100732453|FG003|Open-label Phase|(Not collected)|0|||
33227580|NCT02875834|100732450|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
33227581|NCT02875834|100732451|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
33227582|NCT02875834|100732452|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
33227583|NCT02875834|100732453|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
33227584|NCT02875834|100732450|FG000|Randomized Treatment Phase|Protocol Violation|0|||
33227585|NCT02875834|100732451|FG001|Randomized Treatment Phase|Protocol Violation|2|||
33227586|NCT02875834|100732452|FG002|Randomized Treatment Phase|Protocol Violation|0|||
33227587|NCT02875834|100732453|FG003|Randomized Treatment Phase|Protocol Violation|0|||
33227588|NCT02875834|100732450|FG000|Randomized Treatment Phase|(Not collected)|0|||
33227589|NCT02875834|100732451|FG001|Randomized Treatment Phase|(Not collected)|9|||
33227590|NCT02875834|100732452|FG002|Randomized Treatment Phase|(Not collected)|10|||
33227591|NCT02875834|100732453|FG003|Randomized Treatment Phase|(Not collected)|9|||
33227592|NCT03086018|100732454|FG000|Final Testing for End of Trial|Adverse Event|1|||
33227593|NCT03086018|100732454|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
33227594|NCT03556358|100732458|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
33227595|NCT03556358|100732459|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
33227596|NCT03556358|100732458|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
33418245|NCT04440163|101422356|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
33418246|NCT04440163|101422357|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
33418247|NCT04440163|101422358|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
33418248|NCT04440163|101422359|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
33227597|NCT03556358|100732459|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
33227598|NCT03556358|100732458|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
33227599|NCT03556358|100732459|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
33227600|NCT03556358|100732458|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
33227601|NCT03556358|100732459|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
33227602|NCT03556358|100732458|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
33227603|NCT03556358|100732459|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
33366397|NCT03502707|101227376|FG010|Overall Study|Protocol Violation|0|||
33366398|NCT03502707|101227377|FG011|Overall Study|Protocol Violation|0|||
33366399|NCT03502707|101227378|FG012|Overall Study|Protocol Violation|0|||
33366400|NCT03502707|101227379|FG013|Overall Study|Protocol Violation|0|||
33366401|NCT03502707|101227380|FG014|Overall Study|Protocol Violation|0|||
33366402|NCT03502707|101227381|FG015|Overall Study|Protocol Violation|1|||
33366403|NCT03502707|101227382|FG016|Overall Study|Protocol Violation|0|||
33366404|NCT03502707|101227383|FG017|Overall Study|Protocol Violation|0|||
33366405|NCT03502707|101227366|FG000|Overall Study|Withdrawal by Subject|1|||
33366406|NCT03502707|101227367|FG001|Overall Study|Withdrawal by Subject|1|||
33366407|NCT03502707|101227368|FG002|Overall Study|Withdrawal by Subject|0|||
33366408|NCT03502707|101227369|FG003|Overall Study|Withdrawal by Subject|0|||
33366409|NCT03502707|101227370|FG004|Overall Study|Withdrawal by Subject|0|||
33366410|NCT03502707|101227371|FG005|Overall Study|Withdrawal by Subject|2|||
33366411|NCT03502707|101227372|FG006|Overall Study|Withdrawal by Subject|0|||
33366412|NCT03502707|101227373|FG007|Overall Study|Withdrawal by Subject|3|||
33366413|NCT03502707|101227374|FG008|Overall Study|Withdrawal by Subject|1|||
33366414|NCT03502707|101227375|FG009|Overall Study|Withdrawal by Subject|2|||
33366415|NCT03502707|101227376|FG010|Overall Study|Withdrawal by Subject|12|||
33366416|NCT03502707|101227377|FG011|Overall Study|Withdrawal by Subject|23|||
33366417|NCT03502707|101227378|FG012|Overall Study|Withdrawal by Subject|5|||
33366418|NCT03502707|101227379|FG013|Overall Study|Withdrawal by Subject|3|||
33366419|NCT03502707|101227380|FG014|Overall Study|Withdrawal by Subject|3|||
33366420|NCT03502707|101227381|FG015|Overall Study|Withdrawal by Subject|43|||
33366421|NCT03502707|101227382|FG016|Overall Study|Withdrawal by Subject|44|||
33366422|NCT03502707|101227383|FG017|Overall Study|Withdrawal by Subject|18|||
33366423|NCT03502707|101227366|FG000|Overall Study|Sponsor's Decision|1|||
33366424|NCT03502707|101227367|FG001|Overall Study|Sponsor's Decision|0|||
33418249|NCT04440163|101422360|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
33227604|NCT03556358|100732458|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
33366425|NCT03502707|101227368|FG002|Overall Study|Sponsor's Decision|0|||
33366426|NCT03502707|101227369|FG003|Overall Study|Sponsor's Decision|0|||
33366427|NCT03502707|101227370|FG004|Overall Study|Sponsor's Decision|0|||
33366428|NCT03502707|101227371|FG005|Overall Study|Sponsor's Decision|0|||
33418250|NCT04440163|101422361|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
33227605|NCT03556358|100732459|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
33227606|NCT03556358|100732458|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
33227607|NCT03556358|100732459|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
33227608|NCT02961881|100732460|FG000|Overall Study|Adverse Event|1|||
33227609|NCT02961881|100732461|FG001|Overall Study|Adverse Event|2|||
33227610|NCT02961881|100732462|FG002|Overall Study|Adverse Event|2|||
33227611|NCT02961881|100732463|FG003|Overall Study|Adverse Event|0|||
33227612|NCT02961881|100732464|FG004|Overall Study|Adverse Event|1|||
33227613|NCT02961881|100732460|FG000|Overall Study|Participant request|0|||
33227614|NCT02961881|100732461|FG001|Overall Study|Participant request|2|||
33227615|NCT02961881|100732462|FG002|Overall Study|Participant request|0|||
33227616|NCT02961881|100732463|FG003|Overall Study|Participant request|0|||
33227617|NCT02961881|100732464|FG004|Overall Study|Participant request|0|||
33227618|NCT02961881|100732460|FG000|Overall Study|Disease progression|1|||
33227619|NCT02961881|100732461|FG001|Overall Study|Disease progression|0|||
33227620|NCT02961881|100732462|FG002|Overall Study|Disease progression|1|||
33418251|NCT04440163|101422354|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
33227621|NCT02961881|100732463|FG003|Overall Study|Disease progression|0|||
33227622|NCT02961881|100732464|FG004|Overall Study|Disease progression|0|||
33633175|NCT00870740|102208773|FG004|Overall Study|Adverse Event|1|||
33227623|NCT01126060|100735632|FG000|Overall Study|Protocol Violation|0|||
33227624|NCT01126060|100735633|FG001|Overall Study|Protocol Violation|2|||
33227625|NCT01233609|100735638|FG000|Overall Study|Death|1|||
33227626|NCT01233609|100735639|FG001|Overall Study|Death|0|||
33227627|NCT01233609|100735638|FG000|Overall Study|Lost to Follow-up|3|||
33227628|NCT01233609|100735639|FG001|Overall Study|Lost to Follow-up|1|||
33227629|NCT01233609|100735638|FG000|Overall Study|Adverse Event|2|||
33418252|NCT04440163|101422355|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
33418253|NCT04440163|101422356|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
33418254|NCT04440163|101422357|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
33227630|NCT01233609|100735639|FG001|Overall Study|Adverse Event|1|||
33227631|NCT01233609|100735638|FG000|Overall Study|Withdrawal by Subject|3|||
33227632|NCT01233609|100735639|FG001|Overall Study|Withdrawal by Subject|0|||
33227633|NCT02667886|100735642|FG000|Dose Escalation (Part A)|Adverse Event|1|||
33227634|NCT02667886|100735643|FG001|Dose Escalation (Part A)|Adverse Event|3|||
33227635|NCT02667886|100735644|FG002|Dose Escalation (Part A)|Adverse Event|1|||
33227636|NCT02667886|100735645|FG003|Dose Escalation (Part A)|Adverse Event|0|||
33570415|NCT01055028|101982514|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
33227637|NCT02667886|100735646|FG004|Dose Escalation (Part A)|Adverse Event|0|||
33227638|NCT02667886|100735642|FG000|Dose Escalation (Part A)|Disease Progression|1|||
33227639|NCT02667886|100735643|FG001|Dose Escalation (Part A)|Disease Progression|4|||
33227640|NCT02667886|100735644|FG002|Dose Escalation (Part A)|Disease Progression|3|||
33227641|NCT02667886|100735645|FG003|Dose Escalation (Part A)|Disease Progression|0|||
33227642|NCT02667886|100735646|FG004|Dose Escalation (Part A)|Disease Progression|0|||
33227643|NCT02667886|100735642|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
33227644|NCT02667886|100735643|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
33227645|NCT02667886|100735644|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
33227646|NCT02667886|100735645|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
33227647|NCT02667886|100735646|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
33227648|NCT02667886|100735642|FG000|Dose Expansion (Part B)|Adverse Event|0|||
33227649|NCT02667886|100735643|FG001|Dose Expansion (Part B)|Adverse Event|0|||
33227650|NCT02667886|100735644|FG002|Dose Expansion (Part B)|Adverse Event|0|||
33227651|NCT02667886|100735645|FG003|Dose Expansion (Part B)|Adverse Event|9|||
33227652|NCT02667886|100735646|FG004|Dose Expansion (Part B)|Adverse Event|0|||
33227653|NCT02667886|100735642|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
33227654|NCT02667886|100735643|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
33227655|NCT02667886|100735644|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
33227656|NCT02667886|100735645|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
33227657|NCT02667886|100735646|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
33227658|NCT02667886|100735642|FG000|Dose Expansion (Part B)|Disease Progression|0|||
33227659|NCT02667886|100735643|FG001|Dose Expansion (Part B)|Disease Progression|0|||
33227660|NCT02667886|100735644|FG002|Dose Expansion (Part B)|Disease Progression|0|||
33227661|NCT02667886|100735645|FG003|Dose Expansion (Part B)|Disease Progression|38|||
33418255|NCT04440163|101422358|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
33418256|NCT04440163|101422359|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
33418257|NCT04440163|101422360|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
33418258|NCT04440163|101422361|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
33418259|NCT04440163|101422354|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
33418260|NCT04440163|101422355|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
33570416|NCT01055028|101982515|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
33227662|NCT02667886|100735646|FG004|Dose Expansion (Part B)|Disease Progression|0|||
33570417|NCT03556891|101982518|FG000|Overall Study|Adverse Event|4|||
33570418|NCT03556891|101982518|FG000|Overall Study|MRI Need|3|||
33570419|NCT03556891|101982518|FG000|Overall Study|Device Failure|1|||
33227663|NCT02667886|100735642|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
33227664|NCT02667886|100735643|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
33227665|NCT02667886|100735644|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
33227666|NCT02667886|100735645|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
33227667|NCT02667886|100735646|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
33418261|NCT04440163|101422356|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
33570420|NCT03556891|101982518|FG000|Overall Study|Death|1|||
33570421|NCT03556891|101982518|FG000|Overall Study|Lost to Follow-up|1|||
33227668|NCT02667886|100735642|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
33227669|NCT02667886|100735643|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
33227670|NCT02667886|100735644|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
33227671|NCT02667886|100735645|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
33227672|NCT02667886|100735646|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
33227673|NCT02667886|100735642|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
33227674|NCT02667886|100735643|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
33227675|NCT02667886|100735644|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
33227676|NCT02667886|100735645|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
33227677|NCT02667886|100735646|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
33227678|NCT00979602|100735647|FG000|Overall Study|Serious Adverse Event|5|||
33227679|NCT00979602|100735648|FG001|Overall Study|Serious Adverse Event|3|||
33227680|NCT00979602|100735647|FG000|Overall Study|Protocol Violation|3|||
33227681|NCT00979602|100735648|FG001|Overall Study|Protocol Violation|0|||
33227682|NCT00979602|100735647|FG000|Overall Study|Withdrawal by Subject|31|||
33227683|NCT00979602|100735648|FG001|Overall Study|Withdrawal by Subject|25|||
33418262|NCT04440163|101422357|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
33418263|NCT04440163|101422358|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
33570422|NCT03556891|101982518|FG000|Overall Study|Missing at random|1|||
33570423|NCT03556891|101982518|FG000|Overall Study|Missing due to COVID|1|||
33570424|NCT03556891|101982518|FG000|Overall Study|Protocol Violation|1|||
33570425|NCT00760552|101982521|FG000|Overall Study|Death|2|||
33570426|NCT00760552|101982522|FG001|Overall Study|Death|0|||
33570427|NCT00760552|101982521|FG000|Overall Study|Lost to Follow-up|11|||
33570428|NCT00760552|101982522|FG001|Overall Study|Lost to Follow-up|10|||
33570429|NCT00730327|101982523|FG000|Overall Study|Lost to Follow-up|14|||
33570430|NCT00730327|101982524|FG001|Overall Study|Lost to Follow-up|16|||
33570431|NCT00730327|101982523|FG000|Overall Study|Adverse Event|8|||
33570432|NCT00730327|101982524|FG001|Overall Study|Adverse Event|1|||
33570433|NCT00730327|101982523|FG000|Overall Study|Withdrawal by Subject|3|||
33570434|NCT00730327|101982524|FG001|Overall Study|Withdrawal by Subject|13|||
33570435|NCT00730327|101982523|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
33570436|NCT00730327|101982524|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
33570437|NCT04476784|101982529|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
33570438|NCT04476784|101982530|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
33570439|NCT01605097|101982531|FG000|Overall Study|Protocol Violation|1|||
33570440|NCT01397253|101982532|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
33570441|NCT01397253|101982533|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
33570442|NCT03283241|101982534|FG000|Overall Study|Adverse Event|4|||
33366429|NCT03502707|101227372|FG006|Overall Study|Sponsor's Decision|0|||
33366430|NCT03502707|101227373|FG007|Overall Study|Sponsor's Decision|0|||
33366431|NCT03502707|101227374|FG008|Overall Study|Sponsor's Decision|0|||
33366432|NCT03502707|101227375|FG009|Overall Study|Sponsor's Decision|1|||
33366433|NCT03502707|101227376|FG010|Overall Study|Sponsor's Decision|0|||
33366434|NCT03502707|101227377|FG011|Overall Study|Sponsor's Decision|0|||
33366435|NCT03502707|101227378|FG012|Overall Study|Sponsor's Decision|0|||
33366436|NCT03502707|101227379|FG013|Overall Study|Sponsor's Decision|0|||
33366437|NCT03502707|101227380|FG014|Overall Study|Sponsor's Decision|0|||
33366438|NCT03502707|101227381|FG015|Overall Study|Sponsor's Decision|2|||
33366439|NCT03502707|101227382|FG016|Overall Study|Sponsor's Decision|1|||
33366440|NCT03502707|101227383|FG017|Overall Study|Sponsor's Decision|0|||
33366441|NCT03502707|101227366|FG000|Overall Study|Initiated Prohibited Medication|0|||
33366442|NCT03502707|101227367|FG001|Overall Study|Initiated Prohibited Medication|0|||
33366443|NCT03502707|101227368|FG002|Overall Study|Initiated Prohibited Medication|0|||
33366444|NCT03502707|101227369|FG003|Overall Study|Initiated Prohibited Medication|0|||
33366445|NCT03502707|101227370|FG004|Overall Study|Initiated Prohibited Medication|0|||
33366446|NCT03502707|101227371|FG005|Overall Study|Initiated Prohibited Medication|0|||
33366447|NCT03502707|101227372|FG006|Overall Study|Initiated Prohibited Medication|0|||
33366448|NCT03502707|101227373|FG007|Overall Study|Initiated Prohibited Medication|0|||
33366449|NCT03502707|101227374|FG008|Overall Study|Initiated Prohibited Medication|0|||
33366450|NCT03502707|101227375|FG009|Overall Study|Initiated Prohibited Medication|0|||
33366451|NCT03502707|101227376|FG010|Overall Study|Initiated Prohibited Medication|0|||
33366452|NCT03502707|101227377|FG011|Overall Study|Initiated Prohibited Medication|0|||
33366453|NCT03502707|101227378|FG012|Overall Study|Initiated Prohibited Medication|0|||
33366454|NCT03502707|101227379|FG013|Overall Study|Initiated Prohibited Medication|0|||
33366455|NCT03502707|101227380|FG014|Overall Study|Initiated Prohibited Medication|0|||
33366456|NCT03502707|101227381|FG015|Overall Study|Initiated Prohibited Medication|0|||
33570443|NCT03283241|101982535|FG001|Overall Study|Adverse Event|1|||
33633176|NCT00870740|102208774|FG005|Overall Study|Adverse Event|6|||
33366457|NCT03502707|101227382|FG016|Overall Study|Initiated Prohibited Medication|1|||
33366458|NCT03502707|101227383|FG017|Overall Study|Initiated Prohibited Medication|0|||
33366459|NCT03502707|101227366|FG000|Overall Study|Other|0|||
33366460|NCT03502707|101227367|FG001|Overall Study|Other|0|||
33418264|NCT04440163|101422359|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
33227684|NCT00979602|100735647|FG000|Overall Study|Lost to Follow-up|100|||
33227685|NCT00979602|100735648|FG001|Overall Study|Lost to Follow-up|96|||
33227686|NCT00979602|100735647|FG000|Overall Study|Migrated/moved from study area|3|||
33366461|NCT03502707|101227368|FG002|Overall Study|Other|0|||
33366462|NCT03502707|101227369|FG003|Overall Study|Other|0|||
33366463|NCT03502707|101227370|FG004|Overall Study|Other|0|||
33366464|NCT03502707|101227371|FG005|Overall Study|Other|0|||
33366465|NCT03502707|101227372|FG006|Overall Study|Other|0|||
33227687|NCT00979602|100735648|FG001|Overall Study|Migrated/moved from study area|6|||
33227688|NCT00979602|100735647|FG000|Overall Study|Others|3|||
33366466|NCT03502707|101227373|FG007|Overall Study|Other|0|||
33418265|NCT04440163|101422360|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
33418266|NCT04440163|101422361|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
33418267|NCT04440163|101422354|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
33418268|NCT04440163|101422355|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
33418269|NCT04440163|101422356|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
33418270|NCT04440163|101422357|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
33418271|NCT04440163|101422358|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
33418272|NCT04440163|101422359|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
33418273|NCT04440163|101422360|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
33418274|NCT04440163|101422361|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
33418275|NCT04440163|101422354|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
33418276|NCT04440163|101422355|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
33570444|NCT03283241|101982534|FG000|Overall Study|Withdrawal by Subject|0|||
33570445|NCT03283241|101982535|FG001|Overall Study|Withdrawal by Subject|1|||
33570446|NCT03283241|101982534|FG000|Overall Study|Subject relocated to Finland|0|||
33570447|NCT03283241|101982535|FG001|Overall Study|Subject relocated to Finland|1|||
33570448|NCT03958331|101982536|FG000|Overall Study|Withdrawal by Subject|3|||
33570449|NCT03958331|101982537|FG001|Overall Study|Withdrawal by Subject|1|||
33366467|NCT03502707|101227374|FG008|Overall Study|Other|1|||
33366468|NCT03502707|101227375|FG009|Overall Study|Other|1|||
33366469|NCT03502707|101227376|FG010|Overall Study|Other|2|||
33366470|NCT03502707|101227377|FG011|Overall Study|Other|0|||
33418277|NCT04440163|101422356|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
33418278|NCT04440163|101422357|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
33418279|NCT04440163|101422358|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
33418280|NCT04440163|101422359|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
33418281|NCT04440163|101422360|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
33366471|NCT03502707|101227378|FG012|Overall Study|Other|0|||
33366472|NCT03502707|101227379|FG013|Overall Study|Other|0|||
33366473|NCT03502707|101227380|FG014|Overall Study|Other|0|||
33366474|NCT03502707|101227381|FG015|Overall Study|Other|4|||
33366475|NCT03502707|101227382|FG016|Overall Study|Other|1|||
33366476|NCT03502707|101227383|FG017|Overall Study|Other|0|||
33366477|NCT03502707|101227366|FG000|Overall Study|Randomized but not vaccinated|0|||
33366478|NCT03502707|101227367|FG001|Overall Study|Randomized but not vaccinated|0|||
33366479|NCT03502707|101227368|FG002|Overall Study|Randomized but not vaccinated|0|||
33366480|NCT03502707|101227369|FG003|Overall Study|Randomized but not vaccinated|0|||
33366481|NCT03502707|101227370|FG004|Overall Study|Randomized but not vaccinated|0|||
33366482|NCT03502707|101227371|FG005|Overall Study|Randomized but not vaccinated|0|||
33366483|NCT03502707|101227372|FG006|Overall Study|Randomized but not vaccinated|0|||
33366484|NCT03502707|101227373|FG007|Overall Study|Randomized but not vaccinated|0|||
33366485|NCT03502707|101227374|FG008|Overall Study|Randomized but not vaccinated|0|||
33366486|NCT03502707|101227375|FG009|Overall Study|Randomized but not vaccinated|0|||
33366487|NCT03502707|101227376|FG010|Overall Study|Randomized but not vaccinated|0|||
33366488|NCT03502707|101227377|FG011|Overall Study|Randomized but not vaccinated|1|||
33366489|NCT03502707|101227378|FG012|Overall Study|Randomized but not vaccinated|0|||
33366490|NCT03502707|101227379|FG013|Overall Study|Randomized but not vaccinated|0|||
33366491|NCT03502707|101227380|FG014|Overall Study|Randomized but not vaccinated|0|||
33366492|NCT03502707|101227381|FG015|Overall Study|Randomized but not vaccinated|0|||
33366493|NCT03502707|101227382|FG016|Overall Study|Randomized but not vaccinated|0|||
33366494|NCT03502707|101227383|FG017|Overall Study|Randomized but not vaccinated|1|||
33418282|NCT04440163|101422361|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
33418283|NCT01933932|101422362|FG000|Overall Study|Death|173|||
33570450|NCT03958331|101982538|FG002|Overall Study|Withdrawal by Subject|5|||
33227689|NCT00979602|100735648|FG001|Overall Study|Others|3|||
33366495|NCT03666143|101227384|FG000|Overall Study|Death|158|||
33366496|NCT03666143|101227384|FG000|Overall Study|Sponsor Decision|31|||
33366497|NCT03666143|101227384|FG000|Overall Study|Withdrawal by Subject|11|||
33366498|NCT03666143|101227384|FG000|Overall Study|Lost to Follow-up|5|||
33227690|NCT03560258|100735649|FG000|Overall Study|Lost to Follow-up|3|||
33227691|NCT03560258|100735650|FG001|Overall Study|Lost to Follow-up|0|||
33227692|NCT03560258|100735651|FG002|Overall Study|Lost to Follow-up|0|||
33227693|NCT03560258|100735649|FG000|Overall Study|Protocol Violation|0|||
33570451|NCT03958331|101982536|FG000|Overall Study|Weaned from medicine|2|||
33570452|NCT03958331|101982537|FG001|Overall Study|Weaned from medicine|0|||
33570453|NCT03958331|101982538|FG002|Overall Study|Weaned from medicine|0|||
33366499|NCT03666143|101227384|FG000|Overall Study|Physician Decision|1|||
33366500|NCT03666143|101227384|FG000|Overall Study|Rolled into extension study|9|||
33570454|NCT03958331|101982536|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
33570455|NCT03958331|101982537|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
33570456|NCT03958331|101982538|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
33570457|NCT00457626|101982539|FG000|Overall Study|Adverse Event|3|||
33570458|NCT00457626|101982539|FG000|Overall Study|Administrative Problems|2|||
33570459|NCT00457626|101982539|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
33633177|NCT00870740|102208769|FG000|Overall Study|Consent Withdrawn|6|||
33366501|NCT03666143|101227384|FG000|Overall Study|Progressive Disease|1|||
33366502|NCT04220866|101227385|FG000|Overall Study|Death|4|||
33366503|NCT04220866|101227386|FG001|Overall Study|Death|5|||
33366504|NCT04220866|101227385|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
33366505|NCT04220866|101227386|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
33366506|NCT04220866|101227385|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
33366507|NCT04220866|101227386|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
33366508|NCT04220866|101227385|FG000|Overall Study|Withdrawal by Subject|0|||
33366509|NCT04220866|101227386|FG001|Overall Study|Withdrawal by Subject|1|||
33366510|NCT02702193|101227389|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
33633178|NCT00870740|102208770|FG001|Overall Study|Consent Withdrawn|3|||
33633179|NCT00870740|102208771|FG002|Overall Study|Consent Withdrawn|4|||
33633180|NCT00870740|102208772|FG003|Overall Study|Consent Withdrawn|6|||
33633181|NCT00870740|102208773|FG004|Overall Study|Consent Withdrawn|6|||
33633182|NCT00870740|102208774|FG005|Overall Study|Consent Withdrawn|5|||
33633183|NCT00870740|102208769|FG000|Overall Study|Investigator Decision|2|||
33633184|NCT00870740|102208770|FG001|Overall Study|Investigator Decision|0|||
33633185|NCT00870740|102208771|FG002|Overall Study|Investigator Decision|1|||
33633186|NCT00870740|102208772|FG003|Overall Study|Investigator Decision|0|||
33633187|NCT00870740|102208773|FG004|Overall Study|Investigator Decision|0|||
33633188|NCT00870740|102208774|FG005|Overall Study|Investigator Decision|0|||
33633189|NCT00870740|102208769|FG000|Overall Study|Subject Non-compliance|0|||
33633190|NCT00870740|102208770|FG001|Overall Study|Subject Non-compliance|0|||
33633191|NCT00870740|102208771|FG002|Overall Study|Subject Non-compliance|0|||
33633192|NCT00870740|102208772|FG003|Overall Study|Subject Non-compliance|0|||
33633193|NCT00870740|102208773|FG004|Overall Study|Subject Non-compliance|0|||
33633194|NCT00870740|102208774|FG005|Overall Study|Subject Non-compliance|1|||
33633195|NCT00870740|102208769|FG000|Overall Study|Death|0|||
33633196|NCT00870740|102208770|FG001|Overall Study|Death|0|||
33633197|NCT00870740|102208771|FG002|Overall Study|Death|0|||
33633198|NCT00870740|102208772|FG003|Overall Study|Death|0|||
33366511|NCT02702193|101227390|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
33366512|NCT02702193|101227389|FG000|4 Month Follow up|Withdrawal by Subject|1|||
33366513|NCT02702193|101227390|FG001|4 Month Follow up|Withdrawal by Subject|0|||
33366514|NCT02702193|101227389|FG000|4 Month Follow up|Lost to Follow-up|17|||
33366515|NCT02702193|101227390|FG001|4 Month Follow up|Lost to Follow-up|18|||
33418284|NCT01933932|101422363|FG001|Overall Study|Death|163|||
33227694|NCT03560258|100735650|FG001|Overall Study|Protocol Violation|1|||
33227695|NCT03560258|100735651|FG002|Overall Study|Protocol Violation|0|||
33366516|NCT02702193|101227389|FG000|8 Month Follow up|Withdrawal by Subject|1|||
33570460|NCT01734902|101982540|FG000|Overall Study|Other than listed|0|||
33633199|NCT00870740|102208773|FG004|Overall Study|Death|1|||
33633200|NCT00870740|102208774|FG005|Overall Study|Death|0|||
33633201|NCT00870740|102208769|FG000|Overall Study|Other|2|||
33366517|NCT02702193|101227390|FG001|8 Month Follow up|Withdrawal by Subject|0|||
33418285|NCT01933932|101422362|FG000|Overall Study|Withdrawal by Subject|11|||
33418286|NCT01933932|101422363|FG001|Overall Study|Withdrawal by Subject|14|||
33570461|NCT01734902|101982541|FG001|Overall Study|Other than listed|2|||
33570462|NCT00841815|101982542|FG000|Washout|Withdrawal by Subject|0|||
33570463|NCT00841815|101982543|FG001|Washout|Withdrawal by Subject|1|||
33570464|NCT03498716|101982544|FG000|Overall Study|Withdrawal by Subject|88|||
33570465|NCT03498716|101982545|FG001|Overall Study|Withdrawal by Subject|73|||
33570466|NCT03498716|101982544|FG000|Overall Study|Study Terminated By Sponsor|933|||
33570467|NCT03498716|101982545|FG001|Overall Study|Study Terminated By Sponsor|927|||
33570468|NCT03498716|101982544|FG000|Overall Study|Lost to Follow-up|15|||
33570469|NCT03498716|101982545|FG001|Overall Study|Lost to Follow-up|26|||
33570470|NCT03498716|101982544|FG000|Overall Study|Disease Relapse|0|||
33633202|NCT00870740|102208770|FG001|Overall Study|Other|5|||
33227696|NCT03560258|100735649|FG000|Overall Study|Withdrawal by Subject|0|||
33227697|NCT03560258|100735650|FG001|Overall Study|Withdrawal by Subject|0|||
33227698|NCT03560258|100735651|FG002|Overall Study|Withdrawal by Subject|1|||
33633203|NCT00870740|102208771|FG002|Overall Study|Other|2|||
33570471|NCT03498716|101982545|FG001|Overall Study|Disease Relapse|1|||
33570472|NCT03498716|101982544|FG000|Overall Study|Death|58|||
33227699|NCT00674323|100735652|FG000|Overall Study|Adverse Event|0|||
33227700|NCT00674323|100735653|FG001|Overall Study|Adverse Event|1|||
33570473|NCT03498716|101982545|FG001|Overall Study|Death|72|||
33570474|NCT03498716|101982544|FG000|Overall Study|Physician Decision|4|||
33570475|NCT03498716|101982545|FG001|Overall Study|Physician Decision|2|||
33633204|NCT00870740|102208772|FG003|Overall Study|Other|4|||
33633205|NCT00870740|102208773|FG004|Overall Study|Other|3|||
33633206|NCT00870740|102208774|FG005|Overall Study|Other|5|||
33633207|NCT00385671|102208775|FG000|Overall Study|Adverse Event|14|||
33633208|NCT00385671|102208776|FG001|Overall Study|Adverse Event|27|||
33633209|NCT00385671|102208777|FG002|Overall Study|Adverse Event|18|||
33633210|NCT00385671|102208775|FG000|Overall Study|Lack of Efficacy|5|||
33633211|NCT00385671|102208776|FG001|Overall Study|Lack of Efficacy|9|||
33633212|NCT00385671|102208777|FG002|Overall Study|Lack of Efficacy|5|||
33633213|NCT00385671|102208775|FG000|Overall Study|Lost to Follow-up|6|||
33633214|NCT00385671|102208776|FG001|Overall Study|Lost to Follow-up|6|||
33633215|NCT00385671|102208777|FG002|Overall Study|Lost to Follow-up|5|||
33633216|NCT00385671|102208775|FG000|Overall Study|Physician Decision|2|||
33633217|NCT00385671|102208776|FG001|Overall Study|Physician Decision|1|||
33633218|NCT00385671|102208777|FG002|Overall Study|Physician Decision|2|||
33633219|NCT00385671|102208775|FG000|Overall Study|Protocol Violation|5|||
33633220|NCT00385671|102208776|FG001|Overall Study|Protocol Violation|2|||
33633221|NCT00385671|102208777|FG002|Overall Study|Protocol Violation|1|||
33633222|NCT00385671|102208775|FG000|Overall Study|Sponsor Decision|2|||
33633223|NCT00385671|102208776|FG001|Overall Study|Sponsor Decision|2|||
33633224|NCT00385671|102208777|FG002|Overall Study|Sponsor Decision|1|||
33633225|NCT00385671|102208775|FG000|Overall Study|Withdrawal by Subject|4|||
33633226|NCT00385671|102208776|FG001|Overall Study|Withdrawal by Subject|4|||
33633227|NCT00385671|102208777|FG002|Overall Study|Withdrawal by Subject|4|||
33633228|NCT01668784|102208778|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
33633229|NCT01668784|102208779|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
33633230|NCT01668784|102208778|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
33633231|NCT01668784|102208779|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
33633232|NCT01668784|102208778|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
33633233|NCT01668784|102208779|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
33633234|NCT01668784|102208778|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
33633235|NCT01668784|102208779|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
33633236|NCT01668784|102208778|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
33633237|NCT01668784|102208779|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
33633238|NCT01668784|102208778|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
33633239|NCT01668784|102208779|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
33633240|NCT01668784|102208778|FG000|Treatment Period|Disease Progression|316|||
33633241|NCT01668784|102208779|FG001|Treatment Period|Disease Progression|293|||
33633242|NCT01668784|102208778|FG000|Treatment Period|Study Drug Toxicity|46|||
33633243|NCT01668784|102208779|FG001|Treatment Period|Study Drug Toxicity|53|||
33633244|NCT01668784|102208778|FG000|Treatment Period|Death|1|||
33633245|NCT01668784|102208779|FG001|Treatment Period|Death|1|||
33633246|NCT01668784|102208778|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
33633247|NCT01668784|102208779|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
33633248|NCT01668784|102208778|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
33633249|NCT01668784|102208779|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
33633250|NCT01668784|102208778|FG000|Treatment Period|Withdrawal by Subject|5|||
33633251|NCT01668784|102208779|FG001|Treatment Period|Withdrawal by Subject|3|||
33633252|NCT01668784|102208778|FG000|Treatment Period|Maximal Clinical Benefit|3|||
33633253|NCT01668784|102208779|FG001|Treatment Period|Maximal Clinical Benefit|3|||
33633254|NCT01668784|102208778|FG000|Treatment Period|Other|2|||
33418287|NCT01933932|101422362|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33418288|NCT01933932|101422363|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33633255|NCT01668784|102208779|FG001|Treatment Period|Other|8|||
33633256|NCT01668784|102208778|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
33633257|NCT01668784|102208779|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
33633258|NCT00910650|102208780|FG000|Overall Study|Death|2|||
33633259|NCT02023086|102208781|FG000|Overall Study|Withdrawal by Subject|2|||
33633260|NCT02023086|102208782|FG001|Overall Study|Withdrawal by Subject|0|||
33633261|NCT02992288|102208786|FG000|Overall Study|Adverse Event|8|||
33633262|NCT02992288|102208787|FG001|Overall Study|Adverse Event|2|||
33366518|NCT02702193|101227389|FG000|8 Month Follow up|Lost to Follow-up|14|||
33366519|NCT02702193|101227390|FG001|8 Month Follow up|Lost to Follow-up|18|||
33366520|NCT02702193|101227389|FG000|12 Month Follow up|Withdrawal by Subject|1|||
33570476|NCT03612570|101982546|FG000|Overall Study|Lost to Follow-up|1|||
33570477|NCT03950856|101982547|FG000|Overall Study|Death|1|||
33570478|NCT03950856|101982548|FG001|Overall Study|Death|2|||
33570479|NCT03950856|101982549|FG002|Overall Study|Death|0|||
33570480|NCT03950856|101982550|FG003|Overall Study|Death|0|||
33570481|NCT03950856|101982547|FG000|Overall Study|Lost to Follow-up|5|||
33570482|NCT03950856|101982548|FG001|Overall Study|Lost to Follow-up|6|||
33570483|NCT03950856|101982549|FG002|Overall Study|Lost to Follow-up|8|||
33570484|NCT03950856|101982550|FG003|Overall Study|Lost to Follow-up|2|||
33570485|NCT03950856|101982547|FG000|Overall Study|Protocol Violation|2|||
33570486|NCT03950856|101982548|FG001|Overall Study|Protocol Violation|0|||
33570487|NCT03950856|101982549|FG002|Overall Study|Protocol Violation|0|||
33570488|NCT03950856|101982550|FG003|Overall Study|Protocol Violation|1|||
33570489|NCT03950856|101982547|FG000|Overall Study|Withdrawal by Subject|4|||
33570490|NCT03950856|101982548|FG001|Overall Study|Withdrawal by Subject|1|||
33570491|NCT03950856|101982549|FG002|Overall Study|Withdrawal by Subject|3|||
33570492|NCT03950856|101982550|FG003|Overall Study|Withdrawal by Subject|1|||
33570493|NCT03950856|101982547|FG000|Overall Study|Unable to phone|7|||
33570494|NCT03950856|101982548|FG001|Overall Study|Unable to phone|6|||
33570495|NCT03950856|101982549|FG002|Overall Study|Unable to phone|7|||
33570496|NCT03950856|101982550|FG003|Overall Study|Unable to phone|2|||
33570497|NCT01968980|101982555|FG000|Overall Study|Death|0|||
33570498|NCT01968980|101982556|FG001|Overall Study|Death|1|||
33570499|NCT01968980|101982555|FG000|Overall Study|Adverse Event|1|||
33570500|NCT01968980|101982556|FG001|Overall Study|Adverse Event|3|||
33570501|NCT01968980|101982555|FG000|Overall Study|Does not meet entry criteria|1|||
33570502|NCT01968980|101982556|FG001|Overall Study|Does not meet entry criteria|3|||
33570503|NCT01968980|101982555|FG000|Overall Study|Withdrawal by Subject|13|||
33570504|NCT01968980|101982556|FG001|Overall Study|Withdrawal by Subject|5|||
33570505|NCT01968980|101982555|FG000|Overall Study|Other unspecified|1|||
33570506|NCT01968980|101982556|FG001|Overall Study|Other unspecified|2|||
33570507|NCT03243084|101982557|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
33570508|NCT03243084|101982558|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
33570509|NCT01378195|101982559|FG000|Overall Study|Lost to Follow-up|29|||
33570510|NCT01378195|101982560|FG001|Overall Study|Lost to Follow-up|18|||
33570511|NCT02660229|101982561|FG000|Overall Study|Adverse Event|2|||
33570512|NCT02660229|101982562|FG001|Overall Study|Adverse Event|0|||
33570513|NCT02660229|101982561|FG000|Overall Study|Withdrawal by Subject|0|||
33570514|NCT02660229|101982562|FG001|Overall Study|Withdrawal by Subject|1|||
33570515|NCT03801525|101982563|FG000|Overall Study|Adverse Event|17|||
33570516|NCT03801525|101982564|FG001|Overall Study|Adverse Event|1|||
33570517|NCT03801525|101982565|FG002|Overall Study|Adverse Event|0|||
33570518|NCT03801525|101982563|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
33366521|NCT02702193|101227390|FG001|12 Month Follow up|Withdrawal by Subject|0|||
33366522|NCT02702193|101227389|FG000|12 Month Follow up|Lost to Follow-up|16|||
33570519|NCT03801525|101982564|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
33570520|NCT03801525|101982565|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
33570521|NCT03801525|101982563|FG000|Overall Study|Death|29|||
33366523|NCT02702193|101227390|FG001|12 Month Follow up|Lost to Follow-up|18|||
33366524|NCT02090114|101227391|FG000|Overall Study|Withdrawal by Subject|3|||
33570522|NCT03801525|101982564|FG001|Overall Study|Death|1|||
33570523|NCT03801525|101982565|FG002|Overall Study|Death|4|||
33633263|NCT02992288|102208788|FG002|Overall Study|Adverse Event|2|||
33633264|NCT02992288|102208789|FG003|Overall Study|Adverse Event|2|||
33633265|NCT02992288|102208790|FG004|Overall Study|Adverse Event|2|||
33633266|NCT02992288|102208791|FG005|Overall Study|Adverse Event|7|||
33633267|NCT02992288|102208786|FG000|Overall Study|Non-compliance with study drug|0|||
33633268|NCT02992288|102208787|FG001|Overall Study|Non-compliance with study drug|1|||
33633269|NCT02992288|102208788|FG002|Overall Study|Non-compliance with study drug|1|||
33633270|NCT02992288|102208789|FG003|Overall Study|Non-compliance with study drug|0|||
33633271|NCT02992288|102208790|FG004|Overall Study|Non-compliance with study drug|1|||
33633272|NCT02992288|102208791|FG005|Overall Study|Non-compliance with study drug|0|||
33633273|NCT02992288|102208786|FG000|Overall Study|Physician Decision|3|||
33633274|NCT02992288|102208787|FG001|Overall Study|Physician Decision|0|||
33418289|NCT01066039|101422364|FG000|Overall Study|Adverse Event|6|||
33418290|NCT01066039|101422364|FG000|Overall Study|Withdrawal by Subject|17|||
33418291|NCT01066039|101422364|FG000|Overall Study|Protocol Violation|2|||
33570524|NCT03801525|101982563|FG000|Overall Study|Disease Progression|6|||
33570525|NCT03801525|101982564|FG001|Overall Study|Disease Progression|0|||
33570526|NCT03801525|101982565|FG002|Overall Study|Disease Progression|1|||
33570527|NCT03801525|101982563|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
33570528|NCT03801525|101982564|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
33570529|NCT03801525|101982565|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
33570530|NCT03801525|101982563|FG000|Overall Study|Investigator Decision|18|||
33570531|NCT03801525|101982564|FG001|Overall Study|Investigator Decision|1|||
33570532|NCT03801525|101982565|FG002|Overall Study|Investigator Decision|0|||
33570533|NCT03801525|101982563|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
33570534|NCT03801525|101982564|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
33227701|NCT00674323|100735654|FG002|Overall Study|Adverse Event|0|||
33227702|NCT00674323|100735652|FG000|Overall Study|Protocol Violation|1|||
33227703|NCT00674323|100735653|FG001|Overall Study|Protocol Violation|0|||
33227704|NCT00674323|100735654|FG002|Overall Study|Protocol Violation|0|||
33227705|NCT00885352|100735659|FG000|Overall Study|Adverse Event|2|||
33418292|NCT01066039|101422364|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
33633275|NCT02992288|102208788|FG002|Overall Study|Physician Decision|1|||
33633276|NCT02992288|102208789|FG003|Overall Study|Physician Decision|0|||
33227706|NCT00885352|100735660|FG001|Overall Study|Adverse Event|3|||
33633277|NCT02992288|102208790|FG004|Overall Study|Physician Decision|0|||
33633278|NCT02992288|102208791|FG005|Overall Study|Physician Decision|1|||
33633279|NCT02992288|102208786|FG000|Overall Study|Death|2|||
33227707|NCT00885352|100735659|FG000|Overall Study|Lost to Follow-up|2|||
33418293|NCT01066039|101422364|FG000|Overall Study|Investigator's Request|1|||
33570535|NCT03801525|101982565|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
33570536|NCT03801525|101982563|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
33570537|NCT03801525|101982564|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
33570538|NCT03801525|101982565|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
33570539|NCT03801525|101982563|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
33570540|NCT03801525|101982564|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
33570541|NCT03801525|101982565|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
33570542|NCT03801525|101982563|FG000|Overall Study|Withdrawal of Subject Consent|38|||
33570543|NCT03801525|101982564|FG001|Overall Study|Withdrawal of Subject Consent|2|||
33570544|NCT03801525|101982565|FG002|Overall Study|Withdrawal of Subject Consent|1|||
33570545|NCT03801525|101982563|FG000|Overall Study|Reason not Specified|4|||
33570546|NCT03801525|101982564|FG001|Overall Study|Reason not Specified|0|||
33570547|NCT03801525|101982565|FG002|Overall Study|Reason not Specified|4|||
33570548|NCT00163189|101982568|FG000|Overall Study|Other|6|||
33633280|NCT02992288|102208787|FG001|Overall Study|Death|0|||
33633281|NCT02992288|102208788|FG002|Overall Study|Death|2|||
33633282|NCT02992288|102208789|FG003|Overall Study|Death|1|||
33633283|NCT02992288|102208790|FG004|Overall Study|Death|2|||
33633284|NCT02992288|102208791|FG005|Overall Study|Death|0|||
33633285|NCT02992288|102208786|FG000|Overall Study|Lost to Follow-up|0|||
33633286|NCT02992288|102208787|FG001|Overall Study|Lost to Follow-up|0|||
33633287|NCT02992288|102208788|FG002|Overall Study|Lost to Follow-up|0|||
33633288|NCT02992288|102208789|FG003|Overall Study|Lost to Follow-up|1|||
33633289|NCT02992288|102208790|FG004|Overall Study|Lost to Follow-up|0|||
33633290|NCT02992288|102208791|FG005|Overall Study|Lost to Follow-up|0|||
33633291|NCT02992288|102208786|FG000|Overall Study|Protocol Violation|0|||
33633292|NCT02992288|102208787|FG001|Overall Study|Protocol Violation|0|||
33633293|NCT02992288|102208788|FG002|Overall Study|Protocol Violation|0|||
33633294|NCT02992288|102208789|FG003|Overall Study|Protocol Violation|0|||
33633295|NCT02992288|102208790|FG004|Overall Study|Protocol Violation|0|||
33633296|NCT02992288|102208791|FG005|Overall Study|Protocol Violation|1|||
33633297|NCT02992288|102208786|FG000|Overall Study|Withdrawal by Subject|4|||
33633298|NCT02992288|102208787|FG001|Overall Study|Withdrawal by Subject|2|||
33633299|NCT02992288|102208788|FG002|Overall Study|Withdrawal by Subject|1|||
33633300|NCT02992288|102208789|FG003|Overall Study|Withdrawal by Subject|5|||
33633301|NCT02992288|102208790|FG004|Overall Study|Withdrawal by Subject|3|||
33633302|NCT02992288|102208791|FG005|Overall Study|Withdrawal by Subject|4|||
33366525|NCT02090114|101227392|FG001|Overall Study|Withdrawal by Subject|6|||
33633303|NCT03413891|102208792|FG000|Overall Study|Lost to Follow-up|2|||
33366526|NCT02090114|101227393|FG002|Overall Study|Withdrawal by Subject|2|||
33366527|NCT02090114|101227394|FG003|Overall Study|Withdrawal by Subject|1|||
33366528|NCT02090114|101227391|FG000|Overall Study|Physician Decision|5|||
33366529|NCT02090114|101227392|FG001|Overall Study|Physician Decision|0|||
33366530|NCT02090114|101227393|FG002|Overall Study|Physician Decision|1|||
33366531|NCT02090114|101227394|FG003|Overall Study|Physician Decision|1|||
33366532|NCT02090114|101227391|FG000|Overall Study|Adverse Event|1|||
33366533|NCT02090114|101227392|FG001|Overall Study|Adverse Event|2|||
33366534|NCT02090114|101227393|FG002|Overall Study|Adverse Event|2|||
33366535|NCT02090114|101227394|FG003|Overall Study|Adverse Event|0|||
33366536|NCT02090114|101227391|FG000|Overall Study|Progressive Disease|20|||
33366537|NCT02090114|101227392|FG001|Overall Study|Progressive Disease|21|||
33366538|NCT02090114|101227393|FG002|Overall Study|Progressive Disease|23|||
33366539|NCT02090114|101227394|FG003|Overall Study|Progressive Disease|6|||
33366540|NCT02090114|101227391|FG000|Overall Study|Death|1|||
33366541|NCT02090114|101227392|FG001|Overall Study|Death|0|||
33366542|NCT02090114|101227393|FG002|Overall Study|Death|1|||
33366543|NCT02090114|101227394|FG003|Overall Study|Death|0|||
33366544|NCT00769704|101227397|FG000|Overall Study|Lost to Follow-up|3|||
33366545|NCT00769704|101227398|FG001|Overall Study|Lost to Follow-up|2|||
33366546|NCT00769704|101227397|FG000|Overall Study|Death|95|||
33366547|NCT00769704|101227398|FG001|Overall Study|Death|190|||
33366548|NCT00769704|101227397|FG000|Overall Study|Withdrawal by Subject|12|||
33366549|NCT00769704|101227398|FG001|Overall Study|Withdrawal by Subject|5|||
33366550|NCT00769704|101227397|FG000|Overall Study|Other|1|||
33366551|NCT00769704|101227398|FG001|Overall Study|Other|2|||
33366552|NCT03648996|101227401|FG000|Overall Study|Withdrawal by Subject|0|||
33366553|NCT03648996|101227402|FG001|Overall Study|Withdrawal by Subject|2|||
33366554|NCT03648996|101227403|FG002|Overall Study|Withdrawal by Subject|2|||
33366555|NCT03648996|101227401|FG000|Overall Study|Physician Decision|2|||
33366556|NCT03648996|101227402|FG001|Overall Study|Physician Decision|0|||
33570549|NCT00163189|101982568|FG000|Overall Study|Lost to Follow-up|1|||
33633304|NCT03413891|102208793|FG001|Overall Study|Lost to Follow-up|1|||
33633305|NCT03413891|102208792|FG000|Overall Study|Protocol Violation|0|||
33366557|NCT03648996|101227403|FG002|Overall Study|Physician Decision|0|||
33366558|NCT00893113|101227404|FG000|Overall Study|Lost to Follow-up|4|||
33366559|NCT00893113|101227405|FG001|Overall Study|Lost to Follow-up|8|||
33366560|NCT00893113|101227404|FG000|Overall Study|Early Termination|1|||
33570550|NCT00163189|101982568|FG000|Overall Study|Protocol Violation|2|||
33570551|NCT00163189|101982568|FG000|Overall Study|Death|3|||
33570552|NCT00163189|101982568|FG000|Overall Study|Adverse Event|6|||
33570553|NCT00163189|101982568|FG000|Overall Study|Lack of Efficacy|7|||
33570554|NCT00163189|101982568|FG000|Overall Study|Study terminated by sponsor|11|||
33570555|NCT00163189|101982568|FG000|Overall Study|Withdrawal by Subject|11|||
33570556|NCT00163189|101982568|FG000|Overall Study|Did not meet continuation criterion|16|||
33570557|NCT00940602|101982569|FG000|Overall Study|Administrative problems|1|||
33570558|NCT00940602|101982570|FG001|Overall Study|Administrative problems|1|||
33633306|NCT03413891|102208793|FG001|Overall Study|Protocol Violation|1|||
33633307|NCT06271993|102208799|FG000|Overall Study|Not reactive to histamine|5|||
33633308|NCT06271993|102208800|FG001|Overall Study|Not reactive to histamine|5|||
33633309|NCT06271993|102208801|FG002|Overall Study|Not reactive to histamine|5|||
33633310|NCT02003924|102208802|FG000|Double-blind Phase|Lost to Follow-up|2|||
33633311|NCT02003924|102208803|FG001|Double-blind Phase|Lost to Follow-up|1|||
33633312|NCT02003924|102208804|FG002|Double-blind Phase|Lost to Follow-up|0|||
33418294|NCT01066039|101422364|FG000|Overall Study|Dropout due to Insulin Administration|1|||
33418295|NCT01066039|101422364|FG000|Overall Study|Additional Antihypertensive Required|4|||
33418296|NCT01066039|101422364|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
33418297|NCT01066039|101422364|FG000|Overall Study|Failure to Control Blood Pressure|1|||
33633313|NCT02003924|102208802|FG000|Double-blind Phase|Protocol Violation|1|||
33633314|NCT02003924|102208803|FG001|Double-blind Phase|Protocol Violation|2|||
33633315|NCT02003924|102208804|FG002|Double-blind Phase|Protocol Violation|0|||
33633316|NCT02003924|102208802|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
33633317|NCT02003924|102208803|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
33633318|NCT02003924|102208804|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
33633319|NCT02003924|102208802|FG000|Double-blind Phase|Disease Progression|229|||
33633320|NCT02003924|102208803|FG001|Double-blind Phase|Disease Progression|247|||
33633321|NCT02003924|102208804|FG002|Double-blind Phase|Disease Progression|0|||
33633322|NCT02003924|102208802|FG000|Double-blind Phase|Adverse Event|120|||
33418298|NCT01066039|101422364|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
33418299|NCT00358670|101422365|FG000|Overall Study|Adverse Event|26|||
33570559|NCT00940602|101982569|FG000|Overall Study|Patient/guardian decision|13|||
33633323|NCT02003924|102208803|FG001|Double-blind Phase|Adverse Event|31|||
33633324|NCT02003924|102208804|FG002|Double-blind Phase|Adverse Event|0|||
33633325|NCT02003924|102208802|FG000|Double-blind Phase|Randomized But not Treated|3|||
33633326|NCT02003924|102208803|FG001|Double-blind Phase|Randomized But not Treated|3|||
33633327|NCT02003924|102208804|FG002|Double-blind Phase|Randomized But not Treated|0|||
33633328|NCT02003924|102208802|FG000|Double-blind Phase|Other|29|||
33418300|NCT00358670|101422366|FG001|Overall Study|Adverse Event|29|||
33418301|NCT00358670|101422365|FG000|Overall Study|Lack of Efficacy|20|||
33570560|NCT00940602|101982570|FG001|Overall Study|Patient/guardian decision|28|||
33227708|NCT00885352|100735660|FG001|Overall Study|Lost to Follow-up|2|||
33227709|NCT00885352|100735659|FG000|Overall Study|Physician Decision|0|||
33227710|NCT00885352|100735660|FG001|Overall Study|Physician Decision|3|||
33227711|NCT00885352|100735659|FG000|Overall Study|Protocol Violation|0|||
33227712|NCT00885352|100735660|FG001|Overall Study|Protocol Violation|2|||
33227713|NCT00885352|100735659|FG000|Overall Study|Withdrawal by Subject|1|||
33227714|NCT00885352|100735660|FG001|Overall Study|Withdrawal by Subject|5|||
33227715|NCT00885352|100735659|FG000|Overall Study|Contradiction to study medication|0|||
33227716|NCT00885352|100735660|FG001|Overall Study|Contradiction to study medication|2|||
33227717|NCT00885352|100735659|FG000|Overall Study|Excluded medication|2|||
33227718|NCT00885352|100735660|FG001|Overall Study|Excluded medication|2|||
33227719|NCT00885352|100735659|FG000|Overall Study|Lab abnormalities|1|||
33227720|NCT00885352|100735660|FG001|Overall Study|Lab abnormalities|1|||
33227721|NCT02086162|100735667|FG000|Overall Study|Withdrawal by Subject|4|||
33227722|NCT02086162|100735668|FG001|Overall Study|Withdrawal by Subject|4|||
33227723|NCT02086162|100735667|FG000|Overall Study|moved|1|||
33227724|NCT02086162|100735668|FG001|Overall Study|moved|1|||
33227725|NCT02086162|100735667|FG000|Overall Study|Lost to Follow-up|4|||
33418302|NCT00358670|101422366|FG001|Overall Study|Lack of Efficacy|23|||
33418303|NCT00358670|101422365|FG000|Overall Study|Protocol Violation|6|||
33227726|NCT02086162|100735668|FG001|Overall Study|Lost to Follow-up|2|||
33227727|NCT02086162|100735667|FG000|Overall Study|Death|1|||
33227728|NCT02086162|100735668|FG001|Overall Study|Death|0|||
33227729|NCT00544544|100735670|FG000|Overall Study|Withdrawal by Subject|1|||
33227730|NCT00544544|100735670|FG000|Overall Study|Adverse Event|1|||
33227731|NCT00544544|100735670|FG000|Overall Study|Lost to Follow-up|1|||
33227732|NCT00308737|100735674|FG000|Overall Study|Adverse Event|104|||
33418304|NCT00358670|101422366|FG001|Overall Study|Protocol Violation|9|||
33227733|NCT00308737|100735675|FG001|Overall Study|Adverse Event|9|||
33227734|NCT00308737|100735676|FG002|Overall Study|Adverse Event|0|||
33227735|NCT00308737|100735674|FG000|Overall Study|Death|4|||
33227736|NCT00308737|100735675|FG001|Overall Study|Death|3|||
33227737|NCT00308737|100735676|FG002|Overall Study|Death|0|||
33227738|NCT00308737|100735674|FG000|Overall Study|Lost to Follow-up|56|||
33227739|NCT00308737|100735675|FG001|Overall Study|Lost to Follow-up|80|||
33227740|NCT00308737|100735676|FG002|Overall Study|Lost to Follow-up|5|||
33227741|NCT00308737|100735674|FG000|Overall Study|Physician Decision|15|||
33227742|NCT00308737|100735675|FG001|Overall Study|Physician Decision|2|||
33227743|NCT00308737|100735676|FG002|Overall Study|Physician Decision|1|||
33227744|NCT00308737|100735674|FG000|Overall Study|Protocol Violation|34|||
33227745|NCT00308737|100735675|FG001|Overall Study|Protocol Violation|9|||
33227746|NCT00308737|100735676|FG002|Overall Study|Protocol Violation|5|||
33227747|NCT00308737|100735674|FG000|Overall Study|Withdrawal by Subject|218|||
33227748|NCT00308737|100735675|FG001|Overall Study|Withdrawal by Subject|166|||
33227749|NCT00308737|100735676|FG002|Overall Study|Withdrawal by Subject|18|||
33227750|NCT00308737|100735674|FG000|Overall Study|Various|32|||
33227751|NCT00308737|100735675|FG001|Overall Study|Various|20|||
33227752|NCT00308737|100735676|FG002|Overall Study|Various|8|||
33227753|NCT01306201|100735677|FG000|Overall Study|Arrhythmia|4|||
33227754|NCT01306201|100735677|FG000|Overall Study|Files could not be processed|3|||
33227755|NCT01306201|100735677|FG000|Overall Study|Files unreadable|3|||
33227756|NCT01821898|100735678|FG000|Overall Study|Withdrawal by Subject|2|||
33227757|NCT01821898|100735679|FG001|Overall Study|Withdrawal by Subject|1|||
33227758|NCT00672958|100735680|FG000|Overall Study|Adverse Event|11|||
33227759|NCT00672958|100735681|FG001|Overall Study|Adverse Event|9|||
33227760|NCT00672958|100735680|FG000|Overall Study|Lack of Efficacy|6|||
33227761|NCT00672958|100735681|FG001|Overall Study|Lack of Efficacy|11|||
33227762|NCT00672958|100735680|FG000|Overall Study|Non-compliance with study drug|2|||
33227763|NCT00672958|100735681|FG001|Overall Study|Non-compliance with study drug|3|||
33227764|NCT00672958|100735680|FG000|Overall Study|Protocol deviations|11|||
33227765|NCT00672958|100735681|FG001|Overall Study|Protocol deviations|5|||
33227766|NCT00672958|100735680|FG000|Overall Study|Voluntary withdrawal|12|||
33227767|NCT00672958|100735681|FG001|Overall Study|Voluntary withdrawal|8|||
33227768|NCT00672958|100735680|FG000|Overall Study|Lost to Follow-up|22|||
33227769|NCT00672958|100735681|FG001|Overall Study|Lost to Follow-up|17|||
33227770|NCT00672958|100735680|FG000|Overall Study|Reason not specified|0|||
33227771|NCT00672958|100735681|FG001|Overall Study|Reason not specified|3|||
33227772|NCT01302938|100735684|FG000|Overall Study|Withdrawal by Subject|1|||
33227773|NCT01302938|100735685|FG001|Overall Study|Withdrawal by Subject|0|||
33227774|NCT01302938|100735684|FG000|Overall Study|Adverse Event|1|||
33227775|NCT01302938|100735685|FG001|Overall Study|Adverse Event|0|||
33227776|NCT02712398|100735692|FG000|Overall Study|Withdrawal by Subject|6|||
33227777|NCT02712398|100735692|FG000|Overall Study|Lost to Follow-up|6|||
33227778|NCT02712398|100735692|FG000|Overall Study|Sponsor Decision|1|||
33227779|NCT02712398|100735692|FG000|Overall Study|Physician Decision|1|||
33227780|NCT02712398|100735692|FG000|Overall Study|Death|2|||
33227781|NCT02712398|100735692|FG000|Overall Study|Re-operation|21|||
33227782|NCT01027364|100735705|FG000|Overall Study|Adverse Event|1|||
33227783|NCT01027364|100735706|FG001|Overall Study|Adverse Event|0|||
33227784|NCT01027364|100735707|FG002|Overall Study|Adverse Event|1|||
33227785|NCT01027364|100735708|FG003|Overall Study|Adverse Event|0|||
33570561|NCT00940602|101982569|FG000|Overall Study|Physician Decision|8|||
33570562|NCT00940602|101982570|FG001|Overall Study|Physician Decision|5|||
33227786|NCT01027364|100735705|FG000|Overall Study|Lost to Follow-up|1|||
33227787|NCT01027364|100735706|FG001|Overall Study|Lost to Follow-up|0|||
33227788|NCT01027364|100735707|FG002|Overall Study|Lost to Follow-up|0|||
33227789|NCT01027364|100735708|FG003|Overall Study|Lost to Follow-up|0|||
33570563|NCT00940602|101982569|FG000|Overall Study|Pregnancy|1|||
33227790|NCT01027364|100735705|FG000|Overall Study|Protocol Violation|1|||
33227791|NCT01027364|100735706|FG001|Overall Study|Protocol Violation|0|||
33227792|NCT01027364|100735707|FG002|Overall Study|Protocol Violation|0|||
33418305|NCT00358670|101422365|FG000|Overall Study|Lost to Follow-up|4|||
33570564|NCT00940602|101982570|FG001|Overall Study|Pregnancy|0|||
33418306|NCT00358670|101422366|FG001|Overall Study|Lost to Follow-up|5|||
33570565|NCT00940602|101982569|FG000|Overall Study|Protocol Deviation (untreated)|1|||
33227793|NCT01027364|100735708|FG003|Overall Study|Protocol Violation|1|||
33227794|NCT01027364|100735705|FG000|Overall Study|Withdrawal by Subject|1|||
33227795|NCT01027364|100735706|FG001|Overall Study|Withdrawal by Subject|2|||
33227796|NCT01027364|100735707|FG002|Overall Study|Withdrawal by Subject|0|||
33227797|NCT01027364|100735708|FG003|Overall Study|Withdrawal by Subject|0|||
33633329|NCT02003924|102208803|FG001|Double-blind Phase|Other|50|||
33633330|NCT02003924|102208804|FG002|Double-blind Phase|Other|0|||
33633331|NCT02003924|102208802|FG000|Open-label Phase|Lost to Follow-up|0|||
33633332|NCT02003924|102208803|FG001|Open-label Phase|Lost to Follow-up|0|||
33633333|NCT02003924|102208804|FG002|Open-label Phase|Lost to Follow-up|1|||
33633334|NCT02003924|102208802|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
33633335|NCT02003924|102208803|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
33633336|NCT02003924|102208804|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
33633337|NCT02003924|102208802|FG000|Open-label Phase|Disease Progression|59|||
33633338|NCT02003924|102208803|FG001|Open-label Phase|Disease Progression|0|||
33633339|NCT02003924|102208804|FG002|Open-label Phase|Disease Progression|5|||
33633340|NCT02003924|102208802|FG000|Open-label Phase|Adverse Event|25|||
33633341|NCT02003924|102208803|FG001|Open-label Phase|Adverse Event|0|||
33418307|NCT00358670|101422365|FG000|Overall Study|Withdrawal by Subject|13|||
33418308|NCT00358670|101422366|FG001|Overall Study|Withdrawal by Subject|24|||
33418309|NCT00358670|101422365|FG000|Overall Study|Protocol Defined Clinical Event|0|||
33418310|NCT00358670|101422366|FG001|Overall Study|Protocol Defined Clinical Event|1|||
33418311|NCT00358670|101422365|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
33418312|NCT00358670|101422366|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
33418313|NCT00358670|101422365|FG000|Overall Study|Administrative|153|||
33418314|NCT00358670|101422366|FG001|Overall Study|Administrative|125|||
33418315|NCT03443973|101422367|FG000|Double-blind Treatment Period|Adverse Event|5|||
33418316|NCT03443973|101422368|FG001|Double-blind Treatment Period|Adverse Event|19|||
33418317|NCT03443973|101422369|FG002|Double-blind Treatment Period|Adverse Event|0|||
33418318|NCT03443973|101422370|FG003|Double-blind Treatment Period|Adverse Event|0|||
33418319|NCT03443973|101422367|FG000|Double-blind Treatment Period|Death|5|||
33418320|NCT03443973|101422368|FG001|Double-blind Treatment Period|Death|7|||
33418321|NCT03443973|101422369|FG002|Double-blind Treatment Period|Death|0|||
33418322|NCT03443973|101422370|FG003|Double-blind Treatment Period|Death|0|||
33418323|NCT03443973|101422367|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
33418324|NCT03443973|101422368|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
33418325|NCT03443973|101422369|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
33418326|NCT03443973|101422370|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
33418327|NCT03443973|101422367|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
33418328|NCT03443973|101422368|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
33418329|NCT03443973|101422369|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
33633342|NCT02003924|102208804|FG002|Open-label Phase|Adverse Event|10|||
33633343|NCT02003924|102208802|FG000|Open-label Phase|Other|7|||
33633344|NCT02003924|102208803|FG001|Open-label Phase|Other|0|||
33633345|NCT02003924|102208804|FG002|Open-label Phase|Other|0|||
33418330|NCT03443973|101422370|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
33418331|NCT03443973|101422367|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
33418332|NCT03443973|101422368|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
33633346|NCT02003924|102208802|FG000|Long-term Follow-up Phase|Death|288|||
33366561|NCT00893113|101227405|FG001|Overall Study|Early Termination|1|||
33570566|NCT00940602|101982570|FG001|Overall Study|Protocol Deviation (untreated)|0|||
33570567|NCT00940602|101982569|FG000|Overall Study|Disease progression|8|||
33570568|NCT00940602|101982570|FG001|Overall Study|Disease progression|2|||
33366562|NCT00893113|101227404|FG000|Overall Study|Withdrew Consent|8|||
33366563|NCT00893113|101227405|FG001|Overall Study|Withdrew Consent|7|||
33633347|NCT02003924|102208803|FG001|Long-term Follow-up Phase|Death|174|||
33570569|NCT00940602|101982569|FG000|Overall Study|Death|38|||
33366564|NCT01519427|101227409|FG000|Overall Study|disease progression|2|||
33570570|NCT00940602|101982570|FG001|Overall Study|Death|19|||
33570571|NCT00940602|101982569|FG000|Overall Study|Lost to Follow-up|3|||
33570572|NCT00940602|101982570|FG001|Overall Study|Lost to Follow-up|1|||
33570573|NCT00940602|101982569|FG000|Overall Study|Patient withdrew consent|26|||
33570574|NCT00940602|101982570|FG001|Overall Study|Patient withdrew consent|13|||
33570575|NCT00940602|101982569|FG000|Overall Study|Adverse Event|7|||
33570576|NCT00940602|101982570|FG001|Overall Study|Adverse Event|2|||
33570577|NCT00940602|101982569|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
33570578|NCT00940602|101982570|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
33570579|NCT00718315|101982573|FG000|Overall Study|Adverse Event|1|||
33570580|NCT00718315|101982574|FG001|Overall Study|Adverse Event|2|||
33570581|NCT00718315|101982575|FG002|Overall Study|Adverse Event|3|||
33570582|NCT00718315|101982573|FG000|Overall Study|Death|6|||
33570583|NCT00718315|101982574|FG001|Overall Study|Death|6|||
33570584|NCT00718315|101982575|FG002|Overall Study|Death|5|||
33570585|NCT00718315|101982573|FG000|Overall Study|Lost to Follow-up|2|||
33570586|NCT00718315|101982574|FG001|Overall Study|Lost to Follow-up|3|||
33633348|NCT02003924|102208804|FG002|Long-term Follow-up Phase|Death|4|||
33633349|NCT02003924|102208802|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
33633350|NCT02003924|102208803|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
33633351|NCT02003924|102208804|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
33633352|NCT02003924|102208802|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
33633353|NCT02003924|102208803|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
33633354|NCT02003924|102208804|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
33633355|NCT02003924|102208802|FG000|Long-term Follow-up Phase|Other|5|||
33633356|NCT02003924|102208803|FG001|Long-term Follow-up Phase|Other|2|||
33633357|NCT02003924|102208804|FG002|Long-term Follow-up Phase|Other|1|||
33633358|NCT00762164|102208806|FG000|Overall Study|Lost to Follow-up|1|||
33570587|NCT00718315|101982575|FG002|Overall Study|Lost to Follow-up|4|||
33570588|NCT00718315|101982573|FG000|Overall Study|Protocol Violation|5|||
33570589|NCT00718315|101982574|FG001|Overall Study|Protocol Violation|5|||
33570590|NCT00718315|101982575|FG002|Overall Study|Protocol Violation|3|||
33570591|NCT00718315|101982573|FG000|Overall Study|Erlotinib dose decreased|4|||
33227798|NCT01375205|100735709|FG000|Overall Study|Lost to Follow-up|15|||
33227799|NCT01375205|100735710|FG001|Overall Study|Lost to Follow-up|12|||
33227800|NCT01375205|100735709|FG000|Overall Study|Withdrawal by Subject|6|||
33227801|NCT01375205|100735710|FG001|Overall Study|Withdrawal by Subject|1|||
33227802|NCT01913639|100735711|FG000|Overall Study|Not Eligible|3|||
33227803|NCT01719237|100735712|FG000|Overall Study|Physician Decision|0|||
33227804|NCT01719237|100735713|FG001|Overall Study|Physician Decision|1|||
33227805|NCT01862991|100735714|FG000|Overall Study|Lost to Follow-up|2|||
33227806|NCT01862991|100735715|FG001|Overall Study|Lost to Follow-up|1|||
33227807|NCT01862991|100735716|FG002|Overall Study|Lost to Follow-up|1|||
33227808|NCT01862991|100735714|FG000|Overall Study|Protocol Violation|1|||
33227809|NCT01862991|100735715|FG001|Overall Study|Protocol Violation|0|||
33227810|NCT01862991|100735716|FG002|Overall Study|Protocol Violation|0|||
33227811|NCT00957931|100735717|FG000|Overall Study|Death|4|||
33227812|NCT03283696|100735718|FG000|Overall Study|Physician Decision|5|||
33227813|NCT03283696|100735719|FG001|Overall Study|Physician Decision|6|||
33227814|NCT03283696|100735718|FG000|Overall Study|Withdrawal by Subject|2|||
33227815|NCT03283696|100735719|FG001|Overall Study|Withdrawal by Subject|0|||
33227816|NCT04250337|100735722|FG000|Overall Study|Adverse Event|0|||
33227817|NCT04250337|100735723|FG001|Overall Study|Adverse Event|3|||
33227818|NCT04250337|100735722|FG000|Overall Study|Lack of Efficacy|1|||
33227819|NCT04250337|100735723|FG001|Overall Study|Lack of Efficacy|3|||
33227820|NCT04250337|100735722|FG000|Overall Study|Physician Decision|1|||
33227821|NCT04250337|100735723|FG001|Overall Study|Physician Decision|0|||
33227822|NCT04250337|100735722|FG000|Overall Study|Protocol Deviation|2|||
33227823|NCT04250337|100735723|FG001|Overall Study|Protocol Deviation|2|||
33227824|NCT04250337|100735722|FG000|Overall Study|Withdrawal by Subject|4|||
33227825|NCT04250337|100735723|FG001|Overall Study|Withdrawal by Subject|3|||
33227826|NCT00409786|100735724|FG000|Overall Study|Withdrawal by Subject|3|||
33227827|NCT02635724|100735725|FG000|Overall Study|Withdrawal by Subject|0|||
33227828|NCT02635724|100735726|FG001|Overall Study|Withdrawal by Subject|1|||
33227829|NCT02635724|100735727|FG002|Overall Study|Withdrawal by Subject|0|||
33227830|NCT01320735|100735728|FG000|Overall Study|Adverse Event|3|||
33227831|NCT01320735|100735728|FG000|Overall Study|Withdrawal by Subject|3|||
33227832|NCT01320735|100735728|FG000|Overall Study|Lost to Follow-up|13|||
33227833|NCT01320735|100735728|FG000|Overall Study|Administrative Reason|6|||
33227834|NCT01320735|100735728|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
33227835|NCT01320735|100735728|FG000|Overall Study|Protocol Violation|1|||
33227836|NCT01320735|100735728|FG000|Overall Study|Other|1|||
33227837|NCT01320735|100735728|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
33227838|NCT01320735|100735728|FG000|Overall Study|Investigator Unable to be Contacted|17|||
33227839|NCT04182880|100735729|FG000|Overall Study|Pregnancy|1|||
33227840|NCT04182880|100735730|FG001|Overall Study|Pregnancy|0|||
33227841|NCT00068380|100735734|FG000|Overall Study|Withdrawal by Subject|3|||
33227842|NCT00068380|100735734|FG000|Overall Study|Adverse Event|2|||
33227843|NCT03321006|100735735|FG000|Overall Study|Death|1|||
33227844|NCT03321006|100735736|FG001|Overall Study|Death|0|||
33227845|NCT03321006|100735735|FG000|Overall Study|Lack of Efficacy|1|||
33227846|NCT03321006|100735736|FG001|Overall Study|Lack of Efficacy|0|||
33227847|NCT01679301|100735737|FG000|Screening Period|screen failure|3|||
33633359|NCT00762164|102208807|FG001|Overall Study|Lost to Follow-up|1|||
33633360|NCT00762164|102208806|FG000|Overall Study|Discontinued medication|2|||
33633361|NCT00762164|102208807|FG001|Overall Study|Discontinued medication|0|||
33633362|NCT00762164|102208806|FG000|Overall Study|Withdrawal by Subject|0|||
33633363|NCT00762164|102208807|FG001|Overall Study|Withdrawal by Subject|1|||
33633364|NCT01980017|102208810|FG000|Overall Study|Lost to Follow-up|30|||
33633365|NCT01980017|102208811|FG001|Overall Study|Lost to Follow-up|21|||
33633366|NCT01980017|102208810|FG000|Overall Study|Death|0|||
33633367|NCT01980017|102208811|FG001|Overall Study|Death|1|||
33633368|NCT01838694|102208813|FG000|Overall Study|Adverse Event|0|||
33227848|NCT01679301|100735738|FG001|Screening Period|screen failure|0|||
33227849|NCT01679301|100735739|FG002|Screening Period|screen failure|0|||
33227850|NCT01346514|100735740|FG000|Overall Study|Lost to Follow-up|19|||
33227851|NCT01346514|100735741|FG001|Overall Study|Lost to Follow-up|30|||
33633369|NCT01838694|102208814|FG001|Overall Study|Adverse Event|1|||
33633370|NCT04456504|102208815|FG000|Overall Study|Lost to Follow-up|2|||
33633371|NCT02063724|102208816|FG000|Overall Study|Disease progression|1|||
33633372|NCT00904982|102211807|FG000|Overall Study|Withdrawal by Subject|2|||
33633373|NCT00904982|102211808|FG001|Overall Study|Withdrawal by Subject|0|||
33633374|NCT00904982|102211809|FG002|Overall Study|Withdrawal by Subject|0|||
33633375|NCT00904982|102211810|FG003|Overall Study|Withdrawal by Subject|0|||
33633376|NCT00665652|102211811|FG000|Overall Study|Adverse Event|4|||
33633377|NCT00665652|102211811|FG000|Overall Study|Death|1|||
33633378|NCT00665652|102211811|FG000|Overall Study|No longer met inclusion criteria.|1|||
33633379|NCT02603887|102211818|FG000|Stage 1|Adverse Event|4|||
33418333|NCT03443973|101422369|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
33418334|NCT03443973|101422370|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
33418335|NCT03443973|101422367|FG000|Double-blind Treatment Period|Physician Decision|5|||
33418336|NCT03443973|101422368|FG001|Double-blind Treatment Period|Physician Decision|6|||
33418337|NCT03443973|101422369|FG002|Double-blind Treatment Period|Physician Decision|0|||
33418338|NCT03443973|101422370|FG003|Double-blind Treatment Period|Physician Decision|0|||
33418339|NCT03443973|101422367|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
33418340|NCT03443973|101422368|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
33418341|NCT03443973|101422369|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
33418342|NCT03443973|101422370|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
33418343|NCT03443973|101422367|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
33418344|NCT03443973|101422368|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
33418345|NCT03443973|101422369|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33418346|NCT03443973|101422370|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
33418347|NCT03443973|101422367|FG000|Open-label Extension Period|Reason Not Specified|0|||
33418348|NCT03443973|101422368|FG001|Open-label Extension Period|Reason Not Specified|0|||
33418349|NCT03443973|101422369|FG002|Open-label Extension Period|Reason Not Specified|3|||
33418350|NCT03443973|101422370|FG003|Open-label Extension Period|Reason Not Specified|0|||
33418351|NCT03443973|101422367|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
33570592|NCT00718315|101982574|FG001|Overall Study|Erlotinib dose decreased|3|||
33570593|NCT00718315|101982575|FG002|Overall Study|Erlotinib dose decreased|1|||
33570594|NCT00718315|101982573|FG000|Overall Study|Use of Minocyclin|1|||
33570595|NCT00718315|101982574|FG001|Overall Study|Use of Minocyclin|1|||
33633380|NCT02603887|102211818|FG000|Stage 1|Disease progression|1|||
33633381|NCT02603887|102211818|FG000|Stage 2|FDA guidance|1|||
33633382|NCT01488890|102211819|FG000|Overall Study|Serious adverse event|2|||
33633383|NCT01488890|102211820|FG001|Overall Study|Serious adverse event|0|||
33633384|NCT01488890|102211821|FG002|Overall Study|Serious adverse event|0|||
33633385|NCT01488890|102211822|FG003|Overall Study|Serious adverse event|0|||
33633386|NCT01488890|102211819|FG000|Overall Study|Protocol Violation|3|||
33633387|NCT01488890|102211820|FG001|Overall Study|Protocol Violation|0|||
33570596|NCT00718315|101982575|FG002|Overall Study|Use of Minocyclin|1|||
33570597|NCT00718315|101982573|FG000|Overall Study|Disease progression|0|||
33570598|NCT00718315|101982574|FG001|Overall Study|Disease progression|1|||
33570599|NCT00718315|101982575|FG002|Overall Study|Disease progression|1|||
33570600|NCT00718315|101982573|FG000|Overall Study|Other|0|||
33570601|NCT00718315|101982574|FG001|Overall Study|Other|0|||
33570602|NCT00718315|101982575|FG002|Overall Study|Other|1|||
33570603|NCT00718315|101982573|FG000|Overall Study|Use of ATB and Corticoids|0|||
33570604|NCT00718315|101982574|FG001|Overall Study|Use of ATB and Corticoids|1|||
33570605|NCT00718315|101982575|FG002|Overall Study|Use of ATB and Corticoids|2|||
33570606|NCT02538614|101982583|FG000|Overall Study|Progressive Disease|2|||
33570607|NCT00049543|101982586|FG000|Overall Study|still on treatment|2|||
33570608|NCT00049543|101982587|FG001|Overall Study|still on treatment|9|||
33570609|NCT04290624|101982588|FG000|Overall Study|Adverse Event|1|||
33570610|NCT04290624|101982589|FG001|Overall Study|Adverse Event|0|||
33570611|NCT02684461|101982595|FG000|Overall Study|Adverse Event|1|||
33570612|NCT02684461|101982596|FG001|Overall Study|Adverse Event|0|||
33570613|NCT02684461|101982597|FG002|Overall Study|Adverse Event|0|||
33633388|NCT01488890|102211821|FG002|Overall Study|Protocol Violation|4|||
33633389|NCT01488890|102211822|FG003|Overall Study|Protocol Violation|0|||
33633390|NCT01488890|102211819|FG000|Overall Study|Lost to Follow-up|13|||
33633391|NCT01488890|102211820|FG001|Overall Study|Lost to Follow-up|10|||
33633392|NCT01488890|102211821|FG002|Overall Study|Lost to Follow-up|20|||
33633393|NCT01488890|102211822|FG003|Overall Study|Lost to Follow-up|3|||
33570614|NCT02684461|101982595|FG000|Overall Study|Lack of Efficacy|1|||
33570615|NCT02684461|101982596|FG001|Overall Study|Lack of Efficacy|2|||
33570616|NCT02684461|101982597|FG002|Overall Study|Lack of Efficacy|0|||
33418352|NCT03443973|101422368|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
33418353|NCT03443973|101422369|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
33418354|NCT03443973|101422370|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
33570617|NCT04573972|101982603|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
33570618|NCT04573972|101982604|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
33633394|NCT01488890|102211819|FG000|Overall Study|Withdrawal by Subject|14|||
33633395|NCT01488890|102211820|FG001|Overall Study|Withdrawal by Subject|10|||
33570619|NCT04507763|101982605|FG000|Overall Study|Participants did not meet entrance criteria|201|||
33570620|NCT01209767|101982606|FG000|Overall Study|Withdrawal by Subject|1|||
33570621|NCT01209767|101982606|FG000|Overall Study|Lost to Follow-up|3|||
33570622|NCT00907621|101982609|FG000|Overall Study|Lost to Follow-up|6|||
33570623|NCT00907621|101982610|FG001|Overall Study|Lost to Follow-up|3|||
33570624|NCT00907621|101982609|FG000|Overall Study|intercurrent febrile illness|1|||
33570625|NCT00907621|101982610|FG001|Overall Study|intercurrent febrile illness|1|||
33570626|NCT03983421|101982614|FG000|Overall Study|Lost to Follow-up|1|||
33366565|NCT02452970|101227412|FG000|Overall Study|Adverse Event|1|||
33366566|NCT05258058|101227413|FG000|Overall Study|Withdrawal by Subject|2|||
33366567|NCT01996319|101227419|FG000|Overall Study|Protocol Violation|1|||
33366568|NCT01996319|101227420|FG001|Overall Study|Protocol Violation|0|||
33366569|NCT01996319|101227419|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
33366570|NCT01996319|101227420|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
33366571|NCT01996319|101227419|FG000|Overall Study|Adverse Event|2|||
33366572|NCT01996319|101227420|FG001|Overall Study|Adverse Event|2|||
33366573|NCT03792750|101227426|FG000|Overall Study|Death|3|||
33366574|NCT01070784|101227427|FG000|Overall Study|Withdrawal by Subject|6|||
33366575|NCT01070784|101227428|FG001|Overall Study|Withdrawal by Subject|9|||
33366576|NCT01070784|101227427|FG000|Overall Study|Adverse Event|14|||
33366577|NCT01070784|101227428|FG001|Overall Study|Adverse Event|9|||
33366578|NCT01505491|101227433|FG000|Overall Study|Other reason not listed|1|||
33366579|NCT01505491|101227434|FG001|Overall Study|Other reason not listed|0|||
33366580|NCT01505491|101227435|FG002|Overall Study|Other reason not listed|0|||
33366581|NCT01505491|101227433|FG000|Overall Study|Withdrawal by Subject|1|||
33366582|NCT01505491|101227434|FG001|Overall Study|Withdrawal by Subject|1|||
33366583|NCT01505491|101227435|FG002|Overall Study|Withdrawal by Subject|4|||
33366584|NCT01505491|101227433|FG000|Overall Study|Lost to Follow-up|0|||
33366585|NCT01505491|101227434|FG001|Overall Study|Lost to Follow-up|0|||
33366586|NCT01505491|101227435|FG002|Overall Study|Lost to Follow-up|1|||
33366587|NCT02433210|101227440|FG000|Overall Study|Physician Decision|1|||
33366588|NCT02433210|101227441|FG001|Overall Study|Physician Decision|0|||
33366589|NCT02433210|101227442|FG002|Overall Study|Physician Decision|0|||
33366590|NCT04328623|101227444|FG000|Overall Study|Protocol Violation|0|||
33366591|NCT04328623|101227445|FG001|Overall Study|Protocol Violation|1|||
33366592|NCT05232097|101227449|FG000|Overall Study|Physician Decision|1|||
33366593|NCT01259297|101227450|FG000|Double Blind Randomized Period|Death|1|||
33366594|NCT01259297|101227451|FG001|Double Blind Randomized Period|Death|1|||
33366595|NCT01259297|101227452|FG002|Double Blind Randomized Period|Death|1|||
33366596|NCT01259297|101227453|FG003|Double Blind Randomized Period|Death|2|||
33366597|NCT01259297|101227454|FG004|Double Blind Randomized Period|Death|1|||
33366598|NCT01259297|101227455|FG005|Double Blind Randomized Period|Death|5|||
33366599|NCT01259297|101227456|FG006|Double Blind Randomized Period|Death|2|||
33366600|NCT01259297|101227457|FG007|Double Blind Randomized Period|Death|1|||
33366601|NCT01259297|101227450|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
33366602|NCT01259297|101227451|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
33366603|NCT01259297|101227452|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
33366604|NCT01259297|101227453|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
33366605|NCT01259297|101227454|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
33366606|NCT01259297|101227455|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
33366607|NCT01259297|101227456|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
33366608|NCT01259297|101227457|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
33366609|NCT01259297|101227450|FG000|Double Blind Randomized Period|Other reasons|0|||
33366610|NCT01259297|101227451|FG001|Double Blind Randomized Period|Other reasons|1|||
33366611|NCT01259297|101227452|FG002|Double Blind Randomized Period|Other reasons|0|||
33366612|NCT01259297|101227453|FG003|Double Blind Randomized Period|Other reasons|0|||
33366613|NCT01259297|101227454|FG004|Double Blind Randomized Period|Other reasons|1|||
33366614|NCT01259297|101227455|FG005|Double Blind Randomized Period|Other reasons|2|||
33366615|NCT01259297|101227456|FG006|Double Blind Randomized Period|Other reasons|3|||
33366616|NCT01259297|101227457|FG007|Double Blind Randomized Period|Other reasons|1|||
33366617|NCT01809262|101230040|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
33366618|NCT01809262|101230041|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
33366619|NCT01809262|101230042|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
33366620|NCT01809262|101230043|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
33366621|NCT01809262|101230044|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
33570627|NCT01133847|101982615|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
33570628|NCT01133847|101982616|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
33570629|NCT01133847|101982617|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
33570630|NCT01133847|101982615|FG000|Follow-Up Phase|Lost to Follow-up|1|||
33366622|NCT01809262|101230045|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
33570631|NCT01133847|101982616|FG001|Follow-Up Phase|Lost to Follow-up|3|||
33570632|NCT01133847|101982617|FG002|Follow-Up Phase|Lost to Follow-up|7|||
33633396|NCT01488890|102211821|FG002|Overall Study|Withdrawal by Subject|11|||
33633397|NCT01488890|102211822|FG003|Overall Study|Withdrawal by Subject|2|||
33633398|NCT01774721|102211823|FG000|Overall Study|Death|133|||
33633399|NCT01774721|102211824|FG001|Overall Study|Death|152|||
33633400|NCT01774721|102211823|FG000|Overall Study|Withdrawal by Subject|20|||
33366623|NCT01809262|101230046|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
33366624|NCT01809262|101230047|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
33366625|NCT01809262|101230048|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
33366626|NCT01809262|101230049|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
33366627|NCT01809262|101230040|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33366628|NCT01809262|101230041|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
33366629|NCT01809262|101230042|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33366630|NCT01809262|101230043|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33366631|NCT01809262|101230044|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33366632|NCT01809262|101230045|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33366633|NCT01809262|101230046|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33366634|NCT01809262|101230047|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33366635|NCT01809262|101230048|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33366636|NCT01809262|101230049|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
33366637|NCT00109733|101230050|FG000|Overall Study|Protocol Violation|0|||
33366638|NCT00109733|101230051|FG001|Overall Study|Protocol Violation|1|||
33366639|NCT00109733|101230050|FG000|Overall Study|Stopped taking study drug|1|||
33366640|NCT00109733|101230051|FG001|Overall Study|Stopped taking study drug|1|||
33418355|NCT02380248|101422378|FG000|Overall Study|Lost to Follow-up|11|||
33418356|NCT02380248|101422378|FG000|Overall Study|Withdrawal by Subject|3|||
33418357|NCT03237481|101422382|FG000|Overall Study|Lost to Follow-up|1|||
33418358|NCT03237481|101422383|FG001|Overall Study|Lost to Follow-up|0|||
33418359|NCT03237481|101422384|FG002|Overall Study|Lost to Follow-up|0|||
33418360|NCT03237481|101422382|FG000|Overall Study|Protocol Violation|1|||
33418361|NCT03237481|101422383|FG001|Overall Study|Protocol Violation|0|||
33418362|NCT03237481|101422384|FG002|Overall Study|Protocol Violation|0|||
33418363|NCT03237481|101422382|FG000|Overall Study|Withdrawal by Subject|3|||
33418364|NCT03237481|101422383|FG001|Overall Study|Withdrawal by Subject|2|||
33418365|NCT03237481|101422384|FG002|Overall Study|Withdrawal by Subject|1|||
33418366|NCT03428217|101422391|FG000|Overall Study|Death|89|||
33418367|NCT03428217|101422392|FG001|Overall Study|Death|93|||
33418368|NCT03428217|101422391|FG000|Overall Study|Withdrawal by Subject|8|||
33418369|NCT03428217|101422392|FG001|Overall Study|Withdrawal by Subject|7|||
33418370|NCT03428217|101422391|FG000|Overall Study|Lost to Follow-up|1|||
33418371|NCT03428217|101422392|FG001|Overall Study|Lost to Follow-up|3|||
33418372|NCT03428217|101422391|FG000|Overall Study|Study terminated by sponsor|124|||
33418373|NCT03428217|101422392|FG001|Overall Study|Study terminated by sponsor|118|||
33418374|NCT03428217|101422391|FG000|Overall Study|Other, Not Specified|1|||
33418375|NCT03428217|101422392|FG001|Overall Study|Other, Not Specified|0|||
33227852|NCT01346514|100735740|FG000|Overall Study|Withdrawal by Subject|7|||
33227853|NCT01346514|100735741|FG001|Overall Study|Withdrawal by Subject|3|||
33227854|NCT01346514|100735740|FG000|Overall Study|Death|3|||
33227855|NCT01346514|100735741|FG001|Overall Study|Death|4|||
33227856|NCT02200939|100735742|FG000|Overall Study|Participant withdrew consent|0|||
33227857|NCT02200939|100735743|FG001|Overall Study|Participant withdrew consent|1|||
33227858|NCT02200939|100735742|FG000|Overall Study|Lost to Follow-up|2|||
33227859|NCT02200939|100735743|FG001|Overall Study|Lost to Follow-up|9|||
33227860|NCT02200939|100735742|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
33227861|NCT02200939|100735743|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
33227862|NCT01190215|100735744|FG000|Up to Month 6|Lost to Follow-up|2|||
33227863|NCT01190215|100735745|FG001|Up to Month 6|Lost to Follow-up|0|||
33227864|NCT00882921|100735746|FG000|Overall Study|Death|2|||
33227865|NCT00882921|100735746|FG000|Overall Study|Other|3|||
33227866|NCT00882921|100735746|FG000|Overall Study|Lost to Follow-up|2|||
33227867|NCT00882921|100735746|FG000|Overall Study|Termination By Investigator|3|||
33227868|NCT00882921|100735746|FG000|Overall Study|Withdrawal Of Consent|1|||
33227869|NCT02223754|100735749|FG000|Period 1|Adverse Event|1|||
33227870|NCT02223754|100735750|FG001|Period 1|Adverse Event|0|||
33227871|NCT02223754|100735749|FG000|Period 1|Lost to Follow-up|0|||
33227872|NCT02223754|100735750|FG001|Period 1|Lost to Follow-up|1|||
33227873|NCT02223754|100735749|FG000|Period 1|Protocol Violation|2|||
33227874|NCT02223754|100735750|FG001|Period 1|Protocol Violation|4|||
33227875|NCT02223754|100735749|FG000|Period 1|Withdrawal by Subject|0|||
33227876|NCT02223754|100735750|FG001|Period 1|Withdrawal by Subject|4|||
33227877|NCT02223754|100735749|FG000|Period 1|Test Article No Longer Available|1|||
33227878|NCT02223754|100735750|FG001|Period 1|Test Article No Longer Available|5|||
33227879|NCT02223754|100735749|FG000|Period 1|Unsatisfactory Visual Response|0|||
33227880|NCT02223754|100735750|FG001|Period 1|Unsatisfactory Visual Response|1|||
33227881|NCT02223754|100735749|FG000|Period 2|Adverse Event|0|||
33227882|NCT02223754|100735750|FG001|Period 2|Adverse Event|1|||
33227883|NCT02223754|100735749|FG000|Period 2|Protocol Violation|1|||
33227884|NCT02223754|100735750|FG001|Period 2|Protocol Violation|0|||
33227885|NCT02223754|100735749|FG000|Period 2|Lens Discomfort|1|||
33227886|NCT02223754|100735750|FG001|Period 2|Lens Discomfort|1|||
33227887|NCT02223754|100735749|FG000|Period 2|Lost to Follow-up|1|||
33227888|NCT02223754|100735750|FG001|Period 2|Lost to Follow-up|0|||
33227889|NCT02223754|100735749|FG000|Period 2|Test Article No Longer Available|0|||
33227890|NCT02223754|100735750|FG001|Period 2|Test Article No Longer Available|1|||
33227891|NCT02281760|100735752|FG000|Overall Study|Withdrawal by Subject|1|||
33227892|NCT02357810|100735757|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
33227893|NCT02357810|100735757|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
33227894|NCT02357810|100735757|FG000|Reached 12 Weeks Response|Adverse Event|5|||
33227895|NCT02357810|100735757|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
33366641|NCT00109733|101230050|FG000|Overall Study|Non-compliant|0|||
33227896|NCT02357810|100735757|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
33227897|NCT02357810|100735757|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
33366642|NCT00109733|101230051|FG001|Overall Study|Non-compliant|1|||
33366643|NCT00109733|101230050|FG000|Overall Study|Could not commit time for study|1|||
33366644|NCT00109733|101230051|FG001|Overall Study|Could not commit time for study|1|||
33366645|NCT05091060|101230053|FG000|Overall Study|Lost to Follow-up|1|||
33366646|NCT03242928|101230056|FG000|Overall Study|Adverse Event|2|||
33570633|NCT00725985|101982618|FG000|ITP- Treatment Disposition|Adverse Event|20|||
33227898|NCT02357810|100735757|FG000|Reached 12 Weeks Response|Death|1|||
33418376|NCT05674721|101422396|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
33418377|NCT05674721|101422397|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
33418378|NCT05674721|101422396|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
33418379|NCT05674721|101422397|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
33418380|NCT02094573|101422399|FG000|Overall Study|Adverse Event|4|||
33418381|NCT02094573|101422400|FG001|Overall Study|Adverse Event|14|||
33418382|NCT02094573|101422399|FG000|Overall Study|Clinical Progressive Disease|9|||
33418383|NCT02094573|101422400|FG001|Overall Study|Clinical Progressive Disease|13|||
33418384|NCT02094573|101422399|FG000|Overall Study|Death|11|||
33418385|NCT02094573|101422400|FG001|Overall Study|Death|3|||
33418386|NCT02094573|101422399|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
33418387|NCT02094573|101422400|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
33418388|NCT02094573|101422399|FG000|Overall Study|Non-compliance with Study Drug|1|||
33418389|NCT02094573|101422400|FG001|Overall Study|Non-compliance with Study Drug|1|||
33418390|NCT02094573|101422399|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
33418391|NCT02094573|101422400|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
33418392|NCT02094573|101422399|FG000|Overall Study|Physician Decision|4|||
33418393|NCT02094573|101422400|FG001|Overall Study|Physician Decision|4|||
33418394|NCT02094573|101422399|FG000|Overall Study|Site Terminated by Sponsor|10|||
33418395|NCT02094573|101422400|FG001|Overall Study|Site Terminated by Sponsor|17|||
33418396|NCT02094573|101422399|FG000|Overall Study|Withdrawal by Subject|6|||
33418397|NCT02094573|101422400|FG001|Overall Study|Withdrawal by Subject|8|||
33418398|NCT02094573|101422399|FG000|Overall Study|Randomized but not Treated|3|||
33418399|NCT02094573|101422400|FG001|Overall Study|Randomized but not Treated|0|||
33418400|NCT03514121|101422401|FG000|Overall Study|Withdrawal by Subject|0|||
33570634|NCT00725985|101982619|FG001|ITP- Treatment Disposition|Adverse Event|10|||
33570635|NCT00725985|101982620|FG002|ITP- Treatment Disposition|Adverse Event|5|||
33418401|NCT03514121|101422402|FG001|Overall Study|Withdrawal by Subject|0|||
33633401|NCT01774721|102211824|FG001|Overall Study|Withdrawal by Subject|14|||
33418402|NCT03514121|101422403|FG002|Overall Study|Withdrawal by Subject|0|||
33418403|NCT03514121|101422404|FG003|Overall Study|Withdrawal by Subject|0|||
33418404|NCT03514121|101422405|FG004|Overall Study|Withdrawal by Subject|1|||
33418405|NCT03514121|101422406|FG005|Overall Study|Withdrawal by Subject|2|||
33418406|NCT03514121|101422407|FG006|Overall Study|Withdrawal by Subject|1|||
33418407|NCT03514121|101422408|FG007|Overall Study|Withdrawal by Subject|1|||
33418408|NCT03514121|101422409|FG008|Overall Study|Withdrawal by Subject|7|||
33418409|NCT03514121|101422410|FG009|Overall Study|Withdrawal by Subject|2|||
33418410|NCT03514121|101422401|FG000|Overall Study|Death|0|||
33418411|NCT03514121|101422402|FG001|Overall Study|Death|0|||
33418412|NCT03514121|101422403|FG002|Overall Study|Death|0|||
33418413|NCT03514121|101422404|FG003|Overall Study|Death|0|||
33418414|NCT03514121|101422405|FG004|Overall Study|Death|0|||
33418415|NCT03514121|101422406|FG005|Overall Study|Death|3|||
33418416|NCT03514121|101422407|FG006|Overall Study|Death|2|||
33418417|NCT03514121|101422408|FG007|Overall Study|Death|1|||
33418418|NCT03514121|101422409|FG008|Overall Study|Death|26|||
33418419|NCT03514121|101422410|FG009|Overall Study|Death|3|||
33418420|NCT03514121|101422401|FG000|Overall Study|Lost to Follow-up|0|||
33418421|NCT03514121|101422402|FG001|Overall Study|Lost to Follow-up|0|||
33418422|NCT03514121|101422403|FG002|Overall Study|Lost to Follow-up|1|||
33418423|NCT03514121|101422404|FG003|Overall Study|Lost to Follow-up|0|||
33418424|NCT03514121|101422405|FG004|Overall Study|Lost to Follow-up|0|||
33418425|NCT03514121|101422406|FG005|Overall Study|Lost to Follow-up|0|||
33418426|NCT03514121|101422407|FG006|Overall Study|Lost to Follow-up|0|||
33418427|NCT03514121|101422408|FG007|Overall Study|Lost to Follow-up|0|||
33418428|NCT03514121|101422409|FG008|Overall Study|Lost to Follow-up|1|||
33418429|NCT03514121|101422410|FG009|Overall Study|Lost to Follow-up|0|||
33418430|NCT03514121|101422401|FG000|Overall Study|Adverse Event|0|||
33418431|NCT03514121|101422402|FG001|Overall Study|Adverse Event|0|||
33570636|NCT00725985|101982621|FG003|ITP- Treatment Disposition|Adverse Event|0|||
33570637|NCT00725985|101982622|FG004|ITP- Treatment Disposition|Adverse Event|0|||
33570638|NCT00725985|101982623|FG005|ITP- Treatment Disposition|Adverse Event|0|||
33570639|NCT00725985|101982624|FG006|ITP- Treatment Disposition|Adverse Event|0|||
33570640|NCT00725985|101982625|FG007|ITP- Treatment Disposition|Adverse Event|0|||
33570641|NCT00725985|101982626|FG008|ITP- Treatment Disposition|Adverse Event|0|||
33570642|NCT00725985|101982627|FG009|ITP- Treatment Disposition|Adverse Event|0|||
33227899|NCT02357810|100735757|FG000|Reached 12 Weeks Response|Physician Decision|1|||
33418432|NCT03514121|101422403|FG002|Overall Study|Adverse Event|0|||
33570643|NCT00725985|101982628|FG010|ITP- Treatment Disposition|Adverse Event|0|||
33418433|NCT03514121|101422404|FG003|Overall Study|Adverse Event|0|||
33418434|NCT03514121|101422405|FG004|Overall Study|Adverse Event|0|||
33418435|NCT03514121|101422406|FG005|Overall Study|Adverse Event|0|||
33418436|NCT03514121|101422407|FG006|Overall Study|Adverse Event|1|||
33418437|NCT03514121|101422408|FG007|Overall Study|Adverse Event|0|||
33418438|NCT03514121|101422409|FG008|Overall Study|Adverse Event|0|||
33570644|NCT00725985|101982629|FG011|ITP- Treatment Disposition|Adverse Event|0|||
33570645|NCT00725985|101982618|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
33633402|NCT01774721|102211823|FG000|Overall Study|Lost to Follow-up|6|||
33633403|NCT01774721|102211824|FG001|Overall Study|Lost to Follow-up|7|||
33633404|NCT01774721|102211823|FG000|Overall Study|Did not meet eligibility criteria|0|||
33633405|NCT01774721|102211824|FG001|Overall Study|Did not meet eligibility criteria|3|||
33418439|NCT03514121|101422410|FG009|Overall Study|Adverse Event|0|||
33633406|NCT01774721|102211823|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
33633407|NCT01774721|102211824|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
33227900|NCT02357810|100735757|FG000|Reached 12 Weeks Response|Other|1|||
33227901|NCT02357810|100735757|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
33227902|NCT02357810|100735757|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
33570646|NCT00725985|101982619|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
33570647|NCT00725985|101982620|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
33570648|NCT00725985|101982621|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
33570649|NCT00725985|101982622|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
33570650|NCT00725985|101982623|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
33570651|NCT00725985|101982624|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
33570652|NCT00725985|101982625|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
33570653|NCT00725985|101982626|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
33570654|NCT00725985|101982627|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
33570655|NCT00725985|101982628|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
33570656|NCT00725985|101982629|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
33570657|NCT00725985|101982618|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
33570658|NCT00725985|101982619|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
33570659|NCT00725985|101982620|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
33570660|NCT00725985|101982621|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
33570661|NCT00725985|101982622|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
33570662|NCT00725985|101982623|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
33570663|NCT00725985|101982624|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
33570664|NCT00725985|101982625|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
33570665|NCT00725985|101982626|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
33570666|NCT00725985|101982627|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
33570667|NCT00725985|101982628|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
33570668|NCT00725985|101982629|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
33570669|NCT00725985|101982618|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
33570670|NCT00725985|101982619|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
33633408|NCT01774721|102211823|FG000|Overall Study|Study terminated by sponsor|5|||
33633409|NCT01774721|102211824|FG001|Overall Study|Study terminated by sponsor|0|||
33633410|NCT01774721|102211823|FG000|Overall Study|Disease progression|5|||
33633411|NCT01774721|102211824|FG001|Overall Study|Disease progression|0|||
33633412|NCT02491684|102211825|FG000|Treatment Phase|Adverse Event|2|||
33633413|NCT02491684|102211826|FG001|Treatment Phase|Adverse Event|2|||
33633414|NCT02491684|102211825|FG000|Treatment Phase|Incorrect randomisation|1|||
33633415|NCT02491684|102211826|FG001|Treatment Phase|Incorrect randomisation|0|||
33633416|NCT02491684|102211825|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
33633417|NCT02491684|102211826|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
33633418|NCT03592186|102211827|FG000|Overall Study|Withdrawal by Subject|1|||
33633419|NCT03592186|102211828|FG001|Overall Study|Withdrawal by Subject|0|||
33633420|NCT03592186|102211827|FG000|Overall Study|Lost to Follow-up|16|||
33633421|NCT03592186|102211828|FG001|Overall Study|Lost to Follow-up|11|||
33633422|NCT02855125|102211829|FG000|Overall Study|Withdrawal by Subject|2|||
33633423|NCT02855125|102211830|FG001|Overall Study|Withdrawal by Subject|2|||
33633424|NCT02855125|102211829|FG000|Overall Study|Clinical Disease Progression|5|||
33633425|NCT02855125|102211830|FG001|Overall Study|Clinical Disease Progression|4|||
33633426|NCT02855125|102211829|FG000|Overall Study|Radiologic Disease Progression|36|||
33633427|NCT02855125|102211830|FG001|Overall Study|Radiologic Disease Progression|39|||
33633428|NCT02855125|102211829|FG000|Overall Study|Adverse Event|11|||
33633429|NCT02855125|102211830|FG001|Overall Study|Adverse Event|7|||
33633430|NCT02855125|102211829|FG000|Overall Study|Physician Decision|1|||
33633431|NCT02855125|102211830|FG001|Overall Study|Physician Decision|0|||
33633432|NCT02855125|102211829|FG000|Overall Study|On Treatment|9|||
33633433|NCT02855125|102211830|FG001|Overall Study|On Treatment|11|||
33633434|NCT02855125|102211829|FG000|Overall Study|Randomized but not treated|0|||
33633435|NCT02855125|102211830|FG001|Overall Study|Randomized but not treated|1|||
33633436|NCT00726063|102211836|FG000|Overall Study|Adverse Event|9|||
33633437|NCT00726063|102211837|FG001|Overall Study|Adverse Event|7|||
33633438|NCT00651742|102211838|FG000|Overall Study|Objective Disease Progression|22|||
33633439|NCT00651742|102211838|FG000|Overall Study|Toxicity|3|||
33633440|NCT00651742|102211838|FG000|Overall Study|Investigator Judgment|1|||
33633441|NCT00651742|102211838|FG000|Overall Study|Withdrawal of Consent|1|||
33227903|NCT02357810|100735757|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
33227904|NCT02357810|100735757|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
33570671|NCT00725985|101982620|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
33570672|NCT00725985|101982621|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
33570673|NCT00725985|101982622|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
33633442|NCT00651742|102211838|FG000|Overall Study|Enrolled but not treated|1|||
33633443|NCT02589938|102211847|FG000|Overall Study|Withdrawal by Subject|11|||
33633444|NCT02589938|102211848|FG001|Overall Study|Withdrawal by Subject|5|||
33227905|NCT02357810|100735757|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
33227906|NCT02357810|100735757|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
33418440|NCT03514121|101422401|FG000|Overall Study|Other|0|||
33418441|NCT03514121|101422402|FG001|Overall Study|Other|1|||
33418442|NCT03514121|101422403|FG002|Overall Study|Other|1|||
33418443|NCT03514121|101422404|FG003|Overall Study|Other|0|||
33418444|NCT03514121|101422405|FG004|Overall Study|Other|1|||
33418445|NCT03514121|101422406|FG005|Overall Study|Other|2|||
33418446|NCT03514121|101422407|FG006|Overall Study|Other|3|||
33418447|NCT03514121|101422408|FG007|Overall Study|Other|2|||
33418448|NCT03514121|101422409|FG008|Overall Study|Other|7|||
33418449|NCT03514121|101422410|FG009|Overall Study|Other|3|||
33418450|NCT03514121|101422401|FG000|Overall Study|Study termination by Sponsor|0|||
33418451|NCT03514121|101422402|FG001|Overall Study|Study termination by Sponsor|0|||
33418452|NCT03514121|101422403|FG002|Overall Study|Study termination by Sponsor|0|||
33418453|NCT03514121|101422404|FG003|Overall Study|Study termination by Sponsor|0|||
33418454|NCT03514121|101422405|FG004|Overall Study|Study termination by Sponsor|0|||
33418455|NCT03514121|101422406|FG005|Overall Study|Study termination by Sponsor|0|||
33570674|NCT00725985|101982623|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
33570675|NCT00725985|101982624|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
33570676|NCT00725985|101982625|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
33570677|NCT00725985|101982626|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
33570678|NCT00725985|101982627|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
33570679|NCT00725985|101982628|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
33570680|NCT00725985|101982629|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
33570681|NCT00725985|101982618|FG000|ITP- Treatment Disposition|Other|50|||
33633445|NCT02589938|102211849|FG002|Overall Study|Withdrawal by Subject|6|||
33633446|NCT02589938|102211847|FG000|Overall Study|Lost to Follow-up|3|||
33633447|NCT02589938|102211848|FG001|Overall Study|Lost to Follow-up|3|||
33633448|NCT02589938|102211849|FG002|Overall Study|Lost to Follow-up|3|||
33633449|NCT02589938|102211847|FG000|Overall Study|Death|1|||
33633450|NCT02589938|102211848|FG001|Overall Study|Death|0|||
33633451|NCT02589938|102211849|FG002|Overall Study|Death|1|||
33633452|NCT02589938|102211847|FG000|Overall Study|Protocol Violation|6|||
33633453|NCT02589938|102211848|FG001|Overall Study|Protocol Violation|2|||
33633454|NCT02589938|102211849|FG002|Overall Study|Protocol Violation|3|||
33633455|NCT02589938|102211847|FG000|Overall Study|Physician Decision|1|||
33570682|NCT00725985|101982619|FG001|ITP- Treatment Disposition|Other|38|||
33570683|NCT00725985|101982620|FG002|ITP- Treatment Disposition|Other|24|||
33570684|NCT00725985|101982621|FG003|ITP- Treatment Disposition|Other|0|||
33570685|NCT00725985|101982622|FG004|ITP- Treatment Disposition|Other|0|||
33570686|NCT00725985|101982623|FG005|ITP- Treatment Disposition|Other|0|||
33570687|NCT00725985|101982624|FG006|ITP- Treatment Disposition|Other|0|||
33570688|NCT00725985|101982625|FG007|ITP- Treatment Disposition|Other|0|||
33570689|NCT00725985|101982626|FG008|ITP- Treatment Disposition|Other|0|||
33570690|NCT00725985|101982627|FG009|ITP- Treatment Disposition|Other|0|||
33570691|NCT00725985|101982628|FG010|ITP- Treatment Disposition|Other|0|||
33570692|NCT00725985|101982629|FG011|ITP- Treatment Disposition|Other|0|||
33570693|NCT00725985|101982618|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33570694|NCT00725985|101982619|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33570695|NCT00725985|101982620|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33570696|NCT00725985|101982621|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
33570697|NCT00725985|101982622|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
33570698|NCT00725985|101982623|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
33570699|NCT00725985|101982624|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33570700|NCT00725985|101982625|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33570701|NCT00725985|101982626|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33570702|NCT00725985|101982627|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33570703|NCT00725985|101982628|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33570704|NCT00725985|101982629|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
33570705|NCT00725985|101982618|FG000|OLMP (Up to 96 Weeks)|Death|0|||
33570706|NCT00725985|101982619|FG001|OLMP (Up to 96 Weeks)|Death|0|||
33633456|NCT02589938|102211848|FG001|Overall Study|Physician Decision|0|||
33633457|NCT02589938|102211849|FG002|Overall Study|Physician Decision|0|||
33227907|NCT04296890|100735762|FG000|Overall Study|Withdrawal by Subject|1|||
33227908|NCT04296890|100735762|FG000|Overall Study|Death|62|||
33227909|NCT04296890|100735762|FG000|Overall Study|Lost to Follow-up|3|||
33227910|NCT04296890|100735762|FG000|Overall Study|Other than specified|2|||
33227911|NCT02001974|100735763|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
33227912|NCT02001974|100735764|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
33227913|NCT02001974|100735765|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
33570707|NCT00725985|101982620|FG002|OLMP (Up to 96 Weeks)|Death|0|||
33570708|NCT00725985|101982621|FG003|OLMP (Up to 96 Weeks)|Death|0|||
33570709|NCT00725985|101982622|FG004|OLMP (Up to 96 Weeks)|Death|1|||
33570710|NCT00725985|101982623|FG005|OLMP (Up to 96 Weeks)|Death|0|||
33570711|NCT00725985|101982624|FG006|OLMP (Up to 96 Weeks)|Death|0|||
33570712|NCT00725985|101982625|FG007|OLMP (Up to 96 Weeks)|Death|0|||
33570713|NCT00725985|101982626|FG008|OLMP (Up to 96 Weeks)|Death|0|||
33570714|NCT00725985|101982627|FG009|OLMP (Up to 96 Weeks)|Death|0|||
33570715|NCT00725985|101982628|FG010|OLMP (Up to 96 Weeks)|Death|0|||
33570716|NCT00725985|101982629|FG011|OLMP (Up to 96 Weeks)|Death|0|||
33570717|NCT00725985|101982618|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33570718|NCT00725985|101982619|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33570719|NCT00725985|101982620|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33570720|NCT00725985|101982621|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
33570721|NCT00725985|101982622|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33570722|NCT00725985|101982623|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33570723|NCT00725985|101982624|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33570724|NCT00725985|101982625|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33570725|NCT00725985|101982626|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33570726|NCT00725985|101982627|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33570727|NCT00725985|101982628|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33570728|NCT00725985|101982629|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
33570729|NCT00725985|101982618|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
33570730|NCT00725985|101982619|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
33570731|NCT00725985|101982620|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
33227914|NCT02001974|100735763|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
33227915|NCT02001974|100735764|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
33227916|NCT02001974|100735765|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
33227917|NCT02001974|100735763|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
33227918|NCT02001974|100735764|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
33227919|NCT02001974|100735765|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
33227920|NCT02001974|100735763|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
33227921|NCT02001974|100735764|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
33227922|NCT02001974|100735765|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
33227923|NCT00597714|100735766|FG000|Overall Study|Death|56|||
33227924|NCT00597714|100735767|FG001|Overall Study|Death|46|||
33227925|NCT00597714|100735768|FG002|Overall Study|Death|0|||
33227926|NCT00597714|100735766|FG000|Overall Study|Recipient death|0|||
33227927|NCT00597714|100735767|FG001|Overall Study|Recipient death|0|||
33227928|NCT00597714|100735768|FG002|Overall Study|Recipient death|10|||
33227929|NCT01512745|100735771|FG000|Overall Study|Adverse Event|22|||
33227930|NCT01512745|100735772|FG001|Overall Study|Adverse Event|3|||
33227931|NCT01512745|100735771|FG000|Overall Study|Death|9|||
33227932|NCT01512745|100735772|FG001|Overall Study|Death|13|||
33227933|NCT01512745|100735771|FG000|Overall Study|Withdrawal by Subject|2|||
33227934|NCT01512745|100735772|FG001|Overall Study|Withdrawal by Subject|2|||
33227935|NCT01512745|100735771|FG000|Overall Study|Lost to Follow-up|4|||
33227936|NCT01512745|100735772|FG001|Overall Study|Lost to Follow-up|0|||
33227937|NCT01512745|100735771|FG000|Overall Study|Lack of Efficacy|2|||
33227938|NCT01512745|100735772|FG001|Overall Study|Lack of Efficacy|2|||
33227939|NCT01512745|100735771|FG000|Overall Study|Protocol Violation|1|||
33227940|NCT01512745|100735772|FG001|Overall Study|Protocol Violation|0|||
33227941|NCT01231503|100735773|FG000|Overall Study|Adverse Event|0|||
33227942|NCT01231503|100735774|FG001|Overall Study|Adverse Event|0|||
33227943|NCT01231503|100735775|FG002|Overall Study|Adverse Event|0|||
33227944|NCT01231503|100735776|FG003|Overall Study|Adverse Event|0|||
33227945|NCT01231503|100735777|FG004|Overall Study|Adverse Event|0|||
33227946|NCT01231503|100735778|FG005|Overall Study|Adverse Event|1|||
33227947|NCT01231503|100735779|FG006|Overall Study|Adverse Event|0|||
33227948|NCT01231503|100735780|FG007|Overall Study|Adverse Event|0|||
33227949|NCT01231503|100735773|FG000|Overall Study|Adverse event, serious fatal|0|||
33227950|NCT01231503|100735774|FG001|Overall Study|Adverse event, serious fatal|0|||
33227951|NCT01231503|100735775|FG002|Overall Study|Adverse event, serious fatal|1|||
33227952|NCT01231503|100735776|FG003|Overall Study|Adverse event, serious fatal|1|||
33227953|NCT01231503|100735777|FG004|Overall Study|Adverse event, serious fatal|0|||
33227954|NCT01231503|100735778|FG005|Overall Study|Adverse event, serious fatal|1|||
33227955|NCT01231503|100735779|FG006|Overall Study|Adverse event, serious fatal|0|||
33227956|NCT01231503|100735780|FG007|Overall Study|Adverse event, serious fatal|0|||
33227957|NCT01231503|100735773|FG000|Overall Study|Withdrawal by Subject|6|||
33570732|NCT00725985|101982621|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
33570733|NCT00725985|101982622|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
33570734|NCT00725985|101982623|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
33227958|NCT01231503|100735774|FG001|Overall Study|Withdrawal by Subject|3|||
33570735|NCT00725985|101982624|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
33570736|NCT00725985|101982625|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
33570737|NCT00725985|101982626|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
33570738|NCT00725985|101982627|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
33570739|NCT00725985|101982628|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
33570740|NCT00725985|101982629|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
33570741|NCT00725985|101982618|FG000|OLMP (Up to 96 Weeks)|Other|0|||
33633458|NCT02589938|102211847|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
33633459|NCT02589938|102211848|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
33227959|NCT01231503|100735775|FG002|Overall Study|Withdrawal by Subject|3|||
33227960|NCT01231503|100735776|FG003|Overall Study|Withdrawal by Subject|1|||
33227961|NCT01231503|100735777|FG004|Overall Study|Withdrawal by Subject|3|||
33570742|NCT00725985|101982619|FG001|OLMP (Up to 96 Weeks)|Other|0|||
33570743|NCT00725985|101982620|FG002|OLMP (Up to 96 Weeks)|Other|0|||
33227962|NCT01231503|100735778|FG005|Overall Study|Withdrawal by Subject|5|||
33227963|NCT01231503|100735779|FG006|Overall Study|Withdrawal by Subject|1|||
33227964|NCT01231503|100735780|FG007|Overall Study|Withdrawal by Subject|2|||
33227965|NCT01231503|100735773|FG000|Overall Study|Lost to Follow-up|8|||
33227966|NCT01231503|100735774|FG001|Overall Study|Lost to Follow-up|10|||
33227967|NCT01231503|100735775|FG002|Overall Study|Lost to Follow-up|8|||
33227968|NCT01231503|100735776|FG003|Overall Study|Lost to Follow-up|5|||
33227969|NCT01231503|100735777|FG004|Overall Study|Lost to Follow-up|7|||
33227970|NCT01231503|100735778|FG005|Overall Study|Lost to Follow-up|9|||
33227971|NCT01231503|100735779|FG006|Overall Study|Lost to Follow-up|6|||
33227972|NCT01231503|100735780|FG007|Overall Study|Lost to Follow-up|6|||
33227973|NCT01231503|100735773|FG000|Overall Study|Protocol Violation|0|||
33227974|NCT01231503|100735774|FG001|Overall Study|Protocol Violation|0|||
33227975|NCT01231503|100735775|FG002|Overall Study|Protocol Violation|0|||
33227976|NCT01231503|100735776|FG003|Overall Study|Protocol Violation|1|||
33227977|NCT01231503|100735777|FG004|Overall Study|Protocol Violation|0|||
33227978|NCT01231503|100735778|FG005|Overall Study|Protocol Violation|0|||
33227979|NCT01231503|100735779|FG006|Overall Study|Protocol Violation|0|||
33227980|NCT01231503|100735780|FG007|Overall Study|Protocol Violation|0|||
33227981|NCT01290822|100735781|FG000|Overall Study|Withdrawal by Subject|1|||
33227982|NCT01290822|100735781|FG000|Overall Study|Physician Decision|10|||
33227983|NCT02120664|100735787|FG000|Overall Study|Withdrawal by Subject|0|||
33227984|NCT02120664|100735788|FG001|Overall Study|Withdrawal by Subject|0|||
33227985|NCT02120664|100735789|FG002|Overall Study|Withdrawal by Subject|0|||
33227986|NCT02120664|100735790|FG003|Overall Study|Withdrawal by Subject|1|||
33227987|NCT02120664|100735791|FG004|Overall Study|Withdrawal by Subject|0|||
33227988|NCT02778399|100735792|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
33366647|NCT03242928|101230057|FG001|Overall Study|Adverse Event|1|||
33366648|NCT03242928|101230056|FG000|Overall Study|Lost to Follow-up|2|||
33366649|NCT03242928|101230057|FG001|Overall Study|Lost to Follow-up|0|||
33366650|NCT03242928|101230056|FG000|Overall Study|Physician Decision|0|||
33366651|NCT03242928|101230057|FG001|Overall Study|Physician Decision|1|||
33366652|NCT03242928|101230056|FG000|Overall Study|Withdrawal by Subject|5|||
33366653|NCT03242928|101230057|FG001|Overall Study|Withdrawal by Subject|3|||
33366654|NCT02207530|101230058|FG000|Overall Study|Worsening condition under investigation|78|||
33366655|NCT02207530|101230058|FG000|Overall Study|Patient decision to stop study treatment|5|||
33366656|NCT02207530|101230058|FG000|Overall Study|Adverse Event|8|||
33366657|NCT01671085|101230059|FG000|Overall Study|Withdrawal by Subject|1|||
33366658|NCT01671085|101230060|FG001|Overall Study|Withdrawal by Subject|0|||
33366659|NCT02582749|101230063|FG000|Overall Study|Study terminated by funder|5|||
33366660|NCT02582749|101230064|FG001|Overall Study|Study terminated by funder|10|||
33366661|NCT02582749|101230063|FG000|Overall Study|Withdrawal by Subject|0|||
33366662|NCT02582749|101230064|FG001|Overall Study|Withdrawal by Subject|1|||
33633460|NCT02589938|102211849|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
33633461|NCT05530252|102211850|FG000|Overall Study|Lost to Follow-up|1|||
33633462|NCT05530252|102211851|FG001|Overall Study|Lost to Follow-up|1|||
33633463|NCT05530252|102211852|FG002|Overall Study|Lost to Follow-up|1|||
33633464|NCT00536744|102211853|FG000|Overall Study|Adverse Event|13|||
33633465|NCT00536744|102211854|FG001|Overall Study|Adverse Event|10|||
33633466|NCT00536744|102211853|FG000|Overall Study|Death|2|||
33633467|NCT00536744|102211854|FG001|Overall Study|Death|1|||
33633468|NCT00536744|102211853|FG000|Overall Study|Physician Decision|3|||
33633469|NCT00536744|102211854|FG001|Overall Study|Physician Decision|1|||
33633470|NCT00536744|102211853|FG000|Overall Study|Lost to Follow-up|3|||
33633471|NCT00536744|102211854|FG001|Overall Study|Lost to Follow-up|5|||
33633472|NCT00536744|102211853|FG000|Overall Study|Withdrawal by Subject|7|||
33366663|NCT02564120|101230065|FG000|Overall Study|Did not return release forms|160|||
33366664|NCT02564120|101230065|FG000|Overall Study|Death|58|||
33366665|NCT02564120|101230065|FG000|Overall Study|Withdrawal by Subject|204|||
33366666|NCT02564120|101230065|FG000|Overall Study|Other medical condition|24|||
33366667|NCT02375698|101230070|FG000|Overall Study|Withdrawal by Subject|0|||
33366668|NCT02375698|101230071|FG001|Overall Study|Withdrawal by Subject|2|||
33366669|NCT02375698|101230070|FG000|Overall Study|Physician Decision|2|||
33366670|NCT02375698|101230071|FG001|Overall Study|Physician Decision|0|||
33633473|NCT00536744|102211854|FG001|Overall Study|Withdrawal by Subject|8|||
33633474|NCT00536744|102211853|FG000|Overall Study|PI tried alternative treatment|1|||
33633475|NCT00536744|102211854|FG001|Overall Study|PI tried alternative treatment|3|||
33633476|NCT03674411|102211855|FG000|Overall Study|Non-treatment|4|||
33633477|NCT00906204|102211856|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
33633478|NCT00906204|102211857|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
33633479|NCT00906204|102211856|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
33366671|NCT00301067|101230072|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
33366672|NCT00301067|101230073|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
33633480|NCT00906204|102211857|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
33366673|NCT00301067|101230074|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
33366674|NCT00301067|101230075|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
33366675|NCT00301067|101230072|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
33366676|NCT00301067|101230073|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
33418456|NCT03514121|101422407|FG006|Overall Study|Study termination by Sponsor|0|||
33418457|NCT03514121|101422408|FG007|Overall Study|Study termination by Sponsor|0|||
33418458|NCT03514121|101422409|FG008|Overall Study|Study termination by Sponsor|11|||
33418459|NCT03514121|101422410|FG009|Overall Study|Study termination by Sponsor|3|||
33418460|NCT03514121|101422401|FG000|Overall Study|Investigator decision|0|||
33418461|NCT03514121|101422402|FG001|Overall Study|Investigator decision|0|||
33418462|NCT03514121|101422403|FG002|Overall Study|Investigator decision|0|||
33418463|NCT03514121|101422404|FG003|Overall Study|Investigator decision|0|||
33418464|NCT03514121|101422405|FG004|Overall Study|Investigator decision|0|||
33418465|NCT03514121|101422406|FG005|Overall Study|Investigator decision|0|||
33418466|NCT03514121|101422407|FG006|Overall Study|Investigator decision|0|||
33418467|NCT03514121|101422408|FG007|Overall Study|Investigator decision|0|||
33418468|NCT03514121|101422409|FG008|Overall Study|Investigator decision|1|||
33418469|NCT03514121|101422410|FG009|Overall Study|Investigator decision|0|||
33418470|NCT03079869|101422411|FG000|Overall Study|Adverse Event|6|||
33418471|NCT03079869|101422412|FG001|Overall Study|Adverse Event|8|||
33418472|NCT03079869|101422411|FG000|Overall Study|Withdrawal by Subject|4|||
33418473|NCT03079869|101422412|FG001|Overall Study|Withdrawal by Subject|1|||
33418474|NCT03079869|101422411|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
33418475|NCT03079869|101422412|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
33418476|NCT01238172|101422413|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
33418477|NCT01238172|101422414|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
33418478|NCT01238172|101422413|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
33418479|NCT01238172|101422414|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
33418480|NCT00402779|101422415|FG000|Overall Study|Screen Failure|77|||
33418481|NCT00402779|101422416|FG001|Overall Study|Screen Failure|76|||
33418482|NCT03286400|101422417|FG000|Overall Study|Death|10|||
33418483|NCT03286400|101422417|FG000|Overall Study|Lost to Follow-up|10|||
33418484|NCT03286400|101422417|FG000|Overall Study|Physician Decision|1|||
33418485|NCT03286400|101422417|FG000|Overall Study|Scheduling difficulty|4|||
33418486|NCT01966107|101422418|FG000|Overall Study|excluded from FAS|21|||
33418487|NCT01966107|101422419|FG001|Overall Study|excluded from FAS|20|||
33418488|NCT01966107|101422418|FG000|Overall Study|discontinued treatment|345|||
33418489|NCT01966107|101422419|FG001|Overall Study|discontinued treatment|372|||
33418490|NCT01966107|101422418|FG000|Overall Study|due to study closure|164|||
33418491|NCT01966107|101422419|FG001|Overall Study|due to study closure|186|||
33418492|NCT01966107|101422418|FG000|Overall Study|withdrew from the study|272|||
33418493|NCT01966107|101422419|FG001|Overall Study|withdrew from the study|303|||
33418494|NCT02125734|101422420|FG000|Period 2|Adverse Event|0|||
33418495|NCT02125734|101422421|FG001|Period 2|Adverse Event|1|||
33418496|NCT02494583|101422422|FG000|Overall Study|Death|224|||
33418497|NCT02494583|101422423|FG001|Overall Study|Death|214|||
33570744|NCT00725985|101982621|FG003|OLMP (Up to 96 Weeks)|Other|15|||
33570745|NCT00725985|101982622|FG004|OLMP (Up to 96 Weeks)|Other|20|||
33570746|NCT00725985|101982623|FG005|OLMP (Up to 96 Weeks)|Other|44|||
33570747|NCT00725985|101982624|FG006|OLMP (Up to 96 Weeks)|Other|0|||
33570748|NCT00725985|101982625|FG007|OLMP (Up to 96 Weeks)|Other|0|||
33570749|NCT00725985|101982626|FG008|OLMP (Up to 96 Weeks)|Other|0|||
33633481|NCT00906204|102211856|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
33227989|NCT02778399|100735793|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
33227990|NCT02778399|100735794|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
33227991|NCT02778399|100735795|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
33366677|NCT00301067|101230074|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
33366678|NCT00301067|101230075|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
33366679|NCT00301067|101230072|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
33366680|NCT00301067|101230073|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
33366681|NCT00301067|101230074|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
33366682|NCT00301067|101230075|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
33366683|NCT00301067|101230072|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
33366684|NCT00301067|101230073|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
33366685|NCT00301067|101230074|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
33366686|NCT00301067|101230075|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
33366687|NCT00301067|101230072|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
33366688|NCT00301067|101230073|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
33366689|NCT00301067|101230074|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
33366690|NCT00301067|101230075|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
33366691|NCT00301067|101230072|FG000|Follow up Until Death|Alive at last data cut point|1|||
33366692|NCT00301067|101230073|FG001|Follow up Until Death|Alive at last data cut point|0|||
33366693|NCT00301067|101230074|FG002|Follow up Until Death|Alive at last data cut point|0|||
33418498|NCT02494583|101422424|FG002|Overall Study|Death|225|||
33570750|NCT00725985|101982627|FG009|OLMP (Up to 96 Weeks)|Other|0|||
33633482|NCT00906204|102211857|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
33366694|NCT00301067|101230075|FG003|Follow up Until Death|Alive at last data cut point|1|||
33570751|NCT00725985|101982628|FG010|OLMP (Up to 96 Weeks)|Other|0|||
33570752|NCT00725985|101982629|FG011|OLMP (Up to 96 Weeks)|Other|0|||
33570753|NCT00725985|101982618|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33570754|NCT00725985|101982619|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33570755|NCT00725985|101982620|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33570756|NCT00725985|101982621|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33570757|NCT00725985|101982622|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33570758|NCT00725985|101982623|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33570759|NCT00725985|101982624|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33570760|NCT00725985|101982625|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
33570761|NCT00725985|101982626|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33570762|NCT00725985|101982627|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33570763|NCT00725985|101982628|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33570764|NCT00725985|101982629|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
33570765|NCT00725985|101982618|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33570766|NCT00725985|101982619|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33570767|NCT00725985|101982620|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33570768|NCT00725985|101982621|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33570769|NCT00725985|101982622|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33570770|NCT00725985|101982623|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33570771|NCT00725985|101982624|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33570772|NCT00725985|101982625|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33570773|NCT00725985|101982626|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
33570774|NCT00725985|101982627|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33570775|NCT00725985|101982628|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33570776|NCT00725985|101982629|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
33570777|NCT00725985|101982618|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33570778|NCT00725985|101982619|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33570779|NCT00725985|101982620|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33570780|NCT00725985|101982621|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33570781|NCT00725985|101982622|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33570782|NCT00725985|101982623|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33570783|NCT00725985|101982624|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
33570784|NCT00725985|101982625|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
33570785|NCT00725985|101982626|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
33570786|NCT00725985|101982627|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33633483|NCT00906204|102211856|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
33633484|NCT00906204|102211857|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
33633485|NCT00906204|102211856|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
33633486|NCT00906204|102211857|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
33633487|NCT04323124|102211858|FG000|Overall Study|Adverse Event|0|||
33633488|NCT04323124|102211859|FG001|Overall Study|Adverse Event|0|||
33633489|NCT04323124|102211860|FG002|Overall Study|Adverse Event|0|||
33633490|NCT04323124|102211861|FG003|Overall Study|Adverse Event|0|||
33633491|NCT04323124|102211862|FG004|Overall Study|Adverse Event|0|||
33633492|NCT04323124|102211863|FG005|Overall Study|Adverse Event|1|||
33633493|NCT04323124|102211864|FG006|Overall Study|Adverse Event|0|||
33633494|NCT04323124|102211865|FG007|Overall Study|Adverse Event|1|||
33633495|NCT04323124|102211866|FG008|Overall Study|Adverse Event|1|||
33633496|NCT04323124|102211867|FG009|Overall Study|Adverse Event|0|||
33633497|NCT04323124|102211868|FG010|Overall Study|Adverse Event|0|||
33633498|NCT04323124|102211869|FG011|Overall Study|Adverse Event|0|||
33633499|NCT04323124|102211870|FG012|Overall Study|Adverse Event|0|||
33633500|NCT04323124|102211871|FG013|Overall Study|Adverse Event|0|||
33633501|NCT04323124|102211872|FG014|Overall Study|Adverse Event|0|||
33633502|NCT04323124|102211858|FG000|Overall Study|Other|0|||
33633503|NCT04323124|102211859|FG001|Overall Study|Other|0|||
33227992|NCT02778399|100735796|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
33227993|NCT02778399|100735797|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
33227994|NCT02778399|100735792|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
33227995|NCT02778399|100735793|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
33633504|NCT04323124|102211860|FG002|Overall Study|Other|0|||
33633505|NCT04323124|102211861|FG003|Overall Study|Other|0|||
33633506|NCT04323124|102211862|FG004|Overall Study|Other|1|||
33633507|NCT04323124|102211863|FG005|Overall Study|Other|0|||
33633508|NCT04323124|102211864|FG006|Overall Study|Other|0|||
33633509|NCT04323124|102211865|FG007|Overall Study|Other|0|||
33633510|NCT04323124|102211866|FG008|Overall Study|Other|1|||
33633511|NCT04323124|102211867|FG009|Overall Study|Other|0|||
33633512|NCT04323124|102211868|FG010|Overall Study|Other|0|||
33633513|NCT04323124|102211869|FG011|Overall Study|Other|0|||
33633514|NCT04323124|102211870|FG012|Overall Study|Other|0|||
33633515|NCT04323124|102211871|FG013|Overall Study|Other|0|||
33633516|NCT04323124|102211872|FG014|Overall Study|Other|0|||
33633517|NCT04323124|102211858|FG000|Overall Study|Coming from a red zone (COVID)|0|||
33633518|NCT04323124|102211859|FG001|Overall Study|Coming from a red zone (COVID)|0|||
33633519|NCT04323124|102211860|FG002|Overall Study|Coming from a red zone (COVID)|0|||
33633520|NCT04323124|102211861|FG003|Overall Study|Coming from a red zone (COVID)|0|||
33633521|NCT04323124|102211862|FG004|Overall Study|Coming from a red zone (COVID)|1|||
33633522|NCT04323124|102211863|FG005|Overall Study|Coming from a red zone (COVID)|1|||
33633523|NCT04323124|102211864|FG006|Overall Study|Coming from a red zone (COVID)|0|||
33633524|NCT04323124|102211865|FG007|Overall Study|Coming from a red zone (COVID)|0|||
33633525|NCT04323124|102211866|FG008|Overall Study|Coming from a red zone (COVID)|0|||
33633526|NCT04323124|102211867|FG009|Overall Study|Coming from a red zone (COVID)|0|||
33633527|NCT04323124|102211868|FG010|Overall Study|Coming from a red zone (COVID)|0|||
33633528|NCT04323124|102211869|FG011|Overall Study|Coming from a red zone (COVID)|0|||
33633529|NCT04323124|102211870|FG012|Overall Study|Coming from a red zone (COVID)|0|||
33633530|NCT04323124|102211871|FG013|Overall Study|Coming from a red zone (COVID)|0|||
33633531|NCT04323124|102211872|FG014|Overall Study|Coming from a red zone (COVID)|0|||
33633532|NCT04323124|102211858|FG000|Overall Study|No longer meets eligibility criteria|0|||
33633533|NCT04323124|102211859|FG001|Overall Study|No longer meets eligibility criteria|0|||
33633534|NCT04323124|102211860|FG002|Overall Study|No longer meets eligibility criteria|0|||
33570787|NCT00725985|101982628|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33570788|NCT00725985|101982629|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
33633535|NCT04323124|102211861|FG003|Overall Study|No longer meets eligibility criteria|0|||
33633536|NCT04323124|102211862|FG004|Overall Study|No longer meets eligibility criteria|0|||
33633537|NCT04323124|102211863|FG005|Overall Study|No longer meets eligibility criteria|0|||
33633538|NCT04323124|102211864|FG006|Overall Study|No longer meets eligibility criteria|0|||
33633539|NCT04323124|102211865|FG007|Overall Study|No longer meets eligibility criteria|1|||
33633540|NCT04323124|102211866|FG008|Overall Study|No longer meets eligibility criteria|0|||
33633541|NCT04323124|102211867|FG009|Overall Study|No longer meets eligibility criteria|0|||
33633542|NCT04323124|102211868|FG010|Overall Study|No longer meets eligibility criteria|0|||
33633543|NCT04323124|102211869|FG011|Overall Study|No longer meets eligibility criteria|0|||
33633544|NCT04323124|102211870|FG012|Overall Study|No longer meets eligibility criteria|0|||
33633545|NCT04323124|102211871|FG013|Overall Study|No longer meets eligibility criteria|1|||
33633546|NCT04323124|102211872|FG014|Overall Study|No longer meets eligibility criteria|1|||
33633547|NCT04323124|102211858|FG000|Overall Study|Study terminated by sponsor|0|||
33633548|NCT04323124|102211859|FG001|Overall Study|Study terminated by sponsor|0|||
33633549|NCT04323124|102211860|FG002|Overall Study|Study terminated by sponsor|0|||
33633550|NCT04323124|102211861|FG003|Overall Study|Study terminated by sponsor|0|||
33633551|NCT04323124|102211862|FG004|Overall Study|Study terminated by sponsor|0|||
33633552|NCT04323124|102211863|FG005|Overall Study|Study terminated by sponsor|0|||
33633553|NCT04323124|102211864|FG006|Overall Study|Study terminated by sponsor|0|||
33633554|NCT04323124|102211865|FG007|Overall Study|Study terminated by sponsor|0|||
33366695|NCT02815397|101230080|FG000|Overall Study|Physician Decision|2|||
33570789|NCT00725985|101982618|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33570790|NCT00725985|101982619|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33570791|NCT00725985|101982620|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33570792|NCT00725985|101982621|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33570793|NCT00725985|101982622|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33570794|NCT00725985|101982623|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33570795|NCT00725985|101982624|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33570796|NCT00725985|101982625|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33570797|NCT00725985|101982626|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
33570798|NCT00725985|101982627|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
33570799|NCT00725985|101982628|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
33570800|NCT00725985|101982629|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
33570801|NCT00543985|101982630|FG000|Overall Study|Withdrawal by Subject|4|||
33570802|NCT01994876|101982631|FG000|Test Period 1|Withdrawal by Subject|0|||
33570803|NCT01994876|101982632|FG001|Test Period 1|Withdrawal by Subject|1|||
33570804|NCT01994876|101982631|FG000|Test Period 1|Adverse Event|0|||
33570805|NCT01994876|101982632|FG001|Test Period 1|Adverse Event|1|||
33633555|NCT04323124|102211866|FG008|Overall Study|Study terminated by sponsor|0|||
33633556|NCT04323124|102211867|FG009|Overall Study|Study terminated by sponsor|0|||
33633557|NCT04323124|102211868|FG010|Overall Study|Study terminated by sponsor|0|||
33633558|NCT04323124|102211869|FG011|Overall Study|Study terminated by sponsor|2|||
33633559|NCT04323124|102211870|FG012|Overall Study|Study terminated by sponsor|1|||
33633560|NCT04323124|102211871|FG013|Overall Study|Study terminated by sponsor|0|||
33633561|NCT04323124|102211872|FG014|Overall Study|Study terminated by sponsor|0|||
33633562|NCT03173248|102211873|FG000|Overall Study|Death|28|||
33570806|NCT01994876|101982631|FG000|Test Period 2|Adverse Event|1|||
33570807|NCT01994876|101982632|FG001|Test Period 2|Adverse Event|0|||
33570808|NCT01994876|101982631|FG000|Test Period 2|Protocol Violation|0|||
33633563|NCT03173248|102211874|FG001|Overall Study|Death|46|||
33633564|NCT03173248|102211873|FG000|Overall Study|Lost to Follow-up|0|||
33633565|NCT03173248|102211874|FG001|Overall Study|Lost to Follow-up|1|||
33633566|NCT03173248|102211873|FG000|Overall Study|Withdrawal by Subject|6|||
33633567|NCT03173248|102211874|FG001|Overall Study|Withdrawal by Subject|4|||
33633568|NCT03173248|102211873|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
33633569|NCT03173248|102211874|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
33633570|NCT02488915|102211877|FG000|Overall Study|Death|21|||
33633571|NCT02488915|102211877|FG000|Overall Study|Lost to Follow-up|4|||
33633572|NCT02488915|102211877|FG000|Overall Study|Withdrawal by Subject|1|||
33227996|NCT02778399|100735794|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
33227997|NCT02778399|100735795|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
33366696|NCT00390780|101230081|FG000|Overall Study|Not completed|10|||
33366697|NCT00390780|101230082|FG001|Overall Study|Not completed|4|||
33366698|NCT00390780|101230081|FG000|Overall Study|Protocol Violation|6|||
33366699|NCT00390780|101230082|FG001|Overall Study|Protocol Violation|4|||
33366700|NCT00390780|101230081|FG000|Overall Study|Lost to Follow-up|3|||
33366701|NCT00390780|101230082|FG001|Overall Study|Lost to Follow-up|6|||
33366702|NCT00390780|101230081|FG000|Overall Study|Adverse Event|2|||
33366703|NCT00390780|101230082|FG001|Overall Study|Adverse Event|3|||
33418499|NCT02494583|101422422|FG000|Overall Study|Lost to Follow-up|1|||
33366704|NCT00390780|101230081|FG000|Overall Study|Death|1|||
33366705|NCT00390780|101230082|FG001|Overall Study|Death|3|||
33366706|NCT00390780|101230081|FG000|Overall Study|Withdrawal by Subject|1|||
33366707|NCT00390780|101230082|FG001|Overall Study|Withdrawal by Subject|2|||
33366708|NCT00390780|101230081|FG000|Overall Study|Inclusion criteria not satisfied|0|||
33418500|NCT02494583|101422423|FG001|Overall Study|Lost to Follow-up|0|||
33418501|NCT02494583|101422424|FG002|Overall Study|Lost to Follow-up|0|||
33418502|NCT02494583|101422422|FG000|Overall Study|Protocol Violation|1|||
33418503|NCT02494583|101422423|FG001|Overall Study|Protocol Violation|2|||
33418504|NCT02494583|101422424|FG002|Overall Study|Protocol Violation|0|||
33418505|NCT02494583|101422422|FG000|Overall Study|Screen Failure|0|||
33418506|NCT02494583|101422423|FG001|Overall Study|Screen Failure|1|||
33418507|NCT02494583|101422424|FG002|Overall Study|Screen Failure|0|||
33418508|NCT02494583|101422422|FG000|Overall Study|Transferred to Extension Study|15|||
33418509|NCT02494583|101422423|FG001|Overall Study|Transferred to Extension Study|15|||
33418510|NCT02494583|101422424|FG002|Overall Study|Transferred to Extension Study|6|||
33366709|NCT00390780|101230082|FG001|Overall Study|Inclusion criteria not satisfied|2|||
33570809|NCT01994876|101982632|FG001|Test Period 2|Protocol Violation|1|||
33633573|NCT01099267|102211882|FG000|MDS-003 Study|Adverse Event|37|||
33633574|NCT01099267|102211882|FG000|MDS-003 Study|Lack of Efficacy|52|||
33633575|NCT01099267|102211882|FG000|MDS-003 Study|Withdrawal by Subject|8|||
33633576|NCT01099267|102211882|FG000|MDS-003 Study|Lost to Follow-up|1|||
33227998|NCT02778399|100735796|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
33227999|NCT02778399|100735797|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
33228000|NCT02778399|100735792|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
33228001|NCT02778399|100735793|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
33570810|NCT02095106|101982633|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
33570811|NCT02095106|101982634|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
33570812|NCT00492557|101982635|FG000|Overall Study|Subject request|12|||
33570813|NCT00492557|101982636|FG001|Overall Study|Subject request|11|||
33570814|NCT00492557|101982635|FG000|Overall Study|Protocol Violation|7|||
33570815|NCT00492557|101982636|FG001|Overall Study|Protocol Violation|8|||
33570816|NCT00492557|101982635|FG000|Overall Study|Other|2|||
33570817|NCT00492557|101982636|FG001|Overall Study|Other|2|||
33570818|NCT00492557|101982635|FG000|Overall Study|Death|1|||
33570819|NCT00492557|101982636|FG001|Overall Study|Death|1|||
33570820|NCT00492557|101982635|FG000|Overall Study|Adverse Event|1|||
33570821|NCT00492557|101982636|FG001|Overall Study|Adverse Event|0|||
33570822|NCT00492557|101982635|FG000|Overall Study|Failed to return|1|||
33570823|NCT00492557|101982636|FG001|Overall Study|Failed to return|0|||
33228002|NCT02778399|100735794|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
33228003|NCT02778399|100735795|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
33228004|NCT02778399|100735796|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
33228005|NCT02778399|100735797|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
33418511|NCT02494583|101422422|FG000|Overall Study|Did Not Continue on Extension Study|8|||
33418512|NCT02494583|101422423|FG001|Overall Study|Did Not Continue on Extension Study|10|||
33418513|NCT02494583|101422424|FG002|Overall Study|Did Not Continue on Extension Study|4|||
33418514|NCT02494583|101422422|FG000|Overall Study|Withdrawal by Subject|7|||
33418515|NCT02494583|101422423|FG001|Overall Study|Withdrawal by Subject|15|||
33418516|NCT02494583|101422424|FG002|Overall Study|Withdrawal by Subject|15|||
33418517|NCT03591107|101422425|FG000|Overall Study|Same patient in both arms|1|||
33418518|NCT03591107|101422426|FG001|Overall Study|Same patient in both arms|1|||
33418519|NCT03591107|101422425|FG000|Overall Study|Sought care at other clinics|0|||
33418520|NCT03591107|101422426|FG001|Overall Study|Sought care at other clinics|2|||
33418521|NCT03591107|101422425|FG000|Overall Study|Discharged from clinic|0|||
33418522|NCT03591107|101422426|FG001|Overall Study|Discharged from clinic|1|||
33418523|NCT03591107|101422425|FG000|Overall Study|Withdrawal by Subject|0|||
33418524|NCT03591107|101422426|FG001|Overall Study|Withdrawal by Subject|1|||
33418525|NCT00728988|101422427|FG000|Overall Study|Not Treated|2|||
33418526|NCT00728988|101422428|FG001|Overall Study|Not Treated|2|||
33418527|NCT00728988|101422427|FG000|Overall Study|Death|1|||
33418528|NCT00728988|101422428|FG001|Overall Study|Death|1|||
33418529|NCT00728988|101422427|FG000|Overall Study|Adverse Event|3|||
33418530|NCT00728988|101422428|FG001|Overall Study|Adverse Event|2|||
33418531|NCT00728988|101422427|FG000|Overall Study|Other|85|||
33418532|NCT00728988|101422428|FG001|Overall Study|Other|77|||
33418533|NCT00728988|101422427|FG000|Overall Study|Withdrawal by Subject|2|||
33418534|NCT00728988|101422428|FG001|Overall Study|Withdrawal by Subject|6|||
33418535|NCT05788237|101422446|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
33418536|NCT05788237|101422447|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
33418537|NCT05788237|101422448|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
33418538|NCT05788237|101422449|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
33418539|NCT05788237|101422446|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
33418540|NCT05788237|101422447|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
33418541|NCT05788237|101422448|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
33418542|NCT05788237|101422449|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
33418543|NCT05788237|101422446|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
33418544|NCT05788237|101422447|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
33418545|NCT05788237|101422448|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
33418546|NCT05788237|101422449|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
33418547|NCT05788237|101422446|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
33570824|NCT00492557|101982635|FG000|Overall Study|Lost to Follow-up|0|||
33570825|NCT00492557|101982636|FG001|Overall Study|Lost to Follow-up|1|||
33570826|NCT02164864|101982637|FG000|Overall Study|Trial disease worsening|7|||
33228006|NCT02778399|100735792|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
33228007|NCT02778399|100735793|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
33228008|NCT02778399|100735794|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
33418548|NCT05788237|101422447|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
33418549|NCT05788237|101422448|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
33418550|NCT05788237|101422449|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
33418551|NCT05788237|101422446|FG000|SSA (Approximately 2 Months)|Death|0|||
33570827|NCT02164864|101982638|FG001|Overall Study|Trial disease worsening|5|||
33228009|NCT02778399|100735795|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
33418552|NCT05788237|101422447|FG001|SSA (Approximately 2 Months)|Death|1|||
33570828|NCT02164864|101982639|FG002|Overall Study|Trial disease worsening|1|||
33633577|NCT01099267|102211882|FG000|MDS-003 Study|Death|11|||
33570829|NCT02164864|101982637|FG000|Overall Study|Other pre-existing disease worsening|6|||
33570830|NCT02164864|101982638|FG001|Overall Study|Other pre-existing disease worsening|4|||
33570831|NCT02164864|101982639|FG002|Overall Study|Other pre-existing disease worsening|9|||
33570832|NCT02164864|101982637|FG000|Overall Study|Other Adverse Event (AE)|52|||
33570833|NCT02164864|101982638|FG001|Overall Study|Other Adverse Event (AE)|32|||
33570834|NCT02164864|101982639|FG002|Overall Study|Other Adverse Event (AE)|49|||
33570835|NCT02164864|101982637|FG000|Overall Study|Protocol Violation|2|||
33633578|NCT01099267|102211882|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
33633579|NCT01099267|102211882|FG000|MDS-003 Study|Disease Progression|7|||
33633580|NCT01099267|102211882|FG000|MDS-003 Study|Investigator Decision|2|||
33633581|NCT01099267|102211882|FG000|MDS-003 Study|Non-Compliance|2|||
33633582|NCT01099267|102211882|FG000|MDS-003 Study|Loss of Response|1|||
33633583|NCT01099267|102211882|FG000|MDS-003 Study|Secondary Malign Disease|1|||
33633584|NCT03198715|102211883|FG000|Overall Study|Death|0|||
33633585|NCT03198715|102211884|FG001|Overall Study|Death|0|||
33633586|NCT03198715|102211885|FG002|Overall Study|Death|1|||
33633587|NCT03198715|102211886|FG003|Overall Study|Death|0|||
33633588|NCT03198715|102211887|FG004|Overall Study|Death|2|||
33633589|NCT03198715|102211883|FG000|Overall Study|Other|0|||
33633590|NCT03198715|102211884|FG001|Overall Study|Other|1|||
33633591|NCT03198715|102211885|FG002|Overall Study|Other|1|||
33633592|NCT03198715|102211886|FG003|Overall Study|Other|0|||
33633593|NCT03198715|102211887|FG004|Overall Study|Other|0|||
33633594|NCT01084655|102211888|FG000|Overall Study|Radiographic disease progression|3|||
33633595|NCT01084655|102211889|FG001|Overall Study|Radiographic disease progression|2|||
33633596|NCT01084655|102211890|FG002|Overall Study|Radiographic disease progression|8|||
33633597|NCT01084655|102211888|FG000|Overall Study|Withdrawal by Subject|1|||
33633598|NCT01084655|102211889|FG001|Overall Study|Withdrawal by Subject|0|||
33633599|NCT01084655|102211890|FG002|Overall Study|Withdrawal by Subject|4|||
33633600|NCT01084655|102211888|FG000|Overall Study|Adverse Event|2|||
33633601|NCT01084655|102211889|FG001|Overall Study|Adverse Event|1|||
33633602|NCT01084655|102211890|FG002|Overall Study|Adverse Event|2|||
33633603|NCT01084655|102211888|FG000|Overall Study|Other|0|||
33633604|NCT01084655|102211889|FG001|Overall Study|Other|3|||
33633605|NCT01084655|102211890|FG002|Overall Study|Other|2|||
33633606|NCT01084655|102211888|FG000|Overall Study|Symptomatic deterioration|0|||
33633607|NCT01084655|102211889|FG001|Overall Study|Symptomatic deterioration|0|||
33633608|NCT01084655|102211890|FG002|Overall Study|Symptomatic deterioration|2|||
33633609|NCT01084655|102211888|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
33633610|NCT01084655|102211889|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
33633611|NCT01084655|102211890|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
33633612|NCT01724346|102211891|FG000|Overall Study|Death|42|||
33633613|NCT01724346|102211892|FG001|Overall Study|Death|42|||
33633614|NCT01724346|102211891|FG000|Overall Study|Lost to Follow-up|5|||
33633615|NCT01724346|102211892|FG001|Overall Study|Lost to Follow-up|1|||
33633616|NCT01724346|102211891|FG000|Overall Study|Withdrawal by Subject|27|||
33633617|NCT01724346|102211892|FG001|Overall Study|Withdrawal by Subject|19|||
33633618|NCT01724346|102211891|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
33633619|NCT01724346|102211892|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
33633620|NCT04730804|102211895|FG000|Overall Study|Physician Decision|0|||
33633621|NCT04730804|102211896|FG001|Overall Study|Physician Decision|0|||
33633622|NCT04730804|102211897|FG002|Overall Study|Physician Decision|0|||
33633623|NCT04730804|102211898|FG003|Overall Study|Physician Decision|0|||
33633624|NCT04730804|102211899|FG004|Overall Study|Physician Decision|0|||
33633625|NCT04730804|102211900|FG005|Overall Study|Physician Decision|1|||
33633626|NCT04730804|102211895|FG000|Overall Study|Withdrawal by Subject|0|||
33633627|NCT04730804|102211896|FG001|Overall Study|Withdrawal by Subject|0|||
33570836|NCT02164864|101982638|FG001|Overall Study|Protocol Violation|4|||
33570837|NCT02164864|101982639|FG002|Overall Study|Protocol Violation|1|||
33570838|NCT02164864|101982637|FG000|Overall Study|Lost to Follow-up|4|||
33570839|NCT02164864|101982638|FG001|Overall Study|Lost to Follow-up|3|||
33570840|NCT02164864|101982639|FG002|Overall Study|Lost to Follow-up|2|||
33633628|NCT04730804|102211897|FG002|Overall Study|Withdrawal by Subject|0|||
33633629|NCT04730804|102211898|FG003|Overall Study|Withdrawal by Subject|0|||
33633630|NCT04730804|102211899|FG004|Overall Study|Withdrawal by Subject|1|||
33633631|NCT04730804|102211900|FG005|Overall Study|Withdrawal by Subject|2|||
33633632|NCT01131507|102211902|FG000|Overall Study|Adverse Event|1|||
33633633|NCT01131507|102211902|FG000|Overall Study|Lost to Follow-up|1|||
33633634|NCT01131507|102211902|FG000|Overall Study|Withdrawal by Subject|1|||
33633635|NCT00003475|102211903|FG000|Overall Study|Not evaluable|13|||
33633636|NCT00992108|102211904|FG000|Overall Study|Lost to Follow-up|0|||
33633637|NCT00992108|102211905|FG001|Overall Study|Lost to Follow-up|1|||
33633638|NCT00283296|102211908|FG000|Overall Study|in-home trial not completed|5|||
33633639|NCT00551642|102211909|FG000|Treatment Period|Protocol Deviation|6|||
33633640|NCT00551642|102211910|FG001|Treatment Period|Protocol Deviation|11|||
33633641|NCT00551642|102211909|FG000|Treatment Period|Delivery device failure|1|||
33633642|NCT00551642|102211910|FG001|Treatment Period|Delivery device failure|3|||
33633643|NCT00551642|102211909|FG000|Treatment Period|Physician Decision|0|||
33418553|NCT05788237|101422448|FG002|SSA (Approximately 2 Months)|Death|0|||
33418554|NCT05788237|101422449|FG003|SSA (Approximately 2 Months)|Death|0|||
33418555|NCT05788237|101422446|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
33418556|NCT05788237|101422447|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
33418557|NCT05788237|101422448|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
33418558|NCT05788237|101422449|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
33418559|NCT05788237|101422446|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
33418560|NCT05788237|101422447|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
33418561|NCT05788237|101422448|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
33418562|NCT05788237|101422449|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
33418563|NCT05788237|101422446|FG000|SSB (Approximately 1 Month)|Other|0|||
33418564|NCT05788237|101422447|FG001|SSB (Approximately 1 Month)|Other|0|||
33418565|NCT05788237|101422448|FG002|SSB (Approximately 1 Month)|Other|0|||
33418566|NCT05788237|101422449|FG003|SSB (Approximately 1 Month)|Other|1|||
33418567|NCT00759759|101422450|FG000|Overall Study|didn't return for period 2|1|||
33418568|NCT00759759|101422451|FG001|Overall Study|didn't return for period 2|0|||
33418569|NCT00759759|101422450|FG000|Overall Study|Didn't receive drug in period 2|1|||
33418570|NCT00759759|101422451|FG001|Overall Study|Didn't receive drug in period 2|0|||
33418571|NCT00759759|101422450|FG000|Overall Study|Withdrawal by Subject|2|||
33418572|NCT00759759|101422451|FG001|Overall Study|Withdrawal by Subject|1|||
33418573|NCT02720094|101425544|FG000|Overall Study|Scheduled exit visit/end of study|2|||
33418574|NCT02720094|101425545|FG001|Overall Study|Scheduled exit visit/end of study|1|||
33418575|NCT02720094|101425544|FG000|Overall Study|Death|4|||
33418576|NCT02720094|101425545|FG001|Overall Study|Death|7|||
33418577|NCT02720094|101425544|FG000|Overall Study|Withdrawal by Subject|55|||
33418578|NCT02720094|101425545|FG001|Overall Study|Withdrawal by Subject|56|||
33418579|NCT02720094|101425544|FG000|Overall Study|Lost to Follow-up|2|||
33418580|NCT02720094|101425545|FG001|Overall Study|Lost to Follow-up|7|||
33418581|NCT02720094|101425544|FG000|Overall Study|Physician Decision|1|||
33418582|NCT02720094|101425545|FG001|Overall Study|Physician Decision|3|||
33418583|NCT02720094|101425544|FG000|Overall Study|Inappropriate enrollment|1|||
33418584|NCT02720094|101425545|FG001|Overall Study|Inappropriate enrollment|3|||
33418585|NCT02720094|101425544|FG000|Overall Study|Ongoing|2210|||
33418586|NCT02720094|101425545|FG001|Overall Study|Ongoing|2203|||
33418587|NCT02720094|101425544|FG000|Overall Study|Relocation|1|||
33633644|NCT00551642|102211910|FG001|Treatment Period|Physician Decision|1|||
33633645|NCT00551642|102211909|FG000|Treatment Period|Death|33|||
33633646|NCT00551642|102211910|FG001|Treatment Period|Death|31|||
33633647|NCT00551642|102211909|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
33633648|NCT00551642|102211910|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
33633649|NCT00551642|102211909|FG000|Treatment Period|Adverse Event|15|||
33633650|NCT00551642|102211910|FG001|Treatment Period|Adverse Event|12|||
33633651|NCT00551642|102211909|FG000|Treatment Period|Withdrawal by Subject|2|||
33228010|NCT02778399|100735796|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
33418588|NCT02720094|101425545|FG001|Overall Study|Relocation|1|||
33418589|NCT03722849|101425546|FG000|Overall Study|Withdrawal by Subject|1|||
33418590|NCT03722849|101425547|FG001|Overall Study|Withdrawal by Subject|1|||
33418591|NCT02499406|101425548|FG000|Overall Study|missed 3 treatment sessions|4|||
33418592|NCT04380701|101425549|FG000|Overall Study|Pregnancy|0|||
33418593|NCT04380701|101425550|FG001|Overall Study|Pregnancy|0|||
33418594|NCT04380701|101425551|FG002|Overall Study|Pregnancy|0|||
33418595|NCT04380701|101425552|FG003|Overall Study|Pregnancy|0|||
33418596|NCT04380701|101425553|FG004|Overall Study|Pregnancy|0|||
33418597|NCT04380701|101425554|FG005|Overall Study|Pregnancy|0|||
33418598|NCT04380701|101425555|FG006|Overall Study|Pregnancy|0|||
33418599|NCT04380701|101425556|FG007|Overall Study|Pregnancy|0|||
33418600|NCT04380701|101425557|FG008|Overall Study|Pregnancy|0|||
33418601|NCT04380701|101425558|FG009|Overall Study|Pregnancy|0|||
33418602|NCT04380701|101425559|FG010|Overall Study|Pregnancy|0|||
33418603|NCT04380701|101425560|FG011|Overall Study|Pregnancy|0|||
33418604|NCT04380701|101425561|FG012|Overall Study|Pregnancy|0|||
33633652|NCT00551642|102211910|FG001|Treatment Period|Withdrawal by Subject|1|||
33633653|NCT03043872|102211917|FG000|Overall Study|Withdrawal by Subject|6|||
33418605|NCT04380701|101425562|FG013|Overall Study|Pregnancy|0|||
33418606|NCT04380701|101425563|FG014|Overall Study|Pregnancy|0|||
33633654|NCT03043872|102211918|FG001|Overall Study|Withdrawal by Subject|6|||
33418607|NCT04380701|101425564|FG015|Overall Study|Pregnancy|0|||
33418608|NCT04380701|101425565|FG016|Overall Study|Pregnancy|0|||
33418609|NCT04380701|101425566|FG017|Overall Study|Pregnancy|0|||
33418610|NCT04380701|101425567|FG018|Overall Study|Pregnancy|0|||
33418611|NCT04380701|101425568|FG019|Overall Study|Pregnancy|0|||
33418612|NCT04380701|101425569|FG020|Overall Study|Pregnancy|0|||
33418613|NCT04380701|101425570|FG021|Overall Study|Pregnancy|0|||
33418614|NCT04380701|101425571|FG022|Overall Study|Pregnancy|0|||
33418615|NCT04380701|101425572|FG023|Overall Study|Pregnancy|0|||
33418616|NCT04380701|101425573|FG024|Overall Study|Pregnancy|0|||
33633655|NCT03043872|102211919|FG002|Overall Study|Withdrawal by Subject|15|||
33633656|NCT03043872|102211917|FG000|Overall Study|Lost to Follow-up|2|||
33418617|NCT04380701|101425574|FG025|Overall Study|Pregnancy|0|||
33570841|NCT02164864|101982637|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
33570842|NCT02164864|101982638|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
33570843|NCT02164864|101982639|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
33570844|NCT02164864|101982637|FG000|Overall Study|Other than stated|3|||
33570845|NCT02164864|101982638|FG001|Overall Study|Other than stated|4|||
33570846|NCT02164864|101982639|FG002|Overall Study|Other than stated|14|||
33570847|NCT01822925|101982640|FG000|Overall Study|Adverse Event|1|||
33570848|NCT01822925|101982641|FG001|Overall Study|Adverse Event|1|||
33570849|NCT01822925|101982642|FG002|Overall Study|Adverse Event|1|||
33570850|NCT01822925|101982643|FG003|Overall Study|Adverse Event|1|||
33570851|NCT01822925|101982640|FG000|Overall Study|Lost to Follow-up|0|||
33418618|NCT04380701|101425575|FG026|Overall Study|Pregnancy|0|||
33418619|NCT04380701|101425576|FG027|Overall Study|Pregnancy|0|||
33418620|NCT04380701|101425577|FG028|Overall Study|Pregnancy|0|||
33418621|NCT04380701|101425578|FG029|Overall Study|Pregnancy|0|||
33418622|NCT04380701|101425579|FG030|Overall Study|Pregnancy|0|||
33570852|NCT01822925|101982641|FG001|Overall Study|Lost to Follow-up|1|||
33570853|NCT01822925|101982642|FG002|Overall Study|Lost to Follow-up|0|||
33570854|NCT01822925|101982643|FG003|Overall Study|Lost to Follow-up|0|||
33570855|NCT01822925|101982640|FG000|Overall Study|Protocol Violation|1|||
33570856|NCT01822925|101982641|FG001|Overall Study|Protocol Violation|0|||
33570857|NCT01822925|101982642|FG002|Overall Study|Protocol Violation|0|||
33633657|NCT03043872|102211918|FG001|Overall Study|Lost to Follow-up|1|||
33633658|NCT03043872|102211919|FG002|Overall Study|Lost to Follow-up|1|||
33633659|NCT03043872|102211917|FG000|Overall Study|Death|270|||
33633660|NCT03043872|102211918|FG001|Overall Study|Death|269|||
33633661|NCT03043872|102211919|FG002|Overall Study|Death|296|||
33633662|NCT01550003|102211920|FG000|Overall Study|Adverse Event|0|||
33633663|NCT01550003|102211921|FG001|Overall Study|Adverse Event|9|||
33633664|NCT01550003|102211922|FG002|Overall Study|Adverse Event|15|||
33633665|NCT01550003|102211920|FG000|Overall Study|Lack of Efficacy|4|||
33633666|NCT01550003|102211921|FG001|Overall Study|Lack of Efficacy|11|||
33228011|NCT02778399|100735797|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
33228012|NCT02778399|100735792|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
33418623|NCT04380701|101425580|FG031|Overall Study|Pregnancy|0|||
33570858|NCT01822925|101982643|FG003|Overall Study|Protocol Violation|1|||
33570859|NCT01822925|101982640|FG000|Overall Study|Withdrawal by Subject|2|||
33418624|NCT04380701|101425581|FG032|Overall Study|Pregnancy|1|||
33418625|NCT04380701|101425582|FG033|Overall Study|Pregnancy|0|||
33570860|NCT01822925|101982641|FG001|Overall Study|Withdrawal by Subject|0|||
33570861|NCT01822925|101982642|FG002|Overall Study|Withdrawal by Subject|2|||
33633667|NCT01550003|102211922|FG002|Overall Study|Lack of Efficacy|15|||
33633668|NCT01550003|102211920|FG000|Overall Study|Protocol Violation|0|||
33633669|NCT01550003|102211921|FG001|Overall Study|Protocol Violation|3|||
33633670|NCT01550003|102211922|FG002|Overall Study|Protocol Violation|2|||
33633671|NCT01550003|102211920|FG000|Overall Study|Lost to Follow-up|1|||
33418626|NCT04380701|101425549|FG000|Overall Study|Lost to Follow-up|0|||
33228013|NCT02778399|100735793|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
33228014|NCT02778399|100735794|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
33228015|NCT02778399|100735795|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
33228016|NCT02778399|100735796|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
33228017|NCT02778399|100735797|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
33228018|NCT02778399|100735792|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
33228019|NCT02778399|100735793|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
33228020|NCT02778399|100735794|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
33228021|NCT02778399|100735795|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
33228022|NCT02778399|100735796|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
33228023|NCT02778399|100735797|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
33570862|NCT01822925|101982643|FG003|Overall Study|Withdrawal by Subject|2|||
33570863|NCT01822925|101982640|FG000|Overall Study|Taking prohibited medication|2|||
33570864|NCT01822925|101982641|FG001|Overall Study|Taking prohibited medication|0|||
33570865|NCT01822925|101982642|FG002|Overall Study|Taking prohibited medication|0|||
33570866|NCT01822925|101982643|FG003|Overall Study|Taking prohibited medication|1|||
33570867|NCT00656370|101982648|FG000|Overall Study|Screen Failures|7|||
33570868|NCT00656370|101982648|FG000|Overall Study|Alternates|3|||
33570869|NCT04194450|101982649|FG000|Overall Study|not eligible|1|||
33570870|NCT04194450|101982650|FG001|Overall Study|not eligible|0|||
33570871|NCT03235050|101982651|FG000|Overall Study|Adverse Event|0|||
33633672|NCT01550003|102211921|FG001|Overall Study|Lost to Follow-up|4|||
33633673|NCT01550003|102211922|FG002|Overall Study|Lost to Follow-up|8|||
33633674|NCT01550003|102211920|FG000|Overall Study|Consent withdrawn|2|||
33633675|NCT01550003|102211921|FG001|Overall Study|Consent withdrawn|11|||
33633676|NCT01550003|102211922|FG002|Overall Study|Consent withdrawn|23|||
33633677|NCT01550003|102211920|FG000|Overall Study|Missing|1|||
33633678|NCT01550003|102211921|FG001|Overall Study|Missing|0|||
33633679|NCT01550003|102211922|FG002|Overall Study|Missing|2|||
33633680|NCT01550003|102211920|FG000|Overall Study|Study closure as announced by sponsor|7|||
33633681|NCT01550003|102211921|FG001|Overall Study|Study closure as announced by sponsor|6|||
33633682|NCT01550003|102211922|FG002|Overall Study|Study closure as announced by sponsor|24|||
33633683|NCT01550003|102211920|FG000|Overall Study|Protocol Noncompliance|1|||
33633684|NCT01550003|102211921|FG001|Overall Study|Protocol Noncompliance|0|||
33633685|NCT01550003|102211922|FG002|Overall Study|Protocol Noncompliance|0|||
33633686|NCT01550003|102211920|FG000|Overall Study|Study closure|0|||
33418627|NCT04380701|101425550|FG001|Overall Study|Lost to Follow-up|0|||
33570872|NCT03235050|101982652|FG001|Overall Study|Adverse Event|0|||
33570873|NCT03235050|101982653|FG002|Overall Study|Adverse Event|1|||
33570874|NCT03235050|101982654|FG003|Overall Study|Adverse Event|4|||
33633687|NCT01550003|102211921|FG001|Overall Study|Study closure|1|||
33633688|NCT01550003|102211922|FG002|Overall Study|Study closure|1|||
33633689|NCT01550003|102211920|FG000|Overall Study|Patient reached adulthood|0|||
33570875|NCT03235050|101982655|FG004|Overall Study|Adverse Event|1|||
33570876|NCT03235050|101982651|FG000|Overall Study|Death|0|||
33570877|NCT03235050|101982652|FG001|Overall Study|Death|0|||
33570878|NCT03235050|101982653|FG002|Overall Study|Death|0|||
33570879|NCT03235050|101982654|FG003|Overall Study|Death|2|||
33570880|NCT03235050|101982655|FG004|Overall Study|Death|1|||
33633690|NCT01550003|102211921|FG001|Overall Study|Patient reached adulthood|1|||
33570881|NCT03235050|101982651|FG000|Overall Study|Lost to Follow-up|1|||
33228024|NCT02778399|100735792|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
33228025|NCT02778399|100735793|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
33228026|NCT02778399|100735794|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
33228027|NCT02778399|100735795|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
33228028|NCT02778399|100735796|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
33228029|NCT02778399|100735797|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
33228030|NCT02778399|100735792|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
33228031|NCT02778399|100735793|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
33228032|NCT02778399|100735794|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
33228033|NCT02778399|100735795|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
33228034|NCT02778399|100735796|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
33228035|NCT02778399|100735797|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
33228036|NCT02778399|100735792|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
33228037|NCT02778399|100735793|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
33228038|NCT02778399|100735794|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
33228039|NCT02778399|100735795|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
33228040|NCT02778399|100735796|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
33228041|NCT02778399|100735797|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
33228042|NCT02778399|100735792|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
33228043|NCT02778399|100735793|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
33228044|NCT02778399|100735794|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
33228045|NCT02778399|100735795|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
33228046|NCT02778399|100735796|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
33228047|NCT02778399|100735797|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
33228048|NCT02778399|100735792|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
33228049|NCT02778399|100735793|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
33228050|NCT02778399|100735794|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
33228051|NCT02778399|100735795|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
33228052|NCT02778399|100735796|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
33228053|NCT02778399|100735797|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
33228054|NCT01381874|100735798|FG000|Overall Study|Lost to Follow-up|1|||
33228055|NCT01381874|100735799|FG001|Overall Study|Lost to Follow-up|1|||
33228056|NCT01381874|100735800|FG002|Overall Study|Lost to Follow-up|0|||
33228057|NCT01381874|100735798|FG000|Overall Study|Withdrawal by Subject|9|||
33228058|NCT01381874|100735799|FG001|Overall Study|Withdrawal by Subject|10|||
33228059|NCT01381874|100735800|FG002|Overall Study|Withdrawal by Subject|9|||
33228060|NCT01381874|100735798|FG000|Overall Study|Other|67|||
33228061|NCT01381874|100735799|FG001|Overall Study|Other|52|||
33228062|NCT01381874|100735800|FG002|Overall Study|Other|67|||
33228063|NCT02756832|100735801|FG000|Overall Study|Lost for Observation after Baseline|6|||
33228064|NCT02756832|100735801|FG000|Overall Study|Lost for Observation|13|||
33228065|NCT02756832|100735801|FG000|Overall Study|Patient's Unwillingness|12|||
33228066|NCT02756832|100735801|FG000|Overall Study|Insufficient Efficacy|2|||
33228067|NCT02756832|100735801|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
33228068|NCT02756832|100735801|FG000|Overall Study|Reason not Specified|9|||
33228069|NCT02756832|100735801|FG000|Overall Study|Protocol Deviation|10|||
33228070|NCT02401308|100735802|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
33228071|NCT02401308|100735803|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
33228072|NCT04651114|100735804|FG000|Overall Study|Withdrawal by Subject|8|||
33228073|NCT00245856|100735805|FG000|Period Two|Withdrawal by Subject|0|||
33228074|NCT00245856|100735806|FG001|Period Two|Withdrawal by Subject|1|||
33228075|NCT01535274|100735813|FG000|Overall Study|Determined to be ineligible|0|||
33228076|NCT01535274|100735814|FG001|Overall Study|Determined to be ineligible|1|||
33366710|NCT00390780|101230081|FG000|Overall Study|Lost to follow up and other reasons|0|||
33366711|NCT00390780|101230082|FG001|Overall Study|Lost to follow up and other reasons|1|||
33366712|NCT00390780|101230081|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
33366713|NCT00390780|101230082|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
33366714|NCT00390780|101230081|FG000|Overall Study|SAE, death|0|||
33366715|NCT00390780|101230082|FG001|Overall Study|SAE, death|1|||
33366716|NCT01158534|101230086|FG000|Overall Study|Withdrawal by Subject|1|||
33366717|NCT01158534|101230086|FG000|Overall Study|Death|1|||
33366718|NCT01158534|101230086|FG000|Overall Study|Other|1|||
33570882|NCT03235050|101982652|FG001|Overall Study|Lost to Follow-up|2|||
33228077|NCT01535274|100735813|FG000|Overall Study|Misallocated to propofol intervention|0|||
33228078|NCT01535274|100735814|FG001|Overall Study|Misallocated to propofol intervention|1|||
33228079|NCT01370603|100735815|FG000|Period 1|Adverse Event|5|||
33228080|NCT01370603|100735816|FG001|Period 1|Adverse Event|3|||
33366719|NCT01108809|101230087|FG000|Overall Study|Adverse Event|3|||
33366720|NCT01108809|101230087|FG000|Overall Study|Lost to Follow-up|1|||
33366721|NCT03567291|101230092|FG000|Period I|Adverse Event|14|||
33366722|NCT03567291|101230093|FG001|Period I|Adverse Event|0|||
33228081|NCT01370603|100735815|FG000|Period 1|Lost to Follow-up|2|||
33228082|NCT01370603|100735816|FG001|Period 1|Lost to Follow-up|0|||
33228083|NCT01370603|100735815|FG000|Period 1|Protocol Violation|2|||
33228084|NCT01370603|100735816|FG001|Period 1|Protocol Violation|2|||
33228085|NCT01370603|100735815|FG000|Period 1|Withdrawal by Subject|5|||
33228086|NCT01370603|100735816|FG001|Period 1|Withdrawal by Subject|5|||
33228087|NCT01370603|100735815|FG000|Crossover Washout|Adverse Event|2|||
33228088|NCT01370603|100735816|FG001|Crossover Washout|Adverse Event|1|||
33228089|NCT01370603|100735815|FG000|Crossover Washout|Lost to Follow-up|2|||
33228090|NCT01370603|100735816|FG001|Crossover Washout|Lost to Follow-up|0|||
33228091|NCT01370603|100735815|FG000|Crossover Washout|Protocol Violation|1|||
33228092|NCT01370603|100735816|FG001|Crossover Washout|Protocol Violation|0|||
33228093|NCT01370603|100735815|FG000|Crossover Washout|Withdrawal by Subject|4|||
33228094|NCT01370603|100735816|FG001|Crossover Washout|Withdrawal by Subject|1|||
33228095|NCT01370603|100735815|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
33228096|NCT01370603|100735816|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
33228097|NCT01370603|100735815|FG000|Period 2|Adverse Event|1|||
33228098|NCT01370603|100735816|FG001|Period 2|Adverse Event|4|||
33228099|NCT01370603|100735815|FG000|Period 2|Lost to Follow-up|1|||
33228100|NCT01370603|100735816|FG001|Period 2|Lost to Follow-up|0|||
33228101|NCT01370603|100735815|FG000|Period 2|Withdrawal by Subject|1|||
33228102|NCT01370603|100735816|FG001|Period 2|Withdrawal by Subject|0|||
33228103|NCT04581200|100735818|FG000|Overall Study|Lost to Follow-up|6|||
33228104|NCT04581200|100735819|FG001|Overall Study|Lost to Follow-up|5|||
33228105|NCT02387216|100735822|FG000|Overall Study|Progressive disease|2|||
33228106|NCT02387216|100735823|FG001|Overall Study|Progressive disease|0|||
33228107|NCT02387216|100735822|FG000|Overall Study|Withdrawal by Subject|3|||
33228108|NCT02387216|100735823|FG001|Overall Study|Withdrawal by Subject|5|||
33228109|NCT02387216|100735822|FG000|Overall Study|Physician Decision|2|||
33228110|NCT02387216|100735823|FG001|Overall Study|Physician Decision|0|||
33228111|NCT02387216|100735822|FG000|Overall Study|Sponsor Decision|28|||
33228112|NCT02387216|100735823|FG001|Overall Study|Sponsor Decision|12|||
33228113|NCT02387216|100735822|FG000|Overall Study|Death|60|||
33228114|NCT02387216|100735823|FG001|Overall Study|Death|23|||
33228115|NCT02387216|100735822|FG000|Overall Study|Other|5|||
33228116|NCT02387216|100735823|FG001|Overall Study|Other|4|||
33228117|NCT02387216|100735822|FG000|Overall Study|Lost to Follow-up|0|||
33228118|NCT02387216|100735823|FG001|Overall Study|Lost to Follow-up|3|||
33228119|NCT02790073|100735827|FG000|Overall Study|Death|1|||
33228120|NCT02790073|100735827|FG000|Overall Study|Withdrawal from HD|1|||
33228121|NCT02790073|100735827|FG000|Overall Study|Withdrawal by Subject|1|||
33228122|NCT00857805|100735828|FG000|Overall Study|Withdrawal by Subject|1|||
33228123|NCT00857805|100735829|FG001|Overall Study|Withdrawal by Subject|1|||
33418628|NCT04380701|101425551|FG002|Overall Study|Lost to Follow-up|0|||
33570883|NCT03235050|101982653|FG002|Overall Study|Lost to Follow-up|1|||
33570884|NCT03235050|101982654|FG003|Overall Study|Lost to Follow-up|2|||
33570885|NCT03235050|101982655|FG004|Overall Study|Lost to Follow-up|0|||
33228124|NCT02690077|100735830|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
33228125|NCT02690077|100735831|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
33228126|NCT02690077|100735830|FG000|Overall Study|Withdrawal by Subject|0|||
33228127|NCT02690077|100735831|FG001|Overall Study|Withdrawal by Subject|5|||
33228128|NCT02690077|100735830|FG000|Overall Study|Excluded by IRB|0|||
33228129|NCT02690077|100735831|FG001|Overall Study|Excluded by IRB|2|||
33228130|NCT00244374|100735833|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
33228131|NCT00244374|100735834|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
33570886|NCT03235050|101982651|FG000|Overall Study|Withdrawal by Subject|3|||
33570887|NCT03235050|101982652|FG001|Overall Study|Withdrawal by Subject|2|||
33570888|NCT03235050|101982653|FG002|Overall Study|Withdrawal by Subject|2|||
33570889|NCT03235050|101982654|FG003|Overall Study|Withdrawal by Subject|5|||
33570890|NCT03235050|101982655|FG004|Overall Study|Withdrawal by Subject|7|||
33570891|NCT03235050|101982651|FG000|Overall Study|Other reasons|0|||
33570892|NCT03235050|101982652|FG001|Overall Study|Other reasons|1|||
33570893|NCT03235050|101982653|FG002|Overall Study|Other reasons|0|||
33570894|NCT03235050|101982654|FG003|Overall Study|Other reasons|1|||
33570895|NCT03235050|101982655|FG004|Overall Study|Other reasons|2|||
33570896|NCT00746811|101982664|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
33570897|NCT00746811|101982665|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
33570898|NCT00980044|101982666|FG000|Overall Study|Withdrawal by Subject|5|||
33570899|NCT00980044|101982667|FG001|Overall Study|Withdrawal by Subject|7|||
33570900|NCT00980044|101982668|FG002|Overall Study|Withdrawal by Subject|3|||
33570901|NCT00980044|101982666|FG000|Overall Study|Protocol Violation|0|||
33570902|NCT00980044|101982667|FG001|Overall Study|Protocol Violation|0|||
33570903|NCT00980044|101982668|FG002|Overall Study|Protocol Violation|2|||
33570904|NCT02746809|101982669|FG000|Enrollment|Inclusion Exclusion not met|9|||
33570905|NCT02746809|101982669|FG000|Enrollment|Withdrawal by Subject|1|||
33570906|NCT02746809|101982669|FG000|Enrollment|Expected Enrollment Met|2|||
33570907|NCT02746809|101982669|FG000|Procedure|Death|1|||
33570908|NCT02746809|101982669|FG000|1-Month|Death|5|||
33570909|NCT02746809|101982669|FG000|6-Month|Death|2|||
33570910|NCT02746809|101982669|FG000|6-Month|Withdrawal by Subject|1|||
33570911|NCT02746809|101982669|FG000|12-Month|Death|3|||
33570912|NCT02746809|101982669|FG000|12-Month|Withdrawal by Subject|2|||
33570913|NCT02746809|101982669|FG000|24-Month|Death|1|||
33570914|NCT02746809|101982669|FG000|24-Month|Withdrawal by Subject|1|||
33570915|NCT02746809|101982669|FG000|36-Month|Death|8|||
33570916|NCT02746809|101982669|FG000|36-Month|Withdrawal by Subject|1|||
33570917|NCT02746809|101982669|FG000|48-Month|Death|7|||
33570918|NCT02746809|101982669|FG000|48-Month|Withdrawal by Subject|1|||
33570919|NCT02746809|101982669|FG000|60-Month|Death|1|||
33570920|NCT02746809|101982669|FG000|60-Month|Lost to Follow-up|2|||
33570921|NCT03837509|101982673|FG000|Phase 1|Death|5|||
33570922|NCT03837509|101982674|FG001|Phase 1|Death|2|||
33570923|NCT03837509|101982675|FG002|Phase 1|Death|0|||
33570924|NCT03837509|101982676|FG003|Phase 1|Death|0|||
33570925|NCT03837509|101982677|FG004|Phase 1|Death|0|||
33570926|NCT03837509|101982673|FG000|Phase 2|Death|0|||
33633691|NCT01550003|102211922|FG002|Overall Study|Patient reached adulthood|0|||
33633692|NCT01550003|102211920|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
33633693|NCT01550003|102211921|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
33633694|NCT01550003|102211922|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
33633695|NCT01550003|102211920|FG000|Overall Study|Sponsor's order|0|||
33633696|NCT01550003|102211921|FG001|Overall Study|Sponsor's order|3|||
33633697|NCT01550003|102211922|FG002|Overall Study|Sponsor's order|3|||
33366723|NCT03567291|101230094|FG002|Period I|Adverse Event|0|||
33366724|NCT03567291|101230095|FG003|Period I|Adverse Event|0|||
33366725|NCT03567291|101230092|FG000|Period I|Protocol Violation|1|||
33366726|NCT03567291|101230093|FG001|Period I|Protocol Violation|0|||
33633698|NCT01550003|102211920|FG000|Overall Study|Sponsor's decision|1|||
33633699|NCT01550003|102211921|FG001|Overall Study|Sponsor's decision|5|||
33633700|NCT01550003|102211922|FG002|Overall Study|Sponsor's decision|4|||
33633701|NCT01550003|102211920|FG000|Overall Study|Subject mother passed away|0|||
33633702|NCT01550003|102211921|FG001|Overall Study|Subject mother passed away|1|||
33633703|NCT01550003|102211922|FG002|Overall Study|Subject mother passed away|0|||
33633704|NCT01550003|102211920|FG000|Overall Study|Discontinuation|0|||
33633705|NCT01550003|102211921|FG001|Overall Study|Discontinuation|1|||
33633706|NCT01550003|102211922|FG002|Overall Study|Discontinuation|0|||
33633707|NCT01550003|102211920|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
33633708|NCT01550003|102211921|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
33633709|NCT01550003|102211922|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
33228132|NCT00244374|100735835|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
33228133|NCT00244374|100735836|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
33228134|NCT00244374|100735837|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
33228135|NCT00244374|100735833|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
33228136|NCT00244374|100735834|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
33570927|NCT03837509|101982674|FG001|Phase 2|Death|0|||
33570928|NCT03837509|101982675|FG002|Phase 2|Death|0|||
33570929|NCT03837509|101982676|FG003|Phase 2|Death|1|||
33366727|NCT03567291|101230094|FG002|Period I|Protocol Violation|0|||
33366728|NCT03567291|101230095|FG003|Period I|Protocol Violation|0|||
33570930|NCT03837509|101982677|FG004|Phase 2|Death|1|||
33570931|NCT02891226|101982679|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
33570932|NCT02891226|101982680|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
33570933|NCT02891226|101982681|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
33570934|NCT02891226|101982682|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33570935|NCT02891226|101982683|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33570936|NCT02891226|101982684|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33570937|NCT02891226|101982685|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33570938|NCT02891226|101982686|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33570939|NCT02891226|101982687|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33570940|NCT02891226|101982688|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33570941|NCT02891226|101982689|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33570942|NCT02891226|101982690|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33570943|NCT02891226|101982691|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33570944|NCT02891226|101982692|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33570945|NCT02891226|101982693|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33570946|NCT02891226|101982694|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
33570947|NCT02891226|101982679|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
33570948|NCT02891226|101982680|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
33570949|NCT02891226|101982681|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33633710|NCT01550003|102211920|FG000|Overall Study|Site closure|0|||
33633711|NCT01550003|102211921|FG001|Overall Study|Site closure|2|||
33633712|NCT01550003|102211922|FG002|Overall Study|Site closure|0|||
33633713|NCT01550003|102211920|FG000|Overall Study|Pregnancy|0|||
33633714|NCT01550003|102211921|FG001|Overall Study|Pregnancy|1|||
33633715|NCT01550003|102211922|FG002|Overall Study|Pregnancy|0|||
33633716|NCT01550003|102211920|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
33228137|NCT00244374|100735835|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
33228138|NCT00244374|100735836|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
33570950|NCT02891226|101982682|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33570951|NCT02891226|101982683|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33570952|NCT02891226|101982684|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33570953|NCT02891226|101982685|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33366729|NCT03567291|101230092|FG000|Period I|Withdrawal by Subject|23|||
33366730|NCT03567291|101230093|FG001|Period I|Withdrawal by Subject|0|||
33570954|NCT02891226|101982686|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33570955|NCT02891226|101982687|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33570956|NCT02891226|101982688|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33570957|NCT02891226|101982689|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33366731|NCT03567291|101230094|FG002|Period I|Withdrawal by Subject|0|||
33570958|NCT02891226|101982690|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33570959|NCT02891226|101982691|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33570960|NCT02891226|101982692|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33570961|NCT02891226|101982693|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33570962|NCT02891226|101982694|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33570963|NCT02891226|101982679|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33570964|NCT02891226|101982680|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33570965|NCT02891226|101982681|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33570966|NCT02891226|101982682|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
33570967|NCT02891226|101982683|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33570968|NCT02891226|101982684|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33570969|NCT02891226|101982685|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33570970|NCT02891226|101982686|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33366732|NCT03567291|101230095|FG003|Period I|Withdrawal by Subject|0|||
33366733|NCT03567291|101230092|FG000|Period I|Lost to Follow-up|2|||
33366734|NCT03567291|101230093|FG001|Period I|Lost to Follow-up|0|||
33366735|NCT03567291|101230094|FG002|Period I|Lost to Follow-up|0|||
33633717|NCT01550003|102211921|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
33633718|NCT01550003|102211922|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
33633719|NCT01550003|102211920|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
33633720|NCT01550003|102211921|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
33633721|NCT01550003|102211922|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
33633722|NCT01550003|102211920|FG000|Overall Study|Switching to adult rheumatologist|0|||
33633723|NCT01550003|102211921|FG001|Overall Study|Switching to adult rheumatologist|0|||
33633724|NCT01550003|102211922|FG002|Overall Study|Switching to adult rheumatologist|1|||
33633725|NCT01550003|102211920|FG000|Overall Study|Patient transition to adult care|0|||
33633726|NCT01550003|102211921|FG001|Overall Study|Patient transition to adult care|0|||
33633727|NCT01550003|102211922|FG002|Overall Study|Patient transition to adult care|1|||
33633728|NCT01550003|102211920|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
33633729|NCT01550003|102211921|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
33633730|NCT01550003|102211922|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
33633731|NCT01550003|102211920|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
33633732|NCT01550003|102211921|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
33633733|NCT01550003|102211922|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
33633734|NCT01550003|102211920|FG000|Overall Study|Per Sponsor request|1|||
33633735|NCT01550003|102211921|FG001|Overall Study|Per Sponsor request|0|||
33633736|NCT01550003|102211922|FG002|Overall Study|Per Sponsor request|1|||
33633737|NCT01550003|102211920|FG000|Overall Study|Patient not compliance|0|||
33633738|NCT01550003|102211921|FG001|Overall Study|Patient not compliance|0|||
33633739|NCT01550003|102211922|FG002|Overall Study|Patient not compliance|1|||
33633740|NCT01550003|102211920|FG000|Overall Study|Non-compliance|0|||
33633741|NCT01550003|102211921|FG001|Overall Study|Non-compliance|0|||
33633742|NCT01550003|102211922|FG002|Overall Study|Non-compliance|1|||
33633743|NCT01550003|102211920|FG000|Overall Study|Study closed|0|||
33633744|NCT01550003|102211921|FG001|Overall Study|Study closed|1|||
33633745|NCT01550003|102211922|FG002|Overall Study|Study closed|0|||
33633746|NCT01550003|102211920|FG000|Overall Study|Transitioned to adult rheumatology|0|||
33633747|NCT01550003|102211921|FG001|Overall Study|Transitioned to adult rheumatology|0|||
33633748|NCT01550003|102211922|FG002|Overall Study|Transitioned to adult rheumatology|1|||
33633749|NCT03011099|102211925|FG000|Overall Study|Withdrawal by Subject|0|||
33633750|NCT03011099|102211926|FG001|Overall Study|Withdrawal by Subject|2|||
33633751|NCT02195518|102211927|FG000|Overall Study|Adverse Event|1|||
33633752|NCT02195518|102211927|FG000|Overall Study|Protocol Violation|4|||
33633753|NCT02195518|102211927|FG000|Overall Study|Pregnancy|2|||
33633754|NCT02195518|102211927|FG000|Overall Study|Withdrawal by Subject|1|||
33633755|NCT02195518|102211927|FG000|Overall Study|Lost to Follow-up|1|||
33633756|NCT00728689|102211928|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
33633757|NCT00728689|102211929|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
33633758|NCT03085095|102211930|FG000|Overall Study|Adverse Event|23|||
33633759|NCT03085095|102211931|FG001|Overall Study|Adverse Event|8|||
33633760|NCT03085095|102211930|FG000|Overall Study|Protocol Violation|0|||
33633761|NCT03085095|102211931|FG001|Overall Study|Protocol Violation|1|||
33366736|NCT03567291|101230095|FG003|Period I|Lost to Follow-up|0|||
33570971|NCT02891226|101982687|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33570972|NCT02891226|101982688|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33633762|NCT03085095|102211930|FG000|Overall Study|Lost to Follow-up|2|||
33570973|NCT02891226|101982689|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33570974|NCT02891226|101982690|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33633763|NCT03085095|102211931|FG001|Overall Study|Lost to Follow-up|1|||
33633764|NCT03085095|102211930|FG000|Overall Study|Withdrawal by Subject|17|||
33633765|NCT03085095|102211931|FG001|Overall Study|Withdrawal by Subject|6|||
33366737|NCT03567291|101230092|FG000|Period I|Terminated by sponsor|44|||
33366738|NCT03567291|101230093|FG001|Period I|Terminated by sponsor|0|||
33570975|NCT02891226|101982691|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33633766|NCT03085095|102211930|FG000|Overall Study|Physician Decision|9|||
33633767|NCT03085095|102211931|FG001|Overall Study|Physician Decision|3|||
33633768|NCT03085095|102211930|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
33633769|NCT03085095|102211931|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
33633770|NCT03085095|102211930|FG000|Overall Study|Did not Receive Study Drug|2|||
33633771|NCT03085095|102211931|FG001|Overall Study|Did not Receive Study Drug|2|||
33633772|NCT03085095|102211930|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
33633773|NCT03085095|102211931|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
33633774|NCT02220920|102211932|FG000|Overall Study|Adverse Event|1|||
33633775|NCT02220920|102211933|FG001|Overall Study|Adverse Event|0|||
33633776|NCT02220920|102211932|FG000|Overall Study|Lack of Efficacy|0|||
33633777|NCT02220920|102211933|FG001|Overall Study|Lack of Efficacy|1|||
33633778|NCT02220920|102211932|FG000|Overall Study|Withdrawal by Subject|1|||
33633779|NCT02220920|102211933|FG001|Overall Study|Withdrawal by Subject|0|||
33633780|NCT02220920|102211932|FG000|Overall Study|Conflict with the stopping criteria|1|||
33633781|NCT02220920|102211933|FG001|Overall Study|Conflict with the stopping criteria|2|||
33633782|NCT02151058|102211934|FG000|Overall Study|Withdrawal by Subject|1|||
33633783|NCT02151058|102211935|FG001|Overall Study|Withdrawal by Subject|1|||
33633784|NCT02151058|102211936|FG002|Overall Study|Withdrawal by Subject|3|||
33633785|NCT02151058|102211934|FG000|Overall Study|Lost to Follow-up|1|||
33633786|NCT02151058|102211935|FG001|Overall Study|Lost to Follow-up|0|||
33633787|NCT02151058|102211936|FG002|Overall Study|Lost to Follow-up|2|||
33633788|NCT00914849|102211939|FG000|Overall Study|Withdrawal by Subject|1|||
33633789|NCT00914849|102211940|FG001|Overall Study|Withdrawal by Subject|0|||
33633790|NCT00914849|102211939|FG000|Overall Study|Not eligible|0|||
33633791|NCT00914849|102211940|FG001|Overall Study|Not eligible|1|||
33633792|NCT00630838|102211943|FG000|Overall Study|Death|0|||
33633793|NCT00630838|102211944|FG001|Overall Study|Death|1|||
33633794|NCT00630838|102211943|FG000|Overall Study|Lost to Follow-up|0|||
33633795|NCT00630838|102211944|FG001|Overall Study|Lost to Follow-up|1|||
33633796|NCT00389610|102211945|FG000|Overall Study|Disease Progression|0|||
33633797|NCT00389610|102211946|FG001|Overall Study|Disease Progression|19|||
33633798|NCT00389610|102211945|FG000|Overall Study|Death|0|||
33633799|NCT00389610|102211946|FG001|Overall Study|Death|1|||
33633800|NCT00389610|102211945|FG000|Overall Study|Physician Decision|0|||
33633801|NCT00389610|102211946|FG001|Overall Study|Physician Decision|1|||
33633802|NCT00389610|102211945|FG000|Overall Study|Withdrawal by Subject|0|||
33633803|NCT00389610|102211946|FG001|Overall Study|Withdrawal by Subject|1|||
33633804|NCT00561925|102211950|FG000|14 Day Lead-In Period|Adverse Event|38|||
33633805|NCT00561925|102211951|FG001|14 Day Lead-In Period|Adverse Event|0|||
33633806|NCT00561925|102211952|FG002|14 Day Lead-In Period|Adverse Event|0|||
33570976|NCT02891226|101982692|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33570977|NCT02891226|101982693|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33570978|NCT02891226|101982694|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33570979|NCT02891226|101982679|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570980|NCT02891226|101982680|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570981|NCT02891226|101982681|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
33570982|NCT02891226|101982682|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570983|NCT02891226|101982683|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570984|NCT02891226|101982684|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570985|NCT02891226|101982685|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570986|NCT02891226|101982686|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570987|NCT02891226|101982687|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570988|NCT02891226|101982688|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570989|NCT02891226|101982689|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570990|NCT02891226|101982690|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570991|NCT02891226|101982691|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570992|NCT02891226|101982692|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570993|NCT02891226|101982693|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570994|NCT02891226|101982694|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
33570995|NCT02891226|101982679|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33570996|NCT02891226|101982680|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33633807|NCT00561925|102211953|FG003|14 Day Lead-In Period|Adverse Event|0|||
33633808|NCT00561925|102211954|FG004|14 Day Lead-In Period|Adverse Event|0|||
33633809|NCT00561925|102211950|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
33633810|NCT00561925|102211951|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
33633811|NCT00561925|102211952|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
33286408|NCT00092521|100943968|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
33570997|NCT02891226|101982681|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33570998|NCT02891226|101982682|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
33633812|NCT00561925|102211953|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
33633813|NCT00561925|102211954|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
33633814|NCT00561925|102211950|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
33633815|NCT00561925|102211951|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
33228139|NCT00244374|100735837|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
33228140|NCT00244374|100735833|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
33228141|NCT00244374|100735834|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
33228142|NCT00244374|100735835|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
33228143|NCT00244374|100735836|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
33228144|NCT00244374|100735837|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
33228145|NCT00244374|100735833|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
33228146|NCT00244374|100735834|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
33228147|NCT00244374|100735835|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
33228148|NCT00244374|100735836|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
33228149|NCT00244374|100735837|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
33366739|NCT03567291|101230094|FG002|Period I|Terminated by sponsor|0|||
33570999|NCT02891226|101982683|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33571000|NCT02891226|101982684|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33571001|NCT02891226|101982685|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33571002|NCT02891226|101982686|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33571003|NCT02891226|101982687|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33571004|NCT02891226|101982688|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33571005|NCT02891226|101982689|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33571006|NCT02891226|101982690|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33571007|NCT02891226|101982691|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33571008|NCT02891226|101982692|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33571009|NCT02891226|101982693|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33571010|NCT02891226|101982694|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
33571011|NCT02891226|101982679|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571012|NCT02891226|101982680|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571013|NCT02891226|101982681|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571014|NCT02891226|101982682|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
33571015|NCT02891226|101982683|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571016|NCT02891226|101982684|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571017|NCT02891226|101982685|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571018|NCT02891226|101982686|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571019|NCT02891226|101982687|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571020|NCT02891226|101982688|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571021|NCT02891226|101982689|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571022|NCT02891226|101982690|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571023|NCT02891226|101982691|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571024|NCT02891226|101982692|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571025|NCT02891226|101982693|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571026|NCT02891226|101982694|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
33571027|NCT02891226|101982679|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33571028|NCT02891226|101982680|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33571029|NCT02891226|101982681|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33571030|NCT02891226|101982682|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33571031|NCT02891226|101982683|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33571032|NCT02891226|101982684|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33571033|NCT02891226|101982685|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
33571034|NCT02891226|101982686|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
33571035|NCT02891226|101982687|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
33571036|NCT02891226|101982688|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
33571037|NCT02891226|101982689|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33571038|NCT02891226|101982690|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33571039|NCT02891226|101982691|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33571040|NCT02891226|101982692|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33571041|NCT02891226|101982693|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33571042|NCT02891226|101982694|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
33571043|NCT02891226|101982679|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33571044|NCT02891226|101982680|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33571045|NCT02891226|101982681|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33571046|NCT02891226|101982682|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33571047|NCT02891226|101982683|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33571048|NCT02891226|101982684|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
33571049|NCT02891226|101982685|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33571050|NCT02891226|101982686|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33571051|NCT02891226|101982687|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33571052|NCT02891226|101982688|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
33571053|NCT02891226|101982689|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33228150|NCT00244374|100735833|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
33228151|NCT00244374|100735834|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
33418629|NCT04380701|101425552|FG003|Overall Study|Lost to Follow-up|0|||
33571054|NCT02891226|101982690|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33571055|NCT02891226|101982691|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33571056|NCT02891226|101982692|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33571057|NCT02891226|101982693|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33571058|NCT02891226|101982694|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
33571059|NCT02891226|101982679|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33228152|NCT00244374|100735835|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
33228153|NCT00244374|100735836|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
33633816|NCT00561925|102211952|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
33633817|NCT00561925|102211953|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
33633818|NCT00561925|102211954|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
33633819|NCT00561925|102211950|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
33633820|NCT00561925|102211951|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
33633821|NCT00561925|102211952|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
33228154|NCT00244374|100735837|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
33366740|NCT03567291|101230095|FG003|Period I|Terminated by sponsor|0|||
33571060|NCT02891226|101982680|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33571061|NCT02891226|101982681|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33571062|NCT02891226|101982682|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33571063|NCT02891226|101982683|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33571064|NCT02891226|101982684|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33571065|NCT02891226|101982685|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
33571066|NCT02891226|101982686|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
33571067|NCT02891226|101982687|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
33571068|NCT02891226|101982688|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
33571069|NCT02891226|101982689|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33571070|NCT02891226|101982690|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33571071|NCT02891226|101982691|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33571072|NCT02891226|101982692|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33571073|NCT02891226|101982693|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33571074|NCT02891226|101982694|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
33571075|NCT02891226|101982679|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33571076|NCT02891226|101982680|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33571077|NCT02891226|101982681|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33571078|NCT02891226|101982682|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33571079|NCT02891226|101982683|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
33633822|NCT00561925|102211953|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
33633823|NCT00561925|102211954|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
33633824|NCT00561925|102211950|FG000|14 Day Lead-In Period|Other|5|||
33633825|NCT00561925|102211951|FG001|14 Day Lead-In Period|Other|0|||
33633826|NCT00561925|102211952|FG002|14 Day Lead-In Period|Other|0|||
33418630|NCT04380701|101425553|FG004|Overall Study|Lost to Follow-up|0|||
33418631|NCT04380701|101425554|FG005|Overall Study|Lost to Follow-up|0|||
33633827|NCT00561925|102211953|FG003|14 Day Lead-In Period|Other|0|||
33633828|NCT00561925|102211954|FG004|14 Day Lead-In Period|Other|0|||
33633829|NCT00561925|102211950|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
33633830|NCT00561925|102211951|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
33633831|NCT00561925|102211952|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
33633832|NCT00561925|102211953|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
33633833|NCT00561925|102211954|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
33633834|NCT00561925|102211950|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
33633835|NCT00561925|102211951|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
33633836|NCT00561925|102211952|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
33633837|NCT00561925|102211953|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
33633838|NCT00561925|102211954|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
33418632|NCT04380701|101425555|FG006|Overall Study|Lost to Follow-up|0|||
33571080|NCT02891226|101982684|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33571081|NCT02891226|101982685|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33571082|NCT02891226|101982686|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33571083|NCT02891226|101982687|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33418633|NCT04380701|101425556|FG007|Overall Study|Lost to Follow-up|0|||
33418634|NCT04380701|101425557|FG008|Overall Study|Lost to Follow-up|0|||
33418635|NCT04380701|101425558|FG009|Overall Study|Lost to Follow-up|0|||
33571084|NCT02891226|101982688|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33418636|NCT04380701|101425559|FG010|Overall Study|Lost to Follow-up|0|||
33571085|NCT02891226|101982689|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33571086|NCT02891226|101982690|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33571087|NCT02891226|101982691|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33571088|NCT02891226|101982692|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33571089|NCT02891226|101982693|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33571090|NCT02891226|101982694|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
33571091|NCT02891226|101982679|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33571092|NCT02891226|101982680|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33633839|NCT00561925|102211950|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
33633840|NCT00561925|102211951|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
33571093|NCT02891226|101982681|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33571094|NCT02891226|101982682|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33571095|NCT02891226|101982683|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33571096|NCT02891226|101982684|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33571097|NCT02891226|101982685|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
33571098|NCT02891226|101982686|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33571099|NCT02891226|101982687|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33571100|NCT02891226|101982688|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33571101|NCT02891226|101982689|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33571102|NCT02891226|101982690|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33571103|NCT02891226|101982691|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33571104|NCT02891226|101982692|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33571105|NCT02891226|101982693|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33571106|NCT02891226|101982694|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
33571107|NCT02891226|101982679|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33418637|NCT04380701|101425560|FG011|Overall Study|Lost to Follow-up|0|||
33571108|NCT02891226|101982680|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33633841|NCT00561925|102211952|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
33418638|NCT04380701|101425561|FG012|Overall Study|Lost to Follow-up|0|||
33418639|NCT04380701|101425562|FG013|Overall Study|Lost to Follow-up|0|||
33571109|NCT02891226|101982681|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33571110|NCT02891226|101982682|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33571111|NCT02891226|101982683|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33571112|NCT02891226|101982684|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33571113|NCT02891226|101982685|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33571114|NCT02891226|101982686|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
33571115|NCT02891226|101982687|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
33571116|NCT02891226|101982688|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
33571117|NCT02891226|101982689|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33571118|NCT02891226|101982690|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33571119|NCT02891226|101982691|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33571120|NCT02891226|101982692|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33571121|NCT02891226|101982693|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33571122|NCT02891226|101982694|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
33571123|NCT02891226|101982679|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571124|NCT02891226|101982680|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571125|NCT02891226|101982681|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571126|NCT02891226|101982682|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571127|NCT02891226|101982683|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571128|NCT02891226|101982684|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571129|NCT02891226|101982685|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571130|NCT02891226|101982686|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
33571131|NCT02891226|101982687|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571132|NCT02891226|101982688|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571133|NCT02891226|101982689|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571134|NCT02891226|101982690|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571135|NCT02891226|101982691|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571136|NCT02891226|101982692|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571137|NCT02891226|101982693|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571138|NCT02891226|101982694|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
33571139|NCT02891226|101982679|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571140|NCT02891226|101982680|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571141|NCT02891226|101982681|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571142|NCT02891226|101982682|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571143|NCT02891226|101982683|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571144|NCT02891226|101982684|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571145|NCT02891226|101982685|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571146|NCT02891226|101982686|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571147|NCT02891226|101982687|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
33571148|NCT02891226|101982688|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571149|NCT02891226|101982689|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571150|NCT02891226|101982690|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571151|NCT02891226|101982691|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571152|NCT02891226|101982692|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571153|NCT02891226|101982693|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571154|NCT02891226|101982694|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
33571155|NCT02891226|101982679|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571156|NCT02891226|101982680|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571157|NCT02891226|101982681|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571158|NCT02891226|101982682|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571159|NCT02891226|101982683|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571160|NCT02891226|101982684|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571161|NCT02891226|101982685|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571162|NCT02891226|101982686|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571163|NCT02891226|101982687|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571164|NCT02891226|101982688|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
33571165|NCT02891226|101982689|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571166|NCT02891226|101982690|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571167|NCT02891226|101982691|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571168|NCT02891226|101982692|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571169|NCT02891226|101982693|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571170|NCT02891226|101982694|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
33571171|NCT02891226|101982679|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33571172|NCT02891226|101982680|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33571173|NCT02891226|101982681|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33571174|NCT02891226|101982682|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33571175|NCT02891226|101982683|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33571176|NCT02891226|101982684|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33571177|NCT02891226|101982685|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33571178|NCT02891226|101982686|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33633842|NCT00561925|102211953|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
33633843|NCT00561925|102211954|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
33633844|NCT00561925|102211950|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
33228155|NCT00244374|100735833|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
33228156|NCT00244374|100735834|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
33228157|NCT00244374|100735835|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
33228158|NCT00244374|100735836|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
33228159|NCT00244374|100735837|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
33228160|NCT00244374|100735833|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
33633845|NCT00561925|102211951|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
33633846|NCT00561925|102211952|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
33633847|NCT00561925|102211953|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
33633848|NCT00561925|102211954|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
33633849|NCT00561925|102211950|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
33633850|NCT00561925|102211951|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
33633851|NCT00561925|102211952|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
33633852|NCT00561925|102211953|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
33633853|NCT00561925|102211954|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
33633854|NCT00561925|102211950|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
33633855|NCT00561925|102211951|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
33633856|NCT00561925|102211952|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
33633857|NCT00561925|102211953|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
33633858|NCT00561925|102211954|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
33633859|NCT00561925|102211950|FG000|144-week Double-blind, Double-dummy|Death|0|||
33633860|NCT00561925|102211951|FG001|144-week Double-blind, Double-dummy|Death|6|||
33228161|NCT00244374|100735834|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
33228162|NCT00244374|100735835|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
33228163|NCT00244374|100735836|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
33228164|NCT00244374|100735837|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
33228165|NCT00244374|100735833|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
33228166|NCT00244374|100735834|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
33228167|NCT00244374|100735835|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
33228168|NCT00244374|100735836|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
33228169|NCT00244374|100735837|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
33228170|NCT00244374|100735833|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
33228171|NCT00244374|100735834|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
33228172|NCT00244374|100735835|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
33228173|NCT00244374|100735836|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
33228174|NCT00244374|100735837|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
33228175|NCT01923896|100735844|FG000|Overall Study|Adverse Event|1|||
33228176|NCT01923896|100735845|FG001|Overall Study|Adverse Event|0|||
33228177|NCT00332332|100735847|FG000|Overall Study|Adverse Event|13|||
33228178|NCT00332332|100735847|FG000|Overall Study|Death|1|||
33228179|NCT00332332|100735847|FG000|Overall Study|Withdrawal by Subject|8|||
33228180|NCT00332332|100735847|FG000|Overall Study|Physician Decision|1|||
33228181|NCT00332332|100735847|FG000|Overall Study|Lost to Follow-up|3|||
33228182|NCT00332332|100735847|FG000|Overall Study|Protocol deviation|4|||
33228183|NCT00332332|100735847|FG000|Overall Study|Noncompliance|2|||
33228184|NCT00332332|100735847|FG000|Overall Study|Disease progression|2|||
33228185|NCT00332332|100735847|FG000|Overall Study|Other|18|||
33228186|NCT00332332|100735847|FG000|Overall Study|Did not receive study treatment|16|||
33228187|NCT00251927|100735848|FG000|Overall Study|Adverse Event|3|||
33228188|NCT00251927|100735849|FG001|Overall Study|Adverse Event|15|||
33228189|NCT00251927|100735848|FG000|Overall Study|Lack of Efficacy|22|||
33228190|NCT00251927|100735849|FG001|Overall Study|Lack of Efficacy|16|||
33228191|NCT00251927|100735848|FG000|Overall Study|Lost to Follow-up|22|||
33228192|NCT00251927|100735849|FG001|Overall Study|Lost to Follow-up|8|||
33228193|NCT00251927|100735848|FG000|Overall Study|Protocol Violation|1|||
33228194|NCT00251927|100735849|FG001|Overall Study|Protocol Violation|2|||
33228195|NCT00251927|100735848|FG000|Overall Study|Pregnancy|2|||
33571179|NCT02891226|101982687|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33571180|NCT02891226|101982688|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
33571181|NCT02891226|101982689|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33571182|NCT02891226|101982690|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33571183|NCT02891226|101982691|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33571184|NCT02891226|101982692|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33571185|NCT02891226|101982693|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33571186|NCT02891226|101982694|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
33571187|NCT02891226|101982679|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33571188|NCT02891226|101982680|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33228196|NCT00251927|100735849|FG001|Overall Study|Pregnancy|0|||
33228197|NCT00251927|100735848|FG000|Overall Study|Withdrawal by Subject|40|||
33228198|NCT00251927|100735849|FG001|Overall Study|Withdrawal by Subject|25|||
33228199|NCT00251927|100735848|FG000|Overall Study|Study-specific discont. achieved|13|||
33228200|NCT00251927|100735849|FG001|Overall Study|Study-specific discont. achieved|2|||
33366741|NCT03567291|101230092|FG000|Period I|Missing or unknown|7|||
33571189|NCT02891226|101982681|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33418640|NCT04380701|101425563|FG014|Overall Study|Lost to Follow-up|0|||
33571190|NCT02891226|101982682|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33228201|NCT00251927|100735848|FG000|Overall Study|Study procedure non-compliance|5|||
33228202|NCT00251927|100735849|FG001|Overall Study|Study procedure non-compliance|6|||
33228203|NCT01806740|100735850|FG000|Overall Study|Withdrawal by Subject|4|||
33228204|NCT01806740|100735850|FG000|Overall Study|Physician Decision|1|||
33228205|NCT01806740|100735850|FG000|Overall Study|Patient's refusal of treatment|1|||
33366742|NCT03567291|101230093|FG001|Period I|Missing or unknown|0|||
33366743|NCT03567291|101230094|FG002|Period I|Missing or unknown|0|||
33418641|NCT04380701|101425564|FG015|Overall Study|Lost to Follow-up|0|||
33571191|NCT02891226|101982683|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33571192|NCT02891226|101982684|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33571193|NCT02891226|101982685|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33571194|NCT02891226|101982686|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33366744|NCT03567291|101230095|FG003|Period I|Missing or unknown|0|||
33366745|NCT03567291|101230092|FG000|Period II|Adverse Event|0|||
33366746|NCT03567291|101230093|FG001|Period II|Adverse Event|1|||
33571195|NCT02891226|101982687|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33571196|NCT02891226|101982688|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33571197|NCT02891226|101982689|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
33571198|NCT02891226|101982690|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33571199|NCT02891226|101982691|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33571200|NCT02891226|101982692|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33571201|NCT02891226|101982693|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33571202|NCT02891226|101982694|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
33633861|NCT00561925|102211952|FG002|144-week Double-blind, Double-dummy|Death|3|||
33633862|NCT00561925|102211953|FG003|144-week Double-blind, Double-dummy|Death|0|||
33633863|NCT00561925|102211954|FG004|144-week Double-blind, Double-dummy|Death|0|||
33633864|NCT00561925|102211950|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
33418642|NCT04380701|101425565|FG016|Overall Study|Lost to Follow-up|0|||
33418643|NCT04380701|101425566|FG017|Overall Study|Lost to Follow-up|0|||
33418644|NCT04380701|101425567|FG018|Overall Study|Lost to Follow-up|0|||
33633865|NCT00561925|102211951|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
33418645|NCT04380701|101425568|FG019|Overall Study|Lost to Follow-up|0|||
33418646|NCT04380701|101425569|FG020|Overall Study|Lost to Follow-up|1|||
33418647|NCT04380701|101425570|FG021|Overall Study|Lost to Follow-up|0|||
33418648|NCT04380701|101425571|FG022|Overall Study|Lost to Follow-up|0|||
33418649|NCT04380701|101425572|FG023|Overall Study|Lost to Follow-up|1|||
33418650|NCT04380701|101425573|FG024|Overall Study|Lost to Follow-up|0|||
33633866|NCT00561925|102211952|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
33633867|NCT00561925|102211953|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
33633868|NCT00561925|102211954|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
33633869|NCT00561925|102211950|FG000|144-week Double-blind, Double-dummy|Other|0|||
33418651|NCT04380701|101425574|FG025|Overall Study|Lost to Follow-up|0|||
33418652|NCT04380701|101425575|FG026|Overall Study|Lost to Follow-up|0|||
33418653|NCT04380701|101425576|FG027|Overall Study|Lost to Follow-up|0|||
33418654|NCT04380701|101425577|FG028|Overall Study|Lost to Follow-up|0|||
33418655|NCT04380701|101425578|FG029|Overall Study|Lost to Follow-up|1|||
33633870|NCT00561925|102211951|FG001|144-week Double-blind, Double-dummy|Other|8|||
33633871|NCT00561925|102211952|FG002|144-week Double-blind, Double-dummy|Other|11|||
33633872|NCT00561925|102211953|FG003|144-week Double-blind, Double-dummy|Other|0|||
33633873|NCT00561925|102211954|FG004|144-week Double-blind, Double-dummy|Other|0|||
33633874|NCT00561925|102211950|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
33366747|NCT03567291|101230094|FG002|Period II|Adverse Event|0|||
33366748|NCT03567291|101230095|FG003|Period II|Adverse Event|0|||
33366749|NCT03567291|101230092|FG000|Period II|Missing or unknown|0|||
33366750|NCT03567291|101230093|FG001|Period II|Missing or unknown|2|||
33366751|NCT03567291|101230094|FG002|Period II|Missing or unknown|1|||
33366752|NCT03567291|101230095|FG003|Period II|Missing or unknown|0|||
33366753|NCT03567291|101230092|FG000|Period III|Adverse Event|0|||
33418656|NCT04380701|101425579|FG030|Overall Study|Lost to Follow-up|0|||
33418657|NCT04380701|101425580|FG031|Overall Study|Lost to Follow-up|0|||
33418658|NCT04380701|101425581|FG032|Overall Study|Lost to Follow-up|0|||
33418659|NCT04380701|101425582|FG033|Overall Study|Lost to Follow-up|1|||
33418660|NCT04380701|101425549|FG000|Overall Study|Private reason(s)|0|||
33418661|NCT04380701|101425550|FG001|Overall Study|Private reason(s)|0|||
33571203|NCT02891226|101982679|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33418662|NCT04380701|101425551|FG002|Overall Study|Private reason(s)|0|||
33418663|NCT04380701|101425552|FG003|Overall Study|Private reason(s)|0|||
33571204|NCT02891226|101982680|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33571205|NCT02891226|101982681|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33366754|NCT03567291|101230093|FG001|Period III|Adverse Event|0|||
33366755|NCT03567291|101230094|FG002|Period III|Adverse Event|0|||
33633875|NCT00561925|102211951|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
33633876|NCT00561925|102211952|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
33633877|NCT00561925|102211953|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
33633878|NCT00561925|102211954|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
33633879|NCT04596267|102211956|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
33633880|NCT04596267|102211957|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
33633881|NCT04596267|102211956|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
33633882|NCT04596267|102211957|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
33633883|NCT01207414|102211958|FG000|Overall Study|Adverse Event|25|||
33633884|NCT01207414|102211959|FG001|Overall Study|Adverse Event|39|||
33633885|NCT01207414|102211958|FG000|Overall Study|Abnormal test procedure results|0|||
33633886|NCT01207414|102211959|FG001|Overall Study|Abnormal test procedure results|1|||
33633887|NCT01207414|102211958|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
33633888|NCT01207414|102211959|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
33633889|NCT01207414|102211958|FG000|Overall Study|Patient withdrew consent|14|||
33633890|NCT01207414|102211959|FG001|Overall Study|Patient withdrew consent|11|||
33633891|NCT01207414|102211958|FG000|Overall Study|Lost to Follow-up|15|||
33633892|NCT01207414|102211959|FG001|Overall Study|Lost to Follow-up|17|||
33633893|NCT01207414|102211958|FG000|Overall Study|Administrative problems|1|||
33633894|NCT01207414|102211959|FG001|Overall Study|Administrative problems|1|||
33633895|NCT01207414|102211958|FG000|Overall Study|Protocol deviation|12|||
33633896|NCT01207414|102211959|FG001|Overall Study|Protocol deviation|9|||
33633897|NCT01207414|102211958|FG000|Overall Study|Randomized in error|1|||
33633898|NCT01207414|102211959|FG001|Overall Study|Randomized in error|0|||
33633899|NCT01046396|102211964|FG000|Overall Study|Withdrawal by Subject|5|||
33633900|NCT02594124|102211965|FG000|Overall Study|Adverse Event|0|||
33633901|NCT02594124|102211966|FG001|Overall Study|Adverse Event|5|||
33633902|NCT02594124|102211967|FG002|Overall Study|Adverse Event|8|||
33633903|NCT02594124|102211968|FG003|Overall Study|Adverse Event|1|||
33633904|NCT02594124|102211969|FG004|Overall Study|Adverse Event|0|||
33633905|NCT02594124|102211970|FG005|Overall Study|Adverse Event|0|||
33633906|NCT02594124|102211971|FG006|Overall Study|Adverse Event|2|||
33633907|NCT02594124|102211972|FG007|Overall Study|Adverse Event|2|||
33633908|NCT02594124|102211973|FG008|Overall Study|Adverse Event|0|||
33633909|NCT02594124|102211965|FG000|Overall Study|Withdrawal by Subject|2|||
33633910|NCT02594124|102211966|FG001|Overall Study|Withdrawal by Subject|3|||
33633911|NCT02594124|102211967|FG002|Overall Study|Withdrawal by Subject|5|||
33633912|NCT02594124|102211968|FG003|Overall Study|Withdrawal by Subject|1|||
33633913|NCT02594124|102211969|FG004|Overall Study|Withdrawal by Subject|8|||
33633914|NCT02594124|102211970|FG005|Overall Study|Withdrawal by Subject|4|||
33633915|NCT02594124|102211971|FG006|Overall Study|Withdrawal by Subject|13|||
33633916|NCT02594124|102211972|FG007|Overall Study|Withdrawal by Subject|19|||
33633917|NCT02594124|102211973|FG008|Overall Study|Withdrawal by Subject|0|||
33633918|NCT02594124|102211965|FG000|Overall Study|Physician Decision|0|||
33633919|NCT02594124|102211966|FG001|Overall Study|Physician Decision|2|||
33633920|NCT02594124|102211967|FG002|Overall Study|Physician Decision|0|||
33633921|NCT02594124|102211968|FG003|Overall Study|Physician Decision|0|||
33633922|NCT02594124|102211969|FG004|Overall Study|Physician Decision|0|||
33633923|NCT02594124|102211970|FG005|Overall Study|Physician Decision|0|||
33633924|NCT02594124|102211971|FG006|Overall Study|Physician Decision|0|||
33633925|NCT02594124|102211972|FG007|Overall Study|Physician Decision|1|||
33633926|NCT02594124|102211973|FG008|Overall Study|Physician Decision|0|||
33633927|NCT02594124|102211965|FG000|Overall Study|Commercial drug|0|||
33633928|NCT02594124|102211966|FG001|Overall Study|Commercial drug|1|||
33633929|NCT02594124|102211967|FG002|Overall Study|Commercial drug|6|||
33633930|NCT02594124|102211968|FG003|Overall Study|Commercial drug|3|||
33633931|NCT02594124|102211969|FG004|Overall Study|Commercial drug|0|||
33633932|NCT02594124|102211970|FG005|Overall Study|Commercial drug|0|||
33366756|NCT03567291|101230095|FG003|Period III|Adverse Event|4|||
33633933|NCT02594124|102211971|FG006|Overall Study|Commercial drug|7|||
33633934|NCT02594124|102211972|FG007|Overall Study|Commercial drug|11|||
33633935|NCT02594124|102211973|FG008|Overall Study|Commercial drug|2|||
33633936|NCT02594124|102211965|FG000|Overall Study|Reason Not Specified|1|||
33633937|NCT02594124|102211966|FG001|Overall Study|Reason Not Specified|3|||
33633938|NCT02594124|102211967|FG002|Overall Study|Reason Not Specified|4|||
33418664|NCT04380701|101425553|FG004|Overall Study|Private reason(s)|0|||
33418665|NCT04380701|101425554|FG005|Overall Study|Private reason(s)|0|||
33633939|NCT02594124|102211968|FG003|Overall Study|Reason Not Specified|0|||
33633940|NCT02594124|102211969|FG004|Overall Study|Reason Not Specified|0|||
33633941|NCT02594124|102211970|FG005|Overall Study|Reason Not Specified|1|||
33633942|NCT02594124|102211971|FG006|Overall Study|Reason Not Specified|1|||
33633943|NCT02594124|102211972|FG007|Overall Study|Reason Not Specified|6|||
33366757|NCT03567291|101230092|FG000|Period III|Withdrawal by Subject|0|||
33418666|NCT04380701|101425555|FG006|Overall Study|Private reason(s)|1|||
33418667|NCT04380701|101425556|FG007|Overall Study|Private reason(s)|0|||
33633944|NCT02594124|102211973|FG008|Overall Study|Reason Not Specified|1|||
33633945|NCT03877510|102211975|FG000|Overall Study|Death|6|||
33633946|NCT03877510|102211975|FG000|Overall Study|Lost to Follow-up|2|||
33633947|NCT03877510|102211975|FG000|Overall Study|Non-compliance with study drug|2|||
33633948|NCT03877510|102211975|FG000|Overall Study|Lack of Efficacy|14|||
33633949|NCT03877510|102211975|FG000|Overall Study|Adverse Event|20|||
33633950|NCT03877510|102211975|FG000|Overall Study|Withdrawal by Subject|22|||
33633951|NCT03877510|102211975|FG000|Overall Study|Miscellaneous|1|||
33633952|NCT00928408|102211977|FG000|Overall Study|Other|2|||
33633953|NCT00928408|102211977|FG000|Overall Study|Withdrawal by Subject|4|||
33633954|NCT00928408|102211977|FG000|Overall Study|Death|5|||
33633955|NCT00928408|102211977|FG000|Overall Study|Lost to Follow-up|12|||
33633956|NCT01972217|102211978|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
33633957|NCT01972217|102211979|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
33418668|NCT04380701|101425557|FG008|Overall Study|Private reason(s)|1|||
33418669|NCT04380701|101425558|FG009|Overall Study|Private reason(s)|1|||
33418670|NCT04380701|101425559|FG010|Overall Study|Private reason(s)|0|||
33418671|NCT04380701|101425560|FG011|Overall Study|Private reason(s)|0|||
33418672|NCT04380701|101425561|FG012|Overall Study|Private reason(s)|0|||
33418673|NCT04380701|101425562|FG013|Overall Study|Private reason(s)|0|||
33418674|NCT04380701|101425563|FG014|Overall Study|Private reason(s)|0|||
33418675|NCT04380701|101425564|FG015|Overall Study|Private reason(s)|0|||
33571206|NCT02891226|101982682|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33571207|NCT02891226|101982683|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33571208|NCT02891226|101982684|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33571209|NCT02891226|101982685|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33571210|NCT02891226|101982686|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33571211|NCT02891226|101982687|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33571212|NCT02891226|101982688|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33571213|NCT02891226|101982689|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
33571214|NCT02891226|101982690|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33571215|NCT02891226|101982691|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33571216|NCT02891226|101982692|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33571217|NCT02891226|101982693|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33571218|NCT02891226|101982694|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
33571219|NCT02891226|101982679|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33633958|NCT01972217|102211980|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
33633959|NCT01972217|102211981|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
33633960|NCT01972217|102211978|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
33633961|NCT01972217|102211979|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
33633962|NCT01972217|102211980|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
33633963|NCT01972217|102211981|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
33633964|NCT01972217|102211978|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
33633965|NCT01972217|102211979|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
33633966|NCT01972217|102211980|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
33633967|NCT01972217|102211981|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
33633968|NCT01972217|102211978|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
33633969|NCT01972217|102211979|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
33633970|NCT01972217|102211980|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
33633971|NCT01972217|102211981|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
33633972|NCT01972217|102211978|FG000|Part B Double-blind, Randomised Period|Death|0|||
33633973|NCT01972217|102211979|FG001|Part B Double-blind, Randomised Period|Death|0|||
33633974|NCT01972217|102211980|FG002|Part B Double-blind, Randomised Period|Death|43|||
33633975|NCT01972217|102211981|FG003|Part B Double-blind, Randomised Period|Death|44|||
33633976|NCT01972217|102211978|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
33633977|NCT01972217|102211979|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
33633978|NCT01972217|102211980|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
33633979|NCT01972217|102211981|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
33633980|NCT01972217|102211978|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
33633981|NCT01972217|102211979|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
33633982|NCT01972217|102211980|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
33633983|NCT01972217|102211981|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
33633984|NCT01972217|102211978|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
33633985|NCT01972217|102211979|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
33633986|NCT01972217|102211980|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
33633987|NCT01972217|102211981|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
33633988|NCT01972217|102211978|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
33633989|NCT01972217|102211979|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
33633990|NCT01972217|102211980|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
33633991|NCT01972217|102211981|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
33633992|NCT02536976|102211982|FG000|Overall Study|Physician Decision|0|||
33633993|NCT02536976|102211983|FG001|Overall Study|Physician Decision|1|||
33633994|NCT03493464|102211986|FG000|Overall Study|Surgery not performed|1|||
33633995|NCT02761330|102211991|FG000|Treatment Week 1|Withdrawal by Subject|0|||
33633996|NCT02761330|102211992|FG001|Treatment Week 1|Withdrawal by Subject|0|||
33633997|NCT02761330|102211993|FG002|Treatment Week 1|Withdrawal by Subject|0|||
33633998|NCT02761330|102211994|FG003|Treatment Week 1|Withdrawal by Subject|1|||
33633999|NCT02761330|102211995|FG004|Treatment Week 1|Withdrawal by Subject|0|||
33634000|NCT02761330|102211996|FG005|Treatment Week 1|Withdrawal by Subject|1|||
33634001|NCT01074502|102211997|FG000|Overall Study|Withdrawal by Subject|1|||
33634002|NCT01317472|102212000|FG000|Overall Study|Withdrawal by Subject|1|||
33634003|NCT01317472|102212001|FG001|Overall Study|Withdrawal by Subject|0|||
33634004|NCT01317472|102212000|FG000|Overall Study|Unrelated hospitalization|1|||
33634005|NCT01317472|102212001|FG001|Overall Study|Unrelated hospitalization|0|||
33228206|NCT01679236|100735851|FG000|Overall Study|Lost to Follow-up|15|||
33228207|NCT01679236|100735852|FG001|Overall Study|Lost to Follow-up|15|||
33228208|NCT03363659|100735853|FG000|Overall Study|Adverse Event|1|||
33634006|NCT01553084|102212002|FG000|Overall Study|Withdrawal by Subject|15|||
33571220|NCT02891226|101982680|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33571221|NCT02891226|101982681|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33634007|NCT01553084|102212003|FG001|Overall Study|Withdrawal by Subject|13|||
33634008|NCT01553084|102212004|FG002|Overall Study|Withdrawal by Subject|35|||
33571222|NCT02891226|101982682|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33571223|NCT02891226|101982683|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33571224|NCT02891226|101982684|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33571225|NCT02891226|101982685|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33571226|NCT02891226|101982686|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33571227|NCT02891226|101982687|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33571228|NCT02891226|101982688|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33571229|NCT02891226|101982689|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
33571230|NCT02891226|101982690|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33571231|NCT02891226|101982691|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33571232|NCT02891226|101982692|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33571233|NCT02891226|101982693|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33571234|NCT02891226|101982694|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
33571235|NCT02891226|101982679|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33571236|NCT02891226|101982680|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33571237|NCT02891226|101982681|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33571238|NCT02891226|101982682|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33571239|NCT02891226|101982683|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33366758|NCT03567291|101230093|FG001|Period III|Withdrawal by Subject|0|||
33366759|NCT03567291|101230094|FG002|Period III|Withdrawal by Subject|0|||
33366760|NCT03567291|101230095|FG003|Period III|Withdrawal by Subject|4|||
33366761|NCT03567291|101230092|FG000|Period III|Lost to Follow-up|0|||
33366762|NCT03567291|101230093|FG001|Period III|Lost to Follow-up|0|||
33366763|NCT03567291|101230094|FG002|Period III|Lost to Follow-up|0|||
33366764|NCT03567291|101230095|FG003|Period III|Lost to Follow-up|1|||
33418676|NCT04380701|101425565|FG016|Overall Study|Private reason(s)|0|||
33571240|NCT02891226|101982684|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33571241|NCT02891226|101982685|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33571242|NCT02891226|101982686|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33571243|NCT02891226|101982687|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33571244|NCT02891226|101982688|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33571245|NCT02891226|101982689|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
33571246|NCT02891226|101982690|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33571247|NCT02891226|101982691|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33571248|NCT02891226|101982692|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33571249|NCT02891226|101982693|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33571250|NCT02891226|101982694|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
33571251|NCT02891226|101982679|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571252|NCT02891226|101982680|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571253|NCT02891226|101982681|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571254|NCT02891226|101982682|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571255|NCT02891226|101982683|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571256|NCT02891226|101982684|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571257|NCT02891226|101982685|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571258|NCT02891226|101982686|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571259|NCT02891226|101982687|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571260|NCT02891226|101982688|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571261|NCT02891226|101982689|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
33571262|NCT02891226|101982690|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571263|NCT02891226|101982691|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571264|NCT02891226|101982692|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571265|NCT02891226|101982693|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571266|NCT02891226|101982694|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
33571267|NCT02891226|101982679|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33571268|NCT02891226|101982680|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33571269|NCT02891226|101982681|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33634009|NCT03895203|102212005|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
33571270|NCT02891226|101982682|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33634010|NCT03895203|102212006|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
33634011|NCT03895203|102212007|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
33634012|NCT03895203|102212008|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
33366765|NCT03567291|101230092|FG000|Period III|Terminated by sponsor|0|||
33366766|NCT03567291|101230093|FG001|Period III|Terminated by sponsor|0|||
33571271|NCT02891226|101982683|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33571272|NCT02891226|101982684|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33571273|NCT02891226|101982685|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33571274|NCT02891226|101982686|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33571275|NCT02891226|101982687|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33571276|NCT02891226|101982688|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33634013|NCT03895203|102212009|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
33366767|NCT03567291|101230094|FG002|Period III|Terminated by sponsor|0|||
33366768|NCT03567291|101230095|FG003|Period III|Terminated by sponsor|68|||
33366769|NCT03567291|101230092|FG000|Period III|Missing or unknown|0|||
33366770|NCT03567291|101230093|FG001|Period III|Missing or unknown|0|||
33366771|NCT03567291|101230094|FG002|Period III|Missing or unknown|0|||
33366772|NCT03567291|101230095|FG003|Period III|Missing or unknown|8|||
33366773|NCT03032068|101230103|FG000|Overall Study|Adverse Event|1|||
33366774|NCT01798706|101230104|FG000|Overall Study|Adverse Event|15|||
33366775|NCT01798706|101230105|FG001|Overall Study|Adverse Event|10|||
33418677|NCT04380701|101425566|FG017|Overall Study|Private reason(s)|0|||
33418678|NCT04380701|101425567|FG018|Overall Study|Private reason(s)|0|||
33418679|NCT04380701|101425568|FG019|Overall Study|Private reason(s)|0|||
33418680|NCT04380701|101425569|FG020|Overall Study|Private reason(s)|0|||
33418681|NCT04380701|101425570|FG021|Overall Study|Private reason(s)|0|||
33418682|NCT04380701|101425571|FG022|Overall Study|Private reason(s)|0|||
33418683|NCT04380701|101425572|FG023|Overall Study|Private reason(s)|1|||
33418684|NCT04380701|101425573|FG024|Overall Study|Private reason(s)|0|||
33418685|NCT04380701|101425574|FG025|Overall Study|Private reason(s)|0|||
33418686|NCT04380701|101425575|FG026|Overall Study|Private reason(s)|0|||
33571277|NCT02891226|101982689|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
33571278|NCT02891226|101982690|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33571279|NCT02891226|101982691|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33571280|NCT02891226|101982692|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33571281|NCT02891226|101982693|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33571282|NCT02891226|101982694|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
33571283|NCT02891226|101982679|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33571284|NCT02891226|101982680|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33571285|NCT02891226|101982681|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33571286|NCT02891226|101982682|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33571287|NCT02891226|101982683|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33571288|NCT02891226|101982684|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33571289|NCT02891226|101982685|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33571290|NCT02891226|101982686|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33418687|NCT04380701|101425576|FG027|Overall Study|Private reason(s)|0|||
33418688|NCT04380701|101425577|FG028|Overall Study|Private reason(s)|0|||
33366776|NCT01798706|101230104|FG000|Overall Study|Lack of Efficacy|0|||
33571291|NCT02891226|101982687|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33571292|NCT02891226|101982688|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33571293|NCT02891226|101982689|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
33571294|NCT02891226|101982690|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33571295|NCT02891226|101982691|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33571296|NCT02891226|101982692|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33571297|NCT02891226|101982693|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33571298|NCT02891226|101982694|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
33571299|NCT02891226|101982679|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571300|NCT02891226|101982680|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571301|NCT02891226|101982681|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571302|NCT02891226|101982682|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571303|NCT02891226|101982683|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571304|NCT02891226|101982684|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571305|NCT02891226|101982685|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571306|NCT02891226|101982686|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571307|NCT02891226|101982687|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571308|NCT02891226|101982688|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571309|NCT02891226|101982689|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
33571310|NCT02891226|101982690|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571311|NCT02891226|101982691|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571312|NCT02891226|101982692|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571313|NCT02891226|101982693|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571314|NCT02891226|101982694|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
33571315|NCT02891226|101982679|FG000|Follow-up Period|Withdrawal by Subject|0|||
33571316|NCT02891226|101982680|FG001|Follow-up Period|Withdrawal by Subject|0|||
33571317|NCT02891226|101982681|FG002|Follow-up Period|Withdrawal by Subject|0|||
33571318|NCT02891226|101982682|FG003|Follow-up Period|Withdrawal by Subject|0|||
33571319|NCT02891226|101982683|FG004|Follow-up Period|Withdrawal by Subject|0|||
33571320|NCT02891226|101982684|FG005|Follow-up Period|Withdrawal by Subject|0|||
33571321|NCT02891226|101982685|FG006|Follow-up Period|Withdrawal by Subject|0|||
33571322|NCT02891226|101982686|FG007|Follow-up Period|Withdrawal by Subject|0|||
33571323|NCT02891226|101982687|FG008|Follow-up Period|Withdrawal by Subject|0|||
33571324|NCT02891226|101982688|FG009|Follow-up Period|Withdrawal by Subject|0|||
33571325|NCT02891226|101982689|FG010|Follow-up Period|Withdrawal by Subject|0|||
33571326|NCT02891226|101982690|FG011|Follow-up Period|Withdrawal by Subject|1|||
33571327|NCT02891226|101982691|FG012|Follow-up Period|Withdrawal by Subject|0|||
33571328|NCT02891226|101982692|FG013|Follow-up Period|Withdrawal by Subject|0|||
33571329|NCT02891226|101982693|FG014|Follow-up Period|Withdrawal by Subject|1|||
33571330|NCT02891226|101982694|FG015|Follow-up Period|Withdrawal by Subject|1|||
33571331|NCT00189423|101982695|FG000|Overall Study|Death|746|||
33571332|NCT00189423|101982696|FG001|Overall Study|Death|747|||
33571333|NCT00189423|101982695|FG000|Overall Study|Withdrawal by Subject|9|||
33571334|NCT00189423|101982696|FG001|Overall Study|Withdrawal by Subject|9|||
33571335|NCT00189423|101982695|FG000|Overall Study|Lost to Follow-up|10|||
33571336|NCT00189423|101982696|FG001|Overall Study|Lost to Follow-up|10|||
33571337|NCT00590317|101982699|FG000|Overall Study|Lack of Efficacy|1|||
33571338|NCT00590317|101982700|FG001|Overall Study|Lack of Efficacy|5|||
33571339|NCT01736917|101982701|FG000|Overall Study|Adverse Event|1|||
33571340|NCT01736917|101982701|FG000|Overall Study|Protocol Violation|10|||
33571341|NCT01493414|101982702|FG000|Overall Study|Adverse Event|405|||
33571342|NCT01493414|101982702|FG000|Overall Study|Disease progression|204|||
33571343|NCT01493414|101982702|FG000|Overall Study|Death|101|||
33634014|NCT03895203|102212010|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
33634015|NCT03895203|102212005|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
33634016|NCT03895203|102212006|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
33634017|NCT03895203|102212007|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
33634018|NCT03895203|102212008|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
33634019|NCT03895203|102212009|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
33634020|NCT03895203|102212010|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
33634021|NCT03895203|102212005|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
33634022|NCT03895203|102212006|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
33634023|NCT03895203|102212007|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
33366777|NCT01798706|101230105|FG001|Overall Study|Lack of Efficacy|2|||
33418689|NCT04380701|101425578|FG029|Overall Study|Private reason(s)|1|||
33418690|NCT04380701|101425579|FG030|Overall Study|Private reason(s)|0|||
33418691|NCT04380701|101425580|FG031|Overall Study|Private reason(s)|0|||
33418692|NCT04380701|101425581|FG032|Overall Study|Private reason(s)|0|||
33418693|NCT04380701|101425582|FG033|Overall Study|Private reason(s)|0|||
33418694|NCT04380701|101425549|FG000|Overall Study|Withdrawal by Subject|0|||
33418695|NCT04380701|101425550|FG001|Overall Study|Withdrawal by Subject|0|||
33418696|NCT04380701|101425551|FG002|Overall Study|Withdrawal by Subject|0|||
33418697|NCT04380701|101425552|FG003|Overall Study|Withdrawal by Subject|0|||
33418698|NCT04380701|101425553|FG004|Overall Study|Withdrawal by Subject|0|||
33418699|NCT04380701|101425554|FG005|Overall Study|Withdrawal by Subject|0|||
33418700|NCT04380701|101425555|FG006|Overall Study|Withdrawal by Subject|1|||
33418701|NCT04380701|101425556|FG007|Overall Study|Withdrawal by Subject|1|||
33418702|NCT04380701|101425557|FG008|Overall Study|Withdrawal by Subject|0|||
33418703|NCT04380701|101425558|FG009|Overall Study|Withdrawal by Subject|0|||
33418704|NCT04380701|101425559|FG010|Overall Study|Withdrawal by Subject|0|||
33418705|NCT04380701|101425560|FG011|Overall Study|Withdrawal by Subject|1|||
33418706|NCT04380701|101425561|FG012|Overall Study|Withdrawal by Subject|0|||
33418707|NCT04380701|101425562|FG013|Overall Study|Withdrawal by Subject|1|||
33418708|NCT04380701|101425563|FG014|Overall Study|Withdrawal by Subject|0|||
33418709|NCT04380701|101425564|FG015|Overall Study|Withdrawal by Subject|0|||
33418710|NCT04380701|101425565|FG016|Overall Study|Withdrawal by Subject|1|||
33418711|NCT04380701|101425566|FG017|Overall Study|Withdrawal by Subject|0|||
33418712|NCT04380701|101425567|FG018|Overall Study|Withdrawal by Subject|0|||
33418713|NCT04380701|101425568|FG019|Overall Study|Withdrawal by Subject|0|||
33418714|NCT04380701|101425569|FG020|Overall Study|Withdrawal by Subject|0|||
33418715|NCT04380701|101425570|FG021|Overall Study|Withdrawal by Subject|0|||
33418716|NCT04380701|101425571|FG022|Overall Study|Withdrawal by Subject|2|||
33418717|NCT04380701|101425572|FG023|Overall Study|Withdrawal by Subject|2|||
33571344|NCT01493414|101982702|FG000|Overall Study|Physician Decision|93|||
33571345|NCT01493414|101982702|FG000|Overall Study|Withdrawal by Subject|79|||
33571346|NCT01493414|101982702|FG000|Overall Study|Protocol deviation|27|||
33571347|NCT01493414|101982702|FG000|Overall Study|Administrative problems|25|||
33571348|NCT01493414|101982702|FG000|Overall Study|Lost to Follow-up|16|||
33571349|NCT01368614|101982705|FG000|Screening Period|Screen Failure|58|||
33571350|NCT01368614|101982706|FG001|Screening Period|Screen Failure|0|||
33571351|NCT01368614|101982707|FG002|Screening Period|Screen Failure|0|||
33418718|NCT04380701|101425573|FG024|Overall Study|Withdrawal by Subject|1|||
33418719|NCT04380701|101425574|FG025|Overall Study|Withdrawal by Subject|1|||
33418720|NCT04380701|101425575|FG026|Overall Study|Withdrawal by Subject|0|||
33418721|NCT04380701|101425576|FG027|Overall Study|Withdrawal by Subject|0|||
33418722|NCT04380701|101425577|FG028|Overall Study|Withdrawal by Subject|0|||
33418723|NCT04380701|101425578|FG029|Overall Study|Withdrawal by Subject|0|||
33418724|NCT04380701|101425579|FG030|Overall Study|Withdrawal by Subject|0|||
33418725|NCT04380701|101425580|FG031|Overall Study|Withdrawal by Subject|0|||
33418726|NCT04380701|101425581|FG032|Overall Study|Withdrawal by Subject|0|||
33418727|NCT04380701|101425582|FG033|Overall Study|Withdrawal by Subject|0|||
33418728|NCT04380701|101425549|FG000|Overall Study|Adverse Event|0|||
33418729|NCT04380701|101425550|FG001|Overall Study|Adverse Event|0|||
33418730|NCT04380701|101425551|FG002|Overall Study|Adverse Event|0|||
33418731|NCT04380701|101425552|FG003|Overall Study|Adverse Event|0|||
33571352|NCT01368614|101982708|FG003|Screening Period|Screen Failure|0|||
33634024|NCT03895203|102212008|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
33634025|NCT03895203|102212009|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
33418732|NCT04380701|101425553|FG004|Overall Study|Adverse Event|0|||
33634026|NCT03895203|102212010|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
33418733|NCT04380701|101425554|FG005|Overall Study|Adverse Event|1|||
33418734|NCT04380701|101425555|FG006|Overall Study|Adverse Event|0|||
33418735|NCT04380701|101425556|FG007|Overall Study|Adverse Event|0|||
33418736|NCT04380701|101425557|FG008|Overall Study|Adverse Event|0|||
33418737|NCT04380701|101425558|FG009|Overall Study|Adverse Event|0|||
33418738|NCT04380701|101425559|FG010|Overall Study|Adverse Event|0|||
33418739|NCT04380701|101425560|FG011|Overall Study|Adverse Event|0|||
33418740|NCT04380701|101425561|FG012|Overall Study|Adverse Event|0|||
33418741|NCT04380701|101425562|FG013|Overall Study|Adverse Event|0|||
33418742|NCT04380701|101425563|FG014|Overall Study|Adverse Event|0|||
33418743|NCT04380701|101425564|FG015|Overall Study|Adverse Event|1|||
33418744|NCT04380701|101425565|FG016|Overall Study|Adverse Event|0|||
33571353|NCT01368614|101982705|FG000|Study Period|Withdrawal by Subject|0|||
33571354|NCT01368614|101982706|FG001|Study Period|Withdrawal by Subject|1|||
33228209|NCT03363659|100735853|FG000|Overall Study|Screen fail|1|||
33228210|NCT03363659|100735853|FG000|Overall Study|Withdrawal by Subject|1|||
33228211|NCT00154310|100735856|FG000|Overall Study|Adverse Event|19|||
33228212|NCT00154310|100735857|FG001|Overall Study|Adverse Event|9|||
33228213|NCT00154310|100735856|FG000|Overall Study|Lack of Efficacy|5|||
33228214|NCT00154310|100735857|FG001|Overall Study|Lack of Efficacy|4|||
33228215|NCT00154310|100735856|FG000|Overall Study|Protocol Violation|4|||
33228216|NCT00154310|100735857|FG001|Overall Study|Protocol Violation|2|||
33366778|NCT01798706|101230104|FG000|Overall Study|Poor compliance to protocol|1|||
33366779|NCT01798706|101230105|FG001|Overall Study|Poor compliance to protocol|0|||
33366780|NCT01798706|101230104|FG000|Overall Study|Other than specified above|5|||
33366781|NCT01798706|101230105|FG001|Overall Study|Other than specified above|9|||
33571355|NCT01368614|101982707|FG002|Study Period|Withdrawal by Subject|1|||
33571356|NCT01368614|101982708|FG003|Study Period|Withdrawal by Subject|3|||
33571357|NCT01368614|101982705|FG000|Study Period|Lost to Follow-up|0|||
33571358|NCT01368614|101982706|FG001|Study Period|Lost to Follow-up|0|||
33571359|NCT01368614|101982707|FG002|Study Period|Lost to Follow-up|1|||
33571360|NCT01368614|101982708|FG003|Study Period|Lost to Follow-up|0|||
33571361|NCT03435380|101982711|FG000|Overall Study|Death|1|||
33571362|NCT03435380|101982712|FG001|Overall Study|Death|2|||
33571363|NCT03435380|101982713|FG002|Overall Study|Death|1|||
33571364|NCT03435380|101982711|FG000|Overall Study|Lost to Follow-up|12|||
33418745|NCT04380701|101425566|FG017|Overall Study|Adverse Event|0|||
33418746|NCT04380701|101425567|FG018|Overall Study|Adverse Event|0|||
33418747|NCT04380701|101425568|FG019|Overall Study|Adverse Event|1|||
33418748|NCT04380701|101425569|FG020|Overall Study|Adverse Event|0|||
33418749|NCT04380701|101425570|FG021|Overall Study|Adverse Event|0|||
33418750|NCT04380701|101425571|FG022|Overall Study|Adverse Event|0|||
33418751|NCT04380701|101425572|FG023|Overall Study|Adverse Event|0|||
33418752|NCT04380701|101425573|FG024|Overall Study|Adverse Event|0|||
33418753|NCT04380701|101425574|FG025|Overall Study|Adverse Event|0|||
33418754|NCT04380701|101425575|FG026|Overall Study|Adverse Event|0|||
33418755|NCT04380701|101425576|FG027|Overall Study|Adverse Event|0|||
33418756|NCT04380701|101425577|FG028|Overall Study|Adverse Event|0|||
33634027|NCT03895203|102212005|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
33634028|NCT03895203|102212006|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
33634029|NCT03895203|102212007|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
33634030|NCT03895203|102212008|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
33634031|NCT03895203|102212009|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
33634032|NCT03895203|102212010|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
33634033|NCT03895203|102212005|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
33634034|NCT03895203|102212006|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
33634035|NCT03895203|102212007|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
33634036|NCT03895203|102212008|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
33634037|NCT03895203|102212009|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
33634038|NCT03895203|102212010|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
33634039|NCT03895203|102212005|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
33634040|NCT03895203|102212006|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
33634041|NCT03895203|102212007|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
33366782|NCT01264965|101230106|FG000|Overall Study|Withdrawal by Subject|10|||
33366783|NCT03196297|101230110|FG000|Main Period|Withdrawal by Subject|4|||
33418757|NCT04380701|101425578|FG029|Overall Study|Adverse Event|0|||
33418758|NCT04380701|101425579|FG030|Overall Study|Adverse Event|0|||
33418759|NCT04380701|101425580|FG031|Overall Study|Adverse Event|0|||
33366784|NCT03196297|101230110|FG000|Extension Period|Withdrawal by Subject|1|||
33366785|NCT03196297|101230110|FG000|Extension Period|Lack of Efficacy|2|||
33366786|NCT01555463|101230111|FG000|Treatment|Adverse Event|6|||
33418760|NCT04380701|101425581|FG032|Overall Study|Adverse Event|0|||
33418761|NCT04380701|101425582|FG033|Overall Study|Adverse Event|0|||
33418762|NCT04380701|101425549|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
33418763|NCT04380701|101425550|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
33418764|NCT04380701|101425551|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
33418765|NCT04380701|101425552|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
33418766|NCT04380701|101425553|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
33418767|NCT04380701|101425554|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
33228217|NCT00154310|100735856|FG000|Overall Study|Withdrawal by Subject|9|||
33228218|NCT00154310|100735857|FG001|Overall Study|Withdrawal by Subject|3|||
33366787|NCT01555463|101230112|FG001|Treatment|Adverse Event|12|||
33366788|NCT01555463|101230111|FG000|Treatment|Withdrawal by Subject|24|||
33418768|NCT04380701|101425555|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
33571365|NCT03435380|101982712|FG001|Overall Study|Lost to Follow-up|8|||
33571366|NCT03435380|101982713|FG002|Overall Study|Lost to Follow-up|6|||
33571367|NCT03435380|101982711|FG000|Overall Study|Physician Decision|1|||
33571368|NCT03435380|101982712|FG001|Overall Study|Physician Decision|0|||
33571369|NCT03435380|101982713|FG002|Overall Study|Physician Decision|0|||
33571370|NCT03435380|101982711|FG000|Overall Study|Withdrawal by Subject|0|||
33571371|NCT03435380|101982712|FG001|Overall Study|Withdrawal by Subject|1|||
33571372|NCT03435380|101982713|FG002|Overall Study|Withdrawal by Subject|1|||
33571373|NCT03435380|101982711|FG000|Overall Study|Ineligible|0|||
33571374|NCT03435380|101982712|FG001|Overall Study|Ineligible|1|||
33571375|NCT03435380|101982713|FG002|Overall Study|Ineligible|1|||
33571376|NCT05201807|101982717|FG000|Overall Study|Adverse Event|1|||
33571377|NCT05201807|101982717|FG000|Overall Study|COVID-19 Related|1|||
33571378|NCT00427700|101982718|FG000|Overall Study|Lost to Follow-up|2|||
33571379|NCT00427700|101982719|FG001|Overall Study|Lost to Follow-up|5|||
33571380|NCT00427700|101982718|FG000|Overall Study|no induction of menses|1|||
33571381|NCT00427700|101982719|FG001|Overall Study|no induction of menses|4|||
33571382|NCT00427700|101982718|FG000|Overall Study|Pregnancy|0|||
33571383|NCT00427700|101982719|FG001|Overall Study|Pregnancy|2|||
33571384|NCT04881760|101982720|FG000|Overall Study|Adverse Event|0|||
33571385|NCT04881760|101982721|FG001|Overall Study|Adverse Event|1|||
33571386|NCT04881760|101982722|FG002|Overall Study|Adverse Event|1|||
33571387|NCT04881760|101982723|FG003|Overall Study|Adverse Event|0|||
33571388|NCT04881760|101982724|FG004|Overall Study|Adverse Event|1|||
33571389|NCT04881760|101982725|FG005|Overall Study|Adverse Event|1|||
33571390|NCT04881760|101982726|FG006|Overall Study|Adverse Event|2|||
33571391|NCT04881760|101982720|FG000|Overall Study|Death|0|||
33571392|NCT04881760|101982721|FG001|Overall Study|Death|0|||
33571393|NCT04881760|101982722|FG002|Overall Study|Death|0|||
33571394|NCT04881760|101982723|FG003|Overall Study|Death|1|||
33571395|NCT04881760|101982724|FG004|Overall Study|Death|0|||
33571396|NCT04881760|101982725|FG005|Overall Study|Death|0|||
33571397|NCT04881760|101982726|FG006|Overall Study|Death|0|||
33571398|NCT04881760|101982720|FG000|Overall Study|Lost to Follow-up|5|||
33228219|NCT00154310|100735856|FG000|Overall Study|Lost to Follow-up|0|||
33228220|NCT00154310|100735857|FG001|Overall Study|Lost to Follow-up|8|||
33228221|NCT00154310|100735856|FG000|Overall Study|Administrative problems|0|||
33228222|NCT00154310|100735857|FG001|Overall Study|Administrative problems|1|||
33228223|NCT00154310|100735856|FG000|Overall Study|Death|0|||
33228224|NCT00154310|100735857|FG001|Overall Study|Death|1|||
33228225|NCT02302066|100735859|FG000|Overall Study|Adverse Event|1|||
33228226|NCT02302066|100735860|FG001|Overall Study|Adverse Event|1|||
33228227|NCT02302066|100735861|FG002|Overall Study|Adverse Event|3|||
33228228|NCT02302066|100735862|FG003|Overall Study|Adverse Event|0|||
33228229|NCT02302066|100735859|FG000|Overall Study|Lost to Follow-up|4|||
33228230|NCT02302066|100735860|FG001|Overall Study|Lost to Follow-up|5|||
33228231|NCT02302066|100735861|FG002|Overall Study|Lost to Follow-up|24|||
33228232|NCT02302066|100735862|FG003|Overall Study|Lost to Follow-up|7|||
33228233|NCT02302066|100735859|FG000|Overall Study|Withdrawal by Subject|25|||
33228234|NCT02302066|100735860|FG001|Overall Study|Withdrawal by Subject|58|||
33228235|NCT02302066|100735861|FG002|Overall Study|Withdrawal by Subject|124|||
33228236|NCT02302066|100735862|FG003|Overall Study|Withdrawal by Subject|33|||
33228237|NCT02302066|100735859|FG000|Overall Study|Pregnancy|2|||
33228238|NCT02302066|100735860|FG001|Overall Study|Pregnancy|10|||
33418769|NCT04380701|101425556|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
33418770|NCT04380701|101425557|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
33228239|NCT02302066|100735861|FG002|Overall Study|Pregnancy|12|||
33228240|NCT02302066|100735862|FG003|Overall Study|Pregnancy|0|||
33228241|NCT02302066|100735859|FG000|Overall Study|Reason Not Specified|1|||
33418771|NCT04380701|101425558|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
33418772|NCT04380701|101425559|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
33418773|NCT04380701|101425560|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
33571399|NCT04881760|101982721|FG001|Overall Study|Lost to Follow-up|7|||
33571400|NCT04881760|101982722|FG002|Overall Study|Lost to Follow-up|5|||
33571401|NCT04881760|101982723|FG003|Overall Study|Lost to Follow-up|1|||
33571402|NCT04881760|101982724|FG004|Overall Study|Lost to Follow-up|2|||
33571403|NCT04881760|101982725|FG005|Overall Study|Lost to Follow-up|4|||
33571404|NCT04881760|101982726|FG006|Overall Study|Lost to Follow-up|4|||
33571405|NCT04881760|101982720|FG000|Overall Study|Withdrawal by Subject|13|||
33571406|NCT04881760|101982721|FG001|Overall Study|Withdrawal by Subject|1|||
33571407|NCT04881760|101982722|FG002|Overall Study|Withdrawal by Subject|1|||
33228242|NCT02302066|100735860|FG001|Overall Study|Reason Not Specified|1|||
33228243|NCT02302066|100735861|FG002|Overall Study|Reason Not Specified|9|||
33228244|NCT02302066|100735862|FG003|Overall Study|Reason Not Specified|1|||
33228245|NCT00684762|100735863|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
33228246|NCT00684762|100735864|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
33228247|NCT03734991|100735865|FG000|Overall Study|Adverse Event|4|||
33228248|NCT03734991|100735866|FG001|Overall Study|Adverse Event|0|||
33228249|NCT03734991|100735865|FG000|Overall Study|Lost to Follow-up|4|||
33228250|NCT03734991|100735866|FG001|Overall Study|Lost to Follow-up|0|||
33228251|NCT03734991|100735865|FG000|Overall Study|Physician Decision|0|||
33228252|NCT03734991|100735866|FG001|Overall Study|Physician Decision|1|||
33228253|NCT03734991|100735865|FG000|Overall Study|Pregnancy|1|||
33571408|NCT04881760|101982723|FG003|Overall Study|Withdrawal by Subject|4|||
33571409|NCT04881760|101982724|FG004|Overall Study|Withdrawal by Subject|2|||
33571410|NCT04881760|101982725|FG005|Overall Study|Withdrawal by Subject|1|||
33571411|NCT04881760|101982726|FG006|Overall Study|Withdrawal by Subject|2|||
33571412|NCT04881760|101982720|FG000|Overall Study|Randomized but Never Treated|0|||
33571413|NCT04881760|101982721|FG001|Overall Study|Randomized but Never Treated|0|||
33571414|NCT04881760|101982722|FG002|Overall Study|Randomized but Never Treated|0|||
33571415|NCT04881760|101982723|FG003|Overall Study|Randomized but Never Treated|1|||
33571416|NCT04881760|101982724|FG004|Overall Study|Randomized but Never Treated|0|||
33571417|NCT04881760|101982725|FG005|Overall Study|Randomized but Never Treated|0|||
33571418|NCT04881760|101982726|FG006|Overall Study|Randomized but Never Treated|0|||
33228254|NCT03734991|100735866|FG001|Overall Study|Pregnancy|0|||
33228255|NCT03734991|100735865|FG000|Overall Study|Withdrawal by Subject|6|||
33228256|NCT03734991|100735866|FG001|Overall Study|Withdrawal by Subject|3|||
33228257|NCT03734991|100735865|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
33228258|NCT03734991|100735866|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
33228259|NCT03734991|100735865|FG000|Overall Study|Other|2|||
33228260|NCT03734991|100735866|FG001|Overall Study|Other|2|||
33228261|NCT02254421|100735867|FG000|Overall Study|Randomized but Not Treated|1|||
33228262|NCT02254421|100735868|FG001|Overall Study|Randomized but Not Treated|0|||
33228263|NCT02254421|100735867|FG000|Overall Study|Death|0|||
33228264|NCT02254421|100735868|FG001|Overall Study|Death|2|||
33228265|NCT02254421|100735867|FG000|Overall Study|Withdrew Consent|1|||
33228266|NCT02254421|100735868|FG001|Overall Study|Withdrew Consent|1|||
33228267|NCT01976364|100735869|FG000|Main Study (36 Months)|Adverse Event|63|||
33228268|NCT01976364|100735870|FG001|Main Study (36 Months)|Adverse Event|0|||
33228269|NCT01976364|100735871|FG002|Main Study (36 Months)|Adverse Event|0|||
33228270|NCT01976364|100735869|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
33228271|NCT01976364|100735870|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
33228272|NCT01976364|100735871|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
33228273|NCT01976364|100735869|FG000|Main Study (36 Months)|Other|13|||
33228274|NCT01976364|100735870|FG001|Main Study (36 Months)|Other|0|||
33228275|NCT01976364|100735871|FG002|Main Study (36 Months)|Other|0|||
33228276|NCT01976364|100735869|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
33228277|NCT01976364|100735870|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
33228278|NCT01976364|100735871|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
33228279|NCT01976364|100735869|FG000|Main Study (36 Months)|Medication error|1|||
33228280|NCT01976364|100735870|FG001|Main Study (36 Months)|Medication error|0|||
33228281|NCT01976364|100735871|FG002|Main Study (36 Months)|Medication error|0|||
33228282|NCT01976364|100735869|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
33228283|NCT01976364|100735870|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
33228284|NCT01976364|100735871|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
33418774|NCT04380701|101425561|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
33418775|NCT04380701|101425562|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
33418776|NCT04380701|101425563|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
33418777|NCT04380701|101425564|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
33418778|NCT04380701|101425565|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
33418779|NCT04380701|101425566|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
33366789|NCT01555463|101230112|FG001|Treatment|Withdrawal by Subject|36|||
33366790|NCT01555463|101230111|FG000|Treatment|Lost to Follow-up|28|||
33366791|NCT01555463|101230112|FG001|Treatment|Lost to Follow-up|23|||
33366792|NCT01555463|101230111|FG000|Treatment|Protocol Violation|4|||
33366793|NCT01555463|101230112|FG001|Treatment|Protocol Violation|5|||
33366794|NCT01555463|101230111|FG000|Treatment|Other reason|2|||
33366795|NCT01555463|101230112|FG001|Treatment|Other reason|3|||
33366796|NCT01555463|101230111|FG000|Follow up|Adverse Event|2|||
33228285|NCT01976364|100735869|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
33228286|NCT01976364|100735870|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
33228287|NCT01976364|100735871|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
33228288|NCT01976364|100735869|FG000|Main Study (36 Months)|Protocol Violation|13|||
33228289|NCT01976364|100735870|FG001|Main Study (36 Months)|Protocol Violation|0|||
33228290|NCT01976364|100735871|FG002|Main Study (36 Months)|Protocol Violation|0|||
33366797|NCT01555463|101230112|FG001|Follow up|Adverse Event|5|||
33571419|NCT04881760|101982720|FG000|Overall Study|Inadvertent Enrollment|2|||
33571420|NCT04881760|101982721|FG001|Overall Study|Inadvertent Enrollment|0|||
33571421|NCT04881760|101982722|FG002|Overall Study|Inadvertent Enrollment|0|||
33571422|NCT04881760|101982723|FG003|Overall Study|Inadvertent Enrollment|0|||
33571423|NCT04881760|101982724|FG004|Overall Study|Inadvertent Enrollment|0|||
33571424|NCT04881760|101982725|FG005|Overall Study|Inadvertent Enrollment|0|||
33571425|NCT04881760|101982726|FG006|Overall Study|Inadvertent Enrollment|0|||
33571426|NCT04881760|101982720|FG000|Overall Study|Site Closure|0|||
33571427|NCT04881760|101982721|FG001|Overall Study|Site Closure|0|||
33571428|NCT04881760|101982722|FG002|Overall Study|Site Closure|0|||
33228291|NCT01976364|100735869|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
33228292|NCT01976364|100735870|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
33228293|NCT01976364|100735871|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
33228294|NCT01976364|100735869|FG000|Main Study (36 Months)|Death|5|||
33228295|NCT01976364|100735870|FG001|Main Study (36 Months)|Death|0|||
33228296|NCT01976364|100735871|FG002|Main Study (36 Months)|Death|0|||
33228297|NCT01976364|100735869|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
33228298|NCT01976364|100735870|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
33228299|NCT01976364|100735871|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
33228300|NCT01976364|100735869|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
33228301|NCT01976364|100735870|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
33228302|NCT01976364|100735871|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
33228303|NCT01976364|100735869|FG000|Sub-study (12 Months)|Protocol Violation|0|||
33228304|NCT01976364|100735870|FG001|Sub-study (12 Months)|Protocol Violation|1|||
33228305|NCT01976364|100735871|FG002|Sub-study (12 Months)|Protocol Violation|1|||
33228306|NCT01976364|100735869|FG000|Sub-study (12 Months)|Adverse Event|0|||
33228307|NCT01976364|100735870|FG001|Sub-study (12 Months)|Adverse Event|4|||
33228308|NCT01976364|100735871|FG002|Sub-study (12 Months)|Adverse Event|3|||
33228309|NCT00545363|100735872|FG000|Overall Study|Adverse Event|6|||
33228310|NCT00545363|100735873|FG001|Overall Study|Adverse Event|7|||
33228311|NCT00545363|100735872|FG000|Overall Study|Withdrawal by Subject|6|||
33228312|NCT00545363|100735873|FG001|Overall Study|Withdrawal by Subject|5|||
33228313|NCT00545363|100735872|FG000|Overall Study|Non-compliance|3|||
33228314|NCT00545363|100735873|FG001|Overall Study|Non-compliance|1|||
33228315|NCT00545363|100735872|FG000|Overall Study|Did not meet entry criteria|1|||
33228316|NCT00545363|100735873|FG001|Overall Study|Did not meet entry criteria|1|||
33228317|NCT00545363|100735872|FG000|Overall Study|Lost to Follow-up|2|||
33228318|NCT00545363|100735873|FG001|Overall Study|Lost to Follow-up|0|||
33228319|NCT00545363|100735872|FG000|Overall Study|Other|1|||
33228320|NCT00545363|100735873|FG001|Overall Study|Other|1|||
33228321|NCT03679767|100735878|FG000|Overall Study|Death|16|||
33228322|NCT03679767|100735879|FG001|Overall Study|Death|11|||
33228323|NCT03679767|100735880|FG002|Overall Study|Death|17|||
33228324|NCT03679767|100735881|FG003|Overall Study|Death|10|||
33228325|NCT03679767|100735878|FG000|Overall Study|Lost to Follow-up|1|||
33228326|NCT03679767|100735879|FG001|Overall Study|Lost to Follow-up|1|||
33228327|NCT03679767|100735880|FG002|Overall Study|Lost to Follow-up|1|||
33228328|NCT03679767|100735881|FG003|Overall Study|Lost to Follow-up|1|||
33228329|NCT03679767|100735878|FG000|Overall Study|Withdrawal by Subject|0|||
33228330|NCT03679767|100735879|FG001|Overall Study|Withdrawal by Subject|0|||
33228331|NCT03679767|100735880|FG002|Overall Study|Withdrawal by Subject|0|||
33228332|NCT03679767|100735881|FG003|Overall Study|Withdrawal by Subject|1|||
33228333|NCT03679767|100735878|FG000|Overall Study|Follow-up Completed|18|||
33228334|NCT03679767|100735879|FG001|Overall Study|Follow-up Completed|11|||
33228335|NCT03679767|100735880|FG002|Overall Study|Follow-up Completed|11|||
33228336|NCT03679767|100735881|FG003|Overall Study|Follow-up Completed|20|||
33228337|NCT03679767|100735878|FG000|Overall Study|Entered Hospice Care|0|||
33228338|NCT03679767|100735879|FG001|Overall Study|Entered Hospice Care|0|||
33228339|NCT03679767|100735880|FG002|Overall Study|Entered Hospice Care|0|||
33228340|NCT03679767|100735881|FG003|Overall Study|Entered Hospice Care|1|||
33228341|NCT03679767|100735878|FG000|Overall Study|Progressive Disease|0|||
33228342|NCT03679767|100735879|FG001|Overall Study|Progressive Disease|0|||
33228343|NCT03679767|100735880|FG002|Overall Study|Progressive Disease|0|||
33228344|NCT03679767|100735881|FG003|Overall Study|Progressive Disease|1|||
33228345|NCT01893827|100735883|FG000|Overall Study|Lost to Follow-up|19|||
33228346|NCT01893827|100735884|FG001|Overall Study|Lost to Follow-up|26|||
33228347|NCT02294474|100735885|FG000|Overall Study|Adverse Event|7|||
33228348|NCT02294474|100735886|FG001|Overall Study|Adverse Event|7|||
33228349|NCT02294474|100735885|FG000|Overall Study|Lack of Efficacy|2|||
33228350|NCT02294474|100735886|FG001|Overall Study|Lack of Efficacy|1|||
33228351|NCT02294474|100735885|FG000|Overall Study|Protocol Violation|4|||
33228352|NCT02294474|100735886|FG001|Overall Study|Protocol Violation|2|||
33228353|NCT02294474|100735885|FG000|Overall Study|Other than specified above|12|||
33228354|NCT02294474|100735886|FG001|Overall Study|Other than specified above|12|||
33228355|NCT00747123|100735887|FG000|Overall Study|Investigator's request|0|||
33228356|NCT00747123|100735888|FG001|Overall Study|Investigator's request|0|||
33228357|NCT00747123|100735889|FG002|Overall Study|Investigator's request|1|||
33228358|NCT00747123|100735890|FG003|Overall Study|Investigator's request|0|||
33366798|NCT01555463|101230111|FG000|Follow up|Death|0|||
33228359|NCT00747123|100735887|FG000|Overall Study|Withdrew consent|0|||
33228360|NCT00747123|100735888|FG001|Overall Study|Withdrew consent|1|||
33228361|NCT00747123|100735889|FG002|Overall Study|Withdrew consent|0|||
33228362|NCT00747123|100735890|FG003|Overall Study|Withdrew consent|0|||
33228363|NCT00747123|100735887|FG000|Overall Study|Adverse Event|0|||
33228364|NCT00747123|100735888|FG001|Overall Study|Adverse Event|1|||
33228365|NCT00747123|100735889|FG002|Overall Study|Adverse Event|0|||
33228366|NCT00747123|100735890|FG003|Overall Study|Adverse Event|1|||
33228367|NCT03430063|100735891|FG000|Overall Study|Adverse Event|0|||
33228368|NCT03430063|100735892|FG001|Overall Study|Adverse Event|1|||
33228369|NCT03430063|100735893|FG002|Overall Study|Adverse Event|0|||
33228370|NCT03430063|100735891|FG000|Overall Study|Death|3|||
33228371|NCT03430063|100735892|FG001|Overall Study|Death|2|||
33228372|NCT03430063|100735893|FG002|Overall Study|Death|3|||
33228373|NCT03430063|100735891|FG000|Overall Study|Lost to Follow-up|0|||
33228374|NCT03430063|100735892|FG001|Overall Study|Lost to Follow-up|1|||
33228375|NCT03430063|100735893|FG002|Overall Study|Lost to Follow-up|0|||
33228376|NCT03430063|100735891|FG000|Overall Study|Withdrawal by Subject|0|||
33228377|NCT03430063|100735892|FG001|Overall Study|Withdrawal by Subject|0|||
33228378|NCT03430063|100735893|FG002|Overall Study|Withdrawal by Subject|1|||
33228379|NCT03430063|100735891|FG000|Overall Study|Withdrawal of consent|3|||
33228380|NCT03430063|100735892|FG001|Overall Study|Withdrawal of consent|1|||
33228381|NCT03430063|100735893|FG002|Overall Study|Withdrawal of consent|2|||
33228382|NCT03430063|100735891|FG000|Overall Study|Progressive disease|1|||
33228383|NCT03430063|100735892|FG001|Overall Study|Progressive disease|2|||
33228384|NCT03430063|100735893|FG002|Overall Study|Progressive disease|1|||
33228385|NCT03430063|100735891|FG000|Overall Study|Other un-specified|1|||
33418780|NCT04380701|101425567|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
33418781|NCT04380701|101425568|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
33418782|NCT04380701|101425569|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
33418783|NCT04380701|101425570|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
33418784|NCT04380701|101425571|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
33418785|NCT04380701|101425572|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
33228386|NCT03430063|100735892|FG001|Overall Study|Other un-specified|1|||
33228387|NCT03430063|100735893|FG002|Overall Study|Other un-specified|0|||
33228388|NCT03430063|100735891|FG000|Overall Study|Randomized, but never treated|0|||
33228389|NCT03430063|100735892|FG001|Overall Study|Randomized, but never treated|0|||
33228390|NCT03430063|100735893|FG002|Overall Study|Randomized, but never treated|1|||
33228391|NCT01932294|100735898|FG000|Overall Study|Death|43|||
33228392|NCT01932294|100735898|FG000|Overall Study|Lost to Follow-up|8|||
33228393|NCT01932294|100735898|FG000|Overall Study|VAD Implantation|20|||
33228394|NCT01932294|100735898|FG000|Overall Study|Heart Transplantation|16|||
33228395|NCT01932294|100735898|FG000|Overall Study|Transferred to other hospitals|12|||
33228396|NCT01582789|100735899|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
33228397|NCT01582789|100735900|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
33228398|NCT00152971|100735901|FG000|Overall Study|Adverse Event|12|||
33228399|NCT00152971|100735902|FG001|Overall Study|Adverse Event|10|||
33228400|NCT00152971|100735903|FG002|Overall Study|Adverse Event|9|||
33228401|NCT00152971|100735901|FG000|Overall Study|Protocol Violation|10|||
33228402|NCT00152971|100735902|FG001|Overall Study|Protocol Violation|11|||
33228403|NCT00152971|100735903|FG002|Overall Study|Protocol Violation|8|||
33228404|NCT00152971|100735901|FG000|Overall Study|Lost to Follow-up|17|||
33228405|NCT00152971|100735902|FG001|Overall Study|Lost to Follow-up|14|||
33228406|NCT00152971|100735903|FG002|Overall Study|Lost to Follow-up|13|||
33228407|NCT00152971|100735901|FG000|Overall Study|Withdrawal by Subject|9|||
33228408|NCT00152971|100735902|FG001|Overall Study|Withdrawal by Subject|8|||
33228409|NCT00152971|100735903|FG002|Overall Study|Withdrawal by Subject|14|||
33228410|NCT00152971|100735901|FG000|Overall Study|Other|3|||
33228411|NCT00152971|100735902|FG001|Overall Study|Other|5|||
33228412|NCT00152971|100735903|FG002|Overall Study|Other|5|||
33228413|NCT00152971|100735901|FG000|Treatment|Adverse Event|49|||
33228414|NCT00152971|100735902|FG001|Treatment|Adverse Event|40|||
33228415|NCT00152971|100735903|FG002|Treatment|Adverse Event|54|||
33228416|NCT00152971|100735901|FG000|Treatment|Protocol Violation|8|||
33228417|NCT00152971|100735902|FG001|Treatment|Protocol Violation|6|||
33228418|NCT00152971|100735903|FG002|Treatment|Protocol Violation|10|||
33228419|NCT00152971|100735901|FG000|Treatment|Lost to Follow-up|1|||
33228420|NCT00152971|100735902|FG001|Treatment|Lost to Follow-up|2|||
33228421|NCT00152971|100735903|FG002|Treatment|Lost to Follow-up|1|||
33228422|NCT00152971|100735901|FG000|Treatment|Withdrawal by Subject|4|||
33228423|NCT00152971|100735902|FG001|Treatment|Withdrawal by Subject|4|||
33228424|NCT00152971|100735903|FG002|Treatment|Withdrawal by Subject|5|||
33228425|NCT00152971|100735901|FG000|Treatment|Other|9|||
33228426|NCT00152971|100735902|FG001|Treatment|Other|11|||
33634042|NCT03895203|102212008|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
33634043|NCT03895203|102212009|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
33228427|NCT00152971|100735903|FG002|Treatment|Other|10|||
33228428|NCT02611830|100735908|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
33228429|NCT02611830|100735909|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
33228430|NCT02611830|100735910|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
33634044|NCT03895203|102212010|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
33228431|NCT02611830|100735911|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
33228432|NCT02611830|100735908|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
33228433|NCT02611830|100735909|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
33228434|NCT02611830|100735910|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
33228435|NCT02611830|100735911|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
33571429|NCT04881760|101982723|FG003|Overall Study|Site Closure|1|||
33228436|NCT02611830|100735908|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
33228437|NCT02611830|100735909|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
33228438|NCT02611830|100735910|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
33228439|NCT02611830|100735911|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
33228440|NCT02611830|100735908|FG000|OL Induction Phase|Lack of Efficacy|9|||
33228441|NCT02611830|100735909|FG001|OL Induction Phase|Lack of Efficacy|0|||
33228442|NCT02611830|100735910|FG002|OL Induction Phase|Lack of Efficacy|0|||
33228443|NCT02611830|100735911|FG003|OL Induction Phase|Lack of Efficacy|0|||
33228444|NCT02611830|100735908|FG000|OL Induction Phase|Reason not specified|3|||
33228445|NCT02611830|100735909|FG001|OL Induction Phase|Reason not specified|0|||
33228446|NCT02611830|100735910|FG002|OL Induction Phase|Reason not specified|0|||
33228447|NCT02611830|100735911|FG003|OL Induction Phase|Reason not specified|0|||
33228448|NCT02611830|100735908|FG000|Maintenance Phase|Lack of Efficacy|0|||
33228449|NCT02611830|100735909|FG001|Maintenance Phase|Lack of Efficacy|29|||
33228450|NCT02611830|100735910|FG002|Maintenance Phase|Lack of Efficacy|18|||
33228451|NCT02611830|100735911|FG003|Maintenance Phase|Lack of Efficacy|6|||
33228452|NCT02611830|100735908|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
33571430|NCT04881760|101982724|FG004|Overall Study|Site Closure|0|||
33571431|NCT04881760|101982725|FG005|Overall Study|Site Closure|0|||
33571432|NCT04881760|101982726|FG006|Overall Study|Site Closure|0|||
33571433|NCT02604511|101982727|FG000|Overall Study|Adverse Event|3|||
33571434|NCT02604511|101982727|FG000|Overall Study|Disease Progression|4|||
33571435|NCT02604511|101982727|FG000|Overall Study|Withdrawal by Subject|3|||
33571436|NCT02604511|101982727|FG000|Overall Study|Participant ineligible|1|||
33571437|NCT02604511|101982727|FG000|Overall Study|Intercurrent illness|1|||
33571438|NCT02317627|101982728|FG000|Overall Study|Withdrawal by Subject|0|||
33571439|NCT02317627|101982729|FG001|Overall Study|Withdrawal by Subject|1|||
33571440|NCT02317627|101982730|FG002|Overall Study|Withdrawal by Subject|1|||
33571441|NCT02317627|101982728|FG000|Overall Study|Lost to Follow-up|2|||
33571442|NCT02317627|101982729|FG001|Overall Study|Lost to Follow-up|0|||
33571443|NCT02317627|101982730|FG002|Overall Study|Lost to Follow-up|0|||
33571444|NCT02317627|101982728|FG000|Overall Study|Stopped by Investigator|0|||
33571445|NCT02317627|101982729|FG001|Overall Study|Stopped by Investigator|1|||
33571446|NCT02317627|101982730|FG002|Overall Study|Stopped by Investigator|0|||
33571447|NCT02317627|101982728|FG000|Overall Study|Adverse Event|0|||
33228453|NCT02611830|100735909|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
33228454|NCT02611830|100735910|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
33228455|NCT02611830|100735911|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
33228456|NCT02611830|100735908|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
33228457|NCT02611830|100735909|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
33571448|NCT02317627|101982729|FG001|Overall Study|Adverse Event|2|||
33571449|NCT02317627|101982730|FG002|Overall Study|Adverse Event|3|||
33228458|NCT02611830|100735910|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
33228459|NCT02611830|100735911|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
33228460|NCT02611830|100735908|FG000|Maintenance Phase|Lost to Follow-up|0|||
33228461|NCT02611830|100735909|FG001|Maintenance Phase|Lost to Follow-up|0|||
33228462|NCT02611830|100735910|FG002|Maintenance Phase|Lost to Follow-up|0|||
33228463|NCT02611830|100735911|FG003|Maintenance Phase|Lost to Follow-up|1|||
33228464|NCT02611830|100735908|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
33228465|NCT02611830|100735909|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
33228466|NCT02611830|100735910|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
33228467|NCT02611830|100735911|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
33228468|NCT02611830|100735908|FG000|Maintenance Phase|Pregnancy|0|||
33228469|NCT02611830|100735909|FG001|Maintenance Phase|Pregnancy|0|||
33228470|NCT02611830|100735910|FG002|Maintenance Phase|Pregnancy|1|||
33228471|NCT02611830|100735911|FG003|Maintenance Phase|Pregnancy|0|||
33228472|NCT02611830|100735908|FG000|Maintenance Phase|Reason not specified|0|||
33228473|NCT02611830|100735909|FG001|Maintenance Phase|Reason not specified|1|||
33228474|NCT02611830|100735910|FG002|Maintenance Phase|Reason not specified|4|||
33228475|NCT02611830|100735911|FG003|Maintenance Phase|Reason not specified|0|||
33228476|NCT03447730|100735912|FG000|Overall Study|Adverse Event|0|||
33228477|NCT03447730|100735913|FG001|Overall Study|Adverse Event|2|||
33228478|NCT03447730|100735914|FG002|Overall Study|Adverse Event|0|||
33418786|NCT04380701|101425573|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
33571450|NCT02317627|101982728|FG000|Overall Study|Non-compliance with study drug|0|||
33228479|NCT01155661|100735915|FG000|Overall Study|Adverse Event|101|||
33228480|NCT01155661|100735915|FG000|Overall Study|Death|1|||
33228481|NCT01155661|100735915|FG000|Overall Study|Lack of Efficacy|32|||
33228482|NCT01155661|100735915|FG000|Overall Study|Lost to Follow-up|22|||
33418787|NCT04380701|101425574|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
33571451|NCT02317627|101982729|FG001|Overall Study|Non-compliance with study drug|1|||
33571452|NCT02317627|101982730|FG002|Overall Study|Non-compliance with study drug|0|||
33228483|NCT01155661|100735915|FG000|Overall Study|Physician Decision|3|||
33228484|NCT01155661|100735915|FG000|Overall Study|Protocol Violation|35|||
33571453|NCT00791648|101982731|FG000|Overall Study|Physician Decision|0|||
33571454|NCT00791648|101982732|FG001|Overall Study|Physician Decision|1|||
33571455|NCT00791648|101982731|FG000|Overall Study|Withdrawal by Subject|0|||
33571456|NCT00791648|101982732|FG001|Overall Study|Withdrawal by Subject|1|||
33228485|NCT01155661|100735915|FG000|Overall Study|Withdrawal by Subject|73|||
33228486|NCT01155661|100735915|FG000|Overall Study|Sponsor Decision|13|||
33228487|NCT02367716|100735917|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
33228488|NCT01678820|100735921|FG000|Overall Study|Study Terminated by Sponsor|45|||
33228489|NCT01678820|100735922|FG001|Overall Study|Study Terminated by Sponsor|43|||
33228490|NCT01678820|100735923|FG002|Overall Study|Study Terminated by Sponsor|43|||
33228491|NCT01678820|100735921|FG000|Overall Study|Withdrawal by Subject|2|||
33228492|NCT01678820|100735922|FG001|Overall Study|Withdrawal by Subject|5|||
33228493|NCT01678820|100735923|FG002|Overall Study|Withdrawal by Subject|2|||
33634045|NCT03895203|102212005|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
33634046|NCT03895203|102212006|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
33634047|NCT03895203|102212007|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
33634048|NCT03895203|102212008|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
33634049|NCT03895203|102212009|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
33634050|NCT03895203|102212010|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
33634051|NCT03895203|102212005|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
33634052|NCT03895203|102212006|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
33634053|NCT03895203|102212007|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
33634054|NCT03895203|102212008|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
33634055|NCT03895203|102212009|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
33634056|NCT03895203|102212010|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
33634057|NCT03895203|102212005|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
33634058|NCT03895203|102212006|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
33634059|NCT03895203|102212007|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
33634060|NCT03895203|102212008|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
33634061|NCT03895203|102212009|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
33634062|NCT03895203|102212010|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
33634063|NCT03895203|102212005|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
33634064|NCT03895203|102212006|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
33634065|NCT03895203|102212007|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
33634066|NCT03895203|102212008|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
33634067|NCT03895203|102212009|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
33634068|NCT03895203|102212010|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
33634069|NCT03895203|102212005|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
33634070|NCT03895203|102212006|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
33634071|NCT03895203|102212007|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
33634072|NCT03895203|102212008|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
33634073|NCT03895203|102212009|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
33634074|NCT03895203|102212010|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
33634075|NCT03895203|102212005|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
33634076|NCT03895203|102212006|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
33634077|NCT03895203|102212007|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
33634078|NCT03895203|102212008|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
33634079|NCT03895203|102212009|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
33634080|NCT03895203|102212010|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
33634081|NCT03895203|102212005|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
33634082|NCT03895203|102212006|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
33634083|NCT03895203|102212007|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
33634084|NCT03895203|102212008|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
33634085|NCT03895203|102212009|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
33634086|NCT03895203|102212010|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
33634087|NCT03895203|102212005|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
33228494|NCT01678820|100735921|FG000|Overall Study|Protocol Specified Criteria|2|||
33228495|NCT01678820|100735922|FG001|Overall Study|Protocol Specified Criteria|3|||
33418788|NCT04380701|101425575|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
33418789|NCT04380701|101425576|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
33418790|NCT04380701|101425577|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
33418791|NCT04380701|101425578|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
33418792|NCT04380701|101425579|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
33418793|NCT04380701|101425580|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
33571457|NCT04549454|101982733|FG000|T1 to T2|Lost to Follow-up|22|||
33571458|NCT04549454|101982734|FG001|T1 to T2|Lost to Follow-up|26|||
33571459|NCT04549454|101982733|FG000|T1 to T3|Lost to Follow-up|31|||
33571460|NCT04549454|101982734|FG001|T1 to T3|Lost to Follow-up|36|||
33571461|NCT04614324|101982736|FG000|Overall Study|Lost to Follow-up|3|||
33571462|NCT04614324|101982736|FG000|Overall Study|Physician Decision|1|||
33571463|NCT04614324|101982736|FG000|Overall Study|Withdrawal by Subject|2|||
33571464|NCT04614324|101982736|FG000|Overall Study|Remaining in Follow up|123|||
33571465|NCT01441960|101982737|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
33571466|NCT01441960|101982738|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
33571467|NCT01441960|101982737|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
33571468|NCT01441960|101982738|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
33571469|NCT01441960|101982737|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
33571470|NCT01441960|101982738|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
33571471|NCT02561962|101982739|FG000|Overall Study|Withdrawal by Subject|1|||
33571472|NCT02561962|101982740|FG001|Overall Study|Withdrawal by Subject|0|||
33571473|NCT02561962|101982741|FG002|Overall Study|Withdrawal by Subject|0|||
33571474|NCT02561962|101982742|FG003|Overall Study|Withdrawal by Subject|0|||
33571475|NCT02561962|101982743|FG004|Overall Study|Withdrawal by Subject|1|||
33571476|NCT02561962|101982744|FG005|Overall Study|Withdrawal by Subject|1|||
33571477|NCT02561962|101982745|FG006|Overall Study|Withdrawal by Subject|2|||
33571478|NCT02561962|101982746|FG007|Overall Study|Withdrawal by Subject|1|||
33571479|NCT02561962|101982747|FG008|Overall Study|Withdrawal by Subject|0|||
33571480|NCT02561962|101982739|FG000|Overall Study|Decision by sponsor|0|||
33571481|NCT02561962|101982740|FG001|Overall Study|Decision by sponsor|0|||
33571482|NCT02561962|101982741|FG002|Overall Study|Decision by sponsor|0|||
33571483|NCT02561962|101982742|FG003|Overall Study|Decision by sponsor|0|||
33571484|NCT02561962|101982743|FG004|Overall Study|Decision by sponsor|1|||
33571485|NCT02561962|101982744|FG005|Overall Study|Decision by sponsor|1|||
33571486|NCT02561962|101982745|FG006|Overall Study|Decision by sponsor|0|||
33571487|NCT02561962|101982746|FG007|Overall Study|Decision by sponsor|3|||
33228496|NCT01678820|100735923|FG002|Overall Study|Protocol Specified Criteria|1|||
33366799|NCT01555463|101230112|FG001|Follow up|Death|1|||
33366800|NCT01555463|101230111|FG000|Follow up|Withdrawal by Subject|22|||
33366801|NCT01555463|101230112|FG001|Follow up|Withdrawal by Subject|22|||
33366802|NCT01555463|101230111|FG000|Follow up|Lost to Follow-up|9|||
33366803|NCT01555463|101230112|FG001|Follow up|Lost to Follow-up|10|||
33366804|NCT01555463|101230111|FG000|Follow up|Protocol Violation|2|||
33366805|NCT01555463|101230112|FG001|Follow up|Protocol Violation|4|||
33366806|NCT01555463|101230111|FG000|Follow up|Other reason|3|||
33366807|NCT01555463|101230112|FG001|Follow up|Other reason|3|||
33366808|NCT00938327|101230115|FG000|Overall Study|Adverse Event|2|||
33366809|NCT00938327|101230115|FG000|Overall Study|Protocol Violation|1|||
33366810|NCT00938327|101230115|FG000|Overall Study|Withdrawal by Subject|4|||
33366811|NCT00938327|101230115|FG000|Overall Study|Lost to Follow-up|37|||
33366812|NCT00938327|101230115|FG000|Overall Study|2nd dose received outside of the study|7|||
33366813|NCT00938327|101230115|FG000|Overall Study|Vaccine not received as out of stock|9|||
33366814|NCT03408873|101230116|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
33366815|NCT03408873|101230116|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
33366816|NCT03408873|101230116|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
33366817|NCT03408873|101230116|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
33366818|NCT03408873|101230116|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
33366819|NCT03408873|101230116|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
33366820|NCT01912872|101230117|FG000|Overall Study|Lost to Follow-up|2|||
33366821|NCT01912872|101230118|FG001|Overall Study|Lost to Follow-up|3|||
33366822|NCT01912872|101230119|FG002|Overall Study|Lost to Follow-up|5|||
33366823|NCT01912872|101230120|FG003|Overall Study|Lost to Follow-up|5|||
33366824|NCT01912872|101230117|FG000|Overall Study|Other unspecified|3|||
33366825|NCT01912872|101230118|FG001|Overall Study|Other unspecified|1|||
33366826|NCT01912872|101230119|FG002|Overall Study|Other unspecified|3|||
33366827|NCT01912872|101230120|FG003|Overall Study|Other unspecified|0|||
33366828|NCT01912872|101230117|FG000|Overall Study|Informed consent withdrawn|0|||
33366829|NCT01912872|101230118|FG001|Overall Study|Informed consent withdrawn|0|||
33418794|NCT04380701|101425581|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
33418795|NCT04380701|101425582|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
33571488|NCT02561962|101982747|FG008|Overall Study|Decision by sponsor|0|||
33228497|NCT01678820|100735921|FG000|Overall Study|Adverse Event|2|||
33571489|NCT02561962|101982739|FG000|Overall Study|Lost to Follow-up|0|||
33571490|NCT02561962|101982740|FG001|Overall Study|Lost to Follow-up|0|||
33571491|NCT02561962|101982741|FG002|Overall Study|Lost to Follow-up|0|||
33228498|NCT01678820|100735922|FG001|Overall Study|Adverse Event|2|||
33228499|NCT01678820|100735923|FG002|Overall Study|Adverse Event|2|||
33228500|NCT01678820|100735921|FG000|Overall Study|Lost to Follow-up|7|||
33228501|NCT01678820|100735922|FG001|Overall Study|Lost to Follow-up|2|||
33228502|NCT01678820|100735923|FG002|Overall Study|Lost to Follow-up|2|||
33228503|NCT01678820|100735921|FG000|Overall Study|Non-compliance with study drug|0|||
33228504|NCT01678820|100735922|FG001|Overall Study|Non-compliance with study drug|1|||
33228505|NCT01678820|100735923|FG002|Overall Study|Non-compliance with study drug|0|||
33228506|NCT01678820|100735921|FG000|Overall Study|Physician Decision|0|||
33418796|NCT04380701|101425549|FG000|Overall Study|Physician Decision|0|||
33418797|NCT04380701|101425550|FG001|Overall Study|Physician Decision|0|||
33418798|NCT04380701|101425551|FG002|Overall Study|Physician Decision|0|||
33418799|NCT04380701|101425552|FG003|Overall Study|Physician Decision|0|||
33418800|NCT04380701|101425553|FG004|Overall Study|Physician Decision|0|||
33418801|NCT04380701|101425554|FG005|Overall Study|Physician Decision|0|||
33418802|NCT04380701|101425555|FG006|Overall Study|Physician Decision|0|||
33418803|NCT04380701|101425556|FG007|Overall Study|Physician Decision|0|||
33418804|NCT04380701|101425557|FG008|Overall Study|Physician Decision|0|||
33418805|NCT04380701|101425558|FG009|Overall Study|Physician Decision|0|||
33418806|NCT04380701|101425559|FG010|Overall Study|Physician Decision|0|||
33418807|NCT04380701|101425560|FG011|Overall Study|Physician Decision|0|||
33418808|NCT04380701|101425561|FG012|Overall Study|Physician Decision|0|||
33418809|NCT04380701|101425562|FG013|Overall Study|Physician Decision|0|||
33418810|NCT04380701|101425563|FG014|Overall Study|Physician Decision|0|||
33418811|NCT04380701|101425564|FG015|Overall Study|Physician Decision|0|||
33418812|NCT04380701|101425565|FG016|Overall Study|Physician Decision|0|||
33418813|NCT04380701|101425566|FG017|Overall Study|Physician Decision|0|||
33418814|NCT04380701|101425567|FG018|Overall Study|Physician Decision|0|||
33418815|NCT04380701|101425568|FG019|Overall Study|Physician Decision|0|||
33418816|NCT04380701|101425569|FG020|Overall Study|Physician Decision|0|||
33418817|NCT04380701|101425570|FG021|Overall Study|Physician Decision|0|||
33571492|NCT02561962|101982742|FG003|Overall Study|Lost to Follow-up|0|||
33571493|NCT02561962|101982743|FG004|Overall Study|Lost to Follow-up|0|||
33571494|NCT02561962|101982744|FG005|Overall Study|Lost to Follow-up|1|||
33571495|NCT02561962|101982745|FG006|Overall Study|Lost to Follow-up|0|||
33571496|NCT02561962|101982746|FG007|Overall Study|Lost to Follow-up|0|||
33571497|NCT02561962|101982747|FG008|Overall Study|Lost to Follow-up|0|||
33571498|NCT01634152|101982748|FG000|Overall Study|Adverse Event|2|||
33571499|NCT01634152|101982749|FG001|Overall Study|Adverse Event|0|||
33571500|NCT01634152|101982750|FG002|Overall Study|Adverse Event|2|||
33571501|NCT01634152|101982748|FG000|Overall Study|Consent withdrawn not due to AE|1|||
33571502|NCT01634152|101982749|FG001|Overall Study|Consent withdrawn not due to AE|0|||
33571503|NCT01634152|101982750|FG002|Overall Study|Consent withdrawn not due to AE|1|||
33571504|NCT01634152|101982748|FG000|Overall Study|Not treated|0|||
33571505|NCT01634152|101982749|FG001|Overall Study|Not treated|1|||
33571506|NCT01634152|101982750|FG002|Overall Study|Not treated|0|||
33571507|NCT01634152|101982748|FG000|Overall Study|Other reason not defined above|1|||
33571508|NCT01634152|101982749|FG001|Overall Study|Other reason not defined above|0|||
33571509|NCT01634152|101982750|FG002|Overall Study|Other reason not defined above|1|||
33571510|NCT00949533|101982751|FG000|Overall Study|Lost to Follow-up|0|||
33571511|NCT00949533|101982752|FG001|Overall Study|Lost to Follow-up|1|||
33571512|NCT01646827|101982754|FG000|Overall Study|Lost to Follow-up|0|||
33571513|NCT01646827|101982755|FG001|Overall Study|Lost to Follow-up|3|||
33571514|NCT01646827|101982754|FG000|Overall Study|Physician Decision|1|||
33571515|NCT01646827|101982755|FG001|Overall Study|Physician Decision|2|||
33571516|NCT01646827|101982754|FG000|Overall Study|Withdrawal by Subject|1|||
33571517|NCT01646827|101982755|FG001|Overall Study|Withdrawal by Subject|0|||
33571518|NCT02154061|101982758|FG000|Overall Study|Pregnancy|1|||
33228507|NCT01678820|100735922|FG001|Overall Study|Physician Decision|0|||
33571519|NCT02154061|101982759|FG001|Overall Study|Pregnancy|0|||
33571520|NCT02154061|101982758|FG000|Overall Study|enrolled but not vaccinated|1|||
33228508|NCT01678820|100735923|FG002|Overall Study|Physician Decision|1|||
33418818|NCT04380701|101425571|FG022|Overall Study|Physician Decision|0|||
33418819|NCT04380701|101425572|FG023|Overall Study|Physician Decision|0|||
33418820|NCT04380701|101425573|FG024|Overall Study|Physician Decision|2|||
33418821|NCT04380701|101425574|FG025|Overall Study|Physician Decision|0|||
33418822|NCT04380701|101425575|FG026|Overall Study|Physician Decision|0|||
33571521|NCT02154061|101982759|FG001|Overall Study|enrolled but not vaccinated|0|||
33571522|NCT02297516|101982760|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
33571523|NCT02297516|101982761|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
33571524|NCT02297516|101982760|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
33228509|NCT01678820|100735921|FG000|Overall Study|Protocol Violation|4|||
33228510|NCT01678820|100735922|FG001|Overall Study|Protocol Violation|5|||
33228511|NCT01678820|100735923|FG002|Overall Study|Protocol Violation|4|||
33228512|NCT01678820|100735921|FG000|Overall Study|Not treated with double-blind study drug|0|||
33228513|NCT01678820|100735922|FG001|Overall Study|Not treated with double-blind study drug|2|||
33228514|NCT01678820|100735923|FG002|Overall Study|Not treated with double-blind study drug|2|||
33228515|NCT03239873|100735924|FG000|Overall Study|Lost to Follow-up|15|||
33228516|NCT03239873|100735925|FG001|Overall Study|Lost to Follow-up|16|||
33228517|NCT03239873|100735924|FG000|Overall Study|Physician Decision|1|||
33228518|NCT03239873|100735925|FG001|Overall Study|Physician Decision|0|||
33228519|NCT03239873|100735924|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
33228520|NCT03239873|100735925|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
33228521|NCT03239873|100735924|FG000|Overall Study|Withdrawal by Subject|2|||
33228522|NCT03239873|100735925|FG001|Overall Study|Withdrawal by Subject|0|||
33228523|NCT03239873|100735924|FG000|Overall Study|Contraindication to study medication|1|||
33228524|NCT03239873|100735925|FG001|Overall Study|Contraindication to study medication|0|||
33228525|NCT03239873|100735924|FG000|Overall Study|Protocol Violation|1|||
33228526|NCT03239873|100735925|FG001|Overall Study|Protocol Violation|0|||
33418823|NCT04380701|101425576|FG027|Overall Study|Physician Decision|0|||
33418824|NCT04380701|101425577|FG028|Overall Study|Physician Decision|0|||
33418825|NCT04380701|101425578|FG029|Overall Study|Physician Decision|0|||
33418826|NCT04380701|101425579|FG030|Overall Study|Physician Decision|0|||
33418827|NCT04380701|101425580|FG031|Overall Study|Physician Decision|0|||
33418828|NCT04380701|101425581|FG032|Overall Study|Physician Decision|0|||
33418829|NCT04380701|101425582|FG033|Overall Study|Physician Decision|0|||
33418830|NCT04380701|101425549|FG000|Overall Study|Death|0|||
33418831|NCT04380701|101425550|FG001|Overall Study|Death|0|||
33418832|NCT04380701|101425551|FG002|Overall Study|Death|0|||
33418833|NCT04380701|101425552|FG003|Overall Study|Death|0|||
33571525|NCT02297516|101982761|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
33228527|NCT02396537|100735926|FG000|Overall Study|Protocol Violation|0|||
33228528|NCT02396537|100735927|FG001|Overall Study|Protocol Violation|1|||
33571526|NCT02297516|101982760|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
33228529|NCT05033080|100735928|FG000|Overall Study|Adverse Event|4|||
33228530|NCT05033080|100735929|FG001|Overall Study|Adverse Event|4|||
33418834|NCT04380701|101425553|FG004|Overall Study|Death|0|||
33418835|NCT04380701|101425554|FG005|Overall Study|Death|0|||
33418836|NCT04380701|101425555|FG006|Overall Study|Death|0|||
33418837|NCT04380701|101425556|FG007|Overall Study|Death|0|||
33418838|NCT04380701|101425557|FG008|Overall Study|Death|0|||
33418839|NCT04380701|101425558|FG009|Overall Study|Death|0|||
33418840|NCT04380701|101425559|FG010|Overall Study|Death|0|||
33228531|NCT05033080|100735928|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
33228532|NCT05033080|100735929|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
33228533|NCT05033080|100735928|FG000|Overall Study|Lost to Follow-up|1|||
33228534|NCT05033080|100735929|FG001|Overall Study|Lost to Follow-up|0|||
33228535|NCT05033080|100735928|FG000|Overall Study|Other non-compliance|0|||
33228536|NCT05033080|100735929|FG001|Overall Study|Other non-compliance|1|||
33228537|NCT05033080|100735928|FG000|Overall Study|Physician Decision|0|||
33228538|NCT05033080|100735929|FG001|Overall Study|Physician Decision|1|||
33228539|NCT05033080|100735928|FG000|Overall Study|Other|1|||
33228540|NCT05033080|100735929|FG001|Overall Study|Other|1|||
33418841|NCT04380701|101425560|FG011|Overall Study|Death|0|||
33634088|NCT03895203|102212006|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
33634089|NCT03895203|102212007|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
33228541|NCT00735644|100735934|FG000|Overall Study|Did not receive study vaccine|0|||
33228542|NCT00735644|100735935|FG001|Overall Study|Did not receive study vaccine|1|||
33228543|NCT00735644|100735936|FG002|Overall Study|Did not receive study vaccine|0|||
33634090|NCT03895203|102212008|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
33634091|NCT03895203|102212009|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
33634092|NCT03895203|102212010|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
33634093|NCT00325897|102212014|FG000|Overall Study|Lost to Follow-up|12|||
33634094|NCT00325897|102212015|FG001|Overall Study|Lost to Follow-up|13|||
33634095|NCT01586364|102212016|FG000|Overall Study|Withdrawal by Subject|40|||
33634096|NCT01586364|102212016|FG000|Overall Study|Adverse Event|37|||
33634097|NCT01586364|102212016|FG000|Overall Study|Lost to Follow-up|17|||
33634098|NCT01586364|102212016|FG000|Overall Study|Protocol Violation|16|||
33634099|NCT01586364|102212016|FG000|Overall Study|Lack of Efficacy|1|||
33634100|NCT01586364|102212016|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
33634101|NCT01586364|102212016|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
33634102|NCT01586364|102212016|FG000|Overall Study|Other-Site closure due to PI illness|1|||
33634103|NCT01586364|102212016|FG000|Overall Study|Other-PI discretion, site closing|2|||
33228544|NCT00735644|100735937|FG003|Overall Study|Did not receive study vaccine|0|||
33228545|NCT00735644|100735938|FG004|Overall Study|Did not receive study vaccine|0|||
33228546|NCT00735644|100735934|FG000|Overall Study|Withdrawal by Subject|0|||
33228547|NCT00735644|100735935|FG001|Overall Study|Withdrawal by Subject|1|||
33366830|NCT01912872|101230119|FG002|Overall Study|Informed consent withdrawn|1|||
33366831|NCT01912872|101230120|FG003|Overall Study|Informed consent withdrawn|1|||
33418842|NCT04380701|101425561|FG012|Overall Study|Death|0|||
33418843|NCT04380701|101425562|FG013|Overall Study|Death|0|||
33418844|NCT04380701|101425563|FG014|Overall Study|Death|0|||
33418845|NCT04380701|101425564|FG015|Overall Study|Death|0|||
33418846|NCT04380701|101425565|FG016|Overall Study|Death|0|||
33418847|NCT04380701|101425566|FG017|Overall Study|Death|0|||
33418848|NCT04380701|101425567|FG018|Overall Study|Death|0|||
33418849|NCT04380701|101425568|FG019|Overall Study|Death|0|||
33366832|NCT01912872|101230117|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
33366833|NCT01912872|101230118|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
33366834|NCT01912872|101230119|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
33366835|NCT01912872|101230120|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
33366836|NCT01912872|101230117|FG000|Overall Study|Protocol Violation|0|||
33366837|NCT01912872|101230118|FG001|Overall Study|Protocol Violation|0|||
33366838|NCT01912872|101230119|FG002|Overall Study|Protocol Violation|1|||
33366839|NCT01912872|101230120|FG003|Overall Study|Protocol Violation|0|||
33366840|NCT01912872|101230117|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33366841|NCT01912872|101230118|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33366842|NCT01912872|101230119|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33366843|NCT01912872|101230120|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
33366844|NCT01912872|101230117|FG000|Overall Study|Withdrawal of study medication|0|||
33571527|NCT02297516|101982761|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
33571528|NCT02546323|101982762|FG000|Overall Study|Withdrawal by Subject|36|||
33366845|NCT01912872|101230118|FG001|Overall Study|Withdrawal of study medication|0|||
33366846|NCT01912872|101230119|FG002|Overall Study|Withdrawal of study medication|0|||
33366847|NCT01912872|101230120|FG003|Overall Study|Withdrawal of study medication|2|||
33418850|NCT04380701|101425569|FG020|Overall Study|Death|0|||
33418851|NCT04380701|101425570|FG021|Overall Study|Death|0|||
33418852|NCT04380701|101425571|FG022|Overall Study|Death|0|||
33418853|NCT04380701|101425572|FG023|Overall Study|Death|0|||
33418854|NCT04380701|101425573|FG024|Overall Study|Death|1|||
33418855|NCT04380701|101425574|FG025|Overall Study|Death|0|||
33418856|NCT04380701|101425575|FG026|Overall Study|Death|0|||
33418857|NCT04380701|101425576|FG027|Overall Study|Death|0|||
33418858|NCT04380701|101425577|FG028|Overall Study|Death|0|||
33418859|NCT04380701|101425578|FG029|Overall Study|Death|0|||
33418860|NCT04380701|101425579|FG030|Overall Study|Death|0|||
33418861|NCT04380701|101425580|FG031|Overall Study|Death|0|||
33418862|NCT04380701|101425581|FG032|Overall Study|Death|0|||
33418863|NCT04380701|101425582|FG033|Overall Study|Death|0|||
33418864|NCT04380701|101425549|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418865|NCT04380701|101425550|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418866|NCT04380701|101425551|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418867|NCT04380701|101425552|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33634104|NCT01586364|102212016|FG000|Overall Study|Other-Not specified|1|||
33634105|NCT04314284|102212017|FG000|Overall Study|Withdrawal by Subject|4|||
33366848|NCT01912872|101230117|FG000|Overall Study|Missing|0|||
33366849|NCT01912872|101230118|FG001|Overall Study|Missing|0|||
33366850|NCT01912872|101230119|FG002|Overall Study|Missing|0|||
33366851|NCT01912872|101230120|FG003|Overall Study|Missing|1|||
33366852|NCT04983940|101230121|FG000|Overall Study|Lost to Follow-up|14|||
33366853|NCT04983940|101230121|FG000|Overall Study|Lack of Efficacy|2|||
33366854|NCT03288779|101230122|FG000|Overall Study|Withdrawal by Subject|3|||
33366855|NCT01981122|101230123|FG000|Overall Study|Withdrawal by Subject|0|||
33366856|NCT01981122|101230124|FG001|Overall Study|Withdrawal by Subject|2|||
33634106|NCT04314284|102212018|FG001|Overall Study|Withdrawal by Subject|7|||
33634107|NCT04314284|102212017|FG000|Overall Study|Consented but did not complete survey|0|||
33634108|NCT04314284|102212018|FG001|Overall Study|Consented but did not complete survey|6|||
33634109|NCT01347112|102212021|FG000|Overall Study|Withdrawal by Subject|1|||
33634110|NCT01347112|102212022|FG001|Overall Study|Withdrawal by Subject|7|||
33634111|NCT01347112|102212021|FG000|Overall Study|Lost to Follow-up|3|||
33634112|NCT01347112|102212022|FG001|Overall Study|Lost to Follow-up|5|||
33634113|NCT02072668|102212024|FG000|Second Intervention|Lost to Follow-up|1|||
33634114|NCT02072668|102212025|FG001|Second Intervention|Lost to Follow-up|0|||
33366857|NCT01981122|101230123|FG000|Overall Study|Protocol Violation|0|||
33366858|NCT01981122|101230124|FG001|Overall Study|Protocol Violation|1|||
33366859|NCT01981122|101230123|FG000|Overall Study|Lost to Follow-up|0|||
33634115|NCT01283139|102212028|FG000|Overall Study|Lost to Follow-up|5|||
33634116|NCT01283139|102212029|FG001|Overall Study|Lost to Follow-up|2|||
33634117|NCT01283139|102212030|FG002|Overall Study|Lost to Follow-up|3|||
33634118|NCT01283139|102212031|FG003|Overall Study|Lost to Follow-up|1|||
33634119|NCT01283139|102212028|FG000|Overall Study|Withdrawal by Subject|8|||
33634120|NCT01283139|102212029|FG001|Overall Study|Withdrawal by Subject|8|||
33634121|NCT01283139|102212030|FG002|Overall Study|Withdrawal by Subject|6|||
33228548|NCT00735644|100735936|FG002|Overall Study|Withdrawal by Subject|1|||
33366860|NCT01981122|101230124|FG001|Overall Study|Lost to Follow-up|1|||
33366861|NCT01981122|101230123|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
33418868|NCT04380701|101425553|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418869|NCT04380701|101425554|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418870|NCT04380701|101425555|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33634122|NCT01283139|102212031|FG003|Overall Study|Withdrawal by Subject|8|||
33634123|NCT01283139|102212028|FG000|Overall Study|Death|2|||
33634124|NCT01283139|102212029|FG001|Overall Study|Death|0|||
33634125|NCT01283139|102212030|FG002|Overall Study|Death|2|||
33634126|NCT01283139|102212031|FG003|Overall Study|Death|2|||
33366862|NCT01981122|101230124|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
33366863|NCT01981122|101230123|FG000|Overall Study|Death|14|||
33366864|NCT01981122|101230124|FG001|Overall Study|Death|15|||
33366865|NCT01400971|101230128|FG000|Overall Study|Death|82|||
33366866|NCT01400971|101230128|FG000|Overall Study|Lost to Follow-up|196|||
33366867|NCT01400971|101230128|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
33366868|NCT01400971|101230128|FG000|Overall Study|Physician Decision|57|||
33366869|NCT01400971|101230128|FG000|Overall Study|Withdrawal by Subject|158|||
33366870|NCT01400971|101230128|FG000|Overall Study|Other|422|||
33366871|NCT03643432|101230133|FG000|Overall Study|Lost to Follow-up|1|||
33366872|NCT03643432|101230134|FG001|Overall Study|Lost to Follow-up|0|||
33366873|NCT00611455|101230135|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
33366874|NCT00611455|101230136|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
33366875|NCT00611455|101230137|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
33366876|NCT00611455|101230135|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
33366877|NCT00611455|101230136|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
33418871|NCT04380701|101425556|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418872|NCT04380701|101425557|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33366878|NCT00611455|101230137|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
33366879|NCT00611455|101230135|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
33366880|NCT00611455|101230136|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
33366881|NCT00611455|101230137|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
33366882|NCT00611455|101230135|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
33418873|NCT04380701|101425558|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418874|NCT04380701|101425559|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418875|NCT04380701|101425560|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418876|NCT04380701|101425561|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418877|NCT04380701|101425562|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33571529|NCT02546323|101982763|FG001|Overall Study|Withdrawal by Subject|33|||
33571530|NCT02546323|101982762|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
33571531|NCT02546323|101982763|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
33571532|NCT02546323|101982762|FG000|Overall Study|Adverse Event|17|||
33571533|NCT02546323|101982763|FG001|Overall Study|Adverse Event|11|||
33571534|NCT02546323|101982762|FG000|Overall Study|Patient Specific Reasons|1|||
33571535|NCT02546323|101982763|FG001|Overall Study|Patient Specific Reasons|2|||
33571536|NCT02546323|101982762|FG000|Overall Study|Lost to Follow-up|2|||
33571537|NCT02546323|101982763|FG001|Overall Study|Lost to Follow-up|3|||
33571538|NCT02546323|101982762|FG000|Overall Study|Non-compliance with Study Drug|2|||
33571539|NCT02546323|101982763|FG001|Overall Study|Non-compliance with Study Drug|2|||
33571540|NCT02546323|101982762|FG000|Overall Study|Met Withdrawal Criteria|2|||
33571541|NCT02546323|101982763|FG001|Overall Study|Met Withdrawal Criteria|14|||
33571542|NCT00261833|101982764|FG000|Overall Study|Death|1|||
33571543|NCT00261833|101982765|FG001|Overall Study|Death|3|||
33571544|NCT00261833|101982764|FG000|Overall Study|Adverse Event|1|||
33571545|NCT00261833|101982765|FG001|Overall Study|Adverse Event|4|||
33571546|NCT00261833|101982764|FG000|Overall Study|Withdrawal by Subject|5|||
33571547|NCT00261833|101982765|FG001|Overall Study|Withdrawal by Subject|7|||
33571548|NCT00261833|101982764|FG000|Overall Study|Protocol Violation|0|||
33571549|NCT00261833|101982765|FG001|Overall Study|Protocol Violation|1|||
33571550|NCT00261833|101982764|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
33571551|NCT00261833|101982765|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
33571552|NCT00261833|101982764|FG000|Overall Study|Lung transplantation|1|||
33571553|NCT00261833|101982765|FG001|Overall Study|Lung transplantation|1|||
33571554|NCT00261833|101982764|FG000|Overall Study|Missing reason|1|||
33634127|NCT01283139|102212028|FG000|Overall Study|Lack of Efficacy|1|||
33634128|NCT01283139|102212029|FG001|Overall Study|Lack of Efficacy|2|||
33634129|NCT01283139|102212030|FG002|Overall Study|Lack of Efficacy|2|||
33634130|NCT01283139|102212031|FG003|Overall Study|Lack of Efficacy|1|||
33634131|NCT01283139|102212028|FG000|Overall Study|Early termination due to AE/SAE|1|||
33571555|NCT00261833|101982765|FG001|Overall Study|Missing reason|0|||
33366883|NCT00611455|101230136|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
33366884|NCT00611455|101230137|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33366885|NCT00611455|101230135|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
33571556|NCT00261833|101982764|FG000|Overall Study|Not interested in being participant|0|||
33571557|NCT00261833|101982765|FG001|Overall Study|Not interested in being participant|1|||
33571558|NCT00557193|101982766|FG000|Induction|Adverse Event|2|||
33571559|NCT00557193|101982767|FG001|Induction|Adverse Event|0|||
33571560|NCT00557193|101982768|FG002|Induction|Adverse Event|0|||
33571561|NCT00557193|101982769|FG003|Induction|Adverse Event|0|||
33571562|NCT00557193|101982770|FG004|Induction|Adverse Event|0|||
33571563|NCT00557193|101982771|FG005|Induction|Adverse Event|0|||
33571564|NCT00557193|101982766|FG000|Induction|Death|6|||
33571565|NCT00557193|101982767|FG001|Induction|Death|0|||
33571566|NCT00557193|101982768|FG002|Induction|Death|0|||
33571567|NCT00557193|101982769|FG003|Induction|Death|0|||
33571568|NCT00557193|101982770|FG004|Induction|Death|0|||
33571569|NCT00557193|101982771|FG005|Induction|Death|0|||
33571570|NCT00557193|101982766|FG000|Induction|Physician Decision|3|||
33571571|NCT00557193|101982767|FG001|Induction|Physician Decision|0|||
33571572|NCT00557193|101982768|FG002|Induction|Physician Decision|0|||
33571573|NCT00557193|101982769|FG003|Induction|Physician Decision|0|||
33571574|NCT00557193|101982770|FG004|Induction|Physician Decision|0|||
33571575|NCT00557193|101982771|FG005|Induction|Physician Decision|0|||
33571576|NCT00557193|101982766|FG000|Induction|Withdrawal by Subject|1|||
33571577|NCT00557193|101982767|FG001|Induction|Withdrawal by Subject|0|||
33571578|NCT00557193|101982768|FG002|Induction|Withdrawal by Subject|0|||
33571579|NCT00557193|101982769|FG003|Induction|Withdrawal by Subject|0|||
33571580|NCT00557193|101982770|FG004|Induction|Withdrawal by Subject|0|||
33571581|NCT00557193|101982771|FG005|Induction|Withdrawal by Subject|0|||
33571582|NCT00557193|101982766|FG000|Induction|Refusal of Further Protocol Therapy|2|||
33571583|NCT00557193|101982767|FG001|Induction|Refusal of Further Protocol Therapy|0|||
33571584|NCT00557193|101982768|FG002|Induction|Refusal of Further Protocol Therapy|0|||
33571585|NCT00557193|101982769|FG003|Induction|Refusal of Further Protocol Therapy|0|||
33571586|NCT00557193|101982770|FG004|Induction|Refusal of Further Protocol Therapy|0|||
33571587|NCT00557193|101982771|FG005|Induction|Refusal of Further Protocol Therapy|0|||
33571588|NCT00557193|101982766|FG000|Induction|Ineligible|8|||
33571589|NCT00557193|101982767|FG001|Induction|Ineligible|0|||
33571590|NCT00557193|101982768|FG002|Induction|Ineligible|0|||
33571591|NCT00557193|101982769|FG003|Induction|Ineligible|0|||
33571592|NCT00557193|101982770|FG004|Induction|Ineligible|0|||
33571593|NCT00557193|101982771|FG005|Induction|Ineligible|0|||
33571594|NCT00557193|101982766|FG000|Induction|Inevaluable for post Induction|2|||
33571595|NCT00557193|101982767|FG001|Induction|Inevaluable for post Induction|0|||
33571596|NCT00557193|101982768|FG002|Induction|Inevaluable for post Induction|0|||
33634132|NCT01283139|102212029|FG001|Overall Study|Early termination due to AE/SAE|1|||
33634133|NCT01283139|102212030|FG002|Overall Study|Early termination due to AE/SAE|0|||
33634134|NCT01283139|102212031|FG003|Overall Study|Early termination due to AE/SAE|0|||
33634135|NCT01283139|102212028|FG000|Overall Study|Participant's refusal to continue|0|||
33634136|NCT01283139|102212029|FG001|Overall Study|Participant's refusal to continue|3|||
33634137|NCT01283139|102212030|FG002|Overall Study|Participant's refusal to continue|1|||
33634138|NCT01283139|102212031|FG003|Overall Study|Participant's refusal to continue|1|||
33634139|NCT01283139|102212028|FG000|Overall Study|Pregnancy|0|||
33634140|NCT01283139|102212029|FG001|Overall Study|Pregnancy|1|||
33634141|NCT01283139|102212030|FG002|Overall Study|Pregnancy|1|||
33634142|NCT01283139|102212031|FG003|Overall Study|Pregnancy|0|||
33634143|NCT01283139|102212028|FG000|Overall Study|Missed follow-up visit|0|||
33634144|NCT01283139|102212029|FG001|Overall Study|Missed follow-up visit|1|||
33634145|NCT01283139|102212030|FG002|Overall Study|Missed follow-up visit|2|||
33634146|NCT01283139|102212031|FG003|Overall Study|Missed follow-up visit|2|||
33634147|NCT01283139|102212028|FG000|Overall Study|Participant randomized in error|0|||
33634148|NCT01283139|102212029|FG001|Overall Study|Participant randomized in error|0|||
33634149|NCT01283139|102212030|FG002|Overall Study|Participant randomized in error|1|||
33634150|NCT01283139|102212031|FG003|Overall Study|Participant randomized in error|0|||
33634151|NCT00307801|102212032|FG000|Overall Study|Adverse Event|12|||
33634152|NCT00307801|102212033|FG001|Overall Study|Adverse Event|4|||
33634153|NCT00307801|102212032|FG000|Overall Study|Withdrawal by Subject|9|||
33571597|NCT00557193|101982769|FG003|Induction|Inevaluable for post Induction|0|||
33571598|NCT00557193|101982770|FG004|Induction|Inevaluable for post Induction|0|||
33571599|NCT00557193|101982771|FG005|Induction|Inevaluable for post Induction|0|||
33571600|NCT00557193|101982766|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
33571601|NCT00557193|101982767|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
33571602|NCT00557193|101982768|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
33571603|NCT00557193|101982769|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
33634154|NCT00307801|102212033|FG001|Overall Study|Withdrawal by Subject|4|||
33634155|NCT00307801|102212032|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
33634156|NCT00307801|102212033|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
33634157|NCT00307801|102212032|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
33571604|NCT00557193|101982770|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
33571605|NCT00557193|101982771|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
33571606|NCT00557193|101982766|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
33571607|NCT00557193|101982767|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
33571608|NCT00557193|101982768|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
33571609|NCT00557193|101982769|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
33571610|NCT00557193|101982770|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
33571611|NCT00557193|101982771|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
33571612|NCT00557193|101982766|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
33571613|NCT00557193|101982767|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
33571614|NCT00557193|101982768|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
33571615|NCT00557193|101982769|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
33571616|NCT00557193|101982770|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
33571617|NCT00557193|101982771|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
33634158|NCT00307801|102212033|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
33634159|NCT00307801|102212032|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
33228549|NCT00735644|100735937|FG003|Overall Study|Withdrawal by Subject|1|||
33228550|NCT00735644|100735938|FG004|Overall Study|Withdrawal by Subject|0|||
33228551|NCT00482274|100739093|FG000|Overall Study|Adverse Event|1|||
33228552|NCT04186403|100739094|FG000|Overall Study|Adverse Event|1|||
33228553|NCT04186403|100739095|FG001|Overall Study|Adverse Event|8|||
33228554|NCT04186403|100739094|FG000|Overall Study|Lost to Follow-up|7|||
33366886|NCT00611455|101230136|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
33366887|NCT00611455|101230137|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
33366888|NCT00611455|101230135|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
33366889|NCT00611455|101230136|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
33366890|NCT00611455|101230137|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
33366891|NCT00611455|101230135|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
33366892|NCT00611455|101230136|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
33366893|NCT00611455|101230137|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
33366894|NCT00611455|101230135|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
33366895|NCT00611455|101230136|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
33418878|NCT04380701|101425563|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418879|NCT04380701|101425564|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418880|NCT04380701|101425565|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418881|NCT04380701|101425566|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418882|NCT04380701|101425567|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418883|NCT04380701|101425568|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418884|NCT04380701|101425569|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418885|NCT04380701|101425570|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
33418886|NCT04380701|101425571|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
33418887|NCT04380701|101425572|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
33418888|NCT04380701|101425573|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
33418889|NCT04380701|101425574|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418890|NCT04380701|101425575|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418891|NCT04380701|101425576|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418892|NCT04380701|101425577|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418893|NCT04380701|101425578|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418894|NCT04380701|101425579|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418895|NCT04380701|101425580|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418896|NCT04380701|101425581|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33571618|NCT00557193|101982766|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
33634160|NCT00307801|102212033|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
33634161|NCT00307801|102212032|FG000|Overall Study|Wrong Randomization|1|||
33366896|NCT00611455|101230137|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
33228555|NCT04186403|100739095|FG001|Overall Study|Lost to Follow-up|3|||
33571619|NCT00557193|101982767|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
33571620|NCT00557193|101982768|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
33571621|NCT00557193|101982769|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
33571622|NCT00557193|101982770|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
33571623|NCT00557193|101982771|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
33571624|NCT00557193|101982766|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
33571625|NCT00557193|101982767|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
33571626|NCT00557193|101982768|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
33571627|NCT00557193|101982769|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
33571628|NCT00557193|101982770|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
33571629|NCT00557193|101982771|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
33571630|NCT00557193|101982766|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
33571631|NCT00557193|101982767|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
33571632|NCT00557193|101982768|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
33418897|NCT04380701|101425582|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
33418898|NCT01785472|101425585|FG000|Overall Study|Adverse Event|5|||
33418899|NCT01785472|101425586|FG001|Overall Study|Adverse Event|4|||
33418900|NCT01785472|101425587|FG002|Overall Study|Adverse Event|6|||
33418901|NCT01785472|101425585|FG000|Overall Study|Lack of Efficacy|2|||
33418902|NCT01785472|101425586|FG001|Overall Study|Lack of Efficacy|0|||
33228556|NCT04186403|100739094|FG000|Overall Study|Physician Decision|1|||
33418903|NCT01785472|101425587|FG002|Overall Study|Lack of Efficacy|1|||
33418904|NCT01785472|101425585|FG000|Overall Study|Lost to Follow-up|1|||
33571633|NCT00557193|101982769|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
33571634|NCT00557193|101982770|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
33571635|NCT00557193|101982771|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
33634162|NCT00307801|102212033|FG001|Overall Study|Wrong Randomization|0|||
33228557|NCT04186403|100739095|FG001|Overall Study|Physician Decision|0|||
33228558|NCT04186403|100739094|FG000|Overall Study|Withdrawal by Subject|7|||
33228559|NCT04186403|100739095|FG001|Overall Study|Withdrawal by Subject|8|||
33228560|NCT04186403|100739094|FG000|Overall Study|Other: Not Related to Covid-19|3|||
33228561|NCT04186403|100739095|FG001|Overall Study|Other: Not Related to Covid-19|0|||
33228562|NCT04041440|100739096|FG000|Overall Study|Withdrawal by Subject|0|||
33228563|NCT04041440|100739097|FG001|Overall Study|Withdrawal by Subject|1|||
33228564|NCT04041440|100739096|FG000|Overall Study|Lost to Follow-up|0|||
33228565|NCT04041440|100739097|FG001|Overall Study|Lost to Follow-up|1|||
33228566|NCT03077620|100739102|FG000|Overall Study|Unable to place lumbar catheter|1|||
33228567|NCT03077620|100739103|FG001|Overall Study|Unable to place lumbar catheter|0|||
33228568|NCT03077620|100739104|FG002|Overall Study|Unable to place lumbar catheter|1|||
33228569|NCT03077620|100739105|FG003|Overall Study|Unable to place lumbar catheter|0|||
33228570|NCT03077620|100739102|FG000|Overall Study|Withdrawal by Subject|0|||
33228571|NCT03077620|100739103|FG001|Overall Study|Withdrawal by Subject|1|||
33228572|NCT03077620|100739104|FG002|Overall Study|Withdrawal by Subject|0|||
33228573|NCT03077620|100739105|FG003|Overall Study|Withdrawal by Subject|0|||
33228574|NCT03077620|100739102|FG000|Overall Study|Physician Decision|0|||
33228575|NCT03077620|100739103|FG001|Overall Study|Physician Decision|0|||
33228576|NCT03077620|100739104|FG002|Overall Study|Physician Decision|1|||
33228577|NCT03077620|100739105|FG003|Overall Study|Physician Decision|0|||
33228578|NCT04567693|100739107|FG000|Overall Study|Death|0|||
33228579|NCT04567693|100739108|FG001|Overall Study|Death|0|||
33228580|NCT04567693|100739109|FG002|Overall Study|Death|2|||
33228581|NCT04567693|100739107|FG000|Overall Study|Lost to Follow-up|1|||
33228582|NCT04567693|100739108|FG001|Overall Study|Lost to Follow-up|0|||
33228583|NCT04567693|100739109|FG002|Overall Study|Lost to Follow-up|2|||
33228584|NCT04567693|100739107|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
33228585|NCT04567693|100739108|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
33228586|NCT04567693|100739109|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
33228587|NCT01464021|100739110|FG000|Overall Study|Withdrawal by Subject|13|||
33228588|NCT01464021|100739110|FG000|Overall Study|Lost to Follow-up|1|||
33228589|NCT01464021|100739110|FG000|Overall Study|Lack of Efficacy|1|||
33228590|NCT01464021|100739110|FG000|Overall Study|various|11|||
33228591|NCT04498247|100739111|FG000|Overall Study|Lost to Follow-up|0|||
33228592|NCT04498247|100739112|FG001|Overall Study|Lost to Follow-up|0|||
33228593|NCT04498247|100739113|FG002|Overall Study|Lost to Follow-up|0|||
33228594|NCT04498247|100739114|FG003|Overall Study|Lost to Follow-up|1|||
33228595|NCT04498247|100739115|FG004|Overall Study|Lost to Follow-up|0|||
33228596|NCT04498247|100739116|FG005|Overall Study|Lost to Follow-up|0|||
33228597|NCT04498247|100739117|FG006|Overall Study|Lost to Follow-up|0|||
33228598|NCT04498247|100739118|FG007|Overall Study|Lost to Follow-up|0|||
33228599|NCT04498247|100739111|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
33228600|NCT04498247|100739112|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
33228601|NCT04498247|100739113|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
33228602|NCT04498247|100739114|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
33228603|NCT04498247|100739115|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
33228604|NCT04498247|100739116|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
33228605|NCT04498247|100739117|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
33228606|NCT04498247|100739118|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
33228607|NCT04498247|100739111|FG000|Overall Study|Withdrawal by Subject|0|||
33228608|NCT04498247|100739112|FG001|Overall Study|Withdrawal by Subject|8|||
33228609|NCT04498247|100739113|FG002|Overall Study|Withdrawal by Subject|0|||
33228610|NCT04498247|100739114|FG003|Overall Study|Withdrawal by Subject|7|||
33228611|NCT04498247|100739115|FG004|Overall Study|Withdrawal by Subject|0|||
33228612|NCT04498247|100739116|FG005|Overall Study|Withdrawal by Subject|0|||
33228613|NCT04498247|100739117|FG006|Overall Study|Withdrawal by Subject|1|||
33228614|NCT04498247|100739118|FG007|Overall Study|Withdrawal by Subject|0|||
33228615|NCT04498247|100739111|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
33228616|NCT04498247|100739112|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
33228617|NCT04498247|100739113|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
33228618|NCT04498247|100739114|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
33228619|NCT04498247|100739115|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
33228620|NCT04498247|100739116|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
33228621|NCT04498247|100739117|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
33228622|NCT04498247|100739118|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
33228623|NCT03327402|100739124|FG000|Overall Study|Withdrawal by Subject|1|||
33228624|NCT03327402|100739124|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
33228625|NCT00366301|100739128|FG000|Overall Study|Lost to Follow-up|4|||
33228626|NCT00366301|100739129|FG001|Overall Study|Lost to Follow-up|4|||
33228627|NCT00366301|100739130|FG002|Overall Study|Lost to Follow-up|3|||
33228628|NCT00366301|100739131|FG003|Overall Study|Lost to Follow-up|7|||
33228629|NCT00366301|100739128|FG000|Overall Study|Withdrawal by Subject|4|||
33228630|NCT00366301|100739129|FG001|Overall Study|Withdrawal by Subject|2|||
33228631|NCT00366301|100739130|FG002|Overall Study|Withdrawal by Subject|1|||
33228632|NCT00366301|100739131|FG003|Overall Study|Withdrawal by Subject|1|||
33228633|NCT01024959|100739132|FG000|Overall Study|ineligible|12|||
33228634|NCT01024959|100739132|FG000|Overall Study|results not evaluable|12|||
33228635|NCT01024959|100739132|FG000|Overall Study|missing results required for analysis|17|||
33228636|NCT01263106|100739134|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
33228637|NCT01263106|100739135|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
33228638|NCT01597505|100739142|FG000|Overall Study|Physician Decision|5|||
33228639|NCT01597505|100739143|FG001|Overall Study|Physician Decision|0|||
33228640|NCT01597505|100739142|FG000|Overall Study|Adverse Event|19|||
33228641|NCT01597505|100739143|FG001|Overall Study|Adverse Event|7|||
33228642|NCT01597505|100739142|FG000|Overall Study|Lost to Follow-up|4|||
33228643|NCT01597505|100739143|FG001|Overall Study|Lost to Follow-up|2|||
33228644|NCT01597505|100739142|FG000|Overall Study|Withdrawal by Subject|10|||
33228645|NCT01597505|100739143|FG001|Overall Study|Withdrawal by Subject|18|||
33228646|NCT01597505|100739142|FG000|Overall Study|Other|5|||
33634163|NCT00307801|102212032|FG000|Overall Study|Lack of Efficacy|0|||
33634164|NCT00307801|102212033|FG001|Overall Study|Lack of Efficacy|2|||
33634165|NCT00307801|102212032|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
33634166|NCT00307801|102212033|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
33634167|NCT00307801|102212032|FG000|Overall Study|Frustration with e-diary|1|||
33634168|NCT00307801|102212033|FG001|Overall Study|Frustration with e-diary|0|||
33228647|NCT01597505|100739143|FG001|Overall Study|Other|6|||
33228648|NCT01597505|100739142|FG000|Overall Study|Missing|1|||
33228649|NCT01597505|100739143|FG001|Overall Study|Missing|0|||
33228650|NCT00119262|100739146|FG000|Overall Study|Lack of Efficacy|0|||
33228651|NCT00119262|100739147|FG001|Overall Study|Lack of Efficacy|3|||
33228652|NCT00119262|100739146|FG000|Overall Study|Withdrawal by Subject|12|||
33228653|NCT00119262|100739147|FG001|Overall Study|Withdrawal by Subject|11|||
33228654|NCT00119262|100739146|FG000|Overall Study|Adverse Event|33|||
33228655|NCT00119262|100739147|FG001|Overall Study|Adverse Event|35|||
33228656|NCT00119262|100739146|FG000|Overall Study|other disease|0|||
33228657|NCT00119262|100739147|FG001|Overall Study|other disease|2|||
33228658|NCT00119262|100739146|FG000|Overall Study|ineligble|1|||
33228659|NCT00119262|100739147|FG001|Overall Study|ineligble|2|||
33571636|NCT00557193|101982766|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
33634169|NCT00307801|102212032|FG000|Overall Study|Protocol Violation|3|||
33228660|NCT00119262|100739146|FG000|Overall Study|others|0|||
33228661|NCT00119262|100739147|FG001|Overall Study|others|5|||
33228662|NCT00423293|100739148|FG000|Overall Study|Ineligible / No protocol treatment|11|||
33228663|NCT02145078|100739149|FG000|Overall Study|Death|1|||
33418905|NCT01785472|101425586|FG001|Overall Study|Lost to Follow-up|2|||
33418906|NCT01785472|101425587|FG002|Overall Study|Lost to Follow-up|0|||
33418907|NCT01785472|101425585|FG000|Overall Study|Physician Decision|1|||
33418908|NCT01785472|101425586|FG001|Overall Study|Physician Decision|1|||
33418909|NCT01785472|101425587|FG002|Overall Study|Physician Decision|1|||
33418910|NCT01785472|101425585|FG000|Overall Study|Protocol deviation|0|||
33418911|NCT01785472|101425586|FG001|Overall Study|Protocol deviation|2|||
33418912|NCT01785472|101425587|FG002|Overall Study|Protocol deviation|2|||
33418913|NCT01785472|101425585|FG000|Overall Study|Subject/guardian decision|15|||
33418914|NCT01785472|101425586|FG001|Overall Study|Subject/guardian decision|10|||
33418915|NCT01785472|101425587|FG002|Overall Study|Subject/guardian decision|11|||
33418916|NCT01785472|101425585|FG000|Overall Study|Technical problems|0|||
33418917|NCT01785472|101425586|FG001|Overall Study|Technical problems|0|||
33418918|NCT01785472|101425587|FG002|Overall Study|Technical problems|1|||
33418919|NCT05048342|101425588|FG000|Overall Study|Adverse Event|1|||
33418920|NCT05048342|101425588|FG000|Overall Study|Subject decision|2|||
33634170|NCT00307801|102212033|FG001|Overall Study|Protocol Violation|2|||
33634171|NCT00307801|102212032|FG000|Overall Study|No reason specified|2|||
33228664|NCT02145078|100739149|FG000|Overall Study|Reason not given|3|||
33228665|NCT01051063|100739151|FG000|Overall Study|Death|2|||
33228666|NCT01051063|100739152|FG001|Overall Study|Death|2|||
33228667|NCT01051063|100739151|FG000|Overall Study|Withdrawal by Subject|1|||
33418921|NCT05166421|101425594|FG000|Overall Study|Other|3|||
33228668|NCT01051063|100739152|FG001|Overall Study|Withdrawal by Subject|1|||
33228669|NCT01051063|100739151|FG000|Overall Study|Termination of the study|5|||
33228670|NCT01051063|100739152|FG001|Overall Study|Termination of the study|0|||
33228671|NCT01051063|100739151|FG000|Overall Study|Moved from the study site area|1|||
33228672|NCT01051063|100739152|FG001|Overall Study|Moved from the study site area|0|||
33228673|NCT01051063|100739151|FG000|Overall Study|Other|1|||
33228674|NCT01051063|100739152|FG001|Overall Study|Other|0|||
33228675|NCT01051063|100739151|FG000|Overall Study|Lost to Follow-up|0|||
33228676|NCT01051063|100739152|FG001|Overall Study|Lost to Follow-up|1|||
33228677|NCT00562978|100739153|FG000|Overall Study|Patient had imaging dose only|1|||
33228678|NCT00562978|100739154|FG001|Overall Study|Patient had imaging dose only|11|||
33228679|NCT00318149|100739158|FG000|Overall Study|Adverse Event|0|||
33228680|NCT00318149|100739159|FG001|Overall Study|Adverse Event|0|||
33228681|NCT00318149|100739160|FG002|Overall Study|Adverse Event|0|||
33366897|NCT00611455|101230135|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
33366898|NCT00611455|101230136|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
33634172|NCT00307801|102212033|FG001|Overall Study|No reason specified|0|||
33634173|NCT00307801|102212032|FG000|Overall Study|Pregnancy|0|||
33634174|NCT00307801|102212033|FG001|Overall Study|Pregnancy|1|||
33634175|NCT03278249|102212034|FG000|Overall Study|Withdrawal by Subject|2|||
33634176|NCT03278249|102212034|FG000|Overall Study|Lost to Follow-up|1|||
33634177|NCT00888173|102212035|FG000|Overall Study|Wrong Primary|1|||
33634178|NCT00888173|102212035|FG000|Overall Study|Ineligible: required test not done|1|||
33634179|NCT01188343|102212036|FG000|Overall Study|Not vaccinated|0|||
33366899|NCT00611455|101230137|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
33366900|NCT00611455|101230135|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
33366901|NCT00611455|101230136|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
33366902|NCT00611455|101230137|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
33366903|NCT00611455|101230135|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
33571637|NCT00557193|101982767|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
33571638|NCT00557193|101982768|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
33571639|NCT00557193|101982769|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
33571640|NCT00557193|101982770|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
33571641|NCT00557193|101982771|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
33571642|NCT00557193|101982766|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
33571643|NCT00557193|101982767|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
33634180|NCT01188343|102212037|FG001|Overall Study|Not vaccinated|2|||
33634181|NCT01188343|102212038|FG002|Overall Study|Not vaccinated|1|||
33634182|NCT01188343|102212036|FG000|Overall Study|Withdrawal by Subject|1|||
33634183|NCT01188343|102212037|FG001|Overall Study|Withdrawal by Subject|24|||
33366904|NCT00611455|101230136|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
33366905|NCT00611455|101230137|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
33634184|NCT01188343|102212038|FG002|Overall Study|Withdrawal by Subject|0|||
33634185|NCT00092417|102212041|FG000|Overall Study|Lost to Follow-up|2|||
33634186|NCT00092417|102212042|FG001|Overall Study|Lost to Follow-up|0|||
33634187|NCT00092417|102212041|FG000|Overall Study|Withdrawal by Subject|2|||
33634188|NCT00092417|102212042|FG001|Overall Study|Withdrawal by Subject|1|||
33634189|NCT00092417|102212041|FG000|Overall Study|Other|1|||
33634190|NCT00092417|102212042|FG001|Overall Study|Other|0|||
33634191|NCT03331315|102212046|FG000|Overall Study|Physician Decision|18|||
33634192|NCT03331315|102212047|FG001|Overall Study|Physician Decision|14|||
33634193|NCT00853307|102212048|FG000|Overall Study|Adverse Event|1|||
33634194|NCT00853307|102212049|FG001|Overall Study|Adverse Event|2|||
33634195|NCT00853307|102212048|FG000|Overall Study|Withdrawal by Subject|1|||
33634196|NCT00853307|102212049|FG001|Overall Study|Withdrawal by Subject|2|||
33634197|NCT00853307|102212048|FG000|Overall Study|Reason Not Specified|0|||
33634198|NCT00853307|102212049|FG001|Overall Study|Reason Not Specified|1|||
33634199|NCT04030143|102212050|FG000|Overall Study|Adverse Event|5|||
33634200|NCT04030143|102212051|FG001|Overall Study|Adverse Event|10|||
33634201|NCT04030143|102212050|FG000|Overall Study|Lost to Follow-up|3|||
33634202|NCT04030143|102212051|FG001|Overall Study|Lost to Follow-up|7|||
33228682|NCT00318149|100739161|FG003|Overall Study|Adverse Event|0|||
33228683|NCT00318149|100739162|FG004|Overall Study|Adverse Event|0|||
33366906|NCT00611455|101230135|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
33366907|NCT00611455|101230136|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
33228684|NCT00318149|100739163|FG005|Overall Study|Adverse Event|2|||
33228685|NCT04078035|100739171|FG000|Session 2|Lost to Follow-up|3|||
33634203|NCT04030143|102212050|FG000|Overall Study|Protocol Deviation|2|||
33634204|NCT04030143|102212051|FG001|Overall Study|Protocol Deviation|2|||
33228686|NCT04078035|100739172|FG001|Session 2|Lost to Follow-up|1|||
33634205|NCT04030143|102212050|FG000|Overall Study|Withdrawal by Subject|16|||
33634206|NCT04030143|102212051|FG001|Overall Study|Withdrawal by Subject|18|||
33634207|NCT04030143|102212050|FG000|Overall Study|Physician Decision|1|||
33634208|NCT04030143|102212051|FG001|Overall Study|Physician Decision|1|||
33634209|NCT04030143|102212050|FG000|Overall Study|Due to Covid-19|2|||
33634210|NCT04030143|102212051|FG001|Overall Study|Due to Covid-19|3|||
33634211|NCT04030143|102212050|FG000|Overall Study|Not Due to Covid-19|1|||
33634212|NCT04030143|102212051|FG001|Overall Study|Not Due to Covid-19|1|||
33634213|NCT01001221|102212054|FG000|Overall Study|Adverse Event|1|||
33634214|NCT01001221|102212055|FG001|Overall Study|Adverse Event|2|||
33634215|NCT01001221|102212056|FG002|Overall Study|Adverse Event|0|||
33634216|NCT01001221|102212057|FG003|Overall Study|Adverse Event|2|||
33634217|NCT01001221|102212058|FG004|Overall Study|Adverse Event|0|||
33634218|NCT01001221|102212054|FG000|Overall Study|Disease progression|3|||
33634219|NCT01001221|102212055|FG001|Overall Study|Disease progression|2|||
33634220|NCT01001221|102212056|FG002|Overall Study|Disease progression|2|||
33634221|NCT01001221|102212057|FG003|Overall Study|Disease progression|4|||
33634222|NCT01001221|102212058|FG004|Overall Study|Disease progression|0|||
33634223|NCT01001221|102212054|FG000|Overall Study|Other|1|||
33634224|NCT01001221|102212055|FG001|Overall Study|Other|1|||
33634225|NCT01001221|102212056|FG002|Overall Study|Other|0|||
33634226|NCT01001221|102212057|FG003|Overall Study|Other|0|||
33634227|NCT01001221|102212058|FG004|Overall Study|Other|0|||
33634228|NCT01001221|102212054|FG000|Overall Study|Not treated; protocol exclusion|0|||
33634229|NCT01001221|102212055|FG001|Overall Study|Not treated; protocol exclusion|0|||
33634230|NCT01001221|102212056|FG002|Overall Study|Not treated; protocol exclusion|1|||
33634231|NCT01001221|102212057|FG003|Overall Study|Not treated; protocol exclusion|0|||
33634232|NCT01001221|102212058|FG004|Overall Study|Not treated; protocol exclusion|0|||
33634233|NCT03299166|102212059|FG000|Overall Study|Adverse Event|9|||
33634234|NCT03299166|102212060|FG001|Overall Study|Adverse Event|4|||
33634235|NCT03299166|102212059|FG000|Overall Study|Withdrawal by Subject|6|||
33634236|NCT03299166|102212060|FG001|Overall Study|Withdrawal by Subject|5|||
33634237|NCT03299166|102212059|FG000|Overall Study|Physician Decision|1|||
33634238|NCT03299166|102212060|FG001|Overall Study|Physician Decision|1|||
33634239|NCT03299166|102212059|FG000|Overall Study|Sponsor Decision|3|||
33634240|NCT03299166|102212060|FG001|Overall Study|Sponsor Decision|0|||
33634241|NCT03299166|102212059|FG000|Overall Study|Lost to Follow-up|2|||
33634242|NCT03299166|102212060|FG001|Overall Study|Lost to Follow-up|4|||
33634243|NCT03299166|102212059|FG000|Overall Study|Randomization Error|0|||
33634244|NCT03299166|102212060|FG001|Overall Study|Randomization Error|1|||
33634245|NCT03299166|102212059|FG000|Overall Study|Subject unable to return due to COVID|1|||
33571644|NCT00557193|101982768|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
33571645|NCT00557193|101982769|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
33634246|NCT03299166|102212060|FG001|Overall Study|Subject unable to return due to COVID|0|||
33634247|NCT03299166|102212059|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
33634248|NCT03299166|102212060|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
33634249|NCT00696072|102212061|FG000|Overall Study|continuing active treatment|10|||
33634250|NCT00696072|102212062|FG001|Overall Study|continuing active treatment|13|||
33634251|NCT00696072|102212061|FG000|Overall Study|Adverse Event|10|||
33634252|NCT00696072|102212062|FG001|Overall Study|Adverse Event|6|||
33571646|NCT00557193|101982770|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
33571647|NCT00557193|101982771|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
33571648|NCT00557193|101982766|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
33571649|NCT00557193|101982767|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
33571650|NCT00557193|101982768|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
33571651|NCT00557193|101982769|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
33571652|NCT00557193|101982770|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
33571653|NCT00557193|101982771|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
33571654|NCT00787150|101982779|FG000|Overall Study|Adverse Event|4|||
33571655|NCT00787150|101982780|FG001|Overall Study|Adverse Event|4|||
33571656|NCT00787150|101982781|FG002|Overall Study|Adverse Event|4|||
33571657|NCT00787150|101982779|FG000|Overall Study|Physician Decision|1|||
33571658|NCT00787150|101982780|FG001|Overall Study|Physician Decision|2|||
33571659|NCT00787150|101982781|FG002|Overall Study|Physician Decision|1|||
33571660|NCT00787150|101982779|FG000|Overall Study|Withdrawal by Subject|2|||
33571661|NCT00787150|101982780|FG001|Overall Study|Withdrawal by Subject|1|||
33571662|NCT00787150|101982781|FG002|Overall Study|Withdrawal by Subject|0|||
33571663|NCT00787150|101982779|FG000|Overall Study|Dosing incorrect study durg|2|||
33571664|NCT00787150|101982780|FG001|Overall Study|Dosing incorrect study durg|0|||
33634253|NCT00696072|102212061|FG000|Overall Study|Patient Request|3|||
33634254|NCT00696072|102212062|FG001|Overall Study|Patient Request|7|||
33634255|NCT00696072|102212061|FG000|Overall Study|Investigator Request|1|||
33634256|NCT00696072|102212062|FG001|Overall Study|Investigator Request|4|||
33634257|NCT00696072|102212061|FG000|Overall Study|Sponsor Request|0|||
33634258|NCT00696072|102212062|FG001|Overall Study|Sponsor Request|1|||
33634259|NCT00696072|102212061|FG000|Overall Study|Disease Progression|32|||
33634260|NCT00696072|102212062|FG001|Overall Study|Disease Progression|30|||
33634261|NCT00696072|102212061|FG000|Overall Study|Non-specified|1|||
33634262|NCT00696072|102212062|FG001|Overall Study|Non-specified|2|||
33634263|NCT02017405|102212063|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
33228687|NCT04078035|100739171|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
33228688|NCT04078035|100739172|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
33228689|NCT01291225|100739176|FG000|Overall Study|Lost to Follow-up|85|||
33228690|NCT01291225|100739177|FG001|Overall Study|Lost to Follow-up|39|||
33228691|NCT01107743|100739179|FG000|Overall Study|Protocol Violation|46|||
33228692|NCT02305381|100739180|FG000|Overall Study|Unclassified|5|||
33228693|NCT02305381|100739181|FG001|Overall Study|Unclassified|5|||
33228694|NCT02305381|100739182|FG002|Overall Study|Unclassified|7|||
33571665|NCT00787150|101982781|FG002|Overall Study|Dosing incorrect study durg|0|||
33571666|NCT01168596|101982795|FG000|Overall Study|Withdrawal by Subject|3|||
33571667|NCT01168596|101982796|FG001|Overall Study|Withdrawal by Subject|1|||
33571668|NCT00399529|101982797|FG000|Overall Study|Off Study Prior to Treatment|2|||
33571669|NCT04079738|101982799|FG000|Study Treatment|Death|1|||
33571670|NCT04079738|101982800|FG001|Study Treatment|Death|0|||
33571671|NCT04079738|101982801|FG002|Study Treatment|Death|0|||
33571672|NCT04079738|101982802|FG003|Study Treatment|Death|0|||
33571673|NCT04079738|101982799|FG000|Study Treatment|Adverse Event|2|||
33571674|NCT04079738|101982800|FG001|Study Treatment|Adverse Event|0|||
33571675|NCT04079738|101982801|FG002|Study Treatment|Adverse Event|0|||
33571676|NCT04079738|101982802|FG003|Study Treatment|Adverse Event|0|||
33571677|NCT04079738|101982799|FG000|Study Treatment|withdrawal before treatment|1|||
33571678|NCT04079738|101982800|FG001|Study Treatment|withdrawal before treatment|0|||
33571679|NCT04079738|101982801|FG002|Study Treatment|withdrawal before treatment|0|||
33571680|NCT04079738|101982802|FG003|Study Treatment|withdrawal before treatment|0|||
33571681|NCT04079738|101982799|FG000|Study Treatment|symptomatic deterioration|2|||
33571682|NCT04079738|101982800|FG001|Study Treatment|symptomatic deterioration|0|||
33571683|NCT04079738|101982801|FG002|Study Treatment|symptomatic deterioration|0|||
33571684|NCT04079738|101982802|FG003|Study Treatment|symptomatic deterioration|0|||
33571685|NCT04079738|101982799|FG000|Study Treatment|Disease Progression|1|||
33571686|NCT04079738|101982800|FG001|Study Treatment|Disease Progression|0|||
33571687|NCT04079738|101982801|FG002|Study Treatment|Disease Progression|0|||
33571688|NCT04079738|101982802|FG003|Study Treatment|Disease Progression|0|||
33571689|NCT04079738|101982799|FG000|Study Treatment|withdrawal after treatment|1|||
33571690|NCT04079738|101982800|FG001|Study Treatment|withdrawal after treatment|0|||
33571691|NCT04079738|101982801|FG002|Study Treatment|withdrawal after treatment|0|||
33571692|NCT04079738|101982802|FG003|Study Treatment|withdrawal after treatment|0|||
33571693|NCT04079738|101982799|FG000|Follow up|Withdrawal by Subject|3|||
33571694|NCT04079738|101982800|FG001|Follow up|Withdrawal by Subject|0|||
33571695|NCT04079738|101982801|FG002|Follow up|Withdrawal by Subject|0|||
33571696|NCT04079738|101982802|FG003|Follow up|Withdrawal by Subject|0|||
33571697|NCT04079738|101982799|FG000|Follow up|Death|5|||
33571698|NCT04079738|101982800|FG001|Follow up|Death|0|||
33571699|NCT04079738|101982801|FG002|Follow up|Death|0|||
33571700|NCT04079738|101982802|FG003|Follow up|Death|0|||
33571701|NCT02271880|101982803|FG000|Overall Study|Premature discontinuation of study|3|||
33571702|NCT02271880|101982804|FG001|Overall Study|Premature discontinuation of study|4|||
33571703|NCT03069716|101982820|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
33571704|NCT03069716|101982821|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
33571705|NCT03069716|101982822|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
33571706|NCT03069716|101982820|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
33571707|NCT03069716|101982821|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
33571708|NCT03069716|101982822|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
33571709|NCT03069716|101982820|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
33571710|NCT03069716|101982821|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
33571711|NCT03069716|101982822|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
33571712|NCT03069716|101982820|FG000|Randomized Treatment|Withdrawal by Subject|0|||
33571713|NCT03069716|101982821|FG001|Randomized Treatment|Withdrawal by Subject|2|||
33571714|NCT03069716|101982822|FG002|Randomized Treatment|Withdrawal by Subject|0|||
33571715|NCT01983111|101982828|FG000|Overall Study|Withdrawal by Subject|8|||
33571716|NCT01983111|101982829|FG001|Overall Study|Withdrawal by Subject|6|||
33571717|NCT01983111|101982828|FG000|Overall Study|Adverse Event|4|||
33571718|NCT01983111|101982829|FG001|Overall Study|Adverse Event|0|||
33571719|NCT01983111|101982828|FG000|Overall Study|Protocol Violation|0|||
33571720|NCT01983111|101982829|FG001|Overall Study|Protocol Violation|1|||
33571721|NCT01280968|101982830|FG000|Overall Study|Lost to Follow-up|8|||
33571722|NCT01280968|101982831|FG001|Overall Study|Lost to Follow-up|2|||
33571723|NCT01280968|101982830|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
33571724|NCT01280968|101982831|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
33571725|NCT01280968|101982830|FG000|Overall Study|Commuting Problems|2|||
33571726|NCT01280968|101982831|FG001|Overall Study|Commuting Problems|0|||
33571727|NCT01280968|101982830|FG000|Overall Study|Anxiety|2|||
33571728|NCT01280968|101982831|FG001|Overall Study|Anxiety|0|||
33571729|NCT01280968|101982830|FG000|Overall Study|Adverse Event|1|||
33571730|NCT01280968|101982831|FG001|Overall Study|Adverse Event|0|||
33571731|NCT01280968|101982830|FG000|Overall Study|Scheduling Conflicts|1|||
33571732|NCT01280968|101982831|FG001|Overall Study|Scheduling Conflicts|1|||
33571733|NCT01280968|101982830|FG000|Overall Study|Pre-existing Neurological Condition|1|||
33571734|NCT01280968|101982831|FG001|Overall Study|Pre-existing Neurological Condition|0|||
33571735|NCT01280968|101982830|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
33571736|NCT01280968|101982831|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
33571737|NCT02378480|101982832|FG000|Overall Study|Physician Decision|1|||
33571738|NCT02378480|101982833|FG001|Overall Study|Physician Decision|1|||
33571739|NCT02378480|101982832|FG000|Overall Study|Death|1|||
33571740|NCT02378480|101982833|FG001|Overall Study|Death|2|||
33571741|NCT02378480|101982832|FG000|Overall Study|Randomized, but Not Treated|6|||
33571742|NCT02378480|101982833|FG001|Overall Study|Randomized, but Not Treated|4|||
33571743|NCT02378480|101982832|FG000|Overall Study|Adverse Event|0|||
33571744|NCT02378480|101982833|FG001|Overall Study|Adverse Event|1|||
33571745|NCT02378480|101982832|FG000|Overall Study|Missed EOT/PTE Visit|1|||
33571746|NCT02378480|101982833|FG001|Overall Study|Missed EOT/PTE Visit|2|||
33571747|NCT02378480|101982832|FG000|Overall Study|Withdrawal by Subject|9|||
33571748|NCT02378480|101982833|FG001|Overall Study|Withdrawal by Subject|4|||
33571749|NCT02378480|101982832|FG000|Overall Study|Lost to Follow-up|10|||
33571750|NCT02378480|101982833|FG001|Overall Study|Lost to Follow-up|18|||
33228695|NCT01960790|100739184|FG000|Overall Study|Survey forms could not be recovered|3|||
33228696|NCT01960790|100739184|FG000|Overall Study|Treat with Humira outside survey period|3|||
33228697|NCT01960790|100739184|FG000|Overall Study|Transferred to another hospital|4|||
33228698|NCT01960790|100739184|FG000|Overall Study|Unevaluable for safety|1|||
33228699|NCT00871403|100739187|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
33228700|NCT00871403|100739188|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
33228701|NCT00871403|100739189|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
33228702|NCT00871403|100739187|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
33571751|NCT04570384|101982838|FG000|Overall Study|Adverse Event|2|||
33571752|NCT04570384|101982839|FG001|Overall Study|Adverse Event|1|||
33571753|NCT04570384|101982838|FG000|Overall Study|Death|2|||
33571754|NCT04570384|101982839|FG001|Overall Study|Death|5|||
33571755|NCT04570384|101982838|FG000|Overall Study|Lost to Follow-up|1|||
33571756|NCT04570384|101982839|FG001|Overall Study|Lost to Follow-up|0|||
33571757|NCT04570384|101982838|FG000|Overall Study|Other|1|||
33571758|NCT04570384|101982839|FG001|Overall Study|Other|0|||
33571759|NCT04570384|101982838|FG000|Overall Study|Protocol Violation|0|||
33571760|NCT04570384|101982839|FG001|Overall Study|Protocol Violation|1|||
33571761|NCT04570384|101982838|FG000|Overall Study|Sponsor Decision|1|||
33571762|NCT04570384|101982839|FG001|Overall Study|Sponsor Decision|0|||
33571763|NCT04570384|101982838|FG000|Overall Study|Withdrawal by Subject|4|||
33571764|NCT04570384|101982839|FG001|Overall Study|Withdrawal by Subject|2|||
33571765|NCT04856527|101982840|FG000|Overall Study|Unable to complete experimental task|2|||
33571766|NCT04856527|101982841|FG001|Overall Study|Unable to complete experimental task|0|||
33571767|NCT01365455|101982842|FG000|Induction Period|Adverse Event|5|||
33571768|NCT01365455|101982843|FG001|Induction Period|Adverse Event|3|||
33571769|NCT01365455|101982844|FG002|Induction Period|Adverse Event|4|||
33571770|NCT01365455|101982845|FG003|Induction Period|Adverse Event|0|||
33571771|NCT01365455|101982846|FG004|Induction Period|Adverse Event|0|||
33571772|NCT01365455|101982842|FG000|Induction Period|Lack of Efficacy|1|||
33571773|NCT01365455|101982843|FG001|Induction Period|Lack of Efficacy|1|||
33571774|NCT01365455|101982844|FG002|Induction Period|Lack of Efficacy|0|||
33571775|NCT01365455|101982845|FG003|Induction Period|Lack of Efficacy|0|||
33571776|NCT01365455|101982846|FG004|Induction Period|Lack of Efficacy|0|||
33571777|NCT01365455|101982842|FG000|Induction Period|Pregnancy|0|||
33571778|NCT01365455|101982843|FG001|Induction Period|Pregnancy|1|||
33571779|NCT01365455|101982844|FG002|Induction Period|Pregnancy|0|||
33571780|NCT01365455|101982845|FG003|Induction Period|Pregnancy|0|||
33571781|NCT01365455|101982846|FG004|Induction Period|Pregnancy|0|||
33571782|NCT01365455|101982842|FG000|Induction Period|Protocol deviation|0|||
33571783|NCT01365455|101982843|FG001|Induction Period|Protocol deviation|1|||
33571784|NCT01365455|101982844|FG002|Induction Period|Protocol deviation|1|||
33571785|NCT01365455|101982845|FG003|Induction Period|Protocol deviation|0|||
33571786|NCT01365455|101982846|FG004|Induction Period|Protocol deviation|0|||
33571787|NCT01365455|101982842|FG000|Induction Period|Subject/guardian decision|9|||
33571788|NCT01365455|101982843|FG001|Induction Period|Subject/guardian decision|1|||
33571789|NCT01365455|101982844|FG002|Induction Period|Subject/guardian decision|8|||
33571790|NCT01365455|101982845|FG003|Induction Period|Subject/guardian decision|0|||
33571791|NCT01365455|101982846|FG004|Induction Period|Subject/guardian decision|0|||
33571792|NCT01365455|101982842|FG000|Induction Period|Lost to Follow-up|0|||
33571793|NCT01365455|101982843|FG001|Induction Period|Lost to Follow-up|0|||
33571794|NCT01365455|101982844|FG002|Induction Period|Lost to Follow-up|3|||
33571795|NCT01365455|101982845|FG003|Induction Period|Lost to Follow-up|0|||
33571796|NCT01365455|101982846|FG004|Induction Period|Lost to Follow-up|0|||
33571797|NCT01365455|101982842|FG000|Maintenance Period|Adverse Event|12|||
33571798|NCT01365455|101982843|FG001|Maintenance Period|Adverse Event|5|||
33366908|NCT00611455|101230137|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
33366909|NCT00611455|101230135|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
33366910|NCT00611455|101230136|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
33366911|NCT00611455|101230137|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
33366912|NCT00611455|101230135|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
33366913|NCT00611455|101230136|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
33418922|NCT05166421|101425595|FG001|Overall Study|Other|1|||
33418923|NCT05166421|101425596|FG002|Overall Study|Other|1|||
33418924|NCT05166421|101425594|FG000|Overall Study|Withdrawal by Subject|5|||
33418925|NCT05166421|101425595|FG001|Overall Study|Withdrawal by Subject|3|||
33418926|NCT05166421|101425596|FG002|Overall Study|Withdrawal by Subject|6|||
33418927|NCT05166421|101425594|FG000|Overall Study|Lost to Follow-up|4|||
33418928|NCT05166421|101425595|FG001|Overall Study|Lost to Follow-up|1|||
33418929|NCT05166421|101425596|FG002|Overall Study|Lost to Follow-up|7|||
33418930|NCT00000135|101425598|FG000|Overall Study|Death|27|||
33418931|NCT00000135|101425599|FG001|Overall Study|Death|14|||
33418932|NCT00981019|101425600|FG000|Overall Study|Did not respond|65|||
33418933|NCT00981019|101425600|FG000|Overall Study|Did not match target population|94|||
33418934|NCT00981019|101425600|FG000|Overall Study|Inadvertent exclusion|239|||
33418935|NCT00981019|101425600|FG000|Overall Study|Hit the survey after closure|79|||
33418936|NCT00585039|101425603|FG000|Overall Study|medication spilled|2|||
33418937|NCT00585039|101425604|FG001|Overall Study|medication spilled|0|||
33418938|NCT00756652|101425609|FG000|Original Phase|Withdrawal by Subject|864|||
33418939|NCT00756652|101425610|FG001|Original Phase|Withdrawal by Subject|23|||
33418940|NCT00756652|101425609|FG000|Original Phase|Lost to Follow-up|601|||
33418941|NCT00756652|101425610|FG001|Original Phase|Lost to Follow-up|0|||
33418942|NCT00756652|101425609|FG000|Original Phase|Other Discontinuation|797|||
33418943|NCT00756652|101425610|FG001|Original Phase|Other Discontinuation|5|||
33418944|NCT00756652|101425609|FG000|Original Phase|Participant Noncompliance|18622|||
33571799|NCT01365455|101982844|FG002|Maintenance Period|Adverse Event|1|||
33571800|NCT01365455|101982845|FG003|Maintenance Period|Adverse Event|2|||
33571801|NCT01365455|101982846|FG004|Maintenance Period|Adverse Event|4|||
33571802|NCT01365455|101982842|FG000|Maintenance Period|Lack of Efficacy|10|||
33571803|NCT01365455|101982843|FG001|Maintenance Period|Lack of Efficacy|2|||
33571804|NCT01365455|101982844|FG002|Maintenance Period|Lack of Efficacy|0|||
33571805|NCT01365455|101982845|FG003|Maintenance Period|Lack of Efficacy|2|||
33571806|NCT01365455|101982846|FG004|Maintenance Period|Lack of Efficacy|2|||
33571807|NCT01365455|101982842|FG000|Maintenance Period|Lost to Follow-up|2|||
33571808|NCT01365455|101982843|FG001|Maintenance Period|Lost to Follow-up|4|||
33571809|NCT01365455|101982844|FG002|Maintenance Period|Lost to Follow-up|0|||
33571810|NCT01365455|101982845|FG003|Maintenance Period|Lost to Follow-up|0|||
33571811|NCT01365455|101982846|FG004|Maintenance Period|Lost to Follow-up|3|||
33571812|NCT01365455|101982842|FG000|Maintenance Period|Non-compliance with study treatment|0|||
33571813|NCT01365455|101982843|FG001|Maintenance Period|Non-compliance with study treatment|0|||
33571814|NCT01365455|101982844|FG002|Maintenance Period|Non-compliance with study treatment|0|||
33571815|NCT01365455|101982845|FG003|Maintenance Period|Non-compliance with study treatment|1|||
33571816|NCT01365455|101982846|FG004|Maintenance Period|Non-compliance with study treatment|0|||
33571817|NCT01365455|101982842|FG000|Maintenance Period|Physician Decision|0|||
33571818|NCT01365455|101982843|FG001|Maintenance Period|Physician Decision|1|||
33571819|NCT01365455|101982844|FG002|Maintenance Period|Physician Decision|0|||
33571820|NCT01365455|101982845|FG003|Maintenance Period|Physician Decision|0|||
33571821|NCT01365455|101982846|FG004|Maintenance Period|Physician Decision|1|||
33571822|NCT01365455|101982842|FG000|Maintenance Period|Pregnancy|0|||
33571823|NCT01365455|101982843|FG001|Maintenance Period|Pregnancy|4|||
33571824|NCT01365455|101982844|FG002|Maintenance Period|Pregnancy|0|||
33571825|NCT01365455|101982845|FG003|Maintenance Period|Pregnancy|0|||
33571826|NCT01365455|101982846|FG004|Maintenance Period|Pregnancy|2|||
33571827|NCT01365455|101982842|FG000|Maintenance Period|Protocol deviation|1|||
33571828|NCT01365455|101982843|FG001|Maintenance Period|Protocol deviation|1|||
33571829|NCT01365455|101982844|FG002|Maintenance Period|Protocol deviation|0|||
33571830|NCT01365455|101982845|FG003|Maintenance Period|Protocol deviation|0|||
33418945|NCT00756652|101425610|FG001|Original Phase|Participant Noncompliance|424|||
33418946|NCT00756652|101425609|FG000|Original Phase|Unknown Discontinuation Reason|2|||
33418947|NCT00756652|101425610|FG001|Original Phase|Unknown Discontinuation Reason|0|||
33418948|NCT00756652|101425609|FG000|Original Phase|Participants without data|3259|||
33418949|NCT00756652|101425610|FG001|Original Phase|Participants without data|466|||
33571831|NCT01365455|101982846|FG004|Maintenance Period|Protocol deviation|0|||
33571832|NCT01365455|101982842|FG000|Maintenance Period|Subject/guardian decision|4|||
33571833|NCT01365455|101982843|FG001|Maintenance Period|Subject/guardian decision|6|||
33418950|NCT00756652|101425609|FG000|Original Phase|Death|168|||
33418951|NCT00756652|101425610|FG001|Original Phase|Death|1|||
33418952|NCT00756652|101425609|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
33418953|NCT00756652|101425610|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
33418954|NCT00756652|101425609|FG000|Re-Op Phase|Withdrawal by Subject|62|||
33418955|NCT00756652|101425610|FG001|Re-Op Phase|Withdrawal by Subject|0|||
33571834|NCT01365455|101982844|FG002|Maintenance Period|Subject/guardian decision|2|||
33571835|NCT01365455|101982845|FG003|Maintenance Period|Subject/guardian decision|4|||
33571836|NCT01365455|101982846|FG004|Maintenance Period|Subject/guardian decision|1|||
33571837|NCT02390076|101982847|FG000|Overall Study|Lost to Follow-up|2|||
33228703|NCT00871403|100739188|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
33228704|NCT00871403|100739189|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
33634264|NCT02017405|102212064|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
33634265|NCT02017405|102212065|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
33634266|NCT02017405|102212066|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
33634267|NCT02017405|102212067|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
33634268|NCT02017405|102212068|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
33634269|NCT02017405|102212063|FG000|Open-label Phase|Adverse Event|1|||
33634270|NCT02017405|102212064|FG001|Open-label Phase|Adverse Event|1|||
33634271|NCT02017405|102212065|FG002|Open-label Phase|Adverse Event|0|||
33634272|NCT02017405|102212066|FG003|Open-label Phase|Adverse Event|0|||
33634273|NCT02017405|102212067|FG004|Open-label Phase|Adverse Event|0|||
33634274|NCT02017405|102212068|FG005|Open-label Phase|Adverse Event|0|||
33634275|NCT00004563|102212069|FG000|Overall Study|Withdrawal by Subject|20|||
33634276|NCT00004563|102212070|FG001|Overall Study|Withdrawal by Subject|16|||
33634277|NCT00004563|102212069|FG000|Overall Study|Lack of Efficacy|3|||
33634278|NCT00004563|102212070|FG001|Overall Study|Lack of Efficacy|5|||
33634279|NCT00004563|102212069|FG000|Overall Study|Death|2|||
33571838|NCT02390076|101982848|FG001|Overall Study|Lost to Follow-up|1|||
33571839|NCT02390076|101982849|FG002|Overall Study|Lost to Follow-up|4|||
33571840|NCT03402841|101982850|FG000|Overall Study|Withdrawal by Subject|3|||
33571841|NCT03402841|101982850|FG000|Overall Study|Lost to Follow-up|2|||
33571842|NCT03402841|101982850|FG000|Overall Study|Death|146|||
33228705|NCT00871403|100739187|FG000|Combination Treatment Phase|Adverse Event|0|||
33571843|NCT04622592|101982851|FG000|Overall Study|Death|0|||
33418956|NCT00756652|101425609|FG000|Re-Op Phase|Death|6|||
33571844|NCT04622592|101982852|FG001|Overall Study|Death|0|||
33571845|NCT04622592|101982853|FG002|Overall Study|Death|1|||
33571846|NCT04622592|101982854|FG003|Overall Study|Death|0|||
33571847|NCT04622592|101982855|FG004|Overall Study|Death|0|||
33571848|NCT04622592|101982856|FG005|Overall Study|Death|0|||
33571849|NCT04622592|101982857|FG006|Overall Study|Death|0|||
33571850|NCT04622592|101982858|FG007|Overall Study|Death|1|||
33571851|NCT04622592|101982851|FG000|Overall Study|Lost to Follow-up|0|||
33571852|NCT04622592|101982852|FG001|Overall Study|Lost to Follow-up|0|||
33571853|NCT04622592|101982853|FG002|Overall Study|Lost to Follow-up|0|||
33571854|NCT04622592|101982854|FG003|Overall Study|Lost to Follow-up|3|||
33571855|NCT04622592|101982855|FG004|Overall Study|Lost to Follow-up|1|||
33571856|NCT04622592|101982856|FG005|Overall Study|Lost to Follow-up|0|||
33571857|NCT04622592|101982857|FG006|Overall Study|Lost to Follow-up|2|||
33571858|NCT04622592|101982858|FG007|Overall Study|Lost to Follow-up|2|||
33571859|NCT04622592|101982851|FG000|Overall Study|Physician Decision|0|||
33571860|NCT04622592|101982852|FG001|Overall Study|Physician Decision|0|||
33571861|NCT04622592|101982853|FG002|Overall Study|Physician Decision|0|||
33571862|NCT04622592|101982854|FG003|Overall Study|Physician Decision|0|||
33571863|NCT04622592|101982855|FG004|Overall Study|Physician Decision|1|||
33418957|NCT00756652|101425610|FG001|Re-Op Phase|Death|0|||
33418958|NCT00756652|101425609|FG000|Re-Op Phase|Lost to Follow-up|340|||
33418959|NCT00756652|101425610|FG001|Re-Op Phase|Lost to Follow-up|0|||
33418960|NCT00756652|101425609|FG000|Re-Op Phase|Site Closed|2454|||
33418961|NCT00756652|101425610|FG001|Re-Op Phase|Site Closed|0|||
33571864|NCT04622592|101982856|FG005|Overall Study|Physician Decision|0|||
33571865|NCT04622592|101982857|FG006|Overall Study|Physician Decision|0|||
33571866|NCT04622592|101982858|FG007|Overall Study|Physician Decision|0|||
33571867|NCT04622592|101982851|FG000|Overall Study|Withdrawal by Subject|1|||
33571868|NCT04622592|101982852|FG001|Overall Study|Withdrawal by Subject|0|||
33634280|NCT00004563|102212070|FG001|Overall Study|Death|3|||
33634281|NCT04123470|102212071|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
33634282|NCT04123470|102212072|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
33418962|NCT00756652|101425609|FG000|Re-Op Phase|Withdrawn after explant|14|||
33228706|NCT00871403|100739188|FG001|Combination Treatment Phase|Adverse Event|17|||
33228707|NCT00871403|100739189|FG002|Combination Treatment Phase|Adverse Event|2|||
33228708|NCT00871403|100739187|FG000|Combination Treatment Phase|Disease Progression|0|||
33228709|NCT00871403|100739188|FG001|Combination Treatment Phase|Disease Progression|8|||
33228710|NCT00871403|100739189|FG002|Combination Treatment Phase|Disease Progression|5|||
33228711|NCT00871403|100739187|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
33228712|NCT00871403|100739188|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
33228713|NCT00871403|100739189|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
33228714|NCT00871403|100739187|FG000|Combination Treatment Phase|Physician Decision|0|||
33228715|NCT00871403|100739188|FG001|Combination Treatment Phase|Physician Decision|1|||
33228716|NCT00871403|100739189|FG002|Combination Treatment Phase|Physician Decision|3|||
33228717|NCT00871403|100739187|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
33228718|NCT00871403|100739188|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
33228719|NCT00871403|100739189|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
33228720|NCT00871403|100739187|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
33228721|NCT00871403|100739188|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
33228722|NCT00871403|100739189|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
33228723|NCT03691948|100739190|FG000|Overall Study|Lost to Follow-up|1|||
33228724|NCT03691948|100739191|FG001|Overall Study|Lost to Follow-up|3|||
33228725|NCT02441946|100739192|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
33228726|NCT02441946|100739193|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
33228727|NCT02441946|100739194|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
33228728|NCT02441946|100739192|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
33228729|NCT02441946|100739193|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
33228730|NCT02441946|100739194|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
33228731|NCT02441946|100739192|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
33228732|NCT02441946|100739193|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
33228733|NCT02441946|100739194|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
33228734|NCT02441946|100739192|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
33228735|NCT02441946|100739193|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
33228736|NCT02441946|100739194|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
33228737|NCT02441946|100739192|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
33228738|NCT02441946|100739193|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
33228739|NCT02441946|100739194|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
33228740|NCT02441946|100739192|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
33228741|NCT02441946|100739193|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
33228742|NCT02441946|100739194|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
33228743|NCT02441946|100739192|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
33228744|NCT02441946|100739193|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
33228745|NCT02441946|100739194|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
33228746|NCT02441946|100739192|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
33228747|NCT02441946|100739193|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
33228748|NCT02441946|100739194|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
33228749|NCT02441946|100739192|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
33228750|NCT02441946|100739193|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
33228751|NCT02441946|100739194|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
33228752|NCT02441946|100739192|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
33228753|NCT02441946|100739193|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
33228754|NCT02441946|100739194|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
33228755|NCT02441946|100739192|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
33228756|NCT02441946|100739193|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
33228757|NCT02441946|100739194|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
33228758|NCT00847301|100739195|FG000|Overall Study|Adverse Event|35|||
33228759|NCT00847301|100739195|FG000|Overall Study|Switch to other anticoagulants|16|||
33228760|NCT00847301|100739195|FG000|Overall Study|Lost to Follow-up|1|||
33228761|NCT00847301|100739195|FG000|Overall Study|No prescription after hospital discharge|1|||
33228762|NCT00847301|100739195|FG000|Overall Study|Other reason not defined above|1|||
33228763|NCT02340520|100739196|FG000|Overall Study|Lost to Follow-up|1|||
33228764|NCT02340520|100739196|FG000|Overall Study|Patient did not take drug as specified|1|||
33418963|NCT00756652|101425610|FG001|Re-Op Phase|Withdrawn after explant|0|||
33418964|NCT00808015|101425611|FG000|Overall Study|Death|1|||
33228765|NCT02340520|100739196|FG000|Overall Study|Withdrawal by Subject|1|||
33228766|NCT00758160|100739203|FG000|Overall Study|No Longer Requires Study Medication|4|||
33228767|NCT00758160|100739203|FG000|Overall Study|Administration Problems|3|||
33228768|NCT00758160|100739203|FG000|Overall Study|Adverse Event|15|||
33228769|NCT00758160|100739203|FG000|Overall Study|Lack of Efficacy|10|||
33228770|NCT00758160|100739203|FG000|Overall Study|Lost to Follow-up|14|||
33228771|NCT00758160|100739203|FG000|Overall Study|Protocol Violation|12|||
33228772|NCT00758160|100739203|FG000|Overall Study|Withdrawal by Subject|8|||
33228773|NCT02494921|100739204|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
33418965|NCT00808015|101425611|FG000|Overall Study|Lack of Efficacy|58|||
33366914|NCT00611455|101230137|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
33366915|NCT00611455|101230135|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
33366916|NCT00611455|101230136|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
33366917|NCT00611455|101230137|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
33366918|NCT00611455|101230135|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
33228774|NCT02494921|100739205|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
33228775|NCT02494921|100739206|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
33228776|NCT02494921|100739207|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
33228777|NCT02494921|100739208|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
33228778|NCT02494921|100739204|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
33228779|NCT02494921|100739205|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
33228780|NCT02494921|100739206|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
33228781|NCT02494921|100739207|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
33228782|NCT02494921|100739208|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
33228783|NCT02494921|100739204|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
33228784|NCT02494921|100739205|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
33228785|NCT02494921|100739206|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
33228786|NCT02494921|100739207|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
33228787|NCT02494921|100739208|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
33228788|NCT03015116|100739209|FG000|Overall Study|Lost to Follow-up|3|||
33228789|NCT03015116|100739210|FG001|Overall Study|Lost to Follow-up|0|||
33228790|NCT03015116|100739211|FG002|Overall Study|Lost to Follow-up|2|||
33228791|NCT03015116|100739209|FG000|Overall Study|Withdrawal by Subject|3|||
33228792|NCT03015116|100739210|FG001|Overall Study|Withdrawal by Subject|1|||
33228793|NCT03015116|100739211|FG002|Overall Study|Withdrawal by Subject|0|||
33228794|NCT03015116|100739209|FG000|Overall Study|Subject has New Medical Status|1|||
33228795|NCT03015116|100739210|FG001|Overall Study|Subject has New Medical Status|0|||
33228796|NCT03015116|100739211|FG002|Overall Study|Subject has New Medical Status|0|||
33228797|NCT03015116|100739209|FG000|Overall Study|Physician Decision|0|||
33228798|NCT03015116|100739210|FG001|Overall Study|Physician Decision|1|||
33228799|NCT03015116|100739211|FG002|Overall Study|Physician Decision|0|||
33228800|NCT02468934|100739215|FG000|Overall Study|Withdrawal by Subject|4|||
33228801|NCT02468934|100739215|FG000|Overall Study|Screen Failure|3|||
33228802|NCT00708305|100739216|FG000|Period 1|Protocol Violation|1|||
33228803|NCT00708305|100739217|FG001|Period 1|Protocol Violation|0|||
33228804|NCT00708305|100739218|FG002|Period 1|Protocol Violation|1|||
33228805|NCT00708305|100739219|FG003|Period 1|Protocol Violation|0|||
33228806|NCT00708305|100739216|FG000|Period 1|Other Reason|0|||
33228807|NCT00708305|100739217|FG001|Period 1|Other Reason|0|||
33228808|NCT00708305|100739218|FG002|Period 1|Other Reason|0|||
33228809|NCT00708305|100739219|FG003|Period 1|Other Reason|2|||
33228810|NCT00708305|100739216|FG000|Period 2|Lost to Follow-up|0|||
33228811|NCT00708305|100739217|FG001|Period 2|Lost to Follow-up|1|||
33228812|NCT00708305|100739218|FG002|Period 2|Lost to Follow-up|0|||
33228813|NCT00708305|100739219|FG003|Period 2|Lost to Follow-up|0|||
33228814|NCT00708305|100739216|FG000|Period 2|Protocol Violation|0|||
33228815|NCT00708305|100739217|FG001|Period 2|Protocol Violation|1|||
33228816|NCT00708305|100739218|FG002|Period 2|Protocol Violation|0|||
33228817|NCT00708305|100739219|FG003|Period 2|Protocol Violation|0|||
33228818|NCT00708305|100739216|FG000|Period 2|Other Reason|1|||
33228819|NCT00708305|100739217|FG001|Period 2|Other Reason|0|||
33228820|NCT00708305|100739218|FG002|Period 2|Other Reason|0|||
33228821|NCT00708305|100739219|FG003|Period 2|Other Reason|1|||
33228822|NCT00708305|100739216|FG000|Period 3|Protocol Violation|0|||
33228823|NCT00708305|100739217|FG001|Period 3|Protocol Violation|2|||
33228824|NCT00708305|100739218|FG002|Period 3|Protocol Violation|0|||
33228825|NCT00708305|100739219|FG003|Period 3|Protocol Violation|0|||
33228826|NCT00708305|100739216|FG000|Period 3|Other Reason|1|||
33228827|NCT00708305|100739217|FG001|Period 3|Other Reason|0|||
33228828|NCT00708305|100739218|FG002|Period 3|Other Reason|0|||
33228829|NCT00708305|100739219|FG003|Period 3|Other Reason|0|||
33228830|NCT03075501|100739220|FG000|Overall Study|Scheduling difficulties|15|||
33366919|NCT00611455|101230136|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
33366920|NCT00611455|101230137|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
33366921|NCT00611455|101230135|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
33571869|NCT04622592|101982853|FG002|Overall Study|Withdrawal by Subject|2|||
33571870|NCT04622592|101982854|FG003|Overall Study|Withdrawal by Subject|0|||
33228831|NCT03075501|100739221|FG001|Overall Study|Scheduling difficulties|9|||
33366922|NCT00611455|101230136|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
33571871|NCT04622592|101982855|FG004|Overall Study|Withdrawal by Subject|0|||
33571872|NCT04622592|101982856|FG005|Overall Study|Withdrawal by Subject|0|||
33228832|NCT00077636|100739222|FG000|Overall Study|Refused Treatment|9|||
33228833|NCT00077636|100739223|FG001|Overall Study|Refused Treatment|31|||
33228834|NCT00077636|100739222|FG000|Overall Study|Admin|3|||
33228835|NCT00077636|100739223|FG001|Overall Study|Admin|3|||
33228836|NCT00077636|100739222|FG000|Overall Study|Withdrawal by Subject|2|||
33228837|NCT00077636|100739223|FG001|Overall Study|Withdrawal by Subject|2|||
33228838|NCT00077636|100739222|FG000|Overall Study|Adverse Event|17|||
33228839|NCT00077636|100739223|FG001|Overall Study|Adverse Event|34|||
33228840|NCT00077636|100739222|FG000|Overall Study|Protocol Violation|0|||
33228841|NCT00077636|100739223|FG001|Overall Study|Protocol Violation|2|||
33228842|NCT00077636|100739222|FG000|Overall Study|Lost to Follow-up|10|||
33228843|NCT00077636|100739223|FG001|Overall Study|Lost to Follow-up|18|||
33228844|NCT00077636|100739222|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
33228845|NCT00077636|100739223|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
33228846|NCT03853317|100739224|FG000|Overall Study|Progressive Disease|5|||
33228847|NCT03853317|100739224|FG000|Overall Study|Adverse Event|1|||
33228848|NCT03853317|100739224|FG000|Overall Study|Death|1|||
33228849|NCT03853317|100739224|FG000|Overall Study|other event|2|||
33228850|NCT01844115|100739225|FG000|Overall Study|Adverse Event|4|||
33228851|NCT01844115|100739226|FG001|Overall Study|Adverse Event|22|||
33228852|NCT01844115|100739225|FG000|Overall Study|Lack of Efficacy|1|||
33228853|NCT01844115|100739226|FG001|Overall Study|Lack of Efficacy|4|||
33228854|NCT01844115|100739225|FG000|Overall Study|Protocol Violation|12|||
33228855|NCT01844115|100739226|FG001|Overall Study|Protocol Violation|10|||
33228856|NCT01844115|100739225|FG000|Overall Study|Withdrawal by Subject|11|||
33228857|NCT01844115|100739226|FG001|Overall Study|Withdrawal by Subject|11|||
33228858|NCT01844115|100739225|FG000|Overall Study|Lost to Follow-up|11|||
33228859|NCT01844115|100739226|FG001|Overall Study|Lost to Follow-up|10|||
33228860|NCT01844115|100739225|FG000|Overall Study|Pregnancy|0|||
33228861|NCT01844115|100739226|FG001|Overall Study|Pregnancy|1|||
33228862|NCT02796963|100739227|FG000|Overall Study|Lost to Follow-up|89|||
33228863|NCT02796963|100739228|FG001|Overall Study|Lost to Follow-up|76|||
33228864|NCT02796963|100739229|FG002|Overall Study|Lost to Follow-up|69|||
33228865|NCT02796963|100739230|FG003|Overall Study|Lost to Follow-up|72|||
33228866|NCT00553202|100739233|FG000|Overall Study|Death|16|||
33228867|NCT00553202|100739233|FG000|Overall Study|Lost to Follow-up|1|||
33228868|NCT00553202|100739233|FG000|Overall Study|Physician Decision|28|||
33228869|NCT00553202|100739233|FG000|Overall Study|Withdrawal by Subject|1|||
33228870|NCT00553202|100739233|FG000|Overall Study|No donor identified|16|||
33228871|NCT00553202|100739233|FG000|Overall Study|Fails to meet organ function|6|||
33228872|NCT00406419|100739245|FG000|Overall Study|Death|3|||
33228873|NCT00406419|100739246|FG001|Overall Study|Death|1|||
33228874|NCT00406419|100739247|FG002|Overall Study|Death|4|||
33228875|NCT00406419|100739245|FG000|Overall Study|Protocol Violation|6|||
33228876|NCT00406419|100739246|FG001|Overall Study|Protocol Violation|2|||
33228877|NCT00406419|100739247|FG002|Overall Study|Protocol Violation|5|||
33228878|NCT00406419|100739245|FG000|Overall Study|Study Terminated by Sponsor|260|||
33228879|NCT00406419|100739246|FG001|Overall Study|Study Terminated by Sponsor|288|||
33228880|NCT00406419|100739247|FG002|Overall Study|Study Terminated by Sponsor|282|||
33228881|NCT00406419|100739245|FG000|Overall Study|Withdrawal by Subject|17|||
33228882|NCT00406419|100739246|FG001|Overall Study|Withdrawal by Subject|24|||
33228883|NCT00406419|100739247|FG002|Overall Study|Withdrawal by Subject|26|||
33228884|NCT00406419|100739245|FG000|Overall Study|Lack of Efficacy|12|||
33228885|NCT00406419|100739246|FG001|Overall Study|Lack of Efficacy|1|||
33228886|NCT00406419|100739247|FG002|Overall Study|Lack of Efficacy|6|||
33228887|NCT00406419|100739245|FG000|Overall Study|Non-Compliance with Study Drug|5|||
33228888|NCT00406419|100739246|FG001|Overall Study|Non-Compliance with Study Drug|6|||
33228889|NCT00406419|100739247|FG002|Overall Study|Non-Compliance with Study Drug|3|||
33228890|NCT00406419|100739245|FG000|Overall Study|Adverse Event|10|||
33228891|NCT00406419|100739246|FG001|Overall Study|Adverse Event|12|||
33228892|NCT00406419|100739247|FG002|Overall Study|Adverse Event|16|||
33228893|NCT00406419|100739245|FG000|Overall Study|Lost to Follow-up|11|||
33228894|NCT00406419|100739246|FG001|Overall Study|Lost to Follow-up|10|||
33228895|NCT00406419|100739247|FG002|Overall Study|Lost to Follow-up|5|||
33228896|NCT00779584|100739251|FG000|Overall Study|Protocol Violation|0|||
33228897|NCT00779584|100739252|FG001|Overall Study|Protocol Violation|0|||
33228898|NCT00779584|100739253|FG002|Overall Study|Protocol Violation|0|||
33228899|NCT00779584|100739254|FG003|Overall Study|Protocol Violation|0|||
33228900|NCT00779584|100739255|FG004|Overall Study|Protocol Violation|0|||
33228901|NCT00779584|100739256|FG005|Overall Study|Protocol Violation|1|||
33366923|NCT00611455|101230137|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
33366924|NCT00611455|101230135|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
33228902|NCT00779584|100739257|FG006|Overall Study|Protocol Violation|0|||
33228903|NCT00779584|100739258|FG007|Overall Study|Protocol Violation|0|||
33228904|NCT00779584|100739259|FG008|Overall Study|Protocol Violation|0|||
33228905|NCT00779584|100739251|FG000|Overall Study|Withdrawal by Subject|1|||
33228906|NCT00779584|100739252|FG001|Overall Study|Withdrawal by Subject|1|||
33228907|NCT00779584|100739253|FG002|Overall Study|Withdrawal by Subject|2|||
33228908|NCT00779584|100739254|FG003|Overall Study|Withdrawal by Subject|0|||
33228909|NCT00779584|100739255|FG004|Overall Study|Withdrawal by Subject|0|||
33228910|NCT00779584|100739256|FG005|Overall Study|Withdrawal by Subject|2|||
33228911|NCT00779584|100739257|FG006|Overall Study|Withdrawal by Subject|1|||
33228912|NCT00779584|100739258|FG007|Overall Study|Withdrawal by Subject|0|||
33228913|NCT00779584|100739259|FG008|Overall Study|Withdrawal by Subject|0|||
33228914|NCT00779584|100739251|FG000|Overall Study|Lost to Follow-up|0|||
33228915|NCT00779584|100739252|FG001|Overall Study|Lost to Follow-up|0|||
33228916|NCT00779584|100739253|FG002|Overall Study|Lost to Follow-up|0|||
33228917|NCT00779584|100739254|FG003|Overall Study|Lost to Follow-up|0|||
33228918|NCT00779584|100739255|FG004|Overall Study|Lost to Follow-up|1|||
33228919|NCT00779584|100739256|FG005|Overall Study|Lost to Follow-up|0|||
33228920|NCT00779584|100739257|FG006|Overall Study|Lost to Follow-up|0|||
33228921|NCT00779584|100739258|FG007|Overall Study|Lost to Follow-up|0|||
33228922|NCT00779584|100739259|FG008|Overall Study|Lost to Follow-up|0|||
33228923|NCT00779584|100739251|FG000|Overall Study|Progression of Disease|0|||
33228924|NCT00779584|100739252|FG001|Overall Study|Progression of Disease|1|||
33228925|NCT00779584|100739253|FG002|Overall Study|Progression of Disease|2|||
33228926|NCT00779584|100739254|FG003|Overall Study|Progression of Disease|6|||
33366925|NCT00611455|101230136|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
33366926|NCT00611455|101230137|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
33366927|NCT00611455|101230135|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
33366928|NCT00611455|101230136|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
33366929|NCT00611455|101230137|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
33366930|NCT00611455|101230135|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
33366931|NCT00611455|101230136|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
33366932|NCT00611455|101230137|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
33366933|NCT00611455|101230135|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
33366934|NCT00611455|101230136|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
33366935|NCT00611455|101230137|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
33366936|NCT02775864|101230138|FG000|Overall Study|Data ended end of 2010|1764|||
33366937|NCT02775864|101230139|FG001|Overall Study|Data ended end of 2010|2880|||
33366938|NCT02775864|101230140|FG002|Overall Study|Data ended end of 2010|1140|||
33366939|NCT02775864|101230141|FG003|Overall Study|Data ended end of 2010|1194|||
33366940|NCT02775864|101230138|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
33366941|NCT02775864|101230139|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
33366942|NCT02775864|101230140|FG002|Overall Study|Medicaid eligibility discontinued|720|||
33366943|NCT02775864|101230141|FG003|Overall Study|Medicaid eligibility discontinued|890|||
33366944|NCT02137772|101230142|FG000|Overall Study|Adverse Event|6|||
33366945|NCT02137772|101230143|FG001|Overall Study|Adverse Event|3|||
33366946|NCT02137772|101230142|FG000|Overall Study|Death|71|||
33366947|NCT02137772|101230143|FG001|Overall Study|Death|44|||
33366948|NCT02137772|101230142|FG000|Overall Study|Lost to Follow-up|8|||
33366949|NCT02137772|101230143|FG001|Overall Study|Lost to Follow-up|4|||
33366950|NCT02137772|101230142|FG000|Overall Study|Physician Decision|15|||
33366951|NCT02137772|101230143|FG001|Overall Study|Physician Decision|5|||
33366952|NCT02137772|101230142|FG000|Overall Study|Withdrawal by Subject|28|||
33366953|NCT02137772|101230143|FG001|Overall Study|Withdrawal by Subject|17|||
33366954|NCT02137772|101230142|FG000|Overall Study|Non-compliance with study drug|1|||
33366955|NCT02137772|101230143|FG001|Overall Study|Non-compliance with study drug|0|||
33418966|NCT00808015|101425611|FG000|Overall Study|Lost to Follow-up|76|||
33418967|NCT00808015|101425611|FG000|Overall Study|Participants not willing to participate|158|||
33418968|NCT00808015|101425611|FG000|Overall Study|Adverse Event|22|||
33418969|NCT00808015|101425611|FG000|Overall Study|Other|25|||
33418970|NCT00808015|101425611|FG000|Overall Study|Enrolled but not treated|4|||
33418971|NCT01643928|101425612|FG000|Overall Study|Lost to Follow-up|1|||
33418972|NCT01643928|101425613|FG001|Overall Study|Lost to Follow-up|0|||
33418973|NCT01643928|101425614|FG002|Overall Study|Lost to Follow-up|2|||
33418974|NCT01643928|101425615|FG003|Overall Study|Lost to Follow-up|0|||
33418975|NCT01643928|101425616|FG004|Overall Study|Lost to Follow-up|0|||
33418976|NCT01643928|101425612|FG000|Overall Study|Withdrawal by Subject|2|||
33418977|NCT01643928|101425613|FG001|Overall Study|Withdrawal by Subject|0|||
33418978|NCT01643928|101425614|FG002|Overall Study|Withdrawal by Subject|0|||
33418979|NCT01643928|101425615|FG003|Overall Study|Withdrawal by Subject|1|||
33418980|NCT01643928|101425616|FG004|Overall Study|Withdrawal by Subject|0|||
33418981|NCT01643928|101425612|FG000|Overall Study|Pregnancy|0|||
33418982|NCT01643928|101425613|FG001|Overall Study|Pregnancy|0|||
33418983|NCT01643928|101425614|FG002|Overall Study|Pregnancy|0|||
33418984|NCT01643928|101425615|FG003|Overall Study|Pregnancy|1|||
33366956|NCT02137772|101230142|FG000|Overall Study|Not treated|3|||
33366957|NCT02137772|101230143|FG001|Overall Study|Not treated|2|||
33366958|NCT03865407|101230150|FG000|Overall Study|Adverse Event|1|||
33366959|NCT03865407|101230151|FG001|Overall Study|Adverse Event|0|||
33366960|NCT03865407|101230150|FG000|Overall Study|Withdrawal by Subject|1|||
33366961|NCT03865407|101230151|FG001|Overall Study|Withdrawal by Subject|0|||
33366962|NCT03865407|101230150|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
33418985|NCT01643928|101425616|FG004|Overall Study|Pregnancy|0|||
33228927|NCT00779584|100739255|FG004|Overall Study|Progression of Disease|5|||
33418986|NCT01643928|101425612|FG000|Overall Study|Other|5|||
33418987|NCT01643928|101425613|FG001|Overall Study|Other|1|||
33418988|NCT01643928|101425614|FG002|Overall Study|Other|1|||
33228928|NCT00779584|100739256|FG005|Overall Study|Progression of Disease|1|||
33634283|NCT04123470|102212071|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
33634284|NCT04123470|102212072|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
33634285|NCT04123470|102212071|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
33634286|NCT04123470|102212072|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
33634287|NCT04123470|102212071|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
33634288|NCT04123470|102212072|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
33634289|NCT02807402|102212073|FG000|Overall Study|Failure to Return|1|||
33634290|NCT02807402|102212073|FG000|Overall Study|Death|3|||
33634291|NCT02807402|102212073|FG000|Overall Study|Other|2|||
33418989|NCT01643928|101425615|FG003|Overall Study|Other|0|||
33634292|NCT03051178|102214558|FG000|Overall Study|Withdrawal by Subject|5|||
33634293|NCT02749422|102214559|FG000|Overall Study|Lost to Follow-up|0|||
33634294|NCT02749422|102214560|FG001|Overall Study|Lost to Follow-up|2|||
33634295|NCT02749422|102214559|FG000|Overall Study|Ineligible|0|||
33634296|NCT02749422|102214560|FG001|Overall Study|Ineligible|1|||
33634297|NCT03100149|102214561|FG000|Overall Study|Adverse Event|0|||
33634298|NCT03100149|102214562|FG001|Overall Study|Adverse Event|1|||
33634299|NCT03100149|102214563|FG002|Overall Study|Adverse Event|0|||
33634300|NCT03100149|102214561|FG000|Overall Study|Participant Moved out of Country|0|||
33228929|NCT00779584|100739257|FG006|Overall Study|Progression of Disease|4|||
33228930|NCT00779584|100739258|FG007|Overall Study|Progression of Disease|2|||
33228931|NCT00779584|100739259|FG008|Overall Study|Progression of Disease|1|||
33228932|NCT00779584|100739251|FG000|Overall Study|Adverse Event|1|||
33228933|NCT00779584|100739252|FG001|Overall Study|Adverse Event|0|||
33228934|NCT00779584|100739253|FG002|Overall Study|Adverse Event|2|||
33228935|NCT00779584|100739254|FG003|Overall Study|Adverse Event|0|||
33228936|NCT00779584|100739255|FG004|Overall Study|Adverse Event|0|||
33228937|NCT00779584|100739256|FG005|Overall Study|Adverse Event|0|||
33366963|NCT03865407|101230151|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
33366964|NCT00863928|101230156|FG000|Overall Study|Protocol Violation|26|||
33366965|NCT00863928|101230157|FG001|Overall Study|Protocol Violation|0|||
33366966|NCT00863928|101230156|FG000|Overall Study|Withdrawal by Subject|3|||
33366967|NCT00863928|101230157|FG001|Overall Study|Withdrawal by Subject|0|||
33366968|NCT00863928|101230156|FG000|Overall Study|surgery cancellation|4|||
33366969|NCT00863928|101230157|FG001|Overall Study|surgery cancellation|0|||
33366970|NCT00863928|101230156|FG000|Overall Study|medication allergy|3|||
33366971|NCT00863928|101230157|FG001|Overall Study|medication allergy|0|||
33366972|NCT00536731|101230158|FG000|Overall Study|Adverse Event|3|||
33366973|NCT00536731|101230159|FG001|Overall Study|Adverse Event|2|||
33366974|NCT00536731|101230160|FG002|Overall Study|Adverse Event|3|||
33366975|NCT00536731|101230158|FG000|Overall Study|Withdrawal by Subject|0|||
33418990|NCT01643928|101425616|FG004|Overall Study|Other|0|||
33418991|NCT01643928|101425612|FG000|Overall Study|Adverse Event|2|||
33571873|NCT04622592|101982857|FG006|Overall Study|Withdrawal by Subject|1|||
33228938|NCT00779584|100739257|FG006|Overall Study|Adverse Event|2|||
33228939|NCT00779584|100739258|FG007|Overall Study|Adverse Event|1|||
33228940|NCT00779584|100739259|FG008|Overall Study|Adverse Event|1|||
33228941|NCT00779584|100739251|FG000|Overall Study|Symptomatic Deterioration|1|||
33228942|NCT00779584|100739252|FG001|Overall Study|Symptomatic Deterioration|1|||
33228943|NCT00779584|100739253|FG002|Overall Study|Symptomatic Deterioration|1|||
33228944|NCT00779584|100739254|FG003|Overall Study|Symptomatic Deterioration|0|||
33228945|NCT00779584|100739255|FG004|Overall Study|Symptomatic Deterioration|0|||
33228946|NCT00779584|100739256|FG005|Overall Study|Symptomatic Deterioration|1|||
33228947|NCT00779584|100739257|FG006|Overall Study|Symptomatic Deterioration|1|||
33228948|NCT00779584|100739258|FG007|Overall Study|Symptomatic Deterioration|0|||
33228949|NCT00779584|100739259|FG008|Overall Study|Symptomatic Deterioration|0|||
33228950|NCT00779584|100739251|FG000|Overall Study|Ongoing in Study|0|||
33228951|NCT00779584|100739252|FG001|Overall Study|Ongoing in Study|0|||
33228952|NCT00779584|100739253|FG002|Overall Study|Ongoing in Study|0|||
33228953|NCT00779584|100739254|FG003|Overall Study|Ongoing in Study|0|||
33228954|NCT00779584|100739255|FG004|Overall Study|Ongoing in Study|1|||
33228955|NCT00779584|100739256|FG005|Overall Study|Ongoing in Study|1|||
33228956|NCT00779584|100739257|FG006|Overall Study|Ongoing in Study|0|||
33366976|NCT00536731|101230159|FG001|Overall Study|Withdrawal by Subject|2|||
33571874|NCT04622592|101982858|FG007|Overall Study|Withdrawal by Subject|4|||
33228957|NCT00779584|100739258|FG007|Overall Study|Ongoing in Study|0|||
33571875|NCT04622592|101982851|FG000|Overall Study|Other than specified above|0|||
33571876|NCT04622592|101982852|FG001|Overall Study|Other than specified above|0|||
33571877|NCT04622592|101982853|FG002|Overall Study|Other than specified above|1|||
33571878|NCT04622592|101982854|FG003|Overall Study|Other than specified above|0|||
33571879|NCT04622592|101982855|FG004|Overall Study|Other than specified above|0|||
33571880|NCT04622592|101982856|FG005|Overall Study|Other than specified above|0|||
33571881|NCT04622592|101982857|FG006|Overall Study|Other than specified above|0|||
33571882|NCT04622592|101982858|FG007|Overall Study|Other than specified above|0|||
33571883|NCT00485173|101982859|FG000|Overall Study|Death|4|||
33571884|NCT00485173|101982860|FG001|Overall Study|Death|3|||
33571885|NCT00485173|101982859|FG000|Overall Study|Lost to Follow-up|32|||
33634301|NCT03100149|102214562|FG001|Overall Study|Participant Moved out of Country|0|||
33634302|NCT03100149|102214563|FG002|Overall Study|Participant Moved out of Country|1|||
33634303|NCT03100149|102214561|FG000|Overall Study|Withdrawal by Subject|0|||
33634304|NCT03100149|102214562|FG001|Overall Study|Withdrawal by Subject|3|||
33634305|NCT03100149|102214563|FG002|Overall Study|Withdrawal by Subject|1|||
33634306|NCT03067077|102214564|FG000|Overall Study|Did not receive surgery|4|||
33634307|NCT03067077|102214565|FG001|Overall Study|Did not receive surgery|5|||
33634308|NCT03067077|102214564|FG000|Overall Study|Lost to Follow-up|3|||
33634309|NCT03067077|102214565|FG001|Overall Study|Lost to Follow-up|2|||
33634310|NCT01456039|102214566|FG000|Phase 1 (First Step)|Disease Progression|1|||
33634311|NCT01456039|102214567|FG001|Phase 1 (First Step)|Disease Progression|1|||
33634312|NCT01456039|102214568|FG002|Phase 1 (First Step)|Disease Progression|0|||
33634313|NCT01456039|102214566|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
33571886|NCT00485173|101982860|FG001|Overall Study|Lost to Follow-up|61|||
33366977|NCT00536731|101230160|FG002|Overall Study|Withdrawal by Subject|0|||
33366978|NCT00536731|101230158|FG000|Overall Study|Intake of prohibited conc. medication|0|||
33366979|NCT00536731|101230159|FG001|Overall Study|Intake of prohibited conc. medication|0|||
33366980|NCT00536731|101230160|FG002|Overall Study|Intake of prohibited conc. medication|1|||
33366981|NCT00536731|101230158|FG000|Overall Study|Safety reasons|0|||
33366982|NCT00536731|101230159|FG001|Overall Study|Safety reasons|0|||
33366983|NCT00536731|101230160|FG002|Overall Study|Safety reasons|1|||
33366984|NCT00536731|101230158|FG000|Overall Study|Other|1|||
33366985|NCT00536731|101230159|FG001|Overall Study|Other|1|||
33366986|NCT00536731|101230160|FG002|Overall Study|Other|0|||
33366987|NCT01097330|101230162|FG000|Overall Study|Study terminated early|7|||
33571887|NCT01728246|101982864|FG000|Overall Study|Participant needed rescue medication|1|||
33571888|NCT01728246|101982865|FG001|Overall Study|Participant needed rescue medication|5|||
33571889|NCT01728246|101982864|FG000|Overall Study|Protocol Violation|1|||
33571890|NCT01728246|101982865|FG001|Overall Study|Protocol Violation|0|||
33571891|NCT01728246|101982864|FG000|Overall Study|Withdrawal by Subject|2|||
33571892|NCT01728246|101982865|FG001|Overall Study|Withdrawal by Subject|3|||
33571893|NCT01728246|101982864|FG000|Overall Study|Lost to Follow-up|23|||
33571894|NCT01728246|101982865|FG001|Overall Study|Lost to Follow-up|22|||
33571895|NCT01728246|101982864|FG000|Overall Study|Lack of Efficacy|1|||
33571896|NCT01728246|101982865|FG001|Overall Study|Lack of Efficacy|1|||
33571897|NCT01728246|101982864|FG000|Overall Study|Adverse Event|8|||
33571898|NCT01728246|101982865|FG001|Overall Study|Adverse Event|5|||
33571899|NCT04442269|101985830|FG000|Overall Study|Adverse Event|1|||
33571900|NCT04442269|101985831|FG001|Overall Study|Adverse Event|0|||
33571901|NCT04442269|101985830|FG000|Overall Study|Death|0|||
33571902|NCT04442269|101985831|FG001|Overall Study|Death|1|||
33571903|NCT04442269|101985830|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
33571904|NCT04442269|101985831|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
33571905|NCT04442269|101985830|FG000|Overall Study|Lost to Follow-up|1|||
33571906|NCT04442269|101985831|FG001|Overall Study|Lost to Follow-up|0|||
33571907|NCT04442269|101985830|FG000|Overall Study|Withdrawal by Subject|3|||
33571908|NCT04442269|101985831|FG001|Overall Study|Withdrawal by Subject|2|||
33571909|NCT04442269|101985830|FG000|Overall Study|Protocol Deviation|0|||
33571910|NCT04442269|101985831|FG001|Overall Study|Protocol Deviation|1|||
33571911|NCT04442269|101985830|FG000|Overall Study|Travel Limitations|1|||
33571912|NCT04442269|101985831|FG001|Overall Study|Travel Limitations|1|||
33571913|NCT01448616|101985832|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
33571914|NCT01448616|101985833|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
33571915|NCT01448616|101985834|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
33571916|NCT01448616|101985835|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
33571917|NCT01448616|101985832|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
33571918|NCT01448616|101985833|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
33571919|NCT01448616|101985834|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
33571920|NCT01448616|101985835|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
33571921|NCT01448616|101985832|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
33571922|NCT01448616|101985833|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
33571923|NCT01448616|101985834|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
33571924|NCT01448616|101985835|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
33571925|NCT01448616|101985832|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
33571926|NCT01448616|101985833|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
33634314|NCT01456039|102214567|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
33634315|NCT01456039|102214568|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
33634316|NCT01456039|102214566|FG000|Phase 1 (First Step)|Adverse Event|0|||
33571927|NCT01448616|101985834|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
33571928|NCT01448616|101985835|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
33634317|NCT01456039|102214567|FG001|Phase 1 (First Step)|Adverse Event|3|||
33634318|NCT01456039|102214568|FG002|Phase 1 (First Step)|Adverse Event|0|||
33366988|NCT01097330|101230163|FG001|Overall Study|Study terminated early|5|||
33366989|NCT02853331|101230168|FG000|Overall Study|Death|59|||
33634319|NCT01456039|102214566|FG000|Phase 1 (First Step)|Other|0|||
33634320|NCT01456039|102214567|FG001|Phase 1 (First Step)|Other|1|||
33634321|NCT01456039|102214568|FG002|Phase 1 (First Step)|Other|0|||
33634322|NCT01456039|102214566|FG000|Phase 2 (Second Step)|Disease Progression|0|||
33634323|NCT01456039|102214567|FG001|Phase 2 (Second Step)|Disease Progression|0|||
33634324|NCT01456039|102214568|FG002|Phase 2 (Second Step)|Disease Progression|17|||
33634325|NCT01456039|102214566|FG000|Phase 2 (Second Step)|Adverse Event|0|||
33634326|NCT01456039|102214567|FG001|Phase 2 (Second Step)|Adverse Event|0|||
33228958|NCT00779584|100739259|FG008|Overall Study|Ongoing in Study|0|||
33228959|NCT01478113|100739262|FG000|Overall Study|Withdrawal by Subject|0|||
33228960|NCT01478113|100739263|FG001|Overall Study|Withdrawal by Subject|1|||
33228961|NCT01478113|100739262|FG000|Overall Study|Physician Decision|1|||
33228962|NCT01478113|100739263|FG001|Overall Study|Physician Decision|0|||
33228963|NCT02049710|100739265|FG000|Overall Study|Lost to Follow-up|319|||
33228964|NCT02049710|100739266|FG001|Overall Study|Lost to Follow-up|324|||
33228965|NCT00393523|100739267|FG000|Overall Study|Lost to Follow-up|0|||
33228966|NCT00393523|100739268|FG001|Overall Study|Lost to Follow-up|0|||
33228967|NCT00393523|100739269|FG002|Overall Study|Lost to Follow-up|0|||
33228968|NCT00393523|100739270|FG003|Overall Study|Lost to Follow-up|2|||
33228969|NCT00393523|100739271|FG004|Overall Study|Lost to Follow-up|1|||
33228970|NCT00393523|100739267|FG000|Overall Study|Protocol Violation|6|||
33228971|NCT00393523|100739268|FG001|Overall Study|Protocol Violation|2|||
33228972|NCT00393523|100739269|FG002|Overall Study|Protocol Violation|0|||
33228973|NCT00393523|100739270|FG003|Overall Study|Protocol Violation|1|||
33228974|NCT00393523|100739271|FG004|Overall Study|Protocol Violation|0|||
33228975|NCT00393523|100739267|FG000|Overall Study|Withdrawal by Subject|6|||
33228976|NCT00393523|100739268|FG001|Overall Study|Withdrawal by Subject|7|||
33228977|NCT00393523|100739269|FG002|Overall Study|Withdrawal by Subject|2|||
33228978|NCT00393523|100739270|FG003|Overall Study|Withdrawal by Subject|3|||
33228979|NCT00393523|100739271|FG004|Overall Study|Withdrawal by Subject|0|||
33228980|NCT00393523|100739267|FG000|Overall Study|Difficulties in specimen collection|0|||
33366990|NCT02853331|101230169|FG001|Overall Study|Death|95|||
33366991|NCT02853331|101230168|FG000|Overall Study|Withdrawal by Subject|5|||
33366992|NCT02853331|101230169|FG001|Overall Study|Withdrawal by Subject|9|||
33366993|NCT02853331|101230168|FG000|Overall Study|Ongoing in study|368|||
33571929|NCT01448616|101985832|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
33228981|NCT00393523|100739268|FG001|Overall Study|Difficulties in specimen collection|0|||
33228982|NCT00393523|100739269|FG002|Overall Study|Difficulties in specimen collection|1|||
33228983|NCT00393523|100739270|FG003|Overall Study|Difficulties in specimen collection|0|||
33228984|NCT00393523|100739271|FG004|Overall Study|Difficulties in specimen collection|0|||
33366994|NCT02853331|101230169|FG001|Overall Study|Ongoing in study|325|||
33228985|NCT00393523|100739267|FG000|Overall Study|Vaccine supply issue|0|||
33228986|NCT00393523|100739268|FG001|Overall Study|Vaccine supply issue|0|||
33571930|NCT01448616|101985833|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
33571931|NCT01448616|101985834|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
33571932|NCT01448616|101985835|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
33571933|NCT01664624|101985836|FG000|Overall Study|Adverse Event|0|||
33571934|NCT01664624|101985837|FG001|Overall Study|Adverse Event|1|||
33571935|NCT01664624|101985838|FG002|Overall Study|Adverse Event|0|||
33571936|NCT01664624|101985839|FG003|Overall Study|Adverse Event|0|||
33571937|NCT03673176|101985840|FG000|Overall Study|Death prior to intervention|1|||
33571938|NCT03673176|101985840|FG000|Overall Study|Death following intervention|3|||
33571939|NCT03673176|101985840|FG000|Overall Study|Withdrawal by Subject|1|||
33571940|NCT02234362|101985846|FG000|Overall Study|Not eligible after first screening visit|17|||
33571941|NCT02234362|101985846|FG000|Overall Study|Lost to Follow-up|6|||
33571942|NCT02234362|101985846|FG000|Overall Study|Withdrawal by Subject|3|||
33571943|NCT03610048|101985847|FG000|Overall Study|Study terminated by sponsor|84|||
33571944|NCT03610048|101985847|FG000|Overall Study|Adverse Event|32|||
33571945|NCT03610048|101985847|FG000|Overall Study|Withdrawal by Subject|31|||
33571946|NCT03610048|101985847|FG000|Overall Study|Lost to Follow-up|8|||
33571947|NCT03610048|101985847|FG000|Overall Study|Other|4|||
33571948|NCT03610048|101985847|FG000|Overall Study|Physician Decision|1|||
33571949|NCT03610048|101985847|FG000|Overall Study|Pregnancy|1|||
33571950|NCT01987557|101985851|FG000|Overall Study|Protocol Violation|1|||
33571951|NCT01987557|101985852|FG001|Overall Study|Protocol Violation|0|||
33571952|NCT01987557|101985853|FG002|Overall Study|Protocol Violation|1|||
33571953|NCT01987557|101985851|FG000|Overall Study|Withdrawal by Subject|2|||
33571954|NCT01987557|101985852|FG001|Overall Study|Withdrawal by Subject|1|||
33571955|NCT01987557|101985853|FG002|Overall Study|Withdrawal by Subject|2|||
33571956|NCT01987557|101985851|FG000|Overall Study|Adverse Event|0|||
33571957|NCT01987557|101985852|FG001|Overall Study|Adverse Event|2|||
33571958|NCT01987557|101985853|FG002|Overall Study|Adverse Event|0|||
33571959|NCT00133705|101985857|FG000|Overall Study|Withdrawal by Subject|2|||
33571960|NCT00133705|101985858|FG001|Overall Study|Withdrawal by Subject|3|||
33571961|NCT01342094|101985859|FG000|Overall Study|Adverse Event|5|||
33571962|NCT01342094|101985860|FG001|Overall Study|Adverse Event|0|||
33228987|NCT00393523|100739269|FG002|Overall Study|Vaccine supply issue|1|||
33228988|NCT00393523|100739270|FG003|Overall Study|Vaccine supply issue|0|||
33228989|NCT00393523|100739271|FG004|Overall Study|Vaccine supply issue|0|||
33228990|NCT01254890|100739272|FG000|Overall Study|Ineligible|0|||
33228991|NCT01254890|100739273|FG001|Overall Study|Ineligible|3|||
33228992|NCT01254890|100739272|FG000|Overall Study|Withdrawal by Subject|1|||
33228993|NCT01254890|100739273|FG001|Overall Study|Withdrawal by Subject|2|||
33228994|NCT01254890|100739272|FG000|Overall Study|Disease Progression|0|||
33228995|NCT01254890|100739273|FG001|Overall Study|Disease Progression|5|||
33228996|NCT03075904|100739275|FG000|Overall Study|Physician Decision|3|||
33228997|NCT03075904|100739275|FG000|Overall Study|Need for Medication not Permitted|1|||
33228998|NCT01868035|100739276|FG000|Overall Study|Lost to Follow-up|3|||
33228999|NCT01868035|100739276|FG000|Overall Study|Withdrawal by Subject|1|||
33229000|NCT01868035|100739276|FG000|Overall Study|Progressive Disease|2|||
33571963|NCT01342094|101985859|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
33571964|NCT01342094|101985860|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
33571965|NCT01342094|101985859|FG000|Overall Study|Withdrawal by Subject|0|||
33571966|NCT01342094|101985860|FG001|Overall Study|Withdrawal by Subject|2|||
33634327|NCT01456039|102214568|FG002|Phase 2 (Second Step)|Adverse Event|10|||
33634328|NCT01456039|102214566|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
33634329|NCT01456039|102214567|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
33634330|NCT01456039|102214568|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
33634331|NCT01456039|102214566|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
33634332|NCT01456039|102214567|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
33634333|NCT01456039|102214568|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
33634334|NCT01456039|102214566|FG000|Phase 2 (Second Step)|Other|0|||
33634335|NCT01456039|102214567|FG001|Phase 2 (Second Step)|Other|0|||
33571967|NCT02284191|101985864|FG000|Overall Study|Withdrawal by Subject|1|||
33571968|NCT02284191|101985865|FG001|Overall Study|Withdrawal by Subject|3|||
33571969|NCT02284191|101985864|FG000|Overall Study|Lost to Follow-up|1|||
33571970|NCT02284191|101985865|FG001|Overall Study|Lost to Follow-up|0|||
33366995|NCT00406640|101230174|FG000|Acute Phase|Adverse Event|18|||
33366996|NCT00406640|101230175|FG001|Acute Phase|Adverse Event|13|||
33366997|NCT00406640|101230174|FG000|Acute Phase|Failed to Return|5|||
33366998|NCT00406640|101230175|FG001|Acute Phase|Failed to Return|1|||
33366999|NCT00406640|101230174|FG000|Acute Phase|Physician Decision|0|||
33229001|NCT01868035|100739276|FG000|Overall Study|Non-compliance|1|||
33229002|NCT00569803|100739277|FG000|Overall Study|Lost to Follow-up|1|||
33229003|NCT00569803|100739278|FG001|Overall Study|Lost to Follow-up|0|||
33229004|NCT00569803|100739279|FG002|Overall Study|Lost to Follow-up|0|||
33229005|NCT00569803|100739280|FG003|Overall Study|Lost to Follow-up|0|||
33229006|NCT00569803|100739281|FG004|Overall Study|Lost to Follow-up|0|||
33229007|NCT00569803|100739282|FG005|Overall Study|Lost to Follow-up|0|||
33229008|NCT00569803|100739283|FG006|Overall Study|Lost to Follow-up|0|||
33229009|NCT00569803|100739284|FG007|Overall Study|Lost to Follow-up|0|||
33229010|NCT00569803|100739277|FG000|Overall Study|injection syringe leaked during dosing|0|||
33229011|NCT00569803|100739278|FG001|Overall Study|injection syringe leaked during dosing|0|||
33229012|NCT00569803|100739279|FG002|Overall Study|injection syringe leaked during dosing|0|||
33229013|NCT00569803|100739280|FG003|Overall Study|injection syringe leaked during dosing|1|||
33229014|NCT00569803|100739281|FG004|Overall Study|injection syringe leaked during dosing|0|||
33229015|NCT00569803|100739282|FG005|Overall Study|injection syringe leaked during dosing|0|||
33229016|NCT00569803|100739283|FG006|Overall Study|injection syringe leaked during dosing|0|||
33571971|NCT01214837|101985866|FG000|Overall Study|Death|0|||
33571972|NCT01214837|101985867|FG001|Overall Study|Death|0|||
33229017|NCT00569803|100739284|FG007|Overall Study|injection syringe leaked during dosing|0|||
33229018|NCT00569803|100739277|FG000|Overall Study|Withdrawal by Subject|0|||
33229019|NCT00569803|100739278|FG001|Overall Study|Withdrawal by Subject|0|||
33367000|NCT00406640|101230175|FG001|Acute Phase|Physician Decision|1|||
33367001|NCT00406640|101230174|FG000|Acute Phase|Lost to Follow-up|7|||
33367002|NCT00406640|101230175|FG001|Acute Phase|Lost to Follow-up|4|||
33571973|NCT01214837|101985868|FG002|Overall Study|Death|1|||
33634336|NCT01456039|102214568|FG002|Phase 2 (Second Step)|Other|1|||
33634337|NCT01217229|102214569|FG000|Overall Study|Adverse Event|1|||
33634338|NCT01217229|102214569|FG000|Overall Study|Disease progression, deterioration|2|||
33571974|NCT01214837|101985866|FG000|Overall Study|Adverse Event|1|||
33571975|NCT01214837|101985867|FG001|Overall Study|Adverse Event|2|||
33634339|NCT01217229|102214569|FG000|Overall Study|Disease progression, Cheson criteria|14|||
33229020|NCT00569803|100739279|FG002|Overall Study|Withdrawal by Subject|0|||
33229021|NCT00569803|100739280|FG003|Overall Study|Withdrawal by Subject|0|||
33229022|NCT00569803|100739281|FG004|Overall Study|Withdrawal by Subject|0|||
33229023|NCT00569803|100739282|FG005|Overall Study|Withdrawal by Subject|0|||
33229024|NCT00569803|100739283|FG006|Overall Study|Withdrawal by Subject|0|||
33229025|NCT00569803|100739284|FG007|Overall Study|Withdrawal by Subject|1|||
33229026|NCT00692406|100739285|FG000|Overall Study|PI dropped, bad data|57|||
33367003|NCT00406640|101230174|FG000|Acute Phase|Protocol deviation|4|||
33571976|NCT01214837|101985868|FG002|Overall Study|Adverse Event|1|||
33634340|NCT01217229|102214569|FG000|Overall Study|Protocol Violation|1|||
33634341|NCT01217229|102214569|FG000|Overall Study|Disease progression not confirmed|2|||
33634342|NCT01748292|102214571|FG000|Overall Study|Adverse Event|2|||
33634343|NCT01748292|102214572|FG001|Overall Study|Adverse Event|4|||
33634344|NCT01748292|102214571|FG000|Overall Study|Lost to Follow-up|0|||
33634345|NCT01748292|102214572|FG001|Overall Study|Lost to Follow-up|3|||
33634346|NCT01748292|102214571|FG000|Overall Study|Death|0|||
33634347|NCT01748292|102214572|FG001|Overall Study|Death|3|||
33634348|NCT01748292|102214571|FG000|Overall Study|Withdrawal by Subject|0|||
33634349|NCT01748292|102214572|FG001|Overall Study|Withdrawal by Subject|2|||
33634350|NCT05135767|102214576|FG000|Baseline|Lost to Follow-up|1|||
33634351|NCT05135767|102214577|FG001|Baseline|Lost to Follow-up|1|||
33634352|NCT05135767|102214576|FG000|Baseline|Withdrawal by Subject|0|||
33634353|NCT05135767|102214577|FG001|Baseline|Withdrawal by Subject|2|||
33634354|NCT05135767|102214576|FG000|Active Study Phase|Lost to Follow-up|2|||
33634355|NCT05135767|102214577|FG001|Active Study Phase|Lost to Follow-up|0|||
33634356|NCT04944992|102214578|FG000|Overall Study|Lost to Follow-up|1|||
33634357|NCT04944992|102214579|FG001|Overall Study|Lost to Follow-up|1|||
33634358|NCT04944992|102214578|FG000|Overall Study|Physician Decision|1|||
33634359|NCT04944992|102214579|FG001|Overall Study|Physician Decision|0|||
33634360|NCT04944992|102214578|FG000|Overall Study|Withdrawal by Subject|6|||
33634361|NCT04944992|102214579|FG001|Overall Study|Withdrawal by Subject|1|||
33634362|NCT00361296|102214580|FG000|Overall Study|Physician Decision|1|||
33634363|NCT00361296|102214580|FG000|Overall Study|Lack of Efficacy|2|||
33634364|NCT01393821|102214581|FG000|Overall Study|Cancel|1|||
33634365|NCT01393821|102214582|FG001|Overall Study|Cancel|1|||
33634366|NCT01393821|102214581|FG000|Overall Study|not evaluable for primary endpoint|4|||
33634367|NCT01393821|102214582|FG001|Overall Study|not evaluable for primary endpoint|2|||
33634368|NCT02113982|102214583|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
33634369|NCT02113982|102214584|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
33634370|NCT02113982|102214585|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
33634371|NCT02113982|102214586|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
33634372|NCT02113982|102214587|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
33634373|NCT02113982|102214588|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
33634374|NCT02113982|102214589|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
33634375|NCT02113982|102214590|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
33634376|NCT02113982|102214591|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
33634377|NCT02113982|102214592|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
33634378|NCT02113982|102214593|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
33634379|NCT02113982|102214594|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
33634380|NCT02113982|102214595|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
33634381|NCT02113982|102214596|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
33634382|NCT02113982|102214583|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
33634383|NCT02113982|102214584|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
33634384|NCT02113982|102214585|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
33634385|NCT02113982|102214586|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
33634386|NCT02113982|102214587|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
33634387|NCT02113982|102214588|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
33634388|NCT02113982|102214589|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
33634389|NCT02113982|102214590|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
33634390|NCT02113982|102214591|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
33634391|NCT02113982|102214592|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
33634392|NCT02113982|102214593|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
33634393|NCT02113982|102214594|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
33634394|NCT02113982|102214595|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
33634395|NCT02113982|102214596|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
33634396|NCT02113982|102214583|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
33634397|NCT02113982|102214584|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
33634398|NCT02113982|102214585|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
33634399|NCT02113982|102214586|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
33634400|NCT02113982|102214587|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
33634401|NCT02113982|102214588|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
33634402|NCT02113982|102214589|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
33634403|NCT02113982|102214590|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
33634404|NCT02113982|102214591|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
33634405|NCT02113982|102214592|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
33634406|NCT02113982|102214593|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
33634407|NCT02113982|102214594|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
33634408|NCT02113982|102214595|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
33634409|NCT02113982|102214596|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
33634410|NCT02113982|102214583|FG000|Stage 1: Dose Escalation|Transplant|0|||
33634411|NCT02113982|102214584|FG001|Stage 1: Dose Escalation|Transplant|1|||
33634412|NCT02113982|102214585|FG002|Stage 1: Dose Escalation|Transplant|0|||
33634413|NCT02113982|102214586|FG003|Stage 1: Dose Escalation|Transplant|0|||
33634414|NCT02113982|102214587|FG004|Stage 1: Dose Escalation|Transplant|0|||
33634415|NCT02113982|102214588|FG005|Stage 1: Dose Escalation|Transplant|1|||
33634416|NCT02113982|102214589|FG006|Stage 1: Dose Escalation|Transplant|0|||
33634417|NCT02113982|102214590|FG007|Stage 1: Dose Escalation|Transplant|0|||
33634418|NCT02113982|102214591|FG008|Stage 1: Dose Escalation|Transplant|0|||
33634419|NCT02113982|102214592|FG009|Stage 1: Dose Escalation|Transplant|0|||
33634420|NCT02113982|102214593|FG010|Stage 1: Dose Escalation|Transplant|0|||
33634421|NCT02113982|102214594|FG011|Stage 1: Dose Escalation|Transplant|0|||
33634422|NCT02113982|102214595|FG012|Stage 1: Dose Escalation|Transplant|0|||
33634423|NCT02113982|102214596|FG013|Stage 1: Dose Escalation|Transplant|0|||
33571977|NCT01214837|101985866|FG000|Overall Study|Withdrawal by Subject|27|||
33367004|NCT00406640|101230175|FG001|Acute Phase|Protocol deviation|10|||
33367005|NCT00406640|101230174|FG000|Acute Phase|Protocol Violation|3|||
33367006|NCT00406640|101230175|FG001|Acute Phase|Protocol Violation|2|||
33367007|NCT00406640|101230174|FG000|Acute Phase|Withdrawal by Subject|11|||
33634424|NCT02113982|102214583|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
33571978|NCT01214837|101985867|FG001|Overall Study|Withdrawal by Subject|36|||
33571979|NCT01214837|101985868|FG002|Overall Study|Withdrawal by Subject|28|||
33571980|NCT01214837|101985866|FG000|Overall Study|Lost to Follow-up|20|||
33571981|NCT01214837|101985867|FG001|Overall Study|Lost to Follow-up|15|||
33571982|NCT01214837|101985868|FG002|Overall Study|Lost to Follow-up|21|||
33571983|NCT01214837|101985866|FG000|Overall Study|Inappropriate Enrolment|0|||
33571984|NCT01214837|101985867|FG001|Overall Study|Inappropriate Enrolment|1|||
33571985|NCT01214837|101985868|FG002|Overall Study|Inappropriate Enrolment|2|||
33367008|NCT00406640|101230175|FG001|Acute Phase|Withdrawal by Subject|9|||
33367009|NCT00406640|101230174|FG000|Acute Phase|Lack of Efficacy|3|||
33367010|NCT00406640|101230175|FG001|Acute Phase|Lack of Efficacy|3|||
33367011|NCT00406640|101230174|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
33367012|NCT00406640|101230175|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
33367013|NCT00406640|101230174|FG000|DB Continuation Phase for Responders|Death|1|||
33367014|NCT00406640|101230175|FG001|DB Continuation Phase for Responders|Death|0|||
33367015|NCT00406640|101230174|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
33367016|NCT00406640|101230175|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
33367017|NCT00406640|101230174|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
33367018|NCT00406640|101230175|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
33367019|NCT00406640|101230174|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
33367020|NCT00406640|101230175|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
33367021|NCT00406640|101230174|FG000|DB Continuation Phase for Responders|non-compliance|7|||
33367022|NCT00406640|101230175|FG001|DB Continuation Phase for Responders|non-compliance|5|||
33367023|NCT00406640|101230174|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
33367024|NCT00406640|101230175|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
33367025|NCT00406640|101230174|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
33367026|NCT00406640|101230175|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
33367027|NCT00406640|101230174|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
33367028|NCT00406640|101230175|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
33367029|NCT00406640|101230174|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
33367030|NCT00406640|101230175|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
33367031|NCT00406640|101230174|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
33367032|NCT00406640|101230175|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
33367033|NCT00406640|101230174|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
33634425|NCT02113982|102214584|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
33634426|NCT02113982|102214585|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
33634427|NCT02113982|102214586|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
33634428|NCT02113982|102214587|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
33634429|NCT02113982|102214588|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
33634430|NCT02113982|102214589|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
33634431|NCT02113982|102214590|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
33634432|NCT02113982|102214591|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
33367034|NCT00406640|101230175|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
33367035|NCT00406640|101230174|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
33367036|NCT00406640|101230175|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
33367037|NCT00406640|101230174|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
33367038|NCT00406640|101230175|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
33367039|NCT00406640|101230174|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
33367040|NCT00406640|101230175|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
33367041|NCT00406640|101230174|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
33571986|NCT01214837|101985866|FG000|Overall Study|Administrative Reason|2|||
33571987|NCT01214837|101985867|FG001|Overall Study|Administrative Reason|6|||
33634433|NCT02113982|102214592|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
33634434|NCT02113982|102214593|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
33229027|NCT03893825|100739288|FG000|Overall Study|Death|2|||
33634435|NCT02113982|102214594|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
33229028|NCT03893825|100739289|FG001|Overall Study|Death|1|||
33229029|NCT03893825|100739288|FG000|Overall Study|Adverse Event|0|||
33229030|NCT03893825|100739289|FG001|Overall Study|Adverse Event|2|||
33367042|NCT00406640|101230175|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
33367043|NCT01345786|101230176|FG000|Overall Study|Adverse Event|0|||
33367044|NCT01345786|101230177|FG001|Overall Study|Adverse Event|1|||
33418992|NCT01643928|101425613|FG001|Overall Study|Adverse Event|1|||
33418993|NCT01643928|101425614|FG002|Overall Study|Adverse Event|0|||
33418994|NCT01643928|101425615|FG003|Overall Study|Adverse Event|1|||
33418995|NCT01643928|101425616|FG004|Overall Study|Adverse Event|2|||
33367045|NCT01345786|101230178|FG002|Overall Study|Adverse Event|3|||
33367046|NCT01345786|101230179|FG003|Overall Study|Adverse Event|1|||
33367047|NCT01345786|101230176|FG000|Overall Study|Subject withdrew consent|2|||
33367048|NCT01345786|101230177|FG001|Overall Study|Subject withdrew consent|2|||
33367049|NCT01345786|101230178|FG002|Overall Study|Subject withdrew consent|1|||
33367050|NCT01345786|101230179|FG003|Overall Study|Subject withdrew consent|0|||
33367051|NCT01345786|101230176|FG000|Overall Study|Noncompliance with protocol|1|||
33367052|NCT01345786|101230177|FG001|Overall Study|Noncompliance with protocol|0|||
33367053|NCT01345786|101230178|FG002|Overall Study|Noncompliance with protocol|1|||
33367054|NCT01345786|101230179|FG003|Overall Study|Noncompliance with protocol|0|||
33367055|NCT01345786|101230176|FG000|Overall Study|Administrative|3|||
33367056|NCT01345786|101230177|FG001|Overall Study|Administrative|5|||
33367057|NCT01345786|101230178|FG002|Overall Study|Administrative|0|||
33367058|NCT01345786|101230179|FG003|Overall Study|Administrative|0|||
33367059|NCT01345786|101230176|FG000|Overall Study|Lost to Follow-up|0|||
33367060|NCT01345786|101230177|FG001|Overall Study|Lost to Follow-up|0|||
33367061|NCT01345786|101230178|FG002|Overall Study|Lost to Follow-up|0|||
33367062|NCT01345786|101230179|FG003|Overall Study|Lost to Follow-up|2|||
33367063|NCT04267562|101230180|FG000|Assessed for Eligibility|Screen Failure|64|||
33367064|NCT04267562|101230180|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
33367065|NCT04267562|101230180|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
33367066|NCT04267562|101230180|FG000|Assessed for Eligibility|Site closure|6|||
33367067|NCT04267562|101230180|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
33367068|NCT04267562|101230180|FG000|Assessed for Eligibility|Physician Decision|1|||
33367069|NCT04267562|101230180|FG000|Month 24|Elective hysterectomy|1|||
33367070|NCT04267562|101230180|FG000|Month 24|Lost to Follow-up|1|||
33367071|NCT04267562|101230180|FG000|Month 36|Elective hysterectomy|2|||
33367072|NCT04267562|101230180|FG000|Month 36|Lost to Follow-up|3|||
33367073|NCT01539837|101230181|FG000|Overall Study|reduce neutrophil level|0|||
33367074|NCT01539837|101230182|FG001|Overall Study|reduce neutrophil level|1|||
33367075|NCT01539837|101230183|FG002|Overall Study|reduce neutrophil level|1|||
33367076|NCT01539837|101230181|FG000|Overall Study|bad compliance|0|||
33367077|NCT01539837|101230182|FG001|Overall Study|bad compliance|0|||
33367078|NCT01539837|101230183|FG002|Overall Study|bad compliance|1|||
33367079|NCT01757704|101230184|FG000|Overall Study|Protocol Violation|1|||
33367080|NCT01757704|101230185|FG001|Overall Study|Protocol Violation|3|||
33367081|NCT00858702|101230188|FG000|Overall Study|Lack of Efficacy|1|||
33418996|NCT01563029|101425622|FG000|Overall Study|Adverse Event|1|||
33367082|NCT00858702|101230189|FG001|Overall Study|Lack of Efficacy|0|||
33367083|NCT00858702|101230188|FG000|Overall Study|Protocol Violation|1|||
33367084|NCT00858702|101230189|FG001|Overall Study|Protocol Violation|1|||
33367085|NCT00858702|101230188|FG000|Overall Study|Other|2|||
33367086|NCT00858702|101230189|FG001|Overall Study|Other|1|||
33367087|NCT00858702|101230188|FG000|Overall Study|Withdrawal by Subject|1|||
33367088|NCT00858702|101230189|FG001|Overall Study|Withdrawal by Subject|0|||
33367089|NCT04489771|101230196|FG000|Overall Study|Death|27|||
33367090|NCT04489771|101230197|FG001|Overall Study|Death|25|||
33367091|NCT04489771|101230196|FG000|Overall Study|Withdrawal by Subject|1|||
33418997|NCT01563029|101425623|FG001|Overall Study|Adverse Event|0|||
33367092|NCT04489771|101230197|FG001|Overall Study|Withdrawal by Subject|0|||
33367093|NCT04489771|101230196|FG000|Overall Study|Participants Ongoing in Study|50|||
33367094|NCT04489771|101230197|FG001|Overall Study|Participants Ongoing in Study|51|||
33367095|NCT01454401|101230199|FG000|Overall Study|Death|1|||
33367096|NCT01454401|101230199|FG000|Overall Study|hospitalised|1|||
33367097|NCT01454401|101230199|FG000|Overall Study|osteomyelitis|2|||
33367098|NCT01454401|101230199|FG000|Overall Study|non-adherence|1|||
33418998|NCT01563029|101425624|FG002|Overall Study|Adverse Event|1|||
33367099|NCT01605396|101230200|FG000|Overall Study|Adverse Event|5|||
33367100|NCT01605396|101230201|FG001|Overall Study|Adverse Event|3|||
33367101|NCT01605396|101230200|FG000|Overall Study|Lost to Follow-up|1|||
33367102|NCT01605396|101230201|FG001|Overall Study|Lost to Follow-up|0|||
33367103|NCT01605396|101230200|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33367104|NCT01605396|101230201|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33367105|NCT01605396|101230200|FG000|Overall Study|Physician Decision|2|||
33367106|NCT01605396|101230201|FG001|Overall Study|Physician Decision|2|||
33367107|NCT01605396|101230200|FG000|Overall Study|Progressive Disease|23|||
33418999|NCT01563029|101425625|FG003|Overall Study|Adverse Event|2|||
33419000|NCT01563029|101425626|FG004|Overall Study|Adverse Event|1|||
33419001|NCT01563029|101425622|FG000|Overall Study|Lack of Efficacy|42|||
33419002|NCT01563029|101425623|FG001|Overall Study|Lack of Efficacy|16|||
33419003|NCT01563029|101425624|FG002|Overall Study|Lack of Efficacy|23|||
33571988|NCT01214837|101985868|FG002|Overall Study|Administrative Reason|4|||
33571989|NCT01214837|101985866|FG000|Overall Study|Protocol Violation|3|||
33571990|NCT01214837|101985867|FG001|Overall Study|Protocol Violation|1|||
33571991|NCT01214837|101985868|FG002|Overall Study|Protocol Violation|5|||
33571992|NCT01214837|101985866|FG000|Overall Study|Unable to Classify|1|||
33571993|NCT01214837|101985867|FG001|Overall Study|Unable to Classify|3|||
33571994|NCT01214837|101985868|FG002|Overall Study|Unable to Classify|0|||
33571995|NCT00448448|101985872|FG000|Overall Study|Withdrawal by Subject|13|||
33571996|NCT00448448|101985873|FG001|Overall Study|Withdrawal by Subject|2|||
33571997|NCT00448448|101985872|FG000|Overall Study|On protocol when study ended|83|||
33571998|NCT00448448|101985873|FG001|Overall Study|On protocol when study ended|36|||
33571999|NCT00448448|101985872|FG000|Overall Study|Lost to Follow-up|2|||
33572000|NCT00448448|101985873|FG001|Overall Study|Lost to Follow-up|1|||
33572001|NCT00448448|101985872|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
33572002|NCT00448448|101985873|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
33572003|NCT00448448|101985872|FG000|Overall Study|Signed consent lost|0|||
33572004|NCT00448448|101985873|FG001|Overall Study|Signed consent lost|1|||
33572005|NCT04749914|101985876|FG000|Period 1|Adverse Event|1|||
33572006|NCT04749914|101985877|FG001|Period 1|Adverse Event|0|||
33572007|NCT04749914|101985878|FG002|Period 1|Adverse Event|0|||
33572008|NCT04749914|101985879|FG003|Period 1|Adverse Event|0|||
33572009|NCT04749914|101985876|FG000|Period 1|Withdrawal by Subject|1|||
33572010|NCT04749914|101985877|FG001|Period 1|Withdrawal by Subject|0|||
33572011|NCT04749914|101985878|FG002|Period 1|Withdrawal by Subject|1|||
33572012|NCT04749914|101985879|FG003|Period 1|Withdrawal by Subject|0|||
33572013|NCT03412929|101985881|FG000|Overall Study|Protocol Violation|3|||
33572014|NCT01832727|101985882|FG000|Overall Study|Adverse Event|4|||
33572015|NCT01832727|101985883|FG001|Overall Study|Adverse Event|6|||
33572016|NCT01832727|101985884|FG002|Overall Study|Adverse Event|1|||
33572017|NCT01832727|101985885|FG003|Overall Study|Adverse Event|0|||
33572018|NCT01832727|101985886|FG004|Overall Study|Adverse Event|1|||
33229031|NCT03893825|100739288|FG000|Overall Study|Withdrawal by Subject|19|||
33419004|NCT01563029|101425625|FG003|Overall Study|Lack of Efficacy|21|||
33572019|NCT01832727|101985887|FG005|Overall Study|Adverse Event|1|||
33572020|NCT01832727|101985888|FG006|Overall Study|Adverse Event|2|||
33229032|NCT03893825|100739289|FG001|Overall Study|Withdrawal by Subject|21|||
33572021|NCT01832727|101985889|FG007|Overall Study|Adverse Event|1|||
33572022|NCT01832727|101985890|FG008|Overall Study|Adverse Event|9|||
33572023|NCT01832727|101985882|FG000|Overall Study|Disease progression|3|||
33572024|NCT01832727|101985883|FG001|Overall Study|Disease progression|0|||
33572025|NCT01832727|101985884|FG002|Overall Study|Disease progression|2|||
33572026|NCT01832727|101985885|FG003|Overall Study|Disease progression|1|||
33572027|NCT01832727|101985886|FG004|Overall Study|Disease progression|3|||
33572028|NCT01832727|101985887|FG005|Overall Study|Disease progression|3|||
33367108|NCT01605396|101230201|FG001|Overall Study|Progressive Disease|27|||
33367109|NCT01605396|101230200|FG000|Overall Study|Withdrawal by Subject|4|||
33419005|NCT01563029|101425626|FG004|Overall Study|Lack of Efficacy|19|||
33572029|NCT01832727|101985888|FG006|Overall Study|Disease progression|6|||
33572030|NCT01832727|101985889|FG007|Overall Study|Disease progression|2|||
33572031|NCT01832727|101985890|FG008|Overall Study|Disease progression|7|||
33572032|NCT01832727|101985882|FG000|Overall Study|Lost to Follow-up|0|||
33572033|NCT01832727|101985883|FG001|Overall Study|Lost to Follow-up|0|||
33572034|NCT01832727|101985884|FG002|Overall Study|Lost to Follow-up|0|||
33572035|NCT01832727|101985885|FG003|Overall Study|Lost to Follow-up|1|||
33572036|NCT01832727|101985886|FG004|Overall Study|Lost to Follow-up|0|||
33572037|NCT01832727|101985887|FG005|Overall Study|Lost to Follow-up|0|||
33572038|NCT01832727|101985888|FG006|Overall Study|Lost to Follow-up|0|||
33572039|NCT01832727|101985889|FG007|Overall Study|Lost to Follow-up|0|||
33572040|NCT01832727|101985890|FG008|Overall Study|Lost to Follow-up|0|||
33572041|NCT01832727|101985882|FG000|Overall Study|Physician Decision|1|||
33572042|NCT01832727|101985883|FG001|Overall Study|Physician Decision|0|||
33572043|NCT01832727|101985884|FG002|Overall Study|Physician Decision|0|||
33572044|NCT01832727|101985885|FG003|Overall Study|Physician Decision|1|||
33572045|NCT01832727|101985886|FG004|Overall Study|Physician Decision|0|||
33572046|NCT01832727|101985887|FG005|Overall Study|Physician Decision|1|||
33572047|NCT01832727|101985888|FG006|Overall Study|Physician Decision|0|||
33572048|NCT01832727|101985889|FG007|Overall Study|Physician Decision|0|||
33572049|NCT01832727|101985890|FG008|Overall Study|Physician Decision|0|||
33572050|NCT01832727|101985882|FG000|Overall Study|Withdrawal by Subject|1|||
33572051|NCT01832727|101985883|FG001|Overall Study|Withdrawal by Subject|1|||
33572052|NCT01832727|101985884|FG002|Overall Study|Withdrawal by Subject|0|||
33572053|NCT01832727|101985885|FG003|Overall Study|Withdrawal by Subject|1|||
33572054|NCT01832727|101985886|FG004|Overall Study|Withdrawal by Subject|0|||
33572055|NCT01832727|101985887|FG005|Overall Study|Withdrawal by Subject|1|||
33572056|NCT01832727|101985888|FG006|Overall Study|Withdrawal by Subject|0|||
33572057|NCT01832727|101985889|FG007|Overall Study|Withdrawal by Subject|2|||
33572058|NCT01832727|101985890|FG008|Overall Study|Withdrawal by Subject|1|||
33572059|NCT01832727|101985882|FG000|Overall Study|Study terminated by sponsor|0|||
33572060|NCT01832727|101985883|FG001|Overall Study|Study terminated by sponsor|0|||
33572061|NCT01832727|101985884|FG002|Overall Study|Study terminated by sponsor|0|||
33634436|NCT02113982|102214595|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
33634437|NCT02113982|102214596|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
33634438|NCT02113982|102214583|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
33634439|NCT02113982|102214584|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
33634440|NCT02113982|102214585|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
33634441|NCT02113982|102214586|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
33367110|NCT01605396|101230201|FG001|Overall Study|Withdrawal by Subject|2|||
33367111|NCT01605396|101230200|FG000|Overall Study|Transfer Off Study|4|||
33634442|NCT02113982|102214587|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
33634443|NCT02113982|102214588|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
33634444|NCT02113982|102214589|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
33634445|NCT02113982|102214590|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
33367112|NCT01605396|101230201|FG001|Overall Study|Transfer Off Study|5|||
33367113|NCT01372878|101230202|FG000|Overall Study|Withdrawal by Subject|63|||
33367114|NCT01372878|101230202|FG000|Overall Study|Protocol Violation|17|||
33367115|NCT01372878|101230202|FG000|Overall Study|incomplete study procedure|104|||
33634446|NCT02113982|102214591|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
33367116|NCT00651118|101230203|FG000|Overall Study|Adverse Event|4|||
33572062|NCT01832727|101985885|FG003|Overall Study|Study terminated by sponsor|0|||
33572063|NCT01832727|101985886|FG004|Overall Study|Study terminated by sponsor|0|||
33572064|NCT01832727|101985887|FG005|Overall Study|Study terminated by sponsor|0|||
33572065|NCT01832727|101985888|FG006|Overall Study|Study terminated by sponsor|0|||
33572066|NCT01832727|101985889|FG007|Overall Study|Study terminated by sponsor|1|||
33572067|NCT01832727|101985890|FG008|Overall Study|Study terminated by sponsor|1|||
33367117|NCT00651118|101230204|FG001|Overall Study|Adverse Event|0|||
33367118|NCT00651118|101230205|FG002|Overall Study|Adverse Event|1|||
33572068|NCT02993263|101985892|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
33572069|NCT00854360|101985897|FG000|Overall Study|Adverse Event|0|||
33572070|NCT00854360|101985898|FG001|Overall Study|Adverse Event|1|||
33572071|NCT00854360|101985899|FG002|Overall Study|Adverse Event|2|||
33572072|NCT00854360|101985900|FG003|Overall Study|Adverse Event|6|||
33572073|NCT00854360|101985897|FG000|Overall Study|Withdrawal by Subject|0|||
33572074|NCT00854360|101985898|FG001|Overall Study|Withdrawal by Subject|0|||
33572075|NCT00854360|101985899|FG002|Overall Study|Withdrawal by Subject|0|||
33572076|NCT00854360|101985900|FG003|Overall Study|Withdrawal by Subject|1|||
33572077|NCT00854360|101985897|FG000|Overall Study|Pregnancy|0|||
33572078|NCT00854360|101985898|FG001|Overall Study|Pregnancy|1|||
33572079|NCT00854360|101985899|FG002|Overall Study|Pregnancy|0|||
33572080|NCT00854360|101985900|FG003|Overall Study|Pregnancy|0|||
33572081|NCT00854360|101985897|FG000|Overall Study|Lack of Efficacy|2|||
33572082|NCT00854360|101985898|FG001|Overall Study|Lack of Efficacy|1|||
33572083|NCT00854360|101985899|FG002|Overall Study|Lack of Efficacy|0|||
33572084|NCT00854360|101985900|FG003|Overall Study|Lack of Efficacy|0|||
33572085|NCT00854360|101985897|FG000|Overall Study|Other|0|||
33572086|NCT00854360|101985898|FG001|Overall Study|Other|0|||
33634447|NCT02113982|102214592|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
33634448|NCT02113982|102214593|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
33634449|NCT02113982|102214594|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
33634450|NCT02113982|102214595|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
33634451|NCT02113982|102214596|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
33634452|NCT02113982|102214583|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
33634453|NCT02113982|102214584|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
33634454|NCT02113982|102214585|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
33634455|NCT02113982|102214586|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
33634456|NCT02113982|102214587|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
33634457|NCT02113982|102214588|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
33634458|NCT02113982|102214589|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
33634459|NCT02113982|102214590|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
33634460|NCT02113982|102214591|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
33634461|NCT02113982|102214592|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
33634462|NCT02113982|102214593|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
33634463|NCT02113982|102214594|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
33634464|NCT02113982|102214595|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
33634465|NCT02113982|102214596|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
33634466|NCT02113982|102214583|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
33634467|NCT02113982|102214584|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
33634468|NCT02113982|102214585|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
33634469|NCT02113982|102214586|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
33634470|NCT02113982|102214587|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
33634471|NCT02113982|102214588|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
33634472|NCT02113982|102214589|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
33634473|NCT02113982|102214590|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
33634474|NCT02113982|102214591|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
33634475|NCT02113982|102214592|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
33634476|NCT02113982|102214593|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
33634477|NCT02113982|102214594|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
33634478|NCT02113982|102214595|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
33634479|NCT02113982|102214596|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
33634480|NCT02113982|102214583|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
33634481|NCT02113982|102214584|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
33634482|NCT02113982|102214585|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
33634483|NCT02113982|102214586|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
33634484|NCT02113982|102214587|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
33634485|NCT02113982|102214588|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
33634486|NCT02113982|102214589|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
33634487|NCT02113982|102214590|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
33634488|NCT02113982|102214591|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
33634489|NCT02113982|102214592|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
33634490|NCT02113982|102214593|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
33634491|NCT02113982|102214594|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
33634492|NCT02113982|102214595|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
33634493|NCT02113982|102214596|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
33572087|NCT00854360|101985899|FG002|Overall Study|Other|0|||
33572088|NCT00854360|101985900|FG003|Overall Study|Other|3|||
33572089|NCT01656161|101985901|FG000|Overall Study|Death|3|||
33572090|NCT01656161|101985901|FG000|Overall Study|Adverse Event|2|||
33572091|NCT01656161|101985901|FG000|Overall Study|Protocol Violation|1|||
33634494|NCT02113982|102214583|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
33634495|NCT02113982|102214584|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
33634496|NCT02113982|102214585|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
33634497|NCT02113982|102214586|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
33634498|NCT02113982|102214587|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
33572092|NCT01656161|101985901|FG000|Overall Study|Withdrawal by Subject|1|||
33572093|NCT04138056|101985902|FG000|Primary Study|Lost to Follow-up|3|||
33572094|NCT04138056|101985903|FG001|Primary Study|Lost to Follow-up|4|||
33572095|NCT04138056|101985904|FG002|Primary Study|Lost to Follow-up|1|||
33572096|NCT04138056|101985905|FG003|Primary Study|Lost to Follow-up|1|||
33572097|NCT04138056|101985906|FG004|Primary Study|Lost to Follow-up|4|||
33572098|NCT04138056|101985902|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
33572099|NCT04138056|101985903|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
33572100|NCT04138056|101985904|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
33572101|NCT04138056|101985905|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
33572102|NCT04138056|101985906|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
33572103|NCT04138056|101985902|FG000|Extension Study|Lost to Follow-up|1|||
33572104|NCT04138056|101985903|FG001|Extension Study|Lost to Follow-up|2|||
33572105|NCT04138056|101985904|FG002|Extension Study|Lost to Follow-up|1|||
33572106|NCT04138056|101985905|FG003|Extension Study|Lost to Follow-up|0|||
33572107|NCT04138056|101985906|FG004|Extension Study|Lost to Follow-up|1|||
33572108|NCT00560417|101985909|FG000|Overall Study|Adverse Event|3|||
33572109|NCT00560417|101985910|FG001|Overall Study|Adverse Event|2|||
33572110|NCT00560417|101985909|FG000|Overall Study|Entry Criteria Not Met|1|||
33572111|NCT00560417|101985910|FG001|Overall Study|Entry Criteria Not Met|0|||
33572112|NCT00560417|101985909|FG000|Overall Study|Lost to Follow-up|0|||
33572113|NCT00560417|101985910|FG001|Overall Study|Lost to Follow-up|1|||
33572114|NCT00560417|101985909|FG000|Overall Study|Physician Decision|2|||
33572115|NCT00560417|101985910|FG001|Overall Study|Physician Decision|6|||
33572116|NCT00560417|101985909|FG000|Overall Study|Protocol Violation|6|||
33572117|NCT00560417|101985910|FG001|Overall Study|Protocol Violation|5|||
33229033|NCT03893825|100739288|FG000|Overall Study|Protocol deviation|1|||
33229034|NCT03893825|100739289|FG001|Overall Study|Protocol deviation|0|||
33367119|NCT00651118|101230206|FG003|Overall Study|Adverse Event|1|||
33229035|NCT03893825|100739288|FG000|Overall Study|Lost to Follow-up|10|||
33572118|NCT00560417|101985909|FG000|Overall Study|Sponsor Decision|2|||
33572119|NCT00560417|101985910|FG001|Overall Study|Sponsor Decision|0|||
33572120|NCT00560417|101985909|FG000|Overall Study|Withdrawal by Subject|3|||
33572121|NCT00560417|101985910|FG001|Overall Study|Withdrawal by Subject|3|||
33572122|NCT04484857|101985912|FG000|Overall Study|Adverse Event|2|||
33572123|NCT04484857|101985912|FG000|Overall Study|Death|10|||
33572124|NCT04484857|101985912|FG000|Overall Study|Withdrawal by Subject|3|||
33572125|NCT04484857|101985912|FG000|Overall Study|Transferred/Relocation|5|||
33572126|NCT04484857|101985912|FG000|Overall Study|Kidney Transplant|7|||
33572127|NCT04484857|101985912|FG000|Overall Study|Other than specified|4|||
33572128|NCT04484857|101985912|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
33572129|NCT03605693|101985917|FG000|Overall Study|Lost to Follow-up|4|||
33572130|NCT03605693|101985918|FG001|Overall Study|Lost to Follow-up|0|||
33572131|NCT03605693|101985917|FG000|Overall Study|Physician Decision|1|||
33572132|NCT03605693|101985918|FG001|Overall Study|Physician Decision|0|||
33572133|NCT03502681|101985919|FG000|Overall Study|Adverse Event|1|||
33572134|NCT03502681|101985920|FG001|Overall Study|Adverse Event|1|||
33572135|NCT03502681|101985919|FG000|Overall Study|Disease Progression|2|||
33572136|NCT03502681|101985920|FG001|Overall Study|Disease Progression|1|||
33572137|NCT01083602|101985921|FG000|Overall Study|Adverse Event|11|||
33572138|NCT01083602|101985921|FG000|Overall Study|New Cancer Therapy|2|||
33572139|NCT01083602|101985921|FG000|Overall Study|Death|1|||
33572140|NCT01083602|101985921|FG000|Overall Study|Withdrawal by Subject|5|||
33572141|NCT01083602|101985921|FG000|Overall Study|Lack of Efficacy|36|||
33572142|NCT01307449|101985924|FG000|Overall Study|Adverse Event|1|||
33572143|NCT01307449|101985925|FG001|Overall Study|Adverse Event|0|||
33572144|NCT01307449|101985926|FG002|Overall Study|Adverse Event|0|||
33572145|NCT01307449|101985927|FG003|Overall Study|Adverse Event|0|||
33572146|NCT00744861|101985929|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
33572147|NCT00744861|101985930|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
33572148|NCT00744861|101985931|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
33572149|NCT00744861|101985932|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
33572150|NCT00744861|101985929|FG000|Feasibility Stage 1|Pregnancy|0|||
33572151|NCT00744861|101985930|FG001|Feasibility Stage 1|Pregnancy|1|||
33572152|NCT00744861|101985931|FG002|Feasibility Stage 1|Pregnancy|0|||
33572153|NCT00744861|101985932|FG003|Feasibility Stage 1|Pregnancy|0|||
33572154|NCT00744861|101985929|FG000|Pivotal Stage 2|Adverse Event|0|||
33572155|NCT00744861|101985930|FG001|Pivotal Stage 2|Adverse Event|0|||
33572156|NCT00744861|101985931|FG002|Pivotal Stage 2|Adverse Event|6|||
33572157|NCT00744861|101985932|FG003|Pivotal Stage 2|Adverse Event|11|||
33572158|NCT00744861|101985929|FG000|Pivotal Stage 2|Death|0|||
33572159|NCT00744861|101985930|FG001|Pivotal Stage 2|Death|0|||
33572160|NCT00744861|101985931|FG002|Pivotal Stage 2|Death|0|||
33572161|NCT00744861|101985932|FG003|Pivotal Stage 2|Death|1|||
33572162|NCT00744861|101985929|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
33572163|NCT00744861|101985930|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
33229036|NCT03893825|100739289|FG001|Overall Study|Lost to Follow-up|10|||
33229037|NCT03893825|100739288|FG000|Overall Study|Other than specified|7|||
33229038|NCT03893825|100739289|FG001|Overall Study|Other than specified|6|||
33229039|NCT02247804|100739290|FG000|Treatment Period 1|Adverse Event|9|||
33229040|NCT02247804|100739291|FG001|Treatment Period 1|Adverse Event|2|||
33419006|NCT01563029|101425622|FG000|Overall Study|Protocol Violation|1|||
33572164|NCT00744861|101985931|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
33572165|NCT00744861|101985932|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
33572166|NCT00744861|101985929|FG000|Pivotal Stage 2|Physician Decision|0|||
33572167|NCT00744861|101985930|FG001|Pivotal Stage 2|Physician Decision|0|||
33572168|NCT00744861|101985931|FG002|Pivotal Stage 2|Physician Decision|3|||
33572169|NCT00744861|101985932|FG003|Pivotal Stage 2|Physician Decision|1|||
33572170|NCT00744861|101985929|FG000|Pivotal Stage 2|Protocol Violation|0|||
33229041|NCT02247804|100739292|FG002|Treatment Period 1|Adverse Event|0|||
33572171|NCT00744861|101985930|FG001|Pivotal Stage 2|Protocol Violation|0|||
33572172|NCT00744861|101985931|FG002|Pivotal Stage 2|Protocol Violation|0|||
33572173|NCT00744861|101985932|FG003|Pivotal Stage 2|Protocol Violation|1|||
33229042|NCT02247804|100739290|FG000|Treatment Period 1|Lack of Efficacy|0|||
33229043|NCT02247804|100739291|FG001|Treatment Period 1|Lack of Efficacy|0|||
33229044|NCT02247804|100739292|FG002|Treatment Period 1|Lack of Efficacy|2|||
33229045|NCT02247804|100739290|FG000|Treatment Period 1|Lost to Follow-up|1|||
33229046|NCT02247804|100739291|FG001|Treatment Period 1|Lost to Follow-up|0|||
33229047|NCT02247804|100739292|FG002|Treatment Period 1|Lost to Follow-up|2|||
33229048|NCT02247804|100739290|FG000|Treatment Period 1|Personal Reasons|7|||
33229049|NCT02247804|100739291|FG001|Treatment Period 1|Personal Reasons|1|||
33229050|NCT02247804|100739292|FG002|Treatment Period 1|Personal Reasons|2|||
33229051|NCT02247804|100739290|FG000|Treatment Period 1|Protocol Deviation|0|||
33229052|NCT02247804|100739291|FG001|Treatment Period 1|Protocol Deviation|0|||
33229053|NCT02247804|100739292|FG002|Treatment Period 1|Protocol Deviation|1|||
33229054|NCT02247804|100739290|FG000|Treatment Period 1|Randomized but not Treated|5|||
33229055|NCT02247804|100739291|FG001|Treatment Period 1|Randomized but not Treated|1|||
33229056|NCT02247804|100739292|FG002|Treatment Period 1|Randomized but not Treated|1|||
33229057|NCT02247804|100739290|FG000|Treatment Period 2|Adverse Event|6|||
33229058|NCT02247804|100739291|FG001|Treatment Period 2|Adverse Event|3|||
33229059|NCT02247804|100739292|FG002|Treatment Period 2|Adverse Event|3|||
33634499|NCT02113982|102214588|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
33634500|NCT02113982|102214589|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
33634501|NCT02113982|102214590|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
33634502|NCT02113982|102214591|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
33229060|NCT02247804|100739290|FG000|Treatment Period 2|Lack of Efficacy|0|||
33229061|NCT02247804|100739291|FG001|Treatment Period 2|Lack of Efficacy|0|||
33229062|NCT02247804|100739292|FG002|Treatment Period 2|Lack of Efficacy|1|||
33229063|NCT02247804|100739290|FG000|Treatment Period 2|Lost to Follow-up|0|||
33229064|NCT02247804|100739291|FG001|Treatment Period 2|Lost to Follow-up|1|||
33229065|NCT02247804|100739292|FG002|Treatment Period 2|Lost to Follow-up|1|||
33229066|NCT02247804|100739290|FG000|Treatment Period 2|Personal Reasons|2|||
33229067|NCT02247804|100739291|FG001|Treatment Period 2|Personal Reasons|1|||
33229068|NCT02247804|100739292|FG002|Treatment Period 2|Personal Reasons|1|||
33229069|NCT02247804|100739290|FG000|Treatment Period 2|Reason not Specified|0|||
33229070|NCT02247804|100739291|FG001|Treatment Period 2|Reason not Specified|0|||
33229071|NCT02247804|100739292|FG002|Treatment Period 2|Reason not Specified|2|||
33229072|NCT02247804|100739290|FG000|Treatment Period 3|Adverse Event|4|||
33229073|NCT02247804|100739291|FG001|Treatment Period 3|Adverse Event|3|||
33229074|NCT02247804|100739292|FG002|Treatment Period 3|Adverse Event|3|||
33229075|NCT02247804|100739290|FG000|Treatment Period 3|Lack of Efficacy|0|||
33229076|NCT02247804|100739291|FG001|Treatment Period 3|Lack of Efficacy|1|||
33229077|NCT02247804|100739292|FG002|Treatment Period 3|Lack of Efficacy|0|||
33229078|NCT02247804|100739290|FG000|Treatment Period 3|Lost to Follow-up|1|||
33229079|NCT02247804|100739291|FG001|Treatment Period 3|Lost to Follow-up|2|||
33229080|NCT02247804|100739292|FG002|Treatment Period 3|Lost to Follow-up|2|||
33229081|NCT02247804|100739290|FG000|Treatment Period 3|Personal Reasons|4|||
33229082|NCT02247804|100739291|FG001|Treatment Period 3|Personal Reasons|3|||
33229083|NCT02247804|100739292|FG002|Treatment Period 3|Personal Reasons|2|||
33229084|NCT02247804|100739290|FG000|Treatment Period 3|Reason not Specified|2|||
33229085|NCT02247804|100739291|FG001|Treatment Period 3|Reason not Specified|1|||
33229086|NCT02247804|100739292|FG002|Treatment Period 3|Reason not Specified|3|||
33229087|NCT01348776|100739293|FG000|Overall Study|Lost to Follow-up|3|||
33229088|NCT00147225|100739294|FG000|Overall Study|Withdrawal by Subject|1|||
33229089|NCT00147225|100739295|FG001|Overall Study|Withdrawal by Subject|0|||
33229090|NCT00147225|100739296|FG002|Overall Study|Withdrawal by Subject|1|||
33229091|NCT00147225|100739297|FG003|Overall Study|Withdrawal by Subject|0|||
33229092|NCT00147225|100739298|FG004|Overall Study|Withdrawal by Subject|0|||
33229093|NCT00147225|100739299|FG005|Overall Study|Withdrawal by Subject|1|||
33229094|NCT00147225|100739294|FG000|Overall Study|Adverse Event|0|||
33229095|NCT00147225|100739295|FG001|Overall Study|Adverse Event|0|||
33229096|NCT00147225|100739296|FG002|Overall Study|Adverse Event|1|||
33229097|NCT00147225|100739297|FG003|Overall Study|Adverse Event|1|||
33229098|NCT00147225|100739298|FG004|Overall Study|Adverse Event|0|||
33229099|NCT00147225|100739299|FG005|Overall Study|Adverse Event|0|||
33229100|NCT00147225|100739294|FG000|Overall Study|Screen Failure|0|||
33229101|NCT00147225|100739295|FG001|Overall Study|Screen Failure|0|||
33229102|NCT00147225|100739296|FG002|Overall Study|Screen Failure|0|||
33229103|NCT00147225|100739297|FG003|Overall Study|Screen Failure|0|||
33229104|NCT00147225|100739298|FG004|Overall Study|Screen Failure|1|||
33229105|NCT00147225|100739299|FG005|Overall Study|Screen Failure|0|||
33229106|NCT00147225|100739294|FG000|Overall Study|Chemotherapy Changed|0|||
33634503|NCT02113982|102214592|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
33634504|NCT02113982|102214593|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
33634505|NCT02113982|102214594|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
33229107|NCT00147225|100739295|FG001|Overall Study|Chemotherapy Changed|0|||
33229108|NCT00147225|100739296|FG002|Overall Study|Chemotherapy Changed|0|||
33229109|NCT00147225|100739297|FG003|Overall Study|Chemotherapy Changed|0|||
33634506|NCT02113982|102214595|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
33634507|NCT02113982|102214596|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
33229110|NCT00147225|100739298|FG004|Overall Study|Chemotherapy Changed|0|||
33229111|NCT00147225|100739299|FG005|Overall Study|Chemotherapy Changed|1|||
33229112|NCT02593305|100739300|FG000|Post 1|Comparison only group. No intervention.|0|||
33229113|NCT02593305|100739301|FG001|Post 1|Comparison only group. No intervention.|0|||
33229114|NCT02593305|100739302|FG002|Post 1|Comparison only group. No intervention.|10|||
33229115|NCT03661996|100739311|FG000|Overall Study|Adverse Event|0|||
33229116|NCT03661996|100739312|FG001|Overall Study|Adverse Event|0|||
33229117|NCT03661996|100739313|FG002|Overall Study|Adverse Event|1|||
33229118|NCT03661996|100739314|FG003|Overall Study|Adverse Event|1|||
33229119|NCT03661996|100739315|FG004|Overall Study|Adverse Event|0|||
33229120|NCT03661996|100739311|FG000|Overall Study|Lost to Follow-up|5|||
33229121|NCT03661996|100739312|FG001|Overall Study|Lost to Follow-up|1|||
33229122|NCT03661996|100739313|FG002|Overall Study|Lost to Follow-up|2|||
33229123|NCT03661996|100739314|FG003|Overall Study|Lost to Follow-up|2|||
33229124|NCT03661996|100739315|FG004|Overall Study|Lost to Follow-up|6|||
33229125|NCT03661996|100739311|FG000|Overall Study|Physician Decision|1|||
33229126|NCT03661996|100739312|FG001|Overall Study|Physician Decision|1|||
33229127|NCT03661996|100739313|FG002|Overall Study|Physician Decision|1|||
33229128|NCT03661996|100739314|FG003|Overall Study|Physician Decision|2|||
33229129|NCT03661996|100739315|FG004|Overall Study|Physician Decision|0|||
33229130|NCT03661996|100739311|FG000|Overall Study|Protocol Violation|0|||
33229131|NCT03661996|100739312|FG001|Overall Study|Protocol Violation|0|||
33229132|NCT03661996|100739313|FG002|Overall Study|Protocol Violation|0|||
33229133|NCT03661996|100739314|FG003|Overall Study|Protocol Violation|0|||
33229134|NCT03661996|100739315|FG004|Overall Study|Protocol Violation|1|||
33229135|NCT03661996|100739311|FG000|Overall Study|Withdrawal by Subject|3|||
33229136|NCT03661996|100739312|FG001|Overall Study|Withdrawal by Subject|5|||
33229137|NCT03661996|100739313|FG002|Overall Study|Withdrawal by Subject|1|||
33229138|NCT03661996|100739314|FG003|Overall Study|Withdrawal by Subject|7|||
33229139|NCT03661996|100739315|FG004|Overall Study|Withdrawal by Subject|7|||
33229140|NCT03661996|100739311|FG000|Overall Study|Sponsors Decision|2|||
33229141|NCT03661996|100739312|FG001|Overall Study|Sponsors Decision|0|||
33229142|NCT03661996|100739313|FG002|Overall Study|Sponsors Decision|0|||
33419007|NCT01563029|101425623|FG001|Overall Study|Protocol Violation|2|||
33634508|NCT02113982|102214583|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
33229143|NCT03661996|100739314|FG003|Overall Study|Sponsors Decision|0|||
33229144|NCT03661996|100739315|FG004|Overall Study|Sponsors Decision|0|||
33229145|NCT03661996|100739311|FG000|Overall Study|Other|1|||
33229146|NCT03661996|100739312|FG001|Overall Study|Other|1|||
33229147|NCT03661996|100739313|FG002|Overall Study|Other|1|||
33229148|NCT03661996|100739314|FG003|Overall Study|Other|1|||
33229149|NCT03661996|100739315|FG004|Overall Study|Other|0|||
33229150|NCT02638623|100739316|FG000|Overall Study|Surgery timing|5|||
33229151|NCT02638623|100739317|FG001|Overall Study|Surgery timing|6|||
33229152|NCT02638623|100739316|FG000|Overall Study|Not given intervention|2|||
33229153|NCT02638623|100739317|FG001|Overall Study|Not given intervention|0|||
33229154|NCT00383240|100739318|FG000|Overall Study|Adverse Event|4|||
33229155|NCT00383240|100739319|FG001|Overall Study|Adverse Event|6|||
33229156|NCT00383240|100739320|FG002|Overall Study|Adverse Event|9|||
33572174|NCT00744861|101985929|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
33572175|NCT00744861|101985930|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
33572176|NCT00744861|101985931|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
33572177|NCT00744861|101985932|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
33572178|NCT00744861|101985929|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
33572179|NCT00744861|101985930|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
33572180|NCT00744861|101985931|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
33572181|NCT00744861|101985932|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
33572182|NCT02254291|101985933|FG000|Overall Study|Withdrawal by Subject|0|||
33572183|NCT02254291|101985934|FG001|Overall Study|Withdrawal by Subject|3|||
33572184|NCT02254291|101985935|FG002|Overall Study|Withdrawal by Subject|1|||
33572185|NCT02254291|101985933|FG000|Overall Study|Missing follow-up information|0|||
33572186|NCT02254291|101985934|FG001|Overall Study|Missing follow-up information|0|||
33572187|NCT02254291|101985935|FG002|Overall Study|Missing follow-up information|1|||
33572188|NCT01876381|101985938|FG000|Overall Study|Lack of Efficacy|5|||
33572189|NCT01876381|101985938|FG000|Overall Study|Physician Decision|1|||
33572190|NCT01876381|101985938|FG000|Overall Study|Withdrawal by Subject|1|||
33572191|NCT02441218|101985940|FG000|Overall Study|Death|503|||
33572192|NCT02441218|101985941|FG001|Overall Study|Death|553|||
33572193|NCT02441218|101985940|FG000|Overall Study|Withdrawal by Subject|73|||
33572194|NCT02441218|101985941|FG001|Overall Study|Withdrawal by Subject|58|||
33572195|NCT02441218|101985940|FG000|Overall Study|Lost to Follow-up|2|||
33572196|NCT02441218|101985941|FG001|Overall Study|Lost to Follow-up|1|||
33572197|NCT01444781|101985954|FG000|Overall Study|Lost to Follow-up|0|||
33572198|NCT01444781|101985955|FG001|Overall Study|Lost to Follow-up|3|||
33572199|NCT01444781|101985956|FG002|Overall Study|Lost to Follow-up|1|||
33229157|NCT00383240|100739321|FG003|Overall Study|Adverse Event|7|||
33229158|NCT00383240|100739318|FG000|Overall Study|Treatment Failure|8|||
33229159|NCT00383240|100739319|FG001|Overall Study|Treatment Failure|13|||
33229160|NCT00383240|100739320|FG002|Overall Study|Treatment Failure|47|||
33367120|NCT00651118|101230203|FG000|Overall Study|Protocol Violation|2|||
33229161|NCT00383240|100739321|FG003|Overall Study|Treatment Failure|46|||
33572200|NCT01444781|101985954|FG000|Overall Study|Withdrawal by Subject|3|||
33572201|NCT01444781|101985955|FG001|Overall Study|Withdrawal by Subject|1|||
33572202|NCT01444781|101985956|FG002|Overall Study|Withdrawal by Subject|2|||
33634509|NCT02113982|102214584|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
33634510|NCT02113982|102214585|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
33367121|NCT00651118|101230204|FG001|Overall Study|Protocol Violation|2|||
33572203|NCT02629861|101985961|FG000|Overall Study|Adverse Event|7|||
33572204|NCT02629861|101985962|FG001|Overall Study|Adverse Event|5|||
33572205|NCT02629861|101985963|FG002|Overall Study|Adverse Event|4|||
33572206|NCT02629861|101985961|FG000|Overall Study|Withdrawal by Subject|5|||
33572207|NCT02629861|101985962|FG001|Overall Study|Withdrawal by Subject|8|||
33572208|NCT02629861|101985963|FG002|Overall Study|Withdrawal by Subject|13|||
33572209|NCT02629861|101985961|FG000|Overall Study|Protocol Violation|2|||
33572210|NCT02629861|101985962|FG001|Overall Study|Protocol Violation|3|||
33634511|NCT02113982|102214586|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
33634512|NCT02113982|102214587|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
33367122|NCT00651118|101230205|FG002|Overall Study|Protocol Violation|6|||
33367123|NCT00651118|101230206|FG003|Overall Study|Protocol Violation|2|||
33367124|NCT00651118|101230203|FG000|Overall Study|Lost to Follow-up|2|||
33367125|NCT00651118|101230204|FG001|Overall Study|Lost to Follow-up|0|||
33367126|NCT00651118|101230205|FG002|Overall Study|Lost to Follow-up|1|||
33367127|NCT00651118|101230206|FG003|Overall Study|Lost to Follow-up|2|||
33367128|NCT00651118|101230203|FG000|Overall Study|administrative|1|||
33367129|NCT00651118|101230204|FG001|Overall Study|administrative|4|||
33367130|NCT00651118|101230205|FG002|Overall Study|administrative|2|||
33367131|NCT00651118|101230206|FG003|Overall Study|administrative|1|||
33367132|NCT00651118|101230203|FG000|Overall Study|Withdrawal by Subject|0|||
33367133|NCT00651118|101230204|FG001|Overall Study|Withdrawal by Subject|1|||
33367134|NCT00651118|101230205|FG002|Overall Study|Withdrawal by Subject|1|||
33634513|NCT02113982|102214588|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
33634514|NCT02113982|102214589|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
33634515|NCT02113982|102214590|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
33634516|NCT02113982|102214591|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
33634517|NCT02113982|102214592|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
33634518|NCT02113982|102214593|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
33634519|NCT02113982|102214594|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
33634520|NCT02113982|102214595|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
33634521|NCT02113982|102214596|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
33634522|NCT02113982|102214583|FG000|Stage 2: Cohort Expansion|Transplant|0|||
33634523|NCT02113982|102214584|FG001|Stage 2: Cohort Expansion|Transplant|0|||
33634524|NCT02113982|102214585|FG002|Stage 2: Cohort Expansion|Transplant|0|||
33634525|NCT02113982|102214586|FG003|Stage 2: Cohort Expansion|Transplant|0|||
33634526|NCT02113982|102214587|FG004|Stage 2: Cohort Expansion|Transplant|0|||
33634527|NCT02113982|102214588|FG005|Stage 2: Cohort Expansion|Transplant|0|||
33634528|NCT02113982|102214589|FG006|Stage 2: Cohort Expansion|Transplant|0|||
33367135|NCT00651118|101230206|FG003|Overall Study|Withdrawal by Subject|1|||
33367136|NCT00069095|101230207|FG000|Primary Treatment Phase|Ongoing|0|||
33367137|NCT00069095|101230208|FG001|Primary Treatment Phase|Ongoing|0|||
33367138|NCT00069095|101230209|FG002|Primary Treatment Phase|Ongoing|5|||
33367139|NCT00069095|101230210|FG003|Primary Treatment Phase|Ongoing|7|||
33634529|NCT02113982|102214590|FG007|Stage 2: Cohort Expansion|Transplant|0|||
33634530|NCT02113982|102214591|FG008|Stage 2: Cohort Expansion|Transplant|0|||
33634531|NCT02113982|102214592|FG009|Stage 2: Cohort Expansion|Transplant|4|||
33229162|NCT00383240|100739318|FG000|Overall Study|Lost to Follow-up|3|||
33367140|NCT00069095|101230211|FG004|Primary Treatment Phase|Ongoing|7|||
33634532|NCT02113982|102214593|FG010|Stage 2: Cohort Expansion|Transplant|2|||
33367141|NCT00069095|101230212|FG005|Primary Treatment Phase|Ongoing|4|||
33367142|NCT00069095|101230207|FG000|Primary Treatment Phase|Admin/Other|29|||
33367143|NCT00069095|101230208|FG001|Primary Treatment Phase|Admin/Other|38|||
33367144|NCT00069095|101230209|FG002|Primary Treatment Phase|Admin/Other|31|||
33367145|NCT00069095|101230210|FG003|Primary Treatment Phase|Admin/Other|45|||
33572211|NCT02629861|101985963|FG002|Overall Study|Protocol Violation|7|||
33572212|NCT02629861|101985961|FG000|Overall Study|Lost to Follow-up|12|||
33634533|NCT02113982|102214594|FG011|Stage 2: Cohort Expansion|Transplant|0|||
33229163|NCT00383240|100739319|FG001|Overall Study|Lost to Follow-up|0|||
33229164|NCT00383240|100739320|FG002|Overall Study|Lost to Follow-up|0|||
33229165|NCT00383240|100739321|FG003|Overall Study|Lost to Follow-up|2|||
33229166|NCT00383240|100739318|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
33229167|NCT00383240|100739319|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
33229168|NCT00383240|100739320|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
33229169|NCT00383240|100739321|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
33229170|NCT00383240|100739318|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
33229171|NCT00383240|100739319|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
33229172|NCT00383240|100739320|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
33229173|NCT00383240|100739321|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
33229174|NCT00383240|100739318|FG000|Overall Study|Protocol Violation|4|||
33572213|NCT02629861|101985962|FG001|Overall Study|Lost to Follow-up|9|||
33572214|NCT02629861|101985963|FG002|Overall Study|Lost to Follow-up|4|||
33229175|NCT00383240|100739319|FG001|Overall Study|Protocol Violation|5|||
33229176|NCT00383240|100739320|FG002|Overall Study|Protocol Violation|9|||
33229177|NCT00383240|100739321|FG003|Overall Study|Protocol Violation|6|||
33229178|NCT00383240|100739318|FG000|Overall Study|Did not meet protocol eligibility|9|||
33229179|NCT00383240|100739319|FG001|Overall Study|Did not meet protocol eligibility|4|||
33229180|NCT00383240|100739320|FG002|Overall Study|Did not meet protocol eligibility|9|||
33229181|NCT00383240|100739321|FG003|Overall Study|Did not meet protocol eligibility|3|||
33229182|NCT00383240|100739318|FG000|Overall Study|Administrative|1|||
33229183|NCT00383240|100739319|FG001|Overall Study|Administrative|1|||
33229184|NCT00383240|100739320|FG002|Overall Study|Administrative|0|||
33229185|NCT00383240|100739321|FG003|Overall Study|Administrative|0|||
33229186|NCT01112514|100739323|FG000|Overall Study|Lost to Follow-up|1|||
33229187|NCT01671748|100739329|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
33229188|NCT01671748|100739330|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
33229189|NCT01671748|100739329|FG000|4 Week run-in Phase|Adverse Event|1|||
33229190|NCT01671748|100739330|FG001|4 Week run-in Phase|Adverse Event|0|||
33229191|NCT01671748|100739329|FG000|4 Week run-in Phase|Not eligible|9|||
33229192|NCT01671748|100739330|FG001|4 Week run-in Phase|Not eligible|0|||
33572215|NCT02629861|101985961|FG000|Overall Study|Other|1|||
33572216|NCT02629861|101985962|FG001|Overall Study|Other|1|||
33572217|NCT02629861|101985963|FG002|Overall Study|Other|0|||
33572218|NCT02629861|101985961|FG000|Overall Study|Pregnancy|2|||
33572219|NCT02629861|101985962|FG001|Overall Study|Pregnancy|1|||
33572220|NCT02629861|101985963|FG002|Overall Study|Pregnancy|0|||
33572221|NCT01373281|101985966|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
33572222|NCT01373281|101985967|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
33229193|NCT02058290|100739341|FG000|Overall Study|Protocol Violation|2|||
33229194|NCT02058290|100739342|FG001|Overall Study|Protocol Violation|1|||
33229195|NCT02058290|100739341|FG000|Overall Study|Physician Decision|1|||
33229196|NCT02058290|100739342|FG001|Overall Study|Physician Decision|0|||
33229197|NCT02058290|100739341|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
33229198|NCT02058290|100739342|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
33229199|NCT02058290|100739341|FG000|Overall Study|Withdrawal by Subject|0|||
33229200|NCT02058290|100739342|FG001|Overall Study|Withdrawal by Subject|1|||
33229201|NCT00539643|100739343|FG000|Overall Study|Adverse Event|1|||
33229202|NCT00539643|100739344|FG001|Overall Study|Adverse Event|0|||
33229203|NCT00539643|100739343|FG000|Overall Study|Death|2|||
33229204|NCT00539643|100739344|FG001|Overall Study|Death|1|||
33229205|NCT00539643|100739343|FG000|Overall Study|Physician Decision|3|||
33229206|NCT00539643|100739344|FG001|Overall Study|Physician Decision|1|||
33229207|NCT00539643|100739343|FG000|Overall Study|Withdrawal by Subject|0|||
33229208|NCT00539643|100739344|FG001|Overall Study|Withdrawal by Subject|1|||
33229209|NCT03857841|100739350|FG000|Overall Study|Death|1|||
33229210|NCT03857841|100739351|FG001|Overall Study|Death|0|||
33229211|NCT03857841|100739352|FG002|Overall Study|Death|0|||
33229212|NCT03857841|100739353|FG003|Overall Study|Death|0|||
33229213|NCT03857841|100739350|FG000|Overall Study|Study Terminated by Sponsor|1|||
33229214|NCT03857841|100739351|FG001|Overall Study|Study Terminated by Sponsor|0|||
33229215|NCT03857841|100739352|FG002|Overall Study|Study Terminated by Sponsor|0|||
33229216|NCT03857841|100739353|FG003|Overall Study|Study Terminated by Sponsor|0|||
33572223|NCT01373281|101985966|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
33572224|NCT01373281|101985967|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
33634534|NCT02113982|102214595|FG012|Stage 2: Cohort Expansion|Transplant|0|||
33634535|NCT02113982|102214596|FG013|Stage 2: Cohort Expansion|Transplant|0|||
33229217|NCT02440594|100739356|FG000|Overall Study|Lost to Follow-up|34|||
33229218|NCT02440594|100739357|FG001|Overall Study|Lost to Follow-up|33|||
33229219|NCT02440594|100739358|FG002|Overall Study|Lost to Follow-up|54|||
33229220|NCT02440594|100739359|FG003|Overall Study|Lost to Follow-up|47|||
33229221|NCT02440594|100739360|FG004|Overall Study|Lost to Follow-up|5|||
33229222|NCT02440594|100739361|FG005|Overall Study|Lost to Follow-up|4|||
33229223|NCT02440594|100739362|FG006|Overall Study|Lost to Follow-up|28|||
33229224|NCT02440594|100739363|FG007|Overall Study|Lost to Follow-up|48|||
33229225|NCT02440594|100739356|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
33229226|NCT02440594|100739357|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
33229227|NCT02440594|100739358|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
33229228|NCT02440594|100739359|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
33229229|NCT02440594|100739360|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
33229230|NCT02440594|100739361|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
33229231|NCT02440594|100739362|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
33229232|NCT02440594|100739363|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
33229233|NCT02440594|100739356|FG000|Overall Study|Withdrawal by Subject|81|||
33229234|NCT02440594|100739357|FG001|Overall Study|Withdrawal by Subject|67|||
33229235|NCT02440594|100739358|FG002|Overall Study|Withdrawal by Subject|59|||
33229236|NCT02440594|100739359|FG003|Overall Study|Withdrawal by Subject|38|||
33229237|NCT02440594|100739360|FG004|Overall Study|Withdrawal by Subject|2|||
33229238|NCT02440594|100739361|FG005|Overall Study|Withdrawal by Subject|2|||
33229239|NCT02440594|100739362|FG006|Overall Study|Withdrawal by Subject|7|||
33229240|NCT02440594|100739363|FG007|Overall Study|Withdrawal by Subject|7|||
33229241|NCT02440594|100739356|FG000|Overall Study|Administratively w/drawn|3|||
33229242|NCT02440594|100739357|FG001|Overall Study|Administratively w/drawn|2|||
33229243|NCT02440594|100739358|FG002|Overall Study|Administratively w/drawn|0|||
33229244|NCT02440594|100739359|FG003|Overall Study|Administratively w/drawn|0|||
33229245|NCT02440594|100739360|FG004|Overall Study|Administratively w/drawn|0|||
33229246|NCT02440594|100739361|FG005|Overall Study|Administratively w/drawn|0|||
33634536|NCT02113982|102214583|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
33634537|NCT02113982|102214584|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
33634538|NCT02113982|102214585|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
33634539|NCT02113982|102214586|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
33634540|NCT02113982|102214587|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
33634541|NCT02113982|102214588|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
33634542|NCT02113982|102214589|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
33634543|NCT02113982|102214590|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
33229247|NCT02440594|100739362|FG006|Overall Study|Administratively w/drawn|2|||
33229248|NCT02440594|100739363|FG007|Overall Study|Administratively w/drawn|1|||
33229249|NCT02285595|100739364|FG000|Overall Study|Lost to Follow-up|14|||
33367146|NCT00069095|101230211|FG004|Primary Treatment Phase|Admin/Other|48|||
33634544|NCT02113982|102214591|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
33634545|NCT02113982|102214592|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
33419008|NCT01563029|101425624|FG002|Overall Study|Protocol Violation|3|||
33419009|NCT01563029|101425625|FG003|Overall Study|Protocol Violation|1|||
33419010|NCT01563029|101425626|FG004|Overall Study|Protocol Violation|3|||
33419011|NCT01563029|101425622|FG000|Overall Study|Protocol defined stopping criteria|1|||
33572225|NCT01373281|101985966|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
33634546|NCT02113982|102214593|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
33634547|NCT02113982|102214594|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
33634548|NCT02113982|102214595|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
33634549|NCT02113982|102214596|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
33572226|NCT01373281|101985967|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
33572227|NCT01373281|101985966|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
33572228|NCT01373281|101985967|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
33572229|NCT01373281|101985966|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
33572230|NCT01373281|101985967|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
33572231|NCT01373281|101985966|FG000|Surveillance Expansion Period|Protocol Violation|9|||
33572232|NCT01373281|101985967|FG001|Surveillance Expansion Period|Protocol Violation|1|||
33229250|NCT02285595|100739364|FG000|Overall Study|Withdrawal by Subject|1|||
33367147|NCT00069095|101230212|FG005|Primary Treatment Phase|Admin/Other|42|||
33367148|NCT00069095|101230207|FG000|Primary Treatment Phase|Adverse Event|99|||
33419012|NCT01563029|101425623|FG001|Overall Study|Protocol defined stopping criteria|0|||
33572233|NCT01373281|101985966|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
33572234|NCT01373281|101985967|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
33572235|NCT01373281|101985966|FG000|Surveillance Expansion Period|Serious adverse event|3|||
33572236|NCT01373281|101985967|FG001|Surveillance Expansion Period|Serious adverse event|4|||
33634550|NCT02113982|102214583|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
33229251|NCT02388074|100739365|FG000|Overall Study|Lost in Transit|2|||
33229252|NCT02388074|100739365|FG000|Overall Study|Sample Not Returned|1|||
33229253|NCT02959671|100739366|FG000|Overall Study|Adverse Event|2|||
33229254|NCT02959671|100739366|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
33419013|NCT01563029|101425624|FG002|Overall Study|Protocol defined stopping criteria|0|||
33634551|NCT02113982|102214584|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
33229255|NCT01234649|100739367|FG000|Overall Study|Withdrawal by Subject|32|||
33229256|NCT01234649|100739368|FG001|Overall Study|Withdrawal by Subject|26|||
33229257|NCT01234649|100739367|FG000|Overall Study|Pregnancy|6|||
33229258|NCT01234649|100739368|FG001|Overall Study|Pregnancy|6|||
33229259|NCT01234649|100739367|FG000|Overall Study|intolerant to side effects|4|||
33229260|NCT01234649|100739368|FG001|Overall Study|intolerant to side effects|3|||
33229261|NCT01234649|100739367|FG000|Overall Study|Allergic reaction|1|||
33229262|NCT01234649|100739368|FG001|Overall Study|Allergic reaction|0|||
33229263|NCT01234649|100739367|FG000|Overall Study|Lack of Efficacy|0|||
33229264|NCT01234649|100739368|FG001|Overall Study|Lack of Efficacy|3|||
33229265|NCT04278417|100739369|FG000|Overall Study|Withdrawal by Subject|13|||
33229266|NCT04278417|100739370|FG001|Overall Study|Withdrawal by Subject|12|||
33229267|NCT04278417|100739369|FG000|Overall Study|Progressive disease|0|||
33229268|NCT04278417|100739370|FG001|Overall Study|Progressive disease|1|||
33229269|NCT04278417|100739369|FG000|Overall Study|Physician Decision|2|||
33229270|NCT04278417|100739370|FG001|Overall Study|Physician Decision|1|||
33229271|NCT04278417|100739369|FG000|Overall Study|Lost to Follow-up|7|||
33229272|NCT04278417|100739370|FG001|Overall Study|Lost to Follow-up|8|||
33229273|NCT04278417|100739369|FG000|Overall Study|Death|6|||
33229274|NCT04278417|100739370|FG001|Overall Study|Death|3|||
33229275|NCT04278417|100739369|FG000|Overall Study|Adverse Event|2|||
33229276|NCT04278417|100739370|FG001|Overall Study|Adverse Event|4|||
33229277|NCT04278417|100739369|FG000|Overall Study|Ongoing, did not complete Week 54|31|||
33229278|NCT04278417|100739370|FG001|Overall Study|Ongoing, did not complete Week 54|27|||
33229279|NCT02307513|100739371|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
33229280|NCT02307513|100739372|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
33229281|NCT02307513|100739371|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
33229282|NCT02307513|100739372|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
33229283|NCT02307513|100739371|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
33229284|NCT02307513|100739372|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
33229285|NCT02307513|100739371|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
33229286|NCT02307513|100739372|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
33229287|NCT02307513|100739371|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
33229288|NCT02307513|100739372|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
33229289|NCT02307513|100739371|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
33229290|NCT02307513|100739372|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
33229291|NCT02307513|100739371|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
33229292|NCT02307513|100739372|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
33229293|NCT02307513|100739371|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
33229294|NCT02307513|100739372|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
33229295|NCT02307513|100739371|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
33229296|NCT02307513|100739372|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
33229297|NCT02307513|100739371|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
33229298|NCT02307513|100739372|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
33229299|NCT02307513|100739371|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
33229300|NCT02307513|100739372|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
33229301|NCT02307513|100739371|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
33229302|NCT02307513|100739372|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
33229303|NCT02307513|100739371|FG000|Long-term Extension|Physician Decision|1|||
33229304|NCT02307513|100739372|FG001|Long-term Extension|Physician Decision|0|||
33229305|NCT00579982|100739373|FG000|Overall Study|Adverse Event|4|||
33229306|NCT00579982|100739373|FG000|Overall Study|Protocol Violation|4|||
33229307|NCT01216293|100739376|FG000|Main Study|Adverse Event|1|||
33229308|NCT01216293|100739377|FG001|Main Study|Adverse Event|4|||
33229309|NCT01216293|100739378|FG002|Main Study|Adverse Event|2|||
33229310|NCT01216293|100739376|FG000|Main Study|Major Protocol Deviation|1|||
33229311|NCT01216293|100739377|FG001|Main Study|Major Protocol Deviation|0|||
33229312|NCT01216293|100739378|FG002|Main Study|Major Protocol Deviation|1|||
33229313|NCT01216293|100739376|FG000|Main Study|Lost to Follow-up|3|||
33229314|NCT01216293|100739377|FG001|Main Study|Lost to Follow-up|1|||
33229315|NCT01216293|100739378|FG002|Main Study|Lost to Follow-up|0|||
33229316|NCT01216293|100739376|FG000|Main Study|Voluntary Withdrawal|2|||
33229317|NCT01216293|100739377|FG001|Main Study|Voluntary Withdrawal|2|||
33229318|NCT01216293|100739378|FG002|Main Study|Voluntary Withdrawal|2|||
33229319|NCT01216293|100739376|FG000|Main Study|Other Reason Not Specified|0|||
33229320|NCT01216293|100739377|FG001|Main Study|Other Reason Not Specified|1|||
33229321|NCT01216293|100739378|FG002|Main Study|Other Reason Not Specified|1|||
33229322|NCT01216293|100739376|FG000|Main Study|Randomized, Not Treated|1|||
33229323|NCT01216293|100739377|FG001|Main Study|Randomized, Not Treated|0|||
33229324|NCT01216293|100739378|FG002|Main Study|Randomized, Not Treated|0|||
33229325|NCT01216293|100739376|FG000|Calcium Absorption Substudy|Adverse Event|0|||
33229326|NCT01216293|100739377|FG001|Calcium Absorption Substudy|Adverse Event|2|||
33229327|NCT01216293|100739378|FG002|Calcium Absorption Substudy|Adverse Event|0|||
33572237|NCT01677988|101985968|FG000|Overall Study|Lack of Efficacy|2|||
33229328|NCT01216293|100739376|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
33229329|NCT01216293|100739377|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
33229330|NCT01216293|100739378|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
33229331|NCT01216293|100739376|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
33229332|NCT01216293|100739377|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
33229333|NCT01216293|100739378|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
33229334|NCT00592319|100739379|FG000|Overall Study|Lost to Follow-up|0|||
33229335|NCT00592319|100739380|FG001|Overall Study|Lost to Follow-up|3|||
33229336|NCT02936037|100739381|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
33229337|NCT02936037|100739382|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
33229338|NCT02936037|100739381|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
33229339|NCT02936037|100739382|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
33229340|NCT02936037|100739381|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
33229341|NCT02936037|100739382|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
33229342|NCT02936037|100739381|FG000|Double-Blind Treatment Period|Death|0|||
33229343|NCT02936037|100739382|FG001|Double-Blind Treatment Period|Death|1|||
33229344|NCT02936037|100739381|FG000|Double-Blind Treatment Period|Adverse Event|11|||
33229345|NCT02936037|100739382|FG001|Double-Blind Treatment Period|Adverse Event|11|||
33229346|NCT02936037|100739381|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
33229347|NCT02936037|100739382|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
33229348|NCT02936037|100739381|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33229349|NCT02936037|100739382|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
33229350|NCT02936037|100739381|FG000|Open Label Extension|Adverse Event|0|||
33229351|NCT02936037|100739382|FG001|Open Label Extension|Adverse Event|3|||
33229352|NCT02936037|100739381|FG000|Open Label Extension|Other|0|||
33229353|NCT02936037|100739382|FG001|Open Label Extension|Other|3|||
33229354|NCT02936037|100739381|FG000|Open Label Extension|Withdrawal by Subject|0|||
33229355|NCT02936037|100739382|FG001|Open Label Extension|Withdrawal by Subject|4|||
33229356|NCT01515189|100739383|FG000|Induction|Disease Progression|109|||
33229357|NCT01515189|100739384|FG001|Induction|Disease Progression|155|||
33367149|NCT00069095|101230208|FG001|Primary Treatment Phase|Adverse Event|92|||
33367150|NCT00069095|101230209|FG002|Primary Treatment Phase|Adverse Event|71|||
33367151|NCT00069095|101230210|FG003|Primary Treatment Phase|Adverse Event|72|||
33367152|NCT00069095|101230211|FG004|Primary Treatment Phase|Adverse Event|109|||
33367153|NCT00069095|101230212|FG005|Primary Treatment Phase|Adverse Event|101|||
33367154|NCT00069095|101230207|FG000|Primary Treatment Phase|Death|14|||
33367155|NCT00069095|101230208|FG001|Primary Treatment Phase|Death|8|||
33367156|NCT00069095|101230209|FG002|Primary Treatment Phase|Death|2|||
33367157|NCT00069095|101230210|FG003|Primary Treatment Phase|Death|5|||
33367158|NCT00069095|101230211|FG004|Primary Treatment Phase|Death|8|||
33367159|NCT00069095|101230212|FG005|Primary Treatment Phase|Death|8|||
33367160|NCT00069095|101230207|FG000|Primary Treatment Phase|Failure to return|5|||
33367161|NCT00069095|101230208|FG001|Primary Treatment Phase|Failure to return|5|||
33367162|NCT00069095|101230209|FG002|Primary Treatment Phase|Failure to return|0|||
33367163|NCT00069095|101230210|FG003|Primary Treatment Phase|Failure to return|0|||
33367164|NCT00069095|101230211|FG004|Primary Treatment Phase|Failure to return|0|||
33367165|NCT00069095|101230212|FG005|Primary Treatment Phase|Failure to return|2|||
33367166|NCT00069095|101230207|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
33367167|NCT00069095|101230208|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
33367168|NCT00069095|101230209|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
33367169|NCT00069095|101230210|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
33367170|NCT00069095|101230211|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
33367171|NCT00069095|101230212|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
33367172|NCT00069095|101230207|FG000|Primary Treatment Phase|Refused treatment|15|||
33367173|NCT00069095|101230208|FG001|Primary Treatment Phase|Refused treatment|26|||
33367174|NCT00069095|101230209|FG002|Primary Treatment Phase|Refused treatment|17|||
33367175|NCT00069095|101230210|FG003|Primary Treatment Phase|Refused treatment|31|||
33367176|NCT00069095|101230211|FG004|Primary Treatment Phase|Refused treatment|24|||
33367177|NCT00069095|101230212|FG005|Primary Treatment Phase|Refused treatment|27|||
33367178|NCT00069095|101230207|FG000|Primary Treatment Phase|Withdrew|2|||
33367179|NCT00069095|101230208|FG001|Primary Treatment Phase|Withdrew|3|||
33367180|NCT00069095|101230209|FG002|Primary Treatment Phase|Withdrew|8|||
33367181|NCT00069095|101230210|FG003|Primary Treatment Phase|Withdrew|2|||
33229358|NCT01515189|100739383|FG000|Induction|Study drug toxicity|86|||
33229359|NCT01515189|100739384|FG001|Induction|Study drug toxicity|36|||
33229360|NCT01515189|100739383|FG000|Induction|Death|24|||
33229361|NCT01515189|100739384|FG001|Induction|Death|17|||
33229362|NCT01515189|100739383|FG000|Induction|Adverse Event|14|||
33229363|NCT01515189|100739384|FG001|Induction|Adverse Event|9|||
33229364|NCT01515189|100739383|FG000|Induction|Withdrawal by Subject|3|||
33229365|NCT01515189|100739384|FG001|Induction|Withdrawal by Subject|9|||
33367182|NCT00069095|101230211|FG004|Primary Treatment Phase|Withdrew|4|||
33367183|NCT00069095|101230212|FG005|Primary Treatment Phase|Withdrew|9|||
33367184|NCT00069095|101230207|FG000|Primary Treatment Phase|Other Violation|0|||
33367185|NCT00069095|101230208|FG001|Primary Treatment Phase|Other Violation|1|||
33229366|NCT01515189|100739383|FG000|Induction|No longer meets study criteria|0|||
33229367|NCT01515189|100739384|FG001|Induction|No longer meets study criteria|2|||
33229368|NCT01515189|100739383|FG000|Induction|Lost to Follow-up|1|||
33229369|NCT01515189|100739384|FG001|Induction|Lost to Follow-up|0|||
33229370|NCT01515189|100739383|FG000|Induction|Other|0|||
33229371|NCT01515189|100739384|FG001|Induction|Other|4|||
33229372|NCT01515189|100739383|FG000|First Re-Induction Phase|Disease progression|6|||
33229373|NCT01515189|100739384|FG001|First Re-Induction Phase|Disease progression|14|||
33229374|NCT01515189|100739383|FG000|First Re-Induction Phase|Study drug toxicity|5|||
33229375|NCT01515189|100739384|FG001|First Re-Induction Phase|Study drug toxicity|0|||
33229376|NCT01515189|100739383|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
33229377|NCT01515189|100739384|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
33367186|NCT00069095|101230209|FG002|Primary Treatment Phase|Other Violation|1|||
33419014|NCT01563029|101425625|FG003|Overall Study|Protocol defined stopping criteria|0|||
33419015|NCT01563029|101425626|FG004|Overall Study|Protocol defined stopping criteria|0|||
33419016|NCT01563029|101425622|FG000|Overall Study|Lost to Follow-up|1|||
33419017|NCT01563029|101425623|FG001|Overall Study|Lost to Follow-up|0|||
33419018|NCT01563029|101425624|FG002|Overall Study|Lost to Follow-up|1|||
33419019|NCT01563029|101425625|FG003|Overall Study|Lost to Follow-up|1|||
33419020|NCT01563029|101425626|FG004|Overall Study|Lost to Follow-up|1|||
33419021|NCT01563029|101425622|FG000|Overall Study|Physician Decision|3|||
33419022|NCT01563029|101425623|FG001|Overall Study|Physician Decision|5|||
33419023|NCT01563029|101425624|FG002|Overall Study|Physician Decision|2|||
33419024|NCT01563029|101425625|FG003|Overall Study|Physician Decision|4|||
33419025|NCT01563029|101425626|FG004|Overall Study|Physician Decision|2|||
33419026|NCT01563029|101425622|FG000|Overall Study|Withdrawal by Subject|4|||
33419027|NCT01563029|101425623|FG001|Overall Study|Withdrawal by Subject|1|||
33419028|NCT01563029|101425624|FG002|Overall Study|Withdrawal by Subject|3|||
33419029|NCT01563029|101425625|FG003|Overall Study|Withdrawal by Subject|4|||
33419030|NCT01563029|101425626|FG004|Overall Study|Withdrawal by Subject|3|||
33419031|NCT03338673|101425627|FG000|Overall Study|Lost to Follow-up|1|||
33572238|NCT01475721|101985969|FG000|Overall Study|Death|3|||
33572239|NCT01475721|101985970|FG001|Overall Study|Death|6|||
33572240|NCT01475721|101985969|FG000|Overall Study|Withdrawal by Subject|8|||
33572241|NCT01475721|101985970|FG001|Overall Study|Withdrawal by Subject|8|||
33572242|NCT02434081|101985972|FG000|Overall Study|Death (never started treatment)|2|||
33572243|NCT02434081|101985972|FG000|Overall Study|Death|2|||
33229378|NCT01515189|100739383|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
33367187|NCT00069095|101230210|FG003|Primary Treatment Phase|Other Violation|1|||
33367188|NCT00069095|101230211|FG004|Primary Treatment Phase|Other Violation|0|||
33367189|NCT00069095|101230212|FG005|Primary Treatment Phase|Other Violation|1|||
33367190|NCT00069095|101230207|FG000|Primary Treatment Phase|Violation criteria|0|||
33367191|NCT00069095|101230208|FG001|Primary Treatment Phase|Violation criteria|2|||
33367192|NCT00069095|101230209|FG002|Primary Treatment Phase|Violation criteria|4|||
33367193|NCT00069095|101230210|FG003|Primary Treatment Phase|Violation criteria|3|||
33367194|NCT00069095|101230211|FG004|Primary Treatment Phase|Violation criteria|1|||
33367195|NCT00069095|101230212|FG005|Primary Treatment Phase|Violation criteria|5|||
33367196|NCT00069095|101230207|FG000|Post-study Treatment Phase|Missing reason|1|||
33367197|NCT00069095|101230208|FG001|Post-study Treatment Phase|Missing reason|3|||
33367198|NCT00069095|101230209|FG002|Post-study Treatment Phase|Missing reason|12|||
33367199|NCT00069095|101230210|FG003|Post-study Treatment Phase|Missing reason|8|||
33367200|NCT00069095|101230211|FG004|Post-study Treatment Phase|Missing reason|18|||
33367201|NCT00069095|101230212|FG005|Post-study Treatment Phase|Missing reason|17|||
33367202|NCT00069095|101230207|FG000|Post-study Treatment Phase|Adverse Event|2|||
33419032|NCT03338673|101425628|FG001|Overall Study|Lost to Follow-up|1|||
33419033|NCT01850108|101425629|FG000|Overall Study|Lost to Follow-up|4|||
33419034|NCT01850108|101425629|FG000|Overall Study|Not eligible|1|||
33229379|NCT01515189|100739384|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
33367203|NCT00069095|101230208|FG001|Post-study Treatment Phase|Adverse Event|3|||
33419035|NCT01850108|101425629|FG000|Overall Study|Failed engraftment|2|||
33572244|NCT02434081|101985972|FG000|Overall Study|Progression|20|||
33367204|NCT00069095|101230209|FG002|Post-study Treatment Phase|Adverse Event|1|||
33419036|NCT01850108|101425629|FG000|Overall Study|Physician Decision|1|||
33572245|NCT02434081|101985972|FG000|Overall Study|Adverse Event|20|||
33419037|NCT02411110|101425630|FG000|Treatment Period 1|Adverse Event|4|||
33419038|NCT02411110|101425631|FG001|Treatment Period 1|Adverse Event|2|||
33419039|NCT02411110|101425630|FG000|Treatment Period 1|Lost to Follow-up|1|||
33419040|NCT02411110|101425631|FG001|Treatment Period 1|Lost to Follow-up|0|||
33572246|NCT02434081|101985972|FG000|Overall Study|Physician Decision|2|||
33572247|NCT02434081|101985972|FG000|Overall Study|Withdrawal by Subject|1|||
33572248|NCT02434081|101985972|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
33572249|NCT01038323|101985975|FG000|Overall Study|Withdrawal by Subject|3|||
33572250|NCT01038323|101985976|FG001|Overall Study|Withdrawal by Subject|2|||
33572251|NCT01038323|101985977|FG002|Overall Study|Withdrawal by Subject|4|||
33572252|NCT00582907|101985978|FG000|1st Course|Withdrawal by Subject|1|||
33572253|NCT00582907|101985979|FG001|1st Course|Withdrawal by Subject|0|||
33572254|NCT00582907|101985980|FG002|1st Course|Withdrawal by Subject|0|||
33572255|NCT00582907|101985981|FG003|1st Course|Withdrawal by Subject|0|||
33634552|NCT02113982|102214585|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
33634553|NCT02113982|102214586|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
33634554|NCT02113982|102214587|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
33634555|NCT02113982|102214588|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
33634556|NCT02113982|102214589|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
33229380|NCT01515189|100739383|FG000|First Re-Induction Phase|Other|1|||
33229381|NCT01515189|100739384|FG001|First Re-Induction Phase|Other|0|||
33419041|NCT02411110|101425630|FG000|Treatment Period 1|Personal Reasons|2|||
33419042|NCT02411110|101425631|FG001|Treatment Period 1|Personal Reasons|5|||
33572256|NCT00582907|101985978|FG000|1st Course|Lost to Follow-up|0|||
33572257|NCT00582907|101985979|FG001|1st Course|Lost to Follow-up|0|||
33572258|NCT00582907|101985980|FG002|1st Course|Lost to Follow-up|0|||
33572259|NCT00582907|101985981|FG003|1st Course|Lost to Follow-up|1|||
33634557|NCT02113982|102214590|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
33229382|NCT00152763|100739385|FG000|Overall Study|Death|4|||
33634558|NCT02113982|102214591|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
33634559|NCT02113982|102214592|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
33634560|NCT02113982|102214593|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
33367205|NCT00069095|101230210|FG003|Post-study Treatment Phase|Adverse Event|0|||
33367206|NCT00069095|101230211|FG004|Post-study Treatment Phase|Adverse Event|5|||
33367207|NCT00069095|101230212|FG005|Post-study Treatment Phase|Adverse Event|1|||
33367208|NCT00069095|101230207|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
33367209|NCT00069095|101230208|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
33367210|NCT00069095|101230209|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
33367211|NCT00069095|101230210|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
33367212|NCT00069095|101230211|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
33367213|NCT00069095|101230212|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
33367214|NCT00069095|101230207|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
33367215|NCT00069095|101230208|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
33367216|NCT00069095|101230209|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
33367217|NCT00069095|101230210|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
33367218|NCT00069095|101230211|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
33367219|NCT00069095|101230212|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
33572260|NCT00582907|101985978|FG000|2nd Course|Lack of Efficacy|1|||
33572261|NCT00582907|101985979|FG001|2nd Course|Lack of Efficacy|0|||
33572262|NCT00582907|101985980|FG002|2nd Course|Lack of Efficacy|0|||
33572263|NCT00582907|101985981|FG003|2nd Course|Lack of Efficacy|0|||
33634561|NCT02113982|102214594|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
33634562|NCT02113982|102214595|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
33634563|NCT02113982|102214596|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
33634564|NCT02113982|102214583|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
33367220|NCT00069095|101230207|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
33572264|NCT05489328|101985983|FG000|Overall Study|Lost to Follow-up|0|||
33572265|NCT05489328|101985984|FG001|Overall Study|Lost to Follow-up|0|||
33572266|NCT05489328|101985985|FG002|Overall Study|Lost to Follow-up|1|||
33572267|NCT05489328|101985986|FG003|Overall Study|Lost to Follow-up|0|||
33572268|NCT05489328|101985987|FG004|Overall Study|Lost to Follow-up|2|||
33572269|NCT05489328|101985988|FG005|Overall Study|Lost to Follow-up|0|||
33572270|NCT05489328|101985989|FG006|Overall Study|Lost to Follow-up|0|||
33572271|NCT05489328|101985990|FG007|Overall Study|Lost to Follow-up|1|||
33572272|NCT05489328|101985991|FG008|Overall Study|Lost to Follow-up|0|||
33572273|NCT05489328|101985983|FG000|Overall Study|Withdrawal by Subject|0|||
33572274|NCT05489328|101985984|FG001|Overall Study|Withdrawal by Subject|0|||
33419043|NCT02411110|101425630|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
33572275|NCT05489328|101985985|FG002|Overall Study|Withdrawal by Subject|0|||
33572276|NCT05489328|101985986|FG003|Overall Study|Withdrawal by Subject|0|||
33572277|NCT05489328|101985987|FG004|Overall Study|Withdrawal by Subject|0|||
33634565|NCT02113982|102214584|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
33367221|NCT00069095|101230208|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
33367222|NCT00069095|101230209|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
33367223|NCT00069095|101230210|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
33367224|NCT00069095|101230211|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
33367225|NCT00069095|101230212|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
33367226|NCT00069095|101230207|FG000|Post-study Treatment Phase|Participant had complete response|1|||
33367227|NCT00069095|101230208|FG001|Post-study Treatment Phase|Participant had complete response|1|||
33572278|NCT05489328|101985988|FG005|Overall Study|Withdrawal by Subject|0|||
33367228|NCT00069095|101230209|FG002|Post-study Treatment Phase|Participant had complete response|0|||
33367229|NCT00069095|101230210|FG003|Post-study Treatment Phase|Participant had complete response|0|||
33367230|NCT00069095|101230211|FG004|Post-study Treatment Phase|Participant had complete response|0|||
33367231|NCT00069095|101230212|FG005|Post-study Treatment Phase|Participant had complete response|0|||
33572279|NCT05489328|101985989|FG006|Overall Study|Withdrawal by Subject|1|||
33572280|NCT05489328|101985990|FG007|Overall Study|Withdrawal by Subject|1|||
33572281|NCT05489328|101985991|FG008|Overall Study|Withdrawal by Subject|0|||
33572282|NCT05489328|101985983|FG000|Overall Study|Other|0|||
33572283|NCT05489328|101985984|FG001|Overall Study|Other|0|||
33572284|NCT05489328|101985985|FG002|Overall Study|Other|0|||
33572285|NCT05489328|101985986|FG003|Overall Study|Other|0|||
33572286|NCT05489328|101985987|FG004|Overall Study|Other|0|||
33367232|NCT00069095|101230207|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
33572287|NCT05489328|101985988|FG005|Overall Study|Other|0|||
33572288|NCT05489328|101985989|FG006|Overall Study|Other|0|||
33572289|NCT05489328|101985990|FG007|Overall Study|Other|1|||
33572290|NCT05489328|101985991|FG008|Overall Study|Other|1|||
33572291|NCT03639610|101985993|FG000|Overall Study|Adverse Event|7|||
33572292|NCT03639610|101985994|FG001|Overall Study|Adverse Event|1|||
33572293|NCT03639610|101985995|FG002|Overall Study|Adverse Event|0|||
33572294|NCT03639610|101985993|FG000|Overall Study|Physician Decision|3|||
33572295|NCT03639610|101985994|FG001|Overall Study|Physician Decision|1|||
33572296|NCT03639610|101985995|FG002|Overall Study|Physician Decision|0|||
33572297|NCT03639610|101985993|FG000|Overall Study|Disease progression|8|||
33572298|NCT03639610|101985994|FG001|Overall Study|Disease progression|5|||
33572299|NCT03639610|101985995|FG002|Overall Study|Disease progression|3|||
33572300|NCT03639610|101985993|FG000|Overall Study|Study terminated by sponsor|2|||
33572301|NCT03639610|101985994|FG001|Overall Study|Study terminated by sponsor|1|||
33572302|NCT03639610|101985995|FG002|Overall Study|Study terminated by sponsor|1|||
33572303|NCT03639610|101985993|FG000|Overall Study|Patient request to stop treatment|1|||
33572304|NCT03639610|101985994|FG001|Overall Study|Patient request to stop treatment|2|||
33572305|NCT03639610|101985995|FG002|Overall Study|Patient request to stop treatment|0|||
33572306|NCT01561976|101985996|FG000|Period 1|Adverse Event|0|||
33572307|NCT01561976|101985997|FG001|Period 1|Adverse Event|0|||
33572308|NCT01561976|101985998|FG002|Period 1|Adverse Event|1|||
33572309|NCT01561976|101985999|FG003|Period 1|Adverse Event|0|||
33572310|NCT01561976|101986000|FG004|Period 1|Adverse Event|0|||
33572311|NCT01561976|101986001|FG005|Period 1|Adverse Event|0|||
33572312|NCT01561976|101985996|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
33572313|NCT01561976|101985997|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
33572314|NCT01561976|101985998|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
33572315|NCT01561976|101985999|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
33572316|NCT01561976|101986000|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
33572317|NCT01561976|101986001|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
33572318|NCT01561976|101985996|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33572319|NCT01561976|101985997|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33572320|NCT01561976|101985998|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33572321|NCT01561976|101985999|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33634566|NCT02113982|102214585|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
33634567|NCT02113982|102214586|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
33634568|NCT02113982|102214587|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
33634569|NCT02113982|102214588|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
33634570|NCT02113982|102214589|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
33634571|NCT02113982|102214590|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
33634572|NCT02113982|102214591|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
33634573|NCT02113982|102214592|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
33634574|NCT02113982|102214593|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
33634575|NCT02113982|102214594|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
33634576|NCT02113982|102214595|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
33634577|NCT02113982|102214596|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
33634578|NCT02113982|102214583|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
33634579|NCT02113982|102214584|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
33634580|NCT02113982|102214585|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
33634581|NCT02113982|102214586|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
33634582|NCT02113982|102214587|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
33634583|NCT02113982|102214588|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
33634584|NCT02113982|102214589|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
33634585|NCT02113982|102214590|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
33634586|NCT02113982|102214591|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
33634587|NCT02113982|102214592|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
33634588|NCT02113982|102214593|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
33634589|NCT02113982|102214594|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
33634590|NCT02113982|102214595|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
33634591|NCT02113982|102214596|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
33634592|NCT02113982|102214583|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
33634593|NCT02113982|102214584|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
33634594|NCT02113982|102214585|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
33634595|NCT02113982|102214586|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
33419044|NCT02411110|101425631|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
33572322|NCT01561976|101986000|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
33572323|NCT01561976|101986001|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
33572324|NCT01561976|101985996|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
33572325|NCT01561976|101985997|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
33572326|NCT01561976|101985998|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
33572327|NCT01561976|101985999|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
33572328|NCT01561976|101986000|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
33634596|NCT02113982|102214587|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
33634597|NCT02113982|102214588|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
33572329|NCT01561976|101986001|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
33634598|NCT02113982|102214589|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
33229383|NCT00152763|100739386|FG001|Overall Study|Death|1|||
33229384|NCT00152763|100739387|FG002|Overall Study|Death|2|||
33229385|NCT00152763|100739388|FG003|Overall Study|Death|1|||
33229386|NCT00152763|100739385|FG000|Overall Study|Lost to Follow-up|6|||
33572330|NCT00545779|101986002|FG000|Overall Study|Violation of selection criteria at entry|8|||
33572331|NCT00545779|101986002|FG000|Overall Study|Other protocol violation|1|||
33367233|NCT00069095|101230208|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
33367234|NCT00069095|101230209|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
33367235|NCT00069095|101230210|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
33229387|NCT00152763|100739386|FG001|Overall Study|Lost to Follow-up|4|||
33229388|NCT00152763|100739387|FG002|Overall Study|Lost to Follow-up|2|||
33229389|NCT00152763|100739388|FG003|Overall Study|Lost to Follow-up|13|||
33229390|NCT01709305|100739389|FG000|Phase 1|Clinical Adverse Event|80|||
33229391|NCT01709305|100739390|FG001|Phase 1|Clinical Adverse Event|0|||
33229392|NCT01709305|100739391|FG002|Phase 1|Clinical Adverse Event|0|||
33229393|NCT01709305|100739392|FG003|Phase 1|Clinical Adverse Event|0|||
33229394|NCT01709305|100739393|FG004|Phase 1|Clinical Adverse Event|0|||
33229395|NCT01709305|100739389|FG000|Phase 1|Death|2|||
33229396|NCT01709305|100739390|FG001|Phase 1|Death|0|||
33229397|NCT01709305|100739391|FG002|Phase 1|Death|0|||
33229398|NCT01709305|100739392|FG003|Phase 1|Death|0|||
33229399|NCT01709305|100739393|FG004|Phase 1|Death|0|||
33229400|NCT01709305|100739389|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
33229401|NCT01709305|100739390|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
33367236|NCT00069095|101230211|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
33572332|NCT00545779|101986002|FG000|Overall Study|Did not cooperate|7|||
33572333|NCT00545779|101986002|FG000|Overall Study|Withdrawal by Subject|20|||
33367237|NCT00069095|101230212|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
33367238|NCT00069095|101230207|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
33367239|NCT00069095|101230208|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
33419045|NCT02411110|101425630|FG000|Treatment Period 2|Adverse Event|1|||
33419046|NCT02411110|101425631|FG001|Treatment Period 2|Adverse Event|0|||
33419047|NCT02411110|101425630|FG000|Treatment Period 2|Lost to Follow-up|0|||
33572334|NCT00545779|101986002|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
33572335|NCT00545779|101986002|FG000|Overall Study|Failure to return|3|||
33572336|NCT00805389|101986003|FG000|Overall Study|Adverse Event|0|||
33572337|NCT00805389|101986004|FG001|Overall Study|Adverse Event|0|||
33634599|NCT02113982|102214590|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
33634600|NCT02113982|102214591|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
33634601|NCT02113982|102214592|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
33419048|NCT02411110|101425631|FG001|Treatment Period 2|Lost to Follow-up|2|||
33229402|NCT01709305|100739391|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
33229403|NCT01709305|100739392|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
33229404|NCT01709305|100739393|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
33229405|NCT01709305|100739389|FG000|Phase 1|Laboratory Adverse Event|16|||
33572338|NCT00805389|101986005|FG002|Overall Study|Adverse Event|1|||
33229406|NCT01709305|100739390|FG001|Phase 1|Laboratory Adverse Event|0|||
33229407|NCT01709305|100739391|FG002|Phase 1|Laboratory Adverse Event|0|||
33229408|NCT01709305|100739392|FG003|Phase 1|Laboratory Adverse Event|0|||
33229409|NCT01709305|100739393|FG004|Phase 1|Laboratory Adverse Event|0|||
33229410|NCT01709305|100739389|FG000|Phase 1|Lost to Follow-up|147|||
33229411|NCT01709305|100739390|FG001|Phase 1|Lost to Follow-up|0|||
33229412|NCT01709305|100739391|FG002|Phase 1|Lost to Follow-up|0|||
33229413|NCT01709305|100739392|FG003|Phase 1|Lost to Follow-up|0|||
33229414|NCT01709305|100739393|FG004|Phase 1|Lost to Follow-up|0|||
33229415|NCT01709305|100739389|FG000|Phase 1|Travel, moving, etc.|30|||
33229416|NCT01709305|100739390|FG001|Phase 1|Travel, moving, etc.|0|||
33229417|NCT01709305|100739391|FG002|Phase 1|Travel, moving, etc.|0|||
33229418|NCT01709305|100739392|FG003|Phase 1|Travel, moving, etc.|0|||
33229419|NCT01709305|100739393|FG004|Phase 1|Travel, moving, etc.|0|||
33229420|NCT01709305|100739389|FG000|Phase 1|Physician Decision|13|||
33229421|NCT01709305|100739390|FG001|Phase 1|Physician Decision|0|||
33229422|NCT01709305|100739391|FG002|Phase 1|Physician Decision|0|||
33229423|NCT01709305|100739392|FG003|Phase 1|Physician Decision|0|||
33229424|NCT01709305|100739393|FG004|Phase 1|Physician Decision|0|||
33229425|NCT01709305|100739389|FG000|Phase 1|Protocol Violation|118|||
33229426|NCT01709305|100739390|FG001|Phase 1|Protocol Violation|0|||
33229427|NCT01709305|100739391|FG002|Phase 1|Protocol Violation|0|||
33229428|NCT01709305|100739392|FG003|Phase 1|Protocol Violation|0|||
33229429|NCT01709305|100739393|FG004|Phase 1|Protocol Violation|0|||
33229430|NCT01709305|100739389|FG000|Phase 1|Withdrawal by Subject|218|||
33229431|NCT01709305|100739390|FG001|Phase 1|Withdrawal by Subject|0|||
33229432|NCT01709305|100739391|FG002|Phase 1|Withdrawal by Subject|0|||
33229433|NCT01709305|100739392|FG003|Phase 1|Withdrawal by Subject|0|||
33229434|NCT01709305|100739393|FG004|Phase 1|Withdrawal by Subject|0|||
33229435|NCT01709305|100739389|FG000|Phase 2|Clinical Adverse Event|0|||
33229436|NCT01709305|100739390|FG001|Phase 2|Clinical Adverse Event|10|||
33229437|NCT01709305|100739391|FG002|Phase 2|Clinical Adverse Event|10|||
33229438|NCT01709305|100739392|FG003|Phase 2|Clinical Adverse Event|6|||
33229439|NCT01709305|100739393|FG004|Phase 2|Clinical Adverse Event|11|||
33229440|NCT01709305|100739389|FG000|Phase 2|Death|0|||
33229441|NCT01709305|100739390|FG001|Phase 2|Death|0|||
33229442|NCT01709305|100739391|FG002|Phase 2|Death|1|||
33229443|NCT01709305|100739392|FG003|Phase 2|Death|0|||
33229444|NCT01709305|100739393|FG004|Phase 2|Death|0|||
33572339|NCT00805389|101986006|FG003|Overall Study|Adverse Event|2|||
33572340|NCT00805389|101986007|FG004|Overall Study|Adverse Event|0|||
33572341|NCT00805389|101986003|FG000|Overall Study|Lost to Follow-up|4|||
33572342|NCT00805389|101986004|FG001|Overall Study|Lost to Follow-up|3|||
33572343|NCT00805389|101986005|FG002|Overall Study|Lost to Follow-up|6|||
33572344|NCT00805389|101986006|FG003|Overall Study|Lost to Follow-up|10|||
33572345|NCT00805389|101986007|FG004|Overall Study|Lost to Follow-up|9|||
33572346|NCT00805389|101986003|FG000|Overall Study|Protocol Violation|0|||
33229445|NCT01709305|100739389|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
33229446|NCT01709305|100739390|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
33572347|NCT00805389|101986004|FG001|Overall Study|Protocol Violation|0|||
33572348|NCT00805389|101986005|FG002|Overall Study|Protocol Violation|1|||
33572349|NCT00805389|101986006|FG003|Overall Study|Protocol Violation|0|||
33572350|NCT00805389|101986007|FG004|Overall Study|Protocol Violation|0|||
33572351|NCT00805389|101986003|FG000|Overall Study|Withdrawal by Subject|3|||
33572352|NCT00805389|101986004|FG001|Overall Study|Withdrawal by Subject|2|||
33634602|NCT02113982|102214593|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
33229447|NCT01709305|100739391|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
33229448|NCT01709305|100739392|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
33229449|NCT01709305|100739393|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
33229450|NCT01709305|100739389|FG000|Phase 2|Laboratory Adverse Event|0|||
33229451|NCT01709305|100739390|FG001|Phase 2|Laboratory Adverse Event|1|||
33229452|NCT01709305|100739391|FG002|Phase 2|Laboratory Adverse Event|0|||
33229453|NCT01709305|100739392|FG003|Phase 2|Laboratory Adverse Event|1|||
33572353|NCT00805389|101986005|FG002|Overall Study|Withdrawal by Subject|4|||
33229454|NCT01709305|100739393|FG004|Phase 2|Laboratory Adverse Event|1|||
33229455|NCT01709305|100739389|FG000|Phase 2|Lost to Follow-up|0|||
33229456|NCT01709305|100739390|FG001|Phase 2|Lost to Follow-up|10|||
33229457|NCT01709305|100739391|FG002|Phase 2|Lost to Follow-up|6|||
33229458|NCT01709305|100739392|FG003|Phase 2|Lost to Follow-up|9|||
33229459|NCT01709305|100739393|FG004|Phase 2|Lost to Follow-up|5|||
33229460|NCT01709305|100739389|FG000|Phase 2|Travel, moving, etc.|0|||
33229461|NCT01709305|100739390|FG001|Phase 2|Travel, moving, etc.|2|||
33229462|NCT01709305|100739391|FG002|Phase 2|Travel, moving, etc.|3|||
33229463|NCT01709305|100739392|FG003|Phase 2|Travel, moving, etc.|3|||
33229464|NCT01709305|100739393|FG004|Phase 2|Travel, moving, etc.|5|||
33229465|NCT01709305|100739389|FG000|Phase 2|Physician Decision|0|||
33229466|NCT01709305|100739390|FG001|Phase 2|Physician Decision|2|||
33229467|NCT01709305|100739391|FG002|Phase 2|Physician Decision|0|||
33229468|NCT01709305|100739392|FG003|Phase 2|Physician Decision|1|||
33229469|NCT01709305|100739393|FG004|Phase 2|Physician Decision|2|||
33229470|NCT01709305|100739389|FG000|Phase 2|Protocol Violation|0|||
33229471|NCT01709305|100739390|FG001|Phase 2|Protocol Violation|19|||
33229472|NCT01709305|100739391|FG002|Phase 2|Protocol Violation|19|||
33229473|NCT01709305|100739392|FG003|Phase 2|Protocol Violation|13|||
33229474|NCT01709305|100739393|FG004|Phase 2|Protocol Violation|9|||
33229475|NCT01709305|100739389|FG000|Phase 2|Withdrawal by Subject|0|||
33229476|NCT01709305|100739390|FG001|Phase 2|Withdrawal by Subject|8|||
33229477|NCT01709305|100739391|FG002|Phase 2|Withdrawal by Subject|6|||
33229478|NCT01709305|100739392|FG003|Phase 2|Withdrawal by Subject|15|||
33572354|NCT00805389|101986006|FG003|Overall Study|Withdrawal by Subject|5|||
33572355|NCT00805389|101986007|FG004|Overall Study|Withdrawal by Subject|4|||
33229479|NCT01709305|100739393|FG004|Phase 2|Withdrawal by Subject|12|||
33229480|NCT02960763|100739394|FG000|Step 1|Withdrawal by Subject|10|||
33572356|NCT00673920|101986008|FG000|Baseline up to Week 48|Withdrew consent|1|||
33572357|NCT00673920|101986009|FG001|Baseline up to Week 48|Withdrew consent|0|||
33572358|NCT00673920|101986010|FG002|Baseline up to Week 48|Withdrew consent|2|||
33572359|NCT00673920|101986011|FG003|Baseline up to Week 48|Withdrew consent|0|||
33572360|NCT00673920|101986012|FG004|Baseline up to Week 48|Withdrew consent|0|||
33572361|NCT00673920|101986013|FG005|Baseline up to Week 48|Withdrew consent|0|||
33572362|NCT00673920|101986014|FG006|Baseline up to Week 48|Withdrew consent|0|||
33572363|NCT00673920|101986015|FG007|Baseline up to Week 48|Withdrew consent|0|||
33229481|NCT02960763|100739395|FG001|Step 1|Withdrawal by Subject|8|||
33229482|NCT02960763|100739396|FG002|Step 1|Withdrawal by Subject|13|||
33229483|NCT02960763|100739397|FG003|Step 1|Withdrawal by Subject|0|||
33229484|NCT02960763|100739398|FG004|Step 1|Withdrawal by Subject|0|||
33229485|NCT02960763|100739394|FG000|Step 1|Lost to Follow-up|7|||
33229486|NCT02960763|100739395|FG001|Step 1|Lost to Follow-up|9|||
33229487|NCT02960763|100739396|FG002|Step 1|Lost to Follow-up|12|||
33229488|NCT02960763|100739397|FG003|Step 1|Lost to Follow-up|0|||
33229489|NCT02960763|100739398|FG004|Step 1|Lost to Follow-up|0|||
33229490|NCT02960763|100739394|FG000|Step 1|Death|1|||
33229491|NCT02960763|100739395|FG001|Step 1|Death|1|||
33229492|NCT02960763|100739396|FG002|Step 1|Death|1|||
33229493|NCT02960763|100739397|FG003|Step 1|Death|0|||
33572364|NCT00673920|101986008|FG000|Baseline up to Week 48|Refused treatment|1|||
33572365|NCT00673920|101986009|FG001|Baseline up to Week 48|Refused treatment|0|||
33572366|NCT00673920|101986010|FG002|Baseline up to Week 48|Refused treatment|0|||
33572367|NCT00673920|101986011|FG003|Baseline up to Week 48|Refused treatment|0|||
33572368|NCT00673920|101986012|FG004|Baseline up to Week 48|Refused treatment|0|||
33572369|NCT00673920|101986013|FG005|Baseline up to Week 48|Refused treatment|0|||
33229494|NCT02960763|100739398|FG004|Step 1|Death|0|||
33229495|NCT02960763|100739394|FG000|Step 1|Investigator discretion|1|||
33229496|NCT02960763|100739395|FG001|Step 1|Investigator discretion|0|||
33229497|NCT02960763|100739396|FG002|Step 1|Investigator discretion|1|||
33229498|NCT02960763|100739397|FG003|Step 1|Investigator discretion|0|||
33229499|NCT02960763|100739398|FG004|Step 1|Investigator discretion|0|||
33572370|NCT00673920|101986014|FG006|Baseline up to Week 48|Refused treatment|0|||
33572371|NCT00673920|101986015|FG007|Baseline up to Week 48|Refused treatment|0|||
33229500|NCT02960763|100739394|FG000|Step 1|Other|0|||
33229501|NCT02960763|100739395|FG001|Step 1|Other|0|||
33229502|NCT02960763|100739396|FG002|Step 1|Other|1|||
33229503|NCT02960763|100739397|FG003|Step 1|Other|0|||
33229504|NCT02960763|100739398|FG004|Step 1|Other|0|||
33572372|NCT00673920|101986008|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
33572373|NCT00673920|101986009|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
33572374|NCT00673920|101986010|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
33572375|NCT00673920|101986011|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
33229505|NCT02960763|100739394|FG000|Step 2|Withdrawal by Subject|0|||
33229506|NCT02960763|100739395|FG001|Step 2|Withdrawal by Subject|0|||
33229507|NCT02960763|100739396|FG002|Step 2|Withdrawal by Subject|0|||
33229508|NCT02960763|100739397|FG003|Step 2|Withdrawal by Subject|7|||
33229509|NCT02960763|100739398|FG004|Step 2|Withdrawal by Subject|3|||
33229510|NCT02960763|100739394|FG000|Step 2|Lost to Follow-up|0|||
33367240|NCT00069095|101230209|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
33634603|NCT02113982|102214594|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
33634604|NCT02113982|102214595|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
33634605|NCT02113982|102214596|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
33634606|NCT02113982|102214583|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
33367241|NCT00069095|101230210|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
33367242|NCT00069095|101230211|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
33367243|NCT00069095|101230212|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
33367244|NCT00069095|101230207|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
33572376|NCT00673920|101986012|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
33572377|NCT00673920|101986013|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
33572378|NCT00673920|101986014|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
33572379|NCT00673920|101986015|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
33572380|NCT00673920|101986008|FG000|Baseline up to Week 48|Protocol Violation|0|||
33572381|NCT00673920|101986009|FG001|Baseline up to Week 48|Protocol Violation|0|||
33572382|NCT00673920|101986010|FG002|Baseline up to Week 48|Protocol Violation|1|||
33572383|NCT00673920|101986011|FG003|Baseline up to Week 48|Protocol Violation|0|||
33572384|NCT00673920|101986012|FG004|Baseline up to Week 48|Protocol Violation|0|||
33572385|NCT00673920|101986013|FG005|Baseline up to Week 48|Protocol Violation|0|||
33572386|NCT00673920|101986014|FG006|Baseline up to Week 48|Protocol Violation|0|||
33572387|NCT00673920|101986015|FG007|Baseline up to Week 48|Protocol Violation|0|||
33572388|NCT00673920|101986008|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
33572389|NCT00673920|101986009|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
33572390|NCT00673920|101986010|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
33572391|NCT00673920|101986011|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
33572392|NCT00673920|101986012|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
33572393|NCT00673920|101986013|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
33572394|NCT00673920|101986014|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
33572395|NCT00673920|101986015|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
33572396|NCT00673920|101986008|FG000|Baseline up to Week 48|Administrative/Other|0|||
33572397|NCT00673920|101986009|FG001|Baseline up to Week 48|Administrative/Other|1|||
33572398|NCT00673920|101986010|FG002|Baseline up to Week 48|Administrative/Other|2|||
33572399|NCT00673920|101986011|FG003|Baseline up to Week 48|Administrative/Other|0|||
33572400|NCT00673920|101986012|FG004|Baseline up to Week 48|Administrative/Other|0|||
33572401|NCT00673920|101986013|FG005|Baseline up to Week 48|Administrative/Other|0|||
33634607|NCT02113982|102214584|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
33634608|NCT02113982|102214585|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
33367245|NCT00069095|101230208|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
33367246|NCT00069095|101230209|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
33367247|NCT00069095|101230210|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
33367248|NCT00069095|101230211|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
33367249|NCT00069095|101230212|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
33367250|NCT00069095|101230207|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
33367251|NCT00069095|101230208|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
33367252|NCT00069095|101230209|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
33367253|NCT00069095|101230210|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
33367254|NCT00069095|101230211|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
33572402|NCT00673920|101986014|FG006|Baseline up to Week 48|Administrative/Other|0|||
33572403|NCT00673920|101986015|FG007|Baseline up to Week 48|Administrative/Other|0|||
33572404|NCT00673920|101986008|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
33572405|NCT00673920|101986009|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
33572406|NCT00673920|101986010|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
33572407|NCT00673920|101986011|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
33634609|NCT02113982|102214586|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
33634610|NCT02113982|102214587|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
33634611|NCT02113982|102214588|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
33229511|NCT02960763|100739395|FG001|Step 2|Lost to Follow-up|0|||
33229512|NCT02960763|100739396|FG002|Step 2|Lost to Follow-up|0|||
33419049|NCT02411110|101425630|FG000|Treatment Period 2|Personal Reasons|0|||
33419050|NCT02411110|101425631|FG001|Treatment Period 2|Personal Reasons|2|||
33419051|NCT02564952|101425634|FG000|Overall Study|Adverse Event|6|||
33419052|NCT02564952|101425634|FG000|Overall Study|Lost to Follow-up|1|||
33419053|NCT02564952|101425634|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
33419054|NCT02564952|101425634|FG000|Overall Study|Withdrawal by Subject|1|||
33419055|NCT02564952|101425634|FG000|Overall Study|Low Efficacy|1|||
33572408|NCT00673920|101986012|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
33572409|NCT00673920|101986013|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
33572410|NCT00673920|101986014|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
33572411|NCT00673920|101986015|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
33572412|NCT00673920|101986008|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
33572413|NCT00673920|101986009|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
33572414|NCT00673920|101986010|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
33572415|NCT00673920|101986011|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
33572416|NCT00673920|101986012|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
33572417|NCT00673920|101986013|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
33572418|NCT00673920|101986014|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
33572419|NCT00673920|101986015|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
33572420|NCT00673920|101986008|FG000|Week 24 to Week 48|Failure to return|0|||
33572421|NCT00673920|101986009|FG001|Week 24 to Week 48|Failure to return|0|||
33572422|NCT00673920|101986010|FG002|Week 24 to Week 48|Failure to return|0|||
33572423|NCT00673920|101986011|FG003|Week 24 to Week 48|Failure to return|0|||
33572424|NCT00673920|101986012|FG004|Week 24 to Week 48|Failure to return|0|||
33572425|NCT00673920|101986013|FG005|Week 24 to Week 48|Failure to return|1|||
33572426|NCT00673920|101986014|FG006|Week 24 to Week 48|Failure to return|0|||
33572427|NCT00673920|101986015|FG007|Week 24 to Week 48|Failure to return|0|||
33572428|NCT00673920|101986008|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
33572429|NCT00673920|101986009|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
33572430|NCT00673920|101986010|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
33634612|NCT02113982|102214589|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
33634613|NCT02113982|102214590|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
33634614|NCT02113982|102214591|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
33634615|NCT02113982|102214592|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
33634616|NCT02113982|102214593|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
33634617|NCT02113982|102214594|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
33634618|NCT02113982|102214595|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
33634619|NCT02113982|102214596|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
33367255|NCT00069095|101230212|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
33367256|NCT00069095|101230207|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
33367257|NCT00069095|101230208|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
33367258|NCT00069095|101230209|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
33367259|NCT00069095|101230210|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
33367260|NCT00069095|101230211|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
33367261|NCT00069095|101230212|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
33367262|NCT00069095|101230207|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
33367263|NCT00069095|101230208|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
33367264|NCT00069095|101230209|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
33367265|NCT00069095|101230210|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
33367266|NCT00069095|101230211|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
33367267|NCT00069095|101230212|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
33367268|NCT00069095|101230207|FG000|Post-study Treatment Phase|Surgery|0|||
33367269|NCT00069095|101230208|FG001|Post-study Treatment Phase|Surgery|0|||
33367270|NCT00069095|101230209|FG002|Post-study Treatment Phase|Surgery|0|||
33367271|NCT00069095|101230210|FG003|Post-study Treatment Phase|Surgery|1|||
33367272|NCT00069095|101230211|FG004|Post-study Treatment Phase|Surgery|1|||
33367273|NCT00069095|101230212|FG005|Post-study Treatment Phase|Surgery|0|||
33367274|NCT00069095|101230207|FG000|Post-study Treatment Phase|Death|0|||
33367275|NCT00069095|101230208|FG001|Post-study Treatment Phase|Death|0|||
33367276|NCT00069095|101230209|FG002|Post-study Treatment Phase|Death|0|||
33367277|NCT00069095|101230210|FG003|Post-study Treatment Phase|Death|0|||
33367278|NCT00069095|101230211|FG004|Post-study Treatment Phase|Death|1|||
33367279|NCT00069095|101230212|FG005|Post-study Treatment Phase|Death|0|||
33367280|NCT00069095|101230207|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
33419056|NCT02564952|101425634|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
33419057|NCT00833976|101425635|FG000|Overall Study|Withdrawal by Subject|5|||
33572431|NCT00673920|101986011|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
33572432|NCT00673920|101986012|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
33634620|NCT02113982|102214583|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
33634621|NCT02113982|102214584|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
33634622|NCT02113982|102214585|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
33572433|NCT00673920|101986013|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
33572434|NCT00673920|101986014|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
33572435|NCT00673920|101986015|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
33572436|NCT00673920|101986008|FG000|Week 24 to Week 48|Death|0|||
33572437|NCT00673920|101986009|FG001|Week 24 to Week 48|Death|0|||
33572438|NCT00673920|101986010|FG002|Week 24 to Week 48|Death|0|||
33572439|NCT00673920|101986011|FG003|Week 24 to Week 48|Death|0|||
33572440|NCT00673920|101986012|FG004|Week 24 to Week 48|Death|0|||
33572441|NCT00673920|101986013|FG005|Week 24 to Week 48|Death|1|||
33572442|NCT00673920|101986014|FG006|Week 24 to Week 48|Death|0|||
33572443|NCT00673920|101986015|FG007|Week 24 to Week 48|Death|0|||
33572444|NCT00673920|101986008|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
33634623|NCT02113982|102214586|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
33634624|NCT02113982|102214587|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
33634625|NCT02113982|102214588|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
33634626|NCT02113982|102214589|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
33634627|NCT02113982|102214590|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
33634628|NCT02113982|102214591|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
33634629|NCT02113982|102214592|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
33419058|NCT00833976|101425635|FG000|Overall Study|Lost to Follow-up|4|||
33419059|NCT00833976|101425635|FG000|Overall Study|Did not meet eligibility criteria|41|||
33634630|NCT02113982|102214593|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
33634631|NCT02113982|102214594|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
33634632|NCT02113982|102214595|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
33634633|NCT02113982|102214596|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
33634634|NCT02113982|102214583|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
33419060|NCT00833976|101425635|FG000|Overall Study|Physician Decision|1|||
33419061|NCT00378482|101425638|FG000|Overall Study|Lost to Follow-up|1|||
33419062|NCT00378482|101425638|FG000|Overall Study|Lack of Efficacy|8|||
33419063|NCT00378482|101425638|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
33419064|NCT00378482|101425638|FG000|Overall Study|Withdrawal by Subject|4|||
33419065|NCT00378482|101425638|FG000|Overall Study|Adverse Event|9|||
33419066|NCT04199104|101425640|FG000|Overall Study|Death|148|||
33419067|NCT04199104|101425641|FG001|Overall Study|Death|134|||
33419068|NCT04199104|101425640|FG000|Overall Study|Lost to Follow-up|1|||
33419069|NCT04199104|101425641|FG001|Overall Study|Lost to Follow-up|1|||
33419070|NCT04199104|101425640|FG000|Overall Study|Withdrawal by Subject|4|||
33419071|NCT04199104|101425641|FG001|Overall Study|Withdrawal by Subject|4|||
33419072|NCT04199104|101425640|FG000|Overall Study|Participants Ongoing|103|||
33419073|NCT04199104|101425641|FG001|Overall Study|Participants Ongoing|116|||
33419074|NCT00689273|101425642|FG000|Overall Study|Adverse Event|3|||
33419075|NCT00689273|101425643|FG001|Overall Study|Adverse Event|1|||
33419076|NCT00689273|101425642|FG000|Overall Study|Lack of Efficacy|3|||
33419077|NCT00689273|101425643|FG001|Overall Study|Lack of Efficacy|0|||
33419078|NCT00689273|101425642|FG000|Overall Study|Lost to Follow-up|0|||
33419079|NCT00689273|101425643|FG001|Overall Study|Lost to Follow-up|2|||
33419080|NCT00689273|101425642|FG000|Overall Study|Other|6|||
33419081|NCT00689273|101425643|FG001|Overall Study|Other|2|||
33419082|NCT00689273|101425642|FG000|Overall Study|Randomized but not Treated|1|||
33419083|NCT00689273|101425643|FG001|Overall Study|Randomized but not Treated|0|||
33419084|NCT02367781|101425649|FG000|Overall Study|Withdrawal by Subject|20|||
33419085|NCT02367781|101425650|FG001|Overall Study|Withdrawal by Subject|13|||
33419086|NCT02367781|101425649|FG000|Overall Study|Protocol Violation|0|||
33419087|NCT02367781|101425650|FG001|Overall Study|Protocol Violation|1|||
33419088|NCT02367781|101425649|FG000|Overall Study|Physician Decision|7|||
33419089|NCT02367781|101425650|FG001|Overall Study|Physician Decision|0|||
33419090|NCT02367781|101425649|FG000|Overall Study|Randomized in Error|5|||
33419091|NCT02367781|101425650|FG001|Overall Study|Randomized in Error|4|||
33572445|NCT00673920|101986009|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
33572446|NCT00673920|101986010|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
33572447|NCT00673920|101986011|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
33572448|NCT00673920|101986012|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
33572449|NCT00673920|101986013|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
33634635|NCT02113982|102214584|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
33419092|NCT02367781|101425649|FG000|Overall Study|Non-Compliance|1|||
33572450|NCT00673920|101986014|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
33572451|NCT00673920|101986015|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
33572452|NCT00237042|101986018|FG000|Treatment|Became ineligible post-randomization|0|||
33419093|NCT02367781|101425650|FG001|Overall Study|Non-Compliance|0|||
33419094|NCT02367781|101425649|FG000|Overall Study|Lost to Follow-up|1|||
33419095|NCT02367781|101425650|FG001|Overall Study|Lost to Follow-up|2|||
33419096|NCT02367781|101425649|FG000|Overall Study|Death|330|||
33419097|NCT02367781|101425650|FG001|Overall Study|Death|176|||
33419098|NCT02367781|101425649|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
33572453|NCT00237042|101986019|FG001|Treatment|Became ineligible post-randomization|1|||
33572454|NCT00237042|101986020|FG002|Treatment|Became ineligible post-randomization|16|||
33572455|NCT00237042|101986018|FG000|Treatment|Moved out of state|1|||
33572456|NCT00237042|101986019|FG001|Treatment|Moved out of state|1|||
33572457|NCT00237042|101986020|FG002|Treatment|Moved out of state|1|||
33572458|NCT00237042|101986018|FG000|Treatment|Completed no treatment|5|||
33572459|NCT00237042|101986019|FG001|Treatment|Completed no treatment|5|||
33229513|NCT02960763|100739397|FG003|Step 2|Lost to Follow-up|4|||
33419099|NCT02367781|101425650|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
33572460|NCT00237042|101986020|FG002|Treatment|Completed no treatment|21|||
33572461|NCT00237042|101986018|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
33572462|NCT00237042|101986019|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
33572463|NCT00237042|101986020|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
33572464|NCT00237042|101986018|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
33572465|NCT00237042|101986019|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
33572466|NCT00237042|101986020|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
33572467|NCT03383666|101986022|FG000|Overall Study|Withdrawal by Subject|2|||
33572468|NCT03383666|101986022|FG000|Overall Study|Lost to Follow-up|2|||
33572469|NCT02257684|101986023|FG000|Overall Study|Adverse Event|2|||
33572470|NCT02257684|101986023|FG000|Overall Study|Lack of Efficacy|1|||
33572471|NCT02257684|101986023|FG000|Overall Study|Sponsor's Decision|1|||
33572472|NCT00698841|101986024|FG000|Overall Study|Withdrawal by Subject|2|||
33572473|NCT00698841|101986024|FG000|Overall Study|Adverse Event|3|||
33572474|NCT00698841|101986024|FG000|Overall Study|Disease progression|7|||
33572475|NCT00698841|101986024|FG000|Overall Study|Failure to meet eligibility criteria|2|||
33572476|NCT00698841|101986024|FG000|Overall Study|Study drug toxicity|2|||
33572477|NCT00698841|101986024|FG000|Overall Study|Other|2|||
33229514|NCT02960763|100739398|FG004|Step 2|Lost to Follow-up|1|||
33229515|NCT02960763|100739394|FG000|Step 2|Investigator discretion|0|||
33229516|NCT02960763|100739395|FG001|Step 2|Investigator discretion|0|||
33572478|NCT00902330|101986025|FG000|Overall Study|Too overwhelmed by treatment|2|||
33572479|NCT00902330|101986026|FG001|Overall Study|Too overwhelmed by treatment|5|||
33572480|NCT00902330|101986025|FG000|Overall Study|Adverse Event|1|||
33572481|NCT00902330|101986026|FG001|Overall Study|Adverse Event|0|||
33572482|NCT00902330|101986025|FG000|Overall Study|No post baseline data|1|||
33572483|NCT00902330|101986026|FG001|Overall Study|No post baseline data|0|||
33419100|NCT02367781|101425649|FG000|Overall Study|Prolonged Hospitalization|1|||
33419101|NCT02367781|101425650|FG001|Overall Study|Prolonged Hospitalization|0|||
33229517|NCT02960763|100739396|FG002|Step 2|Investigator discretion|0|||
33229518|NCT02960763|100739397|FG003|Step 2|Investigator discretion|0|||
33229519|NCT02960763|100739398|FG004|Step 2|Investigator discretion|1|||
33367281|NCT00069095|101230208|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
33419102|NCT02367781|101425649|FG000|Overall Study|Death Prior First Dose|1|||
33367282|NCT00069095|101230209|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
33367283|NCT00069095|101230210|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
33572484|NCT00474903|101986027|FG000|Overall Study|Protocol Violation|1|||
33572485|NCT00474903|101986028|FG001|Overall Study|Protocol Violation|5|||
33572486|NCT00474903|101986029|FG002|Overall Study|Protocol Violation|2|||
33572487|NCT04046939|101986030|FG000|Primary Assessment Period|Adverse Event|1|||
33572488|NCT04046939|101986031|FG001|Primary Assessment Period|Adverse Event|0|||
33572489|NCT04046939|101986032|FG002|Primary Assessment Period|Adverse Event|0|||
33634636|NCT02113982|102214585|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
33367284|NCT00069095|101230211|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
33419103|NCT02367781|101425650|FG001|Overall Study|Death Prior First Dose|0|||
33419104|NCT02367781|101425649|FG000|Overall Study|Administrative-Change Facility|1|||
33419105|NCT02367781|101425650|FG001|Overall Study|Administrative-Change Facility|0|||
33572490|NCT04046939|101986033|FG003|Primary Assessment Period|Adverse Event|0|||
33572491|NCT04046939|101986030|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
33572492|NCT04046939|101986031|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
33367285|NCT00069095|101230212|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
33367286|NCT00069095|101230207|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
33367287|NCT00069095|101230208|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
33367288|NCT00069095|101230209|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
33367289|NCT00069095|101230210|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
33419106|NCT02367781|101425649|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
33572493|NCT04046939|101986032|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
33572494|NCT04046939|101986033|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
33572495|NCT04046939|101986030|FG000|Primary Assessment Period|Physician Decision|0|||
33229520|NCT02887989|100739401|FG000|Overall Study|Withdrawal by Subject|8|||
33229521|NCT02887989|100739402|FG001|Overall Study|Withdrawal by Subject|11|||
33572496|NCT04046939|101986031|FG001|Primary Assessment Period|Physician Decision|0|||
33572497|NCT04046939|101986032|FG002|Primary Assessment Period|Physician Decision|1|||
33572498|NCT04046939|101986033|FG003|Primary Assessment Period|Physician Decision|0|||
33572499|NCT04046939|101986030|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
33229522|NCT02887989|100739401|FG000|Overall Study|Death|1|||
33229523|NCT02887989|100739402|FG001|Overall Study|Death|0|||
33229524|NCT00390455|100739403|FG000|Overall Study|Adverse Event|17|||
33229525|NCT00390455|100739404|FG001|Overall Study|Adverse Event|3|||
33229526|NCT00390455|100739403|FG000|Overall Study|Withdrawal by Subject|8|||
33229527|NCT00390455|100739404|FG001|Overall Study|Withdrawal by Subject|8|||
33229528|NCT00390455|100739403|FG000|Overall Study|Alternate Treatment|0|||
33229529|NCT00390455|100739404|FG001|Overall Study|Alternate Treatment|1|||
33229530|NCT00390455|100739403|FG000|Overall Study|Other Medical Reasons|7|||
33229531|NCT00390455|100739404|FG001|Overall Study|Other Medical Reasons|11|||
33229532|NCT01588990|100739406|FG000|Phase A|Withdrawal by Subject|5|||
33229533|NCT01588990|100739406|FG000|Phase A|Physician Decision|11|||
33229534|NCT01588990|100739406|FG000|Phase A|Other|14|||
33367290|NCT00069095|101230211|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
33367291|NCT00069095|101230212|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
33367292|NCT00069095|101230207|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
33572500|NCT04046939|101986031|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
33572501|NCT04046939|101986032|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
33572502|NCT04046939|101986033|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
33572503|NCT01074931|101986034|FG000|Overall Study|Economic reasons|1|||
33572504|NCT01074931|101986034|FG000|Overall Study|Death|5|||
33634637|NCT02113982|102214586|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
33634638|NCT02113982|102214587|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
33634639|NCT02113982|102214588|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
33634640|NCT02113982|102214589|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
33634641|NCT02113982|102214590|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
33634642|NCT02113982|102214591|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
33634643|NCT02113982|102214592|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
33634644|NCT02113982|102214593|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
33634645|NCT02113982|102214594|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
33634646|NCT02113982|102214595|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
33634647|NCT02113982|102214596|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
33634648|NCT02113982|102214583|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
33229535|NCT01588990|100739406|FG000|Phase A|Lost to Follow-up|1|||
33367293|NCT00069095|101230208|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
33367294|NCT00069095|101230209|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
33367295|NCT00069095|101230210|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
33367296|NCT00069095|101230211|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
33367297|NCT00069095|101230212|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
33367298|NCT00069095|101230207|FG000|Post-study Treatment Phase|Investigator decision|0|||
33367299|NCT00069095|101230208|FG001|Post-study Treatment Phase|Investigator decision|0|||
33367300|NCT00069095|101230209|FG002|Post-study Treatment Phase|Investigator decision|0|||
33367301|NCT00069095|101230210|FG003|Post-study Treatment Phase|Investigator decision|0|||
33367302|NCT00069095|101230211|FG004|Post-study Treatment Phase|Investigator decision|0|||
33367303|NCT00069095|101230212|FG005|Post-study Treatment Phase|Investigator decision|1|||
33634649|NCT02113982|102214584|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
33634650|NCT02113982|102214585|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
33634651|NCT02113982|102214586|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
33634652|NCT02113982|102214587|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
33229536|NCT01588990|100739406|FG000|Phase A|Death|5|||
33229537|NCT01588990|100739406|FG000|Phase A|Adverse Event|28|||
33229538|NCT01588990|100739406|FG000|Phase A|Still on therapy at end of study|6|||
33229539|NCT01588990|100739406|FG000|Phase B|Adverse Event|2|||
33229540|NCT01588990|100739406|FG000|Phase B|Still on therapy at end of study|5|||
33572505|NCT03434834|101986035|FG000|Overall Study|unable to swallow OCT probe|16|||
33367304|NCT00069095|101230207|FG000|Follow-up Phase|Death|174|||
33367305|NCT00069095|101230208|FG001|Follow-up Phase|Death|206|||
33367306|NCT00069095|101230209|FG002|Follow-up Phase|Death|120|||
33229541|NCT01588990|100739406|FG000|Phase B|Withdrawal by Subject|3|||
33229542|NCT01588990|100739406|FG000|Phase B|Physician Decision|4|||
33229543|NCT01588990|100739406|FG000|Phase B|Other|2|||
33229544|NCT01719224|100739407|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
33229545|NCT01719224|100739408|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
33229546|NCT02366936|100739413|FG000|Overall Study|Withdrawal by Subject|2|||
33229547|NCT02366936|100739413|FG000|Overall Study|Lost to Follow-up|4|||
33229548|NCT02366936|100739413|FG000|Overall Study|Physician Decision|2|||
33367307|NCT00069095|101230210|FG003|Follow-up Phase|Death|112|||
33229549|NCT04091360|100739416|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33229550|NCT04091360|100739417|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33572506|NCT04618471|101986036|FG000|Overall Study|Screen Failure|62|||
33572507|NCT04618471|101986036|FG000|Overall Study|Withdrawal by Subject|6|||
33572508|NCT04618471|101986036|FG000|Overall Study|Physician Decision|2|||
33229551|NCT04091360|100739418|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33367308|NCT00069095|101230211|FG004|Follow-up Phase|Death|92|||
33367309|NCT00069095|101230212|FG005|Follow-up Phase|Death|101|||
33229552|NCT04091360|100739419|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33229553|NCT04091360|100739420|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33229554|NCT04091360|100739421|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33229555|NCT04091360|100739422|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33229556|NCT04091360|100739423|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
33229557|NCT04091360|100739424|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
33229558|NCT04091360|100739425|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
33229559|NCT04091360|100739416|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33229560|NCT04091360|100739417|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33229561|NCT04091360|100739418|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33419107|NCT02367781|101425650|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
33419108|NCT02367781|101425649|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
33419109|NCT02367781|101425650|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
33419110|NCT02367781|101425649|FG000|Overall Study|Study Terminated by Sponsor|3|||
33229562|NCT04091360|100739419|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33419111|NCT02367781|101425650|FG001|Overall Study|Study Terminated by Sponsor|1|||
33634653|NCT02113982|102214588|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
33229563|NCT04091360|100739420|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33229564|NCT04091360|100739421|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33229565|NCT04091360|100739422|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
33229566|NCT04091360|100739423|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
33229567|NCT04091360|100739424|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33229568|NCT04091360|100739425|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
33229569|NCT04091360|100739416|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33229570|NCT04091360|100739417|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33229571|NCT04091360|100739418|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33229572|NCT04091360|100739419|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33229573|NCT04091360|100739420|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33229574|NCT04091360|100739421|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33229575|NCT04091360|100739422|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
33229576|NCT04091360|100739423|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33229577|NCT04091360|100739424|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
33229578|NCT04091360|100739425|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
33229579|NCT00810082|100739426|FG000|Overall Study|Lost to Follow-up|0|||
33229580|NCT00810082|100739427|FG001|Overall Study|Lost to Follow-up|4|||
33229581|NCT04192630|100742358|FG000|Overall Study|Discontinued before surgery|2|||
33229582|NCT04192630|100742359|FG001|Overall Study|Discontinued before surgery|0|||
33229583|NCT04192630|100742358|FG000|Overall Study|Discontinued after surgery|5|||
33229584|NCT04192630|100742359|FG001|Overall Study|Discontinued after surgery|3|||
33229585|NCT00235443|100742360|FG000|Overall Study|Adverse Event|4|||
33229586|NCT00235443|100742361|FG001|Overall Study|Adverse Event|12|||
33229587|NCT00235443|100742362|FG002|Overall Study|Adverse Event|17|||
33229588|NCT00235443|100742363|FG003|Overall Study|Adverse Event|44|||
33229589|NCT00235443|100742364|FG004|Overall Study|Adverse Event|10|||
33229590|NCT00235443|100742365|FG005|Overall Study|Adverse Event|15|||
33229591|NCT00235443|100742360|FG000|Overall Study|Lack of Efficacy|0|||
33229592|NCT00235443|100742361|FG001|Overall Study|Lack of Efficacy|1|||
33229593|NCT00235443|100742362|FG002|Overall Study|Lack of Efficacy|5|||
33229594|NCT00235443|100742363|FG003|Overall Study|Lack of Efficacy|12|||
33229595|NCT00235443|100742364|FG004|Overall Study|Lack of Efficacy|2|||
33229596|NCT00235443|100742365|FG005|Overall Study|Lack of Efficacy|9|||
33229597|NCT00235443|100742360|FG000|Overall Study|Withdrawal by Subject|3|||
33229598|NCT00235443|100742361|FG001|Overall Study|Withdrawal by Subject|9|||
33229599|NCT00235443|100742362|FG002|Overall Study|Withdrawal by Subject|25|||
33229600|NCT00235443|100742363|FG003|Overall Study|Withdrawal by Subject|24|||
33229601|NCT00235443|100742364|FG004|Overall Study|Withdrawal by Subject|10|||
33229602|NCT00235443|100742365|FG005|Overall Study|Withdrawal by Subject|12|||
33229603|NCT00235443|100742360|FG000|Overall Study|Lost to Follow-up|0|||
33229604|NCT00235443|100742361|FG001|Overall Study|Lost to Follow-up|8|||
33229605|NCT00235443|100742362|FG002|Overall Study|Lost to Follow-up|6|||
33229606|NCT00235443|100742363|FG003|Overall Study|Lost to Follow-up|6|||
33229607|NCT00235443|100742364|FG004|Overall Study|Lost to Follow-up|4|||
33229608|NCT00235443|100742365|FG005|Overall Study|Lost to Follow-up|3|||
33229609|NCT00235443|100742360|FG000|Overall Study|Unsatisfactory compliance|0|||
33229610|NCT00235443|100742361|FG001|Overall Study|Unsatisfactory compliance|2|||
33229611|NCT00235443|100742362|FG002|Overall Study|Unsatisfactory compliance|3|||
33229612|NCT00235443|100742363|FG003|Overall Study|Unsatisfactory compliance|4|||
33229613|NCT00235443|100742364|FG004|Overall Study|Unsatisfactory compliance|1|||
33229614|NCT00235443|100742365|FG005|Overall Study|Unsatisfactory compliance|0|||
33229615|NCT00235443|100742360|FG000|Overall Study|Other reasons for premature termination|1|||
33229616|NCT00235443|100742361|FG001|Overall Study|Other reasons for premature termination|6|||
33229617|NCT00235443|100742362|FG002|Overall Study|Other reasons for premature termination|6|||
33229618|NCT00235443|100742363|FG003|Overall Study|Other reasons for premature termination|7|||
33229619|NCT00235443|100742364|FG004|Overall Study|Other reasons for premature termination|3|||
33229620|NCT00235443|100742365|FG005|Overall Study|Other reasons for premature termination|6|||
33229621|NCT00734214|100742366|FG000|Overall Study|Withdrawal by Subject|3|||
33229622|NCT00734214|100742367|FG001|Overall Study|Withdrawal by Subject|4|||
33229623|NCT00734214|100742366|FG000|Overall Study|MD withdrawal|1|||
33229624|NCT00734214|100742367|FG001|Overall Study|MD withdrawal|0|||
33229625|NCT02318719|100742369|FG000|Double-blind Phase|Adverse Event|7|||
33229626|NCT02318719|100742370|FG001|Double-blind Phase|Adverse Event|6|||
33229627|NCT02318719|100742371|FG002|Double-blind Phase|Adverse Event|12|||
33229628|NCT02318719|100742372|FG003|Double-blind Phase|Adverse Event|4|||
33229629|NCT02318719|100742373|FG004|Double-blind Phase|Adverse Event|0|||
33229630|NCT02318719|100742369|FG000|Double-blind Phase|Lack of Efficacy|5|||
33229631|NCT02318719|100742370|FG001|Double-blind Phase|Lack of Efficacy|0|||
33229632|NCT02318719|100742371|FG002|Double-blind Phase|Lack of Efficacy|1|||
33229633|NCT02318719|100742372|FG003|Double-blind Phase|Lack of Efficacy|1|||
33229634|NCT02318719|100742373|FG004|Double-blind Phase|Lack of Efficacy|0|||
33229635|NCT02318719|100742369|FG000|Double-blind Phase|Protocol Violation|0|||
33229636|NCT02318719|100742370|FG001|Double-blind Phase|Protocol Violation|1|||
33229637|NCT02318719|100742371|FG002|Double-blind Phase|Protocol Violation|3|||
33229638|NCT02318719|100742372|FG003|Double-blind Phase|Protocol Violation|0|||
33229639|NCT02318719|100742373|FG004|Double-blind Phase|Protocol Violation|0|||
33229640|NCT02318719|100742369|FG000|Double-blind Phase|Withdrawal by Subject|25|||
33229641|NCT02318719|100742370|FG001|Double-blind Phase|Withdrawal by Subject|7|||
33229642|NCT02318719|100742371|FG002|Double-blind Phase|Withdrawal by Subject|9|||
33229643|NCT02318719|100742372|FG003|Double-blind Phase|Withdrawal by Subject|10|||
33229644|NCT02318719|100742373|FG004|Double-blind Phase|Withdrawal by Subject|0|||
33229645|NCT02318719|100742369|FG000|Double-blind Phase|Other|1|||
33229646|NCT02318719|100742370|FG001|Double-blind Phase|Other|2|||
33229647|NCT02318719|100742371|FG002|Double-blind Phase|Other|0|||
33229648|NCT02318719|100742372|FG003|Double-blind Phase|Other|0|||
33229649|NCT02318719|100742373|FG004|Double-blind Phase|Other|0|||
33229650|NCT02318719|100742369|FG000|Open-label Extension Phase|Adverse Event|0|||
33229651|NCT02318719|100742370|FG001|Open-label Extension Phase|Adverse Event|0|||
33229652|NCT02318719|100742371|FG002|Open-label Extension Phase|Adverse Event|0|||
33229653|NCT02318719|100742372|FG003|Open-label Extension Phase|Adverse Event|0|||
33229654|NCT02318719|100742373|FG004|Open-label Extension Phase|Adverse Event|15|||
33229655|NCT02318719|100742369|FG000|Open-label Extension Phase|Death|0|||
33229656|NCT02318719|100742370|FG001|Open-label Extension Phase|Death|0|||
33572509|NCT04618471|101986036|FG000|Overall Study|Lost to Follow-up|1|||
33572510|NCT04618471|101986036|FG000|Overall Study|Various other reasons|2|||
33572511|NCT04618471|101986036|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
33572512|NCT03122184|101986037|FG000|Overall Study|Lost to Follow-up|4|||
33572513|NCT03122184|101986038|FG001|Overall Study|Lost to Follow-up|6|||
33572514|NCT03122184|101986037|FG000|Overall Study|Withdrawal by Subject|3|||
33572515|NCT03122184|101986038|FG001|Overall Study|Withdrawal by Subject|0|||
33572516|NCT03122184|101986037|FG000|Overall Study|Terminated due to cognitive problem|1|||
33572517|NCT03122184|101986038|FG001|Overall Study|Terminated due to cognitive problem|0|||
33572518|NCT00320606|101986039|FG000|Overall Study|Adverse Event|1|||
33572519|NCT00320606|101986039|FG000|Overall Study|Protocol Violation|1|||
33572520|NCT00320606|101986039|FG000|Overall Study|Withdrawal by Subject|1|||
33572521|NCT01570387|101986042|FG000|Overall Study|Adverse Event|1|||
33572522|NCT01570387|101986043|FG001|Overall Study|Adverse Event|0|||
33572523|NCT01570387|101986044|FG002|Overall Study|Adverse Event|0|||
33572524|NCT01570387|101986045|FG003|Overall Study|Adverse Event|0|||
33572525|NCT01570387|101986042|FG000|Overall Study|Death|0|||
33572526|NCT01570387|101986043|FG001|Overall Study|Death|0|||
33572527|NCT01570387|101986044|FG002|Overall Study|Death|0|||
33572528|NCT01570387|101986045|FG003|Overall Study|Death|1|||
33572529|NCT01570387|101986042|FG000|Overall Study|Withdrawal by Subject|0|||
33572530|NCT01570387|101986043|FG001|Overall Study|Withdrawal by Subject|0|||
33572531|NCT01570387|101986044|FG002|Overall Study|Withdrawal by Subject|0|||
33572532|NCT01570387|101986045|FG003|Overall Study|Withdrawal by Subject|1|||
33572533|NCT01854528|101986046|FG000|Overall Study|Adverse Event|0|||
33572534|NCT01854528|101986047|FG001|Overall Study|Adverse Event|4|||
33572535|NCT01854528|101986046|FG000|Overall Study|Withdrawal by Subject|0|||
33229657|NCT02318719|100742371|FG002|Open-label Extension Phase|Death|0|||
33572536|NCT01854528|101986047|FG001|Overall Study|Withdrawal by Subject|2|||
33572537|NCT01854528|101986046|FG000|Overall Study|Virologic Failure|0|||
33572538|NCT01854528|101986047|FG001|Overall Study|Virologic Failure|9|||
33229658|NCT02318719|100742372|FG003|Open-label Extension Phase|Death|0|||
33229659|NCT02318719|100742373|FG004|Open-label Extension Phase|Death|1|||
33229660|NCT02318719|100742369|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
33229661|NCT02318719|100742370|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
33229662|NCT02318719|100742371|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
33229663|NCT02318719|100742372|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
33229664|NCT02318719|100742373|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
33229665|NCT02318719|100742369|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
33229666|NCT02318719|100742370|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
33229667|NCT02318719|100742371|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
33229668|NCT02318719|100742372|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
33229669|NCT02318719|100742373|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
33229670|NCT02318719|100742369|FG000|Open-label Extension Phase|Other|0|||
33229671|NCT02318719|100742370|FG001|Open-label Extension Phase|Other|0|||
33229672|NCT02318719|100742371|FG002|Open-label Extension Phase|Other|0|||
33229673|NCT02318719|100742372|FG003|Open-label Extension Phase|Other|0|||
33229674|NCT02318719|100742373|FG004|Open-label Extension Phase|Other|7|||
33229675|NCT04105972|100742383|FG000|Overall Study|Adverse Event|2|||
33229676|NCT04105972|100742384|FG001|Overall Study|Adverse Event|1|||
33229677|NCT01827254|100742385|FG000|Overall Study|Death|10|||
33229678|NCT01827254|100742385|FG000|Overall Study|Case report form not completed|4|||
33229679|NCT01827254|100742385|FG000|Overall Study|Invalidated centre|3|||
33229680|NCT01827254|100742385|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
33229681|NCT01827254|100742385|FG000|Overall Study|Did not complete re-challenge|1|||
33229682|NCT01827254|100742385|FG000|Overall Study|Disease progression|36|||
33229683|NCT01827254|100742385|FG000|Overall Study|Intolerance to treatment|4|||
33229684|NCT01267253|100742386|FG000|Overall Study|Ineligible - required test not done|1|||
33229685|NCT01267253|100742386|FG000|Overall Study|Inevaluable-never received study treatme|2|||
33229686|NCT01493960|100742388|FG000|Overall Study|Adverse Event|0|||
33229687|NCT01493960|100742389|FG001|Overall Study|Adverse Event|1|||
33229688|NCT01493960|100742388|FG000|Overall Study|Lack of Efficacy|15|||
33229689|NCT01493960|100742389|FG001|Overall Study|Lack of Efficacy|9|||
33229690|NCT01493960|100742388|FG000|Overall Study|Protocol Violation|3|||
33229691|NCT01493960|100742389|FG001|Overall Study|Protocol Violation|0|||
33572539|NCT02519842|101986048|FG000|Base Study: Cycle 1|Screening Failure|1|||
33572540|NCT02519842|101986049|FG001|Base Study: Cycle 1|Screening Failure|1|||
33229692|NCT01493960|100742388|FG000|Overall Study|Withdrawal by Subject|10|||
33229693|NCT01493960|100742389|FG001|Overall Study|Withdrawal by Subject|4|||
33229694|NCT01493960|100742388|FG000|Overall Study|Non-specified|4|||
33229695|NCT01493960|100742389|FG001|Overall Study|Non-specified|4|||
33229696|NCT04422639|100742390|FG000|Overall Study|Death|1|||
33229697|NCT04422639|100742391|FG001|Overall Study|Death|0|||
33229698|NCT04422639|100742390|FG000|Overall Study|study closed prior to completion of FU visits|0|||
33229699|NCT04422639|100742391|FG001|Overall Study|study closed prior to completion of FU visits|2|||
33229700|NCT01630590|100742399|FG000|Overall Study|Adverse Event|9|||
33229701|NCT01630590|100742399|FG000|Overall Study|Lack of Efficacy|37|||
33229702|NCT01630590|100742399|FG000|Overall Study|Withdrawal by Subject|4|||
33229703|NCT01630590|100742399|FG000|Overall Study|2nd primary tumor|2|||
33229704|NCT01630590|100742399|FG000|Overall Study|Automobile accident|1|||
33229705|NCT01630590|100742399|FG000|Overall Study|Maximum benefit|4|||
33229706|NCT00098254|100742406|FG000|Overall Study|Adverse Event|2|||
33229707|NCT00098254|100742406|FG000|Overall Study|Death|1|||
33229708|NCT02906202|100742407|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
33229709|NCT01613027|100742408|FG000|Overall Study|Lost to Follow-up|5|||
33229710|NCT01613027|100742408|FG000|Overall Study|Switched Physician|1|||
33229711|NCT01613027|100742408|FG000|Overall Study|Lack of Efficacy|1|||
33229712|NCT01613027|100742408|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
33229713|NCT01382940|100742414|FG000|Overall Study|Adverse Event|19|||
33229714|NCT01382940|100742414|FG000|Overall Study|Lost to Follow-up|4|||
33229715|NCT01382940|100742414|FG000|Overall Study|Physician Decision|7|||
33229716|NCT01382940|100742414|FG000|Overall Study|Withdrawal by Subject|23|||
33572541|NCT02519842|101986050|FG002|Base Study: Cycle 1|Screening Failure|0|||
33572542|NCT02519842|101986048|FG000|Base Study: Cycle 1|Adverse Event|1|||
33229717|NCT01382940|100742414|FG000|Overall Study|Protocol Violation|20|||
33229718|NCT03119610|100742415|FG000|Overall Study|Adverse Event|1|||
33229719|NCT03119610|100742416|FG001|Overall Study|Adverse Event|0|||
33229720|NCT03119610|100742415|FG000|Overall Study|Lost to Follow-up|0|||
33229721|NCT03119610|100742416|FG001|Overall Study|Lost to Follow-up|1|||
33229722|NCT01463293|100742417|FG000|Overall Study|Lost to Follow-up|1|||
33489718|NCT02899962|101686772|FG000|Open-label Phase|Lost to Follow-up|9|||
33572543|NCT02519842|101986049|FG001|Base Study: Cycle 1|Adverse Event|0|||
33572544|NCT02519842|101986050|FG002|Base Study: Cycle 1|Adverse Event|0|||
33229723|NCT01463293|100742418|FG001|Overall Study|Lost to Follow-up|4|||
33229724|NCT01463293|100742419|FG002|Overall Study|Lost to Follow-up|5|||
33229725|NCT01463293|100742417|FG000|Overall Study|Adverse Event|1|||
33229726|NCT01463293|100742418|FG001|Overall Study|Adverse Event|2|||
33229727|NCT01463293|100742419|FG002|Overall Study|Adverse Event|0|||
33572545|NCT02519842|101986048|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
33572546|NCT02519842|101986049|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
33572547|NCT02519842|101986050|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
33572548|NCT02519842|101986048|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
33572549|NCT02519842|101986049|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
33572550|NCT02519842|101986050|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
33572551|NCT02519842|101986048|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
33572552|NCT02519842|101986049|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
33572553|NCT02519842|101986050|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
33229728|NCT01463293|100742417|FG000|Overall Study|Withdrawal by Subject|4|||
33229729|NCT01463293|100742418|FG001|Overall Study|Withdrawal by Subject|10|||
33229730|NCT01463293|100742419|FG002|Overall Study|Withdrawal by Subject|5|||
33229731|NCT01463293|100742417|FG000|Overall Study|Other|0|||
33572554|NCT02519842|101986048|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
33229732|NCT01463293|100742418|FG001|Overall Study|Other|0|||
33229733|NCT01463293|100742419|FG002|Overall Study|Other|2|||
33229734|NCT01544582|100742422|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
33367310|NCT04359823|101230217|FG000|Overall Study|Lost to Follow-up|0|||
33367311|NCT04359823|101230218|FG001|Overall Study|Lost to Follow-up|1|||
33367312|NCT04359823|101230217|FG000|Overall Study|Withdrawal by Subject|0|||
33367313|NCT04359823|101230218|FG001|Overall Study|Withdrawal by Subject|1|||
33367314|NCT02460822|101230221|FG000|Overall Study|Withdrawal by Subject|1|||
33367315|NCT00935220|101230222|FG000|Overall Study|Adverse Event|1|||
33367316|NCT00935220|101230222|FG000|Overall Study|Other reason (not specified)|1|||
33367317|NCT02691247|101230224|FG000|Overall Study|Withdrawal by Subject|1|||
33367318|NCT02691247|101230225|FG001|Overall Study|Withdrawal by Subject|2|||
33367319|NCT02691247|101230226|FG002|Overall Study|Withdrawal by Subject|2|||
33367320|NCT02691247|101230224|FG000|Overall Study|Lost to Follow-up|2|||
33367321|NCT02691247|101230225|FG001|Overall Study|Lost to Follow-up|0|||
33367322|NCT02691247|101230226|FG002|Overall Study|Lost to Follow-up|1|||
33367323|NCT00637273|101230227|FG000|Overall Study|Adverse Event|11|||
33367324|NCT00637273|101230228|FG001|Overall Study|Adverse Event|5|||
33367325|NCT00637273|101230229|FG002|Overall Study|Adverse Event|7|||
33367326|NCT00637273|101230227|FG000|Overall Study|Lost to Follow-up|8|||
33367327|NCT00637273|101230228|FG001|Overall Study|Lost to Follow-up|9|||
33367328|NCT00637273|101230229|FG002|Overall Study|Lost to Follow-up|13|||
33367329|NCT00637273|101230227|FG000|Overall Study|Protocol Violation|2|||
33367330|NCT00637273|101230228|FG001|Overall Study|Protocol Violation|4|||
33367331|NCT00637273|101230229|FG002|Overall Study|Protocol Violation|1|||
33367332|NCT00637273|101230227|FG000|Overall Study|Withdrawal of Consent|18|||
33367333|NCT00637273|101230228|FG001|Overall Study|Withdrawal of Consent|6|||
33367334|NCT00637273|101230229|FG002|Overall Study|Withdrawal of Consent|18|||
33367335|NCT00637273|101230227|FG000|Overall Study|Investigator Decision|1|||
33367336|NCT00637273|101230228|FG001|Overall Study|Investigator Decision|3|||
33367337|NCT00637273|101230229|FG002|Overall Study|Investigator Decision|1|||
33367338|NCT00637273|101230227|FG000|Overall Study|Administrative|2|||
33229735|NCT01544582|100742423|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
33229736|NCT01544582|100742424|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
33367339|NCT00637273|101230228|FG001|Overall Study|Administrative|0|||
33367340|NCT00637273|101230229|FG002|Overall Study|Administrative|0|||
33367341|NCT00637273|101230227|FG000|Overall Study|Loss of Glucose Control|1|||
33367342|NCT00637273|101230228|FG001|Overall Study|Loss of Glucose Control|1|||
33367343|NCT00637273|101230229|FG002|Overall Study|Loss of Glucose Control|1|||
33367344|NCT01881620|101230232|FG000|Overall Study|Protocol Violation|4|||
33419112|NCT02367781|101425649|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
33419113|NCT02367781|101425650|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
33419114|NCT02367781|101425649|FG000|Overall Study|Sponsor Decision|2|||
33419115|NCT02367781|101425650|FG001|Overall Study|Sponsor Decision|0|||
33367345|NCT02584634|101230239|FG000|Overall Study|Adverse Event|3|||
33367346|NCT02584634|101230240|FG001|Overall Study|Adverse Event|5|||
33367347|NCT02584634|101230239|FG000|Overall Study|Death|0|||
33367348|NCT02584634|101230240|FG001|Overall Study|Death|1|||
33367349|NCT02584634|101230239|FG000|Overall Study|Lost to Follow-up|0|||
33367350|NCT02584634|101230240|FG001|Overall Study|Lost to Follow-up|1|||
33367351|NCT02584634|101230239|FG000|Overall Study|Physician Decision|1|||
33367352|NCT02584634|101230240|FG001|Overall Study|Physician Decision|2|||
33367353|NCT02584634|101230239|FG000|Overall Study|Progressive disease|7|||
33367354|NCT02584634|101230240|FG001|Overall Study|Progressive disease|15|||
33572555|NCT02519842|101986049|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
33367355|NCT02584634|101230239|FG000|Overall Study|Withdrawal by Subject|1|||
33367356|NCT02584634|101230240|FG001|Overall Study|Withdrawal by Subject|1|||
33367357|NCT02584634|101230239|FG000|Overall Study|Other|0|||
33367358|NCT02584634|101230240|FG001|Overall Study|Other|6|||
33419116|NCT02367781|101425649|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
33419117|NCT02367781|101425650|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
33419118|NCT04723173|101425654|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
33419119|NCT05302414|101425659|FG000|Pretest to Posttest|Lost to Follow-up|12|||
33419120|NCT05302414|101425660|FG001|Pretest to Posttest|Lost to Follow-up|8|||
33419121|NCT05302414|101425661|FG002|Pretest to Posttest|Lost to Follow-up|8|||
33419122|NCT05302414|101425659|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
33419123|NCT05302414|101425660|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
33419124|NCT05302414|101425661|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
33419125|NCT00981409|101425663|FG000|Overall Study|Adverse Event|4|||
33419126|NCT00981409|101425664|FG001|Overall Study|Adverse Event|0|||
33419127|NCT00981409|101425663|FG000|Overall Study|Protocol Violation|0|||
33419128|NCT00981409|101425664|FG001|Overall Study|Protocol Violation|1|||
33419129|NCT00981409|101425663|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
33419130|NCT00981409|101425664|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
33572556|NCT02519842|101986050|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
33572557|NCT02519842|101986048|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
33572558|NCT02519842|101986049|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
33572559|NCT02519842|101986050|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
33572560|NCT02519842|101986048|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
33572561|NCT02519842|101986049|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
33572562|NCT02519842|101986050|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
33572563|NCT02519842|101986048|FG000|Optional Extension: Cycles 2-6|Death|0|||
33572564|NCT02519842|101986049|FG001|Optional Extension: Cycles 2-6|Death|0|||
33572565|NCT02519842|101986050|FG002|Optional Extension: Cycles 2-6|Death|1|||
33572566|NCT02519842|101986048|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
33572567|NCT02519842|101986049|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
33572568|NCT02519842|101986050|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
33572569|NCT02519842|101986048|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
33572570|NCT02519842|101986049|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
33572571|NCT02519842|101986050|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
33572572|NCT02519842|101986048|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
33572573|NCT02519842|101986049|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
33367359|NCT02260193|101230241|FG000|Overall Study|Lack of Efficacy|0|||
33367360|NCT02260193|101230242|FG001|Overall Study|Lack of Efficacy|1|||
33367361|NCT02260193|101230243|FG002|Overall Study|Lack of Efficacy|6|||
33419131|NCT00759174|101425665|FG000|Overall Study|Other|0|||
33367362|NCT02260193|101230241|FG000|Overall Study|Adverse Event|3|||
33367363|NCT02260193|101230242|FG001|Overall Study|Adverse Event|4|||
33367364|NCT02260193|101230243|FG002|Overall Study|Adverse Event|1|||
33367365|NCT02260193|101230241|FG000|Overall Study|Protocol Violation|0|||
33367366|NCT02260193|101230242|FG001|Overall Study|Protocol Violation|4|||
33419132|NCT00759174|101425666|FG001|Overall Study|Other|2|||
33419133|NCT00445458|101425671|FG000|Overall Study|Disease Progression|3|||
33419134|NCT00445458|101425672|FG001|Overall Study|Disease Progression|4|||
33419135|NCT00445458|101425673|FG002|Overall Study|Disease Progression|54|||
33419136|NCT00445458|101425674|FG003|Overall Study|Disease Progression|27|||
33572574|NCT02519842|101986050|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
33572575|NCT02519842|101986048|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
33572576|NCT02519842|101986049|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
33572577|NCT02519842|101986050|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
33572578|NCT01374425|101986051|FG000|Overall Study|Radiographic Disease Progression|86|||
33572579|NCT01374425|101986052|FG001|Overall Study|Radiographic Disease Progression|81|||
33572580|NCT01374425|101986051|FG000|Overall Study|Clinical Disease Progression|9|||
33572581|NCT01374425|101986052|FG001|Overall Study|Clinical Disease Progression|6|||
33572582|NCT01374425|101986051|FG000|Overall Study|Adverse Event|29|||
33229737|NCT01544582|100742425|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
33229738|NCT01544582|100742422|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
33229739|NCT01544582|100742423|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
33229740|NCT01544582|100742424|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
33229741|NCT01544582|100742425|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
33367367|NCT02260193|101230243|FG002|Overall Study|Protocol Violation|0|||
33367368|NCT02260193|101230241|FG000|Overall Study|Withdrawal by Subject|3|||
33634654|NCT02113982|102214589|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
33634655|NCT02113982|102214590|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
33634656|NCT02113982|102214591|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
33634657|NCT02113982|102214592|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
33634658|NCT02113982|102214593|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
33634659|NCT02113982|102214594|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
33634660|NCT02113982|102214595|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
33634661|NCT02113982|102214596|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
33634662|NCT02113982|102214583|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
33634663|NCT02113982|102214584|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
33634664|NCT02113982|102214585|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
33634665|NCT02113982|102214586|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
33634666|NCT02113982|102214587|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
33634667|NCT02113982|102214588|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
33634668|NCT02113982|102214589|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
33634669|NCT02113982|102214590|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
33634670|NCT02113982|102214591|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
33634671|NCT02113982|102214592|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
33634672|NCT02113982|102214593|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
33634673|NCT02113982|102214594|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
33634674|NCT02113982|102214595|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
33634675|NCT02113982|102214596|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
33634676|NCT02113982|102214583|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
33634677|NCT02113982|102214584|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
33367369|NCT02260193|101230242|FG001|Overall Study|Withdrawal by Subject|0|||
33367370|NCT02260193|101230243|FG002|Overall Study|Withdrawal by Subject|2|||
33367371|NCT02260193|101230241|FG000|Overall Study|Kidney Transplantation|0|||
33367372|NCT02260193|101230242|FG001|Overall Study|Kidney Transplantation|0|||
33367373|NCT02260193|101230243|FG002|Overall Study|Kidney Transplantation|1|||
33367374|NCT02761993|101230244|FG000|Overall Study|Adverse Event|0|||
33367375|NCT02761993|101230245|FG001|Overall Study|Adverse Event|2|||
33367376|NCT02761993|101230246|FG002|Overall Study|Adverse Event|0|||
33367377|NCT02761993|101230244|FG000|Overall Study|Lost to Follow-up|1|||
33367378|NCT02761993|101230245|FG001|Overall Study|Lost to Follow-up|3|||
33367379|NCT02761993|101230246|FG002|Overall Study|Lost to Follow-up|2|||
33367380|NCT02761993|101230244|FG000|Overall Study|Withdrawal by Subject|1|||
33572583|NCT01374425|101986052|FG001|Overall Study|Adverse Event|18|||
33572584|NCT01374425|101986051|FG000|Overall Study|Death (Progression of Disease)|1|||
33572585|NCT01374425|101986052|FG001|Overall Study|Death (Progression of Disease)|0|||
33419137|NCT00445458|101425671|FG000|Overall Study|Withdrawal by Subject|0|||
33572586|NCT01374425|101986051|FG000|Overall Study|Death (Adverse Event)|2|||
33572587|NCT01374425|101986052|FG001|Overall Study|Death (Adverse Event)|4|||
33572588|NCT01374425|101986051|FG000|Overall Study|Withdrawal by Subject|6|||
33572589|NCT01374425|101986052|FG001|Overall Study|Withdrawal by Subject|7|||
33572590|NCT01374425|101986051|FG000|Overall Study|Refused Treatment|10|||
33572591|NCT01374425|101986052|FG001|Overall Study|Refused Treatment|24|||
33572592|NCT01374425|101986051|FG000|Overall Study|Protocol Violation|2|||
33572593|NCT01374425|101986052|FG001|Overall Study|Protocol Violation|3|||
33572594|NCT01374425|101986051|FG000|Overall Study|Sponsor Decision|0|||
33367381|NCT02761993|101230245|FG001|Overall Study|Withdrawal by Subject|1|||
33367382|NCT02761993|101230246|FG002|Overall Study|Withdrawal by Subject|2|||
33367383|NCT00130208|101230247|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
33572595|NCT01374425|101986052|FG001|Overall Study|Sponsor Decision|1|||
33572596|NCT01374425|101986051|FG000|Overall Study|Lost to Follow-up|2|||
33572597|NCT01374425|101986052|FG001|Overall Study|Lost to Follow-up|1|||
33572598|NCT01374425|101986051|FG000|Overall Study|Other|41|||
33572599|NCT01374425|101986052|FG001|Overall Study|Other|43|||
33367384|NCT00130208|101230248|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
33367385|NCT00130208|101230247|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
33367386|NCT00130208|101230248|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
33419138|NCT00445458|101425672|FG001|Overall Study|Withdrawal by Subject|0|||
33419139|NCT00445458|101425673|FG002|Overall Study|Withdrawal by Subject|7|||
33419140|NCT00445458|101425674|FG003|Overall Study|Withdrawal by Subject|0|||
33419141|NCT00445458|101425671|FG000|Overall Study|Adverse Event|0|||
33634678|NCT02113982|102214585|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
33634679|NCT02113982|102214586|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
33367387|NCT00130208|101230247|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
33419142|NCT00445458|101425672|FG001|Overall Study|Adverse Event|0|||
33419143|NCT00445458|101425673|FG002|Overall Study|Adverse Event|3|||
33572600|NCT00431964|101986053|FG000|Overall Study|Adverse Event|1|||
33419144|NCT00445458|101425674|FG003|Overall Study|Adverse Event|0|||
33419145|NCT00445458|101425671|FG000|Overall Study|Death|0|||
33572601|NCT00431964|101986054|FG001|Overall Study|Adverse Event|0|||
33572602|NCT00431964|101986053|FG000|Overall Study|Lost to Follow-up|1|||
33572603|NCT00431964|101986054|FG001|Overall Study|Lost to Follow-up|2|||
33229742|NCT01544582|100742422|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
33229743|NCT01544582|100742423|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
33229744|NCT01544582|100742424|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
33229745|NCT01544582|100742425|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
33229746|NCT01544582|100742422|FG000|Analysis Population|Physician Decision|0|||
33229747|NCT01544582|100742423|FG001|Analysis Population|Physician Decision|13|||
33229748|NCT01544582|100742424|FG002|Analysis Population|Physician Decision|10|||
33229749|NCT01544582|100742425|FG003|Analysis Population|Physician Decision|9|||
33229750|NCT01544582|100742422|FG000|Analysis Population|Safety Reason|0|||
33229751|NCT01544582|100742423|FG001|Analysis Population|Safety Reason|33|||
33229752|NCT01544582|100742424|FG002|Analysis Population|Safety Reason|31|||
33229753|NCT01544582|100742425|FG003|Analysis Population|Safety Reason|8|||
33229754|NCT01544582|100742422|FG000|Analysis Population|Effectiveness Reason|0|||
33229755|NCT01544582|100742423|FG001|Analysis Population|Effectiveness Reason|48|||
33572604|NCT00431964|101986053|FG000|Overall Study|Physician Decision|2|||
33229756|NCT01544582|100742424|FG002|Analysis Population|Effectiveness Reason|29|||
33229757|NCT01544582|100742425|FG003|Analysis Population|Effectiveness Reason|12|||
33572605|NCT00431964|101986054|FG001|Overall Study|Physician Decision|2|||
33229758|NCT01544582|100742422|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
33229759|NCT01544582|100742423|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
33229760|NCT01544582|100742424|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
33572606|NCT00431964|101986053|FG000|Overall Study|Withdrawal by Subject|2|||
33229761|NCT01544582|100742425|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
33229762|NCT01544582|100742422|FG000|Analysis Population|Lost to Follow-up|0|||
33229763|NCT01544582|100742423|FG001|Analysis Population|Lost to Follow-up|6|||
33572607|NCT00431964|101986054|FG001|Overall Study|Withdrawal by Subject|1|||
33229764|NCT01544582|100742424|FG002|Analysis Population|Lost to Follow-up|6|||
33229765|NCT01544582|100742425|FG003|Analysis Population|Lost to Follow-up|5|||
33229766|NCT01544582|100742422|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
33572608|NCT00431964|101986053|FG000|Overall Study|Parental Consent Withdrawn|0|||
33572609|NCT00431964|101986054|FG001|Overall Study|Parental Consent Withdrawn|2|||
33572610|NCT00431964|101986053|FG000|Overall Study|Due to Unstable Health|0|||
33572611|NCT00431964|101986054|FG001|Overall Study|Due to Unstable Health|1|||
33572612|NCT01928433|101986055|FG000|Overall Study|Adverse Event|5|||
33572613|NCT01928433|101986056|FG001|Overall Study|Adverse Event|2|||
33572614|NCT01928433|101986057|FG002|Overall Study|Adverse Event|5|||
33572615|NCT01928433|101986055|FG000|Overall Study|Protocol Violation|0|||
33572616|NCT01928433|101986056|FG001|Overall Study|Protocol Violation|0|||
33572617|NCT01928433|101986057|FG002|Overall Study|Protocol Violation|2|||
33572618|NCT01928433|101986055|FG000|Overall Study|Lack of Efficacy|5|||
33572619|NCT01928433|101986056|FG001|Overall Study|Lack of Efficacy|4|||
33572620|NCT01928433|101986057|FG002|Overall Study|Lack of Efficacy|4|||
33572621|NCT01928433|101986055|FG000|Overall Study|Withdrawal by Subject|0|||
33572622|NCT01928433|101986056|FG001|Overall Study|Withdrawal by Subject|4|||
33572623|NCT01928433|101986057|FG002|Overall Study|Withdrawal by Subject|0|||
33572624|NCT01928433|101986055|FG000|Overall Study|Negative screening urine culture|7|||
33572625|NCT01928433|101986056|FG001|Overall Study|Negative screening urine culture|6|||
33572626|NCT01928433|101986057|FG002|Overall Study|Negative screening urine culture|10|||
33572627|NCT01928433|101986055|FG000|Overall Study|Lost to Follow-up|0|||
33572628|NCT01928433|101986056|FG001|Overall Study|Lost to Follow-up|2|||
33572629|NCT01928433|101986057|FG002|Overall Study|Lost to Follow-up|3|||
33572630|NCT01928433|101986055|FG000|Overall Study|Other reasons|3|||
33572631|NCT01928433|101986056|FG001|Overall Study|Other reasons|3|||
33572632|NCT01928433|101986057|FG002|Overall Study|Other reasons|4|||
33572633|NCT00575666|101986058|FG000|Overall Study|Withdrawal by Subject|3|||
33572634|NCT00575666|101986059|FG001|Overall Study|Withdrawal by Subject|2|||
33572635|NCT00575666|101986058|FG000|Overall Study|Physician Decision|1|||
33572636|NCT00575666|101986059|FG001|Overall Study|Physician Decision|1|||
33572637|NCT01849276|101986063|FG000|Followed for Survival for 5 Years|Death|1|||
33572638|NCT01849276|101986063|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
33572639|NCT01152437|101986068|FG000|Overall Study|Other Adverse Event|8|||
33572640|NCT01152437|101986069|FG001|Overall Study|Other Adverse Event|1|||
33572641|NCT01152437|101986070|FG002|Overall Study|Other Adverse Event|7|||
33572642|NCT01152437|101986068|FG000|Overall Study|Not treated|0|||
33572643|NCT01152437|101986069|FG001|Overall Study|Not treated|1|||
33572644|NCT01152437|101986070|FG002|Overall Study|Not treated|2|||
33572645|NCT01152437|101986068|FG000|Overall Study|Progressive disease|27|||
33572646|NCT01152437|101986069|FG001|Overall Study|Progressive disease|13|||
33572647|NCT01152437|101986070|FG002|Overall Study|Progressive disease|32|||
33572648|NCT01152437|101986068|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
33572649|NCT01152437|101986069|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
33572650|NCT01152437|101986070|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
33572651|NCT02806414|101986071|FG000|Overall Study|Lost to Follow-up|2|||
33572652|NCT02303262|101986072|FG000|Overall Study|Withdrawal by Subject|2|||
33572653|NCT00786422|101986080|FG000|Rivaroxaban Treatment|Death|2|||
33572654|NCT00786422|101986080|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
33572655|NCT00786422|101986080|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
33572656|NCT00786422|101986080|FG000|Rivaroxaban Treatment|Physician Decision|1|||
33572657|NCT00786422|101986080|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
33572658|NCT00786422|101986080|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
33572659|NCT00786422|101986080|FG000|Rivaroxaban Treatment|Adverse Event|2|||
33572660|NCT00786422|101986080|FG000|Follow-up Period|Death|1|||
33572661|NCT00786422|101986080|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
33572662|NCT02112656|101986081|FG000|Overall Study|Death|78|||
33572663|NCT02112656|101986082|FG001|Overall Study|Death|82|||
33572664|NCT02112656|101986081|FG000|Overall Study|Withdrawal by Subject|9|||
33572665|NCT02112656|101986082|FG001|Overall Study|Withdrawal by Subject|11|||
33572666|NCT02112656|101986081|FG000|Overall Study|Lost to Follow-up|2|||
33572667|NCT02112656|101986082|FG001|Overall Study|Lost to Follow-up|4|||
33572668|NCT02112656|101986081|FG000|Overall Study|Noncompliance|1|||
33572669|NCT02112656|101986082|FG001|Overall Study|Noncompliance|2|||
33572670|NCT00876447|101986084|FG000|Overall Study|Other miscellaneous reasons|3|||
33572671|NCT00876447|101986085|FG001|Overall Study|Other miscellaneous reasons|8|||
33572672|NCT00876447|101986084|FG000|Overall Study|Site closure|19|||
33634680|NCT02113982|102214587|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
33634681|NCT02113982|102214588|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
33634682|NCT02113982|102214589|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
33634683|NCT02113982|102214590|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
33634684|NCT02113982|102214591|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
33634685|NCT02113982|102214592|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
33634686|NCT02113982|102214593|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
33634687|NCT02113982|102214594|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
33634688|NCT02113982|102214595|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
33634689|NCT02113982|102214596|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
33634690|NCT02113982|102214583|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
33634691|NCT02113982|102214584|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
33634692|NCT02113982|102214585|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
33634693|NCT02113982|102214586|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
33634694|NCT02113982|102214587|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
33634695|NCT02113982|102214588|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
33634696|NCT02113982|102214589|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
33634697|NCT02113982|102214590|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
33634698|NCT02113982|102214591|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
33634699|NCT02113982|102214592|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
33634700|NCT02113982|102214593|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
33634701|NCT02113982|102214594|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
33634702|NCT02113982|102214595|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
33572673|NCT00876447|101986085|FG001|Overall Study|Site closure|14|||
33634703|NCT02113982|102214596|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
33572674|NCT00876447|101986084|FG000|Overall Study|Protocol Violation|9|||
33572675|NCT00876447|101986085|FG001|Overall Study|Protocol Violation|3|||
33572676|NCT00876447|101986084|FG000|Overall Study|Personal reasons|30|||
33572677|NCT00876447|101986085|FG001|Overall Study|Personal reasons|28|||
33572678|NCT00876447|101986084|FG000|Overall Study|Lost to Follow-up|6|||
33572679|NCT00876447|101986085|FG001|Overall Study|Lost to Follow-up|15|||
33572680|NCT00876447|101986084|FG000|Overall Study|Pregnancy|4|||
33572681|NCT00876447|101986085|FG001|Overall Study|Pregnancy|2|||
33572682|NCT00876447|101986084|FG000|Overall Study|Lack of Efficacy|5|||
33572683|NCT00876447|101986085|FG001|Overall Study|Lack of Efficacy|3|||
33572684|NCT00876447|101986084|FG000|Overall Study|Adverse Event|4|||
33572685|NCT00876447|101986085|FG001|Overall Study|Adverse Event|8|||
33572686|NCT03047135|101986086|FG000|Overall Study|Still being treated|3|||
33572687|NCT02712788|101986094|FG000|Overall Study|Physician Decision|1|||
33572688|NCT02712788|101986095|FG001|Overall Study|Physician Decision|0|||
33572689|NCT02712788|101986094|FG000|Overall Study|Protocol Violation|1|||
33572690|NCT02712788|101986095|FG001|Overall Study|Protocol Violation|0|||
33572691|NCT04976777|101986096|FG000|Overall Study|COVID-19 Infection|1|||
33572692|NCT04976777|101986097|FG001|Overall Study|COVID-19 Infection|0|||
33572693|NCT02394561|101986098|FG000|CORE Phase|Adverse Event|7|||
33572694|NCT02394561|101986099|FG001|CORE Phase|Adverse Event|9|||
33572695|NCT02394561|101986098|FG000|CORE Phase|Death|0|||
33572696|NCT02394561|101986099|FG001|CORE Phase|Death|1|||
33572697|NCT02394561|101986098|FG000|CORE Phase|Pregnancy|1|||
33572698|NCT02394561|101986099|FG001|CORE Phase|Pregnancy|0|||
33572699|NCT02394561|101986098|FG000|CORE Phase|Lost to Follow-up|1|||
33572700|NCT02394561|101986099|FG001|CORE Phase|Lost to Follow-up|0|||
33572701|NCT02394561|101986098|FG000|CORE Phase|Physician Decision|1|||
33572702|NCT02394561|101986099|FG001|CORE Phase|Physician Decision|1|||
33572703|NCT02394561|101986098|FG000|CORE Phase|Withdrawal by Subject|2|||
33572704|NCT02394561|101986099|FG001|CORE Phase|Withdrawal by Subject|2|||
33229767|NCT01544582|100742423|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
33229768|NCT01544582|100742424|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
33229769|NCT01544582|100742425|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
33419146|NCT00445458|101425672|FG001|Overall Study|Death|1|||
33419147|NCT00445458|101425673|FG002|Overall Study|Death|2|||
33419148|NCT00445458|101425674|FG003|Overall Study|Death|0|||
33419149|NCT00445458|101425671|FG000|Overall Study|Physician Decision|0|||
33419150|NCT00445458|101425672|FG001|Overall Study|Physician Decision|0|||
33419151|NCT00445458|101425673|FG002|Overall Study|Physician Decision|1|||
33419152|NCT00445458|101425674|FG003|Overall Study|Physician Decision|1|||
33419153|NCT00445458|101425671|FG000|Overall Study|Surgery|0|||
33419154|NCT00445458|101425672|FG001|Overall Study|Surgery|0|||
33419155|NCT00445458|101425673|FG002|Overall Study|Surgery|1|||
33419156|NCT00445458|101425674|FG003|Overall Study|Surgery|0|||
33419157|NCT05293743|101425675|FG000|Overall Study|Withdrawal by Subject|1|||
33419158|NCT05293743|101425676|FG001|Overall Study|Withdrawal by Subject|0|||
33419159|NCT00005879|101425677|FG000|Overall Study|Withdrawal by Subject|8|||
33419160|NCT00005879|101425678|FG001|Overall Study|Withdrawal by Subject|10|||
33419161|NCT04057118|101425688|FG000|Overall Study|Adverse Event|1|||
33419162|NCT04057118|101425689|FG001|Overall Study|Adverse Event|0|||
33419163|NCT04057118|101425690|FG002|Overall Study|Adverse Event|1|||
33419164|NCT04057118|101425691|FG003|Overall Study|Adverse Event|1|||
33419165|NCT04057118|101425688|FG000|Overall Study|Physician Decision|0|||
33419166|NCT04057118|101425689|FG001|Overall Study|Physician Decision|0|||
33419167|NCT04057118|101425690|FG002|Overall Study|Physician Decision|1|||
33419168|NCT04057118|101425691|FG003|Overall Study|Physician Decision|1|||
33419169|NCT04057118|101425688|FG000|Overall Study|Withdrawal by Subject|2|||
33419170|NCT04057118|101425689|FG001|Overall Study|Withdrawal by Subject|2|||
33419171|NCT04057118|101425690|FG002|Overall Study|Withdrawal by Subject|0|||
33419172|NCT04057118|101425691|FG003|Overall Study|Withdrawal by Subject|2|||
33419173|NCT04057118|101425688|FG000|Overall Study|Not Specific|0|||
33419174|NCT04057118|101425689|FG001|Overall Study|Not Specific|0|||
33419175|NCT04057118|101425690|FG002|Overall Study|Not Specific|1|||
33572705|NCT02394561|101986098|FG000|CORE Phase|Lack of Efficacy|1|||
33572706|NCT02394561|101986099|FG001|CORE Phase|Lack of Efficacy|6|||
33572707|NCT02394561|101986098|FG000|Extension Phase|Adverse Event|6|||
33572708|NCT02394561|101986099|FG001|Extension Phase|Adverse Event|1|||
33572709|NCT02394561|101986098|FG000|Extension Phase|Death|0|||
33229770|NCT01544582|100742422|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
33229771|NCT01544582|100742423|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
33229772|NCT01544582|100742424|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
33229773|NCT01544582|100742425|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
33229774|NCT01544582|100742422|FG000|Analysis Population|Intolerance|0|||
33229775|NCT01544582|100742423|FG001|Analysis Population|Intolerance|1|||
33229776|NCT01544582|100742424|FG002|Analysis Population|Intolerance|0|||
33229777|NCT01544582|100742425|FG003|Analysis Population|Intolerance|0|||
33229778|NCT01544582|100742422|FG000|Analysis Population|Liver Transplantation|0|||
33229779|NCT01544582|100742423|FG001|Analysis Population|Liver Transplantation|0|||
33229780|NCT01544582|100742424|FG002|Analysis Population|Liver Transplantation|1|||
33229781|NCT01544582|100742425|FG003|Analysis Population|Liver Transplantation|0|||
33229782|NCT01544582|100742422|FG000|Analysis Population|No Social Insurance|0|||
33229783|NCT01544582|100742423|FG001|Analysis Population|No Social Insurance|0|||
33229784|NCT01544582|100742424|FG002|Analysis Population|No Social Insurance|1|||
33229785|NCT01544582|100742425|FG003|Analysis Population|No Social Insurance|0|||
33229786|NCT01544582|100742422|FG000|Analysis Population|Poor Adherence|0|||
33229787|NCT01544582|100742423|FG001|Analysis Population|Poor Adherence|0|||
33229788|NCT01544582|100742424|FG002|Analysis Population|Poor Adherence|1|||
33229789|NCT01544582|100742425|FG003|Analysis Population|Poor Adherence|0|||
33229790|NCT01544582|100742422|FG000|Analysis Population|Poor Participant Compliance|0|||
33229791|NCT01544582|100742423|FG001|Analysis Population|Poor Participant Compliance|1|||
33229792|NCT01544582|100742424|FG002|Analysis Population|Poor Participant Compliance|0|||
33229793|NCT01544582|100742425|FG003|Analysis Population|Poor Participant Compliance|0|||
33229794|NCT01544582|100742422|FG000|Analysis Population|Programmed Surgery|0|||
33229795|NCT01544582|100742423|FG001|Analysis Population|Programmed Surgery|1|||
33229796|NCT01544582|100742424|FG002|Analysis Population|Programmed Surgery|0|||
33229797|NCT01544582|100742425|FG003|Analysis Population|Programmed Surgery|0|||
33229798|NCT01544582|100742422|FG000|Analysis Population|Participant in Jail|0|||
33229799|NCT01544582|100742423|FG001|Analysis Population|Participant in Jail|0|||
33229800|NCT01544582|100742424|FG002|Analysis Population|Participant in Jail|1|||
33229801|NCT01544582|100742425|FG003|Analysis Population|Participant in Jail|0|||
33229802|NCT01146574|100742428|FG000|Overall Study|Death|0|||
33229803|NCT01146574|100742429|FG001|Overall Study|Death|1|||
33229804|NCT01146574|100742430|FG002|Overall Study|Death|1|||
33229805|NCT01146574|100742431|FG003|Overall Study|Death|0|||
33229806|NCT01146574|100742432|FG004|Overall Study|Death|0|||
33229807|NCT01146574|100742433|FG005|Overall Study|Death|0|||
33229808|NCT01146574|100742434|FG006|Overall Study|Death|0|||
33229809|NCT01146574|100742428|FG000|Overall Study|Other reasons|0|||
33229810|NCT01146574|100742429|FG001|Overall Study|Other reasons|0|||
33229811|NCT01146574|100742430|FG002|Overall Study|Other reasons|3|||
33229812|NCT01146574|100742431|FG003|Overall Study|Other reasons|0|||
33229813|NCT01146574|100742432|FG004|Overall Study|Other reasons|0|||
33229814|NCT01146574|100742433|FG005|Overall Study|Other reasons|0|||
33229815|NCT01146574|100742434|FG006|Overall Study|Other reasons|0|||
33229816|NCT01146574|100742428|FG000|Overall Study|Kidney transplant|0|||
33229817|NCT01146574|100742429|FG001|Overall Study|Kidney transplant|0|||
33229818|NCT01146574|100742430|FG002|Overall Study|Kidney transplant|1|||
33229819|NCT01146574|100742431|FG003|Overall Study|Kidney transplant|1|||
33229820|NCT01146574|100742432|FG004|Overall Study|Kidney transplant|0|||
33229821|NCT01146574|100742433|FG005|Overall Study|Kidney transplant|0|||
33229822|NCT01146574|100742434|FG006|Overall Study|Kidney transplant|0|||
33229823|NCT01146574|100742428|FG000|Overall Study|Withdrew consent|0|||
33229824|NCT01146574|100742429|FG001|Overall Study|Withdrew consent|0|||
33229825|NCT01146574|100742430|FG002|Overall Study|Withdrew consent|1|||
33229826|NCT01146574|100742431|FG003|Overall Study|Withdrew consent|1|||
33419176|NCT04057118|101425691|FG003|Overall Study|Not Specific|1|||
33419177|NCT03692078|101425694|FG000|Overall Study|Adverse Event|0|||
33419178|NCT03692078|101425695|FG001|Overall Study|Adverse Event|0|||
33229827|NCT01146574|100742432|FG004|Overall Study|Withdrew consent|2|||
33229828|NCT01146574|100742433|FG005|Overall Study|Withdrew consent|1|||
33229829|NCT01146574|100742434|FG006|Overall Study|Withdrew consent|1|||
33229830|NCT00064025|100742435|FG000|Overall Study|Ineligible|4|||
33229831|NCT00064025|100742435|FG000|Overall Study|Inevaluable|3|||
33229832|NCT03285295|100742436|FG000|Alinity s HBsAg|Protocol Violation|11|||
33229833|NCT03285295|100742437|FG001|Alinity s HBsAg|Protocol Violation|0|||
33229834|NCT03285295|100742438|FG002|Alinity s HBsAg|Protocol Violation|0|||
33229835|NCT03285295|100742439|FG003|Alinity s HBsAg|Protocol Violation|0|||
33229836|NCT03285295|100742440|FG004|Alinity s HBsAg|Protocol Violation|0|||
33229837|NCT03285295|100742436|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
33229838|NCT03285295|100742437|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
33229839|NCT03285295|100742438|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
33229840|NCT03285295|100742439|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
33229841|NCT03285295|100742440|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
33419179|NCT03692078|101425696|FG002|Overall Study|Adverse Event|0|||
33229842|NCT03285295|100742436|FG000|Alinity s HBsAg|No Results Generated|74|||
33229843|NCT03285295|100742437|FG001|Alinity s HBsAg|No Results Generated|6|||
33229844|NCT03285295|100742438|FG002|Alinity s HBsAg|No Results Generated|0|||
33229845|NCT03285295|100742439|FG003|Alinity s HBsAg|No Results Generated|0|||
33229846|NCT03285295|100742440|FG004|Alinity s HBsAg|No Results Generated|0|||
33229847|NCT03285295|100742436|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
33229848|NCT03285295|100742437|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
33229849|NCT03285295|100742438|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
33229850|NCT03285295|100742439|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
33229851|NCT03285295|100742440|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
33229852|NCT03285295|100742436|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
33229853|NCT03285295|100742437|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
33229854|NCT03285295|100742438|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
33229855|NCT03285295|100742439|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
33229856|NCT03285295|100742440|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
33229857|NCT03285295|100742436|FG000|Alinity s HTLV I/II|No Results Generated|70|||
33229858|NCT03285295|100742437|FG001|Alinity s HTLV I/II|No Results Generated|0|||
33229859|NCT03285295|100742438|FG002|Alinity s HTLV I/II|No Results Generated|0|||
33229860|NCT03285295|100742439|FG003|Alinity s HTLV I/II|No Results Generated|0|||
33229861|NCT03285295|100742440|FG004|Alinity s HTLV I/II|No Results Generated|0|||
33229862|NCT03285295|100742436|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
33229863|NCT03285295|100742437|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
33229864|NCT03285295|100742438|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
33229865|NCT03285295|100742439|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
33229866|NCT03285295|100742440|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
33229867|NCT03285295|100742436|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
33229868|NCT03285295|100742437|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
33229869|NCT03285295|100742438|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
33229870|NCT03285295|100742439|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
33229871|NCT03285295|100742440|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
33229872|NCT03285295|100742436|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
33229873|NCT03285295|100742437|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
33229874|NCT03285295|100742438|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
33229875|NCT03285295|100742439|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
33229876|NCT03285295|100742440|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
33229877|NCT03285295|100742436|FG000|Alinity s Anti-HCV|No Results Generated|71|||
33229878|NCT03285295|100742437|FG001|Alinity s Anti-HCV|No Results Generated|0|||
33229879|NCT03285295|100742438|FG002|Alinity s Anti-HCV|No Results Generated|0|||
33229880|NCT03285295|100742439|FG003|Alinity s Anti-HCV|No Results Generated|0|||
33229881|NCT03285295|100742440|FG004|Alinity s Anti-HCV|No Results Generated|0|||
33229882|NCT03285295|100742436|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
33229883|NCT03285295|100742437|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
33229884|NCT03285295|100742438|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
33229885|NCT03285295|100742439|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
33229886|NCT03285295|100742440|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
33229887|NCT03285295|100742436|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
33229888|NCT03285295|100742437|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
33229889|NCT03285295|100742438|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
33229890|NCT03285295|100742439|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
33229891|NCT03285295|100742440|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
33229892|NCT03285295|100742436|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
33229893|NCT03285295|100742437|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
33229894|NCT03285295|100742438|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
33229895|NCT03285295|100742439|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
33229896|NCT03285295|100742440|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
33229897|NCT03285295|100742436|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
33229898|NCT03285295|100742437|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
33229899|NCT03285295|100742438|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
33229900|NCT03285295|100742439|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
33229901|NCT03285295|100742440|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
33229902|NCT03285295|100742436|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
33229903|NCT03285295|100742437|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
33229904|NCT03285295|100742438|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
33229905|NCT03285295|100742439|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
33229906|NCT03285295|100742440|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
33229907|NCT03285295|100742436|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
33229908|NCT03285295|100742437|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
33572710|NCT02394561|101986099|FG001|Extension Phase|Death|1|||
33572711|NCT02394561|101986098|FG000|Extension Phase|Protocol Violation|1|||
33572712|NCT02394561|101986099|FG001|Extension Phase|Protocol Violation|0|||
33572713|NCT02394561|101986098|FG000|Extension Phase|Lost to Follow-up|1|||
33572714|NCT02394561|101986099|FG001|Extension Phase|Lost to Follow-up|0|||
33572715|NCT02394561|101986098|FG000|Extension Phase|Physician Decision|0|||
33572716|NCT02394561|101986099|FG001|Extension Phase|Physician Decision|2|||
33572717|NCT02394561|101986098|FG000|Extension Phase|Withdrawal by Subject|0|||
33229909|NCT03285295|100742438|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
33229910|NCT03285295|100742439|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
33229911|NCT03285295|100742440|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
33572718|NCT02394561|101986099|FG001|Extension Phase|Withdrawal by Subject|5|||
33572719|NCT02394561|101986098|FG000|Extension Phase|Lack of Efficacy|3|||
33572720|NCT02394561|101986099|FG001|Extension Phase|Lack of Efficacy|3|||
33572721|NCT05223673|101986100|FG000|Overall Study|Protocol Violation|1|||
33572722|NCT05223673|101986100|FG000|Overall Study|Study termination|6|||
33572723|NCT03213509|101986103|FG000|Overall Study|Did not consent for verbal autopsy|4|||
33572724|NCT03213509|101986104|FG001|Overall Study|Did not consent for verbal autopsy|5|||
33229912|NCT03285295|100742436|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
33229913|NCT03285295|100742437|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
33229914|NCT03285295|100742438|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
33229915|NCT03285295|100742439|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
33229916|NCT03285295|100742440|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
33229917|NCT03285295|100742436|FG000|Alinity s Anti-HBc|No Results Generated|70|||
33229918|NCT03285295|100742437|FG001|Alinity s Anti-HBc|No Results Generated|0|||
33229919|NCT03285295|100742438|FG002|Alinity s Anti-HBc|No Results Generated|0|||
33229920|NCT03285295|100742439|FG003|Alinity s Anti-HBc|No Results Generated|0|||
33229921|NCT03285295|100742440|FG004|Alinity s Anti-HBc|No Results Generated|0|||
33229922|NCT03285295|100742436|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
33229923|NCT03285295|100742437|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
33229924|NCT03285295|100742438|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
33229925|NCT03285295|100742439|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
33229926|NCT03285295|100742440|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
33229927|NCT03285295|100742436|FG000|Alinity s Chagas|Protocol Violation|76|||
33229928|NCT03285295|100742437|FG001|Alinity s Chagas|Protocol Violation|0|||
33229929|NCT03285295|100742438|FG002|Alinity s Chagas|Protocol Violation|0|||
33229930|NCT03285295|100742439|FG003|Alinity s Chagas|Protocol Violation|0|||
33229931|NCT03285295|100742440|FG004|Alinity s Chagas|Protocol Violation|0|||
33229932|NCT03285295|100742436|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
33229933|NCT03285295|100742437|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
33229934|NCT03285295|100742438|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
33229935|NCT03285295|100742439|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
33229936|NCT03285295|100742440|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
33229937|NCT03285295|100742436|FG000|Alinity s Chagas|No Results Generated|105|||
33229938|NCT03285295|100742437|FG001|Alinity s Chagas|No Results Generated|0|||
33229939|NCT03285295|100742438|FG002|Alinity s Chagas|No Results Generated|0|||
33229940|NCT03285295|100742439|FG003|Alinity s Chagas|No Results Generated|0|||
33229941|NCT03285295|100742440|FG004|Alinity s Chagas|No Results Generated|0|||
33229942|NCT03285295|100742436|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
33229943|NCT03285295|100742437|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
33229944|NCT03285295|100742438|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
33229945|NCT03285295|100742439|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
33229946|NCT03285295|100742440|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
33229947|NCT00514046|100742441|FG000|Overall Study|transferred to another protocol|2|||
33229948|NCT00514046|100742442|FG001|Overall Study|transferred to another protocol|1|||
33229949|NCT00514046|100742443|FG002|Overall Study|transferred to another protocol|3|||
33229950|NCT00514046|100742444|FG003|Overall Study|transferred to another protocol|0|||
33229951|NCT00514046|100742445|FG004|Overall Study|transferred to another protocol|1|||
33229952|NCT00514046|100742446|FG005|Overall Study|transferred to another protocol|0|||
33229953|NCT00514046|100742447|FG006|Overall Study|transferred to another protocol|0|||
33229954|NCT00514046|100742448|FG007|Overall Study|transferred to another protocol|0|||
33229955|NCT00514046|100742449|FG008|Overall Study|transferred to another protocol|0|||
33229956|NCT00514046|100742441|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
33229957|NCT00514046|100742442|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
33229958|NCT00514046|100742443|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
33229959|NCT00514046|100742444|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
33229960|NCT00514046|100742445|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
33229961|NCT00514046|100742446|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
33229962|NCT00514046|100742447|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
33229963|NCT00514046|100742448|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
33229964|NCT00514046|100742449|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
33229965|NCT00514046|100742441|FG000|Overall Study|Disease progression on study|0|||
33229966|NCT00514046|100742442|FG001|Overall Study|Disease progression on study|0|||
33229967|NCT00514046|100742443|FG002|Overall Study|Disease progression on study|2|||
33229968|NCT00514046|100742444|FG003|Overall Study|Disease progression on study|0|||
33229969|NCT00514046|100742445|FG004|Overall Study|Disease progression on study|0|||
33229970|NCT00514046|100742446|FG005|Overall Study|Disease progression on study|1|||
33229971|NCT00514046|100742447|FG006|Overall Study|Disease progression on study|0|||
33229972|NCT00514046|100742448|FG007|Overall Study|Disease progression on study|0|||
33229973|NCT00514046|100742449|FG008|Overall Study|Disease progression on study|0|||
33229974|NCT02009696|100742450|FG000|Overall Study|Withdrawal by Subject|2|||
33229975|NCT03292146|100742454|FG000|Baseline to 12 Months|Relocation|1|||
33229976|NCT03292146|100742455|FG001|Baseline to 12 Months|Relocation|0|||
33229977|NCT03292146|100742454|FG000|Baseline to 12 Months|Seeking higher level of care for eating disorder|1|||
33229978|NCT03292146|100742455|FG001|Baseline to 12 Months|Seeking higher level of care for eating disorder|0|||
33229979|NCT03292146|100742454|FG000|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|0|||
33229980|NCT03292146|100742455|FG001|Baseline to 12 Months|Seeking treatment for chronic fatigue syndrome|1|||
33229981|NCT03292146|100742454|FG000|12 Months to 24 Months|Planning pregnancy|2|||
33229982|NCT03292146|100742455|FG001|12 Months to 24 Months|Planning pregnancy|2|||
33229983|NCT03292146|100742454|FG000|12 Months to 24 Months|Personal reasons|1|||
33229984|NCT03292146|100742455|FG001|12 Months to 24 Months|Personal reasons|0|||
33229985|NCT03292146|100742454|FG000|12 Months to 24 Months|Lost to Follow-up|0|||
33229986|NCT03292146|100742455|FG001|12 Months to 24 Months|Lost to Follow-up|1|||
33229987|NCT04076020|100742458|FG000|Overall Study|Death|4|||
33229988|NCT04076020|100742459|FG001|Overall Study|Death|6|||
33229989|NCT04076020|100742458|FG000|Overall Study|Withdrawal by Subject|12|||
33229990|NCT04076020|100742459|FG001|Overall Study|Withdrawal by Subject|8|||
33229991|NCT00924469|100742460|FG000|Overall Study|Adverse Event|2|||
33229992|NCT00924469|100742461|FG001|Overall Study|Adverse Event|0|||
33229993|NCT00924469|100742460|FG000|Overall Study|Withdrawal by Subject|0|||
33229994|NCT00924469|100742461|FG001|Overall Study|Withdrawal by Subject|1|||
33229995|NCT00924469|100742460|FG000|Overall Study|Lost to Follow-up|0|||
33229996|NCT00924469|100742461|FG001|Overall Study|Lost to Follow-up|1|||
33229997|NCT01973491|100742462|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
33229998|NCT01973491|100742462|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
33229999|NCT01973491|100742462|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
33572725|NCT00462826|101986105|FG000|Overall Study|Ineligible - second primary|1|||
33572726|NCT00462826|101986105|FG000|Overall Study|Ineligible - wrong cell type|1|||
33230000|NCT02693834|100742466|FG000|Baseline Measurement|Withdrawal by Subject|1|||
33230001|NCT02693834|100742467|FG001|Baseline Measurement|Withdrawal by Subject|0|||
33230002|NCT02693834|100742466|FG000|Baseline Measurement|Adverse Event|1|||
33230003|NCT02693834|100742467|FG001|Baseline Measurement|Adverse Event|0|||
33230004|NCT02693834|100742466|FG000|Week 2 Practice|Adverse Event|0|||
33230005|NCT02693834|100742467|FG001|Week 2 Practice|Adverse Event|1|||
33230006|NCT01912781|100742472|FG000|Overall Study|Withdrawal by Subject|2|||
33230007|NCT01912781|100742473|FG001|Overall Study|Withdrawal by Subject|0|||
33230008|NCT02293837|100742474|FG000|Overall Study|Lost to Follow-up|0|||
33230009|NCT02293837|100742475|FG001|Overall Study|Lost to Follow-up|2|||
33230010|NCT02293837|100742476|FG002|Overall Study|Lost to Follow-up|1|||
33230011|NCT02293837|100742477|FG003|Overall Study|Lost to Follow-up|0|||
33367388|NCT00130208|101230248|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
33367389|NCT00130208|101230247|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
33367390|NCT00130208|101230248|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
33367391|NCT00130208|101230247|FG000|Maintenance Period (26 Weeks)|Other|1|||
33367392|NCT00130208|101230248|FG001|Maintenance Period (26 Weeks)|Other|1|||
33572727|NCT00462826|101986105|FG000|Overall Study|Ineligible - wrong primary|2|||
33572728|NCT00462826|101986105|FG000|Overall Study|Never treated|1|||
33572729|NCT01263119|101989708|FG000|Period 1|Protocol Violation|2|||
33572730|NCT01263119|101989708|FG000|Period 2|Adverse Event|2|||
33572731|NCT04577781|101989712|FG000|Overall Study|Adverse Event|2|||
33572732|NCT04577781|101989713|FG001|Overall Study|Adverse Event|2|||
33572733|NCT04577781|101989712|FG000|Overall Study|Physician Decision|1|||
33572734|NCT04577781|101989713|FG001|Overall Study|Physician Decision|0|||
33572735|NCT00730886|101989714|FG000|Overall Study|Lost to Follow-up|1|||
33572736|NCT00730886|101989715|FG001|Overall Study|Lost to Follow-up|0|||
33572737|NCT00730886|101989714|FG000|Overall Study|Physician Decision|1|||
33572738|NCT00730886|101989715|FG001|Overall Study|Physician Decision|0|||
33572739|NCT02081586|101989716|FG000|Overall Study|Lost to Follow-up|0|||
33572740|NCT02081586|101989717|FG001|Overall Study|Lost to Follow-up|1|||
33572741|NCT02081586|101989718|FG002|Overall Study|Lost to Follow-up|0|||
33572742|NCT02081586|101989719|FG003|Overall Study|Lost to Follow-up|1|||
33572743|NCT02081586|101989716|FG000|Overall Study|Head injury not related to study|0|||
33572744|NCT02081586|101989717|FG001|Overall Study|Head injury not related to study|0|||
33572745|NCT02081586|101989718|FG002|Overall Study|Head injury not related to study|1|||
33572746|NCT02081586|101989719|FG003|Overall Study|Head injury not related to study|0|||
33572747|NCT03508050|101989720|FG000|Overall Study|Pleural adhesions|1|||
33572748|NCT03508050|101989721|FG001|Overall Study|Pleural adhesions|0|||
33572749|NCT03508050|101989720|FG000|Overall Study|Mucus plug|1|||
33572750|NCT03508050|101989721|FG001|Overall Study|Mucus plug|0|||
33572751|NCT03508050|101989720|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
33572752|NCT03508050|101989721|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
33634704|NCT02113982|102214583|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
33634705|NCT02113982|102214584|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
33634706|NCT02113982|102214585|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
33230012|NCT02293837|100742474|FG000|Overall Study|Withdrawal by Subject|2|||
33230013|NCT02293837|100742475|FG001|Overall Study|Withdrawal by Subject|1|||
33230014|NCT02293837|100742476|FG002|Overall Study|Withdrawal by Subject|2|||
33230015|NCT02293837|100742477|FG003|Overall Study|Withdrawal by Subject|1|||
33230016|NCT02293837|100742474|FG000|Overall Study|COVID-19 Related|1|||
33230017|NCT02293837|100742475|FG001|Overall Study|COVID-19 Related|1|||
33230018|NCT02293837|100742476|FG002|Overall Study|COVID-19 Related|0|||
33230019|NCT02293837|100742477|FG003|Overall Study|COVID-19 Related|0|||
33572753|NCT03508050|101989720|FG000|Overall Study|Sustained desaturation|0|||
33572754|NCT03508050|101989721|FG001|Overall Study|Sustained desaturation|1|||
33572755|NCT01425814|101989722|FG000|Period 1|Stability criteria not fulfilled|0|||
33572756|NCT01425814|101989723|FG001|Period 1|Stability criteria not fulfilled|1|||
33572757|NCT01425814|101989724|FG002|Period 1|Stability criteria not fulfilled|0|||
33572758|NCT01425814|101989725|FG003|Period 1|Stability criteria not fulfilled|0|||
33230020|NCT02293837|100742474|FG000|Overall Study|Participant ill and could not be infused|0|||
33230021|NCT02293837|100742475|FG001|Overall Study|Participant ill and could not be infused|0|||
33230022|NCT02293837|100742476|FG002|Overall Study|Participant ill and could not be infused|1|||
33230023|NCT02293837|100742477|FG003|Overall Study|Participant ill and could not be infused|0|||
33230024|NCT03462706|100742481|FG000|Overall Study|Polyp was pedunculated|1|||
33230025|NCT03462706|100742482|FG001|Overall Study|Polyp was pedunculated|0|||
33230026|NCT03462706|100742483|FG002|Overall Study|Polyp was pedunculated|1|||
33230027|NCT03462706|100742484|FG003|Overall Study|Polyp was pedunculated|0|||
33230028|NCT03462706|100742481|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
33230029|NCT03462706|100742482|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
33230030|NCT03462706|100742483|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
33230031|NCT03462706|100742484|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
33230032|NCT02153359|100742492|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
33230033|NCT02153359|100742493|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
33230034|NCT01536145|100742495|FG000|Overall Study|Progressive disease|3|||
33230035|NCT01536145|100742496|FG001|Overall Study|Progressive disease|4|||
33230036|NCT01536145|100742497|FG002|Overall Study|Progressive disease|1|||
33230037|NCT01536145|100742498|FG003|Overall Study|Progressive disease|2|||
33230038|NCT01536145|100742499|FG004|Overall Study|Progressive disease|1|||
33230039|NCT01536145|100742500|FG005|Overall Study|Progressive disease|2|||
33230040|NCT01536145|100742501|FG006|Overall Study|Progressive disease|1|||
33230041|NCT01536145|100742502|FG007|Overall Study|Progressive disease|2|||
33230042|NCT01536145|100742503|FG008|Overall Study|Progressive disease|1|||
33230043|NCT01536145|100742504|FG009|Overall Study|Progressive disease|3|||
33230044|NCT01536145|100742505|FG010|Overall Study|Progressive disease|3|||
33230045|NCT01536145|100742495|FG000|Overall Study|Withdrawal by Subject|0|||
33230046|NCT01536145|100742496|FG001|Overall Study|Withdrawal by Subject|0|||
33230047|NCT01536145|100742497|FG002|Overall Study|Withdrawal by Subject|1|||
33230048|NCT01536145|100742498|FG003|Overall Study|Withdrawal by Subject|0|||
33230049|NCT01536145|100742499|FG004|Overall Study|Withdrawal by Subject|0|||
33230050|NCT01536145|100742500|FG005|Overall Study|Withdrawal by Subject|1|||
33230051|NCT01536145|100742501|FG006|Overall Study|Withdrawal by Subject|0|||
33230052|NCT01536145|100742502|FG007|Overall Study|Withdrawal by Subject|0|||
33419180|NCT03692078|101425697|FG003|Overall Study|Adverse Event|0|||
33419181|NCT03692078|101425698|FG004|Overall Study|Adverse Event|0|||
33419182|NCT03692078|101425699|FG005|Overall Study|Adverse Event|1|||
33419183|NCT03692078|101425700|FG006|Overall Study|Adverse Event|0|||
33419184|NCT03692078|101425694|FG000|Overall Study|Enrollment Closed|5|||
33419185|NCT03692078|101425695|FG001|Overall Study|Enrollment Closed|0|||
33419186|NCT03692078|101425696|FG002|Overall Study|Enrollment Closed|0|||
33419187|NCT03692078|101425697|FG003|Overall Study|Enrollment Closed|0|||
33419188|NCT03692078|101425698|FG004|Overall Study|Enrollment Closed|0|||
33419189|NCT03692078|101425699|FG005|Overall Study|Enrollment Closed|0|||
33572759|NCT01425814|101989726|FG004|Period 1|Stability criteria not fulfilled|0|||
33572760|NCT01425814|101989727|FG005|Period 1|Stability criteria not fulfilled|0|||
33572761|NCT01425814|101989722|FG000|Period 2|Stability criteria not fulfilled|0|||
33572762|NCT01425814|101989723|FG001|Period 2|Stability criteria not fulfilled|1|||
33419190|NCT03692078|101425700|FG006|Overall Study|Enrollment Closed|0|||
33419191|NCT03692078|101425694|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
33419192|NCT03692078|101425695|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
33419193|NCT03692078|101425696|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
33419194|NCT03692078|101425697|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
33572763|NCT01425814|101989724|FG002|Period 2|Stability criteria not fulfilled|0|||
33572764|NCT01425814|101989725|FG003|Period 2|Stability criteria not fulfilled|0|||
33572765|NCT01425814|101989726|FG004|Period 2|Stability criteria not fulfilled|0|||
33572766|NCT01425814|101989727|FG005|Period 2|Stability criteria not fulfilled|0|||
33572767|NCT01425814|101989722|FG000|Period 3|Adverse Event|0|||
33572768|NCT01425814|101989723|FG001|Period 3|Adverse Event|0|||
33572769|NCT01425814|101989724|FG002|Period 3|Adverse Event|0|||
33572770|NCT01425814|101989725|FG003|Period 3|Adverse Event|0|||
33572771|NCT01425814|101989726|FG004|Period 3|Adverse Event|0|||
33572772|NCT01425814|101989727|FG005|Period 3|Adverse Event|1|||
33572773|NCT01425814|101989722|FG000|Period 4|Adverse Event|1|||
33230053|NCT01536145|100742503|FG008|Overall Study|Withdrawal by Subject|2|||
33230054|NCT01536145|100742504|FG009|Overall Study|Withdrawal by Subject|0|||
33230055|NCT01536145|100742505|FG010|Overall Study|Withdrawal by Subject|2|||
33230056|NCT01536145|100742495|FG000|Overall Study|Other|0|||
33419195|NCT03692078|101425698|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
33419196|NCT03692078|101425699|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
33230057|NCT01536145|100742496|FG001|Overall Study|Other|0|||
33230058|NCT01536145|100742497|FG002|Overall Study|Other|0|||
33230059|NCT01536145|100742498|FG003|Overall Study|Other|0|||
33230060|NCT01536145|100742499|FG004|Overall Study|Other|1|||
33230061|NCT01536145|100742500|FG005|Overall Study|Other|0|||
33419197|NCT03692078|101425700|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
33572774|NCT01425814|101989723|FG001|Period 4|Adverse Event|0|||
33572775|NCT01425814|101989724|FG002|Period 4|Adverse Event|1|||
33572776|NCT01425814|101989725|FG003|Period 4|Adverse Event|0|||
33572777|NCT01425814|101989726|FG004|Period 4|Adverse Event|0|||
33572778|NCT01425814|101989727|FG005|Period 4|Adverse Event|0|||
33572779|NCT01425814|101989722|FG000|Period 5|Stability criteria not fulfilled|0|||
33572780|NCT01425814|101989723|FG001|Period 5|Stability criteria not fulfilled|0|||
33572781|NCT01425814|101989724|FG002|Period 5|Stability criteria not fulfilled|1|||
33572782|NCT01425814|101989725|FG003|Period 5|Stability criteria not fulfilled|0|||
33572783|NCT01425814|101989726|FG004|Period 5|Stability criteria not fulfilled|0|||
33572784|NCT01425814|101989727|FG005|Period 5|Stability criteria not fulfilled|1|||
33572785|NCT03559270|101989728|FG000|Overall Study|Adverse Event|6|||
33572786|NCT03559270|101989729|FG001|Overall Study|Adverse Event|5|||
33572787|NCT03559270|101989730|FG002|Overall Study|Adverse Event|3|||
33572788|NCT03559270|101989731|FG003|Overall Study|Adverse Event|0|||
33572789|NCT03559270|101989728|FG000|Overall Study|Lack of Efficacy|34|||
33572790|NCT03559270|101989729|FG001|Overall Study|Lack of Efficacy|52|||
33572791|NCT03559270|101989730|FG002|Overall Study|Lack of Efficacy|37|||
33572792|NCT03559270|101989731|FG003|Overall Study|Lack of Efficacy|2|||
33572793|NCT03559270|101989728|FG000|Overall Study|Death|0|||
33572794|NCT03559270|101989729|FG001|Overall Study|Death|2|||
33572795|NCT03559270|101989730|FG002|Overall Study|Death|0|||
33572796|NCT03559270|101989731|FG003|Overall Study|Death|0|||
33572797|NCT03559270|101989728|FG000|Overall Study|Lost to Follow-up|16|||
33230062|NCT01536145|100742501|FG006|Overall Study|Other|0|||
33419198|NCT03692078|101425694|FG000|Overall Study|Withdrawal by Subject|0|||
33419199|NCT03692078|101425695|FG001|Overall Study|Withdrawal by Subject|2|||
33572798|NCT03559270|101989729|FG001|Overall Study|Lost to Follow-up|4|||
33572799|NCT03559270|101989730|FG002|Overall Study|Lost to Follow-up|12|||
33572800|NCT03559270|101989731|FG003|Overall Study|Lost to Follow-up|3|||
33572801|NCT03559270|101989728|FG000|Overall Study|Sponsor Decision|38|||
33572802|NCT03559270|101989729|FG001|Overall Study|Sponsor Decision|31|||
33572803|NCT03559270|101989730|FG002|Overall Study|Sponsor Decision|35|||
33572804|NCT03559270|101989731|FG003|Overall Study|Sponsor Decision|18|||
33572805|NCT03559270|101989728|FG000|Overall Study|Withdrawal by Subject|19|||
33572806|NCT03559270|101989729|FG001|Overall Study|Withdrawal by Subject|21|||
33572807|NCT03559270|101989730|FG002|Overall Study|Withdrawal by Subject|18|||
33572808|NCT03559270|101989731|FG003|Overall Study|Withdrawal by Subject|7|||
33572809|NCT03559270|101989728|FG000|Overall Study|Physician Decision|3|||
33572810|NCT03559270|101989729|FG001|Overall Study|Physician Decision|2|||
33572811|NCT03559270|101989730|FG002|Overall Study|Physician Decision|1|||
33572812|NCT03559270|101989731|FG003|Overall Study|Physician Decision|0|||
33572813|NCT03559270|101989728|FG000|Overall Study|Pregnancy|0|||
33572814|NCT03559270|101989729|FG001|Overall Study|Pregnancy|1|||
33572815|NCT03559270|101989730|FG002|Overall Study|Pregnancy|0|||
33572816|NCT03559270|101989731|FG003|Overall Study|Pregnancy|0|||
33572817|NCT03559270|101989728|FG000|Overall Study|Protocol Violation|1|||
33572818|NCT03559270|101989729|FG001|Overall Study|Protocol Violation|0|||
33572819|NCT03559270|101989730|FG002|Overall Study|Protocol Violation|2|||
33572820|NCT03559270|101989731|FG003|Overall Study|Protocol Violation|0|||
33572821|NCT04068922|101989732|FG000|Overall Study|Lost to Follow-up|5|||
33572822|NCT04068922|101989732|FG000|Overall Study|Withdrawal by Subject|7|||
33572823|NCT04068922|101989732|FG000|Overall Study|Adverse Event|1|||
33572824|NCT01673126|101989733|FG000|Overall Study|change of diagnosis|4|||
33572825|NCT01673126|101989734|FG001|Overall Study|change of diagnosis|3|||
33572826|NCT00529633|101989735|FG000|Overall Study|Withdrawal by Subject|1|||
33572827|NCT00529633|101989736|FG001|Overall Study|Withdrawal by Subject|1|||
33634707|NCT02113982|102214586|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
33419200|NCT03692078|101425696|FG002|Overall Study|Withdrawal by Subject|0|||
33419201|NCT03692078|101425697|FG003|Overall Study|Withdrawal by Subject|1|||
33419202|NCT03692078|101425698|FG004|Overall Study|Withdrawal by Subject|5|||
33419203|NCT03692078|101425699|FG005|Overall Study|Withdrawal by Subject|3|||
33419204|NCT03692078|101425700|FG006|Overall Study|Withdrawal by Subject|3|||
33419205|NCT03543046|101425701|FG000|Overall Study|Adverse Event|1|||
33572828|NCT00806585|101989741|FG000|Overall Study|Study terminated by Sponsor|0|||
33572829|NCT00806585|101989742|FG001|Overall Study|Study terminated by Sponsor|0|||
33572830|NCT00806585|101989743|FG002|Overall Study|Study terminated by Sponsor|1|||
33572831|NCT00806585|101989744|FG003|Overall Study|Study terminated by Sponsor|2|||
33572832|NCT00806585|101989745|FG004|Overall Study|Study terminated by Sponsor|0|||
33572833|NCT00806585|101989741|FG000|Overall Study|Protocol Violation|3|||
33572834|NCT00806585|101989742|FG001|Overall Study|Protocol Violation|1|||
33572835|NCT00806585|101989743|FG002|Overall Study|Protocol Violation|2|||
33572836|NCT00806585|101989744|FG003|Overall Study|Protocol Violation|0|||
33419206|NCT03543046|101425702|FG001|Overall Study|Adverse Event|1|||
33419207|NCT03543046|101425701|FG000|Overall Study|Physician Decision|1|||
33367393|NCT00130208|101230247|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
33572837|NCT00806585|101989745|FG004|Overall Study|Protocol Violation|0|||
33572838|NCT00806585|101989741|FG000|Overall Study|Physician Decision|0|||
33367394|NCT00130208|101230248|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
33367395|NCT00130208|101230247|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
33367396|NCT00130208|101230248|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
33367397|NCT00130208|101230247|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
33367398|NCT00130208|101230248|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
33367399|NCT00130208|101230247|FG000|Washout Period (8 Weeks)|Other|1|||
33367400|NCT00130208|101230248|FG001|Washout Period (8 Weeks)|Other|1|||
33367401|NCT02869867|101230257|FG000|Overall Study|Protocol Violation|1|||
33367402|NCT02869867|101230258|FG001|Overall Study|Protocol Violation|0|||
33419208|NCT03543046|101425702|FG001|Overall Study|Physician Decision|1|||
33419209|NCT03543046|101425701|FG000|Overall Study|Protocol Violation|1|||
33419210|NCT03543046|101425702|FG001|Overall Study|Protocol Violation|0|||
33367403|NCT02869867|101230257|FG000|Overall Study|Lost to Follow-up|5|||
33572839|NCT00806585|101989742|FG001|Overall Study|Physician Decision|2|||
33367404|NCT02869867|101230258|FG001|Overall Study|Lost to Follow-up|5|||
33419211|NCT03909971|101425703|FG000|Overall Study|Other Reasons Not Specified|0|||
33572840|NCT00806585|101989743|FG002|Overall Study|Physician Decision|3|||
33572841|NCT00806585|101989744|FG003|Overall Study|Physician Decision|0|||
33367405|NCT00950690|101230259|FG000|Overall Study|Death|4|||
33572842|NCT00806585|101989745|FG004|Overall Study|Physician Decision|1|||
33419212|NCT03909971|101425704|FG001|Overall Study|Other Reasons Not Specified|1|||
33419213|NCT03909971|101425703|FG000|Overall Study|Global Deterioration of Health Status|2|||
33419214|NCT03909971|101425704|FG001|Overall Study|Global Deterioration of Health Status|1|||
33419215|NCT03909971|101425703|FG000|Overall Study|Progressive Disease|6|||
33419216|NCT03909971|101425704|FG001|Overall Study|Progressive Disease|14|||
33419217|NCT03909971|101425703|FG000|Overall Study|Death|2|||
33419218|NCT03909971|101425704|FG001|Overall Study|Death|6|||
33419219|NCT01010230|101425705|FG000|Overall Study|Withdrawal by Subject|6|||
33419220|NCT01010230|101425706|FG001|Overall Study|Withdrawal by Subject|5|||
33419221|NCT01010230|101425705|FG000|Overall Study|Lost to Follow-up|4|||
33572843|NCT00806585|101989741|FG000|Overall Study|Lost to Follow-up|2|||
33419222|NCT01010230|101425706|FG001|Overall Study|Lost to Follow-up|2|||
33419223|NCT05246111|101425707|FG000|Period 01|NOT ELIGIBLE IC5|1|||
33419224|NCT05246111|101425708|FG001|Period 01|NOT ELIGIBLE IC5|0|||
33572844|NCT00806585|101989742|FG001|Overall Study|Lost to Follow-up|1|||
33572845|NCT00806585|101989743|FG002|Overall Study|Lost to Follow-up|2|||
33419225|NCT03284424|101425710|FG000|Overall Study|Death|70|||
33419226|NCT03284424|101425711|FG001|Overall Study|Death|24|||
33419227|NCT03284424|101425710|FG000|Overall Study|Lost to Follow-up|3|||
33419228|NCT03284424|101425711|FG001|Overall Study|Lost to Follow-up|1|||
33419229|NCT03284424|101425710|FG000|Overall Study|Physician Decision|1|||
33419230|NCT03284424|101425711|FG001|Overall Study|Physician Decision|2|||
33419231|NCT03284424|101425710|FG000|Overall Study|Withdrawal by Subject|4|||
33419232|NCT03284424|101425711|FG001|Overall Study|Withdrawal by Subject|5|||
33419233|NCT03284424|101425710|FG000|Overall Study|Sponsor's decision|27|||
33419234|NCT03284424|101425711|FG001|Overall Study|Sponsor's decision|22|||
33419235|NCT01256398|101425712|FG000|Overall Study|Withdrawal by Subject|1|||
33419236|NCT01466673|101425719|FG000|Overall Study|Non-compliance with study treatment|2|||
33419237|NCT01466673|101425720|FG001|Overall Study|Non-compliance with study treatment|0|||
33419238|NCT01466673|101425719|FG000|Overall Study|Lost to Follow-up|3|||
33419239|NCT01466673|101425720|FG001|Overall Study|Lost to Follow-up|5|||
33419240|NCT01466673|101425719|FG000|Overall Study|Adverse Event|2|||
33419241|NCT01466673|101425720|FG001|Overall Study|Adverse Event|1|||
33419242|NCT03402126|101425721|FG000|Overall Study|Lost to Follow-up|6|||
33419243|NCT03402126|101425721|FG000|Overall Study|Protocol Violation|10|||
33419244|NCT03402126|101425721|FG000|Overall Study|Sponsor request/Study termination|29|||
33419245|NCT03402126|101425721|FG000|Overall Study|Study product no longer in use|1|||
33419246|NCT03402126|101425721|FG000|Overall Study|Technical problems|1|||
33419247|NCT03402126|101425721|FG000|Overall Study|Withdrawal by Subject|6|||
33230063|NCT01536145|100742502|FG007|Overall Study|Other|0|||
33230064|NCT01536145|100742503|FG008|Overall Study|Other|0|||
33419248|NCT03402126|101425721|FG000|Overall Study|Physician Decision|2|||
33419249|NCT03402126|101425721|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
33419250|NCT03402126|101425721|FG000|Overall Study|Death|4|||
33419251|NCT03869684|101425722|FG000|Overall Study|Adverse Event|0|||
33419252|NCT03869684|101425723|FG001|Overall Study|Adverse Event|3|||
33419253|NCT03869684|101425724|FG002|Overall Study|Adverse Event|1|||
33572846|NCT00806585|101989744|FG003|Overall Study|Lost to Follow-up|2|||
33572847|NCT00806585|101989745|FG004|Overall Study|Lost to Follow-up|5|||
33572848|NCT00806585|101989741|FG000|Overall Study|Lack of Efficacy|1|||
33572849|NCT00806585|101989742|FG001|Overall Study|Lack of Efficacy|0|||
33572850|NCT00806585|101989743|FG002|Overall Study|Lack of Efficacy|0|||
33572851|NCT00806585|101989744|FG003|Overall Study|Lack of Efficacy|0|||
33572852|NCT00806585|101989745|FG004|Overall Study|Lack of Efficacy|0|||
33572853|NCT00806585|101989741|FG000|Overall Study|Adverse Event|1|||
33572854|NCT00806585|101989742|FG001|Overall Study|Adverse Event|5|||
33572855|NCT00806585|101989743|FG002|Overall Study|Adverse Event|3|||
33572856|NCT00806585|101989744|FG003|Overall Study|Adverse Event|4|||
33572857|NCT00806585|101989745|FG004|Overall Study|Adverse Event|2|||
33572858|NCT00806585|101989741|FG000|Overall Study|Withdrawal by Subject|10|||
33634708|NCT02113982|102214587|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
33634709|NCT02113982|102214588|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
33634710|NCT02113982|102214589|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
33634711|NCT02113982|102214590|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
33634712|NCT02113982|102214591|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
33634713|NCT02113982|102214592|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
33634714|NCT02113982|102214593|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
33572859|NCT00806585|101989742|FG001|Overall Study|Withdrawal by Subject|8|||
33572860|NCT00806585|101989743|FG002|Overall Study|Withdrawal by Subject|9|||
33634715|NCT02113982|102214594|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
33634716|NCT02113982|102214595|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
33572861|NCT00806585|101989744|FG003|Overall Study|Withdrawal by Subject|3|||
33572862|NCT00806585|101989745|FG004|Overall Study|Withdrawal by Subject|11|||
33572863|NCT00806585|101989741|FG000|Overall Study|Completion status unknown|15|||
33572864|NCT00806585|101989742|FG001|Overall Study|Completion status unknown|14|||
33572865|NCT00806585|101989743|FG002|Overall Study|Completion status unknown|12|||
33572866|NCT00806585|101989744|FG003|Overall Study|Completion status unknown|4|||
33572867|NCT00806585|101989745|FG004|Overall Study|Completion status unknown|12|||
33572868|NCT00016354|101989747|FG000|Overall Study|Lack of Efficacy|0|||
33572869|NCT00016354|101989748|FG001|Overall Study|Lack of Efficacy|0|||
33572870|NCT00016354|101989749|FG002|Overall Study|Lack of Efficacy|0|||
33572871|NCT00016354|101989750|FG003|Overall Study|Lack of Efficacy|0|||
33572872|NCT00016354|101989751|FG004|Overall Study|Lack of Efficacy|0|||
33572873|NCT00016354|101989752|FG005|Overall Study|Lack of Efficacy|0|||
33572874|NCT00016354|101989753|FG006|Overall Study|Lack of Efficacy|0|||
33634717|NCT02113982|102214596|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
33634718|NCT02326155|102214600|FG000|Overall Study|Adverse Event|21|||
33634719|NCT02326155|102214601|FG001|Overall Study|Adverse Event|5|||
33634720|NCT02326155|102214600|FG000|Overall Study|Death|3|||
33634721|NCT02326155|102214601|FG001|Overall Study|Death|0|||
33634722|NCT02326155|102214600|FG000|Overall Study|Lack of Efficacy|49|||
33634723|NCT02326155|102214601|FG001|Overall Study|Lack of Efficacy|5|||
33634724|NCT02326155|102214600|FG000|Overall Study|Lost to Follow-up|14|||
33634725|NCT02326155|102214601|FG001|Overall Study|Lost to Follow-up|3|||
33634726|NCT02326155|102214600|FG000|Overall Study|Protocol Violation|2|||
33634727|NCT02326155|102214601|FG001|Overall Study|Protocol Violation|0|||
33634728|NCT02326155|102214600|FG000|Overall Study|Withdrawal by Subject|34|||
33634729|NCT02326155|102214601|FG001|Overall Study|Withdrawal by Subject|11|||
33634730|NCT02326155|102214600|FG000|Overall Study|Disease progression|37|||
33634731|NCT02326155|102214601|FG001|Overall Study|Disease progression|4|||
33634732|NCT02326155|102214600|FG000|Overall Study|Study close|188|||
33634733|NCT02326155|102214601|FG001|Overall Study|Study close|21|||
33634734|NCT02326155|102214600|FG000|Overall Study|except for study close|46|||
33634735|NCT02326155|102214601|FG001|Overall Study|except for study close|13|||
33634736|NCT01256788|102214607|FG000|Overall Study|Lost to Follow-up|5|||
33634737|NCT01256788|102214608|FG001|Overall Study|Lost to Follow-up|8|||
33634738|NCT01256788|102214609|FG002|Overall Study|Lost to Follow-up|3|||
33634739|NCT02201953|102214610|FG000|Overall Study|Randomized but Never Treated|1|||
33634740|NCT02201953|102214611|FG001|Overall Study|Randomized but Never Treated|5|||
33634741|NCT02201953|102214610|FG000|Overall Study|Lack of Efficacy|9|||
33634742|NCT02201953|102214611|FG001|Overall Study|Lack of Efficacy|30|||
33634743|NCT02201953|102214610|FG000|Overall Study|Lost to Follow-up|8|||
33634744|NCT02201953|102214611|FG001|Overall Study|Lost to Follow-up|8|||
33634745|NCT02201953|102214610|FG000|Overall Study|Withdrew Consent|2|||
33634746|NCT02201953|102214611|FG001|Overall Study|Withdrew Consent|5|||
33634747|NCT02201953|102214610|FG000|Overall Study|Adverse Event|0|||
33634748|NCT02201953|102214611|FG001|Overall Study|Adverse Event|5|||
33634749|NCT02201953|102214610|FG000|Overall Study|Death|0|||
33634750|NCT02201953|102214611|FG001|Overall Study|Death|3|||
33634751|NCT00423579|102214614|FG000|Overall Study|Lost to Follow-up|3|||
33634752|NCT00423579|102214615|FG001|Overall Study|Lost to Follow-up|0|||
33634753|NCT00423579|102214614|FG000|Overall Study|Protocol Violation|1|||
33634754|NCT00423579|102214615|FG001|Overall Study|Protocol Violation|3|||
33634755|NCT00423579|102214614|FG000|Overall Study|Diagnosis of diabetes|0|||
33634756|NCT00423579|102214615|FG001|Overall Study|Diagnosis of diabetes|1|||
33634757|NCT02703597|102214618|FG000|Assignment to Baseline|Lost to Follow-up|17|||
33634758|NCT02703597|102214619|FG001|Assignment to Baseline|Lost to Follow-up|16|||
33634759|NCT02703597|102214618|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
33634760|NCT02703597|102214619|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
33634761|NCT02703597|102214618|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
33634762|NCT02703597|102214619|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
33634763|NCT02703597|102214618|FG000|First Post-test to First Follow-up|Site drop out|0|||
33634764|NCT02703597|102214619|FG001|First Post-test to First Follow-up|Site drop out|58|||
33634765|NCT02703597|102214618|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
33634766|NCT02703597|102214619|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
33634767|NCT02703597|102214618|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
33634768|NCT02703597|102214619|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
33634769|NCT02703597|102214618|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
33634770|NCT02703597|102214619|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
33634771|NCT01907854|102214622|FG000|Overall Study|Protocol Violation|1|||
33572875|NCT00016354|101989754|FG007|Overall Study|Lack of Efficacy|1|||
33572876|NCT00523978|101989758|FG000|Overall Study|Withdrawal by Subject|3|||
33367406|NCT00950690|101230259|FG000|Overall Study|Adverse Event|15|||
33419254|NCT03869684|101425722|FG000|Overall Study|Withdrawal by Subject|1|||
33367407|NCT00950690|101230259|FG000|Overall Study|Lack of Efficacy|22|||
33367408|NCT00950690|101230259|FG000|Overall Study|Lost to Follow-up|40|||
33367409|NCT00950690|101230259|FG000|Overall Study|Other|163|||
33367410|NCT01915849|101230260|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
33367411|NCT01915849|101230261|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
33367412|NCT01915849|101230262|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
33367413|NCT01915849|101230263|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
33367414|NCT01915849|101230260|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
33419255|NCT03869684|101425723|FG001|Overall Study|Withdrawal by Subject|0|||
33419256|NCT03869684|101425724|FG002|Overall Study|Withdrawal by Subject|0|||
33419257|NCT03869684|101425722|FG000|Overall Study|Lost to Follow-up|1|||
33367415|NCT01915849|101230261|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
33419258|NCT03869684|101425723|FG001|Overall Study|Lost to Follow-up|0|||
33572877|NCT00523978|101989759|FG001|Overall Study|Withdrawal by Subject|7|||
33572878|NCT00523978|101989758|FG000|Overall Study|Screen Failures|5|||
33572879|NCT00523978|101989759|FG001|Overall Study|Screen Failures|1|||
33572880|NCT00523978|101989758|FG000|Overall Study|Death|1|||
33572881|NCT00523978|101989759|FG001|Overall Study|Death|0|||
33572882|NCT00444106|101989760|FG000|Overall Study|Lost to Follow-up|2|||
33572883|NCT00444106|101989761|FG001|Overall Study|Lost to Follow-up|1|||
33572884|NCT00444106|101989762|FG002|Overall Study|Lost to Follow-up|0|||
33572885|NCT00444106|101989760|FG000|Overall Study|Abnormal Test Procedure Results|0|||
33572886|NCT00444106|101989761|FG001|Overall Study|Abnormal Test Procedure Results|0|||
33572887|NCT00444106|101989762|FG002|Overall Study|Abnormal Test Procedure Results|1|||
33572888|NCT01784029|101989763|FG000|Overall Study|Lost to Follow-up|19|||
33634772|NCT01907854|102214623|FG001|Overall Study|Protocol Violation|1|||
33634773|NCT01907854|102214622|FG000|Overall Study|Withdrawal by Subject|9|||
33634774|NCT01907854|102214623|FG001|Overall Study|Withdrawal by Subject|7|||
33634775|NCT01907854|102214622|FG000|Overall Study|Lost to Follow-up|2|||
33634776|NCT01907854|102214623|FG001|Overall Study|Lost to Follow-up|2|||
33634777|NCT01907854|102214622|FG000|Overall Study|Unclassified|4|||
33634778|NCT01907854|102214623|FG001|Overall Study|Unclassified|3|||
33634779|NCT03591406|102214629|FG000|Overall Study|Adverse Event|5|||
33572889|NCT01784029|101989764|FG001|Overall Study|Lost to Follow-up|20|||
33572890|NCT01784029|101989765|FG002|Overall Study|Lost to Follow-up|22|||
33572891|NCT02471144|101989772|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
33572892|NCT02471144|101989773|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
33572893|NCT02471144|101989774|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
33572894|NCT02471144|101989775|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
33572895|NCT02471144|101989776|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
33572896|NCT02471144|101989777|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
33634780|NCT03591406|102214630|FG001|Overall Study|Adverse Event|3|||
33634781|NCT03591406|102214629|FG000|Overall Study|Protocol Violation|2|||
33634782|NCT03591406|102214630|FG001|Overall Study|Protocol Violation|1|||
33634783|NCT03591406|102214629|FG000|Overall Study|Withdrawal by Subject|0|||
33634784|NCT03591406|102214630|FG001|Overall Study|Withdrawal by Subject|5|||
33634785|NCT00089297|102214631|FG000|Overall Study|Adverse Event|9|||
33634786|NCT00089297|102214631|FG000|Overall Study|Death|1|||
33634787|NCT00089297|102214631|FG000|Overall Study|Withdrawal by Subject|12|||
33634788|NCT00089297|102214631|FG000|Overall Study|Disease progression|2|||
33634789|NCT00089297|102214631|FG000|Overall Study|Ineligible|11|||
33634790|NCT00089297|102214631|FG000|Overall Study|Secondary malignancy|1|||
33634791|NCT00089297|102214631|FG000|Overall Study|IRB approval not ready|1|||
33572897|NCT02471144|101989778|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
33572898|NCT02471144|101989779|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
33634792|NCT00089297|102214631|FG000|Overall Study|Non-compliance|1|||
33634793|NCT01409707|102214632|FG000|Overall Study|Withdrawal by Subject|5|||
33634794|NCT01409707|102214633|FG001|Overall Study|Withdrawal by Subject|17|||
33634795|NCT01409707|102214634|FG002|Overall Study|Withdrawal by Subject|16|||
33572899|NCT02471144|101989780|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
33572900|NCT02471144|101989781|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
33572901|NCT02471144|101989782|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
33572902|NCT02471144|101989772|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33572903|NCT02471144|101989773|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33572904|NCT02471144|101989774|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33572905|NCT02471144|101989775|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
33572906|NCT02471144|101989776|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33572907|NCT02471144|101989777|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33572908|NCT02471144|101989778|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33572909|NCT02471144|101989779|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33572910|NCT02471144|101989780|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33572911|NCT02471144|101989781|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33572912|NCT02471144|101989782|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
33572913|NCT02471144|101989772|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33572914|NCT02471144|101989773|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33572915|NCT02471144|101989774|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
33572916|NCT02471144|101989775|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33572917|NCT02471144|101989776|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33230065|NCT01536145|100742504|FG009|Overall Study|Other|3|||
33230066|NCT01536145|100742505|FG010|Overall Study|Other|2|||
33230067|NCT01536145|100742495|FG000|Overall Study|Death|0|||
33230068|NCT01536145|100742496|FG001|Overall Study|Death|0|||
33230069|NCT01536145|100742497|FG002|Overall Study|Death|0|||
33230070|NCT01536145|100742498|FG003|Overall Study|Death|0|||
33230071|NCT01536145|100742499|FG004|Overall Study|Death|0|||
33230072|NCT01536145|100742500|FG005|Overall Study|Death|0|||
33230073|NCT01536145|100742501|FG006|Overall Study|Death|1|||
33230074|NCT01536145|100742502|FG007|Overall Study|Death|0|||
33230075|NCT01536145|100742503|FG008|Overall Study|Death|0|||
33230076|NCT01536145|100742504|FG009|Overall Study|Death|0|||
33230077|NCT01536145|100742505|FG010|Overall Study|Death|0|||
33230078|NCT01536145|100742495|FG000|Overall Study|Adverse Event|0|||
33230079|NCT01536145|100742496|FG001|Overall Study|Adverse Event|0|||
33230080|NCT01536145|100742497|FG002|Overall Study|Adverse Event|0|||
33230081|NCT01536145|100742498|FG003|Overall Study|Adverse Event|0|||
33230082|NCT01536145|100742499|FG004|Overall Study|Adverse Event|0|||
33230083|NCT01536145|100742500|FG005|Overall Study|Adverse Event|0|||
33230084|NCT01536145|100742501|FG006|Overall Study|Adverse Event|0|||
33230085|NCT01536145|100742502|FG007|Overall Study|Adverse Event|2|||
33230086|NCT01536145|100742503|FG008|Overall Study|Adverse Event|0|||
33230087|NCT01536145|100742504|FG009|Overall Study|Adverse Event|0|||
33230088|NCT01536145|100742505|FG010|Overall Study|Adverse Event|3|||
33230089|NCT00210119|100742511|FG000|Overall Study|Protocol Violation|1|||
33230090|NCT00210119|100742511|FG000|Overall Study|Withdrawal by Subject|1|||
33230091|NCT00630058|100742512|FG000|Overall Study|Adverse Event|1|||
33230092|NCT00630058|100742513|FG001|Overall Study|Adverse Event|1|||
33367416|NCT01915849|101230262|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
33367417|NCT01915849|101230263|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
33367418|NCT00521339|101230266|FG000|Treatment Phase|Adverse Event|2|||
33367419|NCT00521339|101230267|FG001|Treatment Phase|Adverse Event|0|||
33367420|NCT00521339|101230268|FG002|Treatment Phase|Adverse Event|0|||
33367421|NCT00521339|101230266|FG000|Treatment Phase|Intolerability to study drug|2|||
33367422|NCT00521339|101230267|FG001|Treatment Phase|Intolerability to study drug|0|||
33367423|NCT00521339|101230268|FG002|Treatment Phase|Intolerability to study drug|0|||
33367424|NCT00521339|101230266|FG000|Treatment Phase|Lack of Efficacy|3|||
33367425|NCT00521339|101230267|FG001|Treatment Phase|Lack of Efficacy|0|||
33367426|NCT00521339|101230268|FG002|Treatment Phase|Lack of Efficacy|0|||
33367427|NCT00521339|101230266|FG000|Treatment Phase|Withdrawal by Subject|3|||
33419259|NCT03869684|101425724|FG002|Overall Study|Lost to Follow-up|0|||
33419260|NCT03869684|101425722|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
33572918|NCT02471144|101989777|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33572919|NCT02471144|101989778|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33419261|NCT03869684|101425723|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
33572920|NCT02471144|101989779|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33572921|NCT02471144|101989780|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33230093|NCT00630058|100742512|FG000|Overall Study|Withdrawal by Subject|0|||
33230094|NCT00630058|100742513|FG001|Overall Study|Withdrawal by Subject|1|||
33230095|NCT00630058|100742512|FG000|Overall Study|stopping criteria|3|||
33230096|NCT00630058|100742513|FG001|Overall Study|stopping criteria|2|||
33367428|NCT00521339|101230267|FG001|Treatment Phase|Withdrawal by Subject|0|||
33572922|NCT02471144|101989781|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33230097|NCT03377790|100742514|FG000|Overall Study|Withdrawal by Subject|1|||
33230098|NCT03377790|100742515|FG001|Overall Study|Withdrawal by Subject|0|||
33230099|NCT03377790|100742514|FG000|Overall Study|Adverse Event|1|||
33230100|NCT03377790|100742515|FG001|Overall Study|Adverse Event|0|||
33230101|NCT03377790|100742514|FG000|Overall Study|Lost to Follow-up|0|||
33230102|NCT03377790|100742515|FG001|Overall Study|Lost to Follow-up|2|||
33230103|NCT03377790|100742514|FG000|Overall Study|Randomized but not treated|1|||
33230104|NCT03377790|100742515|FG001|Overall Study|Randomized but not treated|0|||
33230105|NCT03377790|100742514|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
33230106|NCT03377790|100742515|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
33230107|NCT04827134|100742519|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
33230108|NCT04827134|100742520|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
33230109|NCT04827134|100742521|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
33230110|NCT04827134|100742522|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
33230111|NCT00452413|100742523|FG000|Overall Study|Progressive Disease|4|||
33230112|NCT00452413|100742524|FG001|Overall Study|Progressive Disease|11|||
33230113|NCT00452413|100742525|FG002|Overall Study|Progressive Disease|30|||
33230114|NCT00452413|100742523|FG000|Overall Study|Withdrawal by Subject|0|||
33230115|NCT00452413|100742524|FG001|Overall Study|Withdrawal by Subject|1|||
33230116|NCT00452413|100742525|FG002|Overall Study|Withdrawal by Subject|4|||
33230117|NCT00452413|100742523|FG000|Overall Study|Adverse Event|0|||
33230118|NCT00452413|100742524|FG001|Overall Study|Adverse Event|0|||
33230119|NCT00452413|100742525|FG002|Overall Study|Adverse Event|5|||
33230120|NCT00452413|100742523|FG000|Overall Study|Physician Decision|0|||
33230121|NCT00452413|100742524|FG001|Overall Study|Physician Decision|0|||
33230122|NCT00452413|100742525|FG002|Overall Study|Physician Decision|4|||
33230123|NCT00452413|100742523|FG000|Overall Study|Death due to study disease|0|||
33230124|NCT00452413|100742524|FG001|Overall Study|Death due to study disease|0|||
33230125|NCT00452413|100742525|FG002|Overall Study|Death due to study disease|2|||
33230126|NCT00452413|100742523|FG000|Overall Study|Death due to adverse event (AE)|0|||
33230127|NCT00452413|100742524|FG001|Overall Study|Death due to adverse event (AE)|0|||
33230128|NCT00452413|100742525|FG002|Overall Study|Death due to adverse event (AE)|1|||
33230129|NCT00452413|100742523|FG000|Overall Study|On treatment|0|||
33230130|NCT00452413|100742524|FG001|Overall Study|On treatment|0|||
33230131|NCT00452413|100742525|FG002|Overall Study|On treatment|3|||
33230132|NCT00519636|100742526|FG000|Treatment Period 1|Adverse Event|1|||
33230133|NCT00519636|100742527|FG001|Treatment Period 1|Adverse Event|0|||
33230134|NCT00519636|100742528|FG002|Treatment Period 1|Adverse Event|1|||
33230135|NCT00519636|100742529|FG003|Treatment Period 1|Adverse Event|0|||
33230136|NCT00519636|100742526|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
33230137|NCT00519636|100742527|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
33230138|NCT00519636|100742528|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
33230139|NCT00519636|100742529|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
33230140|NCT00519636|100742526|FG000|Washout Period|Adverse Event|2|||
33230141|NCT00519636|100742527|FG001|Washout Period|Adverse Event|1|||
33230142|NCT00519636|100742528|FG002|Washout Period|Adverse Event|1|||
33230143|NCT00519636|100742529|FG003|Washout Period|Adverse Event|0|||
33230144|NCT00519636|100742526|FG000|Washout Period|Lost to Follow-up|1|||
33230145|NCT00519636|100742527|FG001|Washout Period|Lost to Follow-up|0|||
33230146|NCT00519636|100742528|FG002|Washout Period|Lost to Follow-up|0|||
33230147|NCT00519636|100742529|FG003|Washout Period|Lost to Follow-up|0|||
33230148|NCT00519636|100742526|FG000|Washout Period|Protocol Violation|0|||
33230149|NCT00519636|100742527|FG001|Washout Period|Protocol Violation|0|||
33230150|NCT00519636|100742528|FG002|Washout Period|Protocol Violation|1|||
33230151|NCT00519636|100742529|FG003|Washout Period|Protocol Violation|2|||
33230152|NCT00519636|100742526|FG000|Washout Period|Withdrawal by Subject|1|||
33230153|NCT00519636|100742527|FG001|Washout Period|Withdrawal by Subject|0|||
33230154|NCT00519636|100742528|FG002|Washout Period|Withdrawal by Subject|1|||
33230155|NCT00519636|100742529|FG003|Washout Period|Withdrawal by Subject|0|||
33230156|NCT00519636|100742526|FG000|Washout Period|Failed to meet continuation criteria|14|||
33230157|NCT00519636|100742527|FG001|Washout Period|Failed to meet continuation criteria|11|||
33230158|NCT00519636|100742528|FG002|Washout Period|Failed to meet continuation criteria|9|||
33230159|NCT00519636|100742529|FG003|Washout Period|Failed to meet continuation criteria|3|||
33230160|NCT00519636|100742526|FG000|Washout Period|Out of pollen area > 48 hours|1|||
33230161|NCT00519636|100742527|FG001|Washout Period|Out of pollen area > 48 hours|0|||
33230162|NCT00519636|100742528|FG002|Washout Period|Out of pollen area > 48 hours|0|||
33230163|NCT00519636|100742529|FG003|Washout Period|Out of pollen area > 48 hours|0|||
33367429|NCT00521339|101230268|FG002|Treatment Phase|Withdrawal by Subject|0|||
33419262|NCT03869684|101425724|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
33230164|NCT00519636|100742526|FG000|Washout Period|Participating in study at another site|1|||
33230165|NCT00519636|100742527|FG001|Washout Period|Participating in study at another site|0|||
33230166|NCT00519636|100742528|FG002|Washout Period|Participating in study at another site|0|||
33230167|NCT00519636|100742529|FG003|Washout Period|Participating in study at another site|0|||
33230168|NCT00519636|100742526|FG000|Washout Period|Non-compliant|0|||
33230169|NCT00519636|100742527|FG001|Washout Period|Non-compliant|1|||
33230170|NCT00519636|100742528|FG002|Washout Period|Non-compliant|0|||
33230171|NCT00519636|100742529|FG003|Washout Period|Non-compliant|0|||
33230172|NCT00519636|100742526|FG000|Washout Period|Per doctors request|0|||
33230173|NCT00519636|100742527|FG001|Washout Period|Per doctors request|1|||
33230174|NCT00519636|100742528|FG002|Washout Period|Per doctors request|0|||
33230175|NCT00519636|100742529|FG003|Washout Period|Per doctors request|0|||
33230176|NCT00519636|100742526|FG000|Washout Period|Subject randomized in error|0|||
33230177|NCT00519636|100742527|FG001|Washout Period|Subject randomized in error|0|||
33230178|NCT00519636|100742528|FG002|Washout Period|Subject randomized in error|1|||
33230179|NCT00519636|100742529|FG003|Washout Period|Subject randomized in error|0|||
33230180|NCT00519636|100742526|FG000|Washout Period|Prohibited medications|0|||
33230181|NCT00519636|100742527|FG001|Washout Period|Prohibited medications|0|||
33230182|NCT00519636|100742528|FG002|Washout Period|Prohibited medications|1|||
33230183|NCT00519636|100742529|FG003|Washout Period|Prohibited medications|0|||
33230184|NCT00519636|100742526|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
33230185|NCT00519636|100742527|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
33230186|NCT00519636|100742528|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
33230187|NCT00519636|100742529|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
33230188|NCT00519636|100742526|FG000|Treatment Period 2|Subject randomized in error|0|||
33230189|NCT00519636|100742527|FG001|Treatment Period 2|Subject randomized in error|1|||
33230190|NCT00519636|100742528|FG002|Treatment Period 2|Subject randomized in error|0|||
33230191|NCT00519636|100742529|FG003|Treatment Period 2|Subject randomized in error|0|||
33230192|NCT00519636|100742526|FG000|Treatment Period 2|Per doctors request|0|||
33230193|NCT00519636|100742527|FG001|Treatment Period 2|Per doctors request|0|||
33230194|NCT00519636|100742528|FG002|Treatment Period 2|Per doctors request|1|||
33230195|NCT00519636|100742529|FG003|Treatment Period 2|Per doctors request|0|||
33230196|NCT00519636|100742526|FG000|Treatment Period 2|Subject misrandomized|0|||
33230197|NCT00519636|100742527|FG001|Treatment Period 2|Subject misrandomized|0|||
33230198|NCT00519636|100742528|FG002|Treatment Period 2|Subject misrandomized|0|||
33230199|NCT00519636|100742529|FG003|Treatment Period 2|Subject misrandomized|1|||
33230200|NCT00519636|100742526|FG000|Post Study Period|Subject randomized in error|0|||
33230201|NCT00519636|100742527|FG001|Post Study Period|Subject randomized in error|0|||
33230202|NCT00519636|100742528|FG002|Post Study Period|Subject randomized in error|0|||
33230203|NCT00519636|100742529|FG003|Post Study Period|Subject randomized in error|1|||
33230204|NCT04397523|100742536|FG000|Overall Study|Lost to Follow-up|3|||
33230205|NCT04397523|100742536|FG000|Overall Study|Transfer from/to other hospital|8|||
33230206|NCT01289041|100742538|FG000|Overall Study|Adverse Event|24|||
33230207|NCT01289041|100742538|FG000|Overall Study|Physician Decision|1|||
33230208|NCT01289041|100742538|FG000|Overall Study|Progressive Disease|41|||
33230209|NCT01289041|100742538|FG000|Overall Study|Withdrawal by Subject|3|||
33230210|NCT01289041|100742538|FG000|Overall Study|Death|1|||
33230211|NCT01213173|100742545|FG000|Overall Study|Protocol Violation|2|||
33230212|NCT01213173|100742546|FG001|Overall Study|Protocol Violation|0|||
33230213|NCT01213173|100742545|FG000|Overall Study|Adverse Event|4|||
33230214|NCT01213173|100742546|FG001|Overall Study|Adverse Event|8|||
33230215|NCT01213173|100742545|FG000|Overall Study|Withdrawal by Subject|5|||
33230216|NCT01213173|100742546|FG001|Overall Study|Withdrawal by Subject|5|||
33230217|NCT01213173|100742545|FG000|Overall Study|Incorrect Enrollment|1|||
33230218|NCT01213173|100742546|FG001|Overall Study|Incorrect Enrollment|3|||
33230219|NCT00003458|100742550|FG000|Overall Study|Not evaluable|4|||
33230220|NCT02138747|100742551|FG000|Treatment Period 1|Adverse Event|10|||
33230221|NCT02138747|100742552|FG001|Treatment Period 1|Adverse Event|14|||
33230222|NCT02138747|100742553|FG002|Treatment Period 1|Adverse Event|2|||
33230223|NCT02138747|100742554|FG003|Treatment Period 1|Adverse Event|1|||
33230224|NCT02138747|100742551|FG000|Treatment Period 1|Lost to Follow-up|0|||
33230225|NCT02138747|100742552|FG001|Treatment Period 1|Lost to Follow-up|1|||
33230226|NCT02138747|100742553|FG002|Treatment Period 1|Lost to Follow-up|1|||
33230227|NCT02138747|100742554|FG003|Treatment Period 1|Lost to Follow-up|0|||
33230228|NCT02138747|100742551|FG000|Treatment Period 1|Protocol Violation|0|||
33230229|NCT02138747|100742552|FG001|Treatment Period 1|Protocol Violation|2|||
33230230|NCT02138747|100742553|FG002|Treatment Period 1|Protocol Violation|0|||
33419263|NCT03746080|101425731|FG000|Overall Study|In follow up|2|||
33230231|NCT02138747|100742554|FG003|Treatment Period 1|Protocol Violation|0|||
33230232|NCT02138747|100742551|FG000|Treatment Period 1|Withdrawal by Subject|8|||
33230233|NCT02138747|100742552|FG001|Treatment Period 1|Withdrawal by Subject|4|||
33419264|NCT03746080|101425731|FG000|Overall Study|Death|15|||
33230234|NCT02138747|100742553|FG002|Treatment Period 1|Withdrawal by Subject|1|||
33230235|NCT02138747|100742554|FG003|Treatment Period 1|Withdrawal by Subject|3|||
33230236|NCT02138747|100742551|FG000|Treatment Period 1|Other - Miscellaneous|2|||
33230237|NCT02138747|100742552|FG001|Treatment Period 1|Other - Miscellaneous|4|||
33230238|NCT02138747|100742553|FG002|Treatment Period 1|Other - Miscellaneous|0|||
33230239|NCT02138747|100742554|FG003|Treatment Period 1|Other - Miscellaneous|0|||
33230240|NCT02138747|100742551|FG000|Treatment Period 2|Adverse Event|6|||
33634796|NCT00535496|102214635|FG000|Overall Study|Lost to Follow-up|0|||
33634797|NCT00535496|102214636|FG001|Overall Study|Lost to Follow-up|1|||
33634798|NCT00535496|102214637|FG002|Overall Study|Lost to Follow-up|0|||
33634799|NCT00535496|102214638|FG003|Overall Study|Lost to Follow-up|0|||
33634800|NCT00535496|102214635|FG000|Overall Study|Not treated with sugammadex|0|||
33634801|NCT00535496|102214636|FG001|Overall Study|Not treated with sugammadex|1|||
33634802|NCT00535496|102214637|FG002|Overall Study|Not treated with sugammadex|0|||
33634803|NCT00535496|102214638|FG003|Overall Study|Not treated with sugammadex|0|||
33634804|NCT00303069|102214649|FG000|Overall Study|Lost to Follow-up|1|||
33634805|NCT00303069|102214650|FG001|Overall Study|Lost to Follow-up|0|||
33634806|NCT00303069|102214651|FG002|Overall Study|Lost to Follow-up|0|||
33634807|NCT00303069|102214652|FG003|Overall Study|Lost to Follow-up|2|||
33634808|NCT00303069|102214649|FG000|Overall Study|subject moved|1|||
33634809|NCT00303069|102214650|FG001|Overall Study|subject moved|0|||
33634810|NCT00303069|102214651|FG002|Overall Study|subject moved|0|||
33634811|NCT00303069|102214652|FG003|Overall Study|subject moved|0|||
33634812|NCT00303069|102214649|FG000|Overall Study|Recruitment into Army Reserves|0|||
33634813|NCT00303069|102214650|FG001|Overall Study|Recruitment into Army Reserves|0|||
33634814|NCT00303069|102214651|FG002|Overall Study|Recruitment into Army Reserves|1|||
33634815|NCT00303069|102214652|FG003|Overall Study|Recruitment into Army Reserves|0|||
33634816|NCT03304626|102214653|FG000|Overall Study|Adverse Event|1|||
33634817|NCT03304626|102214654|FG001|Overall Study|Adverse Event|0|||
33634818|NCT03304626|102214653|FG000|Overall Study|Lack of Efficacy|1|||
33634819|NCT03304626|102214654|FG001|Overall Study|Lack of Efficacy|1|||
33634820|NCT02158546|102214655|FG000|Overall Study|Physician Decision|0|||
33634821|NCT02158546|102214656|FG001|Overall Study|Physician Decision|1|||
33634822|NCT02158546|102214657|FG002|Overall Study|Physician Decision|0|||
33634823|NCT02158546|102214658|FG003|Overall Study|Physician Decision|0|||
33634824|NCT02158546|102214655|FG000|Overall Study|Non-compliance|0|||
33634825|NCT02158546|102214656|FG001|Overall Study|Non-compliance|1|||
33634826|NCT02158546|102214657|FG002|Overall Study|Non-compliance|0|||
33634827|NCT02158546|102214658|FG003|Overall Study|Non-compliance|1|||
33634828|NCT02158546|102214655|FG000|Overall Study|Failure to meet eligibility criteria|0|||
33634829|NCT02158546|102214656|FG001|Overall Study|Failure to meet eligibility criteria|1|||
33634830|NCT02158546|102214657|FG002|Overall Study|Failure to meet eligibility criteria|0|||
33634831|NCT02158546|102214658|FG003|Overall Study|Failure to meet eligibility criteria|0|||
33634832|NCT02158546|102214655|FG000|Overall Study|Lack of Efficacy|1|||
33634833|NCT02158546|102214656|FG001|Overall Study|Lack of Efficacy|1|||
33634834|NCT02158546|102214657|FG002|Overall Study|Lack of Efficacy|0|||
33634835|NCT02158546|102214658|FG003|Overall Study|Lack of Efficacy|0|||
33634836|NCT02158546|102214655|FG000|Overall Study|Adverse Event|2|||
33634837|NCT02158546|102214656|FG001|Overall Study|Adverse Event|2|||
33634838|NCT02158546|102214657|FG002|Overall Study|Adverse Event|0|||
33634839|NCT02158546|102214658|FG003|Overall Study|Adverse Event|0|||
33634840|NCT02158546|102214655|FG000|Overall Study|Withdrawal by Subject|6|||
33634841|NCT02158546|102214656|FG001|Overall Study|Withdrawal by Subject|2|||
33634842|NCT02158546|102214657|FG002|Overall Study|Withdrawal by Subject|1|||
33634843|NCT02158546|102214658|FG003|Overall Study|Withdrawal by Subject|0|||
33634844|NCT02158546|102214655|FG000|Overall Study|Lost to Follow-up|5|||
33634845|NCT02158546|102214656|FG001|Overall Study|Lost to Follow-up|4|||
33634846|NCT02158546|102214657|FG002|Overall Study|Lost to Follow-up|0|||
33634847|NCT02158546|102214658|FG003|Overall Study|Lost to Follow-up|1|||
33230241|NCT02138747|100742552|FG001|Treatment Period 2|Adverse Event|3|||
33367430|NCT00521339|101230266|FG000|Treatment Phase|Lost to Follow-up|1|||
33634848|NCT02158546|102214655|FG000|Overall Study|Site Excluded|5|||
33634849|NCT02158546|102214656|FG001|Overall Study|Site Excluded|5|||
33634850|NCT02158546|102214657|FG002|Overall Study|Site Excluded|3|||
33634851|NCT02158546|102214658|FG003|Overall Study|Site Excluded|4|||
33634852|NCT00907335|102214663|FG000|Overall Study|Withdrawal by Subject|2|||
33634853|NCT00907335|102214664|FG001|Overall Study|Withdrawal by Subject|0|||
33634854|NCT00907335|102214663|FG000|Overall Study|Adverse Event|4|||
33634855|NCT00907335|102214664|FG001|Overall Study|Adverse Event|1|||
33634856|NCT00907335|102214663|FG000|Overall Study|Lost to Follow-up|2|||
33634857|NCT00907335|102214664|FG001|Overall Study|Lost to Follow-up|0|||
33634858|NCT03137381|102214665|FG000|Overall Study|Adverse Event|3|||
33634859|NCT03137381|102214666|FG001|Overall Study|Adverse Event|0|||
33634860|NCT03137381|102214667|FG002|Overall Study|Adverse Event|2|||
33634861|NCT03137381|102214668|FG003|Overall Study|Adverse Event|0|||
33230242|NCT02138747|100742553|FG002|Treatment Period 2|Adverse Event|1|||
33230243|NCT02138747|100742554|FG003|Treatment Period 2|Adverse Event|1|||
33419265|NCT00572156|101425732|FG000|Overall Study|Adverse Event|3|||
33419266|NCT00572156|101425733|FG001|Overall Study|Adverse Event|1|||
33419267|NCT00572156|101425734|FG002|Overall Study|Adverse Event|5|||
33419268|NCT00572156|101425735|FG003|Overall Study|Adverse Event|1|||
33419269|NCT00572156|101425732|FG000|Overall Study|Lost to Follow-up|1|||
33419270|NCT00572156|101425733|FG001|Overall Study|Lost to Follow-up|1|||
33419271|NCT00572156|101425734|FG002|Overall Study|Lost to Follow-up|1|||
33419272|NCT00572156|101425735|FG003|Overall Study|Lost to Follow-up|0|||
33419273|NCT00572156|101425732|FG000|Overall Study|Protocol Violation|1|||
33419274|NCT00572156|101425733|FG001|Overall Study|Protocol Violation|2|||
33419275|NCT00572156|101425734|FG002|Overall Study|Protocol Violation|0|||
33419276|NCT00572156|101425735|FG003|Overall Study|Protocol Violation|2|||
33419277|NCT00572156|101425732|FG000|Overall Study|Patient/Parent Decision|1|||
33419278|NCT00572156|101425733|FG001|Overall Study|Patient/Parent Decision|6|||
33230244|NCT02138747|100742551|FG000|Treatment Period 2|Lost to Follow-up|2|||
33230245|NCT02138747|100742552|FG001|Treatment Period 2|Lost to Follow-up|0|||
33230246|NCT02138747|100742553|FG002|Treatment Period 2|Lost to Follow-up|0|||
33230247|NCT02138747|100742554|FG003|Treatment Period 2|Lost to Follow-up|0|||
33230248|NCT02138747|100742551|FG000|Treatment Period 2|Protocol Violation|1|||
33230249|NCT02138747|100742552|FG001|Treatment Period 2|Protocol Violation|0|||
33230250|NCT02138747|100742553|FG002|Treatment Period 2|Protocol Violation|0|||
33230251|NCT02138747|100742554|FG003|Treatment Period 2|Protocol Violation|0|||
33230252|NCT02138747|100742551|FG000|Treatment Period 2|Withdrawal by Subject|5|||
33230253|NCT02138747|100742552|FG001|Treatment Period 2|Withdrawal by Subject|4|||
33230254|NCT02138747|100742553|FG002|Treatment Period 2|Withdrawal by Subject|1|||
33230255|NCT02138747|100742554|FG003|Treatment Period 2|Withdrawal by Subject|2|||
33230256|NCT02138747|100742551|FG000|Treatment Period 2|Other - Miscellaneous|3|||
33230257|NCT02138747|100742552|FG001|Treatment Period 2|Other - Miscellaneous|0|||
33230258|NCT02138747|100742553|FG002|Treatment Period 2|Other - Miscellaneous|0|||
33230259|NCT02138747|100742554|FG003|Treatment Period 2|Other - Miscellaneous|0|||
33230260|NCT04362137|100742555|FG000|Overall Study|Death|9|||
33230261|NCT04362137|100742556|FG001|Overall Study|Death|3|||
33230262|NCT04362137|100742555|FG000|Overall Study|Patient decision|6|||
33230263|NCT04362137|100742556|FG001|Overall Study|Patient decision|3|||
33230264|NCT04362137|100742555|FG000|Overall Study|Adverse Event|1|||
33230265|NCT04362137|100742556|FG001|Overall Study|Adverse Event|0|||
33230266|NCT04362137|100742555|FG000|Overall Study|Lost to Follow-up|1|||
33230267|NCT04362137|100742556|FG001|Overall Study|Lost to Follow-up|0|||
33230268|NCT04362137|100742555|FG000|Overall Study|Protocol deviation|1|||
33230269|NCT04362137|100742556|FG001|Overall Study|Protocol deviation|0|||
33230270|NCT00195715|100742557|FG000|Overall Study|Adverse Event|122|||
33230271|NCT00195715|100742557|FG000|Overall Study|Withdrawal by Subject|58|||
33230272|NCT00195715|100742557|FG000|Overall Study|Lost to Follow-up|27|||
33230273|NCT00195715|100742557|FG000|Overall Study|Protocol Violation|13|||
33230274|NCT00195715|100742557|FG000|Overall Study|Lack of Efficacy|93|||
33230275|NCT00195715|100742557|FG000|Overall Study|Pregnancy|14|||
33230276|NCT00195715|100742557|FG000|Overall Study|Investigative site closure|8|||
33230277|NCT00195715|100742557|FG000|Overall Study|Subject moved/relocated|7|||
33230278|NCT00195715|100742557|FG000|Overall Study|Subject non-compliance|6|||
33230279|NCT00195715|100742557|FG000|Overall Study|Subject started commercial Humira|5|||
33230280|NCT00195715|100742557|FG000|Overall Study|Subject choice|3|||
33230281|NCT00195715|100742557|FG000|Overall Study|Loss of response/no improvement|3|||
33230282|NCT00195715|100742557|FG000|Overall Study|Sponsor stopped study|1|||
33230283|NCT00195715|100742557|FG000|Overall Study|Administrative reasons|2|||
33230284|NCT00195715|100742557|FG000|Overall Study|Investigator's decision|2|||
33230285|NCT00195715|100742557|FG000|Overall Study|Subject wants to get pregnant|4|||
33230286|NCT00195715|100742557|FG000|Overall Study|Use of prohibited medication|2|||
33230287|NCT00195715|100742557|FG000|Overall Study|Planned surgery|2|||
33230288|NCT00195715|100742557|FG000|Overall Study|Increased infection rate|1|||
33230289|NCT00195715|100742557|FG000|Overall Study|Ineligible|1|||
33419279|NCT00572156|101425734|FG002|Overall Study|Patient/Parent Decision|4|||
33419280|NCT00572156|101425735|FG003|Overall Study|Patient/Parent Decision|3|||
33419281|NCT00572156|101425732|FG000|Overall Study|Sponsor Decision|20|||
33419282|NCT00572156|101425733|FG001|Overall Study|Sponsor Decision|16|||
33419283|NCT00572156|101425734|FG002|Overall Study|Sponsor Decision|17|||
33419284|NCT00572156|101425735|FG003|Overall Study|Sponsor Decision|19|||
33230290|NCT00195715|100742557|FG000|Overall Study|Colonic stricture|1|||
33230291|NCT00195715|100742557|FG000|Overall Study|Sponsor discontinued trial|1|||
33230292|NCT00195715|100742557|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
33230293|NCT01987830|100742558|FG000|Overall Study|Never received baseline scan|1|||
33230294|NCT05284019|100742561|FG000|Overall Study|Study terminated|2|||
33230295|NCT05284019|100742562|FG001|Overall Study|Study terminated|2|||
33230296|NCT05284019|100742563|FG002|Overall Study|Study terminated|2|||
33230297|NCT05284019|100742564|FG003|Overall Study|Study terminated|5|||
33230298|NCT05284019|100742565|FG004|Overall Study|Study terminated|15|||
33419285|NCT00411762|101425736|FG000|Overall Study|Withdrawal by Subject|5|||
33230299|NCT05284019|100742561|FG000|Overall Study|Withdrawal by Subject|0|||
33230300|NCT05284019|100742562|FG001|Overall Study|Withdrawal by Subject|0|||
33230301|NCT05284019|100742563|FG002|Overall Study|Withdrawal by Subject|0|||
33367431|NCT00521339|101230267|FG001|Treatment Phase|Lost to Follow-up|0|||
33367432|NCT00521339|101230268|FG002|Treatment Phase|Lost to Follow-up|0|||
33367433|NCT00521339|101230266|FG000|Treatment Phase|Protocol Violation|1|||
33367434|NCT00521339|101230267|FG001|Treatment Phase|Protocol Violation|0|||
33572923|NCT02471144|101989782|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
33367435|NCT00521339|101230268|FG002|Treatment Phase|Protocol Violation|0|||
33367436|NCT00521339|101230266|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
33367437|NCT00521339|101230267|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
33367438|NCT00521339|101230268|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
33367439|NCT00521339|101230266|FG000|Treatment Extension Phase|Death|0|||
33419286|NCT01988493|101425737|FG000|Overall Study|Randomized but not treated|0|||
33572924|NCT02471144|101989772|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
33572925|NCT02471144|101989773|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
33572926|NCT02471144|101989774|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33572927|NCT02471144|101989775|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33572928|NCT02471144|101989776|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33572929|NCT02471144|101989777|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33572930|NCT02471144|101989778|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33572931|NCT02471144|101989779|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33572932|NCT02471144|101989780|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33572933|NCT02471144|101989781|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33572934|NCT02471144|101989782|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
33572935|NCT02471144|101989772|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33572936|NCT02471144|101989773|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33572937|NCT02471144|101989774|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33572938|NCT02471144|101989775|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33572939|NCT02471144|101989776|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
33572940|NCT02471144|101989777|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33572941|NCT02471144|101989778|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
33572942|NCT02471144|101989779|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33572943|NCT02471144|101989780|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
33572944|NCT02471144|101989781|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33572945|NCT02471144|101989782|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
33572946|NCT02471144|101989772|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33572947|NCT02471144|101989773|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33572948|NCT02471144|101989774|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33572949|NCT02471144|101989775|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33572950|NCT02471144|101989776|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33572951|NCT02471144|101989777|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
33572952|NCT02471144|101989778|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33572953|NCT02471144|101989779|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33572954|NCT02471144|101989780|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
33572955|NCT02471144|101989781|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33572956|NCT02471144|101989782|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
33230302|NCT05284019|100742564|FG003|Overall Study|Withdrawal by Subject|1|||
33367440|NCT00521339|101230267|FG001|Treatment Extension Phase|Death|0|||
33419287|NCT01988493|101425738|FG001|Overall Study|Randomized but not treated|0|||
33419288|NCT01988493|101425739|FG002|Overall Study|Randomized but not treated|0|||
33419289|NCT01988493|101425740|FG003|Overall Study|Randomized but not treated|0|||
33419290|NCT01988493|101425741|FG004|Overall Study|Randomized but not treated|1|||
33419291|NCT02703454|101425742|FG000|Overall Study|Not treated|1|||
33419292|NCT02703454|101425743|FG001|Overall Study|Not treated|3|||
33419293|NCT02703454|101425742|FG000|Overall Study|Withdrawal by Subject|4|||
33419294|NCT02703454|101425743|FG001|Overall Study|Withdrawal by Subject|3|||
33419295|NCT02703454|101425742|FG000|Overall Study|Lost to Follow-up|1|||
33419296|NCT02703454|101425743|FG001|Overall Study|Lost to Follow-up|2|||
33419297|NCT02703454|101425742|FG000|Overall Study|Study discontinuation|5|||
33419298|NCT02703454|101425743|FG001|Overall Study|Study discontinuation|8|||
33419299|NCT01508325|101425744|FG000|Overall Study|Withdrawal by Subject|8|||
33419300|NCT01508325|101425745|FG001|Overall Study|Withdrawal by Subject|9|||
33419301|NCT01508325|101425744|FG000|Overall Study|Protocol Violation|0|||
33419302|NCT01508325|101425745|FG001|Overall Study|Protocol Violation|3|||
33419303|NCT01508325|101425744|FG000|Overall Study|Physician Decision|2|||
33419304|NCT01508325|101425745|FG001|Overall Study|Physician Decision|1|||
33419305|NCT01508325|101425744|FG000|Overall Study|Adverse Event|1|||
33419306|NCT01508325|101425745|FG001|Overall Study|Adverse Event|0|||
33419307|NCT01508325|101425744|FG000|Overall Study|Lost to Follow-up|5|||
33572957|NCT02471144|101989772|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33572958|NCT02471144|101989773|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33572959|NCT02471144|101989774|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33572960|NCT02471144|101989775|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33572961|NCT02471144|101989776|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33572962|NCT02471144|101989777|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33572963|NCT02471144|101989778|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33572964|NCT02471144|101989779|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33572965|NCT02471144|101989780|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
33572966|NCT02471144|101989781|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33572967|NCT02471144|101989782|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
33634862|NCT03137381|102214665|FG000|Overall Study|Lost to Follow-up|2|||
33634863|NCT03137381|102214666|FG001|Overall Study|Lost to Follow-up|1|||
33634864|NCT03137381|102214667|FG002|Overall Study|Lost to Follow-up|1|||
33634865|NCT03137381|102214668|FG003|Overall Study|Lost to Follow-up|0|||
33634866|NCT03137381|102214665|FG000|Overall Study|Protocol deviation|1|||
33634867|NCT03137381|102214666|FG001|Overall Study|Protocol deviation|1|||
33634868|NCT03137381|102214667|FG002|Overall Study|Protocol deviation|0|||
33634869|NCT03137381|102214668|FG003|Overall Study|Protocol deviation|1|||
33634870|NCT03137381|102214665|FG000|Overall Study|Withdrawal by Investigator|0|||
33634871|NCT03137381|102214666|FG001|Overall Study|Withdrawal by Investigator|1|||
33634872|NCT03137381|102214667|FG002|Overall Study|Withdrawal by Investigator|1|||
33634873|NCT03137381|102214668|FG003|Overall Study|Withdrawal by Investigator|0|||
33634874|NCT03137381|102214665|FG000|Overall Study|Withdrawal by Subject|3|||
33634875|NCT03137381|102214666|FG001|Overall Study|Withdrawal by Subject|4|||
33634876|NCT03137381|102214667|FG002|Overall Study|Withdrawal by Subject|3|||
33634877|NCT03137381|102214668|FG003|Overall Study|Withdrawal by Subject|0|||
33634878|NCT03137381|102214665|FG000|Overall Study|Pregnancy|0|||
33419308|NCT01508325|101425745|FG001|Overall Study|Lost to Follow-up|6|||
33419309|NCT01508325|101425744|FG000|Overall Study|Other|2|||
33419310|NCT01508325|101425745|FG001|Overall Study|Other|2|||
33419311|NCT03576131|101425746|FG000|Overall Study|Investigator decision|0|||
33419312|NCT03576131|101425747|FG001|Overall Study|Investigator decision|0|||
33419313|NCT03576131|101425748|FG002|Overall Study|Investigator decision|0|||
33419314|NCT03576131|101425749|FG003|Overall Study|Investigator decision|1|||
33572968|NCT02471144|101989772|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33572969|NCT02471144|101989773|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33572970|NCT02471144|101989774|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33419315|NCT03576131|101425750|FG004|Overall Study|Investigator decision|0|||
33419316|NCT03576131|101425751|FG005|Overall Study|Investigator decision|1|||
33419317|NCT03576131|101425752|FG006|Overall Study|Investigator decision|0|||
33572971|NCT02471144|101989775|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33634879|NCT03137381|102214666|FG001|Overall Study|Pregnancy|0|||
33634880|NCT03137381|102214667|FG002|Overall Study|Pregnancy|1|||
33634881|NCT03137381|102214668|FG003|Overall Study|Pregnancy|0|||
33634882|NCT00656513|102214669|FG000|Overall Study|Protocol Violation|1|||
33634883|NCT00656513|102214670|FG001|Overall Study|Protocol Violation|0|||
33634884|NCT00656513|102214671|FG002|Overall Study|Protocol Violation|2|||
33634885|NCT00656513|102214669|FG000|Overall Study|Withdrawal by Subject|0|||
33634886|NCT00656513|102214670|FG001|Overall Study|Withdrawal by Subject|11|||
33634887|NCT00656513|102214671|FG002|Overall Study|Withdrawal by Subject|4|||
33634888|NCT00656513|102214669|FG000|Overall Study|Death|0|||
33634889|NCT00656513|102214670|FG001|Overall Study|Death|0|||
33634890|NCT00656513|102214671|FG002|Overall Study|Death|1|||
33634891|NCT00656513|102214669|FG000|Overall Study|Missing data|0|||
33634892|NCT00656513|102214670|FG001|Overall Study|Missing data|11|||
33572972|NCT02471144|101989776|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33572973|NCT02471144|101989777|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33572974|NCT02471144|101989778|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33572975|NCT02471144|101989779|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
33572976|NCT02471144|101989780|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
33572977|NCT02471144|101989781|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33634893|NCT00656513|102214671|FG002|Overall Study|Missing data|9|||
33634894|NCT00656513|102214669|FG000|Overall Study|Incomplete treatment|3|||
33634895|NCT00656513|102214670|FG001|Overall Study|Incomplete treatment|0|||
33634896|NCT00656513|102214671|FG002|Overall Study|Incomplete treatment|0|||
33634897|NCT00656513|102214669|FG000|Overall Study|Treatment completed outside of timeframe|0|||
33634898|NCT00656513|102214670|FG001|Overall Study|Treatment completed outside of timeframe|3|||
33634899|NCT00656513|102214671|FG002|Overall Study|Treatment completed outside of timeframe|1|||
33634900|NCT00656513|102214669|FG000|Overall Study|Missing baseline form|0|||
33634901|NCT00656513|102214670|FG001|Overall Study|Missing baseline form|5|||
33634902|NCT00656513|102214671|FG002|Overall Study|Missing baseline form|5|||
33634903|NCT04885998|102214674|FG000|Overall Study|Ongoing in study|3|||
33634904|NCT04885998|102214675|FG001|Overall Study|Ongoing in study|2|||
33634905|NCT04885998|102214676|FG002|Overall Study|Ongoing in study|2|||
33634906|NCT04885998|102214677|FG003|Overall Study|Ongoing in study|6|||
33634907|NCT04885998|102214674|FG000|Overall Study|Withdrawal by Subject|0|||
33634908|NCT04885998|102214675|FG001|Overall Study|Withdrawal by Subject|2|||
33634909|NCT04885998|102214676|FG002|Overall Study|Withdrawal by Subject|1|||
33634910|NCT04885998|102214677|FG003|Overall Study|Withdrawal by Subject|1|||
33634911|NCT04885998|102214674|FG000|Overall Study|Lost to Follow-up|1|||
33634912|NCT04885998|102214675|FG001|Overall Study|Lost to Follow-up|0|||
33634913|NCT04885998|102214676|FG002|Overall Study|Lost to Follow-up|0|||
33634914|NCT04885998|102214677|FG003|Overall Study|Lost to Follow-up|0|||
33572978|NCT02471144|101989782|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
33572979|NCT02471144|101989772|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33634915|NCT04885998|102214674|FG000|Overall Study|Death|2|||
33634916|NCT04885998|102214675|FG001|Overall Study|Death|1|||
33634917|NCT04885998|102214676|FG002|Overall Study|Death|1|||
33230303|NCT05284019|100742565|FG004|Overall Study|Withdrawal by Subject|1|||
33230304|NCT05284019|100742561|FG000|Overall Study|Lost to Follow-up|1|||
33230305|NCT05284019|100742562|FG001|Overall Study|Lost to Follow-up|0|||
33230306|NCT05284019|100742563|FG002|Overall Study|Lost to Follow-up|0|||
33367441|NCT00521339|101230268|FG002|Treatment Extension Phase|Death|1|||
33367442|NCT00406315|101230269|FG000|Overall Study|Death|1|||
33367443|NCT00406315|101230269|FG000|Overall Study|Adverse Event|39|||
33367444|NCT00406315|101230269|FG000|Overall Study|Laboratory Abnormality|4|||
33367445|NCT00406315|101230269|FG000|Overall Study|Lack of Efficacy|13|||
33230307|NCT05284019|100742564|FG003|Overall Study|Lost to Follow-up|2|||
33367446|NCT00406315|101230269|FG000|Overall Study|Other|33|||
33367447|NCT00406315|101230269|FG000|Overall Study|Lost to Follow-up|21|||
33572980|NCT02471144|101989773|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33572981|NCT02471144|101989774|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33572982|NCT02471144|101989775|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33634918|NCT04885998|102214677|FG003|Overall Study|Death|0|||
33634919|NCT03873116|102214678|FG000|Part 1|Study drug discontinuation due to rash|0|||
33634920|NCT03873116|102214679|FG001|Part 1|Study drug discontinuation due to rash|0|||
33634921|NCT03873116|102214680|FG002|Part 1|Study drug discontinuation due to rash|0|||
33634922|NCT03873116|102214681|FG003|Part 1|Study drug discontinuation due to rash|0|||
33634923|NCT03873116|102214682|FG004|Part 1|Study drug discontinuation due to rash|0|||
33634924|NCT03873116|102214683|FG005|Part 1|Study drug discontinuation due to rash|1|||
33419318|NCT03576131|101425753|FG007|Overall Study|Investigator decision|0|||
33419319|NCT03576131|101425746|FG000|Overall Study|Withdrawal by Subject|1|||
33419320|NCT03576131|101425747|FG001|Overall Study|Withdrawal by Subject|1|||
33419321|NCT03576131|101425748|FG002|Overall Study|Withdrawal by Subject|0|||
33419322|NCT03576131|101425749|FG003|Overall Study|Withdrawal by Subject|1|||
33419323|NCT03576131|101425750|FG004|Overall Study|Withdrawal by Subject|2|||
33419324|NCT03576131|101425751|FG005|Overall Study|Withdrawal by Subject|3|||
33419325|NCT03576131|101425752|FG006|Overall Study|Withdrawal by Subject|1|||
33419326|NCT03576131|101425753|FG007|Overall Study|Withdrawal by Subject|0|||
33419327|NCT03576131|101425746|FG000|Overall Study|Death|3|||
33419328|NCT03576131|101425747|FG001|Overall Study|Death|3|||
33419329|NCT03576131|101425748|FG002|Overall Study|Death|1|||
33419330|NCT03576131|101425749|FG003|Overall Study|Death|5|||
33419331|NCT03576131|101425750|FG004|Overall Study|Death|4|||
33419332|NCT03576131|101425751|FG005|Overall Study|Death|1|||
33419333|NCT03576131|101425752|FG006|Overall Study|Death|0|||
33419334|NCT03576131|101425753|FG007|Overall Study|Death|1|||
33419335|NCT03576131|101425746|FG000|Overall Study|New anti-cancer treatment|5|||
33419336|NCT03576131|101425747|FG001|Overall Study|New anti-cancer treatment|1|||
33419337|NCT03576131|101425748|FG002|Overall Study|New anti-cancer treatment|2|||
33419338|NCT03576131|101425749|FG003|Overall Study|New anti-cancer treatment|3|||
33419339|NCT03576131|101425750|FG004|Overall Study|New anti-cancer treatment|0|||
33419340|NCT03576131|101425751|FG005|Overall Study|New anti-cancer treatment|0|||
33419341|NCT03576131|101425752|FG006|Overall Study|New anti-cancer treatment|0|||
33419342|NCT03576131|101425753|FG007|Overall Study|New anti-cancer treatment|0|||
33419343|NCT03576131|101425746|FG000|Overall Study|Unspecified reason|0|||
33419344|NCT03576131|101425747|FG001|Overall Study|Unspecified reason|0|||
33419345|NCT03576131|101425748|FG002|Overall Study|Unspecified reason|1|||
33419346|NCT03576131|101425749|FG003|Overall Study|Unspecified reason|1|||
33419347|NCT03576131|101425750|FG004|Overall Study|Unspecified reason|1|||
33419348|NCT03576131|101425751|FG005|Overall Study|Unspecified reason|1|||
33419349|NCT03576131|101425752|FG006|Overall Study|Unspecified reason|0|||
33419350|NCT03576131|101425753|FG007|Overall Study|Unspecified reason|0|||
33419351|NCT03576131|101425746|FG000|Overall Study|Subject non-compliance|0|||
33419352|NCT03576131|101425747|FG001|Overall Study|Subject non-compliance|0|||
33419353|NCT03576131|101425748|FG002|Overall Study|Subject non-compliance|0|||
33419354|NCT03576131|101425749|FG003|Overall Study|Subject non-compliance|0|||
33419355|NCT03576131|101425750|FG004|Overall Study|Subject non-compliance|0|||
33419356|NCT03576131|101425751|FG005|Overall Study|Subject non-compliance|1|||
33419357|NCT03576131|101425752|FG006|Overall Study|Subject non-compliance|0|||
33419358|NCT03576131|101425753|FG007|Overall Study|Subject non-compliance|0|||
33419359|NCT02574260|101425756|FG000|Overall Study|Disease Progression|1|||
33419360|NCT02989610|101425757|FG000|Overall Study|Withdrawal by Subject|20|||
33419361|NCT02989610|101425757|FG000|Overall Study|Departure of PI from Site|8|||
33419362|NCT02989610|101425757|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
33230308|NCT05284019|100742565|FG004|Overall Study|Lost to Follow-up|1|||
33419363|NCT02989610|101425757|FG000|Overall Study|Lost to Follow-up|3|||
33419364|NCT02989610|101425757|FG000|Overall Study|Death|3|||
33419365|NCT02989610|101425757|FG000|Overall Study|System Explant|3|||
33419366|NCT02989610|101425757|FG000|Overall Study|Subject Non-Compliance|2|||
33419367|NCT02989610|101425757|FG000|Overall Study|System Revision|2|||
33419368|NCT02989610|101425757|FG000|Overall Study|PI Left, Study Closing|1|||
33419369|NCT02989610|101425757|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
33634925|NCT03873116|102214678|FG000|Part 2|Withdrawal by Subject|0|||
33419370|NCT02989610|101425757|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
33419371|NCT03725722|101425758|FG000|Overall Study|Lack of Efficacy|2|||
33419372|NCT03725722|101425759|FG001|Overall Study|Lack of Efficacy|1|||
33419373|NCT03725722|101425760|FG002|Overall Study|Lack of Efficacy|2|||
33419374|NCT03725722|101425761|FG003|Overall Study|Lack of Efficacy|0|||
33419375|NCT03725722|101425762|FG004|Overall Study|Lack of Efficacy|2|||
33419376|NCT03725722|101425758|FG000|Overall Study|Adverse Event|2|||
33419377|NCT03725722|101425759|FG001|Overall Study|Adverse Event|2|||
33419378|NCT03725722|101425760|FG002|Overall Study|Adverse Event|1|||
33419379|NCT03725722|101425761|FG003|Overall Study|Adverse Event|0|||
33419380|NCT03725722|101425762|FG004|Overall Study|Adverse Event|6|||
33419381|NCT03725722|101425758|FG000|Overall Study|Withdrawal by Subject|4|||
33419382|NCT03725722|101425759|FG001|Overall Study|Withdrawal by Subject|1|||
33419383|NCT03725722|101425760|FG002|Overall Study|Withdrawal by Subject|0|||
33419384|NCT03725722|101425761|FG003|Overall Study|Withdrawal by Subject|4|||
33419385|NCT03725722|101425762|FG004|Overall Study|Withdrawal by Subject|4|||
33419386|NCT03725722|101425758|FG000|Overall Study|Lost to Follow-up|3|||
33419387|NCT03725722|101425759|FG001|Overall Study|Lost to Follow-up|1|||
33419388|NCT03725722|101425760|FG002|Overall Study|Lost to Follow-up|2|||
33419389|NCT03725722|101425761|FG003|Overall Study|Lost to Follow-up|2|||
33419390|NCT03725722|101425762|FG004|Overall Study|Lost to Follow-up|1|||
33419391|NCT03725722|101425758|FG000|Overall Study|Personal reasons|0|||
33419392|NCT03725722|101425759|FG001|Overall Study|Personal reasons|0|||
33419393|NCT03725722|101425760|FG002|Overall Study|Personal reasons|1|||
33419394|NCT03725722|101425761|FG003|Overall Study|Personal reasons|0|||
33419395|NCT03725722|101425762|FG004|Overall Study|Personal reasons|1|||
33419396|NCT03725722|101425758|FG000|Overall Study|COVID-19 situation|0|||
33419397|NCT03725722|101425759|FG001|Overall Study|COVID-19 situation|1|||
33419398|NCT03725722|101425760|FG002|Overall Study|COVID-19 situation|0|||
33419399|NCT03725722|101425761|FG003|Overall Study|COVID-19 situation|0|||
33419400|NCT03725722|101425762|FG004|Overall Study|COVID-19 situation|0|||
33419401|NCT05473247|101425763|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
33419402|NCT05553600|101425765|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
33419403|NCT05553600|101425766|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
33419404|NCT05553600|101425767|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
33419405|NCT05553600|101425768|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
33419406|NCT05553600|101425765|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
33419407|NCT05553600|101425766|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
33419408|NCT05553600|101425767|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
33419409|NCT05553600|101425768|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
33419410|NCT05553600|101425765|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
33419411|NCT05553600|101425766|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
33419412|NCT05553600|101425767|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
33419413|NCT05553600|101425768|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
33419414|NCT05553600|101425765|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
33419415|NCT05553600|101425766|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
33419416|NCT05553600|101425767|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
33572983|NCT02471144|101989776|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33572984|NCT02471144|101989777|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33572985|NCT02471144|101989778|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33367448|NCT00406315|101230269|FG000|Overall Study|Withdrawal by Subject|30|||
33367449|NCT00698516|101230270|FG000|Overall Study|Study Termination|2|||
33367450|NCT00698516|101230270|FG000|Overall Study|Withdrawal by Subject|3|||
33367451|NCT01259492|101230273|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
33367452|NCT01259492|101230274|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
33367453|NCT01259492|101230275|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
33367454|NCT01259492|101230276|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
33367455|NCT01259492|101230273|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
33367456|NCT01259492|101230274|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
33367457|NCT01259492|101230275|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
33367458|NCT01259492|101230276|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
33367459|NCT01259492|101230273|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
33572986|NCT02471144|101989779|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33419417|NCT05553600|101425768|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
33419418|NCT05553600|101425765|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
33419419|NCT05553600|101425766|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
33419420|NCT05553600|101425767|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
33419421|NCT05553600|101425768|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
33230309|NCT01794117|100742579|FG000|Overall Study|Adverse Event|1|||
33367460|NCT01259492|101230274|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
33367461|NCT01259492|101230275|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
33572987|NCT02471144|101989780|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
33367462|NCT01259492|101230276|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
33367463|NCT01259492|101230273|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
33367464|NCT01259492|101230274|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
33367465|NCT01259492|101230275|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
33367466|NCT01259492|101230276|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
33367467|NCT01259492|101230273|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
33367468|NCT01259492|101230274|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
33367469|NCT01259492|101230275|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
33367470|NCT01259492|101230276|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
33419422|NCT05553600|101425765|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
33419423|NCT05553600|101425766|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
33419424|NCT05553600|101425767|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
33419425|NCT05553600|101425768|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
33419426|NCT05553600|101425765|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
33419427|NCT05553600|101425766|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
33419428|NCT05553600|101425767|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
33419429|NCT05553600|101425768|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
33419430|NCT05553600|101425765|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
33419431|NCT05553600|101425766|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
33419432|NCT05553600|101425767|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
33419433|NCT05553600|101425768|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
33419434|NCT05553600|101425765|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
33419435|NCT05553600|101425766|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
33419436|NCT05553600|101425767|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
33419437|NCT05553600|101425768|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
33419438|NCT05553600|101425765|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
33419439|NCT05553600|101425766|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
33419440|NCT05553600|101425767|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
33419441|NCT05553600|101425768|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
33419442|NCT05553600|101425765|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
33419443|NCT05553600|101425766|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
33419444|NCT05553600|101425767|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
33419445|NCT05553600|101425768|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
33419446|NCT05553600|101425765|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
33419447|NCT05553600|101425766|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
33419448|NCT05553600|101425767|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
33419449|NCT05553600|101425768|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
33419450|NCT00817778|101425771|FG000|Overall Study|Adverse Event|1|||
33419451|NCT00817778|101425772|FG001|Overall Study|Adverse Event|0|||
33419452|NCT00817778|101425771|FG000|Overall Study|Withdrawal by Subject|1|||
33419453|NCT00817778|101425772|FG001|Overall Study|Withdrawal by Subject|1|||
33419454|NCT00817778|101425771|FG000|Overall Study|Protocol Violation|0|||
33419455|NCT00817778|101425772|FG001|Overall Study|Protocol Violation|1|||
33419456|NCT00817778|101425771|FG000|Overall Study|Study-specific discontinuation criteria|0|||
33419457|NCT00817778|101425772|FG001|Overall Study|Study-specific discontinuation criteria|1|||
33419458|NCT00817778|101425771|FG000|Overall Study|Poor venous access|1|||
33419459|NCT00817778|101425772|FG001|Overall Study|Poor venous access|0|||
33419460|NCT03151226|101425775|FG000|Overall Study|Withdrawal by Subject|2|||
33419461|NCT03151226|101425775|FG000|Overall Study|not wear device correctly|1|||
33419462|NCT03159611|101425780|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
33419463|NCT03159611|101425781|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
33419464|NCT03159611|101425780|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
33419465|NCT03159611|101425781|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
33419466|NCT03159611|101425780|FG000|Overall Study|Protocol Violation|7|||
33230310|NCT01794117|100742580|FG001|Overall Study|Adverse Event|0|||
33419467|NCT03159611|101425781|FG001|Overall Study|Protocol Violation|4|||
33419468|NCT03159611|101425780|FG000|Overall Study|Adverse Event|1|||
33419469|NCT03159611|101425781|FG001|Overall Study|Adverse Event|0|||
33419470|NCT03159611|101425780|FG000|Overall Study|Withdrawal by Subject|1|||
33419471|NCT03159611|101425781|FG001|Overall Study|Withdrawal by Subject|1|||
33419472|NCT03159611|101425780|FG000|Overall Study|Non-compliance with protocol requirement|3|||
33572988|NCT02471144|101989781|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
33419473|NCT03159611|101425781|FG001|Overall Study|Non-compliance with protocol requirement|2|||
33419474|NCT03159611|101425780|FG000|Overall Study|Inability to perform procedures|1|||
33572989|NCT02471144|101989782|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
33230311|NCT01794117|100742581|FG002|Overall Study|Adverse Event|0|||
33572990|NCT02471144|101989772|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33230312|NCT01794117|100742582|FG003|Overall Study|Adverse Event|0|||
33367471|NCT01259492|101230273|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
33572991|NCT02471144|101989773|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33572992|NCT02471144|101989774|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33572993|NCT02471144|101989775|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33572994|NCT02471144|101989776|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33572995|NCT02471144|101989777|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33572996|NCT02471144|101989778|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33572997|NCT02471144|101989779|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33572998|NCT02471144|101989780|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33572999|NCT02471144|101989781|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
33573000|NCT02471144|101989782|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
33573001|NCT02471144|101989772|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33573002|NCT02471144|101989773|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33573003|NCT02471144|101989774|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33573004|NCT02471144|101989775|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33573005|NCT02471144|101989776|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33634926|NCT03873116|102214679|FG001|Part 2|Withdrawal by Subject|0|||
33634927|NCT03873116|102214680|FG002|Part 2|Withdrawal by Subject|1|||
33634928|NCT03873116|102214681|FG003|Part 2|Withdrawal by Subject|0|||
33634929|NCT03873116|102214682|FG004|Part 2|Withdrawal by Subject|0|||
33634930|NCT03873116|102214683|FG005|Part 2|Withdrawal by Subject|0|||
33634931|NCT03873116|102214678|FG000|Part 2|Lab abnormality or AE|0|||
33634932|NCT03873116|102214679|FG001|Part 2|Lab abnormality or AE|0|||
33634933|NCT03873116|102214680|FG002|Part 2|Lab abnormality or AE|0|||
33634934|NCT03873116|102214681|FG003|Part 2|Lab abnormality or AE|0|||
33634935|NCT03873116|102214682|FG004|Part 2|Lab abnormality or AE|1|||
33634936|NCT03873116|102214683|FG005|Part 2|Lab abnormality or AE|0|||
33634937|NCT03873116|102214678|FG000|Part 3|Withdrawal by Subject|0|||
33634938|NCT03873116|102214679|FG001|Part 3|Withdrawal by Subject|0|||
33634939|NCT03873116|102214680|FG002|Part 3|Withdrawal by Subject|0|||
33634940|NCT03873116|102214681|FG003|Part 3|Withdrawal by Subject|0|||
33634941|NCT03873116|102214682|FG004|Part 3|Withdrawal by Subject|1|||
33634942|NCT03873116|102214683|FG005|Part 3|Withdrawal by Subject|0|||
33634943|NCT01310777|102214688|FG000|Overall Study|Adverse Event|23|||
33634944|NCT01310777|102214689|FG001|Overall Study|Adverse Event|1|||
33634945|NCT01310777|102214690|FG002|Overall Study|Adverse Event|15|||
33634946|NCT01310777|102214688|FG000|Overall Study|Lost to Follow-up|0|||
33634947|NCT01310777|102214689|FG001|Overall Study|Lost to Follow-up|4|||
33634948|NCT01310777|102214690|FG002|Overall Study|Lost to Follow-up|1|||
33634949|NCT01310777|102214688|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
33634950|NCT01310777|102214689|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
33634951|NCT01310777|102214690|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
33634952|NCT01310777|102214688|FG000|Overall Study|Inadequate Control of IOP|5|||
33634953|NCT01310777|102214689|FG001|Overall Study|Inadequate Control of IOP|7|||
33419475|NCT03159611|101425781|FG001|Overall Study|Inability to perform procedures|0|||
33419476|NCT00530088|101425782|FG000|Overall Study|Disease Progression|4|||
33419477|NCT00530088|101425782|FG000|Overall Study|Physician Decision|4|||
33573006|NCT02471144|101989777|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33573007|NCT02471144|101989778|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33573008|NCT02471144|101989779|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33573009|NCT02471144|101989780|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33573010|NCT02471144|101989781|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
33634954|NCT01310777|102214690|FG002|Overall Study|Inadequate Control of IOP|10|||
33634955|NCT01310777|102214688|FG000|Overall Study|Other|4|||
33634956|NCT01310777|102214689|FG001|Overall Study|Other|1|||
33634957|NCT01310777|102214690|FG002|Overall Study|Other|2|||
33634958|NCT01709721|102214692|FG000|Open Label Phase|Withdrawal by Subject|0|||
33634959|NCT01709721|102214693|FG001|Open Label Phase|Withdrawal by Subject|0|||
33634960|NCT01709721|102214694|FG002|Open Label Phase|Withdrawal by Subject|5|||
33634961|NCT01709721|102214692|FG000|Open Label Phase|Adverse Event|0|||
33634962|NCT01709721|102214693|FG001|Open Label Phase|Adverse Event|0|||
33634963|NCT01709721|102214694|FG002|Open Label Phase|Adverse Event|8|||
33230313|NCT01794117|100742579|FG000|Overall Study|Participant noncompliance|0|||
33230314|NCT01794117|100742580|FG001|Overall Study|Participant noncompliance|1|||
33230315|NCT01794117|100742581|FG002|Overall Study|Participant noncompliance|0|||
33573011|NCT02471144|101989782|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
33573012|NCT02471144|101989772|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
33573013|NCT02471144|101989773|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
33573014|NCT02471144|101989774|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
33573015|NCT02471144|101989775|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
33573016|NCT02471144|101989776|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
33573017|NCT02471144|101989777|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
33573018|NCT02471144|101989778|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
33634964|NCT01709721|102214692|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
33634965|NCT01709721|102214693|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
33634966|NCT01709721|102214694|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
33634967|NCT01709721|102214692|FG000|Open Label Phase|Investigator Decision|0|||
33634968|NCT01709721|102214693|FG001|Open Label Phase|Investigator Decision|0|||
33634969|NCT01709721|102214694|FG002|Open Label Phase|Investigator Decision|1|||
33634970|NCT01709721|102214692|FG000|Open Label Phase|Sponsor Decision|0|||
33634971|NCT01709721|102214693|FG001|Open Label Phase|Sponsor Decision|0|||
33634972|NCT01709721|102214694|FG002|Open Label Phase|Sponsor Decision|2|||
33634973|NCT01709721|102214692|FG000|Open Label Phase|Protocol Violation|0|||
33634974|NCT01709721|102214693|FG001|Open Label Phase|Protocol Violation|0|||
33573019|NCT02471144|101989779|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
33573020|NCT02471144|101989780|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
33573021|NCT02471144|101989781|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
33634975|NCT01709721|102214694|FG002|Open Label Phase|Protocol Violation|1|||
33230316|NCT01794117|100742582|FG003|Overall Study|Participant noncompliance|0|||
33634976|NCT01709721|102214692|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
33634977|NCT01709721|102214693|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
33367472|NCT01259492|101230274|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
33367473|NCT01259492|101230275|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
33367474|NCT01259492|101230276|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
33367475|NCT01259492|101230273|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
33367476|NCT01259492|101230274|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
33634978|NCT01709721|102214694|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
33634979|NCT01709721|102214692|FG000|Open Label Phase|Inadequate Pain Control|0|||
33634980|NCT01709721|102214693|FG001|Open Label Phase|Inadequate Pain Control|0|||
33634981|NCT01709721|102214694|FG002|Open Label Phase|Inadequate Pain Control|37|||
33634982|NCT01709721|102214692|FG000|Open Label Phase|Other, Specify in text field in database|0|||
33634983|NCT01709721|102214693|FG001|Open Label Phase|Other, Specify in text field in database|0|||
33634984|NCT01709721|102214694|FG002|Open Label Phase|Other, Specify in text field in database|14|||
33634985|NCT01709721|102214692|FG000|Randomized Phase|Adverse Event|0|||
33634986|NCT01709721|102214693|FG001|Randomized Phase|Adverse Event|1|||
33634987|NCT01709721|102214694|FG002|Randomized Phase|Adverse Event|0|||
33634988|NCT01709721|102214692|FG000|Randomized Phase|Lost to Follow-up|1|||
33634989|NCT01709721|102214693|FG001|Randomized Phase|Lost to Follow-up|0|||
33634990|NCT01709721|102214694|FG002|Randomized Phase|Lost to Follow-up|0|||
33634991|NCT01709721|102214692|FG000|Randomized Phase|Inadequate Pain Control|1|||
33367477|NCT01259492|101230275|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
33367478|NCT01259492|101230276|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
33367479|NCT01259492|101230273|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
33367480|NCT01259492|101230274|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
33367481|NCT01259492|101230275|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
33367482|NCT01259492|101230276|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
33367483|NCT01259492|101230273|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
33367484|NCT01259492|101230274|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
33367485|NCT01259492|101230275|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
33367486|NCT01259492|101230276|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
33367487|NCT01259492|101230273|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
33367488|NCT01259492|101230274|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
33367489|NCT01259492|101230275|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
33367490|NCT01259492|101230276|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
33367491|NCT01259492|101230273|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
33367492|NCT01259492|101230274|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
33367493|NCT01259492|101230275|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
33367494|NCT01259492|101230276|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
33367495|NCT01259492|101230273|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
33367496|NCT01259492|101230274|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
33367497|NCT01259492|101230275|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
33367498|NCT01259492|101230276|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
33367499|NCT01259492|101230273|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
33367500|NCT01259492|101230274|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
33367501|NCT01259492|101230275|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
33367502|NCT01259492|101230276|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
33367503|NCT01259492|101230273|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
33367504|NCT01259492|101230274|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
33367505|NCT01259492|101230275|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
33367506|NCT01259492|101230276|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
33367507|NCT01259492|101230273|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
33367508|NCT01259492|101230274|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
33367509|NCT01259492|101230275|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
33367510|NCT01259492|101230276|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
33367511|NCT01259492|101230273|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
33367512|NCT01259492|101230274|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
33367513|NCT01259492|101230275|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
33367514|NCT01259492|101230276|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
33367515|NCT01259492|101230273|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
33367516|NCT01259492|101230274|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
33419478|NCT00530088|101425782|FG000|Overall Study|Other Not Specified|2|||
33634992|NCT01709721|102214693|FG001|Randomized Phase|Inadequate Pain Control|2|||
33634993|NCT01709721|102214694|FG002|Randomized Phase|Inadequate Pain Control|0|||
33230317|NCT01794117|100742579|FG000|Overall Study|Refused further treatment|0|||
33367517|NCT01259492|101230275|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
33367518|NCT01259492|101230276|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
33634994|NCT01709721|102214692|FG000|Randomized Phase|Other, Specify text field in database|1|||
33634995|NCT01709721|102214693|FG001|Randomized Phase|Other, Specify text field in database|3|||
33573022|NCT02471144|101989782|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
33573023|NCT02471144|101989772|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
33573024|NCT02471144|101989773|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
33573025|NCT02471144|101989774|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
33573026|NCT02471144|101989775|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
33573027|NCT02471144|101989776|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
33573028|NCT02471144|101989777|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
33573029|NCT02471144|101989778|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
33573030|NCT02471144|101989779|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
33573031|NCT02471144|101989780|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
33573032|NCT02471144|101989781|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
33573033|NCT02471144|101989782|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
33573034|NCT02471144|101989772|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
33573035|NCT02471144|101989773|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
33573036|NCT02471144|101989774|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
33573037|NCT02471144|101989775|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
33573038|NCT02471144|101989776|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
33573039|NCT02471144|101989777|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
33573040|NCT02471144|101989778|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
33573041|NCT02471144|101989779|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
33573042|NCT02471144|101989780|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
33573043|NCT02471144|101989781|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
33573044|NCT02471144|101989782|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
33634996|NCT01709721|102214694|FG002|Randomized Phase|Other, Specify text field in database|0|||
33634997|NCT02345070|102214695|FG000|Overall Study|Adverse Event|12|||
33634998|NCT02345070|102214696|FG001|Overall Study|Adverse Event|8|||
33634999|NCT02345070|102214697|FG002|Overall Study|Adverse Event|16|||
33635000|NCT02345070|102214695|FG000|Overall Study|Poor compliance to protocol|2|||
33635001|NCT02345070|102214696|FG001|Overall Study|Poor compliance to protocol|0|||
33635002|NCT02345070|102214697|FG002|Overall Study|Poor compliance to protocol|0|||
33635003|NCT02345070|102214695|FG000|Overall Study|Other than specified above|6|||
33635004|NCT02345070|102214696|FG001|Overall Study|Other than specified above|3|||
33635005|NCT02345070|102214697|FG002|Overall Study|Other than specified above|7|||
33635006|NCT04102098|102214698|FG000|Main Study Period|Ongoing in study|302|||
33635007|NCT04102098|102214699|FG001|Main Study Period|Ongoing in study|291|||
33635008|NCT04102098|102214698|FG000|Main Study Period|Death|20|||
33635009|NCT04102098|102214699|FG001|Main Study Period|Death|27|||
33635010|NCT04102098|102214698|FG000|Main Study Period|Lost to Follow-up|1|||
33635011|NCT04102098|102214699|FG001|Main Study Period|Lost to Follow-up|1|||
33635012|NCT04102098|102214698|FG000|Main Study Period|Physician Decision|0|||
33635013|NCT04102098|102214699|FG001|Main Study Period|Physician Decision|1|||
33230318|NCT01794117|100742580|FG001|Overall Study|Refused further treatment|2|||
33367519|NCT01259492|101230273|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
33367520|NCT01259492|101230274|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
33367521|NCT01259492|101230275|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
33573045|NCT00127855|101989788|FG000|Primary Vaccination Course|Adverse Event|0|||
33573046|NCT00127855|101989789|FG001|Primary Vaccination Course|Adverse Event|0|||
33573047|NCT00127855|101989790|FG002|Primary Vaccination Course|Adverse Event|1|||
33573048|NCT00127855|101989791|FG003|Primary Vaccination Course|Adverse Event|0|||
33573049|NCT00127855|101989792|FG004|Primary Vaccination Course|Adverse Event|0|||
33573050|NCT00127855|101989788|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
33573051|NCT00127855|101989789|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
33573052|NCT00127855|101989790|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
33573053|NCT00127855|101989791|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
33573054|NCT00127855|101989792|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
33573055|NCT00127855|101989788|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
33573056|NCT00127855|101989789|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
33635014|NCT04102098|102214698|FG000|Main Study Period|Withdrawal by Subject|11|||
33635015|NCT04102098|102214699|FG001|Main Study Period|Withdrawal by Subject|14|||
33635016|NCT04102098|102214698|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
33367522|NCT01259492|101230276|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
33635017|NCT04102098|102214699|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
33573057|NCT00127855|101989790|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
33573058|NCT00127855|101989791|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
33573059|NCT00127855|101989792|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
33573060|NCT00127855|101989788|FG000|Primary Vaccination Course|Other|0|||
33573061|NCT00127855|101989789|FG001|Primary Vaccination Course|Other|0|||
33573062|NCT00127855|101989790|FG002|Primary Vaccination Course|Other|0|||
33573063|NCT00127855|101989791|FG003|Primary Vaccination Course|Other|0|||
33573064|NCT00127855|101989792|FG004|Primary Vaccination Course|Other|1|||
33573065|NCT02639390|101989796|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
33573066|NCT02639390|101989797|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
33573067|NCT04490278|101989798|FG000|Overall Study|Lost to Follow-up|6|||
33573068|NCT00831389|101989801|FG000|Overall Study|Withdrawal by Subject|0|||
33573069|NCT00831389|101989802|FG001|Overall Study|Withdrawal by Subject|1|||
33573070|NCT01517984|101989804|FG000|Overall Study|Lost to Follow-up|0|||
33573071|NCT01517984|101989805|FG001|Overall Study|Lost to Follow-up|1|||
33573072|NCT01517984|101989806|FG002|Overall Study|Lost to Follow-up|0|||
33573073|NCT01517984|101989807|FG003|Overall Study|Lost to Follow-up|0|||
33573074|NCT01517984|101989804|FG000|Overall Study|Withdrawal by Subject|1|||
33635018|NCT04102098|102214698|FG000|Crossover: AS Who Crossed Over|Death|11|||
33635019|NCT04102098|102214699|FG001|Crossover: AS Who Crossed Over|Death|0|||
33635020|NCT04102098|102214698|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
33635021|NCT04102098|102214699|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
33635022|NCT02351817|102214701|FG000|Period 1|Adverse Event|1|||
33635023|NCT02351817|102214702|FG001|Period 1|Adverse Event|2|||
33635024|NCT02351817|102214701|FG000|Period 1|Lack of Efficacy|0|||
33635025|NCT02351817|102214702|FG001|Period 1|Lack of Efficacy|1|||
33635026|NCT02351817|102214701|FG000|Period 2|Adverse Event|0|||
33635027|NCT02351817|102214702|FG001|Period 2|Adverse Event|2|||
33635028|NCT02351817|102214701|FG000|Period 2|Protocol Violation|1|||
33635029|NCT02351817|102214702|FG001|Period 2|Protocol Violation|0|||
33635030|NCT00702221|102214703|FG000|Overall Study|Adverse Event|4|||
33635031|NCT00702221|102214704|FG001|Overall Study|Adverse Event|3|||
33635032|NCT02144610|102214705|FG000|Overall Study|Physician Decision|1|||
33635033|NCT02144610|102214706|FG001|Overall Study|Physician Decision|0|||
33635034|NCT02144610|102214705|FG000|Overall Study|Withdrawal by Subject|1|||
33635035|NCT02144610|102214706|FG001|Overall Study|Withdrawal by Subject|5|||
33573075|NCT01517984|101989805|FG001|Overall Study|Withdrawal by Subject|8|||
33573076|NCT01517984|101989806|FG002|Overall Study|Withdrawal by Subject|4|||
33573077|NCT01517984|101989807|FG003|Overall Study|Withdrawal by Subject|1|||
33573078|NCT01517984|101989804|FG000|Overall Study|Screen Failure|4|||
33573079|NCT01517984|101989805|FG001|Overall Study|Screen Failure|0|||
33573080|NCT01517984|101989806|FG002|Overall Study|Screen Failure|0|||
33635036|NCT02144610|102214705|FG000|Overall Study|Death|2|||
33635037|NCT02144610|102214706|FG001|Overall Study|Death|2|||
33635038|NCT02144610|102214705|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
33635039|NCT02144610|102214706|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
33635040|NCT02144610|102214705|FG000|Overall Study|Other|0|||
33230319|NCT01794117|100742581|FG002|Overall Study|Refused further treatment|0|||
33230320|NCT01794117|100742582|FG003|Overall Study|Refused further treatment|0|||
33230321|NCT03154359|100742592|FG000|Overall Study|Adverse Event|1|||
33230322|NCT03154359|100742592|FG000|Overall Study|Lack of Efficacy|2|||
33230323|NCT03154359|100742592|FG000|Overall Study|Lost to Follow-up|3|||
33230324|NCT03154359|100742592|FG000|Overall Study|Physician Decision|3|||
33230325|NCT03154359|100742592|FG000|Overall Study|Protocol Violation|4|||
33230326|NCT03154359|100742592|FG000|Overall Study|Withdrawal by Subject|5|||
33230327|NCT03154359|100742592|FG000|Overall Study|Disruption of study due to COVID-19|4|||
33230328|NCT01265823|100742599|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
33230329|NCT01265823|100742599|FG000|Overall Study|Failure to Return|4|||
33230330|NCT01265823|100742599|FG000|Overall Study|Protocol Violation|1|||
33230331|NCT01265823|100742599|FG000|Overall Study|Participant Request|1|||
33230332|NCT02133924|100742602|FG000|Overall Study|Death|38|||
33230333|NCT02133924|100742602|FG000|Overall Study|Physician Decision|1|||
33230334|NCT02133924|100742602|FG000|Overall Study|Withdrawal by Subject|3|||
33230335|NCT03406702|100742603|FG000|Overall Study|Missed Day 27 Dosing|1|||
33230336|NCT01950273|100742604|FG000|Overall Study|Protocol Violation|1|||
33367523|NCT01259492|101230273|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
33367524|NCT01259492|101230274|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
33367525|NCT01259492|101230275|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
33367526|NCT01259492|101230276|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
33367527|NCT01259492|101230273|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
33573081|NCT01517984|101989807|FG003|Overall Study|Screen Failure|0|||
33573082|NCT01517984|101989804|FG000|Overall Study|Ineligible for randomization|0|||
33573083|NCT01517984|101989805|FG001|Overall Study|Ineligible for randomization|14|||
33573084|NCT01517984|101989806|FG002|Overall Study|Ineligible for randomization|0|||
33573085|NCT01517984|101989807|FG003|Overall Study|Ineligible for randomization|0|||
33573086|NCT01359956|101989808|FG000|Overall Study|Death|58|||
33573087|NCT01359956|101989809|FG001|Overall Study|Death|60|||
33573088|NCT01359956|101989810|FG002|Overall Study|Death|66|||
33573089|NCT01359956|101989811|FG003|Overall Study|Death|57|||
33573090|NCT01359956|101989808|FG000|Overall Study|Lost to Follow-up|3|||
33573091|NCT01359956|101989809|FG001|Overall Study|Lost to Follow-up|4|||
33573092|NCT01359956|101989810|FG002|Overall Study|Lost to Follow-up|1|||
33573093|NCT01359956|101989811|FG003|Overall Study|Lost to Follow-up|1|||
33573094|NCT03186638|101989818|FG000|Overall Study|Withdrawal by Subject|4|||
33573095|NCT03186638|101989819|FG001|Overall Study|Withdrawal by Subject|4|||
33573096|NCT03186638|101989818|FG000|Overall Study|Withdrawn due to medical problem|3|||
33573097|NCT03186638|101989819|FG001|Overall Study|Withdrawn due to medical problem|2|||
33573098|NCT03186638|101989818|FG000|Overall Study|Lost to Follow-up|1|||
33573099|NCT03186638|101989819|FG001|Overall Study|Lost to Follow-up|0|||
33573100|NCT05645757|101989820|FG000|Overall Study|Enrolled but treatment not administered|0|||
33573101|NCT05645757|101989821|FG001|Overall Study|Enrolled but treatment not administered|0|||
33573102|NCT05645757|101989822|FG002|Overall Study|Enrolled but treatment not administered|0|||
33573103|NCT05645757|101989823|FG003|Overall Study|Enrolled but treatment not administered|0|||
33367528|NCT01259492|101230274|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
33367529|NCT01259492|101230275|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
33367530|NCT01259492|101230276|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
33367531|NCT02028338|101230277|FG000|Overall Study|Withdrawal by Subject|3|||
33367532|NCT02028338|101230278|FG001|Overall Study|Withdrawal by Subject|1|||
33367533|NCT02028338|101230277|FG000|Overall Study|Unable to contact participant|1|||
33367534|NCT02028338|101230278|FG001|Overall Study|Unable to contact participant|0|||
33367535|NCT03117049|101230279|FG000|Overall Study|Continued the follow-up period|109|||
33367536|NCT03117049|101230280|FG001|Overall Study|Continued the follow-up period|129|||
33367537|NCT03117049|101230279|FG000|Overall Study|Died|82|||
33367538|NCT03117049|101230280|FG001|Overall Study|Died|93|||
33367539|NCT03117049|101230279|FG000|Overall Study|Consent withdrawal|7|||
33367540|NCT03117049|101230280|FG001|Overall Study|Consent withdrawal|6|||
33367541|NCT03117049|101230279|FG000|Overall Study|Missing contact|3|||
33573104|NCT05645757|101989824|FG004|Overall Study|Enrolled but treatment not administered|1|||
33230337|NCT01950273|100742605|FG001|Overall Study|Protocol Violation|0|||
33230338|NCT01950273|100742604|FG000|Overall Study|Withdrawal by Subject|2|||
33419479|NCT01831596|101425783|FG000|Overall Study|Other|8|||
33573105|NCT05645757|101989825|FG005|Overall Study|Enrolled but treatment not administered|1|||
33573106|NCT05645757|101989826|FG006|Overall Study|Enrolled but treatment not administered|0|||
33573107|NCT05645757|101989827|FG007|Overall Study|Enrolled but treatment not administered|0|||
33573108|NCT01887717|101989828|FG000|Overall Study|Withdrawal by Subject|1|||
33230339|NCT01950273|100742605|FG001|Overall Study|Withdrawal by Subject|0|||
33230340|NCT01950273|100742604|FG000|Overall Study|Other not defined above|1|||
33367542|NCT03117049|101230280|FG001|Overall Study|Missing contact|3|||
33367543|NCT02379923|101230283|FG000|Overall Study|Death|5|||
33367544|NCT01905397|101232645|FG000|Overall Study|Death|0|||
33367545|NCT01905397|101232646|FG001|Overall Study|Death|1|||
33367546|NCT01905397|101232645|FG000|Overall Study|Withdrawal by Subject|2|||
33573109|NCT01887717|101989829|FG001|Overall Study|Withdrawal by Subject|7|||
33573110|NCT01887717|101989828|FG000|Overall Study|Physician Decision|0|||
33573111|NCT01887717|101989829|FG001|Overall Study|Physician Decision|2|||
33230341|NCT01950273|100742605|FG001|Overall Study|Other not defined above|0|||
33230342|NCT03545113|100742608|FG000|Overall Study|Surgery Cancelled|1|||
33230343|NCT03545113|100742609|FG001|Overall Study|Surgery Cancelled|0|||
33230344|NCT03545113|100742608|FG000|Overall Study|Death|1|||
33230345|NCT03545113|100742609|FG001|Overall Study|Death|0|||
33230346|NCT03545113|100742608|FG000|Overall Study|Adverse Event|2|||
33230347|NCT03545113|100742609|FG001|Overall Study|Adverse Event|0|||
33230348|NCT03545113|100742608|FG000|Overall Study|Received different surgery|1|||
33230349|NCT03545113|100742609|FG001|Overall Study|Received different surgery|0|||
33230350|NCT02023879|100742620|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
33230351|NCT02023879|100742621|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
33230352|NCT02023879|100742622|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
33230353|NCT02023879|100742620|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
33230354|NCT02023879|100742621|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
33230355|NCT02023879|100742622|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
33230356|NCT02023879|100742620|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
33230357|NCT02023879|100742621|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
33230358|NCT02023879|100742622|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
33230359|NCT02023879|100742620|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
33230360|NCT02023879|100742621|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
33230361|NCT02023879|100742622|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
33419480|NCT01220128|101425784|FG000|Overall Study|Progressive disease|0|||
33419481|NCT01220128|101425785|FG001|Overall Study|Progressive disease|0|||
33573112|NCT01887717|101989828|FG000|Overall Study|Administrative reasons|5|||
33573113|NCT01887717|101989829|FG001|Overall Study|Administrative reasons|2|||
33573114|NCT04696146|101989834|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
33573115|NCT04696146|101989835|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
33635041|NCT02144610|102214706|FG001|Overall Study|Other|1|||
33230362|NCT02023879|100742620|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
33230363|NCT02023879|100742621|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
33230364|NCT02023879|100742622|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
33230365|NCT02023879|100742620|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
33230366|NCT02023879|100742621|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
33230367|NCT02023879|100742622|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
33230368|NCT02023879|100742620|FG000|Extension Open Label Treatment|Adverse Event|1|||
33230369|NCT02023879|100742621|FG001|Extension Open Label Treatment|Adverse Event|7|||
33230370|NCT02023879|100742622|FG002|Extension Open Label Treatment|Adverse Event|3|||
33230371|NCT02023879|100742620|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
33230372|NCT02023879|100742621|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
33230373|NCT02023879|100742622|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
33230374|NCT02023879|100742620|FG000|Extension Open Label Treatment|Participant moved|1|||
33230375|NCT02023879|100742621|FG001|Extension Open Label Treatment|Participant moved|2|||
33230376|NCT02023879|100742622|FG002|Extension Open Label Treatment|Participant moved|0|||
33230377|NCT02023879|100742620|FG000|Extension Open Label Treatment|Other than specified above|2|||
33230378|NCT02023879|100742621|FG001|Extension Open Label Treatment|Other than specified above|7|||
33230379|NCT02023879|100742622|FG002|Extension Open Label Treatment|Other than specified above|2|||
33230380|NCT01380990|100742624|FG000|Overall Study|Treatment Failure|1|||
33230381|NCT01380990|100742625|FG001|Overall Study|Treatment Failure|0|||
33230382|NCT01380990|100742624|FG000|Overall Study|Death|0|||
33230383|NCT01380990|100742625|FG001|Overall Study|Death|1|||
33230384|NCT00130793|100742630|FG000|Overall Study|Lost to Follow-up|1|||
33230385|NCT00130793|100742631|FG001|Overall Study|Lost to Follow-up|4|||
33230386|NCT00130793|100742630|FG000|Overall Study|Withdrew consent|2|||
33230387|NCT00130793|100742631|FG001|Overall Study|Withdrew consent|0|||
33230388|NCT00936221|100742636|FG000|Overall Study|Withdrawal by Subject|1|||
33230389|NCT00936221|100742637|FG001|Overall Study|Withdrawal by Subject|1|||
33230390|NCT03856996|100742638|FG000|Overall Study|Withdrawal by Subject|1|||
33230391|NCT03856996|100742639|FG001|Overall Study|Withdrawal by Subject|0|||
33230392|NCT03856996|100742638|FG000|Overall Study|Lost to Follow-up|0|||
33230393|NCT03856996|100742639|FG001|Overall Study|Lost to Follow-up|1|||
33230394|NCT03856996|100742638|FG000|Overall Study|Adverse Event|1|||
33230395|NCT03856996|100742639|FG001|Overall Study|Adverse Event|1|||
33230396|NCT03856996|100742638|FG000|Overall Study|Other|1|||
33230397|NCT03856996|100742639|FG001|Overall Study|Other|0|||
33230398|NCT01590771|100742640|FG000|Overall Study|Other Protocol Specified Criteria|5|||
33230399|NCT01590771|100742641|FG001|Overall Study|Other Protocol Specified Criteria|14|||
33230400|NCT01590771|100742640|FG000|Overall Study|Withdrawal by Subject|8|||
33230401|NCT01590771|100742641|FG001|Overall Study|Withdrawal by Subject|15|||
33230402|NCT01590771|100742640|FG000|Overall Study|Protocol Violation|1|||
33230403|NCT01590771|100742641|FG001|Overall Study|Protocol Violation|2|||
33230404|NCT01590771|100742640|FG000|Overall Study|Lost to Follow-up|1|||
33230405|NCT01590771|100742641|FG001|Overall Study|Lost to Follow-up|1|||
33230406|NCT01590771|100742640|FG000|Overall Study|Lack of Efficacy|1|||
33230407|NCT01590771|100742641|FG001|Overall Study|Lack of Efficacy|0|||
33573116|NCT04696146|101989834|FG000|Overall Study|Off hours issue with product|1|||
33573117|NCT04696146|101989835|FG001|Overall Study|Off hours issue with product|0|||
33573118|NCT03580044|101989836|FG000|Overall Study|Death|2|||
33573119|NCT03580044|101989837|FG001|Overall Study|Death|1|||
33573120|NCT03580044|101989836|FG000|Overall Study|Withdrawal by Subject|1|||
33230408|NCT01590771|100742640|FG000|Overall Study|Adverse Event|3|||
33230409|NCT01590771|100742641|FG001|Overall Study|Adverse Event|7|||
33230410|NCT00572624|100742642|FG000|Overall Study|Lost to Follow-up|10|||
33573121|NCT03580044|101989837|FG001|Overall Study|Withdrawal by Subject|1|||
33573122|NCT01198587|101989838|FG000|Overall Study|Lost to Follow-up|8|||
33573123|NCT01198587|101989839|FG001|Overall Study|Lost to Follow-up|0|||
33230411|NCT00572624|100742643|FG001|Overall Study|Lost to Follow-up|4|||
33230412|NCT00572624|100742642|FG000|Overall Study|Wanted to do a different diet program|1|||
33230413|NCT00572624|100742643|FG001|Overall Study|Wanted to do a different diet program|0|||
33230414|NCT00572624|100742642|FG000|Overall Study|Medication change|1|||
33230415|NCT00572624|100742643|FG001|Overall Study|Medication change|0|||
33230416|NCT00572624|100742642|FG000|Overall Study|Started a new job-- no time for study|1|||
33573124|NCT01198587|101989840|FG002|Overall Study|Lost to Follow-up|9|||
33230417|NCT00572624|100742643|FG001|Overall Study|Started a new job-- no time for study|0|||
33230418|NCT00572624|100742642|FG000|Overall Study|Admitted to being a smoker|1|||
33230419|NCT00572624|100742643|FG001|Overall Study|Admitted to being a smoker|0|||
33230420|NCT00572624|100742642|FG000|Overall Study|Refused to do the stress test|1|||
33230421|NCT00572624|100742643|FG001|Overall Study|Refused to do the stress test|0|||
33230422|NCT00572624|100742642|FG000|Overall Study|Problem with vascular access|1|||
33230423|NCT00572624|100742643|FG001|Overall Study|Problem with vascular access|0|||
33230424|NCT00572624|100742642|FG000|Overall Study|Health issues unrelated to the study|1|||
33230425|NCT00572624|100742643|FG001|Overall Study|Health issues unrelated to the study|0|||
33230426|NCT00636792|100742644|FG000|Overall Study|Adverse Event|16|||
33230427|NCT00636792|100742644|FG000|Overall Study|Physician Decision|7|||
33230428|NCT00636792|100742644|FG000|Overall Study|Progressive Disease|4|||
33230429|NCT00636792|100742644|FG000|Overall Study|Withdrawal by Subject|3|||
33573125|NCT01198587|101989841|FG003|Overall Study|Lost to Follow-up|0|||
33573126|NCT01276704|101989842|FG000|Overall Study|Lost to Follow-up|2|||
33573127|NCT01276704|101989843|FG001|Overall Study|Lost to Follow-up|3|||
33573128|NCT01276704|101989842|FG000|Overall Study|Non-compliant|2|||
33573129|NCT01276704|101989843|FG001|Overall Study|Non-compliant|2|||
33573130|NCT01276704|101989842|FG000|Overall Study|Withdrawal by Subject|7|||
33573131|NCT01276704|101989843|FG001|Overall Study|Withdrawal by Subject|1|||
33573132|NCT01276704|101989842|FG000|Overall Study|Physician Decision|3|||
33635042|NCT02059278|102214709|FG000|Overall Study|Adverse Event|1|||
33635043|NCT02059278|102214710|FG001|Overall Study|Adverse Event|1|||
33635044|NCT02059278|102214709|FG000|Overall Study|Lost to Follow-up|1|||
33635045|NCT02059278|102214710|FG001|Overall Study|Lost to Follow-up|0|||
33367547|NCT01905397|101232646|FG001|Overall Study|Withdrawal by Subject|0|||
33367548|NCT01905397|101232645|FG000|Overall Study|Surgery canceled/aborted|9|||
33367549|NCT01905397|101232646|FG001|Overall Study|Surgery canceled/aborted|5|||
33367550|NCT01905397|101232645|FG000|Overall Study|Incision < 7 cm|2|||
33367551|NCT01905397|101232646|FG001|Overall Study|Incision < 7 cm|0|||
33367552|NCT01905397|101232645|FG000|Overall Study|Wrong treatment|1|||
33367553|NCT01905397|101232646|FG001|Overall Study|Wrong treatment|1|||
33367554|NCT01905397|101232645|FG000|Overall Study|Device not applied|3|||
33367555|NCT01905397|101232646|FG001|Overall Study|Device not applied|0|||
33419482|NCT01220128|101425786|FG002|Overall Study|Progressive disease|2|||
33419483|NCT01220128|101425787|FG003|Overall Study|Progressive disease|0|||
33573133|NCT01276704|101989843|FG001|Overall Study|Physician Decision|5|||
33573134|NCT01990742|101989844|FG000|Overall Study|Withdrawal by facility|407|||
33573135|NCT01990742|101989845|FG001|Overall Study|Withdrawal by facility|1083|||
33635046|NCT02059278|102214709|FG000|Overall Study|Withdrawal by Subject|0|||
33635047|NCT02059278|102214710|FG001|Overall Study|Withdrawal by Subject|3|||
33635048|NCT02059278|102214709|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
33635049|NCT02059278|102214710|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
33635050|NCT01615939|102214713|FG000|Overall Study|Lost to Follow-up|5|||
33635051|NCT01615939|102214714|FG001|Overall Study|Lost to Follow-up|0|||
33635052|NCT01910298|102214715|FG000|Overall Study|Adverse Event|1|||
33635053|NCT01910298|102214716|FG001|Overall Study|Adverse Event|0|||
33635054|NCT01910298|102214715|FG000|Overall Study|Withdrawal by Subject|2|||
33635055|NCT01910298|102214716|FG001|Overall Study|Withdrawal by Subject|7|||
33635056|NCT01910298|102214715|FG000|Overall Study|Protocol Deviation|0|||
33635057|NCT01910298|102214716|FG001|Overall Study|Protocol Deviation|5|||
33635058|NCT01910298|102214715|FG000|Overall Study|Lost to Follow-up|1|||
33635059|NCT01910298|102214716|FG001|Overall Study|Lost to Follow-up|1|||
33635060|NCT01910298|102214715|FG000|Overall Study|Study Terminated by Sponsor|1|||
33635061|NCT01910298|102214716|FG001|Overall Study|Study Terminated by Sponsor|17|||
33635062|NCT01910298|102214715|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33635063|NCT01910298|102214716|FG001|Overall Study|Other Miscellaneous Reasons|2|||
33635064|NCT02383576|102214717|FG000|Overall Study|Death|53|||
33635065|NCT02383576|102214718|FG001|Overall Study|Death|33|||
33635066|NCT02383576|102214717|FG000|Overall Study|Lost to Follow-up|7|||
33635067|NCT02383576|102214718|FG001|Overall Study|Lost to Follow-up|1|||
33635068|NCT02383576|102214717|FG000|Overall Study|Withdrew Consent|1|||
33635069|NCT02383576|102214718|FG001|Overall Study|Withdrew Consent|6|||
33635070|NCT02383576|102214717|FG000|Overall Study|Investigator's Decision|0|||
33635071|NCT02383576|102214718|FG001|Overall Study|Investigator's Decision|1|||
33635072|NCT02383576|102214717|FG000|Overall Study|Administrative/Other|2|||
33635073|NCT02383576|102214718|FG001|Overall Study|Administrative/Other|4|||
33635074|NCT00812708|102214719|FG000|Overall Study|Device could not be implanted|2|||
33635075|NCT00812708|102214719|FG000|Overall Study|Lack of medical insurance|1|||
33635076|NCT00812708|102214719|FG000|Overall Study|Switched to another study|1|||
33635077|NCT00812708|102214719|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
33635078|NCT00812708|102214719|FG000|Overall Study|Signed consent but later withdrew|3|||
33635079|NCT01782378|102214720|FG000|First Series|Lost to Follow-up|7|||
33635080|NCT01782378|102214721|FG001|First Series|Lost to Follow-up|8|||
33635081|NCT01782378|102214720|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
33635082|NCT01782378|102214721|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
33635083|NCT01782378|102214720|FG000|Second Series|Lost to Follow-up|8|||
33419484|NCT01220128|101425788|FG004|Overall Study|Progressive disease|0|||
33635084|NCT01782378|102214721|FG001|Second Series|Lost to Follow-up|7|||
33635085|NCT01782378|102214720|FG000|Second Series|Did not choose to complete S2 Optional|18|||
33635086|NCT01782378|102214721|FG001|Second Series|Did not choose to complete S2 Optional|0|||
33635087|NCT04682366|102214722|FG000|Overall Study|Lost to Follow-up|1|||
33635088|NCT04682366|102214723|FG001|Overall Study|Lost to Follow-up|1|||
33635089|NCT00199381|102214724|FG000|Overall Study|Withdrawal by Subject|38|||
33635090|NCT00199381|102214724|FG000|Overall Study|Adverse Event|73|||
33635091|NCT00199381|102214724|FG000|Overall Study|Protocol Violation|6|||
33635092|NCT00199381|102214724|FG000|Overall Study|Lack of Efficacy|27|||
33635093|NCT00199381|102214724|FG000|Overall Study|Not including due to early termination|37|||
33635094|NCT00199381|102214724|FG000|Overall Study|Study termination by Sponsor|323|||
33635095|NCT01780974|102214727|FG000|Overall Study|Death|1|||
33635096|NCT01780974|102214728|FG001|Overall Study|Death|0|||
33635097|NCT01780974|102214727|FG000|Overall Study|Adverse Event|1|||
33635098|NCT01780974|102214728|FG001|Overall Study|Adverse Event|3|||
33635099|NCT01499940|102214729|FG000|Overall Study|Study was withdrawn before completion.|9|||
33419485|NCT01220128|101425789|FG005|Overall Study|Progressive disease|0|||
33419486|NCT01220128|101425790|FG006|Overall Study|Progressive disease|0|||
33419487|NCT01220128|101425784|FG000|Overall Study|Sponsor study termination|0|||
33419488|NCT01220128|101425785|FG001|Overall Study|Sponsor study termination|1|||
33419489|NCT01220128|101425786|FG002|Overall Study|Sponsor study termination|0|||
33419490|NCT01220128|101425787|FG003|Overall Study|Sponsor study termination|0|||
33419491|NCT01220128|101425788|FG004|Overall Study|Sponsor study termination|0|||
33419492|NCT01220128|101425789|FG005|Overall Study|Sponsor study termination|0|||
33419493|NCT01220128|101425790|FG006|Overall Study|Sponsor study termination|1|||
33635100|NCT01352715|102214730|FG000|Overall Study|Death|3|||
33635101|NCT01352715|102214731|FG001|Overall Study|Death|3|||
33635102|NCT01352715|102214730|FG000|Overall Study|Lost to Follow-up|5|||
33635103|NCT01352715|102214731|FG001|Overall Study|Lost to Follow-up|7|||
33419494|NCT01220128|101425784|FG000|Overall Study|Adverse event, serious fatal|2|||
33635104|NCT01352715|102214730|FG000|Overall Study|Withdrawal by Subject|4|||
33635105|NCT01352715|102214731|FG001|Overall Study|Withdrawal by Subject|8|||
33635106|NCT01352715|102214730|FG000|Overall Study|site closure|16|||
33635107|NCT01352715|102214731|FG001|Overall Study|site closure|15|||
33635108|NCT01352715|102214730|FG000|Overall Study|no final visit in closeout period|15|||
33635109|NCT01352715|102214731|FG001|Overall Study|no final visit in closeout period|12|||
33230430|NCT00636792|100742644|FG000|Overall Study|Other|3|||
33230431|NCT04161807|100742646|FG000|Overall Study|Withdrawal by Subject|2|||
33230432|NCT04161807|100742646|FG000|Overall Study|Performed only 1 treatment|2|||
33419495|NCT01220128|101425785|FG001|Overall Study|Adverse event, serious fatal|0|||
33419496|NCT01220128|101425786|FG002|Overall Study|Adverse event, serious fatal|0|||
33419497|NCT01220128|101425787|FG003|Overall Study|Adverse event, serious fatal|0|||
33419498|NCT01220128|101425788|FG004|Overall Study|Adverse event, serious fatal|0|||
33419499|NCT01220128|101425789|FG005|Overall Study|Adverse event, serious fatal|0|||
33419500|NCT01220128|101425790|FG006|Overall Study|Adverse event, serious fatal|1|||
33419501|NCT01220128|101425784|FG000|Overall Study|Adverse event, non-fatal|1|||
33419502|NCT01220128|101425785|FG001|Overall Study|Adverse event, non-fatal|0|||
33419503|NCT01220128|101425786|FG002|Overall Study|Adverse event, non-fatal|0|||
33419504|NCT01220128|101425787|FG003|Overall Study|Adverse event, non-fatal|0|||
33573136|NCT01990742|101989844|FG000|Overall Study|Facility closed|0|||
33573137|NCT01990742|101989845|FG001|Overall Study|Facility closed|270|||
33573138|NCT00586157|101989846|FG000|First Intervention|Worsening behavior|1|||
33573139|NCT00586157|101989847|FG001|First Intervention|Worsening behavior|0|||
33573140|NCT00586157|101989846|FG000|Second Intervention|Withdrawal by Subject|1|||
33573141|NCT00586157|101989847|FG001|Second Intervention|Withdrawal by Subject|0|||
33573142|NCT00586157|101989846|FG000|Second Intervention|Worsening behavior|1|||
33573143|NCT00586157|101989847|FG001|Second Intervention|Worsening behavior|0|||
33573144|NCT00586157|101989846|FG000|Second Intervention|Adverse Event|0|||
33573145|NCT00586157|101989847|FG001|Second Intervention|Adverse Event|1|||
33573146|NCT01880957|101989848|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
33573147|NCT01880957|101989849|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
33573148|NCT01880957|101989848|FG000|Overall Study|Lost to Follow-up|11|||
33573149|NCT01880957|101989849|FG001|Overall Study|Lost to Follow-up|0|||
33573150|NCT01880957|101989848|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
33573151|NCT01880957|101989849|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
33573152|NCT03440385|101989851|FG000|Overall Study|Other Reason|4|||
33573153|NCT03440385|101989852|FG001|Overall Study|Other Reason|1|||
33573154|NCT03440385|101989851|FG000|Overall Study|Site Closed|1|||
33573155|NCT03440385|101989852|FG001|Overall Study|Site Closed|0|||
33573156|NCT03440385|101989851|FG000|Overall Study|Lost to Follow-up|2|||
33573157|NCT03440385|101989852|FG001|Overall Study|Lost to Follow-up|0|||
33573158|NCT03440385|101989851|FG000|Overall Study|Withdrawal by Subject|12|||
33573159|NCT03440385|101989852|FG001|Overall Study|Withdrawal by Subject|6|||
33573160|NCT03440385|101989851|FG000|Overall Study|Lack of Efficacy|9|||
33573161|NCT03440385|101989852|FG001|Overall Study|Lack of Efficacy|2|||
33573162|NCT03440385|101989851|FG000|Overall Study|Adverse Event|15|||
33573163|NCT03440385|101989852|FG001|Overall Study|Adverse Event|11|||
33573164|NCT01464879|101989854|FG000|Overall Study|Physician Decision|1|||
33573165|NCT01464879|101989854|FG000|Overall Study|Non-compliance|1|||
33573166|NCT05136170|101989860|FG000|Overall Study|Withdrawal by Subject|2|||
33573167|NCT05136170|101989861|FG001|Overall Study|Withdrawal by Subject|2|||
33573168|NCT05136170|101989860|FG000|Overall Study|Can no longer make office visits|1|||
33573169|NCT05136170|101989861|FG001|Overall Study|Can no longer make office visits|0|||
33573170|NCT03586973|101989862|FG000|Overall Study|Death|15|||
33573171|NCT03586973|101989863|FG001|Overall Study|Death|8|||
33573172|NCT03586973|101989862|FG000|Overall Study|Site Terminated by Sponsor|3|||
33573173|NCT03586973|101989863|FG001|Overall Study|Site Terminated by Sponsor|6|||
33573174|NCT03586973|101989862|FG000|Overall Study|Withdrawal by Subject|1|||
33573175|NCT03586973|101989863|FG001|Overall Study|Withdrawal by Subject|0|||
33573176|NCT03586973|101989862|FG000|Overall Study|Lost to Follow-up|1|||
33573177|NCT03586973|101989863|FG001|Overall Study|Lost to Follow-up|0|||
33573178|NCT03545672|101989865|FG000|Overall Study|Uncertain diagnosis|2|||
33573179|NCT03545672|101989866|FG001|Overall Study|Uncertain diagnosis|1|||
33573180|NCT03545672|101989865|FG000|Overall Study|Protocol Violation|2|||
33573181|NCT03545672|101989866|FG001|Overall Study|Protocol Violation|2|||
33573182|NCT05899829|101989869|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
33573183|NCT05899829|101989870|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
33573184|NCT05899829|101989869|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
33573185|NCT05899829|101989870|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
33573186|NCT03781414|101989871|FG000|Overall Study|Study terminated by sponsor|39|||
33419505|NCT01220128|101425788|FG004|Overall Study|Adverse event, non-fatal|0|||
33573187|NCT03781414|101989872|FG001|Overall Study|Study terminated by sponsor|34|||
33573188|NCT03781414|101989873|FG002|Overall Study|Study terminated by sponsor|25|||
33573189|NCT03781414|101989871|FG000|Overall Study|Adverse Event|3|||
33573190|NCT03781414|101989872|FG001|Overall Study|Adverse Event|6|||
33635110|NCT01352715|102214730|FG000|Overall Study|major ineligibility|2|||
33635111|NCT01352715|102214731|FG001|Overall Study|major ineligibility|1|||
33635112|NCT02667119|102214734|FG000|Overall Study|Lost to Follow-up|3|||
33635113|NCT02667119|102214735|FG001|Overall Study|Lost to Follow-up|0|||
33635114|NCT01995838|102214739|FG000|Overall Study|Lost to Follow-up|0|||
33635115|NCT01995838|102214740|FG001|Overall Study|Lost to Follow-up|1|||
33635116|NCT01995838|102214741|FG002|Overall Study|Lost to Follow-up|0|||
33635117|NCT01995838|102214742|FG003|Overall Study|Lost to Follow-up|0|||
33635118|NCT01995838|102214743|FG004|Overall Study|Lost to Follow-up|0|||
33635119|NCT01995838|102214744|FG005|Overall Study|Lost to Follow-up|0|||
33635120|NCT01995838|102214745|FG006|Overall Study|Lost to Follow-up|1|||
33635121|NCT01995838|102214739|FG000|Overall Study|Participant choice|2|||
33635122|NCT01995838|102214740|FG001|Overall Study|Participant choice|0|||
33635123|NCT01995838|102214741|FG002|Overall Study|Participant choice|0|||
33635124|NCT01995838|102214742|FG003|Overall Study|Participant choice|0|||
33635125|NCT01995838|102214743|FG004|Overall Study|Participant choice|0|||
33635126|NCT01995838|102214744|FG005|Overall Study|Participant choice|1|||
33635127|NCT01995838|102214745|FG006|Overall Study|Participant choice|1|||
33635128|NCT01995838|102214739|FG000|Overall Study|Adverse Event|0|||
33635129|NCT01995838|102214740|FG001|Overall Study|Adverse Event|0|||
33635130|NCT01995838|102214741|FG002|Overall Study|Adverse Event|0|||
33635131|NCT01995838|102214742|FG003|Overall Study|Adverse Event|0|||
33635132|NCT01995838|102214743|FG004|Overall Study|Adverse Event|0|||
33635133|NCT01995838|102214744|FG005|Overall Study|Adverse Event|0|||
33635134|NCT01995838|102214745|FG006|Overall Study|Adverse Event|1|||
33635135|NCT01995838|102214739|FG000|Overall Study|Withdrawal by Subject|0|||
33635136|NCT01995838|102214740|FG001|Overall Study|Withdrawal by Subject|0|||
33635137|NCT01995838|102214741|FG002|Overall Study|Withdrawal by Subject|0|||
33635138|NCT01995838|102214742|FG003|Overall Study|Withdrawal by Subject|0|||
33635139|NCT01995838|102214743|FG004|Overall Study|Withdrawal by Subject|1|||
33635140|NCT01995838|102214744|FG005|Overall Study|Withdrawal by Subject|0|||
33635141|NCT01995838|102214745|FG006|Overall Study|Withdrawal by Subject|0|||
33573191|NCT03781414|101989873|FG002|Overall Study|Adverse Event|3|||
33573192|NCT03781414|101989871|FG000|Overall Study|Physician Decision|2|||
33573193|NCT03781414|101989872|FG001|Overall Study|Physician Decision|0|||
33573194|NCT03781414|101989873|FG002|Overall Study|Physician Decision|1|||
33573195|NCT03781414|101989871|FG000|Overall Study|Withdrawal by Subject|2|||
33573196|NCT03781414|101989872|FG001|Overall Study|Withdrawal by Subject|3|||
33573197|NCT03781414|101989873|FG002|Overall Study|Withdrawal by Subject|3|||
33573198|NCT03781414|101989871|FG000|Overall Study|Death|1|||
33573199|NCT03781414|101989872|FG001|Overall Study|Death|4|||
33573200|NCT03781414|101989873|FG002|Overall Study|Death|0|||
33573201|NCT03781414|101989871|FG000|Overall Study|Lost to Follow-up|1|||
33573202|NCT03781414|101989872|FG001|Overall Study|Lost to Follow-up|1|||
33573203|NCT03781414|101989873|FG002|Overall Study|Lost to Follow-up|0|||
33230433|NCT00258440|100746157|FG000|Overall Study|Withdrawal by Subject|0|||
33573204|NCT00688597|101989878|FG000|Overall Study|Adverse Event|2|||
33573205|NCT00688597|101989879|FG001|Overall Study|Adverse Event|0|||
33635142|NCT01995838|102214739|FG000|Overall Study|Other|3|||
33635143|NCT01995838|102214740|FG001|Overall Study|Other|1|||
33635144|NCT01995838|102214741|FG002|Overall Study|Other|0|||
33635145|NCT01995838|102214742|FG003|Overall Study|Other|2|||
33635146|NCT01995838|102214743|FG004|Overall Study|Other|1|||
33635147|NCT01995838|102214744|FG005|Overall Study|Other|1|||
33635148|NCT01995838|102214745|FG006|Overall Study|Other|2|||
33635149|NCT00935584|102214746|FG000|Overall Study|Withdrawal by Subject|9|||
33635150|NCT00935584|102214747|FG001|Overall Study|Withdrawal by Subject|0|||
33635151|NCT00935584|102214746|FG000|Overall Study|Death|3|||
33635152|NCT00935584|102214747|FG001|Overall Study|Death|0|||
33635153|NCT00935584|102214746|FG000|Overall Study|Lost to Follow-up|8|||
33635154|NCT00935584|102214747|FG001|Overall Study|Lost to Follow-up|0|||
33635155|NCT00935584|102214746|FG000|Overall Study|No show|9|||
33635156|NCT00935584|102214747|FG001|Overall Study|No show|0|||
33230434|NCT00258440|100746158|FG001|Overall Study|Withdrawal by Subject|0|||
33367556|NCT01905397|101232645|FG000|Overall Study|Dressing not applied in operating room|1|||
33367557|NCT01905397|101232646|FG001|Overall Study|Dressing not applied in operating room|0|||
33367558|NCT01905397|101232645|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
33367559|NCT01905397|101232646|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
33367560|NCT01734993|101232647|FG000|Overall Study|Adverse Event|1|||
33367561|NCT01734993|101232647|FG000|Overall Study|Lack of Efficacy|1|||
33367562|NCT01617434|101232648|FG000|Overall Study|Adverse Event|12|||
33367563|NCT01617434|101232649|FG001|Overall Study|Adverse Event|3|||
33367564|NCT01617434|101232648|FG000|Overall Study|Protocol Violation|8|||
33367565|NCT01617434|101232649|FG001|Overall Study|Protocol Violation|7|||
33367566|NCT01617434|101232648|FG000|Overall Study|Withdrawal Criteria|12|||
33419506|NCT01220128|101425789|FG005|Overall Study|Adverse event, non-fatal|0|||
33419507|NCT01220128|101425790|FG006|Overall Study|Adverse event, non-fatal|3|||
33230435|NCT00258440|100746159|FG002|Overall Study|Withdrawal by Subject|1|||
33367567|NCT01617434|101232649|FG001|Overall Study|Withdrawal Criteria|37|||
33635157|NCT00935584|102214746|FG000|Overall Study|Relocated|3|||
33230436|NCT00996580|100746160|FG000|Overall Study|Adverse Event|466|||
33230437|NCT00996580|100746160|FG000|Overall Study|Lost to Follow-up|480|||
33230438|NCT00996580|100746160|FG000|Overall Study|Noncompliance with the protocol|137|||
33230439|NCT00996580|100746160|FG000|Overall Study|Physician Decision|5|||
33573206|NCT00688597|101989880|FG002|Overall Study|Adverse Event|0|||
33573207|NCT00688597|101989878|FG000|Overall Study|Physician Decision|1|||
33573208|NCT00688597|101989879|FG001|Overall Study|Physician Decision|0|||
33573209|NCT00688597|101989880|FG002|Overall Study|Physician Decision|0|||
33573210|NCT00278161|101989886|FG000|Overall Study|Death|11|||
33573211|NCT01917318|101989888|FG000|First Treatment|Withdrawal by Subject|0|||
33573212|NCT01917318|101989889|FG001|First Treatment|Withdrawal by Subject|1|||
33635158|NCT00935584|102214747|FG001|Overall Study|Relocated|0|||
33573213|NCT01225952|101989890|FG000|Overall Study|Lost to Follow-up|1|||
33419508|NCT01220128|101425784|FG000|Overall Study|Other|0|||
33573214|NCT01225952|101989891|FG001|Overall Study|Lost to Follow-up|0|||
33230440|NCT00996580|100746160|FG000|Overall Study|Pregnancy|68|||
33419509|NCT01220128|101425785|FG001|Overall Study|Other|0|||
33573215|NCT01225952|101989892|FG002|Overall Study|Lost to Follow-up|0|||
33635159|NCT00935584|102214746|FG000|Overall Study|Patient changed provider|3|||
33635160|NCT00935584|102214747|FG001|Overall Study|Patient changed provider|0|||
33635161|NCT00935584|102214746|FG000|Overall Study|Provider dropped out of study|14|||
33635162|NCT00935584|102214747|FG001|Overall Study|Provider dropped out of study|4|||
33635163|NCT03133793|102214748|FG000|Overall Study|Withdrawal by Subject|0|||
33635164|NCT03133793|102214749|FG001|Overall Study|Withdrawal by Subject|4|||
33635165|NCT03133793|102214750|FG002|Overall Study|Withdrawal by Subject|2|||
33635166|NCT03133793|102214751|FG003|Overall Study|Withdrawal by Subject|4|||
33635167|NCT03133793|102214748|FG000|Overall Study|Lost to Follow-up|1|||
33635168|NCT03133793|102214749|FG001|Overall Study|Lost to Follow-up|0|||
33635169|NCT03133793|102214750|FG002|Overall Study|Lost to Follow-up|2|||
33635170|NCT03133793|102214751|FG003|Overall Study|Lost to Follow-up|0|||
33635171|NCT03133793|102214748|FG000|Overall Study|Death|0|||
33635172|NCT03133793|102214749|FG001|Overall Study|Death|0|||
33635173|NCT03133793|102214750|FG002|Overall Study|Death|0|||
33635174|NCT03133793|102214751|FG003|Overall Study|Death|1|||
33635175|NCT00960999|102214752|FG000|Overall Study|Withdrawal by Subject|1|||
33635176|NCT00960999|102214753|FG001|Overall Study|Withdrawal by Subject|0|||
33635177|NCT00960999|102214752|FG000|Overall Study|Protocol Violation|5|||
33635178|NCT00960999|102214753|FG001|Overall Study|Protocol Violation|2|||
33635179|NCT00960999|102214752|FG000|Overall Study|RT dose constraints not met|2|||
33230441|NCT00996580|100746160|FG000|Overall Study|Protocol Violation|16|||
33230442|NCT00996580|100746160|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
33230443|NCT00996580|100746160|FG000|Overall Study|Withdrawal by Subject|217|||
33230444|NCT00996580|100746160|FG000|Overall Study|Other|29|||
33230445|NCT01923428|100746161|FG000|Overall Study|Adverse Event|8|||
33367568|NCT01617434|101232648|FG000|Overall Study|Unclassified|3|||
33635180|NCT00960999|102214753|FG001|Overall Study|RT dose constraints not met|0|||
33635181|NCT00905164|102214759|FG000|Period 1|Protocol Violation|0|||
33635182|NCT00905164|102214760|FG001|Period 1|Protocol Violation|1|||
33635183|NCT00124943|102214763|FG000|Phase II|Adverse Event|0|||
33635184|NCT00124943|102214764|FG001|Phase II|Adverse Event|2|||
33635185|NCT00124943|102214765|FG002|Phase II|Adverse Event|0|||
33635186|NCT00124943|102214766|FG003|Phase II|Adverse Event|1|||
33635187|NCT00124943|102214763|FG000|Phase II|Protocol Violation|0|||
33635188|NCT00124943|102214764|FG001|Phase II|Protocol Violation|0|||
33635189|NCT00124943|102214765|FG002|Phase II|Protocol Violation|0|||
33635190|NCT00124943|102214766|FG003|Phase II|Protocol Violation|1|||
33573216|NCT01225952|101989890|FG000|Overall Study|Study Eye Explanted|0|||
33573217|NCT01225952|101989891|FG001|Overall Study|Study Eye Explanted|0|||
33573218|NCT01225952|101989892|FG002|Overall Study|Study Eye Explanted|1|||
33573219|NCT01225952|101989890|FG000|Overall Study|Withdrawal by Subject|4|||
33573220|NCT01225952|101989891|FG001|Overall Study|Withdrawal by Subject|4|||
33230446|NCT01923428|100746162|FG001|Overall Study|Adverse Event|6|||
33230447|NCT01923428|100746163|FG002|Overall Study|Adverse Event|3|||
33230448|NCT01923428|100746164|FG003|Overall Study|Adverse Event|3|||
33230449|NCT01923428|100746161|FG000|Overall Study|Withdrawal by Subject|5|||
33230450|NCT01923428|100746162|FG001|Overall Study|Withdrawal by Subject|3|||
33230451|NCT01923428|100746163|FG002|Overall Study|Withdrawal by Subject|0|||
33230452|NCT01923428|100746164|FG003|Overall Study|Withdrawal by Subject|4|||
33230453|NCT01923428|100746161|FG000|Overall Study|Lost to Follow-up|2|||
33230454|NCT01923428|100746162|FG001|Overall Study|Lost to Follow-up|1|||
33230455|NCT01923428|100746163|FG002|Overall Study|Lost to Follow-up|5|||
33230456|NCT01923428|100746164|FG003|Overall Study|Lost to Follow-up|0|||
33230457|NCT01923428|100746161|FG000|Overall Study|Protocol Violation|3|||
33230458|NCT01923428|100746162|FG001|Overall Study|Protocol Violation|0|||
33230459|NCT01923428|100746163|FG002|Overall Study|Protocol Violation|2|||
33230460|NCT01923428|100746164|FG003|Overall Study|Protocol Violation|1|||
33230461|NCT01923428|100746161|FG000|Overall Study|Non Compliance to treatment|1|||
33230462|NCT01923428|100746162|FG001|Overall Study|Non Compliance to treatment|2|||
33230463|NCT01923428|100746163|FG002|Overall Study|Non Compliance to treatment|0|||
33230464|NCT01923428|100746164|FG003|Overall Study|Non Compliance to treatment|1|||
33230465|NCT01923428|100746161|FG000|Overall Study|Lack of Efficacy|0|||
33230466|NCT01923428|100746162|FG001|Overall Study|Lack of Efficacy|0|||
33230467|NCT01923428|100746163|FG002|Overall Study|Lack of Efficacy|1|||
33230468|NCT01923428|100746164|FG003|Overall Study|Lack of Efficacy|1|||
33230469|NCT04789577|100746167|FG000|Overall Study|Withdrawal by Subject|1|||
33230470|NCT04789577|100746168|FG001|Overall Study|Withdrawal by Subject|1|||
33230471|NCT04789577|100746169|FG002|Overall Study|Withdrawal by Subject|1|||
33230472|NCT04789577|100746170|FG003|Overall Study|Withdrawal by Subject|3|||
33230473|NCT04789577|100746171|FG004|Overall Study|Withdrawal by Subject|1|||
33230474|NCT04789577|100746172|FG005|Overall Study|Withdrawal by Subject|7|||
33230475|NCT04789577|100746173|FG006|Overall Study|Withdrawal by Subject|1|||
33230476|NCT04789577|100746167|FG000|Overall Study|Lost to Follow-up|7|||
33230477|NCT04789577|100746168|FG001|Overall Study|Lost to Follow-up|12|||
33230478|NCT04789577|100746169|FG002|Overall Study|Lost to Follow-up|7|||
33230479|NCT04789577|100746170|FG003|Overall Study|Lost to Follow-up|10|||
33573221|NCT01225952|101989892|FG002|Overall Study|Withdrawal by Subject|5|||
33573222|NCT01225952|101989890|FG000|Overall Study|Surgical complications|1|||
33573223|NCT01225952|101989891|FG001|Overall Study|Surgical complications|0|||
33573224|NCT01225952|101989892|FG002|Overall Study|Surgical complications|0|||
33573225|NCT02259114|101989893|FG000|Overall Study|Progressive Disease|14|||
33573226|NCT02259114|101989894|FG001|Overall Study|Progressive Disease|2|||
33573227|NCT02259114|101989895|FG002|Overall Study|Progressive Disease|10|||
33573228|NCT02259114|101989896|FG003|Overall Study|Progressive Disease|2|||
33573229|NCT02259114|101989897|FG004|Overall Study|Progressive Disease|5|||
33573230|NCT02259114|101989893|FG000|Overall Study|Adverse Event|2|||
33573231|NCT02259114|101989894|FG001|Overall Study|Adverse Event|1|||
33573232|NCT02259114|101989895|FG002|Overall Study|Adverse Event|0|||
33573233|NCT02259114|101989896|FG003|Overall Study|Adverse Event|0|||
33573234|NCT02259114|101989897|FG004|Overall Study|Adverse Event|1|||
33573235|NCT02259114|101989893|FG000|Overall Study|Death|3|||
33230480|NCT04789577|100746171|FG004|Overall Study|Lost to Follow-up|8|||
33230481|NCT04789577|100746172|FG005|Overall Study|Lost to Follow-up|6|||
33573236|NCT02259114|101989894|FG001|Overall Study|Death|0|||
33573237|NCT02259114|101989895|FG002|Overall Study|Death|1|||
33230482|NCT04789577|100746173|FG006|Overall Study|Lost to Follow-up|10|||
33230483|NCT04789577|100746167|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
33230484|NCT04789577|100746168|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
33367569|NCT01617434|101232649|FG001|Overall Study|Unclassified|4|||
33230485|NCT04789577|100746169|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
33230486|NCT04789577|100746170|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
33230487|NCT04789577|100746171|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
33230488|NCT04789577|100746172|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
33230489|NCT04789577|100746173|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
33230490|NCT04789577|100746167|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
33230491|NCT04789577|100746168|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
33230492|NCT04789577|100746169|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
33230493|NCT04789577|100746170|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
33230494|NCT04789577|100746171|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
33419510|NCT01220128|101425786|FG002|Overall Study|Other|1|||
33573238|NCT02259114|101989896|FG003|Overall Study|Death|0|||
33573239|NCT02259114|101989897|FG004|Overall Study|Death|0|||
33573240|NCT02259114|101989893|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
33573241|NCT02259114|101989894|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
33573242|NCT02259114|101989895|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
33573243|NCT02259114|101989896|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
33573244|NCT02259114|101989897|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
33573245|NCT02259114|101989893|FG000|Overall Study|Withdrawal by Subject|0|||
33230495|NCT04789577|100746172|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
33230496|NCT04789577|100746173|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
33230497|NCT01763788|100746178|FG000|Overall Study|Lost to Follow-up|0|||
33230498|NCT01763788|100746179|FG001|Overall Study|Lost to Follow-up|0|||
33230499|NCT01763788|100746180|FG002|Overall Study|Lost to Follow-up|1|||
33230500|NCT01763788|100746181|FG003|Overall Study|Lost to Follow-up|0|||
33230501|NCT03714022|100746186|FG000|Overall Study|Adverse Event|1|||
33230502|NCT03714022|100746187|FG001|Overall Study|Adverse Event|0|||
33230503|NCT03714022|100746186|FG000|Overall Study|Consent withdrawal|0|||
33230504|NCT03714022|100746187|FG001|Overall Study|Consent withdrawal|1|||
33230505|NCT03714022|100746186|FG000|Overall Study|Lost to Follow-up|3|||
33230506|NCT03714022|100746187|FG001|Overall Study|Lost to Follow-up|2|||
33230507|NCT00594906|100746188|FG000|Overall Study|Physician Decision|1|||
33230508|NCT00594906|100746189|FG001|Overall Study|Physician Decision|0|||
33230509|NCT00594906|100746188|FG000|Overall Study|Physician Decision|0|||
33230510|NCT00594906|100746189|FG001|Overall Study|Physician Decision|1|||
33230511|NCT00594906|100746188|FG000|Overall Study|Death|0|||
33230512|NCT00594906|100746189|FG001|Overall Study|Death|1|||
33230513|NCT01563978|100746196|FG000|Overall Study|Physician Decision|1|||
33230514|NCT01563978|100746197|FG001|Overall Study|Physician Decision|0|||
33230515|NCT01563978|100746196|FG000|Overall Study|Lost to Follow-up|1|||
33230516|NCT01563978|100746197|FG001|Overall Study|Lost to Follow-up|0|||
33230517|NCT01563978|100746196|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
33230518|NCT01563978|100746197|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
33230519|NCT01563978|100746196|FG000|Overall Study|Adverse Event|1|||
33230520|NCT01563978|100746197|FG001|Overall Study|Adverse Event|2|||
33230521|NCT03151395|100746198|FG000|Overall Study|Adverse Event|2|||
33230522|NCT03151395|100746198|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
33230523|NCT03151395|100746198|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
33230524|NCT03151395|100746198|FG000|Overall Study|Unspecified reason|4|||
33230525|NCT00582491|100746200|FG000|Overall Study|Withdrawal by Subject|1|||
33230526|NCT00582491|100746201|FG001|Overall Study|Withdrawal by Subject|0|||
33230527|NCT00951509|100746202|FG000|Overall Study|Withdrawal by Subject|2|||
33230528|NCT02066532|100746206|FG000|Phase II|Withdrawal by Subject|1|||
33230529|NCT02066532|100746207|FG001|Phase II|Withdrawal by Subject|0|||
33230530|NCT02066532|100746208|FG002|Phase II|Withdrawal by Subject|0|||
33230531|NCT02066532|100746209|FG003|Phase II|Withdrawal by Subject|0|||
33230532|NCT02045433|100746213|FG000|Overall Study|Withdrawal by Subject|1|||
33230533|NCT01250119|100746214|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
33230534|NCT01250119|100746215|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
33230535|NCT01250119|100746214|FG000|Diagnostic Phase|Participants Not Tested|44|||
33230536|NCT01250119|100746215|FG001|Diagnostic Phase|Participants Not Tested|0|||
33230537|NCT01250119|100746214|FG000|Treatment Phase|Progressive Disease|0|||
33230538|NCT01250119|100746215|FG001|Treatment Phase|Progressive Disease|32|||
33230539|NCT01250119|100746214|FG000|Treatment Phase|Death|0|||
33230540|NCT01250119|100746215|FG001|Treatment Phase|Death|2|||
33230541|NCT01250119|100746214|FG000|Treatment Phase|Withdrawal by Subject|0|||
33230542|NCT01250119|100746215|FG001|Treatment Phase|Withdrawal by Subject|1|||
33230543|NCT01250119|100746214|FG000|Treatment Phase|Adverse Event|0|||
33230544|NCT01250119|100746215|FG001|Treatment Phase|Adverse Event|2|||
33230545|NCT01250119|100746214|FG000|Treatment Phase|Unknown reason|0|||
33230546|NCT01250119|100746215|FG001|Treatment Phase|Unknown reason|4|||
33230547|NCT01863043|100746218|FG000|Overall Study|Death|6|||
33230548|NCT01863043|100746219|FG001|Overall Study|Death|1|||
33230549|NCT01863043|100746218|FG000|Overall Study|Withdrawal by Subject|0|||
33230550|NCT01863043|100746219|FG001|Overall Study|Withdrawal by Subject|2|||
33230551|NCT01863043|100746218|FG000|Overall Study|Adverse Event|7|||
33367570|NCT02606045|101232650|FG000|Overall Study|Study closed before treament could begin|1|||
33367571|NCT02606045|101232651|FG001|Overall Study|Study closed before treament could begin|2|||
33230552|NCT01863043|100746219|FG001|Overall Study|Adverse Event|8|||
33230553|NCT01863043|100746218|FG000|Overall Study|exclusion criteria found after enrollment|0|||
33230554|NCT01863043|100746219|FG001|Overall Study|exclusion criteria found after enrollment|1|||
33230555|NCT00423852|100746220|FG000|Overall Study|Removed pior to the high-dose portion|3|||
33230556|NCT01984424|100746221|FG000|Overall Study|Withdrawal by Subject|3|||
33230557|NCT01984424|100746222|FG001|Overall Study|Withdrawal by Subject|5|||
33230558|NCT01984424|100746221|FG000|Overall Study|Sponsor Decision|0|||
33230559|NCT01984424|100746222|FG001|Overall Study|Sponsor Decision|1|||
33230560|NCT01984424|100746221|FG000|Overall Study|Lost to Follow-up|0|||
33230561|NCT01984424|100746222|FG001|Overall Study|Lost to Follow-up|1|||
33230562|NCT02494206|100746223|FG000|Overall Study|Adverse Event|1|||
33230563|NCT02494206|100746223|FG000|Overall Study|Disease Progression|1|||
33230564|NCT02204293|100746226|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
33230565|NCT02204293|100746227|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
33230566|NCT02204293|100746228|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
33230567|NCT02204293|100746229|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
33230568|NCT02204293|100746230|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
33230569|NCT02204293|100746231|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
33230570|NCT02204293|100746226|FG000|Core Study Part I|Adverse Event|1|||
33230571|NCT02204293|100746227|FG001|Core Study Part I|Adverse Event|0|||
33230572|NCT02204293|100746228|FG002|Core Study Part I|Adverse Event|0|||
33230573|NCT02204293|100746229|FG003|Core Study Part I|Adverse Event|0|||
33230574|NCT02204293|100746230|FG004|Core Study Part I|Adverse Event|0|||
33230575|NCT02204293|100746231|FG005|Core Study Part I|Adverse Event|0|||
33230576|NCT02204293|100746226|FG000|Core Study Part I|Physician Decision|0|||
33230577|NCT02204293|100746227|FG001|Core Study Part I|Physician Decision|3|||
33230578|NCT02204293|100746228|FG002|Core Study Part I|Physician Decision|0|||
33230579|NCT02204293|100746229|FG003|Core Study Part I|Physician Decision|0|||
33230580|NCT02204293|100746230|FG004|Core Study Part I|Physician Decision|0|||
33230581|NCT02204293|100746231|FG005|Core Study Part I|Physician Decision|0|||
33230582|NCT02204293|100746226|FG000|LTE Phase|Study Suspended|0|||
33230583|NCT02204293|100746227|FG001|LTE Phase|Study Suspended|0|||
33230584|NCT02204293|100746228|FG002|LTE Phase|Study Suspended|0|||
33230585|NCT02204293|100746229|FG003|LTE Phase|Study Suspended|0|||
33230586|NCT02204293|100746230|FG004|LTE Phase|Study Suspended|0|||
33230587|NCT02204293|100746231|FG005|LTE Phase|Study Suspended|7|||
33230588|NCT01018563|100746232|FG000|Overall Study|Termination of the study by Sponsor|2|||
33573246|NCT02259114|101989894|FG001|Overall Study|Withdrawal by Subject|0|||
33573247|NCT02259114|101989895|FG002|Overall Study|Withdrawal by Subject|1|||
33573248|NCT02259114|101989896|FG003|Overall Study|Withdrawal by Subject|1|||
33573249|NCT02259114|101989897|FG004|Overall Study|Withdrawal by Subject|0|||
33573250|NCT02259114|101989893|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
33573251|NCT02259114|101989894|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
33573252|NCT02259114|101989895|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
33573253|NCT02259114|101989896|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
33573254|NCT02259114|101989897|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
33573255|NCT02259114|101989893|FG000|Overall Study|Not Treated|1|||
33573256|NCT02259114|101989894|FG001|Overall Study|Not Treated|0|||
33573257|NCT02259114|101989895|FG002|Overall Study|Not Treated|0|||
33230589|NCT01018563|100746233|FG001|Overall Study|Termination of the study by Sponsor|1|||
33230590|NCT01284140|100746234|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
33230591|NCT01284140|100746235|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
33230592|NCT01284140|100746234|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
33230593|NCT01284140|100746235|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
33230594|NCT01108510|100746238|FG000|Overall Study|Randomized but Not Treated|5|||
33230595|NCT01108510|100746239|FG001|Overall Study|Randomized but Not Treated|1|||
33230596|NCT01108510|100746238|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
33230597|NCT01108510|100746239|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
33230598|NCT01108510|100746238|FG000|Overall Study|Adverse Event|26|||
33230599|NCT01108510|100746239|FG001|Overall Study|Adverse Event|19|||
33230600|NCT01108510|100746238|FG000|Overall Study|Lost to Follow-up|20|||
33230601|NCT01108510|100746239|FG001|Overall Study|Lost to Follow-up|17|||
33230602|NCT01108510|100746238|FG000|Overall Study|Withdrew Consent|21|||
33230603|NCT01108510|100746239|FG001|Overall Study|Withdrew Consent|15|||
33230604|NCT01108510|100746238|FG000|Overall Study|Investigator's Discretion|12|||
33230605|NCT01108510|100746239|FG001|Overall Study|Investigator's Discretion|10|||
33230606|NCT01108510|100746238|FG000|Overall Study|Participant Noncompliance|5|||
33230607|NCT01108510|100746239|FG001|Overall Study|Participant Noncompliance|7|||
33230608|NCT01108510|100746238|FG000|Overall Study|Lack of Efficacy|3|||
33230609|NCT01108510|100746239|FG001|Overall Study|Lack of Efficacy|0|||
33230610|NCT01108510|100746238|FG000|Overall Study|Pregnancy|0|||
33230611|NCT01108510|100746239|FG001|Overall Study|Pregnancy|3|||
33230612|NCT01108510|100746238|FG000|Overall Study|Death|1|||
33230613|NCT01108510|100746239|FG001|Overall Study|Death|1|||
33230614|NCT02802319|100746240|FG000|Overall Study|Physician Decision|2|||
33230615|NCT02802319|100746241|FG001|Overall Study|Physician Decision|1|||
33230616|NCT02802319|100746240|FG000|Overall Study|Lost to Follow-up|0|||
33230617|NCT02802319|100746241|FG001|Overall Study|Lost to Follow-up|4|||
33573258|NCT02259114|101989896|FG003|Overall Study|Not Treated|0|||
33573259|NCT02259114|101989897|FG004|Overall Study|Not Treated|0|||
33573260|NCT00714948|101989899|FG000|Overall Study|Adverse Event|2|||
33573261|NCT01077063|101989900|FG000|Overall Study|Adverse Event|3|||
33635191|NCT00124943|102214763|FG000|Phase II|Lost to Follow-up|0|||
33230618|NCT04867785|100746243|FG000|Overall Study|Adverse Event|1|||
33230619|NCT04867785|100746244|FG001|Overall Study|Adverse Event|0|||
33230620|NCT04867785|100746245|FG002|Overall Study|Adverse Event|1|||
33230621|NCT04867785|100746246|FG003|Overall Study|Adverse Event|0|||
33230622|NCT04867785|100746247|FG004|Overall Study|Adverse Event|0|||
33230623|NCT04867785|100746248|FG005|Overall Study|Adverse Event|0|||
33230624|NCT04867785|100746249|FG006|Overall Study|Adverse Event|0|||
33230625|NCT04867785|100746250|FG007|Overall Study|Adverse Event|2|||
33230626|NCT04867785|100746243|FG000|Overall Study|Lost to Follow-up|4|||
33230627|NCT04867785|100746244|FG001|Overall Study|Lost to Follow-up|4|||
33573262|NCT01077063|101989901|FG001|Overall Study|Adverse Event|0|||
33573263|NCT01077063|101989900|FG000|Overall Study|Death|1|||
33230628|NCT04867785|100746245|FG002|Overall Study|Lost to Follow-up|3|||
33230629|NCT04867785|100746246|FG003|Overall Study|Lost to Follow-up|2|||
33230630|NCT04867785|100746247|FG004|Overall Study|Lost to Follow-up|0|||
33230631|NCT04867785|100746248|FG005|Overall Study|Lost to Follow-up|1|||
33230632|NCT04867785|100746249|FG006|Overall Study|Lost to Follow-up|0|||
33230633|NCT04867785|100746250|FG007|Overall Study|Lost to Follow-up|1|||
33230634|NCT04867785|100746243|FG000|Overall Study|Withdrawal by Subject|6|||
33230635|NCT04867785|100746244|FG001|Overall Study|Withdrawal by Subject|2|||
33573264|NCT01077063|101989901|FG001|Overall Study|Death|1|||
33573265|NCT01077063|101989900|FG000|Overall Study|Withdrawal by Subject|0|||
33573266|NCT01077063|101989901|FG001|Overall Study|Withdrawal by Subject|2|||
33573267|NCT00461708|101989902|FG000|Overall Study|Adverse Event|17|||
33573268|NCT00461708|101989903|FG001|Overall Study|Adverse Event|7|||
33573269|NCT00461708|101989902|FG000|Overall Study|Lack of Efficacy|68|||
33573270|NCT00461708|101989903|FG001|Overall Study|Lack of Efficacy|20|||
33573271|NCT00461708|101989902|FG000|Overall Study|Physician Decision|10|||
33573272|NCT00461708|101989903|FG001|Overall Study|Physician Decision|4|||
33573273|NCT00461708|101989902|FG000|Overall Study|Withdrawal by Subject|8|||
33573274|NCT00461708|101989903|FG001|Overall Study|Withdrawal by Subject|2|||
33573275|NCT00461708|101989902|FG000|Overall Study|Other|4|||
33573276|NCT00461708|101989903|FG001|Overall Study|Other|4|||
33573277|NCT00461708|101989902|FG000|Overall Study|Death|8|||
33573278|NCT00461708|101989903|FG001|Overall Study|Death|1|||
33573279|NCT00279214|101989904|FG000|Overall Study|Physician Decision|3|||
33573280|NCT00279214|101989905|FG001|Overall Study|Physician Decision|2|||
33573281|NCT02301897|101989906|FG000|Treatment Course 1|Non-Compliance|0|||
33573282|NCT02301897|101989907|FG001|Treatment Course 1|Non-Compliance|0|||
33573283|NCT02301897|101989908|FG002|Treatment Course 1|Non-Compliance|1|||
33573284|NCT02301897|101989906|FG000|Treatment Course 1|Adverse Event|1|||
33573285|NCT02301897|101989907|FG001|Treatment Course 1|Adverse Event|1|||
33573286|NCT02301897|101989908|FG002|Treatment Course 1|Adverse Event|0|||
33230636|NCT04867785|100746245|FG002|Overall Study|Withdrawal by Subject|2|||
33230637|NCT04867785|100746246|FG003|Overall Study|Withdrawal by Subject|1|||
33230638|NCT04867785|100746247|FG004|Overall Study|Withdrawal by Subject|2|||
33230639|NCT04867785|100746248|FG005|Overall Study|Withdrawal by Subject|0|||
33230640|NCT04867785|100746249|FG006|Overall Study|Withdrawal by Subject|2|||
33230641|NCT04867785|100746250|FG007|Overall Study|Withdrawal by Subject|5|||
33367572|NCT04743635|101232652|FG000|Overall Study|Lost to Follow-up|2|||
33367573|NCT04743635|101232653|FG001|Overall Study|Lost to Follow-up|0|||
33367574|NCT01937130|101232654|FG000|Overall Study|Withdrawal by Subject|0|||
33573287|NCT02301897|101989906|FG000|Treatment Course 1|Lost to Follow-up|1|||
33573288|NCT02301897|101989907|FG001|Treatment Course 1|Lost to Follow-up|2|||
33573289|NCT02301897|101989908|FG002|Treatment Course 1|Lost to Follow-up|1|||
33635192|NCT00124943|102214764|FG001|Phase II|Lost to Follow-up|0|||
33635193|NCT00124943|102214765|FG002|Phase II|Lost to Follow-up|0|||
33635194|NCT00124943|102214766|FG003|Phase II|Lost to Follow-up|1|||
33635195|NCT00124943|102214763|FG000|Phase II|Withdrawal by Subject|0|||
33635196|NCT00124943|102214764|FG001|Phase II|Withdrawal by Subject|0|||
33635197|NCT00124943|102214765|FG002|Phase II|Withdrawal by Subject|0|||
33635198|NCT00124943|102214766|FG003|Phase II|Withdrawal by Subject|2|||
33635199|NCT02636595|102214767|FG000|Overall Study|Lost to Follow-up|1|||
33573290|NCT02301897|101989906|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
33635200|NCT02636595|102214767|FG000|Overall Study|Other|1|||
33635201|NCT04177823|102214768|FG000|Overall Study|Physician Decision|1|||
33635202|NCT04177823|102214768|FG000|Overall Study|Withdrawal by Subject|1|||
33635203|NCT00836693|102214769|FG000|Overall Study|Adverse Event|4|||
33635204|NCT00836693|102214770|FG001|Overall Study|Adverse Event|1|||
33230642|NCT04867785|100746243|FG000|Overall Study|Physician Decision|0|||
33230643|NCT04867785|100746244|FG001|Overall Study|Physician Decision|0|||
33573291|NCT02301897|101989907|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
33230644|NCT04867785|100746245|FG002|Overall Study|Physician Decision|0|||
33230645|NCT04867785|100746246|FG003|Overall Study|Physician Decision|0|||
33573292|NCT02301897|101989908|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
33573293|NCT02301897|101989906|FG000|Treatment Course 1|Withdrawal by Subject|0|||
33635205|NCT00836693|102214769|FG000|Overall Study|Sponsor Decision|0|||
33635206|NCT00836693|102214770|FG001|Overall Study|Sponsor Decision|1|||
33635207|NCT00836693|102214769|FG000|Overall Study|Physician Decision|2|||
33573294|NCT02301897|101989907|FG001|Treatment Course 1|Withdrawal by Subject|0|||
33573295|NCT02301897|101989908|FG002|Treatment Course 1|Withdrawal by Subject|2|||
33573296|NCT02301897|101989906|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
33635208|NCT00836693|102214770|FG001|Overall Study|Physician Decision|0|||
33635209|NCT00836693|102214769|FG000|Overall Study|Withdrawal by Subject|9|||
33635210|NCT00836693|102214770|FG001|Overall Study|Withdrawal by Subject|4|||
33635211|NCT00836693|102214769|FG000|Overall Study|Protocol Violation|1|||
33635212|NCT00836693|102214770|FG001|Overall Study|Protocol Violation|0|||
33635213|NCT00836693|102214769|FG000|Overall Study|Lost to Follow-up|1|||
33635214|NCT00836693|102214770|FG001|Overall Study|Lost to Follow-up|0|||
33635215|NCT03405792|102214771|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
33635216|NCT03405792|102214772|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
33635217|NCT03405792|102214771|FG000|Overall Study|o Did not receive pembrolizumab|1|||
33635218|NCT03405792|102214772|FG001|Overall Study|o Did not receive pembrolizumab|0|||
33635219|NCT04322526|102214773|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
33230646|NCT04867785|100746247|FG004|Overall Study|Physician Decision|0|||
33230647|NCT04867785|100746248|FG005|Overall Study|Physician Decision|0|||
33573297|NCT02301897|101989907|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
33573298|NCT02301897|101989908|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
33573299|NCT02301897|101989906|FG000|Treatment Course 2|Lost to Follow-up|0|||
33573300|NCT02301897|101989907|FG001|Treatment Course 2|Lost to Follow-up|2|||
33573301|NCT02301897|101989908|FG002|Treatment Course 2|Lost to Follow-up|0|||
33573302|NCT02301897|101989906|FG000|Treatment Course 2|Pregnancy|0|||
33635220|NCT04322526|102214774|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
33635221|NCT04322526|102214773|FG000|Washout (1 Week)|Lost to Follow-up|1|||
33635222|NCT04322526|102214774|FG001|Washout (1 Week)|Lost to Follow-up|2|||
33635223|NCT00394095|102214775|FG000|Overall Study|Adverse Event|1|||
33635224|NCT00394095|102214776|FG001|Overall Study|Adverse Event|0|||
33635225|NCT00425269|102214778|FG000|Overall Study|Pregnancy|5|||
33635226|NCT00425269|102214779|FG001|Overall Study|Pregnancy|7|||
33635227|NCT00425269|102214778|FG000|Overall Study|Lost to Follow-up|9|||
33635228|NCT00425269|102214779|FG001|Overall Study|Lost to Follow-up|9|||
33635229|NCT00425269|102214778|FG000|Overall Study|moved or medical reason|5|||
33635230|NCT00425269|102214779|FG001|Overall Study|moved or medical reason|4|||
33635231|NCT00807911|102214786|FG000|Overall Study|Withdrawal by Subject|12|||
33635232|NCT00807911|102214787|FG001|Overall Study|Withdrawal by Subject|10|||
33230648|NCT04867785|100746249|FG006|Overall Study|Physician Decision|0|||
33230649|NCT04867785|100746250|FG007|Overall Study|Physician Decision|1|||
33230650|NCT04867785|100746243|FG000|Overall Study|Inadvertent Enrollment|0|||
33230651|NCT04867785|100746244|FG001|Overall Study|Inadvertent Enrollment|0|||
33230652|NCT04867785|100746245|FG002|Overall Study|Inadvertent Enrollment|0|||
33230653|NCT04867785|100746246|FG003|Overall Study|Inadvertent Enrollment|1|||
33230654|NCT04867785|100746247|FG004|Overall Study|Inadvertent Enrollment|1|||
33230655|NCT04867785|100746248|FG005|Overall Study|Inadvertent Enrollment|0|||
33230656|NCT04867785|100746249|FG006|Overall Study|Inadvertent Enrollment|0|||
33230657|NCT04867785|100746250|FG007|Overall Study|Inadvertent Enrollment|1|||
33230658|NCT04867785|100746243|FG000|Overall Study|Eligibility Criteria Not Met|0|||
33230659|NCT04867785|100746244|FG001|Overall Study|Eligibility Criteria Not Met|0|||
33230660|NCT04867785|100746245|FG002|Overall Study|Eligibility Criteria Not Met|0|||
33230661|NCT04867785|100746246|FG003|Overall Study|Eligibility Criteria Not Met|0|||
33230662|NCT04867785|100746247|FG004|Overall Study|Eligibility Criteria Not Met|0|||
33230663|NCT04867785|100746248|FG005|Overall Study|Eligibility Criteria Not Met|0|||
33367575|NCT01937130|101232655|FG001|Overall Study|Withdrawal by Subject|0|||
33367576|NCT01937130|101232656|FG002|Overall Study|Withdrawal by Subject|0|||
33367577|NCT01937130|101232657|FG003|Overall Study|Withdrawal by Subject|1|||
33367578|NCT01937130|101232654|FG000|Overall Study|Adverse Event|0|||
33635233|NCT00807911|102214786|FG000|Overall Study|Ineligible|0|||
33635234|NCT00807911|102214787|FG001|Overall Study|Ineligible|4|||
33635235|NCT04774094|102214805|FG000|Overall Study|Other|2|||
33635236|NCT04774094|102214805|FG000|Overall Study|Withdrawal by Subject|9|||
33635237|NCT04774094|102214805|FG000|Overall Study|Lost to Follow-up|7|||
33635238|NCT04774094|102214805|FG000|Overall Study|Lack of Efficacy|5|||
33230664|NCT04867785|100746249|FG006|Overall Study|Eligibility Criteria Not Met|0|||
33230665|NCT04867785|100746250|FG007|Overall Study|Eligibility Criteria Not Met|1|||
33230666|NCT01004250|100746251|FG000|Induction Therapy Period|Adverse Event|10|||
33230667|NCT01004250|100746251|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
33367579|NCT01937130|101232655|FG001|Overall Study|Adverse Event|1|||
33367580|NCT01937130|101232656|FG002|Overall Study|Adverse Event|0|||
33635239|NCT04774094|102214805|FG000|Overall Study|Death|17|||
33635240|NCT04774094|102214805|FG000|Overall Study|Adverse Event|4|||
33635241|NCT02458313|102214806|FG000|Overall Study|Withdrawal by Subject|6|||
33635242|NCT02458313|102214807|FG001|Overall Study|Withdrawal by Subject|8|||
33635243|NCT02458313|102214806|FG000|Overall Study|Excluded for motion during MRI|1|||
33635244|NCT02458313|102214807|FG001|Overall Study|Excluded for motion during MRI|2|||
33230668|NCT01004250|100746251|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
33230669|NCT01004250|100746251|FG000|Induction Therapy Period|Physician Decision|2|||
33230670|NCT01004250|100746251|FG000|Maintenance Therapy Period|Adverse Event|15|||
33230671|NCT01004250|100746251|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
33230672|NCT01004250|100746251|FG000|Maintenance Therapy Period|Protocol Violation|1|||
33230673|NCT01004250|100746251|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
33230674|NCT01004250|100746251|FG000|Maintenance Therapy Period|Physician Decision|4|||
33230675|NCT01004250|100746251|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
33230676|NCT03548064|100746252|FG000|Overall Study|Withdrawal by Subject|0|||
33230677|NCT03548064|100746253|FG001|Overall Study|Withdrawal by Subject|0|||
33230678|NCT03548064|100746254|FG002|Overall Study|Withdrawal by Subject|0|||
33230679|NCT03548064|100746255|FG003|Overall Study|Withdrawal by Subject|1|||
33230680|NCT03548064|100746256|FG004|Overall Study|Withdrawal by Subject|0|||
33230681|NCT03548064|100746257|FG005|Overall Study|Withdrawal by Subject|0|||
33230682|NCT03548064|100746258|FG006|Overall Study|Withdrawal by Subject|0|||
33230683|NCT03548064|100746259|FG007|Overall Study|Withdrawal by Subject|0|||
33230684|NCT03548064|100746252|FG000|Overall Study|Lost to Follow-up|0|||
33230685|NCT03548064|100746253|FG001|Overall Study|Lost to Follow-up|0|||
33230686|NCT03548064|100746254|FG002|Overall Study|Lost to Follow-up|0|||
33230687|NCT03548064|100746255|FG003|Overall Study|Lost to Follow-up|0|||
33230688|NCT03548064|100746256|FG004|Overall Study|Lost to Follow-up|2|||
33230689|NCT03548064|100746257|FG005|Overall Study|Lost to Follow-up|0|||
33230690|NCT03548064|100746258|FG006|Overall Study|Lost to Follow-up|0|||
33230691|NCT03548064|100746259|FG007|Overall Study|Lost to Follow-up|0|||
33230692|NCT03548064|100746252|FG000|Overall Study|Covid-19 Pandemic|0|||
33230693|NCT03548064|100746253|FG001|Overall Study|Covid-19 Pandemic|0|||
33230694|NCT03548064|100746254|FG002|Overall Study|Covid-19 Pandemic|0|||
33230695|NCT03548064|100746255|FG003|Overall Study|Covid-19 Pandemic|0|||
33230696|NCT03548064|100746256|FG004|Overall Study|Covid-19 Pandemic|10|||
33230697|NCT03548064|100746257|FG005|Overall Study|Covid-19 Pandemic|3|||
33230698|NCT03548064|100746258|FG006|Overall Study|Covid-19 Pandemic|0|||
33230699|NCT03548064|100746259|FG007|Overall Study|Covid-19 Pandemic|0|||
33230700|NCT01242176|100746263|FG000|Washout Period of 7 Days|Adverse Event|0|||
33230701|NCT01242176|100746264|FG001|Washout Period of 7 Days|Adverse Event|2|||
33230702|NCT01242176|100746263|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
33230703|NCT01242176|100746264|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
33230704|NCT02765490|100746265|FG000|Overall Study|Lost to Follow-up|1|||
33230705|NCT02765490|100746266|FG001|Overall Study|Lost to Follow-up|1|||
33230706|NCT02765490|100746265|FG000|Overall Study|Other|0|||
33230707|NCT02765490|100746266|FG001|Overall Study|Other|1|||
33230708|NCT02765490|100746265|FG000|Overall Study|Death|0|||
33230709|NCT02765490|100746266|FG001|Overall Study|Death|1|||
33230710|NCT01586338|100746267|FG000|Overall Study|Adverse Event|3|||
33230711|NCT01586338|100746267|FG000|Overall Study|Lost to Follow-up|1|||
33230712|NCT01586338|100746267|FG000|Overall Study|Withdrawal by participant|3|||
33230713|NCT01586338|100746267|FG000|Overall Study|Other|1|||
33230714|NCT04848662|100746270|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
33230715|NCT04848662|100746271|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
33230716|NCT04880161|100746278|FG000|Overall Study|Withdrawal by Subject|1|||
33230717|NCT04880161|100746279|FG001|Overall Study|Withdrawal by Subject|0|||
33230718|NCT04880161|100746278|FG000|Overall Study|Lack of Compliance|1|||
33230719|NCT04880161|100746279|FG001|Overall Study|Lack of Compliance|1|||
33230720|NCT04880161|100746278|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
33230721|NCT04880161|100746279|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
33573303|NCT02301897|101989907|FG001|Treatment Course 2|Pregnancy|1|||
33573304|NCT02301897|101989908|FG002|Treatment Course 2|Pregnancy|1|||
33573305|NCT02301897|101989906|FG000|Treatment Course 2|Withdrawal by Subject|0|||
33573306|NCT02301897|101989907|FG001|Treatment Course 2|Withdrawal by Subject|2|||
33573307|NCT02301897|101989908|FG002|Treatment Course 2|Withdrawal by Subject|0|||
33573308|NCT02301897|101989906|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
33230722|NCT04880161|100746278|FG000|Overall Study|Screen Failure|0|||
33230723|NCT04880161|100746279|FG001|Overall Study|Screen Failure|1|||
33230724|NCT02757521|100746280|FG000|Overall Study|Adverse Event|1|||
33230725|NCT02757521|100746281|FG001|Overall Study|Adverse Event|0|||
33367581|NCT01937130|101232657|FG003|Overall Study|Adverse Event|1|||
33367582|NCT01937130|101232654|FG000|Overall Study|Death|1|||
33230726|NCT02855164|100746283|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
33230727|NCT02855164|100746284|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
33230728|NCT02855164|100746285|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
33230729|NCT02855164|100746286|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
33230730|NCT02855164|100746287|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
33230731|NCT02855164|100746288|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
33367583|NCT01937130|101232655|FG001|Overall Study|Death|1|||
33367584|NCT01937130|101232656|FG002|Overall Study|Death|1|||
33573309|NCT02301897|101989907|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
33573310|NCT02301897|101989908|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
33573311|NCT05067335|101989909|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
33573312|NCT05067335|101989910|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
33573313|NCT05067335|101989911|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
33573314|NCT05067335|101989912|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
33573315|NCT05067335|101989909|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
33367585|NCT01937130|101232657|FG003|Overall Study|Death|0|||
33367586|NCT01937130|101232654|FG000|Overall Study|Lost to Follow-up|2|||
33367587|NCT01937130|101232655|FG001|Overall Study|Lost to Follow-up|0|||
33367588|NCT01937130|101232656|FG002|Overall Study|Lost to Follow-up|2|||
33367589|NCT01937130|101232657|FG003|Overall Study|Lost to Follow-up|0|||
33635245|NCT03910244|102214808|FG000|Overall Study|Adverse Event|14|||
33635246|NCT03910244|102214809|FG001|Overall Study|Adverse Event|0|||
33635247|NCT03910244|102214808|FG000|Overall Study|Death|1|||
33635248|NCT03910244|102214809|FG001|Overall Study|Death|0|||
33635249|NCT03910244|102214808|FG000|Overall Study|Lost to Follow-up|0|||
33635250|NCT03910244|102214809|FG001|Overall Study|Lost to Follow-up|2|||
33635251|NCT03910244|102214808|FG000|Overall Study|Joint withdrawal decision|1|||
33635252|NCT03910244|102214809|FG001|Overall Study|Joint withdrawal decision|0|||
33635253|NCT03910244|102214808|FG000|Overall Study|Study Terminated by Sponsor|7|||
33635254|NCT03910244|102214809|FG001|Overall Study|Study Terminated by Sponsor|4|||
33635255|NCT03910244|102214808|FG000|Overall Study|Physician Decision|1|||
33635256|NCT03910244|102214809|FG001|Overall Study|Physician Decision|0|||
33635257|NCT03910244|102214808|FG000|Overall Study|Protocol Violation|1|||
33635258|NCT03910244|102214809|FG001|Overall Study|Protocol Violation|0|||
33635259|NCT03910244|102214808|FG000|Overall Study|Withdrawal by Subject|7|||
33635260|NCT03910244|102214809|FG001|Overall Study|Withdrawal by Subject|2|||
33635261|NCT03722238|102214810|FG000|Overall Study|Protocol Violation|1|||
33367590|NCT01937130|101232654|FG000|Overall Study|Physician Decision|0|||
33367591|NCT01937130|101232655|FG001|Overall Study|Physician Decision|1|||
33367592|NCT01937130|101232656|FG002|Overall Study|Physician Decision|0|||
33573316|NCT05067335|101989910|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
33573317|NCT05067335|101989911|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
33573318|NCT05067335|101989912|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
33573319|NCT05067335|101989909|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
33573320|NCT05067335|101989910|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
33573321|NCT05067335|101989911|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
33573322|NCT05067335|101989912|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
33573323|NCT05067335|101989909|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
33573324|NCT05067335|101989910|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
33635262|NCT03722238|102214811|FG001|Overall Study|Protocol Violation|0|||
33635263|NCT03722238|102214810|FG000|Overall Study|Physician Decision|1|||
33635264|NCT03722238|102214811|FG001|Overall Study|Physician Decision|0|||
33635265|NCT03722238|102214810|FG000|Overall Study|Death|1|||
33635266|NCT03722238|102214811|FG001|Overall Study|Death|0|||
33367593|NCT01937130|101232657|FG003|Overall Study|Physician Decision|0|||
33367594|NCT01937130|101232654|FG000|Overall Study|Patients unable to swallow|0|||
33367595|NCT01937130|101232655|FG001|Overall Study|Patients unable to swallow|1|||
33367596|NCT01937130|101232656|FG002|Overall Study|Patients unable to swallow|0|||
33367597|NCT01937130|101232657|FG003|Overall Study|Patients unable to swallow|0|||
33367598|NCT01937130|101232654|FG000|Overall Study|Patient lost to FU due to death|2|||
33367599|NCT01937130|101232655|FG001|Overall Study|Patient lost to FU due to death|0|||
33367600|NCT01937130|101232656|FG002|Overall Study|Patient lost to FU due to death|0|||
33367601|NCT01937130|101232657|FG003|Overall Study|Patient lost to FU due to death|0|||
33367602|NCT00114972|101232658|FG000|Overall Study|Withdrawal by Subject|40|||
33367603|NCT00114972|101232659|FG001|Overall Study|Withdrawal by Subject|7|||
33367604|NCT00114972|101232658|FG000|Overall Study|Lost to Follow-up|8|||
33573325|NCT05067335|101989911|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
33573326|NCT05067335|101989912|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
33635267|NCT03722238|102214810|FG000|Overall Study|Lost to Follow-up|6|||
33635268|NCT03722238|102214811|FG001|Overall Study|Lost to Follow-up|0|||
33635269|NCT03722238|102214810|FG000|Overall Study|Partial missing data|44|||
33367605|NCT00114972|101232659|FG001|Overall Study|Lost to Follow-up|5|||
33367606|NCT02750813|101232660|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
33635270|NCT03722238|102214811|FG001|Overall Study|Partial missing data|1|||
33635271|NCT03722238|102214810|FG000|Overall Study|Withdrawal by Subject|2|||
33635272|NCT03722238|102214811|FG001|Overall Study|Withdrawal by Subject|0|||
33635273|NCT03722238|102214810|FG000|Overall Study|Other|4|||
33635274|NCT03722238|102214811|FG001|Overall Study|Other|0|||
33635275|NCT03722238|102214810|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
33635276|NCT03722238|102214811|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
33635277|NCT03722238|102214810|FG000|Overall Study|Did not meet risk classification group criteria|90|||
33635278|NCT03722238|102214811|FG001|Overall Study|Did not meet risk classification group criteria|0|||
33635279|NCT03722238|102214810|FG000|Overall Study|Did not sign consent|17|||
33635280|NCT03722238|102214811|FG001|Overall Study|Did not sign consent|0|||
33635281|NCT03722238|102214810|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
33635282|NCT03722238|102214811|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
33635283|NCT03722238|102214810|FG000|Overall Study|Not willing to purchase study medication|142|||
33635284|NCT03722238|102214811|FG001|Overall Study|Not willing to purchase study medication|0|||
33635285|NCT03722238|102214810|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
33635286|NCT03722238|102214811|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
33635287|NCT00474487|102214812|FG000|Overall Study|Withdrawal by Subject|6|||
33635288|NCT00474487|102214813|FG001|Overall Study|Withdrawal by Subject|0|||
33635289|NCT00474487|102214814|FG002|Overall Study|Withdrawal by Subject|0|||
33635290|NCT00474487|102214815|FG003|Overall Study|Withdrawal by Subject|0|||
33635291|NCT00474487|102214812|FG000|Overall Study|Lost to Follow-up|20|||
33635292|NCT00474487|102214813|FG001|Overall Study|Lost to Follow-up|1|||
33635293|NCT00474487|102214814|FG002|Overall Study|Lost to Follow-up|7|||
33635294|NCT00474487|102214815|FG003|Overall Study|Lost to Follow-up|0|||
33635295|NCT00474487|102214812|FG000|Overall Study|Inappropriate enrollment|4|||
33635296|NCT00474487|102214813|FG001|Overall Study|Inappropriate enrollment|0|||
33367607|NCT02750813|101232661|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
33367608|NCT02750813|101232660|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
33367609|NCT02750813|101232661|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
33367610|NCT01954121|101232665|FG000|Overall Study|Lack of Efficacy|94|||
33635297|NCT00474487|102214814|FG002|Overall Study|Inappropriate enrollment|7|||
33635298|NCT00474487|102214815|FG003|Overall Study|Inappropriate enrollment|0|||
33635299|NCT00474487|102214812|FG000|Overall Study|Death|0|||
33635300|NCT00474487|102214813|FG001|Overall Study|Death|1|||
33367611|NCT01954121|101232666|FG001|Overall Study|Lack of Efficacy|41|||
33367612|NCT01954121|101232665|FG000|Overall Study|Protocol Violation|0|||
33635301|NCT00474487|102214814|FG002|Overall Study|Death|0|||
33635302|NCT00474487|102214815|FG003|Overall Study|Death|0|||
33635303|NCT05767749|102214816|FG000|Overall Study|Withdrawal by Subject|0|||
33367613|NCT01954121|101232666|FG001|Overall Study|Protocol Violation|2|||
33367614|NCT01954121|101232665|FG000|Overall Study|Lost to Follow-up|5|||
33367615|NCT01954121|101232666|FG001|Overall Study|Lost to Follow-up|6|||
33367616|NCT01954121|101232665|FG000|Overall Study|Withdrawal by Subject|18|||
33367617|NCT01954121|101232666|FG001|Overall Study|Withdrawal by Subject|12|||
33367618|NCT01954121|101232665|FG000|Overall Study|Pregnancy|1|||
33367619|NCT01954121|101232666|FG001|Overall Study|Pregnancy|1|||
33367620|NCT01954121|101232665|FG000|Overall Study|AE, serious fatal|1|||
33367621|NCT01954121|101232666|FG001|Overall Study|AE, serious fatal|0|||
33635304|NCT05767749|102214817|FG001|Overall Study|Withdrawal by Subject|0|||
33635305|NCT05767749|102214818|FG002|Overall Study|Withdrawal by Subject|2|||
33635306|NCT05767749|102214819|FG003|Overall Study|Withdrawal by Subject|2|||
33635307|NCT05767749|102214820|FG004|Overall Study|Withdrawal by Subject|2|||
33635308|NCT05767749|102214821|FG005|Overall Study|Withdrawal by Subject|2|||
33635309|NCT02939287|102214824|FG000|Overall Study|met exclusion criteria|1|||
33367622|NCT01954121|101232665|FG000|Overall Study|AE, non-serious non-fatal|5|||
33367623|NCT01954121|101232666|FG001|Overall Study|AE, non-serious non-fatal|22|||
33367624|NCT01954121|101232665|FG000|Overall Study|SAE, non-fatal|1|||
33367625|NCT01954121|101232666|FG001|Overall Study|SAE, non-fatal|4|||
33419511|NCT01220128|101425787|FG003|Overall Study|Other|0|||
33419512|NCT01220128|101425788|FG004|Overall Study|Other|0|||
33635310|NCT02939287|102214825|FG001|Overall Study|met exclusion criteria|1|||
33635311|NCT02939287|102214826|FG002|Overall Study|met exclusion criteria|1|||
33635312|NCT02939287|102214824|FG000|Overall Study|Did not complete survey|2|||
33635313|NCT02939287|102214825|FG001|Overall Study|Did not complete survey|2|||
33635314|NCT02939287|102214826|FG002|Overall Study|Did not complete survey|0|||
33573327|NCT05067335|101989909|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
33573328|NCT05067335|101989910|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
33573329|NCT05067335|101989911|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
33573330|NCT05067335|101989912|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
33573331|NCT05067335|101989909|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
33135831|NCT00545272|100413292|FG000|Overall Study|Protocol deviation|0|||
33135832|NCT00545272|100413293|FG001|Overall Study|Protocol deviation|1|||
33135833|NCT00545272|100413294|FG002|Overall Study|Protocol deviation|0|||
33135834|NCT00545272|100413295|FG003|Overall Study|Protocol deviation|1|||
33367626|NCT01954121|101232665|FG000|Overall Study|Non-compliant with study procedures|1|||
33367627|NCT01954121|101232666|FG001|Overall Study|Non-compliant with study procedures|0|||
33367628|NCT01954121|101232665|FG000|Overall Study|Non-compliant patient|1|||
33367629|NCT01954121|101232666|FG001|Overall Study|Non-compliant patient|1|||
33367630|NCT01954121|101232665|FG000|Overall Study|Subject did not follow instructions|0|||
33367631|NCT01954121|101232666|FG001|Overall Study|Subject did not follow instructions|2|||
33367632|NCT05301322|101232669|FG000|Overall Study|Adverse Event|7|||
33367633|NCT05301322|101232670|FG001|Overall Study|Adverse Event|3|||
33367634|NCT05301322|101232669|FG000|Overall Study|Death|0|||
33367635|NCT05301322|101232670|FG001|Overall Study|Death|1|||
33367636|NCT05301322|101232669|FG000|Overall Study|Lost to Follow-up|2|||
33367637|NCT05301322|101232670|FG001|Overall Study|Lost to Follow-up|1|||
33367638|NCT05301322|101232669|FG000|Overall Study|Protocol Violation|3|||
33367639|NCT05301322|101232670|FG001|Overall Study|Protocol Violation|1|||
33367640|NCT05301322|101232669|FG000|Overall Study|Withdrawal by Subject|3|||
33367641|NCT05301322|101232670|FG001|Overall Study|Withdrawal by Subject|0|||
33367642|NCT05301322|101232669|FG000|Overall Study|Other|4|||
33367643|NCT05301322|101232670|FG001|Overall Study|Other|0|||
33367644|NCT03123939|101232673|FG000|Overall Study|Lack of Efficacy|6|||
33367645|NCT03123939|101232673|FG000|Overall Study|Death|5|||
33367646|NCT03123939|101232673|FG000|Overall Study|Physician Decision|2|||
33367647|NCT03123939|101232673|FG000|Overall Study|Subject/guardian decision|2|||
33367648|NCT03123939|101232673|FG000|Overall Study|Lost to Follow-up|1|||
33367649|NCT03123939|101232673|FG000|Overall Study|New therapy for study indication|1|||
33367650|NCT03123939|101232673|FG000|Overall Study|Protocol deviation|1|||
33367651|NCT03123939|101232673|FG000|Overall Study|Progressive disease|18|||
33367652|NCT03123939|101232673|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
33367653|NCT03123939|101232673|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
33367654|NCT03345836|101232675|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
33367655|NCT03345836|101232676|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
33367656|NCT03345836|101232677|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
33367657|NCT03345836|101232678|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
33367658|NCT03345836|101232679|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
33367659|NCT03345836|101232680|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
33367660|NCT03345836|101232675|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
33367661|NCT03345836|101232676|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
33367662|NCT03345836|101232677|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
33367663|NCT03345836|101232678|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
33367664|NCT03345836|101232679|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
33367665|NCT03345836|101232680|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
33367666|NCT03345836|101232675|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
33367667|NCT03345836|101232676|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
33367668|NCT03345836|101232677|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
33135835|NCT00545272|100413296|FG004|Overall Study|Protocol deviation|0|||
33135836|NCT00545272|100413297|FG005|Overall Study|Protocol deviation|1|||
33135837|NCT00545272|100413292|FG000|Overall Study|Adverse Event|0|||
33367669|NCT03345836|101232678|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
33367670|NCT03345836|101232679|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
33367671|NCT03345836|101232680|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
33367672|NCT03345836|101232675|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
33367673|NCT03345836|101232676|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
33367674|NCT03345836|101232677|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
33367675|NCT03345836|101232678|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
33419513|NCT01220128|101425789|FG005|Overall Study|Other|0|||
33419514|NCT01220128|101425790|FG006|Overall Study|Other|0|||
33419515|NCT01220128|101425784|FG000|Overall Study|Consent withdrawn by subject|1|||
33419516|NCT01220128|101425785|FG001|Overall Study|Consent withdrawn by subject|0|||
33419517|NCT01220128|101425786|FG002|Overall Study|Consent withdrawn by subject|0|||
33419518|NCT01220128|101425787|FG003|Overall Study|Consent withdrawn by subject|0|||
33419519|NCT01220128|101425788|FG004|Overall Study|Consent withdrawn by subject|0|||
33573332|NCT05067335|101989910|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
33573333|NCT05067335|101989911|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
33573334|NCT05067335|101989912|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
33573335|NCT05067335|101989909|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
33635315|NCT02939287|102214824|FG000|Overall Study|Withdrawal by Subject|1|||
33635316|NCT02939287|102214825|FG001|Overall Study|Withdrawal by Subject|1|||
33635317|NCT02939287|102214826|FG002|Overall Study|Withdrawal by Subject|0|||
33635318|NCT01815918|102214827|FG000|Overall Study|Patient samples not analyzable|3|||
33573336|NCT05067335|101989910|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
33419520|NCT01220128|101425789|FG005|Overall Study|Consent withdrawn by subject|0|||
33419521|NCT01220128|101425790|FG006|Overall Study|Consent withdrawn by subject|0|||
33419522|NCT03911960|101425791|FG000|Overall Study|Lost to Follow-up|5|||
33573337|NCT05067335|101989911|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
33573338|NCT05067335|101989912|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
33573339|NCT05067335|101989909|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
33573340|NCT05067335|101989910|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
33573341|NCT05067335|101989911|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
33573342|NCT05067335|101989912|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
33573343|NCT05067335|101989909|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
33573344|NCT05067335|101989910|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
33573345|NCT05067335|101989911|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
33573346|NCT05067335|101989912|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
33573347|NCT05067335|101989909|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
33573348|NCT05067335|101989910|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
33573349|NCT05067335|101989911|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
33573350|NCT05067335|101989912|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
33573351|NCT02951780|101989913|FG000|Period 1|Adverse Event|0|||
33573352|NCT02951780|101989914|FG001|Period 1|Adverse Event|0|||
33573353|NCT02951780|101989915|FG002|Period 1|Adverse Event|0|||
33573354|NCT02951780|101989916|FG003|Period 1|Adverse Event|1|||
33573355|NCT02951780|101989917|FG004|Period 1|Adverse Event|0|||
33573356|NCT02951780|101989918|FG005|Period 1|Adverse Event|0|||
33573357|NCT02951780|101989919|FG006|Period 1|Adverse Event|0|||
33573358|NCT02951780|101989920|FG007|Period 1|Adverse Event|0|||
33573359|NCT02951780|101989921|FG008|Period 1|Adverse Event|0|||
33573360|NCT02951780|101989913|FG000|Period 1|Scheduling Conflicts|0|||
33573361|NCT02951780|101989914|FG001|Period 1|Scheduling Conflicts|0|||
33635319|NCT01815918|102214828|FG001|Overall Study|Patient samples not analyzable|4|||
33635320|NCT01815918|102214827|FG000|Overall Study|Lack of Efficacy|15|||
33635321|NCT01815918|102214828|FG001|Overall Study|Lack of Efficacy|15|||
33635322|NCT02923726|102214835|FG000|Overall Study|Death|196|||
33635323|NCT02923726|102214836|FG001|Overall Study|Death|175|||
33635324|NCT02923726|102214835|FG000|Overall Study|Withdrawal by Subject|337|||
33635325|NCT02923726|102214836|FG001|Overall Study|Withdrawal by Subject|307|||
33635326|NCT03938259|102214841|FG000|Overall Study|unable to establish baseline for ventilation|1|||
33635327|NCT03938259|102214842|FG001|Overall Study|unable to establish baseline for ventilation|1|||
33635328|NCT04139798|102214843|FG000|Overall Study|Withdrawal by Subject|6|||
33635329|NCT04139798|102214844|FG001|Overall Study|Withdrawal by Subject|5|||
33635330|NCT04139798|102214843|FG000|Overall Study|Lost to Follow-up|2|||
33635331|NCT04139798|102214844|FG001|Overall Study|Lost to Follow-up|5|||
33635332|NCT04139798|102214843|FG000|Overall Study|Discontinued|4|||
33635333|NCT04139798|102214844|FG001|Overall Study|Discontinued|2|||
33635334|NCT04139798|102214843|FG000|Overall Study|Adverse Event|1|||
33635335|NCT04139798|102214844|FG001|Overall Study|Adverse Event|3|||
33135838|NCT00545272|100413293|FG001|Overall Study|Adverse Event|0|||
33135839|NCT00545272|100413294|FG002|Overall Study|Adverse Event|1|||
33135840|NCT00545272|100413295|FG003|Overall Study|Adverse Event|0|||
33635336|NCT04139798|102214843|FG000|Overall Study|Protocol Violation|1|||
33635337|NCT04139798|102214844|FG001|Overall Study|Protocol Violation|0|||
33635338|NCT04201262|102214845|FG000|Overall Study|Adverse Event|1|||
33135841|NCT00545272|100413296|FG004|Overall Study|Adverse Event|0|||
33135842|NCT00545272|100413297|FG005|Overall Study|Adverse Event|1|||
33135843|NCT00545272|100413292|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33635339|NCT04201262|102214846|FG001|Overall Study|Adverse Event|2|||
33573362|NCT02951780|101989915|FG002|Period 1|Scheduling Conflicts|0|||
33573363|NCT02951780|101989916|FG003|Period 1|Scheduling Conflicts|0|||
33573364|NCT02951780|101989917|FG004|Period 1|Scheduling Conflicts|0|||
33573365|NCT02951780|101989918|FG005|Period 1|Scheduling Conflicts|0|||
33573366|NCT02951780|101989919|FG006|Period 1|Scheduling Conflicts|0|||
33573367|NCT02951780|101989920|FG007|Period 1|Scheduling Conflicts|1|||
33573368|NCT02951780|101989921|FG008|Period 1|Scheduling Conflicts|0|||
33573369|NCT02951780|101989913|FG000|Period 2|Scheduling Conflicts|0|||
33573370|NCT02951780|101989914|FG001|Period 2|Scheduling Conflicts|0|||
33573371|NCT02951780|101989915|FG002|Period 2|Scheduling Conflicts|0|||
33573372|NCT02951780|101989916|FG003|Period 2|Scheduling Conflicts|0|||
33573373|NCT02951780|101989917|FG004|Period 2|Scheduling Conflicts|0|||
33573374|NCT02951780|101989918|FG005|Period 2|Scheduling Conflicts|0|||
33635340|NCT04201262|102214845|FG000|Overall Study|Continuing in the study|57|||
33635341|NCT04201262|102214846|FG001|Overall Study|Continuing in the study|0|||
33635342|NCT04201262|102214845|FG000|Overall Study|Withdrawal by Subject|0|||
33635343|NCT04201262|102214846|FG001|Overall Study|Withdrawal by Subject|1|||
33635344|NCT00911170|102214847|FG000|Treatment Period|Randomized in error|1|||
33635345|NCT00911170|102214848|FG001|Treatment Period|Randomized in error|1|||
33635346|NCT00911170|102214847|FG000|Treatment Period|Ineligibility determined|1|||
33635347|NCT00911170|102214848|FG001|Treatment Period|Ineligibility determined|3|||
33635348|NCT00911170|102214847|FG000|Treatment Period|Protocol deviation|1|||
33635349|NCT00911170|102214848|FG001|Treatment Period|Protocol deviation|2|||
33635350|NCT00911170|102214847|FG000|Treatment Period|Adverse Event|9|||
33635351|NCT00911170|102214848|FG001|Treatment Period|Adverse Event|10|||
33635352|NCT00911170|102214847|FG000|Treatment Period|Withdrawal by Subject|4|||
33635353|NCT00911170|102214848|FG001|Treatment Period|Withdrawal by Subject|4|||
33635354|NCT00911170|102214847|FG000|Treatment Period|Disease progression|0|||
33635355|NCT00911170|102214848|FG001|Treatment Period|Disease progression|2|||
33635356|NCT00911170|102214847|FG000|Treatment Period|Physician Decision|5|||
33635357|NCT00911170|102214848|FG001|Treatment Period|Physician Decision|5|||
33635358|NCT00911170|102214847|FG000|Treatment Period|Lost to Follow-up|0|||
33635359|NCT00911170|102214848|FG001|Treatment Period|Lost to Follow-up|1|||
33635360|NCT00911170|102214847|FG000|Treatment Period|Death|6|||
33635361|NCT00911170|102214848|FG001|Treatment Period|Death|9|||
33635362|NCT00911170|102214847|FG000|Long Term Follow-Up|Continuing in study|274|||
33635363|NCT00911170|102214848|FG001|Long Term Follow-Up|Continuing in study|269|||
33635364|NCT00911170|102214847|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
33635365|NCT00911170|102214848|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
33635366|NCT00911170|102214847|FG000|Long Term Follow-Up|Physician Decision|5|||
33635367|NCT00911170|102214848|FG001|Long Term Follow-Up|Physician Decision|4|||
33635368|NCT00911170|102214847|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
33635369|NCT00911170|102214848|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
33635370|NCT00911170|102214847|FG000|Long Term Follow-Up|Death|116|||
33635371|NCT00911170|102214848|FG001|Long Term Follow-Up|Death|121|||
33635372|NCT02976038|102214850|FG000|Overall Study|Physician Decision|22|||
33635373|NCT02976038|102214850|FG000|Overall Study|Withdrawal by Subject|3|||
33635374|NCT02976038|102214850|FG000|Overall Study|Lost to Follow-up|2|||
33635375|NCT02976038|102214850|FG000|Overall Study|Adverse Event|1|||
33635376|NCT03780244|102214851|FG000|Overall Study|Lost to Follow-up|1|||
33635377|NCT03780244|102214852|FG001|Overall Study|Lost to Follow-up|0|||
33635378|NCT02612779|102218382|FG000|Overall Study|Administrative reason by sponsor|4|||
33635379|NCT02612779|102218383|FG001|Overall Study|Administrative reason by sponsor|1|||
33635380|NCT02612779|102218382|FG000|Overall Study|No longer meet study criteria|0|||
33635381|NCT02612779|102218383|FG001|Overall Study|No longer meet study criteria|1|||
33635382|NCT02612779|102218382|FG000|Overall Study|Disease progression|29|||
33635383|NCT02612779|102218383|FG001|Overall Study|Disease progression|2|||
33635384|NCT02612779|102218382|FG000|Overall Study|Study drug toxicity|10|||
33635385|NCT02612779|102218383|FG001|Overall Study|Study drug toxicity|1|||
33635386|NCT02612779|102218382|FG000|Overall Study|Death|1|||
33635387|NCT02612779|102218383|FG001|Overall Study|Death|0|||
33635388|NCT02612779|102218382|FG000|Overall Study|Adverse event unrelated to study drug|5|||
33635389|NCT02612779|102218383|FG001|Overall Study|Adverse event unrelated to study drug|0|||
33635390|NCT02612779|102218382|FG000|Overall Study|Participant withdrew consent|4|||
33635391|NCT02612779|102218383|FG001|Overall Study|Participant withdrew consent|0|||
33635392|NCT02612779|102218382|FG000|Overall Study|Lost to Follow-up|1|||
33635393|NCT02612779|102218383|FG001|Overall Study|Lost to Follow-up|0|||
33635394|NCT02612779|102218382|FG000|Overall Study|Maximum clinical benefit|10|||
33635395|NCT02612779|102218383|FG001|Overall Study|Maximum clinical benefit|1|||
33635396|NCT02612779|102218382|FG000|Overall Study|Other reasons|4|||
33230732|NCT02855164|100746289|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
33419523|NCT03911960|101425792|FG001|Overall Study|Lost to Follow-up|3|||
33573375|NCT02951780|101989919|FG006|Period 2|Scheduling Conflicts|0|||
33635397|NCT02612779|102218383|FG001|Overall Study|Other reasons|0|||
33635398|NCT02420821|102218384|FG000|Overall Study|Lost to Follow-up|6|||
33635399|NCT02420821|102218385|FG001|Overall Study|Lost to Follow-up|6|||
33635400|NCT02420821|102218384|FG000|Overall Study|Non-compliance|0|||
33573376|NCT02951780|101989920|FG007|Period 2|Scheduling Conflicts|1|||
33635401|NCT02420821|102218385|FG001|Overall Study|Non-compliance|2|||
33635402|NCT02420821|102218384|FG000|Overall Study|Physician Decision|6|||
33635403|NCT02420821|102218385|FG001|Overall Study|Physician Decision|2|||
33635404|NCT02420821|102218384|FG000|Overall Study|Withdrawal by Subject|32|||
33635405|NCT02420821|102218385|FG001|Overall Study|Withdrawal by Subject|25|||
33635406|NCT02420821|102218384|FG000|Overall Study|Death|270|||
33635407|NCT02420821|102218385|FG001|Overall Study|Death|263|||
33635408|NCT02420821|102218384|FG000|Overall Study|Study Terminated By Sponsor|145|||
33635409|NCT02420821|102218385|FG001|Overall Study|Study Terminated By Sponsor|149|||
33635410|NCT02420821|102218384|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
33635411|NCT02420821|102218385|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
33635412|NCT02420821|102218384|FG000|Overall Study|Adverse Event|0|||
33635413|NCT02420821|102218385|FG001|Overall Study|Adverse Event|1|||
33635414|NCT02420821|102218384|FG000|Overall Study|Protinuria|0|||
33635415|NCT02420821|102218385|FG001|Overall Study|Protinuria|1|||
33635416|NCT02420821|102218384|FG000|Overall Study|Progressive Disease|1|||
33635417|NCT02420821|102218385|FG001|Overall Study|Progressive Disease|1|||
33635418|NCT02420821|102218384|FG000|Overall Study|Disease Progression|0|||
33635419|NCT02420821|102218385|FG001|Overall Study|Disease Progression|1|||
33635420|NCT02420821|102218384|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
33635421|NCT02420821|102218385|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
33635422|NCT00887809|102218386|FG000|Overall Study|Patient Not Treated|3|||
33635423|NCT00887809|102218387|FG001|Overall Study|Patient Not Treated|0|||
33635424|NCT00887809|102218386|FG000|Overall Study|Death|1|||
33635425|NCT00887809|102218387|FG001|Overall Study|Death|0|||
33635426|NCT00538902|102218388|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
33635427|NCT00538902|102218389|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
33635428|NCT00538902|102218390|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
33635429|NCT00538902|102218388|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
33635430|NCT00538902|102218389|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
33635431|NCT00538902|102218390|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
33635432|NCT00538902|102218388|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
33635433|NCT00538902|102218389|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
33635434|NCT00538902|102218390|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
33635435|NCT00538902|102218388|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
33635436|NCT00538902|102218389|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
33635437|NCT00538902|102218390|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
33635438|NCT00538902|102218388|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
33635439|NCT00538902|102218389|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
33635440|NCT00538902|102218390|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
33635441|NCT00538902|102218388|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
33635442|NCT00538902|102218389|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
33635443|NCT00538902|102218390|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
33635444|NCT00538902|102218388|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
33635445|NCT00538902|102218389|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
33230733|NCT02855164|100746290|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
33230734|NCT02855164|100746283|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
33419524|NCT00545441|101425793|FG000|Overall Study|Fistula draining at 6 months|2|||
33419525|NCT00545441|101425794|FG001|Overall Study|Fistula draining at 6 months|4|||
33635446|NCT00538902|102218390|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
33635447|NCT00538902|102218388|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
33635448|NCT00538902|102218389|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
33635449|NCT00538902|102218390|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
33635450|NCT01959503|102218397|FG000|Overall Study|Death|2|||
33635451|NCT01959503|102218398|FG001|Overall Study|Death|1|||
33635452|NCT01959503|102218397|FG000|Overall Study|Randomized but not treated|1|||
33635453|NCT01959503|102218398|FG001|Overall Study|Randomized but not treated|1|||
33635454|NCT04798196|102218399|FG000|Overall Study|Lost to Follow-up|3|||
33635455|NCT04798196|102218400|FG001|Overall Study|Lost to Follow-up|1|||
33635456|NCT04798196|102218401|FG002|Overall Study|Lost to Follow-up|3|||
33135844|NCT00545272|100413293|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33135845|NCT00545272|100413294|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33635457|NCT03220035|102218402|FG000|Overall Study|Adverse Event|1|||
33635458|NCT03220035|102218402|FG000|Overall Study|Protocol Violation|1|||
33635459|NCT03220035|102218402|FG000|Overall Study|Progressive Disease|2|||
33230735|NCT02855164|100746284|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
33230736|NCT02855164|100746285|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
33419526|NCT00545441|101425793|FG000|Overall Study|Lost to Follow-up|9|||
33635460|NCT02952820|102218403|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
33635461|NCT02952820|102218404|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
33635462|NCT02952820|102218405|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
33230737|NCT02855164|100746286|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
33230738|NCT02855164|100746287|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
33230739|NCT02855164|100746288|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
33230740|NCT02855164|100746289|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
33230741|NCT02855164|100746290|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
33230742|NCT02855164|100746283|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
33135846|NCT00545272|100413295|FG003|Overall Study|Abnormal laboratory value(s)|0|||
33135847|NCT00545272|100413296|FG004|Overall Study|Abnormal laboratory value(s)|0|||
33135848|NCT00545272|100413297|FG005|Overall Study|Abnormal laboratory value(s)|1|||
33135849|NCT00545272|100413292|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33135850|NCT00545272|100413293|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33135851|NCT00545272|100413294|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33135852|NCT00545272|100413295|FG003|Overall Study|Abnormal test procedure result(s)|0|||
33135853|NCT00545272|100413296|FG004|Overall Study|Abnormal test procedure result(s)|1|||
33135854|NCT00545272|100413297|FG005|Overall Study|Abnormal test procedure result(s)|0|||
33135855|NCT00545272|100413292|FG000|Overall Study|Lost to Follow-up|0|||
33135856|NCT00545272|100413293|FG001|Overall Study|Lost to Follow-up|0|||
33135857|NCT00545272|100413294|FG002|Overall Study|Lost to Follow-up|0|||
33135858|NCT00545272|100413295|FG003|Overall Study|Lost to Follow-up|0|||
33135859|NCT00545272|100413296|FG004|Overall Study|Lost to Follow-up|1|||
33135860|NCT00545272|100413297|FG005|Overall Study|Lost to Follow-up|0|||
33135861|NCT02520089|100413306|FG000|Overall Study|Lost to Follow-up|3|||
33135862|NCT02520089|100413307|FG001|Overall Study|Lost to Follow-up|4|||
33135863|NCT02365233|100413308|FG000|Overall Study|IRB withheld the data|1|||
33135864|NCT02365233|100413309|FG001|Overall Study|IRB withheld the data|2|||
33135865|NCT02365233|100413310|FG002|Overall Study|IRB withheld the data|2|||
33135866|NCT03531632|100413316|FG000|Overall Study|Adverse Event|0|||
33135867|NCT03531632|100413317|FG001|Overall Study|Adverse Event|0|||
33135868|NCT03531632|100413318|FG002|Overall Study|Adverse Event|1|||
33135869|NCT03531632|100413316|FG000|Overall Study|Death|4|||
33135870|NCT03531632|100413317|FG001|Overall Study|Death|0|||
33135871|NCT03531632|100413318|FG002|Overall Study|Death|14|||
33135872|NCT03531632|100413316|FG000|Overall Study|Study Terminated|1|||
33135873|NCT03531632|100413317|FG001|Overall Study|Study Terminated|3|||
33135874|NCT03531632|100413318|FG002|Overall Study|Study Terminated|11|||
33135875|NCT01242813|100413319|FG000|Overall Study|Lost to Follow-up|2|||
33135876|NCT01395524|100413323|FG000|Overall Study|Non-compliance with study schedule|1|||
33135877|NCT01395524|100413324|FG001|Overall Study|Non-compliance with study schedule|0|||
33135878|NCT01395524|100413325|FG002|Overall Study|Non-compliance with study schedule|1|||
33135879|NCT01395524|100413323|FG000|Overall Study|Lost to Follow-up|3|||
33135880|NCT01395524|100413324|FG001|Overall Study|Lost to Follow-up|1|||
33135881|NCT01395524|100413325|FG002|Overall Study|Lost to Follow-up|1|||
33135882|NCT01395524|100413323|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
33135883|NCT01395524|100413324|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
33135884|NCT01395524|100413325|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
33135885|NCT01395524|100413323|FG000|Overall Study|Severe noncompliance with protocol|1|||
33135886|NCT01395524|100413324|FG001|Overall Study|Severe noncompliance with protocol|0|||
33135887|NCT01395524|100413325|FG002|Overall Study|Severe noncompliance with protocol|0|||
33135888|NCT01395524|100413323|FG000|Overall Study|Adverse Event|4|||
33135889|NCT01395524|100413324|FG001|Overall Study|Adverse Event|4|||
33135890|NCT01395524|100413325|FG002|Overall Study|Adverse Event|3|||
33135891|NCT01395524|100413323|FG000|Overall Study|Death|1|||
33135892|NCT01395524|100413324|FG001|Overall Study|Death|0|||
33135893|NCT01395524|100413325|FG002|Overall Study|Death|0|||
33135894|NCT01395524|100413323|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
33135895|NCT01395524|100413324|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
33135896|NCT01395524|100413325|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
33135897|NCT01395524|100413323|FG000|Overall Study|Withdrawal by Subject|4|||
33135898|NCT01395524|100413324|FG001|Overall Study|Withdrawal by Subject|8|||
33135899|NCT01395524|100413325|FG002|Overall Study|Withdrawal by Subject|8|||
33230743|NCT02855164|100746284|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
33230744|NCT02855164|100746285|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
33419527|NCT00545441|101425794|FG001|Overall Study|Lost to Follow-up|5|||
33635463|NCT02952820|102218403|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
33135900|NCT01395524|100413323|FG000|Overall Study|Did not receive treatment|1|||
33230745|NCT02855164|100746286|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
33230746|NCT02855164|100746287|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
33419528|NCT00545441|101425793|FG000|Overall Study|Technical failure|0|||
33135901|NCT01395524|100413324|FG001|Overall Study|Did not receive treatment|1|||
33135902|NCT01395524|100413325|FG002|Overall Study|Did not receive treatment|3|||
33135903|NCT01395524|100413323|FG000|Overall Study|Subject had spinal surgery|0|||
33135904|NCT01395524|100413324|FG001|Overall Study|Subject had spinal surgery|0|||
33135905|NCT01395524|100413325|FG002|Overall Study|Subject had spinal surgery|1|||
33135906|NCT00612105|100413326|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
33135907|NCT00612105|100413327|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
33135908|NCT00612105|100413326|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
33135909|NCT00612105|100413327|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
33135910|NCT00612105|100413326|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
33135911|NCT00612105|100413327|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
33135912|NCT00612105|100413326|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
33135913|NCT00612105|100413327|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
33135914|NCT00612105|100413326|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
33135915|NCT00612105|100413327|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
33135916|NCT00612105|100413326|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
33135917|NCT00612105|100413327|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
33135918|NCT00612105|100413326|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
33135919|NCT00612105|100413327|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
33135920|NCT00612105|100413326|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
33135921|NCT00612105|100413327|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
33135922|NCT00612105|100413326|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
33135923|NCT00612105|100413327|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
33135924|NCT00612105|100413326|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
33135925|NCT00612105|100413327|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
33135926|NCT00612105|100413326|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
33135927|NCT00612105|100413327|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
33135928|NCT00612105|100413326|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
33135929|NCT00612105|100413327|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
33135930|NCT00096356|100413328|FG000|Overall Study|Adverse Event|11|||
33135931|NCT00096356|100413329|FG001|Overall Study|Adverse Event|9|||
33135932|NCT00096356|100413328|FG000|Overall Study|Physician Decision|5|||
33135933|NCT00096356|100413329|FG001|Overall Study|Physician Decision|3|||
33135934|NCT00096356|100413328|FG000|Overall Study|Withdrawal by Subject|17|||
33135935|NCT00096356|100413329|FG001|Overall Study|Withdrawal by Subject|23|||
33135936|NCT00096356|100413328|FG000|Overall Study|Lack of Efficacy|1|||
33367676|NCT03345836|101232679|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
33419529|NCT00545441|101425794|FG001|Overall Study|Technical failure|1|||
33419530|NCT00545441|101425793|FG000|Overall Study|Withdrawal by Subject|1|||
33419531|NCT00545441|101425794|FG001|Overall Study|Withdrawal by Subject|1|||
33635464|NCT02952820|102218404|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
33635465|NCT02952820|102218405|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
33635466|NCT02952820|102218403|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
33635467|NCT02952820|102218404|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
33635468|NCT02952820|102218405|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
33635469|NCT02952820|102218403|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
33635470|NCT02952820|102218404|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
33635471|NCT02952820|102218405|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
33635472|NCT02952820|102218403|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
33635473|NCT02952820|102218404|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
33635474|NCT02952820|102218405|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
33635475|NCT02952820|102218403|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
33635476|NCT02952820|102218404|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
33635477|NCT02952820|102218405|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
33635478|NCT02952820|102218403|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
33635479|NCT02952820|102218404|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
33635480|NCT02952820|102218405|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
33635481|NCT02952820|102218403|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
33635482|NCT02952820|102218404|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
33635483|NCT02952820|102218405|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
33635484|NCT02952820|102218403|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
33635485|NCT02952820|102218404|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
33635486|NCT02952820|102218405|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
33635487|NCT02952820|102218403|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
33635488|NCT02952820|102218404|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
33635489|NCT02952820|102218405|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
33635490|NCT02952820|102218403|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
33419532|NCT00545441|101425793|FG000|Overall Study|Persistence or recurrence of fistula|5|||
33635491|NCT02952820|102218404|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
33635492|NCT02952820|102218405|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
33135937|NCT00096356|100413329|FG001|Overall Study|Lack of Efficacy|0|||
33135938|NCT00096356|100413328|FG000|Overall Study|multiple reasons|10|||
33135939|NCT00096356|100413329|FG001|Overall Study|multiple reasons|18|||
33135944|NCT01865552|100413334|FG000|Period 1|Adverse Event|1|||
33135945|NCT01865552|100413335|FG001|Period 1|Adverse Event|0|||
33135946|NCT01865552|100413336|FG002|Period 1|Adverse Event|0|||
33135947|NCT01865552|100413337|FG003|Period 1|Adverse Event|1|||
33135948|NCT01865552|100413338|FG004|Period 1|Adverse Event|1|||
33135949|NCT01865552|100413339|FG005|Period 1|Adverse Event|1|||
33135950|NCT01865552|100413334|FG000|Period 1|Pathological lab|0|||
33135951|NCT01865552|100413335|FG001|Period 1|Pathological lab|0|||
33135952|NCT01865552|100413336|FG002|Period 1|Pathological lab|0|||
33135953|NCT01865552|100413337|FG003|Period 1|Pathological lab|0|||
33135954|NCT01865552|100413338|FG004|Period 1|Pathological lab|1|||
33135955|NCT01865552|100413339|FG005|Period 1|Pathological lab|0|||
33135956|NCT01865552|100413334|FG000|Period 1|Other|0|||
33135957|NCT01865552|100413335|FG001|Period 1|Other|0|||
33135958|NCT01865552|100413336|FG002|Period 1|Other|0|||
33135959|NCT01865552|100413337|FG003|Period 1|Other|0|||
33135960|NCT01865552|100413338|FG004|Period 1|Other|1|||
33135961|NCT01865552|100413339|FG005|Period 1|Other|0|||
33230747|NCT02855164|100746288|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
33573377|NCT02951780|101989921|FG008|Period 2|Scheduling Conflicts|0|||
33573378|NCT03728933|101989927|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
33573379|NCT03728933|101989928|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33573380|NCT03728933|101989929|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
33573381|NCT03728933|101989927|FG000|Overall Study|Withdrawal by Subject|0|||
33573382|NCT03728933|101989928|FG001|Overall Study|Withdrawal by Subject|0|||
33573383|NCT03728933|101989929|FG002|Overall Study|Withdrawal by Subject|1|||
33573384|NCT03728933|101989927|FG000|Overall Study|Lost to Follow-up|0|||
33573385|NCT03728933|101989928|FG001|Overall Study|Lost to Follow-up|1|||
33573386|NCT03728933|101989929|FG002|Overall Study|Lost to Follow-up|0|||
33573387|NCT03728933|101989927|FG000|Overall Study|Adverse Event|1|||
33367677|NCT03345836|101232680|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
33367678|NCT03345836|101232675|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
33367679|NCT03345836|101232676|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
33367680|NCT03345836|101232677|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
33367681|NCT03345836|101232678|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
33367682|NCT03345836|101232679|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
33367683|NCT03345836|101232680|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
33367684|NCT03345836|101232675|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
33367685|NCT03345836|101232676|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
33367686|NCT03345836|101232677|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
33367687|NCT03345836|101232678|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
33367688|NCT03345836|101232679|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
33367689|NCT03345836|101232680|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
33367690|NCT03345836|101232675|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
33367691|NCT03345836|101232676|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
33367692|NCT03345836|101232677|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
33367693|NCT03345836|101232678|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
33367694|NCT03345836|101232679|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
33367695|NCT03345836|101232680|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
33367696|NCT03345836|101232675|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
33367697|NCT03345836|101232676|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
33367698|NCT03345836|101232677|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
33367699|NCT03345836|101232678|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
33367700|NCT03345836|101232679|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
33367701|NCT03345836|101232680|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
33367702|NCT03345836|101232675|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
33367703|NCT03345836|101232676|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
33367704|NCT03345836|101232677|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
33573388|NCT03728933|101989928|FG001|Overall Study|Adverse Event|0|||
33367705|NCT03345836|101232678|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
33573389|NCT03728933|101989929|FG002|Overall Study|Adverse Event|0|||
33230748|NCT02855164|100746289|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
33230749|NCT02855164|100746290|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
33573390|NCT01935947|101989930|FG000|Overall Study|Adverse Event|0|||
33573391|NCT01935947|101989931|FG001|Overall Study|Adverse Event|2|||
33573392|NCT01935947|101989932|FG002|Overall Study|Adverse Event|0|||
33635493|NCT02952820|102218403|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
33635494|NCT02952820|102218404|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
33635495|NCT02952820|102218405|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
33635496|NCT02952820|102218403|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
33635497|NCT02952820|102218404|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
33635498|NCT02952820|102218405|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
33573393|NCT01935947|101989930|FG000|Overall Study|Diease Progression|2|||
33419533|NCT00545441|101425794|FG001|Overall Study|Persistence or recurrence of fistula|2|||
33419534|NCT00545441|101425793|FG000|Overall Study|Patients were not treated|1|||
33419535|NCT00545441|101425794|FG001|Overall Study|Patients were not treated|3|||
33419536|NCT00883740|101425795|FG000|First Intervention|Lost to Follow-up|1|||
33573394|NCT01935947|101989931|FG001|Overall Study|Diease Progression|2|||
33635499|NCT02952820|102218403|FG000|Active Treatment Period (6 Months)|Not treated|0|||
33635500|NCT02952820|102218404|FG001|Active Treatment Period (6 Months)|Not treated|0|||
33635501|NCT02952820|102218405|FG002|Active Treatment Period (6 Months)|Not treated|1|||
33635502|NCT00371150|102218410|FG000|Overall Study|Lost to Follow-up|3|||
33230750|NCT02855164|100746283|FG000|Part C (Randomized Set)|Adverse Event|0|||
33230751|NCT02855164|100746284|FG001|Part C (Randomized Set)|Adverse Event|0|||
33230752|NCT02855164|100746285|FG002|Part C (Randomized Set)|Adverse Event|0|||
33230753|NCT02855164|100746286|FG003|Part C (Randomized Set)|Adverse Event|0|||
33230754|NCT02855164|100746287|FG004|Part C (Randomized Set)|Adverse Event|0|||
33230755|NCT02855164|100746288|FG005|Part C (Randomized Set)|Adverse Event|5|||
33230756|NCT02855164|100746289|FG006|Part C (Randomized Set)|Adverse Event|9|||
33230757|NCT02855164|100746290|FG007|Part C (Randomized Set)|Adverse Event|2|||
33573395|NCT01935947|101989932|FG002|Overall Study|Diease Progression|2|||
33573396|NCT01935947|101989930|FG000|Overall Study|Death|1|||
33573397|NCT01935947|101989931|FG001|Overall Study|Death|0|||
33573398|NCT01935947|101989932|FG002|Overall Study|Death|0|||
33573399|NCT02834819|101989945|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
33573400|NCT02834819|101989946|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
33573401|NCT00060944|101989949|FG000|Overall Study|Adverse Event|12|||
33573402|NCT00060944|101989950|FG001|Overall Study|Adverse Event|10|||
33573403|NCT00060944|101989949|FG000|Overall Study|Death|2|||
33573404|NCT00060944|101989950|FG001|Overall Study|Death|3|||
33573405|NCT00060944|101989949|FG000|Overall Study|Withdrawal by Subject|18|||
33573406|NCT00060944|101989950|FG001|Overall Study|Withdrawal by Subject|5|||
33573407|NCT00060944|101989949|FG000|Overall Study|Disease Progression|93|||
33573408|NCT00060944|101989950|FG001|Overall Study|Disease Progression|94|||
33573409|NCT00060944|101989949|FG000|Overall Study|Lost to Follow-up|1|||
33573410|NCT00060944|101989950|FG001|Overall Study|Lost to Follow-up|0|||
33573411|NCT00060944|101989949|FG000|Overall Study|Subject Ineligible To Continue|2|||
33573412|NCT00060944|101989950|FG001|Overall Study|Subject Ineligible To Continue|1|||
33573413|NCT00060944|101989949|FG000|Overall Study|Treatment Switch|0|||
33573414|NCT00060944|101989950|FG001|Overall Study|Treatment Switch|13|||
33573415|NCT00060944|101989949|FG000|Overall Study|Other|2|||
33573416|NCT00060944|101989950|FG001|Overall Study|Other|4|||
33573417|NCT00060944|101989949|FG000|Overall Study|randomized but not treated|6|||
33573418|NCT00060944|101989950|FG001|Overall Study|randomized but not treated|4|||
33573419|NCT02536664|101989951|FG000|Overall Study|Inadequate completion of documentation|2|||
33230758|NCT02855164|100746283|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
33230759|NCT02855164|100746284|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
33573420|NCT02536664|101989952|FG001|Overall Study|Inadequate completion of documentation|4|||
33573421|NCT02536664|101989951|FG000|Overall Study|Progression|13|||
33635503|NCT00371150|102218411|FG001|Overall Study|Lost to Follow-up|2|||
33635504|NCT00744497|102218416|FG000|Overall Study|Withdrawal by Subject|21|||
33635505|NCT00744497|102218417|FG001|Overall Study|Withdrawal by Subject|18|||
33635506|NCT00744497|102218416|FG000|Overall Study|Death|11|||
33635507|NCT00744497|102218417|FG001|Overall Study|Death|9|||
33635508|NCT00744497|102218416|FG000|Overall Study|Lost to Follow-up|4|||
33635509|NCT00744497|102218417|FG001|Overall Study|Lost to Follow-up|2|||
33635510|NCT00744497|102218416|FG000|Overall Study|Poor compliance/noncompliance|9|||
33635511|NCT00744497|102218417|FG001|Overall Study|Poor compliance/noncompliance|5|||
33635512|NCT00744497|102218416|FG000|Overall Study|No longer meets study criteria|7|||
33635513|NCT00744497|102218417|FG001|Overall Study|No longer meets study criteria|3|||
33635514|NCT00744497|102218416|FG000|Overall Study|Administrative Reason By Sponsor|25|||
33635515|NCT00744497|102218417|FG001|Overall Study|Administrative Reason By Sponsor|8|||
33635516|NCT00744497|102218416|FG000|Overall Study|Disease progression|312|||
33635517|NCT00744497|102218417|FG001|Overall Study|Disease progression|219|||
33573422|NCT02536664|101989952|FG001|Overall Study|Progression|18|||
33573423|NCT02536664|101989951|FG000|Overall Study|Death due to lymphoma|2|||
33573424|NCT02536664|101989952|FG001|Overall Study|Death due to lymphoma|1|||
33573425|NCT02536664|101989951|FG000|Overall Study|Death due to other reason|3|||
33573426|NCT02536664|101989952|FG001|Overall Study|Death due to other reason|2|||
33573427|NCT02536664|101989951|FG000|Overall Study|Intolerability|8|||
33573428|NCT02536664|101989952|FG001|Overall Study|Intolerability|6|||
33573429|NCT02536664|101989951|FG000|Overall Study|Withdrawal by Subject|8|||
33573430|NCT02536664|101989952|FG001|Overall Study|Withdrawal by Subject|5|||
33573431|NCT02536664|101989951|FG000|Overall Study|Other|18|||
33573432|NCT02536664|101989952|FG001|Overall Study|Other|24|||
33573433|NCT02536664|101989951|FG000|Overall Study|Missing|53|||
33573434|NCT02536664|101989952|FG001|Overall Study|Missing|20|||
33573435|NCT02835690|101989953|FG000|Overall Study|Death|12|||
33573436|NCT02835690|101989954|FG001|Overall Study|Death|11|||
33573437|NCT02835690|101989955|FG002|Overall Study|Death|13|||
33573438|NCT02835690|101989953|FG000|Overall Study|Transferred to Extension Study|2|||
33573439|NCT02835690|101989954|FG001|Overall Study|Transferred to Extension Study|2|||
33573440|NCT02835690|101989955|FG002|Overall Study|Transferred to Extension Study|1|||
33573441|NCT02835690|101989953|FG000|Overall Study|Did Not Continue on Extension Study|0|||
33573442|NCT02835690|101989954|FG001|Overall Study|Did Not Continue on Extension Study|0|||
33573443|NCT02835690|101989955|FG002|Overall Study|Did Not Continue on Extension Study|1|||
33573444|NCT02835690|101989953|FG000|Overall Study|Not Treated|0|||
33573445|NCT02835690|101989954|FG001|Overall Study|Not Treated|2|||
33573446|NCT02835690|101989955|FG002|Overall Study|Not Treated|0|||
33573447|NCT00716274|101989956|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
33573448|NCT00716274|101989957|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
33573449|NCT00716274|101989958|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
33573450|NCT00716274|101989959|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
33573451|NCT00716274|101989960|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
33573452|NCT00716274|101989961|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
33573453|NCT00716274|101989956|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
33573454|NCT00716274|101989957|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
33635518|NCT00744497|102218416|FG000|Overall Study|Study drug toxicity|68|||
33573455|NCT00716274|101989958|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
33573456|NCT00716274|101989959|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
33635519|NCT00744497|102218417|FG001|Overall Study|Study drug toxicity|141|||
33635520|NCT00744497|102218416|FG000|Overall Study|Adverse event unrelated to study drug|78|||
33635521|NCT00744497|102218417|FG001|Overall Study|Adverse event unrelated to study drug|122|||
33635522|NCT00744497|102218416|FG000|Overall Study|Patient requested to stop study drug|65|||
33635523|NCT00744497|102218417|FG001|Overall Study|Patient requested to stop study drug|80|||
33230760|NCT02855164|100746285|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
33230761|NCT02855164|100746286|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
33573457|NCT00716274|101989960|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
33573458|NCT00716274|101989961|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
33230762|NCT02855164|100746287|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
33573459|NCT00716274|101989956|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
33230763|NCT02855164|100746288|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
33230764|NCT02855164|100746289|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
33419537|NCT00883740|101425796|FG001|First Intervention|Lost to Follow-up|0|||
33573460|NCT00716274|101989957|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
33573461|NCT00716274|101989958|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
33573462|NCT00716274|101989959|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
33573463|NCT00716274|101989960|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
33573464|NCT00716274|101989961|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
33573465|NCT00716274|101989956|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
33573466|NCT00716274|101989957|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
33573467|NCT00716274|101989958|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
33573468|NCT00716274|101989959|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
33573469|NCT00716274|101989960|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
33573470|NCT00716274|101989961|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
33573471|NCT00716274|101989956|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
33573472|NCT00716274|101989957|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
33573473|NCT00716274|101989958|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
33573474|NCT00716274|101989959|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
33573475|NCT00716274|101989960|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
33573476|NCT00716274|101989961|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
33573477|NCT00716274|101989956|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
33573478|NCT00716274|101989957|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
33573479|NCT00716274|101989958|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
33573480|NCT00716274|101989959|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
33573481|NCT00716274|101989960|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
33573482|NCT00716274|101989961|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
33573483|NCT00716274|101989956|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
33573484|NCT00716274|101989957|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
33573485|NCT00716274|101989958|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
33573486|NCT00716274|101989959|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
33573487|NCT00716274|101989960|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
33573488|NCT00716274|101989961|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
33573489|NCT00716274|101989956|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
33573490|NCT00716274|101989957|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
33573491|NCT00716274|101989958|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
33573492|NCT00716274|101989959|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
33573493|NCT00716274|101989960|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
33573494|NCT00716274|101989961|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
33573495|NCT00716274|101989956|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
33573496|NCT00716274|101989957|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
33573497|NCT00716274|101989958|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
33367706|NCT03345836|101232679|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
33635524|NCT00744497|102218416|FG000|Overall Study|Maximum clinical benefit|141|||
33635525|NCT00744497|102218417|FG001|Overall Study|Maximum clinical benefit|142|||
33635526|NCT00744497|102218416|FG000|Overall Study|Not defined|19|||
33635527|NCT00744497|102218417|FG001|Overall Study|Not defined|13|||
33635528|NCT04467905|102218420|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
33635529|NCT04467905|102218421|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
33635530|NCT04467905|102218422|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
33635531|NCT04467905|102218420|FG000|Overall Study|Conversion to SR|0|||
33136121|NCT01410357|100413397|FG000|Overall Study|Death|2|||
33136122|NCT01410357|100413398|FG001|Overall Study|Death|1|||
33136123|NCT01410357|100413397|FG000|Overall Study|Withdrawal by Subject|1|||
33136124|NCT01410357|100413398|FG001|Overall Study|Withdrawal by Subject|2|||
33136125|NCT01410357|100413397|FG000|Overall Study|Lost to Follow-up|23|||
33136126|NCT01410357|100413398|FG001|Overall Study|Lost to Follow-up|21|||
33136130|NCT01128621|100413402|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
33136131|NCT01128621|100413403|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
33136132|NCT00065429|100413405|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
33136133|NCT00065429|100413406|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
33136134|NCT00065429|100413407|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
33136135|NCT00065429|100413408|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
33136136|NCT00065429|100413409|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
33136137|NCT00065429|100413410|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
33136138|NCT00065429|100413411|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
33136139|NCT00065429|100413405|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
33136140|NCT00065429|100413406|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
33136141|NCT00065429|100413407|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
33136142|NCT00065429|100413408|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
33136143|NCT00065429|100413409|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
33136144|NCT00065429|100413410|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
33136145|NCT00065429|100413411|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
33136146|NCT00065429|100413405|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
33136147|NCT00065429|100413406|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
33136148|NCT00065429|100413407|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
33136149|NCT00065429|100413408|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
33230765|NCT02855164|100746290|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
33230766|NCT02855164|100746283|FG000|Part C (Randomized Set)|Physician Decision|0|||
33230767|NCT02855164|100746284|FG001|Part C (Randomized Set)|Physician Decision|0|||
33230768|NCT02855164|100746285|FG002|Part C (Randomized Set)|Physician Decision|0|||
33230769|NCT02855164|100746286|FG003|Part C (Randomized Set)|Physician Decision|0|||
33230770|NCT02855164|100746287|FG004|Part C (Randomized Set)|Physician Decision|0|||
33230771|NCT02855164|100746288|FG005|Part C (Randomized Set)|Physician Decision|1|||
33230772|NCT02855164|100746289|FG006|Part C (Randomized Set)|Physician Decision|0|||
33367707|NCT03345836|101232680|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
33230773|NCT02855164|100746290|FG007|Part C (Randomized Set)|Physician Decision|1|||
33230774|NCT02855164|100746283|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
33230775|NCT02855164|100746284|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
33230776|NCT02855164|100746285|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
33419538|NCT00883740|101425795|FG000|First Intervention|No longer willing to participate|2|||
33573498|NCT00716274|101989959|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
33573499|NCT00716274|101989960|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
33635532|NCT04467905|102218421|FG001|Overall Study|Conversion to SR|0|||
33635533|NCT04467905|102218422|FG002|Overall Study|Conversion to SR|3|||
33635534|NCT04467905|102218420|FG000|Overall Study|Technical issue with Holter ECG|0|||
33635535|NCT04467905|102218421|FG001|Overall Study|Technical issue with Holter ECG|0|||
33635536|NCT04467905|102218422|FG002|Overall Study|Technical issue with Holter ECG|3|||
33635537|NCT04467905|102218420|FG000|Overall Study|Hemodynamic instability|0|||
33635538|NCT04467905|102218421|FG001|Overall Study|Hemodynamic instability|0|||
33635539|NCT04467905|102218422|FG002|Overall Study|Hemodynamic instability|1|||
33635540|NCT04467905|102218420|FG000|Overall Study|Site misinterpretation of protocol|0|||
33635541|NCT04467905|102218421|FG001|Overall Study|Site misinterpretation of protocol|0|||
33635542|NCT04467905|102218422|FG002|Overall Study|Site misinterpretation of protocol|1|||
33635543|NCT03829228|102218423|FG000|Overall Study|Protocol Violation|1|||
33635544|NCT00091949|102218427|FG000|Overall Study|Withdrawal by Subject|117|||
33635545|NCT00091949|102218428|FG001|Overall Study|Withdrawal by Subject|110|||
33635546|NCT00091949|102218427|FG000|Overall Study|Lost to Follow-up|58|||
33635547|NCT00091949|102218428|FG001|Overall Study|Lost to Follow-up|41|||
33635548|NCT03525678|102218429|FG000|Overall Study|Withdrawal by Subject|8|||
33635549|NCT03525678|102218430|FG001|Overall Study|Withdrawal by Subject|2|||
33635550|NCT03525678|102218431|FG002|Overall Study|Withdrawal by Subject|2|||
33635551|NCT03525678|102218429|FG000|Overall Study|Physician Decision|2|||
33635552|NCT03525678|102218430|FG001|Overall Study|Physician Decision|4|||
33635553|NCT03525678|102218431|FG002|Overall Study|Physician Decision|0|||
33635554|NCT03525678|102218429|FG000|Overall Study|Lost to Follow-up|2|||
33635555|NCT03525678|102218430|FG001|Overall Study|Lost to Follow-up|1|||
33635556|NCT03525678|102218431|FG002|Overall Study|Lost to Follow-up|2|||
33635557|NCT03525678|102218429|FG000|Overall Study|Death|70|||
33635558|NCT03525678|102218430|FG001|Overall Study|Death|80|||
33635559|NCT03525678|102218431|FG002|Overall Study|Death|16|||
33635560|NCT03525678|102218429|FG000|Overall Study|other reasons|14|||
33635561|NCT03525678|102218430|FG001|Overall Study|other reasons|10|||
33635562|NCT03525678|102218431|FG002|Overall Study|other reasons|5|||
33635563|NCT03525678|102218429|FG000|Overall Study|ongoing at the time of analysis|1|||
33635564|NCT03525678|102218430|FG001|Overall Study|ongoing at the time of analysis|2|||
33635565|NCT03525678|102218431|FG002|Overall Study|ongoing at the time of analysis|0|||
33635566|NCT00174187|102218433|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
33635567|NCT00174187|102218434|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
33635568|NCT00174187|102218435|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
33635569|NCT00174187|102218433|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
33635570|NCT00174187|102218434|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
33136150|NCT00065429|100413409|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
33136151|NCT00065429|100413410|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
33136152|NCT00065429|100413411|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
33136153|NCT00065429|100413405|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
33136154|NCT00065429|100413406|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
33573500|NCT00716274|101989961|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
33573501|NCT00716274|101989956|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
33573502|NCT00716274|101989957|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
33573503|NCT00716274|101989958|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
33573504|NCT00716274|101989959|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
33573505|NCT00716274|101989960|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
33573506|NCT00716274|101989961|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
33573507|NCT01729039|101989962|FG000|Overall Study|disqualified|2|||
33573508|NCT01729039|101989963|FG001|Overall Study|disqualified|5|||
33136155|NCT00065429|100413407|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
33136156|NCT00065429|100413408|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
33136157|NCT00065429|100413409|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
33136158|NCT00065429|100413410|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
33136159|NCT00065429|100413411|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
33136160|NCT00065429|100413405|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
33136161|NCT00065429|100413406|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
33136162|NCT00065429|100413407|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
33136163|NCT00065429|100413408|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
33136164|NCT00065429|100413409|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
33136165|NCT00065429|100413410|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
33367708|NCT03345836|101232675|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
33573509|NCT01729039|101989962|FG000|Overall Study|Withdrawal by Subject|8|||
33573510|NCT01729039|101989963|FG001|Overall Study|Withdrawal by Subject|7|||
33635571|NCT00174187|102218435|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
33635572|NCT00174187|102218433|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
33635573|NCT00174187|102218434|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
33635574|NCT00174187|102218435|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
33635575|NCT00174187|102218433|FG000|Period 1 (up to 3 Years)|Other|0|||
33136166|NCT00065429|100413411|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
33136167|NCT00065429|100413405|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
33573511|NCT02553629|101989964|FG000|Overall Study|Logistic reasons|3|||
33136168|NCT00065429|100413406|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
33136169|NCT00065429|100413407|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
33136170|NCT00065429|100413408|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
33136171|NCT00065429|100413409|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
33136172|NCT00065429|100413410|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
33136173|NCT00065429|100413411|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
33136174|NCT00065429|100413405|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
33136175|NCT00065429|100413406|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
33136176|NCT00065429|100413407|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
33136177|NCT00065429|100413408|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
33136178|NCT00065429|100413409|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
33136179|NCT00065429|100413410|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
33136180|NCT00065429|100413411|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
33136181|NCT02855541|100413412|FG000|Overall Study|Change in health status|2|||
33136182|NCT02855541|100413412|FG000|Overall Study|Withdrawal by Subject|2|||
33136183|NCT03595618|100413413|FG000|Overall Study|Adverse Event|16|||
33136184|NCT03595618|100413414|FG001|Overall Study|Adverse Event|17|||
33136185|NCT03595618|100413415|FG002|Overall Study|Adverse Event|20|||
33136186|NCT03595618|100413416|FG003|Overall Study|Adverse Event|8|||
33136187|NCT03595618|100413413|FG000|Overall Study|Withdrawal by Subject|12|||
33136188|NCT03595618|100413414|FG001|Overall Study|Withdrawal by Subject|14|||
33136189|NCT03595618|100413415|FG002|Overall Study|Withdrawal by Subject|14|||
33136190|NCT03595618|100413416|FG003|Overall Study|Withdrawal by Subject|10|||
33136191|NCT03595618|100413413|FG000|Overall Study|Lost to Follow-up|6|||
33136192|NCT03595618|100413414|FG001|Overall Study|Lost to Follow-up|4|||
33136193|NCT03595618|100413415|FG002|Overall Study|Lost to Follow-up|5|||
33136194|NCT03595618|100413416|FG003|Overall Study|Lost to Follow-up|6|||
33136195|NCT03595618|100413413|FG000|Overall Study|Protocol Violation|2|||
33136196|NCT03595618|100413414|FG001|Overall Study|Protocol Violation|0|||
33136197|NCT03595618|100413415|FG002|Overall Study|Protocol Violation|6|||
33136198|NCT03595618|100413416|FG003|Overall Study|Protocol Violation|2|||
33136199|NCT03595618|100413413|FG000|Overall Study|Physician Decision|0|||
33136200|NCT03595618|100413414|FG001|Overall Study|Physician Decision|0|||
33230777|NCT02855164|100746286|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
33230778|NCT02855164|100746287|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
33573512|NCT02553629|101989965|FG001|Overall Study|Logistic reasons|6|||
33573513|NCT01882465|101989967|FG000|Period 1|Lens Discomfort|0|||
33573514|NCT01882465|101989968|FG001|Period 1|Lens Discomfort|0|||
33573515|NCT01882465|101989969|FG002|Period 1|Lens Discomfort|0|||
33573516|NCT01882465|101989970|FG003|Period 1|Lens Discomfort|1|||
33573517|NCT01882465|101989971|FG004|Period 1|Lens Discomfort|0|||
33573518|NCT01882465|101989972|FG005|Period 1|Lens Discomfort|0|||
33136201|NCT03595618|100413415|FG002|Overall Study|Physician Decision|1|||
33136202|NCT03595618|100413416|FG003|Overall Study|Physician Decision|2|||
33573519|NCT01882465|101989973|FG006|Period 1|Lens Discomfort|0|||
33573520|NCT01882465|101989967|FG000|Period 1|Withdrawal by Subject|0|||
33573521|NCT01882465|101989968|FG001|Period 1|Withdrawal by Subject|0|||
33573522|NCT01882465|101989969|FG002|Period 1|Withdrawal by Subject|0|||
33573523|NCT01882465|101989970|FG003|Period 1|Withdrawal by Subject|0|||
33573524|NCT01882465|101989971|FG004|Period 1|Withdrawal by Subject|0|||
33573525|NCT01882465|101989972|FG005|Period 1|Withdrawal by Subject|0|||
33573526|NCT01882465|101989973|FG006|Period 1|Withdrawal by Subject|1|||
33573527|NCT01882465|101989967|FG000|Period 2|Protocol Violation|0|||
33573528|NCT01882465|101989968|FG001|Period 2|Protocol Violation|0|||
33573529|NCT01882465|101989969|FG002|Period 2|Protocol Violation|0|||
33573530|NCT01882465|101989970|FG003|Period 2|Protocol Violation|0|||
33573531|NCT01882465|101989971|FG004|Period 2|Protocol Violation|1|||
33573532|NCT01882465|101989972|FG005|Period 2|Protocol Violation|0|||
33573533|NCT01882465|101989973|FG006|Period 2|Protocol Violation|0|||
33573534|NCT02286895|101989976|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
33573535|NCT02286895|101989977|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
33573536|NCT02286895|101989976|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
33573537|NCT02286895|101989977|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
33573538|NCT02286895|101989976|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
33573539|NCT02286895|101989977|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
33136203|NCT03595618|100413413|FG000|Overall Study|Miscellaneous|7|||
33136204|NCT03595618|100413414|FG001|Overall Study|Miscellaneous|5|||
33136205|NCT03595618|100413415|FG002|Overall Study|Miscellaneous|10|||
33136206|NCT03595618|100413416|FG003|Overall Study|Miscellaneous|6|||
33136207|NCT00913458|100413417|FG000|Phase 1|Non-Responder|54|||
33136208|NCT00913458|100413418|FG001|Phase 1|Non-Responder|0|||
33136209|NCT00913458|100413419|FG002|Phase 1|Non-Responder|0|||
33573540|NCT02569853|101989978|FG000|Overall Study|Adverse Event|2|||
33573541|NCT02569853|101989979|FG001|Overall Study|Adverse Event|0|||
33573542|NCT02569853|101989978|FG000|Overall Study|Withdrawal by Subject|3|||
33136210|NCT00913458|100413420|FG003|Phase 1|Non-Responder|0|||
33136211|NCT00913458|100413421|FG004|Phase 1|Non-Responder|0|||
33573543|NCT02569853|101989979|FG001|Overall Study|Withdrawal by Subject|2|||
33136212|NCT00913458|100413422|FG005|Phase 1|Non-Responder|0|||
33136213|NCT00913458|100413423|FG006|Phase 1|Non-Responder|0|||
33136214|NCT00913458|100413417|FG000|Phase 1|Subject Request|17|||
33136215|NCT00913458|100413418|FG001|Phase 1|Subject Request|0|||
33136216|NCT00913458|100413419|FG002|Phase 1|Subject Request|0|||
33136217|NCT00913458|100413420|FG003|Phase 1|Subject Request|0|||
33136218|NCT00913458|100413421|FG004|Phase 1|Subject Request|0|||
33136219|NCT00913458|100413422|FG005|Phase 1|Subject Request|0|||
33136220|NCT00913458|100413423|FG006|Phase 1|Subject Request|0|||
33136221|NCT00913458|100413417|FG000|Phase 1|Adverse Event|20|||
33136222|NCT00913458|100413418|FG001|Phase 1|Adverse Event|0|||
33136223|NCT00913458|100413419|FG002|Phase 1|Adverse Event|0|||
33136224|NCT00913458|100413420|FG003|Phase 1|Adverse Event|0|||
33136225|NCT00913458|100413421|FG004|Phase 1|Adverse Event|0|||
33136226|NCT00913458|100413422|FG005|Phase 1|Adverse Event|0|||
33136227|NCT00913458|100413423|FG006|Phase 1|Adverse Event|0|||
33136228|NCT00913458|100413417|FG000|Phase 1|Lost to Follow-up|2|||
33136229|NCT00913458|100413418|FG001|Phase 1|Lost to Follow-up|0|||
33573544|NCT02569853|101989978|FG000|Overall Study|Lost to Follow-up|3|||
33573545|NCT02569853|101989979|FG001|Overall Study|Lost to Follow-up|3|||
33573546|NCT02569853|101989978|FG000|Overall Study|Protocol Violation|1|||
33136230|NCT00913458|100413419|FG002|Phase 1|Lost to Follow-up|0|||
33136231|NCT00913458|100413420|FG003|Phase 1|Lost to Follow-up|0|||
33136232|NCT00913458|100413421|FG004|Phase 1|Lost to Follow-up|0|||
33136233|NCT00913458|100413422|FG005|Phase 1|Lost to Follow-up|0|||
33573547|NCT02569853|101989979|FG001|Overall Study|Protocol Violation|1|||
33573548|NCT02569853|101989978|FG000|Overall Study|Did not experience migraine attack|10|||
33573549|NCT02569853|101989979|FG001|Overall Study|Did not experience migraine attack|7|||
33136234|NCT00913458|100413423|FG006|Phase 1|Lost to Follow-up|0|||
33136235|NCT00913458|100413417|FG000|Phase 1|Protocol Violation|10|||
33136236|NCT00913458|100413418|FG001|Phase 1|Protocol Violation|0|||
33136237|NCT00913458|100413419|FG002|Phase 1|Protocol Violation|0|||
33136238|NCT00913458|100413420|FG003|Phase 1|Protocol Violation|0|||
33136239|NCT00913458|100413421|FG004|Phase 1|Protocol Violation|0|||
33136240|NCT00913458|100413422|FG005|Phase 1|Protocol Violation|0|||
33136241|NCT00913458|100413423|FG006|Phase 1|Protocol Violation|0|||
33136242|NCT00913458|100413417|FG000|Phase 1|Sponsor|2|||
33136243|NCT00913458|100413418|FG001|Phase 1|Sponsor|0|||
33367709|NCT03345836|101232676|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
33367710|NCT03345836|101232677|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
33573550|NCT02569853|101989978|FG000|Overall Study|Physician Decision|1|||
33573551|NCT02569853|101989979|FG001|Overall Study|Physician Decision|1|||
33573552|NCT00904371|101989981|FG000|Overall Study|Adverse Event|2|||
33573553|NCT00904371|101989981|FG000|Overall Study|Lost to Follow-up|4|||
33573554|NCT00904371|101989981|FG000|Overall Study|Discontinued at target blood pressure|2|||
33573555|NCT00904371|101989981|FG000|Overall Study|Continued with Tritace|1|||
33573556|NCT00140140|101989982|FG000|Overall Study|Unacceptable toxicity|1|||
33573557|NCT00140140|101989983|FG001|Overall Study|Unacceptable toxicity|1|||
33573558|NCT00140140|101989984|FG002|Overall Study|Unacceptable toxicity|2|||
33573559|NCT00140140|101989982|FG000|Overall Study|Physician Decision|1|||
33573560|NCT00140140|101989983|FG001|Overall Study|Physician Decision|1|||
33573561|NCT00140140|101989984|FG002|Overall Study|Physician Decision|0|||
33573562|NCT02862574|101989985|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33573563|NCT02862574|101989986|FG001|Double-Blind Treatment Period|Adverse Event|1|||
33573564|NCT02862574|101989987|FG002|Double-Blind Treatment Period|Adverse Event|0|||
33573565|NCT02862574|101989985|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
33573566|NCT02862574|101989986|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
33573567|NCT02862574|101989987|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
33573568|NCT02862574|101989985|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
33573569|NCT02862574|101989986|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
33573570|NCT02862574|101989987|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
33573571|NCT00276419|101989988|FG000|First Intervention|Adverse Event|1|||
33573572|NCT00276419|101989989|FG001|First Intervention|Adverse Event|0|||
33573573|NCT00276419|101989988|FG000|First Intervention|Withdrawal by Subject|0|||
33573574|NCT00276419|101989989|FG001|First Intervention|Withdrawal by Subject|2|||
33136244|NCT00913458|100413419|FG002|Phase 1|Sponsor|0|||
33136245|NCT00913458|100413420|FG003|Phase 1|Sponsor|0|||
33136246|NCT00913458|100413421|FG004|Phase 1|Sponsor|0|||
33573575|NCT00442702|101989990|FG000|Titration Period|Adverse Event|2|||
33573576|NCT00442702|101989991|FG001|Titration Period|Adverse Event|0|||
33573577|NCT00442702|101989990|FG000|Titration Period|Death|3|||
33573578|NCT00442702|101989991|FG001|Titration Period|Death|2|||
33573579|NCT00442702|101989990|FG000|Titration Period|Insufficient Therapeutic Response|1|||
33573580|NCT00442702|101989991|FG001|Titration Period|Insufficient Therapeutic Response|0|||
33136247|NCT00913458|100413422|FG005|Phase 1|Sponsor|0|||
33573581|NCT00442702|101989990|FG000|Titration Period|Refused Treatment|4|||
33136248|NCT00913458|100413423|FG006|Phase 1|Sponsor|0|||
33136249|NCT00913458|100413417|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
33136250|NCT00913458|100413418|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
33573582|NCT00442702|101989991|FG001|Titration Period|Refused Treatment|1|||
33573583|NCT00442702|101989990|FG000|Titration Period|Failure to return|1|||
33136251|NCT00913458|100413419|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
33136252|NCT00913458|100413420|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
33136253|NCT00913458|100413421|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
33136254|NCT00913458|100413422|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
33136255|NCT00913458|100413423|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
33136256|NCT00913458|100413417|FG000|Phase 2|Non-Responder|0|||
33136257|NCT00913458|100413418|FG001|Phase 2|Non-Responder|5|||
33136258|NCT00913458|100413419|FG002|Phase 2|Non-Responder|7|||
33136259|NCT00913458|100413420|FG003|Phase 2|Non-Responder|12|||
33136260|NCT00913458|100413421|FG004|Phase 2|Non-Responder|0|||
33136261|NCT00913458|100413422|FG005|Phase 2|Non-Responder|0|||
33136262|NCT00913458|100413423|FG006|Phase 2|Non-Responder|0|||
33136263|NCT00913458|100413417|FG000|Phase 2|Subject Request|0|||
33136264|NCT00913458|100413418|FG001|Phase 2|Subject Request|0|||
33136265|NCT00913458|100413419|FG002|Phase 2|Subject Request|1|||
33136266|NCT00913458|100413420|FG003|Phase 2|Subject Request|2|||
33136267|NCT00913458|100413421|FG004|Phase 2|Subject Request|0|||
33136268|NCT00913458|100413422|FG005|Phase 2|Subject Request|0|||
33136269|NCT00913458|100413423|FG006|Phase 2|Subject Request|0|||
33136270|NCT00913458|100413417|FG000|Phase 2|Adverse Event|0|||
33136271|NCT00913458|100413418|FG001|Phase 2|Adverse Event|3|||
33230779|NCT02855164|100746288|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
33573584|NCT00442702|101989991|FG001|Titration Period|Failure to return|0|||
33573585|NCT00442702|101989990|FG000|Titration Period|Hospitalized in another hospital|1|||
33573586|NCT00442702|101989991|FG001|Titration Period|Hospitalized in another hospital|0|||
33573587|NCT00442702|101989990|FG000|Evaluation Period|Adverse Event|1|||
33573588|NCT00442702|101989991|FG001|Evaluation Period|Adverse Event|0|||
33573589|NCT00442702|101989990|FG000|Evaluation Period|Death|1|||
33573590|NCT00442702|101989991|FG001|Evaluation Period|Death|1|||
33573591|NCT00442702|101989990|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
33573592|NCT00442702|101989991|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
33573593|NCT00442702|101989990|FG000|Evaluation Period|Refused treatment|1|||
33573594|NCT00442702|101989991|FG001|Evaluation Period|Refused treatment|1|||
33573595|NCT00442702|101989990|FG000|Evaluation Period|Renal transplant|0|||
33573596|NCT00442702|101989991|FG001|Evaluation Period|Renal transplant|1|||
33573597|NCT00442702|101989990|FG000|Evaluation Period|Failure to return|1|||
33573598|NCT00442702|101989991|FG001|Evaluation Period|Failure to return|0|||
33573599|NCT00442702|101989990|FG000|Evaluation Period|Site closure|0|||
33573600|NCT00442702|101989991|FG001|Evaluation Period|Site closure|1|||
33573601|NCT01182350|101989992|FG000|Overall Study|Adverse Event|5|||
33573602|NCT01182350|101989993|FG001|Overall Study|Adverse Event|0|||
33573603|NCT01182350|101989994|FG002|Overall Study|Adverse Event|0|||
33573604|NCT01182350|101989995|FG003|Overall Study|Adverse Event|0|||
33573605|NCT01182350|101989996|FG004|Overall Study|Adverse Event|0|||
33573606|NCT01182350|101989992|FG000|Overall Study|Disease Progression|15|||
33573607|NCT01182350|101989993|FG001|Overall Study|Disease Progression|12|||
33573608|NCT01182350|101989994|FG002|Overall Study|Disease Progression|0|||
33573609|NCT01182350|101989995|FG003|Overall Study|Disease Progression|1|||
33573610|NCT01182350|101989996|FG004|Overall Study|Disease Progression|0|||
33573611|NCT01182350|101989992|FG000|Overall Study|Death|0|||
33573612|NCT01182350|101989993|FG001|Overall Study|Death|1|||
33573613|NCT01182350|101989994|FG002|Overall Study|Death|1|||
33573614|NCT01182350|101989995|FG003|Overall Study|Death|0|||
33573615|NCT01182350|101989996|FG004|Overall Study|Death|0|||
33573616|NCT01182350|101989992|FG000|Overall Study|Withdrawal by Subject|3|||
33573617|NCT01182350|101989993|FG001|Overall Study|Withdrawal by Subject|1|||
33573618|NCT01182350|101989994|FG002|Overall Study|Withdrawal by Subject|0|||
33573619|NCT01182350|101989995|FG003|Overall Study|Withdrawal by Subject|1|||
33573620|NCT01182350|101989996|FG004|Overall Study|Withdrawal by Subject|0|||
33136272|NCT00913458|100413419|FG002|Phase 2|Adverse Event|0|||
33136273|NCT00913458|100413420|FG003|Phase 2|Adverse Event|1|||
33136274|NCT00913458|100413421|FG004|Phase 2|Adverse Event|0|||
33136275|NCT00913458|100413422|FG005|Phase 2|Adverse Event|0|||
33136276|NCT00913458|100413423|FG006|Phase 2|Adverse Event|0|||
33573621|NCT01182350|101989992|FG000|Overall Study|Alternative Therapy|2|||
33136277|NCT00913458|100413417|FG000|Phase 2|Lost to Follow-up|0|||
33136278|NCT00913458|100413418|FG001|Phase 2|Lost to Follow-up|0|||
33136279|NCT00913458|100413419|FG002|Phase 2|Lost to Follow-up|0|||
33136280|NCT00913458|100413420|FG003|Phase 2|Lost to Follow-up|1|||
33573622|NCT01182350|101989993|FG001|Overall Study|Alternative Therapy|0|||
33573623|NCT01182350|101989994|FG002|Overall Study|Alternative Therapy|1|||
33136281|NCT00913458|100413421|FG004|Phase 2|Lost to Follow-up|0|||
33573624|NCT01182350|101989995|FG003|Overall Study|Alternative Therapy|0|||
33573625|NCT01182350|101989996|FG004|Overall Study|Alternative Therapy|0|||
33573626|NCT01182350|101989992|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
33573627|NCT01182350|101989993|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
33136282|NCT00913458|100413422|FG005|Phase 2|Lost to Follow-up|0|||
33136283|NCT00913458|100413423|FG006|Phase 2|Lost to Follow-up|0|||
33136284|NCT00913458|100413417|FG000|Phase 2|Protocol Violation|0|||
33230780|NCT02855164|100746289|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
33230781|NCT02855164|100746290|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
33230782|NCT03029247|100746291|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
33230783|NCT03029247|100746292|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
33230784|NCT03029247|100746291|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
33230785|NCT03029247|100746292|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
33230786|NCT03029247|100746291|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
33230787|NCT03029247|100746292|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
33230788|NCT03029247|100746291|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
33230789|NCT03029247|100746292|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
33230790|NCT00641186|100746293|FG000|Overall Study|Adverse Event|3|||
33230791|NCT01354106|100746297|FG000|Overall Study|Withdrawal by Subject|2|||
33230792|NCT00519896|100746298|FG000|Overall Study|Protocol Violation|1|||
33230793|NCT00519896|100746298|FG000|Overall Study|Adverse Event|1|||
33230794|NCT02105636|100746301|FG000|Pre-Treatment|Disease Progression|1|||
33136285|NCT00913458|100413418|FG001|Phase 2|Protocol Violation|2|||
33136286|NCT00913458|100413419|FG002|Phase 2|Protocol Violation|0|||
33136287|NCT00913458|100413420|FG003|Phase 2|Protocol Violation|0|||
33136288|NCT00913458|100413421|FG004|Phase 2|Protocol Violation|0|||
33136289|NCT00913458|100413422|FG005|Phase 2|Protocol Violation|0|||
33136290|NCT00913458|100413423|FG006|Phase 2|Protocol Violation|0|||
33136291|NCT00913458|100413417|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
33136292|NCT00913458|100413418|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
33136293|NCT00913458|100413419|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
33136294|NCT00913458|100413420|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
33136295|NCT00913458|100413421|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
33136296|NCT00913458|100413422|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
33136297|NCT00913458|100413423|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
33136298|NCT00913458|100413417|FG000|Phase 3|Adverse Event|0|||
33136299|NCT00913458|100413418|FG001|Phase 3|Adverse Event|0|||
33136300|NCT00913458|100413419|FG002|Phase 3|Adverse Event|0|||
33136301|NCT00913458|100413420|FG003|Phase 3|Adverse Event|0|||
33136302|NCT00913458|100413421|FG004|Phase 3|Adverse Event|5|||
33136303|NCT00913458|100413422|FG005|Phase 3|Adverse Event|4|||
33230795|NCT02105636|100746302|FG001|Pre-Treatment|Disease Progression|0|||
33230796|NCT02105636|100746301|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
33230797|NCT02105636|100746302|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
33230798|NCT02105636|100746301|FG000|Pre-Treatment|Participant withdrew consent|0|||
33230799|NCT02105636|100746302|FG001|Pre-Treatment|Participant withdrew consent|6|||
33230800|NCT02105636|100746301|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
33230801|NCT02105636|100746302|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
33230802|NCT02105636|100746301|FG000|Treatment|Study Drug Toxicity|14|||
33230803|NCT02105636|100746302|FG001|Treatment|Study Drug Toxicity|10|||
33230804|NCT02105636|100746301|FG000|Treatment|Adverse event unrelated to study drug|19|||
33230805|NCT02105636|100746302|FG001|Treatment|Adverse event unrelated to study drug|3|||
33230806|NCT02105636|100746301|FG000|Treatment|Participant request to discontinue study treatment|8|||
33230807|NCT02105636|100746302|FG001|Treatment|Participant request to discontinue study treatment|6|||
33230808|NCT02105636|100746301|FG000|Treatment|Participant withdrew consent|5|||
33230809|NCT02105636|100746302|FG001|Treatment|Participant withdrew consent|1|||
33230810|NCT02105636|100746301|FG000|Treatment|Lost to Follow-up|1|||
33230811|NCT02105636|100746302|FG001|Treatment|Lost to Follow-up|0|||
33230812|NCT02105636|100746301|FG000|Treatment|Maximum Clinical Benefit|1|||
33230813|NCT02105636|100746302|FG001|Treatment|Maximum Clinical Benefit|3|||
33230814|NCT02105636|100746301|FG000|Treatment|Poor/Non-compliance|0|||
33230815|NCT02105636|100746302|FG001|Treatment|Poor/Non-compliance|1|||
33230816|NCT02105636|100746301|FG000|Treatment|Participant no longer meets study criteria|1|||
33230817|NCT02105636|100746302|FG001|Treatment|Participant no longer meets study criteria|0|||
33230818|NCT02105636|100746301|FG000|Treatment|Other reasons|1|||
33136304|NCT00913458|100413423|FG006|Phase 3|Adverse Event|1|||
33136305|NCT00913458|100413417|FG000|Phase 3|Lost to Follow-up|0|||
33136306|NCT00913458|100413418|FG001|Phase 3|Lost to Follow-up|0|||
33367711|NCT03345836|101232678|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
33230819|NCT02105636|100746302|FG001|Treatment|Other reasons|0|||
33367712|NCT03345836|101232679|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
33419539|NCT00883740|101425796|FG001|First Intervention|No longer willing to participate|0|||
33136307|NCT00913458|100413419|FG002|Phase 3|Lost to Follow-up|0|||
33136308|NCT00913458|100413420|FG003|Phase 3|Lost to Follow-up|0|||
33230820|NCT02105636|100746301|FG000|Treatment|Disease Progression|185|||
33230821|NCT02105636|100746302|FG001|Treatment|Disease Progression|87|||
33230822|NCT01473381|100746303|FG000|Overall Study|Adverse Event|8|||
33230823|NCT01473381|100746304|FG001|Overall Study|Adverse Event|20|||
33136309|NCT00913458|100413421|FG004|Phase 3|Lost to Follow-up|2|||
33230824|NCT01473381|100746305|FG002|Overall Study|Adverse Event|25|||
33230825|NCT01473381|100746306|FG003|Overall Study|Adverse Event|17|||
33230826|NCT01473381|100746303|FG000|Overall Study|Insufficient Therapeutic Response|10|||
33230827|NCT01473381|100746304|FG001|Overall Study|Insufficient Therapeutic Response|1|||
33230828|NCT01473381|100746305|FG002|Overall Study|Insufficient Therapeutic Response|2|||
33230829|NCT01473381|100746306|FG003|Overall Study|Insufficient Therapeutic Response|3|||
33230830|NCT01473381|100746303|FG000|Overall Study|Protocol Violation|17|||
33230831|NCT01473381|100746304|FG001|Overall Study|Protocol Violation|23|||
33230832|NCT01473381|100746305|FG002|Overall Study|Protocol Violation|19|||
33230833|NCT01473381|100746306|FG003|Overall Study|Protocol Violation|17|||
33230834|NCT01473381|100746303|FG000|Overall Study|Withdrawal of Consent|20|||
33230835|NCT01473381|100746304|FG001|Overall Study|Withdrawal of Consent|21|||
33230836|NCT01473381|100746305|FG002|Overall Study|Withdrawal of Consent|20|||
33230837|NCT01473381|100746306|FG003|Overall Study|Withdrawal of Consent|26|||
33230838|NCT01473381|100746303|FG000|Overall Study|Lost to Follow-up|25|||
33230839|NCT01473381|100746304|FG001|Overall Study|Lost to Follow-up|28|||
33230840|NCT01473381|100746305|FG002|Overall Study|Lost to Follow-up|35|||
33230841|NCT01473381|100746306|FG003|Overall Study|Lost to Follow-up|23|||
33230842|NCT01473381|100746303|FG000|Overall Study|Other Reasons|0|||
33230843|NCT01473381|100746304|FG001|Overall Study|Other Reasons|0|||
33230844|NCT01473381|100746305|FG002|Overall Study|Other Reasons|1|||
33230845|NCT01473381|100746306|FG003|Overall Study|Other Reasons|3|||
33230846|NCT00661258|100746309|FG000|Overall Study|Death|1|||
33230847|NCT00661258|100746310|FG001|Overall Study|Death|0|||
33230848|NCT00661258|100746309|FG000|Overall Study|caught by police and in detox center|2|||
33230849|NCT00661258|100746310|FG001|Overall Study|caught by police and in detox center|1|||
33230850|NCT01617005|100746311|FG000|Overall Study|Pregnancy|1|||
33230851|NCT01617005|100746311|FG000|Overall Study|Lack of motivation for treatment|1|||
33230852|NCT04248465|100746317|FG000|Randomized-Controlled Period|Death|12|||
33230853|NCT04248465|100746318|FG001|Randomized-Controlled Period|Death|5|||
33230854|NCT04248465|100746317|FG000|Randomized-Controlled Period|Adverse Event|2|||
33230855|NCT04248465|100746318|FG001|Randomized-Controlled Period|Adverse Event|0|||
33230856|NCT04248465|100746317|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
33230857|NCT04248465|100746318|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
33230858|NCT04248465|100746317|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
33230859|NCT04248465|100746318|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
33230860|NCT04248465|100746317|FG000|Randomized-Controlled Period|Physician Decision|1|||
33230861|NCT04248465|100746318|FG001|Randomized-Controlled Period|Physician Decision|1|||
33230862|NCT04248465|100746317|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
33230863|NCT04248465|100746318|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
33230864|NCT04248465|100746317|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
33230865|NCT04248465|100746318|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
33573628|NCT01182350|101989994|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
33573629|NCT01182350|101989995|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
33573630|NCT01182350|101989996|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
33573631|NCT01182350|101989992|FG000|Overall Study|Unevaluable for Biopsy|0|||
33573632|NCT01182350|101989993|FG001|Overall Study|Unevaluable for Biopsy|0|||
33573633|NCT01182350|101989994|FG002|Overall Study|Unevaluable for Biopsy|0|||
33573634|NCT01182350|101989995|FG003|Overall Study|Unevaluable for Biopsy|0|||
33573635|NCT01182350|101989996|FG004|Overall Study|Unevaluable for Biopsy|3|||
33573636|NCT03984825|101989999|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
33230866|NCT04248465|100746317|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
33230867|NCT04248465|100746318|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
33230868|NCT01539863|100746319|FG000|Overall Study|Lost to Follow-up|5|||
33230869|NCT01539863|100746320|FG001|Overall Study|Lost to Follow-up|4|||
33230870|NCT03662997|100746322|FG000|Overall Study|Adverse Event|0|||
33230871|NCT03662997|100746323|FG001|Overall Study|Adverse Event|2|||
33230872|NCT03662997|100746324|FG002|Overall Study|Adverse Event|0|||
33230873|NCT03662997|100746325|FG003|Overall Study|Adverse Event|0|||
33230874|NCT01258660|100746333|FG000|Overall Study|Adverse Event|2|||
33573637|NCT03984825|101989999|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
33573638|NCT03984825|101989999|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
33230875|NCT01258660|100746334|FG001|Overall Study|Adverse Event|4|||
33230876|NCT01258660|100746333|FG000|Overall Study|Withdrawal by Subject|3|||
33230877|NCT01258660|100746334|FG001|Overall Study|Withdrawal by Subject|0|||
33230878|NCT01258660|100746333|FG000|Overall Study|due to relocation|2|||
33230879|NCT01258660|100746334|FG001|Overall Study|due to relocation|0|||
33230880|NCT01258660|100746333|FG000|Overall Study|Protocol Violation|0|||
33230881|NCT01258660|100746334|FG001|Overall Study|Protocol Violation|1|||
33230882|NCT01258660|100746333|FG000|Overall Study|Invalid for primary analysis data set|4|||
33230883|NCT01258660|100746334|FG001|Overall Study|Invalid for primary analysis data set|6|||
33230884|NCT02397460|100746335|FG000|Treatment Period 2|Adverse Event|0|||
33230885|NCT02397460|100746336|FG001|Treatment Period 2|Adverse Event|0|||
33230886|NCT02397460|100746337|FG002|Treatment Period 2|Adverse Event|0|||
33230887|NCT02397460|100746338|FG003|Treatment Period 2|Adverse Event|0|||
33230888|NCT02397460|100746339|FG004|Treatment Period 2|Adverse Event|0|||
33419540|NCT00883740|101425795|FG000|First Intervention|Protocol Violation|3|||
33230889|NCT02397460|100746340|FG005|Treatment Period 2|Adverse Event|0|||
33230890|NCT02397460|100746341|FG006|Treatment Period 2|Adverse Event|0|||
33230891|NCT02397460|100746342|FG007|Treatment Period 2|Adverse Event|1|||
33230892|NCT02397460|100746335|FG000|Treatment Period 4|Adverse Event|0|||
33230893|NCT02397460|100746336|FG001|Treatment Period 4|Adverse Event|1|||
33230894|NCT02397460|100746337|FG002|Treatment Period 4|Adverse Event|0|||
33230895|NCT02397460|100746338|FG003|Treatment Period 4|Adverse Event|0|||
33230896|NCT02397460|100746339|FG004|Treatment Period 4|Adverse Event|0|||
33230897|NCT02397460|100746340|FG005|Treatment Period 4|Adverse Event|0|||
33230898|NCT02397460|100746341|FG006|Treatment Period 4|Adverse Event|0|||
33230899|NCT02397460|100746342|FG007|Treatment Period 4|Adverse Event|0|||
33230900|NCT02397460|100746335|FG000|Treatment Period 4|Physician Decision|0|||
33230901|NCT02397460|100746336|FG001|Treatment Period 4|Physician Decision|0|||
33573639|NCT00366457|101990000|FG000|Overall Study|never began study therapy|2|||
33573640|NCT00633126|101990001|FG000|Overall Study|Did not receive full dose|1|||
33230902|NCT02397460|100746337|FG002|Treatment Period 4|Physician Decision|0|||
33230903|NCT02397460|100746338|FG003|Treatment Period 4|Physician Decision|0|||
33230904|NCT02397460|100746339|FG004|Treatment Period 4|Physician Decision|1|||
33230905|NCT02397460|100746340|FG005|Treatment Period 4|Physician Decision|0|||
33230906|NCT02397460|100746341|FG006|Treatment Period 4|Physician Decision|0|||
33230907|NCT02397460|100746342|FG007|Treatment Period 4|Physician Decision|0|||
33230908|NCT01088529|100746343|FG000|Overall Study|Did not receive study treatment|0|||
33230909|NCT01088529|100746344|FG001|Overall Study|Did not receive study treatment|1|||
33230910|NCT00089895|100746345|FG000|Overall Study|Consent Withdrawn|11|||
33230911|NCT00089895|100746346|FG001|Overall Study|Consent Withdrawn|14|||
33230912|NCT00089895|100746345|FG000|Overall Study|Technical reason|7|||
33230913|NCT00089895|100746346|FG001|Overall Study|Technical reason|2|||
33230914|NCT00089895|100746345|FG000|Overall Study|Surgery|0|||
33230915|NCT00089895|100746346|FG001|Overall Study|Surgery|1|||
33230916|NCT00089895|100746345|FG000|Overall Study|Bleeding|0|||
33230917|NCT00089895|100746346|FG001|Overall Study|Bleeding|2|||
33230918|NCT00089895|100746345|FG000|Overall Study|Physician Decision|3|||
33230919|NCT00089895|100746346|FG001|Overall Study|Physician Decision|7|||
33230920|NCT00089895|100746345|FG000|Overall Study|Exclusion criteria met|6|||
33230921|NCT00089895|100746346|FG001|Overall Study|Exclusion criteria met|6|||
33230922|NCT00089895|100746345|FG000|Overall Study|Not otherwise specified|4|||
33230923|NCT00089895|100746346|FG001|Overall Study|Not otherwise specified|8|||
33230924|NCT00089895|100746345|FG000|Overall Study|Missing|4|||
33230925|NCT00089895|100746346|FG001|Overall Study|Missing|2|||
33230926|NCT02207374|100746347|FG000|Overall Study|Withdrawal by Subject|5|||
33230927|NCT02207374|100746348|FG001|Overall Study|Withdrawal by Subject|9|||
33230928|NCT02207374|100746349|FG002|Overall Study|Withdrawal by Subject|4|||
33230929|NCT02207374|100746347|FG000|Overall Study|Death|1|||
33230930|NCT02207374|100746348|FG001|Overall Study|Death|0|||
33230931|NCT02207374|100746349|FG002|Overall Study|Death|1|||
33230932|NCT02207374|100746347|FG000|Overall Study|Missing follow-up information|0|||
33230933|NCT02207374|100746348|FG001|Overall Study|Missing follow-up information|1|||
33230934|NCT02207374|100746349|FG002|Overall Study|Missing follow-up information|1|||
33230935|NCT03249376|100746350|FG000|Overall Study|Adverse Event|11|||
33573641|NCT02412670|101990002|FG000|Overall Study|Adverse Event|4|||
33573642|NCT02412670|101990003|FG001|Overall Study|Adverse Event|1|||
33573643|NCT02412670|101990002|FG000|Overall Study|Physician Decision|1|||
33573644|NCT02412670|101990003|FG001|Overall Study|Physician Decision|0|||
33573645|NCT02412670|101990002|FG000|Overall Study|Withdrawal by Subject|1|||
33573646|NCT02412670|101990003|FG001|Overall Study|Withdrawal by Subject|0|||
33635576|NCT00174187|102218434|FG001|Period 1 (up to 3 Years)|Other|1|||
33635577|NCT00174187|102218435|FG002|Period 1 (up to 3 Years)|Other|0|||
33635578|NCT00174187|102218433|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
33635579|NCT00174187|102218434|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
33230936|NCT03249376|100746351|FG001|Overall Study|Adverse Event|5|||
33230937|NCT03249376|100746350|FG000|Overall Study|Lack of Efficacy|2|||
33419541|NCT00883740|101425796|FG001|First Intervention|Protocol Violation|6|||
33230938|NCT03249376|100746351|FG001|Overall Study|Lack of Efficacy|4|||
33230939|NCT03249376|100746350|FG000|Overall Study|Protocol Violation|3|||
33230940|NCT03249376|100746351|FG001|Overall Study|Protocol Violation|2|||
33230941|NCT03249376|100746350|FG000|Overall Study|Physician Decision|0|||
33230942|NCT03249376|100746351|FG001|Overall Study|Physician Decision|2|||
33230943|NCT03249376|100746350|FG000|Overall Study|Withdrawal by Subject|3|||
33230944|NCT03249376|100746351|FG001|Overall Study|Withdrawal by Subject|9|||
33230945|NCT03249376|100746350|FG000|Overall Study|LTFU|2|||
33230946|NCT03249376|100746351|FG001|Overall Study|LTFU|1|||
33573647|NCT02412670|101990002|FG000|Overall Study|Ineligible|1|||
33573648|NCT02412670|101990003|FG001|Overall Study|Ineligible|0|||
33230947|NCT00472186|100746354|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
33230948|NCT00472186|100746355|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
33230949|NCT01486758|100746358|FG000|Overall Study|Lost to Follow-up|0|||
33573649|NCT03323164|101990004|FG000|Overall Study|Poor quality imaging/scans|2|||
33573650|NCT03323164|101990005|FG001|Overall Study|Poor quality imaging/scans|2|||
33573651|NCT00512070|101990015|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
33573652|NCT00512070|101990016|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
33573653|NCT00512070|101990017|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
33573654|NCT00512070|101990015|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
33573655|NCT00512070|101990016|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
33573656|NCT00512070|101990017|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
33573657|NCT02493764|101990021|FG000|Overall Study|Adverse Event|2|||
33573658|NCT02493764|101990022|FG001|Overall Study|Adverse Event|2|||
33573659|NCT02493764|101990021|FG000|Overall Study|Death|44|||
33635580|NCT00174187|102218435|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
33635581|NCT00174187|102218433|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
33635582|NCT00174187|102218434|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
33635583|NCT00174187|102218435|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
33635584|NCT00174187|102218433|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
33635585|NCT00174187|102218434|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
33635586|NCT00174187|102218435|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
33635587|NCT00174187|102218433|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
33635588|NCT00174187|102218434|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
33635589|NCT00174187|102218435|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
33635590|NCT00174187|102218433|FG000|Period 2 (After 3 Years)|Other|0|||
33367713|NCT03345836|101232680|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
33367714|NCT03345836|101232675|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
33367715|NCT03345836|101232676|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
33367716|NCT03345836|101232677|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
33367717|NCT03345836|101232678|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
33367718|NCT03345836|101232679|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
33419542|NCT00883740|101425795|FG000|First Intervention|Adverse Event|1|||
33419543|NCT00883740|101425796|FG001|First Intervention|Adverse Event|2|||
33419544|NCT00883740|101425795|FG000|Second Intervention|Protocol Violation|1|||
33419545|NCT00883740|101425796|FG001|Second Intervention|Protocol Violation|0|||
33419546|NCT00883740|101425795|FG000|Second Intervention|No longer willing to participate|0|||
33419547|NCT00883740|101425796|FG001|Second Intervention|No longer willing to participate|1|||
33419548|NCT01892020|101425800|FG000|Period 1|Adverse Event|1|||
33367719|NCT03345836|101232680|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
33367720|NCT01842620|101232681|FG000|Period 1|Withdrawal by Subject|1|||
33419549|NCT01892020|101425801|FG001|Period 1|Adverse Event|1|||
33419550|NCT01892020|101425800|FG000|Period 1|Protocol Violation|2|||
33419551|NCT01892020|101425801|FG001|Period 1|Protocol Violation|4|||
33419552|NCT01892020|101425800|FG000|Period 1|Unclassified|0|||
33419553|NCT01892020|101425801|FG001|Period 1|Unclassified|1|||
33419554|NCT01892020|101425800|FG000|Period 2|Protocol Violation|1|||
33419555|NCT01892020|101425801|FG001|Period 2|Protocol Violation|0|||
33419556|NCT03669640|101425802|FG000|Overall Study|Study Terminated by Sponsor|0|||
33419557|NCT03669640|101425803|FG001|Overall Study|Study Terminated by Sponsor|0|||
33419558|NCT03669640|101425804|FG002|Overall Study|Study Terminated by Sponsor|0|||
33419559|NCT03669640|101425805|FG003|Overall Study|Study Terminated by Sponsor|0|||
33419560|NCT03669640|101425806|FG004|Overall Study|Study Terminated by Sponsor|1|||
33419561|NCT03669640|101425807|FG005|Overall Study|Study Terminated by Sponsor|0|||
33419562|NCT03669640|101425802|FG000|Overall Study|Lost to Follow-up|0|||
33419563|NCT03669640|101425803|FG001|Overall Study|Lost to Follow-up|0|||
33419564|NCT03669640|101425804|FG002|Overall Study|Lost to Follow-up|2|||
33419565|NCT03669640|101425805|FG003|Overall Study|Lost to Follow-up|0|||
33419566|NCT03669640|101425806|FG004|Overall Study|Lost to Follow-up|0|||
33419567|NCT03669640|101425807|FG005|Overall Study|Lost to Follow-up|0|||
33419568|NCT03669640|101425802|FG000|Overall Study|Death|0|||
33419569|NCT03669640|101425803|FG001|Overall Study|Death|0|||
33419570|NCT03669640|101425804|FG002|Overall Study|Death|1|||
33419571|NCT03669640|101425805|FG003|Overall Study|Death|0|||
33419572|NCT03669640|101425806|FG004|Overall Study|Death|0|||
33419573|NCT03669640|101425807|FG005|Overall Study|Death|0|||
33419574|NCT03669640|101425802|FG000|Overall Study|Withdrawal by Subject|1|||
33419575|NCT03669640|101425803|FG001|Overall Study|Withdrawal by Subject|2|||
33419576|NCT03669640|101425804|FG002|Overall Study|Withdrawal by Subject|1|||
33419577|NCT03669640|101425805|FG003|Overall Study|Withdrawal by Subject|0|||
33419578|NCT03669640|101425806|FG004|Overall Study|Withdrawal by Subject|1|||
33419579|NCT03669640|101425807|FG005|Overall Study|Withdrawal by Subject|3|||
33419580|NCT03669640|101425802|FG000|Overall Study|Protocol Violation|1|||
33419581|NCT03669640|101425803|FG001|Overall Study|Protocol Violation|0|||
33419582|NCT03669640|101425804|FG002|Overall Study|Protocol Violation|0|||
33573660|NCT02493764|101990022|FG001|Overall Study|Death|58|||
33573661|NCT02493764|101990021|FG000|Overall Study|Lost to Follow-up|2|||
33419583|NCT03669640|101425805|FG003|Overall Study|Protocol Violation|0|||
33419584|NCT03669640|101425806|FG004|Overall Study|Protocol Violation|0|||
33573662|NCT02493764|101990022|FG001|Overall Study|Lost to Follow-up|1|||
33573663|NCT02493764|101990021|FG000|Overall Study|Protocol Violation|6|||
33573664|NCT02493764|101990022|FG001|Overall Study|Protocol Violation|7|||
33573665|NCT02493764|101990021|FG000|Overall Study|Physician Decision|1|||
33573666|NCT02493764|101990022|FG001|Overall Study|Physician Decision|1|||
33573667|NCT02493764|101990021|FG000|Overall Study|Participant moved|17|||
33573668|NCT02493764|101990022|FG001|Overall Study|Participant moved|5|||
33573669|NCT02493764|101990021|FG000|Overall Study|Withdrawal parent/guardian|0|||
33573670|NCT02493764|101990022|FG001|Overall Study|Withdrawal parent/guardian|1|||
33573671|NCT02493764|101990021|FG000|Overall Study|Withdrawal by Subject|11|||
33573672|NCT02493764|101990022|FG001|Overall Study|Withdrawal by Subject|7|||
33573673|NCT03139448|101990024|FG000|Overall Study|Lack of Efficacy|6|||
33367721|NCT01842620|101232682|FG001|Period 1|Withdrawal by Subject|0|||
33419585|NCT03669640|101425807|FG005|Overall Study|Protocol Violation|0|||
33419586|NCT03669640|101425802|FG000|Overall Study|Physician Decision|0|||
33419587|NCT03669640|101425803|FG001|Overall Study|Physician Decision|2|||
33419588|NCT03669640|101425804|FG002|Overall Study|Physician Decision|0|||
33419589|NCT03669640|101425805|FG003|Overall Study|Physician Decision|0|||
33419590|NCT03669640|101425806|FG004|Overall Study|Physician Decision|0|||
33419591|NCT03669640|101425807|FG005|Overall Study|Physician Decision|0|||
33419592|NCT03669640|101425802|FG000|Overall Study|Disease Relapse|1|||
33419593|NCT03669640|101425803|FG001|Overall Study|Disease Relapse|0|||
33419594|NCT03669640|101425804|FG002|Overall Study|Disease Relapse|0|||
33419595|NCT03669640|101425805|FG003|Overall Study|Disease Relapse|0|||
33419596|NCT03669640|101425806|FG004|Overall Study|Disease Relapse|0|||
33419597|NCT03669640|101425807|FG005|Overall Study|Disease Relapse|0|||
33419598|NCT03669640|101425802|FG000|Overall Study|Adverse Event|2|||
33419599|NCT03669640|101425803|FG001|Overall Study|Adverse Event|1|||
33419600|NCT03669640|101425804|FG002|Overall Study|Adverse Event|0|||
33419601|NCT03669640|101425805|FG003|Overall Study|Adverse Event|0|||
33419602|NCT03669640|101425806|FG004|Overall Study|Adverse Event|1|||
33419603|NCT03669640|101425807|FG005|Overall Study|Adverse Event|0|||
33419604|NCT00835068|101425808|FG000|Overall Study|Death|1|||
33419605|NCT00835068|101425809|FG001|Overall Study|Death|0|||
33419606|NCT00835068|101425808|FG000|Overall Study|Adverse Event|0|||
33419607|NCT00835068|101425809|FG001|Overall Study|Adverse Event|1|||
33419608|NCT00835068|101425808|FG000|Overall Study|Other|8|||
33419609|NCT00835068|101425809|FG001|Overall Study|Other|0|||
33419610|NCT00835068|101425808|FG000|Overall Study|Withdrawal by Subject|1|||
33419611|NCT00835068|101425809|FG001|Overall Study|Withdrawal by Subject|0|||
33419612|NCT00915473|101425810|FG000|Screening|Withdrawal by Subject|1|||
33419613|NCT00915473|101425811|FG001|Screening|Withdrawal by Subject|0|||
33419614|NCT00915473|101425810|FG000|4-week Follow Up|Lost to Follow-up|1|||
33367722|NCT01295905|101232683|FG000|Overall Study|Did not meet inclusion criteria|1|||
33367723|NCT01295905|101232684|FG001|Overall Study|Did not meet inclusion criteria|0|||
33367724|NCT01295905|101232683|FG000|Overall Study|Met exclusion criteria|1|||
33367725|NCT01295905|101232684|FG001|Overall Study|Met exclusion criteria|0|||
33367726|NCT02064439|101232687|FG000|Overall Study|Adverse Event|51|||
33367727|NCT02064439|101232688|FG001|Overall Study|Adverse Event|47|||
33367728|NCT02064439|101232689|FG002|Overall Study|Adverse Event|46|||
33367729|NCT02064439|101232687|FG000|Overall Study|Death|0|||
33367730|NCT02064439|101232688|FG001|Overall Study|Death|2|||
33367731|NCT02064439|101232689|FG002|Overall Study|Death|3|||
33367732|NCT02064439|101232687|FG000|Overall Study|Withdrawal by Subject|29|||
33367733|NCT02064439|101232688|FG001|Overall Study|Withdrawal by Subject|18|||
33367734|NCT02064439|101232689|FG002|Overall Study|Withdrawal by Subject|26|||
33367735|NCT02064439|101232687|FG000|Overall Study|Protocol Violation|3|||
33367736|NCT02064439|101232688|FG001|Overall Study|Protocol Violation|5|||
33367737|NCT02064439|101232689|FG002|Overall Study|Protocol Violation|3|||
33367738|NCT02064439|101232687|FG000|Overall Study|Lost to Follow-up|1|||
33367739|NCT02064439|101232688|FG001|Overall Study|Lost to Follow-up|3|||
33367740|NCT02064439|101232689|FG002|Overall Study|Lost to Follow-up|4|||
33367741|NCT02064439|101232687|FG000|Overall Study|Non-compliance with study medication|21|||
33367742|NCT02064439|101232688|FG001|Overall Study|Non-compliance with study medication|19|||
33367743|NCT02064439|101232689|FG002|Overall Study|Non-compliance with study medication|23|||
33367744|NCT02064439|101232687|FG000|Overall Study|Physician Decision|0|||
33419615|NCT00915473|101425811|FG001|4-week Follow Up|Lost to Follow-up|5|||
33367745|NCT02064439|101232688|FG001|Overall Study|Physician Decision|1|||
33419616|NCT02261974|101425812|FG000|Overall Study|Withdrawal by Subject|3|||
33419617|NCT02261974|101425813|FG001|Overall Study|Withdrawal by Subject|2|||
33419618|NCT02261974|101425812|FG000|Overall Study|Pregnancy|0|||
33419619|NCT02261974|101425813|FG001|Overall Study|Pregnancy|1|||
33573674|NCT03139448|101990025|FG001|Overall Study|Lack of Efficacy|7|||
33573675|NCT03139448|101990024|FG000|Overall Study|Location of procedure changed|2|||
33419620|NCT02261974|101425812|FG000|Overall Study|Missed treatment cut-off date|6|||
33573676|NCT03139448|101990025|FG001|Overall Study|Location of procedure changed|8|||
33419621|NCT02261974|101425813|FG001|Overall Study|Missed treatment cut-off date|3|||
33419622|NCT02261974|101425812|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
33573677|NCT03139448|101990024|FG000|Overall Study|Withdrawal by Subject|3|||
33419623|NCT02261974|101425813|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
33419624|NCT02261974|101425812|FG000|Overall Study|Lost to Follow-up|2|||
33419625|NCT02261974|101425813|FG001|Overall Study|Lost to Follow-up|0|||
33419626|NCT02261974|101425812|FG000|Overall Study|Adverse Event|1|||
33419627|NCT02261974|101425813|FG001|Overall Study|Adverse Event|0|||
33419628|NCT01494649|101428384|FG000|Overall Study|Lost to Follow-up|0|||
33419629|NCT01494649|101428385|FG001|Overall Study|Lost to Follow-up|1|||
33419630|NCT00343642|101428386|FG000|Overall Study|Lost to Follow-up|0|||
33419631|NCT00343642|101428387|FG001|Overall Study|Lost to Follow-up|1|||
33419632|NCT00343642|101428388|FG002|Overall Study|Lost to Follow-up|0|||
33419633|NCT00343642|101428386|FG000|Overall Study|Pregnancy|1|||
33419634|NCT00343642|101428387|FG001|Overall Study|Pregnancy|0|||
33419635|NCT00343642|101428388|FG002|Overall Study|Pregnancy|2|||
33419636|NCT00343642|101428386|FG000|Overall Study|Withdrawal by Subject|2|||
33419637|NCT00343642|101428387|FG001|Overall Study|Withdrawal by Subject|3|||
33419638|NCT00343642|101428388|FG002|Overall Study|Withdrawal by Subject|4|||
33419639|NCT00343642|101428386|FG000|Overall Study|Adverse Event|0|||
33419640|NCT00343642|101428387|FG001|Overall Study|Adverse Event|0|||
33419641|NCT00343642|101428388|FG002|Overall Study|Adverse Event|1|||
33419642|NCT00343642|101428386|FG000|Overall Study|Flare up|6|||
33419643|NCT00343642|101428387|FG001|Overall Study|Flare up|4|||
33230950|NCT01486758|100746359|FG001|Overall Study|Lost to Follow-up|1|||
33230951|NCT00649389|100746360|FG000|Overall Study|Adverse Event|22|||
33367746|NCT02064439|101232689|FG002|Overall Study|Physician Decision|1|||
33367747|NCT02064439|101232687|FG000|Overall Study|Logistical difficulties|6|||
33367748|NCT02064439|101232688|FG001|Overall Study|Logistical difficulties|5|||
33367749|NCT02064439|101232689|FG002|Overall Study|Logistical difficulties|2|||
33419644|NCT00343642|101428388|FG002|Overall Study|Flare up|0|||
33419645|NCT01325701|101428392|FG000|Overall Study|Adverse Event|12|||
33419646|NCT01325701|101428393|FG001|Overall Study|Adverse Event|0|||
33419647|NCT01325701|101428392|FG000|Overall Study|Protocol Violation|1|||
33419648|NCT01325701|101428393|FG001|Overall Study|Protocol Violation|0|||
33419649|NCT01325701|101428392|FG000|Overall Study|Physician Decision|2|||
33419650|NCT01325701|101428393|FG001|Overall Study|Physician Decision|2|||
33419651|NCT01325701|101428392|FG000|Overall Study|Withdrawal by Subject|2|||
33573678|NCT03139448|101990025|FG001|Overall Study|Withdrawal by Subject|6|||
33367750|NCT02064439|101232687|FG000|Overall Study|Efficacy outcome reached|18|||
33367751|NCT02064439|101232688|FG001|Overall Study|Efficacy outcome reached|16|||
33367752|NCT02064439|101232689|FG002|Overall Study|Efficacy outcome reached|57|||
33367753|NCT02064439|101232687|FG000|Overall Study|Safety outcome reached|12|||
33367754|NCT02064439|101232688|FG001|Overall Study|Safety outcome reached|20|||
33367755|NCT02064439|101232689|FG002|Overall Study|Safety outcome reached|10|||
33367756|NCT02064439|101232687|FG000|Overall Study|Other|2|||
33367757|NCT02064439|101232688|FG001|Overall Study|Other|2|||
33367758|NCT02064439|101232689|FG002|Overall Study|Other|7|||
33367759|NCT02402218|101232690|FG000|Overall Study|Did not pickup study medication|12|||
33367760|NCT02402218|101232691|FG001|Overall Study|Did not pickup study medication|9|||
33367761|NCT02402218|101232692|FG002|Overall Study|Did not pickup study medication|13|||
33367762|NCT02402218|101232690|FG000|Overall Study|Lack of Efficacy|0|||
33367763|NCT02402218|101232691|FG001|Overall Study|Lack of Efficacy|1|||
33367764|NCT02402218|101232692|FG002|Overall Study|Lack of Efficacy|1|||
33367765|NCT02402218|101232690|FG000|Overall Study|Death|1|||
33367766|NCT02402218|101232691|FG001|Overall Study|Death|0|||
33367767|NCT02402218|101232692|FG002|Overall Study|Death|0|||
33367768|NCT02402218|101232690|FG000|Overall Study|Reinfection|0|||
33367769|NCT02402218|101232691|FG001|Overall Study|Reinfection|0|||
33367770|NCT02402218|101232692|FG002|Overall Study|Reinfection|1|||
33367771|NCT02402218|101232690|FG000|Overall Study|Adverse Event|0|||
33367772|NCT02402218|101232691|FG001|Overall Study|Adverse Event|2|||
33367773|NCT02402218|101232692|FG002|Overall Study|Adverse Event|1|||
33367774|NCT02402218|101232690|FG000|Overall Study|Withdrawal by Subject|1|||
33419652|NCT01325701|101428393|FG001|Overall Study|Withdrawal by Subject|1|||
33419653|NCT01325701|101428392|FG000|Overall Study|Rollerover Extension Study|4|||
33419654|NCT01325701|101428393|FG001|Overall Study|Rollerover Extension Study|0|||
33419655|NCT01286207|101428394|FG000|Overall Study|Adverse Event|27|||
33419656|NCT01286207|101428395|FG001|Overall Study|Adverse Event|41|||
33419657|NCT01286207|101428396|FG002|Overall Study|Adverse Event|8|||
33573679|NCT03139448|101990024|FG000|Overall Study|Screen fail|1|||
33419658|NCT01286207|101428394|FG000|Overall Study|Lost to Follow-up|49|||
33573680|NCT03139448|101990025|FG001|Overall Study|Screen fail|3|||
33573681|NCT03139448|101990024|FG000|Overall Study|Physician Decision|0|||
33367775|NCT02402218|101232691|FG001|Overall Study|Withdrawal by Subject|1|||
33367776|NCT02402218|101232692|FG002|Overall Study|Withdrawal by Subject|1|||
33367777|NCT00633139|101232693|FG000|Overall Study|Non compliance|0|||
33367778|NCT00633139|101232694|FG001|Overall Study|Non compliance|0|||
33419659|NCT01286207|101428395|FG001|Overall Study|Lost to Follow-up|43|||
33419660|NCT01286207|101428396|FG002|Overall Study|Lost to Follow-up|20|||
33230952|NCT00649389|100746361|FG001|Overall Study|Adverse Event|46|||
33419661|NCT01286207|101428394|FG000|Overall Study|Withdrawal by Subject|93|||
33419662|NCT01286207|101428395|FG001|Overall Study|Withdrawal by Subject|79|||
33419663|NCT01286207|101428396|FG002|Overall Study|Withdrawal by Subject|41|||
33419664|NCT01286207|101428394|FG000|Overall Study|Lack of Response|92|||
33419665|NCT01286207|101428395|FG001|Overall Study|Lack of Response|38|||
33419666|NCT01286207|101428396|FG002|Overall Study|Lack of Response|8|||
33419667|NCT01286207|101428394|FG000|Overall Study|Other|37|||
33419668|NCT01286207|101428395|FG001|Overall Study|Other|47|||
33419669|NCT01286207|101428396|FG002|Overall Study|Other|13|||
33419670|NCT00874757|101428401|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
33419671|NCT03853213|101428402|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
33419672|NCT03853213|101428403|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
33419673|NCT03853213|101428402|FG000|Overall Study|Other (e.g., too busy)|0|||
33419674|NCT03853213|101428403|FG001|Overall Study|Other (e.g., too busy)|2|||
33419675|NCT03674827|101428414|FG000|Treatment Phase|Adverse Event|0|||
33419676|NCT03674827|101428415|FG001|Treatment Phase|Adverse Event|0|||
33419677|NCT03674827|101428416|FG002|Treatment Phase|Adverse Event|0|||
33419678|NCT03674827|101428417|FG003|Treatment Phase|Adverse Event|0|||
33419679|NCT03674827|101428418|FG004|Treatment Phase|Adverse Event|0|||
33419680|NCT03674827|101428419|FG005|Treatment Phase|Adverse Event|2|||
33419681|NCT03674827|101428414|FG000|Treatment Phase|Death|2|||
33419682|NCT03674827|101428415|FG001|Treatment Phase|Death|0|||
33419683|NCT03674827|101428416|FG002|Treatment Phase|Death|0|||
33419684|NCT03674827|101428417|FG003|Treatment Phase|Death|0|||
33419685|NCT03674827|101428418|FG004|Treatment Phase|Death|1|||
33419686|NCT03674827|101428419|FG005|Treatment Phase|Death|0|||
33419687|NCT03674827|101428414|FG000|Treatment Phase|Progressive Disease|0|||
33419688|NCT03674827|101428415|FG001|Treatment Phase|Progressive Disease|4|||
33419689|NCT03674827|101428416|FG002|Treatment Phase|Progressive Disease|3|||
33419690|NCT03674827|101428417|FG003|Treatment Phase|Progressive Disease|4|||
33573682|NCT03139448|101990025|FG001|Overall Study|Physician Decision|2|||
33136310|NCT00913458|100413422|FG005|Phase 3|Lost to Follow-up|0|||
33136311|NCT00913458|100413423|FG006|Phase 3|Lost to Follow-up|0|||
33136312|NCT00913458|100413417|FG000|Phase 3|Non-Responder|0|||
33136313|NCT00913458|100413418|FG001|Phase 3|Non-Responder|0|||
33136314|NCT00913458|100413419|FG002|Phase 3|Non-Responder|0|||
33367779|NCT00633139|101232695|FG002|Overall Study|Non compliance|1|||
33367780|NCT00633139|101232693|FG000|Overall Study|Withdrawal by Subject|0|||
33367781|NCT00633139|101232694|FG001|Overall Study|Withdrawal by Subject|1|||
33367782|NCT00633139|101232695|FG002|Overall Study|Withdrawal by Subject|0|||
33367783|NCT01106534|101232697|FG000|Overall Study|Withdrawal by Subject|18|||
33367784|NCT01106534|101232697|FG000|Overall Study|Lost to Follow-up|2|||
33367785|NCT01106534|101232697|FG000|Overall Study|Death|16|||
33367786|NCT01106534|101232697|FG000|Overall Study|Physician Decision|1|||
33367787|NCT00320385|101232698|FG000|Overall Study|Lost to Follow-up|7|||
33367788|NCT00320385|101232699|FG001|Overall Study|Lost to Follow-up|10|||
33367789|NCT00320385|101232698|FG000|Overall Study|Withdrawal by Subject|6|||
33367790|NCT00320385|101232699|FG001|Overall Study|Withdrawal by Subject|7|||
33367791|NCT00320385|101232698|FG000|Overall Study|Sponsor Terminated Study|2|||
33367792|NCT00320385|101232699|FG001|Overall Study|Sponsor Terminated Study|1|||
33367793|NCT00320385|101232698|FG000|Overall Study|Investigator Decision|0|||
33367794|NCT00320385|101232699|FG001|Overall Study|Investigator Decision|1|||
33367795|NCT00320385|101232698|FG000|Overall Study|Death|1|||
33367796|NCT00320385|101232699|FG001|Overall Study|Death|2|||
33367797|NCT00320385|101232698|FG000|Overall Study|Serious Adverse Event|1|||
33367798|NCT00320385|101232699|FG001|Overall Study|Serious Adverse Event|0|||
33367799|NCT00320385|101232698|FG000|Overall Study|Withdrew Consent|1|||
33367800|NCT00320385|101232699|FG001|Overall Study|Withdrew Consent|0|||
33367801|NCT00320385|101232698|FG000|Overall Study|Adverse Event|0|||
33367802|NCT00320385|101232699|FG001|Overall Study|Adverse Event|1|||
33367803|NCT04229446|101232704|FG000|Overall Study|Death|12|||
33367804|NCT04229446|101232705|FG001|Overall Study|Death|10|||
33367805|NCT04229446|101232704|FG000|Overall Study|Lost to Follow-up|5|||
33367806|NCT04229446|101232705|FG001|Overall Study|Lost to Follow-up|8|||
33367807|NCT02429427|101232706|FG000|Overall Study|Adverse Event|220|||
33367808|NCT02429427|101232707|FG001|Overall Study|Adverse Event|92|||
33367809|NCT02429427|101232706|FG000|Overall Study|Protocol Violation|10|||
33367810|NCT02429427|101232707|FG001|Overall Study|Protocol Violation|6|||
33419691|NCT03674827|101428418|FG004|Treatment Phase|Progressive Disease|4|||
33573683|NCT00639457|101990026|FG000|Overall Study|Withdrawal by Subject|2|||
33136315|NCT00913458|100413420|FG003|Phase 3|Non-Responder|0|||
33419692|NCT03674827|101428419|FG005|Treatment Phase|Progressive Disease|9|||
33419693|NCT03674827|101428414|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
33573684|NCT00639457|101990027|FG001|Overall Study|Withdrawal by Subject|3|||
33136316|NCT00913458|100413421|FG004|Phase 3|Non-Responder|0|||
33367811|NCT02429427|101232706|FG000|Overall Study|Lost to Follow-up|15|||
33367812|NCT02429427|101232707|FG001|Overall Study|Lost to Follow-up|6|||
33367813|NCT02429427|101232706|FG000|Overall Study|Withdrawal by Subject|64|||
33367814|NCT02429427|101232707|FG001|Overall Study|Withdrawal by Subject|34|||
33419694|NCT03674827|101428415|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
33419695|NCT03674827|101428416|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
33419696|NCT03674827|101428417|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
33419697|NCT03674827|101428418|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
33419698|NCT03674827|101428419|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
33136317|NCT00913458|100413422|FG005|Phase 3|Non-Responder|1|||
33136318|NCT00913458|100413423|FG006|Phase 3|Non-Responder|3|||
33419699|NCT03674827|101428414|FG000|Treatment Phase|Withdrawal by Subject|0|||
33419700|NCT03674827|101428415|FG001|Treatment Phase|Withdrawal by Subject|0|||
33136319|NCT00913458|100413417|FG000|Phase 3|Withdrawal by Subject|0|||
33136320|NCT00913458|100413418|FG001|Phase 3|Withdrawal by Subject|0|||
33136321|NCT00913458|100413419|FG002|Phase 3|Withdrawal by Subject|0|||
33136322|NCT00913458|100413420|FG003|Phase 3|Withdrawal by Subject|0|||
33136323|NCT00913458|100413421|FG004|Phase 3|Withdrawal by Subject|1|||
33136324|NCT00913458|100413422|FG005|Phase 3|Withdrawal by Subject|2|||
33136325|NCT00913458|100413423|FG006|Phase 3|Withdrawal by Subject|0|||
33136326|NCT00913458|100413417|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
33136327|NCT00913458|100413418|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
33136328|NCT00913458|100413419|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
33136329|NCT00913458|100413420|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
33136330|NCT00913458|100413421|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
33136331|NCT00913458|100413422|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
33419701|NCT03674827|101428416|FG002|Treatment Phase|Withdrawal by Subject|0|||
33419702|NCT03674827|101428417|FG003|Treatment Phase|Withdrawal by Subject|0|||
33419703|NCT03674827|101428418|FG004|Treatment Phase|Withdrawal by Subject|0|||
33419704|NCT03674827|101428419|FG005|Treatment Phase|Withdrawal by Subject|1|||
33419705|NCT03674827|101428414|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
33419706|NCT03674827|101428415|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
33419707|NCT03674827|101428416|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
33419708|NCT03674827|101428417|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
33419709|NCT03674827|101428418|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
33419710|NCT03674827|101428419|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
33419711|NCT03674827|101428414|FG000|Treatment Phase|Other|0|||
33419712|NCT03674827|101428415|FG001|Treatment Phase|Other|1|||
33419713|NCT03674827|101428416|FG002|Treatment Phase|Other|0|||
33419714|NCT03674827|101428417|FG003|Treatment Phase|Other|0|||
33419715|NCT03674827|101428418|FG004|Treatment Phase|Other|0|||
33419716|NCT03674827|101428419|FG005|Treatment Phase|Other|1|||
33419717|NCT03674827|101428414|FG000|Long-Term Follow-up Phase|Death|2|||
33419718|NCT03674827|101428415|FG001|Long-Term Follow-up Phase|Death|4|||
33419719|NCT03674827|101428416|FG002|Long-Term Follow-up Phase|Death|2|||
33419720|NCT03674827|101428417|FG003|Long-Term Follow-up Phase|Death|3|||
33419721|NCT03674827|101428418|FG004|Long-Term Follow-up Phase|Death|2|||
33419722|NCT03674827|101428419|FG005|Long-Term Follow-up Phase|Death|6|||
33419723|NCT03674827|101428414|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
33419724|NCT03674827|101428415|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
33419725|NCT03674827|101428416|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
33419726|NCT03674827|101428417|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
33419727|NCT03674827|101428418|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
33419728|NCT03674827|101428419|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
33419729|NCT03674827|101428414|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
33419730|NCT03674827|101428415|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
33419731|NCT03674827|101428416|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
33419732|NCT03674827|101428417|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
33419733|NCT03674827|101428418|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
33136332|NCT00913458|100413423|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
33136333|NCT02522624|100413424|FG000|Overall Study|Technical failure|1|||
33136334|NCT02522624|100413425|FG001|Overall Study|Technical failure|0|||
33136335|NCT02338232|100413428|FG000|Overall Study|Screen Failure|3|||
33419734|NCT03674827|101428419|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
33419735|NCT03496207|101428420|FG000|Base Study|Adverse Event|0|||
33419736|NCT03496207|101428421|FG001|Base Study|Adverse Event|0|||
33419737|NCT03496207|101428422|FG002|Base Study|Adverse Event|1|||
33419738|NCT03496207|101428423|FG003|Base Study|Adverse Event|1|||
33419739|NCT03496207|101428424|FG004|Base Study|Adverse Event|4|||
33419740|NCT03496207|101428420|FG000|Base Study|Death|0|||
33419741|NCT03496207|101428421|FG001|Base Study|Death|0|||
33419742|NCT03496207|101428422|FG002|Base Study|Death|0|||
33419743|NCT03496207|101428423|FG003|Base Study|Death|0|||
33136336|NCT02338232|100413428|FG000|Overall Study|Withdrawal by Subject|6|||
33136337|NCT02338232|100413428|FG000|Overall Study|Adverse Event|2|||
33136338|NCT00486811|100413433|FG000|Overall Study|Adverse Event|28|||
33136339|NCT00486811|100413434|FG001|Overall Study|Adverse Event|60|||
33419744|NCT03496207|101428424|FG004|Base Study|Death|1|||
33419745|NCT03496207|101428420|FG000|Base Study|Withdrawal by Subject|0|||
33419746|NCT03496207|101428421|FG001|Base Study|Withdrawal by Subject|0|||
33419747|NCT03496207|101428422|FG002|Base Study|Withdrawal by Subject|1|||
33419748|NCT03496207|101428423|FG003|Base Study|Withdrawal by Subject|0|||
33419749|NCT03496207|101428424|FG004|Base Study|Withdrawal by Subject|1|||
33419750|NCT03496207|101428420|FG000|Extension Period|Adverse Event|0|||
33419751|NCT03496207|101428421|FG001|Extension Period|Adverse Event|0|||
33419752|NCT03496207|101428422|FG002|Extension Period|Adverse Event|0|||
33419753|NCT03496207|101428423|FG003|Extension Period|Adverse Event|1|||
33419754|NCT03496207|101428424|FG004|Extension Period|Adverse Event|1|||
33419755|NCT03496207|101428420|FG000|Extension Period|Death|1|||
33419756|NCT03496207|101428421|FG001|Extension Period|Death|0|||
33419757|NCT03496207|101428422|FG002|Extension Period|Death|0|||
33419758|NCT03496207|101428423|FG003|Extension Period|Death|1|||
33419759|NCT03496207|101428424|FG004|Extension Period|Death|2|||
33419760|NCT03496207|101428420|FG000|Extension Period|Withdrawal by Subject|1|||
33419761|NCT03496207|101428421|FG001|Extension Period|Withdrawal by Subject|0|||
33419762|NCT03496207|101428422|FG002|Extension Period|Withdrawal by Subject|0|||
33419763|NCT03496207|101428423|FG003|Extension Period|Withdrawal by Subject|1|||
33419764|NCT03496207|101428424|FG004|Extension Period|Withdrawal by Subject|1|||
33419765|NCT03496207|101428420|FG000|Extension Period|Elevated hemoglobin levels|0|||
33419766|NCT03496207|101428421|FG001|Extension Period|Elevated hemoglobin levels|0|||
33419767|NCT03496207|101428422|FG002|Extension Period|Elevated hemoglobin levels|0|||
33419768|NCT03496207|101428423|FG003|Extension Period|Elevated hemoglobin levels|0|||
33419769|NCT03496207|101428424|FG004|Extension Period|Elevated hemoglobin levels|1|||
33419770|NCT04465916|101428425|FG000|Overall Study|Withdrawal by Subject|0|||
33419771|NCT04465916|101428426|FG001|Overall Study|Withdrawal by Subject|1|||
33419772|NCT01339000|101428428|FG000|Overall Study|study closed due to lack of drug supply|1|||
33419773|NCT01339000|101428429|FG001|Overall Study|study closed due to lack of drug supply|0|||
33419774|NCT00457418|101428430|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
33419775|NCT00457418|101428430|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
33419776|NCT00457418|101428430|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
33419777|NCT00457418|101428430|FG000|Post PK Maintenance|Adverse Event|10|||
33419778|NCT00457418|101428430|FG000|Post PK Maintenance|Progression of Disease|6|||
33419779|NCT00457418|101428430|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
33419780|NCT00457418|101428430|FG000|Post PK Maintenance|Lost to Follow-up|1|||
33419781|NCT01396161|101428431|FG000|Overall Study|Withdrawal by Subject|0|||
33419782|NCT01396161|101428432|FG001|Overall Study|Withdrawal by Subject|0|||
33419783|NCT01396161|101428433|FG002|Overall Study|Withdrawal by Subject|0|||
33419784|NCT01396161|101428434|FG003|Overall Study|Withdrawal by Subject|0|||
33419785|NCT01396161|101428435|FG004|Overall Study|Withdrawal by Subject|1|||
33419786|NCT01396161|101428436|FG005|Overall Study|Withdrawal by Subject|0|||
33573685|NCT00271544|101990028|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
33573686|NCT00271544|101990028|FG000|Overall Study|Model 4196 lead not attempted|9|||
33573687|NCT00271544|101990028|FG000|Overall Study|Implant not attempted|4|||
33573688|NCT01076010|101991851|FG000|Overall Study|Death|15|||
33573689|NCT01076010|101991852|FG001|Overall Study|Death|1|||
33573690|NCT01076010|101991853|FG002|Overall Study|Death|0|||
33573691|NCT01076010|101991851|FG000|Overall Study|Adverse Event|7|||
33573692|NCT01076010|101991852|FG001|Overall Study|Adverse Event|2|||
33635591|NCT00174187|102218434|FG001|Period 2 (After 3 Years)|Other|0|||
33635592|NCT00174187|102218435|FG002|Period 2 (After 3 Years)|Other|5|||
33635593|NCT00106704|102218443|FG000|Overall Study|Adverse Event|10|||
33367815|NCT02429427|101232706|FG000|Overall Study|Other|62|||
33367816|NCT02429427|101232707|FG001|Overall Study|Other|41|||
33367817|NCT00833248|101232710|FG000|Overall Study|Adverse Event|3|||
33367818|NCT00833248|101232711|FG001|Overall Study|Adverse Event|0|||
33367819|NCT00833248|101232710|FG000|Overall Study|Protocol Violation|1|||
33367820|NCT00833248|101232711|FG001|Overall Study|Protocol Violation|2|||
33367821|NCT00833248|101232710|FG000|Overall Study|Withdrawal by Subject|0|||
33367822|NCT00833248|101232711|FG001|Overall Study|Withdrawal by Subject|1|||
33367823|NCT00844428|101232712|FG000|Screening Period|Screen Failure|3|||
33367824|NCT00844428|101232712|FG000|Extension Treatment Period|Death|1|||
33367825|NCT00844428|101232712|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
33367826|NCT00540449|101232713|FG000|Overall Study|Adverse Event|12|||
33367827|NCT00540449|101232714|FG001|Overall Study|Adverse Event|32|||
33367828|NCT00540449|101232713|FG000|Overall Study|Sponsor's Decision|1|||
33367829|NCT00540449|101232714|FG001|Overall Study|Sponsor's Decision|1|||
33367830|NCT00540449|101232713|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
33367831|NCT00540449|101232714|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
33367832|NCT00540449|101232713|FG000|Overall Study|Lost to Follow-up|19|||
33367833|NCT00540449|101232714|FG001|Overall Study|Lost to Follow-up|17|||
33367834|NCT00540449|101232713|FG000|Overall Study|Subject Non-Compliant|7|||
33367835|NCT00540449|101232714|FG001|Overall Study|Subject Non-Compliant|5|||
33367836|NCT00540449|101232713|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
33367837|NCT00540449|101232714|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
33419787|NCT01396161|101428437|FG006|Overall Study|Withdrawal by Subject|0|||
33419788|NCT01396161|101428431|FG000|Overall Study|Other|0|||
33419789|NCT01396161|101428432|FG001|Overall Study|Other|0|||
33419790|NCT01396161|101428433|FG002|Overall Study|Other|0|||
33419791|NCT01396161|101428434|FG003|Overall Study|Other|0|||
33419792|NCT01396161|101428435|FG004|Overall Study|Other|0|||
33136340|NCT00486811|100413435|FG002|Overall Study|Adverse Event|135|||
33136341|NCT00486811|100413433|FG000|Overall Study|Lack of Efficacy|34|||
33136342|NCT00486811|100413434|FG001|Overall Study|Lack of Efficacy|14|||
33136343|NCT00486811|100413435|FG002|Overall Study|Lack of Efficacy|7|||
33136344|NCT00486811|100413433|FG000|Overall Study|Lost to Follow-up|4|||
33136345|NCT00486811|100413434|FG001|Overall Study|Lost to Follow-up|6|||
33136346|NCT00486811|100413435|FG002|Overall Study|Lost to Follow-up|4|||
33136347|NCT00486811|100413433|FG000|Overall Study|Withdrawal by Subject|33|||
33136348|NCT00486811|100413434|FG001|Overall Study|Withdrawal by Subject|44|||
33136349|NCT00486811|100413435|FG002|Overall Study|Withdrawal by Subject|58|||
33136350|NCT00486811|100413433|FG000|Overall Study|Study drug non-compliant|5|||
33136351|NCT00486811|100413434|FG001|Overall Study|Study drug non-compliant|6|||
33136352|NCT00486811|100413435|FG002|Overall Study|Study drug non-compliant|3|||
33136353|NCT00486811|100413433|FG000|Overall Study|All other|18|||
33136354|NCT00486811|100413434|FG001|Overall Study|All other|11|||
33136355|NCT00486811|100413435|FG002|Overall Study|All other|7|||
33136356|NCT01596062|100413436|FG000|Overall Study|Adverse Event|1|||
33136357|NCT01596062|100413437|FG001|Overall Study|Adverse Event|0|||
33136358|NCT01596062|100413438|FG002|Overall Study|Adverse Event|2|||
33136359|NCT01596062|100413436|FG000|Overall Study|Lack of Efficacy|0|||
33136360|NCT01596062|100413437|FG001|Overall Study|Lack of Efficacy|0|||
33573693|NCT01076010|101991853|FG002|Overall Study|Adverse Event|0|||
33136361|NCT01596062|100413438|FG002|Overall Study|Lack of Efficacy|1|||
33136362|NCT01541397|100413443|FG000|Overall Study|Study ended prior to data collection|4|||
33136363|NCT01541397|100413444|FG001|Overall Study|Study ended prior to data collection|2|||
33573694|NCT01076010|101991851|FG000|Overall Study|Progressive disease|90|||
33573695|NCT01076010|101991852|FG001|Overall Study|Progressive disease|30|||
33573696|NCT01076010|101991853|FG002|Overall Study|Progressive disease|1|||
33573697|NCT01076010|101991851|FG000|Overall Study|Lack of Efficacy|4|||
33573698|NCT01076010|101991852|FG001|Overall Study|Lack of Efficacy|0|||
33573699|NCT01076010|101991853|FG002|Overall Study|Lack of Efficacy|0|||
33573700|NCT01076010|101991851|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
33573701|NCT01076010|101991852|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
33573702|NCT01076010|101991853|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
33573703|NCT01076010|101991851|FG000|Overall Study|Significant Surgical Procedure|0|||
33573704|NCT01076010|101991852|FG001|Overall Study|Significant Surgical Procedure|1|||
33573705|NCT01076010|101991853|FG002|Overall Study|Significant Surgical Procedure|0|||
33573706|NCT01076010|101991851|FG000|Overall Study|Protocol Violation|0|||
33573707|NCT01076010|101991852|FG001|Overall Study|Protocol Violation|1|||
33573708|NCT01076010|101991853|FG002|Overall Study|Protocol Violation|0|||
33573709|NCT01076010|101991851|FG000|Overall Study|Noncompliance|1|||
33573710|NCT01076010|101991852|FG001|Overall Study|Noncompliance|1|||
33367838|NCT00540449|101232713|FG000|Overall Study|Withdrawal by Subject|10|||
33367839|NCT00540449|101232714|FG001|Overall Study|Withdrawal by Subject|10|||
33367840|NCT00540449|101232713|FG000|Overall Study|Other|1|||
33367841|NCT00540449|101232714|FG001|Overall Study|Other|4|||
33367842|NCT01356602|101232719|FG000|Overall Study|Protocol Deviation|0|||
33367843|NCT01356602|101232720|FG001|Overall Study|Protocol Deviation|1|||
33367844|NCT01356602|101232721|FG002|Overall Study|Protocol Deviation|1|||
33367845|NCT01356602|101232719|FG000|Overall Study|Administrative Problems|1|||
33573711|NCT01076010|101991853|FG002|Overall Study|Noncompliance|0|||
33573712|NCT01076010|101991851|FG000|Overall Study|Withdrawal by Subject|3|||
33573713|NCT01076010|101991852|FG001|Overall Study|Withdrawal by Subject|0|||
33573714|NCT01076010|101991853|FG002|Overall Study|Withdrawal by Subject|1|||
33573715|NCT01076010|101991851|FG000|Overall Study|Other|5|||
33573716|NCT01076010|101991852|FG001|Overall Study|Other|2|||
33573717|NCT01076010|101991853|FG002|Overall Study|Other|0|||
33573718|NCT00967616|101991854|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
33573719|NCT00967616|101991855|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
33573720|NCT00967616|101991854|FG000|Overall Study|Death|0|||
33573721|NCT00967616|101991855|FG001|Overall Study|Death|3|||
33573722|NCT00967616|101991854|FG000|Overall Study|Withdrawal by Subject|8|||
33573723|NCT00967616|101991855|FG001|Overall Study|Withdrawal by Subject|4|||
33573724|NCT00967616|101991854|FG000|Overall Study|Progressive Disease|31|||
33573725|NCT00967616|101991855|FG001|Overall Study|Progressive Disease|18|||
33573726|NCT00967616|101991854|FG000|Overall Study|Other|8|||
33573727|NCT00967616|101991855|FG001|Overall Study|Other|8|||
33573728|NCT00967616|101991854|FG000|Overall Study|Protocol Violation|1|||
33573729|NCT00967616|101991855|FG001|Overall Study|Protocol Violation|0|||
33573730|NCT04108273|101991857|FG000|Overall Study|COVID Pandemic|1|||
33573731|NCT04108273|101991858|FG001|Overall Study|COVID Pandemic|0|||
33573732|NCT00077974|101991866|FG000|Overall Study|Adverse Event|22|||
33573733|NCT00077974|101991866|FG000|Overall Study|Protocol Violation|1|||
33573734|NCT00077974|101991866|FG000|Overall Study|Withdrawal by Subject|3|||
33573735|NCT00077974|101991866|FG000|Overall Study|Lack of Efficacy|76|||
33573736|NCT00077974|101991866|FG000|Overall Study|Decision of Sponsor|2|||
33573737|NCT00710593|101991873|FG000|Overall Study|Incarceration|1|||
33573738|NCT00710593|101991874|FG001|Overall Study|Incarceration|0|||
33573739|NCT00710593|101991873|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
33573740|NCT00710593|101991874|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
33573741|NCT00710593|101991873|FG000|Overall Study|Lost to Follow-up|3|||
33573742|NCT00710593|101991874|FG001|Overall Study|Lost to Follow-up|1|||
33573743|NCT00710593|101991873|FG000|Overall Study|Moved out of area|1|||
33573744|NCT00710593|101991874|FG001|Overall Study|Moved out of area|0|||
33573745|NCT00710593|101991873|FG000|Overall Study|Failure to adhere or complete study eval|1|||
33573746|NCT00710593|101991874|FG001|Overall Study|Failure to adhere or complete study eval|1|||
33573747|NCT00710593|101991873|FG000|Overall Study|Protocol Violation|1|||
33573748|NCT00710593|101991874|FG001|Overall Study|Protocol Violation|1|||
33573749|NCT00710593|101991873|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
33573750|NCT00710593|101991874|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
33573751|NCT02297412|101991876|FG000|Overall Study|Canceled|1|||
33573752|NCT02297412|101991877|FG001|Overall Study|Canceled|1|||
33573753|NCT01645176|101991878|FG000|Overall Study|Lack of Efficacy|4|||
33573754|NCT01645176|101991878|FG000|Overall Study|did not complete final MRI|1|||
33573755|NCT00613106|101991879|FG000|Overall Study|Adverse Event|3|||
33573756|NCT00613106|101991880|FG001|Overall Study|Adverse Event|1|||
33573757|NCT00613106|101991879|FG000|Overall Study|Withdrawal by Subject|6|||
33573758|NCT00613106|101991880|FG001|Overall Study|Withdrawal by Subject|3|||
33573759|NCT00613106|101991879|FG000|Overall Study|Lost to Follow-up|7|||
33573760|NCT00613106|101991880|FG001|Overall Study|Lost to Follow-up|2|||
33573761|NCT00613106|101991879|FG000|Overall Study|misc|4|||
33573762|NCT00613106|101991880|FG001|Overall Study|misc|3|||
33573763|NCT01246960|101991889|FG000|Overall Study|Lost to Follow-up|3|||
33573764|NCT01246960|101991890|FG001|Overall Study|Lost to Follow-up|1|||
33573765|NCT01246960|101991889|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
33573766|NCT01246960|101991890|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
33573767|NCT04043286|101991892|FG000|Overall Study|Withdrawal by Subject|2|||
33573768|NCT04043286|101991893|FG001|Overall Study|Withdrawal by Subject|2|||
33573769|NCT01816295|101991894|FG000|Double Blind Phase|Adverse Event|11|||
33573770|NCT01816295|101991895|FG001|Double Blind Phase|Adverse Event|8|||
33573771|NCT01816295|101991894|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
33573772|NCT01816295|101991895|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
33573773|NCT01816295|101991894|FG000|Double Blind Phase|Lost to Follow-up|3|||
33573774|NCT01816295|101991895|FG001|Double Blind Phase|Lost to Follow-up|5|||
33573775|NCT01816295|101991894|FG000|Double Blind Phase|Physician Decision|2|||
33573776|NCT01816295|101991895|FG001|Double Blind Phase|Physician Decision|2|||
33635594|NCT00106704|102218444|FG001|Overall Study|Adverse Event|7|||
33367846|NCT01356602|101232720|FG001|Overall Study|Administrative Problems|4|||
33367847|NCT01356602|101232721|FG002|Overall Study|Administrative Problems|5|||
33635595|NCT00106704|102218443|FG000|Overall Study|Death|2|||
33635596|NCT00106704|102218444|FG001|Overall Study|Death|1|||
33367848|NCT01356602|101232719|FG000|Overall Study|Lost to Follow-up|4|||
33419793|NCT01396161|101428436|FG005|Overall Study|Other|0|||
33573777|NCT01816295|101991894|FG000|Double Blind Phase|Protocol Violation|17|||
33573778|NCT01816295|101991895|FG001|Double Blind Phase|Protocol Violation|11|||
33573779|NCT01816295|101991894|FG000|Double Blind Phase|Sponsor Decision|8|||
33573780|NCT01816295|101991895|FG001|Double Blind Phase|Sponsor Decision|8|||
33573781|NCT01816295|101991894|FG000|Double Blind Phase|Withdrawal by Subject|22|||
33573782|NCT01816295|101991895|FG001|Double Blind Phase|Withdrawal by Subject|20|||
33136412|NCT00717236|100413456|FG000|Double-Blind Period|Adverse Event|33|||
33136413|NCT00717236|100413457|FG001|Double-Blind Period|Adverse Event|6|||
33136414|NCT00717236|100413456|FG000|Double-Blind Period|Lack of Efficacy|6|||
33136415|NCT00717236|100413457|FG001|Double-Blind Period|Lack of Efficacy|6|||
33136416|NCT00717236|100413456|FG000|Double-Blind Period|Lost to Follow-up|3|||
33136417|NCT00717236|100413457|FG001|Double-Blind Period|Lost to Follow-up|5|||
33136418|NCT00717236|100413456|FG000|Double-Blind Period|Withdrawal by Subject|10|||
33136419|NCT00717236|100413457|FG001|Double-Blind Period|Withdrawal by Subject|2|||
33136420|NCT00717236|100413456|FG000|Double-Blind Period|Loss of efficacy|3|||
33136421|NCT00717236|100413457|FG001|Double-Blind Period|Loss of efficacy|0|||
33136422|NCT00717236|100413456|FG000|Double-Blind Period|Other: Death|1|||
33136423|NCT00717236|100413457|FG001|Double-Blind Period|Other: Death|0|||
33136424|NCT00717236|100413456|FG000|Double-Blind Period|Other: Pregnancy|1|||
33136425|NCT00717236|100413457|FG001|Double-Blind Period|Other: Pregnancy|0|||
33136426|NCT00717236|100413456|FG000|Double-Blind Period|Other: Protocol Violation|2|||
33136427|NCT00717236|100413457|FG001|Double-Blind Period|Other: Protocol Violation|0|||
33136428|NCT00717236|100413456|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
33136429|NCT00717236|100413457|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
33136430|NCT00717236|100413456|FG000|Double-Blind Period|Other: Site withdrew|2|||
33136431|NCT00717236|100413457|FG001|Double-Blind Period|Other: Site withdrew|0|||
33136432|NCT00717236|100413456|FG000|Double-Blind Period|Other: Screening failure|1|||
33136433|NCT00717236|100413457|FG001|Double-Blind Period|Other: Screening failure|0|||
33136434|NCT00717236|100413456|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
33136435|NCT00717236|100413457|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
33136436|NCT00717236|100413456|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
33136437|NCT00717236|100413457|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
33136438|NCT00717236|100413456|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
33136439|NCT00717236|100413457|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
33136440|NCT00717236|100413456|FG000|Double-Blind Period|Other: History of cancer|1|||
33136441|NCT00717236|100413457|FG001|Double-Blind Period|Other: History of cancer|0|||
33136442|NCT00717236|100413456|FG000|Double-Blind Period|Other: Sponsor request|1|||
33136443|NCT00717236|100413457|FG001|Double-Blind Period|Other: Sponsor request|0|||
33136444|NCT00717236|100413456|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
33136445|NCT00717236|100413457|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
33136446|NCT00717236|100413456|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
33136447|NCT00717236|100413457|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
33136448|NCT00717236|100413456|FG000|Double-Blind Period|Other: Subject moved|1|||
33136449|NCT00717236|100413457|FG001|Double-Blind Period|Other: Subject moved|1|||
33136450|NCT00717236|100413456|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
33230953|NCT00649389|100746362|FG002|Overall Study|Adverse Event|38|||
33230954|NCT00649389|100746363|FG003|Overall Study|Adverse Event|48|||
33230955|NCT00649389|100746360|FG000|Overall Study|Lost to Follow-up|15|||
33136451|NCT00717236|100413457|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
33136452|NCT00717236|100413456|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
33136453|NCT00717236|100413457|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
33136454|NCT00717236|100413456|FG000|Double-Blind Period|Other: Transportation problems|0|||
33136455|NCT00717236|100413457|FG001|Double-Blind Period|Other: Transportation problems|1|||
33136456|NCT00717236|100413456|FG000|Double-Blind Period|Other: Investigator Decision|0|||
33136457|NCT00717236|100413457|FG001|Double-Blind Period|Other: Investigator Decision|1|||
33136458|NCT00717236|100413456|FG000|Open-Label Period|Adverse Event|29|||
33136459|NCT00717236|100413457|FG001|Open-Label Period|Adverse Event|4|||
33230956|NCT00649389|100746361|FG001|Overall Study|Lost to Follow-up|17|||
33230957|NCT00649389|100746362|FG002|Overall Study|Lost to Follow-up|21|||
33230958|NCT00649389|100746363|FG003|Overall Study|Lost to Follow-up|26|||
33230959|NCT00649389|100746360|FG000|Overall Study|Protocol Violation|11|||
33230960|NCT00649389|100746361|FG001|Overall Study|Protocol Violation|13|||
33230961|NCT00649389|100746362|FG002|Overall Study|Protocol Violation|9|||
33230962|NCT00649389|100746363|FG003|Overall Study|Protocol Violation|8|||
33230963|NCT00649389|100746360|FG000|Overall Study|Withdrawal by Subject|20|||
33230964|NCT00649389|100746361|FG001|Overall Study|Withdrawal by Subject|21|||
33230965|NCT00649389|100746362|FG002|Overall Study|Withdrawal by Subject|19|||
33230966|NCT00649389|100746363|FG003|Overall Study|Withdrawal by Subject|23|||
33230967|NCT00649389|100746360|FG000|Overall Study|Other|3|||
33230968|NCT00649389|100746361|FG001|Overall Study|Other|9|||
33230969|NCT00649389|100746362|FG002|Overall Study|Other|1|||
33230970|NCT00649389|100746363|FG003|Overall Study|Other|6|||
33230971|NCT00584805|100746366|FG000|Overall Study|No longer at risk of exposure|39|||
33230972|NCT00584805|100746366|FG000|Overall Study|Relocation|36|||
33230973|NCT00584805|100746366|FG000|Overall Study|Withdrawal by Subject|18|||
33230974|NCT00584805|100746366|FG000|Overall Study|Non-compliance|1|||
33230975|NCT00584805|100746366|FG000|Overall Study|Lost to follow up|3|||
33230976|NCT00584805|100746366|FG000|Overall Study|Screen failures|2|||
33230977|NCT00653263|100746369|FG000|Overall Study|Withdrawal by Subject|1|||
33230978|NCT00653263|100746369|FG000|Overall Study|Physician Decision|1|||
33230979|NCT01987596|100746370|FG000|Overall Study|Physician Decision|1|||
33230980|NCT01987596|100746371|FG001|Overall Study|Physician Decision|0|||
33230981|NCT01987596|100746370|FG000|Overall Study|Progressive Disease; missing all period|0|||
33230982|NCT01987596|100746371|FG001|Overall Study|Progressive Disease; missing all period|1|||
33230983|NCT00474929|100746372|FG000|Overall Study|Withdrawal by Subject|0|||
33230984|NCT00474929|100746373|FG001|Overall Study|Withdrawal by Subject|1|||
33230985|NCT00474929|100746374|FG002|Overall Study|Withdrawal by Subject|0|||
33230986|NCT00474929|100746375|FG003|Overall Study|Withdrawal by Subject|0|||
33230987|NCT00474929|100746376|FG004|Overall Study|Withdrawal by Subject|0|||
33230988|NCT00474929|100746372|FG000|Overall Study|Unrelated medical condition|0|||
33230989|NCT00474929|100746373|FG001|Overall Study|Unrelated medical condition|0|||
33230990|NCT00474929|100746374|FG002|Overall Study|Unrelated medical condition|1|||
33230991|NCT00474929|100746375|FG003|Overall Study|Unrelated medical condition|0|||
33230992|NCT00474929|100746376|FG004|Overall Study|Unrelated medical condition|0|||
33230993|NCT00474929|100746372|FG000|Overall Study|Physician Decision|0|||
33230994|NCT00474929|100746373|FG001|Overall Study|Physician Decision|0|||
33230995|NCT00474929|100746374|FG002|Overall Study|Physician Decision|1|||
33230996|NCT00474929|100746375|FG003|Overall Study|Physician Decision|2|||
33230997|NCT00474929|100746376|FG004|Overall Study|Physician Decision|0|||
33230998|NCT00976482|100746381|FG000|Overall Study|Death|208|||
33230999|NCT00976482|100746381|FG000|Overall Study|Withdrawal by Subject|45|||
33231000|NCT00976482|100746381|FG000|Overall Study|Center terminated|1|||
33231001|NCT00976482|100746381|FG000|Overall Study|Protocol Violation|5|||
33231002|NCT00924560|100746382|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
33231003|NCT00924560|100746383|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
33231004|NCT00924560|100746384|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
33231005|NCT00924560|100746382|FG000|Overall Study|Non Compliance with the Protocol|20|||
33231006|NCT00924560|100746383|FG001|Overall Study|Non Compliance with the Protocol|15|||
33231007|NCT00924560|100746384|FG002|Overall Study|Non Compliance with the Protocol|4|||
33231008|NCT00924560|100746382|FG000|Overall Study|Physician Decision|2|||
33231009|NCT00924560|100746383|FG001|Overall Study|Physician Decision|3|||
33231010|NCT00924560|100746384|FG002|Overall Study|Physician Decision|4|||
33635597|NCT00106704|102218443|FG000|Overall Study|Lack of Efficacy|67|||
33635598|NCT00106704|102218444|FG001|Overall Study|Lack of Efficacy|69|||
33635599|NCT00106704|102218443|FG000|Overall Study|Lost to Follow-up|7|||
33635600|NCT00106704|102218444|FG001|Overall Study|Lost to Follow-up|3|||
33635601|NCT00106704|102218443|FG000|Overall Study|Pregnancy|1|||
33635602|NCT00106704|102218444|FG001|Overall Study|Pregnancy|0|||
33635603|NCT00106704|102218443|FG000|Overall Study|Protocol Violation|4|||
33635604|NCT00106704|102218444|FG001|Overall Study|Protocol Violation|7|||
33635605|NCT00106704|102218443|FG000|Overall Study|Withdrawal by Subject|14|||
33635606|NCT00106704|102218444|FG001|Overall Study|Withdrawal by Subject|21|||
33231011|NCT00924560|100746382|FG000|Overall Study|Withdrawal by Subject|50|||
33231012|NCT00924560|100746383|FG001|Overall Study|Withdrawal by Subject|44|||
33419794|NCT01396161|101428437|FG006|Overall Study|Other|1|||
33635607|NCT00106704|102218443|FG000|Overall Study|Patient moved|1|||
33635608|NCT00106704|102218444|FG001|Overall Study|Patient moved|0|||
33231013|NCT00924560|100746384|FG002|Overall Study|Withdrawal by Subject|18|||
33231014|NCT00924560|100746382|FG000|Overall Study|Adverse Event|39|||
33231015|NCT00924560|100746383|FG001|Overall Study|Adverse Event|33|||
33231016|NCT00924560|100746384|FG002|Overall Study|Adverse Event|0|||
33231017|NCT00924560|100746382|FG000|Overall Study|Pregnancy|5|||
33231018|NCT00924560|100746383|FG001|Overall Study|Pregnancy|7|||
33231019|NCT00924560|100746384|FG002|Overall Study|Pregnancy|1|||
33231020|NCT00924560|100746382|FG000|Overall Study|Lost to Follow-up|78|||
33635609|NCT00106704|102218443|FG000|Overall Study|Site terminated|0|||
33635610|NCT00106704|102218444|FG001|Overall Study|Site terminated|1|||
33635611|NCT00106704|102218443|FG000|Overall Study|Planned major surgery|1|||
33231021|NCT00924560|100746383|FG001|Overall Study|Lost to Follow-up|94|||
33231022|NCT00924560|100746384|FG002|Overall Study|Lost to Follow-up|45|||
33231023|NCT00924560|100746382|FG000|Overall Study|Miscellaneous Reasons|13|||
33635612|NCT00106704|102218444|FG001|Overall Study|Planned major surgery|0|||
33635613|NCT00106704|102218443|FG000|Overall Study|Patient Received Glycemic Medication|22|||
33635614|NCT00106704|102218444|FG001|Overall Study|Patient Received Glycemic Medication|41|||
33635615|NCT00106704|102218443|FG000|Overall Study|Unable to re-enter US|1|||
33635616|NCT00106704|102218444|FG001|Overall Study|Unable to re-enter US|0|||
33635617|NCT00106704|102218443|FG000|Overall Study|Laboratory test|1|||
33635618|NCT00106704|102218444|FG001|Overall Study|Laboratory test|1|||
33635619|NCT02606643|102218447|FG000|Overall Study|did not meet inclusion criteria|1|||
33635620|NCT02606643|102218448|FG001|Overall Study|did not meet inclusion criteria|3|||
33635621|NCT04163016|102218451|FG000|Enrollment|Adverse Event|1|||
33635622|NCT04163016|102218452|FG001|Enrollment|Adverse Event|0|||
33635623|NCT04163016|102218453|FG002|Enrollment|Adverse Event|0|||
33635624|NCT04163016|102218454|FG003|Enrollment|Adverse Event|0|||
33635625|NCT04163016|102218451|FG000|Treatment|Adverse Event|0|||
33635626|NCT04163016|102218452|FG001|Treatment|Adverse Event|1|||
33635627|NCT04163016|102218453|FG002|Treatment|Adverse Event|0|||
33635628|NCT04163016|102218454|FG003|Treatment|Adverse Event|0|||
33635629|NCT04163016|102218451|FG000|Treatment|Withdrawal by Subject|0|||
33635630|NCT04163016|102218452|FG001|Treatment|Withdrawal by Subject|2|||
33635631|NCT04163016|102218453|FG002|Treatment|Withdrawal by Subject|0|||
33635632|NCT04163016|102218454|FG003|Treatment|Withdrawal by Subject|0|||
33635633|NCT04163016|102218451|FG000|Treatment|Indeterminate TB-test|0|||
33635634|NCT04163016|102218452|FG001|Treatment|Indeterminate TB-test|0|||
33635635|NCT04163016|102218453|FG002|Treatment|Indeterminate TB-test|0|||
33635636|NCT04163016|102218454|FG003|Treatment|Indeterminate TB-test|1|||
33635637|NCT04163016|102218451|FG000|Treatment|Participant did not want to continue in study|0|||
33635638|NCT04163016|102218452|FG001|Treatment|Participant did not want to continue in study|0|||
33136460|NCT00717236|100413456|FG000|Open-Label Period|Lack of Efficacy|30|||
33136461|NCT00717236|100413457|FG001|Open-Label Period|Lack of Efficacy|8|||
33136462|NCT00717236|100413456|FG000|Open-Label Period|Lost to Follow-up|28|||
33635639|NCT04163016|102218453|FG002|Treatment|Participant did not want to continue in study|0|||
33231024|NCT00924560|100746383|FG001|Overall Study|Miscellaneous Reasons|10|||
33231025|NCT00924560|100746384|FG002|Overall Study|Miscellaneous Reasons|10|||
33231026|NCT01317875|100746387|FG000|Overall Study|Other|0|||
33231027|NCT01317875|100746388|FG001|Overall Study|Other|0|||
33231028|NCT01317875|100746389|FG002|Overall Study|Other|1|||
33231029|NCT01317875|100746390|FG003|Overall Study|Other|0|||
33231030|NCT01317875|100746391|FG004|Overall Study|Other|0|||
33231031|NCT01317875|100746392|FG005|Overall Study|Other|0|||
33231032|NCT01317875|100746393|FG006|Overall Study|Other|0|||
33231033|NCT01317875|100746394|FG007|Overall Study|Other|0|||
33635640|NCT04163016|102218454|FG003|Treatment|Participant did not want to continue in study|1|||
33635641|NCT01780506|102218455|FG000|Double-Blind Phase|Randomized but not Treated|3|||
33635642|NCT01780506|102218456|FG001|Double-Blind Phase|Randomized but not Treated|2|||
33136463|NCT00717236|100413457|FG001|Open-Label Period|Lost to Follow-up|4|||
33136464|NCT00717236|100413456|FG000|Open-Label Period|Withdrawal by Subject|20|||
33136465|NCT00717236|100413457|FG001|Open-Label Period|Withdrawal by Subject|2|||
33136466|NCT00717236|100413456|FG000|Open-Label Period|Loss of Efficacy|6|||
33136467|NCT00717236|100413457|FG001|Open-Label Period|Loss of Efficacy|1|||
33136468|NCT00717236|100413456|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
33231034|NCT01317875|100746395|FG008|Overall Study|Other|0|||
33231035|NCT01317875|100746396|FG009|Overall Study|Other|0|||
33231036|NCT01317875|100746387|FG000|Overall Study|Noncompliance with study drug|0|||
33231037|NCT01317875|100746388|FG001|Overall Study|Noncompliance with study drug|0|||
33231038|NCT01317875|100746389|FG002|Overall Study|Noncompliance with study drug|1|||
33231039|NCT01317875|100746390|FG003|Overall Study|Noncompliance with study drug|0|||
33231040|NCT01317875|100746391|FG004|Overall Study|Noncompliance with study drug|0|||
33231041|NCT01317875|100746392|FG005|Overall Study|Noncompliance with study drug|0|||
33367849|NCT01356602|101232720|FG001|Overall Study|Lost to Follow-up|5|||
33367850|NCT01356602|101232721|FG002|Overall Study|Lost to Follow-up|6|||
33367851|NCT01356602|101232719|FG000|Overall Study|Withdrawal by Subject|4|||
33419795|NCT01976663|101428438|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
33573783|NCT01816295|101991894|FG000|OLE Phase|Adverse Event|17|||
33573784|NCT01816295|101991895|FG001|OLE Phase|Adverse Event|15|||
33573785|NCT01816295|101991894|FG000|OLE Phase|Death|1|||
33573786|NCT01816295|101991895|FG001|OLE Phase|Death|0|||
33573787|NCT01816295|101991894|FG000|OLE Phase|Entry Criteria Not Met|3|||
33573788|NCT01816295|101991895|FG001|OLE Phase|Entry Criteria Not Met|5|||
33573789|NCT01816295|101991894|FG000|OLE Phase|Lost to Follow-up|5|||
33573790|NCT01816295|101991895|FG001|OLE Phase|Lost to Follow-up|5|||
33573791|NCT01816295|101991894|FG000|OLE Phase|Physician Decision|3|||
33573792|NCT01816295|101991895|FG001|OLE Phase|Physician Decision|1|||
33573793|NCT01816295|101991894|FG000|OLE Phase|Protocol Violation|4|||
33573794|NCT01816295|101991895|FG001|OLE Phase|Protocol Violation|4|||
33635643|NCT01780506|102218455|FG000|Double-Blind Phase|Adverse Event|4|||
33635644|NCT01780506|102218456|FG001|Double-Blind Phase|Adverse Event|14|||
33635645|NCT01780506|102218455|FG000|Double-Blind Phase|Death|1|||
33367852|NCT01356602|101232720|FG001|Overall Study|Withdrawal by Subject|3|||
33367853|NCT01356602|101232721|FG002|Overall Study|Withdrawal by Subject|7|||
33419796|NCT01976663|101428438|FG000|Overall Study|Personal Reasons|6|||
33419797|NCT01976663|101428438|FG000|Overall Study|Withdrawal by Subject|4|||
33419798|NCT01976663|101428438|FG000|Overall Study|Screen Failure|3|||
33419799|NCT01976663|101428438|FG000|Overall Study|Adverse Event|2|||
33419800|NCT01976663|101428438|FG000|Overall Study|Lost to Follow-up|3|||
33419801|NCT02525562|101428439|FG000|Overall Study|Death|9|||
33419802|NCT02525562|101428440|FG001|Overall Study|Death|0|||
33367854|NCT01356602|101232719|FG000|Overall Study|Lack of Efficacy|0|||
33367855|NCT01356602|101232720|FG001|Overall Study|Lack of Efficacy|1|||
33367856|NCT01356602|101232721|FG002|Overall Study|Lack of Efficacy|4|||
33367857|NCT01356602|101232719|FG000|Overall Study|Adverse Event|0|||
33367858|NCT01356602|101232720|FG001|Overall Study|Adverse Event|1|||
33136469|NCT00717236|100413457|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
33136470|NCT00717236|100413456|FG000|Open-Label Period|Other: Lack of Compliance|1|||
33419803|NCT02525562|101428441|FG002|Overall Study|Death|0|||
33419804|NCT02525562|101428439|FG000|Overall Study|Lost to Follow-up|19|||
33419805|NCT02525562|101428440|FG001|Overall Study|Lost to Follow-up|0|||
33419806|NCT02525562|101428441|FG002|Overall Study|Lost to Follow-up|0|||
33419807|NCT02525562|101428439|FG000|Overall Study|Withdrawal by Subject|37|||
33419808|NCT02525562|101428440|FG001|Overall Study|Withdrawal by Subject|0|||
33419809|NCT02525562|101428441|FG002|Overall Study|Withdrawal by Subject|0|||
33419810|NCT02525562|101428439|FG000|Overall Study|Revision/Removal of Study Device|4|||
33419811|NCT02525562|101428440|FG001|Overall Study|Revision/Removal of Study Device|0|||
33419812|NCT02525562|101428441|FG002|Overall Study|Revision/Removal of Study Device|0|||
33419813|NCT02525562|101428439|FG000|Overall Study|Study Closed by Sponsor|154|||
33419814|NCT02525562|101428440|FG001|Overall Study|Study Closed by Sponsor|0|||
33419815|NCT02525562|101428441|FG002|Overall Study|Study Closed by Sponsor|0|||
33573795|NCT01816295|101991894|FG000|OLE Phase|Sponsor Decision|7|||
33573796|NCT01816295|101991895|FG001|OLE Phase|Sponsor Decision|9|||
33573797|NCT01816295|101991894|FG000|OLE Phase|Withdrawal by Subject|10|||
33573798|NCT01816295|101991895|FG001|OLE Phase|Withdrawal by Subject|10|||
33573799|NCT01816295|101991894|FG000|OLE Phase|Lack of Efficacy|3|||
33573800|NCT01816295|101991895|FG001|OLE Phase|Lack of Efficacy|7|||
33573801|NCT00328172|101991898|FG000|Overall Study|Adverse Event|3|||
33573802|NCT00328172|101991899|FG001|Overall Study|Adverse Event|2|||
33573803|NCT00328172|101991900|FG002|Overall Study|Adverse Event|1|||
33573804|NCT00328172|101991901|FG003|Overall Study|Adverse Event|2|||
33573805|NCT00328172|101991902|FG004|Overall Study|Adverse Event|1|||
33573806|NCT00328172|101991898|FG000|Overall Study|Protocol Violation|0|||
33573807|NCT00328172|101991899|FG001|Overall Study|Protocol Violation|1|||
33573808|NCT00328172|101991900|FG002|Overall Study|Protocol Violation|1|||
33573809|NCT00328172|101991901|FG003|Overall Study|Protocol Violation|0|||
33573810|NCT00328172|101991902|FG004|Overall Study|Protocol Violation|0|||
33573811|NCT00328172|101991898|FG000|Overall Study|Lost to Follow-up|1|||
33573812|NCT00328172|101991899|FG001|Overall Study|Lost to Follow-up|1|||
33573813|NCT00328172|101991900|FG002|Overall Study|Lost to Follow-up|2|||
33573814|NCT00328172|101991901|FG003|Overall Study|Lost to Follow-up|1|||
33573815|NCT00328172|101991902|FG004|Overall Study|Lost to Follow-up|1|||
33573816|NCT00328172|101991898|FG000|Overall Study|Withdrawal by Subject|1|||
33573817|NCT00328172|101991899|FG001|Overall Study|Withdrawal by Subject|1|||
33573818|NCT00328172|101991900|FG002|Overall Study|Withdrawal by Subject|1|||
33573819|NCT00328172|101991901|FG003|Overall Study|Withdrawal by Subject|6|||
33573820|NCT00328172|101991902|FG004|Overall Study|Withdrawal by Subject|0|||
33573821|NCT00328172|101991898|FG000|Overall Study|Lack of Efficacy|14|||
33573822|NCT00328172|101991899|FG001|Overall Study|Lack of Efficacy|9|||
33573823|NCT00328172|101991900|FG002|Overall Study|Lack of Efficacy|4|||
33573824|NCT00328172|101991901|FG003|Overall Study|Lack of Efficacy|4|||
33573825|NCT00328172|101991902|FG004|Overall Study|Lack of Efficacy|3|||
33573826|NCT00328172|101991898|FG000|Overall Study|Other reason (not specified)|3|||
33573827|NCT00328172|101991899|FG001|Overall Study|Other reason (not specified)|0|||
33573828|NCT00328172|101991900|FG002|Overall Study|Other reason (not specified)|1|||
33573829|NCT00328172|101991901|FG003|Overall Study|Other reason (not specified)|0|||
33573830|NCT00328172|101991902|FG004|Overall Study|Other reason (not specified)|0|||
33573831|NCT03528902|101991908|FG000|Overall Study|Adverse Event|1|||
33573832|NCT03528902|101991909|FG001|Overall Study|Adverse Event|0|||
33136471|NCT00717236|100413457|FG001|Open-Label Period|Other: Lack of Compliance|1|||
33367859|NCT01356602|101232721|FG002|Overall Study|Adverse Event|1|||
33367860|NCT04070378|101232722|FG000|Overall Study|Withdrawal by Subject|2|||
33136472|NCT00717236|100413456|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
33419816|NCT02163694|101428444|FG000|Overall Study|Adverse event- related to progression|3|||
33419817|NCT02163694|101428445|FG001|Overall Study|Adverse event- related to progression|8|||
33419818|NCT02163694|101428444|FG000|Overall Study|Adverse event- not related to progression|7|||
33573833|NCT02031302|101991910|FG000|Overall Study|Death|115|||
33573834|NCT02031302|101991911|FG001|Overall Study|Death|0|||
33573835|NCT02031302|101991910|FG000|Overall Study|Not treated with study valve system|18|||
33635646|NCT01780506|102218456|FG001|Double-Blind Phase|Death|2|||
33136473|NCT00717236|100413457|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
33136474|NCT00717236|100413456|FG000|Open-Label Period|Other: Moved|1|||
33136475|NCT00717236|100413457|FG001|Open-Label Period|Other: Moved|0|||
33136476|NCT00717236|100413456|FG000|Open-Label Period|Other: Investigator Decision|1|||
33136477|NCT00717236|100413457|FG001|Open-Label Period|Other: Investigator Decision|0|||
33136478|NCT00717236|100413456|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
33136479|NCT00717236|100413457|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
33136480|NCT00717236|100413456|FG000|Open-Label Period|Other: Sponsor Request|3|||
33136481|NCT00717236|100413457|FG001|Open-Label Period|Other: Sponsor Request|0|||
33136482|NCT00717236|100413456|FG000|Open-Label Period|Other: Cataract Surgery|1|||
33136483|NCT00717236|100413457|FG001|Open-Label Period|Other: Cataract Surgery|0|||
33136484|NCT00717236|100413456|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
33136485|NCT00717236|100413457|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
33136486|NCT00717236|100413456|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
33136487|NCT00717236|100413457|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
33136488|NCT00717236|100413456|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
33136489|NCT00717236|100413457|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
33136490|NCT04605991|100413458|FG000|Overall Study|Adverse Event|5|||
33136491|NCT04605991|100413458|FG000|Overall Study|Lack of Efficacy|1|||
33136492|NCT04605991|100413458|FG000|Overall Study|Lost to Follow-up|8|||
33136493|NCT04605991|100413458|FG000|Overall Study|Physician Decision|4|||
33136494|NCT04605991|100413458|FG000|Overall Study|Withdrawal by Subject|14|||
33136495|NCT04605991|100413458|FG000|Overall Study|Non-compliance with study|1|||
33136496|NCT00910299|100413459|FG000|Overall Study|Withdrawal by Subject|16|||
33136497|NCT00910299|100413460|FG001|Overall Study|Withdrawal by Subject|13|||
33136498|NCT00910299|100413459|FG000|Overall Study|Sponsor Decision|58|||
33136499|NCT00910299|100413460|FG001|Overall Study|Sponsor Decision|60|||
33136500|NCT00910299|100413459|FG000|Overall Study|Didn't receive any study drug|2|||
33136501|NCT00910299|100413460|FG001|Overall Study|Didn't receive any study drug|1|||
33419819|NCT02163694|101428445|FG001|Overall Study|Adverse event- not related to progression|17|||
33419820|NCT02163694|101428444|FG000|Overall Study|Withdrew consent|8|||
33419821|NCT02163694|101428445|FG001|Overall Study|Withdrew consent|21|||
33419822|NCT02163694|101428444|FG000|Overall Study|Lost to Follow-up|1|||
33419823|NCT02163694|101428445|FG001|Overall Study|Lost to Follow-up|2|||
33419824|NCT02163694|101428444|FG000|Overall Study|Progressive disease per protocol|122|||
33419825|NCT02163694|101428445|FG001|Overall Study|Progressive disease per protocol|197|||
33419826|NCT02163694|101428444|FG000|Overall Study|Other, not specified|13|||
33419827|NCT02163694|101428445|FG001|Overall Study|Other, not specified|22|||
33419828|NCT01227954|101428446|FG000|Overall Study|Protocol Violation|6|||
33419829|NCT01227954|101428446|FG000|Overall Study|No protocol treatment|7|||
33419830|NCT04440007|101428447|FG000|Overall Study|Adverse Event|0|||
33419831|NCT04440007|101428448|FG001|Overall Study|Adverse Event|1|||
33419832|NCT04440007|101428447|FG000|Overall Study|Lost to Follow-up|1|||
33419833|NCT04440007|101428448|FG001|Overall Study|Lost to Follow-up|3|||
33419834|NCT04440007|101428447|FG000|Overall Study|Death|7|||
33419835|NCT04440007|101428448|FG001|Overall Study|Death|2|||
33419836|NCT04440007|101428447|FG000|Overall Study|Physician Decision|1|||
33419837|NCT04440007|101428448|FG001|Overall Study|Physician Decision|1|||
33419838|NCT04440007|101428447|FG000|Overall Study|Withdrawal by Subject|2|||
33573836|NCT02031302|101991911|FG001|Overall Study|Not treated with study valve system|0|||
33573837|NCT02031302|101991910|FG000|Overall Study|Missed Follow Up|27|||
33573838|NCT02031302|101991911|FG001|Overall Study|Missed Follow Up|0|||
33573839|NCT02031302|101991910|FG000|Overall Study|Lost to Follow-up|4|||
33573840|NCT02031302|101991911|FG001|Overall Study|Lost to Follow-up|0|||
33573841|NCT04288089|101991912|FG000|Overall Study|Ongoing Treatment|2|||
33573842|NCT04288089|101991913|FG001|Overall Study|Ongoing Treatment|1|||
33573843|NCT04288089|101991914|FG002|Overall Study|Ongoing Treatment|1|||
33573844|NCT04288089|101991915|FG003|Overall Study|Ongoing Treatment|4|||
33367861|NCT04070378|101232722|FG000|Overall Study|Screen Failure|6|||
33573845|NCT05523323|101991916|FG000|Overall Study|Death|26|||
33367862|NCT04070378|101232722|FG000|Overall Study|Physician Decision|1|||
33419839|NCT04440007|101428448|FG001|Overall Study|Withdrawal by Subject|1|||
33419840|NCT04440007|101428447|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
33573846|NCT05523323|101991917|FG001|Overall Study|Death|21|||
33635647|NCT01780506|102218455|FG000|Double-Blind Phase|Pregnancy|2|||
33419841|NCT04440007|101428448|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
33573847|NCT05523323|101991916|FG000|Overall Study|Ongoing participants|35|||
33573848|NCT05523323|101991917|FG001|Overall Study|Ongoing participants|30|||
33573849|NCT00027560|101991920|FG000|Overall Study|Withdrawal by Subject|1|||
33231042|NCT01317875|100746393|FG006|Overall Study|Noncompliance with study drug|0|||
33231043|NCT01317875|100746394|FG007|Overall Study|Noncompliance with study drug|0|||
33231044|NCT01317875|100746395|FG008|Overall Study|Noncompliance with study drug|0|||
33231045|NCT01317875|100746396|FG009|Overall Study|Noncompliance with study drug|0|||
33231046|NCT01317875|100746387|FG000|Overall Study|Progressive Disease|1|||
33367863|NCT04070378|101232722|FG000|Overall Study|Adverse Event|1|||
33367864|NCT01605071|101232723|FG000|Overall Study|Withdrawal by Subject|3|||
33367865|NCT01605071|101232724|FG001|Overall Study|Withdrawal by Subject|2|||
33367866|NCT03268746|101232731|FG000|Overall Study|Withdrawal by Subject|1|||
33367867|NCT03042611|101232732|FG000|Core Phase|Withdrawal by Subject|13|||
33367868|NCT03042611|101232733|FG001|Core Phase|Withdrawal by Subject|4|||
33367869|NCT03042611|101232734|FG002|Core Phase|Withdrawal by Subject|0|||
33367870|NCT03042611|101232735|FG003|Core Phase|Withdrawal by Subject|0|||
33367871|NCT03042611|101232732|FG000|Core Phase|Death|232|||
33367872|NCT03042611|101232733|FG001|Core Phase|Death|110|||
33367873|NCT03042611|101232734|FG002|Core Phase|Death|0|||
33367874|NCT03042611|101232735|FG003|Core Phase|Death|0|||
33367875|NCT03042611|101232732|FG000|Core Phase|Lost to Follow-up|4|||
33367876|NCT03042611|101232733|FG001|Core Phase|Lost to Follow-up|7|||
33367877|NCT03042611|101232734|FG002|Core Phase|Lost to Follow-up|0|||
33367878|NCT03042611|101232735|FG003|Core Phase|Lost to Follow-up|0|||
33367879|NCT03042611|101232732|FG000|Core Phase|Physician Decision|7|||
33367880|NCT03042611|101232733|FG001|Core Phase|Physician Decision|2|||
33367881|NCT03042611|101232734|FG002|Core Phase|Physician Decision|0|||
33367882|NCT03042611|101232735|FG003|Core Phase|Physician Decision|0|||
33367883|NCT03042611|101232732|FG000|Core Phase|Study Closed|0|||
33367884|NCT03042611|101232733|FG001|Core Phase|Study Closed|1|||
33367885|NCT03042611|101232734|FG002|Core Phase|Study Closed|0|||
33367886|NCT03042611|101232735|FG003|Core Phase|Study Closed|0|||
33367887|NCT03042611|101232732|FG000|Extension Phase|Death|0|||
33367888|NCT03042611|101232733|FG001|Extension Phase|Death|0|||
33367889|NCT03042611|101232734|FG002|Extension Phase|Death|34|||
33367890|NCT03042611|101232735|FG003|Extension Phase|Death|16|||
33367891|NCT03042611|101232732|FG000|Extension Phase|Lost to Follow-up|0|||
33367892|NCT03042611|101232733|FG001|Extension Phase|Lost to Follow-up|0|||
33367893|NCT03042611|101232734|FG002|Extension Phase|Lost to Follow-up|1|||
33367894|NCT03042611|101232735|FG003|Extension Phase|Lost to Follow-up|1|||
33367895|NCT03042611|101232732|FG000|Extension Phase|Study Closed|0|||
33367896|NCT03042611|101232733|FG001|Extension Phase|Study Closed|0|||
33367897|NCT03042611|101232734|FG002|Extension Phase|Study Closed|17|||
33367898|NCT03042611|101232735|FG003|Extension Phase|Study Closed|11|||
33367899|NCT03844633|101232736|FG000|1 Week FU|Lost to Follow-up|0|||
33367900|NCT03844633|101232737|FG001|1 Week FU|Lost to Follow-up|1|||
33367901|NCT03844633|101232738|FG002|1 Week FU|Lost to Follow-up|4|||
33367902|NCT03844633|101232736|FG000|12-month Follow-up|Lost to Follow-up|7|||
33367903|NCT03844633|101232737|FG001|12-month Follow-up|Lost to Follow-up|5|||
33367904|NCT03844633|101232738|FG002|12-month Follow-up|Lost to Follow-up|8|||
33367905|NCT01166659|101232739|FG000|Overall Study|Subject Decision|8|||
33367906|NCT01166659|101232739|FG000|Overall Study|Investigator Decision|2|||
33367907|NCT01166659|101232739|FG000|Overall Study|Death|1|||
33367908|NCT01166659|101232739|FG000|Overall Study|Lost to Follow-up|1|||
33367909|NCT01166659|101232739|FG000|Overall Study|Study Closed at Site|1|||
33367910|NCT00001262|101232747|FG000|Overall Study|Death|10|||
33367911|NCT00001262|101232748|FG001|Overall Study|Death|11|||
33573850|NCT03064074|101991923|FG000|Overall Study|Physician Decision|0|||
33573851|NCT03064074|101991924|FG001|Overall Study|Physician Decision|0|||
33573852|NCT03064074|101991925|FG002|Overall Study|Physician Decision|0|||
33573853|NCT03064074|101991926|FG003|Overall Study|Physician Decision|1|||
33573854|NCT00332696|101991932|FG000|Overall Study|Death|24|||
33573855|NCT00332696|101991933|FG001|Overall Study|Death|14|||
33573856|NCT00332696|101991932|FG000|Overall Study|Insufficient therapeutic effect|4|||
33573857|NCT00332696|101991933|FG001|Overall Study|Insufficient therapeutic effect|11|||
33573858|NCT00332696|101991932|FG000|Overall Study|Adverse Event|1|||
33231047|NCT01317875|100746388|FG001|Overall Study|Progressive Disease|0|||
33367912|NCT00001262|101232749|FG002|Overall Study|Death|0|||
33367913|NCT00001262|101232747|FG000|Overall Study|Withdrawal by Subject|0|||
33367914|NCT00001262|101232748|FG001|Overall Study|Withdrawal by Subject|3|||
33231048|NCT01317875|100746389|FG002|Overall Study|Progressive Disease|2|||
33367915|NCT00001262|101232749|FG002|Overall Study|Withdrawal by Subject|0|||
33367916|NCT02742649|101232750|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
33367917|NCT02742649|101232751|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
33367918|NCT02742649|101232752|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
33367919|NCT02742649|101232753|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
33367920|NCT02742649|101232754|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
33367921|NCT02742649|101232750|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33367922|NCT02742649|101232751|FG001|Double-Blind Treatment Period|Adverse Event|1|||
33367923|NCT02742649|101232752|FG002|Double-Blind Treatment Period|Adverse Event|0|||
33367924|NCT02742649|101232753|FG003|Double-Blind Treatment Period|Adverse Event|0|||
33367925|NCT02742649|101232754|FG004|Double-Blind Treatment Period|Adverse Event|0|||
33367926|NCT02742649|101232750|FG000|Open-Label Period|Lost to Follow-up|0|||
33573859|NCT00332696|101991933|FG001|Overall Study|Adverse Event|2|||
33635648|NCT01780506|102218456|FG001|Double-Blind Phase|Pregnancy|1|||
33635649|NCT01780506|102218455|FG000|Double-Blind Phase|Lack of Efficacy|1|||
33136530|NCT03598114|100413468|FG000|Overall Study|Staff turnover/left the program|3|||
33136531|NCT03598114|100413469|FG001|Overall Study|Staff turnover/left the program|39|||
33635650|NCT01780506|102218456|FG001|Double-Blind Phase|Lack of Efficacy|1|||
33136544|NCT00600119|100413472|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
33136545|NCT00600119|100413473|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
33573860|NCT00332696|101991932|FG000|Overall Study|Condition does not justify treatment|0|||
33573861|NCT00332696|101991933|FG001|Overall Study|Condition does not justify treatment|2|||
33573862|NCT00332696|101991932|FG000|Overall Study|Lost to Follow-up|0|||
33573863|NCT00332696|101991933|FG001|Overall Study|Lost to Follow-up|1|||
33573864|NCT00332696|101991932|FG000|Overall Study|Withdrawal by Subject|1|||
33573865|NCT00332696|101991933|FG001|Overall Study|Withdrawal by Subject|0|||
33573866|NCT01593917|101991939|FG000|Overall Study|Death|67|||
33573867|NCT01593917|101991939|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
33573868|NCT01593917|101991939|FG000|Overall Study|Withdrawal by Subject|23|||
33573869|NCT01593917|101991939|FG000|Overall Study|Lost to Follow-up|12|||
33573870|NCT01593917|101991939|FG000|Overall Study|Protocol Violation|5|||
33573871|NCT01593917|101991939|FG000|Overall Study|Physician Decision|3|||
33573872|NCT01323192|101991940|FG000|Overall Study|Adverse Event|6|||
33573873|NCT01323192|101991941|FG001|Overall Study|Adverse Event|1|||
33635651|NCT01780506|102218455|FG000|Double-Blind Phase|Investigator's Discretion|5|||
33136546|NCT00600119|100413474|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
33136547|NCT00600119|100413475|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
33136548|NCT00600119|100413476|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
33136549|NCT00600119|100413477|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
33136550|NCT00600119|100413472|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33635652|NCT01780506|102218456|FG001|Double-Blind Phase|Investigator's Discretion|2|||
33635653|NCT01780506|102218455|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
33136551|NCT00600119|100413473|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
33136552|NCT00600119|100413474|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
33136553|NCT00600119|100413475|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33367927|NCT02742649|101232751|FG001|Open-Label Period|Lost to Follow-up|0|||
33367928|NCT02742649|101232752|FG002|Open-Label Period|Lost to Follow-up|0|||
33136554|NCT00600119|100413476|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33367929|NCT02742649|101232753|FG003|Open-Label Period|Lost to Follow-up|0|||
33635654|NCT01780506|102218456|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
33635655|NCT01780506|102218455|FG000|Double-Blind Phase|Protocol Violation|4|||
33635656|NCT01780506|102218456|FG001|Double-Blind Phase|Protocol Violation|3|||
33635657|NCT01780506|102218455|FG000|Double-Blind Phase|Withdrew Consent|23|||
33635658|NCT01780506|102218456|FG001|Double-Blind Phase|Withdrew Consent|24|||
33367930|NCT02742649|101232754|FG004|Open-Label Period|Lost to Follow-up|1|||
33367931|NCT01455428|101232755|FG000|Overall Study|Protocol Violation|2|||
33635659|NCT01780506|102218455|FG000|Double-Blind Phase|Lost to Follow-up|23|||
33635660|NCT01780506|102218456|FG001|Double-Blind Phase|Lost to Follow-up|26|||
33635661|NCT01780506|102218455|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
33635662|NCT01780506|102218456|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
33635663|NCT02691507|102218457|FG000|Overall Study|Missed Visit 3|0|||
33635664|NCT02691507|102218458|FG001|Overall Study|Missed Visit 3|1|||
33367932|NCT01455428|101232756|FG001|Overall Study|Protocol Violation|1|||
33367933|NCT01455428|101232755|FG000|Overall Study|Adverse Event|6|||
33367934|NCT01455428|101232756|FG001|Overall Study|Adverse Event|2|||
33367935|NCT01455428|101232755|FG000|Overall Study|Lost to Follow-up|1|||
33367936|NCT01455428|101232756|FG001|Overall Study|Lost to Follow-up|1|||
33367937|NCT01455428|101232755|FG000|Overall Study|Withdrawal by Subject|2|||
33367938|NCT01455428|101232756|FG001|Overall Study|Withdrawal by Subject|5|||
33367939|NCT01455428|101232755|FG000|Overall Study|Did not meet entrance criteria|0|||
33367940|NCT01455428|101232756|FG001|Overall Study|Did not meet entrance criteria|2|||
33367941|NCT01455428|101232755|FG000|Overall Study|Insufficient clinical response|0|||
33367942|NCT01455428|101232756|FG001|Overall Study|Insufficient clinical response|2|||
33367943|NCT01455428|101232755|FG000|Overall Study|Did not receive treatment|1|||
33367944|NCT01455428|101232756|FG001|Overall Study|Did not receive treatment|1|||
33367945|NCT01455428|101232755|FG000|Overall Study|Other|2|||
33367946|NCT01455428|101232756|FG001|Overall Study|Other|4|||
33367947|NCT02778867|101232757|FG000|Phase 1|Withdrawal by Subject|2|||
33367948|NCT02778867|101232758|FG001|Phase 1|Withdrawal by Subject|3|||
33367949|NCT02778867|101232759|FG002|Phase 1|Withdrawal by Subject|0|||
33367950|NCT02778867|101232760|FG003|Phase 1|Withdrawal by Subject|0|||
33367951|NCT02778867|101232757|FG000|Phase 2|Withdrawal by Subject|0|||
33367952|NCT02778867|101232758|FG001|Phase 2|Withdrawal by Subject|0|||
33367953|NCT02778867|101232759|FG002|Phase 2|Withdrawal by Subject|1|||
33367954|NCT02778867|101232760|FG003|Phase 2|Withdrawal by Subject|0|||
33367955|NCT02778867|101232757|FG000|Phase 2|Physician Decision|0|||
33367956|NCT02778867|101232758|FG001|Phase 2|Physician Decision|0|||
33419842|NCT04440007|101428447|FG000|Overall Study|Discontinued prior to dosing|0|||
33419843|NCT04440007|101428448|FG001|Overall Study|Discontinued prior to dosing|2|||
33419844|NCT03343054|101428449|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
33419845|NCT03343054|101428450|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
33419846|NCT03343054|101428451|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
33419847|NCT03343054|101428449|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
33419848|NCT03343054|101428450|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
33419849|NCT03343054|101428451|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
33573874|NCT01323192|101991940|FG000|Overall Study|Withdrawal by Subject|3|||
33573875|NCT01323192|101991941|FG001|Overall Study|Withdrawal by Subject|1|||
33573876|NCT01323192|101991940|FG000|Overall Study|Noncompliance with study medication|0|||
33573877|NCT01323192|101991941|FG001|Overall Study|Noncompliance with study medication|3|||
33573878|NCT01323192|101991940|FG000|Overall Study|Nonmedical reasons|0|||
33573879|NCT01323192|101991941|FG001|Overall Study|Nonmedical reasons|1|||
33573880|NCT03440008|101991943|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
33573881|NCT03440008|101991944|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
33573882|NCT03440008|101991943|FG000|Overall Study|Withdrawal by Subject|1|||
33573883|NCT03440008|101991944|FG001|Overall Study|Withdrawal by Subject|0|||
33573884|NCT00776230|101991946|FG000|Overall Study|Lost to Follow-up|2|||
33573885|NCT00776230|101991947|FG001|Overall Study|Lost to Follow-up|1|||
33635665|NCT00674817|102218460|FG000|Period 1|Withdrawal by Subject|2|||
33635666|NCT00674817|102218460|FG000|Period 1|Protocol Violation|1|||
33635667|NCT00674817|102218460|FG000|Period 3|Adverse Event|1|||
33635668|NCT00674817|102218460|FG000|Period 3|Protocol Violation|1|||
33635669|NCT00674817|102218460|FG000|Period 4|Adverse Event|1|||
33635670|NCT04986904|102218464|FG000|Overall Study|Lost to Follow-up|11|||
33635671|NCT04986904|102218464|FG000|Overall Study|Withdrawal by Subject|1|||
33231049|NCT01317875|100746390|FG003|Overall Study|Progressive Disease|0|||
33367957|NCT02778867|101232759|FG002|Phase 2|Physician Decision|0|||
33367958|NCT02778867|101232760|FG003|Phase 2|Physician Decision|1|||
33573886|NCT00776230|101991948|FG002|Overall Study|Lost to Follow-up|5|||
33635672|NCT00949702|102218465|FG000|Overall Study|Death|40|||
33635673|NCT00949702|102218465|FG000|Overall Study|Disease progression|7|||
33635674|NCT00949702|102218465|FG000|Overall Study|Withdrawal of consent|1|||
33367959|NCT02778867|101232757|FG000|Phase 2|Adverse Event|0|||
33367960|NCT02778867|101232758|FG001|Phase 2|Adverse Event|0|||
33573887|NCT00776230|101991946|FG000|Overall Study|Not vaccinated at Day 0|1|||
33573888|NCT00776230|101991947|FG001|Overall Study|Not vaccinated at Day 0|0|||
33573889|NCT00776230|101991948|FG002|Overall Study|Not vaccinated at Day 0|0|||
33573890|NCT00776230|101991946|FG000|Overall Study|Withdrawal by Subject|0|||
33573891|NCT00776230|101991947|FG001|Overall Study|Withdrawal by Subject|1|||
33573892|NCT00776230|101991948|FG002|Overall Study|Withdrawal by Subject|0|||
33573893|NCT00776230|101991946|FG000|Overall Study|Subject missed Visit 4|0|||
33573894|NCT00776230|101991947|FG001|Overall Study|Subject missed Visit 4|1|||
33573895|NCT00776230|101991948|FG002|Overall Study|Subject missed Visit 4|0|||
33573896|NCT05071053|101991949|FG000|Overall Study|Ongoing study treatment at the time of primary analysis completion|2|||
33573897|NCT05071053|101991949|FG000|Overall Study|Progressive disease|28|||
33136555|NCT00600119|100413477|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
33136556|NCT00600119|100413472|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
33136557|NCT00600119|100413473|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
33136558|NCT00600119|100413474|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
33136559|NCT00600119|100413475|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
33573898|NCT05071053|101991949|FG000|Overall Study|Adverse Event|5|||
33573899|NCT04447755|101991950|FG000|Overall Study|Death|8|||
33573900|NCT04447755|101991951|FG001|Overall Study|Death|14|||
33573901|NCT04447755|101991952|FG002|Overall Study|Death|8|||
33573902|NCT04447755|101991953|FG003|Overall Study|Death|9|||
33573903|NCT04447755|101991954|FG004|Overall Study|Death|7|||
33573904|NCT04447755|101991955|FG005|Overall Study|Death|7|||
33573905|NCT04447755|101991956|FG006|Overall Study|Death|40|||
33573906|NCT04447755|101991950|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33573907|NCT04447755|101991951|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33573908|NCT04447755|101991952|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
33573909|NCT04447755|101991953|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
33573910|NCT04447755|101991954|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
33573911|NCT04447755|101991955|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
33573912|NCT04447755|101991956|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
33573913|NCT04447755|101991950|FG000|Overall Study|Ongoing in Study|1|||
33573914|NCT04447755|101991951|FG001|Overall Study|Ongoing in Study|2|||
33573915|NCT04447755|101991952|FG002|Overall Study|Ongoing in Study|0|||
33573916|NCT04447755|101991953|FG003|Overall Study|Ongoing in Study|0|||
33573917|NCT04447755|101991954|FG004|Overall Study|Ongoing in Study|2|||
33573918|NCT04447755|101991955|FG005|Overall Study|Ongoing in Study|2|||
33573919|NCT04447755|101991956|FG006|Overall Study|Ongoing in Study|26|||
33573920|NCT03941483|101991958|FG000|Overall Study|Miscellaneous|2|||
33573921|NCT03941483|101991959|FG001|Overall Study|Miscellaneous|3|||
33573922|NCT03941483|101991960|FG002|Overall Study|Miscellaneous|0|||
33573923|NCT03941483|101991958|FG000|Overall Study|Study Terminated by Sponsor|1|||
33573924|NCT03941483|101991959|FG001|Overall Study|Study Terminated by Sponsor|0|||
33635675|NCT01958164|102218466|FG000|Overall Study|Adverse Event|0|||
33635676|NCT01958164|102218467|FG001|Overall Study|Adverse Event|2|||
33635677|NCT01958164|102218466|FG000|Overall Study|Lost to Follow-up|2|||
33635678|NCT01958164|102218467|FG001|Overall Study|Lost to Follow-up|3|||
33635679|NCT02120898|102218468|FG000|Overall Study|Withdrawal by Subject|4|||
33635680|NCT02120898|102218469|FG001|Overall Study|Withdrawal by Subject|2|||
33635681|NCT02120898|102218470|FG002|Overall Study|Withdrawal by Subject|2|||
33635682|NCT02120898|102218468|FG000|Overall Study|Non-compliance with study drug|3|||
33635683|NCT02120898|102218469|FG001|Overall Study|Non-compliance with study drug|0|||
33635684|NCT02120898|102218470|FG002|Overall Study|Non-compliance with study drug|0|||
33635685|NCT02120898|102218468|FG000|Overall Study|Adverse Event|1|||
33635686|NCT02120898|102218469|FG001|Overall Study|Adverse Event|2|||
33635687|NCT02120898|102218470|FG002|Overall Study|Adverse Event|1|||
33635688|NCT02120898|102218468|FG000|Overall Study|Protocol Violation|1|||
33635689|NCT02120898|102218469|FG001|Overall Study|Protocol Violation|2|||
33136560|NCT00600119|100413476|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
33136561|NCT00600119|100413477|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
33136562|NCT00600119|100413472|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
33136563|NCT00600119|100413473|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
33136564|NCT00600119|100413474|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
33231050|NCT01317875|100746391|FG004|Overall Study|Progressive Disease|1|||
33231051|NCT01317875|100746392|FG005|Overall Study|Progressive Disease|0|||
33573925|NCT03941483|101991960|FG002|Overall Study|Study Terminated by Sponsor|0|||
33573926|NCT03941483|101991958|FG000|Overall Study|Withdrawal by Subject|1|||
33573927|NCT03941483|101991959|FG001|Overall Study|Withdrawal by Subject|4|||
33573928|NCT03941483|101991960|FG002|Overall Study|Withdrawal by Subject|1|||
33573929|NCT03941483|101991958|FG000|Overall Study|Lost to Follow-up|2|||
33573930|NCT03941483|101991959|FG001|Overall Study|Lost to Follow-up|1|||
33573931|NCT03941483|101991960|FG002|Overall Study|Lost to Follow-up|8|||
33635690|NCT02120898|102218470|FG002|Overall Study|Protocol Violation|0|||
33635691|NCT02120898|102218468|FG000|Overall Study|Lost to Follow-up|0|||
33635692|NCT02120898|102218469|FG001|Overall Study|Lost to Follow-up|0|||
33635693|NCT02120898|102218470|FG002|Overall Study|Lost to Follow-up|1|||
33573932|NCT03941483|101991958|FG000|Overall Study|Death|3|||
33136565|NCT00600119|100413475|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
33136566|NCT00600119|100413476|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
33136567|NCT00600119|100413477|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
33136568|NCT00600119|100413472|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
33136569|NCT00600119|100413473|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
33136570|NCT00600119|100413474|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
33136571|NCT00600119|100413475|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
33136572|NCT00600119|100413476|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
33136573|NCT00600119|100413477|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
33136574|NCT00600119|100413472|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
33136575|NCT00600119|100413473|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
33136576|NCT00600119|100413474|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
33136577|NCT00600119|100413475|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
33136578|NCT00600119|100413476|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
33136579|NCT00600119|100413477|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
33136580|NCT00600119|100413472|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
33136581|NCT00600119|100413473|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
33136582|NCT00600119|100413474|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33136583|NCT00600119|100413475|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
33136584|NCT00600119|100413476|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
33136585|NCT00600119|100413477|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
33136586|NCT00600119|100413472|FG000|Double-blind Treatment Period|Other|0|||
33136587|NCT00600119|100413473|FG001|Double-blind Treatment Period|Other|0|||
33136588|NCT00600119|100413474|FG002|Double-blind Treatment Period|Other|0|||
33136589|NCT00600119|100413475|FG003|Double-blind Treatment Period|Other|0|||
33136590|NCT00600119|100413476|FG004|Double-blind Treatment Period|Other|2|||
33136591|NCT00600119|100413477|FG005|Double-blind Treatment Period|Other|1|||
33136592|NCT00600119|100413472|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
33136593|NCT00600119|100413473|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
33136594|NCT00600119|100413474|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
33136595|NCT00600119|100413475|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
33136596|NCT00600119|100413476|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
33136597|NCT00600119|100413477|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
33136598|NCT00600119|100413472|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
33136599|NCT00600119|100413473|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
33573933|NCT03941483|101991959|FG001|Overall Study|Death|2|||
33573934|NCT03941483|101991960|FG002|Overall Study|Death|6|||
33573935|NCT01668004|101991961|FG000|Overall Study|Adverse Event|7|||
33573936|NCT01668004|101991961|FG000|Overall Study|Withdrawal by Subject|2|||
33573937|NCT01668004|101991961|FG000|Overall Study|Lost to Follow-up|5|||
33573938|NCT01668004|101991961|FG000|Overall Study|Lack of Efficacy|9|||
33573939|NCT01668004|101991961|FG000|Overall Study|Non-compliance with treatment|2|||
33573940|NCT01128569|101991962|FG000|Washout Period 1|Adverse Event|0|||
33573941|NCT01128569|101991963|FG001|Washout Period 1|Adverse Event|0|||
33573942|NCT01128569|101991964|FG002|Washout Period 1|Adverse Event|1|||
33573943|NCT01128569|101991965|FG003|Washout Period 1|Adverse Event|0|||
33136600|NCT00600119|100413474|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
33136601|NCT00600119|100413475|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
33136602|NCT00600119|100413476|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
33136603|NCT00600119|100413477|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
33136604|NCT00600119|100413472|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
33231052|NCT01317875|100746393|FG006|Overall Study|Progressive Disease|0|||
33136605|NCT00600119|100413473|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
33136606|NCT00600119|100413474|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
33136607|NCT00600119|100413475|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
33136608|NCT00600119|100413476|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
33136609|NCT00600119|100413477|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
33231053|NCT01317875|100746394|FG007|Overall Study|Progressive Disease|1|||
33231054|NCT01317875|100746395|FG008|Overall Study|Progressive Disease|0|||
33419850|NCT03343054|101428449|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
33573944|NCT01128569|101991966|FG004|Washout Period 1|Adverse Event|0|||
33136610|NCT00600119|100413472|FG000|Double-blind Treatment Period|Physician Decision|2|||
33573945|NCT01128569|101991967|FG005|Washout Period 1|Adverse Event|0|||
33573946|NCT01128569|101991962|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33573947|NCT01128569|101991963|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33573948|NCT01128569|101991964|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33573949|NCT01128569|101991965|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33573950|NCT01128569|101991966|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33573951|NCT01128569|101991967|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33573952|NCT03366337|101991968|FG000|Overall Study|Lost to Follow-up|1|||
33573953|NCT03366337|101991969|FG001|Overall Study|Lost to Follow-up|0|||
33573954|NCT03366337|101991970|FG002|Overall Study|Lost to Follow-up|1|||
33573955|NCT03366337|101991971|FG003|Overall Study|Lost to Follow-up|0|||
33573956|NCT03366337|101991968|FG000|Overall Study|Withdrawal by Subject|2|||
33573957|NCT03366337|101991969|FG001|Overall Study|Withdrawal by Subject|0|||
33573958|NCT03366337|101991970|FG002|Overall Study|Withdrawal by Subject|1|||
33573959|NCT03366337|101991971|FG003|Overall Study|Withdrawal by Subject|1|||
33573960|NCT00335829|101991979|FG000|Overall Study|Withdrawal by Subject|1|||
33573961|NCT00335829|101991979|FG000|Overall Study|Lost to Follow-up|1|||
33573962|NCT00335829|101991979|FG000|Overall Study|Adverse Event|1|||
33573963|NCT01463527|101991981|FG000|Overall Study|Protocol Violation|1|||
33573964|NCT01463527|101991982|FG001|Overall Study|Protocol Violation|1|||
33573965|NCT01463527|101991981|FG000|Overall Study|Crying >20% of sedation|5|||
33573966|NCT01463527|101991982|FG001|Overall Study|Crying >20% of sedation|6|||
33573967|NCT04778592|101991983|FG000|Overall Study|Adverse Event|1|||
33635694|NCT05786651|102218471|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
33635695|NCT01598532|102218473|FG000|Overall Study|Lost to Follow-up|3|||
33635696|NCT01598532|102218473|FG000|Overall Study|Did not meet inclusion criteria|8|||
33635697|NCT01318915|102218475|FG000|Overall Study|Lost to Follow-up|1|||
33635698|NCT01294553|102218476|FG000|Overall Study|Duplicated Participants|1|||
33635699|NCT01294553|102218476|FG000|Overall Study|Protocol Violation|268|||
33635700|NCT01457703|102218477|FG000|Overall Study|Screen Failure|5|||
33635701|NCT01457703|102218478|FG001|Overall Study|Screen Failure|7|||
33635702|NCT01457703|102218477|FG000|Overall Study|Withdrawal by Subject|1|||
33635703|NCT01457703|102218478|FG001|Overall Study|Withdrawal by Subject|4|||
33635704|NCT00577889|102218479|FG000|Overall Study|Withdrawal by Subject|1|||
33635705|NCT00577889|102218480|FG001|Overall Study|Withdrawal by Subject|0|||
33635706|NCT00577889|102218481|FG002|Overall Study|Withdrawal by Subject|0|||
33635707|NCT02963506|102218483|FG000|Double-Blind Period|Adverse Event|0|||
33635708|NCT02963506|102218484|FG001|Double-Blind Period|Adverse Event|0|||
33635709|NCT02963506|102218485|FG002|Double-Blind Period|Adverse Event|1|||
33635710|NCT02963506|102218486|FG003|Double-Blind Period|Adverse Event|0|||
33635711|NCT02963506|102218487|FG004|Double-Blind Period|Adverse Event|0|||
33635712|NCT02963506|102218488|FG005|Double-Blind Period|Adverse Event|0|||
33635713|NCT02963506|102218489|FG006|Double-Blind Period|Adverse Event|0|||
33635714|NCT02963506|102218490|FG007|Double-Blind Period|Adverse Event|0|||
33635715|NCT02963506|102218491|FG008|Double-Blind Period|Adverse Event|0|||
33635716|NCT02963506|102218492|FG009|Double-Blind Period|Adverse Event|0|||
33635717|NCT02963506|102218493|FG010|Double-Blind Period|Adverse Event|0|||
33635718|NCT02963506|102218494|FG011|Double-Blind Period|Adverse Event|0|||
33635719|NCT02963506|102218495|FG012|Double-Blind Period|Adverse Event|0|||
33635720|NCT02963506|102218483|FG000|Double-Blind Period|Death|0|||
33635721|NCT02963506|102218484|FG001|Double-Blind Period|Death|0|||
33635722|NCT02963506|102218485|FG002|Double-Blind Period|Death|0|||
33635723|NCT02963506|102218486|FG003|Double-Blind Period|Death|1|||
33635724|NCT02963506|102218487|FG004|Double-Blind Period|Death|0|||
33635725|NCT02963506|102218488|FG005|Double-Blind Period|Death|0|||
33635726|NCT02963506|102218489|FG006|Double-Blind Period|Death|0|||
33635727|NCT02963506|102218490|FG007|Double-Blind Period|Death|0|||
33635728|NCT02963506|102218491|FG008|Double-Blind Period|Death|0|||
33635729|NCT02963506|102218492|FG009|Double-Blind Period|Death|0|||
33635730|NCT02963506|102218493|FG010|Double-Blind Period|Death|0|||
33635731|NCT02963506|102218494|FG011|Double-Blind Period|Death|0|||
33635732|NCT02963506|102218495|FG012|Double-Blind Period|Death|0|||
33635733|NCT02963506|102218483|FG000|Double-Blind Period|Lost to Follow-up|0|||
33635734|NCT02963506|102218484|FG001|Double-Blind Period|Lost to Follow-up|1|||
33635735|NCT02963506|102218485|FG002|Double-Blind Period|Lost to Follow-up|0|||
33635736|NCT02963506|102218486|FG003|Double-Blind Period|Lost to Follow-up|0|||
33573968|NCT04778592|101991984|FG001|Overall Study|Adverse Event|2|||
33635737|NCT02963506|102218487|FG004|Double-Blind Period|Lost to Follow-up|0|||
33635738|NCT02963506|102218488|FG005|Double-Blind Period|Lost to Follow-up|0|||
33635739|NCT02963506|102218489|FG006|Double-Blind Period|Lost to Follow-up|0|||
33635740|NCT02963506|102218490|FG007|Double-Blind Period|Lost to Follow-up|0|||
33635741|NCT02963506|102218491|FG008|Double-Blind Period|Lost to Follow-up|0|||
33635742|NCT02963506|102218492|FG009|Double-Blind Period|Lost to Follow-up|0|||
33367961|NCT02778867|101232759|FG002|Phase 2|Adverse Event|0|||
33635743|NCT02963506|102218493|FG010|Double-Blind Period|Lost to Follow-up|0|||
33635744|NCT02963506|102218494|FG011|Double-Blind Period|Lost to Follow-up|0|||
33231055|NCT01317875|100746396|FG009|Overall Study|Progressive Disease|0|||
33231056|NCT01317875|100746387|FG000|Overall Study|Withdrawal by Subject|0|||
33573969|NCT04778592|101991983|FG000|Overall Study|Withdrawal by Subject|1|||
33573970|NCT04778592|101991984|FG001|Overall Study|Withdrawal by Subject|2|||
33573971|NCT02805790|101991987|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
33573972|NCT02805790|101991988|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
33635745|NCT02963506|102218495|FG012|Double-Blind Period|Lost to Follow-up|0|||
33635746|NCT02963506|102218483|FG000|Double-Blind Period|Withdrawal by Subject|0|||
33635747|NCT02963506|102218484|FG001|Double-Blind Period|Withdrawal by Subject|0|||
33136611|NCT00600119|100413473|FG001|Double-blind Treatment Period|Physician Decision|0|||
33136612|NCT00600119|100413474|FG002|Double-blind Treatment Period|Physician Decision|0|||
33136613|NCT00600119|100413475|FG003|Double-blind Treatment Period|Physician Decision|0|||
33136614|NCT00600119|100413476|FG004|Double-blind Treatment Period|Physician Decision|0|||
33136615|NCT00600119|100413477|FG005|Double-blind Treatment Period|Physician Decision|0|||
33136616|NCT00600119|100413472|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
33136617|NCT00600119|100413473|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
33136618|NCT00600119|100413474|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
33136619|NCT00600119|100413475|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
33136620|NCT00600119|100413476|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
33136621|NCT00600119|100413477|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
33136622|NCT00600119|100413472|FG000|Double-blind Treatment Period|Adverse Event|1|||
33136623|NCT00600119|100413473|FG001|Double-blind Treatment Period|Adverse Event|1|||
33231057|NCT01317875|100746388|FG001|Overall Study|Withdrawal by Subject|0|||
33231058|NCT01317875|100746389|FG002|Overall Study|Withdrawal by Subject|0|||
33231059|NCT01317875|100746390|FG003|Overall Study|Withdrawal by Subject|0|||
33231060|NCT01317875|100746391|FG004|Overall Study|Withdrawal by Subject|1|||
33231061|NCT01317875|100746392|FG005|Overall Study|Withdrawal by Subject|0|||
33231062|NCT01317875|100746393|FG006|Overall Study|Withdrawal by Subject|0|||
33231063|NCT01317875|100746394|FG007|Overall Study|Withdrawal by Subject|3|||
33231064|NCT01317875|100746395|FG008|Overall Study|Withdrawal by Subject|0|||
33231065|NCT01317875|100746396|FG009|Overall Study|Withdrawal by Subject|0|||
33231066|NCT01317875|100746387|FG000|Overall Study|Physician Decision|0|||
33231067|NCT01317875|100746388|FG001|Overall Study|Physician Decision|1|||
33231068|NCT01317875|100746389|FG002|Overall Study|Physician Decision|1|||
33231069|NCT01317875|100746390|FG003|Overall Study|Physician Decision|0|||
33231070|NCT01317875|100746391|FG004|Overall Study|Physician Decision|2|||
33231071|NCT01317875|100746392|FG005|Overall Study|Physician Decision|0|||
33367962|NCT02778867|101232760|FG003|Phase 2|Adverse Event|1|||
33367963|NCT02552355|101232764|FG000|Overall Study|Adverse Event|0|||
33367964|NCT02552355|101232765|FG001|Overall Study|Adverse Event|2|||
33367965|NCT02552355|101232766|FG002|Overall Study|Adverse Event|2|||
33367966|NCT02552355|101232767|FG003|Overall Study|Adverse Event|0|||
33367967|NCT02552355|101232764|FG000|Overall Study|Withdrawal by Subject|0|||
33367968|NCT02552355|101232765|FG001|Overall Study|Withdrawal by Subject|0|||
33367969|NCT02552355|101232766|FG002|Overall Study|Withdrawal by Subject|0|||
33367970|NCT02552355|101232767|FG003|Overall Study|Withdrawal by Subject|1|||
33367971|NCT01103349|101232769|FG000|Overall Study|Adverse Event|8|||
33367972|NCT01103349|101232770|FG001|Overall Study|Adverse Event|5|||
33367973|NCT01103349|101232771|FG002|Overall Study|Adverse Event|3|||
33367974|NCT01103349|101232769|FG000|Overall Study|Consent withdrawn|1|||
33367975|NCT01103349|101232770|FG001|Overall Study|Consent withdrawn|0|||
33367976|NCT01103349|101232771|FG002|Overall Study|Consent withdrawn|0|||
33367977|NCT01103349|101232769|FG000|Overall Study|Incorrectly included in the trial|1|||
33367978|NCT01103349|101232770|FG001|Overall Study|Incorrectly included in the trial|0|||
33367979|NCT01103349|101232771|FG002|Overall Study|Incorrectly included in the trial|0|||
33367980|NCT01103349|101232769|FG000|Overall Study|Withdrawal by Subject|1|||
33367981|NCT01103349|101232770|FG001|Overall Study|Withdrawal by Subject|1|||
33367982|NCT01103349|101232771|FG002|Overall Study|Withdrawal by Subject|0|||
33573973|NCT00800735|101991989|FG000|Overall Study|Administrative/Other|2|||
33573974|NCT00800735|101991989|FG000|Overall Study|Insufficient Therapeutic Response|2|||
33573975|NCT00800735|101991989|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
33573976|NCT00800735|101991989|FG000|Overall Study|Withdrew Consent|3|||
33573977|NCT02410772|101991993|FG000|Overall Study|Death|3|||
33573978|NCT02410772|101991994|FG001|Overall Study|Death|4|||
33573979|NCT02410772|101991995|FG002|Overall Study|Death|8|||
33573980|NCT02410772|101991993|FG000|Overall Study|Lost to Follow-up|31|||
33573981|NCT02410772|101991994|FG001|Overall Study|Lost to Follow-up|23|||
33573982|NCT02410772|101991995|FG002|Overall Study|Lost to Follow-up|22|||
33573983|NCT02410772|101991993|FG000|Overall Study|Pregnancy|8|||
33573984|NCT02410772|101991994|FG001|Overall Study|Pregnancy|4|||
33573985|NCT02410772|101991995|FG002|Overall Study|Pregnancy|5|||
33635748|NCT02963506|102218485|FG002|Double-Blind Period|Withdrawal by Subject|1|||
33136624|NCT00600119|100413474|FG002|Double-blind Treatment Period|Adverse Event|0|||
33136625|NCT00600119|100413475|FG003|Double-blind Treatment Period|Adverse Event|1|||
33231072|NCT01317875|100746393|FG006|Overall Study|Physician Decision|0|||
33231073|NCT01317875|100746394|FG007|Overall Study|Physician Decision|2|||
33367983|NCT01103349|101232769|FG000|Overall Study|did not want to take trial medication|0|||
33367984|NCT01103349|101232770|FG001|Overall Study|did not want to take trial medication|1|||
33136626|NCT00600119|100413476|FG004|Double-blind Treatment Period|Adverse Event|2|||
33367985|NCT01103349|101232771|FG002|Overall Study|did not want to take trial medication|0|||
33367986|NCT01103349|101232769|FG000|Overall Study|forgot to take medication|0|||
33367987|NCT01103349|101232770|FG001|Overall Study|forgot to take medication|0|||
33573986|NCT02410772|101991993|FG000|Overall Study|Protocol Violation|8|||
33573987|NCT02410772|101991994|FG001|Overall Study|Protocol Violation|8|||
33573988|NCT02410772|101991995|FG002|Overall Study|Protocol Violation|4|||
33231074|NCT01317875|100746395|FG008|Overall Study|Physician Decision|0|||
33231075|NCT01317875|100746396|FG009|Overall Study|Physician Decision|0|||
33231076|NCT01317875|100746387|FG000|Overall Study|Death|0|||
33231077|NCT01317875|100746388|FG001|Overall Study|Death|0|||
33231078|NCT01317875|100746389|FG002|Overall Study|Death|2|||
33231079|NCT01317875|100746390|FG003|Overall Study|Death|1|||
33231080|NCT01317875|100746391|FG004|Overall Study|Death|0|||
33231081|NCT01317875|100746392|FG005|Overall Study|Death|1|||
33231082|NCT01317875|100746393|FG006|Overall Study|Death|0|||
33231083|NCT01317875|100746394|FG007|Overall Study|Death|4|||
33231084|NCT01317875|100746395|FG008|Overall Study|Death|0|||
33231085|NCT01317875|100746396|FG009|Overall Study|Death|0|||
33231086|NCT01317875|100746387|FG000|Overall Study|Adverse Event|2|||
33231087|NCT01317875|100746388|FG001|Overall Study|Adverse Event|1|||
33231088|NCT01317875|100746389|FG002|Overall Study|Adverse Event|2|||
33231089|NCT01317875|100746390|FG003|Overall Study|Adverse Event|1|||
33231090|NCT01317875|100746391|FG004|Overall Study|Adverse Event|5|||
33231091|NCT01317875|100746392|FG005|Overall Study|Adverse Event|1|||
33231092|NCT01317875|100746393|FG006|Overall Study|Adverse Event|2|||
33231093|NCT01317875|100746394|FG007|Overall Study|Adverse Event|5|||
33231094|NCT01317875|100746395|FG008|Overall Study|Adverse Event|0|||
33231095|NCT01317875|100746396|FG009|Overall Study|Adverse Event|0|||
33231096|NCT02609659|100746397|FG000|Overall Study|Adverse Event|1|||
33231097|NCT02609659|100746397|FG000|Overall Study|Lost to Follow-up|6|||
33231098|NCT02609659|100746397|FG000|Overall Study|Other|1|||
33231099|NCT03358329|100746402|FG000|Overall Study|Lost to Follow-up|2|||
33231100|NCT03358329|100746402|FG000|Overall Study|Withdrawal by Subject|2|||
33231101|NCT02838628|100746403|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
33231102|NCT02838628|100746404|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
33231103|NCT02838628|100746403|FG000|Recurrence Follow-up Period|Adverse Event|1|||
33231104|NCT02838628|100746404|FG001|Recurrence Follow-up Period|Adverse Event|0|||
33231105|NCT02838628|100746403|FG000|Recurrence Follow-up Period|Non-compliance|0|||
33231106|NCT02838628|100746404|FG001|Recurrence Follow-up Period|Non-compliance|1|||
33231107|NCT02838628|100746403|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
33231108|NCT02838628|100746404|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
33231109|NCT02838628|100746403|FG000|Recurrence Follow-up Period|Other un-specified|1|||
33231110|NCT02838628|100746404|FG001|Recurrence Follow-up Period|Other un-specified|1|||
33231111|NCT01225822|100746411|FG000|Overall Study|Adverse Event|13|||
33231112|NCT01225822|100746412|FG001|Overall Study|Adverse Event|31|||
33231113|NCT01225822|100746413|FG002|Overall Study|Adverse Event|18|||
33231114|NCT01225822|100746414|FG003|Overall Study|Adverse Event|23|||
33231115|NCT01225822|100746415|FG004|Overall Study|Adverse Event|14|||
33231116|NCT01225822|100746411|FG000|Overall Study|Protocol Violation|6|||
33231117|NCT01225822|100746412|FG001|Overall Study|Protocol Violation|8|||
33231118|NCT01225822|100746413|FG002|Overall Study|Protocol Violation|6|||
33231119|NCT01225822|100746414|FG003|Overall Study|Protocol Violation|7|||
33231120|NCT01225822|100746415|FG004|Overall Study|Protocol Violation|4|||
33231121|NCT01225822|100746411|FG000|Overall Study|Lost to Follow-up|0|||
33231122|NCT01225822|100746412|FG001|Overall Study|Lost to Follow-up|0|||
33231123|NCT01225822|100746413|FG002|Overall Study|Lost to Follow-up|0|||
33231124|NCT01225822|100746414|FG003|Overall Study|Lost to Follow-up|1|||
33231125|NCT01225822|100746415|FG004|Overall Study|Lost to Follow-up|0|||
33231126|NCT01225822|100746411|FG000|Overall Study|Withdrawal by Subject|6|||
33573989|NCT02410772|101991993|FG000|Overall Study|Baseline Drug Resistance|49|||
33136627|NCT00600119|100413477|FG005|Double-blind Treatment Period|Adverse Event|10|||
33136628|NCT00600119|100413472|FG000|Follow-up Period|Adverse Event|0|||
33136629|NCT00600119|100413473|FG001|Follow-up Period|Adverse Event|0|||
33136630|NCT00600119|100413474|FG002|Follow-up Period|Adverse Event|0|||
33136631|NCT00600119|100413475|FG003|Follow-up Period|Adverse Event|0|||
33136632|NCT00600119|100413476|FG004|Follow-up Period|Adverse Event|0|||
33136633|NCT00600119|100413477|FG005|Follow-up Period|Adverse Event|1|||
33136634|NCT00600119|100413472|FG000|Follow-up Period|Other|1|||
33136635|NCT00600119|100413473|FG001|Follow-up Period|Other|0|||
33231127|NCT01225822|100746412|FG001|Overall Study|Withdrawal by Subject|7|||
33231128|NCT01225822|100746413|FG002|Overall Study|Withdrawal by Subject|7|||
33231129|NCT01225822|100746414|FG003|Overall Study|Withdrawal by Subject|11|||
33231130|NCT01225822|100746415|FG004|Overall Study|Withdrawal by Subject|6|||
33231131|NCT01225822|100746411|FG000|Overall Study|Other|13|||
33231132|NCT01225822|100746412|FG001|Overall Study|Other|10|||
33231133|NCT01225822|100746413|FG002|Overall Study|Other|7|||
33231134|NCT01225822|100746414|FG003|Overall Study|Other|10|||
33231135|NCT01225822|100746415|FG004|Overall Study|Other|7|||
33231136|NCT03354637|100746416|FG000|Double-blind Period|Protocol Violation|2|||
33231137|NCT03354637|100746417|FG001|Double-blind Period|Protocol Violation|0|||
33231138|NCT03354637|100746418|FG002|Double-blind Period|Protocol Violation|0|||
33231139|NCT03354637|100746416|FG000|Double-blind Period|Adverse Event|1|||
33136636|NCT00600119|100413474|FG002|Follow-up Period|Other|0|||
33136637|NCT00600119|100413475|FG003|Follow-up Period|Other|0|||
33231140|NCT03354637|100746417|FG001|Double-blind Period|Adverse Event|2|||
33231141|NCT03354637|100746418|FG002|Double-blind Period|Adverse Event|0|||
33136638|NCT00600119|100413476|FG004|Follow-up Period|Other|0|||
33231142|NCT03354637|100746416|FG000|Double-blind Period|Lost to Follow-up|3|||
33231143|NCT03354637|100746417|FG001|Double-blind Period|Lost to Follow-up|4|||
33573990|NCT02410772|101991994|FG001|Overall Study|Baseline Drug Resistance|40|||
33573991|NCT02410772|101991995|FG002|Overall Study|Baseline Drug Resistance|51|||
33573992|NCT02410772|101991993|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
33573993|NCT02410772|101991994|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
33573994|NCT02410772|101991995|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
33573995|NCT02410772|101991993|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
33573996|NCT02410772|101991994|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
33573997|NCT02410772|101991995|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
33136639|NCT00600119|100413477|FG005|Follow-up Period|Other|0|||
33136640|NCT01139008|100413478|FG000|Overall Study|Withdrawal by Subject|5|||
33136641|NCT01139008|100413478|FG000|Overall Study|Non-compliant, lost product|1|||
33136642|NCT02255435|100413479|FG000|Overall Study|Patient's Limited Time Availability|0|||
33136643|NCT02255435|100413480|FG001|Overall Study|Patient's Limited Time Availability|0|||
33136644|NCT02255435|100413481|FG002|Overall Study|Patient's Limited Time Availability|0|||
33136645|NCT02255435|100413482|FG003|Overall Study|Patient's Limited Time Availability|0|||
33136646|NCT02255435|100413483|FG004|Overall Study|Patient's Limited Time Availability|0|||
33136647|NCT02255435|100413484|FG005|Overall Study|Patient's Limited Time Availability|0|||
33136648|NCT02255435|100413485|FG006|Overall Study|Patient's Limited Time Availability|0|||
33136649|NCT02255435|100413486|FG007|Overall Study|Patient's Limited Time Availability|1|||
33136650|NCT02255435|100413487|FG008|Overall Study|Patient's Limited Time Availability|0|||
33136651|NCT02255435|100413488|FG009|Overall Study|Patient's Limited Time Availability|0|||
33136652|NCT02255435|100413479|FG000|Overall Study|Withdrawal by Subject|0|||
33136653|NCT02255435|100413480|FG001|Overall Study|Withdrawal by Subject|0|||
33136654|NCT02255435|100413481|FG002|Overall Study|Withdrawal by Subject|0|||
33136655|NCT02255435|100413482|FG003|Overall Study|Withdrawal by Subject|0|||
33136656|NCT02255435|100413483|FG004|Overall Study|Withdrawal by Subject|0|||
33136657|NCT02255435|100413484|FG005|Overall Study|Withdrawal by Subject|0|||
33136658|NCT02255435|100413485|FG006|Overall Study|Withdrawal by Subject|0|||
33136659|NCT02255435|100413486|FG007|Overall Study|Withdrawal by Subject|0|||
33136660|NCT02255435|100413487|FG008|Overall Study|Withdrawal by Subject|1|||
33136661|NCT02255435|100413488|FG009|Overall Study|Withdrawal by Subject|4|||
33136662|NCT02255435|100413479|FG000|Overall Study|Administrative reasons|0|||
33136663|NCT02255435|100413480|FG001|Overall Study|Administrative reasons|0|||
33136664|NCT02255435|100413481|FG002|Overall Study|Administrative reasons|0|||
33136665|NCT02255435|100413482|FG003|Overall Study|Administrative reasons|0|||
33136666|NCT02255435|100413483|FG004|Overall Study|Administrative reasons|0|||
33136667|NCT02255435|100413484|FG005|Overall Study|Administrative reasons|0|||
33136668|NCT02255435|100413485|FG006|Overall Study|Administrative reasons|0|||
33136669|NCT02255435|100413486|FG007|Overall Study|Administrative reasons|0|||
33136670|NCT02255435|100413487|FG008|Overall Study|Administrative reasons|0|||
33136671|NCT02255435|100413488|FG009|Overall Study|Administrative reasons|2|||
33136678|NCT02674204|100413514|FG000|Overall Study|Adverse Event|1|||
33136679|NCT02674204|100413515|FG001|Overall Study|Adverse Event|0|||
33136680|NCT00167778|100413516|FG000|Overall Study|Withdrawal by Subject|1|||
33136681|NCT00798759|100413520|FG000|Overall Study|Adverse Event|3|||
33136682|NCT00798759|100413521|FG001|Overall Study|Adverse Event|3|||
33136683|NCT00798759|100413520|FG000|Overall Study|Lost to Follow-up|1|||
33136684|NCT00798759|100413521|FG001|Overall Study|Lost to Follow-up|1|||
33136685|NCT00798759|100413520|FG000|Overall Study|Protocol Violation|4|||
33136686|NCT00798759|100413521|FG001|Overall Study|Protocol Violation|8|||
33136687|NCT00798759|100413520|FG000|Overall Study|Other|0|||
33136688|NCT00798759|100413521|FG001|Overall Study|Other|1|||
33136689|NCT04268823|100413522|FG000|Overall Study|Adverse Event|1|||
33136690|NCT04268823|100413523|FG001|Overall Study|Adverse Event|0|||
33136691|NCT04268823|100413522|FG000|Overall Study|Participant Decision|1|||
33136692|NCT04268823|100413523|FG001|Overall Study|Participant Decision|0|||
33136693|NCT03316911|100413524|FG000|Overall Study|Lost to Follow-up|33|||
33136694|NCT03316911|100413525|FG001|Overall Study|Lost to Follow-up|29|||
33136695|NCT01024309|100413526|FG000|Overall Study|Physician Decision|4|||
33136696|NCT01024309|100413527|FG001|Overall Study|Physician Decision|0|||
33136697|NCT01024309|100413526|FG000|Overall Study|Withdrawal by Subject|4|||
33136698|NCT01024309|100413527|FG001|Overall Study|Withdrawal by Subject|4|||
33573998|NCT01346176|101991996|FG000|Recruited|Protocol Violation|1|||
33573999|NCT01346176|101991997|FG001|Recruited|Protocol Violation|0|||
33635749|NCT02963506|102218486|FG003|Double-Blind Period|Withdrawal by Subject|1|||
33635750|NCT02963506|102218487|FG004|Double-Blind Period|Withdrawal by Subject|0|||
33635751|NCT02963506|102218488|FG005|Double-Blind Period|Withdrawal by Subject|0|||
33635752|NCT02963506|102218489|FG006|Double-Blind Period|Withdrawal by Subject|0|||
33635753|NCT02963506|102218490|FG007|Double-Blind Period|Withdrawal by Subject|0|||
33635754|NCT02963506|102218491|FG008|Double-Blind Period|Withdrawal by Subject|0|||
33635755|NCT02963506|102218492|FG009|Double-Blind Period|Withdrawal by Subject|0|||
33635756|NCT02963506|102218493|FG010|Double-Blind Period|Withdrawal by Subject|0|||
33635757|NCT02963506|102218494|FG011|Double-Blind Period|Withdrawal by Subject|0|||
33635758|NCT02963506|102218495|FG012|Double-Blind Period|Withdrawal by Subject|0|||
33635759|NCT02963506|102218483|FG000|Double-Blind Period|No compliance|0|||
33635760|NCT02963506|102218484|FG001|Double-Blind Period|No compliance|1|||
33635761|NCT02963506|102218485|FG002|Double-Blind Period|No compliance|0|||
33635762|NCT02963506|102218486|FG003|Double-Blind Period|No compliance|0|||
33635763|NCT02963506|102218487|FG004|Double-Blind Period|No compliance|0|||
33635764|NCT02963506|102218488|FG005|Double-Blind Period|No compliance|0|||
33635765|NCT02963506|102218489|FG006|Double-Blind Period|No compliance|0|||
33635766|NCT02963506|102218490|FG007|Double-Blind Period|No compliance|0|||
33136711|NCT03836001|100413537|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
33136712|NCT03836001|100413538|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
33136713|NCT03836001|100413539|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
33136714|NCT03836001|100413537|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
33136715|NCT03836001|100413538|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
33136716|NCT03836001|100413539|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
33136717|NCT03836001|100413537|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
33136718|NCT03836001|100413538|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
33136719|NCT03836001|100413539|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
33136720|NCT03836001|100413537|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
33136721|NCT03836001|100413538|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
33136722|NCT03836001|100413539|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
33136729|NCT00361634|100413544|FG000|Overall Study|Lost to Follow-up|1|||
33574000|NCT01346176|101991998|FG002|Recruited|Protocol Violation|0|||
33574001|NCT01346176|101991996|FG000|Completed Advance Directive|Death|3|||
33574002|NCT01346176|101991997|FG001|Completed Advance Directive|Death|2|||
33574003|NCT01346176|101991998|FG002|Completed Advance Directive|Death|2|||
33574004|NCT01346176|101991996|FG000|Completed Advance Directive|Became Ineligible|3|||
33574005|NCT01346176|101991997|FG001|Completed Advance Directive|Became Ineligible|0|||
33574006|NCT01346176|101991998|FG002|Completed Advance Directive|Became Ineligible|1|||
33574007|NCT01346176|101991996|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
33574008|NCT01346176|101991997|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
33574009|NCT01346176|101991998|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
33574010|NCT01346176|101991996|FG000|Completed Satisfaction Survey|Death|3|||
33574011|NCT01346176|101991997|FG001|Completed Satisfaction Survey|Death|0|||
33574012|NCT01346176|101991998|FG002|Completed Satisfaction Survey|Death|2|||
33574013|NCT01346176|101991996|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
33574014|NCT01346176|101991997|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
33574015|NCT01346176|101991998|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
33574016|NCT02750930|101991999|FG000|Overall Study|Study closed/terminated|8|||
33574017|NCT00145626|101992007|FG000|Overall Study|Did not have NK infusions|2|||
33574018|NCT00145626|101992007|FG000|Overall Study|Turned 2 years old before treatment|1|||
33136730|NCT00361634|100413544|FG000|Overall Study|Withdrawal by Subject|1|||
33231144|NCT03354637|100746418|FG002|Double-blind Period|Lost to Follow-up|3|||
33574019|NCT00145626|101992007|FG000|Overall Study|Death|1|||
33574020|NCT00145626|101992007|FG000|Overall Study|Withdrawal by Subject|1|||
33574021|NCT03473743|101992008|FG000|Overall Study|Withdrawal by Subject|0|||
33136731|NCT02410343|100413545|FG000|Core Period (24 Weeks)|Adverse Event|1|||
33231145|NCT03354637|100746416|FG000|Double-blind Period|Withdrawal by Subject|10|||
33574022|NCT03473743|101992009|FG001|Overall Study|Withdrawal by Subject|0|||
33635767|NCT02963506|102218491|FG008|Double-Blind Period|No compliance|0|||
33635768|NCT02963506|102218492|FG009|Double-Blind Period|No compliance|0|||
33635769|NCT02963506|102218493|FG010|Double-Blind Period|No compliance|0|||
33635770|NCT02963506|102218494|FG011|Double-Blind Period|No compliance|0|||
33635771|NCT02963506|102218495|FG012|Double-Blind Period|No compliance|0|||
33635772|NCT02963506|102218483|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33635773|NCT02963506|102218484|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
33635774|NCT02963506|102218485|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33635775|NCT02963506|102218486|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33635776|NCT02963506|102218487|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33635777|NCT02963506|102218488|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33635778|NCT02963506|102218489|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33635779|NCT02963506|102218490|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33367988|NCT01103349|101232771|FG002|Overall Study|forgot to take medication|1|||
33574023|NCT03473743|101992010|FG002|Overall Study|Withdrawal by Subject|0|||
33574024|NCT03473743|101992011|FG003|Overall Study|Withdrawal by Subject|0|||
33574025|NCT03473743|101992012|FG004|Overall Study|Withdrawal by Subject|0|||
33574026|NCT03473743|101992013|FG005|Overall Study|Withdrawal by Subject|0|||
33574027|NCT03473743|101992014|FG006|Overall Study|Withdrawal by Subject|0|||
33574028|NCT03473743|101992015|FG007|Overall Study|Withdrawal by Subject|3|||
33574029|NCT03473743|101992008|FG000|Overall Study|Other|0|||
33574030|NCT03473743|101992009|FG001|Overall Study|Other|0|||
33574031|NCT03473743|101992010|FG002|Overall Study|Other|0|||
33574032|NCT03473743|101992011|FG003|Overall Study|Other|1|||
33574033|NCT03473743|101992012|FG004|Overall Study|Other|0|||
33574034|NCT03473743|101992013|FG005|Overall Study|Other|0|||
33574035|NCT03473743|101992014|FG006|Overall Study|Other|0|||
33574036|NCT03473743|101992015|FG007|Overall Study|Other|0|||
33574037|NCT03473743|101992008|FG000|Overall Study|Ongoing|0|||
33574038|NCT03473743|101992009|FG001|Overall Study|Ongoing|0|||
33574039|NCT03473743|101992010|FG002|Overall Study|Ongoing|6|||
33574040|NCT03473743|101992011|FG003|Overall Study|Ongoing|8|||
33574041|NCT03473743|101992012|FG004|Overall Study|Ongoing|1|||
33574042|NCT03473743|101992013|FG005|Overall Study|Ongoing|1|||
33574043|NCT03473743|101992014|FG006|Overall Study|Ongoing|22|||
33574044|NCT03473743|101992015|FG007|Overall Study|Ongoing|24|||
33574045|NCT03473743|101992008|FG000|Overall Study|Randomized but not treated|0|||
33574046|NCT03473743|101992009|FG001|Overall Study|Randomized but not treated|0|||
33574047|NCT03473743|101992010|FG002|Overall Study|Randomized but not treated|0|||
33574048|NCT03473743|101992011|FG003|Overall Study|Randomized but not treated|0|||
33574049|NCT03473743|101992012|FG004|Overall Study|Randomized but not treated|0|||
33574050|NCT03473743|101992013|FG005|Overall Study|Randomized but not treated|0|||
33574051|NCT03473743|101992014|FG006|Overall Study|Randomized but not treated|1|||
33574052|NCT03473743|101992015|FG007|Overall Study|Randomized but not treated|1|||
33574053|NCT01959529|101992017|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
33574054|NCT01959529|101992018|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
33574055|NCT01959529|101992017|FG000|Overall Study|Lost to Follow-up|4|||
33574056|NCT01959529|101992018|FG001|Overall Study|Lost to Follow-up|1|||
33574057|NCT01959529|101992017|FG000|Overall Study|Other|70|||
33574058|NCT01959529|101992018|FG001|Overall Study|Other|68|||
33574059|NCT01959529|101992017|FG000|Overall Study|Hypoglycaemia|1|||
33574060|NCT01959529|101992018|FG001|Overall Study|Hypoglycaemia|1|||
33574061|NCT01959529|101992017|FG000|Overall Study|Lack of glycaemic control|1|||
33574062|NCT01959529|101992018|FG001|Overall Study|Lack of glycaemic control|1|||
33574063|NCT00657267|101992024|FG000|Overall Study|Progressive disease|45|||
33574064|NCT00657267|101992024|FG000|Overall Study|Adverse Event|9|||
33574065|NCT01957865|101992028|FG000|Overall Study|Found HIV negative|0|||
33367989|NCT02234583|101232772|FG000|Overall Study|Adverse Event|172|||
33367990|NCT02234583|101232773|FG001|Overall Study|Adverse Event|156|||
33367991|NCT02234583|101232772|FG000|Overall Study|Withdrawal by Subject|109|||
33367992|NCT02234583|101232773|FG001|Overall Study|Withdrawal by Subject|157|||
33367993|NCT02234583|101232772|FG000|Overall Study|Lost to Follow-up|0|||
33367994|NCT02234583|101232773|FG001|Overall Study|Lost to Follow-up|1|||
33367995|NCT02234583|101232772|FG000|Overall Study|Lack of Efficacy|58|||
33367996|NCT02234583|101232773|FG001|Overall Study|Lack of Efficacy|103|||
33574066|NCT01957865|101992029|FG001|Overall Study|Found HIV negative|0|||
33574067|NCT01957865|101992030|FG002|Overall Study|Found HIV negative|1|||
33574068|NCT01957865|101992028|FG000|Overall Study|Lost to Follow-up|0|||
33574069|NCT01957865|101992029|FG001|Overall Study|Lost to Follow-up|2|||
33635780|NCT02963506|102218491|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33574070|NCT01957865|101992030|FG002|Overall Study|Lost to Follow-up|2|||
33574071|NCT00953706|101992034|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
33574072|NCT00953706|101992035|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
33574073|NCT00953706|101992036|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
33635781|NCT02963506|102218492|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33367997|NCT02234583|101232772|FG000|Overall Study|Protocol Violation|35|||
33367998|NCT02234583|101232773|FG001|Overall Study|Protocol Violation|42|||
33574074|NCT00953706|101992037|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
33367999|NCT02234583|101232772|FG000|Overall Study|Other|39|||
33368000|NCT02234583|101232773|FG001|Overall Study|Other|97|||
33368001|NCT00705224|101232774|FG000|Overall Study|Adverse Event|1|||
33368002|NCT00705224|101232774|FG000|Overall Study|Lack of Efficacy|2|||
33368003|NCT00705224|101232774|FG000|Overall Study|Withdrawal by Subject|3|||
33368004|NCT00705224|101232774|FG000|Overall Study|Lost to Follow-up|5|||
33368005|NCT02817555|101232775|FG000|Overall Study|Death|1|||
33574075|NCT00953706|101992034|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
33574076|NCT00953706|101992035|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
33574077|NCT00953706|101992036|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
33574078|NCT00953706|101992037|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
33574079|NCT00953706|101992034|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
33574080|NCT00953706|101992035|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
33574081|NCT00953706|101992036|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
33574082|NCT00953706|101992037|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
33574083|NCT00953706|101992034|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
33574084|NCT00953706|101992035|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
33574085|NCT00953706|101992036|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
33574086|NCT00953706|101992037|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
33574087|NCT00953706|101992034|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
33574088|NCT00953706|101992035|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
33574089|NCT00953706|101992036|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
33231146|NCT03354637|100746417|FG001|Double-blind Period|Withdrawal by Subject|6|||
33231147|NCT03354637|100746418|FG002|Double-blind Period|Withdrawal by Subject|4|||
33231148|NCT03354637|100746416|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
33231149|NCT03354637|100746417|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
33231150|NCT03354637|100746418|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
33231151|NCT03354637|100746416|FG000|Open Label Extension|Adverse Event|0|||
33231152|NCT03354637|100746417|FG001|Open Label Extension|Adverse Event|0|||
33231153|NCT03354637|100746418|FG002|Open Label Extension|Adverse Event|1|||
33231154|NCT03354637|100746416|FG000|Open Label Extension|Lost to Follow-up|0|||
33231155|NCT03354637|100746417|FG001|Open Label Extension|Lost to Follow-up|0|||
33231156|NCT03354637|100746418|FG002|Open Label Extension|Lost to Follow-up|2|||
33231157|NCT03354637|100746416|FG000|Open Label Extension|Withdrawal by Subject|0|||
33231158|NCT03354637|100746417|FG001|Open Label Extension|Withdrawal by Subject|0|||
33231159|NCT03354637|100746418|FG002|Open Label Extension|Withdrawal by Subject|5|||
33231160|NCT03354637|100746416|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
33231161|NCT03354637|100746417|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
33231162|NCT03354637|100746418|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
33231163|NCT03354637|100746416|FG000|Open Label Extension|Subject Noncompliance|0|||
33231164|NCT03354637|100746417|FG001|Open Label Extension|Subject Noncompliance|0|||
33231165|NCT03354637|100746418|FG002|Open Label Extension|Subject Noncompliance|1|||
33231166|NCT03354637|100746416|FG000|Open Label Extension|Lack of Efficacy|0|||
33368006|NCT02817555|101232776|FG001|Overall Study|Death|3|||
33574090|NCT00953706|101992037|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
33574091|NCT00953706|101992034|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
33574092|NCT00953706|101992035|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
33574093|NCT00953706|101992036|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
33574094|NCT00953706|101992037|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
33574095|NCT00953706|101992034|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
33574096|NCT00953706|101992035|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
33574097|NCT00953706|101992036|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
33574098|NCT00953706|101992037|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
33574099|NCT00953706|101992034|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
33574100|NCT00953706|101992035|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
33574101|NCT00953706|101992036|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
33635782|NCT02963506|102218493|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33635783|NCT02963506|102218494|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33635784|NCT02963506|102218495|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
33635785|NCT02963506|102218483|FG000|Dose-Blind Period|Adverse Event|0|||
33635786|NCT02963506|102218484|FG001|Dose-Blind Period|Adverse Event|0|||
33635787|NCT02963506|102218485|FG002|Dose-Blind Period|Adverse Event|0|||
33635788|NCT02963506|102218486|FG003|Dose-Blind Period|Adverse Event|0|||
33635789|NCT02963506|102218487|FG004|Dose-Blind Period|Adverse Event|0|||
33231167|NCT03354637|100746417|FG001|Open Label Extension|Lack of Efficacy|0|||
33368007|NCT02817555|101232775|FG000|Overall Study|moved away|1|||
33368008|NCT02817555|101232776|FG001|Overall Study|moved away|0|||
33368009|NCT02817555|101232775|FG000|Overall Study|transplant|1|||
33635790|NCT02963506|102218488|FG005|Dose-Blind Period|Adverse Event|1|||
33635791|NCT02963506|102218489|FG006|Dose-Blind Period|Adverse Event|3|||
33635792|NCT02963506|102218490|FG007|Dose-Blind Period|Adverse Event|2|||
33635793|NCT02963506|102218491|FG008|Dose-Blind Period|Adverse Event|2|||
33635794|NCT02963506|102218492|FG009|Dose-Blind Period|Adverse Event|2|||
33635795|NCT02963506|102218493|FG010|Dose-Blind Period|Adverse Event|1|||
33635796|NCT02963506|102218494|FG011|Dose-Blind Period|Adverse Event|1|||
33635797|NCT02963506|102218495|FG012|Dose-Blind Period|Adverse Event|6|||
33635798|NCT02963506|102218483|FG000|Dose-Blind Period|Lack of Efficacy|0|||
33635799|NCT02963506|102218484|FG001|Dose-Blind Period|Lack of Efficacy|0|||
33574102|NCT00953706|101992037|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
33635800|NCT02963506|102218485|FG002|Dose-Blind Period|Lack of Efficacy|0|||
33635801|NCT02963506|102218486|FG003|Dose-Blind Period|Lack of Efficacy|0|||
33635802|NCT02963506|102218487|FG004|Dose-Blind Period|Lack of Efficacy|0|||
33635803|NCT02963506|102218488|FG005|Dose-Blind Period|Lack of Efficacy|0|||
33635804|NCT02963506|102218489|FG006|Dose-Blind Period|Lack of Efficacy|0|||
33635805|NCT02963506|102218490|FG007|Dose-Blind Period|Lack of Efficacy|1|||
33635806|NCT02963506|102218491|FG008|Dose-Blind Period|Lack of Efficacy|0|||
33635807|NCT02963506|102218492|FG009|Dose-Blind Period|Lack of Efficacy|1|||
33635808|NCT02963506|102218493|FG010|Dose-Blind Period|Lack of Efficacy|0|||
33635809|NCT02963506|102218494|FG011|Dose-Blind Period|Lack of Efficacy|0|||
33635810|NCT02963506|102218495|FG012|Dose-Blind Period|Lack of Efficacy|0|||
33635811|NCT02963506|102218483|FG000|Dose-Blind Period|Lost to Follow-up|0|||
33635812|NCT02963506|102218484|FG001|Dose-Blind Period|Lost to Follow-up|0|||
33635813|NCT02963506|102218485|FG002|Dose-Blind Period|Lost to Follow-up|0|||
33635814|NCT02963506|102218486|FG003|Dose-Blind Period|Lost to Follow-up|0|||
33635815|NCT02963506|102218487|FG004|Dose-Blind Period|Lost to Follow-up|0|||
33635816|NCT02963506|102218488|FG005|Dose-Blind Period|Lost to Follow-up|1|||
33635817|NCT02963506|102218489|FG006|Dose-Blind Period|Lost to Follow-up|0|||
33635818|NCT02963506|102218490|FG007|Dose-Blind Period|Lost to Follow-up|0|||
33635819|NCT02963506|102218491|FG008|Dose-Blind Period|Lost to Follow-up|1|||
33635820|NCT02963506|102218492|FG009|Dose-Blind Period|Lost to Follow-up|0|||
33635821|NCT02963506|102218493|FG010|Dose-Blind Period|Lost to Follow-up|0|||
33136732|NCT02410343|100413546|FG001|Core Period (24 Weeks)|Adverse Event|0|||
33136733|NCT02410343|100413545|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
33136734|NCT02410343|100413546|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
33136735|NCT02410343|100413545|FG000|Extension Period (12 Months)|Adverse Event|1|||
33136736|NCT02410343|100413546|FG001|Extension Period (12 Months)|Adverse Event|0|||
33136737|NCT02410343|100413545|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
33136738|NCT02410343|100413546|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
33136739|NCT02081859|100413547|FG000|Overall Study|No fertilization|2|||
33136740|NCT02081859|100413548|FG001|Overall Study|No fertilization|2|||
33136741|NCT02081859|100413547|FG000|Overall Study|No sperm|1|||
33136742|NCT02081859|100413548|FG001|Overall Study|No sperm|0|||
33136743|NCT02081859|100413547|FG000|Overall Study|Unanticipated freeze all cycle|2|||
33136744|NCT02081859|100413548|FG001|Overall Study|Unanticipated freeze all cycle|6|||
33136745|NCT02081859|100413547|FG000|Overall Study|< 4 embryos|27|||
33136746|NCT02081859|100413548|FG001|Overall Study|< 4 embryos|23|||
33136747|NCT02081859|100413547|FG000|Overall Study|Other reasons|2|||
33136748|NCT02081859|100413548|FG001|Overall Study|Other reasons|0|||
33574103|NCT00953706|101992034|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
33574104|NCT00953706|101992035|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
33574105|NCT00953706|101992036|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
33574106|NCT00953706|101992037|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
33574107|NCT00953706|101992034|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
33574108|NCT00953706|101992035|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
33574109|NCT00953706|101992036|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
33574110|NCT00953706|101992037|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
33574111|NCT00953706|101992034|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
33574112|NCT00953706|101992035|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
33635822|NCT02963506|102218494|FG011|Dose-Blind Period|Lost to Follow-up|1|||
33635823|NCT02963506|102218495|FG012|Dose-Blind Period|Lost to Follow-up|0|||
33136749|NCT02395172|100413552|FG000|Overall Study|Participants randomized but not treated|3|||
33136750|NCT02395172|100413553|FG001|Overall Study|Participants randomized but not treated|31|||
33136751|NCT01425463|100413560|FG000|Overall Study|Adverse Event|5|||
33136752|NCT01425463|100413561|FG001|Overall Study|Adverse Event|7|||
33136753|NCT01425463|100413560|FG000|Overall Study|Lack of Efficacy|1|||
33368010|NCT02817555|101232776|FG001|Overall Study|transplant|1|||
33368011|NCT02817555|101232775|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
33635824|NCT02963506|102218483|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
33635825|NCT02963506|102218484|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
33635826|NCT02963506|102218485|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
33136754|NCT01425463|100413561|FG001|Overall Study|Lack of Efficacy|1|||
33231168|NCT03354637|100746418|FG002|Open Label Extension|Lack of Efficacy|1|||
33231169|NCT03354637|100746416|FG000|Open Label Extension|Physician Decision|0|||
33231170|NCT03354637|100746417|FG001|Open Label Extension|Physician Decision|0|||
33231171|NCT03354637|100746418|FG002|Open Label Extension|Physician Decision|1|||
33231172|NCT01927731|100746419|FG000|Overall Study|Graft Failure|1|||
33231173|NCT01927731|100746420|FG001|Overall Study|Graft Failure|2|||
33231174|NCT01927731|100746419|FG000|Overall Study|Physician Decision|2|||
33231175|NCT01927731|100746420|FG001|Overall Study|Physician Decision|3|||
33231176|NCT01927731|100746419|FG000|Overall Study|Withdrawal by Subject|0|||
33231177|NCT01927731|100746420|FG001|Overall Study|Withdrawal by Subject|2|||
33231178|NCT01927731|100746419|FG000|Overall Study|Death|0|||
33231179|NCT01927731|100746420|FG001|Overall Study|Death|3|||
33231180|NCT00180713|100746421|FG000|Overall Study|Withdrawal by Subject|2|||
33231181|NCT00180713|100746422|FG001|Overall Study|Withdrawal by Subject|0|||
33231182|NCT00180713|100746421|FG000|Overall Study|Adverse Event|3|||
33231183|NCT00180713|100746422|FG001|Overall Study|Adverse Event|3|||
33231184|NCT03321513|100746425|FG000|Overall Study|Death|11|||
33231185|NCT03321513|100746426|FG001|Overall Study|Death|5|||
33231186|NCT03321513|100746425|FG000|Overall Study|Withdrawal by Subject|5|||
33231187|NCT03321513|100746426|FG001|Overall Study|Withdrawal by Subject|10|||
33231188|NCT03321513|100746425|FG000|Overall Study|Lost to Follow-up|10|||
33231189|NCT03321513|100746426|FG001|Overall Study|Lost to Follow-up|11|||
33231190|NCT04249336|100746429|FG000|Overall Study|Lost to Follow-up|3|||
33231191|NCT04249336|100746430|FG001|Overall Study|Lost to Follow-up|3|||
33231192|NCT04249336|100746431|FG002|Overall Study|Lost to Follow-up|3|||
33231193|NCT04249336|100746432|FG003|Overall Study|Lost to Follow-up|3|||
33231194|NCT02917265|100746435|FG000|Overall Study|Physician Decision|1|||
33231195|NCT02917265|100746436|FG001|Overall Study|Physician Decision|0|||
33231196|NCT02917265|100746435|FG000|Overall Study|Withdrawal by Subject|1|||
33231197|NCT02917265|100746436|FG001|Overall Study|Withdrawal by Subject|0|||
33231198|NCT00305864|100746437|FG000|Overall Study|Ineligible / No protocol treatment|0|||
33231199|NCT00305864|100746438|FG001|Overall Study|Ineligible / No protocol treatment|1|||
33231200|NCT00305864|100746439|FG002|Overall Study|Ineligible / No protocol treatment|1|||
33231201|NCT00305864|100746440|FG003|Overall Study|Ineligible / No protocol treatment|13|||
33231202|NCT04666922|100746441|FG000|Overall Study|Withdrawal by Subject|1|||
33231203|NCT04666922|100746442|FG001|Overall Study|Withdrawal by Subject|0|||
33231204|NCT04666922|100746443|FG002|Overall Study|Withdrawal by Subject|0|||
33231205|NCT04666922|100746444|FG003|Overall Study|Withdrawal by Subject|0|||
33231206|NCT04666922|100746445|FG004|Overall Study|Withdrawal by Subject|0|||
33231207|NCT04666922|100746446|FG005|Overall Study|Withdrawal by Subject|0|||
33231208|NCT04666922|100746447|FG006|Overall Study|Withdrawal by Subject|0|||
33231209|NCT00744237|100746448|FG000|Overall Study|Lack of Efficacy|1|||
33231210|NCT00744237|100746449|FG001|Overall Study|Lack of Efficacy|1|||
33231211|NCT00744237|100746450|FG002|Overall Study|Lack of Efficacy|0|||
33231212|NCT00744237|100746448|FG000|Overall Study|Withdrawal by Subject|9|||
33231213|NCT00744237|100746449|FG001|Overall Study|Withdrawal by Subject|5|||
33231214|NCT00744237|100746450|FG002|Overall Study|Withdrawal by Subject|3|||
33231215|NCT00744237|100746448|FG000|Overall Study|Lost to Follow-up|1|||
33231216|NCT00744237|100746449|FG001|Overall Study|Lost to Follow-up|1|||
33231217|NCT00744237|100746450|FG002|Overall Study|Lost to Follow-up|1|||
33231218|NCT00744237|100746448|FG000|Overall Study|Protocol Violation|3|||
33231219|NCT00744237|100746449|FG001|Overall Study|Protocol Violation|4|||
33231220|NCT00744237|100746450|FG002|Overall Study|Protocol Violation|3|||
33231221|NCT00744237|100746448|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
33231222|NCT00744237|100746449|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
33231223|NCT00744237|100746450|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
33231224|NCT00744237|100746448|FG000|Overall Study|Dosing Error|1|||
33231225|NCT00744237|100746449|FG001|Overall Study|Dosing Error|0|||
33231226|NCT00744237|100746450|FG002|Overall Study|Dosing Error|1|||
33231227|NCT00744237|100746448|FG000|Overall Study|Study Drug Error|1|||
33231228|NCT00744237|100746449|FG001|Overall Study|Study Drug Error|0|||
33231229|NCT00744237|100746450|FG002|Overall Study|Study Drug Error|0|||
33231230|NCT00744237|100746448|FG000|Overall Study|Prohibited Concomitant Medication|0|||
33231231|NCT00744237|100746449|FG001|Overall Study|Prohibited Concomitant Medication|0|||
33231232|NCT00744237|100746450|FG002|Overall Study|Prohibited Concomitant Medication|1|||
33231233|NCT00744237|100746448|FG000|Overall Study|Poor Compliance|0|||
33231234|NCT00744237|100746449|FG001|Overall Study|Poor Compliance|2|||
33231235|NCT00744237|100746450|FG002|Overall Study|Poor Compliance|0|||
33231236|NCT00744237|100746448|FG000|Overall Study|Administrative. Site Closed|1|||
33231237|NCT00744237|100746449|FG001|Overall Study|Administrative. Site Closed|1|||
33231238|NCT00744237|100746450|FG002|Overall Study|Administrative. Site Closed|1|||
33231239|NCT00744237|100746448|FG000|Overall Study|Adverse Event|9|||
33231240|NCT00744237|100746449|FG001|Overall Study|Adverse Event|13|||
33231241|NCT00744237|100746450|FG002|Overall Study|Adverse Event|5|||
33231242|NCT02584855|100746451|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
33231243|NCT02584855|100746452|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
33231244|NCT02584855|100746453|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
33231245|NCT02584855|100746454|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
33231246|NCT02584855|100746455|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
33231247|NCT02584855|100746456|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
33231248|NCT02584855|100746451|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
33231249|NCT02584855|100746452|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
33231250|NCT02584855|100746453|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
33231251|NCT02584855|100746454|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
33231252|NCT02584855|100746455|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
33231253|NCT02584855|100746456|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
33231254|NCT02584855|100746451|FG000|Open-Label Treatment Period|Adverse Event|14|||
33231255|NCT02584855|100746452|FG001|Open-Label Treatment Period|Adverse Event|0|||
33231256|NCT02584855|100746453|FG002|Open-Label Treatment Period|Adverse Event|0|||
33231257|NCT02584855|100746454|FG003|Open-Label Treatment Period|Adverse Event|0|||
33231258|NCT02584855|100746455|FG004|Open-Label Treatment Period|Adverse Event|0|||
33231259|NCT02584855|100746456|FG005|Open-Label Treatment Period|Adverse Event|0|||
33231260|NCT02584855|100746451|FG000|Open-Label Treatment Period|Death|2|||
33231261|NCT02584855|100746452|FG001|Open-Label Treatment Period|Death|0|||
33231262|NCT02584855|100746453|FG002|Open-Label Treatment Period|Death|0|||
33231263|NCT02584855|100746454|FG003|Open-Label Treatment Period|Death|0|||
33231264|NCT02584855|100746455|FG004|Open-Label Treatment Period|Death|0|||
33231265|NCT02584855|100746456|FG005|Open-Label Treatment Period|Death|0|||
33231266|NCT02584855|100746451|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
33231267|NCT02584855|100746452|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
33231268|NCT02584855|100746453|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
33231269|NCT02584855|100746454|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
33231270|NCT02584855|100746455|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
33231271|NCT02584855|100746456|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
33231272|NCT02584855|100746451|FG000|Open-Label Treatment Period|Protocol Violation|1|||
33231273|NCT02584855|100746452|FG001|Open-Label Treatment Period|Protocol Violation|0|||
33231274|NCT02584855|100746453|FG002|Open-Label Treatment Period|Protocol Violation|0|||
33231275|NCT02584855|100746454|FG003|Open-Label Treatment Period|Protocol Violation|0|||
33231276|NCT02584855|100746455|FG004|Open-Label Treatment Period|Protocol Violation|0|||
33231277|NCT02584855|100746456|FG005|Open-Label Treatment Period|Protocol Violation|0|||
33231278|NCT02584855|100746451|FG000|Open-Label Treatment Period|No PI Available|2|||
33231279|NCT02584855|100746452|FG001|Open-Label Treatment Period|No PI Available|0|||
33231280|NCT02584855|100746453|FG002|Open-Label Treatment Period|No PI Available|0|||
33231281|NCT02584855|100746454|FG003|Open-Label Treatment Period|No PI Available|0|||
33231282|NCT02584855|100746455|FG004|Open-Label Treatment Period|No PI Available|0|||
33231283|NCT02584855|100746456|FG005|Open-Label Treatment Period|No PI Available|0|||
33231284|NCT02584855|100746451|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
33231285|NCT02584855|100746452|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
33231286|NCT02584855|100746453|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
33231287|NCT02584855|100746454|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
33231288|NCT02584855|100746455|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
33231289|NCT02584855|100746456|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
33231290|NCT02584855|100746451|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
33231291|NCT02584855|100746452|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
33419851|NCT03343054|101428450|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
33574113|NCT00953706|101992036|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
33574114|NCT00953706|101992037|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
33574115|NCT01816984|101992038|FG000|Overall Study|declining health status|1|||
33574116|NCT01215851|101992044|FG000|Treatment Period|Adverse Event|1|||
33574117|NCT01215851|101992045|FG001|Treatment Period|Adverse Event|1|||
33574118|NCT01215851|101992046|FG002|Treatment Period|Adverse Event|1|||
33574119|NCT01215851|101992047|FG003|Treatment Period|Adverse Event|3|||
33574120|NCT01215851|101992048|FG004|Treatment Period|Adverse Event|0|||
33574121|NCT01215851|101992049|FG005|Treatment Period|Adverse Event|1|||
33574122|NCT01215851|101992044|FG000|Follow up Period|Lost to Follow-up|0|||
33574123|NCT01215851|101992045|FG001|Follow up Period|Lost to Follow-up|0|||
33231292|NCT02584855|100746453|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
33231293|NCT02584855|100746454|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
33231294|NCT02584855|100746455|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
33231295|NCT02584855|100746456|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
33231296|NCT02584855|100746451|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
33231297|NCT02584855|100746452|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
33231298|NCT02584855|100746453|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
33231299|NCT02584855|100746454|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
33231300|NCT02584855|100746455|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
33231301|NCT02584855|100746456|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
33574124|NCT01215851|101992046|FG002|Follow up Period|Lost to Follow-up|0|||
33574125|NCT01215851|101992047|FG003|Follow up Period|Lost to Follow-up|0|||
33574126|NCT01215851|101992048|FG004|Follow up Period|Lost to Follow-up|0|||
33231302|NCT02584855|100746451|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
33231303|NCT02584855|100746452|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
33231304|NCT02584855|100746453|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
33231305|NCT02584855|100746454|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
33231306|NCT02584855|100746455|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
33231307|NCT02584855|100746456|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
33231308|NCT02584855|100746451|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
33231309|NCT02584855|100746452|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
33231310|NCT02584855|100746453|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
33231311|NCT02584855|100746454|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
33368012|NCT02817555|101232776|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
33635827|NCT02963506|102218486|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
33635828|NCT02963506|102218487|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
33635829|NCT02963506|102218488|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
33635830|NCT02963506|102218489|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
33635831|NCT02963506|102218490|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
33635832|NCT02963506|102218491|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
33635833|NCT02963506|102218492|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
33635834|NCT02963506|102218493|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
33635835|NCT02963506|102218494|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
33635836|NCT02963506|102218495|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
33635837|NCT02963506|102218483|FG000|Dose-Blind Period|Sponsor decision|0|||
33635838|NCT02963506|102218484|FG001|Dose-Blind Period|Sponsor decision|0|||
33136755|NCT01425463|100413560|FG000|Overall Study|Protocol Violation|2|||
33136756|NCT01425463|100413561|FG001|Overall Study|Protocol Violation|2|||
33136757|NCT01425463|100413560|FG000|Overall Study|Lost to Follow-up|5|||
33136758|NCT01425463|100413561|FG001|Overall Study|Lost to Follow-up|2|||
33136759|NCT01425463|100413560|FG000|Overall Study|Withdrawal by Subject|7|||
33136760|NCT01425463|100413561|FG001|Overall Study|Withdrawal by Subject|5|||
33136761|NCT01425463|100413560|FG000|Overall Study|Unknown Reason|4|||
33136762|NCT01425463|100413561|FG001|Overall Study|Unknown Reason|7|||
33136763|NCT03126344|100413567|FG000|Overall Study|Lost to Follow-up|0|||
33136764|NCT03126344|100413568|FG001|Overall Study|Lost to Follow-up|0|||
33136765|NCT03126344|100413569|FG002|Overall Study|Lost to Follow-up|5|||
33136788|NCT02881567|100417030|FG000|Overall Study|Adverse Event|1|||
33136789|NCT02881567|100417030|FG000|Overall Study|Lost to Follow-up|3|||
33136790|NCT02881567|100417030|FG000|Overall Study|Consent withdrawn|1|||
33136791|NCT02881567|100417030|FG000|Overall Study|Investigator decision|1|||
33136792|NCT02881567|100417030|FG000|Overall Study|Study terminated by sponsor|9|||
33136793|NCT02881567|100417030|FG000|Overall Study|Reason not Specified|3|||
33136794|NCT04931888|100417031|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
33136795|NCT04931888|100417032|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
33136796|NCT04931888|100417033|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
33136797|NCT04931888|100417034|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
33368013|NCT00850759|101232782|FG000|Overall Study|Lost to Follow-up|7|||
33368014|NCT00850759|101232783|FG001|Overall Study|Lost to Follow-up|5|||
33136798|NCT01433250|100417040|FG000|Overall Study|Protocol Violation|0|||
33136799|NCT01433250|100417041|FG001|Overall Study|Protocol Violation|1|||
33136800|NCT01433250|100417040|FG000|Overall Study|Withdrawal by Subject|3|||
33136801|NCT01433250|100417041|FG001|Overall Study|Withdrawal by Subject|2|||
33136802|NCT04610281|100417042|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
33136803|NCT04610281|100417043|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
33136804|NCT01883453|100417044|FG000|Overall Study|No episode of common cold|25|||
33136805|NCT01883453|100417045|FG001|Overall Study|No episode of common cold|23|||
33136806|NCT00668733|100417046|FG000|Overall Study|Lost to Follow-up|2|||
33231312|NCT02584855|100746455|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
33231313|NCT02584855|100746456|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
33231314|NCT02584855|100746451|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33231315|NCT02584855|100746452|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33231316|NCT02584855|100746453|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33231317|NCT02584855|100746454|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33231318|NCT02584855|100746455|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
33231319|NCT02584855|100746456|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
33231320|NCT02584855|100746451|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
33231321|NCT02584855|100746452|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
33231322|NCT02584855|100746453|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
33231323|NCT02584855|100746454|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
33231324|NCT02584855|100746455|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
33231325|NCT02584855|100746456|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
33231326|NCT03225846|100746459|FG000|Overall Study|Adverse Event|0|||
33231327|NCT03225846|100746460|FG001|Overall Study|Adverse Event|0|||
33231328|NCT03225846|100746461|FG002|Overall Study|Adverse Event|0|||
33231329|NCT03225846|100746462|FG003|Overall Study|Adverse Event|0|||
33231330|NCT03225846|100746463|FG004|Overall Study|Adverse Event|0|||
33231331|NCT03225846|100746464|FG005|Overall Study|Adverse Event|0|||
33231332|NCT03225846|100746465|FG006|Overall Study|Adverse Event|6|||
33231333|NCT03225846|100746459|FG000|Overall Study|Withdrawal by Subject|0|||
33231334|NCT03225846|100746460|FG001|Overall Study|Withdrawal by Subject|1|||
33231335|NCT03225846|100746461|FG002|Overall Study|Withdrawal by Subject|0|||
33231336|NCT03225846|100746462|FG003|Overall Study|Withdrawal by Subject|0|||
33231337|NCT03225846|100746463|FG004|Overall Study|Withdrawal by Subject|0|||
33231338|NCT03225846|100746464|FG005|Overall Study|Withdrawal by Subject|0|||
33231339|NCT03225846|100746465|FG006|Overall Study|Withdrawal by Subject|0|||
33231340|NCT03225846|100746459|FG000|Overall Study|Death|0|||
33231341|NCT03225846|100746460|FG001|Overall Study|Death|1|||
33231342|NCT03225846|100746461|FG002|Overall Study|Death|0|||
33231343|NCT03225846|100746462|FG003|Overall Study|Death|0|||
33231344|NCT03225846|100746463|FG004|Overall Study|Death|0|||
33574127|NCT01215851|101992049|FG005|Follow up Period|Lost to Follow-up|1|||
33574128|NCT01847443|101992050|FG000|Study Period 1|Withdrawal by Subject|0|||
33574129|NCT01847443|101992051|FG001|Study Period 1|Withdrawal by Subject|1|||
33574130|NCT01847443|101992052|FG002|Study Period 1|Withdrawal by Subject|0|||
33574131|NCT01847443|101992053|FG003|Study Period 1|Withdrawal by Subject|0|||
33574132|NCT01847443|101992050|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
33574133|NCT01847443|101992051|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
33574134|NCT01847443|101992052|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
33574135|NCT01847443|101992053|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
33574136|NCT01847443|101992050|FG000|Washout Period Before Study Period 2|Other reason|1|||
33574137|NCT01847443|101992051|FG001|Washout Period Before Study Period 2|Other reason|0|||
33574138|NCT01847443|101992052|FG002|Washout Period Before Study Period 2|Other reason|0|||
33574139|NCT01847443|101992053|FG003|Washout Period Before Study Period 2|Other reason|0|||
33574140|NCT01847443|101992050|FG000|Washout Period Before Study Period 3|Other reason|1|||
33574141|NCT01847443|101992051|FG001|Washout Period Before Study Period 3|Other reason|0|||
33574142|NCT01847443|101992052|FG002|Washout Period Before Study Period 3|Other reason|0|||
33574143|NCT01847443|101992053|FG003|Washout Period Before Study Period 3|Other reason|0|||
33574144|NCT01847443|101992050|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
33574145|NCT01847443|101992051|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
33574146|NCT01847443|101992052|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
33574147|NCT01847443|101992053|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
33574148|NCT01847443|101992050|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
33574149|NCT01847443|101992051|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
33574150|NCT01847443|101992052|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
33574151|NCT01847443|101992053|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
33574152|NCT02921789|101992054|FG000|Overall Study|Adverse Event|0|||
33574153|NCT02921789|101992055|FG001|Overall Study|Adverse Event|1|||
33574154|NCT02921789|101992054|FG000|Overall Study|Lost to Follow-up|1|||
33231345|NCT03225846|100746464|FG005|Overall Study|Death|0|||
33231346|NCT03225846|100746465|FG006|Overall Study|Death|0|||
33231347|NCT03225846|100746459|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
33574155|NCT02921789|101992055|FG001|Overall Study|Lost to Follow-up|0|||
33231348|NCT03225846|100746460|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
33574156|NCT02921789|101992054|FG000|Overall Study|Protocol Deviation|2|||
33635839|NCT02963506|102218485|FG002|Dose-Blind Period|Sponsor decision|0|||
33136807|NCT00668733|100417047|FG001|Overall Study|Lost to Follow-up|3|||
33574157|NCT02921789|101992055|FG001|Overall Study|Protocol Deviation|0|||
33574158|NCT02921789|101992054|FG000|Overall Study|Withdrawal by Subject|2|||
33136808|NCT00668733|100417046|FG000|Overall Study|Withdrawal by Subject|0|||
33136809|NCT00668733|100417047|FG001|Overall Study|Withdrawal by Subject|4|||
33136810|NCT02338882|100417048|FG000|Overall Study|Death|1|||
33136811|NCT02338882|100417049|FG001|Overall Study|Death|0|||
33574159|NCT02921789|101992055|FG001|Overall Study|Withdrawal by Subject|1|||
33574160|NCT02921789|101992054|FG000|Overall Study|Miscellaneous|3|||
33574161|NCT02921789|101992055|FG001|Overall Study|Miscellaneous|2|||
33574162|NCT00976456|101992056|FG000|Overall Study|Adverse Event|17|||
33574163|NCT00976456|101992057|FG001|Overall Study|Adverse Event|22|||
33574164|NCT00976456|101992056|FG000|Overall Study|Death|7|||
33574165|NCT00976456|101992057|FG001|Overall Study|Death|9|||
33574166|NCT00976456|101992056|FG000|Overall Study|Lack of Efficacy|5|||
33574167|NCT00976456|101992057|FG001|Overall Study|Lack of Efficacy|2|||
33574168|NCT00976456|101992056|FG000|Overall Study|Withdrawal by Subject|3|||
33574169|NCT00976456|101992057|FG001|Overall Study|Withdrawal by Subject|1|||
33574170|NCT00976456|101992056|FG000|Overall Study|screening failure, unknown|11|||
33574171|NCT00976456|101992057|FG001|Overall Study|screening failure, unknown|4|||
33574172|NCT01298323|101992058|FG000|Overall Study|Adverse Event|2|||
33574173|NCT01298323|101992059|FG001|Overall Study|Adverse Event|4|||
33574174|NCT01298323|101992058|FG000|Overall Study|Death|11|||
33574175|NCT01298323|101992059|FG001|Overall Study|Death|16|||
33574176|NCT01298323|101992058|FG000|Overall Study|Lost to Follow-up|1|||
33574177|NCT01298323|101992059|FG001|Overall Study|Lost to Follow-up|0|||
33574178|NCT01298323|101992058|FG000|Overall Study|Withdrawal by Subject|6|||
33574179|NCT01298323|101992059|FG001|Overall Study|Withdrawal by Subject|3|||
33574180|NCT01298323|101992058|FG000|Overall Study|Protocol Violation|1|||
33574181|NCT01298323|101992059|FG001|Overall Study|Protocol Violation|0|||
33574182|NCT01298323|101992058|FG000|Overall Study|Other|10|||
33574183|NCT01298323|101992059|FG001|Overall Study|Other|9|||
33574184|NCT01298323|101992058|FG000|Overall Study|Ongoing|55|||
33574185|NCT01298323|101992059|FG001|Overall Study|Ongoing|55|||
33574186|NCT01298323|101992058|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33574187|NCT01298323|101992059|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33574188|NCT03961308|101992061|FG000|Overall Study|Withdrawal by Subject|1|||
33574189|NCT03961308|101992062|FG001|Overall Study|Withdrawal by Subject|0|||
33574190|NCT03961308|101992061|FG000|Overall Study|Other|1|||
33574191|NCT03961308|101992062|FG001|Overall Study|Other|0|||
33574192|NCT03961308|101992061|FG000|Overall Study|Lost to Follow-up|0|||
33574193|NCT03961308|101992062|FG001|Overall Study|Lost to Follow-up|1|||
33574194|NCT03961308|101992061|FG000|Overall Study|Adverse Event|0|||
33574195|NCT03961308|101992062|FG001|Overall Study|Adverse Event|1|||
33574196|NCT02131766|101992063|FG000|Overall Study|Withdrawal by Subject|4|||
33574197|NCT03816176|101992064|FG000|Overall Study|Miscellaneous|5|||
33574198|NCT03816176|101992064|FG000|Overall Study|Lack of Efficacy|4|||
33574199|NCT03816176|101992064|FG000|Overall Study|Adverse Event|3|||
33574200|NCT04567524|101992065|FG000|Overall Study|Adverse Event|1|||
33574201|NCT04567524|101992066|FG001|Overall Study|Adverse Event|1|||
33574202|NCT04567524|101992067|FG002|Overall Study|Adverse Event|0|||
33574203|NCT04567524|101992068|FG003|Overall Study|Adverse Event|0|||
33136812|NCT02338882|100417048|FG000|Overall Study|Lost to Follow-up|6|||
33136813|NCT02338882|100417049|FG001|Overall Study|Lost to Follow-up|3|||
33136814|NCT00311584|100417052|FG000|Overall Study|Death|1|||
33136815|NCT00311584|100417053|FG001|Overall Study|Death|0|||
33136816|NCT00311584|100417052|FG000|Overall Study|Lack of Efficacy|12|||
33136817|NCT00311584|100417053|FG001|Overall Study|Lack of Efficacy|15|||
33136818|NCT00311584|100417052|FG000|Overall Study|Physician Decision|4|||
33136819|NCT00311584|100417053|FG001|Overall Study|Physician Decision|5|||
33136820|NCT00311584|100417052|FG000|Overall Study|Withdrawal by Subject|1|||
33136821|NCT00311584|100417053|FG001|Overall Study|Withdrawal by Subject|1|||
33574204|NCT04567524|101992065|FG000|Overall Study|Withdrawal by Subject|2|||
33574205|NCT04567524|101992066|FG001|Overall Study|Withdrawal by Subject|0|||
33136822|NCT00311584|100417052|FG000|Overall Study|ineligible|2|||
33136823|NCT00311584|100417053|FG001|Overall Study|ineligible|2|||
33136824|NCT01317550|100417054|FG000|Overall Study|Withdrawal by Subject|1|||
33136825|NCT01317550|100417055|FG001|Overall Study|Withdrawal by Subject|0|||
33574206|NCT04567524|101992067|FG002|Overall Study|Withdrawal by Subject|0|||
33574207|NCT04567524|101992068|FG003|Overall Study|Withdrawal by Subject|1|||
33574208|NCT02708680|101994144|FG000|Overall Study|Withdrawal by Subject|4|||
33574209|NCT02708680|101994145|FG001|Overall Study|Withdrawal by Subject|12|||
33574210|NCT02708680|101994146|FG002|Overall Study|Withdrawal by Subject|12|||
33574211|NCT02708680|101994144|FG000|Overall Study|Death|4|||
33574212|NCT02708680|101994145|FG001|Overall Study|Death|19|||
33574213|NCT02708680|101994146|FG002|Overall Study|Death|21|||
33574214|NCT02708680|101994144|FG000|Overall Study|Lost to Follow-up|0|||
33574215|NCT02708680|101994145|FG001|Overall Study|Lost to Follow-up|3|||
33574216|NCT02708680|101994146|FG002|Overall Study|Lost to Follow-up|3|||
33574217|NCT02708680|101994144|FG000|Overall Study|Study Terminated By Sponsor|0|||
33574218|NCT02708680|101994145|FG001|Overall Study|Study Terminated By Sponsor|5|||
33574219|NCT02708680|101994146|FG002|Overall Study|Study Terminated By Sponsor|4|||
33574220|NCT02708680|101994144|FG000|Overall Study|Other than Specified|0|||
33574221|NCT02708680|101994145|FG001|Overall Study|Other than Specified|0|||
33574222|NCT02708680|101994146|FG002|Overall Study|Other than Specified|1|||
33574223|NCT02708680|101994144|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
33574224|NCT02708680|101994145|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
33574225|NCT02708680|101994146|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
33574226|NCT01905540|101994147|FG000|Period 3|Other|1|||
33574227|NCT01905540|101994148|FG001|Period 3|Other|0|||
33574228|NCT01905540|101994149|FG002|Period 3|Other|1|||
33574229|NCT01905540|101994150|FG003|Period 3|Other|1|||
33574230|NCT01071954|101994151|FG000|Overall Study|Noncompliance|4|||
33574231|NCT01071954|101994151|FG000|Overall Study|Adverse Event|1|||
33574232|NCT01071954|101994151|FG000|Overall Study|Withdrawal by Subject|11|||
33574233|NCT01071954|101994151|FG000|Overall Study|Requirement for Alternative Therapy|5|||
33574234|NCT01071954|101994151|FG000|Overall Study|Administrative Decision|5|||
33574235|NCT01071954|101994151|FG000|Overall Study|Protocol Specified Criteria|1|||
33574236|NCT05448950|101994152|FG000|Overall Study|Death|2|||
33574237|NCT05448950|101994152|FG000|Overall Study|Withdrawal by Subject|1|||
33574238|NCT05448950|101994152|FG000|Overall Study|AVG abandoned|4|||
33574239|NCT03218917|101994153|FG000|Overall Study|Adverse Event|3|||
33574240|NCT03218917|101994154|FG001|Overall Study|Adverse Event|3|||
33574241|NCT03218917|101994155|FG002|Overall Study|Adverse Event|2|||
33136826|NCT01317550|100417056|FG002|Overall Study|Withdrawal by Subject|0|||
33136827|NCT01317550|100417057|FG003|Overall Study|Withdrawal by Subject|0|||
33136828|NCT01317550|100417054|FG000|Overall Study|Lack of compliance study med|1|||
33136829|NCT01317550|100417055|FG001|Overall Study|Lack of compliance study med|0|||
33136830|NCT01317550|100417056|FG002|Overall Study|Lack of compliance study med|0|||
33136831|NCT01317550|100417057|FG003|Overall Study|Lack of compliance study med|0|||
33231349|NCT03225846|100746461|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
33231350|NCT03225846|100746462|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
33231351|NCT03225846|100746463|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
33231352|NCT03225846|100746464|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
33231353|NCT03225846|100746465|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
33231354|NCT03225846|100746459|FG000|Overall Study|Patient decision|0|||
33231355|NCT03225846|100746460|FG001|Overall Study|Patient decision|0|||
33231356|NCT03225846|100746461|FG002|Overall Study|Patient decision|0|||
33231357|NCT03225846|100746462|FG003|Overall Study|Patient decision|0|||
33231358|NCT03225846|100746463|FG004|Overall Study|Patient decision|0|||
33231359|NCT03225846|100746464|FG005|Overall Study|Patient decision|0|||
33231360|NCT03225846|100746465|FG006|Overall Study|Patient decision|1|||
33231361|NCT00962585|100746488|FG000|Overall Study|Adverse Event|0|||
33231362|NCT00962585|100746489|FG001|Overall Study|Adverse Event|2|||
33231363|NCT00962585|100746490|FG002|Overall Study|Adverse Event|1|||
33231364|NCT00962585|100746491|FG003|Overall Study|Adverse Event|0|||
33231365|NCT00962585|100746488|FG000|Overall Study|Lost to Follow-up|3|||
33231366|NCT00962585|100746489|FG001|Overall Study|Lost to Follow-up|0|||
33231367|NCT00962585|100746490|FG002|Overall Study|Lost to Follow-up|1|||
33231368|NCT00962585|100746491|FG003|Overall Study|Lost to Follow-up|0|||
33231369|NCT00962585|100746488|FG000|Overall Study|Protocol Violation|0|||
33231370|NCT00962585|100746489|FG001|Overall Study|Protocol Violation|0|||
33231371|NCT00962585|100746490|FG002|Overall Study|Protocol Violation|1|||
33231372|NCT00962585|100746491|FG003|Overall Study|Protocol Violation|0|||
33231373|NCT00962585|100746488|FG000|Overall Study|Withdrawal by Subject|1|||
33231374|NCT00962585|100746489|FG001|Overall Study|Withdrawal by Subject|0|||
33231375|NCT00962585|100746490|FG002|Overall Study|Withdrawal by Subject|0|||
33231376|NCT00962585|100746491|FG003|Overall Study|Withdrawal by Subject|0|||
33231377|NCT00962585|100746488|FG000|Overall Study|Withdrew Consent|2|||
33419852|NCT03343054|101428451|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
33574242|NCT03218917|101994153|FG000|Overall Study|Subject withdrew consent|2|||
33574243|NCT03218917|101994154|FG001|Overall Study|Subject withdrew consent|4|||
33231378|NCT00962585|100746489|FG001|Overall Study|Withdrew Consent|0|||
33231379|NCT00962585|100746490|FG002|Overall Study|Withdrew Consent|0|||
33231380|NCT00962585|100746491|FG003|Overall Study|Withdrew Consent|0|||
33231381|NCT02572817|100746495|FG000|Overall Study|Death|6|||
33231382|NCT02572817|100746496|FG001|Overall Study|Death|3|||
33231383|NCT02572817|100746495|FG000|Overall Study|Lost to Follow-up|3|||
33231384|NCT02572817|100746496|FG001|Overall Study|Lost to Follow-up|3|||
33231385|NCT00904150|100746499|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
33574244|NCT03218917|101994155|FG002|Overall Study|Subject withdrew consent|10|||
33574245|NCT03218917|101994153|FG000|Overall Study|Physician Decision|0|||
33231386|NCT00904150|100746500|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
33574246|NCT03218917|101994154|FG001|Overall Study|Physician Decision|1|||
33574247|NCT03218917|101994155|FG002|Overall Study|Physician Decision|1|||
33574248|NCT03218917|101994153|FG000|Overall Study|Lost to Follow-up|1|||
33574249|NCT03218917|101994154|FG001|Overall Study|Lost to Follow-up|0|||
33574250|NCT03218917|101994155|FG002|Overall Study|Lost to Follow-up|0|||
33574251|NCT03218917|101994153|FG000|Overall Study|Reason Missing|0|||
33574252|NCT03218917|101994154|FG001|Overall Study|Reason Missing|2|||
33574253|NCT03218917|101994155|FG002|Overall Study|Reason Missing|0|||
33574254|NCT03218917|101994153|FG000|Overall Study|Death|0|||
33635840|NCT02963506|102218486|FG003|Dose-Blind Period|Sponsor decision|0|||
33635841|NCT02963506|102218487|FG004|Dose-Blind Period|Sponsor decision|0|||
33635842|NCT02963506|102218488|FG005|Dose-Blind Period|Sponsor decision|1|||
33635843|NCT02963506|102218489|FG006|Dose-Blind Period|Sponsor decision|0|||
33635844|NCT02963506|102218490|FG007|Dose-Blind Period|Sponsor decision|0|||
33635845|NCT02963506|102218491|FG008|Dose-Blind Period|Sponsor decision|0|||
33635846|NCT02963506|102218492|FG009|Dose-Blind Period|Sponsor decision|0|||
33635847|NCT02963506|102218493|FG010|Dose-Blind Period|Sponsor decision|0|||
33635848|NCT02963506|102218494|FG011|Dose-Blind Period|Sponsor decision|0|||
33635849|NCT02963506|102218495|FG012|Dose-Blind Period|Sponsor decision|0|||
33635850|NCT02963506|102218483|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33635851|NCT02963506|102218484|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33635852|NCT02963506|102218485|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33635853|NCT02963506|102218486|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33635854|NCT02963506|102218487|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33635855|NCT02963506|102218488|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33635856|NCT02963506|102218489|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33635857|NCT02963506|102218490|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33635858|NCT02963506|102218491|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33635859|NCT02963506|102218492|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33635860|NCT02963506|102218493|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33368015|NCT00850759|101232784|FG002|Overall Study|Lost to Follow-up|5|||
33368016|NCT00850759|101232785|FG003|Overall Study|Lost to Follow-up|3|||
33368017|NCT03552549|101232789|FG000|Overall Study|Disease progression|25|||
33368018|NCT03552549|101232790|FG001|Overall Study|Disease progression|17|||
33368019|NCT03552549|101232789|FG000|Overall Study|Adverse event in first 12 months|12|||
33368020|NCT03552549|101232790|FG001|Overall Study|Adverse event in first 12 months|8|||
33368021|NCT03552549|101232789|FG000|Overall Study|Withdrawal by Subject|7|||
33368022|NCT03552549|101232790|FG001|Overall Study|Withdrawal by Subject|7|||
33368023|NCT03552549|101232789|FG000|Overall Study|Unknown (no reason provided)|4|||
33419853|NCT03343054|101428449|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
33419854|NCT03343054|101428450|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
33419855|NCT03343054|101428451|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
33419856|NCT00061945|101428452|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
33574255|NCT03218917|101994154|FG001|Overall Study|Death|1|||
33574256|NCT03218917|101994155|FG002|Overall Study|Death|0|||
33574257|NCT03218917|101994153|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33574258|NCT03218917|101994154|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33574259|NCT03218917|101994155|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33574260|NCT01913327|101994157|FG000|Overall Study|Withdrawal by Subject|0|||
33574261|NCT01913327|101994158|FG001|Overall Study|Withdrawal by Subject|1|||
33574262|NCT00506142|101994159|FG000|Overall Study|Adverse Event|8|||
33574263|NCT00506142|101994160|FG001|Overall Study|Adverse Event|7|||
33635861|NCT02963506|102218494|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
33635862|NCT02963506|102218495|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
33635863|NCT00313014|102218498|FG000|Overall Study|Withdrawal by Subject|11|||
33635864|NCT00313014|102218499|FG001|Overall Study|Withdrawal by Subject|7|||
33635865|NCT00313014|102218500|FG002|Overall Study|Withdrawal by Subject|5|||
33635866|NCT00313014|102218498|FG000|Overall Study|Adverse Event|14|||
33635867|NCT00313014|102218499|FG001|Overall Study|Adverse Event|29|||
33635868|NCT00313014|102218500|FG002|Overall Study|Adverse Event|16|||
33635869|NCT00313014|102218498|FG000|Overall Study|Lost to Follow-up|7|||
33635870|NCT00313014|102218499|FG001|Overall Study|Lost to Follow-up|6|||
33635871|NCT00313014|102218500|FG002|Overall Study|Lost to Follow-up|10|||
33635872|NCT00313014|102218498|FG000|Overall Study|Administrative|9|||
33635873|NCT00313014|102218499|FG001|Overall Study|Administrative|6|||
33635874|NCT00313014|102218500|FG002|Overall Study|Administrative|14|||
33635875|NCT00313014|102218498|FG000|Overall Study|Lack of Efficacy|52|||
33635876|NCT00313014|102218499|FG001|Overall Study|Lack of Efficacy|25|||
33635877|NCT00313014|102218500|FG002|Overall Study|Lack of Efficacy|16|||
33635878|NCT01002339|102218502|FG000|Overall Study|Withdrawal by Subject|0|||
33635879|NCT01002339|102218503|FG001|Overall Study|Withdrawal by Subject|1|||
33368024|NCT03552549|101232790|FG001|Overall Study|Unknown (no reason provided)|2|||
33419857|NCT00061945|101428453|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
33635880|NCT01002339|102218504|FG002|Overall Study|Withdrawal by Subject|0|||
33419858|NCT00061945|101428452|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
33635881|NCT01002339|102218502|FG000|Overall Study|Incorrect treatment assignment|0|||
33574264|NCT00506142|101994159|FG000|Overall Study|Lack of Efficacy|21|||
33574265|NCT00506142|101994160|FG001|Overall Study|Lack of Efficacy|7|||
33635882|NCT01002339|102218503|FG001|Overall Study|Incorrect treatment assignment|0|||
33635883|NCT01002339|102218504|FG002|Overall Study|Incorrect treatment assignment|1|||
33635884|NCT01002339|102218502|FG000|Overall Study|Protocol Violation|0|||
33635885|NCT01002339|102218503|FG001|Overall Study|Protocol Violation|0|||
33635886|NCT01002339|102218504|FG002|Overall Study|Protocol Violation|2|||
33635887|NCT01002339|102218502|FG000|Overall Study|Lung cancer detected before transplant|0|||
33635888|NCT01002339|102218503|FG001|Overall Study|Lung cancer detected before transplant|0|||
33635889|NCT01002339|102218504|FG002|Overall Study|Lung cancer detected before transplant|1|||
33635890|NCT01002339|102218502|FG000|Overall Study|Randomized. Not transplanted|0|||
33635891|NCT01002339|102218503|FG001|Overall Study|Randomized. Not transplanted|0|||
33635892|NCT01002339|102218504|FG002|Overall Study|Randomized. Not transplanted|1|||
33635893|NCT02379728|102218505|FG000|Overall Study|Lost to Follow-up|1|||
33635894|NCT02379728|102218506|FG001|Overall Study|Lost to Follow-up|0|||
33635895|NCT02379728|102218507|FG002|Overall Study|Lost to Follow-up|3|||
33635896|NCT02379728|102218508|FG003|Overall Study|Lost to Follow-up|0|||
33635897|NCT02379728|102218505|FG000|Overall Study|Withdrawal by Subject|5|||
33136832|NCT02923921|100417058|FG000|Overall Study|Sponsor Decision|39|||
33136833|NCT02923921|100417059|FG001|Overall Study|Sponsor Decision|38|||
33136834|NCT02923921|100417058|FG000|Overall Study|Lost to Follow-up|1|||
33136835|NCT02923921|100417059|FG001|Overall Study|Lost to Follow-up|0|||
33136836|NCT02923921|100417058|FG000|Overall Study|Withdrawal by Subject|6|||
33136837|NCT02923921|100417059|FG001|Overall Study|Withdrawal by Subject|13|||
33136838|NCT02923921|100417058|FG000|Overall Study|Unknown, Not Collected|7|||
33136839|NCT02923921|100417059|FG001|Overall Study|Unknown, Not Collected|6|||
33136840|NCT01381562|100417060|FG000|Overall Study|Adverse Event|0|||
33136841|NCT01381562|100417061|FG001|Overall Study|Adverse Event|1|||
33136842|NCT01381562|100417062|FG002|Overall Study|Adverse Event|0|||
33136843|NCT02123251|100417063|FG000|Overall Study|Death|1|||
33136844|NCT02123251|100417064|FG001|Overall Study|Death|1|||
33136845|NCT02123251|100417063|FG000|Overall Study|Withdrawal by Subject|0|||
33574266|NCT00506142|101994159|FG000|Overall Study|Withdrawal by Subject|4|||
33574267|NCT00506142|101994160|FG001|Overall Study|Withdrawal by Subject|5|||
33574268|NCT00506142|101994159|FG000|Overall Study|Physician Decision|1|||
33574269|NCT00506142|101994160|FG001|Overall Study|Physician Decision|0|||
33574270|NCT00506142|101994159|FG000|Overall Study|New health condition|1|||
33574271|NCT00506142|101994160|FG001|Overall Study|New health condition|0|||
33574272|NCT05076045|101994161|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
33574273|NCT05076045|101994162|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
33574274|NCT01164007|101994169|FG000|Overall Study|Adverse Event|5|||
33574275|NCT01164007|101994169|FG000|Overall Study|Progression of Disease|30|||
33574276|NCT01164007|101994169|FG000|Overall Study|Protocol Violation|1|||
33574277|NCT01164007|101994169|FG000|Overall Study|Withdrawal by Subject|1|||
33574278|NCT01164007|101994169|FG000|Overall Study|Medical Decision|3|||
33635898|NCT02379728|102218506|FG001|Overall Study|Withdrawal by Subject|0|||
33635899|NCT02379728|102218507|FG002|Overall Study|Withdrawal by Subject|5|||
33635900|NCT02379728|102218508|FG003|Overall Study|Withdrawal by Subject|3|||
33136846|NCT02123251|100417064|FG001|Overall Study|Withdrawal by Subject|3|||
33136847|NCT02123251|100417063|FG000|Overall Study|Lost Medicaid eligibility|29|||
33136848|NCT02123251|100417064|FG001|Overall Study|Lost Medicaid eligibility|22|||
33136849|NCT02123251|100417063|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
33136850|NCT02123251|100417064|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
33136851|NCT00294762|100417065|FG000|Overall Study|Did not receive study treatment|3|||
33231387|NCT00904150|100746499|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
33231388|NCT00904150|100746500|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
33231389|NCT00547911|100746503|FG000|Overall Study|Adverse Event|0|||
33231390|NCT00547911|100746504|FG001|Overall Study|Adverse Event|0|||
33635901|NCT02379728|102218505|FG000|Overall Study|Protocol Violation|0|||
33635902|NCT02379728|102218506|FG001|Overall Study|Protocol Violation|0|||
33635903|NCT02379728|102218507|FG002|Overall Study|Protocol Violation|2|||
33635904|NCT02379728|102218508|FG003|Overall Study|Protocol Violation|0|||
33635905|NCT00815659|102218513|FG000|Overall Study|Adverse Event|9|||
33635906|NCT00815659|102218513|FG000|Overall Study|Withdrawal by Subject|9|||
33635907|NCT00815659|102218513|FG000|Overall Study|Lost to Follow-up|4|||
33635908|NCT00815659|102218513|FG000|Overall Study|Protocol Violation|1|||
33136852|NCT00294762|100417066|FG001|Overall Study|Did not receive study treatment|3|||
33136853|NCT04644315|100417072|FG000|Overall Study|Subject withdrawal of consent|1|||
33136854|NCT00779259|100417073|FG000|Quinine Alone|Adverse Event|2|||
33574279|NCT02393859|101994170|FG000|Overall Study|Decision by Sponsor|2|||
33574280|NCT02393859|101994171|FG001|Overall Study|Decision by Sponsor|4|||
33574281|NCT02393859|101994170|FG000|Overall Study|Withdrawal by Subject|11|||
33574282|NCT02393859|101994171|FG001|Overall Study|Withdrawal by Subject|6|||
33574283|NCT02393859|101994170|FG000|Overall Study|Death|27|||
33574284|NCT02393859|101994171|FG001|Overall Study|Death|10|||
33635909|NCT04949490|102218514|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
33574285|NCT02393859|101994170|FG000|Overall Study|Lost to Follow-up|1|||
33136855|NCT00995566|100417074|FG000|Overall Study|Adverse Event|2|||
33419859|NCT00061945|101428453|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
33419860|NCT00061945|101428452|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
33419861|NCT00061945|101428453|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
33419862|NCT00061945|101428452|FG000|Course IV: Alemtuzumab|Early exits|6|||
33419863|NCT00061945|101428453|FG001|Course IV: Alemtuzumab|Early exits|15|||
33419864|NCT00828516|101428458|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
33419865|NCT02773446|101428459|FG000|First Admission|Withdrawal by Subject|0|||
33419866|NCT02773446|101428460|FG001|First Admission|Withdrawal by Subject|0|||
33419867|NCT02773446|101428461|FG002|First Admission|Withdrawal by Subject|0|||
33419868|NCT02773446|101428462|FG003|First Admission|Withdrawal by Subject|1|||
33419869|NCT02773446|101428463|FG004|First Admission|Withdrawal by Subject|0|||
33419870|NCT02773446|101428464|FG005|First Admission|Withdrawal by Subject|0|||
33635910|NCT04949490|102218515|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
33635911|NCT04949490|102218516|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
33419871|NCT02773446|101428459|FG000|First Admission|Lost to Follow-up|1|||
33419872|NCT02773446|101428460|FG001|First Admission|Lost to Follow-up|0|||
33419873|NCT02773446|101428461|FG002|First Admission|Lost to Follow-up|0|||
33419874|NCT02773446|101428462|FG003|First Admission|Lost to Follow-up|0|||
33419875|NCT02773446|101428463|FG004|First Admission|Lost to Follow-up|0|||
33419876|NCT02773446|101428464|FG005|First Admission|Lost to Follow-up|0|||
33419877|NCT02996448|101428467|FG000|Overall Study|Study terminated due to adverse effects|3|||
33419878|NCT04317053|101428468|FG000|Overall Study|Withdrawn (screen failure)|4|||
33419879|NCT04317053|101428469|FG001|Overall Study|Withdrawn (screen failure)|2|||
33419880|NCT01956123|101428470|FG000|COS Cycle 2|Protocol Violation|8|||
33419881|NCT01956123|101428471|FG001|COS Cycle 2|Protocol Violation|3|||
33419882|NCT01956123|101428472|FG002|COS Cycle 2|Protocol Violation|0|||
33635912|NCT04949490|102218517|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
33635913|NCT04949490|102218518|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
33231391|NCT00547911|100746505|FG002|Overall Study|Adverse Event|0|||
33368025|NCT03552549|101232789|FG000|Overall Study|Not in participant's best interest|2|||
33368026|NCT03552549|101232790|FG001|Overall Study|Not in participant's best interest|1|||
33368027|NCT03552549|101232789|FG000|Overall Study|Did not complete study treatment|2|||
33368028|NCT03552549|101232790|FG001|Overall Study|Did not complete study treatment|3|||
33368029|NCT03552549|101232789|FG000|Overall Study|Did not meet eligibility criteria|1|||
33368030|NCT03552549|101232790|FG001|Overall Study|Did not meet eligibility criteria|0|||
33368031|NCT03552549|101232789|FG000|Overall Study|Administrative|0|||
33368032|NCT03552549|101232790|FG001|Overall Study|Administrative|14|||
33368033|NCT02043301|101232791|FG000|Overall Study|Discontinued|0|||
33368034|NCT02043301|101232792|FG001|Overall Study|Discontinued|1|||
33368035|NCT02043301|101232793|FG002|Overall Study|Discontinued|0|||
33368036|NCT02619253|101232794|FG000|Overall Study|Adverse Event|0|||
33368037|NCT02619253|101232795|FG001|Overall Study|Adverse Event|0|||
33368038|NCT02619253|101232796|FG002|Overall Study|Adverse Event|1|||
33368039|NCT02619253|101232797|FG003|Overall Study|Adverse Event|1|||
33368040|NCT02619253|101232798|FG004|Overall Study|Adverse Event|3|||
33419883|NCT01956123|101428473|FG003|COS Cycle 2|Protocol Violation|0|||
33419884|NCT01956123|101428470|FG000|COS Cycle 2|Adverse Event|3|||
33574286|NCT02393859|101994171|FG001|Overall Study|Lost to Follow-up|1|||
33574287|NCT00387088|101994176|FG000|Overall Study|Adverse Event|143|||
33574288|NCT00387088|101994177|FG001|Overall Study|Adverse Event|156|||
33574289|NCT00387088|101994176|FG000|Overall Study|Protocol Violation|47|||
33574290|NCT00387088|101994177|FG001|Overall Study|Protocol Violation|35|||
33574291|NCT00387088|101994176|FG000|Overall Study|Withdrawal by Subject|20|||
33574292|NCT00387088|101994177|FG001|Overall Study|Withdrawal by Subject|35|||
33574293|NCT00387088|101994176|FG000|Overall Study|Lack of Efficacy|28|||
33574294|NCT00387088|101994177|FG001|Overall Study|Lack of Efficacy|67|||
33574295|NCT00387088|101994176|FG000|Overall Study|Lost to Follow-up|22|||
33574296|NCT00387088|101994177|FG001|Overall Study|Lost to Follow-up|28|||
33574297|NCT00387088|101994176|FG000|Overall Study|Other|58|||
33574298|NCT00387088|101994177|FG001|Overall Study|Other|52|||
33574299|NCT03962855|101994178|FG000|Overall Study|Death|0|||
33574300|NCT03962855|101994179|FG001|Overall Study|Death|1|||
33574301|NCT03962855|101994178|FG000|Overall Study|Lost to Follow-up|0|||
33368041|NCT02619253|101232794|FG000|Overall Study|Alternative Therapy|0|||
33419885|NCT01956123|101428471|FG001|COS Cycle 2|Adverse Event|4|||
33574302|NCT03962855|101994179|FG001|Overall Study|Lost to Follow-up|1|||
33574303|NCT03962855|101994178|FG000|Overall Study|Adverse Event|0|||
33574304|NCT03962855|101994179|FG001|Overall Study|Adverse Event|1|||
33635914|NCT04949490|102218519|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
33368042|NCT02619253|101232795|FG001|Overall Study|Alternative Therapy|0|||
33368043|NCT02619253|101232796|FG002|Overall Study|Alternative Therapy|1|||
33368044|NCT02619253|101232797|FG003|Overall Study|Alternative Therapy|0|||
33419886|NCT01956123|101428472|FG002|COS Cycle 2|Adverse Event|0|||
33419887|NCT01956123|101428473|FG003|COS Cycle 2|Adverse Event|0|||
33419888|NCT01956123|101428470|FG000|COS Cycle 2|Personal Reasons|2|||
33419889|NCT01956123|101428471|FG001|COS Cycle 2|Personal Reasons|0|||
33574305|NCT03962855|101994178|FG000|Overall Study|Physician Decision|0|||
33574306|NCT03962855|101994179|FG001|Overall Study|Physician Decision|2|||
33419890|NCT01956123|101428472|FG002|COS Cycle 2|Personal Reasons|0|||
33419891|NCT01956123|101428473|FG003|COS Cycle 2|Personal Reasons|0|||
33419892|NCT01956123|101428470|FG000|COS Cycle 2|Withdrawal by Subject|1|||
33419893|NCT01956123|101428471|FG001|COS Cycle 2|Withdrawal by Subject|0|||
33419894|NCT01956123|101428472|FG002|COS Cycle 2|Withdrawal by Subject|0|||
33419895|NCT01956123|101428473|FG003|COS Cycle 2|Withdrawal by Subject|0|||
33419896|NCT01956123|101428470|FG000|COS Cycle 3|Protocol Violation|0|||
33635915|NCT04949490|102218514|FG000|Group A and Group B|Withdrawal by Subject|0|||
33635916|NCT04949490|102218515|FG001|Group A and Group B|Withdrawal by Subject|0|||
33635917|NCT04949490|102218516|FG002|Group A and Group B|Withdrawal by Subject|1|||
33635918|NCT04949490|102218517|FG003|Group A and Group B|Withdrawal by Subject|0|||
33635919|NCT04949490|102218518|FG004|Group A and Group B|Withdrawal by Subject|0|||
33635920|NCT04949490|102218519|FG005|Group A and Group B|Withdrawal by Subject|0|||
33635921|NCT04949490|102218514|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
33635922|NCT04949490|102218515|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
33635923|NCT04949490|102218516|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
33635924|NCT04949490|102218517|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
33635925|NCT04949490|102218518|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
33635926|NCT04949490|102218519|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
33635927|NCT04949490|102218514|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
33635928|NCT04949490|102218515|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
33635929|NCT04949490|102218516|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
33635930|NCT04949490|102218517|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
33635931|NCT04949490|102218518|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
33635932|NCT04949490|102218519|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
33635933|NCT01352793|102218525|FG000|Overall Study|Lost to Follow-up|289|||
33635934|NCT01352793|102218526|FG001|Overall Study|Lost to Follow-up|125|||
33635935|NCT01352793|102218525|FG000|Overall Study|Withdrawal by Subject|120|||
33419897|NCT01956123|101428471|FG001|COS Cycle 3|Protocol Violation|0|||
33419898|NCT01956123|101428472|FG002|COS Cycle 3|Protocol Violation|2|||
33419899|NCT01956123|101428473|FG003|COS Cycle 3|Protocol Violation|1|||
33419900|NCT01956123|101428470|FG000|COS Cycle 3|Adverse Event|0|||
33419901|NCT01956123|101428471|FG001|COS Cycle 3|Adverse Event|0|||
33419902|NCT01956123|101428472|FG002|COS Cycle 3|Adverse Event|3|||
33419903|NCT01956123|101428473|FG003|COS Cycle 3|Adverse Event|0|||
33574307|NCT05644002|101994185|FG000|Overall Study|Lost to Follow-up|1|||
33574308|NCT05644002|101994186|FG001|Overall Study|Lost to Follow-up|2|||
33574309|NCT05644002|101994185|FG000|Overall Study|Withdrawal by Subject|0|||
33574310|NCT05644002|101994186|FG001|Overall Study|Withdrawal by Subject|1|||
33574311|NCT02170064|101994187|FG000|Overall Study|Withdrawal by Subject|5|||
33574312|NCT02170064|101994188|FG001|Overall Study|Withdrawal by Subject|1|||
33574313|NCT02170064|101994189|FG002|Overall Study|Withdrawal by Subject|1|||
33574314|NCT02170064|101994187|FG000|Overall Study|Physician Decision|1|||
33574315|NCT02170064|101994188|FG001|Overall Study|Physician Decision|1|||
33574316|NCT02170064|101994189|FG002|Overall Study|Physician Decision|0|||
33635936|NCT01352793|102218526|FG001|Overall Study|Withdrawal by Subject|55|||
33635937|NCT01352793|102218525|FG000|Overall Study|Protocol Violation|44|||
33574317|NCT02359903|101994190|FG000|Overall Study|Adverse Event|0|||
33574318|NCT02359903|101994191|FG001|Overall Study|Adverse Event|2|||
33574319|NCT01740687|101994195|FG000|Overall Study|Lost to Follow-up|11|||
33574320|NCT01740687|101994195|FG000|Overall Study|Withdrawal by Subject|2|||
33574321|NCT01740687|101994195|FG000|Overall Study|other reason|22|||
33574322|NCT01740687|101994195|FG000|Overall Study|treatment not received|2|||
33574323|NCT03929913|101994196|FG000|Overall Study|Death|4|||
33574324|NCT03929913|101994196|FG000|Overall Study|Lost to Follow-up|1|||
33574325|NCT03929913|101994196|FG000|Overall Study|Failed Procedure|2|||
33574326|NCT02704208|101994199|FG000|Overall Study|Lost to Follow-up|42|||
33574327|NCT02704208|101994200|FG001|Overall Study|Lost to Follow-up|37|||
33635938|NCT01352793|102218526|FG001|Overall Study|Protocol Violation|23|||
33635939|NCT01352793|102218525|FG000|Overall Study|Adverse Event|44|||
33231392|NCT00547911|100746506|FG003|Overall Study|Adverse Event|1|||
33231393|NCT00547911|100746507|FG004|Overall Study|Adverse Event|0|||
33231394|NCT00547911|100746508|FG005|Overall Study|Adverse Event|0|||
33419904|NCT01956123|101428470|FG000|COS Cycle 3|Personal Reasons|0|||
33574328|NCT01029535|101994201|FG000|Overall Study|Lost to Follow-up|24|||
33574329|NCT01029535|101994201|FG000|Overall Study|Protocol Violation|2|||
33574330|NCT01029535|101994201|FG000|Overall Study|Participant Withdrew Consent|2|||
33574331|NCT01029535|101994201|FG000|Overall Study|Adverse Event|1|||
33419905|NCT01956123|101428471|FG001|COS Cycle 3|Personal Reasons|0|||
33419906|NCT01956123|101428472|FG002|COS Cycle 3|Personal Reasons|1|||
33574332|NCT01029535|101994201|FG000|Overall Study|Use of Another Treatment|1|||
33574333|NCT01029535|101994201|FG000|Overall Study|Death|1|||
33574334|NCT05246514|101994202|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
33574335|NCT05246514|101994202|FG000|Overall Study|Withdrawal by Subject|1|||
33574336|NCT05246514|101994202|FG000|Overall Study|Death|13|||
33419907|NCT01956123|101428473|FG003|COS Cycle 3|Personal Reasons|0|||
33136856|NCT00995566|100417074|FG000|Overall Study|Early study termination|52|||
33136857|NCT03254459|100417075|FG000|Overall Study|Adverse Event|7|||
33136858|NCT03254459|100417076|FG001|Overall Study|Adverse Event|20|||
33136859|NCT03254459|100417075|FG000|Overall Study|Withdrawal by Subject Consent|3|||
33136860|NCT03254459|100417076|FG001|Overall Study|Withdrawal by Subject Consent|1|||
33231395|NCT02550873|100746509|FG000|Randomized Double Blind|Adverse Event|3|||
33231396|NCT02550873|100746510|FG001|Randomized Double Blind|Adverse Event|1|||
33231397|NCT02550873|100746511|FG002|Randomized Double Blind|Adverse Event|0|||
33231398|NCT02550873|100746509|FG000|Randomized Double Blind|Disease progression|1|||
33231399|NCT02550873|100746510|FG001|Randomized Double Blind|Disease progression|1|||
33231400|NCT02550873|100746511|FG002|Randomized Double Blind|Disease progression|0|||
33231401|NCT02550873|100746509|FG000|Open Label Extension|Study ongoing|0|||
33231402|NCT02550873|100746510|FG001|Open Label Extension|Study ongoing|0|||
33231403|NCT02550873|100746511|FG002|Open Label Extension|Study ongoing|111|||
33231404|NCT03387514|100746518|FG000|Overall Study|Withdrawal by Subject|2|||
33231405|NCT03387514|100746518|FG000|Overall Study|Physician Decision|1|||
33231406|NCT03387514|100746518|FG000|Overall Study|Lost to Follow-up|2|||
33231407|NCT02684903|100746519|FG000|Overall Study|COVID-19 shutdown of lab|4|||
33231408|NCT02684903|100746520|FG001|Overall Study|COVID-19 shutdown of lab|6|||
33231409|NCT02684903|100746519|FG000|Overall Study|Lost to Follow-up|31|||
33231410|NCT02684903|100746520|FG001|Overall Study|Lost to Follow-up|41|||
33231411|NCT01254565|100746521|FG000|Overall Study|Non-compliance to Study Procedures|0|||
33231412|NCT01254565|100746522|FG001|Overall Study|Non-compliance to Study Procedures|0|||
33231413|NCT01254565|100746523|FG002|Overall Study|Non-compliance to Study Procedures|0|||
33231414|NCT01254565|100746524|FG003|Overall Study|Non-compliance to Study Procedures|0|||
33231415|NCT01254565|100746525|FG004|Overall Study|Non-compliance to Study Procedures|1|||
33231416|NCT01254565|100746526|FG005|Overall Study|Non-compliance to Study Procedures|0|||
33231417|NCT01254565|100746521|FG000|Overall Study|Did not Receive Treatment|1|||
33231418|NCT01254565|100746522|FG001|Overall Study|Did not Receive Treatment|1|||
33231419|NCT01254565|100746523|FG002|Overall Study|Did not Receive Treatment|0|||
33231420|NCT01254565|100746524|FG003|Overall Study|Did not Receive Treatment|0|||
33231421|NCT01254565|100746525|FG004|Overall Study|Did not Receive Treatment|3|||
33231422|NCT01254565|100746526|FG005|Overall Study|Did not Receive Treatment|4|||
33231423|NCT01254565|100746521|FG000|Overall Study|Other|0|||
33231424|NCT01254565|100746522|FG001|Overall Study|Other|0|||
33231425|NCT01254565|100746523|FG002|Overall Study|Other|0|||
33231426|NCT01254565|100746524|FG003|Overall Study|Other|1|||
33231427|NCT01254565|100746525|FG004|Overall Study|Other|0|||
33231428|NCT01254565|100746526|FG005|Overall Study|Other|0|||
33231429|NCT00871351|100746527|FG000|Overall Study|Withdrawal by Subject|1|||
33231430|NCT00871351|100746528|FG001|Overall Study|Withdrawal by Subject|0|||
33231431|NCT00871351|100746529|FG002|Overall Study|Withdrawal by Subject|0|||
33231432|NCT00871351|100746527|FG000|Overall Study|Adverse Event|3|||
33231433|NCT00871351|100746528|FG001|Overall Study|Adverse Event|1|||
33231434|NCT00871351|100746529|FG002|Overall Study|Adverse Event|0|||
33231435|NCT00932646|100746530|FG000|Overall Study|Adverse Event|2|||
33231436|NCT00932646|100746531|FG001|Overall Study|Adverse Event|1|||
33231437|NCT00932646|100746532|FG002|Overall Study|Adverse Event|1|||
33231438|NCT00932646|100746533|FG003|Overall Study|Adverse Event|1|||
33231439|NCT00932646|100746530|FG000|Overall Study|Lost to Follow-up|2|||
33231440|NCT00932646|100746531|FG001|Overall Study|Lost to Follow-up|1|||
33231441|NCT00932646|100746532|FG002|Overall Study|Lost to Follow-up|0|||
33231442|NCT00932646|100746533|FG003|Overall Study|Lost to Follow-up|0|||
33231443|NCT00932646|100746530|FG000|Overall Study|Withdrawal by Subject|1|||
33231444|NCT00932646|100746531|FG001|Overall Study|Withdrawal by Subject|1|||
33231445|NCT00932646|100746532|FG002|Overall Study|Withdrawal by Subject|3|||
33574337|NCT04102007|101994203|FG000|Overall Study|Adverse Event|4|||
33574338|NCT04102007|101994203|FG000|Overall Study|Lost to Follow-up|3|||
33574339|NCT04102007|101994203|FG000|Overall Study|Withdrawal by Subject|12|||
33574340|NCT04102007|101994203|FG000|Overall Study|Eligibility Violation|5|||
33574341|NCT04102007|101994203|FG000|Overall Study|Lack of Efficacy|6|||
33574342|NCT04102007|101994203|FG000|Overall Study|Protocol Deviation|5|||
33136861|NCT03254459|100417075|FG000|Overall Study|Lost to Follow-up|0|||
33136862|NCT03254459|100417076|FG001|Overall Study|Lost to Follow-up|1|||
33136863|NCT03254459|100417075|FG000|Overall Study|Miscellaneous|0|||
33231446|NCT00932646|100746533|FG003|Overall Study|Withdrawal by Subject|0|||
33231447|NCT02491892|100746534|FG000|Overall Study|Adverse Event|1|||
33231448|NCT02491892|100746535|FG001|Overall Study|Adverse Event|1|||
33231449|NCT02491892|100746534|FG000|Overall Study|Death|1|||
33231450|NCT02491892|100746535|FG001|Overall Study|Death|1|||
33231451|NCT02491892|100746534|FG000|Overall Study|Lack of Efficacy|37|||
33231452|NCT02491892|100746535|FG001|Overall Study|Lack of Efficacy|36|||
33231453|NCT02491892|100746534|FG000|Overall Study|Refused Treatment|1|||
33136864|NCT03254459|100417076|FG001|Overall Study|Miscellaneous|1|||
33231454|NCT02491892|100746535|FG001|Overall Study|Refused Treatment|0|||
33231455|NCT02491892|100746534|FG000|Overall Study|Lost to Follow-up|1|||
33231456|NCT02491892|100746535|FG001|Overall Study|Lost to Follow-up|0|||
33574343|NCT04102007|101994203|FG000|Overall Study|Protocol Compliance|1|||
33231457|NCT01342887|100746536|FG000|Overall Study|Death|2|||
33231458|NCT00238420|100749834|FG000|Overall Study|Protocol Violation|1|||
33231459|NCT00238420|100749835|FG001|Overall Study|Protocol Violation|1|||
33231460|NCT02788006|100749839|FG000|Overall Study|Patient not treated|1|||
33231461|NCT01591460|100749842|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
33231462|NCT01591460|100749842|FG000|Overall Study|Futility Rule (Week 12)|7|||
33231463|NCT01591460|100749842|FG000|Overall Study|Futility Rule (Week 24)|3|||
33231464|NCT01591460|100749842|FG000|Overall Study|Rebound or Breakthrough|3|||
33231465|NCT01591460|100749842|FG000|Overall Study|Treatment Discontinued by Error|1|||
33231466|NCT01591460|100749842|FG000|Overall Study|Lost to Follow-up|1|||
33231467|NCT01591460|100749842|FG000|Overall Study|Noncompliance|1|||
33231468|NCT01591460|100749842|FG000|Overall Study|Participant Refusal|3|||
33419908|NCT01956123|101428470|FG000|COS Cycle 3|Withdrawal by Subject|0|||
33419909|NCT01956123|101428471|FG001|COS Cycle 3|Withdrawal by Subject|0|||
33419910|NCT01956123|101428472|FG002|COS Cycle 3|Withdrawal by Subject|0|||
33419911|NCT01956123|101428473|FG003|COS Cycle 3|Withdrawal by Subject|1|||
33419912|NCT04529096|101428475|FG000|Overall Study|Adverse Event|6|||
33419913|NCT04529096|101428476|FG001|Overall Study|Adverse Event|1|||
33419914|NCT04529096|101428475|FG000|Overall Study|Lack of Efficacy|1|||
33419915|NCT04529096|101428476|FG001|Overall Study|Lack of Efficacy|0|||
33419916|NCT04529096|101428475|FG000|Overall Study|Lost to Follow-up|1|||
33419917|NCT04529096|101428476|FG001|Overall Study|Lost to Follow-up|1|||
33419918|NCT04529096|101428475|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33419919|NCT04529096|101428476|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33419920|NCT04529096|101428475|FG000|Overall Study|Physician Decision|1|||
33419921|NCT04529096|101428476|FG001|Overall Study|Physician Decision|3|||
33419922|NCT04529096|101428475|FG000|Overall Study|Withdrawal by Subject|5|||
33419923|NCT04529096|101428476|FG001|Overall Study|Withdrawal by Subject|0|||
33419924|NCT01875991|101428477|FG000|Overall Study|Withdrawal by Subject|6|||
33419925|NCT01875991|101428478|FG001|Overall Study|Withdrawal by Subject|6|||
33419926|NCT01875991|101428477|FG000|Overall Study|Sponsor Decision|1|||
33419927|NCT01875991|101428478|FG001|Overall Study|Sponsor Decision|0|||
33419928|NCT00683904|101428479|FG000|Dose Level 1|Disease progression|2|||
33419929|NCT00683904|101428480|FG001|Dose Level 1|Disease progression|0|||
33419930|NCT00683904|101428479|FG000|Dose Level 1|Adverse Event|1|||
33419931|NCT00683904|101428480|FG001|Dose Level 1|Adverse Event|0|||
33419932|NCT00683904|101428479|FG000|Dose Level 2|Adverse Event|0|||
33419933|NCT00683904|101428480|FG001|Dose Level 2|Adverse Event|2|||
33419934|NCT01856686|101428481|FG000|Overall Study|Lost to Follow-up|5|||
33419935|NCT01856686|101428482|FG001|Overall Study|Lost to Follow-up|11|||
33419936|NCT00965263|101428483|FG000|Overall Study|Physician Decision|2|||
33419937|NCT00965263|101428484|FG001|Overall Study|Physician Decision|0|||
33419938|NCT00965263|101428483|FG000|Overall Study|Family emergency|0|||
33419939|NCT00965263|101428484|FG001|Overall Study|Family emergency|1|||
33419940|NCT00965263|101428483|FG000|Overall Study|Protocol Violation|0|||
33419941|NCT00965263|101428484|FG001|Overall Study|Protocol Violation|2|||
33419942|NCT00337129|101428487|FG000|Overall Study|Adverse Event|4|||
33419943|NCT00337129|101428487|FG000|Overall Study|Withdrawal by Subject|1|||
33419944|NCT00337129|101428487|FG000|Overall Study|Lack of Efficacy|32|||
33419945|NCT00337129|101428487|FG000|Overall Study|Death|2|||
33419946|NCT00337129|101428487|FG000|Overall Study|not protocol specified|1|||
33419947|NCT00791154|101428489|FG000|Overall Study|Noncompliance|0|||
33419948|NCT00791154|101428490|FG001|Overall Study|Noncompliance|1|||
33419949|NCT00791154|101428491|FG002|Overall Study|Noncompliance|0|||
33419950|NCT00791154|101428492|FG003|Overall Study|Noncompliance|0|||
33419951|NCT00791154|101428493|FG004|Overall Study|Noncompliance|1|||
33419952|NCT00791154|101428494|FG005|Overall Study|Noncompliance|1|||
33419953|NCT00791154|101428495|FG006|Overall Study|Noncompliance|1|||
33419954|NCT00791154|101428489|FG000|Overall Study|Adverse Event|0|||
33419955|NCT00791154|101428490|FG001|Overall Study|Adverse Event|0|||
33574344|NCT04102007|101994203|FG000|Overall Study|Withdrew Treatment|2|||
33574345|NCT04102007|101994203|FG000|Overall Study|Pregnancy|1|||
33635940|NCT01352793|102218526|FG001|Overall Study|Adverse Event|10|||
33231469|NCT01591460|100749842|FG000|Overall Study|Withdrawal by Subject|1|||
33231470|NCT01591460|100749842|FG000|Overall Study|Protocol Violation|1|||
33231471|NCT00675506|100749845|FG000|Overall Study|Lost to Follow-up|1|||
33231472|NCT00675506|100749846|FG001|Overall Study|Lost to Follow-up|5|||
33419956|NCT00791154|101428491|FG002|Overall Study|Adverse Event|0|||
33231473|NCT00675506|100749845|FG000|Overall Study|Lost interest|3|||
33231474|NCT00675506|100749846|FG001|Overall Study|Lost interest|5|||
33231475|NCT00675506|100749845|FG000|Overall Study|Elevated fasting glucose|2|||
33419957|NCT00791154|101428492|FG003|Overall Study|Adverse Event|0|||
33419958|NCT00791154|101428493|FG004|Overall Study|Adverse Event|2|||
33419959|NCT00791154|101428494|FG005|Overall Study|Adverse Event|0|||
33419960|NCT00791154|101428495|FG006|Overall Study|Adverse Event|1|||
33419961|NCT00791154|101428489|FG000|Overall Study|Full Consent withdrawn|1|||
33419962|NCT00791154|101428490|FG001|Overall Study|Full Consent withdrawn|3|||
33419963|NCT00791154|101428491|FG002|Overall Study|Full Consent withdrawn|0|||
33419964|NCT00791154|101428492|FG003|Overall Study|Full Consent withdrawn|0|||
33635941|NCT01352793|102218525|FG000|Overall Study|Physician Decision|1|||
33231476|NCT00675506|100749846|FG001|Overall Study|Elevated fasting glucose|1|||
33231477|NCT00675506|100749845|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
33231478|NCT00675506|100749846|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
33231479|NCT00675506|100749845|FG000|Overall Study|Elevated IGF-1|2|||
33231480|NCT00675506|100749846|FG001|Overall Study|Elevated IGF-1|0|||
33231481|NCT00675506|100749845|FG000|Overall Study|Hypersensitivity Reaction|1|||
33231482|NCT00675506|100749846|FG001|Overall Study|Hypersensitivity Reaction|0|||
33231483|NCT00675506|100749845|FG000|Overall Study|Disclosed history of cancer|1|||
33231484|NCT00675506|100749846|FG001|Overall Study|Disclosed history of cancer|0|||
33231485|NCT00675506|100749845|FG000|Overall Study|Declined participation|1|||
33231486|NCT00675506|100749846|FG001|Overall Study|Declined participation|0|||
33231487|NCT00675506|100749845|FG000|Overall Study|Schedule conflict|0|||
33231488|NCT00675506|100749846|FG001|Overall Study|Schedule conflict|1|||
33231489|NCT00791921|100749847|FG000|Overall Study|Protocol planed|24|||
33231490|NCT00791921|100749848|FG001|Overall Study|Protocol planed|88|||
33231491|NCT00791921|100749847|FG000|Overall Study|Withdrawal by Subject|1|||
33231492|NCT00791921|100749848|FG001|Overall Study|Withdrawal by Subject|2|||
33231493|NCT00791921|100749847|FG000|Overall Study|Adverse Event|8|||
33231494|NCT00791921|100749848|FG001|Overall Study|Adverse Event|2|||
33574346|NCT01897532|101994204|FG000|Discontinuation From Treatment|Not Treated|7|||
33574347|NCT01897532|101994205|FG001|Discontinuation From Treatment|Not Treated|5|||
33574348|NCT01897532|101994204|FG000|Discontinuation From Treatment|Other reason than specified|196|||
33574349|NCT01897532|101994205|FG001|Discontinuation From Treatment|Other reason than specified|176|||
33574350|NCT01897532|101994204|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
33574351|NCT01897532|101994205|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
33574352|NCT01897532|101994204|FG000|Discontinuation From Treatment|Non compliance|24|||
33574353|NCT01897532|101994205|FG001|Discontinuation From Treatment|Non compliance|15|||
33231495|NCT00791921|100749847|FG000|Overall Study|Lack of Efficacy|0|||
33231496|NCT00791921|100749848|FG001|Overall Study|Lack of Efficacy|2|||
33231497|NCT00791921|100749847|FG000|Overall Study|Lack of study drug administration|1|||
33231498|NCT00791921|100749848|FG001|Overall Study|Lack of study drug administration|1|||
33231499|NCT00791921|100749847|FG000|Overall Study|Reason other than those above|0|||
33231500|NCT00791921|100749848|FG001|Overall Study|Reason other than those above|1|||
33231501|NCT04445155|100749849|FG000|Overall Study|Lost to Follow-up|11|||
33231502|NCT04445155|100749850|FG001|Overall Study|Lost to Follow-up|2|||
33231503|NCT04445155|100749851|FG002|Overall Study|Lost to Follow-up|3|||
33231504|NCT04445155|100749852|FG003|Overall Study|Lost to Follow-up|0|||
33231505|NCT04445155|100749849|FG000|Overall Study|Withdrawal by Subject|8|||
33231506|NCT04445155|100749850|FG001|Overall Study|Withdrawal by Subject|0|||
33231507|NCT04445155|100749851|FG002|Overall Study|Withdrawal by Subject|0|||
33231508|NCT04445155|100749852|FG003|Overall Study|Withdrawal by Subject|0|||
33231509|NCT04445155|100749849|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
33231510|NCT04445155|100749850|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
33231511|NCT04445155|100749851|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
33231512|NCT04445155|100749852|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
33231513|NCT04445155|100749849|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
33231514|NCT04445155|100749850|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
33231515|NCT04445155|100749851|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
33231516|NCT04445155|100749852|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
33231517|NCT00453310|100749853|FG000|Overall Study|Progression of Disease|10|||
33231518|NCT04297241|100749854|FG000|Overall Study|Withdrawal by Subject|1|||
33231519|NCT04297241|100749854|FG000|Overall Study|Adverse Event|1|||
33231520|NCT04297241|100749854|FG000|Overall Study|Physician Decision|3|||
33231521|NCT02222896|100749857|FG000|Abdomen|Did not qualify|34|||
33231522|NCT02222896|100749858|FG001|Abdomen|Did not qualify|10|||
33231523|NCT02222896|100749859|FG002|Abdomen|Did not qualify|32|||
33419965|NCT00791154|101428493|FG004|Overall Study|Full Consent withdrawn|1|||
33231524|NCT02222896|100749857|FG000|Groin|Did not qualify|43|||
33231525|NCT02222896|100749858|FG001|Groin|Did not qualify|9|||
33231526|NCT02222896|100749859|FG002|Groin|Did not qualify|40|||
33231527|NCT02597933|100749862|FG000|Overall Study|Withdrawal by Subject|7|||
33231528|NCT02597933|100749863|FG001|Overall Study|Withdrawal by Subject|5|||
33231529|NCT02597933|100749862|FG000|Overall Study|Protocol Violation|2|||
33231530|NCT02597933|100749863|FG001|Overall Study|Protocol Violation|2|||
33231531|NCT02597933|100749862|FG000|Overall Study|Adverse Event|20|||
33231532|NCT02597933|100749863|FG001|Overall Study|Adverse Event|28|||
33231533|NCT02597933|100749862|FG000|Overall Study|Not treated|2|||
33231534|NCT02597933|100749863|FG001|Overall Study|Not treated|2|||
33231535|NCT02597933|100749862|FG000|Overall Study|Other than stated above|7|||
33231536|NCT02597933|100749863|FG001|Overall Study|Other than stated above|14|||
33231537|NCT03204695|100749869|FG000|Overall Study|Death|1|||
33231538|NCT03204695|100749869|FG000|Overall Study|Participant was treated with another device|1|||
33231539|NCT03204695|100749869|FG000|Overall Study|Physician Decision|2|||
33419966|NCT00791154|101428494|FG005|Overall Study|Full Consent withdrawn|3|||
33419967|NCT00791154|101428495|FG006|Overall Study|Full Consent withdrawn|1|||
33419968|NCT00791154|101428489|FG000|Overall Study|Lost to Follow-up|0|||
33231540|NCT01533714|100749870|FG000|Overall Study|Adverse Event|0|||
33231541|NCT01533714|100749871|FG001|Overall Study|Adverse Event|1|||
33231542|NCT01533714|100749872|FG002|Overall Study|Adverse Event|2|||
33231543|NCT01533714|100749873|FG003|Overall Study|Adverse Event|2|||
33231544|NCT01533714|100749874|FG004|Overall Study|Adverse Event|2|||
33231545|NCT01533714|100749875|FG005|Overall Study|Adverse Event|1|||
33231546|NCT01533714|100749870|FG000|Overall Study|Lack of Efficacy|0|||
33231547|NCT01533714|100749871|FG001|Overall Study|Lack of Efficacy|0|||
33231548|NCT01533714|100749872|FG002|Overall Study|Lack of Efficacy|0|||
33231549|NCT01533714|100749873|FG003|Overall Study|Lack of Efficacy|0|||
33231550|NCT01533714|100749874|FG004|Overall Study|Lack of Efficacy|0|||
33231551|NCT01533714|100749875|FG005|Overall Study|Lack of Efficacy|1|||
33231552|NCT01533714|100749870|FG000|Overall Study|Withdrawal by Subject|0|||
33231553|NCT01533714|100749871|FG001|Overall Study|Withdrawal by Subject|1|||
33231554|NCT01533714|100749872|FG002|Overall Study|Withdrawal by Subject|0|||
33231555|NCT01533714|100749873|FG003|Overall Study|Withdrawal by Subject|1|||
33231556|NCT01533714|100749874|FG004|Overall Study|Withdrawal by Subject|1|||
33231557|NCT01533714|100749875|FG005|Overall Study|Withdrawal by Subject|0|||
33231558|NCT01533714|100749870|FG000|Overall Study|Exclusion criteria|0|||
33231559|NCT01533714|100749871|FG001|Overall Study|Exclusion criteria|1|||
33231560|NCT01533714|100749872|FG002|Overall Study|Exclusion criteria|0|||
33231561|NCT01533714|100749873|FG003|Overall Study|Exclusion criteria|0|||
33231562|NCT01533714|100749874|FG004|Overall Study|Exclusion criteria|0|||
33231563|NCT01533714|100749875|FG005|Overall Study|Exclusion criteria|0|||
33231564|NCT01533714|100749870|FG000|Overall Study|Positive for purified protein derivative|0|||
33231565|NCT01533714|100749871|FG001|Overall Study|Positive for purified protein derivative|0|||
33231566|NCT01533714|100749872|FG002|Overall Study|Positive for purified protein derivative|1|||
33231567|NCT01533714|100749873|FG003|Overall Study|Positive for purified protein derivative|0|||
33231568|NCT01533714|100749874|FG004|Overall Study|Positive for purified protein derivative|1|||
33231569|NCT01533714|100749875|FG005|Overall Study|Positive for purified protein derivative|0|||
33231570|NCT01533714|100749870|FG000|Overall Study|Withdrawal criteria|0|||
33231571|NCT01533714|100749871|FG001|Overall Study|Withdrawal criteria|0|||
33231572|NCT01533714|100749872|FG002|Overall Study|Withdrawal criteria|1|||
33231573|NCT01533714|100749873|FG003|Overall Study|Withdrawal criteria|0|||
33231574|NCT01533714|100749874|FG004|Overall Study|Withdrawal criteria|3|||
33231575|NCT01533714|100749875|FG005|Overall Study|Withdrawal criteria|1|||
33231576|NCT01533714|100749870|FG000|Overall Study|Ineligibility reason|0|||
33231577|NCT01533714|100749871|FG001|Overall Study|Ineligibility reason|0|||
33231578|NCT01533714|100749872|FG002|Overall Study|Ineligibility reason|0|||
33231579|NCT01533714|100749873|FG003|Overall Study|Ineligibility reason|1|||
33231580|NCT01533714|100749874|FG004|Overall Study|Ineligibility reason|0|||
33231581|NCT01533714|100749875|FG005|Overall Study|Ineligibility reason|0|||
33231582|NCT00313911|100749876|FG000|Overall Study|Serious adverse event|6|||
33231583|NCT00313911|100749877|FG001|Overall Study|Serious adverse event|1|||
33231584|NCT00313911|100749876|FG000|Overall Study|Adverse Event|2|||
33231585|NCT00313911|100749877|FG001|Overall Study|Adverse Event|3|||
33231586|NCT00313911|100749876|FG000|Overall Study|Protocol Violation|19|||
33231587|NCT00313911|100749877|FG001|Overall Study|Protocol Violation|10|||
33231588|NCT00313911|100749876|FG000|Overall Study|Lost to Follow-up|27|||
33231589|NCT00313911|100749877|FG001|Overall Study|Lost to Follow-up|14|||
33231590|NCT00313911|100749876|FG000|Overall Study|Withdrawal by Subject|39|||
33231591|NCT00313911|100749877|FG001|Overall Study|Withdrawal by Subject|12|||
33231592|NCT00313911|100749876|FG000|Overall Study|Did not meet age criteria|1|||
33231593|NCT00313911|100749877|FG001|Overall Study|Did not meet age criteria|1|||
33231594|NCT01003184|100749878|FG000|Overall Study|Adverse Event|12|||
33231595|NCT01003184|100749879|FG001|Overall Study|Adverse Event|5|||
33419969|NCT00791154|101428490|FG001|Overall Study|Lost to Follow-up|0|||
33419970|NCT00791154|101428491|FG002|Overall Study|Lost to Follow-up|0|||
33231596|NCT01003184|100749878|FG000|Overall Study|Lost to Follow-up|1|||
33231597|NCT01003184|100749879|FG001|Overall Study|Lost to Follow-up|0|||
33231598|NCT01003184|100749878|FG000|Overall Study|Loss of glucose control|1|||
33231599|NCT01003184|100749879|FG001|Overall Study|Loss of glucose control|1|||
33231600|NCT01003184|100749878|FG000|Overall Study|Protocol Violation|3|||
33231601|NCT01003184|100749879|FG001|Overall Study|Protocol Violation|0|||
33231602|NCT01003184|100749878|FG000|Overall Study|Withdrawal by Subject|1|||
33231603|NCT01003184|100749879|FG001|Overall Study|Withdrawal by Subject|6|||
33231604|NCT01003184|100749878|FG000|Overall Study|Physician Decision|1|||
33231605|NCT01003184|100749879|FG001|Overall Study|Physician Decision|0|||
33231606|NCT02374593|100749885|FG000|Overall Study|non-compliant|2|||
33231607|NCT02374593|100749886|FG001|Overall Study|non-compliant|0|||
33231608|NCT00363896|100749889|FG000|Overall Study|Withdrawal by Subject|29|||
33231609|NCT00363896|100749890|FG001|Overall Study|Withdrawal by Subject|16|||
33231610|NCT00363896|100749889|FG000|Overall Study|Adverse Event|24|||
33419971|NCT00791154|101428492|FG003|Overall Study|Lost to Follow-up|1|||
33419972|NCT00791154|101428493|FG004|Overall Study|Lost to Follow-up|2|||
33231611|NCT00363896|100749890|FG001|Overall Study|Adverse Event|13|||
33231612|NCT00363896|100749889|FG000|Overall Study|COPD exacerbation|13|||
33231613|NCT00363896|100749890|FG001|Overall Study|COPD exacerbation|7|||
33231614|NCT00363896|100749889|FG000|Overall Study|Lack of Efficacy|12|||
33231615|NCT00363896|100749890|FG001|Overall Study|Lack of Efficacy|8|||
33231616|NCT00363896|100749889|FG000|Overall Study|Protocol Violation|6|||
33231617|NCT00363896|100749890|FG001|Overall Study|Protocol Violation|1|||
33231618|NCT00363896|100749889|FG000|Overall Study|Lost to Follow-up|3|||
33231619|NCT00363896|100749890|FG001|Overall Study|Lost to Follow-up|0|||
33231620|NCT00363896|100749889|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
33231621|NCT00363896|100749890|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
33231622|NCT00363896|100749889|FG000|Overall Study|Other|1|||
33231623|NCT00363896|100749890|FG001|Overall Study|Other|2|||
33231624|NCT00556374|100749891|FG000|Overall Study|Withdrawal by Subject|235|||
33231625|NCT00556374|100749892|FG001|Overall Study|Withdrawal by Subject|205|||
33231626|NCT00556374|100749891|FG000|Overall Study|Death|158|||
33231627|NCT00556374|100749892|FG001|Overall Study|Death|127|||
33231628|NCT00556374|100749891|FG000|Overall Study|Lost to Follow-up|24|||
33231629|NCT00556374|100749892|FG001|Overall Study|Lost to Follow-up|17|||
33231630|NCT00556374|100749891|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
33231631|NCT00556374|100749892|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
33231632|NCT05593211|100749896|FG000|Overall Study|Withdrawal by Subject|1|||
33231633|NCT02111213|100749900|FG000|Overall Study|Withdrawal by Subject|3|||
33231634|NCT02111213|100749901|FG001|Overall Study|Withdrawal by Subject|2|||
33231635|NCT02111213|100749900|FG000|Overall Study|Lost to Follow-up|3|||
33231636|NCT02111213|100749901|FG001|Overall Study|Lost to Follow-up|4|||
33231637|NCT01003639|100749902|FG000|Overall Study|Lost to Follow-up|6|||
33574354|NCT01897532|101994204|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
33231638|NCT01003639|100749903|FG001|Overall Study|Lost to Follow-up|9|||
33231639|NCT01003639|100749902|FG000|Overall Study|Withdrawal by Subject|9|||
33231640|NCT01003639|100749903|FG001|Overall Study|Withdrawal by Subject|5|||
33231641|NCT01003639|100749902|FG000|Overall Study|Lack of Efficacy|1|||
33231642|NCT01003639|100749903|FG001|Overall Study|Lack of Efficacy|6|||
33231643|NCT01003639|100749902|FG000|Overall Study|Adverse Event|0|||
33231644|NCT01003639|100749903|FG001|Overall Study|Adverse Event|1|||
33231645|NCT01003639|100749902|FG000|Overall Study|Protocol Violation|0|||
33231646|NCT01003639|100749903|FG001|Overall Study|Protocol Violation|1|||
33231647|NCT01003639|100749902|FG000|Overall Study|Physician Decision|1|||
33231648|NCT01003639|100749903|FG001|Overall Study|Physician Decision|0|||
33231649|NCT04908683|100749909|FG000|Overall Study|Failure to meet continuation criteria|34|||
33231650|NCT04908683|100749910|FG001|Overall Study|Failure to meet continuation criteria|22|||
33231651|NCT04908683|100749909|FG000|Overall Study|Initiated prohibited medication|3|||
33231652|NCT04908683|100749910|FG001|Overall Study|Initiated prohibited medication|0|||
33231653|NCT04908683|100749909|FG000|Overall Study|Randomized by mistake|1|||
33231654|NCT04908683|100749910|FG001|Overall Study|Randomized by mistake|0|||
33231655|NCT04908683|100749909|FG000|Overall Study|Lost to Follow-up|679|||
33231656|NCT04908683|100749910|FG001|Overall Study|Lost to Follow-up|341|||
33231657|NCT04908683|100749909|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
33231658|NCT04908683|100749910|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
33231659|NCT04908683|100749909|FG000|Overall Study|Physician Decision|44|||
33231660|NCT04908683|100749910|FG001|Overall Study|Physician Decision|35|||
33231661|NCT04908683|100749909|FG000|Overall Study|Technical problems|12|||
33231662|NCT04908683|100749910|FG001|Overall Study|Technical problems|9|||
33231663|NCT04908683|100749909|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
33231664|NCT04908683|100749910|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
33231665|NCT04908683|100749909|FG000|Overall Study|Protocol Violation|2|||
33231666|NCT04908683|100749910|FG001|Overall Study|Protocol Violation|0|||
33231667|NCT04908683|100749909|FG000|Overall Study|Withdrawal by Subject|1188|||
33231668|NCT04908683|100749910|FG001|Overall Study|Withdrawal by Subject|570|||
33574355|NCT01897532|101994205|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
33231669|NCT04908683|100749909|FG000|Overall Study|Site Closure by Sponsor|6|||
33231670|NCT04908683|100749910|FG001|Overall Study|Site Closure by Sponsor|3|||
33231671|NCT04908683|100749909|FG000|Overall Study|Adverse Event|21|||
33231672|NCT04908683|100749910|FG001|Overall Study|Adverse Event|11|||
33231673|NCT04908683|100749909|FG000|Overall Study|Death|101|||
33231674|NCT04908683|100749910|FG001|Overall Study|Death|61|||
33231675|NCT04908683|100749909|FG000|Overall Study|Sponsor's decision|14398|||
33231676|NCT04908683|100749910|FG001|Overall Study|Sponsor's decision|7205|||
33231677|NCT04908683|100749909|FG000|Overall Study|Other|92|||
33231678|NCT04908683|100749910|FG001|Overall Study|Other|50|||
33231679|NCT04908683|100749909|FG000|Overall Study|Randomized not vaccinated|108|||
33231680|NCT04908683|100749910|FG001|Overall Study|Randomized not vaccinated|52|||
33231681|NCT03051659|100749914|FG000|Treatment Period|Withdrawal by Subject|0|||
33231682|NCT03051659|100749915|FG001|Treatment Period|Withdrawal by Subject|2|||
33231683|NCT03051659|100749914|FG000|Survival Follow-up|Lost to Follow-up|23|||
33231684|NCT03051659|100749915|FG001|Survival Follow-up|Lost to Follow-up|22|||
33231685|NCT03688711|100749922|FG000|Overall Study|Withdrawal by Subject|0|||
33231686|NCT03688711|100749923|FG001|Overall Study|Withdrawal by Subject|1|||
33231687|NCT03898180|100749924|FG000|Overall Study|Ongoing in Study|133|||
33231688|NCT03898180|100749925|FG001|Overall Study|Ongoing in Study|134|||
33231689|NCT03898180|100749924|FG000|Overall Study|Withdrawal by Subject|3|||
33231690|NCT03898180|100749925|FG001|Overall Study|Withdrawal by Subject|2|||
33231691|NCT03898180|100749924|FG000|Overall Study|Death|109|||
33231692|NCT03898180|100749925|FG001|Overall Study|Death|106|||
33231693|NCT00845871|100749926|FG000|Assessment Period|Adverse Event|2|||
33231694|NCT00845871|100749926|FG000|Assessment Period|Abnormal laboratory values|1|||
33231695|NCT00845871|100749926|FG000|Assessment Period|Abnormal test procedure results|1|||
33231696|NCT00845871|100749926|FG000|Assessment Period|Patient withdrew consent|3|||
33231697|NCT01556763|100749927|FG000|Overall Study|Withdrawal by Subject|0|||
33231698|NCT01556763|100749928|FG001|Overall Study|Withdrawal by Subject|1|||
33231699|NCT01556763|100749929|FG002|Overall Study|Withdrawal by Subject|0|||
33231700|NCT04170296|100749930|FG000|Overall Study|Adverse Event|1|||
33231701|NCT04170296|100749931|FG001|Overall Study|Adverse Event|0|||
33231702|NCT04170296|100749930|FG000|Overall Study|Withdrawal by Subject|3|||
33231703|NCT04170296|100749931|FG001|Overall Study|Withdrawal by Subject|2|||
33231704|NCT04170296|100749930|FG000|Overall Study|Lost to Follow-up|4|||
33231705|NCT04170296|100749931|FG001|Overall Study|Lost to Follow-up|2|||
33231706|NCT00839917|100749932|FG000|Overall Study|Lost to Follow-up|1|||
33231707|NCT00839917|100749933|FG001|Overall Study|Lost to Follow-up|0|||
33231708|NCT00839917|100749932|FG000|Overall Study|Did not receive vaccine|0|||
33231709|NCT00839917|100749933|FG001|Overall Study|Did not receive vaccine|1|||
33231710|NCT04320615|100749934|FG000|Overall Study|Withdrawal by Subject|4|||
33231711|NCT04320615|100749935|FG001|Overall Study|Withdrawal by Subject|10|||
33231712|NCT04320615|100749934|FG000|Overall Study|Physician Decision|2|||
33231713|NCT04320615|100749935|FG001|Overall Study|Physician Decision|0|||
33231714|NCT04320615|100749934|FG000|Overall Study|Other|2|||
33231715|NCT04320615|100749935|FG001|Overall Study|Other|0|||
33231716|NCT04320615|100749934|FG000|Overall Study|Lost to Follow-up|5|||
33231717|NCT04320615|100749935|FG001|Overall Study|Lost to Follow-up|23|||
33231718|NCT04320615|100749934|FG000|Overall Study|Death|35|||
33231719|NCT04320615|100749935|FG001|Overall Study|Death|71|||
33231720|NCT02746575|100749936|FG000|Overall Study|Surgery cancelled or time chaned|13|||
33231721|NCT02746575|100749936|FG000|Overall Study|Received epidural|10|||
33231722|NCT02746575|100749936|FG000|Overall Study|Withdrawal by Subject|3|||
33231723|NCT02746575|100749936|FG000|Overall Study|Bradycardia/hypotension|9|||
33231724|NCT02746575|100749936|FG000|Overall Study|Study paused|8|||
33231725|NCT02746575|100749936|FG000|Overall Study|put on beta-blocker|3|||
33231726|NCT02746575|100749936|FG000|Overall Study|type of surgery|1|||
33231727|NCT02746575|100749936|FG000|Overall Study|typ of surgery|1|||
33231728|NCT02746575|100749936|FG000|Overall Study|PI unavailable|1|||
33231729|NCT02746575|100749936|FG000|Overall Study|Unknown history of CVA|1|||
33368045|NCT02619253|101232798|FG004|Overall Study|Alternative Therapy|0|||
33368046|NCT02619253|101232794|FG000|Overall Study|Death|0|||
33368047|NCT02619253|101232795|FG001|Overall Study|Death|0|||
33368048|NCT02619253|101232796|FG002|Overall Study|Death|0|||
33368049|NCT02619253|101232797|FG003|Overall Study|Death|1|||
33368050|NCT02619253|101232798|FG004|Overall Study|Death|0|||
33574356|NCT01897532|101994204|FG000|Discontinuation From Trial|Not Treated|7|||
33574357|NCT01897532|101994205|FG001|Discontinuation From Trial|Not Treated|5|||
33574358|NCT01897532|101994204|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
33574359|NCT01897532|101994205|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
33574360|NCT04562116|101994206|FG000|Overall Study|Lost to Follow-up|1|||
33574361|NCT04562116|101994206|FG000|Overall Study|Withdrawal by Subject|3|||
33574362|NCT01088503|101994207|FG000|Overall Study|Withdrawal by Subject|118|||
33574363|NCT01088503|101994208|FG001|Overall Study|Withdrawal by Subject|327|||
33574364|NCT01088503|101994209|FG002|Overall Study|Withdrawal by Subject|10|||
33574365|NCT01088503|101994207|FG000|Overall Study|Death|64|||
33574366|NCT01088503|101994208|FG001|Overall Study|Death|358|||
33231730|NCT00309608|100749937|FG000|Overall Study|Adverse Event|1|||
33231731|NCT00309608|100749938|FG001|Overall Study|Adverse Event|5|||
33368051|NCT02619253|101232794|FG000|Overall Study|Disease Progression|4|||
33368052|NCT02619253|101232795|FG001|Overall Study|Disease Progression|2|||
33368053|NCT02619253|101232796|FG002|Overall Study|Disease Progression|8|||
33231732|NCT00309608|100749939|FG002|Overall Study|Adverse Event|3|||
33231733|NCT00309608|100749940|FG003|Overall Study|Adverse Event|2|||
33231734|NCT00309608|100749941|FG004|Overall Study|Adverse Event|3|||
33231735|NCT00309608|100749937|FG000|Overall Study|Protocol Violation|2|||
33231736|NCT00309608|100749938|FG001|Overall Study|Protocol Violation|0|||
33231737|NCT00309608|100749939|FG002|Overall Study|Protocol Violation|0|||
33231738|NCT00309608|100749940|FG003|Overall Study|Protocol Violation|0|||
33231739|NCT00309608|100749941|FG004|Overall Study|Protocol Violation|0|||
33231740|NCT00309608|100749937|FG000|Overall Study|Lost to Follow-up|0|||
33231741|NCT00309608|100749938|FG001|Overall Study|Lost to Follow-up|0|||
33231742|NCT00309608|100749939|FG002|Overall Study|Lost to Follow-up|2|||
33368054|NCT02619253|101232797|FG003|Overall Study|Disease Progression|9|||
33574367|NCT01088503|101994209|FG002|Overall Study|Death|7|||
33574368|NCT02750514|101994210|FG000|Track 1|Disease progression|20|||
33574369|NCT02750514|101994211|FG001|Track 1|Disease progression|1|||
33574370|NCT02750514|101994212|FG002|Track 1|Disease progression|0|||
33574371|NCT02750514|101994213|FG003|Track 1|Disease progression|1|||
33574372|NCT02750514|101994214|FG004|Track 1|Disease progression|0|||
33231743|NCT00309608|100749940|FG003|Overall Study|Lost to Follow-up|0|||
33231744|NCT00309608|100749941|FG004|Overall Study|Lost to Follow-up|1|||
33231745|NCT00309608|100749937|FG000|Overall Study|Withdrawal by Subject|1|||
33231746|NCT00309608|100749938|FG001|Overall Study|Withdrawal by Subject|4|||
33231747|NCT00309608|100749939|FG002|Overall Study|Withdrawal by Subject|2|||
33231748|NCT00309608|100749940|FG003|Overall Study|Withdrawal by Subject|0|||
33231749|NCT00309608|100749941|FG004|Overall Study|Withdrawal by Subject|0|||
33231750|NCT00309608|100749937|FG000|Overall Study|Other incl. Lack of efficacy|10|||
33231751|NCT00309608|100749938|FG001|Overall Study|Other incl. Lack of efficacy|4|||
33231752|NCT00309608|100749939|FG002|Overall Study|Other incl. Lack of efficacy|3|||
33231753|NCT00309608|100749940|FG003|Overall Study|Other incl. Lack of efficacy|4|||
33231754|NCT00309608|100749941|FG004|Overall Study|Other incl. Lack of efficacy|0|||
33231755|NCT03306043|100749945|FG000|Overall Study|Adverse Event|1|||
33231756|NCT03306043|100749945|FG000|Overall Study|Lost to Follow-up|1|||
33231757|NCT03306043|100749945|FG000|Overall Study|Withdrawal by Subject|2|||
33231758|NCT02341456|100749946|FG000|Overall Study|Disease progression|2|||
33231759|NCT02341456|100749947|FG001|Overall Study|Disease progression|3|||
33231760|NCT02341456|100749948|FG002|Overall Study|Disease progression|1|||
33231761|NCT02341456|100749946|FG000|Overall Study|Death|1|||
33231762|NCT02341456|100749947|FG001|Overall Study|Death|1|||
33231763|NCT02341456|100749948|FG002|Overall Study|Death|1|||
33231764|NCT02341456|100749946|FG000|Overall Study|Withdrawal by Subject|0|||
33231765|NCT02341456|100749947|FG001|Overall Study|Withdrawal by Subject|1|||
33231766|NCT02341456|100749948|FG002|Overall Study|Withdrawal by Subject|1|||
33231767|NCT02341456|100749946|FG000|Overall Study|Moved to local access programme.|0|||
33231768|NCT02341456|100749947|FG001|Overall Study|Moved to local access programme.|1|||
33231769|NCT02341456|100749948|FG002|Overall Study|Moved to local access programme.|1|||
33231770|NCT02341456|100749946|FG000|Overall Study|Physician Decision|1|||
33231771|NCT02341456|100749947|FG001|Overall Study|Physician Decision|0|||
33231772|NCT02341456|100749948|FG002|Overall Study|Physician Decision|0|||
33231773|NCT00429494|100749949|FG000|Overall Study|Withdrawal by Subject|9|||
33231774|NCT00429494|100749949|FG000|Overall Study|Death|6|||
33231775|NCT01216176|100749952|FG000|Overall Study|Adverse Event|0|||
33231776|NCT01216176|100749953|FG001|Overall Study|Adverse Event|8|||
33231777|NCT01216176|100749954|FG002|Overall Study|Adverse Event|0|||
33231778|NCT01216176|100749952|FG000|Overall Study|Physician Decision|0|||
33231779|NCT01216176|100749953|FG001|Overall Study|Physician Decision|0|||
33574373|NCT02750514|101994210|FG000|Track 1|Adverse event unrelated to study drug|1|||
33574374|NCT02750514|101994211|FG001|Track 1|Adverse event unrelated to study drug|0|||
33574375|NCT02750514|101994212|FG002|Track 1|Adverse event unrelated to study drug|0|||
33574376|NCT02750514|101994213|FG003|Track 1|Adverse event unrelated to study drug|0|||
33574377|NCT02750514|101994214|FG004|Track 1|Adverse event unrelated to study drug|0|||
33574378|NCT02750514|101994210|FG000|Track 1|Study drug toxicity|4|||
33574379|NCT02750514|101994211|FG001|Track 1|Study drug toxicity|1|||
33574380|NCT02750514|101994212|FG002|Track 1|Study drug toxicity|0|||
33574381|NCT02750514|101994213|FG003|Track 1|Study drug toxicity|1|||
33574382|NCT02750514|101994214|FG004|Track 1|Study drug toxicity|0|||
33574383|NCT02750514|101994210|FG000|Track 1|Participant request to discontinue|1|||
33574384|NCT02750514|101994211|FG001|Track 1|Participant request to discontinue|0|||
33574385|NCT02750514|101994212|FG002|Track 1|Participant request to discontinue|0|||
33574386|NCT02750514|101994213|FG003|Track 1|Participant request to discontinue|0|||
33574387|NCT02750514|101994214|FG004|Track 1|Participant request to discontinue|0|||
33574388|NCT02750514|101994210|FG000|Track 1|Other reasons|1|||
33574389|NCT02750514|101994211|FG001|Track 1|Other reasons|0|||
33231780|NCT01216176|100749954|FG002|Overall Study|Physician Decision|1|||
33231781|NCT01406717|100749965|FG000|Overall Study|Subject non-compliance|4|||
33231782|NCT01406717|100749966|FG001|Overall Study|Subject non-compliance|3|||
33231783|NCT01406717|100749965|FG000|Overall Study|Protocol Violation|5|||
33231784|NCT01406717|100749966|FG001|Overall Study|Protocol Violation|1|||
33231785|NCT01406717|100749965|FG000|Overall Study|Lost to Follow-up|14|||
33231786|NCT01406717|100749966|FG001|Overall Study|Lost to Follow-up|8|||
33231787|NCT01406717|100749965|FG000|Overall Study|Withdrawal by Subject|19|||
33231788|NCT01406717|100749966|FG001|Overall Study|Withdrawal by Subject|15|||
33231789|NCT01406717|100749965|FG000|Overall Study|Adverse Event|1|||
33231790|NCT01406717|100749966|FG001|Overall Study|Adverse Event|2|||
33231791|NCT01406717|100749965|FG000|Overall Study|Lack of Efficacy|0|||
33574390|NCT02750514|101994212|FG002|Track 1|Other reasons|0|||
33574391|NCT02750514|101994213|FG003|Track 1|Other reasons|0|||
33231792|NCT01406717|100749966|FG001|Overall Study|Lack of Efficacy|1|||
33368055|NCT02619253|101232798|FG004|Overall Study|Disease Progression|10|||
33231793|NCT01406717|100749965|FG000|Overall Study|Non-completion of visit activity|0|||
33419973|NCT00791154|101428494|FG005|Overall Study|Lost to Follow-up|0|||
33574392|NCT02750514|101994214|FG004|Track 1|Other reasons|0|||
33231794|NCT01406717|100749966|FG001|Overall Study|Non-completion of visit activity|1|||
33231795|NCT01807221|100749970|FG000|Overall Study|Progressive disease|1|||
33231796|NCT01807221|100749971|FG001|Overall Study|Progressive disease|0|||
33231797|NCT01807221|100749972|FG002|Overall Study|Progressive disease|1|||
33231798|NCT01807221|100749973|FG003|Overall Study|Progressive disease|0|||
33231799|NCT01807221|100749974|FG004|Overall Study|Progressive disease|0|||
33231800|NCT01807221|100749975|FG005|Overall Study|Progressive disease|0|||
33231801|NCT01807221|100749970|FG000|Overall Study|Death|7|||
33231802|NCT01807221|100749971|FG001|Overall Study|Death|9|||
33231803|NCT01807221|100749972|FG002|Overall Study|Death|4|||
33231804|NCT01807221|100749973|FG003|Overall Study|Death|2|||
33231805|NCT01807221|100749974|FG004|Overall Study|Death|1|||
33231806|NCT01807221|100749975|FG005|Overall Study|Death|6|||
33231807|NCT01807221|100749970|FG000|Overall Study|Physician Decision|2|||
33231808|NCT01807221|100749971|FG001|Overall Study|Physician Decision|1|||
33231809|NCT01807221|100749972|FG002|Overall Study|Physician Decision|0|||
33231810|NCT01807221|100749973|FG003|Overall Study|Physician Decision|0|||
33231811|NCT01807221|100749974|FG004|Overall Study|Physician Decision|0|||
33231812|NCT01807221|100749975|FG005|Overall Study|Physician Decision|0|||
33231813|NCT01807221|100749970|FG000|Overall Study|Adverse Event|33|||
33231814|NCT01807221|100749971|FG001|Overall Study|Adverse Event|22|||
33231815|NCT01807221|100749972|FG002|Overall Study|Adverse Event|26|||
33231816|NCT01807221|100749973|FG003|Overall Study|Adverse Event|25|||
33231817|NCT01807221|100749974|FG004|Overall Study|Adverse Event|18|||
33231818|NCT01807221|100749975|FG005|Overall Study|Adverse Event|21|||
33231819|NCT01807221|100749970|FG000|Overall Study|Protocol Violation|0|||
33231820|NCT01807221|100749971|FG001|Overall Study|Protocol Violation|2|||
33231821|NCT01807221|100749972|FG002|Overall Study|Protocol Violation|1|||
33231822|NCT01807221|100749973|FG003|Overall Study|Protocol Violation|2|||
33231823|NCT01807221|100749974|FG004|Overall Study|Protocol Violation|0|||
33231824|NCT01807221|100749975|FG005|Overall Study|Protocol Violation|1|||
33574393|NCT02750514|101994210|FG000|Track 2|Disease progression|4|||
33231825|NCT01807221|100749970|FG000|Overall Study|Non-compliance|1|||
33231826|NCT01807221|100749971|FG001|Overall Study|Non-compliance|2|||
33231827|NCT01807221|100749972|FG002|Overall Study|Non-compliance|0|||
33231828|NCT01807221|100749973|FG003|Overall Study|Non-compliance|1|||
33231829|NCT01807221|100749974|FG004|Overall Study|Non-compliance|0|||
33231830|NCT01807221|100749975|FG005|Overall Study|Non-compliance|0|||
33231831|NCT01807221|100749970|FG000|Overall Study|Logistical difficulties|0|||
33231832|NCT01807221|100749971|FG001|Overall Study|Logistical difficulties|1|||
33231833|NCT01807221|100749972|FG002|Overall Study|Logistical difficulties|0|||
33231834|NCT01807221|100749973|FG003|Overall Study|Logistical difficulties|0|||
33231835|NCT01807221|100749974|FG004|Overall Study|Logistical difficulties|1|||
33231836|NCT01807221|100749975|FG005|Overall Study|Logistical difficulties|0|||
33231837|NCT01807221|100749970|FG000|Overall Study|Withdrawal by Subject|33|||
33231838|NCT01807221|100749971|FG001|Overall Study|Withdrawal by Subject|15|||
33231839|NCT01807221|100749972|FG002|Overall Study|Withdrawal by Subject|8|||
33231840|NCT01807221|100749973|FG003|Overall Study|Withdrawal by Subject|14|||
33231841|NCT01807221|100749974|FG004|Overall Study|Withdrawal by Subject|16|||
33231842|NCT01807221|100749975|FG005|Overall Study|Withdrawal by Subject|13|||
33231843|NCT01807221|100749970|FG000|Overall Study|Sponsor decision|2|||
33231844|NCT01807221|100749971|FG001|Overall Study|Sponsor decision|0|||
33231845|NCT01807221|100749972|FG002|Overall Study|Sponsor decision|1|||
33231846|NCT01807221|100749973|FG003|Overall Study|Sponsor decision|1|||
33231847|NCT01807221|100749974|FG004|Overall Study|Sponsor decision|0|||
33231848|NCT01807221|100749975|FG005|Overall Study|Sponsor decision|0|||
33231849|NCT01807221|100749970|FG000|Overall Study|Lost to Follow-up|1|||
33231850|NCT01807221|100749971|FG001|Overall Study|Lost to Follow-up|0|||
33231851|NCT01807221|100749972|FG002|Overall Study|Lost to Follow-up|2|||
33574394|NCT02750514|101994211|FG001|Track 2|Disease progression|5|||
33231852|NCT01807221|100749973|FG003|Overall Study|Lost to Follow-up|1|||
33231853|NCT01807221|100749974|FG004|Overall Study|Lost to Follow-up|0|||
33231854|NCT01807221|100749975|FG005|Overall Study|Lost to Follow-up|0|||
33231855|NCT01830881|100749977|FG000|Overall Study|Changed decision to have an abortion|0|||
33231856|NCT01830881|100749978|FG001|Overall Study|Changed decision to have an abortion|1|||
33231857|NCT00785538|100749990|FG000|Treatment Period|Adverse Event|1|||
33231858|NCT00785538|100749991|FG001|Treatment Period|Adverse Event|2|||
33231859|NCT00785538|100749992|FG002|Treatment Period|Adverse Event|2|||
33231860|NCT00785538|100749993|FG003|Treatment Period|Adverse Event|0|||
33231861|NCT00785538|100749990|FG000|Treatment Period|Withdrawal by Subject|0|||
33231862|NCT00785538|100749991|FG001|Treatment Period|Withdrawal by Subject|0|||
33231863|NCT00785538|100749992|FG002|Treatment Period|Withdrawal by Subject|0|||
33231864|NCT00785538|100749993|FG003|Treatment Period|Withdrawal by Subject|1|||
33231865|NCT01248962|100749994|FG000|Overall Study|Withdrawal by Subject|1|||
33231866|NCT01248962|100749995|FG001|Overall Study|Withdrawal by Subject|1|||
33231867|NCT01248962|100749994|FG000|Overall Study|Adverse Event|2|||
33231868|NCT01248962|100749995|FG001|Overall Study|Adverse Event|1|||
33231869|NCT01248962|100749994|FG000|Overall Study|Complete Response after 4 Cycles|1|||
33231870|NCT01248962|100749995|FG001|Overall Study|Complete Response after 4 Cycles|0|||
33231871|NCT01248962|100749994|FG000|Overall Study|Complete Response after 3 Cycles|0|||
33231872|NCT01248962|100749995|FG001|Overall Study|Complete Response after 3 Cycles|1|||
33231873|NCT01248962|100749994|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
33231874|NCT01248962|100749995|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
33231875|NCT00557622|100749996|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
33231876|NCT00557622|100749997|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
33231877|NCT00557622|100749996|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
33419974|NCT00791154|101428495|FG006|Overall Study|Lost to Follow-up|4|||
33419975|NCT00791154|101428489|FG000|Overall Study|Death|5|||
33419976|NCT00791154|101428490|FG001|Overall Study|Death|4|||
33419977|NCT00791154|101428491|FG002|Overall Study|Death|4|||
33574395|NCT02750514|101994212|FG002|Track 2|Disease progression|2|||
33574396|NCT02750514|101994213|FG003|Track 2|Disease progression|5|||
33574397|NCT02750514|101994214|FG004|Track 2|Disease progression|0|||
33231878|NCT00557622|100749997|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
33231879|NCT00557622|100749996|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
33231880|NCT00557622|100749997|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
33231881|NCT00127413|100749999|FG000|Overall Study|Lost to Follow-up|6|||
33231882|NCT00127413|100750000|FG001|Overall Study|Lost to Follow-up|4|||
33419978|NCT00791154|101428492|FG003|Overall Study|Death|7|||
33419979|NCT00791154|101428493|FG004|Overall Study|Death|54|||
33419980|NCT00791154|101428494|FG005|Overall Study|Death|54|||
33419981|NCT00791154|101428495|FG006|Overall Study|Death|52|||
33574398|NCT02750514|101994210|FG000|Track 2|Adverse event unrelated to study drug|1|||
33574399|NCT02750514|101994211|FG001|Track 2|Adverse event unrelated to study drug|0|||
33574400|NCT02750514|101994212|FG002|Track 2|Adverse event unrelated to study drug|0|||
33574401|NCT02750514|101994213|FG003|Track 2|Adverse event unrelated to study drug|0|||
33574402|NCT02750514|101994214|FG004|Track 2|Adverse event unrelated to study drug|0|||
33574403|NCT02750514|101994210|FG000|Track 2|Study drug toxicity|1|||
33136865|NCT02116530|100417077|FG000|Overall Study|Withdrawal by Subject|1|||
33136866|NCT02116530|100417078|FG001|Overall Study|Withdrawal by Subject|2|||
33136867|NCT02116530|100417077|FG000|Overall Study|Adverse Event|4|||
33136868|NCT02116530|100417078|FG001|Overall Study|Adverse Event|0|||
33136869|NCT02116530|100417077|FG000|Overall Study|Physician Decision|1|||
33136870|NCT02116530|100417078|FG001|Overall Study|Physician Decision|0|||
33136871|NCT02116530|100417077|FG000|Overall Study|Lost to Follow-up|1|||
33136872|NCT02116530|100417078|FG001|Overall Study|Lost to Follow-up|0|||
33136873|NCT02116530|100417077|FG000|Overall Study|Other Medical Problems|2|||
33136874|NCT02116530|100417078|FG001|Overall Study|Other Medical Problems|2|||
33136875|NCT00934648|100417079|FG000|Overall Study|Failure to return|8|||
33136876|NCT00934648|100417079|FG000|Overall Study|Withdrawal by Subject|1|||
33136877|NCT03658876|100417086|FG000|Overall Study|Protocol Violation|3|||
33136878|NCT03658876|100417087|FG001|Overall Study|Protocol Violation|2|||
33136879|NCT03658876|100417086|FG000|Overall Study|Withdrawal by Subject|2|||
33136880|NCT03658876|100417087|FG001|Overall Study|Withdrawal by Subject|0|||
33136881|NCT03658876|100417086|FG000|Overall Study|Death|0|||
33136882|NCT03658876|100417087|FG001|Overall Study|Death|1|||
33136883|NCT03658876|100417086|FG000|Overall Study|Intercurrent illness|6|||
33136884|NCT03658876|100417087|FG001|Overall Study|Intercurrent illness|4|||
33136885|NCT03658876|100417086|FG000|Overall Study|Transplantation/other operation|1|||
33136886|NCT03658876|100417087|FG001|Overall Study|Transplantation/other operation|5|||
33136887|NCT00732940|100417091|FG000|Overall Study|Withdrawal by Subject|1|||
33136888|NCT00732940|100417092|FG001|Overall Study|Withdrawal by Subject|2|||
33136889|NCT00732940|100417091|FG000|Overall Study|Adverse Event|0|||
33136890|NCT00732940|100417092|FG001|Overall Study|Adverse Event|1|||
33136891|NCT00732940|100417091|FG000|Overall Study|Lost to Follow-up|1|||
33136892|NCT00732940|100417092|FG001|Overall Study|Lost to Follow-up|0|||
33136893|NCT00505778|100417093|FG000|Overall Study|Adverse Event|2|||
33136894|NCT00505778|100417094|FG001|Overall Study|Adverse Event|7|||
33136895|NCT00505778|100417093|FG000|Overall Study|Physician Decision|8|||
33136896|NCT00505778|100417094|FG001|Overall Study|Physician Decision|14|||
33136897|NCT00505778|100417093|FG000|Overall Study|Lost to Follow-up|17|||
33136898|NCT00505778|100417094|FG001|Overall Study|Lost to Follow-up|23|||
33136899|NCT00505778|100417093|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
33231883|NCT00127413|100750001|FG002|Overall Study|Lost to Follow-up|8|||
33231884|NCT00127413|100750002|FG003|Overall Study|Lost to Follow-up|2|||
33231885|NCT01368211|100750005|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
33231886|NCT01368211|100750006|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
33231887|NCT03567993|100750007|FG000|Overall Study|Lost to Follow-up|4|||
33231888|NCT03567993|100750008|FG001|Overall Study|Lost to Follow-up|2|||
33231889|NCT03567993|100750007|FG000|Overall Study|Death|1|||
33231890|NCT03567993|100750008|FG001|Overall Study|Death|1|||
33231891|NCT03567993|100750007|FG000|Overall Study|Withdrawal by Subject|1|||
33419982|NCT00791154|101428489|FG000|Overall Study|Other event|0|||
33419983|NCT00791154|101428490|FG001|Overall Study|Other event|0|||
33419984|NCT00791154|101428491|FG002|Overall Study|Other event|2|||
33136900|NCT00505778|100417094|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
33136901|NCT00505778|100417093|FG000|Overall Study|Protocol Violation|7|||
33231892|NCT03567993|100750008|FG001|Overall Study|Withdrawal by Subject|0|||
33231893|NCT00007475|100750009|FG000|Overall Study|Withdrawal by Subject|1|||
33231894|NCT00007475|100750010|FG001|Overall Study|Withdrawal by Subject|0|||
33231895|NCT00007475|100750011|FG002|Overall Study|Withdrawal by Subject|0|||
33231896|NCT00007475|100750012|FG003|Overall Study|Withdrawal by Subject|0|||
33231897|NCT00007475|100750009|FG000|Overall Study|Adverse Event|3|||
33231898|NCT00007475|100750010|FG001|Overall Study|Adverse Event|0|||
33231899|NCT00007475|100750011|FG002|Overall Study|Adverse Event|0|||
33231900|NCT00007475|100750012|FG003|Overall Study|Adverse Event|0|||
33231901|NCT00358150|100750013|FG000|Overall Study|Adverse Event|3|||
33231902|NCT00358150|100750013|FG000|Overall Study|Withdrawal by Subject|1|||
33231903|NCT00358150|100750013|FG000|Overall Study|Undefined|3|||
33231904|NCT01993823|100750014|FG000|Overall Study|Requested by the patient|6|||
33231905|NCT01993823|100750015|FG001|Overall Study|Requested by the patient|11|||
33231906|NCT01993823|100750014|FG000|Overall Study|Protocol Violation|0|||
33231907|NCT01993823|100750015|FG001|Overall Study|Protocol Violation|1|||
33231908|NCT01993823|100750014|FG000|Overall Study|Lost to Follow-up|1|||
33231909|NCT01993823|100750015|FG001|Overall Study|Lost to Follow-up|4|||
33368056|NCT02619253|101232794|FG000|Overall Study|Needed a disqualifying therapy|0|||
33368057|NCT02619253|101232795|FG001|Overall Study|Needed a disqualifying therapy|0|||
33368058|NCT02619253|101232796|FG002|Overall Study|Needed a disqualifying therapy|1|||
33368059|NCT02619253|101232797|FG003|Overall Study|Needed a disqualifying therapy|0|||
33136902|NCT00505778|100417094|FG001|Overall Study|Protocol Violation|9|||
33136903|NCT00505778|100417093|FG000|Overall Study|Withdrawal by Subject|29|||
33136904|NCT00505778|100417094|FG001|Overall Study|Withdrawal by Subject|14|||
33136905|NCT00505778|100417093|FG000|Overall Study|Relapse|65|||
33136906|NCT00505778|100417094|FG001|Overall Study|Relapse|65|||
33136907|NCT00505778|100417093|FG000|Overall Study|Took No Study Drug|2|||
33136908|NCT00505778|100417094|FG001|Overall Study|Took No Study Drug|2|||
33136909|NCT00955305|100417095|FG000|Overall Study|Disease progression|39|||
33136910|NCT00955305|100417096|FG001|Overall Study|Disease progression|41|||
33368060|NCT02619253|101232798|FG004|Overall Study|Needed a disqualifying therapy|0|||
33368061|NCT02619253|101232794|FG000|Overall Study|Transferred to hospice|0|||
33368062|NCT02619253|101232795|FG001|Overall Study|Transferred to hospice|0|||
33368063|NCT02619253|101232796|FG002|Overall Study|Transferred to hospice|1|||
33368064|NCT02619253|101232797|FG003|Overall Study|Transferred to hospice|0|||
33368065|NCT02619253|101232798|FG004|Overall Study|Transferred to hospice|0|||
33368066|NCT02619253|101232794|FG000|Overall Study|Physician Decision|0|||
33368067|NCT02619253|101232795|FG001|Overall Study|Physician Decision|1|||
33368068|NCT02619253|101232796|FG002|Overall Study|Physician Decision|2|||
33368069|NCT02619253|101232797|FG003|Overall Study|Physician Decision|3|||
33368070|NCT02619253|101232798|FG004|Overall Study|Physician Decision|0|||
33368071|NCT02619253|101232794|FG000|Overall Study|Withdrawal by Subject|0|||
33368072|NCT02619253|101232795|FG001|Overall Study|Withdrawal by Subject|1|||
33368073|NCT02619253|101232796|FG002|Overall Study|Withdrawal by Subject|0|||
33368074|NCT02619253|101232797|FG003|Overall Study|Withdrawal by Subject|0|||
33368075|NCT02619253|101232798|FG004|Overall Study|Withdrawal by Subject|2|||
33368076|NCT04230486|101232799|FG000|Overall Study|Screen Failure|1|||
33368077|NCT01318083|101232801|FG000|Overall Study|Adverse Event|4|||
33368078|NCT01318083|101232802|FG001|Overall Study|Adverse Event|1|||
33368079|NCT01318083|101232803|FG002|Overall Study|Adverse Event|2|||
33368080|NCT01318083|101232801|FG000|Overall Study|Withdrawal by Subject|1|||
33368081|NCT01318083|101232802|FG001|Overall Study|Withdrawal by Subject|0|||
33574404|NCT02750514|101994211|FG001|Track 2|Study drug toxicity|2|||
33574405|NCT02750514|101994212|FG002|Track 2|Study drug toxicity|0|||
33574406|NCT02750514|101994213|FG003|Track 2|Study drug toxicity|2|||
33574407|NCT02750514|101994214|FG004|Track 2|Study drug toxicity|0|||
33574408|NCT02750514|101994210|FG000|Track 2|Participant withdrew consent|0|||
33574409|NCT02750514|101994211|FG001|Track 2|Participant withdrew consent|1|||
33574410|NCT02750514|101994212|FG002|Track 2|Participant withdrew consent|0|||
33574411|NCT02750514|101994213|FG003|Track 2|Participant withdrew consent|0|||
33574412|NCT02750514|101994214|FG004|Track 2|Participant withdrew consent|0|||
33574413|NCT02750514|101994210|FG000|Track 3|Disease progression|0|||
33574414|NCT02750514|101994211|FG001|Track 3|Disease progression|24|||
33136911|NCT00955305|100417095|FG000|Overall Study|Adverse Event|22|||
33231910|NCT01275196|100750016|FG000|Overall Study|Adverse Event|3|||
33231911|NCT01275196|100750017|FG001|Overall Study|Adverse Event|5|||
33231912|NCT01275196|100750016|FG000|Overall Study|Withdrawal by Subject|4|||
33231913|NCT01275196|100750017|FG001|Overall Study|Withdrawal by Subject|5|||
33231914|NCT01275196|100750016|FG000|Overall Study|Lost to Follow-up|1|||
33231915|NCT01275196|100750017|FG001|Overall Study|Lost to Follow-up|0|||
33231916|NCT01275196|100750016|FG000|Overall Study|Disease Progression|6|||
33368082|NCT01318083|101232803|FG002|Overall Study|Withdrawal by Subject|2|||
33368083|NCT01318083|101232801|FG000|Overall Study|Lack of Efficacy|0|||
33368084|NCT01318083|101232802|FG001|Overall Study|Lack of Efficacy|0|||
33368085|NCT01318083|101232803|FG002|Overall Study|Lack of Efficacy|1|||
33231917|NCT01275196|100750017|FG001|Overall Study|Disease Progression|5|||
33231918|NCT01275196|100750016|FG000|Overall Study|Protocol Violation|1|||
33574415|NCT02750514|101994212|FG002|Track 3|Disease progression|13|||
33574416|NCT02750514|101994213|FG003|Track 3|Disease progression|14|||
33574417|NCT02750514|101994214|FG004|Track 3|Disease progression|0|||
33574418|NCT02750514|101994210|FG000|Track 3|Adverse event unrelated to study drug|0|||
33574419|NCT02750514|101994211|FG001|Track 3|Adverse event unrelated to study drug|1|||
33574420|NCT02750514|101994212|FG002|Track 3|Adverse event unrelated to study drug|1|||
33574421|NCT02750514|101994213|FG003|Track 3|Adverse event unrelated to study drug|1|||
33574422|NCT02750514|101994214|FG004|Track 3|Adverse event unrelated to study drug|0|||
33574423|NCT02750514|101994210|FG000|Track 3|Study drug toxicity|0|||
33368086|NCT01318083|101232801|FG000|Overall Study|Treatment Complications|1|||
33368087|NCT01318083|101232802|FG001|Overall Study|Treatment Complications|0|||
33574424|NCT02750514|101994211|FG001|Track 3|Study drug toxicity|3|||
33574425|NCT02750514|101994212|FG002|Track 3|Study drug toxicity|0|||
33574426|NCT02750514|101994213|FG003|Track 3|Study drug toxicity|1|||
33574427|NCT02750514|101994214|FG004|Track 3|Study drug toxicity|0|||
33574428|NCT02750514|101994210|FG000|Track 3|Participant request to discontinue|0|||
33574429|NCT02750514|101994211|FG001|Track 3|Participant request to discontinue|2|||
33574430|NCT02750514|101994212|FG002|Track 3|Participant request to discontinue|0|||
33574431|NCT02750514|101994213|FG003|Track 3|Participant request to discontinue|0|||
33574432|NCT02750514|101994214|FG004|Track 3|Participant request to discontinue|0|||
33574433|NCT02750514|101994210|FG000|Track 3|Participant withdrew consent|0|||
33574434|NCT02750514|101994211|FG001|Track 3|Participant withdrew consent|3|||
33574435|NCT02750514|101994212|FG002|Track 3|Participant withdrew consent|1|||
33368088|NCT01318083|101232803|FG002|Overall Study|Treatment Complications|0|||
33368089|NCT01318083|101232801|FG000|Overall Study|Lack of Study Medication Compliance|0|||
33419985|NCT00791154|101428492|FG003|Overall Study|Other event|0|||
33419986|NCT00791154|101428493|FG004|Overall Study|Other event|2|||
33419987|NCT00791154|101428494|FG005|Overall Study|Other event|4|||
33419988|NCT00791154|101428495|FG006|Overall Study|Other event|2|||
33419989|NCT01154673|101428497|FG000|Overall Study|Lost to Follow-up|1|||
33574436|NCT02750514|101994213|FG003|Track 3|Participant withdrew consent|0|||
33574437|NCT02750514|101994214|FG004|Track 3|Participant withdrew consent|0|||
33368090|NCT01318083|101232802|FG001|Overall Study|Lack of Study Medication Compliance|1|||
33368091|NCT01318083|101232803|FG002|Overall Study|Lack of Study Medication Compliance|0|||
33368092|NCT02065869|101232804|FG000|Overall Study|Death|7|||
33368093|NCT02065869|101232804|FG000|Overall Study|Disease relapse|16|||
33368094|NCT02065869|101232804|FG000|Overall Study|Lost to Follow-up|4|||
33368095|NCT02065869|101232804|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
33368096|NCT02065869|101232804|FG000|Overall Study|Withdrawal by Subject|1|||
33368097|NCT01849250|101232805|FG000|Overall Study|Withdrawal by Subject|1|||
33368098|NCT01849250|101232806|FG001|Overall Study|Withdrawal by Subject|0|||
33368099|NCT01849250|101232805|FG000|Overall Study|Not Evaluable|5|||
33368100|NCT01849250|101232806|FG001|Overall Study|Not Evaluable|3|||
33368101|NCT01849250|101232805|FG000|Overall Study|Screen Failure|1|||
33368102|NCT01849250|101232806|FG001|Overall Study|Screen Failure|0|||
33368103|NCT03074162|101232815|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
33368104|NCT03074162|101232816|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
33368105|NCT03074162|101232817|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
33368106|NCT03074162|101232818|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
33368107|NCT03074162|101232819|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
33368108|NCT03074162|101232820|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
33368109|NCT03074162|101232815|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
33368110|NCT03074162|101232816|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
33368111|NCT03074162|101232817|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
33368112|NCT03074162|101232818|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
33368113|NCT03074162|101232819|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
33368114|NCT03074162|101232820|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
33368115|NCT03074162|101232815|FG000|Period 3|Withdrawal by Subject|1|||
33419990|NCT01154673|101428498|FG001|Overall Study|Lost to Follow-up|0|||
33419991|NCT01154673|101428497|FG000|Overall Study|moved out of province|1|||
33136912|NCT00955305|100417096|FG001|Overall Study|Adverse Event|22|||
33368116|NCT03074162|101232816|FG001|Period 3|Withdrawal by Subject|0|||
33368117|NCT03074162|101232817|FG002|Period 3|Withdrawal by Subject|0|||
33368118|NCT03074162|101232818|FG003|Period 3|Withdrawal by Subject|0|||
33368119|NCT03074162|101232819|FG004|Period 3|Withdrawal by Subject|1|||
33368120|NCT03074162|101232820|FG005|Period 3|Withdrawal by Subject|0|||
33368121|NCT00859898|101232823|FG000|Overall Study|Lack of Efficacy|0|||
33368122|NCT00859898|101232824|FG001|Overall Study|Lack of Efficacy|1|||
33368123|NCT00859898|101232825|FG002|Overall Study|Lack of Efficacy|1|||
33419992|NCT01154673|101428498|FG001|Overall Study|moved out of province|0|||
33419993|NCT03663205|101428501|FG000|Overall Study|Death|144|||
33574438|NCT02750514|101994210|FG000|Track 3|Other reasons|0|||
33574439|NCT02750514|101994211|FG001|Track 3|Other reasons|3|||
33574440|NCT02750514|101994212|FG002|Track 3|Other reasons|0|||
33574441|NCT02750514|101994213|FG003|Track 3|Other reasons|0|||
33574442|NCT02750514|101994214|FG004|Track 3|Other reasons|0|||
33574443|NCT02750514|101994210|FG000|Track 4|Study drug toxicity|0|||
33574444|NCT02750514|101994211|FG001|Track 4|Study drug toxicity|6|||
33574445|NCT02750514|101994212|FG002|Track 4|Study drug toxicity|0|||
33574446|NCT02750514|101994213|FG003|Track 4|Study drug toxicity|5|||
33574447|NCT02750514|101994214|FG004|Track 4|Study drug toxicity|0|||
33574448|NCT02750514|101994210|FG000|Track 4|Participant request to discontinue|0|||
33574449|NCT02750514|101994211|FG001|Track 4|Participant request to discontinue|1|||
33574450|NCT02750514|101994212|FG002|Track 4|Participant request to discontinue|0|||
33574451|NCT02750514|101994213|FG003|Track 4|Participant request to discontinue|1|||
33574452|NCT02750514|101994214|FG004|Track 4|Participant request to discontinue|0|||
33574453|NCT02750514|101994210|FG000|Track 4|Participant withdrew consent|0|||
33574454|NCT02750514|101994211|FG001|Track 4|Participant withdrew consent|1|||
33574455|NCT02750514|101994212|FG002|Track 4|Participant withdrew consent|0|||
33574456|NCT02750514|101994213|FG003|Track 4|Participant withdrew consent|0|||
33574457|NCT02750514|101994214|FG004|Track 4|Participant withdrew consent|0|||
33574458|NCT02750514|101994210|FG000|Track 4|Other reasons|0|||
33574459|NCT02750514|101994211|FG001|Track 4|Other reasons|5|||
33368124|NCT00859898|101232823|FG000|Overall Study|Adverse Event|4|||
33368125|NCT00859898|101232824|FG001|Overall Study|Adverse Event|9|||
33368126|NCT00859898|101232825|FG002|Overall Study|Adverse Event|8|||
33368127|NCT00859898|101232823|FG000|Overall Study|Withdrawal by Subject|11|||
33368128|NCT00859898|101232824|FG001|Overall Study|Withdrawal by Subject|8|||
33368129|NCT00859898|101232825|FG002|Overall Study|Withdrawal by Subject|11|||
33368130|NCT00859898|101232823|FG000|Overall Study|Death|0|||
33368131|NCT00859898|101232824|FG001|Overall Study|Death|0|||
33368132|NCT00859898|101232825|FG002|Overall Study|Death|1|||
33368133|NCT00859898|101232823|FG000|Overall Study|Lost to Follow-up|10|||
33368134|NCT00859898|101232824|FG001|Overall Study|Lost to Follow-up|11|||
33368135|NCT00859898|101232825|FG002|Overall Study|Lost to Follow-up|5|||
33368136|NCT00859898|101232823|FG000|Overall Study|poor/non-compliance|2|||
33368137|NCT00859898|101232824|FG001|Overall Study|poor/non-compliance|0|||
33368138|NCT00859898|101232825|FG002|Overall Study|poor/non-compliance|0|||
33368139|NCT00859898|101232823|FG000|Overall Study|No longer meets criteria|0|||
33368140|NCT00859898|101232824|FG001|Overall Study|No longer meets criteria|1|||
33368141|NCT00859898|101232825|FG002|Overall Study|No longer meets criteria|0|||
33368142|NCT00859898|101232823|FG000|Overall Study|non-specified|1|||
33368143|NCT00859898|101232824|FG001|Overall Study|non-specified|1|||
33368144|NCT00859898|101232825|FG002|Overall Study|non-specified|1|||
33419994|NCT03663205|101428502|FG001|Overall Study|Death|69|||
33419995|NCT03663205|101428501|FG000|Overall Study|Sponsor decision|53|||
33419996|NCT03663205|101428502|FG001|Overall Study|Sponsor decision|19|||
33419997|NCT03663205|101428501|FG000|Overall Study|Withdrawal by Subject|8|||
33419998|NCT03663205|101428502|FG001|Overall Study|Withdrawal by Subject|11|||
33419999|NCT03663205|101428501|FG000|Overall Study|Lost to Follow-up|7|||
33420000|NCT03663205|101428502|FG001|Overall Study|Lost to Follow-up|9|||
33420001|NCT03663205|101428501|FG000|Overall Study|Transferred to long term extension study|11|||
33420002|NCT03663205|101428502|FG001|Overall Study|Transferred to long term extension study|3|||
33420003|NCT04057573|101428503|FG000|24-Week Double-Blind Period|Adverse Event|2|||
33420004|NCT04057573|101428504|FG001|24-Week Double-Blind Period|Adverse Event|0|||
33420005|NCT04057573|101428505|FG002|24-Week Double-Blind Period|Adverse Event|0|||
33420006|NCT04057573|101428506|FG003|24-Week Double-Blind Period|Adverse Event|0|||
33420007|NCT04057573|101428503|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
33420008|NCT04057573|101428504|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
33420009|NCT04057573|101428505|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
33420010|NCT04057573|101428506|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
33420011|NCT04057573|101428503|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
33420012|NCT04057573|101428504|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
33420013|NCT04057573|101428505|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
33420014|NCT04057573|101428506|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
33420015|NCT04057573|101428503|FG000|24-Week Double-Blind Period|Physician Decision|1|||
33420016|NCT04057573|101428504|FG001|24-Week Double-Blind Period|Physician Decision|0|||
33420017|NCT04057573|101428505|FG002|24-Week Double-Blind Period|Physician Decision|0|||
33420018|NCT04057573|101428506|FG003|24-Week Double-Blind Period|Physician Decision|0|||
33420019|NCT04057573|101428503|FG000|24-Week Double-Blind Period|Pregnancy|1|||
33420020|NCT04057573|101428504|FG001|24-Week Double-Blind Period|Pregnancy|0|||
33420021|NCT04057573|101428505|FG002|24-Week Double-Blind Period|Pregnancy|0|||
33420022|NCT04057573|101428506|FG003|24-Week Double-Blind Period|Pregnancy|0|||
33368145|NCT01971476|101232828|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
33368146|NCT01971476|101232829|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
33368147|NCT01971476|101232830|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
33368148|NCT01971476|101232828|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
33420023|NCT04057573|101428503|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
33574460|NCT02750514|101994212|FG002|Track 4|Other reasons|0|||
33574461|NCT02750514|101994213|FG003|Track 4|Other reasons|3|||
33635942|NCT01352793|102218526|FG001|Overall Study|Physician Decision|0|||
33368149|NCT01971476|101232829|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
33420024|NCT04057573|101428504|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
33420025|NCT04057573|101428505|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
33420026|NCT04057573|101428506|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
33420027|NCT04057573|101428503|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
33420028|NCT04057573|101428504|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
33420029|NCT04057573|101428505|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
33420030|NCT04057573|101428506|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
33420031|NCT04057573|101428503|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
33420032|NCT04057573|101428504|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
33420033|NCT04057573|101428505|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
33420034|NCT04057573|101428506|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
33420035|NCT04057573|101428503|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
33420036|NCT04057573|101428504|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
33420037|NCT04057573|101428505|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
33420038|NCT04057573|101428506|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
33420039|NCT04057573|101428503|FG000|24-Week Double-Blind Period|Not Treated|1|||
33420040|NCT04057573|101428504|FG001|24-Week Double-Blind Period|Not Treated|0|||
33420041|NCT04057573|101428505|FG002|24-Week Double-Blind Period|Not Treated|0|||
33420042|NCT04057573|101428506|FG003|24-Week Double-Blind Period|Not Treated|0|||
33420043|NCT04057573|101428503|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
33420044|NCT04057573|101428504|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
33420045|NCT04057573|101428505|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
33420046|NCT04057573|101428506|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
33420047|NCT04057573|101428503|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
33420048|NCT04057573|101428504|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
33420049|NCT04057573|101428505|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
33420050|NCT04057573|101428506|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
33420051|NCT04057573|101428503|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
33420052|NCT04057573|101428504|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
33420053|NCT04057573|101428505|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
33420054|NCT04057573|101428506|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
33420055|NCT04057573|101428503|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
33420056|NCT04057573|101428504|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
33420057|NCT04057573|101428505|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
33420058|NCT04057573|101428506|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
33420059|NCT04057573|101428503|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
33420060|NCT04057573|101428504|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
33420061|NCT04057573|101428505|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
33420062|NCT04057573|101428506|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
33420063|NCT02742818|101428507|FG000|Overall Study|Adverse Event|0|||
33420064|NCT02742818|101428508|FG001|Overall Study|Adverse Event|1|||
33420065|NCT02742818|101428507|FG000|Overall Study|Protocol Violation|0|||
33420066|NCT02742818|101428508|FG001|Overall Study|Protocol Violation|1|||
33420067|NCT02367729|101428510|FG000|Overall Study|Organic disorder diagnosed|2|||
33420068|NCT02367729|101428511|FG001|Overall Study|Organic disorder diagnosed|1|||
33420069|NCT02367729|101428510|FG000|Overall Study|Adverse Event|1|||
33420070|NCT02367729|101428511|FG001|Overall Study|Adverse Event|2|||
33420071|NCT02367729|101428510|FG000|Overall Study|Withdrawal by Subject|0|||
33420072|NCT02367729|101428511|FG001|Overall Study|Withdrawal by Subject|5|||
33420073|NCT01333475|101428512|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
33420074|NCT01333475|101428513|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
33420075|NCT01333475|101428512|FG000|Overall Study|Toxicity|1|||
33368150|NCT01971476|101232830|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
33368151|NCT01971476|101232828|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
33368152|NCT01971476|101232829|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
33368153|NCT01971476|101232830|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
33368154|NCT05523362|101232831|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
33368155|NCT05523362|101232831|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
33368156|NCT05523362|101232831|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
33368157|NCT05523362|101232831|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
33368158|NCT03283163|101232832|FG000|Overall Study|Lost to Follow-up|1|||
33368159|NCT03283163|101232832|FG000|Overall Study|other life commitments|6|||
33368160|NCT03283163|101232832|FG000|Overall Study|COVID-19 institution wide halting|1|||
33368161|NCT03283163|101232832|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
33420076|NCT01333475|101428513|FG001|Overall Study|Toxicity|3|||
33420077|NCT03120520|101428514|FG000|Overall Study|Lost to Follow-up|1|||
33420078|NCT03120520|101428515|FG001|Overall Study|Lost to Follow-up|1|||
33420079|NCT03120520|101428516|FG002|Overall Study|Lost to Follow-up|1|||
33420080|NCT03120520|101428517|FG003|Overall Study|Lost to Follow-up|1|||
33420081|NCT03120520|101428514|FG000|Overall Study|Withdrawal by Subject|3|||
33420082|NCT03120520|101428515|FG001|Overall Study|Withdrawal by Subject|2|||
33420083|NCT03120520|101428516|FG002|Overall Study|Withdrawal by Subject|3|||
33420084|NCT03120520|101428517|FG003|Overall Study|Withdrawal by Subject|2|||
33420085|NCT03120520|101428514|FG000|Overall Study|Other|0|||
33420086|NCT03120520|101428515|FG001|Overall Study|Other|1|||
33420087|NCT03120520|101428516|FG002|Overall Study|Other|0|||
33420088|NCT03120520|101428517|FG003|Overall Study|Other|0|||
33420089|NCT01999322|101428526|FG000|Overall Study|Adverse Event|1|||
33420090|NCT01999322|101428527|FG001|Overall Study|Adverse Event|0|||
33420091|NCT01791127|101428528|FG000|Overall Study|Death|356|||
33420092|NCT01791127|101428528|FG000|Overall Study|Patient has withdrawn from study|293|||
33420093|NCT01791127|101428528|FG000|Overall Study|Lost to Follow-up|42|||
33420094|NCT01791127|101428528|FG000|Overall Study|All Siello leads are explanted|31|||
33420095|NCT01791127|101428528|FG000|Overall Study|Completion of 30 day safety registry|1|||
33420096|NCT01791127|101428528|FG000|Overall Study|Study terminated for EP Passion|749|||
33420097|NCT00602979|101428529|FG000|Overall Study|Lost to Follow-up|3|||
33420098|NCT00602979|101428530|FG001|Overall Study|Lost to Follow-up|2|||
33635943|NCT01352793|102218525|FG000|Overall Study|Pregnancy|26|||
33635944|NCT01352793|102218526|FG001|Overall Study|Pregnancy|8|||
33635945|NCT01352793|102218525|FG000|Overall Study|Other|25|||
33635946|NCT01352793|102218526|FG001|Overall Study|Other|7|||
33635947|NCT01352793|102218525|FG000|Overall Study|Medication error|2|||
33635948|NCT01352793|102218526|FG001|Overall Study|Medication error|2|||
33635949|NCT01352793|102218525|FG000|Overall Study|Death|1|||
33635950|NCT01352793|102218526|FG001|Overall Study|Death|0|||
33635951|NCT01352793|102218525|FG000|Overall Study|Randomized but not vaccinated|8|||
33635952|NCT01352793|102218526|FG001|Overall Study|Randomized but not vaccinated|0|||
33635953|NCT01352793|102218525|FG000|Overall Study|No longer meets eligibility criteria|25|||
33635954|NCT01352793|102218526|FG001|Overall Study|No longer meets eligibility criteria|15|||
33635955|NCT01094119|102218530|FG000|Overall Study|Lack of Efficacy|2|||
33635956|NCT01094119|102218531|FG001|Overall Study|Lack of Efficacy|4|||
33635957|NCT02177032|102218532|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
33635958|NCT02177032|102218533|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
33635959|NCT02177032|102218534|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
33635960|NCT02177032|102218535|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
33635961|NCT02177032|102218532|FG000|Overall Study|Lost to Follow-up|0|||
33635962|NCT02177032|102218533|FG001|Overall Study|Lost to Follow-up|2|||
33136913|NCT00955305|100417095|FG000|Overall Study|Death|2|||
33136914|NCT00955305|100417096|FG001|Overall Study|Death|1|||
33136915|NCT00955305|100417095|FG000|Overall Study|Withdrawal by Subject|5|||
33136916|NCT00955305|100417096|FG001|Overall Study|Withdrawal by Subject|4|||
33136917|NCT00955305|100417095|FG000|Overall Study|Alternative therapy|4|||
33136918|NCT00955305|100417096|FG001|Overall Study|Alternative therapy|0|||
33136919|NCT00955305|100417095|FG000|Overall Study|Other complicating disease|2|||
33136920|NCT00955305|100417096|FG001|Overall Study|Other complicating disease|4|||
33136921|NCT00955305|100417095|FG000|Overall Study|Physician Decision|1|||
33136922|NCT00955305|100417096|FG001|Overall Study|Physician Decision|0|||
33368162|NCT03283163|101232832|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
33368163|NCT01993329|101232833|FG000|Period 2|Adverse Event|0|||
33368164|NCT01993329|101232834|FG001|Period 2|Adverse Event|0|||
33368165|NCT01993329|101232835|FG002|Period 2|Adverse Event|0|||
33368166|NCT01993329|101232836|FG003|Period 2|Adverse Event|0|||
33368167|NCT01993329|101232837|FG004|Period 2|Adverse Event|0|||
33368168|NCT01993329|101232838|FG005|Period 2|Adverse Event|1|||
33368169|NCT01993329|101232833|FG000|Wash-out|Personal reasons|0|||
33368170|NCT01993329|101232834|FG001|Wash-out|Personal reasons|1|||
33368171|NCT01993329|101232835|FG002|Wash-out|Personal reasons|0|||
33368172|NCT01993329|101232836|FG003|Wash-out|Personal reasons|0|||
33368173|NCT01993329|101232837|FG004|Wash-out|Personal reasons|0|||
33368174|NCT01993329|101232838|FG005|Wash-out|Personal reasons|0|||
33420099|NCT00602979|101428531|FG002|Overall Study|Lost to Follow-up|3|||
33420100|NCT00602979|101428532|FG003|Overall Study|Lost to Follow-up|2|||
33420101|NCT00602979|101428533|FG004|Overall Study|Lost to Follow-up|3|||
33368175|NCT02371759|101232839|FG000|Overall Study|Protocol Violation|3|||
33368176|NCT02371759|101232840|FG001|Overall Study|Protocol Violation|1|||
33368177|NCT02371759|101232841|FG002|Overall Study|Protocol Violation|1|||
33368178|NCT02371759|101232842|FG003|Overall Study|Protocol Violation|0|||
33368179|NCT02371759|101232843|FG004|Overall Study|Protocol Violation|3|||
33420102|NCT00602979|101428529|FG000|Overall Study|Failed Intubation|0|||
33420103|NCT00602979|101428530|FG001|Overall Study|Failed Intubation|1|||
33635963|NCT02177032|102218534|FG002|Overall Study|Lost to Follow-up|0|||
33136923|NCT00955305|100417095|FG000|Overall Study|Continued presence of residual disease|0|||
33368180|NCT02371759|101232844|FG005|Overall Study|Protocol Violation|1|||
33368181|NCT02371759|101232845|FG006|Overall Study|Protocol Violation|0|||
33420104|NCT00602979|101428531|FG002|Overall Study|Failed Intubation|0|||
33635964|NCT02177032|102218535|FG003|Overall Study|Lost to Follow-up|0|||
33635965|NCT02177032|102218532|FG000|Overall Study|OTHER|2|||
33136924|NCT00955305|100417096|FG001|Overall Study|Continued presence of residual disease|1|||
33136925|NCT00955305|100417095|FG000|Overall Study|Functional decline|2|||
33136926|NCT00955305|100417096|FG001|Overall Study|Functional decline|0|||
33136927|NCT00955305|100417095|FG000|Overall Study|Maximum response achieved|0|||
33136928|NCT00955305|100417096|FG001|Overall Study|Maximum response achieved|1|||
33136929|NCT00955305|100417095|FG000|Overall Study|Lost to Follow-up|0|||
33136930|NCT00955305|100417096|FG001|Overall Study|Lost to Follow-up|1|||
33136931|NCT00955305|100417095|FG000|Overall Study|No off-treatment reason submitted|1|||
33136932|NCT00955305|100417096|FG001|Overall Study|No off-treatment reason submitted|0|||
33136933|NCT00955305|100417095|FG000|Overall Study|Never started protocol treatment|5|||
33136934|NCT00955305|100417096|FG001|Overall Study|Never started protocol treatment|5|||
33136935|NCT00955305|100417095|FG000|Overall Study|Ineligible|5|||
33136936|NCT00955305|100417096|FG001|Overall Study|Ineligible|7|||
33136937|NCT01261780|100417104|FG000|Overall Study|Withdrawal by Subject|1|||
33136938|NCT01261780|100417105|FG001|Overall Study|Withdrawal by Subject|0|||
33136939|NCT01261780|100417104|FG000|Overall Study|Event not related to subject|1|||
33136940|NCT01261780|100417105|FG001|Overall Study|Event not related to subject|2|||
33136941|NCT02660138|100417108|FG000|Overall Study|Adverse Event|0|||
33136942|NCT02660138|100417109|FG001|Overall Study|Adverse Event|3|||
33136943|NCT02660138|100417110|FG002|Overall Study|Adverse Event|2|||
33136944|NCT02660138|100417108|FG000|Overall Study|Lack of Efficacy|1|||
33136945|NCT02660138|100417109|FG001|Overall Study|Lack of Efficacy|2|||
33136946|NCT02660138|100417110|FG002|Overall Study|Lack of Efficacy|1|||
33136947|NCT02660138|100417108|FG000|Overall Study|Withdrawal by Subject|7|||
33136948|NCT02660138|100417109|FG001|Overall Study|Withdrawal by Subject|6|||
33136949|NCT02660138|100417110|FG002|Overall Study|Withdrawal by Subject|6|||
33136950|NCT02660138|100417108|FG000|Overall Study|Lost to Follow-up|4|||
33136951|NCT02660138|100417109|FG001|Overall Study|Lost to Follow-up|4|||
33136952|NCT02660138|100417110|FG002|Overall Study|Lost to Follow-up|1|||
33136953|NCT02660138|100417108|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
33136954|NCT02660138|100417109|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
33136955|NCT02660138|100417110|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
33136956|NCT02660138|100417108|FG000|Overall Study|Other|1|||
33136957|NCT02660138|100417109|FG001|Overall Study|Other|1|||
33136958|NCT02660138|100417110|FG002|Overall Study|Other|0|||
33136959|NCT02660138|100417108|FG000|Overall Study|Not treated|0|||
33136960|NCT02660138|100417109|FG001|Overall Study|Not treated|1|||
33136961|NCT02660138|100417110|FG002|Overall Study|Not treated|0|||
33136962|NCT00966875|100417111|FG000|Part A|Adverse Event|2|||
33136963|NCT00966875|100417112|FG001|Part A|Adverse Event|1|||
33136964|NCT00966875|100417113|FG002|Part A|Adverse Event|0|||
33136965|NCT00966875|100417114|FG003|Part A|Adverse Event|1|||
33136966|NCT00966875|100417115|FG004|Part A|Adverse Event|0|||
33136967|NCT00966875|100417116|FG005|Part A|Adverse Event|1|||
33136968|NCT00966875|100417117|FG006|Part A|Adverse Event|0|||
33136969|NCT00966875|100417118|FG007|Part A|Adverse Event|3|||
33136970|NCT00966875|100417119|FG008|Part A|Adverse Event|3|||
33136971|NCT00966875|100417111|FG000|Part A|Entry Criteria|0|||
33574462|NCT02750514|101994214|FG004|Track 4|Other reasons|0|||
33574463|NCT02750514|101994210|FG000|Track 4|Disease progression|0|||
33574464|NCT02750514|101994211|FG001|Track 4|Disease progression|33|||
33574465|NCT02750514|101994212|FG002|Track 4|Disease progression|0|||
33574466|NCT02750514|101994213|FG003|Track 4|Disease progression|32|||
33574467|NCT02750514|101994214|FG004|Track 4|Disease progression|0|||
33574468|NCT02750514|101994210|FG000|Track 4|Adverse event unrelated to study drug|0|||
33574469|NCT02750514|101994211|FG001|Track 4|Adverse event unrelated to study drug|5|||
33574470|NCT02750514|101994212|FG002|Track 4|Adverse event unrelated to study drug|0|||
33574471|NCT02750514|101994213|FG003|Track 4|Adverse event unrelated to study drug|0|||
33574472|NCT02750514|101994214|FG004|Track 4|Adverse event unrelated to study drug|0|||
33574473|NCT02750514|101994210|FG000|Track 4|Death|0|||
33574474|NCT02750514|101994211|FG001|Track 4|Death|0|||
33574475|NCT02750514|101994212|FG002|Track 4|Death|0|||
33574476|NCT02750514|101994213|FG003|Track 4|Death|1|||
33574477|NCT02750514|101994214|FG004|Track 4|Death|0|||
33574478|NCT02750514|101994210|FG000|Track 5|Disease progression|0|||
33574479|NCT02750514|101994211|FG001|Track 5|Disease progression|0|||
33574480|NCT02750514|101994212|FG002|Track 5|Disease progression|0|||
33574481|NCT02750514|101994213|FG003|Track 5|Disease progression|0|||
33574482|NCT02750514|101994214|FG004|Track 5|Disease progression|34|||
33574483|NCT02750514|101994210|FG000|Track 5|Adverse event unrelated to study drug|0|||
33136972|NCT00966875|100417112|FG001|Part A|Entry Criteria|0|||
33136973|NCT00966875|100417113|FG002|Part A|Entry Criteria|0|||
33574484|NCT02750514|101994211|FG001|Track 5|Adverse event unrelated to study drug|0|||
33574485|NCT02750514|101994212|FG002|Track 5|Adverse event unrelated to study drug|0|||
33574486|NCT02750514|101994213|FG003|Track 5|Adverse event unrelated to study drug|0|||
33574487|NCT02750514|101994214|FG004|Track 5|Adverse event unrelated to study drug|2|||
33136974|NCT00966875|100417114|FG003|Part A|Entry Criteria|0|||
33136975|NCT00966875|100417115|FG004|Part A|Entry Criteria|0|||
33136976|NCT00966875|100417116|FG005|Part A|Entry Criteria|2|||
33574488|NCT02750514|101994210|FG000|Track 5|Study drug toxicity|0|||
33368182|NCT02371759|101232846|FG007|Overall Study|Protocol Violation|3|||
33368183|NCT02371759|101232839|FG000|Overall Study|Withdrawal by Subject|0|||
33368184|NCT02371759|101232840|FG001|Overall Study|Withdrawal by Subject|0|||
33231919|NCT01275196|100750017|FG001|Overall Study|Protocol Violation|0|||
33231920|NCT01275196|100750016|FG000|Overall Study|Suboptimal response/treatment failure|5|||
33231921|NCT01275196|100750017|FG001|Overall Study|Suboptimal response/treatment failure|6|||
33231922|NCT01468922|100750018|FG000|Overall Study|Screening failure|0|||
33231923|NCT01468922|100750019|FG001|Overall Study|Screening failure|0|||
33231924|NCT01468922|100750020|FG002|Overall Study|Screening failure|0|||
33231925|NCT01468922|100750021|FG003|Overall Study|Screening failure|0|||
33231926|NCT01468922|100750022|FG004|Overall Study|Screening failure|0|||
33231927|NCT01468922|100750023|FG005|Overall Study|Screening failure|0|||
33231928|NCT01468922|100750024|FG006|Overall Study|Screening failure|0|||
33231929|NCT01468922|100750025|FG007|Overall Study|Screening failure|0|||
33231930|NCT01468922|100750026|FG008|Overall Study|Screening failure|1|||
33231931|NCT01468922|100750018|FG000|Overall Study|Per patient choice|1|||
33231932|NCT01468922|100750019|FG001|Overall Study|Per patient choice|0|||
33231933|NCT01468922|100750020|FG002|Overall Study|Per patient choice|0|||
33231934|NCT01468922|100750021|FG003|Overall Study|Per patient choice|0|||
33231935|NCT01468922|100750022|FG004|Overall Study|Per patient choice|0|||
33231936|NCT01468922|100750023|FG005|Overall Study|Per patient choice|0|||
33231937|NCT01468922|100750024|FG006|Overall Study|Per patient choice|0|||
33231938|NCT01468922|100750025|FG007|Overall Study|Per patient choice|0|||
33231939|NCT01468922|100750026|FG008|Overall Study|Per patient choice|0|||
33231940|NCT01468922|100750018|FG000|Overall Study|Switched to alternative treatment|1|||
33231941|NCT01468922|100750019|FG001|Overall Study|Switched to alternative treatment|0|||
33231942|NCT01468922|100750020|FG002|Overall Study|Switched to alternative treatment|0|||
33231943|NCT01468922|100750021|FG003|Overall Study|Switched to alternative treatment|0|||
33231944|NCT01468922|100750022|FG004|Overall Study|Switched to alternative treatment|1|||
33231945|NCT01468922|100750023|FG005|Overall Study|Switched to alternative treatment|0|||
33231946|NCT01468922|100750024|FG006|Overall Study|Switched to alternative treatment|0|||
33231947|NCT01468922|100750025|FG007|Overall Study|Switched to alternative treatment|0|||
33231948|NCT01468922|100750026|FG008|Overall Study|Switched to alternative treatment|0|||
33231949|NCT01468922|100750018|FG000|Overall Study|Enrolled on new protocol|0|||
33231950|NCT01468922|100750019|FG001|Overall Study|Enrolled on new protocol|0|||
33231951|NCT01468922|100750020|FG002|Overall Study|Enrolled on new protocol|0|||
33231952|NCT01468922|100750021|FG003|Overall Study|Enrolled on new protocol|0|||
33368185|NCT02371759|101232841|FG002|Overall Study|Withdrawal by Subject|0|||
33368186|NCT02371759|101232842|FG003|Overall Study|Withdrawal by Subject|0|||
33574489|NCT02750514|101994211|FG001|Track 5|Study drug toxicity|0|||
33574490|NCT02750514|101994212|FG002|Track 5|Study drug toxicity|0|||
33574491|NCT02750514|101994213|FG003|Track 5|Study drug toxicity|0|||
33574492|NCT02750514|101994214|FG004|Track 5|Study drug toxicity|2|||
33574493|NCT02750514|101994210|FG000|Track 5|Participant request to discontinue|0|||
33574494|NCT02750514|101994211|FG001|Track 5|Participant request to discontinue|0|||
33574495|NCT02750514|101994212|FG002|Track 5|Participant request to discontinue|0|||
33574496|NCT02750514|101994213|FG003|Track 5|Participant request to discontinue|0|||
33574497|NCT02750514|101994214|FG004|Track 5|Participant request to discontinue|3|||
33574498|NCT02750514|101994210|FG000|Track 5|Other reasons|0|||
33574499|NCT02750514|101994211|FG001|Track 5|Other reasons|0|||
33574500|NCT02750514|101994212|FG002|Track 5|Other reasons|0|||
33574501|NCT02750514|101994213|FG003|Track 5|Other reasons|0|||
33574502|NCT02750514|101994214|FG004|Track 5|Other reasons|2|||
33574503|NCT01812057|101994215|FG000|Overall Study|Protocol Violation|1|||
33574504|NCT01812057|101994216|FG001|Overall Study|Protocol Violation|0|||
33574505|NCT01812057|101994215|FG000|Overall Study|Physician Decision|1|||
33574506|NCT01812057|101994216|FG001|Overall Study|Physician Decision|0|||
33574507|NCT01621178|101994218|FG000|Overall Study|Adverse Event|5|||
33574508|NCT01621178|101994219|FG001|Overall Study|Adverse Event|2|||
33635966|NCT02177032|102218533|FG001|Overall Study|OTHER|0|||
33231953|NCT01468922|100750022|FG004|Overall Study|Enrolled on new protocol|1|||
33231954|NCT01468922|100750023|FG005|Overall Study|Enrolled on new protocol|0|||
33231955|NCT01468922|100750024|FG006|Overall Study|Enrolled on new protocol|0|||
33231956|NCT01468922|100750025|FG007|Overall Study|Enrolled on new protocol|0|||
33635967|NCT02177032|102218534|FG002|Overall Study|OTHER|1|||
33635968|NCT02177032|102218535|FG003|Overall Study|OTHER|0|||
33231957|NCT01468922|100750026|FG008|Overall Study|Enrolled on new protocol|0|||
33231958|NCT01468922|100750018|FG000|Overall Study|Adverse Event|0|||
33231959|NCT01468922|100750019|FG001|Overall Study|Adverse Event|0|||
33231960|NCT01468922|100750020|FG002|Overall Study|Adverse Event|0|||
33231961|NCT01468922|100750021|FG003|Overall Study|Adverse Event|0|||
33231962|NCT01468922|100750022|FG004|Overall Study|Adverse Event|0|||
33231963|NCT01468922|100750023|FG005|Overall Study|Adverse Event|0|||
33231964|NCT01468922|100750024|FG006|Overall Study|Adverse Event|0|||
33231965|NCT01468922|100750025|FG007|Overall Study|Adverse Event|1|||
33231966|NCT01468922|100750026|FG008|Overall Study|Adverse Event|0|||
33231967|NCT01468922|100750018|FG000|Overall Study|Infection of blood|0|||
33368187|NCT02371759|101232843|FG004|Overall Study|Withdrawal by Subject|0|||
33635969|NCT02177032|102218532|FG000|Overall Study|Withdrawal by Subject|1|||
33635970|NCT02177032|102218533|FG001|Overall Study|Withdrawal by Subject|0|||
33635971|NCT02177032|102218534|FG002|Overall Study|Withdrawal by Subject|1|||
33635972|NCT02177032|102218535|FG003|Overall Study|Withdrawal by Subject|0|||
33635973|NCT01108185|102218538|FG000|Overall Study|Non-compliance|15|||
33635974|NCT01108185|102218538|FG000|Overall Study|Lost to Follow-up|12|||
33231968|NCT01468922|100750019|FG001|Overall Study|Infection of blood|0|||
33231969|NCT01468922|100750020|FG002|Overall Study|Infection of blood|0|||
33231970|NCT01468922|100750021|FG003|Overall Study|Infection of blood|0|||
33231971|NCT01468922|100750022|FG004|Overall Study|Infection of blood|0|||
33231972|NCT01468922|100750023|FG005|Overall Study|Infection of blood|0|||
33231973|NCT01468922|100750024|FG006|Overall Study|Infection of blood|0|||
33231974|NCT01468922|100750025|FG007|Overall Study|Infection of blood|1|||
33635975|NCT03774576|102218539|FG000|Period 2|Adverse Event|1|||
33635976|NCT04960202|102218542|FG000|Overall Study|Other|12|||
33635977|NCT04960202|102218543|FG001|Overall Study|Other|10|||
33231975|NCT01468922|100750026|FG008|Overall Study|Infection of blood|0|||
33231976|NCT01468922|100750018|FG000|Overall Study|Patient choice - surgery|0|||
33231977|NCT01468922|100750019|FG001|Overall Study|Patient choice - surgery|0|||
33231978|NCT01468922|100750020|FG002|Overall Study|Patient choice - surgery|0|||
33231979|NCT01468922|100750021|FG003|Overall Study|Patient choice - surgery|0|||
33231980|NCT01468922|100750022|FG004|Overall Study|Patient choice - surgery|0|||
33231981|NCT01468922|100750023|FG005|Overall Study|Patient choice - surgery|0|||
33231982|NCT01468922|100750024|FG006|Overall Study|Patient choice - surgery|0|||
33231983|NCT01468922|100750025|FG007|Overall Study|Patient choice - surgery|1|||
33231984|NCT01468922|100750026|FG008|Overall Study|Patient choice - surgery|0|||
33231985|NCT01468922|100750018|FG000|Overall Study|Refused further treatment|0|||
33231986|NCT01468922|100750019|FG001|Overall Study|Refused further treatment|0|||
33231987|NCT01468922|100750020|FG002|Overall Study|Refused further treatment|0|||
33231988|NCT01468922|100750021|FG003|Overall Study|Refused further treatment|0|||
33231989|NCT01468922|100750022|FG004|Overall Study|Refused further treatment|0|||
33231990|NCT01468922|100750023|FG005|Overall Study|Refused further treatment|0|||
33231991|NCT01468922|100750024|FG006|Overall Study|Refused further treatment|0|||
33231992|NCT01468922|100750025|FG007|Overall Study|Refused further treatment|1|||
33231993|NCT01468922|100750026|FG008|Overall Study|Refused further treatment|0|||
33231994|NCT02258464|100750027|FG000|Overall Study|Progressive disease (PD)|9|||
33231995|NCT02258464|100750028|FG001|Overall Study|Progressive disease (PD)|17|||
33231996|NCT02258464|100750027|FG000|Overall Study|Study drug never administered|1|||
33231997|NCT02258464|100750028|FG001|Overall Study|Study drug never administered|1|||
33231998|NCT02258464|100750027|FG000|Overall Study|AE not related to clinical PD|1|||
33231999|NCT02258464|100750028|FG001|Overall Study|AE not related to clinical PD|3|||
33232000|NCT02258464|100750027|FG000|Overall Study|Withdrawal by Subject|5|||
33232001|NCT02258464|100750028|FG001|Overall Study|Withdrawal by Subject|4|||
33368188|NCT02371759|101232844|FG005|Overall Study|Withdrawal by Subject|0|||
33368189|NCT02371759|101232845|FG006|Overall Study|Withdrawal by Subject|0|||
33368190|NCT02371759|101232846|FG007|Overall Study|Withdrawal by Subject|1|||
33368191|NCT04752189|101232850|FG000|Overall Study|Withdrawal by Subject|0|||
33368192|NCT04752189|101232851|FG001|Overall Study|Withdrawal by Subject|150|||
33368193|NCT04752189|101232850|FG000|Overall Study|Lost to Follow-up|261|||
33368194|NCT04752189|101232851|FG001|Overall Study|Lost to Follow-up|126|||
33368195|NCT03238235|101232852|FG000|Overall Study|Adverse Event|2|||
33368196|NCT03238235|101232853|FG001|Overall Study|Adverse Event|0|||
33368197|NCT03238235|101232852|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
33368198|NCT03238235|101232853|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
33635978|NCT04960202|102218542|FG000|Overall Study|Withdrawal by Subject|43|||
33136977|NCT00966875|100417117|FG006|Part A|Entry Criteria|0|||
33136978|NCT00966875|100417118|FG007|Part A|Entry Criteria|0|||
33136979|NCT00966875|100417119|FG008|Part A|Entry Criteria|0|||
33136980|NCT00966875|100417111|FG000|Part A|Lack of Efficacy|0|||
33136981|NCT00966875|100417112|FG001|Part A|Lack of Efficacy|1|||
33136982|NCT00966875|100417113|FG002|Part A|Lack of Efficacy|0|||
33136983|NCT00966875|100417114|FG003|Part A|Lack of Efficacy|0|||
33136984|NCT00966875|100417115|FG004|Part A|Lack of Efficacy|0|||
33136985|NCT00966875|100417116|FG005|Part A|Lack of Efficacy|0|||
33136986|NCT00966875|100417117|FG006|Part A|Lack of Efficacy|4|||
33136987|NCT00966875|100417118|FG007|Part A|Lack of Efficacy|0|||
33136988|NCT00966875|100417119|FG008|Part A|Lack of Efficacy|0|||
33136989|NCT00966875|100417111|FG000|Part A|Lost to Follow-up|2|||
33136990|NCT00966875|100417112|FG001|Part A|Lost to Follow-up|0|||
33136991|NCT00966875|100417113|FG002|Part A|Lost to Follow-up|0|||
33136992|NCT00966875|100417114|FG003|Part A|Lost to Follow-up|0|||
33136993|NCT00966875|100417115|FG004|Part A|Lost to Follow-up|0|||
33136994|NCT00966875|100417116|FG005|Part A|Lost to Follow-up|1|||
33136995|NCT00966875|100417117|FG006|Part A|Lost to Follow-up|0|||
33635979|NCT04960202|102218543|FG001|Overall Study|Withdrawal by Subject|45|||
33635980|NCT04960202|102218542|FG000|Overall Study|Lost to Follow-up|20|||
33136996|NCT00966875|100417118|FG007|Part A|Lost to Follow-up|0|||
33136997|NCT00966875|100417119|FG008|Part A|Lost to Follow-up|0|||
33136998|NCT00966875|100417111|FG000|Part A|Parent/Caregiver Decision|0|||
33232002|NCT02258464|100750027|FG000|Overall Study|AE related to clinical PD|1|||
33232003|NCT02258464|100750028|FG001|Overall Study|AE related to clinical PD|0|||
33232004|NCT00917267|100750035|FG000|Overall Study|Adverse Event|15|||
33232005|NCT00917267|100750036|FG001|Overall Study|Adverse Event|36|||
33232006|NCT00917267|100750035|FG000|Overall Study|Physician Decision|2|||
33232007|NCT00917267|100750036|FG001|Overall Study|Physician Decision|4|||
33232008|NCT00917267|100750035|FG000|Overall Study|Protocol Violation|9|||
33232009|NCT00917267|100750036|FG001|Overall Study|Protocol Violation|18|||
33232010|NCT00917267|100750035|FG000|Overall Study|Withdrawal by Subject|5|||
33232011|NCT00917267|100750036|FG001|Overall Study|Withdrawal by Subject|12|||
33232012|NCT00917267|100750035|FG000|Overall Study|Lost to follow up|0|||
33232013|NCT00917267|100750036|FG001|Overall Study|Lost to follow up|2|||
33232014|NCT00917267|100750035|FG000|Overall Study|Entry Criteria Not Met|1|||
33232015|NCT00917267|100750036|FG001|Overall Study|Entry Criteria Not Met|0|||
33232016|NCT00917267|100750035|FG000|Overall Study|Sponsor Decision|5|||
33232017|NCT00917267|100750036|FG001|Overall Study|Sponsor Decision|5|||
33232018|NCT00917267|100750035|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
33232019|NCT00917267|100750036|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
33232020|NCT02769065|100750037|FG000|Overall Study|Voluntary Withdrawal|1|||
33232021|NCT02769065|100750038|FG001|Overall Study|Voluntary Withdrawal|0|||
33232022|NCT02769065|100750039|FG002|Overall Study|Voluntary Withdrawal|0|||
33232023|NCT02769065|100750040|FG003|Overall Study|Voluntary Withdrawal|0|||
33232024|NCT02769065|100750041|FG004|Overall Study|Voluntary Withdrawal|0|||
33232025|NCT02769065|100750042|FG005|Overall Study|Voluntary Withdrawal|0|||
33232026|NCT02769065|100750043|FG006|Overall Study|Voluntary Withdrawal|0|||
33232027|NCT02769065|100750044|FG007|Overall Study|Voluntary Withdrawal|0|||
33232028|NCT02769065|100750045|FG008|Overall Study|Voluntary Withdrawal|0|||
33232029|NCT02769065|100750046|FG009|Overall Study|Voluntary Withdrawal|0|||
33232030|NCT02769065|100750047|FG010|Overall Study|Voluntary Withdrawal|0|||
33232031|NCT02769065|100750048|FG011|Overall Study|Voluntary Withdrawal|0|||
33232032|NCT02769065|100750049|FG012|Overall Study|Voluntary Withdrawal|0|||
33232033|NCT02769065|100750050|FG013|Overall Study|Voluntary Withdrawal|0|||
33232034|NCT02769065|100750051|FG014|Overall Study|Voluntary Withdrawal|0|||
33232035|NCT02769065|100750052|FG015|Overall Study|Voluntary Withdrawal|0|||
33232036|NCT02769065|100750053|FG016|Overall Study|Voluntary Withdrawal|0|||
33232037|NCT02769065|100750054|FG017|Overall Study|Voluntary Withdrawal|0|||
33232038|NCT02769065|100750055|FG018|Overall Study|Voluntary Withdrawal|0|||
33232039|NCT02769065|100750056|FG019|Overall Study|Voluntary Withdrawal|0|||
33232040|NCT02769065|100750057|FG020|Overall Study|Voluntary Withdrawal|0|||
33232041|NCT02769065|100750058|FG021|Overall Study|Voluntary Withdrawal|0|||
33232042|NCT02769065|100750059|FG022|Overall Study|Voluntary Withdrawal|0|||
33232043|NCT02769065|100750060|FG023|Overall Study|Voluntary Withdrawal|0|||
33232044|NCT02769065|100750061|FG024|Overall Study|Voluntary Withdrawal|0|||
33232045|NCT02769065|100750062|FG025|Overall Study|Voluntary Withdrawal|0|||
33232046|NCT02769065|100750063|FG026|Overall Study|Voluntary Withdrawal|0|||
33232047|NCT02769065|100750064|FG027|Overall Study|Voluntary Withdrawal|0|||
33232048|NCT02769065|100750065|FG028|Overall Study|Voluntary Withdrawal|0|||
33232049|NCT02769065|100750066|FG029|Overall Study|Voluntary Withdrawal|0|||
33232050|NCT02769065|100750037|FG000|Overall Study|Reason Not Specified|0|||
33232051|NCT02769065|100750038|FG001|Overall Study|Reason Not Specified|0|||
33232052|NCT02769065|100750039|FG002|Overall Study|Reason Not Specified|0|||
33232053|NCT02769065|100750040|FG003|Overall Study|Reason Not Specified|0|||
33232054|NCT02769065|100750041|FG004|Overall Study|Reason Not Specified|0|||
33232055|NCT02769065|100750042|FG005|Overall Study|Reason Not Specified|0|||
33232056|NCT02769065|100750043|FG006|Overall Study|Reason Not Specified|1|||
33232057|NCT02769065|100750044|FG007|Overall Study|Reason Not Specified|0|||
33232058|NCT02769065|100750045|FG008|Overall Study|Reason Not Specified|0|||
33232059|NCT02769065|100750046|FG009|Overall Study|Reason Not Specified|0|||
33232060|NCT02769065|100750047|FG010|Overall Study|Reason Not Specified|0|||
33368199|NCT01477892|101232861|FG000|Overall Study|Withdrawal by Subject|0|||
33574509|NCT01621178|101994220|FG002|Overall Study|Adverse Event|8|||
33368200|NCT01477892|101232862|FG001|Overall Study|Withdrawal by Subject|2|||
33368201|NCT00878072|101232866|FG000|Overall Study|Withdrew consent|2|||
33574510|NCT01621178|101994218|FG000|Overall Study|Death|6|||
33574511|NCT01621178|101994219|FG001|Overall Study|Death|7|||
33232061|NCT02769065|100750048|FG011|Overall Study|Reason Not Specified|0|||
33368202|NCT04598165|101232874|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
33574512|NCT01621178|101994220|FG002|Overall Study|Death|2|||
33232062|NCT02769065|100750049|FG012|Overall Study|Reason Not Specified|0|||
33232063|NCT02769065|100750050|FG013|Overall Study|Reason Not Specified|0|||
33232064|NCT02769065|100750051|FG014|Overall Study|Reason Not Specified|0|||
33574513|NCT01621178|101994218|FG000|Overall Study|Lost to Follow-up|1|||
33232065|NCT02769065|100750052|FG015|Overall Study|Reason Not Specified|0|||
33232066|NCT02769065|100750053|FG016|Overall Study|Reason Not Specified|0|||
33232067|NCT02769065|100750054|FG017|Overall Study|Reason Not Specified|0|||
33574514|NCT01621178|101994219|FG001|Overall Study|Lost to Follow-up|2|||
33232068|NCT02769065|100750055|FG018|Overall Study|Reason Not Specified|0|||
33232069|NCT02769065|100750056|FG019|Overall Study|Reason Not Specified|0|||
33232070|NCT02769065|100750057|FG020|Overall Study|Reason Not Specified|0|||
33574515|NCT01621178|101994220|FG002|Overall Study|Lost to Follow-up|1|||
33574516|NCT01621178|101994218|FG000|Overall Study|Withdrawal by Subject|14|||
33574517|NCT01621178|101994219|FG001|Overall Study|Withdrawal by Subject|17|||
33574518|NCT01621178|101994220|FG002|Overall Study|Withdrawal by Subject|18|||
33574519|NCT01621178|101994218|FG000|Overall Study|Physician Decision|5|||
33574520|NCT01621178|101994219|FG001|Overall Study|Physician Decision|2|||
33574521|NCT01621178|101994220|FG002|Overall Study|Physician Decision|7|||
33574522|NCT01977222|101994221|FG000|Overall Study|Withdrawal by Subject|1|||
33574523|NCT00403130|101994222|FG000|2 Years From Start of Treatment|Not Eligible|3|||
33574524|NCT00403130|101994222|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
33574525|NCT00403130|101994222|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
33574526|NCT00403130|101994222|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
33574527|NCT00812955|101994225|FG000|Overall Study|Adverse Event|7|||
33574528|NCT00812955|101994226|FG001|Overall Study|Adverse Event|6|||
33574529|NCT00812955|101994227|FG002|Overall Study|Adverse Event|3|||
33574530|NCT00812955|101994228|FG003|Overall Study|Adverse Event|4|||
33232071|NCT02769065|100750058|FG021|Overall Study|Reason Not Specified|0|||
33232072|NCT02769065|100750059|FG022|Overall Study|Reason Not Specified|0|||
33232073|NCT02769065|100750060|FG023|Overall Study|Reason Not Specified|0|||
33232074|NCT02769065|100750061|FG024|Overall Study|Reason Not Specified|0|||
33232075|NCT02769065|100750062|FG025|Overall Study|Reason Not Specified|0|||
33232076|NCT02769065|100750063|FG026|Overall Study|Reason Not Specified|0|||
33232077|NCT02769065|100750064|FG027|Overall Study|Reason Not Specified|0|||
33232078|NCT02769065|100750065|FG028|Overall Study|Reason Not Specified|0|||
33232079|NCT02769065|100750066|FG029|Overall Study|Reason Not Specified|0|||
33232080|NCT02769065|100750037|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232081|NCT02769065|100750038|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232082|NCT02769065|100750039|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232083|NCT02769065|100750040|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232084|NCT02769065|100750041|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232085|NCT02769065|100750042|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232086|NCT02769065|100750043|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232087|NCT02769065|100750044|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232088|NCT02769065|100750045|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232089|NCT02769065|100750046|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232090|NCT02769065|100750047|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
33232091|NCT02769065|100750048|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232092|NCT02769065|100750049|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232093|NCT02769065|100750050|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232094|NCT02769065|100750051|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232095|NCT02769065|100750052|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232096|NCT02769065|100750053|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232097|NCT02769065|100750054|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232098|NCT02769065|100750055|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232099|NCT02769065|100750056|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232100|NCT02769065|100750057|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232101|NCT02769065|100750058|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232102|NCT02769065|100750059|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232103|NCT02769065|100750060|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232104|NCT02769065|100750061|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232105|NCT02769065|100750062|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232106|NCT02769065|100750063|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232107|NCT02769065|100750064|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232108|NCT02769065|100750065|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232109|NCT02769065|100750066|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
33232110|NCT01865617|100750067|FG000|Overall Study|Death|27|||
33232111|NCT01865617|100750068|FG001|Overall Study|Death|3|||
33232112|NCT01865617|100750069|FG002|Overall Study|Death|1|||
33232113|NCT01865617|100750070|FG003|Overall Study|Death|1|||
33368203|NCT04598165|101232875|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
33574531|NCT00812955|101994225|FG000|Overall Study|Lost to Follow-up|2|||
33574532|NCT00812955|101994226|FG001|Overall Study|Lost to Follow-up|1|||
33574533|NCT00812955|101994227|FG002|Overall Study|Lost to Follow-up|1|||
33574534|NCT00812955|101994228|FG003|Overall Study|Lost to Follow-up|2|||
33574535|NCT00812955|101994225|FG000|Overall Study|Withdrawal by Subject|1|||
33574536|NCT00812955|101994226|FG001|Overall Study|Withdrawal by Subject|0|||
33232114|NCT01865617|100750071|FG004|Overall Study|Death|5|||
33232115|NCT01865617|100750072|FG005|Overall Study|Death|1|||
33232116|NCT01865617|100750073|FG006|Overall Study|Death|11|||
33232117|NCT01865617|100750074|FG007|Overall Study|Death|1|||
33232118|NCT01865617|100750075|FG008|Overall Study|Death|11|||
33232119|NCT01865617|100750076|FG009|Overall Study|Death|3|||
33232120|NCT01865617|100750077|FG010|Overall Study|Death|32|||
33232121|NCT01865617|100750078|FG011|Overall Study|Death|6|||
33232122|NCT01865617|100750079|FG012|Overall Study|Death|13|||
33232123|NCT01865617|100750067|FG000|Overall Study|Lost to Follow-up|2|||
33232124|NCT01865617|100750068|FG001|Overall Study|Lost to Follow-up|0|||
33232125|NCT01865617|100750069|FG002|Overall Study|Lost to Follow-up|0|||
33232126|NCT01865617|100750070|FG003|Overall Study|Lost to Follow-up|0|||
33232127|NCT01865617|100750071|FG004|Overall Study|Lost to Follow-up|0|||
33232128|NCT01865617|100750072|FG005|Overall Study|Lost to Follow-up|0|||
33232129|NCT01865617|100750073|FG006|Overall Study|Lost to Follow-up|0|||
33232130|NCT01865617|100750074|FG007|Overall Study|Lost to Follow-up|0|||
33232131|NCT01865617|100750075|FG008|Overall Study|Lost to Follow-up|0|||
33232132|NCT01865617|100750076|FG009|Overall Study|Lost to Follow-up|0|||
33232133|NCT01865617|100750077|FG010|Overall Study|Lost to Follow-up|0|||
33232134|NCT01865617|100750078|FG011|Overall Study|Lost to Follow-up|0|||
33368204|NCT04598165|101232874|FG000|Completed 6-week Follow-up|Death|2|||
33635981|NCT04960202|102218543|FG001|Overall Study|Lost to Follow-up|17|||
33635982|NCT04960202|102218542|FG000|Overall Study|Death|0|||
33136999|NCT00966875|100417112|FG001|Part A|Parent/Caregiver Decision|0|||
33137000|NCT00966875|100417113|FG002|Part A|Parent/Caregiver Decision|0|||
33137001|NCT00966875|100417114|FG003|Part A|Parent/Caregiver Decision|1|||
33137002|NCT00966875|100417115|FG004|Part A|Parent/Caregiver Decision|0|||
33137003|NCT00966875|100417116|FG005|Part A|Parent/Caregiver Decision|0|||
33137004|NCT00966875|100417117|FG006|Part A|Parent/Caregiver Decision|0|||
33137005|NCT00966875|100417118|FG007|Part A|Parent/Caregiver Decision|0|||
33137006|NCT00966875|100417119|FG008|Part A|Parent/Caregiver Decision|0|||
33137007|NCT00966875|100417111|FG000|Part A|Physician Decision|0|||
33137008|NCT00966875|100417112|FG001|Part A|Physician Decision|0|||
33137009|NCT00966875|100417113|FG002|Part A|Physician Decision|0|||
33137010|NCT00966875|100417114|FG003|Part A|Physician Decision|0|||
33137011|NCT00966875|100417115|FG004|Part A|Physician Decision|1|||
33137012|NCT00966875|100417116|FG005|Part A|Physician Decision|0|||
33137013|NCT00966875|100417117|FG006|Part A|Physician Decision|1|||
33137014|NCT00966875|100417118|FG007|Part A|Physician Decision|0|||
33137015|NCT00966875|100417119|FG008|Part A|Physician Decision|2|||
33137016|NCT00966875|100417111|FG000|Part A|Sponsor Decision|0|||
33137017|NCT00966875|100417112|FG001|Part A|Sponsor Decision|0|||
33137018|NCT00966875|100417113|FG002|Part A|Sponsor Decision|1|||
33137019|NCT00966875|100417114|FG003|Part A|Sponsor Decision|0|||
33137020|NCT00966875|100417115|FG004|Part A|Sponsor Decision|1|||
33137021|NCT00966875|100417116|FG005|Part A|Sponsor Decision|0|||
33137022|NCT00966875|100417117|FG006|Part A|Sponsor Decision|0|||
33137023|NCT00966875|100417118|FG007|Part A|Sponsor Decision|2|||
33137024|NCT00966875|100417119|FG008|Part A|Sponsor Decision|1|||
33137025|NCT00966875|100417111|FG000|Part A|Withdrawal by Subject|2|||
33137026|NCT00966875|100417112|FG001|Part A|Withdrawal by Subject|2|||
33137027|NCT00966875|100417113|FG002|Part A|Withdrawal by Subject|1|||
33137028|NCT00966875|100417114|FG003|Part A|Withdrawal by Subject|1|||
33137029|NCT00966875|100417115|FG004|Part A|Withdrawal by Subject|3|||
33137030|NCT00966875|100417116|FG005|Part A|Withdrawal by Subject|0|||
33137031|NCT00966875|100417117|FG006|Part A|Withdrawal by Subject|5|||
33137032|NCT00966875|100417118|FG007|Part A|Withdrawal by Subject|1|||
33137033|NCT00966875|100417119|FG008|Part A|Withdrawal by Subject|1|||
33137034|NCT00966875|100417111|FG000|Part A|Protocol Violation|0|||
33137035|NCT00966875|100417112|FG001|Part A|Protocol Violation|0|||
33137036|NCT00966875|100417113|FG002|Part A|Protocol Violation|0|||
33137037|NCT00966875|100417114|FG003|Part A|Protocol Violation|0|||
33137038|NCT00966875|100417115|FG004|Part A|Protocol Violation|0|||
33137039|NCT00966875|100417116|FG005|Part A|Protocol Violation|0|||
33137040|NCT00966875|100417117|FG006|Part A|Protocol Violation|2|||
33137041|NCT00966875|100417118|FG007|Part A|Protocol Violation|1|||
33137042|NCT00966875|100417119|FG008|Part A|Protocol Violation|1|||
33137043|NCT00966875|100417111|FG000|Part B|Adverse Event|0|||
33137044|NCT00966875|100417112|FG001|Part B|Adverse Event|1|||
33137045|NCT00966875|100417113|FG002|Part B|Adverse Event|1|||
33137046|NCT00966875|100417114|FG003|Part B|Adverse Event|0|||
33137047|NCT00966875|100417115|FG004|Part B|Adverse Event|1|||
33137048|NCT00966875|100417116|FG005|Part B|Adverse Event|0|||
33137049|NCT00966875|100417117|FG006|Part B|Adverse Event|5|||
33137050|NCT00966875|100417118|FG007|Part B|Adverse Event|2|||
33137051|NCT00966875|100417119|FG008|Part B|Adverse Event|2|||
33137052|NCT00966875|100417111|FG000|Part B|Death|0|||
33137053|NCT00966875|100417112|FG001|Part B|Death|0|||
33137054|NCT00966875|100417113|FG002|Part B|Death|1|||
33137055|NCT00966875|100417114|FG003|Part B|Death|0|||
33137056|NCT00966875|100417115|FG004|Part B|Death|0|||
33137057|NCT00966875|100417116|FG005|Part B|Death|0|||
33232135|NCT01865617|100750079|FG012|Overall Study|Lost to Follow-up|0|||
33232136|NCT01865617|100750067|FG000|Overall Study|Withdrawal by Subject|1|||
33232137|NCT01865617|100750068|FG001|Overall Study|Withdrawal by Subject|0|||
33420105|NCT00602979|101428532|FG003|Overall Study|Failed Intubation|1|||
33137058|NCT00966875|100417117|FG006|Part B|Death|0|||
33137059|NCT00966875|100417118|FG007|Part B|Death|1|||
33137060|NCT00966875|100417119|FG008|Part B|Death|0|||
33137061|NCT00966875|100417111|FG000|Part B|Lack of Efficacy|2|||
33137062|NCT00966875|100417112|FG001|Part B|Lack of Efficacy|1|||
33232138|NCT01865617|100750069|FG002|Overall Study|Withdrawal by Subject|0|||
33232139|NCT01865617|100750070|FG003|Overall Study|Withdrawal by Subject|0|||
33232140|NCT01865617|100750071|FG004|Overall Study|Withdrawal by Subject|0|||
33232141|NCT01865617|100750072|FG005|Overall Study|Withdrawal by Subject|0|||
33232142|NCT01865617|100750073|FG006|Overall Study|Withdrawal by Subject|0|||
33232143|NCT01865617|100750074|FG007|Overall Study|Withdrawal by Subject|0|||
33232144|NCT01865617|100750075|FG008|Overall Study|Withdrawal by Subject|0|||
33232145|NCT01865617|100750076|FG009|Overall Study|Withdrawal by Subject|0|||
33137063|NCT00966875|100417113|FG002|Part B|Lack of Efficacy|1|||
33137064|NCT00966875|100417114|FG003|Part B|Lack of Efficacy|1|||
33137065|NCT00966875|100417115|FG004|Part B|Lack of Efficacy|2|||
33137066|NCT00966875|100417116|FG005|Part B|Lack of Efficacy|3|||
33137067|NCT00966875|100417117|FG006|Part B|Lack of Efficacy|12|||
33137068|NCT00966875|100417118|FG007|Part B|Lack of Efficacy|9|||
33137069|NCT00966875|100417119|FG008|Part B|Lack of Efficacy|6|||
33137070|NCT00966875|100417111|FG000|Part B|Lost to Follow-up|0|||
33137071|NCT00966875|100417112|FG001|Part B|Lost to Follow-up|0|||
33137072|NCT00966875|100417113|FG002|Part B|Lost to Follow-up|0|||
33137073|NCT00966875|100417114|FG003|Part B|Lost to Follow-up|1|||
33137074|NCT00966875|100417115|FG004|Part B|Lost to Follow-up|0|||
33137075|NCT00966875|100417116|FG005|Part B|Lost to Follow-up|0|||
33137076|NCT00966875|100417117|FG006|Part B|Lost to Follow-up|0|||
33137077|NCT00966875|100417118|FG007|Part B|Lost to Follow-up|0|||
33137078|NCT00966875|100417119|FG008|Part B|Lost to Follow-up|1|||
33137079|NCT00966875|100417111|FG000|Part B|Physician Decision|0|||
33137080|NCT00966875|100417112|FG001|Part B|Physician Decision|0|||
33137081|NCT00966875|100417113|FG002|Part B|Physician Decision|1|||
33137082|NCT00966875|100417114|FG003|Part B|Physician Decision|0|||
33137083|NCT00966875|100417115|FG004|Part B|Physician Decision|2|||
33137084|NCT00966875|100417116|FG005|Part B|Physician Decision|1|||
33137085|NCT00966875|100417117|FG006|Part B|Physician Decision|0|||
33137086|NCT00966875|100417118|FG007|Part B|Physician Decision|0|||
33137087|NCT00966875|100417119|FG008|Part B|Physician Decision|2|||
33137088|NCT00966875|100417111|FG000|Part B|Sponsor Decision|1|||
33137089|NCT00966875|100417112|FG001|Part B|Sponsor Decision|0|||
33137090|NCT00966875|100417113|FG002|Part B|Sponsor Decision|0|||
33137091|NCT00966875|100417114|FG003|Part B|Sponsor Decision|0|||
33137092|NCT00966875|100417115|FG004|Part B|Sponsor Decision|0|||
33137093|NCT00966875|100417116|FG005|Part B|Sponsor Decision|1|||
33137094|NCT00966875|100417117|FG006|Part B|Sponsor Decision|0|||
33137095|NCT00966875|100417118|FG007|Part B|Sponsor Decision|2|||
33137096|NCT00966875|100417119|FG008|Part B|Sponsor Decision|1|||
33137097|NCT00966875|100417111|FG000|Part B|Withdrawal by Subject|2|||
33137098|NCT00966875|100417112|FG001|Part B|Withdrawal by Subject|1|||
33137099|NCT00966875|100417113|FG002|Part B|Withdrawal by Subject|2|||
33137100|NCT00966875|100417114|FG003|Part B|Withdrawal by Subject|1|||
33137101|NCT00966875|100417115|FG004|Part B|Withdrawal by Subject|2|||
33137102|NCT00966875|100417116|FG005|Part B|Withdrawal by Subject|1|||
33137103|NCT00966875|100417117|FG006|Part B|Withdrawal by Subject|4|||
33137104|NCT00966875|100417118|FG007|Part B|Withdrawal by Subject|5|||
33137105|NCT00966875|100417119|FG008|Part B|Withdrawal by Subject|5|||
33137106|NCT00966875|100417111|FG000|Part B|Entry Criteria|0|||
33137107|NCT00966875|100417112|FG001|Part B|Entry Criteria|0|||
33137108|NCT00966875|100417113|FG002|Part B|Entry Criteria|0|||
33137109|NCT00966875|100417114|FG003|Part B|Entry Criteria|0|||
33137110|NCT00966875|100417115|FG004|Part B|Entry Criteria|0|||
33137111|NCT00966875|100417116|FG005|Part B|Entry Criteria|0|||
33137112|NCT00966875|100417117|FG006|Part B|Entry Criteria|1|||
33137113|NCT00966875|100417118|FG007|Part B|Entry Criteria|0|||
33137114|NCT00966875|100417119|FG008|Part B|Entry Criteria|1|||
33137115|NCT01206322|100417120|FG000|Overall Study|Adverse Event|0|||
33137116|NCT01206322|100417121|FG001|Overall Study|Adverse Event|0|||
33137117|NCT01206322|100417122|FG002|Overall Study|Adverse Event|0|||
33137118|NCT01206322|100417123|FG003|Overall Study|Adverse Event|1|||
33137119|NCT01700439|100417124|FG000|Overall Study|Lost to Follow-up|47|||
33137120|NCT01700439|100417124|FG000|Overall Study|Withdrawal by Subject|183|||
33137121|NCT01700439|100417124|FG000|Overall Study|Death|186|||
33137122|NCT01256190|100417127|FG000|Overall Study|Lost to Follow-up|2|||
33137123|NCT01256190|100417128|FG001|Overall Study|Lost to Follow-up|0|||
33137124|NCT02743611|100417129|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
33137125|NCT02743611|100417130|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
33137126|NCT02743611|100417131|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
33137127|NCT02743611|100417132|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
33137128|NCT00978757|100417133|FG000|Overall Study|Physician Decision|1|||
33137129|NCT00978757|100417134|FG001|Overall Study|Physician Decision|3|||
33137130|NCT00109590|100417140|FG000|Overall Study|Lost to Follow-up|1|||
33137131|NCT00109590|100417141|FG001|Overall Study|Lost to Follow-up|0|||
33137132|NCT00109590|100417142|FG002|Overall Study|Lost to Follow-up|1|||
33137133|NCT00109590|100417140|FG000|Overall Study|Never Started Treatment|1|||
33137134|NCT00109590|100417141|FG001|Overall Study|Never Started Treatment|2|||
33137135|NCT00109590|100417142|FG002|Overall Study|Never Started Treatment|3|||
33137136|NCT03462511|100417143|FG000|Overall Study|Withdrawal by Subject|2|||
33232146|NCT01865617|100750077|FG010|Overall Study|Withdrawal by Subject|0|||
33232147|NCT01865617|100750078|FG011|Overall Study|Withdrawal by Subject|0|||
33232148|NCT01865617|100750079|FG012|Overall Study|Withdrawal by Subject|0|||
33232149|NCT01865617|100750067|FG000|Overall Study|Patient proceeded to new therapy|0|||
33232150|NCT01865617|100750068|FG001|Overall Study|Patient proceeded to new therapy|0|||
33232151|NCT01865617|100750069|FG002|Overall Study|Patient proceeded to new therapy|0|||
33232152|NCT01865617|100750070|FG003|Overall Study|Patient proceeded to new therapy|0|||
33232153|NCT01865617|100750071|FG004|Overall Study|Patient proceeded to new therapy|2|||
33232154|NCT01865617|100750072|FG005|Overall Study|Patient proceeded to new therapy|0|||
33232155|NCT01865617|100750073|FG006|Overall Study|Patient proceeded to new therapy|0|||
33232156|NCT01865617|100750074|FG007|Overall Study|Patient proceeded to new therapy|0|||
33232157|NCT01865617|100750075|FG008|Overall Study|Patient proceeded to new therapy|0|||
33232158|NCT01865617|100750076|FG009|Overall Study|Patient proceeded to new therapy|0|||
33232159|NCT01865617|100750077|FG010|Overall Study|Patient proceeded to new therapy|0|||
33232160|NCT01865617|100750078|FG011|Overall Study|Patient proceeded to new therapy|0|||
33232161|NCT01865617|100750079|FG012|Overall Study|Patient proceeded to new therapy|0|||
33232162|NCT01865617|100750067|FG000|Overall Study|Other|0|||
33232163|NCT01865617|100750068|FG001|Overall Study|Other|0|||
33232164|NCT01865617|100750069|FG002|Overall Study|Other|0|||
33232165|NCT01865617|100750070|FG003|Overall Study|Other|0|||
33232166|NCT01865617|100750071|FG004|Overall Study|Other|0|||
33232167|NCT01865617|100750072|FG005|Overall Study|Other|0|||
33232168|NCT01865617|100750073|FG006|Overall Study|Other|1|||
33232169|NCT01865617|100750074|FG007|Overall Study|Other|0|||
33232170|NCT01865617|100750075|FG008|Overall Study|Other|0|||
33232171|NCT01865617|100750076|FG009|Overall Study|Other|0|||
33232172|NCT01865617|100750077|FG010|Overall Study|Other|0|||
33232173|NCT01865617|100750078|FG011|Overall Study|Other|0|||
33232174|NCT01865617|100750079|FG012|Overall Study|Other|0|||
33232175|NCT00976703|100750082|FG000|Overall Study|Physician Decision|1|||
33232176|NCT00976703|100750083|FG001|Overall Study|Physician Decision|1|||
33232177|NCT00976703|100750082|FG000|Overall Study|ineligible for study|2|||
33232178|NCT00976703|100750083|FG001|Overall Study|ineligible for study|2|||
33232179|NCT00284089|100750086|FG000|Multiple Dose Phase|Adverse Event|1|||
33232180|NCT00284089|100750087|FG001|Multiple Dose Phase|Adverse Event|0|||
33232181|NCT00284089|100750088|FG002|Multiple Dose Phase|Adverse Event|1|||
33232182|NCT00284089|100750089|FG003|Multiple Dose Phase|Adverse Event|1|||
33232183|NCT00284089|100750086|FG000|Multiple Dose Phase|Protocol Violation|0|||
33232184|NCT00284089|100750087|FG001|Multiple Dose Phase|Protocol Violation|0|||
33232185|NCT00284089|100750088|FG002|Multiple Dose Phase|Protocol Violation|1|||
33232186|NCT00284089|100750089|FG003|Multiple Dose Phase|Protocol Violation|0|||
33232187|NCT00284089|100750086|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
33232188|NCT00284089|100750087|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
33232189|NCT00284089|100750088|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
33232190|NCT00284089|100750089|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
33232191|NCT00284089|100750086|FG000|Multiple Dose Phase|Death|0|||
33232192|NCT00284089|100750087|FG001|Multiple Dose Phase|Death|0|||
33232193|NCT00284089|100750088|FG002|Multiple Dose Phase|Death|1|||
33232194|NCT00284089|100750089|FG003|Multiple Dose Phase|Death|1|||
33232195|NCT00284089|100750086|FG000|Extension Phase|Adverse Event|0|||
33232196|NCT00284089|100750087|FG001|Extension Phase|Adverse Event|0|||
33232197|NCT00284089|100750088|FG002|Extension Phase|Adverse Event|2|||
33232198|NCT00284089|100750089|FG003|Extension Phase|Adverse Event|2|||
33232199|NCT00284089|100750086|FG000|Extension Phase|condition no longer requires study drug|2|||
33232200|NCT00284089|100750087|FG001|Extension Phase|condition no longer requires study drug|0|||
33232201|NCT00284089|100750088|FG002|Extension Phase|condition no longer requires study drug|2|||
33232202|NCT00284089|100750089|FG003|Extension Phase|condition no longer requires study drug|7|||
33232203|NCT00284089|100750086|FG000|Extension Phase|Protocol Violation|0|||
33232204|NCT00284089|100750087|FG001|Extension Phase|Protocol Violation|0|||
33232205|NCT00284089|100750088|FG002|Extension Phase|Protocol Violation|1|||
33232206|NCT00284089|100750089|FG003|Extension Phase|Protocol Violation|0|||
33232207|NCT00284089|100750086|FG000|Extension Phase|Withdrawal by Subject|0|||
33232208|NCT00284089|100750087|FG001|Extension Phase|Withdrawal by Subject|0|||
33232209|NCT00284089|100750088|FG002|Extension Phase|Withdrawal by Subject|1|||
33232210|NCT00284089|100750089|FG003|Extension Phase|Withdrawal by Subject|3|||
33232211|NCT00895843|100750090|FG000|Overall Study|Protocol Violation|12|||
33232212|NCT00895843|100750091|FG001|Overall Study|Protocol Violation|12|||
33232213|NCT03810313|100750094|FG000|Overall Study|Study terminated by sponsor|164|||
33232214|NCT03810313|100750095|FG001|Overall Study|Study terminated by sponsor|159|||
33232215|NCT03810313|100750094|FG000|Overall Study|Subject decision|10|||
33232216|NCT03810313|100750095|FG001|Overall Study|Subject decision|11|||
33232217|NCT03810313|100750094|FG000|Overall Study|Lost to Follow-up|3|||
33232218|NCT03810313|100750095|FG001|Overall Study|Lost to Follow-up|3|||
33232219|NCT03810313|100750094|FG000|Overall Study|Adverse Event|2|||
33232220|NCT03810313|100750095|FG001|Overall Study|Adverse Event|1|||
33232221|NCT03810313|100750094|FG000|Overall Study|Death|2|||
33232222|NCT03810313|100750095|FG001|Overall Study|Death|1|||
33232223|NCT03810313|100750094|FG000|Overall Study|Physician Decision|0|||
33232224|NCT03810313|100750095|FG001|Overall Study|Physician Decision|1|||
33232225|NCT01775930|100750096|FG000|Overall Study|Futility stopping boundary met|1|||
33232226|NCT02443103|100750098|FG000|Overall Study|Adverse Event|2|||
33232227|NCT02443103|100750098|FG000|Overall Study|Noncompliance|1|||
33232228|NCT02337478|100750101|FG000|Overall Study|Lack of Efficacy|5|||
33232229|NCT01077362|100750104|FG000|Overall Study|Lack of Efficacy|13|||
33232230|NCT01077362|100750105|FG001|Overall Study|Lack of Efficacy|8|||
33635983|NCT04960202|102218543|FG001|Overall Study|Death|15|||
33232231|NCT01077362|100750106|FG002|Overall Study|Lack of Efficacy|10|||
33232232|NCT01077362|100750104|FG000|Overall Study|Lost to Follow-up|1|||
33232233|NCT01077362|100750105|FG001|Overall Study|Lost to Follow-up|0|||
33232234|NCT01077362|100750106|FG002|Overall Study|Lost to Follow-up|3|||
33232235|NCT01077362|100750104|FG000|Overall Study|Adverse Event|12|||
33232236|NCT01077362|100750105|FG001|Overall Study|Adverse Event|7|||
33232237|NCT01077362|100750106|FG002|Overall Study|Adverse Event|4|||
33232238|NCT01077362|100750104|FG000|Overall Study|Withdrawal by Subject|5|||
33232239|NCT01077362|100750105|FG001|Overall Study|Withdrawal by Subject|3|||
33232240|NCT01077362|100750106|FG002|Overall Study|Withdrawal by Subject|5|||
33232241|NCT01077362|100750104|FG000|Overall Study|Other|0|||
33232242|NCT01077362|100750105|FG001|Overall Study|Other|1|||
33232243|NCT01077362|100750106|FG002|Overall Study|Other|2|||
33232244|NCT05764239|100750108|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
33232245|NCT05764239|100750108|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
33232246|NCT05764239|100750108|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
33232247|NCT05764239|100750108|FG000|DEP (Part 1)|Adverse Event|1|||
33232248|NCT05764239|100750108|FG000|DEP (Part 1)|Lost to Follow-up|1|||
33232249|NCT05764239|100750108|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
33232250|NCT05764239|100750108|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
33232251|NCT05764239|100750108|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
33232252|NCT05764239|100750108|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
33232253|NCT00432835|100750109|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
33232254|NCT00432835|100750110|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
33232255|NCT01644474|100750113|FG000|Overall Study|Poor compliance to protocol|1|||
33232256|NCT01644474|100750114|FG001|Overall Study|Poor compliance to protocol|0|||
33232257|NCT01644474|100750113|FG000|Overall Study|Consent withdrawn by participant|0|||
33232258|NCT01644474|100750114|FG001|Overall Study|Consent withdrawn by participant|1|||
33232259|NCT01644474|100750113|FG000|Overall Study|Participant moved|0|||
33232260|NCT01644474|100750114|FG001|Overall Study|Participant moved|1|||
33232261|NCT01644474|100750113|FG000|Overall Study|Adverse Event|4|||
33232262|NCT01644474|100750114|FG001|Overall Study|Adverse Event|5|||
33232263|NCT01644474|100750113|FG000|Overall Study|Site scheduling error|1|||
33232264|NCT01644474|100750114|FG001|Overall Study|Site scheduling error|1|||
33232265|NCT01644474|100750113|FG000|Overall Study|Protocol Violation|1|||
33232266|NCT01644474|100750114|FG001|Overall Study|Protocol Violation|0|||
33232267|NCT04140890|100750115|FG000|Overall Study|Withdrawal by Subject|0|||
33232268|NCT04140890|100750116|FG001|Overall Study|Withdrawal by Subject|1|||
33232269|NCT03525574|100750117|FG000|Overall Study|Adverse Event|15|||
33232270|NCT03525574|100750118|FG001|Overall Study|Adverse Event|0|||
33232271|NCT03525574|100750117|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
33232272|NCT03525574|100750118|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
33232273|NCT03525574|100750117|FG000|Overall Study|Lost to Follow-up|4|||
33232274|NCT03525574|100750118|FG001|Overall Study|Lost to Follow-up|0|||
33232275|NCT03525574|100750117|FG000|Overall Study|Commercial drug is Available for participant|48|||
33232276|NCT03525574|100750118|FG001|Overall Study|Commercial drug is Available for participant|0|||
33232277|NCT03525574|100750117|FG000|Overall Study|Death|1|||
33232278|NCT03525574|100750118|FG001|Overall Study|Death|0|||
33232279|NCT03525574|100750117|FG000|Overall Study|Other non-compliance|2|||
33635984|NCT00414596|102218544|FG000|Overall Study|Protocol Violation|2|||
33635985|NCT04313244|102218545|FG000|Overall Study|Withdrawal of Consent|3|||
33635986|NCT04313244|102218546|FG001|Overall Study|Withdrawal of Consent|3|||
33635987|NCT04313244|102218545|FG000|Overall Study|Met Exclusion Criteria|1|||
33635988|NCT04313244|102218546|FG001|Overall Study|Met Exclusion Criteria|0|||
33635989|NCT04313244|102218545|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
33232280|NCT03525574|100750118|FG001|Overall Study|Other non-compliance|0|||
33232281|NCT03525574|100750117|FG000|Overall Study|Physician Decision|6|||
33232282|NCT03525574|100750118|FG001|Overall Study|Physician Decision|0|||
33232283|NCT03525574|100750117|FG000|Overall Study|Other|58|||
33232284|NCT03525574|100750118|FG001|Overall Study|Other|0|||
33232285|NCT03525574|100750117|FG000|Overall Study|Enrolled but never dosed|1|||
33232286|NCT03525574|100750118|FG001|Overall Study|Enrolled but never dosed|0|||
33232287|NCT03525574|100750117|FG000|Overall Study|Not enrolled in 105 study|0|||
33232288|NCT03525574|100750118|FG001|Overall Study|Not enrolled in 105 study|3|||
33232289|NCT02762981|100750122|FG000|Overall Study|Adverse Event|2|||
33635990|NCT04313244|102218546|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
33635991|NCT03096288|102218567|FG000|Overall Study|Withdrawal by Subject|0|||
33232290|NCT02762981|100750123|FG001|Overall Study|Adverse Event|3|||
33232291|NCT02762981|100750124|FG002|Overall Study|Adverse Event|1|||
33232292|NCT02762981|100750125|FG003|Overall Study|Adverse Event|1|||
33232293|NCT02762981|100750126|FG004|Overall Study|Adverse Event|3|||
33232294|NCT02762981|100750122|FG000|Overall Study|Physician Decision|0|||
33232295|NCT02762981|100750123|FG001|Overall Study|Physician Decision|1|||
33232296|NCT02762981|100750124|FG002|Overall Study|Physician Decision|0|||
33232297|NCT02762981|100750125|FG003|Overall Study|Physician Decision|0|||
33232298|NCT02762981|100750126|FG004|Overall Study|Physician Decision|1|||
33232299|NCT02762981|100750122|FG000|Overall Study|Disease progression|11|||
33232300|NCT02762981|100750123|FG001|Overall Study|Disease progression|23|||
33232301|NCT02762981|100750124|FG002|Overall Study|Disease progression|4|||
33232302|NCT02762981|100750125|FG003|Overall Study|Disease progression|10|||
33232303|NCT02762981|100750126|FG004|Overall Study|Disease progression|1|||
33232304|NCT02762981|100750122|FG000|Overall Study|Enrolled not treated|1|||
33232305|NCT02762981|100750123|FG001|Overall Study|Enrolled not treated|5|||
33232306|NCT02762981|100750124|FG002|Overall Study|Enrolled not treated|0|||
33232307|NCT02762981|100750125|FG003|Overall Study|Enrolled not treated|2|||
33232308|NCT02762981|100750126|FG004|Overall Study|Enrolled not treated|0|||
33232309|NCT02762981|100750122|FG000|Overall Study|Other|2|||
33232310|NCT02762981|100750123|FG001|Overall Study|Other|3|||
33232311|NCT02762981|100750124|FG002|Overall Study|Other|1|||
33232312|NCT02762981|100750125|FG003|Overall Study|Other|0|||
33232313|NCT02762981|100750126|FG004|Overall Study|Other|0|||
33232314|NCT02762981|100750122|FG000|Overall Study|Missing|1|||
33232315|NCT02762981|100750123|FG001|Overall Study|Missing|0|||
33232316|NCT02762981|100750124|FG002|Overall Study|Missing|0|||
33232317|NCT02762981|100750125|FG003|Overall Study|Missing|0|||
33232318|NCT02762981|100750126|FG004|Overall Study|Missing|0|||
33232319|NCT02762981|100750122|FG000|Overall Study|Withdrawal by Subject|0|||
33232320|NCT02762981|100750123|FG001|Overall Study|Withdrawal by Subject|5|||
33232321|NCT02762981|100750124|FG002|Overall Study|Withdrawal by Subject|1|||
33232322|NCT02762981|100750125|FG003|Overall Study|Withdrawal by Subject|3|||
33232323|NCT02762981|100750126|FG004|Overall Study|Withdrawal by Subject|0|||
33232324|NCT03632434|100750131|FG000|Overall Study|Withdrawal by Subject|2|||
33232325|NCT01266993|100750132|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
33232326|NCT01266993|100750133|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
33232327|NCT01266993|100750132|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
33232328|NCT01266993|100750133|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
33232329|NCT01193582|100750135|FG000|Vaccination Series|Withdrawal by Subject|11|||
33232330|NCT01193582|100750136|FG001|Vaccination Series|Withdrawal by Subject|13|||
33232331|NCT01193582|100750137|FG002|Vaccination Series|Withdrawal by Subject|8|||
33232332|NCT01193582|100750138|FG003|Vaccination Series|Withdrawal by Subject|3|||
33232333|NCT01193582|100750135|FG000|12 Month Follow-up|Death|0|||
33232334|NCT01193582|100750136|FG001|12 Month Follow-up|Death|0|||
33232335|NCT01193582|100750137|FG002|12 Month Follow-up|Death|1|||
33232336|NCT01193582|100750138|FG003|12 Month Follow-up|Death|0|||
33232337|NCT01193582|100750135|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
33232338|NCT01193582|100750136|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
33232339|NCT01193582|100750137|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
33232340|NCT01193582|100750138|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
33232341|NCT02038764|100750144|FG000|Overall Study|Adverse Event|0|||
33232342|NCT02038764|100750145|FG001|Overall Study|Adverse Event|0|||
33232343|NCT02038764|100750146|FG002|Overall Study|Adverse Event|1|||
33232344|NCT02038764|100750147|FG003|Overall Study|Adverse Event|0|||
33232345|NCT02038764|100750148|FG004|Overall Study|Adverse Event|0|||
33232346|NCT02038764|100750144|FG000|Overall Study|Lost to Follow-up|0|||
33232347|NCT02038764|100750145|FG001|Overall Study|Lost to Follow-up|1|||
33232348|NCT02038764|100750146|FG002|Overall Study|Lost to Follow-up|0|||
33232349|NCT02038764|100750147|FG003|Overall Study|Lost to Follow-up|0|||
33574537|NCT00812955|101994227|FG002|Overall Study|Withdrawal by Subject|1|||
33574538|NCT00812955|101994228|FG003|Overall Study|Withdrawal by Subject|2|||
33574539|NCT00812955|101994225|FG000|Overall Study|randomized in error|0|||
33574540|NCT00812955|101994226|FG001|Overall Study|randomized in error|0|||
33574541|NCT00812955|101994227|FG002|Overall Study|randomized in error|1|||
33574542|NCT00812955|101994228|FG003|Overall Study|randomized in error|0|||
33574543|NCT03364647|101994231|FG000|Overall Study|Withdrawal by Subject|3|||
33574544|NCT03364647|101994232|FG001|Overall Study|Withdrawal by Subject|1|||
33232350|NCT02038764|100750148|FG004|Overall Study|Lost to Follow-up|0|||
33232351|NCT02038764|100750144|FG000|Overall Study|Withdrawal by Subject|0|||
33232352|NCT02038764|100750145|FG001|Overall Study|Withdrawal by Subject|0|||
33232353|NCT02038764|100750146|FG002|Overall Study|Withdrawal by Subject|0|||
33232354|NCT02038764|100750147|FG003|Overall Study|Withdrawal by Subject|0|||
33232355|NCT02038764|100750148|FG004|Overall Study|Withdrawal by Subject|1|||
33232356|NCT02038764|100750144|FG000|Overall Study|Other|1|||
33232357|NCT02038764|100750145|FG001|Overall Study|Other|0|||
33232358|NCT02038764|100750146|FG002|Overall Study|Other|1|||
33232359|NCT02038764|100750147|FG003|Overall Study|Other|0|||
33368205|NCT04598165|101232875|FG001|Completed 6-week Follow-up|Death|1|||
33232360|NCT02038764|100750148|FG004|Overall Study|Other|0|||
33232361|NCT01778062|100750153|FG000|Overall Study|Adverse Event|1|||
33232362|NCT01778062|100750154|FG001|Overall Study|Adverse Event|3|||
33574545|NCT04795531|101994233|FG000|Overall Study|Withdrawal by Subject|4|||
33574546|NCT04795531|101994234|FG001|Overall Study|Withdrawal by Subject|4|||
33574547|NCT04795531|101994233|FG000|Overall Study|Lost to Follow-up|0|||
33232363|NCT01778062|100750153|FG000|Overall Study|Consent Withdrawal|1|||
33232364|NCT01778062|100750154|FG001|Overall Study|Consent Withdrawal|5|||
33232365|NCT01778062|100750153|FG000|Overall Study|major protocol deviation|4|||
33232366|NCT01778062|100750154|FG001|Overall Study|major protocol deviation|3|||
33232367|NCT01551303|100750158|FG000|Overall Study|failed awareness check on vision test|4|||
33232368|NCT01551303|100750159|FG001|Overall Study|failed awareness check on vision test|7|||
33232369|NCT03017235|100753688|FG000|Overall Study|Withdrawal by Subject|4|||
33232370|NCT03017235|100753689|FG001|Overall Study|Withdrawal by Subject|3|||
33232371|NCT03017235|100753688|FG000|Overall Study|Lost to Follow-up|2|||
33420106|NCT00602979|101428533|FG004|Overall Study|Failed Intubation|0|||
33420107|NCT00701558|101428534|FG000|Overall Study|Death|7|||
33420108|NCT00701558|101428534|FG000|Overall Study|Lost to Follow-up|8|||
33574548|NCT04795531|101994234|FG001|Overall Study|Lost to Follow-up|1|||
33574549|NCT04795531|101994233|FG000|Overall Study|Physician Decision|0|||
33574550|NCT04795531|101994234|FG001|Overall Study|Physician Decision|2|||
33574551|NCT04795531|101994233|FG000|Overall Study|Death|2|||
33574552|NCT04795531|101994234|FG001|Overall Study|Death|1|||
33574553|NCT00508482|101994235|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
33574554|NCT00508482|101994236|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
33574555|NCT00508482|101994237|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
33574556|NCT00508482|101994235|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
33574557|NCT00508482|101994236|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
33574558|NCT00508482|101994237|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
33574559|NCT00508482|101994235|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
33574560|NCT00508482|101994236|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
33574561|NCT00508482|101994237|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
33574562|NCT00457392|101994240|FG000|Overall Study|Objective Progression or Relapse|229|||
33420109|NCT00435825|101428537|FG000|Overall Study|Abnormality of Laboratory Test|0|||
33420110|NCT00435825|101428538|FG001|Overall Study|Abnormality of Laboratory Test|1|||
33420111|NCT00435825|101428539|FG002|Overall Study|Abnormality of Laboratory Test|0|||
33420112|NCT00435825|101428540|FG003|Overall Study|Abnormality of Laboratory Test|0|||
33420113|NCT00435825|101428537|FG000|Overall Study|Insufficient Therapeutic Response|3|||
33420114|NCT00435825|101428538|FG001|Overall Study|Insufficient Therapeutic Response|1|||
33420115|NCT00435825|101428539|FG002|Overall Study|Insufficient Therapeutic Response|0|||
33420116|NCT00435825|101428540|FG003|Overall Study|Insufficient Therapeutic Response|3|||
33420117|NCT00435825|101428537|FG000|Overall Study|Other Protocol Violation|1|||
33420118|NCT00435825|101428538|FG001|Overall Study|Other Protocol Violation|0|||
33420119|NCT00435825|101428539|FG002|Overall Study|Other Protocol Violation|0|||
33420120|NCT00435825|101428540|FG003|Overall Study|Other Protocol Violation|0|||
33420121|NCT00435825|101428537|FG000|Overall Study|Refused treatment|2|||
33420122|NCT00435825|101428538|FG001|Overall Study|Refused treatment|0|||
33420123|NCT00435825|101428539|FG002|Overall Study|Refused treatment|0|||
33420124|NCT00435825|101428540|FG003|Overall Study|Refused treatment|5|||
33420125|NCT00435825|101428537|FG000|Overall Study|Failure to return|5|||
33420126|NCT00435825|101428538|FG001|Overall Study|Failure to return|0|||
33420127|NCT00435825|101428539|FG002|Overall Study|Failure to return|4|||
33420128|NCT00435825|101428540|FG003|Overall Study|Failure to return|0|||
33420129|NCT00435825|101428537|FG000|Overall Study|Did not receive study drug|1|||
33420130|NCT00435825|101428538|FG001|Overall Study|Did not receive study drug|0|||
33420131|NCT00435825|101428539|FG002|Overall Study|Did not receive study drug|2|||
33420132|NCT00435825|101428540|FG003|Overall Study|Did not receive study drug|0|||
33574563|NCT00457392|101994241|FG001|Overall Study|Objective Progression or Relapse|296|||
33574564|NCT00457392|101994240|FG000|Overall Study|Death|106|||
33574565|NCT00457392|101994241|FG001|Overall Study|Death|106|||
33574566|NCT00457392|101994240|FG000|Overall Study|Adverse Event|84|||
33574567|NCT00457392|101994241|FG001|Overall Study|Adverse Event|41|||
33420133|NCT00435825|101428537|FG000|Overall Study|Did not enter follow-up|0|||
33232372|NCT03017235|100753689|FG001|Overall Study|Lost to Follow-up|7|||
33232373|NCT03017235|100753688|FG000|Overall Study|Adverse Event|0|||
33232374|NCT03017235|100753689|FG001|Overall Study|Adverse Event|1|||
33420134|NCT00435825|101428538|FG001|Overall Study|Did not enter follow-up|4|||
33420135|NCT00435825|101428539|FG002|Overall Study|Did not enter follow-up|1|||
33420136|NCT00435825|101428540|FG003|Overall Study|Did not enter follow-up|3|||
33420137|NCT00435825|101428537|FG000|Overall Study|Did not complete full follow-up period|6|||
33420138|NCT00435825|101428538|FG001|Overall Study|Did not complete full follow-up period|6|||
33420139|NCT00435825|101428539|FG002|Overall Study|Did not complete full follow-up period|4|||
33420140|NCT00435825|101428540|FG003|Overall Study|Did not complete full follow-up period|5|||
33574568|NCT00457392|101994240|FG000|Overall Study|Global Deterioration of Health Status|22|||
33420141|NCT00190684|101428541|FG000|Overall Study|Adverse Event|86|||
33574569|NCT00457392|101994241|FG001|Overall Study|Global Deterioration of Health Status|8|||
33574570|NCT00457392|101994240|FG000|Overall Study|Withdrawal by Subject|14|||
33137137|NCT03462511|100417144|FG001|Overall Study|Withdrawal by Subject|3|||
33137138|NCT03179202|100417145|FG000|Overall Study|Screen Failure|67|||
33635992|NCT03096288|102218568|FG001|Overall Study|Withdrawal by Subject|1|||
33635993|NCT03096288|102218569|FG002|Overall Study|Withdrawal by Subject|0|||
33635994|NCT03096288|102218570|FG003|Overall Study|Withdrawal by Subject|1|||
33635995|NCT02435992|102218571|FG000|Overall Study|non compliance with protocol|2|||
33635996|NCT02435992|102218572|FG001|Overall Study|non compliance with protocol|0|||
33635997|NCT02435992|102218573|FG002|Overall Study|non compliance with protocol|1|||
33635998|NCT02435992|102218574|FG003|Overall Study|non compliance with protocol|0|||
33635999|NCT02435992|102218575|FG004|Overall Study|non compliance with protocol|0|||
33137139|NCT03179202|100417145|FG000|Overall Study|Subject Lost to Follow Up|12|||
33137140|NCT03179202|100417145|FG000|Overall Study|Withdrawal by Subject|7|||
33574571|NCT00457392|101994241|FG001|Overall Study|Withdrawal by Subject|8|||
33574572|NCT00457392|101994240|FG000|Overall Study|Lost to Follow-up|6|||
33574573|NCT00457392|101994241|FG001|Overall Study|Lost to Follow-up|7|||
33574574|NCT00457392|101994240|FG000|Overall Study|Protocol Violation|4|||
33574575|NCT00457392|101994241|FG001|Overall Study|Protocol Violation|3|||
33574576|NCT00457392|101994240|FG000|Overall Study|Other|7|||
33574577|NCT00457392|101994241|FG001|Overall Study|Other|4|||
33574578|NCT00457392|101994240|FG000|Overall Study|Study Terminated by Sponsor|1|||
33574579|NCT00457392|101994241|FG001|Overall Study|Study Terminated by Sponsor|4|||
33574580|NCT00457392|101994240|FG000|Overall Study|Randomized, Not Treated|7|||
33574581|NCT00457392|101994241|FG001|Overall Study|Randomized, Not Treated|3|||
33574582|NCT04565990|101994242|FG000|Overall Study|Death|5|||
33574583|NCT04565990|101994242|FG000|Overall Study|Lost to Follow-up|1|||
33574584|NCT04565990|101994242|FG000|Overall Study|Withdrawal by Subject|1|||
33574585|NCT01378117|101994244|FG000|Overall Study|withdrawal|2|||
33574586|NCT01378117|101994245|FG001|Overall Study|withdrawal|1|||
33574587|NCT01378117|101994246|FG002|Overall Study|withdrawal|2|||
33574588|NCT01378117|101994244|FG000|Overall Study|discharged before med given|2|||
33574589|NCT01378117|101994245|FG001|Overall Study|discharged before med given|0|||
33137141|NCT03179202|100417145|FG000|Overall Study|Adverse Event|3|||
33137142|NCT03179202|100417145|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
33137143|NCT03179202|100417145|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
33137144|NCT01221285|100417146|FG000|Overall Study|Withdrawal by Subject|1|||
33574590|NCT01378117|101994246|FG002|Overall Study|discharged before med given|1|||
33574591|NCT05414175|101994247|FG000|Overall Study|Withdrawal by Subject|1|||
33574592|NCT05414175|101994247|FG000|Overall Study|Other Reasons|1|||
33574593|NCT05653700|101994248|FG000|Overall Study|Non Responders|9|||
33574594|NCT05653700|101994249|FG001|Overall Study|Non Responders|0|||
33574595|NCT04211363|101994250|FG000|Overall Study|Adverse Event|5|||
33574596|NCT04211363|101994251|FG001|Overall Study|Adverse Event|2|||
33574597|NCT04211363|101994250|FG000|Overall Study|Physician Decision|0|||
33574598|NCT04211363|101994251|FG001|Overall Study|Physician Decision|1|||
33137145|NCT02043899|100417149|FG000|Overall Study|Adverse Event|3|||
33574599|NCT04211363|101994250|FG000|Overall Study|Protocol Violation|1|||
33574600|NCT04211363|101994251|FG001|Overall Study|Protocol Violation|0|||
33574601|NCT04211363|101994250|FG000|Overall Study|Pregnancy|1|||
33574602|NCT04211363|101994251|FG001|Overall Study|Pregnancy|0|||
33574603|NCT04211363|101994250|FG000|Overall Study|Lost to Follow-up|12|||
33368206|NCT04598165|101232874|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
33368207|NCT04598165|101232875|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
33368208|NCT04598165|101232874|FG000|Completed 6-week Follow-up|Ineligible|4|||
33368209|NCT04598165|101232875|FG001|Completed 6-week Follow-up|Ineligible|3|||
33368210|NCT04598165|101232874|FG000|Completed 6-week Follow-up|Partner refusal|0|||
33368211|NCT04598165|101232875|FG001|Completed 6-week Follow-up|Partner refusal|1|||
33368212|NCT04598165|101232874|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
33368213|NCT04598165|101232875|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
33368214|NCT03762850|101232877|FG000|Overall Study|Death|0|||
33368215|NCT03762850|101232878|FG001|Overall Study|Death|1|||
33368216|NCT03762850|101232877|FG000|Overall Study|Lost to Follow-up|0|||
33368217|NCT03762850|101232878|FG001|Overall Study|Lost to Follow-up|1|||
33368218|NCT03762850|101232877|FG000|Overall Study|Physician Decision|0|||
33368219|NCT03762850|101232878|FG001|Overall Study|Physician Decision|1|||
33636000|NCT02435992|102218571|FG000|Overall Study|Adverse Event|11|||
33636001|NCT02435992|102218572|FG001|Overall Study|Adverse Event|6|||
33137146|NCT02043899|100417149|FG000|Overall Study|Physician Decision|1|||
33368220|NCT03762850|101232877|FG000|Overall Study|Withdrawal by Subject|4|||
33574604|NCT04211363|101994251|FG001|Overall Study|Lost to Follow-up|4|||
33574605|NCT04211363|101994250|FG000|Overall Study|Withdrawal by Subject|11|||
33574606|NCT04211363|101994251|FG001|Overall Study|Withdrawal by Subject|11|||
33574607|NCT04211363|101994250|FG000|Overall Study|Other|1|||
33574608|NCT04211363|101994251|FG001|Overall Study|Other|2|||
33574609|NCT04047446|101994259|FG000|Overall Study|Physician Decision|1|||
33574610|NCT04047446|101994260|FG001|Overall Study|Physician Decision|0|||
33574611|NCT02013609|101994261|FG000|Overall Study|Withdrawal by Subject|9|||
33574612|NCT02013609|101994261|FG000|Overall Study|Lost to Follow-up|3|||
33137147|NCT02043899|100417149|FG000|Overall Study|Withdrawal by Subject|2|||
33420142|NCT00190684|101428541|FG000|Overall Study|Satisfactory response|80|||
33420143|NCT00190684|101428541|FG000|Overall Study|Lack of efficacy|204|||
33420144|NCT00190684|101428541|FG000|Overall Study|Lost to Follow-up|232|||
33574613|NCT02013609|101994261|FG000|Overall Study|Adverse Event|3|||
33574614|NCT02013609|101994261|FG000|Overall Study|Met Withdrawal Criteria|3|||
33574615|NCT02138825|101994263|FG000|Main Study Treatment|Adverse Event|11|||
33420145|NCT00190684|101428541|FG000|Overall Study|Patient moved|60|||
33420146|NCT00190684|101428541|FG000|Overall Study|Patient Decision|432|||
33420147|NCT00190684|101428541|FG000|Overall Study|Clinical relapse|67|||
33420148|NCT00190684|101428541|FG000|Overall Study|Sponsor's decision|17|||
33420149|NCT00190684|101428541|FG000|Overall Study|Physician Decision|84|||
33420150|NCT00190684|101428541|FG000|Overall Study|Protocol Violation|123|||
33420151|NCT00190684|101428541|FG000|Overall Study|Study Period III Completed|103|||
33420152|NCT00190684|101428541|FG000|Overall Study|Study Period V Completed|1|||
33420153|NCT00430638|101428542|FG000|Overall Study|Adverse Event|15|||
33420154|NCT00430638|101428543|FG001|Overall Study|Adverse Event|15|||
33420155|NCT00430638|101428542|FG000|Overall Study|Uncontrolled blood pressure|48|||
33420156|NCT00430638|101428543|FG001|Overall Study|Uncontrolled blood pressure|13|||
33420157|NCT00430638|101428542|FG000|Overall Study|Lost to Follow-up|1|||
33420158|NCT00430638|101428543|FG001|Overall Study|Lost to Follow-up|7|||
33420159|NCT00430638|101428542|FG000|Overall Study|Protocol Violation|6|||
33420160|NCT00430638|101428543|FG001|Overall Study|Protocol Violation|4|||
33420161|NCT00430638|101428542|FG000|Overall Study|Withdrawal by Subject|4|||
33420162|NCT00430638|101428543|FG001|Overall Study|Withdrawal by Subject|6|||
33420163|NCT00430638|101428542|FG000|Overall Study|Non-compliant|2|||
33420164|NCT00430638|101428543|FG001|Overall Study|Non-compliant|1|||
33420165|NCT00430638|101428542|FG000|Overall Study|Other|2|||
33420166|NCT00430638|101428543|FG001|Overall Study|Other|2|||
33420167|NCT04991311|101428544|FG000|Overall Study|Adverse Event|1|||
33420168|NCT00854607|101428545|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
33420169|NCT00628745|101428548|FG000|Overall Study|Withdrawal by Subject|63|||
33420170|NCT00628745|101428549|FG001|Overall Study|Withdrawal by Subject|3|||
33420171|NCT00628745|101428550|FG002|Overall Study|Withdrawal by Subject|9|||
33420172|NCT00628745|101428551|FG003|Overall Study|Withdrawal by Subject|2|||
33420173|NCT00628745|101428552|FG004|Overall Study|Withdrawal by Subject|69|||
33420174|NCT00628745|101428548|FG000|Overall Study|Does not meet inclusion criteria|0|||
33420175|NCT00628745|101428549|FG001|Overall Study|Does not meet inclusion criteria|12|||
33420176|NCT00628745|101428550|FG002|Overall Study|Does not meet inclusion criteria|0|||
33420177|NCT00628745|101428551|FG003|Overall Study|Does not meet inclusion criteria|0|||
33420178|NCT00628745|101428552|FG004|Overall Study|Does not meet inclusion criteria|18|||
33420179|NCT00628745|101428548|FG000|Overall Study|Participation in an interventional clinical trial|81|||
33574616|NCT02138825|101994264|FG001|Main Study Treatment|Adverse Event|3|||
33574617|NCT02138825|101994263|FG000|Main Study Treatment|Death|1|||
33574618|NCT02138825|101994264|FG001|Main Study Treatment|Death|2|||
33574619|NCT02138825|101994263|FG000|Main Study Treatment|Protocol Violation|2|||
33574620|NCT02138825|101994264|FG001|Main Study Treatment|Protocol Violation|2|||
33574621|NCT02138825|101994263|FG000|Main Study Treatment|Sponsor decision|12|||
33574622|NCT02138825|101994264|FG001|Main Study Treatment|Sponsor decision|18|||
33574623|NCT02138825|101994263|FG000|Main Study Treatment|Study terminated by sponsor|10|||
33574624|NCT02138825|101994264|FG001|Main Study Treatment|Study terminated by sponsor|9|||
33574625|NCT02138825|101994263|FG000|Main Study Treatment|Withdrawal by Subject|3|||
33574626|NCT02138825|101994264|FG001|Main Study Treatment|Withdrawal by Subject|1|||
33574627|NCT02138825|101994263|FG000|Main Study Treatment|Medical decision|1|||
33137148|NCT02043899|100417149|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
33137149|NCT02043899|100417149|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
33137150|NCT02043899|100417149|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
33137151|NCT02043899|100417149|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
33137152|NCT02043899|100417149|FG000|Overall Study|Treatment delayed|1|||
33137153|NCT00870103|100417154|FG000|Overall Study|Physician Decision|2|||
33137154|NCT00870103|100417154|FG000|Overall Study|Lost to Follow-up|2|||
33137155|NCT00444678|100417155|FG000|Overall Study|Toxicity|11|||
33420180|NCT00628745|101428549|FG001|Overall Study|Participation in an interventional clinical trial|4|||
33420181|NCT00628745|101428550|FG002|Overall Study|Participation in an interventional clinical trial|7|||
33420182|NCT00628745|101428551|FG003|Overall Study|Participation in an interventional clinical trial|0|||
33574628|NCT02138825|101994264|FG001|Main Study Treatment|Medical decision|0|||
33574629|NCT02138825|101994263|FG000|Long-term Extension|Study termination by sponsor|32|||
33420183|NCT00628745|101428552|FG004|Overall Study|Participation in an interventional clinical trial|63|||
33420184|NCT00628745|101428548|FG000|Overall Study|Physician Decision|8|||
33420185|NCT00628745|101428549|FG001|Overall Study|Physician Decision|4|||
33574630|NCT02138825|101994264|FG001|Long-term Extension|Study termination by sponsor|38|||
33574631|NCT02138825|101994263|FG000|Safety Follow-up|Adverse Event|4|||
33574632|NCT02138825|101994264|FG001|Safety Follow-up|Adverse Event|3|||
33574633|NCT02138825|101994263|FG000|Safety Follow-up|Death|11|||
33420186|NCT00628745|101428550|FG002|Overall Study|Physician Decision|3|||
33420187|NCT00628745|101428551|FG003|Overall Study|Physician Decision|0|||
33420188|NCT00628745|101428552|FG004|Overall Study|Physician Decision|30|||
33420189|NCT00628745|101428548|FG000|Overall Study|Lost to Follow-up|109|||
33420190|NCT00628745|101428549|FG001|Overall Study|Lost to Follow-up|7|||
33420191|NCT00628745|101428550|FG002|Overall Study|Lost to Follow-up|7|||
33420192|NCT00628745|101428551|FG003|Overall Study|Lost to Follow-up|0|||
33368221|NCT03762850|101232878|FG001|Overall Study|Withdrawal by Subject|9|||
33368222|NCT03884101|101232880|FG000|Overall Study|Participant Ongoing in Study|202|||
33368223|NCT03884101|101232881|FG001|Overall Study|Participant Ongoing in Study|186|||
33368224|NCT03884101|101232880|FG000|Overall Study|Death|212|||
33368225|NCT03884101|101232881|FG001|Overall Study|Death|224|||
33368226|NCT03884101|101232880|FG000|Overall Study|Lost to Follow-up|0|||
33368227|NCT03884101|101232881|FG001|Overall Study|Lost to Follow-up|1|||
33420193|NCT00628745|101428552|FG004|Overall Study|Lost to Follow-up|498|||
33420194|NCT00628745|101428548|FG000|Overall Study|Death|197|||
33420195|NCT00628745|101428549|FG001|Overall Study|Death|81|||
33420196|NCT00628745|101428550|FG002|Overall Study|Death|12|||
33420197|NCT00628745|101428551|FG003|Overall Study|Death|4|||
33420198|NCT00628745|101428552|FG004|Overall Study|Death|939|||
33420199|NCT00628745|101428548|FG000|Overall Study|Participant transferred to another THAOS site|6|||
33420200|NCT00628745|101428549|FG001|Overall Study|Participant transferred to another THAOS site|0|||
33420201|NCT00628745|101428550|FG002|Overall Study|Participant transferred to another THAOS site|0|||
33420202|NCT00628745|101428551|FG003|Overall Study|Participant transferred to another THAOS site|0|||
33420203|NCT00628745|101428552|FG004|Overall Study|Participant transferred to another THAOS site|7|||
33420204|NCT00628745|101428548|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
33420205|NCT00628745|101428549|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
33420206|NCT00628745|101428550|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
33420207|NCT00628745|101428551|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
33420208|NCT00628745|101428552|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
33420209|NCT00628745|101428548|FG000|Overall Study|Site closure|152|||
33420210|NCT00628745|101428549|FG001|Overall Study|Site closure|146|||
33420211|NCT00628745|101428550|FG002|Overall Study|Site closure|6|||
33420212|NCT00628745|101428551|FG003|Overall Study|Site closure|8|||
33420213|NCT00628745|101428552|FG004|Overall Study|Site closure|691|||
33420214|NCT00628745|101428548|FG000|Overall Study|Duplicate participant|0|||
33420215|NCT00628745|101428549|FG001|Overall Study|Duplicate participant|0|||
33420216|NCT00628745|101428550|FG002|Overall Study|Duplicate participant|0|||
33420217|NCT00628745|101428551|FG003|Overall Study|Duplicate participant|0|||
33420218|NCT00628745|101428552|FG004|Overall Study|Duplicate participant|1|||
33420219|NCT00628745|101428548|FG000|Overall Study|Missing|4|||
33420220|NCT00628745|101428549|FG001|Overall Study|Missing|3|||
33420221|NCT00628745|101428550|FG002|Overall Study|Missing|0|||
33420222|NCT00628745|101428551|FG003|Overall Study|Missing|0|||
33420223|NCT00628745|101428552|FG004|Overall Study|Missing|10|||
33420224|NCT00628745|101428548|FG000|Overall Study|Othe reasons|987|||
33420225|NCT00628745|101428549|FG001|Overall Study|Othe reasons|373|||
33420226|NCT00628745|101428550|FG002|Overall Study|Othe reasons|105|||
33420227|NCT00628745|101428551|FG003|Overall Study|Othe reasons|1|||
33420228|NCT00628745|101428552|FG004|Overall Study|Othe reasons|1772|||
33420229|NCT01179191|101428553|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
33420230|NCT01179191|101428553|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
33420231|NCT01179191|101428553|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
33420232|NCT01179191|101428553|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
33420233|NCT01179191|101428553|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
33420234|NCT01179191|101428553|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
33574634|NCT02138825|101994264|FG001|Safety Follow-up|Death|5|||
33574635|NCT02138825|101994263|FG000|Safety Follow-up|Withdrawal by Subject|5|||
33574636|NCT02138825|101994264|FG001|Safety Follow-up|Withdrawal by Subject|3|||
33574637|NCT02138825|101994263|FG000|Safety Follow-up|clinic worsening|1|||
33574638|NCT02138825|101994264|FG001|Safety Follow-up|clinic worsening|0|||
33574639|NCT02138825|101994263|FG000|Safety Follow-up|withdrawal by PI|1|||
33574640|NCT02138825|101994264|FG001|Safety Follow-up|withdrawal by PI|0|||
33574641|NCT02138825|101994263|FG000|Safety Follow-up|logistical difficulties|0|||
33574642|NCT02138825|101994264|FG001|Safety Follow-up|logistical difficulties|1|||
33574643|NCT02138825|101994263|FG000|Safety Follow-up|progressive disease|0|||
33368228|NCT03884101|101232880|FG000|Overall Study|Withdrawal by Subject|6|||
33368229|NCT03884101|101232881|FG001|Overall Study|Withdrawal by Subject|11|||
33368230|NCT00496873|101232882|FG000|Overall Study|Ineligible|2|||
33420235|NCT01179191|101428553|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
33420236|NCT01179191|101428553|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
33420237|NCT01179191|101428553|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
33420238|NCT01179191|101428553|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
33574644|NCT02138825|101994264|FG001|Safety Follow-up|progressive disease|2|||
33420239|NCT01179191|101428553|FG000|Maintenance Phase (8 Weeks)|Other|66|||
33420240|NCT01529749|101428554|FG000|Overall Study|Lost to Follow-up|0|||
33420241|NCT01529749|101428555|FG001|Overall Study|Lost to Follow-up|1|||
33420242|NCT01529749|101428556|FG002|Overall Study|Lost to Follow-up|1|||
33420243|NCT01529749|101428557|FG003|Overall Study|Lost to Follow-up|0|||
33636002|NCT02435992|102218573|FG002|Overall Study|Adverse Event|12|||
33636003|NCT02435992|102218574|FG003|Overall Study|Adverse Event|0|||
33636004|NCT02435992|102218575|FG004|Overall Study|Adverse Event|0|||
33636005|NCT02435992|102218571|FG000|Overall Study|Lack of Efficacy|4|||
33636006|NCT02435992|102218572|FG001|Overall Study|Lack of Efficacy|10|||
33636007|NCT02435992|102218573|FG002|Overall Study|Lack of Efficacy|9|||
33636008|NCT02435992|102218574|FG003|Overall Study|Lack of Efficacy|0|||
33636009|NCT02435992|102218575|FG004|Overall Study|Lack of Efficacy|0|||
33636010|NCT02435992|102218571|FG000|Overall Study|Withdrawal by Subject|10|||
33636011|NCT02435992|102218572|FG001|Overall Study|Withdrawal by Subject|8|||
33636012|NCT02435992|102218573|FG002|Overall Study|Withdrawal by Subject|20|||
33636013|NCT02435992|102218574|FG003|Overall Study|Withdrawal by Subject|0|||
33636014|NCT02435992|102218575|FG004|Overall Study|Withdrawal by Subject|0|||
33636015|NCT02435992|102218571|FG000|Overall Study|Other Reason|1|||
33232375|NCT03017235|100753688|FG000|Overall Study|Protocol Violation|2|||
33232376|NCT03017235|100753689|FG001|Overall Study|Protocol Violation|1|||
33232377|NCT03017235|100753688|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
33232378|NCT03017235|100753689|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
33232379|NCT00854295|100753690|FG000|Overall Study|Death|7|||
33232380|NCT00854295|100753691|FG001|Overall Study|Death|0|||
33232381|NCT00854295|100753692|FG002|Overall Study|Death|1|||
33232382|NCT00854295|100753693|FG003|Overall Study|Death|1|||
33232383|NCT00854295|100753690|FG000|Overall Study|Adverse Event|6|||
33232384|NCT00854295|100753691|FG001|Overall Study|Adverse Event|1|||
33232385|NCT00854295|100753692|FG002|Overall Study|Adverse Event|1|||
33368231|NCT00496873|101232882|FG000|Overall Study|Death|2|||
33368232|NCT00496873|101232882|FG000|Overall Study|Withdrawal by Subject|3|||
33368233|NCT02639182|101232883|FG000|Overall Study|Disease Progression|50|||
33368234|NCT02639182|101232884|FG001|Overall Study|Disease Progression|49|||
33368235|NCT02639182|101232883|FG000|Overall Study|Adverse Event|7|||
33368236|NCT02639182|101232884|FG001|Overall Study|Adverse Event|5|||
33232386|NCT00854295|100753693|FG003|Overall Study|Adverse Event|3|||
33232387|NCT00854295|100753690|FG000|Overall Study|Lost to Follow-up|18|||
33636016|NCT02435992|102218572|FG001|Overall Study|Other Reason|0|||
33636017|NCT02435992|102218573|FG002|Overall Study|Other Reason|0|||
33636018|NCT02435992|102218574|FG003|Overall Study|Other Reason|0|||
33636019|NCT02435992|102218575|FG004|Overall Study|Other Reason|0|||
33368237|NCT02639182|101232883|FG000|Overall Study|Physician Decision|3|||
33368238|NCT02639182|101232884|FG001|Overall Study|Physician Decision|3|||
33368239|NCT02639182|101232883|FG000|Overall Study|Withdrew Consent|5|||
33368240|NCT02639182|101232884|FG001|Overall Study|Withdrew Consent|4|||
33368241|NCT02639182|101232883|FG000|Overall Study|Lost to Follow-up|0|||
33368242|NCT02639182|101232884|FG001|Overall Study|Lost to Follow-up|1|||
33368243|NCT02639182|101232883|FG000|Overall Study|Study Closure|1|||
33368244|NCT02639182|101232884|FG001|Overall Study|Study Closure|2|||
33368245|NCT02639182|101232883|FG000|Overall Study|Sponsor Ended Study|0|||
33368246|NCT02639182|101232884|FG001|Overall Study|Sponsor Ended Study|1|||
33368247|NCT02639182|101232883|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
33368248|NCT02639182|101232884|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
33368249|NCT02951988|101232887|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
33368250|NCT02951988|101232888|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
33368251|NCT02951988|101232889|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
33420244|NCT01529749|101428554|FG000|Overall Study|Physician Decision|0|||
33636020|NCT02435992|102218571|FG000|Overall Study|Physician Decision|0|||
33636021|NCT02435992|102218572|FG001|Overall Study|Physician Decision|0|||
33232388|NCT00854295|100753691|FG001|Overall Study|Lost to Follow-up|5|||
33232389|NCT00854295|100753692|FG002|Overall Study|Lost to Follow-up|21|||
33420245|NCT01529749|101428555|FG001|Overall Study|Physician Decision|0|||
33420246|NCT01529749|101428556|FG002|Overall Study|Physician Decision|0|||
33232390|NCT00854295|100753693|FG003|Overall Study|Lost to Follow-up|21|||
33368252|NCT02951988|101232890|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
33636022|NCT02435992|102218573|FG002|Overall Study|Physician Decision|1|||
33636023|NCT02435992|102218574|FG003|Overall Study|Physician Decision|0|||
33636024|NCT02435992|102218575|FG004|Overall Study|Physician Decision|0|||
33636025|NCT03044106|102218576|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
33636026|NCT03044106|102218577|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
33636027|NCT00912808|102218578|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
33636028|NCT00912808|102218579|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
33368253|NCT02951988|101232887|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
33368254|NCT02951988|101232888|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
33420247|NCT01529749|101428557|FG003|Overall Study|Physician Decision|1|||
33232391|NCT00854295|100753690|FG000|Overall Study|Physician Decision|10|||
33368255|NCT02951988|101232889|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
33636029|NCT00912808|102218578|FG000|Washout|Withdrawal by Subject|0|||
33636030|NCT00912808|102218579|FG001|Washout|Withdrawal by Subject|1|||
33636031|NCT00912808|102218578|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
33636032|NCT00912808|102218579|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
33636033|NCT00912808|102218578|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
33636034|NCT00912808|102218579|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
33636035|NCT03848728|102218580|FG000|Overall Study|Death|16|||
33636036|NCT03848728|102218581|FG001|Overall Study|Death|13|||
33636037|NCT03848728|102218580|FG000|Overall Study|Outmigrated to non-study community|98|||
33636038|NCT03848728|102218581|FG001|Overall Study|Outmigrated to non-study community|106|||
33636039|NCT03848728|102218580|FG000|Overall Study|Transfered to non-study clinic|32|||
33636040|NCT03848728|102218581|FG001|Overall Study|Transfered to non-study clinic|48|||
33636041|NCT03848728|102218580|FG000|Overall Study|Withdrawal by Subject|1|||
33636042|NCT03848728|102218581|FG001|Overall Study|Withdrawal by Subject|0|||
33636043|NCT02161016|102218582|FG000|Overall Study|withdrawn by IRB|1|||
33636044|NCT03697252|102218587|FG000|Overall Study|Adverse Event|3|||
33636045|NCT03697252|102218588|FG001|Overall Study|Adverse Event|2|||
33420248|NCT01529749|101428554|FG000|Overall Study|Withdrawal by Subject|0|||
33420249|NCT01529749|101428555|FG001|Overall Study|Withdrawal by Subject|1|||
33420250|NCT01529749|101428556|FG002|Overall Study|Withdrawal by Subject|1|||
33574645|NCT02138825|101994263|FG000|Safety Follow-up|too unwell to attend the visit|0|||
33574646|NCT02138825|101994264|FG001|Safety Follow-up|too unwell to attend the visit|1|||
33574647|NCT02138825|101994263|FG000|Safety Follow-up|treatment unblinded|0|||
33574648|NCT02138825|101994264|FG001|Safety Follow-up|treatment unblinded|1|||
33574649|NCT02138825|101994263|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
33574650|NCT02138825|101994264|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
33574651|NCT00776789|101994265|FG000|Overall Study|Consent refusal|2|||
33574652|NCT00776789|101994266|FG001|Overall Study|Consent refusal|2|||
33574653|NCT00776789|101994265|FG000|Overall Study|Poor quality video|1|||
33574654|NCT00776789|101994266|FG001|Overall Study|Poor quality video|1|||
33574655|NCT02003222|101994271|FG000|Induction|Never started treatment|0|||
33574656|NCT02003222|101994272|FG001|Induction|Never started treatment|0|||
33574657|NCT02003222|101994273|FG002|Induction|Never started treatment|0|||
33574658|NCT02003222|101994274|FG003|Induction|Never started treatment|0|||
33574659|NCT02003222|101994275|FG004|Induction|Never started treatment|8|||
33574660|NCT02003222|101994271|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
33574661|NCT02003222|101994272|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
33574662|NCT02003222|101994273|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
33574663|NCT02003222|101994274|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
33574664|NCT02003222|101994275|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
33574665|NCT02003222|101994271|FG000|Induction|Adverse Event|0|||
33574666|NCT02003222|101994272|FG001|Induction|Adverse Event|0|||
33574667|NCT02003222|101994273|FG002|Induction|Adverse Event|0|||
33574668|NCT02003222|101994274|FG003|Induction|Adverse Event|0|||
33574669|NCT02003222|101994275|FG004|Induction|Adverse Event|13|||
33574670|NCT02003222|101994271|FG000|Induction|Alternative therapy|0|||
33574671|NCT02003222|101994272|FG001|Induction|Alternative therapy|0|||
33574672|NCT02003222|101994273|FG002|Induction|Alternative therapy|0|||
33574673|NCT02003222|101994274|FG003|Induction|Alternative therapy|0|||
33574674|NCT02003222|101994275|FG004|Induction|Alternative therapy|12|||
33574675|NCT02003222|101994271|FG000|Induction|Disease progression|0|||
33574676|NCT02003222|101994272|FG001|Induction|Disease progression|0|||
33574677|NCT02003222|101994273|FG002|Induction|Disease progression|0|||
33574678|NCT02003222|101994274|FG003|Induction|Disease progression|0|||
33574679|NCT02003222|101994275|FG004|Induction|Disease progression|22|||
33574680|NCT02003222|101994271|FG000|Induction|Death|0|||
33574681|NCT02003222|101994272|FG001|Induction|Death|0|||
33636046|NCT03697252|102218587|FG000|Overall Study|Withdrawal by Subject|14|||
33420251|NCT01529749|101428557|FG003|Overall Study|Withdrawal by Subject|0|||
33420252|NCT01529749|101428554|FG000|Overall Study|Protocol Violation|0|||
33420253|NCT01529749|101428555|FG001|Overall Study|Protocol Violation|0|||
33420254|NCT01529749|101428556|FG002|Overall Study|Protocol Violation|0|||
33574682|NCT02003222|101994273|FG002|Induction|Death|0|||
33574683|NCT02003222|101994274|FG003|Induction|Death|0|||
33574684|NCT02003222|101994275|FG004|Induction|Death|3|||
33574685|NCT02003222|101994271|FG000|Induction|Withdrawal by Subject|0|||
33574686|NCT02003222|101994272|FG001|Induction|Withdrawal by Subject|0|||
33574687|NCT02003222|101994273|FG002|Induction|Withdrawal by Subject|0|||
33574688|NCT02003222|101994274|FG003|Induction|Withdrawal by Subject|0|||
33420255|NCT01529749|101428557|FG003|Overall Study|Protocol Violation|1|||
33574689|NCT02003222|101994275|FG004|Induction|Withdrawal by Subject|8|||
33574690|NCT02003222|101994271|FG000|Induction|Other reasons|0|||
33636047|NCT03697252|102218588|FG001|Overall Study|Withdrawal by Subject|14|||
33636048|NCT03697252|102218587|FG000|Overall Study|Lost to Follow-up|0|||
33636049|NCT03697252|102218588|FG001|Overall Study|Lost to Follow-up|1|||
33636050|NCT03697252|102218587|FG000|Overall Study|Physician Decision|1|||
33420256|NCT04476017|101428558|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
33137156|NCT00444678|100417155|FG000|Overall Study|Disease Progression|12|||
33137157|NCT00444678|100417155|FG000|Overall Study|Death|3|||
33137158|NCT00444678|100417155|FG000|Overall Study|Physician Decision|3|||
33137159|NCT00444678|100417155|FG000|Overall Study|Withdrawal by Subject|2|||
33137160|NCT02730195|100417159|FG000|Overall Study|Withdrawal by Subject|1|||
33137161|NCT03148691|100417160|FG000|Overall Study|Protocol Violation|1|||
33636051|NCT03697252|102218588|FG001|Overall Study|Physician Decision|1|||
33636052|NCT03697252|102218587|FG000|Overall Study|Other|0|||
33137162|NCT03148691|100417161|FG001|Overall Study|Protocol Violation|2|||
33137163|NCT03148691|100417162|FG002|Overall Study|Protocol Violation|7|||
33137164|NCT03148691|100417160|FG000|Overall Study|Lost to Follow-up|0|||
33137165|NCT03148691|100417161|FG001|Overall Study|Lost to Follow-up|0|||
33137166|NCT03148691|100417162|FG002|Overall Study|Lost to Follow-up|1|||
33137167|NCT03148691|100417160|FG000|Overall Study|Other|1|||
33137168|NCT03148691|100417161|FG001|Overall Study|Other|0|||
33137169|NCT03148691|100417162|FG002|Overall Study|Other|0|||
33137170|NCT03148691|100417160|FG000|Overall Study|Withdrawal by Subject|1|||
33137171|NCT03148691|100417161|FG001|Overall Study|Withdrawal by Subject|0|||
33137172|NCT03148691|100417162|FG002|Overall Study|Withdrawal by Subject|0|||
33137173|NCT00608569|100417163|FG000|Overall Study|Death|4|||
33137174|NCT00608569|100417164|FG001|Overall Study|Death|3|||
33137175|NCT00608569|100417163|FG000|Overall Study|Lost to Follow-up|4|||
33137176|NCT00608569|100417164|FG001|Overall Study|Lost to Follow-up|5|||
33137177|NCT00608569|100417163|FG000|Overall Study|Withdrawal by Subject|1|||
33137178|NCT00608569|100417164|FG001|Overall Study|Withdrawal by Subject|0|||
33137179|NCT00608569|100417163|FG000|Overall Study|Adverse Event|1|||
33137180|NCT00608569|100417164|FG001|Overall Study|Adverse Event|0|||
33137181|NCT00608569|100417163|FG000|Overall Study|Unable to adhere with study requirements|0|||
33137182|NCT00608569|100417164|FG001|Overall Study|Unable to adhere with study requirements|1|||
33137183|NCT03254108|100417167|FG000|Overall Study|Adverse Event|0|||
33137184|NCT03254108|100417168|FG001|Overall Study|Adverse Event|2|||
33137185|NCT03254108|100417169|FG002|Overall Study|Adverse Event|0|||
33137186|NCT03254108|100417170|FG003|Overall Study|Adverse Event|1|||
33137187|NCT03254108|100417171|FG004|Overall Study|Adverse Event|1|||
33137188|NCT03254108|100417167|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
33232392|NCT00854295|100753691|FG001|Overall Study|Physician Decision|0|||
33232393|NCT00854295|100753692|FG002|Overall Study|Physician Decision|0|||
33232394|NCT00854295|100753693|FG003|Overall Study|Physician Decision|0|||
33232395|NCT01868074|100753696|FG000|Overall Study|Lost to Follow-up|3|||
33232396|NCT01868074|100753697|FG001|Overall Study|Lost to Follow-up|2|||
33232397|NCT01868074|100753696|FG000|Overall Study|Withdrawal by Subject|4|||
33232398|NCT01868074|100753697|FG001|Overall Study|Withdrawal by Subject|2|||
33232399|NCT00453102|100753700|FG000|Overall Study|Withdrawal by Subject|2|||
33232400|NCT03621982|100753709|FG000|Overall Study|Withdrawal by Subject|1|||
33232401|NCT03621982|100753710|FG001|Overall Study|Withdrawal by Subject|0|||
33232402|NCT03621982|100753711|FG002|Overall Study|Withdrawal by Subject|0|||
33574691|NCT02003222|101994272|FG001|Induction|Other reasons|0|||
33574692|NCT02003222|101994273|FG002|Induction|Other reasons|0|||
33574693|NCT02003222|101994274|FG003|Induction|Other reasons|0|||
33574694|NCT02003222|101994275|FG004|Induction|Other reasons|22|||
33574695|NCT02003222|101994271|FG000|Intensification|Never started treatment|0|||
33574696|NCT02003222|101994272|FG001|Intensification|Never started treatment|0|||
33574697|NCT02003222|101994273|FG002|Intensification|Never started treatment|0|||
33574698|NCT02003222|101994274|FG003|Intensification|Never started treatment|0|||
33574699|NCT02003222|101994275|FG004|Intensification|Never started treatment|2|||
33574700|NCT02003222|101994271|FG000|Intensification|Adverse Event|0|||
33574701|NCT02003222|101994272|FG001|Intensification|Adverse Event|0|||
33574702|NCT02003222|101994273|FG002|Intensification|Adverse Event|0|||
33574703|NCT02003222|101994274|FG003|Intensification|Adverse Event|0|||
33574704|NCT02003222|101994275|FG004|Intensification|Adverse Event|6|||
33137189|NCT03254108|100417168|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
33137190|NCT03254108|100417169|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
33137191|NCT03254108|100417170|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
33137192|NCT03254108|100417171|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
33137193|NCT03560518|100417179|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
33137194|NCT03560518|100417180|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
33137195|NCT03560518|100417181|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
33232403|NCT03621982|100753712|FG003|Overall Study|Withdrawal by Subject|1|||
33420257|NCT04476017|101428559|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
33574705|NCT02003222|101994271|FG000|Intensification|Alternative therapy|0|||
33574706|NCT02003222|101994272|FG001|Intensification|Alternative therapy|0|||
33636053|NCT03697252|102218588|FG001|Overall Study|Other|1|||
33636054|NCT05050318|102218592|FG000|Overall Study|Protocol Deviation|1|||
33137196|NCT03560518|100417179|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
33232404|NCT03621982|100753713|FG004|Overall Study|Withdrawal by Subject|0|||
33232405|NCT03621982|100753714|FG005|Overall Study|Withdrawal by Subject|1|||
33137197|NCT03560518|100417180|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
33137198|NCT03560518|100417181|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
33137199|NCT03560518|100417179|FG000|Double Blind Treatment Period|Protocol Violation|1|||
33232406|NCT03621982|100753715|FG006|Overall Study|Withdrawal by Subject|1|||
33232407|NCT03621982|100753716|FG007|Overall Study|Withdrawal by Subject|0|||
33232408|NCT03621982|100753717|FG008|Overall Study|Withdrawal by Subject|1|||
33232409|NCT03621982|100753718|FG009|Overall Study|Withdrawal by Subject|0|||
33232410|NCT03621982|100753719|FG010|Overall Study|Withdrawal by Subject|2|||
33232411|NCT03621982|100753720|FG011|Overall Study|Withdrawal by Subject|1|||
33232412|NCT03621982|100753721|FG012|Overall Study|Withdrawal by Subject|2|||
33232413|NCT03621982|100753722|FG013|Overall Study|Withdrawal by Subject|2|||
33232414|NCT03621982|100753709|FG000|Overall Study|Investigator/Sponsor decision|0|||
33232415|NCT03621982|100753710|FG001|Overall Study|Investigator/Sponsor decision|0|||
33232416|NCT03621982|100753711|FG002|Overall Study|Investigator/Sponsor decision|0|||
33232417|NCT03621982|100753712|FG003|Overall Study|Investigator/Sponsor decision|0|||
33232418|NCT03621982|100753713|FG004|Overall Study|Investigator/Sponsor decision|0|||
33232419|NCT03621982|100753714|FG005|Overall Study|Investigator/Sponsor decision|0|||
33137200|NCT03560518|100417180|FG001|Double Blind Treatment Period|Protocol Violation|2|||
33137201|NCT03560518|100417181|FG002|Double Blind Treatment Period|Protocol Violation|0|||
33137202|NCT03560518|100417179|FG000|Double Blind Treatment Period|Pregnancy|0|||
33137203|NCT03560518|100417180|FG001|Double Blind Treatment Period|Pregnancy|2|||
33137204|NCT03560518|100417181|FG002|Double Blind Treatment Period|Pregnancy|0|||
33137205|NCT03560518|100417179|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
33137206|NCT03560518|100417180|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
33232420|NCT03621982|100753715|FG006|Overall Study|Investigator/Sponsor decision|0|||
33232421|NCT03621982|100753716|FG007|Overall Study|Investigator/Sponsor decision|0|||
33574707|NCT02003222|101994273|FG002|Intensification|Alternative therapy|0|||
33368256|NCT02951988|101232890|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
33368257|NCT02951988|101232887|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
33368258|NCT02951988|101232888|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
33368259|NCT02951988|101232889|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
33368260|NCT02951988|101232890|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
33368261|NCT02951988|101232887|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
33574708|NCT02003222|101994274|FG003|Intensification|Alternative therapy|0|||
33574709|NCT02003222|101994275|FG004|Intensification|Alternative therapy|8|||
33574710|NCT02003222|101994271|FG000|Intensification|Disease progression|0|||
33368262|NCT02951988|101232888|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
33368263|NCT02951988|101232889|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
33368264|NCT02951988|101232890|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
33368265|NCT02951988|101232887|FG000|Open-Label Treatment Period|Protocol Violation|22|||
33137207|NCT03560518|100417181|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
33232422|NCT03621982|100753717|FG008|Overall Study|Investigator/Sponsor decision|0|||
33232423|NCT03621982|100753718|FG009|Overall Study|Investigator/Sponsor decision|0|||
33232424|NCT03621982|100753719|FG010|Overall Study|Investigator/Sponsor decision|0|||
33232425|NCT03621982|100753720|FG011|Overall Study|Investigator/Sponsor decision|4|||
33232426|NCT03621982|100753721|FG012|Overall Study|Investigator/Sponsor decision|0|||
33232427|NCT03621982|100753722|FG013|Overall Study|Investigator/Sponsor decision|2|||
33232428|NCT03621982|100753709|FG000|Overall Study|Death|2|||
33232429|NCT03621982|100753710|FG001|Overall Study|Death|4|||
33232430|NCT03621982|100753711|FG002|Overall Study|Death|4|||
33232431|NCT03621982|100753712|FG003|Overall Study|Death|3|||
33232432|NCT03621982|100753713|FG004|Overall Study|Death|8|||
33232433|NCT03621982|100753714|FG005|Overall Study|Death|4|||
33232434|NCT03621982|100753715|FG006|Overall Study|Death|6|||
33232435|NCT03621982|100753716|FG007|Overall Study|Death|3|||
33232436|NCT03621982|100753717|FG008|Overall Study|Death|0|||
33232437|NCT03621982|100753718|FG009|Overall Study|Death|3|||
33232438|NCT03621982|100753719|FG010|Overall Study|Death|8|||
33232439|NCT03621982|100753720|FG011|Overall Study|Death|4|||
33368266|NCT02951988|101232888|FG001|Open-Label Treatment Period|Protocol Violation|0|||
33368267|NCT02951988|101232889|FG002|Open-Label Treatment Period|Protocol Violation|0|||
33420258|NCT01393626|101428562|FG000|Overall Study|Adverse Event|2|||
33232440|NCT03621982|100753721|FG012|Overall Study|Death|2|||
33232441|NCT03621982|100753722|FG013|Overall Study|Death|2|||
33232442|NCT03621982|100753709|FG000|Overall Study|Lost to Follow-up|0|||
33232443|NCT03621982|100753710|FG001|Overall Study|Lost to Follow-up|0|||
33232444|NCT03621982|100753711|FG002|Overall Study|Lost to Follow-up|1|||
33232445|NCT03621982|100753712|FG003|Overall Study|Lost to Follow-up|0|||
33232446|NCT03621982|100753713|FG004|Overall Study|Lost to Follow-up|0|||
33232447|NCT03621982|100753714|FG005|Overall Study|Lost to Follow-up|0|||
33232448|NCT03621982|100753715|FG006|Overall Study|Lost to Follow-up|1|||
33420259|NCT01393626|101428563|FG001|Overall Study|Adverse Event|1|||
33420260|NCT01393626|101428564|FG002|Overall Study|Adverse Event|5|||
33574711|NCT02003222|101994272|FG001|Intensification|Disease progression|0|||
33232449|NCT03621982|100753716|FG007|Overall Study|Lost to Follow-up|0|||
33232450|NCT03621982|100753717|FG008|Overall Study|Lost to Follow-up|0|||
33232451|NCT03621982|100753718|FG009|Overall Study|Lost to Follow-up|1|||
33232452|NCT03621982|100753719|FG010|Overall Study|Lost to Follow-up|0|||
33636055|NCT05050318|102218593|FG001|Overall Study|Protocol Deviation|0|||
33636056|NCT05050318|102218594|FG002|Overall Study|Protocol Deviation|0|||
33636057|NCT04225897|102218600|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
33636058|NCT04225897|102218601|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
33636059|NCT04225897|102218602|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
33636060|NCT04225897|102218603|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
33137208|NCT03560518|100417179|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
33232453|NCT03621982|100753720|FG011|Overall Study|Lost to Follow-up|0|||
33232454|NCT03621982|100753721|FG012|Overall Study|Lost to Follow-up|0|||
33232455|NCT03621982|100753722|FG013|Overall Study|Lost to Follow-up|0|||
33232456|NCT02353832|100753727|FG000|Overall Study|Ineligible after enrollment|1|||
33232457|NCT02353832|100753727|FG000|Overall Study|Lost to Follow-up|1|||
33232458|NCT01622348|100753728|FG000|Overall Study|Withdrawal by Subject|1|||
33232459|NCT01622348|100753729|FG001|Overall Study|Withdrawal by Subject|0|||
33232460|NCT01622348|100753730|FG002|Overall Study|Withdrawal by Subject|1|||
33232461|NCT02213055|100753735|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
33232462|NCT02213055|100753736|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
33232463|NCT02213055|100753735|FG000|Overall Study|Protocol was not Followed during Study|1|||
33232464|NCT02213055|100753736|FG001|Overall Study|Protocol was not Followed during Study|0|||
33232465|NCT02213055|100753735|FG000|Overall Study|Documentation Issue at Enrollment|1|||
33232466|NCT02213055|100753736|FG001|Overall Study|Documentation Issue at Enrollment|0|||
33232467|NCT02213055|100753735|FG000|Overall Study|Documentation Issue during Study|10|||
33232468|NCT02213055|100753736|FG001|Overall Study|Documentation Issue during Study|0|||
33232469|NCT02213055|100753735|FG000|Overall Study|Did not have Live Lice|8|||
33232470|NCT02213055|100753736|FG001|Overall Study|Did not have Live Lice|0|||
33232471|NCT02213055|100753735|FG000|Overall Study|Had another Treatment during the Study|3|||
33232472|NCT02213055|100753736|FG001|Overall Study|Had another Treatment during the Study|0|||
33232473|NCT02213055|100753735|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
33232474|NCT02213055|100753736|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
33232475|NCT02213055|100753735|FG000|Overall Study|Did not Return to School|5|||
33232476|NCT02213055|100753736|FG001|Overall Study|Did not Return to School|0|||
33232477|NCT01087723|100753737|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
33232478|NCT01087723|100753738|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
33368268|NCT02951988|101232890|FG003|Open-Label Treatment Period|Protocol Violation|0|||
33368269|NCT02951988|101232887|FG000|Open-Label Treatment Period|Pregnancy|2|||
33368270|NCT02951988|101232888|FG001|Open-Label Treatment Period|Pregnancy|0|||
33368271|NCT02951988|101232889|FG002|Open-Label Treatment Period|Pregnancy|0|||
33368272|NCT02951988|101232890|FG003|Open-Label Treatment Period|Pregnancy|0|||
33368273|NCT02951988|101232887|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
33368274|NCT02951988|101232888|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
33368275|NCT02951988|101232889|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
33368276|NCT02951988|101232890|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
33368277|NCT02951988|101232887|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
33368278|NCT02951988|101232888|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
33368279|NCT02951988|101232889|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
33368280|NCT02951988|101232890|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
33636061|NCT04225897|102218604|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
33636062|NCT04225897|102218605|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
33636063|NCT04225897|102218606|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
33636064|NCT04225897|102218607|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
33636065|NCT04225897|102218608|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
33636066|NCT04225897|102218609|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
33636067|NCT04225897|102218610|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
33636068|NCT04225897|102218611|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
33636069|NCT04225897|102218600|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
33636070|NCT04225897|102218601|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
33636071|NCT04225897|102218602|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
33636072|NCT04225897|102218603|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
33636073|NCT04225897|102218604|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
33636074|NCT04225897|102218605|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
33636075|NCT04225897|102218606|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
33368281|NCT02951988|101232887|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
33368282|NCT02951988|101232888|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
33636076|NCT04225897|102218607|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
33137209|NCT03560518|100417180|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
33137210|NCT03560518|100417181|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
33137211|NCT03560518|100417179|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
33232479|NCT01087723|100753737|FG000|Overall Study|Withdrawal by Subject|10|||
33232480|NCT01087723|100753738|FG001|Overall Study|Withdrawal by Subject|13|||
33232481|NCT01087723|100753737|FG000|Overall Study|Physician Decision|2|||
33232482|NCT01087723|100753738|FG001|Overall Study|Physician Decision|0|||
33232483|NCT01087723|100753737|FG000|Overall Study|Lost to Follow-up|1|||
33232484|NCT01087723|100753738|FG001|Overall Study|Lost to Follow-up|4|||
33232485|NCT01087723|100753737|FG000|Overall Study|Reason Not Specified|1|||
33232486|NCT01087723|100753738|FG001|Overall Study|Reason Not Specified|2|||
33232487|NCT02726399|100753741|FG000|Overall Study|Participant Non-Compliance|1|||
33232488|NCT02726399|100753741|FG000|Overall Study|Adverse Event|2|||
33232489|NCT02726399|100753741|FG000|Overall Study|Progression of disease|4|||
33232490|NCT01992549|100753744|FG000|Overall Study|Lost to Follow-up|2|||
33232491|NCT01992549|100753744|FG000|Overall Study|Serious Adverse Event|1|||
33232492|NCT01992549|100753744|FG000|Overall Study|Product Switch to Extend Half Life|1|||
33232493|NCT01848834|100753750|FG000|Overall Study|Adverse Event|3|||
33232494|NCT01848834|100753751|FG001|Overall Study|Adverse Event|11|||
33232495|NCT01848834|100753752|FG002|Overall Study|Adverse Event|3|||
33232496|NCT01848834|100753753|FG003|Overall Study|Adverse Event|5|||
33232497|NCT01848834|100753754|FG004|Overall Study|Adverse Event|9|||
33232498|NCT01848834|100753750|FG000|Overall Study|Death|2|||
33232499|NCT01848834|100753751|FG001|Overall Study|Death|11|||
33232500|NCT01848834|100753752|FG002|Overall Study|Death|1|||
33232501|NCT01848834|100753753|FG003|Overall Study|Death|8|||
33232502|NCT01848834|100753754|FG004|Overall Study|Death|27|||
33232503|NCT01848834|100753750|FG000|Overall Study|Excluded Medication|5|||
33232504|NCT01848834|100753751|FG001|Overall Study|Excluded Medication|4|||
33232505|NCT01848834|100753752|FG002|Overall Study|Excluded Medication|3|||
33232506|NCT01848834|100753753|FG003|Overall Study|Excluded Medication|6|||
33232507|NCT01848834|100753754|FG004|Overall Study|Excluded Medication|6|||
33232508|NCT01848834|100753750|FG000|Overall Study|Lost to Follow-up|5|||
33232509|NCT01848834|100753751|FG001|Overall Study|Lost to Follow-up|5|||
33232510|NCT01848834|100753752|FG002|Overall Study|Lost to Follow-up|3|||
33232511|NCT01848834|100753753|FG003|Overall Study|Lost to Follow-up|0|||
33232512|NCT01848834|100753754|FG004|Overall Study|Lost to Follow-up|3|||
33232513|NCT01848834|100753750|FG000|Overall Study|Physician Decision|1|||
33232514|NCT01848834|100753751|FG001|Overall Study|Physician Decision|3|||
33232515|NCT01848834|100753752|FG002|Overall Study|Physician Decision|4|||
33232516|NCT01848834|100753753|FG003|Overall Study|Physician Decision|0|||
33232517|NCT01848834|100753754|FG004|Overall Study|Physician Decision|11|||
33232518|NCT01848834|100753750|FG000|Overall Study|Protocol Violation|0|||
33232519|NCT01848834|100753751|FG001|Overall Study|Protocol Violation|0|||
33232520|NCT01848834|100753752|FG002|Overall Study|Protocol Violation|0|||
33232521|NCT01848834|100753753|FG003|Overall Study|Protocol Violation|0|||
33232522|NCT01848834|100753754|FG004|Overall Study|Protocol Violation|1|||
33574712|NCT02003222|101994273|FG002|Intensification|Disease progression|0|||
33574713|NCT02003222|101994274|FG003|Intensification|Disease progression|0|||
33574714|NCT02003222|101994275|FG004|Intensification|Disease progression|18|||
33574715|NCT02003222|101994271|FG000|Intensification|Withdrawal by Subject|0|||
33574716|NCT02003222|101994272|FG001|Intensification|Withdrawal by Subject|0|||
33574717|NCT02003222|101994273|FG002|Intensification|Withdrawal by Subject|0|||
33574718|NCT02003222|101994274|FG003|Intensification|Withdrawal by Subject|0|||
33574719|NCT02003222|101994275|FG004|Intensification|Withdrawal by Subject|5|||
33574720|NCT02003222|101994271|FG000|Intensification|Other reasons|0|||
33574721|NCT02003222|101994272|FG001|Intensification|Other reasons|0|||
33574722|NCT02003222|101994273|FG002|Intensification|Other reasons|0|||
33574723|NCT02003222|101994274|FG003|Intensification|Other reasons|0|||
33574724|NCT02003222|101994275|FG004|Intensification|Other reasons|8|||
33574725|NCT01823289|101994276|FG000|Overall Study|Lost to Follow-up|5|||
33574726|NCT01823289|101994276|FG000|Overall Study|Adverse Event|5|||
33574727|NCT01823289|101994276|FG000|Overall Study|Lack of Efficacy|1|||
33574728|NCT01823289|101994276|FG000|Overall Study|Physician Decision|9|||
33232523|NCT01848834|100753750|FG000|Overall Study|Sponsor Decision|1|||
33232524|NCT01848834|100753751|FG001|Overall Study|Sponsor Decision|1|||
33232525|NCT01848834|100753752|FG002|Overall Study|Sponsor Decision|0|||
33232526|NCT01848834|100753753|FG003|Overall Study|Sponsor Decision|1|||
33232527|NCT01848834|100753754|FG004|Overall Study|Sponsor Decision|1|||
33232528|NCT01848834|100753750|FG000|Overall Study|Withdrawal by Subject|2|||
33232529|NCT01848834|100753751|FG001|Overall Study|Withdrawal by Subject|13|||
33574729|NCT01823289|101994276|FG000|Overall Study|Administered contraindicated medicine|1|||
33574730|NCT01823289|101994276|FG000|Overall Study|Transaminase increased more than 3 times|1|||
33574731|NCT01823289|101994276|FG000|Overall Study|Drug affected efficacy and safety|1|||
33574732|NCT01823289|101994276|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
33232530|NCT01848834|100753752|FG002|Overall Study|Withdrawal by Subject|10|||
33232531|NCT01848834|100753753|FG003|Overall Study|Withdrawal by Subject|6|||
33232532|NCT01848834|100753754|FG004|Overall Study|Withdrawal by Subject|36|||
33232533|NCT03125941|100753757|FG000|Overall Study|did not receive intervention|1|||
33232534|NCT03125941|100753758|FG001|Overall Study|did not receive intervention|2|||
33232535|NCT00663962|100753759|FG000|Overall Study|somnolence|1|||
33232536|NCT00663962|100753760|FG001|Overall Study|somnolence|0|||
33574733|NCT02268383|101994277|FG000|Overall Study|Death|12|||
33574734|NCT02268383|101994277|FG000|Overall Study|Lost to Follow-up|2|||
33574735|NCT02268383|101994277|FG000|Overall Study|Withdrawal by Subject|9|||
33574736|NCT02268383|101994277|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
33574737|NCT02268383|101994277|FG000|Overall Study|Protocol deviation|3|||
33574738|NCT02268383|101994277|FG000|Overall Study|Sponsor decision|22|||
33574739|NCT02268383|101994277|FG000|Overall Study|Not reported|12|||
33574740|NCT02114177|101994278|FG000|Overall Study|Lost to Follow-up|1|||
33574741|NCT02114177|101994279|FG001|Overall Study|Lost to Follow-up|2|||
33574742|NCT02114177|101994278|FG000|Overall Study|Withdrawal by Subject|6|||
33574743|NCT02114177|101994279|FG001|Overall Study|Withdrawal by Subject|1|||
33574744|NCT02114177|101994278|FG000|Overall Study|Other|2|||
33574745|NCT02114177|101994279|FG001|Overall Study|Other|1|||
33574746|NCT01865487|101994284|FG000|Overall Study|Lost to Follow-up|0|||
33574747|NCT01865487|101994285|FG001|Overall Study|Lost to Follow-up|0|||
33574748|NCT01865487|101994286|FG002|Overall Study|Lost to Follow-up|0|||
33574749|NCT01865487|101994287|FG003|Overall Study|Lost to Follow-up|1|||
33574750|NCT01865487|101994288|FG004|Overall Study|Lost to Follow-up|0|||
33574751|NCT01865487|101994289|FG005|Overall Study|Lost to Follow-up|0|||
33574752|NCT01865487|101994290|FG006|Overall Study|Lost to Follow-up|1|||
33574753|NCT01865487|101994291|FG007|Overall Study|Lost to Follow-up|0|||
33574754|NCT01865487|101994292|FG008|Overall Study|Lost to Follow-up|0|||
33574755|NCT01865487|101994293|FG009|Overall Study|Lost to Follow-up|0|||
33574756|NCT01865487|101994284|FG000|Overall Study|Withdrawal by Subject|0|||
33574757|NCT01865487|101994285|FG001|Overall Study|Withdrawal by Subject|0|||
33137212|NCT03560518|100417180|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
33137213|NCT03560518|100417181|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
33137214|NCT03560518|100417179|FG000|Double Blind Treatment Period|Adverse Event|0|||
33574758|NCT01865487|101994286|FG002|Overall Study|Withdrawal by Subject|0|||
33636077|NCT04225897|102218608|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
33636078|NCT04225897|102218609|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
33636079|NCT04225897|102218610|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
33636080|NCT04225897|102218611|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
33137215|NCT03560518|100417180|FG001|Double Blind Treatment Period|Adverse Event|3|||
33137216|NCT03560518|100417181|FG002|Double Blind Treatment Period|Adverse Event|1|||
33137217|NCT05315908|100417189|FG000|Overall Study|Lost to Follow-up|4477|||
33137218|NCT05315908|100417190|FG001|Overall Study|Lost to Follow-up|4606|||
33137219|NCT02785770|100417191|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
33137220|NCT02785770|100417192|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
33137221|NCT02785770|100417193|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
33137222|NCT02785770|100417194|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
33368283|NCT02951988|101232889|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
33368284|NCT02951988|101232890|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
33368285|NCT02951988|101232887|FG000|Open-Label Treatment Period|Adverse Event|45|||
33368286|NCT02951988|101232888|FG001|Open-Label Treatment Period|Adverse Event|0|||
33368287|NCT02951988|101232889|FG002|Open-Label Treatment Period|Adverse Event|0|||
33368288|NCT02951988|101232890|FG003|Open-Label Treatment Period|Adverse Event|0|||
33368289|NCT02951988|101232887|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
33368290|NCT02951988|101232888|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
33368291|NCT02951988|101232889|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
33368292|NCT02951988|101232890|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
33368293|NCT02951988|101232887|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
33368294|NCT02951988|101232888|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
33368295|NCT02951988|101232889|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
33368296|NCT02951988|101232890|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
33368297|NCT02951988|101232887|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
33574759|NCT01865487|101994287|FG003|Overall Study|Withdrawal by Subject|0|||
33137223|NCT02785770|100417191|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
33137224|NCT02785770|100417192|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
33137225|NCT02785770|100417193|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
33137226|NCT02785770|100417194|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
33137227|NCT02785770|100417191|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
33368298|NCT02951988|101232888|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
33574760|NCT01865487|101994288|FG004|Overall Study|Withdrawal by Subject|1|||
33574761|NCT01865487|101994289|FG005|Overall Study|Withdrawal by Subject|0|||
33574762|NCT01865487|101994290|FG006|Overall Study|Withdrawal by Subject|0|||
33574763|NCT01865487|101994291|FG007|Overall Study|Withdrawal by Subject|0|||
33574764|NCT01865487|101994292|FG008|Overall Study|Withdrawal by Subject|0|||
33574765|NCT01865487|101994293|FG009|Overall Study|Withdrawal by Subject|0|||
33574766|NCT01250054|101994294|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
33574767|NCT01250054|101994295|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
33232537|NCT00245011|100753763|FG000|Overall Study|Lack of Efficacy|1|||
33232538|NCT03518658|100753768|FG000|Overall Study|Other|51|||
33232539|NCT03518658|100753769|FG001|Overall Study|Other|0|||
33574768|NCT05134649|101994296|FG000|Overall Study|Lost to Follow-up|12|||
33574769|NCT05134649|101994296|FG000|Overall Study|Withdrawal by Subject|14|||
33574770|NCT05134649|101994296|FG000|Overall Study|Pregnancy|1|||
33574771|NCT05134649|101994296|FG000|Overall Study|Other, not specified|3|||
33574772|NCT01657305|101994297|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
33574773|NCT01657305|101994297|FG000|Overall Study|Withdrawal by Subject|4|||
33574774|NCT01657305|101994297|FG000|Overall Study|Adverse Event|1|||
33232540|NCT01464255|100753770|FG000|Overall Study|unresolve corneal staining|0|||
33232541|NCT01464255|100753771|FG001|Overall Study|unresolve corneal staining|1|||
33232542|NCT04022889|100753775|FG000|Stage 1: Period 1|Adverse Event|1|||
33232543|NCT04022889|100753776|FG001|Stage 1: Period 1|Adverse Event|0|||
33574775|NCT01657305|101994297|FG000|Overall Study|Lost to Follow-up|1|||
33232544|NCT04022889|100753777|FG002|Stage 1: Period 1|Adverse Event|0|||
33232545|NCT04022889|100753775|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
33232546|NCT04022889|100753776|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
33232547|NCT04022889|100753777|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
33232548|NCT04022889|100753775|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
33232549|NCT04022889|100753776|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
33232550|NCT04022889|100753777|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
33232551|NCT04022889|100753775|FG000|Stage 2|Screen Failure|0|||
33232552|NCT04022889|100753776|FG001|Stage 2|Screen Failure|0|||
33232553|NCT04022889|100753777|FG002|Stage 2|Screen Failure|3|||
33232554|NCT04022889|100753775|FG000|Stage 2|Ineligible for apheresis donation|0|||
33232555|NCT04022889|100753776|FG001|Stage 2|Ineligible for apheresis donation|0|||
33232556|NCT04022889|100753777|FG002|Stage 2|Ineligible for apheresis donation|2|||
33232557|NCT04022889|100753775|FG000|Stage 2|Adverse Event|0|||
33232558|NCT04022889|100753776|FG001|Stage 2|Adverse Event|0|||
33232559|NCT04022889|100753777|FG002|Stage 2|Adverse Event|2|||
33232560|NCT04022889|100753775|FG000|Stage 2|Protocol Violation|0|||
33368299|NCT02951988|101232889|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
33368300|NCT02951988|101232890|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
33368301|NCT02951988|101232887|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
33368302|NCT02951988|101232888|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
33368303|NCT02951988|101232889|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
33368304|NCT02951988|101232890|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
33368305|NCT02951988|101232887|FG000|Double-Blind Treatment Period|Pregnancy|0|||
33368306|NCT02951988|101232888|FG001|Double-Blind Treatment Period|Pregnancy|1|||
33368307|NCT02951988|101232889|FG002|Double-Blind Treatment Period|Pregnancy|1|||
33368308|NCT02951988|101232890|FG003|Double-Blind Treatment Period|Pregnancy|0|||
33368309|NCT02951988|101232887|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33368310|NCT02951988|101232888|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
33368311|NCT02951988|101232889|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
33368312|NCT02951988|101232890|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
33368313|NCT02951988|101232887|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33368314|NCT02951988|101232888|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
33368315|NCT02951988|101232889|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
33368316|NCT02951988|101232890|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
33368317|NCT02951988|101232887|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33368318|NCT02951988|101232888|FG001|Double-Blind Treatment Period|Adverse Event|8|||
33368319|NCT02951988|101232889|FG002|Double-Blind Treatment Period|Adverse Event|3|||
33368320|NCT02951988|101232890|FG003|Double-Blind Treatment Period|Adverse Event|6|||
33368321|NCT02951988|101232887|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
33368322|NCT02951988|101232888|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
33368323|NCT02951988|101232889|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
33368324|NCT02951988|101232890|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
33368325|NCT02086565|101232891|FG000|Overall Study|Lost to Follow-up|9|||
33368326|NCT02086565|101232892|FG001|Overall Study|Lost to Follow-up|7|||
33368327|NCT02086565|101232891|FG000|Overall Study|Withdrawal by Subject|2|||
33368328|NCT02086565|101232892|FG001|Overall Study|Withdrawal by Subject|1|||
33368329|NCT02086565|101232891|FG000|Overall Study|Death|3|||
33368330|NCT02086565|101232892|FG001|Overall Study|Death|2|||
33574776|NCT01657305|101994297|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
33232561|NCT04022889|100753776|FG001|Stage 2|Protocol Violation|0|||
33232562|NCT04022889|100753777|FG002|Stage 2|Protocol Violation|1|||
33368331|NCT02086565|101232891|FG000|Overall Study|withdrawn by research team|2|||
33368332|NCT02086565|101232892|FG001|Overall Study|withdrawn by research team|2|||
33368333|NCT01984346|101234804|FG000|Overall Study|Physician Decision|4|||
33368334|NCT01984346|101234805|FG001|Overall Study|Physician Decision|2|||
33574777|NCT03937479|101994298|FG000|Overall Study|Adverse Event|2|||
33232563|NCT04022889|100753775|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
33232564|NCT04022889|100753776|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
33232565|NCT04022889|100753777|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
33232566|NCT02670538|100753778|FG000|Overall Study|Withdrawal of Consent|8|||
33232567|NCT02670538|100753779|FG001|Overall Study|Withdrawal of Consent|6|||
33232568|NCT02670538|100753780|FG002|Overall Study|Withdrawal of Consent|5|||
33232569|NCT02670538|100753778|FG000|Overall Study|Lost to Follow-up|8|||
33232570|NCT02670538|100753779|FG001|Overall Study|Lost to Follow-up|12|||
33232571|NCT02670538|100753780|FG002|Overall Study|Lost to Follow-up|7|||
33232572|NCT02670538|100753778|FG000|Overall Study|Adverse Event|5|||
33232573|NCT02670538|100753779|FG001|Overall Study|Adverse Event|5|||
33232574|NCT02670538|100753780|FG002|Overall Study|Adverse Event|11|||
33232575|NCT02670538|100753778|FG000|Overall Study|Lack of Efficacy|7|||
33574778|NCT03937479|101994299|FG001|Overall Study|Adverse Event|3|||
33574779|NCT03937479|101994300|FG002|Overall Study|Adverse Event|0|||
33574780|NCT03937479|101994301|FG003|Overall Study|Adverse Event|0|||
33574781|NCT03937479|101994302|FG004|Overall Study|Adverse Event|1|||
33137228|NCT02785770|100417192|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
33137229|NCT02785770|100417193|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
33137230|NCT02785770|100417194|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
33137231|NCT01030666|100417195|FG000|Overall Study|Lost to Follow-up|3|||
33137232|NCT01030666|100417196|FG001|Overall Study|Lost to Follow-up|2|||
33137233|NCT01853839|100417197|FG000|Overall Study|Violated inclusion criteria|2|||
33232576|NCT02670538|100753779|FG001|Overall Study|Lack of Efficacy|1|||
33232577|NCT02670538|100753780|FG002|Overall Study|Lack of Efficacy|2|||
33232578|NCT02670538|100753778|FG000|Overall Study|Protocol Violation|3|||
33232579|NCT02670538|100753779|FG001|Overall Study|Protocol Violation|4|||
33232580|NCT02670538|100753780|FG002|Overall Study|Protocol Violation|1|||
33232581|NCT02670538|100753778|FG000|Overall Study|Noncompliance with Study Drug|1|||
33232582|NCT02670538|100753779|FG001|Overall Study|Noncompliance with Study Drug|3|||
33232583|NCT02670538|100753780|FG002|Overall Study|Noncompliance with Study Drug|2|||
33232584|NCT02670538|100753778|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33232585|NCT02670538|100753779|FG001|Overall Study|Other Miscellaneous Reasons|1|||
33232586|NCT02670538|100753780|FG002|Overall Study|Other Miscellaneous Reasons|2|||
33232587|NCT04466618|100753782|FG000|Overall Study|Withdrawal by Subject|0|||
33232588|NCT04466618|100753783|FG001|Overall Study|Withdrawal by Subject|1|||
33232589|NCT02036515|100753785|FG000|Overall Study|Adverse Event|1|||
33232590|NCT02036515|100753786|FG001|Overall Study|Adverse Event|1|||
33232591|NCT02036515|100753787|FG002|Overall Study|Adverse Event|2|||
33232592|NCT02036515|100753785|FG000|Overall Study|Lost to Follow-up|0|||
33232593|NCT02036515|100753786|FG001|Overall Study|Lost to Follow-up|2|||
33232594|NCT02036515|100753787|FG002|Overall Study|Lost to Follow-up|0|||
33232595|NCT02036515|100753785|FG000|Overall Study|Non-compliance with study drug|0|||
33232596|NCT02036515|100753786|FG001|Overall Study|Non-compliance with study drug|0|||
33232597|NCT02036515|100753787|FG002|Overall Study|Non-compliance with study drug|2|||
33232598|NCT02036515|100753785|FG000|Overall Study|Screen failure|0|||
33232599|NCT02036515|100753786|FG001|Overall Study|Screen failure|2|||
33232600|NCT02036515|100753787|FG002|Overall Study|Screen failure|0|||
33232601|NCT02036515|100753785|FG000|Overall Study|Withdrawal by Subject|4|||
33232602|NCT02036515|100753786|FG001|Overall Study|Withdrawal by Subject|7|||
33232603|NCT02036515|100753787|FG002|Overall Study|Withdrawal by Subject|9|||
33232604|NCT02036515|100753785|FG000|Overall Study|Hyperglycemia|0|||
33232605|NCT02036515|100753786|FG001|Overall Study|Hyperglycemia|0|||
33232606|NCT02036515|100753787|FG002|Overall Study|Hyperglycemia|1|||
33232607|NCT03050398|100753788|FG000|Overall Study|Study terminated by sponsor|8|||
33232608|NCT01454830|100753789|FG000|Overall Study|Withdrawal by Subject|4|||
33368335|NCT01984346|101234804|FG000|Overall Study|Withdrawal by Subject|2|||
33368336|NCT01984346|101234805|FG001|Overall Study|Withdrawal by Subject|2|||
33368337|NCT01984346|101234804|FG000|Overall Study|Enrollment Closed|8|||
33368338|NCT01984346|101234805|FG001|Overall Study|Enrollment Closed|1|||
33574782|NCT03937479|101994298|FG000|Overall Study|Withdrawal by Subject|3|||
33574783|NCT03937479|101994299|FG001|Overall Study|Withdrawal by Subject|5|||
33137234|NCT01853839|100417197|FG000|Overall Study|Not meet ITT population definition|58|||
33137235|NCT01853839|100417197|FG000|Overall Study|End of treatment visit too early|33|||
33368339|NCT01984346|101234804|FG000|Overall Study|Insurance Coverage|1|||
33574784|NCT03937479|101994300|FG002|Overall Study|Withdrawal by Subject|2|||
33137236|NCT01853839|100417197|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
33137237|NCT00588861|100417198|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
33137238|NCT00588861|100417199|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
33232609|NCT01454830|100753790|FG001|Overall Study|Withdrawal by Subject|4|||
33232610|NCT01454830|100753789|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
33232611|NCT01454830|100753790|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
33232612|NCT01454830|100753789|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
33232613|NCT01454830|100753790|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
33232614|NCT01454830|100753789|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
33232615|NCT01454830|100753790|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
33368340|NCT01984346|101234805|FG001|Overall Study|Insurance Coverage|0|||
33137239|NCT00588861|100417198|FG000|6 Months|Patients did not return for follow-up|98|||
33636081|NCT04225897|102218600|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
33636082|NCT04225897|102218601|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
33636083|NCT04225897|102218602|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
33636084|NCT04225897|102218603|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
33636085|NCT04225897|102218604|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
33636086|NCT04225897|102218605|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
33636087|NCT04225897|102218606|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
33636088|NCT04225897|102218607|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
33636089|NCT04225897|102218608|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
33636090|NCT04225897|102218609|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
33137240|NCT00588861|100417199|FG001|6 Months|Patients did not return for follow-up|73|||
33232616|NCT01454830|100753789|FG000|Overall Study|Withdrawal - no polysomnography|3|||
33232617|NCT01454830|100753790|FG001|Overall Study|Withdrawal - no polysomnography|2|||
33232618|NCT00840996|100753796|FG000|Overall Study|Withdrawal by Subject|1|||
33232619|NCT00840996|100753797|FG001|Overall Study|Withdrawal by Subject|0|||
33232620|NCT01254305|100753798|FG000|Overall Study|Adverse Event|6|||
33232621|NCT01254305|100753799|FG001|Overall Study|Adverse Event|3|||
33232622|NCT01254305|100753800|FG002|Overall Study|Adverse Event|2|||
33232623|NCT01254305|100753798|FG000|Overall Study|Lack of Efficacy|1|||
33232624|NCT01254305|100753799|FG001|Overall Study|Lack of Efficacy|0|||
33232625|NCT01254305|100753800|FG002|Overall Study|Lack of Efficacy|1|||
33232626|NCT01254305|100753798|FG000|Overall Study|Protocol Violation|1|||
33232627|NCT01254305|100753799|FG001|Overall Study|Protocol Violation|7|||
33232628|NCT01254305|100753800|FG002|Overall Study|Protocol Violation|3|||
33232629|NCT01254305|100753798|FG000|Overall Study|Withdrawal by Subject|4|||
33232630|NCT01254305|100753799|FG001|Overall Study|Withdrawal by Subject|2|||
33232631|NCT01254305|100753800|FG002|Overall Study|Withdrawal by Subject|4|||
33232632|NCT01254305|100753798|FG000|Overall Study|Lost to Follow-up|10|||
33232633|NCT01254305|100753799|FG001|Overall Study|Lost to Follow-up|6|||
33232634|NCT01254305|100753800|FG002|Overall Study|Lost to Follow-up|5|||
33232635|NCT01254305|100753798|FG000|Overall Study|Other Reasons|0|||
33232636|NCT01254305|100753799|FG001|Overall Study|Other Reasons|0|||
33232637|NCT01254305|100753800|FG002|Overall Study|Other Reasons|2|||
33574785|NCT03937479|101994301|FG003|Overall Study|Withdrawal by Subject|2|||
33574786|NCT03937479|101994302|FG004|Overall Study|Withdrawal by Subject|1|||
33574787|NCT03937479|101994298|FG000|Overall Study|Protocol Violation|5|||
33574788|NCT03937479|101994299|FG001|Overall Study|Protocol Violation|6|||
33574789|NCT03937479|101994300|FG002|Overall Study|Protocol Violation|4|||
33574790|NCT03937479|101994301|FG003|Overall Study|Protocol Violation|3|||
33574791|NCT03937479|101994302|FG004|Overall Study|Protocol Violation|2|||
33574792|NCT03937479|101994298|FG000|Overall Study|Lost to Follow-up|0|||
33574793|NCT03937479|101994299|FG001|Overall Study|Lost to Follow-up|1|||
33574794|NCT03937479|101994300|FG002|Overall Study|Lost to Follow-up|0|||
33137241|NCT00588861|100417198|FG000|1 Year|Patients did not return for follow-up|89|||
33574795|NCT03937479|101994301|FG003|Overall Study|Lost to Follow-up|1|||
33574796|NCT03937479|101994302|FG004|Overall Study|Lost to Follow-up|0|||
33636091|NCT04225897|102218610|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
33137242|NCT00588861|100417199|FG001|1 Year|Patients did not return for follow-up|82|||
33137243|NCT00588861|100417198|FG000|2 Years|Patients did not return for follow-up|92|||
33137244|NCT00588861|100417199|FG001|2 Years|Patients did not return for follow-up|87|||
33137245|NCT00588861|100417198|FG000|4 Years|Patients did not return for follow-up|91|||
33137246|NCT00588861|100417199|FG001|4 Years|Patients did not return for follow-up|103|||
33137247|NCT00588861|100417198|FG000|6 Years|Patients did not return for follow-up|104|||
33137248|NCT00588861|100417199|FG001|6 Years|Patients did not return for follow-up|109|||
33137249|NCT00588861|100417198|FG000|8 Years|Patients did not return for follow-up|105|||
33232638|NCT01900054|100753804|FG000|Overall Study|Physician Decision|1|||
33232639|NCT01900054|100753804|FG000|Overall Study|Withdrawal by Subject|1|||
33232640|NCT03864926|100753805|FG000|Overall Study|Death|0|||
33232641|NCT03864926|100753806|FG001|Overall Study|Death|2|||
33232642|NCT01700348|100753807|FG000|Overall Study|Withdrawal by Subject|22|||
33232643|NCT01700348|100753807|FG000|Overall Study|Lost to Follow-up|1|||
33368341|NCT01984346|101234804|FG000|Overall Study|Intra-operative Exclusion|2|||
33368342|NCT01984346|101234805|FG001|Overall Study|Intra-operative Exclusion|0|||
33368343|NCT00804193|101234806|FG000|Overall Study|Lack of baseline fungus|32|||
33368344|NCT00804193|101234807|FG001|Overall Study|Lack of baseline fungus|31|||
33368345|NCT00804193|101234808|FG002|Overall Study|Lack of baseline fungus|19|||
33368346|NCT00804193|101234806|FG000|Overall Study|Adverse Event|0|||
33368347|NCT00804193|101234807|FG001|Overall Study|Adverse Event|0|||
33137250|NCT00588861|100417199|FG001|8 Years|Patients did not return for follow-up|114|||
33232644|NCT01729728|100753808|FG000|Overall Study|Adverse Event|0|||
33232645|NCT01729728|100753809|FG001|Overall Study|Adverse Event|6|||
33232646|NCT01729728|100753810|FG002|Overall Study|Adverse Event|0|||
33232647|NCT01729728|100753808|FG000|Overall Study|Protocol Violation|1|||
33368348|NCT00804193|101234808|FG002|Overall Study|Adverse Event|2|||
33368349|NCT00804193|101234806|FG000|Overall Study|Lack of Efficacy|1|||
33574797|NCT03937479|101994298|FG000|Overall Study|Physician Decision|0|||
33574798|NCT03937479|101994299|FG001|Overall Study|Physician Decision|0|||
33574799|NCT03937479|101994300|FG002|Overall Study|Physician Decision|1|||
33574800|NCT03937479|101994301|FG003|Overall Study|Physician Decision|0|||
33574801|NCT03937479|101994302|FG004|Overall Study|Physician Decision|1|||
33574802|NCT02655887|101994304|FG000|Overall Study|Lost to Follow-up|3|||
33574803|NCT02655887|101994304|FG000|Overall Study|Death|4|||
33574804|NCT02655887|101994304|FG000|Overall Study|Withdrawal by Subject|3|||
33368350|NCT00804193|101234807|FG001|Overall Study|Lack of Efficacy|1|||
33574805|NCT02655887|101994304|FG000|Overall Study|Missed 12-month follow-up visit|4|||
33574806|NCT00546481|101994309|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
33574807|NCT00546481|101994310|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
33574808|NCT00546481|101994311|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
33574809|NCT00546481|101994309|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
33574810|NCT00546481|101994310|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
33574811|NCT00546481|101994311|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
33574812|NCT00546481|101994309|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
33574813|NCT00546481|101994310|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
33574814|NCT00546481|101994311|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
33574815|NCT00546481|101994309|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
33574816|NCT00546481|101994310|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
33574817|NCT00546481|101994311|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
33574818|NCT00546481|101994309|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
33574819|NCT00546481|101994310|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
33574820|NCT00546481|101994311|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
33574821|NCT00546481|101994309|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
33574822|NCT00546481|101994310|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
33574823|NCT00546481|101994311|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
33574824|NCT00546481|101994309|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
33574825|NCT00546481|101994310|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
33574826|NCT00546481|101994311|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
33574827|NCT00546481|101994309|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
33574828|NCT00546481|101994310|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
33574829|NCT00546481|101994311|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
33574830|NCT00546481|101994309|FG000|Maintenance Phase (CERA)|Other Reason|0|||
33574831|NCT00546481|101994310|FG001|Maintenance Phase (CERA)|Other Reason|0|||
33574832|NCT00546481|101994311|FG002|Maintenance Phase (CERA)|Other Reason|1|||
33574833|NCT00894387|101994312|FG000|Overall Study|Adverse Event|44|||
33574834|NCT00894387|101994313|FG001|Overall Study|Adverse Event|45|||
33574835|NCT00894387|101994312|FG000|Overall Study|Abnormal Laboratory values|2|||
33574836|NCT00894387|101994313|FG001|Overall Study|Abnormal Laboratory values|2|||
33574837|NCT00894387|101994312|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33574838|NCT00894387|101994313|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33574839|NCT00894387|101994312|FG000|Overall Study|Lost to Follow-up|3|||
33574840|NCT00894387|101994313|FG001|Overall Study|Lost to Follow-up|5|||
33574841|NCT00894387|101994312|FG000|Overall Study|Administrative problems|2|||
33574842|NCT00894387|101994313|FG001|Overall Study|Administrative problems|2|||
33574843|NCT00894387|101994312|FG000|Overall Study|Death|77|||
33574844|NCT00894387|101994313|FG001|Overall Study|Death|76|||
33574845|NCT00894387|101994312|FG000|Overall Study|Protocol Deviation|4|||
33574846|NCT00894387|101994313|FG001|Overall Study|Protocol Deviation|0|||
33574847|NCT00894387|101994312|FG000|Overall Study|Patient's request|25|||
33574848|NCT00894387|101994313|FG001|Overall Study|Patient's request|30|||
33574849|NCT00894387|101994312|FG000|Overall Study|Other (Missing)|5|||
33574850|NCT00894387|101994313|FG001|Overall Study|Other (Missing)|3|||
33574851|NCT00894387|101994312|FG000|Overall Study|Mis-randomized|13|||
33574852|NCT00894387|101994313|FG001|Overall Study|Mis-randomized|9|||
33574853|NCT00894387|101994312|FG000|Overall Study|GCP non-compliance|0|||
33574854|NCT00894387|101994313|FG001|Overall Study|GCP non-compliance|2|||
33574855|NCT00402987|101994314|FG000|Overall Study|Lack of Efficacy|0|||
33574856|NCT00402987|101994315|FG001|Overall Study|Lack of Efficacy|0|||
33574857|NCT00402987|101994316|FG002|Overall Study|Lack of Efficacy|1|||
33574858|NCT00402987|101994317|FG003|Overall Study|Lack of Efficacy|0|||
33574859|NCT01193101|101994318|FG000|Overall Study|Adverse Event|0|||
33574860|NCT01193101|101994319|FG001|Overall Study|Adverse Event|1|||
33574861|NCT01193101|101994320|FG002|Overall Study|Adverse Event|1|||
33574862|NCT01193101|101994321|FG003|Overall Study|Adverse Event|3|||
33574863|NCT01193101|101994318|FG000|Overall Study|Lack of Efficacy|3|||
33574864|NCT01193101|101994319|FG001|Overall Study|Lack of Efficacy|1|||
33636092|NCT04225897|102218611|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
33574865|NCT01193101|101994320|FG002|Overall Study|Lack of Efficacy|0|||
33574866|NCT01193101|101994321|FG003|Overall Study|Lack of Efficacy|8|||
33636093|NCT04225897|102218600|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
33574867|NCT01193101|101994318|FG000|Overall Study|Withdrawal by Subject|2|||
33574868|NCT01193101|101994319|FG001|Overall Study|Withdrawal by Subject|4|||
33574869|NCT01193101|101994320|FG002|Overall Study|Withdrawal by Subject|1|||
33636094|NCT04225897|102218601|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
33636095|NCT04225897|102218602|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
33137251|NCT00588861|100417198|FG000|10 Years|Incomplete due to study termination|107|||
33137252|NCT00588861|100417199|FG001|10 Years|Incomplete due to study termination|114|||
33137253|NCT03700684|100417203|FG000|Overall Study|COVID-19|0|||
33137254|NCT03700684|100417204|FG001|Overall Study|COVID-19|0|||
33137255|NCT03700684|100417205|FG002|Overall Study|COVID-19|2|||
33137256|NCT00495040|100417206|FG000|Overall Study|Withdrawal by Subject|3|||
33636096|NCT04225897|102218603|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
33636097|NCT04225897|102218604|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
33636098|NCT04225897|102218605|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
33636099|NCT04225897|102218606|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
33137257|NCT01853618|100417207|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
33137258|NCT01853618|100417208|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
33137259|NCT01853618|100417209|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
33137260|NCT01853618|100417210|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
33636100|NCT04225897|102218607|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
33636101|NCT04225897|102218608|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
33636102|NCT04225897|102218609|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
33636103|NCT04225897|102218610|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
33636104|NCT04225897|102218611|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
33636105|NCT02153086|102218615|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
33636106|NCT02153086|102218615|FG000|Overall Study|Other|2|||
33137261|NCT01853618|100417211|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
33137262|NCT01853618|100417207|FG000|Overall Study|Progressive disease|1|||
33137263|NCT01853618|100417208|FG001|Overall Study|Progressive disease|1|||
33636107|NCT01353898|102218616|FG000|Overall Study|Study site terminated|0|||
33636108|NCT01353898|102218617|FG001|Overall Study|Study site terminated|0|||
33636109|NCT01353898|102218618|FG002|Overall Study|Study site terminated|0|||
33636110|NCT01353898|102218619|FG003|Overall Study|Study site terminated|0|||
33636111|NCT01353898|102218620|FG004|Overall Study|Study site terminated|0|||
33636112|NCT01353898|102218621|FG005|Overall Study|Study site terminated|1|||
33137264|NCT01853618|100417209|FG002|Overall Study|Progressive disease|1|||
33137265|NCT01853618|100417210|FG003|Overall Study|Progressive disease|1|||
33137266|NCT01853618|100417211|FG004|Overall Study|Progressive disease|2|||
33137267|NCT01853618|100417207|FG000|Overall Study|Physician Decision|0|||
33137268|NCT01853618|100417208|FG001|Overall Study|Physician Decision|1|||
33137269|NCT01853618|100417209|FG002|Overall Study|Physician Decision|1|||
33137270|NCT01853618|100417210|FG003|Overall Study|Physician Decision|0|||
33137271|NCT01853618|100417211|FG004|Overall Study|Physician Decision|0|||
33137272|NCT01853618|100417207|FG000|Overall Study|Refused further treatment|0|||
33137273|NCT01853618|100417208|FG001|Overall Study|Refused further treatment|0|||
33137274|NCT01853618|100417209|FG002|Overall Study|Refused further treatment|0|||
33232648|NCT01729728|100753809|FG001|Overall Study|Protocol Violation|0|||
33232649|NCT01729728|100753810|FG002|Overall Study|Protocol Violation|1|||
33232650|NCT02087150|100753811|FG000|Overall Study|Death|0|||
33232651|NCT02087150|100753812|FG001|Overall Study|Death|1|||
33574870|NCT01193101|101994321|FG003|Overall Study|Withdrawal by Subject|1|||
33574871|NCT01193101|101994318|FG000|Overall Study|Administrative problems|0|||
33574872|NCT01193101|101994319|FG001|Overall Study|Administrative problems|0|||
33574873|NCT01193101|101994320|FG002|Overall Study|Administrative problems|1|||
33574874|NCT01193101|101994321|FG003|Overall Study|Administrative problems|0|||
33574875|NCT01193101|101994318|FG000|Overall Study|Abnormal test procedure results|0|||
33574876|NCT01193101|101994319|FG001|Overall Study|Abnormal test procedure results|1|||
33574877|NCT01193101|101994320|FG002|Overall Study|Abnormal test procedure results|0|||
33574878|NCT01193101|101994321|FG003|Overall Study|Abnormal test procedure results|0|||
33574879|NCT01173679|101994325|FG000|Overall Study|Death|1|||
33574880|NCT03571971|101994326|FG000|Overall Study|Lost to Follow-up|2|||
33574881|NCT03571971|101994327|FG001|Overall Study|Lost to Follow-up|2|||
33574882|NCT03571971|101994326|FG000|Overall Study|Protocol Violation|2|||
33574883|NCT03571971|101994327|FG001|Overall Study|Protocol Violation|3|||
33574884|NCT03571971|101994326|FG000|Overall Study|Withdrawal by Subject|2|||
33574885|NCT03571971|101994327|FG001|Overall Study|Withdrawal by Subject|0|||
33574886|NCT03571971|101994326|FG000|Overall Study|Incomplete primary outcome data|2|||
33574887|NCT03571971|101994327|FG001|Overall Study|Incomplete primary outcome data|0|||
33574888|NCT03179761|101994328|FG000|Overall Study|Death|2|||
33574889|NCT03179761|101994329|FG001|Overall Study|Death|5|||
33232652|NCT02087150|100753813|FG002|Overall Study|Death|0|||
33137275|NCT01853618|100417210|FG003|Overall Study|Refused further treatment|0|||
33574890|NCT03179761|101994328|FG000|Overall Study|Lost to Follow-up|2|||
33574891|NCT03179761|101994329|FG001|Overall Study|Lost to Follow-up|2|||
33574892|NCT03179761|101994328|FG000|Overall Study|Protocol Violation|1|||
33574893|NCT03179761|101994329|FG001|Overall Study|Protocol Violation|0|||
33574894|NCT03179761|101994328|FG000|Overall Study|Withdrawal by Subject|1|||
33574895|NCT03179761|101994329|FG001|Overall Study|Withdrawal by Subject|4|||
33574896|NCT03179761|101994328|FG000|Overall Study|Investigator Request|0|||
33574897|NCT03179761|101994329|FG001|Overall Study|Investigator Request|2|||
33574898|NCT00069641|101994332|FG000|Overall Study|Death|1|||
33574899|NCT00069641|101994333|FG001|Overall Study|Death|0|||
33574900|NCT00069641|101994334|FG002|Overall Study|Death|1|||
33574901|NCT01932788|101994335|FG000|Overall Study|Protocol Violation|18|||
33574902|NCT01932788|101994336|FG001|Overall Study|Protocol Violation|0|||
33574903|NCT01932788|101994335|FG000|Overall Study|Lost to Follow-up|18|||
33574904|NCT01932788|101994336|FG001|Overall Study|Lost to Follow-up|46|||
33574905|NCT01932788|101994335|FG000|Overall Study|Lack of Efficacy|2|||
33574906|NCT01932788|101994336|FG001|Overall Study|Lack of Efficacy|0|||
33574907|NCT01932788|101994335|FG000|Overall Study|Withdrawal by Subject|0|||
33574908|NCT01932788|101994336|FG001|Overall Study|Withdrawal by Subject|5|||
33574909|NCT03384875|101994339|FG000|Overall Study|Death|1|||
33574910|NCT03384875|101994340|FG001|Overall Study|Death|1|||
33574911|NCT03384875|101994341|FG002|Overall Study|Death|0|||
33574912|NCT03384875|101994339|FG000|Overall Study|Reason not provided|1|||
33574913|NCT03384875|101994340|FG001|Overall Study|Reason not provided|0|||
33574914|NCT03384875|101994341|FG002|Overall Study|Reason not provided|0|||
33574915|NCT00454116|101994344|FG000|Overall Study|Adverse Event|5|||
33574916|NCT00454116|101994345|FG001|Overall Study|Adverse Event|11|||
33574917|NCT00454116|101994346|FG002|Overall Study|Adverse Event|9|||
33574918|NCT00454116|101994344|FG000|Overall Study|Condition under investigation worsened|17|||
33574919|NCT00454116|101994345|FG001|Overall Study|Condition under investigation worsened|13|||
33574920|NCT00454116|101994346|FG002|Overall Study|Condition under investigation worsened|18|||
33574921|NCT00454116|101994344|FG000|Overall Study|Withdrawal by Subject|3|||
33574922|NCT00454116|101994345|FG001|Overall Study|Withdrawal by Subject|3|||
33232653|NCT02087150|100753811|FG000|Overall Study|Lost to Follow-up|6|||
33574923|NCT00454116|101994346|FG002|Overall Study|Withdrawal by Subject|1|||
33574924|NCT00454116|101994344|FG000|Overall Study|Other|2|||
33574925|NCT00454116|101994345|FG001|Overall Study|Other|2|||
33574926|NCT00454116|101994346|FG002|Overall Study|Other|0|||
33574927|NCT01242514|101994347|FG000|Overall Study|e.g., project closure|1042|||
33574928|NCT01242514|101994348|FG001|Overall Study|e.g., project closure|305|||
33137276|NCT01853618|100417211|FG004|Overall Study|Refused further treatment|1|||
33137277|NCT01989468|100417212|FG000|Overall Study|Adverse Event|10|||
33137278|NCT01989468|100417213|FG001|Overall Study|Adverse Event|15|||
33137279|NCT01989468|100417214|FG002|Overall Study|Adverse Event|4|||
33137280|NCT01989468|100417215|FG003|Overall Study|Adverse Event|5|||
33137281|NCT01989468|100417216|FG004|Overall Study|Adverse Event|4|||
33137282|NCT01989468|100417212|FG000|Overall Study|Lack of Efficacy|11|||
33137283|NCT01989468|100417213|FG001|Overall Study|Lack of Efficacy|11|||
33137284|NCT01989468|100417214|FG002|Overall Study|Lack of Efficacy|7|||
33137285|NCT01989468|100417215|FG003|Overall Study|Lack of Efficacy|4|||
33137286|NCT01989468|100417216|FG004|Overall Study|Lack of Efficacy|2|||
33137287|NCT01989468|100417212|FG000|Overall Study|Lost to Follow-up|5|||
33137288|NCT01989468|100417213|FG001|Overall Study|Lost to Follow-up|2|||
33137289|NCT01989468|100417214|FG002|Overall Study|Lost to Follow-up|0|||
33137290|NCT01989468|100417215|FG003|Overall Study|Lost to Follow-up|1|||
33137291|NCT01989468|100417216|FG004|Overall Study|Lost to Follow-up|1|||
33137292|NCT01989468|100417212|FG000|Overall Study|Physician Decision|4|||
33137293|NCT01989468|100417213|FG001|Overall Study|Physician Decision|1|||
33137294|NCT01989468|100417214|FG002|Overall Study|Physician Decision|0|||
33137295|NCT01989468|100417215|FG003|Overall Study|Physician Decision|1|||
33137296|NCT01989468|100417216|FG004|Overall Study|Physician Decision|0|||
33137297|NCT01989468|100417212|FG000|Overall Study|Pregnancy|0|||
33137298|NCT01989468|100417213|FG001|Overall Study|Pregnancy|1|||
33137299|NCT01989468|100417214|FG002|Overall Study|Pregnancy|0|||
33137300|NCT01989468|100417215|FG003|Overall Study|Pregnancy|0|||
33137301|NCT01989468|100417216|FG004|Overall Study|Pregnancy|0|||
33137302|NCT01989468|100417212|FG000|Overall Study|Technical Problems|3|||
33137303|NCT01989468|100417213|FG001|Overall Study|Technical Problems|1|||
33137304|NCT01989468|100417214|FG002|Overall Study|Technical Problems|3|||
33137305|NCT01989468|100417215|FG003|Overall Study|Technical Problems|1|||
33137306|NCT01989468|100417216|FG004|Overall Study|Technical Problems|0|||
33232654|NCT02087150|100753812|FG001|Overall Study|Lost to Follow-up|13|||
33137307|NCT01989468|100417212|FG000|Overall Study|Subject Guardian Decision|11|||
33137308|NCT01989468|100417213|FG001|Overall Study|Subject Guardian Decision|6|||
33137309|NCT01989468|100417214|FG002|Overall Study|Subject Guardian Decision|4|||
33137310|NCT01989468|100417215|FG003|Overall Study|Subject Guardian Decision|4|||
33137311|NCT01989468|100417216|FG004|Overall Study|Subject Guardian Decision|1|||
33137312|NCT01989468|100417212|FG000|Overall Study|Death|3|||
33137313|NCT01989468|100417213|FG001|Overall Study|Death|0|||
33574929|NCT01242514|101994349|FG002|Overall Study|e.g., project closure|171|||
33574930|NCT01242514|101994347|FG000|Overall Study|Subject decision|33|||
33574931|NCT01242514|101994348|FG001|Overall Study|Subject decision|8|||
33574932|NCT01242514|101994349|FG002|Overall Study|Subject decision|2|||
33574933|NCT01242514|101994347|FG000|Overall Study|Severe non-compliance to protocol|5|||
33574934|NCT01242514|101994348|FG001|Overall Study|Severe non-compliance to protocol|2|||
33574935|NCT01242514|101994349|FG002|Overall Study|Severe non-compliance to protocol|1|||
33574936|NCT01242514|101994347|FG000|Overall Study|Lack of therapeutic response|99|||
33574937|NCT01242514|101994348|FG001|Overall Study|Lack of therapeutic response|16|||
33574938|NCT01242514|101994349|FG002|Overall Study|Lack of therapeutic response|10|||
33574939|NCT01242514|101994347|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
33574940|NCT01242514|101994348|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
33574941|NCT01242514|101994349|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
33574942|NCT01242514|101994347|FG000|Overall Study|Lost to Follow-up|14|||
33574943|NCT01242514|101994348|FG001|Overall Study|Lost to Follow-up|5|||
33574944|NCT01242514|101994349|FG002|Overall Study|Lost to Follow-up|4|||
33574945|NCT01242514|101994347|FG000|Overall Study|Adverse Event|129|||
33574946|NCT01242514|101994348|FG001|Overall Study|Adverse Event|18|||
33574947|NCT01242514|101994349|FG002|Overall Study|Adverse Event|19|||
33368351|NCT00804193|101234808|FG002|Overall Study|Lack of Efficacy|3|||
33368352|NCT00804193|101234806|FG000|Overall Study|Protocol Violation|0|||
33368353|NCT00804193|101234807|FG001|Overall Study|Protocol Violation|8|||
33368354|NCT00804193|101234808|FG002|Overall Study|Protocol Violation|2|||
33420261|NCT01393626|101428565|FG003|Overall Study|Adverse Event|0|||
33574948|NCT03097289|101994350|FG000|Overall Study|Adverse Event|1|||
33574949|NCT03097289|101994350|FG000|Overall Study|Equipment failure|2|||
33574950|NCT03097289|101994350|FG000|Overall Study|Collected platelet product unusable|3|||
33636113|NCT02007096|102218622|FG000|Overall Study|medication not available|2|||
33636114|NCT02007096|102218623|FG001|Overall Study|medication not available|0|||
33636115|NCT02007096|102218622|FG000|Overall Study|did not inject saline|0|||
33636116|NCT02007096|102218623|FG001|Overall Study|did not inject saline|3|||
33636117|NCT02007096|102218622|FG000|Overall Study|did not follow postoperative protocol|8|||
33636118|NCT02007096|102218623|FG001|Overall Study|did not follow postoperative protocol|11|||
33636119|NCT02007096|102218622|FG000|Overall Study|converted to open surgery|1|||
33636120|NCT02007096|102218623|FG001|Overall Study|converted to open surgery|1|||
33636121|NCT02007096|102218622|FG000|Overall Study|no mesh placed|0|||
33636122|NCT02007096|102218623|FG001|Overall Study|no mesh placed|1|||
33636123|NCT00321620|102218624|FG000|Overall Study|Death|269|||
33636124|NCT00321620|102218625|FG001|Overall Study|Death|294|||
33636125|NCT00321620|102218624|FG000|Overall Study|Withdrawal by Subject|164|||
33636126|NCT00321620|102218625|FG001|Overall Study|Withdrawal by Subject|147|||
33636127|NCT00321620|102218624|FG000|Overall Study|Disease progression|113|||
33636128|NCT00321620|102218625|FG001|Overall Study|Disease progression|117|||
33636129|NCT00321620|102218624|FG000|Overall Study|Adverse Event|43|||
33636130|NCT00321620|102218625|FG001|Overall Study|Adverse Event|56|||
33636131|NCT00321620|102218624|FG000|Overall Study|Lost to Follow-up|13|||
33636132|NCT00321620|102218625|FG001|Overall Study|Lost to Follow-up|9|||
33636133|NCT00321620|102218624|FG000|Overall Study|Physician Decision|4|||
33636134|NCT00321620|102218625|FG001|Overall Study|Physician Decision|1|||
33636135|NCT00321620|102218624|FG000|Overall Study|Noncompliance|14|||
33636136|NCT00321620|102218625|FG001|Overall Study|Noncompliance|7|||
33636137|NCT00321620|102218624|FG000|Overall Study|Protocol deviation|4|||
33636138|NCT00321620|102218625|FG001|Overall Study|Protocol deviation|3|||
33636139|NCT00321620|102218624|FG000|Overall Study|Ineligibility determined|2|||
33636140|NCT00321620|102218625|FG001|Overall Study|Ineligibility determined|3|||
33636141|NCT00321620|102218624|FG000|Overall Study|Participant request|75|||
33636142|NCT00321620|102218625|FG001|Overall Study|Participant request|52|||
33636143|NCT00321620|102218624|FG000|Overall Study|Other|42|||
33636144|NCT00321620|102218625|FG001|Overall Study|Other|33|||
33636145|NCT01189032|102218628|FG000|Overall Study|Adverse Event|1|||
33636146|NCT01189032|102218629|FG001|Overall Study|Adverse Event|3|||
33636147|NCT01189032|102218630|FG002|Overall Study|Adverse Event|4|||
33636148|NCT01189032|102218628|FG000|Overall Study|Lack of Efficacy|2|||
33636149|NCT01189032|102218629|FG001|Overall Study|Lack of Efficacy|3|||
33636150|NCT01189032|102218630|FG002|Overall Study|Lack of Efficacy|0|||
33636151|NCT01189032|102218628|FG000|Overall Study|Withdrawal by Subject|1|||
33636152|NCT01189032|102218629|FG001|Overall Study|Withdrawal by Subject|0|||
33636153|NCT01189032|102218630|FG002|Overall Study|Withdrawal by Subject|1|||
33636154|NCT01189032|102218628|FG000|Overall Study|Protocol Violation|1|||
33368355|NCT00804193|101234806|FG000|Overall Study|Lost to Follow-up|3|||
33368356|NCT00804193|101234807|FG001|Overall Study|Lost to Follow-up|3|||
33368357|NCT00804193|101234808|FG002|Overall Study|Lost to Follow-up|4|||
33368358|NCT00804193|101234806|FG000|Overall Study|Withdrawal by Subject|3|||
33368359|NCT00804193|101234807|FG001|Overall Study|Withdrawal by Subject|1|||
33368360|NCT00804193|101234808|FG002|Overall Study|Withdrawal by Subject|2|||
33368361|NCT00222729|101234809|FG000|Overall Study|Adverse Event|3|||
33368362|NCT01963117|101234811|FG000|Overall Study|Death|1|||
33368363|NCT00532948|101234814|FG000|Overall Study|Protocol Violation|1|||
33574951|NCT00583219|101996468|FG000|Phase 2|Withdrawal by Subject|1|||
33636155|NCT01189032|102218629|FG001|Overall Study|Protocol Violation|1|||
33636156|NCT01189032|102218630|FG002|Overall Study|Protocol Violation|1|||
33137314|NCT01989468|100417214|FG002|Overall Study|Death|1|||
33137315|NCT01989468|100417215|FG003|Overall Study|Death|0|||
33137316|NCT01989468|100417216|FG004|Overall Study|Death|0|||
33137317|NCT00393510|100417217|FG000|Overall Study|Physician Decision|3|||
33137318|NCT00393510|100417218|FG001|Overall Study|Physician Decision|9|||
33137319|NCT02730793|100417221|FG000|Overall Study|Physician Decision|0|||
33137320|NCT02730793|100417222|FG001|Overall Study|Physician Decision|1|||
33636157|NCT04434937|102218631|FG000|Overall Study|Death|4|||
33137321|NCT02730793|100417221|FG000|Overall Study|Withdrawal by Subject|0|||
33137322|NCT02730793|100417222|FG001|Overall Study|Withdrawal by Subject|1|||
33137323|NCT01806662|100417223|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
33137324|NCT01806662|100417224|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
33137325|NCT01806662|100417223|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
33137326|NCT01806662|100417224|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
33137327|NCT01806662|100417223|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
33137328|NCT01806662|100417224|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
33137329|NCT01806662|100417223|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
33137330|NCT01806662|100417224|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
33137331|NCT01144299|100417225|FG000|Overall Study|Lost to Follow-up|1|||
33137332|NCT01144299|100417226|FG001|Overall Study|Lost to Follow-up|0|||
33137333|NCT01144299|100417225|FG000|Overall Study|Withdrawal by Subject|1|||
33137334|NCT01144299|100417226|FG001|Overall Study|Withdrawal by Subject|0|||
33137335|NCT00934843|100417227|FG000|Overall Study|Protocol Violation|0|||
33137336|NCT00934843|100417228|FG001|Overall Study|Protocol Violation|1|||
33137337|NCT00357760|100417229|FG000|Overall Study|Disease progression|44|||
33137338|NCT00357760|100417230|FG001|Overall Study|Disease progression|17|||
33137339|NCT00357760|100417229|FG000|Overall Study|Adverse Event|10|||
33137340|NCT00357760|100417230|FG001|Overall Study|Adverse Event|7|||
33137341|NCT00357760|100417229|FG000|Overall Study|Death|0|||
33137342|NCT00357760|100417230|FG001|Overall Study|Death|3|||
33137343|NCT00357760|100417229|FG000|Overall Study|Alternative therapy|1|||
33137344|NCT00357760|100417230|FG001|Overall Study|Alternative therapy|0|||
33137345|NCT00357760|100417229|FG000|Overall Study|Withdrawal by Subject|0|||
33137346|NCT00357760|100417230|FG001|Overall Study|Withdrawal by Subject|2|||
33137347|NCT00357760|100417229|FG000|Overall Study|Never started treatment|2|||
33137348|NCT00357760|100417230|FG001|Overall Study|Never started treatment|1|||
33137349|NCT00357760|100417229|FG000|Overall Study|Ineligible|0|||
33420262|NCT01393626|101428562|FG000|Overall Study|Did not meet entrance criteria|1|||
33636158|NCT04434937|102218631|FG000|Overall Study|Withdrawal by Subject|1|||
33636159|NCT04434937|102218631|FG000|Overall Study|Transitioned to Rollover Study|19|||
33636160|NCT04434937|102218631|FG000|Overall Study|Progressive Disease|18|||
33636161|NCT01967940|102218632|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
33636162|NCT01967940|102218633|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
33636163|NCT01967940|102218634|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
33636164|NCT01967940|102218635|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
33636165|NCT01967940|102218632|FG000|Part 2|Adverse Event|0|||
33636166|NCT01967940|102218633|FG001|Part 2|Adverse Event|0|||
33636167|NCT01967940|102218634|FG002|Part 2|Adverse Event|0|||
33636168|NCT01967940|102218635|FG003|Part 2|Adverse Event|1|||
33636169|NCT01967940|102218632|FG000|Part 2|Unknown Reason|0|||
33636170|NCT01967940|102218633|FG001|Part 2|Unknown Reason|0|||
33636171|NCT01967940|102218634|FG002|Part 2|Unknown Reason|0|||
33636172|NCT01967940|102218635|FG003|Part 2|Unknown Reason|1|||
33636173|NCT01389596|102218636|FG000|Overall Study|Protocol Violation|3|||
33636174|NCT01389596|102218637|FG001|Overall Study|Protocol Violation|4|||
33636175|NCT01389596|102218638|FG002|Overall Study|Protocol Violation|3|||
33636176|NCT01389596|102218636|FG000|Overall Study|Withdrawal by Subject|1|||
33636177|NCT01389596|102218637|FG001|Overall Study|Withdrawal by Subject|2|||
33636178|NCT01389596|102218638|FG002|Overall Study|Withdrawal by Subject|2|||
33636179|NCT01389596|102218636|FG000|Overall Study|Insufficient Clinical Response|3|||
33137350|NCT00357760|100417230|FG001|Overall Study|Ineligible|2|||
33137351|NCT00357760|100417229|FG000|Overall Study|Physician Decision|2|||
33137352|NCT00357760|100417230|FG001|Overall Study|Physician Decision|1|||
33137353|NCT00357760|100417229|FG000|Overall Study|Protocol Violation|0|||
33636180|NCT01389596|102218637|FG001|Overall Study|Insufficient Clinical Response|4|||
33636181|NCT01389596|102218638|FG002|Overall Study|Insufficient Clinical Response|5|||
33636182|NCT01389596|102218636|FG000|Overall Study|Adverse Event|1|||
33636183|NCT01389596|102218637|FG001|Overall Study|Adverse Event|4|||
33636184|NCT01389596|102218638|FG002|Overall Study|Adverse Event|0|||
33636185|NCT01389596|102218636|FG000|Overall Study|Death|0|||
33137354|NCT00357760|100417230|FG001|Overall Study|Protocol Violation|1|||
33137355|NCT00357760|100417229|FG000|Overall Study|To receive hospice care|0|||
33137356|NCT00357760|100417230|FG001|Overall Study|To receive hospice care|1|||
33636186|NCT01389596|102218637|FG001|Overall Study|Death|1|||
33137357|NCT01217307|100417234|FG000|Overall Study|Withdrawal by Subject|0|||
33137358|NCT01217307|100417235|FG001|Overall Study|Withdrawal by Subject|1|||
33137359|NCT03751657|100417236|FG000|Overall Study|Physician Decision|0|||
33137360|NCT03751657|100417237|FG001|Overall Study|Physician Decision|1|||
33137361|NCT03751657|100417236|FG000|Overall Study|Withdrawal by Subject|1|||
33137362|NCT03751657|100417237|FG001|Overall Study|Withdrawal by Subject|1|||
33137363|NCT03751657|100417236|FG000|Overall Study|Lost to Follow-up|2|||
33137364|NCT03751657|100417237|FG001|Overall Study|Lost to Follow-up|1|||
33137365|NCT02207946|100417243|FG000|Overall Study|Lost to Follow-up|1|||
33232655|NCT02087150|100753813|FG002|Overall Study|Lost to Follow-up|7|||
33232656|NCT02087150|100753811|FG000|Overall Study|Withdrawal by Subject|2|||
33232657|NCT02087150|100753812|FG001|Overall Study|Withdrawal by Subject|5|||
33232658|NCT02087150|100753813|FG002|Overall Study|Withdrawal by Subject|3|||
33232659|NCT02087150|100753811|FG000|Overall Study|Physician Decision|0|||
33232660|NCT02087150|100753812|FG001|Overall Study|Physician Decision|1|||
33232661|NCT02087150|100753813|FG002|Overall Study|Physician Decision|0|||
33232662|NCT02087150|100753811|FG000|Overall Study|Procedure not done|1|||
33232663|NCT02087150|100753812|FG001|Overall Study|Procedure not done|13|||
33232664|NCT02087150|100753813|FG002|Overall Study|Procedure not done|0|||
33232665|NCT02087150|100753811|FG000|Overall Study|F/U not completed w/in study window|0|||
33232666|NCT02087150|100753812|FG001|Overall Study|F/U not completed w/in study window|0|||
33232667|NCT02087150|100753813|FG002|Overall Study|F/U not completed w/in study window|1|||
33232668|NCT02087150|100753811|FG000|Overall Study|Other|1|||
33232669|NCT02087150|100753812|FG001|Overall Study|Other|0|||
33232670|NCT02087150|100753813|FG002|Overall Study|Other|0|||
33232671|NCT02087150|100753811|FG000|Overall Study|Pt moved out of town|0|||
33232672|NCT02087150|100753812|FG001|Overall Study|Pt moved out of town|1|||
33232673|NCT02087150|100753813|FG002|Overall Study|Pt moved out of town|0|||
33232674|NCT01734850|100753817|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
33232675|NCT01734850|100753818|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
33232676|NCT01734850|100753819|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
33232677|NCT01734850|100753817|FG000|Overall Study|Not infused due to manufacturing failure|0|||
33232678|NCT01734850|100753818|FG001|Overall Study|Not infused due to manufacturing failure|0|||
33232679|NCT01734850|100753819|FG002|Overall Study|Not infused due to manufacturing failure|1|||
33232680|NCT03580356|100753823|FG000|Treatment Period|Withdrawal by Subject|13|||
33232681|NCT03580356|100753824|FG001|Treatment Period|Withdrawal by Subject|0|||
33232682|NCT03580356|100753825|FG002|Treatment Period|Withdrawal by Subject|13|||
33232683|NCT03580356|100753826|FG003|Treatment Period|Withdrawal by Subject|1|||
33232684|NCT03580356|100753827|FG004|Treatment Period|Withdrawal by Subject|17|||
33232685|NCT03580356|100753828|FG005|Treatment Period|Withdrawal by Subject|0|||
33232686|NCT03580356|100753829|FG006|Treatment Period|Withdrawal by Subject|5|||
33232687|NCT03580356|100753830|FG007|Treatment Period|Withdrawal by Subject|0|||
33232688|NCT03580356|100753823|FG000|Treatment Period|Adverse Event|10|||
33232689|NCT03580356|100753824|FG001|Treatment Period|Adverse Event|0|||
33232690|NCT03580356|100753825|FG002|Treatment Period|Adverse Event|13|||
33232691|NCT03580356|100753826|FG003|Treatment Period|Adverse Event|0|||
33232692|NCT03580356|100753827|FG004|Treatment Period|Adverse Event|5|||
33232693|NCT03580356|100753828|FG005|Treatment Period|Adverse Event|0|||
33232694|NCT03580356|100753829|FG006|Treatment Period|Adverse Event|8|||
33232695|NCT03580356|100753830|FG007|Treatment Period|Adverse Event|0|||
33232696|NCT03580356|100753823|FG000|Treatment Period|Protocol Violation|5|||
33232697|NCT03580356|100753824|FG001|Treatment Period|Protocol Violation|0|||
33232698|NCT03580356|100753825|FG002|Treatment Period|Protocol Violation|6|||
33232699|NCT03580356|100753826|FG003|Treatment Period|Protocol Violation|1|||
33232700|NCT03580356|100753827|FG004|Treatment Period|Protocol Violation|9|||
33232701|NCT03580356|100753828|FG005|Treatment Period|Protocol Violation|1|||
33232702|NCT03580356|100753829|FG006|Treatment Period|Protocol Violation|1|||
33232703|NCT03580356|100753830|FG007|Treatment Period|Protocol Violation|0|||
33232704|NCT03580356|100753823|FG000|Treatment Period|Lack of Efficacy|6|||
33232705|NCT03580356|100753824|FG001|Treatment Period|Lack of Efficacy|0|||
33232706|NCT03580356|100753825|FG002|Treatment Period|Lack of Efficacy|2|||
33232707|NCT03580356|100753826|FG003|Treatment Period|Lack of Efficacy|0|||
33137366|NCT02207946|100417244|FG001|Overall Study|Lost to Follow-up|0|||
33137367|NCT02207946|100417243|FG000|Overall Study|Adverse Event|0|||
33232708|NCT03580356|100753827|FG004|Treatment Period|Lack of Efficacy|3|||
33232709|NCT03580356|100753828|FG005|Treatment Period|Lack of Efficacy|0|||
33232710|NCT03580356|100753829|FG006|Treatment Period|Lack of Efficacy|3|||
33232711|NCT03580356|100753830|FG007|Treatment Period|Lack of Efficacy|0|||
33232712|NCT03580356|100753823|FG000|Treatment Period|Pregnancy|1|||
33232713|NCT03580356|100753824|FG001|Treatment Period|Pregnancy|0|||
33232714|NCT03580356|100753825|FG002|Treatment Period|Pregnancy|7|||
33232715|NCT03580356|100753826|FG003|Treatment Period|Pregnancy|0|||
33232716|NCT03580356|100753827|FG004|Treatment Period|Pregnancy|2|||
33232717|NCT03580356|100753828|FG005|Treatment Period|Pregnancy|0|||
33368364|NCT00532948|101234815|FG001|Overall Study|Protocol Violation|0|||
33137368|NCT02207946|100417244|FG001|Overall Study|Adverse Event|1|||
33137369|NCT02880956|100417246|FG000|Overall Study|Adverse Event|3|||
33232718|NCT03580356|100753829|FG006|Treatment Period|Pregnancy|1|||
33232719|NCT03580356|100753830|FG007|Treatment Period|Pregnancy|0|||
33232720|NCT03580356|100753823|FG000|Treatment Period|Physician Decision|2|||
33232721|NCT03580356|100753824|FG001|Treatment Period|Physician Decision|0|||
33232722|NCT03580356|100753825|FG002|Treatment Period|Physician Decision|1|||
33232723|NCT03580356|100753826|FG003|Treatment Period|Physician Decision|0|||
33232724|NCT03580356|100753827|FG004|Treatment Period|Physician Decision|4|||
33232725|NCT03580356|100753828|FG005|Treatment Period|Physician Decision|0|||
33232726|NCT03580356|100753829|FG006|Treatment Period|Physician Decision|2|||
33232727|NCT03580356|100753830|FG007|Treatment Period|Physician Decision|0|||
33232728|NCT03580356|100753823|FG000|Treatment Period|Lost to Follow-up|1|||
33232729|NCT03580356|100753824|FG001|Treatment Period|Lost to Follow-up|1|||
33232730|NCT03580356|100753825|FG002|Treatment Period|Lost to Follow-up|1|||
33232731|NCT03580356|100753826|FG003|Treatment Period|Lost to Follow-up|0|||
33232732|NCT03580356|100753827|FG004|Treatment Period|Lost to Follow-up|3|||
33232733|NCT03580356|100753828|FG005|Treatment Period|Lost to Follow-up|0|||
33232734|NCT03580356|100753829|FG006|Treatment Period|Lost to Follow-up|1|||
33232735|NCT03580356|100753830|FG007|Treatment Period|Lost to Follow-up|0|||
33232736|NCT03580356|100753823|FG000|Treatment Period|Death|0|||
33232737|NCT03580356|100753824|FG001|Treatment Period|Death|0|||
33232738|NCT03580356|100753825|FG002|Treatment Period|Death|1|||
33232739|NCT03580356|100753826|FG003|Treatment Period|Death|0|||
33232740|NCT03580356|100753827|FG004|Treatment Period|Death|0|||
33232741|NCT03580356|100753828|FG005|Treatment Period|Death|0|||
33232742|NCT03580356|100753829|FG006|Treatment Period|Death|0|||
33232743|NCT03580356|100753830|FG007|Treatment Period|Death|0|||
33232744|NCT03580356|100753823|FG000|Treatment Period|Technical problems|0|||
33232745|NCT03580356|100753824|FG001|Treatment Period|Technical problems|0|||
33232746|NCT03580356|100753825|FG002|Treatment Period|Technical problems|0|||
33232747|NCT03580356|100753826|FG003|Treatment Period|Technical problems|0|||
33232748|NCT03580356|100753827|FG004|Treatment Period|Technical problems|1|||
33232749|NCT03580356|100753828|FG005|Treatment Period|Technical problems|0|||
33232750|NCT03580356|100753829|FG006|Treatment Period|Technical problems|0|||
33232751|NCT03580356|100753830|FG007|Treatment Period|Technical problems|0|||
33232752|NCT03580356|100753823|FG000|Treatment Period|Misrandomized, no treatment|0|||
33232753|NCT03580356|100753824|FG001|Treatment Period|Misrandomized, no treatment|0|||
33232754|NCT03580356|100753825|FG002|Treatment Period|Misrandomized, no treatment|1|||
33232755|NCT03580356|100753826|FG003|Treatment Period|Misrandomized, no treatment|0|||
33232756|NCT03580356|100753827|FG004|Treatment Period|Misrandomized, no treatment|2|||
33232757|NCT03580356|100753828|FG005|Treatment Period|Misrandomized, no treatment|0|||
33232758|NCT03580356|100753829|FG006|Treatment Period|Misrandomized, no treatment|0|||
33232759|NCT03580356|100753830|FG007|Treatment Period|Misrandomized, no treatment|0|||
33232760|NCT03580356|100753823|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
33232761|NCT03580356|100753824|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
33232762|NCT03580356|100753825|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
33232763|NCT03580356|100753826|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
33232764|NCT03580356|100753827|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
33232765|NCT03580356|100753828|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
33232766|NCT03580356|100753829|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
33232767|NCT03580356|100753830|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
33232768|NCT03580356|100753823|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
33232769|NCT03580356|100753824|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
33232770|NCT03580356|100753825|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
33232771|NCT03580356|100753826|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
33232772|NCT03580356|100753827|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
33232773|NCT03580356|100753828|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
33232774|NCT03580356|100753829|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
33232775|NCT03580356|100753830|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
33232776|NCT03580356|100753823|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
33232777|NCT03580356|100753824|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
33232778|NCT03580356|100753825|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
33232779|NCT03580356|100753826|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
33232780|NCT03580356|100753827|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
33232781|NCT03580356|100753828|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
33232782|NCT03580356|100753829|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
33232783|NCT03580356|100753830|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
33232784|NCT03580356|100753823|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
33368365|NCT00532948|101234816|FG002|Overall Study|Protocol Violation|0|||
33368366|NCT00532948|101234814|FG000|Overall Study|Death|3|||
33232785|NCT03580356|100753824|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
33232786|NCT03580356|100753825|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
33368367|NCT00532948|101234815|FG001|Overall Study|Death|3|||
33368368|NCT00532948|101234816|FG002|Overall Study|Death|4|||
33420263|NCT01393626|101428563|FG001|Overall Study|Did not meet entrance criteria|0|||
33232787|NCT03580356|100753826|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
33232788|NCT03580356|100753827|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
33368369|NCT00532948|101234814|FG000|Overall Study|Violation of selection criteria at entry|0|||
33137370|NCT02880956|100417247|FG001|Overall Study|Adverse Event|6|||
33137371|NCT02880956|100417248|FG002|Overall Study|Adverse Event|5|||
33137372|NCT02880956|100417249|FG003|Overall Study|Adverse Event|4|||
33137373|NCT02880956|100417246|FG000|Overall Study|Withdrawal by Subject|9|||
33137374|NCT02880956|100417247|FG001|Overall Study|Withdrawal by Subject|4|||
33137375|NCT02880956|100417248|FG002|Overall Study|Withdrawal by Subject|6|||
33137376|NCT02880956|100417249|FG003|Overall Study|Withdrawal by Subject|11|||
33137377|NCT02880956|100417246|FG000|Overall Study|Lost to Follow-up|0|||
33137378|NCT02880956|100417247|FG001|Overall Study|Lost to Follow-up|1|||
33137379|NCT02880956|100417248|FG002|Overall Study|Lost to Follow-up|0|||
33137380|NCT02880956|100417249|FG003|Overall Study|Lost to Follow-up|0|||
33137381|NCT02880956|100417246|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
33137382|NCT02880956|100417247|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
33137383|NCT02880956|100417248|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
33137384|NCT02880956|100417249|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
33137385|NCT02880956|100417246|FG000|Overall Study|Other, Not Specified|4|||
33137386|NCT02880956|100417247|FG001|Overall Study|Other, Not Specified|2|||
33137387|NCT02880956|100417248|FG002|Overall Study|Other, Not Specified|0|||
33137388|NCT02880956|100417249|FG003|Overall Study|Other, Not Specified|3|||
33137389|NCT00308581|100417257|FG000|Induction Phase|Adverse Event|0|||
33137390|NCT00308581|100417258|FG001|Induction Phase|Adverse Event|0|||
33137391|NCT00308581|100417259|FG002|Induction Phase|Adverse Event|37|||
33137392|NCT00308581|100417257|FG000|Induction Phase|Lack of Efficacy|0|||
33137393|NCT00308581|100417258|FG001|Induction Phase|Lack of Efficacy|0|||
33137394|NCT00308581|100417259|FG002|Induction Phase|Lack of Efficacy|121|||
33137395|NCT00308581|100417257|FG000|Induction Phase|Withdrawal by Subject|0|||
33137396|NCT00308581|100417258|FG001|Induction Phase|Withdrawal by Subject|0|||
33137397|NCT00308581|100417259|FG002|Induction Phase|Withdrawal by Subject|5|||
33137398|NCT00308581|100417257|FG000|Induction Phase|Unknown reason|0|||
33137399|NCT00308581|100417258|FG001|Induction Phase|Unknown reason|0|||
33137400|NCT00308581|100417259|FG002|Induction Phase|Unknown reason|3|||
33137401|NCT00308581|100417257|FG000|Randomized Maintenance Phase|Adverse Event|10|||
33137402|NCT00308581|100417258|FG001|Randomized Maintenance Phase|Adverse Event|17|||
33137403|NCT00308581|100417259|FG002|Randomized Maintenance Phase|Adverse Event|0|||
33137404|NCT00308581|100417257|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
33137405|NCT00308581|100417258|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
33137406|NCT00308581|100417259|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
33137407|NCT00308581|100417257|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
33137408|NCT00308581|100417258|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
33137409|NCT00308581|100417259|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
33137410|NCT00308581|100417257|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
33137411|NCT00308581|100417258|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
33137412|NCT00308581|100417259|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
33137413|NCT00308581|100417257|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
33137414|NCT00308581|100417258|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
33137415|NCT00308581|100417259|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
33137416|NCT00308581|100417257|FG000|Randomized Maintenance Phase|Unknown reason|3|||
33137417|NCT00308581|100417258|FG001|Randomized Maintenance Phase|Unknown reason|0|||
33137418|NCT00308581|100417259|FG002|Randomized Maintenance Phase|Unknown reason|0|||
33137419|NCT03353740|100417260|FG000|Overall Study|Images for these participants not viable|52|||
33137420|NCT02051933|100417261|FG000|Overall Study|Physician Decision|0|||
33137421|NCT02051933|100417262|FG001|Overall Study|Physician Decision|1|||
33137422|NCT00864916|100417263|FG000|Overall Study|Lost to Follow-up|4|||
33137423|NCT00864916|100417264|FG001|Overall Study|Lost to Follow-up|4|||
33137424|NCT00864916|100417263|FG000|Overall Study|Protocol Violation|1|||
33137425|NCT00864916|100417264|FG001|Overall Study|Protocol Violation|0|||
33137426|NCT00864916|100417263|FG000|Overall Study|Withdrawal by Subject|1|||
33137427|NCT00864916|100417264|FG001|Overall Study|Withdrawal by Subject|0|||
33137428|NCT05028361|100417265|FG000|Overall Study|Withdrawal by Subject|1|||
33232789|NCT03580356|100753828|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
33137429|NCT05028361|100417266|FG001|Overall Study|Withdrawal by Subject|0|||
33137430|NCT01239992|100417269|FG000|Overall Study|Withdrawal by Subject|2|||
33137431|NCT02551991|100417270|FG000|Overall Study|Death|5|||
33137432|NCT02551991|100417271|FG001|Overall Study|Death|7|||
33137433|NCT02551991|100417272|FG002|Overall Study|Death|8|||
33137434|NCT02551991|100417273|FG003|Overall Study|Death|7|||
33137435|NCT02551991|100417274|FG004|Overall Study|Death|17|||
33137436|NCT02551991|100417270|FG000|Overall Study|Withdrawal by Subject|1|||
33232790|NCT03580356|100753829|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
33137437|NCT02551991|100417271|FG001|Overall Study|Withdrawal by Subject|0|||
33137438|NCT02551991|100417272|FG002|Overall Study|Withdrawal by Subject|0|||
33137439|NCT02551991|100417273|FG003|Overall Study|Withdrawal by Subject|0|||
33137440|NCT02551991|100417274|FG004|Overall Study|Withdrawal by Subject|2|||
33137441|NCT02551991|100417270|FG000|Overall Study|Lost to Follow-up|0|||
33137442|NCT02551991|100417271|FG001|Overall Study|Lost to Follow-up|0|||
33232791|NCT03580356|100753830|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
33232792|NCT03580356|100753823|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
33232793|NCT03580356|100753824|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
33232794|NCT03580356|100753825|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
33232795|NCT03580356|100753826|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
33232796|NCT03580356|100753827|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
33232797|NCT03580356|100753828|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
33232798|NCT03580356|100753829|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
33232799|NCT03580356|100753830|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
33232800|NCT03580356|100753823|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
33232801|NCT03580356|100753824|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
33232802|NCT03580356|100753825|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
33232803|NCT03580356|100753826|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
33232804|NCT03580356|100753827|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
33232805|NCT03580356|100753828|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
33232806|NCT03580356|100753829|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
33232807|NCT03580356|100753830|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
33232808|NCT03580356|100753823|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
33232809|NCT03580356|100753824|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
33232810|NCT03580356|100753825|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
33232811|NCT03580356|100753826|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
33232812|NCT03580356|100753827|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
33232813|NCT03580356|100753828|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
33232814|NCT03580356|100753829|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
33232815|NCT03580356|100753830|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
33232816|NCT03008122|100753835|FG000|Overall Study|Physician Decision|3|||
33232817|NCT03008122|100753836|FG001|Overall Study|Physician Decision|2|||
33232818|NCT03008122|100753837|FG002|Overall Study|Physician Decision|0|||
33232819|NCT03008122|100753835|FG000|Overall Study|Withdrawal by Subject|1|||
33232820|NCT03008122|100753836|FG001|Overall Study|Withdrawal by Subject|3|||
33232821|NCT03008122|100753837|FG002|Overall Study|Withdrawal by Subject|0|||
33232822|NCT03008122|100753835|FG000|Overall Study|Lost to Follow-up|4|||
33232823|NCT03008122|100753836|FG001|Overall Study|Lost to Follow-up|8|||
33232824|NCT03008122|100753837|FG002|Overall Study|Lost to Follow-up|3|||
33232825|NCT03008122|100753835|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
33232826|NCT03008122|100753836|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
33232827|NCT03008122|100753837|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
33232828|NCT03008122|100753835|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
33232829|NCT03008122|100753836|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
33232830|NCT03008122|100753837|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
33232831|NCT03008122|100753835|FG000|Overall Study|Death|0|||
33232832|NCT03008122|100753836|FG001|Overall Study|Death|0|||
33232833|NCT03008122|100753837|FG002|Overall Study|Death|1|||
33232834|NCT02632786|100753843|FG000|Overall Study|Adverse Event|2|||
33232835|NCT02632786|100753844|FG001|Overall Study|Adverse Event|1|||
33232836|NCT02632786|100753843|FG000|Overall Study|Death|3|||
33232837|NCT02632786|100753844|FG001|Overall Study|Death|2|||
33232838|NCT02632786|100753843|FG000|Overall Study|Physician Decision|5|||
33232839|NCT02632786|100753844|FG001|Overall Study|Physician Decision|4|||
33232840|NCT02632786|100753843|FG000|Overall Study|Withdrawal by Subject|1|||
33232841|NCT02632786|100753844|FG001|Overall Study|Withdrawal by Subject|0|||
33232842|NCT00849680|100753845|FG000|Overall Study|Adverse Event|0|||
33368370|NCT00532948|101234815|FG001|Overall Study|Violation of selection criteria at entry|1|||
33368371|NCT00532948|101234816|FG002|Overall Study|Violation of selection criteria at entry|0|||
33368372|NCT00532948|101234814|FG000|Overall Study|Failure to return|0|||
33368373|NCT00532948|101234815|FG001|Overall Study|Failure to return|1|||
33368374|NCT00532948|101234816|FG002|Overall Study|Failure to return|0|||
33368375|NCT02518620|101234817|FG000|Overall Study|Adverse Event|23|||
33368376|NCT02518620|101234818|FG001|Overall Study|Adverse Event|11|||
33368377|NCT02518620|101234817|FG000|Overall Study|Lack of Efficacy|2|||
33368378|NCT02518620|101234818|FG001|Overall Study|Lack of Efficacy|0|||
33420264|NCT01393626|101428564|FG002|Overall Study|Did not meet entrance criteria|0|||
33574952|NCT03375320|101996478|FG000|Overall Study|Adverse Event|34|||
33232843|NCT00849680|100753846|FG001|Overall Study|Adverse Event|0|||
33232844|NCT00849680|100753847|FG002|Overall Study|Adverse Event|0|||
33232845|NCT00849680|100753848|FG003|Overall Study|Adverse Event|0|||
33232846|NCT00849680|100753849|FG004|Overall Study|Adverse Event|0|||
33232847|NCT00849680|100753850|FG005|Overall Study|Adverse Event|0|||
33232848|NCT00849680|100753851|FG006|Overall Study|Adverse Event|2|||
33232849|NCT00849680|100753852|FG007|Overall Study|Adverse Event|0|||
33232850|NCT00849680|100753845|FG000|Overall Study|Lost to Follow-up|7|||
33232851|NCT00849680|100753846|FG001|Overall Study|Lost to Follow-up|3|||
33368379|NCT02518620|101234817|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33368380|NCT02518620|101234818|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33232852|NCT00849680|100753847|FG002|Overall Study|Lost to Follow-up|12|||
33232853|NCT00849680|100753848|FG003|Overall Study|Lost to Follow-up|11|||
33232854|NCT00849680|100753849|FG004|Overall Study|Lost to Follow-up|8|||
33232855|NCT00849680|100753850|FG005|Overall Study|Lost to Follow-up|11|||
33232856|NCT00849680|100753851|FG006|Overall Study|Lost to Follow-up|12|||
33232857|NCT00849680|100753852|FG007|Overall Study|Lost to Follow-up|5|||
33232858|NCT00849680|100753845|FG000|Overall Study|Subject moved|1|||
33232859|NCT00849680|100753846|FG001|Overall Study|Subject moved|0|||
33232860|NCT00849680|100753847|FG002|Overall Study|Subject moved|3|||
33232861|NCT00849680|100753848|FG003|Overall Study|Subject moved|1|||
33232862|NCT00849680|100753849|FG004|Overall Study|Subject moved|0|||
33232863|NCT00849680|100753850|FG005|Overall Study|Subject moved|2|||
33232864|NCT00849680|100753851|FG006|Overall Study|Subject moved|2|||
33232865|NCT00849680|100753852|FG007|Overall Study|Subject moved|2|||
33232866|NCT00849680|100753845|FG000|Overall Study|Withdrawal by Subject|2|||
33232867|NCT00849680|100753846|FG001|Overall Study|Withdrawal by Subject|0|||
33232868|NCT00849680|100753847|FG002|Overall Study|Withdrawal by Subject|0|||
33232869|NCT00849680|100753848|FG003|Overall Study|Withdrawal by Subject|2|||
33232870|NCT00849680|100753849|FG004|Overall Study|Withdrawal by Subject|2|||
33232871|NCT00849680|100753850|FG005|Overall Study|Withdrawal by Subject|2|||
33232872|NCT00849680|100753851|FG006|Overall Study|Withdrawal by Subject|1|||
33232873|NCT00849680|100753852|FG007|Overall Study|Withdrawal by Subject|1|||
33232874|NCT00849680|100753845|FG000|Overall Study|Subject unable to comply with protocol|1|||
33574953|NCT03375320|101996479|FG001|Overall Study|Adverse Event|9|||
33574954|NCT03375320|101996480|FG002|Overall Study|Adverse Event|10|||
33574955|NCT03375320|101996481|FG003|Overall Study|Adverse Event|0|||
33574956|NCT03375320|101996478|FG000|Overall Study|Death|6|||
33574957|NCT03375320|101996479|FG001|Overall Study|Death|3|||
33574958|NCT03375320|101996480|FG002|Overall Study|Death|0|||
33574959|NCT03375320|101996481|FG003|Overall Study|Death|0|||
33574960|NCT03375320|101996478|FG000|Overall Study|Withdrawal by Subject|7|||
33574961|NCT03375320|101996479|FG001|Overall Study|Withdrawal by Subject|4|||
33574962|NCT03375320|101996480|FG002|Overall Study|Withdrawal by Subject|5|||
33574963|NCT03375320|101996481|FG003|Overall Study|Withdrawal by Subject|4|||
33574964|NCT03375320|101996478|FG000|Overall Study|Progressive disease|55|||
33574965|NCT03375320|101996479|FG001|Overall Study|Progressive disease|41|||
33574966|NCT03375320|101996480|FG002|Overall Study|Progressive disease|29|||
33574967|NCT03375320|101996481|FG003|Overall Study|Progressive disease|24|||
33574968|NCT03375320|101996478|FG000|Overall Study|Alternative treatment|6|||
33574969|NCT03375320|101996479|FG001|Overall Study|Alternative treatment|1|||
33574970|NCT03375320|101996480|FG002|Overall Study|Alternative treatment|1|||
33574971|NCT03375320|101996481|FG003|Overall Study|Alternative treatment|0|||
33574972|NCT03375320|101996478|FG000|Overall Study|Other disease|1|||
33574973|NCT03375320|101996479|FG001|Overall Study|Other disease|1|||
33574974|NCT03375320|101996480|FG002|Overall Study|Other disease|3|||
33574975|NCT03375320|101996481|FG003|Overall Study|Other disease|0|||
33574976|NCT03375320|101996478|FG000|Overall Study|Withdrawal prior to initiation|2|||
33574977|NCT03375320|101996479|FG001|Overall Study|Withdrawal prior to initiation|2|||
33574978|NCT03375320|101996480|FG002|Overall Study|Withdrawal prior to initiation|1|||
33574979|NCT03375320|101996481|FG003|Overall Study|Withdrawal prior to initiation|0|||
33574980|NCT03375320|101996478|FG000|Overall Study|Physician Decision|1|||
33574981|NCT03375320|101996479|FG001|Overall Study|Physician Decision|1|||
33232875|NCT00849680|100753846|FG001|Overall Study|Subject unable to comply with protocol|0|||
33232876|NCT00849680|100753847|FG002|Overall Study|Subject unable to comply with protocol|0|||
33232877|NCT00849680|100753848|FG003|Overall Study|Subject unable to comply with protocol|0|||
33232878|NCT00849680|100753849|FG004|Overall Study|Subject unable to comply with protocol|0|||
33368381|NCT02518620|101234817|FG000|Overall Study|Physician Decision|1|||
33368382|NCT02518620|101234818|FG001|Overall Study|Physician Decision|1|||
33368383|NCT02518620|101234817|FG000|Overall Study|Sponsor's Decision|0|||
33368384|NCT02518620|101234818|FG001|Overall Study|Sponsor's Decision|3|||
33368385|NCT02518620|101234817|FG000|Overall Study|Lost to Follow-up|1|||
33368386|NCT02518620|101234818|FG001|Overall Study|Lost to Follow-up|1|||
33368387|NCT02518620|101234817|FG000|Overall Study|Withdrawal by Subject|17|||
33368388|NCT02518620|101234818|FG001|Overall Study|Withdrawal by Subject|9|||
33420265|NCT01393626|101428565|FG003|Overall Study|Did not meet entrance criteria|0|||
33420266|NCT01393626|101428562|FG000|Overall Study|Lack of Efficacy|6|||
33420267|NCT01393626|101428563|FG001|Overall Study|Lack of Efficacy|6|||
33574982|NCT03375320|101996480|FG002|Overall Study|Physician Decision|1|||
33574983|NCT03375320|101996481|FG003|Overall Study|Physician Decision|1|||
33574984|NCT03375320|101996478|FG000|Overall Study|Non-compliance|1|||
33232879|NCT00849680|100753850|FG005|Overall Study|Subject unable to comply with protocol|0|||
33232880|NCT00849680|100753851|FG006|Overall Study|Subject unable to comply with protocol|0|||
33368389|NCT02518620|101234817|FG000|Overall Study|Death|1|||
33368390|NCT02518620|101234818|FG001|Overall Study|Death|0|||
33368391|NCT02518620|101234817|FG000|Overall Study|Pregnancy Wish|3|||
33574985|NCT03375320|101996479|FG001|Overall Study|Non-compliance|0|||
33574986|NCT03375320|101996480|FG002|Overall Study|Non-compliance|0|||
33574987|NCT03375320|101996481|FG003|Overall Study|Non-compliance|0|||
33368392|NCT02518620|101234818|FG001|Overall Study|Pregnancy Wish|0|||
33368393|NCT02518620|101234817|FG000|Overall Study|Pregnancy|1|||
33368394|NCT02518620|101234818|FG001|Overall Study|Pregnancy|0|||
33368395|NCT02518620|101234817|FG000|Overall Study|Relocation|2|||
33368396|NCT02518620|101234818|FG001|Overall Study|Relocation|1|||
33368397|NCT01234402|101234819|FG000|Overall Study|Lost to Follow-up|0|||
33368398|NCT01234402|101234820|FG001|Overall Study|Lost to Follow-up|1|||
33368399|NCT01234402|101234821|FG002|Overall Study|Lost to Follow-up|3|||
33368400|NCT01234402|101234819|FG000|Overall Study|Withdrawal by Subject|1|||
33368401|NCT01234402|101234820|FG001|Overall Study|Withdrawal by Subject|3|||
33368402|NCT01234402|101234821|FG002|Overall Study|Withdrawal by Subject|4|||
33368403|NCT01234402|101234819|FG000|Overall Study|Never treated: Death|0|||
33368404|NCT01234402|101234820|FG001|Overall Study|Never treated: Death|0|||
33368405|NCT01234402|101234821|FG002|Overall Study|Never treated: Death|1|||
33368406|NCT01234402|101234819|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
33368407|NCT01234402|101234820|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
33368408|NCT01234402|101234821|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
33368409|NCT01234402|101234819|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
33137443|NCT02551991|100417272|FG002|Overall Study|Lost to Follow-up|1|||
33137444|NCT02551991|100417273|FG003|Overall Study|Lost to Follow-up|0|||
33137445|NCT02551991|100417274|FG004|Overall Study|Lost to Follow-up|0|||
33137446|NCT02551991|100417270|FG000|Overall Study|Sponsor Decision|1|||
33137447|NCT02551991|100417271|FG001|Overall Study|Sponsor Decision|0|||
33137448|NCT02551991|100417272|FG002|Overall Study|Sponsor Decision|1|||
33137449|NCT02551991|100417273|FG003|Overall Study|Sponsor Decision|0|||
33137450|NCT02551991|100417274|FG004|Overall Study|Sponsor Decision|5|||
33137451|NCT02551991|100417270|FG000|Overall Study|Other|0|||
33137452|NCT02551991|100417271|FG001|Overall Study|Other|0|||
33368410|NCT01234402|101234820|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
33137453|NCT02551991|100417272|FG002|Overall Study|Other|0|||
33137454|NCT02551991|100417273|FG003|Overall Study|Other|0|||
33137455|NCT02551991|100417274|FG004|Overall Study|Other|1|||
33137456|NCT00422084|100417275|FG000|Overall Study|Adverse Event|21|||
33137457|NCT00422084|100417276|FG001|Overall Study|Adverse Event|7|||
33137458|NCT00422084|100417275|FG000|Overall Study|Withdrawal by Subject|12|||
33137459|NCT00422084|100417276|FG001|Overall Study|Withdrawal by Subject|9|||
33137460|NCT00422084|100417275|FG000|Overall Study|Lost to Follow-up|14|||
33137461|NCT00422084|100417276|FG001|Overall Study|Lost to Follow-up|9|||
33137462|NCT00422084|100417275|FG000|Overall Study|Protocol Violation|4|||
33137463|NCT00422084|100417276|FG001|Overall Study|Protocol Violation|1|||
33137464|NCT00422084|100417275|FG000|Overall Study|Lack of Efficacy|40|||
33137465|NCT00422084|100417276|FG001|Overall Study|Lack of Efficacy|42|||
33137466|NCT00422084|100417275|FG000|Overall Study|P. vivax infection|3|||
33137467|NCT00422084|100417276|FG001|Overall Study|P. vivax infection|6|||
33137468|NCT00422084|100417275|FG000|Overall Study|Cyesis|1|||
33137469|NCT00422084|100417276|FG001|Overall Study|Cyesis|0|||
33137470|NCT00422084|100417275|FG000|Overall Study|Withdrawn from study accidentally|1|||
33137471|NCT00422084|100417276|FG001|Overall Study|Withdrawn from study accidentally|0|||
33137472|NCT00422084|100417275|FG000|Overall Study|Non-compliance|1|||
33137473|NCT00422084|100417276|FG001|Overall Study|Non-compliance|0|||
33137474|NCT00422084|100417275|FG000|Overall Study|Re-location|0|||
33137475|NCT00422084|100417276|FG001|Overall Study|Re-location|1|||
33137476|NCT00422084|100417275|FG000|Overall Study|Not defined|1|||
33137477|NCT00422084|100417276|FG001|Overall Study|Not defined|1|||
33137478|NCT01566214|100417277|FG000|Overall Study|Lost to Follow-up|3|||
33137479|NCT01566214|100417278|FG001|Overall Study|Lost to Follow-up|0|||
33368411|NCT01234402|101234821|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
33368412|NCT01752842|101234824|FG000|Overall Study|Adverse Event|3|||
33574988|NCT00105534|101996482|FG000|Overall Study|Adverse Event|2|||
33574989|NCT00105534|101996483|FG001|Overall Study|Adverse Event|5|||
33574990|NCT00105534|101996482|FG000|Overall Study|Protocol Violation|1|||
33574991|NCT00105534|101996483|FG001|Overall Study|Protocol Violation|4|||
33574992|NCT00105534|101996482|FG000|Overall Study|Withdrawal by Subject|6|||
33574993|NCT00105534|101996483|FG001|Overall Study|Withdrawal by Subject|6|||
33574994|NCT00105534|101996482|FG000|Overall Study|Lost to Follow-up|5|||
33574995|NCT00105534|101996483|FG001|Overall Study|Lost to Follow-up|1|||
33574996|NCT00105534|101996482|FG000|Overall Study|Lack of Efficacy|7|||
33574997|NCT00105534|101996483|FG001|Overall Study|Lack of Efficacy|15|||
33574998|NCT00105534|101996482|FG000|Overall Study|Treatment unmasked|1|||
33574999|NCT00105534|101996483|FG001|Overall Study|Treatment unmasked|0|||
33137480|NCT02745145|100417279|FG000|Overall Study|Adverse Event|1|||
33137481|NCT02745145|100417280|FG001|Overall Study|Adverse Event|0|||
33137482|NCT02745145|100417281|FG002|Overall Study|Adverse Event|0|||
33137483|NCT02745145|100417279|FG000|Overall Study|Death|0|||
33137484|NCT02745145|100417280|FG001|Overall Study|Death|1|||
33368413|NCT01752842|101234825|FG001|Overall Study|Adverse Event|0|||
33368414|NCT01752842|101234824|FG000|Overall Study|Withdrawal by Subject|0|||
33137485|NCT02745145|100417281|FG002|Overall Study|Death|0|||
33137486|NCT02745145|100417279|FG000|Overall Study|Progressive disease|0|||
33137487|NCT02745145|100417280|FG001|Overall Study|Progressive disease|0|||
33232881|NCT00849680|100753852|FG007|Overall Study|Subject unable to comply with protocol|0|||
33232882|NCT01364727|100753855|FG000|Overall Study|Not Eligible|2|||
33232883|NCT00154063|100753856|FG000|Overall Study|Adverse Event|4|||
33232884|NCT00154063|100753857|FG001|Overall Study|Adverse Event|8|||
33232885|NCT00154063|100753856|FG000|Overall Study|Protocol Violation|1|||
33232886|NCT00154063|100753857|FG001|Overall Study|Protocol Violation|1|||
33232887|NCT00154063|100753856|FG000|Overall Study|Investigator or Sponsor Request|0|||
33368415|NCT01752842|101234825|FG001|Overall Study|Withdrawal by Subject|2|||
33575000|NCT00105534|101996482|FG000|Overall Study|Other Reason|0|||
33575001|NCT00105534|101996483|FG001|Overall Study|Other Reason|2|||
33575002|NCT04459416|101996484|FG000|Overall Study|Lost to Follow-up|2|||
33575003|NCT04459416|101996485|FG001|Overall Study|Lost to Follow-up|0|||
33575004|NCT04459416|101996484|FG000|Overall Study|Withdrawal by Subject|8|||
33575005|NCT04459416|101996485|FG001|Overall Study|Withdrawal by Subject|10|||
33575006|NCT04459416|101996484|FG000|Overall Study|Disease progression|0|||
33575007|NCT04459416|101996485|FG001|Overall Study|Disease progression|3|||
33575008|NCT02343302|101996486|FG000|Overall Study|Physician Decision|1|||
33575009|NCT02343302|101996487|FG001|Overall Study|Physician Decision|1|||
33575010|NCT03247829|101996488|FG000|Overall Study|Death|3|||
33575011|NCT03247829|101996489|FG001|Overall Study|Death|4|||
33575012|NCT03247829|101996488|FG000|Overall Study|Enter Hospice Care|1|||
33575013|NCT03247829|101996489|FG001|Overall Study|Enter Hospice Care|0|||
33232888|NCT00154063|100753857|FG001|Overall Study|Investigator or Sponsor Request|1|||
33232889|NCT00154063|100753856|FG000|Overall Study|Withdrawal by Subject|4|||
33232890|NCT00154063|100753857|FG001|Overall Study|Withdrawal by Subject|9|||
33232891|NCT00154063|100753856|FG000|Overall Study|Other|3|||
33232892|NCT00154063|100753857|FG001|Overall Study|Other|3|||
33232893|NCT00786474|100753858|FG000|Overall Study|Death|5|||
33232894|NCT00786474|100753859|FG001|Overall Study|Death|4|||
33232895|NCT00786474|100753858|FG000|Overall Study|Withdrawal by Subject|23|||
33232896|NCT00786474|100753859|FG001|Overall Study|Withdrawal by Subject|31|||
33232897|NCT00786474|100753858|FG000|Overall Study|Lost to Follow-up|3|||
33232898|NCT00786474|100753859|FG001|Overall Study|Lost to Follow-up|3|||
33232899|NCT00786474|100753858|FG000|Overall Study|Physician Decision|2|||
33232900|NCT00786474|100753859|FG001|Overall Study|Physician Decision|1|||
33232901|NCT00786474|100753858|FG000|Overall Study|Other|4|||
33232902|NCT00786474|100753859|FG001|Overall Study|Other|4|||
33232903|NCT00312858|100753863|FG000|Overall Study|Adverse Event|0|||
33232904|NCT00312858|100753864|FG001|Overall Study|Adverse Event|1|||
33232905|NCT00312858|100753863|FG000|Overall Study|Lost to Follow-up|25|||
33232906|NCT00312858|100753864|FG001|Overall Study|Lost to Follow-up|42|||
33232907|NCT00312858|100753863|FG000|Overall Study|Protocol Violation|3|||
33232908|NCT00312858|100753864|FG001|Overall Study|Protocol Violation|8|||
33232909|NCT00312858|100753863|FG000|Overall Study|Withdraw by Participant|20|||
33232910|NCT00312858|100753864|FG001|Overall Study|Withdraw by Participant|20|||
33232911|NCT00312858|100753863|FG000|Overall Study|Participant Moved|11|||
33232912|NCT00312858|100753864|FG001|Overall Study|Participant Moved|10|||
33575014|NCT03247829|101996488|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
33575015|NCT03247829|101996489|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
33575016|NCT03247829|101996488|FG000|Overall Study|LVAD Explant|1|||
33575017|NCT03247829|101996489|FG001|Overall Study|LVAD Explant|1|||
33575018|NCT03247829|101996488|FG000|Overall Study|Transplant|1|||
33575019|NCT03247829|101996489|FG001|Overall Study|Transplant|1|||
33575020|NCT01541371|101996495|FG000|Overall Study|Withdrawal by Subject|14|||
33575021|NCT01541371|101996495|FG000|Overall Study|Lost to Follow-up|21|||
33575022|NCT01541371|101996495|FG000|Overall Study|Adverse Event|15|||
33575023|NCT01541371|101996495|FG000|Overall Study|Lack of Efficacy|12|||
33575024|NCT01541371|101996495|FG000|Overall Study|Protocol Violation|6|||
33575025|NCT01541371|101996495|FG000|Overall Study|Study medication non-compliance|3|||
33575026|NCT01541371|101996495|FG000|Overall Study|Other|6|||
33575027|NCT01847755|101996496|FG000|Overall Study|Adverse Event|2|||
33575028|NCT01847755|101996496|FG000|Overall Study|Withdrawal by Subject|2|||
33232913|NCT00312858|100753863|FG000|Overall Study|Other|9|||
33232914|NCT00312858|100753864|FG001|Overall Study|Other|12|||
33232915|NCT03040687|100753865|FG000|Overall Study|Withdrawal by Subject|1|||
33232916|NCT03040687|100753866|FG001|Overall Study|Withdrawal by Subject|0|||
33232917|NCT03040687|100753867|FG002|Overall Study|Withdrawal by Subject|0|||
33575029|NCT01847755|101996496|FG000|Overall Study|Physician Decision|1|||
33232918|NCT00794820|100753872|FG000|Overall Study|Adverse Event|11|||
33232919|NCT00794820|100753872|FG000|Overall Study|Secondary Malignancies|2|||
33232920|NCT00794820|100753872|FG000|Overall Study|Resistant Disease|2|||
33575030|NCT03217266|101996497|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
33575031|NCT03217266|101996498|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
33232921|NCT00794820|100753872|FG000|Overall Study|Ineligible/Screen Failure|1|||
33232922|NCT00211237|100753874|FG000|Baseline|Withdrew|1|||
33368416|NCT00450372|101234826|FG000|Overall Study|Physician Decision|1|||
33232923|NCT00211237|100753875|FG001|Baseline|Withdrew|3|||
33232924|NCT00211237|100753876|FG002|Baseline|Withdrew|0|||
33575032|NCT03217266|101996499|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
33232925|NCT00211237|100753874|FG000|Baseline|Refused random assignment|1|||
33575033|NCT03217266|101996500|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
33575034|NCT03217266|101996497|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
33575035|NCT03217266|101996498|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
33575036|NCT03217266|101996499|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
33232926|NCT00211237|100753875|FG001|Baseline|Refused random assignment|0|||
33232927|NCT00211237|100753876|FG002|Baseline|Refused random assignment|0|||
33232928|NCT00211237|100753874|FG000|1 Month|Death|2|||
33232929|NCT00211237|100753875|FG001|1 Month|Death|1|||
33232930|NCT00211237|100753876|FG002|1 Month|Death|0|||
33232931|NCT00211237|100753874|FG000|1 Month|Lost to Follow-up|0|||
33232932|NCT00211237|100753875|FG001|1 Month|Lost to Follow-up|2|||
33232933|NCT00211237|100753876|FG002|1 Month|Lost to Follow-up|0|||
33232934|NCT00211237|100753874|FG000|1 Month|Withdrew|0|||
33232935|NCT00211237|100753875|FG001|1 Month|Withdrew|4|||
33232936|NCT00211237|100753876|FG002|1 Month|Withdrew|0|||
33232937|NCT00211237|100753874|FG000|1 Month|Additional surgery needed|1|||
33232938|NCT00211237|100753875|FG001|1 Month|Additional surgery needed|0|||
33232939|NCT00211237|100753876|FG002|1 Month|Additional surgery needed|0|||
33232940|NCT00211237|100753874|FG000|1 Month|Non-medical problem|0|||
33232941|NCT00211237|100753875|FG001|1 Month|Non-medical problem|2|||
33575037|NCT03217266|101996500|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
33575038|NCT03217266|101996497|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
33575039|NCT03217266|101996498|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
33575040|NCT03217266|101996499|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
33575041|NCT03217266|101996500|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
33575042|NCT05588440|101996504|FG000|Overall Study|Sponsor Decision|2|||
33575043|NCT05588440|101996505|FG001|Overall Study|Sponsor Decision|0|||
33575044|NCT05588440|101996506|FG002|Overall Study|Sponsor Decision|1|||
33575045|NCT05588440|101996504|FG000|Overall Study|Death|1|||
33575046|NCT05588440|101996505|FG001|Overall Study|Death|1|||
33575047|NCT05588440|101996506|FG002|Overall Study|Death|1|||
33575048|NCT05588440|101996504|FG000|Overall Study|Screen Fail|0|||
33575049|NCT05588440|101996505|FG001|Overall Study|Screen Fail|1|||
33575050|NCT05588440|101996506|FG002|Overall Study|Screen Fail|1|||
33575051|NCT05588440|101996504|FG000|Overall Study|Withdrawal by Subject|0|||
33232942|NCT00211237|100753876|FG002|1 Month|Non-medical problem|0|||
33232943|NCT00211237|100753874|FG000|3 Months|Death|7|||
33232944|NCT00211237|100753875|FG001|3 Months|Death|3|||
33232945|NCT00211237|100753876|FG002|3 Months|Death|0|||
33232946|NCT00211237|100753874|FG000|3 Months|Could not comply with protocol|1|||
33575052|NCT05588440|101996505|FG001|Overall Study|Withdrawal by Subject|0|||
33575053|NCT05588440|101996506|FG002|Overall Study|Withdrawal by Subject|1|||
33575054|NCT04716894|101996510|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
33575055|NCT04716894|101996510|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
33575056|NCT00590967|101996511|FG000|Overall Study|Withdrawal by Subject|1|||
33575057|NCT00590967|101996512|FG001|Overall Study|Withdrawal by Subject|1|||
33575058|NCT00590967|101996511|FG000|Overall Study|Ineligible|1|||
33575059|NCT00590967|101996512|FG001|Overall Study|Ineligible|0|||
33636187|NCT01389596|102218638|FG002|Overall Study|Death|0|||
33636188|NCT01389596|102218636|FG000|Overall Study|Other Unspecified|2|||
33636189|NCT01389596|102218637|FG001|Overall Study|Other Unspecified|1|||
33232947|NCT00211237|100753875|FG001|3 Months|Could not comply with protocol|0|||
33232948|NCT00211237|100753876|FG002|3 Months|Could not comply with protocol|0|||
33232949|NCT00211237|100753874|FG000|3 Months|Withdrew|0|||
33232950|NCT00211237|100753875|FG001|3 Months|Withdrew|1|||
33232951|NCT00211237|100753876|FG002|3 Months|Withdrew|0|||
33232952|NCT00211237|100753874|FG000|3 Months|Non-medical problem|0|||
33232953|NCT00211237|100753875|FG001|3 Months|Non-medical problem|0|||
33232954|NCT00211237|100753876|FG002|3 Months|Non-medical problem|1|||
33232955|NCT00211237|100753874|FG000|6 Months|Death|6|||
33232956|NCT00211237|100753875|FG001|6 Months|Death|0|||
33232957|NCT00211237|100753876|FG002|6 Months|Death|3|||
33232958|NCT00211237|100753874|FG000|6 Months|Lost to Follow-up|2|||
33232959|NCT00211237|100753875|FG001|6 Months|Lost to Follow-up|0|||
33232960|NCT00211237|100753876|FG002|6 Months|Lost to Follow-up|0|||
33232961|NCT00211237|100753874|FG000|6 Months|Could not comply with protocol|0|||
33232962|NCT00211237|100753875|FG001|6 Months|Could not comply with protocol|2|||
33232963|NCT00211237|100753876|FG002|6 Months|Could not comply with protocol|0|||
33232964|NCT00211237|100753874|FG000|12 Months|Death|8|||
33232965|NCT00211237|100753875|FG001|12 Months|Death|2|||
33232966|NCT00211237|100753876|FG002|12 Months|Death|3|||
33575060|NCT00590967|101996511|FG000|Overall Study|Poor performance status|0|||
33575061|NCT00590967|101996512|FG001|Overall Study|Poor performance status|1|||
33575062|NCT00590967|101996511|FG000|Overall Study|Non-compliant|0|||
33575063|NCT00590967|101996512|FG001|Overall Study|Non-compliant|2|||
33575064|NCT00590967|101996511|FG000|Overall Study|Did not sign consent form|0|||
33575065|NCT00590967|101996512|FG001|Overall Study|Did not sign consent form|1|||
33232967|NCT00211237|100753874|FG000|12 Months|Lost to Follow-up|1|||
33232968|NCT00211237|100753875|FG001|12 Months|Lost to Follow-up|0|||
33232969|NCT00211237|100753876|FG002|12 Months|Lost to Follow-up|1|||
33232970|NCT00211237|100753874|FG000|12 Months|Withdrew|0|||
33232971|NCT00211237|100753875|FG001|12 Months|Withdrew|0|||
33232972|NCT00211237|100753876|FG002|12 Months|Withdrew|1|||
33232973|NCT00211237|100753874|FG000|12 Months|unrelated medical problem|0|||
33232974|NCT00211237|100753875|FG001|12 Months|unrelated medical problem|0|||
33232975|NCT00211237|100753876|FG002|12 Months|unrelated medical problem|1|||
33232976|NCT01115491|100753877|FG000|Overall Study|Death|22|||
33232977|NCT01115491|100753877|FG000|Overall Study|Adverse Event|3|||
33232978|NCT01115491|100753877|FG000|Overall Study|Lost to Follow-up|3|||
33232979|NCT01115491|100753877|FG000|Overall Study|Withdrawal by Subject|1|||
33232980|NCT01115491|100753877|FG000|Overall Study|Physician Decision|1|||
33232981|NCT00065468|100753878|FG000|Overall Study|Death|172|||
33232982|NCT00065468|100753879|FG001|Overall Study|Death|169|||
33232983|NCT00065468|100753880|FG002|Overall Study|Death|171|||
33232984|NCT00065468|100753878|FG000|Overall Study|Withdrawal by Subject|3|||
33232985|NCT00065468|100753879|FG001|Overall Study|Withdrawal by Subject|4|||
33232986|NCT00065468|100753880|FG002|Overall Study|Withdrawal by Subject|5|||
33232987|NCT00065468|100753878|FG000|Overall Study|Lost to Follow-up|5|||
33232988|NCT00065468|100753879|FG001|Overall Study|Lost to Follow-up|3|||
33232989|NCT00065468|100753880|FG002|Overall Study|Lost to Follow-up|2|||
33232990|NCT00065468|100753878|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
33232991|NCT00065468|100753879|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
33232992|NCT00065468|100753880|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
33232993|NCT00065468|100753878|FG000|Overall Study|Disease progression|0|||
33232994|NCT00065468|100753879|FG001|Overall Study|Disease progression|0|||
33232995|NCT00065468|100753880|FG002|Overall Study|Disease progression|1|||
33232996|NCT00065468|100753878|FG000|Overall Study|Other|14|||
33232997|NCT00065468|100753879|FG001|Overall Study|Other|24|||
33232998|NCT00065468|100753880|FG002|Overall Study|Other|18|||
33232999|NCT02406261|100753881|FG000|Period 1|Lost to Follow-up|2|||
33233000|NCT02406261|100753882|FG001|Period 1|Lost to Follow-up|0|||
33233001|NCT02406261|100753881|FG000|Period 1|Adverse Event|1|||
33233002|NCT02406261|100753882|FG001|Period 1|Adverse Event|0|||
33233003|NCT02406261|100753881|FG000|Period 2|Physician Decision|0|||
33233004|NCT02406261|100753882|FG001|Period 2|Physician Decision|1|||
33233005|NCT02406261|100753881|FG000|Period 2|Protocol Violation|0|||
33233006|NCT02406261|100753882|FG001|Period 2|Protocol Violation|1|||
33233007|NCT02406261|100753881|FG000|Period 2|Withdrawal by Subject|0|||
33233008|NCT02406261|100753882|FG001|Period 2|Withdrawal by Subject|1|||
33233009|NCT02141659|100753883|FG000|Overall Study|Major Protocol Deviation|0|||
33233010|NCT02141659|100753884|FG001|Overall Study|Major Protocol Deviation|1|||
33575066|NCT00590967|101996511|FG000|Overall Study|Did not receive chemo per protocol|1|||
33575067|NCT00590967|101996512|FG001|Overall Study|Did not receive chemo per protocol|0|||
33575068|NCT01276106|101996513|FG000|Overall Study|Adverse Event|3|||
33233011|NCT02141659|100753885|FG002|Overall Study|Major Protocol Deviation|0|||
33233012|NCT02141659|100753886|FG003|Overall Study|Major Protocol Deviation|0|||
33233013|NCT02141659|100753887|FG004|Overall Study|Major Protocol Deviation|0|||
33233014|NCT02141659|100753888|FG005|Overall Study|Major Protocol Deviation|0|||
33233015|NCT02141659|100753883|FG000|Overall Study|Lack of Efficacy|0|||
33233016|NCT02141659|100753884|FG001|Overall Study|Lack of Efficacy|0|||
33233017|NCT02141659|100753885|FG002|Overall Study|Lack of Efficacy|0|||
33233018|NCT02141659|100753886|FG003|Overall Study|Lack of Efficacy|0|||
33233019|NCT02141659|100753887|FG004|Overall Study|Lack of Efficacy|0|||
33233020|NCT02141659|100753888|FG005|Overall Study|Lack of Efficacy|1|||
33233021|NCT02141659|100753883|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
33233022|NCT02141659|100753884|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
33233023|NCT02141659|100753885|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
33233024|NCT02141659|100753886|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
33233025|NCT02141659|100753887|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
33233026|NCT02141659|100753888|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
33233027|NCT01129336|100753892|FG000|Overall Study|Protocol Violation|1|||
33368417|NCT03422133|101234827|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
33233028|NCT01129336|100753893|FG001|Overall Study|Protocol Violation|0|||
33233029|NCT01129336|100753892|FG000|Overall Study|Disease Progression|1|||
33233030|NCT01129336|100753893|FG001|Overall Study|Disease Progression|4|||
33233031|NCT01129336|100753892|FG000|Overall Study|Lost to Follow-up|1|||
33233032|NCT01129336|100753893|FG001|Overall Study|Lost to Follow-up|0|||
33233033|NCT01129336|100753892|FG000|Overall Study|Withdrawal by Subject|7|||
33233034|NCT01129336|100753893|FG001|Overall Study|Withdrawal by Subject|4|||
33233035|NCT01129336|100753892|FG000|Overall Study|Adverse Event|0|||
33233036|NCT01129336|100753893|FG001|Overall Study|Adverse Event|1|||
33233037|NCT01129336|100753892|FG000|Overall Study|Missing Study Completion Status|2|||
33233038|NCT01129336|100753893|FG001|Overall Study|Missing Study Completion Status|3|||
33233039|NCT01129336|100753892|FG000|Overall Study|Death|0|||
33233040|NCT01129336|100753893|FG001|Overall Study|Death|4|||
33233041|NCT03382600|100753894|FG000|Overall Study|Adverse Event|3|||
33233042|NCT03382600|100753895|FG001|Overall Study|Adverse Event|3|||
33233043|NCT03382600|100753894|FG000|Overall Study|Clinical Disease Progression|2|||
33233044|NCT03382600|100753895|FG001|Overall Study|Clinical Disease Progression|4|||
33233045|NCT03382600|100753894|FG000|Overall Study|Radiological Progression|40|||
33233046|NCT03382600|100753895|FG001|Overall Study|Radiological Progression|31|||
33233047|NCT03382600|100753894|FG000|Overall Study|Withdrawal by Subject|0|||
33636190|NCT01389596|102218638|FG002|Overall Study|Other Unspecified|0|||
33636191|NCT04081103|102218639|FG000|Overall Study|Adverse Event|1|||
33233048|NCT03382600|100753895|FG001|Overall Study|Withdrawal by Subject|1|||
33233049|NCT03382600|100753894|FG000|Overall Study|Other|9|||
33233050|NCT03382600|100753895|FG001|Overall Study|Other|7|||
33233051|NCT01912222|100753896|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
33575069|NCT01276106|101996514|FG001|Overall Study|Adverse Event|3|||
33575070|NCT01276106|101996515|FG002|Overall Study|Adverse Event|11|||
33575071|NCT01276106|101996516|FG003|Overall Study|Adverse Event|3|||
33575072|NCT01276106|101996513|FG000|Overall Study|Withdrawal by Subject|6|||
33575073|NCT01276106|101996514|FG001|Overall Study|Withdrawal by Subject|3|||
33575074|NCT01276106|101996515|FG002|Overall Study|Withdrawal by Subject|1|||
33575075|NCT01276106|101996516|FG003|Overall Study|Withdrawal by Subject|6|||
33575076|NCT01276106|101996513|FG000|Overall Study|Lack of Efficacy|0|||
33575077|NCT01276106|101996514|FG001|Overall Study|Lack of Efficacy|1|||
33636192|NCT04081103|102218640|FG001|Overall Study|Adverse Event|1|||
33636193|NCT04081103|102218641|FG002|Overall Study|Adverse Event|1|||
33636194|NCT04081103|102218639|FG000|Overall Study|Physician Decision|0|||
33233052|NCT01912222|100753897|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
33233053|NCT01912222|100753898|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
33233054|NCT01912222|100753896|FG000|Part B: Treatment Period|Progressive disease|10|||
33233055|NCT01912222|100753897|FG001|Part B: Treatment Period|Progressive disease|12|||
33233056|NCT01912222|100753898|FG002|Part B: Treatment Period|Progressive disease|15|||
33233057|NCT01912222|100753896|FG000|Part B: Treatment Period|Adverse Event|1|||
33233058|NCT01912222|100753897|FG001|Part B: Treatment Period|Adverse Event|2|||
33233059|NCT01912222|100753898|FG002|Part B: Treatment Period|Adverse Event|3|||
33233060|NCT01912222|100753896|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
33233061|NCT01912222|100753897|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
33233062|NCT01912222|100753898|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
33233063|NCT03317379|100753906|FG000|Overall Study|Lost to Follow-up|0|||
33233064|NCT03317379|100753907|FG001|Overall Study|Lost to Follow-up|3|||
33233065|NCT03317379|100753908|FG002|Overall Study|Lost to Follow-up|2|||
33233066|NCT05033743|100753909|FG000|Overall Study|Lost to Follow-up|1|||
33233067|NCT05033743|100753909|FG000|Overall Study|Protocol Violation|2|||
33233068|NCT05033743|100753909|FG000|Overall Study|Withdrawal by Subject|1|||
33233069|NCT02372058|100753910|FG000|Overall Study|Withdrawal by Subject|3|||
33233070|NCT02533258|100753915|FG000|Overall Study|Adverse Event|1|||
33233071|NCT02533258|100753915|FG000|Overall Study|Death|2|||
33233072|NCT02533258|100753915|FG000|Overall Study|Other|1|||
33233073|NCT02533258|100753915|FG000|Overall Study|Economic factor|1|||
33233074|NCT02533258|100753915|FG000|Overall Study|Progression of pleural effusion|1|||
33233075|NCT02533258|100753915|FG000|Overall Study|Lack of Efficacy|2|||
33233076|NCT04039503|100753916|FG000|Overall Study|Adverse Event|3|||
33233077|NCT04039503|100753917|FG001|Overall Study|Adverse Event|0|||
33233078|NCT04039503|100753918|FG002|Overall Study|Adverse Event|2|||
33233079|NCT04039503|100753919|FG003|Overall Study|Adverse Event|0|||
33233080|NCT04039503|100753916|FG000|Overall Study|Lost to Follow-up|0|||
33233081|NCT04039503|100753917|FG001|Overall Study|Lost to Follow-up|0|||
33233082|NCT04039503|100753918|FG002|Overall Study|Lost to Follow-up|1|||
33233083|NCT04039503|100753919|FG003|Overall Study|Lost to Follow-up|0|||
33233084|NCT04039503|100753916|FG000|Overall Study|Protocol Violation|0|||
33636195|NCT04081103|102218640|FG001|Overall Study|Physician Decision|0|||
33636196|NCT04081103|102218641|FG002|Overall Study|Physician Decision|1|||
33636197|NCT02066181|102218642|FG000|Overall Study|Withdrawal by Subject|1|||
33636198|NCT02066181|102218643|FG001|Overall Study|Withdrawal by Subject|1|||
33636199|NCT00459316|102218644|FG000|Steps 1 & 2|Other eligibility failure|1|||
33636200|NCT00459316|102218645|FG001|Steps 1 & 2|Other eligibility failure|1|||
33636201|NCT00459316|102218646|FG002|Steps 1 & 2|Other eligibility failure|0|||
33636202|NCT00459316|102218644|FG000|Steps 1 & 2|Death|1|||
33233085|NCT04039503|100753917|FG001|Overall Study|Protocol Violation|1|||
33420268|NCT01393626|101428564|FG002|Overall Study|Lack of Efficacy|4|||
33420269|NCT01393626|101428565|FG003|Overall Study|Lack of Efficacy|1|||
33233086|NCT04039503|100753918|FG002|Overall Study|Protocol Violation|2|||
33233087|NCT04039503|100753919|FG003|Overall Study|Protocol Violation|1|||
33233088|NCT04039503|100753916|FG000|Overall Study|Withdrawal by Subject|4|||
33233089|NCT04039503|100753917|FG001|Overall Study|Withdrawal by Subject|3|||
33233090|NCT04039503|100753918|FG002|Overall Study|Withdrawal by Subject|5|||
33233091|NCT04039503|100753919|FG003|Overall Study|Withdrawal by Subject|2|||
33233092|NCT00975221|100753920|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
33575078|NCT01276106|101996515|FG002|Overall Study|Lack of Efficacy|0|||
33575079|NCT01276106|101996516|FG003|Overall Study|Lack of Efficacy|1|||
33575080|NCT01276106|101996513|FG000|Overall Study|Lost to Follow-up|2|||
33575081|NCT01276106|101996514|FG001|Overall Study|Lost to Follow-up|1|||
33575082|NCT01276106|101996515|FG002|Overall Study|Lost to Follow-up|1|||
33636203|NCT00459316|102218645|FG001|Steps 1 & 2|Death|1|||
33636204|NCT00459316|102218646|FG002|Steps 1 & 2|Death|0|||
33233093|NCT00975221|100753921|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
33233094|NCT00975221|100753920|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
33233095|NCT00975221|100753921|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
33575083|NCT01276106|101996516|FG003|Overall Study|Lost to Follow-up|0|||
33575084|NCT01276106|101996513|FG000|Overall Study|Physician Decision|0|||
33575085|NCT01276106|101996514|FG001|Overall Study|Physician Decision|0|||
33575086|NCT01276106|101996515|FG002|Overall Study|Physician Decision|1|||
33636205|NCT00459316|102218644|FG000|Steps 1 & 2|Not able to get to clinic|7|||
33636206|NCT00459316|102218645|FG001|Steps 1 & 2|Not able to get to clinic|4|||
33636207|NCT00459316|102218646|FG002|Steps 1 & 2|Not able to get to clinic|0|||
33636208|NCT00459316|102218644|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
33636209|NCT00459316|102218645|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
33636210|NCT00459316|102218646|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
33636211|NCT00459316|102218644|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
33636212|NCT00459316|102218645|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
33636213|NCT00459316|102218646|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
33636214|NCT00459316|102218644|FG000|Steps 1 & 2|Lost to Follow-up|5|||
33636215|NCT00459316|102218645|FG001|Steps 1 & 2|Lost to Follow-up|0|||
33636216|NCT00459316|102218646|FG002|Steps 1 & 2|Lost to Follow-up|2|||
33636217|NCT00459316|102218644|FG000|Step 3|Withdrawal by Subject|3|||
33233096|NCT00975221|100753920|FG000|Titration Phase (Weeks 1-12)|Other|0|||
33233097|NCT00975221|100753921|FG001|Titration Phase (Weeks 1-12)|Other|1|||
33233098|NCT00975221|100753920|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
33233099|NCT00975221|100753921|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
33233100|NCT00975221|100753920|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
33233101|NCT00975221|100753921|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
33233102|NCT00975221|100753920|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
33233103|NCT00975221|100753921|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
33233104|NCT03990363|100753935|FG000|Overall Study|Withdrawal by Subject|10|||
33233105|NCT03990363|100753936|FG001|Overall Study|Withdrawal by Subject|9|||
33233106|NCT03990363|100753937|FG002|Overall Study|Withdrawal by Subject|18|||
33233107|NCT03990363|100753938|FG003|Overall Study|Withdrawal by Subject|11|||
33420270|NCT01393626|101428562|FG000|Overall Study|Lost to Follow-up|1|||
33420271|NCT01393626|101428563|FG001|Overall Study|Lost to Follow-up|1|||
33420272|NCT01393626|101428564|FG002|Overall Study|Lost to Follow-up|1|||
33420273|NCT01393626|101428565|FG003|Overall Study|Lost to Follow-up|0|||
33137488|NCT02745145|100417281|FG002|Overall Study|Progressive disease|1|||
33137489|NCT02745145|100417279|FG000|Overall Study|Withdrew consent|1|||
33137490|NCT02745145|100417280|FG001|Overall Study|Withdrew consent|1|||
33137491|NCT02745145|100417281|FG002|Overall Study|Withdrew consent|1|||
33137492|NCT02745145|100417279|FG000|Overall Study|Study Termination|8|||
33137493|NCT02745145|100417280|FG001|Overall Study|Study Termination|3|||
33137494|NCT02745145|100417281|FG002|Overall Study|Study Termination|7|||
33575087|NCT01276106|101996516|FG003|Overall Study|Physician Decision|1|||
33575088|NCT01276106|101996513|FG000|Overall Study|Protocol Violation|1|||
33575089|NCT01276106|101996514|FG001|Overall Study|Protocol Violation|1|||
33575090|NCT01276106|101996515|FG002|Overall Study|Protocol Violation|0|||
33575091|NCT01276106|101996516|FG003|Overall Study|Protocol Violation|2|||
33575092|NCT01276106|101996513|FG000|Overall Study|Insufficient therapeutic effects|0|||
33575093|NCT01276106|101996514|FG001|Overall Study|Insufficient therapeutic effects|0|||
33575094|NCT01276106|101996515|FG002|Overall Study|Insufficient therapeutic effects|2|||
33575095|NCT01276106|101996516|FG003|Overall Study|Insufficient therapeutic effects|0|||
33575096|NCT03698019|101996521|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
33575097|NCT03698019|101996522|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
33575098|NCT03698019|101996521|FG000|Step 1: Registration|Withdrawal by Subject|7|||
33575099|NCT03698019|101996522|FG001|Step 1: Registration|Withdrawal by Subject|2|||
33575100|NCT03698019|101996521|FG000|Step 1: Registration|Toxicity|0|||
33575101|NCT03698019|101996522|FG001|Step 1: Registration|Toxicity|1|||
33575102|NCT03698019|101996521|FG000|Step 1: Registration|Disease Progression|0|||
33575103|NCT03698019|101996522|FG001|Step 1: Registration|Disease Progression|12|||
33575104|NCT03698019|101996521|FG000|Step 1: Registration|Co-morbidities|0|||
33575105|NCT03698019|101996522|FG001|Step 1: Registration|Co-morbidities|1|||
33575106|NCT03698019|101996521|FG000|Step 1: Registration|Scheduling Issues|1|||
33575107|NCT03698019|101996522|FG001|Step 1: Registration|Scheduling Issues|0|||
33575108|NCT03698019|101996521|FG000|Step 1: Registration|Participant Refusal|0|||
33575109|NCT03698019|101996522|FG001|Step 1: Registration|Participant Refusal|1|||
33575110|NCT03698019|101996521|FG000|Step 2: Surgery|Participant Refusal|2|||
33575111|NCT03698019|101996522|FG001|Step 2: Surgery|Participant Refusal|1|||
33575112|NCT03698019|101996521|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
33575113|NCT03698019|101996522|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
33575114|NCT03698019|101996521|FG000|Step 2: Surgery|Metastatic Disease|16|||
33575115|NCT03698019|101996522|FG001|Step 2: Surgery|Metastatic Disease|9|||
33575116|NCT03698019|101996521|FG000|Step 2: Surgery|Residual Disease|2|||
33636218|NCT00459316|102218645|FG001|Step 3|Withdrawal by Subject|0|||
33636219|NCT00459316|102218646|FG002|Step 3|Withdrawal by Subject|1|||
33636220|NCT01458392|102218647|FG000|Overall Study|Death|2|||
33575117|NCT03698019|101996522|FG001|Step 2: Surgery|Residual Disease|1|||
33575118|NCT03698019|101996521|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
33137495|NCT00662532|100417284|FG000|Overall Study|Adverse Event|0|||
33575119|NCT03698019|101996522|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
33575120|NCT03698019|101996521|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
33575121|NCT03698019|101996522|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
33575122|NCT03698019|101996521|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
33575123|NCT03698019|101996522|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
33575124|NCT03698019|101996521|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
33575125|NCT03698019|101996522|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
33575126|NCT03698019|101996521|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
33575127|NCT03698019|101996522|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
33575128|NCT03698019|101996521|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
33575129|NCT03698019|101996522|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
33575130|NCT03698019|101996521|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
33575131|NCT03698019|101996522|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
33575132|NCT03698019|101996521|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
33575133|NCT03698019|101996522|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
33575134|NCT02122380|101996527|FG000|First Intervention (30 Days)|Adverse Event|1|||
33575135|NCT02122380|101996528|FG001|First Intervention (30 Days)|Adverse Event|0|||
33575136|NCT02122380|101996527|FG000|First Intervention (30 Days)|Physician Decision|0|||
33575137|NCT02122380|101996528|FG001|First Intervention (30 Days)|Physician Decision|1|||
33575138|NCT02122380|101996527|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
33575139|NCT02122380|101996528|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
33575140|NCT02122380|101996527|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
33575141|NCT02122380|101996528|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
33575142|NCT02122380|101996527|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
33575143|NCT02122380|101996528|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
33575144|NCT00399035|101996530|FG000|Overall Study|Death|289|||
33575145|NCT00399035|101996531|FG001|Overall Study|Death|141|||
33575146|NCT00399035|101996532|FG002|Overall Study|Death|234|||
33636221|NCT01458392|102218648|FG001|Overall Study|Death|11|||
33636222|NCT01458392|102218649|FG002|Overall Study|Death|22|||
33636223|NCT01458392|102218647|FG000|Overall Study|At the discretion of the sponsor|0|||
33636224|NCT01458392|102218648|FG001|Overall Study|At the discretion of the sponsor|2|||
33137496|NCT00662532|100417285|FG001|Overall Study|Adverse Event|1|||
33137497|NCT00662532|100417284|FG000|Overall Study|Lost to Follow-up|0|||
33137498|NCT00662532|100417285|FG001|Overall Study|Lost to Follow-up|1|||
33137499|NCT00097981|100417286|FG000|Overall Study|Adverse Event|31|||
33137500|NCT00097981|100417287|FG001|Overall Study|Adverse Event|44|||
33137501|NCT00097981|100417286|FG000|Overall Study|Withdrawal by Subject|10|||
33137502|NCT00097981|100417287|FG001|Overall Study|Withdrawal by Subject|8|||
33137503|NCT00097981|100417286|FG000|Overall Study|Protocol Violation|1|||
33137504|NCT00097981|100417287|FG001|Overall Study|Protocol Violation|1|||
33137505|NCT00097981|100417286|FG000|Overall Study|Death|2|||
33137506|NCT00097981|100417287|FG001|Overall Study|Death|4|||
33137507|NCT00097981|100417286|FG000|Overall Study|Physician Decision|7|||
33137508|NCT00097981|100417287|FG001|Overall Study|Physician Decision|1|||
33137509|NCT00097981|100417286|FG000|Overall Study|Disease Progression|8|||
33137510|NCT00097981|100417287|FG001|Overall Study|Disease Progression|2|||
33575147|NCT00399035|101996530|FG000|Overall Study|Lost to Follow-up|2|||
33575148|NCT00399035|101996531|FG001|Overall Study|Lost to Follow-up|1|||
33575149|NCT00399035|101996532|FG002|Overall Study|Lost to Follow-up|5|||
33636225|NCT01458392|102218649|FG002|Overall Study|At the discretion of the sponsor|7|||
33636226|NCT01458392|102218647|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
33636227|NCT01458392|102218648|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
33636228|NCT01458392|102218649|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
33636229|NCT03213691|102218650|FG000|Overall Study|Adverse Event|2|||
33636230|NCT03213691|102218650|FG000|Overall Study|Death|3|||
33636231|NCT03213691|102218650|FG000|Overall Study|Physician Decision|1|||
33137511|NCT00097981|100417286|FG000|Overall Study|Transplant planned|28|||
33137512|NCT00097981|100417287|FG001|Overall Study|Transplant planned|27|||
33137513|NCT00097981|100417286|FG000|Overall Study|Other|19|||
33233108|NCT03990363|100753939|FG004|Overall Study|Withdrawal by Subject|9|||
33233109|NCT03990363|100753935|FG000|Overall Study|Physician Decision|1|||
33233110|NCT03990363|100753936|FG001|Overall Study|Physician Decision|0|||
33233111|NCT03990363|100753937|FG002|Overall Study|Physician Decision|0|||
33233112|NCT03990363|100753938|FG003|Overall Study|Physician Decision|0|||
33575150|NCT00399035|101996530|FG000|Overall Study|Withdrawal by Subject|19|||
33575151|NCT00399035|101996531|FG001|Overall Study|Withdrawal by Subject|15|||
33575152|NCT00399035|101996532|FG002|Overall Study|Withdrawal by Subject|12|||
33636232|NCT03213691|102218650|FG000|Overall Study|Progressive Disease|14|||
33575153|NCT00399035|101996530|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
33575154|NCT00399035|101996531|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
33575155|NCT00399035|101996532|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
33575156|NCT00399035|101996530|FG000|Overall Study|Severe non-compliance with protocol|2|||
33575157|NCT00399035|101996531|FG001|Overall Study|Severe non-compliance with protocol|1|||
33575158|NCT00399035|101996532|FG002|Overall Study|Severe non-compliance with protocol|0|||
33575159|NCT01342926|101996533|FG000|Overall Study|Adverse Event|5|||
33575160|NCT01342926|101996534|FG001|Overall Study|Adverse Event|8|||
33575161|NCT01342926|101996535|FG002|Overall Study|Adverse Event|10|||
33575162|NCT01342926|101996536|FG003|Overall Study|Adverse Event|7|||
33575163|NCT01342926|101996533|FG000|Overall Study|Lost to Follow-up|0|||
33575164|NCT01342926|101996534|FG001|Overall Study|Lost to Follow-up|1|||
33575165|NCT01342926|101996535|FG002|Overall Study|Lost to Follow-up|1|||
33575166|NCT01342926|101996536|FG003|Overall Study|Lost to Follow-up|0|||
33575167|NCT01342926|101996533|FG000|Overall Study|Investigator Discretion|2|||
33575168|NCT01342926|101996534|FG001|Overall Study|Investigator Discretion|2|||
33575169|NCT01342926|101996535|FG002|Overall Study|Investigator Discretion|0|||
33575170|NCT01342926|101996536|FG003|Overall Study|Investigator Discretion|0|||
33575171|NCT01342926|101996533|FG000|Overall Study|Withdrawal by Subject|2|||
33575172|NCT01342926|101996534|FG001|Overall Study|Withdrawal by Subject|4|||
33575173|NCT01342926|101996535|FG002|Overall Study|Withdrawal by Subject|3|||
33575174|NCT01342926|101996536|FG003|Overall Study|Withdrawal by Subject|5|||
33575175|NCT01493089|101996538|FG000|Overall Study|Protocol Violation|2|||
33575176|NCT01493089|101996539|FG001|Overall Study|Protocol Violation|2|||
33575177|NCT01493089|101996538|FG000|Overall Study|Withdrawal by Subject|1|||
33575178|NCT01493089|101996539|FG001|Overall Study|Withdrawal by Subject|0|||
33575179|NCT01493089|101996538|FG000|Overall Study|Physician Decision|0|||
33575180|NCT01493089|101996539|FG001|Overall Study|Physician Decision|1|||
33636233|NCT03213691|102218650|FG000|Overall Study|Ineligible|1|||
33636234|NCT01198795|102218651|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
33636235|NCT01198795|102218651|FG000|Overall Study|Withdrawal by Subject|17|||
33636236|NCT01198795|102218651|FG000|Overall Study|Lost to Follow-up|15|||
33575181|NCT01171677|101996547|FG000|Overall Study|Withdrawal by Subject|0|||
33575182|NCT01171677|101996548|FG001|Overall Study|Withdrawal by Subject|3|||
33575183|NCT01171677|101996547|FG000|Overall Study|Adverse Event|1|||
33575184|NCT01171677|101996548|FG001|Overall Study|Adverse Event|0|||
33575185|NCT01171677|101996547|FG000|Overall Study|completed <70% IntenSati classes|5|||
33636237|NCT01198795|102218651|FG000|Overall Study|Adverse Event|9|||
33636238|NCT01198795|102218651|FG000|Overall Study|Lack of Efficacy|5|||
33636239|NCT01198795|102218651|FG000|Overall Study|Protocol Violation|2|||
33636240|NCT01198795|102218651|FG000|Overall Study|Other Reason|4|||
33636241|NCT02900378|102218654|FG000|Randomization (Visit 2)|Adverse Event|14|||
33636242|NCT02900378|102218655|FG001|Randomization (Visit 2)|Adverse Event|11|||
33636243|NCT02900378|102218654|FG000|Randomization (Visit 2)|Death|1|||
33636244|NCT02900378|102218655|FG001|Randomization (Visit 2)|Death|4|||
33636245|NCT02900378|102218654|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
33636246|NCT02900378|102218655|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
33636247|NCT02900378|102218654|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
33636248|NCT02900378|102218655|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
33636249|NCT02900378|102218654|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
33636250|NCT02900378|102218655|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
33636251|NCT02900378|102218654|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
33636252|NCT02900378|102218655|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
33636253|NCT02900378|102218654|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
33636254|NCT02900378|102218655|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
33636255|NCT03694353|102218656|FG000|Overall Study|Withdrawal by Subject|1|||
33636256|NCT03694353|102218656|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
33636257|NCT01599637|102218657|FG000|Overall Study|administrative problems|0|||
33636258|NCT01599637|102218658|FG001|Overall Study|administrative problems|2|||
33636259|NCT01599637|102218659|FG002|Overall Study|administrative problems|0|||
33636260|NCT01599637|102218657|FG000|Overall Study|Adverse Event|1|||
33636261|NCT01599637|102218658|FG001|Overall Study|Adverse Event|0|||
33636262|NCT01599637|102218659|FG002|Overall Study|Adverse Event|0|||
33636263|NCT04119414|102218662|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
33636264|NCT04498832|102218663|FG000|Overall Study|Adverse Event|1|||
33636265|NCT04498832|102218664|FG001|Overall Study|Adverse Event|3|||
33636266|NCT04498832|102218663|FG000|Overall Study|Withdrawal by Subject|0|||
33636267|NCT04498832|102218664|FG001|Overall Study|Withdrawal by Subject|1|||
33636268|NCT02158442|102218665|FG000|Overall Study|Withdrawal by Subject|1|||
33420274|NCT01393626|101428562|FG000|Overall Study|Withdrawal by Subject|6|||
33575186|NCT01171677|101996548|FG001|Overall Study|completed <70% IntenSati classes|0|||
33575187|NCT03492177|101996553|FG000|Overall Study|Adverse Event|1|||
33575188|NCT03492177|101996554|FG001|Overall Study|Adverse Event|0|||
33575189|NCT03492177|101996555|FG002|Overall Study|Adverse Event|0|||
33575190|NCT03492177|101996553|FG000|Overall Study|Death|3|||
33575191|NCT03492177|101996554|FG001|Overall Study|Death|0|||
33575192|NCT03492177|101996555|FG002|Overall Study|Death|3|||
33575193|NCT03492177|101996553|FG000|Overall Study|Lack of Efficacy|1|||
33575194|NCT03492177|101996554|FG001|Overall Study|Lack of Efficacy|2|||
33575195|NCT03492177|101996555|FG002|Overall Study|Lack of Efficacy|0|||
33575196|NCT03492177|101996553|FG000|Overall Study|Other|1|||
33575197|NCT03492177|101996554|FG001|Overall Study|Other|0|||
33575198|NCT03492177|101996555|FG002|Overall Study|Other|0|||
33575199|NCT03492177|101996553|FG000|Overall Study|Ongoing|16|||
33575200|NCT03492177|101996554|FG001|Overall Study|Ongoing|19|||
33575201|NCT03492177|101996555|FG002|Overall Study|Ongoing|17|||
33636269|NCT02158442|102218666|FG001|Overall Study|Withdrawal by Subject|0|||
33636270|NCT02158442|102218665|FG000|Overall Study|Perfusion staff not available|1|||
33636271|NCT02158442|102218666|FG001|Overall Study|Perfusion staff not available|0|||
33636272|NCT00888134|102218667|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
33636273|NCT00888134|102218667|FG000|Follow-up|being followed for long-term survival|1|||
33636274|NCT02004093|102218672|FG000|Overall Study|Death|2|||
33636275|NCT02004093|102218673|FG001|Overall Study|Death|1|||
33636276|NCT02004093|102218672|FG000|Overall Study|Lack of Efficacy|66|||
33636277|NCT02004093|102218673|FG001|Overall Study|Lack of Efficacy|62|||
33636278|NCT02004093|102218672|FG000|Overall Study|Protocol Violation|0|||
33636279|NCT02004093|102218673|FG001|Overall Study|Protocol Violation|1|||
33636280|NCT02004093|102218672|FG000|Overall Study|Lost to Follow-up|0|||
33636281|NCT02004093|102218673|FG001|Overall Study|Lost to Follow-up|1|||
33636282|NCT02004093|102218672|FG000|Overall Study|Withdrawal by Subject|3|||
33636283|NCT02004093|102218673|FG001|Overall Study|Withdrawal by Subject|7|||
33636284|NCT02004093|102218672|FG000|Overall Study|Other|3|||
33636285|NCT02004093|102218673|FG001|Overall Study|Other|1|||
33636286|NCT00785785|102218674|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
33636287|NCT00785785|102218675|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
33636288|NCT00785785|102218674|FG000|Core Phase up to 36 Months|Adverse Event|31|||
33636289|NCT00785785|102218675|FG001|Core Phase up to 36 Months|Adverse Event|21|||
33636290|NCT00785785|102218674|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
33636291|NCT00785785|102218675|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
33636292|NCT00785785|102218674|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
33636293|NCT00785785|102218675|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
33636294|NCT00785785|102218674|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
33636295|NCT00785785|102218675|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
33636296|NCT00785785|102218674|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
33636297|NCT00785785|102218675|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
33636298|NCT00785785|102218674|FG000|Core Phase up to 36 Months|Administrative problems|3|||
33636299|NCT00785785|102218675|FG001|Core Phase up to 36 Months|Administrative problems|3|||
33636300|NCT00785785|102218674|FG000|Core Phase up to 36 Months|Death|5|||
33636301|NCT00785785|102218675|FG001|Core Phase up to 36 Months|Death|8|||
33636302|NCT00785785|102218674|FG000|Core Phase up to 36 Months|Disease progression|139|||
33636303|NCT00785785|102218675|FG001|Core Phase up to 36 Months|Disease progression|119|||
33636304|NCT00785785|102218674|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
33636305|NCT00785785|102218675|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
33636306|NCT00785785|102218674|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
33636307|NCT00785785|102218675|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
33636308|NCT00785785|102218674|FG000|Optional Extension Phase|Adverse Event|4|||
33636309|NCT00785785|102218675|FG001|Optional Extension Phase|Adverse Event|5|||
33636310|NCT00785785|102218674|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
33636311|NCT00785785|102218675|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
33636312|NCT00785785|102218674|FG000|Optional Extension Phase|Lost to Follow-up|1|||
33636313|NCT00785785|102218675|FG001|Optional Extension Phase|Lost to Follow-up|0|||
33636314|NCT00785785|102218674|FG000|Optional Extension Phase|Administrative problems|2|||
33636315|NCT00785785|102218675|FG001|Optional Extension Phase|Administrative problems|0|||
33636316|NCT00785785|102218674|FG000|Optional Extension Phase|Death|1|||
33636317|NCT00785785|102218675|FG001|Optional Extension Phase|Death|5|||
33636318|NCT00785785|102218674|FG000|Optional Extension Phase|Disease progression|22|||
33636319|NCT00785785|102218675|FG001|Optional Extension Phase|Disease progression|70|||
33636320|NCT00785785|102218674|FG000|Optional Extension Phase|Protocol deviation|0|||
33233113|NCT03990363|100753939|FG004|Overall Study|Physician Decision|0|||
33233114|NCT03990363|100753935|FG000|Overall Study|Adverse Event|1|||
33636321|NCT00785785|102218675|FG001|Optional Extension Phase|Protocol deviation|2|||
33636322|NCT00785785|102218674|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
33636323|NCT00785785|102218675|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
33636324|NCT01578486|102222762|FG000|Overall Study|Physician Decision|3|||
33636325|NCT01578486|102222762|FG000|Overall Study|Withdrawal by Subject|2|||
33233115|NCT03990363|100753936|FG001|Overall Study|Adverse Event|3|||
33575202|NCT00002766|101996556|FG000|Overall Study|Withdrawal by Subject|0|||
33575203|NCT00002766|101996557|FG001|Overall Study|Withdrawal by Subject|1|||
33575204|NCT00002766|101996556|FG000|Overall Study|Patient Not Treated|1|||
33636326|NCT02057250|102222763|FG000|AID Assessment Phase|Adverse Event|3|||
33636327|NCT02057250|102222764|FG001|AID Assessment Phase|Adverse Event|2|||
33636328|NCT02057250|102222765|FG002|AID Assessment Phase|Adverse Event|6|||
33636329|NCT02057250|102222766|FG003|AID Assessment Phase|Adverse Event|1|||
33636330|NCT02057250|102222767|FG004|AID Assessment Phase|Adverse Event|0|||
33636331|NCT02057250|102222763|FG000|AID Assessment Phase|Other than specified above|1|||
33636332|NCT02057250|102222764|FG001|AID Assessment Phase|Other than specified above|1|||
33636333|NCT02057250|102222765|FG002|AID Assessment Phase|Other than specified above|1|||
33636334|NCT02057250|102222766|FG003|AID Assessment Phase|Other than specified above|1|||
33636335|NCT02057250|102222767|FG004|AID Assessment Phase|Other than specified above|0|||
33636336|NCT02057250|102222763|FG000|Extension Phase|Adverse Event|0|||
33636337|NCT02057250|102222764|FG001|Extension Phase|Adverse Event|0|||
33636338|NCT02057250|102222765|FG002|Extension Phase|Adverse Event|0|||
33636339|NCT02057250|102222766|FG003|Extension Phase|Adverse Event|0|||
33636340|NCT02057250|102222767|FG004|Extension Phase|Adverse Event|15|||
33636341|NCT02057250|102222763|FG000|Extension Phase|Lack of Efficacy|0|||
33636342|NCT02057250|102222764|FG001|Extension Phase|Lack of Efficacy|0|||
33636343|NCT02057250|102222765|FG002|Extension Phase|Lack of Efficacy|0|||
33636344|NCT02057250|102222766|FG003|Extension Phase|Lack of Efficacy|0|||
33636345|NCT02057250|102222767|FG004|Extension Phase|Lack of Efficacy|10|||
33636346|NCT02057250|102222763|FG000|Extension Phase|Entered in this period but not treated|0|||
33636347|NCT02057250|102222764|FG001|Extension Phase|Entered in this period but not treated|0|||
33636348|NCT02057250|102222765|FG002|Extension Phase|Entered in this period but not treated|0|||
33636349|NCT02057250|102222766|FG003|Extension Phase|Entered in this period but not treated|0|||
33636350|NCT02057250|102222767|FG004|Extension Phase|Entered in this period but not treated|4|||
33636351|NCT02057250|102222763|FG000|Extension Phase|Other than specified above|0|||
33636352|NCT02057250|102222764|FG001|Extension Phase|Other than specified above|0|||
33636353|NCT02057250|102222765|FG002|Extension Phase|Other than specified above|0|||
33636354|NCT02057250|102222766|FG003|Extension Phase|Other than specified above|0|||
33636355|NCT02057250|102222767|FG004|Extension Phase|Other than specified above|7|||
33636356|NCT01614886|102222769|FG000|Overall Study|Adverse Event|15|||
33575205|NCT00002766|101996557|FG001|Overall Study|Patient Not Treated|2|||
33575206|NCT00002766|101996556|FG000|Overall Study|Adverse Event|1|||
33575207|NCT00002766|101996557|FG001|Overall Study|Adverse Event|1|||
33575208|NCT00002766|101996556|FG000|Overall Study|Protocol Violation|1|||
33575209|NCT00002766|101996557|FG001|Overall Study|Protocol Violation|0|||
33575210|NCT00956293|101996561|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
33575211|NCT00956293|101996562|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
33575212|NCT00956293|101996563|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
33575213|NCT00956293|101996561|FG000|Main Period (Pre-randomization)|Death|0|||
33575214|NCT00956293|101996562|FG001|Main Period (Pre-randomization)|Death|0|||
33575215|NCT00956293|101996563|FG002|Main Period (Pre-randomization)|Death|1|||
33575216|NCT00956293|101996561|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
33575217|NCT00956293|101996562|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
33575218|NCT00956293|101996563|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
33575219|NCT00956293|101996561|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
33575220|NCT00956293|101996562|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
33575221|NCT00956293|101996563|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
33575222|NCT00956293|101996561|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
33575223|NCT00956293|101996562|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
33575224|NCT00956293|101996563|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
33575225|NCT00956293|101996561|FG000|Main Period (Pre-randomization)|Graft loss|0|||
33575226|NCT00956293|101996562|FG001|Main Period (Pre-randomization)|Graft loss|0|||
33575227|NCT00956293|101996563|FG002|Main Period (Pre-randomization)|Graft loss|7|||
33575228|NCT00956293|101996561|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
33575229|NCT00956293|101996562|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
33575230|NCT00956293|101996563|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
33575231|NCT00956293|101996561|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
33575232|NCT00956293|101996562|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
33575233|NCT00956293|101996563|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
33575234|NCT00956293|101996561|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
33575235|NCT00956293|101996562|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
33636357|NCT01614886|102222770|FG001|Overall Study|Adverse Event|20|||
33636358|NCT01614886|102222769|FG000|Overall Study|Withdrawal by Subject|4|||
33636359|NCT01614886|102222770|FG001|Overall Study|Withdrawal by Subject|4|||
33575236|NCT00956293|101996563|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
33636360|NCT01614886|102222769|FG000|Overall Study|Death|1|||
33636361|NCT01614886|102222770|FG001|Overall Study|Death|0|||
33636362|NCT01614886|102222769|FG000|Overall Study|Protocol deviation|0|||
33575237|NCT00956293|101996561|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
33636363|NCT01614886|102222770|FG001|Overall Study|Protocol deviation|2|||
33636364|NCT01435382|102222771|FG000|Overall Study|Lost to Follow-up|1|||
33575238|NCT00956293|101996562|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
33575239|NCT00956293|101996563|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
33575240|NCT00956293|101996561|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
33575241|NCT00956293|101996562|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
33575242|NCT00956293|101996563|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
33575243|NCT00956293|101996561|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
33575244|NCT00956293|101996562|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
33575245|NCT00956293|101996563|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
33575246|NCT00956293|101996561|FG000|Main Period (Randomization)|Adverse Event|0|||
33575247|NCT00956293|101996562|FG001|Main Period (Randomization)|Adverse Event|15|||
33575248|NCT00956293|101996563|FG002|Main Period (Randomization)|Adverse Event|0|||
33575249|NCT00956293|101996561|FG000|Follow-up Period|Follow-up period was terminated.|20|||
33575250|NCT00956293|101996562|FG001|Follow-up Period|Follow-up period was terminated.|32|||
33636365|NCT01435382|102222772|FG001|Overall Study|Lost to Follow-up|0|||
33636366|NCT01435382|102222773|FG002|Overall Study|Lost to Follow-up|1|||
33636367|NCT01435382|102222774|FG003|Overall Study|Lost to Follow-up|0|||
33636368|NCT01435382|102222771|FG000|Overall Study|Withdrawal by Subject|0|||
33636369|NCT01435382|102222772|FG001|Overall Study|Withdrawal by Subject|2|||
33636370|NCT01435382|102222773|FG002|Overall Study|Withdrawal by Subject|0|||
33636371|NCT01435382|102222774|FG003|Overall Study|Withdrawal by Subject|1|||
33636372|NCT04393454|102222775|FG000|Overall Study|Death|1|||
33137514|NCT00097981|100417287|FG001|Overall Study|Other|13|||
33137515|NCT02788279|100417305|FG000|Overall Study|Death|62|||
33137516|NCT02788279|100417306|FG001|Overall Study|Death|136|||
33137517|NCT02788279|100417307|FG002|Overall Study|Death|72|||
33137518|NCT02788279|100417305|FG000|Overall Study|Withdrawal by Subject|10|||
33137519|NCT02788279|100417306|FG001|Overall Study|Withdrawal by Subject|15|||
33636373|NCT04393454|102222775|FG000|Overall Study|Lost to Follow-up|1|||
33636374|NCT00914316|102222776|FG000|Phase 1|Physician Decision|4|||
33636375|NCT00914316|102222777|FG001|Phase 1|Physician Decision|0|||
33636376|NCT00914316|102222778|FG002|Phase 1|Physician Decision|1|||
33636377|NCT00914316|102222779|FG003|Phase 1|Physician Decision|2|||
33636378|NCT00914316|102222776|FG000|Phase 1|Withdrawal by Subject|0|||
33636379|NCT00914316|102222777|FG001|Phase 1|Withdrawal by Subject|2|||
33636380|NCT00914316|102222778|FG002|Phase 1|Withdrawal by Subject|4|||
33636381|NCT00914316|102222779|FG003|Phase 1|Withdrawal by Subject|0|||
33636382|NCT00914316|102222776|FG000|Phase 1|Adverse Event|1|||
33636383|NCT00914316|102222777|FG001|Phase 1|Adverse Event|0|||
33636384|NCT00914316|102222778|FG002|Phase 1|Adverse Event|0|||
33636385|NCT00914316|102222779|FG003|Phase 1|Adverse Event|0|||
33636386|NCT00914316|102222776|FG000|Phase 2|Withdrawal by Subject|1|||
33636387|NCT00914316|102222777|FG001|Phase 2|Withdrawal by Subject|0|||
33137520|NCT02788279|100417307|FG002|Overall Study|Withdrawal by Subject|5|||
33137521|NCT02788279|100417305|FG000|Overall Study|Lost to Follow-up|0|||
33137522|NCT02788279|100417306|FG001|Overall Study|Lost to Follow-up|3|||
33137523|NCT02788279|100417307|FG002|Overall Study|Lost to Follow-up|2|||
33137524|NCT02788279|100417305|FG000|Overall Study|Sponsor decision|18|||
33137525|NCT02788279|100417306|FG001|Overall Study|Sponsor decision|29|||
33137526|NCT02788279|100417307|FG002|Overall Study|Sponsor decision|11|||
33137527|NCT01185353|100417308|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
33636388|NCT00914316|102222778|FG002|Phase 2|Withdrawal by Subject|1|||
33636389|NCT00914316|102222779|FG003|Phase 2|Withdrawal by Subject|0|||
33636390|NCT01063751|102222784|FG000|Overall Study|Site terminated|45|||
33636391|NCT01063751|102222784|FG000|Overall Study|Lost to Follow-up|28|||
33636392|NCT01063751|102222784|FG000|Overall Study|Withdrawal by Subject|25|||
33636393|NCT01063751|102222784|FG000|Overall Study|Revision|6|||
33636394|NCT01063751|102222784|FG000|Overall Study|Death|12|||
33636395|NCT01063751|102222784|FG000|Overall Study|Physician Decision|4|||
33636396|NCT01063751|102222784|FG000|Overall Study|Active|91|||
33137528|NCT01185353|100417309|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
33137529|NCT01185353|100417310|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
33137530|NCT01185353|100417311|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
33575251|NCT00956293|101996563|FG002|Follow-up Period|Follow-up period was terminated.|0|||
33575252|NCT04099277|101996564|FG000|Overall Study|Physician Decision|1|||
33575253|NCT04099277|101996564|FG000|Overall Study|Withdrawal by Subject|1|||
33575254|NCT03493958|101996565|FG000|Overall Study|Withdrawal by Subject|6|||
33575255|NCT03493958|101996565|FG000|Overall Study|Lost to Follow-up|7|||
33636397|NCT01929317|102222785|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
33636398|NCT01929317|102222786|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
33636399|NCT01929317|102222785|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
33636400|NCT01929317|102222786|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
33137531|NCT01185353|100417312|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
33137532|NCT01185353|100417313|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
33233116|NCT03990363|100753937|FG002|Overall Study|Adverse Event|2|||
33636401|NCT01929317|102222785|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
33636402|NCT01929317|102222786|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
33636403|NCT01929317|102222785|FG000|Long-term Phase|Adverse Event|5|||
33137533|NCT01185353|100417314|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
33137534|NCT01185353|100417315|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
33137535|NCT01185353|100417316|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
33137536|NCT01185353|100417317|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
33137537|NCT01185353|100417308|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33137538|NCT01185353|100417309|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33137539|NCT01185353|100417310|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33137540|NCT01185353|100417311|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33137541|NCT01185353|100417312|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
33137542|NCT01185353|100417313|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33137543|NCT01185353|100417314|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33137544|NCT01185353|100417315|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33137545|NCT01185353|100417316|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33137546|NCT01185353|100417317|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
33137547|NCT01185353|100417308|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
33137548|NCT01185353|100417309|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33137549|NCT01185353|100417310|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33137550|NCT01185353|100417311|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33137551|NCT01185353|100417312|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
33137552|NCT01185353|100417313|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33137553|NCT01185353|100417314|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33137554|NCT01185353|100417315|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33137555|NCT01185353|100417316|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33137556|NCT01185353|100417317|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
33137557|NCT01185353|100417308|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33137558|NCT01185353|100417309|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33137559|NCT01185353|100417310|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
33137560|NCT01185353|100417311|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33137561|NCT01185353|100417312|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
33137562|NCT01185353|100417313|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33137563|NCT01185353|100417314|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33575256|NCT03493958|101996565|FG000|Overall Study|Did not complete all required study procedures|2|||
33575257|NCT02365597|101996568|FG000|Overall Study|Lost to Follow-up|0|||
33575258|NCT02365597|101996569|FG001|Overall Study|Lost to Follow-up|1|||
33575259|NCT02365597|101996570|FG002|Overall Study|Lost to Follow-up|0|||
33137564|NCT01185353|100417315|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33137565|NCT01185353|100417316|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33137566|NCT01185353|100417317|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
33575260|NCT02365597|101996571|FG003|Overall Study|Lost to Follow-up|1|||
33575261|NCT02365597|101996568|FG000|Overall Study|Withdrawal by Subject|1|||
33575262|NCT02365597|101996569|FG001|Overall Study|Withdrawal by Subject|8|||
33575263|NCT02365597|101996570|FG002|Overall Study|Withdrawal by Subject|5|||
33575264|NCT02365597|101996571|FG003|Overall Study|Withdrawal by Subject|1|||
33575265|NCT02365597|101996568|FG000|Overall Study|Sponsor's decision|1|||
33575266|NCT02365597|101996569|FG001|Overall Study|Sponsor's decision|3|||
33575267|NCT02365597|101996570|FG002|Overall Study|Sponsor's decision|13|||
33575268|NCT02365597|101996571|FG003|Overall Study|Sponsor's decision|0|||
33575269|NCT02365597|101996568|FG000|Overall Study|Other|0|||
33575270|NCT02365597|101996569|FG001|Overall Study|Other|4|||
33575271|NCT02365597|101996570|FG002|Overall Study|Other|0|||
33575272|NCT02365597|101996571|FG003|Overall Study|Other|0|||
33575273|NCT02365597|101996568|FG000|Overall Study|Enrolled but not treated|0|||
33575274|NCT02365597|101996569|FG001|Overall Study|Enrolled but not treated|1|||
33575275|NCT02365597|101996570|FG002|Overall Study|Enrolled but not treated|1|||
33575276|NCT02365597|101996571|FG003|Overall Study|Enrolled but not treated|0|||
33575277|NCT02365597|101996568|FG000|Overall Study|Ongoing|0|||
33575278|NCT02365597|101996569|FG001|Overall Study|Ongoing|0|||
33575279|NCT02365597|101996570|FG002|Overall Study|Ongoing|0|||
33575280|NCT02365597|101996571|FG003|Overall Study|Ongoing|17|||
33575281|NCT01985022|101996572|FG000|Overall Study|Lost to Follow-up|0|||
33575282|NCT01985022|101996573|FG001|Overall Study|Lost to Follow-up|1|||
33575283|NCT01985022|101996572|FG000|Overall Study|Protocol Violation|0|||
33575284|NCT01985022|101996573|FG001|Overall Study|Protocol Violation|1|||
33575285|NCT01985022|101996572|FG000|Overall Study|Withdrawal by Subject|4|||
33575286|NCT01985022|101996573|FG001|Overall Study|Withdrawal by Subject|1|||
33575287|NCT02115321|101996574|FG000|Overall Study|Death|1|||
33636404|NCT01929317|102222786|FG001|Long-term Phase|Adverse Event|1|||
33137567|NCT01185353|100417308|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33137568|NCT01185353|100417309|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33137569|NCT01185353|100417310|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33137570|NCT01185353|100417311|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33575288|NCT02115321|101996575|FG001|Overall Study|Death|0|||
33575289|NCT02379052|101996576|FG000|Overall Study|Protocol Violation|0|||
33575290|NCT02379052|101996577|FG001|Overall Study|Protocol Violation|1|||
33575291|NCT02379052|101996576|FG000|Overall Study|Adverse Event|0|||
33575292|NCT02379052|101996577|FG001|Overall Study|Adverse Event|1|||
33575293|NCT02379052|101996576|FG000|Overall Study|Physician Decision|1|||
33137571|NCT01185353|100417312|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
33137572|NCT01185353|100417313|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33137573|NCT01185353|100417314|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33137574|NCT01185353|100417315|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33137575|NCT01185353|100417316|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33137576|NCT01185353|100417317|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
33137577|NCT01185353|100417308|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
33137578|NCT01185353|100417309|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33137579|NCT01185353|100417310|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33575294|NCT02379052|101996577|FG001|Overall Study|Physician Decision|1|||
33575295|NCT02379052|101996576|FG000|Overall Study|Withdrawal by Subject|2|||
33575296|NCT02379052|101996577|FG001|Overall Study|Withdrawal by Subject|0|||
33575297|NCT02379052|101996576|FG000|Overall Study|Lost to Follow-up|2|||
33575298|NCT02379052|101996577|FG001|Overall Study|Lost to Follow-up|1|||
33137580|NCT01185353|100417311|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33137581|NCT01185353|100417312|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
33137582|NCT01185353|100417313|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33137583|NCT01185353|100417314|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33137584|NCT01185353|100417315|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33137585|NCT01185353|100417316|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33137586|NCT01185353|100417317|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
33137587|NCT01185353|100417308|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33137588|NCT01185353|100417309|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33137589|NCT01185353|100417310|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
33137590|NCT01185353|100417311|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33137591|NCT01185353|100417312|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33137592|NCT01185353|100417313|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
33137593|NCT01185353|100417314|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33137594|NCT01185353|100417315|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33137595|NCT01185353|100417316|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33137596|NCT01185353|100417317|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
33137597|NCT01185353|100417308|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33137598|NCT01185353|100417309|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
33137599|NCT01185353|100417310|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33137600|NCT01185353|100417311|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
33137601|NCT01185353|100417312|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33137602|NCT01185353|100417313|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33137603|NCT01185353|100417314|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33137604|NCT01185353|100417315|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33137605|NCT01185353|100417316|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33137606|NCT01185353|100417317|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
33137607|NCT01185353|100417308|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33137608|NCT01185353|100417309|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33137609|NCT01185353|100417310|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33137610|NCT01185353|100417311|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
33137611|NCT01185353|100417312|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33137612|NCT01185353|100417313|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33137613|NCT01185353|100417314|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
33137614|NCT01185353|100417315|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33137615|NCT01185353|100417316|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33137616|NCT01185353|100417317|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
33137617|NCT01185353|100417308|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
33137618|NCT01185353|100417309|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
33137619|NCT01185353|100417310|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
33137620|NCT01185353|100417311|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
33137621|NCT01185353|100417312|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
33137622|NCT01185353|100417313|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
33137623|NCT01185353|100417314|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
33137624|NCT01185353|100417315|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
33575299|NCT02379052|101996576|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
33575300|NCT02379052|101996577|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
33575301|NCT02379052|101996576|FG000|Overall Study|Subject was Incarcerated|0|||
33137625|NCT01185353|100417316|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
33137626|NCT01185353|100417317|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
33137627|NCT01185353|100417308|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33575302|NCT02379052|101996577|FG001|Overall Study|Subject was Incarcerated|1|||
33575303|NCT02850978|101996578|FG000|Overall Study|Uncollectable CRF|27|||
33137628|NCT01185353|100417309|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33137629|NCT01185353|100417310|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33575304|NCT02850978|101996578|FG000|Overall Study|No visit since the first visit|35|||
33575305|NCT02850978|101996578|FG000|Overall Study|Adverse Event|81|||
33575306|NCT02850978|101996578|FG000|Overall Study|Lack of Efficacy|40|||
33575307|NCT02850978|101996578|FG000|Overall Study|Improvement in condition|34|||
33575308|NCT02850978|101996578|FG000|Overall Study|Lost to Follow-up|121|||
33575309|NCT02850978|101996578|FG000|Overall Study|Reason not listed|88|||
33575310|NCT00503984|101996579|FG000|Overall Study|Protocol Violation|0|||
33575311|NCT00503984|101996580|FG001|Overall Study|Protocol Violation|1|||
33575312|NCT00503984|101996581|FG002|Overall Study|Protocol Violation|0|||
33575313|NCT00503984|101996582|FG003|Overall Study|Protocol Violation|0|||
33636405|NCT01929317|102222785|FG000|Long-term Phase|Physician Decision|3|||
33137630|NCT01185353|100417311|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33137631|NCT01185353|100417312|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33137632|NCT01185353|100417313|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33137633|NCT01185353|100417314|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
33137634|NCT01185353|100417315|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33233117|NCT03990363|100753938|FG003|Overall Study|Adverse Event|2|||
33233118|NCT03990363|100753939|FG004|Overall Study|Adverse Event|0|||
33233119|NCT03990363|100753935|FG000|Overall Study|Death|14|||
33233120|NCT03990363|100753936|FG001|Overall Study|Death|8|||
33233121|NCT03990363|100753937|FG002|Overall Study|Death|14|||
33233122|NCT03990363|100753938|FG003|Overall Study|Death|10|||
33233123|NCT03990363|100753939|FG004|Overall Study|Death|11|||
33233124|NCT03990363|100753935|FG000|Overall Study|Failure to meet randomization criteria|0|||
33233125|NCT03990363|100753936|FG001|Overall Study|Failure to meet randomization criteria|1|||
33233126|NCT03990363|100753937|FG002|Overall Study|Failure to meet randomization criteria|1|||
33233127|NCT03990363|100753938|FG003|Overall Study|Failure to meet randomization criteria|0|||
33233128|NCT03990363|100753939|FG004|Overall Study|Failure to meet randomization criteria|0|||
33233129|NCT03990363|100753935|FG000|Overall Study|Lost to Follow-up|0|||
33233130|NCT03990363|100753936|FG001|Overall Study|Lost to Follow-up|0|||
33233131|NCT03990363|100753937|FG002|Overall Study|Lost to Follow-up|0|||
33233132|NCT03990363|100753938|FG003|Overall Study|Lost to Follow-up|1|||
33636406|NCT01929317|102222786|FG001|Long-term Phase|Physician Decision|0|||
33233133|NCT03990363|100753939|FG004|Overall Study|Lost to Follow-up|2|||
33233134|NCT03990363|100753935|FG000|Overall Study|Non-compliance with study drug|2|||
33233135|NCT03990363|100753936|FG001|Overall Study|Non-compliance with study drug|1|||
33233136|NCT03990363|100753937|FG002|Overall Study|Non-compliance with study drug|2|||
33233137|NCT03990363|100753938|FG003|Overall Study|Non-compliance with study drug|0|||
33233138|NCT03990363|100753939|FG004|Overall Study|Non-compliance with study drug|0|||
33233139|NCT03990363|100753935|FG000|Overall Study|Study terminated by sponsor|0|||
33233140|NCT03990363|100753936|FG001|Overall Study|Study terminated by sponsor|1|||
33233141|NCT03990363|100753937|FG002|Overall Study|Study terminated by sponsor|0|||
33233142|NCT03990363|100753938|FG003|Overall Study|Study terminated by sponsor|0|||
33233143|NCT03990363|100753939|FG004|Overall Study|Study terminated by sponsor|0|||
33233144|NCT03990363|100753935|FG000|Overall Study|Site terminated by sponsor|2|||
33233145|NCT03990363|100753936|FG001|Overall Study|Site terminated by sponsor|1|||
33233146|NCT03990363|100753937|FG002|Overall Study|Site terminated by sponsor|2|||
33575314|NCT00503984|101996583|FG004|Overall Study|Protocol Violation|0|||
33636407|NCT01929317|102222785|FG000|Long-term Phase|Withdrawal by Subject|4|||
33636408|NCT01929317|102222786|FG001|Long-term Phase|Withdrawal by Subject|0|||
33636409|NCT01929317|102222785|FG000|Long-term Phase|Protocol Violation|1|||
33636410|NCT01929317|102222786|FG001|Long-term Phase|Protocol Violation|0|||
33636411|NCT01929317|102222785|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
33636412|NCT01929317|102222786|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
33636413|NCT01929317|102222785|FG000|Long-term Phase|Study Closed/Terminated|5|||
33636414|NCT01929317|102222786|FG001|Long-term Phase|Study Closed/Terminated|3|||
33636415|NCT01812252|102222787|FG000|Overall Study|Persistent Disease|1|||
33636416|NCT01812252|102222788|FG001|Overall Study|Persistent Disease|0|||
33636417|NCT01812252|102222787|FG000|Overall Study|Not transplanted|11|||
33636418|NCT01812252|102222788|FG001|Overall Study|Not transplanted|11|||
33636419|NCT01812252|102222787|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
33636420|NCT01812252|102222788|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
33636421|NCT01812252|102222787|FG000|Overall Study|Withdrawal by Subject|1|||
33636422|NCT01812252|102222788|FG001|Overall Study|Withdrawal by Subject|1|||
33636423|NCT01812252|102222787|FG000|Overall Study|Screen Failure|1|||
33137635|NCT01185353|100417316|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33233147|NCT03990363|100753938|FG003|Overall Study|Site terminated by sponsor|0|||
33233148|NCT03990363|100753939|FG004|Overall Study|Site terminated by sponsor|2|||
33233149|NCT03990363|100753935|FG000|Overall Study|Not categorized|5|||
33233150|NCT03990363|100753936|FG001|Overall Study|Not categorized|5|||
33233151|NCT03990363|100753937|FG002|Overall Study|Not categorized|3|||
33233152|NCT03990363|100753938|FG003|Overall Study|Not categorized|2|||
33137636|NCT01185353|100417317|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
33137637|NCT01185353|100417308|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
33137638|NCT01185353|100417309|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
33137639|NCT01185353|100417310|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
33137640|NCT01185353|100417311|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
33137641|NCT01185353|100417312|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
33233153|NCT03990363|100753939|FG004|Overall Study|Not categorized|2|||
33233154|NCT02019602|100753940|FG000|Screening Period|Ineligibility|4|||
33233155|NCT02019602|100753941|FG001|Screening Period|Ineligibility|0|||
33233156|NCT02019602|100753940|FG000|Screening Period|Adverse Event|1|||
33233157|NCT02019602|100753941|FG001|Screening Period|Adverse Event|0|||
33233158|NCT00627042|100753946|FG000|Overall Study|Withdrawal by Subject|2|||
33233159|NCT00988351|100753949|FG000|Overall Study|Withdrawal by Subject|8|||
33233160|NCT00988351|100753950|FG001|Overall Study|Withdrawal by Subject|0|||
33233161|NCT00988351|100753949|FG000|Overall Study|Lost to Follow-up|6|||
33233162|NCT00988351|100753950|FG001|Overall Study|Lost to Follow-up|9|||
33233163|NCT00988351|100753949|FG000|Overall Study|not using CPAP|5|||
33233164|NCT00988351|100753950|FG001|Overall Study|not using CPAP|3|||
33233165|NCT04781647|100753953|FG000|Overall Study|Study terminated by Sponsor|11|||
33233166|NCT04781647|100753954|FG001|Overall Study|Study terminated by Sponsor|9|||
33233167|NCT04781647|100753955|FG002|Overall Study|Study terminated by Sponsor|9|||
33233168|NCT04781647|100753953|FG000|Overall Study|Withdrawal by Subject|1|||
33233169|NCT04781647|100753954|FG001|Overall Study|Withdrawal by Subject|2|||
33233170|NCT04781647|100753955|FG002|Overall Study|Withdrawal by Subject|0|||
33233171|NCT04781647|100753953|FG000|Overall Study|Adverse Event|0|||
33233172|NCT04781647|100753954|FG001|Overall Study|Adverse Event|1|||
33233173|NCT04781647|100753955|FG002|Overall Study|Adverse Event|1|||
33233174|NCT04781647|100753953|FG000|Overall Study|Protocol Violation|1|||
33233175|NCT04781647|100753954|FG001|Overall Study|Protocol Violation|0|||
33233176|NCT04781647|100753955|FG002|Overall Study|Protocol Violation|0|||
33233177|NCT04781647|100753953|FG000|Overall Study|Pregnancy|0|||
33233178|NCT04781647|100753954|FG001|Overall Study|Pregnancy|0|||
33233179|NCT04781647|100753955|FG002|Overall Study|Pregnancy|1|||
33233180|NCT04781647|100753953|FG000|Overall Study|Virology rebounded|1|||
33233181|NCT04781647|100753954|FG001|Overall Study|Virology rebounded|0|||
33233182|NCT04781647|100753955|FG002|Overall Study|Virology rebounded|0|||
33233183|NCT01313923|100753956|FG000|Overall Study|Physician Decision|3|||
33233184|NCT01267825|100753959|FG000|Overall Study|study terminated. no data collected.|1|||
33233185|NCT01267825|100753960|FG001|Overall Study|study terminated. no data collected.|0|||
33233186|NCT01818141|100753961|FG000|Overall Study|Withdrawal by Subject|2|||
33233187|NCT01818141|100753962|FG001|Overall Study|Withdrawal by Subject|0|||
33233188|NCT01818141|100753961|FG000|Overall Study|No baseline C.diff colonies|1|||
33233189|NCT01818141|100753962|FG001|Overall Study|No baseline C.diff colonies|1|||
33233190|NCT01818141|100753961|FG000|Overall Study|Lost to Follow-up|0|||
33233191|NCT01818141|100753962|FG001|Overall Study|Lost to Follow-up|2|||
33233192|NCT00393094|100753963|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
33233193|NCT00393094|100753963|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
33233194|NCT03958630|100753964|FG000|Overall Study|Withdrawal by Subject|0|||
33233195|NCT03958630|100753965|FG001|Overall Study|Withdrawal by Subject|0|||
33420275|NCT01393626|101428563|FG001|Overall Study|Withdrawal by Subject|4|||
33636424|NCT01812252|102222788|FG001|Overall Study|Screen Failure|0|||
33636425|NCT00684021|102222790|FG000|Overall Study|MRI Contraindicated|1|||
33636426|NCT00684021|102222791|FG001|Overall Study|MRI Contraindicated|1|||
33636427|NCT00684021|102222792|FG002|Overall Study|MRI Contraindicated|1|||
33636428|NCT00684021|102222793|FG003|Overall Study|MRI Contraindicated|0|||
33636429|NCT00684021|102222790|FG000|Overall Study|MRI not performed|0|||
33636430|NCT00684021|102222791|FG001|Overall Study|MRI not performed|1|||
33636431|NCT00684021|102222792|FG002|Overall Study|MRI not performed|1|||
33636432|NCT00684021|102222793|FG003|Overall Study|MRI not performed|2|||
33636433|NCT00684021|102222790|FG000|Overall Study|Death|1|||
33636434|NCT00684021|102222791|FG001|Overall Study|Death|0|||
33636435|NCT00684021|102222792|FG002|Overall Study|Death|0|||
33636436|NCT00684021|102222793|FG003|Overall Study|Death|0|||
33636437|NCT01656408|102222794|FG000|Overall Study|Adverse Event|0|||
33137642|NCT01185353|100417313|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
33233196|NCT03958630|100753966|FG002|Overall Study|Withdrawal by Subject|1|||
33233197|NCT03958630|100753964|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
33233198|NCT03958630|100753965|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
33233199|NCT03958630|100753966|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
33233200|NCT02500979|100753967|FG000|Period 1|Hyperglycemia|1|||
33233201|NCT02500979|100753968|FG001|Period 1|Hyperglycemia|0|||
33233202|NCT02500979|100753967|FG000|Period 1|Severe non-compliance to protocol|0|||
33233203|NCT02500979|100753968|FG001|Period 1|Severe non-compliance to protocol|1|||
33233204|NCT02500979|100753967|FG000|Period 1|Adverse Event|1|||
33233205|NCT02500979|100753968|FG001|Period 1|Adverse Event|0|||
33233206|NCT02500979|100753967|FG000|Period 1|Subject decision|2|||
33233207|NCT02500979|100753968|FG001|Period 1|Subject decision|0|||
33636438|NCT01656408|102222795|FG001|Overall Study|Adverse Event|0|||
33233208|NCT02500979|100753967|FG000|Period 2|Change in risk|1|||
33233209|NCT02500979|100753968|FG001|Period 2|Change in risk|0|||
33233210|NCT00993317|100753969|FG000|Overall Study|Adverse Event|2|||
33233211|NCT00993317|100753970|FG001|Overall Study|Adverse Event|4|||
33233212|NCT00993317|100753969|FG000|Overall Study|Lack of Efficacy|18|||
33233213|NCT00993317|100753970|FG001|Overall Study|Lack of Efficacy|18|||
33233214|NCT00993317|100753969|FG000|Overall Study|Withdrawal by Subject|0|||
33233215|NCT00993317|100753970|FG001|Overall Study|Withdrawal by Subject|2|||
33233216|NCT00993317|100753969|FG000|Overall Study|Investigator's opinion|0|||
33233217|NCT00993317|100753970|FG001|Overall Study|Investigator's opinion|1|||
33233218|NCT00993317|100753969|FG000|Overall Study|Early study termination at the site|1|||
33233219|NCT00993317|100753970|FG001|Overall Study|Early study termination at the site|0|||
33233220|NCT02091869|100753971|FG000|Overall Study|Withdrawal by Subject|0|||
33233221|NCT02091869|100753972|FG001|Overall Study|Withdrawal by Subject|3|||
33233222|NCT04276090|100753973|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
33233223|NCT04276090|100753974|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
33233224|NCT02310126|100753975|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
33233225|NCT02310126|100753976|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
33233226|NCT02310126|100753975|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
33233227|NCT02310126|100753976|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
33233228|NCT00287469|100753977|FG000|Overall Study|serious adverse event|1|||
33233229|NCT00287469|100753978|FG001|Overall Study|serious adverse event|6|||
33233230|NCT00287469|100753977|FG000|Overall Study|Adverse Event|1|||
33233231|NCT00287469|100753978|FG001|Overall Study|Adverse Event|1|||
33233232|NCT00287469|100753977|FG000|Overall Study|moved from area|144|||
33233233|NCT00287469|100753978|FG001|Overall Study|moved from area|138|||
33233234|NCT00287469|100753977|FG000|Overall Study|Lost to Follow-up|74|||
33233235|NCT00287469|100753978|FG001|Overall Study|Lost to Follow-up|69|||
33233236|NCT03881059|100753991|FG000|Treatment Period - Part A|Adverse Event|1|||
33233237|NCT03881059|100753992|FG001|Treatment Period - Part A|Adverse Event|3|||
33233238|NCT03881059|100753993|FG002|Treatment Period - Part A|Adverse Event|4|||
33233239|NCT03881059|100753991|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
33233240|NCT03881059|100753992|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
33233241|NCT03881059|100753993|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
33233242|NCT03881059|100753991|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
33233243|NCT03881059|100753992|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
33233244|NCT03881059|100753993|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
33233245|NCT03881059|100753991|FG000|Treatment Period - Part A|Other reasons|2|||
33233246|NCT03881059|100753992|FG001|Treatment Period - Part A|Other reasons|1|||
33233247|NCT03881059|100753993|FG002|Treatment Period - Part A|Other reasons|0|||
33137643|NCT01185353|100417314|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
33137644|NCT01185353|100417315|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
33137645|NCT01185353|100417316|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
33137646|NCT01185353|100417317|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
33137647|NCT01185353|100417308|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
33137648|NCT01185353|100417309|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
33137649|NCT01185353|100417310|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
33137650|NCT01185353|100417311|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
33137651|NCT01185353|100417312|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
33137652|NCT01185353|100417313|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
33137653|NCT01185353|100417314|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
33137654|NCT01185353|100417315|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
33137655|NCT01185353|100417316|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
33137656|NCT01185353|100417317|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
33137657|NCT01185353|100417308|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
33137658|NCT01185353|100417309|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
33137659|NCT01185353|100417310|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
33137660|NCT01185353|100417311|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
33137661|NCT01185353|100417312|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
33137662|NCT01185353|100417313|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
33137663|NCT01185353|100417314|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
33137664|NCT01185353|100417315|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
33137665|NCT01185353|100417316|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
33137666|NCT01185353|100417317|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
33137667|NCT01185353|100417308|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33137668|NCT01185353|100417309|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33137669|NCT01185353|100417310|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33137670|NCT01185353|100417311|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33137671|NCT01185353|100417312|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33137672|NCT01185353|100417313|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33233248|NCT03881059|100753991|FG000|Treatment Period - Part B|Adverse Event|0|||
33233249|NCT03881059|100753992|FG001|Treatment Period - Part B|Adverse Event|0|||
33233250|NCT03881059|100753993|FG002|Treatment Period - Part B|Adverse Event|3|||
33233251|NCT03881059|100753991|FG000|Treatment Period - Part B|Death|0|||
33233252|NCT03881059|100753992|FG001|Treatment Period - Part B|Death|1|||
33233253|NCT03881059|100753993|FG002|Treatment Period - Part B|Death|1|||
33233254|NCT03881059|100753991|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
33233255|NCT03881059|100753992|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
33233256|NCT03881059|100753993|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
33233257|NCT03881059|100753991|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
33233258|NCT03881059|100753992|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
33233259|NCT03881059|100753993|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
33233260|NCT03881059|100753991|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
33233261|NCT03881059|100753992|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
33233262|NCT03881059|100753993|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
33233263|NCT03881059|100753991|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
33233264|NCT03881059|100753992|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
33233265|NCT03881059|100753993|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
33233266|NCT03881059|100753991|FG000|Treatment Period - Part B|Other reasons|4|||
33233267|NCT03881059|100753992|FG001|Treatment Period - Part B|Other reasons|3|||
33233268|NCT03881059|100753993|FG002|Treatment Period - Part B|Other reasons|3|||
33233269|NCT00451217|100753994|FG000|Overall Study|Lost to Follow-up|0|||
33233270|NCT00451217|100753995|FG001|Overall Study|Lost to Follow-up|1|||
33233271|NCT00451217|100753996|FG002|Overall Study|Lost to Follow-up|1|||
33233272|NCT00451217|100753997|FG003|Overall Study|Lost to Follow-up|1|||
33233273|NCT00451217|100753994|FG000|Overall Study|Withdrawal by Subject|1|||
33233274|NCT00451217|100753995|FG001|Overall Study|Withdrawal by Subject|0|||
33233275|NCT00451217|100753996|FG002|Overall Study|Withdrawal by Subject|0|||
33233276|NCT00451217|100753997|FG003|Overall Study|Withdrawal by Subject|0|||
33233277|NCT00451217|100753994|FG000|Overall Study|Not Treated|1|||
33233278|NCT00451217|100753995|FG001|Overall Study|Not Treated|1|||
33233279|NCT00451217|100753996|FG002|Overall Study|Not Treated|3|||
33233280|NCT00451217|100753997|FG003|Overall Study|Not Treated|4|||
33233281|NCT02743793|100753998|FG000|Overall Study|Death|1|||
33233282|NCT02743793|100753999|FG001|Overall Study|Death|1|||
33233283|NCT02743793|100753998|FG000|Overall Study|Withdrawal by Subject|0|||
33233284|NCT02743793|100753999|FG001|Overall Study|Withdrawal by Subject|1|||
33233285|NCT02743793|100753998|FG000|Overall Study|Screen Failure|4|||
33233286|NCT02743793|100753999|FG001|Overall Study|Screen Failure|0|||
33233287|NCT02743793|100753998|FG000|Overall Study|No Primary Care Physician|0|||
33233288|NCT02743793|100753999|FG001|Overall Study|No Primary Care Physician|1|||
33233289|NCT02743793|100753998|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
33233290|NCT02743793|100753999|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
33233291|NCT02743793|100753998|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
33233292|NCT02743793|100753999|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
33233293|NCT04537897|100754004|FG000|Overall Study|Other than listed|0|||
33233294|NCT04537897|100754005|FG001|Overall Study|Other than listed|0|||
33233295|NCT04537897|100754006|FG002|Overall Study|Other than listed|0|||
33233296|NCT04537897|100754007|FG003|Overall Study|Other than listed|0|||
33233297|NCT04537897|100754008|FG004|Overall Study|Other than listed|0|||
33233298|NCT04537897|100754009|FG005|Overall Study|Other than listed|0|||
33575315|NCT00503984|101996584|FG005|Overall Study|Protocol Violation|0|||
33575316|NCT00503984|101996579|FG000|Overall Study|Adverse Event|0|||
33575317|NCT00503984|101996580|FG001|Overall Study|Adverse Event|1|||
33575318|NCT00503984|101996581|FG002|Overall Study|Adverse Event|0|||
33575319|NCT00503984|101996582|FG003|Overall Study|Adverse Event|0|||
33575320|NCT00503984|101996583|FG004|Overall Study|Adverse Event|0|||
33233299|NCT04537897|100754010|FG006|Overall Study|Other than listed|1|||
33575321|NCT00503984|101996584|FG005|Overall Study|Adverse Event|0|||
33575322|NCT00503984|101996579|FG000|Overall Study|Death|0|||
33575323|NCT00503984|101996580|FG001|Overall Study|Death|0|||
33575324|NCT00503984|101996581|FG002|Overall Study|Death|0|||
33575325|NCT00503984|101996582|FG003|Overall Study|Death|0|||
33233300|NCT04537897|100754011|FG007|Overall Study|Other than listed|0|||
33233301|NCT04537897|100754012|FG008|Overall Study|Other than listed|0|||
33233302|NCT04537897|100754004|FG000|Overall Study|Adverse Event|0|||
33575326|NCT00503984|101996583|FG004|Overall Study|Death|1|||
33575327|NCT00503984|101996584|FG005|Overall Study|Death|0|||
33575328|NCT05142306|101996585|FG000|Overall Study|Withdrawal by Subject|0|||
33233303|NCT04537897|100754005|FG001|Overall Study|Adverse Event|0|||
33233304|NCT04537897|100754006|FG002|Overall Study|Adverse Event|0|||
33233305|NCT04537897|100754007|FG003|Overall Study|Adverse Event|1|||
33233306|NCT04537897|100754008|FG004|Overall Study|Adverse Event|0|||
33233307|NCT04537897|100754009|FG005|Overall Study|Adverse Event|0|||
33233308|NCT04537897|100754010|FG006|Overall Study|Adverse Event|0|||
33233309|NCT04537897|100754011|FG007|Overall Study|Adverse Event|0|||
33575329|NCT05142306|101996586|FG001|Overall Study|Withdrawal by Subject|0|||
33575330|NCT05142306|101996587|FG002|Overall Study|Withdrawal by Subject|1|||
33575331|NCT01299389|101996588|FG000|Double-blind|Adverse Event|45|||
33575332|NCT01299389|101996589|FG001|Double-blind|Adverse Event|27|||
33575333|NCT01299389|101996590|FG002|Double-blind|Adverse Event|0|||
33575334|NCT01299389|101996591|FG003|Double-blind|Adverse Event|0|||
33575335|NCT01299389|101996588|FG000|Double-blind|Lack of Efficacy|45|||
33575336|NCT01299389|101996589|FG001|Double-blind|Lack of Efficacy|21|||
33575337|NCT01299389|101996590|FG002|Double-blind|Lack of Efficacy|0|||
33575338|NCT01299389|101996591|FG003|Double-blind|Lack of Efficacy|0|||
33575339|NCT01299389|101996588|FG000|Double-blind|Lost to Follow-up|2|||
33636439|NCT01656408|102222796|FG002|Overall Study|Adverse Event|1|||
33636440|NCT01656408|102222797|FG003|Overall Study|Adverse Event|0|||
33636441|NCT01656408|102222798|FG004|Overall Study|Adverse Event|0|||
33636442|NCT01656408|102222799|FG005|Overall Study|Adverse Event|1|||
33636443|NCT01656408|102222800|FG006|Overall Study|Adverse Event|1|||
33636444|NCT01656408|102222801|FG007|Overall Study|Adverse Event|0|||
33636445|NCT01656408|102222802|FG008|Overall Study|Adverse Event|1|||
33636446|NCT01656408|102222803|FG009|Overall Study|Adverse Event|0|||
33636447|NCT01656408|102222794|FG000|Overall Study|Physician Decision|1|||
33636448|NCT01656408|102222795|FG001|Overall Study|Physician Decision|0|||
33636449|NCT01656408|102222796|FG002|Overall Study|Physician Decision|1|||
33636450|NCT01656408|102222797|FG003|Overall Study|Physician Decision|0|||
33636451|NCT01656408|102222798|FG004|Overall Study|Physician Decision|1|||
33636452|NCT01656408|102222799|FG005|Overall Study|Physician Decision|1|||
33636453|NCT01656408|102222800|FG006|Overall Study|Physician Decision|0|||
33575340|NCT01299389|101996589|FG001|Double-blind|Lost to Follow-up|1|||
33575341|NCT01299389|101996590|FG002|Double-blind|Lost to Follow-up|0|||
33575342|NCT01299389|101996591|FG003|Double-blind|Lost to Follow-up|0|||
33575343|NCT01299389|101996588|FG000|Double-blind|Withdrawal by Subject|16|||
33575344|NCT01299389|101996589|FG001|Double-blind|Withdrawal by Subject|13|||
33636454|NCT01656408|102222801|FG007|Overall Study|Physician Decision|1|||
33636455|NCT01656408|102222802|FG008|Overall Study|Physician Decision|1|||
33636456|NCT01656408|102222803|FG009|Overall Study|Physician Decision|3|||
33636457|NCT02556177|102222806|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
33636458|NCT02556177|102222807|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
33636459|NCT01112917|102222810|FG000|Overall Study|Death|2|||
33137673|NCT01185353|100417314|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33137674|NCT01185353|100417315|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33137675|NCT01185353|100417316|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
33137676|NCT01185353|100417317|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
33137677|NCT01185353|100417308|FG000|Part C (Weeks 24 Through 76)|Death|0|||
33137678|NCT01185353|100417309|FG001|Part C (Weeks 24 Through 76)|Death|0|||
33137679|NCT01185353|100417310|FG002|Part C (Weeks 24 Through 76)|Death|0|||
33137680|NCT01185353|100417311|FG003|Part C (Weeks 24 Through 76)|Death|0|||
33137681|NCT01185353|100417312|FG004|Part C (Weeks 24 Through 76)|Death|0|||
33137682|NCT01185353|100417313|FG005|Part C (Weeks 24 Through 76)|Death|0|||
33137683|NCT01185353|100417314|FG006|Part C (Weeks 24 Through 76)|Death|0|||
33137684|NCT01185353|100417315|FG007|Part C (Weeks 24 Through 76)|Death|0|||
33137685|NCT01185353|100417316|FG008|Part C (Weeks 24 Through 76)|Death|0|||
33137686|NCT01185353|100417317|FG009|Part C (Weeks 24 Through 76)|Death|1|||
33137687|NCT01185353|100417308|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33137688|NCT01185353|100417309|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33137689|NCT01185353|100417310|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33137690|NCT01185353|100417311|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33137691|NCT01185353|100417312|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33137692|NCT01185353|100417313|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33137693|NCT01185353|100417314|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33137694|NCT01185353|100417315|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33137695|NCT01185353|100417316|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
33137696|NCT01185353|100417317|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
33233310|NCT04537897|100754012|FG008|Overall Study|Adverse Event|0|||
33137697|NCT01185353|100417308|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33137698|NCT01185353|100417309|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33137699|NCT01185353|100417310|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33137700|NCT01185353|100417311|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33137701|NCT01185353|100417312|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33233311|NCT04537897|100754004|FG000|Overall Study|Withdrawal by Subject|0|||
33137702|NCT01185353|100417313|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33636460|NCT01112917|102222811|FG001|Overall Study|Death|11|||
33636461|NCT01112917|102222810|FG000|Overall Study|Lost to Follow-up|1|||
33636462|NCT01112917|102222811|FG001|Overall Study|Lost to Follow-up|1|||
33575345|NCT01299389|101996590|FG002|Double-blind|Withdrawal by Subject|0|||
33636463|NCT01112917|102222810|FG000|Overall Study|Withdrawal by Subject|1|||
33575346|NCT01299389|101996591|FG003|Double-blind|Withdrawal by Subject|0|||
33575347|NCT01299389|101996588|FG000|Double-blind|Other|1|||
33636464|NCT01112917|102222811|FG001|Overall Study|Withdrawal by Subject|3|||
33636465|NCT01112917|102222810|FG000|Overall Study|Unable to Convert Filter|3|||
33636466|NCT01112917|102222811|FG001|Overall Study|Unable to Convert Filter|0|||
33636467|NCT00494676|102222812|FG000|Allocation|Withdrawal by Subject|2|||
33636468|NCT00494676|102222813|FG001|Allocation|Withdrawal by Subject|4|||
33636469|NCT00494676|102222812|FG000|First Intervention|Withdrawal by Subject|1|||
33636470|NCT00494676|102222813|FG001|First Intervention|Withdrawal by Subject|3|||
33636471|NCT00494676|102222812|FG000|Second Intervention|Withdrawal by Subject|1|||
33636472|NCT00494676|102222813|FG001|Second Intervention|Withdrawal by Subject|1|||
33636473|NCT01520506|102222814|FG000|Overall Study|Missed Visit|4|||
33636474|NCT01520506|102222814|FG000|Overall Study|Lost to Follow-up|1|||
33636475|NCT01520506|102222814|FG000|Overall Study|Withdrawal by Subject|1|||
33636476|NCT02141295|102222815|FG000|Overall Study|Adverse Event|1|||
33636477|NCT02141295|102222816|FG001|Overall Study|Adverse Event|18|||
33636478|NCT02141295|102222817|FG002|Overall Study|Adverse Event|11|||
33636479|NCT02141295|102222815|FG000|Overall Study|Physician Decision|2|||
33636480|NCT02141295|102222816|FG001|Overall Study|Physician Decision|19|||
33636481|NCT02141295|102222817|FG002|Overall Study|Physician Decision|14|||
33636482|NCT02141295|102222815|FG000|Overall Study|Study terminated by sponsor|0|||
33233312|NCT04537897|100754005|FG001|Overall Study|Withdrawal by Subject|1|||
33233313|NCT04537897|100754006|FG002|Overall Study|Withdrawal by Subject|0|||
33233314|NCT04537897|100754007|FG003|Overall Study|Withdrawal by Subject|0|||
33233315|NCT04537897|100754008|FG004|Overall Study|Withdrawal by Subject|0|||
33233316|NCT04537897|100754009|FG005|Overall Study|Withdrawal by Subject|0|||
33233317|NCT04537897|100754010|FG006|Overall Study|Withdrawal by Subject|0|||
33233318|NCT04537897|100754011|FG007|Overall Study|Withdrawal by Subject|0|||
33233319|NCT04537897|100754012|FG008|Overall Study|Withdrawal by Subject|0|||
33233320|NCT02032173|100754013|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
33233321|NCT01680458|100754014|FG000|Overall Study|Protocol Violation|3|||
33233322|NCT02248961|100757475|FG000|Overall Study|Adverse Event|1|||
33233323|NCT02248961|100757476|FG001|Overall Study|Adverse Event|0|||
33233324|NCT02248961|100757475|FG000|Overall Study|Withdrawal by Subject|1|||
33233325|NCT02248961|100757476|FG001|Overall Study|Withdrawal by Subject|2|||
33233326|NCT02248961|100757475|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
33575348|NCT01299389|101996589|FG001|Double-blind|Other|1|||
33636483|NCT02141295|102222816|FG001|Overall Study|Study terminated by sponsor|6|||
33636484|NCT02141295|102222817|FG002|Overall Study|Study terminated by sponsor|6|||
33636485|NCT02141295|102222815|FG000|Overall Study|Non-compliance|0|||
33636486|NCT02141295|102222816|FG001|Overall Study|Non-compliance|1|||
33636487|NCT02141295|102222817|FG002|Overall Study|Non-compliance|0|||
33233327|NCT02248961|100757476|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
33233328|NCT01785628|100757477|FG000|Overall Study|Lost to Follow-up|2|||
33233329|NCT01785628|100757478|FG001|Overall Study|Lost to Follow-up|3|||
33233330|NCT00655551|100757484|FG000|All Periods Combined|Adverse Event|0|||
33233331|NCT00655551|100757485|FG001|All Periods Combined|Adverse Event|3|||
33368418|NCT03422133|101234828|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
33368419|NCT00872170|101234829|FG000|Overall Study|Adverse Event|1|||
33575349|NCT01299389|101996590|FG002|Double-blind|Other|0|||
33575350|NCT01299389|101996591|FG003|Double-blind|Other|0|||
33233332|NCT00655551|100757486|FG002|All Periods Combined|Adverse Event|4|||
33233333|NCT00655551|100757484|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
33233334|NCT00655551|100757485|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
33233335|NCT00655551|100757486|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
33233336|NCT00655551|100757484|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
33233337|NCT00655551|100757485|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
33233338|NCT00655551|100757486|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
33233339|NCT00655551|100757484|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
33233340|NCT00655551|100757485|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
33233341|NCT00655551|100757486|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
33233342|NCT04213989|100757487|FG000|Overall Study|Withdrawal by Subject|3|||
33233343|NCT04213989|100757488|FG001|Overall Study|Withdrawal by Subject|2|||
33368420|NCT00872170|101234830|FG001|Overall Study|Adverse Event|0|||
33575351|NCT01299389|101996588|FG000|Double-blind|"fail to meet study population criteria"|0|||
33575352|NCT01299389|101996589|FG001|Double-blind|"fail to meet study population criteria"|1|||
33575353|NCT01299389|101996590|FG002|Double-blind|"fail to meet study population criteria"|0|||
33636488|NCT02141295|102222815|FG000|Overall Study|Progressive disease|3|||
33636489|NCT02141295|102222816|FG001|Overall Study|Progressive disease|32|||
33636490|NCT02141295|102222817|FG002|Overall Study|Progressive disease|50|||
33636491|NCT02141295|102222815|FG000|Overall Study|Reason not specified|0|||
33636492|NCT02141295|102222816|FG001|Overall Study|Reason not specified|9|||
33233344|NCT04213989|100757487|FG000|Overall Study|Physician Decision|1|||
33233345|NCT04213989|100757488|FG001|Overall Study|Physician Decision|0|||
33233346|NCT04213989|100757487|FG000|Overall Study|Lost to Follow-up|0|||
33233347|NCT04213989|100757488|FG001|Overall Study|Lost to Follow-up|4|||
33233348|NCT01130883|100757495|FG000|Overall Study|Patient Noncompliance|6|||
33233349|NCT01130883|100757495|FG000|Overall Study|Reason Unknown|1|||
33575354|NCT01299389|101996591|FG003|Double-blind|"fail to meet study population criteria"|0|||
33233350|NCT01130883|100757495|FG000|Overall Study|Adverse Event|3|||
33233351|NCT01448044|100757496|FG000|Treatment Period|Adverse Event|4|||
33233352|NCT01448044|100757497|FG001|Treatment Period|Adverse Event|3|||
33233353|NCT01448044|100757496|FG000|Treatment Period|Lack of Efficacy|5|||
33233354|NCT01448044|100757497|FG001|Treatment Period|Lack of Efficacy|12|||
33233355|NCT01448044|100757496|FG000|Treatment Period|Subject requested discontinue study drug|1|||
33233356|NCT01448044|100757497|FG001|Treatment Period|Subject requested discontinue study drug|0|||
33233357|NCT01448044|100757496|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
33233358|NCT01448044|100757497|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
33233359|NCT01448044|100757496|FG000|Treatment Period|Participant does not meet study criteria|1|||
33233360|NCT01448044|100757497|FG001|Treatment Period|Participant does not meet study criteria|0|||
33368421|NCT01929044|101234831|FG000|Overall Study|Adverse Event|1|||
33368422|NCT01929044|101234832|FG001|Overall Study|Adverse Event|0|||
33368423|NCT01929044|101234831|FG000|Overall Study|Protocol Violation|9|||
33368424|NCT01929044|101234832|FG001|Overall Study|Protocol Violation|14|||
33368425|NCT01929044|101234831|FG000|Overall Study|Not Treated|1|||
33368426|NCT01929044|101234832|FG001|Overall Study|Not Treated|3|||
33368427|NCT01617681|101234833|FG000|Period 1 Double Blind|Adverse Event|2|||
33368428|NCT01617681|101234834|FG001|Period 1 Double Blind|Adverse Event|0|||
33368429|NCT01617681|101234835|FG002|Period 1 Double Blind|Adverse Event|0|||
33368430|NCT01617681|101234836|FG003|Period 1 Double Blind|Adverse Event|2|||
33368431|NCT01617681|101234837|FG004|Period 1 Double Blind|Adverse Event|0|||
33368432|NCT01617681|101234833|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
33368433|NCT01617681|101234834|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
33368434|NCT01617681|101234835|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
33368435|NCT01617681|101234836|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
33368436|NCT01617681|101234837|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
33368437|NCT01617681|101234833|FG000|Period 2 Open Label|Adverse Event|0|||
33368438|NCT01617681|101234834|FG001|Period 2 Open Label|Adverse Event|0|||
33368439|NCT01617681|101234835|FG002|Period 2 Open Label|Adverse Event|0|||
33368440|NCT01617681|101234836|FG003|Period 2 Open Label|Adverse Event|0|||
33368441|NCT01617681|101234837|FG004|Period 2 Open Label|Adverse Event|3|||
33368442|NCT01617681|101234833|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
33368443|NCT01617681|101234834|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
33368444|NCT01617681|101234835|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
33368445|NCT01617681|101234836|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
33368446|NCT01617681|101234837|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
33368447|NCT01921270|101234838|FG000|Overall Study|Withdrawal by Subject|1|||
33368448|NCT00960440|101234840|FG000|Overall Study|Death|0|||
33368449|NCT00960440|101234841|FG001|Overall Study|Death|0|||
33575355|NCT01299389|101996588|FG000|Post-observational|Other|0|||
33575356|NCT01299389|101996589|FG001|Post-observational|Other|0|||
33575357|NCT01299389|101996590|FG002|Post-observational|Other|12|||
33575358|NCT01299389|101996591|FG003|Post-observational|Other|6|||
33636493|NCT02141295|102222817|FG002|Overall Study|Reason not specified|10|||
33636494|NCT02141295|102222815|FG000|Overall Study|Withdrawal by Subject|0|||
33636495|NCT02141295|102222816|FG001|Overall Study|Withdrawal by Subject|9|||
33636496|NCT02141295|102222817|FG002|Overall Study|Withdrawal by Subject|4|||
33636497|NCT04004988|102222818|FG000|Period 1|Physician Decision|2|||
33636498|NCT04004988|102222819|FG001|Period 1|Physician Decision|0|||
33636499|NCT04004988|102222818|FG000|Period 1|Withdrawal by Subject|0|||
33636500|NCT04004988|102222819|FG001|Period 1|Withdrawal by Subject|1|||
33636501|NCT04004988|102222818|FG000|Period 1|Adverse Event|1|||
33636502|NCT04004988|102222819|FG001|Period 1|Adverse Event|2|||
33636503|NCT04139018|102222823|FG000|Overall Study|Screen fail|1|||
33636504|NCT04139018|102222824|FG001|Overall Study|Screen fail|0|||
33636505|NCT04139018|102222823|FG000|Overall Study|Withdrawal by Subject|2|||
33636506|NCT04139018|102222824|FG001|Overall Study|Withdrawal by Subject|0|||
33636507|NCT04139018|102222823|FG000|Overall Study|Lost to Follow-up|0|||
33575359|NCT01644643|101996592|FG000|Overall Study|Death|1|||
33575360|NCT01644643|101996593|FG001|Overall Study|Death|0|||
33575361|NCT01644643|101996594|FG002|Overall Study|Death|3|||
33575362|NCT01644643|101996595|FG003|Overall Study|Death|3|||
33575363|NCT01644643|101996592|FG000|Overall Study|Lost to Follow-up|0|||
33575364|NCT01644643|101996593|FG001|Overall Study|Lost to Follow-up|0|||
33233361|NCT01448044|100757496|FG000|Treatment Period|Lost to Follow-up|2|||
33368450|NCT00960440|101234842|FG002|Overall Study|Death|0|||
33575365|NCT01644643|101996594|FG002|Overall Study|Lost to Follow-up|0|||
33368451|NCT00960440|101234843|FG003|Overall Study|Death|1|||
33575366|NCT01644643|101996595|FG003|Overall Study|Lost to Follow-up|4|||
33636508|NCT04139018|102222824|FG001|Overall Study|Lost to Follow-up|1|||
33636509|NCT03863080|102222825|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
33636510|NCT03863080|102222826|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
33233362|NCT01448044|100757497|FG001|Treatment Period|Lost to Follow-up|1|||
33368452|NCT00960440|101234840|FG000|Overall Study|Adverse Event|12|||
33368453|NCT00960440|101234841|FG001|Overall Study|Adverse Event|12|||
33575367|NCT01644643|101996592|FG000|Overall Study|Withdrawal by Subject|1|||
33575368|NCT01644643|101996593|FG001|Overall Study|Withdrawal by Subject|0|||
33233363|NCT01448044|100757496|FG000|Treatment Period|Other reason|2|||
33233364|NCT01448044|100757497|FG001|Treatment Period|Other reason|0|||
33233365|NCT01448044|100757496|FG000|Follow Up Period|Withdrawal by Subject|1|||
33233366|NCT01448044|100757497|FG001|Follow Up Period|Withdrawal by Subject|1|||
33233367|NCT01448044|100757496|FG000|Follow Up Period|Lost to Follow-up|6|||
33233368|NCT01448044|100757497|FG001|Follow Up Period|Lost to Follow-up|2|||
33233369|NCT01448044|100757496|FG000|Follow Up Period|Other|5|||
33233370|NCT01448044|100757497|FG001|Follow Up Period|Other|11|||
33233371|NCT00967018|100757498|FG000|Overall Study|Adverse Event|2|||
33233372|NCT00967018|100757498|FG000|Overall Study|Physician Decision|7|||
33233373|NCT00967018|100757498|FG000|Overall Study|Lost to Follow-up|2|||
33233374|NCT00967018|100757498|FG000|Overall Study|Withdrawal by Subject|1|||
33233375|NCT00967018|100757498|FG000|Overall Study|Miscellaneous Reasons|9|||
33233376|NCT03653416|100757499|FG000|Overall Study|Protocol Violation|6|||
33233377|NCT03653416|100757500|FG001|Overall Study|Protocol Violation|1|||
33233378|NCT02218489|100757501|FG000|Overall Study|Withdrawal by Subject|4|||
33233379|NCT02218489|100757502|FG001|Overall Study|Withdrawal by Subject|3|||
33233380|NCT02218489|100757501|FG000|Overall Study|Lost to Follow-up|1|||
33233381|NCT02218489|100757502|FG001|Overall Study|Lost to Follow-up|0|||
33233382|NCT01225835|100757509|FG000|Overall Study|Completed protocol|2|||
33233383|NCT01225835|100757510|FG001|Overall Study|Completed protocol|1|||
33233384|NCT01225835|100757509|FG000|Overall Study|Did not meet hCG criterion|2|||
33233385|NCT01225835|100757510|FG001|Overall Study|Did not meet hCG criterion|0|||
33233386|NCT01225835|100757509|FG000|Overall Study|Adverse Event|2|||
33233387|NCT01225835|100757510|FG001|Overall Study|Adverse Event|1|||
33233388|NCT01225835|100757509|FG000|Overall Study|Other|1|||
33233389|NCT01225835|100757510|FG001|Overall Study|Other|1|||
33233390|NCT01235975|100757513|FG000|Overall Study|Serious Adverse Event|0|||
33233391|NCT01235975|100757514|FG001|Overall Study|Serious Adverse Event|1|||
33233392|NCT01235975|100757513|FG000|Overall Study|Withdrawal by Subject|8|||
33233393|NCT01235975|100757514|FG001|Overall Study|Withdrawal by Subject|2|||
33233394|NCT01235975|100757513|FG000|Overall Study|Migrated/moved from study area|2|||
33233395|NCT01235975|100757514|FG001|Overall Study|Migrated/moved from study area|1|||
33233396|NCT01235975|100757513|FG000|Overall Study|Lost to Follow-up|7|||
33233397|NCT01235975|100757514|FG001|Overall Study|Lost to Follow-up|3|||
33233398|NCT02404493|100757515|FG000|Overall Study|Adverse Event|1|||
33233399|NCT02404493|100757516|FG001|Overall Study|Adverse Event|1|||
33233400|NCT00422799|100757519|FG000|Overall Study|Withdrawal by Subject|6|||
33233401|NCT00422799|100757519|FG000|Overall Study|Adverse Event|7|||
33233402|NCT01449721|100757520|FG000|Overall Study|Physician Decision|0|||
33233403|NCT01449721|100757521|FG001|Overall Study|Physician Decision|1|||
33233404|NCT01449721|100757520|FG000|Overall Study|Physician Decision|0|||
33233405|NCT01449721|100757521|FG001|Overall Study|Physician Decision|1|||
33233406|NCT01751113|100757525|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
33233407|NCT01751113|100757526|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
33233408|NCT01751113|100757527|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
33233409|NCT01751113|100757528|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
33233410|NCT01751113|100757529|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
33233411|NCT01751113|100757530|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
33233412|NCT01751113|100757525|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
33233413|NCT01751113|100757526|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
33233414|NCT01751113|100757527|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
33233415|NCT01751113|100757528|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
33233416|NCT01751113|100757529|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
33233417|NCT01751113|100757530|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
33233418|NCT01394250|100757533|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
33233419|NCT01394250|100757534|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
33233420|NCT01394250|100757533|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
33368454|NCT00960440|101234842|FG002|Overall Study|Adverse Event|4|||
33368455|NCT00960440|101234843|FG003|Overall Study|Adverse Event|4|||
33636511|NCT03863080|102222827|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
33636512|NCT03863080|102222828|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
33636513|NCT03863080|102222825|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
33636514|NCT03863080|102222826|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
33636515|NCT03863080|102222827|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
33233421|NCT01394250|100757534|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
33233422|NCT00767104|100757535|FG000|Overall Study|Lost to Follow-up|1|||
33233423|NCT00767104|100757536|FG001|Overall Study|Lost to Follow-up|2|||
33233424|NCT01189890|100757537|FG000|Overall Study|Adverse Event|3|||
33233425|NCT01189890|100757538|FG001|Overall Study|Adverse Event|4|||
33233426|NCT01189890|100757537|FG000|Overall Study|Lack of Efficacy|7|||
33233427|NCT01189890|100757538|FG001|Overall Study|Lack of Efficacy|2|||
33233428|NCT01189890|100757537|FG000|Overall Study|Lost to Follow-up|1|||
33233429|NCT01189890|100757538|FG001|Overall Study|Lost to Follow-up|7|||
33233430|NCT01189890|100757537|FG000|Overall Study|Protocol Violation|1|||
33233431|NCT01189890|100757538|FG001|Overall Study|Protocol Violation|5|||
33233432|NCT01189890|100757537|FG000|Overall Study|Withdrawal by Subject|15|||
33233433|NCT01189890|100757538|FG001|Overall Study|Withdrawal by Subject|11|||
33233434|NCT01189890|100757537|FG000|Overall Study|Non Compliance|0|||
33575369|NCT01644643|101996594|FG002|Overall Study|Withdrawal by Subject|2|||
33233435|NCT01189890|100757538|FG001|Overall Study|Non Compliance|1|||
33233436|NCT01189890|100757537|FG000|Overall Study|Physician Decision|5|||
33575370|NCT01644643|101996595|FG003|Overall Study|Withdrawal by Subject|1|||
33575371|NCT01644643|101996592|FG000|Overall Study|Other Eligibility criteria|0|||
33575372|NCT01644643|101996593|FG001|Overall Study|Other Eligibility criteria|0|||
33233437|NCT01189890|100757538|FG001|Overall Study|Physician Decision|4|||
33233438|NCT01189890|100757537|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
33233439|NCT01189890|100757538|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
33233440|NCT01799720|100757539|FG000|Overall Study|Withdrawal by Subject|3|||
33233441|NCT01799720|100757540|FG001|Overall Study|Withdrawal by Subject|0|||
33233442|NCT01799720|100757541|FG002|Overall Study|Withdrawal by Subject|0|||
33233443|NCT01799720|100757539|FG000|Overall Study|Protocol Violation|0|||
33233444|NCT01799720|100757540|FG001|Overall Study|Protocol Violation|1|||
33233445|NCT01799720|100757541|FG002|Overall Study|Protocol Violation|0|||
33233446|NCT01799720|100757539|FG000|Overall Study|Pregnancy|0|||
33233447|NCT01799720|100757540|FG001|Overall Study|Pregnancy|0|||
33233448|NCT01799720|100757541|FG002|Overall Study|Pregnancy|1|||
33233449|NCT02733042|100757546|FG000|Overall Study|Adverse Event|1|||
33233450|NCT02733042|100757547|FG001|Overall Study|Adverse Event|0|||
33233451|NCT02733042|100757548|FG002|Overall Study|Adverse Event|1|||
33233452|NCT02733042|100757549|FG003|Overall Study|Adverse Event|1|||
33233453|NCT02733042|100757550|FG004|Overall Study|Adverse Event|0|||
33233454|NCT02733042|100757551|FG005|Overall Study|Adverse Event|0|||
33233455|NCT02733042|100757552|FG006|Overall Study|Adverse Event|0|||
33233456|NCT02733042|100757553|FG007|Overall Study|Adverse Event|0|||
33233457|NCT02733042|100757554|FG008|Overall Study|Adverse Event|0|||
33233458|NCT02733042|100757555|FG009|Overall Study|Adverse Event|0|||
33233459|NCT02733042|100757556|FG010|Overall Study|Adverse Event|2|||
33233460|NCT02733042|100757557|FG011|Overall Study|Adverse Event|2|||
33233461|NCT02733042|100757558|FG012|Overall Study|Adverse Event|0|||
33233462|NCT02733042|100757559|FG013|Overall Study|Adverse Event|2|||
33233463|NCT02733042|100757560|FG014|Overall Study|Adverse Event|0|||
33233464|NCT02733042|100757561|FG015|Overall Study|Adverse Event|0|||
33233465|NCT02733042|100757562|FG016|Overall Study|Adverse Event|0|||
33233466|NCT02733042|100757563|FG017|Overall Study|Adverse Event|1|||
33233467|NCT02733042|100757564|FG018|Overall Study|Adverse Event|0|||
33233468|NCT02733042|100757546|FG000|Overall Study|Progressive Disease|2|||
33233469|NCT02733042|100757547|FG001|Overall Study|Progressive Disease|1|||
33233470|NCT02733042|100757548|FG002|Overall Study|Progressive Disease|3|||
33233471|NCT02733042|100757549|FG003|Overall Study|Progressive Disease|1|||
33233472|NCT02733042|100757550|FG004|Overall Study|Progressive Disease|2|||
33233473|NCT02733042|100757551|FG005|Overall Study|Progressive Disease|3|||
33233474|NCT02733042|100757552|FG006|Overall Study|Progressive Disease|0|||
33233475|NCT02733042|100757553|FG007|Overall Study|Progressive Disease|3|||
33233476|NCT02733042|100757554|FG008|Overall Study|Progressive Disease|3|||
33233477|NCT02733042|100757555|FG009|Overall Study|Progressive Disease|2|||
33233478|NCT02733042|100757556|FG010|Overall Study|Progressive Disease|2|||
33233479|NCT02733042|100757557|FG011|Overall Study|Progressive Disease|2|||
33233480|NCT02733042|100757558|FG012|Overall Study|Progressive Disease|8|||
33233481|NCT02733042|100757559|FG013|Overall Study|Progressive Disease|1|||
33233482|NCT02733042|100757560|FG014|Overall Study|Progressive Disease|4|||
33233483|NCT02733042|100757561|FG015|Overall Study|Progressive Disease|7|||
33233484|NCT02733042|100757562|FG016|Overall Study|Progressive Disease|2|||
33233485|NCT02733042|100757563|FG017|Overall Study|Progressive Disease|3|||
33233486|NCT02733042|100757564|FG018|Overall Study|Progressive Disease|4|||
33233487|NCT02733042|100757546|FG000|Overall Study|Withdrawal by Subject|0|||
33233488|NCT02733042|100757547|FG001|Overall Study|Withdrawal by Subject|1|||
33233489|NCT02733042|100757548|FG002|Overall Study|Withdrawal by Subject|2|||
33233490|NCT02733042|100757549|FG003|Overall Study|Withdrawal by Subject|1|||
33368456|NCT00960440|101234840|FG000|Overall Study|Lack of Efficacy|2|||
33368457|NCT00960440|101234841|FG001|Overall Study|Lack of Efficacy|5|||
33233491|NCT02733042|100757550|FG004|Overall Study|Withdrawal by Subject|1|||
33233492|NCT02733042|100757551|FG005|Overall Study|Withdrawal by Subject|0|||
33233493|NCT02733042|100757552|FG006|Overall Study|Withdrawal by Subject|0|||
33233494|NCT02733042|100757553|FG007|Overall Study|Withdrawal by Subject|0|||
33233495|NCT02733042|100757554|FG008|Overall Study|Withdrawal by Subject|1|||
33233496|NCT02733042|100757555|FG009|Overall Study|Withdrawal by Subject|1|||
33233497|NCT02733042|100757556|FG010|Overall Study|Withdrawal by Subject|0|||
33233498|NCT02733042|100757557|FG011|Overall Study|Withdrawal by Subject|2|||
33233499|NCT02733042|100757558|FG012|Overall Study|Withdrawal by Subject|1|||
33233500|NCT02733042|100757559|FG013|Overall Study|Withdrawal by Subject|1|||
33233501|NCT02733042|100757560|FG014|Overall Study|Withdrawal by Subject|0|||
33368458|NCT00960440|101234842|FG002|Overall Study|Lack of Efficacy|3|||
33575373|NCT01644643|101996594|FG002|Overall Study|Other Eligibility criteria|0|||
33636516|NCT03863080|102222828|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
33233502|NCT02733042|100757561|FG015|Overall Study|Withdrawal by Subject|0|||
33233503|NCT02733042|100757562|FG016|Overall Study|Withdrawal by Subject|0|||
33233504|NCT02733042|100757563|FG017|Overall Study|Withdrawal by Subject|0|||
33233505|NCT02733042|100757564|FG018|Overall Study|Withdrawal by Subject|0|||
33233506|NCT02733042|100757546|FG000|Overall Study|Other Reasons|0|||
33233507|NCT02733042|100757547|FG001|Overall Study|Other Reasons|0|||
33233508|NCT02733042|100757548|FG002|Overall Study|Other Reasons|1|||
33233509|NCT02733042|100757549|FG003|Overall Study|Other Reasons|0|||
33233510|NCT02733042|100757550|FG004|Overall Study|Other Reasons|0|||
33233511|NCT02733042|100757551|FG005|Overall Study|Other Reasons|0|||
33233512|NCT02733042|100757552|FG006|Overall Study|Other Reasons|0|||
33233513|NCT02733042|100757553|FG007|Overall Study|Other Reasons|0|||
33233514|NCT02733042|100757554|FG008|Overall Study|Other Reasons|0|||
33233515|NCT02733042|100757555|FG009|Overall Study|Other Reasons|1|||
33233516|NCT02733042|100757556|FG010|Overall Study|Other Reasons|1|||
33233517|NCT02733042|100757557|FG011|Overall Study|Other Reasons|0|||
33233518|NCT02733042|100757558|FG012|Overall Study|Other Reasons|0|||
33233519|NCT02733042|100757559|FG013|Overall Study|Other Reasons|0|||
33233520|NCT02733042|100757560|FG014|Overall Study|Other Reasons|0|||
33233521|NCT02733042|100757561|FG015|Overall Study|Other Reasons|1|||
33233522|NCT02733042|100757562|FG016|Overall Study|Other Reasons|0|||
33233523|NCT02733042|100757563|FG017|Overall Study|Other Reasons|1|||
33233524|NCT02733042|100757564|FG018|Overall Study|Other Reasons|0|||
33233525|NCT02733042|100757546|FG000|Overall Study|Death|0|||
33233526|NCT02733042|100757547|FG001|Overall Study|Death|0|||
33233527|NCT02733042|100757548|FG002|Overall Study|Death|0|||
33233528|NCT02733042|100757549|FG003|Overall Study|Death|0|||
33233529|NCT02733042|100757550|FG004|Overall Study|Death|0|||
33233530|NCT02733042|100757551|FG005|Overall Study|Death|0|||
33233531|NCT02733042|100757552|FG006|Overall Study|Death|1|||
33233532|NCT02733042|100757553|FG007|Overall Study|Death|0|||
33233533|NCT02733042|100757554|FG008|Overall Study|Death|1|||
33233534|NCT02733042|100757555|FG009|Overall Study|Death|0|||
33233535|NCT02733042|100757556|FG010|Overall Study|Death|1|||
33233536|NCT02733042|100757557|FG011|Overall Study|Death|0|||
33233537|NCT02733042|100757558|FG012|Overall Study|Death|0|||
33233538|NCT02733042|100757559|FG013|Overall Study|Death|0|||
33233539|NCT02733042|100757560|FG014|Overall Study|Death|1|||
33233540|NCT02733042|100757561|FG015|Overall Study|Death|2|||
33575374|NCT01644643|101996595|FG003|Overall Study|Other Eligibility criteria|2|||
33575375|NCT02701764|101996596|FG000|Overall Study|Lost to Follow-up|0|||
33575376|NCT02701764|101996597|FG001|Overall Study|Lost to Follow-up|1|||
33575377|NCT03960684|101996598|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
33575378|NCT02388906|101996599|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
33575379|NCT02388906|101996600|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
33575380|NCT02388906|101996599|FG000|Treatment Period|Disease progression|121|||
33575381|NCT02388906|101996600|FG001|Treatment Period|Disease progression|101|||
33575382|NCT02388906|101996599|FG000|Treatment Period|Study drug toxicity|41|||
33575383|NCT02388906|101996600|FG001|Treatment Period|Study drug toxicity|208|||
33575384|NCT02388906|101996599|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
33575385|NCT02388906|101996600|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
33575386|NCT02388906|101996599|FG000|Treatment Period|Participant request to stop treatment|5|||
33575387|NCT02388906|101996600|FG001|Treatment Period|Participant request to stop treatment|9|||
33575388|NCT02388906|101996599|FG000|Treatment Period|Participant withdrew consent|2|||
33575389|NCT02388906|101996600|FG001|Treatment Period|Participant withdrew consent|3|||
33575390|NCT02388906|101996599|FG000|Treatment Period|Poor/non-compliance|0|||
33575391|NCT02388906|101996600|FG001|Treatment Period|Poor/non-compliance|1|||
33575392|NCT02388906|101996599|FG000|Treatment Period|Participant no longer meets study criteria|0|||
33575393|NCT02388906|101996600|FG001|Treatment Period|Participant no longer meets study criteria|1|||
33575394|NCT02388906|101996599|FG000|Treatment Period|Other reasons|3|||
33575395|NCT02388906|101996600|FG001|Treatment Period|Other reasons|3|||
33575396|NCT01334918|101996601|FG000|Overall Study|Did not receive study drug|6|||
33233541|NCT02733042|100757562|FG016|Overall Study|Death|0|||
33233542|NCT02733042|100757563|FG017|Overall Study|Death|0|||
33233543|NCT02733042|100757564|FG018|Overall Study|Death|0|||
33575397|NCT01334918|101996602|FG001|Overall Study|Did not receive study drug|0|||
33233544|NCT03428815|100757565|FG000|Overall Study|Lost to Follow-up|2|||
33233545|NCT03428815|100757566|FG001|Overall Study|Lost to Follow-up|2|||
33233546|NCT03428815|100757565|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
33420276|NCT01393626|101428564|FG002|Overall Study|Withdrawal by Subject|0|||
33575398|NCT01334918|101996601|FG000|Overall Study|Adverse Event|2|||
33575399|NCT01334918|101996602|FG001|Overall Study|Adverse Event|0|||
33233547|NCT03428815|100757566|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
33233548|NCT03428815|100757565|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
33233549|NCT03428815|100757566|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
33233550|NCT01822353|100757568|FG000|Overall Study|Adverse Event|1|||
33233551|NCT01822353|100757569|FG001|Overall Study|Adverse Event|3|||
33233552|NCT01822353|100757570|FG002|Overall Study|Adverse Event|1|||
33233553|NCT01822353|100757568|FG000|Overall Study|Pregnancy|0|||
33233554|NCT01822353|100757569|FG001|Overall Study|Pregnancy|1|||
33233555|NCT01822353|100757570|FG002|Overall Study|Pregnancy|0|||
33233556|NCT01822353|100757568|FG000|Overall Study|Withdrawal by Subject|3|||
33233557|NCT01822353|100757569|FG001|Overall Study|Withdrawal by Subject|1|||
33233558|NCT01822353|100757570|FG002|Overall Study|Withdrawal by Subject|0|||
33233559|NCT00209274|100757575|FG000|Overall Study|Missed visit|3|||
33233560|NCT00209274|100757576|FG001|Overall Study|Missed visit|2|||
33233561|NCT00209274|100757575|FG000|Overall Study|Death|32|||
33233562|NCT00209274|100757576|FG001|Overall Study|Death|15|||
33233563|NCT00209274|100757575|FG000|Overall Study|Withdrawal by Subject|30|||
33233564|NCT00209274|100757576|FG001|Overall Study|Withdrawal by Subject|15|||
33233565|NCT00209274|100757575|FG000|Overall Study|Randomized not treated (RNT)|6|||
33233566|NCT00209274|100757576|FG001|Overall Study|Randomized not treated (RNT)|15|||
33233567|NCT01804816|100757577|FG000|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3|||
33233568|NCT01804816|100757577|FG000|Acupuncture (Second 5 Weeks)|Physician Decision|1|||
33233569|NCT03722264|100757578|FG000|Overall Study|Physician Decision|3|||
33233570|NCT01009047|100757579|FG000|Overall Study|Adverse Event|5|||
33233571|NCT01009047|100757580|FG001|Overall Study|Adverse Event|0|||
33233572|NCT01009047|100757579|FG000|Overall Study|Lost to Follow-up|0|||
33233573|NCT01009047|100757580|FG001|Overall Study|Lost to Follow-up|2|||
33233574|NCT01009047|100757579|FG000|Overall Study|Lack of Efficacy|4|||
33233575|NCT01009047|100757580|FG001|Overall Study|Lack of Efficacy|11|||
33233576|NCT01009047|100757579|FG000|Overall Study|Withdrawal by consent|16|||
33233577|NCT01009047|100757580|FG001|Overall Study|Withdrawal by consent|11|||
33233578|NCT01009047|100757579|FG000|Overall Study|Other|3|||
33233579|NCT01009047|100757580|FG001|Overall Study|Other|2|||
33233580|NCT02846558|100757589|FG000|Overall Study|Adverse Event|1|||
33233581|NCT02846558|100757590|FG001|Overall Study|Adverse Event|0|||
33233582|NCT02846558|100757591|FG002|Overall Study|Adverse Event|0|||
33233583|NCT02846558|100757592|FG003|Overall Study|Adverse Event|0|||
33420277|NCT01393626|101428565|FG003|Overall Study|Withdrawal by Subject|0|||
33137703|NCT01185353|100417314|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33137704|NCT01185353|100417315|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33137705|NCT01185353|100417316|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
33137706|NCT01185353|100417317|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
33137707|NCT01185353|100417308|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
33137708|NCT01185353|100417309|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
33137709|NCT01185353|100417310|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
33137710|NCT01185353|100417311|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
33137711|NCT01185353|100417312|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
33137712|NCT01185353|100417313|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
33137713|NCT01185353|100417314|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
33137714|NCT01185353|100417315|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
33137715|NCT01185353|100417316|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
33137716|NCT01185353|100417317|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
33137717|NCT01185353|100417308|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33137718|NCT01185353|100417309|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33137719|NCT01185353|100417310|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33137720|NCT01185353|100417311|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33137721|NCT01185353|100417312|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33137722|NCT01185353|100417313|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33137723|NCT01185353|100417314|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33137724|NCT01185353|100417315|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
33137725|NCT01185353|100417316|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
33137726|NCT01185353|100417317|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
33137727|NCT01185353|100417308|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
33137728|NCT01185353|100417309|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
33137729|NCT01185353|100417310|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
33137730|NCT01185353|100417311|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
33137731|NCT01185353|100417312|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
33137732|NCT01185353|100417313|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
33233584|NCT02846558|100757589|FG000|Overall Study|Withdrawal by Subject|5|||
33233585|NCT02846558|100757590|FG001|Overall Study|Withdrawal by Subject|4|||
33233586|NCT02846558|100757591|FG002|Overall Study|Withdrawal by Subject|2|||
33233587|NCT02846558|100757592|FG003|Overall Study|Withdrawal by Subject|2|||
33233588|NCT02846558|100757589|FG000|Overall Study|Lost to Follow-up|2|||
33233589|NCT02846558|100757590|FG001|Overall Study|Lost to Follow-up|0|||
33233590|NCT02846558|100757591|FG002|Overall Study|Lost to Follow-up|0|||
33233591|NCT02846558|100757592|FG003|Overall Study|Lost to Follow-up|0|||
33233592|NCT04642469|100757598|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
33420278|NCT01393626|101428562|FG000|Overall Study|Other|1|||
33233593|NCT04642469|100757599|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
33233594|NCT04642469|100757598|FG000|Overall Study|Death|1|||
33233595|NCT04642469|100757599|FG001|Overall Study|Death|2|||
33233596|NCT04642469|100757598|FG000|Overall Study|Study/site closed following amendment 1|11|||
33233597|NCT04642469|100757599|FG001|Overall Study|Study/site closed following amendment 1|11|||
33233598|NCT04642469|100757598|FG000|Overall Study|Other|1|||
33233599|NCT04642469|100757599|FG001|Overall Study|Other|1|||
33233600|NCT04642469|100757598|FG000|Overall Study|Withdrawal by Subject|1|||
33233601|NCT04642469|100757599|FG001|Overall Study|Withdrawal by Subject|0|||
33233602|NCT04157686|100757600|FG000|Overall Study|Adverse Event|1|||
33233603|NCT04157686|100757601|FG001|Overall Study|Adverse Event|0|||
33233604|NCT04157686|100757602|FG002|Overall Study|Adverse Event|1|||
33233605|NCT04157686|100757603|FG003|Overall Study|Adverse Event|0|||
33575400|NCT01334918|101996601|FG000|Overall Study|Withdrawal by Subject|0|||
33575401|NCT01334918|101996602|FG001|Overall Study|Withdrawal by Subject|1|||
33575402|NCT01402869|101996603|FG000|Overall Study|Required Tooth Extraction|0|||
33575403|NCT01402869|101996604|FG001|Overall Study|Required Tooth Extraction|0|||
33575404|NCT01402869|101996605|FG002|Overall Study|Required Tooth Extraction|1|||
33575405|NCT04781816|101996618|FG000|Overall Study|Adverse Event|0|||
33575406|NCT04781816|101996619|FG001|Overall Study|Adverse Event|1|||
33575407|NCT04781816|101996618|FG000|Overall Study|Withdrawal by Subject|1|||
33575408|NCT04781816|101996619|FG001|Overall Study|Withdrawal by Subject|1|||
33575409|NCT04781816|101996618|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
33575410|NCT04781816|101996619|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
33575411|NCT03507127|101996626|FG000|Overall Study|Withdrawal by Subject|1|||
33575412|NCT03507127|101996627|FG001|Overall Study|Withdrawal by Subject|0|||
33575413|NCT03507127|101996626|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
33575414|NCT03507127|101996627|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
33575415|NCT01824290|101996628|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
33137733|NCT01185353|100417314|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
33137734|NCT01185353|100417315|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
33233606|NCT04157686|100757604|FG004|Overall Study|Adverse Event|1|||
33233607|NCT04157686|100757605|FG005|Overall Study|Adverse Event|0|||
33233608|NCT04157686|100757606|FG006|Overall Study|Adverse Event|0|||
33233609|NCT04157686|100757607|FG007|Overall Study|Adverse Event|0|||
33233610|NCT04157686|100757600|FG000|Overall Study|Pregnancy|0|||
33233611|NCT04157686|100757601|FG001|Overall Study|Pregnancy|1|||
33233612|NCT04157686|100757602|FG002|Overall Study|Pregnancy|3|||
33233613|NCT04157686|100757603|FG003|Overall Study|Pregnancy|0|||
33233614|NCT04157686|100757604|FG004|Overall Study|Pregnancy|0|||
33233615|NCT04157686|100757605|FG005|Overall Study|Pregnancy|0|||
33233616|NCT04157686|100757606|FG006|Overall Study|Pregnancy|3|||
33233617|NCT04157686|100757607|FG007|Overall Study|Pregnancy|0|||
33233618|NCT04157686|100757600|FG000|Overall Study|Lost to Follow-up|1|||
33233619|NCT04157686|100757601|FG001|Overall Study|Lost to Follow-up|2|||
33575416|NCT01824290|101996629|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
33575417|NCT01824290|101996630|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
33137735|NCT01185353|100417316|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
33137736|NCT01185353|100417317|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
33137737|NCT01185353|100417308|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33137738|NCT01185353|100417309|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33137739|NCT01185353|100417310|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33137740|NCT01185353|100417311|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33137741|NCT01185353|100417312|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33137742|NCT01185353|100417313|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33137743|NCT01185353|100417314|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33137744|NCT01185353|100417315|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
33137745|NCT01185353|100417316|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
33137746|NCT01185353|100417317|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
33137747|NCT01989208|100417320|FG000|200 mg (7 Days)|Protocol Violation|0|||
33137748|NCT01989208|100417321|FG001|200 mg (7 Days)|Protocol Violation|1|||
33137749|NCT00313781|100417322|FG000|Before Crossover|Death|22|||
33137750|NCT00313781|100417323|FG001|Before Crossover|Death|8|||
33137751|NCT00313781|100417324|FG002|Before Crossover|Death|0|||
33137752|NCT00313781|100417322|FG000|Before Crossover|Lost to Follow-up|0|||
33137753|NCT00313781|100417323|FG001|Before Crossover|Lost to Follow-up|3|||
33137754|NCT00313781|100417324|FG002|Before Crossover|Lost to Follow-up|0|||
33137755|NCT00313781|100417322|FG000|Before Crossover|Withdrawal by Subject|3|||
33137756|NCT00313781|100417323|FG001|Before Crossover|Withdrawal by Subject|1|||
33137757|NCT00313781|100417324|FG002|Before Crossover|Withdrawal by Subject|0|||
33137758|NCT00313781|100417322|FG000|Before Crossover|Other|45|||
33137759|NCT00313781|100417323|FG001|Before Crossover|Other|30|||
33137760|NCT00313781|100417324|FG002|Before Crossover|Other|0|||
33137761|NCT00313781|100417322|FG000|Before Crossover|Crossover|0|||
33233620|NCT04157686|100757602|FG002|Overall Study|Lost to Follow-up|8|||
33575418|NCT01824290|101996631|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
33233621|NCT04157686|100757603|FG003|Overall Study|Lost to Follow-up|6|||
33233622|NCT04157686|100757604|FG004|Overall Study|Lost to Follow-up|6|||
33233623|NCT04157686|100757605|FG005|Overall Study|Lost to Follow-up|3|||
33233624|NCT04157686|100757606|FG006|Overall Study|Lost to Follow-up|7|||
33233625|NCT04157686|100757607|FG007|Overall Study|Lost to Follow-up|9|||
33233626|NCT04157686|100757600|FG000|Overall Study|Lack of Efficacy|0|||
33636517|NCT03863080|102222825|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
33636518|NCT03863080|102222826|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
33233627|NCT04157686|100757601|FG001|Overall Study|Lack of Efficacy|0|||
33233628|NCT04157686|100757602|FG002|Overall Study|Lack of Efficacy|0|||
33233629|NCT04157686|100757603|FG003|Overall Study|Lack of Efficacy|0|||
33233630|NCT04157686|100757604|FG004|Overall Study|Lack of Efficacy|0|||
33233631|NCT04157686|100757605|FG005|Overall Study|Lack of Efficacy|2|||
33233632|NCT04157686|100757606|FG006|Overall Study|Lack of Efficacy|0|||
33233633|NCT04157686|100757607|FG007|Overall Study|Lack of Efficacy|1|||
33233634|NCT04157686|100757600|FG000|Overall Study|Withdrawal by Subject|10|||
33233635|NCT04157686|100757601|FG001|Overall Study|Withdrawal by Subject|10|||
33233636|NCT04157686|100757602|FG002|Overall Study|Withdrawal by Subject|12|||
33233637|NCT04157686|100757603|FG003|Overall Study|Withdrawal by Subject|20|||
33233638|NCT04157686|100757604|FG004|Overall Study|Withdrawal by Subject|12|||
33233639|NCT04157686|100757605|FG005|Overall Study|Withdrawal by Subject|11|||
33233640|NCT04157686|100757606|FG006|Overall Study|Withdrawal by Subject|18|||
33233641|NCT04157686|100757607|FG007|Overall Study|Withdrawal by Subject|24|||
33233642|NCT04157686|100757600|FG000|Overall Study|Physician Decision|0|||
33233643|NCT04157686|100757601|FG001|Overall Study|Physician Decision|0|||
33233644|NCT04157686|100757602|FG002|Overall Study|Physician Decision|1|||
33233645|NCT04157686|100757603|FG003|Overall Study|Physician Decision|0|||
33368459|NCT00960440|101234843|FG003|Overall Study|Lack of Efficacy|8|||
33368460|NCT00960440|101234840|FG000|Overall Study|Protocol Violation|2|||
33368461|NCT00960440|101234841|FG001|Overall Study|Protocol Violation|8|||
33368462|NCT00960440|101234842|FG002|Overall Study|Protocol Violation|3|||
33368463|NCT00960440|101234843|FG003|Overall Study|Protocol Violation|4|||
33575419|NCT01824290|101996628|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
33575420|NCT01824290|101996629|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
33575421|NCT01824290|101996630|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
33575422|NCT01824290|101996631|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
33575423|NCT01824290|101996628|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
33575424|NCT01824290|101996629|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
33575425|NCT01824290|101996630|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
33575426|NCT01824290|101996631|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
33575427|NCT01824290|101996628|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
33575428|NCT01824290|101996629|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
33636519|NCT03863080|102222827|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
33636520|NCT03863080|102222828|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
33636521|NCT02531802|102222829|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
33636522|NCT02531802|102222830|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
33636523|NCT02531802|102222831|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
33636524|NCT02531802|102222832|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
33636525|NCT02531802|102222833|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
33636526|NCT02531802|102222834|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
33137762|NCT00313781|100417323|FG001|Before Crossover|Crossover|37|||
33137763|NCT00313781|100417324|FG002|Before Crossover|Crossover|0|||
33137764|NCT00313781|100417322|FG000|Before Crossover|Randomized, not treated|5|||
33137765|NCT00313781|100417323|FG001|Before Crossover|Randomized, not treated|0|||
33137766|NCT00313781|100417324|FG002|Before Crossover|Randomized, not treated|0|||
33137767|NCT00313781|100417322|FG000|After Crossover|Death|0|||
33137768|NCT00313781|100417323|FG001|After Crossover|Death|0|||
33137769|NCT00313781|100417324|FG002|After Crossover|Death|6|||
33137770|NCT00313781|100417322|FG000|After Crossover|Withdrawal by Subject|0|||
33137771|NCT00313781|100417323|FG001|After Crossover|Withdrawal by Subject|0|||
33137772|NCT00313781|100417324|FG002|After Crossover|Withdrawal by Subject|3|||
33137773|NCT00313781|100417322|FG000|After Crossover|Other|0|||
33137774|NCT00313781|100417323|FG001|After Crossover|Other|0|||
33137775|NCT00313781|100417324|FG002|After Crossover|Other|18|||
33137776|NCT01253811|100417328|FG000|Overall Study|Withdrawal criteria|1|||
33137777|NCT02577887|100417329|FG000|Overall Study|Death|93|||
33137778|NCT02577887|100417329|FG000|Overall Study|Protocol Violation|125|||
33233646|NCT04157686|100757604|FG004|Overall Study|Physician Decision|1|||
33233647|NCT04157686|100757605|FG005|Overall Study|Physician Decision|0|||
33233648|NCT04157686|100757606|FG006|Overall Study|Physician Decision|3|||
33233649|NCT04157686|100757607|FG007|Overall Study|Physician Decision|0|||
33233650|NCT04157686|100757600|FG000|Overall Study|Death|0|||
33233651|NCT04157686|100757601|FG001|Overall Study|Death|0|||
33137779|NCT02577887|100417329|FG000|Overall Study|Withdrawal by Subject|80|||
33368464|NCT00960440|101234840|FG000|Overall Study|Withdrawal by Subject|9|||
33636527|NCT02531802|102222835|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
33636528|NCT02531802|102222836|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
33636529|NCT02531802|102222837|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
33636530|NCT02531802|102222838|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
33636531|NCT02531802|102222839|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
33636532|NCT02531802|102222840|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
33636533|NCT02531802|102222841|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
33636534|NCT02531802|102222842|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
33636535|NCT02531802|102222843|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
33636536|NCT02531802|102222844|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
33636537|NCT02531802|102222845|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
33636538|NCT02531802|102222846|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
33233652|NCT04157686|100757602|FG002|Overall Study|Death|0|||
33233653|NCT04157686|100757603|FG003|Overall Study|Death|2|||
33233654|NCT04157686|100757604|FG004|Overall Study|Death|0|||
33368465|NCT00960440|101234841|FG001|Overall Study|Withdrawal by Subject|5|||
33233655|NCT04157686|100757605|FG005|Overall Study|Death|0|||
33233656|NCT04157686|100757606|FG006|Overall Study|Death|0|||
33233657|NCT04157686|100757607|FG007|Overall Study|Death|0|||
33233658|NCT04157686|100757600|FG000|Overall Study|Protocol Violation|0|||
33233659|NCT04157686|100757601|FG001|Overall Study|Protocol Violation|0|||
33233660|NCT04157686|100757602|FG002|Overall Study|Protocol Violation|0|||
33233661|NCT04157686|100757603|FG003|Overall Study|Protocol Violation|0|||
33233662|NCT04157686|100757604|FG004|Overall Study|Protocol Violation|1|||
33233663|NCT04157686|100757605|FG005|Overall Study|Protocol Violation|0|||
33233664|NCT04157686|100757606|FG006|Overall Study|Protocol Violation|0|||
33233665|NCT04157686|100757607|FG007|Overall Study|Protocol Violation|0|||
33233666|NCT04157686|100757600|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
33233667|NCT04157686|100757601|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
33233668|NCT04157686|100757602|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
33233669|NCT04157686|100757603|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
33233670|NCT04157686|100757604|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
33233671|NCT04157686|100757605|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
33233672|NCT04157686|100757606|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
33233673|NCT04157686|100757607|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
33233674|NCT01816763|100757615|FG000|Overall Study|The main reason for an incomplete survey|4|||
33233675|NCT01816763|100757616|FG001|Overall Study|The main reason for an incomplete survey|15|||
33233676|NCT01816763|100757617|FG002|Overall Study|The main reason for an incomplete survey|11|||
33233677|NCT02593539|100757618|FG000|Overall Study|Adverse Event|1|||
33233678|NCT02411591|100757619|FG000|Overall Study|Adverse Event|0|||
33233679|NCT02411591|100757620|FG001|Overall Study|Adverse Event|4|||
33233680|NCT02411591|100757621|FG002|Overall Study|Adverse Event|2|||
33233681|NCT02411591|100757619|FG000|Overall Study|Withdrawal by Subject|0|||
33233682|NCT02411591|100757620|FG001|Overall Study|Withdrawal by Subject|3|||
33233683|NCT02411591|100757621|FG002|Overall Study|Withdrawal by Subject|0|||
33368466|NCT00960440|101234842|FG002|Overall Study|Withdrawal by Subject|2|||
33368467|NCT00960440|101234843|FG003|Overall Study|Withdrawal by Subject|1|||
33420279|NCT01393626|101428563|FG001|Overall Study|Other|0|||
33575429|NCT01824290|101996630|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
33575430|NCT01824290|101996631|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
33575431|NCT01824290|101996628|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
33575432|NCT01824290|101996629|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
33575433|NCT01824290|101996630|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
33575434|NCT01824290|101996631|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
33575435|NCT01824290|101996628|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
33575436|NCT01824290|101996629|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
33575437|NCT01824290|101996630|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
33575438|NCT01824290|101996631|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
33575439|NCT04592341|101996632|FG000|Overall Study|Physician Decision|5|||
33575440|NCT04592341|101996632|FG000|Overall Study|Study Terminated by Sponsor|5|||
33575441|NCT04592341|101996632|FG000|Overall Study|Withdrawal by Subject|53|||
33575442|NCT04592341|101996632|FG000|Overall Study|Lost to Follow-up|3|||
33575443|NCT04592341|101996632|FG000|Overall Study|Death|1|||
33233684|NCT02411591|100757619|FG000|Overall Study|Physician Decision|0|||
33233685|NCT02411591|100757620|FG001|Overall Study|Physician Decision|3|||
33233686|NCT02411591|100757621|FG002|Overall Study|Physician Decision|1|||
33233687|NCT01349660|100757622|FG000|Overall Study|Still Receiving Study Treatment|0|||
33233688|NCT01349660|100757623|FG001|Overall Study|Still Receiving Study Treatment|0|||
33233689|NCT01349660|100757624|FG002|Overall Study|Still Receiving Study Treatment|1|||
33233690|NCT01349660|100757622|FG000|Overall Study|Disease Progression|2|||
33233691|NCT01349660|100757623|FG001|Overall Study|Disease Progression|4|||
33420280|NCT01393626|101428564|FG002|Overall Study|Other|0|||
33233692|NCT01349660|100757624|FG002|Overall Study|Disease Progression|50|||
33233693|NCT01349660|100757622|FG000|Overall Study|Adverse Event|1|||
33233694|NCT01349660|100757623|FG001|Overall Study|Adverse Event|1|||
33233695|NCT01349660|100757624|FG002|Overall Study|Adverse Event|12|||
33233696|NCT01349660|100757622|FG000|Overall Study|Withdrawal by Subject|2|||
33233697|NCT01349660|100757623|FG001|Overall Study|Withdrawal by Subject|0|||
33233698|NCT01349660|100757624|FG002|Overall Study|Withdrawal by Subject|9|||
33233699|NCT01349660|100757622|FG000|Overall Study|Death|1|||
33233700|NCT01349660|100757623|FG001|Overall Study|Death|1|||
33233701|NCT01349660|100757624|FG002|Overall Study|Death|0|||
33233702|NCT01349660|100757622|FG000|Overall Study|Non-Permitted Interventions|0|||
33233703|NCT01349660|100757623|FG001|Overall Study|Non-Permitted Interventions|0|||
33233704|NCT01349660|100757624|FG002|Overall Study|Non-Permitted Interventions|2|||
33575444|NCT04592341|101996632|FG000|Overall Study|Adverse Event|5|||
33575445|NCT04592341|101996632|FG000|Overall Study|other|4|||
33575446|NCT02761642|101996633|FG000|Overall Study|Did not Receive Study Treatment|3|||
33575447|NCT02761642|101996633|FG000|Overall Study|Adverse Event|13|||
33575448|NCT02761642|101996633|FG000|Overall Study|Withdrawal by Subject|2|||
33575449|NCT02761642|101996633|FG000|Overall Study|Non-compliant|7|||
33575450|NCT02761642|101996633|FG000|Overall Study|Death|3|||
33575451|NCT02761642|101996633|FG000|Overall Study|Lack of Efficacy|20|||
33233705|NCT01349660|100757622|FG000|Overall Study|Study Compliance|0|||
33233706|NCT01349660|100757623|FG001|Overall Study|Study Compliance|0|||
33233707|NCT01349660|100757624|FG002|Overall Study|Study Compliance|1|||
33233708|NCT01349660|100757622|FG000|Overall Study|Declining Performance Status|0|||
33233709|NCT01349660|100757623|FG001|Overall Study|Declining Performance Status|0|||
33233710|NCT01349660|100757624|FG002|Overall Study|Declining Performance Status|1|||
33233711|NCT02531295|100757625|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
33233712|NCT02531295|100757626|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
33233713|NCT02531295|100757627|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
33233714|NCT02531295|100757628|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
33233715|NCT02531295|100757629|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
33233716|NCT02531295|100757630|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
33233717|NCT02325713|100757631|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233718|NCT02325713|100757632|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233719|NCT02325713|100757633|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233720|NCT02325713|100757634|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233721|NCT02325713|100757635|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233722|NCT02325713|100757636|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233723|NCT02325713|100757637|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233724|NCT02325713|100757638|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233725|NCT02325713|100757639|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233726|NCT02325713|100757640|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233727|NCT02325713|100757641|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
33233728|NCT02325713|100757642|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233729|NCT02325713|100757643|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233730|NCT02325713|100757644|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233731|NCT02325713|100757645|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233732|NCT02325713|100757646|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
33233733|NCT02325713|100757631|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
33233734|NCT02325713|100757632|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33233735|NCT02325713|100757633|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33233736|NCT02325713|100757634|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33233737|NCT02325713|100757635|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33233738|NCT02325713|100757636|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33420281|NCT01393626|101428565|FG003|Overall Study|Other|0|||
33420282|NCT01393626|101428562|FG000|Overall Study|Protocol Violation|1|||
33575452|NCT02761642|101996633|FG000|Overall Study|Physician Decision|1|||
33575453|NCT02761642|101996633|FG000|Overall Study|Reason Unspecified|21|||
33575454|NCT02121509|101996634|FG000|Washout Period (35 Days)|Adverse Event|1|||
33575455|NCT02121509|101996635|FG001|Washout Period (35 Days)|Adverse Event|1|||
33575456|NCT02121509|101996636|FG002|Washout Period (35 Days)|Adverse Event|0|||
33575457|NCT02121509|101996637|FG003|Washout Period (35 Days)|Adverse Event|0|||
33233739|NCT02325713|100757637|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33233740|NCT02325713|100757638|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33233741|NCT02325713|100757639|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33233742|NCT02325713|100757640|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33233743|NCT02325713|100757641|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33233744|NCT02325713|100757642|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33233745|NCT02325713|100757643|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33575458|NCT02121509|101996634|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
33233746|NCT02325713|100757644|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33233747|NCT02325713|100757645|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33233748|NCT02325713|100757646|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
33233749|NCT02325713|100757631|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233750|NCT02325713|100757632|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233751|NCT02325713|100757633|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233752|NCT02325713|100757634|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233753|NCT02325713|100757635|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233754|NCT02325713|100757636|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233755|NCT02325713|100757637|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233756|NCT02325713|100757638|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233757|NCT02325713|100757639|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233758|NCT02325713|100757640|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
33233759|NCT02325713|100757641|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233760|NCT02325713|100757642|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233761|NCT02325713|100757643|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233762|NCT02325713|100757644|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233763|NCT02325713|100757645|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233764|NCT02325713|100757646|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
33233765|NCT02471404|100757649|FG000|Overall Study|Adverse Event|7|||
33233766|NCT02471404|100757650|FG001|Overall Study|Adverse Event|1|||
33233767|NCT02471404|100757651|FG002|Overall Study|Adverse Event|2|||
33233768|NCT02471404|100757649|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
33233769|NCT02471404|100757650|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
33233770|NCT02471404|100757651|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
33233771|NCT02471404|100757649|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
33233772|NCT02471404|100757650|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
33233773|NCT02471404|100757651|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
33233774|NCT02471404|100757649|FG000|Overall Study|Lost to Follow-up|1|||
33233775|NCT02471404|100757650|FG001|Overall Study|Lost to Follow-up|1|||
33233776|NCT02471404|100757651|FG002|Overall Study|Lost to Follow-up|3|||
33368468|NCT00960440|101234840|FG000|Overall Study|Other|1|||
33233777|NCT02471404|100757649|FG000|Overall Study|Protocol Violation|1|||
33233778|NCT02471404|100757650|FG001|Overall Study|Protocol Violation|0|||
33233779|NCT02471404|100757651|FG002|Overall Study|Protocol Violation|0|||
33233780|NCT02471404|100757649|FG000|Overall Study|Withdrawal by Subject|8|||
33233781|NCT02471404|100757650|FG001|Overall Study|Withdrawal by Subject|4|||
33233782|NCT02471404|100757651|FG002|Overall Study|Withdrawal by Subject|5|||
33233783|NCT02471404|100757649|FG000|Overall Study|Other reasons not specified|10|||
33233784|NCT02471404|100757650|FG001|Overall Study|Other reasons not specified|7|||
33233785|NCT02471404|100757651|FG002|Overall Study|Other reasons not specified|12|||
33233786|NCT04747275|100757652|FG000|Overall Study|Study terminated|0|||
33233787|NCT04747275|100757653|FG001|Overall Study|Study terminated|1|||
33233788|NCT01163747|100757654|FG000|Overall Study|Adverse Event|0|||
33233789|NCT01163747|100757655|FG001|Overall Study|Adverse Event|5|||
33233790|NCT01163747|100757654|FG000|Overall Study|Insufficient Therapeutic Response|0|||
33233791|NCT01163747|100757655|FG001|Overall Study|Insufficient Therapeutic Response|1|||
33233792|NCT01163747|100757654|FG000|Overall Study|Protocol Violation|0|||
33233793|NCT01163747|100757655|FG001|Overall Study|Protocol Violation|1|||
33233794|NCT01163747|100757654|FG000|Overall Study|Refused Treatment|6|||
33233795|NCT01163747|100757655|FG001|Overall Study|Refused Treatment|4|||
33233796|NCT02878213|100757656|FG000|Overall Study|Withdrawal by Subject|2|||
33233797|NCT02878213|100757656|FG000|Overall Study|Adverse Event|1|||
33233798|NCT02982720|100757657|FG000|Overall Study|Adverse Event|3|||
33233799|NCT02982720|100757657|FG000|Overall Study|Death|1|||
33233800|NCT00358215|100757659|FG000|Overall Study|Ineligibility determined|4|||
33233801|NCT00358215|100757660|FG001|Overall Study|Ineligibility determined|3|||
33233802|NCT00358215|100757659|FG000|Overall Study|Adverse Event|83|||
33233803|NCT00358215|100757660|FG001|Overall Study|Adverse Event|65|||
33233804|NCT00358215|100757659|FG000|Overall Study|Withdrawal by Subject|111|||
33233805|NCT00358215|100757660|FG001|Overall Study|Withdrawal by Subject|102|||
33233806|NCT00358215|100757659|FG000|Overall Study|Participant request|65|||
33420283|NCT01393626|101428563|FG001|Overall Study|Protocol Violation|0|||
33420284|NCT01393626|101428564|FG002|Overall Study|Protocol Violation|2|||
33420285|NCT01393626|101428565|FG003|Overall Study|Protocol Violation|0|||
33233807|NCT00358215|100757660|FG001|Overall Study|Participant request|64|||
33233808|NCT00358215|100757659|FG000|Overall Study|Physician Decision|47|||
33233809|NCT00358215|100757660|FG001|Overall Study|Physician Decision|39|||
33233810|NCT00358215|100757659|FG000|Overall Study|Lost to Follow-up|16|||
33233811|NCT00358215|100757660|FG001|Overall Study|Lost to Follow-up|22|||
33233812|NCT00358215|100757659|FG000|Overall Study|Death|265|||
33233813|NCT00358215|100757660|FG001|Overall Study|Death|281|||
33233814|NCT00358215|100757659|FG000|Overall Study|Protocol Violation|64|||
33233815|NCT00358215|100757660|FG001|Overall Study|Protocol Violation|59|||
33368469|NCT00960440|101234841|FG001|Overall Study|Other|1|||
33233816|NCT00358215|100757659|FG000|Overall Study|Pregnancy|1|||
33233817|NCT00358215|100757660|FG001|Overall Study|Pregnancy|0|||
33233818|NCT00358215|100757659|FG000|Overall Study|Other|21|||
33233819|NCT00358215|100757660|FG001|Overall Study|Other|14|||
33233820|NCT00358215|100757659|FG000|Overall Study|Did not receive investigational product|2|||
33233821|NCT00358215|100757660|FG001|Overall Study|Did not receive investigational product|3|||
33233822|NCT02791490|100757661|FG000|Overall Study|Lost to Follow-up|1|||
33233823|NCT02791490|100757662|FG001|Overall Study|Lost to Follow-up|2|||
33233824|NCT02791490|100757661|FG000|Overall Study|Withdrawal by Subject|2|||
33233825|NCT02791490|100757662|FG001|Overall Study|Withdrawal by Subject|6|||
33233826|NCT00867490|100757663|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
33233827|NCT00867490|100757663|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
33233828|NCT00867490|100757663|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
33233829|NCT00867490|100757663|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
33233830|NCT00867490|100757663|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
33420286|NCT01162135|101428568|FG000|Overall Study|Withdrawal by Subject|1|||
33575459|NCT02121509|101996635|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
33575460|NCT02121509|101996636|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
33575461|NCT02121509|101996637|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
33575462|NCT02121509|101996634|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
33575463|NCT02121509|101996635|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
33575464|NCT02121509|101996636|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
33575465|NCT02121509|101996637|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
33575466|NCT01459666|101996638|FG000|Overall Study|PI left institution|5|||
33575467|NCT01459666|101996639|FG001|Overall Study|PI left institution|4|||
33575468|NCT04661033|101996640|FG000|Overall Study|Adverse Event|0|||
33575469|NCT04661033|101996641|FG001|Overall Study|Adverse Event|0|||
33575470|NCT04661033|101996642|FG002|Overall Study|Adverse Event|1|||
33575471|NCT04661033|101996643|FG003|Overall Study|Adverse Event|0|||
33575472|NCT04661033|101996640|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
33575473|NCT04661033|101996641|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
33575474|NCT04661033|101996642|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
33575475|NCT04661033|101996643|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
33575476|NCT04661033|101996640|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
33575477|NCT04661033|101996641|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
33575478|NCT04661033|101996642|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
33575479|NCT04661033|101996643|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
33575480|NCT04661033|101996640|FG000|Overall Study|Early discontinuation as per PI|1|||
33575481|NCT04661033|101996641|FG001|Overall Study|Early discontinuation as per PI|0|||
33575482|NCT04661033|101996642|FG002|Overall Study|Early discontinuation as per PI|0|||
33575483|NCT04661033|101996643|FG003|Overall Study|Early discontinuation as per PI|0|||
33575484|NCT00329030|101996644|FG000|Overall Study|Withdrawal by Subject|1|||
33575485|NCT00329030|101996645|FG001|Overall Study|Withdrawal by Subject|3|||
33575486|NCT00329030|101996644|FG000|Overall Study|Progressive Disease|6|||
33575487|NCT00329030|101996645|FG001|Overall Study|Progressive Disease|2|||
33575488|NCT00329030|101996644|FG000|Overall Study|Ineligible Pathology|1|||
33575489|NCT00329030|101996645|FG001|Overall Study|Ineligible Pathology|1|||
33575490|NCT00487981|101996650|FG000|Overall Study|Hypothyroidism diagnosis|1|||
33575491|NCT00256126|101996651|FG000|Overall Study|Adverse Event|1|||
33575492|NCT00256126|101996652|FG001|Overall Study|Adverse Event|0|||
33575493|NCT00256126|101996651|FG000|Overall Study|Other|1|||
33575494|NCT00256126|101996652|FG001|Overall Study|Other|2|||
33575495|NCT03894891|101996655|FG000|Overall Study|Withdrawal by Subject|1|||
33575496|NCT03894891|101996655|FG000|Overall Study|Completed protocol treatment per protocol|5|||
33137780|NCT01270802|100417330|FG000|Overall Study|Withdrawal by Subject|1|||
33137781|NCT01270802|100417331|FG001|Overall Study|Withdrawal by Subject|0|||
33137782|NCT01270802|100417330|FG000|Overall Study|Adverse Event|1|||
33137783|NCT01270802|100417331|FG001|Overall Study|Adverse Event|0|||
33137784|NCT01270802|100417330|FG000|Overall Study|Lost to Follow-up|0|||
33137785|NCT01270802|100417331|FG001|Overall Study|Lost to Follow-up|1|||
33137786|NCT04129151|100417332|FG000|Overall Study|Adverse Event|1|||
33137787|NCT04129151|100417332|FG000|Overall Study|Disease Progression|7|||
33137788|NCT04129151|100417332|FG000|Overall Study|Study closure|1|||
33137789|NCT00870584|100420035|FG000|Overall Study|Adverse Event|3|||
33137790|NCT00870584|100420036|FG001|Overall Study|Adverse Event|3|||
33137791|NCT00870584|100420035|FG000|Overall Study|Withdrawal by Subject|6|||
33137792|NCT00870584|100420036|FG001|Overall Study|Withdrawal by Subject|7|||
33137793|NCT00870584|100420035|FG000|Overall Study|Lost to Follow-up|5|||
33137794|NCT00870584|100420036|FG001|Overall Study|Lost to Follow-up|1|||
33137795|NCT00870584|100420035|FG000|Overall Study|Protocol Deviation|2|||
33137796|NCT00870584|100420036|FG001|Overall Study|Protocol Deviation|2|||
33137797|NCT01771809|100420037|FG000|Overall Study|Adverse Event|4|||
33233831|NCT02040090|100757664|FG000|Overall Study|Adverse Event|2|||
33233832|NCT02040090|100757665|FG001|Overall Study|Adverse Event|0|||
33575497|NCT04409834|101996659|FG000|Overall Study|Death|55|||
33575498|NCT04409834|101996660|FG001|Overall Study|Death|62|||
33575499|NCT00692003|101996661|FG000|Overall Study|Sponsor Decision|5|||
33575500|NCT00692003|101996662|FG001|Overall Study|Sponsor Decision|1|||
33575501|NCT05518461|101996666|FG000|Overall Study|Lost to Follow-up|25|||
33575502|NCT03761056|101996667|FG000|Overall Study|Death|8|||
33575503|NCT03761056|101996667|FG000|Overall Study|Enrolled but never treated|2|||
33575504|NCT03761056|101996667|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
33575505|NCT03761056|101996667|FG000|Overall Study|Investigator decision|1|||
33575506|NCT02332928|101996668|FG000|Overall Study|Withdrawal by Subject|0|||
33575507|NCT02332928|101996669|FG001|Overall Study|Withdrawal by Subject|2|||
33575508|NCT02332928|101996668|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
33575509|NCT02332928|101996669|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
33575510|NCT02012218|101996675|FG000|Overall Study|Withdrawal by Subject|1|||
33575511|NCT02012218|101996676|FG001|Overall Study|Withdrawal by Subject|0|||
33575512|NCT02012218|101996677|FG002|Overall Study|Withdrawal by Subject|1|||
33575513|NCT02012218|101996678|FG003|Overall Study|Withdrawal by Subject|1|||
33575514|NCT02012218|101996679|FG004|Overall Study|Withdrawal by Subject|1|||
33575515|NCT02012218|101996675|FG000|Overall Study|Adverse Event|1|||
33575516|NCT02012218|101996676|FG001|Overall Study|Adverse Event|0|||
33575517|NCT02012218|101996677|FG002|Overall Study|Adverse Event|0|||
33575518|NCT02012218|101996678|FG003|Overall Study|Adverse Event|1|||
33575519|NCT02012218|101996679|FG004|Overall Study|Adverse Event|0|||
33575520|NCT02012218|101996675|FG000|Overall Study|Lost to Follow-up|0|||
33575521|NCT02012218|101996676|FG001|Overall Study|Lost to Follow-up|1|||
33575522|NCT02012218|101996677|FG002|Overall Study|Lost to Follow-up|1|||
33575523|NCT02012218|101996678|FG003|Overall Study|Lost to Follow-up|0|||
33575524|NCT02012218|101996679|FG004|Overall Study|Lost to Follow-up|0|||
33137798|NCT01771809|100420038|FG001|Overall Study|Adverse Event|12|||
33137799|NCT01771809|100420037|FG000|Overall Study|Protocol Violation|0|||
33137800|NCT01771809|100420038|FG001|Overall Study|Protocol Violation|1|||
33137801|NCT01771809|100420037|FG000|Overall Study|Withdrawal by Subject|34|||
33137802|NCT01771809|100420038|FG001|Overall Study|Withdrawal by Subject|42|||
33137803|NCT01771809|100420037|FG000|Overall Study|Lost to Follow-up|1|||
33137804|NCT01771809|100420038|FG001|Overall Study|Lost to Follow-up|3|||
33137805|NCT01771809|100420037|FG000|Overall Study|Other (Insufficient clinical response)|22|||
33137806|NCT01771809|100420038|FG001|Overall Study|Other (Insufficient clinical response)|20|||
33137807|NCT01771809|100420037|FG000|Overall Study|Death|1|||
33137808|NCT01771809|100420038|FG001|Overall Study|Death|0|||
33137809|NCT01771809|100420037|FG000|Overall Study|Other (other)|9|||
33137810|NCT01771809|100420038|FG001|Overall Study|Other (other)|5|||
33137811|NCT02364336|100420039|FG000|Overall Study|Adverse Event|0|||
33137812|NCT02364336|100420040|FG001|Overall Study|Adverse Event|1|||
33137813|NCT00811642|100420041|FG000|Overall Study|Adverse Event|3|||
33137814|NCT00811642|100420041|FG000|Overall Study|Protocol Violation|1|||
33137815|NCT00811642|100420041|FG000|Overall Study|Death|2|||
33137816|NCT00811642|100420041|FG000|Overall Study|Withdrawal by Subject|7|||
33575525|NCT02012218|101996675|FG000|Overall Study|Protocol Specified|1|||
33575526|NCT02012218|101996676|FG001|Overall Study|Protocol Specified|0|||
33368470|NCT00960440|101234842|FG002|Overall Study|Other|1|||
33575527|NCT02012218|101996677|FG002|Overall Study|Protocol Specified|0|||
33575528|NCT02012218|101996678|FG003|Overall Study|Protocol Specified|0|||
33575529|NCT02012218|101996679|FG004|Overall Study|Protocol Specified|0|||
33575530|NCT02012218|101996675|FG000|Overall Study|Protocol Deviation|1|||
33636539|NCT02531802|102222847|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
33636540|NCT02531802|102222848|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
33636541|NCT02531802|102222849|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
33636542|NCT02531802|102222829|FG000|Received Vaccination 2|Physician Decision|0|||
33636543|NCT02531802|102222830|FG001|Received Vaccination 2|Physician Decision|0|||
33636544|NCT02531802|102222831|FG002|Received Vaccination 2|Physician Decision|0|||
33636545|NCT02531802|102222832|FG003|Received Vaccination 2|Physician Decision|0|||
33636546|NCT02531802|102222833|FG004|Received Vaccination 2|Physician Decision|0|||
33636547|NCT02531802|102222834|FG005|Received Vaccination 2|Physician Decision|1|||
33636548|NCT02531802|102222835|FG006|Received Vaccination 2|Physician Decision|0|||
33137817|NCT00811642|100420041|FG000|Overall Study|Cumulative use of antifungal agent|2|||
33137818|NCT01087788|100420052|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
33137819|NCT01087788|100420053|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
33233833|NCT02040090|100757664|FG000|Overall Study|Physician Decision|1|||
33368471|NCT00960440|101234843|FG003|Overall Study|Other|0|||
33368472|NCT01465178|101234847|FG000|Overall Study|Withdrawal by Subject|1|||
33420287|NCT01162135|101428568|FG000|Overall Study|Severe back pain|1|||
33420288|NCT01162135|101428568|FG000|Overall Study|Ineligible|1|||
33575531|NCT02012218|101996676|FG001|Overall Study|Protocol Deviation|0|||
33575532|NCT02012218|101996677|FG002|Overall Study|Protocol Deviation|0|||
33575533|NCT02012218|101996678|FG003|Overall Study|Protocol Deviation|0|||
33575534|NCT02012218|101996679|FG004|Overall Study|Protocol Deviation|0|||
33575535|NCT02289469|101996683|FG000|Overall Study|Unable to match a control|6|||
33575536|NCT02289469|101996684|FG001|Overall Study|Unable to match a control|0|||
33575537|NCT03376516|101996685|FG000|Overall Study|Not treated|1|||
33575538|NCT03376516|101996685|FG000|Overall Study|Consent withdrawn|1|||
33575539|NCT00943761|101996686|FG000|Overall Study|Lost to Follow-up|2|||
33575540|NCT00943761|101996687|FG001|Overall Study|Lost to Follow-up|0|||
33575541|NCT00943761|101996686|FG000|Overall Study|Withdrawal by Subject|2|||
33575542|NCT00943761|101996687|FG001|Overall Study|Withdrawal by Subject|1|||
33137820|NCT01087788|100420054|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
33137821|NCT01087788|100420052|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
33137822|NCT01087788|100420053|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
33137823|NCT01087788|100420054|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
33233834|NCT02040090|100757665|FG001|Overall Study|Physician Decision|0|||
33233835|NCT02040090|100757664|FG000|Overall Study|Withdrawal by Subject|0|||
33233836|NCT02040090|100757665|FG001|Overall Study|Withdrawal by Subject|1|||
33233837|NCT02040090|100757664|FG000|Overall Study|Lost to Follow-up|0|||
33233838|NCT02040090|100757665|FG001|Overall Study|Lost to Follow-up|1|||
33233839|NCT00502996|100757666|FG000|Overall Study|Lost to Follow-up|9|||
33233840|NCT00502996|100757666|FG000|Overall Study|Protocol Violation|2|||
33368473|NCT01465178|101234848|FG001|Overall Study|Withdrawal by Subject|0|||
33368474|NCT02699515|101234850|FG000|Overall Study|Death|3|||
33368475|NCT02699515|101234851|FG001|Overall Study|Death|3|||
33368476|NCT02699515|101234852|FG002|Overall Study|Death|3|||
33368477|NCT02699515|101234853|FG003|Overall Study|Death|23|||
33368478|NCT02699515|101234854|FG004|Overall Study|Death|22|||
33368479|NCT02699515|101234855|FG005|Overall Study|Death|23|||
33368480|NCT02699515|101234856|FG006|Overall Study|Death|3|||
33368481|NCT02699515|101234857|FG007|Overall Study|Death|5|||
33368482|NCT02699515|101234850|FG000|Overall Study|Withdrawal by Subject|0|||
33368483|NCT02699515|101234851|FG001|Overall Study|Withdrawal by Subject|0|||
33368484|NCT02699515|101234852|FG002|Overall Study|Withdrawal by Subject|3|||
33368485|NCT02699515|101234853|FG003|Overall Study|Withdrawal by Subject|1|||
33368486|NCT02699515|101234854|FG004|Overall Study|Withdrawal by Subject|5|||
33368487|NCT02699515|101234855|FG005|Overall Study|Withdrawal by Subject|3|||
33368488|NCT02699515|101234856|FG006|Overall Study|Withdrawal by Subject|0|||
33368489|NCT02699515|101234857|FG007|Overall Study|Withdrawal by Subject|1|||
33368490|NCT02699515|101234850|FG000|Overall Study|Other|1|||
33368491|NCT02699515|101234851|FG001|Overall Study|Other|0|||
33368492|NCT02699515|101234852|FG002|Overall Study|Other|1|||
33368493|NCT02699515|101234853|FG003|Overall Study|Other|6|||
33368494|NCT02699515|101234854|FG004|Overall Study|Other|4|||
33368495|NCT02699515|101234855|FG005|Overall Study|Other|3|||
33368496|NCT02699515|101234856|FG006|Overall Study|Other|0|||
33368497|NCT02699515|101234857|FG007|Overall Study|Other|0|||
33368498|NCT00589472|101234864|FG000|Overall Study|Adverse Event|1|||
33368499|NCT03596177|101234867|FG000|Single Blind Period|Withdrawal by Subject|1|||
33368500|NCT03596177|101234868|FG001|Single Blind Period|Withdrawal by Subject|1|||
33368501|NCT03596177|101234867|FG000|Single Blind Period|Other|1|||
33368502|NCT03596177|101234868|FG001|Single Blind Period|Other|0|||
33368503|NCT03596177|101234867|FG000|Double Blind Period|Withdrawal by Subject|0|||
33368504|NCT03596177|101234868|FG001|Double Blind Period|Withdrawal by Subject|1|||
33137824|NCT01087788|100420052|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
33137825|NCT01087788|100420053|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
33368505|NCT03596177|101234867|FG000|Double Blind Period|Other|0|||
33575543|NCT04619004|101996688|FG000|Overall Study|Death|114|||
33575544|NCT04619004|101996689|FG001|Overall Study|Death|28|||
33575545|NCT04619004|101996688|FG000|Overall Study|Lost to Follow-up|1|||
33575546|NCT04619004|101996689|FG001|Overall Study|Lost to Follow-up|1|||
33575547|NCT04619004|101996688|FG000|Overall Study|Withdrawal by Subject|24|||
33575548|NCT04619004|101996689|FG001|Overall Study|Withdrawal by Subject|7|||
33575549|NCT04619004|101996688|FG000|Overall Study|Other - Not specified|0|||
33575550|NCT04619004|101996689|FG001|Overall Study|Other - Not specified|1|||
33575551|NCT02296476|101996690|FG000|Overall Study|Disease Progression|6|||
33575552|NCT02296476|101996691|FG001|Overall Study|Disease Progression|4|||
33575553|NCT02296476|101996692|FG002|Overall Study|Disease Progression|2|||
33575554|NCT02136914|101999808|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
33575555|NCT02136914|101999809|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
33137826|NCT01087788|100420054|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
33368506|NCT03596177|101234868|FG001|Double Blind Period|Other|4|||
33368507|NCT03596177|101234867|FG000|Double Blind Period|Death during safety follow-up|0|||
33137827|NCT01087788|100420052|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
33368508|NCT03596177|101234868|FG001|Double Blind Period|Death during safety follow-up|1|||
33420289|NCT02406742|101428571|FG000|Overall Study|Progression of Disease|5|||
33233841|NCT00502996|100757666|FG000|Overall Study|Treatment failure|25|||
33233842|NCT00502996|100757666|FG000|Overall Study|Withdrawal Informed Consent|6|||
33368509|NCT04078152|101234869|FG000|Overall Study|Other|83|||
33368510|NCT04078152|101234870|FG001|Overall Study|Other|22|||
33368511|NCT04078152|101234871|FG002|Overall Study|Other|25|||
33575556|NCT02136914|101999808|FG000|Overall Study|Withdrawal by Subject|3|||
33575557|NCT02136914|101999809|FG001|Overall Study|Withdrawal by Subject|10|||
33575558|NCT02136914|101999808|FG000|Overall Study|Subject Unwilling to Proceed|7|||
33575559|NCT02136914|101999809|FG001|Overall Study|Subject Unwilling to Proceed|2|||
33575560|NCT02136914|101999808|FG000|Overall Study|Lost to Follow-up|1|||
33575561|NCT02136914|101999809|FG001|Overall Study|Lost to Follow-up|1|||
33575562|NCT02136914|101999808|FG000|Overall Study|Did Not Receive Study Drug|2|||
33575563|NCT02136914|101999809|FG001|Overall Study|Did Not Receive Study Drug|0|||
33636549|NCT02531802|102222836|FG007|Received Vaccination 2|Physician Decision|0|||
33636550|NCT02531802|102222837|FG008|Received Vaccination 2|Physician Decision|0|||
33137828|NCT01087788|100420053|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
33137829|NCT01087788|100420054|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
33137830|NCT01087788|100420052|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
33137831|NCT01087788|100420053|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
33137832|NCT01087788|100420054|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
33137833|NCT01087788|100420052|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
33137834|NCT01087788|100420053|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
33137835|NCT01087788|100420054|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
33137836|NCT01087788|100420052|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
33137837|NCT01087788|100420053|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
33137838|NCT01087788|100420054|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
33233843|NCT00502996|100757666|FG000|Overall Study|Adverse Event|2|||
33233844|NCT02836613|100757667|FG000|Overall Study|Accidental drowning|1|||
33233845|NCT02836613|100757668|FG001|Overall Study|Accidental drowning|0|||
33233846|NCT02836613|100757667|FG000|Overall Study|Lost to Follow-up|0|||
33233847|NCT02836613|100757668|FG001|Overall Study|Lost to Follow-up|1|||
33233848|NCT02836613|100757667|FG000|Overall Study|Withdrawal by Subject|0|||
33233849|NCT02836613|100757668|FG001|Overall Study|Withdrawal by Subject|2|||
33636551|NCT02531802|102222838|FG009|Received Vaccination 2|Physician Decision|2|||
33636552|NCT02531802|102222839|FG010|Received Vaccination 2|Physician Decision|0|||
33420290|NCT02406742|101428572|FG001|Overall Study|Progression of Disease|1|||
33420291|NCT02406742|101428573|FG002|Overall Study|Progression of Disease|6|||
33636553|NCT02531802|102222840|FG011|Received Vaccination 2|Physician Decision|0|||
33636554|NCT02531802|102222841|FG012|Received Vaccination 2|Physician Decision|0|||
33636555|NCT02531802|102222842|FG013|Received Vaccination 2|Physician Decision|1|||
33636556|NCT02531802|102222843|FG014|Received Vaccination 2|Physician Decision|0|||
33636557|NCT02531802|102222844|FG015|Received Vaccination 2|Physician Decision|0|||
33575564|NCT02136914|101999808|FG000|Overall Study|Lack of Efficacy|1|||
33575565|NCT02136914|101999809|FG001|Overall Study|Lack of Efficacy|0|||
33575566|NCT02136914|101999808|FG000|Overall Study|Death|0|||
33575567|NCT02136914|101999809|FG001|Overall Study|Death|1|||
33575568|NCT02670473|101999812|FG000|Overall Study|Withdrawal by Subject|1|||
33575569|NCT02573948|101999813|FG000|Longitudinal Cohort|Death|9|||
33575570|NCT02573948|101999813|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
33575571|NCT02573948|101999813|FG000|Longitudinal Cohort|Incarcerated|25|||
33575572|NCT01732536|101999818|FG000|Overall Study|Withdrawal by Subject|1|||
33575573|NCT01732536|101999819|FG001|Overall Study|Withdrawal by Subject|1|||
33575574|NCT00598650|101999820|FG000|Overall Study|Withdrawal by Subject|3|||
33575575|NCT00598650|101999820|FG000|Overall Study|Adverse Event|18|||
33575576|NCT00598650|101999820|FG000|Overall Study|No treatment for 3 weeks|1|||
33575577|NCT00598650|101999820|FG000|Overall Study|Not eligible|1|||
33575578|NCT00598650|101999820|FG000|Overall Study|Prohibited Concomitant Medication|2|||
33575579|NCT00598650|101999820|FG000|Overall Study|Physician Decision|2|||
33575580|NCT04940130|101999821|FG000|Overall Study|Travel|1|||
33575581|NCT04940130|101999822|FG001|Overall Study|Travel|0|||
33575582|NCT04940130|101999823|FG002|Overall Study|Travel|2|||
33575583|NCT04940130|101999821|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
33575584|NCT04940130|101999822|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
33575585|NCT04940130|101999823|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
33575586|NCT04940130|101999821|FG000|Overall Study|Adverse Event|0|||
33575587|NCT04940130|101999822|FG001|Overall Study|Adverse Event|0|||
33636558|NCT02531802|102222845|FG016|Received Vaccination 2|Physician Decision|0|||
33233850|NCT01995357|100757670|FG000|Period 5|Lack of Efficacy|1|||
33233851|NCT01995357|100757671|FG001|Period 5|Lack of Efficacy|0|||
33420292|NCT02406742|101428571|FG000|Overall Study|Adverse Event|3|||
33420293|NCT02406742|101428572|FG001|Overall Study|Adverse Event|0|||
33420294|NCT02406742|101428573|FG002|Overall Study|Adverse Event|2|||
33420295|NCT02406742|101428571|FG000|Overall Study|Death|1|||
33420296|NCT02406742|101428572|FG001|Overall Study|Death|0|||
33420297|NCT02406742|101428573|FG002|Overall Study|Death|0|||
33420298|NCT02406742|101428571|FG000|Overall Study|Lack of Efficacy|0|||
33420299|NCT02406742|101428572|FG001|Overall Study|Lack of Efficacy|0|||
33575588|NCT04940130|101999823|FG002|Overall Study|Adverse Event|2|||
33575589|NCT04940130|101999821|FG000|Overall Study|Disease progression/treatment failure|0|||
33575590|NCT04940130|101999822|FG001|Overall Study|Disease progression/treatment failure|0|||
33575591|NCT04940130|101999823|FG002|Overall Study|Disease progression/treatment failure|1|||
33420300|NCT02406742|101428573|FG002|Overall Study|Lack of Efficacy|1|||
33420301|NCT02406742|101428571|FG000|Overall Study|Withdrawal by Participant|1|||
33575592|NCT04940130|101999821|FG000|Overall Study|Participant refusal|0|||
33137839|NCT01087788|100420052|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
33137840|NCT01087788|100420053|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
33137841|NCT01087788|100420054|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
33137842|NCT01087788|100420052|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
33137843|NCT01087788|100420053|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
33137844|NCT01087788|100420054|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
33137845|NCT01087788|100420052|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
33137846|NCT01087788|100420053|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
33137847|NCT01087788|100420054|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
33137848|NCT01087788|100420052|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
33137849|NCT01087788|100420053|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
33137850|NCT01087788|100420054|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
33137851|NCT01087788|100420052|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
33137852|NCT01087788|100420053|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
33137853|NCT01087788|100420054|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
33137854|NCT01087788|100420052|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
33137855|NCT01087788|100420053|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
33137856|NCT01087788|100420054|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
33137857|NCT01087788|100420052|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
33137858|NCT01087788|100420053|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
33137859|NCT01087788|100420054|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
33137860|NCT01087788|100420052|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
33137861|NCT01087788|100420053|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
33137862|NCT01087788|100420054|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
33137863|NCT01087788|100420052|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
33137864|NCT01087788|100420053|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
33137865|NCT01087788|100420054|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
33137866|NCT01087788|100420052|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
33137867|NCT01087788|100420053|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
33137868|NCT01087788|100420054|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
33233852|NCT01995357|100757672|FG002|Period 5|Lack of Efficacy|0|||
33233853|NCT01995357|100757673|FG003|Period 5|Lack of Efficacy|0|||
33233854|NCT01995357|100757674|FG004|Period 5|Lack of Efficacy|0|||
33233855|NCT01995357|100757675|FG005|Period 5|Lack of Efficacy|0|||
33233856|NCT01995357|100757670|FG000|Period 5|Adverse Event|1|||
33233857|NCT01995357|100757671|FG001|Period 5|Adverse Event|0|||
33233858|NCT01995357|100757672|FG002|Period 5|Adverse Event|1|||
33233859|NCT01995357|100757673|FG003|Period 5|Adverse Event|0|||
33233860|NCT01995357|100757674|FG004|Period 5|Adverse Event|0|||
33233861|NCT01995357|100757675|FG005|Period 5|Adverse Event|0|||
33233862|NCT01651936|100757676|FG000|Base Study|Adverse Event|3|||
33233863|NCT01651936|100757677|FG001|Base Study|Adverse Event|0|||
33420302|NCT02406742|101428572|FG001|Overall Study|Withdrawal by Participant|2|||
33420303|NCT02406742|101428573|FG002|Overall Study|Withdrawal by Participant|0|||
33420304|NCT02406742|101428571|FG000|Overall Study|Physician Decision|1|||
33420305|NCT02406742|101428572|FG001|Overall Study|Physician Decision|2|||
33137869|NCT01087788|100420052|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
33233864|NCT01651936|100757678|FG002|Base Study|Adverse Event|0|||
33233865|NCT01651936|100757676|FG000|Base Study|Withdrawal by Subject|1|||
33233866|NCT01651936|100757677|FG001|Base Study|Withdrawal by Subject|1|||
33233867|NCT01651936|100757678|FG002|Base Study|Withdrawal by Subject|0|||
33233868|NCT01651936|100757676|FG000|Base Study|Early Escape|2|||
33233869|NCT01651936|100757677|FG001|Base Study|Early Escape|8|||
33233870|NCT01651936|100757678|FG002|Base Study|Early Escape|0|||
33233871|NCT01651936|100757676|FG000|Base Study|Study terminated by sponsor|21|||
33233872|NCT01651936|100757677|FG001|Base Study|Study terminated by sponsor|16|||
33233873|NCT01651936|100757678|FG002|Base Study|Study terminated by sponsor|0|||
33233874|NCT01651936|100757676|FG000|Extension Study|Lack of Efficacy|0|||
33368512|NCT04078152|101234869|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
33368513|NCT04078152|101234870|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
33420306|NCT02406742|101428573|FG002|Overall Study|Physician Decision|1|||
33420307|NCT02406742|101428571|FG000|Overall Study|Transition to other treatment|2|||
33420308|NCT02406742|101428572|FG001|Overall Study|Transition to other treatment|0|||
33420309|NCT02406742|101428573|FG002|Overall Study|Transition to other treatment|1|||
33420310|NCT02406742|101428571|FG000|Overall Study|Other Reasons|1|||
33420311|NCT02406742|101428572|FG001|Overall Study|Other Reasons|11|||
33420312|NCT02406742|101428573|FG002|Overall Study|Other Reasons|5|||
33420313|NCT02428231|101428574|FG000|Overall Study|Other|10|||
33420314|NCT02428231|101428575|FG001|Overall Study|Other|16|||
33420315|NCT02428231|101428574|FG000|Overall Study|Required Symptomatic Therapy|0|||
33233875|NCT01651936|100757677|FG001|Extension Study|Lack of Efficacy|0|||
33420316|NCT02428231|101428575|FG001|Overall Study|Required Symptomatic Therapy|1|||
33420317|NCT02428231|101428574|FG000|Overall Study|Adverse Event|3|||
33137870|NCT01087788|100420053|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
33575593|NCT04940130|101999822|FG001|Overall Study|Participant refusal|0|||
33575594|NCT04940130|101999823|FG002|Overall Study|Participant refusal|1|||
33137871|NCT01087788|100420054|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
33137872|NCT01087788|100420052|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
33137873|NCT01087788|100420053|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
33137874|NCT01087788|100420054|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
33137875|NCT01087788|100420052|FG000|24-weeks Dose-blind Period|Patient moved|0|||
33137876|NCT01087788|100420053|FG001|24-weeks Dose-blind Period|Patient moved|0|||
33137877|NCT01087788|100420054|FG002|24-weeks Dose-blind Period|Patient moved|1|||
33137878|NCT01087788|100420052|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
33137879|NCT01087788|100420053|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
33137880|NCT01087788|100420054|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
33137881|NCT01087788|100420052|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
33137882|NCT01087788|100420053|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
33137883|NCT01087788|100420054|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
33137884|NCT01087788|100420052|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
33137885|NCT01087788|100420053|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
33137886|NCT01087788|100420054|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
33137887|NCT01087788|100420052|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
33137888|NCT01087788|100420053|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
33137889|NCT01087788|100420054|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
33137890|NCT01087788|100420052|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
33137891|NCT01087788|100420053|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
33137892|NCT01087788|100420054|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
33137893|NCT01087788|100420052|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
33137894|NCT01087788|100420053|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
33137895|NCT01087788|100420054|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
33233876|NCT01651936|100757678|FG002|Extension Study|Lack of Efficacy|1|||
33636559|NCT02531802|102222846|FG017|Received Vaccination 2|Physician Decision|1|||
33636560|NCT02531802|102222847|FG018|Received Vaccination 2|Physician Decision|0|||
33636561|NCT02531802|102222848|FG019|Received Vaccination 2|Physician Decision|0|||
33636562|NCT02531802|102222849|FG020|Received Vaccination 2|Physician Decision|0|||
33636563|NCT02531802|102222829|FG000|Received Vaccination 2|Adverse Event|0|||
33636564|NCT02531802|102222830|FG001|Received Vaccination 2|Adverse Event|0|||
33636565|NCT02531802|102222831|FG002|Received Vaccination 2|Adverse Event|0|||
33636566|NCT02531802|102222832|FG003|Received Vaccination 2|Adverse Event|0|||
33636567|NCT02531802|102222833|FG004|Received Vaccination 2|Adverse Event|0|||
33636568|NCT02531802|102222834|FG005|Received Vaccination 2|Adverse Event|2|||
33636569|NCT02531802|102222835|FG006|Received Vaccination 2|Adverse Event|0|||
33636570|NCT02531802|102222836|FG007|Received Vaccination 2|Adverse Event|0|||
33137896|NCT01087788|100420052|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
33233877|NCT01651936|100757676|FG000|Extension Study|Study terminated by sponsor|0|||
33137897|NCT01087788|100420053|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
33137898|NCT01087788|100420054|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
33137899|NCT01087788|100420052|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
33575595|NCT02347085|101999824|FG000|Overall Study|Adverse Event|2|||
33575596|NCT02347085|101999824|FG000|Overall Study|Lack of Efficacy|1|||
33575597|NCT02347085|101999824|FG000|Overall Study|Withdrawal by Subject|4|||
33575598|NCT02347085|101999824|FG000|Overall Study|Lost to Follow-up|1|||
33575599|NCT02347085|101999824|FG000|Overall Study|Protocol Criteria|2|||
33575600|NCT05525910|101999825|FG000|Period 4|Per sponsor due to study timelines|0|||
33575601|NCT05525910|101999826|FG001|Period 4|Per sponsor due to study timelines|0|||
33575602|NCT05525910|101999827|FG002|Period 4|Per sponsor due to study timelines|1|||
33575603|NCT05525910|101999828|FG003|Period 4|Per sponsor due to study timelines|1|||
33575604|NCT05525910|101999829|FG004|Period 4|Per sponsor due to study timelines|1|||
33575605|NCT03423121|101999830|FG000|Overall Study|Lost to Follow-up|2|||
33636571|NCT02531802|102222837|FG008|Received Vaccination 2|Adverse Event|0|||
33636572|NCT02531802|102222838|FG009|Received Vaccination 2|Adverse Event|0|||
33636573|NCT02531802|102222839|FG010|Received Vaccination 2|Adverse Event|0|||
33636574|NCT02531802|102222840|FG011|Received Vaccination 2|Adverse Event|0|||
33636575|NCT02531802|102222841|FG012|Received Vaccination 2|Adverse Event|0|||
33137900|NCT01087788|100420053|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
33137901|NCT01087788|100420054|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
33137902|NCT01087788|100420052|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
33137903|NCT01087788|100420053|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
33137904|NCT01087788|100420054|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
33420318|NCT02428231|101428575|FG001|Overall Study|Adverse Event|0|||
33636576|NCT02531802|102222842|FG013|Received Vaccination 2|Adverse Event|0|||
33636577|NCT02531802|102222843|FG014|Received Vaccination 2|Adverse Event|0|||
33636578|NCT02531802|102222844|FG015|Received Vaccination 2|Adverse Event|0|||
33575606|NCT03423121|101999831|FG001|Overall Study|Lost to Follow-up|6|||
33636579|NCT02531802|102222845|FG016|Received Vaccination 2|Adverse Event|0|||
33636580|NCT02531802|102222846|FG017|Received Vaccination 2|Adverse Event|2|||
33636581|NCT02531802|102222847|FG018|Received Vaccination 2|Adverse Event|1|||
33636582|NCT02531802|102222848|FG019|Received Vaccination 2|Adverse Event|0|||
33636583|NCT02531802|102222849|FG020|Received Vaccination 2|Adverse Event|1|||
33137905|NCT01087788|100420052|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
33137906|NCT01087788|100420053|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
33137907|NCT01087788|100420054|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
33137908|NCT01087788|100420052|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
33636584|NCT02531802|102222829|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
33636585|NCT02531802|102222830|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
33636586|NCT02531802|102222831|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
33636587|NCT02531802|102222832|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
33636588|NCT02531802|102222833|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
33636589|NCT02531802|102222834|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
33636590|NCT02531802|102222835|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
33636591|NCT02531802|102222836|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
33636592|NCT02531802|102222837|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
33636593|NCT02531802|102222838|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
33636594|NCT02531802|102222839|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
33636595|NCT02531802|102222840|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
33636596|NCT02531802|102222841|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
33636597|NCT02531802|102222842|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
33636598|NCT02531802|102222843|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
33636599|NCT02531802|102222844|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
33636600|NCT02531802|102222845|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
33636601|NCT02531802|102222846|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
33636602|NCT02531802|102222847|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
33636603|NCT02531802|102222848|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
33636604|NCT02531802|102222849|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
33636605|NCT01491607|102222851|FG000|Overall Study|Lost to Follow-up|7|||
33636606|NCT01491607|102222851|FG000|Overall Study|Withdrawal by Subject|3|||
33636607|NCT05101122|102222852|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
33636608|NCT05101122|102222852|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
33636609|NCT05101122|102222852|FG000|AD313 80/5|Withdrawal by Subject|1|||
33636610|NCT05101122|102222852|FG000|AD313 80/10|Physician Decision|1|||
33636611|NCT03472885|102222853|FG000|24-Week Treatment Period|Adverse Event|1|||
33636612|NCT02651675|102222855|FG000|Overall Study|Death|0|||
33636613|NCT02651675|102222856|FG001|Overall Study|Death|0|||
33636614|NCT02651675|102222857|FG002|Overall Study|Death|1|||
33636615|NCT00260533|102222858|FG000|Overall Study|Other|3|||
33636616|NCT00260533|102222859|FG001|Overall Study|Other|3|||
33636617|NCT00999804|102222860|FG000|Overall Study|Lack of Efficacy|9|||
33636618|NCT00999804|102222861|FG001|Overall Study|Lack of Efficacy|2|||
33636619|NCT00999804|102222860|FG000|Overall Study|Adverse Event|4|||
33636620|NCT00999804|102222861|FG001|Overall Study|Adverse Event|3|||
33636621|NCT00999804|102222860|FG000|Overall Study|Withdrawal by Subject|4|||
33636622|NCT00999804|102222861|FG001|Overall Study|Withdrawal by Subject|0|||
33636623|NCT00999804|102222860|FG000|Overall Study|Death|1|||
33636624|NCT00999804|102222861|FG001|Overall Study|Death|0|||
33636625|NCT00999804|102222860|FG000|Overall Study|Ineligible|3|||
33636626|NCT00999804|102222861|FG001|Overall Study|Ineligible|0|||
33636627|NCT03367793|102222865|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
33636628|NCT03367793|102222866|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
33636629|NCT03367793|102222867|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
33636630|NCT03367793|102222868|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
33636631|NCT03367793|102222869|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
33636632|NCT03367793|102222870|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
33636633|NCT02129699|102222871|FG000|Overall Study|Did not start treatment|3|||
33636634|NCT02129699|102222872|FG001|Overall Study|Did not start treatment|2|||
33636635|NCT02557139|102222873|FG000|Overall Study|Significant liver elevation|1|||
33636636|NCT02557139|102222874|FG001|Overall Study|Significant liver elevation|0|||
33636637|NCT02557139|102222875|FG002|Overall Study|Significant liver elevation|1|||
33636638|NCT02557139|102222873|FG000|Overall Study|Withdrawal by Subject|1|||
33636639|NCT02557139|102222874|FG001|Overall Study|Withdrawal by Subject|0|||
33420319|NCT02729545|101428577|FG000|Overall Study|Pregnancy|1|||
33636640|NCT02557139|102222875|FG002|Overall Study|Withdrawal by Subject|0|||
33636641|NCT02557139|102222873|FG000|Overall Study|Illness of prohibited medication|0|||
33636642|NCT02557139|102222874|FG001|Overall Study|Illness of prohibited medication|0|||
33636643|NCT02557139|102222875|FG002|Overall Study|Illness of prohibited medication|1|||
33636644|NCT00391586|102222876|FG000|Overall Study|Progressive disease|13|||
33636645|NCT00391586|102222876|FG000|Overall Study|Adverse Event|5|||
33636646|NCT00391586|102222876|FG000|Overall Study|Physician Decision|2|||
33137909|NCT01087788|100420053|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
33636647|NCT00391586|102222876|FG000|Overall Study|Death|4|||
33575607|NCT03423121|101999830|FG000|Overall Study|Adverse Event|1|||
33575608|NCT03423121|101999831|FG001|Overall Study|Adverse Event|0|||
33575609|NCT01783444|101999834|FG000|Treatment Phase|Adverse Event|9|||
33575610|NCT01783444|101999835|FG001|Treatment Phase|Adverse Event|20|||
33575611|NCT01783444|101999836|FG002|Treatment Phase|Adverse Event|19|||
33233878|NCT01651936|100757677|FG001|Extension Study|Study terminated by sponsor|0|||
33233879|NCT01651936|100757678|FG002|Extension Study|Study terminated by sponsor|13|||
33233880|NCT02102464|100757679|FG000|Randomized Study|Withdrawal by Subject|0|||
33233881|NCT02102464|100757680|FG001|Randomized Study|Withdrawal by Subject|1|||
33233882|NCT02102464|100757681|FG002|Randomized Study|Withdrawal by Subject|0|||
33233883|NCT01951092|100757682|FG000|Overall Study|Lost to Follow-up|10|||
33233884|NCT01951092|100757682|FG000|Overall Study|Incarceration|1|||
33233885|NCT01951092|100757682|FG000|Overall Study|Transfer of Care|1|||
33233886|NCT03638635|100757683|FG000|Initial Hospitalization|Study terminated prematurely|0|||
33233887|NCT03638635|100757684|FG001|Initial Hospitalization|Study terminated prematurely|1|||
33233888|NCT03638635|100757683|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
33233889|NCT03638635|100757684|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
33233890|NCT03638635|100757683|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
33233891|NCT03638635|100757684|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
33233892|NCT02169219|100757685|FG000|Overall Study|Lack of Efficacy|6|||
33233893|NCT03935217|100757696|FG000|Overall Study|Adverse Event|1|||
33233894|NCT03935217|100757697|FG001|Overall Study|Adverse Event|0|||
33233895|NCT03935217|100757696|FG000|Overall Study|Lost to Follow-up|0|||
33233896|NCT03935217|100757697|FG001|Overall Study|Lost to Follow-up|1|||
33233897|NCT03935217|100757696|FG000|Overall Study|Withdrawal by Subject|0|||
33233898|NCT03935217|100757697|FG001|Overall Study|Withdrawal by Subject|2|||
33233899|NCT02065570|100757698|FG000|Induction Study|Adverse Event|5|||
33233900|NCT02065570|100757699|FG001|Induction Study|Adverse Event|12|||
33233901|NCT02065570|100757700|FG002|Induction Study|Adverse Event|0|||
33636648|NCT03219723|102222877|FG000|Overall Study|Case Report Forms Uncollected|6|||
33575612|NCT01783444|101999834|FG000|Treatment Phase|Disease Progression|76|||
33575613|NCT01783444|101999835|FG001|Treatment Phase|Disease Progression|66|||
33575614|NCT01783444|101999836|FG002|Treatment Phase|Disease Progression|64|||
33575615|NCT01783444|101999834|FG000|Treatment Phase|Death|2|||
33575616|NCT01783444|101999835|FG001|Treatment Phase|Death|2|||
33575617|NCT01783444|101999836|FG002|Treatment Phase|Death|2|||
33233902|NCT02065570|100757701|FG003|Induction Study|Adverse Event|0|||
33575618|NCT01783444|101999834|FG000|Treatment Phase|Protocol Violation|1|||
33636649|NCT03219723|102222877|FG000|Overall Study|Protocol Deviation|4|||
33636650|NCT05567783|102222878|FG000|Overall Study|Death|2|||
33636651|NCT05567783|102222879|FG001|Overall Study|Death|3|||
33636652|NCT05567783|102222880|FG002|Overall Study|Death|0|||
33636653|NCT05567783|102222878|FG000|Overall Study|Lost to Follow-up|25|||
33636654|NCT05567783|102222879|FG001|Overall Study|Lost to Follow-up|19|||
33636655|NCT05567783|102222880|FG002|Overall Study|Lost to Follow-up|17|||
33636656|NCT05567783|102222878|FG000|Overall Study|Physician Decision|10|||
33636657|NCT05567783|102222879|FG001|Overall Study|Physician Decision|7|||
33233903|NCT02065570|100757698|FG000|Induction Study|Withdrawal by Subject|2|||
33575619|NCT01783444|101999835|FG001|Treatment Phase|Protocol Violation|1|||
33575620|NCT01783444|101999836|FG002|Treatment Phase|Protocol Violation|2|||
33575621|NCT01783444|101999834|FG000|Treatment Phase|Withdrawal by Subject|6|||
33575622|NCT01783444|101999835|FG001|Treatment Phase|Withdrawal by Subject|8|||
33575623|NCT01783444|101999836|FG002|Treatment Phase|Withdrawal by Subject|9|||
33575624|NCT01783444|101999834|FG000|Treatment Phase|Administrative problems|2|||
33575625|NCT01783444|101999835|FG001|Treatment Phase|Administrative problems|0|||
33575626|NCT01783444|101999836|FG002|Treatment Phase|Administrative problems|1|||
33575627|NCT01783444|101999834|FG000|Treatment Phase|Physician Decision|8|||
33575628|NCT01783444|101999835|FG001|Treatment Phase|Physician Decision|6|||
33636658|NCT05567783|102222880|FG002|Overall Study|Physician Decision|9|||
33636659|NCT05567783|102222878|FG000|Overall Study|Study Terminated by Sponsor|924|||
33636660|NCT05567783|102222879|FG001|Overall Study|Study Terminated by Sponsor|937|||
33636661|NCT05567783|102222880|FG002|Overall Study|Study Terminated by Sponsor|941|||
33233904|NCT02065570|100757699|FG001|Induction Study|Withdrawal by Subject|3|||
33233905|NCT02065570|100757700|FG002|Induction Study|Withdrawal by Subject|0|||
33233906|NCT02065570|100757701|FG003|Induction Study|Withdrawal by Subject|0|||
33233907|NCT02065570|100757698|FG000|Induction Study|Lost to Follow-up|1|||
33233908|NCT02065570|100757699|FG001|Induction Study|Lost to Follow-up|1|||
33233909|NCT02065570|100757700|FG002|Induction Study|Lost to Follow-up|0|||
33233910|NCT02065570|100757701|FG003|Induction Study|Lost to Follow-up|0|||
33233911|NCT02065570|100757698|FG000|Induction Study|Other, Not Specified|6|||
33233912|NCT02065570|100757699|FG001|Induction Study|Other, Not Specified|5|||
33575629|NCT01783444|101999836|FG002|Treatment Phase|Physician Decision|5|||
33575630|NCT01783444|101999834|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
33575631|NCT01783444|101999835|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
33636662|NCT05567783|102222878|FG000|Overall Study|Withdrawal by Subject|23|||
33636663|NCT05567783|102222879|FG001|Overall Study|Withdrawal by Subject|27|||
33575632|NCT01783444|101999836|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
33575633|NCT01783444|101999834|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
33575634|NCT01783444|101999835|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
33575635|NCT01783444|101999836|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
33137910|NCT01087788|100420054|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
33137911|NCT01087788|100420052|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
33137912|NCT01087788|100420053|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
33137913|NCT01087788|100420054|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
33137914|NCT01087788|100420052|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
33137915|NCT01087788|100420053|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
33137916|NCT01087788|100420054|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
33137917|NCT01022398|100420055|FG000|Overall Study|Study terminated|2|||
33137918|NCT01022398|100420056|FG001|Overall Study|Study terminated|2|||
33137919|NCT01431638|100420058|FG000|Overall Study|Adverse Event|1|||
33137920|NCT01431638|100420059|FG001|Overall Study|Adverse Event|3|||
33137921|NCT01431638|100420060|FG002|Overall Study|Adverse Event|1|||
33137922|NCT01431638|100420058|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33137923|NCT01431638|100420059|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33137924|NCT01431638|100420060|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
33137925|NCT01431638|100420058|FG000|Overall Study|Participants condition no longer requires study drug|0|||
33137926|NCT01431638|100420059|FG001|Overall Study|Participants condition no longer requires study drug|1|||
33137927|NCT01431638|100420060|FG002|Overall Study|Participants condition no longer requires study drug|0|||
33137928|NCT01431638|100420058|FG000|Overall Study|Participant withdrew consent|14|||
33137929|NCT01431638|100420059|FG001|Overall Study|Participant withdrew consent|5|||
33137930|NCT01431638|100420060|FG002|Overall Study|Participant withdrew consent|8|||
33137931|NCT01431638|100420058|FG000|Overall Study|Lost to Follow-up|7|||
33137932|NCT01431638|100420059|FG001|Overall Study|Lost to Follow-up|9|||
33137933|NCT01431638|100420060|FG002|Overall Study|Lost to Follow-up|7|||
33137934|NCT01431638|100420058|FG000|Overall Study|Administrative problems|1|||
33137935|NCT01431638|100420059|FG001|Overall Study|Administrative problems|4|||
33137936|NCT01431638|100420060|FG002|Overall Study|Administrative problems|6|||
33137937|NCT01431638|100420058|FG000|Overall Study|Death|1|||
33137938|NCT01431638|100420059|FG001|Overall Study|Death|0|||
33137939|NCT01431638|100420060|FG002|Overall Study|Death|0|||
33137940|NCT01431638|100420058|FG000|Overall Study|Protocol deviation|1|||
33137941|NCT01431638|100420059|FG001|Overall Study|Protocol deviation|1|||
33137942|NCT01431638|100420060|FG002|Overall Study|Protocol deviation|4|||
33137943|NCT01431638|100420058|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
33137944|NCT01431638|100420059|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
33137945|NCT01431638|100420060|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
33137946|NCT00883688|100420063|FG000|Overall Study|Ineligible|2|||
33137947|NCT00906971|100420074|FG000|Overall Study|Withdrawal by Subject|8|||
33137948|NCT00906971|100420075|FG001|Overall Study|Withdrawal by Subject|2|||
33137949|NCT00906971|100420074|FG000|Overall Study|Lost to Follow-up|0|||
33137950|NCT00906971|100420075|FG001|Overall Study|Lost to Follow-up|1|||
33137951|NCT01463007|100420078|FG000|Overall Study|Physician Decision|1|||
33137952|NCT03459690|100420080|FG000|Overall Study|Lost to Follow-up|0|||
33137953|NCT03459690|100420081|FG001|Overall Study|Lost to Follow-up|1|||
33137954|NCT03459690|100420080|FG000|Overall Study|Withdrawal by Subject|1|||
33137955|NCT03459690|100420081|FG001|Overall Study|Withdrawal by Subject|1|||
33137956|NCT00561977|100420082|FG000|Overall Study|Withdrawal by Subject|0|||
33137957|NCT00561977|100420083|FG001|Overall Study|Withdrawal by Subject|2|||
33137958|NCT00561977|100420084|FG002|Overall Study|Withdrawal by Subject|1|||
33137959|NCT00561977|100420082|FG000|Overall Study|Pregnancy|0|||
33137960|NCT00561977|100420083|FG001|Overall Study|Pregnancy|1|||
33137961|NCT00561977|100420084|FG002|Overall Study|Pregnancy|1|||
33137962|NCT00129311|100420085|FG000|Overall Study|Withdrawal by Subject|12|||
33137963|NCT00129311|100420086|FG001|Overall Study|Withdrawal by Subject|19|||
33137964|NCT01794338|100420087|FG000|Overall Study|Death|2|||
33137965|NCT01794338|100420088|FG001|Overall Study|Death|0|||
33137966|NCT01794338|100420087|FG000|Overall Study|Lost to Follow-up|6|||
33137967|NCT01794338|100420088|FG001|Overall Study|Lost to Follow-up|9|||
33137968|NCT01395784|100420089|FG000|Overall Study|Lost to Follow-up|7|||
33575636|NCT01783444|101999834|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
33137969|NCT01395784|100420089|FG000|Overall Study|Withdrawal by Subject|3|||
33137970|NCT01395784|100420089|FG000|Overall Study|Physician Decision|5|||
33137971|NCT01888432|100420092|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
33137972|NCT01888432|100420093|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
33137973|NCT01888432|100420092|FG000|12-month Analysis (FAS)|Physician Decision|1|||
33137974|NCT01888432|100420093|FG001|12-month Analysis (FAS)|Physician Decision|1|||
33137975|NCT01888432|100420092|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
33137976|NCT01888432|100420093|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
33575637|NCT01783444|101999835|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
33137977|NCT01888432|100420092|FG000|12-month Analysis (FAS)|Death|4|||
33575638|NCT01783444|101999836|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
33575639|NCT01783444|101999834|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
33575640|NCT01783444|101999835|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
33575641|NCT01783444|101999836|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
33575642|NCT01783444|101999834|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
33575643|NCT01783444|101999835|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
33575644|NCT01783444|101999836|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
33575645|NCT01783444|101999834|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
33575646|NCT01783444|101999835|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
33575647|NCT01783444|101999836|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
33575648|NCT00948688|101999837|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
33575649|NCT00948688|101999838|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
33575650|NCT00948688|101999837|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
33575651|NCT00948688|101999838|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
33575652|NCT00948688|101999837|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
33575653|NCT00948688|101999838|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
33575654|NCT01816048|101999841|FG000|Overall Study|Adverse Event|1|||
33575655|NCT01816048|101999841|FG000|Overall Study|Death|1|||
33575656|NCT01816048|101999841|FG000|Overall Study|Withdrawal by Subject|1|||
33575657|NCT01816048|101999841|FG000|Overall Study|Disease Progression|3|||
33575658|NCT01669902|101999845|FG000|Overall Study|Adverse Event|11|||
33137978|NCT01888432|100420093|FG001|12-month Analysis (FAS)|Death|3|||
33137979|NCT01888432|100420092|FG000|24-month Analysis (FAS)|Graft loss|0|||
33137980|NCT01888432|100420093|FG001|24-month Analysis (FAS)|Graft loss|1|||
33137981|NCT01888432|100420092|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
33137982|NCT01888432|100420093|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
33137983|NCT01888432|100420092|FG000|24-month Analysis (FAS)|Physician Decision|2|||
33137984|NCT01888432|100420093|FG001|24-month Analysis (FAS)|Physician Decision|4|||
33137985|NCT01888432|100420092|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
33137986|NCT01888432|100420093|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
33137987|NCT01888432|100420092|FG000|24-month Analysis (FAS)|Death|8|||
33137988|NCT01888432|100420093|FG001|24-month Analysis (FAS)|Death|4|||
33137989|NCT01888432|100420092|FG000|36-month Analysis (Extension)|Death|1|||
33137990|NCT01888432|100420093|FG001|36-month Analysis (Extension)|Death|0|||
33137991|NCT01713933|100420094|FG000|Overall Study|Lost to Follow-up|2|||
33137992|NCT01713933|100420094|FG000|Overall Study|Withdrawal by Subject|3|||
33137993|NCT01713933|100420094|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
33137994|NCT00523367|100420095|FG000|Overall Study|19 screen failures|19|||
33137995|NCT00523367|100420095|FG000|Overall Study|4 Withdrawn by PI|4|||
33137996|NCT02793622|100420096|FG000|Overall Study|Lost to Follow-up|31|||
33137997|NCT02793622|100420097|FG001|Overall Study|Lost to Follow-up|19|||
33137998|NCT02793622|100420096|FG000|Overall Study|Withdrawal by Subject|21|||
33137999|NCT02793622|100420097|FG001|Overall Study|Withdrawal by Subject|17|||
33138000|NCT02793622|100420096|FG000|Overall Study|Adverse Event|0|||
33138001|NCT02793622|100420097|FG001|Overall Study|Adverse Event|1|||
33138002|NCT02793622|100420096|FG000|Overall Study|Protocol Violation|1|||
33138003|NCT02793622|100420097|FG001|Overall Study|Protocol Violation|5|||
33138004|NCT03320824|100420098|FG000|Overall Study|Withdrawal by Subject|8|||
33138005|NCT03320824|100420099|FG001|Overall Study|Withdrawal by Subject|1|||
33138006|NCT03320824|100420098|FG000|Overall Study|Lost to Follow-up|10|||
33138007|NCT03320824|100420099|FG001|Overall Study|Lost to Follow-up|1|||
33138008|NCT03320824|100420098|FG000|Overall Study|moved out of state|0|||
33138009|NCT03320824|100420099|FG001|Overall Study|moved out of state|1|||
33138010|NCT03320824|100420098|FG000|Overall Study|could not complete final visit|0|||
33138011|NCT03320824|100420099|FG001|Overall Study|could not complete final visit|1|||
33138012|NCT02015221|100420101|FG000|Overall Study|Withdrawal by Subject|8|||
33138013|NCT02015221|100420102|FG001|Overall Study|Withdrawal by Subject|6|||
33138014|NCT02015221|100420101|FG000|Overall Study|Lost to Follow-up|1|||
33138015|NCT02015221|100420102|FG001|Overall Study|Lost to Follow-up|0|||
33138016|NCT02929498|100420107|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
33138017|NCT02929498|100420108|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
33138018|NCT02929498|100420109|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
33368514|NCT04078152|101234871|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
33368515|NCT04078152|101234869|FG000|Overall Study|Withdrawal by Subject|5|||
33575659|NCT01669902|101999845|FG000|Overall Study|Lack of Efficacy|10|||
33575660|NCT01669902|101999845|FG000|Overall Study|Other|8|||
33138019|NCT02929498|100420107|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
33138020|NCT02929498|100420108|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
33138021|NCT02929498|100420109|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
33368516|NCT04078152|101234870|FG001|Overall Study|Withdrawal by Subject|0|||
33575661|NCT01143402|101999846|FG000|Overall Study|Rapid clinical decline|1|||
33138022|NCT01155167|100420117|FG000|Overall Study|Insufficient ultrasound data|2|||
33575662|NCT01143402|101999847|FG001|Overall Study|Rapid clinical decline|1|||
33575663|NCT01143402|101999848|FG002|Overall Study|Rapid clinical decline|0|||
33575664|NCT01143402|101999846|FG000|Overall Study|Not Treated|0|||
33575665|NCT01143402|101999847|FG001|Overall Study|Not Treated|0|||
33575666|NCT01143402|101999848|FG002|Overall Study|Not Treated|1|||
33575667|NCT02505425|101999849|FG000|Overall Study|Lost to Follow-up|41|||
33575668|NCT02505425|101999850|FG001|Overall Study|Lost to Follow-up|61|||
33575669|NCT02505425|101999851|FG002|Overall Study|Lost to Follow-up|31|||
33575670|NCT02505425|101999852|FG003|Overall Study|Lost to Follow-up|19|||
33575671|NCT02505425|101999849|FG000|Overall Study|Withdrawal by Subject|39|||
33575672|NCT02505425|101999850|FG001|Overall Study|Withdrawal by Subject|9|||
33233913|NCT02065570|100757700|FG002|Induction Study|Other, Not Specified|0|||
33233914|NCT02065570|100757701|FG003|Induction Study|Other, Not Specified|0|||
33233915|NCT02065570|100757698|FG000|Maintenance Study|Adverse Event|0|||
33233916|NCT02065570|100757699|FG001|Maintenance Study|Adverse Event|0|||
33233917|NCT02065570|100757700|FG002|Maintenance Study|Adverse Event|8|||
33233918|NCT02065570|100757701|FG003|Maintenance Study|Adverse Event|8|||
33233919|NCT02065570|100757698|FG000|Maintenance Study|Withdrawal by Subject|0|||
33233920|NCT02065570|100757699|FG001|Maintenance Study|Withdrawal by Subject|0|||
33233921|NCT02065570|100757700|FG002|Maintenance Study|Withdrawal by Subject|1|||
33233922|NCT02065570|100757701|FG003|Maintenance Study|Withdrawal by Subject|4|||
33233923|NCT02065570|100757698|FG000|Maintenance Study|Lost to Follow-up|0|||
33233924|NCT02065570|100757699|FG001|Maintenance Study|Lost to Follow-up|0|||
33233925|NCT02065570|100757700|FG002|Maintenance Study|Lost to Follow-up|2|||
33233926|NCT02065570|100757701|FG003|Maintenance Study|Lost to Follow-up|2|||
33233927|NCT02065570|100757698|FG000|Maintenance Study|Other, Not Specified|0|||
33233928|NCT02065570|100757699|FG001|Maintenance Study|Other, Not Specified|0|||
33233929|NCT02065570|100757700|FG002|Maintenance Study|Other, Not Specified|11|||
33233930|NCT02065570|100757701|FG003|Maintenance Study|Other, Not Specified|5|||
33233931|NCT02753530|100757703|FG000|Overall Study|Adverse Event|7|||
33233932|NCT02753530|100757704|FG001|Overall Study|Adverse Event|1|||
33233933|NCT02753530|100757703|FG000|Overall Study|Death|0|||
33233934|NCT02753530|100757704|FG001|Overall Study|Death|1|||
33233935|NCT02753530|100757703|FG000|Overall Study|Physician Decision|0|||
33233936|NCT02753530|100757704|FG001|Overall Study|Physician Decision|1|||
33233937|NCT02753530|100757703|FG000|Overall Study|Protocol Violation|1|||
33233938|NCT02753530|100757704|FG001|Overall Study|Protocol Violation|0|||
33233939|NCT02753530|100757703|FG000|Overall Study|Withdrawal by Subject|4|||
33233940|NCT02753530|100757704|FG001|Overall Study|Withdrawal by Subject|3|||
33233941|NCT00581113|100757705|FG000|Overall Study|Withdrawal by Subject|0|||
33233942|NCT00581113|100757706|FG001|Overall Study|Withdrawal by Subject|1|||
33233943|NCT01425632|100757707|FG000|Overall Study|Adverse Event|0|||
33233944|NCT01425632|100757708|FG001|Overall Study|Adverse Event|1|||
33233945|NCT01425632|100757709|FG002|Overall Study|Adverse Event|1|||
33233946|NCT01425632|100757707|FG000|Overall Study|Physician Decision|1|||
33233947|NCT01425632|100757708|FG001|Overall Study|Physician Decision|0|||
33233948|NCT01425632|100757709|FG002|Overall Study|Physician Decision|0|||
33233949|NCT01425632|100757707|FG000|Overall Study|Protocol Violation|0|||
33575673|NCT02505425|101999851|FG002|Overall Study|Withdrawal by Subject|19|||
33575674|NCT02505425|101999852|FG003|Overall Study|Withdrawal by Subject|7|||
33575675|NCT02505425|101999849|FG000|Overall Study|Death|8|||
33575676|NCT02505425|101999850|FG001|Overall Study|Death|12|||
33575677|NCT02505425|101999851|FG002|Overall Study|Death|0|||
33575678|NCT02505425|101999852|FG003|Overall Study|Death|0|||
33575679|NCT02927795|101999857|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
33575680|NCT02927795|101999857|FG000|Overall Study|Not Treated|4|||
33575681|NCT01008618|101999860|FG000|Period 1 (Titration Period)|Physician Decision|2|||
33575682|NCT01008618|101999861|FG001|Period 1 (Titration Period)|Physician Decision|0|||
33575683|NCT01008618|101999862|FG002|Period 1 (Titration Period)|Physician Decision|0|||
33575684|NCT01008618|101999860|FG000|Period 1 (Titration Period)|Adverse Event|33|||
33575685|NCT01008618|101999861|FG001|Period 1 (Titration Period)|Adverse Event|0|||
33233950|NCT01425632|100757708|FG001|Overall Study|Protocol Violation|0|||
33233951|NCT01425632|100757709|FG002|Overall Study|Protocol Violation|2|||
33233952|NCT01425632|100757707|FG000|Overall Study|Withdrawal by Subject|0|||
33233953|NCT01425632|100757708|FG001|Overall Study|Withdrawal by Subject|0|||
33233954|NCT01425632|100757709|FG002|Overall Study|Withdrawal by Subject|1|||
33233955|NCT02226172|100757713|FG000|Overall Study|Participant refused further follow-up|4|||
33233956|NCT02226172|100757713|FG000|Overall Study|Other|5|||
33233957|NCT02226172|100757713|FG000|Overall Study|Death|1|||
33233958|NCT02226172|100757713|FG000|Overall Study|Study terminated by sponsor|1|||
33233959|NCT02226172|100757713|FG000|Overall Study|Adverse Event|6|||
33575686|NCT01008618|101999862|FG002|Period 1 (Titration Period)|Adverse Event|0|||
33575687|NCT01008618|101999860|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
33575688|NCT01008618|101999861|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
33575689|NCT01008618|101999862|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
33575690|NCT01008618|101999860|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
33575691|NCT01008618|101999861|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
33233960|NCT05221749|100757717|FG000|Overall Study|Lost to Follow-up|2|||
33233961|NCT05221749|100757718|FG001|Overall Study|Lost to Follow-up|3|||
33233962|NCT03000673|100757720|FG000|Overall Study|Withdrawal by Subject|1|||
33233963|NCT03000673|100757721|FG001|Overall Study|Withdrawal by Subject|0|||
33233964|NCT03000673|100757722|FG002|Overall Study|Withdrawal by Subject|0|||
33233965|NCT03000673|100757723|FG003|Overall Study|Withdrawal by Subject|0|||
33233966|NCT01815736|100757724|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
33233967|NCT01815736|100757725|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
33233968|NCT01815736|100757724|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
33233969|NCT01815736|100757725|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
33233970|NCT01815736|100757724|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
33233971|NCT01815736|100757725|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
33233972|NCT01815736|100757724|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
33233973|NCT01815736|100757725|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
33233974|NCT01815736|100757724|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
33233975|NCT01815736|100757725|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
33233976|NCT01815736|100757724|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
33233977|NCT01815736|100757725|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
33233978|NCT01815736|100757724|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
33233979|NCT01815736|100757725|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
33233980|NCT01815736|100757724|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
33233981|NCT01815736|100757725|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
33233982|NCT01815736|100757724|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
33233983|NCT01815736|100757725|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
33233984|NCT01815736|100757724|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
33233985|NCT01815736|100757725|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
33233986|NCT01815736|100757724|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
33233987|NCT01815736|100757725|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
33233988|NCT01815736|100757724|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
33233989|NCT01815736|100757725|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
33233990|NCT01815736|100757724|FG000|Extension Treatment Phase- After Week 96|Death|1|||
33233991|NCT01815736|100757725|FG001|Extension Treatment Phase- After Week 96|Death|0|||
33233992|NCT04430335|100757726|FG000|Overall Study|Withdrawal by Subject|1|||
33233993|NCT02589392|100757727|FG000|Overall Study|Adverse Event|1|||
33233994|NCT02589392|100757728|FG001|Overall Study|Adverse Event|1|||
33233995|NCT02589392|100757727|FG000|Overall Study|Withdrawal by Subject|1|||
33233996|NCT02589392|100757728|FG001|Overall Study|Withdrawal by Subject|2|||
33233997|NCT02589392|100757727|FG000|Overall Study|Protocol Violation|1|||
33233998|NCT02589392|100757728|FG001|Overall Study|Protocol Violation|1|||
33233999|NCT02589392|100757727|FG000|Overall Study|Lost to Follow-up|2|||
33234000|NCT02589392|100757728|FG001|Overall Study|Lost to Follow-up|2|||
33234001|NCT02589392|100757727|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
33234002|NCT02589392|100757728|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
33234003|NCT00197028|100757731|FG000|Overall Study|Adverse Event|2|||
33234004|NCT00197028|100757732|FG001|Overall Study|Adverse Event|2|||
33234005|NCT00197028|100757731|FG000|Overall Study|Protocol Violation|2|||
33234006|NCT00197028|100757732|FG001|Overall Study|Protocol Violation|1|||
33234007|NCT00197028|100757731|FG000|Overall Study|Withdrawal by Subject|8|||
33234008|NCT00197028|100757732|FG001|Overall Study|Withdrawal by Subject|12|||
33234009|NCT00197028|100757731|FG000|Overall Study|Lost to Follow-up|1|||
33234010|NCT00197028|100757732|FG001|Overall Study|Lost to Follow-up|0|||
33234011|NCT00197028|100757731|FG000|Overall Study|Other|3|||
33234012|NCT00197028|100757732|FG001|Overall Study|Other|6|||
33234013|NCT01155388|100757733|FG000|Overall Study|Adverse Event|1|||
33234014|NCT01155388|100757734|FG001|Overall Study|Adverse Event|0|||
33234015|NCT00919893|100757735|FG000|Overall Study|Protocol Violation|19|||
33234016|NCT00919893|100757736|FG001|Overall Study|Protocol Violation|9|||
33234017|NCT00474175|100757737|FG000|Overall Study|Lack of Efficacy|0|||
33234018|NCT00474175|100757738|FG001|Overall Study|Lack of Efficacy|0|||
33234019|NCT00474175|100757739|FG002|Overall Study|Lack of Efficacy|1|||
33234020|NCT00474175|100757737|FG000|Overall Study|Withdrawal by Subject|0|||
33234021|NCT00474175|100757738|FG001|Overall Study|Withdrawal by Subject|1|||
33234022|NCT00474175|100757739|FG002|Overall Study|Withdrawal by Subject|1|||
33234023|NCT00474175|100757737|FG000|Overall Study|Ineligible|1|||
33234024|NCT00474175|100757738|FG001|Overall Study|Ineligible|3|||
33234025|NCT00474175|100757739|FG002|Overall Study|Ineligible|1|||
33234026|NCT00474175|100757737|FG000|Overall Study|Protocol Violation|0|||
33234027|NCT00474175|100757738|FG001|Overall Study|Protocol Violation|2|||
33234028|NCT00474175|100757739|FG002|Overall Study|Protocol Violation|1|||
33234029|NCT00474175|100757737|FG000|Overall Study|Administrative|0|||
33234030|NCT00474175|100757738|FG001|Overall Study|Administrative|1|||
33234031|NCT00474175|100757739|FG002|Overall Study|Administrative|0|||
33234032|NCT00570661|100757744|FG000|Overall Study|Disease worsening|5|||
33234033|NCT00570661|100757744|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
33234034|NCT00570661|100757744|FG000|Overall Study|Adverse Event|1|||
33234035|NCT03541642|100757745|FG000|Overall Study|Withdrawal by Subject|1|||
33234036|NCT03541642|100757746|FG001|Overall Study|Withdrawal by Subject|2|||
33234037|NCT03541642|100757745|FG000|Overall Study|Lost to Follow-up|16|||
33234038|NCT03541642|100757746|FG001|Overall Study|Lost to Follow-up|12|||
33234039|NCT03541642|100757745|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
33234040|NCT03541642|100757746|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
33234041|NCT00729690|100757752|FG000|Overall Study|IT Catheter Malfunction|0|||
33234042|NCT00729690|100757753|FG001|Overall Study|IT Catheter Malfunction|2|||
33234043|NCT00729690|100757754|FG002|Overall Study|IT Catheter Malfunction|2|||
33234044|NCT01928225|100757755|FG000|Overall Study|Pregnancy|1|||
33234045|NCT01928225|100757756|FG001|Overall Study|Pregnancy|0|||
33234046|NCT01928225|100757755|FG000|Overall Study|basaloid cervical cancer|1|||
33234047|NCT01928225|100757756|FG001|Overall Study|basaloid cervical cancer|0|||
33234048|NCT01928225|100757755|FG000|Overall Study|Lost to Follow-up|1|||
33234049|NCT01928225|100757756|FG001|Overall Study|Lost to Follow-up|3|||
33234050|NCT00798174|100757758|FG000|Overall Study|inability to implant azygos coil|3|||
33234051|NCT00798174|100757759|FG001|Overall Study|inability to implant azygos coil|3|||
33234052|NCT00798174|100757758|FG000|Overall Study|Inability to sedate for DFT testing|1|||
33234053|NCT00798174|100757759|FG001|Overall Study|Inability to sedate for DFT testing|0|||
33234054|NCT03230864|100757760|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
33234055|NCT03230864|100757761|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
33234056|NCT03230864|100757762|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
33234057|NCT03230864|100757763|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
33234058|NCT03230864|100757760|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
33234059|NCT03230864|100757761|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
33234060|NCT03230864|100757762|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
33234061|NCT03230864|100757763|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
33234062|NCT03230864|100757760|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
33234063|NCT03230864|100757761|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
33234064|NCT03230864|100757762|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
33234065|NCT03230864|100757763|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
33234066|NCT03230864|100757760|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
33234067|NCT03230864|100757761|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
33234068|NCT03230864|100757762|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
33234069|NCT03230864|100757763|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
33234070|NCT03230864|100757760|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
33234071|NCT03230864|100757761|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
33234072|NCT03230864|100757762|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
33234073|NCT03230864|100757763|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
33234074|NCT03230864|100757760|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
33234075|NCT03230864|100757761|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
33234076|NCT03230864|100757762|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
33234077|NCT03230864|100757763|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
33234078|NCT03230864|100757760|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
33234079|NCT03230864|100757761|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
33234080|NCT03230864|100757762|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
33234081|NCT03230864|100757763|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
33234082|NCT03230864|100757760|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
33234083|NCT03230864|100757761|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
33234084|NCT03230864|100757762|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
33234085|NCT03230864|100757763|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
33234086|NCT03230864|100757760|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
33234087|NCT03230864|100757761|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
33234088|NCT03230864|100757762|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
33234089|NCT03230864|100757763|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
33234090|NCT03230864|100757760|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
33234091|NCT03230864|100757761|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
33234092|NCT03230864|100757762|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
33234093|NCT03230864|100757763|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
33234094|NCT02269943|100757764|FG000|Treatment Period|Death|0|||
33234095|NCT02269943|100757765|FG001|Treatment Period|Death|1|||
33234096|NCT02269943|100757764|FG000|Treatment Period|Adverse Event|1|||
33234097|NCT02269943|100757765|FG001|Treatment Period|Adverse Event|10|||
33234098|NCT02269943|100757764|FG000|Treatment Period|Progressive Disease|5|||
33234099|NCT02269943|100757765|FG001|Treatment Period|Progressive Disease|17|||
33368517|NCT04078152|101234871|FG002|Overall Study|Withdrawal by Subject|1|||
33575692|NCT01008618|101999862|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
33575693|NCT01008618|101999860|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
33575694|NCT01008618|101999861|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
33138023|NCT01155167|100420118|FG001|Overall Study|Insufficient ultrasound data|0|||
33138024|NCT01155167|100420117|FG000|Overall Study|Access site changed to femoral artery|1|||
33138025|NCT01155167|100420118|FG001|Overall Study|Access site changed to femoral artery|0|||
33138026|NCT00917644|100420119|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
33138027|NCT00917644|100420120|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
33138028|NCT00917644|100420119|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
33138029|NCT00917644|100420120|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
33138030|NCT00917644|100420119|FG000|Period 2: Second Intervention|family emergency|1|||
33138031|NCT00917644|100420120|FG001|Period 2: Second Intervention|family emergency|0|||
33138032|NCT02342418|100420121|FG000|Overall Study|Adverse Event|0|||
33138033|NCT02342418|100420122|FG001|Overall Study|Adverse Event|1|||
33138034|NCT00095147|100420125|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
33138035|NCT00095147|100420126|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
33138036|NCT00095147|100420127|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
33138037|NCT00095147|100420128|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
33138038|NCT00095147|100420129|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
33138039|NCT00095147|100420125|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
33138040|NCT00095147|100420126|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
33138041|NCT00095147|100420127|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
33138042|NCT00095147|100420128|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
33138043|NCT00095147|100420129|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
33138044|NCT00095147|100420125|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
33138045|NCT00095147|100420126|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
33138046|NCT00095147|100420127|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
33138047|NCT00095147|100420128|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
33138048|NCT00095147|100420129|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
33138049|NCT00095147|100420125|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
33138050|NCT00095147|100420126|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
33138051|NCT00095147|100420127|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
33138052|NCT00095147|100420128|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
33138053|NCT00095147|100420129|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
33138054|NCT00095147|100420125|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
33138055|NCT00095147|100420126|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
33138056|NCT00095147|100420127|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
33138057|NCT00095147|100420128|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
33138058|NCT00095147|100420129|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
33138059|NCT00095147|100420125|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
33138060|NCT00095147|100420126|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
33138061|NCT00095147|100420127|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
33138062|NCT00095147|100420128|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
33138063|NCT00095147|100420129|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
33138064|NCT00095147|100420125|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
33138065|NCT00095147|100420126|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
33138066|NCT00095147|100420127|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
33138067|NCT00095147|100420128|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
33138068|NCT00095147|100420129|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
33138069|NCT00095147|100420125|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
33138070|NCT00095147|100420126|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
33138071|NCT00095147|100420127|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
33138072|NCT00095147|100420128|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
33138073|NCT00095147|100420129|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
33138074|NCT00095147|100420125|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
33138075|NCT00095147|100420126|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
33138076|NCT00095147|100420127|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
33138077|NCT00095147|100420128|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
33138078|NCT00095147|100420129|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
33138079|NCT00095147|100420125|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
33138080|NCT00095147|100420126|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
33138081|NCT00095147|100420127|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
33138082|NCT00095147|100420128|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
33138083|NCT00095147|100420129|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
33138084|NCT00095147|100420125|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
33138085|NCT00095147|100420126|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
33575695|NCT01008618|101999862|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
33234100|NCT02269943|100757764|FG000|Treatment Period|Symptomatic Deterioration|0|||
33234101|NCT02269943|100757765|FG001|Treatment Period|Symptomatic Deterioration|2|||
33234102|NCT02269943|100757764|FG000|Follow-Up Survival Period|Death|3|||
33234103|NCT02269943|100757765|FG001|Follow-Up Survival Period|Death|16|||
33234104|NCT02269943|100757764|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
33234105|NCT02269943|100757765|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
33234106|NCT02269943|100757764|FG000|Follow-Up Survival Period|Alive|2|||
33234107|NCT02269943|100757765|FG001|Follow-Up Survival Period|Alive|8|||
33234108|NCT00289770|100757768|FG000|Year 15|Withdrawal by Subject|1|||
33234109|NCT03486899|100757774|FG000|Overall Study|Lost to Follow-up|4|||
33234110|NCT03486899|100757775|FG001|Overall Study|Lost to Follow-up|1|||
33234111|NCT03486899|100757776|FG002|Overall Study|Lost to Follow-up|4|||
33234112|NCT03486899|100757777|FG003|Overall Study|Lost to Follow-up|3|||
33234113|NCT03486899|100757774|FG000|Overall Study|Death|1|||
33234114|NCT03486899|100757775|FG001|Overall Study|Death|0|||
33234115|NCT03486899|100757776|FG002|Overall Study|Death|0|||
33234116|NCT03486899|100757777|FG003|Overall Study|Death|1|||
33234117|NCT03486899|100757774|FG000|Overall Study|Adverse Event|0|||
33234118|NCT03486899|100757775|FG001|Overall Study|Adverse Event|2|||
33234119|NCT03486899|100757776|FG002|Overall Study|Adverse Event|0|||
33234120|NCT03486899|100757777|FG003|Overall Study|Adverse Event|2|||
33234121|NCT03486899|100757774|FG000|Overall Study|Withdrawal by Subject|3|||
33234122|NCT03486899|100757775|FG001|Overall Study|Withdrawal by Subject|7|||
33234123|NCT03486899|100757776|FG002|Overall Study|Withdrawal by Subject|4|||
33234124|NCT03486899|100757777|FG003|Overall Study|Withdrawal by Subject|3|||
33234125|NCT03486899|100757774|FG000|Overall Study|Other Reasons|0|||
33234126|NCT03486899|100757775|FG001|Overall Study|Other Reasons|1|||
33234127|NCT03486899|100757776|FG002|Overall Study|Other Reasons|0|||
33234128|NCT03486899|100757777|FG003|Overall Study|Other Reasons|1|||
33234129|NCT00550173|100757778|FG000|Overall Study|Death|45|||
33234130|NCT00550173|100757779|FG001|Overall Study|Death|38|||
33234131|NCT00550173|100757780|FG002|Overall Study|Death|50|||
33234132|NCT00550173|100757778|FG000|Overall Study|Physician Decision|1|||
33234133|NCT00550173|100757779|FG001|Overall Study|Physician Decision|2|||
33234134|NCT00550173|100757780|FG002|Overall Study|Physician Decision|2|||
33234135|NCT00550173|100757778|FG000|Overall Study|Withdrawal by Subject|9|||
33234136|NCT00550173|100757779|FG001|Overall Study|Withdrawal by Subject|12|||
33234137|NCT00550173|100757780|FG002|Overall Study|Withdrawal by Subject|17|||
33234138|NCT00550173|100757778|FG000|Overall Study|Sponsor Decision|13|||
33234139|NCT00550173|100757779|FG001|Overall Study|Sponsor Decision|7|||
33234140|NCT00550173|100757780|FG002|Overall Study|Sponsor Decision|1|||
33234141|NCT00550173|100757778|FG000|Overall Study|Lost to Follow-up|4|||
33234142|NCT00550173|100757779|FG001|Overall Study|Lost to Follow-up|4|||
33234143|NCT00550173|100757780|FG002|Overall Study|Lost to Follow-up|3|||
33234144|NCT03044353|100757781|FG000|Overall Study|Adverse Event|0|||
33234145|NCT03044353|100757782|FG001|Overall Study|Adverse Event|1|||
33234146|NCT03044353|100757783|FG002|Overall Study|Adverse Event|0|||
33234147|NCT01282476|100757804|FG000|Overall Study|Death|11|||
33234148|NCT02698436|100759917|FG000|Overall Study|Adverse Event|1|||
33234149|NCT02698436|100759918|FG001|Overall Study|Adverse Event|0|||
33234150|NCT02698436|100759917|FG000|Overall Study|Withdrawal by Subject|3|||
33234151|NCT02698436|100759918|FG001|Overall Study|Withdrawal by Subject|3|||
33234152|NCT02698436|100759917|FG000|Overall Study|Lost to Follow-up|2|||
33234153|NCT02698436|100759918|FG001|Overall Study|Lost to Follow-up|4|||
33234154|NCT02698436|100759917|FG000|Overall Study|Non-compliance with study regimen|1|||
33234155|NCT02698436|100759918|FG001|Overall Study|Non-compliance with study regimen|0|||
33234156|NCT00873093|100759927|FG000|Overall Study|Adverse Event|0|||
33234157|NCT00873093|100759928|FG001|Overall Study|Adverse Event|2|||
33575696|NCT01008618|101999860|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
33234158|NCT00873093|100759929|FG002|Overall Study|Adverse Event|0|||
33234159|NCT00873093|100759930|FG003|Overall Study|Adverse Event|0|||
33234160|NCT00873093|100759931|FG004|Overall Study|Adverse Event|0|||
33234161|NCT00873093|100759927|FG000|Overall Study|Death|0|||
33234162|NCT00873093|100759928|FG001|Overall Study|Death|3|||
33234163|NCT00873093|100759929|FG002|Overall Study|Death|2|||
33234164|NCT00873093|100759930|FG003|Overall Study|Death|0|||
33234165|NCT00873093|100759931|FG004|Overall Study|Death|0|||
33234166|NCT00873093|100759927|FG000|Overall Study|Physician Decision|0|||
33234167|NCT00873093|100759928|FG001|Overall Study|Physician Decision|17|||
33234168|NCT00873093|100759929|FG002|Overall Study|Physician Decision|10|||
33234169|NCT00873093|100759930|FG003|Overall Study|Physician Decision|10|||
33234170|NCT00873093|100759931|FG004|Overall Study|Physician Decision|2|||
33234171|NCT00873093|100759927|FG000|Overall Study|Withdrawal by Subject|1|||
33234172|NCT00873093|100759928|FG001|Overall Study|Withdrawal by Subject|4|||
33234173|NCT00873093|100759929|FG002|Overall Study|Withdrawal by Subject|4|||
33234174|NCT00873093|100759930|FG003|Overall Study|Withdrawal by Subject|0|||
33234175|NCT00873093|100759931|FG004|Overall Study|Withdrawal by Subject|0|||
33234176|NCT00873093|100759927|FG000|Overall Study|Ineligible|0|||
33234177|NCT00873093|100759928|FG001|Overall Study|Ineligible|1|||
33234178|NCT00873093|100759929|FG002|Overall Study|Ineligible|0|||
33234179|NCT00873093|100759930|FG003|Overall Study|Ineligible|1|||
33234180|NCT00873093|100759931|FG004|Overall Study|Ineligible|0|||
33234181|NCT02118714|100759939|FG000|Overall Study|Lost to Follow-up|2|||
33234182|NCT02118714|100759939|FG000|Overall Study|Protocol Violation|1|||
33234183|NCT00802659|100759943|FG000|Overall Study|Physician Decision|0|||
33234184|NCT00802659|100759944|FG001|Overall Study|Physician Decision|1|||
33234185|NCT00802659|100759945|FG002|Overall Study|Physician Decision|0|||
33234186|NCT00802659|100759946|FG003|Overall Study|Physician Decision|0|||
33234187|NCT00088205|100759947|FG000|Overall Study|Adverse Event|4|||
33234188|NCT00088205|100759947|FG000|Overall Study|Progressive Disease|51|||
33234189|NCT00088205|100759947|FG000|Overall Study|Physician Decision|1|||
33234190|NCT00088205|100759947|FG000|Overall Study|Death Due to Study Disease|4|||
33234191|NCT01091428|100759957|FG000|Phase 1|Progressive Disease|24|||
33234192|NCT01091428|100759958|FG001|Phase 1|Progressive Disease|8|||
33234193|NCT01091428|100759959|FG002|Phase 1|Progressive Disease|0|||
33234194|NCT01091428|100759960|FG003|Phase 1|Progressive Disease|0|||
33234195|NCT01091428|100759957|FG000|Phase 1|Symptomatic Deterioration|3|||
33234196|NCT01091428|100759958|FG001|Phase 1|Symptomatic Deterioration|2|||
33234197|NCT01091428|100759959|FG002|Phase 1|Symptomatic Deterioration|0|||
33234198|NCT01091428|100759960|FG003|Phase 1|Symptomatic Deterioration|0|||
33234199|NCT01091428|100759957|FG000|Phase 1|Adverse Event|2|||
33234200|NCT01091428|100759958|FG001|Phase 1|Adverse Event|0|||
33234201|NCT01091428|100759959|FG002|Phase 1|Adverse Event|0|||
33234202|NCT01091428|100759960|FG003|Phase 1|Adverse Event|0|||
33234203|NCT01091428|100759957|FG000|Phase 1|Withdrawal by Subject|7|||
33234204|NCT01091428|100759958|FG001|Phase 1|Withdrawal by Subject|0|||
33234205|NCT01091428|100759959|FG002|Phase 1|Withdrawal by Subject|0|||
33234206|NCT01091428|100759960|FG003|Phase 1|Withdrawal by Subject|0|||
33234207|NCT01091428|100759957|FG000|Phase 1|Reason not specified|0|||
33234208|NCT01091428|100759958|FG001|Phase 1|Reason not specified|1|||
33234209|NCT01091428|100759959|FG002|Phase 1|Reason not specified|0|||
33234210|NCT01091428|100759960|FG003|Phase 1|Reason not specified|0|||
33234211|NCT01091428|100759957|FG000|Phase 1|Single-Patient IND|2|||
33234212|NCT01091428|100759958|FG001|Phase 1|Single-Patient IND|0|||
33234213|NCT01091428|100759959|FG002|Phase 1|Single-Patient IND|0|||
33234214|NCT01091428|100759960|FG003|Phase 1|Single-Patient IND|0|||
33234215|NCT01091428|100759957|FG000|Phase 2|Progressive Disease|0|||
33234216|NCT01091428|100759958|FG001|Phase 2|Progressive Disease|0|||
33234217|NCT01091428|100759959|FG002|Phase 2|Progressive Disease|44|||
33234218|NCT01091428|100759960|FG003|Phase 2|Progressive Disease|46|||
33234219|NCT01091428|100759957|FG000|Phase 2|Symptomatic Deterioration|0|||
33368518|NCT04078152|101234869|FG000|Overall Study|Death|10|||
33368519|NCT04078152|101234870|FG001|Overall Study|Death|2|||
33368520|NCT04078152|101234871|FG002|Overall Study|Death|12|||
33368521|NCT04078152|101234869|FG000|Overall Study|Adverse Event|1|||
33368522|NCT04078152|101234870|FG001|Overall Study|Adverse Event|0|||
33368523|NCT04078152|101234871|FG002|Overall Study|Adverse Event|0|||
33368524|NCT05485779|101234872|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
33368525|NCT05485779|101234873|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
33368526|NCT05485779|101234874|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
33368527|NCT05485779|101234875|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
33368528|NCT05485779|101234876|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
33368529|NCT05485779|101234877|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
33368530|NCT05485779|101234878|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
33368531|NCT05485779|101234879|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
33368532|NCT05485779|101234880|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
33368533|NCT05485779|101234881|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
33368534|NCT05485779|101234882|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
33368535|NCT05485779|101234872|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
33420320|NCT02729545|101428578|FG001|Overall Study|Pregnancy|1|||
33420321|NCT02729545|101428577|FG000|Overall Study|Lost to Follow-up|0|||
33575697|NCT01008618|101999861|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
33234220|NCT01091428|100759958|FG001|Phase 2|Symptomatic Deterioration|0|||
33368536|NCT05485779|101234873|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
33368537|NCT05485779|101234874|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
33368538|NCT05485779|101234875|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
33420322|NCT02729545|101428578|FG001|Overall Study|Lost to Follow-up|1|||
33234221|NCT01091428|100759959|FG002|Phase 2|Symptomatic Deterioration|1|||
33234222|NCT01091428|100759960|FG003|Phase 2|Symptomatic Deterioration|6|||
33234223|NCT01091428|100759957|FG000|Phase 2|Adverse Event|0|||
33234224|NCT01091428|100759958|FG001|Phase 2|Adverse Event|0|||
33234225|NCT01091428|100759959|FG002|Phase 2|Adverse Event|12|||
33234226|NCT01091428|100759960|FG003|Phase 2|Adverse Event|5|||
33234227|NCT01091428|100759957|FG000|Phase 2|Withdrawal by Subject|0|||
33234228|NCT01091428|100759958|FG001|Phase 2|Withdrawal by Subject|0|||
33234229|NCT01091428|100759959|FG002|Phase 2|Withdrawal by Subject|9|||
33234230|NCT01091428|100759960|FG003|Phase 2|Withdrawal by Subject|8|||
33234231|NCT01091428|100759957|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
33234232|NCT01091428|100759958|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
33234233|NCT01091428|100759959|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
33636664|NCT05567783|102222880|FG002|Overall Study|Withdrawal by Subject|24|||
33636665|NCT05567783|102222878|FG000|Overall Study|Incarcerated|1|||
33636666|NCT05567783|102222879|FG001|Overall Study|Incarcerated|0|||
33636667|NCT05567783|102222880|FG002|Overall Study|Incarcerated|0|||
33636668|NCT05567783|102222878|FG000|Overall Study|Participant randomized in error|4|||
33636669|NCT05567783|102222879|FG001|Overall Study|Participant randomized in error|2|||
33636670|NCT05567783|102222880|FG002|Overall Study|Participant randomized in error|2|||
33636671|NCT00871975|102222881|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
33636672|NCT00871975|102222881|FG000|Overall Study|Catheters could not be inserted|1|||
33636673|NCT00871975|102222881|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
33636674|NCT00871975|102222881|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
33636675|NCT03944577|102222884|FG000|Overall Study|Adverse Event|3|||
33636676|NCT01454102|102222886|FG000|Overall Study|Continuing in the treatment period|0|||
33636677|NCT01454102|102222887|FG001|Overall Study|Continuing in the treatment period|0|||
33636678|NCT01454102|102222888|FG002|Overall Study|Continuing in the treatment period|0|||
33636679|NCT01454102|102222889|FG003|Overall Study|Continuing in the treatment period|0|||
33636680|NCT01454102|102222890|FG004|Overall Study|Continuing in the treatment period|3|||
33636681|NCT01454102|102222891|FG005|Overall Study|Continuing in the treatment period|3|||
33636682|NCT01454102|102222892|FG006|Overall Study|Continuing in the treatment period|2|||
33636683|NCT01454102|102222893|FG007|Overall Study|Continuing in the treatment period|0|||
33636684|NCT01454102|102222894|FG008|Overall Study|Continuing in the treatment period|1|||
33636685|NCT01454102|102222895|FG009|Overall Study|Continuing in the treatment period|0|||
33636686|NCT01454102|102222896|FG010|Overall Study|Continuing in the treatment period|0|||
33636687|NCT01454102|102222897|FG011|Overall Study|Continuing in the treatment period|4|||
33636688|NCT01454102|102222898|FG012|Overall Study|Continuing in the treatment period|7|||
33636689|NCT01454102|102222899|FG013|Overall Study|Continuing in the treatment period|4|||
33636690|NCT01454102|102222900|FG014|Overall Study|Continuing in the treatment period|3|||
33636691|NCT01454102|102222901|FG015|Overall Study|Continuing in the treatment period|1|||
33636692|NCT01523366|102222902|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33636693|NCT01523366|102222903|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33636694|NCT01523366|102222902|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
33636695|NCT01523366|102222903|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
33636696|NCT00525161|102222904|FG000|Overall Study|Adverse Event|1|||
33368539|NCT05485779|101234876|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
33368540|NCT05485779|101234877|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
33368541|NCT05485779|101234878|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
33368542|NCT05485779|101234879|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
33368543|NCT05485779|101234880|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
33368544|NCT05485779|101234881|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
33368545|NCT05485779|101234882|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
33368546|NCT05485779|101234872|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
33368547|NCT05485779|101234873|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
33368548|NCT05485779|101234874|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
33368549|NCT05485779|101234875|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
33368550|NCT05485779|101234876|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
33368551|NCT05485779|101234877|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
33575698|NCT01008618|101999862|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
33575699|NCT01008618|101999860|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
33575700|NCT01008618|101999861|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
33575701|NCT01008618|101999862|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
33575702|NCT01008618|101999860|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
33575703|NCT01008618|101999861|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
33575704|NCT01008618|101999862|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
33575705|NCT01008618|101999860|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
33575706|NCT01008618|101999861|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
33575707|NCT01008618|101999862|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
33575708|NCT01008618|101999860|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
33575709|NCT01008618|101999861|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
33636697|NCT03126591|102222905|FG000|Overall Study|Death|6|||
33636698|NCT03126591|102222906|FG001|Overall Study|Death|3|||
33636699|NCT03126591|102222907|FG002|Overall Study|Death|17|||
33636700|NCT03126591|102222905|FG000|Overall Study|Progressive Disease|0|||
33636701|NCT03126591|102222906|FG001|Overall Study|Progressive Disease|1|||
33636702|NCT03126591|102222907|FG002|Overall Study|Progressive Disease|2|||
33636703|NCT03126591|102222905|FG000|Overall Study|Terminated by Sponsor|0|||
33636704|NCT03126591|102222906|FG001|Overall Study|Terminated by Sponsor|1|||
33138086|NCT00095147|100420127|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
33368552|NCT05485779|101234878|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
33368553|NCT05485779|101234879|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
33368554|NCT05485779|101234880|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
33368555|NCT05485779|101234881|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
33368556|NCT05485779|101234882|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
33368557|NCT04112316|101234885|FG000|First Period (8 Weeks)|Protocol Violation|1|||
33138087|NCT00095147|100420128|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
33138088|NCT00095147|100420129|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
33138089|NCT00095147|100420125|FG000|Long-term Extension Period|Death|0|||
33368558|NCT04112316|101234886|FG001|First Period (8 Weeks)|Protocol Violation|0|||
33636705|NCT03126591|102222907|FG002|Overall Study|Terminated by Sponsor|4|||
33636706|NCT03126591|102222905|FG000|Overall Study|Withdrawal by Subject|1|||
33368559|NCT04112316|101234885|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
33368560|NCT04112316|101234886|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
33368561|NCT04437511|101234887|FG000|Overall Study|Adverse Event|50|||
33368562|NCT04437511|101234888|FG001|Overall Study|Adverse Event|21|||
33636707|NCT03126591|102222906|FG001|Overall Study|Withdrawal by Subject|1|||
33636708|NCT03126591|102222907|FG002|Overall Study|Withdrawal by Subject|4|||
33636709|NCT02156076|102222916|FG000|Treatment Period|no longer meets study criteria|0|||
33636710|NCT02156076|102222917|FG001|Treatment Period|no longer meets study criteria|0|||
33636711|NCT02156076|102222918|FG002|Treatment Period|no longer meets study criteria|1|||
33636712|NCT02156076|102222919|FG003|Treatment Period|no longer meets study criteria|0|||
33636713|NCT02156076|102222916|FG000|Treatment Period|Poor/non-compliance|0|||
33636714|NCT02156076|102222917|FG001|Treatment Period|Poor/non-compliance|1|||
33636715|NCT02156076|102222918|FG002|Treatment Period|Poor/non-compliance|0|||
33636716|NCT02156076|102222919|FG003|Treatment Period|Poor/non-compliance|0|||
33138090|NCT00095147|100420126|FG001|Long-term Extension Period|Death|0|||
33368563|NCT04437511|101234887|FG000|Overall Study|Death|15|||
33368564|NCT04437511|101234888|FG001|Overall Study|Death|10|||
33368565|NCT04437511|101234887|FG000|Overall Study|Lost to Follow-up|11|||
33368566|NCT04437511|101234888|FG001|Overall Study|Lost to Follow-up|11|||
33368567|NCT04437511|101234887|FG000|Overall Study|Physician Decision|19|||
33368568|NCT04437511|101234888|FG001|Overall Study|Physician Decision|10|||
33368569|NCT04437511|101234887|FG000|Overall Study|Progressive Disease|4|||
33368570|NCT04437511|101234888|FG001|Overall Study|Progressive Disease|7|||
33368571|NCT04437511|101234887|FG000|Overall Study|Withdrawal by Subject|111|||
33368572|NCT04437511|101234888|FG001|Overall Study|Withdrawal by Subject|94|||
33368573|NCT04437511|101234887|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
33368574|NCT04437511|101234888|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
33368575|NCT04437511|101234887|FG000|Overall Study|Continuing Study|7|||
33368576|NCT04437511|101234888|FG001|Overall Study|Continuing Study|5|||
33368577|NCT03623321|101234891|FG000|Overall Study|Adverse Event|32|||
33368578|NCT03623321|101234891|FG000|Overall Study|Death|9|||
33368579|NCT03623321|101234891|FG000|Overall Study|Lack of Efficacy|9|||
33368580|NCT03623321|101234891|FG000|Overall Study|Lost to Follow-up|6|||
33368581|NCT03623321|101234891|FG000|Overall Study|Noncompliance with study drug|6|||
33368582|NCT03623321|101234891|FG000|Overall Study|Use of prohibited medication|3|||
33368583|NCT03623321|101234891|FG000|Overall Study|Physician Decision|5|||
33368584|NCT03623321|101234891|FG000|Overall Study|Protocol Violation|1|||
33368585|NCT03623321|101234891|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
33368586|NCT03623321|101234891|FG000|Overall Study|Not further specified|43|||
33368587|NCT04849416|101234892|FG000|Overall Study|Ongoing Treatment|12|||
33368588|NCT04849416|101234893|FG001|Overall Study|Ongoing Treatment|5|||
33368589|NCT04849416|101234894|FG002|Overall Study|Ongoing Treatment|3|||
33368590|NCT04849416|101234892|FG000|Overall Study|On Post-Treatment Follow-up|8|||
33368591|NCT04849416|101234893|FG001|Overall Study|On Post-Treatment Follow-up|9|||
33368592|NCT04849416|101234894|FG002|Overall Study|On Post-Treatment Follow-up|10|||
33368593|NCT04849416|101234892|FG000|Overall Study|Withdrawal by Subject|0|||
33368594|NCT04849416|101234893|FG001|Overall Study|Withdrawal by Subject|0|||
33368595|NCT04849416|101234894|FG002|Overall Study|Withdrawal by Subject|1|||
33368596|NCT04849416|101234892|FG000|Overall Study|Lost to Follow-up|1|||
33138091|NCT00095147|100420127|FG002|Long-term Extension Period|Death|0|||
33138092|NCT00095147|100420128|FG003|Long-term Extension Period|Death|0|||
33368597|NCT04849416|101234893|FG001|Overall Study|Lost to Follow-up|0|||
33368598|NCT04849416|101234894|FG002|Overall Study|Lost to Follow-up|0|||
33368599|NCT05434078|101234895|FG000|Overall Study|Lost to Follow-up|2|||
33636717|NCT02156076|102222916|FG000|Treatment Period|Lost to Follow-up|0|||
33636718|NCT02156076|102222917|FG001|Treatment Period|Lost to Follow-up|0|||
33138093|NCT00095147|100420129|FG004|Long-term Extension Period|Death|3|||
33368600|NCT05434078|101234896|FG001|Overall Study|Lost to Follow-up|1|||
33368601|NCT05434078|101234895|FG000|Overall Study|Withdrawal by Subject|1|||
33368602|NCT05434078|101234896|FG001|Overall Study|Withdrawal by Subject|0|||
33368603|NCT03570892|101234897|FG000|Overall Study|Death|51|||
33368604|NCT03570892|101234898|FG001|Overall Study|Death|45|||
33234234|NCT01091428|100759960|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
33234235|NCT01091428|100759957|FG000|Phase 2|Reason not specified|0|||
33234236|NCT01091428|100759958|FG001|Phase 2|Reason not specified|0|||
33368605|NCT03570892|101234897|FG000|Overall Study|Subject decision|5|||
33368606|NCT03570892|101234898|FG001|Overall Study|Subject decision|3|||
33368607|NCT03570892|101234897|FG000|Overall Study|Protocol Violation|1|||
33368608|NCT03570892|101234898|FG001|Overall Study|Protocol Violation|4|||
33368609|NCT03570892|101234897|FG000|Overall Study|Physician Decision|0|||
33368610|NCT03570892|101234898|FG001|Overall Study|Physician Decision|2|||
33368611|NCT04492722|101234899|FG000|Overall Study|Adverse Event|7|||
33368612|NCT04492722|101234900|FG001|Overall Study|Adverse Event|2|||
33368613|NCT04492722|101234901|FG002|Overall Study|Adverse Event|3|||
33368614|NCT04492722|101234902|FG003|Overall Study|Adverse Event|0|||
33368615|NCT04492722|101234899|FG000|Overall Study|Death|0|||
33368616|NCT04492722|101234900|FG001|Overall Study|Death|0|||
33368617|NCT04492722|101234901|FG002|Overall Study|Death|0|||
33368618|NCT04492722|101234902|FG003|Overall Study|Death|1|||
33368619|NCT04492722|101234899|FG000|Overall Study|Lost to Follow-up|0|||
33368620|NCT04492722|101234900|FG001|Overall Study|Lost to Follow-up|1|||
33368621|NCT04492722|101234901|FG002|Overall Study|Lost to Follow-up|0|||
33368622|NCT04492722|101234902|FG003|Overall Study|Lost to Follow-up|1|||
33368623|NCT04492722|101234899|FG000|Overall Study|Physician Decision|0|||
33368624|NCT04492722|101234900|FG001|Overall Study|Physician Decision|3|||
33368625|NCT04492722|101234901|FG002|Overall Study|Physician Decision|1|||
33368626|NCT04492722|101234902|FG003|Overall Study|Physician Decision|1|||
33368627|NCT04492722|101234899|FG000|Overall Study|Withdrawal by Subject|6|||
33368628|NCT04492722|101234900|FG001|Overall Study|Withdrawal by Subject|6|||
33368629|NCT04492722|101234901|FG002|Overall Study|Withdrawal by Subject|0|||
33368630|NCT04492722|101234902|FG003|Overall Study|Withdrawal by Subject|3|||
33368631|NCT04492722|101234899|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
33368632|NCT04492722|101234900|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
33368633|NCT04492722|101234901|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
33368634|NCT04492722|101234902|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
33368635|NCT04492722|101234899|FG000|Overall Study|Due to Covid-19 pandemic|7|||
33368636|NCT04492722|101234900|FG001|Overall Study|Due to Covid-19 pandemic|3|||
33575710|NCT01008618|101999862|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
33138094|NCT00095147|100420125|FG000|Long-term Extension Period|Adverse Event|0|||
33368637|NCT04492722|101234901|FG002|Overall Study|Due to Covid-19 pandemic|7|||
33368638|NCT04492722|101234902|FG003|Overall Study|Due to Covid-19 pandemic|6|||
33368639|NCT04492722|101234899|FG000|Overall Study|Failure to meet randomisation criteria|2|||
33368640|NCT04492722|101234900|FG001|Overall Study|Failure to meet randomisation criteria|3|||
33575711|NCT01008618|101999860|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
33575712|NCT01008618|101999861|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
33575713|NCT01008618|101999862|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
33575714|NCT01008618|101999860|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
33575715|NCT01008618|101999861|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
33575716|NCT01008618|101999862|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
33575717|NCT04422431|101999866|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
33575718|NCT04422431|101999866|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
33575719|NCT04422431|101999866|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
33575720|NCT04422431|101999866|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
33575721|NCT04422431|101999866|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
33575722|NCT04422431|101999866|FG000|Extension Period (48 Weeks)|Other than specified|2|||
33575723|NCT01757665|101999871|FG000|Overall Study|Still on Study - Visit Completed|240|||
33575724|NCT01757665|101999872|FG001|Overall Study|Still on Study - Visit Completed|30|||
33575725|NCT01757665|101999871|FG000|Overall Study|Still on Study - Visit Pending|398|||
33575726|NCT01757665|101999872|FG001|Overall Study|Still on Study - Visit Pending|40|||
33575727|NCT01757665|101999871|FG000|Overall Study|Still on Study - Missed Visit|14|||
33575728|NCT01757665|101999872|FG001|Overall Study|Still on Study - Missed Visit|1|||
33575729|NCT01757665|101999871|FG000|Overall Study|Death|25|||
33575730|NCT01757665|101999872|FG001|Overall Study|Death|8|||
33575731|NCT01757665|101999871|FG000|Overall Study|Explant|1|||
33575732|NCT01757665|101999872|FG001|Overall Study|Explant|2|||
33575733|NCT01757665|101999871|FG000|Overall Study|Withdrawal by Subject|10|||
33575734|NCT01757665|101999872|FG001|Overall Study|Withdrawal by Subject|0|||
33575735|NCT01757665|101999871|FG000|Overall Study|Lost to Follow-up|1|||
33575736|NCT01757665|101999872|FG001|Overall Study|Lost to Follow-up|1|||
33368641|NCT04492722|101234901|FG002|Overall Study|Failure to meet randomisation criteria|4|||
33368642|NCT04492722|101234902|FG003|Overall Study|Failure to meet randomisation criteria|2|||
33368643|NCT04492722|101234899|FG000|Overall Study|Early termination from the study|54|||
33368644|NCT04492722|101234900|FG001|Overall Study|Early termination from the study|51|||
33368645|NCT04492722|101234901|FG002|Overall Study|Early termination from the study|50|||
33368646|NCT04492722|101234902|FG003|Overall Study|Early termination from the study|50|||
33575737|NCT01757665|101999871|FG000|Overall Study|Not Implanted with Device|5|||
33575738|NCT01757665|101999872|FG001|Overall Study|Not Implanted with Device|1|||
33575739|NCT01049373|101999873|FG000|Overall Study|Protocol Violation|9|||
33575740|NCT01049373|101999874|FG001|Overall Study|Protocol Violation|9|||
33575741|NCT01049373|101999873|FG000|Overall Study|Withdrawal by Subject|8|||
33575742|NCT01049373|101999874|FG001|Overall Study|Withdrawal by Subject|5|||
33575743|NCT01049373|101999873|FG000|Overall Study|Adverse Event|3|||
33575744|NCT01049373|101999874|FG001|Overall Study|Adverse Event|3|||
33575745|NCT01049373|101999873|FG000|Overall Study|Lost to Follow-up|9|||
33575746|NCT01049373|101999874|FG001|Overall Study|Lost to Follow-up|4|||
33234237|NCT01091428|100759959|FG002|Phase 2|Reason not specified|4|||
33575747|NCT01049373|101999873|FG000|Overall Study|no evaluable study values|9|||
33575748|NCT01049373|101999874|FG001|Overall Study|no evaluable study values|21|||
33575749|NCT01049373|101999873|FG000|Overall Study|Other|1|||
33575750|NCT01049373|101999874|FG001|Overall Study|Other|1|||
33575751|NCT01049373|101999873|FG000|Overall Study|Non-cooperation|0|||
33575752|NCT01049373|101999874|FG001|Overall Study|Non-cooperation|1|||
33575753|NCT00003645|101999876|FG000|Overall Study|Death|4|||
33575754|NCT00003645|101999877|FG001|Overall Study|Death|1|||
33575755|NCT00003645|101999876|FG000|Overall Study|Lost to Follow-up|7|||
33575756|NCT00003645|101999877|FG001|Overall Study|Lost to Follow-up|8|||
33575757|NCT00003645|101999876|FG000|Overall Study|Withdrawal by Subject|1|||
33575758|NCT00003645|101999877|FG001|Overall Study|Withdrawal by Subject|3|||
33575759|NCT02961244|101999880|FG000|Overall Study|Protocol Violation|0|||
33575760|NCT02961244|101999881|FG001|Overall Study|Protocol Violation|1|||
33575761|NCT02961244|101999880|FG000|Overall Study|Withdrawal by Subject|1|||
33636719|NCT02156076|102222918|FG002|Treatment Period|Lost to Follow-up|0|||
33636720|NCT02156076|102222919|FG003|Treatment Period|Lost to Follow-up|1|||
33636721|NCT02156076|102222916|FG000|Treatment Period|Withdrawal by Subject|0|||
33636722|NCT02156076|102222917|FG001|Treatment Period|Withdrawal by Subject|0|||
33636723|NCT02156076|102222918|FG002|Treatment Period|Withdrawal by Subject|1|||
33636724|NCT02156076|102222919|FG003|Treatment Period|Withdrawal by Subject|0|||
33636725|NCT02156076|102222916|FG000|Treatment Period|Subject request to discontinue treatment|0|||
33636726|NCT02156076|102222917|FG001|Treatment Period|Subject request to discontinue treatment|1|||
33636727|NCT02156076|102222918|FG002|Treatment Period|Subject request to discontinue treatment|0|||
33636728|NCT02156076|102222919|FG003|Treatment Period|Subject request to discontinue treatment|0|||
33636729|NCT02156076|102222916|FG000|Treatment Period|Adverse Event|0|||
33636730|NCT02156076|102222917|FG001|Treatment Period|Adverse Event|0|||
33636731|NCT02156076|102222918|FG002|Treatment Period|Adverse Event|0|||
33636732|NCT02156076|102222919|FG003|Treatment Period|Adverse Event|1|||
33636733|NCT02156076|102222916|FG000|Follow-up Period|Withdrawal by Subject|1|||
33138095|NCT00095147|100420126|FG001|Long-term Extension Period|Adverse Event|0|||
33636734|NCT02156076|102222917|FG001|Follow-up Period|Withdrawal by Subject|0|||
33636735|NCT02156076|102222918|FG002|Follow-up Period|Withdrawal by Subject|0|||
33636736|NCT02156076|102222919|FG003|Follow-up Period|Withdrawal by Subject|0|||
33636737|NCT02015637|102222922|FG000|Overall Study|Lost to Follow-up|3|||
33636738|NCT02015637|102222923|FG001|Overall Study|Lost to Follow-up|5|||
33636739|NCT02015637|102222922|FG000|Overall Study|Adverse Event|3|||
33636740|NCT02015637|102222923|FG001|Overall Study|Adverse Event|0|||
33636741|NCT02015637|102222922|FG000|Overall Study|Did not take study drug|2|||
33636742|NCT02015637|102222923|FG001|Overall Study|Did not take study drug|0|||
33636743|NCT03879772|102222926|FG000|Overall Study|Adverse Event|2|||
33636744|NCT03879772|102222927|FG001|Overall Study|Adverse Event|2|||
33636745|NCT03879772|102222928|FG002|Overall Study|Adverse Event|3|||
33636746|NCT03879772|102222929|FG003|Overall Study|Adverse Event|4|||
33636747|NCT03879772|102222930|FG004|Overall Study|Adverse Event|3|||
33636748|NCT03879772|102222926|FG000|Overall Study|Treatment Failure|1|||
33636749|NCT03879772|102222927|FG001|Overall Study|Treatment Failure|0|||
33138096|NCT00095147|100420127|FG002|Long-term Extension Period|Adverse Event|0|||
33575762|NCT02961244|101999881|FG001|Overall Study|Withdrawal by Subject|2|||
33636750|NCT03879772|102222928|FG002|Overall Study|Treatment Failure|0|||
33575763|NCT02961244|101999880|FG000|Overall Study|Surgery plan change after study approval|0|||
33575764|NCT02961244|101999881|FG001|Overall Study|Surgery plan change after study approval|2|||
33575765|NCT02961244|101999880|FG000|Overall Study|Lost to Follow-up|0|||
33575766|NCT02961244|101999881|FG001|Overall Study|Lost to Follow-up|2|||
33636751|NCT03879772|102222929|FG003|Overall Study|Treatment Failure|2|||
33636752|NCT03879772|102222930|FG004|Overall Study|Treatment Failure|1|||
33636753|NCT03879772|102222926|FG000|Overall Study|Lost to Follow-up|0|||
33636754|NCT03879772|102222927|FG001|Overall Study|Lost to Follow-up|0|||
33636755|NCT03879772|102222928|FG002|Overall Study|Lost to Follow-up|0|||
33234238|NCT01091428|100759960|FG003|Phase 2|Reason not specified|3|||
33575767|NCT02961244|101999880|FG000|Overall Study|İnadequate data|0|||
33575768|NCT02961244|101999881|FG001|Overall Study|İnadequate data|2|||
33575769|NCT01819272|101999882|FG000|Overall Study|Adverse Event|1|||
33636756|NCT03879772|102222929|FG003|Overall Study|Lost to Follow-up|0|||
33636757|NCT03879772|102222930|FG004|Overall Study|Lost to Follow-up|1|||
33636758|NCT03879772|102222926|FG000|Overall Study|Withdrawal by Subject|0|||
33636759|NCT03879772|102222927|FG001|Overall Study|Withdrawal by Subject|1|||
33234239|NCT01091428|100759957|FG000|Phase 2|Physician Decision|0|||
33234240|NCT01091428|100759958|FG001|Phase 2|Physician Decision|0|||
33234241|NCT01091428|100759959|FG002|Phase 2|Physician Decision|2|||
33234242|NCT01091428|100759960|FG003|Phase 2|Physician Decision|0|||
33234243|NCT01558674|100759961|FG000|Part 1|Study Terminated by Sponsor|10|||
33234244|NCT01558674|100759962|FG001|Part 1|Study Terminated by Sponsor|0|||
33368647|NCT04492722|101234899|FG000|Overall Study|Missing|3|||
33368648|NCT04492722|101234900|FG001|Overall Study|Missing|0|||
33368649|NCT04492722|101234901|FG002|Overall Study|Missing|0|||
33368650|NCT04492722|101234902|FG003|Overall Study|Missing|5|||
33368651|NCT04492722|101234899|FG000|Overall Study|Participants who did not receive treatment|0|||
33368652|NCT04492722|101234900|FG001|Overall Study|Participants who did not receive treatment|1|||
33368653|NCT04492722|101234901|FG002|Overall Study|Participants who did not receive treatment|4|||
33368654|NCT04492722|101234902|FG003|Overall Study|Participants who did not receive treatment|0|||
33368655|NCT02166463|101234903|FG000|Overall Study|Lost to Follow-up|0|||
33368656|NCT02166463|101234904|FG001|Overall Study|Lost to Follow-up|1|||
33368657|NCT02166463|101234903|FG000|Overall Study|Physician Decision|10|||
33368658|NCT02166463|101234904|FG001|Overall Study|Physician Decision|10|||
33368659|NCT02166463|101234903|FG000|Overall Study|Ineligible|11|||
33420323|NCT02729545|101428577|FG000|Overall Study|Withdrawal by Subject|2|||
33420324|NCT02729545|101428578|FG001|Overall Study|Withdrawal by Subject|3|||
33420325|NCT00765999|101428583|FG000|Overall Study|Adverse Event|203|||
33420326|NCT00765999|101428583|FG000|Overall Study|Insufficient Therapeutic Response|100|||
33420327|NCT00765999|101428583|FG000|Overall Study|Protocol Violation|95|||
33420328|NCT00765999|101428583|FG000|Overall Study|Consent Withdrawn|202|||
33420329|NCT00765999|101428583|FG000|Overall Study|Lost to Follow-up|131|||
33420330|NCT00765999|101428583|FG000|Overall Study|Study Terminated by Sponsor|2|||
33420331|NCT00765999|101428583|FG000|Overall Study|Other Miscellaneous Reasons|51|||
33420332|NCT04523831|101428592|FG000|Overall Study|Lost to Follow-up|15|||
33420333|NCT04523831|101428593|FG001|Overall Study|Lost to Follow-up|17|||
33420334|NCT04523831|101428592|FG000|Overall Study|Death|0|||
33420335|NCT04523831|101428593|FG001|Overall Study|Death|3|||
33420336|NCT04523831|101428592|FG000|Overall Study|Adverse Event|2|||
33420337|NCT04523831|101428593|FG001|Overall Study|Adverse Event|0|||
33420338|NCT00656019|101428594|FG000|Overall Study|Not Eligible|10|||
33420339|NCT00656019|101428595|FG001|Overall Study|Not Eligible|0|||
33420340|NCT00656019|101428596|FG002|Overall Study|Not Eligible|0|||
33420341|NCT00656019|101428597|FG003|Overall Study|Not Eligible|0|||
33420342|NCT00656019|101428594|FG000|Overall Study|Withdrawal by Subject|2|||
33420343|NCT00656019|101428595|FG001|Overall Study|Withdrawal by Subject|0|||
33420344|NCT00656019|101428596|FG002|Overall Study|Withdrawal by Subject|0|||
33420345|NCT00656019|101428597|FG003|Overall Study|Withdrawal by Subject|0|||
33575770|NCT01819272|101999883|FG001|Overall Study|Adverse Event|0|||
33368660|NCT02166463|101234904|FG001|Overall Study|Ineligible|2|||
33368661|NCT02166463|101234903|FG000|Overall Study|Progressive Disease|9|||
33368662|NCT02166463|101234904|FG001|Overall Study|Progressive Disease|6|||
33368663|NCT02166463|101234903|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
33368664|NCT02166463|101234904|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
33368665|NCT02166463|101234903|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
33368666|NCT02166463|101234904|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
33368667|NCT02166463|101234903|FG000|Overall Study|Refusal of further protocol therapy|5|||
33368668|NCT02166463|101234904|FG001|Overall Study|Refusal of further protocol therapy|6|||
33368669|NCT01903811|101234905|FG000|Overall Study|No measurable disease|1|||
33368670|NCT01903811|101234906|FG001|Overall Study|No measurable disease|1|||
33368671|NCT01903811|101234905|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
33368672|NCT01903811|101234906|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
33368673|NCT01903811|101234905|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
33420346|NCT00656019|101428594|FG000|Overall Study|Lost to Follow-up|2|||
33420347|NCT00656019|101428595|FG001|Overall Study|Lost to Follow-up|1|||
33420348|NCT00656019|101428596|FG002|Overall Study|Lost to Follow-up|0|||
33575771|NCT01819272|101999884|FG002|Overall Study|Adverse Event|0|||
33575772|NCT01819272|101999885|FG003|Overall Study|Adverse Event|2|||
33575773|NCT01819272|101999886|FG004|Overall Study|Adverse Event|0|||
33575774|NCT01819272|101999887|FG005|Overall Study|Adverse Event|0|||
33575775|NCT01819272|101999882|FG000|Overall Study|Lost to Follow-up|3|||
33575776|NCT01819272|101999883|FG001|Overall Study|Lost to Follow-up|0|||
33575777|NCT01819272|101999884|FG002|Overall Study|Lost to Follow-up|1|||
33575778|NCT01819272|101999885|FG003|Overall Study|Lost to Follow-up|0|||
33636760|NCT03879772|102222928|FG002|Overall Study|Withdrawal by Subject|3|||
33234245|NCT01558674|100759961|FG000|Part 1|Withdrawal by Subject|1|||
33420349|NCT00656019|101428597|FG003|Overall Study|Lost to Follow-up|0|||
33420350|NCT00858234|101428598|FG000|Overall Study|Adverse Event|6|||
33234246|NCT01558674|100759962|FG001|Part 1|Withdrawal by Subject|0|||
33575779|NCT01819272|101999886|FG004|Overall Study|Lost to Follow-up|0|||
33368674|NCT01903811|101234906|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
33368675|NCT01903811|101234905|FG000|Overall Study|Withdrawal by Subject|0|||
33636761|NCT03879772|102222929|FG003|Overall Study|Withdrawal by Subject|1|||
33636762|NCT03879772|102222930|FG004|Overall Study|Withdrawal by Subject|1|||
33636763|NCT03879772|102222926|FG000|Overall Study|Protocol Violation|0|||
33636764|NCT03879772|102222927|FG001|Overall Study|Protocol Violation|0|||
33636765|NCT03879772|102222928|FG002|Overall Study|Protocol Violation|3|||
33636766|NCT03879772|102222929|FG003|Overall Study|Protocol Violation|1|||
33636767|NCT03879772|102222930|FG004|Overall Study|Protocol Violation|2|||
33636768|NCT03879772|102222926|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
33636769|NCT03879772|102222927|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
33636770|NCT03879772|102222928|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
33636771|NCT03879772|102222929|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
33636772|NCT03879772|102222930|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
33636773|NCT00763035|102222934|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
33636774|NCT00763035|102222935|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
33636775|NCT00763035|102222934|FG000|First Intervention|Adverse Event|0|||
33636776|NCT00763035|102222935|FG001|First Intervention|Adverse Event|1|||
33636777|NCT00763035|102222934|FG000|Second Intervention|Adverse Event|1|||
33636778|NCT00763035|102222935|FG001|Second Intervention|Adverse Event|0|||
33636779|NCT00763035|102222934|FG000|Second Intervention|Physician Decision|2|||
33234247|NCT00972179|100759964|FG000|Overall Study|Noncompliance|1|||
33368676|NCT01903811|101234906|FG001|Overall Study|Withdrawal by Subject|1|||
33368677|NCT04145440|101234907|FG000|Overall Study|Physician Decision|3|||
33368678|NCT04145440|101234908|FG001|Overall Study|Physician Decision|0|||
33368679|NCT04145440|101234907|FG000|Overall Study|Use of prohibited therapy|2|||
33368680|NCT04145440|101234908|FG001|Overall Study|Use of prohibited therapy|3|||
33368681|NCT03710603|101234909|FG000|Overall Study|Adverse Event|1|||
33368682|NCT03710603|101234910|FG001|Overall Study|Adverse Event|0|||
33368683|NCT03710603|101234909|FG000|Overall Study|Death|44|||
33368684|NCT03710603|101234910|FG001|Overall Study|Death|34|||
33368685|NCT03710603|101234909|FG000|Overall Study|Lost to Follow-up|3|||
33368686|NCT03710603|101234910|FG001|Overall Study|Lost to Follow-up|5|||
33368687|NCT03710603|101234909|FG000|Overall Study|Withdrawal by Subject|11|||
33368688|NCT03710603|101234910|FG001|Overall Study|Withdrawal by Subject|10|||
33368689|NCT03056755|101234911|FG000|Treatment- Core Phase|Progressive disease|89|||
33368690|NCT03056755|101234912|FG001|Treatment- Core Phase|Progressive disease|88|||
33368691|NCT03056755|101234913|FG002|Treatment- Core Phase|Progressive disease|90|||
33368692|NCT03056755|101234911|FG000|Treatment- Core Phase|Adverse Event|20|||
33368693|NCT03056755|101234912|FG001|Treatment- Core Phase|Adverse Event|14|||
33368694|NCT03056755|101234913|FG002|Treatment- Core Phase|Adverse Event|13|||
33368695|NCT03056755|101234911|FG000|Treatment- Core Phase|Physician Decision|7|||
33368696|NCT03056755|101234912|FG001|Treatment- Core Phase|Physician Decision|13|||
33368697|NCT03056755|101234913|FG002|Treatment- Core Phase|Physician Decision|5|||
33368698|NCT03056755|101234911|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
33368699|NCT03056755|101234912|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
33368700|NCT03056755|101234913|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
33368701|NCT03056755|101234911|FG000|Treatment- Core Phase|Death|3|||
33368702|NCT03056755|101234912|FG001|Treatment- Core Phase|Death|2|||
33368703|NCT03056755|101234913|FG002|Treatment- Core Phase|Death|4|||
33368704|NCT03056755|101234911|FG000|Treatment- Core Phase|Protocol deviation|1|||
33368705|NCT03056755|101234912|FG001|Treatment- Core Phase|Protocol deviation|1|||
33368706|NCT03056755|101234913|FG002|Treatment- Core Phase|Protocol deviation|0|||
33368707|NCT03056755|101234911|FG000|Treatment- Core Phase|Technical problems|1|||
33368708|NCT03056755|101234912|FG001|Treatment- Core Phase|Technical problems|0|||
33368709|NCT03056755|101234913|FG002|Treatment- Core Phase|Technical problems|0|||
33368710|NCT03056755|101234911|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
33368711|NCT03056755|101234912|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
33368712|NCT03056755|101234913|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
33368713|NCT03056755|101234911|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
33368714|NCT03056755|101234912|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
33420351|NCT00858234|101428598|FG000|Overall Study|Progressive disease|2|||
33420352|NCT00858234|101428598|FG000|Overall Study|Status unknown|1|||
33420353|NCT00995930|101428599|FG000|Overall Study|Protocol deviation|2|||
33636780|NCT00763035|102222935|FG001|Second Intervention|Physician Decision|0|||
33636781|NCT00539591|102222936|FG000|Overall Study|Toxicity|3|||
33636782|NCT00539591|102222937|FG001|Overall Study|Toxicity|0|||
33636783|NCT00539591|102222938|FG002|Overall Study|Toxicity|0|||
33636784|NCT00539591|102222936|FG000|Overall Study|Disease progression|2|||
33368715|NCT03056755|101234913|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
33368716|NCT03056755|101234911|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
33368717|NCT03056755|101234912|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
33368718|NCT03056755|101234913|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
33368719|NCT03056755|101234911|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
33368720|NCT03056755|101234912|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
33368721|NCT03056755|101234913|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
33368722|NCT03485729|101234915|FG000|Overall Study|Withdrawal by Subject|0|||
33368723|NCT03485729|101234916|FG001|Overall Study|Withdrawal by Subject|0|||
33575780|NCT01819272|101999887|FG005|Overall Study|Lost to Follow-up|3|||
33575781|NCT01819272|101999882|FG000|Overall Study|Protocol Violation|0|||
33575782|NCT01819272|101999883|FG001|Overall Study|Protocol Violation|0|||
33575783|NCT01819272|101999884|FG002|Overall Study|Protocol Violation|0|||
33575784|NCT01819272|101999885|FG003|Overall Study|Protocol Violation|1|||
33575785|NCT01819272|101999886|FG004|Overall Study|Protocol Violation|2|||
33575786|NCT01819272|101999887|FG005|Overall Study|Protocol Violation|3|||
33575787|NCT01819272|101999882|FG000|Overall Study|Physician Decision|0|||
33575788|NCT01819272|101999883|FG001|Overall Study|Physician Decision|1|||
33575789|NCT01819272|101999884|FG002|Overall Study|Physician Decision|0|||
33575790|NCT01819272|101999885|FG003|Overall Study|Physician Decision|0|||
33575791|NCT01819272|101999886|FG004|Overall Study|Physician Decision|0|||
33575792|NCT01819272|101999887|FG005|Overall Study|Physician Decision|0|||
33575793|NCT01819272|101999882|FG000|Overall Study|Withdrawal of Consent|0|||
33575794|NCT01819272|101999883|FG001|Overall Study|Withdrawal of Consent|1|||
33575795|NCT01819272|101999884|FG002|Overall Study|Withdrawal of Consent|2|||
33575796|NCT01819272|101999885|FG003|Overall Study|Withdrawal of Consent|1|||
33575797|NCT01819272|101999886|FG004|Overall Study|Withdrawal of Consent|0|||
33575798|NCT01819272|101999887|FG005|Overall Study|Withdrawal of Consent|1|||
33575799|NCT01819272|101999882|FG000|Overall Study|Loss of Glucose Control|2|||
33575800|NCT01819272|101999883|FG001|Overall Study|Loss of Glucose Control|1|||
33575801|NCT01819272|101999884|FG002|Overall Study|Loss of Glucose Control|0|||
33575802|NCT01819272|101999885|FG003|Overall Study|Loss of Glucose Control|1|||
33575803|NCT01819272|101999886|FG004|Overall Study|Loss of Glucose Control|2|||
33575804|NCT01819272|101999887|FG005|Overall Study|Loss of Glucose Control|0|||
33575805|NCT01822665|101999888|FG000|Overall Study|Adverse Event|3|||
33575806|NCT01822665|101999888|FG000|Overall Study|Other Reason|5|||
33575807|NCT01535287|101999891|FG000|Overall Study|drug not prepared in time|5|||
33575808|NCT01535287|101999892|FG001|Overall Study|drug not prepared in time|6|||
33575809|NCT01627691|101999893|FG000|Overall Study|Death|11|||
33575810|NCT01627691|101999893|FG000|Overall Study|Lost to Follow-up|3|||
33575811|NCT01627691|101999893|FG000|Overall Study|Withdrawal by Subject|1|||
33575812|NCT01627691|101999893|FG000|Overall Study|Missed the visit|3|||
33575813|NCT02030821|101999894|FG000|Overall Study|Physician Decision|2|||
33575814|NCT02030821|101999895|FG001|Overall Study|Physician Decision|2|||
33575815|NCT02030821|101999896|FG002|Overall Study|Physician Decision|5|||
33575816|NCT02030821|101999897|FG003|Overall Study|Physician Decision|2|||
33575817|NCT02986074|101999898|FG000|First Trial Period|Adverse Event|1|||
33575818|NCT02986074|101999899|FG001|First Trial Period|Adverse Event|0|||
33575819|NCT02986074|101999900|FG002|First Trial Period|Adverse Event|0|||
33575820|NCT02986074|101999901|FG003|First Trial Period|Adverse Event|0|||
33575821|NCT02986074|101999898|FG000|Follow up Period|system explant|0|||
33575822|NCT02986074|101999899|FG001|Follow up Period|system explant|0|||
33575823|NCT02986074|101999900|FG002|Follow up Period|system explant|1|||
33636785|NCT00539591|102222937|FG001|Overall Study|Disease progression|2|||
33636786|NCT00539591|102222938|FG002|Overall Study|Disease progression|3|||
33636787|NCT02121535|102222939|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
33636788|NCT02121535|102222940|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
33636789|NCT02121535|102222939|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
33636790|NCT02121535|102222940|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
33636791|NCT01868997|102222946|FG000|Overall Study|Adverse Event|2|||
33636792|NCT01868997|102222947|FG001|Overall Study|Adverse Event|5|||
33636793|NCT01868997|102222946|FG000|Overall Study|Lack of Efficacy|2|||
33636794|NCT01868997|102222947|FG001|Overall Study|Lack of Efficacy|0|||
33636795|NCT01868997|102222946|FG000|Overall Study|Other|3|||
33636796|NCT01868997|102222947|FG001|Overall Study|Other|1|||
33636797|NCT03058146|102222952|FG000|Overall Study|Withdrawal by Subject|4|||
33636798|NCT03058146|102222953|FG001|Overall Study|Withdrawal by Subject|1|||
33636799|NCT03058146|102222952|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
33138097|NCT00095147|100420128|FG003|Long-term Extension Period|Adverse Event|0|||
33234248|NCT00972179|100759965|FG001|Overall Study|Noncompliance|0|||
33368724|NCT03485729|101234917|FG002|Overall Study|Withdrawal by Subject|1|||
33368725|NCT03485729|101234915|FG000|Overall Study|Disease progression|8|||
33368726|NCT03485729|101234916|FG001|Overall Study|Disease progression|13|||
33575824|NCT02986074|101999901|FG003|Follow up Period|system explant|2|||
33575825|NCT02986074|101999898|FG000|Follow up Period|Physician Decision|0|||
33575826|NCT02986074|101999899|FG001|Follow up Period|Physician Decision|0|||
33575827|NCT02986074|101999900|FG002|Follow up Period|Physician Decision|0|||
33575828|NCT02986074|101999901|FG003|Follow up Period|Physician Decision|1|||
33636800|NCT03058146|102222953|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
33636801|NCT04476797|102222954|FG000|Overall Study|Withdrawal by Subject|1|||
33636802|NCT04476797|102222955|FG001|Overall Study|Withdrawal by Subject|0|||
33636803|NCT04476797|102222956|FG002|Overall Study|Withdrawal by Subject|0|||
33368727|NCT03485729|101234917|FG002|Overall Study|Disease progression|1|||
33575829|NCT00382174|101999907|FG000|Overall Study|Lost to Follow-up|1|||
33575830|NCT00382174|101999908|FG001|Overall Study|Lost to Follow-up|4|||
33138098|NCT00095147|100420129|FG004|Long-term Extension Period|Adverse Event|11|||
33138099|NCT00095147|100420125|FG000|Long-term Extension Period|Lack of Efficacy|0|||
33138100|NCT00095147|100420126|FG001|Long-term Extension Period|Lack of Efficacy|0|||
33575831|NCT00382174|101999909|FG002|Overall Study|Lost to Follow-up|5|||
33138101|NCT00095147|100420127|FG002|Long-term Extension Period|Lack of Efficacy|0|||
33138102|NCT00095147|100420128|FG003|Long-term Extension Period|Lack of Efficacy|0|||
33138103|NCT00095147|100420129|FG004|Long-term Extension Period|Lack of Efficacy|9|||
33138104|NCT00095147|100420125|FG000|Long-term Extension Period|Lost to Follow-up|0|||
33138105|NCT00095147|100420126|FG001|Long-term Extension Period|Lost to Follow-up|0|||
33138106|NCT00095147|100420127|FG002|Long-term Extension Period|Lost to Follow-up|0|||
33575832|NCT00382174|101999907|FG000|Overall Study|Adverse Event|1|||
33575833|NCT00382174|101999908|FG001|Overall Study|Adverse Event|4|||
33575834|NCT00382174|101999909|FG002|Overall Study|Adverse Event|5|||
33575835|NCT00382174|101999907|FG000|Overall Study|Withdrawal by Subject|1|||
33575836|NCT00382174|101999908|FG001|Overall Study|Withdrawal by Subject|4|||
33575837|NCT00382174|101999909|FG002|Overall Study|Withdrawal by Subject|5|||
33575838|NCT00382174|101999907|FG000|Overall Study|Non compliance|1|||
33575839|NCT00382174|101999908|FG001|Overall Study|Non compliance|0|||
33575840|NCT00382174|101999909|FG002|Overall Study|Non compliance|1|||
33575841|NCT00382174|101999907|FG000|Overall Study|Physician Decision|0|||
33575842|NCT00382174|101999908|FG001|Overall Study|Physician Decision|2|||
33575843|NCT00382174|101999909|FG002|Overall Study|Physician Decision|2|||
33575844|NCT00382174|101999907|FG000|Overall Study|Failed to meet criteria|0|||
33575845|NCT00382174|101999908|FG001|Overall Study|Failed to meet criteria|1|||
33575846|NCT00382174|101999909|FG002|Overall Study|Failed to meet criteria|1|||
33575847|NCT00382174|101999907|FG000|Overall Study|Wounds merged|0|||
33575848|NCT00382174|101999908|FG001|Overall Study|Wounds merged|2|||
33575849|NCT00382174|101999909|FG002|Overall Study|Wounds merged|2|||
33575850|NCT03510273|101999910|FG000|Overall Study|Withdrawal by Subject|2|||
33575851|NCT03510273|101999910|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
33575852|NCT03510273|101999910|FG000|Overall Study|Moved away from study area|4|||
33575853|NCT00532844|101999914|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
33575854|NCT00532844|101999915|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
33575855|NCT00532844|101999914|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
33575856|NCT00532844|101999915|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
33575857|NCT00532844|101999914|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
33575858|NCT00532844|101999915|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
33575859|NCT00532844|101999914|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
33138107|NCT00095147|100420128|FG003|Long-term Extension Period|Lost to Follow-up|0|||
33138108|NCT00095147|100420129|FG004|Long-term Extension Period|Lost to Follow-up|6|||
33138109|NCT00095147|100420125|FG000|Long-term Extension Period|Withdrawal of consent|0|||
33138110|NCT00095147|100420126|FG001|Long-term Extension Period|Withdrawal of consent|0|||
33138111|NCT00095147|100420127|FG002|Long-term Extension Period|Withdrawal of consent|0|||
33138112|NCT00095147|100420128|FG003|Long-term Extension Period|Withdrawal of consent|0|||
33138113|NCT00095147|100420129|FG004|Long-term Extension Period|Withdrawal of consent|12|||
33138114|NCT00095147|100420125|FG000|Long-term Extension Period|Pregnancy|0|||
33138115|NCT00095147|100420126|FG001|Long-term Extension Period|Pregnancy|0|||
33138116|NCT00095147|100420127|FG002|Long-term Extension Period|Pregnancy|0|||
33138117|NCT00095147|100420128|FG003|Long-term Extension Period|Pregnancy|0|||
33138118|NCT00095147|100420129|FG004|Long-term Extension Period|Pregnancy|1|||
33138119|NCT00095147|100420125|FG000|Long-term Extension Period|No longer meets study criteria|0|||
33138120|NCT00095147|100420126|FG001|Long-term Extension Period|No longer meets study criteria|0|||
33138121|NCT00095147|100420127|FG002|Long-term Extension Period|No longer meets study criteria|0|||
33138122|NCT00095147|100420128|FG003|Long-term Extension Period|No longer meets study criteria|0|||
33138123|NCT00095147|100420129|FG004|Long-term Extension Period|No longer meets study criteria|1|||
33138124|NCT00095147|100420125|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
33138125|NCT00095147|100420126|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
33138126|NCT00095147|100420127|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
33138127|NCT00095147|100420128|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
33138128|NCT00095147|100420129|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
33138129|NCT00095147|100420125|FG000|Long-term Extension Period|Leaving country|0|||
33575860|NCT00532844|101999915|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
33575861|NCT00532844|101999914|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
33575862|NCT00532844|101999915|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
33575863|NCT03692403|101999916|FG000|Overall Study|Withdrawal by Subject|1|||
33575864|NCT03692403|101999917|FG001|Overall Study|Withdrawal by Subject|0|||
33575865|NCT03692403|101999918|FG002|Overall Study|Withdrawal by Subject|1|||
33636804|NCT04476797|102222954|FG000|Overall Study|Death|0|||
33636805|NCT04476797|102222955|FG001|Overall Study|Death|1|||
33636806|NCT04476797|102222956|FG002|Overall Study|Death|2|||
33636807|NCT04476797|102222954|FG000|Overall Study|Sponsor Terminated Study|0|||
33636808|NCT04476797|102222955|FG001|Overall Study|Sponsor Terminated Study|18|||
33368728|NCT03485729|101234915|FG000|Overall Study|Hospice care|1|||
33575866|NCT03692403|101999919|FG003|Overall Study|Withdrawal by Subject|0|||
33575867|NCT03692403|101999916|FG000|Overall Study|Adverse Event|0|||
33575868|NCT03692403|101999917|FG001|Overall Study|Adverse Event|0|||
33575869|NCT03692403|101999918|FG002|Overall Study|Adverse Event|0|||
33575870|NCT03692403|101999919|FG003|Overall Study|Adverse Event|1|||
33575871|NCT03692403|101999916|FG000|Overall Study|Pregnancy|0|||
33575872|NCT03692403|101999917|FG001|Overall Study|Pregnancy|1|||
33575873|NCT03692403|101999918|FG002|Overall Study|Pregnancy|0|||
33575874|NCT03692403|101999919|FG003|Overall Study|Pregnancy|0|||
33575875|NCT03692403|101999916|FG000|Overall Study|Other|0|||
33575876|NCT03692403|101999917|FG001|Overall Study|Other|0|||
33575877|NCT03692403|101999918|FG002|Overall Study|Other|1|||
33575878|NCT03692403|101999919|FG003|Overall Study|Other|0|||
33575879|NCT00186628|101999921|FG000|Overall Study|Death|2|||
33575880|NCT00186628|101999921|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
33575881|NCT03965403|101999925|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
33575882|NCT01576783|101999927|FG000|Overall Study|Change in Medical Care|1|||
33575883|NCT01576783|101999928|FG001|Overall Study|Change in Medical Care|0|||
33575884|NCT01576783|101999927|FG000|Overall Study|Lost to Follow-up|14|||
33575885|NCT01576783|101999928|FG001|Overall Study|Lost to Follow-up|16|||
33575886|NCT01576783|101999927|FG000|Overall Study|Withdrawal by Subject|5|||
33575887|NCT01576783|101999928|FG001|Overall Study|Withdrawal by Subject|1|||
33575888|NCT01500317|101999929|FG000|Overall Study|Withdrawal by Subject|3|||
33575889|NCT01500317|101999930|FG001|Overall Study|Withdrawal by Subject|2|||
33575890|NCT01500317|101999931|FG002|Overall Study|Withdrawal by Subject|0|||
33575891|NCT01802788|101999932|FG000|Overall Study|Withdrawal by Subject|102|||
33575892|NCT01802788|101999933|FG001|Overall Study|Withdrawal by Subject|5|||
33575893|NCT01802788|101999932|FG000|Overall Study|Death|382|||
33575894|NCT01802788|101999933|FG001|Overall Study|Death|18|||
33575895|NCT01802788|101999932|FG000|Overall Study|Lost to Follow-up|31|||
33575896|NCT01802788|101999933|FG001|Overall Study|Lost to Follow-up|2|||
33575897|NCT01802788|101999932|FG000|Overall Study|Physician Decision|3|||
33575898|NCT01802788|101999933|FG001|Overall Study|Physician Decision|0|||
33575899|NCT01802788|101999932|FG000|Overall Study|Patient Non-Compliance|1|||
33575900|NCT01802788|101999933|FG001|Overall Study|Patient Non-Compliance|0|||
33575901|NCT01802788|101999932|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
33575902|NCT01802788|101999933|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
33575903|NCT01802788|101999932|FG000|Overall Study|Other Reasons|19|||
33575904|NCT01802788|101999933|FG001|Overall Study|Other Reasons|0|||
33575905|NCT01282866|101999936|FG000|Overall Study|Adverse Event|1|||
33575906|NCT03382912|101999937|FG000|Overall Study|Physician Decision|0|||
33636809|NCT04476797|102222956|FG002|Overall Study|Sponsor Terminated Study|17|||
33636810|NCT01286480|102222957|FG000|Overall Study|Withdrawal by Subject|5|||
33636811|NCT01286480|102222958|FG001|Overall Study|Withdrawal by Subject|3|||
33636812|NCT00918255|102222960|FG000|Overall Study|Adverse Event|1|||
33636813|NCT00918255|102222961|FG001|Overall Study|Adverse Event|0|||
33636814|NCT00918255|102222962|FG002|Overall Study|Adverse Event|0|||
33636815|NCT00918255|102222960|FG000|Overall Study|Withdrawal by Subject|1|||
33636816|NCT00918255|102222961|FG001|Overall Study|Withdrawal by Subject|0|||
33636817|NCT00918255|102222962|FG002|Overall Study|Withdrawal by Subject|2|||
33636818|NCT00918255|102222960|FG000|Overall Study|Lack of Efficacy|1|||
33636819|NCT00918255|102222961|FG001|Overall Study|Lack of Efficacy|0|||
33636820|NCT00918255|102222962|FG002|Overall Study|Lack of Efficacy|0|||
33636821|NCT00918255|102222960|FG000|Overall Study|Lost to Follow-up|1|||
33636822|NCT00918255|102222961|FG001|Overall Study|Lost to Follow-up|0|||
33636823|NCT00918255|102222962|FG002|Overall Study|Lost to Follow-up|2|||
33636824|NCT00918255|102222960|FG000|Overall Study|Exceeded allowed number of interventions|0|||
33636825|NCT00918255|102222961|FG001|Overall Study|Exceeded allowed number of interventions|0|||
33636826|NCT00918255|102222962|FG002|Overall Study|Exceeded allowed number of interventions|1|||
33636827|NCT00918255|102222960|FG000|Overall Study|Non-compliance|1|||
33636828|NCT00918255|102222961|FG001|Overall Study|Non-compliance|0|||
33368729|NCT03485729|101234916|FG001|Overall Study|Hospice care|0|||
33575907|NCT03382912|101999938|FG001|Overall Study|Physician Decision|1|||
33575908|NCT03382912|101999937|FG000|Overall Study|Sponsor Decision|6|||
33575909|NCT03382912|101999938|FG001|Overall Study|Sponsor Decision|6|||
33575910|NCT03382912|101999937|FG000|Overall Study|Withdrawal by Subject|0|||
33575911|NCT03382912|101999938|FG001|Overall Study|Withdrawal by Subject|5|||
33575912|NCT02300233|101999939|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
33575913|NCT02300233|101999940|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
33575914|NCT02300233|101999941|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
33575915|NCT02300233|101999939|FG000|Overall Study|Withdrawal by Subject|1|||
33636829|NCT00918255|102222962|FG002|Overall Study|Non-compliance|0|||
33636830|NCT00918255|102222960|FG000|Overall Study|Investigator discretion|1|||
33234249|NCT00972179|100759966|FG002|Overall Study|Noncompliance|0|||
33636831|NCT00918255|102222961|FG001|Overall Study|Investigator discretion|0|||
33636832|NCT00918255|102222962|FG002|Overall Study|Investigator discretion|0|||
33368730|NCT03485729|101234917|FG002|Overall Study|Hospice care|0|||
33234250|NCT00972179|100759967|FG003|Overall Study|Noncompliance|0|||
33234251|NCT00972179|100759968|FG004|Overall Study|Noncompliance|1|||
33234252|NCT00972179|100759969|FG005|Overall Study|Noncompliance|0|||
33234253|NCT00972179|100759970|FG006|Overall Study|Noncompliance|1|||
33368731|NCT03485729|101234915|FG000|Overall Study|Poor performance status|1|||
33368732|NCT03485729|101234916|FG001|Overall Study|Poor performance status|0|||
33368733|NCT03485729|101234917|FG002|Overall Study|Poor performance status|0|||
33368734|NCT03485729|101234915|FG000|Overall Study|Illness|0|||
33368735|NCT03485729|101234916|FG001|Overall Study|Illness|1|||
33368736|NCT03485729|101234917|FG002|Overall Study|Illness|0|||
33368737|NCT03603600|101234918|FG000|Overall Study|Withdrawal by Subject|5|||
33368738|NCT03603600|101234919|FG001|Overall Study|Withdrawal by Subject|7|||
33575916|NCT02300233|101999940|FG001|Overall Study|Withdrawal by Subject|0|||
33575917|NCT02300233|101999941|FG002|Overall Study|Withdrawal by Subject|3|||
33575918|NCT02300233|101999939|FG000|Overall Study|Investigator Judgement|0|||
33575919|NCT02300233|101999940|FG001|Overall Study|Investigator Judgement|0|||
33575920|NCT02300233|101999941|FG002|Overall Study|Investigator Judgement|1|||
33575921|NCT02300233|101999939|FG000|Overall Study|Reason Not Specified|0|||
33575922|NCT02300233|101999940|FG001|Overall Study|Reason Not Specified|0|||
33575923|NCT02300233|101999941|FG002|Overall Study|Reason Not Specified|5|||
33575924|NCT02756403|101999942|FG000|Overall Study|Unable to swallow medication|0|||
33575925|NCT02756403|101999943|FG001|Overall Study|Unable to swallow medication|1|||
33575926|NCT02756403|101999944|FG002|Overall Study|Unable to swallow medication|1|||
33575927|NCT02756403|101999945|FG003|Overall Study|Unable to swallow medication|1|||
33575928|NCT02756403|101999942|FG000|Overall Study|Did not complete Procedure|0|||
33575929|NCT02756403|101999943|FG001|Overall Study|Did not complete Procedure|1|||
33575930|NCT02756403|101999944|FG002|Overall Study|Did not complete Procedure|0|||
33575931|NCT02756403|101999945|FG003|Overall Study|Did not complete Procedure|0|||
33575932|NCT02756403|101999942|FG000|Overall Study|Changed Mind About Procedure|0|||
33575933|NCT02756403|101999943|FG001|Overall Study|Changed Mind About Procedure|0|||
33575934|NCT02756403|101999944|FG002|Overall Study|Changed Mind About Procedure|1|||
33575935|NCT02756403|101999945|FG003|Overall Study|Changed Mind About Procedure|0|||
33575936|NCT02756403|101999942|FG000|Overall Study|Protocol Violation|0|||
33575937|NCT02756403|101999943|FG001|Overall Study|Protocol Violation|1|||
33575938|NCT02756403|101999944|FG002|Overall Study|Protocol Violation|0|||
33575939|NCT02756403|101999945|FG003|Overall Study|Protocol Violation|1|||
33575940|NCT01900665|101999946|FG000|Placebo Controlled Period|Death|9|||
33636833|NCT00716417|102222963|FG000|Overall Study|Adverse Event|0|||
33636834|NCT00716417|102222964|FG001|Overall Study|Adverse Event|0|||
33636835|NCT00716417|102222965|FG002|Overall Study|Adverse Event|2|||
33636836|NCT00716417|102222966|FG003|Overall Study|Adverse Event|1|||
33636837|NCT00716417|102222967|FG004|Overall Study|Adverse Event|0|||
33636838|NCT00716417|102222968|FG005|Overall Study|Adverse Event|0|||
33636839|NCT00716417|102222969|FG006|Overall Study|Adverse Event|3|||
33636840|NCT00716417|102222970|FG007|Overall Study|Adverse Event|1|||
33636841|NCT00716417|102222971|FG008|Overall Study|Adverse Event|0|||
33636842|NCT00716417|102222972|FG009|Overall Study|Adverse Event|3|||
33636843|NCT00716417|102222963|FG000|Overall Study|Withdrawal by Subject|0|||
33636844|NCT00716417|102222964|FG001|Overall Study|Withdrawal by Subject|1|||
33636845|NCT00716417|102222965|FG002|Overall Study|Withdrawal by Subject|0|||
33636846|NCT00716417|102222966|FG003|Overall Study|Withdrawal by Subject|2|||
33636847|NCT00716417|102222967|FG004|Overall Study|Withdrawal by Subject|0|||
33636848|NCT00716417|102222968|FG005|Overall Study|Withdrawal by Subject|0|||
33368739|NCT03603600|101234918|FG000|Overall Study|Lost to Follow-up|2|||
33368740|NCT03603600|101234919|FG001|Overall Study|Lost to Follow-up|3|||
33368741|NCT03603600|101234918|FG000|Overall Study|Death|3|||
33575941|NCT01900665|101999947|FG001|Placebo Controlled Period|Death|16|||
33575942|NCT01900665|101999946|FG000|Placebo Controlled Period|Adverse Event|48|||
33575943|NCT01900665|101999947|FG001|Placebo Controlled Period|Adverse Event|39|||
33575944|NCT01900665|101999946|FG000|Placebo Controlled Period|Protocol Violation|1|||
33636849|NCT00716417|102222969|FG006|Overall Study|Withdrawal by Subject|1|||
33636850|NCT00716417|102222970|FG007|Overall Study|Withdrawal by Subject|0|||
33138130|NCT00095147|100420126|FG001|Long-term Extension Period|Leaving country|0|||
33138131|NCT00095147|100420127|FG002|Long-term Extension Period|Leaving country|0|||
33138132|NCT00095147|100420128|FG003|Long-term Extension Period|Leaving country|0|||
33138133|NCT00095147|100420129|FG004|Long-term Extension Period|Leaving country|1|||
33138134|NCT00510653|100420134|FG000|Overall Study|Withdrawal by Subject|8|||
33138135|NCT00510653|100420134|FG000|Overall Study|Monetary|3|||
33138136|NCT01075191|100420135|FG000|Overall Study|Death|1|||
33234254|NCT00972179|100759964|FG000|Overall Study|Withdrawal by Subject|0|||
33234255|NCT00972179|100759965|FG001|Overall Study|Withdrawal by Subject|3|||
33368742|NCT03603600|101234919|FG001|Overall Study|Death|1|||
33368743|NCT03603600|101234918|FG000|Overall Study|Physician Decision|2|||
33368744|NCT03603600|101234919|FG001|Overall Study|Physician Decision|1|||
33368745|NCT03603600|101234918|FG000|Overall Study|Other reason|1|||
33575945|NCT01900665|101999947|FG001|Placebo Controlled Period|Protocol Violation|7|||
33575946|NCT01900665|101999946|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
33234256|NCT00972179|100759966|FG002|Overall Study|Withdrawal by Subject|0|||
33234257|NCT00972179|100759967|FG003|Overall Study|Withdrawal by Subject|1|||
33234258|NCT00972179|100759968|FG004|Overall Study|Withdrawal by Subject|0|||
33234259|NCT00972179|100759969|FG005|Overall Study|Withdrawal by Subject|0|||
33234260|NCT00972179|100759970|FG006|Overall Study|Withdrawal by Subject|2|||
33234261|NCT00972179|100759964|FG000|Overall Study|Administrative Decision|0|||
33234262|NCT00972179|100759965|FG001|Overall Study|Administrative Decision|0|||
33234263|NCT00972179|100759966|FG002|Overall Study|Administrative Decision|0|||
33234264|NCT00972179|100759967|FG003|Overall Study|Administrative Decision|0|||
33234265|NCT00972179|100759968|FG004|Overall Study|Administrative Decision|1|||
33234266|NCT00972179|100759969|FG005|Overall Study|Administrative Decision|0|||
33234267|NCT00972179|100759970|FG006|Overall Study|Administrative Decision|0|||
33234268|NCT00972179|100759964|FG000|Overall Study|Lost to Follow-up|0|||
33234269|NCT00972179|100759965|FG001|Overall Study|Lost to Follow-up|0|||
33234270|NCT00972179|100759966|FG002|Overall Study|Lost to Follow-up|1|||
33234271|NCT00972179|100759967|FG003|Overall Study|Lost to Follow-up|0|||
33234272|NCT00972179|100759968|FG004|Overall Study|Lost to Follow-up|0|||
33234273|NCT00972179|100759969|FG005|Overall Study|Lost to Follow-up|3|||
33234274|NCT00972179|100759970|FG006|Overall Study|Lost to Follow-up|1|||
33234275|NCT03537261|100759971|FG000|Overall Study|Lost to Follow-up|4|||
33234276|NCT03537261|100759972|FG001|Overall Study|Lost to Follow-up|5|||
33234277|NCT03537261|100759971|FG000|Overall Study|Withdrawal by Subject|4|||
33234278|NCT03537261|100759972|FG001|Overall Study|Withdrawal by Subject|6|||
33234279|NCT03537261|100759971|FG000|Overall Study|Did not return study questionnaires|0|||
33234280|NCT03537261|100759972|FG001|Overall Study|Did not return study questionnaires|1|||
33234281|NCT03918239|100759974|FG000|Overall Study|Lost to Follow-up|3|||
33234282|NCT03918239|100759975|FG001|Overall Study|Lost to Follow-up|1|||
33234283|NCT03918239|100759974|FG000|Overall Study|Pregnancy|0|||
33234284|NCT03918239|100759975|FG001|Overall Study|Pregnancy|2|||
33234285|NCT03918239|100759974|FG000|Overall Study|Withdrawal by Subject|3|||
33234286|NCT03918239|100759975|FG001|Overall Study|Withdrawal by Subject|3|||
33234287|NCT03918239|100759974|FG000|Overall Study|positive urine drug screening results|4|||
33234288|NCT03918239|100759975|FG001|Overall Study|positive urine drug screening results|1|||
33234289|NCT00478608|100759978|FG000|Overall Study|Adverse Event|1|||
33234290|NCT00478608|100759978|FG000|Overall Study|Serious Adverse Event|14|||
33234291|NCT00478608|100759978|FG000|Overall Study|Withdrawal by Subject|2|||
33234292|NCT00478608|100759978|FG000|Overall Study|Protocol Violation|3|||
33234293|NCT04267614|100759980|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
33234294|NCT04267614|100759980|FG000|Overall Study|Lost to Follow-up|115|||
33234295|NCT00437125|100759981|FG000|Overall Study|Adverse Event|12|||
33234296|NCT00437125|100759981|FG000|Overall Study|Death|1|||
33234297|NCT00437125|100759981|FG000|Overall Study|Clinical Relapse|1|||
33234298|NCT00437125|100759981|FG000|Overall Study|Lack of Efficacy|1|||
33234299|NCT00437125|100759981|FG000|Overall Study|Lost to Follow-up|1|||
33234300|NCT00437125|100759981|FG000|Overall Study|Withdrawal by Subject|13|||
33368746|NCT03603600|101234919|FG001|Overall Study|Other reason|0|||
33575947|NCT01900665|101999947|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
33575948|NCT01900665|101999946|FG000|Placebo Controlled Period|Physician Decision|11|||
33575949|NCT01900665|101999947|FG001|Placebo Controlled Period|Physician Decision|7|||
33575950|NCT01900665|101999946|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
33575951|NCT01900665|101999947|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
33575952|NCT01900665|101999946|FG000|Placebo Controlled Period|Caregiver Decision|33|||
33575953|NCT01900665|101999947|FG001|Placebo Controlled Period|Caregiver Decision|41|||
33575954|NCT01900665|101999946|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
33575955|NCT01900665|101999947|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
33575956|NCT01900665|101999946|FG000|Open Label Period|Adverse Event|16|||
33575957|NCT01900665|101999947|FG001|Open Label Period|Adverse Event|20|||
33575958|NCT01900665|101999946|FG000|Open Label Period|Death|5|||
33575959|NCT01900665|101999947|FG001|Open Label Period|Death|6|||
33575960|NCT01900665|101999946|FG000|Open Label Period|Lost to Follow-up|1|||
33575961|NCT01900665|101999947|FG001|Open Label Period|Lost to Follow-up|1|||
33575962|NCT01900665|101999946|FG000|Open Label Period|Parent/Caregiver Decision|33|||
33636851|NCT00716417|102222971|FG008|Overall Study|Withdrawal by Subject|0|||
33368747|NCT05603143|101234920|FG000|Overall Study|Withdrew consent|6|||
33636852|NCT00716417|102222972|FG009|Overall Study|Withdrawal by Subject|0|||
33234301|NCT00437125|100759981|FG000|Overall Study|Withdrawal by Caregiver|2|||
33234302|NCT00437125|100759981|FG000|Overall Study|Physician Decision|1|||
33234303|NCT02291289|100759982|FG000|Induction Treatment|Withdrawal by Subject|0|||
33234304|NCT02291289|100759983|FG001|Induction Treatment|Withdrawal by Subject|0|||
33234305|NCT02291289|100759984|FG002|Induction Treatment|Withdrawal by Subject|0|||
33234306|NCT02291289|100759985|FG003|Induction Treatment|Withdrawal by Subject|24|||
33420354|NCT00995930|101428600|FG001|Overall Study|Protocol deviation|5|||
33234307|NCT02291289|100759986|FG004|Induction Treatment|Withdrawal by Subject|0|||
33234308|NCT02291289|100759987|FG005|Induction Treatment|Withdrawal by Subject|0|||
33420355|NCT00995930|101428599|FG000|Overall Study|Death|0|||
33575963|NCT01900665|101999947|FG001|Open Label Period|Parent/Caregiver Decision|34|||
33234309|NCT02291289|100759988|FG006|Induction Treatment|Withdrawal by Subject|0|||
33234310|NCT02291289|100759989|FG007|Induction Treatment|Withdrawal by Subject|0|||
33234311|NCT02291289|100759990|FG008|Induction Treatment|Withdrawal by Subject|0|||
33234312|NCT02291289|100759991|FG009|Induction Treatment|Withdrawal by Subject|18|||
33234313|NCT02291289|100759992|FG010|Induction Treatment|Withdrawal by Subject|0|||
33234314|NCT02291289|100759993|FG011|Induction Treatment|Withdrawal by Subject|0|||
33234315|NCT02291289|100759994|FG012|Induction Treatment|Withdrawal by Subject|0|||
33234316|NCT02291289|100759982|FG000|Induction Treatment|Adverse Event|0|||
33234317|NCT02291289|100759983|FG001|Induction Treatment|Adverse Event|0|||
33234318|NCT02291289|100759984|FG002|Induction Treatment|Adverse Event|0|||
33234319|NCT02291289|100759985|FG003|Induction Treatment|Adverse Event|3|||
33234320|NCT02291289|100759986|FG004|Induction Treatment|Adverse Event|0|||
33234321|NCT02291289|100759987|FG005|Induction Treatment|Adverse Event|0|||
33234322|NCT02291289|100759988|FG006|Induction Treatment|Adverse Event|0|||
33234323|NCT02291289|100759989|FG007|Induction Treatment|Adverse Event|0|||
33234324|NCT02291289|100759990|FG008|Induction Treatment|Adverse Event|0|||
33234325|NCT02291289|100759991|FG009|Induction Treatment|Adverse Event|1|||
33234326|NCT02291289|100759992|FG010|Induction Treatment|Adverse Event|0|||
33234327|NCT02291289|100759993|FG011|Induction Treatment|Adverse Event|0|||
33234328|NCT02291289|100759994|FG012|Induction Treatment|Adverse Event|0|||
33234329|NCT02291289|100759982|FG000|Induction Treatment|Death|25|||
33234330|NCT02291289|100759983|FG001|Induction Treatment|Death|0|||
33234331|NCT02291289|100759984|FG002|Induction Treatment|Death|0|||
33234332|NCT02291289|100759985|FG003|Induction Treatment|Death|111|||
33234333|NCT02291289|100759986|FG004|Induction Treatment|Death|0|||
33234334|NCT02291289|100759987|FG005|Induction Treatment|Death|0|||
33234335|NCT02291289|100759988|FG006|Induction Treatment|Death|1|||
33234336|NCT02291289|100759989|FG007|Induction Treatment|Death|0|||
33234337|NCT02291289|100759990|FG008|Induction Treatment|Death|0|||
33234338|NCT02291289|100759991|FG009|Induction Treatment|Death|82|||
33234339|NCT02291289|100759992|FG010|Induction Treatment|Death|0|||
33234340|NCT02291289|100759993|FG011|Induction Treatment|Death|0|||
33234341|NCT02291289|100759994|FG012|Induction Treatment|Death|0|||
33234342|NCT02291289|100759982|FG000|Induction Treatment|Lost to Follow-up|1|||
33234343|NCT02291289|100759983|FG001|Induction Treatment|Lost to Follow-up|0|||
33234344|NCT02291289|100759984|FG002|Induction Treatment|Lost to Follow-up|0|||
33234345|NCT02291289|100759985|FG003|Induction Treatment|Lost to Follow-up|12|||
33234346|NCT02291289|100759986|FG004|Induction Treatment|Lost to Follow-up|0|||
33234347|NCT02291289|100759987|FG005|Induction Treatment|Lost to Follow-up|0|||
33234348|NCT02291289|100759988|FG006|Induction Treatment|Lost to Follow-up|0|||
33234349|NCT02291289|100759989|FG007|Induction Treatment|Lost to Follow-up|0|||
33234350|NCT02291289|100759990|FG008|Induction Treatment|Lost to Follow-up|0|||
33234351|NCT02291289|100759991|FG009|Induction Treatment|Lost to Follow-up|9|||
33234352|NCT02291289|100759992|FG010|Induction Treatment|Lost to Follow-up|0|||
33234353|NCT02291289|100759993|FG011|Induction Treatment|Lost to Follow-up|0|||
33234354|NCT02291289|100759994|FG012|Induction Treatment|Lost to Follow-up|0|||
33234355|NCT02291289|100759982|FG000|Induction Treatment|Non-Compliance|0|||
33234356|NCT02291289|100759983|FG001|Induction Treatment|Non-Compliance|0|||
33234357|NCT02291289|100759984|FG002|Induction Treatment|Non-Compliance|0|||
33234358|NCT02291289|100759985|FG003|Induction Treatment|Non-Compliance|1|||
33234359|NCT02291289|100759986|FG004|Induction Treatment|Non-Compliance|0|||
33234360|NCT02291289|100759987|FG005|Induction Treatment|Non-Compliance|0|||
33234361|NCT02291289|100759988|FG006|Induction Treatment|Non-Compliance|0|||
33234362|NCT02291289|100759989|FG007|Induction Treatment|Non-Compliance|0|||
33234363|NCT02291289|100759990|FG008|Induction Treatment|Non-Compliance|0|||
33234364|NCT02291289|100759991|FG009|Induction Treatment|Non-Compliance|1|||
33234365|NCT02291289|100759992|FG010|Induction Treatment|Non-Compliance|0|||
33234366|NCT02291289|100759993|FG011|Induction Treatment|Non-Compliance|0|||
33234367|NCT02291289|100759994|FG012|Induction Treatment|Non-Compliance|0|||
33234368|NCT02291289|100759982|FG000|Induction Treatment|Reason Not Specified|0|||
33234369|NCT02291289|100759983|FG001|Induction Treatment|Reason Not Specified|0|||
33234370|NCT02291289|100759984|FG002|Induction Treatment|Reason Not Specified|0|||
33368748|NCT05603143|101234921|FG001|Overall Study|Withdrew consent|2|||
33636853|NCT00716417|102222963|FG000|Overall Study|Progressive disease|3|||
33636854|NCT00716417|102222964|FG001|Overall Study|Progressive disease|5|||
33234371|NCT02291289|100759985|FG003|Induction Treatment|Reason Not Specified|4|||
33234372|NCT02291289|100759986|FG004|Induction Treatment|Reason Not Specified|0|||
33234373|NCT02291289|100759987|FG005|Induction Treatment|Reason Not Specified|0|||
33234374|NCT02291289|100759988|FG006|Induction Treatment|Reason Not Specified|0|||
33368749|NCT05603143|101234920|FG000|Overall Study|Randomized but never treated|0|||
33636855|NCT00716417|102222965|FG002|Overall Study|Progressive disease|3|||
33636856|NCT00716417|102222966|FG003|Overall Study|Progressive disease|8|||
33234375|NCT02291289|100759989|FG007|Induction Treatment|Reason Not Specified|0|||
33234376|NCT02291289|100759990|FG008|Induction Treatment|Reason Not Specified|0|||
33234377|NCT02291289|100759991|FG009|Induction Treatment|Reason Not Specified|7|||
33234378|NCT02291289|100759992|FG010|Induction Treatment|Reason Not Specified|0|||
33234379|NCT02291289|100759993|FG011|Induction Treatment|Reason Not Specified|0|||
33234380|NCT02291289|100759994|FG012|Induction Treatment|Reason Not Specified|0|||
33234381|NCT02291289|100759982|FG000|Induction Treatment|Physician Decision|0|||
33234382|NCT02291289|100759983|FG001|Induction Treatment|Physician Decision|0|||
33234383|NCT02291289|100759984|FG002|Induction Treatment|Physician Decision|0|||
33234384|NCT02291289|100759985|FG003|Induction Treatment|Physician Decision|3|||
33234385|NCT02291289|100759986|FG004|Induction Treatment|Physician Decision|0|||
33368750|NCT05603143|101234921|FG001|Overall Study|Randomized but never treated|3|||
33368751|NCT05603143|101234920|FG000|Overall Study|Adverse Event|2|||
33368752|NCT05603143|101234921|FG001|Overall Study|Adverse Event|0|||
33368753|NCT05603143|101234920|FG000|Overall Study|Death|0|||
33368754|NCT05603143|101234921|FG001|Overall Study|Death|1|||
33368755|NCT05603143|101234920|FG000|Overall Study|Investigator's discretion|1|||
33368756|NCT05603143|101234921|FG001|Overall Study|Investigator's discretion|0|||
33368757|NCT05603143|101234920|FG000|Overall Study|Lost to Follow-up|0|||
33368758|NCT05603143|101234921|FG001|Overall Study|Lost to Follow-up|1|||
33368759|NCT05603143|101234920|FG000|Overall Study|Protocol Violation|0|||
33368760|NCT05603143|101234921|FG001|Overall Study|Protocol Violation|1|||
33368761|NCT04410042|101234925|FG000|Overall Study|Not Eligible|1|||
33368762|NCT04410042|101234926|FG001|Overall Study|Not Eligible|1|||
33368763|NCT03582033|101234929|FG000|Part A|Other|0|||
33368764|NCT03582033|101234930|FG001|Part A|Other|0|||
33368765|NCT03582033|101234931|FG002|Part A|Other|0|||
33368766|NCT03582033|101234932|FG003|Part A|Other|0|||
33368767|NCT03582033|101234933|FG004|Part A|Other|2|||
33368768|NCT03582033|101234934|FG005|Part A|Other|0|||
33368769|NCT03582033|101234935|FG006|Part A|Other|0|||
33368770|NCT03582033|101234936|FG007|Part A|Other|0|||
33368771|NCT03582033|101234937|FG008|Part A|Other|0|||
33368772|NCT03582033|101234938|FG009|Part A|Other|0|||
33368773|NCT03582033|101234929|FG000|Part A|Death|1|||
33368774|NCT03582033|101234930|FG001|Part A|Death|1|||
33368775|NCT03582033|101234931|FG002|Part A|Death|2|||
33368776|NCT03582033|101234932|FG003|Part A|Death|4|||
33368777|NCT03582033|101234933|FG004|Part A|Death|11|||
33368778|NCT03582033|101234934|FG005|Part A|Death|0|||
33368779|NCT03582033|101234935|FG006|Part A|Death|0|||
33368780|NCT03582033|101234936|FG007|Part A|Death|0|||
33368781|NCT03582033|101234937|FG008|Part A|Death|0|||
33368782|NCT03582033|101234938|FG009|Part A|Death|0|||
33368783|NCT03582033|101234929|FG000|Part A|Lost to Follow-up|0|||
33368784|NCT03582033|101234930|FG001|Part A|Lost to Follow-up|0|||
33368785|NCT03582033|101234931|FG002|Part A|Lost to Follow-up|0|||
33575964|NCT01900665|101999946|FG000|Open Label Period|Physician Decision|4|||
33575965|NCT01900665|101999947|FG001|Open Label Period|Physician Decision|4|||
33575966|NCT01900665|101999946|FG000|Open Label Period|Protocol Violation|0|||
33575967|NCT01900665|101999947|FG001|Open Label Period|Protocol Violation|1|||
33575968|NCT01900665|101999946|FG000|Open Label Period|Sponsor Decision|802|||
33575969|NCT01900665|101999947|FG001|Open Label Period|Sponsor Decision|765|||
33575970|NCT01900665|101999946|FG000|Open Label Period|Withdrawal by Subject|20|||
33368786|NCT03582033|101234932|FG003|Part A|Lost to Follow-up|0|||
33368787|NCT03582033|101234933|FG004|Part A|Lost to Follow-up|1|||
33368788|NCT03582033|101234934|FG005|Part A|Lost to Follow-up|0|||
33368789|NCT03582033|101234935|FG006|Part A|Lost to Follow-up|0|||
33368790|NCT03582033|101234936|FG007|Part A|Lost to Follow-up|0|||
33575971|NCT01900665|101999947|FG001|Open Label Period|Withdrawal by Subject|28|||
33575972|NCT00370292|101999949|FG000|Overall Study|Disease Progression|4|||
33575973|NCT00370292|101999949|FG000|Overall Study|Adverse Event|7|||
33575974|NCT00370292|101999949|FG000|Overall Study|Physician Decision|2|||
33575975|NCT03358030|101999953|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
33575976|NCT03358030|101999954|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
33368791|NCT03582033|101234937|FG008|Part A|Lost to Follow-up|0|||
33368792|NCT03582033|101234938|FG009|Part A|Lost to Follow-up|0|||
33368793|NCT03582033|101234929|FG000|Part A|Study terminated by sponsor|0|||
33368794|NCT03582033|101234930|FG001|Part A|Study terminated by sponsor|0|||
33368795|NCT03582033|101234931|FG002|Part A|Study terminated by sponsor|0|||
33368796|NCT03582033|101234932|FG003|Part A|Study terminated by sponsor|2|||
33368797|NCT03582033|101234933|FG004|Part A|Study terminated by sponsor|1|||
33368798|NCT03582033|101234934|FG005|Part A|Study terminated by sponsor|0|||
33575977|NCT03358030|101999955|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
33368799|NCT03582033|101234935|FG006|Part A|Study terminated by sponsor|0|||
33368800|NCT03582033|101234936|FG007|Part A|Study terminated by sponsor|0|||
33368801|NCT03582033|101234937|FG008|Part A|Study terminated by sponsor|0|||
33368802|NCT03582033|101234938|FG009|Part A|Study terminated by sponsor|0|||
33368803|NCT03582033|101234929|FG000|Part A|Withdrawal by Subject|1|||
33368804|NCT03582033|101234930|FG001|Part A|Withdrawal by Subject|1|||
33368805|NCT03582033|101234931|FG002|Part A|Withdrawal by Subject|0|||
33368806|NCT03582033|101234932|FG003|Part A|Withdrawal by Subject|1|||
33368807|NCT03582033|101234933|FG004|Part A|Withdrawal by Subject|7|||
33368808|NCT03582033|101234934|FG005|Part A|Withdrawal by Subject|0|||
33368809|NCT03582033|101234935|FG006|Part A|Withdrawal by Subject|0|||
33368810|NCT03582033|101234936|FG007|Part A|Withdrawal by Subject|0|||
33575978|NCT03358030|101999956|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
33575979|NCT03358030|101999953|FG000|Overall Study|Ineligibility|0|||
33575980|NCT03358030|101999954|FG001|Overall Study|Ineligibility|0|||
33575981|NCT03358030|101999955|FG002|Overall Study|Ineligibility|0|||
33234386|NCT02291289|100759987|FG005|Induction Treatment|Physician Decision|0|||
33234387|NCT02291289|100759988|FG006|Induction Treatment|Physician Decision|0|||
33234388|NCT02291289|100759989|FG007|Induction Treatment|Physician Decision|0|||
33234389|NCT02291289|100759990|FG008|Induction Treatment|Physician Decision|0|||
33234390|NCT02291289|100759991|FG009|Induction Treatment|Physician Decision|1|||
33234391|NCT02291289|100759992|FG010|Induction Treatment|Physician Decision|0|||
33234392|NCT02291289|100759993|FG011|Induction Treatment|Physician Decision|0|||
33234393|NCT02291289|100759994|FG012|Induction Treatment|Physician Decision|0|||
33234394|NCT02291289|100759982|FG000|Induction Treatment|Protocol Violation|0|||
33234395|NCT02291289|100759983|FG001|Induction Treatment|Protocol Violation|0|||
33234396|NCT02291289|100759984|FG002|Induction Treatment|Protocol Violation|0|||
33234397|NCT02291289|100759985|FG003|Induction Treatment|Protocol Violation|3|||
33234398|NCT02291289|100759986|FG004|Induction Treatment|Protocol Violation|0|||
33234399|NCT02291289|100759987|FG005|Induction Treatment|Protocol Violation|0|||
33234400|NCT02291289|100759988|FG006|Induction Treatment|Protocol Violation|0|||
33234401|NCT02291289|100759989|FG007|Induction Treatment|Protocol Violation|0|||
33234402|NCT02291289|100759990|FG008|Induction Treatment|Protocol Violation|0|||
33234403|NCT02291289|100759991|FG009|Induction Treatment|Protocol Violation|2|||
33234404|NCT02291289|100759992|FG010|Induction Treatment|Protocol Violation|0|||
33234405|NCT02291289|100759993|FG011|Induction Treatment|Protocol Violation|0|||
33234406|NCT02291289|100759994|FG012|Induction Treatment|Protocol Violation|0|||
33234407|NCT02291289|100759982|FG000|Induction Treatment|Missing|4|||
33234408|NCT02291289|100759983|FG001|Induction Treatment|Missing|0|||
33234409|NCT02291289|100759984|FG002|Induction Treatment|Missing|0|||
33234410|NCT02291289|100759985|FG003|Induction Treatment|Missing|14|||
33234411|NCT02291289|100759986|FG004|Induction Treatment|Missing|0|||
33234412|NCT02291289|100759987|FG005|Induction Treatment|Missing|0|||
33234413|NCT02291289|100759988|FG006|Induction Treatment|Missing|0|||
33234414|NCT02291289|100759989|FG007|Induction Treatment|Missing|0|||
33234415|NCT02291289|100759990|FG008|Induction Treatment|Missing|0|||
33234416|NCT02291289|100759991|FG009|Induction Treatment|Missing|54|||
33234417|NCT02291289|100759992|FG010|Induction Treatment|Missing|0|||
33234418|NCT02291289|100759993|FG011|Induction Treatment|Missing|0|||
33234419|NCT02291289|100759994|FG012|Induction Treatment|Missing|0|||
33234420|NCT02291289|100759982|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33234421|NCT02291289|100759983|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33234422|NCT02291289|100759984|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33234423|NCT02291289|100759985|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33575982|NCT03358030|101999956|FG003|Overall Study|Ineligibility|2|||
33575983|NCT03358030|101999953|FG000|Overall Study|Voluntary Withdrawal|1|||
33575984|NCT03358030|101999954|FG001|Overall Study|Voluntary Withdrawal|1|||
33575985|NCT03358030|101999955|FG002|Overall Study|Voluntary Withdrawal|3|||
33575986|NCT03358030|101999956|FG003|Overall Study|Voluntary Withdrawal|1|||
33575987|NCT03358030|101999953|FG000|Overall Study|Other|0|||
33575988|NCT03358030|101999954|FG001|Overall Study|Other|0|||
33575989|NCT03358030|101999955|FG002|Overall Study|Other|1|||
33575990|NCT03358030|101999956|FG003|Overall Study|Other|0|||
33575991|NCT02239926|101999957|FG000|Overall Study|Withdrawal by Subject|0|||
33575992|NCT02239926|101999958|FG001|Overall Study|Withdrawal by Subject|1|||
33575993|NCT01639469|101999959|FG000|Overall Study|Death|4|||
33575994|NCT01639469|101999960|FG001|Overall Study|Death|2|||
33575995|NCT01639469|101999959|FG000|Overall Study|Lost to Follow-up|1|||
33575996|NCT01639469|101999960|FG001|Overall Study|Lost to Follow-up|1|||
33575997|NCT02071771|101999964|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
33575998|NCT02071771|101999965|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
33575999|NCT02071771|101999964|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
33576000|NCT02071771|101999965|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
33636857|NCT00716417|102222967|FG004|Overall Study|Progressive disease|0|||
33636858|NCT00716417|102222968|FG005|Overall Study|Progressive disease|3|||
33234424|NCT02291289|100759986|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
33234425|NCT02291289|100759987|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
33234426|NCT02291289|100759988|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33234427|NCT02291289|100759989|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33138137|NCT01075191|100420135|FG000|Overall Study|Intensification|3|||
33234428|NCT02291289|100759990|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33234429|NCT02291289|100759991|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33234430|NCT02291289|100759992|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
33234431|NCT02291289|100759993|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
33234432|NCT02291289|100759994|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
33576001|NCT00441272|101999967|FG000|Overall Study|Study terminated prior to enrollment|25|||
33576002|NCT00441272|101999968|FG001|Overall Study|Study terminated prior to enrollment|25|||
33576003|NCT01248793|101999969|FG000|Overall Study|Lost to Follow-up|0|||
33576004|NCT01248793|101999970|FG001|Overall Study|Lost to Follow-up|1|||
33576005|NCT01248793|101999969|FG000|Overall Study|Adverse Event|1|||
33234433|NCT02291289|100759982|FG000|Maintenance Treatment Phase|Death|0|||
33234434|NCT02291289|100759983|FG001|Maintenance Treatment Phase|Death|29|||
33234435|NCT02291289|100759984|FG002|Maintenance Treatment Phase|Death|16|||
33234436|NCT02291289|100759985|FG003|Maintenance Treatment Phase|Death|0|||
33576006|NCT01248793|101999970|FG001|Overall Study|Adverse Event|1|||
33576007|NCT01248793|101999969|FG000|Overall Study|Protocol Violation|0|||
33576008|NCT01248793|101999970|FG001|Overall Study|Protocol Violation|1|||
33576009|NCT01248793|101999969|FG000|Overall Study|Withdrawal by Subject|3|||
33576010|NCT01248793|101999970|FG001|Overall Study|Withdrawal by Subject|3|||
33576011|NCT01497197|101999971|FG000|Overall Study|Lost to Follow-up|1|||
33576012|NCT01497197|101999972|FG001|Overall Study|Lost to Follow-up|0|||
33576013|NCT01497197|101999971|FG000|Overall Study|Protocol Violation|0|||
33576014|NCT01497197|101999972|FG001|Overall Study|Protocol Violation|2|||
33576015|NCT01497197|101999971|FG000|Overall Study|Withdrawal by Subject|2|||
33576016|NCT01497197|101999972|FG001|Overall Study|Withdrawal by Subject|1|||
33234437|NCT02291289|100759986|FG004|Maintenance Treatment Phase|Death|188|||
33234438|NCT02291289|100759987|FG005|Maintenance Treatment Phase|Death|107|||
33234439|NCT02291289|100759988|FG006|Maintenance Treatment Phase|Death|0|||
33234440|NCT02291289|100759989|FG007|Maintenance Treatment Phase|Death|1|||
33234441|NCT02291289|100759990|FG008|Maintenance Treatment Phase|Death|1|||
33234442|NCT02291289|100759991|FG009|Maintenance Treatment Phase|Death|0|||
33234443|NCT02291289|100759992|FG010|Maintenance Treatment Phase|Death|46|||
33234444|NCT02291289|100759993|FG011|Maintenance Treatment Phase|Death|19|||
33234445|NCT02291289|100759994|FG012|Maintenance Treatment Phase|Death|0|||
33234446|NCT02291289|100759982|FG000|Maintenance Treatment Phase|Adverse Event|0|||
33234447|NCT02291289|100759983|FG001|Maintenance Treatment Phase|Adverse Event|0|||
33234448|NCT02291289|100759984|FG002|Maintenance Treatment Phase|Adverse Event|0|||
33234449|NCT02291289|100759985|FG003|Maintenance Treatment Phase|Adverse Event|0|||
33234450|NCT02291289|100759986|FG004|Maintenance Treatment Phase|Adverse Event|1|||
33234451|NCT02291289|100759987|FG005|Maintenance Treatment Phase|Adverse Event|1|||
33234452|NCT02291289|100759988|FG006|Maintenance Treatment Phase|Adverse Event|0|||
33576017|NCT01497197|101999971|FG000|Overall Study|Excessive/lack of response to treatment|1|||
33576018|NCT01497197|101999972|FG001|Overall Study|Excessive/lack of response to treatment|0|||
33576019|NCT01497197|101999971|FG000|Overall Study|Risk of OHSS|1|||
33576020|NCT01497197|101999972|FG001|Overall Study|Risk of OHSS|0|||
33576021|NCT01497197|101999971|FG000|Overall Study|No oocytes retrieved|3|||
33576022|NCT01497197|101999972|FG001|Overall Study|No oocytes retrieved|2|||
33576023|NCT01497197|101999971|FG000|Overall Study|No fertilisation|6|||
33576024|NCT01497197|101999972|FG001|Overall Study|No fertilisation|5|||
33576025|NCT01497197|101999971|FG000|Overall Study|Intention to freeze all embryos|0|||
33576026|NCT01497197|101999972|FG001|Overall Study|Intention to freeze all embryos|1|||
33576027|NCT01497197|101999971|FG000|Overall Study|All embryos discarded|0|||
33576028|NCT01497197|101999972|FG001|Overall Study|All embryos discarded|3|||
33576029|NCT01497197|101999971|FG000|Overall Study|Other|3|||
33576030|NCT01497197|101999972|FG001|Overall Study|Other|1|||
33576031|NCT00244621|101999974|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
33576032|NCT00244621|101999975|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
33576033|NCT00244621|101999976|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
33576034|NCT00244621|101999974|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
33576035|NCT00244621|101999975|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
33576036|NCT00244621|101999976|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33576037|NCT00244621|101999974|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
33576038|NCT00244621|101999975|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
33576039|NCT00244621|101999976|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
33576040|NCT00244621|101999974|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
33576041|NCT00244621|101999975|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
33576042|NCT00244621|101999976|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
33576043|NCT00244621|101999974|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
33576044|NCT00244621|101999975|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
33576045|NCT00244621|101999976|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
33576046|NCT00244621|101999974|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
33138138|NCT01075191|100420135|FG000|Overall Study|Co-morbidities|1|||
33368811|NCT03582033|101234937|FG008|Part A|Withdrawal by Subject|0|||
33368812|NCT03582033|101234938|FG009|Part A|Withdrawal by Subject|0|||
33368813|NCT03582033|101234929|FG000|Part B|Death|0|||
33368814|NCT03582033|101234930|FG001|Part B|Death|0|||
33368815|NCT03582033|101234931|FG002|Part B|Death|0|||
33138139|NCT01075191|100420135|FG000|Overall Study|Adverse Event|4|||
33234453|NCT02291289|100759989|FG007|Maintenance Treatment Phase|Adverse Event|0|||
33234454|NCT02291289|100759990|FG008|Maintenance Treatment Phase|Adverse Event|0|||
33234455|NCT02291289|100759991|FG009|Maintenance Treatment Phase|Adverse Event|0|||
33234456|NCT02291289|100759992|FG010|Maintenance Treatment Phase|Adverse Event|0|||
33368816|NCT03582033|101234932|FG003|Part B|Death|0|||
33368817|NCT03582033|101234933|FG004|Part B|Death|0|||
33576047|NCT00244621|101999975|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
33576048|NCT00244621|101999976|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
33576049|NCT00244621|101999974|FG000|Open-label Treatment Period|Adverse Event|0|||
33368818|NCT03582033|101234934|FG005|Part B|Death|2|||
33368819|NCT03582033|101234935|FG006|Part B|Death|0|||
33368820|NCT03582033|101234936|FG007|Part B|Death|0|||
33368821|NCT03582033|101234937|FG008|Part B|Death|0|||
33368822|NCT03582033|101234938|FG009|Part B|Death|0|||
33368823|NCT03582033|101234929|FG000|Part B|Study terminated by sponsor|0|||
33368824|NCT03582033|101234930|FG001|Part B|Study terminated by sponsor|0|||
33368825|NCT03582033|101234931|FG002|Part B|Study terminated by sponsor|0|||
33368826|NCT03582033|101234932|FG003|Part B|Study terminated by sponsor|0|||
33368827|NCT03582033|101234933|FG004|Part B|Study terminated by sponsor|0|||
33368828|NCT03582033|101234934|FG005|Part B|Study terminated by sponsor|12|||
33368829|NCT03582033|101234935|FG006|Part B|Study terminated by sponsor|0|||
33368830|NCT03582033|101234936|FG007|Part B|Study terminated by sponsor|0|||
33368831|NCT03582033|101234937|FG008|Part B|Study terminated by sponsor|0|||
33368832|NCT03582033|101234938|FG009|Part B|Study terminated by sponsor|0|||
33368833|NCT03582033|101234929|FG000|Part B|Withdrawal by Subject|0|||
33368834|NCT03582033|101234930|FG001|Part B|Withdrawal by Subject|0|||
33368835|NCT03582033|101234931|FG002|Part B|Withdrawal by Subject|0|||
33368836|NCT03582033|101234932|FG003|Part B|Withdrawal by Subject|0|||
33368837|NCT03582033|101234933|FG004|Part B|Withdrawal by Subject|0|||
33368838|NCT03582033|101234934|FG005|Part B|Withdrawal by Subject|6|||
33368839|NCT03582033|101234935|FG006|Part B|Withdrawal by Subject|0|||
33368840|NCT03582033|101234936|FG007|Part B|Withdrawal by Subject|0|||
33368841|NCT03582033|101234937|FG008|Part B|Withdrawal by Subject|0|||
33368842|NCT03582033|101234938|FG009|Part B|Withdrawal by Subject|0|||
33368843|NCT03582033|101234929|FG000|Part C|Other|0|||
33368844|NCT03582033|101234930|FG001|Part C|Other|0|||
33368845|NCT03582033|101234931|FG002|Part C|Other|0|||
33420356|NCT00995930|101428600|FG001|Overall Study|Death|1|||
33420357|NCT00995930|101428599|FG000|Overall Study|Administrative problems|4|||
33576050|NCT00244621|101999975|FG001|Open-label Treatment Period|Adverse Event|0|||
33576051|NCT00244621|101999976|FG002|Open-label Treatment Period|Adverse Event|1|||
33576052|NCT00244621|101999974|FG000|Open-label Treatment Period|Moved abroad|0|||
33576053|NCT00244621|101999975|FG001|Open-label Treatment Period|Moved abroad|0|||
33576054|NCT00244621|101999976|FG002|Open-label Treatment Period|Moved abroad|1|||
33234457|NCT02291289|100759993|FG011|Maintenance Treatment Phase|Adverse Event|0|||
33234458|NCT02291289|100759994|FG012|Maintenance Treatment Phase|Adverse Event|0|||
33576055|NCT01897493|101999977|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
33576056|NCT03768427|101999985|FG000|Overall Study|Death|0|||
33576057|NCT03768427|101999986|FG001|Overall Study|Death|0|||
33636859|NCT00716417|102222969|FG006|Overall Study|Progressive disease|3|||
33636860|NCT00716417|102222970|FG007|Overall Study|Progressive disease|1|||
33636861|NCT00716417|102222971|FG008|Overall Study|Progressive disease|5|||
33636862|NCT00716417|102222972|FG009|Overall Study|Progressive disease|0|||
33636863|NCT00716417|102222963|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
33636864|NCT00716417|102222964|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
33636865|NCT00716417|102222965|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
33234459|NCT02291289|100759982|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
33234460|NCT02291289|100759983|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
33234461|NCT02291289|100759984|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
33234462|NCT02291289|100759985|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
33234463|NCT02291289|100759986|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
33234464|NCT02291289|100759987|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
33234465|NCT02291289|100759988|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
33234466|NCT02291289|100759989|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
33234467|NCT02291289|100759990|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
33234468|NCT02291289|100759991|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
33234469|NCT02291289|100759992|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
33234470|NCT02291289|100759993|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
33576058|NCT03768427|101999987|FG002|Overall Study|Death|1|||
33576059|NCT03768427|101999988|FG003|Overall Study|Death|0|||
33576060|NCT03768427|101999985|FG000|Overall Study|Lost to Follow-up|2|||
33576061|NCT03768427|101999986|FG001|Overall Study|Lost to Follow-up|0|||
33576062|NCT03768427|101999987|FG002|Overall Study|Lost to Follow-up|0|||
33576063|NCT03768427|101999988|FG003|Overall Study|Lost to Follow-up|0|||
33576064|NCT03768427|101999985|FG000|Overall Study|Physician Decision|3|||
33234471|NCT02291289|100759994|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
33368846|NCT03582033|101234932|FG003|Part C|Other|0|||
33368847|NCT03582033|101234933|FG004|Part C|Other|0|||
33368848|NCT03582033|101234934|FG005|Part C|Other|0|||
33368849|NCT03582033|101234935|FG006|Part C|Other|2|||
33368850|NCT03582033|101234936|FG007|Part C|Other|0|||
33368851|NCT03582033|101234937|FG008|Part C|Other|0|||
33368852|NCT03582033|101234938|FG009|Part C|Other|0|||
33368853|NCT03582033|101234929|FG000|Part C|Death|0|||
33368854|NCT03582033|101234930|FG001|Part C|Death|0|||
33368855|NCT03582033|101234931|FG002|Part C|Death|0|||
33368856|NCT03582033|101234932|FG003|Part C|Death|0|||
33576065|NCT03768427|101999986|FG001|Overall Study|Physician Decision|2|||
33576066|NCT03768427|101999987|FG002|Overall Study|Physician Decision|4|||
33234472|NCT02291289|100759982|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
33234473|NCT02291289|100759983|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
33234474|NCT02291289|100759984|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
33234475|NCT02291289|100759985|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
33234476|NCT02291289|100759986|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
33234477|NCT02291289|100759987|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
33368857|NCT03582033|101234933|FG004|Part C|Death|0|||
33368858|NCT03582033|101234934|FG005|Part C|Death|0|||
33234478|NCT02291289|100759988|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
33234479|NCT02291289|100759989|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
33234480|NCT02291289|100759990|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
33234481|NCT02291289|100759991|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
33234482|NCT02291289|100759992|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
33576067|NCT03768427|101999988|FG003|Overall Study|Physician Decision|4|||
33576068|NCT03768427|101999985|FG000|Overall Study|Withdrawal by Subject|7|||
33576069|NCT03768427|101999986|FG001|Overall Study|Withdrawal by Subject|2|||
33576070|NCT03768427|101999987|FG002|Overall Study|Withdrawal by Subject|6|||
33576071|NCT03768427|101999988|FG003|Overall Study|Withdrawal by Subject|7|||
33576072|NCT00945659|101999989|FG000|Overall Study|Lost to Follow-up|7|||
33576073|NCT00945659|101999990|FG001|Overall Study|Lost to Follow-up|20|||
33576074|NCT00945659|101999991|FG002|Overall Study|Lost to Follow-up|17|||
33576075|NCT03637491|101999992|FG000|Overall Study|Death|9|||
33576076|NCT03637491|101999993|FG001|Overall Study|Death|9|||
33576077|NCT03637491|101999994|FG002|Overall Study|Death|5|||
33576078|NCT03637491|101999995|FG003|Overall Study|Death|3|||
33576079|NCT03637491|101999992|FG000|Overall Study|Lost to Follow-up|0|||
33576080|NCT03637491|101999993|FG001|Overall Study|Lost to Follow-up|1|||
33576081|NCT03637491|101999994|FG002|Overall Study|Lost to Follow-up|0|||
33576082|NCT03637491|101999995|FG003|Overall Study|Lost to Follow-up|1|||
33576083|NCT03637491|101999992|FG000|Overall Study|Study Terminated By Sponsor|0|||
33576084|NCT03637491|101999993|FG001|Overall Study|Study Terminated By Sponsor|2|||
33576085|NCT03637491|101999994|FG002|Overall Study|Study Terminated By Sponsor|1|||
33576086|NCT03637491|101999995|FG003|Overall Study|Study Terminated By Sponsor|0|||
33576087|NCT03637491|101999992|FG000|Overall Study|Withdrawal by Subject|1|||
33576088|NCT03637491|101999993|FG001|Overall Study|Withdrawal by Subject|0|||
33576089|NCT03637491|101999994|FG002|Overall Study|Withdrawal by Subject|1|||
33576090|NCT03637491|101999995|FG003|Overall Study|Withdrawal by Subject|2|||
33576091|NCT03389308|102000006|FG000|Overall Study|Withdrawal by Subject|5|||
33576092|NCT03389308|102000006|FG000|Overall Study|Lost to Follow-up|3|||
33576093|NCT03389308|102000006|FG000|Overall Study|Adverse Event|2|||
33576094|NCT03389308|102000006|FG000|Overall Study|Sponsor Request|2|||
33576095|NCT02935192|102000007|FG000|Overall Study|Withdrawal by Subject|8|||
33576096|NCT02935192|102000008|FG001|Overall Study|Withdrawal by Subject|4|||
33576097|NCT00181844|102000011|FG000|Signed Consent|Withdrawal by Subject|5|||
33576098|NCT00181844|102000011|FG000|Signed Consent|Did not meet entrance criteria|7|||
33576099|NCT00181844|102000011|FG000|Exposed to Study Medication|Adverse Event|10|||
33576100|NCT00181844|102000011|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
33576101|NCT00181844|102000011|FG000|Exposed to Study Medication|Non-compliance|2|||
33576102|NCT00181844|102000011|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
33576103|NCT00181844|102000011|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
33576104|NCT00920556|102000012|FG000|Overall Study|Adverse Event|16|||
33576105|NCT00920556|102000012|FG000|Overall Study|Physician Decision|7|||
33576106|NCT00920556|102000012|FG000|Overall Study|Withdrawal by Subject|1|||
33576107|NCT03092479|102000013|FG000|Overall Study|Lost to Follow-up|3|||
33576108|NCT03092479|102000014|FG001|Overall Study|Lost to Follow-up|2|||
33576109|NCT03092479|102000013|FG000|Overall Study|Withdrawal by Subject|4|||
33576110|NCT03092479|102000014|FG001|Overall Study|Withdrawal by Subject|0|||
33576111|NCT02137070|102000015|FG000|Overall Study|Adverse Event|12|||
33576112|NCT02137070|102000016|FG001|Overall Study|Adverse Event|3|||
33576113|NCT02137070|102000015|FG000|Overall Study|Death|2|||
33576114|NCT02137070|102000016|FG001|Overall Study|Death|0|||
33138140|NCT01075191|100420135|FG000|Overall Study|Noncompliance|3|||
33576115|NCT02137070|102000015|FG000|Overall Study|Lost to Follow-up|24|||
33576116|NCT02137070|102000016|FG001|Overall Study|Lost to Follow-up|9|||
33576117|NCT02137070|102000015|FG000|Overall Study|Physician Decision|0|||
33576118|NCT02137070|102000016|FG001|Overall Study|Physician Decision|1|||
33576119|NCT02137070|102000015|FG000|Overall Study|Protocol Violation|18|||
33576120|NCT02137070|102000016|FG001|Overall Study|Protocol Violation|4|||
33576121|NCT02137070|102000015|FG000|Overall Study|Withdrawal by Subject|18|||
33576122|NCT02137070|102000016|FG001|Overall Study|Withdrawal by Subject|1|||
33576123|NCT00707993|102000020|FG000|Overall Study|Adverse Event|16|||
33576124|NCT00707993|102000021|FG001|Overall Study|Adverse Event|20|||
33576125|NCT00707993|102000020|FG000|Overall Study|Protocol Violation|4|||
33576126|NCT00707993|102000021|FG001|Overall Study|Protocol Violation|7|||
33576127|NCT00707993|102000020|FG000|Overall Study|Lost to Follow-up|0|||
33234483|NCT02291289|100759993|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
33234484|NCT02291289|100759994|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
33234485|NCT02291289|100759982|FG000|Maintenance Treatment Phase|Physician Decision|0|||
33234486|NCT02291289|100759983|FG001|Maintenance Treatment Phase|Physician Decision|2|||
33234487|NCT02291289|100759984|FG002|Maintenance Treatment Phase|Physician Decision|0|||
33234488|NCT02291289|100759985|FG003|Maintenance Treatment Phase|Physician Decision|0|||
33234489|NCT02291289|100759986|FG004|Maintenance Treatment Phase|Physician Decision|3|||
33234490|NCT02291289|100759987|FG005|Maintenance Treatment Phase|Physician Decision|0|||
33234491|NCT02291289|100759988|FG006|Maintenance Treatment Phase|Physician Decision|0|||
33234492|NCT02291289|100759989|FG007|Maintenance Treatment Phase|Physician Decision|0|||
33234493|NCT02291289|100759990|FG008|Maintenance Treatment Phase|Physician Decision|0|||
33576128|NCT00707993|102000021|FG001|Overall Study|Lost to Follow-up|4|||
33576129|NCT00707993|102000020|FG000|Overall Study|Withdrawal by Subject|12|||
33576130|NCT00707993|102000021|FG001|Overall Study|Withdrawal by Subject|16|||
33576131|NCT00707993|102000020|FG000|Overall Study|Hyperglycemic Rescue|55|||
33576132|NCT00707993|102000021|FG001|Overall Study|Hyperglycemic Rescue|47|||
33576133|NCT00707993|102000020|FG000|Overall Study|Other|2|||
33576134|NCT00707993|102000021|FG001|Overall Study|Other|0|||
33576135|NCT01240863|102000022|FG000|Open-label Titration Period|Adverse Event|47|||
33576136|NCT01240863|102000023|FG001|Open-label Titration Period|Adverse Event|0|||
33576137|NCT01240863|102000024|FG002|Open-label Titration Period|Adverse Event|0|||
33576138|NCT01240863|102000022|FG000|Open-label Titration Period|Lack of Efficacy|19|||
33576139|NCT01240863|102000023|FG001|Open-label Titration Period|Lack of Efficacy|0|||
33576140|NCT01240863|102000024|FG002|Open-label Titration Period|Lack of Efficacy|0|||
33576141|NCT01240863|102000022|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
33576142|NCT01240863|102000023|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
33576143|NCT01240863|102000024|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
33576144|NCT01240863|102000022|FG000|Open-label Titration Period|Protocol Violation|7|||
33576145|NCT01240863|102000023|FG001|Open-label Titration Period|Protocol Violation|0|||
33576146|NCT01240863|102000024|FG002|Open-label Titration Period|Protocol Violation|0|||
33576147|NCT01240863|102000022|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
33576148|NCT01240863|102000023|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
33576149|NCT01240863|102000024|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
33576150|NCT01240863|102000022|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
33576151|NCT01240863|102000023|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
33576152|NCT01240863|102000024|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
33576153|NCT01240863|102000022|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
33576154|NCT01240863|102000023|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
33576155|NCT01240863|102000024|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
33576156|NCT01240863|102000022|FG000|Open-label Titration Period|Other|7|||
33576157|NCT01240863|102000023|FG001|Open-label Titration Period|Other|0|||
33576158|NCT01240863|102000024|FG002|Open-label Titration Period|Other|0|||
33576159|NCT01240863|102000022|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
33576160|NCT01240863|102000023|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
33576161|NCT01240863|102000024|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
33576162|NCT01240863|102000022|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
33576163|NCT01240863|102000023|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
33576164|NCT01240863|102000024|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
33576165|NCT01240863|102000022|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
33234494|NCT02291289|100759991|FG009|Maintenance Treatment Phase|Physician Decision|0|||
33234495|NCT02291289|100759992|FG010|Maintenance Treatment Phase|Physician Decision|1|||
33234496|NCT02291289|100759993|FG011|Maintenance Treatment Phase|Physician Decision|3|||
33234497|NCT02291289|100759994|FG012|Maintenance Treatment Phase|Physician Decision|0|||
33234498|NCT02291289|100759982|FG000|Maintenance Treatment Phase|Not Treated|0|||
33234499|NCT02291289|100759983|FG001|Maintenance Treatment Phase|Not Treated|0|||
33234500|NCT02291289|100759984|FG002|Maintenance Treatment Phase|Not Treated|2|||
33234501|NCT02291289|100759985|FG003|Maintenance Treatment Phase|Not Treated|0|||
33234502|NCT02291289|100759986|FG004|Maintenance Treatment Phase|Not Treated|0|||
33234503|NCT02291289|100759987|FG005|Maintenance Treatment Phase|Not Treated|0|||
33234504|NCT02291289|100759988|FG006|Maintenance Treatment Phase|Not Treated|0|||
33234505|NCT02291289|100759989|FG007|Maintenance Treatment Phase|Not Treated|0|||
33368859|NCT03582033|101234935|FG006|Part C|Death|6|||
33576166|NCT01240863|102000023|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
33138141|NCT01075191|100420135|FG000|Overall Study|Therapy Break|3|||
33138142|NCT01075191|100420135|FG000|Overall Study|Patient's Wish|2|||
33138143|NCT01075191|100420135|FG000|Overall Study|Unknown Reasons|1|||
33138144|NCT04255394|100420137|FG000|Overall Study|Death|35|||
33138145|NCT04255394|100420138|FG001|Overall Study|Death|25|||
33138146|NCT04255394|100420137|FG000|Overall Study|Device removed|2|||
33138147|NCT04255394|100420138|FG001|Overall Study|Device removed|10|||
33138148|NCT04255394|100420137|FG000|Overall Study|Withdrawal by Subject|9|||
33234506|NCT02291289|100759990|FG008|Maintenance Treatment Phase|Not Treated|0|||
33234507|NCT02291289|100759991|FG009|Maintenance Treatment Phase|Not Treated|0|||
33234508|NCT02291289|100759992|FG010|Maintenance Treatment Phase|Not Treated|0|||
33576167|NCT01240863|102000024|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
33234509|NCT02291289|100759993|FG011|Maintenance Treatment Phase|Not Treated|0|||
33234510|NCT02291289|100759994|FG012|Maintenance Treatment Phase|Not Treated|0|||
33234511|NCT02291289|100759982|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
33576168|NCT01240863|102000022|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
33576169|NCT01240863|102000023|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
33576170|NCT01240863|102000024|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
33576171|NCT01240863|102000022|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
33576172|NCT01240863|102000023|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
33576173|NCT01240863|102000024|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
33576174|NCT01240863|102000022|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
33576175|NCT01240863|102000023|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
33576176|NCT01240863|102000024|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
33368860|NCT03582033|101234936|FG007|Part C|Death|1|||
33576177|NCT01240863|102000022|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
33576178|NCT01240863|102000023|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
33368861|NCT03582033|101234937|FG008|Part C|Death|2|||
33368862|NCT03582033|101234938|FG009|Part C|Death|0|||
33368863|NCT03582033|101234929|FG000|Part C|Study terminated by sponsor|0|||
33368864|NCT03582033|101234930|FG001|Part C|Study terminated by sponsor|0|||
33576179|NCT01240863|102000024|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
33576180|NCT01240863|102000022|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
33576181|NCT01240863|102000023|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
33576182|NCT01240863|102000024|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
33576183|NCT04419467|102000025|FG000|Overall Study|Not treated with IP|0|||
33576184|NCT04419467|102000026|FG001|Overall Study|Not treated with IP|0|||
33576185|NCT04419467|102000027|FG002|Overall Study|Not treated with IP|2|||
33576186|NCT04419467|102000025|FG000|Overall Study|Adverse Event|0|||
33576187|NCT04419467|102000026|FG001|Overall Study|Adverse Event|2|||
33576188|NCT04419467|102000027|FG002|Overall Study|Adverse Event|0|||
33576189|NCT04419467|102000025|FG000|Overall Study|Death|1|||
33576190|NCT04419467|102000026|FG001|Overall Study|Death|0|||
33576191|NCT04419467|102000027|FG002|Overall Study|Death|0|||
33576192|NCT04419467|102000025|FG000|Overall Study|Lost to Follow-up|0|||
33576193|NCT04419467|102000026|FG001|Overall Study|Lost to Follow-up|1|||
33576194|NCT04419467|102000027|FG002|Overall Study|Lost to Follow-up|2|||
33576195|NCT04419467|102000025|FG000|Overall Study|Withdrawal by Subject|0|||
33576196|NCT04419467|102000026|FG001|Overall Study|Withdrawal by Subject|0|||
33576197|NCT04419467|102000027|FG002|Overall Study|Withdrawal by Subject|4|||
33576198|NCT04419467|102000025|FG000|Overall Study|Pandemic related|0|||
33576199|NCT04419467|102000026|FG001|Overall Study|Pandemic related|0|||
33576200|NCT04419467|102000027|FG002|Overall Study|Pandemic related|1|||
33576201|NCT04419467|102000025|FG000|Overall Study|Reason not known|1|||
33636866|NCT00716417|102222966|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
33636867|NCT00716417|102222967|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
33138149|NCT04255394|100420138|FG001|Overall Study|Withdrawal by Subject|8|||
33138150|NCT04255394|100420137|FG000|Overall Study|Screen Failure/Not treated|12|||
33138151|NCT04255394|100420138|FG001|Overall Study|Screen Failure/Not treated|8|||
33138152|NCT04255394|100420137|FG000|Overall Study|Lost to Follow-up|123|||
33138153|NCT04255394|100420138|FG001|Overall Study|Lost to Follow-up|265|||
33138154|NCT04255394|100420137|FG000|Overall Study|Adverse Event|1|||
33138155|NCT04255394|100420138|FG001|Overall Study|Adverse Event|3|||
33138156|NCT01120782|100420139|FG000|Overall Study|Test article shipping error|11|||
33138157|NCT03579602|100420141|FG000|Overall Study|Subject unable to receive study drug|0|||
33138158|NCT03579602|100420142|FG001|Overall Study|Subject unable to receive study drug|2|||
33138159|NCT03579602|100420141|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
33138160|NCT03579602|100420142|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
33138161|NCT02248675|100420146|FG000|Overall Study|Lost to Follow-up|3|||
33138162|NCT02248675|100420147|FG001|Overall Study|Lost to Follow-up|1|||
33138163|NCT02518464|100420148|FG000|Overall Study|Adverse Event|2|||
33138164|NCT00958438|100420149|FG000|Overall Study|Protocol Violation|3|||
33138165|NCT00958438|100420150|FG001|Overall Study|Protocol Violation|2|||
33138166|NCT00958438|100420151|FG002|Overall Study|Protocol Violation|2|||
33138167|NCT00958438|100420149|FG000|Overall Study|Withdrawal by Subject|4|||
33138168|NCT00958438|100420150|FG001|Overall Study|Withdrawal by Subject|2|||
33138169|NCT00958438|100420151|FG002|Overall Study|Withdrawal by Subject|1|||
33138170|NCT00958438|100420149|FG000|Overall Study|Adverse Event|0|||
33138171|NCT00958438|100420150|FG001|Overall Study|Adverse Event|3|||
33138172|NCT00958438|100420151|FG002|Overall Study|Adverse Event|0|||
33138173|NCT00958438|100420149|FG000|Overall Study|Physician Decision|1|||
33138174|NCT00958438|100420150|FG001|Overall Study|Physician Decision|0|||
33234512|NCT02291289|100759983|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
33368865|NCT03582033|101234931|FG002|Part C|Study terminated by sponsor|0|||
33576202|NCT04419467|102000026|FG001|Overall Study|Reason not known|0|||
33576203|NCT04419467|102000027|FG002|Overall Study|Reason not known|0|||
33138175|NCT00958438|100420151|FG002|Overall Study|Physician Decision|1|||
33138176|NCT00958438|100420149|FG000|Overall Study|Other than specified above|2|||
33138177|NCT00958438|100420150|FG001|Overall Study|Other than specified above|3|||
33138178|NCT00958438|100420151|FG002|Overall Study|Other than specified above|2|||
33234513|NCT02291289|100759984|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
33576204|NCT00636181|102000030|FG000|Overall Study|Withdrawal by Subject|8|||
33636868|NCT00716417|102222968|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
33234514|NCT02291289|100759985|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
33234515|NCT02291289|100759986|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
33234516|NCT02291289|100759987|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
33636869|NCT00716417|102222969|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
33636870|NCT00716417|102222970|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
33636871|NCT00716417|102222971|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
33636872|NCT00716417|102222972|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
33636873|NCT00716417|102222963|FG000|Overall Study|On patient request due to toxicities|0|||
33636874|NCT00716417|102222964|FG001|Overall Study|On patient request due to toxicities|0|||
33636875|NCT00716417|102222965|FG002|Overall Study|On patient request due to toxicities|0|||
33636876|NCT00716417|102222966|FG003|Overall Study|On patient request due to toxicities|0|||
33636877|NCT00716417|102222967|FG004|Overall Study|On patient request due to toxicities|0|||
33576205|NCT00636181|102000031|FG001|Overall Study|Withdrawal by Subject|6|||
33576206|NCT00636181|102000032|FG002|Overall Study|Withdrawal by Subject|10|||
33576207|NCT02803203|102000033|FG000|Overall Study|Adverse Event|4|||
33576208|NCT02803203|102000033|FG000|Overall Study|Death|4|||
33576209|NCT02803203|102000033|FG000|Overall Study|Progressive disease|29|||
33576210|NCT02803203|102000033|FG000|Overall Study|Withdrawal by Subject|8|||
33576211|NCT02803203|102000033|FG000|Overall Study|Complete resection of target disease|2|||
33576212|NCT02803203|102000033|FG000|Overall Study|Switched to commercial Osi|1|||
33576213|NCT02803203|102000033|FG000|Overall Study|Participant moved away|1|||
33576214|NCT02896257|102000034|FG000|Providers|Without eligible patients|21|||
33576215|NCT02896257|102000035|FG001|Providers|Without eligible patients|28|||
33576216|NCT02896257|102000034|FG000|Patients|PFT entry criteria not met|43|||
33576217|NCT02896257|102000035|FG001|Patients|PFT entry criteria not met|50|||
33576218|NCT02896257|102000034|FG000|Patients|No capacity to review|8|||
33576219|NCT02896257|102000035|FG001|Patients|No capacity to review|11|||
33576220|NCT02896257|102000034|FG000|Patients|Appointment rescheduled/cancelled|5|||
33576221|NCT02896257|102000035|FG001|Patients|Appointment rescheduled/cancelled|7|||
33576222|NCT02896257|102000034|FG000|Patients|PCP not assigned a clinic|4|||
33576223|NCT02896257|102000035|FG001|Patients|PCP not assigned a clinic|0|||
33576224|NCT02896257|102000034|FG000|Patients|No history of COPD|0|||
33576225|NCT02896257|102000035|FG001|Patients|No history of COPD|1|||
33576226|NCT02896257|102000034|FG000|Patients|Deceased between review and index date|0|||
33576227|NCT02896257|102000035|FG001|Patients|Deceased between review and index date|1|||
33576228|NCT02896257|102000034|FG000|Patients|No ICS Rx upon review|1|||
33576229|NCT02896257|102000035|FG001|Patients|No ICS Rx upon review|1|||
33576230|NCT02896257|102000034|FG000|Patients|Protocol Violation|2|||
33636878|NCT00716417|102222968|FG005|Overall Study|On patient request due to toxicities|0|||
33576231|NCT02896257|102000035|FG001|Patients|Protocol Violation|1|||
33636879|NCT00716417|102222969|FG006|Overall Study|On patient request due to toxicities|0|||
33636880|NCT00716417|102222970|FG007|Overall Study|On patient request due to toxicities|1|||
33636881|NCT00716417|102222971|FG008|Overall Study|On patient request due to toxicities|0|||
33636882|NCT00716417|102222972|FG009|Overall Study|On patient request due to toxicities|0|||
33636883|NCT03038100|102222980|FG000|Overall Study|Death|289|||
33576232|NCT02896257|102000034|FG000|Patients|Hospice care|0|||
33576233|NCT02896257|102000035|FG001|Patients|Hospice care|1|||
33576234|NCT01657370|102000036|FG000|Overall Study|Withdrawal by Subject|0|||
33576235|NCT01657370|102000037|FG001|Overall Study|Withdrawal by Subject|0|||
33636884|NCT03038100|102222981|FG001|Overall Study|Death|272|||
33636885|NCT03038100|102222980|FG000|Overall Study|Lost to Follow-up|9|||
33234517|NCT02291289|100759988|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
33368866|NCT03582033|101234932|FG003|Part C|Study terminated by sponsor|0|||
33576236|NCT01657370|102000038|FG002|Overall Study|Withdrawal by Subject|1|||
33636886|NCT03038100|102222981|FG001|Overall Study|Lost to Follow-up|10|||
33138179|NCT01239732|100420154|FG000|Overall Study|Termination of study per protocol|667|||
33576237|NCT01657370|102000039|FG003|Overall Study|Withdrawal by Subject|0|||
33576238|NCT01657370|102000040|FG004|Overall Study|Withdrawal by Subject|0|||
33576239|NCT01657370|102000041|FG005|Overall Study|Withdrawal by Subject|1|||
33576240|NCT01657370|102000036|FG000|Overall Study|Physician Decision|2|||
33576241|NCT01657370|102000037|FG001|Overall Study|Physician Decision|3|||
33576242|NCT01657370|102000038|FG002|Overall Study|Physician Decision|1|||
33576243|NCT01657370|102000039|FG003|Overall Study|Physician Decision|2|||
33576244|NCT01657370|102000040|FG004|Overall Study|Physician Decision|5|||
33576245|NCT01657370|102000041|FG005|Overall Study|Physician Decision|0|||
33576246|NCT01657370|102000036|FG000|Overall Study|Lack of Qualifying Event|1|||
33576247|NCT01657370|102000037|FG001|Overall Study|Lack of Qualifying Event|0|||
33138180|NCT01239732|100420154|FG000|Overall Study|Death|226|||
33138181|NCT01239732|100420154|FG000|Overall Study|Withdrawal by Subject|87|||
33138182|NCT01239732|100420154|FG000|Overall Study|Adverse Event|6|||
33138183|NCT01239732|100420154|FG000|Overall Study|Protocol Violation|3|||
33138184|NCT01239732|100420154|FG000|Overall Study|Participant non compliance|5|||
33138185|NCT01239732|100420154|FG000|Overall Study|Study termination by sponsor|2|||
33138186|NCT01239732|100420154|FG000|Overall Study|Investigator's decision|4|||
33138187|NCT01239732|100420154|FG000|Overall Study|Treatment failure|2|||
33138188|NCT01239732|100420154|FG000|Overall Study|Other|19|||
33138189|NCT01576159|100420159|FG000|Overall Study|Withdrawal by Subject|0|||
33138190|NCT01576159|100420160|FG001|Overall Study|Withdrawal by Subject|1|||
33138191|NCT01576159|100420161|FG002|Overall Study|Withdrawal by Subject|0|||
33138192|NCT01576159|100420162|FG003|Overall Study|Withdrawal by Subject|0|||
33138193|NCT01576159|100420159|FG000|Overall Study|Physician Decision|0|||
33138194|NCT01576159|100420160|FG001|Overall Study|Physician Decision|0|||
33138195|NCT01576159|100420161|FG002|Overall Study|Physician Decision|1|||
33138196|NCT01576159|100420162|FG003|Overall Study|Physician Decision|0|||
33138197|NCT01576159|100420159|FG000|Overall Study|Lost to Follow-up|0|||
33138198|NCT01576159|100420160|FG001|Overall Study|Lost to Follow-up|0|||
33138199|NCT01576159|100420161|FG002|Overall Study|Lost to Follow-up|0|||
33138200|NCT01576159|100420162|FG003|Overall Study|Lost to Follow-up|1|||
33138201|NCT01576159|100420159|FG000|Overall Study|Protocol Violation|1|||
33138202|NCT01576159|100420160|FG001|Overall Study|Protocol Violation|0|||
33138203|NCT01576159|100420161|FG002|Overall Study|Protocol Violation|0|||
33138204|NCT01576159|100420162|FG003|Overall Study|Protocol Violation|0|||
33138205|NCT02617485|100420165|FG000|Treatment and Observation Period|Adverse Event|9|||
33138206|NCT02617485|100420166|FG001|Treatment and Observation Period|Adverse Event|1|||
33138207|NCT02617485|100420165|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
33138208|NCT02617485|100420166|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
33138209|NCT02617485|100420165|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
33138210|NCT02617485|100420166|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
33138211|NCT02617485|100420165|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
33138212|NCT02617485|100420166|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
33138213|NCT02617485|100420165|FG000|Treatment and Observation Period|Physician Decision|0|||
33420358|NCT00995930|101428600|FG001|Overall Study|Administrative problems|2|||
33420359|NCT00995930|101428599|FG000|Overall Study|Lost to Follow-up|1|||
33420360|NCT00995930|101428600|FG001|Overall Study|Lost to Follow-up|2|||
33576248|NCT01657370|102000038|FG002|Overall Study|Lack of Qualifying Event|3|||
33576249|NCT01657370|102000039|FG003|Overall Study|Lack of Qualifying Event|2|||
33576250|NCT01657370|102000040|FG004|Overall Study|Lack of Qualifying Event|1|||
33576251|NCT01657370|102000041|FG005|Overall Study|Lack of Qualifying Event|2|||
33576252|NCT01657370|102000036|FG000|Overall Study|Adverse Event|0|||
33576253|NCT01657370|102000037|FG001|Overall Study|Adverse Event|0|||
33576254|NCT01657370|102000038|FG002|Overall Study|Adverse Event|0|||
33576255|NCT01657370|102000039|FG003|Overall Study|Adverse Event|0|||
33576256|NCT01657370|102000040|FG004|Overall Study|Adverse Event|1|||
33576257|NCT01657370|102000041|FG005|Overall Study|Adverse Event|0|||
33576258|NCT01657370|102000036|FG000|Overall Study|Protocol Violation|1|||
33576259|NCT01657370|102000037|FG001|Overall Study|Protocol Violation|1|||
33576260|NCT01657370|102000038|FG002|Overall Study|Protocol Violation|1|||
33576261|NCT01657370|102000039|FG003|Overall Study|Protocol Violation|1|||
33576262|NCT01657370|102000040|FG004|Overall Study|Protocol Violation|0|||
33576263|NCT01657370|102000041|FG005|Overall Study|Protocol Violation|0|||
33576264|NCT01657370|102000036|FG000|Overall Study|Lost to Follow-up|2|||
33576265|NCT01657370|102000037|FG001|Overall Study|Lost to Follow-up|0|||
33576266|NCT01657370|102000038|FG002|Overall Study|Lost to Follow-up|1|||
33576267|NCT01657370|102000039|FG003|Overall Study|Lost to Follow-up|0|||
33576268|NCT01657370|102000040|FG004|Overall Study|Lost to Follow-up|0|||
33576269|NCT01657370|102000041|FG005|Overall Study|Lost to Follow-up|1|||
33576270|NCT00881894|102000045|FG000|Overall Study|Consent withdrawn|0|||
33138214|NCT02617485|100420166|FG001|Treatment and Observation Period|Physician Decision|1|||
33138215|NCT02617485|100420165|FG000|Follow-up Period|Adverse Event|1|||
33138216|NCT02617485|100420166|FG001|Follow-up Period|Adverse Event|0|||
33138217|NCT02617485|100420165|FG000|Follow-up Period|Withdrawal by Subject|1|||
33420361|NCT00995930|101428599|FG000|Overall Study|Withdrawal by Subject|3|||
33138218|NCT02617485|100420166|FG001|Follow-up Period|Withdrawal by Subject|0|||
33138219|NCT02617485|100420165|FG000|Follow-up Period|Disease progression|2|||
33420362|NCT00995930|101428600|FG001|Overall Study|Withdrawal by Subject|4|||
33576271|NCT00881894|102000046|FG001|Overall Study|Consent withdrawn|1|||
33576272|NCT00881894|102000045|FG000|Overall Study|Other reasons for premature termination|1|||
33576273|NCT00881894|102000046|FG001|Overall Study|Other reasons for premature termination|2|||
33576274|NCT01114737|102000048|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
33576275|NCT01114737|102000049|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
33576276|NCT01114737|102000048|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
33138220|NCT02617485|100420166|FG001|Follow-up Period|Disease progression|1|||
33138221|NCT02617485|100420165|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
33138222|NCT02617485|100420166|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
33138223|NCT02617485|100420165|FG000|Follow-up Period|Patient needed radiotherapy|9|||
33138224|NCT02617485|100420166|FG001|Follow-up Period|Patient needed radiotherapy|5|||
33138225|NCT02617485|100420165|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
33138226|NCT02617485|100420166|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
33138227|NCT03499964|100420175|FG000|Overall Study|Lack of Efficacy|6|||
33138228|NCT03499964|100420176|FG001|Overall Study|Lack of Efficacy|26|||
33138229|NCT03499964|100420175|FG000|Overall Study|Adverse Event|1|||
33138230|NCT03499964|100420176|FG001|Overall Study|Adverse Event|0|||
33138231|NCT03499964|100420175|FG000|Overall Study|Death|1|||
33138232|NCT03499964|100420176|FG001|Overall Study|Death|0|||
33138233|NCT03499964|100420175|FG000|Overall Study|Withdrawal by Subject|2|||
33138234|NCT03499964|100420176|FG001|Overall Study|Withdrawal by Subject|1|||
33138235|NCT03499964|100420175|FG000|Overall Study|Lost to Follow-up|1|||
33138236|NCT03499964|100420176|FG001|Overall Study|Lost to Follow-up|0|||
33138237|NCT00710762|100420180|FG000|Overall Study|Progressive disease|27|||
33234518|NCT02291289|100759989|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
33234519|NCT02291289|100759990|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
33576277|NCT01114737|102000049|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
33576278|NCT01114737|102000048|FG000|Randomized Treatment Period|Pregnancy|1|||
33576279|NCT01114737|102000049|FG001|Randomized Treatment Period|Pregnancy|0|||
33576280|NCT01114737|102000048|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
33576281|NCT01114737|102000049|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
33576282|NCT01114737|102000048|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
33576283|NCT01114737|102000049|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
33576284|NCT01114737|102000048|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
33576285|NCT01114737|102000049|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
33576286|NCT03594110|102000050|FG000|Overall Study|Participant concerned about study treatment|23|||
33576287|NCT03594110|102000051|FG001|Overall Study|Participant concerned about study treatment|28|||
33576288|NCT03594110|102000050|FG000|Overall Study|Doctor advice|38|||
33576289|NCT03594110|102000051|FG001|Overall Study|Doctor advice|40|||
33576290|NCT03594110|102000050|FG000|Overall Study|Participants' wish|89|||
33576291|NCT03594110|102000051|FG001|Overall Study|Participants' wish|68|||
33576292|NCT03594110|102000050|FG000|Overall Study|Adverse Event|119|||
33576293|NCT03594110|102000051|FG001|Overall Study|Adverse Event|116|||
33576294|NCT03594110|102000050|FG000|Overall Study|Study drug stopped, reason missing|337|||
33576295|NCT03594110|102000051|FG001|Overall Study|Study drug stopped, reason missing|295|||
33576296|NCT03594110|102000050|FG000|Overall Study|Cannot attend clinic because of personal problems|8|||
33576297|NCT03594110|102000051|FG001|Overall Study|Cannot attend clinic because of personal problems|16|||
33576298|NCT03594110|102000050|FG000|Overall Study|Cannot attend clinic because moving out of the area|15|||
33576299|NCT03594110|102000051|FG001|Overall Study|Cannot attend clinic because moving out of the area|9|||
33576300|NCT03594110|102000050|FG000|Overall Study|Contraindicated drug started|32|||
33576301|NCT03594110|102000051|FG001|Overall Study|Contraindicated drug started|18|||
33576302|NCT03594110|102000050|FG000|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|58|||
33576303|NCT03594110|102000051|FG001|Overall Study|Other reasons (include any category with a frequency <20 patients in total)|45|||
33576304|NCT03594110|102000050|FG000|Overall Study|Death|129|||
33576305|NCT03594110|102000051|FG001|Overall Study|Death|120|||
33576306|NCT02431325|102000055|FG000|Overall Study|Adverse Event|3|||
33576307|NCT02431325|102000056|FG001|Overall Study|Adverse Event|0|||
33576308|NCT02431325|102000055|FG000|Overall Study|Lost to Follow-up|0|||
33234520|NCT02291289|100759991|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
33576309|NCT02431325|102000056|FG001|Overall Study|Lost to Follow-up|1|||
33576310|NCT02431325|102000055|FG000|Overall Study|Withdrawal by Subject|1|||
33576311|NCT02431325|102000056|FG001|Overall Study|Withdrawal by Subject|2|||
33576312|NCT02431325|102000055|FG000|Overall Study|Declined to take study medication|1|||
33576313|NCT02431325|102000056|FG001|Overall Study|Declined to take study medication|0|||
33576314|NCT02431325|102000055|FG000|Overall Study|Withdrew before starting study medication|1|||
33138238|NCT00710762|100420181|FG001|Overall Study|Progressive disease|30|||
33138239|NCT00710762|100420180|FG000|Overall Study|Adverse Event other disease worsening|2|||
33138240|NCT00710762|100420181|FG001|Overall Study|Adverse Event other disease worsening|1|||
33138241|NCT00710762|100420180|FG000|Overall Study|Other Adverse Event|7|||
33138242|NCT00710762|100420181|FG001|Overall Study|Other Adverse Event|7|||
33234521|NCT02291289|100759992|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
33234522|NCT02291289|100759993|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
33576315|NCT02431325|102000056|FG001|Overall Study|Withdrew before starting study medication|0|||
33576316|NCT02431325|102000055|FG000|Overall Study|Placebo shortage|2|||
33576317|NCT02431325|102000056|FG001|Overall Study|Placebo shortage|0|||
33576318|NCT00100802|102000059|FG000|Overall Study|Adverse Event|9|||
33138243|NCT00710762|100420180|FG000|Overall Study|Lost to Follow-up|1|||
33138244|NCT00710762|100420181|FG001|Overall Study|Lost to Follow-up|0|||
33576319|NCT00100802|102000059|FG000|Overall Study|Death|1|||
33576320|NCT00100802|102000059|FG000|Overall Study|Lack of Efficacy|47|||
33576321|NCT00100802|102000059|FG000|Overall Study|Physician Decision|5|||
33576322|NCT00100802|102000059|FG000|Overall Study|Protocol Violation|1|||
33576323|NCT00100802|102000059|FG000|Overall Study|Withdrawal by Subject|5|||
33576324|NCT00100802|102000059|FG000|Overall Study|Ineligible|12|||
33576325|NCT01979614|102000060|FG000|Overall Study|Adverse Event|1|||
33576326|NCT01979614|102000061|FG001|Overall Study|Adverse Event|1|||
33576327|NCT00501644|102000062|FG000|Overall Study|Adverse Event|4|||
33576328|NCT00501644|102000062|FG000|Overall Study|Withdrawal by Subject|1|||
33576329|NCT00783432|102000065|FG000|Overall Study|Adverse Event|22|||
33576330|NCT00783432|102000066|FG001|Overall Study|Adverse Event|17|||
33576331|NCT00783432|102000065|FG000|Overall Study|Lack of Efficacy|20|||
33576332|NCT00783432|102000066|FG001|Overall Study|Lack of Efficacy|21|||
33576333|NCT00783432|102000065|FG000|Overall Study|Lost to Follow-up|11|||
33576334|NCT00783432|102000066|FG001|Overall Study|Lost to Follow-up|6|||
33576335|NCT00783432|102000065|FG000|Overall Study|Withdrawal by Subject|23|||
33576336|NCT00783432|102000066|FG001|Overall Study|Withdrawal by Subject|20|||
33576337|NCT00783432|102000065|FG000|Overall Study|subject moved|3|||
33576338|NCT00783432|102000066|FG001|Overall Study|subject moved|5|||
33576339|NCT00783432|102000065|FG000|Overall Study|Protocol Violation|6|||
33576340|NCT00783432|102000066|FG001|Overall Study|Protocol Violation|9|||
33576341|NCT00696878|102000067|FG000|Overall Study|Adverse Event|8|||
33576342|NCT00696878|102000067|FG000|Overall Study|Withdrawal by Subject|87|||
33576343|NCT00696878|102000067|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
33576344|NCT00696878|102000067|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
33576345|NCT00696878|102000067|FG000|Overall Study|Trial stopped|32|||
33576346|NCT00696878|102000067|FG000|Overall Study|Other reason (not specified)|55|||
33576347|NCT03783780|102003029|FG000|Overall Study|Withdrawn prior to completion|1|||
33576348|NCT02765399|102003030|FG000|Overall Study|Nausea|1|||
33576349|NCT02765399|102003031|FG001|Overall Study|Nausea|0|||
33576350|NCT00527618|102003036|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
33576351|NCT00527618|102003037|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
33576352|NCT00527618|102003036|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
33576353|NCT00527618|102003037|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
33576354|NCT00527618|102003036|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
33576355|NCT00527618|102003037|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
33576356|NCT00527618|102003036|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
33576357|NCT00527618|102003037|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
33138245|NCT00710762|100420180|FG000|Overall Study|Reason other than listed above|2|||
33138246|NCT00710762|100420181|FG001|Overall Study|Reason other than listed above|2|||
33234523|NCT02291289|100759994|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
33234524|NCT02291289|100759982|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
33234525|NCT02291289|100759983|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
33234526|NCT02291289|100759984|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
33234527|NCT02291289|100759985|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
33234528|NCT02291289|100759986|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
33234529|NCT02291289|100759987|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
33234530|NCT02291289|100759988|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
33234531|NCT02291289|100759989|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
33234532|NCT02291289|100759990|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
33234533|NCT02291289|100759991|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
33234534|NCT02291289|100759992|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
33234535|NCT02291289|100759993|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
33234536|NCT02291289|100759994|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
33234537|NCT02291289|100759982|FG000|Early Disease Progression|Death|0|||
33234538|NCT02291289|100759983|FG001|Early Disease Progression|Death|0|||
33234539|NCT02291289|100759984|FG002|Early Disease Progression|Death|0|||
33234540|NCT02291289|100759985|FG003|Early Disease Progression|Death|0|||
33234541|NCT02291289|100759986|FG004|Early Disease Progression|Death|0|||
33234542|NCT02291289|100759987|FG005|Early Disease Progression|Death|0|||
33234543|NCT02291289|100759988|FG006|Early Disease Progression|Death|0|||
33576358|NCT00527618|102003036|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
33576359|NCT00527618|102003037|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
33576360|NCT00527618|102003036|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
33576361|NCT00527618|102003037|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
33576362|NCT02639247|102003038|FG000|Overall Study|Lost to Follow-up|2|||
33576363|NCT02639247|102003039|FG001|Overall Study|Lost to Follow-up|1|||
33576364|NCT02639247|102003038|FG000|Overall Study|Death|2|||
33576365|NCT02639247|102003039|FG001|Overall Study|Death|0|||
33138247|NCT02285062|100420182|FG000|Pre-Treatment Period|Protocol Violation|0|||
33234544|NCT02291289|100759989|FG007|Early Disease Progression|Death|0|||
33234545|NCT02291289|100759990|FG008|Early Disease Progression|Death|0|||
33234546|NCT02291289|100759991|FG009|Early Disease Progression|Death|0|||
33234547|NCT02291289|100759992|FG010|Early Disease Progression|Death|0|||
33138248|NCT02285062|100420183|FG001|Pre-Treatment Period|Protocol Violation|2|||
33138249|NCT02285062|100420182|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
33138250|NCT02285062|100420183|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
33138251|NCT02586506|100420185|FG000|Overall Study|Protocol Violation|6|||
33138252|NCT02586506|100420185|FG000|Overall Study|Lost to Follow-up|1|||
33138253|NCT02586506|100420185|FG000|Overall Study|Other Reason|2|||
33138254|NCT02184455|100420186|FG000|Overall Study|Lost to Follow-up|1|||
33234548|NCT02291289|100759993|FG011|Early Disease Progression|Death|0|||
33234549|NCT02291289|100759994|FG012|Early Disease Progression|Death|10|||
33234550|NCT02291289|100759982|FG000|Early Disease Progression|Lost to Follow-up|0|||
33234551|NCT02291289|100759983|FG001|Early Disease Progression|Lost to Follow-up|0|||
33234552|NCT02291289|100759984|FG002|Early Disease Progression|Lost to Follow-up|0|||
33234553|NCT02291289|100759985|FG003|Early Disease Progression|Lost to Follow-up|0|||
33234554|NCT02291289|100759986|FG004|Early Disease Progression|Lost to Follow-up|0|||
33234555|NCT02291289|100759987|FG005|Early Disease Progression|Lost to Follow-up|0|||
33234556|NCT02291289|100759988|FG006|Early Disease Progression|Lost to Follow-up|0|||
33234557|NCT02291289|100759989|FG007|Early Disease Progression|Lost to Follow-up|0|||
33234558|NCT02291289|100759990|FG008|Early Disease Progression|Lost to Follow-up|0|||
33234559|NCT02291289|100759991|FG009|Early Disease Progression|Lost to Follow-up|0|||
33234560|NCT02291289|100759992|FG010|Early Disease Progression|Lost to Follow-up|0|||
33234561|NCT02291289|100759993|FG011|Early Disease Progression|Lost to Follow-up|0|||
33234562|NCT02291289|100759994|FG012|Early Disease Progression|Lost to Follow-up|1|||
33234563|NCT01836458|100759997|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
33234564|NCT01836458|100759998|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33234565|NCT01836458|100759999|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
33234566|NCT01836458|100760000|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
33576366|NCT02639247|102003038|FG000|Overall Study|Withdrew Consent|0|||
33576367|NCT02639247|102003039|FG001|Overall Study|Withdrew Consent|1|||
33576368|NCT02639247|102003038|FG000|Overall Study|Protocol Violation|1|||
33576369|NCT02639247|102003039|FG001|Overall Study|Protocol Violation|0|||
33576370|NCT03745768|102003041|FG000|Overall Study|discontinued study|2|||
33576371|NCT03745768|102003042|FG001|Overall Study|discontinued study|0|||
33576372|NCT00976716|102003043|FG000|Overall Study|Adverse Event|1|||
33576373|NCT01349673|102003047|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
33576374|NCT01349673|102003047|FG000|Overall Study|No Longer Qualified For Study|1|||
33576375|NCT01349673|102003047|FG000|Overall Study|Site Closure|10|||
33576376|NCT01349673|102003047|FG000|Overall Study|Withdrawal by Subject|21|||
33576377|NCT01349673|102003047|FG000|Overall Study|Lost to Follow-up|6|||
33576378|NCT01349673|102003047|FG000|Overall Study|Adverse Event|17|||
33576379|NCT01349673|102003047|FG000|Overall Study|Study Terminated By Sponsor|50|||
33576380|NCT01349673|102003047|FG000|Overall Study|Lack of Efficacy|8|||
33576381|NCT00846846|102003048|FG000|Overall Study|Death|56|||
33576382|NCT00846846|102003048|FG000|Overall Study|Withdrawal by Subject|19|||
33576383|NCT01392573|102003051|FG000|Overall Study|Adverse Event|1|||
33576384|NCT01392573|102003052|FG001|Overall Study|Adverse Event|3|||
33576385|NCT01392573|102003051|FG000|Overall Study|Lack of Efficacy|1|||
33576386|NCT01392573|102003052|FG001|Overall Study|Lack of Efficacy|2|||
33576387|NCT01392573|102003051|FG000|Overall Study|Protocol Violation|0|||
33576388|NCT01392573|102003052|FG001|Overall Study|Protocol Violation|2|||
33636887|NCT03038100|102222980|FG000|Overall Study|Protocol Deviation|1|||
33636888|NCT03038100|102222981|FG001|Overall Study|Protocol Deviation|4|||
33576389|NCT01392573|102003051|FG000|Overall Study|Withdrawal Criteria|13|||
33576390|NCT01392573|102003052|FG001|Overall Study|Withdrawal Criteria|15|||
33576391|NCT01392573|102003051|FG000|Overall Study|Site closure|8|||
33576392|NCT01392573|102003052|FG001|Overall Study|Site closure|7|||
33576393|NCT01392573|102003051|FG000|Overall Study|Unclassified|9|||
33576394|NCT01392573|102003052|FG001|Overall Study|Unclassified|6|||
33576395|NCT02197572|102003053|FG000|Overall Study|Progressive Disease|28|||
33636889|NCT03038100|102222980|FG000|Overall Study|Withdrawal by Subject|45|||
33636890|NCT03038100|102222981|FG001|Overall Study|Withdrawal by Subject|51|||
33636891|NCT03038100|102222980|FG000|Overall Study|Study Terminated By Sponsor|305|||
33636892|NCT03038100|102222981|FG001|Overall Study|Study Terminated By Sponsor|311|||
33234567|NCT00776100|100760007|FG000|Overall Study|Disease Progression|1|||
33138255|NCT01499368|100420191|FG000|Overall Study|Did not meet I/E criteria|8|||
33576396|NCT02197572|102003053|FG000|Overall Study|Withdrawal by Subject|9|||
33576397|NCT02197572|102003053|FG000|Overall Study|Adverse Event|3|||
33576398|NCT02197572|102003053|FG000|Overall Study|Reason Not Specified|4|||
33576399|NCT00325143|102003054|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
33636893|NCT03038100|102222980|FG000|Overall Study|Physician Decision|1|||
33138256|NCT01499368|100420192|FG001|Overall Study|Did not meet I/E criteria|4|||
33234568|NCT00776100|100760008|FG001|Overall Study|Disease Progression|0|||
33234569|NCT01310868|100760009|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
33234570|NCT00432679|100760014|FG000|Overall Study|Adverse Event|2|||
33234571|NCT00432679|100760015|FG001|Overall Study|Adverse Event|1|||
33234572|NCT00432679|100760014|FG000|Overall Study|Withdrawal by Subject|3|||
33420363|NCT00995930|101428599|FG000|Overall Study|Adverse Event|11|||
33234573|NCT00432679|100760015|FG001|Overall Study|Withdrawal by Subject|2|||
33234574|NCT00806624|100760020|FG000|Overall Study|Adverse Event|2|||
33234575|NCT00806624|100760021|FG001|Overall Study|Adverse Event|8|||
33234576|NCT00806624|100760022|FG002|Overall Study|Adverse Event|0|||
33234577|NCT00806624|100760020|FG000|Overall Study|Death|0|||
33234578|NCT00806624|100760021|FG001|Overall Study|Death|1|||
33234579|NCT00806624|100760022|FG002|Overall Study|Death|1|||
33234580|NCT00806624|100760020|FG000|Overall Study|Lost to Follow-up|1|||
33234581|NCT00806624|100760021|FG001|Overall Study|Lost to Follow-up|0|||
33234582|NCT00806624|100760022|FG002|Overall Study|Lost to Follow-up|1|||
33234583|NCT00806624|100760020|FG000|Overall Study|Withdrawal by Subject|6|||
33234584|NCT00806624|100760021|FG001|Overall Study|Withdrawal by Subject|3|||
33234585|NCT00806624|100760022|FG002|Overall Study|Withdrawal by Subject|3|||
33234586|NCT00806624|100760020|FG000|Overall Study|discontinued before start of treatment|0|||
33234587|NCT00806624|100760021|FG001|Overall Study|discontinued before start of treatment|0|||
33234588|NCT00806624|100760022|FG002|Overall Study|discontinued before start of treatment|1|||
33234589|NCT01388530|100760024|FG000|Overall Study|Lost to Follow-up|5|||
33234590|NCT04266795|100760028|FG000|Overall Study|Adverse Event|10|||
33234591|NCT04266795|100760029|FG001|Overall Study|Adverse Event|19|||
33234592|NCT04266795|100760028|FG000|Overall Study|Death|7|||
33234593|NCT04266795|100760029|FG001|Overall Study|Death|8|||
33234594|NCT04266795|100760028|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
33234595|NCT04266795|100760029|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
33234596|NCT04266795|100760028|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
33234597|NCT04266795|100760029|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
33234598|NCT04266795|100760028|FG000|Overall Study|Progressive Disease|12|||
33234599|NCT04266795|100760029|FG001|Overall Study|Progressive Disease|9|||
33234600|NCT04266795|100760028|FG000|Overall Study|Withdrawal by Patient|5|||
33234601|NCT04266795|100760029|FG001|Overall Study|Withdrawal by Patient|6|||
33234602|NCT04266795|100760028|FG000|Overall Study|Disease Relapse|3|||
33576400|NCT00325143|102003054|FG000|Overall Study|Migrated/moved from study area|1|||
33576401|NCT00325143|102003054|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
33576402|NCT00325143|102003054|FG000|Overall Study|Withdrawal by Subject|8|||
33576403|NCT00272792|102003056|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
33636894|NCT03038100|102222981|FG001|Overall Study|Physician Decision|3|||
33138257|NCT01499368|100420193|FG002|Overall Study|Did not meet I/E criteria|4|||
33138258|NCT01499368|100420191|FG000|Overall Study|Prohibited Concomitant medication|1|||
33138259|NCT01499368|100420192|FG001|Overall Study|Prohibited Concomitant medication|1|||
33138260|NCT01499368|100420193|FG002|Overall Study|Prohibited Concomitant medication|0|||
33138261|NCT01499368|100420191|FG000|Overall Study|Withdrawal by Subject|11|||
33138262|NCT01499368|100420192|FG001|Overall Study|Withdrawal by Subject|10|||
33138263|NCT01499368|100420193|FG002|Overall Study|Withdrawal by Subject|8|||
33138264|NCT01499368|100420191|FG000|Overall Study|Lost to Follow-up|3|||
33138265|NCT01499368|100420192|FG001|Overall Study|Lost to Follow-up|2|||
33138266|NCT01499368|100420193|FG002|Overall Study|Lost to Follow-up|5|||
33138267|NCT01499368|100420191|FG000|Overall Study|Adverse Event|4|||
33138268|NCT01499368|100420192|FG001|Overall Study|Adverse Event|0|||
33138269|NCT01499368|100420193|FG002|Overall Study|Adverse Event|2|||
33138270|NCT01499368|100420191|FG000|Overall Study|Physician Decision|0|||
33138271|NCT01499368|100420192|FG001|Overall Study|Physician Decision|1|||
33138272|NCT01499368|100420193|FG002|Overall Study|Physician Decision|0|||
33138273|NCT01499368|100420191|FG000|Overall Study|Deviation from visit window|0|||
33138274|NCT01499368|100420192|FG001|Overall Study|Deviation from visit window|0|||
33138275|NCT01499368|100420193|FG002|Overall Study|Deviation from visit window|1|||
33138276|NCT01499368|100420191|FG000|Overall Study|Error of Prescriptions|0|||
33138277|NCT01499368|100420192|FG001|Overall Study|Error of Prescriptions|0|||
33138278|NCT01499368|100420193|FG002|Overall Study|Error of Prescriptions|1|||
33138279|NCT00945906|100420194|FG000|Overall Study|Withdrawal by Subject|1|||
33138280|NCT00945906|100420194|FG000|Overall Study|Did not want to return for last visit|2|||
33138281|NCT00945906|100420194|FG000|Overall Study|Unable to return for last visit|2|||
33138282|NCT00945906|100420194|FG000|Overall Study|Moved to another country|2|||
33138283|NCT00984620|100420199|FG000|Overall Study|Adverse Event|5|||
33138284|NCT00984620|100420200|FG001|Overall Study|Adverse Event|5|||
33138285|NCT00984620|100420199|FG000|Overall Study|Lost to Follow-up|1|||
33138286|NCT00984620|100420200|FG001|Overall Study|Lost to Follow-up|1|||
33138287|NCT00984620|100420199|FG000|Overall Study|Withdrawal by Subject|0|||
33138288|NCT00984620|100420200|FG001|Overall Study|Withdrawal by Subject|2|||
33138289|NCT00984620|100420199|FG000|Overall Study|reason other than listed above|0|||
33138290|NCT00984620|100420200|FG001|Overall Study|reason other than listed above|4|||
33234603|NCT04266795|100760029|FG001|Overall Study|Disease Relapse|6|||
33234604|NCT04266795|100760028|FG000|Overall Study|Reason not Specified|12|||
33234605|NCT04266795|100760029|FG001|Overall Study|Reason not Specified|10|||
33138291|NCT01193257|100420206|FG000|Overall Study|Death|202|||
33138292|NCT01193257|100420207|FG001|Overall Study|Death|391|||
33138293|NCT01193257|100420206|FG000|Overall Study|Study termination by sponsor|0|||
33138294|NCT01193257|100420207|FG001|Overall Study|Study termination by sponsor|3|||
33234606|NCT04266795|100760028|FG000|Overall Study|Participants Ongoing on Treatment|25|||
33234607|NCT04266795|100760029|FG001|Overall Study|Participants Ongoing on Treatment|23|||
33234608|NCT02954575|100760030|FG000|Overall Study|Withdrawal by Subject|2|||
33234609|NCT02954575|100760030|FG000|Overall Study|Adverse Event|1|||
33234610|NCT01824472|100760031|FG000|Overall Study|Lost to Follow-up|0|||
33234611|NCT01824472|100760032|FG001|Overall Study|Lost to Follow-up|0|||
33234612|NCT01824472|100760033|FG002|Overall Study|Lost to Follow-up|1|||
33234613|NCT01824472|100760031|FG000|Overall Study|Withdrawal by Subject|1|||
33576404|NCT00272792|102003057|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
33576405|NCT00272792|102003056|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
33138295|NCT01193257|100420206|FG000|Overall Study|Withdrawal by Subject|26|||
33138296|NCT01193257|100420207|FG001|Overall Study|Withdrawal by Subject|86|||
33138297|NCT01193257|100420206|FG000|Overall Study|Lost to Follow-up|2|||
33138298|NCT01193257|100420207|FG001|Overall Study|Lost to Follow-up|3|||
33138299|NCT01193257|100420206|FG000|Overall Study|Unblinded due to futility|135|||
33138300|NCT01193257|100420207|FG001|Overall Study|Unblinded due to futility|251|||
33138301|NCT03051620|100420208|FG000|Overall Study|Lost to Follow-up|6|||
33138302|NCT03051620|100420208|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
33138303|NCT03077087|100420209|FG000|Overall Study|Physician Decision|2|||
33138304|NCT01306929|100420210|FG000|Overall Study|Withdrawal by Subject|23|||
33138305|NCT01306929|100420210|FG000|Overall Study|Adverse Event|21|||
33138306|NCT01306929|100420210|FG000|Overall Study|Physician Decision|13|||
33138307|NCT01306929|100420210|FG000|Overall Study|Death|8|||
33138308|NCT01306929|100420210|FG000|Overall Study|Withdrawal by parent/guardian|5|||
33138309|NCT01306929|100420210|FG000|Overall Study|Protocol Violation|3|||
33138310|NCT01306929|100420210|FG000|Overall Study|Non-compliance with study drug|2|||
33138311|NCT01306929|100420210|FG000|Overall Study|Lost to Follow-up|2|||
33138312|NCT01306929|100420210|FG000|Overall Study|Various|17|||
33138313|NCT01836276|100420211|FG000|Overall Study|Lost to Follow-up|28|||
33138314|NCT01836276|100420212|FG001|Overall Study|Lost to Follow-up|51|||
33138315|NCT01561898|100420214|FG000|Overall Study|Withdrawal by Subject|0|||
33138316|NCT01561898|100420215|FG001|Overall Study|Withdrawal by Subject|8|||
33138317|NCT01561898|100420216|FG002|Overall Study|Withdrawal by Subject|12|||
33138318|NCT01561898|100420217|FG003|Overall Study|Withdrawal by Subject|5|||
33138319|NCT01561898|100420214|FG000|Overall Study|Lack of Efficacy|0|||
33138320|NCT01561898|100420215|FG001|Overall Study|Lack of Efficacy|8|||
33138321|NCT01561898|100420216|FG002|Overall Study|Lack of Efficacy|10|||
33138322|NCT01561898|100420217|FG003|Overall Study|Lack of Efficacy|5|||
33138323|NCT01561898|100420214|FG000|Overall Study|Worsening of complications|0|||
33138324|NCT01561898|100420215|FG001|Overall Study|Worsening of complications|1|||
33138325|NCT01561898|100420216|FG002|Overall Study|Worsening of complications|0|||
33138326|NCT01561898|100420217|FG003|Overall Study|Worsening of complications|0|||
33138327|NCT01561898|100420214|FG000|Overall Study|Lost to Follow-up|0|||
33138328|NCT01561898|100420215|FG001|Overall Study|Lost to Follow-up|0|||
33138329|NCT01561898|100420216|FG002|Overall Study|Lost to Follow-up|1|||
33138330|NCT01561898|100420217|FG003|Overall Study|Lost to Follow-up|0|||
33138331|NCT01561898|100420214|FG000|Overall Study|Adverse Event|1|||
33138332|NCT01561898|100420215|FG001|Overall Study|Adverse Event|19|||
33234614|NCT01824472|100760032|FG001|Overall Study|Withdrawal by Subject|5|||
33234615|NCT01824472|100760033|FG002|Overall Study|Withdrawal by Subject|3|||
33234616|NCT01824472|100760031|FG000|Overall Study|Ineligible post randomization&screening|0|||
33576406|NCT00272792|102003057|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
33576407|NCT00272792|102003056|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
33576408|NCT00272792|102003057|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
33576409|NCT00272792|102003056|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
33576410|NCT00272792|102003057|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
33576411|NCT04067492|102003059|FG000|Overall Study|Lost to Follow-up|0|||
33576412|NCT04067492|102003060|FG001|Overall Study|Lost to Follow-up|0|||
33576413|NCT04067492|102003061|FG002|Overall Study|Lost to Follow-up|0|||
33576414|NCT04067492|102003062|FG003|Overall Study|Lost to Follow-up|0|||
33576415|NCT04067492|102003063|FG004|Overall Study|Lost to Follow-up|0|||
33576416|NCT04067492|102003064|FG005|Overall Study|Lost to Follow-up|1|||
33576417|NCT04067492|102003059|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
33138333|NCT01561898|100420216|FG002|Overall Study|Adverse Event|14|||
33138334|NCT01561898|100420217|FG003|Overall Study|Adverse Event|9|||
33138335|NCT01561898|100420214|FG000|Overall Study|Physician Decision|1|||
33138336|NCT01561898|100420215|FG001|Overall Study|Physician Decision|5|||
33138337|NCT01561898|100420216|FG002|Overall Study|Physician Decision|7|||
33138338|NCT01561898|100420217|FG003|Overall Study|Physician Decision|1|||
33138339|NCT00329849|100420218|FG000|Overall Study|Withdrawal by Subject|6|||
33138340|NCT00329849|100420219|FG001|Overall Study|Withdrawal by Subject|4|||
33138341|NCT01357850|100420223|FG000|Overall Study|Lost to Follow-up|1|||
33138342|NCT01357850|100420224|FG001|Overall Study|Lost to Follow-up|0|||
33138343|NCT01357850|100420225|FG002|Overall Study|Lost to Follow-up|0|||
33138344|NCT01357850|100420226|FG003|Overall Study|Lost to Follow-up|0|||
33234617|NCT01824472|100760032|FG001|Overall Study|Ineligible post randomization&screening|2|||
33234618|NCT01824472|100760033|FG002|Overall Study|Ineligible post randomization&screening|0|||
33234619|NCT04426006|100760036|FG000|Inclusion|Protocol Violation|1|||
33234620|NCT04426006|100760036|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
33234621|NCT04426006|100760036|FG000|Inclusion|Blood sample at inclusion not done|1|||
33234622|NCT04426006|100760036|FG000|3 Months|Lost to Follow-up|17|||
33234623|NCT04426006|100760036|FG000|12 Months|Lost to Follow-up|38|||
33234624|NCT00445601|100760039|FG000|Overall Study|Withdrawal by Subject|11|||
33234625|NCT00445601|100760040|FG001|Overall Study|Withdrawal by Subject|11|||
33234626|NCT00445601|100760039|FG000|Overall Study|TURBT Complication|12|||
33234627|NCT00445601|100760040|FG001|Overall Study|TURBT Complication|8|||
33234628|NCT00445601|100760039|FG000|Overall Study|Incorrect Disease Status|6|||
33234629|NCT00445601|100760040|FG001|Overall Study|Incorrect Disease Status|6|||
33234630|NCT00445601|100760039|FG000|Overall Study|Drug Delivery Issue|2|||
33234631|NCT00445601|100760040|FG001|Overall Study|Drug Delivery Issue|2|||
33234632|NCT00445601|100760039|FG000|Overall Study|Adverse Event|2|||
33234633|NCT00445601|100760040|FG001|Overall Study|Adverse Event|0|||
33234634|NCT00445601|100760039|FG000|Overall Study|Death prior to TURBT|0|||
33234635|NCT00445601|100760040|FG001|Overall Study|Death prior to TURBT|1|||
33234636|NCT03285113|100760045|FG000|Overall Study|Unable to implant leads|2|||
33234637|NCT01000376|100760046|FG000|Cycle 1 Day 1|Adverse Event|1|||
33234638|NCT01000376|100760047|FG001|Cycle 1 Day 1|Adverse Event|0|||
33234639|NCT01000376|100760046|FG000|Cycle 1 Day 1|Progressive Disease|1|||
33234640|NCT01000376|100760047|FG001|Cycle 1 Day 1|Progressive Disease|0|||
33234641|NCT03873246|100760049|FG000|Overall Study|Adverse Event|1|||
33234642|NCT03873246|100760050|FG001|Overall Study|Adverse Event|3|||
33234643|NCT03873246|100760051|FG002|Overall Study|Adverse Event|3|||
33234644|NCT03873246|100760049|FG000|Overall Study|Lost to Follow-up|4|||
33234645|NCT03873246|100760050|FG001|Overall Study|Lost to Follow-up|4|||
33576418|NCT04067492|102003060|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
33234646|NCT03873246|100760051|FG002|Overall Study|Lost to Follow-up|5|||
33234647|NCT03873246|100760049|FG000|Overall Study|Protocol Violation|0|||
33234648|NCT03873246|100760050|FG001|Overall Study|Protocol Violation|1|||
33234649|NCT03873246|100760051|FG002|Overall Study|Protocol Violation|0|||
33234650|NCT03873246|100760049|FG000|Overall Study|Withdrawal by Subject|0|||
33234651|NCT03873246|100760050|FG001|Overall Study|Withdrawal by Subject|4|||
33234652|NCT03873246|100760051|FG002|Overall Study|Withdrawal by Subject|1|||
33234653|NCT02262260|100760052|FG000|Overall Study|Adverse Event|4|||
33234654|NCT02262260|100760053|FG001|Overall Study|Adverse Event|1|||
33234655|NCT02262260|100760052|FG000|Overall Study|Withdrawal of consent|4|||
33234656|NCT02262260|100760053|FG001|Overall Study|Withdrawal of consent|2|||
33234657|NCT02262260|100760052|FG000|Overall Study|Lost to Follow-up|1|||
33234658|NCT02262260|100760053|FG001|Overall Study|Lost to Follow-up|2|||
33420364|NCT00995930|101428600|FG001|Overall Study|Adverse Event|14|||
33576419|NCT04067492|102003061|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
33576420|NCT04067492|102003062|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
33576421|NCT04067492|102003063|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
33576422|NCT04067492|102003064|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
33576423|NCT04067492|102003059|FG000|Overall Study|COVID-19 epidemiological situation|0|||
33576424|NCT04067492|102003060|FG001|Overall Study|COVID-19 epidemiological situation|0|||
33576425|NCT04067492|102003061|FG002|Overall Study|COVID-19 epidemiological situation|0|||
33576426|NCT04067492|102003062|FG003|Overall Study|COVID-19 epidemiological situation|1|||
33576427|NCT04067492|102003063|FG004|Overall Study|COVID-19 epidemiological situation|0|||
33576428|NCT04067492|102003064|FG005|Overall Study|COVID-19 epidemiological situation|0|||
33576429|NCT00959907|102003069|FG000|Overall Study|Protocol Violation|0|||
33576430|NCT00959907|102003070|FG001|Overall Study|Protocol Violation|1|||
33576431|NCT00959907|102003069|FG000|Overall Study|Adverse Event|1|||
33576432|NCT00959907|102003070|FG001|Overall Study|Adverse Event|0|||
33576433|NCT00959907|102003069|FG000|Overall Study|Withdrawal by Subject|2|||
33576434|NCT00959907|102003070|FG001|Overall Study|Withdrawal by Subject|0|||
33576435|NCT01870869|102003071|FG000|Overall Study|Implanted with nonstudy device|1|||
33576436|NCT01870869|102003072|FG001|Overall Study|Implanted with nonstudy device|3|||
33576437|NCT01870869|102003073|FG002|Overall Study|Implanted with nonstudy device|14|||
33576438|NCT01870869|102003074|FG003|Overall Study|Implanted with nonstudy device|4|||
33234659|NCT02262260|100760052|FG000|Overall Study|Protocol deviation|2|||
33234660|NCT02262260|100760053|FG001|Overall Study|Protocol deviation|5|||
33420365|NCT03174925|101428601|FG000|Overall Study|Elastographic images not retrievable|2|||
33234661|NCT00439179|100760061|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
33234662|NCT00439179|100760062|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
33234663|NCT00439179|100760063|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
33234664|NCT00439179|100760064|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
33234665|NCT03875911|100760066|FG000|Overall Study|Lost to Follow-up|3|||
33234666|NCT03875911|100760067|FG001|Overall Study|Lost to Follow-up|6|||
33234667|NCT03875911|100760068|FG002|Overall Study|Lost to Follow-up|2|||
33234668|NCT03875911|100760066|FG000|Overall Study|Surgery cancelled|1|||
33576439|NCT01870869|102003071|FG000|Overall Study|Death|0|||
33576440|NCT01870869|102003072|FG001|Overall Study|Death|0|||
33576441|NCT01870869|102003073|FG002|Overall Study|Death|7|||
33576442|NCT01870869|102003074|FG003|Overall Study|Death|1|||
33576443|NCT01870869|102003071|FG000|Overall Study|Subject choice|6|||
33576444|NCT01870869|102003072|FG001|Overall Study|Subject choice|2|||
33576445|NCT01870869|102003073|FG002|Overall Study|Subject choice|22|||
33576446|NCT01870869|102003074|FG003|Overall Study|Subject choice|8|||
33636895|NCT04154904|102222982|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
33636896|NCT04154904|102222983|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
33636897|NCT04154904|102222984|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
33234669|NCT03875911|100760067|FG001|Overall Study|Surgery cancelled|0|||
33234670|NCT03875911|100760068|FG002|Overall Study|Surgery cancelled|1|||
33368867|NCT03582033|101234933|FG004|Part C|Study terminated by sponsor|0|||
33368868|NCT03582033|101234934|FG005|Part C|Study terminated by sponsor|0|||
33576447|NCT01870869|102003071|FG000|Overall Study|Lost to Follow-up|10|||
33576448|NCT01870869|102003072|FG001|Overall Study|Lost to Follow-up|2|||
33576449|NCT01870869|102003073|FG002|Overall Study|Lost to Follow-up|25|||
33636898|NCT03337477|102222987|FG000|Overall Study|not categorized into the listed ones|11|||
33636899|NCT03337477|102222988|FG001|Overall Study|not categorized into the listed ones|9|||
33636900|NCT03337477|102222987|FG000|Overall Study|Withdrawal by Subject|0|||
33636901|NCT03337477|102222988|FG001|Overall Study|Withdrawal by Subject|1|||
33636902|NCT03337477|102222987|FG000|Overall Study|Death|0|||
33636903|NCT03337477|102222988|FG001|Overall Study|Death|1|||
33636904|NCT03337477|102222987|FG000|Overall Study|Lost to Follow-up|0|||
33636905|NCT03337477|102222988|FG001|Overall Study|Lost to Follow-up|2|||
33636906|NCT02699749|102222989|FG000|Overall Study|Other|0|||
33636907|NCT02699749|102222990|FG001|Overall Study|Other|0|||
33636908|NCT02699749|102222991|FG002|Overall Study|Other|2|||
33636909|NCT02699749|102222992|FG003|Overall Study|Other|0|||
33636910|NCT02699749|102222993|FG004|Overall Study|Other|0|||
33636911|NCT02699749|102222994|FG005|Overall Study|Other|1|||
33636912|NCT02699749|102222995|FG006|Overall Study|Other|1|||
33636913|NCT02699749|102222996|FG007|Overall Study|Other|0|||
33636914|NCT02699749|102222997|FG008|Overall Study|Other|0|||
33636915|NCT02699749|102222998|FG009|Overall Study|Other|0|||
33636916|NCT02699749|102222999|FG010|Overall Study|Other|1|||
33636917|NCT02699749|102223000|FG011|Overall Study|Other|0|||
33636918|NCT02699749|102223001|FG012|Overall Study|Other|0|||
33636919|NCT02699749|102223002|FG013|Overall Study|Other|0|||
33636920|NCT02699749|102222989|FG000|Overall Study|Progressive Disease|3|||
33636921|NCT02699749|102222990|FG001|Overall Study|Progressive Disease|3|||
33636922|NCT02699749|102222991|FG002|Overall Study|Progressive Disease|14|||
33636923|NCT02699749|102222992|FG003|Overall Study|Progressive Disease|3|||
33636924|NCT02699749|102222993|FG004|Overall Study|Progressive Disease|3|||
33636925|NCT02699749|102222994|FG005|Overall Study|Progressive Disease|7|||
33636926|NCT02699749|102222995|FG006|Overall Study|Progressive Disease|5|||
33636927|NCT02699749|102222996|FG007|Overall Study|Progressive Disease|5|||
33636928|NCT02699749|102222997|FG008|Overall Study|Progressive Disease|6|||
33636929|NCT02699749|102222998|FG009|Overall Study|Progressive Disease|6|||
33636930|NCT02699749|102222999|FG010|Overall Study|Progressive Disease|5|||
33636931|NCT02699749|102223000|FG011|Overall Study|Progressive Disease|4|||
33138345|NCT04658940|100420229|FG000|Overall Study|Withdrawal by Subject|1|||
33138346|NCT02925416|100420232|FG000|Overall Study|Adverse Event|2|||
33636932|NCT02699749|102223001|FG012|Overall Study|Progressive Disease|3|||
33636933|NCT02699749|102223002|FG013|Overall Study|Progressive Disease|5|||
33636934|NCT02699749|102222989|FG000|Overall Study|Death|0|||
33138347|NCT02925416|100420233|FG001|Overall Study|Adverse Event|0|||
33138348|NCT01369329|100420236|FG000|Overall Study|Withdrawal by Subject|8|||
33138349|NCT01369329|100420237|FG001|Overall Study|Withdrawal by Subject|6|||
33138350|NCT01369329|100420238|FG002|Overall Study|Withdrawal by Subject|10|||
33138351|NCT01369329|100420236|FG000|Overall Study|Lost to Follow-up|2|||
33138352|NCT01369329|100420237|FG001|Overall Study|Lost to Follow-up|2|||
33138353|NCT01369329|100420238|FG002|Overall Study|Lost to Follow-up|2|||
33138354|NCT01369329|100420236|FG000|Overall Study|Other|2|||
33138355|NCT01369329|100420237|FG001|Overall Study|Other|3|||
33138356|NCT01369329|100420238|FG002|Overall Study|Other|2|||
33138357|NCT02600871|100420239|FG000|Overall Study|Lost to Follow-up|13|||
33138358|NCT02600871|100420240|FG001|Overall Study|Lost to Follow-up|10|||
33138359|NCT00843778|100420241|FG000|Overall Study|Adverse Event|15|||
33138360|NCT00843778|100420241|FG000|Overall Study|Lack of Efficacy|14|||
33138361|NCT00843778|100420241|FG000|Overall Study|Loss of efficacy|2|||
33138362|NCT00843778|100420241|FG000|Overall Study|Withdrawal by Subject|4|||
33138363|NCT00653432|100420242|FG000|Overall Study|Adverse Event|4|||
33138364|NCT00653432|100420243|FG001|Overall Study|Adverse Event|1|||
33138365|NCT00653432|100420242|FG000|Overall Study|Withdrawal by Subject|4|||
33138366|NCT00653432|100420243|FG001|Overall Study|Withdrawal by Subject|5|||
33138367|NCT00653432|100420242|FG000|Overall Study|Lost to Follow-up|7|||
33138368|NCT00653432|100420243|FG001|Overall Study|Lost to Follow-up|6|||
33138369|NCT00653432|100420242|FG000|Overall Study|Use/Need of Con Therapy|2|||
33138370|NCT00653432|100420243|FG001|Overall Study|Use/Need of Con Therapy|1|||
33234671|NCT03875911|100760066|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
33234672|NCT03875911|100760067|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
33234673|NCT03875911|100760068|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
33234674|NCT01544114|100760070|FG000|Overall Study|Withdrawal by Subject|0|||
33234675|NCT01544114|100760071|FG001|Overall Study|Withdrawal by Subject|0|||
33234676|NCT01544114|100760072|FG002|Overall Study|Withdrawal by Subject|3|||
33234677|NCT01544114|100760070|FG000|Overall Study|Lost to Follow-up|0|||
33138371|NCT00653432|100420242|FG000|Overall Study|Other - Reason Not Provided|5|||
33234678|NCT01544114|100760071|FG001|Overall Study|Lost to Follow-up|2|||
33234679|NCT01544114|100760072|FG002|Overall Study|Lost to Follow-up|0|||
33234680|NCT01544114|100760070|FG000|Overall Study|Adverse Event|1|||
33234681|NCT01544114|100760071|FG001|Overall Study|Adverse Event|1|||
33234682|NCT01544114|100760072|FG002|Overall Study|Adverse Event|2|||
33234683|NCT01544114|100760070|FG000|Overall Study|Protocol Violation|0|||
33234684|NCT01544114|100760071|FG001|Overall Study|Protocol Violation|1|||
33234685|NCT01544114|100760072|FG002|Overall Study|Protocol Violation|0|||
33234686|NCT00604786|100760073|FG000|Overall Study|Lost to Follow-up|2|||
33234687|NCT00604786|100760074|FG001|Overall Study|Lost to Follow-up|0|||
33234688|NCT02499328|100760078|FG000|Overall Study|Withdrawal by Subject|1|||
33234689|NCT02499328|100760079|FG001|Overall Study|Withdrawal by Subject|1|||
33234690|NCT02499328|100760080|FG002|Overall Study|Withdrawal by Subject|5|||
33234691|NCT02499328|100760081|FG003|Overall Study|Withdrawal by Subject|3|||
33234692|NCT02499328|100760082|FG004|Overall Study|Withdrawal by Subject|5|||
33234693|NCT02499328|100760083|FG005|Overall Study|Withdrawal by Subject|0|||
33234694|NCT02499328|100760084|FG006|Overall Study|Withdrawal by Subject|0|||
33234695|NCT02499328|100760085|FG007|Overall Study|Withdrawal by Subject|0|||
33234696|NCT02499328|100760086|FG008|Overall Study|Withdrawal by Subject|2|||
33234697|NCT02499328|100760087|FG009|Overall Study|Withdrawal by Subject|2|||
33234698|NCT02499328|100760088|FG010|Overall Study|Withdrawal by Subject|0|||
33234699|NCT02499328|100760089|FG011|Overall Study|Withdrawal by Subject|3|||
33234700|NCT02499328|100760090|FG012|Overall Study|Withdrawal by Subject|7|||
33234701|NCT02499328|100760091|FG013|Overall Study|Withdrawal by Subject|3|||
33234702|NCT02499328|100760092|FG014|Overall Study|Withdrawal by Subject|1|||
33576450|NCT01870869|102003074|FG003|Overall Study|Lost to Follow-up|3|||
33576451|NCT01870869|102003071|FG000|Overall Study|Reason not Specified|1|||
33576452|NCT01870869|102003072|FG001|Overall Study|Reason not Specified|2|||
33576453|NCT01870869|102003073|FG002|Overall Study|Reason not Specified|20|||
33576454|NCT01870869|102003074|FG003|Overall Study|Reason not Specified|4|||
33576455|NCT01870869|102003071|FG000|Overall Study|Not evaluable|10|||
33576456|NCT01870869|102003072|FG001|Overall Study|Not evaluable|5|||
33576457|NCT01870869|102003073|FG002|Overall Study|Not evaluable|42|||
33576458|NCT01870869|102003074|FG003|Overall Study|Not evaluable|10|||
33138372|NCT00653432|100420243|FG001|Overall Study|Other - Reason Not Provided|3|||
33138373|NCT00727441|100420245|FG000|Overall Study|Disease Progression|11|||
33138374|NCT00727441|100420246|FG001|Overall Study|Disease Progression|14|||
33138375|NCT00727441|100420247|FG002|Overall Study|Disease Progression|17|||
33138376|NCT00727441|100420245|FG000|Overall Study|Eligibility|7|||
33138377|NCT00727441|100420246|FG001|Overall Study|Eligibility|5|||
33138378|NCT00727441|100420247|FG002|Overall Study|Eligibility|7|||
33138379|NCT00727441|100420245|FG000|Overall Study|Death|0|||
33138380|NCT00727441|100420246|FG001|Overall Study|Death|1|||
33138381|NCT00727441|100420247|FG002|Overall Study|Death|1|||
33138382|NCT00727441|100420245|FG000|Overall Study|Physician Decision|0|||
33138383|NCT00727441|100420246|FG001|Overall Study|Physician Decision|1|||
33138384|NCT00727441|100420247|FG002|Overall Study|Physician Decision|0|||
33138385|NCT00727441|100420245|FG000|Overall Study|Withdrawal by Subject|0|||
33138386|NCT00727441|100420246|FG001|Overall Study|Withdrawal by Subject|1|||
33138387|NCT00727441|100420247|FG002|Overall Study|Withdrawal by Subject|0|||
33138388|NCT01375075|100420248|FG000|Overall Study|Adverse Event|0|||
33576459|NCT03698279|102003075|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33576460|NCT03698279|102003076|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33576461|NCT03698279|102003077|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33138389|NCT01375075|100420249|FG001|Overall Study|Adverse Event|0|||
33138390|NCT01375075|100420250|FG002|Overall Study|Adverse Event|3|||
33138391|NCT01375075|100420251|FG003|Overall Study|Adverse Event|1|||
33138392|NCT01375075|100420252|FG004|Overall Study|Adverse Event|0|||
33234703|NCT02499328|100760093|FG015|Overall Study|Withdrawal by Subject|0|||
33234704|NCT02499328|100760094|FG016|Overall Study|Withdrawal by Subject|0|||
33234705|NCT02499328|100760095|FG017|Overall Study|Withdrawal by Subject|3|||
33234706|NCT02499328|100760096|FG018|Overall Study|Withdrawal by Subject|0|||
33234707|NCT02499328|100760078|FG000|Overall Study|Lost to Follow-up|0|||
33234708|NCT02499328|100760079|FG001|Overall Study|Lost to Follow-up|1|||
33234709|NCT02499328|100760080|FG002|Overall Study|Lost to Follow-up|1|||
33576462|NCT03698279|102003078|FG003|Overall Study|Withdrawal by parent/guardian|1|||
33576463|NCT03698279|102003079|FG004|Overall Study|Withdrawal by parent/guardian|0|||
33138393|NCT01375075|100420253|FG005|Overall Study|Adverse Event|1|||
33234710|NCT02499328|100760081|FG003|Overall Study|Lost to Follow-up|2|||
33234711|NCT02499328|100760082|FG004|Overall Study|Lost to Follow-up|0|||
33234712|NCT02499328|100760083|FG005|Overall Study|Lost to Follow-up|0|||
33234713|NCT02499328|100760084|FG006|Overall Study|Lost to Follow-up|0|||
33234714|NCT02499328|100760085|FG007|Overall Study|Lost to Follow-up|2|||
33138394|NCT01375075|100420248|FG000|Overall Study|Entry Criterion Not Met|1|||
33138395|NCT01375075|100420249|FG001|Overall Study|Entry Criterion Not Met|0|||
33138396|NCT01375075|100420250|FG002|Overall Study|Entry Criterion Not Met|0|||
33138397|NCT01375075|100420251|FG003|Overall Study|Entry Criterion Not Met|0|||
33234715|NCT02499328|100760086|FG008|Overall Study|Lost to Follow-up|3|||
33234716|NCT02499328|100760087|FG009|Overall Study|Lost to Follow-up|0|||
33234717|NCT02499328|100760088|FG010|Overall Study|Lost to Follow-up|0|||
33234718|NCT02499328|100760089|FG011|Overall Study|Lost to Follow-up|0|||
33234719|NCT02499328|100760090|FG012|Overall Study|Lost to Follow-up|0|||
33576464|NCT03698279|102003080|FG005|Overall Study|Withdrawal by parent/guardian|0|||
33576465|NCT03698279|102003075|FG000|Overall Study|Protocol deviation|1|||
33576466|NCT03698279|102003076|FG001|Overall Study|Protocol deviation|0|||
33576467|NCT03698279|102003077|FG002|Overall Study|Protocol deviation|1|||
33576468|NCT03698279|102003078|FG003|Overall Study|Protocol deviation|0|||
33576469|NCT03698279|102003079|FG004|Overall Study|Protocol deviation|0|||
33576470|NCT03698279|102003080|FG005|Overall Study|Protocol deviation|0|||
33576471|NCT03698279|102003075|FG000|Overall Study|Withdrawal by Subject|0|||
33576472|NCT03698279|102003076|FG001|Overall Study|Withdrawal by Subject|0|||
33576473|NCT03698279|102003077|FG002|Overall Study|Withdrawal by Subject|1|||
33576474|NCT03698279|102003078|FG003|Overall Study|Withdrawal by Subject|0|||
33576475|NCT03698279|102003079|FG004|Overall Study|Withdrawal by Subject|0|||
33576476|NCT03698279|102003080|FG005|Overall Study|Withdrawal by Subject|0|||
33576477|NCT03698279|102003075|FG000|Overall Study|Lost to Follow-up|3|||
33576478|NCT03698279|102003076|FG001|Overall Study|Lost to Follow-up|1|||
33576479|NCT03698279|102003077|FG002|Overall Study|Lost to Follow-up|4|||
33576480|NCT03698279|102003078|FG003|Overall Study|Lost to Follow-up|5|||
33576481|NCT03698279|102003079|FG004|Overall Study|Lost to Follow-up|0|||
33576482|NCT03698279|102003080|FG005|Overall Study|Lost to Follow-up|0|||
33576483|NCT03500211|102003081|FG000|Overall Study|Withdrawal by Subject|1|||
33576484|NCT03500211|102003082|FG001|Overall Study|Withdrawal by Subject|1|||
33576485|NCT01434654|102003083|FG000|Overall Study|Withdrawal by Subject|1|||
33576486|NCT01434654|102003084|FG001|Overall Study|Withdrawal by Subject|0|||
33576487|NCT01434654|102003083|FG000|Overall Study|Lost to Follow-up|1|||
33636935|NCT02699749|102222990|FG001|Overall Study|Death|0|||
33636936|NCT02699749|102222991|FG002|Overall Study|Death|0|||
33636937|NCT02699749|102222992|FG003|Overall Study|Death|0|||
33636938|NCT02699749|102222993|FG004|Overall Study|Death|0|||
33636939|NCT02699749|102222994|FG005|Overall Study|Death|0|||
33636940|NCT02699749|102222995|FG006|Overall Study|Death|0|||
33636941|NCT02699749|102222996|FG007|Overall Study|Death|0|||
33636942|NCT02699749|102222997|FG008|Overall Study|Death|0|||
33636943|NCT02699749|102222998|FG009|Overall Study|Death|0|||
33636944|NCT02699749|102222999|FG010|Overall Study|Death|0|||
33636945|NCT02699749|102223000|FG011|Overall Study|Death|0|||
33636946|NCT02699749|102223001|FG012|Overall Study|Death|0|||
33636947|NCT02699749|102223002|FG013|Overall Study|Death|1|||
33636948|NCT02699749|102222989|FG000|Overall Study|Lost to Follow-up|0|||
33636949|NCT02699749|102222990|FG001|Overall Study|Lost to Follow-up|0|||
33636950|NCT02699749|102222991|FG002|Overall Study|Lost to Follow-up|0|||
33636951|NCT02699749|102222992|FG003|Overall Study|Lost to Follow-up|0|||
33636952|NCT02699749|102222993|FG004|Overall Study|Lost to Follow-up|0|||
33636953|NCT02699749|102222994|FG005|Overall Study|Lost to Follow-up|1|||
33636954|NCT02699749|102222995|FG006|Overall Study|Lost to Follow-up|0|||
33138398|NCT01375075|100420252|FG004|Overall Study|Entry Criterion Not Met|0|||
33138399|NCT01375075|100420253|FG005|Overall Study|Entry Criterion Not Met|1|||
33234720|NCT02499328|100760091|FG013|Overall Study|Lost to Follow-up|0|||
33234721|NCT02499328|100760092|FG014|Overall Study|Lost to Follow-up|0|||
33576488|NCT01434654|102003084|FG001|Overall Study|Lost to Follow-up|0|||
33576489|NCT00087698|102003085|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
33138400|NCT01375075|100420248|FG000|Overall Study|Withdrawal by Subject|0|||
33138401|NCT01375075|100420249|FG001|Overall Study|Withdrawal by Subject|1|||
33138402|NCT01375075|100420250|FG002|Overall Study|Withdrawal by Subject|0|||
33138403|NCT01375075|100420251|FG003|Overall Study|Withdrawal by Subject|0|||
33576490|NCT00087698|102003085|FG000|Overall Study|Death from Other Causes|3|||
33576491|NCT00087698|102003085|FG000|Overall Study|Adverse Event|4|||
33576492|NCT00087698|102003085|FG000|Overall Study|Withdrawal by Subject|4|||
33576493|NCT00087698|102003085|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
33636955|NCT02699749|102222996|FG007|Overall Study|Lost to Follow-up|1|||
33636956|NCT02699749|102222997|FG008|Overall Study|Lost to Follow-up|0|||
33636957|NCT02699749|102222998|FG009|Overall Study|Lost to Follow-up|0|||
33636958|NCT02699749|102222999|FG010|Overall Study|Lost to Follow-up|0|||
33636959|NCT02699749|102223000|FG011|Overall Study|Lost to Follow-up|0|||
33636960|NCT02699749|102223001|FG012|Overall Study|Lost to Follow-up|0|||
33636961|NCT02699749|102223002|FG013|Overall Study|Lost to Follow-up|0|||
33636962|NCT03131570|102223003|FG000|Overall Study|Adverse Event|1|||
33636963|NCT03131570|102223004|FG001|Overall Study|Adverse Event|0|||
33234722|NCT02499328|100760093|FG015|Overall Study|Lost to Follow-up|0|||
33234723|NCT02499328|100760094|FG016|Overall Study|Lost to Follow-up|0|||
33368869|NCT03582033|101234935|FG006|Part C|Study terminated by sponsor|3|||
33368870|NCT03582033|101234936|FG007|Part C|Study terminated by sponsor|3|||
33138404|NCT01375075|100420252|FG004|Overall Study|Withdrawal by Subject|0|||
33368871|NCT03582033|101234937|FG008|Part C|Study terminated by sponsor|2|||
33368872|NCT03582033|101234938|FG009|Part C|Study terminated by sponsor|0|||
33138405|NCT01375075|100420253|FG005|Overall Study|Withdrawal by Subject|1|||
33138406|NCT00952380|100420256|FG000|Overall Study|Other|0|||
33138407|NCT00952380|100420257|FG001|Overall Study|Other|0|||
33138408|NCT00952380|100420258|FG002|Overall Study|Other|0|||
33138409|NCT00952380|100420259|FG003|Overall Study|Other|0|||
33138410|NCT00952380|100420260|FG004|Overall Study|Other|1|||
33138411|NCT00952380|100420256|FG000|Overall Study|Withdrawal by Subject|0|||
33138412|NCT00952380|100420257|FG001|Overall Study|Withdrawal by Subject|0|||
33138413|NCT00952380|100420258|FG002|Overall Study|Withdrawal by Subject|1|||
33368873|NCT03582033|101234929|FG000|Part C|Withdrawal by Subject|0|||
33368874|NCT03582033|101234930|FG001|Part C|Withdrawal by Subject|0|||
33636964|NCT02083354|102223022|FG000|Overall Study|Withdrawal by Subject|9|||
33636965|NCT02083354|102223022|FG000|Overall Study|Lost to Follow-up|1|||
33636966|NCT02083354|102223022|FG000|Overall Study|Adverse Event|3|||
33636967|NCT02083354|102223022|FG000|Overall Study|Disease progression|46|||
33636968|NCT02083354|102223022|FG000|Overall Study|Study closed/terminated|5|||
33636969|NCT01702311|102223027|FG000|Overall Study|Withdrawal by Subject|3|||
33636970|NCT01702311|102223028|FG001|Overall Study|Withdrawal by Subject|2|||
33636971|NCT01702311|102223027|FG000|Overall Study|Discharge less than 24 hours|10|||
33636972|NCT01702311|102223028|FG001|Overall Study|Discharge less than 24 hours|7|||
33636973|NCT01702311|102223027|FG000|Overall Study|Physician Decision|3|||
33636974|NCT01702311|102223028|FG001|Overall Study|Physician Decision|4|||
33636975|NCT02131259|102223029|FG000|Overall Study|Progressive disease|751|||
33576494|NCT00087698|102003085|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
33576495|NCT00087698|102003085|FG000|Overall Study|Clinical Relapse|1|||
33576496|NCT00087698|102003085|FG000|Overall Study|Death from Study Disease|2|||
33636976|NCT02131259|102223029|FG000|Overall Study|Adverse Event|341|||
33636977|NCT02131259|102223029|FG000|Overall Study|Lost to Follow-up|7|||
33636978|NCT02131259|102223029|FG000|Overall Study|Relocation|32|||
33636979|NCT02131259|102223029|FG000|Overall Study|Other|63|||
33636980|NCT02131259|102223029|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
33636981|NCT02131259|102223029|FG000|Overall Study|Progressive disease/relocation|1|||
33636982|NCT02131259|102223029|FG000|Overall Study|Progressive disease/other|2|||
33636983|NCT02131259|102223029|FG000|Overall Study|AE/lost to follow-up|1|||
33636984|NCT02131259|102223029|FG000|Overall Study|AE/other|1|||
33636985|NCT02131259|102223029|FG000|Overall Study|Progressive disease/AE/other|1|||
33636986|NCT02131259|102223029|FG000|Overall Study|Missing|3|||
33636987|NCT03125395|102223035|FG000|Overall Study|Adverse Event|2|||
33234724|NCT02499328|100760095|FG017|Overall Study|Lost to Follow-up|0|||
33576497|NCT00087698|102003085|FG000|Overall Study|Death from Study Drug Toxicity|2|||
33576498|NCT00087698|102003085|FG000|Overall Study|Protocol Violation|1|||
33576499|NCT00110214|102003086|FG000|Overall Study|Never started treatment|21|||
33576500|NCT00110214|102003087|FG001|Overall Study|Never started treatment|20|||
33576501|NCT00110214|102003086|FG000|Overall Study|Disease progression or death|260|||
33576502|NCT00110214|102003087|FG001|Overall Study|Disease progression or death|151|||
33576503|NCT00110214|102003086|FG000|Overall Study|Adverse Event|115|||
33576504|NCT00110214|102003087|FG001|Overall Study|Adverse Event|192|||
33576505|NCT00110214|102003086|FG000|Overall Study|Refused further treatment|52|||
33576506|NCT00110214|102003087|FG001|Overall Study|Refused further treatment|65|||
33576507|NCT00110214|102003086|FG000|Overall Study|Other (not specified)|61|||
33576508|NCT00110214|102003087|FG001|Overall Study|Other (not specified)|75|||
33576509|NCT01544348|102003095|FG000|Overall Study|Lost to Follow-up|1|||
33576510|NCT01544348|102003096|FG001|Overall Study|Lost to Follow-up|0|||
33576511|NCT01544348|102003097|FG002|Overall Study|Lost to Follow-up|0|||
33138414|NCT00952380|100420259|FG003|Overall Study|Withdrawal by Subject|0|||
33368875|NCT03582033|101234931|FG002|Part C|Withdrawal by Subject|0|||
33576512|NCT01544348|102003098|FG003|Overall Study|Lost to Follow-up|0|||
33368876|NCT03582033|101234932|FG003|Part C|Withdrawal by Subject|0|||
33368877|NCT03582033|101234933|FG004|Part C|Withdrawal by Subject|0|||
33368878|NCT03582033|101234934|FG005|Part C|Withdrawal by Subject|0|||
33576513|NCT01544348|102003099|FG004|Overall Study|Lost to Follow-up|0|||
33576514|NCT01544348|102003100|FG005|Overall Study|Lost to Follow-up|0|||
33576515|NCT01544348|102003101|FG006|Overall Study|Lost to Follow-up|1|||
33576516|NCT01544348|102003102|FG007|Overall Study|Lost to Follow-up|0|||
33636988|NCT03125395|102223035|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
33636989|NCT03125395|102223035|FG000|Overall Study|Physician Decision|2|||
33636990|NCT03125395|102223035|FG000|Overall Study|Commercial drug is available|5|||
33636991|NCT00408317|102223038|FG000|First Intervention Period|Adverse Event|0|||
33636992|NCT00408317|102223039|FG001|First Intervention Period|Adverse Event|1|||
33636993|NCT00408317|102223038|FG000|Second Intervention Period|Adverse Event|2|||
33636994|NCT00408317|102223039|FG001|Second Intervention Period|Adverse Event|0|||
33636995|NCT00408317|102223038|FG000|Second Intervention Period|Protocol Violation|0|||
33636996|NCT00408317|102223039|FG001|Second Intervention Period|Protocol Violation|1|||
33368879|NCT03582033|101234935|FG006|Part C|Withdrawal by Subject|1|||
33368880|NCT03582033|101234936|FG007|Part C|Withdrawal by Subject|2|||
33368881|NCT03582033|101234937|FG008|Part C|Withdrawal by Subject|1|||
33368882|NCT03582033|101234938|FG009|Part C|Withdrawal by Subject|0|||
33368883|NCT03582033|101234929|FG000|Part D|Death|0|||
33368884|NCT03582033|101234930|FG001|Part D|Death|0|||
33368885|NCT03582033|101234931|FG002|Part D|Death|0|||
33368886|NCT03582033|101234932|FG003|Part D|Death|0|||
33368887|NCT03582033|101234933|FG004|Part D|Death|0|||
33368888|NCT03582033|101234934|FG005|Part D|Death|0|||
33368889|NCT03582033|101234935|FG006|Part D|Death|0|||
33368890|NCT03582033|101234936|FG007|Part D|Death|0|||
33636997|NCT00408317|102223038|FG000|Second Intervention Period|Withdrawal of consent|0|||
33636998|NCT00408317|102223039|FG001|Second Intervention Period|Withdrawal of consent|1|||
33636999|NCT02851615|102223040|FG000|Overall Study|Cognitive Issue|1|||
33637000|NCT02851615|102223041|FG001|Overall Study|Cognitive Issue|0|||
33637001|NCT02851615|102223040|FG000|Overall Study|Lost to Follow-up|0|||
33637002|NCT02851615|102223041|FG001|Overall Study|Lost to Follow-up|4|||
33637003|NCT03857867|102223042|FG000|Overall Study|Physician Decision|1|||
33637004|NCT01021020|102223043|FG000|Period I|Protocol Violation|1|||
33637005|NCT01021020|102223043|FG000|Period I|Withdrawal by Subject|1|||
33637006|NCT01021020|102223043|FG000|14 Day Washout Period A|Physician Decision|1|||
33637007|NCT02919995|102223045|FG000|Overall Study|Adverse Event|0|||
33637008|NCT02919995|102223046|FG001|Overall Study|Adverse Event|0|||
33637009|NCT02919995|102223047|FG002|Overall Study|Adverse Event|0|||
33637010|NCT02919995|102223048|FG003|Overall Study|Adverse Event|0|||
33637011|NCT02919995|102223049|FG004|Overall Study|Adverse Event|0|||
33637012|NCT02919995|102223050|FG005|Overall Study|Adverse Event|1|||
33637013|NCT01383356|102223051|FG000|Period 1|Adverse Event|5|||
33637014|NCT01383356|102223052|FG001|Period 1|Adverse Event|3|||
33637015|NCT01383356|102223051|FG000|Period 1|Non-compliance|3|||
33637016|NCT01383356|102223052|FG001|Period 1|Non-compliance|0|||
33637017|NCT01383356|102223051|FG000|Period 1|Out of Range Mid-study-Test|0|||
33637018|NCT01383356|102223052|FG001|Period 1|Out of Range Mid-study-Test|1|||
33637019|NCT01383356|102223051|FG000|Period 1|Personal|0|||
33234725|NCT02499328|100760096|FG018|Overall Study|Lost to Follow-up|1|||
33234726|NCT02499328|100760078|FG000|Overall Study|Death|0|||
33234727|NCT02499328|100760079|FG001|Overall Study|Death|3|||
33234728|NCT02499328|100760080|FG002|Overall Study|Death|3|||
33234729|NCT02499328|100760081|FG003|Overall Study|Death|2|||
33234730|NCT02499328|100760082|FG004|Overall Study|Death|4|||
33234731|NCT02499328|100760083|FG005|Overall Study|Death|7|||
33234732|NCT02499328|100760084|FG006|Overall Study|Death|3|||
33368891|NCT03582033|101234937|FG008|Part D|Death|0|||
33234733|NCT02499328|100760085|FG007|Overall Study|Death|0|||
33234734|NCT02499328|100760086|FG008|Overall Study|Death|2|||
33234735|NCT02499328|100760087|FG009|Overall Study|Death|6|||
33234736|NCT02499328|100760088|FG010|Overall Study|Death|6|||
33234737|NCT02499328|100760089|FG011|Overall Study|Death|20|||
33234738|NCT02499328|100760090|FG012|Overall Study|Death|9|||
33234739|NCT02499328|100760091|FG013|Overall Study|Death|7|||
33234740|NCT02499328|100760092|FG014|Overall Study|Death|3|||
33234741|NCT02499328|100760093|FG015|Overall Study|Death|1|||
33234742|NCT02499328|100760094|FG016|Overall Study|Death|1|||
33234743|NCT02499328|100760095|FG017|Overall Study|Death|16|||
33234744|NCT02499328|100760096|FG018|Overall Study|Death|5|||
33234745|NCT02499328|100760078|FG000|Overall Study|"Other"|2|||
33234746|NCT02499328|100760079|FG001|Overall Study|"Other"|2|||
33234747|NCT02499328|100760080|FG002|Overall Study|"Other"|1|||
33234748|NCT02499328|100760081|FG003|Overall Study|"Other"|3|||
33234749|NCT02499328|100760082|FG004|Overall Study|"Other"|6|||
33234750|NCT02499328|100760083|FG005|Overall Study|"Other"|2|||
33234751|NCT02499328|100760084|FG006|Overall Study|"Other"|3|||
33368892|NCT03582033|101234938|FG009|Part D|Death|1|||
33368893|NCT03582033|101234929|FG000|Part D|Study terminated by sponsor|0|||
33234752|NCT02499328|100760085|FG007|Overall Study|"Other"|4|||
33368894|NCT03582033|101234930|FG001|Part D|Study terminated by sponsor|0|||
33368895|NCT03582033|101234931|FG002|Part D|Study terminated by sponsor|0|||
33637020|NCT01383356|102223052|FG001|Period 1|Personal|2|||
33637021|NCT01532986|102223053|FG000|Overall Study|Death|9|||
33637022|NCT01532986|102223054|FG001|Overall Study|Death|9|||
33637023|NCT01532986|102223053|FG000|Overall Study|Withdrawal by Subject|7|||
33637024|NCT01532986|102223054|FG001|Overall Study|Withdrawal by Subject|10|||
33637025|NCT01532986|102223053|FG000|Overall Study|Physician Decision|7|||
33637026|NCT01532986|102223054|FG001|Overall Study|Physician Decision|5|||
33637027|NCT02202759|102223055|FG000|Overall Study|Study Terminated by Sponsor|3|||
33637028|NCT02202759|102223056|FG001|Overall Study|Study Terminated by Sponsor|3|||
33637029|NCT02202759|102223057|FG002|Overall Study|Study Terminated by Sponsor|3|||
33637030|NCT02202759|102223055|FG000|Overall Study|Withdrawal by Subject|2|||
33637031|NCT02202759|102223056|FG001|Overall Study|Withdrawal by Subject|1|||
33637032|NCT02202759|102223057|FG002|Overall Study|Withdrawal by Subject|1|||
33637033|NCT02202759|102223055|FG000|Overall Study|Reason not Specified|4|||
33234753|NCT02499328|100760086|FG008|Overall Study|"Other"|6|||
33234754|NCT02499328|100760087|FG009|Overall Study|"Other"|16|||
33234755|NCT02499328|100760088|FG010|Overall Study|"Other"|13|||
33234756|NCT02499328|100760089|FG011|Overall Study|"Other"|31|||
33234757|NCT02499328|100760090|FG012|Overall Study|"Other"|8|||
33234758|NCT02499328|100760091|FG013|Overall Study|"Other"|7|||
33234759|NCT02499328|100760092|FG014|Overall Study|"Other"|6|||
33234760|NCT02499328|100760093|FG015|Overall Study|"Other"|0|||
33234761|NCT02499328|100760094|FG016|Overall Study|"Other"|0|||
33234762|NCT02499328|100760095|FG017|Overall Study|"Other"|34|||
33234763|NCT02499328|100760096|FG018|Overall Study|"Other"|43|||
33234764|NCT02499328|100760078|FG000|Overall Study|Disease Progression|0|||
33234765|NCT02499328|100760079|FG001|Overall Study|Disease Progression|0|||
33234766|NCT02499328|100760080|FG002|Overall Study|Disease Progression|0|||
33234767|NCT02499328|100760081|FG003|Overall Study|Disease Progression|0|||
33234768|NCT02499328|100760082|FG004|Overall Study|Disease Progression|0|||
33637034|NCT02202759|102223056|FG001|Overall Study|Reason not Specified|11|||
33637035|NCT02202759|102223057|FG002|Overall Study|Reason not Specified|10|||
33637036|NCT01295814|102223064|FG000|Overall Study|Lack of Efficacy|0|||
33138415|NCT00952380|100420260|FG004|Overall Study|Withdrawal by Subject|2|||
33138416|NCT00952380|100420256|FG000|Overall Study|Adverse Event|0|||
33138417|NCT00952380|100420257|FG001|Overall Study|Adverse Event|1|||
33576517|NCT01544348|102003095|FG000|Overall Study|Withdrawal by Subject|1|||
33576518|NCT01544348|102003096|FG001|Overall Study|Withdrawal by Subject|0|||
33234769|NCT02499328|100760083|FG005|Overall Study|Disease Progression|0|||
33234770|NCT02499328|100760084|FG006|Overall Study|Disease Progression|1|||
33234771|NCT02499328|100760085|FG007|Overall Study|Disease Progression|0|||
33234772|NCT02499328|100760086|FG008|Overall Study|Disease Progression|1|||
33576519|NCT01544348|102003097|FG002|Overall Study|Withdrawal by Subject|0|||
33576520|NCT01544348|102003098|FG003|Overall Study|Withdrawal by Subject|0|||
33576521|NCT01544348|102003099|FG004|Overall Study|Withdrawal by Subject|1|||
33576522|NCT01544348|102003100|FG005|Overall Study|Withdrawal by Subject|2|||
33576523|NCT01544348|102003101|FG006|Overall Study|Withdrawal by Subject|1|||
33576524|NCT01544348|102003102|FG007|Overall Study|Withdrawal by Subject|0|||
33576525|NCT01544348|102003095|FG000|Overall Study|Physician Decision|0|||
33576526|NCT01544348|102003096|FG001|Overall Study|Physician Decision|0|||
33138418|NCT00952380|100420258|FG002|Overall Study|Adverse Event|0|||
33138419|NCT00952380|100420259|FG003|Overall Study|Adverse Event|0|||
33138420|NCT00952380|100420260|FG004|Overall Study|Adverse Event|3|||
33138421|NCT00952380|100420256|FG000|Overall Study|Physician Decision|0|||
33138422|NCT00952380|100420257|FG001|Overall Study|Physician Decision|0|||
33138423|NCT00952380|100420258|FG002|Overall Study|Physician Decision|1|||
33138424|NCT00952380|100420259|FG003|Overall Study|Physician Decision|2|||
33138425|NCT00952380|100420260|FG004|Overall Study|Physician Decision|0|||
33138426|NCT00952380|100420256|FG000|Overall Study|Non-compliant to protocol|0|||
33138427|NCT00952380|100420257|FG001|Overall Study|Non-compliant to protocol|0|||
33138428|NCT00952380|100420258|FG002|Overall Study|Non-compliant to protocol|0|||
33138429|NCT00952380|100420259|FG003|Overall Study|Non-compliant to protocol|1|||
33138430|NCT00952380|100420260|FG004|Overall Study|Non-compliant to protocol|0|||
33138431|NCT02431260|100420264|FG000|Overall Study|Subject Decision|0|||
33138432|NCT02431260|100420265|FG001|Overall Study|Subject Decision|1|||
33138433|NCT02431260|100420266|FG002|Overall Study|Subject Decision|1|||
33138434|NCT02431260|100420267|FG003|Overall Study|Subject Decision|0|||
33138435|NCT02431260|100420268|FG004|Overall Study|Subject Decision|0|||
33138436|NCT02431260|100420269|FG005|Overall Study|Subject Decision|0|||
33138437|NCT02431260|100420270|FG006|Overall Study|Subject Decision|0|||
33138438|NCT02431260|100420271|FG007|Overall Study|Subject Decision|0|||
33138439|NCT02431260|100420272|FG008|Overall Study|Subject Decision|1|||
33138440|NCT02431260|100420273|FG009|Overall Study|Subject Decision|1|||
33138441|NCT02431260|100420274|FG010|Overall Study|Subject Decision|0|||
33138442|NCT02431260|100420275|FG011|Overall Study|Subject Decision|1|||
33138443|NCT02431260|100420276|FG012|Overall Study|Subject Decision|0|||
33138444|NCT02431260|100420277|FG013|Overall Study|Subject Decision|0|||
33138445|NCT02431260|100420264|FG000|Overall Study|Death|4|||
33138446|NCT02431260|100420265|FG001|Overall Study|Death|4|||
33138447|NCT02431260|100420266|FG002|Overall Study|Death|3|||
33138448|NCT02431260|100420267|FG003|Overall Study|Death|4|||
33138449|NCT02431260|100420268|FG004|Overall Study|Death|2|||
33138450|NCT02431260|100420269|FG005|Overall Study|Death|2|||
33138451|NCT02431260|100420270|FG006|Overall Study|Death|3|||
33138452|NCT02431260|100420271|FG007|Overall Study|Death|1|||
33138453|NCT02431260|100420272|FG008|Overall Study|Death|6|||
33138454|NCT02431260|100420273|FG009|Overall Study|Death|6|||
33138455|NCT02431260|100420274|FG010|Overall Study|Death|3|||
33138456|NCT02431260|100420275|FG011|Overall Study|Death|2|||
33138457|NCT02431260|100420276|FG012|Overall Study|Death|5|||
33138458|NCT02431260|100420277|FG013|Overall Study|Death|1|||
33234773|NCT02499328|100760087|FG009|Overall Study|Disease Progression|0|||
33234774|NCT02499328|100760088|FG010|Overall Study|Disease Progression|1|||
33637037|NCT01295814|102223065|FG001|Overall Study|Lack of Efficacy|2|||
33637038|NCT01295814|102223064|FG000|Overall Study|Withdrawal by Subject|2|||
33637039|NCT01295814|102223065|FG001|Overall Study|Withdrawal by Subject|0|||
33234775|NCT02499328|100760089|FG011|Overall Study|Disease Progression|0|||
33234776|NCT02499328|100760090|FG012|Overall Study|Disease Progression|0|||
33234777|NCT02499328|100760091|FG013|Overall Study|Disease Progression|0|||
33234778|NCT02499328|100760092|FG014|Overall Study|Disease Progression|0|||
33234779|NCT02499328|100760093|FG015|Overall Study|Disease Progression|0|||
33234780|NCT02499328|100760094|FG016|Overall Study|Disease Progression|0|||
33234781|NCT02499328|100760095|FG017|Overall Study|Disease Progression|2|||
33234782|NCT02499328|100760096|FG018|Overall Study|Disease Progression|0|||
33234783|NCT02499328|100760078|FG000|Overall Study|Adverse Event|1|||
33234784|NCT02499328|100760079|FG001|Overall Study|Adverse Event|0|||
33234785|NCT02499328|100760080|FG002|Overall Study|Adverse Event|0|||
33234786|NCT02499328|100760081|FG003|Overall Study|Adverse Event|1|||
33576527|NCT01544348|102003097|FG002|Overall Study|Physician Decision|0|||
33576528|NCT01544348|102003098|FG003|Overall Study|Physician Decision|0|||
33576529|NCT01544348|102003099|FG004|Overall Study|Physician Decision|0|||
33576530|NCT01544348|102003100|FG005|Overall Study|Physician Decision|1|||
33637040|NCT02118584|102223067|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
33637041|NCT02118584|102223068|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
33637042|NCT02118584|102223069|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
33637043|NCT02118584|102223067|FG000|Part 1: Open Label Extension Period|Death|9|||
33637044|NCT02118584|102223068|FG001|Part 1: Open Label Extension Period|Death|0|||
33637045|NCT02118584|102223069|FG002|Part 1: Open Label Extension Period|Death|0|||
33637046|NCT02118584|102223067|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
33637047|NCT02118584|102223068|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
33637048|NCT02118584|102223069|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
33637049|NCT02118584|102223067|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
33637050|NCT02118584|102223068|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
33637051|NCT02118584|102223069|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
33637052|NCT02118584|102223067|FG000|Part 1: Open Label Extension Period|Other|135|||
33234787|NCT02499328|100760082|FG004|Overall Study|Adverse Event|0|||
33234788|NCT02499328|100760083|FG005|Overall Study|Adverse Event|0|||
33234789|NCT02499328|100760084|FG006|Overall Study|Adverse Event|0|||
33234790|NCT02499328|100760085|FG007|Overall Study|Adverse Event|0|||
33368896|NCT03582033|101234932|FG003|Part D|Study terminated by sponsor|0|||
33368897|NCT03582033|101234933|FG004|Part D|Study terminated by sponsor|0|||
33368898|NCT03582033|101234934|FG005|Part D|Study terminated by sponsor|0|||
33368899|NCT03582033|101234935|FG006|Part D|Study terminated by sponsor|0|||
33368900|NCT03582033|101234936|FG007|Part D|Study terminated by sponsor|0|||
33368901|NCT03582033|101234937|FG008|Part D|Study terminated by sponsor|0|||
33234791|NCT02499328|100760086|FG008|Overall Study|Adverse Event|0|||
33234792|NCT02499328|100760087|FG009|Overall Study|Adverse Event|0|||
33234793|NCT02499328|100760088|FG010|Overall Study|Adverse Event|0|||
33234794|NCT02499328|100760089|FG011|Overall Study|Adverse Event|0|||
33234795|NCT02499328|100760090|FG012|Overall Study|Adverse Event|1|||
33234796|NCT02499328|100760091|FG013|Overall Study|Adverse Event|0|||
33234797|NCT02499328|100760092|FG014|Overall Study|Adverse Event|0|||
33234798|NCT02499328|100760093|FG015|Overall Study|Adverse Event|0|||
33368902|NCT03582033|101234938|FG009|Part D|Study terminated by sponsor|4|||
33368903|NCT03952559|101234940|FG000|Double Blind Treatment Period|Adverse Event|0|||
33368904|NCT03952559|101234941|FG001|Double Blind Treatment Period|Adverse Event|2|||
33368905|NCT03952559|101234942|FG002|Double Blind Treatment Period|Adverse Event|1|||
33576531|NCT01544348|102003101|FG006|Overall Study|Physician Decision|0|||
33576532|NCT01544348|102003102|FG007|Overall Study|Physician Decision|0|||
33576533|NCT00326599|102003106|FG000|Overall Study|Withdrawal by Subject|1|||
33576534|NCT00326599|102003107|FG001|Overall Study|Withdrawal by Subject|0|||
33576535|NCT00326599|102003108|FG002|Overall Study|Withdrawal by Subject|5|||
33576536|NCT00326599|102003109|FG003|Overall Study|Withdrawal by Subject|2|||
33576537|NCT00326599|102003106|FG000|Overall Study|Adverse Event|1|||
33576538|NCT00326599|102003107|FG001|Overall Study|Adverse Event|0|||
33576539|NCT00326599|102003108|FG002|Overall Study|Adverse Event|32|||
33576540|NCT00326599|102003109|FG003|Overall Study|Adverse Event|3|||
33576541|NCT00326599|102003106|FG000|Overall Study|Disease Progression|3|||
33576542|NCT00326599|102003107|FG001|Overall Study|Disease Progression|1|||
33576543|NCT00326599|102003108|FG002|Overall Study|Disease Progression|13|||
33576544|NCT00326599|102003109|FG003|Overall Study|Disease Progression|11|||
33637053|NCT02118584|102223068|FG001|Part 1: Open Label Extension Period|Other|0|||
33234799|NCT02499328|100760094|FG016|Overall Study|Adverse Event|0|||
33234800|NCT02499328|100760095|FG017|Overall Study|Adverse Event|0|||
33234801|NCT02499328|100760096|FG018|Overall Study|Adverse Event|0|||
33576545|NCT00326599|102003106|FG000|Overall Study|Alternate Treatment|1|||
33576546|NCT00326599|102003107|FG001|Overall Study|Alternate Treatment|0|||
33576547|NCT00326599|102003108|FG002|Overall Study|Alternate Treatment|0|||
33576548|NCT00326599|102003109|FG003|Overall Study|Alternate Treatment|0|||
33576549|NCT00326599|102003106|FG000|Overall Study|Death|0|||
33234802|NCT03685708|100760097|FG000|Overall Study|Withdrawal by Subject|0|||
33368906|NCT03952559|101234943|FG003|Double Blind Treatment Period|Adverse Event|0|||
33637054|NCT02118584|102223069|FG002|Part 1: Open Label Extension Period|Other|0|||
33637055|NCT02118584|102223067|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
33368907|NCT03952559|101234944|FG004|Double Blind Treatment Period|Adverse Event|1|||
33368908|NCT03952559|101234940|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
33368909|NCT03952559|101234941|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
33368910|NCT03952559|101234942|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
33368911|NCT03952559|101234943|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
33368912|NCT03952559|101234944|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
33368913|NCT03952559|101234940|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
33368914|NCT03952559|101234941|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
33368915|NCT03952559|101234942|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
33368916|NCT03952559|101234943|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
33368917|NCT03952559|101234944|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
33368918|NCT03952559|101234940|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
33138459|NCT02431260|100420264|FG000|Overall Study|Lost to Follow-up|0|||
33637056|NCT02118584|102223068|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
33138460|NCT02431260|100420265|FG001|Overall Study|Lost to Follow-up|0|||
33138461|NCT02431260|100420266|FG002|Overall Study|Lost to Follow-up|0|||
33138462|NCT02431260|100420267|FG003|Overall Study|Lost to Follow-up|0|||
33138463|NCT02431260|100420268|FG004|Overall Study|Lost to Follow-up|0|||
33138464|NCT02431260|100420269|FG005|Overall Study|Lost to Follow-up|1|||
33637057|NCT02118584|102223069|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
33637058|NCT02118584|102223067|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
33637059|NCT02118584|102223068|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
33637060|NCT02118584|102223069|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
33138465|NCT02431260|100420270|FG006|Overall Study|Lost to Follow-up|0|||
33138466|NCT02431260|100420271|FG007|Overall Study|Lost to Follow-up|0|||
33138467|NCT02431260|100420272|FG008|Overall Study|Lost to Follow-up|0|||
33138468|NCT02431260|100420273|FG009|Overall Study|Lost to Follow-up|0|||
33138469|NCT02431260|100420274|FG010|Overall Study|Lost to Follow-up|0|||
33138470|NCT02431260|100420275|FG011|Overall Study|Lost to Follow-up|0|||
33138471|NCT02431260|100420276|FG012|Overall Study|Lost to Follow-up|0|||
33138472|NCT02431260|100420277|FG013|Overall Study|Lost to Follow-up|0|||
33138473|NCT02431260|100420264|FG000|Overall Study|Study Terminated by the Sponsor|0|||
33234803|NCT03685708|100760098|FG001|Overall Study|Withdrawal by Subject|0|||
33234804|NCT03685708|100760099|FG002|Overall Study|Withdrawal by Subject|1|||
33234805|NCT03685708|100760097|FG000|Overall Study|Screen Fail|0|||
33234806|NCT03685708|100760098|FG001|Overall Study|Screen Fail|1|||
33234807|NCT03685708|100760099|FG002|Overall Study|Screen Fail|1|||
33234808|NCT03685708|100760097|FG000|Overall Study|COVID 19 Pandemic|1|||
33234809|NCT03685708|100760098|FG001|Overall Study|COVID 19 Pandemic|1|||
33234810|NCT03685708|100760099|FG002|Overall Study|COVID 19 Pandemic|6|||
33234811|NCT03685708|100760097|FG000|Overall Study|Disease Progression|0|||
33234812|NCT03685708|100760098|FG001|Overall Study|Disease Progression|0|||
33234813|NCT03685708|100760099|FG002|Overall Study|Disease Progression|1|||
33234814|NCT03257995|100760103|FG000|Overall Study|Adverse Event|0|||
33234815|NCT03257995|100760104|FG001|Overall Study|Adverse Event|1|||
33234816|NCT03257995|100760105|FG002|Overall Study|Adverse Event|0|||
33234817|NCT03257995|100760106|FG003|Overall Study|Adverse Event|0|||
33234818|NCT03257995|100760107|FG004|Overall Study|Adverse Event|0|||
33234819|NCT03257995|100760108|FG005|Overall Study|Adverse Event|0|||
33234820|NCT03257995|100760103|FG000|Overall Study|Protocol deviation|0|||
33637061|NCT02118584|102223067|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
33637062|NCT02118584|102223068|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
33637063|NCT02118584|102223069|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
33637064|NCT02118584|102223067|FG000|Part 1: Open Label Extension Period|Other|3|||
33637065|NCT02118584|102223068|FG001|Part 1: Open Label Extension Period|Other|0|||
33637066|NCT02118584|102223069|FG002|Part 1: Open Label Extension Period|Other|0|||
33637067|NCT02118584|102223067|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
33234821|NCT03257995|100760104|FG001|Overall Study|Protocol deviation|0|||
33234822|NCT03257995|100760105|FG002|Overall Study|Protocol deviation|0|||
33234823|NCT03257995|100760106|FG003|Overall Study|Protocol deviation|0|||
33234824|NCT03257995|100760107|FG004|Overall Study|Protocol deviation|0|||
33368919|NCT03952559|101234941|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
33368920|NCT03952559|101234942|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
33576550|NCT00326599|102003107|FG001|Overall Study|Death|0|||
33138474|NCT02431260|100420265|FG001|Overall Study|Study Terminated by the Sponsor|0|||
33138475|NCT02431260|100420266|FG002|Overall Study|Study Terminated by the Sponsor|2|||
33234825|NCT03257995|100760108|FG005|Overall Study|Protocol deviation|2|||
33234826|NCT01990300|100760109|FG000|Overall Study|Case Report Forms Uncollected|89|||
33138476|NCT02431260|100420267|FG003|Overall Study|Study Terminated by the Sponsor|1|||
33138477|NCT02431260|100420268|FG004|Overall Study|Study Terminated by the Sponsor|1|||
33138478|NCT02431260|100420269|FG005|Overall Study|Study Terminated by the Sponsor|0|||
33234827|NCT01990300|100760109|FG000|Overall Study|Protocol Deviation|53|||
33234828|NCT01991197|100760110|FG000|Overall Study|Lost to Follow-up|1|||
33234829|NCT01991197|100760111|FG001|Overall Study|Lost to Follow-up|1|||
33234830|NCT01991197|100760110|FG000|Overall Study|Physician Decision|0|||
33234831|NCT01991197|100760111|FG001|Overall Study|Physician Decision|2|||
33234832|NCT01991197|100760110|FG000|Overall Study|Withdrawal by Subject|2|||
33234833|NCT01991197|100760111|FG001|Overall Study|Withdrawal by Subject|0|||
33234834|NCT01592695|100760114|FG000|Overall Study|Lost to Follow-up|8|||
33234835|NCT01592695|100760115|FG001|Overall Study|Lost to Follow-up|4|||
33234836|NCT05886777|100760116|FG000|Overall Study|Lost to Follow-up|1|||
33234837|NCT05886777|100760117|FG001|Overall Study|Lost to Follow-up|0|||
33234838|NCT05886777|100760118|FG002|Overall Study|Lost to Follow-up|2|||
33234839|NCT05886777|100760119|FG003|Overall Study|Lost to Follow-up|1|||
33234840|NCT05886777|100760120|FG004|Overall Study|Lost to Follow-up|0|||
33234841|NCT05886777|100760121|FG005|Overall Study|Lost to Follow-up|2|||
33234842|NCT05886777|100760122|FG006|Overall Study|Lost to Follow-up|0|||
33234843|NCT05886777|100760116|FG000|Overall Study|Other|0|||
33234844|NCT05886777|100760117|FG001|Overall Study|Other|2|||
33234845|NCT05886777|100760118|FG002|Overall Study|Other|1|||
33234846|NCT05886777|100760119|FG003|Overall Study|Other|0|||
33234847|NCT05886777|100760120|FG004|Overall Study|Other|0|||
33234848|NCT05886777|100760121|FG005|Overall Study|Other|0|||
33576551|NCT00326599|102003108|FG002|Overall Study|Death|1|||
33576552|NCT00326599|102003109|FG003|Overall Study|Death|2|||
33576553|NCT00326599|102003106|FG000|Overall Study|Other Unspecified Reason|0|||
33576554|NCT00326599|102003107|FG001|Overall Study|Other Unspecified Reason|0|||
33576555|NCT00326599|102003108|FG002|Overall Study|Other Unspecified Reason|2|||
33576556|NCT00326599|102003109|FG003|Overall Study|Other Unspecified Reason|1|||
33576557|NCT00539240|102003110|FG000|Overall Study|Withdrawal by Subject|0|||
33576558|NCT00539240|102003111|FG001|Overall Study|Withdrawal by Subject|2|||
33576559|NCT00539240|102003112|FG002|Overall Study|Withdrawal by Subject|0|||
33576560|NCT00539240|102003110|FG000|Overall Study|Protocol Violation|1|||
33368921|NCT03952559|101234943|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
33368922|NCT03952559|101234944|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
33576561|NCT00539240|102003111|FG001|Overall Study|Protocol Violation|1|||
33576562|NCT00539240|102003112|FG002|Overall Study|Protocol Violation|4|||
33576563|NCT00539240|102003110|FG000|Overall Study|Lost to Follow-up|2|||
33576564|NCT00539240|102003111|FG001|Overall Study|Lost to Follow-up|3|||
33576565|NCT00539240|102003112|FG002|Overall Study|Lost to Follow-up|1|||
33576566|NCT00539240|102003110|FG000|Overall Study|Adverse Event|3|||
33576567|NCT00539240|102003111|FG001|Overall Study|Adverse Event|1|||
33576568|NCT00539240|102003112|FG002|Overall Study|Adverse Event|10|||
33576569|NCT03423602|102003113|FG000|Overall Study|Death|1|||
33234849|NCT05886777|100760122|FG006|Overall Study|Other|0|||
33234850|NCT05886777|100760116|FG000|Overall Study|Withdrawal by Subject|1|||
33234851|NCT05886777|100760117|FG001|Overall Study|Withdrawal by Subject|0|||
33234852|NCT05886777|100760118|FG002|Overall Study|Withdrawal by Subject|1|||
33234853|NCT05886777|100760119|FG003|Overall Study|Withdrawal by Subject|4|||
33576570|NCT03423602|102003113|FG000|Overall Study|Lost to Follow-up|6|||
33576571|NCT03423602|102003113|FG000|Overall Study|Protocol Violation|1|||
33576572|NCT03423602|102003113|FG000|Overall Study|Withdrawal by Subject|4|||
33576573|NCT01837680|102003115|FG000|Overall Study|Lost to Follow-up|2|||
33576574|NCT01837680|102003116|FG001|Overall Study|Lost to Follow-up|2|||
33576575|NCT01837680|102003115|FG000|Overall Study|lack of insurance|0|||
33576576|NCT01837680|102003116|FG001|Overall Study|lack of insurance|2|||
33576577|NCT01837680|102003115|FG000|Overall Study|allergic reaction|6|||
33576578|NCT01837680|102003116|FG001|Overall Study|allergic reaction|0|||
33576579|NCT01837680|102003115|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
33576580|NCT01837680|102003116|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
33576581|NCT01944020|102003117|FG000|Overall Study|Withdrawal by Subject|5|||
33138479|NCT02431260|100420270|FG006|Overall Study|Study Terminated by the Sponsor|1|||
33234854|NCT05886777|100760120|FG004|Overall Study|Withdrawal by Subject|3|||
33234855|NCT05886777|100760121|FG005|Overall Study|Withdrawal by Subject|1|||
33234856|NCT05886777|100760122|FG006|Overall Study|Withdrawal by Subject|1|||
33234857|NCT05886777|100760116|FG000|Overall Study|Protocol Violation|0|||
33368923|NCT03052608|101234945|FG000|Treatment Phase|Adverse Event|10|||
33576582|NCT01944020|102003118|FG001|Overall Study|Withdrawal by Subject|0|||
33576583|NCT01082614|102003119|FG000|Overall Study|Adverse Event|1|||
33576584|NCT01082614|102003120|FG001|Overall Study|Adverse Event|4|||
33576585|NCT01082614|102003119|FG000|Overall Study|Equipment Malfunction|0|||
33576586|NCT01082614|102003120|FG001|Overall Study|Equipment Malfunction|1|||
33576587|NCT01082614|102003119|FG000|Overall Study|Physician Decision|2|||
33576588|NCT01082614|102003120|FG001|Overall Study|Physician Decision|0|||
33576589|NCT02727322|102003124|FG000|Overall Study|Withdrawal by Subject|1|||
33576590|NCT02727322|102003125|FG001|Overall Study|Withdrawal by Subject|1|||
33234858|NCT05886777|100760117|FG001|Overall Study|Protocol Violation|0|||
33234859|NCT05886777|100760118|FG002|Overall Study|Protocol Violation|1|||
33234860|NCT05886777|100760119|FG003|Overall Study|Protocol Violation|0|||
33234861|NCT05886777|100760120|FG004|Overall Study|Protocol Violation|0|||
33234862|NCT05886777|100760121|FG005|Overall Study|Protocol Violation|0|||
33234863|NCT05886777|100760122|FG006|Overall Study|Protocol Violation|0|||
33576591|NCT02727322|102003124|FG000|Overall Study|Protocol Violation|1|||
33576592|NCT02727322|102003125|FG001|Overall Study|Protocol Violation|0|||
33576593|NCT00800982|102003126|FG000|Overall Study|Lost to Follow-up|1|||
33576594|NCT00800982|102003127|FG001|Overall Study|Lost to Follow-up|2|||
33576595|NCT00800982|102003126|FG000|Overall Study|Withdrawal by Subject|0|||
33576596|NCT00800982|102003127|FG001|Overall Study|Withdrawal by Subject|1|||
33576597|NCT00800982|102003126|FG000|Overall Study|Patient moved out of state|1|||
33576598|NCT00800982|102003127|FG001|Overall Study|Patient moved out of state|0|||
33576599|NCT03606486|102003128|FG000|Overall Study|Unable to collect sample|5|||
33576600|NCT00565409|102003129|FG000|Period 1 Open Label|Adverse Event|17|||
33576601|NCT00565409|102003130|FG001|Period 1 Open Label|Adverse Event|0|||
33576602|NCT00565409|102003131|FG002|Period 1 Open Label|Adverse Event|0|||
33576603|NCT00565409|102003132|FG003|Period 1 Open Label|Adverse Event|0|||
33576604|NCT00565409|102003129|FG000|Period 1 Open Label|Death|2|||
33576605|NCT00565409|102003130|FG001|Period 1 Open Label|Death|0|||
33576606|NCT00565409|102003131|FG002|Period 1 Open Label|Death|0|||
33576607|NCT00565409|102003132|FG003|Period 1 Open Label|Death|0|||
33576608|NCT00565409|102003129|FG000|Period 1 Open Label|Lost to Follow-up|1|||
33576609|NCT00565409|102003130|FG001|Period 1 Open Label|Lost to Follow-up|0|||
33576610|NCT00565409|102003131|FG002|Period 1 Open Label|Lost to Follow-up|0|||
33234864|NCT05886777|100760116|FG000|Overall Study|No longer met eligibility criteria|0|||
33234865|NCT05886777|100760117|FG001|Overall Study|No longer met eligibility criteria|1|||
33234866|NCT05886777|100760118|FG002|Overall Study|No longer met eligibility criteria|0|||
33234867|NCT05886777|100760119|FG003|Overall Study|No longer met eligibility criteria|0|||
33234868|NCT05886777|100760120|FG004|Overall Study|No longer met eligibility criteria|0|||
33234869|NCT05886777|100760121|FG005|Overall Study|No longer met eligibility criteria|0|||
33234870|NCT05886777|100760122|FG006|Overall Study|No longer met eligibility criteria|0|||
33234871|NCT02243631|100760129|FG000|Overall Study|no synovial fluid on second aspirate|0|||
33234872|NCT02243631|100760130|FG001|Overall Study|no synovial fluid on second aspirate|1|||
33234873|NCT01208415|100760131|FG000|Overall Study|Death|1|||
33234874|NCT01208415|100760131|FG000|Overall Study|Lost to Follow-up|2|||
33234875|NCT01208415|100760131|FG000|Overall Study|Withdrawal by Subject|3|||
33234876|NCT01208415|100760131|FG000|Overall Study|Device not placed|1|||
33234877|NCT01208415|100760131|FG000|Overall Study|Still be eligible for follow-up|33|||
33234878|NCT01010217|100760132|FG000|Overall Study|Lost to Follow-up|4|||
33234879|NCT01010217|100760133|FG001|Overall Study|Lost to Follow-up|5|||
33234880|NCT01010217|100760134|FG002|Overall Study|Lost to Follow-up|1|||
33234881|NCT01010217|100760135|FG003|Overall Study|Lost to Follow-up|0|||
33234882|NCT01010217|100760136|FG004|Overall Study|Lost to Follow-up|0|||
33234883|NCT01010217|100760132|FG000|Overall Study|Withdrawal by Subject|1|||
33234884|NCT01010217|100760133|FG001|Overall Study|Withdrawal by Subject|0|||
33234885|NCT01010217|100760134|FG002|Overall Study|Withdrawal by Subject|0|||
33234886|NCT01010217|100760135|FG003|Overall Study|Withdrawal by Subject|0|||
33234887|NCT01010217|100760136|FG004|Overall Study|Withdrawal by Subject|0|||
33234888|NCT01010217|100760132|FG000|Overall Study|Physician Decision|0|||
33234889|NCT01010217|100760133|FG001|Overall Study|Physician Decision|0|||
33234890|NCT01010217|100760134|FG002|Overall Study|Physician Decision|0|||
33234891|NCT01010217|100760135|FG003|Overall Study|Physician Decision|6|||
33234892|NCT01010217|100760136|FG004|Overall Study|Physician Decision|3|||
33234893|NCT01083160|100760137|FG000|Overall Study|Adverse Event|1|||
33234894|NCT00709592|100760138|FG000|Overall Study|Unable to proceed to transplant|0|||
33234895|NCT00709592|100760139|FG001|Overall Study|Unable to proceed to transplant|1|||
33234896|NCT01681368|100760141|FG000|Overall Study|Refused further treatment|1|||
33234897|NCT01681368|100760141|FG000|Overall Study|Refused further follow up|1|||
33234898|NCT01186328|100760142|FG000|Overall Study|Death|1|||
33234899|NCT01186328|100760143|FG001|Overall Study|Death|0|||
33234900|NCT01186328|100760144|FG002|Overall Study|Death|0|||
33234901|NCT02771210|100761771|FG000|Period 1|Adverse Event|5|||
33234902|NCT02771210|100761772|FG001|Period 1|Adverse Event|3|||
33234903|NCT02771210|100761771|FG000|Period 1|Lack of Efficacy|3|||
33234904|NCT02771210|100761772|FG001|Period 1|Lack of Efficacy|6|||
33234905|NCT02771210|100761771|FG000|Period 1|Lost to Follow-up|2|||
33234906|NCT02771210|100761772|FG001|Period 1|Lost to Follow-up|0|||
33576611|NCT00565409|102003132|FG003|Period 1 Open Label|Lost to Follow-up|0|||
33234907|NCT02771210|100761771|FG000|Period 1|Physician Decision|0|||
33234908|NCT02771210|100761772|FG001|Period 1|Physician Decision|1|||
33234909|NCT02771210|100761771|FG000|Period 1|Withdrawal by Subject|0|||
33234910|NCT02771210|100761772|FG001|Period 1|Withdrawal by Subject|3|||
33234911|NCT02771210|100761771|FG000|Period 1|Withdrawal of informed consent|1|||
33234912|NCT02771210|100761772|FG001|Period 1|Withdrawal of informed consent|5|||
33234913|NCT02771210|100761771|FG000|Period 2|Adverse Event|1|||
33234914|NCT02771210|100761772|FG001|Period 2|Adverse Event|0|||
33234915|NCT02771210|100761771|FG000|Period 2|Lack of Efficacy|0|||
33234916|NCT02771210|100761772|FG001|Period 2|Lack of Efficacy|1|||
33576612|NCT00565409|102003129|FG000|Period 1 Open Label|Other|21|||
33576613|NCT00565409|102003130|FG001|Period 1 Open Label|Other|0|||
33576614|NCT00565409|102003131|FG002|Period 1 Open Label|Other|0|||
33576615|NCT00565409|102003132|FG003|Period 1 Open Label|Other|0|||
33234917|NCT02771210|100761771|FG000|Period 2|Withdrawal by Subject|1|||
33576616|NCT00565409|102003129|FG000|Period 1 Open Label|Protocol Violation|14|||
33576617|NCT00565409|102003130|FG001|Period 1 Open Label|Protocol Violation|0|||
33576618|NCT00565409|102003131|FG002|Period 1 Open Label|Protocol Violation|0|||
33576619|NCT00565409|102003132|FG003|Period 1 Open Label|Protocol Violation|0|||
33576620|NCT00565409|102003129|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
33576621|NCT00565409|102003130|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
33576622|NCT00565409|102003131|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
33138480|NCT02431260|100420271|FG007|Overall Study|Study Terminated by the Sponsor|2|||
33138481|NCT02431260|100420272|FG008|Overall Study|Study Terminated by the Sponsor|1|||
33420366|NCT03174925|101428601|FG000|Overall Study|Elastography image not interpretable|1|||
33576623|NCT00565409|102003132|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
33576624|NCT00565409|102003129|FG000|Period 1 Open Label|no conclusion of participation record|1|||
33576625|NCT00565409|102003130|FG001|Period 1 Open Label|no conclusion of participation record|0|||
33576626|NCT00565409|102003131|FG002|Period 1 Open Label|no conclusion of participation record|0|||
33576627|NCT00565409|102003132|FG003|Period 1 Open Label|no conclusion of participation record|0|||
33576628|NCT00565409|102003129|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
33576629|NCT00565409|102003130|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
33576630|NCT00565409|102003131|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
33576631|NCT00565409|102003132|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
33576632|NCT00565409|102003129|FG000|Period 2 Double-Blind|Adverse Event|0|||
33576633|NCT00565409|102003130|FG001|Period 2 Double-Blind|Adverse Event|7|||
33576634|NCT00565409|102003131|FG002|Period 2 Double-Blind|Adverse Event|4|||
33576635|NCT00565409|102003132|FG003|Period 2 Double-Blind|Adverse Event|5|||
33576636|NCT00565409|102003129|FG000|Period 2 Double-Blind|Death|0|||
33576637|NCT00565409|102003130|FG001|Period 2 Double-Blind|Death|2|||
33576638|NCT00565409|102003131|FG002|Period 2 Double-Blind|Death|0|||
33576639|NCT00565409|102003132|FG003|Period 2 Double-Blind|Death|0|||
33576640|NCT00565409|102003129|FG000|Period 2 Double-Blind|Protocol Violation|0|||
33576641|NCT00565409|102003130|FG001|Period 2 Double-Blind|Protocol Violation|4|||
33576642|NCT00565409|102003131|FG002|Period 2 Double-Blind|Protocol Violation|6|||
33576643|NCT00565409|102003132|FG003|Period 2 Double-Blind|Protocol Violation|2|||
33576644|NCT00565409|102003129|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
33576645|NCT00565409|102003130|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
33576646|NCT00565409|102003131|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
33576647|NCT00565409|102003132|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
33576648|NCT00565409|102003129|FG000|Period 2 Double-Blind|Other|0|||
33576649|NCT00565409|102003130|FG001|Period 2 Double-Blind|Other|4|||
33576650|NCT00565409|102003131|FG002|Period 2 Double-Blind|Other|5|||
33576651|NCT00565409|102003132|FG003|Period 2 Double-Blind|Other|9|||
33576652|NCT00565409|102003129|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
33576653|NCT00565409|102003130|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
33576654|NCT00565409|102003131|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
33576655|NCT00565409|102003132|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
33576656|NCT01444430|102003135|FG000|Overall Study|Withdrawal by Subject|53|||
33576657|NCT01444430|102003136|FG001|Overall Study|Withdrawal by Subject|72|||
33576658|NCT01444430|102003135|FG000|Overall Study|Death|6|||
33576659|NCT01444430|102003136|FG001|Overall Study|Death|8|||
33576660|NCT01444430|102003135|FG000|Overall Study|Lost to Follow-up|2|||
33576661|NCT01444430|102003136|FG001|Overall Study|Lost to Follow-up|0|||
33576662|NCT01444430|102003135|FG000|Overall Study|CRF termination module not completed.|0|||
33576663|NCT01444430|102003136|FG001|Overall Study|CRF termination module not completed.|1|||
33576664|NCT01070979|102003141|FG000|Overall Study|Adverse Event|2|||
33576665|NCT01070979|102003142|FG001|Overall Study|Adverse Event|3|||
33576666|NCT01070979|102003143|FG002|Overall Study|Adverse Event|3|||
33576667|NCT01070979|102003141|FG000|Overall Study|Lost to Follow-up|2|||
33576668|NCT01070979|102003142|FG001|Overall Study|Lost to Follow-up|1|||
33576669|NCT01070979|102003143|FG002|Overall Study|Lost to Follow-up|1|||
33576670|NCT01070979|102003141|FG000|Overall Study|Protocol Violation|0|||
33576671|NCT01070979|102003142|FG001|Overall Study|Protocol Violation|2|||
33576672|NCT01070979|102003143|FG002|Overall Study|Protocol Violation|6|||
33576673|NCT01070979|102003141|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
33576674|NCT01070979|102003142|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
33576675|NCT01070979|102003143|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
33576676|NCT01070979|102003141|FG000|Overall Study|Withdrawal by Subject|3|||
33576677|NCT01070979|102003142|FG001|Overall Study|Withdrawal by Subject|1|||
33576678|NCT01070979|102003143|FG002|Overall Study|Withdrawal by Subject|1|||
33576679|NCT01070979|102003141|FG000|Overall Study|No study drug taken|0|||
33138482|NCT02431260|100420273|FG009|Overall Study|Study Terminated by the Sponsor|1|||
33138483|NCT02431260|100420274|FG010|Overall Study|Study Terminated by the Sponsor|1|||
33576680|NCT01070979|102003142|FG001|Overall Study|No study drug taken|1|||
33576681|NCT01070979|102003143|FG002|Overall Study|No study drug taken|0|||
33576682|NCT00165789|102003146|FG000|Overall Study|Adverse Event|0|||
33234918|NCT02771210|100761772|FG001|Period 2|Withdrawal by Subject|0|||
33234919|NCT02771210|100761771|FG000|Period 2|Withdrawal of informed consent|0|||
33234920|NCT02771210|100761772|FG001|Period 2|Withdrawal of informed consent|2|||
33234921|NCT04814186|100761773|FG000|Treatment Phase|Adverse Event|1|||
33234922|NCT04814186|100761773|FG000|Treatment Phase|Death|6|||
33234923|NCT04814186|100761773|FG000|Treatment Phase|Withdrawal by Subject|2|||
33234924|NCT04814186|100761773|FG000|Treatment Phase|Other|1|||
33234925|NCT04814186|100761773|FG000|Follow-Up Phase|Adverse Event|1|||
33234926|NCT04814186|100761773|FG000|Follow-Up Phase|Death|6|||
33234927|NCT04814186|100761773|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
33234928|NCT04814186|100761773|FG000|Follow-Up Phase|Other|1|||
33234929|NCT01544491|100761774|FG000|Overall Study|Withdrawal by Subject|3|||
33234930|NCT01544491|100761775|FG001|Overall Study|Withdrawal by Subject|2|||
33234931|NCT01544491|100761774|FG000|Overall Study|Lost to Follow-up|0|||
33234932|NCT01544491|100761775|FG001|Overall Study|Lost to Follow-up|1|||
33234933|NCT01544491|100761774|FG000|Overall Study|administrative problems|2|||
33234934|NCT01544491|100761775|FG001|Overall Study|administrative problems|0|||
33234935|NCT02942004|100761776|FG000|Overall Study|Withdrawal by Subject|0|||
33234936|NCT02942004|100761777|FG001|Overall Study|Withdrawal by Subject|2|||
33234937|NCT02942004|100761778|FG002|Overall Study|Withdrawal by Subject|3|||
33234938|NCT02942004|100761776|FG000|Overall Study|Lost to Follow-up|1|||
33234939|NCT02942004|100761777|FG001|Overall Study|Lost to Follow-up|1|||
33234940|NCT02942004|100761778|FG002|Overall Study|Lost to Follow-up|2|||
33234941|NCT02942004|100761776|FG000|Overall Study|Randomized but not dosed|3|||
33234942|NCT02942004|100761777|FG001|Overall Study|Randomized but not dosed|9|||
33234943|NCT02942004|100761778|FG002|Overall Study|Randomized but not dosed|4|||
33234944|NCT04838626|100761779|FG000|Overall Study|Adverse Event|2|||
33234945|NCT04838626|100761779|FG000|Overall Study|Physician Decision|6|||
33234946|NCT04838626|100761779|FG000|Overall Study|Protocol Violation|3|||
33234947|NCT04838626|100761779|FG000|Overall Study|Withdrawal by Subject|9|||
33234948|NCT04838626|100761779|FG000|Overall Study|Technical Problems|2|||
33234949|NCT03930186|100761780|FG000|Weeks 0 to 16|Adverse Event|6|||
33234950|NCT03930186|100761780|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
33234951|NCT03930186|100761780|FG000|Weeks 16 to 32|Adverse Event|1|||
33234952|NCT03930186|100761780|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
33234953|NCT01163149|100761781|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
33234954|NCT01163149|100761782|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
33234955|NCT01163149|100761783|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
33234956|NCT01163149|100761781|FG000|Extension Treatment Period|Adverse Event|0|||
33234957|NCT01163149|100761782|FG001|Extension Treatment Period|Adverse Event|1|||
33234958|NCT01163149|100761783|FG002|Extension Treatment Period|Adverse Event|0|||
33234959|NCT01163149|100761781|FG000|Extension Treatment Period|Noncompliance|0|||
33234960|NCT01163149|100761782|FG001|Extension Treatment Period|Noncompliance|0|||
33234961|NCT01163149|100761783|FG002|Extension Treatment Period|Noncompliance|1|||
33234962|NCT03122886|100761784|FG000|Overall Study|Withdrawal by Subject|1|||
33234963|NCT03122886|100761785|FG001|Overall Study|Withdrawal by Subject|2|||
33234964|NCT04163991|100761786|FG000|Overall Study|Adverse Event|0|||
33234965|NCT04163991|100761787|FG001|Overall Study|Adverse Event|0|||
33234966|NCT04163991|100761788|FG002|Overall Study|Adverse Event|0|||
33234967|NCT04163991|100761789|FG003|Overall Study|Adverse Event|1|||
33234968|NCT04163991|100761790|FG004|Overall Study|Adverse Event|0|||
33234969|NCT04163991|100761786|FG000|Overall Study|Death|0|||
33234970|NCT04163991|100761787|FG001|Overall Study|Death|0|||
33234971|NCT04163991|100761788|FG002|Overall Study|Death|1|||
33234972|NCT04163991|100761789|FG003|Overall Study|Death|0|||
33234973|NCT04163991|100761790|FG004|Overall Study|Death|0|||
33234974|NCT04163991|100761786|FG000|Overall Study|Lost to Follow-up|0|||
33234975|NCT04163991|100761787|FG001|Overall Study|Lost to Follow-up|1|||
33234976|NCT04163991|100761788|FG002|Overall Study|Lost to Follow-up|0|||
33234977|NCT04163991|100761789|FG003|Overall Study|Lost to Follow-up|0|||
33234978|NCT04163991|100761790|FG004|Overall Study|Lost to Follow-up|0|||
33234979|NCT04163991|100761786|FG000|Overall Study|Withdrawal by Subject|1|||
33234980|NCT04163991|100761787|FG001|Overall Study|Withdrawal by Subject|1|||
33420367|NCT00963599|101428602|FG000|Overall Study|Adverse Event|2|||
33420368|NCT00963599|101428603|FG001|Overall Study|Adverse Event|0|||
33420369|NCT00963599|101428604|FG002|Overall Study|Adverse Event|1|||
33234981|NCT04163991|100761788|FG002|Overall Study|Withdrawal by Subject|3|||
33234982|NCT04163991|100761789|FG003|Overall Study|Withdrawal by Subject|1|||
33234983|NCT04163991|100761790|FG004|Overall Study|Withdrawal by Subject|1|||
33234984|NCT04163991|100761786|FG000|Overall Study|Other, Not Specified|0|||
33234985|NCT04163991|100761787|FG001|Overall Study|Other, Not Specified|1|||
33234986|NCT04163991|100761788|FG002|Overall Study|Other, Not Specified|1|||
33234987|NCT04163991|100761789|FG003|Overall Study|Other, Not Specified|1|||
33234988|NCT04163991|100761790|FG004|Overall Study|Other, Not Specified|0|||
33234989|NCT03232138|100761791|FG000|Overall Study|Physician Decision|1|||
33234990|NCT03232138|100761792|FG001|Overall Study|Physician Decision|0|||
33234991|NCT03232138|100761791|FG000|Overall Study|Adverse Event|2|||
33234992|NCT03232138|100761792|FG001|Overall Study|Adverse Event|0|||
33420370|NCT00963599|101428605|FG003|Overall Study|Adverse Event|2|||
33420371|NCT00963599|101428602|FG000|Overall Study|Lack of Efficacy|0|||
33234993|NCT03232138|100761791|FG000|Overall Study|Withdrawal by Subject|1|||
33234994|NCT03232138|100761792|FG001|Overall Study|Withdrawal by Subject|2|||
33234995|NCT04581824|100761796|FG000|Overall Study|Ongoing|75|||
33234996|NCT04581824|100761797|FG001|Overall Study|Ongoing|69|||
33234997|NCT04581824|100761796|FG000|Overall Study|Withdrawal by Subject|3|||
33234998|NCT04581824|100761797|FG001|Overall Study|Withdrawal by Subject|5|||
33234999|NCT04581824|100761796|FG000|Overall Study|Lost to Follow-up|1|||
33235000|NCT04581824|100761797|FG001|Overall Study|Lost to Follow-up|0|||
33235001|NCT02723591|100761799|FG000|Overall Study|Adverse Event|48|||
33235002|NCT02723591|100761800|FG001|Overall Study|Adverse Event|40|||
33235003|NCT02723591|100761799|FG000|Overall Study|Death|2|||
33235004|NCT02723591|100761800|FG001|Overall Study|Death|2|||
33235005|NCT02723591|100761799|FG000|Overall Study|Lack of Efficacy|4|||
33235006|NCT02723591|100761800|FG001|Overall Study|Lack of Efficacy|3|||
33235007|NCT02723591|100761799|FG000|Overall Study|Lost to Follow-up|1|||
33235008|NCT02723591|100761800|FG001|Overall Study|Lost to Follow-up|7|||
33235009|NCT02723591|100761799|FG000|Overall Study|Protocol Violation|20|||
33235010|NCT02723591|100761800|FG001|Overall Study|Protocol Violation|23|||
33235011|NCT02723591|100761799|FG000|Overall Study|Withdrawal by Subject|4|||
33235012|NCT02723591|100761800|FG001|Overall Study|Withdrawal by Subject|8|||
33235013|NCT02723591|100761799|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
33235014|NCT02723591|100761800|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
33235015|NCT02723591|100761799|FG000|Overall Study|Miscellaneous|5|||
33420372|NCT00963599|101428603|FG001|Overall Study|Lack of Efficacy|2|||
33420373|NCT00963599|101428604|FG002|Overall Study|Lack of Efficacy|1|||
33420374|NCT00963599|101428605|FG003|Overall Study|Lack of Efficacy|4|||
33420375|NCT00963599|101428602|FG000|Overall Study|Lost to Follow-up|0|||
33420376|NCT00963599|101428603|FG001|Overall Study|Lost to Follow-up|1|||
33420377|NCT00963599|101428604|FG002|Overall Study|Lost to Follow-up|1|||
33420378|NCT00963599|101428605|FG003|Overall Study|Lost to Follow-up|1|||
33420379|NCT00963599|101428602|FG000|Overall Study|Protocol Violation|2|||
33420380|NCT00963599|101428603|FG001|Overall Study|Protocol Violation|2|||
33420381|NCT00963599|101428604|FG002|Overall Study|Protocol Violation|3|||
33420382|NCT00963599|101428605|FG003|Overall Study|Protocol Violation|4|||
33637068|NCT02118584|102223068|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
33637069|NCT02118584|102223069|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
33637070|NCT02118584|102223067|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
33637071|NCT02118584|102223068|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
33637072|NCT02118584|102223069|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
33637073|NCT02118584|102223067|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
33637074|NCT02118584|102223068|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
33637075|NCT02118584|102223069|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
33637076|NCT02118584|102223067|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
33637077|NCT02118584|102223068|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
33235016|NCT02723591|100761800|FG001|Overall Study|Miscellaneous|6|||
33420383|NCT00963599|101428602|FG000|Overall Study|Withdrawal by Subject|2|||
33420384|NCT00963599|101428603|FG001|Overall Study|Withdrawal by Subject|1|||
33420385|NCT00963599|101428604|FG002|Overall Study|Withdrawal by Subject|3|||
33420386|NCT00963599|101428605|FG003|Overall Study|Withdrawal by Subject|3|||
33420387|NCT00755937|101428607|FG000|Recruitment|Unknown if infliximab received|164|||
33576683|NCT00165789|102003147|FG001|Overall Study|Adverse Event|3|||
33576684|NCT00165789|102003148|FG002|Overall Study|Adverse Event|0|||
33576685|NCT00165789|102003149|FG003|Overall Study|Adverse Event|12|||
33576686|NCT00165789|102003146|FG000|Overall Study|Withdrawal by Subject|0|||
33576687|NCT00165789|102003147|FG001|Overall Study|Withdrawal by Subject|1|||
33576688|NCT00165789|102003148|FG002|Overall Study|Withdrawal by Subject|1|||
33576689|NCT00165789|102003149|FG003|Overall Study|Withdrawal by Subject|2|||
33576690|NCT02146131|102003152|FG000|Overall Study|Physician Decision|61|||
33576691|NCT02146131|102003153|FG001|Overall Study|Physician Decision|56|||
33576692|NCT00517699|102003154|FG000|Overall Study|Withdrawal by Subject|1|||
33576693|NCT00517699|102003154|FG000|Overall Study|Lack of Efficacy|1|||
33576694|NCT00517699|102003154|FG000|Overall Study|Administrative error|1|||
33576695|NCT00517699|102003154|FG000|Overall Study|Study terminated by Sponsor|2|||
33576696|NCT01788943|102003155|FG000|Overall Study|Withdrawal by Subject|1|||
33576697|NCT01788943|102003156|FG001|Overall Study|Withdrawal by Subject|0|||
33637078|NCT02118584|102223069|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
33235017|NCT00170573|100761801|FG000|Overall Study|Violation of inclusion criteria|13|||
33235018|NCT03138512|100761807|FG000|Randomization|Participants withdrew consent|0|||
33235019|NCT03138512|100761808|FG001|Randomization|Participants withdrew consent|1|||
33420388|NCT00755937|101428607|FG000|Observational Follow-up|Lost to Follow-up|148|||
33420389|NCT01610167|101428610|FG000|Overall Study|Scheduling conflict.|0|||
33576698|NCT02777086|102003157|FG000|Overall Study|Lost to Follow-up|96|||
33576699|NCT02777086|102003158|FG001|Overall Study|Lost to Follow-up|99|||
33576700|NCT02465931|102003159|FG000|Overall Study|Lost to Follow-up|9|||
33576701|NCT02465931|102003160|FG001|Overall Study|Lost to Follow-up|11|||
33235020|NCT03138512|100761809|FG002|Randomization|Participants withdrew consent|1|||
33576702|NCT02465931|102003159|FG000|Overall Study|Protocol Violation|1|||
33576703|NCT02465931|102003160|FG001|Overall Study|Protocol Violation|0|||
33576704|NCT02465931|102003159|FG000|Overall Study|Withdrawal by Subject|1|||
33576705|NCT02465931|102003160|FG001|Overall Study|Withdrawal by Subject|0|||
33576706|NCT01445847|102003161|FG000|Overall Study|Protocol Violation|13|||
33235021|NCT03138512|100761810|FG003|Randomization|Participants withdrew consent|0|||
33235022|NCT03138512|100761811|FG004|Randomization|Participants withdrew consent|0|||
33235023|NCT03138512|100761807|FG000|Randomization|Participant no longer meets study criteria|0|||
33235024|NCT03138512|100761808|FG001|Randomization|Participant no longer meets study criteria|3|||
33235025|NCT03138512|100761809|FG002|Randomization|Participant no longer meets study criteria|1|||
33235026|NCT03138512|100761810|FG003|Randomization|Participant no longer meets study criteria|1|||
33235027|NCT03138512|100761811|FG004|Randomization|Participant no longer meets study criteria|3|||
33235028|NCT03138512|100761807|FG000|Randomization|Other reasons|1|||
33235029|NCT03138512|100761808|FG001|Randomization|Other reasons|0|||
33235030|NCT03138512|100761809|FG002|Randomization|Other reasons|0|||
33235031|NCT03138512|100761810|FG003|Randomization|Other reasons|0|||
33235032|NCT03138512|100761811|FG004|Randomization|Other reasons|0|||
33235033|NCT03138512|100761807|FG000|Treatment Part A|Disease recurrence|10|||
33235034|NCT03138512|100761808|FG001|Treatment Part A|Disease recurrence|20|||
33235035|NCT03138512|100761809|FG002|Treatment Part A|Disease recurrence|0|||
33235036|NCT03138512|100761810|FG003|Treatment Part A|Disease recurrence|0|||
33235037|NCT03138512|100761811|FG004|Treatment Part A|Disease recurrence|0|||
33235038|NCT03138512|100761807|FG000|Treatment Part A|Study Drug Toxicity|132|||
33368924|NCT03052608|101234946|FG001|Treatment Phase|Adverse Event|12|||
33368925|NCT03052608|101234945|FG000|Treatment Phase|Death|6|||
33368926|NCT03052608|101234946|FG001|Treatment Phase|Death|4|||
33368927|NCT03052608|101234945|FG000|Treatment Phase|Withdrawal by Subject|4|||
33368928|NCT03052608|101234946|FG001|Treatment Phase|Withdrawal by Subject|12|||
33368929|NCT03052608|101234945|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
33368930|NCT03052608|101234946|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
33368931|NCT03052608|101234945|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
33138484|NCT02431260|100420275|FG011|Overall Study|Study Terminated by the Sponsor|0|||
33138485|NCT02431260|100420276|FG012|Overall Study|Study Terminated by the Sponsor|4|||
33138486|NCT02431260|100420277|FG013|Overall Study|Study Terminated by the Sponsor|0|||
33138487|NCT02431260|100420264|FG000|Overall Study|Physician Decision|0|||
33138488|NCT02431260|100420265|FG001|Overall Study|Physician Decision|0|||
33138489|NCT02431260|100420266|FG002|Overall Study|Physician Decision|0|||
33138490|NCT02431260|100420267|FG003|Overall Study|Physician Decision|0|||
33138491|NCT02431260|100420268|FG004|Overall Study|Physician Decision|0|||
33138492|NCT02431260|100420269|FG005|Overall Study|Physician Decision|1|||
33138493|NCT02431260|100420270|FG006|Overall Study|Physician Decision|0|||
33138494|NCT02431260|100420271|FG007|Overall Study|Physician Decision|0|||
33138495|NCT02431260|100420272|FG008|Overall Study|Physician Decision|0|||
33138496|NCT02431260|100420273|FG009|Overall Study|Physician Decision|0|||
33138497|NCT02431260|100420274|FG010|Overall Study|Physician Decision|0|||
33138498|NCT02431260|100420275|FG011|Overall Study|Physician Decision|0|||
33138499|NCT02431260|100420276|FG012|Overall Study|Physician Decision|0|||
33138500|NCT02431260|100420277|FG013|Overall Study|Physician Decision|0|||
33138501|NCT02431260|100420264|FG000|Overall Study|Other Unspecified|0|||
33138502|NCT02431260|100420265|FG001|Overall Study|Other Unspecified|0|||
33138503|NCT02431260|100420266|FG002|Overall Study|Other Unspecified|0|||
33138504|NCT02431260|100420267|FG003|Overall Study|Other Unspecified|0|||
33138505|NCT02431260|100420268|FG004|Overall Study|Other Unspecified|0|||
33138506|NCT02431260|100420269|FG005|Overall Study|Other Unspecified|0|||
33235039|NCT03138512|100761808|FG001|Treatment Part A|Study Drug Toxicity|5|||
33235040|NCT03138512|100761809|FG002|Treatment Part A|Study Drug Toxicity|0|||
33235041|NCT03138512|100761810|FG003|Treatment Part A|Study Drug Toxicity|0|||
33368932|NCT03052608|101234946|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
33368933|NCT03052608|101234945|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
33368934|NCT03052608|101234946|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
33368935|NCT03052608|101234945|FG000|Treatment Phase|Ongoing|103|||
33368936|NCT03052608|101234946|FG001|Treatment Phase|Ongoing|31|||
33368937|NCT03052608|101234945|FG000|Long-Term Follow-up Phase|Death|23|||
33576707|NCT01445847|102003162|FG001|Overall Study|Protocol Violation|14|||
33138507|NCT02431260|100420270|FG006|Overall Study|Other Unspecified|0|||
33138508|NCT02431260|100420271|FG007|Overall Study|Other Unspecified|0|||
33138509|NCT02431260|100420272|FG008|Overall Study|Other Unspecified|0|||
33235042|NCT03138512|100761811|FG004|Treatment Part A|Study Drug Toxicity|0|||
33235043|NCT03138512|100761807|FG000|Treatment Part A|Death|1|||
33138510|NCT02431260|100420273|FG009|Overall Study|Other Unspecified|0|||
33235044|NCT03138512|100761808|FG001|Treatment Part A|Death|0|||
33138511|NCT02431260|100420274|FG010|Overall Study|Other Unspecified|0|||
33138512|NCT02431260|100420275|FG011|Overall Study|Other Unspecified|1|||
33138513|NCT02431260|100420276|FG012|Overall Study|Other Unspecified|1|||
33368938|NCT03052608|101234946|FG001|Long-Term Follow-up Phase|Death|28|||
33576708|NCT01445847|102003161|FG000|Overall Study|Missed Data|1|||
33637079|NCT02118584|102223067|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
33637080|NCT02118584|102223068|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
33637081|NCT02118584|102223069|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
33637082|NCT02118584|102223067|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
33637083|NCT02118584|102223068|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
33637084|NCT02118584|102223069|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
33637085|NCT02118584|102223067|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
33637086|NCT02118584|102223068|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
33637087|NCT02118584|102223069|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
33637088|NCT02118584|102223067|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
33637089|NCT02118584|102223068|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
33637090|NCT02118584|102223069|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
33637091|NCT02118584|102223067|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
33637092|NCT02118584|102223068|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
33637093|NCT02118584|102223069|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
33637094|NCT00912197|102223070|FG000|Overall Study|Withdrawal by Subject|3|||
33637095|NCT00912197|102223071|FG001|Overall Study|Withdrawal by Subject|3|||
33637096|NCT01498068|102223074|FG000|Overall Study|Withdrawal by Subject|1|||
33637097|NCT01498068|102223075|FG001|Overall Study|Withdrawal by Subject|1|||
33235045|NCT03138512|100761809|FG002|Treatment Part A|Death|0|||
33235046|NCT03138512|100761810|FG003|Treatment Part A|Death|0|||
33235047|NCT03138512|100761811|FG004|Treatment Part A|Death|0|||
33368939|NCT03052608|101234945|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
33368940|NCT03052608|101234946|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
33368941|NCT03052608|101234945|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
33235048|NCT03138512|100761807|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
33235049|NCT03138512|100761808|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
33235050|NCT03138512|100761809|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
33235051|NCT03138512|100761810|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
33235052|NCT03138512|100761811|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
33235053|NCT03138512|100761807|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
33235054|NCT03138512|100761808|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
33235055|NCT03138512|100761809|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
33235056|NCT03138512|100761810|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
33235057|NCT03138512|100761811|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
33235058|NCT03138512|100761807|FG000|Treatment Part A|Participant withdrew consent|2|||
33235059|NCT03138512|100761808|FG001|Treatment Part A|Participant withdrew consent|4|||
33235060|NCT03138512|100761809|FG002|Treatment Part A|Participant withdrew consent|0|||
33235061|NCT03138512|100761810|FG003|Treatment Part A|Participant withdrew consent|0|||
33368942|NCT03052608|101234946|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
33576709|NCT01445847|102003162|FG001|Overall Study|Missed Data|0|||
33576710|NCT02949011|102003166|FG000|Overall Study|Adverse Event|6|||
33576711|NCT02949011|102003167|FG001|Overall Study|Adverse Event|7|||
33576712|NCT02949011|102003168|FG002|Overall Study|Adverse Event|3|||
33576713|NCT02949011|102003166|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
33576714|NCT02949011|102003167|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
33576715|NCT02949011|102003168|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
33576716|NCT02949011|102003166|FG000|Overall Study|Protocol Deviation|5|||
33576717|NCT02949011|102003167|FG001|Overall Study|Protocol Deviation|3|||
33576718|NCT02949011|102003168|FG002|Overall Study|Protocol Deviation|3|||
33576719|NCT02949011|102003166|FG000|Overall Study|Lack of Efficacy|0|||
33576720|NCT02949011|102003167|FG001|Overall Study|Lack of Efficacy|2|||
33576721|NCT02949011|102003168|FG002|Overall Study|Lack of Efficacy|0|||
33576722|NCT02949011|102003166|FG000|Overall Study|Withdrawal by Subject|13|||
33576723|NCT02949011|102003167|FG001|Overall Study|Withdrawal by Subject|13|||
33576724|NCT02949011|102003168|FG002|Overall Study|Withdrawal by Subject|21|||
33576725|NCT02949011|102003166|FG000|Overall Study|Lost to Follow-up|7|||
33576726|NCT02949011|102003167|FG001|Overall Study|Lost to Follow-up|5|||
33576727|NCT02949011|102003168|FG002|Overall Study|Lost to Follow-up|5|||
33576728|NCT02949011|102003166|FG000|Overall Study|Death|0|||
33576729|NCT02949011|102003167|FG001|Overall Study|Death|0|||
33576730|NCT02949011|102003168|FG002|Overall Study|Death|1|||
33576731|NCT02949011|102003166|FG000|Overall Study|Miscellaneous|2|||
33576732|NCT02949011|102003167|FG001|Overall Study|Miscellaneous|4|||
33576733|NCT02949011|102003168|FG002|Overall Study|Miscellaneous|6|||
33576734|NCT01334554|102003171|FG000|Overall Study|Adverse Event|4|||
33576735|NCT01334554|102003172|FG001|Overall Study|Adverse Event|2|||
33576736|NCT03465722|102003173|FG000|Overall Study|Withdrawal by Subject|21|||
33576737|NCT03465722|102003174|FG001|Overall Study|Withdrawal by Subject|14|||
33576738|NCT03465722|102003173|FG000|Overall Study|Death|89|||
33576739|NCT03465722|102003174|FG001|Overall Study|Death|87|||
33637098|NCT02839200|102223076|FG000|Overall Study|Withdrawal by Subject|2|||
33637099|NCT02839200|102223077|FG001|Overall Study|Withdrawal by Subject|0|||
33637100|NCT02839200|102223078|FG002|Overall Study|Withdrawal by Subject|1|||
33637101|NCT02839200|102223079|FG003|Overall Study|Withdrawal by Subject|0|||
33637102|NCT02839200|102223080|FG004|Overall Study|Withdrawal by Subject|0|||
33637103|NCT02839200|102223081|FG005|Overall Study|Withdrawal by Subject|1|||
33637104|NCT02839200|102223076|FG000|Overall Study|Lost to Follow-up|2|||
33637105|NCT02839200|102223077|FG001|Overall Study|Lost to Follow-up|0|||
33637106|NCT02839200|102223078|FG002|Overall Study|Lost to Follow-up|0|||
33637107|NCT02839200|102223079|FG003|Overall Study|Lost to Follow-up|0|||
33637108|NCT02839200|102223080|FG004|Overall Study|Lost to Follow-up|1|||
33637109|NCT02839200|102223081|FG005|Overall Study|Lost to Follow-up|0|||
33235062|NCT03138512|100761811|FG004|Treatment Part A|Participant withdrew consent|0|||
33235063|NCT03138512|100761807|FG000|Treatment Part A|Lost to Follow-up|0|||
33235064|NCT03138512|100761808|FG001|Treatment Part A|Lost to Follow-up|1|||
33235065|NCT03138512|100761809|FG002|Treatment Part A|Lost to Follow-up|0|||
33235066|NCT03138512|100761810|FG003|Treatment Part A|Lost to Follow-up|0|||
33235067|NCT03138512|100761811|FG004|Treatment Part A|Lost to Follow-up|0|||
33235068|NCT03138512|100761807|FG000|Treatment Part A|Poor/non-compliance|1|||
33235069|NCT03138512|100761808|FG001|Treatment Part A|Poor/non-compliance|0|||
33235070|NCT03138512|100761809|FG002|Treatment Part A|Poor/non-compliance|0|||
33235071|NCT03138512|100761810|FG003|Treatment Part A|Poor/non-compliance|0|||
33235072|NCT03138512|100761811|FG004|Treatment Part A|Poor/non-compliance|0|||
33235073|NCT03138512|100761807|FG000|Treatment Part A|Pregnancy|0|||
33235074|NCT03138512|100761808|FG001|Treatment Part A|Pregnancy|1|||
33235075|NCT03138512|100761809|FG002|Treatment Part A|Pregnancy|0|||
33235076|NCT03138512|100761810|FG003|Treatment Part A|Pregnancy|0|||
33235077|NCT03138512|100761811|FG004|Treatment Part A|Pregnancy|0|||
33235078|NCT03138512|100761807|FG000|Treatment Part A|Other reasons|11|||
33235079|NCT03138512|100761808|FG001|Treatment Part A|Other reasons|8|||
33235080|NCT03138512|100761809|FG002|Treatment Part A|Other reasons|0|||
33576740|NCT03465722|102003173|FG000|Overall Study|Lost to Follow-up|5|||
33576741|NCT03465722|102003174|FG001|Overall Study|Lost to Follow-up|3|||
33576742|NCT03465722|102003173|FG000|Overall Study|Administrative/Other|33|||
33576743|NCT03465722|102003174|FG001|Overall Study|Administrative/Other|32|||
33576744|NCT03465722|102003173|FG000|Overall Study|Not treated|1|||
33576745|NCT03465722|102003174|FG001|Overall Study|Not treated|2|||
33576746|NCT03465722|102003173|FG000|Overall Study|Sponsor decision|91|||
33576747|NCT03465722|102003174|FG001|Overall Study|Sponsor decision|98|||
33576748|NCT04460183|102003176|FG000|Overall Study|Lost to Follow-up|3|||
33576749|NCT04460183|102003177|FG001|Overall Study|Lost to Follow-up|1|||
33576750|NCT04460183|102003176|FG000|Overall Study|Withdrawal by Subject|1|||
33576751|NCT04460183|102003177|FG001|Overall Study|Withdrawal by Subject|0|||
33576752|NCT01612676|102003178|FG000|Overall Study|Adverse Event|2|||
33576753|NCT01612676|102003179|FG001|Overall Study|Adverse Event|3|||
33576754|NCT01612676|102003180|FG002|Overall Study|Adverse Event|1|||
33576755|NCT01612676|102003181|FG003|Overall Study|Adverse Event|3|||
33576756|NCT01612676|102003178|FG000|Overall Study|Protocol Violation|0|||
33576757|NCT01612676|102003179|FG001|Overall Study|Protocol Violation|1|||
33576758|NCT01612676|102003180|FG002|Overall Study|Protocol Violation|0|||
33576759|NCT01612676|102003181|FG003|Overall Study|Protocol Violation|0|||
33576760|NCT01628913|102003190|FG000|Overall Study|Adverse Event|12|||
33576761|NCT01628913|102003191|FG001|Overall Study|Adverse Event|5|||
33576762|NCT01628913|102003190|FG000|Overall Study|Disease Progression|11|||
33576763|NCT01628913|102003191|FG001|Overall Study|Disease Progression|14|||
33576764|NCT01628913|102003190|FG000|Overall Study|Protocol Violation|1|||
33576765|NCT01628913|102003191|FG001|Overall Study|Protocol Violation|0|||
33576766|NCT01628913|102003190|FG000|Overall Study|Death|1|||
33576767|NCT01628913|102003191|FG001|Overall Study|Death|0|||
33576768|NCT01628913|102003190|FG000|Overall Study|study terminated by Sponsor|4|||
33576769|NCT01628913|102003191|FG001|Overall Study|study terminated by Sponsor|9|||
33576770|NCT01628913|102003190|FG000|Overall Study|Withdrawal by Subject|1|||
33637110|NCT02839200|102223076|FG000|Overall Study|Adverse Event|0|||
33637111|NCT02839200|102223077|FG001|Overall Study|Adverse Event|0|||
33637112|NCT02839200|102223078|FG002|Overall Study|Adverse Event|0|||
33235081|NCT03138512|100761810|FG003|Treatment Part A|Other reasons|0|||
33235082|NCT03138512|100761811|FG004|Treatment Part A|Other reasons|0|||
33235083|NCT03138512|100761807|FG000|Treatment Part B|Disease recurrence|0|||
33235084|NCT03138512|100761808|FG001|Treatment Part B|Disease recurrence|0|||
33576771|NCT01628913|102003191|FG001|Overall Study|Withdrawal by Subject|0|||
33576772|NCT01628913|102003190|FG000|Overall Study|Physician Decision|1|||
33576773|NCT01628913|102003191|FG001|Overall Study|Physician Decision|3|||
33576774|NCT00305877|102003192|FG000|Overall Study|Lack of Efficacy|6|||
33576775|NCT00305877|102003193|FG001|Overall Study|Lack of Efficacy|9|||
33368943|NCT03052608|101234945|FG000|Long-Term Follow-up Phase|Ongoing|122|||
33576776|NCT00305877|102003192|FG000|Overall Study|Adverse Event|9|||
33576777|NCT00305877|102003193|FG001|Overall Study|Adverse Event|14|||
33576778|NCT00305877|102003192|FG000|Overall Study|Death|0|||
33576779|NCT00305877|102003193|FG001|Overall Study|Death|1|||
33368944|NCT03052608|101234946|FG001|Long-Term Follow-up Phase|Ongoing|99|||
33368945|NCT03391466|101234948|FG000|Overall Study|Death|82|||
33368946|NCT03391466|101234949|FG001|Overall Study|Death|85|||
33235085|NCT03138512|100761809|FG002|Treatment Part B|Disease recurrence|6|||
33235086|NCT03138512|100761810|FG003|Treatment Part B|Disease recurrence|12|||
33235087|NCT03138512|100761811|FG004|Treatment Part B|Disease recurrence|10|||
33235088|NCT03138512|100761807|FG000|Treatment Part B|Study drug toxicity|0|||
33235089|NCT03138512|100761808|FG001|Treatment Part B|Study drug toxicity|0|||
33235090|NCT03138512|100761809|FG002|Treatment Part B|Study drug toxicity|63|||
33235091|NCT03138512|100761810|FG003|Treatment Part B|Study drug toxicity|3|||
33235092|NCT03138512|100761811|FG004|Treatment Part B|Study drug toxicity|45|||
33235093|NCT03138512|100761807|FG000|Treatment Part B|Death|0|||
33235094|NCT03138512|100761808|FG001|Treatment Part B|Death|0|||
33235095|NCT03138512|100761809|FG002|Treatment Part B|Death|1|||
33235096|NCT03138512|100761810|FG003|Treatment Part B|Death|0|||
33235097|NCT03138512|100761811|FG004|Treatment Part B|Death|0|||
33235098|NCT03138512|100761807|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
33235099|NCT03138512|100761808|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
33235100|NCT03138512|100761809|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
33235101|NCT03138512|100761810|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
33235102|NCT03138512|100761811|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
33235103|NCT03138512|100761807|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
33235104|NCT03138512|100761808|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
33235105|NCT03138512|100761809|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
33235106|NCT03138512|100761810|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
33235107|NCT03138512|100761811|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
33368947|NCT03391466|101234948|FG000|Overall Study|Still on study|93|||
33368948|NCT03391466|101234949|FG001|Overall Study|Still on study|74|||
33368949|NCT03391466|101234948|FG000|Overall Study|Subject withdrawal of consent from further follow-up|0|||
33368950|NCT03391466|101234949|FG001|Overall Study|Subject withdrawal of consent from further follow-up|13|||
33368951|NCT03391466|101234948|FG000|Overall Study|Lost to Follow-up|5|||
33368952|NCT03391466|101234949|FG001|Overall Study|Lost to Follow-up|5|||
33368953|NCT03391466|101234948|FG000|Overall Study|Investigator decision|0|||
33368954|NCT03391466|101234949|FG001|Overall Study|Investigator decision|1|||
33368955|NCT03391466|101234948|FG000|Overall Study|Other|0|||
33368956|NCT03391466|101234949|FG001|Overall Study|Other|1|||
33368957|NCT03474107|101234950|FG000|Overall Study|Adverse Event|42|||
33368958|NCT03474107|101234951|FG001|Overall Study|Adverse Event|46|||
33576780|NCT00305877|102003192|FG000|Overall Study|Withdrawal by Subject|4|||
33576781|NCT00305877|102003193|FG001|Overall Study|Withdrawal by Subject|2|||
33576782|NCT00305877|102003192|FG000|Overall Study|Physician Decision|1|||
33576783|NCT00305877|102003193|FG001|Overall Study|Physician Decision|1|||
33576784|NCT00305877|102003192|FG000|Overall Study|Never start treatment|2|||
33576785|NCT00305877|102003193|FG001|Overall Study|Never start treatment|5|||
33576786|NCT00305877|102003192|FG000|Overall Study|Ineligible|2|||
33637113|NCT02839200|102223079|FG003|Overall Study|Adverse Event|0|||
33637114|NCT02839200|102223080|FG004|Overall Study|Adverse Event|1|||
33368959|NCT03474107|101234950|FG000|Overall Study|Death|2|||
33576787|NCT00305877|102003193|FG001|Overall Study|Ineligible|1|||
33576788|NCT00305877|102003192|FG000|Overall Study|Transportation issue with daily RT|0|||
33576789|NCT00305877|102003193|FG001|Overall Study|Transportation issue with daily RT|1|||
33576790|NCT02737501|102003194|FG000|Randomized Phase|Died|41|||
33576791|NCT02737501|102003195|FG001|Randomized Phase|Died|29|||
33576792|NCT02737501|102003196|FG002|Randomized Phase|Died|0|||
33576793|NCT02737501|102003194|FG000|Randomized Phase|Withdrawal by Subject|16|||
33576794|NCT02737501|102003195|FG001|Randomized Phase|Withdrawal by Subject|6|||
33637115|NCT02839200|102223081|FG005|Overall Study|Adverse Event|0|||
33637116|NCT02839200|102223076|FG000|Overall Study|Randomized in error|0|||
33637117|NCT02839200|102223077|FG001|Overall Study|Randomized in error|1|||
33637118|NCT02839200|102223078|FG002|Overall Study|Randomized in error|0|||
33368960|NCT03474107|101234951|FG001|Overall Study|Death|2|||
33368961|NCT03474107|101234950|FG000|Overall Study|Lost to Follow-up|0|||
33368962|NCT03474107|101234951|FG001|Overall Study|Lost to Follow-up|1|||
33368963|NCT03474107|101234950|FG000|Overall Study|Progressive Disease|177|||
33368964|NCT03474107|101234951|FG001|Overall Study|Progressive Disease|180|||
33368965|NCT03474107|101234950|FG000|Overall Study|Protocol Violation|1|||
33368966|NCT03474107|101234951|FG001|Overall Study|Protocol Violation|1|||
33368967|NCT03474107|101234950|FG000|Overall Study|Withdrawal by Subject|15|||
33368968|NCT03474107|101234951|FG001|Overall Study|Withdrawal by Subject|27|||
33576795|NCT02737501|102003196|FG002|Randomized Phase|Withdrawal by Subject|0|||
33576796|NCT02737501|102003194|FG000|Randomized Phase|Lost to Follow-up|0|||
33576797|NCT02737501|102003195|FG001|Randomized Phase|Lost to Follow-up|1|||
33637119|NCT02839200|102223079|FG003|Overall Study|Randomized in error|0|||
33576798|NCT02737501|102003196|FG002|Randomized Phase|Lost to Follow-up|0|||
33576799|NCT02737501|102003194|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
33637120|NCT02839200|102223080|FG004|Overall Study|Randomized in error|0|||
33235108|NCT03138512|100761807|FG000|Treatment Part B|Participant withdrew consent|0|||
33235109|NCT03138512|100761808|FG001|Treatment Part B|Participant withdrew consent|0|||
33235110|NCT03138512|100761809|FG002|Treatment Part B|Participant withdrew consent|1|||
33235111|NCT03138512|100761810|FG003|Treatment Part B|Participant withdrew consent|1|||
33235112|NCT03138512|100761811|FG004|Treatment Part B|Participant withdrew consent|2|||
33235113|NCT03138512|100761807|FG000|Treatment Part B|Lost to Follow-up|0|||
33235114|NCT03138512|100761808|FG001|Treatment Part B|Lost to Follow-up|0|||
33235115|NCT03138512|100761809|FG002|Treatment Part B|Lost to Follow-up|0|||
33637121|NCT02839200|102223081|FG005|Overall Study|Randomized in error|0|||
33637122|NCT01213472|102223082|FG000|Overall Study|Recurrence/Progressive disease|25|||
33637123|NCT01213472|102223082|FG000|Overall Study|Withdrawal by Subject|1|||
33637124|NCT01213472|102223082|FG000|Overall Study|Physician Decision|1|||
33637125|NCT01658436|102223083|FG000|Overall Study|Adverse Event|6|||
33637126|NCT01658436|102223084|FG001|Overall Study|Adverse Event|5|||
33637127|NCT01658436|102223083|FG000|Overall Study|Physician Decision|1|||
33637128|NCT01658436|102223084|FG001|Overall Study|Physician Decision|0|||
33637129|NCT01658436|102223083|FG000|Overall Study|Progressive disease|12|||
33637130|NCT01658436|102223084|FG001|Overall Study|Progressive disease|4|||
33637131|NCT01658436|102223083|FG000|Overall Study|Study terminated by sponsor|0|||
33637132|NCT01658436|102223084|FG001|Overall Study|Study terminated by sponsor|1|||
33637133|NCT01658436|102223083|FG000|Overall Study|Subject/guardian decision|0|||
33235116|NCT03138512|100761810|FG003|Treatment Part B|Lost to Follow-up|1|||
33235117|NCT03138512|100761811|FG004|Treatment Part B|Lost to Follow-up|0|||
33420390|NCT01610167|101428611|FG001|Overall Study|Scheduling conflict.|0|||
33420391|NCT01610167|101428612|FG002|Overall Study|Scheduling conflict.|2|||
33420392|NCT02524665|101428613|FG000|Overall Study|Lost to Follow-up|1|||
33420393|NCT01052038|101428617|FG000|Overall Study|Lost to Follow-up|2|||
33576800|NCT02737501|102003195|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
33576801|NCT02737501|102003196|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
33576802|NCT02737501|102003194|FG000|Randomized Phase|Reason not Specified|1|||
33576803|NCT02737501|102003195|FG001|Randomized Phase|Reason not Specified|1|||
33576804|NCT02737501|102003196|FG002|Randomized Phase|Reason not Specified|0|||
33576805|NCT02737501|102003194|FG000|Randomized Phase|Never Treated|1|||
33576806|NCT02737501|102003195|FG001|Randomized Phase|Never Treated|1|||
33576807|NCT02737501|102003196|FG002|Randomized Phase|Never Treated|0|||
33576808|NCT02737501|102003194|FG000|Crossover Phase|Died|0|||
33576809|NCT02737501|102003195|FG001|Crossover Phase|Died|0|||
33576810|NCT02737501|102003196|FG002|Crossover Phase|Died|22|||
33576811|NCT02737501|102003194|FG000|Crossover Phase|Withdrew Consent|0|||
33576812|NCT02737501|102003195|FG001|Crossover Phase|Withdrew Consent|0|||
33576813|NCT02737501|102003196|FG002|Crossover Phase|Withdrew Consent|9|||
33576814|NCT02737501|102003194|FG000|Crossover Phase|Physician Decision|0|||
33576815|NCT02737501|102003195|FG001|Crossover Phase|Physician Decision|0|||
33576816|NCT02737501|102003196|FG002|Crossover Phase|Physician Decision|1|||
33576817|NCT02737501|102003194|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
33576818|NCT02737501|102003195|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
33576819|NCT02737501|102003196|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
33576820|NCT05111145|102003199|FG000|Overall Study|Commercial drug is available for participant|76|||
33576821|NCT05111145|102003199|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
33576822|NCT00698828|102003200|FG000|Overall Study|Adverse Event|3|||
33576823|NCT00698828|102003201|FG001|Overall Study|Adverse Event|4|||
33576824|NCT00698828|102003202|FG002|Overall Study|Adverse Event|4|||
33576825|NCT00698828|102003200|FG000|Overall Study|Death|0|||
33576826|NCT00698828|102003201|FG001|Overall Study|Death|0|||
33576827|NCT00698828|102003202|FG002|Overall Study|Death|1|||
33576828|NCT00698828|102003200|FG000|Overall Study|Exacerbation of COPD|1|||
33576829|NCT00698828|102003201|FG001|Overall Study|Exacerbation of COPD|3|||
33576830|NCT00698828|102003202|FG002|Overall Study|Exacerbation of COPD|0|||
33576831|NCT00698828|102003200|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
33576832|NCT00698828|102003201|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
33576833|NCT00698828|102003202|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
33576834|NCT00698828|102003200|FG000|Overall Study|Investigator/Sponsor decision|1|||
33576835|NCT00698828|102003201|FG001|Overall Study|Investigator/Sponsor decision|0|||
33576836|NCT00698828|102003202|FG002|Overall Study|Investigator/Sponsor decision|2|||
33576837|NCT00698828|102003200|FG000|Overall Study|Lost to Follow-up|1|||
33637134|NCT01658436|102223084|FG001|Overall Study|Subject/guardian decision|1|||
33637135|NCT01658436|102223083|FG000|Overall Study|Death|1|||
33576838|NCT00698828|102003201|FG001|Overall Study|Lost to Follow-up|1|||
33576839|NCT00698828|102003202|FG002|Overall Study|Lost to Follow-up|0|||
33576840|NCT00698828|102003200|FG000|Overall Study|Withdrew consent|0|||
33576841|NCT00698828|102003201|FG001|Overall Study|Withdrew consent|7|||
33235118|NCT03138512|100761807|FG000|Treatment Part B|Poor/non-compliance|0|||
33576842|NCT00698828|102003202|FG002|Overall Study|Withdrew consent|4|||
33576843|NCT00698828|102003200|FG000|Overall Study|Withdrew consent (not treated)|2|||
33576844|NCT00698828|102003201|FG001|Overall Study|Withdrew consent (not treated)|0|||
33637136|NCT01658436|102223084|FG001|Overall Study|Death|0|||
33637137|NCT02892344|102223088|FG000|Overall Study|Protocol deviation|3|||
33637138|NCT02892344|102223089|FG001|Overall Study|Protocol deviation|4|||
33637139|NCT02892344|102223088|FG000|Overall Study|Adverse Event|1|||
33637140|NCT02892344|102223089|FG001|Overall Study|Adverse Event|8|||
33637141|NCT02892344|102223088|FG000|Overall Study|Lost to Follow-up|0|||
33637142|NCT02892344|102223089|FG001|Overall Study|Lost to Follow-up|1|||
33637143|NCT02892344|102223088|FG000|Overall Study|Non-compliance with study treatment|0|||
33637144|NCT02892344|102223089|FG001|Overall Study|Non-compliance with study treatment|1|||
33637145|NCT02892344|102223088|FG000|Overall Study|Physician Decision|0|||
33637146|NCT02892344|102223089|FG001|Overall Study|Physician Decision|2|||
33637147|NCT02892344|102223088|FG000|Overall Study|Subject/guardian decision|0|||
33637148|NCT02892344|102223089|FG001|Overall Study|Subject/guardian decision|4|||
33637149|NCT02892344|102223088|FG000|Overall Study|Technical problems|0|||
33637150|NCT02892344|102223089|FG001|Overall Study|Technical problems|1|||
33637151|NCT01249261|102223092|FG000|Overall Study|Withdrawal by Subject|1|||
33637152|NCT01249261|102223093|FG001|Overall Study|Withdrawal by Subject|0|||
33637153|NCT00942604|102223103|FG000|Overall Study|Protocol Violation|1|||
33637154|NCT00942604|102223104|FG001|Overall Study|Protocol Violation|1|||
33637155|NCT00942604|102223103|FG000|Overall Study|Adverse Event|0|||
33637156|NCT00942604|102223104|FG001|Overall Study|Adverse Event|1|||
33637157|NCT00942604|102223103|FG000|Overall Study|Withdrawal by Subject|0|||
33637158|NCT00942604|102223104|FG001|Overall Study|Withdrawal by Subject|1|||
33637159|NCT00942604|102223103|FG000|Overall Study|Patient relocation|1|||
33637160|NCT00942604|102223104|FG001|Overall Study|Patient relocation|1|||
33637161|NCT03414983|102223105|FG000|Pre-Treatment|Other reasons|1|||
33637162|NCT03414983|102223106|FG001|Pre-Treatment|Other reasons|0|||
33637163|NCT03414983|102223105|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
33637164|NCT03414983|102223106|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
33637165|NCT03414983|102223105|FG000|Pre-Treatment|Participant withdrew consent|1|||
33637166|NCT03414983|102223106|FG001|Pre-Treatment|Participant withdrew consent|3|||
33637167|NCT03414983|102223105|FG000|Treatment|Participant withdrew consent|4|||
33637168|NCT03414983|102223106|FG001|Treatment|Participant withdrew consent|3|||
33637169|NCT03414983|102223105|FG000|Treatment|Participant request to discontinue study treatment|8|||
33637170|NCT03414983|102223106|FG001|Treatment|Participant request to discontinue study treatment|10|||
33637171|NCT03414983|102223105|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
33637172|NCT03414983|102223106|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
33637173|NCT03414983|102223105|FG000|Treatment|Death|0|||
33637174|NCT03414983|102223106|FG001|Treatment|Death|1|||
33637175|NCT03414983|102223105|FG000|Treatment|Study Drug Toxicity|10|||
33637176|NCT03414983|102223106|FG001|Treatment|Study Drug Toxicity|5|||
33576845|NCT00698828|102003202|FG002|Overall Study|Withdrew consent (not treated)|0|||
33576846|NCT01192126|102003207|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
33576847|NCT01192126|102003208|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
33576848|NCT01192126|102003207|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
33576849|NCT01192126|102003208|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
33576850|NCT04021290|102003214|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
33576851|NCT04021290|102003215|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
33576852|NCT04021290|102003216|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
33576853|NCT04021290|102003214|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
33576854|NCT04021290|102003215|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
33576855|NCT04021290|102003216|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
33576856|NCT04021290|102003214|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
33637177|NCT03414983|102223105|FG000|Treatment|Disease Progression|75|||
33637178|NCT03414983|102223106|FG001|Treatment|Disease Progression|29|||
33637179|NCT03414983|102223105|FG000|Treatment|Not reported|1|||
33637180|NCT03414983|102223106|FG001|Treatment|Not reported|0|||
33637181|NCT03414983|102223105|FG000|Treatment|Other reasons|3|||
33637182|NCT03414983|102223106|FG001|Treatment|Other reasons|2|||
33576857|NCT04021290|102003215|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
33576858|NCT04021290|102003216|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
33576859|NCT04021290|102003214|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
33576860|NCT04021290|102003215|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
33576861|NCT04021290|102003216|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
33576862|NCT04021290|102003214|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
33576863|NCT04021290|102003215|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
33576864|NCT04021290|102003216|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
33637183|NCT03414983|102223105|FG000|Treatment|Poor/non-compliance|2|||
33637184|NCT03414983|102223106|FG001|Treatment|Poor/non-compliance|0|||
33637185|NCT03414983|102223105|FG000|Treatment|Maximum clinical benefit|5|||
33637186|NCT03414983|102223106|FG001|Treatment|Maximum clinical benefit|9|||
33637187|NCT03414983|102223105|FG000|Treatment|Lost to Follow-up|0|||
33637188|NCT03414983|102223106|FG001|Treatment|Lost to Follow-up|1|||
33637189|NCT03414983|102223105|FG000|Treatment|Administrative reasons by sponsor|1|||
33637190|NCT03414983|102223106|FG001|Treatment|Administrative reasons by sponsor|0|||
33637191|NCT00432172|102223107|FG000|Overall Study|Physician Decision|0|||
33138514|NCT02431260|100420277|FG013|Overall Study|Other Unspecified|0|||
33138515|NCT02142387|100420282|FG000|Overall Study|<19 years old|49|||
33138516|NCT02142387|100420283|FG001|Overall Study|<19 years old|326|||
33138517|NCT02142387|100420282|FG000|Overall Study|non-cardiac etiology|504|||
33138518|NCT02142387|100420283|FG001|Overall Study|non-cardiac etiology|3431|||
33138519|NCT02142387|100420282|FG000|Overall Study|CPR not performed|74|||
33138520|NCT02142387|100420283|FG001|Overall Study|CPR not performed|473|||
33138521|NCT02142387|100420282|FG000|Overall Study|witnessed by paramedic|139|||
33138522|NCT02142387|100420283|FG001|Overall Study|witnessed by paramedic|917|||
33576865|NCT04021290|102003214|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
33576866|NCT04021290|102003215|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
33576867|NCT04021290|102003216|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
33576868|NCT04021290|102003214|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
33138523|NCT02142387|100420282|FG000|Overall Study|incomplete data|1|||
33138524|NCT02142387|100420283|FG001|Overall Study|incomplete data|9|||
33235119|NCT03138512|100761808|FG001|Treatment Part B|Poor/non-compliance|0|||
33235120|NCT03138512|100761809|FG002|Treatment Part B|Poor/non-compliance|1|||
33235121|NCT03138512|100761810|FG003|Treatment Part B|Poor/non-compliance|1|||
33235122|NCT03138512|100761811|FG004|Treatment Part B|Poor/non-compliance|1|||
33235123|NCT03138512|100761807|FG000|Treatment Part B|Other reasons|0|||
33235124|NCT03138512|100761808|FG001|Treatment Part B|Other reasons|0|||
33420394|NCT01052038|101428618|FG001|Overall Study|Lost to Follow-up|3|||
33420395|NCT01052038|101428619|FG002|Overall Study|Lost to Follow-up|1|||
33420396|NCT01052038|101428617|FG000|Overall Study|Protocol Violation|2|||
33420397|NCT01052038|101428618|FG001|Overall Study|Protocol Violation|3|||
33420398|NCT01052038|101428619|FG002|Overall Study|Protocol Violation|3|||
33420399|NCT00306852|101428620|FG000|Overall Study|Death|14|||
33420400|NCT00306852|101428621|FG001|Overall Study|Death|14|||
33420401|NCT00306852|101428620|FG000|Overall Study|Lost to Follow-up|15|||
33420402|NCT00306852|101428621|FG001|Overall Study|Lost to Follow-up|24|||
33420403|NCT03454672|101428622|FG000|Overall Study|Adverse Event|1|||
33420404|NCT03454672|101428623|FG001|Overall Study|Adverse Event|1|||
33420405|NCT03454672|101428622|FG000|Overall Study|Lost to Follow-up|1|||
33420406|NCT03454672|101428623|FG001|Overall Study|Lost to Follow-up|3|||
33576869|NCT04021290|102003215|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
33576870|NCT04021290|102003216|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
33576871|NCT04021290|102003214|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
33576872|NCT04021290|102003215|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
33576873|NCT04021290|102003216|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
33576874|NCT04021290|102003214|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
33576875|NCT04021290|102003215|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
33576876|NCT04021290|102003216|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
33576877|NCT04021290|102003214|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
33576878|NCT04021290|102003215|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
33576879|NCT04021290|102003216|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
33576880|NCT04021290|102003214|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
33576881|NCT04021290|102003215|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
33576882|NCT04021290|102003216|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
33576883|NCT04021290|102003214|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
33576884|NCT04021290|102003215|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
33576885|NCT04021290|102003216|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
33576886|NCT03654274|102003220|FG000|Overall Study|Adverse Event|19|||
33576887|NCT03654274|102003221|FG001|Overall Study|Adverse Event|23|||
33576888|NCT03654274|102003222|FG002|Overall Study|Adverse Event|24|||
33576889|NCT03654274|102003220|FG000|Overall Study|Protocol Deviation|0|||
33576890|NCT03654274|102003221|FG001|Overall Study|Protocol Deviation|2|||
33576891|NCT03654274|102003222|FG002|Overall Study|Protocol Deviation|0|||
33576892|NCT03654274|102003220|FG000|Overall Study|Lost to Follow-up|8|||
33576893|NCT03654274|102003221|FG001|Overall Study|Lost to Follow-up|6|||
33138525|NCT02142387|100420282|FG000|Overall Study|occurred not at home|298|||
33138526|NCT02142387|100420283|FG001|Overall Study|occurred not at home|2474|||
33576894|NCT03654274|102003222|FG002|Overall Study|Lost to Follow-up|5|||
33576895|NCT03654274|102003220|FG000|Overall Study|Withdrawal by Subject|46|||
33576896|NCT03654274|102003221|FG001|Overall Study|Withdrawal by Subject|25|||
33576897|NCT03654274|102003222|FG002|Overall Study|Withdrawal by Subject|33|||
33576898|NCT03654274|102003220|FG000|Overall Study|Lack of Efficacy|4|||
33138527|NCT03005873|100420288|FG000|Overall Study|Prohibited medication use post radnomization|1|||
33138528|NCT03005873|100420289|FG001|Overall Study|Prohibited medication use post radnomization|1|||
33235125|NCT03138512|100761809|FG002|Treatment Part B|Other reasons|3|||
33235126|NCT03138512|100761810|FG003|Treatment Part B|Other reasons|1|||
33235127|NCT03138512|100761811|FG004|Treatment Part B|Other reasons|5|||
33420407|NCT03454672|101428622|FG000|Overall Study|painful|1|||
33420408|NCT03454672|101428623|FG001|Overall Study|painful|2|||
33420409|NCT03454672|101428622|FG000|Overall Study|Non-compliance|2|||
33235128|NCT04716881|100761812|FG000|Overall Study|Adverse Event|1|||
33235129|NCT04716881|100761812|FG000|Overall Study|Lost to Follow-up|1|||
33235130|NCT02287610|100761813|FG000|Overall Study|Lost to Follow-up|3|||
33235131|NCT02287610|100761813|FG000|Overall Study|Withdrawal by Subject|8|||
33235132|NCT02287610|100761813|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
33235133|NCT04158648|100761814|FG000|Overall Study|Ongoing in the Study|69|||
33235134|NCT04158648|100761814|FG000|Overall Study|Withdrawal by Subject|4|||
33235135|NCT03770273|100761815|FG000|Overall Study|Adverse Event|2|||
33235136|NCT03770273|100761816|FG001|Overall Study|Adverse Event|0|||
33576899|NCT03654274|102003221|FG001|Overall Study|Lack of Efficacy|5|||
33576900|NCT03654274|102003222|FG002|Overall Study|Lack of Efficacy|7|||
33576901|NCT03654274|102003220|FG000|Overall Study|Pregnancy|2|||
33576902|NCT03654274|102003221|FG001|Overall Study|Pregnancy|2|||
33576903|NCT03654274|102003222|FG002|Overall Study|Pregnancy|1|||
33576904|NCT03654274|102003220|FG000|Overall Study|Other|27|||
33576905|NCT03654274|102003221|FG001|Overall Study|Other|29|||
33235137|NCT03770273|100761815|FG000|Overall Study|Lost to Follow-up|1|||
33235138|NCT03770273|100761816|FG001|Overall Study|Lost to Follow-up|1|||
33235139|NCT00434837|100761817|FG000|Overall Study|Lost to Follow-up|20|||
33235140|NCT00434837|100761818|FG001|Overall Study|Lost to Follow-up|23|||
33235141|NCT00434837|100761819|FG002|Overall Study|Lost to Follow-up|30|||
33235142|NCT04214418|100761820|FG000|Overall Study|Withdrawal by Subject|1|||
33235143|NCT04214418|100761821|FG001|Overall Study|Withdrawal by Subject|0|||
33235144|NCT04214418|100761822|FG002|Overall Study|Withdrawal by Subject|0|||
33235145|NCT04214418|100761823|FG003|Overall Study|Withdrawal by Subject|0|||
33235146|NCT04214418|100761824|FG004|Overall Study|Withdrawal by Subject|0|||
33235147|NCT04214418|100761825|FG005|Overall Study|Withdrawal by Subject|0|||
33235148|NCT04214418|100761820|FG000|Overall Study|Adverse Event|0|||
33235149|NCT04214418|100761821|FG001|Overall Study|Adverse Event|2|||
33235150|NCT04214418|100761822|FG002|Overall Study|Adverse Event|0|||
33235151|NCT04214418|100761823|FG003|Overall Study|Adverse Event|0|||
33235152|NCT04214418|100761824|FG004|Overall Study|Adverse Event|0|||
33235153|NCT04214418|100761825|FG005|Overall Study|Adverse Event|0|||
33235154|NCT04214418|100761820|FG000|Overall Study|Death|1|||
33235155|NCT04214418|100761821|FG001|Overall Study|Death|0|||
33235156|NCT04214418|100761822|FG002|Overall Study|Death|0|||
33235157|NCT04214418|100761823|FG003|Overall Study|Death|0|||
33235158|NCT04214418|100761824|FG004|Overall Study|Death|0|||
33235159|NCT04214418|100761825|FG005|Overall Study|Death|0|||
33235160|NCT04585815|100761826|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
33235161|NCT04585815|100761827|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
33235162|NCT04585815|100761828|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
33235163|NCT04585815|100761829|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
33235164|NCT04585815|100761830|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
33235165|NCT04585815|100761831|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
33235166|NCT04585815|100761832|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
33235167|NCT04585815|100761826|FG000|Sub-study A- Treatment Phase|Death|0|||
33235168|NCT04585815|100761827|FG001|Sub-study A- Treatment Phase|Death|1|||
33235169|NCT04585815|100761828|FG002|Sub-study A- Treatment Phase|Death|0|||
33235170|NCT04585815|100761829|FG003|Sub-study A- Treatment Phase|Death|0|||
33235171|NCT04585815|100761830|FG004|Sub-study A- Treatment Phase|Death|0|||
33235172|NCT04585815|100761831|FG005|Sub-study A- Treatment Phase|Death|0|||
33235173|NCT04585815|100761832|FG006|Sub-study A- Treatment Phase|Death|0|||
33235174|NCT04585815|100761826|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
33235175|NCT04585815|100761827|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
33235176|NCT04585815|100761828|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
33235177|NCT04585815|100761829|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
33235178|NCT04585815|100761830|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
33235179|NCT04585815|100761831|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
33235180|NCT04585815|100761832|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
33637192|NCT00432172|102223108|FG001|Overall Study|Physician Decision|0|||
33235181|NCT04585815|100761826|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
33235182|NCT04585815|100761827|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
33420410|NCT03454672|101428623|FG001|Overall Study|Non-compliance|4|||
33576906|NCT03654274|102003222|FG002|Overall Study|Other|32|||
33576907|NCT03654274|102003220|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
33235183|NCT04585815|100761828|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
33235184|NCT04585815|100761829|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
33235185|NCT04585815|100761830|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
33235186|NCT04585815|100761831|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
33235187|NCT04585815|100761832|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
33235188|NCT04585815|100761826|FG000|Sub-study A- Treatment Phase|Other|1|||
33235189|NCT04585815|100761827|FG001|Sub-study A- Treatment Phase|Other|0|||
33235190|NCT04585815|100761828|FG002|Sub-study A- Treatment Phase|Other|0|||
33420411|NCT03454672|101428622|FG000|Overall Study|personal reasons|3|||
33420412|NCT03454672|101428623|FG001|Overall Study|personal reasons|2|||
33420413|NCT03454672|101428622|FG000|Overall Study|Withdrawal by Subject|1|||
33420414|NCT03454672|101428623|FG001|Overall Study|Withdrawal by Subject|0|||
33420415|NCT00530439|101428628|FG000|Overall Study|GDM|9|||
33420416|NCT00530439|101428629|FG001|Overall Study|GDM|3|||
33420417|NCT00530439|101428628|FG000|Overall Study|Withdraw|18|||
33420418|NCT00530439|101428629|FG001|Overall Study|Withdraw|14|||
33420419|NCT00530439|101428628|FG000|Overall Study|Missed abortion|1|||
33420420|NCT00530439|101428629|FG001|Overall Study|Missed abortion|4|||
33420421|NCT00530439|101428628|FG000|Overall Study|Misclassification|2|||
33420422|NCT00530439|101428629|FG001|Overall Study|Misclassification|0|||
33420423|NCT00530439|101428628|FG000|Overall Study|Twin pregnancy|0|||
33420424|NCT00530439|101428629|FG001|Overall Study|Twin pregnancy|2|||
33420425|NCT00530439|101428628|FG000|Overall Study|Severe malformation/abortion|0|||
33420426|NCT00530439|101428629|FG001|Overall Study|Severe malformation/abortion|3|||
33420427|NCT00386100|101428633|FG000|Overall Study|Did not receive study medication|6|||
33420428|NCT00386100|101428634|FG001|Overall Study|Did not receive study medication|4|||
33420429|NCT00386100|101428633|FG000|Overall Study|Adverse Event|15|||
33420430|NCT00386100|101428634|FG001|Overall Study|Adverse Event|25|||
33420431|NCT00386100|101428633|FG000|Overall Study|Death|0|||
33420432|NCT00386100|101428634|FG001|Overall Study|Death|1|||
33420433|NCT00386100|101428633|FG000|Overall Study|Insufficient therapeutic effect|30|||
33420434|NCT00386100|101428634|FG001|Overall Study|Insufficient therapeutic effect|6|||
33420435|NCT00386100|101428633|FG000|Overall Study|Lost to Follow-up|29|||
33420436|NCT00386100|101428634|FG001|Overall Study|Lost to Follow-up|29|||
33420437|NCT00386100|101428633|FG000|Overall Study|Non-compliance|18|||
33420438|NCT00386100|101428634|FG001|Overall Study|Non-compliance|19|||
33420439|NCT00386100|101428633|FG000|Overall Study|Protocol Violation|5|||
33576908|NCT03654274|102003221|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
33576909|NCT03654274|102003222|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
33576910|NCT00775268|102003223|FG000|Baseline|Drug not synthesize dose|1|||
33576911|NCT00775268|102003224|FG001|Baseline|Drug not synthesize dose|0|||
33576912|NCT00775268|102003223|FG000|Baseline|Not treated-ineligible per CT|0|||
33576913|NCT00775268|102003224|FG001|Baseline|Not treated-ineligible per CT|1|||
33576914|NCT00775268|102003223|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
33576915|NCT00775268|102003224|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
33576916|NCT00775268|102003223|FG000|After Completion|Participant missed scan appointment|1|||
33576917|NCT00775268|102003224|FG001|After Completion|Participant missed scan appointment|0|||
33576918|NCT03381287|102003225|FG000|Overall Study|Withdrawal by Subject|0|||
33576919|NCT03381287|102003226|FG001|Overall Study|Withdrawal by Subject|1|||
33576920|NCT03381287|102003227|FG002|Overall Study|Withdrawal by Subject|0|||
33420440|NCT00386100|101428634|FG001|Overall Study|Protocol Violation|3|||
33420441|NCT00386100|101428633|FG000|Overall Study|Withdrawal by Subject|32|||
33420442|NCT00386100|101428634|FG001|Overall Study|Withdrawal by Subject|31|||
33420443|NCT00386100|101428633|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
33420444|NCT00386100|101428634|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
33420445|NCT00386100|101428633|FG000|Overall Study|BMD <2.5|1|||
33420446|NCT00386100|101428634|FG001|Overall Study|BMD <2.5|0|||
33576921|NCT03381287|102003228|FG003|Overall Study|Withdrawal by Subject|0|||
33576922|NCT03381287|102003225|FG000|Overall Study|Adverse Event|0|||
33576923|NCT03381287|102003226|FG001|Overall Study|Adverse Event|0|||
33576924|NCT03381287|102003227|FG002|Overall Study|Adverse Event|0|||
33576925|NCT03381287|102003228|FG003|Overall Study|Adverse Event|1|||
33576926|NCT03381287|102003225|FG000|Overall Study|Physician Decision|0|||
33576927|NCT03381287|102003226|FG001|Overall Study|Physician Decision|0|||
33576928|NCT03381287|102003227|FG002|Overall Study|Physician Decision|0|||
33576929|NCT03381287|102003228|FG003|Overall Study|Physician Decision|1|||
33576930|NCT00670930|102003229|FG000|Overall Study|Adminstrative Problem|0|||
33576931|NCT00670930|102003230|FG001|Overall Study|Adminstrative Problem|1|||
33420447|NCT00386100|101428633|FG000|Overall Study|Consecutive elevated Hba1C|1|||
33420448|NCT00386100|101428634|FG001|Overall Study|Consecutive elevated Hba1C|0|||
33420449|NCT00386100|101428633|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
33420450|NCT00386100|101428634|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
33420451|NCT00386100|101428633|FG000|Overall Study|Laboratory findings|1|||
33576932|NCT00670930|102003229|FG000|Overall Study|Lost to Follow-up|1|||
33576933|NCT00670930|102003230|FG001|Overall Study|Lost to Follow-up|0|||
33576934|NCT03289533|102003231|FG000|Overall Study|Death|12|||
33235191|NCT04585815|100761829|FG003|Sub-study A- Treatment Phase|Other|0|||
33420452|NCT00386100|101428634|FG001|Overall Study|Laboratory findings|0|||
33420453|NCT00386100|101428633|FG000|Overall Study|Participant's concern due to CPK levels|1|||
33420454|NCT00386100|101428634|FG001|Overall Study|Participant's concern due to CPK levels|0|||
33420455|NCT00386100|101428633|FG000|Overall Study|Participant moving out of state|2|||
33420456|NCT00386100|101428634|FG001|Overall Study|Participant moving out of state|0|||
33420457|NCT00386100|101428633|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
33235192|NCT04585815|100761830|FG004|Sub-study A- Treatment Phase|Other|0|||
33138529|NCT03005873|100420290|FG002|Overall Study|Prohibited medication use post radnomization|1|||
33235193|NCT04585815|100761831|FG005|Sub-study A- Treatment Phase|Other|0|||
33235194|NCT04585815|100761832|FG006|Sub-study A- Treatment Phase|Other|0|||
33420458|NCT00386100|101428634|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
33420459|NCT00386100|101428633|FG000|Overall Study|Didn't meet entry criteria|1|||
33138530|NCT03005873|100420288|FG000|Overall Study|Withdrew consent|0|||
33235195|NCT04585815|100761826|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
33235196|NCT04585815|100761827|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
33235197|NCT04585815|100761828|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
33235198|NCT04585815|100761829|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
33235199|NCT04585815|100761830|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
33235200|NCT04585815|100761831|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
33235201|NCT04585815|100761832|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
33235202|NCT04585815|100761826|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
33235203|NCT04585815|100761827|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
33235204|NCT04585815|100761828|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
33235205|NCT04585815|100761829|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
33235206|NCT04585815|100761830|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
33235207|NCT04585815|100761831|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
33235208|NCT04585815|100761832|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
33235209|NCT04585815|100761826|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
33235210|NCT04585815|100761827|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
33235211|NCT04585815|100761828|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
33235212|NCT04585815|100761829|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
33235213|NCT04585815|100761830|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
33235214|NCT04585815|100761831|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
33235215|NCT04585815|100761832|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
33235216|NCT04585815|100761826|FG000|Sub-study B- Treatment Phase|Death|0|||
33368969|NCT03474107|101234950|FG000|Overall Study|Physician Decision|7|||
33368970|NCT03474107|101234951|FG001|Overall Study|Physician Decision|22|||
33368971|NCT03474107|101234950|FG000|Overall Study|Miscellaneous|1|||
33368972|NCT03474107|101234951|FG001|Overall Study|Miscellaneous|6|||
33368973|NCT02677896|101234953|FG000|Double Blind Period (up to 35 Months)|Death|113|||
33368974|NCT02677896|101234954|FG001|Double Blind Period (up to 35 Months)|Death|189|||
33368975|NCT02677896|101234953|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
33368976|NCT02677896|101234954|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
33368977|NCT02677896|101234953|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
33138531|NCT03005873|100420289|FG001|Overall Study|Withdrew consent|1|||
33138532|NCT03005873|100420290|FG002|Overall Study|Withdrew consent|2|||
33138533|NCT03005873|100420288|FG000|Overall Study|Lost to Follow-up|0|||
33138534|NCT03005873|100420289|FG001|Overall Study|Lost to Follow-up|1|||
33138535|NCT03005873|100420290|FG002|Overall Study|Lost to Follow-up|0|||
33138536|NCT03005873|100420288|FG000|Overall Study|Ineligible post randomization|0|||
33138537|NCT03005873|100420289|FG001|Overall Study|Ineligible post randomization|0|||
33138538|NCT03005873|100420290|FG002|Overall Study|Ineligible post randomization|1|||
33138539|NCT00043550|100420291|FG000|Overall Study|Withdrawal by Subject|22|||
33138540|NCT00043550|100420292|FG001|Overall Study|Withdrawal by Subject|12|||
33138541|NCT00043550|100420293|FG002|Overall Study|Withdrawal by Subject|20|||
33138542|NCT03206788|100420296|FG000|Overall Study|Withdrawal by Subject|0|||
33138543|NCT03206788|100420297|FG001|Overall Study|Withdrawal by Subject|1|||
33138544|NCT03206788|100420296|FG000|Overall Study|Adverse Event|0|||
33138545|NCT03206788|100420297|FG001|Overall Study|Adverse Event|1|||
33138546|NCT03206788|100420296|FG000|Overall Study|Physician Decision|0|||
33138547|NCT03206788|100420297|FG001|Overall Study|Physician Decision|1|||
33138548|NCT00853970|100420298|FG000|Overall Study|Withdrawal by Subject|2|||
33138549|NCT00853970|100420299|FG001|Overall Study|Withdrawal by Subject|1|||
33138550|NCT00853970|100420298|FG000|Overall Study|Cancelled surgery|4|||
33138551|NCT00853970|100420299|FG001|Overall Study|Cancelled surgery|2|||
33138552|NCT01101308|100420300|FG000|Period 1|Adverse Event|2|||
33138553|NCT01101308|100420301|FG001|Period 1|Adverse Event|1|||
33138554|NCT01101308|100420300|FG000|Period 1|Positive for cotinine|1|||
33138555|NCT01101308|100420301|FG001|Period 1|Positive for cotinine|0|||
33138556|NCT03255629|100420304|FG000|Overall Study|Adverse Event|1|||
33138557|NCT03255629|100420305|FG001|Overall Study|Adverse Event|0|||
33138558|NCT03255629|100420304|FG000|Overall Study|did not experience hypoglycemia|2|||
33138559|NCT03255629|100420305|FG001|Overall Study|did not experience hypoglycemia|1|||
33138560|NCT00813943|100420306|FG000|Overall Study|Ongoing at cut-off date|5|||
33138561|NCT00813943|100420307|FG001|Overall Study|Ongoing at cut-off date|5|||
33138562|NCT00813943|100420308|FG002|Overall Study|Ongoing at cut-off date|3|||
33138563|NCT01403948|100420311|FG000|Overall Study|Progressive disease|0|||
33138564|NCT01403948|100420312|FG001|Overall Study|Progressive disease|2|||
33138565|NCT01403948|100420313|FG002|Overall Study|Progressive disease|2|||
33138566|NCT01403948|100420314|FG003|Overall Study|Progressive disease|4|||
33138567|NCT01403948|100420315|FG004|Overall Study|Progressive disease|2|||
33420460|NCT00386100|101428634|FG001|Overall Study|Didn't meet entry criteria|1|||
33420461|NCT00386100|101428633|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
33420462|NCT00386100|101428634|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
33420463|NCT00386100|101428633|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
33420464|NCT00386100|101428634|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
33420465|NCT00386100|101428633|FG000|Overall Study|Bad metabolic control & patient security|1|||
33420466|NCT00386100|101428634|FG001|Overall Study|Bad metabolic control & patient security|0|||
33420467|NCT00386100|101428633|FG000|Overall Study|Bone loss by DXA bone scan|1|||
33420468|NCT00386100|101428634|FG001|Overall Study|Bone loss by DXA bone scan|0|||
33420469|NCT00386100|101428633|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
33235217|NCT04585815|100761827|FG001|Sub-study B- Treatment Phase|Death|0|||
33235218|NCT04585815|100761828|FG002|Sub-study B- Treatment Phase|Death|0|||
33235219|NCT04585815|100761829|FG003|Sub-study B- Treatment Phase|Death|1|||
33235220|NCT04585815|100761830|FG004|Sub-study B- Treatment Phase|Death|0|||
33420470|NCT00386100|101428634|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
33420471|NCT00386100|101428633|FG000|Overall Study|7.6% bone loss|1|||
33576935|NCT03289533|102003231|FG000|Overall Study|Terminated from study by sponsor|10|||
33576936|NCT02332187|102003232|FG000|Overall Study|Withdrawal by Subject|2|||
33576937|NCT02332187|102003233|FG001|Overall Study|Withdrawal by Subject|2|||
33576938|NCT02332187|102003232|FG000|Overall Study|Adverse Event|0|||
33576939|NCT02332187|102003233|FG001|Overall Study|Adverse Event|1|||
33576940|NCT01130337|102003234|FG000|Overall Study|Withdrawal by Subject|3|||
33235221|NCT04585815|100761831|FG005|Sub-study B- Treatment Phase|Death|0|||
33235222|NCT04585815|100761832|FG006|Sub-study B- Treatment Phase|Death|0|||
33235223|NCT04585815|100761826|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
33235224|NCT04585815|100761827|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
33235225|NCT04585815|100761828|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
33235226|NCT04585815|100761829|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
33235227|NCT04585815|100761830|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
33235228|NCT04585815|100761831|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
33235229|NCT04585815|100761832|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
33235230|NCT04585815|100761826|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
33235231|NCT04585815|100761827|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
33235232|NCT04585815|100761828|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
33235233|NCT04585815|100761829|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
33235234|NCT04585815|100761830|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
33235235|NCT04585815|100761831|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
33235236|NCT04585815|100761832|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
33235237|NCT04585815|100761826|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
33235238|NCT04585815|100761827|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
33235239|NCT04585815|100761828|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
33235240|NCT04585815|100761829|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
33235241|NCT04585815|100761830|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
33420472|NCT00386100|101428634|FG001|Overall Study|7.6% bone loss|0|||
33420473|NCT00386100|101428633|FG000|Overall Study|Osteoporosis|0|||
33576941|NCT01130337|102003234|FG000|Overall Study|Principal investigator decision|1|||
33576942|NCT01130337|102003234|FG000|Overall Study|Death|1|||
33576943|NCT01130337|102003234|FG000|Overall Study|Disease progression|1|||
33576944|NCT01130337|102003234|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
33576945|NCT01130337|102003234|FG000|Overall Study|Surgical resection (R2)|1|||
33138568|NCT01403948|100420316|FG005|Overall Study|Progressive disease|6|||
33138569|NCT01403948|100420317|FG006|Overall Study|Progressive disease|2|||
33138570|NCT01403948|100420318|FG007|Overall Study|Progressive disease|4|||
33138571|NCT01403948|100420319|FG008|Overall Study|Progressive disease|5|||
33138572|NCT01403948|100420320|FG009|Overall Study|Progressive disease|5|||
33138573|NCT01403948|100420311|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
33138574|NCT01403948|100420312|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
33576946|NCT03710889|102003237|FG000|Overall Study|Adverse Event|2|||
33576947|NCT03710889|102003237|FG000|Overall Study|Protocol Deviation|1|||
33637193|NCT00432172|102223109|FG002|Overall Study|Physician Decision|2|||
33138575|NCT01403948|100420313|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
33138576|NCT01403948|100420314|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
33138577|NCT01403948|100420315|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
33420474|NCT00386100|101428634|FG001|Overall Study|Osteoporosis|1|||
33420475|NCT00386100|101428633|FG000|Overall Study|Positive pregnancy test|1|||
33576948|NCT03314935|102003241|FG000|Phase 1|Death|4|||
33420476|NCT00386100|101428634|FG001|Overall Study|Positive pregnancy test|3|||
33576949|NCT03314935|102003242|FG001|Phase 1|Death|2|||
33138578|NCT01403948|100420316|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
33576950|NCT03314935|102003243|FG002|Phase 1|Death|5|||
33576951|NCT03314935|102003244|FG003|Phase 1|Death|4|||
33576952|NCT03314935|102003245|FG004|Phase 1|Death|3|||
33235242|NCT04585815|100761831|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
33235243|NCT04585815|100761832|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
33235244|NCT04585815|100761826|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
33235245|NCT04585815|100761827|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
33235246|NCT04585815|100761828|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
33235247|NCT04585815|100761829|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
33235248|NCT04585815|100761830|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
33235249|NCT04585815|100761831|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
33235250|NCT04585815|100761832|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
33235251|NCT04585815|100761826|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
33235252|NCT04585815|100761827|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
33235253|NCT04585815|100761828|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
33235254|NCT04585815|100761829|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
33235255|NCT04585815|100761830|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
33235256|NCT04585815|100761831|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
33235257|NCT04585815|100761832|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
33235258|NCT04585815|100761826|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
33235259|NCT04585815|100761827|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
33235260|NCT04585815|100761828|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
33235261|NCT04585815|100761829|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
33235262|NCT04585815|100761830|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
33235263|NCT04585815|100761831|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
33235264|NCT04585815|100761832|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
33235265|NCT04585815|100761826|FG000|Sub-study B- Follow-up Phase|Death|0|||
33235266|NCT04585815|100761827|FG001|Sub-study B- Follow-up Phase|Death|0|||
33235267|NCT04585815|100761828|FG002|Sub-study B- Follow-up Phase|Death|1|||
33637194|NCT00432172|102223110|FG003|Overall Study|Physician Decision|0|||
33637195|NCT00432172|102223107|FG000|Overall Study|Adverse Event|4|||
33637196|NCT00432172|102223108|FG001|Overall Study|Adverse Event|2|||
33637197|NCT00432172|102223109|FG002|Overall Study|Adverse Event|4|||
33637198|NCT00432172|102223110|FG003|Overall Study|Adverse Event|3|||
33637199|NCT00432172|102223107|FG000|Overall Study|Disease progression|0|||
33235268|NCT04585815|100761829|FG003|Sub-study B- Follow-up Phase|Death|3|||
33235269|NCT04585815|100761830|FG004|Sub-study B- Follow-up Phase|Death|0|||
33235270|NCT04585815|100761831|FG005|Sub-study B- Follow-up Phase|Death|0|||
33235271|NCT04585815|100761832|FG006|Sub-study B- Follow-up Phase|Death|1|||
33235272|NCT03443323|100761833|FG000|Overall Study|Lost to Follow-up|2|||
33235273|NCT03443323|100761834|FG001|Overall Study|Lost to Follow-up|2|||
33235274|NCT03443323|100761833|FG000|Overall Study|PI withdrawal|1|||
33235275|NCT03443323|100761834|FG001|Overall Study|PI withdrawal|0|||
33235276|NCT05446870|100761835|FG000|Overall Study|Death|6|||
33235277|NCT05446870|100761836|FG001|Overall Study|Death|2|||
33576953|NCT03314935|102003246|FG005|Phase 1|Death|4|||
33576954|NCT03314935|102003247|FG006|Phase 1|Death|5|||
33576955|NCT03314935|102003248|FG007|Phase 1|Death|4|||
33576956|NCT03314935|102003249|FG008|Phase 1|Death|3|||
33576957|NCT03314935|102003250|FG009|Phase 1|Death|0|||
33576958|NCT03314935|102003251|FG010|Phase 1|Death|0|||
33576959|NCT03314935|102003252|FG011|Phase 1|Death|0|||
33576960|NCT03314935|102003253|FG012|Phase 1|Death|0|||
33576961|NCT03314935|102003254|FG013|Phase 1|Death|0|||
33576962|NCT03314935|102003255|FG014|Phase 1|Death|0|||
33576963|NCT03314935|102003241|FG000|Phase 1|Withdrawal by Subject|2|||
33576964|NCT03314935|102003242|FG001|Phase 1|Withdrawal by Subject|1|||
33576965|NCT03314935|102003243|FG002|Phase 1|Withdrawal by Subject|1|||
33576966|NCT03314935|102003244|FG003|Phase 1|Withdrawal by Subject|2|||
33576967|NCT03314935|102003245|FG004|Phase 1|Withdrawal by Subject|1|||
33576968|NCT03314935|102003246|FG005|Phase 1|Withdrawal by Subject|0|||
33576969|NCT03314935|102003247|FG006|Phase 1|Withdrawal by Subject|1|||
33576970|NCT03314935|102003248|FG007|Phase 1|Withdrawal by Subject|0|||
33576971|NCT03314935|102003249|FG008|Phase 1|Withdrawal by Subject|1|||
33576972|NCT03314935|102003250|FG009|Phase 1|Withdrawal by Subject|0|||
33637200|NCT00432172|102223108|FG001|Overall Study|Disease progression|2|||
33235278|NCT05446870|100761835|FG000|Overall Study|Lost to Follow-up|0|||
33235279|NCT05446870|100761836|FG001|Overall Study|Lost to Follow-up|1|||
33235280|NCT05446870|100761835|FG000|Overall Study|Physician Decision|27|||
33420477|NCT00386100|101428633|FG000|Overall Study|Out of country for 5 months|1|||
33576973|NCT03314935|102003251|FG010|Phase 1|Withdrawal by Subject|0|||
33576974|NCT03314935|102003252|FG011|Phase 1|Withdrawal by Subject|0|||
33576975|NCT03314935|102003253|FG012|Phase 1|Withdrawal by Subject|0|||
33235281|NCT05446870|100761836|FG001|Overall Study|Physician Decision|25|||
33235282|NCT05446870|100761835|FG000|Overall Study|Withdrawal by Subject|3|||
33420478|NCT00386100|101428634|FG001|Overall Study|Out of country for 5 months|0|||
33576976|NCT03314935|102003254|FG013|Phase 1|Withdrawal by Subject|0|||
33576977|NCT03314935|102003255|FG014|Phase 1|Withdrawal by Subject|0|||
33576978|NCT03314935|102003241|FG000|Phase 1|Progressive Disease|2|||
33576979|NCT03314935|102003242|FG001|Phase 1|Progressive Disease|0|||
33637201|NCT00432172|102223109|FG002|Overall Study|Disease progression|5|||
33235283|NCT05446870|100761836|FG001|Overall Study|Withdrawal by Subject|2|||
33235284|NCT05446870|100761835|FG000|Overall Study|Study Ongoing|37|||
33235285|NCT05446870|100761836|FG001|Overall Study|Study Ongoing|43|||
33235286|NCT00686335|100761837|FG000|Run-in Period|Adverse Event|1|||
33235287|NCT00686335|100761837|FG000|Run-in Period|asthma exacerbation|1|||
33235288|NCT00686335|100761837|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
33235289|NCT05459688|100761853|FG000|Overall Study|Lost to Follow-up|6|||
33235290|NCT05459688|100761853|FG000|Overall Study|Physician Decision|1|||
33235291|NCT05459688|100761853|FG000|Overall Study|Withdrawal by Subject|19|||
33235292|NCT05459688|100761853|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
33235293|NCT04306367|100761854|FG000|Overall Study|Progression of Disease|9|||
33235294|NCT04306367|100761854|FG000|Overall Study|Adverse Event|3|||
33235295|NCT04306367|100761854|FG000|Overall Study|Withdrawal by Subject|1|||
33576980|NCT03314935|102003243|FG002|Phase 1|Progressive Disease|0|||
33576981|NCT03314935|102003244|FG003|Phase 1|Progressive Disease|1|||
33576982|NCT03314935|102003245|FG004|Phase 1|Progressive Disease|0|||
33576983|NCT03314935|102003246|FG005|Phase 1|Progressive Disease|0|||
33576984|NCT03314935|102003247|FG006|Phase 1|Progressive Disease|0|||
33235296|NCT01375114|100761855|FG000|Overall Study|Lost to Follow-up|1|||
33235297|NCT01375114|100761856|FG001|Overall Study|Lost to Follow-up|0|||
33235298|NCT01375114|100761857|FG002|Overall Study|Lost to Follow-up|1|||
33235299|NCT01375114|100761855|FG000|Overall Study|Disease Progression|3|||
33235300|NCT01375114|100761856|FG001|Overall Study|Disease Progression|2|||
33235301|NCT01375114|100761857|FG002|Overall Study|Disease Progression|2|||
33235302|NCT01375114|100761855|FG000|Overall Study|Patient Changed Mind|0|||
33235303|NCT01375114|100761856|FG001|Overall Study|Patient Changed Mind|0|||
33235304|NCT01375114|100761857|FG002|Overall Study|Patient Changed Mind|2|||
33235305|NCT01375114|100761855|FG000|Overall Study|Pruritus|0|||
33235306|NCT01375114|100761856|FG001|Overall Study|Pruritus|0|||
33235307|NCT01375114|100761857|FG002|Overall Study|Pruritus|1|||
33235308|NCT01375114|100761855|FG000|Overall Study|Restlessness|0|||
33235309|NCT01375114|100761856|FG001|Overall Study|Restlessness|0|||
33235310|NCT01375114|100761857|FG002|Overall Study|Restlessness|1|||
33235311|NCT01375114|100761855|FG000|Overall Study|Diarrhea|0|||
33235312|NCT01375114|100761856|FG001|Overall Study|Diarrhea|0|||
33235313|NCT01375114|100761857|FG002|Overall Study|Diarrhea|1|||
33235314|NCT01375114|100761855|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
33235315|NCT01375114|100761856|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
33235316|NCT01375114|100761857|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
33235317|NCT01375114|100761855|FG000|Overall Study|Nausea|0|||
33235318|NCT01375114|100761856|FG001|Overall Study|Nausea|1|||
33235319|NCT01375114|100761857|FG002|Overall Study|Nausea|0|||
33235320|NCT01375114|100761855|FG000|Overall Study|Increased AST/ALT|0|||
33235321|NCT01375114|100761856|FG001|Overall Study|Increased AST/ALT|1|||
33235322|NCT01375114|100761857|FG002|Overall Study|Increased AST/ALT|0|||
33235323|NCT01375114|100761855|FG000|Overall Study|Vaginal Hemorrhage|0|||
33235324|NCT01375114|100761856|FG001|Overall Study|Vaginal Hemorrhage|1|||
33235325|NCT01375114|100761857|FG002|Overall Study|Vaginal Hemorrhage|0|||
33235326|NCT01375114|100761855|FG000|Overall Study|Family problem|0|||
33235327|NCT01375114|100761856|FG001|Overall Study|Family problem|1|||
33235328|NCT01375114|100761857|FG002|Overall Study|Family problem|0|||
33235329|NCT01375114|100761855|FG000|Overall Study|Protocol Violation|2|||
33576985|NCT03314935|102003248|FG007|Phase 1|Progressive Disease|0|||
33576986|NCT03314935|102003249|FG008|Phase 1|Progressive Disease|0|||
33576987|NCT03314935|102003250|FG009|Phase 1|Progressive Disease|0|||
33576988|NCT03314935|102003251|FG010|Phase 1|Progressive Disease|0|||
33576989|NCT03314935|102003252|FG011|Phase 1|Progressive Disease|0|||
33576990|NCT03314935|102003253|FG012|Phase 1|Progressive Disease|0|||
33576991|NCT03314935|102003254|FG013|Phase 1|Progressive Disease|0|||
33637202|NCT00432172|102223110|FG003|Overall Study|Disease progression|1|||
33235330|NCT01375114|100761856|FG001|Overall Study|Protocol Violation|0|||
33235331|NCT01375114|100761857|FG002|Overall Study|Protocol Violation|0|||
33637203|NCT00432172|102223107|FG000|Overall Study|Withdrawal by Subject|0|||
33637204|NCT00432172|102223108|FG001|Overall Study|Withdrawal by Subject|1|||
33637205|NCT00432172|102223109|FG002|Overall Study|Withdrawal by Subject|0|||
33637206|NCT00432172|102223110|FG003|Overall Study|Withdrawal by Subject|2|||
33637207|NCT00432172|102223107|FG000|Overall Study|No treatment received|2|||
33637208|NCT00432172|102223108|FG001|Overall Study|No treatment received|2|||
33637209|NCT00432172|102223109|FG002|Overall Study|No treatment received|0|||
33235332|NCT05107401|100761863|FG000|Overall Study|Lost to Follow-up|13|||
33235333|NCT05107401|100761864|FG001|Overall Study|Lost to Follow-up|12|||
33235334|NCT02724878|100761873|FG000|Overall Study|Still on Active Therapy|15|||
33235335|NCT02724878|100761873|FG000|Overall Study|Disease Progression|31|||
33235336|NCT02724878|100761873|FG000|Overall Study|Toxicity|5|||
33235337|NCT02724878|100761873|FG000|Overall Study|Death|1|||
33235338|NCT02724878|100761873|FG000|Overall Study|Withdrawal by Subject|4|||
33576992|NCT03314935|102003255|FG014|Phase 1|Progressive Disease|0|||
33576993|NCT03314935|102003241|FG000|Phase 1|Study Terminated by Sponsor|0|||
33576994|NCT03314935|102003242|FG001|Phase 1|Study Terminated by Sponsor|1|||
33576995|NCT03314935|102003243|FG002|Phase 1|Study Terminated by Sponsor|0|||
33576996|NCT03314935|102003244|FG003|Phase 1|Study Terminated by Sponsor|0|||
33576997|NCT03314935|102003245|FG004|Phase 1|Study Terminated by Sponsor|0|||
33576998|NCT03314935|102003246|FG005|Phase 1|Study Terminated by Sponsor|0|||
33576999|NCT03314935|102003247|FG006|Phase 1|Study Terminated by Sponsor|0|||
33577000|NCT03314935|102003248|FG007|Phase 1|Study Terminated by Sponsor|0|||
33577001|NCT03314935|102003249|FG008|Phase 1|Study Terminated by Sponsor|1|||
33577002|NCT03314935|102003250|FG009|Phase 1|Study Terminated by Sponsor|0|||
33577003|NCT03314935|102003251|FG010|Phase 1|Study Terminated by Sponsor|0|||
33577004|NCT03314935|102003252|FG011|Phase 1|Study Terminated by Sponsor|0|||
33577005|NCT03314935|102003253|FG012|Phase 1|Study Terminated by Sponsor|0|||
33577006|NCT03314935|102003254|FG013|Phase 1|Study Terminated by Sponsor|0|||
33235339|NCT02724878|100761873|FG000|Overall Study|Lost to Follow-up|2|||
33235340|NCT02724878|100761873|FG000|Overall Study|Protocol Violation|1|||
33235341|NCT02724878|100761873|FG000|Overall Study|Ineligible for Study Drug|5|||
33235342|NCT02724878|100761873|FG000|Overall Study|not started|1|||
33235343|NCT03519581|100761883|FG000|Overall Study|Lost to Follow-up|3|||
33235344|NCT03519581|100761884|FG001|Overall Study|Lost to Follow-up|2|||
33235345|NCT03519581|100761883|FG000|Overall Study|Adverse Event|5|||
33235346|NCT03519581|100761884|FG001|Overall Study|Adverse Event|2|||
33235347|NCT03519581|100761883|FG000|Overall Study|Withdrawal by Subject|2|||
33235348|NCT03519581|100761884|FG001|Overall Study|Withdrawal by Subject|0|||
33235349|NCT03519581|100761883|FG000|Overall Study|Change to insurance|2|||
33235350|NCT03519581|100761884|FG001|Overall Study|Change to insurance|1|||
33235351|NCT03519581|100761883|FG000|Overall Study|Other|2|||
33235352|NCT03519581|100761884|FG001|Overall Study|Other|4|||
33235353|NCT03030261|100761887|FG000|Overall Study|Still receiving continuation therapy|5|||
33235354|NCT05546411|100761895|FG000|Overall Study|Progressive Disease|1|||
33637210|NCT00432172|102223110|FG003|Overall Study|No treatment received|1|||
33637211|NCT03771664|102223111|FG000|Overall Study|Adverse Event|1|||
33235355|NCT05546411|100761896|FG001|Overall Study|Progressive Disease|0|||
33235356|NCT05546411|100761895|FG000|Overall Study|Adverse Event|0|||
33235357|NCT05546411|100761896|FG001|Overall Study|Adverse Event|1|||
33235358|NCT05546411|100761895|FG000|Overall Study|Metastatic disease|1|||
33235359|NCT05546411|100761896|FG001|Overall Study|Metastatic disease|0|||
33235360|NCT04281498|100761899|FG000|Overall Study|Progression of disease|1|||
33235361|NCT04281498|100761899|FG000|Overall Study|Planned SCT|1|||
33235362|NCT04281498|100761899|FG000|Overall Study|Alternative Treatment|1|||
33235363|NCT03092674|100761900|FG000|Overall Study|Adverse Event or Side Effects|1|||
33235364|NCT03092674|100761901|FG001|Overall Study|Adverse Event or Side Effects|4|||
33235365|NCT03092674|100761902|FG002|Overall Study|Adverse Event or Side Effects|4|||
33235366|NCT03092674|100761900|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
33235367|NCT03092674|100761901|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
33235368|NCT03092674|100761902|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
33235369|NCT03092674|100761900|FG000|Overall Study|Progression/Relapse|5|||
33235370|NCT03092674|100761901|FG001|Overall Study|Progression/Relapse|4|||
33235371|NCT03092674|100761902|FG002|Overall Study|Progression/Relapse|8|||
33235372|NCT03092674|100761900|FG000|Overall Study|Death|4|||
33235373|NCT03092674|100761901|FG001|Overall Study|Death|8|||
33235374|NCT03092674|100761902|FG002|Overall Study|Death|2|||
33235375|NCT03092674|100761900|FG000|Overall Study|Other - Not Protocol Specified|11|||
33235376|NCT03092674|100761901|FG001|Overall Study|Other - Not Protocol Specified|8|||
33235377|NCT03092674|100761902|FG002|Overall Study|Other - Not Protocol Specified|8|||
33235378|NCT02035787|100761908|FG000|Overall Study- 12 Months|Adverse Event|3|||
33235379|NCT02035787|100761909|FG001|Overall Study- 12 Months|Adverse Event|0|||
33235380|NCT02035787|100761908|FG000|Overall Study- 12 Months|Complete response|4|||
33235381|NCT02035787|100761909|FG001|Overall Study- 12 Months|Complete response|1|||
33235382|NCT02035787|100761908|FG000|Overall Study- 12 Months|Protocol Violation|1|||
33235383|NCT02035787|100761909|FG001|Overall Study- 12 Months|Protocol Violation|1|||
33235384|NCT05035654|100761910|FG000|Overall Study|Physician Decision|0|||
33235385|NCT05035654|100761911|FG001|Overall Study|Physician Decision|1|||
33235386|NCT05035654|100761912|FG002|Overall Study|Physician Decision|0|||
33235387|NCT05035654|100761910|FG000|Overall Study|Adverse Event|0|||
33235388|NCT05035654|100761911|FG001|Overall Study|Adverse Event|1|||
33235389|NCT05035654|100761912|FG002|Overall Study|Adverse Event|0|||
33637212|NCT03771664|102223112|FG001|Overall Study|Adverse Event|0|||
33235390|NCT05035654|100761910|FG000|Overall Study|Withdrawal by Subject|0|||
33235391|NCT05035654|100761911|FG001|Overall Study|Withdrawal by Subject|0|||
33235392|NCT05035654|100761912|FG002|Overall Study|Withdrawal by Subject|4|||
33637213|NCT03771664|102223111|FG000|Overall Study|Lost to Follow-up|1|||
33637214|NCT03771664|102223112|FG001|Overall Study|Lost to Follow-up|0|||
33235393|NCT05035654|100761910|FG000|Overall Study|Bilateral Dislodgement|1|||
33235394|NCT05035654|100761911|FG001|Overall Study|Bilateral Dislodgement|0|||
33235395|NCT05035654|100761912|FG002|Overall Study|Bilateral Dislodgement|0|||
33235396|NCT03237013|100764799|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
33235397|NCT03237013|100764800|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
33420479|NCT00386100|101428633|FG000|Overall Study|Hb1Ac >8%|0|||
33235398|NCT03237013|100764801|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
33138579|NCT01403948|100420317|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
33138580|NCT01403948|100420318|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
33138581|NCT01403948|100420319|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
33235399|NCT01190176|100764804|FG000|Overall Study|Withdrawal by Subject|1|||
33235400|NCT01190176|100764804|FG000|Overall Study|Lost to Follow-up|1|||
33235401|NCT04927364|100764805|FG000|Overall Study|Withdrawal by Subject|3|||
33235402|NCT04927364|100764805|FG000|Overall Study|Unable to complete preassessment MRI|1|||
33235403|NCT01155726|100764813|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
33235404|NCT01155726|100764814|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
33235405|NCT01155726|100764815|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
33235406|NCT01155726|100764816|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
33235407|NCT00737061|100764819|FG000|Waiting Period|Lost to Follow-up|6|||
33235408|NCT00737061|100764819|FG000|Waiting Period|Withdrawal by Subject|1|||
33235409|NCT00737061|100764819|FG000|Waiting Period|Bilateral placement failure|34|||
33235410|NCT00737061|100764819|FG000|Waiting Period|Deemed patent following HSG|26|||
33235411|NCT00737061|100764819|FG000|Waiting Period|Alternative contraception failure|3|||
33235412|NCT00737061|100764819|FG000|Waiting Period|Elected surgical tubal ligation|5|||
33235413|NCT00737061|100764819|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
33235414|NCT00737061|100764819|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
33235415|NCT00737061|100764819|FG000|1 Year Wearing Period|Discontinued reilance|3|||
33235416|NCT00737061|100764819|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
33368978|NCT02677896|101234954|FG001|Double Blind Period (up to 35 Months)|Progressive disease|4|||
33368979|NCT02677896|101234953|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
33577007|NCT03314935|102003255|FG014|Phase 1|Study Terminated by Sponsor|0|||
33577008|NCT03314935|102003241|FG000|Phase 1|"Captured as Other in Database"|0|||
33577009|NCT03314935|102003242|FG001|Phase 1|"Captured as Other in Database"|2|||
33577010|NCT03314935|102003243|FG002|Phase 1|"Captured as Other in Database"|0|||
33577011|NCT03314935|102003244|FG003|Phase 1|"Captured as Other in Database"|0|||
33577012|NCT03314935|102003245|FG004|Phase 1|"Captured as Other in Database"|0|||
33577013|NCT03314935|102003246|FG005|Phase 1|"Captured as Other in Database"|0|||
33577014|NCT03314935|102003247|FG006|Phase 1|"Captured as Other in Database"|1|||
33577015|NCT03314935|102003248|FG007|Phase 1|"Captured as Other in Database"|1|||
33577016|NCT03314935|102003249|FG008|Phase 1|"Captured as Other in Database"|1|||
33577017|NCT03314935|102003250|FG009|Phase 1|"Captured as Other in Database"|0|||
33637215|NCT03771664|102223111|FG000|Overall Study|Withdrawal by Participant|1|||
33637216|NCT03771664|102223112|FG001|Overall Study|Withdrawal by Participant|4|||
33637217|NCT03771664|102223111|FG000|Overall Study|Randomized but not Treated|0|||
33637218|NCT03771664|102223112|FG001|Overall Study|Randomized but not Treated|1|||
33637219|NCT00686712|102223113|FG000|Overall Study|Protocol Violation|8|||
33637220|NCT00686712|102223114|FG001|Overall Study|Protocol Violation|8|||
33637221|NCT00686712|102223115|FG002|Overall Study|Protocol Violation|10|||
33637222|NCT00686712|102223113|FG000|Overall Study|Lost to Follow-up|1|||
33637223|NCT00686712|102223114|FG001|Overall Study|Lost to Follow-up|2|||
33637224|NCT00686712|102223115|FG002|Overall Study|Lost to Follow-up|3|||
33637225|NCT00686712|102223113|FG000|Overall Study|Adverse Event|1|||
33637226|NCT00686712|102223114|FG001|Overall Study|Adverse Event|1|||
33637227|NCT00686712|102223115|FG002|Overall Study|Adverse Event|0|||
33637228|NCT04634253|102223118|FG000|Overall Study|Adverse Event|1|||
33637229|NCT04634253|102223119|FG001|Overall Study|Adverse Event|1|||
33637230|NCT04634253|102223120|FG002|Overall Study|Adverse Event|0|||
33637231|NCT04634253|102223118|FG000|Overall Study|Physician Decision|0|||
33637232|NCT04634253|102223119|FG001|Overall Study|Physician Decision|1|||
33637233|NCT04634253|102223120|FG002|Overall Study|Physician Decision|0|||
33637234|NCT04634253|102223118|FG000|Overall Study|Withdrawal by Subject|1|||
33637235|NCT04634253|102223119|FG001|Overall Study|Withdrawal by Subject|0|||
33637236|NCT04634253|102223120|FG002|Overall Study|Withdrawal by Subject|3|||
33637237|NCT01192191|102223122|FG000|Overall Study|Adverse Event|7|||
33637238|NCT01192191|102223123|FG001|Overall Study|Adverse Event|12|||
33637239|NCT01192191|102223122|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
33637240|NCT01192191|102223123|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
33637241|NCT01192191|102223122|FG000|Overall Study|Lost to Follow-up|0|||
33637242|NCT01192191|102223123|FG001|Overall Study|Lost to Follow-up|1|||
33637243|NCT01192191|102223122|FG000|Overall Study|Withdrawal by Subject|1|||
33637244|NCT01192191|102223123|FG001|Overall Study|Withdrawal by Subject|6|||
33637245|NCT00068692|102223124|FG000|Step 1: Registration|Disese progression/relapse|5|||
33637246|NCT00068692|102223125|FG001|Step 1: Registration|Disese progression/relapse|0|||
33637247|NCT00068692|102223126|FG002|Step 1: Registration|Disese progression/relapse|0|||
33637248|NCT00068692|102223127|FG003|Step 1: Registration|Disese progression/relapse|0|||
33637249|NCT00068692|102223128|FG004|Step 1: Registration|Disese progression/relapse|0|||
33637250|NCT00068692|102223129|FG005|Step 1: Registration|Disese progression/relapse|0|||
33637251|NCT00068692|102223130|FG006|Step 1: Registration|Disese progression/relapse|0|||
33637252|NCT00068692|102223131|FG007|Step 1: Registration|Disese progression/relapse|0|||
33637253|NCT00068692|102223124|FG000|Step 1: Registration|Adverse Event|7|||
33637254|NCT00068692|102223125|FG001|Step 1: Registration|Adverse Event|0|||
33637255|NCT00068692|102223126|FG002|Step 1: Registration|Adverse Event|0|||
33637256|NCT00068692|102223127|FG003|Step 1: Registration|Adverse Event|0|||
33637257|NCT00068692|102223128|FG004|Step 1: Registration|Adverse Event|0|||
33637258|NCT00068692|102223129|FG005|Step 1: Registration|Adverse Event|0|||
33637259|NCT00068692|102223130|FG006|Step 1: Registration|Adverse Event|0|||
33235417|NCT00810641|100764820|FG000|Overall Study|Withdrawal by Subject|0|||
33235418|NCT00810641|100764821|FG001|Overall Study|Withdrawal by Subject|1|||
33637260|NCT00068692|102223131|FG007|Step 1: Registration|Adverse Event|0|||
33637261|NCT00068692|102223124|FG000|Step 1: Registration|Death|1|||
33637262|NCT00068692|102223125|FG001|Step 1: Registration|Death|0|||
33637263|NCT00068692|102223126|FG002|Step 1: Registration|Death|0|||
33637264|NCT00068692|102223127|FG003|Step 1: Registration|Death|0|||
33637265|NCT00068692|102223128|FG004|Step 1: Registration|Death|0|||
33637266|NCT00068692|102223129|FG005|Step 1: Registration|Death|0|||
33637267|NCT00068692|102223130|FG006|Step 1: Registration|Death|0|||
33637268|NCT00068692|102223131|FG007|Step 1: Registration|Death|0|||
33637269|NCT00068692|102223124|FG000|Step 1: Registration|Withdrawal by Subject|11|||
33637270|NCT00068692|102223125|FG001|Step 1: Registration|Withdrawal by Subject|0|||
33637271|NCT00068692|102223126|FG002|Step 1: Registration|Withdrawal by Subject|0|||
33637272|NCT00068692|102223127|FG003|Step 1: Registration|Withdrawal by Subject|0|||
33637273|NCT00068692|102223128|FG004|Step 1: Registration|Withdrawal by Subject|0|||
33637274|NCT00068692|102223129|FG005|Step 1: Registration|Withdrawal by Subject|0|||
33637275|NCT00068692|102223130|FG006|Step 1: Registration|Withdrawal by Subject|0|||
33637276|NCT00068692|102223131|FG007|Step 1: Registration|Withdrawal by Subject|0|||
33637277|NCT00068692|102223124|FG000|Step 1: Registration|Alternative therapy|2|||
33368980|NCT02677896|101234954|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|69|||
33368981|NCT02677896|101234953|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|9|||
33368982|NCT02677896|101234954|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|14|||
33577018|NCT03314935|102003251|FG010|Phase 1|"Captured as Other in Database"|0|||
33577019|NCT03314935|102003252|FG011|Phase 1|"Captured as Other in Database"|0|||
33577020|NCT03314935|102003253|FG012|Phase 1|"Captured as Other in Database"|0|||
33577021|NCT03314935|102003254|FG013|Phase 1|"Captured as Other in Database"|0|||
33577022|NCT03314935|102003255|FG014|Phase 1|"Captured as Other in Database"|0|||
33637278|NCT00068692|102223125|FG001|Step 1: Registration|Alternative therapy|0|||
33637279|NCT00068692|102223126|FG002|Step 1: Registration|Alternative therapy|0|||
33637280|NCT00068692|102223127|FG003|Step 1: Registration|Alternative therapy|0|||
33637281|NCT00068692|102223128|FG004|Step 1: Registration|Alternative therapy|0|||
33637282|NCT00068692|102223129|FG005|Step 1: Registration|Alternative therapy|0|||
33637283|NCT00068692|102223130|FG006|Step 1: Registration|Alternative therapy|0|||
33637284|NCT00068692|102223131|FG007|Step 1: Registration|Alternative therapy|0|||
33637285|NCT00068692|102223124|FG000|Step 1: Registration|Complicating disease|2|||
33577023|NCT03314935|102003241|FG000|Phase 1|Lost to Follow-up|0|||
33577024|NCT03314935|102003242|FG001|Phase 1|Lost to Follow-up|0|||
33577025|NCT03314935|102003243|FG002|Phase 1|Lost to Follow-up|0|||
33577026|NCT03314935|102003244|FG003|Phase 1|Lost to Follow-up|0|||
33577027|NCT03314935|102003245|FG004|Phase 1|Lost to Follow-up|0|||
33577028|NCT03314935|102003246|FG005|Phase 1|Lost to Follow-up|0|||
33577029|NCT03314935|102003247|FG006|Phase 1|Lost to Follow-up|0|||
33577030|NCT03314935|102003248|FG007|Phase 1|Lost to Follow-up|0|||
33577031|NCT03314935|102003249|FG008|Phase 1|Lost to Follow-up|1|||
33577032|NCT03314935|102003250|FG009|Phase 1|Lost to Follow-up|0|||
33577033|NCT03314935|102003251|FG010|Phase 1|Lost to Follow-up|0|||
33577034|NCT03314935|102003252|FG011|Phase 1|Lost to Follow-up|0|||
33577035|NCT03314935|102003253|FG012|Phase 1|Lost to Follow-up|0|||
33637286|NCT00068692|102223125|FG001|Step 1: Registration|Complicating disease|0|||
33637287|NCT00068692|102223126|FG002|Step 1: Registration|Complicating disease|0|||
33637288|NCT00068692|102223127|FG003|Step 1: Registration|Complicating disease|0|||
33637289|NCT00068692|102223128|FG004|Step 1: Registration|Complicating disease|0|||
33368983|NCT02677896|101234953|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|365|||
33368984|NCT02677896|101234954|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|180|||
33368985|NCT02677896|101234953|FG000|Double Blind Period (up to 35 Months)|Followed-up for OS|31|||
33368986|NCT02677896|101234954|FG001|Double Blind Period (up to 35 Months)|Followed-up for OS|108|||
33368987|NCT02677896|101234953|FG000|Open-Label Extension (up to 25 Months)|Death|40|||
33368988|NCT02677896|101234954|FG001|Open-Label Extension (up to 25 Months)|Death|14|||
33637290|NCT00068692|102223129|FG005|Step 1: Registration|Complicating disease|0|||
33368989|NCT02677896|101234953|FG000|Open-Label Extension (up to 25 Months)|Lost to Follow-up|2|||
33368990|NCT02677896|101234954|FG001|Open-Label Extension (up to 25 Months)|Lost to Follow-up|1|||
33637291|NCT00068692|102223130|FG006|Step 1: Registration|Complicating disease|0|||
33577036|NCT03314935|102003254|FG013|Phase 1|Lost to Follow-up|0|||
33577037|NCT03314935|102003255|FG014|Phase 1|Lost to Follow-up|0|||
33577038|NCT03314935|102003241|FG000|Phase 2|Death|0|||
33637292|NCT00068692|102223131|FG007|Step 1: Registration|Complicating disease|0|||
33637293|NCT00068692|102223124|FG000|Step 1: Registration|Protocol Violation|1|||
33637294|NCT00068692|102223125|FG001|Step 1: Registration|Protocol Violation|0|||
33637295|NCT00068692|102223126|FG002|Step 1: Registration|Protocol Violation|0|||
33637296|NCT00068692|102223127|FG003|Step 1: Registration|Protocol Violation|0|||
33637297|NCT00068692|102223128|FG004|Step 1: Registration|Protocol Violation|0|||
33637298|NCT00068692|102223129|FG005|Step 1: Registration|Protocol Violation|0|||
33637299|NCT00068692|102223130|FG006|Step 1: Registration|Protocol Violation|0|||
33637300|NCT00068692|102223131|FG007|Step 1: Registration|Protocol Violation|0|||
33637301|NCT00068692|102223124|FG000|Step 1: Registration|Not eligible|6|||
33637302|NCT00068692|102223125|FG001|Step 1: Registration|Not eligible|0|||
33637303|NCT00068692|102223126|FG002|Step 1: Registration|Not eligible|0|||
33637304|NCT00068692|102223127|FG003|Step 1: Registration|Not eligible|0|||
33637305|NCT00068692|102223128|FG004|Step 1: Registration|Not eligible|0|||
33637306|NCT00068692|102223129|FG005|Step 1: Registration|Not eligible|0|||
33637307|NCT00068692|102223130|FG006|Step 1: Registration|Not eligible|0|||
33637308|NCT00068692|102223131|FG007|Step 1: Registration|Not eligible|0|||
33637309|NCT00068692|102223124|FG000|Step 1: Registration|Other|2|||
33637310|NCT00068692|102223125|FG001|Step 1: Registration|Other|0|||
33637311|NCT00068692|102223126|FG002|Step 1: Registration|Other|0|||
33637312|NCT00068692|102223127|FG003|Step 1: Registration|Other|0|||
33637313|NCT00068692|102223128|FG004|Step 1: Registration|Other|0|||
33637314|NCT00068692|102223129|FG005|Step 1: Registration|Other|0|||
33637315|NCT00068692|102223130|FG006|Step 1: Registration|Other|0|||
33637316|NCT00068692|102223131|FG007|Step 1: Registration|Other|0|||
33637317|NCT00068692|102223124|FG000|Step 1: Registration|Not start protocol therapy|3|||
33637318|NCT00068692|102223125|FG001|Step 1: Registration|Not start protocol therapy|0|||
33420480|NCT00386100|101428634|FG001|Overall Study|Hb1Ac >8%|1|||
33420481|NCT00386100|101428633|FG000|Overall Study|Participant randomized in error|1|||
33637319|NCT00068692|102223126|FG002|Step 1: Registration|Not start protocol therapy|0|||
33637320|NCT00068692|102223127|FG003|Step 1: Registration|Not start protocol therapy|0|||
33637321|NCT00068692|102223128|FG004|Step 1: Registration|Not start protocol therapy|0|||
33637322|NCT00068692|102223129|FG005|Step 1: Registration|Not start protocol therapy|0|||
33637323|NCT00068692|102223130|FG006|Step 1: Registration|Not start protocol therapy|0|||
33637324|NCT00068692|102223131|FG007|Step 1: Registration|Not start protocol therapy|0|||
33637325|NCT00068692|102223124|FG000|Step 1: Registration|Registered but not randomized|0|||
33637326|NCT00068692|102223125|FG001|Step 1: Registration|Registered but not randomized|1|||
33637327|NCT00068692|102223126|FG002|Step 1: Registration|Registered but not randomized|0|||
33637328|NCT00068692|102223127|FG003|Step 1: Registration|Registered but not randomized|0|||
33637329|NCT00068692|102223128|FG004|Step 1: Registration|Registered but not randomized|0|||
33637330|NCT00068692|102223129|FG005|Step 1: Registration|Registered but not randomized|0|||
33637331|NCT00068692|102223130|FG006|Step 1: Registration|Registered but not randomized|0|||
33637332|NCT00068692|102223131|FG007|Step 1: Registration|Registered but not randomized|0|||
33637333|NCT00068692|102223124|FG000|Step 2: Randomization|Disesae progression/replase|0|||
33637334|NCT00068692|102223125|FG001|Step 2: Randomization|Disesae progression/replase|0|||
33138582|NCT01403948|100420320|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
33138583|NCT01403948|100420311|FG000|Overall Study|Lost to Follow-up|0|||
33235419|NCT00810641|100764822|FG002|Overall Study|Withdrawal by Subject|2|||
33235420|NCT01619787|100764823|FG000|Overall Study|Lost to Follow-up|5|||
33368991|NCT02677896|101234953|FG000|Open-Label Extension (up to 25 Months)|Progressive disease|3|||
33368992|NCT02677896|101234954|FG001|Open-Label Extension (up to 25 Months)|Progressive disease|1|||
33368993|NCT02677896|101234953|FG000|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|10|||
33368994|NCT02677896|101234954|FG001|Open-Label Extension (up to 25 Months)|Withdrawal by Subject|9|||
33368995|NCT02677896|101234953|FG000|Open-Label Extension (up to 25 Months)|Miscellaneous|0|||
33368996|NCT02677896|101234954|FG001|Open-Label Extension (up to 25 Months)|Miscellaneous|1|||
33368997|NCT02677896|101234953|FG000|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|261|||
33368998|NCT02677896|101234954|FG001|Open-Label Extension (up to 25 Months)|OLE treatment ongoing|136|||
33420482|NCT00386100|101428634|FG001|Overall Study|Participant randomized in error|0|||
33138584|NCT01403948|100420312|FG001|Overall Study|Lost to Follow-up|0|||
33138585|NCT01403948|100420313|FG002|Overall Study|Lost to Follow-up|0|||
33235421|NCT00610675|100764824|FG000|Overall Study|Untreated|4|||
33235422|NCT00610675|100764824|FG000|Overall Study|Adverse Event|67|||
33235423|NCT00610675|100764824|FG000|Overall Study|Insufficient Effect|31|||
33235424|NCT00610675|100764824|FG000|Overall Study|Withdrawal by Subject|28|||
33235425|NCT00610675|100764824|FG000|Overall Study|Reasons unrelated to trial|27|||
33235426|NCT00610675|100764824|FG000|Overall Study|Lack of Compliance|7|||
33235427|NCT00610675|100764824|FG000|Overall Study|Lost to Follow-up|31|||
33138586|NCT01403948|100420314|FG003|Overall Study|Lost to Follow-up|0|||
33235428|NCT00610675|100764824|FG000|Overall Study|Other reason (not specified)|25|||
33368999|NCT02677896|101234953|FG000|Open-Label Extension (up to 25 Months)|Followed up for OS|49|||
33637335|NCT00068692|102223126|FG002|Step 2: Randomization|Disesae progression/replase|1|||
33637336|NCT00068692|102223127|FG003|Step 2: Randomization|Disesae progression/replase|1|||
33637337|NCT00068692|102223128|FG004|Step 2: Randomization|Disesae progression/replase|0|||
33637338|NCT00068692|102223129|FG005|Step 2: Randomization|Disesae progression/replase|0|||
33637339|NCT00068692|102223130|FG006|Step 2: Randomization|Disesae progression/replase|0|||
33138587|NCT01403948|100420315|FG004|Overall Study|Lost to Follow-up|0|||
33235429|NCT00802841|100764825|FG000|Overall Study|Administrative problems|1|||
33138588|NCT01403948|100420316|FG005|Overall Study|Lost to Follow-up|0|||
33138589|NCT01403948|100420317|FG006|Overall Study|Lost to Follow-up|0|||
33138590|NCT01403948|100420318|FG007|Overall Study|Lost to Follow-up|0|||
33138591|NCT01403948|100420319|FG008|Overall Study|Lost to Follow-up|0|||
33138592|NCT01403948|100420320|FG009|Overall Study|Lost to Follow-up|1|||
33138593|NCT01403948|100420311|FG000|Overall Study|Refused cont. medication|0|||
33138594|NCT01403948|100420312|FG001|Overall Study|Refused cont. medication|0|||
33138595|NCT01403948|100420313|FG002|Overall Study|Refused cont. medication|0|||
33235430|NCT00802841|100764826|FG001|Overall Study|Administrative problems|0|||
33235431|NCT00802841|100764825|FG000|Overall Study|Lost to Follow-up|2|||
33235432|NCT00802841|100764826|FG001|Overall Study|Lost to Follow-up|1|||
33235433|NCT00802841|100764825|FG000|Overall Study|Death|1|||
33235434|NCT00802841|100764826|FG001|Overall Study|Death|2|||
33235435|NCT00802841|100764825|FG000|Overall Study|Adverse Event|8|||
33235436|NCT00802841|100764826|FG001|Overall Study|Adverse Event|2|||
33235437|NCT00802841|100764825|FG000|Overall Study|Disease progression|7|||
33235438|NCT00802841|100764826|FG001|Overall Study|Disease progression|3|||
33235439|NCT00802841|100764825|FG000|Overall Study|Withdrawal by Subject|9|||
33235440|NCT00802841|100764826|FG001|Overall Study|Withdrawal by Subject|5|||
33235441|NCT00802841|100764825|FG000|Overall Study|Protocol deviation|2|||
33420483|NCT03349437|101428635|FG000|Screening|Screen Fail|4|||
33420484|NCT03349437|101428636|FG001|Screening|Screen Fail|0|||
33420485|NCT03349437|101428637|FG002|Screening|Screen Fail|0|||
33420486|NCT03349437|101428635|FG000|Screening|Withdrawn|1|||
33420487|NCT03349437|101428636|FG001|Screening|Withdrawn|0|||
33420488|NCT03349437|101428637|FG002|Screening|Withdrawn|0|||
33235442|NCT00802841|100764826|FG001|Overall Study|Protocol deviation|6|||
33235443|NCT00802841|100764825|FG000|Overall Study|Treatment duration completed|66|||
33235444|NCT00802841|100764826|FG001|Overall Study|Treatment duration completed|76|||
33235445|NCT01994720|100764827|FG000|Overall Study|Withdrawal by Subject|46|||
33235446|NCT01994720|100764828|FG001|Overall Study|Withdrawal by Subject|56|||
33235447|NCT02148718|100764829|FG000|Overall Study|Protocol Violation|26|||
33235448|NCT02148718|100764829|FG000|Overall Study|Discontinued Study Prematurely|5|||
33235449|NCT01500226|100764830|FG000|Overall Study|Adverse Event|31|||
33420489|NCT00666718|101431509|FG000|Overall Study|Adverse Event|0|||
33420490|NCT00666718|101431510|FG001|Overall Study|Adverse Event|1|||
33420491|NCT00666718|101431509|FG000|Overall Study|Death|1|||
33420492|NCT00666718|101431510|FG001|Overall Study|Death|0|||
33420493|NCT00666718|101431509|FG000|Overall Study|Lost to Follow-up|1|||
33420494|NCT00666718|101431510|FG001|Overall Study|Lost to Follow-up|0|||
33420495|NCT00666718|101431509|FG000|Overall Study|Entry Criteria Not Met|2|||
33420496|NCT00666718|101431510|FG001|Overall Study|Entry Criteria Not Met|0|||
33420497|NCT00666718|101431509|FG000|Overall Study|Protocol Violation|1|||
33420498|NCT00666718|101431510|FG001|Overall Study|Protocol Violation|3|||
33420499|NCT00666718|101431509|FG000|Overall Study|Withdrawal by Subject|7|||
33420500|NCT00666718|101431510|FG001|Overall Study|Withdrawal by Subject|12|||
33420501|NCT00666718|101431509|FG000|Overall Study|Physician Decision|0|||
33420502|NCT00666718|101431510|FG001|Overall Study|Physician Decision|2|||
33420503|NCT02239601|101431515|FG000|Overall Study|Withdrawal by Subject|3|||
33420504|NCT02239601|101431516|FG001|Overall Study|Withdrawal by Subject|4|||
33577039|NCT03314935|102003242|FG001|Phase 2|Death|0|||
33577040|NCT03314935|102003243|FG002|Phase 2|Death|0|||
33577041|NCT03314935|102003244|FG003|Phase 2|Death|0|||
33577042|NCT03314935|102003245|FG004|Phase 2|Death|0|||
33577043|NCT03314935|102003246|FG005|Phase 2|Death|0|||
33577044|NCT03314935|102003247|FG006|Phase 2|Death|0|||
33577045|NCT03314935|102003248|FG007|Phase 2|Death|0|||
33577046|NCT03314935|102003249|FG008|Phase 2|Death|0|||
33577047|NCT03314935|102003250|FG009|Phase 2|Death|5|||
33577048|NCT03314935|102003251|FG010|Phase 2|Death|20|||
33577049|NCT03314935|102003252|FG011|Phase 2|Death|6|||
33577050|NCT03314935|102003253|FG012|Phase 2|Death|7|||
33577051|NCT03314935|102003254|FG013|Phase 2|Death|6|||
33577052|NCT03314935|102003255|FG014|Phase 2|Death|17|||
33577053|NCT03314935|102003241|FG000|Phase 2|Withdrawal by Subject|0|||
33138596|NCT01403948|100420314|FG003|Overall Study|Refused cont. medication|0|||
33138597|NCT01403948|100420315|FG004|Overall Study|Refused cont. medication|1|||
33235450|NCT01500226|100764831|FG001|Overall Study|Adverse Event|38|||
33138598|NCT01403948|100420316|FG005|Overall Study|Refused cont. medication|0|||
33235451|NCT01500226|100764830|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
33420505|NCT02239601|101431515|FG000|Overall Study|Protocol Violation|4|||
33420506|NCT02239601|101431516|FG001|Overall Study|Protocol Violation|2|||
33420507|NCT01005680|101431517|FG000|Overall Study|Lost to Follow-up|4|||
33420508|NCT01005680|101431518|FG001|Overall Study|Lost to Follow-up|6|||
33138599|NCT01403948|100420317|FG006|Overall Study|Refused cont. medication|0|||
33420509|NCT01005680|101431517|FG000|Overall Study|Withdrawal by Subject|1|||
33420510|NCT01005680|101431518|FG001|Overall Study|Withdrawal by Subject|4|||
33420511|NCT01005680|101431517|FG000|Overall Study|Physician Decision|1|||
33420512|NCT01005680|101431518|FG001|Overall Study|Physician Decision|1|||
33577054|NCT03314935|102003242|FG001|Phase 2|Withdrawal by Subject|0|||
33577055|NCT03314935|102003243|FG002|Phase 2|Withdrawal by Subject|0|||
33577056|NCT03314935|102003244|FG003|Phase 2|Withdrawal by Subject|0|||
33420513|NCT01289990|101431519|FG000|Overall Study|Death|0|||
33420514|NCT01289990|101431520|FG001|Overall Study|Death|0|||
33420515|NCT01289990|101431521|FG002|Overall Study|Death|0|||
33420516|NCT01289990|101431522|FG003|Overall Study|Death|1|||
33420517|NCT01289990|101431523|FG004|Overall Study|Death|2|||
33420518|NCT01289990|101431524|FG005|Overall Study|Death|1|||
33420519|NCT01289990|101431525|FG006|Overall Study|Death|0|||
33420520|NCT01289990|101431526|FG007|Overall Study|Death|0|||
33420521|NCT01289990|101431527|FG008|Overall Study|Death|0|||
33420522|NCT01289990|101431528|FG009|Overall Study|Death|0|||
33420523|NCT01289990|101431529|FG010|Overall Study|Death|0|||
33420524|NCT01289990|101431530|FG011|Overall Study|Death|1|||
33577057|NCT03314935|102003245|FG004|Phase 2|Withdrawal by Subject|0|||
33577058|NCT03314935|102003246|FG005|Phase 2|Withdrawal by Subject|0|||
33577059|NCT03314935|102003247|FG006|Phase 2|Withdrawal by Subject|0|||
33577060|NCT03314935|102003248|FG007|Phase 2|Withdrawal by Subject|0|||
33577061|NCT03314935|102003249|FG008|Phase 2|Withdrawal by Subject|0|||
33577062|NCT03314935|102003250|FG009|Phase 2|Withdrawal by Subject|1|||
33577063|NCT03314935|102003251|FG010|Phase 2|Withdrawal by Subject|4|||
33577064|NCT03314935|102003252|FG011|Phase 2|Withdrawal by Subject|0|||
33577065|NCT03314935|102003253|FG012|Phase 2|Withdrawal by Subject|1|||
33577066|NCT03314935|102003254|FG013|Phase 2|Withdrawal by Subject|0|||
33577067|NCT03314935|102003255|FG014|Phase 2|Withdrawal by Subject|1|||
33577068|NCT03314935|102003241|FG000|Phase 2|Progressive Disease|0|||
33577069|NCT03314935|102003242|FG001|Phase 2|Progressive Disease|0|||
33577070|NCT03314935|102003243|FG002|Phase 2|Progressive Disease|0|||
33577071|NCT03314935|102003244|FG003|Phase 2|Progressive Disease|0|||
33577072|NCT03314935|102003245|FG004|Phase 2|Progressive Disease|0|||
33577073|NCT03314935|102003246|FG005|Phase 2|Progressive Disease|0|||
33637340|NCT00068692|102223131|FG007|Step 2: Randomization|Disesae progression/replase|0|||
33637341|NCT00068692|102223124|FG000|Step 2: Randomization|Adverse Event|0|||
33577074|NCT03314935|102003247|FG006|Phase 2|Progressive Disease|0|||
33577075|NCT03314935|102003248|FG007|Phase 2|Progressive Disease|0|||
33577076|NCT03314935|102003249|FG008|Phase 2|Progressive Disease|0|||
33577077|NCT03314935|102003250|FG009|Phase 2|Progressive Disease|1|||
33577078|NCT03314935|102003251|FG010|Phase 2|Progressive Disease|1|||
33637342|NCT00068692|102223125|FG001|Step 2: Randomization|Adverse Event|0|||
33637343|NCT00068692|102223126|FG002|Step 2: Randomization|Adverse Event|4|||
33637344|NCT00068692|102223127|FG003|Step 2: Randomization|Adverse Event|2|||
33637345|NCT00068692|102223128|FG004|Step 2: Randomization|Adverse Event|2|||
33637346|NCT00068692|102223129|FG005|Step 2: Randomization|Adverse Event|3|||
33637347|NCT00068692|102223130|FG006|Step 2: Randomization|Adverse Event|4|||
33637348|NCT00068692|102223131|FG007|Step 2: Randomization|Adverse Event|4|||
33637349|NCT00068692|102223124|FG000|Step 2: Randomization|Death|0|||
33637350|NCT00068692|102223125|FG001|Step 2: Randomization|Death|0|||
33637351|NCT00068692|102223126|FG002|Step 2: Randomization|Death|0|||
33637352|NCT00068692|102223127|FG003|Step 2: Randomization|Death|0|||
33637353|NCT00068692|102223128|FG004|Step 2: Randomization|Death|1|||
33637354|NCT00068692|102223129|FG005|Step 2: Randomization|Death|0|||
33637355|NCT00068692|102223130|FG006|Step 2: Randomization|Death|0|||
33637356|NCT00068692|102223131|FG007|Step 2: Randomization|Death|1|||
33637357|NCT00068692|102223124|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
33637358|NCT00068692|102223125|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
33637359|NCT00068692|102223126|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
33235452|NCT01500226|100764831|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
33235453|NCT01500226|100764830|FG000|Overall Study|Withdrawal by Subject|93|||
33235454|NCT01500226|100764831|FG001|Overall Study|Withdrawal by Subject|96|||
33235455|NCT01500226|100764830|FG000|Overall Study|Death|12|||
33235456|NCT01500226|100764831|FG001|Overall Study|Death|4|||
33235457|NCT01500226|100764830|FG000|Overall Study|Disease Progression|16|||
33235458|NCT01500226|100764831|FG001|Overall Study|Disease Progression|14|||
33235459|NCT01500226|100764830|FG000|Overall Study|Protocol Violation|53|||
33637360|NCT00068692|102223127|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
33138600|NCT01403948|100420318|FG007|Overall Study|Refused cont. medication|0|||
33138601|NCT01403948|100420319|FG008|Overall Study|Refused cont. medication|0|||
33235460|NCT01500226|100764831|FG001|Overall Study|Protocol Violation|39|||
33420525|NCT01289990|101431531|FG012|Overall Study|Death|0|||
33420526|NCT01289990|101431519|FG000|Overall Study|Lost to Follow-up|3|||
33420527|NCT01289990|101431520|FG001|Overall Study|Lost to Follow-up|2|||
33637361|NCT00068692|102223128|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
33138602|NCT01403948|100420320|FG009|Overall Study|Refused cont. medication|1|||
33138603|NCT01403948|100420311|FG000|Overall Study|other than above|1|||
33420528|NCT01289990|101431521|FG002|Overall Study|Lost to Follow-up|5|||
33420529|NCT01289990|101431522|FG003|Overall Study|Lost to Follow-up|5|||
33420530|NCT01289990|101431523|FG004|Overall Study|Lost to Follow-up|3|||
33420531|NCT01289990|101431524|FG005|Overall Study|Lost to Follow-up|4|||
33577079|NCT03314935|102003252|FG011|Phase 2|Progressive Disease|1|||
33577080|NCT03314935|102003253|FG012|Phase 2|Progressive Disease|2|||
33577081|NCT03314935|102003254|FG013|Phase 2|Progressive Disease|0|||
33577082|NCT03314935|102003255|FG014|Phase 2|Progressive Disease|1|||
33420532|NCT01289990|101431525|FG006|Overall Study|Lost to Follow-up|2|||
33420533|NCT01289990|101431526|FG007|Overall Study|Lost to Follow-up|2|||
33420534|NCT01289990|101431527|FG008|Overall Study|Lost to Follow-up|1|||
33637362|NCT00068692|102223129|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
33637363|NCT00068692|102223130|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
33637364|NCT00068692|102223131|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
33637365|NCT00068692|102223124|FG000|Step 2: Randomization|alternative therapy|0|||
33637366|NCT00068692|102223125|FG001|Step 2: Randomization|alternative therapy|0|||
33637367|NCT00068692|102223126|FG002|Step 2: Randomization|alternative therapy|0|||
33637368|NCT00068692|102223127|FG003|Step 2: Randomization|alternative therapy|1|||
33637369|NCT00068692|102223128|FG004|Step 2: Randomization|alternative therapy|1|||
33637370|NCT00068692|102223129|FG005|Step 2: Randomization|alternative therapy|0|||
33637371|NCT00068692|102223130|FG006|Step 2: Randomization|alternative therapy|0|||
33637372|NCT00068692|102223131|FG007|Step 2: Randomization|alternative therapy|0|||
33637373|NCT00068692|102223124|FG000|Step 2: Randomization|Physician Decision|0|||
33637374|NCT00068692|102223125|FG001|Step 2: Randomization|Physician Decision|0|||
33637375|NCT00068692|102223126|FG002|Step 2: Randomization|Physician Decision|0|||
33637376|NCT00068692|102223127|FG003|Step 2: Randomization|Physician Decision|1|||
33637377|NCT00068692|102223128|FG004|Step 2: Randomization|Physician Decision|1|||
33637378|NCT00068692|102223129|FG005|Step 2: Randomization|Physician Decision|0|||
33637379|NCT00068692|102223130|FG006|Step 2: Randomization|Physician Decision|0|||
33637380|NCT00068692|102223131|FG007|Step 2: Randomization|Physician Decision|0|||
33637381|NCT00068692|102223124|FG000|Step 2: Randomization|Other|0|||
33138604|NCT01403948|100420312|FG001|Overall Study|other than above|2|||
33138605|NCT01403948|100420313|FG002|Overall Study|other than above|1|||
33138606|NCT01403948|100420314|FG003|Overall Study|other than above|0|||
33138607|NCT01403948|100420315|FG004|Overall Study|other than above|1|||
33138608|NCT01403948|100420316|FG005|Overall Study|other than above|1|||
33138609|NCT01403948|100420317|FG006|Overall Study|other than above|2|||
33138610|NCT01403948|100420318|FG007|Overall Study|other than above|0|||
33138611|NCT01403948|100420319|FG008|Overall Study|other than above|0|||
33138612|NCT01403948|100420320|FG009|Overall Study|other than above|0|||
33235461|NCT01500226|100764830|FG000|Overall Study|Physician Decision|17|||
33420535|NCT01289990|101431528|FG009|Overall Study|Lost to Follow-up|4|||
33420536|NCT01289990|101431529|FG010|Overall Study|Lost to Follow-up|2|||
33420537|NCT01289990|101431530|FG011|Overall Study|Lost to Follow-up|1|||
33420538|NCT01289990|101431531|FG012|Overall Study|Lost to Follow-up|2|||
33420539|NCT01289990|101431519|FG000|Overall Study|Withdrawal by Subject|15|||
33420540|NCT01289990|101431520|FG001|Overall Study|Withdrawal by Subject|14|||
33420541|NCT01289990|101431521|FG002|Overall Study|Withdrawal by Subject|12|||
33420542|NCT01289990|101431522|FG003|Overall Study|Withdrawal by Subject|13|||
33420543|NCT01289990|101431523|FG004|Overall Study|Withdrawal by Subject|8|||
33420544|NCT01289990|101431524|FG005|Overall Study|Withdrawal by Subject|7|||
33420545|NCT01289990|101431525|FG006|Overall Study|Withdrawal by Subject|13|||
33420546|NCT01289990|101431526|FG007|Overall Study|Withdrawal by Subject|9|||
33420547|NCT01289990|101431527|FG008|Overall Study|Withdrawal by Subject|12|||
33420548|NCT01289990|101431528|FG009|Overall Study|Withdrawal by Subject|13|||
33420549|NCT01289990|101431529|FG010|Overall Study|Withdrawal by Subject|11|||
33420550|NCT01289990|101431530|FG011|Overall Study|Withdrawal by Subject|13|||
33420551|NCT01289990|101431531|FG012|Overall Study|Withdrawal by Subject|16|||
33420552|NCT01289990|101431519|FG000|Overall Study|discontinued in preceding trial|18|||
33420553|NCT01289990|101431520|FG001|Overall Study|discontinued in preceding trial|20|||
33420554|NCT01289990|101431521|FG002|Overall Study|discontinued in preceding trial|41|||
33420555|NCT01289990|101431522|FG003|Overall Study|discontinued in preceding trial|17|||
33420556|NCT01289990|101431523|FG004|Overall Study|discontinued in preceding trial|11|||
33420557|NCT01289990|101431524|FG005|Overall Study|discontinued in preceding trial|12|||
33420558|NCT01289990|101431525|FG006|Overall Study|discontinued in preceding trial|18|||
33420559|NCT01289990|101431526|FG007|Overall Study|discontinued in preceding trial|8|||
33420560|NCT01289990|101431527|FG008|Overall Study|discontinued in preceding trial|17|||
33420561|NCT01289990|101431528|FG009|Overall Study|discontinued in preceding trial|21|||
33420562|NCT01289990|101431529|FG010|Overall Study|discontinued in preceding trial|17|||
33637382|NCT00068692|102223125|FG001|Step 2: Randomization|Other|0|||
33637383|NCT00068692|102223126|FG002|Step 2: Randomization|Other|0|||
33235462|NCT01500226|100764831|FG001|Overall Study|Physician Decision|15|||
33235463|NCT01500226|100764830|FG000|Overall Study|Lack of Efficacy|14|||
33235464|NCT01500226|100764831|FG001|Overall Study|Lack of Efficacy|30|||
33637384|NCT00068692|102223127|FG003|Step 2: Randomization|Other|1|||
33637385|NCT00068692|102223128|FG004|Step 2: Randomization|Other|0|||
33235465|NCT01500226|100764830|FG000|Overall Study|Lost to Follow-up|9|||
33235466|NCT01500226|100764831|FG001|Overall Study|Lost to Follow-up|5|||
33138613|NCT01037088|100423759|FG000|Overall Study|Withdrawal by Subject|3|||
33420563|NCT01289990|101431530|FG011|Overall Study|discontinued in preceding trial|17|||
33420564|NCT01289990|101431531|FG012|Overall Study|discontinued in preceding trial|24|||
33420565|NCT01289990|101431519|FG000|Overall Study|did not continue in extension|41|||
33420566|NCT01289990|101431520|FG001|Overall Study|did not continue in extension|45|||
33235467|NCT01500226|100764830|FG000|Overall Study|Other Reasons|19|||
33577083|NCT03314935|102003241|FG000|Phase 2|Study Terminated by Sponsor|0|||
33577084|NCT03314935|102003242|FG001|Phase 2|Study Terminated by Sponsor|0|||
33577085|NCT03314935|102003243|FG002|Phase 2|Study Terminated by Sponsor|0|||
33577086|NCT03314935|102003244|FG003|Phase 2|Study Terminated by Sponsor|0|||
33577087|NCT03314935|102003245|FG004|Phase 2|Study Terminated by Sponsor|0|||
33577088|NCT03314935|102003246|FG005|Phase 2|Study Terminated by Sponsor|0|||
33577089|NCT03314935|102003247|FG006|Phase 2|Study Terminated by Sponsor|0|||
33577090|NCT03314935|102003248|FG007|Phase 2|Study Terminated by Sponsor|0|||
33577091|NCT03314935|102003249|FG008|Phase 2|Study Terminated by Sponsor|0|||
33577092|NCT03314935|102003250|FG009|Phase 2|Study Terminated by Sponsor|0|||
33577093|NCT03314935|102003251|FG010|Phase 2|Study Terminated by Sponsor|7|||
33577094|NCT03314935|102003252|FG011|Phase 2|Study Terminated by Sponsor|2|||
33577095|NCT03314935|102003253|FG012|Phase 2|Study Terminated by Sponsor|1|||
33577096|NCT03314935|102003254|FG013|Phase 2|Study Terminated by Sponsor|4|||
33577097|NCT03314935|102003255|FG014|Phase 2|Study Terminated by Sponsor|4|||
33577098|NCT03314935|102003241|FG000|Phase 2|Lost to Follow-up|0|||
33577099|NCT03314935|102003242|FG001|Phase 2|Lost to Follow-up|0|||
33577100|NCT03314935|102003243|FG002|Phase 2|Lost to Follow-up|0|||
33577101|NCT03314935|102003244|FG003|Phase 2|Lost to Follow-up|0|||
33577102|NCT03314935|102003245|FG004|Phase 2|Lost to Follow-up|0|||
33420567|NCT01289990|101431521|FG002|Overall Study|did not continue in extension|51|||
33420568|NCT01289990|101431522|FG003|Overall Study|did not continue in extension|51|||
33420569|NCT01289990|101431523|FG004|Overall Study|did not continue in extension|48|||
33420570|NCT01289990|101431524|FG005|Overall Study|did not continue in extension|50|||
33420571|NCT01289990|101431525|FG006|Overall Study|did not continue in extension|54|||
33420572|NCT01289990|101431526|FG007|Overall Study|did not continue in extension|36|||
33420573|NCT01289990|101431527|FG008|Overall Study|did not continue in extension|44|||
33420574|NCT01289990|101431528|FG009|Overall Study|did not continue in extension|48|||
33420575|NCT01289990|101431529|FG010|Overall Study|did not continue in extension|45|||
33420576|NCT01289990|101431530|FG011|Overall Study|did not continue in extension|34|||
33420577|NCT01289990|101431531|FG012|Overall Study|did not continue in extension|56|||
33420578|NCT01289990|101431519|FG000|Overall Study|Not treated|0|||
33420579|NCT01289990|101431520|FG001|Overall Study|Not treated|0|||
33420580|NCT01289990|101431521|FG002|Overall Study|Not treated|0|||
33420581|NCT01289990|101431522|FG003|Overall Study|Not treated|0|||
33420582|NCT01289990|101431523|FG004|Overall Study|Not treated|0|||
33420583|NCT01289990|101431524|FG005|Overall Study|Not treated|0|||
33577103|NCT03314935|102003246|FG005|Phase 2|Lost to Follow-up|0|||
33577104|NCT03314935|102003247|FG006|Phase 2|Lost to Follow-up|0|||
33577105|NCT03314935|102003248|FG007|Phase 2|Lost to Follow-up|0|||
33577106|NCT03314935|102003249|FG008|Phase 2|Lost to Follow-up|0|||
33577107|NCT03314935|102003250|FG009|Phase 2|Lost to Follow-up|1|||
33577108|NCT03314935|102003251|FG010|Phase 2|Lost to Follow-up|0|||
33577109|NCT03314935|102003252|FG011|Phase 2|Lost to Follow-up|0|||
33577110|NCT03314935|102003253|FG012|Phase 2|Lost to Follow-up|0|||
33577111|NCT03314935|102003254|FG013|Phase 2|Lost to Follow-up|0|||
33577112|NCT03314935|102003255|FG014|Phase 2|Lost to Follow-up|1|||
33577113|NCT03314935|102003241|FG000|Phase 2|Physician Decision|0|||
33577114|NCT03314935|102003242|FG001|Phase 2|Physician Decision|0|||
33577115|NCT03314935|102003243|FG002|Phase 2|Physician Decision|0|||
33577116|NCT03314935|102003244|FG003|Phase 2|Physician Decision|0|||
33577117|NCT03314935|102003245|FG004|Phase 2|Physician Decision|0|||
33577118|NCT03314935|102003246|FG005|Phase 2|Physician Decision|0|||
33577119|NCT03314935|102003247|FG006|Phase 2|Physician Decision|0|||
33577120|NCT03314935|102003248|FG007|Phase 2|Physician Decision|0|||
33577121|NCT03314935|102003249|FG008|Phase 2|Physician Decision|0|||
33577122|NCT03314935|102003250|FG009|Phase 2|Physician Decision|0|||
33577123|NCT03314935|102003251|FG010|Phase 2|Physician Decision|1|||
33577124|NCT03314935|102003252|FG011|Phase 2|Physician Decision|0|||
33577125|NCT03314935|102003253|FG012|Phase 2|Physician Decision|0|||
33577126|NCT03314935|102003254|FG013|Phase 2|Physician Decision|0|||
33577127|NCT03314935|102003255|FG014|Phase 2|Physician Decision|0|||
33577128|NCT03848416|102003258|FG000|Overall Study|Withdrawal by Subject|1|||
33235468|NCT01500226|100764831|FG001|Overall Study|Other Reasons|16|||
33420584|NCT01289990|101431525|FG006|Overall Study|Not treated|1|||
33420585|NCT01289990|101431526|FG007|Overall Study|Not treated|0|||
33577129|NCT03848416|102003259|FG001|Overall Study|Withdrawal by Subject|0|||
33577130|NCT03848416|102003260|FG002|Overall Study|Withdrawal by Subject|0|||
33577131|NCT03848416|102003258|FG000|Overall Study|Death|0|||
33577132|NCT03848416|102003259|FG001|Overall Study|Death|0|||
33577133|NCT03848416|102003260|FG002|Overall Study|Death|1|||
33637386|NCT00068692|102223129|FG005|Step 2: Randomization|Other|1|||
33420586|NCT01289990|101431527|FG008|Overall Study|Not treated|1|||
33420587|NCT01289990|101431528|FG009|Overall Study|Not treated|0|||
33420588|NCT01289990|101431529|FG010|Overall Study|Not treated|1|||
33420589|NCT01289990|101431530|FG011|Overall Study|Not treated|2|||
33577134|NCT00939107|102003261|FG000|Overall Study|Lost to Follow-up|14|||
33577135|NCT00939107|102003262|FG001|Overall Study|Lost to Follow-up|12|||
33577136|NCT03443687|102003263|FG000|Overall Study|Lost to Follow-up|3|||
33577137|NCT03443687|102003264|FG001|Overall Study|Lost to Follow-up|5|||
33235469|NCT01702428|100764837|FG000|Overall Study|Adverse Event|2|||
33235470|NCT01702428|100764838|FG001|Overall Study|Adverse Event|0|||
33235471|NCT01702428|100764839|FG002|Overall Study|Adverse Event|0|||
33235472|NCT01702428|100764840|FG003|Overall Study|Adverse Event|0|||
33235473|NCT01702428|100764837|FG000|Overall Study|Lost to Follow-up|33|||
33235474|NCT01702428|100764838|FG001|Overall Study|Lost to Follow-up|41|||
33235475|NCT01702428|100764839|FG002|Overall Study|Lost to Follow-up|37|||
33235476|NCT01702428|100764840|FG003|Overall Study|Lost to Follow-up|44|||
33235477|NCT01702428|100764837|FG000|Overall Study|Parents cannot assist to site|1|||
33420590|NCT01289990|101431531|FG012|Overall Study|Not treated|0|||
33420591|NCT00529802|101431532|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
33420592|NCT00529802|101431532|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
33637387|NCT00068692|102223130|FG006|Step 2: Randomization|Other|0|||
33637388|NCT00068692|102223131|FG007|Step 2: Randomization|Other|0|||
33138614|NCT00833417|100423760|FG000|Overall Study|Adverse Event|5|||
33420593|NCT00529802|101431532|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
33420594|NCT00529802|101431532|FG000|Evaluable for Primary Endpoint|Death|1|||
33420595|NCT00529802|101431532|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
33420596|NCT00529802|101431532|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
33420597|NCT00529802|101431532|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
33420598|NCT04508621|101431534|FG000|Overall Study|Adverse Event|39|||
33420599|NCT04508621|101431535|FG001|Overall Study|Adverse Event|16|||
33138615|NCT00833417|100423761|FG001|Overall Study|Adverse Event|16|||
33138616|NCT00833417|100423760|FG000|Overall Study|Death|1|||
33138617|NCT00833417|100423761|FG001|Overall Study|Death|3|||
33138618|NCT00833417|100423760|FG000|Overall Study|Lost to Follow-up|1|||
33138619|NCT00833417|100423761|FG001|Overall Study|Lost to Follow-up|2|||
33138620|NCT00833417|100423760|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
33138621|NCT00833417|100423761|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
33138622|NCT00833417|100423760|FG000|Overall Study|Patient Decision to Withdraw|4|||
33138623|NCT00833417|100423761|FG001|Overall Study|Patient Decision to Withdraw|23|||
33138624|NCT00833417|100423760|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
33138625|NCT00833417|100423761|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
33138626|NCT00833417|100423760|FG000|Overall Study|Disease Progression|18|||
33138627|NCT00833417|100423761|FG001|Overall Study|Disease Progression|17|||
33138628|NCT00833417|100423760|FG000|Overall Study|Reason Not Specified|0|||
33138629|NCT00833417|100423761|FG001|Overall Study|Reason Not Specified|1|||
33138630|NCT00734747|100423772|FG000|SRS Procedure|No staples placed|3|||
33138631|NCT00734747|100423772|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
33138632|NCT02536404|100423773|FG000|Overall Study|Adverse Event|5|||
33138633|NCT02536404|100423774|FG001|Overall Study|Adverse Event|0|||
33138634|NCT02536404|100423773|FG000|Overall Study|Withdrawal by Subject|4|||
33138635|NCT02536404|100423774|FG001|Overall Study|Withdrawal by Subject|1|||
33138636|NCT02536404|100423773|FG000|Overall Study|Physician Decision|10|||
33138637|NCT02536404|100423774|FG001|Overall Study|Physician Decision|0|||
33138638|NCT02536404|100423773|FG000|Overall Study|Sponsor decision|1|||
33138639|NCT02536404|100423774|FG001|Overall Study|Sponsor decision|0|||
33138640|NCT02683746|100423775|FG000|Overall Study|Adverse Event|3|||
33138641|NCT02683746|100423776|FG001|Overall Study|Adverse Event|2|||
33138642|NCT02683746|100423775|FG000|Overall Study|Lost to Follow-up|5|||
33138643|NCT02683746|100423776|FG001|Overall Study|Lost to Follow-up|6|||
33138644|NCT02683746|100423775|FG000|Overall Study|Withdrawal by Subject|6|||
33138645|NCT02683746|100423776|FG001|Overall Study|Withdrawal by Subject|5|||
33138646|NCT02683746|100423775|FG000|Overall Study|Physician Decision|2|||
33138647|NCT02683746|100423776|FG001|Overall Study|Physician Decision|1|||
33138648|NCT02208063|100423777|FG000|Overall Study|Death|3|||
33138649|NCT02208063|100423778|FG001|Overall Study|Death|5|||
33138650|NCT02208063|100423777|FG000|Overall Study|Not Specified in report|3|||
33138651|NCT02208063|100423778|FG001|Overall Study|Not Specified in report|4|||
33138652|NCT02208063|100423777|FG000|Overall Study|Withdrawal by Subject|5|||
33138653|NCT02208063|100423778|FG001|Overall Study|Withdrawal by Subject|2|||
33138654|NCT02208063|100423777|FG000|Overall Study|Lost to Follow-up|1|||
33138655|NCT02208063|100423778|FG001|Overall Study|Lost to Follow-up|0|||
33138656|NCT00725842|100423779|FG000|Overall Study|Lost to Follow-up|19|||
33138657|NCT00725842|100423779|FG000|Overall Study|Death|1|||
33235478|NCT01702428|100764838|FG001|Overall Study|Parents cannot assist to site|0|||
33577138|NCT03443687|102003263|FG000|Overall Study|Withdrawal by Subject|1|||
33138658|NCT00725842|100423779|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
33138659|NCT00725842|100423779|FG000|Overall Study|Consent date prior to study start date|5|||
33138660|NCT00725842|100423779|FG000|Overall Study|Inclusion criterion not met|1|||
33138661|NCT00725842|100423779|FG000|Overall Study|No Visit 1 data|1|||
33235479|NCT01702428|100764839|FG002|Overall Study|Parents cannot assist to site|1|||
33420600|NCT04508621|101431534|FG000|Overall Study|Lack of Efficacy|2|||
33138662|NCT00796445|100423780|FG000|Overall Study|Protocol Violation|5|||
33577139|NCT03443687|102003264|FG001|Overall Study|Withdrawal by Subject|0|||
33138663|NCT00796445|100423781|FG001|Overall Study|Protocol Violation|3|||
33138664|NCT00796445|100423780|FG000|Overall Study|Adverse event, serious fatal|10|||
33369000|NCT02677896|101234954|FG001|Open-Label Extension (up to 25 Months)|Followed up for OS|18|||
33369001|NCT04967599|101236526|FG000|Overall Study|Lost to Follow-up|35|||
33138665|NCT00796445|100423781|FG001|Overall Study|Adverse event, serious fatal|5|||
33369002|NCT04967599|101236527|FG001|Overall Study|Lost to Follow-up|19|||
33369003|NCT04967599|101236528|FG002|Overall Study|Lost to Follow-up|23|||
33138666|NCT00796445|100423780|FG000|Overall Study|Adverse event, non-fatal|4|||
33138667|NCT00796445|100423781|FG001|Overall Study|Adverse event, non-fatal|0|||
33138668|NCT00796445|100423780|FG000|Overall Study|Disease progression/recurrence|537|||
33138669|NCT00796445|100423781|FG001|Overall Study|Disease progression/recurrence|268|||
33369004|NCT05319600|101236531|FG000|Overall Study|Withdrawal by Subject|1|||
33369005|NCT05319600|101236532|FG001|Overall Study|Withdrawal by Subject|0|||
33369006|NCT05319600|101236531|FG000|Overall Study|Lost to Follow-up|0|||
33369007|NCT05319600|101236532|FG001|Overall Study|Lost to Follow-up|4|||
33369008|NCT04549168|101236535|FG000|Randomization Phase|Adverse Event|0|||
33577140|NCT03443687|102003263|FG000|Overall Study|Discontinued intervention|1|||
33577141|NCT03443687|102003264|FG001|Overall Study|Discontinued intervention|1|||
33138670|NCT00796445|100423780|FG000|Overall Study|Other|10|||
33138671|NCT00796445|100423781|FG001|Overall Study|Other|7|||
33235480|NCT01702428|100764840|FG003|Overall Study|Parents cannot assist to site|0|||
33235481|NCT01702428|100764837|FG000|Overall Study|Lost Coverage|0|||
33235482|NCT01702428|100764838|FG001|Overall Study|Lost Coverage|0|||
33235483|NCT01702428|100764839|FG002|Overall Study|Lost Coverage|0|||
33235484|NCT01702428|100764840|FG003|Overall Study|Lost Coverage|1|||
33235485|NCT01702428|100764837|FG000|Overall Study|Lost Health Plan|3|||
33235486|NCT01702428|100764838|FG001|Overall Study|Lost Health Plan|5|||
33138672|NCT00796445|100423780|FG000|Overall Study|Withdrawal by Subject|18|||
33235487|NCT01702428|100764839|FG002|Overall Study|Lost Health Plan|0|||
33235488|NCT01702428|100764840|FG003|Overall Study|Lost Health Plan|2|||
33235489|NCT01702428|100764837|FG000|Overall Study|Mother transferred care|0|||
33235490|NCT01702428|100764838|FG001|Overall Study|Mother transferred care|1|||
33235491|NCT01702428|100764839|FG002|Overall Study|Mother transferred care|0|||
33235492|NCT01702428|100764840|FG003|Overall Study|Mother transferred care|0|||
33235493|NCT01702428|100764837|FG000|Overall Study|Parents too busy|1|||
33235494|NCT01702428|100764838|FG001|Overall Study|Parents too busy|0|||
33235495|NCT01702428|100764839|FG002|Overall Study|Parents too busy|0|||
33235496|NCT01702428|100764840|FG003|Overall Study|Parents too busy|0|||
33235497|NCT01702428|100764837|FG000|Overall Study|Protocol Violation|3|||
33235498|NCT01702428|100764838|FG001|Overall Study|Protocol Violation|0|||
33369009|NCT04549168|101236536|FG001|Randomization Phase|Adverse Event|0|||
33369010|NCT04549168|101236537|FG002|Randomization Phase|Adverse Event|1|||
33577142|NCT01446874|102003265|FG000|Overall Study|Not eligible|1|||
33577143|NCT01446874|102003266|FG001|Overall Study|Not eligible|0|||
33577144|NCT01446874|102003267|FG002|Overall Study|Not eligible|0|||
33577145|NCT01446874|102003265|FG000|Overall Study|No surgery/No qualifying surgery|1|||
33577146|NCT01446874|102003266|FG001|Overall Study|No surgery/No qualifying surgery|0|||
33577147|NCT01446874|102003267|FG002|Overall Study|No surgery/No qualifying surgery|12|||
33577148|NCT01446874|102003265|FG000|Overall Study|Non-compliance|0|||
33577149|NCT01446874|102003266|FG001|Overall Study|Non-compliance|4|||
33577150|NCT01446874|102003267|FG002|Overall Study|Non-compliance|0|||
33577151|NCT01446874|102003265|FG000|Overall Study|Antibiotics for pre-op infection|0|||
33577152|NCT01446874|102003266|FG001|Overall Study|Antibiotics for pre-op infection|0|||
33577153|NCT01446874|102003267|FG002|Overall Study|Antibiotics for pre-op infection|2|||
33577154|NCT01446874|102003265|FG000|Overall Study|Withdrawal by Subject|0|||
33577155|NCT01446874|102003266|FG001|Overall Study|Withdrawal by Subject|0|||
33577156|NCT01446874|102003267|FG002|Overall Study|Withdrawal by Subject|4|||
33577157|NCT00560508|102003269|FG000|12 Week Double-blind Period|Adverse Event|3|||
33577158|NCT00560508|102003270|FG001|12 Week Double-blind Period|Adverse Event|2|||
33577159|NCT00560508|102003269|FG000|12 Week Double-blind Period|Protocol Violation|1|||
33577160|NCT00560508|102003270|FG001|12 Week Double-blind Period|Protocol Violation|0|||
33577161|NCT00560508|102003269|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
33577162|NCT00560508|102003270|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
33577163|NCT00560508|102003269|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
33577164|NCT00560508|102003270|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
33577165|NCT00560508|102003269|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
33577166|NCT00560508|102003270|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
33235499|NCT01702428|100764839|FG002|Overall Study|Protocol Violation|1|||
33235500|NCT01702428|100764840|FG003|Overall Study|Protocol Violation|0|||
33369011|NCT04549168|101236535|FG000|Randomization Phase|Other|0|||
33369012|NCT04549168|101236536|FG001|Randomization Phase|Other|2|||
33577167|NCT00560508|102003269|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
33577168|NCT00560508|102003270|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
33637389|NCT00068692|102223124|FG000|Step 2: Randomization|never start protocol therapy|0|||
33235501|NCT01702428|100764837|FG000|Overall Study|Withdrawal by Subject|21|||
33235502|NCT01702428|100764838|FG001|Overall Study|Withdrawal by Subject|23|||
33369013|NCT04549168|101236537|FG002|Randomization Phase|Other|0|||
33369014|NCT04549168|101236535|FG000|Randomization Phase|Withdrawal by Subject|0|||
33420601|NCT04508621|101431535|FG001|Overall Study|Lack of Efficacy|8|||
33420602|NCT04508621|101431534|FG000|Overall Study|Physician Decision|0|||
33420603|NCT04508621|101431535|FG001|Overall Study|Physician Decision|1|||
33420604|NCT04508621|101431534|FG000|Overall Study|Withdrawal by Subject|10|||
33420605|NCT04508621|101431535|FG001|Overall Study|Withdrawal by Subject|14|||
33420606|NCT04508621|101431534|FG000|Overall Study|Lost to Follow-up|12|||
33420607|NCT04508621|101431535|FG001|Overall Study|Lost to Follow-up|9|||
33420608|NCT04508621|101431534|FG000|Overall Study|COVID-19 related crisis|3|||
33420609|NCT04508621|101431535|FG001|Overall Study|COVID-19 related crisis|0|||
33420610|NCT04508621|101431534|FG000|Overall Study|Subject non-compliance|1|||
33420611|NCT04508621|101431535|FG001|Overall Study|Subject non-compliance|0|||
33420612|NCT00734617|101431538|FG000|Overall Study|Adverse Event|4|||
33420613|NCT00734617|101431539|FG001|Overall Study|Adverse Event|7|||
33420614|NCT00734617|101431538|FG000|Overall Study|Withdrawal by Subject|103|||
33420615|NCT00734617|101431539|FG001|Overall Study|Withdrawal by Subject|95|||
33420616|NCT00975884|101431540|FG000|Overall Study|Adverse Event|1|||
33420617|NCT00975884|101431541|FG001|Overall Study|Adverse Event|0|||
33138673|NCT00796445|100423781|FG001|Overall Study|Withdrawal by Subject|9|||
33138674|NCT00796445|100423780|FG000|Overall Study|Invalid Informed Consent Form|1|||
33138675|NCT00796445|100423781|FG001|Overall Study|Invalid Informed Consent Form|0|||
33138676|NCT01328366|100423784|FG000|Overall Study|Death|1|||
33138677|NCT01328366|100423784|FG000|Overall Study|Withdrawal by Subject|2|||
33138678|NCT01328366|100423784|FG000|Overall Study|Lost to Follow-up|7|||
33138679|NCT05277337|100423787|FG000|Overall Study|Lost to Follow-up|2|||
33138680|NCT05277337|100423788|FG001|Overall Study|Lost to Follow-up|0|||
33138681|NCT05277337|100423787|FG000|Overall Study|Withdrawal by Subject|1|||
33138682|NCT05277337|100423788|FG001|Overall Study|Withdrawal by Subject|0|||
33138683|NCT00545129|100423789|FG000|Overall Study|Lack of Efficacy|2|||
33235503|NCT01702428|100764839|FG002|Overall Study|Withdrawal by Subject|14|||
33420618|NCT00975884|101431540|FG000|Overall Study|Lost to Follow-up|5|||
33420619|NCT00975884|101431541|FG001|Overall Study|Lost to Follow-up|3|||
33420620|NCT00975884|101431540|FG000|Overall Study|Withdrawal by Subject|9|||
33420621|NCT00975884|101431541|FG001|Overall Study|Withdrawal by Subject|9|||
33420622|NCT00975884|101431540|FG000|Overall Study|Other|1|||
33420623|NCT00975884|101431541|FG001|Overall Study|Other|3|||
33420624|NCT04651218|101431542|FG000|Overall Study|Withdrawal by Subject|0|||
33420625|NCT04651218|101431543|FG001|Overall Study|Withdrawal by Subject|2|||
33420626|NCT00478673|101431546|FG000|30-Days Post-Procedure|Death|2|||
33420627|NCT00478673|101431546|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
33420628|NCT00478673|101431546|FG000|30-Days Post-Procedure|Missed Visit|7|||
33420629|NCT00478673|101431546|FG000|12-Months Post-Procedure|Death|23|||
33420630|NCT00478673|101431546|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
33420631|NCT00478673|101431546|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
33420632|NCT00478673|101431546|FG000|12-Months Post-Procedure|Missed Visit|25|||
33420633|NCT00478673|101431546|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
33420634|NCT02173301|101431552|FG000|Overall Study|Adverse Event|7|||
33420635|NCT02173301|101431553|FG001|Overall Study|Adverse Event|8|||
33420636|NCT02173301|101431554|FG002|Overall Study|Adverse Event|13|||
33420637|NCT02173301|101431555|FG003|Overall Study|Adverse Event|5|||
33420638|NCT02173301|101431552|FG000|Overall Study|Withdrawal by Subject|8|||
33138684|NCT00545129|100423790|FG001|Overall Study|Lack of Efficacy|5|||
33138685|NCT00545129|100423789|FG000|Overall Study|Death|2|||
33235504|NCT01702428|100764840|FG003|Overall Study|Withdrawal by Subject|10|||
33369015|NCT04549168|101236536|FG001|Randomization Phase|Withdrawal by Subject|2|||
33369016|NCT04549168|101236537|FG002|Randomization Phase|Withdrawal by Subject|1|||
33369017|NCT04353661|101236538|FG000|Overall Study|Protocol Violation|0|||
33369018|NCT04353661|101236539|FG001|Overall Study|Protocol Violation|0|||
33369019|NCT04353661|101236540|FG002|Overall Study|Protocol Violation|1|||
33369020|NCT04353661|101236538|FG000|Overall Study|Study termination by the Sponsor|1|||
33369021|NCT04353661|101236539|FG001|Overall Study|Study termination by the Sponsor|1|||
33369022|NCT04353661|101236540|FG002|Overall Study|Study termination by the Sponsor|1|||
33235505|NCT02909101|100764851|FG000|Overall Study|Lost to Follow-up|1|||
33369023|NCT04314778|101236541|FG000|Overall Study|Lost to Follow-up|5|||
33369024|NCT04314778|101236542|FG001|Overall Study|Lost to Follow-up|3|||
33369025|NCT03692052|101236543|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
33369026|NCT03692052|101236543|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
33420639|NCT02173301|101431553|FG001|Overall Study|Withdrawal by Subject|10|||
33138686|NCT00545129|100423790|FG001|Overall Study|Death|1|||
33420640|NCT02173301|101431554|FG002|Overall Study|Withdrawal by Subject|4|||
33420641|NCT02173301|101431555|FG003|Overall Study|Withdrawal by Subject|8|||
33420642|NCT02173301|101431552|FG000|Overall Study|Lost to Follow-up|4|||
33420643|NCT02173301|101431553|FG001|Overall Study|Lost to Follow-up|4|||
33420644|NCT02173301|101431554|FG002|Overall Study|Lost to Follow-up|2|||
33138687|NCT00545129|100423789|FG000|Overall Study|Adverse Event|1|||
33420645|NCT02173301|101431555|FG003|Overall Study|Lost to Follow-up|2|||
33420646|NCT02173301|101431552|FG000|Overall Study|Protocol Violation|0|||
33420647|NCT02173301|101431553|FG001|Overall Study|Protocol Violation|1|||
33420648|NCT02173301|101431554|FG002|Overall Study|Protocol Violation|0|||
33420649|NCT02173301|101431555|FG003|Overall Study|Protocol Violation|0|||
33420650|NCT02173301|101431552|FG000|Overall Study|Physician Decision|0|||
33420651|NCT02173301|101431553|FG001|Overall Study|Physician Decision|0|||
33637390|NCT00068692|102223125|FG001|Step 2: Randomization|never start protocol therapy|0|||
33637391|NCT00068692|102223126|FG002|Step 2: Randomization|never start protocol therapy|1|||
33637392|NCT00068692|102223127|FG003|Step 2: Randomization|never start protocol therapy|0|||
33637393|NCT00068692|102223128|FG004|Step 2: Randomization|never start protocol therapy|1|||
33637394|NCT00068692|102223129|FG005|Step 2: Randomization|never start protocol therapy|0|||
33637395|NCT00068692|102223130|FG006|Step 2: Randomization|never start protocol therapy|0|||
33637396|NCT00068692|102223131|FG007|Step 2: Randomization|never start protocol therapy|0|||
33637397|NCT01704599|102223132|FG000|Overall Study|Adverse Event|1|||
33235506|NCT02909101|100764852|FG001|Overall Study|Lost to Follow-up|1|||
33235507|NCT01811563|100764853|FG000|Overall Study|Lost to Follow-up|5|||
33235508|NCT01811563|100764854|FG001|Overall Study|Lost to Follow-up|2|||
33235509|NCT01811563|100764853|FG000|Overall Study|Incorrect Randomization procedure|0|||
33235510|NCT01811563|100764854|FG001|Overall Study|Incorrect Randomization procedure|1|||
33235511|NCT02234310|100764855|FG000|Overall Study|Physician Decision|1|||
33235512|NCT02234310|100764855|FG000|Overall Study|Adverse Event|1|||
33235513|NCT02234310|100764855|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
33235514|NCT02234310|100764855|FG000|Overall Study|Withdrawal by Subject|2|||
33235515|NCT02391038|100764858|FG000|Overall Study|Progressive disease|3|||
33235516|NCT02391038|100764859|FG001|Overall Study|Progressive disease|3|||
33235517|NCT02391038|100764860|FG002|Overall Study|Progressive disease|6|||
33235518|NCT02163447|100764861|FG000|Overall Study|Withdrawal by Subject|2|||
33235519|NCT02163447|100764862|FG001|Overall Study|Withdrawal by Subject|0|||
33235520|NCT02163447|100764863|FG002|Overall Study|Withdrawal by Subject|1|||
33235521|NCT02163447|100764861|FG000|Overall Study|Lost to Follow-up|1|||
33235522|NCT02163447|100764862|FG001|Overall Study|Lost to Follow-up|3|||
33235523|NCT02163447|100764863|FG002|Overall Study|Lost to Follow-up|0|||
33235524|NCT02163447|100764861|FG000|Overall Study|Moved out of study area|2|||
33235525|NCT02163447|100764862|FG001|Overall Study|Moved out of study area|3|||
33235526|NCT02163447|100764863|FG002|Overall Study|Moved out of study area|2|||
33235527|NCT02163447|100764861|FG000|Overall Study|Became HIV infected at time of delivery|1|||
33235528|NCT02163447|100764862|FG001|Overall Study|Became HIV infected at time of delivery|0|||
33235529|NCT02163447|100764863|FG002|Overall Study|Became HIV infected at time of delivery|0|||
33235530|NCT02189863|100764864|FG000|First 2 Weeks|Motion Sickness|4|||
33235531|NCT02189863|100764865|FG001|First 2 Weeks|Motion Sickness|2|||
33235532|NCT01221181|100764875|FG000|Overall Study|Lost to Follow-up|1|||
33235533|NCT03293485|100764876|FG000|Overall Study|Death|1|||
33235534|NCT03293485|100764876|FG000|Overall Study|Screen Failure|2|||
33235535|NCT03293485|100764876|FG000|Overall Study|Withdrawal by Subject|2|||
33420652|NCT02173301|101431554|FG002|Overall Study|Physician Decision|1|||
33420653|NCT02173301|101431555|FG003|Overall Study|Physician Decision|0|||
33420654|NCT02173301|101431552|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
33577169|NCT00560508|102003269|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
33577170|NCT00560508|102003270|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
33577171|NCT02271529|102003271|FG000|Overall Study|Withdrawal by Subject|1|||
33577172|NCT02712996|102003272|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
33577173|NCT02712996|102003273|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
33577174|NCT03289143|102003274|FG000|Overall Study|Caregiver Unavailability|1|||
33577175|NCT03289143|102003275|FG001|Overall Study|Caregiver Unavailability|1|||
33577176|NCT03289143|102003276|FG002|Overall Study|Caregiver Unavailability|0|||
33577177|NCT03289143|102003277|FG003|Overall Study|Caregiver Unavailability|0|||
33577178|NCT03289143|102003274|FG000|Overall Study|Research Department Closure|0|||
33577179|NCT03289143|102003275|FG001|Overall Study|Research Department Closure|0|||
33577180|NCT03289143|102003276|FG002|Overall Study|Research Department Closure|1|||
33577181|NCT03289143|102003277|FG003|Overall Study|Research Department Closure|0|||
33577182|NCT03289143|102003274|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
33577183|NCT03289143|102003275|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
33577184|NCT03289143|102003276|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
33577185|NCT03289143|102003277|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
33577186|NCT03289143|102003274|FG000|Overall Study|Medical Monitor Decision|1|||
33577187|NCT03289143|102003275|FG001|Overall Study|Medical Monitor Decision|0|||
33637398|NCT02863419|102223133|FG000|Overall Study|Lost to Follow-up|0|||
33235536|NCT00003509|100764881|FG000|Overall Study|Not evaluable|5|||
33235537|NCT00507026|100764882|FG000|Overall Study|Lack of Efficacy|6|||
33577188|NCT03289143|102003276|FG002|Overall Study|Medical Monitor Decision|0|||
33138688|NCT00545129|100423790|FG001|Overall Study|Adverse Event|1|||
33235538|NCT00507026|100764883|FG001|Overall Study|Lack of Efficacy|4|||
33235539|NCT00507026|100764884|FG002|Overall Study|Lack of Efficacy|21|||
33577189|NCT03289143|102003277|FG003|Overall Study|Medical Monitor Decision|0|||
33420655|NCT02173301|101431553|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
33235540|NCT00507026|100764882|FG000|Overall Study|Withdrawal by Subject|2|||
33235541|NCT00507026|100764883|FG001|Overall Study|Withdrawal by Subject|0|||
33235542|NCT00507026|100764884|FG002|Overall Study|Withdrawal by Subject|0|||
33235543|NCT00507026|100764882|FG000|Overall Study|Investigator Decision|1|||
33235544|NCT00507026|100764883|FG001|Overall Study|Investigator Decision|0|||
33235545|NCT00507026|100764884|FG002|Overall Study|Investigator Decision|0|||
33235546|NCT00507026|100764882|FG000|Overall Study|Adverse Event|2|||
33235547|NCT00507026|100764883|FG001|Overall Study|Adverse Event|0|||
33235548|NCT00507026|100764884|FG002|Overall Study|Adverse Event|0|||
33235549|NCT00507026|100764882|FG000|Overall Study|Protocol Violation|1|||
33235550|NCT00507026|100764883|FG001|Overall Study|Protocol Violation|0|||
33235551|NCT00507026|100764884|FG002|Overall Study|Protocol Violation|0|||
33235552|NCT00507026|100764882|FG000|Overall Study|Other|1|||
33235553|NCT00507026|100764883|FG001|Overall Study|Other|0|||
33235554|NCT00507026|100764884|FG002|Overall Study|Other|0|||
33235555|NCT03095599|100764888|FG000|Overall Study|Withdrawal by Subject|1|||
33235556|NCT03095599|100764889|FG001|Overall Study|Withdrawal by Subject|0|||
33235557|NCT03095599|100764888|FG000|Overall Study|Lost to Follow-up|1|||
33235558|NCT03095599|100764889|FG001|Overall Study|Lost to Follow-up|0|||
33235559|NCT03095599|100764888|FG000|Overall Study|Withdrawal prior to vaccination|1|||
33235560|NCT03095599|100764889|FG001|Overall Study|Withdrawal prior to vaccination|0|||
33235561|NCT01567163|100764890|FG000|Overall Study|Progressive Disease|2|||
33235562|NCT01567163|100764890|FG000|Overall Study|Lost to Follow-up|2|||
33235563|NCT00131911|100764891|FG000|Overall Study|Withdrawal by Subject|1|||
33577190|NCT03289143|102003274|FG000|Overall Study|Participant Non-Compliance|0|||
33577191|NCT03289143|102003275|FG001|Overall Study|Participant Non-Compliance|0|||
33577192|NCT03289143|102003276|FG002|Overall Study|Participant Non-Compliance|1|||
33577193|NCT03289143|102003277|FG003|Overall Study|Participant Non-Compliance|0|||
33235564|NCT00131911|100764892|FG001|Overall Study|Withdrawal by Subject|0|||
33235565|NCT00663117|100764895|FG000|Overall Study|Lack of Efficacy|1|||
33235566|NCT00663117|100764896|FG001|Overall Study|Lack of Efficacy|0|||
33235567|NCT02577835|100764897|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
33235568|NCT04102540|100764898|FG000|Overall Study|Withdrawn by PI|2|||
33235569|NCT04102540|100764898|FG000|Overall Study|Lost to Follow-up|6|||
33235570|NCT01708187|100764899|FG000|Overall Study|Lost to Follow-up|0|||
33235571|NCT01708187|100764900|FG001|Overall Study|Lost to Follow-up|1|||
33235572|NCT01734382|100764903|FG000|Part 1|Adverse Event|2|||
33235573|NCT01734382|100764904|FG001|Part 1|Adverse Event|0|||
33235574|NCT01734382|100764905|FG002|Part 1|Adverse Event|0|||
33235575|NCT01734382|100764903|FG000|Part 2|Adverse Event|0|||
33235576|NCT01734382|100764904|FG001|Part 2|Adverse Event|0|||
33235577|NCT01734382|100764905|FG002|Part 2|Adverse Event|1|||
33235578|NCT01734382|100764903|FG000|Part 2|Lack of Efficacy|0|||
33235579|NCT01734382|100764904|FG001|Part 2|Lack of Efficacy|1|||
33235580|NCT01734382|100764905|FG002|Part 2|Lack of Efficacy|1|||
33235581|NCT01734382|100764903|FG000|Part 2|Other|0|||
33235582|NCT01734382|100764904|FG001|Part 2|Other|0|||
33235583|NCT01734382|100764905|FG002|Part 2|Other|1|||
33235584|NCT01734382|100764903|FG000|Part 2|Physician Decision|0|||
33235585|NCT01734382|100764904|FG001|Part 2|Physician Decision|0|||
33235586|NCT01734382|100764905|FG002|Part 2|Physician Decision|3|||
33235587|NCT01734382|100764903|FG000|Part 2|Protocol Violation|0|||
33235588|NCT01734382|100764904|FG001|Part 2|Protocol Violation|1|||
33235589|NCT01734382|100764905|FG002|Part 2|Protocol Violation|0|||
33235590|NCT01734382|100764903|FG000|Part 2|Withdrawal by Subject|0|||
33235591|NCT01734382|100764904|FG001|Part 2|Withdrawal by Subject|0|||
33235592|NCT01734382|100764905|FG002|Part 2|Withdrawal by Subject|1|||
33235593|NCT04421378|100764914|FG000|Overall Study|Adverse Event|2|||
33577194|NCT03289143|102003274|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
33577195|NCT03289143|102003275|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
33577196|NCT03289143|102003276|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
33577197|NCT03289143|102003277|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
33577198|NCT03289143|102003274|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
33577199|NCT03289143|102003275|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
33577200|NCT03289143|102003276|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
33637399|NCT02863419|102223134|FG001|Overall Study|Lost to Follow-up|1|||
33235594|NCT04421378|100764915|FG001|Overall Study|Adverse Event|7|||
33235595|NCT04421378|100764916|FG002|Overall Study|Adverse Event|0|||
33235596|NCT04421378|100764917|FG003|Overall Study|Adverse Event|1|||
33235597|NCT04421378|100764918|FG004|Overall Study|Adverse Event|0|||
33235598|NCT04421378|100764914|FG000|Overall Study|Physician Decision|1|||
33235599|NCT04421378|100764915|FG001|Overall Study|Physician Decision|2|||
33235600|NCT04421378|100764916|FG002|Overall Study|Physician Decision|0|||
33235601|NCT04421378|100764917|FG003|Overall Study|Physician Decision|0|||
33235602|NCT04421378|100764918|FG004|Overall Study|Physician Decision|0|||
33235603|NCT04421378|100764914|FG000|Overall Study|Progressive Disease|16|||
33235604|NCT04421378|100764915|FG001|Overall Study|Progressive Disease|4|||
33235605|NCT04421378|100764916|FG002|Overall Study|Progressive Disease|18|||
33235606|NCT04421378|100764917|FG003|Overall Study|Progressive Disease|11|||
33235607|NCT04421378|100764918|FG004|Overall Study|Progressive Disease|3|||
33235608|NCT04421378|100764914|FG000|Overall Study|Study Terminated by Sponsor|0|||
33235609|NCT04421378|100764915|FG001|Overall Study|Study Terminated by Sponsor|1|||
33235610|NCT04421378|100764916|FG002|Overall Study|Study Terminated by Sponsor|1|||
33235611|NCT04421378|100764917|FG003|Overall Study|Study Terminated by Sponsor|0|||
33235612|NCT04421378|100764918|FG004|Overall Study|Study Terminated by Sponsor|0|||
33235613|NCT04421378|100764914|FG000|Overall Study|Withdrawal by Subject|3|||
33235614|NCT04421378|100764915|FG001|Overall Study|Withdrawal by Subject|1|||
33235615|NCT04421378|100764916|FG002|Overall Study|Withdrawal by Subject|0|||
33235616|NCT04421378|100764917|FG003|Overall Study|Withdrawal by Subject|2|||
33235617|NCT04421378|100764918|FG004|Overall Study|Withdrawal by Subject|0|||
33235618|NCT04421378|100764914|FG000|Overall Study|Other|1|||
33235619|NCT04421378|100764915|FG001|Overall Study|Other|0|||
33235620|NCT04421378|100764916|FG002|Overall Study|Other|0|||
33235621|NCT04421378|100764917|FG003|Overall Study|Other|0|||
33577201|NCT03289143|102003277|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
33577202|NCT03289143|102003274|FG000|Overall Study|Caregiver Passed Away|1|||
33577203|NCT03289143|102003275|FG001|Overall Study|Caregiver Passed Away|0|||
33577204|NCT03289143|102003276|FG002|Overall Study|Caregiver Passed Away|0|||
33577205|NCT03289143|102003277|FG003|Overall Study|Caregiver Passed Away|0|||
33577206|NCT03289143|102003274|FG000|Overall Study|Physician Decision|0|||
33577207|NCT03289143|102003275|FG001|Overall Study|Physician Decision|2|||
33577208|NCT03289143|102003276|FG002|Overall Study|Physician Decision|2|||
33577209|NCT03289143|102003277|FG003|Overall Study|Physician Decision|2|||
33577210|NCT03289143|102003274|FG000|Overall Study|Protocol Deviation|2|||
33577211|NCT03289143|102003275|FG001|Overall Study|Protocol Deviation|1|||
33577212|NCT03289143|102003276|FG002|Overall Study|Protocol Deviation|3|||
33235622|NCT04421378|100764918|FG004|Overall Study|Other|0|||
33235623|NCT00219141|100764919|FG000|Overall Study|Adverse Event|4|||
33235624|NCT00219141|100764920|FG001|Overall Study|Adverse Event|10|||
33235625|NCT00219141|100764921|FG002|Overall Study|Adverse Event|5|||
33235626|NCT00219141|100764919|FG000|Overall Study|Lack of Efficacy|3|||
33235627|NCT00219141|100764920|FG001|Overall Study|Lack of Efficacy|2|||
33235628|NCT00219141|100764921|FG002|Overall Study|Lack of Efficacy|0|||
33235629|NCT00219141|100764919|FG000|Overall Study|Administrative problems|0|||
33235630|NCT00219141|100764920|FG001|Overall Study|Administrative problems|1|||
33235631|NCT00219141|100764921|FG002|Overall Study|Administrative problems|0|||
33235632|NCT00219141|100764919|FG000|Overall Study|Lost to Follow-up|2|||
33235633|NCT00219141|100764920|FG001|Overall Study|Lost to Follow-up|4|||
33235634|NCT00219141|100764921|FG002|Overall Study|Lost to Follow-up|1|||
33235635|NCT00219141|100764919|FG000|Overall Study|Protocol Violation|3|||
33235636|NCT00219141|100764920|FG001|Overall Study|Protocol Violation|1|||
33235637|NCT00219141|100764921|FG002|Overall Study|Protocol Violation|1|||
33235638|NCT00219141|100764919|FG000|Overall Study|Withdrawal by Subject|1|||
33235639|NCT00219141|100764920|FG001|Overall Study|Withdrawal by Subject|3|||
33235640|NCT00219141|100764921|FG002|Overall Study|Withdrawal by Subject|5|||
33235641|NCT00219141|100764919|FG000|Overall Study|Condition no longer requires study drug|1|||
33235642|NCT00219141|100764920|FG001|Overall Study|Condition no longer requires study drug|0|||
33235643|NCT00219141|100764921|FG002|Overall Study|Condition no longer requires study drug|0|||
33235644|NCT01007552|100764922|FG000|Overall Study|Withdrawal by Subject|1|||
33577213|NCT03289143|102003277|FG003|Overall Study|Protocol Deviation|1|||
33577214|NCT03289143|102003274|FG000|Overall Study|Study Terminated By Sponsor|101|||
33577215|NCT03289143|102003275|FG001|Overall Study|Study Terminated By Sponsor|75|||
33577216|NCT03289143|102003276|FG002|Overall Study|Study Terminated By Sponsor|100|||
33577217|NCT03289143|102003277|FG003|Overall Study|Study Terminated By Sponsor|69|||
33577218|NCT03289143|102003274|FG000|Overall Study|Withdrawal by Subject|14|||
33577219|NCT03289143|102003275|FG001|Overall Study|Withdrawal by Subject|6|||
33577220|NCT03289143|102003276|FG002|Overall Study|Withdrawal by Subject|14|||
33577221|NCT03289143|102003277|FG003|Overall Study|Withdrawal by Subject|12|||
33577222|NCT03289143|102003274|FG000|Overall Study|Adverse Event|10|||
33637400|NCT02863419|102223135|FG002|Overall Study|Lost to Follow-up|4|||
33235645|NCT02487446|100764923|FG000|Period 1|Physician Decision|0|||
33235646|NCT02487446|100764924|FG001|Period 1|Physician Decision|1|||
33235647|NCT02487446|100764923|FG000|Period 1|Lack of Efficacy|1|||
33235648|NCT02487446|100764924|FG001|Period 1|Lack of Efficacy|0|||
33235649|NCT02487446|100764923|FG000|Period 1|Protocol deviation|3|||
33235650|NCT02487446|100764924|FG001|Period 1|Protocol deviation|2|||
33235651|NCT02487446|100764923|FG000|Period 1|Lost to Follow-up|2|||
33369027|NCT03692052|101236543|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
33369028|NCT03692052|101236543|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
33369029|NCT01897441|101236554|FG000|Overall Study|Lost to Follow-up|0|||
33369030|NCT01897441|101236555|FG001|Overall Study|Lost to Follow-up|0|||
33235652|NCT02487446|100764924|FG001|Period 1|Lost to Follow-up|0|||
33235653|NCT02487446|100764923|FG000|Period 1|Withdrawal by Subject|2|||
33489719|NCT02899962|101686773|FG001|Open-label Phase|Lost to Follow-up|0|||
33577223|NCT03289143|102003275|FG001|Overall Study|Adverse Event|7|||
33577224|NCT03289143|102003276|FG002|Overall Study|Adverse Event|6|||
33577225|NCT03289143|102003277|FG003|Overall Study|Adverse Event|5|||
33235654|NCT02487446|100764924|FG001|Period 1|Withdrawal by Subject|0|||
33235655|NCT02487446|100764923|FG000|Period 1|Adverse Event|5|||
33235656|NCT02487446|100764924|FG001|Period 1|Adverse Event|5|||
33235657|NCT02487446|100764923|FG000|Washout|Lost to Follow-up|0|||
33235658|NCT02487446|100764924|FG001|Washout|Lost to Follow-up|2|||
33235659|NCT02487446|100764923|FG000|Washout|Withdrawal by Subject|1|||
33235660|NCT02487446|100764924|FG001|Washout|Withdrawal by Subject|4|||
33235661|NCT02487446|100764923|FG000|Washout|Adverse Event|2|||
33235662|NCT02487446|100764924|FG001|Washout|Adverse Event|2|||
33235663|NCT02487446|100764923|FG000|Period 2|Protocol deviation|0|||
33235664|NCT02487446|100764924|FG001|Period 2|Protocol deviation|1|||
33235665|NCT02487446|100764923|FG000|Period 2|Lost to Follow-up|1|||
33235666|NCT02487446|100764924|FG001|Period 2|Lost to Follow-up|1|||
33235667|NCT02487446|100764923|FG000|Period 2|Withdrawal by Subject|1|||
33235668|NCT02487446|100764924|FG001|Period 2|Withdrawal by Subject|1|||
33235669|NCT02487446|100764923|FG000|Period 2|Adverse Event|6|||
33235670|NCT02487446|100764924|FG001|Period 2|Adverse Event|2|||
33235671|NCT00725010|100764927|FG000|Overall Study|Toxicity|9|||
33235672|NCT00725010|100764927|FG000|Overall Study|Tumor Progression|7|||
33235673|NCT00725010|100764927|FG000|Overall Study|Withdrawal by Subject|2|||
33235674|NCT00725010|100764927|FG000|Overall Study|Death|1|||
33235675|NCT00725010|100764927|FG000|Overall Study|Lost to Follow-up|1|||
33235676|NCT00725010|100764927|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
33235677|NCT00725010|100764927|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
33235678|NCT00725010|100764927|FG000|Overall Study|No further documentation|1|||
33235679|NCT00725010|100764927|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
33235680|NCT00918749|100764929|FG000|Overall Study|Adverse Event|1|||
33235681|NCT00918749|100764930|FG001|Overall Study|Adverse Event|0|||
33235682|NCT00918749|100764931|FG002|Overall Study|Adverse Event|1|||
33235683|NCT00918749|100764929|FG000|Overall Study|Lost to Follow-up|0|||
33235684|NCT00918749|100764930|FG001|Overall Study|Lost to Follow-up|0|||
33235685|NCT00918749|100764931|FG002|Overall Study|Lost to Follow-up|1|||
33235686|NCT00918749|100764929|FG000|Overall Study|Withdrawal by Subject|5|||
33235687|NCT00918749|100764930|FG001|Overall Study|Withdrawal by Subject|3|||
33235688|NCT00918749|100764931|FG002|Overall Study|Withdrawal by Subject|5|||
33235689|NCT00918749|100764929|FG000|Overall Study|No Study Medication Taken|1|||
33235690|NCT00918749|100764930|FG001|Overall Study|No Study Medication Taken|0|||
33235691|NCT00918749|100764931|FG002|Overall Study|No Study Medication Taken|0|||
33235692|NCT03029780|100764932|FG000|Overall Study|Disease Progression|20|||
33235693|NCT03029780|100764933|FG001|Overall Study|Disease Progression|22|||
33235694|NCT03029780|100764932|FG000|Overall Study|Study Drug Toxicity|15|||
33235695|NCT03029780|100764933|FG001|Overall Study|Study Drug Toxicity|11|||
33235696|NCT03029780|100764932|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
33235697|NCT03029780|100764933|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
33235698|NCT03029780|100764932|FG000|Overall Study|Participant request to discontinue study treatment|4|||
33235699|NCT03029780|100764933|FG001|Overall Study|Participant request to discontinue study treatment|1|||
33235700|NCT03029780|100764932|FG000|Overall Study|Maximum clinical benefit|1|||
33235701|NCT03029780|100764933|FG001|Overall Study|Maximum clinical benefit|0|||
33235702|NCT03029780|100764932|FG000|Overall Study|Participant no longer meets study criteria|0|||
33235703|NCT03029780|100764933|FG001|Overall Study|Participant no longer meets study criteria|1|||
33235704|NCT03029780|100764932|FG000|Overall Study|Other reasons|6|||
33235705|NCT03029780|100764933|FG001|Overall Study|Other reasons|6|||
33235706|NCT03029780|100764932|FG000|Overall Study|Not reported|1|||
33235707|NCT03029780|100764933|FG001|Overall Study|Not reported|1|||
33235708|NCT03029780|100764932|FG000|Overall Study|Death|2|||
33235709|NCT03029780|100764933|FG001|Overall Study|Death|6|||
33235710|NCT00900627|100764943|FG000|Overall Study|Condition under investigation worsened|4|||
33235711|NCT00900627|100764944|FG001|Overall Study|Condition under investigation worsened|0|||
33235712|NCT00900627|100764945|FG002|Overall Study|Condition under investigation worsened|5|||
33235713|NCT00900627|100764946|FG003|Overall Study|Condition under investigation worsened|3|||
33235714|NCT00900627|100764947|FG004|Overall Study|Condition under investigation worsened|0|||
33235715|NCT00900627|100764948|FG005|Overall Study|Condition under investigation worsened|0|||
33235716|NCT00900627|100764943|FG000|Overall Study|Withdrawal by Subject|1|||
33235717|NCT00900627|100764944|FG001|Overall Study|Withdrawal by Subject|0|||
33235718|NCT00900627|100764945|FG002|Overall Study|Withdrawal by Subject|1|||
33235719|NCT00900627|100764946|FG003|Overall Study|Withdrawal by Subject|0|||
33235720|NCT00900627|100764947|FG004|Overall Study|Withdrawal by Subject|1|||
33235721|NCT00900627|100764948|FG005|Overall Study|Withdrawal by Subject|2|||
33235722|NCT00900627|100764943|FG000|Overall Study|Adverse Event|1|||
33235723|NCT00900627|100764944|FG001|Overall Study|Adverse Event|2|||
33235724|NCT00900627|100764945|FG002|Overall Study|Adverse Event|0|||
33235725|NCT00900627|100764946|FG003|Overall Study|Adverse Event|3|||
33235726|NCT00900627|100764947|FG004|Overall Study|Adverse Event|0|||
33235727|NCT00900627|100764948|FG005|Overall Study|Adverse Event|0|||
33235728|NCT00900627|100764943|FG000|Overall Study|Death|0|||
33235729|NCT00900627|100764944|FG001|Overall Study|Death|0|||
33235730|NCT00900627|100764945|FG002|Overall Study|Death|0|||
33235731|NCT00900627|100764946|FG003|Overall Study|Death|0|||
33235732|NCT00900627|100764947|FG004|Overall Study|Death|28|||
33235733|NCT00900627|100764948|FG005|Overall Study|Death|24|||
33235734|NCT04707391|100764949|FG000|Overall Study|Adverse Event|5|||
33235735|NCT04707391|100764950|FG001|Overall Study|Adverse Event|8|||
33235736|NCT04707391|100764949|FG000|Overall Study|Lost to Follow-up|44|||
33235737|NCT04707391|100764950|FG001|Overall Study|Lost to Follow-up|31|||
33235738|NCT04707391|100764949|FG000|Overall Study|Protocol Violation|1|||
33235739|NCT04707391|100764950|FG001|Overall Study|Protocol Violation|5|||
33235740|NCT04707391|100764949|FG000|Overall Study|Withdrawal by Subject|27|||
33235741|NCT04707391|100764950|FG001|Overall Study|Withdrawal by Subject|25|||
33235742|NCT04707391|100764949|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
33235743|NCT04707391|100764950|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
33235744|NCT04707391|100764949|FG000|Overall Study|Other|0|||
33235745|NCT04707391|100764950|FG001|Overall Study|Other|2|||
33235746|NCT00598481|100764953|FG000|Treatment|Physician Decision|1|||
33235747|NCT02206152|100764955|FG000|Pre-Randomization|Withdrawal by Subject|2|||
33235748|NCT00322374|100764956|FG000|Starting Dose|Physician Decision|2|||
33235749|NCT00322374|100764957|FG001|Starting Dose|Physician Decision|0|||
33235750|NCT00322374|100764958|FG002|Starting Dose|Physician Decision|0|||
33235751|NCT00322374|100764959|FG003|Starting Dose|Physician Decision|0|||
33235752|NCT00322374|100764956|FG000|Starting Dose|Study Drug Toxicity|4|||
33235753|NCT00322374|100764957|FG001|Starting Dose|Study Drug Toxicity|0|||
33235754|NCT00322374|100764958|FG002|Starting Dose|Study Drug Toxicity|0|||
33235755|NCT00322374|100764959|FG003|Starting Dose|Study Drug Toxicity|0|||
33235756|NCT00322374|100764956|FG000|First Escalation|Documented Disease Progression|0|||
33235757|NCT00322374|100764957|FG001|First Escalation|Documented Disease Progression|6|||
33235758|NCT00322374|100764958|FG002|First Escalation|Documented Disease Progression|0|||
33235759|NCT00322374|100764959|FG003|First Escalation|Documented Disease Progression|0|||
33235760|NCT00322374|100764956|FG000|First Escalation|Physician Decision|0|||
33235761|NCT00322374|100764957|FG001|First Escalation|Physician Decision|12|||
33235762|NCT00322374|100764958|FG002|First Escalation|Physician Decision|0|||
33235763|NCT00322374|100764959|FG003|First Escalation|Physician Decision|0|||
33235764|NCT00322374|100764956|FG000|First Escalation|Study Drug Toxicity|0|||
33235765|NCT00322374|100764957|FG001|First Escalation|Study Drug Toxicity|11|||
33235766|NCT00322374|100764958|FG002|First Escalation|Study Drug Toxicity|0|||
33235767|NCT00322374|100764959|FG003|First Escalation|Study Drug Toxicity|0|||
33235768|NCT00322374|100764956|FG000|First Escalation|Participant Request|0|||
33235769|NCT00322374|100764957|FG001|First Escalation|Participant Request|1|||
33235770|NCT00322374|100764958|FG002|First Escalation|Participant Request|0|||
33235771|NCT00322374|100764959|FG003|First Escalation|Participant Request|0|||
33235772|NCT00322374|100764956|FG000|Second Escalation|Physician Decision|0|||
33235773|NCT00322374|100764957|FG001|Second Escalation|Physician Decision|0|||
33235774|NCT00322374|100764958|FG002|Second Escalation|Physician Decision|5|||
33235775|NCT00322374|100764959|FG003|Second Escalation|Physician Decision|0|||
33235776|NCT00322374|100764956|FG000|Second Escalation|Study Drug Toxicity|0|||
33235777|NCT00322374|100764957|FG001|Second Escalation|Study Drug Toxicity|0|||
33235778|NCT00322374|100764958|FG002|Second Escalation|Study Drug Toxicity|1|||
33235779|NCT00322374|100764959|FG003|Second Escalation|Study Drug Toxicity|0|||
33235780|NCT04537949|100764960|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
33235781|NCT04537949|100764961|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
33235782|NCT04537949|100764962|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
33420656|NCT02173301|101431554|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
33420657|NCT02173301|101431555|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
33577226|NCT03289143|102003274|FG000|Overall Study|Death|2|||
33577227|NCT03289143|102003275|FG001|Overall Study|Death|0|||
33577228|NCT03289143|102003276|FG002|Overall Study|Death|2|||
33577229|NCT03289143|102003277|FG003|Overall Study|Death|1|||
33577230|NCT03289143|102003274|FG000|Overall Study|Lost to Follow-up|2|||
33577231|NCT03289143|102003275|FG001|Overall Study|Lost to Follow-up|1|||
33577232|NCT03289143|102003276|FG002|Overall Study|Lost to Follow-up|1|||
33577233|NCT03289143|102003277|FG003|Overall Study|Lost to Follow-up|0|||
33577234|NCT03289143|102003274|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
33235783|NCT04537949|100764963|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
33235784|NCT04537949|100764964|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
33235785|NCT04537949|100764965|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
33235786|NCT04537949|100764966|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
33235787|NCT04537949|100764967|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
33235788|NCT04537949|100764960|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
33235789|NCT04537949|100764961|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
33235790|NCT04537949|100764962|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
33235791|NCT04537949|100764963|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
33235792|NCT04537949|100764964|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
33577235|NCT03289143|102003275|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
33577236|NCT03289143|102003276|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
33577237|NCT03289143|102003277|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
33577238|NCT03289143|102003274|FG000|Overall Study|Withdrawal by Caregiver|0|||
33577239|NCT03289143|102003275|FG001|Overall Study|Withdrawal by Caregiver|1|||
33577240|NCT03289143|102003276|FG002|Overall Study|Withdrawal by Caregiver|0|||
33577241|NCT03289143|102003277|FG003|Overall Study|Withdrawal by Caregiver|0|||
33577242|NCT03289143|102003274|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
33577243|NCT03289143|102003275|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
33577244|NCT03289143|102003276|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
33577245|NCT03289143|102003277|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
33577246|NCT03289143|102003274|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
33577247|NCT03289143|102003275|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
33577248|NCT03289143|102003276|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
33577249|NCT03289143|102003277|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
33637401|NCT02863419|102223133|FG000|Overall Study|Withdrawal by Subject|5|||
33637402|NCT02863419|102223134|FG001|Overall Study|Withdrawal by Subject|5|||
33637403|NCT02863419|102223135|FG002|Overall Study|Withdrawal by Subject|3|||
33637404|NCT02863419|102223133|FG000|Overall Study|Died|3|||
33637405|NCT02863419|102223134|FG001|Overall Study|Died|4|||
33637406|NCT02863419|102223135|FG002|Overall Study|Died|1|||
33637407|NCT01281124|102223136|FG000|Overall Study|Death|1|||
33637408|NCT02079246|102223137|FG000|OLEX|Withdrawal before treatment|1|||
33235793|NCT04537949|100764965|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
33235794|NCT04537949|100764966|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
33235795|NCT04537949|100764967|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
33235796|NCT04537949|100764960|FG000|Follow-up Phase|Lost to Follow-up|0|||
33235797|NCT04537949|100764961|FG001|Follow-up Phase|Lost to Follow-up|3|||
33235798|NCT04537949|100764962|FG002|Follow-up Phase|Lost to Follow-up|0|||
33235799|NCT04537949|100764963|FG003|Follow-up Phase|Lost to Follow-up|0|||
33369031|NCT01897441|101236556|FG002|Overall Study|Lost to Follow-up|1|||
33369032|NCT01897441|101236557|FG003|Overall Study|Lost to Follow-up|0|||
33369033|NCT01897441|101236558|FG004|Overall Study|Lost to Follow-up|0|||
33369034|NCT01897441|101236559|FG005|Overall Study|Lost to Follow-up|0|||
33369035|NCT01897441|101236554|FG000|Overall Study|Withdrawal by Subject|0|||
33369036|NCT01897441|101236555|FG001|Overall Study|Withdrawal by Subject|0|||
33369037|NCT01897441|101236556|FG002|Overall Study|Withdrawal by Subject|0|||
33369038|NCT01897441|101236557|FG003|Overall Study|Withdrawal by Subject|0|||
33369039|NCT01897441|101236558|FG004|Overall Study|Withdrawal by Subject|1|||
33369040|NCT01897441|101236559|FG005|Overall Study|Withdrawal by Subject|0|||
33369041|NCT01897441|101236554|FG000|Overall Study|Withdrawn by Provider|0|||
33369042|NCT01897441|101236555|FG001|Overall Study|Withdrawn by Provider|2|||
33369043|NCT01897441|101236556|FG002|Overall Study|Withdrawn by Provider|0|||
33369044|NCT01897441|101236557|FG003|Overall Study|Withdrawn by Provider|0|||
33369045|NCT01897441|101236558|FG004|Overall Study|Withdrawn by Provider|0|||
33369046|NCT01897441|101236559|FG005|Overall Study|Withdrawn by Provider|0|||
33369047|NCT01909453|101236560|FG000|Overall Study|Ongoing|118|||
33369048|NCT01909453|101236561|FG001|Overall Study|Ongoing|103|||
33369049|NCT01909453|101236562|FG002|Overall Study|Ongoing|83|||
33369050|NCT01909453|101236563|FG003|Overall Study|Ongoing|164|||
33369051|NCT01909453|101236564|FG004|Overall Study|Ongoing|50|||
33369052|NCT01909453|101236560|FG000|Overall Study|Death|69|||
33369053|NCT01909453|101236561|FG001|Overall Study|Death|74|||
33577250|NCT00469833|102003282|FG000|Overall Study|No IV access|2|||
33138689|NCT00545129|100423789|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
33138690|NCT00545129|100423790|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
33138691|NCT00545129|100423789|FG000|Overall Study|Other|3|||
33138692|NCT00545129|100423790|FG001|Overall Study|Other|3|||
33138693|NCT00220779|100423795|FG000|Overall Study|Adverse Event|1|||
33138694|NCT00220779|100423796|FG001|Overall Study|Adverse Event|0|||
33138695|NCT00220779|100423797|FG002|Overall Study|Adverse Event|0|||
33138696|NCT00220779|100423795|FG000|Overall Study|Withdrawal by Subject|1|||
33138697|NCT00220779|100423796|FG001|Overall Study|Withdrawal by Subject|4|||
33138698|NCT00220779|100423797|FG002|Overall Study|Withdrawal by Subject|1|||
33235800|NCT04537949|100764964|FG004|Follow-up Phase|Lost to Follow-up|0|||
33577251|NCT01030822|102003283|FG000|Overall Study|Moved/migrated from study area|6|||
33637409|NCT02079246|102223138|FG001|OLEX|Withdrawal before treatment|0|||
33637410|NCT02079246|102223137|FG000|OLEX|Death|11|||
33637411|NCT02079246|102223138|FG001|OLEX|Death|0|||
33138699|NCT00220779|100423795|FG000|Overall Study|Non-compliance|1|||
33235801|NCT04537949|100764965|FG005|Follow-up Phase|Lost to Follow-up|0|||
33369054|NCT01909453|101236562|FG002|Overall Study|Death|88|||
33369055|NCT01909453|101236563|FG003|Overall Study|Death|86|||
33369056|NCT01909453|101236564|FG004|Overall Study|Death|29|||
33369057|NCT01909453|101236560|FG000|Overall Study|Lost to Follow-up|3|||
33369058|NCT01909453|101236561|FG001|Overall Study|Lost to Follow-up|4|||
33369059|NCT01909453|101236562|FG002|Overall Study|Lost to Follow-up|4|||
33369060|NCT01909453|101236563|FG003|Overall Study|Lost to Follow-up|3|||
33235802|NCT04537949|100764966|FG006|Follow-up Phase|Lost to Follow-up|0|||
33235803|NCT04537949|100764967|FG007|Follow-up Phase|Lost to Follow-up|0|||
33235804|NCT04537949|100764960|FG000|Follow-up Phase|personal reasons|0|||
33235805|NCT04537949|100764961|FG001|Follow-up Phase|personal reasons|0|||
33235806|NCT04537949|100764962|FG002|Follow-up Phase|personal reasons|0|||
33235807|NCT04537949|100764963|FG003|Follow-up Phase|personal reasons|1|||
33235808|NCT04537949|100764964|FG004|Follow-up Phase|personal reasons|1|||
33235809|NCT04537949|100764965|FG005|Follow-up Phase|personal reasons|0|||
33235810|NCT04537949|100764966|FG006|Follow-up Phase|personal reasons|0|||
33235811|NCT04537949|100764967|FG007|Follow-up Phase|personal reasons|0|||
33235812|NCT04537949|100764960|FG000|Follow-up Phase|Withdrawal by Subject|0|||
33235813|NCT04537949|100764961|FG001|Follow-up Phase|Withdrawal by Subject|0|||
33235814|NCT04537949|100764962|FG002|Follow-up Phase|Withdrawal by Subject|0|||
33235815|NCT04537949|100764963|FG003|Follow-up Phase|Withdrawal by Subject|0|||
33235816|NCT04537949|100764964|FG004|Follow-up Phase|Withdrawal by Subject|1|||
33235817|NCT04537949|100764965|FG005|Follow-up Phase|Withdrawal by Subject|0|||
33235818|NCT04537949|100764966|FG006|Follow-up Phase|Withdrawal by Subject|0|||
33235819|NCT04537949|100764967|FG007|Follow-up Phase|Withdrawal by Subject|0|||
33235820|NCT03268590|100764970|FG000|Overall Study|Previously unknown exclusion criteria|1|||
33235821|NCT02696226|100764976|FG000|Overall Study|Study terminated - lack of enrollment|1|||
33637412|NCT02079246|102223137|FG000|OLEX|Adverse Event|66|||
33637413|NCT02079246|102223138|FG001|OLEX|Adverse Event|0|||
33637414|NCT02079246|102223137|FG000|OLEX|Withdrawal by Subject|60|||
33637415|NCT02079246|102223138|FG001|OLEX|Withdrawal by Subject|0|||
33637416|NCT02079246|102223137|FG000|OLEX|Lost to Follow-up|6|||
33637417|NCT02079246|102223138|FG001|OLEX|Lost to Follow-up|0|||
33637418|NCT02079246|102223137|FG000|OLEX|Protocol Violation|6|||
33637419|NCT02079246|102223138|FG001|OLEX|Protocol Violation|0|||
33637420|NCT02079246|102223137|FG000|OLEX|Lack of Efficacy|3|||
33637421|NCT02079246|102223138|FG001|OLEX|Lack of Efficacy|0|||
33637422|NCT02079246|102223137|FG000|OLEX|Results of the lead-in studies|58|||
33637423|NCT02079246|102223138|FG001|OLEX|Results of the lead-in studies|0|||
33637424|NCT02079246|102223137|FG000|OLEX|Other: Disallowed medication|8|||
33637425|NCT02079246|102223138|FG001|OLEX|Other: Disallowed medication|0|||
33637426|NCT02079246|102223137|FG000|OLEX|Other: Insufficient compliance|2|||
33637427|NCT02079246|102223138|FG001|OLEX|Other: Insufficient compliance|0|||
33637428|NCT02079246|102223137|FG000|OLEX|Other: Caregiver unavailable|3|||
33420658|NCT00758706|101431556|FG000|Overall Study|Adverse Event|4|||
33420659|NCT00758706|101431557|FG001|Overall Study|Adverse Event|4|||
33420660|NCT00423488|101431560|FG000|Overall Study|No evidence of study drug intake|2|||
33637429|NCT02079246|102223138|FG001|OLEX|Other: Caregiver unavailable|0|||
33637430|NCT02079246|102223137|FG000|OLEX|Other: Coordinator decision|1|||
33637431|NCT02079246|102223138|FG001|OLEX|Other: Coordinator decision|0|||
33637432|NCT02079246|102223137|FG000|OLEX|Other: Worsening of condition|1|||
33637433|NCT02079246|102223138|FG001|OLEX|Other: Worsening of condition|0|||
33235822|NCT02696226|100764977|FG001|Overall Study|Study terminated - lack of enrollment|0|||
33235823|NCT02696226|100764978|FG002|Overall Study|Study terminated - lack of enrollment|2|||
33235824|NCT02696226|100764979|FG003|Overall Study|Study terminated - lack of enrollment|0|||
33235825|NCT01555021|100764980|FG000|Overall Study|Lost to Follow-up|1|||
33235826|NCT01555021|100764981|FG001|Overall Study|Lost to Follow-up|2|||
33235827|NCT02107443|100764982|FG000|Overall Study|Death|42|||
33235828|NCT02107443|100764983|FG001|Overall Study|Death|30|||
33235829|NCT02107443|100764982|FG000|Overall Study|Study Protocol Violation|3|||
33235830|NCT02107443|100764983|FG001|Overall Study|Study Protocol Violation|1|||
33235831|NCT02107443|100764982|FG000|Overall Study|Registered but Not Eligible|0|||
33235832|NCT02107443|100764983|FG001|Overall Study|Registered but Not Eligible|1|||
33235833|NCT02107443|100764982|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
33235834|NCT02107443|100764983|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
33235835|NCT02107443|100764982|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
33235836|NCT02107443|100764983|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
33235837|NCT02107443|100764982|FG000|Overall Study|Withdrawal: Changed Mind|2|||
33235838|NCT02107443|100764983|FG001|Overall Study|Withdrawal: Changed Mind|0|||
33235839|NCT02107443|100764982|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
33235840|NCT02107443|100764983|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
33235841|NCT02107443|100764982|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
33235842|NCT02107443|100764983|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
33637434|NCT02079246|102223137|FG000|OLEX|Other: Moved to nursing home|1|||
33235843|NCT02107443|100764982|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
33235844|NCT02107443|100764983|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
33637435|NCT02079246|102223138|FG001|OLEX|Other: Moved to nursing home|0|||
33637436|NCT02079246|102223137|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
33637437|NCT02079246|102223138|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
33637438|NCT02079246|102223137|FG000|OLEX-MEM|Adverse Event|0|||
33235845|NCT02107443|100764982|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
33235846|NCT02107443|100764983|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
33235847|NCT02107443|100764982|FG000|Overall Study|Withdrawal: Other Medical|9|||
33637439|NCT02079246|102223138|FG001|OLEX-MEM|Adverse Event|6|||
33235848|NCT02107443|100764983|FG001|Overall Study|Withdrawal: Other Medical|5|||
33235849|NCT02107443|100764982|FG000|Overall Study|Withdrawal: Disease Progression|4|||
33235850|NCT02107443|100764983|FG001|Overall Study|Withdrawal: Disease Progression|2|||
33235851|NCT02107443|100764982|FG000|Overall Study|Withdrawal: Personal Issues|0|||
33235852|NCT02107443|100764983|FG001|Overall Study|Withdrawal: Personal Issues|3|||
33235853|NCT03619174|100764986|FG000|Overall Study|Lost to Follow-up|3|||
33235854|NCT03619174|100764987|FG001|Overall Study|Lost to Follow-up|0|||
33235855|NCT03619174|100764986|FG000|Overall Study|Withdrawal by Subject|4|||
33235856|NCT03619174|100764987|FG001|Overall Study|Withdrawal by Subject|3|||
33235857|NCT03619174|100764986|FG000|Overall Study|Pregnancy|1|||
33235858|NCT03619174|100764987|FG001|Overall Study|Pregnancy|1|||
33235859|NCT03619174|100764986|FG000|Overall Study|Discomfort during treatment|1|||
33235860|NCT03619174|100764987|FG001|Overall Study|Discomfort during treatment|0|||
33235861|NCT04424290|100764988|FG000|Overall Study|Not treated|0|||
33235862|NCT04424290|100764989|FG001|Overall Study|Not treated|0|||
33235863|NCT04424290|100764990|FG002|Overall Study|Not treated|1|||
33235864|NCT04424290|100764991|FG003|Overall Study|Not treated|0|||
33235865|NCT04424290|100764992|FG004|Overall Study|Not treated|1|||
33235866|NCT04424290|100764988|FG000|Overall Study|Adverse Event|0|||
33235867|NCT04424290|100764989|FG001|Overall Study|Adverse Event|0|||
33235868|NCT04424290|100764990|FG002|Overall Study|Adverse Event|0|||
33235869|NCT04424290|100764991|FG003|Overall Study|Adverse Event|2|||
33235870|NCT04424290|100764992|FG004|Overall Study|Adverse Event|0|||
33235871|NCT04424290|100764988|FG000|Overall Study|Withdrawal by Subject|0|||
33235872|NCT04424290|100764989|FG001|Overall Study|Withdrawal by Subject|0|||
33235873|NCT04424290|100764990|FG002|Overall Study|Withdrawal by Subject|0|||
33235874|NCT04424290|100764991|FG003|Overall Study|Withdrawal by Subject|0|||
33235875|NCT04424290|100764992|FG004|Overall Study|Withdrawal by Subject|1|||
33235876|NCT04424290|100764988|FG000|Overall Study|Other than listed|0|||
33235877|NCT04424290|100764989|FG001|Overall Study|Other than listed|0|||
33235878|NCT04424290|100764990|FG002|Overall Study|Other than listed|0|||
33235879|NCT04424290|100764991|FG003|Overall Study|Other than listed|1|||
33235880|NCT04424290|100764992|FG004|Overall Study|Other than listed|0|||
33235881|NCT01024751|100764993|FG000|Enrolled Participants|Ineligible at baseline|3|||
33235882|NCT01024751|100764994|FG001|Enrolled Participants|Ineligible at baseline|4|||
33235883|NCT01024751|100764993|FG000|Eligible Participants|Withdrawal by Subject|0|||
33577252|NCT01030822|102003284|FG001|Overall Study|Moved/migrated from study area|7|||
33577253|NCT01030822|102003285|FG002|Overall Study|Moved/migrated from study area|3|||
33577254|NCT01030822|102003283|FG000|Overall Study|Withdrawal by Subject|16|||
33577255|NCT01030822|102003284|FG001|Overall Study|Withdrawal by Subject|13|||
33577256|NCT01030822|102003285|FG002|Overall Study|Withdrawal by Subject|16|||
33235884|NCT01024751|100764994|FG001|Eligible Participants|Withdrawal by Subject|1|||
33235885|NCT01024751|100764993|FG000|Eligible Participants|Lost to Follow-up|0|||
33235886|NCT01024751|100764994|FG001|Eligible Participants|Lost to Follow-up|1|||
33235887|NCT01024751|100764993|FG000|Eligible Participants|Ineligible|0|||
33235888|NCT01024751|100764994|FG001|Eligible Participants|Ineligible|1|||
33235889|NCT01012973|100764995|FG000|Overall Study|Adverse Event|5|||
33235890|NCT01012973|100764996|FG001|Overall Study|Adverse Event|5|||
33235891|NCT01012973|100764995|FG000|Overall Study|Lack of Efficacy|0|||
33235892|NCT01012973|100764996|FG001|Overall Study|Lack of Efficacy|5|||
33235893|NCT01012973|100764995|FG000|Overall Study|Lost to Follow-up|1|||
33235894|NCT01012973|100764996|FG001|Overall Study|Lost to Follow-up|0|||
33235895|NCT01012973|100764995|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
33235896|NCT01012973|100764996|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
33235897|NCT01012973|100764995|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
33235898|NCT01012973|100764996|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
33235899|NCT01012973|100764995|FG000|Overall Study|Protocol Violation|5|||
33235900|NCT01012973|100764996|FG001|Overall Study|Protocol Violation|2|||
33235901|NCT01012973|100764995|FG000|Overall Study|Withdrawal by Subject|4|||
33138700|NCT00220779|100423796|FG001|Overall Study|Non-compliance|0|||
33138701|NCT00220779|100423797|FG002|Overall Study|Non-compliance|0|||
33138702|NCT00220779|100423795|FG000|Overall Study|Too time consuming|1|||
33138703|NCT00220779|100423796|FG001|Overall Study|Too time consuming|0|||
33369061|NCT01909453|101236564|FG004|Overall Study|Lost to Follow-up|3|||
33369062|NCT01909453|101236560|FG000|Overall Study|Withdrawal by Subject|2|||
33577257|NCT01030822|102003283|FG000|Overall Study|Lost to Follow-up|9|||
33138704|NCT00220779|100423797|FG002|Overall Study|Too time consuming|0|||
33138705|NCT00220779|100423795|FG000|Overall Study|Pregnancy|0|||
33138706|NCT00220779|100423796|FG001|Overall Study|Pregnancy|0|||
33138707|NCT00220779|100423797|FG002|Overall Study|Pregnancy|2|||
33138708|NCT00220779|100423795|FG000|Overall Study|Lack of Efficacy|3|||
33138709|NCT00220779|100423796|FG001|Overall Study|Lack of Efficacy|0|||
33138710|NCT00220779|100423797|FG002|Overall Study|Lack of Efficacy|1|||
33138711|NCT01203852|100423798|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
33138712|NCT01203852|100423798|FG000|Washout 2 Weeks|Physician Decision|46|||
33138713|NCT00275821|100423799|FG000|Overall Study|Adverse Event|4|||
33577258|NCT01030822|102003284|FG001|Overall Study|Lost to Follow-up|4|||
33577259|NCT01030822|102003285|FG002|Overall Study|Lost to Follow-up|7|||
33235902|NCT01012973|100764996|FG001|Overall Study|Withdrawal by Subject|6|||
33235903|NCT00231894|100764997|FG000|Overall Study|Withdrawal by Subject|1|||
33235904|NCT00231894|100764998|FG001|Overall Study|Withdrawal by Subject|1|||
33235905|NCT01340482|100764999|FG000|Overall Study|Adverse Event|2|||
33235906|NCT01340482|100765000|FG001|Overall Study|Adverse Event|0|||
33577260|NCT00200967|102003286|FG000|First Treatment Period|Withdrawal by Subject|5|||
33577261|NCT00200967|102003287|FG001|First Treatment Period|Withdrawal by Subject|1|||
33235907|NCT01340482|100765001|FG002|Overall Study|Adverse Event|0|||
33235908|NCT01383993|100765006|FG000|Overall Study|Adverse Event|1|||
33235909|NCT01383993|100765007|FG001|Overall Study|Adverse Event|1|||
33235910|NCT01383993|100765008|FG002|Overall Study|Adverse Event|0|||
33235911|NCT01383993|100765006|FG000|Overall Study|Withdrawal by Subject|0|||
33235912|NCT01383993|100765007|FG001|Overall Study|Withdrawal by Subject|0|||
33235913|NCT01383993|100765008|FG002|Overall Study|Withdrawal by Subject|1|||
33235914|NCT01383993|100765006|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
33235915|NCT01383993|100765007|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
33235916|NCT01383993|100765008|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
33235917|NCT01683994|100765011|FG000|Overall Study|Withdrawal by Subject|1|||
33420661|NCT00423488|101431561|FG001|Overall Study|No evidence of study drug intake|1|||
33420662|NCT00423488|101431560|FG000|Overall Study|No post baseline data|3|||
33420663|NCT00423488|101431561|FG001|Overall Study|No post baseline data|0|||
33420664|NCT04388527|101431562|FG000|Overall Study|Death|14|||
33235918|NCT01683994|100765012|FG001|Overall Study|Withdrawal by Subject|0|||
33235919|NCT01683994|100765013|FG002|Overall Study|Withdrawal by Subject|0|||
33235920|NCT01683994|100765014|FG003|Overall Study|Withdrawal by Subject|1|||
33420665|NCT04388527|101431562|FG000|Overall Study|Withdrawal by Subject|2|||
33420666|NCT04388527|101431562|FG000|Overall Study|Lost to Follow-up|1|||
33420667|NCT01123980|101431563|FG000|Overall Study|Adverse Event|1|||
33420668|NCT01123980|101431564|FG001|Overall Study|Adverse Event|1|||
33420669|NCT01123980|101431563|FG000|Overall Study|Lack of Efficacy|1|||
33420670|NCT01123980|101431564|FG001|Overall Study|Lack of Efficacy|0|||
33420671|NCT01123980|101431563|FG000|Overall Study|Physician Decision|0|||
33420672|NCT01123980|101431564|FG001|Overall Study|Physician Decision|1|||
33420673|NCT01123980|101431563|FG000|Overall Study|Lost to Follow-up|0|||
33420674|NCT01123980|101431564|FG001|Overall Study|Lost to Follow-up|6|||
33420675|NCT01123980|101431563|FG000|Overall Study|Protocol Violation|6|||
33420676|NCT01123980|101431564|FG001|Overall Study|Protocol Violation|6|||
33420677|NCT01123980|101431563|FG000|Overall Study|Withdrawal by Subject|5|||
33577262|NCT00200967|102003286|FG000|First Treatment Period|Pregnancy|1|||
33577263|NCT00200967|102003287|FG001|First Treatment Period|Pregnancy|0|||
33577264|NCT00200967|102003286|FG000|Wash-out Period|Lost to Follow-up|0|||
33577265|NCT00200967|102003287|FG001|Wash-out Period|Lost to Follow-up|1|||
33577266|NCT00200967|102003286|FG000|Second Treatment Period|Withdrawal by Subject|1|||
33577267|NCT00200967|102003287|FG001|Second Treatment Period|Withdrawal by Subject|2|||
33637440|NCT02079246|102223137|FG000|OLEX-MEM|Withdrawal by Subject|0|||
33235921|NCT01683994|100765015|FG004|Overall Study|Withdrawal by Subject|0|||
33235922|NCT01683994|100765011|FG000|Overall Study|Intercurrent illness|0|||
33235923|NCT01683994|100765012|FG001|Overall Study|Intercurrent illness|0|||
33577268|NCT00200967|102003286|FG000|Run-out Period|Lost to Follow-up|1|||
33577269|NCT00200967|102003287|FG001|Run-out Period|Lost to Follow-up|0|||
33577270|NCT03257358|102003288|FG000|Overall Study|Adverse Event|25|||
33577271|NCT03257358|102003289|FG001|Overall Study|Adverse Event|12|||
33577272|NCT03257358|102003288|FG000|Overall Study|Lack of Efficacy|1|||
33577273|NCT03257358|102003289|FG001|Overall Study|Lack of Efficacy|1|||
33577274|NCT03257358|102003288|FG000|Overall Study|Lost to Follow-up|12|||
33577275|NCT03257358|102003289|FG001|Overall Study|Lost to Follow-up|4|||
33577276|NCT03257358|102003288|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
33577277|NCT03257358|102003289|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
33577278|NCT03257358|102003288|FG000|Overall Study|Physician Decision|2|||
33637441|NCT02079246|102223138|FG001|OLEX-MEM|Withdrawal by Subject|7|||
33637442|NCT02079246|102223137|FG000|OLEX-MEM|Protocol Violation|0|||
33637443|NCT02079246|102223138|FG001|OLEX-MEM|Protocol Violation|2|||
33637444|NCT02079246|102223137|FG000|OLEX-MEM|Lost to Follow-up|0|||
33235924|NCT01683994|100765013|FG002|Overall Study|Intercurrent illness|0|||
33235925|NCT01683994|100765014|FG003|Overall Study|Intercurrent illness|2|||
33235926|NCT01683994|100765015|FG004|Overall Study|Intercurrent illness|1|||
33420678|NCT01123980|101431564|FG001|Overall Study|Withdrawal by Subject|3|||
33577279|NCT03257358|102003289|FG001|Overall Study|Physician Decision|2|||
33577280|NCT03257358|102003288|FG000|Overall Study|Protocol Violation|5|||
33577281|NCT03257358|102003289|FG001|Overall Study|Protocol Violation|3|||
33235927|NCT02320721|100765019|FG000|Overall Study|Adverse Event|6|||
33235928|NCT02320721|100765020|FG001|Overall Study|Adverse Event|6|||
33235929|NCT02320721|100765019|FG000|Overall Study|Lack of Efficacy|2|||
33235930|NCT02320721|100765020|FG001|Overall Study|Lack of Efficacy|0|||
33420679|NCT01123980|101431563|FG000|Overall Study|Unclassified|6|||
33420680|NCT01123980|101431564|FG001|Overall Study|Unclassified|7|||
33420681|NCT00996632|101431565|FG000|Overall Study|Physician Decision|0|||
33637445|NCT02079246|102223138|FG001|OLEX-MEM|Lost to Follow-up|1|||
33637446|NCT02079246|102223137|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
33637447|NCT02079246|102223138|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
33637448|NCT01337960|102223139|FG000|Overall Study|Lost to Follow-up|1|||
33637449|NCT01337960|102223140|FG001|Overall Study|Lost to Follow-up|0|||
33637450|NCT01337960|102223141|FG002|Overall Study|Lost to Follow-up|0|||
33637451|NCT01337960|102223139|FG000|Overall Study|Withdrawal by Subject|1|||
33637452|NCT01337960|102223140|FG001|Overall Study|Withdrawal by Subject|0|||
33637453|NCT01337960|102223141|FG002|Overall Study|Withdrawal by Subject|0|||
33637454|NCT01499355|102223149|FG000|Run-In Period|Study Termination|15|||
33637455|NCT01499355|102223150|FG001|Run-In Period|Study Termination|0|||
33637456|NCT01499355|102223151|FG002|Run-In Period|Study Termination|0|||
33637457|NCT01499355|102223152|FG003|Run-In Period|Study Termination|0|||
33637458|NCT01499355|102223149|FG000|Run-In Period|Other|3|||
33637459|NCT01499355|102223150|FG001|Run-In Period|Other|0|||
33637460|NCT01499355|102223151|FG002|Run-In Period|Other|0|||
33637461|NCT01499355|102223152|FG003|Run-In Period|Other|0|||
33637462|NCT01499355|102223149|FG000|Run-In Period|Death|2|||
33637463|NCT01499355|102223150|FG001|Run-In Period|Death|0|||
33637464|NCT01499355|102223151|FG002|Run-In Period|Death|0|||
33637465|NCT01499355|102223152|FG003|Run-In Period|Death|0|||
33637466|NCT01499355|102223149|FG000|Run-In Period|Investigator Decision|2|||
33637467|NCT01499355|102223150|FG001|Run-In Period|Investigator Decision|0|||
33637468|NCT01499355|102223151|FG002|Run-In Period|Investigator Decision|0|||
33637469|NCT01499355|102223152|FG003|Run-In Period|Investigator Decision|0|||
33637470|NCT01499355|102223149|FG000|Run-In Period|Consent Withdrawn|1|||
33637471|NCT01499355|102223150|FG001|Run-In Period|Consent Withdrawn|0|||
33235931|NCT02320721|100765019|FG000|Overall Study|Poor compliance to protocol|3|||
33235932|NCT02320721|100765020|FG001|Overall Study|Poor compliance to protocol|7|||
33235933|NCT02320721|100765019|FG000|Overall Study|Randomized but not treated|0|||
33235934|NCT02320721|100765020|FG001|Overall Study|Randomized but not treated|1|||
33235935|NCT02320721|100765019|FG000|Overall Study|Hypoglycemia|1|||
33235936|NCT02320721|100765020|FG001|Overall Study|Hypoglycemia|0|||
33235937|NCT02320721|100765019|FG000|Overall Study|Other than specified above|15|||
33235938|NCT02320721|100765020|FG001|Overall Study|Other than specified above|20|||
33235939|NCT03055832|100765021|FG000|Week 2|Withdrawal by Subject|1|||
33235940|NCT03055832|100765022|FG001|Week 2|Withdrawal by Subject|0|||
33235941|NCT02564055|100765023|FG000|Overall Study|Adverse Event|1|||
33235942|NCT02564055|100765024|FG001|Overall Study|Adverse Event|0|||
33637472|NCT01499355|102223151|FG002|Run-In Period|Consent Withdrawn|0|||
33637473|NCT01499355|102223152|FG003|Run-In Period|Consent Withdrawn|0|||
33637474|NCT01499355|102223149|FG000|Run-In Period|Adverse Event|8|||
33637475|NCT01499355|102223150|FG001|Run-In Period|Adverse Event|0|||
33637476|NCT01499355|102223151|FG002|Run-In Period|Adverse Event|0|||
33637477|NCT01499355|102223152|FG003|Run-In Period|Adverse Event|0|||
33637478|NCT01499355|102223149|FG000|Double-Blind Period|Adverse Event|0|||
33637479|NCT01499355|102223150|FG001|Double-Blind Period|Adverse Event|2|||
33637480|NCT01499355|102223151|FG002|Double-Blind Period|Adverse Event|3|||
33637481|NCT01499355|102223152|FG003|Double-Blind Period|Adverse Event|2|||
33637482|NCT01499355|102223149|FG000|Double-Blind Period|Study Termination|0|||
33637483|NCT01499355|102223150|FG001|Double-Blind Period|Study Termination|18|||
33637484|NCT01499355|102223151|FG002|Double-Blind Period|Study Termination|16|||
33637485|NCT01499355|102223152|FG003|Double-Blind Period|Study Termination|14|||
33637486|NCT01499355|102223149|FG000|Double-Blind Period|Other|0|||
33637487|NCT01499355|102223150|FG001|Double-Blind Period|Other|1|||
33637488|NCT01499355|102223151|FG002|Double-Blind Period|Other|2|||
33637489|NCT01499355|102223152|FG003|Double-Blind Period|Other|2|||
33637490|NCT01499355|102223149|FG000|Double-Blind Period|Death|0|||
33637491|NCT01499355|102223150|FG001|Double-Blind Period|Death|1|||
33235943|NCT02564055|100765025|FG002|Overall Study|Adverse Event|4|||
33235944|NCT02564055|100765026|FG003|Overall Study|Adverse Event|1|||
33235945|NCT02564055|100765027|FG004|Overall Study|Adverse Event|4|||
33235946|NCT02564055|100765028|FG005|Overall Study|Adverse Event|1|||
33637492|NCT01499355|102223151|FG002|Double-Blind Period|Death|0|||
33637493|NCT01499355|102223152|FG003|Double-Blind Period|Death|0|||
33637494|NCT01499355|102223149|FG000|Double-Blind Period|Investigator Decision|0|||
33637495|NCT01499355|102223150|FG001|Double-Blind Period|Investigator Decision|0|||
33235947|NCT02564055|100765023|FG000|Overall Study|Protocol Violation|1|||
33235948|NCT02564055|100765024|FG001|Overall Study|Protocol Violation|0|||
33235949|NCT02564055|100765025|FG002|Overall Study|Protocol Violation|0|||
33235950|NCT02564055|100765026|FG003|Overall Study|Protocol Violation|0|||
33637496|NCT01499355|102223151|FG002|Double-Blind Period|Investigator Decision|3|||
33637497|NCT01499355|102223152|FG003|Double-Blind Period|Investigator Decision|3|||
33637498|NCT01499355|102223149|FG000|Double-Blind Period|Consent Withdrawn|0|||
33235951|NCT02564055|100765027|FG004|Overall Study|Protocol Violation|0|||
33235952|NCT02564055|100765028|FG005|Overall Study|Protocol Violation|0|||
33637499|NCT01499355|102223150|FG001|Double-Blind Period|Consent Withdrawn|0|||
33637500|NCT01499355|102223151|FG002|Double-Blind Period|Consent Withdrawn|1|||
33637501|NCT01499355|102223152|FG003|Double-Blind Period|Consent Withdrawn|2|||
33637502|NCT01499355|102223149|FG000|Double-Blind Period|Lost to Follow-up|0|||
33637503|NCT01499355|102223150|FG001|Double-Blind Period|Lost to Follow-up|1|||
33138714|NCT00275821|100423800|FG001|Overall Study|Adverse Event|12|||
33138715|NCT00275821|100423801|FG002|Overall Study|Adverse Event|5|||
33138716|NCT00275821|100423799|FG000|Overall Study|Administrative problems|3|||
33138717|NCT00275821|100423800|FG001|Overall Study|Administrative problems|4|||
33138718|NCT00275821|100423801|FG002|Overall Study|Administrative problems|4|||
33138719|NCT00275821|100423799|FG000|Overall Study|Withdrawal by Subject|0|||
33138720|NCT00275821|100423800|FG001|Overall Study|Withdrawal by Subject|2|||
33138721|NCT00275821|100423801|FG002|Overall Study|Withdrawal by Subject|1|||
33138722|NCT00275821|100423799|FG000|Overall Study|Lost to Follow-up|0|||
33138723|NCT00275821|100423800|FG001|Overall Study|Lost to Follow-up|1|||
33235953|NCT02564055|100765023|FG000|Overall Study|Reached stopping criteria|0|||
33235954|NCT02564055|100765024|FG001|Overall Study|Reached stopping criteria|0|||
33235955|NCT02564055|100765025|FG002|Overall Study|Reached stopping criteria|0|||
33235956|NCT02564055|100765026|FG003|Overall Study|Reached stopping criteria|0|||
33577282|NCT03257358|102003288|FG000|Overall Study|Technical problems|4|||
33577283|NCT03257358|102003289|FG001|Overall Study|Technical problems|1|||
33577284|NCT03257358|102003288|FG000|Overall Study|Withdrawal by Subject|8|||
33577285|NCT03257358|102003289|FG001|Overall Study|Withdrawal by Subject|3|||
33577286|NCT03257358|102003288|FG000|Overall Study|Withdrawal of informed consent|9|||
33577287|NCT03257358|102003289|FG001|Overall Study|Withdrawal of informed consent|5|||
33577288|NCT03257358|102003288|FG000|Overall Study|New therapy for study indication|1|||
33577289|NCT03257358|102003289|FG001|Overall Study|New therapy for study indication|0|||
33577290|NCT03257358|102003288|FG000|Overall Study|No longer requires treatment|0|||
33577291|NCT03257358|102003289|FG001|Overall Study|No longer requires treatment|1|||
33577292|NCT01213082|102003290|FG000|Overall Study|Lost to Follow-up|6|||
33577293|NCT01213082|102003291|FG001|Overall Study|Lost to Follow-up|7|||
33577294|NCT01213082|102003292|FG002|Overall Study|Lost to Follow-up|4|||
33577295|NCT01213082|102003290|FG000|Overall Study|Physician Decision|0|||
33577296|NCT01213082|102003291|FG001|Overall Study|Physician Decision|0|||
33577297|NCT01213082|102003292|FG002|Overall Study|Physician Decision|1|||
33577298|NCT03533660|102003294|FG000|Overall Study|Withdrawal by Subject|2|||
33577299|NCT03533660|102003295|FG001|Overall Study|Withdrawal by Subject|2|||
33577300|NCT03533660|102003294|FG000|Overall Study|Death|2|||
33577301|NCT03533660|102003295|FG001|Overall Study|Death|4|||
33577302|NCT03533660|102003294|FG000|Overall Study|Adverse Event|0|||
33577303|NCT03533660|102003295|FG001|Overall Study|Adverse Event|2|||
33577304|NCT00552071|102003298|FG000|Overall Study|Adverse Event|1|||
33577305|NCT00552071|102003299|FG001|Overall Study|Adverse Event|0|||
33577306|NCT00552071|102003298|FG000|Overall Study|Lack of Efficacy|1|||
33577307|NCT00552071|102003299|FG001|Overall Study|Lack of Efficacy|0|||
33577308|NCT00552071|102003298|FG000|Overall Study|Physician Decision|1|||
33577309|NCT00552071|102003299|FG001|Overall Study|Physician Decision|0|||
33577310|NCT00552071|102003298|FG000|Overall Study|Pregnancy|1|||
33577311|NCT00552071|102003299|FG001|Overall Study|Pregnancy|0|||
33577312|NCT00552071|102003298|FG000|Overall Study|Death|0|||
33577313|NCT00552071|102003299|FG001|Overall Study|Death|1|||
33577314|NCT00552071|102003298|FG000|Overall Study|Withdrawal by Subject|0|||
33577315|NCT00552071|102003299|FG001|Overall Study|Withdrawal by Subject|1|||
33577316|NCT03789292|102003301|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
33577317|NCT03789292|102003302|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
33577318|NCT03789292|102003303|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
33577319|NCT03789292|102003301|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
33577320|NCT03789292|102003302|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
33577321|NCT03789292|102003303|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
33577322|NCT03789292|102003301|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
33577323|NCT03789292|102003302|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
33577324|NCT03789292|102003303|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
33577325|NCT03789292|102003301|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
33577326|NCT03789292|102003302|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
33577327|NCT03789292|102003303|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
33577328|NCT03789292|102003301|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
33577329|NCT03789292|102003302|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
33577330|NCT03789292|102003303|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
33577331|NCT03789292|102003301|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
33577332|NCT03789292|102003302|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
33577333|NCT03789292|102003303|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
33577334|NCT03789292|102003301|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
33577335|NCT03789292|102003302|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
33577336|NCT03789292|102003303|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
33577337|NCT03789292|102003301|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
33235957|NCT02564055|100765027|FG004|Overall Study|Reached stopping criteria|0|||
33577338|NCT03789292|102003302|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
33637504|NCT01499355|102223151|FG002|Double-Blind Period|Lost to Follow-up|0|||
33138724|NCT00275821|100423801|FG002|Overall Study|Lost to Follow-up|1|||
33637505|NCT01499355|102223152|FG003|Double-Blind Period|Lost to Follow-up|0|||
33420682|NCT00996632|101431566|FG001|Overall Study|Physician Decision|0|||
33420683|NCT03333382|101431567|FG000|Overall Study|Lost to Follow-up|1|||
33420684|NCT03333382|101431568|FG001|Overall Study|Lost to Follow-up|0|||
33420685|NCT01458132|101431574|FG000|Overall Study|Other|15|||
33420686|NCT01458132|101431575|FG001|Overall Study|Other|3|||
33420687|NCT01652573|101431576|FG000|Overall Study|Adverse Event|0|||
33420688|NCT01652573|101431577|FG001|Overall Study|Adverse Event|1|||
33420689|NCT04333199|101431578|FG000|Evaluated Patients|Lost to Follow-up|0|||
33420690|NCT04333199|101431579|FG001|Evaluated Patients|Lost to Follow-up|1|||
33420691|NCT04333199|101431580|FG002|Evaluated Patients|Lost to Follow-up|2|||
33420692|NCT00943384|101431581|FG000|Overall Study|Dispositioned prior to treatment|23|||
33420693|NCT00943384|101431581|FG000|Overall Study|Treated off protocol-protocol violation|5|||
33420694|NCT00943384|101431581|FG000|Overall Study|Lost to Follow-up|16|||
33420695|NCT00943384|101431581|FG000|Overall Study|Withdrawal by Subject|5|||
33420696|NCT02702271|101431586|FG000|Overall Study|Death|36|||
33420697|NCT02702271|101431587|FG001|Overall Study|Death|7|||
33420698|NCT02702271|101431586|FG000|Overall Study|Lost to Follow-up|12|||
33420699|NCT02702271|101431587|FG001|Overall Study|Lost to Follow-up|0|||
33420700|NCT02702271|101431586|FG000|Overall Study|Withdrawal by Subject|8|||
33420701|NCT02702271|101431587|FG001|Overall Study|Withdrawal by Subject|1|||
33420702|NCT02702271|101431586|FG000|Overall Study|Physician Decision|2|||
33420703|NCT02702271|101431587|FG001|Overall Study|Physician Decision|0|||
33420704|NCT02702271|101431586|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
33420705|NCT02702271|101431587|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
33420706|NCT02567266|101431588|FG000|Overall Study|Withdrawal by Subject|10|||
33420707|NCT02567266|101431589|FG001|Overall Study|Withdrawal by Subject|7|||
33420708|NCT02567266|101431590|FG002|Overall Study|Withdrawal by Subject|6|||
33420709|NCT02567266|101431588|FG000|Overall Study|Lost to Follow-up|13|||
33577339|NCT03789292|102003303|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
33577340|NCT03789292|102003301|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
33577341|NCT03789292|102003302|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
33577342|NCT03789292|102003303|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
33577343|NCT03789292|102003301|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
33577344|NCT03789292|102003302|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
33577345|NCT03789292|102003303|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
33577346|NCT03789292|102003301|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
33577347|NCT03789292|102003302|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
33577348|NCT03789292|102003303|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
33577349|NCT03789292|102003301|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
33138725|NCT00275821|100423799|FG000|Overall Study|Death|0|||
33138726|NCT00275821|100423800|FG001|Overall Study|Death|2|||
33138727|NCT00275821|100423801|FG002|Overall Study|Death|1|||
33138728|NCT00275821|100423799|FG000|Overall Study|Lack of Efficacy|2|||
33138729|NCT00275821|100423800|FG001|Overall Study|Lack of Efficacy|1|||
33138730|NCT00275821|100423801|FG002|Overall Study|Lack of Efficacy|0|||
33235958|NCT02564055|100765028|FG005|Overall Study|Reached stopping criteria|1|||
33235959|NCT02564055|100765023|FG000|Overall Study|Lost to Follow-up|0|||
33420710|NCT02567266|101431589|FG001|Overall Study|Lost to Follow-up|8|||
33577350|NCT03789292|102003302|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
33577351|NCT03789292|102003303|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
33577352|NCT03789292|102003301|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
33577353|NCT03789292|102003302|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
33577354|NCT03789292|102003303|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
33637506|NCT03112603|102223157|FG000|End of Randomization Period|Lost to Follow-up|3|||
33637507|NCT03112603|102223158|FG001|End of Randomization Period|Lost to Follow-up|0|||
33637508|NCT03112603|102223159|FG002|End of Randomization Period|Lost to Follow-up|0|||
33420711|NCT02567266|101431590|FG002|Overall Study|Lost to Follow-up|10|||
33637509|NCT03112603|102223157|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
33637510|NCT03112603|102223158|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
33235960|NCT02564055|100765024|FG001|Overall Study|Lost to Follow-up|1|||
33235961|NCT02564055|100765025|FG002|Overall Study|Lost to Follow-up|4|||
33235962|NCT02564055|100765026|FG003|Overall Study|Lost to Follow-up|2|||
33138731|NCT00275821|100423799|FG000|Overall Study|Protocol Violation|5|||
33235963|NCT02564055|100765027|FG004|Overall Study|Lost to Follow-up|1|||
33235964|NCT02564055|100765028|FG005|Overall Study|Lost to Follow-up|0|||
33420712|NCT02426125|101431593|FG000|Overall Study|Lost to Follow-up|14|||
33420713|NCT02426125|101431594|FG001|Overall Study|Lost to Follow-up|12|||
33420714|NCT02426125|101431593|FG000|Overall Study|Withdrawal by Subject|13|||
33138732|NCT00275821|100423800|FG001|Overall Study|Protocol Violation|1|||
33420715|NCT02426125|101431594|FG001|Overall Study|Withdrawal by Subject|14|||
33138733|NCT00275821|100423801|FG002|Overall Study|Protocol Violation|0|||
33235965|NCT02564055|100765023|FG000|Overall Study|Physician Decision|0|||
33235966|NCT02564055|100765024|FG001|Overall Study|Physician Decision|0|||
33138734|NCT04604132|100423802|FG000|Overall Study|Adverse Event|2|||
33138735|NCT04604132|100423803|FG001|Overall Study|Adverse Event|0|||
33138736|NCT04604132|100423804|FG002|Overall Study|Adverse Event|0|||
33138737|NCT04604132|100423805|FG003|Overall Study|Adverse Event|1|||
33138738|NCT04604132|100423806|FG004|Overall Study|Adverse Event|2|||
33138739|NCT04604132|100423802|FG000|Overall Study|Study terminated by sponsor|0|||
33138740|NCT04604132|100423803|FG001|Overall Study|Study terminated by sponsor|0|||
33138741|NCT04604132|100423804|FG002|Overall Study|Study terminated by sponsor|0|||
33138742|NCT04604132|100423805|FG003|Overall Study|Study terminated by sponsor|0|||
33138743|NCT04604132|100423806|FG004|Overall Study|Study terminated by sponsor|1|||
33138744|NCT04604132|100423802|FG000|Overall Study|Progressive disease: Clinical progression|0|||
33138745|NCT04604132|100423803|FG001|Overall Study|Progressive disease: Clinical progression|0|||
33138746|NCT04604132|100423804|FG002|Overall Study|Progressive disease: Clinical progression|1|||
33138747|NCT04604132|100423805|FG003|Overall Study|Progressive disease: Clinical progression|0|||
33138748|NCT04604132|100423806|FG004|Overall Study|Progressive disease: Clinical progression|0|||
33138749|NCT04604132|100423802|FG000|Overall Study|Progressive disease: Radiological progression|8|||
33138750|NCT04604132|100423803|FG001|Overall Study|Progressive disease: Radiological progression|7|||
33138751|NCT04604132|100423804|FG002|Overall Study|Progressive disease: Radiological progression|10|||
33138752|NCT04604132|100423805|FG003|Overall Study|Progressive disease: Radiological progression|4|||
33138753|NCT04604132|100423806|FG004|Overall Study|Progressive disease: Radiological progression|3|||
33235967|NCT02564055|100765025|FG002|Overall Study|Physician Decision|1|||
33235968|NCT02564055|100765026|FG003|Overall Study|Physician Decision|0|||
33235969|NCT02564055|100765027|FG004|Overall Study|Physician Decision|0|||
33235970|NCT02564055|100765028|FG005|Overall Study|Physician Decision|0|||
33235971|NCT02564055|100765023|FG000|Overall Study|Withdrawal by Subject|4|||
33235972|NCT02564055|100765024|FG001|Overall Study|Withdrawal by Subject|4|||
33235973|NCT02564055|100765025|FG002|Overall Study|Withdrawal by Subject|3|||
33235974|NCT02564055|100765026|FG003|Overall Study|Withdrawal by Subject|3|||
33235975|NCT02564055|100765027|FG004|Overall Study|Withdrawal by Subject|10|||
33235976|NCT02564055|100765028|FG005|Overall Study|Withdrawal by Subject|10|||
33235977|NCT03785340|100765035|FG000|Overall Study|Lost to Follow-up|2|||
33235978|NCT03785340|100765036|FG001|Overall Study|Lost to Follow-up|0|||
33637511|NCT03112603|102223159|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
33637512|NCT03112603|102223157|FG000|End of Randomization Period|Physician Decision|43|||
33637513|NCT03112603|102223158|FG001|End of Randomization Period|Physician Decision|18|||
33637514|NCT03112603|102223159|FG002|End of Randomization Period|Physician Decision|0|||
33637515|NCT03112603|102223157|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
33637516|NCT03112603|102223158|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
33637517|NCT03112603|102223159|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
33637518|NCT03112603|102223157|FG000|End of Randomization Period|Death|10|||
33637519|NCT03112603|102223158|FG001|End of Randomization Period|Death|7|||
33637520|NCT03112603|102223159|FG002|End of Randomization Period|Death|0|||
33637521|NCT03112603|102223157|FG000|End of Randomization Period|Disease Relapse|12|||
33637522|NCT03112603|102223158|FG001|End of Randomization Period|Disease Relapse|7|||
33637523|NCT03112603|102223159|FG002|End of Randomization Period|Disease Relapse|0|||
33637524|NCT03112603|102223157|FG000|End of Randomization Period|Lack of Efficacy|25|||
33637525|NCT03112603|102223158|FG001|End of Randomization Period|Lack of Efficacy|77|||
33637526|NCT03112603|102223159|FG002|End of Randomization Period|Lack of Efficacy|0|||
33637527|NCT03112603|102223157|FG000|End of Randomization Period|Adverse Event|32|||
33637528|NCT03112603|102223158|FG001|End of Randomization Period|Adverse Event|12|||
33637529|NCT03112603|102223159|FG002|End of Randomization Period|Adverse Event|0|||
33637530|NCT03112603|102223157|FG000|End of Cross Over Period|Death|0|||
33637531|NCT03112603|102223158|FG001|End of Cross Over Period|Death|0|||
33637532|NCT03112603|102223159|FG002|End of Cross Over Period|Death|2|||
33637533|NCT03112603|102223157|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
33637534|NCT03112603|102223158|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
33637535|NCT03112603|102223159|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
33637536|NCT03112603|102223157|FG000|End of Cross Over Period|Physician Decision|0|||
33637537|NCT03112603|102223158|FG001|End of Cross Over Period|Physician Decision|0|||
33637538|NCT03112603|102223159|FG002|End of Cross Over Period|Physician Decision|29|||
33138754|NCT04604132|100423802|FG000|Overall Study|Death|3|||
33138755|NCT04604132|100423803|FG001|Overall Study|Death|1|||
33138756|NCT04604132|100423804|FG002|Overall Study|Death|2|||
33138757|NCT04604132|100423805|FG003|Overall Study|Death|1|||
33235979|NCT03785340|100765035|FG000|Overall Study|Adverse Event|1|||
33235980|NCT03785340|100765036|FG001|Overall Study|Adverse Event|0|||
33235981|NCT04227340|100765041|FG000|Overall Study|Withdrawal by Subject|3|||
33235982|NCT03390036|100765042|FG000|Overall Study|Lost to Follow-up|1|||
33138758|NCT04604132|100423806|FG004|Overall Study|Death|0|||
33235983|NCT03390036|100765043|FG001|Overall Study|Lost to Follow-up|0|||
33235984|NCT03390036|100765044|FG002|Overall Study|Lost to Follow-up|0|||
33637539|NCT03112603|102223157|FG000|End of Cross Over Period|Lack of Efficacy|0|||
33637540|NCT03112603|102223158|FG001|End of Cross Over Period|Lack of Efficacy|0|||
33637541|NCT03112603|102223159|FG002|End of Cross Over Period|Lack of Efficacy|8|||
33637542|NCT03112603|102223157|FG000|End of Cross Over Period|Adverse Event|0|||
33235985|NCT03390036|100765042|FG000|Overall Study|Lack of Efficacy|1|||
33138759|NCT01252667|100423807|FG000|Overall Study|Transplant aborted post-conditioning|0|||
33138760|NCT01252667|100423808|FG001|Overall Study|Transplant aborted post-conditioning|0|||
33138761|NCT01252667|100423809|FG002|Overall Study|Transplant aborted post-conditioning|0|||
33637543|NCT03112603|102223158|FG001|End of Cross Over Period|Adverse Event|0|||
33235986|NCT03390036|100765043|FG001|Overall Study|Lack of Efficacy|0|||
33235987|NCT03390036|100765044|FG002|Overall Study|Lack of Efficacy|0|||
33235988|NCT01857323|100765045|FG000|Overall Study|Adverse Event|1|||
33235989|NCT01857323|100765045|FG000|Overall Study|Withdrawal by Subject|3|||
33235990|NCT01857323|100765045|FG000|Overall Study|Non-compliance|1|||
33235991|NCT01857323|100765045|FG000|Overall Study|Protocol Violation|6|||
33235992|NCT01857323|100765045|FG000|Overall Study|Lost to Follow-up|1|||
33235993|NCT01857323|100765045|FG000|Overall Study|Other|4|||
33235994|NCT01857323|100765045|FG000|Overall Study|Did not complete 180 doses|48|||
33235995|NCT01628510|100765046|FG000|Overall Study|Withdrawal by Subject|0|||
33235996|NCT01628510|100765047|FG001|Overall Study|Withdrawal by Subject|4|||
33235997|NCT01628510|100765046|FG000|Overall Study|Death|3|||
33235998|NCT01628510|100765047|FG001|Overall Study|Death|1|||
33235999|NCT00333788|100765062|FG000|Overall Study|Adverse Event|44|||
33236000|NCT00333788|100765062|FG000|Overall Study|Lack of Efficacy|80|||
33236001|NCT00333788|100765062|FG000|Overall Study|Lost to Follow-up|2|||
33236002|NCT00333788|100765062|FG000|Overall Study|Withdrawal by Subject|24|||
33637544|NCT03112603|102223159|FG002|End of Cross Over Period|Adverse Event|6|||
33138762|NCT01252667|100423810|FG003|Overall Study|Transplant aborted post-conditioning|0|||
33138763|NCT01252667|100423811|FG004|Overall Study|Transplant aborted post-conditioning|0|||
33138764|NCT01252667|100423812|FG005|Overall Study|Transplant aborted post-conditioning|1|||
33138765|NCT00395343|100423813|FG000|Overall Study|Adverse Event|13|||
33138766|NCT00395343|100423814|FG001|Overall Study|Adverse Event|5|||
33138767|NCT00395343|100423813|FG000|Overall Study|Lack of Efficacy|0|||
33138768|NCT00395343|100423814|FG001|Overall Study|Lack of Efficacy|1|||
33138769|NCT00395343|100423813|FG000|Overall Study|Lost to Follow-up|4|||
33236003|NCT00333788|100765062|FG000|Overall Study|Other: Non-compliance|2|||
33369063|NCT01909453|101236561|FG001|Overall Study|Withdrawal by Subject|13|||
33369064|NCT01909453|101236562|FG002|Overall Study|Withdrawal by Subject|16|||
33369065|NCT01909453|101236563|FG003|Overall Study|Withdrawal by Subject|5|||
33369066|NCT01909453|101236564|FG004|Overall Study|Withdrawal by Subject|4|||
33369067|NCT03215706|101236566|FG000|Randomization|Adverse Event unrelated to study drug|1|||
33369068|NCT03215706|101236567|FG001|Randomization|Adverse Event unrelated to study drug|0|||
33369069|NCT03215706|101236566|FG000|Randomization|participant withdrew consent|1|||
33369070|NCT03215706|101236567|FG001|Randomization|participant withdrew consent|3|||
33369071|NCT03215706|101236566|FG000|Randomization|no longer meets study criteria|1|||
33369072|NCT03215706|101236567|FG001|Randomization|no longer meets study criteria|4|||
33369073|NCT03215706|101236566|FG000|Randomization|other reasons|0|||
33369074|NCT03215706|101236567|FG001|Randomization|other reasons|2|||
33369075|NCT03215706|101236566|FG000|Treatment Period|Disease Progression|150|||
33369076|NCT03215706|101236567|FG001|Treatment Period|Disease Progression|142|||
33369077|NCT03215706|101236566|FG000|Treatment Period|Study Drug Toxicity|53|||
33369078|NCT03215706|101236567|FG001|Treatment Period|Study Drug Toxicity|21|||
33369079|NCT03215706|101236566|FG000|Treatment Period|Death|2|||
33138770|NCT00395343|100423814|FG001|Overall Study|Lost to Follow-up|4|||
33138771|NCT00395343|100423813|FG000|Overall Study|Physician Decision|2|||
33369080|NCT03215706|101236567|FG001|Treatment Period|Death|1|||
33369081|NCT03215706|101236566|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
33369082|NCT03215706|101236567|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
33369083|NCT03215706|101236566|FG000|Treatment Period|Request to D/C treatment|1|||
33236004|NCT00333788|100765062|FG000|Overall Study|Other: Moved|2|||
33236005|NCT00333788|100765062|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
33236006|NCT00333788|100765062|FG000|Overall Study|Other: Investigator decision|1|||
33369084|NCT03215706|101236567|FG001|Treatment Period|Request to D/C treatment|6|||
33637545|NCT03112603|102223157|FG000|End of Cross Over Period|Disease Relapse|0|||
33637546|NCT03112603|102223158|FG001|End of Cross Over Period|Disease Relapse|0|||
33236007|NCT00333788|100765062|FG000|Overall Study|Other: Quality of life concern|1|||
33369085|NCT03215706|101236566|FG000|Treatment Period|Participant withdrew consent|3|||
33369086|NCT03215706|101236567|FG001|Treatment Period|Participant withdrew consent|4|||
33577355|NCT00003869|102003306|FG000|Overall Study|Adverse Event|14|||
33138772|NCT00395343|100423814|FG001|Overall Study|Physician Decision|4|||
33236008|NCT00333788|100765062|FG000|Overall Study|Other: Sponsor decision|1|||
33236009|NCT00333788|100765062|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
33236010|NCT00333788|100765062|FG000|Overall Study|Other: Medical monitor decision|1|||
33369087|NCT03215706|101236566|FG000|Treatment Period|Lost to Follow-up|0|||
33369088|NCT03215706|101236567|FG001|Treatment Period|Lost to Follow-up|1|||
33637547|NCT03112603|102223159|FG002|End of Cross Over Period|Disease Relapse|2|||
33637548|NCT02516241|102223166|FG000|Overall Study|Death|255|||
33637549|NCT02516241|102223167|FG001|Overall Study|Death|262|||
33637550|NCT02516241|102223168|FG002|Overall Study|Death|270|||
33138773|NCT00395343|100423813|FG000|Overall Study|Protocol Violation|6|||
33138774|NCT00395343|100423814|FG001|Overall Study|Protocol Violation|8|||
33236011|NCT00333788|100765062|FG000|Overall Study|Other: Physician decision|1|||
33236012|NCT00333788|100765062|FG000|Overall Study|Other: Signed consent for another study|1|||
33236013|NCT04006366|100765063|FG000|Overall Study|Withdrawal by Subject|1|||
33236014|NCT03658811|100765064|FG000|Overall Study|Lost to Follow-up|3|||
33236015|NCT01439711|100765067|FG000|Overall Study|Ineligible|13|||
33236016|NCT01439711|100765067|FG000|Overall Study|Cancel|3|||
33236017|NCT01439711|100765067|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
33236018|NCT01439711|100765067|FG000|Overall Study|Adverse Event|5|||
33236019|NCT01439711|100765067|FG000|Overall Study|Withdrawal by Subject|3|||
33236020|NCT01439711|100765067|FG000|Overall Study|Progression During Active Tx|3|||
33236021|NCT01439711|100765067|FG000|Overall Study|Noncompliance|3|||
33236022|NCT01439711|100765067|FG000|Overall Study|No MRI|9|||
33236023|NCT01818700|100765068|FG000|Overall Study|Adverse Event|67|||
33236024|NCT01818700|100765068|FG000|Overall Study|Lack of Efficacy|2|||
33236025|NCT01818700|100765068|FG000|Overall Study|Lost to Follow-up|5|||
33236026|NCT01818700|100765068|FG000|Overall Study|Withdrawal by Subject|27|||
33236027|NCT01818700|100765068|FG000|Overall Study|Protocol Violation|2|||
33236028|NCT01818700|100765068|FG000|Overall Study|Other|1|||
33236029|NCT00109928|100765069|FG000|Overall Study|Adverse Event|2|||
33236030|NCT00109928|100765069|FG000|Overall Study|Progression|6|||
33236031|NCT00109928|100765069|FG000|Overall Study|Death|2|||
33236032|NCT00109928|100765069|FG000|Overall Study|not protocol specified|2|||
33236033|NCT00109928|100765069|FG000|Overall Study|not eligible|1|||
33236034|NCT00386308|100765070|FG000|Overall Study|Adverse Event|3|||
33236035|NCT00386308|100765071|FG001|Overall Study|Adverse Event|3|||
33236036|NCT00386308|100765070|FG000|Overall Study|Protocol Violation|2|||
33236037|NCT00386308|100765071|FG001|Overall Study|Protocol Violation|5|||
33236038|NCT00386308|100765070|FG000|Overall Study|Lack of Efficacy|0|||
33236039|NCT00386308|100765071|FG001|Overall Study|Lack of Efficacy|2|||
33236040|NCT00386308|100765070|FG000|Overall Study|Lost to Follow-up|10|||
33236041|NCT00386308|100765071|FG001|Overall Study|Lost to Follow-up|6|||
33236042|NCT00386308|100765070|FG000|Overall Study|Withdrawal by Subject|6|||
33236043|NCT00386308|100765071|FG001|Overall Study|Withdrawal by Subject|2|||
33236044|NCT00386308|100765070|FG000|Overall Study|Other Event|8|||
33236045|NCT00386308|100765071|FG001|Overall Study|Other Event|1|||
33236046|NCT00577720|100768020|FG000|Overall Study|Adverse Event|2|||
33236047|NCT00577720|100768021|FG001|Overall Study|Adverse Event|1|||
33138775|NCT00395343|100423813|FG000|Overall Study|Withdrawal by Subject|11|||
33138776|NCT00395343|100423814|FG001|Overall Study|Withdrawal by Subject|12|||
33138777|NCT00395343|100423813|FG000|Overall Study|Other|5|||
33138778|NCT00395343|100423814|FG001|Overall Study|Other|2|||
33138779|NCT03387111|100423815|FG000|Overall Study|Progressive Disease|3|||
33138780|NCT03387111|100423815|FG000|Overall Study|Other|1|||
33138781|NCT03339297|100423816|FG000|Overall Study|Relapse of Hematologic Disease|1|||
33138782|NCT03339297|100423817|FG001|Overall Study|Relapse of Hematologic Disease|0|||
33420716|NCT02426125|101431593|FG000|Overall Study|Death|185|||
33138783|NCT03339297|100423816|FG000|Overall Study|Death|10|||
33138784|NCT03339297|100423817|FG001|Overall Study|Death|7|||
33138785|NCT03339297|100423816|FG000|Overall Study|Hepatic Candidosis|1|||
33138786|NCT03339297|100423817|FG001|Overall Study|Hepatic Candidosis|0|||
33138787|NCT03339297|100423816|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
33138788|NCT03339297|100423817|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
33138789|NCT03339297|100423816|FG000|Overall Study|Consent Withdrawn by Participant|3|||
33236048|NCT00577720|100768022|FG002|Overall Study|Adverse Event|0|||
33236049|NCT00577720|100768023|FG003|Overall Study|Adverse Event|4|||
33420717|NCT02426125|101431594|FG001|Overall Study|Death|200|||
33420718|NCT02426125|101431593|FG000|Overall Study|Randomized, But Never Treated|5|||
33138790|NCT03339297|100423817|FG001|Overall Study|Consent Withdrawn by Participant|3|||
33138791|NCT03339297|100423816|FG000|Overall Study|Disease Relapse|2|||
33138792|NCT03339297|100423817|FG001|Overall Study|Disease Relapse|0|||
33138793|NCT03339297|100423816|FG000|Overall Study|Physician Decision|1|||
33236050|NCT00577720|100768020|FG000|Overall Study|Lost to Follow-up|0|||
33236051|NCT00577720|100768021|FG001|Overall Study|Lost to Follow-up|0|||
33236052|NCT00577720|100768022|FG002|Overall Study|Lost to Follow-up|1|||
33236053|NCT00577720|100768023|FG003|Overall Study|Lost to Follow-up|0|||
33420719|NCT02426125|101431594|FG001|Overall Study|Randomized, But Never Treated|2|||
33577356|NCT00003869|102003307|FG001|Overall Study|Adverse Event|3|||
33637551|NCT02516241|102223166|FG000|Overall Study|Lost to Follow-up|1|||
33138794|NCT03339297|100423817|FG001|Overall Study|Physician Decision|1|||
33236054|NCT00577720|100768020|FG000|Overall Study|Protocol Violation|0|||
33138795|NCT03339297|100423816|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
33138796|NCT03339297|100423817|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
33236055|NCT00577720|100768021|FG001|Overall Study|Protocol Violation|0|||
33637552|NCT02516241|102223167|FG001|Overall Study|Lost to Follow-up|1|||
33637553|NCT02516241|102223168|FG002|Overall Study|Lost to Follow-up|3|||
33637554|NCT02516241|102223166|FG000|Overall Study|Withdrawal by Subject|2|||
33637555|NCT02516241|102223167|FG001|Overall Study|Withdrawal by Subject|7|||
33637556|NCT02516241|102223168|FG002|Overall Study|Withdrawal by Subject|12|||
33637557|NCT02516241|102223166|FG000|Overall Study|participants ongoing at data cut-off|84|||
33637558|NCT02516241|102223167|FG001|Overall Study|participants ongoing at data cut-off|76|||
33637559|NCT02516241|102223168|FG002|Overall Study|participants ongoing at data cut-off|59|||
33637560|NCT01772316|102225800|FG000|Overall Study|Serious adverse event|1|||
33637561|NCT01772316|102225800|FG000|Overall Study|Inform consent withdrawn|1|||
33637562|NCT01772316|102225800|FG000|Overall Study|Withdrawn by sponsor decision|5|||
33637563|NCT00787644|102225801|FG000|Overall Study|Lost to Follow-up|1|||
33637564|NCT00787644|102225802|FG001|Overall Study|Lost to Follow-up|1|||
33637565|NCT00787644|102225801|FG000|Overall Study|Withdrawal by Subject|1|||
33637566|NCT00787644|102225802|FG001|Overall Study|Withdrawal by Subject|1|||
33637567|NCT01662102|102225805|FG000|Overall Study|Sponsor's decision|1|||
33637568|NCT01662102|102225806|FG001|Overall Study|Sponsor's decision|0|||
33637569|NCT02454517|102225807|FG000|Overall Study|Withdrawal by Subject|3|||
33637570|NCT02454517|102225808|FG001|Overall Study|Withdrawal by Subject|0|||
33637571|NCT02454517|102225807|FG000|Overall Study|Lost to Follow-up|4|||
33637572|NCT02454517|102225808|FG001|Overall Study|Lost to Follow-up|7|||
33637573|NCT02454517|102225807|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
33637574|NCT02454517|102225808|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
33637575|NCT01721044|102225809|FG000|Treatment Period|Adverse Event|7|||
33637576|NCT01721044|102225810|FG001|Treatment Period|Adverse Event|7|||
33637577|NCT01721044|102225811|FG002|Treatment Period|Adverse Event|10|||
33637578|NCT01721044|102225809|FG000|Treatment Period|Death|0|||
33637579|NCT01721044|102225810|FG001|Treatment Period|Death|0|||
33637580|NCT01721044|102225811|FG002|Treatment Period|Death|1|||
33637581|NCT01721044|102225809|FG000|Treatment Period|Lack of Efficacy|16|||
33637582|NCT01721044|102225810|FG001|Treatment Period|Lack of Efficacy|4|||
33637583|NCT01721044|102225811|FG002|Treatment Period|Lack of Efficacy|4|||
33637584|NCT01721044|102225809|FG000|Treatment Period|Lost to Follow-up|0|||
33637585|NCT01721044|102225810|FG001|Treatment Period|Lost to Follow-up|0|||
33637586|NCT01721044|102225811|FG002|Treatment Period|Lost to Follow-up|1|||
33637587|NCT01721044|102225809|FG000|Treatment Period|Physician Decision|1|||
33637588|NCT01721044|102225810|FG001|Treatment Period|Physician Decision|0|||
33637589|NCT01721044|102225811|FG002|Treatment Period|Physician Decision|2|||
33637590|NCT01721044|102225809|FG000|Treatment Period|Protocol Violation|1|||
33637591|NCT01721044|102225810|FG001|Treatment Period|Protocol Violation|0|||
33637592|NCT01721044|102225811|FG002|Treatment Period|Protocol Violation|0|||
33236056|NCT00577720|100768022|FG002|Overall Study|Protocol Violation|0|||
33236057|NCT00577720|100768023|FG003|Overall Study|Protocol Violation|1|||
33236058|NCT00577720|100768020|FG000|Overall Study|Withdrawal by Subject|2|||
33236059|NCT00577720|100768021|FG001|Overall Study|Withdrawal by Subject|0|||
33236060|NCT00577720|100768022|FG002|Overall Study|Withdrawal by Subject|0|||
33236061|NCT00577720|100768023|FG003|Overall Study|Withdrawal by Subject|2|||
33236062|NCT01804673|100768031|FG000|Overall Study|Adverse Event|4|||
33236063|NCT01804673|100768031|FG000|Overall Study|Withdrawal by Subject|1|||
33236064|NCT01804673|100768031|FG000|Overall Study|Lack of Efficacy|9|||
33236065|NCT01804673|100768031|FG000|Overall Study|Change to Oral Therapy|37|||
33236066|NCT01804673|100768031|FG000|Overall Study|No Further Therapy Required|84|||
33236067|NCT01804673|100768031|FG000|Overall Study|Use of Prohibited Medication|1|||
33236068|NCT01804673|100768031|FG000|Overall Study|Other|4|||
33236069|NCT01167179|100768038|FG000|Overall Study|disease recurrence|4|||
33236070|NCT01167179|100768039|FG001|Overall Study|disease recurrence|4|||
33236071|NCT01167179|100768038|FG000|Overall Study|Death|4|||
33369089|NCT03215706|101236566|FG000|Treatment Period|Other Reasons|4|||
33369090|NCT03215706|101236567|FG001|Treatment Period|Other Reasons|5|||
33369091|NCT03215706|101236566|FG000|Treatment Period|Ongoing in the treatment period|105|||
33369092|NCT03215706|101236567|FG001|Treatment Period|Ongoing in the treatment period|43|||
33369093|NCT03759379|101236568|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
33369094|NCT03759379|101236569|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
33637593|NCT01721044|102225809|FG000|Treatment Period|Withdrawal by Subject|7|||
33637594|NCT01721044|102225810|FG001|Treatment Period|Withdrawal by Subject|6|||
33637595|NCT01721044|102225811|FG002|Treatment Period|Withdrawal by Subject|1|||
33637596|NCT00705016|102225812|FG000|Overall Study|Adverse Event|6|||
33637597|NCT00705016|102225813|FG001|Overall Study|Adverse Event|11|||
33637598|NCT00705016|102225814|FG002|Overall Study|Adverse Event|10|||
33637599|NCT00705016|102225812|FG000|Overall Study|Death|5|||
33637600|NCT00705016|102225813|FG001|Overall Study|Death|7|||
33637601|NCT00705016|102225814|FG002|Overall Study|Death|5|||
33637602|NCT00705016|102225812|FG000|Overall Study|Protocol Violation|0|||
33637603|NCT00705016|102225813|FG001|Overall Study|Protocol Violation|1|||
33637604|NCT00705016|102225814|FG002|Overall Study|Protocol Violation|1|||
33236072|NCT01167179|100768039|FG001|Overall Study|Death|10|||
33369095|NCT03759379|101236568|FG000|Treatment Period|Death|2|||
33369096|NCT03759379|101236569|FG001|Treatment Period|Death|3|||
33369097|NCT03759379|101236568|FG000|Treatment Period|Lost to Follow-up|1|||
33577357|NCT00003869|102003306|FG000|Overall Study|Withdrawal by Subject|21|||
33236073|NCT01167179|100768038|FG000|Overall Study|Withdrawal by Subject|1|||
33236074|NCT01167179|100768039|FG001|Overall Study|Withdrawal by Subject|2|||
33577358|NCT00003869|102003307|FG001|Overall Study|Withdrawal by Subject|3|||
33577359|NCT00003869|102003306|FG000|Overall Study|Death|1|||
33577360|NCT00003869|102003307|FG001|Overall Study|Death|2|||
33577361|NCT00003869|102003306|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
33577362|NCT00003869|102003307|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
33577363|NCT01343888|102003310|FG000|Overall Study|Adverse Event|12|||
33637605|NCT00705016|102225812|FG000|Overall Study|Withdrawal by Subject|4|||
33637606|NCT00705016|102225813|FG001|Overall Study|Withdrawal by Subject|3|||
33637607|NCT00705016|102225814|FG002|Overall Study|Withdrawal by Subject|2|||
33637608|NCT00705016|102225812|FG000|Overall Study|Progressive Disease|33|||
33637609|NCT00705016|102225813|FG001|Overall Study|Progressive Disease|29|||
33637610|NCT00705016|102225814|FG002|Overall Study|Progressive Disease|33|||
33637611|NCT00705016|102225812|FG000|Overall Study|Symptomatic Deterioration|3|||
33637612|NCT00705016|102225813|FG001|Overall Study|Symptomatic Deterioration|1|||
33637613|NCT00705016|102225814|FG002|Overall Study|Symptomatic Deterioration|1|||
33637614|NCT00705016|102225812|FG000|Overall Study|Other|9|||
33637615|NCT00705016|102225813|FG001|Overall Study|Other|6|||
33637616|NCT00705016|102225814|FG002|Overall Study|Other|6|||
33637617|NCT00724698|102225819|FG000|Overall Study|Adverse Event|9|||
33637618|NCT00724698|102225819|FG000|Overall Study|Failure of Therapy|4|||
33637619|NCT00724698|102225819|FG000|Overall Study|Poor Compliance|16|||
33637620|NCT00724698|102225819|FG000|Overall Study|Lost to Follow-up|36|||
33637621|NCT00724698|102225819|FG000|Overall Study|No Info|25|||
33637622|NCT00335777|102225820|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
33637623|NCT00335777|102225820|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
33637624|NCT00335777|102225820|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
33637625|NCT00335777|102225820|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
33637626|NCT00335777|102225820|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
33637627|NCT01747876|102225823|FG000|Overall Study|Adverse Event|1|||
33637628|NCT01747876|102225824|FG001|Overall Study|Adverse Event|0|||
33637629|NCT01747876|102225825|FG002|Overall Study|Adverse Event|2|||
33637630|NCT01747876|102225823|FG000|Overall Study|Withdrawal by Subject|0|||
33637631|NCT01747876|102225824|FG001|Overall Study|Withdrawal by Subject|1|||
33637632|NCT01747876|102225825|FG002|Overall Study|Withdrawal by Subject|1|||
33637633|NCT01747876|102225823|FG000|Overall Study|Disease progression|4|||
33637634|NCT01747876|102225824|FG001|Overall Study|Disease progression|13|||
33637635|NCT01747876|102225825|FG002|Overall Study|Disease progression|8|||
33637636|NCT01747876|102225823|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
33637637|NCT01747876|102225824|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
33637638|NCT01747876|102225825|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
33637639|NCT04237116|102225832|FG000|Overall Study|Adverse Event|0|||
33637640|NCT04237116|102225833|FG001|Overall Study|Adverse Event|1|||
33637641|NCT04237116|102225832|FG000|Overall Study|Study terminated by Sponsor|4|||
33637642|NCT04237116|102225833|FG001|Overall Study|Study terminated by Sponsor|1|||
33637643|NCT03841604|102225834|FG000|Overall Study|Withdrawal by Subject|3|||
33637644|NCT03841604|102225835|FG001|Overall Study|Withdrawal by Subject|1|||
33637645|NCT03841604|102225834|FG000|Overall Study|Adverse Event|4|||
33637646|NCT03841604|102225835|FG001|Overall Study|Adverse Event|2|||
33637647|NCT03841604|102225834|FG000|Overall Study|Physician Decision|1|||
33637648|NCT03841604|102225835|FG001|Overall Study|Physician Decision|0|||
33637649|NCT03822117|102225838|FG000|Overall Study|Death|18|||
33637650|NCT03822117|102225839|FG001|Overall Study|Death|17|||
33637651|NCT03822117|102225840|FG002|Overall Study|Death|12|||
33637652|NCT03822117|102225841|FG003|Overall Study|Death|4|||
33637653|NCT03822117|102225838|FG000|Overall Study|Lost to Follow-up|1|||
33637654|NCT03822117|102225839|FG001|Overall Study|Lost to Follow-up|2|||
33637655|NCT03822117|102225840|FG002|Overall Study|Lost to Follow-up|3|||
33236075|NCT01167179|100768038|FG000|Overall Study|diverse|6|||
33236076|NCT01167179|100768039|FG001|Overall Study|diverse|5|||
33369098|NCT03759379|101236569|FG001|Treatment Period|Lost to Follow-up|0|||
33369099|NCT03759379|101236568|FG000|Treatment Period|Physician Decision|0|||
33577364|NCT01343888|102003311|FG001|Overall Study|Adverse Event|22|||
33637656|NCT03822117|102225841|FG003|Overall Study|Lost to Follow-up|0|||
33637657|NCT03822117|102225838|FG000|Overall Study|Study Terminated by Sponsor|25|||
33637658|NCT03822117|102225839|FG001|Overall Study|Study Terminated by Sponsor|11|||
33637659|NCT03822117|102225840|FG002|Overall Study|Study Terminated by Sponsor|6|||
33637660|NCT03822117|102225841|FG003|Overall Study|Study Terminated by Sponsor|0|||
33637661|NCT03822117|102225838|FG000|Overall Study|Withdrawal by Subject|4|||
33637662|NCT03822117|102225839|FG001|Overall Study|Withdrawal by Subject|0|||
33637663|NCT03822117|102225840|FG002|Overall Study|Withdrawal by Subject|3|||
33236077|NCT04230980|100768040|FG000|Overall Study|Lost to Follow-up|1|||
33369100|NCT03759379|101236569|FG001|Treatment Period|Physician Decision|1|||
33577365|NCT01343888|102003312|FG002|Overall Study|Adverse Event|5|||
33637664|NCT03822117|102225841|FG003|Overall Study|Withdrawal by Subject|0|||
33637665|NCT03822117|102225838|FG000|Overall Study|Disease Progression|1|||
33637666|NCT03822117|102225839|FG001|Overall Study|Disease Progression|2|||
33637667|NCT03822117|102225840|FG002|Overall Study|Disease Progression|1|||
33637668|NCT03822117|102225841|FG003|Overall Study|Disease Progression|0|||
33637669|NCT03822117|102225838|FG000|Overall Study|Never Returned to Hospital|0|||
33637670|NCT03822117|102225839|FG001|Overall Study|Never Returned to Hospital|0|||
33637671|NCT03822117|102225840|FG002|Overall Study|Never Returned to Hospital|1|||
33637672|NCT03822117|102225841|FG003|Overall Study|Never Returned to Hospital|0|||
33236078|NCT04230980|100768041|FG001|Overall Study|Lost to Follow-up|2|||
33236079|NCT04230980|100768040|FG000|Overall Study|Adverse Event|0|||
33236080|NCT04230980|100768041|FG001|Overall Study|Adverse Event|1|||
33236081|NCT04004208|100768048|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33236082|NCT04004208|100768049|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33236083|NCT04004208|100768048|FG000|Overall Study|Death|3|||
33236084|NCT04004208|100768049|FG001|Overall Study|Death|0|||
33236085|NCT04004208|100768048|FG000|Overall Study|COVID-19 pandemic|1|||
33236086|NCT04004208|100768049|FG001|Overall Study|COVID-19 pandemic|0|||
33637673|NCT03023397|102225845|FG000|Run-In|Failed screening allergen challenge|1|||
33577366|NCT01343888|102003310|FG000|Overall Study|Lack of Efficacy|9|||
33577367|NCT01343888|102003311|FG001|Overall Study|Lack of Efficacy|9|||
33577368|NCT01343888|102003312|FG002|Overall Study|Lack of Efficacy|13|||
33577369|NCT01343888|102003310|FG000|Overall Study|Lost to Follow-up|0|||
33577370|NCT01343888|102003311|FG001|Overall Study|Lost to Follow-up|2|||
33637674|NCT03023397|102225846|FG001|Run-In|Failed screening allergen challenge|0|||
33637675|NCT03023397|102225847|FG002|Run-In|Failed screening allergen challenge|0|||
33637676|NCT03023397|102225845|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
33637677|NCT03023397|102225846|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
33637678|NCT03023397|102225847|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
33637679|NCT03387085|102225848|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
33637680|NCT02558296|102225849|FG000|Completed the Study Through Week 24|Adverse Event|9|||
33637681|NCT02558296|102225850|FG001|Completed the Study Through Week 24|Adverse Event|3|||
33236087|NCT04004208|100768048|FG000|Overall Study|Physician Decision|1|||
33236088|NCT04004208|100768049|FG001|Overall Study|Physician Decision|0|||
33236089|NCT04004208|100768048|FG000|Overall Study|Adverse Event|1|||
33236090|NCT04004208|100768049|FG001|Overall Study|Adverse Event|1|||
33236091|NCT04668989|100768050|FG000|First Intervention|Covid-19 related self-isolation|0|||
33236092|NCT04668989|100768051|FG001|First Intervention|Covid-19 related self-isolation|1|||
33236093|NCT04668989|100768050|FG000|Second Intervention|Adverse Event|0|||
33236094|NCT04668989|100768051|FG001|Second Intervention|Adverse Event|1|||
33236095|NCT02080520|100768054|FG000|Overall Study|Self-reported symptoms|5|||
33236096|NCT02080520|100768055|FG001|Overall Study|Self-reported symptoms|6|||
33236097|NCT02080520|100768054|FG000|Overall Study|Unable to contact|2|||
33236098|NCT02080520|100768055|FG001|Overall Study|Unable to contact|1|||
33236099|NCT02080520|100768054|FG000|Overall Study|Initiated aspirin|2|||
33236100|NCT02080520|100768055|FG001|Overall Study|Initiated aspirin|0|||
33236101|NCT02080520|100768054|FG000|Overall Study|Atrial fibrillation|1|||
33236102|NCT02080520|100768055|FG001|Overall Study|Atrial fibrillation|1|||
33236103|NCT02080520|100768054|FG000|Overall Study|Cancer|1|||
33236104|NCT02080520|100768055|FG001|Overall Study|Cancer|2|||
33236105|NCT02080520|100768054|FG000|Overall Study|Not interested in study|1|||
33637682|NCT02558296|102225849|FG000|Completed the Study Through Week 24|Death|7|||
33637683|NCT02558296|102225850|FG001|Completed the Study Through Week 24|Death|7|||
33637684|NCT02558296|102225849|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
33637685|NCT02558296|102225850|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
33637686|NCT02558296|102225849|FG000|Completed the Study Through Week 24|Physician Decision|1|||
33637687|NCT02558296|102225850|FG001|Completed the Study Through Week 24|Physician Decision|0|||
33637688|NCT02558296|102225849|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
33138797|NCT03339297|100423816|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
33138798|NCT03339297|100423817|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
33236106|NCT02080520|100768055|FG001|Overall Study|Not interested in study|3|||
33236107|NCT02080520|100768054|FG000|Overall Study|Too busy|1|||
33236108|NCT02080520|100768055|FG001|Overall Study|Too busy|1|||
33637689|NCT02558296|102225850|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
33369101|NCT05349838|101236570|FG000|Overall Study|Virological Failure|1|||
33369102|NCT05349838|101236571|FG001|Overall Study|Virological Failure|2|||
33236109|NCT02080520|100768054|FG000|Overall Study|Work-related injury|1|||
33236110|NCT02080520|100768055|FG001|Overall Study|Work-related injury|0|||
33236111|NCT02080520|100768054|FG000|Overall Study|Personal reasons|0|||
33236112|NCT02080520|100768055|FG001|Overall Study|Personal reasons|3|||
33236113|NCT04640571|100768056|FG000|Overall Study|Withdrawal by Subject|0|||
33236114|NCT04640571|100768057|FG001|Overall Study|Withdrawal by Subject|0|||
33369103|NCT05349838|101236570|FG000|Overall Study|Withdrawal by Subject|2|||
33577371|NCT01343888|102003312|FG002|Overall Study|Lost to Follow-up|1|||
33577372|NCT01343888|102003310|FG000|Overall Study|Protocol Violation|0|||
33236115|NCT04640571|100768058|FG002|Overall Study|Withdrawal by Subject|0|||
33236116|NCT04640571|100768059|FG003|Overall Study|Withdrawal by Subject|0|||
33577373|NCT01343888|102003311|FG001|Overall Study|Protocol Violation|2|||
33577374|NCT01343888|102003312|FG002|Overall Study|Protocol Violation|0|||
33577375|NCT01343888|102003310|FG000|Overall Study|Withdrawal by Subject|4|||
33577376|NCT01343888|102003311|FG001|Overall Study|Withdrawal by Subject|4|||
33369104|NCT05349838|101236571|FG001|Overall Study|Withdrawal by Subject|3|||
33369105|NCT05349838|101236570|FG000|Overall Study|Adverse Event|3|||
33369106|NCT05349838|101236571|FG001|Overall Study|Adverse Event|1|||
33369107|NCT05349838|101236570|FG000|Overall Study|Lost to Follow-up|1|||
33369108|NCT05349838|101236571|FG001|Overall Study|Lost to Follow-up|2|||
33369109|NCT05349838|101236570|FG000|Overall Study|Other reasons|5|||
33369110|NCT05349838|101236571|FG001|Overall Study|Other reasons|1|||
33369111|NCT01931462|101236574|FG000|Overall Study|Withdrawal by Subject|1|||
33369112|NCT03276936|101236575|FG000|Overall Study|Adverse Event|4|||
33138799|NCT03339297|100423816|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
33138800|NCT03339297|100423817|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
33138801|NCT03339297|100423816|FG000|Overall Study|Adverse Event, Non-fatal|1|||
33138802|NCT03339297|100423817|FG001|Overall Study|Adverse Event, Non-fatal|0|||
33138803|NCT03339297|100423816|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
33236117|NCT04640571|100768060|FG004|Overall Study|Withdrawal by Subject|0|||
33236118|NCT04640571|100768061|FG005|Overall Study|Withdrawal by Subject|2|||
33236119|NCT03824938|100768062|FG000|Overall Study|Withdrawal by Subject|2|||
33236120|NCT03824938|100768063|FG001|Overall Study|Withdrawal by Subject|1|||
33236121|NCT03824938|100768064|FG002|Overall Study|Withdrawal by Subject|0|||
33236122|NCT03824938|100768065|FG003|Overall Study|Withdrawal by Subject|2|||
33236123|NCT03824938|100768066|FG004|Overall Study|Withdrawal by Subject|0|||
33236124|NCT03824938|100768067|FG005|Overall Study|Withdrawal by Subject|1|||
33236125|NCT03824938|100768062|FG000|Overall Study|Lost to Follow-up|0|||
33236126|NCT03824938|100768063|FG001|Overall Study|Lost to Follow-up|1|||
33236127|NCT03824938|100768064|FG002|Overall Study|Lost to Follow-up|0|||
33236128|NCT03824938|100768065|FG003|Overall Study|Lost to Follow-up|0|||
33236129|NCT03824938|100768066|FG004|Overall Study|Lost to Follow-up|1|||
33236130|NCT03824938|100768067|FG005|Overall Study|Lost to Follow-up|0|||
33236131|NCT00972543|100768070|FG000|Overall Study|Adverse Event|1|||
33236132|NCT00972543|100768071|FG001|Overall Study|Adverse Event|0|||
33236133|NCT00972543|100768070|FG000|Overall Study|Early study termination by sponsor|4|||
33236134|NCT00972543|100768071|FG001|Overall Study|Early study termination by sponsor|1|||
33236135|NCT00896454|100768076|FG000|Overall Study|Death|10|||
33236136|NCT00896454|100768076|FG000|Overall Study|Adverse Event|8|||
33236137|NCT00896454|100768076|FG000|Overall Study|Disease Progression|5|||
33236138|NCT00896454|100768076|FG000|Overall Study|Other|4|||
33236139|NCT00896454|100768076|FG000|Overall Study|Requirement for alternative therapy|3|||
33236140|NCT00896454|100768076|FG000|Overall Study|Ongoing in study|2|||
33236141|NCT00896454|100768076|FG000|Overall Study|Withdrawal by Subject|1|||
33236142|NCT01196104|100768077|FG000|Overall Study|Lost to Follow-up|1|||
33236143|NCT01196104|100768078|FG001|Overall Study|Lost to Follow-up|0|||
33236144|NCT01196104|100768077|FG000|Overall Study|Physician Decision|0|||
33236145|NCT01196104|100768078|FG001|Overall Study|Physician Decision|1|||
33236146|NCT01196104|100768077|FG000|Overall Study|Withdrawal by Subject|3|||
33369113|NCT03276936|101236576|FG001|Overall Study|Adverse Event|2|||
33369114|NCT03276936|101236575|FG000|Overall Study|Lost to Follow-up|16|||
33369115|NCT03276936|101236576|FG001|Overall Study|Lost to Follow-up|13|||
33369116|NCT03276936|101236575|FG000|Overall Study|Withdrawal by Subject|30|||
33369117|NCT03276936|101236576|FG001|Overall Study|Withdrawal by Subject|20|||
33577377|NCT01343888|102003312|FG002|Overall Study|Withdrawal by Subject|2|||
33577378|NCT01343888|102003310|FG000|Overall Study|other than stated above|0|||
33577379|NCT01343888|102003311|FG001|Overall Study|other than stated above|0|||
33577380|NCT01343888|102003312|FG002|Overall Study|other than stated above|1|||
33577381|NCT00444925|102006409|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
33577382|NCT00444925|102006410|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
33577383|NCT00444925|102006411|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
33577384|NCT00444925|102006409|FG000|Double-blind Treatment Period|Death|2|||
33577385|NCT00444925|102006410|FG001|Double-blind Treatment Period|Death|0|||
33577386|NCT00444925|102006411|FG002|Double-blind Treatment Period|Death|0|||
33577387|NCT00444925|102006409|FG000|Double-blind Treatment Period|Adverse Event|6|||
33138804|NCT03339297|100423817|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
33138805|NCT03339297|100423816|FG000|Overall Study|Patient Was Not Eligible|1|||
33138806|NCT03339297|100423817|FG001|Overall Study|Patient Was Not Eligible|0|||
33138807|NCT03565367|100423819|FG000|Overall Study|No scan due to technical issues|4|||
33138808|NCT03565367|100423820|FG001|Overall Study|No scan due to technical issues|0|||
33138809|NCT02694757|100423823|FG000|Overall Study|Lack of Efficacy|3|||
33138810|NCT00265148|100423824|FG000|Overall Study|Adverse Event|2|||
33369118|NCT03276936|101236575|FG000|Overall Study|Not mentioned|6|||
33369119|NCT03276936|101236576|FG001|Overall Study|Not mentioned|3|||
33236147|NCT01196104|100768078|FG001|Overall Study|Withdrawal by Subject|3|||
33236148|NCT01196104|100768077|FG000|Overall Study|Various|0|||
33236149|NCT01196104|100768078|FG001|Overall Study|Various|1|||
33236150|NCT01513967|100768080|FG000|Overall Study|Pregnancy|0|||
33236151|NCT01513967|100768081|FG001|Overall Study|Pregnancy|0|||
33236152|NCT01513967|100768082|FG002|Overall Study|Pregnancy|0|||
33236153|NCT01513967|100768083|FG003|Overall Study|Pregnancy|0|||
33236154|NCT01513967|100768084|FG004|Overall Study|Pregnancy|0|||
33236155|NCT01513967|100768085|FG005|Overall Study|Pregnancy|0|||
33236156|NCT01513967|100768086|FG006|Overall Study|Pregnancy|1|||
33236157|NCT01513967|100768087|FG007|Overall Study|Pregnancy|0|||
33236158|NCT01513967|100768080|FG000|Overall Study|missed a study visit|0|||
33236159|NCT01513967|100768081|FG001|Overall Study|missed a study visit|0|||
33236160|NCT01513967|100768082|FG002|Overall Study|missed a study visit|0|||
33236161|NCT01513967|100768083|FG003|Overall Study|missed a study visit|0|||
33236162|NCT01513967|100768084|FG004|Overall Study|missed a study visit|0|||
33236163|NCT01513967|100768085|FG005|Overall Study|missed a study visit|0|||
33236164|NCT01513967|100768086|FG006|Overall Study|missed a study visit|1|||
33236165|NCT01513967|100768087|FG007|Overall Study|missed a study visit|0|||
33236166|NCT01513967|100768080|FG000|Overall Study|excluded due to positive drug screen|0|||
33236167|NCT01513967|100768081|FG001|Overall Study|excluded due to positive drug screen|0|||
33236168|NCT01513967|100768082|FG002|Overall Study|excluded due to positive drug screen|0|||
33236169|NCT01513967|100768083|FG003|Overall Study|excluded due to positive drug screen|0|||
33236170|NCT01513967|100768084|FG004|Overall Study|excluded due to positive drug screen|0|||
33236171|NCT01513967|100768085|FG005|Overall Study|excluded due to positive drug screen|0|||
33236172|NCT01513967|100768086|FG006|Overall Study|excluded due to positive drug screen|0|||
33236173|NCT01513967|100768087|FG007|Overall Study|excluded due to positive drug screen|2|||
33236174|NCT01513967|100768080|FG000|Overall Study|Physician Decision|0|||
33236175|NCT01513967|100768081|FG001|Overall Study|Physician Decision|0|||
33236176|NCT01513967|100768082|FG002|Overall Study|Physician Decision|0|||
33236177|NCT01513967|100768083|FG003|Overall Study|Physician Decision|0|||
33236178|NCT01513967|100768084|FG004|Overall Study|Physician Decision|0|||
33236179|NCT01513967|100768085|FG005|Overall Study|Physician Decision|1|||
33236180|NCT01513967|100768086|FG006|Overall Study|Physician Decision|0|||
33236181|NCT01513967|100768087|FG007|Overall Study|Physician Decision|0|||
33236182|NCT02400307|100768089|FG000|Overall Study|Enrolled and Never Dosed|1|||
33236183|NCT02400307|100768090|FG001|Overall Study|Enrolled and Never Dosed|0|||
33236184|NCT04012814|100768091|FG000|Overall Study|Lost to Follow-up|4|||
33236185|NCT04012814|100768091|FG000|Overall Study|Withdrawal by Subject|2|||
33236186|NCT04012814|100768091|FG000|Overall Study|Protocol Violation|1|||
33236187|NCT04012814|100768091|FG000|Overall Study|Adverse Event|1|||
33236188|NCT02478359|100768092|FG000|Overall Study|Disenrolled from health plan|106|||
33236189|NCT02478359|100768093|FG001|Overall Study|Disenrolled from health plan|65|||
33236190|NCT01058863|100768094|FG000|Overall Study|Lost to Follow-up|1|||
33236191|NCT01058863|100768094|FG000|Overall Study|Withdrawal by Subject|1|||
33236192|NCT01058863|100768094|FG000|Overall Study|Sponsor requested withdrawal|1|||
33236193|NCT01058863|100768094|FG000|Overall Study|Randomized in error|1|||
33236194|NCT02839681|100768095|FG000|Overall Study|Death|2|||
33236195|NCT00388362|100768098|FG000|Enrolled|Ineligible|1|||
33236196|NCT00388362|100768098|FG000|Enrolled|Adverse Event|9|||
33236197|NCT00388362|100768098|FG000|Enrolled|Death|1|||
33369120|NCT03097328|101236577|FG000|Overall Study|Still on Therapy|2|||
33369121|NCT03097328|101236577|FG000|Overall Study|Progressive Disease|29|||
33369122|NCT03097328|101236577|FG000|Overall Study|Adverse Event|4|||
33369123|NCT03097328|101236577|FG000|Overall Study|Withdrawal by Subject|1|||
33369124|NCT03097328|101236577|FG000|Overall Study|Physician Decision|1|||
33577388|NCT00444925|102006410|FG001|Double-blind Treatment Period|Adverse Event|28|||
33577389|NCT00444925|102006411|FG002|Double-blind Treatment Period|Adverse Event|44|||
33577390|NCT00444925|102006409|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
33577391|NCT00444925|102006410|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
33236198|NCT00388362|100768098|FG000|Enrolled|Loss insurance|1|||
33236199|NCT00388362|100768098|FG000|Enrolled|Withdrawal by Subject|1|||
33236200|NCT00388362|100768098|FG000|Remained on Study Median of 514 Days|Death|2|||
33236201|NCT03389893|100768099|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
33236202|NCT03389893|100768100|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
33236203|NCT03389893|100768101|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
33236204|NCT03389893|100768102|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
33236205|NCT03389893|100768099|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
33236206|NCT03389893|100768100|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
33236207|NCT03389893|100768101|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
33236208|NCT03389893|100768102|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
33236209|NCT03389893|100768099|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
33236210|NCT03389893|100768100|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
33236211|NCT03389893|100768101|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
33369125|NCT03097328|101236577|FG000|Overall Study|Patient Decision|1|||
33236212|NCT03389893|100768102|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
33236213|NCT03389893|100768099|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
33236214|NCT03389893|100768100|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
33236215|NCT03389893|100768101|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
33236216|NCT03389893|100768102|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
33236217|NCT01959880|100768103|FG000|Overall Study|Withdrawal by Subject|11|||
33236218|NCT01959880|100768104|FG001|Overall Study|Withdrawal by Subject|13|||
33236219|NCT01959880|100768105|FG002|Overall Study|Withdrawal by Subject|8|||
33236220|NCT01959880|100768106|FG003|Overall Study|Withdrawal by Subject|7|||
33236221|NCT01959880|100768103|FG000|Overall Study|Death|1|||
33236222|NCT01959880|100768104|FG001|Overall Study|Death|10|||
33236223|NCT01959880|100768105|FG002|Overall Study|Death|1|||
33236224|NCT01959880|100768106|FG003|Overall Study|Death|2|||
33236225|NCT01959880|100768103|FG000|Overall Study|Lost to Follow-up|95|||
33236226|NCT01959880|100768104|FG001|Overall Study|Lost to Follow-up|18|||
33236227|NCT01959880|100768105|FG002|Overall Study|Lost to Follow-up|15|||
33236228|NCT01959880|100768106|FG003|Overall Study|Lost to Follow-up|8|||
33236229|NCT01959880|100768103|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
33236230|NCT01959880|100768104|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
33369126|NCT03097328|101236577|FG000|Overall Study|Ineligible for Study Drug|1|||
33369127|NCT03100942|101236578|FG000|Randomized Treatment Period|Withdrew Consent|4|||
33577392|NCT00444925|102006411|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
33577393|NCT00444925|102006409|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
33577394|NCT00444925|102006410|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
33577395|NCT00444925|102006411|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
33577396|NCT00444925|102006409|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
33577397|NCT00444925|102006410|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
33138811|NCT00265148|100423825|FG001|Overall Study|Adverse Event|2|||
33138812|NCT00265148|100423824|FG000|Overall Study|Lack of Efficacy|0|||
33138813|NCT00265148|100423825|FG001|Overall Study|Lack of Efficacy|2|||
33138814|NCT00265148|100423824|FG000|Overall Study|Protocol Violation|3|||
33138815|NCT00265148|100423825|FG001|Overall Study|Protocol Violation|2|||
33138816|NCT00265148|100423824|FG000|Overall Study|Lost to Follow-up|0|||
33138817|NCT00265148|100423825|FG001|Overall Study|Lost to Follow-up|1|||
33138818|NCT00265148|100423824|FG000|Overall Study|Withdrawal by Subject|2|||
33138819|NCT00265148|100423825|FG001|Overall Study|Withdrawal by Subject|1|||
33138820|NCT00265148|100423824|FG000|Overall Study|Physician Decision|1|||
33138821|NCT00265148|100423825|FG001|Overall Study|Physician Decision|0|||
33138822|NCT00265148|100423824|FG000|Overall Study|Increasing frailty|0|||
33138823|NCT00265148|100423825|FG001|Overall Study|Increasing frailty|1|||
33138824|NCT00265148|100423824|FG000|Overall Study|Subject chose to change of the dose|1|||
33138825|NCT00265148|100423825|FG001|Overall Study|Subject chose to change of the dose|0|||
33138826|NCT04966910|100423826|FG000|Baseline|Participant did not complete measure|0|||
33138827|NCT04966910|100423827|FG001|Baseline|Participant did not complete measure|0|||
33138828|NCT04966910|100423828|FG002|Baseline|Participant did not complete measure|1|||
33138829|NCT04966910|100423829|FG003|Baseline|Participant did not complete measure|0|||
33138830|NCT04966910|100423826|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
33138831|NCT04966910|100423827|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
33138832|NCT04966910|100423828|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
33138833|NCT04966910|100423829|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
33138834|NCT04966910|100423826|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
33138835|NCT04966910|100423827|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
33138836|NCT04966910|100423828|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
33138837|NCT04966910|100423829|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
33138838|NCT04966910|100423826|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
33138839|NCT04966910|100423827|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
33138840|NCT04966910|100423828|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
33138841|NCT04966910|100423829|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
33138842|NCT03473548|100423830|FG000|Overall Study|Did not attempt HST testing|3|||
33138843|NCT03473548|100423831|FG001|Overall Study|Did not attempt HST testing|0|||
33138844|NCT00436501|100423832|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
33138845|NCT00436501|100423833|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
33138846|NCT00436501|100423832|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
33138847|NCT00436501|100423833|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
33138848|NCT03472547|100423837|FG000|Overall Study|Withdrawal by Subject|30|||
33138849|NCT00402233|100423843|FG000|Overall Study|Adverse Event|1|||
33138850|NCT00402233|100423844|FG001|Overall Study|Adverse Event|7|||
33138851|NCT00402233|100423845|FG002|Overall Study|Adverse Event|9|||
33138852|NCT00402233|100423846|FG003|Overall Study|Adverse Event|9|||
33138853|NCT00402233|100423843|FG000|Overall Study|Protocol Violation|0|||
33138854|NCT00402233|100423844|FG001|Overall Study|Protocol Violation|1|||
33138855|NCT00402233|100423845|FG002|Overall Study|Protocol Violation|0|||
33138856|NCT00402233|100423846|FG003|Overall Study|Protocol Violation|0|||
33236231|NCT01959880|100768105|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
33236232|NCT01959880|100768106|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
33236233|NCT01959880|100768103|FG000|Overall Study|Study completed early-FDA approved|1003|||
33236234|NCT01959880|100768104|FG001|Overall Study|Study completed early-FDA approved|311|||
33236235|NCT01959880|100768105|FG002|Overall Study|Study completed early-FDA approved|179|||
33236236|NCT01959880|100768106|FG003|Overall Study|Study completed early-FDA approved|152|||
33236237|NCT03405662|100768107|FG000|Overall Study|COVID-19 restriction|1|||
33236238|NCT03405662|100768108|FG001|Overall Study|COVID-19 restriction|0|||
33236239|NCT03405662|100768107|FG000|Overall Study|unblinding|0|||
33236240|NCT03405662|100768108|FG001|Overall Study|unblinding|1|||
33236241|NCT03405662|100768107|FG000|Overall Study|placement in memory care facility|0|||
33236242|NCT03405662|100768108|FG001|Overall Study|placement in memory care facility|2|||
33236243|NCT03890120|100768111|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
33236244|NCT03890120|100768112|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
33236245|NCT03890120|100768113|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
33236246|NCT03890120|100768114|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
33236247|NCT03890120|100768111|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
33236248|NCT03890120|100768112|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
33236249|NCT03890120|100768113|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
33236250|NCT03890120|100768114|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
33236251|NCT03890120|100768111|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
33236252|NCT03890120|100768112|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
33236253|NCT03890120|100768113|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
33236254|NCT03890120|100768114|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
33236255|NCT03890120|100768111|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
33236256|NCT03890120|100768112|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
33236257|NCT03890120|100768113|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
33236258|NCT03890120|100768114|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
33236259|NCT03890120|100768111|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
33236260|NCT03890120|100768112|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
33236261|NCT03890120|100768113|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
33236262|NCT03890120|100768114|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
33236263|NCT03890120|100768111|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
33236264|NCT03890120|100768112|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
33236265|NCT03890120|100768113|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
33236266|NCT03890120|100768114|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
33236267|NCT03890120|100768111|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
33236268|NCT03890120|100768112|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
33236269|NCT03890120|100768113|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
33236270|NCT03890120|100768114|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
33236271|NCT03890120|100768111|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
33236272|NCT03890120|100768112|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
33236273|NCT03890120|100768113|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
33236274|NCT03890120|100768114|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
33236275|NCT03890120|100768111|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
33236276|NCT03890120|100768112|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
33236277|NCT03890120|100768113|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
33236278|NCT03890120|100768114|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
33236279|NCT03890120|100768111|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
33236280|NCT03890120|100768112|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
33236281|NCT03890120|100768113|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
33236282|NCT03890120|100768114|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
33236283|NCT03890120|100768111|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
33236284|NCT03890120|100768112|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
33236285|NCT03890120|100768113|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
33236286|NCT03890120|100768114|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
33236287|NCT03890120|100768111|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
33236288|NCT03890120|100768112|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
33236289|NCT03890120|100768113|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
33236290|NCT03890120|100768114|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
33236291|NCT03890120|100768111|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
33236292|NCT03890120|100768112|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
33236293|NCT03890120|100768113|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
33236294|NCT03890120|100768114|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
33420720|NCT02149199|101431596|FG000|Overall Study|Study specific withdrawal criteria|4|||
33236295|NCT04793464|100768115|FG000|Overall Study|Lost to Follow-up|458|||
33236296|NCT04793464|100768116|FG001|Overall Study|Lost to Follow-up|168|||
33236297|NCT04793464|100768117|FG002|Overall Study|Lost to Follow-up|5|||
33236298|NCT04793464|100768115|FG000|Overall Study|Withdrawal by Subject|43|||
33236299|NCT04793464|100768116|FG001|Overall Study|Withdrawal by Subject|15|||
33236300|NCT04793464|100768117|FG002|Overall Study|Withdrawal by Subject|0|||
33236301|NCT02959138|100768120|FG000|Overall Study|Enrolled but Never Treated|0|||
33236302|NCT02959138|100768121|FG001|Overall Study|Enrolled but Never Treated|1|||
33236303|NCT02959138|100768122|FG002|Overall Study|Enrolled but Never Treated|0|||
33236304|NCT00884286|100768125|FG000|Overall Study|Progressive disease|21|||
33236305|NCT00884286|100768126|FG001|Overall Study|Progressive disease|28|||
33236306|NCT00884286|100768125|FG000|Overall Study|Toxicity|4|||
33236307|NCT00884286|100768126|FG001|Overall Study|Toxicity|1|||
33236308|NCT00884286|100768125|FG000|Overall Study|Death|2|||
33236309|NCT00884286|100768126|FG001|Overall Study|Death|2|||
33236310|NCT00884286|100768125|FG000|Overall Study|Physician Decision|1|||
33236311|NCT00884286|100768126|FG001|Overall Study|Physician Decision|0|||
33236312|NCT00884286|100768125|FG000|Overall Study|Septic shock|1|||
33236313|NCT00884286|100768126|FG001|Overall Study|Septic shock|0|||
33236314|NCT00884286|100768125|FG000|Overall Study|Thrombus in right auricle|1|||
33236315|NCT00884286|100768126|FG001|Overall Study|Thrombus in right auricle|0|||
33637690|NCT02558296|102225849|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
33637691|NCT02558296|102225850|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
33637692|NCT02558296|102225849|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
33637693|NCT02558296|102225850|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
33637694|NCT02558296|102225849|FG000|Completed the Study|Adverse Event|14|||
33637695|NCT02558296|102225850|FG001|Completed the Study|Adverse Event|5|||
33637696|NCT02558296|102225849|FG000|Completed the Study|Death|39|||
33637697|NCT02558296|102225850|FG001|Completed the Study|Death|25|||
33637698|NCT02558296|102225849|FG000|Completed the Study|Lost to Follow-up|31|||
33637699|NCT02558296|102225850|FG001|Completed the Study|Lost to Follow-up|23|||
33637700|NCT02558296|102225849|FG000|Completed the Study|Physician Decision|6|||
33637701|NCT02558296|102225850|FG001|Completed the Study|Physician Decision|0|||
33637702|NCT02558296|102225849|FG000|Completed the Study|Protocol Violation|2|||
33236316|NCT00884286|100768125|FG000|Overall Study|Not treated|2|||
33236317|NCT00884286|100768126|FG001|Overall Study|Not treated|1|||
33236318|NCT00884286|100768125|FG000|Overall Study|Comprised lung carcinoma|0|||
33236319|NCT00884286|100768126|FG001|Overall Study|Comprised lung carcinoma|1|||
33236320|NCT02420327|100768127|FG000|Overall Study|Adverse Event|7|||
33236321|NCT02420327|100768127|FG000|Overall Study|Pregnancy|1|||
33236322|NCT02420327|100768127|FG000|Overall Study|Withdrawal by Subject|6|||
33236323|NCT02420327|100768127|FG000|Overall Study|Lost to Follow-up|1|||
33236324|NCT02420327|100768127|FG000|Overall Study|Protocol Violation|1|||
33236325|NCT04179461|100768128|FG000|Overall Study|Lost to Follow-up|4|||
33236326|NCT00531011|100768129|FG000|Overall Study|Withdrawal by Subject|2|||
33236327|NCT00531011|100768130|FG001|Overall Study|Withdrawal by Subject|4|||
33236328|NCT00531011|100768129|FG000|Overall Study|Death|1|||
33577398|NCT00444925|102006411|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
33577399|NCT00444925|102006409|FG000|Double-blind Treatment Period|Other|7|||
33577400|NCT00444925|102006410|FG001|Double-blind Treatment Period|Other|7|||
33577401|NCT00444925|102006411|FG002|Double-blind Treatment Period|Other|12|||
33577402|NCT01428219|102006413|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
33577403|NCT03273907|102006414|FG000|Overall Study|Death|1|||
33577404|NCT03273907|102006414|FG000|Overall Study|Lost to Follow-up|4|||
33577405|NCT03273907|102006414|FG000|Overall Study|Withdrawal by Subject|2|||
33577406|NCT03273907|102006414|FG000|Overall Study|COVID 19|2|||
33577407|NCT00950651|102006417|FG000|Overall Study|Adverse Event|17|||
33577408|NCT00950651|102006418|FG001|Overall Study|Adverse Event|20|||
33577409|NCT00950651|102006417|FG000|Overall Study|Death|1|||
33577410|NCT00950651|102006418|FG001|Overall Study|Death|0|||
33577411|NCT00950651|102006417|FG000|Overall Study|Lack of Efficacy|2|||
33577412|NCT00950651|102006418|FG001|Overall Study|Lack of Efficacy|2|||
33577413|NCT00950651|102006417|FG000|Overall Study|Protocol Violation|3|||
33577414|NCT00950651|102006418|FG001|Overall Study|Protocol Violation|4|||
33577415|NCT00950651|102006417|FG000|Overall Study|Withdrawal by Subject|8|||
33577416|NCT00950651|102006418|FG001|Overall Study|Withdrawal by Subject|9|||
33577417|NCT00295646|102006419|FG000|Overall Study|Protocol Violation|18|||
33637703|NCT02558296|102225850|FG001|Completed the Study|Protocol Violation|1|||
33236329|NCT00531011|100768130|FG001|Overall Study|Death|0|||
33637704|NCT02558296|102225849|FG000|Completed the Study|Withdrawal by Subject|53|||
33637705|NCT02558296|102225850|FG001|Completed the Study|Withdrawal by Subject|31|||
33236330|NCT00531011|100768129|FG000|Overall Study|Lost to Follow-up|1|||
33577418|NCT00295646|102006420|FG001|Overall Study|Protocol Violation|20|||
33577419|NCT00295646|102006421|FG002|Overall Study|Protocol Violation|20|||
33577420|NCT00295646|102006422|FG003|Overall Study|Protocol Violation|18|||
33577421|NCT00295646|102006419|FG000|Overall Study|Withdrawal by Subject|8|||
33236331|NCT00531011|100768130|FG001|Overall Study|Lost to Follow-up|0|||
33577422|NCT00295646|102006420|FG001|Overall Study|Withdrawal by Subject|9|||
33577423|NCT00295646|102006421|FG002|Overall Study|Withdrawal by Subject|11|||
33577424|NCT00295646|102006422|FG003|Overall Study|Withdrawal by Subject|14|||
33577425|NCT00295646|102006419|FG000|Overall Study|Lost to Follow-up|0|||
33577426|NCT00295646|102006420|FG001|Overall Study|Lost to Follow-up|5|||
33577427|NCT00295646|102006421|FG002|Overall Study|Lost to Follow-up|1|||
33577428|NCT00295646|102006422|FG003|Overall Study|Lost to Follow-up|5|||
33577429|NCT00295646|102006419|FG000|Overall Study|Death|9|||
33577430|NCT00295646|102006420|FG001|Overall Study|Death|7|||
33577431|NCT00295646|102006421|FG002|Overall Study|Death|18|||
33577432|NCT00295646|102006422|FG003|Overall Study|Death|8|||
33637706|NCT02558296|102225849|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
33637707|NCT02558296|102225850|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
33637708|NCT01244893|102225851|FG000|Baseline|Protocol Violation|0|||
33637709|NCT01244893|102225852|FG001|Baseline|Protocol Violation|1|||
33637710|NCT01244893|102225851|FG000|1-Week Follow Up|Lost to Follow-up|1|||
33637711|NCT01244893|102225852|FG001|1-Week Follow Up|Lost to Follow-up|0|||
33637712|NCT04308291|102225858|FG000|Run-In Phase|Withdrawal by Subject|4|||
33637713|NCT04308291|102225858|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
33138857|NCT00402233|100423843|FG000|Overall Study|Withdrawal by Subject|2|||
33138858|NCT00402233|100423844|FG001|Overall Study|Withdrawal by Subject|1|||
33138859|NCT00402233|100423845|FG002|Overall Study|Withdrawal by Subject|2|||
33138860|NCT00402233|100423846|FG003|Overall Study|Withdrawal by Subject|2|||
33138861|NCT00402233|100423843|FG000|Overall Study|Worsening of disease under study|2|||
33138862|NCT00402233|100423844|FG001|Overall Study|Worsening of disease under study|0|||
33138863|NCT00402233|100423845|FG002|Overall Study|Worsening of disease under study|0|||
33138864|NCT00402233|100423846|FG003|Overall Study|Worsening of disease under study|0|||
33138865|NCT00402233|100423843|FG000|Overall Study|Worsening of other pre-existing disease|0|||
33138866|NCT00402233|100423844|FG001|Overall Study|Worsening of other pre-existing disease|1|||
33138867|NCT00402233|100423845|FG002|Overall Study|Worsening of other pre-existing disease|0|||
33138868|NCT00402233|100423846|FG003|Overall Study|Worsening of other pre-existing disease|0|||
33138869|NCT01892384|100423849|FG000|Overall Study|Withdrawal by Subject|1|||
33138870|NCT01892384|100423850|FG001|Overall Study|Withdrawal by Subject|1|||
33138871|NCT01892384|100423851|FG002|Overall Study|Withdrawal by Subject|0|||
33138872|NCT01892384|100423852|FG003|Overall Study|Withdrawal by Subject|0|||
33138873|NCT01122264|100423855|FG000|Overall Study|Adverse Event|6|||
33138874|NCT01122264|100423856|FG001|Overall Study|Adverse Event|5|||
33138875|NCT01122264|100423857|FG002|Overall Study|Adverse Event|7|||
33138876|NCT01122264|100423855|FG000|Overall Study|Death|1|||
33138877|NCT01122264|100423856|FG001|Overall Study|Death|0|||
33138878|NCT01122264|100423857|FG002|Overall Study|Death|0|||
33138879|NCT01122264|100423855|FG000|Overall Study|Lost to Follow-up|5|||
33138880|NCT01122264|100423856|FG001|Overall Study|Lost to Follow-up|9|||
33138881|NCT01122264|100423857|FG002|Overall Study|Lost to Follow-up|13|||
33138882|NCT01122264|100423855|FG000|Overall Study|Entry Criteria Not Met|1|||
33138883|NCT01122264|100423856|FG001|Overall Study|Entry Criteria Not Met|0|||
33138884|NCT01122264|100423857|FG002|Overall Study|Entry Criteria Not Met|0|||
33138885|NCT01122264|100423855|FG000|Overall Study|Protocol Violation|7|||
33138886|NCT01122264|100423856|FG001|Overall Study|Protocol Violation|7|||
33138887|NCT01122264|100423857|FG002|Overall Study|Protocol Violation|9|||
33138888|NCT01122264|100423855|FG000|Overall Study|Withdrawal by Subject|6|||
33138889|NCT01122264|100423856|FG001|Overall Study|Withdrawal by Subject|6|||
33138890|NCT01122264|100423857|FG002|Overall Study|Withdrawal by Subject|16|||
33138891|NCT01122264|100423855|FG000|Overall Study|Physician Decision|3|||
33138892|NCT01122264|100423856|FG001|Overall Study|Physician Decision|1|||
33138893|NCT01122264|100423857|FG002|Overall Study|Physician Decision|1|||
33138894|NCT01122264|100423855|FG000|Overall Study|Lack of Efficacy|3|||
33138895|NCT01122264|100423856|FG001|Overall Study|Lack of Efficacy|1|||
33138896|NCT01122264|100423857|FG002|Overall Study|Lack of Efficacy|1|||
33138897|NCT00835731|100423858|FG000|Overall Study|Withdrawal by Subject|1|||
33138898|NCT00835731|100423859|FG001|Overall Study|Withdrawal by Subject|0|||
33138899|NCT00835731|100423858|FG000|Overall Study|Physician Decision|1|||
33637714|NCT04308291|102225858|FG000|Study Phase 6-M|Physician Decision|2|||
33138900|NCT00835731|100423859|FG001|Overall Study|Physician Decision|1|||
33138901|NCT00435045|100423862|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
33138902|NCT00435045|100423863|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
33138903|NCT00435045|100423862|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
33138904|NCT00435045|100423863|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
33138905|NCT00435045|100423862|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
33138906|NCT00435045|100423863|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
33138907|NCT00435045|100423862|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
33138908|NCT00435045|100423863|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
33138909|NCT00435045|100423862|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
33236332|NCT00531011|100768129|FG000|Overall Study|Physician Decision|0|||
33577433|NCT00421148|102006439|FG000|Overall Study|Lost to Follow-up|0|||
33138910|NCT00435045|100423863|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
33637715|NCT04308291|102225858|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
33637716|NCT04308291|102225858|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
33637717|NCT04308291|102225858|FG000|Study Phase 12-M|Physician Decision|2|||
33637718|NCT04308291|102225858|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
33637719|NCT01001325|102225860|FG000|Overall Study|Lost to Follow-up|16|||
33637720|NCT01001325|102225861|FG001|Overall Study|Lost to Follow-up|10|||
33637721|NCT01001325|102225860|FG000|Overall Study|Protocol Violation|2|||
33138911|NCT00435045|100423862|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
33138912|NCT00435045|100423863|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
33138913|NCT00435045|100423862|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
33138914|NCT00435045|100423863|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
33138915|NCT00435045|100423862|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
33138916|NCT00435045|100423863|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
33138917|NCT00435045|100423862|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
33138918|NCT00435045|100423863|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
33138919|NCT00435045|100423862|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
33138920|NCT00435045|100423863|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
33138921|NCT00435045|100423862|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
33138922|NCT00435045|100423863|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
33138923|NCT01917656|100423871|FG000|Overall Study|Adverse Event|11|||
33138924|NCT01917656|100423872|FG001|Overall Study|Adverse Event|0|||
33138925|NCT01917656|100423871|FG000|Overall Study|Withdrawal criteria|8|||
33138926|NCT01917656|100423872|FG001|Overall Study|Withdrawal criteria|14|||
33138927|NCT01917656|100423871|FG000|Overall Study|Unclassified|0|||
33138928|NCT01917656|100423872|FG001|Overall Study|Unclassified|3|||
33138929|NCT01917656|100423871|FG000|Overall Study|Withdrawal by Subject|4|||
33138930|NCT01917656|100423872|FG001|Overall Study|Withdrawal by Subject|3|||
33138931|NCT01917656|100423871|FG000|Overall Study|Lost to Follow-up|3|||
33138932|NCT01917656|100423872|FG001|Overall Study|Lost to Follow-up|4|||
33138933|NCT01029405|100423875|FG000|Overall Study|Withdrawal by Subject|0|||
33138934|NCT01029405|100423876|FG001|Overall Study|Withdrawal by Subject|1|||
33138935|NCT01029405|100423877|FG002|Overall Study|Withdrawal by Subject|2|||
33138936|NCT01029405|100423878|FG003|Overall Study|Withdrawal by Subject|0|||
33138937|NCT01029405|100423875|FG000|Overall Study|Protocol Violation|0|||
33138938|NCT01029405|100423876|FG001|Overall Study|Protocol Violation|0|||
33138939|NCT01029405|100423877|FG002|Overall Study|Protocol Violation|0|||
33138940|NCT01029405|100423878|FG003|Overall Study|Protocol Violation|1|||
33138941|NCT01029405|100423875|FG000|Overall Study|Adverse Event|0|||
33138942|NCT01029405|100423876|FG001|Overall Study|Adverse Event|0|||
33138943|NCT01029405|100423877|FG002|Overall Study|Adverse Event|1|||
33138944|NCT01029405|100423878|FG003|Overall Study|Adverse Event|1|||
33138945|NCT01029405|100423875|FG000|Overall Study|Lost to Follow-up|2|||
33236333|NCT00531011|100768130|FG001|Overall Study|Physician Decision|3|||
33236334|NCT02781506|100768131|FG000|Overall Study|Adverse Event|5|||
33236335|NCT01767129|100768136|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
33236336|NCT01767129|100768137|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
33236337|NCT02408549|100768138|FG000|Overall Study|Adverse Event|15|||
33236338|NCT02408549|100768138|FG000|Overall Study|Death|4|||
33236339|NCT02408549|100768138|FG000|Overall Study|Lack of Efficacy|17|||
33236340|NCT02408549|100768138|FG000|Overall Study|Protocol Violation|4|||
33236341|NCT02408549|100768138|FG000|Overall Study|Lost to Follow-up|6|||
33236342|NCT02408549|100768138|FG000|Overall Study|Consent withdrawn|30|||
33236343|NCT02408549|100768138|FG000|Overall Study|Neurology research program closing at site|1|||
33236344|NCT02408549|100768138|FG000|Overall Study|Site closure|1|||
33236345|NCT02408549|100768138|FG000|Overall Study|Pregnancy|1|||
33236346|NCT02408549|100768138|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
33236347|NCT02408549|100768138|FG000|Overall Study|Subject moved to another place, far from site|1|||
33637722|NCT01001325|102225861|FG001|Overall Study|Protocol Violation|0|||
33637723|NCT03610269|102225862|FG000|Overall Study|Physician Decision|10|||
33637724|NCT03610269|102225862|FG000|Overall Study|Protocol Violation|1|||
33637725|NCT03610269|102225862|FG000|Overall Study|Unable to draw blood|1|||
33138946|NCT01029405|100423876|FG001|Overall Study|Lost to Follow-up|1|||
33138947|NCT01029405|100423877|FG002|Overall Study|Lost to Follow-up|1|||
33138948|NCT01029405|100423878|FG003|Overall Study|Lost to Follow-up|2|||
33138949|NCT01029405|100423875|FG000|Overall Study|Other|0|||
33236348|NCT02408549|100768138|FG000|Overall Study|Study terminated at site|1|||
33236349|NCT01077024|100768139|FG000|Overall Study|Lost to Follow-up|20|||
33236350|NCT01077024|100768140|FG001|Overall Study|Lost to Follow-up|14|||
33369128|NCT03100942|101236579|FG001|Randomized Treatment Period|Withdrew Consent|5|||
33637726|NCT03610269|102225862|FG000|Overall Study|Screen fail|4|||
33637727|NCT02266888|102225874|FG000|Overall Study|Death|2|||
33138950|NCT01029405|100423876|FG001|Overall Study|Other|1|||
33138951|NCT01029405|100423877|FG002|Overall Study|Other|0|||
33138952|NCT01029405|100423878|FG003|Overall Study|Other|1|||
33637728|NCT02266888|102225875|FG001|Overall Study|Death|2|||
33236351|NCT01077024|100768139|FG000|Overall Study|Withdrawal by Subject|0|||
33236352|NCT01077024|100768140|FG001|Overall Study|Withdrawal by Subject|2|||
33236353|NCT01077024|100768139|FG000|Overall Study|Incarcerated|7|||
33236354|NCT01077024|100768140|FG001|Overall Study|Incarcerated|8|||
33236355|NCT01077024|100768139|FG000|Overall Study|Other|4|||
33236356|NCT01077024|100768140|FG001|Overall Study|Other|4|||
33236357|NCT00442286|100768141|FG000|Overall Study|Death|2|||
33236358|NCT00442286|100768142|FG001|Overall Study|Death|2|||
33236359|NCT00442286|100768141|FG000|Overall Study|Lost to Follow-up|1|||
33236360|NCT00442286|100768142|FG001|Overall Study|Lost to Follow-up|0|||
33236361|NCT00442286|100768141|FG000|Overall Study|Withdrawal by Subject|2|||
33236362|NCT00442286|100768142|FG001|Overall Study|Withdrawal by Subject|0|||
33236363|NCT00442286|100768141|FG000|Overall Study|System explanted|1|||
33236364|NCT00442286|100768142|FG001|Overall Study|System explanted|0|||
33236365|NCT00442286|100768141|FG000|Overall Study|Patient Injury|1|||
33236366|NCT00442286|100768142|FG001|Overall Study|Patient Injury|0|||
33369129|NCT03100942|101236580|FG002|Randomized Treatment Period|Withdrew Consent|3|||
33369130|NCT03100942|101236581|FG003|Randomized Treatment Period|Withdrew Consent|3|||
33637729|NCT02266888|102225876|FG002|Overall Study|Death|4|||
33637730|NCT02266888|102225877|FG003|Overall Study|Death|2|||
33637731|NCT02266888|102225874|FG000|Overall Study|Physician Decision|0|||
33577434|NCT00421148|102006440|FG001|Overall Study|Lost to Follow-up|0|||
33577435|NCT00421148|102006441|FG002|Overall Study|Lost to Follow-up|0|||
33577436|NCT00421148|102006442|FG003|Overall Study|Lost to Follow-up|0|||
33577437|NCT00421148|102006443|FG004|Overall Study|Lost to Follow-up|0|||
33577438|NCT00421148|102006444|FG005|Overall Study|Lost to Follow-up|0|||
33577439|NCT00421148|102006445|FG006|Overall Study|Lost to Follow-up|0|||
33577440|NCT00421148|102006446|FG007|Overall Study|Lost to Follow-up|0|||
33637732|NCT02266888|102225875|FG001|Overall Study|Physician Decision|1|||
33577441|NCT00421148|102006447|FG008|Overall Study|Lost to Follow-up|0|||
33577442|NCT00421148|102006448|FG009|Overall Study|Lost to Follow-up|0|||
33577443|NCT00421148|102006449|FG010|Overall Study|Lost to Follow-up|0|||
33577444|NCT00421148|102006450|FG011|Overall Study|Lost to Follow-up|0|||
33577445|NCT00421148|102006451|FG012|Overall Study|Lost to Follow-up|0|||
33577446|NCT00421148|102006452|FG013|Overall Study|Lost to Follow-up|0|||
33577447|NCT00421148|102006453|FG014|Overall Study|Lost to Follow-up|0|||
33637733|NCT02266888|102225876|FG002|Overall Study|Physician Decision|2|||
33637734|NCT02266888|102225877|FG003|Overall Study|Physician Decision|2|||
33637735|NCT02266888|102225874|FG000|Overall Study|Study Terminated|5|||
33637736|NCT02266888|102225875|FG001|Overall Study|Study Terminated|1|||
33637737|NCT02266888|102225876|FG002|Overall Study|Study Terminated|0|||
33637738|NCT02266888|102225877|FG003|Overall Study|Study Terminated|0|||
33637739|NCT02266888|102225874|FG000|Overall Study|No Longer Eligible|0|||
33637740|NCT02266888|102225875|FG001|Overall Study|No Longer Eligible|0|||
33637741|NCT02266888|102225876|FG002|Overall Study|No Longer Eligible|0|||
33637742|NCT02266888|102225877|FG003|Overall Study|No Longer Eligible|2|||
33637743|NCT02266888|102225874|FG000|Overall Study|Randomization Closed|0|||
33637744|NCT02266888|102225875|FG001|Overall Study|Randomization Closed|0|||
33637745|NCT02266888|102225876|FG002|Overall Study|Randomization Closed|4|||
33637746|NCT02266888|102225877|FG003|Overall Study|Randomization Closed|0|||
33637747|NCT02266888|102225874|FG000|Overall Study|Personnel unavailable at transplant|0|||
33637748|NCT02266888|102225875|FG001|Overall Study|Personnel unavailable at transplant|0|||
33637749|NCT02266888|102225876|FG002|Overall Study|Personnel unavailable at transplant|0|||
33637750|NCT02266888|102225877|FG003|Overall Study|Personnel unavailable at transplant|1|||
33637751|NCT02266888|102225874|FG000|Overall Study|Transfer of care|0|||
33637752|NCT02266888|102225875|FG001|Overall Study|Transfer of care|0|||
33637753|NCT02266888|102225876|FG002|Overall Study|Transfer of care|1|||
33637754|NCT02266888|102225877|FG003|Overall Study|Transfer of care|0|||
33637755|NCT01193244|102225878|FG000|Overall Study|Withdrawal by Subject|79|||
33369131|NCT03100942|101236582|FG004|Randomized Treatment Period|Withdrew Consent|0|||
33420721|NCT02149199|101431597|FG001|Overall Study|Study specific withdrawal criteria|21|||
33420722|NCT02149199|101431598|FG002|Overall Study|Study specific withdrawal criteria|6|||
33577448|NCT00421148|102006454|FG015|Overall Study|Lost to Follow-up|0|||
33577449|NCT00421148|102006455|FG016|Overall Study|Lost to Follow-up|0|||
33637756|NCT01193244|102225879|FG001|Overall Study|Withdrawal by Subject|97|||
33637757|NCT01193244|102225878|FG000|Overall Study|Other|303|||
33637758|NCT01193244|102225879|FG001|Overall Study|Other|278|||
33637759|NCT01193244|102225878|FG000|Overall Study|Lost to Follow-up|6|||
33637760|NCT01193244|102225879|FG001|Overall Study|Lost to Follow-up|15|||
33637761|NCT03486834|102225882|FG000|Overall Study|Withdrawal by Subject|46|||
33637762|NCT03486834|102225883|FG001|Overall Study|Withdrawal by Subject|46|||
33236367|NCT04796935|100768150|FG000|Overall Study|Withdrawal by Subject|0|||
33236368|NCT04796935|100768151|FG001|Overall Study|Withdrawal by Subject|1|||
33236369|NCT04796935|100768150|FG000|Overall Study|Physician Decision|0|||
33637763|NCT03486834|102225884|FG002|Overall Study|Withdrawal by Subject|52|||
33236370|NCT04796935|100768151|FG001|Overall Study|Physician Decision|1|||
33236371|NCT04796935|100768150|FG000|Overall Study|Device not available|1|||
33577450|NCT00421148|102006456|FG017|Overall Study|Lost to Follow-up|1|||
33637764|NCT03486834|102225882|FG000|Overall Study|Adverse Event|8|||
33138953|NCT04518995|100423880|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
33138954|NCT04518995|100423881|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
33138955|NCT04518995|100423882|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
33138956|NCT04518995|100423880|FG000|Overall Study|Lack of Efficacy|2|||
33138957|NCT04518995|100423881|FG001|Overall Study|Lack of Efficacy|1|||
33138958|NCT04518995|100423882|FG002|Overall Study|Lack of Efficacy|0|||
33138959|NCT04518995|100423880|FG000|Overall Study|Non-compliance With Study Drug|0|||
33138960|NCT04518995|100423881|FG001|Overall Study|Non-compliance With Study Drug|3|||
33138961|NCT04518995|100423882|FG002|Overall Study|Non-compliance With Study Drug|2|||
33138962|NCT04518995|100423880|FG000|Overall Study|Pregnancy|0|||
33138963|NCT04518995|100423881|FG001|Overall Study|Pregnancy|0|||
33577451|NCT00421148|102006457|FG018|Overall Study|Lost to Follow-up|0|||
33577452|NCT00421148|102006458|FG019|Overall Study|Lost to Follow-up|0|||
33577453|NCT00421148|102006439|FG000|Overall Study|Withdrawal by Subject|0|||
33577454|NCT00421148|102006440|FG001|Overall Study|Withdrawal by Subject|0|||
33138964|NCT04518995|100423882|FG002|Overall Study|Pregnancy|1|||
33138965|NCT04518995|100423880|FG000|Overall Study|Protocol Violation|2|||
33138966|NCT04518995|100423881|FG001|Overall Study|Protocol Violation|0|||
33138967|NCT04518995|100423882|FG002|Overall Study|Protocol Violation|1|||
33138968|NCT04518995|100423880|FG000|Overall Study|Reason not Specified|4|||
33138969|NCT04518995|100423881|FG001|Overall Study|Reason not Specified|11|||
33138970|NCT04518995|100423882|FG002|Overall Study|Reason not Specified|2|||
33138971|NCT04518995|100423880|FG000|Overall Study|Lost to Follow-up|1|||
33138972|NCT04518995|100423881|FG001|Overall Study|Lost to Follow-up|10|||
33138973|NCT04518995|100423882|FG002|Overall Study|Lost to Follow-up|6|||
33138974|NCT01244490|100423884|FG000|Overall Study|Lack of Efficacy|14|||
33138975|NCT01244490|100423885|FG001|Overall Study|Lack of Efficacy|5|||
33138976|NCT01244490|100423886|FG002|Overall Study|Lack of Efficacy|5|||
33138977|NCT01244490|100423884|FG000|Overall Study|Withdrawal by Subject|4|||
33138978|NCT01244490|100423885|FG001|Overall Study|Withdrawal by Subject|4|||
33138979|NCT01244490|100423886|FG002|Overall Study|Withdrawal by Subject|9|||
33138980|NCT01244490|100423884|FG000|Overall Study|Adverse Event|1|||
33138981|NCT01244490|100423885|FG001|Overall Study|Adverse Event|9|||
33138982|NCT01244490|100423886|FG002|Overall Study|Adverse Event|5|||
33138983|NCT01244490|100423884|FG000|Overall Study|Lost to Follow-up|0|||
33138984|NCT01244490|100423885|FG001|Overall Study|Lost to Follow-up|6|||
33138985|NCT01244490|100423886|FG002|Overall Study|Lost to Follow-up|3|||
33138986|NCT01244490|100423884|FG000|Overall Study|Other|0|||
33138987|NCT01244490|100423885|FG001|Overall Study|Other|0|||
33138988|NCT01244490|100423886|FG002|Overall Study|Other|1|||
33138989|NCT04022733|100423889|FG000|Overall Study|conversion to open surgery|3|||
33138990|NCT04022733|100423890|FG001|Overall Study|conversion to open surgery|2|||
33138991|NCT04022733|100423889|FG000|Overall Study|bradycardia|0|||
33138992|NCT04022733|100423890|FG001|Overall Study|bradycardia|1|||
33138993|NCT00797966|100423891|FG000|Phase A|Lost to Follow-up|0|||
33138994|NCT00797966|100423892|FG001|Phase A|Lost to Follow-up|0|||
33138995|NCT00797966|100423893|FG002|Phase A|Lost to Follow-up|0|||
33138996|NCT00797966|100423894|FG003|Phase A|Lost to Follow-up|0|||
33138997|NCT00797966|100423895|FG004|Phase A|Lost to Follow-up|33|||
33577455|NCT00421148|102006441|FG002|Overall Study|Withdrawal by Subject|0|||
33577456|NCT00421148|102006442|FG003|Overall Study|Withdrawal by Subject|0|||
33577457|NCT00421148|102006443|FG004|Overall Study|Withdrawal by Subject|0|||
33577458|NCT00421148|102006444|FG005|Overall Study|Withdrawal by Subject|0|||
33577459|NCT00421148|102006445|FG006|Overall Study|Withdrawal by Subject|0|||
33577460|NCT00421148|102006446|FG007|Overall Study|Withdrawal by Subject|0|||
33577461|NCT00421148|102006447|FG008|Overall Study|Withdrawal by Subject|0|||
33577462|NCT00421148|102006448|FG009|Overall Study|Withdrawal by Subject|0|||
33577463|NCT00421148|102006449|FG010|Overall Study|Withdrawal by Subject|0|||
33637765|NCT03486834|102225883|FG001|Overall Study|Adverse Event|7|||
33637766|NCT03486834|102225884|FG002|Overall Study|Adverse Event|0|||
33577464|NCT00421148|102006450|FG011|Overall Study|Withdrawal by Subject|0|||
33577465|NCT00421148|102006451|FG012|Overall Study|Withdrawal by Subject|0|||
33577466|NCT00421148|102006452|FG013|Overall Study|Withdrawal by Subject|0|||
33138998|NCT00797966|100423896|FG005|Phase A|Lost to Follow-up|0|||
33138999|NCT00797966|100423891|FG000|Phase A|Adverse Event|0|||
33139000|NCT00797966|100423892|FG001|Phase A|Adverse Event|0|||
33139001|NCT00797966|100423893|FG002|Phase A|Adverse Event|0|||
33139002|NCT00797966|100423894|FG003|Phase A|Adverse Event|0|||
33139003|NCT00797966|100423895|FG004|Phase A|Adverse Event|46|||
33139004|NCT00797966|100423896|FG005|Phase A|Adverse Event|0|||
33637767|NCT03486834|102225882|FG000|Overall Study|Lost to Follow-up|41|||
33637768|NCT03486834|102225883|FG001|Overall Study|Lost to Follow-up|24|||
33139005|NCT00797966|100423891|FG000|Phase A|Met withdrawal criteria|0|||
33139006|NCT00797966|100423892|FG001|Phase A|Met withdrawal criteria|0|||
33139007|NCT00797966|100423893|FG002|Phase A|Met withdrawal criteria|0|||
33139008|NCT00797966|100423894|FG003|Phase A|Met withdrawal criteria|0|||
33139009|NCT00797966|100423895|FG004|Phase A|Met withdrawal criteria|4|||
33139010|NCT00797966|100423896|FG005|Phase A|Met withdrawal criteria|0|||
33139011|NCT00797966|100423891|FG000|Phase A|Physician Decision|0|||
33139012|NCT00797966|100423892|FG001|Phase A|Physician Decision|0|||
33577467|NCT00421148|102006453|FG014|Overall Study|Withdrawal by Subject|0|||
33577468|NCT00421148|102006454|FG015|Overall Study|Withdrawal by Subject|0|||
33577469|NCT00421148|102006455|FG016|Overall Study|Withdrawal by Subject|0|||
33577470|NCT00421148|102006456|FG017|Overall Study|Withdrawal by Subject|1|||
33637769|NCT03486834|102225884|FG002|Overall Study|Lost to Follow-up|39|||
33236372|NCT04796935|100768151|FG001|Overall Study|Device not available|0|||
33236373|NCT04796935|100768150|FG000|Overall Study|Trained provider not available|1|||
33236374|NCT04796935|100768151|FG001|Overall Study|Trained provider not available|0|||
33236375|NCT03100838|100768152|FG000|Overall Study|Adverse Event|1|||
33236376|NCT03100838|100768153|FG001|Overall Study|Adverse Event|0|||
33236377|NCT03100838|100768154|FG002|Overall Study|Adverse Event|0|||
33236378|NCT03100838|100768155|FG003|Overall Study|Adverse Event|0|||
33420723|NCT02149199|101431596|FG000|Overall Study|Other|20|||
33637770|NCT03486834|102225882|FG000|Overall Study|Non-compliance with Study Drug|2|||
33637771|NCT03486834|102225883|FG001|Overall Study|Non-compliance with Study Drug|2|||
33637772|NCT03486834|102225884|FG002|Overall Study|Non-compliance with Study Drug|0|||
33637773|NCT03486834|102225882|FG000|Overall Study|Physician Decision|5|||
33637774|NCT03486834|102225883|FG001|Overall Study|Physician Decision|2|||
33637775|NCT03486834|102225884|FG002|Overall Study|Physician Decision|3|||
33637776|NCT03486834|102225882|FG000|Overall Study|Pregnancy|10|||
33637777|NCT03486834|102225883|FG001|Overall Study|Pregnancy|12|||
33637778|NCT03486834|102225884|FG002|Overall Study|Pregnancy|12|||
33637779|NCT03486834|102225882|FG000|Overall Study|Protocol Deviation|2|||
33637780|NCT03486834|102225883|FG001|Overall Study|Protocol Deviation|3|||
33420724|NCT02149199|101431597|FG001|Overall Study|Other|25|||
33577471|NCT00421148|102006457|FG018|Overall Study|Withdrawal by Subject|0|||
33577472|NCT00421148|102006458|FG019|Overall Study|Withdrawal by Subject|0|||
33577473|NCT00421148|102006439|FG000|Overall Study|Protocol Violation|0|||
33577474|NCT00421148|102006440|FG001|Overall Study|Protocol Violation|0|||
33577475|NCT00421148|102006441|FG002|Overall Study|Protocol Violation|0|||
33577476|NCT00421148|102006442|FG003|Overall Study|Protocol Violation|0|||
33577477|NCT00421148|102006443|FG004|Overall Study|Protocol Violation|0|||
33577478|NCT00421148|102006444|FG005|Overall Study|Protocol Violation|1|||
33577479|NCT00421148|102006445|FG006|Overall Study|Protocol Violation|0|||
33577480|NCT00421148|102006446|FG007|Overall Study|Protocol Violation|0|||
33577481|NCT00421148|102006447|FG008|Overall Study|Protocol Violation|0|||
33577482|NCT00421148|102006448|FG009|Overall Study|Protocol Violation|0|||
33577483|NCT00421148|102006449|FG010|Overall Study|Protocol Violation|0|||
33577484|NCT00421148|102006450|FG011|Overall Study|Protocol Violation|0|||
33577485|NCT00421148|102006451|FG012|Overall Study|Protocol Violation|0|||
33577486|NCT00421148|102006452|FG013|Overall Study|Protocol Violation|0|||
33577487|NCT00421148|102006453|FG014|Overall Study|Protocol Violation|0|||
33577488|NCT00421148|102006454|FG015|Overall Study|Protocol Violation|0|||
33577489|NCT00421148|102006455|FG016|Overall Study|Protocol Violation|0|||
33577490|NCT00421148|102006456|FG017|Overall Study|Protocol Violation|0|||
33577491|NCT00421148|102006457|FG018|Overall Study|Protocol Violation|1|||
33577492|NCT00421148|102006458|FG019|Overall Study|Protocol Violation|0|||
33577493|NCT00700622|102006470|FG000|Overall Study|Adverse Event|4|||
33577494|NCT00700622|102006471|FG001|Overall Study|Adverse Event|0|||
33577495|NCT00700622|102006470|FG000|Overall Study|Lost to Follow-up|0|||
33577496|NCT00700622|102006471|FG001|Overall Study|Lost to Follow-up|1|||
33577497|NCT00700622|102006470|FG000|Overall Study|Physician Decision|2|||
33577498|NCT00700622|102006471|FG001|Overall Study|Physician Decision|1|||
33577499|NCT00700622|102006470|FG000|Overall Study|Protocol Violation|0|||
33577500|NCT00700622|102006471|FG001|Overall Study|Protocol Violation|1|||
33577501|NCT00700622|102006470|FG000|Overall Study|Withdrawal by Subject|4|||
33577502|NCT00700622|102006471|FG001|Overall Study|Withdrawal by Subject|1|||
33577503|NCT00700622|102006470|FG000|Overall Study|Other|3|||
33577504|NCT00700622|102006471|FG001|Overall Study|Other|1|||
33577505|NCT02848092|102006477|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
33577506|NCT02848092|102006478|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
33577507|NCT02848092|102006477|FG000|1-month Post-training Follow-up|Adverse Event|2|||
33577508|NCT02848092|102006478|FG001|1-month Post-training Follow-up|Adverse Event|1|||
33577509|NCT02848092|102006477|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
33577510|NCT02848092|102006478|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
33577511|NCT02848092|102006477|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
33577512|NCT02848092|102006478|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
33637781|NCT03486834|102225884|FG002|Overall Study|Protocol Deviation|3|||
33637782|NCT03486834|102225882|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
33637783|NCT03486834|102225883|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
33577513|NCT02848092|102006477|FG000|1-month Post-training Follow-up|fatigue|0|||
33577514|NCT02848092|102006478|FG001|1-month Post-training Follow-up|fatigue|1|||
33577515|NCT02848092|102006477|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
33577516|NCT02848092|102006478|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
33236379|NCT03100838|100768152|FG000|Overall Study|Physician Decision|1|||
33236380|NCT03100838|100768153|FG001|Overall Study|Physician Decision|1|||
33420725|NCT02149199|101431598|FG002|Overall Study|Other|20|||
33139013|NCT00797966|100423893|FG002|Phase A|Physician Decision|0|||
33139014|NCT00797966|100423894|FG003|Phase A|Physician Decision|0|||
33139015|NCT00797966|100423895|FG004|Phase A|Physician Decision|13|||
33139016|NCT00797966|100423896|FG005|Phase A|Physician Decision|0|||
33139017|NCT00797966|100423891|FG000|Phase A|Withdrawal by Subject|0|||
33139018|NCT00797966|100423892|FG001|Phase A|Withdrawal by Subject|0|||
33139019|NCT00797966|100423893|FG002|Phase A|Withdrawal by Subject|0|||
33139020|NCT00797966|100423894|FG003|Phase A|Withdrawal by Subject|0|||
33139021|NCT00797966|100423895|FG004|Phase A|Withdrawal by Subject|33|||
33139022|NCT00797966|100423896|FG005|Phase A|Withdrawal by Subject|0|||
33139023|NCT00797966|100423891|FG000|Phase A|Protocol deviation|0|||
33139024|NCT00797966|100423892|FG001|Phase A|Protocol deviation|0|||
33139025|NCT00797966|100423893|FG002|Phase A|Protocol deviation|0|||
33139026|NCT00797966|100423894|FG003|Phase A|Protocol deviation|0|||
33139027|NCT00797966|100423895|FG004|Phase A|Protocol deviation|56|||
33139028|NCT00797966|100423896|FG005|Phase A|Protocol deviation|0|||
33139029|NCT00797966|100423891|FG000|Phase B|Lost to Follow-up|0|||
33139030|NCT00797966|100423892|FG001|Phase B|Lost to Follow-up|1|||
33139031|NCT00797966|100423893|FG002|Phase B|Lost to Follow-up|3|||
33139032|NCT00797966|100423894|FG003|Phase B|Lost to Follow-up|0|||
33139033|NCT00797966|100423895|FG004|Phase B|Lost to Follow-up|0|||
33139034|NCT00797966|100423896|FG005|Phase B|Lost to Follow-up|0|||
33139035|NCT00797966|100423891|FG000|Phase B|Adverse Event|2|||
33139036|NCT00797966|100423892|FG001|Phase B|Adverse Event|1|||
33139037|NCT00797966|100423893|FG002|Phase B|Adverse Event|3|||
33139038|NCT00797966|100423894|FG003|Phase B|Adverse Event|1|||
33139039|NCT00797966|100423895|FG004|Phase B|Adverse Event|0|||
33139040|NCT00797966|100423896|FG005|Phase B|Adverse Event|0|||
33139041|NCT00797966|100423891|FG000|Phase B|Met Withdrawal Criteria|3|||
33139042|NCT00797966|100423892|FG001|Phase B|Met Withdrawal Criteria|3|||
33139043|NCT00797966|100423893|FG002|Phase B|Met Withdrawal Criteria|6|||
33139044|NCT00797966|100423894|FG003|Phase B|Met Withdrawal Criteria|1|||
33139045|NCT00797966|100423895|FG004|Phase B|Met Withdrawal Criteria|0|||
33139046|NCT00797966|100423896|FG005|Phase B|Met Withdrawal Criteria|0|||
33139047|NCT00797966|100423891|FG000|Phase B|Physician Decision|1|||
33139048|NCT00797966|100423892|FG001|Phase B|Physician Decision|0|||
33139049|NCT00797966|100423893|FG002|Phase B|Physician Decision|3|||
33139050|NCT00797966|100423894|FG003|Phase B|Physician Decision|1|||
33139051|NCT00797966|100423895|FG004|Phase B|Physician Decision|0|||
33139052|NCT00797966|100423896|FG005|Phase B|Physician Decision|0|||
33139053|NCT00797966|100423891|FG000|Phase B|Withdrawal by Subject|1|||
33139054|NCT00797966|100423892|FG001|Phase B|Withdrawal by Subject|4|||
33139055|NCT00797966|100423893|FG002|Phase B|Withdrawal by Subject|3|||
33139056|NCT00797966|100423894|FG003|Phase B|Withdrawal by Subject|3|||
33139057|NCT00797966|100423895|FG004|Phase B|Withdrawal by Subject|0|||
33139058|NCT00797966|100423896|FG005|Phase B|Withdrawal by Subject|0|||
33139059|NCT00797966|100423891|FG000|Phase B|Protocol Deviation|4|||
33139060|NCT00797966|100423892|FG001|Phase B|Protocol Deviation|8|||
33139061|NCT00797966|100423893|FG002|Phase B|Protocol Deviation|2|||
33139062|NCT00797966|100423894|FG003|Phase B|Protocol Deviation|6|||
33139063|NCT00797966|100423895|FG004|Phase B|Protocol Deviation|0|||
33139064|NCT00797966|100423896|FG005|Phase B|Protocol Deviation|0|||
33139065|NCT00797966|100423891|FG000|Phase B|Lack of Efficacy|0|||
33139066|NCT00797966|100423892|FG001|Phase B|Lack of Efficacy|1|||
33139067|NCT00797966|100423893|FG002|Phase B|Lack of Efficacy|1|||
33139068|NCT00797966|100423894|FG003|Phase B|Lack of Efficacy|4|||
33139069|NCT00797966|100423895|FG004|Phase B|Lack of Efficacy|0|||
33139070|NCT00797966|100423896|FG005|Phase B|Lack of Efficacy|0|||
33139071|NCT00797966|100423891|FG000|Phase A+|Lost to Follow-up|0|||
33139072|NCT00797966|100423892|FG001|Phase A+|Lost to Follow-up|0|||
33139073|NCT00797966|100423893|FG002|Phase A+|Lost to Follow-up|0|||
33139074|NCT00797966|100423894|FG003|Phase A+|Lost to Follow-up|0|||
33139075|NCT00797966|100423895|FG004|Phase A+|Lost to Follow-up|0|||
33139076|NCT00797966|100423896|FG005|Phase A+|Lost to Follow-up|9|||
33139077|NCT00797966|100423891|FG000|Phase A+|Met withdrawal criteria|0|||
33139078|NCT00797966|100423892|FG001|Phase A+|Met withdrawal criteria|0|||
33139079|NCT00797966|100423893|FG002|Phase A+|Met withdrawal criteria|0|||
33139080|NCT00797966|100423894|FG003|Phase A+|Met withdrawal criteria|0|||
33139081|NCT00797966|100423895|FG004|Phase A+|Met withdrawal criteria|0|||
33139082|NCT00797966|100423896|FG005|Phase A+|Met withdrawal criteria|5|||
33139083|NCT00797966|100423891|FG000|Phase A+|Withdrawal by Subject|0|||
33139084|NCT00797966|100423892|FG001|Phase A+|Withdrawal by Subject|0|||
33139085|NCT00797966|100423893|FG002|Phase A+|Withdrawal by Subject|0|||
33577517|NCT02848092|102006477|FG000|6-month Post-training Follow-up|Adverse Event|1|||
33139086|NCT00797966|100423894|FG003|Phase A+|Withdrawal by Subject|0|||
33139087|NCT00797966|100423895|FG004|Phase A+|Withdrawal by Subject|0|||
33139088|NCT00797966|100423896|FG005|Phase A+|Withdrawal by Subject|6|||
33139089|NCT00797966|100423891|FG000|Phase A+|Adverse Event|0|||
33139090|NCT00797966|100423892|FG001|Phase A+|Adverse Event|0|||
33139091|NCT00797966|100423893|FG002|Phase A+|Adverse Event|0|||
33139092|NCT00797966|100423894|FG003|Phase A+|Adverse Event|0|||
33139093|NCT00797966|100423895|FG004|Phase A+|Adverse Event|0|||
33139094|NCT00797966|100423896|FG005|Phase A+|Adverse Event|4|||
33139095|NCT00797966|100423891|FG000|Phase A+|Protocol deviation|0|||
33139096|NCT00797966|100423892|FG001|Phase A+|Protocol deviation|0|||
33139097|NCT00797966|100423893|FG002|Phase A+|Protocol deviation|0|||
33139098|NCT00797966|100423894|FG003|Phase A+|Protocol deviation|0|||
33139099|NCT00797966|100423895|FG004|Phase A+|Protocol deviation|0|||
33139100|NCT00797966|100423896|FG005|Phase A+|Protocol deviation|4|||
33139101|NCT02527200|100423897|FG000|Overall Study|Withdrawal by Subject|3|||
33139102|NCT02527200|100423898|FG001|Overall Study|Withdrawal by Subject|2|||
33139103|NCT02527200|100423899|FG002|Overall Study|Withdrawal by Subject|1|||
33139104|NCT02527200|100423900|FG003|Overall Study|Withdrawal by Subject|0|||
33139105|NCT02527200|100423897|FG000|Overall Study|Unclassified|0|||
33139106|NCT02527200|100423898|FG001|Overall Study|Unclassified|1|||
33139107|NCT02527200|100423899|FG002|Overall Study|Unclassified|0|||
33139108|NCT02527200|100423900|FG003|Overall Study|Unclassified|0|||
33139109|NCT02527200|100423897|FG000|Overall Study|Lost to Follow-up|0|||
33236381|NCT03100838|100768154|FG002|Overall Study|Physician Decision|1|||
33236382|NCT03100838|100768155|FG003|Overall Study|Physician Decision|1|||
33236383|NCT03100838|100768152|FG000|Overall Study|Pregnancy|0|||
33236384|NCT03100838|100768153|FG001|Overall Study|Pregnancy|1|||
33139110|NCT02527200|100423898|FG001|Overall Study|Lost to Follow-up|0|||
33139111|NCT02527200|100423899|FG002|Overall Study|Lost to Follow-up|1|||
33139112|NCT02527200|100423900|FG003|Overall Study|Lost to Follow-up|0|||
33139113|NCT03678870|100423906|FG000|Overall Study|prescribed non- protocol medications|10|||
33139114|NCT03678870|100423907|FG001|Overall Study|prescribed non- protocol medications|6|||
33139115|NCT03678870|100423906|FG000|Overall Study|Lost to Follow-up|3|||
33139116|NCT03678870|100423907|FG001|Overall Study|Lost to Follow-up|2|||
33139117|NCT03859973|100423908|FG000|Overall Study|Other reason than listed|3|||
33139118|NCT03859973|100423909|FG001|Overall Study|Other reason than listed|2|||
33139119|NCT03859973|100423908|FG000|Overall Study|COVID-19 related, not due to AE|3|||
33139120|NCT03859973|100423909|FG001|Overall Study|COVID-19 related, not due to AE|4|||
33139121|NCT03859973|100423908|FG000|Overall Study|Withdrawal by Subject|8|||
33139122|NCT03859973|100423909|FG001|Overall Study|Withdrawal by Subject|9|||
33139123|NCT03859973|100423908|FG000|Overall Study|Lost to Follow-up|2|||
33139124|NCT03859973|100423909|FG001|Overall Study|Lost to Follow-up|3|||
33139125|NCT03859973|100423908|FG000|Overall Study|Protocol Violation|1|||
33139126|NCT03859973|100423909|FG001|Overall Study|Protocol Violation|3|||
33139127|NCT03859973|100423908|FG000|Overall Study|Adverse Event|3|||
33236385|NCT03100838|100768154|FG002|Overall Study|Pregnancy|0|||
33236386|NCT03100838|100768155|FG003|Overall Study|Pregnancy|0|||
33236387|NCT03100838|100768152|FG000|Overall Study|Lost to Follow-up|0|||
33236388|NCT03100838|100768153|FG001|Overall Study|Lost to Follow-up|0|||
33236389|NCT03100838|100768154|FG002|Overall Study|Lost to Follow-up|1|||
33236390|NCT03100838|100768155|FG003|Overall Study|Lost to Follow-up|0|||
33236391|NCT00467142|100768156|FG000|Overall Study|Withdrawal by Subject|1|||
33236392|NCT00467142|100768156|FG000|Overall Study|Adverse Event|1|||
33236393|NCT00467142|100768156|FG000|Overall Study|Protocol Violation|1|||
33236394|NCT00107380|100768157|FG000|Overall Study|Adverse Event|7|||
33577518|NCT02848092|102006478|FG001|6-month Post-training Follow-up|Adverse Event|1|||
33577519|NCT02848092|102006477|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
33139128|NCT03859973|100423909|FG001|Overall Study|Adverse Event|5|||
33139129|NCT02151773|100423910|FG000|Overall Study|Protocol Deviation|64|||
33139130|NCT01235598|100423915|FG000|Overall Study|Adverse Event|0|||
33577520|NCT02848092|102006478|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
33577521|NCT02848092|102006477|FG000|6-month Post-training Follow-up|frustrated with task|1|||
33577522|NCT02848092|102006478|FG001|6-month Post-training Follow-up|frustrated with task|0|||
33577523|NCT02848092|102006477|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
33577524|NCT02848092|102006478|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
33577525|NCT02848092|102006477|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
33577526|NCT02848092|102006478|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
33577527|NCT02026011|102006482|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
33577528|NCT02026011|102006483|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
33577529|NCT02026011|102006482|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
33577530|NCT02026011|102006483|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
33577531|NCT02026011|102006482|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
33139131|NCT01235598|100423916|FG001|Overall Study|Adverse Event|3|||
33139132|NCT01235598|100423915|FG000|Overall Study|Lack of Efficacy|0|||
33139133|NCT01235598|100423916|FG001|Overall Study|Lack of Efficacy|1|||
33139134|NCT01235598|100423915|FG000|Overall Study|Withdrawal by Subject|1|||
33139135|NCT01235598|100423916|FG001|Overall Study|Withdrawal by Subject|0|||
33139136|NCT01236547|100423917|FG000|Overall Study|Protocol Violation|0|||
33139137|NCT01236547|100423918|FG001|Overall Study|Protocol Violation|1|||
33139138|NCT01236547|100423919|FG002|Overall Study|Protocol Violation|1|||
33236395|NCT00107380|100768157|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
33236396|NCT00107380|100768157|FG000|Overall Study|Progression/relapse|4|||
33236397|NCT00107380|100768157|FG000|Overall Study|Death|3|||
33637784|NCT03486834|102225884|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
33637785|NCT03486834|102225882|FG000|Overall Study|Randomized but not treated|4|||
33637786|NCT03486834|102225883|FG001|Overall Study|Randomized but not treated|4|||
33637787|NCT03486834|102225884|FG002|Overall Study|Randomized but not treated|1|||
33637788|NCT03155841|102225885|FG000|Overall Study|Protocol Violation|3|||
33637789|NCT03155841|102225886|FG001|Overall Study|Protocol Violation|4|||
33637790|NCT00521404|102225887|FG000|Overall Study|Adverse Event|13|||
33637791|NCT00521404|102225887|FG000|Overall Study|Disease Progression|33|||
33637792|NCT00521404|102225887|FG000|Overall Study|Investigator decision|5|||
33637793|NCT00521404|102225887|FG000|Overall Study|Withdrawal of consent|3|||
33637794|NCT00521404|102225887|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
33637795|NCT00521404|102225887|FG000|Overall Study|Other|7|||
33637796|NCT00830440|102225888|FG000|Overall Study|Protocol Violation|1|||
33637797|NCT00830440|102225889|FG001|Overall Study|Protocol Violation|0|||
33637798|NCT00830440|102225888|FG000|Overall Study|Withdrawal by Subject|1|||
33236398|NCT00107380|100768157|FG000|Overall Study|Other - not protocol specified|7|||
33236399|NCT00107380|100768157|FG000|Overall Study|Ineligible|2|||
33236400|NCT02764775|100768158|FG000|Overall Study|Death|1|||
33236401|NCT02764775|100768158|FG000|Overall Study|Lost to Follow-up|2|||
33236402|NCT02764775|100768158|FG000|Overall Study|Withdrawal by Subject|3|||
33236403|NCT01290094|100768159|FG000|Overall Study|Withdrawal by Subject|1|||
33236404|NCT01290094|100768159|FG000|Overall Study|Lost to Follow-up|5|||
33236405|NCT01782326|100768160|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
33236406|NCT01782326|100768161|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
33236407|NCT01782326|100768160|FG000|Planned Treatment Epoch|Death|29|||
33236408|NCT01782326|100768161|FG001|Planned Treatment Epoch|Death|30|||
33236409|NCT01782326|100768160|FG000|Planned Treatment Epoch|Physician Decision|18|||
33236410|NCT01782326|100768161|FG001|Planned Treatment Epoch|Physician Decision|16|||
33236411|NCT01782326|100768160|FG000|Planned Treatment Epoch|Protocol deviation|2|||
33236412|NCT01782326|100768161|FG001|Planned Treatment Epoch|Protocol deviation|3|||
33369132|NCT03100942|101236583|FG005|Randomized Treatment Period|Withdrew Consent|0|||
33369133|NCT03100942|101236584|FG006|Randomized Treatment Period|Withdrew Consent|0|||
33369134|NCT03100942|101236578|FG000|Randomized Treatment Period|Adverse Event|5|||
33139139|NCT01236547|100423920|FG003|Overall Study|Protocol Violation|6|||
33139140|NCT01236547|100423921|FG004|Overall Study|Protocol Violation|12|||
33139141|NCT00816023|100423922|FG000|Overall Study|Lost to Follow-up|1|||
33139142|NCT00816023|100423923|FG001|Overall Study|Lost to Follow-up|1|||
33139143|NCT00816023|100423924|FG002|Overall Study|Lost to Follow-up|0|||
33139144|NCT00816023|100423925|FG003|Overall Study|Lost to Follow-up|0|||
33139145|NCT00816023|100423922|FG000|Overall Study|Withdrawal by Subject|1|||
33139146|NCT00816023|100423923|FG001|Overall Study|Withdrawal by Subject|0|||
33139147|NCT00816023|100423924|FG002|Overall Study|Withdrawal by Subject|0|||
33139148|NCT00816023|100423925|FG003|Overall Study|Withdrawal by Subject|0|||
33139149|NCT00816023|100423922|FG000|Overall Study|Physician Decision|0|||
33139150|NCT00816023|100423923|FG001|Overall Study|Physician Decision|0|||
33139151|NCT00816023|100423924|FG002|Overall Study|Physician Decision|1|||
33139152|NCT00816023|100423925|FG003|Overall Study|Physician Decision|0|||
33139153|NCT00816023|100423922|FG000|Overall Study|assessments complete prior to window|1|||
33139154|NCT00816023|100423923|FG001|Overall Study|assessments complete prior to window|1|||
33139155|NCT00816023|100423924|FG002|Overall Study|assessments complete prior to window|2|||
33139156|NCT00816023|100423925|FG003|Overall Study|assessments complete prior to window|1|||
33139157|NCT00816023|100423922|FG000|Overall Study|Randomized Not Treated|6|||
33139158|NCT00816023|100423923|FG001|Overall Study|Randomized Not Treated|4|||
33369135|NCT03100942|101236579|FG001|Randomized Treatment Period|Adverse Event|2|||
33369136|NCT03100942|101236580|FG002|Randomized Treatment Period|Adverse Event|1|||
33369137|NCT03100942|101236581|FG003|Randomized Treatment Period|Adverse Event|0|||
33369138|NCT03100942|101236582|FG004|Randomized Treatment Period|Adverse Event|0|||
33369139|NCT03100942|101236583|FG005|Randomized Treatment Period|Adverse Event|0|||
33369140|NCT03100942|101236584|FG006|Randomized Treatment Period|Adverse Event|0|||
33369141|NCT03100942|101236578|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
33369142|NCT03100942|101236579|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
33420726|NCT02149199|101431596|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
33637799|NCT00830440|102225889|FG001|Overall Study|Withdrawal by Subject|0|||
33637800|NCT00830440|102225888|FG000|Overall Study|unsuccessful procedure|4|||
33637801|NCT00830440|102225889|FG001|Overall Study|unsuccessful procedure|0|||
33139159|NCT00816023|100423924|FG002|Overall Study|Randomized Not Treated|6|||
33637802|NCT00830440|102225888|FG000|Overall Study|Adverse Event|2|||
33139160|NCT00816023|100423925|FG003|Overall Study|Randomized Not Treated|11|||
33139161|NCT02213133|100423926|FG000|Overall Study|Participant discontinued study therapy|2|||
33139162|NCT02213133|100423927|FG001|Overall Study|Participant discontinued study therapy|0|||
33236413|NCT01782326|100768160|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
33236414|NCT01782326|100768161|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
33236415|NCT01782326|100768160|FG000|Planned Treatment Epoch|Technical problems|0|||
33236416|NCT01782326|100768161|FG001|Planned Treatment Epoch|Technical problems|4|||
33236417|NCT01782326|100768160|FG000|Double-blind Treatment|Adverse Event|129|||
33369143|NCT03100942|101236580|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
33369144|NCT03100942|101236581|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
33369145|NCT03100942|101236582|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
33369146|NCT03100942|101236583|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
33637803|NCT00830440|102225889|FG001|Overall Study|Adverse Event|0|||
33236418|NCT01782326|100768161|FG001|Double-blind Treatment|Adverse Event|145|||
33236419|NCT01782326|100768160|FG000|Double-blind Treatment|Subject/guardian decision|111|||
33236420|NCT01782326|100768161|FG001|Double-blind Treatment|Subject/guardian decision|125|||
33236421|NCT01782326|100768160|FG000|Double-blind Treatment|Lack of Efficacy|17|||
33236422|NCT01782326|100768161|FG001|Double-blind Treatment|Lack of Efficacy|22|||
33369147|NCT03100942|101236584|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
33369148|NCT03100942|101236578|FG000|Randomized Treatment Period|Protocol Violation|0|||
33369149|NCT03100942|101236579|FG001|Randomized Treatment Period|Protocol Violation|1|||
33420727|NCT02149199|101431597|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
33420728|NCT02149199|101431598|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
33236423|NCT01782326|100768160|FG000|Double-blind Treatment|Physician Decision|13|||
33236424|NCT01782326|100768161|FG001|Double-blind Treatment|Physician Decision|16|||
33236425|NCT01782326|100768160|FG000|Double-blind Treatment|Protocol deviation|8|||
33236426|NCT01782326|100768161|FG001|Double-blind Treatment|Protocol deviation|7|||
33236427|NCT01782326|100768160|FG000|Double-blind Treatment|Technical problems|0|||
33236428|NCT01782326|100768161|FG001|Double-blind Treatment|Technical problems|5|||
33236429|NCT02139982|100768162|FG000|Overall Study|Lack of Efficacy|0|||
33236430|NCT02139982|100768163|FG001|Overall Study|Lack of Efficacy|1|||
33236431|NCT02139982|100768164|FG002|Overall Study|Lack of Efficacy|0|||
33236432|NCT02139982|100768165|FG003|Overall Study|Lack of Efficacy|1|||
33236433|NCT02139982|100768166|FG004|Overall Study|Lack of Efficacy|0|||
33236434|NCT02139982|100768167|FG005|Overall Study|Lack of Efficacy|0|||
33236435|NCT02139982|100768168|FG006|Overall Study|Lack of Efficacy|0|||
33236436|NCT02139982|100768169|FG007|Overall Study|Lack of Efficacy|0|||
33236437|NCT02139982|100768170|FG008|Overall Study|Lack of Efficacy|0|||
33236438|NCT02139982|100768171|FG009|Overall Study|Lack of Efficacy|0|||
33236439|NCT02025205|100768172|FG000|Overall Study|Withdrawal by Subject|1|||
33236440|NCT02025205|100768173|FG001|Overall Study|Withdrawal by Subject|1|||
33577532|NCT02026011|102006483|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
33577533|NCT02026011|102006482|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
33577534|NCT02026011|102006483|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
33236441|NCT02025205|100768172|FG000|Overall Study|Protocol Violation|2|||
33236442|NCT02025205|100768173|FG001|Overall Study|Protocol Violation|1|||
33236443|NCT02025205|100768172|FG000|Overall Study|Death|0|||
33236444|NCT02025205|100768173|FG001|Overall Study|Death|1|||
33236445|NCT00506285|100768174|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
33236446|NCT00506285|100768175|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
33236447|NCT00506285|100768174|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
33236448|NCT00506285|100768175|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
33236449|NCT00506285|100768174|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
33236450|NCT00506285|100768175|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
33577535|NCT03328832|102006484|FG000|Overall Study|Lost to Follow-up|0|||
33577536|NCT03328832|102006485|FG001|Overall Study|Lost to Follow-up|1|||
33577537|NCT00436436|102006491|FG000|Overall Study|Progression|4|||
33577538|NCT00436436|102006491|FG000|Overall Study|Adverse Event|2|||
33577539|NCT00436436|102006491|FG000|Overall Study|Death|6|||
33577540|NCT01541865|102006496|FG000|Overall Study|Lost to Follow-up|11|||
33577541|NCT01541865|102006496|FG000|Overall Study|Withdrawal by Subject|9|||
33577542|NCT01541865|102006496|FG000|Overall Study|Adverse Event|1|||
33577543|NCT01541865|102006496|FG000|Overall Study|Protocol Violation|1|||
33577544|NCT01856322|102006497|FG000|Overall Study|off study due to lack of accrual|0|||
33577545|NCT01856322|102006498|FG001|Overall Study|off study due to lack of accrual|0|||
33577546|NCT01856322|102006499|FG002|Overall Study|off study due to lack of accrual|3|||
33577547|NCT01061385|102006505|FG000|Overall Study|Lost to Follow-up|1|||
33577548|NCT01061385|102006506|FG001|Overall Study|Lost to Follow-up|0|||
33577549|NCT01061385|102006505|FG000|Overall Study|subject decision not related to AE|0|||
33577550|NCT01061385|102006506|FG001|Overall Study|subject decision not related to AE|1|||
33577551|NCT01492088|102006507|FG000|Overall Study|Withdrawal by Patient|0|||
33236451|NCT00506285|100768174|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
33577552|NCT01492088|102006508|FG001|Overall Study|Withdrawal by Patient|2|||
33577553|NCT01492088|102006509|FG002|Overall Study|Withdrawal by Patient|0|||
33577554|NCT01492088|102006507|FG000|Overall Study|Death|1|||
33577555|NCT01492088|102006508|FG001|Overall Study|Death|6|||
33577556|NCT01492088|102006509|FG002|Overall Study|Death|2|||
33577557|NCT01492088|102006507|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
33637804|NCT02668653|102225890|FG000|Overall Study|Refractory disease|41|||
33236452|NCT00506285|100768175|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
33236453|NCT00506285|100768174|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
33236454|NCT00506285|100768175|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
33236455|NCT00946647|100768176|FG000|Phase 1 Part|Adverse Event|2|||
33236456|NCT00946647|100768177|FG001|Phase 1 Part|Adverse Event|5|||
33236457|NCT00946647|100768178|FG002|Phase 1 Part|Adverse Event|3|||
33236458|NCT00946647|100768179|FG003|Phase 1 Part|Adverse Event|0|||
33236459|NCT00946647|100768180|FG004|Phase 1 Part|Adverse Event|0|||
33236460|NCT00946647|100768176|FG000|Phase 1 Part|Disease progression|3|||
33236461|NCT00946647|100768177|FG001|Phase 1 Part|Disease progression|6|||
33236462|NCT00946647|100768178|FG002|Phase 1 Part|Disease progression|1|||
33236463|NCT00946647|100768179|FG003|Phase 1 Part|Disease progression|0|||
33236464|NCT00946647|100768180|FG004|Phase 1 Part|Disease progression|0|||
33369150|NCT03100942|101236580|FG002|Randomized Treatment Period|Protocol Violation|1|||
33236465|NCT00946647|100768176|FG000|Phase 1 Part|Withdrawal by Subject|1|||
33236466|NCT00946647|100768177|FG001|Phase 1 Part|Withdrawal by Subject|4|||
33236467|NCT00946647|100768178|FG002|Phase 1 Part|Withdrawal by Subject|3|||
33236468|NCT00946647|100768179|FG003|Phase 1 Part|Withdrawal by Subject|0|||
33236469|NCT00946647|100768180|FG004|Phase 1 Part|Withdrawal by Subject|0|||
33236470|NCT00946647|100768176|FG000|Phase 1 Part|Abnormal values|0|||
33236471|NCT00946647|100768177|FG001|Phase 1 Part|Abnormal values|2|||
33236472|NCT00946647|100768178|FG002|Phase 1 Part|Abnormal values|0|||
33236473|NCT00946647|100768179|FG003|Phase 1 Part|Abnormal values|0|||
33236474|NCT00946647|100768180|FG004|Phase 1 Part|Abnormal values|0|||
33236475|NCT00946647|100768176|FG000|Phase 1 Part|Reason missing|0|||
33236476|NCT00946647|100768177|FG001|Phase 1 Part|Reason missing|1|||
33236477|NCT00946647|100768178|FG002|Phase 1 Part|Reason missing|0|||
33236478|NCT00946647|100768179|FG003|Phase 1 Part|Reason missing|0|||
33236479|NCT00946647|100768180|FG004|Phase 1 Part|Reason missing|0|||
33236480|NCT00946647|100768176|FG000|Phase ll Part|Untreated|0|||
33236481|NCT00946647|100768177|FG001|Phase ll Part|Untreated|0|||
33236482|NCT00946647|100768178|FG002|Phase ll Part|Untreated|0|||
33236483|NCT00946647|100768179|FG003|Phase ll Part|Untreated|0|||
33236484|NCT00946647|100768180|FG004|Phase ll Part|Untreated|2|||
33236485|NCT00946647|100768176|FG000|Phase ll Part|Adverse Event|0|||
33236486|NCT00946647|100768177|FG001|Phase ll Part|Adverse Event|0|||
33236487|NCT00946647|100768178|FG002|Phase ll Part|Adverse Event|0|||
33236488|NCT00946647|100768179|FG003|Phase ll Part|Adverse Event|10|||
33236489|NCT00946647|100768180|FG004|Phase ll Part|Adverse Event|6|||
33236490|NCT00946647|100768176|FG000|Phase ll Part|Withdrawal by Subject|0|||
33236491|NCT00946647|100768177|FG001|Phase ll Part|Withdrawal by Subject|0|||
33236492|NCT00946647|100768178|FG002|Phase ll Part|Withdrawal by Subject|0|||
33236493|NCT00946647|100768179|FG003|Phase ll Part|Withdrawal by Subject|8|||
33236494|NCT00946647|100768180|FG004|Phase ll Part|Withdrawal by Subject|6|||
33236495|NCT00946647|100768176|FG000|Phase ll Part|Administrative problems|0|||
33369151|NCT03100942|101236581|FG003|Randomized Treatment Period|Protocol Violation|1|||
33369152|NCT03100942|101236582|FG004|Randomized Treatment Period|Protocol Violation|0|||
33369153|NCT03100942|101236583|FG005|Randomized Treatment Period|Protocol Violation|0|||
33236496|NCT00946647|100768177|FG001|Phase ll Part|Administrative problems|0|||
33236497|NCT00946647|100768178|FG002|Phase ll Part|Administrative problems|0|||
33236498|NCT00946647|100768179|FG003|Phase ll Part|Administrative problems|3|||
33236499|NCT00946647|100768180|FG004|Phase ll Part|Administrative problems|8|||
33236500|NCT00946647|100768176|FG000|Phase ll Part|Death|0|||
33236501|NCT00946647|100768177|FG001|Phase ll Part|Death|0|||
33236502|NCT00946647|100768178|FG002|Phase ll Part|Death|0|||
33236503|NCT00946647|100768179|FG003|Phase ll Part|Death|7|||
33236504|NCT00946647|100768180|FG004|Phase ll Part|Death|4|||
33236505|NCT00946647|100768176|FG000|Phase ll Part|Disease progression|0|||
33236506|NCT00946647|100768177|FG001|Phase ll Part|Disease progression|0|||
33236507|NCT00946647|100768178|FG002|Phase ll Part|Disease progression|0|||
33236508|NCT00946647|100768179|FG003|Phase ll Part|Disease progression|6|||
33236509|NCT00946647|100768180|FG004|Phase ll Part|Disease progression|14|||
33236510|NCT00946647|100768176|FG000|Phase ll Part|Protocol Violation|0|||
33236511|NCT00946647|100768177|FG001|Phase ll Part|Protocol Violation|0|||
33236512|NCT00946647|100768178|FG002|Phase ll Part|Protocol Violation|0|||
33236513|NCT00946647|100768179|FG003|Phase ll Part|Protocol Violation|4|||
33236514|NCT00946647|100768180|FG004|Phase ll Part|Protocol Violation|2|||
33236515|NCT00946647|100768176|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
33236516|NCT00946647|100768177|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
33236517|NCT00946647|100768178|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
33577558|NCT01492088|102006508|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
33236518|NCT00946647|100768179|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
33369154|NCT03100942|101236584|FG006|Randomized Treatment Period|Protocol Violation|0|||
33236519|NCT00946647|100768180|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
33236520|NCT00097370|100768183|FG000|Stage 1|Adverse Event|3|||
33236521|NCT00097370|100768183|FG000|Stage 1|Withdrawal by Subject|1|||
33236522|NCT00097370|100768183|FG000|Stage 1|Lack of Efficacy|2|||
33236523|NCT00097370|100768183|FG000|Stage 2|Adverse Event|5|||
33236524|NCT00097370|100768183|FG000|Stage 2|Withdrawal by Subject|1|||
33236525|NCT00097370|100768183|FG000|Stage 2|Lack of Efficacy|3|||
33236526|NCT00097370|100768183|FG000|Stage 2|Pregnancy|1|||
33236527|NCT00097370|100768183|FG000|Stage 2|Sponsor Terminated Study|2|||
33236528|NCT00097370|100768183|FG000|Stage 2|Lost to Follow-up|1|||
33420729|NCT02149199|101431596|FG000|Overall Study|Withdrawal by Subject|75|||
33420730|NCT02149199|101431597|FG001|Overall Study|Withdrawal by Subject|93|||
33420731|NCT02149199|101431598|FG002|Overall Study|Withdrawal by Subject|77|||
33420732|NCT02149199|101431596|FG000|Overall Study|Protocol Violation|16|||
33577559|NCT01492088|102006509|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
33577560|NCT01492088|102006507|FG000|Overall Study|Alive at Last Follow-up|0|||
33577561|NCT01492088|102006508|FG001|Overall Study|Alive at Last Follow-up|6|||
33577562|NCT01492088|102006509|FG002|Overall Study|Alive at Last Follow-up|11|||
33577563|NCT00339040|102006510|FG000|Stage I|Not able to attend clinic|1|||
33577564|NCT00339040|102006511|FG001|Stage I|Not able to attend clinic|0|||
33577565|NCT00339040|102006510|FG000|Stage I|Protocol Violation|1|||
33577566|NCT00339040|102006511|FG001|Stage I|Protocol Violation|1|||
33577567|NCT00339040|102006510|FG000|Stage II|Lost to Follow-up|3|||
33577568|NCT00339040|102006511|FG001|Stage II|Lost to Follow-up|0|||
33577569|NCT00339040|102006510|FG000|Stage II|Withdrawal by Subject|1|||
33577570|NCT00339040|102006511|FG001|Stage II|Withdrawal by Subject|2|||
33577571|NCT00339040|102006510|FG000|Stage II|Protocol Violation|3|||
33577572|NCT00339040|102006511|FG001|Stage II|Protocol Violation|0|||
33577573|NCT00339040|102006510|FG000|Stage II|Not able to attend clinic|1|||
33577574|NCT00339040|102006511|FG001|Stage II|Not able to attend clinic|0|||
33577575|NCT00339040|102006510|FG000|Stage II|Site closing|2|||
33577576|NCT00339040|102006511|FG001|Stage II|Site closing|0|||
33577577|NCT01123148|102006512|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
33577578|NCT01123148|102006512|FG000|Overall Study|Didn't meet milestone criteria|1|||
33577579|NCT01531998|102006513|FG000|Overall Study|Withdrawal by Subject|3|||
33577580|NCT04828707|102006514|FG000|Overall Study|Lost to Follow-up|3|||
33637805|NCT02668653|102225891|FG001|Overall Study|Refractory disease|70|||
33637806|NCT02668653|102225890|FG000|Overall Study|Relapse|44|||
33577581|NCT04828707|102006515|FG001|Overall Study|Lost to Follow-up|2|||
33577582|NCT04828707|102006514|FG000|Overall Study|Withdrawal by Subject|2|||
33577583|NCT04828707|102006515|FG001|Overall Study|Withdrawal by Subject|1|||
33577584|NCT02078752|102006516|FG000|Overall Study|Death|0|||
33577585|NCT02078752|102006517|FG001|Overall Study|Death|3|||
33577586|NCT02078752|102006518|FG002|Overall Study|Death|0|||
33577587|NCT02078752|102006519|FG003|Overall Study|Death|0|||
33577588|NCT02078752|102006520|FG004|Overall Study|Death|0|||
33577589|NCT02078752|102006521|FG005|Overall Study|Death|1|||
33577590|NCT02078752|102006522|FG006|Overall Study|Death|0|||
33577591|NCT02078752|102006523|FG007|Overall Study|Death|1|||
33577592|NCT02078752|102006524|FG008|Overall Study|Death|0|||
33577593|NCT02078752|102006525|FG009|Overall Study|Death|4|||
33577594|NCT02078752|102006516|FG000|Overall Study|Lost to Follow-up|1|||
33637807|NCT02668653|102225891|FG001|Overall Study|Relapse|65|||
33637808|NCT02668653|102225890|FG000|Overall Study|Adverse Event|58|||
33637809|NCT02668653|102225891|FG001|Overall Study|Adverse Event|23|||
33637810|NCT02668653|102225890|FG000|Overall Study|Subject decision to stop study drug|25|||
33637811|NCT02668653|102225891|FG001|Overall Study|Subject decision to stop study drug|23|||
33637812|NCT02668653|102225890|FG000|Overall Study|Other reasons not specified|16|||
33637813|NCT02668653|102225891|FG001|Overall Study|Other reasons not specified|11|||
33637814|NCT02668653|102225890|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
33637815|NCT02668653|102225891|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
33637816|NCT02668653|102225890|FG000|Overall Study|Investigator decision|10|||
33637817|NCT02668653|102225891|FG001|Overall Study|Investigator decision|7|||
33637818|NCT02668653|102225890|FG000|Overall Study|Failure to meet continuation criteria|5|||
33637819|NCT02668653|102225891|FG001|Overall Study|Failure to meet continuation criteria|12|||
33637820|NCT02668653|102225890|FG000|Overall Study|Lost to Follow-up|1|||
33637821|NCT02668653|102225891|FG001|Overall Study|Lost to Follow-up|0|||
33637822|NCT02668653|102225890|FG000|Overall Study|Pregnancy|0|||
33637823|NCT02668653|102225891|FG001|Overall Study|Pregnancy|1|||
33637824|NCT02668653|102225890|FG000|Overall Study|Death|0|||
33637825|NCT02668653|102225891|FG001|Overall Study|Death|1|||
33637826|NCT03041181|102225892|FG000|Overall Study|Disease Progression|1|||
33637827|NCT03041181|102225893|FG001|Overall Study|Disease Progression|2|||
33420733|NCT02149199|101431597|FG001|Overall Study|Protocol Violation|13|||
33420734|NCT02149199|101431598|FG002|Overall Study|Protocol Violation|15|||
33420735|NCT02149199|101431596|FG000|Overall Study|Lost to Follow-up|3|||
33577595|NCT02078752|102006517|FG001|Overall Study|Lost to Follow-up|0|||
33577596|NCT02078752|102006518|FG002|Overall Study|Lost to Follow-up|0|||
33637828|NCT03312634|102225896|FG000|Overall Study|Adverse Event|11|||
33637829|NCT03312634|102225897|FG001|Overall Study|Adverse Event|0|||
33637830|NCT03312634|102225896|FG000|Overall Study|Sponsor request|2|||
33637831|NCT03312634|102225897|FG001|Overall Study|Sponsor request|0|||
33637832|NCT03312634|102225896|FG000|Overall Study|Withdrawal by Subject|31|||
33637833|NCT03312634|102225897|FG001|Overall Study|Withdrawal by Subject|9|||
33577597|NCT02078752|102006519|FG003|Overall Study|Lost to Follow-up|1|||
33577598|NCT02078752|102006520|FG004|Overall Study|Lost to Follow-up|0|||
33577599|NCT02078752|102006521|FG005|Overall Study|Lost to Follow-up|0|||
33420736|NCT02149199|101431597|FG001|Overall Study|Lost to Follow-up|12|||
33577600|NCT02078752|102006522|FG006|Overall Study|Lost to Follow-up|0|||
33577601|NCT02078752|102006523|FG007|Overall Study|Lost to Follow-up|0|||
33577602|NCT02078752|102006524|FG008|Overall Study|Lost to Follow-up|0|||
33577603|NCT02078752|102006525|FG009|Overall Study|Lost to Follow-up|0|||
33577604|NCT02078752|102006516|FG000|Overall Study|Withdrawal by Subject|1|||
33577605|NCT02078752|102006517|FG001|Overall Study|Withdrawal by Subject|1|||
33577606|NCT02078752|102006518|FG002|Overall Study|Withdrawal by Subject|1|||
33577607|NCT02078752|102006519|FG003|Overall Study|Withdrawal by Subject|1|||
33577608|NCT02078752|102006520|FG004|Overall Study|Withdrawal by Subject|0|||
33577609|NCT02078752|102006521|FG005|Overall Study|Withdrawal by Subject|3|||
33577610|NCT02078752|102006522|FG006|Overall Study|Withdrawal by Subject|2|||
33577611|NCT02078752|102006523|FG007|Overall Study|Withdrawal by Subject|1|||
33577612|NCT02078752|102006524|FG008|Overall Study|Withdrawal by Subject|0|||
33577613|NCT02078752|102006525|FG009|Overall Study|Withdrawal by Subject|1|||
33577614|NCT02078752|102006516|FG000|Overall Study|Other|0|||
33577615|NCT02078752|102006517|FG001|Overall Study|Other|3|||
33577616|NCT02078752|102006518|FG002|Overall Study|Other|0|||
33577617|NCT02078752|102006519|FG003|Overall Study|Other|0|||
33577618|NCT02078752|102006520|FG004|Overall Study|Other|1|||
33577619|NCT02078752|102006521|FG005|Overall Study|Other|0|||
33577620|NCT02078752|102006522|FG006|Overall Study|Other|0|||
33577621|NCT02078752|102006523|FG007|Overall Study|Other|1|||
33577622|NCT02078752|102006524|FG008|Overall Study|Other|0|||
33577623|NCT02078752|102006525|FG009|Overall Study|Other|0|||
33139163|NCT02213133|100423928|FG002|Overall Study|Participant discontinued study therapy|0|||
33139164|NCT02213133|100423926|FG000|Overall Study|Participant withdrew informed consent|2|||
33139165|NCT02213133|100423927|FG001|Overall Study|Participant withdrew informed consent|1|||
33139166|NCT02213133|100423928|FG002|Overall Study|Participant withdrew informed consent|2|||
33139167|NCT02213133|100423926|FG000|Overall Study|Disease progression|11|||
33139168|NCT02213133|100423927|FG001|Overall Study|Disease progression|2|||
33139169|NCT02213133|100423928|FG002|Overall Study|Disease progression|0|||
33139170|NCT02213133|100423926|FG000|Overall Study|Adverse Event (AE)|1|||
33139171|NCT02213133|100423927|FG001|Overall Study|Adverse Event (AE)|0|||
33139172|NCT02213133|100423928|FG002|Overall Study|Adverse Event (AE)|0|||
33139173|NCT02213133|100423926|FG000|Overall Study|Death|16|||
33139174|NCT02213133|100423927|FG001|Overall Study|Death|2|||
33139175|NCT02213133|100423928|FG002|Overall Study|Death|1|||
33139176|NCT02213133|100423926|FG000|Overall Study|Other|5|||
33139177|NCT02213133|100423927|FG001|Overall Study|Other|0|||
33139178|NCT02213133|100423928|FG002|Overall Study|Other|0|||
33139179|NCT00711516|100423929|FG000|Overall Study|Adverse Event|1|||
33139180|NCT00711516|100423930|FG001|Overall Study|Adverse Event|1|||
33139181|NCT00711516|100423929|FG000|Overall Study|Withdrawal by Subject|0|||
33139182|NCT00711516|100423930|FG001|Overall Study|Withdrawal by Subject|1|||
33139183|NCT00711516|100423929|FG000|Overall Study|Protocol Violation|0|||
33139184|NCT00711516|100423930|FG001|Overall Study|Protocol Violation|1|||
33139185|NCT00281658|100423931|FG000|Randomized Phase|Adverse Event|0|||
33139186|NCT00281658|100423932|FG001|Randomized Phase|Adverse Event|2|||
33139187|NCT00281658|100423933|FG002|Randomized Phase|Adverse Event|0|||
33139188|NCT00281658|100423934|FG003|Randomized Phase|Adverse Event|0|||
33139189|NCT00281658|100423931|FG000|Randomized Phase|Lost to Follow-up|34|||
33139190|NCT00281658|100423932|FG001|Randomized Phase|Lost to Follow-up|27|||
33139191|NCT00281658|100423933|FG002|Randomized Phase|Lost to Follow-up|0|||
33139192|NCT00281658|100423934|FG003|Randomized Phase|Lost to Follow-up|0|||
33139193|NCT00281658|100423931|FG000|Randomized Phase|Withdrawal by Subject|8|||
33139194|NCT00281658|100423932|FG001|Randomized Phase|Withdrawal by Subject|7|||
33139195|NCT00281658|100423933|FG002|Randomized Phase|Withdrawal by Subject|0|||
33139196|NCT00281658|100423934|FG003|Randomized Phase|Withdrawal by Subject|0|||
33139197|NCT00281658|100423931|FG000|Randomized Phase|Study closed/terminated|1|||
33139198|NCT00281658|100423932|FG001|Randomized Phase|Study closed/terminated|1|||
33139199|NCT00281658|100423933|FG002|Randomized Phase|Study closed/terminated|0|||
33139200|NCT00281658|100423934|FG003|Randomized Phase|Study closed/terminated|0|||
33139201|NCT00281658|100423931|FG000|Randomized Phase|Disease progression|36|||
33139202|NCT00281658|100423932|FG001|Randomized Phase|Disease progression|27|||
33577624|NCT02078752|102006516|FG000|Overall Study|Study terminated by sponsor|0|||
33577625|NCT02078752|102006517|FG001|Overall Study|Study terminated by sponsor|0|||
33577626|NCT02078752|102006518|FG002|Overall Study|Study terminated by sponsor|0|||
33577627|NCT02078752|102006519|FG003|Overall Study|Study terminated by sponsor|0|||
33139203|NCT00281658|100423933|FG002|Randomized Phase|Disease progression|0|||
33139204|NCT00281658|100423934|FG003|Randomized Phase|Disease progression|0|||
33139205|NCT00281658|100423931|FG000|Randomized Phase|Physician Decision|1|||
33139206|NCT00281658|100423932|FG001|Randomized Phase|Physician Decision|1|||
33139207|NCT00281658|100423933|FG002|Randomized Phase|Physician Decision|0|||
33577628|NCT02078752|102006520|FG004|Overall Study|Study terminated by sponsor|0|||
33577629|NCT02078752|102006521|FG005|Overall Study|Study terminated by sponsor|0|||
33139208|NCT00281658|100423934|FG003|Randomized Phase|Physician Decision|0|||
33139209|NCT00281658|100423931|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
33139210|NCT00281658|100423932|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
33577630|NCT02078752|102006522|FG006|Overall Study|Study terminated by sponsor|0|||
33236529|NCT00097370|100768183|FG000|Stage 3|Adverse Event|2|||
33236530|NCT00097370|100768183|FG000|Stage 3|Withdrawal by Subject|3|||
33236531|NCT00097370|100768183|FG000|Stage 3|Lack of Efficacy|1|||
33236532|NCT00097370|100768183|FG000|Stage 3|Sponsor Terminated Study|52|||
33577631|NCT02078752|102006523|FG007|Overall Study|Study terminated by sponsor|0|||
33637834|NCT03312634|102225896|FG000|Overall Study|Enrolled in an interventional study|0|||
33637835|NCT03312634|102225897|FG001|Overall Study|Enrolled in an interventional study|52|||
33637836|NCT03312634|102225896|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
33637837|NCT03312634|102225897|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
33637838|NCT03312634|102225896|FG000|Overall Study|Death|0|||
33637839|NCT03312634|102225897|FG001|Overall Study|Death|1|||
33637840|NCT03312634|102225896|FG000|Overall Study|Non-compliance|0|||
33637841|NCT03312634|102225897|FG001|Overall Study|Non-compliance|2|||
33637842|NCT03312634|102225896|FG000|Overall Study|Lost to Follow-up|0|||
33637843|NCT03312634|102225897|FG001|Overall Study|Lost to Follow-up|1|||
33637844|NCT03312634|102225896|FG000|Overall Study|Enrolled into non-interventional study|0|||
33637845|NCT03312634|102225897|FG001|Overall Study|Enrolled into non-interventional study|5|||
33637846|NCT03312634|102225896|FG000|Overall Study|Worsening clinical condition|0|||
33637847|NCT03312634|102225897|FG001|Overall Study|Worsening clinical condition|1|||
33637848|NCT03312634|102225896|FG000|Overall Study|Participant did not want to travel|0|||
33577632|NCT02078752|102006524|FG008|Overall Study|Study terminated by sponsor|0|||
33577633|NCT02078752|102006525|FG009|Overall Study|Study terminated by sponsor|5|||
33577634|NCT02504372|102006526|FG000|Overall Study|Death|136|||
33577635|NCT02504372|102006527|FG001|Overall Study|Death|154|||
33577636|NCT02504372|102006526|FG000|Overall Study|Lost to Follow-up|0|||
33577637|NCT02504372|102006527|FG001|Overall Study|Lost to Follow-up|2|||
33577638|NCT02504372|102006526|FG000|Overall Study|Withdrawal of consent|25|||
33577639|NCT02504372|102006527|FG001|Overall Study|Withdrawal of consent|16|||
33577640|NCT02504372|102006526|FG000|Overall Study|Participants ongoing|429|||
33577641|NCT02504372|102006527|FG001|Overall Study|Participants ongoing|415|||
33577642|NCT03688919|102006530|FG000|Overall Study|Lost to Follow-up|2|||
33577643|NCT03688919|102006531|FG001|Overall Study|Lost to Follow-up|1|||
33577644|NCT03688919|102006530|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
33577645|NCT03688919|102006531|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
33577646|NCT04568603|102006533|FG000|Overall Study|Physician Decision|1|||
33637849|NCT03312634|102225897|FG001|Overall Study|Participant did not want to travel|1|||
33637850|NCT03312634|102225896|FG000|Overall Study|Physician Decision|1|||
33637851|NCT03312634|102225897|FG001|Overall Study|Physician Decision|0|||
33637852|NCT03312634|102225896|FG000|Overall Study|Other|13|||
33637853|NCT03312634|102225897|FG001|Overall Study|Other|0|||
33139211|NCT00281658|100423933|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
33139212|NCT00281658|100423934|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
33139213|NCT00281658|100423931|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
33139214|NCT00281658|100423932|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
33139215|NCT00281658|100423933|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
33139216|NCT00281658|100423934|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
33139217|NCT00281658|100423931|FG000|Randomized Phase|Treatment ongoing|1|||
33139218|NCT00281658|100423932|FG001|Randomized Phase|Treatment ongoing|0|||
33139219|NCT00281658|100423933|FG002|Randomized Phase|Treatment ongoing|0|||
33139220|NCT00281658|100423934|FG003|Randomized Phase|Treatment ongoing|0|||
33139221|NCT00281658|100423931|FG000|Open Label Phase|Adverse Event|0|||
33139222|NCT00281658|100423932|FG001|Open Label Phase|Adverse Event|0|||
33139223|NCT00281658|100423933|FG002|Open Label Phase|Adverse Event|1|||
33139224|NCT00281658|100423934|FG003|Open Label Phase|Adverse Event|0|||
33139225|NCT00281658|100423931|FG000|Open Label Phase|Lost to Follow-up|0|||
33139226|NCT00281658|100423932|FG001|Open Label Phase|Lost to Follow-up|0|||
33139227|NCT00281658|100423933|FG002|Open Label Phase|Lost to Follow-up|16|||
33139228|NCT00281658|100423934|FG003|Open Label Phase|Lost to Follow-up|2|||
33139229|NCT00281658|100423931|FG000|Open Label Phase|Withdrawal by Subject|0|||
33139230|NCT00281658|100423932|FG001|Open Label Phase|Withdrawal by Subject|0|||
33139231|NCT00281658|100423933|FG002|Open Label Phase|Withdrawal by Subject|3|||
33577647|NCT01154452|102006534|FG000|Phase Ib|Not Treated|1|||
33577648|NCT01154452|102006535|FG001|Phase Ib|Not Treated|0|||
33577649|NCT01154452|102006536|FG002|Phase Ib|Not Treated|0|||
33577650|NCT01154452|102006537|FG003|Phase Ib|Not Treated|0|||
33637854|NCT03614156|102225898|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
33637855|NCT03614156|102225899|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
33637856|NCT03614156|102225900|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
33139232|NCT00281658|100423934|FG003|Open Label Phase|Withdrawal by Subject|2|||
33139233|NCT00281658|100423931|FG000|Open Label Phase|Disease progression|0|||
33139234|NCT00281658|100423932|FG001|Open Label Phase|Disease progression|0|||
33236533|NCT00097370|100768183|FG000|Stage 3|Lost to Follow-up|1|||
33577651|NCT01154452|102006534|FG000|Phase Ib|Adverse Event|2|||
33577652|NCT01154452|102006535|FG001|Phase Ib|Adverse Event|1|||
33577653|NCT01154452|102006536|FG002|Phase Ib|Adverse Event|0|||
33637857|NCT03614156|102225901|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
33637858|NCT03614156|102225898|FG000|Open-Label Treatment Period|Adverse Event|7|||
33637859|NCT03614156|102225899|FG001|Open-Label Treatment Period|Adverse Event|0|||
33236534|NCT00429793|100768189|FG000|Overall Study|Improper pre-protocol treatment|3|||
33236535|NCT00429793|100768189|FG000|Overall Study|Required test not done|1|||
33236536|NCT00429793|100768189|FG000|Overall Study|Never treated|1|||
33236537|NCT00429793|100768189|FG000|Overall Study|Non-measurable|1|||
33236538|NCT00179010|100768190|FG000|Overall Study|Muscle probe defective|1|||
33236539|NCT00179010|100768191|FG001|Overall Study|Muscle probe defective|1|||
33236540|NCT00179010|100768190|FG000|Overall Study|Failure to place arterial line|0|||
33236541|NCT00179010|100768191|FG001|Overall Study|Failure to place arterial line|1|||
33577654|NCT01154452|102006537|FG003|Phase Ib|Adverse Event|0|||
33577655|NCT01154452|102006534|FG000|Phase II|Withdrawal by Subject|0|||
33577656|NCT01154452|102006535|FG001|Phase II|Withdrawal by Subject|0|||
33637860|NCT03614156|102225900|FG002|Open-Label Treatment Period|Adverse Event|0|||
33637861|NCT03614156|102225901|FG003|Open-Label Treatment Period|Adverse Event|0|||
33637862|NCT03614156|102225898|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
33637863|NCT03614156|102225899|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
33637864|NCT03614156|102225900|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
33637865|NCT03614156|102225901|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
33637866|NCT03614156|102225898|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
33637867|NCT03614156|102225899|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
33637868|NCT03614156|102225900|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
33637869|NCT03614156|102225901|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
33637870|NCT03614156|102225898|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
33637871|NCT03614156|102225899|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
33637872|NCT03614156|102225900|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
33637873|NCT03614156|102225901|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
33637874|NCT03614156|102225898|FG000|Open-Label Treatment Period|Protocol Violation|2|||
33637875|NCT03614156|102225899|FG001|Open-Label Treatment Period|Protocol Violation|0|||
33637876|NCT03614156|102225900|FG002|Open-Label Treatment Period|Protocol Violation|0|||
33236542|NCT03135548|100768192|FG000|Overall Study|Lost to Follow-up|3|||
33236543|NCT03135548|100768193|FG001|Overall Study|Lost to Follow-up|0|||
33236544|NCT03135548|100768194|FG002|Overall Study|Lost to Follow-up|0|||
33236545|NCT03135548|100768192|FG000|Overall Study|Withdrawal by Subject|2|||
33577657|NCT01154452|102006536|FG002|Phase II|Withdrawal by Subject|1|||
33577658|NCT01154452|102006537|FG003|Phase II|Withdrawal by Subject|2|||
33577659|NCT01154452|102006534|FG000|Phase II|Adverse Event|0|||
33577660|NCT01154452|102006535|FG001|Phase II|Adverse Event|0|||
33577661|NCT01154452|102006536|FG002|Phase II|Adverse Event|4|||
33577662|NCT01154452|102006537|FG003|Phase II|Adverse Event|4|||
33577663|NCT00429182|102006538|FG000|Overall Study|Not evaluable, Disease Progression|2|||
33637877|NCT03614156|102225901|FG003|Open-Label Treatment Period|Protocol Violation|0|||
33637878|NCT03614156|102225898|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
33236546|NCT03135548|100768193|FG001|Overall Study|Withdrawal by Subject|2|||
33236547|NCT03135548|100768194|FG002|Overall Study|Withdrawal by Subject|1|||
33236548|NCT03135548|100768192|FG000|Overall Study|Other than listed|0|||
33236549|NCT03135548|100768193|FG001|Overall Study|Other than listed|2|||
33236550|NCT03135548|100768194|FG002|Overall Study|Other than listed|2|||
33236551|NCT02268396|100768195|FG000|Overall Study|Adverse Event|3|||
33236552|NCT02268396|100768195|FG000|Overall Study|Administrative|2|||
33236553|NCT02268396|100768195|FG000|Overall Study|Withdrawal by Subject|1|||
33236554|NCT02268396|100768195|FG000|Overall Study|Lost to Follow-up|2|||
33236555|NCT02268396|100768195|FG000|Overall Study|Protocol-Specified Criteria|2|||
33236556|NCT02268396|100768195|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
33236557|NCT01720797|100768203|FG000|Overall Study|Withdrawal by Subject|3|||
33236558|NCT01720797|100768204|FG001|Overall Study|Withdrawal by Subject|0|||
33236559|NCT02013687|100768208|FG000|Overall Study|Lost to Follow-up|0|||
33236560|NCT02013687|100768209|FG001|Overall Study|Lost to Follow-up|0|||
33236561|NCT02013687|100768210|FG002|Overall Study|Lost to Follow-up|1|||
33236562|NCT02013687|100768211|FG003|Overall Study|Lost to Follow-up|0|||
33236563|NCT02013687|100768208|FG000|Overall Study|Protocol Violation|0|||
33420737|NCT02149199|101431598|FG002|Overall Study|Lost to Follow-up|11|||
33420738|NCT02149199|101431596|FG000|Overall Study|Death|0|||
33577664|NCT00429182|102006538|FG000|Overall Study|Not eligible|5|||
33577665|NCT00648037|102006546|FG000|Overall Study|Not Treated|1|||
33577666|NCT00648037|102006546|FG000|Overall Study|Withdrawal by Subject|1|||
33236564|NCT02013687|100768209|FG001|Overall Study|Protocol Violation|0|||
33236565|NCT02013687|100768210|FG002|Overall Study|Protocol Violation|0|||
33236566|NCT02013687|100768211|FG003|Overall Study|Protocol Violation|1|||
33236567|NCT02013687|100768208|FG000|Overall Study|Withdrawal by Subject|0|||
33236568|NCT02013687|100768209|FG001|Overall Study|Withdrawal by Subject|0|||
33236569|NCT02013687|100768210|FG002|Overall Study|Withdrawal by Subject|0|||
33420739|NCT02149199|101431597|FG001|Overall Study|Death|0|||
33577667|NCT00648037|102006546|FG000|Overall Study|Adverse Event|11|||
33577668|NCT00648037|102006546|FG000|Overall Study|Relapse|2|||
33236570|NCT02013687|100768211|FG003|Overall Study|Withdrawal by Subject|1|||
33236571|NCT02013687|100768208|FG000|Overall Study|Missed visits due to patient travel|0|||
33236572|NCT02013687|100768209|FG001|Overall Study|Missed visits due to patient travel|0|||
33236573|NCT02013687|100768210|FG002|Overall Study|Missed visits due to patient travel|1|||
33236574|NCT02013687|100768211|FG003|Overall Study|Missed visits due to patient travel|0|||
33236575|NCT00178256|100768213|FG000|Overall Study|Adverse Event|2|||
33236576|NCT00178256|100768214|FG001|Overall Study|Adverse Event|0|||
33236577|NCT00178256|100768215|FG002|Overall Study|Adverse Event|0|||
33236578|NCT00178256|100768216|FG003|Overall Study|Adverse Event|0|||
33139235|NCT00281658|100423933|FG002|Open Label Phase|Disease progression|18|||
33139236|NCT00281658|100423934|FG003|Open Label Phase|Disease progression|0|||
33139237|NCT00281658|100423931|FG000|Open Label Phase|Physician Decision|0|||
33139238|NCT00281658|100423932|FG001|Open Label Phase|Physician Decision|0|||
33139239|NCT00281658|100423933|FG002|Open Label Phase|Physician Decision|1|||
33236579|NCT00178256|100768213|FG000|Overall Study|Death|0|||
33236580|NCT00178256|100768214|FG001|Overall Study|Death|1|||
33236581|NCT00178256|100768215|FG002|Overall Study|Death|0|||
33236582|NCT00178256|100768216|FG003|Overall Study|Death|1|||
33236583|NCT00178256|100768213|FG000|Overall Study|Cancer progression|2|||
33236584|NCT00178256|100768214|FG001|Overall Study|Cancer progression|0|||
33236585|NCT00178256|100768215|FG002|Overall Study|Cancer progression|0|||
33236586|NCT00178256|100768216|FG003|Overall Study|Cancer progression|1|||
33236587|NCT02419755|100768218|FG000|Overall Study|Death|1|||
33236588|NCT02419755|100768219|FG001|Overall Study|Death|3|||
33236589|NCT02419755|100768218|FG000|Overall Study|Relapse|0|||
33236590|NCT02419755|100768219|FG001|Overall Study|Relapse|1|||
33236591|NCT02419755|100768218|FG000|Overall Study|Ineligible|1|||
33236592|NCT02419755|100768219|FG001|Overall Study|Ineligible|0|||
33236593|NCT02419755|100768218|FG000|Overall Study|Withdrawal by Subject|1|||
33236594|NCT02419755|100768219|FG001|Overall Study|Withdrawal by Subject|0|||
33236595|NCT00885495|100768220|FG000|Overall Study|Adverse Event|1|||
33236596|NCT00885495|100768221|FG001|Overall Study|Adverse Event|2|||
33236597|NCT00885495|100768220|FG000|Overall Study|Protocol Violation|0|||
33236598|NCT00885495|100768221|FG001|Overall Study|Protocol Violation|1|||
33236599|NCT00885495|100768220|FG000|Overall Study|Withdrawal by Subject|1|||
33236600|NCT00885495|100768221|FG001|Overall Study|Withdrawal by Subject|0|||
33236601|NCT01625338|100768222|FG000|Overall Study|Enrolled but not Treated|0|||
33139240|NCT00281658|100423934|FG003|Open Label Phase|Physician Decision|0|||
33139241|NCT00281658|100423931|FG000|Open Label Phase|Relocation of patient|0|||
33139242|NCT00281658|100423932|FG001|Open Label Phase|Relocation of patient|0|||
33139243|NCT00281658|100423933|FG002|Open Label Phase|Relocation of patient|1|||
33139244|NCT00281658|100423934|FG003|Open Label Phase|Relocation of patient|0|||
33139245|NCT00281658|100423931|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
33139246|NCT00281658|100423932|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
33139247|NCT00281658|100423933|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
33139248|NCT00281658|100423934|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
33139249|NCT00528970|100423939|FG000|Overall Study|Adverse Event|6|||
33139250|NCT00528970|100423940|FG001|Overall Study|Adverse Event|8|||
33139251|NCT00528970|100423941|FG002|Overall Study|Adverse Event|5|||
33139252|NCT00528970|100423939|FG000|Overall Study|Lost to Follow-up|0|||
33139253|NCT00528970|100423940|FG001|Overall Study|Lost to Follow-up|0|||
33139254|NCT00528970|100423941|FG002|Overall Study|Lost to Follow-up|1|||
33139255|NCT00528970|100423939|FG000|Overall Study|Other than specified|2|||
33139256|NCT00528970|100423940|FG001|Overall Study|Other than specified|3|||
33139257|NCT00528970|100423941|FG002|Overall Study|Other than specified|3|||
33139258|NCT00528970|100423939|FG000|Overall Study|Protocol Violation|2|||
33139259|NCT00528970|100423940|FG001|Overall Study|Protocol Violation|1|||
33139260|NCT00528970|100423941|FG002|Overall Study|Protocol Violation|4|||
33139261|NCT00528970|100423939|FG000|Overall Study|Lack of Efficacy|0|||
33420740|NCT02149199|101431598|FG002|Overall Study|Death|1|||
33420741|NCT02149199|101431596|FG000|Overall Study|Adverse Event|6|||
33420742|NCT02149199|101431597|FG001|Overall Study|Adverse Event|15|||
33420743|NCT02149199|101431598|FG002|Overall Study|Adverse Event|9|||
33139262|NCT00528970|100423940|FG001|Overall Study|Lack of Efficacy|0|||
33139263|NCT00528970|100423941|FG002|Overall Study|Lack of Efficacy|1|||
33139264|NCT00528970|100423939|FG000|Overall Study|Withdrawal by Subject|4|||
33139265|NCT00528970|100423940|FG001|Overall Study|Withdrawal by Subject|3|||
33139266|NCT00528970|100423941|FG002|Overall Study|Withdrawal by Subject|5|||
33139267|NCT00528970|100423939|FG000|Overall Study|Randomized but not treated|0|||
33236602|NCT01625338|100768223|FG001|Overall Study|Enrolled but not Treated|0|||
33236603|NCT01625338|100768224|FG002|Overall Study|Enrolled but not Treated|1|||
33236604|NCT01625338|100768222|FG000|Overall Study|Efficacy Failure|27|||
33236605|NCT01625338|100768223|FG001|Overall Study|Efficacy Failure|39|||
33236606|NCT01625338|100768224|FG002|Overall Study|Efficacy Failure|31|||
33236607|NCT01625338|100768222|FG000|Overall Study|Lost to Follow-up|3|||
33236608|NCT01625338|100768223|FG001|Overall Study|Lost to Follow-up|3|||
33236609|NCT01625338|100768224|FG002|Overall Study|Lost to Follow-up|2|||
33420744|NCT02858076|101431599|FG000|Overall Study|Death|6|||
33236610|NCT01625338|100768222|FG000|Overall Study|Investigator Decision|0|||
33236611|NCT01625338|100768223|FG001|Overall Study|Investigator Decision|2|||
33236612|NCT01625338|100768224|FG002|Overall Study|Investigator Decision|1|||
33236613|NCT01625338|100768222|FG000|Overall Study|Subject Withdrew Consent|1|||
33236614|NCT01625338|100768223|FG001|Overall Study|Subject Withdrew Consent|0|||
33236615|NCT01625338|100768224|FG002|Overall Study|Subject Withdrew Consent|2|||
33236616|NCT01625338|100768222|FG000|Overall Study|Adverse Event|1|||
33236617|NCT01625338|100768223|FG001|Overall Study|Adverse Event|0|||
33236618|NCT01625338|100768224|FG002|Overall Study|Adverse Event|1|||
33236619|NCT01625338|100768222|FG000|Overall Study|Study Discontinued by Sponsor|0|||
33236620|NCT01625338|100768223|FG001|Overall Study|Study Discontinued by Sponsor|0|||
33236621|NCT01625338|100768224|FG002|Overall Study|Study Discontinued by Sponsor|1|||
33236622|NCT03615482|100768227|FG000|Overall Study|Death|1|||
33236623|NCT03615482|100768228|FG001|Overall Study|Death|0|||
33236624|NCT03615482|100768227|FG000|Overall Study|Lost to Follow-up|7|||
33236625|NCT03615482|100768228|FG001|Overall Study|Lost to Follow-up|7|||
33236626|NCT03615482|100768227|FG000|Overall Study|Physician Decision|2|||
33236627|NCT03615482|100768228|FG001|Overall Study|Physician Decision|3|||
33236628|NCT03615482|100768227|FG000|Overall Study|Withdrawal by Subject|7|||
33236629|NCT03615482|100768228|FG001|Overall Study|Withdrawal by Subject|7|||
33236630|NCT03073005|100768229|FG000|Overall Study|Death|6|||
33236631|NCT03073005|100768230|FG001|Overall Study|Death|0|||
33236632|NCT03073005|100768231|FG002|Overall Study|Death|7|||
33236633|NCT03073005|100768232|FG003|Overall Study|Death|0|||
33236634|NCT03073005|100768229|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
33236635|NCT03073005|100768230|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
33236636|NCT03073005|100768231|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
33577669|NCT00648037|102006546|FG000|Overall Study|Other|1|||
33577670|NCT04834726|102006548|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
33577671|NCT04834726|102006549|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
33577672|NCT04834726|102006550|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
33577673|NCT04834726|102006551|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
33577674|NCT04834726|102006552|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
33577675|NCT04834726|102006553|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
33577676|NCT04834726|102006554|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
33139268|NCT00528970|100423940|FG001|Overall Study|Randomized but not treated|0|||
33139269|NCT00528970|100423941|FG002|Overall Study|Randomized but not treated|1|||
33139270|NCT04136444|100423942|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
33139271|NCT04136444|100423943|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
33139272|NCT01625260|100423944|FG000|Overall Study|Adverse Event|3|||
33139273|NCT01625260|100423945|FG001|Overall Study|Adverse Event|0|||
33236637|NCT03073005|100768232|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
33236638|NCT03073005|100768229|FG000|Overall Study|Lost to Follow-up|2|||
33236639|NCT03073005|100768230|FG001|Overall Study|Lost to Follow-up|2|||
33236640|NCT03073005|100768231|FG002|Overall Study|Lost to Follow-up|1|||
33139274|NCT01625260|100423944|FG000|Overall Study|Study Terminated by Investigator|2|||
33139275|NCT01625260|100423945|FG001|Overall Study|Study Terminated by Investigator|0|||
33139276|NCT01625260|100423944|FG000|Overall Study|Disease Progression|2|||
33139277|NCT01625260|100423945|FG001|Overall Study|Disease Progression|0|||
33139278|NCT01625260|100423944|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
33139279|NCT01625260|100423945|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
33139280|NCT02386189|100423951|FG000|Overall Study|Lost to Follow-up|2|||
33236641|NCT03073005|100768232|FG003|Overall Study|Lost to Follow-up|2|||
33236642|NCT03073005|100768229|FG000|Overall Study|Withdrawal by Subject|0|||
33236643|NCT03073005|100768230|FG001|Overall Study|Withdrawal by Subject|4|||
33236644|NCT03073005|100768231|FG002|Overall Study|Withdrawal by Subject|4|||
33236645|NCT03073005|100768232|FG003|Overall Study|Withdrawal by Subject|4|||
33236646|NCT01375959|100768233|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
33236647|NCT01375959|100768234|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
33236648|NCT01375959|100768233|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
33420745|NCT02858076|101431600|FG001|Overall Study|Death|3|||
33420746|NCT02858076|101431599|FG000|Overall Study|Withdrawal by Subject|1|||
33420747|NCT02858076|101431600|FG001|Overall Study|Withdrawal by Subject|5|||
33420748|NCT02858076|101431599|FG000|Overall Study|Lost to Follow-up|2|||
33577677|NCT04834726|102006555|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
33139281|NCT02386189|100423952|FG001|Overall Study|Lost to Follow-up|3|||
33236649|NCT01375959|100768234|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
33236650|NCT01375959|100768233|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
33236651|NCT01375959|100768234|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
33236652|NCT01781611|100768235|FG000|Overall Study|Adverse Event|4|||
33236653|NCT01781611|100768236|FG001|Overall Study|Adverse Event|0|||
33236654|NCT01076088|100768237|FG000|Overall Study|Adverse Event|1|||
33236655|NCT01076088|100768238|FG001|Overall Study|Adverse Event|6|||
33236656|NCT01076088|100768239|FG002|Overall Study|Adverse Event|3|||
33236657|NCT01076088|100768240|FG003|Overall Study|Adverse Event|2|||
33236658|NCT01076088|100768241|FG004|Overall Study|Adverse Event|3|||
33236659|NCT01076088|100768242|FG005|Overall Study|Adverse Event|3|||
33236660|NCT01076088|100768237|FG000|Overall Study|Lost to Follow-up|1|||
33236661|NCT01076088|100768238|FG001|Overall Study|Lost to Follow-up|1|||
33236662|NCT01076088|100768239|FG002|Overall Study|Lost to Follow-up|0|||
33236663|NCT01076088|100768240|FG003|Overall Study|Lost to Follow-up|1|||
33236664|NCT01076088|100768241|FG004|Overall Study|Lost to Follow-up|1|||
33236665|NCT01076088|100768242|FG005|Overall Study|Lost to Follow-up|2|||
33236666|NCT01076088|100768237|FG000|Overall Study|Non-compliance with study drug|0|||
33236667|NCT01076088|100768238|FG001|Overall Study|Non-compliance with study drug|0|||
33236668|NCT01076088|100768239|FG002|Overall Study|Non-compliance with study drug|0|||
33236669|NCT01076088|100768240|FG003|Overall Study|Non-compliance with study drug|1|||
33236670|NCT01076088|100768241|FG004|Overall Study|Non-compliance with study drug|0|||
33236671|NCT01076088|100768242|FG005|Overall Study|Non-compliance with study drug|0|||
33236672|NCT01076088|100768237|FG000|Overall Study|Physician Decision|1|||
33577678|NCT04834726|102006556|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
33577679|NCT03192137|102006557|FG000|Overall Study|Adverse Event|10|||
33577680|NCT03192137|102006558|FG001|Overall Study|Adverse Event|11|||
33577681|NCT03192137|102006557|FG000|Overall Study|Physician Decision|1|||
33577682|NCT03192137|102006558|FG001|Overall Study|Physician Decision|0|||
33577683|NCT03192137|102006557|FG000|Overall Study|Lack of Efficacy|20|||
33236673|NCT01076088|100768238|FG001|Overall Study|Physician Decision|3|||
33236674|NCT01076088|100768239|FG002|Overall Study|Physician Decision|0|||
33236675|NCT01076088|100768240|FG003|Overall Study|Physician Decision|1|||
33236676|NCT01076088|100768241|FG004|Overall Study|Physician Decision|1|||
33236677|NCT01076088|100768242|FG005|Overall Study|Physician Decision|0|||
33236678|NCT01076088|100768237|FG000|Overall Study|Withdrawal by Subject|8|||
33236679|NCT01076088|100768238|FG001|Overall Study|Withdrawal by Subject|8|||
33236680|NCT01076088|100768239|FG002|Overall Study|Withdrawal by Subject|14|||
33236681|NCT01076088|100768240|FG003|Overall Study|Withdrawal by Subject|10|||
33236682|NCT01076088|100768241|FG004|Overall Study|Withdrawal by Subject|11|||
33236683|NCT01076088|100768242|FG005|Overall Study|Withdrawal by Subject|17|||
33236684|NCT01076088|100768237|FG000|Overall Study|Other protocol specified criteria|0|||
33236685|NCT01076088|100768238|FG001|Overall Study|Other protocol specified criteria|0|||
33236686|NCT01076088|100768239|FG002|Overall Study|Other protocol specified criteria|0|||
33236687|NCT01076088|100768240|FG003|Overall Study|Other protocol specified criteria|0|||
33236688|NCT01076088|100768241|FG004|Overall Study|Other protocol specified criteria|0|||
33236689|NCT01076088|100768242|FG005|Overall Study|Other protocol specified criteria|1|||
33236690|NCT01628874|100768243|FG000|Overall Study|Physician Decision|1|||
33236691|NCT01628874|100768244|FG001|Overall Study|Physician Decision|1|||
33236692|NCT01628874|100768243|FG000|Overall Study|Age >4 months|4|||
33236693|NCT01628874|100768244|FG001|Overall Study|Age >4 months|2|||
33236694|NCT00209027|100768245|FG000|Overall Study|study terminated|10|||
33236695|NCT00209027|100768246|FG001|Overall Study|study terminated|0|||
33236696|NCT05114590|100768247|FG000|Overall Study|Adverse Event|1|||
33236697|NCT05114590|100768247|FG000|Overall Study|Investigator decision|1|||
33236698|NCT05114590|100768247|FG000|Overall Study|Lost to Follow-up|5|||
33236699|NCT05114590|100768247|FG000|Overall Study|Withdrawal by Subject|5|||
33236700|NCT05114590|100768247|FG000|Overall Study|Other|2|||
33236701|NCT03590743|100768252|FG000|Overall Study|Withdrawal by Subject|0|||
33236702|NCT03590743|100768253|FG001|Overall Study|Withdrawal by Subject|1|||
33236703|NCT01653847|100768254|FG000|Overall Study|Withdrawal by Subject|1|||
33236704|NCT01653847|100768255|FG001|Overall Study|Withdrawal by Subject|0|||
33236705|NCT00605319|100768256|FG000|Overall Study|Adverse Event|6|||
33236706|NCT00372060|100768277|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
33236707|NCT00372060|100768278|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
33236708|NCT00372060|100768277|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
33236709|NCT00372060|100768278|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
33236710|NCT00372060|100768277|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
33420749|NCT02858076|101431600|FG001|Overall Study|Lost to Follow-up|7|||
33577684|NCT03192137|102006558|FG001|Overall Study|Lack of Efficacy|37|||
33577685|NCT03192137|102006557|FG000|Overall Study|Withdrawal by Subject|3|||
33577686|NCT03192137|102006558|FG001|Overall Study|Withdrawal by Subject|3|||
33577687|NCT03192137|102006557|FG000|Overall Study|Protocol Violation|4|||
33577688|NCT03192137|102006558|FG001|Overall Study|Protocol Violation|3|||
33236711|NCT00372060|100768278|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
33236712|NCT00372060|100768277|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
33236713|NCT00372060|100768278|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
33236714|NCT00372060|100768277|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
33236715|NCT00372060|100768278|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
33236716|NCT00372060|100768277|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
33236717|NCT00372060|100768278|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
33577689|NCT03192137|102006557|FG000|Overall Study|Surgery Cancelled|4|||
33577690|NCT03192137|102006558|FG001|Overall Study|Surgery Cancelled|1|||
33577691|NCT03192137|102006557|FG000|Overall Study|Other - Various Administrative Reasons|8|||
33577692|NCT03192137|102006558|FG001|Overall Study|Other - Various Administrative Reasons|3|||
33577693|NCT01904721|102006561|FG000|Overall Study|Other Reasons|0|||
33577694|NCT01904721|102006562|FG001|Overall Study|Other Reasons|0|||
33577695|NCT01904721|102006563|FG002|Overall Study|Other Reasons|1|||
33577696|NCT01904721|102006564|FG003|Overall Study|Other Reasons|1|||
33577697|NCT01904721|102006565|FG004|Overall Study|Other Reasons|2|||
33577698|NCT01904721|102006566|FG005|Overall Study|Other Reasons|2|||
33236718|NCT01458275|100768279|FG000|Overall Study|Adverse Event|3|||
33236719|NCT01458275|100768280|FG001|Overall Study|Adverse Event|4|||
33236720|NCT01458275|100768281|FG002|Overall Study|Adverse Event|1|||
33236721|NCT01458275|100768279|FG000|Overall Study|Lost to Follow-up|3|||
33236722|NCT01458275|100768280|FG001|Overall Study|Lost to Follow-up|2|||
33236723|NCT01458275|100768281|FG002|Overall Study|Lost to Follow-up|5|||
33236724|NCT01458275|100768279|FG000|Overall Study|Protocol Violation|5|||
33236725|NCT01458275|100768280|FG001|Overall Study|Protocol Violation|5|||
33236726|NCT01458275|100768281|FG002|Overall Study|Protocol Violation|2|||
33236727|NCT01458275|100768279|FG000|Overall Study|Withdrawal by Subject|3|||
33236728|NCT01458275|100768280|FG001|Overall Study|Withdrawal by Subject|2|||
33236729|NCT01458275|100768281|FG002|Overall Study|Withdrawal by Subject|1|||
33236730|NCT01923389|100768282|FG000|Overall Study|Protocol Violation|1|||
33236731|NCT01923389|100768283|FG001|Overall Study|Protocol Violation|0|||
33236732|NCT00513019|100768290|FG000|Overall Study|Adverse Event|1|||
33236733|NCT00513019|100768291|FG001|Overall Study|Adverse Event|0|||
33236734|NCT00513019|100768290|FG000|Overall Study|Withdrawal by Subject|4|||
33236735|NCT00513019|100768291|FG001|Overall Study|Withdrawal by Subject|5|||
33577699|NCT01904721|102006567|FG006|Overall Study|Other Reasons|2|||
33139282|NCT02386189|100423951|FG000|Overall Study|Withdrawal by Subject|1|||
33577700|NCT01904721|102006561|FG000|Overall Study|Personal Reasons|0|||
33577701|NCT01904721|102006562|FG001|Overall Study|Personal Reasons|0|||
33577702|NCT01904721|102006563|FG002|Overall Study|Personal Reasons|0|||
33577703|NCT01904721|102006564|FG003|Overall Study|Personal Reasons|0|||
33139283|NCT02386189|100423952|FG001|Overall Study|Withdrawal by Subject|0|||
33139284|NCT02386189|100423951|FG000|Overall Study|Death|1|||
33139285|NCT02386189|100423952|FG001|Overall Study|Death|0|||
33139286|NCT01038869|100423957|FG000|Overall Study|Withdrawal by Subject|1|||
33139287|NCT01038869|100423957|FG000|Overall Study|Lost to Follow-up|6|||
33139288|NCT00045942|100423959|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
33139289|NCT00045942|100423960|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33139290|NCT00045942|100423961|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33139291|NCT00045942|100423962|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33139292|NCT00045942|100423963|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33139293|NCT00045942|100423964|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33139294|NCT00045942|100423965|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33139295|NCT00045942|100423966|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33139296|NCT00045942|100423967|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
33139297|NCT00045942|100423959|FG000|PKC412A2104 (Core)|Adverse Event|5|||
33139298|NCT00045942|100423960|FG001|PKC412A2104 (Core)|Adverse Event|0|||
33139299|NCT00045942|100423961|FG002|PKC412A2104 (Core)|Adverse Event|0|||
33139300|NCT00045942|100423962|FG003|PKC412A2104 (Core)|Adverse Event|0|||
33139301|NCT00045942|100423963|FG004|PKC412A2104 (Core)|Adverse Event|0|||
33139302|NCT00045942|100423964|FG005|PKC412A2104 (Core)|Adverse Event|0|||
33139303|NCT00045942|100423965|FG006|PKC412A2104 (Core)|Adverse Event|0|||
33139304|NCT00045942|100423966|FG007|PKC412A2104 (Core)|Adverse Event|0|||
33139305|NCT00045942|100423967|FG008|PKC412A2104 (Core)|Adverse Event|0|||
33139306|NCT00045942|100423959|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
33139307|NCT00045942|100423960|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
33139308|NCT00045942|100423961|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
33139309|NCT00045942|100423962|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
33139310|NCT00045942|100423963|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
33139311|NCT00045942|100423964|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
33139312|NCT00045942|100423965|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
33139313|NCT00045942|100423966|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
33139314|NCT00045942|100423967|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
33139315|NCT00045942|100423959|FG000|PKC412A2104 (Core)|Death|1|||
33139316|NCT00045942|100423960|FG001|PKC412A2104 (Core)|Death|0|||
33139317|NCT00045942|100423961|FG002|PKC412A2104 (Core)|Death|0|||
33139318|NCT00045942|100423962|FG003|PKC412A2104 (Core)|Death|0|||
33139319|NCT00045942|100423963|FG004|PKC412A2104 (Core)|Death|0|||
33139320|NCT00045942|100423964|FG005|PKC412A2104 (Core)|Death|0|||
33139321|NCT00045942|100423965|FG006|PKC412A2104 (Core)|Death|0|||
33139322|NCT00045942|100423966|FG007|PKC412A2104 (Core)|Death|0|||
33139323|NCT00045942|100423967|FG008|PKC412A2104 (Core)|Death|0|||
33577704|NCT01904721|102006565|FG004|Overall Study|Personal Reasons|2|||
33577705|NCT01904721|102006566|FG005|Overall Study|Personal Reasons|3|||
33139324|NCT00045942|100423959|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
33236736|NCT02337361|100768292|FG000|3-month Follow-up|Lost to Follow-up|19|||
33236737|NCT02337361|100768293|FG001|3-month Follow-up|Lost to Follow-up|14|||
33236738|NCT02337361|100768292|FG000|6-month Follow-up|Lost to Follow-up|2|||
33236739|NCT02337361|100768293|FG001|6-month Follow-up|Lost to Follow-up|4|||
33236740|NCT02930122|100768294|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
33236741|NCT02930122|100768295|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
33236742|NCT00479674|100768305|FG000|Overall Study|Adverse Event|18|||
33236743|NCT00479674|100768305|FG000|Overall Study|Withdrawal by Subject|6|||
33236744|NCT00479674|100768305|FG000|Overall Study|Physician Decision|14|||
33236745|NCT00479674|100768305|FG000|Overall Study|none provided|3|||
33236746|NCT03053492|100768306|FG000|Overall Study|Adverse Event|1|||
33236747|NCT03053492|100768307|FG001|Overall Study|Adverse Event|1|||
33236748|NCT03053492|100768306|FG000|Overall Study|Withdrawal by Subject|7|||
33236749|NCT03053492|100768307|FG001|Overall Study|Withdrawal by Subject|5|||
33236750|NCT02176928|100768314|FG000|Overall Study|Lost to Follow-up|2|||
33236751|NCT02176928|100768315|FG001|Overall Study|Lost to Follow-up|4|||
33236752|NCT03712098|100768316|FG000|Overall Study|Lost to Follow-up|3|||
33236753|NCT03712098|100768317|FG001|Overall Study|Lost to Follow-up|7|||
33236754|NCT03712098|100768316|FG000|Overall Study|Withdrawal by Subject|9|||
33236755|NCT03712098|100768317|FG001|Overall Study|Withdrawal by Subject|4|||
33236756|NCT03712098|100768316|FG000|Overall Study|Protocol Violation|2|||
33236757|NCT03712098|100768317|FG001|Overall Study|Protocol Violation|1|||
33236758|NCT03523871|100768318|FG000|Overall Study|Death|1|||
33236759|NCT00262743|100768323|FG000|Overall Study|Adverse Event|0|||
33236760|NCT00262743|100768324|FG001|Overall Study|Adverse Event|9|||
33236761|NCT00262743|100768323|FG000|Overall Study|Disease progression|0|||
33236762|NCT00262743|100768324|FG001|Overall Study|Disease progression|3|||
33236763|NCT00280293|100768325|FG000|Overall Study|Protocol Violation|3|||
33236764|NCT00280293|100768326|FG001|Overall Study|Protocol Violation|0|||
33236765|NCT00280293|100768325|FG000|Overall Study|Physician Decision|5|||
33236766|NCT00280293|100768326|FG001|Overall Study|Physician Decision|4|||
33236767|NCT00280293|100768325|FG000|Overall Study|Lost to Follow-up|14|||
33236768|NCT00280293|100768326|FG001|Overall Study|Lost to Follow-up|12|||
33236769|NCT00280293|100768325|FG000|Overall Study|Withdrawal by Subject|3|||
33236770|NCT00280293|100768326|FG001|Overall Study|Withdrawal by Subject|5|||
33236771|NCT00280293|100768325|FG000|Overall Study|Incarceration/Legal Reasons|1|||
33236772|NCT00280293|100768326|FG001|Overall Study|Incarceration/Legal Reasons|1|||
33236773|NCT00280293|100768325|FG000|Overall Study|Adverse Event|0|||
33236774|NCT00280293|100768326|FG001|Overall Study|Adverse Event|1|||
33236775|NCT00802737|100768327|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
33236776|NCT00802737|100768328|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
33236777|NCT00802737|100768329|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
33236778|NCT00802737|100768327|FG000|Overall Study|Death|6|||
33236779|NCT00802737|100768328|FG001|Overall Study|Death|5|||
33236780|NCT00802737|100768329|FG002|Overall Study|Death|1|||
33236781|NCT00802737|100768327|FG000|Overall Study|Adverse Event|1|||
33236782|NCT00802737|100768328|FG001|Overall Study|Adverse Event|0|||
33236783|NCT00802737|100768329|FG002|Overall Study|Adverse Event|0|||
33236784|NCT00802737|100768327|FG000|Overall Study|Received Prohibited Therapy|1|||
33420750|NCT02858076|101431599|FG000|Overall Study|Completed Out of Window|1|||
33637879|NCT03614156|102225899|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
33637880|NCT03614156|102225900|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
33637881|NCT03614156|102225901|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
33637882|NCT03614156|102225898|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
33637883|NCT03614156|102225899|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
33637884|NCT03614156|102225900|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
33637885|NCT03614156|102225901|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
33420751|NCT02858076|101431600|FG001|Overall Study|Completed Out of Window|3|||
33420752|NCT01787188|101431601|FG000|Overall Study|Adverse Event|2|||
33420753|NCT01787188|101431602|FG001|Overall Study|Adverse Event|4|||
33420754|NCT01787188|101431603|FG002|Overall Study|Adverse Event|6|||
33420755|NCT01787188|101431601|FG000|Overall Study|Lack of Efficacy|7|||
33420756|NCT01787188|101431602|FG001|Overall Study|Lack of Efficacy|3|||
33577706|NCT01904721|102006567|FG006|Overall Study|Personal Reasons|3|||
33577707|NCT01904721|102006561|FG000|Overall Study|Lost to Follow-up|0|||
33577708|NCT01904721|102006562|FG001|Overall Study|Lost to Follow-up|0|||
33577709|NCT01904721|102006563|FG002|Overall Study|Lost to Follow-up|0|||
33577710|NCT01904721|102006564|FG003|Overall Study|Lost to Follow-up|0|||
33577711|NCT01904721|102006565|FG004|Overall Study|Lost to Follow-up|1|||
33577712|NCT01904721|102006566|FG005|Overall Study|Lost to Follow-up|3|||
33236785|NCT00802737|100768328|FG001|Overall Study|Received Prohibited Therapy|0|||
33236786|NCT00802737|100768329|FG002|Overall Study|Received Prohibited Therapy|0|||
33236787|NCT00802737|100768327|FG000|Overall Study|Ongoing CLL-Treatment|0|||
33236788|NCT00802737|100768328|FG001|Overall Study|Ongoing CLL-Treatment|1|||
33420757|NCT01787188|101431603|FG002|Overall Study|Lack of Efficacy|5|||
33577713|NCT01904721|102006567|FG006|Overall Study|Lost to Follow-up|1|||
33236789|NCT00802737|100768329|FG002|Overall Study|Ongoing CLL-Treatment|0|||
33236790|NCT00802737|100768327|FG000|Overall Study|Participant too Unwell|0|||
33236791|NCT00802737|100768328|FG001|Overall Study|Participant too Unwell|2|||
33236792|NCT00802737|100768329|FG002|Overall Study|Participant too Unwell|0|||
33236793|NCT04467840|100768330|FG000|Overall Study|Death|35|||
33236794|NCT04467840|100768331|FG001|Overall Study|Death|39|||
33236795|NCT04467840|100768330|FG000|Overall Study|Withdrawal by Subject|8|||
33236796|NCT04467840|100768331|FG001|Overall Study|Withdrawal by Subject|4|||
33236797|NCT04467840|100768330|FG000|Overall Study|Adverse Event|2|||
33236798|NCT04467840|100768331|FG001|Overall Study|Adverse Event|0|||
33236799|NCT04467840|100768330|FG000|Overall Study|Lost to Follow-up|1|||
33236800|NCT04467840|100768331|FG001|Overall Study|Lost to Follow-up|3|||
33236801|NCT04467840|100768330|FG000|Overall Study|Physician Decision|1|||
33236802|NCT04467840|100768331|FG001|Overall Study|Physician Decision|0|||
33236803|NCT04467840|100768330|FG000|Overall Study|Other|1|||
33236804|NCT04467840|100768331|FG001|Overall Study|Other|5|||
33236805|NCT04467840|100768330|FG000|Overall Study|Missing study completion status|3|||
33236806|NCT04467840|100768331|FG001|Overall Study|Missing study completion status|1|||
33236807|NCT00750893|100768332|FG000|Overall Study|Adverse Event|5|||
33236808|NCT00750893|100768332|FG000|Overall Study|Withdrawal by Subject|10|||
33420758|NCT01787188|101431601|FG000|Overall Study|Non-compliance with Study Drug|0|||
33420759|NCT01787188|101431602|FG001|Overall Study|Non-compliance with Study Drug|1|||
33420760|NCT01787188|101431603|FG002|Overall Study|Non-compliance with Study Drug|0|||
33420761|NCT01787188|101431601|FG000|Overall Study|Withdrawal by Subject|4|||
33420762|NCT01787188|101431602|FG001|Overall Study|Withdrawal by Subject|3|||
33420763|NCT01787188|101431603|FG002|Overall Study|Withdrawal by Subject|2|||
33420764|NCT01787188|101431601|FG000|Overall Study|Protocol Violation|3|||
33420765|NCT01787188|101431602|FG001|Overall Study|Protocol Violation|2|||
33420766|NCT01787188|101431603|FG002|Overall Study|Protocol Violation|3|||
33420767|NCT01787188|101431601|FG000|Overall Study|Lost to Follow-up|1|||
33420768|NCT01787188|101431602|FG001|Overall Study|Lost to Follow-up|2|||
33420769|NCT01787188|101431603|FG002|Overall Study|Lost to Follow-up|2|||
33236809|NCT00750893|100768332|FG000|Overall Study|Lost to Follow-up|510|||
33420770|NCT01787188|101431601|FG000|Overall Study|Other, including patient moved|0|||
33420771|NCT01787188|101431602|FG001|Overall Study|Other, including patient moved|3|||
33236810|NCT00750893|100768332|FG000|Overall Study|Other|17|||
33236811|NCT00777803|100768333|FG000|Overall Study|Lost to Follow-up|12|||
33236812|NCT00777803|100768334|FG001|Overall Study|Lost to Follow-up|5|||
33236813|NCT00777803|100768333|FG000|Overall Study|Adverse Event|1|||
33420772|NCT01787188|101431603|FG002|Overall Study|Other, including patient moved|0|||
33420773|NCT02756078|101431606|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
33420774|NCT02756078|101431607|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
33420775|NCT02756078|101431606|FG000|Period 1|Lost to Follow-up|0|||
33420776|NCT02756078|101431607|FG001|Period 1|Lost to Follow-up|2|||
33420777|NCT02756078|101431606|FG000|Period 1|Protocol Violation|0|||
33420778|NCT02756078|101431607|FG001|Period 1|Protocol Violation|1|||
33420779|NCT02756078|101431606|FG000|Period 1|Adverse Event|1|||
33420780|NCT02756078|101431607|FG001|Period 1|Adverse Event|10|||
33420781|NCT02756078|101431606|FG000|Period 1|Withdrawal by Subject|6|||
33420782|NCT02756078|101431607|FG001|Period 1|Withdrawal by Subject|6|||
33420783|NCT02756078|101431606|FG000|Period 1|Lens Discomfort|2|||
33420784|NCT02756078|101431607|FG001|Period 1|Lens Discomfort|2|||
33420785|NCT02756078|101431606|FG000|Period 2|Adverse Event|3|||
33420786|NCT02756078|101431607|FG001|Period 2|Adverse Event|5|||
33236814|NCT00777803|100768334|FG001|Overall Study|Adverse Event|0|||
33236815|NCT00777803|100768333|FG000|Overall Study|Non-compliance|2|||
33236816|NCT00777803|100768334|FG001|Overall Study|Non-compliance|2|||
33236817|NCT02117544|100768335|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
33236818|NCT02117544|100768336|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
33236819|NCT01651403|100768342|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
33420787|NCT02756078|101431606|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
33577714|NCT01904721|102006561|FG000|Overall Study|Lack of Efficacy|0|||
33637886|NCT03614156|102225898|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
33637887|NCT03614156|102225899|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
33420788|NCT02756078|101431607|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
33420789|NCT02756078|101431606|FG000|Period 2|Withdrawal by Subject|3|||
33420790|NCT02756078|101431607|FG001|Period 2|Withdrawal by Subject|1|||
33420791|NCT00468312|101431611|FG000|Overall Study|Adverse Event|2|||
33420792|NCT00468312|101431612|FG001|Overall Study|Adverse Event|1|||
33420793|NCT00468312|101431611|FG000|Overall Study|Lack of Efficacy|0|||
33420794|NCT00468312|101431612|FG001|Overall Study|Lack of Efficacy|1|||
33236820|NCT01651403|100768343|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
33236821|NCT01651403|100768342|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
33236822|NCT01651403|100768343|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
33236823|NCT01651403|100768342|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
33236824|NCT01651403|100768343|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
33420795|NCT00468312|101431611|FG000|Overall Study|Withdrawal by Subject|0|||
33236825|NCT01651403|100768342|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
33236826|NCT01651403|100768343|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
33236827|NCT01651403|100768342|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
33236828|NCT01651403|100768343|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
33236829|NCT01651403|100768342|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
33236830|NCT01651403|100768343|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
33236831|NCT00311155|100768352|FG000|Overall Study|Adverse Event|21|||
33236832|NCT00311155|100768352|FG000|Overall Study|Withdrawal by Subject|17|||
33236833|NCT00311155|100768352|FG000|Overall Study|Did not meet entry criteria|55|||
33236834|NCT02718417|100768353|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
33236835|NCT02718417|100768354|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
33236836|NCT02718417|100768355|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
33236837|NCT02718417|100768353|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
33236838|NCT02718417|100768354|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
33236839|NCT02718417|100768355|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
33577715|NCT01904721|102006562|FG001|Overall Study|Lack of Efficacy|0|||
33577716|NCT01904721|102006563|FG002|Overall Study|Lack of Efficacy|0|||
33577717|NCT01904721|102006564|FG003|Overall Study|Lack of Efficacy|0|||
33577718|NCT01904721|102006565|FG004|Overall Study|Lack of Efficacy|0|||
33577719|NCT01904721|102006566|FG005|Overall Study|Lack of Efficacy|0|||
33577720|NCT01904721|102006567|FG006|Overall Study|Lack of Efficacy|1|||
33577721|NCT01904721|102006561|FG000|Overall Study|Adverse Event|0|||
33577722|NCT01904721|102006562|FG001|Overall Study|Adverse Event|0|||
33577723|NCT01904721|102006563|FG002|Overall Study|Adverse Event|0|||
33577724|NCT01904721|102006564|FG003|Overall Study|Adverse Event|0|||
33577725|NCT01904721|102006565|FG004|Overall Study|Adverse Event|3|||
33577726|NCT01904721|102006566|FG005|Overall Study|Adverse Event|1|||
33577727|NCT01904721|102006567|FG006|Overall Study|Adverse Event|0|||
33637888|NCT03614156|102225900|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
33637889|NCT03614156|102225901|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
33637890|NCT03614156|102225898|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
33637891|NCT03614156|102225899|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
33637892|NCT03614156|102225900|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
33637893|NCT03614156|102225901|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
33637894|NCT03614156|102225898|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33637895|NCT03614156|102225899|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33637896|NCT03614156|102225900|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
33637897|NCT03614156|102225901|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
33236840|NCT02718417|100768353|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
33236841|NCT02718417|100768354|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
33236842|NCT02718417|100768355|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
33236843|NCT02718417|100768353|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
33236844|NCT02718417|100768354|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
33236845|NCT02718417|100768355|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
33236846|NCT02718417|100768353|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
33236847|NCT02718417|100768354|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
33236848|NCT02718417|100768355|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
33236849|NCT02718417|100768353|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
33236850|NCT02718417|100768354|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
33236851|NCT02718417|100768355|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
33236852|NCT02718417|100768353|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
33236853|NCT02718417|100768354|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
33236854|NCT02718417|100768355|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
33577728|NCT00558636|102006570|FG000|Treatment|Adverse Event|9|||
33577729|NCT00558636|102006571|FG001|Treatment|Adverse Event|2|||
33577730|NCT00558636|102006570|FG000|Treatment|Withdrawal by Subject|2|||
33577731|NCT00558636|102006571|FG001|Treatment|Withdrawal by Subject|0|||
33577732|NCT00558636|102006570|FG000|Treatment|Premature termination of the study|35|||
33577733|NCT00558636|102006571|FG001|Treatment|Premature termination of the study|37|||
33577734|NCT00558636|102006570|FG000|Treatment|Disease progression|1|||
33577735|NCT00558636|102006571|FG001|Treatment|Disease progression|5|||
33577736|NCT00558636|102006570|FG000|Follow-up|Premature termination of the study|12|||
33637898|NCT03614156|102225898|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
33236855|NCT02718417|100768353|FG000|Chemotherapy Phase (CP)|Other|2|||
33236856|NCT02718417|100768354|FG001|Chemotherapy Phase (CP)|Other|0|||
33236857|NCT02718417|100768355|FG002|Chemotherapy Phase (CP)|Other|1|||
33577737|NCT00558636|102006571|FG001|Follow-up|Premature termination of the study|7|||
33577738|NCT00803361|102006572|FG000|Overall Study|Adverse Event|13|||
33577739|NCT00803361|102006573|FG001|Overall Study|Adverse Event|3|||
33637899|NCT03614156|102225899|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
33637900|NCT03614156|102225900|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
33637901|NCT03614156|102225901|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
33637902|NCT03614156|102225898|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
33637903|NCT03614156|102225899|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
33637904|NCT03614156|102225900|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
33637905|NCT03614156|102225901|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
33637906|NCT03614156|102225898|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
33637907|NCT03614156|102225899|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
33637908|NCT03614156|102225900|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
33637909|NCT03614156|102225901|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
33637910|NCT03614156|102225898|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
33637911|NCT03614156|102225899|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
33637912|NCT03614156|102225900|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
33637913|NCT03614156|102225901|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
33637914|NCT03614156|102225898|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
33637915|NCT03614156|102225899|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
33637916|NCT03614156|102225900|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
33637917|NCT03614156|102225901|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
33637918|NCT03614156|102225898|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
33637919|NCT03614156|102225899|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
33637920|NCT03614156|102225900|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
33139325|NCT00045942|100423960|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
33139326|NCT00045942|100423961|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
33139327|NCT00045942|100423962|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
33139328|NCT00045942|100423963|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
33139329|NCT00045942|100423964|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
33369155|NCT03100942|101236578|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
33369156|NCT03100942|101236579|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
33369157|NCT03100942|101236580|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
33637921|NCT03614156|102225901|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
33637922|NCT01263197|102225902|FG000|First Intervention (Period 1)|Adverse Event|0|||
33637923|NCT01263197|102225903|FG001|First Intervention (Period 1)|Adverse Event|0|||
33420796|NCT00468312|101431612|FG001|Overall Study|Withdrawal by Subject|1|||
33420797|NCT00468312|101431611|FG000|Overall Study|Protocol Violation|2|||
33420798|NCT00468312|101431612|FG001|Overall Study|Protocol Violation|1|||
33420799|NCT00468312|101431611|FG000|Overall Study|Did not meet protocol eligibility|0|||
33369158|NCT03100942|101236581|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
33369159|NCT03100942|101236582|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
33369160|NCT03100942|101236583|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
33369161|NCT03100942|101236584|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
33369162|NCT03100942|101236578|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
33369163|NCT03100942|101236579|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
33369164|NCT03100942|101236580|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
33369165|NCT03100942|101236581|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
33369166|NCT03100942|101236582|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
33369167|NCT03100942|101236583|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
33369168|NCT03100942|101236584|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
33420800|NCT00468312|101431612|FG001|Overall Study|Did not meet protocol eligibility|1|||
33420801|NCT01374906|101431619|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33420802|NCT01374906|101431620|FG001|Overall Study|Abnormal laboratory value(s)|3|||
33420803|NCT01374906|101431619|FG000|Overall Study|Administrative problems|2|||
33420804|NCT01374906|101431620|FG001|Overall Study|Administrative problems|2|||
33420805|NCT01374906|101431619|FG000|Overall Study|Adverse Event|10|||
33420806|NCT01374906|101431620|FG001|Overall Study|Adverse Event|11|||
33420807|NCT01374906|101431619|FG000|Overall Study|Death|0|||
33420808|NCT01374906|101431620|FG001|Overall Study|Death|2|||
33420809|NCT01374906|101431619|FG000|Overall Study|Protocol Violation|2|||
33637924|NCT01263197|102225904|FG002|First Intervention (Period 1)|Adverse Event|0|||
33637925|NCT01263197|102225905|FG003|First Intervention (Period 1)|Adverse Event|0|||
33637926|NCT01263197|102225906|FG004|First Intervention (Period 1)|Adverse Event|0|||
33637927|NCT01263197|102225907|FG005|First Intervention (Period 1)|Adverse Event|1|||
33139330|NCT00045942|100423965|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
33420810|NCT01374906|101431620|FG001|Overall Study|Protocol Violation|2|||
33637928|NCT01263197|102225902|FG000|Washout Period 1|Protocol Violation|0|||
33637929|NCT01263197|102225903|FG001|Washout Period 1|Protocol Violation|0|||
33637930|NCT01263197|102225904|FG002|Washout Period 1|Protocol Violation|0|||
33139331|NCT00045942|100423966|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
33139332|NCT00045942|100423967|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
33139333|NCT00045942|100423959|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
33420811|NCT01374906|101431619|FG000|Overall Study|Withdrawal by Subject|15|||
33637931|NCT01263197|102225905|FG003|Washout Period 1|Protocol Violation|0|||
33637932|NCT01263197|102225906|FG004|Washout Period 1|Protocol Violation|1|||
33637933|NCT01263197|102225907|FG005|Washout Period 1|Protocol Violation|0|||
33637934|NCT01263197|102225902|FG000|Washout Period 2|Physician Decision|0|||
33637935|NCT01263197|102225903|FG001|Washout Period 2|Physician Decision|0|||
33637936|NCT01263197|102225904|FG002|Washout Period 2|Physician Decision|0|||
33637937|NCT01263197|102225905|FG003|Washout Period 2|Physician Decision|0|||
33637938|NCT01263197|102225906|FG004|Washout Period 2|Physician Decision|0|||
33637939|NCT01263197|102225907|FG005|Washout Period 2|Physician Decision|1|||
33637940|NCT01263197|102225902|FG000|Washout Period 2|Protocol Violation|0|||
33236858|NCT02718417|100768353|FG000|Maintenance Phase (MP)|Adverse Event|21|||
33236859|NCT02718417|100768354|FG001|Maintenance Phase (MP)|Adverse Event|26|||
33236860|NCT02718417|100768355|FG002|Maintenance Phase (MP)|Adverse Event|0|||
33236861|NCT02718417|100768353|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
33236862|NCT02718417|100768354|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
33236863|NCT02718417|100768355|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
33236864|NCT02718417|100768353|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
33236865|NCT02718417|100768354|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
33236866|NCT02718417|100768355|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
33236867|NCT02718417|100768353|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
33236868|NCT02718417|100768354|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
33236869|NCT02718417|100768355|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
33236870|NCT02718417|100768353|FG000|Maintenance Phase (MP)|Physician's decision|6|||
33369169|NCT03100942|101236578|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
33369170|NCT03100942|101236579|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
33369171|NCT03100942|101236580|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
33369172|NCT03100942|101236581|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
33369173|NCT03100942|101236582|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
33369174|NCT03100942|101236583|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
33577740|NCT00803361|102006572|FG000|Overall Study|Lack of Efficacy|4|||
33577741|NCT00803361|102006573|FG001|Overall Study|Lack of Efficacy|13|||
33577742|NCT00803361|102006572|FG000|Overall Study|Lost to Follow-up|1|||
33577743|NCT00803361|102006573|FG001|Overall Study|Lost to Follow-up|2|||
33577744|NCT00803361|102006572|FG000|Overall Study|Physician Decision|1|||
33577745|NCT00803361|102006573|FG001|Overall Study|Physician Decision|0|||
33577746|NCT00803361|102006572|FG000|Overall Study|Protocol Violation|2|||
33577747|NCT00803361|102006573|FG001|Overall Study|Protocol Violation|4|||
33577748|NCT00803361|102006572|FG000|Overall Study|Withdrawal by Subject|5|||
33577749|NCT00803361|102006573|FG001|Overall Study|Withdrawal by Subject|6|||
33577750|NCT00570713|102006574|FG000|Overall Study|Adverse Event|16|||
33577751|NCT00570713|102006575|FG001|Overall Study|Adverse Event|9|||
33577752|NCT00570713|102006574|FG000|Overall Study|Death|7|||
33577753|NCT00570713|102006575|FG001|Overall Study|Death|7|||
33577754|NCT00570713|102006574|FG000|Overall Study|Lack of Efficacy|40|||
33577755|NCT00570713|102006575|FG001|Overall Study|Lack of Efficacy|49|||
33577756|NCT00570713|102006574|FG000|Overall Study|Physician Decision|2|||
33577757|NCT00570713|102006575|FG001|Overall Study|Physician Decision|2|||
33577758|NCT00570713|102006574|FG000|Overall Study|Withdrawal by Subject|3|||
33577759|NCT00570713|102006575|FG001|Overall Study|Withdrawal by Subject|3|||
33577760|NCT00570713|102006574|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
33577761|NCT00570713|102006575|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
33577762|NCT01147393|102006576|FG000|Dose Level 1|Dose limiting Toxicity|2|||
33577763|NCT01147393|102006576|FG000|Dose Level -1|Dose Limited Toxicity|1|||
33577764|NCT02185534|102006577|FG000|First Period|Withdrawal by Subject|0|||
33577765|NCT02185534|102006578|FG001|First Period|Withdrawal by Subject|0|||
33577766|NCT02185534|102006579|FG002|First Period|Withdrawal by Subject|0|||
33577767|NCT02185534|102006580|FG003|First Period|Withdrawal by Subject|1|||
33577768|NCT02185534|102006581|FG004|First Period|Withdrawal by Subject|0|||
33577769|NCT02185534|102006582|FG005|First Period|Withdrawal by Subject|0|||
33577770|NCT02185534|102006577|FG000|First Washout Period|Withdrawal by Subject|1|||
33577771|NCT02185534|102006578|FG001|First Washout Period|Withdrawal by Subject|0|||
33577772|NCT02185534|102006579|FG002|First Washout Period|Withdrawal by Subject|0|||
33637941|NCT01263197|102225903|FG001|Washout Period 2|Protocol Violation|0|||
33637942|NCT01263197|102225904|FG002|Washout Period 2|Protocol Violation|0|||
33637943|NCT01263197|102225905|FG003|Washout Period 2|Protocol Violation|1|||
33577773|NCT02185534|102006580|FG003|First Washout Period|Withdrawal by Subject|0|||
33637944|NCT01263197|102225906|FG004|Washout Period 2|Protocol Violation|0|||
33637945|NCT01263197|102225907|FG005|Washout Period 2|Protocol Violation|0|||
33236871|NCT02718417|100768354|FG001|Maintenance Phase (MP)|Physician's decision|7|||
33577774|NCT02185534|102006581|FG004|First Washout Period|Withdrawal by Subject|1|||
33577775|NCT02185534|102006582|FG005|First Washout Period|Withdrawal by Subject|0|||
33577776|NCT02185534|102006577|FG000|First Washout Period|Protocol Violation|0|||
33577777|NCT02185534|102006578|FG001|First Washout Period|Protocol Violation|0|||
33637946|NCT01263197|102225902|FG000|Third Intervention (Period 3)|Adverse Event|0|||
33577778|NCT02185534|102006579|FG002|First Washout Period|Protocol Violation|0|||
33577779|NCT02185534|102006580|FG003|First Washout Period|Protocol Violation|0|||
33577780|NCT02185534|102006581|FG004|First Washout Period|Protocol Violation|0|||
33577781|NCT02185534|102006582|FG005|First Washout Period|Protocol Violation|1|||
33577782|NCT01534481|102006587|FG000|Overall Study|Lost to Follow-up|29|||
33577783|NCT01534481|102006588|FG001|Overall Study|Lost to Follow-up|24|||
33577784|NCT01534481|102006587|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
33637947|NCT01263197|102225903|FG001|Third Intervention (Period 3)|Adverse Event|1|||
33577785|NCT01534481|102006588|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
33577786|NCT02581891|102006590|FG000|Overall Study|Adverse Event|4|||
33577787|NCT02581891|102006591|FG001|Overall Study|Adverse Event|6|||
33577788|NCT02581891|102006590|FG000|Overall Study|Death|3|||
33577789|NCT02581891|102006591|FG001|Overall Study|Death|4|||
33577790|NCT02581891|102006590|FG000|Overall Study|Lost to Follow-up|1|||
33577791|NCT02581891|102006591|FG001|Overall Study|Lost to Follow-up|2|||
33577792|NCT02581891|102006590|FG000|Overall Study|Physician Decision|0|||
33637948|NCT01263197|102225904|FG002|Third Intervention (Period 3)|Adverse Event|0|||
33637949|NCT01263197|102225905|FG003|Third Intervention (Period 3)|Adverse Event|0|||
33637950|NCT01263197|102225906|FG004|Third Intervention (Period 3)|Adverse Event|0|||
33637951|NCT01263197|102225907|FG005|Third Intervention (Period 3)|Adverse Event|0|||
33637952|NCT00318643|102225908|FG000|Overall Study|Adverse Event|0|||
33637953|NCT00318643|102225909|FG001|Overall Study|Adverse Event|0|||
33637954|NCT00318643|102225910|FG002|Overall Study|Adverse Event|0|||
33637955|NCT00318643|102225911|FG003|Overall Study|Adverse Event|0|||
33637956|NCT00318643|102225912|FG004|Overall Study|Adverse Event|1|||
33637957|NCT00318643|102225908|FG000|Overall Study|Participant's Decision|0|||
33637958|NCT00318643|102225909|FG001|Overall Study|Participant's Decision|0|||
33637959|NCT00318643|102225910|FG002|Overall Study|Participant's Decision|0|||
33577793|NCT02581891|102006591|FG001|Overall Study|Physician Decision|1|||
33577794|NCT02581891|102006590|FG000|Overall Study|Withdrawal by Subject|4|||
33577795|NCT02581891|102006591|FG001|Overall Study|Withdrawal by Subject|5|||
33577796|NCT02581891|102006590|FG000|Overall Study|Other Reasons|3|||
33577797|NCT02581891|102006591|FG001|Overall Study|Other Reasons|1|||
33577798|NCT02581891|102006590|FG000|Overall Study|Discontinued during followup|1|||
33637960|NCT00318643|102225911|FG003|Overall Study|Participant's Decision|0|||
33637961|NCT00318643|102225912|FG004|Overall Study|Participant's Decision|1|||
33637962|NCT00318643|102225908|FG000|Overall Study|Investigator's Decision|0|||
33637963|NCT00318643|102225909|FG001|Overall Study|Investigator's Decision|0|||
33139334|NCT00045942|100423960|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
33577799|NCT02581891|102006591|FG001|Overall Study|Discontinued during followup|0|||
33577800|NCT04240886|102006593|FG000|Treatment Phase|Death|4|||
33577801|NCT04240886|102006593|FG000|Treatment Phase|Discontinuation by Subject|1|||
33577802|NCT04240886|102006593|FG000|Treatment Phase|Adverse Event|5|||
33139335|NCT00045942|100423961|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
33139336|NCT00045942|100423962|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
33139337|NCT00045942|100423963|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
33139338|NCT00045942|100423964|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
33369175|NCT03100942|101236584|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
33577803|NCT04240886|102006593|FG000|Follow-up Phase|Withdrawal by Subject|1|||
33577804|NCT04240886|102006593|FG000|Follow-up Phase|Discontinuation by Subject|1|||
33577805|NCT04240886|102006593|FG000|Follow-up Phase|Death|2|||
33369176|NCT01199263|101236585|FG000|Overall Study|Ineligible|0|||
33369177|NCT01199263|101236586|FG001|Overall Study|Ineligible|2|||
33369178|NCT01199263|101236585|FG000|Overall Study|Never Treated|6|||
33369179|NCT01199263|101236586|FG001|Overall Study|Never Treated|0|||
33369180|NCT03259334|101236587|FG000|Overall Study|Adverse Event|3|||
33369181|NCT03259334|101236588|FG001|Overall Study|Adverse Event|8|||
33369182|NCT03259334|101236589|FG002|Overall Study|Adverse Event|5|||
33369183|NCT03259334|101236587|FG000|Overall Study|Withdrawal by Subject|4|||
33369184|NCT03259334|101236588|FG001|Overall Study|Withdrawal by Subject|2|||
33369185|NCT03259334|101236589|FG002|Overall Study|Withdrawal by Subject|4|||
33369186|NCT03259334|101236587|FG000|Overall Study|Physician Decision|1|||
33369187|NCT03259334|101236588|FG001|Overall Study|Physician Decision|0|||
33369188|NCT03259334|101236589|FG002|Overall Study|Physician Decision|0|||
33369189|NCT03259334|101236587|FG000|Overall Study|Lost to Follow-up|0|||
33369190|NCT03259334|101236588|FG001|Overall Study|Lost to Follow-up|2|||
33369191|NCT03259334|101236589|FG002|Overall Study|Lost to Follow-up|1|||
33369192|NCT03259334|101236587|FG000|Overall Study|Protocol Deviation|0|||
33577806|NCT01595529|102006596|FG000|Overall Study|Adverse Event|2|||
33577807|NCT01595529|102006597|FG001|Overall Study|Adverse Event|0|||
33577808|NCT01595529|102006596|FG000|Overall Study|Subject Non-Compliant|2|||
33577809|NCT01595529|102006597|FG001|Overall Study|Subject Non-Compliant|0|||
33577810|NCT01595529|102006596|FG000|Overall Study|Lost to Follow-up|8|||
33577811|NCT01595529|102006597|FG001|Overall Study|Lost to Follow-up|14|||
33637964|NCT00318643|102225910|FG002|Overall Study|Investigator's Decision|0|||
33637965|NCT00318643|102225911|FG003|Overall Study|Investigator's Decision|0|||
33637966|NCT00318643|102225912|FG004|Overall Study|Investigator's Decision|1|||
33577812|NCT01595529|102006596|FG000|Overall Study|Protocol Violation|1|||
33577813|NCT01595529|102006597|FG001|Overall Study|Protocol Violation|2|||
33577814|NCT01595529|102006596|FG000|Overall Study|Physician Decision|1|||
33577815|NCT01595529|102006597|FG001|Overall Study|Physician Decision|0|||
33577816|NCT01595529|102006596|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
33577817|NCT01595529|102006597|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
33577818|NCT01595529|102006596|FG000|Overall Study|Administrative Decision|1|||
33577819|NCT01595529|102006597|FG001|Overall Study|Administrative Decision|0|||
33577820|NCT01595529|102006596|FG000|Overall Study|Entry Failure/Screening Failure|6|||
33577821|NCT01595529|102006597|FG001|Overall Study|Entry Failure/Screening Failure|1|||
33577822|NCT04819113|102006608|FG000|Overall Study|Withdrawal by parent/guardian|3|||
33577823|NCT04819113|102006608|FG000|Overall Study|Lost to Follow-up|1|||
33577824|NCT04819113|102006608|FG000|Overall Study|Withdrawn before vaccination|2|||
33577825|NCT02808429|102006612|FG000|Overall Study|Lost to Follow-up|1|||
33577826|NCT02808429|102006613|FG001|Overall Study|Lost to Follow-up|0|||
33577827|NCT02808429|102006614|FG002|Overall Study|Lost to Follow-up|0|||
33577828|NCT02808429|102006612|FG000|Overall Study|Protocol Violation|0|||
33577829|NCT02808429|102006613|FG001|Overall Study|Protocol Violation|1|||
33577830|NCT02808429|102006614|FG002|Overall Study|Protocol Violation|0|||
33577831|NCT02808429|102006612|FG000|Overall Study|Premature study termination by sponsor|2|||
33577832|NCT02808429|102006613|FG001|Overall Study|Premature study termination by sponsor|0|||
33577833|NCT02808429|102006614|FG002|Overall Study|Premature study termination by sponsor|1|||
33577834|NCT02808429|102006612|FG000|Overall Study|Relocation|0|||
33577835|NCT02808429|102006613|FG001|Overall Study|Relocation|0|||
33577836|NCT02808429|102006614|FG002|Overall Study|Relocation|1|||
33577837|NCT01508910|102006618|FG000|Treatment|Death|2|||
33577838|NCT01508910|102006619|FG001|Treatment|Death|3|||
33577839|NCT01508910|102006620|FG002|Treatment|Death|2|||
33577840|NCT01508910|102006621|FG003|Treatment|Death|0|||
33577841|NCT01508910|102006618|FG000|Treatment|Lost to Follow-up|0|||
33577842|NCT01508910|102006619|FG001|Treatment|Lost to Follow-up|0|||
33577843|NCT01508910|102006620|FG002|Treatment|Lost to Follow-up|2|||
33577844|NCT01508910|102006621|FG003|Treatment|Lost to Follow-up|1|||
33577845|NCT01508910|102006618|FG000|Treatment|Withdrawal by Subject|0|||
33577846|NCT01508910|102006619|FG001|Treatment|Withdrawal by Subject|1|||
33577847|NCT01508910|102006620|FG002|Treatment|Withdrawal by Subject|6|||
33577848|NCT01508910|102006621|FG003|Treatment|Withdrawal by Subject|1|||
33577849|NCT01508910|102006618|FG000|Treatment|Sponsor Decision|0|||
33577850|NCT01508910|102006619|FG001|Treatment|Sponsor Decision|0|||
33577851|NCT01508910|102006620|FG002|Treatment|Sponsor Decision|0|||
33577852|NCT01508910|102006621|FG003|Treatment|Sponsor Decision|1|||
33577853|NCT03484429|102006622|FG000|Overall Study|Withdrawal by Subject|1|||
33577854|NCT03484429|102006623|FG001|Overall Study|Withdrawal by Subject|0|||
33577855|NCT03484429|102006622|FG000|Overall Study|Adverse Event|2|||
33577856|NCT03484429|102006623|FG001|Overall Study|Adverse Event|0|||
33577857|NCT00600067|102006624|FG000|Overall Study|Adverse Event|0|||
33577858|NCT00600067|102006625|FG001|Overall Study|Adverse Event|1|||
33577859|NCT00600067|102006624|FG000|Overall Study|Lost to Follow-up|2|||
33577860|NCT00600067|102006625|FG001|Overall Study|Lost to Follow-up|3|||
33577861|NCT00600067|102006624|FG000|Overall Study|protocol non-compliance|0|||
33577862|NCT00600067|102006625|FG001|Overall Study|protocol non-compliance|3|||
33577863|NCT00600067|102006624|FG000|Overall Study|Lack of Efficacy|1|||
33577864|NCT00600067|102006625|FG001|Overall Study|Lack of Efficacy|0|||
33637967|NCT00760617|102225913|FG000|Overall Study|Adverse Event|5|||
33236872|NCT02718417|100768355|FG002|Maintenance Phase (MP)|Physician's decision|0|||
33236873|NCT02718417|100768353|FG000|Maintenance Phase (MP)|Progressive disease|100|||
33236874|NCT02718417|100768354|FG001|Maintenance Phase (MP)|Progressive disease|88|||
33236875|NCT02718417|100768355|FG002|Maintenance Phase (MP)|Progressive disease|0|||
33236876|NCT02718417|100768353|FG000|Maintenance Phase (MP)|Other|2|||
33236877|NCT02718417|100768354|FG001|Maintenance Phase (MP)|Other|1|||
33236878|NCT02718417|100768355|FG002|Maintenance Phase (MP)|Other|0|||
33236879|NCT02718417|100768353|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
33236880|NCT02718417|100768354|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
33236881|NCT02718417|100768355|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
33637968|NCT00760617|102225914|FG001|Overall Study|Adverse Event|2|||
33236882|NCT02718417|100768353|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
33236883|NCT02718417|100768354|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
33236884|NCT02718417|100768355|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
33577865|NCT00806260|102006626|FG000|Period 1 (1 Day)|Adverse Event|0|||
33577866|NCT00806260|102006627|FG001|Period 1 (1 Day)|Adverse Event|0|||
33577867|NCT00806260|102006628|FG002|Period 1 (1 Day)|Adverse Event|0|||
33577868|NCT00806260|102006629|FG003|Period 1 (1 Day)|Adverse Event|0|||
33577869|NCT00806260|102006630|FG004|Period 1 (1 Day)|Adverse Event|3|||
33577870|NCT00806260|102006631|FG005|Period 1 (1 Day)|Adverse Event|0|||
33577871|NCT00806260|102006626|FG000|Period 2|Adverse Event|0|||
33577872|NCT00806260|102006627|FG001|Period 2|Adverse Event|0|||
33577873|NCT00806260|102006628|FG002|Period 2|Adverse Event|0|||
33577874|NCT00806260|102006629|FG003|Period 2|Adverse Event|1|||
33577875|NCT00806260|102006630|FG004|Period 2|Adverse Event|0|||
33577876|NCT00806260|102006631|FG005|Period 2|Adverse Event|0|||
33577877|NCT00806260|102006626|FG000|Period 2|Protocol Violation|1|||
33577878|NCT00806260|102006627|FG001|Period 2|Protocol Violation|0|||
33577879|NCT00806260|102006628|FG002|Period 2|Protocol Violation|1|||
33577880|NCT00806260|102006629|FG003|Period 2|Protocol Violation|0|||
33577881|NCT00806260|102006630|FG004|Period 2|Protocol Violation|0|||
33577882|NCT00806260|102006631|FG005|Period 2|Protocol Violation|0|||
33577883|NCT00806260|102006626|FG000|Period 2|Need to take concomitant medication|1|||
33577884|NCT00806260|102006627|FG001|Period 2|Need to take concomitant medication|0|||
33577885|NCT00806260|102006628|FG002|Period 2|Need to take concomitant medication|0|||
33236885|NCT02718417|100768353|FG000|Observation Phase (OP)|Adverse Event|0|||
33236886|NCT02718417|100768354|FG001|Observation Phase (OP)|Adverse Event|0|||
33236887|NCT02718417|100768355|FG002|Observation Phase (OP)|Adverse Event|1|||
33236888|NCT02718417|100768353|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
33236889|NCT02718417|100768354|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
33369193|NCT03259334|101236588|FG001|Overall Study|Protocol Deviation|3|||
33369194|NCT03259334|101236589|FG002|Overall Study|Protocol Deviation|2|||
33369195|NCT03259334|101236587|FG000|Overall Study|Lack of Efficacy|2|||
33369196|NCT03259334|101236588|FG001|Overall Study|Lack of Efficacy|0|||
33369197|NCT03259334|101236589|FG002|Overall Study|Lack of Efficacy|1|||
33369198|NCT03259334|101236587|FG000|Overall Study|Randomized but never treated|0|||
33369199|NCT03259334|101236588|FG001|Overall Study|Randomized but never treated|2|||
33369200|NCT03259334|101236589|FG002|Overall Study|Randomized but never treated|0|||
33420812|NCT01374906|101431620|FG001|Overall Study|Withdrawal by Subject|9|||
33420813|NCT01374906|101431619|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
33420814|NCT01374906|101431620|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
33577886|NCT00806260|102006629|FG003|Period 2|Need to take concomitant medication|0|||
33420815|NCT00589693|101431621|FG000|Overall Study|randomized in error|12|||
33420816|NCT00589693|101431622|FG001|Overall Study|randomized in error|6|||
33420817|NCT00589693|101431621|FG000|Overall Study|Adverse Event|4|||
33420818|NCT00589693|101431622|FG001|Overall Study|Adverse Event|4|||
33420819|NCT00589693|101431621|FG000|Overall Study|Death|26|||
33420820|NCT00589693|101431622|FG001|Overall Study|Death|16|||
33420821|NCT00589693|101431621|FG000|Overall Study|Lack of Efficacy|0|||
33420822|NCT00589693|101431622|FG001|Overall Study|Lack of Efficacy|1|||
33420823|NCT00589693|101431621|FG000|Overall Study|Lost to Follow-up|1|||
33420824|NCT00589693|101431622|FG001|Overall Study|Lost to Follow-up|0|||
33420825|NCT00589693|101431621|FG000|Overall Study|Physician Decision|0|||
33420826|NCT00589693|101431622|FG001|Overall Study|Physician Decision|1|||
33420827|NCT00589693|101431621|FG000|Overall Study|Protocol Violation|1|||
33420828|NCT00589693|101431622|FG001|Overall Study|Protocol Violation|1|||
33420829|NCT00434148|101431623|FG000|Overall Study|Adverse Event|18|||
33420830|NCT00434148|101431624|FG001|Overall Study|Adverse Event|18|||
33420831|NCT00434148|101431623|FG000|Overall Study|Lack of Efficacy|25|||
33420832|NCT00434148|101431624|FG001|Overall Study|Lack of Efficacy|28|||
33420833|NCT00434148|101431623|FG000|Overall Study|Withdrawal by Subject|15|||
33577887|NCT00806260|102006630|FG004|Period 2|Need to take concomitant medication|0|||
33577888|NCT00806260|102006631|FG005|Period 2|Need to take concomitant medication|0|||
33577889|NCT00806260|102006626|FG000|Period 2|sponsor request|0|||
33139339|NCT00045942|100423965|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
33139340|NCT00045942|100423966|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
33139341|NCT00045942|100423967|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
33139342|NCT00045942|100423959|FG000|PKC412A2104E1|Lack of Efficacy|0|||
33139343|NCT00045942|100423960|FG001|PKC412A2104E1|Lack of Efficacy|11|||
33139344|NCT00045942|100423961|FG002|PKC412A2104E1|Lack of Efficacy|11|||
33139345|NCT00045942|100423962|FG003|PKC412A2104E1|Lack of Efficacy|23|||
33139346|NCT00045942|100423963|FG004|PKC412A2104E1|Lack of Efficacy|17|||
33139347|NCT00045942|100423964|FG005|PKC412A2104E1|Lack of Efficacy|0|||
33139348|NCT00045942|100423965|FG006|PKC412A2104E1|Lack of Efficacy|0|||
33139349|NCT00045942|100423966|FG007|PKC412A2104E1|Lack of Efficacy|0|||
33139350|NCT00045942|100423967|FG008|PKC412A2104E1|Lack of Efficacy|0|||
33139351|NCT00045942|100423959|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
33139352|NCT00045942|100423960|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
33369201|NCT03484923|101236595|FG000|Overall Study|Adverse Event|3|||
33420834|NCT00434148|101431624|FG001|Overall Study|Withdrawal by Subject|15|||
33420835|NCT00434148|101431623|FG000|Overall Study|Protocol Violation|4|||
33577890|NCT00806260|102006627|FG001|Period 2|sponsor request|0|||
33236890|NCT02718417|100768355|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
33236891|NCT02718417|100768353|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
33420836|NCT00434148|101431624|FG001|Overall Study|Protocol Violation|0|||
33577891|NCT00806260|102006628|FG002|Period 2|sponsor request|1|||
33577892|NCT00806260|102006629|FG003|Period 2|sponsor request|1|||
33577893|NCT00806260|102006630|FG004|Period 2|sponsor request|0|||
33577894|NCT00806260|102006631|FG005|Period 2|sponsor request|0|||
33369202|NCT03484923|101236596|FG001|Overall Study|Adverse Event|3|||
33420837|NCT00434148|101431623|FG000|Overall Study|Administrative problems|6|||
33577895|NCT00806260|102006626|FG000|Period 3|Protocol Violation|0|||
33577896|NCT00806260|102006627|FG001|Period 3|Protocol Violation|1|||
33577897|NCT00806260|102006628|FG002|Period 3|Protocol Violation|1|||
33577898|NCT00806260|102006629|FG003|Period 3|Protocol Violation|0|||
33577899|NCT00806260|102006630|FG004|Period 3|Protocol Violation|0|||
33577900|NCT00806260|102006631|FG005|Period 3|Protocol Violation|0|||
33577901|NCT00806260|102006626|FG000|Period 3|Pregnancy|1|||
33236892|NCT02718417|100768354|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
33236893|NCT02718417|100768355|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
33236894|NCT02718417|100768353|FG000|Observation Phase (OP)|Physician Decision|0|||
33236895|NCT02718417|100768354|FG001|Observation Phase (OP)|Physician Decision|0|||
33236896|NCT02718417|100768355|FG002|Observation Phase (OP)|Physician Decision|9|||
33236897|NCT02718417|100768353|FG000|Observation Phase (OP)|Progressive disease|0|||
33236898|NCT02718417|100768354|FG001|Observation Phase (OP)|Progressive disease|0|||
33236899|NCT02718417|100768355|FG002|Observation Phase (OP)|Progressive disease|92|||
33236900|NCT02718417|100768353|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
33236901|NCT02718417|100768354|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
33236902|NCT02718417|100768355|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
33236903|NCT02718417|100768353|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
33236904|NCT02718417|100768354|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
33236905|NCT02718417|100768355|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
33236906|NCT02718417|100768353|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
33236907|NCT02718417|100768354|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
33236908|NCT02718417|100768355|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
33236909|NCT02718417|100768353|FG000|Observation Phase (OP)|Other|0|||
33236910|NCT02718417|100768354|FG001|Observation Phase (OP)|Other|0|||
33236911|NCT02718417|100768355|FG002|Observation Phase (OP)|Other|7|||
33236912|NCT02718417|100768353|FG000|Follow-up Phase|Adverse Event|3|||
33236913|NCT02718417|100768354|FG001|Follow-up Phase|Adverse Event|1|||
33236914|NCT02718417|100768355|FG002|Follow-up Phase|Adverse Event|1|||
33236915|NCT02718417|100768353|FG000|Follow-up Phase|Other|4|||
33236916|NCT02718417|100768354|FG001|Follow-up Phase|Other|6|||
33236917|NCT02718417|100768355|FG002|Follow-up Phase|Other|4|||
33236918|NCT02718417|100768353|FG000|Follow-up Phase|Withdrawal by Subject|19|||
33236919|NCT02718417|100768354|FG001|Follow-up Phase|Withdrawal by Subject|17|||
33236920|NCT02718417|100768355|FG002|Follow-up Phase|Withdrawal by Subject|5|||
33236921|NCT02718417|100768353|FG000|Follow-up Phase|Study terminated by sponsor|100|||
33236922|NCT02718417|100768354|FG001|Follow-up Phase|Study terminated by sponsor|138|||
33236923|NCT02718417|100768355|FG002|Follow-up Phase|Study terminated by sponsor|6|||
33236924|NCT02718417|100768353|FG000|Follow-up Phase|Lost to Follow-up|2|||
33236925|NCT02718417|100768354|FG001|Follow-up Phase|Lost to Follow-up|3|||
33236926|NCT02718417|100768355|FG002|Follow-up Phase|Lost to Follow-up|0|||
33236927|NCT02718417|100768353|FG000|Follow-up Phase|Death leading to discontinuation|7|||
33236928|NCT02718417|100768354|FG001|Follow-up Phase|Death leading to discontinuation|7|||
33236929|NCT02718417|100768355|FG002|Follow-up Phase|Death leading to discontinuation|3|||
33236930|NCT02718417|100768353|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
33236931|NCT02718417|100768354|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
33236932|NCT02718417|100768355|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
33236933|NCT02718417|100768353|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
33236934|NCT02718417|100768354|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
33236935|NCT02718417|100768355|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
33236936|NCT02718417|100768353|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
33236937|NCT02718417|100768354|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
33236938|NCT02718417|100768355|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
33236939|NCT02718417|100768353|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
33236940|NCT02718417|100768354|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
33236941|NCT02718417|100768355|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
33236942|NCT02718417|100768353|FG000|Long-term Follow-up Phase|Other|0|||
33236943|NCT02718417|100768354|FG001|Long-term Follow-up Phase|Other|2|||
33236944|NCT02718417|100768355|FG002|Long-term Follow-up Phase|Other|0|||
33236945|NCT01458249|100768356|FG000|Overall Study|Not treated|1|||
33236946|NCT01458249|100768356|FG000|Overall Study|Adverse Event|4|||
33236947|NCT01458249|100768356|FG000|Overall Study|Other|2|||
33236948|NCT01458249|100768356|FG000|Overall Study|Ongoing|1|||
33236949|NCT01489020|100772076|FG000|Overall Study|Withdrawal by Subject|1|||
33236950|NCT01489020|100772077|FG001|Overall Study|Withdrawal by Subject|0|||
33577902|NCT00806260|102006627|FG001|Period 3|Pregnancy|0|||
33577903|NCT00806260|102006628|FG002|Period 3|Pregnancy|0|||
33369203|NCT03484923|101236597|FG002|Overall Study|Adverse Event|5|||
33577904|NCT00806260|102006629|FG003|Period 3|Pregnancy|0|||
33577905|NCT00806260|102006630|FG004|Period 3|Pregnancy|0|||
33577906|NCT00806260|102006631|FG005|Period 3|Pregnancy|0|||
33236951|NCT01489020|100772078|FG002|Overall Study|Withdrawal by Subject|0|||
33577907|NCT00107276|102006634|FG000|Overall Study|Progression|46|||
33577908|NCT00107276|102006634|FG000|Overall Study|Adverse Event|6|||
33577909|NCT00107276|102006634|FG000|Overall Study|M.D. decision|2|||
33236952|NCT01489020|100772079|FG003|Overall Study|Withdrawal by Subject|0|||
33236953|NCT01489020|100772080|FG004|Overall Study|Withdrawal by Subject|0|||
33236954|NCT01489020|100772081|FG005|Overall Study|Withdrawal by Subject|0|||
33236955|NCT01489020|100772076|FG000|Overall Study|Adverse Event|0|||
33236956|NCT01489020|100772077|FG001|Overall Study|Adverse Event|0|||
33236957|NCT01489020|100772078|FG002|Overall Study|Adverse Event|3|||
33236958|NCT01489020|100772079|FG003|Overall Study|Adverse Event|0|||
33236959|NCT01489020|100772080|FG004|Overall Study|Adverse Event|3|||
33236960|NCT01489020|100772081|FG005|Overall Study|Adverse Event|0|||
33236961|NCT01489020|100772076|FG000|Overall Study|Concomitant disease|0|||
33236962|NCT01489020|100772077|FG001|Overall Study|Concomitant disease|0|||
33637969|NCT00760617|102225915|FG002|Overall Study|Adverse Event|0|||
33236963|NCT01489020|100772078|FG002|Overall Study|Concomitant disease|0|||
33236964|NCT01489020|100772079|FG003|Overall Study|Concomitant disease|0|||
33236965|NCT01489020|100772080|FG004|Overall Study|Concomitant disease|3|||
33236966|NCT01489020|100772081|FG005|Overall Study|Concomitant disease|0|||
33236967|NCT01177813|100772088|FG000|Overall Study|Adverse Event|8|||
33236968|NCT01177813|100772089|FG001|Overall Study|Adverse Event|2|||
33236969|NCT01177813|100772090|FG002|Overall Study|Adverse Event|4|||
33236970|NCT01177813|100772091|FG003|Overall Study|Adverse Event|6|||
33236971|NCT01177813|100772092|FG004|Overall Study|Adverse Event|3|||
33236972|NCT01177813|100772088|FG000|Overall Study|Lack of Efficacy|1|||
33236973|NCT01177813|100772089|FG001|Overall Study|Lack of Efficacy|0|||
33236974|NCT01177813|100772090|FG002|Overall Study|Lack of Efficacy|0|||
33236975|NCT01177813|100772091|FG003|Overall Study|Lack of Efficacy|0|||
33236976|NCT01177813|100772092|FG004|Overall Study|Lack of Efficacy|0|||
33236977|NCT01177813|100772088|FG000|Overall Study|Protocol Violation|3|||
33236978|NCT01177813|100772089|FG001|Overall Study|Protocol Violation|2|||
33236979|NCT01177813|100772090|FG002|Overall Study|Protocol Violation|2|||
33236980|NCT01177813|100772091|FG003|Overall Study|Protocol Violation|0|||
33236981|NCT01177813|100772092|FG004|Overall Study|Protocol Violation|1|||
33236982|NCT01177813|100772088|FG000|Overall Study|Lost to Follow-up|12|||
33236983|NCT01177813|100772089|FG001|Overall Study|Lost to Follow-up|5|||
33236984|NCT01177813|100772090|FG002|Overall Study|Lost to Follow-up|6|||
33236985|NCT01177813|100772091|FG003|Overall Study|Lost to Follow-up|3|||
33236986|NCT01177813|100772092|FG004|Overall Study|Lost to Follow-up|0|||
33236987|NCT01177813|100772088|FG000|Overall Study|Withdrawal by Subject|12|||
33236988|NCT01177813|100772089|FG001|Overall Study|Withdrawal by Subject|7|||
33236989|NCT01177813|100772090|FG002|Overall Study|Withdrawal by Subject|6|||
33236990|NCT01177813|100772091|FG003|Overall Study|Withdrawal by Subject|5|||
33236991|NCT01177813|100772092|FG004|Overall Study|Withdrawal by Subject|3|||
33236992|NCT01177813|100772088|FG000|Overall Study|Other reason not defined above|5|||
33236993|NCT01177813|100772089|FG001|Overall Study|Other reason not defined above|2|||
33236994|NCT01177813|100772090|FG002|Overall Study|Other reason not defined above|2|||
33236995|NCT01177813|100772091|FG003|Overall Study|Other reason not defined above|3|||
33236996|NCT01177813|100772092|FG004|Overall Study|Other reason not defined above|2|||
33236997|NCT01349829|100772094|FG000|Overall Study|Lost to Follow-up|4|||
33236998|NCT01349829|100772095|FG001|Overall Study|Lost to Follow-up|8|||
33236999|NCT01349829|100772094|FG000|Overall Study|Consent withdrawal|3|||
33237000|NCT01349829|100772095|FG001|Overall Study|Consent withdrawal|8|||
33237001|NCT01349829|100772094|FG000|Overall Study|Migrated/moved|2|||
33237002|NCT01349829|100772095|FG001|Overall Study|Migrated/moved|7|||
33237003|NCT02322775|100772099|FG000|Overall Study|Adverse Event|1|||
33237004|NCT02322775|100772100|FG001|Overall Study|Adverse Event|0|||
33237005|NCT02322775|100772099|FG000|Overall Study|Lost to Follow-up|0|||
33237006|NCT02322775|100772100|FG001|Overall Study|Lost to Follow-up|1|||
33237007|NCT02322775|100772099|FG000|Overall Study|Protocol Violation|1|||
33237008|NCT02322775|100772100|FG001|Overall Study|Protocol Violation|0|||
33237009|NCT02322775|100772099|FG000|Overall Study|Withdrawal by Subject|3|||
33237010|NCT02322775|100772100|FG001|Overall Study|Withdrawal by Subject|4|||
33237011|NCT02322775|100772099|FG000|Overall Study|Not willing to perform all FU visits|0|||
33237012|NCT02322775|100772100|FG001|Overall Study|Not willing to perform all FU visits|1|||
33237013|NCT03379233|100772105|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
33237014|NCT03379233|100772106|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
33237015|NCT01052662|100772107|FG000|Overall Study|Lost to Follow-up|15|||
33237016|NCT01052662|100772108|FG001|Overall Study|Lost to Follow-up|13|||
33237017|NCT01052662|100772109|FG002|Overall Study|Lost to Follow-up|18|||
33369204|NCT03484923|101236598|FG003|Overall Study|Adverse Event|11|||
33369205|NCT03484923|101236599|FG004|Overall Study|Adverse Event|1|||
33369206|NCT03484923|101236595|FG000|Overall Study|Death|2|||
33237018|NCT01052662|100772107|FG000|Overall Study|Withdrawal by Subject|3|||
33237019|NCT01052662|100772108|FG001|Overall Study|Withdrawal by Subject|2|||
33237020|NCT01052662|100772109|FG002|Overall Study|Withdrawal by Subject|1|||
33237021|NCT01052662|100772107|FG000|Overall Study|Pharmacy issue|1|||
33237022|NCT01052662|100772108|FG001|Overall Study|Pharmacy issue|3|||
33237023|NCT01052662|100772109|FG002|Overall Study|Pharmacy issue|3|||
33237024|NCT01052662|100772107|FG000|Overall Study|Adverse Event|1|||
33369207|NCT03484923|101236596|FG001|Overall Study|Death|2|||
33637970|NCT00760617|102225913|FG000|Overall Study|Lost to Follow-up|0|||
33237025|NCT01052662|100772108|FG001|Overall Study|Adverse Event|1|||
33237026|NCT01052662|100772109|FG002|Overall Study|Adverse Event|0|||
33237027|NCT01052662|100772107|FG000|Overall Study|Legal Problem|2|||
33237028|NCT01052662|100772108|FG001|Overall Study|Legal Problem|0|||
33237029|NCT01052662|100772109|FG002|Overall Study|Legal Problem|0|||
33237030|NCT01052662|100772107|FG000|Overall Study|Administrative|0|||
33237031|NCT01052662|100772108|FG001|Overall Study|Administrative|3|||
33237032|NCT01052662|100772109|FG002|Overall Study|Administrative|0|||
33237033|NCT02297503|100772110|FG000|Overall Study|Withdrawal by Subject|1|||
33237034|NCT02297503|100772111|FG001|Overall Study|Withdrawal by Subject|1|||
33237035|NCT02297503|100772110|FG000|Overall Study|Protocol Violation|1|||
33237036|NCT02297503|100772111|FG001|Overall Study|Protocol Violation|0|||
33237037|NCT02297503|100772110|FG000|Overall Study|Pregnancy|0|||
33237038|NCT02297503|100772111|FG001|Overall Study|Pregnancy|1|||
33237039|NCT02297503|100772110|FG000|Overall Study|Lost to Follow-up|0|||
33237040|NCT02297503|100772111|FG001|Overall Study|Lost to Follow-up|1|||
33237041|NCT02297503|100772110|FG000|Overall Study|Medical reason|0|||
33237042|NCT02297503|100772111|FG001|Overall Study|Medical reason|1|||
33237043|NCT02412761|100772114|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33237044|NCT02412761|100772115|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
33237045|NCT02412761|100772116|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
33237046|NCT02412761|100772117|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33577910|NCT00107276|102006634|FG000|Overall Study|Patient refusal|1|||
33577911|NCT00107276|102006634|FG000|Overall Study|Death|1|||
33577912|NCT00107276|102006634|FG000|Overall Study|Ineligible|16|||
33577913|NCT01273038|102006636|FG000|Second Intervention (14 Days)|Adverse Event|0|||
33577914|NCT01273038|102006637|FG001|Second Intervention (14 Days)|Adverse Event|1|||
33577915|NCT01273038|102006636|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
33237047|NCT02412761|100772118|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33237048|NCT02412761|100772119|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
33237049|NCT01676220|100772120|FG000|Overall Study|Randomized But Not Treated|4|||
33237050|NCT01676220|100772121|FG001|Overall Study|Randomized But Not Treated|1|||
33237051|NCT01676220|100772120|FG000|Overall Study|Adverse Event|10|||
33237052|NCT01676220|100772121|FG001|Overall Study|Adverse Event|8|||
33237053|NCT01676220|100772120|FG000|Overall Study|Lack of Efficacy|2|||
33237054|NCT01676220|100772121|FG001|Overall Study|Lack of Efficacy|5|||
33237055|NCT01676220|100772120|FG000|Overall Study|Protocol Violation|11|||
33237056|NCT01676220|100772121|FG001|Overall Study|Protocol Violation|12|||
33237057|NCT01676220|100772120|FG000|Overall Study|Received Rescue Therapy|14|||
33237058|NCT01676220|100772121|FG001|Overall Study|Received Rescue Therapy|22|||
33237059|NCT01676220|100772120|FG000|Overall Study|Personal Reason|34|||
33237060|NCT01676220|100772121|FG001|Overall Study|Personal Reason|45|||
33237061|NCT01676220|100772120|FG000|Overall Study|Lost to Follow-up|11|||
33237062|NCT01676220|100772121|FG001|Overall Study|Lost to Follow-up|18|||
33237063|NCT01676220|100772120|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
33237064|NCT01676220|100772121|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
33237065|NCT01676220|100772120|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
33237066|NCT01676220|100772121|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
33237067|NCT01676220|100772120|FG000|Overall Study|Perceived Lack of Efficacy|3|||
33237068|NCT01676220|100772121|FG001|Overall Study|Perceived Lack of Efficacy|1|||
33237069|NCT01676220|100772120|FG000|Overall Study|Non Serious Hypoglycemia|2|||
33237070|NCT01676220|100772121|FG001|Overall Study|Non Serious Hypoglycemia|0|||
33237071|NCT01676220|100772120|FG000|Overall Study|No More Need of Insulin|1|||
33237072|NCT01676220|100772121|FG001|Overall Study|No More Need of Insulin|0|||
33237073|NCT03018106|100772122|FG000|Overall Study|Lost to Follow-up|0|||
33237074|NCT03018106|100772123|FG001|Overall Study|Lost to Follow-up|1|||
33237075|NCT03023332|100772128|FG000|Overall Study|Withdrawal by Subject|10|||
33237076|NCT03023332|100772129|FG001|Overall Study|Withdrawal by Subject|5|||
33237077|NCT03023332|100772130|FG002|Overall Study|Withdrawal by Subject|4|||
33237078|NCT03023332|100772131|FG003|Overall Study|Withdrawal by Subject|7|||
33237079|NCT03023332|100772128|FG000|Overall Study|Lost to Follow-up|13|||
33237080|NCT03023332|100772129|FG001|Overall Study|Lost to Follow-up|16|||
33237081|NCT03023332|100772130|FG002|Overall Study|Lost to Follow-up|8|||
33237082|NCT03023332|100772131|FG003|Overall Study|Lost to Follow-up|13|||
33237083|NCT03023332|100772128|FG000|Overall Study|Death|1|||
33237084|NCT03023332|100772129|FG001|Overall Study|Death|0|||
33237085|NCT03023332|100772130|FG002|Overall Study|Death|0|||
33237086|NCT03023332|100772131|FG003|Overall Study|Death|0|||
33237087|NCT01327547|100772132|FG000|Overall Study|Adverse Event|4|||
33237088|NCT01327547|100772133|FG001|Overall Study|Adverse Event|1|||
33577916|NCT01273038|102006637|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
33237089|NCT01327547|100772132|FG000|Overall Study|Death|1|||
33237090|NCT01327547|100772133|FG001|Overall Study|Death|2|||
33237091|NCT01327547|100772132|FG000|Overall Study|Lost to Follow-up|6|||
33237092|NCT01327547|100772133|FG001|Overall Study|Lost to Follow-up|6|||
33237093|NCT01327547|100772132|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
33237094|NCT01327547|100772133|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
33237095|NCT01327547|100772132|FG000|Overall Study|Withdrawal by Subject|3|||
33237096|NCT01327547|100772133|FG001|Overall Study|Withdrawal by Subject|7|||
33237097|NCT01327547|100772132|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
33237098|NCT01327547|100772133|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
33237099|NCT01327547|100772132|FG000|Overall Study|Protocol Violation|1|||
33237100|NCT01327547|100772133|FG001|Overall Study|Protocol Violation|0|||
33237101|NCT01327547|100772132|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
33237102|NCT01327547|100772133|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
33237103|NCT01327547|100772132|FG000|Overall Study|Required prohibited medication|2|||
33237104|NCT01327547|100772133|FG001|Overall Study|Required prohibited medication|0|||
33237105|NCT01327547|100772132|FG000|Overall Study|Non-compliance with study procedures|1|||
33237106|NCT01327547|100772133|FG001|Overall Study|Non-compliance with study procedures|0|||
33237107|NCT01327547|100772132|FG000|Overall Study|By investigator in subject's interest|0|||
33237108|NCT01327547|100772133|FG001|Overall Study|By investigator in subject's interest|1|||
33237109|NCT00373295|100772135|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
33237110|NCT00373295|100772136|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
33237111|NCT00373295|100772137|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
33237112|NCT00373295|100772138|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
33237113|NCT00373295|100772139|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
33237114|NCT00373295|100772140|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
33237115|NCT04147260|100772141|FG000|Overall Study|Adverse Event|1|||
33237116|NCT04147260|100772142|FG001|Overall Study|Adverse Event|0|||
33237117|NCT04147260|100772143|FG002|Overall Study|Adverse Event|1|||
33237118|NCT04147260|100772144|FG003|Overall Study|Adverse Event|2|||
33237119|NCT04147260|100772145|FG004|Overall Study|Adverse Event|0|||
33237120|NCT04147260|100772141|FG000|Overall Study|Withdrawal by Subject|0|||
33237121|NCT04147260|100772142|FG001|Overall Study|Withdrawal by Subject|0|||
33237122|NCT04147260|100772143|FG002|Overall Study|Withdrawal by Subject|1|||
33237123|NCT04147260|100772144|FG003|Overall Study|Withdrawal by Subject|1|||
33237124|NCT04147260|100772145|FG004|Overall Study|Withdrawal by Subject|0|||
33237125|NCT04963062|100772147|FG000|Overall Study|withdrew by the study team|4|||
33237126|NCT04963062|100772148|FG001|Overall Study|withdrew by the study team|2|||
33237127|NCT01473420|100772149|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
33237128|NCT01473420|100772150|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
33237129|NCT01473420|100772149|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
33237130|NCT01473420|100772150|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
33637971|NCT00760617|102225914|FG001|Overall Study|Lost to Follow-up|0|||
33237131|NCT01473420|100772149|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
33237132|NCT01473420|100772150|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
33237133|NCT01473420|100772149|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
33237134|NCT01473420|100772150|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
33237135|NCT01473420|100772149|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
33237136|NCT01473420|100772150|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
33237137|NCT01473420|100772149|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
33237138|NCT01473420|100772150|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
33237139|NCT01473420|100772149|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
33237140|NCT01473420|100772150|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
33237141|NCT01473420|100772149|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
33237142|NCT01473420|100772150|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
33237143|NCT01473420|100772149|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
33237144|NCT01473420|100772150|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
33369208|NCT03484923|101236597|FG002|Overall Study|Death|3|||
33369209|NCT03484923|101236598|FG003|Overall Study|Death|0|||
33637972|NCT00760617|102225915|FG002|Overall Study|Lost to Follow-up|5|||
33237145|NCT01473420|100772149|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
33237146|NCT01473420|100772150|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
33237147|NCT01473420|100772149|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
33237148|NCT01473420|100772150|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
33237149|NCT01473420|100772149|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
33237150|NCT01473420|100772150|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
33237151|NCT01473420|100772149|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
33237152|NCT01473420|100772150|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
33237153|NCT02998528|100772156|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
33237154|NCT02998528|100772157|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
33237155|NCT02998528|100772158|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
33237156|NCT02998528|100772156|FG000|Randomization Period|Participant withdrew consent|0|||
33237157|NCT02998528|100772157|FG001|Randomization Period|Participant withdrew consent|3|||
33237158|NCT02998528|100772158|FG002|Randomization Period|Participant withdrew consent|0|||
33237159|NCT02998528|100772156|FG000|Randomization Period|Participant no longer meets study criteria|1|||
33369210|NCT03484923|101236599|FG004|Overall Study|Death|1|||
33637973|NCT00148317|102225918|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
33637974|NCT00148317|102225918|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
33637975|NCT00148317|102225918|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
33637976|NCT01104311|102225920|FG000|Overall Study|Withdrawal by Subject|6|||
33637977|NCT01104311|102225921|FG001|Overall Study|Withdrawal by Subject|6|||
33577917|NCT02954458|102006640|FG000|Overall Study|Adverse Event|0|||
33577918|NCT02954458|102006641|FG001|Overall Study|Adverse Event|0|||
33577919|NCT02954458|102006642|FG002|Overall Study|Adverse Event|0|||
33577920|NCT02954458|102006643|FG003|Overall Study|Adverse Event|1|||
33637978|NCT01104311|102225920|FG000|Overall Study|Protocol Violation|0|||
33637979|NCT01104311|102225921|FG001|Overall Study|Protocol Violation|1|||
33637980|NCT01104311|102225920|FG000|Overall Study|Physician Decision|2|||
33637981|NCT01104311|102225921|FG001|Overall Study|Physician Decision|2|||
33139353|NCT00045942|100423961|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
33139354|NCT00045942|100423962|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
33139355|NCT00045942|100423963|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
33139356|NCT00045942|100423964|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
33139357|NCT00045942|100423965|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
33139358|NCT00045942|100423966|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
33139359|NCT00045942|100423967|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
33577921|NCT02954458|102006640|FG000|Overall Study|Withdrawal by Subject|0|||
33577922|NCT02954458|102006641|FG001|Overall Study|Withdrawal by Subject|0|||
33577923|NCT02954458|102006642|FG002|Overall Study|Withdrawal by Subject|0|||
33577924|NCT02954458|102006643|FG003|Overall Study|Withdrawal by Subject|1|||
33577925|NCT02954458|102006640|FG000|Overall Study|Physician Decision|0|||
33577926|NCT02954458|102006641|FG001|Overall Study|Physician Decision|0|||
33577927|NCT02954458|102006642|FG002|Overall Study|Physician Decision|1|||
33577928|NCT02954458|102006643|FG003|Overall Study|Physician Decision|1|||
33577929|NCT02954458|102006640|FG000|Overall Study|Lost to Follow-up|1|||
33577930|NCT02954458|102006641|FG001|Overall Study|Lost to Follow-up|0|||
33577931|NCT02954458|102006642|FG002|Overall Study|Lost to Follow-up|0|||
33577932|NCT02954458|102006643|FG003|Overall Study|Lost to Follow-up|1|||
33577933|NCT02954458|102006640|FG000|Overall Study|Death|0|||
33577934|NCT02954458|102006641|FG001|Overall Study|Death|0|||
33577935|NCT02954458|102006642|FG002|Overall Study|Death|0|||
33577936|NCT02954458|102006643|FG003|Overall Study|Death|1|||
33577937|NCT02954458|102006640|FG000|Overall Study|Other|0|||
33577938|NCT02954458|102006641|FG001|Overall Study|Other|0|||
33577939|NCT02954458|102006642|FG002|Overall Study|Other|0|||
33577940|NCT02954458|102006643|FG003|Overall Study|Other|7|||
33577941|NCT01119287|102006644|FG000|Overall Study|Patient Decision, not related to AE|0|||
33577942|NCT01119287|102006645|FG001|Overall Study|Patient Decision, not related to AE|0|||
33577943|NCT01119287|102006646|FG002|Overall Study|Patient Decision, not related to AE|2|||
33577944|NCT01119287|102006647|FG003|Overall Study|Patient Decision, not related to AE|2|||
33577945|NCT01119287|102006648|FG004|Overall Study|Patient Decision, not related to AE|1|||
33577946|NCT01119287|102006649|FG005|Overall Study|Patient Decision, not related to AE|0|||
33577947|NCT00997984|102006650|FG000|Overall Study|Adverse Event|1|||
33577948|NCT00997984|102006651|FG001|Overall Study|Adverse Event|8|||
33577949|NCT00997984|102006652|FG002|Overall Study|Adverse Event|8|||
33577950|NCT00997984|102006650|FG000|Overall Study|Protocol Violation|1|||
33577951|NCT00997984|102006651|FG001|Overall Study|Protocol Violation|3|||
33577952|NCT00997984|102006652|FG002|Overall Study|Protocol Violation|0|||
33577953|NCT00997984|102006650|FG000|Overall Study|Withdrawal by Subject|6|||
33577954|NCT00997984|102006651|FG001|Overall Study|Withdrawal by Subject|9|||
33577955|NCT00997984|102006652|FG002|Overall Study|Withdrawal by Subject|5|||
33577956|NCT00997984|102006650|FG000|Overall Study|Lost to Follow-up|8|||
33577957|NCT00997984|102006651|FG001|Overall Study|Lost to Follow-up|5|||
33577958|NCT00997984|102006652|FG002|Overall Study|Lost to Follow-up|4|||
33577959|NCT00997984|102006650|FG000|Overall Study|Lack of Efficacy|20|||
33577960|NCT00997984|102006651|FG001|Overall Study|Lack of Efficacy|6|||
33577961|NCT00997984|102006652|FG002|Overall Study|Lack of Efficacy|3|||
33577962|NCT00997984|102006650|FG000|Overall Study|Met exclusion criteria|1|||
33637982|NCT01104311|102225920|FG000|Overall Study|low compliance|1|||
33637983|NCT01104311|102225921|FG001|Overall Study|low compliance|1|||
33139360|NCT00045942|100423959|FG000|PKC412A2104E1|Adverse Event|0|||
33139361|NCT00045942|100423960|FG001|PKC412A2104E1|Adverse Event|1|||
33139362|NCT00045942|100423961|FG002|PKC412A2104E1|Adverse Event|1|||
33139363|NCT00045942|100423962|FG003|PKC412A2104E1|Adverse Event|3|||
33139364|NCT00045942|100423963|FG004|PKC412A2104E1|Adverse Event|6|||
33237160|NCT02998528|100772157|FG001|Randomization Period|Participant no longer meets study criteria|3|||
33237161|NCT02998528|100772158|FG002|Randomization Period|Participant no longer meets study criteria|2|||
33369211|NCT03484923|101236595|FG000|Overall Study|Physician Decision|6|||
33577963|NCT00997984|102006651|FG001|Overall Study|Met exclusion criteria|0|||
33577964|NCT00997984|102006652|FG002|Overall Study|Met exclusion criteria|0|||
33577965|NCT00997984|102006650|FG000|Overall Study|non-compliance|0|||
33577966|NCT00997984|102006651|FG001|Overall Study|non-compliance|2|||
33577967|NCT00997984|102006652|FG002|Overall Study|non-compliance|3|||
33637984|NCT01104311|102225920|FG000|Overall Study|Adverse Event|1|||
33637985|NCT01104311|102225921|FG001|Overall Study|Adverse Event|2|||
33139365|NCT00045942|100423964|FG005|PKC412A2104E1|Adverse Event|0|||
33139366|NCT00045942|100423965|FG006|PKC412A2104E1|Adverse Event|0|||
33139367|NCT00045942|100423966|FG007|PKC412A2104E1|Adverse Event|0|||
33139368|NCT00045942|100423967|FG008|PKC412A2104E1|Adverse Event|0|||
33139369|NCT00045942|100423959|FG000|PKC412A2104E1|Death|0|||
33139370|NCT00045942|100423960|FG001|PKC412A2104E1|Death|4|||
33139371|NCT00045942|100423961|FG002|PKC412A2104E1|Death|1|||
33139372|NCT00045942|100423962|FG003|PKC412A2104E1|Death|1|||
33139373|NCT00045942|100423963|FG004|PKC412A2104E1|Death|1|||
33139374|NCT00045942|100423964|FG005|PKC412A2104E1|Death|0|||
33139375|NCT00045942|100423965|FG006|PKC412A2104E1|Death|0|||
33237162|NCT02998528|100772156|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
33237163|NCT02998528|100772157|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
33237164|NCT02998528|100772158|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
33237165|NCT02998528|100772156|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
33237166|NCT02998528|100772157|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
33237167|NCT02998528|100772158|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
33237168|NCT02998528|100772156|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
33237169|NCT02998528|100772157|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
33237170|NCT02998528|100772158|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
33237171|NCT02998528|100772156|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
33237172|NCT02998528|100772157|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
33237173|NCT02998528|100772158|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
33237174|NCT02998528|100772156|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
33237175|NCT02998528|100772157|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
33237176|NCT02998528|100772158|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
33237177|NCT02998528|100772156|FG000|Neoadjuvant Treatment Period|Death|1|||
33237178|NCT02998528|100772157|FG001|Neoadjuvant Treatment Period|Death|0|||
33237179|NCT02998528|100772158|FG002|Neoadjuvant Treatment Period|Death|0|||
33237180|NCT02998528|100772156|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
33237181|NCT02998528|100772157|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
33237182|NCT02998528|100772158|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
33237183|NCT02998528|100772156|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
33369212|NCT03484923|101236596|FG001|Overall Study|Physician Decision|7|||
33369213|NCT03484923|101236597|FG002|Overall Study|Physician Decision|6|||
33369214|NCT03484923|101236598|FG003|Overall Study|Physician Decision|3|||
33369215|NCT03484923|101236599|FG004|Overall Study|Physician Decision|2|||
33139376|NCT00045942|100423966|FG007|PKC412A2104E1|Death|0|||
33139377|NCT00045942|100423967|FG008|PKC412A2104E1|Death|0|||
33369216|NCT03484923|101236595|FG000|Overall Study|Progressive disease|33|||
33369217|NCT03484923|101236596|FG001|Overall Study|Progressive disease|28|||
33369218|NCT03484923|101236597|FG002|Overall Study|Progressive disease|26|||
33369219|NCT03484923|101236598|FG003|Overall Study|Progressive disease|30|||
33369220|NCT03484923|101236599|FG004|Overall Study|Progressive disease|16|||
33369221|NCT03484923|101236595|FG000|Overall Study|Subject Decision|1|||
33369222|NCT03484923|101236596|FG001|Overall Study|Subject Decision|3|||
33369223|NCT03484923|101236597|FG002|Overall Study|Subject Decision|3|||
33369224|NCT03484923|101236598|FG003|Overall Study|Subject Decision|0|||
33369225|NCT03484923|101236599|FG004|Overall Study|Subject Decision|1|||
33369226|NCT02042404|101236600|FG000|Overall Study|Death|1|||
33369227|NCT02042404|101236601|FG001|Overall Study|Death|0|||
33369228|NCT02042404|101236600|FG000|Overall Study|Unrelated Adverse Event|3|||
33369229|NCT02042404|101236601|FG001|Overall Study|Unrelated Adverse Event|0|||
33369230|NCT02042404|101236600|FG000|Overall Study|Inability to meet time requirements|1|||
33369231|NCT02042404|101236601|FG001|Overall Study|Inability to meet time requirements|0|||
33369232|NCT01355068|101236603|FG000|First Intervention Period|Adverse Event|0|||
33369233|NCT01355068|101236604|FG001|First Intervention Period|Adverse Event|1|||
33369234|NCT01355068|101236603|FG000|First Intervention Period|Withdrawal by Subject|0|||
33369235|NCT01355068|101236604|FG001|First Intervention Period|Withdrawal by Subject|1|||
33369236|NCT02214186|101236608|FG000|Overall Study|Lost to Follow-up|1|||
33369237|NCT02214186|101236609|FG001|Overall Study|Lost to Follow-up|1|||
33369238|NCT02214186|101236608|FG000|Overall Study|Protocol Violation|1|||
33420838|NCT00434148|101431624|FG001|Overall Study|Administrative problems|10|||
33369239|NCT02214186|101236609|FG001|Overall Study|Protocol Violation|1|||
33369240|NCT05460871|101236610|FG000|Overall Study|Withdrawal by Subject|1|||
33420839|NCT00434148|101431623|FG000|Overall Study|Lost to Follow-up|0|||
33420840|NCT00434148|101431624|FG001|Overall Study|Lost to Follow-up|1|||
33420841|NCT00434148|101431623|FG000|Overall Study|Condition no longer requires study drug|1|||
33139378|NCT00045942|100423959|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
33139379|NCT00045942|100423960|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
33139380|NCT00045942|100423961|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
33369241|NCT05460871|101236611|FG001|Overall Study|Withdrawal by Subject|2|||
33369242|NCT01543490|101236612|FG000|Overall Study|Adverse Event|4|||
33139381|NCT00045942|100423962|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
33420842|NCT00434148|101431624|FG001|Overall Study|Condition no longer requires study drug|0|||
33420843|NCT00434148|101431623|FG000|Overall Study|Abnormal test procedure result|0|||
33637986|NCT02085161|102225924|FG000|Overall Study|Not Treated|1|||
33637987|NCT02085161|102225925|FG001|Overall Study|Not Treated|0|||
33637988|NCT02085161|102225926|FG002|Overall Study|Not Treated|0|||
33637989|NCT02085161|102225927|FG003|Overall Study|Not Treated|0|||
33637990|NCT02085161|102225924|FG000|Overall Study|Adverse Event|8|||
33369243|NCT01543490|101236613|FG001|Overall Study|Adverse Event|0|||
33369244|NCT01543490|101236612|FG000|Overall Study|Physician Decision|1|||
33369245|NCT01543490|101236613|FG001|Overall Study|Physician Decision|0|||
33369246|NCT01543490|101236612|FG000|Overall Study|Lack of Efficacy|3|||
33369247|NCT01543490|101236613|FG001|Overall Study|Lack of Efficacy|3|||
33369248|NCT01543490|101236612|FG000|Overall Study|Lost to Follow-up|5|||
33369249|NCT01543490|101236613|FG001|Overall Study|Lost to Follow-up|0|||
33369250|NCT01543490|101236612|FG000|Overall Study|Withdrawal by Subject|2|||
33369251|NCT01543490|101236613|FG001|Overall Study|Withdrawal by Subject|0|||
33369252|NCT01543490|101236612|FG000|Overall Study|Other-Various Administrative Reasons|1|||
33420844|NCT00434148|101431624|FG001|Overall Study|Abnormal test procedure result|1|||
33369253|NCT01543490|101236613|FG001|Overall Study|Other-Various Administrative Reasons|2|||
33369254|NCT00748540|101236614|FG000|Overall Study|Physician Decision|1|||
33369255|NCT03493685|101236619|FG000|Overall Study|Death|4|||
33369256|NCT03493685|101236620|FG001|Overall Study|Death|3|||
33369257|NCT03493685|101236619|FG000|Overall Study|Lost to Follow-up|3|||
33369258|NCT03493685|101236620|FG001|Overall Study|Lost to Follow-up|2|||
33369259|NCT03493685|101236619|FG000|Overall Study|Physician Decision|2|||
33369260|NCT03493685|101236620|FG001|Overall Study|Physician Decision|0|||
33369261|NCT03493685|101236619|FG000|Overall Study|Withdrawal by Subject|7|||
33369262|NCT03493685|101236620|FG001|Overall Study|Withdrawal by Subject|11|||
33369263|NCT03011840|101236621|FG000|Overall Study|Not received PIL in post PIL phase|0|||
33637991|NCT02085161|102225925|FG001|Overall Study|Adverse Event|5|||
33637992|NCT02085161|102225926|FG002|Overall Study|Adverse Event|4|||
33637993|NCT02085161|102225927|FG003|Overall Study|Adverse Event|5|||
33637994|NCT02085161|102225924|FG000|Overall Study|Protocol Violation|0|||
33637995|NCT02085161|102225925|FG001|Overall Study|Protocol Violation|1|||
33637996|NCT02085161|102225926|FG002|Overall Study|Protocol Violation|0|||
33637997|NCT02085161|102225927|FG003|Overall Study|Protocol Violation|1|||
33637998|NCT02085161|102225924|FG000|Overall Study|Withdrawal by Subject|2|||
33637999|NCT02085161|102225925|FG001|Overall Study|Withdrawal by Subject|4|||
33638000|NCT02085161|102225926|FG002|Overall Study|Withdrawal by Subject|0|||
33638001|NCT02085161|102225927|FG003|Overall Study|Withdrawal by Subject|3|||
33638002|NCT02085161|102225924|FG000|Overall Study|Other Reason|1|||
33638003|NCT02085161|102225925|FG001|Overall Study|Other Reason|0|||
33638004|NCT02085161|102225926|FG002|Overall Study|Other Reason|1|||
33638005|NCT02085161|102225927|FG003|Overall Study|Other Reason|1|||
33638006|NCT01654302|102225928|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
33638007|NCT01654302|102225929|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
33638008|NCT01759446|102225930|FG000|Overall Study|Protocol Violation|1|||
33638009|NCT01759446|102225931|FG001|Overall Study|Protocol Violation|0|||
33638010|NCT01759446|102225932|FG002|Overall Study|Protocol Violation|1|||
33139382|NCT00045942|100423963|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
33369264|NCT03011840|101236622|FG001|Overall Study|Not received PIL in post PIL phase|21|||
33369265|NCT02626819|101236625|FG000|Overall Study|Lost to Follow-up|3|||
33369266|NCT02626819|101236626|FG001|Overall Study|Lost to Follow-up|2|||
33369267|NCT02626819|101236625|FG000|Overall Study|Withdrawal by Subject|1|||
33369268|NCT02626819|101236626|FG001|Overall Study|Withdrawal by Subject|0|||
33420845|NCT01682512|101431629|FG000|Overall Study|Adverse Event|6|||
33420846|NCT01682512|101431630|FG001|Overall Study|Adverse Event|5|||
33420847|NCT01682512|101431631|FG002|Overall Study|Adverse Event|2|||
33420848|NCT01682512|101431629|FG000|Overall Study|Withdrawal by Subject|2|||
33420849|NCT01682512|101431630|FG001|Overall Study|Withdrawal by Subject|6|||
33420850|NCT01682512|101431631|FG002|Overall Study|Withdrawal by Subject|3|||
33420851|NCT01682512|101431629|FG000|Overall Study|Physician Decision|0|||
33420852|NCT01682512|101431630|FG001|Overall Study|Physician Decision|2|||
33638011|NCT01759446|102225933|FG003|Overall Study|Protocol Violation|0|||
33638012|NCT01759446|102225934|FG004|Overall Study|Protocol Violation|0|||
33420853|NCT01682512|101431631|FG002|Overall Study|Physician Decision|0|||
33420854|NCT01682512|101431629|FG000|Overall Study|Study terminated by sponsor|46|||
33638013|NCT01759446|102225930|FG000|Overall Study|Withdrawal by Subject|0|||
33638014|NCT01759446|102225931|FG001|Overall Study|Withdrawal by Subject|1|||
33638015|NCT01759446|102225932|FG002|Overall Study|Withdrawal by Subject|0|||
33638016|NCT01759446|102225933|FG003|Overall Study|Withdrawal by Subject|1|||
33638017|NCT01759446|102225934|FG004|Overall Study|Withdrawal by Subject|0|||
33638018|NCT01472289|102225937|FG000|Overall Study|Death|2|||
33369269|NCT02626819|101236625|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
33369270|NCT02626819|101236626|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
33420855|NCT01682512|101431630|FG001|Overall Study|Study terminated by sponsor|43|||
33638019|NCT02170077|102225938|FG000|Overall Study|Withdrawal by Subject|3|||
33638020|NCT02170077|102225939|FG001|Overall Study|Withdrawal by Subject|4|||
33638021|NCT02170077|102225940|FG002|Overall Study|Withdrawal by Subject|2|||
33638022|NCT02170077|102225938|FG000|Overall Study|Adverse Event|4|||
33638023|NCT02170077|102225939|FG001|Overall Study|Adverse Event|4|||
33638024|NCT02170077|102225940|FG002|Overall Study|Adverse Event|4|||
33638025|NCT02170077|102225938|FG000|Overall Study|Lost to Follow-up|0|||
33638026|NCT02170077|102225939|FG001|Overall Study|Lost to Follow-up|1|||
33638027|NCT02170077|102225940|FG002|Overall Study|Lost to Follow-up|0|||
33638028|NCT02170077|102225938|FG000|Overall Study|Exclusion criteria|2|||
33638029|NCT02170077|102225939|FG001|Overall Study|Exclusion criteria|2|||
33638030|NCT02170077|102225940|FG002|Overall Study|Exclusion criteria|5|||
33638031|NCT02170077|102225938|FG000|Overall Study|Exacerbation of seizures|0|||
33638032|NCT02170077|102225939|FG001|Overall Study|Exacerbation of seizures|2|||
33638033|NCT02170077|102225940|FG002|Overall Study|Exacerbation of seizures|1|||
33638034|NCT02873377|102225943|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
33638035|NCT02873377|102225944|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
33638036|NCT02873377|102225943|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
33638037|NCT02873377|102225944|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
33638038|NCT01744977|102225945|FG000|Overall Study|Withdrawal by Subject|1|||
33638039|NCT01744977|102225946|FG001|Overall Study|Withdrawal by Subject|2|||
33638040|NCT01744977|102225945|FG000|Overall Study|Death|2|||
33638041|NCT01744977|102225946|FG001|Overall Study|Death|3|||
33638042|NCT01744977|102225945|FG000|Overall Study|Lost to Follow-up|2|||
33638043|NCT01744977|102225946|FG001|Overall Study|Lost to Follow-up|0|||
33638044|NCT01744977|102225945|FG000|Overall Study|No longer meets inclusion|6|||
33638045|NCT01744977|102225946|FG001|Overall Study|No longer meets inclusion|0|||
33638046|NCT02504151|102225947|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
33638047|NCT02504151|102225948|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
33638048|NCT02504151|102225947|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
33638049|NCT02504151|102225948|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
33638050|NCT02504151|102225947|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
33638051|NCT02504151|102225948|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
33638052|NCT02504151|102225947|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
33638053|NCT02504151|102225948|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
33369271|NCT03827473|101236627|FG000|Overall Study|Withdrawal by Subject|1|||
33369272|NCT03827473|101236628|FG001|Overall Study|Withdrawal by Subject|0|||
33369273|NCT02680847|101236629|FG000|Overall Study|Other|2|||
33369274|NCT02680847|101236630|FG001|Overall Study|Other|0|||
33369275|NCT02680847|101236631|FG002|Overall Study|Other|0|||
33369276|NCT02680847|101236629|FG000|Overall Study|No longer met eligibility criteria|2|||
33369277|NCT02680847|101236630|FG001|Overall Study|No longer met eligibility criteria|2|||
33369278|NCT02680847|101236631|FG002|Overall Study|No longer met eligibility criteria|0|||
33369279|NCT02680847|101236629|FG000|Overall Study|Unwilling to participate in study|1|||
33369280|NCT02680847|101236630|FG001|Overall Study|Unwilling to participate in study|1|||
33369281|NCT02680847|101236631|FG002|Overall Study|Unwilling to participate in study|0|||
33638054|NCT02592798|102225951|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
33369282|NCT02680847|101236629|FG000|Overall Study|Lack of Efficacy|0|||
33369283|NCT02680847|101236630|FG001|Overall Study|Lack of Efficacy|0|||
33369284|NCT02680847|101236631|FG002|Overall Study|Lack of Efficacy|2|||
33369285|NCT02680847|101236629|FG000|Overall Study|Adverse Event|0|||
33369286|NCT02680847|101236630|FG001|Overall Study|Adverse Event|0|||
33369287|NCT02680847|101236631|FG002|Overall Study|Adverse Event|1|||
33369288|NCT02531035|101236634|FG000|Overall Study|Death|0|||
33638055|NCT02592798|102225952|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
33638056|NCT02592798|102225951|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
33638057|NCT02592798|102225952|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
33638058|NCT02592798|102225951|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
33638059|NCT02592798|102225952|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
33638060|NCT02592798|102225951|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
33638061|NCT02592798|102225952|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
33638062|NCT02592798|102225951|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
33638063|NCT02592798|102225952|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
33638064|NCT02592798|102225951|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
33369289|NCT02531035|101236635|FG001|Overall Study|Death|1|||
33369290|NCT02531035|101236634|FG000|Overall Study|Protocol Violation|1|||
33638065|NCT02592798|102225952|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
33369291|NCT02531035|101236635|FG001|Overall Study|Protocol Violation|1|||
33638066|NCT02592798|102225951|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
33638067|NCT02592798|102225952|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
33638068|NCT02592798|102225951|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
33369292|NCT02531035|101236634|FG000|Overall Study|Noncompliance with study drug|8|||
33369293|NCT02531035|101236635|FG001|Overall Study|Noncompliance with study drug|3|||
33369294|NCT02531035|101236634|FG000|Overall Study|Physician Decision|1|||
33369295|NCT02531035|101236635|FG001|Overall Study|Physician Decision|0|||
33638069|NCT02592798|102225952|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
33638070|NCT02592798|102225951|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
33638071|NCT02592798|102225952|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
33638072|NCT02592798|102225951|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
33638073|NCT02592798|102225952|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
33638074|NCT02592798|102225951|FG000|Transition From DB2 to OLE|Other reasons|1|||
33638075|NCT02592798|102225952|FG001|Transition From DB2 to OLE|Other reasons|0|||
33638076|NCT02592798|102225951|FG000|Open Label Period (OLE)|Other reasons|0|||
33638077|NCT02592798|102225952|FG001|Open Label Period (OLE)|Other reasons|2|||
33638078|NCT02592798|102225951|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
33638079|NCT02592798|102225952|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
33638080|NCT02592798|102225951|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
33139383|NCT00045942|100423964|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
33638081|NCT02592798|102225952|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
33638082|NCT02592798|102225951|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
33638083|NCT02592798|102225952|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
33638084|NCT02592798|102225951|FG000|Open Label Period (OLE)|Adverse Event|0|||
33638085|NCT02592798|102225952|FG001|Open Label Period (OLE)|Adverse Event|1|||
33638086|NCT01598506|102225954|FG000|Overall Study|Withdrawal by Subject|2|||
33638087|NCT00446849|102225955|FG000|Acute Phase|Lack of Efficacy|64|||
33638088|NCT00446849|102225955|FG000|Acute Phase|Protocol Violation|10|||
33638089|NCT00446849|102225955|FG000|Acute Phase|Consent withdrawn|4|||
33638090|NCT00446849|102225955|FG000|Acute Phase|Lost to Follow-up|2|||
33638091|NCT00446849|102225955|FG000|Acute Phase|Physician Decision|1|||
33638092|NCT00446849|102225955|FG000|Acute Phase|noncompliance|1|||
33638093|NCT00446849|102225955|FG000|Maintenance Phase|Lack of Efficacy|40|||
33638094|NCT00446849|102225955|FG000|Maintenance Phase|Protocol Violation|7|||
33638095|NCT00446849|102225955|FG000|Maintenance Phase|Adverse Event|6|||
33638096|NCT00446849|102225955|FG000|Maintenance Phase|Consent withdrawn|5|||
33638097|NCT00446849|102225955|FG000|Maintenance Phase|Lost to Follow-up|3|||
33638098|NCT00446849|102225955|FG000|Maintenance Phase|Pregnancy|1|||
33638099|NCT00446849|102225955|FG000|Maintenance Phase|noncompliance|2|||
33638100|NCT00446849|102225955|FG000|Maintenance Phase|prohibited medication use|2|||
33638101|NCT00446849|102225955|FG000|Maintenance Phase|antibiotic use|1|||
33638102|NCT00446849|102225955|FG000|Maintenance Phase|study closure|1|||
33139384|NCT00045942|100423965|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
33139385|NCT00045942|100423966|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
33139386|NCT00045942|100423967|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
33577968|NCT00997984|102006650|FG000|Overall Study|Wrong medication dispensed|0|||
33577969|NCT00997984|102006651|FG001|Overall Study|Wrong medication dispensed|1|||
33577970|NCT00997984|102006652|FG002|Overall Study|Wrong medication dispensed|0|||
33577971|NCT00997984|102006650|FG000|Overall Study|Suicidal ideation|0|||
33577972|NCT00997984|102006651|FG001|Overall Study|Suicidal ideation|0|||
33577973|NCT00997984|102006652|FG002|Overall Study|Suicidal ideation|1|||
33577974|NCT00997984|102006650|FG000|Overall Study|Work schedule|0|||
33577975|NCT00997984|102006651|FG001|Overall Study|Work schedule|0|||
33638103|NCT00446849|102225955|FG000|Maintenance Phase|hydrocodone use|1|||
33638104|NCT00446849|102225955|FG000|Maintenance Phase|concomitant medication use|1|||
33139387|NCT00045942|100423959|FG000|PKC412A2104E2|Lost to Follow-up|0|||
33139388|NCT00045942|100423960|FG001|PKC412A2104E2|Lost to Follow-up|0|||
33139389|NCT00045942|100423961|FG002|PKC412A2104E2|Lost to Follow-up|0|||
33139390|NCT00045942|100423962|FG003|PKC412A2104E2|Lost to Follow-up|0|||
33139391|NCT00045942|100423963|FG004|PKC412A2104E2|Lost to Follow-up|0|||
33139392|NCT00045942|100423964|FG005|PKC412A2104E2|Lost to Follow-up|0|||
33139393|NCT00045942|100423965|FG006|PKC412A2104E2|Lost to Follow-up|0|||
33139394|NCT00045942|100423966|FG007|PKC412A2104E2|Lost to Follow-up|3|||
33139395|NCT00045942|100423967|FG008|PKC412A2104E2|Lost to Follow-up|0|||
33139396|NCT00045942|100423959|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
33139397|NCT00045942|100423960|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
33139398|NCT00045942|100423961|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
33139399|NCT00045942|100423962|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
33139400|NCT00045942|100423963|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
33139401|NCT00045942|100423964|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
33237184|NCT02998528|100772157|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
33237185|NCT02998528|100772158|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
33638105|NCT01055197|102225956|FG000|Overall Study|Protocol Violation|7|||
33638106|NCT01055197|102225957|FG001|Overall Study|Protocol Violation|2|||
33638107|NCT01055197|102225956|FG000|Overall Study|Withdrawal by Subject|2|||
33638108|NCT01055197|102225957|FG001|Overall Study|Withdrawal by Subject|0|||
33638109|NCT02628873|102225958|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
33139402|NCT00045942|100423965|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
33139403|NCT00045942|100423966|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
33237186|NCT02998528|100772156|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
33237187|NCT02998528|100772157|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
33638110|NCT02628873|102225959|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
33139404|NCT00045942|100423967|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
33139405|NCT00045942|100423959|FG000|PKC412A2104E2|Lack of Efficacy|0|||
33638111|NCT02628873|102225958|FG000|Second Test (1 Hour)|Physician Decision|1|||
33638112|NCT02628873|102225959|FG001|Second Test (1 Hour)|Physician Decision|0|||
33638113|NCT00750438|102225961|FG000|Overall Study|Protocol Violation|4|||
33638114|NCT00750438|102225962|FG001|Overall Study|Protocol Violation|1|||
33638115|NCT00750438|102225961|FG000|Overall Study|Physician Decision|2|||
33638116|NCT00750438|102225962|FG001|Overall Study|Physician Decision|2|||
33638117|NCT00750438|102225961|FG000|Overall Study|Withdrawal by Subject|1|||
33638118|NCT00750438|102225962|FG001|Overall Study|Withdrawal by Subject|1|||
33638119|NCT04226742|102225969|FG000|Overall Study|Lost to Follow-up|16|||
33638120|NCT04226742|102225970|FG001|Overall Study|Lost to Follow-up|13|||
33638121|NCT04226742|102225969|FG000|Overall Study|Withdrawal by Subject|5|||
33638122|NCT04226742|102225970|FG001|Overall Study|Withdrawal by Subject|3|||
33638123|NCT00936715|102225971|FG000|Overall Study|Investigators Discretion|1|||
33638124|NCT00936715|102225971|FG000|Overall Study|Protocol Violation|1|||
33638125|NCT00936715|102225971|FG000|Overall Study|Safety or Tolerability Reasons|4|||
33638126|NCT01147874|102225974|FG000|Overall Study|Adverse Event|5|||
33638127|NCT01147874|102225974|FG000|Overall Study|Investigator's Request|1|||
33638128|NCT01147874|102225974|FG000|Overall Study|Lost to Follow-up|25|||
33638129|NCT01147874|102225974|FG000|Overall Study|Other|5|||
33638130|NCT01147874|102225974|FG000|Overall Study|Protocol Violation|5|||
33638131|NCT01147874|102225974|FG000|Overall Study|Sponsor's Decision|2|||
33638132|NCT01147874|102225974|FG000|Overall Study|Withdrawal by Subject|24|||
33139406|NCT00045942|100423960|FG001|PKC412A2104E2|Lack of Efficacy|0|||
33139407|NCT00045942|100423961|FG002|PKC412A2104E2|Lack of Efficacy|0|||
33139408|NCT00045942|100423962|FG003|PKC412A2104E2|Lack of Efficacy|0|||
33139409|NCT00045942|100423963|FG004|PKC412A2104E2|Lack of Efficacy|0|||
33139410|NCT00045942|100423964|FG005|PKC412A2104E2|Lack of Efficacy|3|||
33577976|NCT00997984|102006652|FG002|Overall Study|Work schedule|2|||
33577977|NCT03824392|102006653|FG000|Overall Study|Adverse Event|1|||
33577978|NCT03824392|102006654|FG001|Overall Study|Adverse Event|0|||
33577979|NCT03824392|102006655|FG002|Overall Study|Adverse Event|0|||
33577980|NCT03824392|102006656|FG003|Overall Study|Adverse Event|0|||
33577981|NCT03824392|102006653|FG000|Overall Study|Investigator Decision|0|||
33577982|NCT03824392|102006654|FG001|Overall Study|Investigator Decision|1|||
33577983|NCT03824392|102006655|FG002|Overall Study|Investigator Decision|0|||
33577984|NCT03824392|102006656|FG003|Overall Study|Investigator Decision|0|||
33577985|NCT03824392|102006653|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
33577986|NCT03824392|102006654|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
33577987|NCT03824392|102006655|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
33577988|NCT03824392|102006656|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
33577989|NCT02329743|102006657|FG000|Overall Study|Adverse Event|1|||
33577990|NCT02329743|102006658|FG001|Overall Study|Adverse Event|1|||
33577991|NCT02329743|102006659|FG002|Overall Study|Adverse Event|3|||
33577992|NCT02329743|102006657|FG000|Overall Study|Lost to Follow-up|1|||
33577993|NCT02329743|102006658|FG001|Overall Study|Lost to Follow-up|0|||
33577994|NCT02329743|102006659|FG002|Overall Study|Lost to Follow-up|1|||
33577995|NCT02329743|102006657|FG000|Overall Study|Withdrawal by Subject|4|||
33577996|NCT02329743|102006658|FG001|Overall Study|Withdrawal by Subject|4|||
33577997|NCT02329743|102006659|FG002|Overall Study|Withdrawal by Subject|1|||
33577998|NCT02329743|102006657|FG000|Overall Study|Other|0|||
33577999|NCT02329743|102006658|FG001|Overall Study|Other|2|||
33578000|NCT02329743|102006659|FG002|Overall Study|Other|3|||
33578001|NCT01770743|102006660|FG000|Overall Study|Adverse Event|1|||
33578002|NCT01770743|102006661|FG001|Overall Study|Adverse Event|0|||
33578003|NCT01770743|102006662|FG002|Overall Study|Adverse Event|0|||
33578004|NCT01770743|102006663|FG003|Overall Study|Adverse Event|0|||
33578005|NCT01770743|102006664|FG004|Overall Study|Adverse Event|0|||
33578006|NCT01770743|102006660|FG000|Overall Study|Withdrawal by Subject|0|||
33578007|NCT01770743|102006661|FG001|Overall Study|Withdrawal by Subject|0|||
33578008|NCT01770743|102006662|FG002|Overall Study|Withdrawal by Subject|1|||
33578009|NCT01770743|102006663|FG003|Overall Study|Withdrawal by Subject|1|||
33578010|NCT01770743|102006664|FG004|Overall Study|Withdrawal by Subject|1|||
33578011|NCT01770743|102006660|FG000|Overall Study|Lost to Follow-up|0|||
33578012|NCT01770743|102006661|FG001|Overall Study|Lost to Follow-up|2|||
33578013|NCT01770743|102006662|FG002|Overall Study|Lost to Follow-up|0|||
33578014|NCT01770743|102006663|FG003|Overall Study|Lost to Follow-up|0|||
33578015|NCT01770743|102006664|FG004|Overall Study|Lost to Follow-up|1|||
33578016|NCT01770743|102006660|FG000|Overall Study|Sponsor Terminated Subject|1|||
33578017|NCT01770743|102006661|FG001|Overall Study|Sponsor Terminated Subject|0|||
33578018|NCT01770743|102006662|FG002|Overall Study|Sponsor Terminated Subject|0|||
33578019|NCT01770743|102006663|FG003|Overall Study|Sponsor Terminated Subject|1|||
33578020|NCT01770743|102006664|FG004|Overall Study|Sponsor Terminated Subject|0|||
33578021|NCT01770743|102006660|FG000|Overall Study|Moving Out of State|0|||
33638133|NCT02991040|102225975|FG000|Overall Study|Withdrawal by Subject|2|||
33638134|NCT02991040|102225975|FG000|Overall Study|Lost to Follow-up|2|||
33638135|NCT03739203|102225976|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
33369296|NCT02531035|101236634|FG000|Overall Study|Adverse Event|16|||
33369297|NCT02531035|101236635|FG001|Overall Study|Adverse Event|45|||
33369298|NCT02531035|101236634|FG000|Overall Study|Other|3|||
33369299|NCT02531035|101236635|FG001|Overall Study|Other|2|||
33578022|NCT01770743|102006661|FG001|Overall Study|Moving Out of State|1|||
33578023|NCT01770743|102006662|FG002|Overall Study|Moving Out of State|0|||
33578024|NCT01770743|102006663|FG003|Overall Study|Moving Out of State|0|||
33578025|NCT01770743|102006664|FG004|Overall Study|Moving Out of State|0|||
33578026|NCT01331681|102006665|FG000|Overall Study|Adverse Event|10|||
33578027|NCT01331681|102006666|FG001|Overall Study|Adverse Event|13|||
33578028|NCT01331681|102006667|FG002|Overall Study|Adverse Event|10|||
33578029|NCT01331681|102006665|FG000|Overall Study|Death|6|||
33578030|NCT01331681|102006666|FG001|Overall Study|Death|6|||
33578031|NCT01331681|102006667|FG002|Overall Study|Death|2|||
33578032|NCT01331681|102006665|FG000|Overall Study|Lack of Efficacy|0|||
33578033|NCT01331681|102006666|FG001|Overall Study|Lack of Efficacy|1|||
33578034|NCT01331681|102006667|FG002|Overall Study|Lack of Efficacy|0|||
33578035|NCT01331681|102006665|FG000|Overall Study|Withdrawal by Subject|12|||
33578036|NCT01331681|102006666|FG001|Overall Study|Withdrawal by Subject|8|||
33578037|NCT01331681|102006667|FG002|Overall Study|Withdrawal by Subject|15|||
33578038|NCT01331681|102006665|FG000|Overall Study|Protocol Violation|1|||
33369300|NCT02531035|101236634|FG000|Overall Study|Withdrawal by Subject|42|||
33369301|NCT02531035|101236635|FG001|Overall Study|Withdrawal by Subject|32|||
33369302|NCT02531035|101236634|FG000|Overall Study|Lost to Follow-up|8|||
33369303|NCT02531035|101236635|FG001|Overall Study|Lost to Follow-up|10|||
33369304|NCT02531035|101236634|FG000|Overall Study|Randomized, not treated|2|||
33369305|NCT02531035|101236635|FG001|Overall Study|Randomized, not treated|1|||
33369306|NCT03885726|101236636|FG000|Overall Study|Staffing issues/lost interest|1|||
33369307|NCT03885726|101236636|FG000|Overall Study|Early discharge from hospital|3|||
33369308|NCT03488472|101236644|FG000|Overall Study|disease progression additional mets|1|||
33369309|NCT01028651|101236645|FG000|Overall Study|Death|2|||
33369310|NCT01028651|101236645|FG000|Overall Study|Adverse Event|1|||
33369311|NCT03158688|101236646|FG000|Overall Study|Withdrawal by Subject|14|||
33369312|NCT03158688|101236647|FG001|Overall Study|Withdrawal by Subject|28|||
33369313|NCT03158688|101236646|FG000|Overall Study|Decision by sponsor|13|||
33369314|NCT03158688|101236647|FG001|Overall Study|Decision by sponsor|37|||
33369315|NCT03158688|101236646|FG000|Overall Study|Lost to Follow-up|4|||
33369316|NCT03158688|101236647|FG001|Overall Study|Lost to Follow-up|3|||
33369317|NCT03158688|101236646|FG000|Overall Study|Death|74|||
33369318|NCT03158688|101236647|FG001|Overall Study|Death|142|||
33369319|NCT01998581|101236648|FG000|Overall Study|Refused repeat treatment|20|||
33369320|NCT01998581|101236649|FG001|Overall Study|Refused repeat treatment|4|||
33369321|NCT01998581|101236648|FG000|Overall Study|Protocol Violation|1|||
33369322|NCT01998581|101236649|FG001|Overall Study|Protocol Violation|0|||
33369323|NCT01998581|101236648|FG000|Overall Study|Withdrawal by Subject|8|||
33369324|NCT01998581|101236649|FG001|Overall Study|Withdrawal by Subject|1|||
33369325|NCT01998581|101236648|FG000|Overall Study|Lost to Follow-up|12|||
33369326|NCT01998581|101236649|FG001|Overall Study|Lost to Follow-up|4|||
33369327|NCT01998581|101236648|FG000|Overall Study|Adverse Event|1|||
33369328|NCT01998581|101236649|FG001|Overall Study|Adverse Event|1|||
33369329|NCT01998581|101236648|FG000|Overall Study|Other reasons|3|||
33369330|NCT01998581|101236649|FG001|Overall Study|Other reasons|2|||
33369331|NCT01998581|101236648|FG000|Overall Study|Randomized but withdrew before treatment|1|||
33369332|NCT01998581|101236649|FG001|Overall Study|Randomized but withdrew before treatment|0|||
33369333|NCT00392171|101236650|FG000|Overall Study|Did not meet inclusion criteria|4|||
33369334|NCT00392171|101236650|FG000|Overall Study|Disease progression|101|||
33369335|NCT01058369|101236653|FG000|Overall Study|Adverse Event|1|||
33369336|NCT01058369|101236653|FG000|Overall Study|Early termination study|1|||
33369337|NCT01814800|101236665|FG000|Overall Study|Adverse Event|2|||
33369338|NCT01814800|101236665|FG000|Overall Study|Pregnancy|1|||
33369339|NCT01814800|101236665|FG000|Overall Study|Sponsor decision|1|||
33369340|NCT01814800|101236665|FG000|Overall Study|Subject relocation|1|||
33369341|NCT03041116|101236667|FG000|Double-blind|Death|0|||
33369342|NCT03041116|101236668|FG001|Double-blind|Death|2|||
33369343|NCT03041116|101236667|FG000|Double-blind|Withdrawal by Subject|0|||
33369344|NCT03041116|101236668|FG001|Double-blind|Withdrawal by Subject|4|||
33578039|NCT01331681|102006666|FG001|Overall Study|Protocol Violation|1|||
33638136|NCT03739203|102225977|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
33369345|NCT03041116|101236667|FG000|Open-label|Death|1|||
33369346|NCT03041116|101236668|FG001|Open-label|Death|0|||
33369347|NCT03041116|101236667|FG000|Open-label|Termination of the study by Sponsor|39|||
33578040|NCT01331681|102006667|FG002|Overall Study|Protocol Violation|0|||
33578041|NCT01331681|102006665|FG000|Overall Study|Lost to Follow-up|2|||
33638137|NCT03739203|102225978|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
33369348|NCT03041116|101236668|FG001|Open-label|Termination of the study by Sponsor|37|||
33369349|NCT03041116|101236667|FG000|Open-label|Withdrawal by Subject|1|||
33369350|NCT03041116|101236668|FG001|Open-label|Withdrawal by Subject|0|||
33578042|NCT01331681|102006666|FG001|Overall Study|Lost to Follow-up|4|||
33578043|NCT01331681|102006667|FG002|Overall Study|Lost to Follow-up|1|||
33638138|NCT03739203|102225976|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
33638139|NCT03739203|102225977|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33638140|NCT03739203|102225978|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
33638141|NCT03739203|102225976|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
33638142|NCT03739203|102225977|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
33139411|NCT00045942|100423965|FG006|PKC412A2104E2|Lack of Efficacy|2|||
33139412|NCT00045942|100423966|FG007|PKC412A2104E2|Lack of Efficacy|2|||
33139413|NCT00045942|100423967|FG008|PKC412A2104E2|Lack of Efficacy|6|||
33139414|NCT00045942|100423959|FG000|PKC412A2104E2|Adverse Event|0|||
33139415|NCT00045942|100423960|FG001|PKC412A2104E2|Adverse Event|0|||
33139416|NCT00045942|100423961|FG002|PKC412A2104E2|Adverse Event|0|||
33139417|NCT00045942|100423962|FG003|PKC412A2104E2|Adverse Event|0|||
33139418|NCT00045942|100423963|FG004|PKC412A2104E2|Adverse Event|0|||
33578044|NCT01331681|102006665|FG000|Overall Study|Physician Decision|2|||
33578045|NCT01331681|102006666|FG001|Overall Study|Physician Decision|0|||
33578046|NCT01331681|102006667|FG002|Overall Study|Physician Decision|4|||
33578047|NCT01331681|102006665|FG000|Overall Study|Therapeutic procedure required|1|||
33578048|NCT01331681|102006666|FG001|Overall Study|Therapeutic procedure required|0|||
33578049|NCT01331681|102006667|FG002|Overall Study|Therapeutic procedure required|0|||
33578050|NCT01331681|102006665|FG000|Overall Study|Sponsor decision|1|||
33578051|NCT01331681|102006666|FG001|Overall Study|Sponsor decision|1|||
33578052|NCT01331681|102006667|FG002|Overall Study|Sponsor decision|0|||
33578053|NCT01331681|102006665|FG000|Overall Study|Switching to other therapy|0|||
33578054|NCT01331681|102006666|FG001|Overall Study|Switching to other therapy|0|||
33578055|NCT01331681|102006667|FG002|Overall Study|Switching to other therapy|1|||
33578056|NCT01331681|102006665|FG000|Overall Study|Not Received Study Treatment|0|||
33578057|NCT01331681|102006666|FG001|Overall Study|Not Received Study Treatment|0|||
33578058|NCT01331681|102006667|FG002|Overall Study|Not Received Study Treatment|2|||
33578059|NCT01466491|102006668|FG000|Overall Study|Protocol Violation|0|||
33638143|NCT03739203|102225978|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
33638144|NCT03739203|102225976|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
33139419|NCT00045942|100423964|FG005|PKC412A2104E2|Adverse Event|4|||
33139420|NCT00045942|100423965|FG006|PKC412A2104E2|Adverse Event|3|||
33139421|NCT00045942|100423966|FG007|PKC412A2104E2|Adverse Event|1|||
33139422|NCT00045942|100423967|FG008|PKC412A2104E2|Adverse Event|0|||
33139423|NCT00045942|100423959|FG000|PKC412A2104E2|Death|0|||
33139424|NCT00045942|100423960|FG001|PKC412A2104E2|Death|0|||
33139425|NCT00045942|100423961|FG002|PKC412A2104E2|Death|0|||
33237188|NCT02998528|100772158|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
33237189|NCT02998528|100772156|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
33237190|NCT02998528|100772157|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
33237191|NCT02998528|100772158|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
33237192|NCT02998528|100772156|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
33237193|NCT02998528|100772157|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
33237194|NCT02998528|100772158|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
33237195|NCT02998528|100772156|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
33369351|NCT04346628|101236669|FG000|Overall Study|Lost to Follow-up|4|||
33369352|NCT04346628|101236670|FG001|Overall Study|Lost to Follow-up|4|||
33369353|NCT04346628|101236669|FG000|Overall Study|Withdrew (had personal reasons)|2|||
33369354|NCT04346628|101236670|FG001|Overall Study|Withdrew (had personal reasons)|5|||
33369355|NCT04346628|101236669|FG000|Overall Study|Withdrew (medication intolerant)|0|||
33369356|NCT04346628|101236670|FG001|Overall Study|Withdrew (medication intolerant)|3|||
33369357|NCT04346628|101236669|FG000|Overall Study|Withdrew (declined intervention)|0|||
33369358|NCT04346628|101236670|FG001|Overall Study|Withdrew (declined intervention)|1|||
33369359|NCT01379534|101236671|FG000|Treatment Phase|Withdrawal by Subject|2|||
33369360|NCT01379534|101236672|FG001|Treatment Phase|Withdrawal by Subject|2|||
33369361|NCT01379534|101236671|FG000|Treatment Phase|Progressive disease|13|||
33369362|NCT01379534|101236672|FG001|Treatment Phase|Progressive disease|22|||
33369363|NCT01379534|101236671|FG000|Treatment Phase|Adverse Event|7|||
33369364|NCT01379534|101236672|FG001|Treatment Phase|Adverse Event|7|||
33369365|NCT01379534|101236671|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
33369366|NCT01379534|101236672|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
33369367|NCT01379534|101236671|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
33369368|NCT01379534|101236672|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
33369369|NCT01379534|101236671|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
33369370|NCT01379534|101236672|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
33578060|NCT01466491|102006669|FG001|Overall Study|Protocol Violation|3|||
33578061|NCT01466491|102006670|FG002|Overall Study|Protocol Violation|2|||
33578062|NCT01466491|102006671|FG003|Overall Study|Protocol Violation|0|||
33139426|NCT00045942|100423962|FG003|PKC412A2104E2|Death|0|||
33139427|NCT00045942|100423963|FG004|PKC412A2104E2|Death|0|||
33139428|NCT00045942|100423964|FG005|PKC412A2104E2|Death|1|||
33237196|NCT02998528|100772157|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
33237197|NCT02998528|100772158|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
33237198|NCT01113463|100772159|FG000|Overall Study|Physician Decision|5|||
33237199|NCT01477749|100772160|FG000|Overall Study|Physician Decision|4|||
33237200|NCT01579578|100772161|FG000|Overall Study|Death|4|||
33237201|NCT01579578|100772162|FG001|Overall Study|Death|1|||
33237202|NCT01579578|100772161|FG000|Overall Study|Lost to Follow-up|1|||
33237203|NCT01579578|100772162|FG001|Overall Study|Lost to Follow-up|1|||
33237204|NCT01579578|100772161|FG000|Overall Study|Withdrawal by Subject|2|||
33237205|NCT01579578|100772162|FG001|Overall Study|Withdrawal by Subject|1|||
33237206|NCT01579578|100772161|FG000|Overall Study|Eligibility criteria|3|||
33237207|NCT01579578|100772162|FG001|Overall Study|Eligibility criteria|9|||
33237208|NCT01579578|100772161|FG000|Overall Study|Ongoing|3|||
33237209|NCT01579578|100772162|FG001|Overall Study|Ongoing|0|||
33237210|NCT03101592|100772163|FG000|Overall Study|participant files could not be located|111|||
33237211|NCT03101592|100772164|FG001|Overall Study|participant files could not be located|170|||
33237212|NCT03101592|100772165|FG002|Overall Study|participant files could not be located|118|||
33237213|NCT02886728|100772166|FG000|Overall Study|Withdrew Consent|31|||
33237214|NCT02886728|100772167|FG001|Overall Study|Withdrew Consent|13|||
33237215|NCT02886728|100772168|FG002|Overall Study|Withdrew Consent|11|||
33237216|NCT02886728|100772169|FG003|Overall Study|Withdrew Consent|47|||
33237217|NCT02886728|100772166|FG000|Overall Study|Lost to Follow-up|12|||
33237218|NCT02886728|100772167|FG001|Overall Study|Lost to Follow-up|6|||
33237219|NCT02886728|100772168|FG002|Overall Study|Lost to Follow-up|13|||
33237220|NCT02886728|100772169|FG003|Overall Study|Lost to Follow-up|12|||
33237221|NCT02886728|100772166|FG000|Overall Study|Adverse Event|13|||
33237222|NCT02886728|100772167|FG001|Overall Study|Adverse Event|5|||
33237223|NCT02886728|100772168|FG002|Overall Study|Adverse Event|5|||
33237224|NCT02886728|100772169|FG003|Overall Study|Adverse Event|11|||
33237225|NCT02886728|100772166|FG000|Overall Study|Investigator's Discretion|11|||
33237226|NCT02886728|100772167|FG001|Overall Study|Investigator's Discretion|7|||
33237227|NCT02886728|100772168|FG002|Overall Study|Investigator's Discretion|5|||
33237228|NCT02886728|100772169|FG003|Overall Study|Investigator's Discretion|11|||
33237229|NCT02886728|100772166|FG000|Overall Study|Death|3|||
33237230|NCT02886728|100772167|FG001|Overall Study|Death|1|||
33237231|NCT02886728|100772168|FG002|Overall Study|Death|0|||
33237232|NCT02886728|100772169|FG003|Overall Study|Death|0|||
33237233|NCT02886728|100772166|FG000|Overall Study|Protocol Violation|0|||
33237234|NCT02886728|100772167|FG001|Overall Study|Protocol Violation|0|||
33237235|NCT02886728|100772168|FG002|Overall Study|Protocol Violation|0|||
33237236|NCT02886728|100772169|FG003|Overall Study|Protocol Violation|4|||
33237237|NCT02886728|100772166|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33237238|NCT02886728|100772167|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33237239|NCT02886728|100772168|FG002|Overall Study|Non-Compliance with Study Drug|1|||
33237240|NCT02886728|100772169|FG003|Overall Study|Non-Compliance with Study Drug|0|||
33237241|NCT02886728|100772166|FG000|Overall Study|Pregnancy|0|||
33237242|NCT02886728|100772167|FG001|Overall Study|Pregnancy|0|||
33237243|NCT02886728|100772168|FG002|Overall Study|Pregnancy|1|||
33237244|NCT02886728|100772169|FG003|Overall Study|Pregnancy|0|||
33237245|NCT02886728|100772166|FG000|Overall Study|Randomized but Not Dosed|1|||
33237246|NCT02886728|100772167|FG001|Overall Study|Randomized but Not Dosed|0|||
33237247|NCT02886728|100772168|FG002|Overall Study|Randomized but Not Dosed|0|||
33237248|NCT02886728|100772169|FG003|Overall Study|Randomized but Not Dosed|2|||
33237249|NCT01880515|100772172|FG000|Overall Study|Lost to Follow-up|3|||
33237250|NCT01880515|100772173|FG001|Overall Study|Lost to Follow-up|2|||
33237251|NCT01880515|100772172|FG000|Overall Study|Disease Progression|5|||
33237252|NCT01880515|100772173|FG001|Overall Study|Disease Progression|7|||
33237253|NCT00681187|100772174|FG000|Overall Study|Withdrawal by Subject|1|||
33237254|NCT00681187|100772175|FG001|Overall Study|Withdrawal by Subject|0|||
33237255|NCT00681187|100772174|FG000|Overall Study|Death|0|||
33237256|NCT00681187|100772175|FG001|Overall Study|Death|1|||
33578063|NCT01466491|102006668|FG000|Overall Study|Missing Data|0|||
33578064|NCT01466491|102006669|FG001|Overall Study|Missing Data|0|||
33578065|NCT01466491|102006670|FG002|Overall Study|Missing Data|1|||
33237257|NCT00681187|100772174|FG000|Overall Study|Adverse Event|0|||
33578066|NCT01466491|102006671|FG003|Overall Study|Missing Data|0|||
33578067|NCT00533429|102006672|FG000|Overall Study|Adverse Event|3|||
33237258|NCT00681187|100772175|FG001|Overall Study|Adverse Event|1|||
33237259|NCT00463151|100772176|FG000|Overall Study|Adverse Event|0|||
33237260|NCT00463151|100772177|FG001|Overall Study|Adverse Event|0|||
33237261|NCT00463151|100772178|FG002|Overall Study|Adverse Event|1|||
33237262|NCT00463151|100772179|FG003|Overall Study|Adverse Event|0|||
33237263|NCT00463151|100772176|FG000|Overall Study|Lack of Efficacy|2|||
33578068|NCT00533429|102006673|FG001|Overall Study|Adverse Event|1|||
33237264|NCT00463151|100772177|FG001|Overall Study|Lack of Efficacy|5|||
33237265|NCT00463151|100772178|FG002|Overall Study|Lack of Efficacy|2|||
33237266|NCT00463151|100772179|FG003|Overall Study|Lack of Efficacy|5|||
33237267|NCT00463151|100772176|FG000|Overall Study|Protocol Violation|0|||
33578069|NCT00533429|102006672|FG000|Overall Study|Death|1|||
33578070|NCT00533429|102006673|FG001|Overall Study|Death|0|||
33578071|NCT00533429|102006672|FG000|Overall Study|Withdrawal by Subject|2|||
33578072|NCT00533429|102006673|FG001|Overall Study|Withdrawal by Subject|0|||
33578073|NCT00533429|102006672|FG000|Overall Study|Progressive Disease|12|||
33578074|NCT00533429|102006673|FG001|Overall Study|Progressive Disease|13|||
33578075|NCT00533429|102006672|FG000|Overall Study|Symptomatic deterioration|1|||
33578076|NCT00533429|102006673|FG001|Overall Study|Symptomatic deterioration|2|||
33578077|NCT01436110|102006675|FG000|Overall Study|Lack of Efficacy|23|||
33578078|NCT01436110|102006676|FG001|Overall Study|Lack of Efficacy|14|||
33578079|NCT01436110|102006677|FG002|Overall Study|Lack of Efficacy|9|||
33638145|NCT03739203|102225977|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
33638146|NCT03739203|102225978|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
33237268|NCT00463151|100772177|FG001|Overall Study|Protocol Violation|0|||
33237269|NCT00463151|100772178|FG002|Overall Study|Protocol Violation|0|||
33237270|NCT00463151|100772179|FG003|Overall Study|Protocol Violation|1|||
33237271|NCT00463151|100772176|FG000|Overall Study|Withdrawal by Subject|0|||
33237272|NCT00463151|100772177|FG001|Overall Study|Withdrawal by Subject|0|||
33237273|NCT00463151|100772178|FG002|Overall Study|Withdrawal by Subject|0|||
33237274|NCT00463151|100772179|FG003|Overall Study|Withdrawal by Subject|1|||
33237275|NCT02761629|100772180|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
33237276|NCT02761629|100772181|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
33237277|NCT02761629|100772180|FG000|Overall Study|Insufficient Therapeutic Response|2|||
33237278|NCT02761629|100772181|FG001|Overall Study|Insufficient Therapeutic Response|7|||
33237279|NCT02761629|100772180|FG000|Overall Study|Failure to Return|2|||
33237280|NCT02761629|100772181|FG001|Overall Study|Failure to Return|4|||
33237281|NCT02761629|100772180|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
33237282|NCT02761629|100772181|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
33237283|NCT02761629|100772180|FG000|Overall Study|Protocol Violation|2|||
33237284|NCT02761629|100772181|FG001|Overall Study|Protocol Violation|2|||
33237285|NCT02761629|100772180|FG000|Overall Study|Withdrawal by Subject|0|||
33237286|NCT02761629|100772181|FG001|Overall Study|Withdrawal by Subject|3|||
33237287|NCT02761629|100772180|FG000|Overall Study|Other|0|||
33237288|NCT02761629|100772181|FG001|Overall Study|Other|2|||
33237289|NCT02761629|100772180|FG000|Overall Study|Lost to Follow-up|4|||
33237290|NCT02761629|100772181|FG001|Overall Study|Lost to Follow-up|1|||
33237291|NCT02761629|100772180|FG000|Overall Study|Randomized But Not Treated|8|||
33237292|NCT02761629|100772181|FG001|Overall Study|Randomized But Not Treated|4|||
33237293|NCT03677375|100772182|FG000|Overall Study|Incomplete procedure|8|||
33237294|NCT03677375|100772182|FG000|Overall Study|Adverse Event|3|||
33237295|NCT03677375|100772182|FG000|Overall Study|Physician Decision|1|||
33237296|NCT01461993|100772183|FG000|Overall Study|Withdrawal by Subject|60|||
33237297|NCT01461993|100772184|FG001|Overall Study|Withdrawal by Subject|53|||
33237298|NCT01461993|100772185|FG002|Overall Study|Withdrawal by Subject|16|||
33237299|NCT01461993|100772183|FG000|Overall Study|Lost to Follow-up|44|||
33237300|NCT01461993|100772184|FG001|Overall Study|Lost to Follow-up|48|||
33237301|NCT01461993|100772185|FG002|Overall Study|Lost to Follow-up|22|||
33237302|NCT01461993|100772183|FG000|Overall Study|Protocol Violation|10|||
33237303|NCT01461993|100772184|FG001|Overall Study|Protocol Violation|9|||
33237304|NCT01461993|100772185|FG002|Overall Study|Protocol Violation|7|||
33237305|NCT01461993|100772183|FG000|Overall Study|Adverse Event|9|||
33237306|NCT01461993|100772184|FG001|Overall Study|Adverse Event|11|||
33237307|NCT01461993|100772185|FG002|Overall Study|Adverse Event|3|||
33237308|NCT01461993|100772183|FG000|Overall Study|No longer met eligibility criteria|13|||
33237309|NCT01461993|100772184|FG001|Overall Study|No longer met eligibility criteria|18|||
33237310|NCT01461993|100772185|FG002|Overall Study|No longer met eligibility criteria|10|||
33237311|NCT01461993|100772183|FG000|Overall Study|Did not meet entrance criteria|2|||
33237312|NCT01461993|100772184|FG001|Overall Study|Did not meet entrance criteria|3|||
33237313|NCT01461993|100772185|FG002|Overall Study|Did not meet entrance criteria|0|||
33237314|NCT01461993|100772183|FG000|Overall Study|Other|13|||
33578080|NCT01436110|102006675|FG000|Overall Study|Withdrawal by Subject|6|||
33578081|NCT01436110|102006676|FG001|Overall Study|Withdrawal by Subject|8|||
33578082|NCT01436110|102006677|FG002|Overall Study|Withdrawal by Subject|4|||
33578083|NCT01436110|102006675|FG000|Overall Study|Adverse Event|2|||
33638147|NCT03739203|102225976|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
33237315|NCT01461993|100772184|FG001|Overall Study|Other|15|||
33237316|NCT01461993|100772185|FG002|Overall Study|Other|6|||
33237317|NCT00619151|100772187|FG000|Overall Study|Study terminated prior to followup|1|||
33237318|NCT00619151|100772188|FG001|Overall Study|Study terminated prior to followup|0|||
33237319|NCT00680056|100772189|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
33578084|NCT01436110|102006676|FG001|Overall Study|Adverse Event|1|||
33237320|NCT00680056|100772190|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
33237321|NCT00680056|100772189|FG000|Second Intervention|Protocol Violation|3|||
33237322|NCT00680056|100772190|FG001|Second Intervention|Protocol Violation|1|||
33237323|NCT03220737|100772191|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
33578085|NCT01436110|102006677|FG002|Overall Study|Adverse Event|2|||
33578086|NCT01436110|102006675|FG000|Overall Study|Physician Decision|3|||
33578087|NCT01436110|102006676|FG001|Overall Study|Physician Decision|1|||
33237324|NCT03220737|100772192|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
33237325|NCT03220737|100772193|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
33237326|NCT03220737|100772194|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
33237327|NCT03220737|100772195|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
33237328|NCT03220737|100772196|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
33237329|NCT03220737|100772197|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
33237330|NCT03220737|100772191|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
33237331|NCT03220737|100772192|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
33237332|NCT03220737|100772193|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
33237333|NCT03220737|100772194|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
33237334|NCT03220737|100772195|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
33237335|NCT03220737|100772196|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
33237336|NCT03220737|100772197|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
33237337|NCT03220737|100772191|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
33237338|NCT03220737|100772192|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
33237339|NCT03220737|100772193|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
33237340|NCT03220737|100772194|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
33237341|NCT03220737|100772195|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
33237342|NCT03220737|100772196|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
33237343|NCT03220737|100772197|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
33237344|NCT03220737|100772191|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
33237345|NCT03220737|100772192|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
33237346|NCT03220737|100772193|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
33237347|NCT03220737|100772194|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
33237348|NCT03220737|100772195|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
33237349|NCT03220737|100772196|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
33237350|NCT03220737|100772197|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
33237351|NCT03220737|100772191|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
33237352|NCT03220737|100772192|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
33237353|NCT03220737|100772193|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
33237354|NCT03220737|100772194|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
33237355|NCT03220737|100772195|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
33237356|NCT03220737|100772196|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
33237357|NCT03220737|100772197|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
33578088|NCT01436110|102006677|FG002|Overall Study|Physician Decision|1|||
33237358|NCT03220737|100772191|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
33237359|NCT03220737|100772192|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
33237360|NCT03220737|100772193|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
33237361|NCT03220737|100772194|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
33237362|NCT03220737|100772195|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
33237363|NCT03220737|100772196|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
33237364|NCT03220737|100772197|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
33237365|NCT03220737|100772191|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
33237366|NCT03220737|100772192|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
33237367|NCT03220737|100772193|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
33237368|NCT03220737|100772194|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
33237369|NCT03220737|100772195|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
33237370|NCT03220737|100772196|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
33237371|NCT03220737|100772197|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
33237372|NCT03220737|100772191|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
33237373|NCT03220737|100772192|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
33237374|NCT03220737|100772193|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
33237375|NCT03220737|100772194|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
33237376|NCT03220737|100772195|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
33237377|NCT03220737|100772196|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
33237378|NCT03220737|100772197|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
33237379|NCT00848211|100772200|FG000|Overall Study|Protocol Violation|0|||
33237380|NCT00848211|100772201|FG001|Overall Study|Protocol Violation|1|||
33578089|NCT01436110|102006675|FG000|Overall Study|Lost to Follow-up|1|||
33578090|NCT01436110|102006676|FG001|Overall Study|Lost to Follow-up|1|||
33578091|NCT01436110|102006677|FG002|Overall Study|Lost to Follow-up|3|||
33578092|NCT01436110|102006675|FG000|Overall Study|Protocol Violation|3|||
33578093|NCT01436110|102006676|FG001|Overall Study|Protocol Violation|1|||
33578094|NCT01436110|102006677|FG002|Overall Study|Protocol Violation|1|||
33578095|NCT01436110|102006675|FG000|Overall Study|Did Not Receive Trial Medication|1|||
33578096|NCT01436110|102006676|FG001|Overall Study|Did Not Receive Trial Medication|0|||
33578097|NCT01436110|102006677|FG002|Overall Study|Did Not Receive Trial Medication|3|||
33578098|NCT00833027|102006678|FG000|Overall Study|Adverse Event|33|||
33578099|NCT00833027|102006678|FG000|Overall Study|Death|1|||
33139429|NCT00045942|100423965|FG006|PKC412A2104E2|Death|2|||
33139430|NCT00045942|100423966|FG007|PKC412A2104E2|Death|0|||
33139431|NCT00045942|100423967|FG008|PKC412A2104E2|Death|0|||
33139432|NCT02168387|100423968|FG000|Overall Study|Planned exubation|6|||
33139433|NCT02168387|100423969|FG001|Overall Study|Planned exubation|3|||
33139434|NCT02168387|100423968|FG000|Overall Study|Death|1|||
33139435|NCT02168387|100423969|FG001|Overall Study|Death|0|||
33139436|NCT00329901|100423970|FG000|Overall Study|Withdrawal by Subject|4|||
33578100|NCT00833027|102006678|FG000|Overall Study|Lack of Efficacy|12|||
33578101|NCT00833027|102006678|FG000|Overall Study|Lost to Follow-up|24|||
33578102|NCT00833027|102006678|FG000|Overall Study|Protocol Violation|115|||
33578103|NCT00833027|102006678|FG000|Overall Study|Withdrawal by Subject|16|||
33578104|NCT00833027|102006678|FG000|Overall Study|Missing|10|||
33578105|NCT00465972|102006680|FG000|Overall Study|Withdrawal by Subject|2|||
33578106|NCT00465972|102006681|FG001|Overall Study|Withdrawal by Subject|1|||
33578107|NCT01451749|102006684|FG000|Overall Study|Protocol Violation|14|||
33578108|NCT01451749|102006685|FG001|Overall Study|Protocol Violation|7|||
33578109|NCT01451749|102006684|FG000|Overall Study|Lost to Follow-up|15|||
33638148|NCT03739203|102225977|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
33638149|NCT03739203|102225978|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
33638150|NCT03739203|102225976|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
33638151|NCT03739203|102225977|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
33638152|NCT03739203|102225978|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
33638153|NCT03739203|102225976|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
33638154|NCT03739203|102225977|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
33638155|NCT03739203|102225978|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
33638156|NCT03739203|102225976|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
33638157|NCT03739203|102225977|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
33638158|NCT03739203|102225978|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
33638159|NCT03739203|102225976|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
33638160|NCT03739203|102225977|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
33638161|NCT03739203|102225978|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
33638162|NCT03739203|102225976|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
33638163|NCT03739203|102225977|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
33638164|NCT03739203|102225978|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
33638165|NCT03739203|102225976|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
33638166|NCT03739203|102225977|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
33638167|NCT03739203|102225978|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
33638168|NCT00753506|102225991|FG000|Overall Study|Withdrawal by Subject|4|||
33638169|NCT00753506|102225992|FG001|Overall Study|Withdrawal by Subject|1|||
33638170|NCT00753506|102225991|FG000|Overall Study|Lost to Follow-up|2|||
33638171|NCT00753506|102225992|FG001|Overall Study|Lost to Follow-up|0|||
33638172|NCT00753506|102225991|FG000|Overall Study|Other reason|1|||
33638173|NCT00753506|102225992|FG001|Overall Study|Other reason|1|||
33638174|NCT01208207|102225995|FG000|Part I|Adverse Event|19|||
33638175|NCT01208207|102225996|FG001|Part I|Adverse Event|2|||
33638176|NCT01208207|102225997|FG002|Part I|Adverse Event|6|||
33638177|NCT01208207|102225998|FG003|Part I|Adverse Event|0|||
33638178|NCT01208207|102225999|FG004|Part I|Adverse Event|0|||
33638179|NCT01208207|102226000|FG005|Part I|Adverse Event|0|||
33638180|NCT01208207|102226001|FG006|Part I|Adverse Event|0|||
33638181|NCT01208207|102225995|FG000|Part I|Lack of Efficacy|21|||
33638182|NCT01208207|102225996|FG001|Part I|Lack of Efficacy|3|||
33638183|NCT01208207|102225997|FG002|Part I|Lack of Efficacy|2|||
33638184|NCT01208207|102225998|FG003|Part I|Lack of Efficacy|0|||
33139437|NCT00329901|100423971|FG001|Overall Study|Withdrawal by Subject|3|||
33139438|NCT00329901|100423972|FG002|Overall Study|Withdrawal by Subject|2|||
33139439|NCT00329901|100423970|FG000|Overall Study|Lost to Follow-up|2|||
33139440|NCT00329901|100423971|FG001|Overall Study|Lost to Follow-up|0|||
33139441|NCT00329901|100423972|FG002|Overall Study|Lost to Follow-up|1|||
33638185|NCT01208207|102225999|FG004|Part I|Lack of Efficacy|0|||
33638186|NCT01208207|102226000|FG005|Part I|Lack of Efficacy|0|||
33638187|NCT01208207|102226001|FG006|Part I|Lack of Efficacy|0|||
33638188|NCT01208207|102225995|FG000|Part I|Lost to Follow-up|6|||
33638189|NCT01208207|102225996|FG001|Part I|Lost to Follow-up|1|||
33139442|NCT00329901|100423970|FG000|Overall Study|Protocol Violation|1|||
33139443|NCT00329901|100423971|FG001|Overall Study|Protocol Violation|0|||
33139444|NCT00329901|100423972|FG002|Overall Study|Protocol Violation|1|||
33139445|NCT00329901|100423970|FG000|Overall Study|Unable to classify|2|||
33237381|NCT00848211|100772202|FG002|Overall Study|Protocol Violation|1|||
33638190|NCT01208207|102225997|FG002|Part I|Lost to Follow-up|0|||
33638191|NCT01208207|102225998|FG003|Part I|Lost to Follow-up|0|||
33638192|NCT01208207|102225999|FG004|Part I|Lost to Follow-up|0|||
33638193|NCT01208207|102226000|FG005|Part I|Lost to Follow-up|0|||
33638194|NCT01208207|102226001|FG006|Part I|Lost to Follow-up|0|||
33139446|NCT00329901|100423971|FG001|Overall Study|Unable to classify|2|||
33578110|NCT01451749|102006685|FG001|Overall Study|Lost to Follow-up|5|||
33237382|NCT00848211|100772203|FG003|Overall Study|Protocol Violation|0|||
33237383|NCT00848211|100772200|FG000|Overall Study|Adverse Event|0|||
33237384|NCT00848211|100772201|FG001|Overall Study|Adverse Event|0|||
33638195|NCT01208207|102225995|FG000|Part I|Non-Compliance With Study Drug|1|||
33139447|NCT00329901|100423972|FG002|Overall Study|Unable to classify|0|||
33237385|NCT00848211|100772202|FG002|Overall Study|Adverse Event|0|||
33237386|NCT00848211|100772203|FG003|Overall Study|Adverse Event|0|||
33237387|NCT04529538|100772204|FG000|Overall Study|Lost to Follow-up|3|||
33237388|NCT04529538|100772205|FG001|Overall Study|Lost to Follow-up|2|||
33237389|NCT04529538|100772206|FG002|Overall Study|Lost to Follow-up|1|||
33237390|NCT04529538|100772207|FG003|Overall Study|Lost to Follow-up|0|||
33237391|NCT04529538|100772208|FG004|Overall Study|Lost to Follow-up|1|||
33237392|NCT04529538|100772209|FG005|Overall Study|Lost to Follow-up|1|||
33237393|NCT04529538|100772210|FG006|Overall Study|Lost to Follow-up|2|||
33237394|NCT04529538|100772211|FG007|Overall Study|Lost to Follow-up|0|||
33237395|NCT04529538|100772204|FG000|Overall Study|Not eligible at enrollment|0|||
33237396|NCT04529538|100772205|FG001|Overall Study|Not eligible at enrollment|1|||
33237397|NCT04529538|100772206|FG002|Overall Study|Not eligible at enrollment|2|||
33237398|NCT04529538|100772207|FG003|Overall Study|Not eligible at enrollment|1|||
33237399|NCT04529538|100772208|FG004|Overall Study|Not eligible at enrollment|0|||
33237400|NCT04529538|100772209|FG005|Overall Study|Not eligible at enrollment|0|||
33369371|NCT01379534|101236671|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
33369372|NCT01379534|101236672|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
33369373|NCT00740779|101236674|FG000|Overall Study|Adverse Event|4|||
33369374|NCT00740779|101236675|FG001|Overall Study|Adverse Event|6|||
33369375|NCT00740779|101236676|FG002|Overall Study|Adverse Event|3|||
33369376|NCT00740779|101236674|FG000|Overall Study|Protocol Violation|1|||
33369377|NCT00740779|101236675|FG001|Overall Study|Protocol Violation|1|||
33369378|NCT00740779|101236676|FG002|Overall Study|Protocol Violation|1|||
33369379|NCT00740779|101236674|FG000|Overall Study|Lack of Efficacy|0|||
33369380|NCT00740779|101236675|FG001|Overall Study|Lack of Efficacy|0|||
33369381|NCT00740779|101236676|FG002|Overall Study|Lack of Efficacy|2|||
33369382|NCT00740779|101236674|FG000|Overall Study|Withdrawal by Subject|2|||
33369383|NCT00740779|101236675|FG001|Overall Study|Withdrawal by Subject|4|||
33420856|NCT01682512|101431631|FG002|Overall Study|Study terminated by sponsor|0|||
33420857|NCT01682512|101431629|FG000|Overall Study|Lost to Follow-up|3|||
33420858|NCT01682512|101431630|FG001|Overall Study|Lost to Follow-up|0|||
33420859|NCT01682512|101431631|FG002|Overall Study|Lost to Follow-up|2|||
33420860|NCT01682512|101431629|FG000|Overall Study|Protocol Violation|2|||
33420861|NCT01682512|101431630|FG001|Overall Study|Protocol Violation|3|||
33638196|NCT01208207|102225996|FG001|Part I|Non-Compliance With Study Drug|0|||
33139448|NCT02650921|100423975|FG000|Overall Study|Withdrawal by Subject|4|||
33139449|NCT02650921|100423975|FG000|Overall Study|Lost to Follow-up|2|||
33139450|NCT02650921|100423975|FG000|Overall Study|Adverse Event|1|||
33139451|NCT02650921|100423975|FG000|Overall Study|Due to Medical Condition|1|||
33139452|NCT04620798|100423976|FG000|Overall Study|Lost to Follow-up|126|||
33139453|NCT04620798|100423977|FG001|Overall Study|Lost to Follow-up|138|||
33139454|NCT00322621|100423978|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
33139455|NCT00322621|100423979|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
33139456|NCT00322621|100423980|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
33139457|NCT00322621|100423978|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
33139458|NCT00322621|100423979|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
33139459|NCT00322621|100423980|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
33139460|NCT00322621|100423978|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
33139461|NCT00322621|100423979|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
33139462|NCT00322621|100423980|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
33139463|NCT00322621|100423978|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
33139464|NCT00322621|100423979|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
33139465|NCT00322621|100423980|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
33139466|NCT00322621|100423978|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
33139467|NCT00322621|100423979|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
33139468|NCT00322621|100423980|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
33139469|NCT00322621|100423978|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
33139470|NCT00322621|100423979|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
33139471|NCT00322621|100423980|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
33139472|NCT00322621|100423978|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
33139473|NCT00322621|100423979|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
33139474|NCT00322621|100423980|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
33139475|NCT00322621|100423978|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
33139476|NCT00322621|100423979|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
33139477|NCT00322621|100423980|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
33139478|NCT00322621|100423978|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
33420862|NCT01682512|101431631|FG002|Overall Study|Protocol Violation|2|||
33420863|NCT01682512|101431629|FG000|Overall Study|Primary lack of efficacy|10|||
33420864|NCT01682512|101431630|FG001|Overall Study|Primary lack of efficacy|7|||
33578111|NCT01451749|102006684|FG000|Overall Study|Meet the exclusion criteria,and|1|||
33638197|NCT01208207|102225997|FG002|Part I|Non-Compliance With Study Drug|1|||
33638198|NCT01208207|102225998|FG003|Part I|Non-Compliance With Study Drug|0|||
33638199|NCT01208207|102225999|FG004|Part I|Non-Compliance With Study Drug|0|||
33638200|NCT01208207|102226000|FG005|Part I|Non-Compliance With Study Drug|0|||
33237401|NCT04529538|100772210|FG006|Overall Study|Not eligible at enrollment|0|||
33237402|NCT04529538|100772211|FG007|Overall Study|Not eligible at enrollment|1|||
33237403|NCT04529538|100772204|FG000|Overall Study|Withdrawal by Subject|0|||
33237404|NCT04529538|100772205|FG001|Overall Study|Withdrawal by Subject|1|||
33237405|NCT04529538|100772206|FG002|Overall Study|Withdrawal by Subject|1|||
33237406|NCT04529538|100772207|FG003|Overall Study|Withdrawal by Subject|2|||
33237407|NCT04529538|100772208|FG004|Overall Study|Withdrawal by Subject|0|||
33237408|NCT04529538|100772209|FG005|Overall Study|Withdrawal by Subject|2|||
33237409|NCT04529538|100772210|FG006|Overall Study|Withdrawal by Subject|3|||
33237410|NCT04529538|100772211|FG007|Overall Study|Withdrawal by Subject|0|||
33237411|NCT04529538|100772204|FG000|Overall Study|Other|0|||
33237412|NCT04529538|100772205|FG001|Overall Study|Other|1|||
33237413|NCT04529538|100772206|FG002|Overall Study|Other|0|||
33237414|NCT04529538|100772207|FG003|Overall Study|Other|0|||
33237415|NCT04529538|100772208|FG004|Overall Study|Other|0|||
33237416|NCT04529538|100772209|FG005|Overall Study|Other|0|||
33237417|NCT04529538|100772210|FG006|Overall Study|Other|0|||
33237418|NCT04529538|100772211|FG007|Overall Study|Other|0|||
33237419|NCT04529538|100772204|FG000|Overall Study|Adverse Event|0|||
33237420|NCT04529538|100772205|FG001|Overall Study|Adverse Event|0|||
33237421|NCT04529538|100772206|FG002|Overall Study|Adverse Event|0|||
33237422|NCT04529538|100772207|FG003|Overall Study|Adverse Event|1|||
33237423|NCT04529538|100772208|FG004|Overall Study|Adverse Event|0|||
33237424|NCT04529538|100772209|FG005|Overall Study|Adverse Event|0|||
33578112|NCT01451749|102006685|FG001|Overall Study|Meet the exclusion criteria,and|1|||
33578113|NCT01451749|102006684|FG000|Overall Study|Adverse Event|2|||
33578114|NCT01451749|102006685|FG001|Overall Study|Adverse Event|0|||
33578115|NCT01451749|102006684|FG000|Overall Study|Withdrawal by Subject|0|||
33578116|NCT01451749|102006685|FG001|Overall Study|Withdrawal by Subject|1|||
33578117|NCT01976299|102006692|FG000|Overall Study|Withdrawal by Subject|3|||
33578118|NCT01976299|102006693|FG001|Overall Study|Withdrawal by Subject|1|||
33578119|NCT01976299|102006692|FG000|Overall Study|Death|4|||
33578120|NCT01976299|102006693|FG001|Overall Study|Death|2|||
33578121|NCT01976299|102006692|FG000|Overall Study|Lost to Follow-up|7|||
33578122|NCT01976299|102006693|FG001|Overall Study|Lost to Follow-up|1|||
33578123|NCT01976299|102006692|FG000|Overall Study|See clarification above in comments|9|||
33578124|NCT01976299|102006693|FG001|Overall Study|See clarification above in comments|2|||
33578125|NCT00811720|102006697|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
33578126|NCT00811720|102006698|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
33578127|NCT00811720|102006697|FG000|All Treated Patients|Adverse Event|20|||
33578128|NCT00811720|102006698|FG001|All Treated Patients|Adverse Event|62|||
33578129|NCT00811720|102006697|FG000|All Treated Patients|Lack of Efficacy|22|||
33578130|NCT00811720|102006698|FG001|All Treated Patients|Lack of Efficacy|18|||
33578131|NCT00811720|102006697|FG000|All Treated Patients|Non-compliance|0|||
33578132|NCT00811720|102006698|FG001|All Treated Patients|Non-compliance|14|||
33578133|NCT00811720|102006697|FG000|All Treated Patients|Protocol Violation|9|||
33578134|NCT00811720|102006698|FG001|All Treated Patients|Protocol Violation|16|||
33578135|NCT00811720|102006697|FG000|All Treated Patients|Withdrawal by Subject|28|||
33578136|NCT00811720|102006698|FG001|All Treated Patients|Withdrawal by Subject|34|||
33578137|NCT00811720|102006697|FG000|All Treated Patients|Lost to Follow-up|10|||
33578138|NCT00811720|102006698|FG001|All Treated Patients|Lost to Follow-up|16|||
33578139|NCT00811720|102006697|FG000|All Treated Patients|Other Reason|7|||
33578140|NCT00811720|102006698|FG001|All Treated Patients|Other Reason|4|||
33638201|NCT01208207|102226001|FG006|Part I|Non-Compliance With Study Drug|0|||
33638202|NCT01208207|102225995|FG000|Part I|Physician Decision|0|||
33638203|NCT01208207|102225996|FG001|Part I|Physician Decision|1|||
33638204|NCT01208207|102225997|FG002|Part I|Physician Decision|0|||
33237425|NCT04529538|100772210|FG006|Overall Study|Adverse Event|0|||
33237426|NCT04529538|100772211|FG007|Overall Study|Adverse Event|0|||
33237427|NCT04529538|100772204|FG000|Overall Study|Protocol Deviation|0|||
33237428|NCT04529538|100772205|FG001|Overall Study|Protocol Deviation|0|||
33578141|NCT00742625|102006700|FG000|Remission Induction|Progression|6|||
33578142|NCT00742625|102006700|FG000|Remission Induction|Failed induction|8|||
33578143|NCT00742625|102006700|FG000|Remission Induction|Adverse Event|3|||
33578144|NCT00742625|102006700|FG000|Remission Induction|Death|10|||
33578145|NCT00742625|102006700|FG000|Remission Induction|Refusal|5|||
33638205|NCT01208207|102225998|FG003|Part I|Physician Decision|0|||
33638206|NCT01208207|102225999|FG004|Part I|Physician Decision|0|||
33237429|NCT04529538|100772206|FG002|Overall Study|Protocol Deviation|0|||
33420865|NCT01682512|101431631|FG002|Overall Study|Primary lack of efficacy|7|||
33578146|NCT00742625|102006700|FG000|Remission Induction|Non protocol treatment|17|||
33578147|NCT00742625|102006700|FG000|Remission Induction|Other, not specified|5|||
33578148|NCT00742625|102006700|FG000|Consolidation|Progression|5|||
33578149|NCT00742625|102006700|FG000|Consolidation|Adverse Event|1|||
33578150|NCT00742625|102006700|FG000|Consolidation|Death|1|||
33578151|NCT00742625|102006700|FG000|Consolidation|Refused|1|||
33578152|NCT00742625|102006700|FG000|Consolidation|Non protocol therapy|13|||
33578153|NCT01490918|102006717|FG000|Overall Study|Lost to Follow-up|2|||
33578154|NCT01490918|102006718|FG001|Overall Study|Lost to Follow-up|1|||
33578155|NCT01490918|102006719|FG002|Overall Study|Lost to Follow-up|0|||
33578156|NCT01490918|102006717|FG000|Overall Study|Withdrawal by Subject|7|||
33578157|NCT01490918|102006718|FG001|Overall Study|Withdrawal by Subject|8|||
33578158|NCT01490918|102006719|FG002|Overall Study|Withdrawal by Subject|3|||
33578159|NCT01490918|102006717|FG000|Overall Study|Adverse Event|0|||
33578160|NCT01490918|102006718|FG001|Overall Study|Adverse Event|0|||
33578161|NCT01490918|102006719|FG002|Overall Study|Adverse Event|1|||
33578162|NCT01490918|102006717|FG000|Overall Study|other cause|4|||
33578163|NCT01490918|102006718|FG001|Overall Study|other cause|5|||
33578164|NCT01490918|102006719|FG002|Overall Study|other cause|8|||
33638207|NCT01208207|102226000|FG005|Part I|Physician Decision|0|||
33638208|NCT01208207|102226001|FG006|Part I|Physician Decision|0|||
33638209|NCT01208207|102225995|FG000|Part I|Progressive Disease|1|||
33638210|NCT01208207|102225996|FG001|Part I|Progressive Disease|0|||
33638211|NCT01208207|102225997|FG002|Part I|Progressive Disease|0|||
33638212|NCT01208207|102225998|FG003|Part I|Progressive Disease|0|||
33638213|NCT01208207|102225999|FG004|Part I|Progressive Disease|0|||
33139479|NCT00322621|100423979|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
33139480|NCT00322621|100423980|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
33139481|NCT00322621|100423978|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
33139482|NCT00322621|100423979|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
33578165|NCT01908140|102006720|FG000|Overall Study|Other or Progressive Disease|5|||
33139483|NCT00322621|100423980|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
33139484|NCT00322621|100423978|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
33139485|NCT00322621|100423979|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
33237430|NCT04529538|100772207|FG003|Overall Study|Protocol Deviation|1|||
33237431|NCT04529538|100772208|FG004|Overall Study|Protocol Deviation|0|||
33237432|NCT04529538|100772209|FG005|Overall Study|Protocol Deviation|0|||
33237433|NCT04529538|100772210|FG006|Overall Study|Protocol Deviation|0|||
33237434|NCT04529538|100772211|FG007|Overall Study|Protocol Deviation|0|||
33237435|NCT04529538|100772204|FG000|Overall Study|Physician Decision|0|||
33237436|NCT04529538|100772205|FG001|Overall Study|Physician Decision|0|||
33237437|NCT04529538|100772206|FG002|Overall Study|Physician Decision|0|||
33237438|NCT04529538|100772207|FG003|Overall Study|Physician Decision|0|||
33237439|NCT04529538|100772208|FG004|Overall Study|Physician Decision|0|||
33237440|NCT04529538|100772209|FG005|Overall Study|Physician Decision|1|||
33237441|NCT04529538|100772210|FG006|Overall Study|Physician Decision|0|||
33237442|NCT04529538|100772211|FG007|Overall Study|Physician Decision|1|||
33237443|NCT02059161|100772212|FG000|Overall Study|Pregnancy|0|||
33237444|NCT02059161|100772213|FG001|Overall Study|Pregnancy|2|||
33237445|NCT02059161|100772212|FG000|Overall Study|Adverse Event|2|||
33237446|NCT02059161|100772213|FG001|Overall Study|Adverse Event|6|||
33237447|NCT02059161|100772212|FG000|Overall Study|Lost to Follow-up|20|||
33237448|NCT02059161|100772213|FG001|Overall Study|Lost to Follow-up|12|||
33237449|NCT02059161|100772212|FG000|Overall Study|Physician Decision|4|||
33237450|NCT02059161|100772213|FG001|Overall Study|Physician Decision|4|||
33237451|NCT02059161|100772212|FG000|Overall Study|Protocol Violation|1|||
33237452|NCT02059161|100772213|FG001|Overall Study|Protocol Violation|1|||
33369384|NCT00740779|101236676|FG002|Overall Study|Withdrawal by Subject|2|||
33369385|NCT00740779|101236674|FG000|Overall Study|Lost to Follow-up|2|||
33369386|NCT00740779|101236675|FG001|Overall Study|Lost to Follow-up|3|||
33369387|NCT00740779|101236676|FG002|Overall Study|Lost to Follow-up|5|||
33139486|NCT00322621|100423980|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
33369388|NCT04095286|101236677|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33369389|NCT04095286|101236678|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
33369390|NCT04095286|101236679|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33237453|NCT02059161|100772212|FG000|Overall Study|Withdrawal by Subject|16|||
33237454|NCT02059161|100772213|FG001|Overall Study|Withdrawal by Subject|13|||
33369391|NCT04095286|101236680|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33578166|NCT01908140|102006721|FG001|Overall Study|Other or Progressive Disease|12|||
33237455|NCT02059161|100772212|FG000|Overall Study|Randomized in error, no study drug|0|||
33237456|NCT02059161|100772213|FG001|Overall Study|Randomized in error, no study drug|1|||
33578167|NCT01908140|102006720|FG000|Overall Study|Lack of Efficacy|7|||
33578168|NCT01908140|102006721|FG001|Overall Study|Lack of Efficacy|5|||
33578169|NCT01908140|102006720|FG000|Overall Study|Withdrawal by Subject|23|||
33578170|NCT01908140|102006721|FG001|Overall Study|Withdrawal by Subject|24|||
33638214|NCT01208207|102226000|FG005|Part I|Progressive Disease|0|||
33638215|NCT01208207|102226001|FG006|Part I|Progressive Disease|0|||
33237457|NCT02059161|100772212|FG000|Overall Study|Non-compliance with study drug|6|||
33237458|NCT02059161|100772213|FG001|Overall Study|Non-compliance with study drug|2|||
33237459|NCT02501811|100772214|FG000|Overall Study|Death|1|||
33237460|NCT02501811|100772215|FG001|Overall Study|Death|3|||
33237461|NCT02501811|100772216|FG002|Overall Study|Death|2|||
33237462|NCT02501811|100772217|FG003|Overall Study|Death|3|||
33237463|NCT02501811|100772214|FG000|Overall Study|Withdrawal by Subject|3|||
33237464|NCT02501811|100772215|FG001|Overall Study|Withdrawal by Subject|3|||
33237465|NCT02501811|100772216|FG002|Overall Study|Withdrawal by Subject|2|||
33237466|NCT02501811|100772217|FG003|Overall Study|Withdrawal by Subject|3|||
33237467|NCT02501811|100772214|FG000|Overall Study|Lost to Follow-up|0|||
33237468|NCT02501811|100772215|FG001|Overall Study|Lost to Follow-up|0|||
33237469|NCT02501811|100772216|FG002|Overall Study|Lost to Follow-up|2|||
33237470|NCT02501811|100772217|FG003|Overall Study|Lost to Follow-up|1|||
33237471|NCT00235495|100772218|FG000|Overall Study|Death|52|||
33237472|NCT00235495|100772219|FG001|Overall Study|Death|42|||
33237473|NCT00235495|100772218|FG000|Overall Study|Withdrawal by Subject|5|||
33237474|NCT00235495|100772219|FG001|Overall Study|Withdrawal by Subject|3|||
33578171|NCT01908140|102006720|FG000|Overall Study|Lost to Follow-up|1|||
33578172|NCT01908140|102006721|FG001|Overall Study|Lost to Follow-up|6|||
33578173|NCT01908140|102006720|FG000|Overall Study|Protocol Violation|8|||
33578174|NCT01908140|102006721|FG001|Overall Study|Protocol Violation|9|||
33578175|NCT01908140|102006720|FG000|Overall Study|Adverse Event|22|||
33578176|NCT01908140|102006721|FG001|Overall Study|Adverse Event|23|||
33578177|NCT00616642|102006722|FG000|Overall Study|Withdrawal by Subject|0|||
33578178|NCT00616642|102006723|FG001|Overall Study|Withdrawal by Subject|1|||
33578179|NCT03801928|102006724|FG000|Overall Study|Adverse Event|1|||
33578180|NCT03801928|102006725|FG001|Overall Study|Adverse Event|0|||
33578181|NCT03801928|102006726|FG002|Overall Study|Adverse Event|1|||
33578182|NCT03801928|102006727|FG003|Overall Study|Adverse Event|2|||
33578183|NCT03801928|102006728|FG004|Overall Study|Adverse Event|0|||
33578184|NCT03801928|102006729|FG005|Overall Study|Adverse Event|2|||
33578185|NCT03801928|102006724|FG000|Overall Study|Lack of Efficacy|0|||
33578186|NCT03801928|102006725|FG001|Overall Study|Lack of Efficacy|0|||
33578187|NCT03801928|102006726|FG002|Overall Study|Lack of Efficacy|1|||
33578188|NCT03801928|102006727|FG003|Overall Study|Lack of Efficacy|0|||
33578189|NCT03801928|102006728|FG004|Overall Study|Lack of Efficacy|0|||
33578190|NCT03801928|102006729|FG005|Overall Study|Lack of Efficacy|0|||
33578191|NCT03801928|102006724|FG000|Overall Study|Lost to Follow-up|5|||
33578192|NCT03801928|102006725|FG001|Overall Study|Lost to Follow-up|1|||
33578193|NCT03801928|102006726|FG002|Overall Study|Lost to Follow-up|1|||
33578194|NCT03801928|102006727|FG003|Overall Study|Lost to Follow-up|4|||
33578195|NCT03801928|102006728|FG004|Overall Study|Lost to Follow-up|4|||
33578196|NCT03801928|102006729|FG005|Overall Study|Lost to Follow-up|2|||
33578197|NCT03801928|102006724|FG000|Overall Study|Withdrawal by Subject|0|||
33578198|NCT03801928|102006725|FG001|Overall Study|Withdrawal by Subject|0|||
33578199|NCT03801928|102006726|FG002|Overall Study|Withdrawal by Subject|2|||
33578200|NCT03801928|102006727|FG003|Overall Study|Withdrawal by Subject|1|||
33578201|NCT03801928|102006728|FG004|Overall Study|Withdrawal by Subject|0|||
33578202|NCT03801928|102006729|FG005|Overall Study|Withdrawal by Subject|0|||
33578203|NCT03801928|102006724|FG000|Overall Study|Other|0|||
33578204|NCT03801928|102006725|FG001|Overall Study|Other|2|||
33578205|NCT03801928|102006726|FG002|Overall Study|Other|0|||
33578206|NCT03801928|102006727|FG003|Overall Study|Other|1|||
33578207|NCT03801928|102006728|FG004|Overall Study|Other|0|||
33578208|NCT03801928|102006729|FG005|Overall Study|Other|1|||
33578209|NCT04389866|102006731|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
33578210|NCT04389866|102006732|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
33578211|NCT04846231|102006733|FG000|Overall Study|Lost to Follow-up|1|||
33578212|NCT04846231|102006734|FG001|Overall Study|Lost to Follow-up|0|||
33578213|NCT04846231|102006735|FG002|Overall Study|Lost to Follow-up|0|||
33578214|NCT04846231|102006736|FG003|Overall Study|Lost to Follow-up|0|||
33578215|NCT04846231|102006737|FG004|Overall Study|Lost to Follow-up|0|||
33578216|NCT04846231|102006738|FG005|Overall Study|Lost to Follow-up|0|||
33578217|NCT04846231|102006739|FG006|Overall Study|Lost to Follow-up|0|||
33578218|NCT04846231|102006740|FG007|Overall Study|Lost to Follow-up|1|||
33578219|NCT04846231|102006733|FG000|Overall Study|Withdrawal by Subject|0|||
33578220|NCT04846231|102006734|FG001|Overall Study|Withdrawal by Subject|1|||
33578221|NCT04846231|102006735|FG002|Overall Study|Withdrawal by Subject|2|||
33139487|NCT00770146|100423984|FG000|Treatment Period|Withdrawal by Subject|6|||
33139488|NCT00770146|100423985|FG001|Treatment Period|Withdrawal by Subject|13|||
33237475|NCT00235495|100772218|FG000|Overall Study|Lost to Follow-up|11|||
33578222|NCT04846231|102006736|FG003|Overall Study|Withdrawal by Subject|1|||
33237476|NCT00235495|100772219|FG001|Overall Study|Lost to Follow-up|13|||
33237477|NCT00235495|100772218|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
33578223|NCT04846231|102006737|FG004|Overall Study|Withdrawal by Subject|0|||
33638216|NCT01208207|102225995|FG000|Part I|Protocol Violation|8|||
33578224|NCT04846231|102006738|FG005|Overall Study|Withdrawal by Subject|0|||
33578225|NCT04846231|102006739|FG006|Overall Study|Withdrawal by Subject|0|||
33237478|NCT00235495|100772219|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
33237479|NCT00701311|100772220|FG000|Overall Study|Lack of Efficacy|3|||
33237480|NCT00701311|100772220|FG000|Overall Study|Adverse Event|3|||
33237481|NCT00701311|100772220|FG000|Overall Study|Withdrawal by Subject|2|||
33237482|NCT01871285|100772221|FG000|First Intervention (1 Day)|Adverse Event|1|||
33237483|NCT01871285|100772222|FG001|First Intervention (1 Day)|Adverse Event|0|||
33237484|NCT01871285|100772223|FG002|First Intervention (1 Day)|Adverse Event|0|||
33237485|NCT01871285|100772224|FG003|First Intervention (1 Day)|Adverse Event|0|||
33237486|NCT01871285|100772221|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
33237487|NCT01871285|100772222|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
33237488|NCT01871285|100772223|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
33237489|NCT01871285|100772224|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
33237490|NCT00647348|100772225|FG000|Overall Study|Lost to Follow-up|3|||
33237491|NCT00647348|100772226|FG001|Overall Study|Lost to Follow-up|6|||
33237492|NCT00329719|100772227|FG000|Overall Study|Lost to Follow-up|0|||
33237493|NCT00329719|100772228|FG001|Overall Study|Lost to Follow-up|0|||
33237494|NCT00329719|100772229|FG002|Overall Study|Lost to Follow-up|0|||
33237495|NCT00329719|100772230|FG003|Overall Study|Lost to Follow-up|1|||
33237496|NCT01625910|100772233|FG000|Overall Study|Lost to Follow-up|3|||
33237497|NCT01625910|100772234|FG001|Overall Study|Lost to Follow-up|4|||
33237498|NCT01813422|100772235|FG000|Overall Study|Withdrawal by Subject|14|||
33237499|NCT01813422|100772236|FG001|Overall Study|Withdrawal by Subject|8|||
33237500|NCT01813422|100772235|FG000|Overall Study|Death|2|||
33237501|NCT01813422|100772236|FG001|Overall Study|Death|3|||
33237502|NCT01813422|100772235|FG000|Overall Study|Sponsor Decision|2|||
33237503|NCT01813422|100772236|FG001|Overall Study|Sponsor Decision|1|||
33237504|NCT01813422|100772235|FG000|Overall Study|Lost to Follow-up|2|||
33237505|NCT01813422|100772236|FG001|Overall Study|Lost to Follow-up|4|||
33237506|NCT01925170|100772238|FG000|Overall Study|Unverified cancer status|53|||
33237507|NCT01646320|100772239|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
33237508|NCT01646320|100772240|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
33237509|NCT01646320|100772239|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
33237510|NCT01646320|100772240|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
33237511|NCT01646320|100772239|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
33237512|NCT01646320|100772240|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
33237513|NCT01646320|100772239|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
33237514|NCT01646320|100772240|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
33237515|NCT01646320|100772239|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
33237516|NCT01646320|100772240|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
33237517|NCT01646320|100772239|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
33237518|NCT01646320|100772240|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
33237519|NCT01646320|100772239|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
33237520|NCT01646320|100772240|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
33237521|NCT01646320|100772239|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
33237522|NCT01646320|100772240|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
33237523|NCT01646320|100772239|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
33237524|NCT01646320|100772240|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
33237525|NCT01646320|100772239|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
33237526|NCT01646320|100772240|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
33237527|NCT01646320|100772239|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
33237528|NCT01646320|100772240|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
33237529|NCT01656759|100772241|FG000|Overall Study|Protocol Violation|2|||
33237530|NCT01656759|100772242|FG001|Overall Study|Protocol Violation|3|||
33237531|NCT00372528|100772246|FG000|Overall Study|Lack of Efficacy|1|||
33237532|NCT00372528|100772246|FG000|Overall Study|Adverse Event|1|||
33237533|NCT00372528|100772246|FG000|Overall Study|Study Terminated by Sponsor|18|||
33237534|NCT00372528|100772246|FG000|Overall Study|Other|1|||
33237535|NCT00965484|100772247|FG000|Overall Study|Protocol Violation|1|||
33237536|NCT00965484|100772247|FG000|Overall Study|Withdrawal by Subject|1|||
33237537|NCT02819479|100772248|FG000|Overall Study|Adverse Event|2|||
33237538|NCT03285711|100772266|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
33237539|NCT03285711|100772267|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
33237540|NCT03285711|100772268|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
33237541|NCT03285711|100772269|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
33237542|NCT03285711|100772266|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
33237543|NCT03285711|100772267|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
33237544|NCT03285711|100772268|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
33237545|NCT03285711|100772269|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
33237546|NCT03285711|100772266|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
33237547|NCT03285711|100772267|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
33237548|NCT03285711|100772268|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
33237549|NCT03285711|100772269|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
33237550|NCT03285711|100772266|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
33237551|NCT03285711|100772267|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
33237552|NCT03285711|100772268|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
33237553|NCT03285711|100772269|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
33237554|NCT01158378|100772270|FG000|Overall Study|Death|4|||
33237555|NCT01158378|100772271|FG001|Overall Study|Death|5|||
33237556|NCT01158378|100772270|FG000|Overall Study|Lost to Follow-up|2|||
33237557|NCT01158378|100772271|FG001|Overall Study|Lost to Follow-up|4|||
33237558|NCT01158378|100772270|FG000|Overall Study|Withdrawal by Subject|4|||
33237559|NCT01158378|100772271|FG001|Overall Study|Withdrawal by Subject|0|||
33237560|NCT04496167|100772272|FG000|Overall Study|Adverse Event|6|||
33237561|NCT04496167|100772273|FG001|Overall Study|Adverse Event|2|||
33237562|NCT04496167|100772272|FG000|Overall Study|Withdrawal by Subject|7|||
33237563|NCT04496167|100772273|FG001|Overall Study|Withdrawal by Subject|6|||
33237564|NCT04496167|100772272|FG000|Overall Study|Lost to Follow-up|3|||
33237565|NCT04496167|100772273|FG001|Overall Study|Lost to Follow-up|5|||
33237566|NCT04496167|100772272|FG000|Overall Study|Not Treated|1|||
33237567|NCT04496167|100772273|FG001|Overall Study|Not Treated|2|||
33578226|NCT04846231|102006740|FG007|Overall Study|Withdrawal by Subject|0|||
33578227|NCT04846231|102006733|FG000|Overall Study|Protocol Violation|0|||
33578228|NCT04846231|102006734|FG001|Overall Study|Protocol Violation|1|||
33638217|NCT01208207|102225996|FG001|Part I|Protocol Violation|0|||
33638218|NCT01208207|102225997|FG002|Part I|Protocol Violation|2|||
33638219|NCT01208207|102225998|FG003|Part I|Protocol Violation|0|||
33638220|NCT01208207|102225999|FG004|Part I|Protocol Violation|0|||
33638221|NCT01208207|102226000|FG005|Part I|Protocol Violation|0|||
33638222|NCT01208207|102226001|FG006|Part I|Protocol Violation|0|||
33638223|NCT01208207|102225995|FG000|Part I|Withdrawal by Subject|14|||
33638224|NCT01208207|102225996|FG001|Part I|Withdrawal by Subject|4|||
33638225|NCT01208207|102225997|FG002|Part I|Withdrawal by Subject|4|||
33638226|NCT01208207|102225998|FG003|Part I|Withdrawal by Subject|0|||
33638227|NCT01208207|102225999|FG004|Part I|Withdrawal by Subject|0|||
33638228|NCT01208207|102226000|FG005|Part I|Withdrawal by Subject|0|||
33638229|NCT01208207|102226001|FG006|Part I|Withdrawal by Subject|0|||
33638230|NCT01208207|102225995|FG000|Part II|Withdrawal by Subject|0|||
33638231|NCT01208207|102225996|FG001|Part II|Withdrawal by Subject|0|||
33638232|NCT01208207|102225997|FG002|Part II|Withdrawal by Subject|0|||
33638233|NCT01208207|102225998|FG003|Part II|Withdrawal by Subject|10|||
33638234|NCT01208207|102225999|FG004|Part II|Withdrawal by Subject|9|||
33638235|NCT01208207|102226000|FG005|Part II|Withdrawal by Subject|3|||
33638236|NCT01208207|102226001|FG006|Part II|Withdrawal by Subject|5|||
33638237|NCT01208207|102225995|FG000|Part II|Adverse Event|0|||
33638238|NCT01208207|102225996|FG001|Part II|Adverse Event|0|||
33638239|NCT01208207|102225997|FG002|Part II|Adverse Event|0|||
33578229|NCT04846231|102006735|FG002|Overall Study|Protocol Violation|0|||
33578230|NCT04846231|102006736|FG003|Overall Study|Protocol Violation|0|||
33578231|NCT04846231|102006737|FG004|Overall Study|Protocol Violation|0|||
33578232|NCT04846231|102006738|FG005|Overall Study|Protocol Violation|0|||
33578233|NCT04846231|102006739|FG006|Overall Study|Protocol Violation|0|||
33578234|NCT04846231|102006740|FG007|Overall Study|Protocol Violation|0|||
33578235|NCT04846231|102006733|FG000|Overall Study|Adverse Event|0|||
33578236|NCT04846231|102006734|FG001|Overall Study|Adverse Event|0|||
33578237|NCT04846231|102006735|FG002|Overall Study|Adverse Event|0|||
33578238|NCT04846231|102006736|FG003|Overall Study|Adverse Event|0|||
33578239|NCT04846231|102006737|FG004|Overall Study|Adverse Event|0|||
33578240|NCT04846231|102006738|FG005|Overall Study|Adverse Event|0|||
33578241|NCT04846231|102006739|FG006|Overall Study|Adverse Event|1|||
33578242|NCT04846231|102006740|FG007|Overall Study|Adverse Event|1|||
33578243|NCT01182298|102006741|FG000|Overall Study|Lack of Efficacy|4|||
33578244|NCT01182298|102006741|FG000|Overall Study|Withdrawal by Subject|2|||
33578245|NCT00374595|102006742|FG000|Overall Study|Death|23|||
33578246|NCT00374595|102006742|FG000|Overall Study|Withdrawal by Subject|39|||
33578247|NCT00374595|102006742|FG000|Overall Study|Lost to Follow-up|3|||
33578248|NCT00374595|102006742|FG000|Overall Study|too much time commitment|1|||
33638240|NCT01208207|102225998|FG003|Part II|Adverse Event|5|||
33638241|NCT01208207|102225999|FG004|Part II|Adverse Event|9|||
33638242|NCT01208207|102226000|FG005|Part II|Adverse Event|4|||
33638243|NCT01208207|102226001|FG006|Part II|Adverse Event|2|||
33638244|NCT01208207|102225995|FG000|Part II|Lack of Efficacy|0|||
33237568|NCT04496167|100772272|FG000|Overall Study|Other Than Specified|1|||
33237569|NCT04496167|100772273|FG001|Overall Study|Other Than Specified|1|||
33237570|NCT01152554|100772274|FG000|Overall Study|Withdrawal by Subject|73|||
33237571|NCT01152554|100772275|FG001|Overall Study|Withdrawal by Subject|28|||
33578249|NCT00374595|102006742|FG000|Overall Study|transfer care to other clinical site|1|||
33578250|NCT00374595|102006742|FG000|Overall Study|relocation|3|||
33638245|NCT01208207|102225996|FG001|Part II|Lack of Efficacy|0|||
33638246|NCT01208207|102225997|FG002|Part II|Lack of Efficacy|0|||
33638247|NCT01208207|102225998|FG003|Part II|Lack of Efficacy|6|||
33638248|NCT01208207|102225999|FG004|Part II|Lack of Efficacy|4|||
33638249|NCT01208207|102226000|FG005|Part II|Lack of Efficacy|3|||
33638250|NCT01208207|102226001|FG006|Part II|Lack of Efficacy|3|||
33139489|NCT00770146|100423984|FG000|Treatment Period|Adverse Event|2|||
33139490|NCT00770146|100423985|FG001|Treatment Period|Adverse Event|26|||
33139491|NCT00770146|100423984|FG000|Treatment Period|Other|1|||
33139492|NCT00770146|100423985|FG001|Treatment Period|Other|5|||
33139493|NCT00770146|100423984|FG000|Treatment Period|Protocol non-compliance|0|||
33139494|NCT00770146|100423985|FG001|Treatment Period|Protocol non-compliance|1|||
33139495|NCT00770146|100423984|FG000|Follow-up Period|Withdrawal by Subject|7|||
33237572|NCT01152554|100772274|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
33237573|NCT01152554|100772275|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
33237574|NCT01152554|100772274|FG000|Overall Study|Adverse Event|67|||
33237575|NCT01152554|100772275|FG001|Overall Study|Adverse Event|14|||
33237576|NCT01152554|100772274|FG000|Overall Study|Severe non-compliance to protocol|36|||
33237577|NCT01152554|100772275|FG001|Overall Study|Severe non-compliance to protocol|14|||
33237578|NCT01152554|100772274|FG000|Overall Study|Condition under investigation worsened|5|||
33237579|NCT01152554|100772275|FG001|Overall Study|Condition under investigation worsened|2|||
33237580|NCT01152554|100772274|FG000|Overall Study|Lack of Efficacy|20|||
33237581|NCT01152554|100772275|FG001|Overall Study|Lack of Efficacy|3|||
33237582|NCT01152554|100772274|FG000|Overall Study|Study-specific withdrawal criteria|17|||
33237583|NCT01152554|100772275|FG001|Overall Study|Study-specific withdrawal criteria|8|||
33237584|NCT01152554|100772274|FG000|Overall Study|Lost to Follow-up|87|||
33237585|NCT01152554|100772275|FG001|Overall Study|Lost to Follow-up|32|||
33237586|NCT01152554|100772274|FG000|Overall Study|Other|28|||
33237587|NCT01152554|100772275|FG001|Overall Study|Other|8|||
33237588|NCT01152554|100772274|FG000|Overall Study|Death|1|||
33237589|NCT01152554|100772275|FG001|Overall Study|Death|1|||
33420866|NCT01682512|101431629|FG000|Overall Study|Secondary lack of efficacy|1|||
33420867|NCT01682512|101431630|FG001|Overall Study|Secondary lack of efficacy|1|||
33420868|NCT01682512|101431631|FG002|Overall Study|Secondary lack of efficacy|0|||
33578251|NCT04339413|102006743|FG000|Overall Study|Reason Not Specified|2|||
33578252|NCT04339413|102006744|FG001|Overall Study|Reason Not Specified|7|||
33578253|NCT04339413|102006743|FG000|Overall Study|Study Terminated by Sponsor|30|||
33578254|NCT04339413|102006744|FG001|Overall Study|Study Terminated by Sponsor|33|||
33578255|NCT04339413|102006743|FG000|Overall Study|Progressive Disease|9|||
33578256|NCT04339413|102006744|FG001|Overall Study|Progressive Disease|6|||
33578257|NCT04339413|102006743|FG000|Overall Study|Withdrawal by Subject|9|||
33578258|NCT04339413|102006744|FG001|Overall Study|Withdrawal by Subject|10|||
33578259|NCT04339413|102006743|FG000|Overall Study|Physician Decision|3|||
33578260|NCT04339413|102006744|FG001|Overall Study|Physician Decision|1|||
33578261|NCT04339413|102006743|FG000|Overall Study|Death|2|||
33578262|NCT04339413|102006744|FG001|Overall Study|Death|0|||
33578263|NCT04339413|102006743|FG000|Overall Study|Adverse Event|3|||
33578264|NCT04339413|102006744|FG001|Overall Study|Adverse Event|0|||
33578265|NCT02580877|102006745|FG000|Overall Study|Withdrawal by Subject|1|||
33578266|NCT02580877|102006746|FG001|Overall Study|Withdrawal by Subject|3|||
33578267|NCT02580877|102006745|FG000|Overall Study|Adverse Event|0|||
33578268|NCT02580877|102006746|FG001|Overall Study|Adverse Event|1|||
33578269|NCT01881789|102006747|FG000|Overall Study|Withdrawal by Subject|0|||
33578270|NCT01881789|102006748|FG001|Overall Study|Withdrawal by Subject|2|||
33578271|NCT01881789|102006749|FG002|Overall Study|Withdrawal by Subject|1|||
33578272|NCT01881789|102006750|FG003|Overall Study|Withdrawal by Subject|0|||
33578273|NCT01881789|102006751|FG004|Overall Study|Withdrawal by Subject|1|||
33578274|NCT01881789|102006752|FG005|Overall Study|Withdrawal by Subject|1|||
33578275|NCT01881789|102006747|FG000|Overall Study|Study Terminated by Sponsor|0|||
33578276|NCT01881789|102006748|FG001|Overall Study|Study Terminated by Sponsor|0|||
33578277|NCT01881789|102006749|FG002|Overall Study|Study Terminated by Sponsor|0|||
33578278|NCT01881789|102006750|FG003|Overall Study|Study Terminated by Sponsor|0|||
33578279|NCT01881789|102006751|FG004|Overall Study|Study Terminated by Sponsor|0|||
33578280|NCT01881789|102006752|FG005|Overall Study|Study Terminated by Sponsor|1|||
33578281|NCT01881789|102006747|FG000|Overall Study|Other|3|||
33578282|NCT01881789|102006748|FG001|Overall Study|Other|5|||
33578283|NCT01881789|102006749|FG002|Overall Study|Other|2|||
33578284|NCT01881789|102006750|FG003|Overall Study|Other|3|||
33578285|NCT01881789|102006751|FG004|Overall Study|Other|1|||
33578286|NCT01881789|102006752|FG005|Overall Study|Other|1|||
33578287|NCT02240121|102009448|FG000|Overall Study|Protocol Violation|1|||
33578288|NCT02240121|102009449|FG001|Overall Study|Protocol Violation|2|||
33578289|NCT02240121|102009448|FG000|Overall Study|Physician Decision|0|||
33139496|NCT00770146|100423985|FG001|Follow-up Period|Withdrawal by Subject|13|||
33237590|NCT01244763|100772276|FG000|Overall Study|Adverse Event|1|||
33237591|NCT01244763|100772277|FG001|Overall Study|Adverse Event|0|||
33237592|NCT01244763|100772278|FG002|Overall Study|Adverse Event|0|||
33420869|NCT01682512|101431629|FG000|Overall Study|Other than stated above|2|||
33578290|NCT02240121|102009449|FG001|Overall Study|Physician Decision|1|||
33578291|NCT02240121|102009448|FG000|Overall Study|Change in protocol interpretation|1|||
33578292|NCT02240121|102009449|FG001|Overall Study|Change in protocol interpretation|0|||
33578293|NCT02240121|102009448|FG000|Overall Study|Lack of Efficacy|2|||
33578294|NCT02240121|102009449|FG001|Overall Study|Lack of Efficacy|3|||
33578295|NCT02240121|102009448|FG000|Overall Study|Site closed|1|||
33638251|NCT01208207|102225995|FG000|Part II|Lost to Follow-up|0|||
33638252|NCT01208207|102225996|FG001|Part II|Lost to Follow-up|0|||
33638253|NCT01208207|102225997|FG002|Part II|Lost to Follow-up|0|||
33638254|NCT01208207|102225998|FG003|Part II|Lost to Follow-up|4|||
33638255|NCT01208207|102225999|FG004|Part II|Lost to Follow-up|0|||
33638256|NCT01208207|102226000|FG005|Part II|Lost to Follow-up|2|||
33638257|NCT01208207|102226001|FG006|Part II|Lost to Follow-up|1|||
33638258|NCT01208207|102225995|FG000|Part II|Non-Compliance With Study Drug|0|||
33638259|NCT01208207|102225996|FG001|Part II|Non-Compliance With Study Drug|0|||
33638260|NCT01208207|102225997|FG002|Part II|Non-Compliance With Study Drug|0|||
33638261|NCT01208207|102225998|FG003|Part II|Non-Compliance With Study Drug|4|||
33369392|NCT04095286|101236681|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33369393|NCT04095286|101236682|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33369394|NCT04095286|101236677|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
33369395|NCT04095286|101236678|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
33369396|NCT04095286|101236679|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
33369397|NCT04095286|101236680|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
33369398|NCT04095286|101236681|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
33369399|NCT04095286|101236682|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
33369400|NCT04095286|101236677|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
33369401|NCT04095286|101236678|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
33369402|NCT04095286|101236679|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
33369403|NCT04095286|101236680|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
33369404|NCT04095286|101236681|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
33369405|NCT04095286|101236682|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
33369406|NCT04095286|101236677|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33369407|NCT04095286|101236678|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33369408|NCT04095286|101236679|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
33369409|NCT04095286|101236680|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33369410|NCT04095286|101236681|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33369411|NCT04095286|101236682|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
33369412|NCT04095286|101236677|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
33369413|NCT04095286|101236678|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
33369414|NCT04095286|101236679|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
33369415|NCT04095286|101236680|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
33369416|NCT04095286|101236681|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
33578296|NCT02240121|102009449|FG001|Overall Study|Site closed|1|||
33578297|NCT02240121|102009448|FG000|Overall Study|Pregnancy|1|||
33578298|NCT02240121|102009449|FG001|Overall Study|Pregnancy|0|||
33578299|NCT02240121|102009448|FG000|Overall Study|Adverse Event|2|||
33578300|NCT02240121|102009449|FG001|Overall Study|Adverse Event|4|||
33578301|NCT02240121|102009448|FG000|Overall Study|Withdrawal by Subject|6|||
33578302|NCT02240121|102009449|FG001|Overall Study|Withdrawal by Subject|2|||
33638262|NCT01208207|102225999|FG004|Part II|Non-Compliance With Study Drug|1|||
33638263|NCT01208207|102226000|FG005|Part II|Non-Compliance With Study Drug|1|||
33638264|NCT01208207|102226001|FG006|Part II|Non-Compliance With Study Drug|0|||
33638265|NCT01208207|102225995|FG000|Part II|Physician Decision|0|||
33638266|NCT01208207|102225996|FG001|Part II|Physician Decision|0|||
33638267|NCT01208207|102225997|FG002|Part II|Physician Decision|0|||
33638268|NCT01208207|102225998|FG003|Part II|Physician Decision|1|||
33638269|NCT01208207|102225999|FG004|Part II|Physician Decision|0|||
33638270|NCT01208207|102226000|FG005|Part II|Physician Decision|2|||
33638271|NCT01208207|102226001|FG006|Part II|Physician Decision|0|||
33638272|NCT01208207|102225995|FG000|Part II|Protocol Violation|0|||
33638273|NCT01208207|102225996|FG001|Part II|Protocol Violation|0|||
33638274|NCT01208207|102225997|FG002|Part II|Protocol Violation|0|||
33638275|NCT01208207|102225998|FG003|Part II|Protocol Violation|1|||
33638276|NCT01208207|102225999|FG004|Part II|Protocol Violation|0|||
33638277|NCT01208207|102226000|FG005|Part II|Protocol Violation|0|||
33638278|NCT01208207|102226001|FG006|Part II|Protocol Violation|0|||
33638279|NCT01208207|102225995|FG000|Part II|Technical Problems|0|||
33139497|NCT00770146|100423984|FG000|Follow-up Period|Adverse Event|0|||
33139498|NCT00770146|100423985|FG001|Follow-up Period|Adverse Event|2|||
33139499|NCT00770146|100423984|FG000|Follow-up Period|Other|4|||
33578303|NCT02240121|102009448|FG000|Overall Study|Lost to Follow-up|3|||
33578304|NCT02240121|102009449|FG001|Overall Study|Lost to Follow-up|4|||
33638280|NCT01208207|102225996|FG001|Part II|Technical Problems|0|||
33638281|NCT01208207|102225997|FG002|Part II|Technical Problems|0|||
33638282|NCT01208207|102225998|FG003|Part II|Technical Problems|1|||
33638283|NCT01208207|102225999|FG004|Part II|Technical Problems|0|||
33638284|NCT01208207|102226000|FG005|Part II|Technical Problems|1|||
33638285|NCT01208207|102226001|FG006|Part II|Technical Problems|0|||
33638286|NCT02215252|102226002|FG000|Overall Study|Adverse Event|1|||
33638287|NCT02215252|102226003|FG001|Overall Study|Adverse Event|5|||
33638288|NCT02215252|102226004|FG002|Overall Study|Adverse Event|2|||
33638289|NCT02215252|102226002|FG000|Overall Study|Lost to Follow-up|0|||
33638290|NCT02215252|102226003|FG001|Overall Study|Lost to Follow-up|0|||
33638291|NCT02215252|102226004|FG002|Overall Study|Lost to Follow-up|1|||
33638292|NCT02215252|102226002|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
33638293|NCT02215252|102226003|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
33638294|NCT02215252|102226004|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
33638295|NCT02215252|102226002|FG000|Overall Study|Protocol Violation|0|||
33638296|NCT02215252|102226003|FG001|Overall Study|Protocol Violation|1|||
33638297|NCT02215252|102226004|FG002|Overall Study|Protocol Violation|0|||
33638298|NCT02215252|102226002|FG000|Overall Study|Withdrawal by Subject|1|||
33638299|NCT02215252|102226003|FG001|Overall Study|Withdrawal by Subject|0|||
33578305|NCT02240121|102009448|FG000|Overall Study|Other than specified|1|||
33578306|NCT02240121|102009449|FG001|Overall Study|Other than specified|3|||
33578307|NCT02625220|102009453|FG000|Overall Study|Adverse Event|2|||
33578308|NCT02625220|102009453|FG000|Overall Study|Lost to Follow-up|2|||
33578309|NCT02625220|102009453|FG000|Overall Study|Protocol Violation|1|||
33578310|NCT02625220|102009453|FG000|Overall Study|Study discontinued at site|2|||
33578311|NCT00570323|102009454|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
33578312|NCT00570323|102009455|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
33578313|NCT00570323|102009454|FG000|Started Treatment After Randomization|Protocol Violation|1|||
33578314|NCT00570323|102009455|FG001|Started Treatment After Randomization|Protocol Violation|0|||
33578315|NCT00570323|102009454|FG000|Started Treatment After Randomization|Physician Decision|1|||
33578316|NCT00570323|102009455|FG001|Started Treatment After Randomization|Physician Decision|0|||
33578317|NCT00570323|102009454|FG000|Complete Study After Start|Lost to Follow-up|0|||
33578318|NCT00570323|102009455|FG001|Complete Study After Start|Lost to Follow-up|1|||
33578319|NCT00570323|102009454|FG000|Complete Study After Start|Withdrawal by Subject|2|||
33578320|NCT00570323|102009455|FG001|Complete Study After Start|Withdrawal by Subject|0|||
33578321|NCT00570323|102009454|FG000|Complete Study After Start|Physician Decision|1|||
33578322|NCT00570323|102009455|FG001|Complete Study After Start|Physician Decision|0|||
33578323|NCT02311881|102009456|FG000|Overall Study|Did not meet the study criteria|2|||
33578324|NCT02311881|102009457|FG001|Overall Study|Did not meet the study criteria|2|||
33578325|NCT02311881|102009458|FG002|Overall Study|Did not meet the study criteria|0|||
33578326|NCT02311881|102009456|FG000|Overall Study|Adverse Event|7|||
33578327|NCT02311881|102009457|FG001|Overall Study|Adverse Event|15|||
33578328|NCT02311881|102009458|FG002|Overall Study|Adverse Event|8|||
33578329|NCT02311881|102009456|FG000|Overall Study|Lost to Follow-up|3|||
33638300|NCT02215252|102226004|FG002|Overall Study|Withdrawal by Subject|0|||
33638301|NCT02215252|102226002|FG000|Overall Study|Other|0|||
33638302|NCT02215252|102226003|FG001|Overall Study|Other|1|||
33638303|NCT02215252|102226004|FG002|Overall Study|Other|1|||
33638304|NCT02453321|102226005|FG000|Overall Study|Weakness|1|||
33638305|NCT02453321|102226006|FG001|Overall Study|Weakness|1|||
33638306|NCT02453321|102226007|FG002|Overall Study|Weakness|2|||
33638307|NCT02453321|102226005|FG000|Overall Study|Deep Venous Thrombosis|0|||
33638308|NCT02453321|102226006|FG001|Overall Study|Deep Venous Thrombosis|1|||
33638309|NCT02453321|102226007|FG002|Overall Study|Deep Venous Thrombosis|0|||
33638310|NCT01106690|102226043|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
33638311|NCT01106690|102226044|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
33638312|NCT01106690|102226045|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
33638313|NCT01106690|102226043|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
33638314|NCT01106690|102226044|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
33638315|NCT01106690|102226045|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
33638316|NCT01106690|102226043|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
33638317|NCT01106690|102226044|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
33638318|NCT01106690|102226045|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
33638319|NCT01106690|102226043|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
33638320|NCT01106690|102226044|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
33638321|NCT01106690|102226045|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
33638322|NCT01106690|102226043|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
33638323|NCT01106690|102226044|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
33139500|NCT00770146|100423985|FG001|Follow-up Period|Other|5|||
33369417|NCT04095286|101236682|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
33369418|NCT01087528|101236684|FG000|Overall Study|Withdrawal by Subject|1|||
33369419|NCT01087528|101236684|FG000|Overall Study|Incomplete CE procedure|6|||
33578330|NCT02311881|102009457|FG001|Overall Study|Lost to Follow-up|3|||
33578331|NCT02311881|102009458|FG002|Overall Study|Lost to Follow-up|2|||
33578332|NCT02311881|102009456|FG000|Overall Study|Protocol Violation|1|||
33638324|NCT01106690|102226045|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
33638325|NCT01106690|102226043|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33638326|NCT01106690|102226044|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
33638327|NCT01106690|102226045|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33139501|NCT02815280|100423989|FG000|Double-Blind Phase|Adverse Event|1|||
33139502|NCT02815280|100423990|FG001|Double-Blind Phase|Adverse Event|1|||
33139503|NCT02815280|100423989|FG000|Double-Blind Phase|Lost to Follow-up|10|||
33139504|NCT02815280|100423990|FG001|Double-Blind Phase|Lost to Follow-up|9|||
33139505|NCT02815280|100423989|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
33139506|NCT02815280|100423990|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
33139507|NCT02815280|100423989|FG000|Double-Blind Phase|Protocol Violation|2|||
33139508|NCT02815280|100423990|FG001|Double-Blind Phase|Protocol Violation|2|||
33139509|NCT02815280|100423989|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
33139510|NCT02815280|100423990|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
33369420|NCT01554956|101236685|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
33369421|NCT01554956|101236686|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
33369422|NCT01554956|101236687|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
33369423|NCT01554956|101236685|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
33369424|NCT01554956|101236686|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
33369425|NCT01554956|101236687|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
33369426|NCT01554956|101236685|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
33369427|NCT01554956|101236686|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
33369428|NCT01554956|101236687|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
33369429|NCT00883558|101236688|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
33369430|NCT00883558|101236689|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
33369431|NCT00883558|101236690|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
33369432|NCT00883558|101236688|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
33369433|NCT00883558|101236689|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
33369434|NCT00883558|101236690|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
33369435|NCT00883558|101236688|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
33369436|NCT00883558|101236689|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
33369437|NCT00883558|101236690|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
33578333|NCT02311881|102009457|FG001|Overall Study|Protocol Violation|2|||
33578334|NCT02311881|102009458|FG002|Overall Study|Protocol Violation|3|||
33578335|NCT02311881|102009456|FG000|Overall Study|Withdrawal of consent|14|||
33578336|NCT02311881|102009457|FG001|Overall Study|Withdrawal of consent|16|||
33578337|NCT02311881|102009458|FG002|Overall Study|Withdrawal of consent|17|||
33578338|NCT02311881|102009456|FG000|Overall Study|Other|0|||
33578339|NCT02311881|102009457|FG001|Overall Study|Other|0|||
33578340|NCT02311881|102009458|FG002|Overall Study|Other|1|||
33578341|NCT02311881|102009456|FG000|Overall Study|Lack of Efficacy|1|||
33578342|NCT02311881|102009457|FG001|Overall Study|Lack of Efficacy|2|||
33578343|NCT02311881|102009458|FG002|Overall Study|Lack of Efficacy|0|||
33578344|NCT02311881|102009456|FG000|Overall Study|Subject has border line pregnancy test|1|||
33578345|NCT02311881|102009457|FG001|Overall Study|Subject has border line pregnancy test|0|||
33578346|NCT02311881|102009458|FG002|Overall Study|Subject has border line pregnancy test|0|||
33578347|NCT02311881|102009456|FG000|Overall Study|Withdrawal by Subject|3|||
33578348|NCT02311881|102009457|FG001|Overall Study|Withdrawal by Subject|1|||
33578349|NCT02311881|102009458|FG002|Overall Study|Withdrawal by Subject|4|||
33578350|NCT02311881|102009456|FG000|Overall Study|Sponsor Decision|1|||
33578351|NCT02311881|102009457|FG001|Overall Study|Sponsor Decision|1|||
33578352|NCT02311881|102009458|FG002|Overall Study|Sponsor Decision|1|||
33578353|NCT02311881|102009456|FG000|Overall Study|Protocol Deviation|1|||
33578354|NCT02311881|102009457|FG001|Overall Study|Protocol Deviation|0|||
33578355|NCT02311881|102009458|FG002|Overall Study|Protocol Deviation|0|||
33578356|NCT02311881|102009456|FG000|Overall Study|Non-Compliance|1|||
33578357|NCT02311881|102009457|FG001|Overall Study|Non-Compliance|0|||
33578358|NCT02311881|102009458|FG002|Overall Study|Non-Compliance|2|||
33578359|NCT02311881|102009456|FG000|Overall Study|Physician Decision|0|||
33578360|NCT02311881|102009457|FG001|Overall Study|Physician Decision|0|||
33578361|NCT02311881|102009458|FG002|Overall Study|Physician Decision|1|||
33578362|NCT02311881|102009456|FG000|Overall Study|Medical Monitor Discretion|0|||
33578363|NCT02311881|102009457|FG001|Overall Study|Medical Monitor Discretion|0|||
33578364|NCT02311881|102009458|FG002|Overall Study|Medical Monitor Discretion|1|||
33578365|NCT02311881|102009456|FG000|Overall Study|Participant taking another medication|0|||
33578366|NCT02311881|102009457|FG001|Overall Study|Participant taking another medication|0|||
33578367|NCT02311881|102009458|FG002|Overall Study|Participant taking another medication|1|||
33578368|NCT02311881|102009456|FG000|Overall Study|Serious Adverse Event|0|||
33578369|NCT02311881|102009457|FG001|Overall Study|Serious Adverse Event|1|||
33578370|NCT02311881|102009458|FG002|Overall Study|Serious Adverse Event|0|||
33578371|NCT04179305|102009459|FG000|Overall Study|Death|1|||
33578372|NCT04179305|102009460|FG001|Overall Study|Death|1|||
33578373|NCT04179305|102009461|FG002|Overall Study|Death|0|||
33139511|NCT02815280|100423989|FG000|Open-Label Phase|Adverse Event|2|||
33578374|NCT04179305|102009462|FG003|Overall Study|Death|0|||
33638328|NCT01106690|102226043|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
33638329|NCT01106690|102226044|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
33638330|NCT01106690|102226045|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
33638331|NCT01106690|102226043|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
33638332|NCT01106690|102226044|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
33369438|NCT00883558|101236688|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
33369439|NCT00883558|101236689|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
33369440|NCT00883558|101236690|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
33369441|NCT00883558|101236688|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
33369442|NCT00883558|101236689|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
33369443|NCT00883558|101236690|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
33369444|NCT03382899|101236691|FG000|Overall Study|Ineligibility Determined|0|||
33369445|NCT03382899|101236692|FG001|Overall Study|Ineligibility Determined|1|||
33369446|NCT03382899|101236691|FG000|Overall Study|Lost to Follow-up|0|||
33369447|NCT03382899|101236692|FG001|Overall Study|Lost to Follow-up|1|||
33369448|NCT03382899|101236691|FG000|Overall Study|Sponsor's decision|31|||
33369449|NCT03382899|101236692|FG001|Overall Study|Sponsor's decision|28|||
33369450|NCT03382899|101236691|FG000|Overall Study|Withdrawal by Subject|0|||
33369451|NCT03382899|101236692|FG001|Overall Study|Withdrawal by Subject|5|||
33139512|NCT02815280|100423990|FG001|Open-Label Phase|Adverse Event|3|||
33139513|NCT02815280|100423989|FG000|Open-Label Phase|Lost to Follow-up|18|||
33139514|NCT02815280|100423990|FG001|Open-Label Phase|Lost to Follow-up|9|||
33139515|NCT02815280|100423989|FG000|Open-Label Phase|Withdrawal by Subject|33|||
33139516|NCT02815280|100423990|FG001|Open-Label Phase|Withdrawal by Subject|18|||
33139517|NCT02815280|100423989|FG000|Open-Label Phase|Protocol Violation|3|||
33139518|NCT02815280|100423990|FG001|Open-Label Phase|Protocol Violation|0|||
33139519|NCT02815280|100423989|FG000|Open-Label Phase|Administrative|26|||
33139520|NCT02815280|100423990|FG001|Open-Label Phase|Administrative|12|||
33369452|NCT01850563|101239770|FG000|Overall Study|Not eligible|3|||
33369453|NCT01850563|101239771|FG001|Overall Study|Not eligible|0|||
33369454|NCT01689207|101239772|FG000|Overall Study|Adverse Event|0|||
33369455|NCT01689207|101239773|FG001|Overall Study|Adverse Event|1|||
33369456|NCT01689207|101239774|FG002|Overall Study|Adverse Event|0|||
33369457|NCT01689207|101239775|FG003|Overall Study|Adverse Event|0|||
33369458|NCT01689207|101239776|FG004|Overall Study|Adverse Event|2|||
33369459|NCT01689207|101239777|FG005|Overall Study|Adverse Event|1|||
33369460|NCT01689207|101239778|FG006|Overall Study|Adverse Event|0|||
33369461|NCT01689207|101239779|FG007|Overall Study|Adverse Event|0|||
33638333|NCT01106690|102226045|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
33638334|NCT01106690|102226043|FG000|Core Period: Baseline to Week 26|Other|10|||
33638335|NCT01106690|102226044|FG001|Core Period: Baseline to Week 26|Other|2|||
33638336|NCT01106690|102226045|FG002|Core Period: Baseline to Week 26|Other|6|||
33638337|NCT01106690|102226043|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
33638338|NCT01106690|102226044|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
33638339|NCT01106690|102226045|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
33638340|NCT01106690|102226043|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33638341|NCT01106690|102226044|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
33638342|NCT01106690|102226045|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
33638343|NCT01106690|102226043|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33139521|NCT02815280|100423989|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
33139522|NCT02815280|100423990|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
33369462|NCT01689207|101239780|FG008|Overall Study|Adverse Event|1|||
33369463|NCT01689207|101239781|FG009|Overall Study|Adverse Event|0|||
33369464|NCT01689207|101239782|FG010|Overall Study|Adverse Event|0|||
33369465|NCT00488033|101239786|FG000|Overall Study|Withdrawal by Subject|1|||
33638344|NCT01106690|102226044|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
33638345|NCT01106690|102226045|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
33638346|NCT01106690|102226043|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
33638347|NCT01106690|102226044|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
33638348|NCT01106690|102226045|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
33638349|NCT01106690|102226043|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
33638350|NCT01106690|102226044|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
33139523|NCT01954927|100423991|FG000|Overall Study|Withdrawal by Subject|3|||
33139524|NCT01954927|100423992|FG001|Overall Study|Withdrawal by Subject|1|||
33139525|NCT02984943|100423993|FG000|Overall Study|Withdrawal by Subject|3|||
33369466|NCT00488033|101239787|FG001|Overall Study|Withdrawal by Subject|0|||
33369467|NCT00257192|101239788|FG000|Overall Study|Adverse Event|21|||
33369468|NCT00257192|101239789|FG001|Overall Study|Adverse Event|10|||
33369469|NCT00257192|101239788|FG000|Overall Study|Laboratory abnormality|1|||
33369470|NCT00257192|101239789|FG001|Overall Study|Laboratory abnormality|1|||
33638351|NCT01106690|102226045|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
33638352|NCT01106690|102226043|FG000|Extension Period: Week 26 to Week 52|Other|8|||
33638353|NCT01106690|102226044|FG001|Extension Period: Week 26 to Week 52|Other|3|||
33638354|NCT01106690|102226045|FG002|Extension Period: Week 26 to Week 52|Other|4|||
33638355|NCT01106690|102226043|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
33638356|NCT01106690|102226044|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33638357|NCT01106690|102226045|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33638358|NCT03131219|102226046|FG000|Initial Evaluation Period|Adverse Event|2|||
33638359|NCT03131219|102226047|FG001|Initial Evaluation Period|Adverse Event|0|||
33638360|NCT03131219|102226046|FG000|Initial Evaluation Period|Protocol Violation|1|||
33638361|NCT03131219|102226047|FG001|Initial Evaluation Period|Protocol Violation|0|||
33638362|NCT03131219|102226046|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
33638363|NCT03131219|102226047|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
33638364|NCT03131219|102226046|FG000|Initial Evaluation Period|Physician Decision|1|||
33638365|NCT03131219|102226047|FG001|Initial Evaluation Period|Physician Decision|0|||
33638366|NCT03131219|102226046|FG000|Extension Period|Physician Decision|1|||
33638367|NCT03131219|102226047|FG001|Extension Period|Physician Decision|0|||
33638368|NCT01987453|102226053|FG000|Overall Study|Death|0|||
33638369|NCT01987453|102226054|FG001|Overall Study|Death|0|||
33139526|NCT02984943|100423993|FG000|Overall Study|Physician Decision|1|||
33139527|NCT00538785|100423994|FG000|Overall Study|Death|9|||
33139528|NCT00538785|100423995|FG001|Overall Study|Death|10|||
33139529|NCT00538785|100423994|FG000|Overall Study|Withdrawal of consent|9|||
33139530|NCT00538785|100423995|FG001|Overall Study|Withdrawal of consent|7|||
33139531|NCT00538785|100423994|FG000|Overall Study|Lost to Follow-up|1|||
33139532|NCT00538785|100423995|FG001|Overall Study|Lost to Follow-up|0|||
33139533|NCT02434471|100423996|FG000|Overall Study|Physician Decision|9|||
33139534|NCT02122783|100423999|FG000|Overall Study|Adverse Event|0|||
33139535|NCT02122783|100424000|FG001|Overall Study|Adverse Event|1|||
33139536|NCT02232880|100424001|FG000|Overall Study|study stopped prior to randomization|1|||
33139537|NCT00282347|100424002|FG000|Treatment Period|Death|2|||
33139538|NCT00282347|100424003|FG001|Treatment Period|Death|0|||
33139539|NCT00282347|100424002|FG000|Treatment Period|Lost to Follow-up|2|||
33139540|NCT00282347|100424003|FG001|Treatment Period|Lost to Follow-up|5|||
33139541|NCT00282347|100424002|FG000|Treatment Period|Withdrawal by Subject|1|||
33139542|NCT00282347|100424003|FG001|Treatment Period|Withdrawal by Subject|3|||
33139543|NCT00282347|100424002|FG000|Treatment Period|Physician Decision|0|||
33139544|NCT00282347|100424003|FG001|Treatment Period|Physician Decision|1|||
33139545|NCT00282347|100424002|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
33139546|NCT00282347|100424003|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
33578375|NCT04179305|102009459|FG000|Overall Study|Lost to Follow-up|1|||
33578376|NCT04179305|102009460|FG001|Overall Study|Lost to Follow-up|1|||
33578377|NCT04179305|102009461|FG002|Overall Study|Lost to Follow-up|0|||
33578378|NCT04179305|102009462|FG003|Overall Study|Lost to Follow-up|0|||
33578379|NCT04179305|102009459|FG000|Overall Study|Withdrawal by Subject|0|||
33578380|NCT04179305|102009460|FG001|Overall Study|Withdrawal by Subject|1|||
33578381|NCT04179305|102009461|FG002|Overall Study|Withdrawal by Subject|0|||
33578382|NCT04179305|102009462|FG003|Overall Study|Withdrawal by Subject|0|||
33578383|NCT04179305|102009459|FG000|Overall Study|Did not have scan|1|||
33578384|NCT04179305|102009460|FG001|Overall Study|Did not have scan|0|||
33578385|NCT04179305|102009461|FG002|Overall Study|Did not have scan|0|||
33578386|NCT04179305|102009462|FG003|Overall Study|Did not have scan|0|||
33578387|NCT04179305|102009459|FG000|Overall Study|In hospice care|3|||
33578388|NCT04179305|102009460|FG001|Overall Study|In hospice care|0|||
33578389|NCT04179305|102009461|FG002|Overall Study|In hospice care|0|||
33578390|NCT04179305|102009462|FG003|Overall Study|In hospice care|0|||
33578391|NCT00658541|102009463|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
33578392|NCT00658541|102009464|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33578393|NCT00658541|102009463|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
33369471|NCT00257192|101239788|FG000|Overall Study|Lost to Follow-up|3|||
33369472|NCT00257192|101239789|FG001|Overall Study|Lost to Follow-up|3|||
33369473|NCT00257192|101239788|FG000|Overall Study|Insufficient clinical response|18|||
33578394|NCT00658541|102009464|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33578395|NCT01082081|102009465|FG000|Overall Study|Lost to Follow-up|0|||
33638370|NCT01987453|102226055|FG002|Overall Study|Death|1|||
33638371|NCT01987453|102226053|FG000|Overall Study|Lack of Efficacy|1|||
33139547|NCT00282347|100424002|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
33139548|NCT00282347|100424003|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
33369474|NCT00257192|101239789|FG001|Overall Study|Insufficient clinical response|18|||
33638372|NCT01987453|102226054|FG001|Overall Study|Lack of Efficacy|12|||
33638373|NCT01987453|102226055|FG002|Overall Study|Lack of Efficacy|0|||
33139549|NCT00282347|100424002|FG000|Safety Follow-up Period|Physician Decision|1|||
33578396|NCT01082081|102009466|FG001|Overall Study|Lost to Follow-up|0|||
33578397|NCT01082081|102009467|FG002|Overall Study|Lost to Follow-up|1|||
33578398|NCT01082081|102009465|FG000|Overall Study|Withdrawal by Subject|0|||
33578399|NCT01082081|102009466|FG001|Overall Study|Withdrawal by Subject|0|||
33139550|NCT00282347|100424003|FG001|Safety Follow-up Period|Physician Decision|1|||
33139551|NCT00282347|100424002|FG000|Safety Follow-up Period|Protocol Deviation|0|||
33139552|NCT00282347|100424003|FG001|Safety Follow-up Period|Protocol Deviation|2|||
33139553|NCT00282347|100424002|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
33139554|NCT00282347|100424003|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
33139555|NCT00282347|100424002|FG000|B Cell Follow-up Period|Physician Decision|1|||
33237593|NCT01244763|100772279|FG003|Overall Study|Adverse Event|0|||
33578400|NCT01082081|102009467|FG002|Overall Study|Withdrawal by Subject|1|||
33578401|NCT01082081|102009465|FG000|Overall Study|Other Reason|0|||
33578402|NCT01082081|102009466|FG001|Overall Study|Other Reason|1|||
33578403|NCT01082081|102009467|FG002|Overall Study|Other Reason|0|||
33578404|NCT04865289|102009470|FG000|Overall Study|Participant ongoing in study|47|||
33578405|NCT04865289|102009471|FG001|Overall Study|Participant ongoing in study|35|||
33578406|NCT04865289|102009470|FG000|Overall Study|Death|27|||
33578407|NCT04865289|102009471|FG001|Overall Study|Death|21|||
33578408|NCT00756275|102009478|FG000|Overall Study|Lost to Follow-up|25|||
33578409|NCT00756275|102009479|FG001|Overall Study|Lost to Follow-up|21|||
33578410|NCT00756275|102009478|FG000|Overall Study|Withdrawal by Subject|4|||
33578411|NCT00756275|102009479|FG001|Overall Study|Withdrawal by Subject|7|||
33578412|NCT03073525|102009480|FG000|Overall Study|Withdrawal by Subject|0|||
33578413|NCT03073525|102009481|FG001|Overall Study|Withdrawal by Subject|0|||
33578414|NCT03073525|102009482|FG002|Overall Study|Withdrawal by Subject|3|||
33578415|NCT01152788|102009483|FG000|Overall Study|Withdrawal by Subject|0|||
33578416|NCT01152788|102009484|FG001|Overall Study|Withdrawal by Subject|3|||
33578417|NCT01152788|102009483|FG000|Overall Study|No treatment|0|||
33578418|NCT01152788|102009484|FG001|Overall Study|No treatment|1|||
33578419|NCT00443118|102009485|FG000|Overall Study|unknown primary outcome|3|||
33578420|NCT00443118|102009486|FG001|Overall Study|unknown primary outcome|1|||
33578421|NCT00443118|102009487|FG002|Overall Study|unknown primary outcome|0|||
33578422|NCT00443118|102009485|FG000|Overall Study|Withdrawal by Subject|1|||
33578423|NCT00443118|102009486|FG001|Overall Study|Withdrawal by Subject|0|||
33578424|NCT00443118|102009487|FG002|Overall Study|Withdrawal by Subject|0|||
33578425|NCT02651116|102009488|FG000|Overall Study|Adverse Event|0|||
33578426|NCT02651116|102009489|FG001|Overall Study|Adverse Event|1|||
33578427|NCT02651116|102009488|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
33578428|NCT02651116|102009489|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
33578429|NCT01055613|102009490|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
33578430|NCT01055613|102009491|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33578431|NCT01055613|102009490|FG000|Overall Study|Unacceptable lens fit|1|||
33578432|NCT01055613|102009491|FG001|Overall Study|Unacceptable lens fit|0|||
33578433|NCT01055613|102009490|FG000|Overall Study|Discomfort|2|||
33578434|NCT01055613|102009491|FG001|Overall Study|Discomfort|1|||
33578435|NCT01055613|102009490|FG000|Overall Study|Lost to Follow-up|1|||
33578436|NCT01055613|102009491|FG001|Overall Study|Lost to Follow-up|1|||
33578437|NCT01055613|102009490|FG000|Overall Study|Protocol Violation|1|||
33578438|NCT01055613|102009491|FG001|Overall Study|Protocol Violation|1|||
33578439|NCT01055613|102009490|FG000|Overall Study|Subject Disinterest|1|||
33578440|NCT01055613|102009491|FG001|Overall Study|Subject Disinterest|1|||
33578441|NCT03110029|102009492|FG000|Overall Study|Withdrawal by Subject|1|||
33578442|NCT03110029|102009493|FG001|Overall Study|Withdrawal by Subject|1|||
33578443|NCT01016132|102009496|FG000|Overall Study|Discomfort|1|||
33578444|NCT02852967|102009498|FG000|Overall Study|Adverse Event|3|||
33578445|NCT02852967|102009499|FG001|Overall Study|Adverse Event|1|||
33578446|NCT02852967|102009500|FG002|Overall Study|Adverse Event|0|||
33578447|NCT02852967|102009501|FG003|Overall Study|Adverse Event|1|||
33578448|NCT02852967|102009502|FG004|Overall Study|Adverse Event|0|||
33578449|NCT02852967|102009498|FG000|Overall Study|Death|1|||
33578450|NCT02852967|102009499|FG001|Overall Study|Death|0|||
33578451|NCT02852967|102009500|FG002|Overall Study|Death|0|||
33578452|NCT02852967|102009501|FG003|Overall Study|Death|0|||
33578453|NCT02852967|102009502|FG004|Overall Study|Death|0|||
33139556|NCT00282347|100424003|FG001|B Cell Follow-up Period|Physician Decision|0|||
33237594|NCT01244763|100772280|FG004|Overall Study|Adverse Event|0|||
33237595|NCT01244763|100772281|FG005|Overall Study|Adverse Event|1|||
33369475|NCT00257192|101239788|FG000|Overall Study|Withdrawal by Subject|14|||
33369476|NCT00257192|101239789|FG001|Overall Study|Withdrawal by Subject|2|||
33237596|NCT01244763|100772276|FG000|Overall Study|Death|1|||
33578454|NCT02852967|102009498|FG000|Overall Study|Lost to Follow-up|1|||
33578455|NCT02852967|102009499|FG001|Overall Study|Lost to Follow-up|2|||
33578456|NCT02852967|102009500|FG002|Overall Study|Lost to Follow-up|3|||
33578457|NCT02852967|102009501|FG003|Overall Study|Lost to Follow-up|4|||
33578458|NCT02852967|102009502|FG004|Overall Study|Lost to Follow-up|4|||
33578459|NCT02852967|102009498|FG000|Overall Study|Withdrawal by Subject|6|||
33578460|NCT02852967|102009499|FG001|Overall Study|Withdrawal by Subject|12|||
33578461|NCT02852967|102009500|FG002|Overall Study|Withdrawal by Subject|7|||
33578462|NCT02852967|102009501|FG003|Overall Study|Withdrawal by Subject|10|||
33578463|NCT02852967|102009502|FG004|Overall Study|Withdrawal by Subject|10|||
33578464|NCT02852967|102009498|FG000|Overall Study|SAE|0|||
33369477|NCT00257192|101239788|FG000|Overall Study|Randomized but not treated|0|||
33369478|NCT00257192|101239789|FG001|Overall Study|Randomized but not treated|1|||
33369479|NCT00257192|101239788|FG000|Overall Study|Study terminated by sponsor|1|||
33369480|NCT00257192|101239789|FG001|Overall Study|Study terminated by sponsor|0|||
33369481|NCT00257192|101239788|FG000|Overall Study|Miscellaneous|0|||
33369482|NCT00257192|101239789|FG001|Overall Study|Miscellaneous|4|||
33638374|NCT02396199|102226056|FG000|Overall Study|Lost to Follow-up|1|||
33638375|NCT02396199|102226056|FG000|Overall Study|Death|4|||
33638376|NCT00067002|102226058|FG000|Overall Study|Early Death|1|||
33638377|NCT00067002|102226059|FG001|Overall Study|Early Death|2|||
33638378|NCT00067002|102226058|FG000|Overall Study|Delayed|1|||
33638379|NCT00067002|102226059|FG001|Overall Study|Delayed|1|||
33638380|NCT00067002|102226058|FG000|Overall Study|Graft Failure|5|||
33638381|NCT00067002|102226059|FG001|Overall Study|Graft Failure|6|||
33638382|NCT00354432|102226060|FG000|Overall Study|Adverse Event|3|||
33638383|NCT00354432|102226061|FG001|Overall Study|Adverse Event|1|||
33638384|NCT00354432|102226062|FG002|Overall Study|Adverse Event|5|||
33578465|NCT02852967|102009499|FG001|Overall Study|SAE|0|||
33578466|NCT02852967|102009500|FG002|Overall Study|SAE|0|||
33578467|NCT02852967|102009501|FG003|Overall Study|SAE|3|||
33578468|NCT02852967|102009502|FG004|Overall Study|SAE|0|||
33578469|NCT02852967|102009498|FG000|Overall Study|Elevated Liver Enzymes|2|||
33578470|NCT02852967|102009499|FG001|Overall Study|Elevated Liver Enzymes|0|||
33578471|NCT02852967|102009500|FG002|Overall Study|Elevated Liver Enzymes|0|||
33638385|NCT00354432|102226063|FG003|Overall Study|Adverse Event|5|||
33139557|NCT00282347|100424002|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
33139558|NCT00282347|100424003|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
33369483|NCT01989546|101239790|FG000|Overall Study|Clinical Progression|1|||
33369484|NCT01989546|101239790|FG000|Overall Study|Disease progression on study|8|||
33369485|NCT01100307|101239791|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
33369486|NCT01100307|101239792|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
33369487|NCT01100307|101239791|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
33369488|NCT01100307|101239792|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
33369489|NCT01100307|101239791|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
33369490|NCT01100307|101239792|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
33369491|NCT01100307|101239791|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
33369492|NCT01100307|101239792|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
33369493|NCT01100307|101239791|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
33369494|NCT01100307|101239792|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
33369495|NCT01100307|101239791|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
33369496|NCT01100307|101239792|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
33369497|NCT01215734|101239793|FG000|Overall Study|Death|0|||
33369498|NCT01215734|101239794|FG001|Overall Study|Death|1|||
33369499|NCT01585961|101239796|FG000|Overall Study|Death|6|||
33369500|NCT01585961|101239796|FG000|Overall Study|Physician Decision|1|||
33369501|NCT01585961|101239796|FG000|Overall Study|Decision to use non-study catheter|1|||
33369502|NCT01585961|101239796|FG000|Overall Study|Withdrawal by Subject|1|||
33578472|NCT02852967|102009501|FG003|Overall Study|Elevated Liver Enzymes|2|||
33578473|NCT02852967|102009502|FG004|Overall Study|Elevated Liver Enzymes|2|||
33578474|NCT02852967|102009498|FG000|Overall Study|Physician Decision|0|||
33578475|NCT02852967|102009499|FG001|Overall Study|Physician Decision|0|||
33578476|NCT02852967|102009500|FG002|Overall Study|Physician Decision|0|||
33578477|NCT02852967|102009501|FG003|Overall Study|Physician Decision|1|||
33578478|NCT02852967|102009502|FG004|Overall Study|Physician Decision|0|||
33578479|NCT02852967|102009498|FG000|Overall Study|Lack of Efficacy|0|||
33578480|NCT02852967|102009499|FG001|Overall Study|Lack of Efficacy|1|||
33578481|NCT02852967|102009500|FG002|Overall Study|Lack of Efficacy|0|||
33578482|NCT02852967|102009501|FG003|Overall Study|Lack of Efficacy|0|||
33578483|NCT02852967|102009502|FG004|Overall Study|Lack of Efficacy|0|||
33578484|NCT02852967|102009498|FG000|Overall Study|Non-compliance|0|||
33578485|NCT02852967|102009499|FG001|Overall Study|Non-compliance|0|||
33578486|NCT02852967|102009500|FG002|Overall Study|Non-compliance|1|||
33578487|NCT02852967|102009501|FG003|Overall Study|Non-compliance|1|||
33578488|NCT02852967|102009502|FG004|Overall Study|Non-compliance|0|||
33578489|NCT02852967|102009498|FG000|Overall Study|Dispensing Drug Violation|0|||
33578490|NCT02852967|102009499|FG001|Overall Study|Dispensing Drug Violation|0|||
33578491|NCT02852967|102009500|FG002|Overall Study|Dispensing Drug Violation|1|||
33578492|NCT02852967|102009501|FG003|Overall Study|Dispensing Drug Violation|0|||
33578493|NCT02852967|102009502|FG004|Overall Study|Dispensing Drug Violation|0|||
33578494|NCT02852967|102009498|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
33638386|NCT00354432|102226060|FG000|Overall Study|Off/Toxicity|3|||
33638387|NCT00354432|102226061|FG001|Overall Study|Off/Toxicity|7|||
33578495|NCT02852967|102009499|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
33578496|NCT02852967|102009500|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
33578497|NCT02852967|102009501|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
33139559|NCT00729469|100424011|FG000|Overall Study|Adverse Event|14|||
33638388|NCT00354432|102226062|FG002|Overall Study|Off/Toxicity|5|||
33578498|NCT02852967|102009502|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
33578499|NCT03364231|102009503|FG000|Overall Study|Adverse Event|1|||
33578500|NCT03364231|102009504|FG001|Overall Study|Adverse Event|4|||
33578501|NCT03364231|102009503|FG000|Overall Study|Death|1|||
33578502|NCT03364231|102009504|FG001|Overall Study|Death|0|||
33578503|NCT03364231|102009503|FG000|Overall Study|Investigator Decision|2|||
33139560|NCT00729469|100424012|FG001|Overall Study|Adverse Event|25|||
33139561|NCT00729469|100424011|FG000|Overall Study|Lost to Follow-up|9|||
33638389|NCT00354432|102226063|FG003|Overall Study|Off/Toxicity|5|||
33638390|NCT05024032|102226067|FG000|Overall Study|Withdrawal by Subject|0|||
33578504|NCT03364231|102009504|FG001|Overall Study|Investigator Decision|2|||
33578505|NCT03364231|102009503|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
33578506|NCT03364231|102009504|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
33578507|NCT03364231|102009503|FG000|Overall Study|Withdrawal of Subject Consent|1|||
33578508|NCT03364231|102009504|FG001|Overall Study|Withdrawal of Subject Consent|0|||
33578509|NCT03364231|102009503|FG000|Overall Study|Reason Not Specified|1|||
33578510|NCT03364231|102009504|FG001|Overall Study|Reason Not Specified|0|||
33578511|NCT03364231|102009503|FG000|Overall Study|Disease Progression|0|||
33578512|NCT03364231|102009504|FG001|Overall Study|Disease Progression|6|||
33578513|NCT00066690|102009507|FG000|Overall Study|Adverse Event|145|||
33578514|NCT00066690|102009508|FG001|Overall Study|Adverse Event|58|||
33578515|NCT00066690|102009509|FG002|Overall Study|Adverse Event|126|||
33578516|NCT00066690|102009507|FG000|Overall Study|Death|3|||
33578517|NCT00066690|102009508|FG001|Overall Study|Death|0|||
33578518|NCT00066690|102009509|FG002|Overall Study|Death|2|||
33578519|NCT00066690|102009507|FG000|Overall Study|Lack of Efficacy|114|||
33578520|NCT00066690|102009508|FG001|Overall Study|Lack of Efficacy|110|||
33578521|NCT00066690|102009509|FG002|Overall Study|Lack of Efficacy|76|||
33578522|NCT00066690|102009507|FG000|Overall Study|Lost to Follow-up|40|||
33578523|NCT00066690|102009508|FG001|Overall Study|Lost to Follow-up|21|||
33578524|NCT00066690|102009509|FG002|Overall Study|Lost to Follow-up|29|||
33578525|NCT00066690|102009507|FG000|Overall Study|Withdrawal by Subject|50|||
33578526|NCT00066690|102009508|FG001|Overall Study|Withdrawal by Subject|55|||
33578527|NCT00066690|102009509|FG002|Overall Study|Withdrawal by Subject|49|||
33578528|NCT00066690|102009507|FG000|Overall Study|Treatment Ongoing|246|||
33578529|NCT00066690|102009508|FG001|Overall Study|Treatment Ongoing|278|||
33578530|NCT00066690|102009509|FG002|Overall Study|Treatment Ongoing|282|||
33578531|NCT01265992|102009510|FG000|Overall Study|Lost to Follow-up|1|||
33578532|NCT01265992|102009510|FG000|Overall Study|Withdrawal by Subject|1|||
33578533|NCT01265992|102009510|FG000|Overall Study|Adverse Event|1|||
33578534|NCT01265992|102009510|FG000|Overall Study|Administrative reasons|2|||
33578535|NCT01265992|102009510|FG000|Overall Study|Stopped treatment|3|||
33578536|NCT01265992|102009510|FG000|Overall Study|Did not receive treatment|1|||
33578537|NCT00524121|102009511|FG000|Overall Study|Disease progression|6|||
33638391|NCT05024032|102226068|FG001|Overall Study|Withdrawal by Subject|3|||
33638392|NCT05024032|102226069|FG002|Overall Study|Withdrawal by Subject|4|||
33638393|NCT05024032|102226067|FG000|Overall Study|Adverse Event|0|||
33638394|NCT05024032|102226068|FG001|Overall Study|Adverse Event|1|||
33638395|NCT05024032|102226069|FG002|Overall Study|Adverse Event|0|||
33638396|NCT05024032|102226067|FG000|Overall Study|Protocol Deviation|1|||
33638397|NCT05024032|102226068|FG001|Overall Study|Protocol Deviation|0|||
33638398|NCT05024032|102226069|FG002|Overall Study|Protocol Deviation|0|||
33638399|NCT03584789|102226070|FG000|Overall Study|refused EHR permission|19|||
33638400|NCT03584789|102226071|FG001|Overall Study|refused EHR permission|28|||
33638401|NCT03584789|102226072|FG002|Overall Study|refused EHR permission|23|||
33638402|NCT03584789|102226070|FG000|Overall Study|patients tied to a provider who retired|0|||
33638403|NCT03584789|102226071|FG001|Overall Study|patients tied to a provider who retired|0|||
33638404|NCT03584789|102226072|FG002|Overall Study|patients tied to a provider who retired|3|||
33638405|NCT02461134|102226073|FG000|Overall Study|Adverse Event|1|||
33638406|NCT00807001|102226074|FG000|Overall Study|Non-compliance|0|||
33638407|NCT00807001|102226075|FG001|Overall Study|Non-compliance|1|||
33638408|NCT00807001|102226076|FG002|Overall Study|Non-compliance|0|||
33638409|NCT00807001|102226077|FG003|Overall Study|Non-compliance|0|||
33578538|NCT00524121|102009511|FG000|Overall Study|Adverse Event|4|||
33578539|NCT00524121|102009511|FG000|Overall Study|Patient refused|2|||
33578540|NCT00524121|102009511|FG000|Overall Study|Other|1|||
33420870|NCT01682512|101431630|FG001|Overall Study|Other than stated above|4|||
33578541|NCT00524121|102009511|FG000|Overall Study|Death|1|||
33638410|NCT00807001|102226078|FG004|Overall Study|Non-compliance|0|||
33638411|NCT01597596|102226079|FG000|Overall Study|Study terminated by sponsor|1|||
33638412|NCT01597596|102226080|FG001|Overall Study|Study terminated by sponsor|0|||
33638413|NCT01597596|102226079|FG000|Overall Study|Physician Decision|0|||
33139562|NCT00729469|100424012|FG001|Overall Study|Lost to Follow-up|9|||
33578542|NCT00524121|102009511|FG000|Overall Study|Not treated (became ineligible)|4|||
33578543|NCT00524121|102009511|FG000|Overall Study|Not treated (changed mind)|1|||
33578544|NCT01673646|102009514|FG000|Overall Study|Adverse Event|2|||
33578545|NCT01673646|102009515|FG001|Overall Study|Adverse Event|1|||
33638414|NCT01597596|102226080|FG001|Overall Study|Physician Decision|1|||
33139563|NCT00729469|100424011|FG000|Overall Study|Protocol Violation|2|||
33139564|NCT00729469|100424012|FG001|Overall Study|Protocol Violation|1|||
33139565|NCT00729469|100424011|FG000|Overall Study|Withdrawal by Subject|19|||
33139566|NCT00729469|100424012|FG001|Overall Study|Withdrawal by Subject|8|||
33139567|NCT00729469|100424011|FG000|Overall Study|Other-Not mentioned|9|||
33237597|NCT01244763|100772277|FG001|Overall Study|Death|0|||
33638415|NCT02766023|102226082|FG000|Overall Study|Lost to Follow-up|23|||
33638416|NCT02766023|102226083|FG001|Overall Study|Lost to Follow-up|11|||
33638417|NCT02766023|102226082|FG000|Overall Study|Pregnancy|1|||
33638418|NCT02766023|102226083|FG001|Overall Study|Pregnancy|0|||
33237598|NCT01244763|100772278|FG002|Overall Study|Death|1|||
33237599|NCT01244763|100772279|FG003|Overall Study|Death|0|||
33578546|NCT01673646|102009516|FG002|Overall Study|Adverse Event|1|||
33578547|NCT01673646|102009514|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33578548|NCT01673646|102009515|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33578549|NCT01673646|102009516|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33578550|NCT01673646|102009514|FG000|Overall Study|Condition no longer requires study drug|0|||
33578551|NCT01673646|102009515|FG001|Overall Study|Condition no longer requires study drug|1|||
33578552|NCT01673646|102009516|FG002|Overall Study|Condition no longer requires study drug|0|||
33578553|NCT01673646|102009514|FG000|Overall Study|Withdrawal by Subject|0|||
33578554|NCT01673646|102009515|FG001|Overall Study|Withdrawal by Subject|2|||
33578555|NCT01673646|102009516|FG002|Overall Study|Withdrawal by Subject|2|||
33578556|NCT01673646|102009514|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
33578557|NCT01673646|102009515|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
33578558|NCT01673646|102009516|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
33578559|NCT00889707|102009517|FG000|Overall Study|Adverse Event|1|||
33578560|NCT00889707|102009518|FG001|Overall Study|Adverse Event|0|||
33578561|NCT00889707|102009517|FG000|Overall Study|Withdrawal by Subject|4|||
33578562|NCT00889707|102009518|FG001|Overall Study|Withdrawal by Subject|3|||
33578563|NCT00889707|102009517|FG000|Overall Study|Lost to Follow-up|0|||
33578564|NCT00889707|102009518|FG001|Overall Study|Lost to Follow-up|2|||
33578565|NCT00889707|102009517|FG000|Overall Study|Lack of Efficacy|2|||
33578566|NCT00889707|102009518|FG001|Overall Study|Lack of Efficacy|5|||
33578567|NCT01840943|102009521|FG000|Overall Study|Withdrawal by Subject|5|||
33578568|NCT01840943|102009522|FG001|Overall Study|Withdrawal by Subject|6|||
33578569|NCT01840943|102009521|FG000|Overall Study|Physician Decision|4|||
33578570|NCT01840943|102009522|FG001|Overall Study|Physician Decision|2|||
33578571|NCT01840943|102009521|FG000|Overall Study|Lost to Follow-up|4|||
33578572|NCT01840943|102009522|FG001|Overall Study|Lost to Follow-up|4|||
33578573|NCT02230189|102009523|FG000|Overall Study|Withdrawal by Subject|3|||
33578574|NCT02230189|102009524|FG001|Overall Study|Withdrawal by Subject|0|||
33578575|NCT02230189|102009525|FG002|Overall Study|Withdrawal by Subject|1|||
33578576|NCT02230189|102009523|FG000|Overall Study|Lost to Follow-up|1|||
33578577|NCT02230189|102009524|FG001|Overall Study|Lost to Follow-up|0|||
33578578|NCT02230189|102009525|FG002|Overall Study|Lost to Follow-up|0|||
33578579|NCT02230189|102009523|FG000|Overall Study|Physician Decision|1|||
33578580|NCT02230189|102009524|FG001|Overall Study|Physician Decision|0|||
33578581|NCT02230189|102009525|FG002|Overall Study|Physician Decision|0|||
33578582|NCT04154605|102009527|FG000|Overall Study|Procedure Canceled|1|||
33578583|NCT04154605|102009528|FG001|Overall Study|Procedure Canceled|1|||
33638419|NCT02766023|102226082|FG000|Overall Study|Adverse Event|1|||
33638420|NCT02766023|102226083|FG001|Overall Study|Adverse Event|0|||
33638421|NCT02766023|102226082|FG000|Overall Study|Withdrawal by Subject|4|||
33638422|NCT02766023|102226083|FG001|Overall Study|Withdrawal by Subject|5|||
33638423|NCT02766023|102226082|FG000|Overall Study|Physician Decision|1|||
33638424|NCT02766023|102226083|FG001|Overall Study|Physician Decision|0|||
33237600|NCT01244763|100772280|FG004|Overall Study|Death|2|||
33237601|NCT01244763|100772281|FG005|Overall Study|Death|0|||
33237602|NCT01244763|100772276|FG000|Overall Study|Physician Decision|0|||
33237603|NCT01244763|100772277|FG001|Overall Study|Physician Decision|0|||
33369503|NCT01585961|101239796|FG000|Overall Study|Lost to Follow-up|23|||
33578584|NCT04154605|102009527|FG000|Overall Study|Missed follow up|1|||
33578585|NCT04154605|102009528|FG001|Overall Study|Missed follow up|1|||
33638425|NCT02766023|102226082|FG000|Overall Study|Not Eligible at Enrollment|0|||
33638426|NCT02766023|102226083|FG001|Overall Study|Not Eligible at Enrollment|1|||
33638427|NCT02000440|102226084|FG000|Overall Study|Adverse Event|3|||
33578586|NCT04154605|102009527|FG000|Overall Study|Withdrawal by Subject|1|||
33578587|NCT04154605|102009528|FG001|Overall Study|Withdrawal by Subject|0|||
33578588|NCT00928187|102009531|FG000|Overall Study|Death|1|||
33578589|NCT00928187|102009532|FG001|Overall Study|Death|2|||
33578590|NCT00928187|102009533|FG002|Overall Study|Death|3|||
33578591|NCT00928187|102009531|FG000|Overall Study|Lost to Follow-up|1|||
33578592|NCT00928187|102009532|FG001|Overall Study|Lost to Follow-up|2|||
33578593|NCT00928187|102009533|FG002|Overall Study|Lost to Follow-up|1|||
33139568|NCT00729469|100424012|FG001|Overall Study|Other-Not mentioned|4|||
33139569|NCT00617669|100424018|FG000|Overall Study|Withdrawal by Subject|71|||
33139570|NCT00617669|100424019|FG001|Overall Study|Withdrawal by Subject|77|||
33139571|NCT00617669|100424018|FG000|Overall Study|Lost to Follow-up|3|||
33237604|NCT01244763|100772278|FG002|Overall Study|Physician Decision|1|||
33237605|NCT01244763|100772279|FG003|Overall Study|Physician Decision|0|||
33237606|NCT01244763|100772280|FG004|Overall Study|Physician Decision|0|||
33237607|NCT01244763|100772281|FG005|Overall Study|Physician Decision|0|||
33237608|NCT01244763|100772276|FG000|Overall Study|Withdrawal by Subject|1|||
33237609|NCT01244763|100772277|FG001|Overall Study|Withdrawal by Subject|2|||
33237610|NCT01244763|100772278|FG002|Overall Study|Withdrawal by Subject|0|||
33237611|NCT01244763|100772279|FG003|Overall Study|Withdrawal by Subject|1|||
33237612|NCT01244763|100772280|FG004|Overall Study|Withdrawal by Subject|1|||
33237613|NCT01244763|100772281|FG005|Overall Study|Withdrawal by Subject|2|||
33237614|NCT01244763|100772276|FG000|Overall Study|Lost to Follow-up|0|||
33237615|NCT01244763|100772277|FG001|Overall Study|Lost to Follow-up|1|||
33237616|NCT01244763|100772278|FG002|Overall Study|Lost to Follow-up|0|||
33237617|NCT01244763|100772279|FG003|Overall Study|Lost to Follow-up|0|||
33237618|NCT01244763|100772280|FG004|Overall Study|Lost to Follow-up|0|||
33237619|NCT01244763|100772281|FG005|Overall Study|Lost to Follow-up|0|||
33237620|NCT01244763|100772276|FG000|Overall Study|Enrolled into the Extension Study|0|||
33237621|NCT01244763|100772277|FG001|Overall Study|Enrolled into the Extension Study|0|||
33237622|NCT01244763|100772278|FG002|Overall Study|Enrolled into the Extension Study|0|||
33237623|NCT01244763|100772279|FG003|Overall Study|Enrolled into the Extension Study|0|||
33237624|NCT01244763|100772280|FG004|Overall Study|Enrolled into the Extension Study|0|||
33237625|NCT01244763|100772281|FG005|Overall Study|Enrolled into the Extension Study|1|||
33237626|NCT00163215|100772285|FG000|Overall Study|Lack of Efficacy|3|||
33237627|NCT00163215|100772285|FG000|Overall Study|Withdrawal by Subject|5|||
33237628|NCT00163215|100772285|FG000|Overall Study|Other|7|||
33237629|NCT01040780|100772286|FG000|Overall Study|Protocol Violation|1|||
33237630|NCT01040780|100772287|FG001|Overall Study|Protocol Violation|3|||
33237631|NCT00504348|100772288|FG000|Overall Study|Adverse Event|3|||
33237632|NCT00504348|100772288|FG000|Overall Study|Lack of Efficacy|4|||
33237633|NCT00504348|100772288|FG000|Overall Study|Physician Decision|1|||
33237634|NCT00180674|100772289|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
33237635|NCT00180674|100772289|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
33237636|NCT04242875|100772294|FG000|Overall Study|Adverse Event|2|||
33237637|NCT01603121|100772303|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
33578594|NCT00928187|102009531|FG000|Overall Study|Withdrawal by Subject|0|||
33578595|NCT00928187|102009532|FG001|Overall Study|Withdrawal by Subject|1|||
33578596|NCT00928187|102009533|FG002|Overall Study|Withdrawal by Subject|1|||
33578597|NCT00928187|102009531|FG000|Overall Study|Protocol Violation|0|||
33578598|NCT00928187|102009532|FG001|Overall Study|Protocol Violation|1|||
33578599|NCT00928187|102009533|FG002|Overall Study|Protocol Violation|0|||
33578600|NCT01581684|102009534|FG000|Overall Study|Other reason not defined|0|||
33578601|NCT01581684|102009535|FG001|Overall Study|Other reason not defined|0|||
33578602|NCT01581684|102009536|FG002|Overall Study|Other reason not defined|0|||
33578603|NCT01581684|102009537|FG003|Overall Study|Other reason not defined|0|||
33578604|NCT01581684|102009538|FG004|Overall Study|Other reason not defined|0|||
33578605|NCT01581684|102009539|FG005|Overall Study|Other reason not defined|0|||
33578606|NCT01581684|102009540|FG006|Overall Study|Other reason not defined|0|||
33578607|NCT01581684|102009541|FG007|Overall Study|Other reason not defined|0|||
33578608|NCT01581684|102009542|FG008|Overall Study|Other reason not defined|1|||
33578609|NCT01581684|102009543|FG009|Overall Study|Other reason not defined|0|||
33578610|NCT02503085|102009544|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
33578611|NCT02503085|102009545|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
33578612|NCT02503085|102009546|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
33578613|NCT02503085|102009547|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
33578614|NCT00506779|102009551|FG000|Overall Study|Withdrawal by Subject|1|||
33578615|NCT00506779|102009552|FG001|Overall Study|Withdrawal by Subject|0|||
33578616|NCT00506779|102009553|FG002|Overall Study|Withdrawal by Subject|1|||
33578617|NCT00506779|102009554|FG003|Overall Study|Withdrawal by Subject|0|||
33578618|NCT00506779|102009551|FG000|Overall Study|Adverse Event|0|||
33578619|NCT00506779|102009552|FG001|Overall Study|Adverse Event|1|||
33578620|NCT00506779|102009553|FG002|Overall Study|Adverse Event|1|||
33578621|NCT00506779|102009554|FG003|Overall Study|Adverse Event|1|||
33578622|NCT01000506|102009557|FG000|Overall Study|Adverse Event|6|||
33578623|NCT01000506|102009558|FG001|Overall Study|Adverse Event|5|||
33638428|NCT02000440|102226084|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
33638429|NCT00976560|102226085|FG000|Overall Study|Adverse Event|5|||
33578624|NCT01000506|102009559|FG002|Overall Study|Adverse Event|8|||
33638430|NCT00976560|102226086|FG001|Overall Study|Adverse Event|5|||
33638431|NCT00976560|102226085|FG000|Overall Study|Lack of Efficacy|3|||
33237638|NCT01603121|100772304|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
33237639|NCT03499600|100772307|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
33237640|NCT03499600|100772308|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
33237641|NCT02448719|100772310|FG000|Overall Study|Withdrawal by Subject|0|||
33237642|NCT02448719|100772311|FG001|Overall Study|Withdrawal by Subject|0|||
33237643|NCT02448719|100772312|FG002|Overall Study|Withdrawal by Subject|0|||
33578625|NCT01000506|102009560|FG003|Overall Study|Adverse Event|9|||
33578626|NCT01000506|102009557|FG000|Overall Study|Lack of Efficacy|8|||
33578627|NCT01000506|102009558|FG001|Overall Study|Lack of Efficacy|6|||
33578628|NCT01000506|102009559|FG002|Overall Study|Lack of Efficacy|4|||
33578629|NCT01000506|102009560|FG003|Overall Study|Lack of Efficacy|4|||
33578630|NCT01000506|102009557|FG000|Overall Study|Protocol Violation|1|||
33578631|NCT01000506|102009558|FG001|Overall Study|Protocol Violation|1|||
33578632|NCT01000506|102009559|FG002|Overall Study|Protocol Violation|0|||
33578633|NCT01000506|102009560|FG003|Overall Study|Protocol Violation|0|||
33578634|NCT01000506|102009557|FG000|Overall Study|Lost to Follow-up|1|||
33578635|NCT01000506|102009558|FG001|Overall Study|Lost to Follow-up|1|||
33578636|NCT01000506|102009559|FG002|Overall Study|Lost to Follow-up|4|||
33578637|NCT01000506|102009560|FG003|Overall Study|Lost to Follow-up|0|||
33578638|NCT01000506|102009557|FG000|Overall Study|Physician Decision|1|||
33578639|NCT01000506|102009558|FG001|Overall Study|Physician Decision|3|||
33578640|NCT01000506|102009559|FG002|Overall Study|Physician Decision|3|||
33578641|NCT01000506|102009560|FG003|Overall Study|Physician Decision|3|||
33237644|NCT02448719|100772313|FG003|Overall Study|Withdrawal by Subject|0|||
33237645|NCT02448719|100772314|FG004|Overall Study|Withdrawal by Subject|1|||
33237646|NCT02448719|100772315|FG005|Overall Study|Withdrawal by Subject|0|||
33237647|NCT02448719|100772316|FG006|Overall Study|Withdrawal by Subject|0|||
33237648|NCT02448719|100772317|FG007|Overall Study|Withdrawal by Subject|0|||
33237649|NCT02448719|100772318|FG008|Overall Study|Withdrawal by Subject|0|||
33237650|NCT02448719|100772319|FG009|Overall Study|Withdrawal by Subject|0|||
33237651|NCT02448719|100772320|FG010|Overall Study|Withdrawal by Subject|0|||
33237652|NCT02427646|100772323|FG000|Overall Study|Lack of Efficacy|2|||
33237653|NCT02427646|100772324|FG001|Overall Study|Lack of Efficacy|3|||
33237654|NCT02427646|100772323|FG000|Overall Study|Physician Decision|1|||
33237655|NCT02427646|100772324|FG001|Overall Study|Physician Decision|4|||
33237656|NCT02427646|100772323|FG000|Overall Study|Protocol Violation|3|||
33237657|NCT02427646|100772324|FG001|Overall Study|Protocol Violation|3|||
33237658|NCT02427646|100772323|FG000|Overall Study|Bothersome hand weakness|2|||
33237659|NCT02427646|100772324|FG001|Overall Study|Bothersome hand weakness|4|||
33237660|NCT01880554|100772325|FG000|Overall Study|Protocol Violation|14|||
33237661|NCT01880554|100772325|FG000|Overall Study|Simon's design requirements|2|||
33237662|NCT03929302|100772326|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
33237663|NCT03929302|100772327|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
33237664|NCT03929302|100772328|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
33237665|NCT03929302|100772326|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
33237666|NCT03929302|100772327|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
33237667|NCT03929302|100772328|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
33237668|NCT03929302|100772326|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
33237669|NCT03929302|100772327|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
33237670|NCT03929302|100772328|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
33237671|NCT01712789|100772330|FG000|Overall Study|Lack of Efficacy|2|||
33237672|NCT01712789|100772330|FG000|Overall Study|Lost to Follow-up|1|||
33237673|NCT01712789|100772330|FG000|Overall Study|Progressive Disease|504|||
33237674|NCT01712789|100772330|FG000|Overall Study|Death|57|||
33237675|NCT01712789|100772330|FG000|Overall Study|Adverse Event|52|||
33237676|NCT01712789|100772330|FG000|Overall Study|Miscellaneous|31|||
33237677|NCT01712789|100772330|FG000|Overall Study|Withdrawal by Subject|21|||
33237678|NCT01712789|100772330|FG000|Overall Study|Transition to Commercial Treatment|8|||
33237679|NCT01712789|100772330|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
33237680|NCT01561079|100772331|FG000|Overall Study|Physician Decision|17|||
33237681|NCT01561079|100772331|FG000|Overall Study|Withdrawal by Subject|59|||
33237682|NCT01561079|100772331|FG000|Overall Study|Protocol Violation|2|||
33237683|NCT01318811|100772334|FG000|Overall Study|Physician Decision|1|||
33237684|NCT01318811|100772335|FG001|Overall Study|Physician Decision|1|||
33369504|NCT01585961|101239796|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
33578642|NCT01000506|102009557|FG000|Overall Study|Withdrawal by Subject|11|||
33578643|NCT01000506|102009558|FG001|Overall Study|Withdrawal by Subject|8|||
33578644|NCT01000506|102009559|FG002|Overall Study|Withdrawal by Subject|2|||
33237685|NCT01318811|100772334|FG000|Overall Study|CRRT stopped for head CT|0|||
33237686|NCT01318811|100772335|FG001|Overall Study|CRRT stopped for head CT|1|||
33237687|NCT01318811|100772334|FG000|Overall Study|Death|0|||
33237688|NCT01318811|100772335|FG001|Overall Study|Death|1|||
33237689|NCT01318811|100772334|FG000|Overall Study|CRRT stopped for head MRI|0|||
33369505|NCT03987620|101239799|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
33369506|NCT03987620|101239800|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
33578645|NCT01000506|102009560|FG003|Overall Study|Withdrawal by Subject|7|||
33578646|NCT01206517|102009561|FG000|Overall Study|Withdrawal by Subject|0|||
33578647|NCT01206517|102009562|FG001|Overall Study|Withdrawal by Subject|0|||
33237690|NCT01318811|100772335|FG001|Overall Study|CRRT stopped for head MRI|1|||
33237691|NCT01349907|100772338|FG000|Overall Study|Adverse Event|37|||
33237692|NCT01349907|100772339|FG001|Overall Study|Adverse Event|11|||
33578648|NCT01206517|102009563|FG002|Overall Study|Withdrawal by Subject|2|||
33237693|NCT01349907|100772338|FG000|Overall Study|Treatment failure|13|||
33237694|NCT01349907|100772339|FG001|Overall Study|Treatment failure|4|||
33237695|NCT01349907|100772338|FG000|Overall Study|Lost to Follow-up|25|||
33237696|NCT01349907|100772339|FG001|Overall Study|Lost to Follow-up|6|||
33237697|NCT01349907|100772338|FG000|Overall Study|Withdrawal by Subject|30|||
33237698|NCT01349907|100772339|FG001|Overall Study|Withdrawal by Subject|8|||
33237699|NCT01349907|100772338|FG000|Overall Study|Protocol Violation|33|||
33237700|NCT01349907|100772339|FG001|Overall Study|Protocol Violation|13|||
33237701|NCT01349907|100772338|FG000|Overall Study|Administrative|1|||
33237702|NCT01349907|100772339|FG001|Overall Study|Administrative|1|||
33237703|NCT02169830|100772340|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
33237704|NCT02169830|100772341|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
33237705|NCT02169830|100772342|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
33638432|NCT00976560|102226086|FG001|Overall Study|Lack of Efficacy|5|||
33638433|NCT00976560|102226085|FG000|Overall Study|Protocol Violation|1|||
33638434|NCT00976560|102226086|FG001|Overall Study|Protocol Violation|0|||
33638435|NCT00976560|102226085|FG000|Overall Study|Lost to Follow-up|1|||
33237706|NCT02169830|100772340|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
33237707|NCT02169830|100772341|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
33237708|NCT02169830|100772342|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
33237709|NCT02169830|100772340|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
33237710|NCT02169830|100772341|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
33237711|NCT02169830|100772342|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
33237712|NCT02169830|100772340|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
33237713|NCT02169830|100772341|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
33237714|NCT02169830|100772342|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
33237715|NCT02169830|100772340|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
33237716|NCT02169830|100772341|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
33237717|NCT02169830|100772342|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
33237718|NCT00738530|100772347|FG000|Overall Study|Death|220|||
33237719|NCT00738530|100772348|FG001|Overall Study|Death|224|||
33237720|NCT00738530|100772347|FG000|Overall Study|Lost to Follow-up|8|||
33237721|NCT00738530|100772348|FG001|Overall Study|Lost to Follow-up|6|||
33237722|NCT00738530|100772347|FG000|Overall Study|Withdrawal by Subject|6|||
33237723|NCT00738530|100772348|FG001|Overall Study|Withdrawal by Subject|8|||
33237724|NCT01017120|100772353|FG000|Overall Study|Adverse Event|9|||
33237725|NCT01017120|100772354|FG001|Overall Study|Adverse Event|0|||
33237726|NCT01017120|100772353|FG000|Overall Study|Lost to Follow-up|13|||
33237727|NCT01017120|100772354|FG001|Overall Study|Lost to Follow-up|11|||
33237728|NCT01017120|100772353|FG000|Overall Study|Lack of Efficacy|1|||
33237729|NCT01017120|100772354|FG001|Overall Study|Lack of Efficacy|0|||
33237730|NCT01017120|100772353|FG000|Overall Study|Withdrawal by Subject|39|||
33237731|NCT01017120|100772354|FG001|Overall Study|Withdrawal by Subject|21|||
33237732|NCT01017120|100772353|FG000|Overall Study|Pregnancy|1|||
33237733|NCT01017120|100772354|FG001|Overall Study|Pregnancy|1|||
33237734|NCT01017120|100772353|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
33237735|NCT01017120|100772354|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
33578649|NCT01206517|102009564|FG003|Overall Study|Withdrawal by Subject|0|||
33578650|NCT01206517|102009565|FG004|Overall Study|Withdrawal by Subject|1|||
33578651|NCT01206517|102009566|FG005|Overall Study|Withdrawal by Subject|0|||
33578652|NCT02015039|102009567|FG000|Overall Study|Not eligible|0|||
33578653|NCT02015039|102009568|FG001|Overall Study|Not eligible|1|||
33578654|NCT00473889|102009569|FG000|Overall Study|Did not receive study medication|1|||
33638436|NCT00976560|102226086|FG001|Overall Study|Lost to Follow-up|0|||
33638437|NCT00976560|102226085|FG000|Overall Study|Physician Decision|2|||
33369507|NCT03987620|101239799|FG000|Overall Study|Adverse Event|3|||
33369508|NCT03987620|101239800|FG001|Overall Study|Adverse Event|0|||
33369509|NCT03987620|101239799|FG000|Overall Study|Lost to Follow-up|1|||
33369510|NCT03987620|101239800|FG001|Overall Study|Lost to Follow-up|2|||
33369511|NCT03987620|101239799|FG000|Overall Study|Physician Decision|0|||
33638438|NCT00976560|102226086|FG001|Overall Study|Physician Decision|0|||
33638439|NCT00976560|102226085|FG000|Overall Study|Withdrawal by Subject|2|||
33237736|NCT01017120|100772353|FG000|Overall Study|Relocated Out of Town|0|||
33237737|NCT01017120|100772354|FG001|Overall Study|Relocated Out of Town|2|||
33369512|NCT03987620|101239800|FG001|Overall Study|Physician Decision|1|||
33369513|NCT03987620|101239799|FG000|Overall Study|Pregnancy|1|||
33369514|NCT03987620|101239800|FG001|Overall Study|Pregnancy|0|||
33638440|NCT00976560|102226086|FG001|Overall Study|Withdrawal by Subject|3|||
33237738|NCT01017120|100772353|FG000|Overall Study|Protocol Violation|1|||
33237739|NCT01017120|100772354|FG001|Overall Study|Protocol Violation|0|||
33237740|NCT01017120|100772353|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
33237741|NCT01017120|100772354|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
33237742|NCT03330119|100772355|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
33369515|NCT03987620|101239799|FG000|Overall Study|Withdrawal by Subject|7|||
33578655|NCT00473889|102009570|FG001|Overall Study|Did not receive study medication|4|||
33578656|NCT00473889|102009569|FG000|Overall Study|Adverse Event|30|||
33638441|NCT00477386|102226087|FG000|Overall Study|Adverse Event|4|||
33638442|NCT00477386|102226088|FG001|Overall Study|Adverse Event|8|||
33638443|NCT00477386|102226087|FG000|Overall Study|Disease progression, relapse|3|||
33638444|NCT00477386|102226088|FG001|Overall Study|Disease progression, relapse|4|||
33638445|NCT00477386|102226087|FG000|Overall Study|Disease progression, refractory|1|||
33638446|NCT00477386|102226088|FG001|Overall Study|Disease progression, refractory|3|||
33638447|NCT00477386|102226087|FG000|Overall Study|Other|1|||
33638448|NCT00477386|102226088|FG001|Overall Study|Other|2|||
33638449|NCT00477386|102226087|FG000|Overall Study|Physician Decision|1|||
33638450|NCT00477386|102226088|FG001|Overall Study|Physician Decision|0|||
33638451|NCT00477386|102226087|FG000|Overall Study|Withdrawal by Subject|1|||
33237743|NCT03330119|100772356|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
33237744|NCT01154036|100772357|FG000|Phase I|Physician Decision|0|||
33578657|NCT00473889|102009570|FG001|Overall Study|Adverse Event|17|||
33578658|NCT00473889|102009569|FG000|Overall Study|Protocol Violation|4|||
33578659|NCT00473889|102009570|FG001|Overall Study|Protocol Violation|2|||
33578660|NCT00473889|102009569|FG000|Overall Study|Lack of Efficacy|28|||
33578661|NCT00473889|102009570|FG001|Overall Study|Lack of Efficacy|29|||
33578662|NCT00473889|102009569|FG000|Overall Study|Lost to Follow-up|2|||
33578663|NCT00473889|102009570|FG001|Overall Study|Lost to Follow-up|1|||
33578664|NCT00473889|102009569|FG000|Overall Study|Physician Decision|10|||
33578665|NCT00473889|102009570|FG001|Overall Study|Physician Decision|5|||
33578666|NCT00473889|102009569|FG000|Overall Study|Trial Terminated|3|||
33237745|NCT01154036|100772358|FG001|Phase I|Physician Decision|1|||
33237746|NCT01154036|100772359|FG002|Phase I|Physician Decision|0|||
33237747|NCT01154036|100772360|FG003|Phase I|Physician Decision|0|||
33237748|NCT01154036|100772361|FG004|Phase I|Physician Decision|0|||
33237749|NCT01154036|100772362|FG005|Phase I|Physician Decision|0|||
33237750|NCT01154036|100772363|FG006|Phase I|Physician Decision|0|||
33237751|NCT01154036|100772364|FG007|Phase I|Physician Decision|0|||
33237752|NCT01154036|100772357|FG000|Phase I|Lost to Follow-up|0|||
33237753|NCT01154036|100772358|FG001|Phase I|Lost to Follow-up|3|||
33237754|NCT01154036|100772359|FG002|Phase I|Lost to Follow-up|6|||
33237755|NCT01154036|100772360|FG003|Phase I|Lost to Follow-up|0|||
33578667|NCT00473889|102009570|FG001|Overall Study|Trial Terminated|6|||
33578668|NCT00473889|102009569|FG000|Overall Study|Withdrawal by Subject|5|||
33578669|NCT00473889|102009570|FG001|Overall Study|Withdrawal by Subject|0|||
33578670|NCT01603043|102009572|FG000|Overall Study|Study Futility|7|||
33578671|NCT01603043|102009573|FG001|Overall Study|Study Futility|3|||
33578672|NCT03159468|102009574|FG000|Overall Study|Withdrawal by Subject|0|||
33578673|NCT03159468|102009575|FG001|Overall Study|Withdrawal by Subject|0|||
33578674|NCT03159468|102009576|FG002|Overall Study|Withdrawal by Subject|3|||
33578675|NCT03159468|102009577|FG003|Overall Study|Withdrawal by Subject|0|||
33638452|NCT00477386|102226088|FG001|Overall Study|Withdrawal by Subject|0|||
33638453|NCT00889720|102226089|FG000|Overall Study|Withdrawal by Subject|4|||
33638454|NCT00889720|102226089|FG000|Overall Study|Other|4|||
33638455|NCT02500797|102226092|FG000|Overall Study|Cancel (rapid disease progression)|0|||
33638456|NCT02500797|102226093|FG001|Overall Study|Cancel (rapid disease progression)|0|||
33578676|NCT03159468|102009578|FG004|Overall Study|Withdrawal by Subject|0|||
33638457|NCT02500797|102226094|FG002|Overall Study|Cancel (rapid disease progression)|0|||
33638458|NCT02500797|102226095|FG003|Overall Study|Cancel (rapid disease progression)|0|||
33638459|NCT02500797|102226096|FG004|Overall Study|Cancel (rapid disease progression)|1|||
33638460|NCT02500797|102226097|FG005|Overall Study|Cancel (rapid disease progression)|1|||
33638461|NCT02500797|102226098|FG006|Overall Study|Cancel (rapid disease progression)|0|||
33139572|NCT00617669|100424019|FG001|Overall Study|Lost to Follow-up|2|||
33139573|NCT00617669|100424018|FG000|Overall Study|Adverse Event|87|||
33237756|NCT01154036|100772361|FG004|Phase I|Lost to Follow-up|0|||
33237757|NCT01154036|100772362|FG005|Phase I|Lost to Follow-up|0|||
33237758|NCT01154036|100772363|FG006|Phase I|Lost to Follow-up|0|||
33237759|NCT01154036|100772364|FG007|Phase I|Lost to Follow-up|0|||
33237760|NCT01154036|100772357|FG000|Phase I|Protocol Violation|0|||
33369516|NCT03987620|101239800|FG001|Overall Study|Withdrawal by Subject|1|||
33369517|NCT03987620|101239799|FG000|Overall Study|Other|2|||
33369518|NCT03987620|101239800|FG001|Overall Study|Other|5|||
33369519|NCT00237796|101239801|FG000|Overall Study|Baseline and one other ILSS required|10|||
33369520|NCT00237796|101239802|FG001|Overall Study|Baseline and one other ILSS required|5|||
33578677|NCT03159468|102009579|FG005|Overall Study|Withdrawal by Subject|0|||
33578678|NCT02383862|102009581|FG000|3 Month Follow up|Lost to Follow-up|23|||
33578679|NCT02383862|102009582|FG001|3 Month Follow up|Lost to Follow-up|21|||
33578680|NCT01791517|102009585|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
33578681|NCT01791517|102009586|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
33237761|NCT01154036|100772358|FG001|Phase I|Protocol Violation|3|||
33578682|NCT01791517|102009587|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
33578683|NCT01791517|102009588|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
33638462|NCT02500797|102226099|FG007|Overall Study|Cancel (rapid disease progression)|0|||
33638463|NCT02500797|102226092|FG000|Overall Study|Withdrawal by Subject|1|||
33638464|NCT02500797|102226093|FG001|Overall Study|Withdrawal by Subject|0|||
33638465|NCT02500797|102226094|FG002|Overall Study|Withdrawal by Subject|0|||
33578684|NCT01791517|102009589|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
33578685|NCT01791517|102009590|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
33578686|NCT01791517|102009591|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
33578687|NCT01791517|102009592|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
33578688|NCT01791517|102009593|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
33237762|NCT01154036|100772359|FG002|Phase I|Protocol Violation|9|||
33237763|NCT01154036|100772360|FG003|Phase I|Protocol Violation|0|||
33578689|NCT01791517|102009594|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
33578690|NCT01791517|102009595|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
33578691|NCT01791517|102009596|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
33237764|NCT01154036|100772361|FG004|Phase I|Protocol Violation|0|||
33237765|NCT01154036|100772362|FG005|Phase I|Protocol Violation|0|||
33237766|NCT01154036|100772363|FG006|Phase I|Protocol Violation|0|||
33237767|NCT01154036|100772364|FG007|Phase I|Protocol Violation|0|||
33237768|NCT01154036|100772357|FG000|Phase I|Withdrawal by Subject|2|||
33237769|NCT01154036|100772358|FG001|Phase I|Withdrawal by Subject|10|||
33578692|NCT01791517|102009585|FG000|Phase I: Period 1|Adverse Event|0|||
33578693|NCT01791517|102009586|FG001|Phase I: Period 1|Adverse Event|0|||
33578694|NCT01791517|102009587|FG002|Phase I: Period 1|Adverse Event|1|||
33578695|NCT01791517|102009588|FG003|Phase I: Period 1|Adverse Event|1|||
33578696|NCT01791517|102009589|FG004|Phase I: Period 1|Adverse Event|0|||
33578697|NCT01791517|102009590|FG005|Phase I: Period 1|Adverse Event|0|||
33578698|NCT01791517|102009591|FG006|Phase I: Period 1|Adverse Event|0|||
33578699|NCT01791517|102009592|FG007|Phase I: Period 1|Adverse Event|0|||
33578700|NCT01791517|102009593|FG008|Phase I: Period 1|Adverse Event|0|||
33578701|NCT01791517|102009594|FG009|Phase I: Period 1|Adverse Event|0|||
33578702|NCT01791517|102009595|FG010|Phase I: Period 1|Adverse Event|0|||
33578703|NCT01791517|102009596|FG011|Phase I: Period 1|Adverse Event|0|||
33578704|NCT01791517|102009585|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
33578705|NCT01791517|102009586|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33578706|NCT01791517|102009587|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33237770|NCT01154036|100772359|FG002|Phase I|Withdrawal by Subject|29|||
33237771|NCT01154036|100772360|FG003|Phase I|Withdrawal by Subject|0|||
33237772|NCT01154036|100772361|FG004|Phase I|Withdrawal by Subject|0|||
33578707|NCT01791517|102009588|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33237773|NCT01154036|100772362|FG005|Phase I|Withdrawal by Subject|0|||
33237774|NCT01154036|100772363|FG006|Phase I|Withdrawal by Subject|0|||
33237775|NCT01154036|100772364|FG007|Phase I|Withdrawal by Subject|0|||
33237776|NCT01154036|100772357|FG000|Phase I|Adverse Event|1|||
33237777|NCT01154036|100772358|FG001|Phase I|Adverse Event|11|||
33237778|NCT01154036|100772359|FG002|Phase I|Adverse Event|12|||
33578708|NCT01791517|102009589|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33578709|NCT01791517|102009590|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33578710|NCT01791517|102009591|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33638466|NCT02500797|102226095|FG003|Overall Study|Withdrawal by Subject|0|||
33638467|NCT02500797|102226096|FG004|Overall Study|Withdrawal by Subject|0|||
33638468|NCT02500797|102226097|FG005|Overall Study|Withdrawal by Subject|0|||
33369521|NCT05896761|101239804|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
33369522|NCT05896761|101239805|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
33369523|NCT05896761|101239804|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
33369524|NCT05896761|101239805|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
33369525|NCT02433288|101239808|FG000|Overall Study|Severe non-compliance to protocol|13|||
33369526|NCT02433288|101239809|FG001|Overall Study|Severe non-compliance to protocol|7|||
33237779|NCT01154036|100772360|FG003|Phase I|Adverse Event|0|||
33237780|NCT01154036|100772361|FG004|Phase I|Adverse Event|0|||
33369527|NCT02433288|101239808|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
33369528|NCT02433288|101239809|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
33369529|NCT02433288|101239808|FG000|Overall Study|Withdrawal by Subject|101|||
33369530|NCT02433288|101239809|FG001|Overall Study|Withdrawal by Subject|99|||
33369531|NCT02433288|101239808|FG000|Overall Study|Lost to Follow-up|2|||
33369532|NCT02433288|101239809|FG001|Overall Study|Lost to Follow-up|14|||
33369533|NCT02433288|101239808|FG000|Overall Study|Death|0|||
33369534|NCT02433288|101239809|FG001|Overall Study|Death|3|||
33420871|NCT01682512|101431631|FG002|Overall Study|Other than stated above|2|||
33578711|NCT01791517|102009592|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33578712|NCT01791517|102009593|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33578713|NCT01791517|102009594|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33578714|NCT01791517|102009595|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33578715|NCT01791517|102009596|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
33578716|NCT01791517|102009585|FG000|Phase I: Period 1|Protocol Violation|0|||
33578717|NCT01791517|102009586|FG001|Phase I: Period 1|Protocol Violation|1|||
33578718|NCT01791517|102009587|FG002|Phase I: Period 1|Protocol Violation|0|||
33237781|NCT01154036|100772362|FG005|Phase I|Adverse Event|0|||
33237782|NCT01154036|100772363|FG006|Phase I|Adverse Event|0|||
33237783|NCT01154036|100772364|FG007|Phase I|Adverse Event|0|||
33237784|NCT01154036|100772357|FG000|Phase II|Adverse Event|0|||
33237785|NCT01154036|100772358|FG001|Phase II|Adverse Event|0|||
33369535|NCT01576016|101239813|FG000|Lead Safety|Death|132|||
33369536|NCT01576016|101239814|FG001|Lead Safety|Death|0|||
33369537|NCT01576016|101239813|FG000|Lead Safety|Withdrawal by Subject|81|||
33369538|NCT01576016|101239814|FG001|Lead Safety|Withdrawal by Subject|0|||
33369539|NCT01576016|101239813|FG000|Lead Safety|System Explanted without Replacement|24|||
33369540|NCT01576016|101239814|FG001|Lead Safety|System Explanted without Replacement|0|||
33369541|NCT01576016|101239813|FG000|Lead Safety|Physician Decision|14|||
33369542|NCT01576016|101239814|FG001|Lead Safety|Physician Decision|0|||
33369543|NCT01576016|101239813|FG000|Lead Safety|Lost to Follow-up|13|||
33369544|NCT01576016|101239814|FG001|Lead Safety|Lost to Follow-up|0|||
33369545|NCT01576016|101239813|FG000|Lead Safety|Unsuccessful implant|2|||
33369546|NCT01576016|101239814|FG001|Lead Safety|Unsuccessful implant|0|||
33369547|NCT01576016|101239813|FG000|Lead Safety|Sponsor request|1|||
33369548|NCT01576016|101239814|FG001|Lead Safety|Sponsor request|0|||
33369549|NCT01576016|101239813|FG000|Lead Safety|Device replaced with CRT-D|1|||
33369550|NCT01576016|101239814|FG001|Lead Safety|Device replaced with CRT-D|0|||
33369551|NCT01576016|101239813|FG000|Lead Safety|Patient on Palliative Care|1|||
33369552|NCT01576016|101239814|FG001|Lead Safety|Patient on Palliative Care|0|||
33369553|NCT01576016|101239813|FG000|Lead Safety|Patient noncompliance|1|||
33369554|NCT01576016|101239814|FG001|Lead Safety|Patient noncompliance|0|||
33369555|NCT01576016|101239813|FG000|Lead Safety|Too far from study site|1|||
33369556|NCT01576016|101239814|FG001|Lead Safety|Too far from study site|0|||
33369557|NCT01576016|101239813|FG000|Lead Safety|System deactivated|1|||
33369558|NCT01576016|101239814|FG001|Lead Safety|System deactivated|0|||
33369559|NCT01576016|101239813|FG000|Lead Safety|Patient no longer followed by study PI|1|||
33139574|NCT00617669|100424019|FG001|Overall Study|Adverse Event|76|||
33139575|NCT00617669|100424018|FG000|Overall Study|Protocol Violation|2|||
33139576|NCT00617669|100424019|FG001|Overall Study|Protocol Violation|3|||
33139577|NCT00617669|100424018|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
33139578|NCT00617669|100424019|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
33139579|NCT00617669|100424018|FG000|Overall Study|Patients randomized but not treated|2|||
33139580|NCT00617669|100424019|FG001|Overall Study|Patients randomized but not treated|3|||
33139581|NCT00923364|100424020|FG000|Overall Study|Death|3|||
33139582|NCT00923364|100424021|FG001|Overall Study|Death|0|||
33139583|NCT00923364|100424020|FG000|Overall Study|Did not go to transplant|1|||
33139584|NCT00923364|100424021|FG001|Overall Study|Did not go to transplant|0|||
33139585|NCT02216812|100424023|FG000|Overall Study|Lost to Follow-up|10|||
33139586|NCT02216812|100424024|FG001|Overall Study|Lost to Follow-up|5|||
33139587|NCT00910624|100424025|FG000|Treatment Phase|Adverse Event|2|||
33139588|NCT00910624|100424026|FG001|Treatment Phase|Adverse Event|6|||
33139589|NCT00910624|100424027|FG002|Treatment Phase|Adverse Event|6|||
33139590|NCT00910624|100424028|FG003|Treatment Phase|Adverse Event|0|||
33139591|NCT00910624|100424025|FG000|Treatment Phase|Treatment Failure|23|||
33139592|NCT00910624|100424026|FG001|Treatment Phase|Treatment Failure|10|||
33139593|NCT00910624|100424027|FG002|Treatment Phase|Treatment Failure|0|||
33139594|NCT00910624|100424028|FG003|Treatment Phase|Treatment Failure|0|||
33237786|NCT01154036|100772359|FG002|Phase II|Adverse Event|0|||
33237787|NCT01154036|100772360|FG003|Phase II|Adverse Event|0|||
33237788|NCT01154036|100772361|FG004|Phase II|Adverse Event|1|||
33237789|NCT01154036|100772362|FG005|Phase II|Adverse Event|1|||
33237790|NCT01154036|100772363|FG006|Phase II|Adverse Event|1|||
33237791|NCT01154036|100772364|FG007|Phase II|Adverse Event|1|||
33369560|NCT01576016|101239814|FG001|Lead Safety|Patient no longer followed by study PI|0|||
33369561|NCT01576016|101239813|FG000|MRI Safety|Withdrawal by Subject|0|||
33369562|NCT01576016|101239814|FG001|MRI Safety|Withdrawal by Subject|10|||
33369563|NCT01576016|101239813|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
33578719|NCT01791517|102009588|FG003|Phase I: Period 1|Protocol Violation|0|||
33578720|NCT01791517|102009589|FG004|Phase I: Period 1|Protocol Violation|0|||
33578721|NCT01791517|102009590|FG005|Phase I: Period 1|Protocol Violation|0|||
33578722|NCT01791517|102009591|FG006|Phase I: Period 1|Protocol Violation|0|||
33578723|NCT01791517|102009592|FG007|Phase I: Period 1|Protocol Violation|0|||
33578724|NCT01791517|102009593|FG008|Phase I: Period 1|Protocol Violation|0|||
33578725|NCT01791517|102009594|FG009|Phase I: Period 1|Protocol Violation|0|||
33578726|NCT01791517|102009595|FG010|Phase I: Period 1|Protocol Violation|0|||
33578727|NCT01791517|102009596|FG011|Phase I: Period 1|Protocol Violation|0|||
33578728|NCT01791517|102009585|FG000|Phase I: Period 1|Lost to Follow-up|0|||
33139595|NCT00910624|100424025|FG000|Treatment Phase|Lost to Follow-up|0|||
33139596|NCT00910624|100424026|FG001|Treatment Phase|Lost to Follow-up|0|||
33139597|NCT00910624|100424027|FG002|Treatment Phase|Lost to Follow-up|1|||
33237792|NCT01154036|100772357|FG000|Phase II|Physician Decision|0|||
33369564|NCT01576016|101239814|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
33369565|NCT01576016|101239813|FG000|MRI Safety|Has not yet completed MRI scan|0|||
33578729|NCT01791517|102009586|FG001|Phase I: Period 1|Lost to Follow-up|0|||
33578730|NCT01791517|102009587|FG002|Phase I: Period 1|Lost to Follow-up|0|||
33369566|NCT01576016|101239814|FG001|MRI Safety|Has not yet completed MRI scan|56|||
33369567|NCT01576016|101239813|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
33578731|NCT01791517|102009588|FG003|Phase I: Period 1|Lost to Follow-up|1|||
33237793|NCT01154036|100772358|FG001|Phase II|Physician Decision|0|||
33237794|NCT01154036|100772359|FG002|Phase II|Physician Decision|0|||
33139598|NCT00910624|100424028|FG003|Treatment Phase|Lost to Follow-up|0|||
33237795|NCT01154036|100772360|FG003|Phase II|Physician Decision|0|||
33237796|NCT01154036|100772361|FG004|Phase II|Physician Decision|0|||
33237797|NCT01154036|100772362|FG005|Phase II|Physician Decision|0|||
33237798|NCT01154036|100772363|FG006|Phase II|Physician Decision|1|||
33237799|NCT01154036|100772364|FG007|Phase II|Physician Decision|0|||
33237800|NCT01154036|100772357|FG000|Phase II|Lost to Follow-up|0|||
33237801|NCT01154036|100772358|FG001|Phase II|Lost to Follow-up|0|||
33237802|NCT01154036|100772359|FG002|Phase II|Lost to Follow-up|0|||
33237803|NCT01154036|100772360|FG003|Phase II|Lost to Follow-up|1|||
33237804|NCT01154036|100772361|FG004|Phase II|Lost to Follow-up|2|||
33237805|NCT01154036|100772362|FG005|Phase II|Lost to Follow-up|0|||
33237806|NCT01154036|100772363|FG006|Phase II|Lost to Follow-up|2|||
33237807|NCT01154036|100772364|FG007|Phase II|Lost to Follow-up|1|||
33237808|NCT01154036|100772357|FG000|Phase II|Protocol Violation|0|||
33237809|NCT01154036|100772358|FG001|Phase II|Protocol Violation|0|||
33237810|NCT01154036|100772359|FG002|Phase II|Protocol Violation|0|||
33237811|NCT01154036|100772360|FG003|Phase II|Protocol Violation|0|||
33237812|NCT01154036|100772361|FG004|Phase II|Protocol Violation|1|||
33237813|NCT01154036|100772362|FG005|Phase II|Protocol Violation|2|||
33237814|NCT01154036|100772363|FG006|Phase II|Protocol Violation|0|||
33237815|NCT01154036|100772364|FG007|Phase II|Protocol Violation|0|||
33237816|NCT01154036|100772357|FG000|Phase II|Withdrawal by Subject|0|||
33237817|NCT01154036|100772358|FG001|Phase II|Withdrawal by Subject|0|||
33237818|NCT01154036|100772359|FG002|Phase II|Withdrawal by Subject|0|||
33237819|NCT01154036|100772360|FG003|Phase II|Withdrawal by Subject|0|||
33237820|NCT01154036|100772361|FG004|Phase II|Withdrawal by Subject|4|||
33237821|NCT01154036|100772362|FG005|Phase II|Withdrawal by Subject|2|||
33237822|NCT01154036|100772363|FG006|Phase II|Withdrawal by Subject|5|||
33237823|NCT01154036|100772364|FG007|Phase II|Withdrawal by Subject|4|||
33237824|NCT02507219|100772371|FG000|Overall Study|Physician Decision|1|||
33237825|NCT02507219|100772372|FG001|Overall Study|Physician Decision|0|||
33237826|NCT02507219|100772373|FG002|Overall Study|Physician Decision|0|||
33237827|NCT02507219|100772374|FG003|Overall Study|Physician Decision|0|||
33237828|NCT02507219|100772375|FG004|Overall Study|Physician Decision|0|||
33237829|NCT02507219|100772376|FG005|Overall Study|Physician Decision|0|||
33237830|NCT02507219|100772371|FG000|Overall Study|Withdrawal by Subject|0|||
33237831|NCT02507219|100772372|FG001|Overall Study|Withdrawal by Subject|0|||
33237832|NCT02507219|100772373|FG002|Overall Study|Withdrawal by Subject|0|||
33237833|NCT02507219|100772374|FG003|Overall Study|Withdrawal by Subject|0|||
33237834|NCT02507219|100772375|FG004|Overall Study|Withdrawal by Subject|1|||
33237835|NCT02507219|100772376|FG005|Overall Study|Withdrawal by Subject|0|||
33237836|NCT00136916|100772377|FG000|Overall Study|Never received study treatment|3|||
33237837|NCT00136916|100772378|FG001|Overall Study|Never received study treatment|5|||
33237838|NCT00136916|100772377|FG000|Overall Study|Death|1|||
33237839|NCT00136916|100772378|FG001|Overall Study|Death|3|||
33237840|NCT00136916|100772377|FG000|Overall Study|Adverse Event|27|||
33237841|NCT00136916|100772378|FG001|Overall Study|Adverse Event|8|||
33237842|NCT00136916|100772377|FG000|Overall Study|Laboratory abnormality|0|||
33237843|NCT00136916|100772378|FG001|Overall Study|Laboratory abnormality|1|||
33237844|NCT00136916|100772377|FG000|Overall Study|Lack of Efficacy|13|||
33237845|NCT00136916|100772378|FG001|Overall Study|Lack of Efficacy|3|||
33237846|NCT00136916|100772377|FG000|Overall Study|Lost to Follow-up|12|||
33237847|NCT00136916|100772378|FG001|Overall Study|Lost to Follow-up|14|||
33237848|NCT00136916|100772377|FG000|Overall Study|Withdrawal by Subject|44|||
33237849|NCT00136916|100772378|FG001|Overall Study|Withdrawal by Subject|46|||
33237850|NCT00136916|100772377|FG000|Overall Study|Other|22|||
33237851|NCT00136916|100772378|FG001|Overall Study|Other|24|||
33237852|NCT00136916|100772377|FG000|Overall Study|Discontinued in follow up period|3|||
33237853|NCT00136916|100772378|FG001|Overall Study|Discontinued in follow up period|0|||
33237854|NCT01853254|100772379|FG000|Overall Study|Abnormal Laboratory Test|1|||
33237855|NCT01853254|100772379|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
33237856|NCT01853254|100772379|FG000|Overall Study|Death|1|||
33139599|NCT00910624|100424025|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
33139600|NCT00910624|100424026|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
33139601|NCT00910624|100424027|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
33139602|NCT00910624|100424028|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
33139603|NCT00910624|100424025|FG000|Treatment Phase|Withdrawal by Subject|2|||
33139604|NCT00910624|100424026|FG001|Treatment Phase|Withdrawal by Subject|1|||
33139605|NCT00910624|100424027|FG002|Treatment Phase|Withdrawal by Subject|0|||
33139606|NCT00910624|100424028|FG003|Treatment Phase|Withdrawal by Subject|0|||
33139607|NCT00910624|100424025|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
33139608|NCT00910624|100424026|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
33139609|NCT00910624|100424027|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
33139610|NCT00910624|100424028|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
33139611|NCT00910624|100424025|FG000|Follow-Up Phase|Adverse Event|0|||
33139612|NCT00910624|100424026|FG001|Follow-Up Phase|Adverse Event|0|||
33237857|NCT01853254|100772379|FG000|Overall Study|Failure to Return|43|||
33237858|NCT01853254|100772379|FG000|Overall Study|Insufficient Therapeutic Response|22|||
33237859|NCT01853254|100772379|FG000|Overall Study|Refusal of Treatment|1|||
33237860|NCT01853254|100772379|FG000|Overall Study|Other Protocol Violation|1|||
33237861|NCT01853254|100772379|FG000|Overall Study|Withdrawal of Consent|16|||
33237862|NCT01853254|100772379|FG000|Overall Study|Administrative/Other|16|||
33237863|NCT01222247|100772382|FG000|Overall Study|Lost to Follow-up|2|||
33237864|NCT01222247|100772383|FG001|Overall Study|Lost to Follow-up|2|||
33237865|NCT02061761|100772386|FG000|Overall Study|Disease progression|2|||
33237866|NCT02061761|100772387|FG001|Overall Study|Disease progression|8|||
33237867|NCT02061761|100772388|FG002|Overall Study|Disease progression|4|||
33237868|NCT02061761|100772389|FG003|Overall Study|Disease progression|5|||
33237869|NCT02061761|100772390|FG004|Overall Study|Disease progression|9|||
33237870|NCT02061761|100772391|FG005|Overall Study|Disease progression|3|||
33237871|NCT02061761|100772392|FG006|Overall Study|Disease progression|1|||
33237872|NCT02061761|100772393|FG007|Overall Study|Disease progression|2|||
33237873|NCT02061761|100772394|FG008|Overall Study|Disease progression|28|||
33237874|NCT02061761|100772386|FG000|Overall Study|Study Drug toxicity|0|||
33237875|NCT02061761|100772387|FG001|Overall Study|Study Drug toxicity|0|||
33237876|NCT02061761|100772388|FG002|Overall Study|Study Drug toxicity|0|||
33237877|NCT02061761|100772389|FG003|Overall Study|Study Drug toxicity|0|||
33237878|NCT02061761|100772390|FG004|Overall Study|Study Drug toxicity|0|||
33237879|NCT02061761|100772391|FG005|Overall Study|Study Drug toxicity|1|||
33237880|NCT02061761|100772392|FG006|Overall Study|Study Drug toxicity|0|||
33237881|NCT02061761|100772393|FG007|Overall Study|Study Drug toxicity|2|||
33237882|NCT02061761|100772394|FG008|Overall Study|Study Drug toxicity|6|||
33237883|NCT02061761|100772386|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
33237884|NCT02061761|100772387|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
33139613|NCT00910624|100424027|FG002|Follow-Up Phase|Adverse Event|1|||
33139614|NCT00910624|100424028|FG003|Follow-Up Phase|Adverse Event|0|||
33139615|NCT00910624|100424025|FG000|Follow-Up Phase|Lost to Follow-up|3|||
33139616|NCT00910624|100424026|FG001|Follow-Up Phase|Lost to Follow-up|1|||
33139617|NCT00910624|100424027|FG002|Follow-Up Phase|Lost to Follow-up|2|||
33139618|NCT00910624|100424028|FG003|Follow-Up Phase|Lost to Follow-up|0|||
33139619|NCT00910624|100424025|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
33139620|NCT00910624|100424026|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
33139621|NCT00910624|100424027|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
33139622|NCT00910624|100424028|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
33139623|NCT00910624|100424025|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
33139624|NCT00910624|100424026|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
33139625|NCT00910624|100424027|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
33139626|NCT00910624|100424028|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
33139627|NCT00910624|100424025|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
33139628|NCT00910624|100424026|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
33139629|NCT00910624|100424027|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
33139630|NCT00910624|100424028|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
33139631|NCT00910624|100424025|FG000|Follow-Up Phase|Administrative|0|||
33139632|NCT00910624|100424026|FG001|Follow-Up Phase|Administrative|1|||
33139633|NCT00910624|100424027|FG002|Follow-Up Phase|Administrative|1|||
33139634|NCT00910624|100424028|FG003|Follow-Up Phase|Administrative|0|||
33139635|NCT02848729|100424029|FG000|Overall Study|Withdrawal by Subject|1|||
33139636|NCT02848729|100424030|FG001|Overall Study|Withdrawal by Subject|0|||
33139637|NCT02848729|100424029|FG000|Overall Study|Emesis|15|||
33139638|NCT02848729|100424030|FG001|Overall Study|Emesis|11|||
33139639|NCT02296138|100424032|FG000|Overall Study|Adverse Event|348|||
33139640|NCT02296138|100424033|FG001|Overall Study|Adverse Event|259|||
33139641|NCT02296138|100424032|FG000|Overall Study|Lack of Efficacy|59|||
33139642|NCT02296138|100424033|FG001|Overall Study|Lack of Efficacy|37|||
33139643|NCT02296138|100424032|FG000|Overall Study|Protocol Violation|35|||
33139644|NCT02296138|100424033|FG001|Overall Study|Protocol Violation|36|||
33237885|NCT02061761|100772388|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
33237886|NCT02061761|100772389|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
33237887|NCT02061761|100772390|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
33237888|NCT02061761|100772391|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
33237889|NCT02061761|100772392|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
33237890|NCT02061761|100772393|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
33237891|NCT02061761|100772394|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
33237892|NCT02061761|100772386|FG000|Overall Study|Participant request to discontinue study treatment|0|||
33139645|NCT02296138|100424032|FG000|Overall Study|Lost to Follow-up|9|||
33139646|NCT02296138|100424033|FG001|Overall Study|Lost to Follow-up|12|||
33139647|NCT02296138|100424032|FG000|Overall Study|Withdrawal by Subject|184|||
33139648|NCT02296138|100424033|FG001|Overall Study|Withdrawal by Subject|131|||
33139649|NCT02296138|100424032|FG000|Overall Study|Not Treated|1|||
33139650|NCT02296138|100424033|FG001|Overall Study|Not Treated|1|||
33139651|NCT02296138|100424032|FG000|Overall Study|Patients with data irregularities|10|||
33139652|NCT02296138|100424033|FG001|Overall Study|Patients with data irregularities|11|||
33139653|NCT02296138|100424032|FG000|Overall Study|Other than specified|15|||
33139654|NCT02296138|100424033|FG001|Overall Study|Other than specified|13|||
33139655|NCT01328444|100424038|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
33139656|NCT01328444|100424039|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
33139657|NCT01328444|100424040|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
33139658|NCT01328444|100424041|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
33139659|NCT01328444|100424042|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
33139660|NCT01328444|100424043|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
33139661|NCT01328444|100424038|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
33139662|NCT01328444|100424039|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
33139663|NCT01328444|100424040|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
33139664|NCT01328444|100424041|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
33139665|NCT01328444|100424042|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
33139666|NCT01328444|100424043|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
33638469|NCT02500797|102226098|FG006|Overall Study|Withdrawal by Subject|0|||
33638470|NCT02500797|102226099|FG007|Overall Study|Withdrawal by Subject|0|||
33638471|NCT01354314|102226100|FG000|Overall Study|Lost to Follow-up|1|||
33369568|NCT01576016|101239814|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
33369569|NCT05515601|101239815|FG000|Overall Study|Withdrawal by Subject|1|||
33369570|NCT05515601|101239816|FG001|Overall Study|Withdrawal by Subject|3|||
33369571|NCT05515601|101239817|FG002|Overall Study|Withdrawal by Subject|2|||
33638472|NCT01354314|102226101|FG001|Overall Study|Lost to Follow-up|0|||
33638473|NCT01354314|102226102|FG002|Overall Study|Lost to Follow-up|1|||
33638474|NCT01354314|102226103|FG003|Overall Study|Lost to Follow-up|1|||
33638475|NCT01354314|102226100|FG000|Overall Study|Withdrawal by Subject|0|||
33638476|NCT01354314|102226101|FG001|Overall Study|Withdrawal by Subject|0|||
33638477|NCT01354314|102226102|FG002|Overall Study|Withdrawal by Subject|1|||
33139667|NCT01328444|100424038|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
33139668|NCT01328444|100424039|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
33139669|NCT01328444|100424040|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
33139670|NCT01328444|100424041|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
33139671|NCT01328444|100424042|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
33139672|NCT01328444|100424043|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
33139673|NCT01328444|100424038|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
33139674|NCT01328444|100424039|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
33139675|NCT01328444|100424040|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
33139676|NCT01328444|100424041|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
33139677|NCT01328444|100424042|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
33139678|NCT01328444|100424043|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
33139679|NCT01328444|100424038|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
33139680|NCT01328444|100424039|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33139681|NCT01328444|100424040|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33139682|NCT01328444|100424041|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
33139683|NCT01328444|100424042|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33139684|NCT01328444|100424043|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
33139685|NCT01328444|100424038|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33139686|NCT01328444|100424039|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
33139687|NCT01328444|100424040|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
33139688|NCT01328444|100424041|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
33139689|NCT01328444|100424042|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
33139690|NCT01328444|100424043|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33139691|NCT01328444|100424038|FG000|Washout Period (14 Days)|Adverse Event|1|||
33139692|NCT01328444|100424039|FG001|Washout Period (14 Days)|Adverse Event|1|||
33139693|NCT01328444|100424040|FG002|Washout Period (14 Days)|Adverse Event|0|||
33139694|NCT01328444|100424041|FG003|Washout Period (14 Days)|Adverse Event|1|||
33139695|NCT01328444|100424042|FG004|Washout Period (14 Days)|Adverse Event|1|||
33139696|NCT01328444|100424043|FG005|Washout Period (14 Days)|Adverse Event|2|||
33139697|NCT01328444|100424038|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
33139698|NCT01328444|100424039|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
33139699|NCT01328444|100424040|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
33139700|NCT01328444|100424041|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
33369572|NCT05515601|101239818|FG003|Overall Study|Withdrawal by Subject|1|||
33369573|NCT05515601|101239819|FG004|Overall Study|Withdrawal by Subject|1|||
33369574|NCT05515601|101239820|FG005|Overall Study|Withdrawal by Subject|1|||
33369575|NCT05515601|101239815|FG000|Overall Study|Lost to Follow-up|0|||
33139701|NCT01328444|100424042|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
33139702|NCT01328444|100424043|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
33139703|NCT01328444|100424038|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
33139704|NCT01328444|100424039|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
33638478|NCT01354314|102226103|FG003|Overall Study|Withdrawal by Subject|0|||
33638479|NCT01354314|102226100|FG000|Overall Study|Adverse Event|0|||
33369576|NCT05515601|101239816|FG001|Overall Study|Lost to Follow-up|0|||
33369577|NCT05515601|101239817|FG002|Overall Study|Lost to Follow-up|0|||
33369578|NCT05515601|101239818|FG003|Overall Study|Lost to Follow-up|0|||
33369579|NCT05515601|101239819|FG004|Overall Study|Lost to Follow-up|1|||
33369580|NCT05515601|101239820|FG005|Overall Study|Lost to Follow-up|0|||
33369581|NCT00431847|101239821|FG000|Overall Study|completion of less than two study visits|6|||
33369582|NCT00431847|101239822|FG001|Overall Study|completion of less than two study visits|3|||
33369583|NCT00431847|101239823|FG002|Overall Study|completion of less than two study visits|4|||
33369584|NCT00431847|101239824|FG003|Overall Study|completion of less than two study visits|14|||
33369585|NCT00431847|101239825|FG004|Overall Study|completion of less than two study visits|0|||
33369586|NCT00431847|101239821|FG000|Overall Study|Protocol Violation|0|||
33369587|NCT00431847|101239822|FG001|Overall Study|Protocol Violation|0|||
33369588|NCT00431847|101239823|FG002|Overall Study|Protocol Violation|0|||
33638480|NCT01354314|102226101|FG001|Overall Study|Adverse Event|0|||
33638481|NCT01354314|102226102|FG002|Overall Study|Adverse Event|0|||
33638482|NCT01354314|102226103|FG003|Overall Study|Adverse Event|1|||
33638483|NCT01354314|102226100|FG000|Overall Study|Protocol Violation|1|||
33638484|NCT01354314|102226101|FG001|Overall Study|Protocol Violation|1|||
33638485|NCT01354314|102226102|FG002|Overall Study|Protocol Violation|0|||
33638486|NCT01354314|102226103|FG003|Overall Study|Protocol Violation|0|||
33638487|NCT01354314|102226100|FG000|Overall Study|Less than 90% Adherence|4|||
33638488|NCT01354314|102226101|FG001|Overall Study|Less than 90% Adherence|2|||
33638489|NCT01354314|102226102|FG002|Overall Study|Less than 90% Adherence|6|||
33638490|NCT01354314|102226103|FG003|Overall Study|Less than 90% Adherence|4|||
33638491|NCT05038982|102229207|FG000|Overall Study|Withdrawal by Subject|0|||
33638492|NCT05038982|102229208|FG001|Overall Study|Withdrawal by Subject|2|||
33638493|NCT02224560|102229209|FG000|Overall Study|Protocol Deviation|1|||
33638494|NCT02224560|102229210|FG001|Overall Study|Protocol Deviation|0|||
33638495|NCT02224560|102229211|FG002|Overall Study|Protocol Deviation|0|||
33638496|NCT02224560|102229209|FG000|Overall Study|Withdrawal by Subject|2|||
33139705|NCT01328444|100424040|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
33139706|NCT01328444|100424041|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
33139707|NCT01328444|100424042|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
33369589|NCT00431847|101239824|FG003|Overall Study|Protocol Violation|0|||
33369590|NCT00431847|101239825|FG004|Overall Study|Protocol Violation|1|||
33139708|NCT01328444|100424043|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
33139709|NCT01328444|100424038|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
33139710|NCT01328444|100424039|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
33139711|NCT01328444|100424040|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
33139712|NCT01328444|100424041|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
33139713|NCT01328444|100424042|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
33139714|NCT01328444|100424043|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
33139715|NCT01328444|100424038|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
33139716|NCT01328444|100424039|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
33139717|NCT01328444|100424040|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
33139718|NCT01328444|100424041|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
33139719|NCT01328444|100424042|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
33139720|NCT01328444|100424043|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
33139721|NCT01328444|100424038|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
33139722|NCT01328444|100424039|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
33139723|NCT01328444|100424040|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
33139724|NCT01328444|100424041|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
33139725|NCT01328444|100424042|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
33139726|NCT01328444|100424043|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
33139727|NCT01328444|100424038|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
33139728|NCT01328444|100424039|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
33139729|NCT01328444|100424040|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
33139730|NCT01328444|100424041|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
33139731|NCT01328444|100424042|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
33139732|NCT01328444|100424043|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
33139733|NCT01328444|100424038|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
33139734|NCT01328444|100424039|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
33139735|NCT01328444|100424040|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
33369591|NCT03744676|101239829|FG000|Pre-Treatment Phase|Death|7|||
33369592|NCT03744676|101239829|FG000|Pre-Treatment Phase|Disease related complications|2|||
33369593|NCT03744676|101239829|FG000|Pre-Treatment Phase|No longer meets eligibility criteria for other reasons|4|||
33369594|NCT03744676|101239829|FG000|Pre-Treatment Phase|Other reasons|8|||
33369595|NCT03744676|101239829|FG000|Treatment Phase|Ongoing in study|18|||
33369596|NCT03744676|101239829|FG000|Treatment Phase|Death|31|||
33638497|NCT02224560|102229210|FG001|Overall Study|Withdrawal by Subject|0|||
33638498|NCT02224560|102229211|FG002|Overall Study|Withdrawal by Subject|1|||
33638499|NCT02224560|102229209|FG000|Overall Study|Met Withdrawal Criteria|1|||
33578732|NCT01791517|102009589|FG004|Phase I: Period 1|Lost to Follow-up|0|||
33578733|NCT01791517|102009590|FG005|Phase I: Period 1|Lost to Follow-up|0|||
33578734|NCT01791517|102009591|FG006|Phase I: Period 1|Lost to Follow-up|1|||
33578735|NCT01791517|102009592|FG007|Phase I: Period 1|Lost to Follow-up|0|||
33578736|NCT01791517|102009593|FG008|Phase I: Period 1|Lost to Follow-up|1|||
33578737|NCT01791517|102009594|FG009|Phase I: Period 1|Lost to Follow-up|1|||
33578738|NCT01791517|102009595|FG010|Phase I: Period 1|Lost to Follow-up|0|||
33578739|NCT01791517|102009596|FG011|Phase I: Period 1|Lost to Follow-up|0|||
33578740|NCT01791517|102009585|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
33578741|NCT01791517|102009586|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
33638500|NCT02224560|102229210|FG001|Overall Study|Met Withdrawal Criteria|0|||
33638501|NCT02224560|102229211|FG002|Overall Study|Met Withdrawal Criteria|0|||
33638502|NCT02224560|102229209|FG000|Overall Study|Adverse Event|4|||
33638503|NCT02224560|102229210|FG001|Overall Study|Adverse Event|1|||
33638504|NCT02224560|102229211|FG002|Overall Study|Adverse Event|1|||
33638505|NCT02224560|102229209|FG000|Overall Study|Withdrawn by Investigator|1|||
33638506|NCT02224560|102229210|FG001|Overall Study|Withdrawn by Investigator|1|||
33638507|NCT02224560|102229211|FG002|Overall Study|Withdrawn by Investigator|0|||
33638508|NCT00616759|102229214|FG000|Overall Study|Physician Decision|2|||
33638509|NCT00616759|102229215|FG001|Overall Study|Physician Decision|0|||
33638510|NCT00616759|102229214|FG000|Overall Study|Withdrawal by Subject|1|||
33638511|NCT00616759|102229215|FG001|Overall Study|Withdrawal by Subject|2|||
33638512|NCT01523756|102229216|FG000|Baseline Period|Adverse Event|0|||
33638513|NCT01523756|102229217|FG001|Baseline Period|Adverse Event|1|||
33638514|NCT01523756|102229216|FG000|Test Period 1|Adverse Event|1|||
33638515|NCT01523756|102229217|FG001|Test Period 1|Adverse Event|0|||
33638516|NCT01523756|102229216|FG000|Test Period 2|Withdrawal by Subject|0|||
33638517|NCT01523756|102229217|FG001|Test Period 2|Withdrawal by Subject|1|||
33638518|NCT00071058|102229223|FG000|Overall Study|brain tumor-removed from study|1|||
33638519|NCT00286468|102229228|FG000|Overall Study|Hyperglycemic Rescue|28|||
33638520|NCT00286468|102229229|FG001|Overall Study|Hyperglycemic Rescue|30|||
33638521|NCT00286468|102229230|FG002|Overall Study|Hyperglycemic Rescue|31|||
33638522|NCT00286468|102229228|FG000|Overall Study|Adverse Event|2|||
33638523|NCT00286468|102229229|FG001|Overall Study|Adverse Event|6|||
33638524|NCT00286468|102229230|FG002|Overall Study|Adverse Event|4|||
33638525|NCT00286468|102229228|FG000|Overall Study|Protocol Violation|0|||
33638526|NCT00286468|102229229|FG001|Overall Study|Protocol Violation|3|||
33638527|NCT00286468|102229230|FG002|Overall Study|Protocol Violation|1|||
33638528|NCT00286468|102229228|FG000|Overall Study|Lost to Follow-up|1|||
33638529|NCT00286468|102229229|FG001|Overall Study|Lost to Follow-up|1|||
33638530|NCT00286468|102229230|FG002|Overall Study|Lost to Follow-up|2|||
33638531|NCT00286468|102229228|FG000|Overall Study|Withdrawal by Subject|3|||
33638532|NCT00286468|102229229|FG001|Overall Study|Withdrawal by Subject|8|||
33638533|NCT00286468|102229230|FG002|Overall Study|Withdrawal by Subject|11|||
33638534|NCT00286468|102229228|FG000|Overall Study|Physician Decision|3|||
33638535|NCT00286468|102229229|FG001|Overall Study|Physician Decision|2|||
33638536|NCT00286468|102229230|FG002|Overall Study|Physician Decision|1|||
33638537|NCT01198977|102229238|FG000|Overall Study|Lost to Follow-up|1|||
33638538|NCT01198977|102229239|FG001|Overall Study|Lost to Follow-up|0|||
33638539|NCT01716234|102229240|FG000|Overall Study|Protocol Violation|0|||
33638540|NCT01716234|102229241|FG001|Overall Study|Protocol Violation|0|||
33638541|NCT01716234|102229242|FG002|Overall Study|Protocol Violation|0|||
33638542|NCT01716234|102229243|FG003|Overall Study|Protocol Violation|1|||
33638543|NCT01716234|102229244|FG004|Overall Study|Protocol Violation|1|||
33638544|NCT01716234|102229245|FG005|Overall Study|Protocol Violation|1|||
33638545|NCT01716234|102229246|FG006|Overall Study|Protocol Violation|0|||
33638546|NCT01716234|102229240|FG000|Overall Study|Lack of Efficacy|0|||
33638547|NCT01716234|102229241|FG001|Overall Study|Lack of Efficacy|0|||
33638548|NCT01716234|102229242|FG002|Overall Study|Lack of Efficacy|0|||
33638549|NCT01716234|102229243|FG003|Overall Study|Lack of Efficacy|1|||
33638550|NCT01716234|102229244|FG004|Overall Study|Lack of Efficacy|0|||
33638551|NCT01716234|102229245|FG005|Overall Study|Lack of Efficacy|0|||
33638552|NCT01716234|102229246|FG006|Overall Study|Lack of Efficacy|0|||
33638553|NCT01716234|102229240|FG000|Overall Study|Did not meet protocol eligibility|0|||
33638554|NCT01716234|102229241|FG001|Overall Study|Did not meet protocol eligibility|0|||
33638555|NCT01716234|102229242|FG002|Overall Study|Did not meet protocol eligibility|1|||
33638556|NCT01716234|102229243|FG003|Overall Study|Did not meet protocol eligibility|0|||
33638557|NCT01716234|102229244|FG004|Overall Study|Did not meet protocol eligibility|0|||
33638558|NCT01716234|102229245|FG005|Overall Study|Did not meet protocol eligibility|4|||
33638559|NCT01716234|102229246|FG006|Overall Study|Did not meet protocol eligibility|0|||
33638560|NCT01716234|102229240|FG000|Overall Study|Adverse Event|7|||
33638561|NCT01716234|102229241|FG001|Overall Study|Adverse Event|10|||
33638562|NCT01716234|102229242|FG002|Overall Study|Adverse Event|2|||
33638563|NCT01716234|102229243|FG003|Overall Study|Adverse Event|8|||
33638564|NCT01716234|102229244|FG004|Overall Study|Adverse Event|3|||
33638565|NCT01716234|102229245|FG005|Overall Study|Adverse Event|6|||
33638566|NCT01716234|102229246|FG006|Overall Study|Adverse Event|0|||
33638567|NCT01716234|102229240|FG000|Overall Study|Withdrawal by Subject|3|||
33638568|NCT01716234|102229241|FG001|Overall Study|Withdrawal by Subject|0|||
33638569|NCT01716234|102229242|FG002|Overall Study|Withdrawal by Subject|2|||
33638570|NCT01716234|102229243|FG003|Overall Study|Withdrawal by Subject|2|||
33638571|NCT01716234|102229244|FG004|Overall Study|Withdrawal by Subject|1|||
33369597|NCT03744676|101239829|FG000|Treatment Phase|Withdrawal of consent|8|||
33369598|NCT03744676|101239829|FG000|Treatment Phase|Other reasons|6|||
33369599|NCT01597622|101239830|FG000|Overall Study|Adverse Event|7|||
33369600|NCT01597622|101239830|FG000|Overall Study|Lack of Efficacy|3|||
33369601|NCT01597622|101239830|FG000|Overall Study|Protocol Violation|1|||
33369602|NCT01597622|101239830|FG000|Overall Study|Lost to Follow-up|1|||
33369603|NCT01597622|101239830|FG000|Overall Study|Investigator Discretion|5|||
33369604|NCT01597622|101239830|FG000|Overall Study|Withdrawal by Subject|20|||
33369605|NCT01597622|101239830|FG000|Overall Study|Death|1|||
33369606|NCT04429503|101239834|FG000|Overall Study|Non-compliance with protocol by the subject|2|||
33420872|NCT02913261|101431632|FG000|Overall Study|Technical problems|0|||
33420873|NCT02913261|101431633|FG001|Overall Study|Technical problems|1|||
33420874|NCT02913261|101431632|FG000|Overall Study|Lack of Efficacy|32|||
33578742|NCT01791517|102009587|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
33578743|NCT01791517|102009588|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
33578744|NCT01791517|102009589|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
33578745|NCT01791517|102009590|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
33578746|NCT01791517|102009591|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
33578747|NCT01791517|102009592|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
33578748|NCT01791517|102009593|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
33578749|NCT01791517|102009594|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
33578750|NCT01791517|102009595|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
33369607|NCT04429503|101239835|FG001|Overall Study|Non-compliance with protocol by the subject|1|||
33369608|NCT04429503|101239836|FG002|Overall Study|Non-compliance with protocol by the subject|0|||
33369609|NCT04429503|101239834|FG000|Overall Study|Adverse Event|1|||
33369610|NCT04429503|101239835|FG001|Overall Study|Adverse Event|9|||
33578751|NCT01791517|102009596|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
33369611|NCT04429503|101239836|FG002|Overall Study|Adverse Event|2|||
33369612|NCT04429503|101239834|FG000|Overall Study|Decision by the investigator/sponsor|2|||
33369613|NCT04429503|101239835|FG001|Overall Study|Decision by the investigator/sponsor|9|||
33369614|NCT04429503|101239836|FG002|Overall Study|Decision by the investigator/sponsor|3|||
33369615|NCT04429503|101239834|FG000|Overall Study|Withdrawal by Subject|9|||
33369616|NCT04429503|101239835|FG001|Overall Study|Withdrawal by Subject|17|||
33369617|NCT04429503|101239836|FG002|Overall Study|Withdrawal by Subject|8|||
33369618|NCT04429503|101239834|FG000|Overall Study|Lost to Follow-up|5|||
33369619|NCT04429503|101239835|FG001|Overall Study|Lost to Follow-up|19|||
33369620|NCT04429503|101239836|FG002|Overall Study|Lost to Follow-up|7|||
33369621|NCT04429503|101239834|FG000|Overall Study|Death|9|||
33369622|NCT04429503|101239835|FG001|Overall Study|Death|18|||
33369623|NCT04429503|101239836|FG002|Overall Study|Death|5|||
33369624|NCT03569293|101239837|FG000|Overall Study|Adverse Event|4|||
33369625|NCT03569293|101239838|FG001|Overall Study|Adverse Event|1|||
33369626|NCT03569293|101239839|FG002|Overall Study|Adverse Event|5|||
33369627|NCT03569293|101239840|FG003|Overall Study|Adverse Event|1|||
33369628|NCT03569293|101239841|FG004|Overall Study|Adverse Event|0|||
33369629|NCT03569293|101239842|FG005|Overall Study|Adverse Event|0|||
33369630|NCT03569293|101239837|FG000|Overall Study|Withdrawal by Subject|16|||
33420875|NCT02913261|101431633|FG001|Overall Study|Lack of Efficacy|69|||
33420876|NCT02913261|101431632|FG000|Overall Study|Adverse Event|27|||
33578752|NCT01791517|102009585|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
33578753|NCT01791517|102009586|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33578754|NCT01791517|102009587|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33578755|NCT01791517|102009588|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33578756|NCT01791517|102009589|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33578757|NCT01791517|102009590|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33578758|NCT01791517|102009591|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33578759|NCT01791517|102009592|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33578760|NCT01791517|102009593|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33578761|NCT01791517|102009594|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33578762|NCT01791517|102009595|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33578763|NCT01791517|102009596|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
33578764|NCT01791517|102009585|FG000|Phase I: Period 2|Protocol Violation|0|||
33578765|NCT01791517|102009586|FG001|Phase I: Period 2|Protocol Violation|0|||
33578766|NCT01791517|102009587|FG002|Phase I: Period 2|Protocol Violation|0|||
33578767|NCT01791517|102009588|FG003|Phase I: Period 2|Protocol Violation|1|||
33578768|NCT01791517|102009589|FG004|Phase I: Period 2|Protocol Violation|0|||
33638572|NCT01716234|102229245|FG005|Overall Study|Withdrawal by Subject|3|||
33369631|NCT03569293|101239838|FG001|Overall Study|Withdrawal by Subject|2|||
33369632|NCT03569293|101239839|FG002|Overall Study|Withdrawal by Subject|4|||
33369633|NCT03569293|101239840|FG003|Overall Study|Withdrawal by Subject|1|||
33420877|NCT02913261|101431633|FG001|Overall Study|Adverse Event|5|||
33420878|NCT02913261|101431632|FG000|Overall Study|Death|25|||
33638573|NCT01716234|102229246|FG006|Overall Study|Withdrawal by Subject|0|||
33638574|NCT03399552|102229252|FG000|Overall Study|No evidence of disease|1|||
33638575|NCT03399552|102229252|FG000|Overall Study|Unevaluable|1|||
33638576|NCT02581410|102229260|FG000|Vaccination Phase|Adverse Event|2|||
33638577|NCT02581410|102229261|FG001|Vaccination Phase|Adverse Event|1|||
33638578|NCT02581410|102229260|FG000|Vaccination Phase|Withdrawal by Subject|0|||
33638579|NCT02581410|102229261|FG001|Vaccination Phase|Withdrawal by Subject|1|||
33638580|NCT02581410|102229260|FG000|Vaccination Phase|Migrated/moved from study area|0|||
33638581|NCT02581410|102229261|FG001|Vaccination Phase|Migrated/moved from study area|1|||
33638582|NCT02581410|102229260|FG000|End of Study Phase|Adverse Event|4|||
33638583|NCT02581410|102229261|FG001|End of Study Phase|Adverse Event|3|||
33638584|NCT02581410|102229260|FG000|End of Study Phase|Withdrawal by Subject|1|||
33638585|NCT02581410|102229261|FG001|End of Study Phase|Withdrawal by Subject|2|||
33638586|NCT02581410|102229260|FG000|End of Study Phase|Migrated/moved from study area|0|||
33638587|NCT02581410|102229261|FG001|End of Study Phase|Migrated/moved from study area|3|||
33638588|NCT02581410|102229260|FG000|End of Study Phase|Lost to Follow-up|0|||
33638589|NCT02581410|102229261|FG001|End of Study Phase|Lost to Follow-up|2|||
33638590|NCT02581410|102229260|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
33638591|NCT02581410|102229261|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
33638592|NCT00891904|102229262|FG000|Overall Study|Death|1|||
33638593|NCT00891904|102229262|FG000|Overall Study|Adverse Event|1|||
33638594|NCT01931566|102229263|FG000|Overall Study|Randomized But Not Treated|6|||
33638595|NCT01931566|102229264|FG001|Overall Study|Randomized But Not Treated|9|||
33638596|NCT01931566|102229265|FG002|Overall Study|Randomized But Not Treated|14|||
33578769|NCT01791517|102009590|FG005|Phase I: Period 2|Protocol Violation|0|||
33578770|NCT01791517|102009591|FG006|Phase I: Period 2|Protocol Violation|0|||
33578771|NCT01791517|102009592|FG007|Phase I: Period 2|Protocol Violation|0|||
33578772|NCT01791517|102009593|FG008|Phase I: Period 2|Protocol Violation|0|||
33578773|NCT01791517|102009594|FG009|Phase I: Period 2|Protocol Violation|0|||
33578774|NCT01791517|102009595|FG010|Phase I: Period 2|Protocol Violation|0|||
33578775|NCT01791517|102009596|FG011|Phase I: Period 2|Protocol Violation|0|||
33578776|NCT01791517|102009585|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
33578777|NCT01791517|102009586|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
33578778|NCT01791517|102009587|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
33578779|NCT01791517|102009588|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
33578780|NCT01791517|102009589|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
33578781|NCT01791517|102009590|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
33578782|NCT01791517|102009591|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
33578783|NCT01791517|102009592|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
33578784|NCT01791517|102009593|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
33578785|NCT01791517|102009594|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
33578786|NCT01791517|102009595|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
33578787|NCT01791517|102009596|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
33578788|NCT01791517|102009585|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33638597|NCT01931566|102229263|FG000|Overall Study|Adverse Event|37|||
33638598|NCT01931566|102229264|FG001|Overall Study|Adverse Event|167|||
33638599|NCT01931566|102229265|FG002|Overall Study|Adverse Event|132|||
33638600|NCT01931566|102229263|FG000|Overall Study|Major Protocol Deviation|5|||
33638601|NCT01931566|102229264|FG001|Overall Study|Major Protocol Deviation|14|||
33638602|NCT01931566|102229265|FG002|Overall Study|Major Protocol Deviation|21|||
33638603|NCT01931566|102229263|FG000|Overall Study|Lost to Follow-up|3|||
33638604|NCT01931566|102229264|FG001|Overall Study|Lost to Follow-up|26|||
33638605|NCT01931566|102229265|FG002|Overall Study|Lost to Follow-up|23|||
33638606|NCT01931566|102229263|FG000|Overall Study|Voluntary Withdrawal|78|||
33638607|NCT01931566|102229264|FG001|Overall Study|Voluntary Withdrawal|245|||
33638608|NCT01931566|102229265|FG002|Overall Study|Voluntary Withdrawal|225|||
33638609|NCT01931566|102229263|FG000|Overall Study|Study Termination|289|||
33638610|NCT01931566|102229264|FG001|Overall Study|Study Termination|968|||
33237893|NCT02061761|100772387|FG001|Overall Study|Participant request to discontinue study treatment|0|||
33237894|NCT02061761|100772388|FG002|Overall Study|Participant request to discontinue study treatment|2|||
33420879|NCT02913261|101431633|FG001|Overall Study|Death|22|||
33638611|NCT01931566|102229265|FG002|Overall Study|Study Termination|1037|||
33638612|NCT01931566|102229263|FG000|Overall Study|Reason Not Specified|11|||
33420880|NCT02913261|101431632|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
33578789|NCT01791517|102009586|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33578790|NCT01791517|102009587|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33578791|NCT01791517|102009588|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33578792|NCT01791517|102009589|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33638613|NCT01931566|102229264|FG001|Overall Study|Reason Not Specified|47|||
33638614|NCT01931566|102229265|FG002|Overall Study|Reason Not Specified|53|||
33638615|NCT01931566|102229263|FG000|Overall Study|Missing|0|||
33638616|NCT01931566|102229264|FG001|Overall Study|Missing|0|||
33638617|NCT01931566|102229265|FG002|Overall Study|Missing|1|||
33638618|NCT02395081|102229268|FG000|Overall Study|Withdrawal by Subject|1|||
33638619|NCT02395081|102229269|FG001|Overall Study|Withdrawal by Subject|1|||
33638620|NCT02395081|102229270|FG002|Overall Study|Withdrawal by Subject|0|||
33638621|NCT02395081|102229268|FG000|Overall Study|Moved where blood couldn't be collected|4|||
33638622|NCT02395081|102229269|FG001|Overall Study|Moved where blood couldn't be collected|1|||
33638623|NCT02395081|102229270|FG002|Overall Study|Moved where blood couldn't be collected|3|||
33638624|NCT02395081|102229268|FG000|Overall Study|Fetal Loss|2|||
33638625|NCT02395081|102229269|FG001|Overall Study|Fetal Loss|3|||
33638626|NCT02395081|102229270|FG002|Overall Study|Fetal Loss|1|||
33638627|NCT03388164|102229271|FG000|Overall Study|Withdrawal by Subject|3|||
33638628|NCT03388164|102229272|FG001|Overall Study|Withdrawal by Subject|1|||
33638629|NCT04198714|102229273|FG000|Overall Study|Physician Decision|0|||
33638630|NCT04198714|102229274|FG001|Overall Study|Physician Decision|1|||
33638631|NCT04292899|102229279|FG000|Overall Study|Death|21|||
33578793|NCT01791517|102009590|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33578794|NCT01791517|102009591|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33638632|NCT04292899|102229280|FG001|Overall Study|Death|28|||
33638633|NCT04292899|102229281|FG002|Overall Study|Death|188|||
33638634|NCT04292899|102229282|FG003|Overall Study|Death|371|||
33638635|NCT04292899|102229279|FG000|Overall Study|Lost to Follow-up|8|||
33638636|NCT04292899|102229280|FG001|Overall Study|Lost to Follow-up|4|||
33638637|NCT04292899|102229281|FG002|Overall Study|Lost to Follow-up|22|||
33638638|NCT04292899|102229282|FG003|Overall Study|Lost to Follow-up|235|||
33638639|NCT04292899|102229279|FG000|Overall Study|Withdrew consent|1|||
33638640|NCT04292899|102229280|FG001|Overall Study|Withdrew consent|0|||
33638641|NCT04292899|102229281|FG002|Overall Study|Withdrew consent|11|||
33638642|NCT04292899|102229282|FG003|Overall Study|Withdrew consent|32|||
33638643|NCT04292899|102229279|FG000|Overall Study|Adverse Event|2|||
33638644|NCT04292899|102229280|FG001|Overall Study|Adverse Event|1|||
33638645|NCT04292899|102229281|FG002|Overall Study|Adverse Event|2|||
33638646|NCT04292899|102229282|FG003|Overall Study|Adverse Event|2|||
33638647|NCT04292899|102229279|FG000|Overall Study|Investigator's Discretion|0|||
33638648|NCT04292899|102229280|FG001|Overall Study|Investigator's Discretion|0|||
33638649|NCT04292899|102229281|FG002|Overall Study|Investigator's Discretion|0|||
33638650|NCT04292899|102229282|FG003|Overall Study|Investigator's Discretion|3|||
33638651|NCT04292899|102229279|FG000|Overall Study|Non-compliance With Study Drug|0|||
33638652|NCT04292899|102229280|FG001|Overall Study|Non-compliance With Study Drug|0|||
33638653|NCT04292899|102229281|FG002|Overall Study|Non-compliance With Study Drug|0|||
33638654|NCT04292899|102229282|FG003|Overall Study|Non-compliance With Study Drug|1|||
33638655|NCT04292899|102229279|FG000|Overall Study|Protocol Violation|0|||
33638656|NCT04292899|102229280|FG001|Overall Study|Protocol Violation|0|||
33638657|NCT04292899|102229281|FG002|Overall Study|Protocol Violation|0|||
33638658|NCT04292899|102229282|FG003|Overall Study|Protocol Violation|1|||
33638659|NCT02578706|102229283|FG000|Overall Study|Withdrawal by Subject|1|||
33638660|NCT02578706|102229284|FG001|Overall Study|Withdrawal by Subject|0|||
33638661|NCT02578706|102229285|FG002|Overall Study|Withdrawal by Subject|0|||
33638662|NCT02578706|102229283|FG000|Overall Study|Lost to Follow-up|0|||
33638663|NCT02578706|102229284|FG001|Overall Study|Lost to Follow-up|4|||
33638664|NCT02578706|102229285|FG002|Overall Study|Lost to Follow-up|0|||
33638665|NCT02578706|102229283|FG000|Overall Study|Physician Decision|0|||
33638666|NCT02578706|102229284|FG001|Overall Study|Physician Decision|1|||
33638667|NCT02578706|102229285|FG002|Overall Study|Physician Decision|0|||
33638668|NCT01600716|102229286|FG000|Overall Study|Other Reasons|3|||
33578795|NCT01791517|102009592|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33578796|NCT01791517|102009593|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33578797|NCT01791517|102009594|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33578798|NCT01791517|102009595|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
33578799|NCT01791517|102009596|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
33578800|NCT01791517|102009585|FG000|Phase I: Period 2|Lens Discomfort|0|||
33578801|NCT01791517|102009586|FG001|Phase I: Period 2|Lens Discomfort|0|||
33578802|NCT01791517|102009587|FG002|Phase I: Period 2|Lens Discomfort|0|||
33578803|NCT01791517|102009588|FG003|Phase I: Period 2|Lens Discomfort|0|||
33578804|NCT01791517|102009589|FG004|Phase I: Period 2|Lens Discomfort|0|||
33578805|NCT01791517|102009590|FG005|Phase I: Period 2|Lens Discomfort|1|||
33578806|NCT01791517|102009591|FG006|Phase I: Period 2|Lens Discomfort|0|||
33578807|NCT01791517|102009592|FG007|Phase I: Period 2|Lens Discomfort|0|||
33638669|NCT01600716|102229287|FG001|Overall Study|Other Reasons|1|||
33638670|NCT01600716|102229286|FG000|Overall Study|Personal Reasons|0|||
33638671|NCT01600716|102229287|FG001|Overall Study|Personal Reasons|2|||
33638672|NCT01600716|102229286|FG000|Overall Study|Lost to Follow-up|0|||
33638673|NCT01600716|102229287|FG001|Overall Study|Lost to Follow-up|2|||
33638674|NCT01600716|102229286|FG000|Overall Study|Pregnancy|1|||
33638675|NCT01600716|102229287|FG001|Overall Study|Pregnancy|0|||
33638676|NCT01600716|102229286|FG000|Overall Study|Lack of Efficacy|2|||
33638677|NCT01600716|102229287|FG001|Overall Study|Lack of Efficacy|1|||
33638678|NCT01600716|102229286|FG000|Overall Study|Adverse Event|1|||
33638679|NCT01600716|102229287|FG001|Overall Study|Adverse Event|1|||
33638680|NCT00831181|102229288|FG000|Overall Study|Adverse Event|12|||
33638681|NCT02506244|102229289|FG000|Overall Study|Did not undergo active monitoring|458|||
33638682|NCT02506244|102229290|FG001|Overall Study|Did not undergo active monitoring|459|||
33139736|NCT01328444|100424041|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
33638683|NCT02506244|102229291|FG002|Overall Study|Did not undergo active monitoring|0|||
33638684|NCT00439517|102229296|FG000|Overall Study|Subject on treatment|1|||
33638685|NCT00439517|102229297|FG001|Overall Study|Subject on treatment|0|||
33638686|NCT00439517|102229296|FG000|Overall Study|Subject in survival follow-up|1|||
33638687|NCT00439517|102229297|FG001|Overall Study|Subject in survival follow-up|0|||
33638688|NCT02419001|102229298|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
33638689|NCT02419001|102229299|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
33638690|NCT00885170|102229301|FG000|Overall Study|Adverse Event|12|||
33638691|NCT00885170|102229302|FG001|Overall Study|Adverse Event|4|||
33638692|NCT00885170|102229301|FG000|Overall Study|Excessive bone loss|6|||
33139737|NCT01328444|100424042|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
33237895|NCT02061761|100772389|FG003|Overall Study|Participant request to discontinue study treatment|2|||
33237896|NCT02061761|100772390|FG004|Overall Study|Participant request to discontinue study treatment|0|||
33237897|NCT02061761|100772391|FG005|Overall Study|Participant request to discontinue study treatment|1|||
33237898|NCT02061761|100772392|FG006|Overall Study|Participant request to discontinue study treatment|0|||
33237899|NCT02061761|100772393|FG007|Overall Study|Participant request to discontinue study treatment|0|||
33237900|NCT02061761|100772394|FG008|Overall Study|Participant request to discontinue study treatment|2|||
33237901|NCT02061761|100772386|FG000|Overall Study|Withdrawal by Subject|0|||
33237902|NCT02061761|100772387|FG001|Overall Study|Withdrawal by Subject|0|||
33237903|NCT02061761|100772388|FG002|Overall Study|Withdrawal by Subject|0|||
33638693|NCT00885170|102229302|FG001|Overall Study|Excessive bone loss|3|||
33638694|NCT00885170|102229301|FG000|Overall Study|Lost to Follow-up|2|||
33638695|NCT00885170|102229302|FG001|Overall Study|Lost to Follow-up|1|||
33638696|NCT00885170|102229301|FG000|Overall Study|Physician Decision|2|||
33638697|NCT00885170|102229302|FG001|Overall Study|Physician Decision|1|||
33638698|NCT00885170|102229301|FG000|Overall Study|Protocol Violation|3|||
33638699|NCT00885170|102229302|FG001|Overall Study|Protocol Violation|1|||
33638700|NCT00885170|102229301|FG000|Overall Study|Withdrawal by Subject|13|||
33638701|NCT00885170|102229302|FG001|Overall Study|Withdrawal by Subject|13|||
33638702|NCT03040336|102229310|FG000|Overall Study|Death|1|||
33638703|NCT03040336|102229311|FG001|Overall Study|Death|0|||
33638704|NCT03040336|102229310|FG000|Overall Study|Withdrawal by Subject|2|||
33638705|NCT03040336|102229311|FG001|Overall Study|Withdrawal by Subject|3|||
33638706|NCT03557034|102229312|FG000|Overall Study|Withdrawal by Subject|1|||
33638707|NCT03557034|102229313|FG001|Overall Study|Withdrawal by Subject|0|||
33638708|NCT00628108|102229314|FG000|Overall Study|Adverse Event|0|||
33139738|NCT01328444|100424043|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
33237904|NCT02061761|100772389|FG003|Overall Study|Withdrawal by Subject|0|||
33237905|NCT02061761|100772390|FG004|Overall Study|Withdrawal by Subject|0|||
33237906|NCT02061761|100772391|FG005|Overall Study|Withdrawal by Subject|0|||
33237907|NCT02061761|100772392|FG006|Overall Study|Withdrawal by Subject|0|||
33237908|NCT02061761|100772393|FG007|Overall Study|Withdrawal by Subject|0|||
33237909|NCT02061761|100772394|FG008|Overall Study|Withdrawal by Subject|2|||
33237910|NCT02061761|100772386|FG000|Overall Study|Maximum clinical benefit|0|||
33237911|NCT02061761|100772387|FG001|Overall Study|Maximum clinical benefit|0|||
33237912|NCT02061761|100772388|FG002|Overall Study|Maximum clinical benefit|0|||
33237913|NCT02061761|100772389|FG003|Overall Study|Maximum clinical benefit|1|||
33237914|NCT02061761|100772390|FG004|Overall Study|Maximum clinical benefit|0|||
33237915|NCT02061761|100772391|FG005|Overall Study|Maximum clinical benefit|0|||
33237916|NCT02061761|100772392|FG006|Overall Study|Maximum clinical benefit|0|||
33237917|NCT02061761|100772393|FG007|Overall Study|Maximum clinical benefit|0|||
33237918|NCT02061761|100772394|FG008|Overall Study|Maximum clinical benefit|6|||
33237919|NCT02061761|100772386|FG000|Overall Study|Participant no longer meets study criteria|0|||
33237920|NCT02061761|100772387|FG001|Overall Study|Participant no longer meets study criteria|0|||
33237921|NCT02061761|100772388|FG002|Overall Study|Participant no longer meets study criteria|0|||
33237922|NCT02061761|100772389|FG003|Overall Study|Participant no longer meets study criteria|0|||
33237923|NCT02061761|100772390|FG004|Overall Study|Participant no longer meets study criteria|0|||
33237924|NCT02061761|100772391|FG005|Overall Study|Participant no longer meets study criteria|0|||
33237925|NCT02061761|100772392|FG006|Overall Study|Participant no longer meets study criteria|0|||
33237926|NCT02061761|100772393|FG007|Overall Study|Participant no longer meets study criteria|0|||
33237927|NCT02061761|100772394|FG008|Overall Study|Participant no longer meets study criteria|1|||
33237928|NCT02061761|100772386|FG000|Overall Study|Other reasons|0|||
33237929|NCT02061761|100772387|FG001|Overall Study|Other reasons|0|||
33369634|NCT03569293|101239841|FG004|Overall Study|Withdrawal by Subject|0|||
33369635|NCT03569293|101239842|FG005|Overall Study|Withdrawal by Subject|0|||
33638709|NCT00628108|102229315|FG001|Overall Study|Adverse Event|3|||
33638710|NCT00628108|102229314|FG000|Overall Study|Withdrawal by Subject|1|||
33638711|NCT00628108|102229315|FG001|Overall Study|Withdrawal by Subject|0|||
33638712|NCT03848832|102229316|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
33638713|NCT03848832|102229317|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
33638714|NCT03848832|102229318|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
33369636|NCT03569293|101239837|FG000|Overall Study|Lost to Follow-up|1|||
33369637|NCT03569293|101239838|FG001|Overall Study|Lost to Follow-up|3|||
33369638|NCT03569293|101239839|FG002|Overall Study|Lost to Follow-up|1|||
33578808|NCT01791517|102009593|FG008|Phase I: Period 2|Lens Discomfort|0|||
33578809|NCT01791517|102009594|FG009|Phase I: Period 2|Lens Discomfort|0|||
33578810|NCT01791517|102009595|FG010|Phase I: Period 2|Lens Discomfort|0|||
33578811|NCT01791517|102009596|FG011|Phase I: Period 2|Lens Discomfort|0|||
33578812|NCT01791517|102009585|FG000|Phase I: Period 2|Lost to Follow-up|0|||
33578813|NCT01791517|102009586|FG001|Phase I: Period 2|Lost to Follow-up|3|||
33578814|NCT01791517|102009587|FG002|Phase I: Period 2|Lost to Follow-up|2|||
33578815|NCT01791517|102009588|FG003|Phase I: Period 2|Lost to Follow-up|0|||
33578816|NCT01791517|102009589|FG004|Phase I: Period 2|Lost to Follow-up|0|||
33578817|NCT01791517|102009590|FG005|Phase I: Period 2|Lost to Follow-up|0|||
33578818|NCT01791517|102009591|FG006|Phase I: Period 2|Lost to Follow-up|0|||
33578819|NCT01791517|102009592|FG007|Phase I: Period 2|Lost to Follow-up|0|||
33578820|NCT01791517|102009593|FG008|Phase I: Period 2|Lost to Follow-up|0|||
33578821|NCT01791517|102009594|FG009|Phase I: Period 2|Lost to Follow-up|0|||
33638715|NCT03848832|102229316|FG000|Overall Study|Withdrawal by Subject|0|||
33638716|NCT03848832|102229317|FG001|Overall Study|Withdrawal by Subject|0|||
33638717|NCT03848832|102229318|FG002|Overall Study|Withdrawal by Subject|1|||
33638718|NCT03848832|102229316|FG000|Overall Study|Withdrawal (Covid-19)|0|||
33638719|NCT03848832|102229317|FG001|Overall Study|Withdrawal (Covid-19)|2|||
33638720|NCT03848832|102229318|FG002|Overall Study|Withdrawal (Covid-19)|0|||
33638721|NCT03848832|102229316|FG000|Overall Study|Physician Decision|2|||
33638722|NCT03848832|102229317|FG001|Overall Study|Physician Decision|1|||
33638723|NCT03848832|102229318|FG002|Overall Study|Physician Decision|3|||
33638724|NCT03848832|102229316|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
33638725|NCT03848832|102229317|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
33638726|NCT03848832|102229318|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
33638727|NCT03848832|102229316|FG000|Overall Study|Adverse Event|1|||
33638728|NCT03848832|102229317|FG001|Overall Study|Adverse Event|0|||
33638729|NCT03848832|102229318|FG002|Overall Study|Adverse Event|0|||
33638730|NCT02608684|102229319|FG000|Overall Study|Physician Decision|2|||
33638731|NCT02608684|102229319|FG000|Overall Study|Withdrawal by Subject|1|||
33638732|NCT00369265|102229320|FG000|Overall Study|Study terminated|4|||
33638733|NCT00369265|102229321|FG001|Overall Study|Study terminated|7|||
33638734|NCT02536963|102229327|FG000|Overall Study|Withdrawal by Subject|18|||
33638735|NCT03350672|102229331|FG000|Overall Study|Withdrawal by Subject|7|||
33638736|NCT03350672|102229332|FG001|Overall Study|Withdrawal by Subject|0|||
33638737|NCT03350672|102229333|FG002|Overall Study|Withdrawal by Subject|0|||
33638738|NCT03809104|102229338|FG000|Overall Study|Withdrawal by Subject|3|||
33638739|NCT05660577|102229339|FG000|Overall Study|Discontinued|9|||
33638740|NCT00719472|102229340|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
33638741|NCT00719472|102229340|FG000|Enrolled in Study|Subject decision to withdraw|8|||
33638742|NCT00719472|102229340|FG000|Enrolled in Study|Various Reasons|17|||
33638743|NCT00719472|102229340|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
33638744|NCT00719472|102229340|FG000|Received Cycle 1 Treatment|Death|5|||
33638745|NCT00719472|102229340|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
33638746|NCT00719472|102229340|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
33638747|NCT00719472|102229340|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
33638748|NCT00719472|102229340|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
33638749|NCT00719472|102229340|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
33638750|NCT00719472|102229340|FG000|Received Cycle 2 Treatment|Death|6|||
33638751|NCT00719472|102229340|FG000|Received Cycle 2 Treatment|Disease progression|3|||
33638752|NCT00719472|102229340|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
33638753|NCT00719472|102229340|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
33638754|NCT00719472|102229340|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
33638755|NCT00719472|102229340|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
33638756|NCT00131248|102229341|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
33638757|NCT00131248|102229342|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
33638758|NCT05021978|102229343|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
33638759|NCT05021978|102229344|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
33638760|NCT05021978|102229345|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
33638761|NCT05021978|102229346|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
33638762|NCT05021978|102229343|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
33638763|NCT05021978|102229344|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
33638764|NCT05021978|102229345|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
33638765|NCT05021978|102229346|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
33638766|NCT01327482|102229347|FG000|Overall Study|Adverse Event|1|||
33638767|NCT03818321|102229348|FG000|Overall Study|Withdrawal by Subject|1|||
33638768|NCT03818321|102229349|FG001|Overall Study|Withdrawal by Subject|2|||
33638769|NCT01143246|102229353|FG000|Overall Study|Adverse Event|24|||
33638770|NCT01143246|102229354|FG001|Overall Study|Adverse Event|28|||
33638771|NCT01143246|102229353|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
33139739|NCT01328444|100424038|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33139740|NCT01328444|100424039|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33139741|NCT01328444|100424040|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33139742|NCT01328444|100424041|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33139743|NCT01328444|100424042|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33139744|NCT01328444|100424043|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33139745|NCT03562767|100424044|FG000|Overall Study|Physician Decision|2|||
33139746|NCT03562767|100424045|FG001|Overall Study|Physician Decision|0|||
33139747|NCT03562767|100424046|FG002|Overall Study|Physician Decision|0|||
33139748|NCT03562767|100424044|FG000|Overall Study|Logistic Reason|1|||
33139749|NCT03562767|100424045|FG001|Overall Study|Logistic Reason|3|||
33139750|NCT03562767|100424046|FG002|Overall Study|Logistic Reason|0|||
33139751|NCT00927940|100424047|FG000|Overall Study|Death|1|||
33139752|NCT00713310|100424048|FG000|Overall Study|Adverse Event|5|||
33139753|NCT00713310|100424049|FG001|Overall Study|Adverse Event|2|||
33139754|NCT00713310|100424048|FG000|Overall Study|Lack of Efficacy|0|||
33139755|NCT00713310|100424049|FG001|Overall Study|Lack of Efficacy|2|||
33139756|NCT00713310|100424048|FG000|Overall Study|Withdrawal by Subject|0|||
33139757|NCT00713310|100424049|FG001|Overall Study|Withdrawal by Subject|2|||
33139758|NCT00266864|100424052|FG000|Overall Study|Lost to Follow-up|4|||
33139759|NCT00266864|100424053|FG001|Overall Study|Lost to Follow-up|1|||
33139760|NCT00266864|100424052|FG000|Overall Study|Withdrawal by Subject|1|||
33139761|NCT00266864|100424053|FG001|Overall Study|Withdrawal by Subject|1|||
33139762|NCT00535288|100424054|FG000|Overall Study|Adverse Event|20|||
33139763|NCT00535288|100424055|FG001|Overall Study|Adverse Event|19|||
33139764|NCT00535288|100424056|FG002|Overall Study|Adverse Event|25|||
33139765|NCT00535288|100424057|FG003|Overall Study|Adverse Event|20|||
33139766|NCT00535288|100424058|FG004|Overall Study|Adverse Event|30|||
33139767|NCT00535288|100424054|FG000|Overall Study|Lost to Follow-up|0|||
33139768|NCT00535288|100424055|FG001|Overall Study|Lost to Follow-up|3|||
33139769|NCT00535288|100424056|FG002|Overall Study|Lost to Follow-up|0|||
33578822|NCT01791517|102009595|FG010|Phase I: Period 2|Lost to Follow-up|0|||
33578823|NCT01791517|102009596|FG011|Phase I: Period 2|Lost to Follow-up|0|||
33578824|NCT01791517|102009585|FG000|Phase I: Period 3|Lens Discomfort|0|||
33578825|NCT01791517|102009586|FG001|Phase I: Period 3|Lens Discomfort|0|||
33578826|NCT01791517|102009587|FG002|Phase I: Period 3|Lens Discomfort|0|||
33578827|NCT01791517|102009588|FG003|Phase I: Period 3|Lens Discomfort|0|||
33578828|NCT01791517|102009589|FG004|Phase I: Period 3|Lens Discomfort|0|||
33139770|NCT00535288|100424057|FG003|Overall Study|Lost to Follow-up|0|||
33139771|NCT00535288|100424058|FG004|Overall Study|Lost to Follow-up|0|||
33237930|NCT02061761|100772388|FG002|Overall Study|Other reasons|0|||
33237931|NCT02061761|100772389|FG003|Overall Study|Other reasons|0|||
33139772|NCT00535288|100424054|FG000|Overall Study|Lack of Efficacy|26|||
33139773|NCT00535288|100424055|FG001|Overall Study|Lack of Efficacy|3|||
33139774|NCT00535288|100424056|FG002|Overall Study|Lack of Efficacy|4|||
33139775|NCT00535288|100424057|FG003|Overall Study|Lack of Efficacy|4|||
33237932|NCT02061761|100772390|FG004|Overall Study|Other reasons|2|||
33237933|NCT02061761|100772391|FG005|Overall Study|Other reasons|0|||
33237934|NCT02061761|100772392|FG006|Overall Study|Other reasons|0|||
33237935|NCT02061761|100772393|FG007|Overall Study|Other reasons|0|||
33237936|NCT02061761|100772394|FG008|Overall Study|Other reasons|6|||
33237937|NCT00419003|100772395|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
33237938|NCT00419003|100772396|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
33237939|NCT00419003|100772395|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
33237940|NCT00419003|100772396|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
33237941|NCT02449044|100772397|FG000|Overall Study|Lost to Follow-up|2|||
33237942|NCT02449044|100772397|FG000|Overall Study|Withdrawal by Subject|13|||
33578829|NCT01791517|102009590|FG005|Phase I: Period 3|Lens Discomfort|0|||
33578830|NCT01791517|102009591|FG006|Phase I: Period 3|Lens Discomfort|0|||
33578831|NCT01791517|102009592|FG007|Phase I: Period 3|Lens Discomfort|0|||
33139776|NCT00535288|100424058|FG004|Overall Study|Lack of Efficacy|7|||
33139777|NCT00535288|100424054|FG000|Overall Study|Unwilling to cooperate|6|||
33369639|NCT03569293|101239840|FG003|Overall Study|Lost to Follow-up|1|||
33369640|NCT03569293|101239841|FG004|Overall Study|Lost to Follow-up|0|||
33369641|NCT03569293|101239842|FG005|Overall Study|Lost to Follow-up|0|||
33369642|NCT03569293|101239837|FG000|Overall Study|Other|8|||
33369643|NCT03569293|101239838|FG001|Overall Study|Other|2|||
33139778|NCT00535288|100424055|FG001|Overall Study|Unwilling to cooperate|6|||
33237943|NCT02449044|100772397|FG000|Overall Study|Adverse Event|30|||
33237944|NCT02449044|100772397|FG000|Overall Study|Met Withdrawal Criteria|7|||
33139779|NCT00535288|100424056|FG002|Overall Study|Unwilling to cooperate|3|||
33139780|NCT00535288|100424057|FG003|Overall Study|Unwilling to cooperate|3|||
33139781|NCT00535288|100424058|FG004|Overall Study|Unwilling to cooperate|4|||
33369644|NCT03569293|101239839|FG002|Overall Study|Other|1|||
33578832|NCT01791517|102009593|FG008|Phase I: Period 3|Lens Discomfort|0|||
33578833|NCT01791517|102009594|FG009|Phase I: Period 3|Lens Discomfort|0|||
33578834|NCT01791517|102009595|FG010|Phase I: Period 3|Lens Discomfort|0|||
33139782|NCT00535288|100424054|FG000|Overall Study|Other|2|||
33139783|NCT00535288|100424055|FG001|Overall Study|Other|1|||
33139784|NCT00535288|100424056|FG002|Overall Study|Other|1|||
33638772|NCT01143246|102229354|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
33638773|NCT01143246|102229353|FG000|Overall Study|Lost to Follow-up|0|||
33638774|NCT01143246|102229354|FG001|Overall Study|Lost to Follow-up|1|||
33638775|NCT01143246|102229353|FG000|Overall Study|Death|16|||
33139785|NCT00535288|100424057|FG003|Overall Study|Other|2|||
33139786|NCT00535288|100424058|FG004|Overall Study|Other|1|||
33139787|NCT04224688|100424059|FG000|Overall Study|Withdrawal by Subject|1|||
33139788|NCT04224688|100424060|FG001|Overall Study|Withdrawal by Subject|3|||
33139789|NCT04224688|100424059|FG000|Overall Study|Lack of Efficacy|1|||
33139790|NCT04224688|100424060|FG001|Overall Study|Lack of Efficacy|1|||
33139791|NCT04224688|100424059|FG000|Overall Study|Adverse event, not fatal|0|||
33139792|NCT04224688|100424060|FG001|Overall Study|Adverse event, not fatal|2|||
33139793|NCT04224688|100424059|FG000|Overall Study|COVID-19|0|||
33139794|NCT04224688|100424060|FG001|Overall Study|COVID-19|1|||
33237945|NCT02449044|100772397|FG000|Overall Study|Physician Decision|9|||
33237946|NCT02449044|100772397|FG000|Overall Study|Sponsor Discontinued Trial|3|||
33237947|NCT01866917|100772398|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
33237948|NCT01866917|100772399|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
33237949|NCT01023308|100772400|FG000|Overall Study|Abnormal test proceedure results|3|||
33237950|NCT01023308|100772401|FG001|Overall Study|Abnormal test proceedure results|8|||
33237951|NCT01023308|100772400|FG000|Overall Study|Administrative problems|2|||
33237952|NCT01023308|100772401|FG001|Overall Study|Administrative problems|1|||
33237953|NCT01023308|100772400|FG000|Overall Study|Adverse Event|130|||
33237954|NCT01023308|100772401|FG001|Overall Study|Adverse Event|66|||
33237955|NCT01023308|100772400|FG000|Overall Study|Death|21|||
33638776|NCT01143246|102229354|FG001|Overall Study|Death|15|||
33638777|NCT01143246|102229353|FG000|Overall Study|Reason not Specified|3|||
33638778|NCT01143246|102229354|FG001|Overall Study|Reason not Specified|5|||
33638779|NCT00297258|102229355|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
33638780|NCT00297258|102229355|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
33638781|NCT00297258|102229355|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
33638782|NCT00297258|102229355|FG000|Overall Study|Intercurrent Illness|3|||
33638783|NCT00297258|102229355|FG000|Overall Study|Intercurrent Death|2|||
33638784|NCT00297258|102229355|FG000|Overall Study|Deteriorization of General Condition|1|||
33638785|NCT00297258|102229355|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
33638786|NCT00297258|102229355|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
33638787|NCT00297258|102229355|FG000|Overall Study|Switch to Commercial Treatment|1|||
33638788|NCT00297258|102229355|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
33638789|NCT00118417|102229357|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
33638790|NCT00118417|102229358|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
33638791|NCT00118417|102229357|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
33638792|NCT00118417|102229358|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
33638793|NCT00118417|102229357|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
33638794|NCT00118417|102229358|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
33638795|NCT00118417|102229357|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
33638796|NCT00118417|102229358|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
33638797|NCT00118417|102229357|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
33638798|NCT00118417|102229358|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
33638799|NCT01709084|102229361|FG000|Overall Study|Lost to Follow-up|4|||
33638800|NCT01709084|102229362|FG001|Overall Study|Lost to Follow-up|7|||
33237956|NCT01023308|100772401|FG001|Overall Study|Death|17|||
33237957|NCT01023308|100772400|FG000|Overall Study|Disease progression|82|||
33237958|NCT01023308|100772401|FG001|Overall Study|Disease progression|153|||
33237959|NCT01023308|100772400|FG000|Overall Study|New Cancer therapy|4|||
33237960|NCT01023308|100772401|FG001|Overall Study|New Cancer therapy|7|||
33237961|NCT01023308|100772400|FG000|Overall Study|Protocol Violation|3|||
33237962|NCT01023308|100772401|FG001|Overall Study|Protocol Violation|4|||
33237963|NCT01023308|100772400|FG000|Overall Study|Untreated|5|||
33237964|NCT01023308|100772401|FG001|Overall Study|Untreated|5|||
33237965|NCT01023308|100772400|FG000|Overall Study|Lost to Follow-up|1|||
33237966|NCT01023308|100772401|FG001|Overall Study|Lost to Follow-up|0|||
33237967|NCT01023308|100772400|FG000|Overall Study|Withdrawal by Subject|34|||
33237968|NCT01023308|100772401|FG001|Overall Study|Withdrawal by Subject|18|||
33237969|NCT02015663|100772403|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
33237970|NCT02015663|100772404|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
33237971|NCT02015663|100772403|FG000|Overall Study|Withdrawal by Subject|1|||
33237972|NCT02015663|100772404|FG001|Overall Study|Withdrawal by Subject|0|||
33237973|NCT02015663|100772403|FG000|Overall Study|Protocol Violation|0|||
33237974|NCT02015663|100772404|FG001|Overall Study|Protocol Violation|1|||
33237975|NCT02015663|100772403|FG000|Overall Study|Adverse Event|3|||
33237976|NCT02015663|100772404|FG001|Overall Study|Adverse Event|0|||
33638801|NCT01709084|102229361|FG000|Overall Study|Withdrawal by Subject|2|||
33638802|NCT01709084|102229362|FG001|Overall Study|Withdrawal by Subject|2|||
33638803|NCT01709084|102229361|FG000|Overall Study|Adverse Event|5|||
33638804|NCT01709084|102229362|FG001|Overall Study|Adverse Event|0|||
33369645|NCT03569293|101239840|FG003|Overall Study|Other|1|||
33369646|NCT03569293|101239841|FG004|Overall Study|Other|0|||
33369647|NCT03569293|101239842|FG005|Overall Study|Other|0|||
33369648|NCT03569293|101239837|FG000|Overall Study|Ongoing at Time of Analysis|8|||
33369649|NCT03569293|101239838|FG001|Overall Study|Ongoing at Time of Analysis|1|||
33369650|NCT03569293|101239839|FG002|Overall Study|Ongoing at Time of Analysis|3|||
33369651|NCT03569293|101239840|FG003|Overall Study|Ongoing at Time of Analysis|0|||
33369652|NCT03569293|101239841|FG004|Overall Study|Ongoing at Time of Analysis|0|||
33369653|NCT03569293|101239842|FG005|Overall Study|Ongoing at Time of Analysis|0|||
33369654|NCT01096446|101239846|FG000|Overall Study|Death|1|||
33369655|NCT01096446|101239847|FG001|Overall Study|Death|0|||
33369656|NCT01096446|101239846|FG000|Overall Study|Protocol Violation|2|||
33369657|NCT01096446|101239847|FG001|Overall Study|Protocol Violation|0|||
33369658|NCT01242020|101239850|FG000|Overall Study|Withdrawal by Subject|2|||
33369659|NCT01242020|101239851|FG001|Overall Study|Withdrawal by Subject|0|||
33369660|NCT01242020|101239850|FG000|Overall Study|Failed screening|1|||
33369661|NCT01242020|101239851|FG001|Overall Study|Failed screening|0|||
33369662|NCT02179515|101239856|FG000|Overall Study|switched to alternative treatment|0|||
33369663|NCT02179515|101239857|FG001|Overall Study|switched to alternative treatment|1|||
33369664|NCT02179515|101239858|FG002|Overall Study|switched to alternative treatment|1|||
33369665|NCT02179515|101239856|FG000|Overall Study|Death|0|||
33369666|NCT02179515|101239857|FG001|Overall Study|Death|1|||
33369667|NCT02179515|101239858|FG002|Overall Study|Death|1|||
33369668|NCT02179515|101239856|FG000|Overall Study|refused further treatment|0|||
33369669|NCT02179515|101239857|FG001|Overall Study|refused further treatment|3|||
33369670|NCT02179515|101239858|FG002|Overall Study|refused further treatment|4|||
33369671|NCT02179515|101239856|FG000|Overall Study|Disease progression on study|2|||
33369672|NCT02179515|101239857|FG001|Overall Study|Disease progression on study|11|||
33369673|NCT02179515|101239858|FG002|Overall Study|Disease progression on study|8|||
33369674|NCT02739594|101239861|FG000|Overall Study|Undesired Event|3|||
33369675|NCT02739594|101239862|FG001|Overall Study|Undesired Event|4|||
33369676|NCT02739594|101239861|FG000|Overall Study|Violation of Eligibility Criteria|1|||
33369677|NCT02739594|101239862|FG001|Overall Study|Violation of Eligibility Criteria|2|||
33369678|NCT02739594|101239861|FG000|Overall Study|Protocol Violation|5|||
33369679|NCT02739594|101239862|FG001|Overall Study|Protocol Violation|6|||
33369680|NCT02739594|101239861|FG000|Overall Study|Death|4|||
33369681|NCT02739594|101239862|FG001|Overall Study|Death|2|||
33369682|NCT02739594|101239861|FG000|Overall Study|Renal Insufficiency|4|||
33369683|NCT02739594|101239862|FG001|Overall Study|Renal Insufficiency|6|||
33369684|NCT02739594|101239861|FG000|Overall Study|Administrative Reasons|1|||
33369685|NCT02739594|101239862|FG001|Overall Study|Administrative Reasons|3|||
33369686|NCT02739594|101239861|FG000|Overall Study|Withdrawal by Subject|1|||
33369687|NCT02739594|101239862|FG001|Overall Study|Withdrawal by Subject|1|||
33369688|NCT02739594|101239861|FG000|Overall Study|Lost to Follow-up|0|||
33369689|NCT02739594|101239862|FG001|Overall Study|Lost to Follow-up|1|||
33369690|NCT02739594|101239861|FG000|Overall Study|Elevated Serum Creatinine|0|||
33369691|NCT02739594|101239862|FG001|Overall Study|Elevated Serum Creatinine|1|||
33369692|NCT02739594|101239861|FG000|Overall Study|Other|6|||
33369693|NCT02739594|101239862|FG001|Overall Study|Other|2|||
33369694|NCT00972244|101239863|FG000|Overall Study|Incorrect Enrolment|1|||
33369695|NCT00972244|101239864|FG001|Overall Study|Incorrect Enrolment|0|||
33578835|NCT01791517|102009596|FG011|Phase I: Period 3|Lens Discomfort|1|||
33578836|NCT01791517|102009585|FG000|Phase I: Period 3|Lost to Follow-up|0|||
33578837|NCT01791517|102009586|FG001|Phase I: Period 3|Lost to Follow-up|1|||
33578838|NCT01791517|102009587|FG002|Phase I: Period 3|Lost to Follow-up|0|||
33578839|NCT01791517|102009588|FG003|Phase I: Period 3|Lost to Follow-up|0|||
33578840|NCT01791517|102009589|FG004|Phase I: Period 3|Lost to Follow-up|1|||
33578841|NCT01791517|102009590|FG005|Phase I: Period 3|Lost to Follow-up|0|||
33578842|NCT01791517|102009591|FG006|Phase I: Period 3|Lost to Follow-up|0|||
33578843|NCT01791517|102009592|FG007|Phase I: Period 3|Lost to Follow-up|0|||
33578844|NCT01791517|102009593|FG008|Phase I: Period 3|Lost to Follow-up|0|||
33578845|NCT01791517|102009594|FG009|Phase I: Period 3|Lost to Follow-up|0|||
33578846|NCT01791517|102009595|FG010|Phase I: Period 3|Lost to Follow-up|0|||
33578847|NCT01791517|102009596|FG011|Phase I: Period 3|Lost to Follow-up|0|||
33578848|NCT01791517|102009585|FG000|Phase I: Period 3|Adverse Event|0|||
33578849|NCT01791517|102009586|FG001|Phase I: Period 3|Adverse Event|0|||
33578850|NCT01791517|102009587|FG002|Phase I: Period 3|Adverse Event|0|||
33578851|NCT01791517|102009588|FG003|Phase I: Period 3|Adverse Event|1|||
33369696|NCT00972244|101239865|FG002|Overall Study|Incorrect Enrolment|0|||
33369697|NCT00972244|101239866|FG003|Overall Study|Incorrect Enrolment|0|||
33369698|NCT00972244|101239867|FG004|Overall Study|Incorrect Enrolment|0|||
33369699|NCT00972244|101239863|FG000|Overall Study|Adverse Event|0|||
33578852|NCT01791517|102009589|FG004|Phase I: Period 3|Adverse Event|0|||
33578853|NCT01791517|102009590|FG005|Phase I: Period 3|Adverse Event|0|||
33578854|NCT01791517|102009591|FG006|Phase I: Period 3|Adverse Event|0|||
33578855|NCT01791517|102009592|FG007|Phase I: Period 3|Adverse Event|0|||
33369700|NCT00972244|101239864|FG001|Overall Study|Adverse Event|1|||
33369701|NCT00972244|101239865|FG002|Overall Study|Adverse Event|1|||
33578856|NCT01791517|102009593|FG008|Phase I: Period 3|Adverse Event|0|||
33578857|NCT01791517|102009594|FG009|Phase I: Period 3|Adverse Event|0|||
33578858|NCT01791517|102009595|FG010|Phase I: Period 3|Adverse Event|0|||
33578859|NCT01791517|102009596|FG011|Phase I: Period 3|Adverse Event|0|||
33578860|NCT01791517|102009585|FG000|Phase II|Lost to Follow-up|1|||
33578861|NCT01791517|102009586|FG001|Phase II|Lost to Follow-up|0|||
33139795|NCT02946931|100427835|FG000|Overall Study|Did not require collection of CRFs|588|||
33139796|NCT02946931|100427835|FG000|Overall Study|Other than listed|37|||
33638805|NCT01709084|102229361|FG000|Overall Study|Other|5|||
33638806|NCT01709084|102229362|FG001|Overall Study|Other|3|||
33638807|NCT01709084|102229361|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
33638808|NCT01709084|102229362|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
33638809|NCT01709084|102229361|FG000|Overall Study|Not Treated|0|||
33638810|NCT01709084|102229362|FG001|Overall Study|Not Treated|2|||
33578862|NCT01791517|102009587|FG002|Phase II|Lost to Follow-up|1|||
33578863|NCT01791517|102009588|FG003|Phase II|Lost to Follow-up|0|||
33578864|NCT01791517|102009589|FG004|Phase II|Lost to Follow-up|1|||
33578865|NCT01791517|102009590|FG005|Phase II|Lost to Follow-up|2|||
33578866|NCT01791517|102009591|FG006|Phase II|Lost to Follow-up|0|||
33578867|NCT01791517|102009592|FG007|Phase II|Lost to Follow-up|1|||
33578868|NCT01791517|102009593|FG008|Phase II|Lost to Follow-up|1|||
33578869|NCT01791517|102009594|FG009|Phase II|Lost to Follow-up|1|||
33578870|NCT01791517|102009595|FG010|Phase II|Lost to Follow-up|0|||
33578871|NCT01791517|102009596|FG011|Phase II|Lost to Follow-up|0|||
33578872|NCT01791517|102009585|FG000|Phase II|Withdrawal by Subject|1|||
33578873|NCT01791517|102009586|FG001|Phase II|Withdrawal by Subject|0|||
33578874|NCT01791517|102009587|FG002|Phase II|Withdrawal by Subject|0|||
33578875|NCT01791517|102009588|FG003|Phase II|Withdrawal by Subject|0|||
33578876|NCT01791517|102009589|FG004|Phase II|Withdrawal by Subject|0|||
33578877|NCT01791517|102009590|FG005|Phase II|Withdrawal by Subject|2|||
33578878|NCT01791517|102009591|FG006|Phase II|Withdrawal by Subject|0|||
33578879|NCT01791517|102009592|FG007|Phase II|Withdrawal by Subject|1|||
33578880|NCT01791517|102009593|FG008|Phase II|Withdrawal by Subject|0|||
33578881|NCT01791517|102009594|FG009|Phase II|Withdrawal by Subject|0|||
33578882|NCT01791517|102009595|FG010|Phase II|Withdrawal by Subject|1|||
33638811|NCT04396639|102229363|FG000|Overall Study|Withdrawal by Subject|1|||
33638812|NCT04396639|102229363|FG000|Overall Study|Other|1|||
33638813|NCT01942837|102229364|FG000|Overall Study|Death|1|||
33638814|NCT01942837|102229364|FG000|Overall Study|Symptomatic or radiographic progression|49|||
33638815|NCT01942837|102229364|FG000|Overall Study|Adverse Event|6|||
33638816|NCT01942837|102229364|FG000|Overall Study|Physician Decision|3|||
33139797|NCT02946931|100427835|FG000|Overall Study|Discharge from hospital|118|||
33139798|NCT02946931|100427835|FG000|Overall Study|Adverse Event|81|||
33139799|NCT02946931|100427835|FG000|Overall Study|CRFs not valid|1|||
33139800|NCT02946931|100427835|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
33139801|NCT01106092|100427839|FG000|Overall Study|Withdrawal by Subject|0|||
33139802|NCT01106092|100427840|FG001|Overall Study|Withdrawal by Subject|0|||
33139803|NCT01106092|100427841|FG002|Overall Study|Withdrawal by Subject|0|||
33139804|NCT01106092|100427842|FG003|Overall Study|Withdrawal by Subject|1|||
33578883|NCT01791517|102009596|FG011|Phase II|Withdrawal by Subject|0|||
33638817|NCT01942837|102229364|FG000|Overall Study|Withdrawal by Subject|2|||
33139805|NCT01743001|100427845|FG000|Overall Study|Physician Decision|1|||
33139806|NCT01743001|100427846|FG001|Overall Study|Physician Decision|0|||
33139807|NCT01743001|100427845|FG000|Overall Study|Pregnancy|1|||
33139808|NCT01743001|100427846|FG001|Overall Study|Pregnancy|0|||
33139809|NCT01743001|100427845|FG000|Overall Study|Death|1|||
33139810|NCT01743001|100427846|FG001|Overall Study|Death|0|||
33139811|NCT00362180|100427847|FG000|Treated Period|Withdrawal by Subject|1|||
33369702|NCT00972244|101239866|FG003|Overall Study|Adverse Event|0|||
33369703|NCT00972244|101239867|FG004|Overall Study|Adverse Event|0|||
33369704|NCT00972244|101239863|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
33369705|NCT00972244|101239864|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
33369706|NCT00972244|101239865|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
33369707|NCT00972244|101239866|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
33369708|NCT00972244|101239867|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
33369709|NCT00972244|101239863|FG000|Overall Study|Withdrawal by Subject|1|||
33369710|NCT00972244|101239864|FG001|Overall Study|Withdrawal by Subject|2|||
33369711|NCT00972244|101239865|FG002|Overall Study|Withdrawal by Subject|1|||
33369712|NCT00972244|101239866|FG003|Overall Study|Withdrawal by Subject|0|||
33578884|NCT01791517|102009585|FG000|Phase II|Lack of Efficacy|0|||
33578885|NCT01791517|102009586|FG001|Phase II|Lack of Efficacy|0|||
33578886|NCT01791517|102009587|FG002|Phase II|Lack of Efficacy|0|||
33578887|NCT01791517|102009588|FG003|Phase II|Lack of Efficacy|0|||
33578888|NCT01791517|102009589|FG004|Phase II|Lack of Efficacy|1|||
33578889|NCT01791517|102009590|FG005|Phase II|Lack of Efficacy|0|||
33578890|NCT01791517|102009591|FG006|Phase II|Lack of Efficacy|0|||
33578891|NCT01791517|102009592|FG007|Phase II|Lack of Efficacy|0|||
33638818|NCT01942837|102229364|FG000|Overall Study|Intercurrent Illness|1|||
33638819|NCT01942837|102229364|FG000|Overall Study|On treatment|3|||
33638820|NCT01942837|102229364|FG000|Overall Study|Never initiate the treatment|2|||
33638821|NCT00275509|102229366|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
33578892|NCT01791517|102009593|FG008|Phase II|Lack of Efficacy|0|||
33578893|NCT01791517|102009594|FG009|Phase II|Lack of Efficacy|0|||
33578894|NCT01791517|102009595|FG010|Phase II|Lack of Efficacy|0|||
33578895|NCT01791517|102009596|FG011|Phase II|Lack of Efficacy|0|||
33578896|NCT01791517|102009585|FG000|Phase II|Adverse Event|0|||
33578897|NCT01791517|102009586|FG001|Phase II|Adverse Event|0|||
33578898|NCT01791517|102009587|FG002|Phase II|Adverse Event|0|||
33578899|NCT01791517|102009588|FG003|Phase II|Adverse Event|0|||
33578900|NCT01791517|102009589|FG004|Phase II|Adverse Event|0|||
33578901|NCT01791517|102009590|FG005|Phase II|Adverse Event|0|||
33578902|NCT01791517|102009591|FG006|Phase II|Adverse Event|2|||
33578903|NCT01791517|102009592|FG007|Phase II|Adverse Event|1|||
33578904|NCT01791517|102009593|FG008|Phase II|Adverse Event|0|||
33578905|NCT01791517|102009594|FG009|Phase II|Adverse Event|1|||
33578906|NCT01791517|102009595|FG010|Phase II|Adverse Event|0|||
33578907|NCT01791517|102009596|FG011|Phase II|Adverse Event|0|||
33578908|NCT01791517|102009585|FG000|Phase II|Lens Handling Difficulties|0|||
33578909|NCT01791517|102009586|FG001|Phase II|Lens Handling Difficulties|0|||
33578910|NCT01791517|102009587|FG002|Phase II|Lens Handling Difficulties|0|||
33578911|NCT01791517|102009588|FG003|Phase II|Lens Handling Difficulties|0|||
33578912|NCT01791517|102009589|FG004|Phase II|Lens Handling Difficulties|0|||
33578913|NCT01791517|102009590|FG005|Phase II|Lens Handling Difficulties|0|||
33578914|NCT01791517|102009591|FG006|Phase II|Lens Handling Difficulties|0|||
33578915|NCT01791517|102009592|FG007|Phase II|Lens Handling Difficulties|0|||
33578916|NCT01791517|102009593|FG008|Phase II|Lens Handling Difficulties|1|||
33578917|NCT01791517|102009594|FG009|Phase II|Lens Handling Difficulties|0|||
33578918|NCT01791517|102009595|FG010|Phase II|Lens Handling Difficulties|0|||
33578919|NCT01791517|102009596|FG011|Phase II|Lens Handling Difficulties|0|||
33578920|NCT01791517|102009585|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
33578921|NCT01791517|102009586|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
33578922|NCT01791517|102009587|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
33638822|NCT00275509|102229367|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
33638823|NCT01120964|102229368|FG000|Overall Study|Did not receive full treatment|1|||
33638824|NCT01120964|102229369|FG001|Overall Study|Did not receive full treatment|0|||
33638825|NCT00473564|102229370|FG000|Overall Study|robot surgery aborted in OR|23|||
33638826|NCT00043979|102229371|FG000|Period 1|recipient with progressive disease|7|||
33638827|NCT00043979|102229372|FG001|Period 1|recipient with progressive disease|4|||
33638828|NCT00043979|102229373|FG002|Period 1|recipient with progressive disease|3|||
33638829|NCT00658359|102229376|FG000|Overall Study|Death|3|||
33638830|NCT00658359|102229377|FG001|Overall Study|Death|1|||
33638831|NCT00658359|102229378|FG002|Overall Study|Death|2|||
33638832|NCT00658359|102229376|FG000|Overall Study|Adverse Event|13|||
33638833|NCT00658359|102229377|FG001|Overall Study|Adverse Event|6|||
33638834|NCT00658359|102229378|FG002|Overall Study|Adverse Event|9|||
33638835|NCT00658359|102229376|FG000|Overall Study|Protocol Violation|1|||
33638836|NCT00658359|102229377|FG001|Overall Study|Protocol Violation|0|||
33638837|NCT00658359|102229378|FG002|Overall Study|Protocol Violation|0|||
33638838|NCT00658359|102229376|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
33638839|NCT00658359|102229377|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
33638840|NCT00658359|102229378|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
33638841|NCT00658359|102229376|FG000|Overall Study|Withdrawal by Subject|7|||
33638842|NCT00658359|102229377|FG001|Overall Study|Withdrawal by Subject|4|||
33578923|NCT01791517|102009588|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
33578924|NCT01791517|102009589|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
33578925|NCT01791517|102009590|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
33578926|NCT01791517|102009591|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
33638843|NCT00658359|102229378|FG002|Overall Study|Withdrawal by Subject|2|||
33638844|NCT00658359|102229376|FG000|Overall Study|Lost to Follow-up|2|||
33638845|NCT00658359|102229377|FG001|Overall Study|Lost to Follow-up|2|||
33638846|NCT00658359|102229378|FG002|Overall Study|Lost to Follow-up|4|||
33638847|NCT00658359|102229376|FG000|Overall Study|Lack of Efficacy|0|||
33638848|NCT00658359|102229377|FG001|Overall Study|Lack of Efficacy|1|||
33638849|NCT00658359|102229378|FG002|Overall Study|Lack of Efficacy|0|||
33638850|NCT02392624|102229379|FG000|Overall Study|Withdrawal by Subject|15|||
33638851|NCT02392624|102229380|FG001|Overall Study|Withdrawal by Subject|12|||
33578927|NCT01791517|102009592|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
33578928|NCT01791517|102009593|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
33578929|NCT01791517|102009594|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
33578930|NCT01791517|102009595|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
33578931|NCT01791517|102009596|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
33578932|NCT01791517|102009585|FG000|Phase II|Pre-Existing Ocular Issue|0|||
33638852|NCT02392624|102229381|FG002|Overall Study|Withdrawal by Subject|9|||
33638853|NCT02392624|102229379|FG000|Overall Study|Adverse Event|4|||
33638854|NCT02392624|102229380|FG001|Overall Study|Adverse Event|1|||
33638855|NCT02392624|102229381|FG002|Overall Study|Adverse Event|2|||
33638856|NCT02392624|102229379|FG000|Overall Study|Pregnancy|1|||
33638857|NCT02392624|102229380|FG001|Overall Study|Pregnancy|0|||
33638858|NCT02392624|102229381|FG002|Overall Study|Pregnancy|0|||
33638859|NCT02392624|102229379|FG000|Overall Study|Protocol Violation|0|||
33638860|NCT02392624|102229380|FG001|Overall Study|Protocol Violation|0|||
33638861|NCT02392624|102229381|FG002|Overall Study|Protocol Violation|1|||
33638862|NCT02392624|102229379|FG000|Overall Study|Sponsor/Investigator Decision|2|||
33237977|NCT02015663|100772403|FG000|Overall Study|Administrative problems|10|||
33237978|NCT02015663|100772404|FG001|Overall Study|Administrative problems|11|||
33237979|NCT02015195|100772406|FG000|Overall Study|Adverse Event|0|||
33638863|NCT02392624|102229380|FG001|Overall Study|Sponsor/Investigator Decision|1|||
33638864|NCT02392624|102229381|FG002|Overall Study|Sponsor/Investigator Decision|0|||
33638865|NCT02392624|102229379|FG000|Overall Study|Other|49|||
33638866|NCT02392624|102229380|FG001|Overall Study|Other|1|||
33638867|NCT02392624|102229381|FG002|Overall Study|Other|1|||
33638868|NCT02633306|102229382|FG000|Overall Study|Withdrawal by Subject|3|||
33638869|NCT02318706|102229383|FG000|Double-blind Phase|Adverse Event|7|||
33638870|NCT02318706|102229384|FG001|Double-blind Phase|Adverse Event|4|||
33638871|NCT02318706|102229385|FG002|Double-blind Phase|Adverse Event|3|||
33638872|NCT02318706|102229386|FG003|Double-blind Phase|Adverse Event|10|||
33638873|NCT02318706|102229387|FG004|Double-blind Phase|Adverse Event|0|||
33638874|NCT02318706|102229383|FG000|Double-blind Phase|Lost to Follow-up|1|||
33638875|NCT02318706|102229384|FG001|Double-blind Phase|Lost to Follow-up|0|||
33369713|NCT00972244|101239867|FG004|Overall Study|Withdrawal by Subject|1|||
33237980|NCT02015195|100772407|FG001|Overall Study|Adverse Event|0|||
33237981|NCT02015195|100772408|FG002|Overall Study|Adverse Event|0|||
33369714|NCT00972244|101239863|FG000|Overall Study|Safety|0|||
33578933|NCT01791517|102009586|FG001|Phase II|Pre-Existing Ocular Issue|0|||
33578934|NCT01791517|102009587|FG002|Phase II|Pre-Existing Ocular Issue|0|||
33578935|NCT01791517|102009588|FG003|Phase II|Pre-Existing Ocular Issue|0|||
33578936|NCT01791517|102009589|FG004|Phase II|Pre-Existing Ocular Issue|0|||
33578937|NCT01791517|102009590|FG005|Phase II|Pre-Existing Ocular Issue|0|||
33578938|NCT01791517|102009591|FG006|Phase II|Pre-Existing Ocular Issue|0|||
33578939|NCT01791517|102009592|FG007|Phase II|Pre-Existing Ocular Issue|0|||
33578940|NCT01791517|102009593|FG008|Phase II|Pre-Existing Ocular Issue|0|||
33578941|NCT01791517|102009594|FG009|Phase II|Pre-Existing Ocular Issue|0|||
33578942|NCT01791517|102009595|FG010|Phase II|Pre-Existing Ocular Issue|0|||
33578943|NCT01791517|102009596|FG011|Phase II|Pre-Existing Ocular Issue|1|||
33578944|NCT03386435|102009597|FG000|Overall Study|Protocol Violation|5|||
33578945|NCT03386435|102009598|FG001|Overall Study|Protocol Violation|7|||
33578946|NCT00784368|102009606|FG000|Overall Study|Physician Decision|0|||
33578947|NCT00784368|102009607|FG001|Overall Study|Physician Decision|0|||
33578948|NCT00784368|102009608|FG002|Overall Study|Physician Decision|6|||
33578949|NCT00784368|102009606|FG000|Overall Study|Lack of Efficacy|2|||
33578950|NCT00784368|102009607|FG001|Overall Study|Lack of Efficacy|0|||
33578951|NCT00784368|102009608|FG002|Overall Study|Lack of Efficacy|1|||
33578952|NCT00784368|102009606|FG000|Overall Study|Adverse Event|6|||
33578953|NCT00784368|102009607|FG001|Overall Study|Adverse Event|9|||
33578954|NCT00784368|102009608|FG002|Overall Study|Adverse Event|2|||
33578955|NCT00784368|102009606|FG000|Overall Study|Diagnosis of fever|0|||
33578956|NCT00784368|102009607|FG001|Overall Study|Diagnosis of fever|0|||
33638876|NCT02318706|102229385|FG002|Double-blind Phase|Lost to Follow-up|0|||
33638877|NCT02318706|102229386|FG003|Double-blind Phase|Lost to Follow-up|0|||
33638878|NCT02318706|102229387|FG004|Double-blind Phase|Lost to Follow-up|0|||
33578957|NCT00784368|102009608|FG002|Overall Study|Diagnosis of fever|1|||
33638879|NCT02318706|102229383|FG000|Double-blind Phase|Protocol Violation|4|||
33638880|NCT02318706|102229384|FG001|Double-blind Phase|Protocol Violation|2|||
33638881|NCT02318706|102229385|FG002|Double-blind Phase|Protocol Violation|4|||
33237982|NCT02015195|100772409|FG003|Overall Study|Adverse Event|1|||
33237983|NCT02015195|100772410|FG004|Overall Study|Adverse Event|0|||
33237984|NCT02015195|100772411|FG005|Overall Study|Adverse Event|0|||
33578958|NCT00784368|102009606|FG000|Overall Study|Worsening of complications|0|||
33237985|NCT02015195|100772412|FG006|Overall Study|Adverse Event|0|||
33237986|NCT00146640|100772413|FG000|Overall Study|Adverse Event|12|||
33237987|NCT00146640|100772414|FG001|Overall Study|Adverse Event|10|||
33237988|NCT00146640|100772413|FG000|Overall Study|Medical Reasons|3|||
33578959|NCT00784368|102009607|FG001|Overall Study|Worsening of complications|0|||
33237989|NCT00146640|100772414|FG001|Overall Study|Medical Reasons|0|||
33237990|NCT00146640|100772413|FG000|Overall Study|Non-Medical Reasons|8|||
33237991|NCT00146640|100772414|FG001|Overall Study|Non-Medical Reasons|4|||
33369715|NCT00972244|101239864|FG001|Overall Study|Safety|0|||
33578960|NCT00784368|102009608|FG002|Overall Study|Worsening of complications|1|||
33578961|NCT00784368|102009606|FG000|Overall Study|Worsening of symptoms|0|||
33638882|NCT02318706|102229386|FG003|Double-blind Phase|Protocol Violation|3|||
33638883|NCT02318706|102229387|FG004|Double-blind Phase|Protocol Violation|0|||
33638884|NCT02318706|102229383|FG000|Double-blind Phase|Withdrawal by Subject|9|||
33638885|NCT02318706|102229384|FG001|Double-blind Phase|Withdrawal by Subject|5|||
33638886|NCT02318706|102229385|FG002|Double-blind Phase|Withdrawal by Subject|7|||
33578962|NCT00784368|102009607|FG001|Overall Study|Worsening of symptoms|1|||
33578963|NCT00784368|102009608|FG002|Overall Study|Worsening of symptoms|0|||
33578964|NCT00784368|102009606|FG000|Overall Study|Withdrawal of informed consent|0|||
33578965|NCT00784368|102009607|FG001|Overall Study|Withdrawal of informed consent|1|||
33578966|NCT00784368|102009608|FG002|Overall Study|Withdrawal of informed consent|0|||
33578967|NCT00427011|102009611|FG000|Overall Study|Adverse Event|10|||
33578968|NCT00427011|102009611|FG000|Overall Study|Withdrawal by Subject|1|||
33578969|NCT00427011|102009611|FG000|Overall Study|Lack of Efficacy|2|||
33578970|NCT00427011|102009611|FG000|Overall Study|Other|12|||
33578971|NCT03306433|102009612|FG000|Overall Study|Lost to Follow-up|3|||
33578972|NCT03306433|102009612|FG000|Overall Study|Patient did not have teeth extracted|1|||
33578973|NCT03306433|102009612|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
33578974|NCT00825994|102009615|FG000|Overall Study|Withdrawal by Subject|2|||
33578975|NCT00825994|102009615|FG000|Overall Study|Lost to Follow-up|1|||
33578976|NCT00825994|102009615|FG000|Overall Study|Protocol Violation|1|||
33578977|NCT00825994|102009615|FG000|Overall Study|Placebo Responder at V2|1|||
33578978|NCT00856323|102009616|FG000|Overall Study|Withdrawal by Subject|2|||
33578979|NCT00980148|102009622|FG000|Overall Study|Discharged from facility|89|||
33578980|NCT00980148|102009623|FG001|Overall Study|Discharged from facility|96|||
33578981|NCT00980148|102009622|FG000|Overall Study|Received other antichlamydia treatment|20|||
33578982|NCT00980148|102009623|FG001|Overall Study|Received other antichlamydia treatment|14|||
33578983|NCT00980148|102009622|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
33578984|NCT00980148|102009623|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
33578985|NCT00980148|102009622|FG000|Overall Study|Various other reasons|8|||
33578986|NCT00980148|102009623|FG001|Overall Study|Various other reasons|9|||
33578987|NCT03886493|102009624|FG000|Overall Study|Adverse Event|1|||
33638887|NCT02318706|102229386|FG003|Double-blind Phase|Withdrawal by Subject|10|||
33638888|NCT02318706|102229387|FG004|Double-blind Phase|Withdrawal by Subject|0|||
33139812|NCT00362180|100427848|FG001|Treated Period|Withdrawal by Subject|0|||
33139813|NCT00362180|100427849|FG002|Treated Period|Withdrawal by Subject|0|||
33369716|NCT00972244|101239865|FG002|Overall Study|Safety|0|||
33369717|NCT00972244|101239866|FG003|Overall Study|Safety|0|||
33369718|NCT00972244|101239867|FG004|Overall Study|Safety|1|||
33139814|NCT00362180|100427850|FG003|Treated Period|Withdrawal by Subject|0|||
33369719|NCT00972244|101239863|FG000|Overall Study|Death|1|||
33369720|NCT00972244|101239864|FG001|Overall Study|Death|0|||
33369721|NCT00972244|101239865|FG002|Overall Study|Death|0|||
33369722|NCT00972244|101239866|FG003|Overall Study|Death|0|||
33369723|NCT00972244|101239867|FG004|Overall Study|Death|0|||
33237992|NCT01440049|100772419|FG000|Overall Study|Adverse Event|5|||
33237993|NCT00691028|100775734|FG000|Open-label Period|Adverse Event|0|||
33237994|NCT00691028|100775735|FG001|Open-label Period|Adverse Event|0|||
33237995|NCT00691028|100775736|FG002|Open-label Period|Adverse Event|0|||
33237996|NCT00691028|100775737|FG003|Open-label Period|Adverse Event|16|||
33237997|NCT00691028|100775734|FG000|Open-label Period|Withdrawal by Subject|0|||
33237998|NCT00691028|100775735|FG001|Open-label Period|Withdrawal by Subject|0|||
33237999|NCT00691028|100775736|FG002|Open-label Period|Withdrawal by Subject|0|||
33238000|NCT00691028|100775737|FG003|Open-label Period|Withdrawal by Subject|3|||
33238001|NCT00691028|100775734|FG000|Open-label Period|not come to a hospital|0|||
33369724|NCT00972244|101239863|FG000|Overall Study|Various|0|||
33369725|NCT00972244|101239864|FG001|Overall Study|Various|0|||
33369726|NCT00972244|101239865|FG002|Overall Study|Various|0|||
33369727|NCT00972244|101239866|FG003|Overall Study|Various|0|||
33369728|NCT00972244|101239867|FG004|Overall Study|Various|2|||
33369729|NCT04285346|101239868|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
33369730|NCT04285346|101239869|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
33369731|NCT04285346|101239868|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
33578988|NCT00142792|102009625|FG000|Overall Study|Death|0|||
33578989|NCT00142792|102009626|FG001|Overall Study|Death|0|||
33578990|NCT00142792|102009627|FG002|Overall Study|Death|1|||
33638889|NCT02318706|102229383|FG000|Double-blind Phase|Other|4|||
33139815|NCT00362180|100427851|FG004|Treated Period|Withdrawal by Subject|0|||
33139816|NCT00362180|100427852|FG005|Treated Period|Withdrawal by Subject|0|||
33139817|NCT00362180|100427853|FG006|Treated Period|Withdrawal by Subject|0|||
33139818|NCT00362180|100427854|FG007|Treated Period|Withdrawal by Subject|0|||
33139819|NCT00362180|100427855|FG008|Treated Period|Withdrawal by Subject|0|||
33139820|NCT00362180|100427847|FG000|Treated Period|Adverse Event|0|||
33139821|NCT00362180|100427848|FG001|Treated Period|Adverse Event|0|||
33139822|NCT00362180|100427849|FG002|Treated Period|Adverse Event|0|||
33139823|NCT00362180|100427850|FG003|Treated Period|Adverse Event|0|||
33139824|NCT00362180|100427851|FG004|Treated Period|Adverse Event|0|||
33139825|NCT00362180|100427852|FG005|Treated Period|Adverse Event|1|||
33139826|NCT00362180|100427853|FG006|Treated Period|Adverse Event|0|||
33139827|NCT00362180|100427854|FG007|Treated Period|Adverse Event|1|||
33139828|NCT00362180|100427855|FG008|Treated Period|Adverse Event|0|||
33139829|NCT00745849|100427856|FG000|First Intervention|Withdrawal by Subject|0|||
33139830|NCT00745849|100427857|FG001|First Intervention|Withdrawal by Subject|1|||
33139831|NCT00745849|100427856|FG000|First Intervention|Lost to Follow-up|1|||
33139832|NCT00745849|100427857|FG001|First Intervention|Lost to Follow-up|1|||
33238002|NCT00691028|100775735|FG001|Open-label Period|not come to a hospital|0|||
33238003|NCT00691028|100775736|FG002|Open-label Period|not come to a hospital|0|||
33238004|NCT00691028|100775737|FG003|Open-label Period|not come to a hospital|1|||
33238005|NCT00691028|100775734|FG000|Double-blind Period|Adverse Event|8|||
33238006|NCT00691028|100775735|FG001|Double-blind Period|Adverse Event|9|||
33238007|NCT00691028|100775736|FG002|Double-blind Period|Adverse Event|6|||
33238008|NCT00691028|100775737|FG003|Double-blind Period|Adverse Event|0|||
33238009|NCT00691028|100775734|FG000|Double-blind Period|Lack of Efficacy|4|||
33238010|NCT00691028|100775735|FG001|Double-blind Period|Lack of Efficacy|3|||
33238011|NCT00691028|100775736|FG002|Double-blind Period|Lack of Efficacy|2|||
33238012|NCT00691028|100775737|FG003|Double-blind Period|Lack of Efficacy|0|||
33238013|NCT00691028|100775734|FG000|Double-blind Period|Withdrawal by Subject|1|||
33238014|NCT00691028|100775735|FG001|Double-blind Period|Withdrawal by Subject|0|||
33238015|NCT00691028|100775736|FG002|Double-blind Period|Withdrawal by Subject|1|||
33238016|NCT00691028|100775737|FG003|Double-blind Period|Withdrawal by Subject|0|||
33238017|NCT00691028|100775734|FG000|Double-blind Period|not come to a hospital.|0|||
33238018|NCT00691028|100775735|FG001|Double-blind Period|not come to a hospital.|1|||
33238019|NCT00691028|100775736|FG002|Double-blind Period|not come to a hospital.|0|||
33238020|NCT00691028|100775737|FG003|Double-blind Period|not come to a hospital.|0|||
33238021|NCT00654238|100775740|FG000|Overall Study|Screen Failures|4|||
33238022|NCT01316692|100775744|FG000|Overall Study|Adverse Event|5|||
33238023|NCT01316692|100775744|FG000|Overall Study|Disease Progression|7|||
33238024|NCT00590980|100775745|FG000|Overall Study|Did not meet all inclusion criteria|10|||
33238025|NCT01755689|100775748|FG000|Overall Study|Withdrawal by Subject|1|||
33238026|NCT01755689|100775749|FG001|Overall Study|Withdrawal by Subject|3|||
33238027|NCT01755689|100775750|FG002|Overall Study|Withdrawal by Subject|2|||
33238028|NCT01755689|100775751|FG003|Overall Study|Withdrawal by Subject|1|||
33238029|NCT01755689|100775752|FG004|Overall Study|Withdrawal by Subject|1|||
33238030|NCT01755689|100775748|FG000|Overall Study|Migrated/moved from study area|0|||
33238031|NCT01755689|100775749|FG001|Overall Study|Migrated/moved from study area|1|||
33238032|NCT01755689|100775750|FG002|Overall Study|Migrated/moved from study area|1|||
33238033|NCT01755689|100775751|FG003|Overall Study|Migrated/moved from study area|1|||
33238034|NCT01755689|100775752|FG004|Overall Study|Migrated/moved from study area|1|||
33238035|NCT01755689|100775748|FG000|Overall Study|Lost to Follow-up|1|||
33238036|NCT01755689|100775749|FG001|Overall Study|Lost to Follow-up|0|||
33238037|NCT01755689|100775750|FG002|Overall Study|Lost to Follow-up|1|||
33238038|NCT01755689|100775751|FG003|Overall Study|Lost to Follow-up|0|||
33238039|NCT01755689|100775752|FG004|Overall Study|Lost to Follow-up|2|||
33238040|NCT01755689|100775748|FG000|Overall Study|Pregnancy|1|||
33238041|NCT01755689|100775749|FG001|Overall Study|Pregnancy|1|||
33238042|NCT01755689|100775750|FG002|Overall Study|Pregnancy|2|||
33238043|NCT01755689|100775751|FG003|Overall Study|Pregnancy|4|||
33238044|NCT01755689|100775752|FG004|Overall Study|Pregnancy|2|||
33238045|NCT00997243|100775753|FG000|Overall Study|Early termination of study by sponsor|7|||
33238046|NCT03255941|100775755|FG000|Overall Study|Not eligible or refused injection|37|||
33238047|NCT03255941|100775756|FG001|Overall Study|Not eligible or refused injection|44|||
33369732|NCT04285346|101239869|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
33369733|NCT04285346|101239868|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
33369734|NCT04285346|101239869|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
33369735|NCT01793051|101239875|FG000|Overall Study|Withdrawal by Subject|6|||
33369736|NCT01793051|101239876|FG001|Overall Study|Withdrawal by Subject|4|||
33369737|NCT01793051|101239875|FG000|Overall Study|Adverse Event|0|||
33369738|NCT01793051|101239876|FG001|Overall Study|Adverse Event|2|||
33369739|NCT01793051|101239875|FG000|Overall Study|Too ill to continue|1|||
33369740|NCT01793051|101239876|FG001|Overall Study|Too ill to continue|0|||
33578991|NCT00142792|102009625|FG000|Overall Study|Withdrawal by Subject|3|||
33578992|NCT00142792|102009626|FG001|Overall Study|Withdrawal by Subject|2|||
33578993|NCT00142792|102009627|FG002|Overall Study|Withdrawal by Subject|3|||
33578994|NCT00142792|102009625|FG000|Overall Study|Lost to Follow-up|8|||
33578995|NCT00142792|102009626|FG001|Overall Study|Lost to Follow-up|11|||
33238048|NCT03255941|100775757|FG002|Overall Study|Not eligible or refused injection|5|||
33238049|NCT03255941|100775758|FG003|Overall Study|Not eligible or refused injection|6|||
33238050|NCT03255941|100775755|FG000|Overall Study|Did not complete exit interview|1|||
33238051|NCT03255941|100775756|FG001|Overall Study|Did not complete exit interview|2|||
33238052|NCT03255941|100775757|FG002|Overall Study|Did not complete exit interview|0|||
33238053|NCT03255941|100775758|FG003|Overall Study|Did not complete exit interview|0|||
33238054|NCT01719861|100775765|FG000|Cycle 1|Death|4|||
33238055|NCT01719861|100775765|FG000|Cycle 2|Death|1|||
33238056|NCT01528709|100775766|FG000|Overall Study|Death|2|||
33238057|NCT01528709|100775767|FG001|Overall Study|Death|0|||
33238058|NCT01528709|100775766|FG000|Overall Study|Withdrawal by Subject|10|||
33238059|NCT01528709|100775767|FG001|Overall Study|Withdrawal by Subject|15|||
33238060|NCT01528709|100775766|FG000|Overall Study|allergy|1|||
33238061|NCT01528709|100775767|FG001|Overall Study|allergy|0|||
33369741|NCT01793051|101239875|FG000|Overall Study|Switched chemo|1|||
33369742|NCT01793051|101239876|FG001|Overall Study|Switched chemo|1|||
33578996|NCT00142792|102009627|FG002|Overall Study|Lost to Follow-up|7|||
33238062|NCT04319094|100775773|FG000|Baseline|Lost to Follow-up|4|||
33238063|NCT04319094|100775774|FG001|Baseline|Lost to Follow-up|5|||
33238064|NCT04319094|100775773|FG000|Baseline|Protocol Violation|0|||
33238065|NCT04319094|100775774|FG001|Baseline|Protocol Violation|3|||
33238066|NCT04319094|100775773|FG000|Baseline|Withdrawal by Subject|2|||
33238067|NCT04319094|100775774|FG001|Baseline|Withdrawal by Subject|1|||
33238068|NCT04319094|100775773|FG000|Post-Intervention|Death|0|||
33238069|NCT04319094|100775774|FG001|Post-Intervention|Death|1|||
33238070|NCT04319094|100775773|FG000|Post-Intervention|Lost to Follow-up|4|||
33238071|NCT04319094|100775774|FG001|Post-Intervention|Lost to Follow-up|4|||
33238072|NCT04319094|100775773|FG000|Post-Intervention|Withdrawal by Subject|8|||
33238073|NCT04319094|100775774|FG001|Post-Intervention|Withdrawal by Subject|5|||
33238074|NCT04319094|100775773|FG000|Post-Intervention|Incomplete Data Collection|1|||
33238075|NCT04319094|100775774|FG001|Post-Intervention|Incomplete Data Collection|3|||
33238076|NCT04319094|100775773|FG000|3-month|Death|1|||
33238077|NCT04319094|100775774|FG001|3-month|Death|0|||
33238078|NCT04319094|100775773|FG000|3-month|Lost to Follow-up|2|||
33238079|NCT04319094|100775774|FG001|3-month|Lost to Follow-up|2|||
33238080|NCT04319094|100775773|FG000|3-month|Withdrawal by Subject|0|||
33238081|NCT04319094|100775774|FG001|3-month|Withdrawal by Subject|3|||
33238082|NCT04319094|100775773|FG000|3-month|Incomplete data collection|9|||
33238083|NCT04319094|100775774|FG001|3-month|Incomplete data collection|7|||
33238084|NCT04319094|100775773|FG000|6-month|Lost to Follow-up|1|||
33238085|NCT04319094|100775774|FG001|6-month|Lost to Follow-up|1|||
33238086|NCT04319094|100775773|FG000|6-month|Withdrawal by Subject|0|||
33238087|NCT04319094|100775774|FG001|6-month|Withdrawal by Subject|3|||
33238088|NCT04319094|100775773|FG000|6-month|Incomplete data collection|14|||
33238089|NCT04319094|100775774|FG001|6-month|Incomplete data collection|9|||
33238090|NCT04319094|100775773|FG000|9-month|Lost to Follow-up|8|||
33238091|NCT04319094|100775774|FG001|9-month|Lost to Follow-up|4|||
33238092|NCT04319094|100775773|FG000|9-month|Withdrawal by Subject|0|||
33238093|NCT04319094|100775774|FG001|9-month|Withdrawal by Subject|1|||
33238094|NCT04319094|100775773|FG000|9-month|Incomplete data collection|8|||
33238095|NCT04319094|100775774|FG001|9-month|Incomplete data collection|5|||
33238096|NCT04319094|100775773|FG000|12-month|Lost to Follow-up|11|||
33238097|NCT04319094|100775774|FG001|12-month|Lost to Follow-up|8|||
33238098|NCT04545619|100775775|FG000|Overall Study|due to equipment challenges|1|||
33238099|NCT00999661|100775776|FG000|Overall Study|Lost to Follow-up|59|||
33238100|NCT00999661|100775776|FG000|Overall Study|Adverse Event|1|||
33238101|NCT00999661|100775776|FG000|Overall Study|Withdrawal by Subject|1|||
33238102|NCT00999661|100775776|FG000|Overall Study|Not meeting eligibility criteria|9|||
33578997|NCT00142792|102009625|FG000|Overall Study|No category|1|||
33578998|NCT00142792|102009626|FG001|Overall Study|No category|2|||
33578999|NCT00142792|102009627|FG002|Overall Study|No category|1|||
33579000|NCT01369199|102009628|FG000|Overall Study|Withdrawal by Subject|1|||
33579001|NCT01369199|102009628|FG000|Overall Study|Lost to Follow-up|2|||
33579002|NCT00856609|102009634|FG000|Overall Study|Adverse Event|1|||
33579003|NCT00856609|102009635|FG001|Overall Study|Adverse Event|0|||
33579004|NCT00811954|102009638|FG000|Overall Study|Death|10|||
33579005|NCT00811954|102009639|FG001|Overall Study|Death|6|||
33579006|NCT00811954|102009640|FG002|Overall Study|Death|13|||
33579007|NCT00811954|102009638|FG000|Overall Study|Lost to Follow-up|29|||
33579008|NCT00811954|102009639|FG001|Overall Study|Lost to Follow-up|23|||
33579009|NCT00811954|102009640|FG002|Overall Study|Lost to Follow-up|34|||
33579010|NCT00811954|102009638|FG000|Overall Study|Not able to get to clinic|28|||
33579011|NCT00811954|102009639|FG001|Overall Study|Not able to get to clinic|35|||
33579012|NCT00811954|102009640|FG002|Overall Study|Not able to get to clinic|30|||
33579013|NCT00811954|102009638|FG000|Overall Study|Not willing to adhere to requirements|12|||
33579014|NCT00811954|102009639|FG001|Overall Study|Not willing to adhere to requirements|2|||
33579015|NCT00811954|102009640|FG002|Overall Study|Not willing to adhere to requirements|16|||
33579016|NCT00811954|102009638|FG000|Overall Study|Withdraw consent prior study completion|4|||
33579017|NCT00811954|102009639|FG001|Overall Study|Withdraw consent prior study completion|6|||
33579018|NCT00811954|102009640|FG002|Overall Study|Withdraw consent prior study completion|5|||
33579019|NCT00811954|102009638|FG000|Overall Study|Site Closure|4|||
33579020|NCT00811954|102009639|FG001|Overall Study|Site Closure|0|||
33579021|NCT00811954|102009640|FG002|Overall Study|Site Closure|1|||
33579022|NCT00811954|102009638|FG000|Overall Study|Severe Debilitation|2|||
33579023|NCT00811954|102009639|FG001|Overall Study|Severe Debilitation|0|||
33238103|NCT02414828|100775779|FG000|Overall Study|Lost to Follow-up|0|||
33238104|NCT02414828|100775780|FG001|Overall Study|Lost to Follow-up|1|||
33238105|NCT02414828|100775781|FG002|Overall Study|Lost to Follow-up|1|||
33238106|NCT02414828|100775782|FG003|Overall Study|Lost to Follow-up|2|||
33238107|NCT00333138|100775783|FG000|Core Study (6 Months)|Adverse Event|4|||
33238108|NCT00333138|100775784|FG001|Core Study (6 Months)|Adverse Event|5|||
33238109|NCT00333138|100775785|FG002|Core Study (6 Months)|Adverse Event|8|||
33238110|NCT00333138|100775783|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
33238111|NCT00333138|100775784|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
33238112|NCT00333138|100775785|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
33579024|NCT00811954|102009640|FG002|Overall Study|Severe Debilitation|1|||
33139833|NCT00745849|100427856|FG000|Second Intervention|Lost to Follow-up|2|||
33139834|NCT00745849|100427857|FG001|Second Intervention|Lost to Follow-up|1|||
33139835|NCT03104816|100427858|FG000|Overall Study|Lack of Efficacy|0|||
33139836|NCT03104816|100427859|FG001|Overall Study|Lack of Efficacy|2|||
33139837|NCT03104816|100427860|FG002|Overall Study|Lack of Efficacy|0|||
33139838|NCT03104816|100427858|FG000|Overall Study|Protocol Violation|2|||
33139839|NCT03104816|100427859|FG001|Overall Study|Protocol Violation|0|||
33139840|NCT03104816|100427860|FG002|Overall Study|Protocol Violation|2|||
33139841|NCT00321646|100427861|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
33139842|NCT00321646|100427861|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
33139843|NCT00321646|100427861|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
33139844|NCT03985878|100427862|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
33139845|NCT03985878|100427862|FG000|Overall Study|Study Terminated by Sponsor|12|||
33139846|NCT03985878|100427862|FG000|Overall Study|Withdrawal by Subject|1|||
33139847|NCT00475423|100427867|FG000|Overall Study|Protocol Violation|5|||
33139848|NCT00475423|100427867|FG000|Overall Study|Adverse Event|4|||
33238113|NCT00333138|100775783|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
33238114|NCT00333138|100775784|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
33238115|NCT00333138|100775785|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
33238116|NCT00333138|100775783|FG000|Core Study (6 Months)|Protocol Violation|1|||
33238117|NCT00333138|100775784|FG001|Core Study (6 Months)|Protocol Violation|0|||
33238118|NCT00333138|100775785|FG002|Core Study (6 Months)|Protocol Violation|1|||
33238119|NCT00333138|100775783|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
33238120|NCT00333138|100775784|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
33238121|NCT00333138|100775785|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
33238122|NCT00333138|100775783|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
33238123|NCT00333138|100775784|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
33238124|NCT00333138|100775785|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
33369743|NCT01793051|101239875|FG000|Overall Study|Lack of compliance|1|||
33369744|NCT01793051|101239876|FG001|Overall Study|Lack of compliance|0|||
33369745|NCT01793051|101239875|FG000|Overall Study|Requested to be removed from the study|1|||
33369746|NCT01793051|101239876|FG001|Overall Study|Requested to be removed from the study|1|||
33238125|NCT00333138|100775783|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
33238126|NCT00333138|100775784|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
33238127|NCT00333138|100775785|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
33238128|NCT00333138|100775783|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
33369747|NCT01728584|101239877|FG000|Overall Study|Adverse Event|1|||
33369748|NCT01728584|101239878|FG001|Overall Study|Adverse Event|0|||
33369749|NCT01728584|101239879|FG002|Overall Study|Adverse Event|0|||
33369750|NCT01728584|101239880|FG003|Overall Study|Adverse Event|0|||
33369751|NCT01728584|101239877|FG000|Overall Study|Physician Decision|4|||
33369752|NCT01728584|101239878|FG001|Overall Study|Physician Decision|0|||
33369753|NCT01728584|101239879|FG002|Overall Study|Physician Decision|1|||
33369754|NCT01728584|101239880|FG003|Overall Study|Physician Decision|0|||
33369755|NCT01728584|101239877|FG000|Overall Study|Withdrawal by Subject|1|||
33369756|NCT01728584|101239878|FG001|Overall Study|Withdrawal by Subject|0|||
33369757|NCT01728584|101239879|FG002|Overall Study|Withdrawal by Subject|0|||
33369758|NCT01728584|101239880|FG003|Overall Study|Withdrawal by Subject|0|||
33369759|NCT01728584|101239877|FG000|Overall Study|Screen failure|1|||
33369760|NCT01728584|101239878|FG001|Overall Study|Screen failure|0|||
33369761|NCT01728584|101239879|FG002|Overall Study|Screen failure|0|||
33369762|NCT01728584|101239880|FG003|Overall Study|Screen failure|0|||
33369763|NCT01728584|101239877|FG000|Overall Study|Other reason (not specified)|1|||
33369764|NCT01728584|101239878|FG001|Overall Study|Other reason (not specified)|0|||
33369765|NCT01728584|101239879|FG002|Overall Study|Other reason (not specified)|0|||
33579025|NCT00811954|102009638|FG000|Overall Study|Complete Protocol: No follow-up|0|||
33579026|NCT00811954|102009639|FG001|Overall Study|Complete Protocol: No follow-up|0|||
33579027|NCT00811954|102009640|FG002|Overall Study|Complete Protocol: No follow-up|1|||
33238129|NCT00333138|100775784|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
33369766|NCT01728584|101239880|FG003|Overall Study|Other reason (not specified)|1|||
33369767|NCT01035606|101239881|FG000|Overall Study|change in health, job demands,family|3|||
33579028|NCT03154476|102009644|FG000|Overall Study|Lost to Follow-up|4|||
33139849|NCT00475423|100427867|FG000|Overall Study|Withdrawal by Subject|6|||
33139850|NCT00475423|100427867|FG000|Overall Study|Lack of Efficacy|8|||
33139851|NCT00475423|100427867|FG000|Overall Study|Death|1|||
33139852|NCT00475423|100427867|FG000|Overall Study|Reason not specified|1|||
33139853|NCT00475423|100427867|FG000|Overall Study|Lost to Follow-up|7|||
33139854|NCT01589770|100427868|FG000|Overall Study|EGFR <60ml/min|6|||
33139855|NCT01589770|100427869|FG001|Overall Study|EGFR <60ml/min|4|||
33139856|NCT01589770|100427868|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
33139857|NCT01589770|100427869|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
33369768|NCT01035606|101239882|FG001|Overall Study|change in health, job demands,family|3|||
33369769|NCT01035606|101239883|FG002|Overall Study|change in health, job demands,family|4|||
33139858|NCT02656680|100427870|FG000|Overall Study|Lost to Follow-up|0|||
33238130|NCT00333138|100775785|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
33369770|NCT01675531|101239884|FG000|Overall Study|Adverse Event|9|||
33369771|NCT01675531|101239884|FG000|Overall Study|Withdrawal by Subject|7|||
33369772|NCT01675531|101239884|FG000|Overall Study|Lack of Efficacy|1|||
33369773|NCT01675531|101239884|FG000|Overall Study|Protocol Violation|8|||
33369774|NCT04160468|101239885|FG000|Overall Study|Lost to Follow-up|19|||
33369775|NCT04160468|101239886|FG001|Overall Study|Lost to Follow-up|4|||
33238131|NCT00333138|100775783|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
33238132|NCT00333138|100775784|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
33238133|NCT00333138|100775785|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
33238134|NCT00333138|100775783|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
33238135|NCT00333138|100775784|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
33238136|NCT00333138|100775785|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
33238137|NCT00333138|100775783|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
33238138|NCT00333138|100775784|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
33238139|NCT00333138|100775785|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
33238140|NCT00333138|100775783|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
33369776|NCT04160468|101239885|FG000|Overall Study|Randomized but not dosed|6|||
33369777|NCT04160468|101239886|FG001|Overall Study|Randomized but not dosed|0|||
33369778|NCT04160468|101239885|FG000|Overall Study|Withdrawal by Subject|4|||
33238141|NCT00333138|100775784|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
33238142|NCT00333138|100775785|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
33238143|NCT00333138|100775783|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
33238144|NCT00333138|100775784|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
33238145|NCT00333138|100775785|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
33238146|NCT00333138|100775783|FG000|Extension Study (Month6 to End of Study)|Death|0|||
33238147|NCT00333138|100775784|FG001|Extension Study (Month6 to End of Study)|Death|1|||
33238148|NCT00333138|100775785|FG002|Extension Study (Month6 to End of Study)|Death|0|||
33238149|NCT02303574|100775791|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33238150|NCT02303574|100775792|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33238151|NCT02303574|100775793|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
33238152|NCT02303574|100775794|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33238153|NCT02303574|100775795|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33238154|NCT02303574|100775796|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33238155|NCT02303574|100775797|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33238156|NCT02303574|100775798|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33238157|NCT02303574|100775799|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33238158|NCT02303574|100775800|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
33238159|NCT02303574|100775791|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33238160|NCT02303574|100775792|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33238161|NCT02303574|100775793|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33238162|NCT02303574|100775794|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33238163|NCT02303574|100775795|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33238164|NCT02303574|100775796|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33238165|NCT02303574|100775797|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33238166|NCT02303574|100775798|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
33238167|NCT02303574|100775799|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33238168|NCT02303574|100775800|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
33238169|NCT04990440|100775808|FG000|Overall Study|Sponsor's Decision|0|||
33238170|NCT04990440|100775809|FG001|Overall Study|Sponsor's Decision|0|||
33238171|NCT04990440|100775810|FG002|Overall Study|Sponsor's Decision|1|||
33369779|NCT04160468|101239886|FG001|Overall Study|Withdrawal by Subject|1|||
33369780|NCT04160468|101239885|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
33369781|NCT04160468|101239886|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
33638890|NCT02318706|102229384|FG001|Double-blind Phase|Other|1|||
33638891|NCT02318706|102229385|FG002|Double-blind Phase|Other|2|||
33369782|NCT04160468|101239885|FG000|Overall Study|Participant incarcerated|1|||
33369783|NCT04160468|101239886|FG001|Overall Study|Participant incarcerated|0|||
33369784|NCT04436822|101239887|FG000|Overall Study|Physician Decision|2|||
33638892|NCT02318706|102229386|FG003|Double-blind Phase|Other|1|||
33638893|NCT02318706|102229387|FG004|Double-blind Phase|Other|0|||
33638894|NCT02318706|102229383|FG000|Double-blind Phase|Death|0|||
33139859|NCT02656680|100427871|FG001|Overall Study|Lost to Follow-up|1|||
33139860|NCT02656680|100427872|FG002|Overall Study|Lost to Follow-up|7|||
33139861|NCT03400956|100427873|FG000|Treatment Period 1|Adverse Event|0|||
33369785|NCT04436822|101239888|FG001|Overall Study|Physician Decision|0|||
33638895|NCT02318706|102229384|FG001|Double-blind Phase|Death|0|||
33638896|NCT02318706|102229385|FG002|Double-blind Phase|Death|2|||
33638897|NCT02318706|102229386|FG003|Double-blind Phase|Death|0|||
33139862|NCT03400956|100427874|FG001|Treatment Period 1|Adverse Event|1|||
33369786|NCT04436822|101239887|FG000|Overall Study|Sponsor request|1|||
33369787|NCT04436822|101239888|FG001|Overall Study|Sponsor request|0|||
33369788|NCT04436822|101239887|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33369789|NCT04436822|101239888|FG001|Overall Study|Withdrawal by parent/guardian|3|||
33369790|NCT04436822|101239887|FG000|Overall Study|Unsuccessful procedure|0|||
33369791|NCT04436822|101239888|FG001|Overall Study|Unsuccessful procedure|1|||
33369792|NCT04436822|101239887|FG000|Overall Study|Withdrawal due to Covid-19|8|||
33369793|NCT04436822|101239888|FG001|Overall Study|Withdrawal due to Covid-19|1|||
33369794|NCT04436822|101239887|FG000|Overall Study|Withdrawal by Subject|1|||
33369795|NCT04436822|101239888|FG001|Overall Study|Withdrawal by Subject|0|||
33369796|NCT04436822|101239887|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
33369797|NCT04436822|101239888|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
33369798|NCT01798134|101239889|FG000|Overall Study|Lost to Follow-up|1|||
33369799|NCT01798134|101239889|FG000|Overall Study|Withdrawal by Subject|3|||
33369800|NCT01798134|101239889|FG000|Overall Study|Death|2|||
33369801|NCT01798134|101239889|FG000|Overall Study|Adverse Event|3|||
33369802|NCT01798134|101239889|FG000|Overall Study|Physician Decision|3|||
33369803|NCT01798134|101239889|FG000|Overall Study|Liver transplant/surgery|4|||
33369804|NCT03161678|101239890|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
33369805|NCT03161678|101239891|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
33369806|NCT03161678|101239892|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
33369807|NCT03161678|101239893|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
33369808|NCT03161678|101239894|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
33369809|NCT03161678|101239895|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
33369810|NCT03161678|101239890|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
33369811|NCT03161678|101239891|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
33369812|NCT03161678|101239892|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
33579029|NCT03154476|102009645|FG001|Overall Study|Lost to Follow-up|4|||
33579030|NCT02131662|102009646|FG000|Overall Study|Protocol Violation|1|||
33579031|NCT02131662|102009647|FG001|Overall Study|Protocol Violation|0|||
33139863|NCT03400956|100427875|FG002|Treatment Period 1|Adverse Event|0|||
33139864|NCT03400956|100427873|FG000|Treatment Period 1|Lost to Follow-up|0|||
33139865|NCT03400956|100427874|FG001|Treatment Period 1|Lost to Follow-up|0|||
33139866|NCT03400956|100427875|FG002|Treatment Period 1|Lost to Follow-up|1|||
33139867|NCT03400956|100427873|FG000|Treatment Period 1|Protocol Violation|0|||
33139868|NCT03400956|100427874|FG001|Treatment Period 1|Protocol Violation|2|||
33139869|NCT03400956|100427875|FG002|Treatment Period 1|Protocol Violation|0|||
33139870|NCT03400956|100427873|FG000|Treatment Period 1|Study terminated by sponsor|3|||
33139871|NCT03400956|100427874|FG001|Treatment Period 1|Study terminated by sponsor|1|||
33139872|NCT03400956|100427875|FG002|Treatment Period 1|Study terminated by sponsor|1|||
33139873|NCT03400956|100427873|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33139874|NCT03400956|100427874|FG001|Treatment Period 1|Withdrawal by Subject|2|||
33139875|NCT03400956|100427875|FG002|Treatment Period 1|Withdrawal by Subject|4|||
33139876|NCT03400956|100427873|FG000|Treatment Period 1|Other|1|||
33139877|NCT03400956|100427874|FG001|Treatment Period 1|Other|2|||
33139878|NCT03400956|100427875|FG002|Treatment Period 1|Other|3|||
33369813|NCT03161678|101239893|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
33369814|NCT03161678|101239894|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
33579032|NCT02131662|102009648|FG002|Overall Study|Protocol Violation|0|||
33579033|NCT02131662|102009649|FG003|Overall Study|Protocol Violation|0|||
33579034|NCT02131662|102009650|FG004|Overall Study|Protocol Violation|0|||
33579035|NCT02131662|102009646|FG000|Overall Study|Other|2|||
33579036|NCT02131662|102009647|FG001|Overall Study|Other|4|||
33579037|NCT02131662|102009648|FG002|Overall Study|Other|3|||
33579038|NCT02131662|102009649|FG003|Overall Study|Other|3|||
33579039|NCT02131662|102009650|FG004|Overall Study|Other|4|||
33579040|NCT02131662|102009646|FG000|Overall Study|Adverse Event|0|||
33579041|NCT02131662|102009647|FG001|Overall Study|Adverse Event|1|||
33579042|NCT02131662|102009648|FG002|Overall Study|Adverse Event|1|||
33579043|NCT02131662|102009649|FG003|Overall Study|Adverse Event|1|||
33579044|NCT02131662|102009650|FG004|Overall Study|Adverse Event|3|||
33579045|NCT02131662|102009646|FG000|Overall Study|Pregnancy|0|||
33579046|NCT02131662|102009647|FG001|Overall Study|Pregnancy|1|||
33579047|NCT02131662|102009648|FG002|Overall Study|Pregnancy|0|||
33139879|NCT03400956|100427873|FG000|Post-treatment Period 1|Adverse Event|0|||
33579048|NCT02131662|102009649|FG003|Overall Study|Pregnancy|1|||
33579049|NCT02131662|102009650|FG004|Overall Study|Pregnancy|0|||
33579050|NCT02131662|102009646|FG000|Overall Study|Wish for pregnancy|0|||
33579051|NCT02131662|102009647|FG001|Overall Study|Wish for pregnancy|0|||
33139880|NCT03400956|100427874|FG001|Post-treatment Period 1|Adverse Event|0|||
33139881|NCT03400956|100427875|FG002|Post-treatment Period 1|Adverse Event|1|||
33139882|NCT03400956|100427873|FG000|Post-treatment Period 1|Physician Decision|2|||
33139883|NCT03400956|100427874|FG001|Post-treatment Period 1|Physician Decision|3|||
33139884|NCT03400956|100427875|FG002|Post-treatment Period 1|Physician Decision|0|||
33139885|NCT03400956|100427873|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
33579052|NCT02131662|102009648|FG002|Overall Study|Wish for pregnancy|0|||
33238172|NCT01333943|100775811|FG000|Overall Study|Known neuropathy|1|||
33638898|NCT02318706|102229387|FG004|Double-blind Phase|Death|0|||
33638899|NCT02318706|102229383|FG000|Open-label Extension Phase|Adverse Event|0|||
33638900|NCT02318706|102229384|FG001|Open-label Extension Phase|Adverse Event|0|||
33638901|NCT02318706|102229385|FG002|Open-label Extension Phase|Adverse Event|0|||
33638902|NCT02318706|102229386|FG003|Open-label Extension Phase|Adverse Event|0|||
33638903|NCT02318706|102229387|FG004|Open-label Extension Phase|Adverse Event|21|||
33638904|NCT02318706|102229383|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
33638905|NCT02318706|102229384|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
33638906|NCT02318706|102229385|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
33369815|NCT03161678|101239895|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
33369816|NCT03161678|101239890|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
33369817|NCT03161678|101239891|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
33369818|NCT03161678|101239892|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
33369819|NCT03161678|101239893|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
33369820|NCT03161678|101239894|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
33369821|NCT03161678|101239895|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
33369822|NCT03161678|101239890|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
33369823|NCT03161678|101239891|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
33369824|NCT03161678|101239892|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
33369825|NCT03161678|101239893|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
33369826|NCT03161678|101239894|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
33369827|NCT03161678|101239895|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
33369828|NCT03807739|101239896|FG000|Overall Study|Adverse Event|1|||
33369829|NCT03807739|101239897|FG001|Overall Study|Adverse Event|0|||
33369830|NCT03807739|101239898|FG002|Overall Study|Adverse Event|0|||
33369831|NCT03807739|101239899|FG003|Overall Study|Adverse Event|0|||
33369832|NCT03807739|101239896|FG000|Overall Study|Withdrawal by Subject|1|||
33369833|NCT03807739|101239897|FG001|Overall Study|Withdrawal by Subject|0|||
33369834|NCT03807739|101239898|FG002|Overall Study|Withdrawal by Subject|0|||
33369835|NCT03807739|101239899|FG003|Overall Study|Withdrawal by Subject|0|||
33369836|NCT03123354|101239908|FG000|Overall Study|Physician Decision|6|||
33369837|NCT04045613|101239909|FG000|Overall Study|Adverse Event|2|||
33369838|NCT04045613|101239910|FG001|Overall Study|Adverse Event|2|||
33579053|NCT02131662|102009649|FG003|Overall Study|Wish for pregnancy|0|||
33638907|NCT02318706|102229386|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
33638908|NCT02318706|102229387|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
33638909|NCT02318706|102229383|FG000|Open-label Extension Phase|Death|0|||
33579054|NCT02131662|102009650|FG004|Overall Study|Wish for pregnancy|1|||
33579055|NCT02131662|102009646|FG000|Overall Study|Lack of Efficacy|1|||
33579056|NCT02131662|102009647|FG001|Overall Study|Lack of Efficacy|0|||
33579057|NCT02131662|102009648|FG002|Overall Study|Lack of Efficacy|0|||
33579058|NCT02131662|102009649|FG003|Overall Study|Lack of Efficacy|0|||
33579059|NCT02131662|102009650|FG004|Overall Study|Lack of Efficacy|1|||
33579060|NCT02131662|102009646|FG000|Overall Study|Withdrawal by Subject|1|||
33579061|NCT02131662|102009647|FG001|Overall Study|Withdrawal by Subject|5|||
33579062|NCT02131662|102009648|FG002|Overall Study|Withdrawal by Subject|1|||
33579063|NCT02131662|102009649|FG003|Overall Study|Withdrawal by Subject|5|||
33579064|NCT02131662|102009650|FG004|Overall Study|Withdrawal by Subject|6|||
33579065|NCT02131662|102009646|FG000|Overall Study|Lost to Follow-up|1|||
33579066|NCT02131662|102009647|FG001|Overall Study|Lost to Follow-up|3|||
33579067|NCT02131662|102009648|FG002|Overall Study|Lost to Follow-up|0|||
33579068|NCT02131662|102009649|FG003|Overall Study|Lost to Follow-up|9|||
33579069|NCT02131662|102009650|FG004|Overall Study|Lost to Follow-up|0|||
33579070|NCT02131662|102009646|FG000|Overall Study|Not treated|2|||
33579071|NCT02131662|102009647|FG001|Overall Study|Not treated|0|||
33579072|NCT02131662|102009648|FG002|Overall Study|Not treated|2|||
33579073|NCT02131662|102009649|FG003|Overall Study|Not treated|2|||
33579074|NCT02131662|102009650|FG004|Overall Study|Not treated|3|||
33139886|NCT03400956|100427874|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
33369839|NCT04045613|101239911|FG002|Overall Study|Adverse Event|1|||
33369840|NCT04045613|101239912|FG003|Overall Study|Adverse Event|1|||
33369841|NCT04045613|101239913|FG004|Overall Study|Adverse Event|0|||
33579075|NCT00488514|102009652|FG000|Overall Study|Adverse Event|41|||
33579076|NCT00488514|102009652|FG000|Overall Study|Lost to Follow-up|44|||
33579077|NCT00488514|102009652|FG000|Overall Study|Protocol Violation|32|||
33579078|NCT00488514|102009652|FG000|Overall Study|Withdrawal by Subject|106|||
33579079|NCT00488514|102009652|FG000|Overall Study|Lack of Efficacy|28|||
33579080|NCT00488514|102009652|FG000|Overall Study|Did not meet criteria for treatment|30|||
33638910|NCT02318706|102229384|FG001|Open-label Extension Phase|Death|0|||
33369842|NCT04045613|101239914|FG005|Overall Study|Adverse Event|0|||
33369843|NCT04045613|101239915|FG006|Overall Study|Adverse Event|1|||
33369844|NCT04045613|101239909|FG000|Overall Study|Withdrawal by Subject|0|||
33579081|NCT00488514|102009652|FG000|Overall Study|Postive drug screen|1|||
33579082|NCT00488514|102009652|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
33638911|NCT02318706|102229385|FG002|Open-label Extension Phase|Death|0|||
33638912|NCT02318706|102229386|FG003|Open-label Extension Phase|Death|0|||
33638913|NCT02318706|102229387|FG004|Open-label Extension Phase|Death|1|||
33369845|NCT04045613|101239910|FG001|Overall Study|Withdrawal by Subject|5|||
33369846|NCT04045613|101239911|FG002|Overall Study|Withdrawal by Subject|0|||
33369847|NCT04045613|101239912|FG003|Overall Study|Withdrawal by Subject|0|||
33369848|NCT04045613|101239913|FG004|Overall Study|Withdrawal by Subject|0|||
33638914|NCT02318706|102229383|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
33139887|NCT03400956|100427875|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
33139888|NCT03400956|100427873|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
33139889|NCT03400956|100427874|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
33369849|NCT04045613|101239914|FG005|Overall Study|Withdrawal by Subject|1|||
33369850|NCT04045613|101239915|FG006|Overall Study|Withdrawal by Subject|0|||
33369851|NCT04045613|101239909|FG000|Overall Study|Physician Decision|2|||
33369852|NCT04045613|101239910|FG001|Overall Study|Physician Decision|0|||
33369853|NCT04045613|101239911|FG002|Overall Study|Physician Decision|0|||
33369854|NCT04045613|101239912|FG003|Overall Study|Physician Decision|0|||
33369855|NCT04045613|101239913|FG004|Overall Study|Physician Decision|1|||
33369856|NCT04045613|101239914|FG005|Overall Study|Physician Decision|0|||
33369857|NCT04045613|101239915|FG006|Overall Study|Physician Decision|0|||
33369858|NCT04045613|101239909|FG000|Overall Study|Death|3|||
33369859|NCT04045613|101239910|FG001|Overall Study|Death|0|||
33369860|NCT04045613|101239911|FG002|Overall Study|Death|0|||
33369861|NCT04045613|101239912|FG003|Overall Study|Death|0|||
33369862|NCT04045613|101239913|FG004|Overall Study|Death|0|||
33369863|NCT04045613|101239914|FG005|Overall Study|Death|0|||
33369864|NCT04045613|101239915|FG006|Overall Study|Death|1|||
33369865|NCT04045613|101239909|FG000|Overall Study|Other reasons|0|||
33369866|NCT04045613|101239910|FG001|Overall Study|Other reasons|1|||
33369867|NCT04045613|101239911|FG002|Overall Study|Other reasons|0|||
33369868|NCT04045613|101239912|FG003|Overall Study|Other reasons|0|||
33369869|NCT04045613|101239913|FG004|Overall Study|Other reasons|0|||
33369870|NCT04045613|101239914|FG005|Overall Study|Other reasons|0|||
33369871|NCT04045613|101239915|FG006|Overall Study|Other reasons|1|||
33369872|NCT04045613|101239909|FG000|Overall Study|Progressive disease: Clinical progression|1|||
33369873|NCT04045613|101239910|FG001|Overall Study|Progressive disease: Clinical progression|0|||
33369874|NCT04045613|101239911|FG002|Overall Study|Progressive disease: Clinical progression|3|||
33369875|NCT04045613|101239912|FG003|Overall Study|Progressive disease: Clinical progression|1|||
33369876|NCT04045613|101239913|FG004|Overall Study|Progressive disease: Clinical progression|1|||
33369877|NCT04045613|101239914|FG005|Overall Study|Progressive disease: Clinical progression|3|||
33369878|NCT04045613|101239915|FG006|Overall Study|Progressive disease: Clinical progression|3|||
33369879|NCT04045613|101239909|FG000|Overall Study|Progressive disease: Radiological progression|24|||
33369880|NCT04045613|101239910|FG001|Overall Study|Progressive disease: Radiological progression|6|||
33369881|NCT04045613|101239911|FG002|Overall Study|Progressive disease: Radiological progression|8|||
33369882|NCT04045613|101239912|FG003|Overall Study|Progressive disease: Radiological progression|0|||
33369883|NCT04045613|101239913|FG004|Overall Study|Progressive disease: Radiological progression|6|||
33369884|NCT04045613|101239914|FG005|Overall Study|Progressive disease: Radiological progression|6|||
33369885|NCT04045613|101239915|FG006|Overall Study|Progressive disease: Radiological progression|11|||
33369886|NCT01552928|101239916|FG000|Period 3|Adverse Event|0|||
33369887|NCT01552928|101239917|FG001|Period 3|Adverse Event|0|||
33369888|NCT01552928|101239918|FG002|Period 3|Adverse Event|1|||
33369889|NCT01552928|101239919|FG003|Period 3|Adverse Event|0|||
33369890|NCT01701583|101239923|FG000|Overall Study|Withdrawal by Subject|2|||
33369891|NCT01701583|101239924|FG001|Overall Study|Withdrawal by Subject|0|||
33369892|NCT01975272|101239931|FG000|Overall Study|Excluded after protocol amendment|1|||
33369893|NCT01975272|101239932|FG001|Overall Study|Excluded after protocol amendment|1|||
33369894|NCT01975272|101239933|FG002|Overall Study|Excluded after protocol amendment|2|||
33369895|NCT01987986|101239934|FG000|Overall Study|Lost to Follow-up|1|||
33369896|NCT01987986|101239935|FG001|Overall Study|Lost to Follow-up|0|||
33369897|NCT01987986|101239936|FG002|Overall Study|Lost to Follow-up|0|||
33369898|NCT01987986|101239937|FG003|Overall Study|Lost to Follow-up|0|||
33369899|NCT01987986|101239934|FG000|Overall Study|Adverse Event|1|||
33369900|NCT01987986|101239935|FG001|Overall Study|Adverse Event|0|||
33579083|NCT00488514|102009652|FG000|Overall Study|Investigator decision|1|||
33579084|NCT00488514|102009652|FG000|Overall Study|Participant had too few migraines|5|||
33579085|NCT00488514|102009652|FG000|Overall Study|Increase in number of migraines|2|||
33579086|NCT00488514|102009652|FG000|Overall Study|Increased use of concomitant medication|1|||
33579087|NCT01306643|102009653|FG000|Overall Study|Adverse Event|5|||
33579088|NCT01306643|102009653|FG000|Overall Study|Disease Progression|7|||
33579089|NCT01306643|102009653|FG000|Overall Study|Other: Change in Eligibility Status|1|||
33638915|NCT02318706|102229384|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
33369901|NCT01987986|101239936|FG002|Overall Study|Adverse Event|2|||
33369902|NCT01987986|101239937|FG003|Overall Study|Adverse Event|0|||
33369903|NCT00610935|101239938|FG000|Overall Study|Lost to Follow-up|0|||
33369904|NCT00610935|101239939|FG001|Overall Study|Lost to Follow-up|1|||
33369905|NCT00610935|101239938|FG000|Overall Study|Withdrawal by Subject|0|||
33369906|NCT00610935|101239939|FG001|Overall Study|Withdrawal by Subject|2|||
33369907|NCT00610935|101239938|FG000|Overall Study|Sponsor Discontinuation|1|||
33369908|NCT00610935|101239939|FG001|Overall Study|Sponsor Discontinuation|0|||
33369909|NCT02689219|101239940|FG000|Overall Study|Death|1|||
33369910|NCT02689219|101239941|FG001|Overall Study|Death|1|||
33369911|NCT02689219|101239940|FG000|Overall Study|Disease Progression|10|||
33369912|NCT02689219|101239941|FG001|Overall Study|Disease Progression|6|||
33369913|NCT00601523|101239946|FG000|Overall Study|Adverse Event|42|||
33369914|NCT00601523|101239947|FG001|Overall Study|Adverse Event|14|||
33369915|NCT00601523|101239946|FG000|Overall Study|Lack of Efficacy|3|||
33369916|NCT00601523|101239947|FG001|Overall Study|Lack of Efficacy|0|||
33369917|NCT00601523|101239946|FG000|Overall Study|Protocol Violation|5|||
33369918|NCT00601523|101239947|FG001|Overall Study|Protocol Violation|1|||
33369919|NCT00601523|101239946|FG000|Overall Study|Lost to Follow-up|0|||
33369920|NCT00601523|101239947|FG001|Overall Study|Lost to Follow-up|1|||
33369921|NCT00601523|101239946|FG000|Overall Study|Withdrawal by Subject|18|||
33369922|NCT00601523|101239947|FG001|Overall Study|Withdrawal by Subject|9|||
33369923|NCT00601523|101239946|FG000|Overall Study|Other|9|||
33369924|NCT00601523|101239947|FG001|Overall Study|Other|1|||
33369925|NCT04072146|101239948|FG000|Overall Study|Adverse Event|0|||
33369926|NCT04072146|101239949|FG001|Overall Study|Adverse Event|1|||
33369927|NCT00367640|101239950|FG000|Overall Study|Adverse Event|3|||
33638916|NCT02318706|102229385|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
33638917|NCT02318706|102229386|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
33638918|NCT02318706|102229387|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
33638919|NCT01076361|102229388|FG000|Overall Study|22 leads were excluded from analysis|21|||
33369928|NCT00367640|101239951|FG001|Overall Study|Adverse Event|6|||
33369929|NCT00367640|101239952|FG002|Overall Study|Adverse Event|8|||
33369930|NCT00367640|101239953|FG003|Overall Study|Adverse Event|0|||
33369931|NCT00367640|101239950|FG000|Overall Study|Withdrawal by Subject|8|||
33369932|NCT00367640|101239951|FG001|Overall Study|Withdrawal by Subject|11|||
33369933|NCT00367640|101239952|FG002|Overall Study|Withdrawal by Subject|8|||
33369934|NCT00367640|101239953|FG003|Overall Study|Withdrawal by Subject|6|||
33369935|NCT00367640|101239950|FG000|Overall Study|Any other reason not above-mentioned|7|||
33638920|NCT00892099|102229389|FG000|Overall Study|Death|1|||
33139890|NCT03400956|100427875|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
33638921|NCT00892099|102229390|FG001|Overall Study|Death|0|||
33638922|NCT00892099|102229391|FG002|Overall Study|Death|1|||
33638923|NCT00892099|102229389|FG000|Overall Study|Adverse Event|1|||
33638924|NCT00892099|102229390|FG001|Overall Study|Adverse Event|0|||
33638925|NCT00892099|102229391|FG002|Overall Study|Adverse Event|0|||
33638926|NCT00892099|102229389|FG000|Overall Study|replocated|1|||
33638927|NCT00892099|102229390|FG001|Overall Study|replocated|0|||
33638928|NCT00892099|102229391|FG002|Overall Study|replocated|2|||
33638929|NCT00892099|102229389|FG000|Overall Study|Prolonged hospitalization|1|||
33638930|NCT00892099|102229390|FG001|Overall Study|Prolonged hospitalization|0|||
33638931|NCT00892099|102229391|FG002|Overall Study|Prolonged hospitalization|1|||
33638932|NCT00892099|102229389|FG000|Overall Study|no further details|1|||
33638933|NCT00892099|102229390|FG001|Overall Study|no further details|0|||
33638934|NCT00892099|102229391|FG002|Overall Study|no further details|1|||
33638935|NCT00892099|102229389|FG000|Overall Study|kidney function recovered|0|||
33638936|NCT00892099|102229390|FG001|Overall Study|kidney function recovered|1|||
33638937|NCT00892099|102229391|FG002|Overall Study|kidney function recovered|0|||
33638938|NCT00892099|102229389|FG000|Overall Study|investigator decision|0|||
33638939|NCT00892099|102229390|FG001|Overall Study|investigator decision|0|||
33638940|NCT00892099|102229391|FG002|Overall Study|investigator decision|1|||
33638941|NCT00892099|102229389|FG000|Overall Study|Lost to Follow-up|0|||
33638942|NCT00892099|102229390|FG001|Overall Study|Lost to Follow-up|0|||
33638943|NCT00892099|102229391|FG002|Overall Study|Lost to Follow-up|1|||
33638944|NCT00759941|102229392|FG000|Overall Study|Use of medication|1|||
33638945|NCT00759941|102229393|FG001|Overall Study|Use of medication|0|||
33638946|NCT00759941|102229392|FG000|Overall Study|Adverse Event|1|||
33139891|NCT03400956|100427873|FG000|Post-treatment Period 1|Other|4|||
33139892|NCT03400956|100427874|FG001|Post-treatment Period 1|Other|3|||
33369936|NCT00367640|101239951|FG001|Overall Study|Any other reason not above-mentioned|5|||
33139893|NCT03400956|100427875|FG002|Post-treatment Period 1|Other|4|||
33638947|NCT00759941|102229393|FG001|Overall Study|Adverse Event|0|||
33638948|NCT00759941|102229392|FG000|Overall Study|Exited in error by site|1|||
33638949|NCT00759941|102229393|FG001|Overall Study|Exited in error by site|1|||
33638950|NCT00927953|102229394|FG000|Overall Study|Death|2|||
33638951|NCT00927953|102229395|FG001|Overall Study|Death|1|||
33638952|NCT02304367|102229396|FG000|Overall Study|Lack of Response to Bruosumab|1|||
33638953|NCT02304367|102229396|FG000|Overall Study|Sponsor Decision|3|||
33638954|NCT02304367|102229396|FG000|Overall Study|Death|2|||
33638955|NCT02304367|102229396|FG000|Overall Study|Physician Decision|1|||
33369937|NCT00367640|101239952|FG002|Overall Study|Any other reason not above-mentioned|3|||
33369938|NCT00367640|101239953|FG003|Overall Study|Any other reason not above-mentioned|4|||
33369939|NCT00875017|101239954|FG000|First Intervention|Withdrawal by Subject|1|||
33369940|NCT00875017|101239955|FG001|First Intervention|Withdrawal by Subject|0|||
33638956|NCT02304367|102229396|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
33139894|NCT03400956|100427873|FG000|Treatment Period 2|Adverse Event|2|||
33139895|NCT03400956|100427874|FG001|Treatment Period 2|Adverse Event|1|||
33579090|NCT04677543|102009675|FG000|Overall Study|Withdrawal by Subject|4|||
33579091|NCT04677543|102009676|FG001|Overall Study|Withdrawal by Subject|1|||
33579092|NCT04677543|102009675|FG000|Overall Study|Physician Decision|0|||
33579093|NCT04677543|102009676|FG001|Overall Study|Physician Decision|1|||
33579094|NCT04677543|102009675|FG000|Overall Study|Adverse Event|0|||
33579095|NCT04677543|102009676|FG001|Overall Study|Adverse Event|1|||
33579096|NCT04749745|102009682|FG000|Overall Study|Withdrawal by Subject|1|||
33579097|NCT04749745|102009683|FG001|Overall Study|Withdrawal by Subject|0|||
33579098|NCT00955474|102009684|FG000|Overall Study|Physician Decision|7|||
33579099|NCT00955474|102009685|FG001|Overall Study|Physician Decision|5|||
33579100|NCT05173974|102009686|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
33579101|NCT05173974|102009687|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
33579102|NCT05173974|102009688|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
33579103|NCT05173974|102009689|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
33579104|NCT05173974|102009686|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
33579105|NCT05173974|102009687|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
33579106|NCT05173974|102009688|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
33579107|NCT05173974|102009689|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
33579108|NCT00363311|102009690|FG000|Overall Study|Adverse Event|6|||
33579109|NCT00363311|102009691|FG001|Overall Study|Adverse Event|4|||
33579110|NCT00363311|102009690|FG000|Overall Study|Lost to Follow-up|3|||
33579111|NCT00363311|102009691|FG001|Overall Study|Lost to Follow-up|0|||
33579112|NCT00363311|102009690|FG000|Overall Study|Protocol Violation|1|||
33579113|NCT00363311|102009691|FG001|Overall Study|Protocol Violation|2|||
33579114|NCT00363311|102009690|FG000|Overall Study|Withdrawal by Subject|12|||
33579115|NCT00363311|102009691|FG001|Overall Study|Withdrawal by Subject|6|||
33579116|NCT00363311|102009690|FG000|Overall Study|Physician Decision|1|||
33579117|NCT00363311|102009691|FG001|Overall Study|Physician Decision|1|||
33579118|NCT00363311|102009690|FG000|Overall Study|Sponsor Terminated Study|2|||
33579119|NCT00363311|102009691|FG001|Overall Study|Sponsor Terminated Study|2|||
33579120|NCT00363311|102009690|FG000|Overall Study|Disease Progression|46|||
33579121|NCT00363311|102009691|FG001|Overall Study|Disease Progression|26|||
33579122|NCT00363311|102009690|FG000|Overall Study|Non-Compliance|1|||
33579123|NCT00363311|102009691|FG001|Overall Study|Non-Compliance|1|||
33579124|NCT00363311|102009690|FG000|Overall Study|Participant Refused Biopsy|1|||
33579125|NCT00363311|102009691|FG001|Overall Study|Participant Refused Biopsy|0|||
33579126|NCT00363311|102009690|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
33579127|NCT00363311|102009691|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
33579128|NCT00363311|102009690|FG000|Overall Study|Participant Opted for Treatment|1|||
33579129|NCT00363311|102009691|FG001|Overall Study|Participant Opted for Treatment|0|||
33579130|NCT00363311|102009690|FG000|Overall Study|Participant Moved to Another Country|1|||
33579131|NCT00363311|102009691|FG001|Overall Study|Participant Moved to Another Country|0|||
33579132|NCT00363311|102009690|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
33579133|NCT00363311|102009691|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
33579134|NCT00363311|102009690|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
33579135|NCT00363311|102009691|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
33579136|NCT00363311|102009690|FG000|Overall Study|Participant Moved to Louisiana|0|||
33579137|NCT00363311|102009691|FG001|Overall Study|Participant Moved to Louisiana|1|||
33579138|NCT04872569|102009692|FG000|Overall Study|Withdrawal by Subject|2|||
33579139|NCT01456130|102009693|FG000|Overall Study|Adverse Event|4|||
33579140|NCT01456130|102009693|FG000|Overall Study|Voluntary Withdrawal|1|||
33579141|NCT01456130|102009693|FG000|Overall Study|Lack of Efficacy|4|||
33579142|NCT01456130|102009693|FG000|Overall Study|Other|1|||
33579143|NCT01354223|102009696|FG000|Overall Study|Withdrawal by Subject|3|||
33579144|NCT01354223|102009697|FG001|Overall Study|Withdrawal by Subject|1|||
33579145|NCT02980107|102009698|FG000|Overall Study|Withdrawal by Subject|51|||
33579146|NCT02980107|102009699|FG001|Overall Study|Withdrawal by Subject|62|||
33579147|NCT00952705|102009701|FG000|Overall Study|Lost to Follow-up|24|||
33579148|NCT00952705|102009702|FG001|Overall Study|Lost to Follow-up|8|||
33579149|NCT00952705|102009703|FG002|Overall Study|Lost to Follow-up|9|||
33638957|NCT02819804|102229397|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
33139896|NCT03400956|100427875|FG002|Treatment Period 2|Adverse Event|1|||
33139897|NCT03400956|100427873|FG000|Treatment Period 2|Lost to Follow-up|1|||
33139898|NCT03400956|100427874|FG001|Treatment Period 2|Lost to Follow-up|1|||
33238173|NCT01333943|100775812|FG001|Overall Study|Known neuropathy|0|||
33238174|NCT00830947|100775813|FG000|Overall Study|Lost to Follow-up|4|||
33420881|NCT02913261|101431633|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
33139899|NCT03400956|100427875|FG002|Treatment Period 2|Lost to Follow-up|0|||
33579150|NCT00952705|102009701|FG000|Overall Study|Withdrawal by Subject|2|||
33579151|NCT00952705|102009702|FG001|Overall Study|Withdrawal by Subject|1|||
33579152|NCT00952705|102009703|FG002|Overall Study|Withdrawal by Subject|1|||
33579153|NCT00952705|102009701|FG000|Overall Study|Death|2|||
33579154|NCT00952705|102009702|FG001|Overall Study|Death|0|||
33139900|NCT03400956|100427873|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33139901|NCT03400956|100427874|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33139902|NCT03400956|100427875|FG002|Treatment Period 2|Withdrawal by Subject|3|||
33139903|NCT03400956|100427873|FG000|Treatment Period 2|Other|1|||
33139904|NCT03400956|100427874|FG001|Treatment Period 2|Other|1|||
33139905|NCT03400956|100427875|FG002|Treatment Period 2|Other|0|||
33139906|NCT03400956|100427873|FG000|Follow-up Period|Withdrawal by Subject|0|||
33139907|NCT03400956|100427874|FG001|Follow-up Period|Withdrawal by Subject|0|||
33139908|NCT03400956|100427875|FG002|Follow-up Period|Withdrawal by Subject|1|||
33139909|NCT03400956|100427873|FG000|Follow-up Period|Other|0|||
33139910|NCT03400956|100427874|FG001|Follow-up Period|Other|0|||
33139911|NCT03400956|100427875|FG002|Follow-up Period|Other|1|||
33139912|NCT03911843|100427876|FG000|Overall Study|Adverse Event|2|||
33139913|NCT03911843|100427877|FG001|Overall Study|Adverse Event|0|||
33139914|NCT03911843|100427876|FG000|Overall Study|Protocol Violation|2|||
33139915|NCT03911843|100427877|FG001|Overall Study|Protocol Violation|0|||
33139916|NCT03911843|100427876|FG000|Overall Study|Lost to Follow-up|0|||
33139917|NCT03911843|100427877|FG001|Overall Study|Lost to Follow-up|1|||
33139918|NCT02241889|100427878|FG000|Overall Study|device issues|0|||
33139919|NCT02241889|100427879|FG001|Overall Study|device issues|0|||
33139920|NCT02241889|100427880|FG002|Overall Study|device issues|1|||
33139921|NCT02241889|100427881|FG003|Overall Study|device issues|0|||
33139922|NCT02241889|100427882|FG004|Overall Study|device issues|0|||
33139923|NCT02241889|100427883|FG005|Overall Study|device issues|0|||
33139924|NCT02241889|100427878|FG000|Overall Study|Withdrawal by Subject|0|||
33139925|NCT02241889|100427879|FG001|Overall Study|Withdrawal by Subject|0|||
33139926|NCT02241889|100427880|FG002|Overall Study|Withdrawal by Subject|0|||
33139927|NCT02241889|100427881|FG003|Overall Study|Withdrawal by Subject|0|||
33139928|NCT02241889|100427882|FG004|Overall Study|Withdrawal by Subject|0|||
33139929|NCT02241889|100427883|FG005|Overall Study|Withdrawal by Subject|1|||
33139930|NCT03709576|100427884|FG000|Overall Study|progression prior to enrollment|1|||
33139931|NCT02545543|100427885|FG000|Overall Study|Lost to Follow-up|67|||
33139932|NCT02545543|100427886|FG001|Overall Study|Lost to Follow-up|25|||
33139933|NCT02545543|100427885|FG000|Overall Study|Physician Decision|3|||
33139934|NCT02545543|100427886|FG001|Overall Study|Physician Decision|0|||
33638958|NCT01867671|102229398|FG000|Overall Study|Adverse Event|5|||
33638959|NCT01867671|102229399|FG001|Overall Study|Adverse Event|3|||
33638960|NCT01867671|102229398|FG000|Overall Study|Anaphylaxis|0|||
33638961|NCT01867671|102229399|FG001|Overall Study|Anaphylaxis|1|||
33638962|NCT01867671|102229398|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
33638963|NCT01867671|102229399|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
33638964|NCT01867671|102229398|FG000|Overall Study|Lost to Follow-up|0|||
33638965|NCT01867671|102229399|FG001|Overall Study|Lost to Follow-up|1|||
33638966|NCT01867671|102229398|FG000|Overall Study|Non-compliance with Study Drug|1|||
33638967|NCT01867671|102229399|FG001|Overall Study|Non-compliance with Study Drug|2|||
33638968|NCT01867671|102229398|FG000|Overall Study|Withdrawal by Subject|21|||
33638969|NCT01867671|102229399|FG001|Overall Study|Withdrawal by Subject|21|||
33638970|NCT00599339|102229400|FG000|Overall Study|Adverse Event|79|||
33638971|NCT00599339|102229400|FG000|Overall Study|Withdrawal by Subject|137|||
33638972|NCT00599339|102229400|FG000|Overall Study|Other Reason|179|||
33638973|NCT00599339|102229400|FG000|Overall Study|Lost to Follow-up|221|||
33638974|NCT00599339|102229400|FG000|Overall Study|No valid data consent|36|||
33638975|NCT00599339|102229400|FG000|Overall Study|Study Termination Status Unknown|12|||
33638976|NCT01083771|102229402|FG000|Overall Study|non-compliant|2|||
33638977|NCT01083771|102229402|FG000|Overall Study|Withdrawal by Subject|3|||
33638978|NCT00998296|102229403|FG000|Overall Study|Progressive disease|0|||
33638979|NCT00998296|102229404|FG001|Overall Study|Progressive disease|1|||
33139935|NCT02545543|100427885|FG000|Overall Study|Withdrawal by Subject|9|||
33139936|NCT02545543|100427886|FG001|Overall Study|Withdrawal by Subject|8|||
33139937|NCT02545543|100427885|FG000|Overall Study|Noncomplaince|1|||
33139938|NCT02545543|100427886|FG001|Overall Study|Noncomplaince|0|||
33139939|NCT02545543|100427885|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
33139940|NCT02545543|100427886|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
33638980|NCT00998296|102229405|FG002|Overall Study|Progressive disease|0|||
33139941|NCT01715129|100427887|FG000|Overall Study|Adverse Event, fatal|1|||
33139942|NCT01715129|100427887|FG000|Overall Study|Lack of Efficacy|3|||
33638981|NCT00998296|102229406|FG003|Overall Study|Progressive disease|0|||
33139943|NCT01715129|100427887|FG000|Overall Study|Protocol Violation|1|||
33139944|NCT01715129|100427887|FG000|Overall Study|Consent Withdrawn|2|||
33139945|NCT01715129|100427887|FG000|Overall Study|Lost to Follow-up|1|||
33139946|NCT01715129|100427887|FG000|Overall Study|Other|1|||
33139947|NCT00567255|100427888|FG000|Overall Study|Adverse Event|241|||
33139948|NCT00567255|100427889|FG001|Overall Study|Adverse Event|68|||
33638982|NCT00998296|102229407|FG004|Overall Study|Progressive disease|0|||
33638983|NCT00998296|102229408|FG005|Overall Study|Progressive disease|0|||
33638984|NCT00998296|102229409|FG006|Overall Study|Progressive disease|1|||
33638985|NCT00998296|102229410|FG007|Overall Study|Progressive disease|0|||
33638986|NCT00998296|102229411|FG008|Overall Study|Progressive disease|0|||
33139949|NCT00567255|100427888|FG000|Overall Study|Lost to Follow-up|77|||
33139950|NCT00567255|100427889|FG001|Overall Study|Lost to Follow-up|48|||
33139951|NCT00567255|100427888|FG000|Overall Study|Withdrawal by Subject|75|||
33139952|NCT00567255|100427889|FG001|Overall Study|Withdrawal by Subject|56|||
33139953|NCT00567255|100427888|FG000|Overall Study|Lack of Efficacy|19|||
33139954|NCT00567255|100427889|FG001|Overall Study|Lack of Efficacy|33|||
33139955|NCT00567255|100427888|FG000|Overall Study|Protocol Violation|20|||
33139956|NCT00567255|100427889|FG001|Overall Study|Protocol Violation|8|||
33139957|NCT00567255|100427888|FG000|Overall Study|Pregnancy|6|||
33139958|NCT00567255|100427889|FG001|Overall Study|Pregnancy|0|||
33139959|NCT00567255|100427888|FG000|Overall Study|Drug noncompliance,moved,other|25|||
33139960|NCT00567255|100427889|FG001|Overall Study|Drug noncompliance,moved,other|15|||
33139961|NCT05347147|100427891|FG000|Overall Study|Lost to Follow-up|0|||
33139962|NCT05347147|100427892|FG001|Overall Study|Lost to Follow-up|1|||
33139963|NCT05347147|100427891|FG000|Overall Study|Sponsor request|3|||
33139964|NCT05347147|100427892|FG001|Overall Study|Sponsor request|3|||
33139965|NCT05347147|100427891|FG000|Overall Study|Study termination|2|||
33139966|NCT05347147|100427892|FG001|Overall Study|Study termination|1|||
33139967|NCT01658813|100427893|FG000|Overall Study|Disease progression|3|||
33139968|NCT01073462|100427900|FG000|Overall Study|Death|14|||
33139969|NCT01073462|100427900|FG000|Overall Study|Kidney transplant|10|||
33139970|NCT01073462|100427900|FG000|Overall Study|Low parathyroid hormone levels|8|||
33139971|NCT01073462|100427900|FG000|Overall Study|Serious adverse event|2|||
33139972|NCT01073462|100427900|FG000|Overall Study|Lost to Follow-up|7|||
33139973|NCT02882152|100427901|FG000|Overall Study|Lost to Follow-up|1|||
33139974|NCT02882152|100427902|FG001|Overall Study|Lost to Follow-up|0|||
33139975|NCT03739242|100427908|FG000|Overall Study|Withdrawal by Subject|1|||
33139976|NCT03739242|100427909|FG001|Overall Study|Withdrawal by Subject|1|||
33139977|NCT03739242|100427908|FG000|Overall Study|Protocol Violation|0|||
33139978|NCT03739242|100427909|FG001|Overall Study|Protocol Violation|1|||
33139979|NCT00130247|100427910|FG000|Overall Study|Pregnancy|1|||
33139980|NCT00130247|100427911|FG001|Overall Study|Pregnancy|0|||
33139981|NCT00130247|100427910|FG000|Overall Study|Post-randomization exclusion|1|||
33139982|NCT00130247|100427911|FG001|Overall Study|Post-randomization exclusion|2|||
33139983|NCT00130247|100427910|FG000|Overall Study|Not compliant with DOT|0|||
33139984|NCT00130247|100427911|FG001|Overall Study|Not compliant with DOT|2|||
33139985|NCT02635646|100427915|FG000|Overall Study|Lost to Follow-up|24|||
33139986|NCT02635646|100427916|FG001|Overall Study|Lost to Follow-up|25|||
33139987|NCT02635646|100427915|FG000|Overall Study|Pregnancy|1|||
33139988|NCT02635646|100427916|FG001|Overall Study|Pregnancy|1|||
33139989|NCT04473235|100427917|FG000|Overall Study|Lost to Follow-up|6|||
33139990|NCT04473235|100427918|FG001|Overall Study|Lost to Follow-up|5|||
33139991|NCT04473235|100427917|FG000|Overall Study|Declined continuation|2|||
33139992|NCT04473235|100427918|FG001|Overall Study|Declined continuation|0|||
33139993|NCT04473235|100427917|FG000|Overall Study|Physician Decision|1|||
33139994|NCT04473235|100427918|FG001|Overall Study|Physician Decision|1|||
33139995|NCT04473235|100427917|FG000|Overall Study|Protocol Violation|10|||
33139996|NCT04473235|100427918|FG001|Overall Study|Protocol Violation|6|||
33139997|NCT02279407|100427919|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
33139998|NCT02279407|100427920|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
33139999|NCT02279407|100427921|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
33140000|NCT02279407|100427922|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
33140001|NCT02279407|100427919|FG000|Overall Study|Withdrawal by Subject|1|||
33140002|NCT02279407|100427920|FG001|Overall Study|Withdrawal by Subject|0|||
33140003|NCT02279407|100427921|FG002|Overall Study|Withdrawal by Subject|1|||
33140004|NCT02279407|100427922|FG003|Overall Study|Withdrawal by Subject|1|||
33140005|NCT02279407|100427919|FG000|Overall Study|Adverse Event|1|||
33140006|NCT02279407|100427920|FG001|Overall Study|Adverse Event|1|||
33140007|NCT02279407|100427921|FG002|Overall Study|Adverse Event|2|||
33140008|NCT02279407|100427922|FG003|Overall Study|Adverse Event|0|||
33140009|NCT01343901|100427928|FG000|Overall Study|Death|85|||
33140010|NCT01343901|100427928|FG000|Overall Study|Physician Decision|4|||
33140011|NCT01343901|100427928|FG000|Overall Study|Lost to Follow-up|12|||
33140012|NCT01343901|100427928|FG000|Overall Study|Management by another medical team|11|||
33140013|NCT01343901|100427928|FG000|Overall Study|Participant decision|1|||
33140014|NCT02186301|100427929|FG000|Overall Study|Progressive Disease|7|||
33140015|NCT02186301|100427930|FG001|Overall Study|Progressive Disease|22|||
33140016|NCT02186301|100427931|FG002|Overall Study|Progressive Disease|27|||
33238175|NCT00830947|100775814|FG001|Overall Study|Lost to Follow-up|4|||
33238176|NCT00813488|100775815|FG000|Titration Period 1|Adverse Event|6|||
33140017|NCT02186301|100427929|FG000|Overall Study|Adverse Event|5|||
33140018|NCT02186301|100427930|FG001|Overall Study|Adverse Event|5|||
33140019|NCT02186301|100427931|FG002|Overall Study|Adverse Event|5|||
33140020|NCT02186301|100427929|FG000|Overall Study|Death|1|||
33140021|NCT02186301|100427930|FG001|Overall Study|Death|0|||
33140022|NCT02186301|100427931|FG002|Overall Study|Death|0|||
33140023|NCT02186301|100427929|FG000|Overall Study|Withdrawal by Subject|5|||
33140024|NCT02186301|100427930|FG001|Overall Study|Withdrawal by Subject|1|||
33140025|NCT02186301|100427931|FG002|Overall Study|Withdrawal by Subject|3|||
33140026|NCT02186301|100427929|FG000|Overall Study|Physician Decision|1|||
33140027|NCT02186301|100427930|FG001|Overall Study|Physician Decision|0|||
33140028|NCT02186301|100427931|FG002|Overall Study|Physician Decision|1|||
33140029|NCT02186301|100427929|FG000|Overall Study|Study Terminated by Sponsor|1|||
33140030|NCT02186301|100427930|FG001|Overall Study|Study Terminated by Sponsor|0|||
33140031|NCT02186301|100427931|FG002|Overall Study|Study Terminated by Sponsor|11|||
33140032|NCT02186301|100427929|FG000|Overall Study|Protocol Deviation|0|||
33140033|NCT02186301|100427930|FG001|Overall Study|Protocol Deviation|2|||
33140034|NCT02186301|100427931|FG002|Overall Study|Protocol Deviation|0|||
33140035|NCT02186301|100427929|FG000|Overall Study|Missing|0|||
33140036|NCT02186301|100427930|FG001|Overall Study|Missing|0|||
33140037|NCT02186301|100427931|FG002|Overall Study|Missing|2|||
33140038|NCT02186301|100427929|FG000|Overall Study|Other|0|||
33140039|NCT02186301|100427930|FG001|Overall Study|Other|0|||
33140040|NCT02186301|100427931|FG002|Overall Study|Other|1|||
33140041|NCT02446171|100427932|FG000|Overall Study|Withdrawal by Subject|0|||
33140042|NCT02446171|100427933|FG001|Overall Study|Withdrawal by Subject|0|||
33140043|NCT02446171|100427934|FG002|Overall Study|Withdrawal by Subject|2|||
33140044|NCT02446171|100427935|FG003|Overall Study|Withdrawal by Subject|0|||
33140045|NCT00331552|100427936|FG000|Period 3: Phase II|Neurological Symptoms|1|||
33140046|NCT00331552|100427937|FG001|Period 3: Phase II|Neurological Symptoms|0|||
33140047|NCT00331552|100427936|FG000|Period 3: Phase II|Severe Nausea|1|||
33140048|NCT00331552|100427937|FG001|Period 3: Phase II|Severe Nausea|0|||
33140049|NCT03452527|100427938|FG000|Overall Study|Withdrawal by Subject|1|||
33140050|NCT03452527|100427939|FG001|Overall Study|Withdrawal by Subject|1|||
33140051|NCT03452527|100427938|FG000|Overall Study|Study Terminated|2|||
33140052|NCT03452527|100427939|FG001|Overall Study|Study Terminated|3|||
33140053|NCT01579812|100427940|FG000|Overall Study|Ineligible after treatment start|40|||
33140054|NCT01579812|100427940|FG000|Overall Study|Patient choice|3|||
33140055|NCT01579812|100427940|FG000|Overall Study|Noncompliance|3|||
33140056|NCT01579812|100427940|FG000|Overall Study|Withdrawal by Subject|6|||
33140057|NCT01924429|100427941|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
33140058|NCT01924429|100427942|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
33140059|NCT02661178|100427944|FG000|Part 1|Protocol Violation|1|||
33140060|NCT02661178|100427945|FG001|Part 1|Protocol Violation|0|||
33140061|NCT02661178|100427946|FG002|Part 1|Protocol Violation|0|||
33140062|NCT02661178|100427947|FG003|Part 1|Protocol Violation|0|||
33140063|NCT02661178|100427948|FG004|Part 1|Protocol Violation|0|||
33140064|NCT02661178|100427949|FG005|Part 1|Protocol Violation|0|||
33140065|NCT02661178|100427950|FG006|Part 1|Protocol Violation|0|||
33140066|NCT02661178|100427951|FG007|Part 1|Protocol Violation|0|||
33140067|NCT02661178|100427952|FG008|Part 1|Protocol Violation|0|||
33140068|NCT02661178|100427953|FG009|Part 1|Protocol Violation|0|||
33140069|NCT02661178|100427954|FG010|Part 1|Protocol Violation|0|||
33140070|NCT02661178|100427955|FG011|Part 1|Protocol Violation|0|||
33140071|NCT02661178|100427956|FG012|Part 1|Protocol Violation|0|||
33140072|NCT02661178|100427957|FG013|Part 1|Protocol Violation|0|||
33579155|NCT00952705|102009703|FG002|Overall Study|Death|0|||
33579156|NCT00952705|102009701|FG000|Overall Study|Incarcerated post dose|5|||
33579157|NCT00952705|102009702|FG001|Overall Study|Incarcerated post dose|0|||
33579158|NCT00952705|102009703|FG002|Overall Study|Incarcerated post dose|0|||
33579159|NCT00952705|102009701|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
33579160|NCT00952705|102009702|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
33579161|NCT00952705|102009703|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
33579162|NCT02131311|102009706|FG000|Overall Study|Adverse Event|2|||
33579163|NCT02131311|102009706|FG000|Overall Study|Protocol Violation|1|||
33579164|NCT02131311|102009706|FG000|Overall Study|Lost to Follow-up|1|||
33140073|NCT02661178|100427958|FG014|Part 1|Protocol Violation|0|||
33140074|NCT00722371|100427963|FG000|Overall Study|Adverse Event|6|||
33140075|NCT00722371|100427964|FG001|Overall Study|Adverse Event|13|||
33140076|NCT00722371|100427965|FG002|Overall Study|Adverse Event|9|||
33140077|NCT00722371|100427966|FG003|Overall Study|Adverse Event|10|||
33140078|NCT00722371|100427967|FG004|Overall Study|Adverse Event|6|||
33140079|NCT00722371|100427968|FG005|Overall Study|Adverse Event|8|||
33140080|NCT00722371|100427969|FG006|Overall Study|Adverse Event|4|||
33140081|NCT00722371|100427963|FG000|Overall Study|Contraindication|0|||
33140082|NCT00722371|100427964|FG001|Overall Study|Contraindication|0|||
33140083|NCT00722371|100427965|FG002|Overall Study|Contraindication|1|||
33140084|NCT00722371|100427966|FG003|Overall Study|Contraindication|0|||
33140085|NCT00722371|100427967|FG004|Overall Study|Contraindication|0|||
33140086|NCT00722371|100427968|FG005|Overall Study|Contraindication|0|||
33140087|NCT00722371|100427969|FG006|Overall Study|Contraindication|0|||
33140088|NCT00722371|100427963|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
33140089|NCT00722371|100427964|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
33140090|NCT00722371|100427965|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
33140091|NCT00722371|100427966|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
33140092|NCT00722371|100427967|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
33140093|NCT00722371|100427968|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
33140094|NCT00722371|100427969|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
33140095|NCT00722371|100427963|FG000|Overall Study|Excluded medication|0|||
33140096|NCT00722371|100427964|FG001|Overall Study|Excluded medication|1|||
33140097|NCT00722371|100427965|FG002|Overall Study|Excluded medication|1|||
33140098|NCT00722371|100427966|FG003|Overall Study|Excluded medication|0|||
33140099|NCT00722371|100427967|FG004|Overall Study|Excluded medication|0|||
33140100|NCT00722371|100427968|FG005|Overall Study|Excluded medication|0|||
33140101|NCT00722371|100427969|FG006|Overall Study|Excluded medication|1|||
33140102|NCT00722371|100427963|FG000|Overall Study|Hyperglycemia|2|||
33140103|NCT00722371|100427964|FG001|Overall Study|Hyperglycemia|6|||
33140104|NCT00722371|100427965|FG002|Overall Study|Hyperglycemia|4|||
33140105|NCT00722371|100427966|FG003|Overall Study|Hyperglycemia|2|||
33140106|NCT00722371|100427967|FG004|Overall Study|Hyperglycemia|5|||
33140107|NCT00722371|100427968|FG005|Overall Study|Hyperglycemia|1|||
33140108|NCT00722371|100427969|FG006|Overall Study|Hyperglycemia|1|||
33140109|NCT00722371|100427963|FG000|Overall Study|Hypoglycemia|1|||
33140110|NCT00722371|100427964|FG001|Overall Study|Hypoglycemia|0|||
33140111|NCT00722371|100427965|FG002|Overall Study|Hypoglycemia|0|||
33140112|NCT00722371|100427966|FG003|Overall Study|Hypoglycemia|0|||
33140113|NCT00722371|100427967|FG004|Overall Study|Hypoglycemia|0|||
33140114|NCT00722371|100427968|FG005|Overall Study|Hypoglycemia|0|||
33140115|NCT00722371|100427969|FG006|Overall Study|Hypoglycemia|0|||
33140116|NCT00722371|100427963|FG000|Overall Study|Lack of Efficacy|4|||
33140117|NCT00722371|100427964|FG001|Overall Study|Lack of Efficacy|6|||
33140118|NCT00722371|100427965|FG002|Overall Study|Lack of Efficacy|6|||
33140119|NCT00722371|100427966|FG003|Overall Study|Lack of Efficacy|6|||
33140120|NCT00722371|100427967|FG004|Overall Study|Lack of Efficacy|2|||
33140121|NCT00722371|100427968|FG005|Overall Study|Lack of Efficacy|3|||
33140122|NCT00722371|100427969|FG006|Overall Study|Lack of Efficacy|0|||
33140123|NCT00722371|100427963|FG000|Overall Study|Lost to Follow-up|11|||
33140124|NCT00722371|100427964|FG001|Overall Study|Lost to Follow-up|14|||
33140125|NCT00722371|100427965|FG002|Overall Study|Lost to Follow-up|21|||
33140126|NCT00722371|100427966|FG003|Overall Study|Lost to Follow-up|13|||
33140127|NCT00722371|100427967|FG004|Overall Study|Lost to Follow-up|8|||
33140128|NCT00722371|100427968|FG005|Overall Study|Lost to Follow-up|16|||
33140129|NCT00722371|100427969|FG006|Overall Study|Lost to Follow-up|13|||
33140130|NCT00722371|100427963|FG000|Overall Study|Physician Decision|5|||
33140131|NCT00722371|100427964|FG001|Overall Study|Physician Decision|2|||
33140132|NCT00722371|100427965|FG002|Overall Study|Physician Decision|2|||
33140133|NCT00722371|100427966|FG003|Overall Study|Physician Decision|5|||
33140134|NCT00722371|100427967|FG004|Overall Study|Physician Decision|2|||
33140135|NCT00722371|100427968|FG005|Overall Study|Physician Decision|3|||
33140136|NCT00722371|100427969|FG006|Overall Study|Physician Decision|4|||
33140137|NCT00722371|100427963|FG000|Overall Study|Pregnancy|1|||
33140138|NCT00722371|100427964|FG001|Overall Study|Pregnancy|1|||
33140139|NCT00722371|100427965|FG002|Overall Study|Pregnancy|0|||
33369941|NCT00875017|101239956|FG002|First Intervention|Withdrawal by Subject|1|||
33369942|NCT00875017|101239957|FG003|First Intervention|Withdrawal by Subject|0|||
33369943|NCT00875017|101239958|FG004|First Intervention|Withdrawal by Subject|0|||
33369944|NCT00875017|101239959|FG005|First Intervention|Withdrawal by Subject|0|||
33369945|NCT00875017|101239954|FG000|First Intervention|Adverse Event|0|||
33369946|NCT00875017|101239955|FG001|First Intervention|Adverse Event|0|||
33369947|NCT00875017|101239956|FG002|First Intervention|Adverse Event|0|||
33369948|NCT00875017|101239957|FG003|First Intervention|Adverse Event|1|||
33369949|NCT00875017|101239958|FG004|First Intervention|Adverse Event|0|||
33369950|NCT00875017|101239959|FG005|First Intervention|Adverse Event|0|||
33369951|NCT00875017|101239954|FG000|First Intervention|Problems collecting rectal effluent|1|||
33369952|NCT00875017|101239955|FG001|First Intervention|Problems collecting rectal effluent|0|||
33369953|NCT00875017|101239956|FG002|First Intervention|Problems collecting rectal effluent|0|||
33579165|NCT01126190|102009707|FG000|Double-Blind Phase|Death|0|||
33579166|NCT01126190|102009708|FG001|Double-Blind Phase|Death|1|||
33579167|NCT01126190|102009709|FG002|Double-Blind Phase|Death|0|||
33140140|NCT00722371|100427966|FG003|Overall Study|Pregnancy|0|||
33369954|NCT00875017|101239957|FG003|First Intervention|Problems collecting rectal effluent|0|||
33369955|NCT00875017|101239958|FG004|First Intervention|Problems collecting rectal effluent|0|||
33369956|NCT00875017|101239959|FG005|First Intervention|Problems collecting rectal effluent|0|||
33579168|NCT01126190|102009707|FG000|Double-Blind Phase|Adverse Event|1|||
33140141|NCT00722371|100427967|FG004|Overall Study|Pregnancy|0|||
33140142|NCT00722371|100427968|FG005|Overall Study|Pregnancy|1|||
33140143|NCT00722371|100427969|FG006|Overall Study|Pregnancy|0|||
33140144|NCT00722371|100427963|FG000|Overall Study|Protocol Violation|6|||
33140145|NCT00722371|100427964|FG001|Overall Study|Protocol Violation|1|||
33140146|NCT00722371|100427965|FG002|Overall Study|Protocol Violation|0|||
33140147|NCT00722371|100427966|FG003|Overall Study|Protocol Violation|1|||
33140148|NCT00722371|100427967|FG004|Overall Study|Protocol Violation|4|||
33140149|NCT00722371|100427968|FG005|Overall Study|Protocol Violation|2|||
33140150|NCT00722371|100427969|FG006|Overall Study|Protocol Violation|1|||
33140151|NCT00722371|100427963|FG000|Overall Study|Withdrawal by Subject|18|||
33140152|NCT00722371|100427964|FG001|Overall Study|Withdrawal by Subject|27|||
33140153|NCT00722371|100427965|FG002|Overall Study|Withdrawal by Subject|19|||
33140154|NCT00722371|100427966|FG003|Overall Study|Withdrawal by Subject|23|||
33140155|NCT00722371|100427967|FG004|Overall Study|Withdrawal by Subject|19|||
33420882|NCT02913261|101431632|FG000|Overall Study|Disease relapse|8|||
33140156|NCT00722371|100427968|FG005|Overall Study|Withdrawal by Subject|18|||
33140157|NCT00722371|100427969|FG006|Overall Study|Withdrawal by Subject|26|||
33140158|NCT01642732|100427970|FG000|Overall Study|Withdrawal by Subject|1|||
33140159|NCT01958827|100427971|FG000|Overall Study|Adverse Event|3|||
33140160|NCT01958827|100427971|FG000|Overall Study|Lack of Efficacy|6|||
33140161|NCT01958827|100427971|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
33140162|NCT02395302|100427972|FG000|Overall Study|Screen Failure|3|||
33140163|NCT02395302|100427972|FG000|Overall Study|Run In Failure|7|||
33140164|NCT02395302|100427972|FG000|Overall Study|Withdrawal by Subject|2|||
33140165|NCT02395302|100427972|FG000|Overall Study|Physician Decision|2|||
33140166|NCT02052414|100427973|FG000|Overall Study|Adverse Event|12|||
33140167|NCT02052414|100427973|FG000|Overall Study|Lack of Efficacy|2|||
33140168|NCT02052414|100427973|FG000|Overall Study|Withdrawal by Subject|3|||
33140169|NCT00246571|100427974|FG000|Overall Study|Adverse Event|7|||
33140170|NCT00246571|100427975|FG001|Overall Study|Adverse Event|0|||
33140171|NCT00246571|100427974|FG000|Overall Study|Protocol Violation|0|||
33140172|NCT00246571|100427975|FG001|Overall Study|Protocol Violation|1|||
33140173|NCT00246571|100427974|FG000|Overall Study|Withdrawal by Subject|2|||
33140174|NCT00246571|100427975|FG001|Overall Study|Withdrawal by Subject|3|||
33140175|NCT00246571|100427974|FG000|Overall Study|Lack of Efficacy|84|||
33140176|NCT00246571|100427975|FG001|Overall Study|Lack of Efficacy|21|||
33140177|NCT00246571|100427974|FG000|Overall Study|Death|17|||
33140178|NCT00246571|100427975|FG001|Overall Study|Death|3|||
33140179|NCT00246571|100427974|FG000|Overall Study|Sponsor|0|||
33140180|NCT00246571|100427975|FG001|Overall Study|Sponsor|1|||
33140181|NCT00246571|100427974|FG000|Overall Study|Did not meet entrance criteria|2|||
33140182|NCT00246571|100427975|FG001|Overall Study|Did not meet entrance criteria|1|||
33140183|NCT00246571|100427974|FG000|Overall Study|Laboratory abnormalities|1|||
33140184|NCT00246571|100427975|FG001|Overall Study|Laboratory abnormalities|0|||
33140185|NCT00246571|100427974|FG000|Overall Study|Crossover participants|0|||
33579169|NCT01126190|102009708|FG001|Double-Blind Phase|Adverse Event|2|||
33579170|NCT01126190|102009709|FG002|Double-Blind Phase|Adverse Event|0|||
33579171|NCT01126190|102009707|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
33579172|NCT01126190|102009708|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
33579173|NCT01126190|102009709|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
33579174|NCT01126190|102009707|FG000|Double-Blind Phase|Request of Investigator|1|||
33579175|NCT01126190|102009708|FG001|Double-Blind Phase|Request of Investigator|0|||
33140186|NCT00246571|100427975|FG001|Overall Study|Crossover participants|74|||
33140187|NCT00282464|100427983|FG000|Overall Study|Adverse Event|26|||
33140188|NCT00282464|100427984|FG001|Overall Study|Adverse Event|20|||
33140189|NCT00282464|100427983|FG000|Overall Study|Lack of Efficacy|8|||
33140190|NCT00282464|100427984|FG001|Overall Study|Lack of Efficacy|8|||
33140191|NCT00282464|100427983|FG000|Overall Study|Lost to Follow-up|10|||
33140192|NCT00282464|100427984|FG001|Overall Study|Lost to Follow-up|10|||
33140193|NCT00282464|100427983|FG000|Overall Study|Withdrawal by Subject|24|||
33140194|NCT00282464|100427984|FG001|Overall Study|Withdrawal by Subject|10|||
33140195|NCT00282464|100427983|FG000|Overall Study|laboratory abnormality|1|||
33140196|NCT00282464|100427984|FG001|Overall Study|laboratory abnormality|2|||
33140197|NCT00282464|100427983|FG000|Overall Study|Protocol Violation|0|||
33140198|NCT00282464|100427984|FG001|Overall Study|Protocol Violation|7|||
33140199|NCT00282464|100427983|FG000|Overall Study|Patient moved|1|||
33140200|NCT00282464|100427984|FG001|Overall Study|Patient moved|0|||
33140201|NCT00282464|100427983|FG000|Overall Study|patient non-compliant|3|||
33140202|NCT00282464|100427984|FG001|Overall Study|patient non-compliant|0|||
33579176|NCT01126190|102009709|FG002|Double-Blind Phase|Request of Investigator|0|||
33579177|NCT01126190|102009707|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
33579178|NCT01126190|102009708|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
33579179|NCT01126190|102009709|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
33579180|NCT01126190|102009707|FG000|Double-Blind Phase|Non-compliance|1|||
33140203|NCT00282464|100427983|FG000|Overall Study|patient no show|0|||
33140204|NCT00282464|100427984|FG001|Overall Study|patient no show|1|||
33140205|NCT00282464|100427983|FG000|Overall Study|patient incarcerated|0|||
33140206|NCT00282464|100427984|FG001|Overall Study|patient incarcerated|1|||
33140207|NCT00282464|100427983|FG000|Overall Study|family crisis|0|||
33140208|NCT00282464|100427984|FG001|Overall Study|family crisis|1|||
33140209|NCT00282464|100427983|FG000|Overall Study|dispensed wrong kit|0|||
33140210|NCT00282464|100427984|FG001|Overall Study|dispensed wrong kit|1|||
33140211|NCT00282464|100427983|FG000|Overall Study|dropped due to missed visits|0|||
33140212|NCT00282464|100427984|FG001|Overall Study|dropped due to missed visits|1|||
33140213|NCT01009840|100427993|FG000|Overall Study|Lost to Follow-up|1|||
33140214|NCT01009840|100427993|FG000|Overall Study|Adverse Event|4|||
33140215|NCT01009840|100427993|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
33140216|NCT01009840|100427993|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
33140217|NCT01009840|100427993|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
33140218|NCT02160002|100427994|FG000|Overall Study|Withdrawal by Subject|2|||
33140219|NCT02160002|100427995|FG001|Overall Study|Withdrawal by Subject|1|||
33140220|NCT04740905|100428006|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
33579181|NCT01126190|102009708|FG001|Double-Blind Phase|Non-compliance|0|||
33579182|NCT01126190|102009709|FG002|Double-Blind Phase|Non-compliance|0|||
33638987|NCT00998296|102229412|FG009|Overall Study|Progressive disease|14|||
33638988|NCT00998296|102229413|FG010|Overall Study|Progressive disease|5|||
33638989|NCT00998296|102229403|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
33369957|NCT00875017|101239954|FG000|First Intervention|Intolerance to nasogastric tube|0|||
33369958|NCT00875017|101239955|FG001|First Intervention|Intolerance to nasogastric tube|0|||
33369959|NCT00875017|101239956|FG002|First Intervention|Intolerance to nasogastric tube|0|||
33369960|NCT00875017|101239957|FG003|First Intervention|Intolerance to nasogastric tube|0|||
33369961|NCT00875017|101239958|FG004|First Intervention|Intolerance to nasogastric tube|1|||
33369962|NCT00875017|101239959|FG005|First Intervention|Intolerance to nasogastric tube|0|||
33369963|NCT00875017|101239954|FG000|Washout|Problem collecting rectal effluent|0|||
33369964|NCT00875017|101239955|FG001|Washout|Problem collecting rectal effluent|0|||
33369965|NCT00875017|101239956|FG002|Washout|Problem collecting rectal effluent|1|||
33579183|NCT01126190|102009707|FG000|Double-Blind Phase|Lost to Follow-up|1|||
33638990|NCT00998296|102229404|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
33638991|NCT00998296|102229405|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
33638992|NCT00998296|102229406|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
33638993|NCT00998296|102229407|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
33638994|NCT00998296|102229408|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
33579184|NCT01126190|102009708|FG001|Double-Blind Phase|Lost to Follow-up|3|||
33579185|NCT01126190|102009709|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33579186|NCT01126190|102009707|FG000|Open-Label Phase|Death|0|||
33579187|NCT01126190|102009708|FG001|Open-Label Phase|Death|0|||
33579188|NCT01126190|102009709|FG002|Open-Label Phase|Death|1|||
33579189|NCT01126190|102009707|FG000|Open-Label Phase|Adverse Event|0|||
33579190|NCT01126190|102009708|FG001|Open-Label Phase|Adverse Event|0|||
33579191|NCT01126190|102009709|FG002|Open-Label Phase|Adverse Event|4|||
33579192|NCT01126190|102009707|FG000|Open-Label Phase|Withdrawal by Subject|0|||
33579193|NCT01126190|102009708|FG001|Open-Label Phase|Withdrawal by Subject|0|||
33579194|NCT01126190|102009709|FG002|Open-Label Phase|Withdrawal by Subject|6|||
33579195|NCT01775553|102009710|FG000|Overall Study|Adverse Event|1|||
33579196|NCT01775553|102009710|FG000|Overall Study|Disease Progression|12|||
33579197|NCT00673231|102009711|FG000|Overall Study|Withdrawal by Subject|14|||
33579198|NCT00673231|102009712|FG001|Overall Study|Withdrawal by Subject|10|||
33579199|NCT00673231|102009713|FG002|Overall Study|Withdrawal by Subject|8|||
33579200|NCT00673231|102009714|FG003|Overall Study|Withdrawal by Subject|6|||
33579201|NCT00673231|102009711|FG000|Overall Study|Adverse Event|6|||
33579202|NCT00673231|102009712|FG001|Overall Study|Adverse Event|5|||
33579203|NCT00673231|102009713|FG002|Overall Study|Adverse Event|9|||
33579204|NCT00673231|102009714|FG003|Overall Study|Adverse Event|6|||
33579205|NCT00673231|102009711|FG000|Overall Study|Lost to Follow-up|1|||
33579206|NCT00673231|102009712|FG001|Overall Study|Lost to Follow-up|2|||
33579207|NCT00673231|102009713|FG002|Overall Study|Lost to Follow-up|1|||
33579208|NCT00673231|102009714|FG003|Overall Study|Lost to Follow-up|2|||
33579209|NCT00673231|102009711|FG000|Overall Study|Death|0|||
33579210|NCT00673231|102009712|FG001|Overall Study|Death|0|||
33579211|NCT00673231|102009713|FG002|Overall Study|Death|1|||
33579212|NCT00673231|102009714|FG003|Overall Study|Death|0|||
33579213|NCT00673231|102009711|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
33579214|NCT00673231|102009712|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
33579215|NCT00673231|102009713|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
33579216|NCT00673231|102009714|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
33579217|NCT00645840|102009715|FG000|Overall Study|Protocol Violation|3|||
33579218|NCT00363142|102009716|FG000|Overall Study|Adverse Event|2|||
33638995|NCT00998296|102229409|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
33638996|NCT00998296|102229410|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
33638997|NCT00998296|102229411|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
33638998|NCT00998296|102229412|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
33638999|NCT00998296|102229413|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
33639000|NCT00998296|102229403|FG000|Overall Study|Other adverse event|0|||
33639001|NCT00998296|102229404|FG001|Overall Study|Other adverse event|0|||
33639002|NCT00998296|102229405|FG002|Overall Study|Other adverse event|0|||
33639003|NCT00998296|102229406|FG003|Overall Study|Other adverse event|0|||
33639004|NCT00998296|102229407|FG004|Overall Study|Other adverse event|1|||
33639005|NCT00998296|102229408|FG005|Overall Study|Other adverse event|0|||
33238177|NCT00813488|100775816|FG001|Titration Period 1|Adverse Event|1|||
33369966|NCT00875017|101239957|FG003|Washout|Problem collecting rectal effluent|0|||
33579219|NCT00363142|102009717|FG001|Overall Study|Adverse Event|0|||
33579220|NCT00363142|102009716|FG000|Overall Study|Lack of Efficacy|0|||
33579221|NCT00363142|102009717|FG001|Overall Study|Lack of Efficacy|1|||
33639006|NCT00998296|102229409|FG006|Overall Study|Other adverse event|0|||
33639007|NCT00998296|102229410|FG007|Overall Study|Other adverse event|0|||
33579222|NCT00363142|102009716|FG000|Overall Study|Lost to Follow-up|1|||
33579223|NCT00363142|102009717|FG001|Overall Study|Lost to Follow-up|0|||
33238178|NCT00813488|100775815|FG000|Titration Period 1|Lack of Efficacy|9|||
33238179|NCT00813488|100775816|FG001|Titration Period 1|Lack of Efficacy|7|||
33238180|NCT00813488|100775815|FG000|Titration Period 1|Withdrawal by Subject|2|||
33238181|NCT00813488|100775816|FG001|Titration Period 1|Withdrawal by Subject|2|||
33238182|NCT00813488|100775815|FG000|Titration Period 1|Protocol Violation|4|||
33238183|NCT00813488|100775816|FG001|Titration Period 1|Protocol Violation|3|||
33238184|NCT00813488|100775815|FG000|Titration Period 1|Non-compliance to study medication|4|||
33238185|NCT00813488|100775816|FG001|Titration Period 1|Non-compliance to study medication|1|||
33238186|NCT00813488|100775815|FG000|Titration Period 1|Non-compliance to study procedures|2|||
33238187|NCT00813488|100775816|FG001|Titration Period 1|Non-compliance to study procedures|2|||
33238188|NCT00813488|100775815|FG000|Titration Period 1|Technical Difficulties|0|||
33238189|NCT00813488|100775816|FG001|Titration Period 1|Technical Difficulties|1|||
33238190|NCT00813488|100775815|FG000|Titration Period 2|Adverse Event|2|||
33369967|NCT00875017|101239958|FG004|Washout|Problem collecting rectal effluent|0|||
33369968|NCT00875017|101239959|FG005|Washout|Problem collecting rectal effluent|0|||
33369969|NCT00875017|101239954|FG000|Second Intervention|Adverse Event|0|||
33369970|NCT00875017|101239955|FG001|Second Intervention|Adverse Event|0|||
33369971|NCT00875017|101239956|FG002|Second Intervention|Adverse Event|0|||
33369972|NCT00875017|101239957|FG003|Second Intervention|Adverse Event|1|||
33369973|NCT00875017|101239958|FG004|Second Intervention|Adverse Event|0|||
33369974|NCT00875017|101239959|FG005|Second Intervention|Adverse Event|0|||
33369975|NCT00875017|101239954|FG000|Washout|Problems collecting rectal effluent|0|||
33369976|NCT00875017|101239955|FG001|Washout|Problems collecting rectal effluent|1|||
33369977|NCT00875017|101239956|FG002|Washout|Problems collecting rectal effluent|0|||
33369978|NCT00875017|101239957|FG003|Washout|Problems collecting rectal effluent|0|||
33369979|NCT00875017|101239958|FG004|Washout|Problems collecting rectal effluent|0|||
33369980|NCT00875017|101239959|FG005|Washout|Problems collecting rectal effluent|0|||
33369981|NCT00875017|101239954|FG000|Third Intervention|Adverse Event|0|||
33369982|NCT00875017|101239955|FG001|Third Intervention|Adverse Event|1|||
33369983|NCT00875017|101239956|FG002|Third Intervention|Adverse Event|1|||
33369984|NCT00875017|101239957|FG003|Third Intervention|Adverse Event|0|||
33369985|NCT00875017|101239958|FG004|Third Intervention|Adverse Event|0|||
33369986|NCT00875017|101239959|FG005|Third Intervention|Adverse Event|0|||
33369987|NCT00875017|101239954|FG000|Washout|Withdrawal by Subject|0|||
33369988|NCT00875017|101239955|FG001|Washout|Withdrawal by Subject|0|||
33369989|NCT00875017|101239956|FG002|Washout|Withdrawal by Subject|0|||
33369990|NCT00875017|101239957|FG003|Washout|Withdrawal by Subject|0|||
33369991|NCT00875017|101239958|FG004|Washout|Withdrawal by Subject|1|||
33369992|NCT00875017|101239959|FG005|Washout|Withdrawal by Subject|0|||
33420883|NCT02913261|101431633|FG001|Overall Study|Disease relapse|13|||
33579224|NCT00363142|102009716|FG000|Overall Study|Non-compliance|1|||
33579225|NCT00363142|102009717|FG001|Overall Study|Non-compliance|1|||
33579226|NCT00363142|102009716|FG000|Overall Study|Withdrawal by Subject|3|||
33579227|NCT00363142|102009717|FG001|Overall Study|Withdrawal by Subject|1|||
33579228|NCT01133665|102009718|FG000|Overall Study|Physician Decision|2|||
33579229|NCT01261975|102009723|FG000|Overall Study|Surgical complication|1|||
33579230|NCT03089047|102009725|FG000|Overall Study|Lost to Follow-up|1|||
33579231|NCT03089047|102009726|FG001|Overall Study|Lost to Follow-up|0|||
33579232|NCT00573391|102009727|FG000|Overall Study|study stopped|2|||
33579233|NCT00573391|102009728|FG001|Overall Study|study stopped|2|||
33579234|NCT00573391|102009727|FG000|Overall Study|Death|1|||
33579235|NCT00573391|102009728|FG001|Overall Study|Death|0|||
33579236|NCT04403919|102009729|FG000|Overall Study|Lost to Follow-up|0|||
33579237|NCT04403919|102009730|FG001|Overall Study|Lost to Follow-up|0|||
33579238|NCT04403919|102009731|FG002|Overall Study|Lost to Follow-up|0|||
33579239|NCT04403919|102009732|FG003|Overall Study|Lost to Follow-up|1|||
33579240|NCT00038948|102009733|FG000|Overall Study|Adverse Event|131|||
33579241|NCT00038948|102009734|FG001|Overall Study|Adverse Event|43|||
33579242|NCT00038948|102009733|FG000|Overall Study|Lost to Follow-up|4|||
33579243|NCT00038948|102009734|FG001|Overall Study|Lost to Follow-up|4|||
33579244|NCT00038948|102009733|FG000|Overall Study|Nonmedical event|5|||
33579245|NCT00038948|102009734|FG001|Overall Study|Nonmedical event|7|||
33579246|NCT00038948|102009733|FG000|Overall Study|Withdrawal by Subject|23|||
33140221|NCT04740905|100428007|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
33140222|NCT04740905|100428006|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
33140223|NCT04740905|100428007|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
33238191|NCT00813488|100775816|FG001|Titration Period 2|Adverse Event|3|||
33369993|NCT00875017|101239954|FG000|Fourth Intervention|Inability to comply with fasting|0|||
33369994|NCT00875017|101239955|FG001|Fourth Intervention|Inability to comply with fasting|0|||
33238192|NCT00813488|100775815|FG000|Titration Period 2|Lack of Efficacy|8|||
33238193|NCT00813488|100775816|FG001|Titration Period 2|Lack of Efficacy|4|||
33420884|NCT02913261|101431632|FG000|Overall Study|Physician Decision|8|||
33369995|NCT00875017|101239956|FG002|Fourth Intervention|Inability to comply with fasting|0|||
33579247|NCT00038948|102009734|FG001|Overall Study|Withdrawal by Subject|10|||
33579248|NCT00038948|102009733|FG000|Overall Study|Protocol Violation|3|||
33579249|NCT00038948|102009734|FG001|Overall Study|Protocol Violation|7|||
33579250|NCT00038948|102009733|FG000|Overall Study|Lack of Efficacy|3|||
33140224|NCT04740905|100428006|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
33140225|NCT04740905|100428007|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
33140226|NCT04740905|100428006|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
33140227|NCT04740905|100428007|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
33140228|NCT04740905|100428006|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
33140229|NCT04740905|100428007|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
33140230|NCT04740905|100428006|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
33140231|NCT04740905|100428007|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
33140232|NCT04740905|100428006|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
33140233|NCT04740905|100428007|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
33140234|NCT04740905|100428006|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
33140235|NCT04740905|100428007|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
33140236|NCT04740905|100428006|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
33140237|NCT04740905|100428007|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
33140238|NCT04740905|100428006|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
33140239|NCT04740905|100428007|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
33140240|NCT04740905|100428006|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
33140241|NCT04740905|100428007|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
33140242|NCT04740905|100428006|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
33140243|NCT04740905|100428007|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
33140244|NCT04740905|100428006|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
33140245|NCT04740905|100428007|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
33140246|NCT04740905|100428006|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
33140247|NCT04740905|100428007|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
33140248|NCT00274924|100428008|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
33140249|NCT00274924|100428009|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
33140250|NCT00274924|100428010|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
33140251|NCT00274924|100428008|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
33140252|NCT00274924|100428009|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
33140253|NCT00274924|100428010|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
33140254|NCT00274924|100428008|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
33140255|NCT00274924|100428009|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
33140256|NCT00274924|100428010|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
33140257|NCT00274924|100428008|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
33140258|NCT00274924|100428009|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
33140259|NCT00274924|100428010|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
33140260|NCT00274924|100428008|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
33140261|NCT00274924|100428009|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
33140262|NCT00274924|100428010|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
33140263|NCT00274924|100428008|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
33140264|NCT00274924|100428009|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
33140265|NCT00274924|100428010|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
33140266|NCT00274924|100428008|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
33140267|NCT00274924|100428009|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
33140268|NCT00274924|100428010|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
33140269|NCT00274924|100428008|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
33140270|NCT00274924|100428009|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
33140271|NCT00274924|100428010|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
33140272|NCT00274924|100428008|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
33140273|NCT00274924|100428009|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
33369996|NCT00875017|101239957|FG003|Fourth Intervention|Inability to comply with fasting|0|||
33369997|NCT00875017|101239958|FG004|Fourth Intervention|Inability to comply with fasting|0|||
33369998|NCT00875017|101239959|FG005|Fourth Intervention|Inability to comply with fasting|1|||
33369999|NCT03229759|101239960|FG000|Overall Study|Screen Failure|30|||
33579251|NCT00038948|102009734|FG001|Overall Study|Lack of Efficacy|6|||
33579252|NCT01023217|102009735|FG000|Overall Study|Withdrawal by Subject|1|||
33579253|NCT01023217|102009736|FG001|Overall Study|Withdrawal by Subject|0|||
33579254|NCT02457247|102009737|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
33579255|NCT02457247|102009738|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
33579256|NCT02457247|102009739|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
33579257|NCT02457247|102009740|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
33579258|NCT02457247|102009737|FG000|Period 1|Significant Protocol Deviation|1|||
33579259|NCT02457247|102009738|FG001|Period 1|Significant Protocol Deviation|1|||
33579260|NCT02457247|102009739|FG002|Period 1|Significant Protocol Deviation|0|||
33579261|NCT02457247|102009740|FG003|Period 1|Significant Protocol Deviation|0|||
33140274|NCT00274924|100428010|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
33140275|NCT00274924|100428008|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
33140276|NCT00274924|100428009|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
33370000|NCT01425190|101239973|FG000|Overall Study|Full dose not consumed.|1|||
33370001|NCT01425190|101239974|FG001|Overall Study|Full dose not consumed.|0|||
33639008|NCT00998296|102229411|FG008|Overall Study|Other adverse event|0|||
33639009|NCT00998296|102229412|FG009|Overall Study|Other adverse event|1|||
33639010|NCT00998296|102229413|FG010|Overall Study|Other adverse event|2|||
33579262|NCT02457247|102009737|FG000|Period 1|Voluntary Withdrawal|1|||
33579263|NCT02457247|102009738|FG001|Period 1|Voluntary Withdrawal|0|||
33579264|NCT02457247|102009739|FG002|Period 1|Voluntary Withdrawal|0|||
33579265|NCT02457247|102009740|FG003|Period 1|Voluntary Withdrawal|0|||
33579266|NCT02457247|102009737|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
33579267|NCT02457247|102009738|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
33579268|NCT02457247|102009739|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
33639011|NCT00998296|102229403|FG000|Overall Study|Refused to continue taking trial med.|0|||
33639012|NCT00998296|102229404|FG001|Overall Study|Refused to continue taking trial med.|0|||
33639013|NCT00998296|102229405|FG002|Overall Study|Refused to continue taking trial med.|0|||
33639014|NCT00998296|102229406|FG003|Overall Study|Refused to continue taking trial med.|0|||
33238194|NCT00813488|100775815|FG000|Titration Period 2|Protocol Violation|3|||
33238195|NCT00813488|100775816|FG001|Titration Period 2|Protocol Violation|2|||
33238196|NCT00813488|100775815|FG000|Titration Period 2|Lost to Follow-up|1|||
33238197|NCT00813488|100775816|FG001|Titration Period 2|Lost to Follow-up|0|||
33238198|NCT00813488|100775815|FG000|Titration Period 2|Non-compliance with study procedures|2|||
33238199|NCT00813488|100775816|FG001|Titration Period 2|Non-compliance with study procedures|1|||
33238200|NCT00813488|100775815|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
33238201|NCT00813488|100775816|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
33238202|NCT00813488|100775815|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
33238203|NCT00813488|100775816|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
33238204|NCT00813488|100775815|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
33238205|NCT00813488|100775816|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
33238206|NCT00813488|100775815|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
33238207|NCT00813488|100775816|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
33238208|NCT00813488|100775815|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
33238209|NCT00813488|100775816|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
33238210|NCT00813488|100775815|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
33238211|NCT00813488|100775816|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
33238212|NCT00813488|100775815|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
33238213|NCT00813488|100775816|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
33238214|NCT00813488|100775815|FG000|Double-blind Treatment Period 2|Other|1|||
33238215|NCT00813488|100775816|FG001|Double-blind Treatment Period 2|Other|0|||
33238216|NCT00813488|100775815|FG000|Open-label Extension|Adverse Event|1|||
33238217|NCT00813488|100775816|FG001|Open-label Extension|Adverse Event|2|||
33238218|NCT00813488|100775815|FG000|Open-label Extension|Lack of Efficacy|3|||
33238219|NCT00813488|100775816|FG001|Open-label Extension|Lack of Efficacy|0|||
33238220|NCT00813488|100775815|FG000|Open-label Extension|Withdrawal by Subject|0|||
33238221|NCT00813488|100775816|FG001|Open-label Extension|Withdrawal by Subject|2|||
33238222|NCT00813488|100775815|FG000|Open-label Extension|Protocol Violation|1|||
33238223|NCT00813488|100775816|FG001|Open-label Extension|Protocol Violation|2|||
33238224|NCT00813488|100775815|FG000|Open-label Extension|Non-compliance study medication|4|||
33238225|NCT00813488|100775816|FG001|Open-label Extension|Non-compliance study medication|0|||
33238226|NCT00813488|100775815|FG000|Open-label Extension|Non-compliance study procedures|2|||
33238227|NCT00813488|100775816|FG001|Open-label Extension|Non-compliance study procedures|1|||
33238228|NCT00813488|100775815|FG000|Open-label Extension|Other|1|||
33238229|NCT00813488|100775816|FG001|Open-label Extension|Other|0|||
33238230|NCT03673098|100775822|FG000|Overall Study|Lost to Follow-up|2|||
33370002|NCT01425190|101239975|FG002|Overall Study|Full dose not consumed.|0|||
33370003|NCT04009096|101239976|FG000|Overall Study|Withdrawal by Subject|0|||
33370004|NCT04009096|101239977|FG001|Overall Study|Withdrawal by Subject|7|||
33370005|NCT04009096|101239978|FG002|Overall Study|Withdrawal by Subject|0|||
33370006|NCT04009096|101239976|FG000|Overall Study|Physician Decision|0|||
33579269|NCT02457247|102009740|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
33579270|NCT02457247|102009737|FG000|Period 2|Significant Protocol Deviation|1|||
33639015|NCT00998296|102229407|FG004|Overall Study|Refused to continue taking trial med.|0|||
33639016|NCT00998296|102229408|FG005|Overall Study|Refused to continue taking trial med.|0|||
33238231|NCT03673098|100775823|FG001|Overall Study|Lost to Follow-up|3|||
33579271|NCT02457247|102009738|FG001|Period 2|Significant Protocol Deviation|0|||
33579272|NCT02457247|102009739|FG002|Period 2|Significant Protocol Deviation|0|||
33579273|NCT02457247|102009740|FG003|Period 2|Significant Protocol Deviation|0|||
33639017|NCT00998296|102229409|FG006|Overall Study|Refused to continue taking trial med.|0|||
33238232|NCT03673098|100775822|FG000|Overall Study|Withdrawal by Subject|6|||
33370007|NCT04009096|101239977|FG001|Overall Study|Physician Decision|1|||
33238233|NCT03673098|100775823|FG001|Overall Study|Withdrawal by Subject|1|||
33370008|NCT04009096|101239978|FG002|Overall Study|Physician Decision|0|||
33579274|NCT02457247|102009737|FG000|Period 2|Lost to Follow-up|0|||
33579275|NCT02457247|102009738|FG001|Period 2|Lost to Follow-up|1|||
33238234|NCT03673098|100775822|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
33238235|NCT03673098|100775823|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
33238236|NCT00445692|100775827|FG000|Overall Study|Adverse Event|11|||
33238237|NCT00445692|100775827|FG000|Overall Study|Lack of Efficacy|5|||
33238238|NCT02240680|100775828|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
33238239|NCT02240680|100775829|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
33238240|NCT02240680|100775830|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
33238241|NCT02240680|100775831|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
33238242|NCT02240680|100775828|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
33238243|NCT02240680|100775829|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
33238244|NCT02240680|100775830|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
33238245|NCT02240680|100775831|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
33238246|NCT02240680|100775828|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
33238247|NCT02240680|100775829|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
33238248|NCT02240680|100775830|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
33238249|NCT02240680|100775831|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
33238250|NCT02240680|100775828|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
33238251|NCT02240680|100775829|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
33238252|NCT02240680|100775830|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
33238253|NCT02240680|100775831|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
33238254|NCT02240680|100775828|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
33238255|NCT02240680|100775829|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
33238256|NCT02240680|100775830|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
33238257|NCT02240680|100775831|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
33238258|NCT02240680|100775828|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
33238259|NCT02240680|100775829|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
33238260|NCT02240680|100775830|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
33238261|NCT02240680|100775831|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
33238262|NCT02240680|100775828|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
33238263|NCT02240680|100775829|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
33238264|NCT02240680|100775830|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
33238265|NCT02240680|100775831|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
33238266|NCT02240680|100775828|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
33238267|NCT02240680|100775829|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
33238268|NCT02240680|100775830|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
33238269|NCT02240680|100775831|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
33238270|NCT01066156|100775834|FG000|Overall Study|ineligible|2|||
33238271|NCT01066156|100775834|FG000|Overall Study|Lost to Follow-up|7|||
33238272|NCT01066156|100775834|FG000|Overall Study|Withdrawal by Subject|1|||
33238273|NCT03019458|100775835|FG000|Overall Study|Death|0|||
33238274|NCT03019458|100775836|FG001|Overall Study|Death|1|||
33238275|NCT01661881|100775837|FG000|Overall Study|Disease Progression|1|||
33238276|NCT01932996|100775838|FG000|Overall Study|Protocol Violation|2|||
33238277|NCT01932996|100775839|FG001|Overall Study|Protocol Violation|0|||
33238278|NCT02800928|100775840|FG000|Overall Study|Withdrawal by Subject|1|||
33238279|NCT02800928|100775841|FG001|Overall Study|Withdrawal by Subject|1|||
33238280|NCT02800928|100775840|FG000|Overall Study|Protocol Violation|1|||
33140277|NCT00274924|100428010|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
33140278|NCT00274924|100428008|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
33140279|NCT00274924|100428009|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
33140280|NCT00274924|100428010|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
33140281|NCT00274924|100428008|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
33140282|NCT00274924|100428009|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
33140283|NCT00274924|100428010|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
33140284|NCT00274924|100428008|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
33140285|NCT00274924|100428009|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
33140286|NCT00274924|100428010|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
33140287|NCT01268579|100428011|FG000|Overall Study|Adverse Event|1|||
33140288|NCT01268579|100428011|FG000|Overall Study|Withdrawal by Subject|2|||
33140289|NCT02810444|100428020|FG000|Overall Study|Screen Failures|14|||
33140290|NCT02810444|100428020|FG000|Overall Study|Withdrawal by Subject|4|||
33238281|NCT02800928|100775841|FG001|Overall Study|Protocol Violation|1|||
33238282|NCT02555371|100775849|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
33238283|NCT02555371|100775850|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
33639018|NCT00998296|102229410|FG007|Overall Study|Refused to continue taking trial med.|0|||
33639019|NCT00998296|102229411|FG008|Overall Study|Refused to continue taking trial med.|0|||
33639020|NCT00998296|102229412|FG009|Overall Study|Refused to continue taking trial med.|2|||
33238284|NCT02555371|100775851|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
33639021|NCT00998296|102229413|FG010|Overall Study|Refused to continue taking trial med.|0|||
33639022|NCT00998296|102229403|FG000|Overall Study|Reason other than those specified above|0|||
33639023|NCT00998296|102229404|FG001|Overall Study|Reason other than those specified above|0|||
33238285|NCT02555371|100775852|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
33238286|NCT02555371|100775853|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
33238287|NCT02555371|100775849|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
33238288|NCT02555371|100775850|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
33238289|NCT02555371|100775851|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
33238290|NCT02555371|100775852|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
33238291|NCT02555371|100775853|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
33238292|NCT02555371|100775849|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
33238293|NCT02555371|100775850|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
33238294|NCT02555371|100775851|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
33238295|NCT02555371|100775852|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
33238296|NCT02555371|100775853|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
33238297|NCT02555371|100775849|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
33238298|NCT02555371|100775850|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
33238299|NCT02555371|100775851|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
33238300|NCT02555371|100775852|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
33238301|NCT02555371|100775853|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
33238302|NCT02555371|100775849|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
33238303|NCT02555371|100775850|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
33238304|NCT02555371|100775851|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
33238305|NCT02555371|100775852|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
33238306|NCT02555371|100775853|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
33238307|NCT02555371|100775849|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
33238308|NCT02555371|100775850|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
33238309|NCT02555371|100775851|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
33238310|NCT02555371|100775852|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
33238311|NCT02555371|100775853|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
33238312|NCT02555371|100775849|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
33238313|NCT02555371|100775850|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
33238314|NCT02555371|100775851|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
33238315|NCT02555371|100775852|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
33238316|NCT02555371|100775853|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
33238317|NCT02555371|100775849|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
33238318|NCT02555371|100775850|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
33579276|NCT02457247|102009739|FG002|Period 2|Lost to Follow-up|0|||
33579277|NCT02457247|102009740|FG003|Period 2|Lost to Follow-up|0|||
33579278|NCT02457247|102009737|FG000|Period 2|Voluntary Withdrawal|1|||
33579279|NCT02457247|102009738|FG001|Period 2|Voluntary Withdrawal|1|||
33579280|NCT02457247|102009739|FG002|Period 2|Voluntary Withdrawal|0|||
33579281|NCT02457247|102009740|FG003|Period 2|Voluntary Withdrawal|0|||
33579282|NCT01485796|102009743|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
33579283|NCT01485796|102009743|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
33579284|NCT01485796|102009743|FG000|Period 2: Epoch 2|Adverse Event|3|||
33579285|NCT01485796|102009743|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
33579286|NCT01485796|102009743|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
33579287|NCT01485796|102009743|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
33579288|NCT01485796|102009743|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
33579289|NCT01485796|102009743|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
33579290|NCT02903823|102009744|FG000|Overall Study|Physician Decision|5|||
33579291|NCT02903823|102009744|FG000|Overall Study|Could not advance catheter|1|||
33579292|NCT02903823|102009744|FG000|Overall Study|Catheter dislodgement|1|||
33579293|NCT01991483|102009745|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
33579294|NCT01991483|102009746|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
33579295|NCT01991483|102009747|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
33579296|NCT01991483|102009748|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
33579297|NCT01991483|102009745|FG000|Dose Level 600 mg|Physician Decision|0|||
33579298|NCT01991483|102009746|FG001|Dose Level 600 mg|Physician Decision|0|||
33579299|NCT01991483|102009747|FG002|Dose Level 600 mg|Physician Decision|1|||
33579300|NCT01991483|102009748|FG003|Dose Level 600 mg|Physician Decision|0|||
33579301|NCT01991483|102009745|FG000|Dose Level 1000 mg|Protocol Violation|0|||
33579302|NCT01991483|102009746|FG001|Dose Level 1000 mg|Protocol Violation|0|||
33639024|NCT00998296|102229405|FG002|Overall Study|Reason other than those specified above|0|||
33639025|NCT00998296|102229406|FG003|Overall Study|Reason other than those specified above|0|||
33370009|NCT03648476|101239979|FG000|Overall Study|Withdrawal by Subject|2|||
33579303|NCT01991483|102009747|FG002|Dose Level 1000 mg|Protocol Violation|0|||
33579304|NCT01991483|102009748|FG003|Dose Level 1000 mg|Protocol Violation|1|||
33140291|NCT02810444|100428020|FG000|Overall Study|Adverse Event|3|||
33238319|NCT02555371|100775851|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
33579305|NCT04162470|102009749|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
33639026|NCT00998296|102229407|FG004|Overall Study|Reason other than those specified above|0|||
33639027|NCT00998296|102229408|FG005|Overall Study|Reason other than those specified above|0|||
33639028|NCT00998296|102229409|FG006|Overall Study|Reason other than those specified above|0|||
33639029|NCT00998296|102229410|FG007|Overall Study|Reason other than those specified above|0|||
33639030|NCT00998296|102229411|FG008|Overall Study|Reason other than those specified above|0|||
33639031|NCT00998296|102229412|FG009|Overall Study|Reason other than those specified above|1|||
33639032|NCT00998296|102229413|FG010|Overall Study|Reason other than those specified above|0|||
33639033|NCT00541385|102229415|FG000|Overall Study|Adverse Event|6|||
33639034|NCT00541385|102229416|FG001|Overall Study|Adverse Event|3|||
33639035|NCT00541385|102229415|FG000|Overall Study|Withdrawal by Subject|2|||
33639036|NCT00541385|102229416|FG001|Overall Study|Withdrawal by Subject|2|||
33639037|NCT00541385|102229415|FG000|Overall Study|Lost to Follow-up|6|||
33639038|NCT00541385|102229416|FG001|Overall Study|Lost to Follow-up|1|||
33639039|NCT00541385|102229415|FG000|Overall Study|Parasite reappearance/malaria|67|||
33639040|NCT00541385|102229416|FG001|Overall Study|Parasite reappearance/malaria|32|||
33639041|NCT00560352|102229417|FG000|Overall Study|Adverse event unrelated to study drug|2|||
33639042|NCT00560352|102229418|FG001|Overall Study|Adverse event unrelated to study drug|1|||
33639043|NCT00560352|102229419|FG002|Overall Study|Adverse event unrelated to study drug|1|||
33639044|NCT00560352|102229417|FG000|Overall Study|Study drug toxicity|3|||
33639045|NCT00560352|102229418|FG001|Overall Study|Study drug toxicity|0|||
33639046|NCT00560352|102229419|FG002|Overall Study|Study drug toxicity|1|||
33639047|NCT00560352|102229417|FG000|Overall Study|Disease progression|0|||
33639048|NCT00560352|102229418|FG001|Overall Study|Disease progression|1|||
33639049|NCT00560352|102229419|FG002|Overall Study|Disease progression|1|||
33639050|NCT00560352|102229417|FG000|Overall Study|Withdrawal by Subject|1|||
33639051|NCT00560352|102229418|FG001|Overall Study|Withdrawal by Subject|1|||
33639052|NCT00560352|102229419|FG002|Overall Study|Withdrawal by Subject|1|||
33639053|NCT00560352|102229417|FG000|Overall Study|Maximum clinical benefit|1|||
33639054|NCT00560352|102229418|FG001|Overall Study|Maximum clinical benefit|0|||
33639055|NCT00560352|102229419|FG002|Overall Study|Maximum clinical benefit|0|||
33639056|NCT00929695|102229420|FG000|Overall Study|Death|2|||
33639057|NCT00929695|102229421|FG001|Overall Study|Death|1|||
33639058|NCT00929695|102229420|FG000|Overall Study|Withdrawal by Subject|0|||
33639059|NCT00929695|102229421|FG001|Overall Study|Withdrawal by Subject|2|||
33639060|NCT00929695|102229420|FG000|Overall Study|discharge home|4|||
33639061|NCT00929695|102229421|FG001|Overall Study|discharge home|3|||
33639062|NCT00929695|102229420|FG000|Overall Study|incorrect stratification|2|||
33639063|NCT00929695|102229421|FG001|Overall Study|incorrect stratification|0|||
33639064|NCT01635153|102229422|FG000|Overall Study|Lost to Follow-up|40|||
33639065|NCT01635153|102229423|FG001|Overall Study|Lost to Follow-up|43|||
33639066|NCT05097963|102229424|FG000|Overall Study|Protocol Violation|13|||
33639067|NCT05097963|102229424|FG000|Overall Study|Withdrawal by Subject|21|||
33639068|NCT03181932|102229429|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
33639069|NCT03181932|102229430|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
33639070|NCT03181932|102229429|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
33639071|NCT03181932|102229430|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
33639072|NCT03181932|102229429|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
33639073|NCT03181932|102229430|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
33238320|NCT02555371|100775852|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
33238321|NCT02555371|100775853|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
33238322|NCT02555371|100775849|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
33238323|NCT02555371|100775850|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
33639074|NCT03181932|102229429|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
33639075|NCT03181932|102229430|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
33639076|NCT03181932|102229429|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
33639077|NCT03181932|102229430|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
33639078|NCT03181932|102229429|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
33639079|NCT03181932|102229430|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
33639080|NCT03181932|102229429|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
33639081|NCT03181932|102229430|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
33238324|NCT02555371|100775851|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
33639082|NCT03181932|102229429|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
33639083|NCT03181932|102229430|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
33639084|NCT03181932|102229429|FG000|Period 2 (Open-label Period)|Reason missing|2|||
33639085|NCT03181932|102229430|FG001|Period 2 (Open-label Period)|Reason missing|0|||
33639086|NCT02461758|102229434|FG000|Overall Study|Lost to Follow-up|0|||
33639087|NCT02461758|102229435|FG001|Overall Study|Lost to Follow-up|1|||
33639088|NCT02461758|102229436|FG002|Overall Study|Lost to Follow-up|1|||
33639089|NCT02461758|102229437|FG003|Overall Study|Lost to Follow-up|0|||
33639090|NCT00198822|102229438|FG000|Overall Study|Lost to Follow-up|14|||
33639091|NCT00198822|102229439|FG001|Overall Study|Lost to Follow-up|20|||
33579306|NCT03108521|102013040|FG000|Overall Study|Lost to Follow-up|3|||
33579307|NCT03108521|102013041|FG001|Overall Study|Lost to Follow-up|0|||
33579308|NCT03108521|102013040|FG000|Overall Study|Lack of Efficacy|2|||
33579309|NCT03108521|102013041|FG001|Overall Study|Lack of Efficacy|0|||
33579310|NCT03108521|102013040|FG000|Overall Study|Physician Decision|4|||
33579311|NCT03108521|102013041|FG001|Overall Study|Physician Decision|0|||
33579312|NCT03108521|102013040|FG000|Overall Study|Adverse Event|3|||
33238325|NCT02555371|100775852|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
33238326|NCT02555371|100775853|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
33238327|NCT02555371|100775849|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
33238328|NCT02555371|100775850|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
33238329|NCT02555371|100775851|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
33238330|NCT02555371|100775852|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
33238331|NCT02555371|100775853|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
33238332|NCT02555371|100775849|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
33238333|NCT02555371|100775850|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
33238334|NCT02555371|100775851|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
33238335|NCT02555371|100775852|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
33238336|NCT02555371|100775853|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
33238337|NCT02555371|100775849|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
33238338|NCT02555371|100775850|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
33238339|NCT02555371|100775851|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
33238340|NCT02555371|100775852|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
33238341|NCT02555371|100775853|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
33238342|NCT02555371|100775849|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
33238343|NCT02555371|100775850|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
33238344|NCT02555371|100775851|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
33238345|NCT02555371|100775852|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
33238346|NCT02555371|100775853|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
33238347|NCT02555371|100775849|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
33238348|NCT02555371|100775850|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
33238349|NCT02555371|100775851|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
33238350|NCT02555371|100775852|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
33238351|NCT02555371|100775853|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
33238352|NCT00742885|100775854|FG000|Overall Study|Lost to Follow-up|1|||
33238353|NCT00742885|100775855|FG001|Overall Study|Lost to Follow-up|0|||
33238354|NCT00604721|100775860|FG000|Overall Study|Physician Decision|1|||
33238355|NCT00604721|100775860|FG000|Overall Study|Withdrawal by Subject|1|||
33238356|NCT04254679|100775870|FG000|Overall Study|Protocol Violation|1|||
33238357|NCT04254679|100775871|FG001|Overall Study|Protocol Violation|1|||
33238358|NCT04254679|100775870|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
33238359|NCT04254679|100775871|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
33238360|NCT00184028|100775874|FG000|Overall Study|Death|1|||
33238361|NCT00184028|100775874|FG000|Overall Study|Lack of Efficacy|4|||
33238362|NCT00184028|100775874|FG000|Overall Study|Adverse Event|2|||
33238363|NCT00184028|100775874|FG000|Overall Study|Withdrawal by Subject|1|||
33238364|NCT00184028|100775874|FG000|Overall Study|Non-compliance|2|||
33238365|NCT00742274|100775875|FG000|Overall Study|Death|1|||
33238366|NCT00742274|100775876|FG001|Overall Study|Death|0|||
33238367|NCT00742274|100775875|FG000|Overall Study|Withdrawal by Subject|1|||
33238368|NCT00742274|100775876|FG001|Overall Study|Withdrawal by Subject|2|||
33238369|NCT00742274|100775875|FG000|Overall Study|Removed for medical reasons|1|||
33238370|NCT00742274|100775876|FG001|Overall Study|Removed for medical reasons|1|||
33238371|NCT03398356|100775877|FG000|Before Treatment|Lost to Follow-up|1|||
33238372|NCT03398356|100775878|FG001|Before Treatment|Lost to Follow-up|2|||
33579313|NCT03108521|102013041|FG001|Overall Study|Adverse Event|0|||
33579314|NCT00305448|102013042|FG000|Overall Study|Protocol Violation|0|||
33579315|NCT00305448|102013043|FG001|Overall Study|Protocol Violation|1|||
33579316|NCT00305448|102013044|FG002|Overall Study|Protocol Violation|0|||
33579317|NCT00305448|102013042|FG000|Overall Study|Withdrawal by Subject|2|||
33579318|NCT00305448|102013043|FG001|Overall Study|Withdrawal by Subject|0|||
33639092|NCT00198822|102229440|FG002|Overall Study|Lost to Follow-up|21|||
33639093|NCT00930046|102229443|FG000|Overall Study|Wound catheter malfunctioned|1|||
33639094|NCT00930046|102229444|FG001|Overall Study|Wound catheter malfunctioned|2|||
33639095|NCT02565108|102229446|FG000|Overall Study|Adverse Event|1|||
33579319|NCT00305448|102013044|FG002|Overall Study|Withdrawal by Subject|1|||
33639096|NCT02565108|102229447|FG001|Overall Study|Adverse Event|0|||
33238373|NCT03398356|100775879|FG002|Before Treatment|Lost to Follow-up|0|||
33238374|NCT03398356|100775877|FG000|Before Treatment|drug intolerance|2|||
33238375|NCT03398356|100775878|FG001|Before Treatment|drug intolerance|1|||
33579320|NCT00305448|102013042|FG000|Overall Study|Adverse Event|1|||
33579321|NCT00305448|102013043|FG001|Overall Study|Adverse Event|0|||
33238376|NCT03398356|100775879|FG002|Before Treatment|drug intolerance|0|||
33238377|NCT03398356|100775877|FG000|Before Treatment|Withdrawal by Subject|0|||
33639097|NCT02565108|102229446|FG000|Overall Study|Withdrew Consent|1|||
33238378|NCT03398356|100775878|FG001|Before Treatment|Withdrawal by Subject|5|||
33639098|NCT02565108|102229447|FG001|Overall Study|Withdrew Consent|0|||
33639099|NCT01519921|102229452|FG000|Overall Study|Adverse Event|10|||
33639100|NCT01519921|102229453|FG001|Overall Study|Adverse Event|9|||
33579322|NCT00305448|102013044|FG002|Overall Study|Adverse Event|1|||
33639101|NCT01519921|102229452|FG000|Overall Study|Lack of Efficacy|4|||
33639102|NCT01519921|102229453|FG001|Overall Study|Lack of Efficacy|3|||
33639103|NCT01519921|102229452|FG000|Overall Study|Withdrawal by Subject|3|||
33639104|NCT01519921|102229453|FG001|Overall Study|Withdrawal by Subject|0|||
33639105|NCT01519921|102229452|FG000|Overall Study|Lost to Follow-up|2|||
33639106|NCT01519921|102229453|FG001|Overall Study|Lost to Follow-up|1|||
33639107|NCT01519921|102229452|FG000|Overall Study|Treatment refusal|2|||
33639108|NCT01519921|102229453|FG001|Overall Study|Treatment refusal|1|||
33639109|NCT01519921|102229452|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
33639110|NCT01519921|102229453|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
33639111|NCT01039519|102229454|FG000|Treatment|Progressive disease|20|||
33238379|NCT03398356|100775879|FG002|Before Treatment|Withdrawal by Subject|0|||
33238380|NCT03398356|100775877|FG000|Before Treatment|Physician Decision|0|||
33238381|NCT03398356|100775878|FG001|Before Treatment|Physician Decision|0|||
33238382|NCT03398356|100775879|FG002|Before Treatment|Physician Decision|11|||
33238383|NCT03398356|100775877|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
33238384|NCT03398356|100775878|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
33238385|NCT03398356|100775879|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
33238386|NCT01106976|100775880|FG000|Overall Study|Lost to Follow-up|8|||
33238387|NCT00958009|100775881|FG000|Overall Study|Adverse Event|1|||
33238388|NCT00958009|100775881|FG000|Overall Study|Subject found device difficult to use|1|||
33370010|NCT03648476|101239980|FG001|Overall Study|Withdrawal by Subject|1|||
33370011|NCT00532883|101239984|FG000|Overall Study|Adverse Event|1|||
33579323|NCT00305448|102013042|FG000|Overall Study|Disease Progression|27|||
33579324|NCT00305448|102013043|FG001|Overall Study|Disease Progression|31|||
33579325|NCT00305448|102013044|FG002|Overall Study|Disease Progression|28|||
33579326|NCT00305448|102013042|FG000|Overall Study|Subjective Disease Progression|1|||
33579327|NCT00305448|102013043|FG001|Overall Study|Subjective Disease Progression|2|||
33579328|NCT00305448|102013044|FG002|Overall Study|Subjective Disease Progression|2|||
33579329|NCT00305448|102013042|FG000|Overall Study|Tumor Marker Elevation|0|||
33579330|NCT00305448|102013043|FG001|Overall Study|Tumor Marker Elevation|0|||
33579331|NCT00305448|102013044|FG002|Overall Study|Tumor Marker Elevation|1|||
33579332|NCT00925002|102013051|FG000|Overall Study|Other|1|||
33579333|NCT00925002|102013052|FG001|Overall Study|Other|4|||
33579334|NCT00925002|102013053|FG002|Overall Study|Other|0|||
33579335|NCT00925002|102013051|FG000|Overall Study|Death|1|||
33579336|NCT00925002|102013052|FG001|Overall Study|Death|1|||
33579337|NCT00925002|102013053|FG002|Overall Study|Death|5|||
33579338|NCT00925002|102013051|FG000|Overall Study|Adverse Event|3|||
33579339|NCT00925002|102013052|FG001|Overall Study|Adverse Event|1|||
33579340|NCT00925002|102013053|FG002|Overall Study|Adverse Event|2|||
33579341|NCT00925002|102013051|FG000|Overall Study|Participant withdrew consent|1|||
33579342|NCT00925002|102013052|FG001|Overall Study|Participant withdrew consent|3|||
33579343|NCT00925002|102013053|FG002|Overall Study|Participant withdrew consent|3|||
33579344|NCT03012334|102013056|FG000|Period 1|Withdrawal by Subject|0|||
33579345|NCT03012334|102013057|FG001|Period 1|Withdrawal by Subject|0|||
33579346|NCT03012334|102013058|FG002|Period 1|Withdrawal by Subject|0|||
33579347|NCT03012334|102013059|FG003|Period 1|Withdrawal by Subject|0|||
33579348|NCT03012334|102013060|FG004|Period 1|Withdrawal by Subject|0|||
33579349|NCT03012334|102013061|FG005|Period 1|Withdrawal by Subject|0|||
33579350|NCT03012334|102013062|FG006|Period 1|Withdrawal by Subject|0|||
33579351|NCT03012334|102013063|FG007|Period 1|Withdrawal by Subject|0|||
33579352|NCT03012334|102013064|FG008|Period 1|Withdrawal by Subject|0|||
33579353|NCT03012334|102013065|FG009|Period 1|Withdrawal by Subject|1|||
33579354|NCT03012334|102013056|FG000|Period 2|Withdrawal by Subject|0|||
33579355|NCT03012334|102013057|FG001|Period 2|Withdrawal by Subject|1|||
33238389|NCT04562779|100775886|FG000|Overall Study|Lost to Follow-up|7|||
33579356|NCT03012334|102013058|FG002|Period 2|Withdrawal by Subject|0|||
33579357|NCT03012334|102013059|FG003|Period 2|Withdrawal by Subject|0|||
33579358|NCT03012334|102013060|FG004|Period 2|Withdrawal by Subject|0|||
33579359|NCT03012334|102013061|FG005|Period 2|Withdrawal by Subject|0|||
33579360|NCT03012334|102013062|FG006|Period 2|Withdrawal by Subject|0|||
33579361|NCT03012334|102013063|FG007|Period 2|Withdrawal by Subject|0|||
33579362|NCT03012334|102013064|FG008|Period 2|Withdrawal by Subject|0|||
33639112|NCT01039519|102229454|FG000|Treatment|Treatment failure|2|||
33639113|NCT01039519|102229454|FG000|Treatment|Adverse Event|3|||
33639114|NCT01039519|102229454|FG000|Treatment|Physician Decision|2|||
33639115|NCT01039519|102229454|FG000|Survival Follow-up|Death|23|||
33639116|NCT01039519|102229454|FG000|Survival Follow-up|Sponsor decision|4|||
33639117|NCT00803569|102229455|FG000|Overall Study|Progressive Disease|3|||
33579363|NCT03012334|102013065|FG009|Period 2|Withdrawal by Subject|0|||
33140292|NCT01107379|100428021|FG000|Overall Study|Withdrawal by Subject|18|||
33140293|NCT01107379|100428021|FG000|Overall Study|Lost to Follow-up|3|||
33140294|NCT03149848|100428022|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
33140295|NCT03149848|100428022|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
33140296|NCT00409331|100428023|FG000|Overall Study|Physician Decision|1|||
33140297|NCT00492063|100428031|FG000|Overall Study|Death|0|||
33140298|NCT00492063|100428032|FG001|Overall Study|Death|0|||
33140299|NCT00492063|100428033|FG002|Overall Study|Death|1|||
33140300|NCT00492063|100428034|FG003|Overall Study|Death|2|||
33140301|NCT00492063|100428031|FG000|Overall Study|Withdrawal by Subject|4|||
33140302|NCT00492063|100428032|FG001|Overall Study|Withdrawal by Subject|3|||
33140303|NCT00492063|100428033|FG002|Overall Study|Withdrawal by Subject|5|||
33140304|NCT00492063|100428034|FG003|Overall Study|Withdrawal by Subject|4|||
33140305|NCT00492063|100428031|FG000|Overall Study|Lost to Follow-up|6|||
33140306|NCT00492063|100428032|FG001|Overall Study|Lost to Follow-up|11|||
33140307|NCT00492063|100428033|FG002|Overall Study|Lost to Follow-up|5|||
33140308|NCT00492063|100428034|FG003|Overall Study|Lost to Follow-up|3|||
33140309|NCT00492063|100428031|FG000|Overall Study|Protocol Violation|0|||
33140310|NCT00492063|100428032|FG001|Overall Study|Protocol Violation|0|||
33140311|NCT00492063|100428033|FG002|Overall Study|Protocol Violation|0|||
33140312|NCT00492063|100428034|FG003|Overall Study|Protocol Violation|1|||
33140313|NCT03996369|100428035|FG000|Overall Study|Protocol deviation|1|||
33140314|NCT03996369|100428036|FG001|Overall Study|Protocol deviation|1|||
33140315|NCT03996369|100428035|FG000|Overall Study|Physician Decision|4|||
33140316|NCT03996369|100428036|FG001|Overall Study|Physician Decision|2|||
33140317|NCT03996369|100428035|FG000|Overall Study|Participant decision|0|||
33140318|NCT03996369|100428036|FG001|Overall Study|Participant decision|1|||
33140319|NCT03996369|100428035|FG000|Overall Study|Lack of Efficacy|4|||
33639118|NCT00803569|102229455|FG000|Overall Study|Noncompliance|1|||
33639119|NCT01391546|102229458|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
33639120|NCT01391546|102229459|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
33639121|NCT01166282|102229465|FG000|Open-label Period|Adverse Event|0|||
33639122|NCT01166282|102229466|FG001|Open-label Period|Adverse Event|0|||
33639123|NCT01166282|102229467|FG002|Open-label Period|Adverse Event|6|||
33140320|NCT03996369|100428036|FG001|Overall Study|Lack of Efficacy|0|||
33140321|NCT03996369|100428035|FG000|Overall Study|Adverse Event|9|||
33140322|NCT03996369|100428036|FG001|Overall Study|Adverse Event|0|||
33140323|NCT03996369|100428035|FG000|Overall Study|Withdrawal by Subject|6|||
33140324|NCT03996369|100428036|FG001|Overall Study|Withdrawal by Subject|8|||
33140325|NCT03996369|100428035|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
33140326|NCT03996369|100428036|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
33238390|NCT04562779|100775887|FG001|Overall Study|Lost to Follow-up|5|||
33238391|NCT04562779|100775888|FG002|Overall Study|Lost to Follow-up|10|||
33370012|NCT00532883|101239985|FG001|Overall Study|Adverse Event|0|||
33370013|NCT00532883|101239986|FG002|Overall Study|Adverse Event|0|||
33370014|NCT00532883|101239987|FG003|Overall Study|Adverse Event|1|||
33370015|NCT00532883|101239984|FG000|Overall Study|Lost to Follow-up|1|||
33639124|NCT01166282|102229465|FG000|Open-label Period|Withdrawal by Subject|0|||
33639125|NCT01166282|102229466|FG001|Open-label Period|Withdrawal by Subject|0|||
33639126|NCT01166282|102229467|FG002|Open-label Period|Withdrawal by Subject|4|||
33639127|NCT01166282|102229465|FG000|Open-label Period|Lack of Efficacy|0|||
33639128|NCT01166282|102229466|FG001|Open-label Period|Lack of Efficacy|0|||
33639129|NCT01166282|102229467|FG002|Open-label Period|Lack of Efficacy|2|||
33639130|NCT01166282|102229465|FG000|Open-label Period|Remission|0|||
33639131|NCT01166282|102229466|FG001|Open-label Period|Remission|0|||
33639132|NCT01166282|102229467|FG002|Open-label Period|Remission|4|||
33639133|NCT01166282|102229465|FG000|Open-label Period|Irregular Compliance|0|||
33370016|NCT00532883|101239985|FG001|Overall Study|Lost to Follow-up|1|||
33370017|NCT00532883|101239986|FG002|Overall Study|Lost to Follow-up|1|||
33370018|NCT00532883|101239987|FG003|Overall Study|Lost to Follow-up|0|||
33370019|NCT00532883|101239984|FG000|Overall Study|Withdrawal by Subject|0|||
33370020|NCT00532883|101239985|FG001|Overall Study|Withdrawal by Subject|1|||
33370021|NCT00532883|101239986|FG002|Overall Study|Withdrawal by Subject|1|||
33370022|NCT00532883|101239987|FG003|Overall Study|Withdrawal by Subject|0|||
33370023|NCT00532883|101239984|FG000|Overall Study|Subject was Nonadherent|0|||
33639134|NCT01166282|102229466|FG001|Open-label Period|Irregular Compliance|0|||
33639135|NCT01166282|102229467|FG002|Open-label Period|Irregular Compliance|1|||
33140327|NCT03996369|100428035|FG000|Overall Study|Lost to Follow-up|0|||
33238392|NCT04562779|100775886|FG000|Overall Study|Protocol Violation|2|||
33370024|NCT00532883|101239985|FG001|Overall Study|Subject was Nonadherent|1|||
33370025|NCT00532883|101239986|FG002|Overall Study|Subject was Nonadherent|1|||
33140328|NCT03996369|100428036|FG001|Overall Study|Lost to Follow-up|1|||
33140329|NCT01909791|100428037|FG000|Overall Study|Death|9|||
33140330|NCT01909791|100428038|FG001|Overall Study|Death|8|||
33140331|NCT01909791|100428039|FG002|Overall Study|Death|4|||
33140332|NCT01909791|100428037|FG000|Overall Study|Withdrawal by Subject|5|||
33140333|NCT01909791|100428038|FG001|Overall Study|Withdrawal by Subject|9|||
33420885|NCT02913261|101431633|FG001|Overall Study|Physician Decision|9|||
33370026|NCT00532883|101239987|FG003|Overall Study|Subject was Nonadherent|0|||
33639136|NCT01462370|102229468|FG000|Overall Study|Lack of Qualifying Event|1|||
33639137|NCT01462370|102229469|FG001|Overall Study|Lack of Qualifying Event|1|||
33639138|NCT01462370|102229468|FG000|Overall Study|Physician Decision|0|||
33639139|NCT01462370|102229469|FG001|Overall Study|Physician Decision|1|||
33639140|NCT01462370|102229468|FG000|Overall Study|Withdrawal by Subject|0|||
33639141|NCT01462370|102229469|FG001|Overall Study|Withdrawal by Subject|3|||
33140334|NCT01909791|100428039|FG002|Overall Study|Withdrawal by Subject|13|||
33639142|NCT02377817|102229475|FG000|Overall Study|Transportation/childcare barriers.|2|||
33639143|NCT02377817|102229476|FG001|Overall Study|Transportation/childcare barriers.|0|||
33639144|NCT02377817|102229475|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
33140335|NCT01909791|100428037|FG000|Overall Study|Lost to Follow-up|5|||
33140336|NCT01909791|100428038|FG001|Overall Study|Lost to Follow-up|11|||
33140337|NCT01909791|100428039|FG002|Overall Study|Lost to Follow-up|10|||
33140338|NCT01909791|100428037|FG000|Overall Study|Missed Visit|2|||
33140339|NCT01909791|100428038|FG001|Overall Study|Missed Visit|0|||
33140340|NCT01909791|100428039|FG002|Overall Study|Missed Visit|1|||
33140341|NCT02969408|100428042|FG000|Overall Study|Adverse Event|2|||
33370027|NCT00532883|101239984|FG000|Overall Study|Early Study Termination|4|||
33370028|NCT00532883|101239985|FG001|Overall Study|Early Study Termination|4|||
33370029|NCT00532883|101239986|FG002|Overall Study|Early Study Termination|1|||
33370030|NCT00532883|101239987|FG003|Overall Study|Early Study Termination|4|||
33370031|NCT01958671|101239988|FG000|Overall Study|Adverse Event|1|||
33370032|NCT01958671|101239989|FG001|Overall Study|Adverse Event|1|||
33370033|NCT01958671|101239990|FG002|Overall Study|Adverse Event|5|||
33370034|NCT01958671|101239988|FG000|Overall Study|Death|1|||
33370035|NCT01958671|101239989|FG001|Overall Study|Death|0|||
33370036|NCT01958671|101239990|FG002|Overall Study|Death|0|||
33370037|NCT01958671|101239988|FG000|Overall Study|Excluded medication|0|||
33370038|NCT01958671|101239989|FG001|Overall Study|Excluded medication|0|||
33370039|NCT01958671|101239990|FG002|Overall Study|Excluded medication|1|||
33370040|NCT01958671|101239988|FG000|Overall Study|Hyperglycemia|0|||
33370041|NCT01958671|101239989|FG001|Overall Study|Hyperglycemia|0|||
33370042|NCT01958671|101239990|FG002|Overall Study|Hyperglycemia|2|||
33420886|NCT02913261|101431632|FG000|Overall Study|Subject/guardian decision|4|||
33579364|NCT03012334|102013056|FG000|Period 2|Protocol Violation|0|||
33579365|NCT03012334|102013057|FG001|Period 2|Protocol Violation|0|||
33579366|NCT03012334|102013058|FG002|Period 2|Protocol Violation|1|||
33370043|NCT01958671|101239988|FG000|Overall Study|Lost to Follow-up|7|||
33579367|NCT03012334|102013059|FG003|Period 2|Protocol Violation|0|||
33579368|NCT03012334|102013060|FG004|Period 2|Protocol Violation|0|||
33579369|NCT03012334|102013061|FG005|Period 2|Protocol Violation|0|||
33579370|NCT03012334|102013062|FG006|Period 2|Protocol Violation|0|||
33579371|NCT03012334|102013063|FG007|Period 2|Protocol Violation|1|||
33579372|NCT03012334|102013064|FG008|Period 2|Protocol Violation|0|||
33579373|NCT03012334|102013065|FG009|Period 2|Protocol Violation|0|||
33579374|NCT03012334|102013056|FG000|Period 4|Non-Compliance|0|||
33579375|NCT03012334|102013057|FG001|Period 4|Non-Compliance|0|||
33579376|NCT03012334|102013058|FG002|Period 4|Non-Compliance|0|||
33579377|NCT03012334|102013059|FG003|Period 4|Non-Compliance|0|||
33579378|NCT03012334|102013060|FG004|Period 4|Non-Compliance|0|||
33579379|NCT03012334|102013061|FG005|Period 4|Non-Compliance|0|||
33579380|NCT03012334|102013062|FG006|Period 4|Non-Compliance|1|||
33579381|NCT03012334|102013063|FG007|Period 4|Non-Compliance|0|||
33579382|NCT03012334|102013064|FG008|Period 4|Non-Compliance|0|||
33579383|NCT03012334|102013065|FG009|Period 4|Non-Compliance|0|||
33579384|NCT03012334|102013056|FG000|Period 4|Adverse Event|0|||
33579385|NCT03012334|102013057|FG001|Period 4|Adverse Event|0|||
33579386|NCT03012334|102013058|FG002|Period 4|Adverse Event|0|||
33579387|NCT03012334|102013059|FG003|Period 4|Adverse Event|0|||
33579388|NCT03012334|102013060|FG004|Period 4|Adverse Event|0|||
33579389|NCT03012334|102013061|FG005|Period 4|Adverse Event|0|||
33579390|NCT03012334|102013062|FG006|Period 4|Adverse Event|0|||
33579391|NCT03012334|102013063|FG007|Period 4|Adverse Event|0|||
33639145|NCT02377817|102229476|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
33140342|NCT02969408|100428042|FG000|Overall Study|Withdrawal by Subject|8|||
33140343|NCT02969408|100428042|FG000|Overall Study|Lost to Follow-up|4|||
33140344|NCT02969408|100428042|FG000|Overall Study|Protocol Violation|1|||
33370044|NCT01958671|101239989|FG001|Overall Study|Lost to Follow-up|11|||
33370045|NCT01958671|101239990|FG002|Overall Study|Lost to Follow-up|7|||
33420887|NCT02913261|101431633|FG001|Overall Study|Subject/guardian decision|6|||
33420888|NCT02913261|101431632|FG000|Overall Study|Graft loss|2|||
33579392|NCT03012334|102013064|FG008|Period 4|Adverse Event|1|||
33579393|NCT03012334|102013065|FG009|Period 4|Adverse Event|0|||
33579394|NCT00592631|102013066|FG000|Overall Study|Lost to Follow-up|0|||
33579395|NCT00592631|102013067|FG001|Overall Study|Lost to Follow-up|2|||
33579396|NCT01462929|102013077|FG000|Overall Study|Adverse Event|3|||
33579397|NCT01462929|102013078|FG001|Overall Study|Adverse Event|3|||
33579398|NCT01462929|102013079|FG002|Overall Study|Adverse Event|4|||
33579399|NCT01462929|102013077|FG000|Overall Study|Withdrawal by Subject|2|||
33639146|NCT04639258|102229478|FG000|Overall Study|Screen failure|5|||
33639147|NCT04639258|102229478|FG000|Overall Study|Physician Decision|2|||
33639148|NCT04639258|102229478|FG000|Overall Study|Early study termination|3|||
33639149|NCT04639258|102229478|FG000|Overall Study|Withdrawal by Subject|1|||
33639150|NCT00357006|102229479|FG000|Overall Study|Lost to Follow-up|1|||
33639151|NCT00357006|102229480|FG001|Overall Study|Lost to Follow-up|2|||
33238393|NCT04562779|100775887|FG001|Overall Study|Protocol Violation|2|||
33639152|NCT00357006|102229481|FG002|Overall Study|Lost to Follow-up|1|||
33639153|NCT00357006|102229479|FG000|Overall Study|Withdrawal by Subject|1|||
33238394|NCT04562779|100775888|FG002|Overall Study|Protocol Violation|0|||
33238395|NCT02223182|100775889|FG000|Double-Blind Period|Adverse Event|0|||
33238396|NCT02223182|100775890|FG001|Double-Blind Period|Adverse Event|2|||
33238397|NCT02223182|100775891|FG002|Double-Blind Period|Adverse Event|1|||
33238398|NCT02223182|100775892|FG003|Double-Blind Period|Adverse Event|0|||
33238399|NCT02223182|100775889|FG000|Double-Blind Period|Withdrawal by Subject|1|||
33238400|NCT02223182|100775890|FG001|Double-Blind Period|Withdrawal by Subject|1|||
33370046|NCT01958671|101239988|FG000|Overall Study|Non-compliance with study drug|1|||
33639154|NCT00357006|102229480|FG001|Overall Study|Withdrawal by Subject|3|||
33639155|NCT00357006|102229481|FG002|Overall Study|Withdrawal by Subject|2|||
33639156|NCT00482053|102229484|FG000|Inter-treatment Period|Disease progression|1|||
33639157|NCT01746901|102229489|FG000|Naloxone Challenge Phase|Adverse Event|2|||
33639158|NCT01746901|102229490|FG001|Naloxone Challenge Phase|Adverse Event|0|||
33639159|NCT01746901|102229491|FG002|Naloxone Challenge Phase|Adverse Event|0|||
33639160|NCT01746901|102229492|FG003|Naloxone Challenge Phase|Adverse Event|0|||
33639161|NCT01746901|102229493|FG004|Naloxone Challenge Phase|Adverse Event|0|||
33639162|NCT01746901|102229494|FG005|Naloxone Challenge Phase|Adverse Event|0|||
33639163|NCT01746901|102229495|FG006|Naloxone Challenge Phase|Adverse Event|0|||
33639164|NCT01746901|102229496|FG007|Naloxone Challenge Phase|Adverse Event|0|||
33639165|NCT01746901|102229497|FG008|Naloxone Challenge Phase|Adverse Event|0|||
33639166|NCT01746901|102229489|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
33639167|NCT01746901|102229490|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33639168|NCT01746901|102229491|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33639169|NCT01746901|102229492|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33639170|NCT01746901|102229493|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33639171|NCT01746901|102229494|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33639172|NCT01746901|102229495|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33140345|NCT02969408|100428042|FG000|Overall Study|Other than specified|1|||
33140346|NCT00412373|100428043|FG000|Overall Study|Adverse Event|8|||
33140347|NCT00412373|100428044|FG001|Overall Study|Adverse Event|13|||
33140348|NCT00412373|100428043|FG000|Overall Study|Lack of Efficacy|16|||
33140349|NCT00412373|100428044|FG001|Overall Study|Lack of Efficacy|22|||
33140350|NCT00412373|100428043|FG000|Overall Study|Lost to Follow-up|7|||
33140351|NCT00412373|100428044|FG001|Overall Study|Lost to Follow-up|13|||
33140352|NCT00412373|100428043|FG000|Overall Study|Withdrawal by Subject|8|||
33140353|NCT00412373|100428044|FG001|Overall Study|Withdrawal by Subject|27|||
33140354|NCT00412373|100428043|FG000|Overall Study|Other|2|||
33140355|NCT00412373|100428044|FG001|Overall Study|Other|2|||
33140356|NCT00669409|100428049|FG000|Part 2|Withdrawal by Subject|0|||
33140357|NCT00669409|100428050|FG001|Part 2|Withdrawal by Subject|0|||
33140358|NCT00669409|100428051|FG002|Part 2|Withdrawal by Subject|0|||
33140359|NCT00669409|100428052|FG003|Part 2|Withdrawal by Subject|0|||
33140360|NCT00669409|100428053|FG004|Part 2|Withdrawal by Subject|0|||
33140361|NCT00669409|100428054|FG005|Part 2|Withdrawal by Subject|0|||
33140362|NCT00669409|100428055|FG006|Part 2|Withdrawal by Subject|0|||
33140363|NCT00669409|100428056|FG007|Part 2|Withdrawal by Subject|0|||
33140364|NCT00669409|100428057|FG008|Part 2|Withdrawal by Subject|0|||
33140365|NCT00669409|100428058|FG009|Part 2|Withdrawal by Subject|1|||
33140366|NCT00669409|100428059|FG010|Part 2|Withdrawal by Subject|0|||
33140367|NCT01238588|100428060|FG000|Overall Study|Withdrawal by Subject|1|||
33140368|NCT01238588|100428060|FG000|Overall Study|Physician Decision|2|||
33140369|NCT00509262|100428061|FG000|Overall Study|Adverse Event|16|||
33140370|NCT00509262|100428062|FG001|Overall Study|Adverse Event|18|||
33140371|NCT00509262|100428061|FG000|Overall Study|Other|2|||
33140372|NCT00509262|100428062|FG001|Overall Study|Other|2|||
33140373|NCT00509262|100428061|FG000|Overall Study|Lack of Efficacy|1|||
33140374|NCT00509262|100428062|FG001|Overall Study|Lack of Efficacy|0|||
33140375|NCT00509262|100428061|FG000|Overall Study|Lost to Follow-up|1|||
33140376|NCT00509262|100428062|FG001|Overall Study|Lost to Follow-up|6|||
33140377|NCT00509262|100428061|FG000|Overall Study|Physician Decision|1|||
33140378|NCT00509262|100428062|FG001|Overall Study|Physician Decision|3|||
33140379|NCT00509262|100428061|FG000|Overall Study|Protocol Violation|2|||
33140380|NCT00509262|100428062|FG001|Overall Study|Protocol Violation|2|||
33140381|NCT00509262|100428061|FG000|Overall Study|Withdrawal by Subject|24|||
33140382|NCT00509262|100428062|FG001|Overall Study|Withdrawal by Subject|11|||
33140383|NCT02009384|100428063|FG000|Overall Study|Death|2|||
33140384|NCT00991952|100428069|FG000|Overall Study|Adverse Event|0|||
33140385|NCT00991952|100428070|FG001|Overall Study|Adverse Event|1|||
33140386|NCT03011892|100428071|FG000|Double Blind (DB) Period|Adverse Event|0|||
33140387|NCT03011892|100428072|FG001|Double Blind (DB) Period|Adverse Event|1|||
33238401|NCT02223182|100775891|FG002|Double-Blind Period|Withdrawal by Subject|1|||
33238402|NCT02223182|100775892|FG003|Double-Blind Period|Withdrawal by Subject|0|||
33238403|NCT02223182|100775889|FG000|Double-Blind Period|Lost to Follow-up|0|||
33238404|NCT02223182|100775890|FG001|Double-Blind Period|Lost to Follow-up|1|||
33238405|NCT02223182|100775891|FG002|Double-Blind Period|Lost to Follow-up|0|||
33238406|NCT02223182|100775892|FG003|Double-Blind Period|Lost to Follow-up|0|||
33238407|NCT02223182|100775889|FG000|Double-Blind Period|Non Compliance|0|||
33238408|NCT02223182|100775890|FG001|Double-Blind Period|Non Compliance|0|||
33238409|NCT02223182|100775891|FG002|Double-Blind Period|Non Compliance|0|||
33238410|NCT02223182|100775892|FG003|Double-Blind Period|Non Compliance|1|||
33238411|NCT02223182|100775889|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
33238412|NCT02223182|100775890|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
33238413|NCT02223182|100775891|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
33140388|NCT03011892|100428073|FG002|Double Blind (DB) Period|Adverse Event|1|||
33140389|NCT03011892|100428074|FG003|Double Blind (DB) Period|Adverse Event|0|||
33140390|NCT03011892|100428075|FG004|Double Blind (DB) Period|Adverse Event|0|||
33140391|NCT03011892|100428076|FG005|Double Blind (DB) Period|Adverse Event|0|||
33238414|NCT02223182|100775892|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
33238415|NCT02223182|100775889|FG000|Open-Label 500 Period|Adverse Event|1|||
33238416|NCT02223182|100775890|FG001|Open-Label 500 Period|Adverse Event|0|||
33238417|NCT02223182|100775891|FG002|Open-Label 500 Period|Adverse Event|2|||
33238418|NCT02223182|100775892|FG003|Open-Label 500 Period|Adverse Event|1|||
33238419|NCT02223182|100775889|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
33238420|NCT02223182|100775890|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
33238421|NCT02223182|100775891|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
33238422|NCT02223182|100775892|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
33238423|NCT02223182|100775889|FG000|Open-Label 500 Period|Physician Decision|0|||
33238424|NCT02223182|100775890|FG001|Open-Label 500 Period|Physician Decision|0|||
33238425|NCT02223182|100775891|FG002|Open-Label 500 Period|Physician Decision|0|||
33238426|NCT02223182|100775892|FG003|Open-Label 500 Period|Physician Decision|1|||
33370047|NCT01958671|101239989|FG001|Overall Study|Non-compliance with study drug|1|||
33579400|NCT01462929|102013078|FG001|Overall Study|Withdrawal by Subject|1|||
33579401|NCT01462929|102013079|FG002|Overall Study|Withdrawal by Subject|0|||
33579402|NCT01462929|102013077|FG000|Overall Study|Lack of Efficacy|0|||
33140392|NCT03011892|100428077|FG006|Double Blind (DB) Period|Adverse Event|0|||
33140393|NCT03011892|100428078|FG007|Double Blind (DB) Period|Adverse Event|0|||
33140394|NCT03011892|100428079|FG008|Double Blind (DB) Period|Adverse Event|0|||
33140395|NCT03011892|100428080|FG009|Double Blind (DB) Period|Adverse Event|0|||
33140396|NCT03011892|100428081|FG010|Double Blind (DB) Period|Adverse Event|0|||
33140397|NCT03011892|100428082|FG011|Double Blind (DB) Period|Adverse Event|0|||
33140398|NCT03011892|100428071|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
33140399|NCT03011892|100428072|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
33140400|NCT03011892|100428073|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
33140401|NCT03011892|100428074|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
33140402|NCT03011892|100428075|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
33140403|NCT03011892|100428076|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
33579403|NCT01462929|102013078|FG001|Overall Study|Lack of Efficacy|0|||
33579404|NCT01462929|102013079|FG002|Overall Study|Lack of Efficacy|1|||
33579405|NCT00132301|102013080|FG000|Overall Study|Death|7|||
33579406|NCT00132301|102013081|FG001|Overall Study|Death|6|||
33579407|NCT00132301|102013080|FG000|Overall Study|Withdrawal by Subject|5|||
33579408|NCT00132301|102013081|FG001|Overall Study|Withdrawal by Subject|2|||
33579409|NCT00132301|102013080|FG000|Overall Study|Physician Decision|1|||
33579410|NCT00132301|102013081|FG001|Overall Study|Physician Decision|1|||
33579411|NCT00132301|102013080|FG000|Overall Study|Lost to Follow-up|5|||
33579412|NCT00132301|102013081|FG001|Overall Study|Lost to Follow-up|3|||
33579413|NCT00132301|102013080|FG000|Overall Study|Other|1|||
33579414|NCT00132301|102013081|FG001|Overall Study|Other|1|||
33639173|NCT01746901|102229496|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33639174|NCT01746901|102229497|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
33140404|NCT03011892|100428077|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
33140405|NCT03011892|100428078|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
33238427|NCT02223182|100775889|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
33238428|NCT02223182|100775890|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
33238429|NCT02223182|100775891|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
33238430|NCT02223182|100775892|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
33238431|NCT02223182|100775889|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
33579415|NCT00132301|102013080|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
33579416|NCT00132301|102013081|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
33140406|NCT03011892|100428079|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
33579417|NCT02479880|102013082|FG000|Overall Study|Study Terminated by Sponsor|13|||
33579418|NCT02479880|102013083|FG001|Overall Study|Study Terminated by Sponsor|12|||
33140407|NCT03011892|100428080|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
33579419|NCT02479880|102013082|FG000|Overall Study|Pregnancy|0|||
33639175|NCT01746901|102229489|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33639176|NCT01746901|102229490|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
33639177|NCT01746901|102229491|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33639178|NCT01746901|102229492|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33639179|NCT01746901|102229493|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33639180|NCT01746901|102229494|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33639181|NCT01746901|102229495|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33639182|NCT01746901|102229496|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33639183|NCT01746901|102229497|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33639184|NCT01746901|102229489|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
33639185|NCT01746901|102229490|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
33639186|NCT01746901|102229491|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
33639187|NCT01746901|102229492|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
33639188|NCT01746901|102229493|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
33639189|NCT01746901|102229494|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
33639190|NCT01746901|102229495|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
33639191|NCT01746901|102229496|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
33639192|NCT01746901|102229497|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
33639193|NCT01746901|102229489|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
33639194|NCT01746901|102229490|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
33639195|NCT01746901|102229491|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
33639196|NCT01746901|102229492|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
33639197|NCT01746901|102229493|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
33639198|NCT01746901|102229494|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
33639199|NCT01746901|102229495|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
33639200|NCT01746901|102229496|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
33639201|NCT01746901|102229497|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
33639202|NCT01746901|102229489|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33639203|NCT01746901|102229490|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
33639204|NCT01746901|102229491|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
33639205|NCT01746901|102229492|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33639206|NCT01746901|102229493|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33639207|NCT01746901|102229494|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33639208|NCT01746901|102229495|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33639209|NCT01746901|102229496|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33639210|NCT01746901|102229497|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33639211|NCT01746901|102229489|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
33639212|NCT01746901|102229490|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
33639213|NCT01746901|102229491|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
33639214|NCT01746901|102229492|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
33639215|NCT01746901|102229493|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
33639216|NCT01746901|102229494|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
33639217|NCT01746901|102229495|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
33639218|NCT01746901|102229496|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
33639219|NCT01746901|102229497|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
33639220|NCT01746901|102229489|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33639221|NCT01746901|102229490|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33639222|NCT01746901|102229491|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33639223|NCT01746901|102229492|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33140408|NCT03011892|100428081|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
33140409|NCT03011892|100428082|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
33140410|NCT03011892|100428071|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
33140411|NCT03011892|100428072|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
33140412|NCT03011892|100428073|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
33140413|NCT03011892|100428074|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
33140414|NCT03011892|100428075|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
33140415|NCT03011892|100428076|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
33140416|NCT03011892|100428077|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
33140417|NCT03011892|100428078|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
33140418|NCT03011892|100428079|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
33140419|NCT03011892|100428080|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
33140420|NCT03011892|100428081|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
33140421|NCT03011892|100428082|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
33238432|NCT02223182|100775890|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
33238433|NCT02223182|100775891|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
33238434|NCT02223182|100775892|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
33140422|NCT03011892|100428071|FG000|Double Blind (DB) Period|Other|1|||
33639224|NCT01746901|102229493|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33639225|NCT01746901|102229494|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33639226|NCT01746901|102229495|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33639227|NCT01746901|102229496|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
33639228|NCT01746901|102229497|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
33639229|NCT01746901|102229489|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
33639230|NCT01746901|102229490|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
33639231|NCT01746901|102229491|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
33140423|NCT03011892|100428072|FG001|Double Blind (DB) Period|Other|1|||
33140424|NCT03011892|100428073|FG002|Double Blind (DB) Period|Other|1|||
33140425|NCT03011892|100428074|FG003|Double Blind (DB) Period|Other|0|||
33140426|NCT03011892|100428075|FG004|Double Blind (DB) Period|Other|1|||
33140427|NCT03011892|100428076|FG005|Double Blind (DB) Period|Other|0|||
33140428|NCT03011892|100428077|FG006|Double Blind (DB) Period|Other|0|||
33140429|NCT03011892|100428078|FG007|Double Blind (DB) Period|Other|0|||
33140430|NCT03011892|100428079|FG008|Double Blind (DB) Period|Other|0|||
33140431|NCT03011892|100428080|FG009|Double Blind (DB) Period|Other|0|||
33140432|NCT03011892|100428081|FG010|Double Blind (DB) Period|Other|0|||
33140433|NCT03011892|100428082|FG011|Double Blind (DB) Period|Other|0|||
33140434|NCT03011892|100428071|FG000|Double Blind (DB) Period|Physician Decision|1|||
33140435|NCT03011892|100428072|FG001|Double Blind (DB) Period|Physician Decision|0|||
33238435|NCT02223182|100775889|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
33579420|NCT02479880|102013083|FG001|Overall Study|Pregnancy|1|||
33579421|NCT00413660|102013088|FG000|Up To Week 12|Adverse Event|1|||
33579422|NCT00413660|102013089|FG001|Up To Week 12|Adverse Event|3|||
33579423|NCT00413660|102013090|FG002|Up To Week 12|Adverse Event|1|||
33579424|NCT00413660|102013091|FG003|Up To Week 12|Adverse Event|4|||
33579425|NCT00413660|102013092|FG004|Up To Week 12|Adverse Event|6|||
33579426|NCT00413660|102013093|FG005|Up To Week 12|Adverse Event|4|||
33579427|NCT00413660|102013094|FG006|Up To Week 12|Adverse Event|1|||
33579428|NCT00413660|102013095|FG007|Up To Week 12|Adverse Event|0|||
33579429|NCT00413660|102013096|FG008|Up To Week 12|Adverse Event|0|||
33579430|NCT00413660|102013097|FG009|Up To Week 12|Adverse Event|0|||
33579431|NCT00413660|102013098|FG010|Up To Week 12|Adverse Event|0|||
33579432|NCT00413660|102013088|FG000|Up To Week 12|Lack of Efficacy|2|||
33579433|NCT00413660|102013089|FG001|Up To Week 12|Lack of Efficacy|0|||
33579434|NCT00413660|102013090|FG002|Up To Week 12|Lack of Efficacy|0|||
33579435|NCT00413660|102013091|FG003|Up To Week 12|Lack of Efficacy|0|||
33579436|NCT00413660|102013092|FG004|Up To Week 12|Lack of Efficacy|0|||
33579437|NCT00413660|102013093|FG005|Up To Week 12|Lack of Efficacy|0|||
33579438|NCT00413660|102013094|FG006|Up To Week 12|Lack of Efficacy|5|||
33579439|NCT00413660|102013095|FG007|Up To Week 12|Lack of Efficacy|0|||
33579440|NCT00413660|102013096|FG008|Up To Week 12|Lack of Efficacy|0|||
33579441|NCT00413660|102013097|FG009|Up To Week 12|Lack of Efficacy|0|||
33579442|NCT00413660|102013098|FG010|Up To Week 12|Lack of Efficacy|0|||
33579443|NCT00413660|102013088|FG000|Up To Week 12|Lost to Follow-up|0|||
33579444|NCT00413660|102013089|FG001|Up To Week 12|Lost to Follow-up|1|||
33579445|NCT00413660|102013090|FG002|Up To Week 12|Lost to Follow-up|0|||
33579446|NCT00413660|102013091|FG003|Up To Week 12|Lost to Follow-up|0|||
33579447|NCT00413660|102013092|FG004|Up To Week 12|Lost to Follow-up|1|||
33579448|NCT00413660|102013093|FG005|Up To Week 12|Lost to Follow-up|0|||
33579449|NCT00413660|102013094|FG006|Up To Week 12|Lost to Follow-up|0|||
33579450|NCT00413660|102013095|FG007|Up To Week 12|Lost to Follow-up|0|||
33579451|NCT00413660|102013096|FG008|Up To Week 12|Lost to Follow-up|0|||
33579452|NCT00413660|102013097|FG009|Up To Week 12|Lost to Follow-up|0|||
33579453|NCT00413660|102013098|FG010|Up To Week 12|Lost to Follow-up|0|||
33579454|NCT00413660|102013088|FG000|Up To Week 12|Withdrawal by Subject|0|||
33579455|NCT00413660|102013089|FG001|Up To Week 12|Withdrawal by Subject|2|||
33579456|NCT00413660|102013090|FG002|Up To Week 12|Withdrawal by Subject|0|||
33579457|NCT00413660|102013091|FG003|Up To Week 12|Withdrawal by Subject|2|||
33579458|NCT00413660|102013092|FG004|Up To Week 12|Withdrawal by Subject|0|||
33579459|NCT00413660|102013093|FG005|Up To Week 12|Withdrawal by Subject|2|||
33579460|NCT00413660|102013094|FG006|Up To Week 12|Withdrawal by Subject|2|||
33238436|NCT02223182|100775890|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
33238437|NCT02223182|100775891|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
33140436|NCT03011892|100428073|FG002|Double Blind (DB) Period|Physician Decision|1|||
33140437|NCT03011892|100428074|FG003|Double Blind (DB) Period|Physician Decision|0|||
33579461|NCT00413660|102013095|FG007|Up To Week 12|Withdrawal by Subject|0|||
33579462|NCT00413660|102013096|FG008|Up To Week 12|Withdrawal by Subject|0|||
33579463|NCT00413660|102013097|FG009|Up To Week 12|Withdrawal by Subject|0|||
33579464|NCT00413660|102013098|FG010|Up To Week 12|Withdrawal by Subject|0|||
33579465|NCT00413660|102013088|FG000|Up To Week 12|Randomized, Not Treated|1|||
33579466|NCT00413660|102013089|FG001|Up To Week 12|Randomized, Not Treated|0|||
33579467|NCT00413660|102013090|FG002|Up To Week 12|Randomized, Not Treated|0|||
33579468|NCT00413660|102013091|FG003|Up To Week 12|Randomized, Not Treated|1|||
33579469|NCT00413660|102013092|FG004|Up To Week 12|Randomized, Not Treated|0|||
33370048|NCT01958671|101239990|FG002|Overall Study|Non-compliance with study drug|1|||
33639232|NCT01746901|102229492|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
33639233|NCT01746901|102229493|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
33639234|NCT01746901|102229494|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
33639235|NCT01746901|102229495|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
33639236|NCT01746901|102229496|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
33639237|NCT01746901|102229497|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
33639238|NCT01746901|102229489|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33639239|NCT01746901|102229490|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33639240|NCT01746901|102229491|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33639241|NCT01746901|102229492|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
33639242|NCT01746901|102229493|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33639243|NCT01746901|102229494|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33639244|NCT01746901|102229495|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33639245|NCT01746901|102229496|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33639246|NCT01746901|102229497|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
33639247|NCT01746901|102229489|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
33639248|NCT01746901|102229490|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
33639249|NCT01746901|102229491|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
33639250|NCT01746901|102229492|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
33639251|NCT01746901|102229493|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
33639252|NCT01746901|102229494|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
33639253|NCT01746901|102229495|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
33639254|NCT01746901|102229496|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
33639255|NCT01746901|102229497|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
33639256|NCT01746901|102229489|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
33639257|NCT01746901|102229490|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
33639258|NCT01746901|102229491|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
33639259|NCT01746901|102229492|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
33639260|NCT01746901|102229493|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
33639261|NCT01746901|102229494|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
33639262|NCT01746901|102229495|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
33639263|NCT01746901|102229496|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
33639264|NCT01746901|102229497|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
33639265|NCT01298648|102229498|FG000|Overall Study|Withdrawal by Subject|2|||
33639266|NCT01298648|102229498|FG000|Overall Study|Lost to Follow-up|21|||
33639267|NCT01821118|102229499|FG000|Overall Study|Death|0|||
33639268|NCT01821118|102229500|FG001|Overall Study|Death|1|||
33639269|NCT00993967|102229503|FG000|Overall Study|Adverse Event|8|||
33639270|NCT00993967|102229503|FG000|Overall Study|Death|1|||
33639271|NCT00993967|102229503|FG000|Overall Study|Lost to Follow-up|14|||
33639272|NCT00993967|102229503|FG000|Overall Study|Withdrawal by Subject|36|||
33639273|NCT00993967|102229503|FG000|Overall Study|Protocol Violation|2|||
33639274|NCT02754440|102229505|FG000|Overall Study|Protocol Violation|3|||
33639275|NCT02754440|102229506|FG001|Overall Study|Protocol Violation|2|||
33639276|NCT02754440|102229507|FG002|Overall Study|Protocol Violation|2|||
33639277|NCT02754440|102229508|FG003|Overall Study|Protocol Violation|6|||
33639278|NCT02754440|102229505|FG000|Overall Study|Adverse Event|3|||
33639279|NCT02754440|102229506|FG001|Overall Study|Adverse Event|1|||
33639280|NCT02754440|102229507|FG002|Overall Study|Adverse Event|0|||
33639281|NCT02754440|102229508|FG003|Overall Study|Adverse Event|9|||
33639282|NCT02754440|102229505|FG000|Overall Study|Withdrawal by Subject|0|||
33639283|NCT02754440|102229506|FG001|Overall Study|Withdrawal by Subject|0|||
33639284|NCT02754440|102229507|FG002|Overall Study|Withdrawal by Subject|0|||
33639285|NCT02754440|102229508|FG003|Overall Study|Withdrawal by Subject|1|||
33639286|NCT02754440|102229505|FG000|Overall Study|Equipment failure|0|||
33639287|NCT02754440|102229506|FG001|Overall Study|Equipment failure|5|||
33639288|NCT02754440|102229507|FG002|Overall Study|Equipment failure|5|||
33639289|NCT02754440|102229508|FG003|Overall Study|Equipment failure|7|||
33639290|NCT02754440|102229505|FG000|Overall Study|Subject issues not resulting in AE|0|||
33639291|NCT02754440|102229506|FG001|Overall Study|Subject issues not resulting in AE|0|||
33639292|NCT02754440|102229507|FG002|Overall Study|Subject issues not resulting in AE|0|||
33639293|NCT02754440|102229508|FG003|Overall Study|Subject issues not resulting in AE|12|||
33639294|NCT04540913|102229509|FG000|Overall Study|Withdrawal by Subject|14|||
33639295|NCT04540913|102229510|FG001|Overall Study|Withdrawal by Subject|3|||
33140438|NCT03011892|100428075|FG004|Double Blind (DB) Period|Physician Decision|0|||
33140439|NCT03011892|100428076|FG005|Double Blind (DB) Period|Physician Decision|0|||
33140440|NCT03011892|100428077|FG006|Double Blind (DB) Period|Physician Decision|0|||
33140441|NCT03011892|100428078|FG007|Double Blind (DB) Period|Physician Decision|0|||
33639296|NCT00345358|102232642|FG000|Primary Vaccination Phase|Other|0|||
33370049|NCT01958671|101239988|FG000|Overall Study|Pregnancy|0|||
33140442|NCT03011892|100428079|FG008|Double Blind (DB) Period|Physician Decision|0|||
33140443|NCT03011892|100428080|FG009|Double Blind (DB) Period|Physician Decision|0|||
33140444|NCT03011892|100428081|FG010|Double Blind (DB) Period|Physician Decision|0|||
33140445|NCT03011892|100428082|FG011|Double Blind (DB) Period|Physician Decision|0|||
33140446|NCT03011892|100428071|FG000|Double Blind (DB) Period|Pregnancy|0|||
33140447|NCT03011892|100428072|FG001|Double Blind (DB) Period|Pregnancy|0|||
33140448|NCT03011892|100428073|FG002|Double Blind (DB) Period|Pregnancy|0|||
33140449|NCT03011892|100428074|FG003|Double Blind (DB) Period|Pregnancy|0|||
33140450|NCT03011892|100428075|FG004|Double Blind (DB) Period|Pregnancy|1|||
33140451|NCT03011892|100428076|FG005|Double Blind (DB) Period|Pregnancy|0|||
33140452|NCT03011892|100428077|FG006|Double Blind (DB) Period|Pregnancy|0|||
33140453|NCT03011892|100428078|FG007|Double Blind (DB) Period|Pregnancy|0|||
33140454|NCT03011892|100428079|FG008|Double Blind (DB) Period|Pregnancy|0|||
33140455|NCT03011892|100428080|FG009|Double Blind (DB) Period|Pregnancy|0|||
33140456|NCT03011892|100428081|FG010|Double Blind (DB) Period|Pregnancy|0|||
33140457|NCT03011892|100428082|FG011|Double Blind (DB) Period|Pregnancy|0|||
33140458|NCT03011892|100428071|FG000|Double Blind (DB) Period|Protocol Violation|1|||
33140459|NCT03011892|100428072|FG001|Double Blind (DB) Period|Protocol Violation|0|||
33140460|NCT03011892|100428073|FG002|Double Blind (DB) Period|Protocol Violation|0|||
33140461|NCT03011892|100428074|FG003|Double Blind (DB) Period|Protocol Violation|0|||
33140462|NCT03011892|100428075|FG004|Double Blind (DB) Period|Protocol Violation|0|||
33140463|NCT03011892|100428076|FG005|Double Blind (DB) Period|Protocol Violation|0|||
33140464|NCT03011892|100428077|FG006|Double Blind (DB) Period|Protocol Violation|0|||
33140465|NCT03011892|100428078|FG007|Double Blind (DB) Period|Protocol Violation|0|||
33140466|NCT03011892|100428079|FG008|Double Blind (DB) Period|Protocol Violation|0|||
33140467|NCT03011892|100428080|FG009|Double Blind (DB) Period|Protocol Violation|0|||
33140468|NCT03011892|100428081|FG010|Double Blind (DB) Period|Protocol Violation|0|||
33140469|NCT03011892|100428082|FG011|Double Blind (DB) Period|Protocol Violation|0|||
33140470|NCT03011892|100428071|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
33140471|NCT03011892|100428072|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
33140472|NCT03011892|100428073|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
33140473|NCT03011892|100428074|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
33140474|NCT03011892|100428075|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
33140475|NCT03011892|100428076|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
33140476|NCT03011892|100428077|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
33140477|NCT03011892|100428078|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
33140478|NCT03011892|100428079|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
33140479|NCT03011892|100428080|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
33238438|NCT02223182|100775892|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
33238439|NCT02223182|100775889|FG000|Open-Label 300 Period|Non Compliance|0|||
33579470|NCT00413660|102013093|FG005|Up To Week 12|Randomized, Not Treated|0|||
33579471|NCT00413660|102013094|FG006|Up To Week 12|Randomized, Not Treated|0|||
33579472|NCT00413660|102013095|FG007|Up To Week 12|Randomized, Not Treated|0|||
33579473|NCT00413660|102013096|FG008|Up To Week 12|Randomized, Not Treated|0|||
33579474|NCT00413660|102013097|FG009|Up To Week 12|Randomized, Not Treated|0|||
33579475|NCT00413660|102013098|FG010|Up To Week 12|Randomized, Not Treated|0|||
33579476|NCT00413660|102013088|FG000|Up To Week 12|Other|3|||
33579477|NCT00413660|102013089|FG001|Up To Week 12|Other|1|||
33579478|NCT00413660|102013090|FG002|Up To Week 12|Other|6|||
33579479|NCT00413660|102013091|FG003|Up To Week 12|Other|1|||
33639297|NCT00345358|102232643|FG001|Primary Vaccination Phase|Other|1|||
33639298|NCT00345358|102232644|FG002|Primary Vaccination Phase|Other|1|||
33639299|NCT00345358|102232645|FG003|Primary Vaccination Phase|Other|0|||
33639300|NCT00345358|102232642|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
33639301|NCT00345358|102232643|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
33639302|NCT00345358|102232644|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
33639303|NCT00345358|102232645|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
33639304|NCT00345358|102232642|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
33639305|NCT00345358|102232643|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
33639306|NCT00345358|102232644|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
33140480|NCT03011892|100428081|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
33140481|NCT03011892|100428082|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
33238440|NCT02223182|100775890|FG001|Open-Label 300 Period|Non Compliance|2|||
33370050|NCT01958671|101239989|FG001|Overall Study|Pregnancy|0|||
33579480|NCT00413660|102013092|FG004|Up To Week 12|Other|2|||
33639307|NCT00345358|102232645|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
33140482|NCT03011892|100428071|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
33140483|NCT03011892|100428072|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
33140484|NCT03011892|100428073|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
33579481|NCT00413660|102013093|FG005|Up To Week 12|Other|4|||
33579482|NCT00413660|102013094|FG006|Up To Week 12|Other|3|||
33579483|NCT00413660|102013095|FG007|Up To Week 12|Other|0|||
33579484|NCT00413660|102013096|FG008|Up To Week 12|Other|0|||
33639308|NCT00345358|102232642|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
33639309|NCT00345358|102232643|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
33639310|NCT00345358|102232644|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
33639311|NCT00345358|102232645|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
33639312|NCT00345358|102232642|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
33639313|NCT00345358|102232643|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
33639314|NCT00345358|102232644|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
33639315|NCT00345358|102232645|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
33639316|NCT00345358|102232642|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
33639317|NCT00345358|102232643|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
33639318|NCT00345358|102232644|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
33639319|NCT00345358|102232645|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
33639320|NCT00478023|102232649|FG000|Overall Study|Adverse Event|11|||
33639321|NCT00478023|102232650|FG001|Overall Study|Adverse Event|7|||
33639322|NCT00478023|102232651|FG002|Overall Study|Adverse Event|8|||
33639323|NCT00478023|102232652|FG003|Overall Study|Adverse Event|14|||
33639324|NCT00478023|102232653|FG004|Overall Study|Adverse Event|6|||
33639325|NCT00478023|102232649|FG000|Overall Study|Death|1|||
33639326|NCT00478023|102232650|FG001|Overall Study|Death|0|||
33639327|NCT00478023|102232651|FG002|Overall Study|Death|0|||
33639328|NCT00478023|102232652|FG003|Overall Study|Death|0|||
33639329|NCT00478023|102232653|FG004|Overall Study|Death|0|||
33639330|NCT00478023|102232649|FG000|Overall Study|Lack of Efficacy|11|||
33639331|NCT00478023|102232650|FG001|Overall Study|Lack of Efficacy|10|||
33639332|NCT00478023|102232651|FG002|Overall Study|Lack of Efficacy|4|||
33639333|NCT00478023|102232652|FG003|Overall Study|Lack of Efficacy|5|||
33639334|NCT00478023|102232653|FG004|Overall Study|Lack of Efficacy|41|||
33639335|NCT00478023|102232649|FG000|Overall Study|Lost to Follow-up|3|||
33639336|NCT00478023|102232650|FG001|Overall Study|Lost to Follow-up|1|||
33639337|NCT00478023|102232651|FG002|Overall Study|Lost to Follow-up|1|||
33639338|NCT00478023|102232652|FG003|Overall Study|Lost to Follow-up|1|||
33639339|NCT00478023|102232653|FG004|Overall Study|Lost to Follow-up|0|||
33639340|NCT00478023|102232649|FG000|Overall Study|Withdrawal by Subject|2|||
33639341|NCT00478023|102232650|FG001|Overall Study|Withdrawal by Subject|3|||
33639342|NCT00478023|102232651|FG002|Overall Study|Withdrawal by Subject|2|||
33639343|NCT00478023|102232652|FG003|Overall Study|Withdrawal by Subject|4|||
33639344|NCT00478023|102232653|FG004|Overall Study|Withdrawal by Subject|5|||
33639345|NCT00478023|102232649|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
33639346|NCT00478023|102232650|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
33639347|NCT00478023|102232651|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
33639348|NCT00478023|102232652|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
33639349|NCT00478023|102232653|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
33639350|NCT00396253|102232654|FG000|Overall Study|Protocol Violation|1|||
33639351|NCT00396253|102232654|FG000|Overall Study|Withdrawal by Subject|7|||
33639352|NCT00396253|102232654|FG000|Overall Study|Death|3|||
33639353|NCT00396253|102232654|FG000|Overall Study|Physician Decision|1|||
33639354|NCT00396253|102232654|FG000|Overall Study|Change in eligibility status|1|||
33639355|NCT01054885|102232655|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
33639356|NCT01054885|102232656|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33639357|NCT01054885|102232657|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33639358|NCT01054885|102232658|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33639359|NCT01054885|102232659|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33639360|NCT01054885|102232660|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33639361|NCT01054885|102232661|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33639362|NCT01054885|102232655|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
33639363|NCT01054885|102232656|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
33639364|NCT01054885|102232657|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
33639365|NCT01054885|102232658|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
33639366|NCT01054885|102232659|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
33639367|NCT01054885|102232660|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
33639368|NCT01054885|102232661|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
33639369|NCT01054885|102232655|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
33639370|NCT01054885|102232656|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33639371|NCT01054885|102232657|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33639372|NCT01054885|102232658|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33639373|NCT01054885|102232659|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33140485|NCT03011892|100428074|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
33639374|NCT01054885|102232660|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33639375|NCT01054885|102232661|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33639376|NCT01054885|102232655|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
33140486|NCT03011892|100428075|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
33639377|NCT01054885|102232656|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33639378|NCT01054885|102232657|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33639379|NCT01054885|102232658|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33639380|NCT01054885|102232659|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33140487|NCT03011892|100428076|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
33140488|NCT03011892|100428077|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
33370051|NCT01958671|101239990|FG002|Overall Study|Pregnancy|1|||
33370052|NCT01958671|101239988|FG000|Overall Study|Protocol Violation|0|||
33370053|NCT01958671|101239989|FG001|Overall Study|Protocol Violation|1|||
33370054|NCT01958671|101239990|FG002|Overall Study|Protocol Violation|0|||
33370055|NCT01958671|101239988|FG000|Overall Study|Study site terminated by sponsor|1|||
33370056|NCT01958671|101239989|FG001|Overall Study|Study site terminated by sponsor|0|||
33370057|NCT01958671|101239990|FG002|Overall Study|Study site terminated by sponsor|1|||
33370058|NCT01958671|101239988|FG000|Overall Study|Participant moved|0|||
33370059|NCT01958671|101239989|FG001|Overall Study|Participant moved|0|||
33370060|NCT01958671|101239990|FG002|Overall Study|Participant moved|1|||
33370061|NCT01958671|101239988|FG000|Overall Study|Withdrawal by Subject|8|||
33370062|NCT01958671|101239989|FG001|Overall Study|Withdrawal by Subject|10|||
33370063|NCT01958671|101239990|FG002|Overall Study|Withdrawal by Subject|13|||
33370064|NCT01469013|101239991|FG000|Part A (Treatment Period)|Adverse Event|1|||
33370065|NCT01469013|101239992|FG001|Part A (Treatment Period)|Adverse Event|0|||
33370066|NCT01469013|101239993|FG002|Part A (Treatment Period)|Adverse Event|0|||
33370067|NCT01469013|101239994|FG003|Part A (Treatment Period)|Adverse Event|0|||
33370068|NCT01469013|101239995|FG004|Part A (Treatment Period)|Adverse Event|1|||
33370069|NCT01469013|101239996|FG005|Part A (Treatment Period)|Adverse Event|0|||
33370070|NCT01469013|101239997|FG006|Part A (Treatment Period)|Adverse Event|0|||
33370071|NCT01469013|101239998|FG007|Part A (Treatment Period)|Adverse Event|0|||
33370072|NCT01469013|101239999|FG008|Part A (Treatment Period)|Adverse Event|0|||
33370073|NCT01469013|101240000|FG009|Part A (Treatment Period)|Adverse Event|0|||
33370074|NCT01469013|101240001|FG010|Part A (Treatment Period)|Adverse Event|0|||
33370075|NCT01469013|101240002|FG011|Part A (Treatment Period)|Adverse Event|0|||
33140489|NCT03011892|100428078|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
33140490|NCT03011892|100428079|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
33140491|NCT03011892|100428080|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
33140492|NCT03011892|100428081|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
33140493|NCT03011892|100428082|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
33140494|NCT03011892|100428071|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
33140495|NCT03011892|100428072|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
33140496|NCT03011892|100428073|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
33140497|NCT03011892|100428074|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
33140498|NCT03011892|100428075|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
33140499|NCT03011892|100428076|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
33140500|NCT03011892|100428077|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
33140501|NCT03011892|100428078|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
33140502|NCT03011892|100428079|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
33140503|NCT03011892|100428080|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
33140504|NCT03011892|100428081|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
33140505|NCT03011892|100428082|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
33140506|NCT03011892|100428071|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
33140507|NCT03011892|100428072|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
33140508|NCT03011892|100428073|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
33140509|NCT03011892|100428074|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
33140510|NCT03011892|100428075|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
33140511|NCT03011892|100428076|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
33140512|NCT03011892|100428077|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
33140513|NCT03011892|100428078|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
33140514|NCT03011892|100428079|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
33140515|NCT03011892|100428080|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
33140516|NCT03011892|100428081|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
33140517|NCT03011892|100428082|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
33140518|NCT03011892|100428071|FG000|Open Label (OL) Period|Reason not specified|0|||
33140519|NCT03011892|100428072|FG001|Open Label (OL) Period|Reason not specified|0|||
33140520|NCT03011892|100428073|FG002|Open Label (OL) Period|Reason not specified|0|||
33140521|NCT03011892|100428074|FG003|Open Label (OL) Period|Reason not specified|0|||
33140522|NCT03011892|100428075|FG004|Open Label (OL) Period|Reason not specified|0|||
33370076|NCT01469013|101240003|FG012|Part A (Treatment Period)|Adverse Event|0|||
33370077|NCT01469013|101239991|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
33639381|NCT01054885|102232660|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33370078|NCT01469013|101239992|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
33370079|NCT01469013|101239993|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
33370080|NCT01469013|101239994|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
33370081|NCT01469013|101239995|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
33140523|NCT03011892|100428076|FG005|Open Label (OL) Period|Reason not specified|0|||
33140524|NCT03011892|100428077|FG006|Open Label (OL) Period|Reason not specified|0|||
33140525|NCT03011892|100428078|FG007|Open Label (OL) Period|Reason not specified|1|||
33140526|NCT03011892|100428079|FG008|Open Label (OL) Period|Reason not specified|0|||
33140527|NCT03011892|100428080|FG009|Open Label (OL) Period|Reason not specified|0|||
33140528|NCT03011892|100428081|FG010|Open Label (OL) Period|Reason not specified|0|||
33140529|NCT03011892|100428082|FG011|Open Label (OL) Period|Reason not specified|0|||
33140530|NCT01227629|100428088|FG000|Overall Study|Adverse Event|2|||
33579485|NCT00413660|102013097|FG009|Up To Week 12|Other|0|||
33579486|NCT00413660|102013098|FG010|Up To Week 12|Other|0|||
33579487|NCT00413660|102013088|FG000|Post Week 12|Adverse Event|2|||
33579488|NCT00413660|102013089|FG001|Post Week 12|Adverse Event|0|||
33579489|NCT00413660|102013090|FG002|Post Week 12|Adverse Event|2|||
33579490|NCT00413660|102013091|FG003|Post Week 12|Adverse Event|1|||
33579491|NCT00413660|102013092|FG004|Post Week 12|Adverse Event|4|||
33579492|NCT00413660|102013093|FG005|Post Week 12|Adverse Event|2|||
33140531|NCT01227629|100428089|FG001|Overall Study|Adverse Event|2|||
33140532|NCT01227629|100428090|FG002|Overall Study|Adverse Event|1|||
33238441|NCT02223182|100775891|FG002|Open-Label 300 Period|Non Compliance|1|||
33238442|NCT02223182|100775892|FG003|Open-Label 300 Period|Non Compliance|0|||
33238443|NCT02276547|100775895|FG000|Overall Study|Death|2|||
33579493|NCT00413660|102013094|FG006|Post Week 12|Adverse Event|2|||
33579494|NCT00413660|102013095|FG007|Post Week 12|Adverse Event|0|||
33579495|NCT00413660|102013096|FG008|Post Week 12|Adverse Event|0|||
33579496|NCT00413660|102013097|FG009|Post Week 12|Adverse Event|0|||
33579497|NCT00413660|102013098|FG010|Post Week 12|Adverse Event|0|||
33579498|NCT00413660|102013088|FG000|Post Week 12|Lack of Efficacy|0|||
33579499|NCT00413660|102013089|FG001|Post Week 12|Lack of Efficacy|0|||
33238444|NCT02276547|100775895|FG000|Overall Study|Explant|2|||
33238445|NCT01744496|100775897|FG000|Titration Period|Adverse Event|2|||
33238446|NCT01744496|100775898|FG001|Titration Period|Adverse Event|1|||
33238447|NCT01744496|100775897|FG000|Titration Period|Personal reasons|0|||
33238448|NCT01744496|100775898|FG001|Titration Period|Personal reasons|1|||
33238449|NCT01744496|100775897|FG000|Maintenance Period|Adverse Event|1|||
33238450|NCT01744496|100775898|FG001|Maintenance Period|Adverse Event|3|||
33238451|NCT01744496|100775897|FG000|Maintenance Period|Protocol Violation|1|||
33238452|NCT01744496|100775898|FG001|Maintenance Period|Protocol Violation|0|||
33420889|NCT02913261|101431633|FG001|Overall Study|Graft loss|0|||
33420890|NCT00319020|101431639|FG000|Overall Study|Death|2|||
33420891|NCT00319020|101431640|FG001|Overall Study|Death|2|||
33420892|NCT00319020|101431639|FG000|Overall Study|Withdrawal by Subject|4|||
33420893|NCT00319020|101431640|FG001|Overall Study|Withdrawal by Subject|1|||
33420894|NCT00319020|101431639|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
33420895|NCT00319020|101431640|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
33420896|NCT00319020|101431639|FG000|Overall Study|Administrative reason|0|||
33420897|NCT00319020|101431640|FG001|Overall Study|Administrative reason|5|||
33420898|NCT00319020|101431639|FG000|Overall Study|Disease progression|0|||
33420899|NCT00319020|101431640|FG001|Overall Study|Disease progression|2|||
33420900|NCT00319020|101431639|FG000|Overall Study|Transplant|0|||
33420901|NCT00319020|101431640|FG001|Overall Study|Transplant|1|||
33420902|NCT00319020|101431639|FG000|Overall Study|Treatment failure|0|||
33420903|NCT00319020|101431640|FG001|Overall Study|Treatment failure|1|||
33420904|NCT00319020|101431639|FG000|Overall Study|Adverse Event|0|||
33420905|NCT00319020|101431640|FG001|Overall Study|Adverse Event|1|||
33420906|NCT01959230|101431641|FG000|Overall Study|Failure to follow study procedures|0|||
33420907|NCT01959230|101431642|FG001|Overall Study|Failure to follow study procedures|1|||
33420908|NCT01959230|101431641|FG000|Overall Study|Administrative reasons|2|||
33420909|NCT01959230|101431642|FG001|Overall Study|Administrative reasons|0|||
33420910|NCT01959230|101431641|FG000|Overall Study|Withdrawal by Subject|2|||
33420911|NCT01959230|101431642|FG001|Overall Study|Withdrawal by Subject|0|||
33420912|NCT03506425|101431643|FG000|Overall Study|Adverse Event|1|||
33420913|NCT03506425|101431644|FG001|Overall Study|Adverse Event|3|||
33420914|NCT03506425|101431645|FG002|Overall Study|Adverse Event|0|||
33579500|NCT00413660|102013090|FG002|Post Week 12|Lack of Efficacy|1|||
33579501|NCT00413660|102013091|FG003|Post Week 12|Lack of Efficacy|0|||
33579502|NCT00413660|102013092|FG004|Post Week 12|Lack of Efficacy|0|||
33140533|NCT01227629|100428091|FG003|Overall Study|Adverse Event|6|||
33140534|NCT01227629|100428092|FG004|Overall Study|Adverse Event|1|||
33238453|NCT01744496|100775897|FG000|Maintenance Period|Withdrawal by Subject|1|||
33238454|NCT01744496|100775898|FG001|Maintenance Period|Withdrawal by Subject|1|||
33238455|NCT01744496|100775897|FG000|Maintenance Period|Subject left town|1|||
33420915|NCT03506425|101431643|FG000|Overall Study|Death|1|||
33420916|NCT03506425|101431644|FG001|Overall Study|Death|0|||
33420917|NCT03506425|101431645|FG002|Overall Study|Death|0|||
33420918|NCT03506425|101431643|FG000|Overall Study|Withdrawal by Subject|0|||
33420919|NCT03506425|101431644|FG001|Overall Study|Withdrawal by Subject|0|||
33420920|NCT03506425|101431645|FG002|Overall Study|Withdrawal by Subject|1|||
33579503|NCT00413660|102013093|FG005|Post Week 12|Lack of Efficacy|0|||
33579504|NCT00413660|102013094|FG006|Post Week 12|Lack of Efficacy|0|||
33370082|NCT01469013|101239996|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
33370083|NCT01469013|101239997|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
33370084|NCT01469013|101239998|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
33370085|NCT01469013|101239999|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
33370086|NCT01469013|101240000|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
33370087|NCT01469013|101240001|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
33370088|NCT01469013|101240002|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
33370089|NCT01469013|101240003|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
33370090|NCT01469013|101239991|FG000|Part B (Extension Period)|Adverse Event|0|||
33370091|NCT01469013|101239992|FG001|Part B (Extension Period)|Adverse Event|0|||
33370092|NCT01469013|101239993|FG002|Part B (Extension Period)|Adverse Event|0|||
33370093|NCT01469013|101239994|FG003|Part B (Extension Period)|Adverse Event|0|||
33370094|NCT01469013|101239995|FG004|Part B (Extension Period)|Adverse Event|0|||
33579505|NCT00413660|102013095|FG007|Post Week 12|Lack of Efficacy|0|||
33579506|NCT00413660|102013096|FG008|Post Week 12|Lack of Efficacy|0|||
33579507|NCT00413660|102013097|FG009|Post Week 12|Lack of Efficacy|1|||
33579508|NCT00413660|102013098|FG010|Post Week 12|Lack of Efficacy|0|||
33639382|NCT01054885|102232661|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33639383|NCT01054885|102232655|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
33639384|NCT01054885|102232656|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
33639385|NCT01054885|102232657|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
33639386|NCT01054885|102232658|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
33639387|NCT01054885|102232659|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
33639388|NCT01054885|102232660|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
33639389|NCT01054885|102232661|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
33639390|NCT01054885|102232655|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
33639391|NCT01054885|102232656|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33639392|NCT01054885|102232657|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33639393|NCT01054885|102232658|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33639394|NCT01054885|102232659|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33639395|NCT01054885|102232660|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33639396|NCT01054885|102232661|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
33639397|NCT01054885|102232655|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
33639398|NCT01054885|102232656|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
33639399|NCT01054885|102232657|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
33639400|NCT01054885|102232658|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
33639401|NCT01054885|102232659|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
33639402|NCT01054885|102232660|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
33639403|NCT01054885|102232661|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
33639404|NCT01054885|102232655|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33639405|NCT01054885|102232656|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33639406|NCT01054885|102232657|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
33639407|NCT01054885|102232658|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
33579509|NCT00413660|102013088|FG000|Post Week 12|Lost to Follow-up|0|||
33579510|NCT00413660|102013089|FG001|Post Week 12|Lost to Follow-up|1|||
33579511|NCT00413660|102013090|FG002|Post Week 12|Lost to Follow-up|1|||
33579512|NCT00413660|102013091|FG003|Post Week 12|Lost to Follow-up|0|||
33579513|NCT00413660|102013092|FG004|Post Week 12|Lost to Follow-up|0|||
33579514|NCT00413660|102013093|FG005|Post Week 12|Lost to Follow-up|0|||
33579515|NCT00413660|102013094|FG006|Post Week 12|Lost to Follow-up|0|||
33579516|NCT00413660|102013095|FG007|Post Week 12|Lost to Follow-up|0|||
33579517|NCT00413660|102013096|FG008|Post Week 12|Lost to Follow-up|0|||
33579518|NCT00413660|102013097|FG009|Post Week 12|Lost to Follow-up|0|||
33579519|NCT00413660|102013098|FG010|Post Week 12|Lost to Follow-up|0|||
33579520|NCT00413660|102013088|FG000|Post Week 12|Withdrawal by Subject|0|||
33579521|NCT00413660|102013089|FG001|Post Week 12|Withdrawal by Subject|1|||
33579522|NCT00413660|102013090|FG002|Post Week 12|Withdrawal by Subject|1|||
33579523|NCT00413660|102013091|FG003|Post Week 12|Withdrawal by Subject|0|||
33579524|NCT00413660|102013092|FG004|Post Week 12|Withdrawal by Subject|1|||
33579525|NCT00413660|102013093|FG005|Post Week 12|Withdrawal by Subject|0|||
33579526|NCT00413660|102013094|FG006|Post Week 12|Withdrawal by Subject|0|||
33579527|NCT00413660|102013095|FG007|Post Week 12|Withdrawal by Subject|0|||
33579528|NCT00413660|102013096|FG008|Post Week 12|Withdrawal by Subject|0|||
33579529|NCT00413660|102013097|FG009|Post Week 12|Withdrawal by Subject|0|||
33579530|NCT00413660|102013098|FG010|Post Week 12|Withdrawal by Subject|1|||
33370095|NCT01469013|101239996|FG005|Part B (Extension Period)|Adverse Event|2|||
33579531|NCT00413660|102013088|FG000|Post Week 12|Other|1|||
33579532|NCT00413660|102013089|FG001|Post Week 12|Other|2|||
33579533|NCT00413660|102013090|FG002|Post Week 12|Other|3|||
33579534|NCT00413660|102013091|FG003|Post Week 12|Other|0|||
33579535|NCT00413660|102013092|FG004|Post Week 12|Other|1|||
33579536|NCT00413660|102013093|FG005|Post Week 12|Other|1|||
33140535|NCT01227629|100428093|FG005|Overall Study|Adverse Event|1|||
33140536|NCT01227629|100428094|FG006|Overall Study|Adverse Event|6|||
33140537|NCT01227629|100428095|FG007|Overall Study|Adverse Event|6|||
33140538|NCT01227629|100428096|FG008|Overall Study|Adverse Event|4|||
33140539|NCT01227629|100428097|FG009|Overall Study|Adverse Event|0|||
33370096|NCT01469013|101239997|FG006|Part B (Extension Period)|Adverse Event|5|||
33370097|NCT01469013|101239998|FG007|Part B (Extension Period)|Adverse Event|5|||
33370098|NCT01469013|101239999|FG008|Part B (Extension Period)|Adverse Event|3|||
33370099|NCT01469013|101240000|FG009|Part B (Extension Period)|Adverse Event|3|||
33370100|NCT01469013|101240001|FG010|Part B (Extension Period)|Adverse Event|1|||
33370101|NCT01469013|101240002|FG011|Part B (Extension Period)|Adverse Event|6|||
33370102|NCT01469013|101240003|FG012|Part B (Extension Period)|Adverse Event|3|||
33370103|NCT01469013|101239991|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
33370104|NCT01469013|101239992|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
33370105|NCT01469013|101239993|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
33370106|NCT01469013|101239994|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
33370107|NCT01469013|101239995|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
33370108|NCT01469013|101239996|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
33370109|NCT01469013|101239997|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
33370110|NCT01469013|101239998|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
33370111|NCT01469013|101239999|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
33370112|NCT01469013|101240000|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
33370113|NCT01469013|101240001|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
33370114|NCT01469013|101240002|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
33370115|NCT01469013|101240003|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
33370116|NCT00807846|101240004|FG000|Overall Study|Adverse Event|5|||
33370117|NCT00807846|101240005|FG001|Overall Study|Adverse Event|0|||
33370118|NCT00807846|101240004|FG000|Overall Study|Lack of Efficacy|2|||
33370119|NCT00807846|101240005|FG001|Overall Study|Lack of Efficacy|0|||
33370120|NCT00807846|101240004|FG000|Overall Study|Protocol Violation|2|||
33370121|NCT00807846|101240005|FG001|Overall Study|Protocol Violation|1|||
33370122|NCT00807846|101240004|FG000|Overall Study|Withdrawal by Subject|2|||
33370123|NCT00807846|101240005|FG001|Overall Study|Withdrawal by Subject|1|||
33370124|NCT00807846|101240004|FG000|Overall Study|Other|1|||
33370125|NCT00807846|101240005|FG001|Overall Study|Other|2|||
33370126|NCT01428063|101240006|FG000|Overall Study|Lack of Efficacy|8|||
33370127|NCT01428063|101240007|FG001|Overall Study|Lack of Efficacy|4|||
33370128|NCT01428063|101240008|FG002|Overall Study|Lack of Efficacy|1|||
33370129|NCT01428063|101240006|FG000|Overall Study|Adverse Event|2|||
33370130|NCT01428063|101240007|FG001|Overall Study|Adverse Event|3|||
33370131|NCT01428063|101240008|FG002|Overall Study|Adverse Event|0|||
33370132|NCT01428063|101240006|FG000|Overall Study|Lost to Follow-up|0|||
33370133|NCT01428063|101240007|FG001|Overall Study|Lost to Follow-up|2|||
33370134|NCT01428063|101240008|FG002|Overall Study|Lost to Follow-up|0|||
33370135|NCT01428063|101240006|FG000|Overall Study|No longer meets study criteria|0|||
33370136|NCT01428063|101240007|FG001|Overall Study|No longer meets study criteria|1|||
33370137|NCT01428063|101240008|FG002|Overall Study|No longer meets study criteria|0|||
33370138|NCT00527111|101240014|FG000|Overall Study|Adverse Event|14|||
33370139|NCT00527111|101240015|FG001|Overall Study|Adverse Event|13|||
33370140|NCT00527111|101240014|FG000|Overall Study|Death|0|||
33370141|NCT00527111|101240015|FG001|Overall Study|Death|1|||
33370142|NCT00527111|101240014|FG000|Overall Study|Investigator Request|2|||
33370143|NCT00527111|101240015|FG001|Overall Study|Investigator Request|1|||
33370144|NCT00527111|101240014|FG000|Overall Study|Patient Request|2|||
33370145|NCT00527111|101240015|FG001|Overall Study|Patient Request|5|||
33370146|NCT00527111|101240014|FG000|Overall Study|Other|2|||
33370147|NCT00527111|101240015|FG001|Overall Study|Other|2|||
33370148|NCT01879618|101240016|FG000|Overall Study|Does not meet entrance criteria|1|||
33370149|NCT01879618|101240016|FG000|Overall Study|Withdrawal by Subject|1|||
33370150|NCT01879618|101240016|FG000|Overall Study|Surgery;changed schedule; not available|8|||
33370151|NCT01879618|101240016|FG000|Overall Study|Protocol Violation|6|||
33370152|NCT01879618|101240016|FG000|Overall Study|Adverse Event|5|||
33370153|NCT03342469|101240017|FG000|Overall Study|Withdrawal by Subject|0|||
33370154|NCT03342469|101240018|FG001|Overall Study|Withdrawal by Subject|1|||
33420921|NCT00450177|101431650|FG000|Overall Study|Adverse Event|7|||
33370155|NCT03342469|101240019|FG002|Overall Study|Withdrawal by Subject|0|||
33370156|NCT03342469|101240020|FG003|Overall Study|Withdrawal by Subject|0|||
33370157|NCT01839188|101240029|FG000|Overall Study|Withdrawal by Subject|1|||
33420922|NCT00450177|101431651|FG001|Overall Study|Adverse Event|4|||
33420923|NCT00450177|101431650|FG000|Overall Study|Withdrawal by Subject|1|||
33140540|NCT01227629|100428088|FG000|Overall Study|Protocol Violation|0|||
33370158|NCT02588248|101240030|FG000|Overall Study|Physician Decision|4|||
33370159|NCT02588248|101240031|FG001|Overall Study|Physician Decision|3|||
33370160|NCT03196505|101240032|FG000|Overall Study|Physician Decision|26|||
33370161|NCT03196505|101240033|FG001|Overall Study|Physician Decision|26|||
33370162|NCT00718419|101240034|FG000|Overall Study|Adverse Event|2|||
33140541|NCT01227629|100428089|FG001|Overall Study|Protocol Violation|0|||
33370163|NCT00718419|101240035|FG001|Overall Study|Adverse Event|1|||
33370164|NCT00718419|101240034|FG000|Overall Study|Physician Decision|1|||
33370165|NCT00718419|101240035|FG001|Overall Study|Physician Decision|6|||
33579537|NCT00413660|102013094|FG006|Post Week 12|Other|1|||
33140542|NCT01227629|100428090|FG002|Overall Study|Protocol Violation|0|||
33140543|NCT01227629|100428091|FG003|Overall Study|Protocol Violation|1|||
33140544|NCT01227629|100428092|FG004|Overall Study|Protocol Violation|0|||
33140545|NCT01227629|100428093|FG005|Overall Study|Protocol Violation|0|||
33140546|NCT01227629|100428094|FG006|Overall Study|Protocol Violation|0|||
33140547|NCT01227629|100428095|FG007|Overall Study|Protocol Violation|0|||
33140548|NCT01227629|100428096|FG008|Overall Study|Protocol Violation|0|||
33140549|NCT01227629|100428097|FG009|Overall Study|Protocol Violation|0|||
33140550|NCT01227629|100428088|FG000|Overall Study|Lost to Follow-up|0|||
33140551|NCT01227629|100428089|FG001|Overall Study|Lost to Follow-up|0|||
33140552|NCT01227629|100428090|FG002|Overall Study|Lost to Follow-up|0|||
33140553|NCT01227629|100428091|FG003|Overall Study|Lost to Follow-up|0|||
33140554|NCT01227629|100428092|FG004|Overall Study|Lost to Follow-up|1|||
33140555|NCT01227629|100428093|FG005|Overall Study|Lost to Follow-up|0|||
33140556|NCT01227629|100428094|FG006|Overall Study|Lost to Follow-up|0|||
33140557|NCT01227629|100428095|FG007|Overall Study|Lost to Follow-up|0|||
33140558|NCT01227629|100428096|FG008|Overall Study|Lost to Follow-up|0|||
33140559|NCT01227629|100428097|FG009|Overall Study|Lost to Follow-up|0|||
33140560|NCT01227629|100428088|FG000|Overall Study|Withdrawal by Subject|0|||
33140561|NCT01227629|100428089|FG001|Overall Study|Withdrawal by Subject|0|||
33140562|NCT01227629|100428090|FG002|Overall Study|Withdrawal by Subject|0|||
33140563|NCT01227629|100428091|FG003|Overall Study|Withdrawal by Subject|0|||
33579538|NCT00413660|102013095|FG007|Post Week 12|Other|0|||
33579539|NCT00413660|102013096|FG008|Post Week 12|Other|0|||
33579540|NCT00413660|102013097|FG009|Post Week 12|Other|0|||
33579541|NCT00413660|102013098|FG010|Post Week 12|Other|0|||
33579542|NCT01465386|102013100|FG000|Overall Study|Lack of Efficacy|3|||
33579543|NCT01465386|102013100|FG000|Overall Study|Adverse Event|1|||
33579544|NCT02473471|102013104|FG000|Overall Study|poor oral hygiene|2|||
33579545|NCT02473471|102013104|FG000|Overall Study|Lost to Follow-up|1|||
33140564|NCT01227629|100428092|FG004|Overall Study|Withdrawal by Subject|0|||
33140565|NCT01227629|100428093|FG005|Overall Study|Withdrawal by Subject|0|||
33140566|NCT01227629|100428094|FG006|Overall Study|Withdrawal by Subject|2|||
33140567|NCT01227629|100428095|FG007|Overall Study|Withdrawal by Subject|0|||
33140568|NCT01227629|100428096|FG008|Overall Study|Withdrawal by Subject|0|||
33140569|NCT01227629|100428097|FG009|Overall Study|Withdrawal by Subject|1|||
33140570|NCT01227629|100428088|FG000|Overall Study|Other|0|||
33140571|NCT01227629|100428089|FG001|Overall Study|Other|0|||
33140572|NCT01227629|100428090|FG002|Overall Study|Other|0|||
33140573|NCT01227629|100428091|FG003|Overall Study|Other|1|||
33140574|NCT01227629|100428092|FG004|Overall Study|Other|0|||
33140575|NCT01227629|100428093|FG005|Overall Study|Other|0|||
33140576|NCT01227629|100428094|FG006|Overall Study|Other|0|||
33140577|NCT01227629|100428095|FG007|Overall Study|Other|0|||
33140578|NCT01227629|100428096|FG008|Overall Study|Other|2|||
33140579|NCT01227629|100428097|FG009|Overall Study|Other|1|||
33140580|NCT01445548|100428098|FG000|Overall Study|Adverse Event|1|||
33140581|NCT00869778|100428101|FG000|Overall Study|Adverse Event|2|||
33140582|NCT00869778|100428102|FG001|Overall Study|Adverse Event|0|||
33140583|NCT00869778|100428103|FG002|Overall Study|Adverse Event|0|||
33140584|NCT00869778|100428101|FG000|Overall Study|Withdrawal by Subject|3|||
33238456|NCT01744496|100775898|FG001|Maintenance Period|Subject left town|0|||
33238457|NCT01004263|100775899|FG000|Overall Study|Adverse Event|15|||
33579546|NCT03082677|102013105|FG000|Overall Study|Not Treated|2|||
33579547|NCT03281629|102013106|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
33579548|NCT03281629|102013107|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
33579549|NCT03281629|102013106|FG000|Overall Study|Death|0|||
33579550|NCT03281629|102013107|FG001|Overall Study|Death|1|||
33140585|NCT00869778|100428102|FG001|Overall Study|Withdrawal by Subject|4|||
33140586|NCT00869778|100428103|FG002|Overall Study|Withdrawal by Subject|5|||
33140587|NCT00869778|100428101|FG000|Overall Study|Pregnancy|1|||
33140588|NCT00869778|100428102|FG001|Overall Study|Pregnancy|0|||
33140589|NCT00869778|100428103|FG002|Overall Study|Pregnancy|0|||
33140590|NCT00869778|100428101|FG000|Overall Study|Protocol Violation|5|||
33140591|NCT00869778|100428102|FG001|Overall Study|Protocol Violation|3|||
33140592|NCT00869778|100428103|FG002|Overall Study|Protocol Violation|5|||
33140593|NCT00869778|100428101|FG000|Overall Study|Unblinding|1|||
33238458|NCT01004263|100775899|FG000|Overall Study|Withdrawal by Subject|58|||
33238459|NCT01004263|100775899|FG000|Overall Study|Protocol Violation|10|||
33370166|NCT00718419|101240034|FG000|Overall Study|Sponsor decision|0|||
33579551|NCT03281629|102013106|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
33579552|NCT03281629|102013107|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
33579553|NCT02315703|102013108|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
33579554|NCT02315703|102013109|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
33140594|NCT00869778|100428102|FG001|Overall Study|Unblinding|0|||
33140595|NCT00869778|100428103|FG002|Overall Study|Unblinding|0|||
33579555|NCT02315703|102013110|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
33579556|NCT02315703|102013111|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
33579557|NCT02315703|102013112|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
33579558|NCT02315703|102013113|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
33579559|NCT02315703|102013114|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
33579560|NCT02315703|102013115|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
33579561|NCT02315703|102013108|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
33579562|NCT02315703|102013109|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
33579563|NCT02315703|102013110|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
33579564|NCT02315703|102013111|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
33238460|NCT01004263|100775899|FG000|Overall Study|Lost to Follow-up|64|||
33238461|NCT01004263|100775899|FG000|Overall Study|Lack of Efficacy|13|||
33238462|NCT01004263|100775899|FG000|Overall Study|Pregnancy|2|||
33238463|NCT01004263|100775899|FG000|Overall Study|Physician Decision|15|||
33238464|NCT01004263|100775899|FG000|Overall Study|Lack of Qualifying Event|2|||
33238465|NCT00983619|100775900|FG000|Overall Study|Lost to Follow-up|0|||
33238466|NCT00983619|100775901|FG001|Overall Study|Lost to Follow-up|1|||
33238467|NCT00983619|100775902|FG002|Overall Study|Lost to Follow-up|0|||
33238468|NCT00983619|100775903|FG003|Overall Study|Lost to Follow-up|0|||
33238469|NCT00983619|100775904|FG004|Overall Study|Lost to Follow-up|0|||
33238470|NCT00983619|100775905|FG005|Overall Study|Lost to Follow-up|2|||
33238471|NCT00983619|100775906|FG006|Overall Study|Lost to Follow-up|0|||
33238472|NCT00983619|100775907|FG007|Overall Study|Lost to Follow-up|0|||
33238473|NCT00983619|100775908|FG008|Overall Study|Lost to Follow-up|0|||
33238474|NCT00983619|100775909|FG009|Overall Study|Lost to Follow-up|0|||
33238475|NCT00983619|100775910|FG010|Overall Study|Lost to Follow-up|0|||
33238476|NCT00983619|100775911|FG011|Overall Study|Lost to Follow-up|2|||
33238477|NCT00983619|100775900|FG000|Overall Study|Withdrawal by Subject|2|||
33238478|NCT00983619|100775901|FG001|Overall Study|Withdrawal by Subject|1|||
33238479|NCT00983619|100775902|FG002|Overall Study|Withdrawal by Subject|1|||
33238480|NCT00983619|100775903|FG003|Overall Study|Withdrawal by Subject|3|||
33238481|NCT00983619|100775904|FG004|Overall Study|Withdrawal by Subject|1|||
33238482|NCT00983619|100775905|FG005|Overall Study|Withdrawal by Subject|23|||
33238483|NCT00983619|100775906|FG006|Overall Study|Withdrawal by Subject|0|||
33238484|NCT00983619|100775907|FG007|Overall Study|Withdrawal by Subject|0|||
33238485|NCT00983619|100775908|FG008|Overall Study|Withdrawal by Subject|0|||
33639408|NCT01054885|102232659|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33639409|NCT01054885|102232660|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
33639410|NCT01054885|102232661|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33639411|NCT01054885|102232655|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
33238486|NCT00983619|100775909|FG009|Overall Study|Withdrawal by Subject|0|||
33238487|NCT00983619|100775910|FG010|Overall Study|Withdrawal by Subject|1|||
33238488|NCT00983619|100775911|FG011|Overall Study|Withdrawal by Subject|1|||
33238489|NCT00983619|100775900|FG000|Overall Study|Death|0|||
33238490|NCT00983619|100775901|FG001|Overall Study|Death|2|||
33238491|NCT00983619|100775902|FG002|Overall Study|Death|2|||
33238492|NCT00983619|100775903|FG003|Overall Study|Death|1|||
33238493|NCT00983619|100775904|FG004|Overall Study|Death|2|||
33238494|NCT00983619|100775905|FG005|Overall Study|Death|30|||
33579565|NCT02315703|102013112|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
33639412|NCT01054885|102232656|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
33639413|NCT01054885|102232657|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
33639414|NCT01054885|102232658|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
33639415|NCT01054885|102232659|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
33639416|NCT01054885|102232660|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
33639417|NCT01054885|102232661|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
33639418|NCT01054885|102232655|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
33639419|NCT01054885|102232656|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
33639420|NCT01054885|102232657|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
33639421|NCT01054885|102232658|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
33639422|NCT01054885|102232659|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
33639423|NCT01054885|102232660|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
33238495|NCT00983619|100775906|FG006|Overall Study|Death|1|||
33238496|NCT00983619|100775907|FG007|Overall Study|Death|0|||
33238497|NCT00983619|100775908|FG008|Overall Study|Death|1|||
33238498|NCT00983619|100775909|FG009|Overall Study|Death|2|||
33238499|NCT00983619|100775910|FG010|Overall Study|Death|9|||
33238500|NCT00983619|100775911|FG011|Overall Study|Death|8|||
33238501|NCT00983619|100775900|FG000|Overall Study|Other|1|||
33238502|NCT00983619|100775901|FG001|Overall Study|Other|0|||
33238503|NCT00983619|100775902|FG002|Overall Study|Other|0|||
33238504|NCT00983619|100775903|FG003|Overall Study|Other|1|||
33238505|NCT00983619|100775904|FG004|Overall Study|Other|0|||
33238506|NCT00983619|100775905|FG005|Overall Study|Other|12|||
33238507|NCT00983619|100775906|FG006|Overall Study|Other|2|||
33238508|NCT00983619|100775907|FG007|Overall Study|Other|2|||
33238509|NCT00983619|100775908|FG008|Overall Study|Other|0|||
33238510|NCT00983619|100775909|FG009|Overall Study|Other|1|||
33238511|NCT00983619|100775910|FG010|Overall Study|Other|1|||
33238512|NCT00983619|100775911|FG011|Overall Study|Other|0|||
33238513|NCT04212169|100775916|FG000|Overall Study|Adverse Event|0|||
33238514|NCT04212169|100775917|FG001|Overall Study|Adverse Event|0|||
33238515|NCT04212169|100775918|FG002|Overall Study|Adverse Event|0|||
33238516|NCT04212169|100775919|FG003|Overall Study|Adverse Event|2|||
33238517|NCT04212169|100775916|FG000|Overall Study|Lost to Follow-up|1|||
33238518|NCT04212169|100775917|FG001|Overall Study|Lost to Follow-up|0|||
33238519|NCT04212169|100775918|FG002|Overall Study|Lost to Follow-up|0|||
33238520|NCT04212169|100775919|FG003|Overall Study|Lost to Follow-up|2|||
33238521|NCT04212169|100775916|FG000|Overall Study|Withdrawal by Subject|10|||
33370167|NCT00718419|101240035|FG001|Overall Study|Sponsor decision|1|||
33370168|NCT00718419|101240034|FG000|Overall Study|Withdrawal by Subject|0|||
33579566|NCT02315703|102013113|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
33579567|NCT02315703|102013114|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
33579568|NCT02315703|102013115|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
33140596|NCT01129583|100428104|FG000|Overall Study|Death|1|||
33140597|NCT01129583|100428105|FG001|Overall Study|Death|0|||
33140598|NCT01129583|100428104|FG000|Overall Study|Lost to Follow-up|1|||
33579569|NCT02315703|102013108|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
33579570|NCT02315703|102013109|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
33579571|NCT02315703|102013110|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
33579572|NCT02315703|102013111|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
33140599|NCT01129583|100428105|FG001|Overall Study|Lost to Follow-up|1|||
33140600|NCT01129583|100428104|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
33140601|NCT01129583|100428105|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
33140602|NCT03726996|100428108|FG000|Overall Study|Parent's decision|2|||
33140603|NCT03726996|100428108|FG000|Overall Study|Study early termination|2|||
33140604|NCT00621621|100428111|FG000|Overall Study|Subjects were exited at EP study|30|||
33140605|NCT00621621|100428112|FG001|Overall Study|Subjects were exited at EP study|0|||
33140606|NCT01894568|100428113|FG000|Overall Study|Adverse Event|2|||
33140607|NCT01894568|100428114|FG001|Overall Study|Adverse Event|3|||
33140608|NCT01894568|100428113|FG000|Overall Study|Protocol required discontinuation|2|||
33140609|NCT01894568|100428114|FG001|Overall Study|Protocol required discontinuation|1|||
33140610|NCT01894568|100428113|FG000|Overall Study|Withdrawal by Subject|5|||
33140611|NCT01894568|100428114|FG001|Overall Study|Withdrawal by Subject|5|||
33140612|NCT01894568|100428113|FG000|Overall Study|Physician Decision|1|||
33140613|NCT01894568|100428114|FG001|Overall Study|Physician Decision|0|||
33140614|NCT01894568|100428113|FG000|Overall Study|Lost to Follow-up|0|||
33140615|NCT01894568|100428114|FG001|Overall Study|Lost to Follow-up|1|||
33140616|NCT00534313|100428120|FG000|Short-term Period|Adverse Event|1|||
33140617|NCT00534313|100428121|FG001|Short-term Period|Adverse Event|2|||
33140618|NCT00534313|100428122|FG002|Short-term Period|Adverse Event|1|||
33140619|NCT00534313|100428123|FG003|Short-term Period|Adverse Event|3|||
33140620|NCT00534313|100428120|FG000|Short-term Period|Lack of Efficacy|3|||
33140621|NCT00534313|100428121|FG001|Short-term Period|Lack of Efficacy|4|||
33140622|NCT00534313|100428122|FG002|Short-term Period|Lack of Efficacy|0|||
33140623|NCT00534313|100428123|FG003|Short-term Period|Lack of Efficacy|3|||
33140624|NCT00534313|100428120|FG000|Short-term Period|Participant not meeting study criteria|0|||
33140625|NCT00534313|100428121|FG001|Short-term Period|Participant not meeting study criteria|0|||
33140626|NCT00534313|100428122|FG002|Short-term Period|Participant not meeting study criteria|0|||
33140627|NCT00534313|100428123|FG003|Short-term Period|Participant not meeting study criteria|1|||
33140628|NCT00534313|100428120|FG000|Short-term Period|Participant withdrew consent|2|||
33140629|NCT00534313|100428121|FG001|Short-term Period|Participant withdrew consent|0|||
33140630|NCT00534313|100428122|FG002|Short-term Period|Participant withdrew consent|0|||
33140631|NCT00534313|100428123|FG003|Short-term Period|Participant withdrew consent|2|||
33140632|NCT00534313|100428120|FG000|Short-term Period|Pregnancy|0|||
33140633|NCT00534313|100428121|FG001|Short-term Period|Pregnancy|0|||
33140634|NCT00534313|100428122|FG002|Short-term Period|Pregnancy|1|||
33140635|NCT00534313|100428123|FG003|Short-term Period|Pregnancy|0|||
33140636|NCT00534313|100428120|FG000|Long-term Period|Adverse Event|2|||
33140637|NCT00534313|100428121|FG001|Long-term Period|Adverse Event|1|||
33140638|NCT00534313|100428122|FG002|Long-term Period|Adverse Event|0|||
33140639|NCT00534313|100428123|FG003|Long-term Period|Adverse Event|1|||
33140640|NCT00534313|100428120|FG000|Long-term Period|Lack of Efficacy|14|||
33140641|NCT00534313|100428121|FG001|Long-term Period|Lack of Efficacy|10|||
33140642|NCT00534313|100428122|FG002|Long-term Period|Lack of Efficacy|14|||
33140643|NCT00534313|100428123|FG003|Long-term Period|Lack of Efficacy|12|||
33140644|NCT00534313|100428120|FG000|Long-term Period|Lost to Follow-up|1|||
33238522|NCT04212169|100775917|FG001|Overall Study|Withdrawal by Subject|2|||
33238523|NCT04212169|100775918|FG002|Overall Study|Withdrawal by Subject|5|||
33639424|NCT01054885|102232661|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
33639425|NCT01054885|102232655|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
33639426|NCT01054885|102232656|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
33639427|NCT01054885|102232657|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
33639428|NCT01054885|102232658|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
33639429|NCT01054885|102232659|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
33639430|NCT01054885|102232660|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
33639431|NCT01054885|102232661|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
33639432|NCT01054885|102232655|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
33639433|NCT01054885|102232656|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
33639434|NCT01054885|102232657|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
33639435|NCT01054885|102232658|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
33639436|NCT01054885|102232659|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
33639437|NCT01054885|102232660|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
33639438|NCT01054885|102232661|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
33639439|NCT01054885|102232655|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33639440|NCT01054885|102232656|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
33639441|NCT01054885|102232657|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
33639442|NCT01054885|102232658|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33639443|NCT01054885|102232659|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33639444|NCT01054885|102232660|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
33238524|NCT04212169|100775919|FG003|Overall Study|Withdrawal by Subject|7|||
33238525|NCT04212169|100775916|FG000|Overall Study|Other reason, unspecified|3|||
33238526|NCT04212169|100775917|FG001|Overall Study|Other reason, unspecified|1|||
33238527|NCT04212169|100775918|FG002|Overall Study|Other reason, unspecified|0|||
33238528|NCT04212169|100775919|FG003|Overall Study|Other reason, unspecified|2|||
33238529|NCT00322868|100775922|FG000|Overall Study|disease progression|1|||
33238530|NCT01723826|100775925|FG000|Overall Study|Adverse Event|4|||
33238531|NCT01723826|100775926|FG001|Overall Study|Adverse Event|1|||
33238532|NCT01723826|100775927|FG002|Overall Study|Adverse Event|4|||
33238533|NCT01723826|100775928|FG003|Overall Study|Adverse Event|5|||
33238534|NCT01723826|100775925|FG000|Overall Study|Death according to AE eCRF|2|||
33238535|NCT01723826|100775926|FG001|Overall Study|Death according to AE eCRF|3|||
33238536|NCT01723826|100775927|FG002|Overall Study|Death according to AE eCRF|3|||
33238537|NCT01723826|100775928|FG003|Overall Study|Death according to AE eCRF|7|||
33238538|NCT01723826|100775925|FG000|Overall Study|Lost to Follow-up|1|||
33238539|NCT01723826|100775926|FG001|Overall Study|Lost to Follow-up|3|||
33238540|NCT01723826|100775927|FG002|Overall Study|Lost to Follow-up|1|||
33238541|NCT01723826|100775928|FG003|Overall Study|Lost to Follow-up|1|||
33238542|NCT01723826|100775925|FG000|Overall Study|Non-compliance|0|||
33238543|NCT01723826|100775926|FG001|Overall Study|Non-compliance|1|||
33238544|NCT01723826|100775927|FG002|Overall Study|Non-compliance|3|||
33238545|NCT01723826|100775928|FG003|Overall Study|Non-compliance|3|||
33238546|NCT01723826|100775925|FG000|Overall Study|Non-compliance With Study Drug|0|||
33238547|NCT01723826|100775926|FG001|Overall Study|Non-compliance With Study Drug|1|||
33238548|NCT01723826|100775927|FG002|Overall Study|Non-compliance With Study Drug|0|||
33238549|NCT01723826|100775928|FG003|Overall Study|Non-compliance With Study Drug|0|||
33238550|NCT01723826|100775925|FG000|Overall Study|Other Reason|8|||
33238551|NCT01723826|100775926|FG001|Overall Study|Other Reason|6|||
33238552|NCT01723826|100775927|FG002|Overall Study|Other Reason|12|||
33238553|NCT01723826|100775928|FG003|Overall Study|Other Reason|14|||
33238554|NCT01723826|100775925|FG000|Overall Study|Physician Decision|1|||
33238555|NCT01723826|100775926|FG001|Overall Study|Physician Decision|3|||
33238556|NCT01723826|100775927|FG002|Overall Study|Physician Decision|4|||
33238557|NCT01723826|100775928|FG003|Overall Study|Physician Decision|11|||
33238558|NCT01723826|100775925|FG000|Overall Study|Protocol Violation|1|||
33238559|NCT01723826|100775926|FG001|Overall Study|Protocol Violation|1|||
33370169|NCT00718419|101240035|FG001|Overall Study|Withdrawal by Subject|5|||
33370170|NCT00718419|101240034|FG000|Overall Study|Progressive Disease|7|||
33370171|NCT00718419|101240035|FG001|Overall Study|Progressive Disease|25|||
33238560|NCT01723826|100775927|FG002|Overall Study|Protocol Violation|3|||
33238561|NCT01723826|100775928|FG003|Overall Study|Protocol Violation|1|||
33238562|NCT01723826|100775925|FG000|Overall Study|Withdrawal by Subject|10|||
33238563|NCT01723826|100775926|FG001|Overall Study|Withdrawal by Subject|17|||
33238564|NCT01723826|100775927|FG002|Overall Study|Withdrawal by Subject|27|||
33238565|NCT01723826|100775928|FG003|Overall Study|Withdrawal by Subject|48|||
33370172|NCT00718419|101240034|FG000|Overall Study|Death Due to Progressive Disease|2|||
33238566|NCT01403987|100775932|FG000|Overall Study|Residents forgot their secret PIN|18|||
33238567|NCT01403987|100775933|FG001|Overall Study|Residents forgot their secret PIN|17|||
33238568|NCT01403987|100775934|FG002|Overall Study|Residents forgot their secret PIN|18|||
33238569|NCT02431533|100775935|FG000|Overall Study|Withdrawal by Subject|1|||
33238570|NCT02431533|100775936|FG001|Overall Study|Withdrawal by Subject|3|||
33238571|NCT02431533|100775935|FG000|Overall Study|Developed Exclusionary criteria|1|||
33238572|NCT02431533|100775936|FG001|Overall Study|Developed Exclusionary criteria|0|||
33238573|NCT01474512|100775937|FG000|Induction Period|Adverse Event|6|||
33238574|NCT01474512|100775938|FG001|Induction Period|Adverse Event|10|||
33238575|NCT01474512|100775939|FG002|Induction Period|Adverse Event|10|||
33238576|NCT01474512|100775940|FG003|Induction Period|Adverse Event|0|||
33238577|NCT01474512|100775941|FG004|Induction Period|Adverse Event|0|||
33238578|NCT01474512|100775942|FG005|Induction Period|Adverse Event|0|||
33238579|NCT01474512|100775943|FG006|Induction Period|Adverse Event|0|||
33238580|NCT01474512|100775944|FG007|Induction Period|Adverse Event|0|||
33238581|NCT01474512|100775945|FG008|Induction Period|Adverse Event|0|||
33238582|NCT01474512|100775946|FG009|Induction Period|Adverse Event|0|||
33238583|NCT01474512|100775947|FG010|Induction Period|Adverse Event|0|||
33238584|NCT01474512|100775948|FG011|Induction Period|Adverse Event|0|||
33639445|NCT01054885|102232661|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
33639446|NCT01054885|102232655|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
33238585|NCT01474512|100775949|FG012|Induction Period|Adverse Event|0|||
33238586|NCT01474512|100775950|FG013|Induction Period|Adverse Event|0|||
33238587|NCT01474512|100775951|FG014|Induction Period|Adverse Event|0|||
33238588|NCT01474512|100775952|FG015|Induction Period|Adverse Event|0|||
33238589|NCT01474512|100775953|FG016|Induction Period|Adverse Event|0|||
33238590|NCT01474512|100775954|FG017|Induction Period|Adverse Event|0|||
33238591|NCT01474512|100775937|FG000|Induction Period|Lack of Efficacy|7|||
33238592|NCT01474512|100775938|FG001|Induction Period|Lack of Efficacy|1|||
33238593|NCT01474512|100775939|FG002|Induction Period|Lack of Efficacy|0|||
33238594|NCT01474512|100775940|FG003|Induction Period|Lack of Efficacy|0|||
33238595|NCT01474512|100775941|FG004|Induction Period|Lack of Efficacy|0|||
33238596|NCT01474512|100775942|FG005|Induction Period|Lack of Efficacy|0|||
33238597|NCT01474512|100775943|FG006|Induction Period|Lack of Efficacy|0|||
33238598|NCT01474512|100775944|FG007|Induction Period|Lack of Efficacy|0|||
33238599|NCT01474512|100775945|FG008|Induction Period|Lack of Efficacy|0|||
33238600|NCT01474512|100775946|FG009|Induction Period|Lack of Efficacy|0|||
33238601|NCT01474512|100775947|FG010|Induction Period|Lack of Efficacy|0|||
33238602|NCT01474512|100775948|FG011|Induction Period|Lack of Efficacy|0|||
33238603|NCT01474512|100775949|FG012|Induction Period|Lack of Efficacy|0|||
33238604|NCT01474512|100775950|FG013|Induction Period|Lack of Efficacy|0|||
33238605|NCT01474512|100775951|FG014|Induction Period|Lack of Efficacy|0|||
33238606|NCT01474512|100775952|FG015|Induction Period|Lack of Efficacy|0|||
33238607|NCT01474512|100775953|FG016|Induction Period|Lack of Efficacy|0|||
33238608|NCT01474512|100775954|FG017|Induction Period|Lack of Efficacy|0|||
33238609|NCT01474512|100775937|FG000|Induction Period|Withdrawal by Subject|6|||
33238610|NCT01474512|100775938|FG001|Induction Period|Withdrawal by Subject|6|||
33238611|NCT01474512|100775939|FG002|Induction Period|Withdrawal by Subject|5|||
33238612|NCT01474512|100775940|FG003|Induction Period|Withdrawal by Subject|0|||
33238613|NCT01474512|100775941|FG004|Induction Period|Withdrawal by Subject|0|||
33639447|NCT01054885|102232656|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
33639448|NCT01054885|102232657|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
33639449|NCT01054885|102232658|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
33639450|NCT01054885|102232659|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
33238614|NCT01474512|100775942|FG005|Induction Period|Withdrawal by Subject|0|||
33238615|NCT01474512|100775943|FG006|Induction Period|Withdrawal by Subject|0|||
33238616|NCT01474512|100775944|FG007|Induction Period|Withdrawal by Subject|0|||
33238617|NCT01474512|100775945|FG008|Induction Period|Withdrawal by Subject|0|||
33238618|NCT01474512|100775946|FG009|Induction Period|Withdrawal by Subject|0|||
33238619|NCT01474512|100775947|FG010|Induction Period|Withdrawal by Subject|0|||
33238620|NCT01474512|100775948|FG011|Induction Period|Withdrawal by Subject|0|||
33238621|NCT01474512|100775949|FG012|Induction Period|Withdrawal by Subject|0|||
33238622|NCT01474512|100775950|FG013|Induction Period|Withdrawal by Subject|0|||
33238623|NCT01474512|100775951|FG014|Induction Period|Withdrawal by Subject|0|||
33238624|NCT01474512|100775952|FG015|Induction Period|Withdrawal by Subject|0|||
33238625|NCT01474512|100775953|FG016|Induction Period|Withdrawal by Subject|0|||
33238626|NCT01474512|100775954|FG017|Induction Period|Withdrawal by Subject|0|||
33238627|NCT01474512|100775937|FG000|Induction Period|Protocol Violation|3|||
33238628|NCT01474512|100775938|FG001|Induction Period|Protocol Violation|6|||
33238629|NCT01474512|100775939|FG002|Induction Period|Protocol Violation|0|||
33238630|NCT01474512|100775940|FG003|Induction Period|Protocol Violation|0|||
33639451|NCT01054885|102232660|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
33238631|NCT01474512|100775941|FG004|Induction Period|Protocol Violation|0|||
33238632|NCT01474512|100775942|FG005|Induction Period|Protocol Violation|0|||
33238633|NCT01474512|100775943|FG006|Induction Period|Protocol Violation|0|||
33238634|NCT01474512|100775944|FG007|Induction Period|Protocol Violation|0|||
33238635|NCT01474512|100775945|FG008|Induction Period|Protocol Violation|0|||
33238636|NCT01474512|100775946|FG009|Induction Period|Protocol Violation|0|||
33238637|NCT01474512|100775947|FG010|Induction Period|Protocol Violation|0|||
33238638|NCT01474512|100775948|FG011|Induction Period|Protocol Violation|0|||
33238639|NCT01474512|100775949|FG012|Induction Period|Protocol Violation|0|||
33238640|NCT01474512|100775950|FG013|Induction Period|Protocol Violation|0|||
33238641|NCT01474512|100775951|FG014|Induction Period|Protocol Violation|0|||
33238642|NCT01474512|100775952|FG015|Induction Period|Protocol Violation|0|||
33238643|NCT01474512|100775953|FG016|Induction Period|Protocol Violation|0|||
33238644|NCT01474512|100775954|FG017|Induction Period|Protocol Violation|0|||
33238645|NCT01474512|100775937|FG000|Induction Period|Sponsor Decision|1|||
33238646|NCT01474512|100775938|FG001|Induction Period|Sponsor Decision|1|||
33370173|NCT00718419|101240035|FG001|Overall Study|Death Due to Progressive Disease|0|||
33370174|NCT00718419|101240034|FG000|Overall Study|Death Due to Study Drug Related|0|||
33370175|NCT00718419|101240035|FG001|Overall Study|Death Due to Study Drug Related|1|||
33370176|NCT00718419|101240034|FG000|Overall Study|Death Due to Adverse Events|1|||
33370177|NCT00718419|101240035|FG001|Overall Study|Death Due to Adverse Events|0|||
33370178|NCT04594239|101240039|FG000|Overall Study|Withdrawal by Subject|3|||
33370179|NCT04594239|101240040|FG001|Overall Study|Withdrawal by Subject|4|||
33370180|NCT04594239|101240041|FG002|Overall Study|Withdrawal by Subject|2|||
33579573|NCT02315703|102013112|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
33579574|NCT02315703|102013113|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
33579575|NCT02315703|102013114|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
33579576|NCT02315703|102013115|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
33579577|NCT02315703|102013108|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
33579578|NCT02315703|102013109|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
33579579|NCT02315703|102013110|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
33579580|NCT02315703|102013111|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
33579581|NCT02315703|102013112|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
33579582|NCT02315703|102013113|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
33579583|NCT02315703|102013114|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
33579584|NCT02315703|102013115|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
33579585|NCT02315703|102013108|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
33639452|NCT01054885|102232661|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
33639453|NCT01054885|102232655|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
33370181|NCT04594239|101240042|FG003|Overall Study|Withdrawal by Subject|4|||
33370182|NCT04594239|101240039|FG000|Overall Study|Lost to Follow-up|8|||
33370183|NCT04594239|101240040|FG001|Overall Study|Lost to Follow-up|5|||
33579586|NCT02315703|102013109|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
33639454|NCT01054885|102232656|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
33140645|NCT00534313|100428121|FG001|Long-term Period|Lost to Follow-up|2|||
33140646|NCT00534313|100428122|FG002|Long-term Period|Lost to Follow-up|0|||
33140647|NCT00534313|100428123|FG003|Long-term Period|Lost to Follow-up|0|||
33140648|NCT00534313|100428120|FG000|Long-term Period|Withdrawal by Subject|2|||
33140649|NCT00534313|100428121|FG001|Long-term Period|Withdrawal by Subject|2|||
33140650|NCT00534313|100428122|FG002|Long-term Period|Withdrawal by Subject|0|||
33140651|NCT00534313|100428123|FG003|Long-term Period|Withdrawal by Subject|0|||
33140652|NCT00534313|100428120|FG000|Long-term Period|No longer meets study criteria|0|||
33140653|NCT00534313|100428121|FG001|Long-term Period|No longer meets study criteria|1|||
33140654|NCT00534313|100428122|FG002|Long-term Period|No longer meets study criteria|0|||
33140655|NCT00534313|100428123|FG003|Long-term Period|No longer meets study criteria|0|||
33140656|NCT00534313|100428120|FG000|Long-term Period|Poor compliance/noncompliance|0|||
33140657|NCT00534313|100428121|FG001|Long-term Period|Poor compliance/noncompliance|1|||
33140658|NCT00534313|100428122|FG002|Long-term Period|Poor compliance/noncompliance|1|||
33140659|NCT00534313|100428123|FG003|Long-term Period|Poor compliance/noncompliance|0|||
33140660|NCT00534313|100428120|FG000|Long-term Period|Administrative reason by sponsor|17|||
33140661|NCT00534313|100428121|FG001|Long-term Period|Administrative reason by sponsor|15|||
33140662|NCT00534313|100428122|FG002|Long-term Period|Administrative reason by sponsor|26|||
33140663|NCT00534313|100428123|FG003|Long-term Period|Administrative reason by sponsor|18|||
33140664|NCT00534313|100428120|FG000|Long-term Period|Other|1|||
33140665|NCT00534313|100428121|FG001|Long-term Period|Other|2|||
33140666|NCT00534313|100428122|FG002|Long-term Period|Other|2|||
33140667|NCT00534313|100428123|FG003|Long-term Period|Other|2|||
33140668|NCT01215916|100428124|FG000|Overall Study|Progressive Disease|0|||
33140669|NCT01215916|100428125|FG001|Overall Study|Progressive Disease|2|||
33140670|NCT01215916|100428126|FG002|Overall Study|Progressive Disease|1|||
33140671|NCT01215916|100428127|FG003|Overall Study|Progressive Disease|2|||
33140672|NCT01215916|100428128|FG004|Overall Study|Progressive Disease|5|||
33140673|NCT01215916|100428129|FG005|Overall Study|Progressive Disease|4|||
33140674|NCT01215916|100428130|FG006|Overall Study|Progressive Disease|5|||
33140675|NCT01215916|100428131|FG007|Overall Study|Progressive Disease|3|||
33140676|NCT01215916|100428132|FG008|Overall Study|Progressive Disease|1|||
33140677|NCT01215916|100428124|FG000|Overall Study|Adverse Event|1|||
33140678|NCT01215916|100428125|FG001|Overall Study|Adverse Event|1|||
33140679|NCT01215916|100428126|FG002|Overall Study|Adverse Event|0|||
33140680|NCT01215916|100428127|FG003|Overall Study|Adverse Event|1|||
33238647|NCT01474512|100775939|FG002|Induction Period|Sponsor Decision|1|||
33238648|NCT01474512|100775940|FG003|Induction Period|Sponsor Decision|0|||
33238649|NCT01474512|100775941|FG004|Induction Period|Sponsor Decision|0|||
33238650|NCT01474512|100775942|FG005|Induction Period|Sponsor Decision|0|||
33238651|NCT01474512|100775943|FG006|Induction Period|Sponsor Decision|0|||
33238652|NCT01474512|100775944|FG007|Induction Period|Sponsor Decision|0|||
33238653|NCT01474512|100775945|FG008|Induction Period|Sponsor Decision|0|||
33238654|NCT01474512|100775946|FG009|Induction Period|Sponsor Decision|0|||
33238655|NCT01474512|100775947|FG010|Induction Period|Sponsor Decision|0|||
33238656|NCT01474512|100775948|FG011|Induction Period|Sponsor Decision|0|||
33238657|NCT01474512|100775949|FG012|Induction Period|Sponsor Decision|0|||
33238658|NCT01474512|100775950|FG013|Induction Period|Sponsor Decision|0|||
33238659|NCT01474512|100775951|FG014|Induction Period|Sponsor Decision|0|||
33238660|NCT01474512|100775952|FG015|Induction Period|Sponsor Decision|0|||
33238661|NCT01474512|100775953|FG016|Induction Period|Sponsor Decision|0|||
33238662|NCT01474512|100775954|FG017|Induction Period|Sponsor Decision|0|||
33238663|NCT01474512|100775937|FG000|Induction Period|Lost to Follow-up|1|||
33238664|NCT01474512|100775938|FG001|Induction Period|Lost to Follow-up|0|||
33238665|NCT01474512|100775939|FG002|Induction Period|Lost to Follow-up|2|||
33238666|NCT01474512|100775940|FG003|Induction Period|Lost to Follow-up|0|||
33238667|NCT01474512|100775941|FG004|Induction Period|Lost to Follow-up|0|||
33238668|NCT01474512|100775942|FG005|Induction Period|Lost to Follow-up|0|||
33238669|NCT01474512|100775943|FG006|Induction Period|Lost to Follow-up|0|||
33238670|NCT01474512|100775944|FG007|Induction Period|Lost to Follow-up|0|||
33238671|NCT01474512|100775945|FG008|Induction Period|Lost to Follow-up|0|||
33238672|NCT01474512|100775946|FG009|Induction Period|Lost to Follow-up|0|||
33238673|NCT01474512|100775947|FG010|Induction Period|Lost to Follow-up|0|||
33238674|NCT01474512|100775948|FG011|Induction Period|Lost to Follow-up|0|||
33238675|NCT01474512|100775949|FG012|Induction Period|Lost to Follow-up|0|||
33238676|NCT01474512|100775950|FG013|Induction Period|Lost to Follow-up|0|||
33238677|NCT01474512|100775951|FG014|Induction Period|Lost to Follow-up|0|||
33238678|NCT01474512|100775952|FG015|Induction Period|Lost to Follow-up|0|||
33238679|NCT01474512|100775953|FG016|Induction Period|Lost to Follow-up|0|||
33238680|NCT01474512|100775954|FG017|Induction Period|Lost to Follow-up|0|||
33238681|NCT01474512|100775937|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33238682|NCT01474512|100775938|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33238683|NCT01474512|100775939|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33238684|NCT01474512|100775940|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
33238685|NCT01474512|100775941|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
33238686|NCT01474512|100775942|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
33238687|NCT01474512|100775943|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
33238688|NCT01474512|100775944|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33238689|NCT01474512|100775945|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33238690|NCT01474512|100775946|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33238691|NCT01474512|100775947|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33238692|NCT01474512|100775948|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33238693|NCT01474512|100775949|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33238694|NCT01474512|100775950|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33579587|NCT02315703|102013110|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
33579588|NCT02315703|102013111|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
33579589|NCT02315703|102013112|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
33579590|NCT02315703|102013113|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
33579591|NCT02315703|102013114|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
33579592|NCT02315703|102013115|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
33579593|NCT02315703|102013108|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
33579594|NCT02315703|102013109|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
33579595|NCT02315703|102013110|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
33579596|NCT02315703|102013111|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
33579597|NCT02315703|102013112|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
33579598|NCT02315703|102013113|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
33579599|NCT02315703|102013114|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
33579600|NCT02315703|102013115|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
33579601|NCT02315703|102013108|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
33579602|NCT02315703|102013109|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
33579603|NCT02315703|102013110|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
33579604|NCT02315703|102013111|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
33579605|NCT02315703|102013112|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
33238695|NCT01474512|100775951|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33238696|NCT01474512|100775952|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33238697|NCT01474512|100775953|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33238698|NCT01474512|100775954|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
33140681|NCT01215916|100428128|FG004|Overall Study|Adverse Event|0|||
33238699|NCT01474512|100775937|FG000|Maintenance Period|Adverse Event|0|||
33579606|NCT02315703|102013113|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
33639455|NCT01054885|102232657|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
33639456|NCT01054885|102232658|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
33639457|NCT01054885|102232659|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
33639458|NCT01054885|102232660|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
33639459|NCT01054885|102232661|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
33639460|NCT03714672|102232664|FG000|Overall Study|Adverse Event|0|||
33639461|NCT03714672|102232665|FG001|Overall Study|Adverse Event|0|||
33639462|NCT03714672|102232666|FG002|Overall Study|Adverse Event|3|||
33639463|NCT03714672|102232667|FG003|Overall Study|Adverse Event|0|||
33639464|NCT03714672|102232664|FG000|Overall Study|Physician Decision|0|||
33639465|NCT03714672|102232665|FG001|Overall Study|Physician Decision|1|||
33639466|NCT03714672|102232666|FG002|Overall Study|Physician Decision|0|||
33639467|NCT03714672|102232667|FG003|Overall Study|Physician Decision|0|||
33639468|NCT03714672|102232664|FG000|Overall Study|Other Reason|1|||
33639469|NCT03714672|102232665|FG001|Overall Study|Other Reason|2|||
33639470|NCT03714672|102232666|FG002|Overall Study|Other Reason|1|||
33639471|NCT03714672|102232667|FG003|Overall Study|Other Reason|1|||
33639472|NCT03714672|102232664|FG000|Overall Study|Lost to Follow-up|1|||
33639473|NCT03714672|102232665|FG001|Overall Study|Lost to Follow-up|1|||
33639474|NCT03714672|102232666|FG002|Overall Study|Lost to Follow-up|0|||
33639475|NCT03714672|102232667|FG003|Overall Study|Lost to Follow-up|0|||
33639476|NCT02858362|102232676|FG000|Overall Study|Protocol Violation|0|||
33639477|NCT02858362|102232677|FG001|Overall Study|Protocol Violation|1|||
33639478|NCT02858362|102232678|FG002|Overall Study|Protocol Violation|0|||
33639479|NCT02858362|102232676|FG000|Overall Study|Withdrawal by Subject|1|||
33639480|NCT02858362|102232677|FG001|Overall Study|Withdrawal by Subject|0|||
33639481|NCT02858362|102232678|FG002|Overall Study|Withdrawal by Subject|0|||
33639482|NCT02858362|102232676|FG000|Overall Study|Early Study Termination|0|||
33639483|NCT02858362|102232677|FG001|Overall Study|Early Study Termination|0|||
33639484|NCT02858362|102232678|FG002|Overall Study|Early Study Termination|3|||
33639485|NCT02858362|102232676|FG000|Overall Study|Lost to Follow-up|1|||
33639486|NCT02858362|102232677|FG001|Overall Study|Lost to Follow-up|0|||
33140682|NCT01215916|100428129|FG005|Overall Study|Adverse Event|0|||
33140683|NCT01215916|100428130|FG006|Overall Study|Adverse Event|3|||
33370184|NCT04594239|101240041|FG002|Overall Study|Lost to Follow-up|4|||
33370185|NCT04594239|101240042|FG003|Overall Study|Lost to Follow-up|6|||
33639487|NCT02858362|102232678|FG002|Overall Study|Lost to Follow-up|0|||
33639488|NCT05375760|102232679|FG000|Overall Study|Adverse Event|1|||
33639489|NCT05375760|102232680|FG001|Overall Study|Adverse Event|0|||
33639490|NCT05375760|102232679|FG000|Overall Study|Death|0|||
33639491|NCT05375760|102232680|FG001|Overall Study|Death|1|||
33639492|NCT05375760|102232679|FG000|Overall Study|Lost to Follow-up|6|||
33639493|NCT05375760|102232680|FG001|Overall Study|Lost to Follow-up|6|||
33370186|NCT04594239|101240039|FG000|Overall Study|Subject relocated|0|||
33579607|NCT02315703|102013114|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
33579608|NCT02315703|102013115|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
33370187|NCT04594239|101240040|FG001|Overall Study|Subject relocated|0|||
33370188|NCT04594239|101240041|FG002|Overall Study|Subject relocated|0|||
33579609|NCT02315703|102013108|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
33579610|NCT02315703|102013109|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
33370189|NCT04594239|101240042|FG003|Overall Study|Subject relocated|1|||
33579611|NCT02315703|102013110|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
33579612|NCT02315703|102013111|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
33579613|NCT02315703|102013112|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
33579614|NCT02315703|102013113|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
33579615|NCT02315703|102013114|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
33579616|NCT02315703|102013115|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
33579617|NCT02315703|102013108|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
33579618|NCT02315703|102013109|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
33579619|NCT02315703|102013110|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
33579620|NCT02315703|102013111|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
33579621|NCT02315703|102013112|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
33579622|NCT02315703|102013113|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
33579623|NCT02315703|102013114|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
33639494|NCT05375760|102232679|FG000|Overall Study|Withdrawal by Subject|17|||
33639495|NCT05375760|102232680|FG001|Overall Study|Withdrawal by Subject|19|||
33639496|NCT05375760|102232679|FG000|Overall Study|Dosing halted by FDA|96|||
33639497|NCT05375760|102232680|FG001|Overall Study|Dosing halted by FDA|100|||
33639498|NCT05375760|102232679|FG000|Overall Study|Not compliant with study visit|2|||
33639499|NCT05375760|102232680|FG001|Overall Study|Not compliant with study visit|0|||
33140684|NCT01215916|100428131|FG007|Overall Study|Adverse Event|0|||
33370190|NCT01441440|101240043|FG000|Overall Study|Death|1|||
33639500|NCT05375760|102232679|FG000|Overall Study|Physician Decision|1|||
33639501|NCT05375760|102232680|FG001|Overall Study|Physician Decision|0|||
33579624|NCT02315703|102013115|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
33579625|NCT02175277|102013116|FG000|Overall Study|Protocol-specified Criteria|1|||
33140685|NCT01215916|100428132|FG008|Overall Study|Adverse Event|0|||
33579626|NCT01151020|102013121|FG000|Overall Study|Death|25|||
33140686|NCT01215916|100428124|FG000|Overall Study|Withdrawal by Subject|0|||
33140687|NCT01215916|100428125|FG001|Overall Study|Withdrawal by Subject|1|||
33140688|NCT01215916|100428126|FG002|Overall Study|Withdrawal by Subject|1|||
33140689|NCT01215916|100428127|FG003|Overall Study|Withdrawal by Subject|2|||
33140690|NCT01215916|100428128|FG004|Overall Study|Withdrawal by Subject|0|||
33140691|NCT01215916|100428129|FG005|Overall Study|Withdrawal by Subject|0|||
33140692|NCT01215916|100428130|FG006|Overall Study|Withdrawal by Subject|1|||
33140693|NCT01215916|100428131|FG007|Overall Study|Withdrawal by Subject|0|||
33579627|NCT01151020|102013121|FG000|Overall Study|Conversion to open repair|1|||
33579628|NCT01151020|102013121|FG000|Overall Study|Lost to Follow-up|4|||
33579629|NCT01151020|102013121|FG000|Overall Study|Withdrawal by Subject|22|||
33579630|NCT01151020|102013121|FG000|Overall Study|Patients did not receive the device|2|||
33579631|NCT02969915|102013123|FG000|Overall Study|Death|104|||
33579632|NCT02969915|102013124|FG001|Overall Study|Death|125|||
33579633|NCT02969915|102013123|FG000|Overall Study|Lost to Follow-up|108|||
33579634|NCT02969915|102013124|FG001|Overall Study|Lost to Follow-up|112|||
33579635|NCT02969915|102013123|FG000|Overall Study|Censored due to COVID-19|481|||
33579636|NCT02969915|102013124|FG001|Overall Study|Censored due to COVID-19|471|||
33579637|NCT02141672|102013125|FG000|Overall Study|Adverse Event|0|||
33579638|NCT02141672|102013126|FG001|Overall Study|Adverse Event|1|||
33579639|NCT02141672|102013127|FG002|Overall Study|Adverse Event|0|||
33579640|NCT02141672|102013125|FG000|Overall Study|Death|10|||
33579641|NCT02141672|102013126|FG001|Overall Study|Death|2|||
33579642|NCT02141672|102013127|FG002|Overall Study|Death|1|||
33579643|NCT02141672|102013125|FG000|Overall Study|Lack of Efficacy|0|||
33579644|NCT02141672|102013126|FG001|Overall Study|Lack of Efficacy|0|||
33579645|NCT02141672|102013127|FG002|Overall Study|Lack of Efficacy|2|||
33579646|NCT02141672|102013125|FG000|Overall Study|Lost to Follow-up|1|||
33579647|NCT02141672|102013126|FG001|Overall Study|Lost to Follow-up|1|||
33579648|NCT02141672|102013127|FG002|Overall Study|Lost to Follow-up|3|||
33579649|NCT02141672|102013125|FG000|Overall Study|Physician Decision|1|||
33579650|NCT02141672|102013126|FG001|Overall Study|Physician Decision|2|||
33579651|NCT02141672|102013127|FG002|Overall Study|Physician Decision|5|||
33579652|NCT02141672|102013125|FG000|Overall Study|Protocol Violation|0|||
33579653|NCT02141672|102013126|FG001|Overall Study|Protocol Violation|0|||
33579654|NCT02141672|102013127|FG002|Overall Study|Protocol Violation|1|||
33579655|NCT02141672|102013125|FG000|Overall Study|Withdrawal by Subject|3|||
33579656|NCT02141672|102013126|FG001|Overall Study|Withdrawal by Subject|2|||
33579657|NCT02141672|102013127|FG002|Overall Study|Withdrawal by Subject|5|||
33579658|NCT02141672|102013125|FG000|Overall Study|refused to follow-up|1|||
33579659|NCT02141672|102013126|FG001|Overall Study|refused to follow-up|0|||
33579660|NCT02141672|102013127|FG002|Overall Study|refused to follow-up|1|||
33579661|NCT02688192|102013128|FG000|Overall Study|Lost to Follow-up|11|||
33579662|NCT02688192|102013129|FG001|Overall Study|Lost to Follow-up|5|||
33579663|NCT02688192|102013128|FG000|Overall Study|Physician Decision|1|||
33579664|NCT02688192|102013129|FG001|Overall Study|Physician Decision|0|||
33579665|NCT00375674|102013130|FG000|Overall Study|Other|26|||
33579666|NCT00375674|102013131|FG001|Overall Study|Other|18|||
33579667|NCT00375674|102013130|FG000|Overall Study|Death|67|||
33579668|NCT00375674|102013131|FG001|Overall Study|Death|76|||
33579669|NCT00375674|102013130|FG000|Overall Study|Participants refused further follow-up|31|||
33579670|NCT00375674|102013131|FG001|Overall Study|Participants refused further follow-up|30|||
33579671|NCT00375674|102013130|FG000|Overall Study|Lost to Follow-up|17|||
33579672|NCT00375674|102013131|FG001|Overall Study|Lost to Follow-up|15|||
33140694|NCT01215916|100428132|FG008|Overall Study|Withdrawal by Subject|0|||
33140695|NCT01215916|100428124|FG000|Overall Study|Death|0|||
33140696|NCT01215916|100428125|FG001|Overall Study|Death|1|||
33238700|NCT01474512|100775938|FG001|Maintenance Period|Adverse Event|0|||
33238701|NCT01474512|100775939|FG002|Maintenance Period|Adverse Event|0|||
33238702|NCT01474512|100775940|FG003|Maintenance Period|Adverse Event|4|||
33420924|NCT00450177|101431651|FG001|Overall Study|Withdrawal by Subject|6|||
33140697|NCT01215916|100428126|FG002|Overall Study|Death|0|||
33140698|NCT01215916|100428127|FG003|Overall Study|Death|0|||
33140699|NCT01215916|100428128|FG004|Overall Study|Death|1|||
33420925|NCT00450177|101431650|FG000|Overall Study|Withdrawal by Primary Team|1|||
33579673|NCT00375674|102013130|FG000|Overall Study|Enrolled but not treated|3|||
33579674|NCT00375674|102013131|FG001|Overall Study|Enrolled but not treated|2|||
33579675|NCT01509846|102013134|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
33579676|NCT01509846|102013135|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
33579677|NCT01509846|102013136|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
33579678|NCT01509846|102013137|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
33579679|NCT01509846|102013138|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
33579680|NCT01509846|102013134|FG000|Received Vaccination 2|Illness|0|||
33579681|NCT01509846|102013135|FG001|Received Vaccination 2|Illness|0|||
33579682|NCT01509846|102013136|FG002|Received Vaccination 2|Illness|0|||
33579683|NCT01509846|102013137|FG003|Received Vaccination 2|Illness|0|||
33579684|NCT01509846|102013138|FG004|Received Vaccination 2|Illness|1|||
33639502|NCT05375760|102232679|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
33639503|NCT05375760|102232680|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
33639504|NCT05375760|102232679|FG000|Overall Study|Participant moved|1|||
33639505|NCT05375760|102232680|FG001|Overall Study|Participant moved|0|||
33639506|NCT03224819|102232681|FG000|Overall Study|Withdrawal by Subject|0|||
33639507|NCT03224819|102232682|FG001|Overall Study|Withdrawal by Subject|0|||
33639508|NCT03224819|102232683|FG002|Overall Study|Withdrawal by Subject|0|||
33639509|NCT03224819|102232684|FG003|Overall Study|Withdrawal by Subject|0|||
33639510|NCT03224819|102232685|FG004|Overall Study|Withdrawal by Subject|0|||
33639511|NCT03224819|102232686|FG005|Overall Study|Withdrawal by Subject|0|||
33639512|NCT03224819|102232687|FG006|Overall Study|Withdrawal by Subject|0|||
33639513|NCT03224819|102232688|FG007|Overall Study|Withdrawal by Subject|0|||
33639514|NCT03224819|102232689|FG008|Overall Study|Withdrawal by Subject|0|||
33639515|NCT03224819|102232690|FG009|Overall Study|Withdrawal by Subject|0|||
33639516|NCT03224819|102232691|FG010|Overall Study|Withdrawal by Subject|0|||
33639517|NCT03224819|102232692|FG011|Overall Study|Withdrawal by Subject|0|||
33639518|NCT03224819|102232693|FG012|Overall Study|Withdrawal by Subject|1|||
33639519|NCT03224819|102232694|FG013|Overall Study|Withdrawal by Subject|0|||
33639520|NCT03224819|102232681|FG000|Overall Study|Sponsor Decision|0|||
33639521|NCT03224819|102232682|FG001|Overall Study|Sponsor Decision|0|||
33140700|NCT01215916|100428129|FG005|Overall Study|Death|0|||
33238703|NCT01474512|100775941|FG004|Maintenance Period|Adverse Event|2|||
33238704|NCT01474512|100775942|FG005|Maintenance Period|Adverse Event|7|||
33238705|NCT01474512|100775943|FG006|Maintenance Period|Adverse Event|0|||
33370191|NCT01441440|101240044|FG001|Overall Study|Death|0|||
33370192|NCT01441440|101240045|FG002|Overall Study|Death|1|||
33579685|NCT01509846|102013134|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
33579686|NCT01509846|102013135|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
33579687|NCT01509846|102013136|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
33579688|NCT01509846|102013137|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
33579689|NCT01509846|102013138|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
33579690|NCT01509846|102013134|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
33579691|NCT01509846|102013135|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
33579692|NCT01509846|102013136|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
33579693|NCT01509846|102013137|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
33579694|NCT01509846|102013138|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
33579695|NCT01509846|102013134|FG000|Received Vaccination 3|Pregnancy|0|||
33579696|NCT01509846|102013135|FG001|Received Vaccination 3|Pregnancy|0|||
33579697|NCT01509846|102013136|FG002|Received Vaccination 3|Pregnancy|0|||
33579698|NCT01509846|102013137|FG003|Received Vaccination 3|Pregnancy|1|||
33579699|NCT01509846|102013138|FG004|Received Vaccination 3|Pregnancy|0|||
33579700|NCT01509846|102013134|FG000|Received Vaccination 3|Lost to Follow-up|0|||
33579701|NCT01509846|102013135|FG001|Received Vaccination 3|Lost to Follow-up|0|||
33579702|NCT01509846|102013136|FG002|Received Vaccination 3|Lost to Follow-up|1|||
33579703|NCT01509846|102013137|FG003|Received Vaccination 3|Lost to Follow-up|0|||
33579704|NCT01509846|102013138|FG004|Received Vaccination 3|Lost to Follow-up|0|||
33579705|NCT01737762|102013139|FG000|Overall Study|Adverse Event|2|||
33579706|NCT01737762|102013140|FG001|Overall Study|Adverse Event|2|||
33579707|NCT01737762|102013139|FG000|Overall Study|Lost to Follow-up|1|||
33579708|NCT01737762|102013140|FG001|Overall Study|Lost to Follow-up|0|||
33579709|NCT01737762|102013139|FG000|Overall Study|Withdrawal by Subject|2|||
33579710|NCT01737762|102013140|FG001|Overall Study|Withdrawal by Subject|2|||
33579711|NCT01737762|102013139|FG000|Overall Study|Progressive disease|1|||
33579712|NCT01737762|102013140|FG001|Overall Study|Progressive disease|2|||
33579713|NCT01737762|102013139|FG000|Overall Study|Physician Decision|1|||
33579714|NCT01737762|102013140|FG001|Overall Study|Physician Decision|1|||
33579715|NCT01737762|102013139|FG000|Overall Study|Moved from area|2|||
33579716|NCT01737762|102013140|FG001|Overall Study|Moved from area|1|||
33579717|NCT01737762|102013139|FG000|Overall Study|Trial termination|11|||
33579718|NCT01737762|102013140|FG001|Overall Study|Trial termination|9|||
33579719|NCT01027650|102013150|FG000|Overall Study|Personal Reasons|0|||
33639522|NCT03224819|102232683|FG002|Overall Study|Sponsor Decision|0|||
33639523|NCT03224819|102232684|FG003|Overall Study|Sponsor Decision|1|||
33639524|NCT03224819|102232685|FG004|Overall Study|Sponsor Decision|1|||
33639525|NCT03224819|102232686|FG005|Overall Study|Sponsor Decision|2|||
33140701|NCT01215916|100428130|FG006|Overall Study|Death|0|||
33140702|NCT01215916|100428131|FG007|Overall Study|Death|0|||
33140703|NCT01215916|100428132|FG008|Overall Study|Death|1|||
33579720|NCT01027650|102013151|FG001|Overall Study|Personal Reasons|0|||
33579721|NCT01027650|102013152|FG002|Overall Study|Personal Reasons|0|||
33579722|NCT01027650|102013153|FG003|Overall Study|Personal Reasons|0|||
33579723|NCT01027650|102013154|FG004|Overall Study|Personal Reasons|2|||
33579724|NCT01027650|102013155|FG005|Overall Study|Personal Reasons|1|||
33579725|NCT01027650|102013156|FG006|Overall Study|Personal Reasons|0|||
33140704|NCT01215916|100428124|FG000|Overall Study|Physician Decision|0|||
33140705|NCT01215916|100428125|FG001|Overall Study|Physician Decision|0|||
33579726|NCT01027650|102013157|FG007|Overall Study|Personal Reasons|0|||
33639526|NCT03224819|102232687|FG006|Overall Study|Sponsor Decision|1|||
33639527|NCT03224819|102232688|FG007|Overall Study|Sponsor Decision|1|||
33639528|NCT03224819|102232689|FG008|Overall Study|Sponsor Decision|1|||
33639529|NCT03224819|102232690|FG009|Overall Study|Sponsor Decision|2|||
33639530|NCT03224819|102232691|FG010|Overall Study|Sponsor Decision|1|||
33639531|NCT03224819|102232692|FG011|Overall Study|Sponsor Decision|1|||
33639532|NCT03224819|102232693|FG012|Overall Study|Sponsor Decision|1|||
33639533|NCT03224819|102232694|FG013|Overall Study|Sponsor Decision|0|||
33639534|NCT03224819|102232681|FG000|Overall Study|Lost to Follow-up|0|||
33639535|NCT03224819|102232682|FG001|Overall Study|Lost to Follow-up|0|||
33639536|NCT03224819|102232683|FG002|Overall Study|Lost to Follow-up|0|||
33639537|NCT03224819|102232684|FG003|Overall Study|Lost to Follow-up|0|||
33639538|NCT03224819|102232685|FG004|Overall Study|Lost to Follow-up|0|||
33639539|NCT03224819|102232686|FG005|Overall Study|Lost to Follow-up|0|||
33639540|NCT03224819|102232687|FG006|Overall Study|Lost to Follow-up|0|||
33639541|NCT03224819|102232688|FG007|Overall Study|Lost to Follow-up|0|||
33639542|NCT03224819|102232689|FG008|Overall Study|Lost to Follow-up|1|||
33639543|NCT03224819|102232690|FG009|Overall Study|Lost to Follow-up|0|||
33639544|NCT03224819|102232691|FG010|Overall Study|Lost to Follow-up|0|||
33639545|NCT03224819|102232692|FG011|Overall Study|Lost to Follow-up|0|||
33639546|NCT03224819|102232693|FG012|Overall Study|Lost to Follow-up|0|||
33639547|NCT03224819|102232694|FG013|Overall Study|Lost to Follow-up|0|||
33639548|NCT03224819|102232681|FG000|Overall Study|Death|0|||
33639549|NCT03224819|102232682|FG001|Overall Study|Death|1|||
33639550|NCT03224819|102232683|FG002|Overall Study|Death|0|||
33639551|NCT03224819|102232684|FG003|Overall Study|Death|0|||
33639552|NCT03224819|102232685|FG004|Overall Study|Death|0|||
33140706|NCT01215916|100428126|FG002|Overall Study|Physician Decision|1|||
33140707|NCT01215916|100428127|FG003|Overall Study|Physician Decision|1|||
33639553|NCT03224819|102232686|FG005|Overall Study|Death|0|||
33639554|NCT03224819|102232687|FG006|Overall Study|Death|0|||
33639555|NCT03224819|102232688|FG007|Overall Study|Death|1|||
33579727|NCT01027650|102013150|FG000|Overall Study|Lost to Follow-up|0|||
33579728|NCT01027650|102013151|FG001|Overall Study|Lost to Follow-up|0|||
33579729|NCT01027650|102013152|FG002|Overall Study|Lost to Follow-up|0|||
33579730|NCT01027650|102013153|FG003|Overall Study|Lost to Follow-up|0|||
33579731|NCT01027650|102013154|FG004|Overall Study|Lost to Follow-up|0|||
33579732|NCT01027650|102013155|FG005|Overall Study|Lost to Follow-up|0|||
33579733|NCT01027650|102013156|FG006|Overall Study|Lost to Follow-up|1|||
33579734|NCT01027650|102013157|FG007|Overall Study|Lost to Follow-up|0|||
33579735|NCT01027650|102013150|FG000|Overall Study|Lack of Efficacy|0|||
33579736|NCT01027650|102013151|FG001|Overall Study|Lack of Efficacy|0|||
33579737|NCT01027650|102013152|FG002|Overall Study|Lack of Efficacy|0|||
33639556|NCT03224819|102232689|FG008|Overall Study|Death|0|||
33639557|NCT03224819|102232690|FG009|Overall Study|Death|0|||
33639558|NCT03224819|102232691|FG010|Overall Study|Death|0|||
33639559|NCT03224819|102232692|FG011|Overall Study|Death|1|||
33639560|NCT03224819|102232693|FG012|Overall Study|Death|0|||
33639561|NCT03224819|102232694|FG013|Overall Study|Death|0|||
33639562|NCT00811018|102232695|FG000|Overall Study|Additional Chronic Treatment|31|||
33639563|NCT00811018|102232695|FG000|Overall Study|Adverse Event|79|||
33639564|NCT00811018|102232695|FG000|Overall Study|Death|147|||
33639565|NCT00811018|102232695|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
33639566|NCT00811018|102232695|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
33639567|NCT00811018|102232695|FG000|Overall Study|Investigator Decision|57|||
33639568|NCT00811018|102232695|FG000|Overall Study|Lost to Follow-up|19|||
33639569|NCT00811018|102232695|FG000|Overall Study|Pregnancy|6|||
33639570|NCT00811018|102232695|FG000|Overall Study|Sponsor Decision|450|||
33639571|NCT00811018|102232695|FG000|Overall Study|Withdrawal by Subject|70|||
33639572|NCT00811018|102232695|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
33639573|NCT00811018|102232695|FG000|Overall Study|Other|26|||
33370193|NCT01441440|101240043|FG000|Overall Study|Adverse Event|2|||
33238706|NCT01474512|100775944|FG007|Maintenance Period|Adverse Event|19|||
33639574|NCT01803607|102232696|FG000|Overall Study|Adverse Event|5|||
33639575|NCT01803607|102232697|FG001|Overall Study|Adverse Event|3|||
33238707|NCT01474512|100775945|FG008|Maintenance Period|Adverse Event|1|||
33370194|NCT01441440|101240044|FG001|Overall Study|Adverse Event|9|||
33579738|NCT01027650|102013153|FG003|Overall Study|Lack of Efficacy|0|||
33579739|NCT01027650|102013154|FG004|Overall Study|Lack of Efficacy|0|||
33579740|NCT01027650|102013155|FG005|Overall Study|Lack of Efficacy|1|||
33639576|NCT01803607|102232696|FG000|Overall Study|Lack of Efficacy|0|||
33579741|NCT01027650|102013156|FG006|Overall Study|Lack of Efficacy|0|||
33579742|NCT01027650|102013157|FG007|Overall Study|Lack of Efficacy|0|||
33639577|NCT01803607|102232697|FG001|Overall Study|Lack of Efficacy|1|||
33639578|NCT01803607|102232696|FG000|Overall Study|Protocol Violation|3|||
33639579|NCT01803607|102232697|FG001|Overall Study|Protocol Violation|2|||
33639580|NCT01803607|102232696|FG000|Overall Study|Study terminated by sponsor|54|||
33639581|NCT01803607|102232697|FG001|Overall Study|Study terminated by sponsor|56|||
33639582|NCT01803607|102232696|FG000|Overall Study|Withdrawal by Subject|6|||
33639583|NCT01803607|102232697|FG001|Overall Study|Withdrawal by Subject|5|||
33639584|NCT02367833|102232698|FG000|Overall Study|Withdrawal by Subject|1|||
33639585|NCT02367833|102232699|FG001|Overall Study|Withdrawal by Subject|1|||
33639586|NCT02367833|102232700|FG002|Overall Study|Withdrawal by Subject|0|||
33639587|NCT02892448|102232701|FG000|Overall Study|Screening failure|2|||
33639588|NCT02892448|102232702|FG001|Overall Study|Screening failure|2|||
33639589|NCT02892448|102232703|FG002|Overall Study|Screening failure|1|||
33140708|NCT01215916|100428128|FG004|Overall Study|Physician Decision|0|||
33140709|NCT01215916|100428129|FG005|Overall Study|Physician Decision|0|||
33140710|NCT01215916|100428130|FG006|Overall Study|Physician Decision|0|||
33140711|NCT01215916|100428131|FG007|Overall Study|Physician Decision|0|||
33140712|NCT01215916|100428132|FG008|Overall Study|Physician Decision|0|||
33140713|NCT04987944|100428133|FG000|Overall Study|Adverse Event|0|||
33140714|NCT04987944|100428134|FG001|Overall Study|Adverse Event|1|||
33140715|NCT04987944|100428133|FG000|Overall Study|Withdrawal by Subject|0|||
33140716|NCT04987944|100428134|FG001|Overall Study|Withdrawal by Subject|1|||
33140717|NCT05070546|100428135|FG000|Overall Study|Death|0|||
33140718|NCT05070546|100428136|FG001|Overall Study|Death|0|||
33140719|NCT05070546|100428137|FG002|Overall Study|Death|0|||
33140720|NCT05070546|100428138|FG003|Overall Study|Death|0|||
33140721|NCT05070546|100428139|FG004|Overall Study|Death|0|||
33140722|NCT05070546|100428140|FG005|Overall Study|Death|1|||
33140723|NCT05070546|100428135|FG000|Overall Study|Lost to Follow-up|8|||
33140724|NCT05070546|100428136|FG001|Overall Study|Lost to Follow-up|2|||
33140725|NCT05070546|100428137|FG002|Overall Study|Lost to Follow-up|7|||
33140726|NCT05070546|100428138|FG003|Overall Study|Lost to Follow-up|1|||
33140727|NCT05070546|100428139|FG004|Overall Study|Lost to Follow-up|2|||
33140728|NCT05070546|100428140|FG005|Overall Study|Lost to Follow-up|0|||
33140729|NCT05070546|100428135|FG000|Overall Study|Withdrawal by Subject|1|||
33140730|NCT05070546|100428136|FG001|Overall Study|Withdrawal by Subject|1|||
33140731|NCT05070546|100428137|FG002|Overall Study|Withdrawal by Subject|3|||
33140732|NCT05070546|100428138|FG003|Overall Study|Withdrawal by Subject|0|||
33140733|NCT05070546|100428139|FG004|Overall Study|Withdrawal by Subject|0|||
33140734|NCT05070546|100428140|FG005|Overall Study|Withdrawal by Subject|0|||
33140735|NCT05070546|100428135|FG000|Overall Study|Other|0|||
33140736|NCT05070546|100428136|FG001|Overall Study|Other|0|||
33140737|NCT05070546|100428137|FG002|Overall Study|Other|0|||
33140738|NCT05070546|100428138|FG003|Overall Study|Other|0|||
33140739|NCT05070546|100428139|FG004|Overall Study|Other|3|||
33140740|NCT05070546|100428140|FG005|Overall Study|Other|0|||
33140741|NCT05070546|100428135|FG000|Overall Study|Randomized but not vaccinated|1|||
33140742|NCT05070546|100428136|FG001|Overall Study|Randomized but not vaccinated|0|||
33140743|NCT05070546|100428137|FG002|Overall Study|Randomized but not vaccinated|1|||
33140744|NCT05070546|100428138|FG003|Overall Study|Randomized but not vaccinated|1|||
33140745|NCT05070546|100428139|FG004|Overall Study|Randomized but not vaccinated|3|||
33140746|NCT05070546|100428140|FG005|Overall Study|Randomized but not vaccinated|0|||
33140747|NCT03874429|100428141|FG000|Overall Study|Adverse Event|2|||
33238708|NCT01474512|100775946|FG009|Maintenance Period|Adverse Event|3|||
33238709|NCT01474512|100775947|FG010|Maintenance Period|Adverse Event|0|||
33238710|NCT01474512|100775948|FG011|Maintenance Period|Adverse Event|0|||
33238711|NCT01474512|100775949|FG012|Maintenance Period|Adverse Event|0|||
33238712|NCT01474512|100775950|FG013|Maintenance Period|Adverse Event|0|||
33238713|NCT01474512|100775951|FG014|Maintenance Period|Adverse Event|0|||
33238714|NCT01474512|100775952|FG015|Maintenance Period|Adverse Event|0|||
33238715|NCT01474512|100775953|FG016|Maintenance Period|Adverse Event|0|||
33238716|NCT01474512|100775954|FG017|Maintenance Period|Adverse Event|0|||
33238717|NCT01474512|100775937|FG000|Maintenance Period|Withdrawal by Subject|0|||
33238718|NCT01474512|100775938|FG001|Maintenance Period|Withdrawal by Subject|0|||
33238719|NCT01474512|100775939|FG002|Maintenance Period|Withdrawal by Subject|0|||
33639590|NCT02284243|102232704|FG000|Overall Study|Lack of Efficacy|3|||
33639591|NCT02284243|102232705|FG001|Overall Study|Lack of Efficacy|3|||
33238720|NCT01474512|100775940|FG003|Maintenance Period|Withdrawal by Subject|6|||
33238721|NCT01474512|100775941|FG004|Maintenance Period|Withdrawal by Subject|2|||
33238722|NCT01474512|100775942|FG005|Maintenance Period|Withdrawal by Subject|3|||
33238723|NCT01474512|100775943|FG006|Maintenance Period|Withdrawal by Subject|1|||
33238724|NCT01474512|100775944|FG007|Maintenance Period|Withdrawal by Subject|6|||
33238725|NCT01474512|100775945|FG008|Maintenance Period|Withdrawal by Subject|3|||
33370195|NCT01441440|101240045|FG002|Overall Study|Adverse Event|9|||
33639592|NCT02284243|102232704|FG000|Overall Study|Adverse Event|1|||
33639593|NCT02284243|102232705|FG001|Overall Study|Adverse Event|0|||
33238726|NCT01474512|100775946|FG009|Maintenance Period|Withdrawal by Subject|1|||
33639594|NCT04543279|102232706|FG000|Overall Study|Withdrawal by Subject|1|||
33140748|NCT03874429|100428142|FG001|Overall Study|Adverse Event|2|||
33140749|NCT03874429|100428141|FG000|Overall Study|Lack of Efficacy|0|||
33140750|NCT03874429|100428142|FG001|Overall Study|Lack of Efficacy|1|||
33140751|NCT03874429|100428141|FG000|Overall Study|Covid-19 pandemic|4|||
33140752|NCT03874429|100428142|FG001|Overall Study|Covid-19 pandemic|2|||
33140753|NCT01782469|100428151|FG000|Overall Study|Lost to Follow-up|1|||
33238727|NCT01474512|100775947|FG010|Maintenance Period|Withdrawal by Subject|0|||
33639595|NCT04543279|102232707|FG001|Overall Study|Withdrawal by Subject|0|||
33639596|NCT04543279|102232706|FG000|Overall Study|Adverse Event|1|||
33370196|NCT01441440|101240043|FG000|Overall Study|Lost to Follow-up|0|||
33639597|NCT04543279|102232707|FG001|Overall Study|Adverse Event|0|||
33238728|NCT01474512|100775948|FG011|Maintenance Period|Withdrawal by Subject|0|||
33238729|NCT01474512|100775949|FG012|Maintenance Period|Withdrawal by Subject|0|||
33238730|NCT01474512|100775950|FG013|Maintenance Period|Withdrawal by Subject|0|||
33639598|NCT04543279|102232706|FG000|Overall Study|Physician Decision|1|||
33639599|NCT04543279|102232707|FG001|Overall Study|Physician Decision|0|||
33639600|NCT01265537|102232708|FG000|Overall Study|Adverse Event|2|||
33639601|NCT01265537|102232709|FG001|Overall Study|Adverse Event|1|||
33639602|NCT01265537|102232708|FG000|Overall Study|Physician Decision|0|||
33639603|NCT01265537|102232709|FG001|Overall Study|Physician Decision|1|||
33639604|NCT01526733|102232710|FG000|Phase 1|Protocol Violation|1|||
33639605|NCT01526733|102232711|FG001|Phase 1|Protocol Violation|0|||
33639606|NCT01526733|102232710|FG000|Phase 1|Withdrawal by Subject|1|||
33639607|NCT01526733|102232711|FG001|Phase 1|Withdrawal by Subject|1|||
33639608|NCT01459497|102232713|FG000|Overall Study|Inability to meet trial constraints.|1|||
33639609|NCT01459497|102232714|FG001|Overall Study|Inability to meet trial constraints.|0|||
33639610|NCT01459497|102232713|FG000|Overall Study|Physician Decision|1|||
33370197|NCT01441440|101240044|FG001|Overall Study|Lost to Follow-up|2|||
33370198|NCT01441440|101240045|FG002|Overall Study|Lost to Follow-up|1|||
33370199|NCT01441440|101240043|FG000|Overall Study|Withdrawal by Subject|11|||
33370200|NCT01441440|101240044|FG001|Overall Study|Withdrawal by Subject|9|||
33370201|NCT01441440|101240045|FG002|Overall Study|Withdrawal by Subject|9|||
33370202|NCT01441440|101240043|FG000|Overall Study|Pregnancy|1|||
33370203|NCT01441440|101240044|FG001|Overall Study|Pregnancy|0|||
33370204|NCT01441440|101240045|FG002|Overall Study|Pregnancy|0|||
33370205|NCT01441440|101240043|FG000|Overall Study|Lack of Efficacy|1|||
33370206|NCT01441440|101240044|FG001|Overall Study|Lack of Efficacy|0|||
33370207|NCT01441440|101240045|FG002|Overall Study|Lack of Efficacy|1|||
33370208|NCT01441440|101240043|FG000|Overall Study|Moving|0|||
33370209|NCT01441440|101240044|FG001|Overall Study|Moving|1|||
33370210|NCT01441440|101240045|FG002|Overall Study|Moving|1|||
33370211|NCT01441440|101240043|FG000|Overall Study|Work-related matter|0|||
33370212|NCT01441440|101240044|FG001|Overall Study|Work-related matter|1|||
33370213|NCT01441440|101240045|FG002|Overall Study|Work-related matter|0|||
33370214|NCT01441440|101240043|FG000|Overall Study|Difficllty in keeping the schedule|1|||
33370215|NCT01441440|101240044|FG001|Overall Study|Difficllty in keeping the schedule|1|||
33370216|NCT01441440|101240045|FG002|Overall Study|Difficllty in keeping the schedule|0|||
33370217|NCT00830037|101240046|FG000|Overall Study|Withdrawal by Subject|2|||
33370218|NCT00830037|101240047|FG001|Overall Study|Withdrawal by Subject|3|||
33370219|NCT00830037|101240046|FG000|Overall Study|Lost to Follow-up|1|||
33370220|NCT00830037|101240047|FG001|Overall Study|Lost to Follow-up|2|||
33370221|NCT00830037|101240046|FG000|Overall Study|Active when terminated by DSMB|15|||
33370222|NCT00830037|101240047|FG001|Overall Study|Active when terminated by DSMB|14|||
33370223|NCT05058664|101240048|FG000|Overall Study|No follow-up data provided|4|||
33639611|NCT01459497|102232714|FG001|Overall Study|Physician Decision|1|||
33639612|NCT01459497|102232713|FG000|Overall Study|Hospitalization.|0|||
33639613|NCT01459497|102232714|FG001|Overall Study|Hospitalization.|3|||
33639614|NCT01459497|102232713|FG000|Overall Study|Disease progression.|0|||
33639615|NCT01459497|102232714|FG001|Overall Study|Disease progression.|1|||
33639616|NCT04032093|102232715|FG000|Overall Study|Lost to Follow-up|7|||
33639617|NCT04032093|102232716|FG001|Overall Study|Lost to Follow-up|7|||
33639618|NCT04032093|102232717|FG002|Overall Study|Lost to Follow-up|6|||
33639619|NCT04032093|102232718|FG003|Overall Study|Lost to Follow-up|10|||
33238731|NCT01474512|100775951|FG014|Maintenance Period|Withdrawal by Subject|0|||
33238732|NCT01474512|100775952|FG015|Maintenance Period|Withdrawal by Subject|0|||
33238733|NCT01474512|100775953|FG016|Maintenance Period|Withdrawal by Subject|0|||
33238734|NCT01474512|100775954|FG017|Maintenance Period|Withdrawal by Subject|0|||
33238735|NCT01474512|100775937|FG000|Maintenance Period|Lost to Follow-up|0|||
33238736|NCT01474512|100775938|FG001|Maintenance Period|Lost to Follow-up|0|||
33238737|NCT01474512|100775939|FG002|Maintenance Period|Lost to Follow-up|0|||
33238738|NCT01474512|100775940|FG003|Maintenance Period|Lost to Follow-up|3|||
33238739|NCT01474512|100775941|FG004|Maintenance Period|Lost to Follow-up|3|||
33238740|NCT01474512|100775942|FG005|Maintenance Period|Lost to Follow-up|0|||
33238741|NCT01474512|100775943|FG006|Maintenance Period|Lost to Follow-up|0|||
33370224|NCT05058664|101240049|FG001|Overall Study|No follow-up data provided|0|||
33370225|NCT05058664|101240050|FG002|Overall Study|No follow-up data provided|2|||
33370226|NCT05058664|101240048|FG000|Overall Study|Withdrawal by Subject|0|||
33370227|NCT05058664|101240049|FG001|Overall Study|Withdrawal by Subject|0|||
33370228|NCT05058664|101240050|FG002|Overall Study|Withdrawal by Subject|1|||
33370229|NCT05118386|101240053|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
33639620|NCT04032093|102232719|FG004|Overall Study|Lost to Follow-up|13|||
33639621|NCT04032093|102232720|FG005|Overall Study|Lost to Follow-up|7|||
33639622|NCT04032093|102232721|FG006|Overall Study|Lost to Follow-up|7|||
33639623|NCT04032093|102232722|FG007|Overall Study|Lost to Follow-up|5|||
33639624|NCT04032093|102232723|FG008|Overall Study|Lost to Follow-up|9|||
33639625|NCT04032093|102232724|FG009|Overall Study|Lost to Follow-up|12|||
33639626|NCT04032093|102232715|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33140754|NCT02937584|100428156|FG000|Period 1|Adverse Event|1|||
33140755|NCT02937584|100428157|FG001|Period 1|Adverse Event|2|||
33140756|NCT02937584|100428156|FG000|Washout|Adverse Event|0|||
33140757|NCT02937584|100428157|FG001|Washout|Adverse Event|1|||
33140758|NCT00592774|100428161|FG000|Overall Study|Adverse Event|5|||
33140759|NCT00592774|100428162|FG001|Overall Study|Adverse Event|19|||
33140760|NCT00592774|100428163|FG002|Overall Study|Adverse Event|2|||
33140761|NCT00592774|100428164|FG003|Overall Study|Adverse Event|14|||
33140762|NCT00592774|100428165|FG004|Overall Study|Adverse Event|8|||
33140763|NCT00592774|100428161|FG000|Overall Study|Protocol Violation|0|||
33140764|NCT00592774|100428162|FG001|Overall Study|Protocol Violation|1|||
33140765|NCT00592774|100428163|FG002|Overall Study|Protocol Violation|0|||
33140766|NCT00592774|100428164|FG003|Overall Study|Protocol Violation|0|||
33140767|NCT00592774|100428165|FG004|Overall Study|Protocol Violation|1|||
33140768|NCT00592774|100428161|FG000|Overall Study|Withdrawal by Subject|3|||
33140769|NCT00592774|100428162|FG001|Overall Study|Withdrawal by Subject|7|||
33140770|NCT00592774|100428163|FG002|Overall Study|Withdrawal by Subject|0|||
33140771|NCT00592774|100428164|FG003|Overall Study|Withdrawal by Subject|0|||
33140772|NCT00592774|100428165|FG004|Overall Study|Withdrawal by Subject|0|||
33140773|NCT00592774|100428161|FG000|Overall Study|Lack of Efficacy|3|||
33140774|NCT00592774|100428162|FG001|Overall Study|Lack of Efficacy|3|||
33140775|NCT00592774|100428163|FG002|Overall Study|Lack of Efficacy|0|||
33140776|NCT00592774|100428164|FG003|Overall Study|Lack of Efficacy|0|||
33140777|NCT00592774|100428165|FG004|Overall Study|Lack of Efficacy|2|||
33140778|NCT00592774|100428161|FG000|Overall Study|Physician Decision|0|||
33140779|NCT00592774|100428162|FG001|Overall Study|Physician Decision|1|||
33140780|NCT00592774|100428163|FG002|Overall Study|Physician Decision|1|||
33140781|NCT00592774|100428164|FG003|Overall Study|Physician Decision|0|||
33140782|NCT00592774|100428165|FG004|Overall Study|Physician Decision|1|||
33140783|NCT00592774|100428161|FG000|Overall Study|Other|0|||
33140784|NCT00592774|100428162|FG001|Overall Study|Other|1|||
33140785|NCT00592774|100428163|FG002|Overall Study|Other|1|||
33140786|NCT00592774|100428164|FG003|Overall Study|Other|0|||
33140787|NCT00592774|100428165|FG004|Overall Study|Other|2|||
33140788|NCT00852371|100428169|FG000|Overall Study|Lost to Follow-up|2|||
33140789|NCT00852371|100428170|FG001|Overall Study|Lost to Follow-up|3|||
33140790|NCT00852371|100428171|FG002|Overall Study|Lost to Follow-up|4|||
33140791|NCT00852371|100428172|FG003|Overall Study|Lost to Follow-up|2|||
33140792|NCT01006603|100428175|FG000|Overall Study|Withdrawal by Subject|17|||
33140793|NCT01006603|100428176|FG001|Overall Study|Withdrawal by Subject|19|||
33140794|NCT01006603|100428175|FG000|Overall Study|Lost to Follow-up|0|||
33140795|NCT01006603|100428176|FG001|Overall Study|Lost to Follow-up|1|||
33140796|NCT01006603|100428175|FG000|Overall Study|Safety reason|1|||
33140797|NCT01006603|100428176|FG001|Overall Study|Safety reason|1|||
33140798|NCT01006603|100428175|FG000|Overall Study|Protocol Violation|1|||
33140799|NCT01006603|100428176|FG001|Overall Study|Protocol Violation|3|||
33140800|NCT01006603|100428175|FG000|Overall Study|Incorrect enrolment|0|||
33140801|NCT01006603|100428176|FG001|Overall Study|Incorrect enrolment|2|||
33140802|NCT01006603|100428175|FG000|Overall Study|Adverse Event|15|||
33140803|NCT01006603|100428176|FG001|Overall Study|Adverse Event|7|||
33140804|NCT01006603|100428175|FG000|Overall Study|Death|1|||
33140805|NCT01006603|100428176|FG001|Overall Study|Death|1|||
33140806|NCT01006603|100428175|FG000|Overall Study|Study specific discontinuation criteria|33|||
33140807|NCT01006603|100428176|FG001|Overall Study|Study specific discontinuation criteria|34|||
33140808|NCT01006603|100428175|FG000|Overall Study|Other|3|||
33140809|NCT01006603|100428176|FG001|Overall Study|Other|7|||
33140810|NCT04738318|100428177|FG000|Overall Study|Protocol Violation|1|||
33140811|NCT04738318|100428178|FG001|Overall Study|Protocol Violation|0|||
33140812|NCT04839562|100428179|FG000|Overall Study|Withdrawal by Subject|0|||
33140813|NCT04839562|100428180|FG001|Overall Study|Withdrawal by Subject|1|||
33140814|NCT04839562|100428179|FG000|Overall Study|Physician Decision|0|||
33370230|NCT05118386|101240054|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
33370231|NCT05118386|101240055|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
33370232|NCT05118386|101240056|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
33370233|NCT05118386|101240057|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
33140815|NCT04839562|100428180|FG001|Overall Study|Physician Decision|1|||
33140816|NCT00053898|100428181|FG000|Overall Study|No follow-up data from any source|9|||
33140817|NCT00053898|100428182|FG001|Overall Study|No follow-up data from any source|12|||
33140818|NCT00053898|100428181|FG000|Overall Study|Follow-up from telephone contact only|5|||
33140819|NCT00053898|100428182|FG001|Overall Study|Follow-up from telephone contact only|1|||
33140820|NCT00890045|100431462|FG000|Overall Study|Death|0|||
33140821|NCT00890045|100431463|FG001|Overall Study|Death|1|||
33140822|NCT00890045|100431462|FG000|Overall Study|Did not receive HeRO Graft|0|||
33140823|NCT00890045|100431463|FG001|Overall Study|Did not receive HeRO Graft|2|||
33140824|NCT00890045|100431462|FG000|Overall Study|Lost to Follow-up|5|||
33140825|NCT00890045|100431463|FG001|Overall Study|Lost to Follow-up|7|||
33140826|NCT02048241|100431464|FG000|Overall Study|Withdrawal by Subject|0|||
33140827|NCT02048241|100431465|FG001|Overall Study|Withdrawal by Subject|1|||
33140828|NCT01120067|100431466|FG000|Overall Study|Lost to Follow-up|3|||
33140829|NCT01120067|100431467|FG001|Overall Study|Lost to Follow-up|1|||
33140830|NCT01120067|100431466|FG000|Overall Study|fail to engage >3 sessions|2|||
33140831|NCT01120067|100431467|FG001|Overall Study|fail to engage >3 sessions|0|||
33140832|NCT00727532|100431468|FG000|Overall Study|Adverse Event|1|||
33140833|NCT00727532|100431468|FG000|Overall Study|Withdrawal by Subject|1|||
33140834|NCT01001299|100431469|FG000|Overall Study|Insufficient Therapeutic Response|20|||
33140835|NCT01001299|100431469|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
33140836|NCT01001299|100431469|FG000|Overall Study|Death|1|||
33140837|NCT01001299|100431469|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
33140838|NCT01001299|100431469|FG000|Overall Study|Withdrew Consent|1|||
33140839|NCT01993836|100431470|FG000|Overall Study|Surgery Cancelled|3|||
33140840|NCT01993836|100431471|FG001|Overall Study|Surgery Cancelled|0|||
33140841|NCT01993836|100431472|FG002|Overall Study|Surgery Cancelled|0|||
33140842|NCT01993836|100431470|FG000|Overall Study|Physician Decision|2|||
33140843|NCT01993836|100431471|FG001|Overall Study|Physician Decision|1|||
33140844|NCT01993836|100431472|FG002|Overall Study|Physician Decision|0|||
33140845|NCT01993836|100431470|FG000|Overall Study|Death|0|||
33140846|NCT01993836|100431471|FG001|Overall Study|Death|2|||
33140847|NCT01993836|100431472|FG002|Overall Study|Death|0|||
33140848|NCT01993836|100431470|FG000|Overall Study|Withdrawal by Subject|12|||
33140849|NCT01993836|100431471|FG001|Overall Study|Withdrawal by Subject|10|||
33140850|NCT01993836|100431472|FG002|Overall Study|Withdrawal by Subject|5|||
33140851|NCT03774823|100431473|FG000|Overall Study|Withdrawal by Subject|1|||
33140852|NCT03774823|100431474|FG001|Overall Study|Withdrawal by Subject|1|||
33140853|NCT00159822|100431475|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
33140854|NCT00159822|100431475|FG000|Voriconazole Treatment Period|Adverse Event|9|||
33140855|NCT00159822|100431475|FG000|Voriconazole Treatment Period|Death|4|||
33140856|NCT00159822|100431475|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
33140857|NCT00159822|100431475|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
33140858|NCT00159822|100431475|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
33140859|NCT00159822|100431475|FG000|Post-treatment Follow-up Period|Death|1|||
33238742|NCT01474512|100775944|FG007|Maintenance Period|Lost to Follow-up|2|||
33238743|NCT01474512|100775945|FG008|Maintenance Period|Lost to Follow-up|1|||
33238744|NCT01474512|100775946|FG009|Maintenance Period|Lost to Follow-up|1|||
33238745|NCT01474512|100775947|FG010|Maintenance Period|Lost to Follow-up|0|||
33238746|NCT01474512|100775948|FG011|Maintenance Period|Lost to Follow-up|0|||
33238747|NCT01474512|100775949|FG012|Maintenance Period|Lost to Follow-up|0|||
33238748|NCT01474512|100775950|FG013|Maintenance Period|Lost to Follow-up|0|||
33238749|NCT01474512|100775951|FG014|Maintenance Period|Lost to Follow-up|0|||
33238750|NCT01474512|100775952|FG015|Maintenance Period|Lost to Follow-up|0|||
33370234|NCT05118386|101240058|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
33579743|NCT01106157|102013160|FG000|Overall Study|Withdrawal by Subject|1|||
33579744|NCT01106157|102013161|FG001|Overall Study|Withdrawal by Subject|0|||
33579745|NCT01724216|102013162|FG000|Overall Study|Scan was not completed|1|||
33579746|NCT00443703|102013163|FG000|Overall Study|Never Treated|3|||
33579747|NCT00443703|102013164|FG001|Overall Study|Never Treated|1|||
33579748|NCT00443703|102013163|FG000|Overall Study|Adverse Event|7|||
33579749|NCT00443703|102013164|FG001|Overall Study|Adverse Event|3|||
33579750|NCT00443703|102013163|FG000|Overall Study|Lack of Efficacy|3|||
33579751|NCT00443703|102013164|FG001|Overall Study|Lack of Efficacy|1|||
33579752|NCT00443703|102013163|FG000|Overall Study|Lost to Follow-up|0|||
33579753|NCT00443703|102013164|FG001|Overall Study|Lost to Follow-up|4|||
33579754|NCT00443703|102013163|FG000|Overall Study|Physician Decision|4|||
33579755|NCT00443703|102013164|FG001|Overall Study|Physician Decision|2|||
33639627|NCT04032093|102232716|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33639628|NCT04032093|102232717|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
33639629|NCT04032093|102232718|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
33639630|NCT04032093|102232719|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
33639631|NCT04032093|102232720|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
33639632|NCT04032093|102232721|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
33639633|NCT04032093|102232722|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
33639634|NCT04032093|102232723|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
33639635|NCT04032093|102232724|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
33579756|NCT00443703|102013163|FG000|Overall Study|Protocol Violation|1|||
33579757|NCT00443703|102013164|FG001|Overall Study|Protocol Violation|1|||
33579758|NCT00443703|102013163|FG000|Overall Study|Withdrawal by Subject|9|||
33579759|NCT00443703|102013164|FG001|Overall Study|Withdrawal by Subject|6|||
33140860|NCT00159822|100431475|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
33238751|NCT01474512|100775953|FG016|Maintenance Period|Lost to Follow-up|0|||
33238752|NCT01474512|100775954|FG017|Maintenance Period|Lost to Follow-up|0|||
33579760|NCT00443703|102013163|FG000|Overall Study|Progressive Disease|1|||
33579761|NCT00443703|102013164|FG001|Overall Study|Progressive Disease|0|||
33238753|NCT01474512|100775937|FG000|Maintenance Period|Death|0|||
33579762|NCT03519997|102013166|FG000|Overall Study|Adverse Event|4|||
33639636|NCT04032093|102232715|FG000|Overall Study|Other|1|||
33639637|NCT04032093|102232716|FG001|Overall Study|Other|0|||
33639638|NCT04032093|102232717|FG002|Overall Study|Other|0|||
33639639|NCT04032093|102232718|FG003|Overall Study|Other|1|||
33639640|NCT04032093|102232719|FG004|Overall Study|Other|1|||
33639641|NCT04032093|102232720|FG005|Overall Study|Other|0|||
33639642|NCT04032093|102232721|FG006|Overall Study|Other|0|||
33639643|NCT04032093|102232722|FG007|Overall Study|Other|0|||
33639644|NCT04032093|102232723|FG008|Overall Study|Other|0|||
33639645|NCT04032093|102232724|FG009|Overall Study|Other|1|||
33639646|NCT04032093|102232715|FG000|Overall Study|Withdrawal by Subject|1|||
33639647|NCT04032093|102232716|FG001|Overall Study|Withdrawal by Subject|3|||
33639648|NCT04032093|102232717|FG002|Overall Study|Withdrawal by Subject|2|||
33579763|NCT03519997|102013166|FG000|Overall Study|Withdrawal by Subject|2|||
33579764|NCT03519997|102013166|FG000|Overall Study|Protocol Violation|1|||
33639649|NCT04032093|102232718|FG003|Overall Study|Withdrawal by Subject|2|||
33140861|NCT00159822|100431475|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
33579765|NCT02967679|102013167|FG000|Overall Study|Adverse Event|1|||
33639650|NCT04032093|102232719|FG004|Overall Study|Withdrawal by Subject|3|||
33639651|NCT04032093|102232720|FG005|Overall Study|Withdrawal by Subject|0|||
33639652|NCT04032093|102232721|FG006|Overall Study|Withdrawal by Subject|0|||
33639653|NCT04032093|102232722|FG007|Overall Study|Withdrawal by Subject|0|||
33639654|NCT04032093|102232723|FG008|Overall Study|Withdrawal by Subject|0|||
33639655|NCT04032093|102232724|FG009|Overall Study|Withdrawal by Subject|0|||
33639656|NCT04032093|102232715|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33639657|NCT04032093|102232716|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33639658|NCT04032093|102232717|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
33639659|NCT04032093|102232718|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
33639660|NCT04032093|102232719|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
33639661|NCT04032093|102232720|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
33639662|NCT04032093|102232721|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
33639663|NCT04032093|102232722|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
33639664|NCT04032093|102232723|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
33639665|NCT04032093|102232724|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
33639666|NCT04032093|102232715|FG000|Overall Study|Adverse Event|0|||
33639667|NCT04032093|102232716|FG001|Overall Study|Adverse Event|0|||
33639668|NCT04032093|102232717|FG002|Overall Study|Adverse Event|0|||
33639669|NCT04032093|102232718|FG003|Overall Study|Adverse Event|0|||
33140862|NCT00686634|100431476|FG000|Overall Study|Protocol Violation|6|||
33140863|NCT02108262|100431477|FG000|Overall Study|Non-compliance|0|||
33579766|NCT03599518|102013168|FG000|Overall Study|Clinical progression|0|||
33579767|NCT03599518|102013169|FG001|Overall Study|Clinical progression|0|||
33579768|NCT03599518|102013170|FG002|Overall Study|Clinical progression|0|||
33579769|NCT03599518|102013171|FG003|Overall Study|Clinical progression|0|||
33579770|NCT03599518|102013172|FG004|Overall Study|Clinical progression|1|||
33370235|NCT05118386|101240053|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
33370236|NCT05118386|101240054|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
33579771|NCT03599518|102013168|FG000|Overall Study|Adverse Event|0|||
33639670|NCT04032093|102232719|FG004|Overall Study|Adverse Event|0|||
33370237|NCT05118386|101240055|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
33370238|NCT05118386|101240056|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
33370239|NCT05118386|101240057|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
33370240|NCT05118386|101240058|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
33370241|NCT03375112|101240059|FG000|Overall Study|Withdrawal by Subject|3|||
33370242|NCT03375112|101240060|FG001|Overall Study|Withdrawal by Subject|0|||
33370243|NCT01597557|101240061|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
33370244|NCT01597557|101240062|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
33370245|NCT01703286|101240063|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
33370246|NCT01703286|101240064|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
33370247|NCT01703286|101240065|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
33370248|NCT01703286|101240066|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
33140864|NCT02108262|100431478|FG001|Overall Study|Non-compliance|2|||
33140865|NCT02108262|100431479|FG002|Overall Study|Non-compliance|1|||
33140866|NCT02108262|100431480|FG003|Overall Study|Non-compliance|1|||
33140867|NCT02108262|100431477|FG000|Overall Study|Randomized by error/screen failure|0|||
33370249|NCT01703286|101240067|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
33639671|NCT04032093|102232720|FG005|Overall Study|Adverse Event|0|||
33639672|NCT04032093|102232721|FG006|Overall Study|Adverse Event|0|||
33639673|NCT04032093|102232722|FG007|Overall Study|Adverse Event|0|||
33639674|NCT04032093|102232723|FG008|Overall Study|Adverse Event|0|||
33639675|NCT04032093|102232724|FG009|Overall Study|Adverse Event|1|||
33639676|NCT04032093|102232715|FG000|Overall Study|Physician Decision|0|||
33639677|NCT04032093|102232716|FG001|Overall Study|Physician Decision|0|||
33639678|NCT04032093|102232717|FG002|Overall Study|Physician Decision|0|||
33639679|NCT04032093|102232718|FG003|Overall Study|Physician Decision|0|||
33238754|NCT01474512|100775938|FG001|Maintenance Period|Death|0|||
33238755|NCT01474512|100775939|FG002|Maintenance Period|Death|0|||
33238756|NCT01474512|100775940|FG003|Maintenance Period|Death|0|||
33238757|NCT01474512|100775941|FG004|Maintenance Period|Death|0|||
33238758|NCT01474512|100775942|FG005|Maintenance Period|Death|2|||
33238759|NCT01474512|100775943|FG006|Maintenance Period|Death|0|||
33238760|NCT01474512|100775944|FG007|Maintenance Period|Death|0|||
33238761|NCT01474512|100775945|FG008|Maintenance Period|Death|0|||
33238762|NCT01474512|100775946|FG009|Maintenance Period|Death|0|||
33238763|NCT01474512|100775947|FG010|Maintenance Period|Death|0|||
33238764|NCT01474512|100775948|FG011|Maintenance Period|Death|0|||
33238765|NCT01474512|100775949|FG012|Maintenance Period|Death|0|||
33238766|NCT01474512|100775950|FG013|Maintenance Period|Death|0|||
33238767|NCT01474512|100775951|FG014|Maintenance Period|Death|0|||
33238768|NCT01474512|100775952|FG015|Maintenance Period|Death|0|||
33238769|NCT01474512|100775953|FG016|Maintenance Period|Death|0|||
33238770|NCT01474512|100775954|FG017|Maintenance Period|Death|0|||
33238771|NCT01474512|100775937|FG000|Maintenance Period|Physician Decision|0|||
33238772|NCT01474512|100775938|FG001|Maintenance Period|Physician Decision|0|||
33579772|NCT03599518|102013169|FG001|Overall Study|Adverse Event|0|||
33579773|NCT03599518|102013170|FG002|Overall Study|Adverse Event|0|||
33238773|NCT01474512|100775939|FG002|Maintenance Period|Physician Decision|0|||
33238774|NCT01474512|100775940|FG003|Maintenance Period|Physician Decision|0|||
33238775|NCT01474512|100775941|FG004|Maintenance Period|Physician Decision|0|||
33238776|NCT01474512|100775942|FG005|Maintenance Period|Physician Decision|1|||
33238777|NCT01474512|100775943|FG006|Maintenance Period|Physician Decision|0|||
33238778|NCT01474512|100775944|FG007|Maintenance Period|Physician Decision|2|||
33238779|NCT01474512|100775945|FG008|Maintenance Period|Physician Decision|0|||
33238780|NCT01474512|100775946|FG009|Maintenance Period|Physician Decision|0|||
33238781|NCT01474512|100775947|FG010|Maintenance Period|Physician Decision|0|||
33238782|NCT01474512|100775948|FG011|Maintenance Period|Physician Decision|0|||
33238783|NCT01474512|100775949|FG012|Maintenance Period|Physician Decision|0|||
33238784|NCT01474512|100775950|FG013|Maintenance Period|Physician Decision|0|||
33238785|NCT01474512|100775951|FG014|Maintenance Period|Physician Decision|0|||
33238786|NCT01474512|100775952|FG015|Maintenance Period|Physician Decision|0|||
33238787|NCT01474512|100775953|FG016|Maintenance Period|Physician Decision|0|||
33238788|NCT01474512|100775954|FG017|Maintenance Period|Physician Decision|0|||
33238789|NCT01474512|100775937|FG000|Maintenance Period|Clinical Relapse|0|||
33238790|NCT01474512|100775938|FG001|Maintenance Period|Clinical Relapse|0|||
33238791|NCT01474512|100775939|FG002|Maintenance Period|Clinical Relapse|0|||
33238792|NCT01474512|100775940|FG003|Maintenance Period|Clinical Relapse|1|||
33238793|NCT01474512|100775941|FG004|Maintenance Period|Clinical Relapse|0|||
33238794|NCT01474512|100775942|FG005|Maintenance Period|Clinical Relapse|0|||
33238795|NCT01474512|100775943|FG006|Maintenance Period|Clinical Relapse|0|||
33238796|NCT01474512|100775944|FG007|Maintenance Period|Clinical Relapse|0|||
33238797|NCT01474512|100775945|FG008|Maintenance Period|Clinical Relapse|0|||
33238798|NCT01474512|100775946|FG009|Maintenance Period|Clinical Relapse|0|||
33238799|NCT01474512|100775947|FG010|Maintenance Period|Clinical Relapse|0|||
33238800|NCT01474512|100775948|FG011|Maintenance Period|Clinical Relapse|0|||
33238801|NCT01474512|100775949|FG012|Maintenance Period|Clinical Relapse|0|||
33238802|NCT01474512|100775950|FG013|Maintenance Period|Clinical Relapse|0|||
33238803|NCT01474512|100775951|FG014|Maintenance Period|Clinical Relapse|0|||
33238804|NCT01474512|100775952|FG015|Maintenance Period|Clinical Relapse|0|||
33238805|NCT01474512|100775953|FG016|Maintenance Period|Clinical Relapse|0|||
33238806|NCT01474512|100775954|FG017|Maintenance Period|Clinical Relapse|0|||
33238807|NCT01474512|100775937|FG000|Maintenance Period|Lack of Efficacy|0|||
33238808|NCT01474512|100775938|FG001|Maintenance Period|Lack of Efficacy|0|||
33238809|NCT01474512|100775939|FG002|Maintenance Period|Lack of Efficacy|0|||
33579774|NCT03599518|102013171|FG003|Overall Study|Adverse Event|0|||
33579775|NCT03599518|102013172|FG004|Overall Study|Adverse Event|1|||
33579776|NCT03599518|102013168|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
33238810|NCT01474512|100775940|FG003|Maintenance Period|Lack of Efficacy|1|||
33238811|NCT01474512|100775941|FG004|Maintenance Period|Lack of Efficacy|0|||
33238812|NCT01474512|100775942|FG005|Maintenance Period|Lack of Efficacy|0|||
33238813|NCT01474512|100775943|FG006|Maintenance Period|Lack of Efficacy|0|||
33579777|NCT03599518|102013169|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
33579778|NCT03599518|102013170|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
33579779|NCT03599518|102013171|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
33238814|NCT01474512|100775944|FG007|Maintenance Period|Lack of Efficacy|11|||
33238815|NCT01474512|100775945|FG008|Maintenance Period|Lack of Efficacy|11|||
33238816|NCT01474512|100775946|FG009|Maintenance Period|Lack of Efficacy|12|||
33238817|NCT01474512|100775947|FG010|Maintenance Period|Lack of Efficacy|0|||
33238818|NCT01474512|100775948|FG011|Maintenance Period|Lack of Efficacy|0|||
33238819|NCT01474512|100775949|FG012|Maintenance Period|Lack of Efficacy|0|||
33238820|NCT01474512|100775950|FG013|Maintenance Period|Lack of Efficacy|0|||
33238821|NCT01474512|100775951|FG014|Maintenance Period|Lack of Efficacy|0|||
33238822|NCT01474512|100775952|FG015|Maintenance Period|Lack of Efficacy|0|||
33238823|NCT01474512|100775953|FG016|Maintenance Period|Lack of Efficacy|0|||
33238824|NCT01474512|100775954|FG017|Maintenance Period|Lack of Efficacy|0|||
33238825|NCT01474512|100775937|FG000|Maintenance Period|Protocol Violation|0|||
33238826|NCT01474512|100775938|FG001|Maintenance Period|Protocol Violation|0|||
33238827|NCT01474512|100775939|FG002|Maintenance Period|Protocol Violation|0|||
33238828|NCT01474512|100775940|FG003|Maintenance Period|Protocol Violation|1|||
33238829|NCT01474512|100775941|FG004|Maintenance Period|Protocol Violation|0|||
33238830|NCT01474512|100775942|FG005|Maintenance Period|Protocol Violation|0|||
33238831|NCT01474512|100775943|FG006|Maintenance Period|Protocol Violation|0|||
33238832|NCT01474512|100775944|FG007|Maintenance Period|Protocol Violation|1|||
33238833|NCT01474512|100775945|FG008|Maintenance Period|Protocol Violation|0|||
33238834|NCT01474512|100775946|FG009|Maintenance Period|Protocol Violation|1|||
33238835|NCT01474512|100775947|FG010|Maintenance Period|Protocol Violation|0|||
33238836|NCT01474512|100775948|FG011|Maintenance Period|Protocol Violation|0|||
33238837|NCT01474512|100775949|FG012|Maintenance Period|Protocol Violation|0|||
33238838|NCT01474512|100775950|FG013|Maintenance Period|Protocol Violation|0|||
33238839|NCT01474512|100775951|FG014|Maintenance Period|Protocol Violation|0|||
33238840|NCT01474512|100775952|FG015|Maintenance Period|Protocol Violation|0|||
33238841|NCT01474512|100775953|FG016|Maintenance Period|Protocol Violation|0|||
33238842|NCT01474512|100775954|FG017|Maintenance Period|Protocol Violation|0|||
33370250|NCT01703286|101240068|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
33370251|NCT01703286|101240063|FG000|Period 2 Including Washout|Adverse Event|0|||
33370252|NCT01703286|101240064|FG001|Period 2 Including Washout|Adverse Event|0|||
33370253|NCT01703286|101240065|FG002|Period 2 Including Washout|Adverse Event|0|||
33238843|NCT01474512|100775937|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
33238844|NCT01474512|100775938|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
33238845|NCT01474512|100775939|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
33238846|NCT01474512|100775940|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
33238847|NCT01474512|100775941|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
33238848|NCT01474512|100775942|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
33238849|NCT01474512|100775943|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
33238850|NCT01474512|100775944|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
33238851|NCT01474512|100775945|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
33238852|NCT01474512|100775946|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
33238853|NCT01474512|100775947|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
33238854|NCT01474512|100775948|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
33238855|NCT01474512|100775949|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
33238856|NCT01474512|100775950|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
33238857|NCT01474512|100775951|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
33238858|NCT01474512|100775952|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
33238859|NCT01474512|100775953|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
33238860|NCT01474512|100775954|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
33238861|NCT01474512|100775937|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
33238862|NCT01474512|100775938|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
33238863|NCT01474512|100775939|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
33238864|NCT01474512|100775940|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
33238865|NCT01474512|100775941|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
33238866|NCT01474512|100775942|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
33238867|NCT01474512|100775943|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
33238868|NCT01474512|100775944|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
33238869|NCT01474512|100775945|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
33238870|NCT01474512|100775946|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
33238871|NCT01474512|100775947|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
33238872|NCT01474512|100775948|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
33238873|NCT01474512|100775949|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
33238874|NCT01474512|100775950|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
33238875|NCT01474512|100775951|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
33238876|NCT01474512|100775952|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
33238877|NCT01474512|100775953|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
33238878|NCT01474512|100775954|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
33238879|NCT01474512|100775937|FG000|Long-Term Extension Period|Adverse Event|0|||
33238880|NCT01474512|100775938|FG001|Long-Term Extension Period|Adverse Event|0|||
33238881|NCT01474512|100775939|FG002|Long-Term Extension Period|Adverse Event|0|||
33238882|NCT01474512|100775940|FG003|Long-Term Extension Period|Adverse Event|0|||
33238883|NCT01474512|100775941|FG004|Long-Term Extension Period|Adverse Event|0|||
33238884|NCT01474512|100775942|FG005|Long-Term Extension Period|Adverse Event|0|||
33238885|NCT01474512|100775943|FG006|Long-Term Extension Period|Adverse Event|0|||
33370254|NCT01703286|101240066|FG003|Period 2 Including Washout|Adverse Event|1|||
33370255|NCT01703286|101240067|FG004|Period 2 Including Washout|Adverse Event|0|||
33370256|NCT01703286|101240068|FG005|Period 2 Including Washout|Adverse Event|0|||
33370257|NCT02245568|101240069|FG000|Overall Study|Study terminated by Sponsor|346|||
33238886|NCT01474512|100775944|FG007|Long-Term Extension Period|Adverse Event|0|||
33238887|NCT01474512|100775945|FG008|Long-Term Extension Period|Adverse Event|0|||
33238888|NCT01474512|100775946|FG009|Long-Term Extension Period|Adverse Event|0|||
33238889|NCT01474512|100775947|FG010|Long-Term Extension Period|Adverse Event|0|||
33238890|NCT01474512|100775948|FG011|Long-Term Extension Period|Adverse Event|1|||
33238891|NCT01474512|100775949|FG012|Long-Term Extension Period|Adverse Event|57|||
33238892|NCT01474512|100775950|FG013|Long-Term Extension Period|Adverse Event|58|||
33238893|NCT01474512|100775951|FG014|Long-Term Extension Period|Adverse Event|0|||
33238894|NCT01474512|100775952|FG015|Long-Term Extension Period|Adverse Event|0|||
33238895|NCT01474512|100775953|FG016|Long-Term Extension Period|Adverse Event|0|||
33238896|NCT01474512|100775954|FG017|Long-Term Extension Period|Adverse Event|0|||
33238897|NCT01474512|100775937|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
33238898|NCT01474512|100775938|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
33238899|NCT01474512|100775939|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
33238900|NCT01474512|100775940|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
33238901|NCT01474512|100775941|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
33238902|NCT01474512|100775942|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
33238903|NCT01474512|100775943|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
33238904|NCT01474512|100775944|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
33238905|NCT01474512|100775945|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
33238906|NCT01474512|100775946|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
33238907|NCT01474512|100775947|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
33238908|NCT01474512|100775948|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
33238909|NCT01474512|100775949|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
33238910|NCT01474512|100775950|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
33238911|NCT01474512|100775951|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
33238912|NCT01474512|100775952|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
33238913|NCT01474512|100775953|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
33238914|NCT01474512|100775954|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
33238915|NCT01474512|100775937|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
33238916|NCT01474512|100775938|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
33238917|NCT01474512|100775939|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
33238918|NCT01474512|100775940|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
33238919|NCT01474512|100775941|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
33238920|NCT01474512|100775942|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
33238921|NCT01474512|100775943|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
33238922|NCT01474512|100775944|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
33238923|NCT01474512|100775945|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
33238924|NCT01474512|100775946|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
33639680|NCT04032093|102232719|FG004|Overall Study|Physician Decision|0|||
33639681|NCT04032093|102232720|FG005|Overall Study|Physician Decision|1|||
33639682|NCT04032093|102232721|FG006|Overall Study|Physician Decision|0|||
33639683|NCT04032093|102232722|FG007|Overall Study|Physician Decision|0|||
33639684|NCT04032093|102232723|FG008|Overall Study|Physician Decision|0|||
33238925|NCT01474512|100775947|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
33238926|NCT01474512|100775948|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
33238927|NCT01474512|100775949|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
33238928|NCT01474512|100775950|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
33238929|NCT01474512|100775951|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
33238930|NCT01474512|100775952|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
33238931|NCT01474512|100775953|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
33238932|NCT01474512|100775954|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
33238933|NCT01474512|100775937|FG000|Long-Term Extension Period|Physician Decision|0|||
33370258|NCT02245568|101240069|FG000|Overall Study|Adverse Event|144|||
33370259|NCT02245568|101240069|FG000|Overall Study|Lack of Efficacy|98|||
33370260|NCT02245568|101240069|FG000|Overall Study|Withdrawal by Caregiver|85|||
33370261|NCT02245568|101240069|FG000|Overall Study|Withdrawal by Subject|77|||
33370262|NCT02245568|101240069|FG000|Overall Study|Withdrawal by Legal Representative|31|||
33370263|NCT02245568|101240069|FG000|Overall Study|Missing (Site closure)|16|||
33639685|NCT04032093|102232724|FG009|Overall Study|Physician Decision|0|||
33639686|NCT01064947|102232725|FG000|Overall Study|negative culture|41|||
33639687|NCT04294680|102232728|FG000|Overall Study|Withdrawal by Subject|2|||
33639688|NCT04294680|102232729|FG001|Overall Study|Withdrawal by Subject|1|||
33639689|NCT04294680|102232728|FG000|Overall Study|Follow-up visits completed outside of window|1|||
33639690|NCT04294680|102232729|FG001|Overall Study|Follow-up visits completed outside of window|0|||
33238934|NCT01474512|100775938|FG001|Long-Term Extension Period|Physician Decision|0|||
33238935|NCT01474512|100775939|FG002|Long-Term Extension Period|Physician Decision|0|||
33370264|NCT02245568|101240069|FG000|Overall Study|Physician Decision|14|||
33639691|NCT00737672|102232730|FG000|Overall Study|Graft Abandonment|48|||
33420926|NCT00450177|101431651|FG001|Overall Study|Withdrawal by Primary Team|1|||
33370265|NCT02245568|101240069|FG000|Overall Study|Non-compliance with study drug|11|||
33639692|NCT00737672|102232731|FG001|Overall Study|Graft Abandonment|56|||
33639693|NCT00737672|102232730|FG000|Overall Study|Death|23|||
33639694|NCT00737672|102232731|FG001|Overall Study|Death|22|||
33639695|NCT00737672|102232730|FG000|Overall Study|Withdrawal by Subject|1|||
33639696|NCT00737672|102232731|FG001|Overall Study|Withdrawal by Subject|2|||
33639697|NCT00737672|102232730|FG000|Overall Study|Lost to Follow-up|1|||
33639698|NCT00737672|102232731|FG001|Overall Study|Lost to Follow-up|0|||
33639699|NCT00737672|102232730|FG000|Overall Study|Miscellaneous|7|||
33639700|NCT00737672|102232731|FG001|Overall Study|Miscellaneous|1|||
33639701|NCT00737672|102232730|FG000|Overall Study|Physician Decision|0|||
33639702|NCT00737672|102232731|FG001|Overall Study|Physician Decision|2|||
33639703|NCT03710161|102232732|FG000|Overall Study|Study halted due to COVID pandemic|3|||
33639704|NCT03710161|102232733|FG001|Overall Study|Study halted due to COVID pandemic|2|||
33639705|NCT01077076|102232734|FG000|First Intervention|Withdrawal by Subject|1|||
33639706|NCT01077076|102232735|FG001|First Intervention|Withdrawal by Subject|0|||
33639707|NCT01077076|102232736|FG002|First Intervention|Withdrawal by Subject|0|||
33639708|NCT01077076|102232737|FG003|First Intervention|Withdrawal by Subject|0|||
33639709|NCT01077076|102232738|FG004|First Intervention|Withdrawal by Subject|0|||
33639710|NCT01077076|102232739|FG005|First Intervention|Withdrawal by Subject|0|||
33639711|NCT01077076|102232734|FG000|Third Intervention|Death in the participant's family|0|||
33639712|NCT01077076|102232735|FG001|Third Intervention|Death in the participant's family|0|||
33639713|NCT01077076|102232736|FG002|Third Intervention|Death in the participant's family|0|||
33639714|NCT01077076|102232737|FG003|Third Intervention|Death in the participant's family|0|||
33639715|NCT01077076|102232738|FG004|Third Intervention|Death in the participant's family|0|||
33639716|NCT01077076|102232739|FG005|Third Intervention|Death in the participant's family|1|||
33639717|NCT01671319|102232740|FG000|Overall Study|Withdrawal by Subject|1|||
33639718|NCT00472030|102232741|FG000|Overall Study|Physician Decision|1|||
33639719|NCT00472030|102232742|FG001|Overall Study|Physician Decision|0|||
33639720|NCT00357903|102232743|FG000|Overall Study|Adverse Event|87|||
33639721|NCT00357903|102232744|FG001|Overall Study|Adverse Event|4|||
33639722|NCT00357903|102232743|FG000|Overall Study|Death|33|||
33639723|NCT00357903|102232744|FG001|Overall Study|Death|0|||
33639724|NCT00357903|102232743|FG000|Overall Study|Lost to Follow-up|23|||
33639725|NCT00357903|102232744|FG001|Overall Study|Lost to Follow-up|4|||
33639726|NCT00357903|102232743|FG000|Overall Study|Physician Decision|39|||
33639727|NCT00357903|102232744|FG001|Overall Study|Physician Decision|5|||
33639728|NCT00357903|102232743|FG000|Overall Study|Withdrawal by Subject|57|||
33639729|NCT00357903|102232744|FG001|Overall Study|Withdrawal by Subject|7|||
33639730|NCT00357903|102232743|FG000|Overall Study|Completed month 12 only|0|||
33639731|NCT00357903|102232744|FG001|Overall Study|Completed month 12 only|1|||
33639732|NCT00357903|102232743|FG000|Overall Study|Protocol issues|14|||
33639733|NCT00357903|102232744|FG001|Overall Study|Protocol issues|3|||
33639734|NCT00357903|102232743|FG000|Overall Study|Response status|61|||
33639735|NCT00357903|102232744|FG001|Overall Study|Response status|9|||
33639736|NCT00357903|102232743|FG000|Overall Study|Other|49|||
33639737|NCT00357903|102232744|FG001|Overall Study|Other|10|||
33639738|NCT02745119|102232750|FG000|Overall Study|Adverse Event|1|||
33639739|NCT02745119|102232751|FG001|Overall Study|Adverse Event|0|||
33639740|NCT02745119|102232752|FG002|Overall Study|Adverse Event|1|||
33639741|NCT02745119|102232753|FG003|Overall Study|Adverse Event|3|||
33639742|NCT02745119|102232750|FG000|Overall Study|Death|3|||
33639743|NCT02745119|102232751|FG001|Overall Study|Death|3|||
33370266|NCT02245568|101240069|FG000|Overall Study|Death|9|||
33370267|NCT02245568|101240069|FG000|Overall Study|Blue staining|6|||
33370268|NCT02245568|101240069|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
33370269|NCT02245568|101240069|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
33370270|NCT02245568|101240069|FG000|Overall Study|Lost to Follow-up|5|||
33370271|NCT01577160|101240073|FG000|Overall Study|Adverse Event|9|||
33639744|NCT02745119|102232752|FG002|Overall Study|Death|0|||
33639745|NCT02745119|102232753|FG003|Overall Study|Death|4|||
33639746|NCT02745119|102232750|FG000|Overall Study|Lost to Follow-up|0|||
33370272|NCT01577160|101240073|FG000|Overall Study|Lack of Efficacy|15|||
33370273|NCT01577160|101240073|FG000|Overall Study|Lost to Follow-up|40|||
33639747|NCT02745119|102232751|FG001|Overall Study|Lost to Follow-up|0|||
33639748|NCT02745119|102232752|FG002|Overall Study|Lost to Follow-up|0|||
33639749|NCT02745119|102232753|FG003|Overall Study|Lost to Follow-up|1|||
33639750|NCT02745119|102232750|FG000|Overall Study|Protocol Deviation|0|||
33639751|NCT02745119|102232751|FG001|Overall Study|Protocol Deviation|0|||
33370274|NCT01577160|101240073|FG000|Overall Study|Withdrawal by Subject|18|||
33370275|NCT01577160|101240073|FG000|Overall Study|Subject Uncooperative|7|||
33639752|NCT02745119|102232752|FG002|Overall Study|Protocol Deviation|0|||
33639753|NCT02745119|102232753|FG003|Overall Study|Protocol Deviation|1|||
33639754|NCT02745119|102232750|FG000|Overall Study|Withdrawal by Subject|7|||
33639755|NCT02745119|102232751|FG001|Overall Study|Withdrawal by Subject|15|||
33639756|NCT02745119|102232752|FG002|Overall Study|Withdrawal by Subject|8|||
33639757|NCT02745119|102232753|FG003|Overall Study|Withdrawal by Subject|14|||
33639758|NCT02745119|102232750|FG000|Overall Study|Study Terminated by Sponsor|134|||
33639759|NCT02745119|102232751|FG001|Overall Study|Study Terminated by Sponsor|252|||
33639760|NCT02745119|102232752|FG002|Overall Study|Study Terminated by Sponsor|135|||
33639761|NCT02745119|102232753|FG003|Overall Study|Study Terminated by Sponsor|251|||
33370276|NCT01577160|101240073|FG000|Overall Study|Other|9|||
33370277|NCT01081873|101240075|FG000|Overall Study|Death|86|||
33370278|NCT01081873|101240075|FG000|Overall Study|Withdrawal by Subject|10|||
33370279|NCT01081873|101240075|FG000|Overall Study|Lost to Follow-up|142|||
33370280|NCT01081873|101240075|FG000|Overall Study|Progression of prostate cancer|13|||
33370281|NCT01081873|101240075|FG000|Overall Study|Other|47|||
33370282|NCT03633227|101240076|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
33370283|NCT03633227|101240077|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
33370284|NCT03633227|101240076|FG000|Double Blind (DB), up to Week 48|Death|2|||
33370285|NCT03633227|101240077|FG001|Double Blind (DB), up to Week 48|Death|1|||
33370286|NCT03633227|101240076|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
33370287|NCT03633227|101240077|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
33370288|NCT03633227|101240076|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
33370289|NCT03633227|101240077|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
33370290|NCT03633227|101240076|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
33370291|NCT03633227|101240077|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
33370292|NCT03633227|101240076|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
33370293|NCT03633227|101240077|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
33370294|NCT03633227|101240076|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
33639762|NCT02745119|102232750|FG000|Overall Study|Physician Decision|0|||
33639763|NCT02745119|102232751|FG001|Overall Study|Physician Decision|2|||
33639764|NCT02745119|102232752|FG002|Overall Study|Physician Decision|2|||
33639765|NCT02745119|102232753|FG003|Overall Study|Physician Decision|2|||
33639766|NCT02745119|102232750|FG000|Overall Study|Reason Not Specified|0|||
33639767|NCT02745119|102232751|FG001|Overall Study|Reason Not Specified|2|||
33639768|NCT02745119|102232752|FG002|Overall Study|Reason Not Specified|0|||
33370295|NCT03633227|101240077|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
33370296|NCT03633227|101240076|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
33370297|NCT03633227|101240077|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
33370298|NCT03633227|101240076|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
33370299|NCT03633227|101240077|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
33370300|NCT03633227|101240076|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
33370301|NCT03633227|101240077|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
33370302|NCT03633227|101240076|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
33370303|NCT03633227|101240077|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
33370304|NCT03633227|101240076|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
33370305|NCT03633227|101240077|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
33140868|NCT02108262|100431478|FG001|Overall Study|Randomized by error/screen failure|0|||
33140869|NCT02108262|100431479|FG002|Overall Study|Randomized by error/screen failure|1|||
33140870|NCT02108262|100431480|FG003|Overall Study|Randomized by error/screen failure|0|||
33140871|NCT02108262|100431477|FG000|Overall Study|Distance to center|0|||
33140872|NCT02108262|100431478|FG001|Overall Study|Distance to center|1|||
33140873|NCT02108262|100431479|FG002|Overall Study|Distance to center|1|||
33140874|NCT02108262|100431480|FG003|Overall Study|Distance to center|0|||
33140875|NCT02108262|100431477|FG000|Overall Study|Adverse Event|0|||
33140876|NCT02108262|100431478|FG001|Overall Study|Adverse Event|11|||
33140877|NCT02108262|100431479|FG002|Overall Study|Adverse Event|6|||
33370306|NCT02411201|101240078|FG000|Overall Study|Adverse Event|2|||
33370307|NCT02411201|101240078|FG000|Overall Study|Withdrawal by Subject|2|||
33370308|NCT02411201|101240078|FG000|Overall Study|Age group completed|2|||
33639769|NCT02745119|102232753|FG003|Overall Study|Reason Not Specified|1|||
33370309|NCT01120093|101240079|FG000|Treatment Period 1|Adverse Event|0|||
33370310|NCT01120093|101240080|FG001|Treatment Period 1|Adverse Event|0|||
33370311|NCT01120093|101240081|FG002|Treatment Period 1|Adverse Event|1|||
33370312|NCT01120093|101240082|FG003|Treatment Period 1|Adverse Event|0|||
33370313|NCT01120093|101240083|FG004|Treatment Period 1|Adverse Event|1|||
33370314|NCT01120093|101240079|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33639770|NCT01216189|102232754|FG000|Overall Study|Lost to Follow-up|21|||
33639771|NCT01216189|102232755|FG001|Overall Study|Lost to Follow-up|3|||
33639772|NCT01216189|102232754|FG000|Overall Study|Death|4|||
33639773|NCT01216189|102232755|FG001|Overall Study|Death|2|||
33639774|NCT03077412|102232756|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
33639775|NCT03077412|102232757|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
33639776|NCT03077412|102232758|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
33639777|NCT03077412|102232756|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
33140878|NCT02108262|100431480|FG003|Overall Study|Adverse Event|12|||
33140879|NCT02108262|100431477|FG000|Overall Study|Death|0|||
33140880|NCT02108262|100431478|FG001|Overall Study|Death|2|||
33140881|NCT02108262|100431479|FG002|Overall Study|Death|2|||
33370315|NCT01120093|101240080|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33370316|NCT01120093|101240081|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33238936|NCT01474512|100775940|FG003|Long-Term Extension Period|Physician Decision|0|||
33370317|NCT01120093|101240082|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33370318|NCT01120093|101240083|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33370319|NCT01120093|101240079|FG000|Treatment Period 2|Adverse Event|0|||
33370320|NCT01120093|101240080|FG001|Treatment Period 2|Adverse Event|0|||
33370321|NCT01120093|101240081|FG002|Treatment Period 2|Adverse Event|0|||
33370322|NCT01120093|101240082|FG003|Treatment Period 2|Adverse Event|1|||
33370323|NCT01120093|101240083|FG004|Treatment Period 2|Adverse Event|0|||
33370324|NCT01120093|101240079|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33370325|NCT01120093|101240080|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33370326|NCT01120093|101240081|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33370327|NCT01120093|101240082|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33370328|NCT01120093|101240083|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33370329|NCT01120093|101240079|FG000|Treatment Period 3|Lack of Efficacy|0|||
33370330|NCT01120093|101240080|FG001|Treatment Period 3|Lack of Efficacy|0|||
33639778|NCT03077412|102232757|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
33238937|NCT01474512|100775941|FG004|Long-Term Extension Period|Physician Decision|0|||
33238938|NCT01474512|100775942|FG005|Long-Term Extension Period|Physician Decision|0|||
33238939|NCT01474512|100775943|FG006|Long-Term Extension Period|Physician Decision|0|||
33639779|NCT03077412|102232758|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
33238940|NCT01474512|100775944|FG007|Long-Term Extension Period|Physician Decision|0|||
33238941|NCT01474512|100775945|FG008|Long-Term Extension Period|Physician Decision|0|||
33238942|NCT01474512|100775946|FG009|Long-Term Extension Period|Physician Decision|0|||
33238943|NCT01474512|100775947|FG010|Long-Term Extension Period|Physician Decision|0|||
33238944|NCT01474512|100775948|FG011|Long-Term Extension Period|Physician Decision|0|||
33238945|NCT01474512|100775949|FG012|Long-Term Extension Period|Physician Decision|21|||
33238946|NCT01474512|100775950|FG013|Long-Term Extension Period|Physician Decision|21|||
33238947|NCT01474512|100775951|FG014|Long-Term Extension Period|Physician Decision|0|||
33238948|NCT01474512|100775952|FG015|Long-Term Extension Period|Physician Decision|0|||
33238949|NCT01474512|100775953|FG016|Long-Term Extension Period|Physician Decision|0|||
33238950|NCT01474512|100775954|FG017|Long-Term Extension Period|Physician Decision|0|||
33238951|NCT01474512|100775937|FG000|Long-Term Extension Period|Clinical Relapse|0|||
33238952|NCT01474512|100775938|FG001|Long-Term Extension Period|Clinical Relapse|0|||
33238953|NCT01474512|100775939|FG002|Long-Term Extension Period|Clinical Relapse|0|||
33238954|NCT01474512|100775940|FG003|Long-Term Extension Period|Clinical Relapse|0|||
33238955|NCT01474512|100775941|FG004|Long-Term Extension Period|Clinical Relapse|0|||
33238956|NCT01474512|100775942|FG005|Long-Term Extension Period|Clinical Relapse|0|||
33238957|NCT01474512|100775943|FG006|Long-Term Extension Period|Clinical Relapse|0|||
33370331|NCT01120093|101240081|FG002|Treatment Period 3|Lack of Efficacy|0|||
33370332|NCT01120093|101240082|FG003|Treatment Period 3|Lack of Efficacy|1|||
33639780|NCT03077412|102232756|FG000|Overall Study|Adverse Event|1|||
33639781|NCT03077412|102232757|FG001|Overall Study|Adverse Event|2|||
33639782|NCT03077412|102232758|FG002|Overall Study|Adverse Event|2|||
33639783|NCT03077412|102232756|FG000|Overall Study|Investigator's Discretion|0|||
33639784|NCT03077412|102232757|FG001|Overall Study|Investigator's Discretion|1|||
33639785|NCT03077412|102232758|FG002|Overall Study|Investigator's Discretion|1|||
33639786|NCT03077412|102232756|FG000|Overall Study|Withdrew Consent|0|||
33639787|NCT03077412|102232757|FG001|Overall Study|Withdrew Consent|2|||
33639788|NCT03077412|102232758|FG002|Overall Study|Withdrew Consent|0|||
33639789|NCT04161157|102232759|FG000|Overall Study|Lost to Follow-up|4|||
33639790|NCT04161157|102232759|FG000|Overall Study|Death|3|||
33639791|NCT04161157|102232759|FG000|Overall Study|Ineligible|2|||
33639792|NCT04161157|102232759|FG000|Overall Study|Withdrawal by Subject|4|||
33639793|NCT00622440|102232760|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
33639794|NCT00622440|102232761|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
33639795|NCT00622440|102232760|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
33639796|NCT00622440|102232761|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
33639797|NCT00622440|102232760|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
33639798|NCT00622440|102232761|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
33639799|NCT00622440|102232760|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
33639800|NCT00622440|102232761|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
33639801|NCT01554241|102232762|FG000|Overall Study|Death|3|||
33238958|NCT01474512|100775944|FG007|Long-Term Extension Period|Clinical Relapse|0|||
33238959|NCT01474512|100775945|FG008|Long-Term Extension Period|Clinical Relapse|0|||
33370333|NCT01120093|101240083|FG004|Treatment Period 3|Lack of Efficacy|0|||
33370334|NCT01120093|101240079|FG000|Treatment Period 3|Adverse Event|0|||
33370335|NCT01120093|101240080|FG001|Treatment Period 3|Adverse Event|0|||
33420927|NCT00782275|101431658|FG000|Overall Study|Adverse Event|11|||
33639802|NCT01554241|102232763|FG001|Overall Study|Death|1|||
33639803|NCT01554241|102232764|FG002|Overall Study|Death|1|||
33639804|NCT01554241|102232765|FG003|Overall Study|Death|0|||
33639805|NCT01554241|102232762|FG000|Overall Study|protocol specified renal stone|0|||
33639806|NCT01554241|102232763|FG001|Overall Study|protocol specified renal stone|0|||
33140882|NCT02108262|100431480|FG003|Overall Study|Death|1|||
33140883|NCT02108262|100431477|FG000|Overall Study|Lost to Follow-up|0|||
33140884|NCT02108262|100431478|FG001|Overall Study|Lost to Follow-up|0|||
33140885|NCT02108262|100431479|FG002|Overall Study|Lost to Follow-up|1|||
33140886|NCT02108262|100431480|FG003|Overall Study|Lost to Follow-up|0|||
33140887|NCT02108262|100431477|FG000|Overall Study|Physician Decision|0|||
33140888|NCT02108262|100431478|FG001|Overall Study|Physician Decision|0|||
33140889|NCT02108262|100431479|FG002|Overall Study|Physician Decision|2|||
33639807|NCT01554241|102232764|FG002|Overall Study|protocol specified renal stone|0|||
33639808|NCT01554241|102232765|FG003|Overall Study|protocol specified renal stone|1|||
33639809|NCT01554241|102232762|FG000|Overall Study|protocol specified change in eGFR|0|||
33639810|NCT01554241|102232763|FG001|Overall Study|protocol specified change in eGFR|0|||
33140890|NCT02108262|100431480|FG003|Overall Study|Physician Decision|0|||
33140891|NCT02108262|100431477|FG000|Overall Study|Withdrawal by Subject|0|||
33140892|NCT02108262|100431478|FG001|Overall Study|Withdrawal by Subject|7|||
33140893|NCT02108262|100431479|FG002|Overall Study|Withdrawal by Subject|3|||
33140894|NCT02108262|100431480|FG003|Overall Study|Withdrawal by Subject|4|||
33140895|NCT02108262|100431477|FG000|Overall Study|Due to key hepatic values|0|||
33238960|NCT01474512|100775946|FG009|Long-Term Extension Period|Clinical Relapse|0|||
33238961|NCT01474512|100775947|FG010|Long-Term Extension Period|Clinical Relapse|0|||
33238962|NCT01474512|100775948|FG011|Long-Term Extension Period|Clinical Relapse|0|||
33238963|NCT01474512|100775949|FG012|Long-Term Extension Period|Clinical Relapse|9|||
33238964|NCT01474512|100775950|FG013|Long-Term Extension Period|Clinical Relapse|9|||
33238965|NCT01474512|100775951|FG014|Long-Term Extension Period|Clinical Relapse|0|||
33420928|NCT00782275|101431658|FG000|Overall Study|Withdrawal by Subject|1|||
33420929|NCT00782275|101431658|FG000|Overall Study|Progressive Disease|21|||
33420930|NCT00782275|101431658|FG000|Overall Study|Physician Decision|4|||
33639811|NCT01554241|102232764|FG002|Overall Study|protocol specified change in eGFR|1|||
33639812|NCT01554241|102232765|FG003|Overall Study|protocol specified change in eGFR|0|||
33639813|NCT01554241|102232762|FG000|Overall Study|Withdrawal by Subject|0|||
33639814|NCT01554241|102232763|FG001|Overall Study|Withdrawal by Subject|0|||
33639815|NCT01554241|102232764|FG002|Overall Study|Withdrawal by Subject|2|||
33639816|NCT01554241|102232765|FG003|Overall Study|Withdrawal by Subject|0|||
33639817|NCT02035267|102232768|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
33639818|NCT02035267|102232769|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
33639819|NCT02035267|102232770|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
33639820|NCT02035267|102232771|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
33639821|NCT02035267|102232768|FG000|Overall Study|Adverse Event|0|||
33639822|NCT02035267|102232769|FG001|Overall Study|Adverse Event|0|||
33639823|NCT02035267|102232770|FG002|Overall Study|Adverse Event|1|||
33639824|NCT02035267|102232771|FG003|Overall Study|Adverse Event|0|||
33639825|NCT02035267|102232768|FG000|Overall Study|Lost to Follow-up|0|||
33639826|NCT02035267|102232769|FG001|Overall Study|Lost to Follow-up|0|||
33639827|NCT02035267|102232770|FG002|Overall Study|Lost to Follow-up|0|||
33639828|NCT02035267|102232771|FG003|Overall Study|Lost to Follow-up|1|||
33639829|NCT02035267|102232768|FG000|Overall Study|Other unspecified|0|||
33639830|NCT02035267|102232769|FG001|Overall Study|Other unspecified|1|||
33639831|NCT02035267|102232770|FG002|Overall Study|Other unspecified|0|||
33639832|NCT02035267|102232771|FG003|Overall Study|Other unspecified|0|||
33639833|NCT04041414|102232774|FG000|Overall Study|Lost to Follow-up|1|||
33639834|NCT04041414|102232775|FG001|Overall Study|Lost to Follow-up|2|||
33639835|NCT00670748|102232778|FG000|Overall Study|Death during treatment|1|||
33639836|NCT00670748|102232779|FG001|Overall Study|Death during treatment|1|||
33140896|NCT02108262|100431478|FG001|Overall Study|Due to key hepatic values|1|||
33140897|NCT02108262|100431479|FG002|Overall Study|Due to key hepatic values|0|||
33238966|NCT01474512|100775952|FG015|Long-Term Extension Period|Clinical Relapse|0|||
33238967|NCT01474512|100775953|FG016|Long-Term Extension Period|Clinical Relapse|0|||
33238968|NCT01474512|100775954|FG017|Long-Term Extension Period|Clinical Relapse|0|||
33238969|NCT01474512|100775937|FG000|Long-Term Extension Period|Death|0|||
33238970|NCT01474512|100775938|FG001|Long-Term Extension Period|Death|0|||
33238971|NCT01474512|100775939|FG002|Long-Term Extension Period|Death|0|||
33238972|NCT01474512|100775940|FG003|Long-Term Extension Period|Death|0|||
33238973|NCT01474512|100775941|FG004|Long-Term Extension Period|Death|0|||
33238974|NCT01474512|100775942|FG005|Long-Term Extension Period|Death|0|||
33238975|NCT01474512|100775943|FG006|Long-Term Extension Period|Death|0|||
33238976|NCT01474512|100775944|FG007|Long-Term Extension Period|Death|0|||
33420931|NCT00782275|101431658|FG000|Overall Study|Not started treatment|1|||
33639837|NCT00670748|102232780|FG002|Overall Study|Death during treatment|1|||
33140898|NCT02108262|100431480|FG003|Overall Study|Due to key hepatic values|0|||
33140899|NCT02108262|100431477|FG000|Overall Study|Unable to contact patient|0|||
33639838|NCT00670748|102232781|FG003|Overall Study|Death during treatment|0|||
33639839|NCT00670748|102232778|FG000|Overall Study|Not off study|2|||
33639840|NCT00670748|102232779|FG001|Overall Study|Not off study|1|||
33639841|NCT00670748|102232780|FG002|Overall Study|Not off study|1|||
33639842|NCT00670748|102232781|FG003|Overall Study|Not off study|1|||
33639843|NCT00996333|102232783|FG000|Overall Study|Screen failure|1|||
33140900|NCT02108262|100431478|FG001|Overall Study|Unable to contact patient|3|||
33140901|NCT02108262|100431479|FG002|Overall Study|Unable to contact patient|1|||
33140902|NCT02108262|100431480|FG003|Overall Study|Unable to contact patient|2|||
33140903|NCT02108262|100431477|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
33140904|NCT02108262|100431478|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
33140905|NCT02108262|100431479|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
33140906|NCT02108262|100431480|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
33140907|NCT02108262|100431477|FG000|Overall Study|Patient did not want another infusion|0|||
33140908|NCT02108262|100431478|FG001|Overall Study|Patient did not want another infusion|3|||
33140909|NCT02108262|100431479|FG002|Overall Study|Patient did not want another infusion|3|||
33140910|NCT02108262|100431480|FG003|Overall Study|Patient did not want another infusion|2|||
33140911|NCT02108262|100431477|FG000|Overall Study|Vacation|0|||
33140912|NCT02108262|100431478|FG001|Overall Study|Vacation|1|||
33140913|NCT02108262|100431479|FG002|Overall Study|Vacation|0|||
33140914|NCT02108262|100431480|FG003|Overall Study|Vacation|0|||
33140915|NCT02108262|100431477|FG000|Overall Study|Patient decision|0|||
33140916|NCT02108262|100431478|FG001|Overall Study|Patient decision|7|||
33140917|NCT02108262|100431479|FG002|Overall Study|Patient decision|9|||
33140918|NCT02108262|100431480|FG003|Overall Study|Patient decision|14|||
33140919|NCT02108262|100431477|FG000|Overall Study|Missed IV due to pharmacy error|0|||
33140920|NCT02108262|100431478|FG001|Overall Study|Missed IV due to pharmacy error|0|||
33140921|NCT02108262|100431479|FG002|Overall Study|Missed IV due to pharmacy error|1|||
33140922|NCT02108262|100431480|FG003|Overall Study|Missed IV due to pharmacy error|0|||
33140923|NCT01604278|100431481|FG000|Overall Study|Lack of Efficacy|0|||
33140924|NCT01604278|100431482|FG001|Overall Study|Lack of Efficacy|1|||
33140925|NCT01604278|100431481|FG000|Overall Study|Lost to Follow-up|1|||
33370336|NCT01120093|101240081|FG002|Treatment Period 3|Adverse Event|0|||
33370337|NCT01120093|101240082|FG003|Treatment Period 3|Adverse Event|0|||
33370338|NCT01120093|101240083|FG004|Treatment Period 3|Adverse Event|1|||
33140926|NCT01604278|100431482|FG001|Overall Study|Lost to Follow-up|0|||
33140927|NCT01604278|100431481|FG000|Overall Study|Administrative problems|2|||
33238977|NCT01474512|100775945|FG008|Long-Term Extension Period|Death|0|||
33238978|NCT01474512|100775946|FG009|Long-Term Extension Period|Death|0|||
33238979|NCT01474512|100775947|FG010|Long-Term Extension Period|Death|0|||
33238980|NCT01474512|100775948|FG011|Long-Term Extension Period|Death|0|||
33238981|NCT01474512|100775949|FG012|Long-Term Extension Period|Death|9|||
33238982|NCT01474512|100775950|FG013|Long-Term Extension Period|Death|9|||
33238983|NCT01474512|100775951|FG014|Long-Term Extension Period|Death|0|||
33238984|NCT01474512|100775952|FG015|Long-Term Extension Period|Death|0|||
33238985|NCT01474512|100775953|FG016|Long-Term Extension Period|Death|0|||
33238986|NCT01474512|100775954|FG017|Long-Term Extension Period|Death|0|||
33238987|NCT01474512|100775937|FG000|Long-Term Extension Period|Sponsor Decision|0|||
33238988|NCT01474512|100775938|FG001|Long-Term Extension Period|Sponsor Decision|0|||
33238989|NCT01474512|100775939|FG002|Long-Term Extension Period|Sponsor Decision|0|||
33420932|NCT00782275|101431658|FG000|Overall Study|Other|3|||
33140928|NCT01604278|100431482|FG001|Overall Study|Administrative problems|1|||
33140929|NCT01604278|100431481|FG000|Overall Study|Withdrawal by Subject|3|||
33140930|NCT01604278|100431482|FG001|Overall Study|Withdrawal by Subject|3|||
33238990|NCT01474512|100775940|FG003|Long-Term Extension Period|Sponsor Decision|0|||
33370339|NCT01120093|101240079|FG000|Treatment Period 3|Withdrawal by Subject|0|||
33370340|NCT01120093|101240080|FG001|Treatment Period 3|Withdrawal by Subject|0|||
33370341|NCT01120093|101240081|FG002|Treatment Period 3|Withdrawal by Subject|1|||
33370342|NCT01120093|101240082|FG003|Treatment Period 3|Withdrawal by Subject|0|||
33370343|NCT01120093|101240083|FG004|Treatment Period 3|Withdrawal by Subject|0|||
33370344|NCT01120093|101240079|FG000|Treatment Period 4|Adverse Event|1|||
33370345|NCT01120093|101240080|FG001|Treatment Period 4|Adverse Event|0|||
33370346|NCT01120093|101240081|FG002|Treatment Period 4|Adverse Event|0|||
33370347|NCT01120093|101240082|FG003|Treatment Period 4|Adverse Event|0|||
33370348|NCT01120093|101240083|FG004|Treatment Period 4|Adverse Event|0|||
33370349|NCT01120093|101240079|FG000|Treatment Period 5|Adverse Event|0|||
33370350|NCT01120093|101240080|FG001|Treatment Period 5|Adverse Event|1|||
33370351|NCT01120093|101240081|FG002|Treatment Period 5|Adverse Event|0|||
33370352|NCT01120093|101240082|FG003|Treatment Period 5|Adverse Event|1|||
33370353|NCT01120093|101240083|FG004|Treatment Period 5|Adverse Event|0|||
33370354|NCT00337467|101240084|FG000|Overall Study|Adverse Event|3|||
33420933|NCT03499249|101431661|FG000|Overall Study|Physician Decision|1|||
33420934|NCT00995488|101431665|FG000|Overall Study|Withdrawal by Subject|1|||
33238991|NCT01474512|100775941|FG004|Long-Term Extension Period|Sponsor Decision|0|||
33238992|NCT01474512|100775942|FG005|Long-Term Extension Period|Sponsor Decision|0|||
33238993|NCT01474512|100775943|FG006|Long-Term Extension Period|Sponsor Decision|0|||
33370355|NCT00337467|101240084|FG000|Overall Study|Subject Withdrew Consent|2|||
33370356|NCT00337467|101240084|FG000|Overall Study|Pregnancy|1|||
33370357|NCT00337467|101240084|FG000|Overall Study|Lost to Follow-up|2|||
33370358|NCT00337467|101240084|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
33140931|NCT01604278|100431481|FG000|Overall Study|Adverse Event|3|||
33140932|NCT01604278|100431482|FG001|Overall Study|Adverse Event|5|||
33238994|NCT01474512|100775944|FG007|Long-Term Extension Period|Sponsor Decision|0|||
33238995|NCT01474512|100775945|FG008|Long-Term Extension Period|Sponsor Decision|0|||
33238996|NCT01474512|100775946|FG009|Long-Term Extension Period|Sponsor Decision|0|||
33238997|NCT01474512|100775947|FG010|Long-Term Extension Period|Sponsor Decision|0|||
33238998|NCT01474512|100775948|FG011|Long-Term Extension Period|Sponsor Decision|0|||
33238999|NCT01474512|100775949|FG012|Long-Term Extension Period|Sponsor Decision|6|||
33239000|NCT01474512|100775950|FG013|Long-Term Extension Period|Sponsor Decision|6|||
33239001|NCT01474512|100775951|FG014|Long-Term Extension Period|Sponsor Decision|0|||
33239002|NCT01474512|100775952|FG015|Long-Term Extension Period|Sponsor Decision|0|||
33239003|NCT01474512|100775953|FG016|Long-Term Extension Period|Sponsor Decision|0|||
33239004|NCT01474512|100775954|FG017|Long-Term Extension Period|Sponsor Decision|0|||
33239005|NCT01474512|100775937|FG000|Long-Term Extension Period|Protocol Violation|0|||
33239006|NCT01474512|100775938|FG001|Long-Term Extension Period|Protocol Violation|0|||
33239007|NCT01474512|100775939|FG002|Long-Term Extension Period|Protocol Violation|0|||
33239008|NCT01474512|100775940|FG003|Long-Term Extension Period|Protocol Violation|0|||
33239009|NCT01474512|100775941|FG004|Long-Term Extension Period|Protocol Violation|0|||
33239010|NCT01474512|100775942|FG005|Long-Term Extension Period|Protocol Violation|0|||
33239011|NCT01474512|100775943|FG006|Long-Term Extension Period|Protocol Violation|0|||
33239012|NCT01474512|100775944|FG007|Long-Term Extension Period|Protocol Violation|0|||
33239013|NCT01474512|100775945|FG008|Long-Term Extension Period|Protocol Violation|0|||
33239014|NCT01474512|100775946|FG009|Long-Term Extension Period|Protocol Violation|0|||
33239015|NCT01474512|100775947|FG010|Long-Term Extension Period|Protocol Violation|0|||
33639844|NCT00996333|102232783|FG000|Overall Study|Withdrawal by Subject|1|||
33639845|NCT00996333|102232783|FG000|Overall Study|Death|4|||
33639846|NCT00996333|102232783|FG000|Overall Study|Adverse Event|1|||
33639847|NCT00996333|102232783|FG000|Overall Study|Physician Decision|1|||
33639848|NCT00996333|102232783|FG000|Overall Study|Other|5|||
33639849|NCT03530124|102232786|FG000|Overall Study|Withdrawal by Subject|0|||
33639850|NCT03530124|102232787|FG001|Overall Study|Withdrawal by Subject|1|||
33639851|NCT03530124|102232786|FG000|Overall Study|Protocol Violation|1|||
33639852|NCT03530124|102232787|FG001|Overall Study|Protocol Violation|0|||
33639853|NCT03530124|102232786|FG000|Overall Study|Discharged prior to study completion|1|||
33639854|NCT03530124|102232787|FG001|Overall Study|Discharged prior to study completion|0|||
33639855|NCT03895840|102232790|FG000|Overall Study|Withdrawal by Subject|21|||
33639856|NCT04411667|102232791|FG000|Overall Study|Physician Decision|1|||
33639857|NCT04411667|102232792|FG001|Overall Study|Physician Decision|0|||
33639858|NCT00790842|102232793|FG000|Dose Level 1|Adverse Event|1|||
33639859|NCT00790842|102232794|FG001|Dose Level 1|Adverse Event|0|||
33639860|NCT00790842|102232795|FG002|Dose Level 1|Adverse Event|0|||
33639861|NCT00790842|102232796|FG003|Dose Level 1|Adverse Event|2|||
33639862|NCT00790842|102232797|FG004|Dose Level 1|Adverse Event|0|||
33639863|NCT00790842|102232798|FG005|Dose Level 1|Adverse Event|0|||
33639864|NCT00790842|102232799|FG006|Dose Level 1|Adverse Event|0|||
33639865|NCT00790842|102232800|FG007|Dose Level 1|Adverse Event|1|||
33639866|NCT00790842|102232801|FG008|Dose Level 1|Adverse Event|0|||
33639867|NCT00790842|102232802|FG009|Dose Level 1|Adverse Event|0|||
33639868|NCT00790842|102232803|FG010|Dose Level 1|Adverse Event|0|||
33639869|NCT00790842|102232793|FG000|Dose Level 1|Physician Decision|1|||
33639870|NCT00790842|102232794|FG001|Dose Level 1|Physician Decision|0|||
33639871|NCT00790842|102232795|FG002|Dose Level 1|Physician Decision|0|||
33639872|NCT00790842|102232796|FG003|Dose Level 1|Physician Decision|0|||
33639873|NCT00790842|102232797|FG004|Dose Level 1|Physician Decision|0|||
33639874|NCT00790842|102232798|FG005|Dose Level 1|Physician Decision|0|||
33639875|NCT00790842|102232799|FG006|Dose Level 1|Physician Decision|0|||
33639876|NCT00790842|102232800|FG007|Dose Level 1|Physician Decision|1|||
33639877|NCT00790842|102232801|FG008|Dose Level 1|Physician Decision|0|||
33639878|NCT00790842|102232802|FG009|Dose Level 1|Physician Decision|0|||
33639879|NCT00790842|102232803|FG010|Dose Level 1|Physician Decision|0|||
33639880|NCT00790842|102232793|FG000|Dose Level 1|Withdrawal by Subject|1|||
33639881|NCT00790842|102232794|FG001|Dose Level 1|Withdrawal by Subject|0|||
33639882|NCT00790842|102232795|FG002|Dose Level 1|Withdrawal by Subject|0|||
33639883|NCT00790842|102232796|FG003|Dose Level 1|Withdrawal by Subject|0|||
33639884|NCT00790842|102232797|FG004|Dose Level 1|Withdrawal by Subject|0|||
33239016|NCT01474512|100775948|FG011|Long-Term Extension Period|Protocol Violation|0|||
33239017|NCT01474512|100775949|FG012|Long-Term Extension Period|Protocol Violation|5|||
33239018|NCT01474512|100775950|FG013|Long-Term Extension Period|Protocol Violation|5|||
33370359|NCT00850460|101240085|FG000|Overall Study|Lost to Follow-up|4|||
33639885|NCT00790842|102232798|FG005|Dose Level 1|Withdrawal by Subject|0|||
33639886|NCT00790842|102232799|FG006|Dose Level 1|Withdrawal by Subject|0|||
33639887|NCT00790842|102232800|FG007|Dose Level 1|Withdrawal by Subject|0|||
33639888|NCT00790842|102232801|FG008|Dose Level 1|Withdrawal by Subject|0|||
33639889|NCT00790842|102232802|FG009|Dose Level 1|Withdrawal by Subject|0|||
33639890|NCT00790842|102232803|FG010|Dose Level 1|Withdrawal by Subject|0|||
33639891|NCT00790842|102232793|FG000|Dose Level 2|Death|0|||
33639892|NCT00790842|102232794|FG001|Dose Level 2|Death|1|||
33639893|NCT00790842|102232795|FG002|Dose Level 2|Death|0|||
33239019|NCT01474512|100775951|FG014|Long-Term Extension Period|Protocol Violation|0|||
33239020|NCT01474512|100775952|FG015|Long-Term Extension Period|Protocol Violation|0|||
33239021|NCT01474512|100775953|FG016|Long-Term Extension Period|Protocol Violation|0|||
33239022|NCT01474512|100775954|FG017|Long-Term Extension Period|Protocol Violation|0|||
33239023|NCT01474512|100775937|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239024|NCT01474512|100775938|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239025|NCT01474512|100775939|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239026|NCT01474512|100775940|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239027|NCT01474512|100775941|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239028|NCT01474512|100775942|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239029|NCT01474512|100775943|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239030|NCT01474512|100775944|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239031|NCT01474512|100775945|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239032|NCT01474512|100775946|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239033|NCT01474512|100775947|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239034|NCT01474512|100775948|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239035|NCT01474512|100775949|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
33239036|NCT01474512|100775950|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
33239037|NCT01474512|100775951|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239038|NCT01474512|100775952|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33639894|NCT00790842|102232796|FG003|Dose Level 2|Death|0|||
33639895|NCT00790842|102232797|FG004|Dose Level 2|Death|1|||
33639896|NCT00790842|102232798|FG005|Dose Level 2|Death|0|||
33639897|NCT00790842|102232799|FG006|Dose Level 2|Death|0|||
33639898|NCT00790842|102232800|FG007|Dose Level 2|Death|0|||
33639899|NCT00790842|102232801|FG008|Dose Level 2|Death|0|||
33239039|NCT01474512|100775953|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239040|NCT01474512|100775954|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
33239041|NCT01474512|100775937|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239042|NCT01474512|100775938|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239043|NCT01474512|100775939|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239044|NCT01474512|100775940|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239045|NCT01474512|100775941|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239046|NCT01474512|100775942|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239047|NCT01474512|100775943|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239048|NCT01474512|100775944|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239049|NCT01474512|100775945|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239050|NCT01474512|100775946|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239051|NCT01474512|100775947|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239052|NCT01474512|100775948|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
33239053|NCT01474512|100775949|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239054|NCT01474512|100775950|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239055|NCT01474512|100775951|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239056|NCT01474512|100775952|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239057|NCT01474512|100775953|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239058|NCT01474512|100775954|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
33239059|NCT01474512|100775937|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
33239060|NCT01474512|100775938|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
33239061|NCT01474512|100775939|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
33239062|NCT01474512|100775940|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
33239063|NCT01474512|100775941|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
33239064|NCT01474512|100775942|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
33239065|NCT01474512|100775943|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
33239066|NCT01474512|100775944|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
33239067|NCT01474512|100775945|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
33239068|NCT01474512|100775946|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
33639900|NCT00790842|102232802|FG009|Dose Level 2|Death|0|||
33639901|NCT00790842|102232803|FG010|Dose Level 2|Death|0|||
33639902|NCT00790842|102232793|FG000|Dose Level 2|Physician Decision|0|||
33639903|NCT00790842|102232794|FG001|Dose Level 2|Physician Decision|1|||
33639904|NCT00790842|102232795|FG002|Dose Level 2|Physician Decision|0|||
33239069|NCT01474512|100775947|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
33239070|NCT01474512|100775948|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
33239071|NCT01474512|100775949|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
33239072|NCT01474512|100775950|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
33239073|NCT01474512|100775951|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
33239074|NCT01474512|100775952|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
33239075|NCT01474512|100775953|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
33639905|NCT00790842|102232796|FG003|Dose Level 2|Physician Decision|0|||
33639906|NCT00790842|102232797|FG004|Dose Level 2|Physician Decision|0|||
33639907|NCT00790842|102232798|FG005|Dose Level 2|Physician Decision|0|||
33239076|NCT01474512|100775954|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
33239077|NCT01474512|100775937|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33239078|NCT01474512|100775938|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33239079|NCT01474512|100775939|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33239080|NCT01474512|100775940|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33239081|NCT01474512|100775941|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33239082|NCT01474512|100775942|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33239083|NCT01474512|100775943|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33239084|NCT01474512|100775944|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33239085|NCT01474512|100775945|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33239086|NCT01474512|100775946|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33239087|NCT01474512|100775947|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33239088|NCT01474512|100775948|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33239089|NCT01474512|100775949|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33239090|NCT01474512|100775950|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
33239091|NCT01474512|100775951|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
33239092|NCT01474512|100775952|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
33239093|NCT01474512|100775953|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
33239094|NCT01474512|100775954|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
33239095|NCT01474512|100775937|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33239096|NCT01474512|100775938|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33239097|NCT01474512|100775939|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33239098|NCT01474512|100775940|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33239099|NCT01474512|100775941|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33239100|NCT01474512|100775942|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33239101|NCT01474512|100775943|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33239102|NCT01474512|100775944|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33239103|NCT01474512|100775945|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33239104|NCT01474512|100775946|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33239105|NCT01474512|100775947|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33239106|NCT01474512|100775948|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33239107|NCT01474512|100775949|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33239108|NCT01474512|100775950|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
33239109|NCT01474512|100775951|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
33239110|NCT01474512|100775952|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
33239111|NCT01474512|100775953|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
33239112|NCT01474512|100775954|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
33239113|NCT01474512|100775937|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33239114|NCT01474512|100775938|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33239115|NCT01474512|100775939|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33370360|NCT00850460|101240086|FG001|Overall Study|Lost to Follow-up|4|||
33239116|NCT01474512|100775940|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33239117|NCT01474512|100775941|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33239118|NCT01474512|100775942|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33239119|NCT01474512|100775943|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33239120|NCT01474512|100775944|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33370361|NCT00907881|101240088|FG000|Overall Study|Lost to Follow-up|59|||
33370362|NCT00907881|101240088|FG000|Overall Study|Noncompliance|5|||
33370363|NCT00907881|101240088|FG000|Overall Study|Withdrawal by Subject|5|||
33370364|NCT00907881|101240088|FG000|Overall Study|Protocol Violation|1|||
33370365|NCT00907881|101240088|FG000|Overall Study|Missing discontinuation information|15|||
33370366|NCT01519245|101240089|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
33370367|NCT01519245|101240090|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
33370368|NCT00631488|101240091|FG000|Overall Study|Adverse Event|1|||
33370369|NCT00631488|101240092|FG001|Overall Study|Adverse Event|0|||
33370370|NCT00631488|101240093|FG002|Overall Study|Adverse Event|0|||
33370371|NCT00631488|101240091|FG000|Overall Study|Lost to Follow-up|2|||
33370372|NCT00631488|101240092|FG001|Overall Study|Lost to Follow-up|2|||
33370373|NCT00631488|101240093|FG002|Overall Study|Lost to Follow-up|0|||
33370374|NCT00631488|101240091|FG000|Overall Study|Physician Decision|1|||
33370375|NCT00631488|101240092|FG001|Overall Study|Physician Decision|0|||
33239121|NCT01474512|100775945|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33239122|NCT01474512|100775946|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33370376|NCT00631488|101240093|FG002|Overall Study|Physician Decision|1|||
33370377|NCT00631488|101240091|FG000|Overall Study|Protocol Violation|0|||
33239123|NCT01474512|100775947|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33239124|NCT01474512|100775948|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33370378|NCT00631488|101240092|FG001|Overall Study|Protocol Violation|0|||
33370379|NCT00631488|101240093|FG002|Overall Study|Protocol Violation|1|||
33239125|NCT01474512|100775949|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33239126|NCT01474512|100775950|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33370380|NCT00002663|101240094|FG000|Overall Study|Death|4|||
33370381|NCT00002663|101240095|FG001|Overall Study|Death|1|||
33370382|NCT00002663|101240096|FG002|Overall Study|Death|1|||
33239127|NCT01474512|100775951|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33239128|NCT01474512|100775952|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
33239129|NCT01474512|100775953|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
33239130|NCT01474512|100775954|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
33239131|NCT01474512|100775937|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
33239132|NCT01474512|100775938|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
33239133|NCT01474512|100775939|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
33239134|NCT01474512|100775940|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
33239135|NCT01474512|100775941|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
33239136|NCT01474512|100775942|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
33239137|NCT01474512|100775943|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
33239138|NCT01474512|100775944|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
33239139|NCT01474512|100775945|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
33239140|NCT01474512|100775946|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
33239141|NCT01474512|100775947|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
33239142|NCT01474512|100775948|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
33239143|NCT01474512|100775949|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
33239144|NCT01474512|100775950|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
33239145|NCT01474512|100775951|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
33239146|NCT01474512|100775952|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
33239147|NCT01474512|100775953|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
33239148|NCT01474512|100775954|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
33239149|NCT01474512|100775937|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
33239150|NCT01474512|100775938|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
33239151|NCT01474512|100775939|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
33239152|NCT01474512|100775940|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
33239153|NCT01474512|100775941|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
33239154|NCT01474512|100775942|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
33239155|NCT01474512|100775943|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
33239156|NCT01474512|100775944|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
33239157|NCT01474512|100775945|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
33370383|NCT00002663|101240097|FG003|Overall Study|Death|0|||
33370384|NCT00002663|101240098|FG004|Overall Study|Death|0|||
33370385|NCT00002663|101240099|FG005|Overall Study|Death|13|||
33370386|NCT00002663|101240100|FG006|Overall Study|Death|0|||
33370387|NCT00002663|101240101|FG007|Overall Study|Death|1|||
33370388|NCT00002663|101240102|FG008|Overall Study|Death|1|||
33639908|NCT00790842|102232799|FG006|Dose Level 2|Physician Decision|0|||
33639909|NCT00790842|102232800|FG007|Dose Level 2|Physician Decision|0|||
33639910|NCT00790842|102232801|FG008|Dose Level 2|Physician Decision|0|||
33639911|NCT00790842|102232802|FG009|Dose Level 2|Physician Decision|0|||
33639912|NCT00790842|102232803|FG010|Dose Level 2|Physician Decision|0|||
33639913|NCT00790842|102232793|FG000|Dose Level 2|Withdrawal by Subject|0|||
33239158|NCT01474512|100775946|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
33239159|NCT01474512|100775947|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
33239160|NCT01474512|100775948|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
33140933|NCT01604278|100431481|FG000|Overall Study|Protocol Deviation|5|||
33140934|NCT01604278|100431482|FG001|Overall Study|Protocol Deviation|3|||
33140935|NCT02158364|100431483|FG000|Overall Study|Case report forms uncollected|10|||
33140936|NCT02158364|100431483|FG000|Overall Study|Protocol Deviation|50|||
33140937|NCT04054947|100431490|FG000|Overall Study|Withdrawal by Subject|1|||
33140938|NCT04054947|100431491|FG001|Overall Study|Withdrawal by Subject|0|||
33140939|NCT04054947|100431490|FG000|Overall Study|Lost to Follow-up|2|||
33639914|NCT00790842|102232794|FG001|Dose Level 2|Withdrawal by Subject|1|||
33639915|NCT00790842|102232795|FG002|Dose Level 2|Withdrawal by Subject|0|||
33639916|NCT00790842|102232796|FG003|Dose Level 2|Withdrawal by Subject|0|||
33639917|NCT00790842|102232797|FG004|Dose Level 2|Withdrawal by Subject|0|||
33639918|NCT00790842|102232798|FG005|Dose Level 2|Withdrawal by Subject|0|||
33639919|NCT00790842|102232799|FG006|Dose Level 2|Withdrawal by Subject|0|||
33140940|NCT04054947|100431491|FG001|Overall Study|Lost to Follow-up|5|||
33140941|NCT00807573|100431500|FG000|Overall Study|Withdrawal by Subject|1|||
33140942|NCT00807573|100431500|FG000|Overall Study|Adverse Event|1|||
33239161|NCT01474512|100775949|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
33239162|NCT01474512|100775950|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
33239163|NCT01474512|100775951|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
33239164|NCT01474512|100775952|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
33239165|NCT01474512|100775953|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
33370389|NCT00002663|101240103|FG009|Overall Study|Death|1|||
33639920|NCT00790842|102232800|FG007|Dose Level 2|Withdrawal by Subject|0|||
33239166|NCT01474512|100775954|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
33370390|NCT00002663|101240094|FG000|Overall Study|Lost to Follow-up|3|||
33370391|NCT00002663|101240095|FG001|Overall Study|Lost to Follow-up|0|||
33639921|NCT00790842|102232801|FG008|Dose Level 2|Withdrawal by Subject|0|||
33239167|NCT01474512|100775937|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
33370392|NCT00002663|101240096|FG002|Overall Study|Lost to Follow-up|0|||
33639922|NCT00790842|102232802|FG009|Dose Level 2|Withdrawal by Subject|0|||
33639923|NCT00790842|102232803|FG010|Dose Level 2|Withdrawal by Subject|0|||
33639924|NCT00790842|102232793|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33639925|NCT00790842|102232794|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33639926|NCT00790842|102232795|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33639927|NCT00790842|102232796|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33639928|NCT00790842|102232797|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33639929|NCT00790842|102232798|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33639930|NCT00790842|102232799|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33639931|NCT00790842|102232800|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33639932|NCT00790842|102232801|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
33639933|NCT00790842|102232802|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33639934|NCT00790842|102232803|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
33639935|NCT00790842|102232793|FG000|Dose Level 3|Adverse Event|0|||
33639936|NCT00790842|102232794|FG001|Dose Level 3|Adverse Event|0|||
33639937|NCT00790842|102232795|FG002|Dose Level 3|Adverse Event|1|||
33639938|NCT00790842|102232796|FG003|Dose Level 3|Adverse Event|0|||
33639939|NCT00790842|102232797|FG004|Dose Level 3|Adverse Event|0|||
33639940|NCT00790842|102232798|FG005|Dose Level 3|Adverse Event|0|||
33639941|NCT00790842|102232799|FG006|Dose Level 3|Adverse Event|0|||
33639942|NCT00790842|102232800|FG007|Dose Level 3|Adverse Event|0|||
33639943|NCT00790842|102232801|FG008|Dose Level 3|Adverse Event|0|||
33639944|NCT00790842|102232802|FG009|Dose Level 3|Adverse Event|0|||
33639945|NCT00790842|102232803|FG010|Dose Level 3|Adverse Event|0|||
33140943|NCT02217527|100431501|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
33140944|NCT02217527|100431502|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
33140945|NCT02217527|100431501|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
33140946|NCT02217527|100431502|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
33140947|NCT02674854|100431504|FG000|Overall Study|Adverse Event|17|||
33140948|NCT02674854|100431505|FG001|Overall Study|Adverse Event|15|||
33140949|NCT02674854|100431506|FG002|Overall Study|Adverse Event|5|||
33140950|NCT02674854|100431504|FG000|Overall Study|Withdrawal by Subject|1|||
33140951|NCT02674854|100431505|FG001|Overall Study|Withdrawal by Subject|5|||
33140952|NCT02674854|100431506|FG002|Overall Study|Withdrawal by Subject|4|||
33140953|NCT02674854|100431504|FG000|Overall Study|No-compliant subject|1|||
33140954|NCT02674854|100431505|FG001|Overall Study|No-compliant subject|0|||
33239168|NCT01474512|100775938|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
33239169|NCT01474512|100775939|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
33239170|NCT01474512|100775940|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
33239171|NCT01474512|100775941|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
33239172|NCT01474512|100775942|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
33239173|NCT01474512|100775943|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
33239174|NCT01474512|100775944|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
33239175|NCT01474512|100775945|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
33239176|NCT01474512|100775946|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
33239177|NCT01474512|100775947|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
33239178|NCT01474512|100775948|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
33239179|NCT01474512|100775949|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
33239180|NCT01474512|100775950|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
33239181|NCT01474512|100775951|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
33239182|NCT01474512|100775952|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
33239183|NCT01474512|100775953|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
33239184|NCT01474512|100775954|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
33239185|NCT01474512|100775937|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
33370393|NCT00002663|101240097|FG003|Overall Study|Lost to Follow-up|1|||
33370394|NCT00002663|101240098|FG004|Overall Study|Lost to Follow-up|0|||
33370395|NCT00002663|101240099|FG005|Overall Study|Lost to Follow-up|1|||
33370396|NCT00002663|101240100|FG006|Overall Study|Lost to Follow-up|0|||
33370397|NCT00002663|101240101|FG007|Overall Study|Lost to Follow-up|0|||
33370398|NCT00002663|101240102|FG008|Overall Study|Lost to Follow-up|0|||
33370399|NCT00002663|101240103|FG009|Overall Study|Lost to Follow-up|0|||
33370400|NCT00002663|101240094|FG000|Overall Study|Other|0|||
33370401|NCT00002663|101240095|FG001|Overall Study|Other|1|||
33370402|NCT00002663|101240096|FG002|Overall Study|Other|0|||
33370403|NCT00002663|101240097|FG003|Overall Study|Other|0|||
33370404|NCT00002663|101240098|FG004|Overall Study|Other|0|||
33639946|NCT00790842|102232793|FG000|Dose Level 3|Withdrawal by Subject|0|||
33639947|NCT00790842|102232794|FG001|Dose Level 3|Withdrawal by Subject|0|||
33639948|NCT00790842|102232795|FG002|Dose Level 3|Withdrawal by Subject|3|||
33239186|NCT01474512|100775938|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
33639949|NCT00790842|102232796|FG003|Dose Level 3|Withdrawal by Subject|0|||
33370405|NCT00002663|101240099|FG005|Overall Study|Other|1|||
33370406|NCT00002663|101240100|FG006|Overall Study|Other|1|||
33639950|NCT00790842|102232797|FG004|Dose Level 3|Withdrawal by Subject|0|||
33639951|NCT00790842|102232798|FG005|Dose Level 3|Withdrawal by Subject|0|||
33239187|NCT01474512|100775939|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
33239188|NCT01474512|100775940|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
33239189|NCT01474512|100775941|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
33239190|NCT01474512|100775942|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
33239191|NCT01474512|100775943|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
33239192|NCT01474512|100775944|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
33239193|NCT01474512|100775945|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
33239194|NCT01474512|100775946|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
33239195|NCT01474512|100775947|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
33239196|NCT01474512|100775948|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
33239197|NCT01474512|100775949|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
33239198|NCT01474512|100775950|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
33239199|NCT01474512|100775951|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
33239200|NCT01474512|100775952|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
33239201|NCT01474512|100775953|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
33639952|NCT00790842|102232799|FG006|Dose Level 3|Withdrawal by Subject|0|||
33639953|NCT00790842|102232800|FG007|Dose Level 3|Withdrawal by Subject|0|||
33639954|NCT00790842|102232801|FG008|Dose Level 3|Withdrawal by Subject|0|||
33239202|NCT01474512|100775954|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
33239203|NCT01474512|100775937|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33239204|NCT01474512|100775938|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33239205|NCT01474512|100775939|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33239206|NCT01474512|100775940|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33239207|NCT01474512|100775941|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33239208|NCT01474512|100775942|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33239209|NCT01474512|100775943|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33239210|NCT01474512|100775944|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33239211|NCT01474512|100775945|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33239212|NCT01474512|100775946|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33239213|NCT01474512|100775947|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33239214|NCT01474512|100775948|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33239215|NCT01474512|100775949|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33639955|NCT00790842|102232802|FG009|Dose Level 3|Withdrawal by Subject|2|||
33639956|NCT00790842|102232803|FG010|Dose Level 3|Withdrawal by Subject|0|||
33639957|NCT00790842|102232793|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33639958|NCT00790842|102232794|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33639959|NCT00790842|102232795|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33639960|NCT00790842|102232796|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33639961|NCT00790842|102232797|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33639962|NCT00790842|102232798|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
33639963|NCT00790842|102232799|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33639964|NCT00790842|102232800|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33639965|NCT00790842|102232801|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33639966|NCT00790842|102232802|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33639967|NCT00790842|102232803|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
33639968|NCT00790842|102232793|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33639969|NCT00790842|102232794|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33639970|NCT00790842|102232795|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
33639971|NCT00790842|102232796|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33639972|NCT00790842|102232797|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33639973|NCT00790842|102232798|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33639974|NCT00790842|102232799|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33639975|NCT00790842|102232800|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33639976|NCT00790842|102232801|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33639977|NCT00790842|102232802|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33639978|NCT00790842|102232803|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
33639979|NCT00790842|102232793|FG000|Dose Level 4|Adverse Event|0|||
33239216|NCT01474512|100775950|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33239217|NCT01474512|100775951|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
33239218|NCT01474512|100775952|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33239219|NCT01474512|100775953|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
33420935|NCT03515837|101431671|FG000|Overall Study|Death|219|||
33420936|NCT03515837|101431672|FG001|Overall Study|Death|227|||
33239220|NCT01474512|100775954|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
33420937|NCT03515837|101431671|FG000|Overall Study|Lost to Follow-up|0|||
33420938|NCT03515837|101431672|FG001|Overall Study|Lost to Follow-up|1|||
33639980|NCT00790842|102232794|FG001|Dose Level 4|Adverse Event|0|||
33639981|NCT00790842|102232795|FG002|Dose Level 4|Adverse Event|0|||
33639982|NCT00790842|102232796|FG003|Dose Level 4|Adverse Event|0|||
33639983|NCT00790842|102232797|FG004|Dose Level 4|Adverse Event|0|||
33639984|NCT00790842|102232798|FG005|Dose Level 4|Adverse Event|0|||
33239221|NCT01474512|100775937|FG000|Post-Treatment Follow-Up|Death|0|||
33239222|NCT01474512|100775938|FG001|Post-Treatment Follow-Up|Death|0|||
33239223|NCT01474512|100775939|FG002|Post-Treatment Follow-Up|Death|0|||
33239224|NCT01474512|100775940|FG003|Post-Treatment Follow-Up|Death|0|||
33239225|NCT01474512|100775941|FG004|Post-Treatment Follow-Up|Death|0|||
33239226|NCT01474512|100775942|FG005|Post-Treatment Follow-Up|Death|0|||
33239227|NCT01474512|100775943|FG006|Post-Treatment Follow-Up|Death|0|||
33239228|NCT01474512|100775944|FG007|Post-Treatment Follow-Up|Death|0|||
33239229|NCT01474512|100775945|FG008|Post-Treatment Follow-Up|Death|0|||
33239230|NCT01474512|100775946|FG009|Post-Treatment Follow-Up|Death|0|||
33239231|NCT01474512|100775947|FG010|Post-Treatment Follow-Up|Death|0|||
33239232|NCT01474512|100775948|FG011|Post-Treatment Follow-Up|Death|0|||
33239233|NCT01474512|100775949|FG012|Post-Treatment Follow-Up|Death|0|||
33239234|NCT01474512|100775950|FG013|Post-Treatment Follow-Up|Death|0|||
33239235|NCT01474512|100775951|FG014|Post-Treatment Follow-Up|Death|0|||
33239236|NCT01474512|100775952|FG015|Post-Treatment Follow-Up|Death|0|||
33239237|NCT01474512|100775953|FG016|Post-Treatment Follow-Up|Death|1|||
33239238|NCT01474512|100775954|FG017|Post-Treatment Follow-Up|Death|0|||
33239239|NCT00664521|100775955|FG000|Overall Study|Adverse Event|4|||
33239240|NCT00664521|100775956|FG001|Overall Study|Adverse Event|1|||
33239241|NCT00664521|100775955|FG000|Overall Study|Lost to Follow-up|1|||
33239242|NCT00664521|100775956|FG001|Overall Study|Lost to Follow-up|0|||
33239243|NCT00664521|100775955|FG000|Overall Study|Other|1|||
33239244|NCT00664521|100775956|FG001|Overall Study|Other|0|||
33239245|NCT01256476|100775958|FG000|Overall Study|Adverse Event|2|||
33239246|NCT01256476|100775959|FG001|Overall Study|Adverse Event|1|||
33239247|NCT01256476|100775958|FG000|Overall Study|Withdrawal by Subject|2|||
33239248|NCT01256476|100775959|FG001|Overall Study|Withdrawal by Subject|1|||
33239249|NCT01256476|100775958|FG000|Overall Study|Lost to Follow-up|1|||
33239250|NCT01256476|100775959|FG001|Overall Study|Lost to Follow-up|2|||
33239251|NCT01256476|100775958|FG000|Overall Study|Persistent ALT or AST elevation|1|||
33239252|NCT01256476|100775959|FG001|Overall Study|Persistent ALT or AST elevation|0|||
33239253|NCT01256476|100775958|FG000|Overall Study|Physician Decision|0|||
33239254|NCT01256476|100775959|FG001|Overall Study|Physician Decision|1|||
33239255|NCT01256476|100775958|FG000|Overall Study|Subject non-compliance|0|||
33239256|NCT01256476|100775959|FG001|Overall Study|Subject non-compliance|1|||
33239257|NCT01256476|100775958|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
33239258|NCT01256476|100775959|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
33239259|NCT00654940|100775960|FG000|Period 1|Adverse Event|0|||
33239260|NCT00654940|100775961|FG001|Period 1|Adverse Event|1|||
33239261|NCT00654940|100775960|FG000|Period 1|Intolerable Pain Level|1|||
33239262|NCT00654940|100775961|FG001|Period 1|Intolerable Pain Level|0|||
33239263|NCT02696785|100775962|FG000|Blinded Treatment Period|Adverse Event|0|||
33239264|NCT02696785|100775963|FG001|Blinded Treatment Period|Adverse Event|1|||
33239265|NCT02696785|100775964|FG002|Blinded Treatment Period|Adverse Event|3|||
33239266|NCT02696785|100775965|FG003|Blinded Treatment Period|Adverse Event|0|||
33239267|NCT02696785|100775962|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
33239268|NCT02696785|100775963|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
33140955|NCT02674854|100431506|FG002|Overall Study|No-compliant subject|1|||
33140956|NCT02674854|100431504|FG000|Overall Study|Lost to Follow-up|1|||
33140957|NCT02674854|100431505|FG001|Overall Study|Lost to Follow-up|0|||
33140958|NCT02674854|100431506|FG002|Overall Study|Lost to Follow-up|2|||
33140959|NCT02674854|100431504|FG000|Overall Study|Lack of Efficacy|0|||
33140960|NCT02674854|100431505|FG001|Overall Study|Lack of Efficacy|3|||
33140961|NCT02674854|100431506|FG002|Overall Study|Lack of Efficacy|0|||
33140962|NCT02674854|100431504|FG000|Overall Study|Disallowed Concurrent Medication|2|||
33140963|NCT02674854|100431505|FG001|Overall Study|Disallowed Concurrent Medication|2|||
33140964|NCT02674854|100431506|FG002|Overall Study|Disallowed Concurrent Medication|0|||
33140965|NCT02674854|100431504|FG000|Overall Study|Protocol Violation|1|||
33140966|NCT02674854|100431505|FG001|Overall Study|Protocol Violation|1|||
33140967|NCT02674854|100431506|FG002|Overall Study|Protocol Violation|2|||
33140968|NCT02674854|100431504|FG000|Overall Study|Death|0|||
33140969|NCT02674854|100431505|FG001|Overall Study|Death|1|||
33140970|NCT02674854|100431506|FG002|Overall Study|Death|0|||
33140971|NCT02674854|100431504|FG000|Overall Study|Subject missed V6.2|1|||
33140972|NCT02674854|100431505|FG001|Overall Study|Subject missed V6.2|0|||
33140973|NCT02674854|100431506|FG002|Overall Study|Subject missed V6.2|0|||
33140974|NCT01092832|100431510|FG000|Overall Study|Other|1|||
33140975|NCT01092832|100431511|FG001|Overall Study|Other|0|||
33140976|NCT02276027|100431512|FG000|Overall Study|Death|1|||
33140977|NCT02276027|100431513|FG001|Overall Study|Death|0|||
33140978|NCT02276027|100431514|FG002|Overall Study|Death|0|||
33140979|NCT02276027|100431515|FG003|Overall Study|Death|2|||
33140980|NCT02276027|100431512|FG000|Overall Study|Physician Decision|0|||
33140981|NCT02276027|100431513|FG001|Overall Study|Physician Decision|0|||
33140982|NCT02276027|100431514|FG002|Overall Study|Physician Decision|0|||
33140983|NCT02276027|100431515|FG003|Overall Study|Physician Decision|1|||
33140984|NCT02276027|100431512|FG000|Overall Study|Progressive disease|1|||
33140985|NCT02276027|100431513|FG001|Overall Study|Progressive disease|13|||
33639985|NCT00790842|102232799|FG006|Dose Level 4|Adverse Event|1|||
33639986|NCT00790842|102232800|FG007|Dose Level 4|Adverse Event|0|||
33639987|NCT00790842|102232801|FG008|Dose Level 4|Adverse Event|0|||
33639988|NCT00790842|102232802|FG009|Dose Level 4|Adverse Event|0|||
33639989|NCT00790842|102232803|FG010|Dose Level 4|Adverse Event|0|||
33639990|NCT00790842|102232793|FG000|Dose Level 4|Physician Decision|0|||
33639991|NCT00790842|102232794|FG001|Dose Level 4|Physician Decision|0|||
33639992|NCT00790842|102232795|FG002|Dose Level 4|Physician Decision|0|||
33639993|NCT00790842|102232796|FG003|Dose Level 4|Physician Decision|0|||
33639994|NCT00790842|102232797|FG004|Dose Level 4|Physician Decision|0|||
33140986|NCT02276027|100431514|FG002|Overall Study|Progressive disease|12|||
33140987|NCT02276027|100431515|FG003|Overall Study|Progressive disease|14|||
33140988|NCT02276027|100431512|FG000|Overall Study|Subject/guardian decision|0|||
33140989|NCT02276027|100431513|FG001|Overall Study|Subject/guardian decision|1|||
33140990|NCT02276027|100431514|FG002|Overall Study|Subject/guardian decision|0|||
33140991|NCT02276027|100431515|FG003|Overall Study|Subject/guardian decision|3|||
33140992|NCT02276027|100431512|FG000|Overall Study|Adverse Event|0|||
33140993|NCT02276027|100431513|FG001|Overall Study|Adverse Event|2|||
33140994|NCT02276027|100431514|FG002|Overall Study|Adverse Event|8|||
33140995|NCT02276027|100431515|FG003|Overall Study|Adverse Event|2|||
33140996|NCT01323920|100431516|FG000|Overall Study|Death|5|||
33140997|NCT01323920|100431516|FG000|Overall Study|Withdrawal by Subject|1|||
33140998|NCT04585009|100431517|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
33140999|NCT04585009|100431518|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
33141000|NCT04585009|100431519|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
33141001|NCT04585009|100431520|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
33141002|NCT04585009|100431521|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
33141003|NCT04585009|100431522|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
33141004|NCT04585009|100431523|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
33141005|NCT04585009|100431524|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
33141006|NCT04585009|100431525|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
33141007|NCT04585009|100431526|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
33141008|NCT04585009|100431527|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
33141009|NCT04585009|100431528|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
33141010|NCT04585009|100431517|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
33141011|NCT04585009|100431518|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
33141012|NCT04585009|100431519|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
33141013|NCT04585009|100431520|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
33141014|NCT04585009|100431521|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
33141015|NCT04585009|100431522|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
33141016|NCT04585009|100431523|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
33141017|NCT04585009|100431524|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
33141018|NCT04585009|100431525|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
33141019|NCT04585009|100431526|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
33141020|NCT04585009|100431527|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
33141021|NCT04585009|100431528|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
33141022|NCT04585009|100431517|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
33141023|NCT04585009|100431518|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
33141024|NCT04585009|100431519|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
33141025|NCT04585009|100431520|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
33141026|NCT04585009|100431521|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
33141027|NCT04585009|100431522|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
33141028|NCT04585009|100431523|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
33141029|NCT04585009|100431524|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
33141030|NCT04585009|100431525|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
33141031|NCT04585009|100431526|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
33141032|NCT04585009|100431527|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
33141033|NCT04585009|100431528|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
33141034|NCT04585009|100431517|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
33141035|NCT04585009|100431518|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
33141036|NCT04585009|100431519|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
33141037|NCT04585009|100431520|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
33141038|NCT04585009|100431521|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
33370407|NCT00002663|101240101|FG007|Overall Study|Other|0|||
33639995|NCT00790842|102232798|FG005|Dose Level 4|Physician Decision|0|||
33639996|NCT00790842|102232799|FG006|Dose Level 4|Physician Decision|1|||
33639997|NCT00790842|102232800|FG007|Dose Level 4|Physician Decision|0|||
33639998|NCT00790842|102232801|FG008|Dose Level 4|Physician Decision|0|||
33639999|NCT00790842|102232802|FG009|Dose Level 4|Physician Decision|0|||
33640000|NCT00790842|102232803|FG010|Dose Level 4|Physician Decision|1|||
33640001|NCT00790842|102232793|FG000|Dose Level 4|Withdrawal by Subject|0|||
33640002|NCT00790842|102232794|FG001|Dose Level 4|Withdrawal by Subject|0|||
33640003|NCT00790842|102232795|FG002|Dose Level 4|Withdrawal by Subject|0|||
33640004|NCT00790842|102232796|FG003|Dose Level 4|Withdrawal by Subject|0|||
33640005|NCT00790842|102232797|FG004|Dose Level 4|Withdrawal by Subject|0|||
33640006|NCT00790842|102232798|FG005|Dose Level 4|Withdrawal by Subject|0|||
33640007|NCT00790842|102232799|FG006|Dose Level 4|Withdrawal by Subject|0|||
33239269|NCT02696785|100775964|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
33239270|NCT02696785|100775965|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
33239271|NCT02696785|100775962|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
33239272|NCT02696785|100775963|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
33239273|NCT02696785|100775964|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
33239274|NCT02696785|100775965|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
33239275|NCT02696785|100775962|FG000|Blinded Treatment Period|Screen Failure|1|||
33239276|NCT02696785|100775963|FG001|Blinded Treatment Period|Screen Failure|0|||
33239277|NCT02696785|100775964|FG002|Blinded Treatment Period|Screen Failure|0|||
33239278|NCT02696785|100775965|FG003|Blinded Treatment Period|Screen Failure|0|||
33239279|NCT02696785|100775962|FG000|Washout Period|Withdrawal by Subject|0|||
33239280|NCT02696785|100775963|FG001|Washout Period|Withdrawal by Subject|1|||
33239281|NCT02696785|100775964|FG002|Washout Period|Withdrawal by Subject|0|||
33239282|NCT02696785|100775965|FG003|Washout Period|Withdrawal by Subject|0|||
33239283|NCT02696785|100775962|FG000|Washout Period|Lack of Efficacy|0|||
33239284|NCT02696785|100775963|FG001|Washout Period|Lack of Efficacy|1|||
33239285|NCT02696785|100775964|FG002|Washout Period|Lack of Efficacy|0|||
33239286|NCT02696785|100775965|FG003|Washout Period|Lack of Efficacy|0|||
33239287|NCT02696785|100775962|FG000|Extended Treatment Period|Adverse Event|2|||
33239288|NCT02696785|100775963|FG001|Extended Treatment Period|Adverse Event|3|||
33239289|NCT02696785|100775964|FG002|Extended Treatment Period|Adverse Event|2|||
33239290|NCT02696785|100775965|FG003|Extended Treatment Period|Adverse Event|1|||
33239291|NCT02696785|100775962|FG000|Extended Treatment Period|Lack of Efficacy|0|||
33239292|NCT02696785|100775963|FG001|Extended Treatment Period|Lack of Efficacy|1|||
33239293|NCT02696785|100775964|FG002|Extended Treatment Period|Lack of Efficacy|0|||
33239294|NCT02696785|100775965|FG003|Extended Treatment Period|Lack of Efficacy|0|||
33239295|NCT02696785|100775962|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
33239296|NCT02696785|100775963|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
33239297|NCT02696785|100775964|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
33239298|NCT02696785|100775965|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
33239299|NCT02696785|100775962|FG000|Follow-up Period|Adverse Event|0|||
33239300|NCT02696785|100775963|FG001|Follow-up Period|Adverse Event|0|||
33239301|NCT02696785|100775964|FG002|Follow-up Period|Adverse Event|8|||
33239302|NCT02696785|100775965|FG003|Follow-up Period|Adverse Event|2|||
33239303|NCT02696785|100775962|FG000|Follow-up Period|Lost to Follow-up|0|||
33239304|NCT02696785|100775963|FG001|Follow-up Period|Lost to Follow-up|0|||
33239305|NCT02696785|100775964|FG002|Follow-up Period|Lost to Follow-up|0|||
33239306|NCT02696785|100775965|FG003|Follow-up Period|Lost to Follow-up|1|||
33239307|NCT02696785|100775962|FG000|Follow-up Period|Lack of Efficacy|0|||
33239308|NCT02696785|100775963|FG001|Follow-up Period|Lack of Efficacy|0|||
33239309|NCT02696785|100775964|FG002|Follow-up Period|Lack of Efficacy|0|||
33239310|NCT02696785|100775965|FG003|Follow-up Period|Lack of Efficacy|1|||
33239311|NCT02696785|100775962|FG000|Follow-up Period|Withdrawal by Subject|1|||
33239312|NCT02696785|100775963|FG001|Follow-up Period|Withdrawal by Subject|0|||
33239313|NCT02696785|100775964|FG002|Follow-up Period|Withdrawal by Subject|5|||
33239314|NCT02696785|100775965|FG003|Follow-up Period|Withdrawal by Subject|4|||
33239315|NCT00765362|100775969|FG000|Overall Study|Death|9|||
33239316|NCT00765362|100775969|FG000|Overall Study|Adverse Event|2|||
33239317|NCT00765362|100775969|FG000|Overall Study|Protocol Violation|18|||
33239318|NCT00765362|100775969|FG000|Overall Study|Withdrawal by Subject|13|||
33239319|NCT00765362|100775969|FG000|Overall Study|Lost to Follow-up|95|||
33239320|NCT01347645|100775976|FG000|Overall Study|Death|1|||
33239321|NCT01347645|100775977|FG001|Overall Study|Death|5|||
33239322|NCT01347645|100775978|FG002|Overall Study|Death|2|||
33239323|NCT01347645|100775979|FG003|Overall Study|Death|7|||
33239324|NCT01347645|100775980|FG004|Overall Study|Death|7|||
33640008|NCT00790842|102232800|FG007|Dose Level 4|Withdrawal by Subject|0|||
33239325|NCT01347645|100775976|FG000|Overall Study|Lost to Follow-up|1|||
33239326|NCT01347645|100775977|FG001|Overall Study|Lost to Follow-up|1|||
33239327|NCT01347645|100775978|FG002|Overall Study|Lost to Follow-up|0|||
33239328|NCT01347645|100775979|FG003|Overall Study|Lost to Follow-up|1|||
33239329|NCT01347645|100775980|FG004|Overall Study|Lost to Follow-up|1|||
33239330|NCT01347645|100775976|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
33640009|NCT00790842|102232801|FG008|Dose Level 4|Withdrawal by Subject|0|||
33640010|NCT00790842|102232802|FG009|Dose Level 4|Withdrawal by Subject|0|||
33239331|NCT01347645|100775977|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
33286409|NCT00092521|100943969|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
33370408|NCT00002663|101240102|FG008|Overall Study|Other|0|||
33640011|NCT00790842|102232803|FG010|Dose Level 4|Withdrawal by Subject|1|||
33640012|NCT00790842|102232793|FG000|Expansion Cohort|Adverse Event|0|||
33640013|NCT00790842|102232794|FG001|Expansion Cohort|Adverse Event|0|||
33640014|NCT00790842|102232795|FG002|Expansion Cohort|Adverse Event|0|||
33640015|NCT00790842|102232796|FG003|Expansion Cohort|Adverse Event|0|||
33640016|NCT00790842|102232797|FG004|Expansion Cohort|Adverse Event|0|||
33640017|NCT00790842|102232798|FG005|Expansion Cohort|Adverse Event|0|||
33640018|NCT00790842|102232799|FG006|Expansion Cohort|Adverse Event|1|||
33640019|NCT00790842|102232800|FG007|Expansion Cohort|Adverse Event|0|||
33640020|NCT00790842|102232801|FG008|Expansion Cohort|Adverse Event|0|||
33640021|NCT00790842|102232802|FG009|Expansion Cohort|Adverse Event|0|||
33640022|NCT00790842|102232803|FG010|Expansion Cohort|Adverse Event|0|||
33640023|NCT00790842|102232793|FG000|Expansion Cohort|Death|0|||
33640024|NCT00790842|102232794|FG001|Expansion Cohort|Death|0|||
33640025|NCT00790842|102232795|FG002|Expansion Cohort|Death|2|||
33640026|NCT00790842|102232796|FG003|Expansion Cohort|Death|0|||
33640027|NCT00790842|102232797|FG004|Expansion Cohort|Death|0|||
33640028|NCT00790842|102232798|FG005|Expansion Cohort|Death|0|||
33640029|NCT00790842|102232799|FG006|Expansion Cohort|Death|0|||
33640030|NCT00790842|102232800|FG007|Expansion Cohort|Death|0|||
33141039|NCT04585009|100431522|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
33141040|NCT04585009|100431523|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
33141041|NCT04585009|100431524|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
33141042|NCT04585009|100431525|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
33141043|NCT04585009|100431526|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
33141044|NCT04585009|100431527|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
33141045|NCT04585009|100431528|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
33141046|NCT04585009|100431517|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
33141047|NCT04585009|100431518|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
33141048|NCT04585009|100431519|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
33141049|NCT04585009|100431520|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
33141050|NCT04585009|100431521|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
33141051|NCT04585009|100431522|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
33141052|NCT04585009|100431523|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
33141053|NCT04585009|100431524|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
33141054|NCT04585009|100431525|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
33141055|NCT04585009|100431526|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
33141056|NCT04585009|100431527|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
33141057|NCT04585009|100431528|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
33141058|NCT04585009|100431517|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
33141059|NCT04585009|100431518|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
33141060|NCT04585009|100431519|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
33141061|NCT04585009|100431520|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
33141062|NCT04585009|100431521|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
33141063|NCT04585009|100431522|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
33141064|NCT04585009|100431523|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
33141065|NCT04585009|100431524|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
33141066|NCT04585009|100431525|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
33141067|NCT04585009|100431526|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
33141068|NCT04585009|100431527|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
33141069|NCT04585009|100431528|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
33141070|NCT00859638|100431531|FG000|Overall Study|Lost to Follow-up|6|||
33141071|NCT00859638|100431532|FG001|Overall Study|Lost to Follow-up|1|||
33141072|NCT00859638|100431531|FG000|Overall Study|Withdrawal by Subject|3|||
33141073|NCT00859638|100431532|FG001|Overall Study|Withdrawal by Subject|2|||
33141074|NCT00859638|100431531|FG000|Overall Study|Ill health|1|||
33141075|NCT00859638|100431532|FG001|Overall Study|Ill health|1|||
33141076|NCT01470989|100431536|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
33141077|NCT01470989|100431537|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
33141078|NCT01470989|100431536|FG000|Overall Study|Adverse Event|2|||
33141079|NCT01470989|100431537|FG001|Overall Study|Adverse Event|5|||
33141080|NCT01470989|100431536|FG000|Overall Study|Abnormal laboratory value|1|||
33141081|NCT01470989|100431537|FG001|Overall Study|Abnormal laboratory value|1|||
33141082|NCT01470989|100431536|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33141083|NCT01470989|100431537|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
33141084|NCT01470989|100431536|FG000|Overall Study|Withdrawal by Subject|19|||
33141085|NCT01470989|100431537|FG001|Overall Study|Withdrawal by Subject|17|||
33640031|NCT00790842|102232801|FG008|Expansion Cohort|Death|0|||
33640032|NCT00790842|102232802|FG009|Expansion Cohort|Death|0|||
33640033|NCT00790842|102232803|FG010|Expansion Cohort|Death|0|||
33640034|NCT00790842|102232793|FG000|Expansion Cohort|Physician Decision|0|||
33640035|NCT00790842|102232794|FG001|Expansion Cohort|Physician Decision|0|||
33640036|NCT00790842|102232795|FG002|Expansion Cohort|Physician Decision|1|||
33640037|NCT00790842|102232796|FG003|Expansion Cohort|Physician Decision|0|||
33640038|NCT00790842|102232797|FG004|Expansion Cohort|Physician Decision|0|||
33640039|NCT00790842|102232798|FG005|Expansion Cohort|Physician Decision|0|||
33640040|NCT00790842|102232799|FG006|Expansion Cohort|Physician Decision|0|||
33640041|NCT00790842|102232800|FG007|Expansion Cohort|Physician Decision|0|||
33640042|NCT00790842|102232801|FG008|Expansion Cohort|Physician Decision|0|||
33640043|NCT00790842|102232802|FG009|Expansion Cohort|Physician Decision|0|||
33640044|NCT00790842|102232803|FG010|Expansion Cohort|Physician Decision|0|||
33640045|NCT00790842|102232793|FG000|Expansion Cohort|Withdrawal by Subject|0|||
33640046|NCT00790842|102232794|FG001|Expansion Cohort|Withdrawal by Subject|0|||
33640047|NCT00790842|102232795|FG002|Expansion Cohort|Withdrawal by Subject|3|||
33640048|NCT00790842|102232796|FG003|Expansion Cohort|Withdrawal by Subject|0|||
33640049|NCT00790842|102232797|FG004|Expansion Cohort|Withdrawal by Subject|0|||
33640050|NCT00790842|102232798|FG005|Expansion Cohort|Withdrawal by Subject|0|||
33640051|NCT00790842|102232799|FG006|Expansion Cohort|Withdrawal by Subject|0|||
33640052|NCT00790842|102232800|FG007|Expansion Cohort|Withdrawal by Subject|0|||
33640053|NCT00790842|102232801|FG008|Expansion Cohort|Withdrawal by Subject|0|||
33640054|NCT00790842|102232802|FG009|Expansion Cohort|Withdrawal by Subject|0|||
33640055|NCT00790842|102232803|FG010|Expansion Cohort|Withdrawal by Subject|0|||
33640056|NCT00790842|102232793|FG000|Expansion Cohort|Study Closure|0|||
33640057|NCT00790842|102232794|FG001|Expansion Cohort|Study Closure|0|||
33640058|NCT00790842|102232795|FG002|Expansion Cohort|Study Closure|1|||
33640059|NCT00790842|102232796|FG003|Expansion Cohort|Study Closure|0|||
33640060|NCT00790842|102232797|FG004|Expansion Cohort|Study Closure|0|||
33640061|NCT00790842|102232798|FG005|Expansion Cohort|Study Closure|0|||
33640062|NCT00790842|102232799|FG006|Expansion Cohort|Study Closure|0|||
33640063|NCT00790842|102232800|FG007|Expansion Cohort|Study Closure|0|||
33640064|NCT00790842|102232801|FG008|Expansion Cohort|Study Closure|0|||
33640065|NCT00790842|102232802|FG009|Expansion Cohort|Study Closure|0|||
33640066|NCT00790842|102232803|FG010|Expansion Cohort|Study Closure|0|||
33640067|NCT01287741|102232813|FG000|Overall Study|Withdrawal by Subject|35|||
33640068|NCT01287741|102232814|FG001|Overall Study|Withdrawal by Subject|38|||
33640069|NCT01287741|102232813|FG000|Overall Study|Protocol Violation|2|||
33640070|NCT01287741|102232814|FG001|Overall Study|Protocol Violation|0|||
33640071|NCT01287741|102232813|FG000|Overall Study|Physician Decision|15|||
33640072|NCT01287741|102232814|FG001|Overall Study|Physician Decision|23|||
33640073|NCT01287741|102232813|FG000|Overall Study|Non-compliance|8|||
33640074|NCT01287741|102232814|FG001|Overall Study|Non-compliance|6|||
33640075|NCT01287741|102232813|FG000|Overall Study|Lost to Follow-up|10|||
33640076|NCT01287741|102232814|FG001|Overall Study|Lost to Follow-up|8|||
33640077|NCT01287741|102232813|FG000|Overall Study|Death|32|||
33640078|NCT01287741|102232814|FG001|Overall Study|Death|44|||
33640079|NCT01287741|102232813|FG000|Overall Study|Adverse Event|4|||
33640080|NCT01287741|102232814|FG001|Overall Study|Adverse Event|6|||
33640081|NCT01287741|102232813|FG000|Overall Study|Study terminated by Sponsor|307|||
33640082|NCT01287741|102232814|FG001|Overall Study|Study terminated by Sponsor|315|||
33640083|NCT01287741|102232813|FG000|Overall Study|Progressive disease|190|||
33640084|NCT01287741|102232814|FG001|Overall Study|Progressive disease|166|||
33640085|NCT01287741|102232813|FG000|Overall Study|Reason not specified|23|||
33640086|NCT01287741|102232814|FG001|Overall Study|Reason not specified|9|||
33640087|NCT00753649|102232821|FG000|Overall Study|Migrated/moved from study area|1|||
33640088|NCT00753649|102232822|FG001|Overall Study|Migrated/moved from study area|0|||
33640089|NCT00753649|102232821|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
33640090|NCT00753649|102232822|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
33640091|NCT00753649|102232821|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
33640092|NCT00753649|102232822|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
33640093|NCT00753649|102232821|FG000|Overall Study|Protocol Violation|2|||
33640094|NCT00753649|102232822|FG001|Overall Study|Protocol Violation|0|||
33640095|NCT01165216|102232823|FG000|Overall Study|Adverse Event|6|||
33640096|NCT01165216|102232824|FG001|Overall Study|Adverse Event|3|||
33640097|NCT01165216|102232823|FG000|Overall Study|Withdrawal by Subject|1|||
33640098|NCT01165216|102232824|FG001|Overall Study|Withdrawal by Subject|1|||
33640099|NCT01165216|102232823|FG000|Overall Study|Disease progression|1|||
33640100|NCT01165216|102232824|FG001|Overall Study|Disease progression|3|||
33640101|NCT01467960|102232825|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
33640102|NCT01467960|102232826|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
33640103|NCT01467960|102232827|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
33640104|NCT01467960|102232828|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
33640105|NCT01467960|102232829|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
33640106|NCT01467960|102232830|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
33640107|NCT00256997|102232832|FG000|Overall Study|Protocol Violation|1|||
33640108|NCT00256997|102232833|FG001|Overall Study|Protocol Violation|4|||
33141086|NCT01470989|100431536|FG000|Overall Study|Lost to Follow-up|18|||
33640109|NCT00256997|102232832|FG000|Overall Study|Lack of Efficacy|1|||
33640110|NCT00256997|102232833|FG001|Overall Study|Lack of Efficacy|4|||
33640111|NCT00256997|102232832|FG000|Overall Study|Death|2|||
33640112|NCT00256997|102232833|FG001|Overall Study|Death|0|||
33640113|NCT00256997|102232832|FG000|Overall Study|Adverse Event|4|||
33640114|NCT00256997|102232833|FG001|Overall Study|Adverse Event|0|||
33640115|NCT00256997|102232832|FG000|Overall Study|Lost to Follow-up|3|||
33640116|NCT00256997|102232833|FG001|Overall Study|Lost to Follow-up|5|||
33640117|NCT00256997|102232832|FG000|Overall Study|Withdrawal by Subject|13|||
33640118|NCT00256997|102232833|FG001|Overall Study|Withdrawal by Subject|3|||
33640119|NCT00256997|102232832|FG000|Overall Study|Started but not treated|2|||
33640120|NCT00256997|102232833|FG001|Overall Study|Started but not treated|0|||
33640121|NCT00256997|102232832|FG000|Overall Study|Other|5|||
33640122|NCT00256997|102232833|FG001|Overall Study|Other|8|||
33640123|NCT00256997|102232832|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
33640124|NCT00256997|102232833|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
33640125|NCT00256997|102232832|FG000|Overall Study|Participant Non-compliant|3|||
33640126|NCT00256997|102232833|FG001|Overall Study|Participant Non-compliant|6|||
33640127|NCT00256997|102232832|FG000|Overall Study|Investigator Withdrew Participant|2|||
33640128|NCT00256997|102232833|FG001|Overall Study|Investigator Withdrew Participant|1|||
33640129|NCT02106390|102232836|FG000|Overall Study|Withdrawal by Subject|15|||
33640130|NCT02106390|102232837|FG001|Overall Study|Withdrawal by Subject|16|||
33640131|NCT02106390|102232838|FG002|Overall Study|Withdrawal by Subject|15|||
33640132|NCT02106390|102232836|FG000|Overall Study|Lost to Follow-up|25|||
33640133|NCT02106390|102232837|FG001|Overall Study|Lost to Follow-up|20|||
33640134|NCT02106390|102232838|FG002|Overall Study|Lost to Follow-up|13|||
33640135|NCT02106390|102232836|FG000|Overall Study|Other: Administrative Reason|8|||
33640136|NCT02106390|102232837|FG001|Overall Study|Other: Administrative Reason|5|||
33640137|NCT02106390|102232838|FG002|Overall Study|Other: Administrative Reason|12|||
33640138|NCT02106390|102232836|FG000|Overall Study|Other: Unspecified|1|||
33640139|NCT02106390|102232837|FG001|Overall Study|Other: Unspecified|4|||
33640140|NCT02106390|102232838|FG002|Overall Study|Other: Unspecified|2|||
33640141|NCT02106390|102232836|FG000|Overall Study|Adverse Event|0|||
33640142|NCT02106390|102232837|FG001|Overall Study|Adverse Event|2|||
33640143|NCT02106390|102232838|FG002|Overall Study|Adverse Event|1|||
33640144|NCT02106390|102232836|FG000|Overall Study|Protocol Violation|0|||
33640145|NCT02106390|102232837|FG001|Overall Study|Protocol Violation|1|||
33640146|NCT02106390|102232838|FG002|Overall Study|Protocol Violation|0|||
33640147|NCT00829504|102232839|FG000|First Intervention|Adverse Event|1|||
33640148|NCT00829504|102232840|FG001|First Intervention|Adverse Event|0|||
33640149|NCT00829504|102232839|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
33141087|NCT01470989|100431537|FG001|Overall Study|Lost to Follow-up|13|||
33640150|NCT00829504|102232840|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
33640151|NCT00829504|102232839|FG000|Second Intervention|Physician Decision|1|||
33640152|NCT00829504|102232840|FG001|Second Intervention|Physician Decision|0|||
33640153|NCT02395471|102232845|FG000|Overall Study|Lost to Follow-up|2|||
33640154|NCT02395471|102232846|FG001|Overall Study|Lost to Follow-up|0|||
33640155|NCT02395471|102232845|FG000|Overall Study|Withdrawal by Subject|2|||
33640156|NCT02395471|102232846|FG001|Overall Study|Withdrawal by Subject|1|||
33640157|NCT02395471|102232845|FG000|Overall Study|Physician Decision|1|||
33640158|NCT02395471|102232846|FG001|Overall Study|Physician Decision|0|||
33141088|NCT01470989|100431536|FG000|Overall Study|Administrative problems|2|||
33141089|NCT01470989|100431537|FG001|Overall Study|Administrative problems|4|||
33141090|NCT01470989|100431536|FG000|Overall Study|Death|2|||
33141091|NCT01470989|100431537|FG001|Overall Study|Death|2|||
33141092|NCT01470989|100431536|FG000|Overall Study|Protocol deviation|1|||
33141093|NCT01470989|100431537|FG001|Overall Study|Protocol deviation|2|||
33141094|NCT01966432|100431539|FG000|Overall Study|Lost to Follow-up|3|||
33141095|NCT01966432|100431540|FG001|Overall Study|Lost to Follow-up|2|||
33370409|NCT00002663|101240103|FG009|Overall Study|Other|0|||
33370410|NCT00002663|101240094|FG000|Overall Study|Physician Decision|0|||
33370411|NCT00002663|101240095|FG001|Overall Study|Physician Decision|0|||
33370412|NCT00002663|101240096|FG002|Overall Study|Physician Decision|0|||
33370413|NCT00002663|101240097|FG003|Overall Study|Physician Decision|0|||
33370414|NCT00002663|101240098|FG004|Overall Study|Physician Decision|1|||
33370415|NCT00002663|101240099|FG005|Overall Study|Physician Decision|0|||
33370416|NCT00002663|101240100|FG006|Overall Study|Physician Decision|0|||
33370417|NCT00002663|101240101|FG007|Overall Study|Physician Decision|0|||
33640159|NCT02395471|102232845|FG000|Overall Study|Protocol Violation|0|||
33640160|NCT02395471|102232846|FG001|Overall Study|Protocol Violation|1|||
33640161|NCT02395471|102232845|FG000|Overall Study|Failure to swollow sponge twice|1|||
33640162|NCT02395471|102232846|FG001|Overall Study|Failure to swollow sponge twice|0|||
33640163|NCT02395471|102232845|FG000|Overall Study|Patient did not return for procedure|0|||
33640164|NCT02395471|102232846|FG001|Overall Study|Patient did not return for procedure|1|||
33640165|NCT02395471|102232845|FG000|Overall Study|Subject not eligible|1|||
33640166|NCT02395471|102232846|FG001|Overall Study|Subject not eligible|0|||
33141096|NCT01966432|100431541|FG002|Overall Study|Lost to Follow-up|5|||
33141097|NCT01966432|100431539|FG000|Overall Study|Withdrawal by Subject|1|||
33640167|NCT00802945|102232852|FG000|Overall Study|Death|27|||
33640168|NCT00802945|102232853|FG001|Overall Study|Death|23|||
33640169|NCT00802945|102232852|FG000|Overall Study|Terminated by sponsor|8|||
33640170|NCT00802945|102232853|FG001|Overall Study|Terminated by sponsor|12|||
33640171|NCT01442103|102232854|FG000|Overall Study|Lost to Follow-up|2|||
33141098|NCT01966432|100431540|FG001|Overall Study|Withdrawal by Subject|3|||
33141099|NCT01966432|100431541|FG002|Overall Study|Withdrawal by Subject|0|||
33141100|NCT01966432|100431539|FG000|Overall Study|Subject Incarcerated|0|||
33239332|NCT01347645|100775978|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
33640172|NCT02840461|102232855|FG000|Overall Study|Adverse Event|1|||
33640173|NCT02840461|102232856|FG001|Overall Study|Adverse Event|5|||
33640174|NCT02840461|102232857|FG002|Overall Study|Adverse Event|3|||
33640175|NCT02840461|102232855|FG000|Overall Study|Lost to Follow-up|10|||
33640176|NCT02840461|102232856|FG001|Overall Study|Lost to Follow-up|7|||
33640177|NCT02840461|102232857|FG002|Overall Study|Lost to Follow-up|6|||
33640178|NCT02840461|102232855|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
33640179|NCT02840461|102232856|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
33640180|NCT02840461|102232857|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
33640181|NCT02840461|102232855|FG000|Overall Study|Protocol Violation|2|||
33640182|NCT02840461|102232856|FG001|Overall Study|Protocol Violation|3|||
33640183|NCT02840461|102232857|FG002|Overall Study|Protocol Violation|1|||
33640184|NCT02840461|102232855|FG000|Overall Study|Withdrawal by Subject|10|||
33640185|NCT02840461|102232856|FG001|Overall Study|Withdrawal by Subject|6|||
33640186|NCT02840461|102232857|FG002|Overall Study|Withdrawal by Subject|2|||
33640187|NCT02840461|102232855|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
33640188|NCT02840461|102232856|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
33640189|NCT02840461|102232857|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
33640190|NCT04085289|102232858|FG000|Overall Study|Withdrawal by Subject|0|||
33640191|NCT04085289|102232859|FG001|Overall Study|Withdrawal by Subject|0|||
33640192|NCT04085289|102232860|FG002|Overall Study|Withdrawal by Subject|1|||
33640193|NCT02675634|102232861|FG000|Test Period 1|Adverse Event|0|||
33640194|NCT02675634|102232862|FG001|Test Period 1|Adverse Event|1|||
33640195|NCT02675634|102232863|FG002|Test Period 1|Adverse Event|0|||
33640196|NCT02675634|102232864|FG003|Test Period 1|Adverse Event|1|||
33640197|NCT02675634|102232865|FG004|Test Period 1|Adverse Event|0|||
33640198|NCT02675634|102232866|FG005|Test Period 1|Adverse Event|0|||
33640199|NCT02675634|102232861|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
33640200|NCT02675634|102232862|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
33640201|NCT02675634|102232863|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
33640202|NCT02675634|102232864|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
33640203|NCT02675634|102232865|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
33640204|NCT02675634|102232866|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
33640205|NCT02675634|102232861|FG000|Test Period 2|Lack of Efficacy|1|||
33640206|NCT02675634|102232862|FG001|Test Period 2|Lack of Efficacy|0|||
33640207|NCT02675634|102232863|FG002|Test Period 2|Lack of Efficacy|0|||
33640208|NCT02675634|102232864|FG003|Test Period 2|Lack of Efficacy|0|||
33640209|NCT02675634|102232865|FG004|Test Period 2|Lack of Efficacy|0|||
33640210|NCT02675634|102232866|FG005|Test Period 2|Lack of Efficacy|0|||
33640211|NCT02675634|102232861|FG000|Test Period 2|Adverse Event|0|||
33640212|NCT02675634|102232862|FG001|Test Period 2|Adverse Event|0|||
33640213|NCT02675634|102232863|FG002|Test Period 2|Adverse Event|0|||
33640214|NCT02675634|102232864|FG003|Test Period 2|Adverse Event|0|||
33640215|NCT02675634|102232865|FG004|Test Period 2|Adverse Event|0|||
33640216|NCT02675634|102232866|FG005|Test Period 2|Adverse Event|1|||
33640217|NCT00721968|102232867|FG000|Overall Study|Lost to Follow-up|2|||
33640218|NCT00721968|102232868|FG001|Overall Study|Lost to Follow-up|0|||
33640219|NCT01012440|102232869|FG000|Overall Study|Withdrawal by Subject|2|||
33640220|NCT02379091|102232870|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33640221|NCT02379091|102232871|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
33640222|NCT02379091|102232872|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
33640223|NCT02379091|102232873|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
33640224|NCT02379091|102232870|FG000|Overall Study|Principal Investigator Discretion|0|||
33640225|NCT02379091|102232871|FG001|Overall Study|Principal Investigator Discretion|1|||
33640226|NCT02379091|102232872|FG002|Overall Study|Principal Investigator Discretion|0|||
33640227|NCT02379091|102232873|FG003|Overall Study|Principal Investigator Discretion|0|||
33640228|NCT02379091|102232870|FG000|Overall Study|Lost to Follow-up|0|||
33640229|NCT02379091|102232871|FG001|Overall Study|Lost to Follow-up|0|||
33640230|NCT02379091|102232872|FG002|Overall Study|Lost to Follow-up|0|||
33370418|NCT00002663|101240102|FG008|Overall Study|Physician Decision|1|||
33370419|NCT00002663|101240103|FG009|Overall Study|Physician Decision|1|||
33370420|NCT00002663|101240094|FG000|Overall Study|Adverse Event|0|||
33640231|NCT02379091|102232873|FG003|Overall Study|Lost to Follow-up|1|||
33640232|NCT02379091|102232870|FG000|Overall Study|Voluntary Withdrawal|2|||
33640233|NCT02379091|102232871|FG001|Overall Study|Voluntary Withdrawal|5|||
33640234|NCT02379091|102232872|FG002|Overall Study|Voluntary Withdrawal|2|||
33640235|NCT02379091|102232873|FG003|Overall Study|Voluntary Withdrawal|4|||
33640236|NCT02379091|102232870|FG000|Overall Study|Study Termination|7|||
33640237|NCT02379091|102232871|FG001|Overall Study|Study Termination|2|||
33141101|NCT01966432|100431540|FG001|Overall Study|Subject Incarcerated|0|||
33640238|NCT02379091|102232872|FG002|Overall Study|Study Termination|5|||
33640239|NCT02379091|102232873|FG003|Overall Study|Study Termination|8|||
33640240|NCT02379091|102232870|FG000|Overall Study|Lack of Efficacy|3|||
33640241|NCT02379091|102232871|FG001|Overall Study|Lack of Efficacy|0|||
33640242|NCT02379091|102232872|FG002|Overall Study|Lack of Efficacy|0|||
33640243|NCT02379091|102232873|FG003|Overall Study|Lack of Efficacy|0|||
33640244|NCT02302339|102232874|FG000|Overall Study|Lost to Follow-up|1|||
33640245|NCT02302339|102232875|FG001|Overall Study|Lost to Follow-up|0|||
33640246|NCT02302339|102232876|FG002|Overall Study|Lost to Follow-up|0|||
33640247|NCT02302339|102232877|FG003|Overall Study|Lost to Follow-up|0|||
33640248|NCT02302339|102232874|FG000|Overall Study|Withdrawal by Subject|0|||
33640249|NCT02302339|102232875|FG001|Overall Study|Withdrawal by Subject|2|||
33640250|NCT02302339|102232876|FG002|Overall Study|Withdrawal by Subject|1|||
33640251|NCT02302339|102232877|FG003|Overall Study|Withdrawal by Subject|0|||
33640252|NCT00060840|102232884|FG000|Overall Study|Change in surgical plan|2|||
33640253|NCT00060840|102232885|FG001|Overall Study|Change in surgical plan|6|||
33640254|NCT00060840|102232884|FG000|Overall Study|Death|0|||
33640255|NCT00060840|102232885|FG001|Overall Study|Death|1|||
33640256|NCT00060840|102232884|FG000|Overall Study|Withdrawal by Subject|0|||
33640257|NCT00060840|102232885|FG001|Overall Study|Withdrawal by Subject|1|||
33640258|NCT00060840|102232884|FG000|Overall Study|Subinvestigator unavailable|0|||
33370421|NCT00002663|101240095|FG001|Overall Study|Adverse Event|0|||
33640259|NCT00060840|102232885|FG001|Overall Study|Subinvestigator unavailable|1|||
33640260|NCT00060840|102232884|FG000|Overall Study|Physician Decision|1|||
33640261|NCT00060840|102232885|FG001|Overall Study|Physician Decision|0|||
33640262|NCT00060840|102232884|FG000|Overall Study|Other|1|||
33640263|NCT00060840|102232885|FG001|Overall Study|Other|0|||
33640264|NCT00865566|102232888|FG000|Overall Study|Death|1|||
33640265|NCT00865566|102232889|FG001|Overall Study|Death|11|||
33640266|NCT00865566|102232888|FG000|Overall Study|Lost to Follow-up|314|||
33640267|NCT00865566|102232889|FG001|Overall Study|Lost to Follow-up|315|||
33640268|NCT00865566|102232888|FG000|Overall Study|Withdrawal by Subject|45|||
33640269|NCT00865566|102232889|FG001|Overall Study|Withdrawal by Subject|65|||
33640270|NCT00865566|102232888|FG000|Overall Study|Physician Decision|0|||
33640271|NCT00865566|102232889|FG001|Overall Study|Physician Decision|1|||
33640272|NCT00865566|102232888|FG000|Overall Study|Participant relocated|78|||
33640273|NCT00865566|102232889|FG001|Overall Study|Participant relocated|107|||
33640274|NCT00865566|102232888|FG000|Overall Study|Participant unable to adhere|27|||
33640275|NCT00865566|102232889|FG001|Overall Study|Participant unable to adhere|42|||
33640276|NCT00865566|102232888|FG000|Overall Study|Other; N=245 due to early study closure|154|||
33640277|NCT00865566|102232889|FG001|Overall Study|Other; N=245 due to early study closure|139|||
33640278|NCT00865566|102232888|FG000|Overall Study|HIV infection|5|||
33640279|NCT00865566|102232889|FG001|Overall Study|HIV infection|7|||
33640280|NCT00048074|102232895|FG000|Overall Study|Adverse Event|46|||
33640281|NCT00048074|102232896|FG001|Overall Study|Adverse Event|41|||
33640282|NCT00048074|102232897|FG002|Overall Study|Adverse Event|53|||
33640283|NCT00048074|102232895|FG000|Overall Study|Death|3|||
33640284|NCT00048074|102232896|FG001|Overall Study|Death|3|||
33640285|NCT00048074|102232897|FG002|Overall Study|Death|2|||
33640286|NCT00048074|102232895|FG000|Overall Study|Lost to Follow-up|2|||
33640287|NCT00048074|102232896|FG001|Overall Study|Lost to Follow-up|6|||
33640288|NCT00048074|102232897|FG002|Overall Study|Lost to Follow-up|6|||
33640289|NCT00048074|102232895|FG000|Overall Study|Withdrawal by Subject|28|||
33640290|NCT00048074|102232896|FG001|Overall Study|Withdrawal by Subject|30|||
33640291|NCT00048074|102232897|FG002|Overall Study|Withdrawal by Subject|35|||
33640292|NCT00048074|102232895|FG000|Overall Study|Protocol Violation|1|||
33640293|NCT00048074|102232896|FG001|Overall Study|Protocol Violation|3|||
33640294|NCT00048074|102232897|FG002|Overall Study|Protocol Violation|0|||
33640295|NCT00048074|102232895|FG000|Overall Study|Study participation was terminated|0|||
33640296|NCT00048074|102232896|FG001|Overall Study|Study participation was terminated|1|||
33640297|NCT00048074|102232897|FG002|Overall Study|Study participation was terminated|0|||
33640298|NCT00048074|102232895|FG000|Overall Study|Husband ill|0|||
33640299|NCT00048074|102232896|FG001|Overall Study|Husband ill|1|||
33640300|NCT00048074|102232897|FG002|Overall Study|Husband ill|0|||
33640301|NCT00048074|102232895|FG000|Overall Study|Poor compliance|0|||
33640302|NCT00048074|102232896|FG001|Overall Study|Poor compliance|1|||
33640303|NCT00048074|102232897|FG002|Overall Study|Poor compliance|0|||
33640304|NCT00048074|102232895|FG000|Overall Study|Out of station|0|||
33640305|NCT00048074|102232896|FG001|Overall Study|Out of station|1|||
33640306|NCT00048074|102232897|FG002|Overall Study|Out of station|1|||
33640307|NCT00048074|102232895|FG000|Overall Study|Social reasons|1|||
33640308|NCT00048074|102232896|FG001|Overall Study|Social reasons|0|||
33640309|NCT00048074|102232897|FG002|Overall Study|Social reasons|0|||
33640310|NCT01342211|102232898|FG000|Overall Study|Lost to Follow-up|0|||
33640311|NCT01342211|102232899|FG001|Overall Study|Lost to Follow-up|0|||
33370422|NCT00002663|101240096|FG002|Overall Study|Adverse Event|0|||
33640312|NCT01342211|102232900|FG002|Overall Study|Lost to Follow-up|0|||
33640313|NCT01342211|102232901|FG003|Overall Study|Lost to Follow-up|1|||
33640314|NCT01342211|102232902|FG004|Overall Study|Lost to Follow-up|0|||
33640315|NCT01342211|102232898|FG000|Overall Study|Adverse Event|0|||
33640316|NCT01342211|102232899|FG001|Overall Study|Adverse Event|0|||
33640317|NCT01342211|102232900|FG002|Overall Study|Adverse Event|0|||
33640318|NCT01342211|102232901|FG003|Overall Study|Adverse Event|0|||
33640319|NCT01342211|102232902|FG004|Overall Study|Adverse Event|1|||
33640320|NCT01342211|102232898|FG000|Overall Study|Withdrawal by Subject|0|||
33640321|NCT01342211|102232899|FG001|Overall Study|Withdrawal by Subject|0|||
33640322|NCT01342211|102232900|FG002|Overall Study|Withdrawal by Subject|0|||
33640323|NCT01342211|102232901|FG003|Overall Study|Withdrawal by Subject|1|||
33640324|NCT01342211|102232902|FG004|Overall Study|Withdrawal by Subject|0|||
33640325|NCT01342211|102232898|FG000|Overall Study|Randomized, but not Treated|0|||
33640326|NCT01342211|102232899|FG001|Overall Study|Randomized, but not Treated|2|||
33640327|NCT01342211|102232900|FG002|Overall Study|Randomized, but not Treated|0|||
33640328|NCT01342211|102232901|FG003|Overall Study|Randomized, but not Treated|0|||
33640329|NCT01342211|102232902|FG004|Overall Study|Randomized, but not Treated|1|||
33640330|NCT00346697|102232903|FG000|Overall Study|Lost to Follow-up|0|||
33640331|NCT00346697|102232904|FG001|Overall Study|Lost to Follow-up|1|||
33640332|NCT02357368|102232911|FG000|Overall Study|Lost to Follow-up|0|||
33640333|NCT02357368|102232912|FG001|Overall Study|Lost to Follow-up|0|||
33640334|NCT02357368|102232913|FG002|Overall Study|Lost to Follow-up|0|||
33640335|NCT02357368|102232914|FG003|Overall Study|Lost to Follow-up|1|||
33640336|NCT02357368|102232911|FG000|Overall Study|Pregnancy|3|||
33640337|NCT02357368|102232912|FG001|Overall Study|Pregnancy|2|||
33640338|NCT02357368|102232913|FG002|Overall Study|Pregnancy|0|||
33579780|NCT03599518|102013172|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
33640339|NCT02357368|102232914|FG003|Overall Study|Pregnancy|0|||
33141102|NCT01966432|100431541|FG002|Overall Study|Subject Incarcerated|1|||
33141103|NCT01966432|100431539|FG000|Overall Study|SBIRT program ended|1|||
33141104|NCT01966432|100431540|FG001|Overall Study|SBIRT program ended|8|||
33141105|NCT01966432|100431541|FG002|Overall Study|SBIRT program ended|20|||
33141106|NCT01436162|100431545|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
33141107|NCT01436162|100431546|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
33141108|NCT01436162|100431547|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
33141109|NCT01436162|100431545|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
33141110|NCT01436162|100431546|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
33141111|NCT01436162|100431547|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
33141112|NCT01436162|100431545|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
33141113|NCT01436162|100431546|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
33370423|NCT00002663|101240097|FG003|Overall Study|Adverse Event|1|||
33370424|NCT00002663|101240098|FG004|Overall Study|Adverse Event|0|||
33370425|NCT00002663|101240099|FG005|Overall Study|Adverse Event|0|||
33370426|NCT00002663|101240100|FG006|Overall Study|Adverse Event|0|||
33370427|NCT00002663|101240101|FG007|Overall Study|Adverse Event|1|||
33370428|NCT00002663|101240102|FG008|Overall Study|Adverse Event|0|||
33370429|NCT00002663|101240103|FG009|Overall Study|Adverse Event|0|||
33370430|NCT02575079|101240104|FG000|Overall Study|Death|3|||
33370431|NCT02575079|101240105|FG001|Overall Study|Death|0|||
33370432|NCT02575079|101240104|FG000|Overall Study|Withdrawal by Subject|3|||
33370433|NCT02575079|101240105|FG001|Overall Study|Withdrawal by Subject|0|||
33370434|NCT00968253|101243422|FG000|Overall Study|Death|0|||
33370435|NCT00968253|101243423|FG001|Overall Study|Death|0|||
33370436|NCT00968253|101243424|FG002|Overall Study|Death|2|||
33370437|NCT00968253|101243422|FG000|Overall Study|Withdrawal by Subject|0|||
33370438|NCT00968253|101243423|FG001|Overall Study|Withdrawal by Subject|0|||
33420939|NCT03515837|101431671|FG000|Overall Study|Withdrawal by Subject|0|||
33579781|NCT03599518|102013168|FG000|Overall Study|Participant withdrawal from study treatment|0|||
33579782|NCT03599518|102013169|FG001|Overall Study|Participant withdrawal from study treatment|0|||
33579783|NCT03599518|102013170|FG002|Overall Study|Participant withdrawal from study treatment|1|||
33579784|NCT03599518|102013171|FG003|Overall Study|Participant withdrawal from study treatment|0|||
33579785|NCT03599518|102013172|FG004|Overall Study|Participant withdrawal from study treatment|0|||
33579786|NCT00992056|102013173|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
33579787|NCT00992056|102013174|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
33579788|NCT00992056|102013173|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
33579789|NCT00992056|102013174|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
33579790|NCT02140970|102013175|FG000|Overall Study|Lost to Follow-up|1|||
33579791|NCT02140970|102013176|FG001|Overall Study|Lost to Follow-up|2|||
33579792|NCT02140970|102013175|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
33579793|NCT02140970|102013176|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
33579794|NCT02140970|102013175|FG000|Overall Study|Did not meet inclusion criteria|0|||
33579795|NCT02140970|102013176|FG001|Overall Study|Did not meet inclusion criteria|1|||
33579796|NCT03369665|102013177|FG000|Overall Study|Adverse Event|3|||
33640340|NCT02357368|102232911|FG000|Overall Study|Withdrawal by Subject|3|||
33640341|NCT02357368|102232912|FG001|Overall Study|Withdrawal by Subject|1|||
33141114|NCT01436162|100431547|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
33370439|NCT00968253|101243424|FG002|Overall Study|Withdrawal by Subject|1|||
33640342|NCT02357368|102232913|FG002|Overall Study|Withdrawal by Subject|1|||
33640343|NCT02357368|102232914|FG003|Overall Study|Withdrawal by Subject|2|||
33640344|NCT02038933|102232915|FG000|Overall Study|Disease progression|104|||
33640345|NCT02038933|102232915|FG000|Overall Study|Study drug toxicity|6|||
33370440|NCT00968253|101243422|FG000|Overall Study|Disease Progression|0|||
33370441|NCT00968253|101243423|FG001|Overall Study|Disease Progression|3|||
33579797|NCT03369665|102013177|FG000|Overall Study|Lost to Follow-up|7|||
33579798|NCT03369665|102013177|FG000|Overall Study|Withdrawal by Subject|15|||
33579799|NCT03369665|102013177|FG000|Overall Study|Progression Disease|2|||
33579800|NCT03369665|102013177|FG000|Overall Study|Not classified|3|||
33579801|NCT00414076|102013178|FG000|Overall Study|Progression|1|||
33579802|NCT00414076|102013179|FG001|Overall Study|Progression|2|||
33579803|NCT00414076|102013178|FG000|Overall Study|Withdrawal by Subject|1|||
33579804|NCT00414076|102013179|FG001|Overall Study|Withdrawal by Subject|3|||
33579805|NCT00414076|102013178|FG000|Overall Study|Adverse Event|1|||
33579806|NCT00414076|102013179|FG001|Overall Study|Adverse Event|0|||
33579807|NCT03188263|102013180|FG000|Overall Study|Withdrawal by Subject|3|||
33579808|NCT03188263|102013181|FG001|Overall Study|Withdrawal by Subject|0|||
33579809|NCT03188263|102013180|FG000|Overall Study|Physician Decision|1|||
33579810|NCT03188263|102013181|FG001|Overall Study|Physician Decision|0|||
33579811|NCT00401843|102013182|FG000|Overall Study|Achieved Complete Response|1|||
33579812|NCT00401843|102013183|FG001|Overall Study|Achieved Complete Response|5|||
33579813|NCT00401843|102013184|FG002|Overall Study|Achieved Complete Response|11|||
33579814|NCT00401843|102013182|FG000|Overall Study|Adverse Event|7|||
33579815|NCT00401843|102013183|FG001|Overall Study|Adverse Event|26|||
33579816|NCT00401843|102013184|FG002|Overall Study|Adverse Event|27|||
33579817|NCT00401843|102013182|FG000|Overall Study|Death|0|||
33579818|NCT00401843|102013183|FG001|Overall Study|Death|8|||
33579819|NCT00401843|102013184|FG002|Overall Study|Death|10|||
33579820|NCT00401843|102013182|FG000|Overall Study|Disease progression|10|||
33579821|NCT00401843|102013183|FG001|Overall Study|Disease progression|60|||
33579822|NCT00401843|102013184|FG002|Overall Study|Disease progression|49|||
33579823|NCT00401843|102013182|FG000|Overall Study|End of Study|1|||
33579824|NCT00401843|102013183|FG001|Overall Study|End of Study|1|||
33579825|NCT00401843|102013184|FG002|Overall Study|End of Study|2|||
33579826|NCT00401843|102013182|FG000|Overall Study|Lost to Follow-up|0|||
33579827|NCT00401843|102013183|FG001|Overall Study|Lost to Follow-up|0|||
33579828|NCT00401843|102013184|FG002|Overall Study|Lost to Follow-up|2|||
33640346|NCT02038933|102232915|FG000|Overall Study|Adverse event unrelated to study drug|6|||
33640347|NCT02038933|102232915|FG000|Overall Study|Participant request to discontinue treatment|2|||
33640348|NCT02038933|102232915|FG000|Overall Study|Lost to Follow-up|1|||
33640349|NCT02038933|102232915|FG000|Overall Study|Other reasons|2|||
33640350|NCT01301027|102232920|FG000|Overall Study|Physician Decision|2|||
33640351|NCT01301027|102232921|FG001|Overall Study|Physician Decision|0|||
33640352|NCT01301027|102232920|FG000|Overall Study|Withdrawal by Subject|2|||
33640353|NCT01301027|102232921|FG001|Overall Study|Withdrawal by Subject|3|||
33640354|NCT01301027|102232920|FG000|Overall Study|Adverse Event|0|||
33640355|NCT01301027|102232921|FG001|Overall Study|Adverse Event|2|||
33640356|NCT01301027|102232920|FG000|Overall Study|Fracture|1|||
33640357|NCT01301027|102232921|FG001|Overall Study|Fracture|3|||
33640358|NCT01301027|102232920|FG000|Overall Study|Transplant|0|||
33640359|NCT01301027|102232921|FG001|Overall Study|Transplant|2|||
33640360|NCT01301027|102232920|FG000|Overall Study|Volume Overload|3|||
33640361|NCT01301027|102232921|FG001|Overall Study|Volume Overload|0|||
33640362|NCT02351856|102232922|FG000|Overall Study|Adverse Event|2|||
33640363|NCT02351856|102232922|FG000|Overall Study|Physician Decision|5|||
33640364|NCT02351856|102232922|FG000|Overall Study|Study terminated by sponsor|1|||
33640365|NCT02999672|102232925|FG000|Overall Study|Death|0|||
33640366|NCT02999672|102232926|FG001|Overall Study|Death|1|||
33640367|NCT02999672|102232925|FG000|Overall Study|Study Terminated by Sponsor|0|||
33640368|NCT02999672|102232926|FG001|Overall Study|Study Terminated by Sponsor|1|||
33640369|NCT02999672|102232925|FG000|Overall Study|Progressive Disease|9|||
33640370|NCT02999672|102232926|FG001|Overall Study|Progressive Disease|5|||
33640371|NCT02999672|102232925|FG000|Overall Study|Adverse Event|4|||
33640372|NCT02999672|102232926|FG001|Overall Study|Adverse Event|0|||
33640373|NCT00953056|102232931|FG000|Overall Study|Withdrew Consent|0|||
33640374|NCT00953056|102232932|FG001|Overall Study|Withdrew Consent|0|||
33640375|NCT00953056|102232933|FG002|Overall Study|Withdrew Consent|0|||
33640376|NCT00953056|102232934|FG003|Overall Study|Withdrew Consent|0|||
33370442|NCT00968253|101243424|FG002|Overall Study|Disease Progression|3|||
33420940|NCT03515837|101431672|FG001|Overall Study|Withdrawal by Subject|4|||
33579829|NCT00401843|102013182|FG000|Overall Study|Other Unspecified|0|||
33579830|NCT00401843|102013183|FG001|Overall Study|Other Unspecified|3|||
33579831|NCT00401843|102013184|FG002|Overall Study|Other Unspecified|5|||
33579832|NCT00401843|102013182|FG000|Overall Study|Physician Decision|0|||
33579833|NCT00401843|102013183|FG001|Overall Study|Physician Decision|16|||
33579834|NCT00401843|102013184|FG002|Overall Study|Physician Decision|10|||
33579835|NCT00401843|102013182|FG000|Overall Study|Protocol Violation|0|||
33579836|NCT00401843|102013183|FG001|Overall Study|Protocol Violation|0|||
33640377|NCT00953056|102232935|FG004|Overall Study|Withdrew Consent|2|||
33640378|NCT00953056|102232936|FG005|Overall Study|Withdrew Consent|3|||
33640379|NCT00953056|102232931|FG000|Overall Study|Serious Adverse Event|0|||
33141115|NCT01436162|100431545|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
33141116|NCT01436162|100431546|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
33141117|NCT01436162|100431547|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
33141118|NCT01436162|100431545|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
33141119|NCT01436162|100431546|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
33141120|NCT01436162|100431547|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
33141121|NCT01436162|100431545|FG000|Single-blind Lead-in Phase|Other|107|||
33141122|NCT01436162|100431546|FG001|Single-blind Lead-in Phase|Other|0|||
33141123|NCT01436162|100431547|FG002|Single-blind Lead-in Phase|Other|0|||
33579837|NCT00401843|102013184|FG002|Overall Study|Protocol Violation|1|||
33579838|NCT00401843|102013182|FG000|Overall Study|Withdrawal by Subject|1|||
33579839|NCT00401843|102013183|FG001|Overall Study|Withdrawal by Subject|5|||
33579840|NCT00401843|102013184|FG002|Overall Study|Withdrawal by Subject|5|||
33579841|NCT00401843|102013182|FG000|Overall Study|Withdrawal of consent to study agent|1|||
33579842|NCT00401843|102013183|FG001|Overall Study|Withdrawal of consent to study agent|15|||
33579843|NCT00401843|102013184|FG002|Overall Study|Withdrawal of consent to study agent|17|||
33579844|NCT00401843|102013182|FG000|Overall Study|Randomized but not Treated|0|||
33579845|NCT00401843|102013183|FG001|Overall Study|Randomized but not Treated|2|||
33579846|NCT00401843|102013184|FG002|Overall Study|Randomized but not Treated|3|||
33579847|NCT00401843|102013182|FG000|Overall Study|Received incorrect treatment|0|||
33579848|NCT00401843|102013183|FG001|Overall Study|Received incorrect treatment|3|||
33579849|NCT00401843|102013184|FG002|Overall Study|Received incorrect treatment|0|||
33579850|NCT00589797|102013185|FG000|Overall Study|Death|1|||
33141124|NCT01436162|100431545|FG000|Randomized Phase|Adverse Event|1|||
33141125|NCT01436162|100431546|FG001|Randomized Phase|Adverse Event|5|||
33141126|NCT01436162|100431547|FG002|Randomized Phase|Adverse Event|6|||
33141127|NCT01436162|100431545|FG000|Randomized Phase|Protocol Violation|4|||
33141128|NCT01436162|100431546|FG001|Randomized Phase|Protocol Violation|4|||
33141129|NCT01436162|100431547|FG002|Randomized Phase|Protocol Violation|2|||
33141130|NCT01436162|100431545|FG000|Randomized Phase|Withdrawal by Subject|16|||
33141131|NCT01436162|100431546|FG001|Randomized Phase|Withdrawal by Subject|9|||
33141132|NCT01436162|100431547|FG002|Randomized Phase|Withdrawal by Subject|8|||
33141133|NCT01436162|100431545|FG000|Randomized Phase|Lost to Follow-up|17|||
33141134|NCT01436162|100431546|FG001|Randomized Phase|Lost to Follow-up|5|||
33141135|NCT01436162|100431547|FG002|Randomized Phase|Lost to Follow-up|4|||
33141136|NCT01436162|100431545|FG000|Randomized Phase|Lack of Efficacy|0|||
33141137|NCT01436162|100431546|FG001|Randomized Phase|Lack of Efficacy|1|||
33141138|NCT01436162|100431547|FG002|Randomized Phase|Lack of Efficacy|1|||
33141139|NCT01436162|100431545|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
33141140|NCT01436162|100431546|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
33141141|NCT01436162|100431547|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
33141142|NCT01436162|100431545|FG000|Randomized Phase|Other|2|||
33141143|NCT01436162|100431546|FG001|Randomized Phase|Other|5|||
33141144|NCT01436162|100431547|FG002|Randomized Phase|Other|4|||
33579851|NCT00589797|102013186|FG001|Overall Study|Death|0|||
33579852|NCT00589797|102013185|FG000|Overall Study|Lost to Follow-up|12|||
33579853|NCT00589797|102013186|FG001|Overall Study|Lost to Follow-up|9|||
33579854|NCT00589797|102013185|FG000|Overall Study|Physician Decision|8|||
33579855|NCT00589797|102013186|FG001|Overall Study|Physician Decision|3|||
33579856|NCT00589797|102013185|FG000|Overall Study|Withdrawal by Subject|6|||
33141145|NCT00775203|100431548|FG000|Overall Study|Adverse Event|25|||
33141146|NCT00775203|100431549|FG001|Overall Study|Adverse Event|6|||
33141147|NCT00775203|100431548|FG000|Overall Study|Lack of Efficacy|8|||
33141148|NCT00775203|100431549|FG001|Overall Study|Lack of Efficacy|9|||
33141149|NCT00775203|100431548|FG000|Overall Study|Withdrawal by Subject|11|||
33141150|NCT00775203|100431549|FG001|Overall Study|Withdrawal by Subject|9|||
33141151|NCT00775203|100431548|FG000|Overall Study|Lost to Follow-up|11|||
33141152|NCT00775203|100431549|FG001|Overall Study|Lost to Follow-up|15|||
33141153|NCT00775203|100431548|FG000|Overall Study|Administrative reason|2|||
33141154|NCT00775203|100431549|FG001|Overall Study|Administrative reason|0|||
33141155|NCT00775203|100431548|FG000|Overall Study|Noncompliance|4|||
33141156|NCT00775203|100431549|FG001|Overall Study|Noncompliance|2|||
33579857|NCT00589797|102013186|FG001|Overall Study|Withdrawal by Subject|5|||
33579858|NCT00589797|102013185|FG000|Overall Study|Non-Randomized Training Subjects|46|||
33579859|NCT00589797|102013186|FG001|Overall Study|Non-Randomized Training Subjects|6|||
33579860|NCT03759600|102013187|FG000|Overall Study|Adverse Event|2|||
33579861|NCT03759600|102013187|FG000|Overall Study|Progressive Disease|15|||
33579862|NCT03759600|102013187|FG000|Overall Study|Site Terminated by Sponsor|3|||
33579863|NCT05384834|102013192|FG000|Overall Study|Lost to Follow-up|43|||
33141157|NCT00775203|100431548|FG000|Overall Study|Protocol Violation|0|||
33579864|NCT05384834|102013192|FG000|Overall Study|Withdrawal by Subject|5|||
33579865|NCT01665911|102013193|FG000|Overall Study|Protocol Violation|4|||
33141158|NCT00775203|100431549|FG001|Overall Study|Protocol Violation|1|||
33141159|NCT00775203|100431548|FG000|Overall Study|Entered other study|1|||
33141160|NCT00775203|100431549|FG001|Overall Study|Entered other study|0|||
33141161|NCT00775203|100431548|FG000|Overall Study|Physician Decision|0|||
33239333|NCT01347645|100775979|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
33239334|NCT01347645|100775980|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
33239335|NCT01347645|100775976|FG000|Overall Study|Other|1|||
33239336|NCT01347645|100775977|FG001|Overall Study|Other|0|||
33239337|NCT01347645|100775978|FG002|Overall Study|Other|0|||
33239338|NCT01347645|100775979|FG003|Overall Study|Other|0|||
33239339|NCT01347645|100775980|FG004|Overall Study|Other|1|||
33239340|NCT01347645|100775976|FG000|Overall Study|Withdrawal by Subject|0|||
33239341|NCT01347645|100775977|FG001|Overall Study|Withdrawal by Subject|0|||
33239342|NCT01347645|100775978|FG002|Overall Study|Withdrawal by Subject|0|||
33239343|NCT01347645|100775979|FG003|Overall Study|Withdrawal by Subject|3|||
33239344|NCT01347645|100775980|FG004|Overall Study|Withdrawal by Subject|3|||
33239345|NCT01347645|100775976|FG000|Overall Study|Physician Decision|0|||
33239346|NCT01347645|100775977|FG001|Overall Study|Physician Decision|0|||
33239347|NCT01347645|100775978|FG002|Overall Study|Physician Decision|0|||
33239348|NCT01347645|100775979|FG003|Overall Study|Physician Decision|0|||
33239349|NCT01347645|100775980|FG004|Overall Study|Physician Decision|1|||
33239350|NCT01347645|100775976|FG000|Overall Study|Adverse Event|0|||
33239351|NCT01347645|100775977|FG001|Overall Study|Adverse Event|0|||
33239352|NCT01347645|100775978|FG002|Overall Study|Adverse Event|0|||
33239353|NCT01347645|100775979|FG003|Overall Study|Adverse Event|1|||
33579866|NCT01665911|102013193|FG000|Overall Study|Withdrawal by Subject|1|||
33579867|NCT01665911|102013193|FG000|Overall Study|Adverse Event|1|||
33579868|NCT00642707|102013194|FG000|Overall Study|Adverse Event|0|||
33579869|NCT00642707|102013195|FG001|Overall Study|Adverse Event|0|||
33579870|NCT00642707|102013196|FG002|Overall Study|Adverse Event|0|||
33579871|NCT00642707|102013197|FG003|Overall Study|Adverse Event|2|||
33579872|NCT00642707|102013194|FG000|Overall Study|Withdrawal by Subject|1|||
33579873|NCT00642707|102013195|FG001|Overall Study|Withdrawal by Subject|0|||
33579874|NCT00642707|102013196|FG002|Overall Study|Withdrawal by Subject|0|||
33579875|NCT00642707|102013197|FG003|Overall Study|Withdrawal by Subject|0|||
33579876|NCT00049257|102013198|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
33579877|NCT00049257|102013198|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
33579878|NCT00049257|102013198|FG000|Carboplatin, Paclitaxel|Death|2|||
33640380|NCT00953056|102232932|FG001|Overall Study|Serious Adverse Event|0|||
33640381|NCT00953056|102232933|FG002|Overall Study|Serious Adverse Event|0|||
33239354|NCT01347645|100775980|FG004|Overall Study|Adverse Event|1|||
33239355|NCT00683449|100775999|FG000|Overall Study|Lost to Follow-up|0|||
33239356|NCT00683449|100776000|FG001|Overall Study|Lost to Follow-up|1|||
33239357|NCT00683449|100776001|FG002|Overall Study|Lost to Follow-up|0|||
33239358|NCT00683449|100776002|FG003|Overall Study|Lost to Follow-up|0|||
33239359|NCT00683449|100776003|FG004|Overall Study|Lost to Follow-up|0|||
33239360|NCT03909165|100776004|FG000|Overall Study|Physician Decision|0|||
33239361|NCT03909165|100776005|FG001|Overall Study|Physician Decision|1|||
33239362|NCT03909165|100776006|FG002|Overall Study|Physician Decision|0|||
33239363|NCT03909165|100776007|FG003|Overall Study|Physician Decision|0|||
33239364|NCT03909165|100776008|FG004|Overall Study|Physician Decision|0|||
33239365|NCT03909165|100776004|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33239366|NCT03909165|100776005|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33239367|NCT03909165|100776006|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33239368|NCT03909165|100776007|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33239369|NCT03909165|100776008|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
33239370|NCT03909165|100776004|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
33239371|NCT03909165|100776005|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
33239372|NCT03909165|100776006|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
33239373|NCT03909165|100776007|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
33420941|NCT03515837|101431671|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
33420942|NCT03515837|101431672|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
33579879|NCT00049257|102013198|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
33579880|NCT02484443|102013202|FG000|Overall Study|Lack of Efficacy|28|||
33579881|NCT02484443|102013202|FG000|Overall Study|Physician Decision|2|||
33640382|NCT00953056|102232934|FG003|Overall Study|Serious Adverse Event|0|||
33640383|NCT00953056|102232935|FG004|Overall Study|Serious Adverse Event|0|||
33239374|NCT03909165|100776008|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
33239375|NCT03909165|100776004|FG000|Overall Study|Previous Drug Exposure|0|||
33239376|NCT03909165|100776005|FG001|Overall Study|Previous Drug Exposure|0|||
33239377|NCT03909165|100776006|FG002|Overall Study|Previous Drug Exposure|1|||
33239378|NCT03909165|100776007|FG003|Overall Study|Previous Drug Exposure|0|||
33239379|NCT03909165|100776008|FG004|Overall Study|Previous Drug Exposure|0|||
33239380|NCT03909165|100776004|FG000|Overall Study|Early Discharge|1|||
33239381|NCT03909165|100776005|FG001|Overall Study|Early Discharge|0|||
33239382|NCT03909165|100776006|FG002|Overall Study|Early Discharge|0|||
33239383|NCT03909165|100776007|FG003|Overall Study|Early Discharge|0|||
33579882|NCT02484443|102013202|FG000|Overall Study|Ineligible|2|||
33579883|NCT04571060|102013203|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
33141162|NCT00775203|100431549|FG001|Overall Study|Physician Decision|1|||
33141163|NCT00266877|100431554|FG000|Overall Study|Death|1|||
33579884|NCT04571060|102013204|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
33579885|NCT04571060|102013203|FG000|Overall Study|Never treated migraine|47|||
33579886|NCT04571060|102013204|FG001|Overall Study|Never treated migraine|36|||
33579887|NCT04571060|102013203|FG000|Overall Study|Protocol Violation|4|||
33579888|NCT04571060|102013204|FG001|Overall Study|Protocol Violation|2|||
33579889|NCT04571060|102013203|FG000|Overall Study|Withdrawal by Subject|6|||
33579890|NCT04571060|102013204|FG001|Overall Study|Withdrawal by Subject|2|||
33579891|NCT04571060|102013203|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
33579892|NCT04571060|102013204|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
33141164|NCT00266877|100431555|FG001|Overall Study|Death|1|||
33141165|NCT00266877|100431556|FG002|Overall Study|Death|1|||
33141166|NCT00266877|100431554|FG000|Overall Study|Adverse Event|6|||
33141167|NCT00266877|100431555|FG001|Overall Study|Adverse Event|4|||
33579893|NCT01277822|102013205|FG000|Overall Study|Adverse Event|2|||
33579894|NCT01277822|102013206|FG001|Overall Study|Adverse Event|1|||
33579895|NCT01277822|102013205|FG000|Overall Study|Withdrawal by Subject|6|||
33579896|NCT01277822|102013206|FG001|Overall Study|Withdrawal by Subject|7|||
33579897|NCT01277822|102013205|FG000|Overall Study|Physician Decision|1|||
33579898|NCT01277822|102013206|FG001|Overall Study|Physician Decision|1|||
33579899|NCT01277822|102013205|FG000|Overall Study|Protocol Violation|1|||
33579900|NCT01277822|102013206|FG001|Overall Study|Protocol Violation|0|||
33579901|NCT01277822|102013205|FG000|Overall Study|Lost to Follow-up|2|||
33579902|NCT01277822|102013206|FG001|Overall Study|Lost to Follow-up|1|||
33579903|NCT01277822|102013205|FG000|Overall Study|Contraindicated medication used|2|||
33579904|NCT01277822|102013206|FG001|Overall Study|Contraindicated medication used|1|||
33579905|NCT01277822|102013205|FG000|Overall Study|Participant moved|1|||
33579906|NCT01277822|102013206|FG001|Overall Study|Participant moved|0|||
33579907|NCT01664247|102013207|FG000|Overall Study|Adverse Event|5|||
33579908|NCT01664247|102013208|FG001|Overall Study|Adverse Event|3|||
33579909|NCT01664247|102013207|FG000|Overall Study|Protocol Violation|3|||
33579910|NCT01664247|102013208|FG001|Overall Study|Protocol Violation|5|||
33579911|NCT01664247|102013207|FG000|Overall Study|Withdrawal Criteria|1|||
33579912|NCT01664247|102013208|FG001|Overall Study|Withdrawal Criteria|4|||
33579913|NCT01664247|102013207|FG000|Overall Study|Unclassified|5|||
33579914|NCT01664247|102013208|FG001|Overall Study|Unclassified|29|||
33579915|NCT00972023|102013209|FG000|Overall Study|Withdrawal by Subject|1|||
33579916|NCT02168101|102013210|FG000|Overall Study|Death|2|||
33579917|NCT02168101|102013211|FG001|Overall Study|Death|2|||
33579918|NCT02168101|102013212|FG002|Overall Study|Death|1|||
33579919|NCT02015481|102013213|FG000|Overall Study|Death|1|||
33579920|NCT01558596|102013214|FG000|Overall Study|Withdrawal by Subject|1|||
33239384|NCT03909165|100776008|FG004|Overall Study|Early Discharge|0|||
33239385|NCT02554513|100776016|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
33239386|NCT02554513|100776017|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
33239387|NCT00877851|100776018|FG000|Overall Study|Lost to Follow-up|5|||
33239388|NCT00877851|100776019|FG001|Overall Study|Lost to Follow-up|5|||
33239389|NCT00877851|100776018|FG000|Overall Study|computer problem|3|||
33239390|NCT00877851|100776019|FG001|Overall Study|computer problem|0|||
33239391|NCT00877851|100776018|FG000|Overall Study|no longer interested in participating|1|||
33239392|NCT00877851|100776019|FG001|Overall Study|no longer interested in participating|0|||
33239393|NCT03005288|100776020|FG000|Overall Study|Withdrawal by Subject|7|||
33239394|NCT03005288|100776021|FG001|Overall Study|Withdrawal by Subject|5|||
33239395|NCT03005288|100776020|FG000|Overall Study|Lost to Follow-up|0|||
33239396|NCT03005288|100776021|FG001|Overall Study|Lost to Follow-up|1|||
33239397|NCT03005288|100776020|FG000|Overall Study|Adverse Event|5|||
33239398|NCT03005288|100776021|FG001|Overall Study|Adverse Event|0|||
33239399|NCT03005288|100776020|FG000|Overall Study|Protocol deviation|0|||
33239400|NCT03005288|100776021|FG001|Overall Study|Protocol deviation|1|||
33370443|NCT00968253|101243422|FG000|Overall Study|Adverse Event|0|||
33370444|NCT00968253|101243423|FG001|Overall Study|Adverse Event|0|||
33370445|NCT00968253|101243424|FG002|Overall Study|Adverse Event|1|||
33579921|NCT01558596|102013215|FG001|Overall Study|Withdrawal by Subject|0|||
33579922|NCT01558596|102013214|FG000|Overall Study|surgery elsewhere or cancelled|1|||
33141168|NCT00266877|100431556|FG002|Overall Study|Adverse Event|1|||
33141169|NCT00266877|100431554|FG000|Overall Study|Physician Decision|2|||
33141170|NCT00266877|100431555|FG001|Overall Study|Physician Decision|1|||
33420943|NCT01488071|101431673|FG000|Overall Study|Adverse Event|15|||
33239401|NCT03005288|100776020|FG000|Overall Study|Physician Decision|0|||
33370446|NCT02928406|101243425|FG000|Overall Study|Death|780|||
33579923|NCT01558596|102013215|FG001|Overall Study|surgery elsewhere or cancelled|1|||
33141171|NCT00266877|100431556|FG002|Overall Study|Physician Decision|1|||
33141172|NCT00266877|100431554|FG000|Overall Study|Withdrawal by Subject|3|||
33239402|NCT03005288|100776021|FG001|Overall Study|Physician Decision|1|||
33239403|NCT00372567|100776022|FG000|Phase 3 Study|Adverse Event|5|||
33239404|NCT00372567|100776023|FG001|Phase 3 Study|Adverse Event|1|||
33239405|NCT00372567|100776024|FG002|Phase 3 Study|Adverse Event|1|||
33141173|NCT00266877|100431555|FG001|Overall Study|Withdrawal by Subject|1|||
33141174|NCT00266877|100431556|FG002|Overall Study|Withdrawal by Subject|1|||
33141175|NCT00266877|100431554|FG000|Overall Study|Disease Progression|72|||
33141176|NCT00266877|100431555|FG001|Overall Study|Disease Progression|37|||
33141177|NCT00266877|100431556|FG002|Overall Study|Disease Progression|23|||
33141178|NCT00266877|100431554|FG000|Overall Study|Symptomatic Deterioration|6|||
33141179|NCT00266877|100431555|FG001|Overall Study|Symptomatic Deterioration|3|||
33141180|NCT00266877|100431556|FG002|Overall Study|Symptomatic Deterioration|1|||
33141181|NCT00266877|100431554|FG000|Overall Study|Hospitalization|1|||
33141182|NCT00266877|100431555|FG001|Overall Study|Hospitalization|0|||
33141183|NCT00266877|100431556|FG002|Overall Study|Hospitalization|0|||
33141184|NCT00266877|100431554|FG000|Overall Study|Concomitant Radiotherapy|0|||
33141185|NCT00266877|100431555|FG001|Overall Study|Concomitant Radiotherapy|1|||
33141186|NCT00266877|100431556|FG002|Overall Study|Concomitant Radiotherapy|0|||
33141187|NCT01904773|100431558|FG000|Screen|Screen failure|3|||
33141188|NCT01904773|100431559|FG001|Screen|Screen failure|0|||
33141189|NCT01904773|100431560|FG002|Screen|Screen failure|0|||
33141190|NCT01904773|100431561|FG003|Screen|Screen failure|0|||
33141191|NCT01904773|100431562|FG004|Screen|Screen failure|0|||
33141192|NCT01904773|100431563|FG005|Screen|Screen failure|0|||
33141193|NCT01904773|100431564|FG006|Screen|Screen failure|0|||
33579924|NCT01558596|102013214|FG000|Overall Study|Protocol Violation|1|||
33579925|NCT01558596|102013215|FG001|Overall Study|Protocol Violation|0|||
33579926|NCT02685826|102013216|FG000|Overall Study|Adverse Event|2|||
33579927|NCT02685826|102013217|FG001|Overall Study|Adverse Event|0|||
33640384|NCT00953056|102232936|FG005|Overall Study|Serious Adverse Event|1|||
33141194|NCT01904773|100431565|FG007|Screen|Screen failure|0|||
33141195|NCT01904773|100431566|FG008|Screen|Screen failure|0|||
33141196|NCT01904773|100431558|FG000|Screen|Withdrawal by Subject|1|||
33141197|NCT01904773|100431559|FG001|Screen|Withdrawal by Subject|0|||
33141198|NCT01904773|100431560|FG002|Screen|Withdrawal by Subject|0|||
33141199|NCT01904773|100431561|FG003|Screen|Withdrawal by Subject|0|||
33141200|NCT01904773|100431562|FG004|Screen|Withdrawal by Subject|0|||
33141201|NCT01904773|100431563|FG005|Screen|Withdrawal by Subject|0|||
33239406|NCT00372567|100776022|FG000|Phase 3 Study|Death|1|||
33239407|NCT00372567|100776023|FG001|Phase 3 Study|Death|1|||
33239408|NCT00372567|100776024|FG002|Phase 3 Study|Death|0|||
33239409|NCT00372567|100776022|FG000|Phase 3 Study|Protocol Violation|0|||
33579928|NCT02685826|102013218|FG002|Overall Study|Adverse Event|1|||
33579929|NCT02685826|102013216|FG000|Overall Study|Progressive Disease|2|||
33579930|NCT02685826|102013217|FG001|Overall Study|Progressive Disease|1|||
33579931|NCT02685826|102013218|FG002|Overall Study|Progressive Disease|0|||
33579932|NCT02685826|102013216|FG000|Overall Study|Withdrawal by Subject|2|||
33579933|NCT02685826|102013217|FG001|Overall Study|Withdrawal by Subject|0|||
33239410|NCT00372567|100776023|FG001|Phase 3 Study|Protocol Violation|0|||
33239411|NCT00372567|100776024|FG002|Phase 3 Study|Protocol Violation|1|||
33239412|NCT00372567|100776022|FG000|Phase 3 Study|Objective progression or relapse|10|||
33239413|NCT00372567|100776023|FG001|Phase 3 Study|Objective progression or relapse|13|||
33239414|NCT00372567|100776024|FG002|Phase 3 Study|Objective progression or relapse|4|||
33420944|NCT01488071|101431674|FG001|Overall Study|Adverse Event|23|||
33579934|NCT02685826|102013218|FG002|Overall Study|Withdrawal by Subject|0|||
33579935|NCT02685826|102013216|FG000|Overall Study|Full Clinical Hold by FDA|19|||
33579936|NCT02685826|102013217|FG001|Overall Study|Full Clinical Hold by FDA|9|||
33579937|NCT02685826|102013218|FG002|Overall Study|Full Clinical Hold by FDA|20|||
33640385|NCT01668589|102232939|FG000|Overall Study|Lost to Follow-up|29|||
33640386|NCT01668589|102232940|FG001|Overall Study|Lost to Follow-up|37|||
33640387|NCT01668589|102232941|FG002|Overall Study|Lost to Follow-up|15|||
33640388|NCT01668589|102232942|FG003|Overall Study|Lost to Follow-up|5|||
33640389|NCT01668589|102232939|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
33640390|NCT01668589|102232940|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
33640391|NCT01668589|102232941|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
33640392|NCT01668589|102232942|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
33640393|NCT01668589|102232939|FG000|Overall Study|Death|12|||
33640394|NCT01668589|102232940|FG001|Overall Study|Death|3|||
33141202|NCT01904773|100431564|FG006|Screen|Withdrawal by Subject|0|||
33640395|NCT01668589|102232941|FG002|Overall Study|Death|2|||
33640396|NCT01668589|102232942|FG003|Overall Study|Death|11|||
33141203|NCT01904773|100431565|FG007|Screen|Withdrawal by Subject|0|||
33141204|NCT01904773|100431566|FG008|Screen|Withdrawal by Subject|0|||
33141205|NCT01904773|100431558|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
33239415|NCT00372567|100776022|FG000|Phase 3 Study|Global deterioration of health status|0|||
33239416|NCT00372567|100776023|FG001|Phase 3 Study|Global deterioration of health status|1|||
33579938|NCT00355030|102013219|FG000|Study Period 1 Treatment|Adverse Event|1|||
33579939|NCT00355030|102013220|FG001|Study Period 1 Treatment|Adverse Event|1|||
33141206|NCT01904773|100431559|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33141207|NCT01904773|100431560|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33239417|NCT00372567|100776024|FG002|Phase 3 Study|Global deterioration of health status|0|||
33579940|NCT00355030|102013219|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
33239418|NCT00372567|100776022|FG000|Phase 3 Study|Other|2|||
33239419|NCT00372567|100776023|FG001|Phase 3 Study|Other|2|||
33239420|NCT00372567|100776024|FG002|Phase 3 Study|Other|1|||
33640397|NCT01668589|102232939|FG000|Overall Study|Other|44|||
33640398|NCT01668589|102232940|FG001|Overall Study|Other|10|||
33640399|NCT01668589|102232941|FG002|Overall Study|Other|7|||
33640400|NCT01668589|102232942|FG003|Overall Study|Other|15|||
33640401|NCT01470326|102232945|FG000|Overall Study|Protocol Violation|32|||
33640402|NCT01470326|102232945|FG000|Overall Study|No Drug Administration Information|2|||
33640403|NCT01470326|102232945|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
33640404|NCT01092546|102232946|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
33640405|NCT00515619|102232947|FG000|Overall Study|Adverse Event|34|||
33239421|NCT00372567|100776022|FG000|Phase 3 Study|study terminated by sponsor|13|||
33239422|NCT00372567|100776023|FG001|Phase 3 Study|study terminated by sponsor|8|||
33239423|NCT00372567|100776024|FG002|Phase 3 Study|study terminated by sponsor|5|||
33239424|NCT02687919|100776025|FG000|Overall Study|Withdrawal by Subject|6|||
33239425|NCT02687919|100776026|FG001|Overall Study|Withdrawal by Subject|6|||
33239426|NCT02687919|100776025|FG000|Overall Study|Protocol Violation|2|||
33239427|NCT02687919|100776026|FG001|Overall Study|Protocol Violation|0|||
33239428|NCT00619476|100776034|FG000|Overall Study|Adverse Event|12|||
33239429|NCT00619476|100776035|FG001|Overall Study|Adverse Event|6|||
33239430|NCT00619476|100776036|FG002|Overall Study|Adverse Event|12|||
33239431|NCT00619476|100776037|FG003|Overall Study|Adverse Event|16|||
33239432|NCT00619476|100776034|FG000|Overall Study|Lack of Efficacy|6|||
33239433|NCT00619476|100776035|FG001|Overall Study|Lack of Efficacy|1|||
33239434|NCT00619476|100776036|FG002|Overall Study|Lack of Efficacy|1|||
33239435|NCT00619476|100776037|FG003|Overall Study|Lack of Efficacy|4|||
33239436|NCT00619476|100776034|FG000|Overall Study|Protocol Violation|5|||
33239437|NCT00619476|100776035|FG001|Overall Study|Protocol Violation|4|||
33239438|NCT00619476|100776036|FG002|Overall Study|Protocol Violation|4|||
33239439|NCT00619476|100776037|FG003|Overall Study|Protocol Violation|9|||
33239440|NCT00619476|100776034|FG000|Overall Study|Lost to Follow-up|1|||
33239441|NCT00619476|100776035|FG001|Overall Study|Lost to Follow-up|2|||
33239442|NCT00619476|100776036|FG002|Overall Study|Lost to Follow-up|0|||
33239443|NCT00619476|100776037|FG003|Overall Study|Lost to Follow-up|1|||
33239444|NCT00619476|100776034|FG000|Overall Study|Investigator Discretion|2|||
33239445|NCT00619476|100776035|FG001|Overall Study|Investigator Discretion|2|||
33239446|NCT00619476|100776036|FG002|Overall Study|Investigator Discretion|2|||
33239447|NCT00619476|100776037|FG003|Overall Study|Investigator Discretion|0|||
33239448|NCT00619476|100776034|FG000|Overall Study|Withdrawal by Subject|5|||
33239449|NCT00619476|100776035|FG001|Overall Study|Withdrawal by Subject|7|||
33239450|NCT00619476|100776036|FG002|Overall Study|Withdrawal by Subject|5|||
33239451|NCT00619476|100776037|FG003|Overall Study|Withdrawal by Subject|4|||
33239452|NCT05124899|100776038|FG000|Overall Study|Lost to Follow-up|3|||
33239453|NCT01237678|100776048|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
33239454|NCT01237678|100776049|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
33239455|NCT01237678|100776050|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
33370447|NCT02928406|101243425|FG000|Overall Study|Progressive disease|3|||
33640406|NCT00515619|102232947|FG000|Overall Study|Lack of Efficacy|92|||
33640407|NCT00515619|102232947|FG000|Overall Study|Withdrawal by Subject|66|||
33640408|NCT00515619|102232947|FG000|Overall Study|Protocol Violation|3|||
33640409|NCT00515619|102232947|FG000|Overall Study|Lost to Follow-up|4|||
33640410|NCT00515619|102232947|FG000|Overall Study|Unsatisfactory compliance|6|||
33640411|NCT00515619|102232947|FG000|Overall Study|Other: Site discontinuing trials|2|||
33640412|NCT00515619|102232947|FG000|Overall Study|Other: Subject cannot attend visits|2|||
33640413|NCT00515619|102232947|FG000|Overall Study|Other: Subject required surgery|1|||
33640414|NCT00515619|102232947|FG000|Overall Study|Other: Subject moved to another country|1|||
33640415|NCT00515619|102232947|FG000|Overall Study|Other: Investigator decision|1|||
33640416|NCT00515619|102232947|FG000|Overall Study|Other: Subject became pregnant|1|||
33370448|NCT02928406|101243425|FG000|Overall Study|Lost to Follow-up|49|||
33370449|NCT02928406|101243425|FG000|Overall Study|Non-compliance|2|||
33640417|NCT00515619|102232947|FG000|Overall Study|Other: Request from sponsor|1|||
33239456|NCT01237678|100776048|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
33640418|NCT00515619|102232947|FG000|Overall Study|Other: Drug available on license|1|||
33640419|NCT00515619|102232947|FG000|Overall Study|Other: Subject interested in other AED|1|||
33640420|NCT00714870|102232948|FG000|Overall Study|Lost to Follow-up|22|||
33239457|NCT01237678|100776049|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
33239458|NCT01237678|100776050|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
33239459|NCT01237678|100776048|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
33239460|NCT01237678|100776049|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
33239461|NCT01237678|100776050|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
33239462|NCT01237678|100776048|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
33370450|NCT02928406|101243425|FG000|Overall Study|Withdrawal by Subject|40|||
33640421|NCT00714870|102232949|FG001|Overall Study|Lost to Follow-up|5|||
33640422|NCT00714870|102232948|FG000|Overall Study|patient unable to come b/c back pain|1|||
33239463|NCT01237678|100776049|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
33239464|NCT01237678|100776050|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
33239465|NCT01237678|100776048|FG000|Phase II|Adverse Event|0|||
33239466|NCT01237678|100776049|FG001|Phase II|Adverse Event|39|||
33239467|NCT01237678|100776050|FG002|Phase II|Adverse Event|9|||
33239468|NCT01237678|100776048|FG000|Phase II|Death|0|||
33239469|NCT01237678|100776049|FG001|Phase II|Death|0|||
33239470|NCT01237678|100776050|FG002|Phase II|Death|2|||
33239471|NCT01237678|100776048|FG000|Phase II|Lack of Efficacy|0|||
33239472|NCT01237678|100776049|FG001|Phase II|Lack of Efficacy|25|||
33239473|NCT01237678|100776050|FG002|Phase II|Lack of Efficacy|3|||
33239474|NCT01237678|100776048|FG000|Phase II|Withdrawal by Subject|0|||
33239475|NCT01237678|100776049|FG001|Phase II|Withdrawal by Subject|1|||
33239476|NCT01237678|100776050|FG002|Phase II|Withdrawal by Subject|5|||
33239477|NCT01237678|100776048|FG000|Phase II|Completed Cycles 4-6|0|||
33579941|NCT00355030|102013220|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
33239478|NCT01237678|100776049|FG001|Phase II|Completed Cycles 4-6|11|||
33239479|NCT01237678|100776050|FG002|Phase II|Completed Cycles 4-6|21|||
33239480|NCT01237678|100776048|FG000|Phase II|Sponsor Decision/Study Closed|0|||
33239481|NCT01237678|100776049|FG001|Phase II|Sponsor Decision/Study Closed|18|||
33239482|NCT01237678|100776050|FG002|Phase II|Sponsor Decision/Study Closed|7|||
33239483|NCT01237678|100776048|FG000|Phase II|Randomized but were not treated|0|||
33239484|NCT01237678|100776049|FG001|Phase II|Randomized but were not treated|4|||
33239485|NCT01237678|100776050|FG002|Phase II|Randomized but were not treated|3|||
33239486|NCT04159896|100776054|FG000|Overall Study|Lack of Efficacy|7|||
33239487|NCT04159896|100776054|FG000|Overall Study|Withdrawal by Subject|1|||
33239488|NCT04159896|100776054|FG000|Overall Study|Adverse Event|1|||
33239489|NCT04159896|100776054|FG000|Overall Study|A transient ischaemic attack|1|||
33239490|NCT03704298|100776059|FG000|Overall Study|Death|3|||
33239491|NCT03704298|100776060|FG001|Overall Study|Death|1|||
33239492|NCT03704298|100776061|FG002|Overall Study|Death|1|||
33239493|NCT03704298|100776062|FG003|Overall Study|Death|0|||
33239494|NCT03704298|100776059|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
33239495|NCT03704298|100776060|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
33239496|NCT03704298|100776061|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
33239497|NCT03704298|100776062|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
33239498|NCT03704298|100776059|FG000|Overall Study|Withdrawal by Subject|1|||
33239499|NCT03704298|100776060|FG001|Overall Study|Withdrawal by Subject|0|||
33239500|NCT03704298|100776061|FG002|Overall Study|Withdrawal by Subject|0|||
33239501|NCT03704298|100776062|FG003|Overall Study|Withdrawal by Subject|0|||
33239502|NCT03704298|100776059|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
33579942|NCT00355030|102013219|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
33579943|NCT00355030|102013220|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
33579944|NCT00355030|102013219|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
33579945|NCT00355030|102013220|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
33579946|NCT00355030|102013219|FG000|Study Period 1 Treatment|Physician Decision|0|||
33579947|NCT00355030|102013220|FG001|Study Period 1 Treatment|Physician Decision|1|||
33579948|NCT00355030|102013219|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
33579949|NCT00355030|102013220|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
33579950|NCT00355030|102013219|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
33579951|NCT00355030|102013220|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
33579952|NCT00355030|102013219|FG000|Study Period 1 Treatment|Other|2|||
33579953|NCT00355030|102013220|FG001|Study Period 1 Treatment|Other|6|||
33579954|NCT00355030|102013219|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
33579955|NCT00355030|102013220|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
33579956|NCT00355030|102013219|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
33579957|NCT00355030|102013220|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
33579958|NCT05219253|102013222|FG000|Overall Study|Withdrawal by Subject|1|||
33239503|NCT03704298|100776060|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
33239504|NCT03704298|100776061|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
33239505|NCT03704298|100776062|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
33239506|NCT02956967|100776063|FG000|Overall Study|Adverse Event|3|||
33239507|NCT02956967|100776063|FG000|Overall Study|Reason non-related to neutropenia|10|||
33239508|NCT02956967|100776063|FG000|Overall Study|Lost to Follow-up|5|||
33420945|NCT01488071|101431673|FG000|Overall Study|Lack of Efficacy|11|||
33579959|NCT05219253|102013223|FG001|Overall Study|Withdrawal by Subject|2|||
33579960|NCT03341637|102013235|FG000|Overall Study|Lost to Follow-up|1|||
33239509|NCT02956967|100776063|FG000|Overall Study|Missing|1|||
33370451|NCT02928406|101243425|FG000|Overall Study|Study terminated by sponsor|57|||
33579961|NCT03341637|102013236|FG001|Overall Study|Lost to Follow-up|0|||
33239510|NCT02956967|100776063|FG000|Overall Study|Termination of Nivestim administration|29|||
33239511|NCT01668147|100776064|FG000|Overall Study|Withdrawal by Subject|6|||
33239512|NCT01115998|100779740|FG000|Overall Study|Lost to Follow-up|6|||
33239513|NCT01115998|100779741|FG001|Overall Study|Lost to Follow-up|6|||
33239514|NCT02462083|100779742|FG000|Overall Study|Sponsor request|39|||
33239515|NCT02462083|100779742|FG000|Overall Study|Withdrawal by Subject|87|||
33239516|NCT02462083|100779742|FG000|Overall Study|Lost to Follow-up|41|||
33239517|NCT02462083|100779742|FG000|Overall Study|Lack of Efficacy|151|||
33239518|NCT02462083|100779742|FG000|Overall Study|Pregnancy|1|||
33239519|NCT02462083|100779742|FG000|Overall Study|Protocol Violation|6|||
33239520|NCT02462083|100779742|FG000|Overall Study|Adverse Event|33|||
33239521|NCT02462083|100779742|FG000|Overall Study|Worsening condition|16|||
33239522|NCT02462083|100779742|FG000|Overall Study|Other than specified|45|||
33239523|NCT00924664|100779743|FG000|Overall Study|Adverse Event|23|||
33239524|NCT00924664|100779744|FG001|Overall Study|Adverse Event|39|||
33239525|NCT00924664|100779743|FG000|Overall Study|Lack of Efficacy|10|||
33239526|NCT00924664|100779744|FG001|Overall Study|Lack of Efficacy|15|||
33239527|NCT00924664|100779743|FG000|Overall Study|Lost to Follow-up|10|||
33239528|NCT00924664|100779744|FG001|Overall Study|Lost to Follow-up|12|||
33239529|NCT00924664|100779743|FG000|Overall Study|Withdrawal by Subject|47|||
33239530|NCT00924664|100779744|FG001|Overall Study|Withdrawal by Subject|71|||
33239531|NCT00924664|100779743|FG000|Overall Study|Protocol Violation|2|||
33239532|NCT00924664|100779744|FG001|Overall Study|Protocol Violation|5|||
33239533|NCT00924664|100779743|FG000|Overall Study|Pregnancy|1|||
33239534|NCT00924664|100779744|FG001|Overall Study|Pregnancy|1|||
33239535|NCT00924664|100779743|FG000|Overall Study|Death|0|||
33239536|NCT00924664|100779744|FG001|Overall Study|Death|2|||
33239537|NCT00924664|100779743|FG000|Overall Study|Study terminated by sponsor|199|||
33239538|NCT00924664|100779744|FG001|Overall Study|Study terminated by sponsor|330|||
33239539|NCT00924664|100779743|FG000|Overall Study|Other|29|||
33239540|NCT00924664|100779744|FG001|Overall Study|Other|52|||
33239541|NCT00924664|100779743|FG000|Overall Study|Randomized but not Treated|1|||
33239542|NCT00924664|100779744|FG001|Overall Study|Randomized but not Treated|0|||
33239543|NCT00630539|100779747|FG000|Overall Study|Adverse Event|1|||
33239544|NCT00630539|100779748|FG001|Overall Study|Adverse Event|3|||
33239545|NCT00630539|100779749|FG002|Overall Study|Adverse Event|1|||
33239546|NCT00630539|100779750|FG003|Overall Study|Adverse Event|2|||
33239547|NCT00630539|100779747|FG000|Overall Study|Withdrawal by Subject|0|||
33239548|NCT00630539|100779748|FG001|Overall Study|Withdrawal by Subject|1|||
33239549|NCT00630539|100779749|FG002|Overall Study|Withdrawal by Subject|0|||
33239550|NCT00630539|100779750|FG003|Overall Study|Withdrawal by Subject|1|||
33239551|NCT01511536|100779751|FG000|Phase 1|Other|0|||
33239552|NCT01511536|100779752|FG001|Phase 1|Other|1|||
33239553|NCT01511536|100779753|FG002|Phase 1|Other|0|||
33239554|NCT01511536|100779751|FG000|Phase 2|Other|0|||
33239555|NCT01511536|100779752|FG001|Phase 2|Other|0|||
33239556|NCT01511536|100779753|FG002|Phase 2|Other|9|||
33239557|NCT03697460|100779754|FG000|Overall Study|Withdrawal by Subject|3|||
33239558|NCT02886936|100779755|FG000|Overall Study|Lost to Follow-up|4|||
33239559|NCT02886936|100779756|FG001|Overall Study|Lost to Follow-up|3|||
33370452|NCT02928406|101243425|FG000|Overall Study|Physician Decision|1|||
33370453|NCT02928406|101243425|FG000|Overall Study|Various reasons|72|||
33370454|NCT01912768|101243426|FG000|Overall Study|Adverse Event|2|||
33370455|NCT01912768|101243427|FG001|Overall Study|Adverse Event|0|||
33370456|NCT01912768|101243426|FG000|Overall Study|Lost to Follow-up|2|||
33370457|NCT01912768|101243427|FG001|Overall Study|Lost to Follow-up|1|||
33370458|NCT01912768|101243426|FG000|Overall Study|Withdrawal by Subject|5|||
33370459|NCT01912768|101243427|FG001|Overall Study|Withdrawal by Subject|3|||
33370460|NCT01912768|101243426|FG000|Overall Study|Randomized in error|1|||
33370461|NCT01912768|101243427|FG001|Overall Study|Randomized in error|0|||
33370462|NCT03132805|101243428|FG000|Overall Study|Lost to Follow-up|142|||
33370463|NCT03132805|101243429|FG001|Overall Study|Lost to Follow-up|141|||
33370464|NCT03132805|101243430|FG002|Overall Study|Lost to Follow-up|113|||
33370465|NCT03977727|101243431|FG000|Second Treatment|Lost to Follow-up|0|||
33370466|NCT03977727|101243432|FG001|Second Treatment|Lost to Follow-up|3|||
33370467|NCT00421343|101243439|FG000|Overall Study|Death|1|||
33370468|NCT00421343|101243439|FG000|Overall Study|Withdrawal by Subject|2|||
33370469|NCT00421343|101243439|FG000|Overall Study|Lost to Follow-up|3|||
33370470|NCT00894413|101243440|FG000|Overall Study|Physician Decision|0|||
33370471|NCT00894413|101243441|FG001|Overall Study|Physician Decision|2|||
33370472|NCT00894413|101243440|FG000|Overall Study|Adverse Event|0|||
33370473|NCT00894413|101243441|FG001|Overall Study|Adverse Event|2|||
33370474|NCT00894413|101243440|FG000|Overall Study|Withdrawal by Subject|0|||
33370475|NCT00894413|101243441|FG001|Overall Study|Withdrawal by Subject|4|||
33420946|NCT01488071|101431674|FG001|Overall Study|Lack of Efficacy|17|||
33370476|NCT04360187|101243442|FG000|Double-Blind Treatment|Adverse Event|9|||
33239560|NCT02886936|100779757|FG002|Overall Study|Lost to Follow-up|0|||
33239561|NCT01400893|100779762|FG000|Overall Study|Death|27|||
33239562|NCT01400893|100779763|FG001|Overall Study|Death|21|||
33239563|NCT01400893|100779762|FG000|Overall Study|Lost to Follow-up|0|||
33239564|NCT01400893|100779763|FG001|Overall Study|Lost to Follow-up|6|||
33239565|NCT03660943|100779764|FG000|Overall Study|Adverse Event|5|||
33239566|NCT03660943|100779765|FG001|Overall Study|Adverse Event|3|||
33239567|NCT03660943|100779764|FG000|Overall Study|Death|0|||
33370477|NCT04360187|101243443|FG001|Double-Blind Treatment|Adverse Event|11|||
33239568|NCT03660943|100779765|FG001|Overall Study|Death|2|||
33239569|NCT03660943|100779764|FG000|Overall Study|Lost to Follow-up|7|||
33239570|NCT03660943|100779765|FG001|Overall Study|Lost to Follow-up|3|||
33239571|NCT03660943|100779764|FG000|Overall Study|Protocol Violation|3|||
33239572|NCT03660943|100779765|FG001|Overall Study|Protocol Violation|5|||
33239573|NCT03660943|100779764|FG000|Overall Study|Withdrawal by Subject|8|||
33239574|NCT03660943|100779765|FG001|Overall Study|Withdrawal by Subject|15|||
33239575|NCT03660943|100779764|FG000|Overall Study|Lack of Efficacy|9|||
33239576|NCT03660943|100779765|FG001|Overall Study|Lack of Efficacy|12|||
33239577|NCT03660943|100779764|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
33239578|NCT03660943|100779765|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
33239579|NCT00293462|100779766|FG000|Overall Study|Withdrawal by Subject|4|||
33239580|NCT00293462|100779767|FG001|Overall Study|Withdrawal by Subject|3|||
33239581|NCT00293462|100779768|FG002|Overall Study|Withdrawal by Subject|8|||
33239582|NCT00293462|100779766|FG000|Overall Study|Death|1|||
33239583|NCT00293462|100779767|FG001|Overall Study|Death|0|||
33239584|NCT00293462|100779768|FG002|Overall Study|Death|0|||
33239585|NCT00293462|100779766|FG000|Overall Study|Lost to Follow-up|0|||
33239586|NCT00293462|100779767|FG001|Overall Study|Lost to Follow-up|1|||
33239587|NCT00293462|100779768|FG002|Overall Study|Lost to Follow-up|0|||
33239588|NCT00293462|100779766|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
33239589|NCT00293462|100779767|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
33239590|NCT00293462|100779768|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
33239591|NCT00293462|100779766|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
33239592|NCT00293462|100779767|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
33239593|NCT00293462|100779768|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
33239594|NCT00293462|100779766|FG000|Overall Study|Refuse Radiation Treatment|1|||
33239595|NCT00293462|100779767|FG001|Overall Study|Refuse Radiation Treatment|0|||
33239596|NCT00293462|100779768|FG002|Overall Study|Refuse Radiation Treatment|0|||
33239597|NCT00293462|100779766|FG000|Overall Study|No Show|0|||
33239598|NCT00293462|100779767|FG001|Overall Study|No Show|0|||
33239599|NCT00293462|100779768|FG002|Overall Study|No Show|1|||
33239600|NCT00293462|100779766|FG000|Overall Study|Went back to his home country|0|||
33239601|NCT00293462|100779767|FG001|Overall Study|Went back to his home country|0|||
33239602|NCT00293462|100779768|FG002|Overall Study|Went back to his home country|1|||
33239603|NCT00293462|100779766|FG000|Overall Study|Blood clot after chemotherapy|0|||
33239604|NCT00293462|100779767|FG001|Overall Study|Blood clot after chemotherapy|0|||
33239605|NCT00293462|100779768|FG002|Overall Study|Blood clot after chemotherapy|1|||
33239606|NCT00293462|100779766|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
33239607|NCT00293462|100779767|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
33239608|NCT00293462|100779768|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
33239609|NCT00293462|100779766|FG000|Overall Study|Possible Tracheostomy leakage|0|||
33239610|NCT00293462|100779767|FG001|Overall Study|Possible Tracheostomy leakage|1|||
33239611|NCT00293462|100779768|FG002|Overall Study|Possible Tracheostomy leakage|0|||
33239612|NCT00293462|100779766|FG000|Overall Study|Low radiation dose in oral cavity|0|||
33239613|NCT00293462|100779767|FG001|Overall Study|Low radiation dose in oral cavity|1|||
33239614|NCT00293462|100779768|FG002|Overall Study|Low radiation dose in oral cavity|0|||
33239615|NCT00293462|100779766|FG000|Overall Study|Physician Decision|0|||
33239616|NCT00293462|100779767|FG001|Overall Study|Physician Decision|1|||
33239617|NCT00293462|100779768|FG002|Overall Study|Physician Decision|0|||
33239618|NCT03772314|100779773|FG000|Overall Study|Adverse Event|7|||
33239619|NCT03772314|100779774|FG001|Overall Study|Adverse Event|2|||
33239620|NCT00801242|100779775|FG000|Overall Study|Adverse Event|10|||
33239621|NCT00801242|100779775|FG000|Overall Study|Withdrawal by Subject|13|||
33239622|NCT00801242|100779775|FG000|Overall Study|Protocol Violation|5|||
33239623|NCT00801242|100779775|FG000|Overall Study|Physician Decision|3|||
33239624|NCT00801242|100779775|FG000|Overall Study|Lost to Follow-up|1|||
33239625|NCT00801242|100779775|FG000|Overall Study|Miscellaneous reasons|20|||
33239626|NCT01449929|100779778|FG000|Randomization Phase 96 Week|Adverse Event|5|||
33239627|NCT01449929|100779779|FG001|Randomization Phase 96 Week|Adverse Event|13|||
33239628|NCT01449929|100779780|FG002|Randomization Phase 96 Week|Adverse Event|0|||
33239629|NCT01449929|100779778|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
33239630|NCT01449929|100779779|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
33239631|NCT01449929|100779780|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
33239632|NCT01449929|100779778|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
33239633|NCT01449929|100779779|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
33579962|NCT03341637|102013235|FG000|Overall Study|Withdrawal by Subject|3|||
33579963|NCT03341637|102013236|FG001|Overall Study|Withdrawal by Subject|3|||
33579964|NCT03341637|102013235|FG000|Overall Study|Reason not Specified|1|||
33239634|NCT01449929|100779780|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
33239635|NCT01449929|100779778|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
33239636|NCT01449929|100779779|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
33370478|NCT04360187|101243442|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
33579965|NCT03341637|102013236|FG001|Overall Study|Reason not Specified|1|||
33239637|NCT01449929|100779780|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
33239638|NCT01449929|100779778|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
33420947|NCT01488071|101431673|FG000|Overall Study|Non-compliance with study drug|2|||
33420948|NCT01488071|101431674|FG001|Overall Study|Non-compliance with study drug|0|||
33420949|NCT01488071|101431673|FG000|Overall Study|Protocol Violation|5|||
33420950|NCT01488071|101431674|FG001|Overall Study|Protocol Violation|7|||
33420951|NCT01488071|101431673|FG000|Overall Study|Withdrawal of Consent|14|||
33420952|NCT01488071|101431674|FG001|Overall Study|Withdrawal of Consent|12|||
33420953|NCT01488071|101431673|FG000|Overall Study|Lost to Follow-up|1|||
33420954|NCT01488071|101431674|FG001|Overall Study|Lost to Follow-up|0|||
33420955|NCT01488071|101431673|FG000|Overall Study|Administrative or Other Reason(s)|5|||
33420956|NCT01488071|101431674|FG001|Overall Study|Administrative or Other Reason(s)|4|||
33420957|NCT00550420|101431675|FG000|Overall Study|Adverse Event|28|||
33420958|NCT00550420|101431675|FG000|Overall Study|Lost to Follow-up|8|||
33420959|NCT00550420|101431675|FG000|Overall Study|Protocol Violation|11|||
33420960|NCT00550420|101431675|FG000|Overall Study|Withdrawal by Subject|30|||
33420961|NCT00550420|101431675|FG000|Overall Study|Still in study at termination|206|||
33420962|NCT00550420|101431675|FG000|Overall Study|Missing|2|||
33420963|NCT00550420|101431675|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
33420964|NCT00550420|101431675|FG000|Overall Study|Investigators opinion|1|||
33579966|NCT00553631|102013237|FG000|Overall Study|Withdrawal by Subject|0|||
33239639|NCT01449929|100779779|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
33239640|NCT01449929|100779780|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
33239641|NCT01449929|100779778|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
33239642|NCT01449929|100779779|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
33239643|NCT01449929|100779780|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
33239644|NCT01449929|100779778|FG000|Randomization Phase 96 Week|Physician Decision|2|||
33239645|NCT01449929|100779779|FG001|Randomization Phase 96 Week|Physician Decision|3|||
33239646|NCT01449929|100779780|FG002|Randomization Phase 96 Week|Physician Decision|0|||
33239647|NCT01449929|100779778|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
33239648|NCT01449929|100779779|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
33239649|NCT01449929|100779780|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
33239650|NCT01449929|100779778|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
33239651|NCT01449929|100779779|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
33239652|NCT01449929|100779780|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
33239653|NCT01449929|100779778|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
33239654|NCT01449929|100779779|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
33239655|NCT01449929|100779780|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
33239656|NCT01449929|100779778|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
33239657|NCT01449929|100779779|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
33239658|NCT01449929|100779780|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
33239659|NCT01770860|100779781|FG000|Overall Study|Withdrawal by Subject|4|||
33239660|NCT01770860|100779781|FG000|Overall Study|Lost to Follow-up|1|||
33239661|NCT01770860|100779781|FG000|Overall Study|Administrative decision made by the PI|1|||
33239662|NCT04668144|100779782|FG000|Overall Study|Protocol Violation|0|||
33239663|NCT04668144|100779783|FG001|Overall Study|Protocol Violation|1|||
33239664|NCT04668144|100779784|FG002|Overall Study|Protocol Violation|2|||
33239665|NCT01321073|100779785|FG000|Overall Study|Did not attempt implant|4|||
33239666|NCT01321073|100779785|FG000|Overall Study|Death|3|||
33239667|NCT03628924|100779792|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
33239668|NCT03628924|100779793|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
33239669|NCT03628924|100779794|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
33239670|NCT03628924|100779795|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
33239671|NCT03628924|100779796|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
33239672|NCT03628924|100779797|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
33239673|NCT03628924|100779798|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
33239674|NCT03628924|100779792|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33239675|NCT03628924|100779793|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33239676|NCT03628924|100779794|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
33579967|NCT00553631|102013238|FG001|Overall Study|Withdrawal by Subject|1|||
33579968|NCT00553631|102013237|FG000|Overall Study|Lost to Follow-up|1|||
33579969|NCT00553631|102013238|FG001|Overall Study|Lost to Follow-up|0|||
33579970|NCT01408277|102013239|FG000|Overall Study|Adverse Event|3|||
33239677|NCT03628924|100779795|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33420965|NCT00550420|101431675|FG000|Overall Study|Lack of curative effect|1|||
33370479|NCT04360187|101243443|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
33420966|NCT00550420|101431675|FG000|Overall Study|Unethical stop of enrollment|2|||
33420967|NCT00550420|101431675|FG000|Overall Study|Caregiver's decision to withdraw|1|||
33420968|NCT00550420|101431675|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
33579971|NCT01408277|102013240|FG001|Overall Study|Adverse Event|4|||
33579972|NCT01408277|102013239|FG000|Overall Study|Lost to Follow-up|1|||
33239678|NCT03628924|100779796|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33239679|NCT03628924|100779797|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33239680|NCT03628924|100779798|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
33239681|NCT03628924|100779792|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
33239682|NCT03628924|100779793|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
33239683|NCT03628924|100779794|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
33239684|NCT03628924|100779795|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
33239685|NCT03628924|100779796|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
33239686|NCT03628924|100779797|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
33239687|NCT03628924|100779798|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
33239688|NCT03628924|100779792|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33239689|NCT03628924|100779793|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
33239690|NCT03628924|100779794|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33239691|NCT03628924|100779795|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33239692|NCT03628924|100779796|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33239693|NCT03628924|100779797|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33239694|NCT03628924|100779798|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
33239695|NCT03628924|100779792|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
33239696|NCT03628924|100779793|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
33239697|NCT03628924|100779794|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
33239698|NCT03628924|100779795|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
33239699|NCT03628924|100779796|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
33239700|NCT03628924|100779797|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
33239701|NCT03628924|100779798|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
33239702|NCT03628924|100779792|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
33239703|NCT03628924|100779793|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
33239704|NCT03628924|100779794|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
33239705|NCT03628924|100779795|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
33239706|NCT03628924|100779796|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
33239707|NCT03628924|100779797|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
33239708|NCT03628924|100779798|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
33239709|NCT03628924|100779792|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
33239710|NCT03628924|100779793|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
33239711|NCT03628924|100779794|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
33239712|NCT03628924|100779795|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
33239713|NCT03628924|100779796|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
33239714|NCT03628924|100779797|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
33239715|NCT03628924|100779798|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
33239716|NCT03628924|100779792|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
33239717|NCT03628924|100779793|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
33239718|NCT03628924|100779794|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
33239719|NCT03628924|100779795|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
33239720|NCT03628924|100779796|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
33239721|NCT03628924|100779797|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
33239722|NCT03628924|100779798|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
33239723|NCT03628924|100779792|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
33239724|NCT03628924|100779793|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
33239725|NCT03628924|100779794|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
33239726|NCT03628924|100779795|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
33239727|NCT03628924|100779796|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
33239728|NCT03628924|100779797|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
33239729|NCT03628924|100779798|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
33239730|NCT03628924|100779792|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
33239731|NCT03628924|100779793|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
33239732|NCT03628924|100779794|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
33239733|NCT03628924|100779795|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
33239734|NCT03628924|100779796|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
33239735|NCT03628924|100779797|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
33239736|NCT03628924|100779798|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
33239737|NCT04296942|100779802|FG000|Overall Study|Study closure by sponsor|1|||
33370480|NCT04360187|101243442|FG000|Double-Blind Treatment|Physician Decision|1|||
33370481|NCT04360187|101243443|FG001|Double-Blind Treatment|Physician Decision|0|||
33370482|NCT04360187|101243442|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
33370483|NCT04360187|101243443|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
33579973|NCT01408277|102013240|FG001|Overall Study|Lost to Follow-up|0|||
33239738|NCT04296942|100779803|FG001|Overall Study|Study closure by sponsor|0|||
33239739|NCT04296942|100779804|FG002|Overall Study|Study closure by sponsor|0|||
33239740|NCT03015740|100779805|FG000|Overall Study|Adverse Event|1|||
33239741|NCT03015740|100779806|FG001|Overall Study|Adverse Event|0|||
33239742|NCT03015740|100779807|FG002|Overall Study|Adverse Event|0|||
33239743|NCT03015740|100779805|FG000|Overall Study|Death|3|||
33239744|NCT03015740|100779806|FG001|Overall Study|Death|5|||
33239745|NCT03015740|100779807|FG002|Overall Study|Death|0|||
33239746|NCT03015740|100779805|FG000|Overall Study|Withdrawal by Subject|2|||
33239747|NCT03015740|100779806|FG001|Overall Study|Withdrawal by Subject|0|||
33239748|NCT03015740|100779807|FG002|Overall Study|Withdrawal by Subject|0|||
33239749|NCT04394624|100779808|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|6|||
33239750|NCT04394624|100779808|FG000|Overall Study|Adverse Event|5|||
33239751|NCT04394624|100779808|FG000|Overall Study|Progressive disease|20|||
33239752|NCT04714216|100779821|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
33239753|NCT04714216|100779821|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
33239754|NCT03212365|100779824|FG000|Overall Study|Discharged prior to Xa level|12|||
33239755|NCT03212365|100779825|FG001|Overall Study|Discharged prior to Xa level|8|||
33239756|NCT03212365|100779824|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
33239757|NCT03212365|100779825|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
33239758|NCT03212365|100779824|FG000|Overall Study|Refused study medication|3|||
33239759|NCT03212365|100779825|FG001|Overall Study|Refused study medication|0|||
33239760|NCT03212365|100779824|FG000|Overall Study|Initiated heparin infusion on floor|1|||
33239761|NCT03212365|100779825|FG001|Overall Study|Initiated heparin infusion on floor|1|||
33239762|NCT03212365|100779824|FG000|Overall Study|Unexpected return to OR|1|||
33239763|NCT03212365|100779825|FG001|Overall Study|Unexpected return to OR|1|||
33239764|NCT03212365|100779824|FG000|Overall Study|Medication distribution error|1|||
33239765|NCT03212365|100779825|FG001|Overall Study|Medication distribution error|0|||
33239766|NCT03212365|100779824|FG000|Overall Study|Required epidural placement|1|||
33239767|NCT03212365|100779825|FG001|Overall Study|Required epidural placement|0|||
33239768|NCT03212365|100779824|FG000|Overall Study|Withdrawal by Subject|0|||
33239769|NCT03212365|100779825|FG001|Overall Study|Withdrawal by Subject|1|||
33239770|NCT03212365|100779824|FG000|Overall Study|developed acute renal failure|0|||
33239771|NCT03212365|100779825|FG001|Overall Study|developed acute renal failure|1|||
33239772|NCT02955277|100779831|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
33239773|NCT02955277|100779832|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
33239774|NCT02955277|100779831|FG000|Post to Follow-up|Lost to Follow-up|8|||
33239775|NCT02955277|100779832|FG001|Post to Follow-up|Lost to Follow-up|11|||
33239776|NCT03251378|100779833|FG000|Overall Study|Death|3|||
33239777|NCT03251378|100779834|FG001|Overall Study|Death|2|||
33239778|NCT03251378|100779835|FG002|Overall Study|Death|3|||
33239779|NCT03251378|100779836|FG003|Overall Study|Death|30|||
33239780|NCT03251378|100779837|FG004|Overall Study|Death|24|||
33239781|NCT03251378|100779838|FG005|Overall Study|Death|12|||
33239782|NCT03251378|100779839|FG006|Overall Study|Death|12|||
33239783|NCT03251378|100779833|FG000|Overall Study|Lost to Follow-up|0|||
33239784|NCT03251378|100779834|FG001|Overall Study|Lost to Follow-up|0|||
33239785|NCT03251378|100779835|FG002|Overall Study|Lost to Follow-up|1|||
33579974|NCT01408277|102013239|FG000|Overall Study|Withdrawal by Subject|2|||
33579975|NCT01408277|102013240|FG001|Overall Study|Withdrawal by Subject|0|||
33579976|NCT01408277|102013239|FG000|Overall Study|Protocol Violation|2|||
33579977|NCT01408277|102013240|FG001|Overall Study|Protocol Violation|0|||
33579978|NCT04232943|102013241|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
33579979|NCT04232943|102013242|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
33579980|NCT04232943|102013243|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
33579981|NCT04232943|102013241|FG000|Overall Study|Withdrawal by Subject|1|||
33579982|NCT04232943|102013242|FG001|Overall Study|Withdrawal by Subject|1|||
33579983|NCT04232943|102013243|FG002|Overall Study|Withdrawal by Subject|0|||
33141208|NCT01904773|100431561|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33239786|NCT03251378|100779836|FG003|Overall Study|Lost to Follow-up|3|||
33239787|NCT03251378|100779837|FG004|Overall Study|Lost to Follow-up|0|||
33239788|NCT03251378|100779838|FG005|Overall Study|Lost to Follow-up|0|||
33239789|NCT03251378|100779839|FG006|Overall Study|Lost to Follow-up|0|||
33239790|NCT03251378|100779833|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
33239791|NCT03251378|100779834|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
33239792|NCT03251378|100779835|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
33239793|NCT03251378|100779836|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
33239794|NCT03251378|100779837|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
33239795|NCT03251378|100779838|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
33239796|NCT03251378|100779839|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
33579984|NCT02389465|102013244|FG000|Overall Study|Lost to Follow-up|1|||
33579985|NCT02389465|102013245|FG001|Overall Study|Lost to Follow-up|3|||
33579986|NCT02389465|102013246|FG002|Overall Study|Lost to Follow-up|3|||
33239797|NCT03251378|100779833|FG000|Overall Study|Progressive disease|2|||
33239798|NCT03251378|100779834|FG001|Overall Study|Progressive disease|0|||
33239799|NCT03251378|100779835|FG002|Overall Study|Progressive disease|0|||
33239800|NCT03251378|100779836|FG003|Overall Study|Progressive disease|1|||
33239801|NCT03251378|100779837|FG004|Overall Study|Progressive disease|0|||
33239802|NCT03251378|100779838|FG005|Overall Study|Progressive disease|0|||
33239803|NCT03251378|100779839|FG006|Overall Study|Progressive disease|0|||
33239804|NCT03251378|100779833|FG000|Overall Study|Physician Decision|0|||
33239805|NCT03251378|100779834|FG001|Overall Study|Physician Decision|2|||
33239806|NCT03251378|100779835|FG002|Overall Study|Physician Decision|0|||
33239807|NCT03251378|100779836|FG003|Overall Study|Physician Decision|0|||
33239808|NCT03251378|100779837|FG004|Overall Study|Physician Decision|0|||
33239809|NCT03251378|100779838|FG005|Overall Study|Physician Decision|0|||
33239810|NCT03251378|100779839|FG006|Overall Study|Physician Decision|0|||
33239811|NCT03251378|100779833|FG000|Overall Study|Other|2|||
33239812|NCT03251378|100779834|FG001|Overall Study|Other|3|||
33239813|NCT03251378|100779835|FG002|Overall Study|Other|2|||
33239814|NCT03251378|100779836|FG003|Overall Study|Other|0|||
33239815|NCT03251378|100779837|FG004|Overall Study|Other|1|||
33239816|NCT03251378|100779838|FG005|Overall Study|Other|1|||
33239817|NCT03251378|100779839|FG006|Overall Study|Other|1|||
33239818|NCT03251378|100779833|FG000|Overall Study|Other|0|||
33239819|NCT03251378|100779834|FG001|Overall Study|Other|0|||
33239820|NCT03251378|100779835|FG002|Overall Study|Other|0|||
33239821|NCT03251378|100779836|FG003|Overall Study|Other|4|||
33239822|NCT03251378|100779837|FG004|Overall Study|Other|13|||
33239823|NCT03251378|100779838|FG005|Overall Study|Other|0|||
33239824|NCT03251378|100779839|FG006|Overall Study|Other|0|||
33239825|NCT03300817|100779865|FG000|Overall Study|Withdrawal by Subject|1|||
33239826|NCT03300817|100779865|FG000|Overall Study|Adverse Event|1|||
33239827|NCT03300817|100779865|FG000|Overall Study|Subject Found to be Ineligible|2|||
33239828|NCT04922021|100779866|FG000|Overall Study|Withdrawal by Subject|4|||
33239829|NCT04922021|100779867|FG001|Overall Study|Withdrawal by Subject|10|||
33239830|NCT04922021|100779866|FG000|Overall Study|Adverse Event|2|||
33239831|NCT04922021|100779867|FG001|Overall Study|Adverse Event|2|||
33239832|NCT04922021|100779866|FG000|Overall Study|Lack of Efficacy|0|||
33239833|NCT04922021|100779867|FG001|Overall Study|Lack of Efficacy|1|||
33239834|NCT04922021|100779866|FG000|Overall Study|Multiple reasons|1|||
33239835|NCT04922021|100779867|FG001|Overall Study|Multiple reasons|0|||
33239836|NCT04174560|100779868|FG000|Overall Study|Lost to Follow-up|1|||
33239837|NCT04174560|100779869|FG001|Overall Study|Lost to Follow-up|0|||
33239838|NCT04174560|100779870|FG002|Overall Study|Lost to Follow-up|0|||
33239839|NCT04174560|100779871|FG003|Overall Study|Lost to Follow-up|0|||
33239840|NCT04174560|100779868|FG000|Overall Study|Withdrawal by Subject|0|||
33239841|NCT04174560|100779869|FG001|Overall Study|Withdrawal by Subject|0|||
33239842|NCT04174560|100779870|FG002|Overall Study|Withdrawal by Subject|2|||
33239843|NCT04174560|100779871|FG003|Overall Study|Withdrawal by Subject|0|||
33239844|NCT04834362|100779872|FG000|Overall Study|Death|1|||
33239845|NCT04834362|100779873|FG001|Overall Study|Death|2|||
33239846|NCT00901485|100779874|FG000|Overall Study|Lack of Efficacy|0|||
33239847|NCT00901485|100779875|FG001|Overall Study|Lack of Efficacy|2|||
33239848|NCT00901485|100779874|FG000|Overall Study|Withdrawal by Subject|1|||
33239849|NCT00901485|100779875|FG001|Overall Study|Withdrawal by Subject|2|||
33239850|NCT00783718|100779877|FG000|Induction Phase|Adverse Event|4|||
33239851|NCT00783718|100779878|FG001|Induction Phase|Adverse Event|0|||
33239852|NCT00783718|100779879|FG002|Induction Phase|Adverse Event|7|||
33239853|NCT00783718|100779880|FG003|Induction Phase|Adverse Event|0|||
33239854|NCT00783718|100779881|FG004|Induction Phase|Adverse Event|0|||
33239855|NCT00783718|100779882|FG005|Induction Phase|Adverse Event|0|||
33239856|NCT00783718|100779883|FG006|Induction Phase|Adverse Event|0|||
33239857|NCT00783718|100779877|FG000|Induction Phase|Protocol Violation|1|||
33239858|NCT00783718|100779878|FG001|Induction Phase|Protocol Violation|1|||
33239859|NCT00783718|100779879|FG002|Induction Phase|Protocol Violation|6|||
33239860|NCT00783718|100779880|FG003|Induction Phase|Protocol Violation|0|||
33239861|NCT00783718|100779881|FG004|Induction Phase|Protocol Violation|0|||
33239862|NCT00783718|100779882|FG005|Induction Phase|Protocol Violation|0|||
33239863|NCT00783718|100779883|FG006|Induction Phase|Protocol Violation|0|||
33420969|NCT00550420|101431675|FG000|Overall Study|Exclusion criteria|1|||
33239864|NCT00783718|100779877|FG000|Induction Phase|Lack of Efficacy|5|||
33420970|NCT00550420|101431675|FG000|Overall Study|Prohibited medicine|1|||
33239865|NCT00783718|100779878|FG001|Induction Phase|Lack of Efficacy|2|||
33239866|NCT00783718|100779879|FG002|Induction Phase|Lack of Efficacy|14|||
33239867|NCT00783718|100779880|FG003|Induction Phase|Lack of Efficacy|0|||
33239868|NCT00783718|100779881|FG004|Induction Phase|Lack of Efficacy|0|||
33239869|NCT00783718|100779882|FG005|Induction Phase|Lack of Efficacy|0|||
33239870|NCT00783718|100779883|FG006|Induction Phase|Lack of Efficacy|0|||
33239871|NCT00783718|100779877|FG000|Induction Phase|Withdrawal by Subject|3|||
33239872|NCT00783718|100779878|FG001|Induction Phase|Withdrawal by Subject|4|||
33239873|NCT00783718|100779879|FG002|Induction Phase|Withdrawal by Subject|8|||
33239874|NCT00783718|100779880|FG003|Induction Phase|Withdrawal by Subject|0|||
33239875|NCT00783718|100779881|FG004|Induction Phase|Withdrawal by Subject|0|||
33239876|NCT00783718|100779882|FG005|Induction Phase|Withdrawal by Subject|0|||
33239877|NCT00783718|100779883|FG006|Induction Phase|Withdrawal by Subject|0|||
33640423|NCT00714870|102232949|FG001|Overall Study|patient unable to come b/c back pain|0|||
33640424|NCT00714870|102232948|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
33640425|NCT00714870|102232949|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
33640426|NCT02362282|102232950|FG000|Overall Study|Withdrawal by Subject|1|||
33640427|NCT02362282|102232951|FG001|Overall Study|Withdrawal by Subject|0|||
33640428|NCT00885534|102232952|FG000|Overall Study|Patient deemed ineligible|1|||
33640429|NCT00706238|102232955|FG000|Overall Study|Disease progression|4|||
33640430|NCT00706238|102232955|FG000|Overall Study|Other|1|||
33640431|NCT03349034|102232956|FG000|Overall Study|catheters dislodged during transport|2|||
33640432|NCT03349034|102232957|FG001|Overall Study|catheters dislodged during transport|0|||
33640433|NCT03349034|102232956|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
33640434|NCT03349034|102232957|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
33640435|NCT03349034|102232956|FG000|Overall Study|soft tissue flap used|1|||
33640436|NCT03349034|102232957|FG001|Overall Study|soft tissue flap used|0|||
33640437|NCT03349034|102232956|FG000|Overall Study|Other|0|||
33640438|NCT03349034|102232957|FG001|Overall Study|Other|1|||
33640439|NCT03345784|102232961|FG000|Overall Study|Withdrawal by Subject|2|||
33640440|NCT03345784|102232962|FG001|Overall Study|Withdrawal by Subject|1|||
33640441|NCT01584440|102232963|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
33640442|NCT01584440|102232964|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
33640443|NCT01584440|102232965|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
33640444|NCT01584440|102232966|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
33640445|NCT01584440|102232967|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
33640446|NCT01584440|102232963|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
33239878|NCT00783718|100779877|FG000|Induction Phase|Lost to Follow-up|1|||
33239879|NCT00783718|100779878|FG001|Induction Phase|Lost to Follow-up|0|||
33239880|NCT00783718|100779879|FG002|Induction Phase|Lost to Follow-up|1|||
33239881|NCT00783718|100779880|FG003|Induction Phase|Lost to Follow-up|0|||
33239882|NCT00783718|100779881|FG004|Induction Phase|Lost to Follow-up|0|||
33239883|NCT00783718|100779882|FG005|Induction Phase|Lost to Follow-up|0|||
33239884|NCT00783718|100779883|FG006|Induction Phase|Lost to Follow-up|0|||
33239885|NCT00783718|100779877|FG000|Maintenance Phase|Adverse Event|12|||
33239886|NCT00783718|100779878|FG001|Maintenance Phase|Adverse Event|0|||
33239887|NCT00783718|100779879|FG002|Maintenance Phase|Adverse Event|0|||
33239888|NCT00783718|100779880|FG003|Maintenance Phase|Adverse Event|15|||
33239889|NCT00783718|100779881|FG004|Maintenance Phase|Adverse Event|7|||
33239890|NCT00783718|100779882|FG005|Maintenance Phase|Adverse Event|6|||
33239891|NCT00783718|100779883|FG006|Maintenance Phase|Adverse Event|16|||
33239892|NCT00783718|100779877|FG000|Maintenance Phase|Protocol Violation|1|||
33239893|NCT00783718|100779878|FG001|Maintenance Phase|Protocol Violation|0|||
33239894|NCT00783718|100779879|FG002|Maintenance Phase|Protocol Violation|0|||
33239895|NCT00783718|100779880|FG003|Maintenance Phase|Protocol Violation|0|||
33239896|NCT00783718|100779881|FG004|Maintenance Phase|Protocol Violation|0|||
33239897|NCT00783718|100779882|FG005|Maintenance Phase|Protocol Violation|0|||
33239898|NCT00783718|100779883|FG006|Maintenance Phase|Protocol Violation|2|||
33239899|NCT00783718|100779877|FG000|Maintenance Phase|Lack of Efficacy|83|||
33239900|NCT00783718|100779878|FG001|Maintenance Phase|Lack of Efficacy|0|||
33239901|NCT00783718|100779879|FG002|Maintenance Phase|Lack of Efficacy|0|||
33239902|NCT00783718|100779880|FG003|Maintenance Phase|Lack of Efficacy|61|||
33239903|NCT00783718|100779881|FG004|Maintenance Phase|Lack of Efficacy|31|||
33239904|NCT00783718|100779882|FG005|Maintenance Phase|Lack of Efficacy|33|||
33239905|NCT00783718|100779883|FG006|Maintenance Phase|Lack of Efficacy|155|||
33420971|NCT01461369|101431677|FG000|Overall Study|Lack of Efficacy|2|||
33420972|NCT01461369|101431678|FG001|Overall Study|Lack of Efficacy|0|||
33640447|NCT01584440|102232964|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
33640448|NCT01584440|102232965|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
33640449|NCT01584440|102232966|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
33640450|NCT01584440|102232967|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
33640451|NCT01584440|102232963|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
33640452|NCT01584440|102232964|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
33640453|NCT01584440|102232965|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
33640454|NCT01584440|102232966|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
33640455|NCT01584440|102232967|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
33239906|NCT00783718|100779877|FG000|Maintenance Phase|Withdrawal by Subject|6|||
33640456|NCT01584440|102232963|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
33640457|NCT01584440|102232964|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
33640458|NCT01584440|102232965|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
33640459|NCT01584440|102232966|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
33239907|NCT00783718|100779878|FG001|Maintenance Phase|Withdrawal by Subject|0|||
33420973|NCT01461369|101431679|FG002|Overall Study|Lack of Efficacy|6|||
33239908|NCT00783718|100779879|FG002|Maintenance Phase|Withdrawal by Subject|0|||
33239909|NCT00783718|100779880|FG003|Maintenance Phase|Withdrawal by Subject|2|||
33239910|NCT00783718|100779881|FG004|Maintenance Phase|Withdrawal by Subject|5|||
33640460|NCT01584440|102232967|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
33640461|NCT01584440|102232963|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
33640462|NCT01584440|102232964|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
33640463|NCT01584440|102232965|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
33640464|NCT01584440|102232966|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
33640465|NCT01584440|102232967|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
33640466|NCT01584440|102232963|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
33640467|NCT01584440|102232964|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
33640468|NCT01584440|102232965|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
33640469|NCT01584440|102232966|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
33640470|NCT01584440|102232967|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
33640471|NCT01584440|102232963|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
33640472|NCT01584440|102232964|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
33640473|NCT01584440|102232965|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
33640474|NCT01584440|102232966|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
33640475|NCT01584440|102232967|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
33640476|NCT01584440|102232963|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
33640477|NCT01584440|102232964|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
33640478|NCT01584440|102232965|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
33640479|NCT01584440|102232966|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
33640480|NCT01584440|102232967|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
33239911|NCT00783718|100779882|FG005|Maintenance Phase|Withdrawal by Subject|2|||
33239912|NCT00783718|100779883|FG006|Maintenance Phase|Withdrawal by Subject|20|||
33239913|NCT00783718|100779877|FG000|Maintenance Phase|Lost to Follow-up|3|||
33239914|NCT00783718|100779878|FG001|Maintenance Phase|Lost to Follow-up|0|||
33239915|NCT00783718|100779879|FG002|Maintenance Phase|Lost to Follow-up|0|||
33239916|NCT00783718|100779880|FG003|Maintenance Phase|Lost to Follow-up|0|||
33239917|NCT00783718|100779881|FG004|Maintenance Phase|Lost to Follow-up|2|||
33239918|NCT00783718|100779882|FG005|Maintenance Phase|Lost to Follow-up|0|||
33239919|NCT00783718|100779883|FG006|Maintenance Phase|Lost to Follow-up|2|||
33239920|NCT00665561|100779884|FG000|Overall Study|Death recorded on subject summary pages|75|||
33239921|NCT00665561|100779885|FG001|Overall Study|Death recorded on subject summary pages|75|||
33239922|NCT00665561|100779884|FG000|Overall Study|Does not meet entrance criteria|19|||
33239923|NCT00665561|100779885|FG001|Overall Study|Does not meet entrance criteria|21|||
33239924|NCT00665561|100779884|FG000|Overall Study|Lost to Follow-up|203|||
33239925|NCT00665561|100779885|FG001|Overall Study|Lost to Follow-up|264|||
33239926|NCT00665561|100779884|FG000|Overall Study|Withdrawal by Subject|74|||
33239927|NCT00665561|100779885|FG001|Overall Study|Withdrawal by Subject|65|||
33239928|NCT00665561|100779884|FG000|Overall Study|Other|123|||
33239929|NCT00665561|100779885|FG001|Overall Study|Other|108|||
33239930|NCT00665561|100779884|FG000|Overall Study|Site closed|8|||
33239931|NCT00665561|100779885|FG001|Overall Study|Site closed|0|||
33239932|NCT00665561|100779884|FG000|Overall Study|Withdrawn due to pregnancy|0|||
33239933|NCT00665561|100779885|FG001|Overall Study|Withdrawn due to pregnancy|1|||
33239934|NCT03169361|100779886|FG000|Overall Study|Protocol Violation|32|||
33239935|NCT01982760|100779891|FG000|Overall Study|Physician Decision|1|||
33239936|NCT01982760|100779892|FG001|Overall Study|Physician Decision|0|||
33239937|NCT01394991|100779893|FG000|Overall Study|Adverse Event|0|||
33239938|NCT01394991|100779894|FG001|Overall Study|Adverse Event|4|||
33239939|NCT01394991|100779893|FG000|Overall Study|Lack of Efficacy|5|||
33239940|NCT01394991|100779894|FG001|Overall Study|Lack of Efficacy|7|||
33239941|NCT01394991|100779893|FG000|Overall Study|Lost to Follow-up|6|||
33579987|NCT02389465|102013247|FG003|Overall Study|Lost to Follow-up|0|||
33579988|NCT02389465|102013244|FG000|Overall Study|Physician Decision|0|||
33579989|NCT02389465|102013245|FG001|Overall Study|Physician Decision|0|||
33579990|NCT02389465|102013246|FG002|Overall Study|Physician Decision|0|||
33579991|NCT02389465|102013247|FG003|Overall Study|Physician Decision|1|||
33579992|NCT02389465|102013244|FG000|Overall Study|Withdrawal by Subject|0|||
33579993|NCT02389465|102013245|FG001|Overall Study|Withdrawal by Subject|1|||
33579994|NCT02389465|102013246|FG002|Overall Study|Withdrawal by Subject|2|||
33579995|NCT02389465|102013247|FG003|Overall Study|Withdrawal by Subject|2|||
33579996|NCT00437268|102013248|FG000|Overall Study|Adverse Event|1|||
33579997|NCT00437268|102013249|FG001|Overall Study|Adverse Event|1|||
33579998|NCT00437268|102013248|FG000|Overall Study|Withdrawal by Subject|2|||
33579999|NCT00437268|102013249|FG001|Overall Study|Withdrawal by Subject|2|||
33580000|NCT00437268|102013248|FG000|Overall Study|Progressive disease|9|||
33640481|NCT01584440|102232963|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
33239942|NCT01394991|100779894|FG001|Overall Study|Lost to Follow-up|8|||
33239943|NCT01394991|100779893|FG000|Overall Study|Physician Decision|1|||
33239944|NCT01394991|100779894|FG001|Overall Study|Physician Decision|3|||
33239945|NCT01394991|100779893|FG000|Overall Study|Protocol Violation|1|||
33370484|NCT04360187|101243442|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
33370485|NCT04360187|101243443|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
33640482|NCT01584440|102232964|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
33640483|NCT01584440|102232965|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
33580001|NCT00437268|102013249|FG001|Overall Study|Progressive disease|9|||
33580002|NCT00437268|102013248|FG000|Overall Study|Physician Decision|1|||
33580003|NCT00437268|102013249|FG001|Overall Study|Physician Decision|0|||
33580004|NCT00437268|102013248|FG000|Overall Study|Death|0|||
33580005|NCT00437268|102013249|FG001|Overall Study|Death|1|||
33580006|NCT04245709|102013250|FG000|Overall Study|Adverse Event|13|||
33580007|NCT04245709|102013250|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
33580008|NCT00661830|102013251|FG000|Overall Study|Death|37|||
33580009|NCT00661830|102013252|FG001|Overall Study|Death|33|||
33580010|NCT00661830|102013251|FG000|Overall Study|Lost to Follow-up|1|||
33580011|NCT00661830|102013252|FG001|Overall Study|Lost to Follow-up|3|||
33580012|NCT00661830|102013251|FG000|Overall Study|Withdrawal by Subject|1|||
33580013|NCT00661830|102013252|FG001|Overall Study|Withdrawal by Subject|1|||
33580014|NCT00661830|102013251|FG000|Overall Study|Other reason|1|||
33580015|NCT00661830|102013252|FG001|Overall Study|Other reason|5|||
33580016|NCT00503425|102013253|FG000|Overall Study|Participant files lost|6|||
33580017|NCT00503425|102013253|FG000|Overall Study|Adverse Event|5|||
33580018|NCT00503425|102013253|FG000|Overall Study|Lack of Efficacy|25|||
33580019|NCT00503425|102013253|FG000|Overall Study|Withdrawal by Subject|8|||
33580020|NCT00503425|102013253|FG000|Overall Study|Lost to Follow-up|3|||
33580021|NCT00503425|102013253|FG000|Overall Study|Death|3|||
33580022|NCT00503425|102013253|FG000|Overall Study|Missing Data/Unknown|4|||
33580023|NCT00355368|102013256|FG000|Overall Study|Protocol Violation|8|||
33580024|NCT00355368|102013257|FG001|Overall Study|Protocol Violation|7|||
33580025|NCT00355368|102013256|FG000|Overall Study|cardiac arrest prior to intubation|2|||
33580026|NCT00355368|102013257|FG001|Overall Study|cardiac arrest prior to intubation|2|||
33580027|NCT01963767|102013258|FG000|Overall Study|Withdrawal by Subject|4|||
33580028|NCT01963767|102013259|FG001|Overall Study|Withdrawal by Subject|2|||
33580029|NCT01963767|102013258|FG000|Overall Study|Adverse Event|2|||
33580030|NCT01963767|102013259|FG001|Overall Study|Adverse Event|0|||
33580031|NCT01194245|102013260|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
33580032|NCT01194245|102013261|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
33580033|NCT01194245|102013262|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
33580034|NCT01194245|102013263|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
33580035|NCT01194245|102013264|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
33580036|NCT01194245|102013260|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
33580037|NCT01194245|102013261|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
33580038|NCT01194245|102013262|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
33640484|NCT01584440|102232966|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
33640485|NCT01584440|102232967|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
33640486|NCT01421719|102232970|FG000|Overall Study|Withdrawal by Subject|4|||
33640487|NCT02453711|102232971|FG000|Overall Study|Withdrawal by Subject|5|||
33640488|NCT02453711|102232972|FG001|Overall Study|Withdrawal by Subject|4|||
33640489|NCT02453711|102232973|FG002|Overall Study|Withdrawal by Subject|6|||
33640490|NCT02453711|102232974|FG003|Overall Study|Withdrawal by Subject|4|||
33640491|NCT02453711|102232975|FG004|Overall Study|Withdrawal by Subject|1|||
33640492|NCT02453711|102232976|FG005|Overall Study|Withdrawal by Subject|1|||
33640493|NCT02453711|102232977|FG006|Overall Study|Withdrawal by Subject|0|||
33640494|NCT02453711|102232978|FG007|Overall Study|Withdrawal by Subject|1|||
33640495|NCT02453711|102232979|FG008|Overall Study|Withdrawal by Subject|7|||
33640496|NCT02453711|102232971|FG000|Overall Study|Lost to Follow-up|5|||
33640497|NCT02453711|102232972|FG001|Overall Study|Lost to Follow-up|3|||
33640498|NCT02453711|102232973|FG002|Overall Study|Lost to Follow-up|2|||
33640499|NCT02453711|102232974|FG003|Overall Study|Lost to Follow-up|3|||
33640500|NCT02453711|102232975|FG004|Overall Study|Lost to Follow-up|1|||
33640501|NCT02453711|102232976|FG005|Overall Study|Lost to Follow-up|5|||
33640502|NCT02453711|102232977|FG006|Overall Study|Lost to Follow-up|2|||
33640503|NCT02453711|102232978|FG007|Overall Study|Lost to Follow-up|6|||
33640504|NCT02453711|102232979|FG008|Overall Study|Lost to Follow-up|6|||
33640505|NCT02453711|102232971|FG000|Overall Study|Death|0|||
33580039|NCT01194245|102013263|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
33580040|NCT01194245|102013264|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
33640506|NCT02453711|102232972|FG001|Overall Study|Death|0|||
33640507|NCT02453711|102232973|FG002|Overall Study|Death|0|||
33640508|NCT02453711|102232974|FG003|Overall Study|Death|0|||
33580041|NCT01194245|102013260|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
33580042|NCT01194245|102013261|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
33580043|NCT01194245|102013262|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
33640509|NCT02453711|102232975|FG004|Overall Study|Death|0|||
33640510|NCT02453711|102232976|FG005|Overall Study|Death|0|||
33370486|NCT04360187|101243442|FG000|Follow-Up|Lost to Follow-up|1|||
33580044|NCT01194245|102013263|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
33580045|NCT01194245|102013264|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
33640511|NCT02453711|102232977|FG006|Overall Study|Death|1|||
33640512|NCT02453711|102232978|FG007|Overall Study|Death|0|||
33640513|NCT02453711|102232979|FG008|Overall Study|Death|0|||
33640514|NCT02453711|102232971|FG000|Overall Study|Unclassified|1|||
33640515|NCT02453711|102232972|FG001|Overall Study|Unclassified|0|||
33640516|NCT02453711|102232973|FG002|Overall Study|Unclassified|1|||
33640517|NCT02453711|102232974|FG003|Overall Study|Unclassified|0|||
33640518|NCT02453711|102232975|FG004|Overall Study|Unclassified|0|||
33640519|NCT02453711|102232976|FG005|Overall Study|Unclassified|0|||
33640520|NCT02453711|102232977|FG006|Overall Study|Unclassified|0|||
33640521|NCT02453711|102232978|FG007|Overall Study|Unclassified|0|||
33640522|NCT02453711|102232979|FG008|Overall Study|Unclassified|0|||
33640523|NCT00248040|102236395|FG000|Overall Study|transplantectomy|2|||
33640524|NCT00248040|102236396|FG001|Overall Study|transplantectomy|1|||
33640525|NCT00248040|102236397|FG002|Overall Study|transplantectomy|3|||
33640526|NCT00248040|102236395|FG000|Overall Study|transplant cancelled post treat start|1|||
33640527|NCT00248040|102236396|FG001|Overall Study|transplant cancelled post treat start|0|||
33640528|NCT00248040|102236397|FG002|Overall Study|transplant cancelled post treat start|0|||
33640529|NCT00248040|102236395|FG000|Overall Study|Death|0|||
33640530|NCT00248040|102236396|FG001|Overall Study|Death|0|||
33640531|NCT00248040|102236397|FG002|Overall Study|Death|1|||
33640532|NCT01941186|102236398|FG000|Follow-up|Lost to Follow-up|1|||
33640533|NCT01941186|102236399|FG001|Follow-up|Lost to Follow-up|0|||
33640534|NCT00380367|102236400|FG000|Overall Study|Lost to Follow-up|1|||
33640535|NCT00380367|102236400|FG000|Overall Study|Withdrawal by Subject|1|||
33640536|NCT00943618|102236402|FG000|Overall Study|Lost to Follow-up|38|||
33640537|NCT00943618|102236403|FG001|Overall Study|Lost to Follow-up|48|||
33640538|NCT00943618|102236404|FG002|Overall Study|Lost to Follow-up|20|||
33640539|NCT00943618|102236402|FG000|Overall Study|Discontinued Medication|17|||
33640540|NCT00943618|102236403|FG001|Overall Study|Discontinued Medication|29|||
33640541|NCT00943618|102236404|FG002|Overall Study|Discontinued Medication|11|||
33640542|NCT02447302|102236405|FG000|Overall Study|Physician Decision|1|||
33640543|NCT02447302|102236406|FG001|Overall Study|Physician Decision|0|||
33640544|NCT02447302|102236407|FG002|Overall Study|Physician Decision|0|||
33239946|NCT01394991|100779894|FG001|Overall Study|Protocol Violation|1|||
33239947|NCT01394991|100779893|FG000|Overall Study|Withdrawal by Subject|20|||
33239948|NCT01394991|100779894|FG001|Overall Study|Withdrawal by Subject|17|||
33239949|NCT01394991|100779893|FG000|Overall Study|Chemotherapy Termination|10|||
33239950|NCT01394991|100779894|FG001|Overall Study|Chemotherapy Termination|15|||
33239951|NCT01394991|100779893|FG000|Overall Study|Disease Progression|7|||
33239952|NCT01394991|100779894|FG001|Overall Study|Disease Progression|7|||
33239953|NCT01394991|100779893|FG000|Overall Study|Prematurely Termination of Trial|9|||
33239954|NCT01394991|100779894|FG001|Overall Study|Prematurely Termination of Trial|10|||
33239955|NCT01089556|100779900|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
33239956|NCT01089556|100779901|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
33239957|NCT01089556|100779902|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
33239958|NCT01089556|100779903|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
33239959|NCT01089556|100779904|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
33239960|NCT01089556|100779905|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
33239961|NCT01089556|100779900|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
33239962|NCT01089556|100779901|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
33239963|NCT01089556|100779902|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
33239964|NCT01089556|100779903|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
33239965|NCT01089556|100779904|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
33239966|NCT01089556|100779905|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
33239967|NCT01089556|100779900|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
33239968|NCT01089556|100779901|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
33239969|NCT01089556|100779902|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
33239970|NCT01089556|100779903|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
33239971|NCT01089556|100779904|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
33239972|NCT01089556|100779905|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
33239973|NCT01089556|100779900|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
33239974|NCT01089556|100779901|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
33239975|NCT01089556|100779902|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
33239976|NCT01089556|100779903|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
33239977|NCT01089556|100779904|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
33239978|NCT01089556|100779905|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
33239979|NCT01089556|100779900|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
33239980|NCT01089556|100779901|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
33239981|NCT01089556|100779902|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
33239982|NCT01089556|100779903|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
33239983|NCT01089556|100779904|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
33239984|NCT01089556|100779905|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
33370487|NCT04360187|101243443|FG001|Follow-Up|Lost to Follow-up|0|||
33640545|NCT02447302|102236405|FG000|Overall Study|Adverse Event|4|||
33640546|NCT02447302|102236406|FG001|Overall Study|Adverse Event|3|||
33640547|NCT02447302|102236407|FG002|Overall Study|Adverse Event|0|||
33640548|NCT02447302|102236405|FG000|Overall Study|Withdrawal by Subject|0|||
33640549|NCT02447302|102236406|FG001|Overall Study|Withdrawal by Subject|1|||
33640550|NCT02447302|102236407|FG002|Overall Study|Withdrawal by Subject|5|||
33640551|NCT02447302|102236405|FG000|Overall Study|Sponsor Decision|0|||
33141209|NCT01904773|100431562|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33141210|NCT01904773|100431563|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33141211|NCT01904773|100431564|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33141212|NCT01904773|100431565|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33141213|NCT01904773|100431566|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
33141214|NCT01904773|100431558|FG000|First Intervention|Adverse Event|0|||
33141215|NCT01904773|100431559|FG001|First Intervention|Adverse Event|0|||
33141216|NCT01904773|100431560|FG002|First Intervention|Adverse Event|0|||
33141217|NCT01904773|100431561|FG003|First Intervention|Adverse Event|0|||
33141218|NCT01904773|100431562|FG004|First Intervention|Adverse Event|0|||
33141219|NCT01904773|100431563|FG005|First Intervention|Adverse Event|0|||
33141220|NCT01904773|100431564|FG006|First Intervention|Adverse Event|1|||
33141221|NCT01904773|100431565|FG007|First Intervention|Adverse Event|0|||
33141222|NCT01904773|100431566|FG008|First Intervention|Adverse Event|0|||
33141223|NCT01904773|100431558|FG000|Placebo Washout First Intervention|Condition worsened|0|||
33141224|NCT01904773|100431559|FG001|Placebo Washout First Intervention|Condition worsened|1|||
33141225|NCT01904773|100431560|FG002|Placebo Washout First Intervention|Condition worsened|0|||
33141226|NCT01904773|100431561|FG003|Placebo Washout First Intervention|Condition worsened|0|||
33141227|NCT01904773|100431562|FG004|Placebo Washout First Intervention|Condition worsened|0|||
33141228|NCT01904773|100431563|FG005|Placebo Washout First Intervention|Condition worsened|0|||
33141229|NCT01904773|100431564|FG006|Placebo Washout First Intervention|Condition worsened|0|||
33141230|NCT01904773|100431565|FG007|Placebo Washout First Intervention|Condition worsened|0|||
33141231|NCT01904773|100431566|FG008|Placebo Washout First Intervention|Condition worsened|0|||
33141232|NCT01904773|100431558|FG000|Fifth Intervention|Adverse Event|0|||
33640552|NCT02447302|102236406|FG001|Overall Study|Sponsor Decision|0|||
33640553|NCT02447302|102236407|FG002|Overall Study|Sponsor Decision|1|||
33640554|NCT01185080|102236415|FG000|Overall Study|Adverse Event|1|||
33640555|NCT01185080|102236416|FG001|Overall Study|Adverse Event|1|||
33640556|NCT01185080|102236417|FG002|Overall Study|Adverse Event|0|||
33640557|NCT01185080|102236415|FG000|Overall Study|Personal reasons|0|||
33640558|NCT01185080|102236416|FG001|Overall Study|Personal reasons|0|||
33640559|NCT01185080|102236417|FG002|Overall Study|Personal reasons|1|||
33640560|NCT01388335|102236418|FG000|Period 1|Progressive Disease|1|||
33640561|NCT01388335|102236418|FG000|Period 2|Progressive Disease|2|||
33640562|NCT01388335|102236418|FG000|Period 2|Sponsor Decision|1|||
33640563|NCT01388335|102236418|FG000|Safety Extension|Progressive Disease|7|||
33640564|NCT00357552|102236422|FG000|Screening|Did not meet eligibility criteria|84|||
33640565|NCT00357552|102236422|FG000|Weeks 0 to 24|Death|1|||
33640566|NCT00357552|102236422|FG000|Weeks 24 to 104|Death|3|||
33640567|NCT00357552|102236422|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
33640568|NCT00214201|102236423|FG000|Overall Study|Withdrawal by Subject|2|||
33640569|NCT00214201|102236424|FG001|Overall Study|Withdrawal by Subject|0|||
33640570|NCT00214201|102236423|FG000|Overall Study|Death|0|||
33640571|NCT00214201|102236424|FG001|Overall Study|Death|2|||
33370488|NCT00553059|101243447|FG000|Overall Study|Deemed ineligible|1|||
33640572|NCT00641667|102236429|FG000|Overall Study|Withdrawal by Subject|1|||
33640573|NCT00641667|102236429|FG000|Overall Study|Adverse Event|1|||
33640574|NCT00641667|102236429|FG000|Overall Study|Physician Decision|1|||
33640575|NCT00641667|102236429|FG000|Overall Study|Worsening of underlying disease|3|||
33640576|NCT03038880|102236430|FG000|Overall Study|Death|1|||
33640577|NCT03038880|102236431|FG001|Overall Study|Death|2|||
33640578|NCT03038880|102236432|FG002|Overall Study|Death|0|||
33640579|NCT03038880|102236430|FG000|Overall Study|Physician Decision|2|||
33640580|NCT03038880|102236431|FG001|Overall Study|Physician Decision|1|||
33640581|NCT03038880|102236432|FG002|Overall Study|Physician Decision|0|||
33640582|NCT03847896|102236442|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
33640583|NCT03847896|102236443|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
33640584|NCT03847896|102236444|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
33640585|NCT03847896|102236445|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
33640586|NCT03847896|102236446|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
33640587|NCT03847896|102236442|FG000|Overall Study|Withdrawal by Subject|2|||
33640588|NCT03847896|102236443|FG001|Overall Study|Withdrawal by Subject|10|||
33640589|NCT03847896|102236444|FG002|Overall Study|Withdrawal by Subject|5|||
33640590|NCT03847896|102236445|FG003|Overall Study|Withdrawal by Subject|9|||
33141233|NCT01904773|100431559|FG001|Fifth Intervention|Adverse Event|0|||
33141234|NCT01904773|100431560|FG002|Fifth Intervention|Adverse Event|0|||
33141235|NCT01904773|100431561|FG003|Fifth Intervention|Adverse Event|0|||
33141236|NCT01904773|100431562|FG004|Fifth Intervention|Adverse Event|0|||
33640591|NCT03847896|102236446|FG004|Overall Study|Withdrawal by Subject|8|||
33141237|NCT01904773|100431563|FG005|Fifth Intervention|Adverse Event|0|||
33141238|NCT01904773|100431564|FG006|Fifth Intervention|Adverse Event|0|||
33640592|NCT03847896|102236442|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33640593|NCT03847896|102236443|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33640594|NCT03847896|102236444|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33239985|NCT01089556|100779900|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
33239986|NCT01089556|100779901|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
33239987|NCT01089556|100779902|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
33141239|NCT01904773|100431565|FG007|Fifth Intervention|Adverse Event|1|||
33141240|NCT01904773|100431566|FG008|Fifth Intervention|Adverse Event|0|||
33141241|NCT01904773|100431558|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33141242|NCT01904773|100431559|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
33640595|NCT03847896|102236445|FG003|Overall Study|Withdrawal by parent/guardian|0|||
33640596|NCT03847896|102236446|FG004|Overall Study|Withdrawal by parent/guardian|0|||
33640597|NCT03847896|102236442|FG000|Overall Study|Adverse Event|2|||
33640598|NCT03847896|102236443|FG001|Overall Study|Adverse Event|1|||
33640599|NCT03847896|102236444|FG002|Overall Study|Adverse Event|3|||
33640600|NCT03847896|102236445|FG003|Overall Study|Adverse Event|2|||
33640601|NCT03847896|102236446|FG004|Overall Study|Adverse Event|4|||
33640602|NCT03847896|102236442|FG000|Overall Study|A severe exacerbation event|0|||
33640603|NCT03847896|102236443|FG001|Overall Study|A severe exacerbation event|0|||
33640604|NCT03847896|102236444|FG002|Overall Study|A severe exacerbation event|0|||
33640605|NCT03847896|102236445|FG003|Overall Study|A severe exacerbation event|0|||
33640606|NCT03847896|102236446|FG004|Overall Study|A severe exacerbation event|3|||
33640607|NCT03847896|102236442|FG000|Overall Study|Protocol Violation|0|||
33640608|NCT03847896|102236443|FG001|Overall Study|Protocol Violation|2|||
33640609|NCT03847896|102236444|FG002|Overall Study|Protocol Violation|1|||
33640610|NCT03847896|102236445|FG003|Overall Study|Protocol Violation|0|||
33640611|NCT03847896|102236446|FG004|Overall Study|Protocol Violation|2|||
33640612|NCT03847896|102236442|FG000|Overall Study|Lost to Follow-up|0|||
33640613|NCT03847896|102236443|FG001|Overall Study|Lost to Follow-up|0|||
33640614|NCT03847896|102236444|FG002|Overall Study|Lost to Follow-up|0|||
33640615|NCT03847896|102236445|FG003|Overall Study|Lost to Follow-up|1|||
33640616|NCT03847896|102236446|FG004|Overall Study|Lost to Follow-up|0|||
33640617|NCT03847896|102236442|FG000|Overall Study|Condition under investigation worsened|0|||
33640618|NCT03847896|102236443|FG001|Overall Study|Condition under investigation worsened|0|||
33640619|NCT03847896|102236444|FG002|Overall Study|Condition under investigation worsened|0|||
33640620|NCT03847896|102236445|FG003|Overall Study|Condition under investigation worsened|1|||
33640621|NCT03847896|102236446|FG004|Overall Study|Condition under investigation worsened|1|||
33640622|NCT03847896|102236442|FG000|Overall Study|Lack of Efficacy|0|||
33640623|NCT03847896|102236443|FG001|Overall Study|Lack of Efficacy|0|||
33640624|NCT03847896|102236444|FG002|Overall Study|Lack of Efficacy|0|||
33640625|NCT03847896|102236445|FG003|Overall Study|Lack of Efficacy|2|||
33640626|NCT03847896|102236446|FG004|Overall Study|Lack of Efficacy|2|||
33640627|NCT03847896|102236442|FG000|Overall Study|Other reasons|3|||
33640628|NCT03847896|102236443|FG001|Overall Study|Other reasons|3|||
33239988|NCT01089556|100779903|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
33239989|NCT01089556|100779904|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
33640629|NCT03847896|102236444|FG002|Overall Study|Other reasons|1|||
33141243|NCT01904773|100431560|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33141244|NCT01904773|100431561|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33141245|NCT01904773|100431562|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33141246|NCT01904773|100431563|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33141247|NCT01904773|100431564|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33141248|NCT01904773|100431565|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33141249|NCT01904773|100431566|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
33141250|NCT03505710|100431571|FG000|Overall Study|Progressive Disease|22|||
33141251|NCT03505710|100431572|FG001|Overall Study|Progressive Disease|9|||
33141252|NCT03505710|100431573|FG002|Overall Study|Progressive Disease|34|||
33239990|NCT01089556|100779905|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
33239991|NCT01089556|100779900|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
33239992|NCT01089556|100779901|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
33239993|NCT01089556|100779902|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
33239994|NCT01089556|100779903|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
33239995|NCT01089556|100779904|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
33239996|NCT01089556|100779905|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
33370489|NCT00553059|101243448|FG001|Overall Study|Deemed ineligible|1|||
33141253|NCT03505710|100431571|FG000|Overall Study|Clinical Progression|6|||
33370490|NCT00553059|101243447|FG000|Overall Study|Drug supply not available|0|||
33370491|NCT00553059|101243448|FG001|Overall Study|Drug supply not available|1|||
33370492|NCT02868216|101243452|FG000|Overall Study|Death|0|||
33370493|NCT02868216|101243453|FG001|Overall Study|Death|1|||
33640630|NCT03847896|102236445|FG003|Overall Study|Other reasons|2|||
33640631|NCT03847896|102236446|FG004|Overall Study|Other reasons|1|||
33640632|NCT02492763|102236448|FG000|Overall Study|Withdrawal by Subject|0|||
33640633|NCT02492763|102236449|FG001|Overall Study|Withdrawal by Subject|2|||
33640634|NCT02492763|102236450|FG002|Overall Study|Withdrawal by Subject|1|||
33640635|NCT02492763|102236451|FG003|Overall Study|Withdrawal by Subject|0|||
33141254|NCT03505710|100431572|FG001|Overall Study|Clinical Progression|6|||
33141255|NCT03505710|100431573|FG002|Overall Study|Clinical Progression|3|||
33141256|NCT03505710|100431571|FG000|Overall Study|Adverse Event|12|||
33141257|NCT03505710|100431572|FG001|Overall Study|Adverse Event|5|||
33141258|NCT03505710|100431573|FG002|Overall Study|Adverse Event|27|||
33141259|NCT03505710|100431571|FG000|Overall Study|Withdrawal by Subject|1|||
33141260|NCT03505710|100431572|FG001|Overall Study|Withdrawal by Subject|3|||
33141261|NCT03505710|100431573|FG002|Overall Study|Withdrawal by Subject|3|||
33141262|NCT03505710|100431571|FG000|Overall Study|Physician Decision|1|||
33141263|NCT03505710|100431572|FG001|Overall Study|Physician Decision|0|||
33141264|NCT03505710|100431573|FG002|Overall Study|Physician Decision|2|||
33141265|NCT03505710|100431571|FG000|Overall Study|Death|4|||
33141266|NCT03505710|100431572|FG001|Overall Study|Death|3|||
33141267|NCT03505710|100431573|FG002|Overall Study|Death|6|||
33141268|NCT03505710|100431571|FG000|Overall Study|Other Reasons|1|||
33141269|NCT03505710|100431572|FG001|Overall Study|Other Reasons|1|||
33141270|NCT03505710|100431573|FG002|Overall Study|Other Reasons|1|||
33141271|NCT00369629|100431582|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
33141272|NCT00369629|100431583|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
33141273|NCT00369629|100431584|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
33141274|NCT00369629|100431585|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
33141275|NCT00369629|100431582|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
33141276|NCT00369629|100431583|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
33141277|NCT00369629|100431584|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
33141278|NCT00369629|100431585|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
33141279|NCT00369629|100431582|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
33141280|NCT00369629|100431583|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
33141281|NCT00369629|100431584|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
33141282|NCT00369629|100431585|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
33141283|NCT00369629|100431582|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
33141284|NCT00369629|100431583|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
33141285|NCT00369629|100431584|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
33141286|NCT00369629|100431585|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
33141287|NCT00369629|100431582|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
33141288|NCT00369629|100431583|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
33640636|NCT02492763|102236448|FG000|Overall Study|Adverse Event|3|||
33640637|NCT02492763|102236449|FG001|Overall Study|Adverse Event|1|||
33640638|NCT02492763|102236450|FG002|Overall Study|Adverse Event|1|||
33640639|NCT02492763|102236451|FG003|Overall Study|Adverse Event|2|||
33640640|NCT02492763|102236448|FG000|Overall Study|Death|0|||
33640641|NCT02492763|102236449|FG001|Overall Study|Death|0|||
33640642|NCT02492763|102236450|FG002|Overall Study|Death|1|||
33640643|NCT02492763|102236451|FG003|Overall Study|Death|0|||
33640644|NCT02492763|102236448|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
33640645|NCT02492763|102236449|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
33640646|NCT02492763|102236450|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
33640647|NCT02492763|102236451|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
33640648|NCT02492763|102236448|FG000|Overall Study|Lost to Follow-up|0|||
33640649|NCT02492763|102236449|FG001|Overall Study|Lost to Follow-up|0|||
33640650|NCT02492763|102236450|FG002|Overall Study|Lost to Follow-up|1|||
33640651|NCT02492763|102236451|FG003|Overall Study|Lost to Follow-up|0|||
33640652|NCT02492763|102236448|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33640653|NCT02492763|102236449|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33640654|NCT02492763|102236450|FG002|Overall Study|Non-Compliance With Study Drug|0|||
33640655|NCT02492763|102236451|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33640656|NCT02492763|102236448|FG000|Overall Study|Screen Failure|0|||
33640657|NCT02492763|102236449|FG001|Overall Study|Screen Failure|0|||
33640658|NCT02492763|102236450|FG002|Overall Study|Screen Failure|0|||
33640659|NCT02492763|102236451|FG003|Overall Study|Screen Failure|1|||
33640660|NCT02492763|102236448|FG000|Overall Study|Study Terminated by Sponsor|13|||
33141289|NCT00369629|100431584|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
33141290|NCT00369629|100431585|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
33141291|NCT00369629|100431582|FG000|Completed 4 More Cycles|Progressive disease|2|||
33141292|NCT00369629|100431583|FG001|Completed 4 More Cycles|Progressive disease|1|||
33141293|NCT00369629|100431584|FG002|Completed 4 More Cycles|Progressive disease|2|||
33640661|NCT02492763|102236449|FG001|Overall Study|Study Terminated by Sponsor|10|||
33640662|NCT02492763|102236450|FG002|Overall Study|Study Terminated by Sponsor|6|||
33640663|NCT02492763|102236451|FG003|Overall Study|Study Terminated by Sponsor|10|||
33640664|NCT00670306|102236452|FG000|Overall Study|Adverse Event|8|||
33640665|NCT00670306|102236452|FG000|Overall Study|Lack of Efficacy|10|||
33640666|NCT00670306|102236452|FG000|Overall Study|Withdrawal by Subject|9|||
33640667|NCT00670306|102236452|FG000|Overall Study|Physician Decision|1|||
33640668|NCT00670306|102236452|FG000|Overall Study|Lost to Follow-up|8|||
33640669|NCT00670306|102236452|FG000|Overall Study|incl/excl criterias did not meet|19|||
33141294|NCT00369629|100431585|FG003|Completed 4 More Cycles|Progressive disease|0|||
33141295|NCT00369629|100431582|FG000|Follow up for 1 Year|Death|2|||
33141296|NCT00369629|100431583|FG001|Follow up for 1 Year|Death|1|||
33141297|NCT00369629|100431584|FG002|Follow up for 1 Year|Death|1|||
33141298|NCT00369629|100431585|FG003|Follow up for 1 Year|Death|0|||
33141299|NCT00369629|100431582|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
33141300|NCT00369629|100431583|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
33141301|NCT00369629|100431584|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
33141302|NCT00369629|100431585|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
33141303|NCT00369629|100431582|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
33141304|NCT00369629|100431583|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
33141305|NCT00369629|100431584|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
33141306|NCT00369629|100431585|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
33141307|NCT02496676|100431593|FG000|Phase 1 - Period 1|Adverse Event|0|||
33141308|NCT02496676|100431594|FG001|Phase 1 - Period 1|Adverse Event|1|||
33141309|NCT02496676|100431593|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
33141310|NCT02496676|100431594|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
33141311|NCT00604214|100431596|FG000|Baseline to Day 28|Death|223|||
33141312|NCT00604214|100431597|FG001|Baseline to Day 28|Death|202|||
33141313|NCT00604214|100431596|FG000|Baseline to Day 28|Lost to Follow-up|2|||
33141314|NCT00604214|100431597|FG001|Baseline to Day 28|Lost to Follow-up|4|||
33141315|NCT00604214|100431596|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
33141316|NCT00604214|100431597|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
33141317|NCT00604214|100431596|FG000|Day 29 to Day 90|Death|64|||
33141318|NCT00604214|100431597|FG001|Day 29 to Day 90|Death|67|||
33141319|NCT00604214|100431596|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
33141320|NCT00604214|100431597|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
33141321|NCT00604214|100431596|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
33141322|NCT00604214|100431597|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
33141323|NCT00604214|100431596|FG000|Day 91 to Day 180|Death|19|||
33141324|NCT00604214|100431597|FG001|Day 91 to Day 180|Death|23|||
33141325|NCT00604214|100431596|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
33141326|NCT00604214|100431597|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
33141327|NCT00604214|100431596|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
33141328|NCT00604214|100431597|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
33141329|NCT03338959|100431598|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
33141330|NCT03338959|100431598|FG000|Overall Study|Physician Decision|1|||
33141331|NCT01143389|100431599|FG000|Overall Study|Lost to Follow-up|26|||
33141332|NCT01143389|100431600|FG001|Overall Study|Lost to Follow-up|25|||
33141333|NCT03007888|100431601|FG000|First Intervention (14 Days)|Adverse Event|1|||
33141334|NCT03007888|100431602|FG001|First Intervention (14 Days)|Adverse Event|0|||
33141335|NCT04381988|100431603|FG000|Overall Study|The study was terminated|4|||
33141336|NCT04381988|100431604|FG001|Overall Study|The study was terminated|0|||
33141337|NCT05463198|100431607|FG000|Overall Study|Withdrawal by Subject|19|||
33141338|NCT05463198|100431607|FG000|Overall Study|Procedure Notes Missing|18|||
33141339|NCT01104376|100431621|FG000|Overall Study|Withdrawal by Subject|15|||
33141340|NCT01104376|100431621|FG000|Overall Study|Consented but excluded after labs|13|||
33141341|NCT01185301|100431622|FG000|Overall Study|Adverse Event|3|||
33141342|NCT01185301|100431623|FG001|Overall Study|Adverse Event|0|||
33141343|NCT01185301|100431624|FG002|Overall Study|Adverse Event|2|||
33141344|NCT01185301|100431625|FG003|Overall Study|Adverse Event|3|||
33141345|NCT01185301|100431622|FG000|Overall Study|Withdrawal by Subject|7|||
33141346|NCT01185301|100431623|FG001|Overall Study|Withdrawal by Subject|5|||
33141347|NCT01185301|100431624|FG002|Overall Study|Withdrawal by Subject|2|||
33141348|NCT01185301|100431625|FG003|Overall Study|Withdrawal by Subject|3|||
33141349|NCT01185301|100431622|FG000|Overall Study|Lost to Follow-up|2|||
33141350|NCT01185301|100431623|FG001|Overall Study|Lost to Follow-up|0|||
33141351|NCT01185301|100431624|FG002|Overall Study|Lost to Follow-up|0|||
33141352|NCT01185301|100431625|FG003|Overall Study|Lost to Follow-up|1|||
33141353|NCT01185301|100431622|FG000|Overall Study|Other Reason|3|||
33141354|NCT01185301|100431623|FG001|Overall Study|Other Reason|2|||
33141355|NCT01185301|100431624|FG002|Overall Study|Other Reason|2|||
33141356|NCT01185301|100431625|FG003|Overall Study|Other Reason|2|||
33141357|NCT01343823|100431626|FG000|Overall Study|Study Terminated|1|||
33141358|NCT01343823|100431627|FG001|Overall Study|Study Terminated|0|||
33141359|NCT01343823|100431628|FG002|Overall Study|Study Terminated|0|||
33141360|NCT01343823|100431629|FG003|Overall Study|Study Terminated|1|||
33141361|NCT01343823|100431626|FG000|Overall Study|Withdrawal by Subject|1|||
33141362|NCT01343823|100431627|FG001|Overall Study|Withdrawal by Subject|0|||
33141363|NCT01343823|100431628|FG002|Overall Study|Withdrawal by Subject|0|||
33141364|NCT01343823|100431629|FG003|Overall Study|Withdrawal by Subject|0|||
33141365|NCT00392379|100431630|FG000|Overall Study|Withdrawal by Subject|17|||
33141366|NCT00392379|100431631|FG001|Overall Study|Withdrawal by Subject|28|||
33141367|NCT00392379|100431630|FG000|Overall Study|Lost to Follow-up|4|||
33141368|NCT00392379|100431631|FG001|Overall Study|Lost to Follow-up|9|||
33141369|NCT00392379|100431630|FG000|Overall Study|Adverse Event|1|||
33141370|NCT00392379|100431631|FG001|Overall Study|Adverse Event|1|||
33141371|NCT00424255|100431650|FG000|Overall Study|Death|115|||
33141372|NCT00424255|100431651|FG001|Overall Study|Death|111|||
33141373|NCT00424255|100431650|FG000|Overall Study|Lost to Follow-up|26|||
33141374|NCT00424255|100431651|FG001|Overall Study|Lost to Follow-up|20|||
33141375|NCT00424255|100431650|FG000|Overall Study|Protocol Violation|0|||
33141376|NCT00424255|100431651|FG001|Overall Study|Protocol Violation|1|||
33141377|NCT00424255|100431650|FG000|Overall Study|Withdrawal by Subject|34|||
33141378|NCT00424255|100431651|FG001|Overall Study|Withdrawal by Subject|38|||
33141379|NCT00424255|100431650|FG000|Overall Study|Physician Decision|3|||
33141380|NCT00424255|100431651|FG001|Overall Study|Physician Decision|7|||
33141381|NCT00424255|100431650|FG000|Overall Study|Cognitive Disturbance|1|||
33141382|NCT00424255|100431651|FG001|Overall Study|Cognitive Disturbance|0|||
33141383|NCT00424255|100431650|FG000|Overall Study|Non-compliance by Participants|1|||
33141384|NCT00424255|100431651|FG001|Overall Study|Non-compliance by Participants|0|||
33141385|NCT00424255|100431650|FG000|Overall Study|Fatigue|1|||
33141386|NCT00424255|100431651|FG001|Overall Study|Fatigue|0|||
33141387|NCT00424255|100431650|FG000|Overall Study|Disease Progression|0|||
33141388|NCT00424255|100431651|FG001|Overall Study|Disease Progression|2|||
33141389|NCT00424255|100431650|FG000|Overall Study|Sponsor Terminated Study|161|||
33141390|NCT00424255|100431651|FG001|Overall Study|Sponsor Terminated Study|167|||
33141391|NCT03330002|100431652|FG000|Overall Study|Lost to Follow-up|15|||
33141392|NCT03330002|100431652|FG000|Overall Study|Death|7|||
33141393|NCT00075270|100431659|FG000|Overall Study|Withdrawal by Subject|28|||
33141394|NCT00075270|100431660|FG001|Overall Study|Withdrawal by Subject|21|||
33141395|NCT00075270|100431659|FG000|Overall Study|Lost to Follow-up|25|||
33141396|NCT00075270|100431660|FG001|Overall Study|Lost to Follow-up|28|||
33141397|NCT00075270|100431659|FG000|Overall Study|Protocol Violation|0|||
33141398|NCT00075270|100431660|FG001|Overall Study|Protocol Violation|2|||
33141399|NCT00075270|100431659|FG000|Overall Study|Death|198|||
33141400|NCT00075270|100431660|FG001|Overall Study|Death|215|||
33141401|NCT00075270|100431659|FG000|Overall Study|Other/Unknown|9|||
33141402|NCT00075270|100431660|FG001|Overall Study|Other/Unknown|5|||
33141403|NCT00075270|100431659|FG000|Overall Study|Missing|26|||
33141404|NCT00075270|100431660|FG001|Overall Study|Missing|13|||
33141405|NCT02125604|100431662|FG000|Overall Study|Other|4|||
33141406|NCT02125604|100431662|FG000|Overall Study|Investigator Decision|1|||
33141407|NCT02125604|100431662|FG000|Overall Study|Lost to Follow-up|2|||
33141408|NCT02125604|100431662|FG000|Overall Study|Consent Withdrawn|4|||
33141409|NCT02125604|100431662|FG000|Overall Study|Adverse Event|20|||
33141410|NCT00169442|100431663|FG000|Overall Study|Withdrawal by Subject|0|||
33141411|NCT00169442|100431664|FG001|Overall Study|Withdrawal by Subject|0|||
33141412|NCT00169442|100431665|FG002|Overall Study|Withdrawal by Subject|1|||
33141413|NCT00169442|100431666|FG003|Overall Study|Withdrawal by Subject|0|||
33141414|NCT00169442|100431667|FG004|Overall Study|Withdrawal by Subject|0|||
33141415|NCT00169442|100431668|FG005|Overall Study|Withdrawal by Subject|0|||
33141416|NCT00169442|100431663|FG000|Overall Study|Migrated/moved from study area|0|||
33141417|NCT00169442|100431664|FG001|Overall Study|Migrated/moved from study area|0|||
33141418|NCT00169442|100431665|FG002|Overall Study|Migrated/moved from study area|0|||
33141419|NCT00169442|100431666|FG003|Overall Study|Migrated/moved from study area|0|||
33141420|NCT00169442|100431667|FG004|Overall Study|Migrated/moved from study area|0|||
33141421|NCT00169442|100431668|FG005|Overall Study|Migrated/moved from study area|2|||
33141422|NCT00169442|100431663|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
33141423|NCT00169442|100431664|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
33141424|NCT00169442|100431665|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
33141425|NCT00169442|100431666|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
33141426|NCT00169442|100431667|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
33141427|NCT00169442|100431668|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
33141428|NCT00169442|100431663|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
33141429|NCT00169442|100431664|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
33141430|NCT00169442|100431665|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
33141431|NCT00169442|100431666|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
33141432|NCT00169442|100431667|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
33141433|NCT00169442|100431668|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
33141434|NCT00586664|100431669|FG000|Overall Study|Withdrawal by Subject|3|||
33141435|NCT00586664|100431670|FG001|Overall Study|Withdrawal by Subject|7|||
33141436|NCT00586664|100431671|FG002|Overall Study|Withdrawal by Subject|1|||
33141437|NCT00586664|100431669|FG000|Overall Study|Exclusion criteria met|2|||
33141438|NCT00586664|100431670|FG001|Overall Study|Exclusion criteria met|0|||
33141439|NCT00586664|100431671|FG002|Overall Study|Exclusion criteria met|0|||
33141440|NCT03680742|100431673|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
33141441|NCT01534182|100431674|FG000|Overall Study|Administrative problems|1|||
33141442|NCT01534182|100431675|FG001|Overall Study|Administrative problems|0|||
33141443|NCT01534182|100431674|FG000|Overall Study|Withdrawal by Subject|4|||
33141444|NCT01534182|100431675|FG001|Overall Study|Withdrawal by Subject|7|||
33141445|NCT01534182|100431674|FG000|Overall Study|Adverse Event|7|||
33141446|NCT01534182|100431675|FG001|Overall Study|Adverse Event|3|||
33141447|NCT00821509|100431676|FG000|Overall Study|Withdrawal by Subject|12|||
33141448|NCT00821509|100431677|FG001|Overall Study|Withdrawal by Subject|11|||
33141449|NCT00821509|100431678|FG002|Overall Study|Withdrawal by Subject|34|||
33141450|NCT02095132|100431682|FG000|Overall Study|Adverse Event|0|||
33580046|NCT01194245|102013260|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
33141451|NCT02095132|100431683|FG001|Overall Study|Adverse Event|0|||
33141452|NCT02095132|100431684|FG002|Overall Study|Adverse Event|0|||
33141453|NCT02095132|100431685|FG003|Overall Study|Adverse Event|0|||
33141454|NCT02095132|100431686|FG004|Overall Study|Adverse Event|1|||
33141455|NCT02095132|100431687|FG005|Overall Study|Adverse Event|0|||
33141456|NCT02095132|100431688|FG006|Overall Study|Adverse Event|1|||
33141457|NCT02095132|100431689|FG007|Overall Study|Adverse Event|0|||
33141458|NCT02095132|100431690|FG008|Overall Study|Adverse Event|0|||
33141459|NCT02095132|100431682|FG000|Overall Study|Death|0|||
33141460|NCT02095132|100431683|FG001|Overall Study|Death|0|||
33141461|NCT02095132|100431684|FG002|Overall Study|Death|0|||
33141462|NCT02095132|100431685|FG003|Overall Study|Death|0|||
33580047|NCT01194245|102013261|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
33580048|NCT01194245|102013262|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
33141463|NCT02095132|100431686|FG004|Overall Study|Death|0|||
33141464|NCT02095132|100431687|FG005|Overall Study|Death|0|||
33141465|NCT02095132|100431688|FG006|Overall Study|Death|1|||
33141466|NCT02095132|100431689|FG007|Overall Study|Death|0|||
33141467|NCT02095132|100431690|FG008|Overall Study|Death|0|||
33141468|NCT02095132|100431682|FG000|Overall Study|Lack of Efficacy|3|||
33141469|NCT02095132|100431683|FG001|Overall Study|Lack of Efficacy|5|||
33141470|NCT02095132|100431684|FG002|Overall Study|Lack of Efficacy|2|||
33141471|NCT02095132|100431685|FG003|Overall Study|Lack of Efficacy|8|||
33141472|NCT02095132|100431686|FG004|Overall Study|Lack of Efficacy|3|||
33141473|NCT02095132|100431687|FG005|Overall Study|Lack of Efficacy|6|||
33141474|NCT02095132|100431688|FG006|Overall Study|Lack of Efficacy|10|||
33141475|NCT02095132|100431689|FG007|Overall Study|Lack of Efficacy|9|||
33141476|NCT02095132|100431690|FG008|Overall Study|Lack of Efficacy|8|||
33141477|NCT02095132|100431682|FG000|Overall Study|Physician Decision|1|||
33141478|NCT02095132|100431683|FG001|Overall Study|Physician Decision|0|||
33141479|NCT02095132|100431684|FG002|Overall Study|Physician Decision|0|||
33141480|NCT02095132|100431685|FG003|Overall Study|Physician Decision|0|||
33141481|NCT02095132|100431686|FG004|Overall Study|Physician Decision|0|||
33141482|NCT02095132|100431687|FG005|Overall Study|Physician Decision|0|||
33141483|NCT02095132|100431688|FG006|Overall Study|Physician Decision|1|||
33141484|NCT02095132|100431689|FG007|Overall Study|Physician Decision|0|||
33141485|NCT02095132|100431690|FG008|Overall Study|Physician Decision|2|||
33141486|NCT02095132|100431682|FG000|Overall Study|Withdrawal by Subject|0|||
33141487|NCT02095132|100431683|FG001|Overall Study|Withdrawal by Subject|0|||
33141488|NCT02095132|100431684|FG002|Overall Study|Withdrawal by Subject|2|||
33141489|NCT02095132|100431685|FG003|Overall Study|Withdrawal by Subject|2|||
33370494|NCT02868216|101243452|FG000|Overall Study|coronary artery bypass|1|||
33370495|NCT02868216|101243453|FG001|Overall Study|coronary artery bypass|0|||
33580049|NCT01194245|102013263|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
33580050|NCT01194245|102013264|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
33141490|NCT02095132|100431686|FG004|Overall Study|Withdrawal by Subject|3|||
33141491|NCT02095132|100431687|FG005|Overall Study|Withdrawal by Subject|0|||
33141492|NCT02095132|100431688|FG006|Overall Study|Withdrawal by Subject|5|||
33141493|NCT02095132|100431689|FG007|Overall Study|Withdrawal by Subject|0|||
33141494|NCT02095132|100431690|FG008|Overall Study|Withdrawal by Subject|0|||
33141495|NCT01829243|100431691|FG000|First Intervention|Screen Failure|4|||
33141496|NCT01829243|100431692|FG001|First Intervention|Screen Failure|2|||
33141497|NCT01444092|100431693|FG000|Overall Study|Adverse Event|8|||
33141498|NCT01444092|100431693|FG000|Overall Study|Protocol Violation|1|||
33141499|NCT01444092|100431693|FG000|Overall Study|Withdrawal by Subject|1|||
33141500|NCT01444092|100431693|FG000|Overall Study|Other Eligibility criteria|7|||
33141501|NCT02915874|100431694|FG000|Overall Study|Lost to Follow-up|5|||
33141502|NCT02915874|100431695|FG001|Overall Study|Lost to Follow-up|4|||
33141503|NCT02915874|100431694|FG000|Overall Study|Withdrawal by Subject|1|||
33141504|NCT02915874|100431695|FG001|Overall Study|Withdrawal by Subject|1|||
33141505|NCT02915874|100431694|FG000|Overall Study|Started New Anxiety Medication|0|||
33239997|NCT01089556|100779900|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
33239998|NCT01089556|100779901|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
33370496|NCT02868216|101243452|FG000|Overall Study|Withdrawal by Subject|7|||
33370497|NCT02868216|101243453|FG001|Overall Study|Withdrawal by Subject|5|||
33370498|NCT03235544|101243457|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
33370499|NCT03235544|101243458|FG001|Overall Study|Participants Still Ongoing in the Study|13|||
33141506|NCT02915874|100431695|FG001|Overall Study|Started New Anxiety Medication|1|||
33141507|NCT03821844|100431698|FG000|Overall Study|Death|37|||
33141508|NCT03821844|100431699|FG001|Overall Study|Death|31|||
33141509|NCT03821844|100431698|FG000|Overall Study|Discharged|10|||
33370500|NCT03235544|101243459|FG002|Overall Study|Participants Still Ongoing in the Study|19|||
33141510|NCT03821844|100431699|FG001|Overall Study|Discharged|14|||
33141511|NCT03821844|100431698|FG000|Overall Study|Not present in facility at followup|2|||
33141512|NCT03821844|100431699|FG001|Overall Study|Not present in facility at followup|3|||
33141513|NCT04575597|100431700|FG000|Overall Study|Death|0|||
33141514|NCT04575597|100431701|FG001|Overall Study|Death|0|||
33141515|NCT04575597|100431702|FG002|Overall Study|Death|0|||
33141516|NCT04575597|100431703|FG003|Overall Study|Death|1|||
33141517|NCT04575597|100431704|FG004|Overall Study|Death|3|||
33141518|NCT04575597|100431705|FG005|Overall Study|Death|14|||
33141519|NCT04575597|100431700|FG000|Overall Study|Lost to Follow-up|2|||
33141520|NCT04575597|100431701|FG001|Overall Study|Lost to Follow-up|1|||
33141521|NCT04575597|100431702|FG002|Overall Study|Lost to Follow-up|1|||
33141522|NCT04575597|100431703|FG003|Overall Study|Lost to Follow-up|2|||
33141523|NCT04575597|100431704|FG004|Overall Study|Lost to Follow-up|10|||
33141524|NCT04575597|100431705|FG005|Overall Study|Lost to Follow-up|8|||
33141525|NCT04575597|100431700|FG000|Overall Study|Withdrawal by Subject|2|||
33141526|NCT04575597|100431701|FG001|Overall Study|Withdrawal by Subject|2|||
33141527|NCT04575597|100431702|FG002|Overall Study|Withdrawal by Subject|4|||
33640670|NCT03682770|102236453|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
33640671|NCT03682770|102236454|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
33640672|NCT03682770|102236455|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
33640673|NCT03682770|102236456|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
33640674|NCT03682770|102236457|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
33640675|NCT03682770|102236458|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
33640676|NCT03682770|102236459|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
33640677|NCT03682770|102236453|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
33141528|NCT04575597|100431703|FG003|Overall Study|Withdrawal by Subject|2|||
33141529|NCT04575597|100431704|FG004|Overall Study|Withdrawal by Subject|25|||
33141530|NCT04575597|100431705|FG005|Overall Study|Withdrawal by Subject|28|||
33141531|NCT04575597|100431700|FG000|Overall Study|Not Recorded|0|||
33239999|NCT01089556|100779902|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
33640678|NCT03682770|102236454|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
33640679|NCT03682770|102236455|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
33640680|NCT03682770|102236456|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
33640681|NCT03682770|102236457|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
33640682|NCT03682770|102236458|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
33640683|NCT03682770|102236459|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
33640684|NCT03682770|102236453|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
33640685|NCT03682770|102236454|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
33640686|NCT03682770|102236455|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
33640687|NCT03682770|102236456|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
33640688|NCT03682770|102236457|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
33640689|NCT03682770|102236458|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
33640690|NCT03682770|102236459|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
33640691|NCT03682770|102236453|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
33640692|NCT03682770|102236454|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
33640693|NCT03682770|102236455|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
33640694|NCT03682770|102236456|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
33640695|NCT03682770|102236457|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
33640696|NCT03682770|102236458|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
33640697|NCT03682770|102236459|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
33640698|NCT03682770|102236453|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
33640699|NCT03682770|102236454|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
33640700|NCT03682770|102236455|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
33640701|NCT03682770|102236456|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
33640702|NCT03682770|102236457|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
33640703|NCT03682770|102236458|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
33640704|NCT03682770|102236459|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
33640705|NCT03682770|102236453|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
33640706|NCT03682770|102236454|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
33640707|NCT03682770|102236455|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
33640708|NCT03682770|102236456|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
33640709|NCT03682770|102236457|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
33640710|NCT03682770|102236458|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
33640711|NCT03682770|102236459|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
33141532|NCT04575597|100431701|FG001|Overall Study|Not Recorded|0|||
33141533|NCT04575597|100431702|FG002|Overall Study|Not Recorded|0|||
33141534|NCT04575597|100431703|FG003|Overall Study|Not Recorded|0|||
33141535|NCT04575597|100431704|FG004|Overall Study|Not Recorded|0|||
33141536|NCT04575597|100431705|FG005|Overall Study|Not Recorded|2|||
33141537|NCT04575597|100431700|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33141538|NCT04575597|100431701|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33141539|NCT04575597|100431702|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33141540|NCT04575597|100431703|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33141541|NCT04575597|100431704|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
33141542|NCT04575597|100431705|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
33141543|NCT04905498|100431710|FG000|Overall Study|Lost to Follow-up|0|||
33141544|NCT04905498|100431711|FG001|Overall Study|Lost to Follow-up|2|||
33141545|NCT04905498|100431710|FG000|Overall Study|COVID lockdown|1|||
33141546|NCT04905498|100431711|FG001|Overall Study|COVID lockdown|0|||
33141547|NCT02312687|100431712|FG000|Overall Study|Other, Not Specified|1|||
33141548|NCT01262352|100431714|FG000|Period 1|Illness after randomization|1|||
33141549|NCT01262352|100431715|FG001|Period 1|Illness after randomization|0|||
33141550|NCT01262352|100431714|FG000|Washout|Adverse Event|1|||
33141551|NCT01262352|100431715|FG001|Washout|Adverse Event|1|||
33141552|NCT01262352|100431714|FG000|Washout|Extended Washout|0|||
33141553|NCT01262352|100431715|FG001|Washout|Extended Washout|1|||
33370501|NCT03235544|101243460|FG003|Overall Study|Participants Still Ongoing in the Study|55|||
33370502|NCT03235544|101243457|FG000|Overall Study|Death|11|||
33370503|NCT03235544|101243458|FG001|Overall Study|Death|23|||
33370504|NCT03235544|101243459|FG002|Overall Study|Death|11|||
33141554|NCT00913692|100431716|FG000|Screening (4 Months)|Physician Decision|3|||
33141555|NCT00913692|100431716|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
33141556|NCT00913692|100431716|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
33141557|NCT04559529|100431717|FG000|First Intervention (1 Day)|Adverse Event|0|||
33141558|NCT04559529|100431718|FG001|First Intervention (1 Day)|Adverse Event|0|||
33141559|NCT04559529|100431719|FG002|First Intervention (1 Day)|Adverse Event|0|||
33141560|NCT04559529|100431720|FG003|First Intervention (1 Day)|Adverse Event|1|||
33141561|NCT04559529|100431717|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
33141562|NCT04559529|100431718|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
33141563|NCT04559529|100431719|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
33141564|NCT04559529|100431720|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
33141565|NCT04559529|100431717|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
33141566|NCT04559529|100431718|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
33141567|NCT04559529|100431719|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
33141568|NCT04559529|100431720|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
33141569|NCT00527488|100431723|FG000|Overall Study|Withdrawn prior to dosing|0|||
33141570|NCT00527488|100431724|FG001|Overall Study|Withdrawn prior to dosing|1|||
33141571|NCT00527488|100431725|FG002|Overall Study|Withdrawn prior to dosing|1|||
33141572|NCT00527488|100431726|FG003|Overall Study|Withdrawn prior to dosing|0|||
33141573|NCT01945710|100431727|FG000|Overall Study|Progressive Disease|5|||
33141574|NCT01945710|100431728|FG001|Overall Study|Progressive Disease|4|||
33141575|NCT01945710|100431729|FG002|Overall Study|Progressive Disease|3|||
33141576|NCT01945710|100431730|FG003|Overall Study|Progressive Disease|2|||
33141577|NCT01945710|100431731|FG004|Overall Study|Progressive Disease|7|||
33141578|NCT01945710|100431732|FG005|Overall Study|Progressive Disease|3|||
33141579|NCT01945710|100431733|FG006|Overall Study|Progressive Disease|19|||
33141580|NCT01945710|100431727|FG000|Overall Study|Adverse Event|0|||
33141581|NCT01945710|100431728|FG001|Overall Study|Adverse Event|1|||
33141582|NCT01945710|100431729|FG002|Overall Study|Adverse Event|0|||
33141583|NCT01945710|100431730|FG003|Overall Study|Adverse Event|0|||
33141584|NCT01945710|100431731|FG004|Overall Study|Adverse Event|0|||
33141585|NCT01945710|100431732|FG005|Overall Study|Adverse Event|0|||
33141586|NCT01945710|100431733|FG006|Overall Study|Adverse Event|0|||
33141587|NCT01945710|100431727|FG000|Overall Study|Other|2|||
33141588|NCT01945710|100431728|FG001|Overall Study|Other|0|||
33141589|NCT01945710|100431729|FG002|Overall Study|Other|3|||
33240000|NCT01089556|100779903|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
33240001|NCT01089556|100779904|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
33240002|NCT01089556|100779905|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
33370505|NCT03235544|101243460|FG003|Overall Study|Death|20|||
33370506|NCT03235544|101243457|FG000|Overall Study|Lost to Follow-up|0|||
33141590|NCT01945710|100431730|FG003|Overall Study|Other|1|||
33141591|NCT01945710|100431731|FG004|Overall Study|Other|1|||
33141592|NCT01945710|100431732|FG005|Overall Study|Other|0|||
33141593|NCT01945710|100431733|FG006|Overall Study|Other|4|||
33141594|NCT01945710|100431727|FG000|Overall Study|Withdrawal by Subject|0|||
33141595|NCT01945710|100431728|FG001|Overall Study|Withdrawal by Subject|1|||
33141596|NCT01945710|100431729|FG002|Overall Study|Withdrawal by Subject|1|||
33240003|NCT01089556|100779900|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
33141597|NCT01945710|100431730|FG003|Overall Study|Withdrawal by Subject|0|||
33141598|NCT01945710|100431731|FG004|Overall Study|Withdrawal by Subject|1|||
33141599|NCT01945710|100431732|FG005|Overall Study|Withdrawal by Subject|0|||
33370507|NCT03235544|101243458|FG001|Overall Study|Lost to Follow-up|1|||
33370508|NCT03235544|101243459|FG002|Overall Study|Lost to Follow-up|0|||
33240004|NCT01089556|100779901|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
33240005|NCT01089556|100779902|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
33240006|NCT01089556|100779903|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
33240007|NCT01089556|100779904|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
33240008|NCT01089556|100779905|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
33240009|NCT01089556|100779900|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
33240010|NCT01089556|100779901|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
33240011|NCT01089556|100779902|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
33240012|NCT01089556|100779903|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
33240013|NCT01089556|100779904|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
33240014|NCT01089556|100779905|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
33240015|NCT01089556|100779900|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
33240016|NCT01089556|100779901|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
33240017|NCT01089556|100779902|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
33240018|NCT01089556|100779903|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
33240019|NCT01089556|100779904|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
33240020|NCT01089556|100779905|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
33580051|NCT01194245|102013260|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33580052|NCT01194245|102013261|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33580053|NCT01194245|102013262|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33580054|NCT01194245|102013263|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
33580055|NCT01194245|102013264|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
33580056|NCT01194245|102013260|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33580057|NCT01194245|102013261|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
33580058|NCT01194245|102013262|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
33580059|NCT01194245|102013263|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
33580060|NCT01194245|102013264|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
33580061|NCT03768089|102013265|FG000|Part A|Lost to Follow-up|0|||
33580062|NCT03768089|102013266|FG001|Part A|Lost to Follow-up|0|||
33580063|NCT03768089|102013267|FG002|Part A|Lost to Follow-up|0|||
33580064|NCT03768089|102013268|FG003|Part A|Lost to Follow-up|0|||
33580065|NCT03768089|102013269|FG004|Part A|Lost to Follow-up|1|||
33580066|NCT03768089|102013270|FG005|Part A|Lost to Follow-up|0|||
33580067|NCT03768089|102013271|FG006|Part A|Lost to Follow-up|0|||
33580068|NCT03768089|102013272|FG007|Part A|Lost to Follow-up|0|||
33580069|NCT03768089|102013273|FG008|Part A|Lost to Follow-up|0|||
33580070|NCT03768089|102013274|FG009|Part A|Lost to Follow-up|0|||
33580071|NCT03768089|102013275|FG010|Part A|Lost to Follow-up|0|||
33580072|NCT03768089|102013276|FG011|Part A|Lost to Follow-up|0|||
33580073|NCT03768089|102013277|FG012|Part A|Lost to Follow-up|0|||
33580074|NCT03768089|102013278|FG013|Part A|Lost to Follow-up|0|||
33580075|NCT03768089|102013279|FG014|Part A|Lost to Follow-up|0|||
33580076|NCT03768089|102013280|FG015|Part A|Lost to Follow-up|0|||
33580077|NCT03768089|102013281|FG016|Part A|Lost to Follow-up|0|||
33580078|NCT03768089|102013282|FG017|Part A|Lost to Follow-up|0|||
33580079|NCT03768089|102013265|FG000|Part C|Randomized, Never Dosed|0|||
33580080|NCT03768089|102013266|FG001|Part C|Randomized, Never Dosed|0|||
33580081|NCT03768089|102013267|FG002|Part C|Randomized, Never Dosed|0|||
33580082|NCT03768089|102013268|FG003|Part C|Randomized, Never Dosed|0|||
33580083|NCT03768089|102013269|FG004|Part C|Randomized, Never Dosed|0|||
33580084|NCT03768089|102013270|FG005|Part C|Randomized, Never Dosed|0|||
33580085|NCT03768089|102013271|FG006|Part C|Randomized, Never Dosed|0|||
33580086|NCT03768089|102013272|FG007|Part C|Randomized, Never Dosed|0|||
33580087|NCT03768089|102013273|FG008|Part C|Randomized, Never Dosed|0|||
33580088|NCT03768089|102013274|FG009|Part C|Randomized, Never Dosed|0|||
33580089|NCT03768089|102013275|FG010|Part C|Randomized, Never Dosed|0|||
33580090|NCT03768089|102013276|FG011|Part C|Randomized, Never Dosed|0|||
33580091|NCT03768089|102013277|FG012|Part C|Randomized, Never Dosed|0|||
33580092|NCT03768089|102013278|FG013|Part C|Randomized, Never Dosed|0|||
33580093|NCT03768089|102013279|FG014|Part C|Randomized, Never Dosed|1|||
33580094|NCT03768089|102013280|FG015|Part C|Randomized, Never Dosed|0|||
33580095|NCT03768089|102013281|FG016|Part C|Randomized, Never Dosed|0|||
33240021|NCT01089556|100779900|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
33240022|NCT01089556|100779901|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
33240023|NCT01089556|100779902|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
33370509|NCT03235544|101243460|FG003|Overall Study|Lost to Follow-up|1|||
33370510|NCT03235544|101243457|FG000|Overall Study|Withdrawal by Participant|0|||
33420974|NCT01461369|101431677|FG000|Overall Study|Lost to Follow-up|0|||
33580096|NCT03768089|102013282|FG017|Part C|Randomized, Never Dosed|0|||
33580097|NCT00251693|102013283|FG000|Overall Study|Adverse Event|17|||
33580098|NCT00251693|102013284|FG001|Overall Study|Adverse Event|9|||
33580099|NCT00251693|102013285|FG002|Overall Study|Adverse Event|9|||
33580100|NCT00251693|102013283|FG000|Overall Study|Protocol Violation|2|||
33580101|NCT00251693|102013284|FG001|Overall Study|Protocol Violation|0|||
33580102|NCT00251693|102013285|FG002|Overall Study|Protocol Violation|2|||
33580103|NCT00251693|102013283|FG000|Overall Study|Lost to Follow-up|12|||
33640712|NCT03682770|102236453|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
33640713|NCT03682770|102236454|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
33640714|NCT03682770|102236455|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
33640715|NCT03682770|102236456|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
33640716|NCT03682770|102236457|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
33640717|NCT03682770|102236458|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
33640718|NCT03682770|102236459|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
33640719|NCT03682770|102236453|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
33640720|NCT03682770|102236454|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
33640721|NCT03682770|102236455|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
33640722|NCT03682770|102236456|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
33640723|NCT03682770|102236457|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
33640724|NCT03682770|102236458|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
33640725|NCT03682770|102236459|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
33640726|NCT03682770|102236453|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
33640727|NCT03682770|102236454|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
33640728|NCT03682770|102236455|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
33640729|NCT03682770|102236456|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
33640730|NCT03682770|102236457|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
33640731|NCT03682770|102236458|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
33141600|NCT01945710|100431733|FG006|Overall Study|Withdrawal by Subject|0|||
33141601|NCT00674154|100431734|FG000|Overall Study|Withdrawal by Subject|3|||
33141602|NCT00674154|100431735|FG001|Overall Study|Withdrawal by Subject|1|||
33141603|NCT00674154|100431734|FG000|Overall Study|Did not want parathyroidectomy|0|||
33141604|NCT00674154|100431735|FG001|Overall Study|Did not want parathyroidectomy|2|||
33370511|NCT03235544|101243458|FG001|Overall Study|Withdrawal by Participant|0|||
33370512|NCT03235544|101243459|FG002|Overall Study|Withdrawal by Participant|1|||
33370513|NCT03235544|101243460|FG003|Overall Study|Withdrawal by Participant|0|||
33370514|NCT03235544|101243457|FG000|Overall Study|Reason not Specified|0|||
33420975|NCT01461369|101431678|FG001|Overall Study|Lost to Follow-up|0|||
33420976|NCT01461369|101431679|FG002|Overall Study|Lost to Follow-up|3|||
33420977|NCT01461369|101431677|FG000|Overall Study|Adverse Event|9|||
33420978|NCT01461369|101431678|FG001|Overall Study|Adverse Event|12|||
33420979|NCT01461369|101431679|FG002|Overall Study|Adverse Event|4|||
33420980|NCT01461369|101431677|FG000|Overall Study|Protocol Violation|1|||
33420981|NCT01461369|101431678|FG001|Overall Study|Protocol Violation|2|||
33420982|NCT01461369|101431679|FG002|Overall Study|Protocol Violation|2|||
33420983|NCT01461369|101431677|FG000|Overall Study|Withdrawal by Subject|1|||
33420984|NCT01461369|101431678|FG001|Overall Study|Withdrawal by Subject|3|||
33420985|NCT01461369|101431679|FG002|Overall Study|Withdrawal by Subject|2|||
33420986|NCT01238211|101431680|FG000|Overall Study|Continues active treatment|31|||
33420987|NCT01238211|101431680|FG000|Overall Study|Adverse Event|7|||
33420988|NCT01238211|101431680|FG000|Overall Study|Death|4|||
33420989|NCT01238211|101431680|FG000|Overall Study|Relapse/Progression|2|||
33420990|NCT01238211|101431680|FG000|Overall Study|Withdrawal by Subject|7|||
33420991|NCT01238211|101431680|FG000|Overall Study|Non-protocol treatment|4|||
33420992|NCT01238211|101431680|FG000|Overall Study|Investigator/Patient Decision|3|||
33420993|NCT00078312|101431681|FG000|Overall Study|Adverse Event|43|||
33420994|NCT00078312|101431681|FG000|Overall Study|Lack of Efficacy|15|||
33420995|NCT00078312|101431681|FG000|Overall Study|Lost to Follow-up|41|||
33420996|NCT00078312|101431681|FG000|Overall Study|Physician Decision|9|||
33420997|NCT00078312|101431681|FG000|Overall Study|Protocol Violation|3|||
33420998|NCT00078312|101431681|FG000|Overall Study|Withdrawal by Subject|33|||
33420999|NCT00078312|101431681|FG000|Overall Study|Miscellaneous|33|||
33421000|NCT03672396|101431682|FG000|Overall Study|Withdrawal by Subject|4|||
33421001|NCT03672396|101431682|FG000|Overall Study|Physician Decision|1|||
33421002|NCT03672396|101431682|FG000|Overall Study|Adverse Event|1|||
33421003|NCT00388674|101431685|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
33421004|NCT00388674|101431686|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
33370515|NCT03235544|101243458|FG001|Overall Study|Reason not Specified|4|||
33370516|NCT03235544|101243459|FG002|Overall Study|Reason not Specified|0|||
33370517|NCT03235544|101243460|FG003|Overall Study|Reason not Specified|1|||
33421005|NCT00388674|101431685|FG000|Initial Treatment|Adverse Event|22|||
33141605|NCT00278915|100431736|FG000|Overall Study|Disease progression|1|||
33141606|NCT05615935|100431739|FG000|Overall Study|Lost to Follow-up|1|||
33141607|NCT05615935|100431740|FG001|Overall Study|Lost to Follow-up|1|||
33370518|NCT01153763|101243463|FG000|Overall Study|Study Closed|16|||
33421006|NCT00388674|101431686|FG001|Initial Treatment|Adverse Event|87|||
33370519|NCT01153763|101243463|FG000|Overall Study|Lost to Follow-up|1|||
33370520|NCT01153763|101243463|FG000|Overall Study|Physician Decision|2|||
33421007|NCT00388674|101431685|FG000|Initial Treatment|Death|215|||
33421008|NCT00388674|101431686|FG001|Initial Treatment|Death|216|||
33421009|NCT00388674|101431685|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
33141608|NCT02093351|100431741|FG000|Part A|Adverse Event|0|||
33141609|NCT02093351|100431742|FG001|Part A|Adverse Event|1|||
33141610|NCT02093351|100431743|FG002|Part A|Adverse Event|1|||
33141611|NCT02093351|100431744|FG003|Part A|Adverse Event|0|||
33141612|NCT02093351|100431741|FG000|Part A|Condition under investigation worsened|2|||
33141613|NCT02093351|100431742|FG001|Part A|Condition under investigation worsened|0|||
33141614|NCT02093351|100431743|FG002|Part A|Condition under investigation worsened|2|||
33141615|NCT02093351|100431744|FG003|Part A|Condition under investigation worsened|0|||
33141616|NCT02093351|100431741|FG000|Part A|Death|0|||
33141617|NCT02093351|100431742|FG001|Part A|Death|1|||
33141618|NCT02093351|100431743|FG002|Part A|Death|0|||
33141619|NCT02093351|100431744|FG003|Part A|Death|0|||
33141620|NCT02093351|100431741|FG000|Part B|Patient decision|0|||
33141621|NCT02093351|100431742|FG001|Part B|Patient decision|0|||
33141622|NCT02093351|100431743|FG002|Part B|Patient decision|0|||
33141623|NCT02093351|100431744|FG003|Part B|Patient decision|3|||
33141624|NCT02093351|100431741|FG000|Part B|Disease progression|0|||
33141625|NCT02093351|100431742|FG001|Part B|Disease progression|0|||
33141626|NCT02093351|100431743|FG002|Part B|Disease progression|0|||
33141627|NCT02093351|100431744|FG003|Part B|Disease progression|4|||
33141628|NCT02093351|100431741|FG000|Part B|Complete response|0|||
33141629|NCT02093351|100431742|FG001|Part B|Complete response|0|||
33141630|NCT02093351|100431743|FG002|Part B|Complete response|0|||
33141631|NCT02093351|100431744|FG003|Part B|Complete response|1|||
33141632|NCT02093351|100431741|FG000|Part B|Adverse event + disease progression|0|||
33141633|NCT02093351|100431742|FG001|Part B|Adverse event + disease progression|0|||
33141634|NCT02093351|100431743|FG002|Part B|Adverse event + disease progression|0|||
33141635|NCT02093351|100431744|FG003|Part B|Adverse event + disease progression|1|||
33141636|NCT02093351|100431741|FG000|Part B|Lack of therapeutic response|0|||
33141637|NCT02093351|100431742|FG001|Part B|Lack of therapeutic response|0|||
33141638|NCT02093351|100431743|FG002|Part B|Lack of therapeutic response|0|||
33141639|NCT02093351|100431744|FG003|Part B|Lack of therapeutic response|12|||
33141640|NCT02093351|100431741|FG000|Part B|Condition under investigation worsened|0|||
33141641|NCT02093351|100431742|FG001|Part B|Condition under investigation worsened|0|||
33141642|NCT02093351|100431743|FG002|Part B|Condition under investigation worsened|0|||
33141643|NCT02093351|100431744|FG003|Part B|Condition under investigation worsened|39|||
33141644|NCT02093351|100431741|FG000|Part B|Adverse Event|0|||
33141645|NCT02093351|100431742|FG001|Part B|Adverse Event|0|||
33141646|NCT02093351|100431743|FG002|Part B|Adverse Event|0|||
33141647|NCT02093351|100431744|FG003|Part B|Adverse Event|2|||
33141648|NCT02093351|100431741|FG000|Part B|Death|0|||
33141649|NCT02093351|100431742|FG001|Part B|Death|0|||
33141650|NCT02093351|100431743|FG002|Part B|Death|0|||
33141651|NCT02093351|100431744|FG003|Part B|Death|1|||
33141652|NCT02616601|100431752|FG000|Overall Study|Withdrawal by Subject|4|||
33141653|NCT02616601|100431753|FG001|Overall Study|Withdrawal by Subject|4|||
33141654|NCT02616601|100431754|FG002|Overall Study|Withdrawal by Subject|3|||
33141655|NCT02616601|100431752|FG000|Overall Study|Adverse Event|2|||
33141656|NCT02616601|100431753|FG001|Overall Study|Adverse Event|0|||
33141657|NCT02616601|100431754|FG002|Overall Study|Adverse Event|2|||
33141658|NCT02616601|100431752|FG000|Overall Study|Death|1|||
33141659|NCT02616601|100431753|FG001|Overall Study|Death|0|||
33141660|NCT02616601|100431754|FG002|Overall Study|Death|0|||
33141661|NCT02616601|100431752|FG000|Overall Study|Lost to Follow-up|1|||
33141662|NCT02616601|100431753|FG001|Overall Study|Lost to Follow-up|0|||
33141663|NCT02616601|100431754|FG002|Overall Study|Lost to Follow-up|1|||
33141664|NCT02616601|100431752|FG000|Overall Study|Non-Compliance with Test Article|1|||
33141665|NCT02616601|100431753|FG001|Overall Study|Non-Compliance with Test Article|0|||
33141666|NCT02616601|100431754|FG002|Overall Study|Non-Compliance with Test Article|1|||
33141667|NCT00591578|100431755|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
33141668|NCT00591578|100431756|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
33141669|NCT00591578|100431757|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
33421010|NCT00388674|101431686|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
33141670|NCT00591578|100431755|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
33141671|NCT00591578|100431756|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
33141672|NCT00591578|100431757|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
33141673|NCT00591578|100431755|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
33141674|NCT00591578|100431756|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
33141675|NCT00591578|100431757|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
33141676|NCT00591578|100431755|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
33141677|NCT00591578|100431756|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
33141678|NCT00591578|100431757|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
33141679|NCT00591578|100431755|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
33141680|NCT00591578|100431756|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
33141681|NCT00591578|100431757|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
33141682|NCT00591578|100431755|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
33141683|NCT00591578|100431756|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
33141684|NCT00591578|100431757|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
33240024|NCT01089556|100779903|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
33421011|NCT00388674|101431685|FG000|Initial Treatment|HCC|12|||
33141685|NCT00591578|100431755|FG000|Double-Blind Treatment Phase|Other|4|||
33141686|NCT00591578|100431756|FG001|Double-Blind Treatment Phase|Other|9|||
33141687|NCT00591578|100431757|FG002|Double-Blind Treatment Phase|Other|4|||
33141688|NCT00591578|100431755|FG000|Open-Label Extension Phase|Adverse Event|3|||
33141689|NCT00591578|100431756|FG001|Open-Label Extension Phase|Adverse Event|5|||
33141690|NCT00591578|100431757|FG002|Open-Label Extension Phase|Adverse Event|0|||
33141691|NCT00591578|100431755|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
33141692|NCT00591578|100431756|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
33141693|NCT00591578|100431757|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
33580104|NCT00251693|102013284|FG001|Overall Study|Lost to Follow-up|7|||
33580105|NCT00251693|102013285|FG002|Overall Study|Lost to Follow-up|8|||
33580106|NCT00251693|102013283|FG000|Overall Study|Withdrawal by Subject|11|||
33580107|NCT00251693|102013284|FG001|Overall Study|Withdrawal by Subject|17|||
33580108|NCT00251693|102013285|FG002|Overall Study|Withdrawal by Subject|14|||
33580109|NCT00251693|102013283|FG000|Overall Study|Lack of Efficacy|0|||
33580110|NCT00251693|102013284|FG001|Overall Study|Lack of Efficacy|1|||
33141694|NCT00591578|100431755|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
33141695|NCT00591578|100431756|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
33141696|NCT00591578|100431757|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
33141697|NCT00591578|100431755|FG000|Open-Label Extension Phase|Other|1|||
33141698|NCT00591578|100431756|FG001|Open-Label Extension Phase|Other|0|||
33141699|NCT00591578|100431757|FG002|Open-Label Extension Phase|Other|0|||
33141700|NCT03222492|100431758|FG000|Overall Study|Withdrawal by Subject|0|||
33141701|NCT03222492|100431759|FG001|Overall Study|Withdrawal by Subject|0|||
33141702|NCT03222492|100431760|FG002|Overall Study|Withdrawal by Subject|1|||
33240025|NCT01089556|100779904|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
33421012|NCT00388674|101431686|FG001|Initial Treatment|HCC|20|||
33421013|NCT00388674|101431685|FG000|Initial Treatment|Lost to Follow-up|526|||
33421014|NCT00388674|101431686|FG001|Initial Treatment|Lost to Follow-up|624|||
33421015|NCT00388674|101431685|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
33240026|NCT01089556|100779905|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
33240027|NCT01089556|100779900|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
33421016|NCT00388674|101431686|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
33421017|NCT00388674|101431685|FG000|Initial Treatment|Never Treated with Study Medication|1|||
33421018|NCT00388674|101431686|FG001|Initial Treatment|Never Treated with Study Medication|7|||
33421019|NCT00388674|101431685|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
33421020|NCT00388674|101431686|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
33421021|NCT00388674|101431685|FG000|Initial Treatment|Not Defined|125|||
33421022|NCT00388674|101431686|FG001|Initial Treatment|Not Defined|172|||
33421023|NCT00388674|101431685|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
33421024|NCT00388674|101431686|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
33421025|NCT00388674|101431685|FG000|Initial Treatment|Pregnancy|26|||
33421026|NCT00388674|101431686|FG001|Initial Treatment|Pregnancy|16|||
33421027|NCT00388674|101431685|FG000|Initial Treatment|Study Drug Toxicity|5|||
33421028|NCT00388674|101431686|FG001|Initial Treatment|Study Drug Toxicity|92|||
33421029|NCT00388674|101431685|FG000|Initial Treatment|Participant Request|501|||
33421030|NCT00388674|101431686|FG001|Initial Treatment|Participant Request|673|||
33421031|NCT00388674|101431685|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
33421032|NCT00388674|101431686|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
33421033|NCT00388674|101431685|FG000|Initial Treatment|Not Reported|10|||
33421034|NCT00388674|101431686|FG001|Initial Treatment|Not Reported|12|||
33421035|NCT00388674|101431685|FG000|End of Study|Administrative Reason By Sponsor|299|||
33421036|NCT00388674|101431686|FG001|End of Study|Administrative Reason By Sponsor|253|||
33421037|NCT00388674|101431685|FG000|End of Study|Death|239|||
33421038|NCT00388674|101431686|FG001|End of Study|Death|262|||
33421039|NCT00388674|101431685|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
33421040|NCT00388674|101431686|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
33421041|NCT00388674|101431685|FG000|End of Study|HCC|8|||
33421042|NCT00388674|101431686|FG001|End of Study|HCC|7|||
33421043|NCT00388674|101431685|FG000|End of Study|Lost to Follow-up|587|||
33421044|NCT00388674|101431686|FG001|End of Study|Lost to Follow-up|715|||
33421045|NCT00388674|101431685|FG000|End of Study|Malignancy (Non-HCC)|1|||
33421046|NCT00388674|101431686|FG001|End of Study|Malignancy (Non-HCC)|1|||
33421047|NCT00388674|101431685|FG000|End of Study|Non-Study Related Comorbidities|3|||
33421048|NCT00388674|101431686|FG001|End of Study|Non-Study Related Comorbidities|4|||
33421049|NCT00388674|101431685|FG000|End of Study|Not Defined|135|||
33421050|NCT00388674|101431686|FG001|End of Study|Not Defined|214|||
33421051|NCT00388674|101431685|FG000|End of Study|Participant Withdrew Consent|437|||
33421052|NCT00388674|101431686|FG001|End of Study|Participant Withdrew Consent|673|||
33580111|NCT00251693|102013285|FG002|Overall Study|Lack of Efficacy|0|||
33580112|NCT00251693|102013283|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
33141703|NCT03222492|100431761|FG003|Overall Study|Withdrawal by Subject|0|||
33421053|NCT00388674|101431685|FG000|End of Study|No Off-Treatment Status Data|22|||
33141704|NCT03222492|100431758|FG000|Overall Study|COVID-19 related|0|||
33141705|NCT03222492|100431759|FG001|Overall Study|COVID-19 related|0|||
33141706|NCT03222492|100431760|FG002|Overall Study|COVID-19 related|1|||
33141707|NCT03222492|100431761|FG003|Overall Study|COVID-19 related|0|||
33141708|NCT00938886|100431762|FG000|Overall Study|Death|0|||
33141709|NCT00938886|100431763|FG001|Overall Study|Death|1|||
33141710|NCT00938886|100431762|FG000|Overall Study|Withdrawal by Subject|4|||
33141711|NCT00938886|100431763|FG001|Overall Study|Withdrawal by Subject|7|||
33141712|NCT00938886|100431762|FG000|Overall Study|Lost to Follow-up|3|||
33141713|NCT00938886|100431763|FG001|Overall Study|Lost to Follow-up|2|||
33141714|NCT01903252|100431768|FG000|Double-Blind Induction|Adverse Event|20|||
33141715|NCT01903252|100431769|FG001|Double-Blind Induction|Adverse Event|18|||
33141716|NCT01903252|100431770|FG002|Double-Blind Induction|Adverse Event|0|||
33141717|NCT01903252|100431771|FG003|Double-Blind Induction|Adverse Event|0|||
33141718|NCT01903252|100431772|FG004|Double-Blind Induction|Adverse Event|0|||
33141719|NCT01903252|100431773|FG005|Double-Blind Induction|Adverse Event|0|||
33141720|NCT01903252|100431768|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
33141721|NCT01903252|100431769|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
33141722|NCT01903252|100431770|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
33141723|NCT01903252|100431771|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
33141724|NCT01903252|100431772|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
33141725|NCT01903252|100431773|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
33141726|NCT01903252|100431768|FG000|Double-Blind Induction|Physician Decision|2|||
33141727|NCT01903252|100431769|FG001|Double-Blind Induction|Physician Decision|3|||
33141728|NCT01903252|100431770|FG002|Double-Blind Induction|Physician Decision|0|||
33141729|NCT01903252|100431771|FG003|Double-Blind Induction|Physician Decision|0|||
33141730|NCT01903252|100431772|FG004|Double-Blind Induction|Physician Decision|0|||
33141731|NCT01903252|100431773|FG005|Double-Blind Induction|Physician Decision|0|||
33141732|NCT01903252|100431768|FG000|Double-Blind Induction|non-compliance,|7|||
33580113|NCT00251693|102013284|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
33580114|NCT00251693|102013285|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
33580115|NCT00251693|102013283|FG000|Overall Study|Noncompliant|0|||
33580116|NCT00251693|102013284|FG001|Overall Study|Noncompliant|0|||
33580117|NCT00251693|102013285|FG002|Overall Study|Noncompliant|2|||
33580118|NCT00251693|102013283|FG000|Overall Study|Possible Barrett's esophagus|3|||
33580119|NCT00251693|102013284|FG001|Overall Study|Possible Barrett's esophagus|5|||
33580120|NCT00251693|102013285|FG002|Overall Study|Possible Barrett's esophagus|2|||
33580121|NCT00251693|102013283|FG000|Overall Study|Subject request/subject unavailable|1|||
33580122|NCT00251693|102013284|FG001|Overall Study|Subject request/subject unavailable|2|||
33580123|NCT00251693|102013285|FG002|Overall Study|Subject request/subject unavailable|0|||
33580124|NCT00251693|102013283|FG000|Overall Study|Abnormal laboratory findings|0|||
33580125|NCT00251693|102013284|FG001|Overall Study|Abnormal laboratory findings|0|||
33580126|NCT00251693|102013285|FG002|Overall Study|Abnormal laboratory findings|1|||
33580127|NCT03432494|102013286|FG000|Overall Study|Death|1|||
33580128|NCT03432494|102013286|FG000|Overall Study|Noncompliance|1|||
33580129|NCT00310375|102013287|FG000|Primary Reporting Phase|Adverse Event|28|||
33580130|NCT00310375|102013288|FG001|Primary Reporting Phase|Adverse Event|22|||
33580131|NCT00310375|102013289|FG002|Primary Reporting Phase|Adverse Event|0|||
33580132|NCT00310375|102013287|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
33580133|NCT00310375|102013288|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
33580134|NCT00310375|102013289|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
33580135|NCT00310375|102013287|FG000|Primary Reporting Phase|Pregnancy|2|||
33580136|NCT00310375|102013288|FG001|Primary Reporting Phase|Pregnancy|2|||
33580137|NCT00310375|102013289|FG002|Primary Reporting Phase|Pregnancy|0|||
33580138|NCT00310375|102013287|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
33580139|NCT00310375|102013288|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
33580140|NCT00310375|102013289|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
33580141|NCT00310375|102013287|FG000|Primary Reporting Phase|Protocol Violation|8|||
33141733|NCT01903252|100431769|FG001|Double-Blind Induction|non-compliance,|7|||
33141734|NCT01903252|100431770|FG002|Double-Blind Induction|non-compliance,|0|||
33141735|NCT01903252|100431771|FG003|Double-Blind Induction|non-compliance,|0|||
33141736|NCT01903252|100431772|FG004|Double-Blind Induction|non-compliance,|0|||
33141737|NCT01903252|100431773|FG005|Double-Blind Induction|non-compliance,|0|||
33141738|NCT01903252|100431768|FG000|Extended Induction, Open-Label|Adverse Event|0|||
33141739|NCT01903252|100431769|FG001|Extended Induction, Open-Label|Adverse Event|0|||
33141740|NCT01903252|100431770|FG002|Extended Induction, Open-Label|Adverse Event|17|||
33240028|NCT01089556|100779901|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
33580142|NCT00310375|102013288|FG001|Primary Reporting Phase|Protocol Violation|5|||
33580143|NCT00310375|102013289|FG002|Primary Reporting Phase|Protocol Violation|0|||
33580144|NCT00310375|102013287|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
33580145|NCT00310375|102013288|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
33580146|NCT00310375|102013289|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
33141741|NCT01903252|100431771|FG003|Extended Induction, Open-Label|Adverse Event|0|||
33141742|NCT01903252|100431772|FG004|Extended Induction, Open-Label|Adverse Event|0|||
33580147|NCT00310375|102013287|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
33580148|NCT00310375|102013288|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
33580149|NCT00310375|102013289|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
33580150|NCT00310375|102013287|FG000|Primary Reporting Phase|Physician Decision|5|||
33580151|NCT00310375|102013288|FG001|Primary Reporting Phase|Physician Decision|3|||
33580152|NCT00310375|102013289|FG002|Primary Reporting Phase|Physician Decision|0|||
33580153|NCT00310375|102013287|FG000|Primary Reporting Phase|Request of the sponsor|2|||
33370521|NCT01153763|101243463|FG000|Overall Study|Withdrawal by Subject|2|||
33370522|NCT00488618|101243464|FG000|Overall Study|Adverse Event|13|||
33370523|NCT00488618|101243465|FG001|Overall Study|Adverse Event|17|||
33370524|NCT00488618|101243464|FG000|Overall Study|Insufficient Therapeutic Response|18|||
33370525|NCT00488618|101243465|FG001|Overall Study|Insufficient Therapeutic Response|11|||
33370526|NCT00488618|101243464|FG000|Overall Study|Protocol Violation|0|||
33370527|NCT00488618|101243465|FG001|Overall Study|Protocol Violation|2|||
33370528|NCT00488618|101243464|FG000|Overall Study|Withdrawal of Consent|15|||
33370529|NCT00488618|101243465|FG001|Overall Study|Withdrawal of Consent|13|||
33370530|NCT00488618|101243464|FG000|Overall Study|Lost to Follow-up|1|||
33370531|NCT00488618|101243465|FG001|Overall Study|Lost to Follow-up|0|||
33580154|NCT00310375|102013288|FG001|Primary Reporting Phase|Request of the sponsor|2|||
33580155|NCT00310375|102013289|FG002|Primary Reporting Phase|Request of the sponsor|0|||
33580156|NCT00310375|102013287|FG000|Primary Reporting Phase|Failed to return|1|||
33640732|NCT03682770|102236459|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
33640733|NCT03682770|102236453|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
33240029|NCT01089556|100779902|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
33240030|NCT01089556|100779903|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
33240031|NCT01089556|100779904|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
33240032|NCT01089556|100779905|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
33240033|NCT01089556|100779900|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
33240034|NCT01089556|100779901|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
33240035|NCT01089556|100779902|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
33240036|NCT01089556|100779903|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
33240037|NCT01089556|100779904|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
33240038|NCT01089556|100779905|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
33240039|NCT01089556|100779900|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
33240040|NCT01089556|100779901|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
33240041|NCT01089556|100779902|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
33240042|NCT01089556|100779903|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
33240043|NCT01089556|100779904|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
33240044|NCT01089556|100779905|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
33240045|NCT02748512|100779906|FG000|Overall Study|Lost to Follow-up|1|||
33240046|NCT02748512|100779907|FG001|Overall Study|Lost to Follow-up|1|||
33240047|NCT00614744|100779908|FG000|Overall Study|Lost to Follow-up|5|||
33240048|NCT00614744|100779909|FG001|Overall Study|Lost to Follow-up|4|||
33240049|NCT00614744|100779908|FG000|Overall Study|Incomplete for Behavior Issues|0|||
33240050|NCT00614744|100779909|FG001|Overall Study|Incomplete for Behavior Issues|2|||
33240051|NCT00772928|100779916|FG000|Overall Study|Lost to Follow-up|9|||
33240052|NCT00772928|100779917|FG001|Overall Study|Lost to Follow-up|6|||
33240053|NCT00772928|100779916|FG000|Overall Study|Protocol Violation|10|||
33240054|NCT00772928|100779917|FG001|Overall Study|Protocol Violation|12|||
33240055|NCT00772928|100779916|FG000|Overall Study|Withdrawal by Subject|25|||
33240056|NCT00772928|100779917|FG001|Overall Study|Withdrawal by Subject|22|||
33240057|NCT00772928|100779916|FG000|Overall Study|Did not receive vaccine|0|||
33240058|NCT00772928|100779917|FG001|Overall Study|Did not receive vaccine|1|||
33240059|NCT02559817|100779920|FG000|Treatment Period|Adverse Event|1|||
33240060|NCT02559817|100779921|FG001|Treatment Period|Adverse Event|0|||
33240061|NCT02559817|100779922|FG002|Treatment Period|Adverse Event|1|||
33240062|NCT02559817|100779923|FG003|Treatment Period|Adverse Event|0|||
33370532|NCT00365716|101243466|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
33370533|NCT00365716|101243467|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
33370534|NCT00365716|101243468|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
33370535|NCT00365716|101243469|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
33580157|NCT00310375|102013288|FG001|Primary Reporting Phase|Failed to return|3|||
33240063|NCT02559817|100779924|FG004|Treatment Period|Adverse Event|0|||
33240064|NCT02559817|100779920|FG000|Treatment Period|Lack of Efficacy|0|||
33240065|NCT02559817|100779921|FG001|Treatment Period|Lack of Efficacy|1|||
33240066|NCT02559817|100779922|FG002|Treatment Period|Lack of Efficacy|0|||
33240067|NCT02559817|100779923|FG003|Treatment Period|Lack of Efficacy|0|||
33240068|NCT02559817|100779924|FG004|Treatment Period|Lack of Efficacy|0|||
33240069|NCT02559817|100779920|FG000|Treatment Period|Lost to Follow-up|0|||
33240070|NCT02559817|100779921|FG001|Treatment Period|Lost to Follow-up|1|||
33580158|NCT00310375|102013289|FG002|Primary Reporting Phase|Failed to return|0|||
33580159|NCT00310375|102013287|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
33240071|NCT02559817|100779922|FG002|Treatment Period|Lost to Follow-up|0|||
33240072|NCT02559817|100779923|FG003|Treatment Period|Lost to Follow-up|1|||
33240073|NCT02559817|100779924|FG004|Treatment Period|Lost to Follow-up|0|||
33240074|NCT02559817|100779920|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
33240075|NCT02559817|100779921|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
33240076|NCT02559817|100779922|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
33240077|NCT02559817|100779923|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
33240078|NCT02559817|100779924|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
33240079|NCT02559817|100779920|FG000|Treatment Period|Protocol Violation|0|||
33240080|NCT02559817|100779921|FG001|Treatment Period|Protocol Violation|0|||
33240081|NCT02559817|100779922|FG002|Treatment Period|Protocol Violation|0|||
33240082|NCT02559817|100779923|FG003|Treatment Period|Protocol Violation|1|||
33240083|NCT02559817|100779924|FG004|Treatment Period|Protocol Violation|0|||
33240084|NCT00681811|100779927|FG000|Overall Study|Adverse Event|1|||
33240085|NCT00681811|100779928|FG001|Overall Study|Adverse Event|1|||
33240086|NCT00681811|100779927|FG000|Overall Study|Withdrawal by Subject|2|||
33240087|NCT00681811|100779928|FG001|Overall Study|Withdrawal by Subject|2|||
33240088|NCT00681811|100779927|FG000|Overall Study|Non-compliance|0|||
33240089|NCT00681811|100779928|FG001|Overall Study|Non-compliance|1|||
33240090|NCT01515319|100779929|FG000|Overall Study|Withdrawal by Subject|0|||
33240091|NCT01515319|100779930|FG001|Overall Study|Withdrawal by Subject|0|||
33240092|NCT01515319|100779931|FG002|Overall Study|Withdrawal by Subject|0|||
33240093|NCT01515319|100779932|FG003|Overall Study|Withdrawal by Subject|0|||
33240094|NCT01515319|100779933|FG004|Overall Study|Withdrawal by Subject|0|||
33240095|NCT01515319|100779934|FG005|Overall Study|Withdrawal by Subject|0|||
33240096|NCT01515319|100779935|FG006|Overall Study|Withdrawal by Subject|1|||
33240097|NCT01515319|100779936|FG007|Overall Study|Withdrawal by Subject|0|||
33240098|NCT01515319|100779937|FG008|Overall Study|Withdrawal by Subject|0|||
33240099|NCT01515319|100779938|FG009|Overall Study|Withdrawal by Subject|0|||
33240100|NCT01515319|100779929|FG000|Overall Study|Adverse Event|0|||
33240101|NCT01515319|100779930|FG001|Overall Study|Adverse Event|0|||
33240102|NCT01515319|100779931|FG002|Overall Study|Adverse Event|0|||
33240103|NCT01515319|100779932|FG003|Overall Study|Adverse Event|0|||
33240104|NCT01515319|100779933|FG004|Overall Study|Adverse Event|0|||
33240105|NCT01515319|100779934|FG005|Overall Study|Adverse Event|0|||
33240106|NCT01515319|100779935|FG006|Overall Study|Adverse Event|0|||
33240107|NCT01515319|100779936|FG007|Overall Study|Adverse Event|0|||
33240108|NCT01515319|100779937|FG008|Overall Study|Adverse Event|3|||
33240109|NCT01515319|100779938|FG009|Overall Study|Adverse Event|0|||
33240110|NCT01515319|100779929|FG000|Overall Study|Protocol Violation|0|||
33240111|NCT01515319|100779930|FG001|Overall Study|Protocol Violation|0|||
33240112|NCT01515319|100779931|FG002|Overall Study|Protocol Violation|0|||
33240113|NCT01515319|100779932|FG003|Overall Study|Protocol Violation|0|||
33240114|NCT01515319|100779933|FG004|Overall Study|Protocol Violation|0|||
33240115|NCT01515319|100779934|FG005|Overall Study|Protocol Violation|0|||
33240116|NCT01515319|100779935|FG006|Overall Study|Protocol Violation|0|||
33240117|NCT01515319|100779936|FG007|Overall Study|Protocol Violation|0|||
33370536|NCT00365716|101243470|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
33370537|NCT00365716|101243471|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
33370538|NCT00365716|101243472|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
33370539|NCT00365716|101243466|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
33370540|NCT00365716|101243467|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
33370541|NCT00365716|101243468|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
33370542|NCT00365716|101243469|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
33370543|NCT00365716|101243470|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
33370544|NCT00365716|101243471|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
33370545|NCT00365716|101243472|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
33640734|NCT03682770|102236454|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
33640735|NCT03682770|102236455|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
33240118|NCT01515319|100779937|FG008|Overall Study|Protocol Violation|2|||
33240119|NCT01515319|100779938|FG009|Overall Study|Protocol Violation|0|||
33370546|NCT00365716|101243466|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
33580160|NCT00310375|102013288|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
33240120|NCT04003974|100779939|FG000|Overall Study|Missing|1|||
33240121|NCT04003974|100779940|FG001|Overall Study|Missing|0|||
33240122|NCT04003974|100779939|FG000|Overall Study|Withdrawal by Subject|0|||
33240123|NCT04003974|100779940|FG001|Overall Study|Withdrawal by Subject|2|||
33370547|NCT00365716|101243467|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
33370548|NCT00365716|101243468|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
33240124|NCT01232556|100779941|FG000|Overall Study|Withdrawal by Subject|21|||
33240125|NCT01232556|100779942|FG001|Overall Study|Withdrawal by Subject|17|||
33240126|NCT01232556|100779941|FG000|Overall Study|Death|97|||
33240127|NCT01232556|100779942|FG001|Overall Study|Death|97|||
33240128|NCT01232556|100779941|FG000|Overall Study|Lost to Follow-up|0|||
33240129|NCT01232556|100779942|FG001|Overall Study|Lost to Follow-up|2|||
33240130|NCT01232556|100779941|FG000|Overall Study|Terminated by Sponsor|35|||
33240131|NCT01232556|100779942|FG001|Overall Study|Terminated by Sponsor|51|||
33240132|NCT01232556|100779941|FG000|Overall Study|Other|6|||
33240133|NCT01232556|100779942|FG001|Overall Study|Other|4|||
33240134|NCT00557505|100779943|FG000|Overall Study|Death|0|||
33240135|NCT00557505|100779944|FG001|Overall Study|Death|0|||
33240136|NCT00557505|100779945|FG002|Overall Study|Death|0|||
33240137|NCT00557505|100779946|FG003|Overall Study|Death|0|||
33240138|NCT00557505|100779947|FG004|Overall Study|Death|0|||
33240139|NCT00557505|100779948|FG005|Overall Study|Death|0|||
33240140|NCT00557505|100779949|FG006|Overall Study|Death|0|||
33240141|NCT00557505|100779950|FG007|Overall Study|Death|0|||
33240142|NCT00557505|100779951|FG008|Overall Study|Death|1|||
33240143|NCT00557505|100779943|FG000|Overall Study|Adverse Event|0|||
33240144|NCT00557505|100779944|FG001|Overall Study|Adverse Event|0|||
33240145|NCT00557505|100779945|FG002|Overall Study|Adverse Event|1|||
33240146|NCT00557505|100779946|FG003|Overall Study|Adverse Event|0|||
33240147|NCT00557505|100779947|FG004|Overall Study|Adverse Event|0|||
33240148|NCT00557505|100779948|FG005|Overall Study|Adverse Event|0|||
33240149|NCT00557505|100779949|FG006|Overall Study|Adverse Event|1|||
33240150|NCT00557505|100779950|FG007|Overall Study|Adverse Event|0|||
33240151|NCT00557505|100779951|FG008|Overall Study|Adverse Event|0|||
33240152|NCT00557505|100779943|FG000|Overall Study|Global deterioration of health|1|||
33240153|NCT00557505|100779944|FG001|Overall Study|Global deterioration of health|0|||
33240154|NCT00557505|100779945|FG002|Overall Study|Global deterioration of health|0|||
33240155|NCT00557505|100779946|FG003|Overall Study|Global deterioration of health|0|||
33240156|NCT00557505|100779947|FG004|Overall Study|Global deterioration of health|0|||
33240157|NCT00557505|100779948|FG005|Overall Study|Global deterioration of health|0|||
33240158|NCT00557505|100779949|FG006|Overall Study|Global deterioration of health|0|||
33240159|NCT00557505|100779950|FG007|Overall Study|Global deterioration of health|0|||
33240160|NCT00557505|100779951|FG008|Overall Study|Global deterioration of health|0|||
33240161|NCT00557505|100779943|FG000|Overall Study|Objective progression or relapse|2|||
33240162|NCT00557505|100779944|FG001|Overall Study|Objective progression or relapse|3|||
33240163|NCT00557505|100779945|FG002|Overall Study|Objective progression or relapse|3|||
33240164|NCT00557505|100779946|FG003|Overall Study|Objective progression or relapse|2|||
33240165|NCT00557505|100779947|FG004|Overall Study|Objective progression or relapse|2|||
33240166|NCT00557505|100779948|FG005|Overall Study|Objective progression or relapse|3|||
33240167|NCT00557505|100779949|FG006|Overall Study|Objective progression or relapse|2|||
33240168|NCT00557505|100779950|FG007|Overall Study|Objective progression or relapse|5|||
33240169|NCT00557505|100779951|FG008|Overall Study|Objective progression or relapse|15|||
33240170|NCT00557505|100779943|FG000|Overall Study|Withdrawal by Subject|0|||
33240171|NCT00557505|100779944|FG001|Overall Study|Withdrawal by Subject|0|||
33240172|NCT00557505|100779945|FG002|Overall Study|Withdrawal by Subject|0|||
33240173|NCT00557505|100779946|FG003|Overall Study|Withdrawal by Subject|1|||
33240174|NCT00557505|100779947|FG004|Overall Study|Withdrawal by Subject|0|||
33240175|NCT00557505|100779948|FG005|Overall Study|Withdrawal by Subject|0|||
33240176|NCT00557505|100779949|FG006|Overall Study|Withdrawal by Subject|0|||
33240177|NCT00557505|100779950|FG007|Overall Study|Withdrawal by Subject|0|||
33240178|NCT00557505|100779951|FG008|Overall Study|Withdrawal by Subject|1|||
33240179|NCT02451930|100779952|FG000|Overall Study|Death|0|||
33240180|NCT02451930|100779953|FG001|Overall Study|Death|15|||
33240181|NCT02451930|100779952|FG000|Overall Study|Lost to Follow-up|0|||
33580161|NCT00310375|102013289|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
33580162|NCT00310375|102013287|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
33580163|NCT00310375|102013288|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
33580164|NCT00310375|102013289|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
33580165|NCT00310375|102013287|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
33580166|NCT00310375|102013288|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
33580167|NCT00310375|102013289|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
33580168|NCT00310375|102013287|FG000|Primary Reporting Phase|Site closure|3|||
33580169|NCT00310375|102013288|FG001|Primary Reporting Phase|Site closure|0|||
33141743|NCT01903252|100431773|FG005|Extended Induction, Open-Label|Adverse Event|0|||
33141744|NCT01903252|100431768|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
33240182|NCT02451930|100779953|FG001|Overall Study|Lost to Follow-up|3|||
33240183|NCT02451930|100779952|FG000|Overall Study|Sponsor Decision|2|||
33240184|NCT02451930|100779953|FG001|Overall Study|Sponsor Decision|10|||
33240185|NCT02451930|100779952|FG000|Overall Study|Withdrawal by Subject|0|||
33240186|NCT02451930|100779953|FG001|Overall Study|Withdrawal by Subject|1|||
33240187|NCT02451930|100779952|FG000|Overall Study|Other|0|||
33240188|NCT02451930|100779953|FG001|Overall Study|Other|1|||
33240189|NCT00231179|100779956|FG000|Overall Study|Lost to Follow-up|21|||
33240190|NCT00231179|100779957|FG001|Overall Study|Lost to Follow-up|21|||
33240191|NCT00231179|100779956|FG000|Overall Study|Withdrawal by Subject|3|||
33240192|NCT00231179|100779957|FG001|Overall Study|Withdrawal by Subject|3|||
33240193|NCT00062868|100779960|FG000|Dose Level 1|Death|2|||
33240194|NCT00062868|100779961|FG001|Dose Level 1|Death|0|||
33240195|NCT00062868|100779962|FG002|Dose Level 1|Death|0|||
33240196|NCT00062868|100779963|FG003|Dose Level 1|Death|2|||
33240197|NCT00062868|100779964|FG004|Dose Level 1|Death|0|||
33240198|NCT00062868|100779965|FG005|Dose Level 1|Death|0|||
33240199|NCT00062868|100779966|FG006|Dose Level 1|Death|3|||
33240200|NCT00062868|100779967|FG007|Dose Level 1|Death|0|||
33240201|NCT00062868|100779968|FG008|Dose Level 1|Death|0|||
33240202|NCT00062868|100779969|FG009|Dose Level 1|Death|0|||
33240203|NCT00062868|100779970|FG010|Dose Level 1|Death|0|||
33240204|NCT00062868|100779971|FG011|Dose Level 1|Death|0|||
33240205|NCT00062868|100779972|FG012|Dose Level 1|Death|0|||
33240206|NCT00062868|100779973|FG013|Dose Level 1|Death|0|||
33240207|NCT00062868|100779974|FG014|Dose Level 1|Death|0|||
33240208|NCT00062868|100779975|FG015|Dose Level 1|Death|0|||
33240209|NCT00062868|100779976|FG016|Dose Level 1|Death|0|||
33240210|NCT00062868|100779977|FG017|Dose Level 1|Death|0|||
33240211|NCT00062868|100779978|FG018|Dose Level 1|Death|7|||
33240212|NCT00062868|100779979|FG019|Dose Level 1|Death|0|||
33421054|NCT00388674|101431686|FG001|End of Study|No Off-Treatment Status Data|30|||
33421055|NCT00388674|101431685|FG000|End of Study|Not Reported|0|||
33421056|NCT00388674|101431686|FG001|End of Study|Not Reported|1|||
33640736|NCT03682770|102236456|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
33640737|NCT03682770|102236457|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
33421057|NCT00810615|101431687|FG000|Overall Study|Withdrawal by Subject|1|||
33421058|NCT00810615|101431688|FG001|Overall Study|Withdrawal by Subject|1|||
33141745|NCT01903252|100431769|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
33141746|NCT01903252|100431770|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
33240213|NCT00062868|100779980|FG020|Dose Level 1|Death|1|||
33240214|NCT00062868|100779960|FG000|Dose Level 1|Lost to Follow-up|0|||
33240215|NCT00062868|100779961|FG001|Dose Level 1|Lost to Follow-up|0|||
33421059|NCT01954082|101431689|FG000|Overall Study|Study Suspension|42|||
33421060|NCT01954082|101431690|FG001|Overall Study|Study Suspension|36|||
33421061|NCT01954082|101431689|FG000|Overall Study|Adverse Event|10|||
33421062|NCT01954082|101431690|FG001|Overall Study|Adverse Event|4|||
33421063|NCT01954082|101431689|FG000|Overall Study|Intolerance|0|||
33421064|NCT01954082|101431690|FG001|Overall Study|Intolerance|1|||
33421065|NCT01954082|101431689|FG000|Overall Study|Non-compliance|6|||
33580170|NCT00310375|102013289|FG002|Primary Reporting Phase|Site closure|0|||
33580171|NCT00310375|102013287|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
33240216|NCT00062868|100779962|FG002|Dose Level 1|Lost to Follow-up|0|||
33240217|NCT00062868|100779963|FG003|Dose Level 1|Lost to Follow-up|0|||
33240218|NCT00062868|100779964|FG004|Dose Level 1|Lost to Follow-up|0|||
33240219|NCT00062868|100779965|FG005|Dose Level 1|Lost to Follow-up|0|||
33370549|NCT00365716|101243469|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
33370550|NCT00365716|101243470|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
33370551|NCT00365716|101243471|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
33370552|NCT00365716|101243472|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
33370553|NCT00365716|101243466|FG000|Base Study (Day 1 to Month 7)|Other|0|||
33370554|NCT00365716|101243467|FG001|Base Study (Day 1 to Month 7)|Other|1|||
33370555|NCT00365716|101243468|FG002|Base Study (Day 1 to Month 7)|Other|0|||
33370556|NCT00365716|101243469|FG003|Base Study (Day 1 to Month 7)|Other|0|||
33370557|NCT00365716|101243470|FG004|Base Study (Day 1 to Month 7)|Other|0|||
33370558|NCT00365716|101243471|FG005|Base Study (Day 1 to Month 7)|Other|0|||
33370559|NCT00365716|101243472|FG006|Base Study (Day 1 to Month 7)|Other|0|||
33370560|NCT00365716|101243466|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
33370561|NCT00365716|101243467|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
33370562|NCT00365716|101243468|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
33370563|NCT00365716|101243469|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
33370564|NCT00365716|101243470|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
33370565|NCT00365716|101243471|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
33370566|NCT00365716|101243472|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
33370567|NCT00365716|101243466|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
33370568|NCT00365716|101243467|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
33370569|NCT00365716|101243468|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
33580172|NCT00310375|102013288|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
33580173|NCT00310375|102013289|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
33580174|NCT00310375|102013287|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
33580175|NCT00310375|102013288|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
33421066|NCT01954082|101431690|FG001|Overall Study|Non-compliance|4|||
33580176|NCT00310375|102013289|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
33240220|NCT00062868|100779966|FG006|Dose Level 1|Lost to Follow-up|0|||
33580177|NCT00310375|102013287|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
33240221|NCT00062868|100779967|FG007|Dose Level 1|Lost to Follow-up|0|||
33240222|NCT00062868|100779968|FG008|Dose Level 1|Lost to Follow-up|0|||
33240223|NCT00062868|100779969|FG009|Dose Level 1|Lost to Follow-up|0|||
33240224|NCT00062868|100779970|FG010|Dose Level 1|Lost to Follow-up|0|||
33421067|NCT01954082|101431689|FG000|Overall Study|Physician Decision|2|||
33580178|NCT00310375|102013288|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
33580179|NCT00310375|102013289|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
33580180|NCT00310375|102013287|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
33580181|NCT00310375|102013288|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
33580182|NCT00310375|102013289|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
33580183|NCT01853462|102013293|FG000|Overall Study|Withdrawal by Subject|1|||
33141747|NCT01903252|100431771|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
33141748|NCT01903252|100431772|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
33141749|NCT01903252|100431773|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
33141750|NCT01903252|100431768|FG000|Extended Induction, Open-Label|Physician Decision|0|||
33141751|NCT01903252|100431769|FG001|Extended Induction, Open-Label|Physician Decision|0|||
33141752|NCT01903252|100431770|FG002|Extended Induction, Open-Label|Physician Decision|1|||
33141753|NCT01903252|100431771|FG003|Extended Induction, Open-Label|Physician Decision|0|||
33141754|NCT01903252|100431772|FG004|Extended Induction, Open-Label|Physician Decision|0|||
33240225|NCT00062868|100779971|FG011|Dose Level 1|Lost to Follow-up|0|||
33240226|NCT00062868|100779972|FG012|Dose Level 1|Lost to Follow-up|1|||
33240227|NCT00062868|100779973|FG013|Dose Level 1|Lost to Follow-up|0|||
33240228|NCT00062868|100779974|FG014|Dose Level 1|Lost to Follow-up|0|||
33240229|NCT00062868|100779975|FG015|Dose Level 1|Lost to Follow-up|0|||
33240230|NCT00062868|100779976|FG016|Dose Level 1|Lost to Follow-up|0|||
33240231|NCT00062868|100779977|FG017|Dose Level 1|Lost to Follow-up|0|||
33240232|NCT00062868|100779978|FG018|Dose Level 1|Lost to Follow-up|2|||
33240233|NCT00062868|100779979|FG019|Dose Level 1|Lost to Follow-up|0|||
33240234|NCT00062868|100779980|FG020|Dose Level 1|Lost to Follow-up|1|||
33240235|NCT00062868|100779960|FG000|Dose Level 2|Death|0|||
33240236|NCT00062868|100779961|FG001|Dose Level 2|Death|3|||
33240237|NCT00062868|100779962|FG002|Dose Level 2|Death|0|||
33240238|NCT00062868|100779963|FG003|Dose Level 2|Death|0|||
33240239|NCT00062868|100779964|FG004|Dose Level 2|Death|2|||
33240240|NCT00062868|100779965|FG005|Dose Level 2|Death|0|||
33240241|NCT00062868|100779966|FG006|Dose Level 2|Death|0|||
33240242|NCT00062868|100779967|FG007|Dose Level 2|Death|0|||
33240243|NCT00062868|100779968|FG008|Dose Level 2|Death|0|||
33240244|NCT00062868|100779969|FG009|Dose Level 2|Death|0|||
33240245|NCT00062868|100779970|FG010|Dose Level 2|Death|1|||
33240246|NCT00062868|100779971|FG011|Dose Level 2|Death|0|||
33240247|NCT00062868|100779972|FG012|Dose Level 2|Death|0|||
33240248|NCT00062868|100779973|FG013|Dose Level 2|Death|0|||
33240249|NCT00062868|100779974|FG014|Dose Level 2|Death|0|||
33240250|NCT00062868|100779975|FG015|Dose Level 2|Death|0|||
33240251|NCT00062868|100779976|FG016|Dose Level 2|Death|2|||
33240252|NCT00062868|100779977|FG017|Dose Level 2|Death|0|||
33240253|NCT00062868|100779978|FG018|Dose Level 2|Death|0|||
33141755|NCT01903252|100431773|FG005|Extended Induction, Open-Label|Physician Decision|0|||
33141756|NCT01903252|100431768|FG000|Maintenance, Open-Label|Adverse Event|0|||
33370570|NCT00365716|101243469|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
33370571|NCT00365716|101243470|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
33370572|NCT00365716|101243471|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
33370573|NCT00365716|101243472|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
33370574|NCT00365716|101243466|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
33370575|NCT00365716|101243467|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
33421068|NCT01954082|101431690|FG001|Overall Study|Physician Decision|0|||
33240254|NCT00062868|100779979|FG019|Dose Level 2|Death|0|||
33240255|NCT00062868|100779980|FG020|Dose Level 2|Death|0|||
33370576|NCT00365716|101243468|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
33370577|NCT00365716|101243469|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
33421069|NCT01954082|101431689|FG000|Overall Study|Parent Decision|1|||
33421070|NCT01954082|101431690|FG001|Overall Study|Parent Decision|0|||
33421071|NCT01954082|101431689|FG000|Overall Study|Withdrawal by Subject|0|||
33421072|NCT01954082|101431690|FG001|Overall Study|Withdrawal by Subject|1|||
33421073|NCT01954082|101431689|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
33421074|NCT01954082|101431690|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
33421075|NCT01954082|101431689|FG000|Overall Study|Redirection of Care|0|||
33421076|NCT01954082|101431690|FG001|Overall Study|Redirection of Care|2|||
33421077|NCT01954082|101431689|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
33421078|NCT01954082|101431690|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
33580184|NCT01853462|102013294|FG001|Overall Study|Withdrawal by Subject|1|||
33580185|NCT00763256|102013306|FG000|Overall Study|Didn't return for appointments|7|||
33240256|NCT00062868|100779960|FG000|Dose Level 2|Lost to Follow-up|0|||
33240257|NCT00062868|100779961|FG001|Dose Level 2|Lost to Follow-up|0|||
33370578|NCT00365716|101243470|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
33240258|NCT00062868|100779962|FG002|Dose Level 2|Lost to Follow-up|0|||
33240259|NCT00062868|100779963|FG003|Dose Level 2|Lost to Follow-up|0|||
33240260|NCT00062868|100779964|FG004|Dose Level 2|Lost to Follow-up|0|||
33240261|NCT00062868|100779965|FG005|Dose Level 2|Lost to Follow-up|0|||
33421079|NCT01954082|101431689|FG000|Overall Study|Comfort Care|0|||
33580186|NCT00763256|102013307|FG001|Overall Study|Didn't return for appointments|10|||
33640738|NCT03682770|102236458|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
33640739|NCT03682770|102236459|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
33141757|NCT01903252|100431769|FG001|Maintenance, Open-Label|Adverse Event|0|||
33421080|NCT01954082|101431690|FG001|Overall Study|Comfort Care|1|||
33421081|NCT01954082|101431689|FG000|Overall Study|Infant Moved|0|||
33421082|NCT01954082|101431690|FG001|Overall Study|Infant Moved|1|||
33421083|NCT01954082|101431689|FG000|Overall Study|Randomized not Treated|4|||
33421084|NCT01954082|101431690|FG001|Overall Study|Randomized not Treated|2|||
33421085|NCT03056001|101431697|FG000|Overall Study|Death|24|||
33421086|NCT01169844|101431698|FG000|Overall Study|Adverse Event|0|||
33421087|NCT01169844|101431699|FG001|Overall Study|Adverse Event|1|||
33141758|NCT01903252|100431770|FG002|Maintenance, Open-Label|Adverse Event|0|||
33141759|NCT01903252|100431771|FG003|Maintenance, Open-Label|Adverse Event|3|||
33141760|NCT01903252|100431772|FG004|Maintenance, Open-Label|Adverse Event|9|||
33141761|NCT01903252|100431773|FG005|Maintenance, Open-Label|Adverse Event|14|||
33580187|NCT01964378|102013308|FG000|Overall Study|Disc. due to death before first dosing|0|||
33141762|NCT01903252|100431768|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
33141763|NCT01903252|100431769|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
33141764|NCT01903252|100431770|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
33141765|NCT01903252|100431771|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
33141766|NCT01903252|100431772|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
33141767|NCT01903252|100431773|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
33141768|NCT01903252|100431768|FG000|Maintenance, Open-Label|Other|0|||
33141769|NCT01903252|100431769|FG001|Maintenance, Open-Label|Other|0|||
33141770|NCT01903252|100431770|FG002|Maintenance, Open-Label|Other|0|||
33240262|NCT00062868|100779966|FG006|Dose Level 2|Lost to Follow-up|0|||
33240263|NCT00062868|100779967|FG007|Dose Level 2|Lost to Follow-up|0|||
33240264|NCT00062868|100779968|FG008|Dose Level 2|Lost to Follow-up|0|||
33240265|NCT00062868|100779969|FG009|Dose Level 2|Lost to Follow-up|0|||
33240266|NCT00062868|100779970|FG010|Dose Level 2|Lost to Follow-up|0|||
33240267|NCT00062868|100779971|FG011|Dose Level 2|Lost to Follow-up|0|||
33240268|NCT00062868|100779972|FG012|Dose Level 2|Lost to Follow-up|0|||
33240269|NCT00062868|100779973|FG013|Dose Level 2|Lost to Follow-up|1|||
33240270|NCT00062868|100779974|FG014|Dose Level 2|Lost to Follow-up|0|||
33240271|NCT00062868|100779975|FG015|Dose Level 2|Lost to Follow-up|0|||
33240272|NCT00062868|100779976|FG016|Dose Level 2|Lost to Follow-up|1|||
33240273|NCT00062868|100779977|FG017|Dose Level 2|Lost to Follow-up|0|||
33240274|NCT00062868|100779978|FG018|Dose Level 2|Lost to Follow-up|0|||
33240275|NCT00062868|100779979|FG019|Dose Level 2|Lost to Follow-up|0|||
33240276|NCT00062868|100779980|FG020|Dose Level 2|Lost to Follow-up|0|||
33580188|NCT01964378|102013309|FG001|Overall Study|Disc. due to death before first dosing|1|||
33580189|NCT01964378|102013308|FG000|Overall Study|Disc. due to AE before first dosing|1|||
33580190|NCT01964378|102013309|FG001|Overall Study|Disc. due to AE before first dosing|0|||
33580191|NCT01964378|102013308|FG000|Overall Study|Death|3|||
33580192|NCT01964378|102013309|FG001|Overall Study|Death|2|||
33580193|NCT01964378|102013308|FG000|Overall Study|Adverse Event|12|||
33580194|NCT01964378|102013309|FG001|Overall Study|Adverse Event|5|||
33580195|NCT01964378|102013308|FG000|Overall Study|Lack of Efficacy|0|||
33580196|NCT01964378|102013309|FG001|Overall Study|Lack of Efficacy|1|||
33580197|NCT01964378|102013308|FG000|Overall Study|Protocol Violation|0|||
33580198|NCT01964378|102013309|FG001|Overall Study|Protocol Violation|1|||
33580199|NCT01964378|102013308|FG000|Overall Study|Lost to Follow-up|0|||
33580200|NCT01964378|102013309|FG001|Overall Study|Lost to Follow-up|1|||
33580201|NCT01964378|102013308|FG000|Overall Study|Withdrawal by Subject|7|||
33580202|NCT01964378|102013309|FG001|Overall Study|Withdrawal by Subject|5|||
33580203|NCT01964378|102013308|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
33580204|NCT01964378|102013309|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
33580205|NCT01964378|102013308|FG000|Overall Study|Other|1|||
33580206|NCT01964378|102013309|FG001|Overall Study|Other|2|||
33580207|NCT00120627|102013310|FG000|Overall Study|Withdrawal by Subject|5|||
33580208|NCT00120627|102013311|FG001|Overall Study|Withdrawal by Subject|5|||
33580209|NCT03036852|102013312|FG000|Overall Study|Death|2|||
33640740|NCT03682770|102236453|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
33640741|NCT03682770|102236454|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
33640742|NCT03682770|102236455|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
33141771|NCT01903252|100431771|FG003|Maintenance, Open-Label|Other|2|||
33141772|NCT01903252|100431772|FG004|Maintenance, Open-Label|Other|6|||
33240277|NCT00062868|100779960|FG000|Dose Level 3|Death|0|||
33240278|NCT00062868|100779961|FG001|Dose Level 3|Death|0|||
33240279|NCT00062868|100779962|FG002|Dose Level 3|Death|0|||
33240280|NCT00062868|100779963|FG003|Dose Level 3|Death|0|||
33421088|NCT01169844|101431698|FG000|Overall Study|Patient withdrew consent|4|||
33421089|NCT01169844|101431699|FG001|Overall Study|Patient withdrew consent|0|||
33580210|NCT03036852|102013312|FG000|Overall Study|Lack of Efficacy|2|||
33580211|NCT03036852|102013312|FG000|Overall Study|Adverse Event|1|||
33580212|NCT03036852|102013312|FG000|Overall Study|Lost to Follow-up|1|||
33580213|NCT04466384|102013313|FG000|First Phase|Protocol Violation|1|||
33141773|NCT01903252|100431773|FG005|Maintenance, Open-Label|Other|2|||
33141774|NCT04250077|100431774|FG000|Overall Study|Withdrawal by Subject|0|||
33141775|NCT04250077|100431775|FG001|Overall Study|Withdrawal by Subject|1|||
33141776|NCT04250077|100431776|FG002|Overall Study|Withdrawal by Subject|0|||
33141777|NCT04250077|100431774|FG000|Overall Study|Lost to Follow-up|2|||
33421090|NCT01169844|101431698|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33421091|NCT01169844|101431699|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33640743|NCT03682770|102236456|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
33640744|NCT03682770|102236457|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
33640745|NCT03682770|102236458|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
33640746|NCT03682770|102236459|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
33640747|NCT03682770|102236453|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
33640748|NCT03682770|102236454|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
33640749|NCT03682770|102236455|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
33640750|NCT03682770|102236456|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
33640751|NCT03682770|102236457|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
33640752|NCT03682770|102236458|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
33640753|NCT03682770|102236459|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
33640754|NCT01413204|102236460|FG000|Overall Study|Adverse Event|1|||
33640755|NCT01413204|102236461|FG001|Overall Study|Adverse Event|2|||
33640756|NCT01413204|102236462|FG002|Overall Study|Adverse Event|2|||
33640757|NCT01413204|102236460|FG000|Overall Study|Physician Decision|3|||
33640758|NCT01413204|102236461|FG001|Overall Study|Physician Decision|0|||
33640759|NCT01413204|102236462|FG002|Overall Study|Physician Decision|2|||
33640760|NCT01413204|102236460|FG000|Overall Study|Withdrawal by Subject|1|||
33640761|NCT01413204|102236461|FG001|Overall Study|Withdrawal by Subject|4|||
33640762|NCT01413204|102236462|FG002|Overall Study|Withdrawal by Subject|4|||
33640763|NCT01413204|102236460|FG000|Overall Study|Clearly not eligible for the study|0|||
33640764|NCT01413204|102236461|FG001|Overall Study|Clearly not eligible for the study|0|||
33640765|NCT01413204|102236462|FG002|Overall Study|Clearly not eligible for the study|1|||
33640766|NCT01413204|102236460|FG000|Overall Study|Fasting plasma glucose level increased|1|||
33640767|NCT01413204|102236461|FG001|Overall Study|Fasting plasma glucose level increased|0|||
33640768|NCT01413204|102236462|FG002|Overall Study|Fasting plasma glucose level increased|10|||
33421092|NCT03087773|101431706|FG000|Overall Study|Withdrawal by Subject|8|||
33421093|NCT03087773|101431707|FG001|Overall Study|Withdrawal by Subject|4|||
33421094|NCT03087773|101431706|FG000|Overall Study|Lost to Follow-up|12|||
33580214|NCT04466384|102013314|FG001|First Phase|Protocol Violation|0|||
33580215|NCT04466384|102013313|FG000|First Phase|Missing data|1|||
33580216|NCT04466384|102013314|FG001|First Phase|Missing data|0|||
33580217|NCT04466384|102013313|FG000|Cross Over Phase|Physician Decision|1|||
33580218|NCT04466384|102013314|FG001|Cross Over Phase|Physician Decision|0|||
33580219|NCT04466384|102013313|FG000|Cross Over Phase|Withdrawal by Subject|0|||
33580220|NCT04466384|102013314|FG001|Cross Over Phase|Withdrawal by Subject|1|||
33580221|NCT02553928|102013315|FG000|Overall Study|Adverse Event|2|||
33580222|NCT02553928|102013316|FG001|Overall Study|Adverse Event|1|||
33580223|NCT02553928|102013315|FG000|Overall Study|Lost to Follow-up|0|||
33580224|NCT02553928|102013316|FG001|Overall Study|Lost to Follow-up|1|||
33580225|NCT02553928|102013315|FG000|Overall Study|Administrative reason(s)|0|||
33580226|NCT02553928|102013316|FG001|Overall Study|Administrative reason(s)|1|||
33580227|NCT02948582|102013317|FG000|Washout Period 1|Adverse Event|0|||
33580228|NCT02948582|102013318|FG001|Washout Period 1|Adverse Event|2|||
33580229|NCT02948582|102013319|FG002|Washout Period 1|Adverse Event|0|||
33580230|NCT02948582|102013320|FG003|Washout Period 1|Adverse Event|0|||
33580231|NCT02948582|102013321|FG004|Washout Period 1|Adverse Event|0|||
33580232|NCT02948582|102013322|FG005|Washout Period 1|Adverse Event|0|||
33580233|NCT02948582|102013317|FG000|Washout Period 1|Protocol Violation|0|||
33580234|NCT02948582|102013318|FG001|Washout Period 1|Protocol Violation|0|||
33580235|NCT02948582|102013319|FG002|Washout Period 1|Protocol Violation|0|||
33580236|NCT02948582|102013320|FG003|Washout Period 1|Protocol Violation|0|||
33580237|NCT02948582|102013321|FG004|Washout Period 1|Protocol Violation|0|||
33580238|NCT02948582|102013322|FG005|Washout Period 1|Protocol Violation|1|||
33580239|NCT02948582|102013317|FG000|Washout Period 2|Adverse Event|0|||
33580240|NCT02948582|102013318|FG001|Washout Period 2|Adverse Event|1|||
33580241|NCT02948582|102013319|FG002|Washout Period 2|Adverse Event|0|||
33640769|NCT01432730|102236463|FG000|Period 1|Adverse Event|2|||
33141778|NCT04250077|100431775|FG001|Overall Study|Lost to Follow-up|3|||
33240281|NCT00062868|100779964|FG004|Dose Level 3|Death|0|||
33240282|NCT00062868|100779965|FG005|Dose Level 3|Death|0|||
33580242|NCT02948582|102013320|FG003|Washout Period 2|Adverse Event|0|||
33580243|NCT02948582|102013321|FG004|Washout Period 2|Adverse Event|0|||
33580244|NCT02948582|102013322|FG005|Washout Period 2|Adverse Event|0|||
33580245|NCT02948582|102013317|FG000|Washout Period 2|personal reasons|0|||
33580246|NCT02948582|102013318|FG001|Washout Period 2|personal reasons|0|||
33580247|NCT02948582|102013319|FG002|Washout Period 2|personal reasons|0|||
33640770|NCT01432730|102236464|FG001|Period 1|Adverse Event|0|||
33640771|NCT01432730|102236463|FG000|Period 2|Adverse Event|0|||
33640772|NCT01432730|102236464|FG001|Period 2|Adverse Event|4|||
33640773|NCT01273519|102236469|FG000|Overall Study|Adverse Event|3|||
33640774|NCT01273519|102236470|FG001|Overall Study|Adverse Event|0|||
33640775|NCT01273519|102236471|FG002|Overall Study|Adverse Event|0|||
33640776|NCT01273519|102236469|FG000|Overall Study|Lost to Follow-up|2|||
33640777|NCT01273519|102236470|FG001|Overall Study|Lost to Follow-up|1|||
33640778|NCT01273519|102236471|FG002|Overall Study|Lost to Follow-up|3|||
33141779|NCT04250077|100431776|FG002|Overall Study|Lost to Follow-up|0|||
33141780|NCT00783302|100431779|FG000|Overall Study|Lost to Follow-up|17|||
33141781|NCT00783302|100431779|FG000|Overall Study|Technical Problems|11|||
33141782|NCT00783302|100431779|FG000|Overall Study|Protocol Violation|3|||
33141783|NCT00783302|100431779|FG000|Overall Study|Physician Decision|1|||
33141784|NCT00783302|100431779|FG000|Overall Study|Withdrawal by Subject|3|||
33141785|NCT05672667|100431780|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
33141786|NCT02195011|100431781|FG000|Overall Study|Adverse Event|4|||
33141787|NCT02195011|100431782|FG001|Overall Study|Adverse Event|0|||
33141788|NCT02195011|100431781|FG000|Overall Study|Progressive Disease|18|||
33141789|NCT02195011|100431782|FG001|Overall Study|Progressive Disease|1|||
33141790|NCT02195011|100431781|FG000|Overall Study|Withdrawal by Subject|3|||
33141791|NCT02195011|100431782|FG001|Overall Study|Withdrawal by Subject|0|||
33141792|NCT00217464|100431783|FG000|Overall Study|Progression|15|||
33141793|NCT00217464|100431783|FG000|Overall Study|Other|2|||
33141794|NCT02412488|100431784|FG000|Overall Study|Lost to Follow-up|10|||
33141795|NCT02412488|100431784|FG000|Overall Study|Withdrawal by Subject|5|||
33141796|NCT02412488|100431784|FG000|Overall Study|Physician Decision|1|||
33141797|NCT02412488|100431784|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
33240283|NCT00062868|100779966|FG006|Dose Level 3|Death|0|||
33580248|NCT02948582|102013320|FG003|Washout Period 2|personal reasons|1|||
33580249|NCT02948582|102013321|FG004|Washout Period 2|personal reasons|0|||
33580250|NCT02948582|102013322|FG005|Washout Period 2|personal reasons|0|||
33580251|NCT02948582|102013317|FG000|Washout Period 4|Adverse Event|1|||
33580252|NCT02948582|102013318|FG001|Washout Period 4|Adverse Event|0|||
33580253|NCT02948582|102013319|FG002|Washout Period 4|Adverse Event|1|||
33580254|NCT02948582|102013320|FG003|Washout Period 4|Adverse Event|0|||
33580255|NCT02948582|102013321|FG004|Washout Period 4|Adverse Event|0|||
33580256|NCT02948582|102013322|FG005|Washout Period 4|Adverse Event|0|||
33580257|NCT00892008|102013323|FG000|Overall Study|Death|5|||
33580258|NCT00892008|102013323|FG000|Overall Study|Lack of Efficacy|3|||
33580259|NCT00892008|102013323|FG000|Overall Study|Lost to Follow-up|142|||
33580260|NCT00892008|102013323|FG000|Overall Study|Other|378|||
33580261|NCT00892008|102013323|FG000|Overall Study|Adverse Event|37|||
33580262|NCT00937495|102013328|FG000|Overall Study|Protocol Violation|2|||
33580263|NCT04011735|102013329|FG000|Overall Study|Withdrawal by Subject|1|||
33580264|NCT04011735|102013330|FG001|Overall Study|Withdrawal by Subject|0|||
33580265|NCT04011735|102013331|FG002|Overall Study|Withdrawal by Subject|1|||
33580266|NCT04011735|102013329|FG000|Overall Study|Met exclusion criteria after study entry|0|||
33580267|NCT04011735|102013330|FG001|Overall Study|Met exclusion criteria after study entry|1|||
33580268|NCT04011735|102013331|FG002|Overall Study|Met exclusion criteria after study entry|0|||
33580269|NCT02041299|102013332|FG000|Overall Study|Adverse Event|9|||
33580270|NCT02041299|102013333|FG001|Overall Study|Adverse Event|3|||
33580271|NCT02041299|102013332|FG000|Overall Study|Lost to Follow-up|4|||
33580272|NCT02041299|102013333|FG001|Overall Study|Lost to Follow-up|1|||
33580273|NCT02041299|102013332|FG000|Overall Study|Physician Decision|1|||
33580274|NCT02041299|102013333|FG001|Overall Study|Physician Decision|1|||
33580275|NCT02041299|102013332|FG000|Overall Study|Withdrawal by Subject|13|||
33580276|NCT02041299|102013333|FG001|Overall Study|Withdrawal by Subject|7|||
33580277|NCT02041299|102013332|FG000|Overall Study|Protocol Violation|11|||
33580278|NCT02041299|102013333|FG001|Overall Study|Protocol Violation|4|||
33580279|NCT02041299|102013332|FG000|Overall Study|Termination of the study|7|||
33580280|NCT02041299|102013333|FG001|Overall Study|Termination of the study|3|||
33580281|NCT02041299|102013332|FG000|Overall Study|Required bone marrow transplant|0|||
33141798|NCT02412488|100431784|FG000|Overall Study|Reveal LINQ explant|1|||
33580282|NCT02041299|102013333|FG001|Overall Study|Required bone marrow transplant|1|||
33580283|NCT02041299|102013332|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
33580284|NCT02041299|102013333|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
33580285|NCT02949024|102013334|FG000|Overall Study|Withdrawal by Subject|0|||
33580286|NCT02949024|102013335|FG001|Overall Study|Withdrawal by Subject|1|||
33580287|NCT00755807|102013337|FG000|Acute Phase|Adverse Event|16|||
33580288|NCT00755807|102013338|FG001|Acute Phase|Adverse Event|5|||
33580289|NCT00755807|102013337|FG000|Acute Phase|Protocol Violation|1|||
33580290|NCT00755807|102013338|FG001|Acute Phase|Protocol Violation|3|||
33580291|NCT00755807|102013337|FG000|Acute Phase|Withdrawal by Subject|1|||
33580292|NCT00755807|102013338|FG001|Acute Phase|Withdrawal by Subject|2|||
33240284|NCT00062868|100779967|FG007|Dose Level 3|Death|0|||
33580293|NCT00755807|102013337|FG000|Acute Phase|Lack of Efficacy|0|||
33640779|NCT01273519|102236469|FG000|Overall Study|Lack of Efficacy|8|||
33640780|NCT01273519|102236470|FG001|Overall Study|Lack of Efficacy|3|||
33640781|NCT01273519|102236471|FG002|Overall Study|Lack of Efficacy|4|||
33141799|NCT01998984|100431785|FG000|Overall Study|Adverse Event|0|||
33141800|NCT01998984|100431786|FG001|Overall Study|Adverse Event|0|||
33141801|NCT01998984|100431787|FG002|Overall Study|Adverse Event|0|||
33141802|NCT01998984|100431788|FG003|Overall Study|Adverse Event|1|||
33141803|NCT01998984|100431785|FG000|Overall Study|Lost to Follow-up|0|||
33141804|NCT01998984|100431786|FG001|Overall Study|Lost to Follow-up|1|||
33141805|NCT01998984|100431787|FG002|Overall Study|Lost to Follow-up|0|||
33141806|NCT01998984|100431788|FG003|Overall Study|Lost to Follow-up|1|||
33141807|NCT01998984|100431785|FG000|Overall Study|Withdrawal by Subject|0|||
33141808|NCT01998984|100431786|FG001|Overall Study|Withdrawal by Subject|0|||
33141809|NCT01998984|100431787|FG002|Overall Study|Withdrawal by Subject|1|||
33141810|NCT01998984|100431788|FG003|Overall Study|Withdrawal by Subject|0|||
33141811|NCT01998984|100431785|FG000|Overall Study|Other|0|||
33141812|NCT01998984|100431786|FG001|Overall Study|Other|0|||
33141813|NCT01998984|100431787|FG002|Overall Study|Other|0|||
33141814|NCT01998984|100431788|FG003|Overall Study|Other|1|||
33141815|NCT01227824|100434668|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
33141816|NCT01227824|100434669|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
33240285|NCT00062868|100779968|FG008|Dose Level 3|Death|0|||
33240286|NCT00062868|100779969|FG009|Dose Level 3|Death|0|||
33240287|NCT00062868|100779970|FG010|Dose Level 3|Death|0|||
33640782|NCT01273519|102236469|FG000|Overall Study|Other|6|||
33141817|NCT01227824|100434670|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
33141818|NCT01227824|100434668|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
33141819|NCT01227824|100434669|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
33141820|NCT01227824|100434670|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
33141821|NCT01227824|100434668|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
33141822|NCT01227824|100434669|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
33141823|NCT01227824|100434670|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
33141824|NCT01227824|100434668|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
33141825|NCT01227824|100434669|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
33141826|NCT01227824|100434670|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
33141827|NCT01227824|100434668|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
33141828|NCT01227824|100434669|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
33141829|NCT01227824|100434670|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
33141830|NCT01227824|100434668|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
33141831|NCT01227824|100434669|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
33141832|NCT01227824|100434670|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
33141833|NCT01227824|100434668|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
33141834|NCT01227824|100434669|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
33141835|NCT01227824|100434670|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
33141836|NCT01227824|100434668|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
33141837|NCT01227824|100434669|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
33141838|NCT01227824|100434670|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
33141839|NCT01227824|100434668|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
33141840|NCT01227824|100434669|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
33141841|NCT01227824|100434670|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
33141842|NCT01227824|100434668|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
33141843|NCT01227824|100434669|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
33141844|NCT01227824|100434670|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
33240288|NCT00062868|100779971|FG011|Dose Level 3|Death|1|||
33240289|NCT00062868|100779972|FG012|Dose Level 3|Death|0|||
33240290|NCT00062868|100779973|FG013|Dose Level 3|Death|0|||
33580294|NCT00755807|102013338|FG001|Acute Phase|Lack of Efficacy|1|||
33580295|NCT00755807|102013337|FG000|Acute Phase|Physician Decision|0|||
33580296|NCT00755807|102013338|FG001|Acute Phase|Physician Decision|1|||
33580297|NCT00755807|102013337|FG000|Open-label Extension Phase|Adverse Event|7|||
33580298|NCT00755807|102013338|FG001|Open-label Extension Phase|Adverse Event|7|||
33580299|NCT00755807|102013337|FG000|Open-label Extension Phase|Protocol Violation|5|||
33580300|NCT00755807|102013338|FG001|Open-label Extension Phase|Protocol Violation|2|||
33580301|NCT00755807|102013337|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
33580302|NCT00755807|102013338|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
33580303|NCT00755807|102013337|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
33580304|NCT00755807|102013338|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
33640783|NCT01273519|102236470|FG001|Overall Study|Other|1|||
33640784|NCT01273519|102236471|FG002|Overall Study|Other|1|||
33240291|NCT00062868|100779974|FG014|Dose Level 3|Death|0|||
33240292|NCT00062868|100779975|FG015|Dose Level 3|Death|0|||
33240293|NCT00062868|100779976|FG016|Dose Level 3|Death|0|||
33580305|NCT00755807|102013337|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
33640785|NCT02598583|102236472|FG000|Extension Period|Withdrawal by Subject|1|||
33640786|NCT02598583|102236473|FG001|Extension Period|Withdrawal by Subject|0|||
33141845|NCT01227824|100434668|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
33141846|NCT01227824|100434669|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
33141847|NCT01227824|100434670|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
33141848|NCT01227824|100434668|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
33141849|NCT01227824|100434669|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
33141850|NCT01227824|100434670|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
33141851|NCT01227824|100434668|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
33141852|NCT01227824|100434669|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
33141853|NCT01227824|100434670|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
33141854|NCT01227824|100434668|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
33141855|NCT01227824|100434669|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
33141856|NCT01227824|100434670|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
33141857|NCT01227824|100434668|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
33141858|NCT01227824|100434669|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
33141859|NCT01227824|100434670|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
33141860|NCT01027273|100434676|FG000|Overall Study|Lost to Follow-up|57|||
33141861|NCT01027273|100434677|FG001|Overall Study|Lost to Follow-up|31|||
33141862|NCT01027273|100434676|FG000|Overall Study|Death|2|||
33141863|NCT01027273|100434677|FG001|Overall Study|Death|2|||
33141864|NCT03189381|100434678|FG000|Overall Study|Death|1|||
33141865|NCT03189381|100434679|FG001|Overall Study|Death|0|||
33141866|NCT00348933|100434680|FG000|Overall Study|Withdrawal by Subject|10|||
33141867|NCT00348933|100434680|FG000|Overall Study|Lost to Follow-up|6|||
33141868|NCT00348933|100434680|FG000|Overall Study|Protocol Violation|2|||
33141869|NCT00348933|100434680|FG000|Overall Study|Adverse Event|7|||
33141870|NCT02106923|100434683|FG000|Overall Study|Protocol Violation|0|||
33141871|NCT02106923|100434684|FG001|Overall Study|Protocol Violation|0|||
33141872|NCT02106923|100434685|FG002|Overall Study|Protocol Violation|0|||
33141873|NCT02106923|100434686|FG003|Overall Study|Protocol Violation|0|||
33141874|NCT02106923|100434687|FG004|Overall Study|Protocol Violation|0|||
33141875|NCT02106923|100434688|FG005|Overall Study|Protocol Violation|1|||
33141876|NCT01565343|100434691|FG000|Overall Study|Administrative decision/technical issues|1|||
33141877|NCT01565343|100434692|FG001|Overall Study|Administrative decision/technical issues|0|||
33141878|NCT01565343|100434693|FG002|Overall Study|Administrative decision/technical issues|0|||
33141879|NCT01820260|100434694|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33141880|NCT01820260|100434695|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33141881|NCT01820260|100434696|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33141882|NCT01820260|100434697|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33141883|NCT01820260|100434698|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33141884|NCT01820260|100434699|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33580306|NCT00755807|102013338|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
33580307|NCT00755807|102013337|FG000|Open-label Extension Phase|Sponsor Decision|0|||
33141885|NCT01820260|100434700|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
33141886|NCT01820260|100434701|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33141887|NCT01820260|100434702|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33141888|NCT01820260|100434703|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33141889|NCT01820260|100434704|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33141890|NCT01820260|100434705|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33141891|NCT01820260|100434706|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33141892|NCT01820260|100434707|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
33141893|NCT01820260|100434694|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33141894|NCT01820260|100434695|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33141895|NCT01820260|100434696|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33141896|NCT01820260|100434697|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33141897|NCT01820260|100434698|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33141898|NCT01820260|100434699|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33141899|NCT01820260|100434700|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33141900|NCT01820260|100434701|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33141901|NCT01820260|100434702|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33240294|NCT00062868|100779977|FG017|Dose Level 3|Death|1|||
33580308|NCT00755807|102013338|FG001|Open-label Extension Phase|Sponsor Decision|1|||
33141902|NCT01820260|100434703|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
33240295|NCT00062868|100779978|FG018|Dose Level 3|Death|0|||
33240296|NCT00062868|100779979|FG019|Dose Level 3|Death|0|||
33240297|NCT00062868|100779980|FG020|Dose Level 3|Death|0|||
33240298|NCT00062868|100779960|FG000|Dose Level 3|Lost to Follow-up|0|||
33240299|NCT00062868|100779961|FG001|Dose Level 3|Lost to Follow-up|0|||
33240300|NCT00062868|100779962|FG002|Dose Level 3|Lost to Follow-up|0|||
33141903|NCT01820260|100434704|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33141904|NCT01820260|100434705|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33141905|NCT01820260|100434706|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33141906|NCT01820260|100434707|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
33370579|NCT00365716|101243471|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
33370580|NCT00365716|101243472|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
33370581|NCT00365716|101243466|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
33370582|NCT00365716|101243467|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
33370583|NCT00365716|101243468|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
33580309|NCT02336815|102013339|FG000|Overall Study|Disease Progression|45|||
33580310|NCT02336815|102013340|FG001|Overall Study|Disease Progression|70|||
33580311|NCT02336815|102013339|FG000|Overall Study|Adverse Event|18|||
33580312|NCT02336815|102013340|FG001|Overall Study|Adverse Event|39|||
33580313|NCT02336815|102013339|FG000|Overall Study|Physician Decision|11|||
33580314|NCT02336815|102013340|FG001|Overall Study|Physician Decision|4|||
33580315|NCT02336815|102013339|FG000|Overall Study|Withdrawal by Subject|3|||
33580316|NCT02336815|102013340|FG001|Overall Study|Withdrawal by Subject|2|||
33580317|NCT02336815|102013339|FG000|Overall Study|Lost to Follow-up|1|||
33580318|NCT02336815|102013340|FG001|Overall Study|Lost to Follow-up|3|||
33580319|NCT02336815|102013339|FG000|Overall Study|Other|1|||
33580320|NCT02336815|102013340|FG001|Overall Study|Other|5|||
33580321|NCT01847092|102013343|FG000|Overall Study|Adverse Event|12|||
33580322|NCT01847092|102013344|FG001|Overall Study|Adverse Event|3|||
33580323|NCT01847092|102013343|FG000|Overall Study|Withdrawal by Subject|5|||
33580324|NCT01847092|102013344|FG001|Overall Study|Withdrawal by Subject|5|||
33580325|NCT01847092|102013343|FG000|Overall Study|Protocol Specified|8|||
33580326|NCT01847092|102013344|FG001|Overall Study|Protocol Specified|0|||
33580327|NCT01847092|102013343|FG000|Overall Study|Physician Decision|1|||
33580328|NCT01847092|102013344|FG001|Overall Study|Physician Decision|1|||
33580329|NCT01847092|102013343|FG000|Overall Study|Protocol Violation|0|||
33580330|NCT01847092|102013344|FG001|Overall Study|Protocol Violation|2|||
33580331|NCT02897115|102013347|FG000|Overall Study|Early termination of study by sponsor|11|||
33580332|NCT02897115|102013348|FG001|Overall Study|Early termination of study by sponsor|8|||
33580333|NCT01118780|102013350|FG000|Overall Study|Adverse Event|15|||
33580334|NCT01118780|102013351|FG001|Overall Study|Adverse Event|15|||
33580335|NCT01118780|102013350|FG000|Overall Study|Death|1|||
33580336|NCT01118780|102013351|FG001|Overall Study|Death|0|||
33580337|NCT01118780|102013350|FG000|Overall Study|Lack of Efficacy|2|||
33580338|NCT01118780|102013351|FG001|Overall Study|Lack of Efficacy|6|||
33580339|NCT01118780|102013350|FG000|Overall Study|Physician Decision|2|||
33580340|NCT01118780|102013351|FG001|Overall Study|Physician Decision|0|||
33580341|NCT01118780|102013350|FG000|Overall Study|Protocol Violation|3|||
33580342|NCT01118780|102013351|FG001|Overall Study|Protocol Violation|6|||
33580343|NCT01118780|102013350|FG000|Overall Study|Withdrawal by Subject|13|||
33580344|NCT01118780|102013351|FG001|Overall Study|Withdrawal by Subject|8|||
33580345|NCT02973997|102013352|FG000|Overall Study|Withdrawal by Subject|4|||
33580346|NCT02973997|102013353|FG001|Overall Study|Withdrawal by Subject|0|||
33580347|NCT02973997|102013352|FG000|Overall Study|Adverse Event|4|||
33580348|NCT02973997|102013353|FG001|Overall Study|Adverse Event|1|||
33580349|NCT02973997|102013352|FG000|Overall Study|Disease Progression|11|||
33580350|NCT02973997|102013353|FG001|Overall Study|Disease Progression|20|||
33580351|NCT02973997|102013352|FG000|Overall Study|Alternative Therapy|3|||
33580352|NCT02973997|102013353|FG001|Overall Study|Alternative Therapy|0|||
33580353|NCT02973997|102013352|FG000|Overall Study|Other complicating disease|0|||
33580354|NCT02973997|102013353|FG001|Overall Study|Other complicating disease|1|||
33640787|NCT00606593|102236474|FG000|Overall Study|Adverse Event|0|||
33370584|NCT00365716|101243469|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
33370585|NCT00365716|101243470|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
33370586|NCT00365716|101243471|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
33370587|NCT00365716|101243472|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
33421095|NCT03087773|101431707|FG001|Overall Study|Lost to Follow-up|8|||
33580355|NCT02973997|102013352|FG000|Overall Study|Death|0|||
33580356|NCT02973997|102013353|FG001|Overall Study|Death|1|||
33580357|NCT01890265|102013357|FG000|Overall Study|Other (Unspecified reason)|0|||
33580358|NCT01890265|102013358|FG001|Overall Study|Other (Unspecified reason)|1|||
33141907|NCT00130442|100434708|FG000|Overall Study|Withdrawal by Subject|0|||
33370588|NCT00365716|101243466|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
33421096|NCT02561000|101431708|FG000|Overall Study|Withdrawal by Subject|2|||
33580359|NCT01890265|102013359|FG002|Overall Study|Other (Unspecified reason)|0|||
33580360|NCT01890265|102013360|FG003|Overall Study|Other (Unspecified reason)|0|||
33580361|NCT01890265|102013361|FG004|Overall Study|Other (Unspecified reason)|0|||
33580362|NCT01890265|102013362|FG005|Overall Study|Other (Unspecified reason)|0|||
33580363|NCT01890265|102013357|FG000|Overall Study|Progressive disease|6|||
33580364|NCT01890265|102013358|FG001|Overall Study|Progressive disease|6|||
33580365|NCT01890265|102013359|FG002|Overall Study|Progressive disease|0|||
33580366|NCT01890265|102013360|FG003|Overall Study|Progressive disease|0|||
33141908|NCT00130442|100434709|FG001|Overall Study|Withdrawal by Subject|1|||
33370589|NCT00365716|101243467|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
33370590|NCT00365716|101243468|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
33141909|NCT00130442|100434708|FG000|Overall Study|did not meet criteria|1|||
33141910|NCT00130442|100434709|FG001|Overall Study|did not meet criteria|1|||
33141911|NCT01146860|100434711|FG000|Overall Study|Withdrawal by Subject|0|||
33141912|NCT01146860|100434712|FG001|Overall Study|Withdrawal by Subject|1|||
33141913|NCT00555425|100434713|FG000|Overall Study|Missed Medication > 1 wk|34|||
33141914|NCT00555425|100434714|FG001|Overall Study|Missed Medication > 1 wk|15|||
33141915|NCT00555425|100434713|FG000|Overall Study|Missed 3 physician management visits|1|||
33141916|NCT00555425|100434714|FG001|Overall Study|Missed 3 physician management visits|0|||
33141917|NCT00555425|100434713|FG000|Overall Study|Met criteria for protective transfer|16|||
33141918|NCT00555425|100434714|FG001|Overall Study|Met criteria for protective transfer|3|||
33141919|NCT00555425|100434713|FG000|Overall Study|Became pregnant and transferred care|0|||
33141920|NCT00555425|100434714|FG001|Overall Study|Became pregnant and transferred care|1|||
33141921|NCT02068768|100434717|FG000|Overall Study|Lost to Follow-up|5|||
33141922|NCT02068768|100434717|FG000|Overall Study|Early Termination by Sponsor|2|||
33141923|NCT01155479|100434720|FG000|Part I|Adverse Event|13|||
33141924|NCT01155479|100434721|FG001|Part I|Adverse Event|8|||
33141925|NCT01155479|100434722|FG002|Part I|Adverse Event|18|||
33141926|NCT01155479|100434723|FG003|Part I|Adverse Event|7|||
33141927|NCT01155479|100434724|FG004|Part I|Adverse Event|6|||
33141928|NCT01155479|100434720|FG000|Part I|Administrative|2|||
33141929|NCT01155479|100434721|FG001|Part I|Administrative|2|||
33141930|NCT01155479|100434722|FG002|Part I|Administrative|2|||
33141931|NCT01155479|100434723|FG003|Part I|Administrative|0|||
33141932|NCT01155479|100434724|FG004|Part I|Administrative|0|||
33141933|NCT01155479|100434720|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
33141934|NCT01155479|100434721|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
33141935|NCT01155479|100434722|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
33370591|NCT00365716|101243469|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
33370592|NCT00365716|101243470|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
33370593|NCT00365716|101243471|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
33370594|NCT00365716|101243472|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
33370595|NCT00365716|101243466|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
33370596|NCT00365716|101243467|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
33370597|NCT00365716|101243468|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
33370598|NCT00365716|101243469|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
33370599|NCT00365716|101243470|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
33370600|NCT00365716|101243471|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
33370601|NCT00365716|101243472|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
33370602|NCT00365716|101243466|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
33370603|NCT00365716|101243467|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
33370604|NCT00365716|101243468|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
33370605|NCT00365716|101243469|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
33370606|NCT00365716|101243470|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
33370607|NCT00365716|101243471|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
33370608|NCT00365716|101243472|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
33370609|NCT00365716|101243466|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
33370610|NCT00365716|101243467|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
33370611|NCT00365716|101243468|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
33370612|NCT00365716|101243469|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
33370613|NCT00365716|101243470|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
33370614|NCT00365716|101243471|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
33370615|NCT00365716|101243472|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
33370616|NCT00365716|101243466|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
33370617|NCT00365716|101243467|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
33370618|NCT00365716|101243468|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
33580367|NCT01890265|102013361|FG004|Overall Study|Progressive disease|0|||
33580368|NCT01890265|102013362|FG005|Overall Study|Progressive disease|0|||
33580369|NCT01890265|102013357|FG000|Overall Study|Adverse Event|2|||
33580370|NCT01890265|102013358|FG001|Overall Study|Adverse Event|1|||
33580371|NCT01890265|102013359|FG002|Overall Study|Adverse Event|0|||
33580372|NCT01890265|102013360|FG003|Overall Study|Adverse Event|0|||
33141936|NCT01155479|100434723|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
33141937|NCT01155479|100434724|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
33141938|NCT01155479|100434720|FG000|Part I|Withdrawal by Subject|11|||
33141939|NCT01155479|100434721|FG001|Part I|Withdrawal by Subject|13|||
33141940|NCT01155479|100434722|FG002|Part I|Withdrawal by Subject|8|||
33141941|NCT01155479|100434723|FG003|Part I|Withdrawal by Subject|8|||
33141942|NCT01155479|100434724|FG004|Part I|Withdrawal by Subject|9|||
33141943|NCT01155479|100434720|FG000|Part I|Lost to Follow-up|0|||
33141944|NCT01155479|100434721|FG001|Part I|Lost to Follow-up|0|||
33141945|NCT01155479|100434722|FG002|Part I|Lost to Follow-up|1|||
33141946|NCT01155479|100434723|FG003|Part I|Lost to Follow-up|1|||
33141947|NCT01155479|100434724|FG004|Part I|Lost to Follow-up|0|||
33141948|NCT01155479|100434720|FG000|Part I|Treatment Failure|3|||
33141949|NCT01155479|100434721|FG001|Part I|Treatment Failure|0|||
33141950|NCT01155479|100434722|FG002|Part I|Treatment Failure|3|||
33141951|NCT01155479|100434723|FG003|Part I|Treatment Failure|1|||
33640788|NCT00606593|102236475|FG001|Overall Study|Adverse Event|0|||
33640789|NCT00606593|102236476|FG002|Overall Study|Adverse Event|0|||
33640790|NCT00606593|102236477|FG003|Overall Study|Adverse Event|1|||
33640791|NCT00606593|102236478|FG004|Overall Study|Adverse Event|1|||
33640792|NCT00606593|102236479|FG005|Overall Study|Adverse Event|0|||
33640793|NCT00606593|102236480|FG006|Overall Study|Adverse Event|1|||
33640794|NCT00606593|102236481|FG007|Overall Study|Adverse Event|2|||
33640795|NCT00606593|102236482|FG008|Overall Study|Adverse Event|1|||
33640796|NCT00606593|102236483|FG009|Overall Study|Adverse Event|0|||
33640797|NCT00606593|102236474|FG000|Overall Study|Withdrawal of consent|1|||
33640798|NCT00606593|102236475|FG001|Overall Study|Withdrawal of consent|0|||
33640799|NCT00606593|102236476|FG002|Overall Study|Withdrawal of consent|1|||
33640800|NCT00606593|102236477|FG003|Overall Study|Withdrawal of consent|0|||
33640801|NCT00606593|102236478|FG004|Overall Study|Withdrawal of consent|0|||
33640802|NCT00606593|102236479|FG005|Overall Study|Withdrawal of consent|0|||
33640803|NCT00606593|102236480|FG006|Overall Study|Withdrawal of consent|0|||
33640804|NCT00606593|102236481|FG007|Overall Study|Withdrawal of consent|0|||
33640805|NCT00606593|102236482|FG008|Overall Study|Withdrawal of consent|0|||
33640806|NCT00606593|102236483|FG009|Overall Study|Withdrawal of consent|0|||
33141952|NCT01155479|100434724|FG004|Part I|Treatment Failure|2|||
33141953|NCT01155479|100434720|FG000|Part I|Did Not Receive Treatment|4|||
33141954|NCT01155479|100434721|FG001|Part I|Did Not Receive Treatment|2|||
33421097|NCT02561000|101431709|FG001|Overall Study|Withdrawal by Subject|3|||
33421098|NCT02561000|101431710|FG002|Overall Study|Withdrawal by Subject|0|||
33421099|NCT02561000|101431708|FG000|Overall Study|Adverse Event|0|||
33580373|NCT01890265|102013361|FG004|Overall Study|Adverse Event|0|||
33580374|NCT01890265|102013362|FG005|Overall Study|Adverse Event|0|||
33580375|NCT01890265|102013357|FG000|Overall Study|Death|2|||
33580376|NCT01890265|102013358|FG001|Overall Study|Death|3|||
33580377|NCT01890265|102013359|FG002|Overall Study|Death|1|||
33580378|NCT01890265|102013360|FG003|Overall Study|Death|0|||
33580379|NCT01890265|102013361|FG004|Overall Study|Death|0|||
33580380|NCT01890265|102013362|FG005|Overall Study|Death|0|||
33580381|NCT01890265|102013357|FG000|Overall Study|Withdrawal by Subject|0|||
33580382|NCT01890265|102013358|FG001|Overall Study|Withdrawal by Subject|2|||
33580383|NCT01890265|102013359|FG002|Overall Study|Withdrawal by Subject|3|||
33580384|NCT01890265|102013360|FG003|Overall Study|Withdrawal by Subject|0|||
33580385|NCT01890265|102013361|FG004|Overall Study|Withdrawal by Subject|2|||
33580386|NCT01890265|102013362|FG005|Overall Study|Withdrawal by Subject|0|||
33580387|NCT01042158|102013363|FG000|Overall Study|Physician Decision|1|||
33580388|NCT03135431|102013364|FG000|Overall Study|Study Surgeon not available|2|||
33580389|NCT03135431|102013365|FG001|Overall Study|Study Surgeon not available|0|||
33580390|NCT00972517|102016818|FG000|Overall Study|Adverse Event|0|||
33580391|NCT00972517|102016819|FG001|Overall Study|Adverse Event|0|||
33580392|NCT00972517|102016820|FG002|Overall Study|Adverse Event|0|||
33580393|NCT00972517|102016821|FG003|Overall Study|Adverse Event|1|||
33580394|NCT00972517|102016822|FG004|Overall Study|Adverse Event|0|||
33580395|NCT00972517|102016823|FG005|Overall Study|Adverse Event|0|||
33580396|NCT00972517|102016818|FG000|Overall Study|Withdrawal by Subject|0|||
33580397|NCT00972517|102016819|FG001|Overall Study|Withdrawal by Subject|1|||
33580398|NCT00972517|102016820|FG002|Overall Study|Withdrawal by Subject|0|||
33580399|NCT00972517|102016821|FG003|Overall Study|Withdrawal by Subject|2|||
33580400|NCT00972517|102016822|FG004|Overall Study|Withdrawal by Subject|1|||
33580401|NCT00972517|102016823|FG005|Overall Study|Withdrawal by Subject|0|||
33640807|NCT00606593|102236474|FG000|Overall Study|Administrative/Other|0|||
33580402|NCT00628446|102016855|FG000|Overall Study|Lost to Follow-up|3|||
33141955|NCT01155479|100434722|FG002|Part I|Did Not Receive Treatment|2|||
33141956|NCT01155479|100434723|FG003|Part I|Did Not Receive Treatment|6|||
33141957|NCT01155479|100434724|FG004|Part I|Did Not Receive Treatment|1|||
33580403|NCT00628446|102016855|FG000|Overall Study|Withdrawal by Subject|1|||
33580404|NCT00628446|102016855|FG000|Overall Study|Protocol Violation|3|||
33580405|NCT03745638|102016862|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
33141958|NCT01155479|100434720|FG000|Part I|Non-Compliance with Protocol|2|||
33141959|NCT01155479|100434721|FG001|Part I|Non-Compliance with Protocol|1|||
33421100|NCT02561000|101431709|FG001|Overall Study|Adverse Event|1|||
33580406|NCT03745638|102016863|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
33580407|NCT03745638|102016864|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
33580408|NCT03745638|102016865|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33640808|NCT00606593|102236475|FG001|Overall Study|Administrative/Other|0|||
33640809|NCT00606593|102236476|FG002|Overall Study|Administrative/Other|1|||
33640810|NCT00606593|102236477|FG003|Overall Study|Administrative/Other|0|||
33141960|NCT01155479|100434722|FG002|Part I|Non-Compliance with Protocol|3|||
33141961|NCT01155479|100434723|FG003|Part I|Non-Compliance with Protocol|3|||
33141962|NCT01155479|100434724|FG004|Part I|Non-Compliance with Protocol|2|||
33141963|NCT01155479|100434720|FG000|Part II|Adverse Event|7|||
33141964|NCT01155479|100434721|FG001|Part II|Adverse Event|6|||
33141965|NCT01155479|100434722|FG002|Part II|Adverse Event|8|||
33141966|NCT01155479|100434723|FG003|Part II|Adverse Event|3|||
33141967|NCT01155479|100434724|FG004|Part II|Adverse Event|4|||
33141968|NCT01155479|100434720|FG000|Part II|Administrative|43|||
33141969|NCT01155479|100434721|FG001|Part II|Administrative|49|||
33141970|NCT01155479|100434722|FG002|Part II|Administrative|36|||
33141971|NCT01155479|100434723|FG003|Part II|Administrative|38|||
33141972|NCT01155479|100434724|FG004|Part II|Administrative|46|||
33141973|NCT01155479|100434720|FG000|Part II|Withdrawal by Subject|8|||
33141974|NCT01155479|100434721|FG001|Part II|Withdrawal by Subject|4|||
33141975|NCT01155479|100434722|FG002|Part II|Withdrawal by Subject|12|||
33141976|NCT01155479|100434723|FG003|Part II|Withdrawal by Subject|7|||
33141977|NCT01155479|100434724|FG004|Part II|Withdrawal by Subject|3|||
33141978|NCT01155479|100434720|FG000|Part II|Lost to Follow-up|1|||
33141979|NCT01155479|100434721|FG001|Part II|Lost to Follow-up|0|||
33141980|NCT01155479|100434722|FG002|Part II|Lost to Follow-up|0|||
33141981|NCT01155479|100434723|FG003|Part II|Lost to Follow-up|0|||
33141982|NCT01155479|100434724|FG004|Part II|Lost to Follow-up|1|||
33141983|NCT01155479|100434720|FG000|Part II|Treatment Failure|0|||
33141984|NCT01155479|100434721|FG001|Part II|Treatment Failure|1|||
33141985|NCT01155479|100434722|FG002|Part II|Treatment Failure|2|||
33141986|NCT01155479|100434723|FG003|Part II|Treatment Failure|0|||
33141987|NCT01155479|100434724|FG004|Part II|Treatment Failure|1|||
33141988|NCT01155479|100434720|FG000|Part II|Non-Compliance with Protocol|0|||
33141989|NCT01155479|100434721|FG001|Part II|Non-Compliance with Protocol|1|||
33141990|NCT01155479|100434722|FG002|Part II|Non-Compliance with Protocol|0|||
33141991|NCT01155479|100434723|FG003|Part II|Non-Compliance with Protocol|2|||
33141992|NCT01155479|100434724|FG004|Part II|Non-Compliance with Protocol|0|||
33141993|NCT01119937|100434727|FG000|Overall Study|Adverse Event|11|||
33141994|NCT01119937|100434728|FG001|Overall Study|Adverse Event|5|||
33141995|NCT01119937|100434727|FG000|Overall Study|Protocol deviation|3|||
33141996|NCT01119937|100434728|FG001|Overall Study|Protocol deviation|1|||
33141997|NCT01119937|100434727|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
33141998|NCT01119937|100434728|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33141999|NCT01119937|100434727|FG000|Overall Study|Withdrawal by Subject|2|||
33142000|NCT01119937|100434728|FG001|Overall Study|Withdrawal by Subject|1|||
33142001|NCT00409175|100434729|FG000|Overall Study|Adverse Event|4|||
33142002|NCT00409175|100434730|FG001|Overall Study|Adverse Event|3|||
33240301|NCT00062868|100779963|FG003|Dose Level 3|Lost to Follow-up|0|||
33240302|NCT00062868|100779964|FG004|Dose Level 3|Lost to Follow-up|0|||
33240303|NCT00062868|100779965|FG005|Dose Level 3|Lost to Follow-up|0|||
33240304|NCT00062868|100779966|FG006|Dose Level 3|Lost to Follow-up|0|||
33240305|NCT00062868|100779967|FG007|Dose Level 3|Lost to Follow-up|0|||
33240306|NCT00062868|100779968|FG008|Dose Level 3|Lost to Follow-up|0|||
33240307|NCT00062868|100779969|FG009|Dose Level 3|Lost to Follow-up|0|||
33240308|NCT00062868|100779970|FG010|Dose Level 3|Lost to Follow-up|0|||
33240309|NCT00062868|100779971|FG011|Dose Level 3|Lost to Follow-up|0|||
33240310|NCT00062868|100779972|FG012|Dose Level 3|Lost to Follow-up|0|||
33240311|NCT00062868|100779973|FG013|Dose Level 3|Lost to Follow-up|0|||
33240312|NCT00062868|100779974|FG014|Dose Level 3|Lost to Follow-up|1|||
33240313|NCT00062868|100779975|FG015|Dose Level 3|Lost to Follow-up|0|||
33240314|NCT00062868|100779976|FG016|Dose Level 3|Lost to Follow-up|0|||
33240315|NCT00062868|100779977|FG017|Dose Level 3|Lost to Follow-up|0|||
33240316|NCT00062868|100779978|FG018|Dose Level 3|Lost to Follow-up|0|||
33240317|NCT00062868|100779979|FG019|Dose Level 3|Lost to Follow-up|0|||
33240318|NCT00062868|100779980|FG020|Dose Level 3|Lost to Follow-up|0|||
33240319|NCT00062868|100779960|FG000|Dose Level 3|Withdrew|0|||
33240320|NCT00062868|100779961|FG001|Dose Level 3|Withdrew|0|||
33240321|NCT00062868|100779962|FG002|Dose Level 3|Withdrew|2|||
33240322|NCT00062868|100779963|FG003|Dose Level 3|Withdrew|0|||
33240323|NCT00062868|100779964|FG004|Dose Level 3|Withdrew|0|||
33142003|NCT00409175|100434729|FG000|Overall Study|Withdrawal by Subject|1|||
33142004|NCT00409175|100434730|FG001|Overall Study|Withdrawal by Subject|2|||
33142005|NCT00409175|100434729|FG000|Overall Study|Negative genotype|0|||
33142006|NCT00409175|100434730|FG001|Overall Study|Negative genotype|1|||
33142007|NCT00409175|100434729|FG000|Overall Study|Liver transplantation|13|||
33142008|NCT00409175|100434730|FG001|Overall Study|Liver transplantation|13|||
33142009|NCT00924170|100434731|FG000|Overall Study|Refused further treatment|0|||
33142010|NCT00924170|100434732|FG001|Overall Study|Refused further treatment|1|||
33142011|NCT00924170|100434731|FG000|Overall Study|Physician Decision|0|||
33142012|NCT00924170|100434732|FG001|Overall Study|Physician Decision|1|||
33142013|NCT00924170|100434731|FG000|Overall Study|Progressive disease|3|||
33142014|NCT00924170|100434732|FG001|Overall Study|Progressive disease|6|||
33240324|NCT00062868|100779965|FG005|Dose Level 3|Withdrew|0|||
33240325|NCT00062868|100779966|FG006|Dose Level 3|Withdrew|0|||
33240326|NCT00062868|100779967|FG007|Dose Level 3|Withdrew|0|||
33240327|NCT00062868|100779968|FG008|Dose Level 3|Withdrew|0|||
33240328|NCT00062868|100779969|FG009|Dose Level 3|Withdrew|0|||
33240329|NCT00062868|100779970|FG010|Dose Level 3|Withdrew|0|||
33240330|NCT00062868|100779971|FG011|Dose Level 3|Withdrew|0|||
33240331|NCT00062868|100779972|FG012|Dose Level 3|Withdrew|0|||
33240332|NCT00062868|100779973|FG013|Dose Level 3|Withdrew|0|||
33240333|NCT00062868|100779974|FG014|Dose Level 3|Withdrew|0|||
33240334|NCT00062868|100779975|FG015|Dose Level 3|Withdrew|0|||
33240335|NCT00062868|100779976|FG016|Dose Level 3|Withdrew|0|||
33240336|NCT00062868|100779977|FG017|Dose Level 3|Withdrew|0|||
33240337|NCT00062868|100779978|FG018|Dose Level 3|Withdrew|0|||
33240338|NCT00062868|100779979|FG019|Dose Level 3|Withdrew|0|||
33240339|NCT00062868|100779980|FG020|Dose Level 3|Withdrew|0|||
33240340|NCT02300311|100779981|FG000|Overall Study|Other than the reason specified|1|||
33240341|NCT02300311|100779982|FG001|Overall Study|Other than the reason specified|0|||
33240342|NCT02300311|100779981|FG000|Overall Study|Refused to continue taking medication|18|||
33240343|NCT02300311|100779982|FG001|Overall Study|Refused to continue taking medication|0|||
33240344|NCT01627340|100779983|FG000|Overall Study|Adverse Event|1|||
33240345|NCT01627340|100779984|FG001|Overall Study|Adverse Event|0|||
33240346|NCT01627340|100779983|FG000|Overall Study|Lost to Follow-up|8|||
33240347|NCT01627340|100779984|FG001|Overall Study|Lost to Follow-up|4|||
33240348|NCT01627340|100779983|FG000|Overall Study|Pregnancy|1|||
33240349|NCT01627340|100779984|FG001|Overall Study|Pregnancy|0|||
33240350|NCT01627340|100779983|FG000|Overall Study|Withdrawal by Subject|2|||
33240351|NCT01627340|100779984|FG001|Overall Study|Withdrawal by Subject|0|||
33240352|NCT03633903|100779985|FG000|Overall Study|Withdrawal by Subject|1|||
33240353|NCT03633903|100779986|FG001|Overall Study|Withdrawal by Subject|2|||
33240354|NCT03633903|100779985|FG000|Overall Study|Lost to Follow-up|5|||
33240355|NCT03633903|100779986|FG001|Overall Study|Lost to Follow-up|5|||
33240356|NCT01712685|100779987|FG000|Overall Study|pt declined to participate before trmt|1|||
33240357|NCT03699124|100779988|FG000|Overall Study|Adverse Event|6|||
33240358|NCT03699124|100779989|FG001|Overall Study|Adverse Event|5|||
33240359|NCT03699124|100779990|FG002|Overall Study|Adverse Event|2|||
33240360|NCT03699124|100779988|FG000|Overall Study|Death|0|||
33240361|NCT03699124|100779989|FG001|Overall Study|Death|2|||
33370619|NCT00365716|101243469|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
33370620|NCT00365716|101243470|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
33370621|NCT00365716|101243471|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
33370622|NCT00365716|101243472|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
33370623|NCT00365716|101243466|FG000|Extension 1|Lost to Follow-up|0|||
33370624|NCT00365716|101243467|FG001|Extension 1|Lost to Follow-up|0|||
33370625|NCT00365716|101243468|FG002|Extension 1|Lost to Follow-up|0|||
33370626|NCT00365716|101243469|FG003|Extension 1|Lost to Follow-up|0|||
33370627|NCT00365716|101243470|FG004|Extension 1|Lost to Follow-up|0|||
33370628|NCT00365716|101243471|FG005|Extension 1|Lost to Follow-up|1|||
33370629|NCT00365716|101243472|FG006|Extension 1|Lost to Follow-up|0|||
33370630|NCT00365716|101243466|FG000|Extension 1|Other|0|||
33370631|NCT00365716|101243467|FG001|Extension 1|Other|0|||
33370632|NCT00365716|101243468|FG002|Extension 1|Other|0|||
33370633|NCT00365716|101243469|FG003|Extension 1|Other|0|||
33640811|NCT00606593|102236478|FG004|Overall Study|Administrative/Other|0|||
33640812|NCT00606593|102236479|FG005|Overall Study|Administrative/Other|0|||
33640813|NCT00606593|102236480|FG006|Overall Study|Administrative/Other|0|||
33142015|NCT00924170|100434731|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
33142016|NCT00924170|100434732|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
33240362|NCT03699124|100779990|FG002|Overall Study|Death|0|||
33240363|NCT03699124|100779988|FG000|Overall Study|Lost to Follow-up|20|||
33240364|NCT03699124|100779989|FG001|Overall Study|Lost to Follow-up|16|||
33240365|NCT03699124|100779990|FG002|Overall Study|Lost to Follow-up|15|||
33370634|NCT00365716|101243470|FG004|Extension 1|Other|0|||
33580409|NCT03745638|102016866|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33580410|NCT03745638|102016867|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33580411|NCT03745638|102016868|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33580412|NCT03745638|102016862|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
33580413|NCT03745638|102016863|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33580414|NCT03745638|102016864|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33580415|NCT03745638|102016865|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33580416|NCT03745638|102016866|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33580417|NCT03745638|102016867|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33240366|NCT03699124|100779988|FG000|Overall Study|Protocol Violation|1|||
33370635|NCT00365716|101243471|FG005|Extension 1|Other|9|||
33370636|NCT00365716|101243472|FG006|Extension 1|Other|0|||
33580418|NCT03745638|102016868|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
33240367|NCT03699124|100779989|FG001|Overall Study|Protocol Violation|0|||
33240368|NCT03699124|100779990|FG002|Overall Study|Protocol Violation|0|||
33370637|NCT00365716|101243466|FG000|Extension 1|Moved|0|||
33240369|NCT03699124|100779988|FG000|Overall Study|Withdrawal by Subject|13|||
33240370|NCT03699124|100779989|FG001|Overall Study|Withdrawal by Subject|14|||
33370638|NCT00365716|101243467|FG001|Extension 1|Moved|0|||
33142017|NCT00924170|100434731|FG000|Overall Study|Death|1|||
33142018|NCT00924170|100434732|FG001|Overall Study|Death|0|||
33142019|NCT01879579|100434733|FG000|Overall Study|Phone incompatible with texting platform|3|||
33142020|NCT01879579|100434734|FG001|Overall Study|Phone incompatible with texting platform|0|||
33142021|NCT01879579|100434733|FG000|Overall Study|Did not enroll in texting platform|1|||
33142022|NCT01879579|100434734|FG001|Overall Study|Did not enroll in texting platform|0|||
33142023|NCT01879579|100434733|FG000|Overall Study|Did not initiate insulin treatment|1|||
33142024|NCT01879579|100434734|FG001|Overall Study|Did not initiate insulin treatment|0|||
33142025|NCT01879579|100434733|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
33142026|NCT01879579|100434734|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
33142027|NCT01879579|100434733|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
33142028|NCT01879579|100434734|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
33142029|NCT00718237|100434735|FG000|Overall Study|Adverse Event|1|||
33142030|NCT00718237|100434736|FG001|Overall Study|Adverse Event|3|||
33142031|NCT00718237|100434735|FG000|Overall Study|Lost to Follow-up|2|||
33142032|NCT00718237|100434736|FG001|Overall Study|Lost to Follow-up|2|||
33142033|NCT00718237|100434735|FG000|Overall Study|Physician Decision|1|||
33142034|NCT00718237|100434736|FG001|Overall Study|Physician Decision|0|||
33142035|NCT00718237|100434735|FG000|Overall Study|Withdrawal by Subject|9|||
33142036|NCT00718237|100434736|FG001|Overall Study|Withdrawal by Subject|10|||
33142037|NCT00635024|100434737|FG000|Overall Study|Adverse Event|1|||
33142038|NCT00459056|100434738|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
33142039|NCT00459056|100434739|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
33142040|NCT00969280|100434741|FG000|Overall Study|Protocol Violation|2|||
33142041|NCT00969280|100434742|FG001|Overall Study|Protocol Violation|1|||
33142042|NCT00969280|100434741|FG000|Overall Study|Withdrawal by Subject|0|||
33142043|NCT00969280|100434742|FG001|Overall Study|Withdrawal by Subject|1|||
33142044|NCT00969280|100434741|FG000|Overall Study|infection of influenza A(H1N1)|0|||
33142045|NCT00969280|100434742|FG001|Overall Study|infection of influenza A(H1N1)|1|||
33142046|NCT00584740|100434743|FG000|Overall Study|Adverse Event|1|||
33142047|NCT00584740|100434744|FG001|Overall Study|Adverse Event|1|||
33142048|NCT00584740|100434743|FG000|Overall Study|Lack of Efficacy|8|||
33142049|NCT00584740|100434744|FG001|Overall Study|Lack of Efficacy|2|||
33142050|NCT00584740|100434743|FG000|Overall Study|Withdrawal by Subject|3|||
33142051|NCT00584740|100434744|FG001|Overall Study|Withdrawal by Subject|2|||
33142052|NCT00584740|100434743|FG000|Overall Study|Lost to Follow-up|0|||
33142053|NCT00584740|100434744|FG001|Overall Study|Lost to Follow-up|1|||
33142054|NCT00870233|100434745|FG000|Overall Study|Withdrawal by Subject|18|||
33142055|NCT00870233|100434745|FG000|Overall Study|Did not undergo laparotomy|3|||
33142056|NCT00870233|100434745|FG000|Overall Study|Incompatible internet browser|2|||
33142057|NCT00870233|100434745|FG000|Overall Study|Death|1|||
33580419|NCT03745638|102016862|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
33580420|NCT03745638|102016863|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
33580421|NCT03745638|102016864|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
33580422|NCT03745638|102016865|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33580423|NCT03745638|102016866|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33580424|NCT03745638|102016867|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33640814|NCT00606593|102236481|FG007|Overall Study|Administrative/Other|0|||
33640815|NCT00606593|102236482|FG008|Overall Study|Administrative/Other|0|||
33640816|NCT00606593|102236483|FG009|Overall Study|Administrative/Other|0|||
33142058|NCT00256282|100434746|FG000|Overall Study|Disease progression, relapse during acti|12|||
33142059|NCT00256282|100434746|FG000|Overall Study|Adverse Event|3|||
33142060|NCT00256282|100434746|FG000|Overall Study|Physician Decision|1|||
33142061|NCT01246466|100434747|FG000|Overall Study|Death|1|||
33142062|NCT01246466|100434747|FG000|Overall Study|Withdrawal by Subject|1|||
33580425|NCT03745638|102016868|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33580426|NCT03745638|102016862|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
33580427|NCT03745638|102016863|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
33580428|NCT03745638|102016864|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33142063|NCT04140227|100434754|FG000|Overall Study|Withdrawal by Subject|26|||
33142064|NCT04140227|100434754|FG000|Overall Study|Lost to Follow-up|8|||
33142065|NCT04140227|100434754|FG000|Overall Study|Adverse Event|8|||
33142066|NCT04140227|100434754|FG000|Overall Study|Death|1|||
33421101|NCT02561000|101431710|FG002|Overall Study|Adverse Event|0|||
33142067|NCT04140227|100434754|FG000|Overall Study|Other|3|||
33640817|NCT03527732|102236484|FG000|Overall Study|Lost to Follow-up|21|||
33142068|NCT04140227|100434754|FG000|Overall Study|Protocol Violation|2|||
33142069|NCT01659554|100434763|FG000|Overall Study|Study Termination|4|||
33142070|NCT02320903|100434764|FG000|Overall Study|Withdrawal by Subject|0|||
33142071|NCT02320903|100434765|FG001|Overall Study|Withdrawal by Subject|9|||
33142072|NCT02320903|100434766|FG002|Overall Study|Withdrawal by Subject|9|||
33142073|NCT02320903|100434764|FG000|Overall Study|Exited therapy; no longer eligible|8|||
33142074|NCT02320903|100434765|FG001|Overall Study|Exited therapy; no longer eligible|2|||
33142075|NCT02320903|100434766|FG002|Overall Study|Exited therapy; no longer eligible|2|||
33142076|NCT02320903|100434764|FG000|Overall Study|Lost to Follow-up|0|||
33142077|NCT02320903|100434765|FG001|Overall Study|Lost to Follow-up|5|||
33580429|NCT03745638|102016865|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33580430|NCT03745638|102016866|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33580431|NCT03745638|102016867|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33580432|NCT03745638|102016868|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33580433|NCT03745638|102016862|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
33580434|NCT03745638|102016863|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
33580435|NCT03745638|102016864|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
33580436|NCT03745638|102016865|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
33580437|NCT03745638|102016866|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
33580438|NCT03745638|102016867|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
33580439|NCT03745638|102016868|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
33580440|NCT03745638|102016862|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33142078|NCT02320903|100434766|FG002|Overall Study|Lost to Follow-up|5|||
33142079|NCT00570232|100434767|FG000|Overall Study|Adverse Event|10|||
33142080|NCT00570232|100434767|FG000|Overall Study|discontinued due to medical condition|3|||
33142081|NCT00570232|100434767|FG000|Overall Study|discontinued due to recurrence|8|||
33142082|NCT00570232|100434767|FG000|Overall Study|discontinued due to noncompliance|2|||
33142083|NCT02230527|100434768|FG000|Overall Study|Withdrawal by Subject|1|||
33142084|NCT02230527|100434769|FG001|Overall Study|Withdrawal by Subject|1|||
33142085|NCT02230527|100434768|FG000|Overall Study|Death|1|||
33142086|NCT02230527|100434769|FG001|Overall Study|Death|0|||
33142087|NCT02230527|100434768|FG000|Overall Study|Lost to Follow-up|2|||
33142088|NCT02230527|100434769|FG001|Overall Study|Lost to Follow-up|1|||
33142089|NCT02230527|100434768|FG000|Overall Study|Other|1|||
33142090|NCT02230527|100434769|FG001|Overall Study|Other|0|||
33142091|NCT03390101|100434772|FG000|Weeks 0-12|Withdrawal by Subject|0|||
33640818|NCT03527732|102236485|FG001|Overall Study|Lost to Follow-up|23|||
33640819|NCT03527732|102236486|FG002|Overall Study|Lost to Follow-up|80|||
33640820|NCT03527732|102236487|FG003|Overall Study|Lost to Follow-up|62|||
33142092|NCT03390101|100434773|FG001|Weeks 0-12|Withdrawal by Subject|1|||
33142093|NCT03390101|100434774|FG002|Weeks 0-12|Withdrawal by Subject|1|||
33142094|NCT03390101|100434772|FG000|Weeks 0-12|Lost to Follow-up|0|||
33421102|NCT03944707|101431711|FG000|Overall Study|Adverse Event|0|||
33421103|NCT03944707|101431712|FG001|Overall Study|Adverse Event|2|||
33421104|NCT03944707|101431711|FG000|Overall Study|Study terminated by sponsor|12|||
33421105|NCT03944707|101431712|FG001|Overall Study|Study terminated by sponsor|7|||
33580441|NCT03745638|102016863|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
33580442|NCT03745638|102016864|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33580443|NCT03745638|102016865|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33580444|NCT03745638|102016866|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33580445|NCT03745638|102016867|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33580446|NCT03745638|102016868|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33580447|NCT03745638|102016862|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
33580448|NCT03745638|102016863|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
33580449|NCT03745638|102016864|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
33640821|NCT03527732|102236488|FG004|Overall Study|Lost to Follow-up|12|||
33640822|NCT03527732|102236489|FG005|Overall Study|Lost to Follow-up|20|||
33640823|NCT01663103|102236498|FG000|Overall Study|Withdrawal by Subject|1|||
33640824|NCT01663103|102236499|FG001|Overall Study|Withdrawal by Subject|2|||
33640825|NCT01663103|102236498|FG000|Overall Study|Adverse Event|1|||
33640826|NCT01663103|102236499|FG001|Overall Study|Adverse Event|0|||
33640827|NCT01663103|102236498|FG000|Overall Study|dog bite|1|||
33640828|NCT01663103|102236499|FG001|Overall Study|dog bite|0|||
33640829|NCT02282605|102236501|FG000|Overall Study|negative SA result on Day -1|3|||
33640830|NCT02282605|102236502|FG001|Overall Study|negative SA result on Day -1|0|||
33640831|NCT02282605|102236503|FG002|Overall Study|negative SA result on Day -1|0|||
33640832|NCT02259088|102236506|FG000|Overall Study|Adverse Event|6|||
33640833|NCT02259088|102236507|FG001|Overall Study|Adverse Event|4|||
33640834|NCT02259088|102236506|FG000|Overall Study|Lost to Follow-up|2|||
33640835|NCT02259088|102236507|FG001|Overall Study|Lost to Follow-up|0|||
33640836|NCT02259088|102236506|FG000|Overall Study|Death|2|||
33142095|NCT03390101|100434773|FG001|Weeks 0-12|Lost to Follow-up|1|||
33142096|NCT03390101|100434774|FG002|Weeks 0-12|Lost to Follow-up|0|||
33142097|NCT03390101|100434772|FG000|Weeks 12-54|Withdrawal by Subject|0|||
33142098|NCT03390101|100434773|FG001|Weeks 12-54|Withdrawal by Subject|3|||
33142099|NCT03390101|100434774|FG002|Weeks 12-54|Withdrawal by Subject|1|||
33142100|NCT03390101|100434772|FG000|Weeks 12-54|Pregnancy|1|||
33640837|NCT02259088|102236507|FG001|Overall Study|Death|0|||
33142101|NCT03390101|100434773|FG001|Weeks 12-54|Pregnancy|0|||
33142102|NCT03390101|100434774|FG002|Weeks 12-54|Pregnancy|0|||
33142103|NCT03390101|100434772|FG000|Weeks 12-54|Adverse Event|2|||
33421106|NCT03944707|101431711|FG000|Overall Study|Subject decision|0|||
33640838|NCT02259088|102236506|FG000|Overall Study|Physician Decision|5|||
33640839|NCT02259088|102236507|FG001|Overall Study|Physician Decision|2|||
33640840|NCT02259088|102236506|FG000|Overall Study|Protocol deviation|5|||
33640841|NCT02259088|102236507|FG001|Overall Study|Protocol deviation|0|||
33580450|NCT03745638|102016865|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33580451|NCT03745638|102016866|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33580452|NCT03745638|102016867|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33580453|NCT03745638|102016868|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33580454|NCT03745638|102016862|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
33580455|NCT03745638|102016863|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
33580456|NCT03745638|102016864|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
33640842|NCT02259088|102236506|FG000|Overall Study|Subject/guardian decision|8|||
33640843|NCT02259088|102236507|FG001|Overall Study|Subject/guardian decision|8|||
33240371|NCT03699124|100779990|FG002|Overall Study|Withdrawal by Subject|13|||
33240372|NCT03699124|100779988|FG000|Overall Study|Other reasons|5|||
33240373|NCT03699124|100779989|FG001|Overall Study|Other reasons|3|||
33240374|NCT03699124|100779990|FG002|Overall Study|Other reasons|10|||
33240375|NCT00410384|100779992|FG000|Overall Study|Withdrawal by Subject|28|||
33240376|NCT00410384|100779993|FG001|Overall Study|Withdrawal by Subject|17|||
33240377|NCT00410384|100779994|FG002|Overall Study|Withdrawal by Subject|20|||
33240378|NCT00410384|100779992|FG000|Overall Study|Adverse Event|23|||
33240379|NCT00410384|100779993|FG001|Overall Study|Adverse Event|18|||
33240380|NCT00410384|100779994|FG002|Overall Study|Adverse Event|23|||
33240381|NCT00410384|100779992|FG000|Overall Study|Lack of Efficacy|20|||
33240382|NCT00410384|100779993|FG001|Overall Study|Lack of Efficacy|12|||
33240383|NCT00410384|100779994|FG002|Overall Study|Lack of Efficacy|17|||
33240384|NCT00410384|100779992|FG000|Overall Study|Lack of Compliance|2|||
33240385|NCT00410384|100779993|FG001|Overall Study|Lack of Compliance|2|||
33240386|NCT00410384|100779994|FG002|Overall Study|Lack of Compliance|2|||
33240387|NCT00410384|100779992|FG000|Overall Study|Lost to Follow-up|4|||
33240388|NCT00410384|100779993|FG001|Overall Study|Lost to Follow-up|6|||
33240389|NCT00410384|100779994|FG002|Overall Study|Lost to Follow-up|6|||
33240390|NCT00410384|100779992|FG000|Overall Study|Protocol Violation|6|||
33240391|NCT00410384|100779993|FG001|Overall Study|Protocol Violation|6|||
33240392|NCT00410384|100779994|FG002|Overall Study|Protocol Violation|6|||
33240393|NCT00410384|100779992|FG000|Overall Study|Physician Decision|3|||
33240394|NCT00410384|100779993|FG001|Overall Study|Physician Decision|3|||
33240395|NCT00410384|100779994|FG002|Overall Study|Physician Decision|4|||
33240396|NCT00410384|100779992|FG000|Overall Study|Other|3|||
33580457|NCT03745638|102016865|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
33580458|NCT03745638|102016866|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
33580459|NCT03745638|102016867|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
33580460|NCT03745638|102016868|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
33580461|NCT03745638|102016862|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33580462|NCT03745638|102016863|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33580463|NCT03745638|102016864|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33580464|NCT03745638|102016865|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33580465|NCT03745638|102016866|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33580466|NCT03745638|102016867|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
33580467|NCT03745638|102016868|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
33580468|NCT03745638|102016862|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33580469|NCT03745638|102016863|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33580470|NCT03745638|102016864|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33580471|NCT03745638|102016865|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
33580472|NCT03745638|102016866|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33580473|NCT03745638|102016867|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
33580474|NCT03745638|102016868|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
33580475|NCT03745638|102016862|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33580476|NCT03745638|102016863|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33580477|NCT03745638|102016864|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33580478|NCT03745638|102016865|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
33580479|NCT03745638|102016866|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
33640844|NCT03524118|102236510|FG000|Overall Study|Lost to Follow-up|0|||
33421107|NCT03944707|101431712|FG001|Overall Study|Subject decision|1|||
33421108|NCT02046369|101431714|FG000|Overall Study|Adverse Event|3|||
33640845|NCT03524118|102236511|FG001|Overall Study|Lost to Follow-up|0|||
33640846|NCT03524118|102236512|FG002|Overall Study|Lost to Follow-up|0|||
33640847|NCT03524118|102236513|FG003|Overall Study|Lost to Follow-up|0|||
33240397|NCT00410384|100779993|FG001|Overall Study|Other|8|||
33240398|NCT00410384|100779994|FG002|Overall Study|Other|4|||
33240399|NCT01272011|100779995|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
33240400|NCT01272011|100779996|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
33240401|NCT01272011|100779997|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
33240402|NCT04822298|100780000|FG000|Overall Study|Death|3|||
33240403|NCT02162732|100780001|FG000|Overall Study|Biopsy not performed.|18|||
33240404|NCT03824236|100780002|FG000|Overall Study|Lost to Follow-up|0|||
33240405|NCT03824236|100780003|FG001|Overall Study|Lost to Follow-up|0|||
33240406|NCT03824236|100780004|FG002|Overall Study|Lost to Follow-up|1|||
33240407|NCT02081391|100780007|FG000|12-hour Treatment|Withdrawal by Subject|3|||
33240408|NCT02081391|100780008|FG001|12-hour Treatment|Withdrawal by Subject|2|||
33240409|NCT02081391|100780009|FG002|12-hour Treatment|Withdrawal by Subject|0|||
33240410|NCT02081391|100780010|FG003|12-hour Treatment|Withdrawal by Subject|0|||
33240411|NCT02081391|100780007|FG000|12-hour Treatment|Physician Decision|4|||
33240412|NCT02081391|100780008|FG001|12-hour Treatment|Physician Decision|1|||
33240413|NCT02081391|100780009|FG002|12-hour Treatment|Physician Decision|0|||
33240414|NCT02081391|100780010|FG003|12-hour Treatment|Physician Decision|0|||
33240415|NCT02081391|100780007|FG000|12-hour Treatment|Lack of Efficacy|3|||
33240416|NCT02081391|100780008|FG001|12-hour Treatment|Lack of Efficacy|0|||
33240417|NCT02081391|100780009|FG002|12-hour Treatment|Lack of Efficacy|0|||
33240418|NCT02081391|100780010|FG003|12-hour Treatment|Lack of Efficacy|0|||
33240419|NCT02081391|100780007|FG000|12-hour Treatment|Adverse Event|4|||
33240420|NCT02081391|100780008|FG001|12-hour Treatment|Adverse Event|2|||
33240421|NCT02081391|100780009|FG002|12-hour Treatment|Adverse Event|0|||
33240422|NCT02081391|100780010|FG003|12-hour Treatment|Adverse Event|0|||
33240423|NCT02081391|100780007|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
33240424|NCT02081391|100780008|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
33240425|NCT02081391|100780009|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
33240426|NCT02081391|100780010|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
33240427|NCT02081391|100780007|FG000|12-hour Treatment|Further reasons|2|||
33240428|NCT02081391|100780008|FG001|12-hour Treatment|Further reasons|1|||
33240429|NCT02081391|100780009|FG002|12-hour Treatment|Further reasons|0|||
33240430|NCT02081391|100780010|FG003|12-hour Treatment|Further reasons|0|||
33240431|NCT02081391|100780007|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
33240432|NCT02081391|100780008|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
33240433|NCT02081391|100780009|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
33240434|NCT02081391|100780010|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
33240435|NCT02081391|100780007|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
33240436|NCT02081391|100780008|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
33240437|NCT02081391|100780009|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
33240438|NCT02081391|100780010|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
33240439|NCT02081391|100780007|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
33370639|NCT00365716|101243468|FG002|Extension 1|Moved|0|||
33370640|NCT00365716|101243469|FG003|Extension 1|Moved|0|||
33370641|NCT00365716|101243470|FG004|Extension 1|Moved|0|||
33370642|NCT00365716|101243471|FG005|Extension 1|Moved|4|||
33370643|NCT00365716|101243472|FG006|Extension 1|Moved|0|||
33370644|NCT00365716|101243466|FG000|Extension 1|Withdrawal by Subject|0|||
33370645|NCT00365716|101243467|FG001|Extension 1|Withdrawal by Subject|0|||
33370646|NCT00365716|101243468|FG002|Extension 1|Withdrawal by Subject|0|||
33370647|NCT00365716|101243469|FG003|Extension 1|Withdrawal by Subject|0|||
33370648|NCT00365716|101243470|FG004|Extension 1|Withdrawal by Subject|0|||
33370649|NCT00365716|101243471|FG005|Extension 1|Withdrawal by Subject|3|||
33370650|NCT00365716|101243472|FG006|Extension 1|Withdrawal by Subject|0|||
33370651|NCT00365716|101243466|FG000|Extension 1|Pregnancy|0|||
33370652|NCT00365716|101243467|FG001|Extension 1|Pregnancy|0|||
33370653|NCT00365716|101243468|FG002|Extension 1|Pregnancy|0|||
33370654|NCT00365716|101243469|FG003|Extension 1|Pregnancy|0|||
33370655|NCT00365716|101243470|FG004|Extension 1|Pregnancy|0|||
33370656|NCT00365716|101243471|FG005|Extension 1|Pregnancy|4|||
33370657|NCT00365716|101243472|FG006|Extension 1|Pregnancy|0|||
33370658|NCT00365716|101243466|FG000|Extension 1|Protocol Violation|0|||
33370659|NCT00365716|101243467|FG001|Extension 1|Protocol Violation|0|||
33580480|NCT03745638|102016867|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
33240440|NCT02081391|100780008|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
33370660|NCT00365716|101243468|FG002|Extension 1|Protocol Violation|0|||
33370661|NCT00365716|101243469|FG003|Extension 1|Protocol Violation|0|||
33370662|NCT00365716|101243470|FG004|Extension 1|Protocol Violation|0|||
33370663|NCT00365716|101243471|FG005|Extension 1|Protocol Violation|1|||
33370664|NCT00365716|101243472|FG006|Extension 1|Protocol Violation|0|||
33370665|NCT00365716|101243466|FG000|Extension 2|Lost to Follow-up|0|||
33370666|NCT00365716|101243467|FG001|Extension 2|Lost to Follow-up|0|||
33370667|NCT00365716|101243468|FG002|Extension 2|Lost to Follow-up|0|||
33370668|NCT00365716|101243469|FG003|Extension 2|Lost to Follow-up|0|||
33240441|NCT02081391|100780009|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
33240442|NCT02081391|100780010|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
33240443|NCT02081391|100780007|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
33370669|NCT00365716|101243470|FG004|Extension 2|Lost to Follow-up|0|||
33370670|NCT00365716|101243471|FG005|Extension 2|Lost to Follow-up|0|||
33370671|NCT00365716|101243472|FG006|Extension 2|Lost to Follow-up|2|||
33240444|NCT02081391|100780008|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
33240445|NCT02081391|100780009|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
33240446|NCT02081391|100780010|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
33240447|NCT02081391|100780007|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
33240448|NCT02081391|100780008|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
33240449|NCT02081391|100780009|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
33240450|NCT02081391|100780010|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
33240451|NCT02081391|100780007|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
33240452|NCT02081391|100780008|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
33240453|NCT02081391|100780009|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
33240454|NCT02081391|100780010|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
33240455|NCT04482855|100780017|FG000|Overall Study|Lost to Follow-up|1|||
33240456|NCT04482855|100780018|FG001|Overall Study|Lost to Follow-up|0|||
33240457|NCT04482855|100780017|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
33240458|NCT04482855|100780018|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
33240459|NCT04482855|100780017|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
33240460|NCT04482855|100780018|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
33240461|NCT01809210|100780030|FG000|Overall Study|Withdrawal by Subject|0|||
33240462|NCT01809210|100780031|FG001|Overall Study|Withdrawal by Subject|0|||
33240463|NCT01809210|100780032|FG002|Overall Study|Withdrawal by Subject|1|||
33240464|NCT01809210|100780033|FG003|Overall Study|Withdrawal by Subject|1|||
33240465|NCT01809210|100780034|FG004|Overall Study|Withdrawal by Subject|1|||
33240466|NCT01809210|100780035|FG005|Overall Study|Withdrawal by Subject|0|||
33240467|NCT01809210|100780036|FG006|Overall Study|Withdrawal by Subject|4|||
33240468|NCT01809210|100780030|FG000|Overall Study|Death|1|||
33240469|NCT01809210|100780031|FG001|Overall Study|Death|1|||
33240470|NCT01809210|100780032|FG002|Overall Study|Death|2|||
33240471|NCT01809210|100780033|FG003|Overall Study|Death|0|||
33240472|NCT01809210|100780034|FG004|Overall Study|Death|1|||
33240473|NCT01809210|100780035|FG005|Overall Study|Death|3|||
33240474|NCT01809210|100780036|FG006|Overall Study|Death|1|||
33240475|NCT02950545|100780038|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
33240476|NCT02950545|100780039|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
33240477|NCT02950545|100780040|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
33240478|NCT02950545|100780041|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
33240479|NCT02950545|100780042|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
33240480|NCT02950545|100780043|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
33240481|NCT02950545|100780038|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
33240482|NCT02950545|100780039|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
33240483|NCT02950545|100780040|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
33240484|NCT02950545|100780041|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
33240485|NCT02950545|100780042|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
33240486|NCT02950545|100780043|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
33240487|NCT02950545|100780038|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
33240488|NCT02950545|100780039|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
33240489|NCT02950545|100780040|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
33240490|NCT02950545|100780041|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
33240491|NCT02950545|100780042|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
33240492|NCT02950545|100780043|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
33240493|NCT02950545|100780038|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
33240494|NCT02950545|100780039|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
33240495|NCT02950545|100780040|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
33240496|NCT02950545|100780041|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
33240497|NCT02950545|100780042|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
33240498|NCT02950545|100780043|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
33240499|NCT02950545|100780038|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
33240500|NCT02950545|100780039|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
33240501|NCT02950545|100780040|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
33240502|NCT02950545|100780041|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
33240503|NCT02950545|100780042|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
33240504|NCT02950545|100780043|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
33240505|NCT03738241|100780044|FG000|Overall Study|Withdrawal by Subject|0|||
33240506|NCT03738241|100780045|FG001|Overall Study|Withdrawal by Subject|0|||
33421109|NCT02046369|101431715|FG001|Overall Study|Adverse Event|3|||
33240507|NCT03738241|100780046|FG002|Overall Study|Withdrawal by Subject|0|||
33240508|NCT03738241|100780047|FG003|Overall Study|Withdrawal by Subject|0|||
33240509|NCT03738241|100780048|FG004|Overall Study|Withdrawal by Subject|0|||
33240510|NCT03738241|100780049|FG005|Overall Study|Withdrawal by Subject|0|||
33240511|NCT03738241|100780050|FG006|Overall Study|Withdrawal by Subject|0|||
33240512|NCT03738241|100780051|FG007|Overall Study|Withdrawal by Subject|0|||
33240513|NCT03738241|100780052|FG008|Overall Study|Withdrawal by Subject|0|||
33240514|NCT03738241|100780053|FG009|Overall Study|Withdrawal by Subject|1|||
33240515|NCT03738241|100780044|FG000|Overall Study|Physician Decision|0|||
33240516|NCT03738241|100780045|FG001|Overall Study|Physician Decision|0|||
33240517|NCT03738241|100780046|FG002|Overall Study|Physician Decision|0|||
33240518|NCT03738241|100780047|FG003|Overall Study|Physician Decision|0|||
33240519|NCT03738241|100780048|FG004|Overall Study|Physician Decision|0|||
33240520|NCT03738241|100780049|FG005|Overall Study|Physician Decision|0|||
33240521|NCT03738241|100780050|FG006|Overall Study|Physician Decision|0|||
33240522|NCT03738241|100780051|FG007|Overall Study|Physician Decision|0|||
33240523|NCT03738241|100780052|FG008|Overall Study|Physician Decision|1|||
33240524|NCT03738241|100780053|FG009|Overall Study|Physician Decision|0|||
33240525|NCT03738241|100780044|FG000|Overall Study|Adverse Event|1|||
33240526|NCT03738241|100780045|FG001|Overall Study|Adverse Event|0|||
33240527|NCT03738241|100780046|FG002|Overall Study|Adverse Event|0|||
33240528|NCT03738241|100780047|FG003|Overall Study|Adverse Event|0|||
33240529|NCT03738241|100780048|FG004|Overall Study|Adverse Event|0|||
33240530|NCT03738241|100780049|FG005|Overall Study|Adverse Event|0|||
33240531|NCT03738241|100780050|FG006|Overall Study|Adverse Event|0|||
33240532|NCT03738241|100780051|FG007|Overall Study|Adverse Event|0|||
33240533|NCT03738241|100780052|FG008|Overall Study|Adverse Event|0|||
33240534|NCT03738241|100780053|FG009|Overall Study|Adverse Event|0|||
33240535|NCT00057811|100780055|FG000|Overall Study|Lack of Efficacy|1|||
33240536|NCT00057811|100780056|FG001|Overall Study|Lack of Efficacy|4|||
33240537|NCT00057811|100780055|FG000|Overall Study|Physician Decision|1|||
33240538|NCT00057811|100780056|FG001|Overall Study|Physician Decision|0|||
33240539|NCT00057811|100780055|FG000|Overall Study|Withdrawal by Subject|3|||
33240540|NCT00057811|100780056|FG001|Overall Study|Withdrawal by Subject|4|||
33580481|NCT03745638|102016868|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
33580482|NCT03745638|102016862|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33580483|NCT03745638|102016863|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33580484|NCT03745638|102016864|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33580485|NCT03745638|102016865|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33580486|NCT03745638|102016866|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
33640848|NCT03524118|102236514|FG004|Overall Study|Lost to Follow-up|1|||
33640849|NCT03524118|102236515|FG005|Overall Study|Lost to Follow-up|0|||
33640850|NCT03524118|102236510|FG000|Overall Study|Other|0|||
33640851|NCT03524118|102236511|FG001|Overall Study|Other|1|||
33640852|NCT03524118|102236512|FG002|Overall Study|Other|0|||
33640853|NCT03524118|102236513|FG003|Overall Study|Other|0|||
33640854|NCT03524118|102236514|FG004|Overall Study|Other|1|||
33640855|NCT03524118|102236515|FG005|Overall Study|Other|1|||
33640856|NCT03524118|102236510|FG000|Overall Study|Physician Decision|0|||
33640857|NCT03524118|102236511|FG001|Overall Study|Physician Decision|0|||
33640858|NCT03524118|102236512|FG002|Overall Study|Physician Decision|0|||
33640859|NCT03524118|102236513|FG003|Overall Study|Physician Decision|0|||
33640860|NCT03524118|102236514|FG004|Overall Study|Physician Decision|1|||
33580487|NCT03745638|102016867|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
33580488|NCT03745638|102016868|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33580489|NCT03745638|102016862|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33580490|NCT03745638|102016863|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33580491|NCT03745638|102016864|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33580492|NCT03745638|102016865|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33580493|NCT03745638|102016866|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33640861|NCT03524118|102236515|FG005|Overall Study|Physician Decision|0|||
33640862|NCT03524118|102236510|FG000|Overall Study|Protocol Violation|0|||
33640863|NCT03524118|102236511|FG001|Overall Study|Protocol Violation|0|||
33640864|NCT03524118|102236512|FG002|Overall Study|Protocol Violation|1|||
33640865|NCT03524118|102236513|FG003|Overall Study|Protocol Violation|0|||
33640866|NCT03524118|102236514|FG004|Overall Study|Protocol Violation|1|||
33640867|NCT03524118|102236515|FG005|Overall Study|Protocol Violation|0|||
33640868|NCT03524118|102236510|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33640869|NCT03524118|102236511|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33640870|NCT03524118|102236512|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
33142104|NCT03390101|100434773|FG001|Weeks 12-54|Adverse Event|1|||
33142105|NCT03390101|100434774|FG002|Weeks 12-54|Adverse Event|1|||
33640871|NCT03524118|102236513|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
33240541|NCT00057811|100780055|FG000|Overall Study|Ineligible|4|||
33240542|NCT00057811|100780056|FG001|Overall Study|Ineligible|2|||
33240543|NCT00057811|100780055|FG000|Overall Study|Inevaluable|1|||
33240544|NCT00057811|100780056|FG001|Overall Study|Inevaluable|2|||
33240545|NCT03369951|100780068|FG000|Overall Study|Withdrawal by Subject|3|||
33240546|NCT03369951|100780068|FG000|Overall Study|Death|1|||
33640872|NCT03524118|102236514|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
33640873|NCT03524118|102236515|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
33240547|NCT03369951|100780068|FG000|Overall Study|Lost to Follow-up|1|||
33580494|NCT03745638|102016867|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
33640874|NCT02577718|102236516|FG000|Overall Study|Death|6|||
33640875|NCT02577718|102236516|FG000|Overall Study|Withdrawal by Subject|2|||
33640876|NCT00196313|102236517|FG000|Overall Study|Protocol Violation|2|||
33640877|NCT00196313|102236518|FG001|Overall Study|Protocol Violation|3|||
33640878|NCT00196313|102236517|FG000|Overall Study|Withdrawal by Subject|3|||
33640879|NCT00196313|102236518|FG001|Overall Study|Withdrawal by Subject|1|||
33640880|NCT00196313|102236517|FG000|Overall Study|Adverse Event|3|||
33640881|NCT00196313|102236518|FG001|Overall Study|Adverse Event|1|||
33580495|NCT03745638|102016868|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33580496|NCT03745638|102016862|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33580497|NCT03745638|102016863|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33580498|NCT03745638|102016864|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33580499|NCT03745638|102016865|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
33580500|NCT03745638|102016866|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
33580501|NCT03745638|102016867|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
33580502|NCT03745638|102016868|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
33580503|NCT03745638|102016862|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
33580504|NCT03745638|102016863|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
33580505|NCT03745638|102016864|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
33580506|NCT03745638|102016865|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
33580507|NCT03745638|102016866|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
33580508|NCT03745638|102016867|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
33580509|NCT03745638|102016868|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
33580510|NCT00996658|102016874|FG000|Overall Study|Adverse Event|2|||
33580511|NCT00996658|102016875|FG001|Overall Study|Adverse Event|5|||
33580512|NCT00996658|102016874|FG000|Overall Study|Protocol Violation|0|||
33580513|NCT00996658|102016875|FG001|Overall Study|Protocol Violation|1|||
33580514|NCT00996658|102016874|FG000|Overall Study|Lost to Follow-up|2|||
33580515|NCT00996658|102016875|FG001|Overall Study|Lost to Follow-up|5|||
33580516|NCT00996658|102016874|FG000|Overall Study|Non-compliance issues|3|||
33580517|NCT00996658|102016875|FG001|Overall Study|Non-compliance issues|3|||
33580518|NCT00996658|102016874|FG000|Overall Study|Other|9|||
33580519|NCT00996658|102016875|FG001|Overall Study|Other|7|||
33580520|NCT02709720|102016876|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
33580521|NCT02709720|102016876|FG000|Overall Study|Protocol Violation|1|||
33580522|NCT02709720|102016876|FG000|Overall Study|Not take study medication|1|||
33580523|NCT03782064|102016877|FG000|Overall Study|Lack of Efficacy|2|||
33580524|NCT03782064|102016877|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
33580525|NCT00130039|102016878|FG000|Overall Study|Withdrawal by Subject|15|||
33580526|NCT00130039|102016879|FG001|Overall Study|Withdrawal by Subject|11|||
33580527|NCT00130039|102016878|FG000|Overall Study|Lost to Follow-up|3|||
33580528|NCT00130039|102016879|FG001|Overall Study|Lost to Follow-up|1|||
33580529|NCT00130039|102016878|FG000|Overall Study|Adverse Event|4|||
33580530|NCT00130039|102016879|FG001|Overall Study|Adverse Event|2|||
33580531|NCT00130039|102016878|FG000|Overall Study|Physician Decision|3|||
33580532|NCT00130039|102016879|FG001|Overall Study|Physician Decision|0|||
33580533|NCT00130039|102016878|FG000|Overall Study|clinical events without follow up MRI|5|||
33580534|NCT00130039|102016879|FG001|Overall Study|clinical events without follow up MRI|4|||
33580535|NCT04971967|102016882|FG000|Overall Study|Lost to Follow-up|6|||
33580536|NCT04971967|102016883|FG001|Overall Study|Lost to Follow-up|7|||
33580537|NCT03554018|102016886|FG000|Overall Study|Lost to Follow-up|3|||
33580538|NCT03554018|102016887|FG001|Overall Study|Lost to Follow-up|7|||
33640882|NCT00196313|102236517|FG000|Overall Study|Subject Pregnant|1|||
33640883|NCT00196313|102236518|FG001|Overall Study|Subject Pregnant|1|||
33640884|NCT00196313|102236517|FG000|Overall Study|Lost to Follow-up|2|||
33640885|NCT00196313|102236518|FG001|Overall Study|Lost to Follow-up|2|||
33370672|NCT00365716|101243466|FG000|Extension 2|Other|0|||
33370673|NCT00365716|101243467|FG001|Extension 2|Other|0|||
33370674|NCT00365716|101243468|FG002|Extension 2|Other|0|||
33580539|NCT01063348|102016888|FG000|Overall Study|Lost to Follow-up|3|||
33580540|NCT01063348|102016889|FG001|Overall Study|Lost to Follow-up|10|||
33580541|NCT03547908|102016890|FG000|Overall Study|Still On Study|115|||
33580542|NCT03547908|102016891|FG001|Overall Study|Still On Study|118|||
33580543|NCT03547908|102016890|FG000|Overall Study|Lost to Follow-up|2|||
33640886|NCT01587924|102236519|FG000|Overall Study|Adverse Event|0|||
33240548|NCT03369951|100780068|FG000|Overall Study|Protocol Violation|1|||
33370675|NCT00365716|101243469|FG003|Extension 2|Other|0|||
33370676|NCT00365716|101243470|FG004|Extension 2|Other|0|||
33580544|NCT03547908|102016891|FG001|Overall Study|Lost to Follow-up|2|||
33580545|NCT03547908|102016890|FG000|Overall Study|Withdrew Consent|2|||
33580546|NCT03547908|102016891|FG001|Overall Study|Withdrew Consent|1|||
33580547|NCT03547908|102016890|FG000|Overall Study|Adverse Event|1|||
33580548|NCT03547908|102016891|FG001|Overall Study|Adverse Event|0|||
33640887|NCT01587924|102236520|FG001|Overall Study|Adverse Event|2|||
33640888|NCT01587924|102236521|FG002|Overall Study|Adverse Event|0|||
33640889|NCT01587924|102236522|FG003|Overall Study|Adverse Event|0|||
33640890|NCT01587924|102236519|FG000|Overall Study|Protocol Violation|2|||
33370677|NCT00365716|101243471|FG005|Extension 2|Other|0|||
33640891|NCT01587924|102236520|FG001|Overall Study|Protocol Violation|1|||
33640892|NCT01587924|102236521|FG002|Overall Study|Protocol Violation|2|||
33640893|NCT01587924|102236522|FG003|Overall Study|Protocol Violation|1|||
33640894|NCT01587924|102236519|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
33640895|NCT01587924|102236520|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
33640896|NCT01587924|102236521|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
33640897|NCT01587924|102236522|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
33640898|NCT01587924|102236519|FG000|Overall Study|Withdrawal by Subject|0|||
33640899|NCT01587924|102236520|FG001|Overall Study|Withdrawal by Subject|1|||
33640900|NCT01587924|102236521|FG002|Overall Study|Withdrawal by Subject|1|||
33640901|NCT01587924|102236522|FG003|Overall Study|Withdrawal by Subject|0|||
33640902|NCT01708902|102236528|FG000|Overall Study|Adverse Event|3|||
33640903|NCT01708902|102236529|FG001|Overall Study|Adverse Event|4|||
33640904|NCT01708902|102236530|FG002|Overall Study|Adverse Event|9|||
33640905|NCT01708902|102236531|FG003|Overall Study|Adverse Event|2|||
33640906|NCT01708902|102236532|FG004|Overall Study|Adverse Event|7|||
33640907|NCT01708902|102236533|FG005|Overall Study|Adverse Event|3|||
33640908|NCT01708902|102236534|FG006|Overall Study|Adverse Event|5|||
33640909|NCT01708902|102236528|FG000|Overall Study|Lack of Efficacy|3|||
33640910|NCT01708902|102236529|FG001|Overall Study|Lack of Efficacy|1|||
33640911|NCT01708902|102236530|FG002|Overall Study|Lack of Efficacy|0|||
33640912|NCT01708902|102236531|FG003|Overall Study|Lack of Efficacy|0|||
33640913|NCT01708902|102236532|FG004|Overall Study|Lack of Efficacy|0|||
33640914|NCT01708902|102236533|FG005|Overall Study|Lack of Efficacy|1|||
33640915|NCT01708902|102236534|FG006|Overall Study|Lack of Efficacy|0|||
33640916|NCT01708902|102236528|FG000|Overall Study|Non compliance with protocol|0|||
33640917|NCT01708902|102236529|FG001|Overall Study|Non compliance with protocol|2|||
33640918|NCT01708902|102236530|FG002|Overall Study|Non compliance with protocol|1|||
33640919|NCT01708902|102236531|FG003|Overall Study|Non compliance with protocol|3|||
33640920|NCT01708902|102236532|FG004|Overall Study|Non compliance with protocol|0|||
33640921|NCT01708902|102236533|FG005|Overall Study|Non compliance with protocol|0|||
33640922|NCT01708902|102236534|FG006|Overall Study|Non compliance with protocol|0|||
33640923|NCT01708902|102236528|FG000|Overall Study|Lost to Follow-up|2|||
33640924|NCT01708902|102236529|FG001|Overall Study|Lost to Follow-up|1|||
33640925|NCT01708902|102236530|FG002|Overall Study|Lost to Follow-up|2|||
33640926|NCT01708902|102236531|FG003|Overall Study|Lost to Follow-up|2|||
33640927|NCT01708902|102236532|FG004|Overall Study|Lost to Follow-up|0|||
33640928|NCT01708902|102236533|FG005|Overall Study|Lost to Follow-up|0|||
33640929|NCT01708902|102236534|FG006|Overall Study|Lost to Follow-up|1|||
33640930|NCT01708902|102236528|FG000|Overall Study|Refused to continue trial medication|8|||
33640931|NCT01708902|102236529|FG001|Overall Study|Refused to continue trial medication|0|||
33640932|NCT01708902|102236530|FG002|Overall Study|Refused to continue trial medication|4|||
33640933|NCT01708902|102236531|FG003|Overall Study|Refused to continue trial medication|2|||
33640934|NCT01708902|102236532|FG004|Overall Study|Refused to continue trial medication|8|||
33640935|NCT01708902|102236533|FG005|Overall Study|Refused to continue trial medication|1|||
33640936|NCT01708902|102236534|FG006|Overall Study|Refused to continue trial medication|1|||
33640937|NCT01708902|102236528|FG000|Overall Study|Other Reason|1|||
33640938|NCT01708902|102236529|FG001|Overall Study|Other Reason|0|||
33640939|NCT01708902|102236530|FG002|Overall Study|Other Reason|1|||
33640940|NCT01708902|102236531|FG003|Overall Study|Other Reason|1|||
33640941|NCT01708902|102236532|FG004|Overall Study|Other Reason|1|||
33142106|NCT01653132|100434775|FG000|First Intervention|Protocol Violation|1|||
33370678|NCT00365716|101243472|FG006|Extension 2|Other|3|||
33370679|NCT00365716|101243466|FG000|Extension 2|Withdrawal by Subject|0|||
33370680|NCT00365716|101243467|FG001|Extension 2|Withdrawal by Subject|0|||
33370681|NCT00365716|101243468|FG002|Extension 2|Withdrawal by Subject|0|||
33370682|NCT00365716|101243469|FG003|Extension 2|Withdrawal by Subject|0|||
33370683|NCT00365716|101243470|FG004|Extension 2|Withdrawal by Subject|0|||
33640942|NCT01708902|102236533|FG005|Overall Study|Other Reason|2|||
33640943|NCT01708902|102236534|FG006|Overall Study|Other Reason|0|||
33142107|NCT01653132|100434776|FG001|First Intervention|Protocol Violation|0|||
33370684|NCT00365716|101243471|FG005|Extension 2|Withdrawal by Subject|0|||
33142108|NCT00484185|100434777|FG000|Overall Study|Lost to Follow-up|44|||
33640944|NCT00602472|102236535|FG000|Overall Study|Adverse Event|5|||
33640945|NCT00602472|102236536|FG001|Overall Study|Adverse Event|23|||
33640946|NCT00602472|102236535|FG000|Overall Study|Protocol Violation|4|||
33640947|NCT00602472|102236536|FG001|Overall Study|Protocol Violation|19|||
33640948|NCT00602472|102236535|FG000|Overall Study|Withdrawal by Subject|8|||
33142109|NCT00484185|100434777|FG000|Overall Study|Other|20|||
33370685|NCT00365716|101243472|FG006|Extension 2|Withdrawal by Subject|5|||
33370686|NCT03072719|101243473|FG000|Overall Study|Adverse Event|1|||
33370687|NCT03072719|101243474|FG001|Overall Study|Adverse Event|1|||
33640949|NCT00602472|102236536|FG001|Overall Study|Withdrawal by Subject|14|||
33640950|NCT00602472|102236535|FG000|Overall Study|Other incl. lack of efficacy|4|||
33640951|NCT00602472|102236536|FG001|Overall Study|Other incl. lack of efficacy|2|||
33240549|NCT00114959|100780070|FG000|Overall Study|Lack of Efficacy|6|||
33240550|NCT00114959|100780070|FG000|Overall Study|Physician Decision|1|||
33240551|NCT00114959|100780070|FG000|Overall Study|Death|1|||
33240552|NCT01559090|100780073|FG000|Stage I|Withdrawal by Subject|2|||
33240553|NCT01559090|100780074|FG001|Stage I|Withdrawal by Subject|2|||
33240554|NCT01559090|100780075|FG002|Stage I|Withdrawal by Subject|3|||
33421110|NCT02046369|101431714|FG000|Overall Study|Lack of Efficacy|3|||
33421111|NCT02046369|101431715|FG001|Overall Study|Lack of Efficacy|3|||
33421112|NCT02046369|101431714|FG000|Overall Study|Lost to Follow-up|3|||
33421113|NCT02046369|101431715|FG001|Overall Study|Lost to Follow-up|3|||
33421114|NCT02046369|101431714|FG000|Overall Study|Protocol Violation|1|||
33421115|NCT02046369|101431715|FG001|Overall Study|Protocol Violation|2|||
33421116|NCT02046369|101431714|FG000|Overall Study|Withdrawal by Subject|3|||
33421117|NCT02046369|101431715|FG001|Overall Study|Withdrawal by Subject|6|||
33421118|NCT02046369|101431714|FG000|Overall Study|never received study drug|0|||
33421119|NCT02046369|101431715|FG001|Overall Study|never received study drug|1|||
33421120|NCT02046369|101431714|FG000|Overall Study|non compliance|1|||
33421121|NCT02046369|101431715|FG001|Overall Study|non compliance|0|||
33421122|NCT01106352|101431722|FG000|Overall Study|Subjects untreated|0|||
33421123|NCT01106352|101431723|FG001|Overall Study|Subjects untreated|0|||
33421124|NCT01106352|101431724|FG002|Overall Study|Subjects untreated|0|||
33421125|NCT01106352|101431725|FG003|Overall Study|Subjects untreated|3|||
33421126|NCT01106352|101431726|FG004|Overall Study|Subjects untreated|4|||
33421127|NCT01106352|101431722|FG000|Overall Study|Sponsor Decision|1|||
33421128|NCT01106352|101431723|FG001|Overall Study|Sponsor Decision|0|||
33421129|NCT01106352|101431724|FG002|Overall Study|Sponsor Decision|0|||
33421130|NCT01106352|101431725|FG003|Overall Study|Sponsor Decision|0|||
33580549|NCT03547908|102016890|FG000|Overall Study|Death|1|||
33580550|NCT03547908|102016891|FG001|Overall Study|Death|0|||
33580551|NCT03547908|102016890|FG000|Overall Study|Investigator's Discretion|0|||
33580552|NCT03547908|102016891|FG001|Overall Study|Investigator's Discretion|1|||
33580553|NCT03547908|102016890|FG000|Overall Study|Randomized But Never Treated|1|||
33580554|NCT03547908|102016891|FG001|Overall Study|Randomized But Never Treated|0|||
33580555|NCT02382991|102016897|FG000|Overall Study|Adverse Event|1|||
33580556|NCT02382991|102016898|FG001|Overall Study|Adverse Event|2|||
33580557|NCT02382991|102016897|FG000|Overall Study|Lost to Follow-up|1|||
33580558|NCT02382991|102016898|FG001|Overall Study|Lost to Follow-up|0|||
33580559|NCT02382991|102016897|FG000|Overall Study|Withdrawal by Subject|0|||
33640952|NCT00888940|102236538|FG000|Overall Study|Adverse Event|12|||
33240555|NCT01559090|100780073|FG000|Stage II|Withdrawal by Subject|1|||
33240556|NCT01559090|100780074|FG001|Stage II|Withdrawal by Subject|0|||
33240557|NCT01559090|100780075|FG002|Stage II|Withdrawal by Subject|0|||
33370688|NCT03352414|101243476|FG000|Overall Study|Ineligible by operative criteria|12|||
33580560|NCT02382991|102016898|FG001|Overall Study|Withdrawal by Subject|1|||
33580561|NCT01393899|102016899|FG000|Overall Study|Study terminated by sponsor|1|||
33580562|NCT01393899|102016900|FG001|Overall Study|Study terminated by sponsor|0|||
33580563|NCT01393899|102016901|FG002|Overall Study|Study terminated by sponsor|1|||
33580564|NCT01393899|102016899|FG000|Overall Study|Other|1|||
33580565|NCT01393899|102016900|FG001|Overall Study|Other|0|||
33580566|NCT01393899|102016901|FG002|Overall Study|Other|0|||
33580567|NCT01393899|102016899|FG000|Overall Study|Withdrawal by Subject|2|||
33580568|NCT01393899|102016900|FG001|Overall Study|Withdrawal by Subject|2|||
33240558|NCT02403674|100780076|FG000|Base Study|Death|1|||
33240559|NCT02403674|100780077|FG001|Base Study|Death|4|||
33240560|NCT02403674|100780076|FG000|Base Study|Adverse Event|11|||
33240561|NCT02403674|100780077|FG001|Base Study|Adverse Event|26|||
33370689|NCT03352414|101243477|FG001|Overall Study|Ineligible by operative criteria|10|||
33370690|NCT02488551|101243478|FG000|Overall Study|Lost to Follow-up|4|||
33370691|NCT02488551|101243479|FG001|Overall Study|Lost to Follow-up|7|||
33370692|NCT02488551|101243480|FG002|Overall Study|Lost to Follow-up|0|||
33370693|NCT02488551|101243481|FG003|Overall Study|Lost to Follow-up|0|||
33370694|NCT02488551|101243478|FG000|Overall Study|Military Deployment|1|||
33370695|NCT02488551|101243479|FG001|Overall Study|Military Deployment|1|||
33370696|NCT02488551|101243480|FG002|Overall Study|Military Deployment|0|||
33370697|NCT02488551|101243481|FG003|Overall Study|Military Deployment|0|||
33370698|NCT01921257|101243482|FG000|Overall Study|Adverse Event|1|||
33370699|NCT01921257|101243482|FG000|Overall Study|Protocol Violation|1|||
33370700|NCT01921257|101243482|FG000|Overall Study|Withdrawal by Subject|1|||
33370701|NCT00536978|101243483|FG000|Overall Study|Not eligible for Adback Infusion|22|||
33370702|NCT00540436|101243484|FG000|First 12-Week Treatment Period|Adverse Event|1|||
33421131|NCT01106352|101431726|FG004|Overall Study|Sponsor Decision|0|||
33421132|NCT01106352|101431722|FG000|Overall Study|Too ill to come in for the visit|0|||
33421133|NCT01106352|101431723|FG001|Overall Study|Too ill to come in for the visit|0|||
33421134|NCT01106352|101431724|FG002|Overall Study|Too ill to come in for the visit|1|||
33580569|NCT01393899|102016901|FG002|Overall Study|Withdrawal by Subject|1|||
33580570|NCT01393899|102016899|FG000|Overall Study|Lost to Follow-up|0|||
33580571|NCT01393899|102016900|FG001|Overall Study|Lost to Follow-up|0|||
33580572|NCT01393899|102016901|FG002|Overall Study|Lost to Follow-up|1|||
33640953|NCT00888940|102236539|FG001|Overall Study|Adverse Event|3|||
33640954|NCT00888940|102236538|FG000|Overall Study|Lost to Follow-up|5|||
33640955|NCT00888940|102236539|FG001|Overall Study|Lost to Follow-up|5|||
33640956|NCT00888940|102236538|FG000|Overall Study|Randomized Not Treated|11|||
33640957|NCT00888940|102236539|FG001|Overall Study|Randomized Not Treated|13|||
33640958|NCT02633020|102236540|FG000|Overall Study|Adverse Event|1|||
33640959|NCT02633020|102236541|FG001|Overall Study|Adverse Event|0|||
33640960|NCT01967576|102236547|FG000|Overall Study|Withdrawal by Subject|3|||
33370703|NCT00540436|101243484|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
33142110|NCT00484185|100434777|FG000|Overall Study|Randomized but not treated|5|||
33142111|NCT00484185|100434777|FG000|Overall Study|Death|2|||
33370704|NCT00540436|101243484|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
33370705|NCT00540436|101243484|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
33370706|NCT01599754|101243485|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
33370707|NCT01599754|101243486|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
33421135|NCT01106352|101431725|FG003|Overall Study|Too ill to come in for the visit|0|||
33421136|NCT01106352|101431726|FG004|Overall Study|Too ill to come in for the visit|0|||
33580573|NCT01393899|102016899|FG000|Overall Study|Does not meet entrance criteria|1|||
33640961|NCT01967576|102236547|FG000|Overall Study|Progressed/Removed from treatment|1|||
33640962|NCT01967576|102236547|FG000|Overall Study|Study closing at site|1|||
33640963|NCT01967576|102236547|FG000|Overall Study|Adverse Event|1|||
33640964|NCT01967576|102236547|FG000|Overall Study|Refused further treatment|1|||
33640965|NCT01254422|102236548|FG000|Overall Study|Protocol Violation|1|||
33142112|NCT02273739|100434779|FG000|Overall Study|Progression of Disease|3|||
33142113|NCT02273739|100434780|FG001|Overall Study|Progression of Disease|4|||
33142114|NCT02273739|100434781|FG002|Overall Study|Progression of Disease|5|||
33142115|NCT02273739|100434782|FG003|Overall Study|Progression of Disease|2|||
33142116|NCT02273739|100434779|FG000|Overall Study|Death|0|||
33421137|NCT01106352|101431722|FG000|Overall Study|Lost to Follow-up|0|||
33421138|NCT01106352|101431723|FG001|Overall Study|Lost to Follow-up|0|||
33580574|NCT01393899|102016900|FG001|Overall Study|Does not meet entrance criteria|0|||
33580575|NCT01393899|102016901|FG002|Overall Study|Does not meet entrance criteria|1|||
33580576|NCT01393899|102016899|FG000|Overall Study|Lack of Efficacy|26|||
33580577|NCT01393899|102016900|FG001|Overall Study|Lack of Efficacy|21|||
33580578|NCT01393899|102016901|FG002|Overall Study|Lack of Efficacy|16|||
33580579|NCT01393899|102016899|FG000|Overall Study|Adverse Event|1|||
33580580|NCT01393899|102016900|FG001|Overall Study|Adverse Event|5|||
33580581|NCT01393899|102016901|FG002|Overall Study|Adverse Event|3|||
33580582|NCT01345929|102016908|FG000|Overall Study|Withdrawal by Subject|9|||
33580583|NCT01345929|102016909|FG001|Overall Study|Withdrawal by Subject|8|||
33580584|NCT01345929|102016908|FG000|Overall Study|Lost to Follow-up|9|||
33580585|NCT01345929|102016909|FG001|Overall Study|Lost to Follow-up|9|||
33580586|NCT01345929|102016908|FG000|Overall Study|Adverse Event|0|||
33580587|NCT01345929|102016909|FG001|Overall Study|Adverse Event|1|||
33580588|NCT01345929|102016908|FG000|Overall Study|Didn't meet eligibility criteria|2|||
33580589|NCT01345929|102016909|FG001|Overall Study|Didn't meet eligibility criteria|0|||
33580590|NCT01345929|102016908|FG000|Overall Study|40,000 CFU/ML|1|||
33580591|NCT01345929|102016909|FG001|Overall Study|40,000 CFU/ML|0|||
33580592|NCT01345929|102016908|FG000|Overall Study|Patient withdrawal|0|||
33580593|NCT01345929|102016909|FG001|Overall Study|Patient withdrawal|1|||
33580594|NCT02441101|102016910|FG000|Overall Study|Withdrawal by Subject|1|||
33580595|NCT02441101|102016911|FG001|Overall Study|Withdrawal by Subject|0|||
33580596|NCT02441101|102016910|FG000|Overall Study|Lost to Follow-up|1|||
33580597|NCT02441101|102016911|FG001|Overall Study|Lost to Follow-up|0|||
33580598|NCT02441101|102016910|FG000|Overall Study|PI relocated and study terminated|1|||
33580599|NCT02441101|102016911|FG001|Overall Study|PI relocated and study terminated|0|||
33580600|NCT00506454|102016912|FG000|Overall Study|Withdrawal by Subject|1|||
33580601|NCT00506454|102016913|FG001|Overall Study|Withdrawal by Subject|1|||
33580602|NCT00442416|102016914|FG000|Overall Study|Adverse Event|4|||
33580603|NCT00442416|102016915|FG001|Overall Study|Adverse Event|1|||
33580604|NCT00442416|102016914|FG000|Overall Study|Death|1|||
33580605|NCT00442416|102016915|FG001|Overall Study|Death|0|||
33580606|NCT00442416|102016914|FG000|Overall Study|Lack of Efficacy|2|||
33640966|NCT01254422|102236549|FG001|Overall Study|Protocol Violation|0|||
33142117|NCT02273739|100434780|FG001|Overall Study|Death|0|||
33421139|NCT01106352|101431724|FG002|Overall Study|Lost to Follow-up|0|||
33421140|NCT01106352|101431725|FG003|Overall Study|Lost to Follow-up|0|||
33421141|NCT01106352|101431726|FG004|Overall Study|Lost to Follow-up|1|||
33421142|NCT01106352|101431722|FG000|Overall Study|Death|0|||
33580607|NCT00442416|102016915|FG001|Overall Study|Lack of Efficacy|0|||
33580608|NCT00442416|102016914|FG000|Overall Study|Protocol Violation|2|||
33580609|NCT00442416|102016915|FG001|Overall Study|Protocol Violation|3|||
33580610|NCT00442416|102016914|FG000|Overall Study|Withdrew consent|1|||
33580611|NCT00442416|102016915|FG001|Overall Study|Withdrew consent|2|||
33580612|NCT00442416|102016914|FG000|Overall Study|Administrative/Other|27|||
33580613|NCT00442416|102016915|FG001|Overall Study|Administrative/Other|33|||
33640967|NCT01254422|102236548|FG000|Overall Study|Adverse Event|1|||
33142118|NCT02273739|100434781|FG002|Overall Study|Death|0|||
33142119|NCT02273739|100434782|FG003|Overall Study|Death|2|||
33142120|NCT02273739|100434779|FG000|Overall Study|Adverse Event|0|||
33142121|NCT02273739|100434780|FG001|Overall Study|Adverse Event|0|||
33142122|NCT02273739|100434781|FG002|Overall Study|Adverse Event|0|||
33370708|NCT01599754|101243485|FG000|Overall Study|Participant noncompliance|4|||
33580614|NCT01146613|102016918|FG000|Overall Study|Lost to Follow-up|3|||
33580615|NCT01146613|102016919|FG001|Overall Study|Lost to Follow-up|8|||
33580616|NCT01146613|102016918|FG000|Overall Study|Lack of Efficacy|0|||
33580617|NCT01146613|102016919|FG001|Overall Study|Lack of Efficacy|1|||
33580618|NCT01146613|102016918|FG000|Overall Study|Death|1|||
33580619|NCT01146613|102016919|FG001|Overall Study|Death|0|||
33580620|NCT01146613|102016918|FG000|Overall Study|Physician Decision|1|||
33580621|NCT01146613|102016919|FG001|Overall Study|Physician Decision|0|||
33580622|NCT01146613|102016918|FG000|Overall Study|Withdrawal by Subject|0|||
33580623|NCT01146613|102016919|FG001|Overall Study|Withdrawal by Subject|3|||
33580624|NCT01146613|102016918|FG000|Overall Study|schedule conflict|1|||
33580625|NCT01146613|102016919|FG001|Overall Study|schedule conflict|0|||
33580626|NCT01146613|102016918|FG000|Overall Study|Outpatient detox|1|||
33580627|NCT01146613|102016919|FG001|Overall Study|Outpatient detox|0|||
33580628|NCT01722994|102016920|FG000|Overall Study|Missing data|25|||
33580629|NCT01722994|102016921|FG001|Overall Study|Missing data|17|||
33580630|NCT00699413|102016922|FG000|Overall Study|Withdrawal by Subject|0|||
33580631|NCT00699413|102016923|FG001|Overall Study|Withdrawal by Subject|2|||
33580632|NCT00699413|102016922|FG000|Overall Study|Study terminated by sponsor|4|||
33580633|NCT00699413|102016923|FG001|Overall Study|Study terminated by sponsor|2|||
33580634|NCT03943290|102016924|FG000|Overall Study|Sponsor Terminated Study|6|||
33580635|NCT03943290|102016925|FG001|Overall Study|Sponsor Terminated Study|1|||
33580636|NCT03943290|102016926|FG002|Overall Study|Sponsor Terminated Study|11|||
33370709|NCT01599754|101243486|FG001|Overall Study|Participant noncompliance|4|||
33370710|NCT01599754|101243485|FG000|Overall Study|Lost to Follow-up|13|||
33370711|NCT01599754|101243486|FG001|Overall Study|Lost to Follow-up|6|||
33580637|NCT03943290|102016927|FG003|Overall Study|Sponsor Terminated Study|6|||
33580638|NCT03943290|102016928|FG004|Overall Study|Sponsor Terminated Study|7|||
33580639|NCT03943290|102016929|FG005|Overall Study|Sponsor Terminated Study|6|||
33580640|NCT03943290|102016930|FG006|Overall Study|Sponsor Terminated Study|6|||
33580641|NCT03943290|102016931|FG007|Overall Study|Sponsor Terminated Study|7|||
33580642|NCT03943290|102016932|FG008|Overall Study|Sponsor Terminated Study|8|||
33580643|NCT03943290|102016924|FG000|Overall Study|Lost to Follow-up|1|||
33580644|NCT03943290|102016925|FG001|Overall Study|Lost to Follow-up|0|||
33580645|NCT03943290|102016926|FG002|Overall Study|Lost to Follow-up|1|||
33580646|NCT03943290|102016927|FG003|Overall Study|Lost to Follow-up|0|||
33580647|NCT03943290|102016928|FG004|Overall Study|Lost to Follow-up|0|||
33580648|NCT03943290|102016929|FG005|Overall Study|Lost to Follow-up|0|||
33580649|NCT03943290|102016930|FG006|Overall Study|Lost to Follow-up|0|||
33580650|NCT03943290|102016931|FG007|Overall Study|Lost to Follow-up|1|||
33370712|NCT01599754|101243485|FG000|Overall Study|Death|31|||
33370713|NCT01599754|101243486|FG001|Overall Study|Death|33|||
33370714|NCT01599754|101243485|FG000|Overall Study|Adverse Event|3|||
33370715|NCT01599754|101243486|FG001|Overall Study|Adverse Event|2|||
33370716|NCT01599754|101243485|FG000|Overall Study|Investigator decision|1|||
33370717|NCT01599754|101243486|FG001|Overall Study|Investigator decision|3|||
33370718|NCT01599754|101243485|FG000|Overall Study|Withdrawal by Subject|24|||
33370719|NCT01599754|101243486|FG001|Overall Study|Withdrawal by Subject|25|||
33370720|NCT01599754|101243485|FG000|Overall Study|Study terminated by sponsor|282|||
33370721|NCT01599754|101243486|FG001|Overall Study|Study terminated by sponsor|285|||
33370722|NCT01876732|101243487|FG000|Overall Study|MMA was not over 800mg/dL|75|||
33370723|NCT00369668|101243490|FG000|Overall Study|Lack of Efficacy|4|||
33421143|NCT01106352|101431723|FG001|Overall Study|Death|0|||
33421144|NCT01106352|101431724|FG002|Overall Study|Death|1|||
33580651|NCT03943290|102016932|FG008|Overall Study|Lost to Follow-up|0|||
33580652|NCT03943290|102016924|FG000|Overall Study|Withdrawal by Subject|0|||
33580653|NCT03943290|102016925|FG001|Overall Study|Withdrawal by Subject|0|||
33142123|NCT02273739|100434782|FG003|Overall Study|Adverse Event|1|||
33142124|NCT02273739|100434779|FG000|Overall Study|Withdrawal by Subject|0|||
33142125|NCT02273739|100434780|FG001|Overall Study|Withdrawal by Subject|0|||
33640968|NCT01254422|102236549|FG001|Overall Study|Adverse Event|0|||
33142126|NCT02273739|100434781|FG002|Overall Study|Withdrawal by Subject|2|||
33580654|NCT03943290|102016926|FG002|Overall Study|Withdrawal by Subject|1|||
33142127|NCT02273739|100434782|FG003|Overall Study|Withdrawal by Subject|1|||
33142128|NCT02273739|100434779|FG000|Overall Study|Physician Decision|0|||
33370724|NCT00369668|101243491|FG001|Overall Study|Lack of Efficacy|5|||
33370725|NCT00369668|101243492|FG002|Overall Study|Lack of Efficacy|7|||
33421145|NCT01106352|101431725|FG003|Overall Study|Death|3|||
33580655|NCT03943290|102016927|FG003|Overall Study|Withdrawal by Subject|0|||
33580656|NCT03943290|102016928|FG004|Overall Study|Withdrawal by Subject|0|||
33580657|NCT03943290|102016929|FG005|Overall Study|Withdrawal by Subject|0|||
33580658|NCT03943290|102016930|FG006|Overall Study|Withdrawal by Subject|0|||
33580659|NCT03943290|102016931|FG007|Overall Study|Withdrawal by Subject|0|||
33370726|NCT02618928|101243493|FG000|Overall Study|Failure to Return|28|||
33370727|NCT02618928|101243493|FG000|Overall Study|Insufficient Virological Response|1|||
33370728|NCT02618928|101243493|FG000|Overall Study|Withdrawal by Subject|2|||
33370729|NCT02618928|101243493|FG000|Overall Study|Death|3|||
33370730|NCT02618928|101243493|FG000|Overall Study|Other|11|||
33370731|NCT02618928|101243493|FG000|Overall Study|Missing|6|||
33370732|NCT02618928|101243493|FG000|Overall Study|Treatment Never Started|7|||
33370733|NCT01614769|101243494|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
33370734|NCT01614769|101243495|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
33370735|NCT01614769|101243496|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
33370736|NCT01614769|101243497|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
33370737|NCT01614769|101243498|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
33370738|NCT01614769|101243499|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
33370739|NCT01614769|101243494|FG000|Period 1|Protocol Violation|0|||
33370740|NCT01614769|101243495|FG001|Period 1|Protocol Violation|0|||
33370741|NCT01614769|101243496|FG002|Period 1|Protocol Violation|0|||
33370742|NCT01614769|101243497|FG003|Period 1|Protocol Violation|1|||
33370743|NCT01614769|101243498|FG004|Period 1|Protocol Violation|0|||
33370744|NCT01614769|101243499|FG005|Period 1|Protocol Violation|0|||
33370745|NCT01614769|101243494|FG000|Period 1|Withdrawal by Subject|1|||
33370746|NCT01614769|101243495|FG001|Period 1|Withdrawal by Subject|0|||
33370747|NCT01614769|101243496|FG002|Period 1|Withdrawal by Subject|0|||
33421146|NCT01106352|101431726|FG004|Overall Study|Death|1|||
33421147|NCT01106352|101431722|FG000|Overall Study|Disease progression|0|||
33421148|NCT01106352|101431723|FG001|Overall Study|Disease progression|0|||
33421149|NCT01106352|101431724|FG002|Overall Study|Disease progression|0|||
33421150|NCT01106352|101431725|FG003|Overall Study|Disease progression|1|||
33421151|NCT01106352|101431726|FG004|Overall Study|Disease progression|0|||
33421152|NCT01106352|101431722|FG000|Overall Study|Withdrawal by Subject|0|||
33421153|NCT01106352|101431723|FG001|Overall Study|Withdrawal by Subject|0|||
33421154|NCT01106352|101431724|FG002|Overall Study|Withdrawal by Subject|0|||
33421155|NCT01106352|101431725|FG003|Overall Study|Withdrawal by Subject|3|||
33421156|NCT01106352|101431726|FG004|Overall Study|Withdrawal by Subject|2|||
33421157|NCT01106352|101431722|FG000|Overall Study|Went on hospice|0|||
33421158|NCT01106352|101431723|FG001|Overall Study|Went on hospice|0|||
33142129|NCT02273739|100434780|FG001|Overall Study|Physician Decision|0|||
33142130|NCT02273739|100434781|FG002|Overall Study|Physician Decision|0|||
33142131|NCT02273739|100434782|FG003|Overall Study|Physician Decision|1|||
33142132|NCT00817479|100434783|FG000|Overall Study|Physician Decision|1|||
33142133|NCT00817479|100434784|FG001|Overall Study|Physician Decision|1|||
33142134|NCT00134784|100434786|FG000|Overall Study|Withdrawal by Subject|2|||
33142135|NCT00134784|100434787|FG001|Overall Study|Withdrawal by Subject|2|||
33142136|NCT00134784|100434788|FG002|Overall Study|Withdrawal by Subject|2|||
33142137|NCT00134784|100434789|FG003|Overall Study|Withdrawal by Subject|1|||
33142138|NCT02483533|100434798|FG000|Overall Study|Lack of Efficacy|50|||
33142139|NCT02483533|100434799|FG001|Overall Study|Lack of Efficacy|50|||
33142140|NCT00706849|100434800|FG000|Treatment Period|Adverse Event|0|||
33142141|NCT00706849|100434801|FG001|Treatment Period|Adverse Event|9|||
33142142|NCT00706849|100434800|FG000|Treatment Period|Other|0|||
33142143|NCT00706849|100434801|FG001|Treatment Period|Other|1|||
33142144|NCT00706849|100434800|FG000|Follow-up Period|Withdrawal by Subject|0|||
33142145|NCT00706849|100434801|FG001|Follow-up Period|Withdrawal by Subject|2|||
33142146|NCT00706849|100434800|FG000|Follow-up Period|Protocol non-compliance|0|||
33142147|NCT00706849|100434801|FG001|Follow-up Period|Protocol non-compliance|1|||
33142148|NCT00740051|100434802|FG000|Overall Study|Lack of Efficacy|2|||
33142149|NCT00740051|100434803|FG001|Overall Study|Lack of Efficacy|5|||
33142150|NCT00740051|100434802|FG000|Overall Study|Adverse Event|1|||
33142151|NCT00740051|100434803|FG001|Overall Study|Adverse Event|4|||
33142152|NCT00740051|100434802|FG000|Overall Study|Protocol Violation|2|||
33142153|NCT00740051|100434803|FG001|Overall Study|Protocol Violation|6|||
33142154|NCT00740051|100434802|FG000|Overall Study|Lost to Follow-up|3|||
33142155|NCT00740051|100434803|FG001|Overall Study|Lost to Follow-up|8|||
33142156|NCT00740051|100434802|FG000|Overall Study|Withdrawal by Subject|6|||
33240562|NCT02403674|100780076|FG000|Base Study|Lack of Efficacy|31|||
33240563|NCT02403674|100780077|FG001|Base Study|Lack of Efficacy|23|||
33142157|NCT00740051|100434803|FG001|Overall Study|Withdrawal by Subject|8|||
33240564|NCT02403674|100780076|FG000|Base Study|Lost to Follow-up|6|||
33142158|NCT00740051|100434802|FG000|Overall Study|Other reason (not specified)|4|||
33370748|NCT01614769|101243497|FG003|Period 1|Withdrawal by Subject|0|||
33370749|NCT01614769|101243498|FG004|Period 1|Withdrawal by Subject|0|||
33370750|NCT01614769|101243499|FG005|Period 1|Withdrawal by Subject|0|||
33370751|NCT01614769|101243494|FG000|Period 3|Withdrawal by Subject|0|||
33421159|NCT01106352|101431724|FG002|Overall Study|Went on hospice|0|||
33421160|NCT01106352|101431725|FG003|Overall Study|Went on hospice|1|||
33421161|NCT01106352|101431726|FG004|Overall Study|Went on hospice|0|||
33421162|NCT01106352|101431722|FG000|Overall Study|Subject entered hospice|0|||
33421163|NCT01106352|101431723|FG001|Overall Study|Subject entered hospice|0|||
33421164|NCT01106352|101431724|FG002|Overall Study|Subject entered hospice|0|||
33421165|NCT01106352|101431725|FG003|Overall Study|Subject entered hospice|1|||
33580660|NCT03943290|102016932|FG008|Overall Study|Withdrawal by Subject|0|||
33580661|NCT00529243|102016933|FG000|Overall Study|Adverse Event|1|||
33580662|NCT00529243|102016933|FG000|Overall Study|Death|1|||
33580663|NCT00529243|102016933|FG000|Overall Study|Relocated|1|||
33580664|NCT02063984|102016936|FG000|Overall Study|Lost to Follow-up|6|||
33580665|NCT02063984|102016937|FG001|Overall Study|Lost to Follow-up|5|||
33580666|NCT01747915|102016940|FG000|Overall Study|Other|1|||
33580667|NCT01747915|102016941|FG001|Overall Study|Other|1|||
33580668|NCT01747915|102016942|FG002|Overall Study|Other|1|||
33580669|NCT01747915|102016940|FG000|Overall Study|Adverse Event|8|||
33580670|NCT01747915|102016941|FG001|Overall Study|Adverse Event|5|||
33580671|NCT01747915|102016942|FG002|Overall Study|Adverse Event|2|||
33580672|NCT01747915|102016940|FG000|Overall Study|Death|0|||
33580673|NCT01747915|102016941|FG001|Overall Study|Death|0|||
33142159|NCT00740051|100434803|FG001|Overall Study|Other reason (not specified)|1|||
33142160|NCT02274038|100434806|FG000|Overall Study|Death|1|||
33142161|NCT01224782|100434809|FG000|Overall Study|Lost to Follow-up|177|||
33142162|NCT01224782|100434809|FG000|Overall Study|Withdrawal by Subject|16|||
33142163|NCT01224782|100434809|FG000|Overall Study|Death|14|||
33142164|NCT01224782|100434809|FG000|Overall Study|Improvement|13|||
33142165|NCT01224782|100434809|FG000|Overall Study|Adverse Event|12|||
33142166|NCT01224782|100434809|FG000|Overall Study|Adverse Reaction|11|||
33142167|NCT01224782|100434809|FG000|Overall Study|Noncompliance|10|||
33370752|NCT01614769|101243495|FG001|Period 3|Withdrawal by Subject|0|||
33580674|NCT01747915|102016942|FG002|Overall Study|Death|1|||
33580675|NCT01747915|102016940|FG000|Overall Study|Lack of Efficacy|0|||
33580676|NCT01747915|102016941|FG001|Overall Study|Lack of Efficacy|1|||
33580677|NCT01747915|102016942|FG002|Overall Study|Lack of Efficacy|0|||
33580678|NCT01747915|102016940|FG000|Overall Study|Lost to Follow-up|1|||
33580679|NCT01747915|102016941|FG001|Overall Study|Lost to Follow-up|0|||
33580680|NCT01747915|102016942|FG002|Overall Study|Lost to Follow-up|0|||
33580681|NCT01747915|102016940|FG000|Overall Study|Withdrawal by Subject|4|||
33580682|NCT01747915|102016941|FG001|Overall Study|Withdrawal by Subject|4|||
33580683|NCT01747915|102016942|FG002|Overall Study|Withdrawal by Subject|1|||
33580684|NCT01747915|102016940|FG000|Overall Study|Protocol Violation|1|||
33580685|NCT01747915|102016941|FG001|Overall Study|Protocol Violation|0|||
33580686|NCT01747915|102016942|FG002|Overall Study|Protocol Violation|0|||
33580687|NCT01747915|102016940|FG000|Overall Study|Pregnancy|0|||
33580688|NCT01747915|102016941|FG001|Overall Study|Pregnancy|0|||
33580689|NCT01747915|102016942|FG002|Overall Study|Pregnancy|1|||
33580690|NCT03666988|102016943|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
33580691|NCT03666988|102016944|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
33640969|NCT01254422|102236548|FG000|Overall Study|Serious adverse event|0|||
33640970|NCT01254422|102236549|FG001|Overall Study|Serious adverse event|1|||
33640971|NCT01254422|102236548|FG000|Overall Study|Lost to Follow-up|1|||
33640972|NCT01254422|102236549|FG001|Overall Study|Lost to Follow-up|0|||
33640973|NCT02281383|102236550|FG000|Overall Study|Progressive Disease|1|||
33640974|NCT02281383|102236550|FG000|Overall Study|Withdrawal by Subject|6|||
33640975|NCT02281383|102236550|FG000|Overall Study|Protocol Violation|2|||
33640976|NCT02281383|102236550|FG000|Overall Study|Death|1|||
33640977|NCT02281383|102236550|FG000|Overall Study|Adverse Event|2|||
33640978|NCT04646044|102236551|FG000|Overall Study|Lost to Follow-up|0|||
33640979|NCT04646044|102236552|FG001|Overall Study|Lost to Follow-up|0|||
33142168|NCT01224782|100434809|FG000|Overall Study|Other|4|||
33142169|NCT01224782|100434809|FG000|Overall Study|Start of Dialysis|3|||
33370753|NCT01614769|101243496|FG002|Period 3|Withdrawal by Subject|1|||
33370754|NCT01614769|101243497|FG003|Period 3|Withdrawal by Subject|0|||
33370755|NCT01614769|101243498|FG004|Period 3|Withdrawal by Subject|0|||
33370756|NCT01614769|101243499|FG005|Period 3|Withdrawal by Subject|0|||
33370757|NCT01912729|101243500|FG000|Overall Study|Withdrawal by Subject|0|||
33370758|NCT01912729|101243501|FG001|Overall Study|Withdrawal by Subject|1|||
33640980|NCT04646044|102236553|FG002|Overall Study|Lost to Follow-up|1|||
33142170|NCT01224782|100434809|FG000|Overall Study|Change of Treatment|1|||
33370759|NCT01721408|101243502|FG000|Overall Study|Adverse Event|6|||
33580692|NCT03666988|102016945|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
33580693|NCT03666988|102016946|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
33640981|NCT04646044|102236554|FG003|Overall Study|Lost to Follow-up|0|||
33640982|NCT04646044|102236551|FG000|Overall Study|Withdrawal by Subject|0|||
33370760|NCT01721408|101243503|FG001|Overall Study|Adverse Event|1|||
33370761|NCT01721408|101243502|FG000|Overall Study|Death|1|||
33580694|NCT03666988|102016947|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
33580695|NCT03666988|102016948|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
33580696|NCT03666988|102016943|FG000|Part 1 (Up to 28 Months)|Other|0|||
33142171|NCT01224782|100434809|FG000|Overall Study|Financial Reasons|1|||
33580697|NCT03666988|102016944|FG001|Part 1 (Up to 28 Months)|Other|1|||
33142172|NCT01224782|100434809|FG000|Overall Study|Deterioration|1|||
33370762|NCT01721408|101243503|FG001|Overall Study|Death|0|||
33370763|NCT01721408|101243502|FG000|Overall Study|Insufficient clinical response|15|||
33580698|NCT03666988|102016945|FG002|Part 1 (Up to 28 Months)|Other|1|||
33580699|NCT03666988|102016946|FG003|Part 1 (Up to 28 Months)|Other|0|||
33640983|NCT04646044|102236552|FG001|Overall Study|Withdrawal by Subject|1|||
33142173|NCT01224782|100434809|FG000|Overall Study|Transplantation|1|||
33421166|NCT01106352|101431726|FG004|Overall Study|Subject entered hospice|0|||
33421167|NCT01106352|101431722|FG000|Overall Study|Home hospice since July 2013|0|||
33421168|NCT01106352|101431723|FG001|Overall Study|Home hospice since July 2013|0|||
33421169|NCT01106352|101431724|FG002|Overall Study|Home hospice since July 2013|0|||
33421170|NCT01106352|101431725|FG003|Overall Study|Home hospice since July 2013|1|||
33421171|NCT01106352|101431726|FG004|Overall Study|Home hospice since July 2013|0|||
33421172|NCT00647426|101431727|FG000|Overall Study|Withdrawal by Subject|2|||
33421173|NCT05349188|101431728|FG000|Overall Study|Withdrawal by Subject|1|||
33421174|NCT05349188|101431729|FG001|Overall Study|Withdrawal by Subject|0|||
33142174|NCT01505647|100434810|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
33142175|NCT01505647|100434811|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
33580700|NCT03666988|102016947|FG004|Part 1 (Up to 28 Months)|Other|0|||
33580701|NCT03666988|102016948|FG005|Part 1 (Up to 28 Months)|Other|0|||
33580702|NCT03666988|102016943|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
33142176|NCT01505647|100434810|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
33142177|NCT01505647|100434811|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
33142178|NCT01505647|100434810|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
33142179|NCT01505647|100434811|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
33580703|NCT03666988|102016944|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
33580704|NCT03666988|102016945|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
33142180|NCT01505647|100434810|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
33142181|NCT01505647|100434811|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
33142182|NCT01505647|100434810|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
33142183|NCT01505647|100434811|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
33421175|NCT00709735|101431730|FG000|Overall Study|Lost to Follow-up|1|||
33421176|NCT00709735|101431731|FG001|Overall Study|Lost to Follow-up|1|||
33421177|NCT00709735|101431730|FG000|Overall Study|Relapse into Opioid Abuse|0|||
33421178|NCT00709735|101431731|FG001|Overall Study|Relapse into Opioid Abuse|1|||
33421179|NCT00709735|101431730|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
33421180|NCT00709735|101431731|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
33421181|NCT05180630|101431732|FG000|First Intervention|Physician Decision|0|||
33421182|NCT05180630|101431733|FG001|First Intervention|Physician Decision|0|||
33421183|NCT05180630|101431734|FG002|First Intervention|Physician Decision|3|||
33421184|NCT02962739|101431735|FG000|Overall Study|Withdrawal by Subject|0|||
33421185|NCT02962739|101431736|FG001|Overall Study|Withdrawal by Subject|1|||
33421186|NCT02962739|101431737|FG002|Overall Study|Withdrawal by Subject|0|||
33421187|NCT02962739|101431738|FG003|Overall Study|Withdrawal by Subject|0|||
33142184|NCT03044574|100434817|FG000|Overall Study|Lost to Follow-up|37|||
33142185|NCT03044574|100434818|FG001|Overall Study|Lost to Follow-up|45|||
33142186|NCT04461600|100434821|FG000|Overall Study|Death|6|||
33142187|NCT04461600|100434822|FG001|Overall Study|Death|5|||
33240565|NCT02403674|100780077|FG001|Base Study|Lost to Follow-up|8|||
33240566|NCT02403674|100780076|FG000|Base Study|Withdrawal by Subject|10|||
33240567|NCT02403674|100780077|FG001|Base Study|Withdrawal by Subject|17|||
33240568|NCT02403674|100780076|FG000|Base Study|Physician Decision|2|||
33240569|NCT02403674|100780077|FG001|Base Study|Physician Decision|2|||
33240570|NCT02403674|100780076|FG000|Base Study|Pregnancy|2|||
33240571|NCT02403674|100780077|FG001|Base Study|Pregnancy|2|||
33240572|NCT02403674|100780076|FG000|Base Study|Protocol Violation|8|||
33240573|NCT02403674|100780077|FG001|Base Study|Protocol Violation|4|||
33240574|NCT02403674|100780076|FG000|Base Study|Non-Compliance with study drug|1|||
33240575|NCT02403674|100780077|FG001|Base Study|Non-Compliance with study drug|4|||
33421188|NCT02962739|101431739|FG004|Overall Study|Withdrawal by Subject|0|||
33421189|NCT02962739|101431740|FG005|Overall Study|Withdrawal by Subject|0|||
33421190|NCT02962739|101431735|FG000|Overall Study|Protocol Violation|0|||
33580705|NCT03666988|102016946|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
33580706|NCT03666988|102016947|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
33580707|NCT03666988|102016948|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
33580708|NCT03666988|102016943|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
33580709|NCT03666988|102016944|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
33580710|NCT03666988|102016945|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
33580711|NCT03666988|102016946|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
33640984|NCT04646044|102236553|FG002|Overall Study|Withdrawal by Subject|0|||
33640985|NCT04646044|102236554|FG003|Overall Study|Withdrawal by Subject|0|||
33142188|NCT04461600|100434821|FG000|Overall Study|Withdrawal by Subject|0|||
33580712|NCT03666988|102016947|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
33142189|NCT04461600|100434822|FG001|Overall Study|Withdrawal by Subject|1|||
33240576|NCT02403674|100780076|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
33240577|NCT02403674|100780077|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
33240578|NCT02403674|100780076|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
33421191|NCT02962739|101431736|FG001|Overall Study|Protocol Violation|0|||
33421192|NCT02962739|101431737|FG002|Overall Study|Protocol Violation|1|||
33421193|NCT02962739|101431738|FG003|Overall Study|Protocol Violation|0|||
33240579|NCT02403674|100780077|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
33240580|NCT02403674|100780076|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
33240581|NCT02403674|100780077|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
33240582|NCT02403674|100780076|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
33240583|NCT02403674|100780077|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
33240584|NCT02403674|100780076|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
33240585|NCT02403674|100780077|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
33240586|NCT02403674|100780076|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
33240587|NCT02403674|100780077|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
33240588|NCT02403674|100780076|FG000|Study Extension 1 (Open-Label)|Death|1|||
33240589|NCT02403674|100780077|FG001|Study Extension 1 (Open-Label)|Death|0|||
33240590|NCT02403674|100780076|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
33240591|NCT02403674|100780077|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
33240592|NCT02403674|100780076|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
33240593|NCT02403674|100780077|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
33240594|NCT02403674|100780076|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
33240595|NCT02403674|100780077|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
33240596|NCT02403674|100780076|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
33240597|NCT02403674|100780077|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
33240598|NCT02403674|100780076|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
33240599|NCT02403674|100780077|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
33240600|NCT02403674|100780076|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
33240601|NCT02403674|100780077|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
33240602|NCT02403674|100780076|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
33240603|NCT02403674|100780077|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
33240604|NCT02403674|100780076|FG000|Study Extension 2 (Open-Label)|Death|2|||
33240605|NCT02403674|100780077|FG001|Study Extension 2 (Open-Label)|Death|2|||
33240606|NCT02403674|100780076|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
33240607|NCT02403674|100780077|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
33240608|NCT02403674|100780076|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
33240609|NCT02403674|100780077|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
33240610|NCT02403674|100780076|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
33240611|NCT02403674|100780077|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
33240612|NCT02403674|100780076|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
33240613|NCT02403674|100780077|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
33240614|NCT02403674|100780076|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
33240615|NCT02403674|100780077|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
33240616|NCT02403674|100780076|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
33240617|NCT02403674|100780077|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
33240618|NCT02403674|100780076|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
33240619|NCT02403674|100780077|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
33240620|NCT01543685|100783061|FG000|Overall Study|Lack of Efficacy|1|||
33240621|NCT01543685|100783062|FG001|Overall Study|Lack of Efficacy|2|||
33240622|NCT01543685|100783063|FG002|Overall Study|Lack of Efficacy|2|||
33240623|NCT01543685|100783064|FG003|Overall Study|Lack of Efficacy|0|||
33240624|NCT01543685|100783065|FG004|Overall Study|Lack of Efficacy|2|||
33240625|NCT01543685|100783061|FG000|Overall Study|Adverse Event|2|||
33240626|NCT01543685|100783062|FG001|Overall Study|Adverse Event|1|||
33240627|NCT01543685|100783063|FG002|Overall Study|Adverse Event|0|||
33240628|NCT01543685|100783064|FG003|Overall Study|Adverse Event|0|||
33240629|NCT01543685|100783065|FG004|Overall Study|Adverse Event|2|||
33240630|NCT01657682|100783066|FG000|Overall Study|Lost to Follow-up|1|||
33240631|NCT01657682|100783067|FG001|Overall Study|Lost to Follow-up|0|||
33240632|NCT01657682|100783068|FG002|Overall Study|Lost to Follow-up|0|||
33240633|NCT01657682|100783066|FG000|Overall Study|Withdrawal by Subject|0|||
33240634|NCT01657682|100783067|FG001|Overall Study|Withdrawal by Subject|1|||
33240635|NCT01657682|100783068|FG002|Overall Study|Withdrawal by Subject|1|||
33240636|NCT01657682|100783066|FG000|Overall Study|Adverse Event|0|||
33240637|NCT01657682|100783067|FG001|Overall Study|Adverse Event|1|||
33240638|NCT01657682|100783068|FG002|Overall Study|Adverse Event|0|||
33240639|NCT02084082|100783069|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
33370764|NCT01721408|101243503|FG001|Overall Study|Insufficient clinical response|6|||
33370765|NCT01721408|101243502|FG000|Overall Study|No longer willing to participate study|9|||
33240640|NCT02084082|100783070|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
33240641|NCT02084082|100783071|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
33240642|NCT02084082|100783072|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
33240643|NCT02084082|100783069|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
33240644|NCT02084082|100783070|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
33240645|NCT02084082|100783071|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
33240646|NCT02084082|100783072|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
33240647|NCT01244828|100783073|FG000|Overall Study|Adverse Event|37|||
33240648|NCT01244828|100783073|FG000|Overall Study|Withdrawal by Subject|31|||
33370766|NCT01721408|101243503|FG001|Overall Study|No longer willing to participate study|10|||
33370767|NCT01721408|101243502|FG000|Overall Study|Protocol Violation|0|||
33370768|NCT01721408|101243503|FG001|Overall Study|Protocol Violation|2|||
33580713|NCT03666988|102016948|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
33142190|NCT00466687|100434828|FG000|Overall Study|Adverse Event|1|||
33142191|NCT00466687|100434828|FG000|Overall Study|Other complicating illness|3|||
33142192|NCT00466687|100434828|FG000|Overall Study|Withdrawal by Subject|1|||
33142193|NCT00466687|100434828|FG000|Overall Study|Disease progression|29|||
33142194|NCT02554279|100434829|FG000|Overall Study|Adverse Event|2|||
33142195|NCT02554279|100434830|FG001|Overall Study|Adverse Event|5|||
33142196|NCT02554279|100434829|FG000|Overall Study|Lost to Follow-up|3|||
33142197|NCT02554279|100434830|FG001|Overall Study|Lost to Follow-up|2|||
33142198|NCT02554279|100434829|FG000|Overall Study|Withdrawal by Subject|6|||
33142199|NCT02554279|100434830|FG001|Overall Study|Withdrawal by Subject|4|||
33142200|NCT02554279|100434829|FG000|Overall Study|Protocol Violation|2|||
33142201|NCT02554279|100434830|FG001|Overall Study|Protocol Violation|1|||
33142202|NCT02554279|100434829|FG000|Overall Study|Other reason|19|||
33142203|NCT02554279|100434830|FG001|Overall Study|Other reason|6|||
33142204|NCT03055377|100434831|FG000|Treatment Phase|Lost to Follow-up|28|||
33142205|NCT03055377|100434832|FG001|Treatment Phase|Lost to Follow-up|24|||
33142206|NCT03055377|100434831|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
33142207|NCT03055377|100434832|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
33142208|NCT01077375|100434837|FG000|Overall Study|Adverse Event|2|||
33142209|NCT01077375|100434838|FG001|Overall Study|Adverse Event|15|||
33142210|NCT01077375|100434837|FG000|Overall Study|Lack of Efficacy|6|||
33142211|NCT01077375|100434838|FG001|Overall Study|Lack of Efficacy|8|||
33142212|NCT01077375|100434837|FG000|Overall Study|Withdrawal by Subject|0|||
33142213|NCT01077375|100434838|FG001|Overall Study|Withdrawal by Subject|6|||
33142214|NCT01077375|100434837|FG000|Overall Study|Lost to Follow-up|2|||
33142215|NCT01077375|100434838|FG001|Overall Study|Lost to Follow-up|5|||
33142216|NCT01077375|100434837|FG000|Overall Study|Other Reason|0|||
33142217|NCT01077375|100434838|FG001|Overall Study|Other Reason|1|||
33142218|NCT02239120|100434840|FG000|Overall Study|Death|56|||
33142219|NCT02239120|100434841|FG001|Overall Study|Death|58|||
33142220|NCT02239120|100434840|FG000|Overall Study|Lost to Follow-up|19|||
33142221|NCT02239120|100434841|FG001|Overall Study|Lost to Follow-up|14|||
33142222|NCT03467152|100434842|FG000|Overall Study|Adverse Event|4|||
33142223|NCT03467152|100434843|FG001|Overall Study|Adverse Event|5|||
33142224|NCT03467152|100434844|FG002|Overall Study|Adverse Event|0|||
33142225|NCT03467152|100434842|FG000|Overall Study|Subject Choice|1|||
33142226|NCT03467152|100434843|FG001|Overall Study|Subject Choice|3|||
33142227|NCT03467152|100434844|FG002|Overall Study|Subject Choice|0|||
33142228|NCT03467152|100434842|FG000|Overall Study|Lost to Follow-up|1|||
33142229|NCT03467152|100434843|FG001|Overall Study|Lost to Follow-up|0|||
33142230|NCT03467152|100434844|FG002|Overall Study|Lost to Follow-up|0|||
33142231|NCT03467152|100434842|FG000|Overall Study|Withdrawal by Subject|4|||
33142232|NCT03467152|100434843|FG001|Overall Study|Withdrawal by Subject|2|||
33142233|NCT03467152|100434844|FG002|Overall Study|Withdrawal by Subject|0|||
33142234|NCT03467152|100434842|FG000|Overall Study|Others|3|||
33142235|NCT03467152|100434843|FG001|Overall Study|Others|0|||
33142236|NCT03467152|100434844|FG002|Overall Study|Others|0|||
33142237|NCT03467152|100434842|FG000|Overall Study|Not treated|3|||
33142238|NCT03467152|100434843|FG001|Overall Study|Not treated|1|||
33142239|NCT03467152|100434844|FG002|Overall Study|Not treated|6|||
33142240|NCT03761797|100434847|FG000|Overall Study|Changing hospital|11|||
33142241|NCT03761797|100434847|FG000|Overall Study|Improvement/remission|6|||
33142242|NCT03761797|100434847|FG000|Overall Study|Withdrawal by Subject|19|||
33142243|NCT03761797|100434847|FG000|Overall Study|Lost to Follow-up|33|||
33142244|NCT03761797|100434847|FG000|Overall Study|Adverse Event|37|||
33142245|NCT03761797|100434847|FG000|Overall Study|Case report form (CRF) not collected|5|||
33142246|NCT03761797|100434847|FG000|Overall Study|No patient visit after entry|13|||
33142247|NCT03761797|100434847|FG000|Overall Study|Switch to other diabetes medication|10|||
33142248|NCT03761797|100434847|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
33142249|NCT03761797|100434847|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
33142250|NCT03761797|100434847|FG000|Overall Study|Insufficient effectives|2|||
33142251|NCT03761797|100434847|FG000|Overall Study|Excessive alcohol intake|1|||
33580714|NCT03666988|102016943|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
33142252|NCT01185834|100434848|FG000|Overall Study|Lost to Follow-up|2|||
33142253|NCT01185834|100434848|FG000|Overall Study|Discomfort|4|||
33142254|NCT01185834|100434848|FG000|Overall Study|Biomicroscopy|4|||
33142255|NCT01185834|100434848|FG000|Overall Study|Time/Job Conflict|2|||
33142256|NCT01185834|100434848|FG000|Overall Study|Early exit - Site error|2|||
33370769|NCT01721408|101243502|FG000|Overall Study|Other|3|||
33142257|NCT02692651|100434849|FG000|Study Treatment|Death|7|||
33142258|NCT02692651|100434850|FG001|Study Treatment|Death|3|||
33240649|NCT01244828|100783073|FG000|Overall Study|Lack of Efficacy|7|||
33142259|NCT02692651|100434849|FG000|Study Treatment|comfort care|1|||
33142260|NCT02692651|100434850|FG001|Study Treatment|comfort care|1|||
33142261|NCT02692651|100434849|FG000|Study Treatment|Protocol violation per treating team preference|8|||
33240650|NCT01244828|100783073|FG000|Overall Study|Lost to Follow-up|2|||
33240651|NCT01244828|100783073|FG000|Overall Study|Other reason (not specified)|1|||
33240652|NCT02703532|100783076|FG000|Overall Study|Withdrawal by Subject|0|||
33240653|NCT02703532|100783077|FG001|Overall Study|Withdrawal by Subject|1|||
33240654|NCT02703532|100783078|FG002|Overall Study|Withdrawal by Subject|0|||
33240655|NCT02703532|100783079|FG003|Overall Study|Withdrawal by Subject|1|||
33240656|NCT02703532|100783076|FG000|Overall Study|Lost to Follow-up|2|||
33240657|NCT02703532|100783077|FG001|Overall Study|Lost to Follow-up|0|||
33240658|NCT02703532|100783078|FG002|Overall Study|Lost to Follow-up|2|||
33240659|NCT02703532|100783079|FG003|Overall Study|Lost to Follow-up|0|||
33370770|NCT01721408|101243503|FG001|Overall Study|Other|3|||
33370771|NCT01721408|101243502|FG000|Overall Study|Lost to Follow-up|1|||
33370772|NCT01721408|101243503|FG001|Overall Study|Lost to Follow-up|2|||
33370773|NCT01721408|101243502|FG000|Overall Study|Does not meet entrance criteria|1|||
33370774|NCT01721408|101243503|FG001|Overall Study|Does not meet entrance criteria|0|||
33370775|NCT03213626|101243506|FG000|Overall Study|Adverse Event|1|||
33370776|NCT03213626|101243506|FG000|Overall Study|Progressive Disease|6|||
33370777|NCT00940342|101243508|FG000|Overall Study|Adverse Event|0|||
33370778|NCT00940342|101243509|FG001|Overall Study|Adverse Event|2|||
33370779|NCT00940342|101243510|FG002|Overall Study|Adverse Event|1|||
33240660|NCT03717194|100783080|FG000|Overall Study|Withdrawal by Subject|2|||
33240661|NCT03717194|100783081|FG001|Overall Study|Withdrawal by Subject|4|||
33240662|NCT03717194|100783080|FG000|Overall Study|Adverse Event|1|||
33240663|NCT03717194|100783081|FG001|Overall Study|Adverse Event|1|||
33240664|NCT05550337|100783084|FG000|Overall Study|Lack of Efficacy|0|||
33240665|NCT05550337|100783085|FG001|Overall Study|Lack of Efficacy|0|||
33240666|NCT05550337|100783086|FG002|Overall Study|Lack of Efficacy|1|||
33240667|NCT05550337|100783084|FG000|Overall Study|Adverse Event|1|||
33240668|NCT05550337|100783085|FG001|Overall Study|Adverse Event|5|||
33240669|NCT05550337|100783086|FG002|Overall Study|Adverse Event|0|||
33240670|NCT05550337|100783084|FG000|Overall Study|Withdrawal by Subject|8|||
33240671|NCT05550337|100783085|FG001|Overall Study|Withdrawal by Subject|14|||
33240672|NCT05550337|100783086|FG002|Overall Study|Withdrawal by Subject|10|||
33240673|NCT05550337|100783084|FG000|Overall Study|Pregnancy|0|||
33240674|NCT05550337|100783085|FG001|Overall Study|Pregnancy|0|||
33240675|NCT05550337|100783086|FG002|Overall Study|Pregnancy|1|||
33370780|NCT00506077|101243513|FG000|Treatment Period 1|Adverse Event|2|||
33370781|NCT00506077|101243514|FG001|Treatment Period 1|Adverse Event|1|||
33421194|NCT02962739|101431739|FG004|Overall Study|Protocol Violation|1|||
33421195|NCT02962739|101431740|FG005|Overall Study|Protocol Violation|0|||
33580715|NCT03666988|102016944|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
33580716|NCT03666988|102016945|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
33580717|NCT03666988|102016946|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
33580718|NCT03666988|102016947|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
33580719|NCT03666988|102016948|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
33580720|NCT02808897|102016949|FG000|Overall Study|Lost to Follow-up|9|||
33580721|NCT02808897|102016950|FG001|Overall Study|Lost to Follow-up|11|||
33580722|NCT04774380|102016951|FG000|Overall Study|Patients ongoing study at data cut-off|75|||
33580723|NCT00407602|102016952|FG000|Overall Study|Death - unrelated to device|1|||
33580724|NCT00407602|102016952|FG000|Overall Study|Device explanted|5|||
33580725|NCT00407602|102016952|FG000|Overall Study|Withdrawal by Subject|1|||
33580726|NCT02840253|102016955|FG000|Overall Study|Unsuccessful block|4|||
33580727|NCT00790582|102016956|FG000|Overall Study|Death|14|||
33580728|NCT00790582|102016957|FG001|Overall Study|Death|32|||
33580729|NCT00790582|102016956|FG000|Overall Study|Physician Decision|7|||
33580730|NCT00790582|102016957|FG001|Overall Study|Physician Decision|1|||
33580731|NCT00790582|102016956|FG000|Overall Study|Lost to Follow-up|3|||
33580732|NCT00790582|102016957|FG001|Overall Study|Lost to Follow-up|3|||
33580733|NCT00790582|102016956|FG000|Overall Study|Withdrawal by Subject|7|||
33640986|NCT01134055|102236555|FG000|Overall Study|Adverse Event|5|||
33240676|NCT05550337|100783084|FG000|Overall Study|Protocol Violation|1|||
33240677|NCT05550337|100783085|FG001|Overall Study|Protocol Violation|3|||
33240678|NCT05550337|100783086|FG002|Overall Study|Protocol Violation|4|||
33240679|NCT05550337|100783084|FG000|Overall Study|Physician Decision|2|||
33580734|NCT00790582|102016957|FG001|Overall Study|Withdrawal by Subject|51|||
33580735|NCT01445613|102016958|FG000|30-day Follow-up|Withdrawal by Subject|6|||
33580736|NCT01445613|102016958|FG000|30-day Follow-up|Physician Decision|3|||
33240680|NCT05550337|100783085|FG001|Overall Study|Physician Decision|1|||
33240681|NCT05550337|100783086|FG002|Overall Study|Physician Decision|1|||
33240682|NCT05550337|100783084|FG000|Overall Study|Lost to Follow-up|16|||
33580737|NCT01445613|102016958|FG000|30-day Follow-up|Missed visit|23|||
33240683|NCT05550337|100783085|FG001|Overall Study|Lost to Follow-up|11|||
33240684|NCT05550337|100783086|FG002|Overall Study|Lost to Follow-up|11|||
33240685|NCT02056119|100783087|FG000|Overall Study|Death|1|||
33240686|NCT02056119|100783088|FG001|Overall Study|Death|2|||
33240687|NCT02056119|100783087|FG000|Overall Study|Intubated for less than 24 hrs|2|||
33370782|NCT00506077|101243513|FG000|Treatment Period 1|Lost to Follow-up|0|||
33421196|NCT01629693|101431741|FG000|Overall Study|Lost to Follow-up|2|||
33421197|NCT01629693|101431742|FG001|Overall Study|Lost to Follow-up|4|||
33580738|NCT01445613|102016958|FG000|30-day Follow-up|Death|3|||
33580739|NCT01445613|102016958|FG000|1-year Follow-up|Withdrawal by Subject|12|||
33580740|NCT01445613|102016958|FG000|1-year Follow-up|Missed visit|29|||
33580741|NCT01445613|102016958|FG000|1-year Follow-up|Lost to Follow-up|2|||
33580742|NCT01445613|102016958|FG000|1-year Follow-up|Death|30|||
33580743|NCT01445613|102016958|FG000|1-year Follow-up|Physician Decision|2|||
33580744|NCT01445613|102016958|FG000|1-year Follow-up|Received a non-study stent|2|||
33580745|NCT01284959|102016962|FG000|Overall Study|Withdrawal by Subject|1|||
33580746|NCT01284959|102016963|FG001|Overall Study|Withdrawal by Subject|0|||
33580747|NCT01284959|102016964|FG002|Overall Study|Withdrawal by Subject|0|||
33580748|NCT01284959|102016962|FG000|Overall Study|Adverse Event|0|||
33580749|NCT01284959|102016963|FG001|Overall Study|Adverse Event|0|||
33580750|NCT01284959|102016964|FG002|Overall Study|Adverse Event|1|||
33580751|NCT00003631|102016965|FG000|Overall Study|Patient not treated|1|||
33580752|NCT00003631|102016966|FG001|Overall Study|Patient not treated|0|||
33580753|NCT00003631|102016967|FG002|Overall Study|Patient not treated|1|||
33580754|NCT00003631|102016965|FG000|Overall Study|Protocol Violation|1|||
33580755|NCT00003631|102016966|FG001|Overall Study|Protocol Violation|0|||
33580756|NCT00003631|102016967|FG002|Overall Study|Protocol Violation|0|||
33580757|NCT00003631|102016965|FG000|Overall Study|Adverse Event|1|||
33580758|NCT00003631|102016966|FG001|Overall Study|Adverse Event|1|||
33580759|NCT00003631|102016967|FG002|Overall Study|Adverse Event|5|||
33640987|NCT01134055|102236556|FG001|Overall Study|Adverse Event|2|||
33240688|NCT02056119|100783088|FG001|Overall Study|Intubated for less than 24 hrs|7|||
33240689|NCT02056119|100783087|FG000|Overall Study|No aerosol treatments were given.|3|||
33240690|NCT02056119|100783088|FG001|Overall Study|No aerosol treatments were given.|2|||
33580760|NCT00003631|102016965|FG000|Overall Study|Death|0|||
33240691|NCT02056119|100783087|FG000|Overall Study|Received Metaneb treatment|0|||
33240692|NCT02056119|100783088|FG001|Overall Study|Received Metaneb treatment|2|||
33240693|NCT02056119|100783087|FG000|Overall Study|Protocol Violation|4|||
33240694|NCT02056119|100783088|FG001|Overall Study|Protocol Violation|7|||
33240695|NCT04649359|100783089|FG000|Overall Study|Withdrawal by Subject|7|||
33240696|NCT04649359|100783090|FG001|Overall Study|Withdrawal by Subject|7|||
33240697|NCT04649359|100783089|FG000|Overall Study|Death|41|||
33240698|NCT04649359|100783090|FG001|Overall Study|Death|26|||
33240699|NCT04649359|100783089|FG000|Overall Study|Ongoing in the study|75|||
33240700|NCT04649359|100783090|FG001|Overall Study|Ongoing in the study|31|||
33240701|NCT04060680|100783091|FG000|Overall Study|Unsuccessful implant|17|||
33240702|NCT04060680|100783092|FG001|Overall Study|Unsuccessful implant|2|||
33240703|NCT04060680|100783091|FG000|Overall Study|Adverse Event|3|||
33240704|NCT04060680|100783092|FG001|Overall Study|Adverse Event|0|||
33240705|NCT04060680|100783091|FG000|Overall Study|Death|2|||
33240706|NCT04060680|100783092|FG001|Overall Study|Death|0|||
33240707|NCT04060680|100783091|FG000|Overall Study|Study product no longer in use|1|||
33240708|NCT04060680|100783092|FG001|Overall Study|Study product no longer in use|0|||
33240709|NCT04060680|100783091|FG000|Overall Study|Withdrawal by Subject|1|||
33240710|NCT04060680|100783092|FG001|Overall Study|Withdrawal by Subject|0|||
33240711|NCT00795132|100783093|FG000|Overall Study|Death|1|||
33240712|NCT00795132|100783093|FG000|Overall Study|Relapse|2|||
33240713|NCT00003377|100783096|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
33240714|NCT00003377|100783097|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
33240715|NCT00003377|100783098|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
33240716|NCT00003377|100783099|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
33240717|NCT00003377|100783100|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
33240718|NCT00003377|100783096|FG000|Period II|Ureteral stent complications|0|||
33240719|NCT00003377|100783097|FG001|Period II|Ureteral stent complications|0|||
33240720|NCT00003377|100783098|FG002|Period II|Ureteral stent complications|0|||
33240721|NCT00003377|100783099|FG003|Period II|Ureteral stent complications|0|||
33240722|NCT00003377|100783100|FG004|Period II|Ureteral stent complications|1|||
33240723|NCT01427907|100783101|FG000|Overall Study|Withdrawal by Subject|3|||
33240724|NCT01427907|100783102|FG001|Overall Study|Withdrawal by Subject|4|||
33240725|NCT00430677|100783103|FG000|Short-term Period|Death|1|||
33240726|NCT00430677|100783104|FG001|Short-term Period|Death|1|||
33240727|NCT00430677|100783105|FG002|Short-term Period|Death|5|||
33640988|NCT01134055|102236557|FG002|Overall Study|Adverse Event|2|||
33240728|NCT00430677|100783103|FG000|Short-term Period|Adverse Event|15|||
33240729|NCT00430677|100783104|FG001|Short-term Period|Adverse Event|13|||
33240730|NCT00430677|100783105|FG002|Short-term Period|Adverse Event|9|||
33240731|NCT00430677|100783103|FG000|Short-term Period|Lack of Efficacy|5|||
33240732|NCT00430677|100783104|FG001|Short-term Period|Lack of Efficacy|6|||
33240733|NCT00430677|100783105|FG002|Short-term Period|Lack of Efficacy|4|||
33240734|NCT00430677|100783103|FG000|Short-term Period|Withdrawal by Subject|1|||
33240735|NCT00430677|100783104|FG001|Short-term Period|Withdrawal by Subject|1|||
33580761|NCT00003631|102016966|FG001|Overall Study|Death|0|||
33580762|NCT00003631|102016967|FG002|Overall Study|Death|1|||
33580763|NCT00003631|102016965|FG000|Overall Study|Evaluable for toxicity only|0|||
33580764|NCT00003631|102016966|FG001|Overall Study|Evaluable for toxicity only|0|||
33240736|NCT00430677|100783105|FG002|Short-term Period|Withdrawal by Subject|2|||
33240737|NCT00430677|100783103|FG000|Short-term Period|Participant no longer met study criteria|1|||
33240738|NCT00430677|100783104|FG001|Short-term Period|Participant no longer met study criteria|1|||
33240739|NCT00430677|100783105|FG002|Short-term Period|Participant no longer met study criteria|2|||
33240740|NCT00430677|100783103|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
33240741|NCT00430677|100783104|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
33240742|NCT00430677|100783105|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
33240743|NCT00430677|100783103|FG000|Short-term Period|Pregnancy|0|||
33240744|NCT00430677|100783104|FG001|Short-term Period|Pregnancy|2|||
33240745|NCT00430677|100783105|FG002|Short-term Period|Pregnancy|0|||
33240746|NCT00430677|100783103|FG000|Long-term Extension Period|Death|1|||
33240747|NCT00430677|100783104|FG001|Long-term Extension Period|Death|0|||
33240748|NCT00430677|100783105|FG002|Long-term Extension Period|Death|0|||
33240749|NCT00430677|100783103|FG000|Long-term Extension Period|Adverse Event|3|||
33240750|NCT00430677|100783104|FG001|Long-term Extension Period|Adverse Event|2|||
33240751|NCT00430677|100783105|FG002|Long-term Extension Period|Adverse Event|5|||
33240752|NCT00430677|100783103|FG000|Long-term Extension Period|Lack of Efficacy|5|||
33240753|NCT00430677|100783104|FG001|Long-term Extension Period|Lack of Efficacy|3|||
33240754|NCT00430677|100783105|FG002|Long-term Extension Period|Lack of Efficacy|8|||
33240755|NCT00430677|100783103|FG000|Long-term Extension Period|Lost to Follow-up|1|||
33240756|NCT00430677|100783104|FG001|Long-term Extension Period|Lost to Follow-up|1|||
33240757|NCT00430677|100783105|FG002|Long-term Extension Period|Lost to Follow-up|1|||
33240758|NCT00430677|100783103|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
33240759|NCT00430677|100783104|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
33240760|NCT00430677|100783105|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
33240761|NCT00430677|100783103|FG000|Long-term Extension Period|Pregnancy|1|||
33240762|NCT00430677|100783104|FG001|Long-term Extension Period|Pregnancy|1|||
33240763|NCT00430677|100783105|FG002|Long-term Extension Period|Pregnancy|0|||
33240764|NCT00430677|100783103|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
33240765|NCT00430677|100783104|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
33240766|NCT00430677|100783105|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
33240767|NCT00430677|100783103|FG000|Long-term Extension Period|Other|2|||
33240768|NCT00430677|100783104|FG001|Long-term Extension Period|Other|1|||
33240769|NCT00430677|100783105|FG002|Long-term Extension Period|Other|1|||
33240770|NCT00430677|100783103|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
33240771|NCT00430677|100783104|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
33580765|NCT00003631|102016967|FG002|Overall Study|Evaluable for toxicity only|2|||
33580766|NCT00114127|102016982|FG000|Overall Study|Adverse Event|2|||
33580767|NCT00114127|102016983|FG001|Overall Study|Adverse Event|1|||
33580768|NCT00114127|102016982|FG000|Overall Study|Lost to Follow-up|1|||
33580769|NCT00114127|102016983|FG001|Overall Study|Lost to Follow-up|0|||
33580770|NCT00114127|102016982|FG000|Overall Study|Withdrawal by Subject|1|||
33580771|NCT00114127|102016983|FG001|Overall Study|Withdrawal by Subject|3|||
33580772|NCT02544750|102016986|FG000|Overall Study|Physician Decision|3|||
33240772|NCT00430677|100783105|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
33240773|NCT01253200|100783106|FG000|Overall Study|Death|1|||
33240774|NCT01253200|100783107|FG001|Overall Study|Death|0|||
33240775|NCT01253200|100783108|FG002|Overall Study|Death|0|||
33240776|NCT01253200|100783109|FG003|Overall Study|Death|0|||
33240777|NCT01253200|100783110|FG004|Overall Study|Death|0|||
33240778|NCT01253200|100783106|FG000|Overall Study|Lost to Follow-up|1|||
33240779|NCT01253200|100783107|FG001|Overall Study|Lost to Follow-up|1|||
33240780|NCT01253200|100783108|FG002|Overall Study|Lost to Follow-up|0|||
33240781|NCT01253200|100783109|FG003|Overall Study|Lost to Follow-up|0|||
33580773|NCT02544750|102016987|FG001|Overall Study|Physician Decision|1|||
33580774|NCT02544750|102016986|FG000|Overall Study|Other reasons|69|||
33580775|NCT02544750|102016987|FG001|Overall Study|Other reasons|39|||
33580776|NCT02544750|102016986|FG000|Overall Study|Met withdrawal criteria|2|||
33580777|NCT02544750|102016987|FG001|Overall Study|Met withdrawal criteria|2|||
33580778|NCT02544750|102016986|FG000|Overall Study|Transition To Commercial Product|1|||
33580779|NCT02544750|102016987|FG001|Overall Study|Transition To Commercial Product|0|||
33580780|NCT02544750|102016986|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
33580781|NCT02544750|102016987|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
33142262|NCT02692651|100434850|FG001|Study Treatment|Protocol violation per treating team preference|6|||
33142263|NCT02692651|100434849|FG000|Post Study Treatment Follow-up|Death|4|||
33580782|NCT02544750|102016986|FG000|Overall Study|Adverse Event|8|||
33580783|NCT02544750|102016987|FG001|Overall Study|Adverse Event|10|||
33580784|NCT02544750|102016986|FG000|Overall Study|Withdrawal by Subject|10|||
33580785|NCT02544750|102016987|FG001|Overall Study|Withdrawal by Subject|4|||
33580786|NCT02544750|102016986|FG000|Overall Study|Lost to Follow-up|1|||
33580787|NCT02544750|102016987|FG001|Overall Study|Lost to Follow-up|0|||
33580788|NCT00678288|102016990|FG000|Overall Study|Adverse Event|0|||
33240782|NCT01253200|100783110|FG004|Overall Study|Lost to Follow-up|0|||
33240783|NCT01253200|100783106|FG000|Overall Study|Withdrawal by Subject|2|||
33240784|NCT01253200|100783107|FG001|Overall Study|Withdrawal by Subject|0|||
33240785|NCT01253200|100783108|FG002|Overall Study|Withdrawal by Subject|0|||
33240786|NCT01253200|100783109|FG003|Overall Study|Withdrawal by Subject|0|||
33240787|NCT01253200|100783110|FG004|Overall Study|Withdrawal by Subject|0|||
33240788|NCT01253200|100783106|FG000|Overall Study|Protocol Violation|1|||
33240789|NCT01253200|100783107|FG001|Overall Study|Protocol Violation|4|||
33240790|NCT01253200|100783108|FG002|Overall Study|Protocol Violation|0|||
33240791|NCT01253200|100783109|FG003|Overall Study|Protocol Violation|0|||
33240792|NCT01253200|100783110|FG004|Overall Study|Protocol Violation|5|||
33240793|NCT01253200|100783106|FG000|Overall Study|intents|10|||
33240794|NCT01253200|100783107|FG001|Overall Study|intents|10|||
33240795|NCT01253200|100783108|FG002|Overall Study|intents|1|||
33240796|NCT01253200|100783109|FG003|Overall Study|intents|3|||
33240797|NCT01253200|100783110|FG004|Overall Study|intents|0|||
33240798|NCT01253200|100783106|FG000|Overall Study|Attempts|6|||
33240799|NCT01253200|100783107|FG001|Overall Study|Attempts|4|||
33240800|NCT01253200|100783108|FG002|Overall Study|Attempts|1|||
33240801|NCT01253200|100783109|FG003|Overall Study|Attempts|2|||
33240802|NCT01253200|100783110|FG004|Overall Study|Attempts|0|||
33240803|NCT02338609|100783114|FG000|Overall Study|Physician Decision|1|||
33240804|NCT02338609|100783114|FG000|Overall Study|Death|1|||
33240805|NCT04129580|100783118|FG000|Overall Study|Lost to Follow-up|14|||
33240806|NCT04129580|100783119|FG001|Overall Study|Lost to Follow-up|25|||
33240807|NCT00480441|100783120|FG000|Screening|Not Eligible|37|||
33240808|NCT00480441|100783121|FG001|Screening|Not Eligible|0|||
33240809|NCT00480441|100783122|FG002|Screening|Not Eligible|0|||
33240810|NCT00480441|100783120|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
33240811|NCT00480441|100783121|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
33240812|NCT00480441|100783122|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
33240813|NCT00480441|100783120|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
33240814|NCT00480441|100783121|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
33240815|NCT00480441|100783122|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
33240816|NCT00480441|100783120|FG000|Baseline Functional MRI|physical contraindication|4|||
33240817|NCT00480441|100783121|FG001|Baseline Functional MRI|physical contraindication|0|||
33240818|NCT00480441|100783122|FG002|Baseline Functional MRI|physical contraindication|0|||
33240819|NCT00480441|100783120|FG000|Randomization|Lost to Follow-up|0|||
33240820|NCT00480441|100783121|FG001|Randomization|Lost to Follow-up|7|||
33240821|NCT00480441|100783122|FG002|Randomization|Lost to Follow-up|2|||
33240822|NCT00994279|100783128|FG000|Overall Study|Withdrawal by Subject|2|||
33240823|NCT00994279|100783129|FG001|Overall Study|Withdrawal by Subject|2|||
33240824|NCT00994279|100783128|FG000|Overall Study|Toxicity|1|||
33240825|NCT00994279|100783129|FG001|Overall Study|Toxicity|0|||
33240826|NCT00994279|100783128|FG000|Overall Study|Multiple reasons|1|||
33240827|NCT00994279|100783129|FG001|Overall Study|Multiple reasons|3|||
33240828|NCT02851511|100783130|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
33240829|NCT02851511|100783131|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
33240830|NCT02851511|100783132|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
33240831|NCT02851511|100783133|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
33240832|NCT02851511|100783130|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
33240833|NCT02851511|100783131|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
33240834|NCT02851511|100783132|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
33421198|NCT01629693|101431741|FG000|Overall Study|Withdrawal by Subject|2|||
33421199|NCT01629693|101431742|FG001|Overall Study|Withdrawal by Subject|2|||
33421200|NCT01629693|101431741|FG000|Overall Study|Adverse Event|1|||
33421201|NCT01629693|101431742|FG001|Overall Study|Adverse Event|0|||
33240835|NCT02851511|100783133|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
33240836|NCT02851511|100783130|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
33240837|NCT02851511|100783131|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
33240838|NCT02851511|100783132|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
33421202|NCT01629693|101431741|FG000|Overall Study|Investigator decision|0|||
33421203|NCT01629693|101431742|FG001|Overall Study|Investigator decision|1|||
33421204|NCT01629693|101431741|FG000|Overall Study|Poor comfort of study lenses|0|||
33421205|NCT01629693|101431742|FG001|Overall Study|Poor comfort of study lenses|2|||
33421206|NCT01629693|101431741|FG000|Overall Study|Subject decision unrelated to AE|0|||
33421207|NCT01629693|101431742|FG001|Overall Study|Subject decision unrelated to AE|1|||
33580789|NCT00678288|102016991|FG001|Overall Study|Adverse Event|2|||
33580790|NCT00678288|102016990|FG000|Overall Study|Withdrawal by Subject|1|||
33580791|NCT00678288|102016991|FG001|Overall Study|Withdrawal by Subject|1|||
33240839|NCT02851511|100783133|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
33240840|NCT02851511|100783130|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
33240841|NCT02851511|100783131|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
33240842|NCT02851511|100783132|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
33240843|NCT02851511|100783133|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
33240844|NCT02851511|100783130|FG000|Phase I|Physician Decision|0|||
33240845|NCT02851511|100783131|FG001|Phase I|Physician Decision|0|||
33421208|NCT03091400|101431744|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
33421209|NCT03091400|101431745|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
33421210|NCT00929864|101431746|FG000|Overall Study|Death|1|||
33240846|NCT02851511|100783132|FG002|Phase I|Physician Decision|0|||
33240847|NCT02851511|100783133|FG003|Phase I|Physician Decision|1|||
33240848|NCT02851511|100783130|FG000|Phase I|Withdrawal by Subject|2|||
33240849|NCT02851511|100783131|FG001|Phase I|Withdrawal by Subject|1|||
33240850|NCT02851511|100783132|FG002|Phase I|Withdrawal by Subject|0|||
33240851|NCT02851511|100783133|FG003|Phase I|Withdrawal by Subject|3|||
33240852|NCT02851511|100783130|FG000|Phase II|Physician Decision|18|||
33240853|NCT02851511|100783131|FG001|Phase II|Physician Decision|16|||
33240854|NCT02851511|100783132|FG002|Phase II|Physician Decision|0|||
33240855|NCT02851511|100783133|FG003|Phase II|Physician Decision|0|||
33240856|NCT02851511|100783130|FG000|Phase II|Withdrawal by Subject|18|||
33240857|NCT02851511|100783131|FG001|Phase II|Withdrawal by Subject|16|||
33240858|NCT02851511|100783132|FG002|Phase II|Withdrawal by Subject|0|||
33240859|NCT02851511|100783133|FG003|Phase II|Withdrawal by Subject|0|||
33240860|NCT02851511|100783130|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
33240861|NCT02851511|100783131|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
33240862|NCT02851511|100783132|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
33240863|NCT02851511|100783133|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
33240864|NCT02851511|100783130|FG000|Phase II|Lost to Follow-up|0|||
33240865|NCT02851511|100783131|FG001|Phase II|Lost to Follow-up|1|||
33240866|NCT02851511|100783132|FG002|Phase II|Lost to Follow-up|0|||
33240867|NCT02851511|100783133|FG003|Phase II|Lost to Follow-up|0|||
33240868|NCT03302910|100783134|FG000|Overall Study|Protocol Violation|1|||
33240869|NCT03302910|100783135|FG001|Overall Study|Protocol Violation|0|||
33240870|NCT02123966|100783136|FG000|Overall Study|Intercurrent Illness|1|||
33142264|NCT02692651|100434850|FG001|Post Study Treatment Follow-up|Death|4|||
33142265|NCT00400153|100434851|FG000|Overall Study|AE due to study disease worsening|14|||
33142266|NCT00400153|100434852|FG001|Overall Study|AE due to study disease worsening|19|||
33142267|NCT00400153|100434853|FG002|Overall Study|AE due to study disease worsening|20|||
33142268|NCT00400153|100434851|FG000|Overall Study|AE due to other disease worsening|2|||
33142269|NCT00400153|100434852|FG001|Overall Study|AE due to other disease worsening|1|||
33142270|NCT00400153|100434853|FG002|Overall Study|AE due to other disease worsening|0|||
33142271|NCT00400153|100434851|FG000|Overall Study|AE due to other condition|3|||
33142272|NCT00400153|100434852|FG001|Overall Study|AE due to other condition|14|||
33142273|NCT00400153|100434853|FG002|Overall Study|AE due to other condition|15|||
33142274|NCT00400153|100434851|FG000|Overall Study|Protocol Violation|7|||
33142275|NCT00400153|100434852|FG001|Overall Study|Protocol Violation|4|||
33142276|NCT00400153|100434853|FG002|Overall Study|Protocol Violation|9|||
33142277|NCT00400153|100434851|FG000|Overall Study|Lost to Follow-up|2|||
33142278|NCT00400153|100434852|FG001|Overall Study|Lost to Follow-up|1|||
33142279|NCT00400153|100434853|FG002|Overall Study|Lost to Follow-up|4|||
33142280|NCT00400153|100434851|FG000|Overall Study|Withdrawal by Subject|12|||
33142281|NCT00400153|100434852|FG001|Overall Study|Withdrawal by Subject|11|||
33142282|NCT00400153|100434853|FG002|Overall Study|Withdrawal by Subject|10|||
33142283|NCT00400153|100434851|FG000|Overall Study|Other reasons - not mentioned above|8|||
33142284|NCT00400153|100434852|FG001|Overall Study|Other reasons - not mentioned above|5|||
33142285|NCT00400153|100434853|FG002|Overall Study|Other reasons - not mentioned above|3|||
33142286|NCT00830869|100434854|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
33142287|NCT00830869|100434855|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
33142288|NCT00830869|100434856|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
33142289|NCT00830869|100434857|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
33142290|NCT00830869|100434858|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
33142291|NCT00830869|100434859|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
33142292|NCT00830869|100434860|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
33142293|NCT00830869|100434861|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
33142294|NCT00830869|100434862|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
33142295|NCT00830869|100434863|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
33142296|NCT00830869|100434864|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
33142297|NCT00830869|100434865|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
33142298|NCT00830869|100434854|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
33142299|NCT00830869|100434855|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
33142300|NCT00830869|100434856|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
33142301|NCT00830869|100434857|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
33142302|NCT00830869|100434858|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
33142303|NCT00830869|100434859|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
33142304|NCT00830869|100434860|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
33142305|NCT00830869|100434861|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
33142306|NCT00830869|100434862|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
33142307|NCT00830869|100434863|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
33142308|NCT00830869|100434864|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
33142309|NCT00830869|100434865|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
33142310|NCT00830869|100434854|FG000|Period 1: Part 1|Adverse Event|0|||
33142311|NCT00830869|100434855|FG001|Period 1: Part 1|Adverse Event|0|||
33142312|NCT00830869|100434856|FG002|Period 1: Part 1|Adverse Event|0|||
33240871|NCT05349084|100783141|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
33240872|NCT03782727|100783144|FG000|Overall Study|Lost to Follow-up|32|||
33240873|NCT00770211|100783145|FG000|Overall Study|Lost to Follow-up|1|||
33240874|NCT00770211|100783146|FG001|Overall Study|Lost to Follow-up|0|||
33240875|NCT00770211|100783145|FG000|Overall Study|Withdrawal by Subject|0|||
33240876|NCT00770211|100783146|FG001|Overall Study|Withdrawal by Subject|2|||
33240877|NCT04949399|100783147|FG000|Overall Study|Lost to Follow-up|11|||
33240878|NCT04949399|100783148|FG001|Overall Study|Lost to Follow-up|6|||
33240879|NCT04949399|100783147|FG000|Overall Study|Withdrawal by Subject|2|||
33240880|NCT04949399|100783148|FG001|Overall Study|Withdrawal by Subject|3|||
33240881|NCT04285229|100783149|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
33240882|NCT04285229|100783150|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33240883|NCT04285229|100783151|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33240884|NCT04285229|100783152|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33240885|NCT04285229|100783153|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33580792|NCT00678288|102016990|FG000|Overall Study|Study terminated by the sponsor|2|||
33580793|NCT00678288|102016991|FG001|Overall Study|Study terminated by the sponsor|0|||
33580794|NCT00678288|102016990|FG000|Overall Study|Not compliant with study medication|0|||
33580795|NCT00678288|102016991|FG001|Overall Study|Not compliant with study medication|1|||
33580796|NCT00678288|102016990|FG000|Overall Study|Switch to commercial drug|0|||
33580797|NCT00678288|102016991|FG001|Overall Study|Switch to commercial drug|1|||
33580798|NCT00678288|102016990|FG000|Overall Study|Reason not reported|1|||
33640989|NCT01134055|102236558|FG003|Overall Study|Adverse Event|2|||
33640990|NCT01134055|102236559|FG004|Overall Study|Adverse Event|5|||
33640991|NCT01134055|102236560|FG005|Overall Study|Adverse Event|7|||
33240886|NCT04285229|100783154|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33240887|NCT04285229|100783149|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
33240888|NCT04285229|100783150|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
33240889|NCT04285229|100783151|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
33240890|NCT04285229|100783152|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
33240891|NCT04285229|100783153|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
33240892|NCT04285229|100783154|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
33240893|NCT04285229|100783149|FG000|Extended Treatment Period|Adverse Event|0|||
33240894|NCT04285229|100783150|FG001|Extended Treatment Period|Adverse Event|0|||
33240895|NCT04285229|100783151|FG002|Extended Treatment Period|Adverse Event|0|||
33240896|NCT04285229|100783152|FG003|Extended Treatment Period|Adverse Event|1|||
33240897|NCT04285229|100783153|FG004|Extended Treatment Period|Adverse Event|0|||
33240898|NCT04285229|100783154|FG005|Extended Treatment Period|Adverse Event|0|||
33240899|NCT04285229|100783149|FG000|Extended Treatment Period|Physician Decision|0|||
33240900|NCT04285229|100783150|FG001|Extended Treatment Period|Physician Decision|0|||
33240901|NCT04285229|100783151|FG002|Extended Treatment Period|Physician Decision|1|||
33240902|NCT04285229|100783152|FG003|Extended Treatment Period|Physician Decision|0|||
33240903|NCT04285229|100783153|FG004|Extended Treatment Period|Physician Decision|0|||
33240904|NCT04285229|100783154|FG005|Extended Treatment Period|Physician Decision|0|||
33240905|NCT04285229|100783149|FG000|Follow-up Period|Adverse Event|0|||
33240906|NCT04285229|100783150|FG001|Follow-up Period|Adverse Event|0|||
33240907|NCT04285229|100783151|FG002|Follow-up Period|Adverse Event|0|||
33240908|NCT04285229|100783152|FG003|Follow-up Period|Adverse Event|0|||
33240909|NCT04285229|100783153|FG004|Follow-up Period|Adverse Event|1|||
33240910|NCT04285229|100783154|FG005|Follow-up Period|Adverse Event|4|||
33240911|NCT04285229|100783149|FG000|Follow-up Period|Withdrawal by Subject|0|||
33240912|NCT04285229|100783150|FG001|Follow-up Period|Withdrawal by Subject|0|||
33240913|NCT04285229|100783151|FG002|Follow-up Period|Withdrawal by Subject|0|||
33240914|NCT04285229|100783152|FG003|Follow-up Period|Withdrawal by Subject|0|||
33240915|NCT04285229|100783153|FG004|Follow-up Period|Withdrawal by Subject|0|||
33240916|NCT04285229|100783154|FG005|Follow-up Period|Withdrawal by Subject|5|||
33240917|NCT04285229|100783149|FG000|Follow-up Period|Covid-19|0|||
33240918|NCT04285229|100783150|FG001|Follow-up Period|Covid-19|0|||
33240919|NCT04285229|100783151|FG002|Follow-up Period|Covid-19|0|||
33240920|NCT04285229|100783152|FG003|Follow-up Period|Covid-19|0|||
33240921|NCT04285229|100783153|FG004|Follow-up Period|Covid-19|0|||
33240922|NCT04285229|100783154|FG005|Follow-up Period|Covid-19|2|||
33240923|NCT04285229|100783149|FG000|Follow-up Period|Physician Decision|0|||
33240924|NCT04285229|100783150|FG001|Follow-up Period|Physician Decision|0|||
33240925|NCT04285229|100783151|FG002|Follow-up Period|Physician Decision|0|||
33240926|NCT04285229|100783152|FG003|Follow-up Period|Physician Decision|0|||
33240927|NCT04285229|100783153|FG004|Follow-up Period|Physician Decision|0|||
33240928|NCT04285229|100783154|FG005|Follow-up Period|Physician Decision|1|||
33640992|NCT01134055|102236561|FG006|Overall Study|Adverse Event|2|||
33640993|NCT01134055|102236555|FG000|Overall Study|Lost to Follow-up|0|||
33240929|NCT03976362|100783157|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
33240930|NCT03976362|100783158|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
33240931|NCT03976362|100783159|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
33240932|NCT03976362|100783157|FG000|Induction Phase|Death|62|||
33240933|NCT03976362|100783158|FG001|Induction Phase|Death|0|||
33240934|NCT03976362|100783159|FG002|Induction Phase|Death|0|||
33240935|NCT03976362|100783157|FG000|Maintenance Phase|Participants Ongoing|0|||
33240936|NCT03976362|100783158|FG001|Maintenance Phase|Participants Ongoing|106|||
33240937|NCT03976362|100783159|FG002|Maintenance Phase|Participants Ongoing|103|||
33240938|NCT03976362|100783157|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33240939|NCT03976362|100783158|FG001|Maintenance Phase|Withdrawal by Subject|4|||
33240940|NCT03976362|100783159|FG002|Maintenance Phase|Withdrawal by Subject|4|||
33240941|NCT03976362|100783157|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
33240942|NCT03976362|100783158|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
33240943|NCT03976362|100783159|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
33240944|NCT03976362|100783157|FG000|Maintenance Phase|Death|0|||
33240945|NCT03976362|100783158|FG001|Maintenance Phase|Death|186|||
33240946|NCT03976362|100783159|FG002|Maintenance Phase|Death|187|||
33240947|NCT03606460|100783160|FG000|Overall Study|Lost to Follow-up|1|||
33240948|NCT03606460|100783161|FG001|Overall Study|Lost to Follow-up|8|||
33240949|NCT03670602|100783162|FG000|Overall Study|Lost to Follow-up|1|||
33240950|NCT03670602|100783163|FG001|Overall Study|Lost to Follow-up|0|||
33240951|NCT03670602|100783162|FG000|Overall Study|Withdrawal by Subject|0|||
33240952|NCT03670602|100783163|FG001|Overall Study|Withdrawal by Subject|3|||
33240953|NCT00278564|100783164|FG000|Overall Study|Lack of Efficacy|4|||
33240954|NCT04873817|100783165|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
33240955|NCT04873817|100783165|FG000|Overall Study|Lost to Follow-up|4|||
33240956|NCT04873817|100783165|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
33240957|NCT04873817|100783165|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
33240958|NCT04873817|100783165|FG000|Overall Study|Other Reasons|3|||
33240959|NCT01582243|100783168|FG000|Overall Study|Withdrawal by Subject|1|||
33240960|NCT01582243|100783168|FG000|Overall Study|Adverse Event|1|||
33240961|NCT01582243|100783168|FG000|Overall Study|Lost to Follow-up|1|||
33240962|NCT03459729|100783169|FG000|Overall Study|Physician Decision|2|||
33240963|NCT02018861|100783170|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
33240964|NCT02018861|100783171|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
33240965|NCT02018861|100783172|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
33240966|NCT02018861|100783173|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
33240967|NCT02018861|100783174|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
33240968|NCT02018861|100783175|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
33240969|NCT02018861|100783176|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
33240970|NCT02018861|100783177|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
33240971|NCT02018861|100783178|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
33240972|NCT02018861|100783179|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
33240973|NCT02018861|100783170|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33240974|NCT02018861|100783171|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33240975|NCT02018861|100783172|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33240976|NCT02018861|100783173|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
33240977|NCT02018861|100783174|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
33240978|NCT02018861|100783175|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33240979|NCT02018861|100783176|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33240980|NCT02018861|100783177|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33240981|NCT02018861|100783178|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33240982|NCT02018861|100783179|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
33240983|NCT02018861|100783170|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
33240984|NCT02018861|100783171|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
33240985|NCT02018861|100783172|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
33240986|NCT02018861|100783173|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
33240987|NCT02018861|100783174|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
33240988|NCT02018861|100783175|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
33240989|NCT02018861|100783176|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
33240990|NCT02018861|100783177|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
33370783|NCT00506077|101243514|FG001|Treatment Period 1|Lost to Follow-up|2|||
33370784|NCT00506077|101243513|FG000|Treatment Period 1|Withdrawal by Subject|2|||
33370785|NCT00506077|101243514|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33240991|NCT02018861|100783178|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
33240992|NCT02018861|100783179|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
33240993|NCT02018861|100783170|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
33240994|NCT02018861|100783171|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
33240995|NCT02018861|100783172|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
33240996|NCT02018861|100783173|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
33370786|NCT00506077|101243513|FG000|Treatment Period 2|Adverse Event|0|||
33240997|NCT02018861|100783174|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
33580799|NCT00678288|102016991|FG001|Overall Study|Reason not reported|0|||
33580800|NCT00678288|102016990|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
33580801|NCT00678288|102016991|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
33142313|NCT00830869|100434857|FG003|Period 1: Part 1|Adverse Event|0|||
33142314|NCT00830869|100434858|FG004|Period 1: Part 1|Adverse Event|0|||
33142315|NCT00830869|100434859|FG005|Period 1: Part 1|Adverse Event|1|||
33142316|NCT00830869|100434860|FG006|Period 1: Part 1|Adverse Event|1|||
33142317|NCT00830869|100434861|FG007|Period 1: Part 1|Adverse Event|0|||
33240998|NCT02018861|100783175|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
33370787|NCT00506077|101243514|FG001|Treatment Period 2|Adverse Event|1|||
33370788|NCT00506077|101243513|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33370789|NCT00506077|101243514|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33370790|NCT02426658|101243516|FG000|Overall Study|Withdrawal by Subject|1|||
33370791|NCT02426658|101243516|FG000|Overall Study|Patient expired before treatment|2|||
33370792|NCT00988559|101243517|FG000|Overall Study|Withdrawal by Subject|1|||
33370793|NCT00988559|101243518|FG001|Overall Study|Withdrawal by Subject|1|||
33370794|NCT00988559|101243519|FG002|Overall Study|Withdrawal by Subject|0|||
33370795|NCT00988559|101243520|FG003|Overall Study|Withdrawal by Subject|1|||
33370796|NCT00988559|101243517|FG000|Overall Study|Pregnancy|0|||
33370797|NCT00988559|101243518|FG001|Overall Study|Pregnancy|1|||
33370798|NCT00988559|101243519|FG002|Overall Study|Pregnancy|1|||
33370799|NCT00988559|101243520|FG003|Overall Study|Pregnancy|0|||
33580802|NCT00837161|102016993|FG000|Overall Study|refused hysterectomy|2|||
33580803|NCT00375427|102016994|FG000|Overall Study|Adverse Event|21|||
33580804|NCT00375427|102016995|FG001|Overall Study|Adverse Event|27|||
33580805|NCT00375427|102016994|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33580806|NCT00375427|102016995|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33240999|NCT02018861|100783176|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
33241000|NCT02018861|100783177|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
33241001|NCT02018861|100783178|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
33241002|NCT02018861|100783179|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
33241003|NCT02018861|100783170|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33241004|NCT02018861|100783171|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33241005|NCT02018861|100783172|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
33241006|NCT02018861|100783173|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
33241007|NCT02018861|100783174|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33241008|NCT02018861|100783175|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33241009|NCT02018861|100783176|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33241010|NCT02018861|100783177|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33241011|NCT02018861|100783178|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33241012|NCT02018861|100783179|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
33241013|NCT02018861|100783170|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33241014|NCT02018861|100783171|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33241015|NCT02018861|100783172|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33241016|NCT02018861|100783173|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33241017|NCT02018861|100783174|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
33241018|NCT02018861|100783175|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33241019|NCT02018861|100783176|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33241020|NCT02018861|100783177|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33241021|NCT02018861|100783178|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33241022|NCT02018861|100783179|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
33241023|NCT02018861|100783170|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
33241024|NCT02018861|100783171|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
33241025|NCT02018861|100783172|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
33241026|NCT02018861|100783173|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
33241027|NCT02018861|100783174|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
33241028|NCT02018861|100783175|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
33241029|NCT02018861|100783176|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
33241030|NCT02018861|100783177|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
33241031|NCT02018861|100783178|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
33241032|NCT02018861|100783179|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
33241033|NCT02018861|100783170|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33241034|NCT02018861|100783171|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33241035|NCT02018861|100783172|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33241036|NCT02018861|100783173|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
33241037|NCT02018861|100783174|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
33370800|NCT00988559|101243517|FG000|Overall Study|Lost to Follow-up|0|||
33370801|NCT00988559|101243518|FG001|Overall Study|Lost to Follow-up|0|||
33640994|NCT01134055|102236556|FG001|Overall Study|Lost to Follow-up|1|||
33241038|NCT02018861|100783175|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33241039|NCT02018861|100783176|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33241040|NCT02018861|100783177|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33580807|NCT00375427|102016994|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33580808|NCT00375427|102016995|FG001|Overall Study|Abnormal laboratory value(s)|2|||
33580809|NCT00375427|102016994|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33580810|NCT00375427|102016995|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
33580811|NCT00375427|102016994|FG000|Overall Study|Patient no longer requires study drug|3|||
33580812|NCT00375427|102016995|FG001|Overall Study|Patient no longer requires study drug|7|||
33580813|NCT00375427|102016994|FG000|Overall Study|Protocol Violation|10|||
33580814|NCT00375427|102016995|FG001|Overall Study|Protocol Violation|8|||
33580815|NCT00375427|102016994|FG000|Overall Study|Withdrawal by Subject|9|||
33580816|NCT00375427|102016995|FG001|Overall Study|Withdrawal by Subject|13|||
33580817|NCT00375427|102016994|FG000|Overall Study|Lost to Follow-up|1|||
33580818|NCT00375427|102016995|FG001|Overall Study|Lost to Follow-up|1|||
33580819|NCT00375427|102016994|FG000|Overall Study|Administrative reasons|0|||
33580820|NCT00375427|102016995|FG001|Overall Study|Administrative reasons|1|||
33421211|NCT00929864|101431747|FG001|Overall Study|Death|1|||
33421212|NCT00929864|101431746|FG000|Overall Study|Adverse Event|11|||
33241041|NCT02018861|100783178|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33241042|NCT02018861|100783179|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
33241043|NCT02018861|100783170|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33241044|NCT02018861|100783171|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33241045|NCT02018861|100783172|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33241046|NCT02018861|100783173|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33241047|NCT02018861|100783174|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33241048|NCT02018861|100783175|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33241049|NCT02018861|100783176|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
33241050|NCT02018861|100783177|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
33370802|NCT00988559|101243519|FG002|Overall Study|Lost to Follow-up|1|||
33421213|NCT00929864|101431747|FG001|Overall Study|Adverse Event|30|||
33580821|NCT00375427|102016994|FG000|Overall Study|Death|11|||
33580822|NCT00375427|102016995|FG001|Overall Study|Death|10|||
33580823|NCT03604497|102016996|FG000|Overall Study|Protocol Violation|52|||
33580824|NCT00730756|102016997|FG000|Overall Study|Adverse Event|2|||
33580825|NCT00730756|102016998|FG001|Overall Study|Adverse Event|0|||
33580826|NCT00730756|102016997|FG000|Overall Study|Lack of Efficacy|1|||
33580827|NCT00730756|102016998|FG001|Overall Study|Lack of Efficacy|1|||
33580828|NCT00730756|102016997|FG000|Overall Study|Protocol Deviation|1|||
33580829|NCT00730756|102016998|FG001|Overall Study|Protocol Deviation|2|||
33580830|NCT00730756|102016997|FG000|Overall Study|Lost to Follow-up|0|||
33580831|NCT00730756|102016998|FG001|Overall Study|Lost to Follow-up|1|||
33580832|NCT00730756|102016997|FG000|Overall Study|Withdrew Consent|0|||
33580833|NCT00730756|102016998|FG001|Overall Study|Withdrew Consent|1|||
33580834|NCT00803595|102017001|FG000|Overall Study|Adverse Event|3|||
33640995|NCT01134055|102236557|FG002|Overall Study|Lost to Follow-up|0|||
33580835|NCT00803595|102017002|FG001|Overall Study|Adverse Event|4|||
33580836|NCT00803595|102017003|FG002|Overall Study|Adverse Event|1|||
33580837|NCT00803595|102017001|FG000|Overall Study|Protocol Violation|7|||
33580838|NCT00803595|102017002|FG001|Overall Study|Protocol Violation|2|||
33580839|NCT00803595|102017003|FG002|Overall Study|Protocol Violation|12|||
33580840|NCT00803595|102017001|FG000|Overall Study|Withdrawal by Subject|5|||
33580841|NCT00803595|102017002|FG001|Overall Study|Withdrawal by Subject|2|||
33580842|NCT00803595|102017003|FG002|Overall Study|Withdrawal by Subject|3|||
33580843|NCT00041470|102017004|FG000|Overall Study|Loss of Funding|38|||
33370803|NCT00988559|101243520|FG003|Overall Study|Lost to Follow-up|0|||
33370804|NCT01655823|101243521|FG000|Overall Study|Lost to Follow-up|0|||
33370805|NCT01655823|101243522|FG001|Overall Study|Lost to Follow-up|1|||
33370806|NCT01655823|101243523|FG002|Overall Study|Lost to Follow-up|0|||
33370807|NCT01655823|101243524|FG003|Overall Study|Lost to Follow-up|0|||
33370808|NCT01655823|101243525|FG004|Overall Study|Lost to Follow-up|1|||
33370809|NCT01655823|101243521|FG000|Overall Study|Withdrawal by Subject|0|||
33370810|NCT01655823|101243522|FG001|Overall Study|Withdrawal by Subject|1|||
33370811|NCT01655823|101243523|FG002|Overall Study|Withdrawal by Subject|0|||
33370812|NCT01655823|101243524|FG003|Overall Study|Withdrawal by Subject|1|||
33421214|NCT00929864|101431746|FG000|Overall Study|Lack of Efficacy|19|||
33421215|NCT00929864|101431747|FG001|Overall Study|Lack of Efficacy|16|||
33640996|NCT01134055|102236558|FG003|Overall Study|Lost to Follow-up|1|||
33142318|NCT00830869|100434862|FG008|Period 1: Part 1|Adverse Event|0|||
33421216|NCT00929864|101431746|FG000|Overall Study|Lost to Follow-up|7|||
33580844|NCT01396187|102017005|FG000|Overall Study|Adverse Event|0|||
33580845|NCT01396187|102017006|FG001|Overall Study|Adverse Event|1|||
33580846|NCT01396187|102017007|FG002|Overall Study|Adverse Event|0|||
33580847|NCT01396187|102017008|FG003|Overall Study|Adverse Event|0|||
33241051|NCT02018861|100783178|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33241052|NCT02018861|100783179|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
33241053|NCT02018861|100783170|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33241054|NCT02018861|100783171|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33241055|NCT02018861|100783172|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33241056|NCT02018861|100783173|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33241057|NCT02018861|100783174|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33241058|NCT02018861|100783175|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33241059|NCT02018861|100783176|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
33580848|NCT01396187|102017009|FG004|Overall Study|Adverse Event|0|||
33580849|NCT01396187|102017005|FG000|Overall Study|Withdrawal by Subject|0|||
33580850|NCT01396187|102017006|FG001|Overall Study|Withdrawal by Subject|1|||
33580851|NCT01396187|102017007|FG002|Overall Study|Withdrawal by Subject|1|||
33580852|NCT01396187|102017008|FG003|Overall Study|Withdrawal by Subject|0|||
33580853|NCT01396187|102017009|FG004|Overall Study|Withdrawal by Subject|0|||
33580854|NCT01396187|102017005|FG000|Overall Study|Other|1|||
33580855|NCT01396187|102017006|FG001|Overall Study|Other|1|||
33580856|NCT01396187|102017007|FG002|Overall Study|Other|0|||
33580857|NCT01396187|102017008|FG003|Overall Study|Other|0|||
33580858|NCT01396187|102017009|FG004|Overall Study|Other|1|||
33580859|NCT00347932|102017010|FG000|Overall Study|Adverse Event|4|||
33580860|NCT00347932|102017011|FG001|Overall Study|Adverse Event|5|||
33580861|NCT00347932|102017010|FG000|Overall Study|Lack of Efficacy|3|||
33580862|NCT00347932|102017011|FG001|Overall Study|Lack of Efficacy|14|||
33580863|NCT00347932|102017010|FG000|Overall Study|Lost to Follow-up|10|||
33580864|NCT00347932|102017011|FG001|Overall Study|Lost to Follow-up|9|||
33580865|NCT00347932|102017010|FG000|Overall Study|Withdrawal by Subject|10|||
33580866|NCT00347932|102017011|FG001|Overall Study|Withdrawal by Subject|16|||
33580867|NCT00347932|102017010|FG000|Overall Study|Did not meet inclusion criteria|4|||
33580868|NCT00347932|102017011|FG001|Overall Study|Did not meet inclusion criteria|8|||
33580869|NCT00286091|102017012|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
33580870|NCT00286091|102017013|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
33640997|NCT01134055|102236559|FG004|Overall Study|Lost to Follow-up|0|||
33640998|NCT01134055|102236560|FG005|Overall Study|Lost to Follow-up|0|||
33640999|NCT01134055|102236561|FG006|Overall Study|Lost to Follow-up|0|||
33641000|NCT01134055|102236555|FG000|Overall Study|Withdrawal by Subject|3|||
33241060|NCT02018861|100783177|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
33241061|NCT02018861|100783178|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33241062|NCT02018861|100783179|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
33241063|NCT02018861|100783170|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33241064|NCT02018861|100783171|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33241065|NCT02018861|100783172|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33241066|NCT02018861|100783173|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33241067|NCT02018861|100783174|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33241068|NCT02018861|100783175|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33241069|NCT02018861|100783176|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33241070|NCT02018861|100783177|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33241071|NCT02018861|100783178|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
33241072|NCT02018861|100783179|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
33241073|NCT02018861|100783170|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33241074|NCT02018861|100783171|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33241075|NCT02018861|100783172|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33241076|NCT02018861|100783173|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33241077|NCT02018861|100783174|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33241078|NCT02018861|100783175|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33370813|NCT01655823|101243525|FG004|Overall Study|Withdrawal by Subject|0|||
33370814|NCT01402284|101243526|FG000|Overall Study|Withdrawal consent|2|||
33370815|NCT01402284|101243526|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
33370816|NCT01402284|101243526|FG000|Overall Study|Physician Decision|1|||
33370817|NCT01402284|101243526|FG000|Overall Study|Disease progression on study|10|||
33370818|NCT03215264|101243531|FG000|Dose Level 2|Adverse Event|0|||
33370819|NCT03215264|101243532|FG001|Dose Level 2|Adverse Event|1|||
33370820|NCT03215264|101243533|FG002|Dose Level 2|Adverse Event|0|||
33641001|NCT01134055|102236556|FG001|Overall Study|Withdrawal by Subject|3|||
33641002|NCT01134055|102236557|FG002|Overall Study|Withdrawal by Subject|1|||
33370821|NCT03215264|101243531|FG000|Dose Level 3|Withdrawal by Subject|0|||
33580871|NCT00286091|102017012|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
33580872|NCT00286091|102017013|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
33580873|NCT00286091|102017012|FG000|Double-blind Treatment Phase|Death|58|||
33580874|NCT00286091|102017013|FG001|Double-blind Treatment Phase|Death|65|||
33580875|NCT00286091|102017012|FG000|Double-blind Treatment Phase|Adverse Event|28|||
33241079|NCT02018861|100783176|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33241080|NCT02018861|100783177|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33241081|NCT02018861|100783178|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
33241082|NCT02018861|100783179|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
33241083|NCT02018861|100783170|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33241084|NCT02018861|100783171|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33241085|NCT02018861|100783172|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33241086|NCT02018861|100783173|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33241087|NCT02018861|100783174|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33241088|NCT02018861|100783175|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33241089|NCT02018861|100783176|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33241090|NCT02018861|100783177|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33241091|NCT02018861|100783178|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
33241092|NCT02018861|100783179|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
33241093|NCT02711995|100783180|FG000|Washout (90 Days)|Conflicting medication|1|||
33241094|NCT03884231|100783181|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
33241095|NCT03884231|100783181|FG000|Overall Study|Subject Withdrew Consent|1|||
33241096|NCT03884231|100783181|FG000|Overall Study|MRI Scan Not Performed|1|||
33241097|NCT01852162|100783182|FG000|Overall Study|Adverse Event|1|||
33241098|NCT01852162|100783183|FG001|Overall Study|Adverse Event|0|||
33241099|NCT01852162|100783182|FG000|Overall Study|Withdrawal by Subject|3|||
33241100|NCT01852162|100783183|FG001|Overall Study|Withdrawal by Subject|1|||
33241101|NCT03424239|100783190|FG000|Overall Study|Withdrawal by Subject|2|||
33241102|NCT01822821|100783191|FG000|Overall Study|Eligible surgery cancelled|1|||
33241103|NCT01822821|100783192|FG001|Overall Study|Eligible surgery cancelled|1|||
33241104|NCT01822821|100783191|FG000|Overall Study|Other reasons|1|||
33241105|NCT01822821|100783192|FG001|Overall Study|Other reasons|0|||
33241106|NCT02271594|100783195|FG000|Overall Study|Study closed; recruiting failure|19|||
33241107|NCT02271594|100783196|FG001|Overall Study|Study closed; recruiting failure|12|||
33241108|NCT01767909|100783203|FG000|Overall Study|Withdrawal by Subject|4|||
33241109|NCT01767909|100783204|FG001|Overall Study|Withdrawal by Subject|7|||
33241110|NCT01767909|100783203|FG000|Overall Study|Adverse Event|3|||
33241111|NCT01767909|100783204|FG001|Overall Study|Adverse Event|1|||
33241112|NCT01767909|100783203|FG000|Overall Study|Withdrawal by Study Partner|3|||
33241113|NCT01767909|100783204|FG001|Overall Study|Withdrawal by Study Partner|1|||
33241114|NCT01767909|100783203|FG000|Overall Study|Non-Compliance|2|||
33241115|NCT01767909|100783204|FG001|Overall Study|Non-Compliance|0|||
33241116|NCT01767909|100783203|FG000|Overall Study|Perceived Lack of Efficacy|1|||
33241117|NCT01767909|100783204|FG001|Overall Study|Perceived Lack of Efficacy|0|||
33241118|NCT01767909|100783203|FG000|Overall Study|Investigator Recommendation|0|||
33241119|NCT01767909|100783204|FG001|Overall Study|Investigator Recommendation|1|||
33241120|NCT01767909|100783203|FG000|Overall Study|Lost to Follow-up|0|||
33241121|NCT01767909|100783204|FG001|Overall Study|Lost to Follow-up|1|||
33241122|NCT01767909|100783203|FG000|Overall Study|LP uncessessful|0|||
33241123|NCT01767909|100783204|FG001|Overall Study|LP uncessessful|1|||
33241124|NCT01072929|100783206|FG000|Overall Study|Adverse Event|8|||
33241125|NCT01072929|100783207|FG001|Overall Study|Adverse Event|11|||
33241126|NCT01072929|100783208|FG002|Overall Study|Adverse Event|2|||
33241127|NCT01072929|100783206|FG000|Overall Study|Lack of Efficacy|7|||
33241128|NCT01072929|100783207|FG001|Overall Study|Lack of Efficacy|4|||
33241129|NCT01072929|100783208|FG002|Overall Study|Lack of Efficacy|0|||
33241130|NCT01072929|100783206|FG000|Overall Study|Withdrawal by Subject|7|||
33241131|NCT01072929|100783207|FG001|Overall Study|Withdrawal by Subject|15|||
33241132|NCT01072929|100783208|FG002|Overall Study|Withdrawal by Subject|3|||
33241133|NCT01072929|100783206|FG000|Overall Study|Protocol Violation|13|||
33241134|NCT01072929|100783207|FG001|Overall Study|Protocol Violation|11|||
33241135|NCT01072929|100783208|FG002|Overall Study|Protocol Violation|2|||
33241136|NCT01072929|100783206|FG000|Overall Study|Lost to Follow-up|8|||
33241137|NCT01072929|100783207|FG001|Overall Study|Lost to Follow-up|4|||
33241138|NCT01072929|100783208|FG002|Overall Study|Lost to Follow-up|1|||
33241139|NCT01072929|100783206|FG000|Overall Study|Noncompliance with study medication|0|||
33370822|NCT03215264|101243532|FG001|Dose Level 3|Withdrawal by Subject|0|||
33370823|NCT03215264|101243533|FG002|Dose Level 3|Withdrawal by Subject|1|||
33370824|NCT00243230|101243536|FG000|Double-Blind Period|Adverse Event|0|||
33370825|NCT00243230|101243537|FG001|Double-Blind Period|Adverse Event|2|||
33370826|NCT00243230|101243538|FG002|Double-Blind Period|Adverse Event|2|||
33370827|NCT00243230|101243539|FG003|Double-Blind Period|Adverse Event|0|||
33370828|NCT00243230|101243536|FG000|Double-Blind Period|Withdrawal by Subject|1|||
33370829|NCT00243230|101243537|FG001|Double-Blind Period|Withdrawal by Subject|0|||
33370830|NCT00243230|101243538|FG002|Double-Blind Period|Withdrawal by Subject|0|||
33370831|NCT00243230|101243539|FG003|Double-Blind Period|Withdrawal by Subject|0|||
33370832|NCT00243230|101243536|FG000|Double-Blind Period|Protocol Violation|0|||
33241140|NCT01072929|100783207|FG001|Overall Study|Noncompliance with study medication|3|||
33241141|NCT01072929|100783208|FG002|Overall Study|Noncompliance with study medication|0|||
33370833|NCT00243230|101243537|FG001|Double-Blind Period|Protocol Violation|0|||
33421217|NCT00929864|101431747|FG001|Overall Study|Lost to Follow-up|12|||
33421218|NCT00929864|101431746|FG000|Overall Study|Withdrawal by Subject|20|||
33421219|NCT00929864|101431747|FG001|Overall Study|Withdrawal by Subject|9|||
33421220|NCT00929864|101431746|FG000|Overall Study|No longer met criteria|2|||
33421221|NCT00929864|101431747|FG001|Overall Study|No longer met criteria|1|||
33421222|NCT00929864|101431746|FG000|Overall Study|Poor or non-compliance|3|||
33421223|NCT00929864|101431747|FG001|Overall Study|Poor or non-compliance|3|||
33421224|NCT00929864|101431746|FG000|Overall Study|Pregnancy|0|||
33421225|NCT00929864|101431747|FG001|Overall Study|Pregnancy|3|||
33421226|NCT00929864|101431746|FG000|Overall Study|Administrative reason by Sponsor|1|||
33421227|NCT00929864|101431747|FG001|Overall Study|Administrative reason by Sponsor|1|||
33421228|NCT00929864|101431746|FG000|Overall Study|Non-specified|2|||
33421229|NCT00929864|101431747|FG001|Overall Study|Non-specified|7|||
33421230|NCT01383954|101431748|FG000|Overall Study|Lack of Efficacy|2|||
33421231|NCT01383954|101431748|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
33421232|NCT01383954|101431748|FG000|Overall Study|Adverse Event|1|||
33421233|NCT01383954|101431748|FG000|Overall Study|Reason Not Specified|9|||
33421234|NCT00763269|101431750|FG000|Overall Study|Lost to Follow-up|12|||
33421235|NCT00763269|101431751|FG001|Overall Study|Lost to Follow-up|13|||
33421236|NCT01128153|101431752|FG000|Overall Study|Adverse Event|1|||
33370834|NCT00243230|101243538|FG002|Double-Blind Period|Protocol Violation|1|||
33142319|NCT00830869|100434863|FG009|Period 1: Part 1|Adverse Event|0|||
33370835|NCT00243230|101243539|FG003|Double-Blind Period|Protocol Violation|0|||
33641003|NCT01134055|102236558|FG003|Overall Study|Withdrawal by Subject|2|||
33641004|NCT01134055|102236559|FG004|Overall Study|Withdrawal by Subject|0|||
33641005|NCT01134055|102236560|FG005|Overall Study|Withdrawal by Subject|0|||
33641006|NCT01134055|102236561|FG006|Overall Study|Withdrawal by Subject|8|||
33370836|NCT00243230|101243536|FG000|Double-Blind Period|Randomized but Not Treated|0|||
33370837|NCT00243230|101243537|FG001|Double-Blind Period|Randomized but Not Treated|0|||
33370838|NCT00243230|101243538|FG002|Double-Blind Period|Randomized but Not Treated|2|||
33370839|NCT00243230|101243539|FG003|Double-Blind Period|Randomized but Not Treated|0|||
33370840|NCT00243230|101243536|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
33370841|NCT00243230|101243537|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
33370842|NCT00243230|101243538|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
33370843|NCT00243230|101243539|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
33421237|NCT01128153|101431753|FG001|Overall Study|Adverse Event|3|||
33641007|NCT01134055|102236555|FG000|Overall Study|Protocol Violation|0|||
33641008|NCT01134055|102236556|FG001|Overall Study|Protocol Violation|0|||
33641009|NCT01134055|102236557|FG002|Overall Study|Protocol Violation|0|||
33641010|NCT01134055|102236558|FG003|Overall Study|Protocol Violation|1|||
33641011|NCT01134055|102236559|FG004|Overall Study|Protocol Violation|1|||
33641012|NCT01134055|102236560|FG005|Overall Study|Protocol Violation|0|||
33641013|NCT01134055|102236561|FG006|Overall Study|Protocol Violation|0|||
33641014|NCT01134055|102236555|FG000|Overall Study|Physician Decision|0|||
33641015|NCT01134055|102236556|FG001|Overall Study|Physician Decision|0|||
33641016|NCT01134055|102236557|FG002|Overall Study|Physician Decision|0|||
33641017|NCT01134055|102236558|FG003|Overall Study|Physician Decision|0|||
33641018|NCT01134055|102236559|FG004|Overall Study|Physician Decision|0|||
33641019|NCT01134055|102236560|FG005|Overall Study|Physician Decision|0|||
33641020|NCT01134055|102236561|FG006|Overall Study|Physician Decision|1|||
33641021|NCT00828204|102236562|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
33641022|NCT00828204|102236563|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
33641023|NCT00828204|102236562|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
33142320|NCT00830869|100434864|FG010|Period 1: Part 1|Adverse Event|0|||
33142321|NCT00830869|100434865|FG011|Period 1: Part 1|Adverse Event|0|||
33421238|NCT01128153|101431752|FG000|Overall Study|Condition under investigation worsened|8|||
33580876|NCT00286091|102017013|FG001|Double-blind Treatment Phase|Adverse Event|40|||
33580877|NCT00286091|102017012|FG000|Double-blind Treatment Phase|Disease Progression|22|||
33580878|NCT00286091|102017013|FG001|Double-blind Treatment Phase|Disease Progression|35|||
33580879|NCT00286091|102017012|FG000|Double-blind Treatment Phase|Other|25|||
33580880|NCT00286091|102017013|FG001|Double-blind Treatment Phase|Other|33|||
33580881|NCT00286091|102017012|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
33580882|NCT00286091|102017013|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
33580883|NCT00286091|102017012|FG000|Double-blind Treatment Phase|Noncompliance|8|||
33580884|NCT00286091|102017013|FG001|Double-blind Treatment Phase|Noncompliance|8|||
33580885|NCT00286091|102017012|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
33580886|NCT00286091|102017013|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
33421239|NCT01128153|101431753|FG001|Overall Study|Condition under investigation worsened|7|||
33641024|NCT00828204|102236563|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
33641025|NCT00828204|102236562|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
33641026|NCT00828204|102236563|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
33641027|NCT00828204|102236562|FG000|Main Study: After Study Restart|Adverse Event|0|||
33421240|NCT01128153|101431752|FG000|Overall Study|Withdrawal by Subject|2|||
33641028|NCT00828204|102236563|FG001|Main Study: After Study Restart|Adverse Event|2|||
33370844|NCT00243230|101243536|FG000|Open Label Period|Adverse Event|0|||
33370845|NCT00243230|101243537|FG001|Open Label Period|Adverse Event|0|||
33641029|NCT00828204|102236562|FG000|Main Study: After Study Restart|Noncompliance|0|||
33641030|NCT00828204|102236563|FG001|Main Study: After Study Restart|Noncompliance|1|||
33641031|NCT00828204|102236562|FG000|Extension Study|Lost to Follow-up|0|||
33641032|NCT00828204|102236563|FG001|Extension Study|Lost to Follow-up|1|||
33641033|NCT00828204|102236562|FG000|Extension Study|Physician Decision|0|||
33641034|NCT00828204|102236563|FG001|Extension Study|Physician Decision|2|||
33641035|NCT02141204|102236566|FG000|Overall Study|Lost to Follow-up|2|||
33641036|NCT02141204|102236567|FG001|Overall Study|Lost to Follow-up|1|||
33641037|NCT02141204|102236566|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
33641038|NCT02141204|102236567|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
33641039|NCT02141204|102236566|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
33641040|NCT02141204|102236567|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
33641041|NCT02141204|102236566|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
33641042|NCT02141204|102236567|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
33641043|NCT01760733|102236568|FG000|Waiting List|Death|18|||
33641044|NCT01760733|102236568|FG000|Waiting List|Removed from waiting list|41|||
33641045|NCT01760733|102236568|FG000|Waiting List|Not received a transplant yet|13|||
33641046|NCT01760733|102236568|FG000|Transplanted|Not reached 10 years post transplant|184|||
33641047|NCT01760733|102236568|FG000|Transplanted|Death|26|||
33641048|NCT01760733|102236568|FG000|Transplanted|Graft loss|7|||
33142322|NCT00830869|100434854|FG000|Period 1: Part 1|Progressive disease|1|||
33142323|NCT00830869|100434855|FG001|Period 1: Part 1|Progressive disease|0|||
33142324|NCT00830869|100434856|FG002|Period 1: Part 1|Progressive disease|1|||
33142325|NCT00830869|100434857|FG003|Period 1: Part 1|Progressive disease|6|||
33142326|NCT00830869|100434858|FG004|Period 1: Part 1|Progressive disease|4|||
33142327|NCT00830869|100434859|FG005|Period 1: Part 1|Progressive disease|4|||
33142328|NCT00830869|100434860|FG006|Period 1: Part 1|Progressive disease|1|||
33142329|NCT00830869|100434861|FG007|Period 1: Part 1|Progressive disease|0|||
33142330|NCT00830869|100434862|FG008|Period 1: Part 1|Progressive disease|0|||
33142331|NCT00830869|100434863|FG009|Period 1: Part 1|Progressive disease|0|||
33142332|NCT00830869|100434864|FG010|Period 1: Part 1|Progressive disease|0|||
33142333|NCT00830869|100434865|FG011|Period 1: Part 1|Progressive disease|0|||
33142334|NCT00830869|100434854|FG000|Period 2: Part 2|Protocol Violation|0|||
33142335|NCT00830869|100434855|FG001|Period 2: Part 2|Protocol Violation|0|||
33142336|NCT00830869|100434856|FG002|Period 2: Part 2|Protocol Violation|0|||
33142337|NCT00830869|100434857|FG003|Period 2: Part 2|Protocol Violation|0|||
33142338|NCT00830869|100434858|FG004|Period 2: Part 2|Protocol Violation|0|||
33142339|NCT00830869|100434859|FG005|Period 2: Part 2|Protocol Violation|0|||
33142340|NCT00830869|100434860|FG006|Period 2: Part 2|Protocol Violation|0|||
33142341|NCT00830869|100434861|FG007|Period 2: Part 2|Protocol Violation|1|||
33142342|NCT00830869|100434862|FG008|Period 2: Part 2|Protocol Violation|0|||
33142343|NCT00830869|100434863|FG009|Period 2: Part 2|Protocol Violation|1|||
33142344|NCT00830869|100434864|FG010|Period 2: Part 2|Protocol Violation|0|||
33142345|NCT00830869|100434865|FG011|Period 2: Part 2|Protocol Violation|0|||
33142346|NCT00830869|100434854|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
33142347|NCT00830869|100434855|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
33142348|NCT00830869|100434856|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
33142349|NCT00830869|100434857|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
33142350|NCT00830869|100434858|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
33241142|NCT01072929|100783206|FG000|Overall Study|Noncompliance with study procedures|1|||
33241143|NCT01072929|100783207|FG001|Overall Study|Noncompliance with study procedures|0|||
33241144|NCT01072929|100783208|FG002|Overall Study|Noncompliance with study procedures|1|||
33241145|NCT01072929|100783206|FG000|Overall Study|Other|0|||
33241146|NCT01072929|100783207|FG001|Overall Study|Other|3|||
33241147|NCT01072929|100783208|FG002|Overall Study|Other|0|||
33241148|NCT01238575|100783209|FG000|Overall Study|Lack of Efficacy|2|||
33241149|NCT01238575|100783210|FG001|Overall Study|Lack of Efficacy|4|||
33241150|NCT01238575|100783209|FG000|Overall Study|Adverse Event|2|||
33241151|NCT01238575|100783210|FG001|Overall Study|Adverse Event|0|||
33241152|NCT01094743|100783211|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
33641049|NCT04421027|102236569|FG000|Treatment Period|Adverse Event|5|||
33641050|NCT04421027|102236570|FG001|Treatment Period|Adverse Event|3|||
33641051|NCT04421027|102236571|FG002|Treatment Period|Adverse Event|0|||
33142351|NCT00830869|100434859|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
33142352|NCT00830869|100434860|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
33142353|NCT00830869|100434861|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
33142354|NCT00830869|100434862|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
33241153|NCT02264574|100783214|FG000|Overall Study|Death|21|||
33241154|NCT02264574|100783215|FG001|Overall Study|Death|21|||
33241155|NCT02264574|100783214|FG000|Overall Study|Withdrawal by Subject|8|||
33241156|NCT02264574|100783215|FG001|Overall Study|Withdrawal by Subject|6|||
33241157|NCT02264574|100783214|FG000|Overall Study|Other, Not Specified|0|||
33641052|NCT04421027|102236572|FG003|Treatment Period|Adverse Event|0|||
33641053|NCT04421027|102236569|FG000|Treatment Period|Death|98|||
33641054|NCT04421027|102236570|FG001|Treatment Period|Death|61|||
33641055|NCT04421027|102236571|FG002|Treatment Period|Death|0|||
33641056|NCT04421027|102236572|FG003|Treatment Period|Death|0|||
33641057|NCT04421027|102236569|FG000|Treatment Period|Lost to Follow-up|22|||
33641058|NCT04421027|102236570|FG001|Treatment Period|Lost to Follow-up|20|||
33641059|NCT04421027|102236571|FG002|Treatment Period|Lost to Follow-up|0|||
33641060|NCT04421027|102236572|FG003|Treatment Period|Lost to Follow-up|0|||
33641061|NCT04421027|102236569|FG000|Treatment Period|Other-Unknown|15|||
33641062|NCT04421027|102236570|FG001|Treatment Period|Other-Unknown|9|||
33641063|NCT04421027|102236571|FG002|Treatment Period|Other-Unknown|0|||
33641064|NCT04421027|102236572|FG003|Treatment Period|Other-Unknown|0|||
33641065|NCT04421027|102236569|FG000|Treatment Period|Physician Decision|1|||
33641066|NCT04421027|102236570|FG001|Treatment Period|Physician Decision|1|||
33641067|NCT04421027|102236571|FG002|Treatment Period|Physician Decision|0|||
33641068|NCT04421027|102236572|FG003|Treatment Period|Physician Decision|0|||
33641069|NCT04421027|102236569|FG000|Treatment Period|Withdrawal by Subject|7|||
33641070|NCT04421027|102236570|FG001|Treatment Period|Withdrawal by Subject|12|||
33641071|NCT04421027|102236571|FG002|Treatment Period|Withdrawal by Subject|0|||
33641072|NCT04421027|102236572|FG003|Treatment Period|Withdrawal by Subject|0|||
33641073|NCT04421027|102236569|FG000|Treatment Period|Randomized Not Dosed|9|||
33641074|NCT04421027|102236570|FG001|Treatment Period|Randomized Not Dosed|14|||
33641075|NCT04421027|102236571|FG002|Treatment Period|Randomized Not Dosed|0|||
33641076|NCT04421027|102236572|FG003|Treatment Period|Randomized Not Dosed|0|||
33641077|NCT04421027|102236569|FG000|Follow-Up Period|Adverse Event|0|||
33641078|NCT04421027|102236570|FG001|Follow-Up Period|Adverse Event|0|||
33641079|NCT04421027|102236571|FG002|Follow-Up Period|Adverse Event|0|||
33641080|NCT04421027|102236572|FG003|Follow-Up Period|Adverse Event|3|||
33641081|NCT04421027|102236569|FG000|Follow-Up Period|Death|0|||
33641082|NCT04421027|102236570|FG001|Follow-Up Period|Death|0|||
33641083|NCT04421027|102236571|FG002|Follow-Up Period|Death|16|||
33641084|NCT04421027|102236572|FG003|Follow-Up Period|Death|17|||
33641085|NCT04421027|102236569|FG000|Follow-Up Period|Lost to Follow-up|0|||
33641086|NCT04421027|102236570|FG001|Follow-Up Period|Lost to Follow-up|0|||
33641087|NCT04421027|102236571|FG002|Follow-Up Period|Lost to Follow-up|7|||
33641088|NCT04421027|102236572|FG003|Follow-Up Period|Lost to Follow-up|7|||
33641089|NCT04421027|102236569|FG000|Follow-Up Period|Protocol Deviation|0|||
33641090|NCT04421027|102236570|FG001|Follow-Up Period|Protocol Deviation|0|||
33370846|NCT00243230|101243538|FG002|Open Label Period|Adverse Event|0|||
33370847|NCT00243230|101243539|FG003|Open Label Period|Adverse Event|2|||
33370848|NCT00243230|101243536|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
33641091|NCT04421027|102236571|FG002|Follow-Up Period|Protocol Deviation|1|||
33641092|NCT04421027|102236572|FG003|Follow-Up Period|Protocol Deviation|0|||
33641093|NCT04421027|102236569|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
33641094|NCT04421027|102236570|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
33641095|NCT04421027|102236571|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
33641096|NCT04421027|102236572|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
33641097|NCT04421027|102236569|FG000|Follow-Up Period|Left message, participant did not call back|0|||
33641098|NCT04421027|102236570|FG001|Follow-Up Period|Left message, participant did not call back|0|||
33641099|NCT04421027|102236571|FG002|Follow-Up Period|Left message, participant did not call back|0|||
33641100|NCT04421027|102236572|FG003|Follow-Up Period|Left message, participant did not call back|1|||
33641101|NCT04421027|102236569|FG000|Follow-Up Period|Participant died|0|||
33641102|NCT04421027|102236570|FG001|Follow-Up Period|Participant died|0|||
33641103|NCT04421027|102236571|FG002|Follow-Up Period|Participant died|0|||
33641104|NCT04421027|102236572|FG003|Follow-Up Period|Participant died|1|||
33641105|NCT04421027|102236569|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
33641106|NCT04421027|102236570|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
33641107|NCT04421027|102236571|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
33641108|NCT04421027|102236572|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
33641109|NCT03967444|102236573|FG000|Overall Study|Lost to Follow-up|1|||
33641110|NCT03967444|102236574|FG001|Overall Study|Lost to Follow-up|2|||
33641111|NCT02625909|102236575|FG000|Overall Study|Death|2|||
33241158|NCT02264574|100783215|FG001|Overall Study|Other, Not Specified|3|||
33241159|NCT01657032|100783216|FG000|Overall Study|Lost to Follow-up|0|||
33241160|NCT01657032|100783217|FG001|Overall Study|Lost to Follow-up|7|||
33370849|NCT00243230|101243537|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
33370850|NCT00243230|101243538|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
33641112|NCT02625909|102236576|FG001|Overall Study|Death|0|||
33641113|NCT02625909|102236575|FG000|Overall Study|Lost to Follow-up|3|||
33641114|NCT02625909|102236576|FG001|Overall Study|Lost to Follow-up|5|||
33641115|NCT02625909|102236575|FG000|Overall Study|Lack of Efficacy|9|||
33641116|NCT02625909|102236576|FG001|Overall Study|Lack of Efficacy|2|||
33641117|NCT02625909|102236575|FG000|Overall Study|Reinfection|3|||
33641118|NCT02625909|102236576|FG001|Overall Study|Reinfection|2|||
33641119|NCT01376804|102236577|FG000|Treatment Period|Withdrawal by Subject|1|||
33641120|NCT01376804|102236577|FG000|Treatment Period|Adverse Event|6|||
33641121|NCT01376804|102236577|FG000|Treatment Period|Patient did not receive study drug|1|||
33641122|NCT02055118|102236578|FG000|Overall Study|Withdrawal by Subject|0|||
33641123|NCT02055118|102236579|FG001|Overall Study|Withdrawal by Subject|2|||
33641124|NCT02055118|102236580|FG002|Overall Study|Withdrawal by Subject|0|||
33641125|NCT01642589|102236583|FG000|Overall Study|Withdrawal by Subject|1|||
33641126|NCT01642589|102236584|FG001|Overall Study|Withdrawal by Subject|1|||
33641127|NCT01177397|102236585|FG000|Overall Study|Protocol Violation|0|||
33641128|NCT01177397|102236586|FG001|Overall Study|Protocol Violation|0|||
33641129|NCT01177397|102236587|FG002|Overall Study|Protocol Violation|0|||
33641130|NCT01177397|102236588|FG003|Overall Study|Protocol Violation|0|||
33641131|NCT01177397|102236589|FG004|Overall Study|Protocol Violation|0|||
33641132|NCT01177397|102236590|FG005|Overall Study|Protocol Violation|1|||
33641133|NCT01177397|102236591|FG006|Overall Study|Protocol Violation|0|||
33641134|NCT01177397|102236592|FG007|Overall Study|Protocol Violation|0|||
33641135|NCT01177397|102236593|FG008|Overall Study|Protocol Violation|0|||
33641136|NCT01177397|102236594|FG009|Overall Study|Protocol Violation|0|||
33641137|NCT01177397|102236595|FG010|Overall Study|Protocol Violation|0|||
33641138|NCT01177397|102236596|FG011|Overall Study|Protocol Violation|0|||
33641139|NCT01177397|102236585|FG000|Overall Study|Lost to Follow-up|0|||
33641140|NCT01177397|102236586|FG001|Overall Study|Lost to Follow-up|0|||
33641141|NCT01177397|102236587|FG002|Overall Study|Lost to Follow-up|0|||
33641142|NCT01177397|102236588|FG003|Overall Study|Lost to Follow-up|0|||
33641143|NCT01177397|102236589|FG004|Overall Study|Lost to Follow-up|1|||
33641144|NCT01177397|102236590|FG005|Overall Study|Lost to Follow-up|0|||
33641145|NCT01177397|102236591|FG006|Overall Study|Lost to Follow-up|0|||
33641146|NCT01177397|102236592|FG007|Overall Study|Lost to Follow-up|2|||
33641147|NCT01177397|102236593|FG008|Overall Study|Lost to Follow-up|0|||
33641148|NCT01177397|102236594|FG009|Overall Study|Lost to Follow-up|0|||
33641149|NCT01177397|102236595|FG010|Overall Study|Lost to Follow-up|0|||
33641150|NCT01177397|102236596|FG011|Overall Study|Lost to Follow-up|0|||
33641151|NCT01177397|102236585|FG000|Overall Study|Death|0|||
33641152|NCT01177397|102236586|FG001|Overall Study|Death|0|||
33641153|NCT01177397|102236587|FG002|Overall Study|Death|1|||
33641154|NCT01177397|102236588|FG003|Overall Study|Death|1|||
33641155|NCT01177397|102236589|FG004|Overall Study|Death|0|||
33641156|NCT01177397|102236590|FG005|Overall Study|Death|0|||
33641157|NCT01177397|102236591|FG006|Overall Study|Death|0|||
33641158|NCT01177397|102236592|FG007|Overall Study|Death|5|||
33641159|NCT01177397|102236593|FG008|Overall Study|Death|2|||
33641160|NCT01177397|102236594|FG009|Overall Study|Death|1|||
33641161|NCT01177397|102236595|FG010|Overall Study|Death|0|||
33641162|NCT01177397|102236596|FG011|Overall Study|Death|0|||
33641163|NCT01177397|102236585|FG000|Overall Study|Withdrawal by Subject|0|||
33641164|NCT01177397|102236586|FG001|Overall Study|Withdrawal by Subject|0|||
33641165|NCT01177397|102236587|FG002|Overall Study|Withdrawal by Subject|1|||
33641166|NCT01177397|102236588|FG003|Overall Study|Withdrawal by Subject|1|||
33641167|NCT01177397|102236589|FG004|Overall Study|Withdrawal by Subject|1|||
33641168|NCT01177397|102236590|FG005|Overall Study|Withdrawal by Subject|2|||
33641169|NCT01177397|102236591|FG006|Overall Study|Withdrawal by Subject|0|||
33641170|NCT01177397|102236592|FG007|Overall Study|Withdrawal by Subject|5|||
33641171|NCT01177397|102236593|FG008|Overall Study|Withdrawal by Subject|9|||
33641172|NCT01177397|102236594|FG009|Overall Study|Withdrawal by Subject|1|||
33641173|NCT01177397|102236595|FG010|Overall Study|Withdrawal by Subject|1|||
33641174|NCT01177397|102236596|FG011|Overall Study|Withdrawal by Subject|0|||
33641175|NCT01177397|102236585|FG000|Overall Study|Adverse Event|0|||
33641176|NCT01177397|102236586|FG001|Overall Study|Adverse Event|0|||
33641177|NCT01177397|102236587|FG002|Overall Study|Adverse Event|1|||
33142355|NCT00830869|100434863|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
33241161|NCT01700530|100783218|FG000|Overall Study|Withdrawal by Subject|0|||
33241162|NCT01700530|100783219|FG001|Overall Study|Withdrawal by Subject|3|||
33370851|NCT00243230|101243539|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
33370852|NCT00243230|101243536|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
33241163|NCT01700530|100783220|FG002|Overall Study|Withdrawal by Subject|1|||
33421241|NCT01128153|101431753|FG001|Overall Study|Withdrawal by Subject|3|||
33641178|NCT01177397|102236588|FG003|Overall Study|Adverse Event|2|||
33641179|NCT01177397|102236589|FG004|Overall Study|Adverse Event|0|||
33641180|NCT01177397|102236590|FG005|Overall Study|Adverse Event|12|||
33641181|NCT01177397|102236591|FG006|Overall Study|Adverse Event|1|||
33641182|NCT01177397|102236592|FG007|Overall Study|Adverse Event|14|||
33641183|NCT01177397|102236593|FG008|Overall Study|Adverse Event|8|||
33641184|NCT01177397|102236594|FG009|Overall Study|Adverse Event|6|||
33241164|NCT00582790|100783226|FG000|Overall Study|Rapid progression of disease|1|||
33641185|NCT01177397|102236595|FG010|Overall Study|Adverse Event|3|||
33641186|NCT01177397|102236596|FG011|Overall Study|Adverse Event|7|||
33641187|NCT01177397|102236585|FG000|Overall Study|Disease progression|1|||
33641188|NCT01177397|102236586|FG001|Overall Study|Disease progression|2|||
33641189|NCT01177397|102236587|FG002|Overall Study|Disease progression|5|||
33641190|NCT01177397|102236588|FG003|Overall Study|Disease progression|5|||
33641191|NCT01177397|102236589|FG004|Overall Study|Disease progression|4|||
33641192|NCT01177397|102236590|FG005|Overall Study|Disease progression|10|||
33641193|NCT01177397|102236591|FG006|Overall Study|Disease progression|10|||
33641194|NCT01177397|102236592|FG007|Overall Study|Disease progression|21|||
33641195|NCT01177397|102236593|FG008|Overall Study|Disease progression|18|||
33641196|NCT01177397|102236594|FG009|Overall Study|Disease progression|12|||
33641197|NCT01177397|102236595|FG010|Overall Study|Disease progression|10|||
33421242|NCT01128153|101431752|FG000|Overall Study|Incorrect enrolment to study|2|||
33421243|NCT01128153|101431753|FG001|Overall Study|Incorrect enrolment to study|1|||
33241165|NCT01606189|100783228|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
33241166|NCT01606189|100783229|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
33241167|NCT01606189|100783230|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
33241168|NCT01606189|100783231|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
33241169|NCT01606189|100783232|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
33241170|NCT01606189|100783233|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
33241171|NCT01606189|100783228|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
33241172|NCT01606189|100783229|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
33241173|NCT01606189|100783230|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
33241174|NCT01606189|100783231|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
33241175|NCT01606189|100783232|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
33241176|NCT01606189|100783233|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
33241177|NCT02688621|100783238|FG000|Overall Study|Pregnancy|1|||
33241178|NCT02688621|100783239|FG001|Overall Study|Pregnancy|3|||
33241179|NCT02688621|100783238|FG000|Overall Study|Lost to Follow-up|38|||
33241180|NCT02688621|100783239|FG001|Overall Study|Lost to Follow-up|15|||
33421244|NCT01128153|101431752|FG000|Overall Study|Protocol Violation|2|||
33421245|NCT01128153|101431753|FG001|Overall Study|Protocol Violation|0|||
33421246|NCT01128153|101431752|FG000|Overall Study|Developed discontinuation criteria|1|||
33421247|NCT01128153|101431753|FG001|Overall Study|Developed discontinuation criteria|1|||
33421248|NCT00740480|101431754|FG000|Overall Study|Adverse Event|1|||
33421249|NCT00740480|101431754|FG000|Overall Study|Physician Decision|1|||
33421250|NCT00096200|101431755|FG000|Overall Study|Adverse Event|0|||
33421251|NCT00096200|101431756|FG001|Overall Study|Adverse Event|4|||
33421252|NCT00096200|101431757|FG002|Overall Study|Adverse Event|0|||
33421253|NCT00096200|101431755|FG000|Overall Study|Withdrawal by Subject|1|||
33421254|NCT00096200|101431756|FG001|Overall Study|Withdrawal by Subject|2|||
33421255|NCT00096200|101431757|FG002|Overall Study|Withdrawal by Subject|0|||
33421256|NCT00096200|101431755|FG000|Overall Study|Ineligible pathology|0|||
33421257|NCT00096200|101431756|FG001|Overall Study|Ineligible pathology|1|||
33421258|NCT00096200|101431757|FG002|Overall Study|Ineligible pathology|0|||
33421259|NCT02200614|101431758|FG000|Double Blind Treatment|Adverse Event|86|||
33421260|NCT02200614|101431759|FG001|Double Blind Treatment|Adverse Event|48|||
33421261|NCT02200614|101431758|FG000|Double Blind Treatment|Confirmed metastasis|120|||
33421262|NCT02200614|101431759|FG001|Double Blind Treatment|Confirmed metastasis|140|||
33421263|NCT02200614|101431758|FG000|Double Blind Treatment|Judgment of the investigator|59|||
33421264|NCT02200614|101431759|FG001|Double Blind Treatment|Judgment of the investigator|99|||
33421265|NCT02200614|101431758|FG000|Double Blind Treatment|Metastasis by local reading|1|||
33421266|NCT02200614|101431759|FG001|Double Blind Treatment|Metastasis by local reading|3|||
33421267|NCT02200614|101431758|FG000|Double Blind Treatment|Other reason|6|||
33421268|NCT02200614|101431759|FG001|Double Blind Treatment|Other reason|2|||
33421269|NCT02200614|101431758|FG000|Double Blind Treatment|Personal reason|77|||
33421270|NCT02200614|101431759|FG001|Double Blind Treatment|Personal reason|85|||
33421271|NCT02200614|101431758|FG000|Double Blind Treatment|Protocol deviation|14|||
33421272|NCT02200614|101431759|FG001|Double Blind Treatment|Protocol deviation|7|||
33421273|NCT02200614|101431758|FG000|Double Blind Treatment|Not treated|1|||
33421274|NCT02200614|101431759|FG001|Double Blind Treatment|Not treated|0|||
33641198|NCT01177397|102236596|FG011|Overall Study|Disease progression|8|||
33641199|NCT01177397|102236585|FG000|Overall Study|Other reasons|0|||
33421275|NCT02200614|101431758|FG000|Open Label|Adverse Event|41|||
33421276|NCT02200614|101431759|FG001|Open Label|Adverse Event|11|||
33421277|NCT02200614|101431758|FG000|Open Label|Confirmed metastasis|1|||
33421278|NCT02200614|101431759|FG001|Open Label|Confirmed metastasis|0|||
33421279|NCT02200614|101431758|FG000|Open Label|Judgment of the investigator|29|||
33421280|NCT02200614|101431759|FG001|Open Label|Judgment of the investigator|2|||
33421281|NCT02200614|101431758|FG000|Open Label|Metastasis by local reading|138|||
33421282|NCT02200614|101431759|FG001|Open Label|Metastasis by local reading|27|||
33421283|NCT02200614|101431758|FG000|Open Label|Other reason|22|||
33421284|NCT02200614|101431759|FG001|Open Label|Other reason|4|||
33421285|NCT02200614|101431758|FG000|Open Label|Personal reason|60|||
33421286|NCT02200614|101431759|FG001|Open Label|Personal reason|8|||
33641200|NCT01177397|102236586|FG001|Overall Study|Other reasons|0|||
33241181|NCT02688621|100783238|FG000|Overall Study|Withdrawal by Subject|1|||
33241182|NCT02688621|100783239|FG001|Overall Study|Withdrawal by Subject|0|||
33421287|NCT02200614|101431758|FG000|Open Label|Protocol deviation|3|||
33421288|NCT02200614|101431759|FG001|Open Label|Protocol deviation|2|||
33641201|NCT01177397|102236587|FG002|Overall Study|Other reasons|1|||
33641202|NCT01177397|102236588|FG003|Overall Study|Other reasons|0|||
33421289|NCT02200614|101431758|FG000|Open Label|Missing|2|||
33421290|NCT02200614|101431759|FG001|Open Label|Missing|2|||
33421291|NCT02016755|101431760|FG000|Overall Study|Major amputation of index limb|2|||
33421292|NCT02016755|101431760|FG000|Overall Study|Adverse Event|2|||
33421293|NCT02016755|101431760|FG000|Overall Study|Physician Decision|1|||
33421294|NCT02016755|101431760|FG000|Overall Study|Death|2|||
33421295|NCT05003167|101431761|FG000|Overall Study|Withdrawal by Subject|1|||
33421296|NCT05478603|101431762|FG000|Overall Study|Withdrawal by Subject|0|||
33421297|NCT05478603|101431763|FG001|Overall Study|Withdrawal by Subject|1|||
33421298|NCT05478603|101431764|FG002|Overall Study|Withdrawal by Subject|0|||
33421299|NCT05478603|101431765|FG003|Overall Study|Withdrawal by Subject|0|||
33370853|NCT00243230|101243537|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
33370854|NCT00243230|101243538|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
33421300|NCT04330482|101431766|FG000|Overall Study|Lost to Follow-up|2|||
33421301|NCT04330482|101431767|FG001|Overall Study|Lost to Follow-up|1|||
33421302|NCT04330482|101431766|FG000|Overall Study|Withdrawal by Subject|0|||
33421303|NCT04330482|101431767|FG001|Overall Study|Withdrawal by Subject|3|||
33421304|NCT00552617|101431768|FG000|Overall Study|Not Treated|0|||
33421305|NCT00552617|101431769|FG001|Overall Study|Not Treated|0|||
33421306|NCT00552617|101431770|FG002|Overall Study|Not Treated|1|||
33421307|NCT00552617|101431771|FG003|Overall Study|Not Treated|0|||
33421308|NCT00552617|101431772|FG004|Overall Study|Not Treated|0|||
33421309|NCT00552617|101431773|FG005|Overall Study|Not Treated|0|||
33421310|NCT00552617|101431774|FG006|Overall Study|Not Treated|0|||
33421311|NCT00552617|101431775|FG007|Overall Study|Not Treated|0|||
33421312|NCT00552617|101431776|FG008|Overall Study|Not Treated|0|||
33421313|NCT00552617|101431777|FG009|Overall Study|Not Treated|1|||
33421314|NCT00552617|101431768|FG000|Overall Study|Lost to Follow-up|0|||
33421315|NCT00552617|101431769|FG001|Overall Study|Lost to Follow-up|0|||
33142356|NCT00830869|100434864|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
33370855|NCT00243230|101243539|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
33370856|NCT00243230|101243536|FG000|Open Label Period|Lost to Follow-up|0|||
33370857|NCT00243230|101243537|FG001|Open Label Period|Lost to Follow-up|0|||
33370858|NCT00243230|101243538|FG002|Open Label Period|Lost to Follow-up|0|||
33370859|NCT00243230|101243539|FG003|Open Label Period|Lost to Follow-up|2|||
33370860|NCT00243230|101243536|FG000|Open Label Period|Withdrawal by Subject|0|||
33370861|NCT00243230|101243537|FG001|Open Label Period|Withdrawal by Subject|0|||
33370862|NCT00243230|101243538|FG002|Open Label Period|Withdrawal by Subject|0|||
33370863|NCT00243230|101243539|FG003|Open Label Period|Withdrawal by Subject|2|||
33370864|NCT00243230|101243536|FG000|Open Label Period|Protocol Violation|0|||
33370865|NCT00243230|101243537|FG001|Open Label Period|Protocol Violation|0|||
33370866|NCT00243230|101243538|FG002|Open Label Period|Protocol Violation|0|||
33370867|NCT00243230|101243539|FG003|Open Label Period|Protocol Violation|2|||
33370868|NCT00243230|101243536|FG000|Open Label Period|Administrative Reason|0|||
33370869|NCT00243230|101243537|FG001|Open Label Period|Administrative Reason|0|||
33370870|NCT00243230|101243538|FG002|Open Label Period|Administrative Reason|0|||
33370871|NCT00243230|101243539|FG003|Open Label Period|Administrative Reason|63|||
33370872|NCT00634244|101243540|FG000|Overall Study|Never started treatment|0|||
33370873|NCT00634244|101243541|FG001|Overall Study|Never started treatment|1|||
33370874|NCT00634244|101243542|FG002|Overall Study|Never started treatment|0|||
33370875|NCT00634244|101243540|FG000|Overall Study|Death|1|||
33421316|NCT00552617|101431770|FG002|Overall Study|Lost to Follow-up|0|||
33421317|NCT00552617|101431771|FG003|Overall Study|Lost to Follow-up|1|||
33421318|NCT00552617|101431772|FG004|Overall Study|Lost to Follow-up|0|||
33421319|NCT00552617|101431773|FG005|Overall Study|Lost to Follow-up|2|||
33421320|NCT00552617|101431774|FG006|Overall Study|Lost to Follow-up|0|||
33421321|NCT00552617|101431775|FG007|Overall Study|Lost to Follow-up|0|||
33421322|NCT00552617|101431776|FG008|Overall Study|Lost to Follow-up|2|||
33421323|NCT00552617|101431777|FG009|Overall Study|Lost to Follow-up|0|||
33421324|NCT01864525|101431778|FG000|Overall Study|Adverse Event|1|||
33421325|NCT01864525|101431779|FG001|Overall Study|Adverse Event|0|||
33421326|NCT00934622|101431780|FG000|Overall Study|Lost to Follow-up|7|||
33421327|NCT00934622|101431780|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
33580887|NCT00286091|102017012|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
33241183|NCT01536262|100783243|FG000|Overall Study|Adverse Event|6|||
33241184|NCT01536262|100783244|FG001|Overall Study|Adverse Event|1|||
33370876|NCT00634244|101243541|FG001|Overall Study|Death|6|||
33421328|NCT01050673|101434730|FG000|Overall Study|Physician Decision|4|||
33421329|NCT01050673|101434731|FG001|Overall Study|Physician Decision|5|||
33421330|NCT02609178|101434738|FG000|First Crown|Withdrawal by Subject|0|||
33421331|NCT02609178|101434739|FG001|First Crown|Withdrawal by Subject|0|||
33421332|NCT02609178|101434740|FG002|First Crown|Withdrawal by Subject|1|||
33421333|NCT02609178|101434741|FG003|First Crown|Withdrawal by Subject|1|||
33370877|NCT00634244|101243542|FG002|Overall Study|Death|0|||
33421334|NCT02609178|101434742|FG004|First Crown|Withdrawal by Subject|0|||
33370878|NCT00634244|101243540|FG000|Overall Study|Adverse Event|0|||
33370879|NCT00634244|101243541|FG001|Overall Study|Adverse Event|2|||
33370880|NCT00634244|101243542|FG002|Overall Study|Adverse Event|0|||
33421335|NCT02609178|101434743|FG005|First Crown|Withdrawal by Subject|0|||
33142357|NCT00830869|100434865|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
33142358|NCT00830869|100434854|FG000|Period 2: Part 2|Adverse Event|0|||
33142359|NCT00830869|100434855|FG001|Period 2: Part 2|Adverse Event|0|||
33142360|NCT00830869|100434856|FG002|Period 2: Part 2|Adverse Event|0|||
33142361|NCT00830869|100434857|FG003|Period 2: Part 2|Adverse Event|0|||
33142362|NCT00830869|100434858|FG004|Period 2: Part 2|Adverse Event|0|||
33142363|NCT00830869|100434859|FG005|Period 2: Part 2|Adverse Event|0|||
33241185|NCT01536262|100783245|FG002|Overall Study|Adverse Event|2|||
33241186|NCT01536262|100783243|FG000|Overall Study|Withdrawal by Subject|1|||
33241187|NCT01536262|100783244|FG001|Overall Study|Withdrawal by Subject|1|||
33241188|NCT01536262|100783245|FG002|Overall Study|Withdrawal by Subject|0|||
33241189|NCT01536262|100783243|FG000|Overall Study|Other than stated above|1|||
33241190|NCT01536262|100783244|FG001|Overall Study|Other than stated above|0|||
33241191|NCT01536262|100783245|FG002|Overall Study|Other than stated above|0|||
33241192|NCT00409708|100783246|FG000|Treatment|Abnormal test procedure result(s)|1|||
33241193|NCT00409708|100783247|FG001|Treatment|Abnormal test procedure result(s)|0|||
33241194|NCT00409708|100783246|FG000|Treatment|Lack of Efficacy|0|||
33241195|NCT00409708|100783247|FG001|Treatment|Lack of Efficacy|1|||
33241196|NCT00409708|100783246|FG000|Treatment|Protocol Violation|6|||
33241197|NCT00409708|100783247|FG001|Treatment|Protocol Violation|2|||
33241198|NCT00409708|100783246|FG000|Treatment|Withdrawal by Subject|3|||
33241199|NCT00409708|100783247|FG001|Treatment|Withdrawal by Subject|8|||
33241200|NCT00409708|100783246|FG000|Treatment|Lost to Follow-up|0|||
33241201|NCT00409708|100783247|FG001|Treatment|Lost to Follow-up|6|||
33241202|NCT00409708|100783246|FG000|Treatment|Administrative problems|5|||
33241203|NCT00409708|100783247|FG001|Treatment|Administrative problems|0|||
33580888|NCT00286091|102017013|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
33580889|NCT00286091|102017012|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
33580890|NCT00286091|102017013|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
33580891|NCT00286091|102017012|FG000|Open-label Treatment Phase|Physician Decision|24|||
33580892|NCT00286091|102017013|FG001|Open-label Treatment Phase|Physician Decision|21|||
33580893|NCT00286091|102017012|FG000|Open-label Treatment Phase|Adverse Event|5|||
33580894|NCT00286091|102017013|FG001|Open-label Treatment Phase|Adverse Event|16|||
33580895|NCT00286091|102017012|FG000|Open-label Treatment Phase|Other|11|||
33580896|NCT00286091|102017013|FG001|Open-label Treatment Phase|Other|11|||
33580897|NCT00286091|102017012|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
33580898|NCT00286091|102017013|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
33580899|NCT00286091|102017012|FG000|Open-label Treatment Phase|Death|10|||
33580900|NCT00286091|102017013|FG001|Open-label Treatment Phase|Death|7|||
33580901|NCT00286091|102017012|FG000|Open-label Treatment Phase|Disease Progression|9|||
33580902|NCT00286091|102017013|FG001|Open-label Treatment Phase|Disease Progression|3|||
33580903|NCT00286091|102017012|FG000|Open-label Treatment Phase|Noncompliance|3|||
33580904|NCT00286091|102017013|FG001|Open-label Treatment Phase|Noncompliance|1|||
33580905|NCT00286091|102017012|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
33580906|NCT00286091|102017013|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
33580907|NCT00286091|102017012|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
33580908|NCT00286091|102017013|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
33580909|NCT00286091|102017012|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
33580910|NCT00286091|102017013|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
33580911|NCT01881009|102017014|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
33580912|NCT01881009|102017015|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
33580913|NCT02148263|102017016|FG000|Overall Study|Withdrawal by Subject|3|||
33580914|NCT02148263|102017017|FG001|Overall Study|Withdrawal by Subject|2|||
33580915|NCT01135992|102017018|FG000|Overall Study|Adverse Event|1|||
33580916|NCT01135992|102017018|FG000|Overall Study|Lack of Efficacy|1|||
33580917|NCT01135992|102017018|FG000|Overall Study|Protocol Violation|2|||
33580918|NCT01135992|102017018|FG000|Overall Study|Withdrawal criteria|10|||
33580919|NCT01135992|102017018|FG000|Overall Study|Unclassified|7|||
33580920|NCT02628444|102017026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
33580921|NCT02628444|102017027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33580922|NCT02628444|102017028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33580923|NCT02628444|102017029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33580924|NCT02628444|102017030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33580925|NCT02628444|102017031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33580926|NCT02628444|102017032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33641203|NCT01177397|102236589|FG004|Overall Study|Other reasons|1|||
33142364|NCT00830869|100434860|FG006|Period 2: Part 2|Adverse Event|0|||
33241204|NCT00409708|100783246|FG000|Washout|Lack of Efficacy|9|||
33241205|NCT00409708|100783247|FG001|Washout|Lack of Efficacy|1|||
33241206|NCT00409708|100783246|FG000|Washout|Protocol Violation|0|||
33142365|NCT00830869|100434861|FG007|Period 2: Part 2|Adverse Event|4|||
33241207|NCT00409708|100783247|FG001|Washout|Protocol Violation|1|||
33370881|NCT00634244|101243540|FG000|Overall Study|Withdrawal by Subject|0|||
33370882|NCT00634244|101243541|FG001|Overall Study|Withdrawal by Subject|1|||
33370883|NCT00634244|101243542|FG002|Overall Study|Withdrawal by Subject|0|||
33370884|NCT00634244|101243540|FG000|Overall Study|Physician Decision|0|||
33370885|NCT00634244|101243541|FG001|Overall Study|Physician Decision|1|||
33370886|NCT00634244|101243542|FG002|Overall Study|Physician Decision|0|||
33370887|NCT00634244|101243540|FG000|Overall Study|Disease progression/relapse|0|||
33370888|NCT00634244|101243541|FG001|Overall Study|Disease progression/relapse|1|||
33370889|NCT00634244|101243542|FG002|Overall Study|Disease progression/relapse|0|||
33370890|NCT00634244|101243540|FG000|Overall Study|Other complicating disease|0|||
33370891|NCT00634244|101243541|FG001|Overall Study|Other complicating disease|1|||
33421336|NCT00289731|101434745|FG000|Overall Study|Adverse Event|1|||
33421337|NCT00289731|101434746|FG001|Overall Study|Adverse Event|2|||
33421338|NCT00289731|101434747|FG002|Overall Study|Adverse Event|2|||
33421339|NCT00289731|101434745|FG000|Overall Study|Other|1|||
33580927|NCT02628444|102017033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33580928|NCT02628444|102017034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
33580929|NCT02628444|102017026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
33580930|NCT02628444|102017027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
33580931|NCT02628444|102017028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
33580932|NCT02628444|102017029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
33580933|NCT02628444|102017030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
33580934|NCT02628444|102017031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
33580935|NCT02628444|102017032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
33580936|NCT02628444|102017033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
33580937|NCT02628444|102017034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
33641204|NCT01177397|102236590|FG005|Overall Study|Other reasons|1|||
33641205|NCT01177397|102236591|FG006|Overall Study|Other reasons|2|||
33641206|NCT01177397|102236592|FG007|Overall Study|Other reasons|6|||
33641207|NCT01177397|102236593|FG008|Overall Study|Other reasons|10|||
33641208|NCT01177397|102236594|FG009|Overall Study|Other reasons|8|||
33641209|NCT01177397|102236595|FG010|Overall Study|Other reasons|0|||
33641210|NCT01177397|102236596|FG011|Overall Study|Other reasons|2|||
33641211|NCT02447003|102236601|FG000|Overall Study|Other|0|||
33641212|NCT02447003|102236602|FG001|Overall Study|Other|4|||
33241208|NCT00409708|100783246|FG000|Washout|Withdrawal by Subject|11|||
33580938|NCT02628444|102017026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
33580939|NCT02628444|102017027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
33580940|NCT02628444|102017028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
33241209|NCT00409708|100783247|FG001|Washout|Withdrawal by Subject|5|||
33580941|NCT02628444|102017029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
33580942|NCT02628444|102017030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
33580943|NCT02628444|102017031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
33641213|NCT02447003|102236601|FG000|Overall Study|Site discontinued|0|||
33641214|NCT02447003|102236602|FG001|Overall Study|Site discontinued|2|||
33641215|NCT02447003|102236601|FG000|Overall Study|Physician Decision|0|||
33241210|NCT00409708|100783246|FG000|Washout|Lost to Follow-up|1|||
33241211|NCT00409708|100783247|FG001|Washout|Lost to Follow-up|3|||
33241212|NCT01737268|100783250|FG000|Overall Study|Adverse Event|6|||
33241213|NCT01737268|100783250|FG000|Overall Study|Worsening of Target Disease|2|||
33241214|NCT01737268|100783250|FG000|Overall Study|In consideration of the patient's safety|1|||
33241215|NCT00465361|100783251|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
33241216|NCT00670540|100783252|FG000|Overall Study|ineligible|17|||
33241217|NCT00670540|100783252|FG000|Overall Study|not living in France|348|||
33370892|NCT00634244|101243542|FG002|Overall Study|Other complicating disease|0|||
33370893|NCT05131451|101243550|FG000|Overall Study|Protocol Violation|1|||
33370894|NCT05131451|101243551|FG001|Overall Study|Protocol Violation|0|||
33421340|NCT00289731|101434746|FG001|Overall Study|Other|0|||
33641216|NCT02447003|102236602|FG001|Overall Study|Physician Decision|1|||
33641217|NCT02447003|102236601|FG000|Overall Study|Withdrawal by Subject|4|||
33142366|NCT00830869|100434862|FG008|Period 2: Part 2|Adverse Event|3|||
33142367|NCT00830869|100434863|FG009|Period 2: Part 2|Adverse Event|2|||
33142368|NCT00830869|100434864|FG010|Period 2: Part 2|Adverse Event|2|||
33142369|NCT00830869|100434865|FG011|Period 2: Part 2|Adverse Event|0|||
33142370|NCT00830869|100434854|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
33142371|NCT00830869|100434855|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
33142372|NCT00830869|100434856|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
33142373|NCT00830869|100434857|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
33142374|NCT00830869|100434858|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
33370895|NCT01766336|101243565|FG000|Overall Study|Adverse Event|11|||
33370896|NCT01766336|101243566|FG001|Overall Study|Adverse Event|8|||
33370897|NCT01766336|101243565|FG000|Overall Study|Death|4|||
33421341|NCT00289731|101434747|FG002|Overall Study|Other|0|||
33142375|NCT00830869|100434859|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
33142376|NCT00830869|100434860|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
33142377|NCT00830869|100434861|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
33142378|NCT00830869|100434862|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
33142379|NCT00830869|100434863|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
33142380|NCT00830869|100434864|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
33142381|NCT00830869|100434865|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
33142382|NCT00830869|100434854|FG000|Period 2: Part 2|Progressive disease|0|||
33142383|NCT00830869|100434855|FG001|Period 2: Part 2|Progressive disease|0|||
33142384|NCT00830869|100434856|FG002|Period 2: Part 2|Progressive disease|0|||
33142385|NCT00830869|100434857|FG003|Period 2: Part 2|Progressive disease|0|||
33142386|NCT00830869|100434858|FG004|Period 2: Part 2|Progressive disease|0|||
33142387|NCT00830869|100434859|FG005|Period 2: Part 2|Progressive disease|0|||
33142388|NCT00830869|100434860|FG006|Period 2: Part 2|Progressive disease|0|||
33142389|NCT00830869|100434861|FG007|Period 2: Part 2|Progressive disease|14|||
33142390|NCT00830869|100434862|FG008|Period 2: Part 2|Progressive disease|11|||
33142391|NCT00830869|100434863|FG009|Period 2: Part 2|Progressive disease|12|||
33142392|NCT00830869|100434864|FG010|Period 2: Part 2|Progressive disease|8|||
33142393|NCT00830869|100434865|FG011|Period 2: Part 2|Progressive disease|15|||
33142394|NCT00830869|100434854|FG000|Period 2: Part 2|Other|0|||
33142395|NCT00830869|100434855|FG001|Period 2: Part 2|Other|0|||
33142396|NCT00830869|100434856|FG002|Period 2: Part 2|Other|0|||
33142397|NCT00830869|100434857|FG003|Period 2: Part 2|Other|0|||
33142398|NCT00830869|100434858|FG004|Period 2: Part 2|Other|0|||
33142399|NCT00830869|100434859|FG005|Period 2: Part 2|Other|0|||
33142400|NCT00830869|100434860|FG006|Period 2: Part 2|Other|0|||
33142401|NCT00830869|100434861|FG007|Period 2: Part 2|Other|0|||
33142402|NCT00830869|100434862|FG008|Period 2: Part 2|Other|0|||
33142403|NCT00830869|100434863|FG009|Period 2: Part 2|Other|1|||
33142404|NCT00830869|100434864|FG010|Period 2: Part 2|Other|0|||
33142405|NCT00830869|100434865|FG011|Period 2: Part 2|Other|0|||
33142406|NCT03780400|100434871|FG000|Overall Study|Lost to Follow-up|5|||
33142407|NCT03780400|100434871|FG000|Overall Study|Withdrawal by Subject|2|||
33142408|NCT03699475|100434872|FG000|Overall Study|Death|1|||
33142409|NCT00791076|100434873|FG000|Overall Study|Study was terminated,PI left institution|8|||
33142410|NCT00829933|100434876|FG000|Overall Study|Adverse Event|2|||
33142411|NCT00829933|100434877|FG001|Overall Study|Adverse Event|3|||
33142412|NCT00829933|100434878|FG002|Overall Study|Adverse Event|2|||
33142413|NCT00829933|100434879|FG003|Overall Study|Adverse Event|1|||
33142414|NCT00829933|100434876|FG000|Overall Study|Death|0|||
33142415|NCT00829933|100434877|FG001|Overall Study|Death|0|||
33142416|NCT00829933|100434878|FG002|Overall Study|Death|1|||
33142417|NCT00829933|100434879|FG003|Overall Study|Death|1|||
33142418|NCT00829933|100434876|FG000|Overall Study|Lack of Efficacy|0|||
33142419|NCT00829933|100434877|FG001|Overall Study|Lack of Efficacy|1|||
33142420|NCT00829933|100434878|FG002|Overall Study|Lack of Efficacy|0|||
33142421|NCT00829933|100434879|FG003|Overall Study|Lack of Efficacy|0|||
33142422|NCT00829933|100434876|FG000|Overall Study|Physician Decision|5|||
33142423|NCT00829933|100434877|FG001|Overall Study|Physician Decision|7|||
33142424|NCT00829933|100434878|FG002|Overall Study|Physician Decision|8|||
33142425|NCT00829933|100434879|FG003|Overall Study|Physician Decision|1|||
33241218|NCT00670540|100783252|FG000|Overall Study|refused to participate|189|||
33241219|NCT00670540|100783252|FG000|Overall Study|controls randomised for no follow up|2770|||
33241220|NCT00670540|100783252|FG000|Overall Study|missing information inclusion criteria|1|||
33241221|NCT01686932|100783262|FG000|Period 1|Adverse Event|1|||
33241222|NCT01686932|100783263|FG001|Period 1|Adverse Event|1|||
33241223|NCT00031447|100783264|FG000|Overall Study|Lost to Follow-up|0|||
33580944|NCT02628444|102017032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
33580945|NCT02628444|102017033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
33580946|NCT02628444|102017034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
33580947|NCT02628444|102017026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
33580948|NCT02628444|102017027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
33580949|NCT02628444|102017028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
33142426|NCT00829933|100434876|FG000|Overall Study|Pregnancy|0|||
33142427|NCT00829933|100434877|FG001|Overall Study|Pregnancy|0|||
33142428|NCT00829933|100434878|FG002|Overall Study|Pregnancy|0|||
33142429|NCT00829933|100434879|FG003|Overall Study|Pregnancy|2|||
33142430|NCT00829933|100434876|FG000|Overall Study|Protocol Violation|2|||
33142431|NCT00829933|100434877|FG001|Overall Study|Protocol Violation|1|||
33142432|NCT00829933|100434878|FG002|Overall Study|Protocol Violation|0|||
33142433|NCT00829933|100434879|FG003|Overall Study|Protocol Violation|0|||
33142434|NCT00829933|100434876|FG000|Overall Study|withdrew before treatment started|5|||
33142435|NCT00829933|100434877|FG001|Overall Study|withdrew before treatment started|1|||
33142436|NCT00829933|100434878|FG002|Overall Study|withdrew before treatment started|2|||
33142437|NCT00829933|100434879|FG003|Overall Study|withdrew before treatment started|9|||
33241224|NCT00031447|100783265|FG001|Overall Study|Lost to Follow-up|1|||
33580950|NCT02628444|102017029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
33580951|NCT02628444|102017030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
33580952|NCT02628444|102017031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
33580953|NCT02628444|102017032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
33580954|NCT02628444|102017033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
33580955|NCT02628444|102017034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
33580956|NCT02628444|102017026|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
33580957|NCT02628444|102017027|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
33580958|NCT02628444|102017028|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
33580959|NCT02628444|102017029|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
33580960|NCT02628444|102017030|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
33580961|NCT02628444|102017031|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
33580962|NCT02628444|102017032|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
33580963|NCT02628444|102017033|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
33580964|NCT02628444|102017034|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
33580965|NCT02628444|102017026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33580966|NCT02628444|102017027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33580967|NCT02628444|102017028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33580968|NCT02628444|102017029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
33580969|NCT02628444|102017030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33580970|NCT02628444|102017031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33580971|NCT02628444|102017032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33580972|NCT02628444|102017033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33580973|NCT02628444|102017034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
33580974|NCT02628444|102017026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
33580975|NCT02628444|102017027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
33580976|NCT02628444|102017028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
33580977|NCT02628444|102017029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
33580978|NCT02628444|102017030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
33580979|NCT02628444|102017031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
33580980|NCT02628444|102017032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
33580981|NCT02628444|102017033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
33580982|NCT02628444|102017034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
33580983|NCT02628444|102017026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
33580984|NCT02628444|102017027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
33580985|NCT02628444|102017028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
33580986|NCT02628444|102017029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
33580987|NCT02628444|102017030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
33580988|NCT02628444|102017031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
33580989|NCT02628444|102017032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
33580990|NCT02628444|102017033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
33580991|NCT02628444|102017034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
33580992|NCT02628444|102017026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
33580993|NCT02628444|102017027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
33580994|NCT02628444|102017028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
33641218|NCT02447003|102236602|FG001|Overall Study|Withdrawal by Subject|3|||
33641219|NCT02447003|102236601|FG000|Overall Study|Sponsor Decision|6|||
33641220|NCT02447003|102236602|FG001|Overall Study|Sponsor Decision|11|||
33641221|NCT02447003|102236601|FG000|Overall Study|Progressive Disease|1|||
33641222|NCT02447003|102236602|FG001|Overall Study|Progressive Disease|0|||
33641223|NCT02447003|102236601|FG000|Overall Study|Lost to Follow-up|5|||
33641224|NCT02447003|102236602|FG001|Overall Study|Lost to Follow-up|0|||
33641225|NCT02447003|102236601|FG000|Overall Study|Death|154|||
33641226|NCT02447003|102236602|FG001|Overall Study|Death|63|||
33641227|NCT03216226|102236603|FG000|Overall Study|Adverse Event|3|||
33641228|NCT03216226|102236604|FG001|Overall Study|Adverse Event|0|||
33641229|NCT03216226|102236603|FG000|Overall Study|Protocol Violation|1|||
33142438|NCT00064298|100434880|FG000|Overall Study|Withdrawal by Subject|2|||
33142439|NCT00064298|100434881|FG001|Overall Study|Withdrawal by Subject|1|||
33142440|NCT00064298|100434880|FG000|Overall Study|Lost to Follow-up|2|||
33142441|NCT00064298|100434881|FG001|Overall Study|Lost to Follow-up|2|||
33641230|NCT03216226|102236604|FG001|Overall Study|Protocol Violation|3|||
33641231|NCT03216226|102236603|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
33142442|NCT00064298|100434880|FG000|Overall Study|Death|0|||
33142443|NCT00064298|100434881|FG001|Overall Study|Death|1|||
33142444|NCT00064298|100434880|FG000|Overall Study|Disease Progression|2|||
33142445|NCT00064298|100434881|FG001|Overall Study|Disease Progression|1|||
33142446|NCT01511055|100434882|FG000|Overall Study|Withdrawal by Subject|6|||
33142447|NCT02694718|100434888|FG000|Overall Study|Death|1|||
33142448|NCT02694718|100434888|FG000|Overall Study|Withdrawal by Subject|1|||
33142449|NCT00877773|100434889|FG000|Overall Study|Disease Progression|44|||
33142450|NCT01673347|100434890|FG000|Overall Study|failure of allograft|7|||
33142451|NCT03025789|100434891|FG000|Overall Study|Lack of Efficacy|6|||
33142452|NCT03025789|100434892|FG001|Overall Study|Lack of Efficacy|1|||
33142453|NCT03025789|100434891|FG000|Overall Study|Death|1|||
33142454|NCT03025789|100434892|FG001|Overall Study|Death|0|||
33142455|NCT03025789|100434891|FG000|Overall Study|Withdrawal by Subject|0|||
33142456|NCT03025789|100434892|FG001|Overall Study|Withdrawal by Subject|2|||
33142457|NCT01309893|100434895|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
33580995|NCT02628444|102017029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
33580996|NCT02628444|102017030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
33580997|NCT02628444|102017031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
33641232|NCT03216226|102236604|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
33142458|NCT01309893|100434896|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
33142459|NCT01309893|100434895|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
33142460|NCT01309893|100434896|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
33142461|NCT04719832|100434899|FG000|Overall Study|Adverse Event|2|||
33142462|NCT04719832|100434900|FG001|Overall Study|Adverse Event|0|||
33142463|NCT04719832|100434899|FG000|Overall Study|Lack of Efficacy|2|||
33142464|NCT04719832|100434900|FG001|Overall Study|Lack of Efficacy|4|||
33142465|NCT04719832|100434899|FG000|Overall Study|Lost to Follow-up|0|||
33142466|NCT04719832|100434900|FG001|Overall Study|Lost to Follow-up|2|||
33142467|NCT04719832|100434899|FG000|Overall Study|Physician Decision|0|||
33142468|NCT04719832|100434900|FG001|Overall Study|Physician Decision|1|||
33142469|NCT04719832|100434899|FG000|Overall Study|Pregnancy|1|||
33142470|NCT04719832|100434900|FG001|Overall Study|Pregnancy|1|||
33142471|NCT04719832|100434899|FG000|Overall Study|Withdrawal by Subject|5|||
33142472|NCT04719832|100434900|FG001|Overall Study|Withdrawal by Subject|5|||
33142473|NCT04719832|100434899|FG000|Overall Study|Randomized, not treated|0|||
33370898|NCT01766336|101243566|FG001|Overall Study|Death|3|||
33370899|NCT01766336|101243565|FG000|Overall Study|Lost to Follow-up|1|||
33370900|NCT01766336|101243566|FG001|Overall Study|Lost to Follow-up|3|||
33370901|NCT01766336|101243565|FG000|Overall Study|Physician Decision|4|||
33370902|NCT01766336|101243566|FG001|Overall Study|Physician Decision|2|||
33370903|NCT01766336|101243565|FG000|Overall Study|Protocol Violation|0|||
33370904|NCT01766336|101243566|FG001|Overall Study|Protocol Violation|1|||
33370905|NCT01766336|101243565|FG000|Overall Study|Sponsor Decision|52|||
33370906|NCT01766336|101243566|FG001|Overall Study|Sponsor Decision|43|||
33370907|NCT01766336|101243565|FG000|Overall Study|Withdrawal by Subject|18|||
33370908|NCT01766336|101243566|FG001|Overall Study|Withdrawal by Subject|15|||
33421342|NCT00837577|101434748|FG000|Double-blind Period|Clinical Adverse Event|1|||
33421343|NCT00837577|101434749|FG001|Double-blind Period|Clinical Adverse Event|0|||
33421344|NCT00837577|101434748|FG000|Double-blind Period|Withdrawal by Subject|1|||
33421345|NCT00837577|101434749|FG001|Double-blind Period|Withdrawal by Subject|0|||
33580998|NCT02628444|102017032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
33580999|NCT02628444|102017033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
33581000|NCT02628444|102017034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
33581001|NCT02628444|102017026|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
33581002|NCT02628444|102017027|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
33581003|NCT02628444|102017028|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
33581004|NCT02628444|102017029|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
33581005|NCT02628444|102017030|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
33581006|NCT02628444|102017031|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
33581007|NCT02628444|102017032|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
33641233|NCT03216226|102236603|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
33641234|NCT03216226|102236604|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
33641235|NCT03216226|102236603|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
33641236|NCT03216226|102236604|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
33641237|NCT01209689|102236605|FG000|Overall Study|Insufficient Therapeutic Response|7|||
33142474|NCT04719832|100434900|FG001|Overall Study|Randomized, not treated|2|||
33142475|NCT04719832|100434899|FG000|Overall Study|GCP violations|4|||
33142476|NCT04719832|100434900|FG001|Overall Study|GCP violations|7|||
33142477|NCT00976508|100434902|FG000|Overall Study|Death|7|||
33421346|NCT00837577|101434748|FG000|Open-label Period|Clinical Adverse Event|2|||
33142478|NCT00976508|100434903|FG001|Overall Study|Death|1|||
33142479|NCT00976508|100434902|FG000|Overall Study|Lost to Follow-up|1|||
33370909|NCT01754922|101243567|FG000|Overall Study|Adverse Event|0|||
33370910|NCT01754922|101243568|FG001|Overall Study|Adverse Event|1|||
33581008|NCT02628444|102017033|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
33581009|NCT02628444|102017034|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
33581010|NCT00551031|102017038|FG000|Overall Study|Adverse Event|0|||
33581011|NCT00551031|102017039|FG001|Overall Study|Adverse Event|1|||
33581012|NCT00551031|102017040|FG002|Overall Study|Adverse Event|0|||
33581013|NCT00551031|102017041|FG003|Overall Study|Adverse Event|0|||
33581014|NCT00551031|102017042|FG004|Overall Study|Adverse Event|0|||
33581015|NCT00551031|102017038|FG000|Overall Study|Protocol Violation|1|||
33581016|NCT00551031|102017039|FG001|Overall Study|Protocol Violation|1|||
33581017|NCT00551031|102017040|FG002|Overall Study|Protocol Violation|0|||
33581018|NCT00551031|102017041|FG003|Overall Study|Protocol Violation|0|||
33581019|NCT00551031|102017042|FG004|Overall Study|Protocol Violation|0|||
33581020|NCT00551031|102017038|FG000|Overall Study|Lost to Follow-up|0|||
33581021|NCT00551031|102017039|FG001|Overall Study|Lost to Follow-up|1|||
33581022|NCT00551031|102017040|FG002|Overall Study|Lost to Follow-up|0|||
33581023|NCT00551031|102017041|FG003|Overall Study|Lost to Follow-up|1|||
33581024|NCT00551031|102017042|FG004|Overall Study|Lost to Follow-up|1|||
33581025|NCT00551031|102017038|FG000|Overall Study|Withdrawal by Subject|0|||
33581026|NCT00551031|102017039|FG001|Overall Study|Withdrawal by Subject|4|||
33581027|NCT00551031|102017040|FG002|Overall Study|Withdrawal by Subject|1|||
33641238|NCT01209689|102236606|FG001|Overall Study|Insufficient Therapeutic Response|2|||
33641239|NCT01209689|102236605|FG000|Overall Study|Refused Treatment|8|||
33641240|NCT01209689|102236606|FG001|Overall Study|Refused Treatment|3|||
33641241|NCT01209689|102236605|FG000|Overall Study|Adverse Event|4|||
33641242|NCT01209689|102236606|FG001|Overall Study|Adverse Event|0|||
33641243|NCT01209689|102236605|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
33641244|NCT01209689|102236606|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
33641245|NCT01209689|102236605|FG000|Overall Study|Failure to Return|3|||
33142480|NCT00976508|100434903|FG001|Overall Study|Lost to Follow-up|0|||
33142481|NCT00976508|100434902|FG000|Overall Study|Withdrawal by Subject|1|||
33142482|NCT00976508|100434903|FG001|Overall Study|Withdrawal by Subject|0|||
33142483|NCT00976508|100434902|FG000|Overall Study|Disease Progression|4|||
33142484|NCT00976508|100434903|FG001|Overall Study|Disease Progression|4|||
33142485|NCT00976508|100434902|FG000|Overall Study|Subject Enrolled in Hospice|1|||
33142486|NCT00976508|100434903|FG001|Overall Study|Subject Enrolled in Hospice|0|||
33142487|NCT00976508|100434902|FG000|Overall Study|Terminated by the Sponsor|0|||
33142488|NCT00976508|100434903|FG001|Overall Study|Terminated by the Sponsor|1|||
33142489|NCT01758289|100434906|FG000|Overall Study|Premature Study Termination|44|||
33142490|NCT01758289|100434906|FG000|Overall Study|Adverse Event|9|||
33142491|NCT01129024|100434907|FG000|Overall Study|Physician Decision|5|||
33142492|NCT01129024|100434907|FG000|Overall Study|Study Terminated by Sponsor|8|||
33142493|NCT01129024|100434907|FG000|Overall Study|Withdrawal by Subject|2|||
33142494|NCT01129024|100434907|FG000|Overall Study|Lack of Efficacy|3|||
33641246|NCT01209689|102236606|FG001|Overall Study|Failure to Return|0|||
33641247|NCT01209689|102236605|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
33641248|NCT01209689|102236606|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
33641249|NCT00711191|102236609|FG000|Overall Study|Adverse Event|1|||
33641250|NCT00711191|102236610|FG001|Overall Study|Adverse Event|1|||
33142495|NCT01129024|100434907|FG000|Overall Study|Needed a Platelet Transfusion|1|||
33142496|NCT01752036|100434908|FG000|Overall Study|Death|2|||
33142497|NCT02290431|100434909|FG000|Overall Study|Adverse Event|20|||
33142498|NCT02290431|100434909|FG000|Overall Study|Progressive disease|4|||
33142499|NCT02290431|100434909|FG000|Overall Study|Study terminated by Sponsor|1|||
33142500|NCT02290431|100434909|FG000|Overall Study|Physician Decision|2|||
33142501|NCT00827931|100434910|FG000|Overall Study|Death|3|||
33142502|NCT00827931|100434911|FG001|Overall Study|Death|5|||
33142503|NCT00827931|100434910|FG000|Overall Study|Adverse Event|1|||
33142504|NCT00827931|100434911|FG001|Overall Study|Adverse Event|0|||
33581028|NCT00551031|102017041|FG003|Overall Study|Withdrawal by Subject|2|||
33641251|NCT00711191|102236611|FG002|Overall Study|Adverse Event|2|||
33142505|NCT00827931|100434910|FG000|Overall Study|Lost to Follow-up|1|||
33142506|NCT00827931|100434911|FG001|Overall Study|Lost to Follow-up|0|||
33142507|NCT00827931|100434910|FG000|Overall Study|Withdrawal by Subject|0|||
33142508|NCT00827931|100434911|FG001|Overall Study|Withdrawal by Subject|1|||
33142509|NCT00827931|100434910|FG000|Overall Study|Other|1|||
33142510|NCT00827931|100434911|FG001|Overall Study|Other|0|||
33142511|NCT03170232|100434912|FG000|Overall Study|Adverse Event|0|||
33641252|NCT00711191|102236609|FG000|Overall Study|Objective progression or relapse|2|||
33641253|NCT00711191|102236610|FG001|Overall Study|Objective progression or relapse|3|||
33641254|NCT00711191|102236611|FG002|Overall Study|Objective progression or relapse|7|||
33142512|NCT03170232|100434913|FG001|Overall Study|Adverse Event|1|||
33142513|NCT03170232|100434912|FG000|Overall Study|Protocol Violation|0|||
33142514|NCT03170232|100434913|FG001|Overall Study|Protocol Violation|1|||
33142515|NCT03170232|100434912|FG000|Overall Study|Lack of Efficacy|0|||
33142516|NCT03170232|100434913|FG001|Overall Study|Lack of Efficacy|1|||
33581029|NCT00551031|102017042|FG004|Overall Study|Withdrawal by Subject|0|||
33142517|NCT03170232|100434912|FG000|Overall Study|Study closed/terminated|26|||
33581030|NCT00551031|102017038|FG000|Overall Study|Serious Adverse Event|0|||
33241225|NCT00031447|100783264|FG000|Overall Study|Non-compliant|1|||
33241226|NCT00031447|100783265|FG001|Overall Study|Non-compliant|1|||
33241227|NCT00031447|100783264|FG000|Overall Study|Re-activation of Disease|2|||
33241228|NCT00031447|100783265|FG001|Overall Study|Re-activation of Disease|1|||
33241229|NCT00031447|100783264|FG000|Overall Study|Disruption of blinded study drug supply|7|||
33241230|NCT00031447|100783265|FG001|Overall Study|Disruption of blinded study drug supply|4|||
33241231|NCT05233085|100783266|FG000|Overall Study|Adverse Event|1|||
33241232|NCT05233085|100783267|FG001|Overall Study|Adverse Event|0|||
33241233|NCT05233085|100783268|FG002|Overall Study|Adverse Event|0|||
33241234|NCT05233085|100783269|FG003|Overall Study|Adverse Event|0|||
33241235|NCT02068885|100783270|FG000|Overall Study|Withdrew|3|||
33241236|NCT02068885|100783271|FG001|Overall Study|Withdrew|5|||
33241237|NCT02068885|100783272|FG002|Overall Study|Withdrew|8|||
33241238|NCT04172987|100783273|FG000|Lead In Period|Adverse Event|1|||
33241239|NCT04172987|100783273|FG000|Lead In Period|Protocol Violation|1|||
33241240|NCT04172987|100783273|FG000|Period 1|Physician Decision|1|||
33241241|NCT04172987|100783273|FG000|Period 2|Adverse Event|5|||
33241242|NCT04172987|100783273|FG000|Period 2|Dosing Termination by Sponsor|4|||
33241243|NCT02100722|100783274|FG000|Overall Study|Withdrawal pre-procedure|4|||
33241244|NCT02100722|100783275|FG001|Overall Study|Withdrawal pre-procedure|9|||
33241245|NCT02100722|100783274|FG000|Overall Study|Withdrawal post-procedure|0|||
33241246|NCT02100722|100783275|FG001|Overall Study|Withdrawal post-procedure|3|||
33241247|NCT02100722|100783274|FG000|Overall Study|Lost to Follow-up|2|||
33241248|NCT02100722|100783275|FG001|Overall Study|Lost to Follow-up|2|||
33241249|NCT02100722|100783274|FG000|Overall Study|Continuing on study|751|||
33241250|NCT02100722|100783275|FG001|Overall Study|Continuing on study|729|||
33241251|NCT01036087|100783276|FG000|Overall Study|Adverse Event|2|||
33241252|NCT01036087|100783276|FG000|Overall Study|Lack of Efficacy|1|||
33241253|NCT04155424|100783277|FG000|Overall Study|Other than specified|3|||
33241254|NCT04155424|100783277|FG000|Overall Study|Withdrawal by Subject|1|||
33241255|NCT04155424|100783277|FG000|Overall Study|Adverse Event|1|||
33241256|NCT00593554|100783280|FG000|Overall Study|Death|1|||
33241257|NCT00593554|100783281|FG001|Overall Study|Death|2|||
33241258|NCT00593554|100783280|FG000|Overall Study|Physician Decision|0|||
33241259|NCT00593554|100783281|FG001|Overall Study|Physician Decision|1|||
33241260|NCT00593554|100783280|FG000|Overall Study|Withdrawal by Subject|1|||
33241261|NCT00593554|100783281|FG001|Overall Study|Withdrawal by Subject|0|||
33241262|NCT00593554|100783280|FG000|Overall Study|Disease Progression|1|||
33241263|NCT00593554|100783281|FG001|Overall Study|Disease Progression|2|||
33241264|NCT00432159|100783282|FG000|Overall Study|Death|0|||
33241265|NCT00432159|100783283|FG001|Overall Study|Death|1|||
33241266|NCT00432159|100783284|FG002|Overall Study|Death|0|||
33241267|NCT00432159|100783285|FG003|Overall Study|Death|0|||
33241268|NCT00432159|100783286|FG004|Overall Study|Death|0|||
33241269|NCT00432159|100783282|FG000|Overall Study|Failure|9|||
33241270|NCT00432159|100783283|FG001|Overall Study|Failure|5|||
33241271|NCT00432159|100783284|FG002|Overall Study|Failure|3|||
33241272|NCT00432159|100783285|FG003|Overall Study|Failure|2|||
33241273|NCT00432159|100783286|FG004|Overall Study|Failure|3|||
33241274|NCT00432159|100783282|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
33241275|NCT00432159|100783283|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
33241276|NCT00432159|100783284|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
33241277|NCT00432159|100783285|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
33241278|NCT00432159|100783286|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
33241279|NCT00761774|100783289|FG000|Overall Study|Adverse Event|17|||
33370911|NCT00586924|101243569|FG000|Overall Study|Adverse event/serious adverse event|0|||
33370912|NCT00586924|101243570|FG001|Overall Study|Adverse event/serious adverse event|0|||
33370913|NCT00586924|101243571|FG002|Overall Study|Adverse event/serious adverse event|0|||
33370914|NCT00586924|101243572|FG003|Overall Study|Adverse event/serious adverse event|1|||
33370915|NCT00586924|101243573|FG004|Overall Study|Adverse event/serious adverse event|0|||
33370916|NCT00586924|101243574|FG005|Overall Study|Adverse event/serious adverse event|2|||
33370917|NCT00586924|101243569|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
33370918|NCT00586924|101243570|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
33241280|NCT00761774|100783289|FG000|Overall Study|Lack of Efficacy|37|||
33241281|NCT00761774|100783289|FG000|Overall Study|Lost to Follow-up|2|||
33241282|NCT00761774|100783289|FG000|Overall Study|Withdrawal by Subject|9|||
33241283|NCT00761774|100783289|FG000|Overall Study|Non-compliance|4|||
33370919|NCT00586924|101243571|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
33241284|NCT00761774|100783289|FG000|Overall Study|End of study|2|||
33241285|NCT00761774|100783289|FG000|Overall Study|Reclassification of seizures|1|||
33241286|NCT00761774|100783289|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
33241287|NCT00761774|100783289|FG000|Overall Study|Sponsor decision|1|||
33241288|NCT00761774|100783289|FG000|Overall Study|Investigator clinical judgement|1|||
33241289|NCT00761774|100783289|FG000|Overall Study|Patient moved out of study area|1|||
33241290|NCT00761774|100783289|FG000|Overall Study|Coordinator leaving site|1|||
33241291|NCT00761774|100783289|FG000|Overall Study|Subject IP non-compliance|1|||
33370920|NCT00586924|101243572|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
33641255|NCT00711191|102236609|FG000|Overall Study|Withdrawal by Subject|0|||
33641256|NCT00711191|102236610|FG001|Overall Study|Withdrawal by Subject|1|||
33641257|NCT00711191|102236611|FG002|Overall Study|Withdrawal by Subject|3|||
33641258|NCT03860259|102236612|FG000|Overall Study|Lost to Follow-up|5|||
33641259|NCT03860259|102236613|FG001|Overall Study|Lost to Follow-up|5|||
33641260|NCT03860259|102236612|FG000|Overall Study|Protocol Violation|1|||
33641261|NCT03860259|102236613|FG001|Overall Study|Protocol Violation|0|||
33641262|NCT00882557|102236614|FG000|Overall Study|Withdrawal by Subject|1|||
33641263|NCT00882557|102236615|FG001|Overall Study|Withdrawal by Subject|0|||
33142518|NCT03170232|100434913|FG001|Overall Study|Study closed/terminated|23|||
33142519|NCT03170232|100434912|FG000|Overall Study|Lost to Follow-up|1|||
33142520|NCT03170232|100434913|FG001|Overall Study|Lost to Follow-up|0|||
33142521|NCT03170232|100434912|FG000|Overall Study|Withdrawal by Subject|0|||
33142522|NCT03170232|100434913|FG001|Overall Study|Withdrawal by Subject|1|||
33142523|NCT00219544|100434914|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
33142524|NCT00219544|100434915|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
33142525|NCT00219544|100434914|FG000|Single Blind Treatment Period|Adverse Event|9|||
33142526|NCT00219544|100434915|FG001|Single Blind Treatment Period|Adverse Event|0|||
33142527|NCT00219544|100434914|FG000|Single Blind Treatment Period|Protocol Violation|4|||
33142528|NCT00219544|100434915|FG001|Single Blind Treatment Period|Protocol Violation|0|||
33142529|NCT00219544|100434914|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
33241292|NCT00761774|100783289|FG000|Overall Study|IP stopped by hospital physician|1|||
33241293|NCT02906683|100783291|FG000|Overall Study|Adverse Event|0|||
33241294|NCT02906683|100783292|FG001|Overall Study|Adverse Event|1|||
33241295|NCT02906683|100783293|FG002|Overall Study|Adverse Event|0|||
33241296|NCT02906683|100783291|FG000|Overall Study|Physician Decision|0|||
33241297|NCT02906683|100783292|FG001|Overall Study|Physician Decision|1|||
33241298|NCT02906683|100783293|FG002|Overall Study|Physician Decision|1|||
33241299|NCT02906683|100783291|FG000|Overall Study|Withdrawal by Subject|0|||
33241300|NCT02906683|100783292|FG001|Overall Study|Withdrawal by Subject|2|||
33241301|NCT02906683|100783293|FG002|Overall Study|Withdrawal by Subject|1|||
33241302|NCT02906683|100783291|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
33241303|NCT02906683|100783292|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
33241304|NCT02906683|100783293|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
33241305|NCT02906683|100783291|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
33241306|NCT02906683|100783292|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
33241307|NCT02906683|100783293|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
33241308|NCT05257837|100783294|FG000|Overall Study|Excluded (did not find the guns)|4|||
33370921|NCT00586924|101243573|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
33370922|NCT00586924|101243574|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
33370923|NCT00586924|101243569|FG000|Overall Study|Disease progression|0|||
33142530|NCT00219544|100434915|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
33241309|NCT05257837|100783295|FG001|Overall Study|Excluded (did not find the guns)|2|||
33241310|NCT05257837|100783296|FG002|Overall Study|Excluded (did not find the guns)|4|||
33421347|NCT00837577|101434749|FG001|Open-label Period|Clinical Adverse Event|2|||
33421348|NCT00837577|101434748|FG000|Open-label Period|Laboratory Adverse Event|0|||
33421349|NCT00837577|101434749|FG001|Open-label Period|Laboratory Adverse Event|1|||
33421350|NCT00837577|101434748|FG000|Open-label Period|Lack of Efficacy|4|||
33421351|NCT00837577|101434749|FG001|Open-label Period|Lack of Efficacy|3|||
33421352|NCT00837577|101434748|FG000|Open-label Period|Withdrawal by Subject|1|||
33421353|NCT00837577|101434749|FG001|Open-label Period|Withdrawal by Subject|2|||
33421354|NCT00837577|101434748|FG000|Open-label Period|Other Reason|1|||
33421355|NCT00837577|101434749|FG001|Open-label Period|Other Reason|1|||
33142531|NCT00219544|100434914|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
33142532|NCT00219544|100434915|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
33370924|NCT00586924|101243570|FG001|Overall Study|Disease progression|0|||
33370925|NCT00586924|101243571|FG002|Overall Study|Disease progression|0|||
33370926|NCT00586924|101243572|FG003|Overall Study|Disease progression|1|||
33370927|NCT00586924|101243573|FG004|Overall Study|Disease progression|1|||
33370928|NCT00586924|101243574|FG005|Overall Study|Disease progression|0|||
33370929|NCT00586924|101243569|FG000|Overall Study|Development of neutralizing antibodies|2|||
33421356|NCT00743119|101434750|FG000|Overall Study|unreliable|3|||
33421357|NCT00743119|101434750|FG000|Overall Study|Withdrawal by Subject|1|||
33370930|NCT00586924|101243570|FG001|Overall Study|Development of neutralizing antibodies|2|||
33370931|NCT00586924|101243571|FG002|Overall Study|Development of neutralizing antibodies|2|||
33370932|NCT00586924|101243572|FG003|Overall Study|Development of neutralizing antibodies|0|||
33421358|NCT00291330|101434751|FG000|Overall Study|Adverse Event|47|||
33421359|NCT00291330|101434752|FG001|Overall Study|Adverse Event|40|||
33641264|NCT00882557|102236614|FG000|Overall Study|Trouble with Vein Access|1|||
33421360|NCT00291330|101434751|FG000|Overall Study|Protocol Violation|13|||
33641265|NCT00882557|102236615|FG001|Overall Study|Trouble with Vein Access|0|||
33641266|NCT00882557|102236614|FG000|Overall Study|Randomized Not Treated|0|||
33641267|NCT00882557|102236615|FG001|Overall Study|Randomized Not Treated|1|||
33641268|NCT02560558|102236616|FG000|Overall Study|Adverse Event|1|||
33641269|NCT02560558|102236617|FG001|Overall Study|Adverse Event|0|||
33641270|NCT02560558|102236616|FG000|Overall Study|Death|0|||
33641271|NCT02560558|102236617|FG001|Overall Study|Death|2|||
33641272|NCT02560558|102236616|FG000|Overall Study|Lost to Follow-up|0|||
33641273|NCT02560558|102236617|FG001|Overall Study|Lost to Follow-up|4|||
33641274|NCT02560558|102236616|FG000|Overall Study|Protocol Violation|3|||
33641275|NCT02560558|102236617|FG001|Overall Study|Protocol Violation|0|||
33641276|NCT02560558|102236616|FG000|Overall Study|Withdrawal by Subject|3|||
33641277|NCT02560558|102236617|FG001|Overall Study|Withdrawal by Subject|0|||
33641278|NCT00804908|102236618|FG000|Overall Study|Other|115|||
33641279|NCT00804908|102236619|FG001|Overall Study|Other|116|||
33641280|NCT00804908|102236620|FG002|Overall Study|Other|114|||
33641281|NCT00526071|102236621|FG000|Overall Study|Adverse Event|1|||
33641282|NCT00526071|102236621|FG000|Overall Study|Withdrawal by Subject|1|||
33641283|NCT00526071|102236621|FG000|Overall Study|Lack of Response to Study Drug|4|||
33641284|NCT04555616|102236625|FG000|Overall Study|Death|1|||
33641285|NCT04555616|102236626|FG001|Overall Study|Death|0|||
33641286|NCT04555616|102236627|FG002|Overall Study|Death|1|||
33641287|NCT04555616|102236625|FG000|Overall Study|Withdrawal by Subject|2|||
33641288|NCT04555616|102236626|FG001|Overall Study|Withdrawal by Subject|1|||
33641289|NCT04555616|102236627|FG002|Overall Study|Withdrawal by Subject|0|||
33641290|NCT02136069|102236628|FG000|Overall Study|UC flare-up|1|||
33641291|NCT02136069|102236629|FG001|Overall Study|UC flare-up|0|||
33641292|NCT02136069|102236628|FG000|Overall Study|Adverse Event|6|||
33641293|NCT02136069|102236629|FG001|Overall Study|Adverse Event|8|||
33641294|NCT02136069|102236628|FG000|Overall Study|Death|0|||
33641295|NCT02136069|102236629|FG001|Overall Study|Death|1|||
33241311|NCT05257837|100783297|FG003|Overall Study|Excluded (did not find the guns)|0|||
33241312|NCT01118962|100783298|FG000|Overall Study|Adverse Event|2|||
33241313|NCT01118962|100783298|FG000|Overall Study|Lack of Efficacy|1|||
33241314|NCT01118962|100783298|FG000|Overall Study|Protocol Violation|1|||
33241315|NCT01118962|100783298|FG000|Overall Study|Withdrawal by Subject|4|||
33241316|NCT01118962|100783298|FG000|Overall Study|Pregnancy|1|||
33241317|NCT01118962|100783298|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
33241318|NCT02328014|100783301|FG000|Overall Study|Adverse Event|1|||
33241319|NCT02328014|100783302|FG001|Overall Study|Adverse Event|0|||
33241320|NCT02328014|100783303|FG002|Overall Study|Adverse Event|0|||
33241321|NCT02328014|100783304|FG003|Overall Study|Adverse Event|1|||
33241322|NCT02328014|100783301|FG000|Overall Study|Death|0|||
33241323|NCT02328014|100783302|FG001|Overall Study|Death|0|||
33241324|NCT02328014|100783303|FG002|Overall Study|Death|0|||
33241325|NCT02328014|100783304|FG003|Overall Study|Death|4|||
33241326|NCT02328014|100783301|FG000|Overall Study|Physician Decision|0|||
33241327|NCT02328014|100783302|FG001|Overall Study|Physician Decision|0|||
33241328|NCT02328014|100783303|FG002|Overall Study|Physician Decision|0|||
33241329|NCT02328014|100783304|FG003|Overall Study|Physician Decision|1|||
33241330|NCT02328014|100783301|FG000|Overall Study|Disease Progression|1|||
33241331|NCT02328014|100783302|FG001|Overall Study|Disease Progression|0|||
33241332|NCT02328014|100783303|FG002|Overall Study|Disease Progression|1|||
33241333|NCT02328014|100783304|FG003|Overall Study|Disease Progression|3|||
33241334|NCT02328014|100783301|FG000|Overall Study|Study Terminated by Sponsor|4|||
33241335|NCT02328014|100783302|FG001|Overall Study|Study Terminated by Sponsor|1|||
33241336|NCT02328014|100783303|FG002|Overall Study|Study Terminated by Sponsor|1|||
33241337|NCT02328014|100783304|FG003|Overall Study|Study Terminated by Sponsor|0|||
33241338|NCT02328014|100783301|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
33241339|NCT02328014|100783302|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
33641296|NCT02136069|102236628|FG000|Overall Study|Lack of Efficacy|10|||
33641297|NCT02136069|102236629|FG001|Overall Study|Lack of Efficacy|4|||
33641298|NCT02136069|102236628|FG000|Overall Study|Lost to Follow-up|1|||
33641299|NCT02136069|102236629|FG001|Overall Study|Lost to Follow-up|0|||
33142533|NCT00219544|100434914|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
33641300|NCT02136069|102236628|FG000|Overall Study|Non-Compliance|1|||
33641301|NCT02136069|102236629|FG001|Overall Study|Non-Compliance|0|||
33241340|NCT02328014|100783303|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
33241341|NCT02328014|100783304|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
33641302|NCT02136069|102236628|FG000|Overall Study|Physician Decision|5|||
33241342|NCT02328014|100783301|FG000|Overall Study|Withdrawal by Subject|0|||
33241343|NCT02328014|100783302|FG001|Overall Study|Withdrawal by Subject|0|||
33241344|NCT02328014|100783303|FG002|Overall Study|Withdrawal by Subject|0|||
33241345|NCT02328014|100783304|FG003|Overall Study|Withdrawal by Subject|1|||
33241346|NCT02107274|100783305|FG000|Treatment vs. Placebo|Adverse Event|3|||
33241347|NCT02107274|100783306|FG001|Treatment vs. Placebo|Adverse Event|0|||
33641303|NCT02136069|102236629|FG001|Overall Study|Physician Decision|4|||
33641304|NCT02136069|102236628|FG000|Overall Study|Withdrawal by Subject|10|||
33641305|NCT02136069|102236629|FG001|Overall Study|Withdrawal by Subject|11|||
33641306|NCT02817464|102236632|FG000|Overall Study|Lost to Follow-up|1|||
33421361|NCT00291330|101434752|FG001|Overall Study|Protocol Violation|20|||
33421362|NCT00291330|101434751|FG000|Overall Study|Lost to Follow-up|16|||
33421363|NCT00291330|101434752|FG001|Overall Study|Lost to Follow-up|11|||
33421364|NCT00291330|101434751|FG000|Overall Study|Withdrawal by Subject|22|||
33421365|NCT00291330|101434752|FG001|Overall Study|Withdrawal by Subject|25|||
33421366|NCT00291330|101434751|FG000|Overall Study|Other|3|||
33421367|NCT00291330|101434752|FG001|Overall Study|Other|1|||
33421368|NCT02284373|101434757|FG000|Overall Study|Withdrawal by Subject|0|||
33421369|NCT02284373|101434758|FG001|Overall Study|Withdrawal by Subject|1|||
33421370|NCT02284373|101434759|FG002|Overall Study|Withdrawal by Subject|0|||
33421371|NCT02284373|101434757|FG000|Overall Study|Other|0|||
33421372|NCT02284373|101434758|FG001|Overall Study|Other|1|||
33421373|NCT02284373|101434759|FG002|Overall Study|Other|0|||
33421374|NCT02284373|101434757|FG000|Overall Study|Lost to Follow-up|0|||
33421375|NCT02284373|101434758|FG001|Overall Study|Lost to Follow-up|1|||
33421376|NCT02284373|101434759|FG002|Overall Study|Lost to Follow-up|0|||
33421377|NCT02923115|101434761|FG000|Overall Study|Lost to Follow-up|0|||
33421378|NCT02923115|101434762|FG001|Overall Study|Lost to Follow-up|0|||
33421379|NCT02923115|101434763|FG002|Overall Study|Lost to Follow-up|0|||
33421380|NCT02923115|101434764|FG003|Overall Study|Lost to Follow-up|1|||
33421381|NCT02923115|101434765|FG004|Overall Study|Lost to Follow-up|0|||
33421382|NCT02923115|101434766|FG005|Overall Study|Lost to Follow-up|0|||
33421383|NCT02923115|101434761|FG000|Overall Study|Withdrawal by Subject|0|||
33421384|NCT02923115|101434762|FG001|Overall Study|Withdrawal by Subject|1|||
33421385|NCT02923115|101434763|FG002|Overall Study|Withdrawal by Subject|0|||
33421386|NCT02923115|101434764|FG003|Overall Study|Withdrawal by Subject|0|||
33421387|NCT02923115|101434765|FG004|Overall Study|Withdrawal by Subject|0|||
33421388|NCT02923115|101434766|FG005|Overall Study|Withdrawal by Subject|0|||
33421389|NCT02923115|101434761|FG000|Overall Study|Randomized, but not dosed|0|||
33421390|NCT02923115|101434762|FG001|Overall Study|Randomized, but not dosed|0|||
33421391|NCT02923115|101434763|FG002|Overall Study|Randomized, but not dosed|3|||
33421392|NCT02923115|101434764|FG003|Overall Study|Randomized, but not dosed|1|||
33421393|NCT02923115|101434765|FG004|Overall Study|Randomized, but not dosed|5|||
33421394|NCT02923115|101434766|FG005|Overall Study|Randomized, but not dosed|0|||
33421395|NCT04529499|101434767|FG000|Overall Study|Withdrawal by Subject|9|||
33421396|NCT04529499|101434768|FG001|Overall Study|Withdrawal by Subject|11|||
33421397|NCT04529499|101434767|FG000|Overall Study|Physician Decision|1|||
33421398|NCT04529499|101434768|FG001|Overall Study|Physician Decision|2|||
33421399|NCT04529499|101434767|FG000|Overall Study|Adverse Event|4|||
33421400|NCT04529499|101434768|FG001|Overall Study|Adverse Event|4|||
33421401|NCT04529499|101434767|FG000|Overall Study|Death|14|||
33421402|NCT04529499|101434768|FG001|Overall Study|Death|11|||
33421403|NCT04529499|101434767|FG000|Overall Study|Lost to Follow-up|1|||
33581031|NCT00551031|102017039|FG001|Overall Study|Serious Adverse Event|2|||
33142534|NCT00219544|100434915|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
33142535|NCT01925989|100434918|FG000|Period 1|Sponsor Decision|1|||
33142536|NCT01925989|100434919|FG001|Period 1|Sponsor Decision|1|||
33142537|NCT01925989|100434920|FG002|Period 1|Sponsor Decision|0|||
33142538|NCT01925989|100434918|FG000|Period 1|Withdrawal by Subject|0|||
33142539|NCT01925989|100434919|FG001|Period 1|Withdrawal by Subject|1|||
33142540|NCT01925989|100434920|FG002|Period 1|Withdrawal by Subject|0|||
33142541|NCT01606878|100434924|FG000|Overall Study|Adverse Event|1|||
33142542|NCT01606878|100434925|FG001|Overall Study|Adverse Event|1|||
33142543|NCT01606878|100434926|FG002|Overall Study|Adverse Event|0|||
33241348|NCT02107274|100783305|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
33241349|NCT02107274|100783306|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
33142544|NCT01606878|100434927|FG003|Overall Study|Adverse Event|0|||
33142545|NCT01606878|100434928|FG004|Overall Study|Adverse Event|0|||
33142546|NCT01606878|100434929|FG005|Overall Study|Adverse Event|0|||
33142547|NCT01606878|100434930|FG006|Overall Study|Adverse Event|1|||
33142548|NCT01606878|100434931|FG007|Overall Study|Adverse Event|0|||
33142549|NCT01606878|100434932|FG008|Overall Study|Adverse Event|1|||
33241350|NCT02107274|100783305|FG000|Control Phase|Lost to Follow-up|1|||
33241351|NCT02107274|100783306|FG001|Control Phase|Lost to Follow-up|1|||
33241352|NCT02107274|100783305|FG000|Control Phase|Death|2|||
33421404|NCT04529499|101434768|FG001|Overall Study|Lost to Follow-up|1|||
33421405|NCT04529499|101434767|FG000|Overall Study|Others|7|||
33421406|NCT04529499|101434768|FG001|Overall Study|Others|11|||
33421407|NCT03276962|101434769|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
33421408|NCT03276962|101434770|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
33142550|NCT01606878|100434933|FG009|Overall Study|Adverse Event|3|||
33142551|NCT01606878|100434934|FG010|Overall Study|Adverse Event|0|||
33241353|NCT02107274|100783306|FG001|Control Phase|Death|0|||
33142552|NCT01606878|100434924|FG000|Overall Study|Lack of Efficacy|1|||
33142553|NCT01606878|100434925|FG001|Overall Study|Lack of Efficacy|1|||
33421409|NCT03276962|101434771|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
33421410|NCT03276962|101434772|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
33421411|NCT03276962|101434773|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
33421412|NCT03276962|101434769|FG000|Overall Study|Protocol Deviation|2|||
33421413|NCT03276962|101434770|FG001|Overall Study|Protocol Deviation|0|||
33142554|NCT01606878|100434926|FG002|Overall Study|Lack of Efficacy|1|||
33142555|NCT01606878|100434927|FG003|Overall Study|Lack of Efficacy|2|||
33142556|NCT01606878|100434928|FG004|Overall Study|Lack of Efficacy|1|||
33142557|NCT01606878|100434929|FG005|Overall Study|Lack of Efficacy|2|||
33142558|NCT01606878|100434930|FG006|Overall Study|Lack of Efficacy|1|||
33142559|NCT01606878|100434931|FG007|Overall Study|Lack of Efficacy|2|||
33142560|NCT01606878|100434932|FG008|Overall Study|Lack of Efficacy|2|||
33142561|NCT01606878|100434933|FG009|Overall Study|Lack of Efficacy|0|||
33142562|NCT01606878|100434934|FG010|Overall Study|Lack of Efficacy|1|||
33142563|NCT01606878|100434924|FG000|Overall Study|Physician Decision|1|||
33142564|NCT01606878|100434925|FG001|Overall Study|Physician Decision|0|||
33142565|NCT01606878|100434926|FG002|Overall Study|Physician Decision|2|||
33142566|NCT01606878|100434927|FG003|Overall Study|Physician Decision|1|||
33142567|NCT01606878|100434928|FG004|Overall Study|Physician Decision|1|||
33142568|NCT01606878|100434929|FG005|Overall Study|Physician Decision|1|||
33581032|NCT00551031|102017040|FG002|Overall Study|Serious Adverse Event|1|||
33581033|NCT00551031|102017041|FG003|Overall Study|Serious Adverse Event|0|||
33581034|NCT00551031|102017042|FG004|Overall Study|Serious Adverse Event|0|||
33581035|NCT00551031|102017038|FG000|Overall Study|Did not receive vaccine|1|||
33581036|NCT00551031|102017039|FG001|Overall Study|Did not receive vaccine|2|||
33581037|NCT00551031|102017040|FG002|Overall Study|Did not receive vaccine|0|||
33581038|NCT00551031|102017041|FG003|Overall Study|Did not receive vaccine|0|||
33581039|NCT00551031|102017042|FG004|Overall Study|Did not receive vaccine|0|||
33581040|NCT02709577|102017043|FG000|Overall Study|non-accommodating anatomy|0|||
33581041|NCT02709577|102017044|FG001|Overall Study|non-accommodating anatomy|1|||
33581042|NCT02709577|102017045|FG002|Overall Study|non-accommodating anatomy|0|||
33641307|NCT02817464|102236633|FG001|Overall Study|Lost to Follow-up|0|||
33641308|NCT02817464|102236632|FG000|Overall Study|Discontinued early due to personal decision|1|||
33641309|NCT02817464|102236633|FG001|Overall Study|Discontinued early due to personal decision|1|||
33641310|NCT01399372|102236634|FG000|Overall Study|Protocol Violation|3|||
33641311|NCT01399372|102236635|FG001|Overall Study|Protocol Violation|1|||
33641312|NCT01106248|102236648|FG000|Overall Study|Adverse Event|1|||
33641313|NCT01106248|102236648|FG000|Overall Study|Administrative|2|||
33641314|NCT03695367|102236651|FG000|Overall Study|Missed the Day 28 visit.|1|||
33641315|NCT03695367|102236652|FG001|Overall Study|Missed the Day 28 visit.|0|||
33641316|NCT03695367|102236651|FG000|Overall Study|Lost to Follow-up|0|||
33641317|NCT03695367|102236652|FG001|Overall Study|Lost to Follow-up|1|||
33641318|NCT03695367|102236651|FG000|Overall Study|Withdrawal by Subject|0|||
33641319|NCT03695367|102236652|FG001|Overall Study|Withdrawal by Subject|1|||
33641320|NCT03695367|102236651|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
33641321|NCT03695367|102236652|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
33641322|NCT04287517|102236653|FG000|Overall Study|Withdrawal by Subject|1|||
33641323|NCT04287517|102236654|FG001|Overall Study|Withdrawal by Subject|1|||
33641324|NCT01652534|102236657|FG000|Overall Study|Lack of Efficacy|1|||
33641325|NCT01652534|102236658|FG001|Overall Study|Lack of Efficacy|0|||
33641326|NCT02207088|102236664|FG000|Overall Study|Adverse Event|2|||
33641327|NCT00125164|102236665|FG000|Overall Study|Adverse Event|0|||
33641328|NCT00125164|102236666|FG001|Overall Study|Adverse Event|0|||
33641329|NCT00125164|102236667|FG002|Overall Study|Adverse Event|2|||
33641330|NCT00125164|102236668|FG003|Overall Study|Adverse Event|4|||
33641331|NCT00125164|102236665|FG000|Overall Study|Lost to Follow-up|0|||
33142569|NCT01606878|100434930|FG006|Overall Study|Physician Decision|2|||
33142570|NCT01606878|100434931|FG007|Overall Study|Physician Decision|0|||
33142571|NCT01606878|100434932|FG008|Overall Study|Physician Decision|1|||
33142572|NCT01606878|100434933|FG009|Overall Study|Physician Decision|0|||
33142573|NCT01606878|100434934|FG010|Overall Study|Physician Decision|0|||
33142574|NCT01606878|100434924|FG000|Overall Study|Withdrawal by Subject|3|||
33241354|NCT02107274|100783305|FG000|Control Phase|Adverse Event|0|||
33241355|NCT02107274|100783306|FG001|Control Phase|Adverse Event|1|||
33241356|NCT00329303|100783307|FG000|Overall Study|Lack of Efficacy|1|||
33241357|NCT00329303|100783308|FG001|Overall Study|Lack of Efficacy|0|||
33241358|NCT00329303|100783307|FG000|Overall Study|Decision of the sponsor|0|||
33142575|NCT01606878|100434925|FG001|Overall Study|Withdrawal by Subject|2|||
33142576|NCT01606878|100434926|FG002|Overall Study|Withdrawal by Subject|2|||
33581043|NCT02709577|102017046|FG003|Overall Study|non-accommodating anatomy|0|||
33581044|NCT02709577|102017043|FG000|Overall Study|procedural complication|0|||
33581045|NCT02709577|102017044|FG001|Overall Study|procedural complication|1|||
33641332|NCT00125164|102236666|FG001|Overall Study|Lost to Follow-up|0|||
33142577|NCT01606878|100434927|FG003|Overall Study|Withdrawal by Subject|0|||
33142578|NCT01606878|100434928|FG004|Overall Study|Withdrawal by Subject|1|||
33142579|NCT01606878|100434929|FG005|Overall Study|Withdrawal by Subject|1|||
33142580|NCT01606878|100434930|FG006|Overall Study|Withdrawal by Subject|2|||
33241359|NCT00329303|100783308|FG001|Overall Study|Decision of the sponsor|1|||
33641333|NCT00125164|102236667|FG002|Overall Study|Lost to Follow-up|1|||
33142581|NCT01606878|100434931|FG007|Overall Study|Withdrawal by Subject|1|||
33641334|NCT00125164|102236668|FG003|Overall Study|Lost to Follow-up|1|||
33641335|NCT00125164|102236665|FG000|Overall Study|Withdrawal by Subject|2|||
33241360|NCT00329303|100783307|FG000|Overall Study|Patient no longer available|1|||
33241361|NCT00329303|100783308|FG001|Overall Study|Patient no longer available|0|||
33241362|NCT00329303|100783307|FG000|Overall Study|Patient relocated|0|||
33241363|NCT00329303|100783308|FG001|Overall Study|Patient relocated|1|||
33241364|NCT03639675|100783309|FG000|Overall Study|Withdrawal by Subject|1|||
33241365|NCT02034435|100783312|FG000|Overall Study|Withdrawal by Subject|1|||
33142582|NCT01606878|100434932|FG008|Overall Study|Withdrawal by Subject|2|||
33142583|NCT01606878|100434933|FG009|Overall Study|Withdrawal by Subject|0|||
33142584|NCT01606878|100434934|FG010|Overall Study|Withdrawal by Subject|2|||
33142585|NCT02519855|100434937|FG000|Overall Study|Adverse Event|0|||
33142586|NCT02519855|100434938|FG001|Overall Study|Adverse Event|1|||
33142587|NCT02519855|100434937|FG000|Overall Study|Lost to Follow-up|3|||
33142588|NCT02519855|100434938|FG001|Overall Study|Lost to Follow-up|3|||
33142589|NCT01226121|100434939|FG000|Overall Study|Lost to Follow-up|2|||
33142590|NCT01226121|100434940|FG001|Overall Study|Lost to Follow-up|0|||
33142591|NCT01226121|100434941|FG002|Overall Study|Lost to Follow-up|1|||
33142592|NCT01923168|100434946|FG000|Overall Study|Protocol Violation|1|||
33142593|NCT01923168|100434947|FG001|Overall Study|Protocol Violation|1|||
33142594|NCT01923168|100434948|FG002|Overall Study|Protocol Violation|0|||
33142595|NCT01923168|100434946|FG000|Overall Study|Subject/guardian decision|14|||
33142596|NCT01923168|100434947|FG001|Overall Study|Subject/guardian decision|14|||
33142597|NCT01923168|100434948|FG002|Overall Study|Subject/guardian decision|4|||
33142598|NCT01923168|100434946|FG000|Overall Study|Adverse Event|12|||
33142599|NCT01923168|100434947|FG001|Overall Study|Adverse Event|12|||
33142600|NCT01923168|100434948|FG002|Overall Study|Adverse Event|0|||
33142601|NCT01923168|100434946|FG000|Overall Study|Physician Decision|6|||
33142602|NCT01923168|100434947|FG001|Overall Study|Physician Decision|9|||
33241366|NCT02034435|100783313|FG001|Overall Study|Withdrawal by Subject|0|||
33241367|NCT02034435|100783314|FG002|Overall Study|Withdrawal by Subject|0|||
33241368|NCT02034435|100783315|FG003|Overall Study|Withdrawal by Subject|0|||
33241369|NCT02034435|100783312|FG000|Overall Study|Illness|0|||
33241370|NCT02034435|100783313|FG001|Overall Study|Illness|2|||
33241371|NCT02034435|100783314|FG002|Overall Study|Illness|0|||
33241372|NCT02034435|100783315|FG003|Overall Study|Illness|0|||
33241373|NCT02034435|100783312|FG000|Overall Study|Inadequate IV access|1|||
33241374|NCT02034435|100783313|FG001|Overall Study|Inadequate IV access|0|||
33241375|NCT02034435|100783314|FG002|Overall Study|Inadequate IV access|0|||
33241376|NCT02034435|100783315|FG003|Overall Study|Inadequate IV access|1|||
33241377|NCT01033643|100783321|FG000|Overall Study|Withdrew Consent|0|||
33241378|NCT01033643|100783322|FG001|Overall Study|Withdrew Consent|3|||
33241379|NCT01033643|100783323|FG002|Overall Study|Withdrew Consent|0|||
33241380|NCT01033643|100783324|FG003|Overall Study|Withdrew Consent|0|||
33241381|NCT01033643|100783325|FG004|Overall Study|Withdrew Consent|0|||
33241382|NCT01033643|100783326|FG005|Overall Study|Withdrew Consent|1|||
33241383|NCT00821236|100783327|FG000|Overall Study|Lost to Follow-up|3|||
33241384|NCT03382821|100786078|FG000|Overall Study|Did not receive allocated intervention.|0|||
33241385|NCT03382821|100786079|FG001|Overall Study|Did not receive allocated intervention.|3|||
33241386|NCT01562743|100786080|FG000|Overall Study|Adverse Event|29|||
33241387|NCT01562743|100786080|FG000|Overall Study|Lack of Efficacy|3|||
33241388|NCT01562743|100786080|FG000|Overall Study|Withdrawal by Subject|13|||
33241389|NCT01562743|100786080|FG000|Overall Study|Protocol Violation|1|||
33241390|NCT01562743|100786080|FG000|Overall Study|Discontinuation criteria|2|||
33241391|NCT01562743|100786080|FG000|Overall Study|Lost to Follow-up|2|||
33241392|NCT01562743|100786080|FG000|Overall Study|Physician Decision|2|||
33241393|NCT05196737|100786085|FG000|Non-intervention Week|Lost to Follow-up|2|||
33241394|NCT05196737|100786085|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
33241395|NCT01446003|100786089|FG000|Period 1|Protocol Violation|2|||
33241396|NCT01446003|100786090|FG001|Period 1|Protocol Violation|0|||
33241397|NCT01446003|100786089|FG000|Period 2|Adverse Event|1|||
33241398|NCT01446003|100786090|FG001|Period 2|Adverse Event|0|||
33241399|NCT00124982|100786092|FG000|Short-term Period|Death|1|||
33241400|NCT00124982|100786093|FG001|Short-term Period|Death|1|||
33241401|NCT00124982|100786094|FG002|Short-term Period|Death|0|||
33241402|NCT00124982|100786092|FG000|Short-term Period|Adverse Event|17|||
33241403|NCT00124982|100786093|FG001|Short-term Period|Adverse Event|22|||
33241404|NCT00124982|100786094|FG002|Short-term Period|Adverse Event|0|||
33241405|NCT00124982|100786092|FG000|Short-term Period|Lack of Efficacy|32|||
33241406|NCT00124982|100786093|FG001|Short-term Period|Lack of Efficacy|73|||
33241407|NCT00124982|100786094|FG002|Short-term Period|Lack of Efficacy|0|||
33142603|NCT01923168|100434948|FG002|Overall Study|Physician Decision|5|||
33142604|NCT01923168|100434946|FG000|Overall Study|Progressive disease|4|||
33142605|NCT01923168|100434947|FG001|Overall Study|Progressive disease|3|||
33142606|NCT01923168|100434948|FG002|Overall Study|Progressive disease|7|||
33142607|NCT01923168|100434946|FG000|Overall Study|Death|0|||
33142608|NCT01923168|100434947|FG001|Overall Study|Death|0|||
33241408|NCT00124982|100786092|FG000|Short-term Period|Lost to Follow-up|8|||
33241409|NCT00124982|100786093|FG001|Short-term Period|Lost to Follow-up|5|||
33241410|NCT00124982|100786094|FG002|Short-term Period|Lost to Follow-up|0|||
33241411|NCT00124982|100786092|FG000|Short-term Period|Withdrawal of Consent|7|||
33142609|NCT01923168|100434948|FG002|Overall Study|Death|1|||
33142610|NCT01673282|100434951|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
33142611|NCT01673282|100434952|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
33142612|NCT01673282|100434951|FG000|Overall Study|Lack of Efficacy|9|||
33142613|NCT01673282|100434952|FG001|Overall Study|Lack of Efficacy|2|||
33142614|NCT01673282|100434951|FG000|Overall Study|Lost to Follow-up|11|||
33142615|NCT01673282|100434952|FG001|Overall Study|Lost to Follow-up|10|||
33142616|NCT01673282|100434951|FG000|Overall Study|Withdrawal by Subject|3|||
33142617|NCT01673282|100434952|FG001|Overall Study|Withdrawal by Subject|3|||
33142618|NCT01673282|100434951|FG000|Overall Study|Other|1|||
33142619|NCT01673282|100434952|FG001|Overall Study|Other|6|||
33142620|NCT01489111|100434953|FG000|Overall Study|Withdrawal criterion|1|||
33142621|NCT02353143|100434954|FG000|Overall Study|Withdrawal by Subject|1|||
33142622|NCT02353143|100434955|FG001|Overall Study|Withdrawal by Subject|0|||
33142623|NCT02353143|100434956|FG002|Overall Study|Withdrawal by Subject|0|||
33142624|NCT02353143|100434957|FG003|Overall Study|Withdrawal by Subject|0|||
33142625|NCT02353143|100434958|FG004|Overall Study|Withdrawal by Subject|1|||
33142626|NCT02353143|100434959|FG005|Overall Study|Withdrawal by Subject|0|||
33142627|NCT02353143|100434960|FG006|Overall Study|Withdrawal by Subject|0|||
33142628|NCT02353143|100434961|FG007|Overall Study|Withdrawal by Subject|1|||
33142629|NCT02353143|100434962|FG008|Overall Study|Withdrawal by Subject|1|||
33142630|NCT02353143|100434954|FG000|Overall Study|Lack of Efficacy|2|||
33142631|NCT02353143|100434955|FG001|Overall Study|Lack of Efficacy|1|||
33142632|NCT02353143|100434956|FG002|Overall Study|Lack of Efficacy|2|||
33142633|NCT02353143|100434957|FG003|Overall Study|Lack of Efficacy|4|||
33142634|NCT02353143|100434958|FG004|Overall Study|Lack of Efficacy|13|||
33142635|NCT02353143|100434959|FG005|Overall Study|Lack of Efficacy|2|||
33142636|NCT02353143|100434960|FG006|Overall Study|Lack of Efficacy|2|||
33142637|NCT02353143|100434961|FG007|Overall Study|Lack of Efficacy|2|||
33142638|NCT02353143|100434962|FG008|Overall Study|Lack of Efficacy|1|||
33142639|NCT02353143|100434954|FG000|Overall Study|reason not specified|1|||
33142640|NCT02353143|100434955|FG001|Overall Study|reason not specified|2|||
33142641|NCT02353143|100434956|FG002|Overall Study|reason not specified|0|||
33142642|NCT02353143|100434957|FG003|Overall Study|reason not specified|0|||
33142643|NCT02353143|100434958|FG004|Overall Study|reason not specified|6|||
33370933|NCT00586924|101243573|FG004|Overall Study|Development of neutralizing antibodies|0|||
33370934|NCT00586924|101243574|FG005|Overall Study|Development of neutralizing antibodies|22|||
33370935|NCT00586924|101243569|FG000|Overall Study|Complete response|0|||
33370936|NCT00586924|101243570|FG001|Overall Study|Complete response|1|||
33641336|NCT00125164|102236666|FG001|Overall Study|Withdrawal by Subject|0|||
33641337|NCT00125164|102236667|FG002|Overall Study|Withdrawal by Subject|1|||
33641338|NCT00125164|102236668|FG003|Overall Study|Withdrawal by Subject|1|||
33641339|NCT00470275|102236669|FG000|Overall Study|Death|1|||
33641340|NCT00470275|102236669|FG000|Overall Study|Lack of Efficacy|7|||
33641341|NCT00470275|102236669|FG000|Overall Study|Withdrawal by Subject|2|||
33641342|NCT02668393|102236676|FG000|Overall Study|Progressive disease|6|||
33641343|NCT02668393|102236677|FG001|Overall Study|Progressive disease|3|||
33641344|NCT02668393|102236676|FG000|Overall Study|Adverse Event|0|||
33641345|NCT02668393|102236677|FG001|Overall Study|Adverse Event|2|||
33641346|NCT02668393|102236676|FG000|Overall Study|Withdrawal from the trial|0|||
33641347|NCT02668393|102236677|FG001|Overall Study|Withdrawal from the trial|1|||
33641348|NCT02668393|102236676|FG000|Overall Study|Lack of benefit and side effects|1|||
33641349|NCT02668393|102236677|FG001|Overall Study|Lack of benefit and side effects|0|||
33641350|NCT00775190|102236678|FG000|Overall Study|Lost to Follow-up|2|||
33641351|NCT00775190|102236679|FG001|Overall Study|Lost to Follow-up|3|||
33142644|NCT02353143|100434959|FG005|Overall Study|reason not specified|1|||
33370937|NCT00586924|101243571|FG002|Overall Study|Complete response|0|||
33370938|NCT00586924|101243572|FG003|Overall Study|Complete response|0|||
33370939|NCT00586924|101243573|FG004|Overall Study|Complete response|2|||
33641352|NCT00775190|102236678|FG000|Overall Study|Withdrawal by Subject|1|||
33641353|NCT00775190|102236679|FG001|Overall Study|Withdrawal by Subject|2|||
33641354|NCT00775190|102236678|FG000|Overall Study|Protocol Violation|1|||
33641355|NCT00775190|102236679|FG001|Overall Study|Protocol Violation|0|||
33241412|NCT00124982|100786093|FG001|Short-term Period|Withdrawal of Consent|9|||
33142645|NCT02353143|100434960|FG006|Overall Study|reason not specified|0|||
33241413|NCT00124982|100786094|FG002|Short-term Period|Withdrawal of Consent|0|||
33370940|NCT00586924|101243574|FG005|Overall Study|Complete response|2|||
33370941|NCT00586924|101243569|FG000|Overall Study|Other|1|||
33370942|NCT00586924|101243570|FG001|Overall Study|Other|0|||
33370943|NCT00586924|101243571|FG002|Overall Study|Other|1|||
33142646|NCT02353143|100434961|FG007|Overall Study|reason not specified|3|||
33142647|NCT02353143|100434962|FG008|Overall Study|reason not specified|1|||
33142648|NCT02353143|100434954|FG000|Overall Study|Physician Decision|0|||
33142649|NCT02353143|100434955|FG001|Overall Study|Physician Decision|4|||
33142650|NCT02353143|100434956|FG002|Overall Study|Physician Decision|2|||
33142651|NCT02353143|100434957|FG003|Overall Study|Physician Decision|3|||
33142652|NCT02353143|100434958|FG004|Overall Study|Physician Decision|4|||
33370944|NCT00586924|101243572|FG003|Overall Study|Other|1|||
33581046|NCT02709577|102017045|FG002|Overall Study|procedural complication|0|||
33581047|NCT02709577|102017046|FG003|Overall Study|procedural complication|0|||
33142653|NCT02353143|100434959|FG005|Overall Study|Physician Decision|0|||
33142654|NCT02353143|100434960|FG006|Overall Study|Physician Decision|1|||
33142655|NCT02353143|100434961|FG007|Overall Study|Physician Decision|2|||
33142656|NCT02353143|100434962|FG008|Overall Study|Physician Decision|0|||
33142657|NCT02353143|100434954|FG000|Overall Study|Adverse Event|0|||
33142658|NCT02353143|100434955|FG001|Overall Study|Adverse Event|0|||
33142659|NCT02353143|100434956|FG002|Overall Study|Adverse Event|1|||
33142660|NCT02353143|100434957|FG003|Overall Study|Adverse Event|0|||
33142661|NCT02353143|100434958|FG004|Overall Study|Adverse Event|1|||
33142662|NCT02353143|100434959|FG005|Overall Study|Adverse Event|1|||
33142663|NCT02353143|100434960|FG006|Overall Study|Adverse Event|0|||
33142664|NCT02353143|100434961|FG007|Overall Study|Adverse Event|0|||
33142665|NCT02353143|100434962|FG008|Overall Study|Adverse Event|0|||
33142666|NCT02353143|100434954|FG000|Overall Study|patient receiving other treatment for AML|0|||
33142667|NCT02353143|100434955|FG001|Overall Study|patient receiving other treatment for AML|0|||
33142668|NCT02353143|100434956|FG002|Overall Study|patient receiving other treatment for AML|1|||
33241414|NCT00124982|100786092|FG000|Short-term Period|Poor/Non-compliance|3|||
33241415|NCT00124982|100786093|FG001|Short-term Period|Poor/Non-compliance|1|||
33241416|NCT00124982|100786094|FG002|Short-term Period|Poor/Non-compliance|0|||
33241417|NCT00124982|100786092|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
33241418|NCT00124982|100786093|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
33241419|NCT00124982|100786094|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
33241420|NCT00124982|100786092|FG000|Short-term Period|Participant Decision|1|||
33241421|NCT00124982|100786093|FG001|Short-term Period|Participant Decision|0|||
33241422|NCT00124982|100786094|FG002|Short-term Period|Participant Decision|0|||
33241423|NCT00124982|100786092|FG000|Short-term Period|Participant Chose Own Doctor|0|||
33241424|NCT00124982|100786093|FG001|Short-term Period|Participant Chose Own Doctor|1|||
33241425|NCT00124982|100786094|FG002|Short-term Period|Participant Chose Own Doctor|0|||
33241426|NCT00124982|100786092|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
33241427|NCT00124982|100786093|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
33241428|NCT00124982|100786094|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
33241429|NCT00124982|100786092|FG000|Short-term Period|Participant Had Lymphopenia|1|||
33241430|NCT00124982|100786093|FG001|Short-term Period|Participant Had Lymphopenia|0|||
33241431|NCT00124982|100786094|FG002|Short-term Period|Participant Had Lymphopenia|0|||
33241432|NCT00124982|100786092|FG000|Long-term Period|Death|0|||
33241433|NCT00124982|100786093|FG001|Long-term Period|Death|0|||
33241434|NCT00124982|100786094|FG002|Long-term Period|Death|1|||
33241435|NCT00124982|100786092|FG000|Long-term Period|Adverse Event|0|||
33241436|NCT00124982|100786093|FG001|Long-term Period|Adverse Event|0|||
33241437|NCT00124982|100786094|FG002|Long-term Period|Adverse Event|17|||
33241438|NCT00124982|100786092|FG000|Long-term Period|Lack of Efficacy|0|||
33241439|NCT00124982|100786093|FG001|Long-term Period|Lack of Efficacy|0|||
33370945|NCT00586924|101243573|FG004|Overall Study|Other|1|||
33370946|NCT00586924|101243574|FG005|Overall Study|Other|6|||
33370947|NCT03201198|101243577|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
33370948|NCT03201198|101243578|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
33370949|NCT03201198|101243577|FG000|Overall Study|Withdrawal by Subject|2|||
33370950|NCT03201198|101243578|FG001|Overall Study|Withdrawal by Subject|3|||
33370951|NCT05142332|101243580|FG000|Overall Study|Withdrawal by Subject|0|||
33370952|NCT05142332|101243581|FG001|Overall Study|Withdrawal by Subject|1|||
33370953|NCT05142332|101243582|FG002|Overall Study|Withdrawal by Subject|2|||
33370954|NCT05142332|101243583|FG003|Overall Study|Withdrawal by Subject|0|||
33370955|NCT05142332|101243584|FG004|Overall Study|Withdrawal by Subject|0|||
33370956|NCT05142332|101243585|FG005|Overall Study|Withdrawal by Subject|2|||
33370957|NCT05142332|101243586|FG006|Overall Study|Withdrawal by Subject|6|||
33370958|NCT05142332|101243580|FG000|Overall Study|Left ED|3|||
33370959|NCT05142332|101243581|FG001|Overall Study|Left ED|0|||
33370960|NCT05142332|101243582|FG002|Overall Study|Left ED|4|||
33581048|NCT02709577|102017043|FG000|Overall Study|Withdrawal by Subject|2|||
33581049|NCT02709577|102017044|FG001|Overall Study|Withdrawal by Subject|3|||
33581050|NCT02709577|102017045|FG002|Overall Study|Withdrawal by Subject|2|||
33241440|NCT00124982|100786094|FG002|Long-term Period|Lack of Efficacy|46|||
33581051|NCT02709577|102017046|FG003|Overall Study|Withdrawal by Subject|0|||
33142669|NCT02353143|100434957|FG003|Overall Study|patient receiving other treatment for AML|0|||
33241441|NCT00124982|100786092|FG000|Long-term Period|Lost to Follow-up|0|||
33241442|NCT00124982|100786093|FG001|Long-term Period|Lost to Follow-up|0|||
33241443|NCT00124982|100786094|FG002|Long-term Period|Lost to Follow-up|4|||
33241444|NCT00124982|100786092|FG000|Long-term Period|Withdrawal by Subject|0|||
33370961|NCT05142332|101243583|FG003|Overall Study|Left ED|6|||
33370962|NCT05142332|101243584|FG004|Overall Study|Left ED|1|||
33370963|NCT05142332|101243585|FG005|Overall Study|Left ED|2|||
33370964|NCT05142332|101243586|FG006|Overall Study|Left ED|6|||
33142670|NCT02353143|100434958|FG004|Overall Study|patient receiving other treatment for AML|0|||
33241445|NCT00124982|100786093|FG001|Long-term Period|Withdrawal by Subject|0|||
33241446|NCT00124982|100786094|FG002|Long-term Period|Withdrawal by Subject|16|||
33241447|NCT00124982|100786092|FG000|Long-term Period|Pregnancy|0|||
33241448|NCT00124982|100786093|FG001|Long-term Period|Pregnancy|0|||
33241449|NCT00124982|100786094|FG002|Long-term Period|Pregnancy|1|||
33241450|NCT00124982|100786092|FG000|Long-term Period|Poor/Non-compliance|0|||
33241451|NCT00124982|100786093|FG001|Long-term Period|Poor/Non-compliance|0|||
33241452|NCT00124982|100786094|FG002|Long-term Period|Poor/Non-compliance|2|||
33641356|NCT02561832|102236692|FG000|Overall Study|Withdrawal by Subject|1|||
33641357|NCT02561832|102236693|FG001|Overall Study|Withdrawal by Subject|1|||
33641358|NCT02561832|102236692|FG000|Overall Study|Adverse Event|3|||
33641359|NCT02561832|102236693|FG001|Overall Study|Adverse Event|0|||
33641360|NCT02561832|102236692|FG000|Overall Study|Disease progression|3|||
33641361|NCT02561832|102236693|FG001|Overall Study|Disease progression|3|||
33641362|NCT01936870|102236694|FG000|Overall Study|No Visit After Treatment|176|||
33641363|NCT01936870|102236694|FG000|Overall Study|Protocol Violation|12|||
33641364|NCT01936870|102236694|FG000|Overall Study|No Drug Administration|1|||
33641365|NCT01310075|102236695|FG000|Overall Study|Lost to Follow-up|1|||
33641366|NCT01310075|102236696|FG001|Overall Study|Lost to Follow-up|0|||
33641367|NCT01310075|102236695|FG000|Overall Study|Physician Decision|10|||
33641368|NCT01310075|102236696|FG001|Overall Study|Physician Decision|7|||
33641369|NCT01310075|102236695|FG000|Overall Study|Protocol Violation|2|||
33641370|NCT01310075|102236696|FG001|Overall Study|Protocol Violation|2|||
33641371|NCT01310075|102236695|FG000|Overall Study|Withdrawal by Subject|1|||
33641372|NCT01310075|102236696|FG001|Overall Study|Withdrawal by Subject|1|||
33641373|NCT00686686|102236697|FG000|Overall Study|Non-compliance|1|||
33641374|NCT00686686|102236697|FG000|Overall Study|Adverse Event|2|||
33641375|NCT00686686|102236697|FG000|Overall Study|Lost to Follow-up|3|||
33641376|NCT02157883|102236700|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
33641377|NCT02157883|102236700|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
33641378|NCT02157883|102236700|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
33641379|NCT02157883|102236700|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
33641380|NCT02157883|102236700|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
33641381|NCT01253577|102236703|FG000|Overall Study|Lost to Follow-up|3|||
33641382|NCT02346721|102236706|FG000|Overall Study|Withdrew Consent|3|||
33641383|NCT02346721|102236706|FG000|Overall Study|Lack of Efficacy|1|||
33641384|NCT03252925|102236707|FG000|Overall Study|Withdrawal by Subject|1|||
33641385|NCT03252925|102236708|FG001|Overall Study|Withdrawal by Subject|0|||
33641386|NCT03252925|102236707|FG000|Overall Study|Protocol Violation|6|||
33641387|NCT03252925|102236708|FG001|Overall Study|Protocol Violation|0|||
33641388|NCT03252925|102236707|FG000|Overall Study|Adverse Event|1|||
33641389|NCT03252925|102236708|FG001|Overall Study|Adverse Event|0|||
33241453|NCT00124982|100786092|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
33241454|NCT00124982|100786093|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
33241455|NCT00124982|100786094|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
33241456|NCT00124982|100786092|FG000|Long-term Period|Neurologist Recommendation|0|||
33241457|NCT00124982|100786093|FG001|Long-term Period|Neurologist Recommendation|0|||
33241458|NCT00124982|100786094|FG002|Long-term Period|Neurologist Recommendation|1|||
33241459|NCT04096365|100786095|FG000|Overall Study|Adverse Event|1|||
33241460|NCT01641861|100786096|FG000|Overall Study|Lost to Follow-up|21|||
33241461|NCT01641861|100786097|FG001|Overall Study|Lost to Follow-up|16|||
33241462|NCT01641861|100786096|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
33241463|NCT01641861|100786097|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
33241464|NCT01641861|100786096|FG000|Overall Study|Died due to drowning|0|||
33241465|NCT01641861|100786097|FG001|Overall Study|Died due to drowning|1|||
33241466|NCT03682536|100786098|FG000|Randomization|Withdrawal by Subject|0|||
33241467|NCT03682536|100786099|FG001|Randomization|Withdrawal by Subject|2|||
33241468|NCT03682536|100786098|FG000|Treatment|Other Reasons|8|||
33241469|NCT03682536|100786099|FG001|Treatment|Other Reasons|7|||
33241470|NCT03682536|100786098|FG000|Treatment|Physician Decision|5|||
33241471|NCT03682536|100786099|FG001|Treatment|Physician Decision|5|||
33241472|NCT03682536|100786098|FG000|Treatment|Protocol Violation|1|||
33641390|NCT03252925|102236707|FG000|Overall Study|Lost to Follow-up|6|||
33241473|NCT03682536|100786099|FG001|Treatment|Protocol Violation|0|||
33241474|NCT03682536|100786098|FG000|Treatment|Study Terminated by Sponsor|1|||
33241475|NCT03682536|100786099|FG001|Treatment|Study Terminated by Sponsor|2|||
33241476|NCT03682536|100786098|FG000|Treatment|Lost to Follow-up|0|||
33241477|NCT03682536|100786099|FG001|Treatment|Lost to Follow-up|1|||
33241478|NCT03682536|100786098|FG000|Treatment|Withdrawal by Subject|16|||
33641391|NCT03252925|102236708|FG001|Overall Study|Lost to Follow-up|6|||
33641392|NCT00755183|102236710|FG000|Overall Study|Adverse Event|5|||
33641393|NCT00755183|102236711|FG001|Overall Study|Adverse Event|2|||
33641394|NCT00755183|102236710|FG000|Overall Study|Protocol Violation|0|||
33641395|NCT00755183|102236711|FG001|Overall Study|Protocol Violation|1|||
33641396|NCT00755183|102236710|FG000|Overall Study|Withdrawal by Subject|0|||
33641397|NCT00755183|102236711|FG001|Overall Study|Withdrawal by Subject|2|||
33641398|NCT00755183|102236710|FG000|Overall Study|Administrative|2|||
33241479|NCT03682536|100786099|FG001|Treatment|Withdrawal by Subject|18|||
33241480|NCT03682536|100786098|FG000|Treatment|Lack of Efficacy|41|||
33241481|NCT03682536|100786099|FG001|Treatment|Lack of Efficacy|68|||
33241482|NCT03682536|100786098|FG000|Treatment|Disease Progression|9|||
33241483|NCT03682536|100786099|FG001|Treatment|Disease Progression|7|||
33241484|NCT03682536|100786098|FG000|Treatment|Adverse Event|9|||
33241485|NCT03682536|100786099|FG001|Treatment|Adverse Event|5|||
33241486|NCT03682536|100786098|FG000|Treatment|Death|14|||
33241487|NCT03682536|100786099|FG001|Treatment|Death|13|||
33241488|NCT04170023|100786100|FG000|LTE Period|Withdrawal by Subject|1|||
33241489|NCT04170023|100786101|FG001|LTE Period|Withdrawal by Subject|0|||
33241490|NCT04170023|100786102|FG002|LTE Period|Withdrawal by Subject|0|||
33241491|NCT04170023|100786100|FG000|LTE Period|Study Termination|11|||
33241492|NCT04170023|100786101|FG001|LTE Period|Study Termination|11|||
33241493|NCT04170023|100786102|FG002|LTE Period|Study Termination|5|||
33241494|NCT02724020|100786103|FG000|Overall Study|Death|16|||
33241495|NCT02724020|100786104|FG001|Overall Study|Death|18|||
33241496|NCT02724020|100786105|FG002|Overall Study|Death|19|||
33241497|NCT02724020|100786103|FG000|Overall Study|Lost to Follow-up|0|||
33241498|NCT02724020|100786104|FG001|Overall Study|Lost to Follow-up|3|||
33241499|NCT02724020|100786105|FG002|Overall Study|Lost to Follow-up|0|||
33241500|NCT02724020|100786103|FG000|Overall Study|Site Terminated by Sponsor|15|||
33241501|NCT02724020|100786104|FG001|Overall Study|Site Terminated by Sponsor|8|||
33241502|NCT02724020|100786105|FG002|Overall Study|Site Terminated by Sponsor|8|||
33241503|NCT02724020|100786103|FG000|Overall Study|Withdrawal by Subject|1|||
33241504|NCT02724020|100786104|FG001|Overall Study|Withdrawal by Subject|3|||
33241505|NCT02724020|100786105|FG002|Overall Study|Withdrawal by Subject|5|||
33241506|NCT00724061|100786106|FG000|Dose Escalation Phase|Adverse Event|2|||
33241507|NCT00724061|100786106|FG000|Dose Escalation Phase|Disease Progression|3|||
33241508|NCT00562965|100786107|FG000|Overall Study|Withdrawal by Subject|0|||
33241509|NCT00562965|100786108|FG001|Overall Study|Withdrawal by Subject|1|||
33241510|NCT00562965|100786107|FG000|Overall Study|Death|2|||
33241511|NCT00562965|100786108|FG001|Overall Study|Death|4|||
33241512|NCT00562965|100786107|FG000|Overall Study|Lost to Follow-up|1|||
33241513|NCT00562965|100786108|FG001|Overall Study|Lost to Follow-up|0|||
33241514|NCT00562965|100786107|FG000|Overall Study|Other|0|||
33241515|NCT00562965|100786108|FG001|Overall Study|Other|1|||
33241516|NCT02323880|100786109|FG000|Overall Study|Adverse Event|2|||
33241517|NCT02323880|100786110|FG001|Overall Study|Adverse Event|0|||
33241518|NCT02323880|100786111|FG002|Overall Study|Adverse Event|1|||
33241519|NCT02323880|100786112|FG003|Overall Study|Adverse Event|1|||
33241520|NCT02323880|100786113|FG004|Overall Study|Adverse Event|1|||
33370965|NCT05142332|101243580|FG000|Overall Study|Physician Decision|0|||
33581052|NCT02454530|102017049|FG000|Overall Study|Other|8|||
33581053|NCT02454530|102017050|FG001|Overall Study|Other|13|||
33581054|NCT02454530|102017049|FG000|Overall Study|Missing information|56|||
33581055|NCT02454530|102017050|FG001|Overall Study|Missing information|69|||
33581056|NCT02454530|102017049|FG000|Overall Study|Death|2|||
33581057|NCT02454530|102017050|FG001|Overall Study|Death|41|||
33581058|NCT02454530|102017049|FG000|Overall Study|Lost to Follow-up|4|||
33581059|NCT02454530|102017050|FG001|Overall Study|Lost to Follow-up|4|||
33581060|NCT02534883|102017057|FG000|Overall Study|Early Termination|8|||
33581061|NCT02534883|102017058|FG001|Overall Study|Early Termination|3|||
33581062|NCT02567799|102017061|FG000|Concurrent Chemoradiotherapy|Death|1|||
33142671|NCT02353143|100434959|FG005|Overall Study|patient receiving other treatment for AML|0|||
33142672|NCT02353143|100434960|FG006|Overall Study|patient receiving other treatment for AML|0|||
33142673|NCT02353143|100434961|FG007|Overall Study|patient receiving other treatment for AML|0|||
33142674|NCT02353143|100434962|FG008|Overall Study|patient receiving other treatment for AML|0|||
33142675|NCT02353143|100434954|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
33142676|NCT02353143|100434955|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
33370966|NCT05142332|101243581|FG001|Overall Study|Physician Decision|0|||
33581063|NCT02567799|102017062|FG001|Concurrent Chemoradiotherapy|Death|0|||
33641399|NCT00755183|102236711|FG001|Overall Study|Administrative|1|||
33641400|NCT02736578|102236713|FG000|Overall Study|Adverse Event|1|||
33142677|NCT02353143|100434956|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
33142678|NCT02353143|100434957|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
33142679|NCT02353143|100434958|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
33142680|NCT02353143|100434959|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
33241521|NCT02323880|100786114|FG005|Overall Study|Adverse Event|0|||
33241522|NCT02323880|100786115|FG006|Overall Study|Adverse Event|1|||
33241523|NCT02323880|100786116|FG007|Overall Study|Adverse Event|0|||
33241524|NCT02323880|100786109|FG000|Overall Study|Death|0|||
33241525|NCT02323880|100786110|FG001|Overall Study|Death|0|||
33241526|NCT02323880|100786111|FG002|Overall Study|Death|0|||
33241527|NCT02323880|100786112|FG003|Overall Study|Death|0|||
33241528|NCT02323880|100786113|FG004|Overall Study|Death|0|||
33241529|NCT02323880|100786114|FG005|Overall Study|Death|1|||
33581064|NCT02567799|102017063|FG002|Concurrent Chemoradiotherapy|Death|0|||
33581065|NCT02567799|102017061|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
33581066|NCT02567799|102017062|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
33241530|NCT02323880|100786115|FG006|Overall Study|Death|0|||
33241531|NCT02323880|100786116|FG007|Overall Study|Death|0|||
33241532|NCT02323880|100786109|FG000|Overall Study|Lack of Efficacy|4|||
33241533|NCT02323880|100786110|FG001|Overall Study|Lack of Efficacy|11|||
33241534|NCT02323880|100786111|FG002|Overall Study|Lack of Efficacy|5|||
33241535|NCT02323880|100786112|FG003|Overall Study|Lack of Efficacy|5|||
33241536|NCT02323880|100786113|FG004|Overall Study|Lack of Efficacy|4|||
33241537|NCT02323880|100786114|FG005|Overall Study|Lack of Efficacy|8|||
33241538|NCT02323880|100786115|FG006|Overall Study|Lack of Efficacy|4|||
33241539|NCT02323880|100786116|FG007|Overall Study|Lack of Efficacy|6|||
33241540|NCT02323880|100786109|FG000|Overall Study|Physician Decision|0|||
33241541|NCT02323880|100786110|FG001|Overall Study|Physician Decision|0|||
33241542|NCT02323880|100786111|FG002|Overall Study|Physician Decision|0|||
33241543|NCT02323880|100786112|FG003|Overall Study|Physician Decision|0|||
33241544|NCT02323880|100786113|FG004|Overall Study|Physician Decision|1|||
33241545|NCT02323880|100786114|FG005|Overall Study|Physician Decision|1|||
33241546|NCT02323880|100786115|FG006|Overall Study|Physician Decision|1|||
33241547|NCT02323880|100786116|FG007|Overall Study|Physician Decision|0|||
33241548|NCT02323880|100786109|FG000|Overall Study|Withdrawal by Subject|0|||
33241549|NCT02323880|100786110|FG001|Overall Study|Withdrawal by Subject|2|||
33241550|NCT02323880|100786111|FG002|Overall Study|Withdrawal by Subject|0|||
33241551|NCT02323880|100786112|FG003|Overall Study|Withdrawal by Subject|0|||
33241552|NCT02323880|100786113|FG004|Overall Study|Withdrawal by Subject|0|||
33241553|NCT02323880|100786114|FG005|Overall Study|Withdrawal by Subject|0|||
33241554|NCT02323880|100786115|FG006|Overall Study|Withdrawal by Subject|0|||
33241555|NCT02323880|100786116|FG007|Overall Study|Withdrawal by Subject|0|||
33241556|NCT00689104|100786118|FG000|Overall Study|Eligibility criterion not met|5|||
33241557|NCT00689104|100786119|FG001|Overall Study|Eligibility criterion not met|8|||
33241558|NCT00689104|100786120|FG002|Overall Study|Eligibility criterion not met|0|||
33241559|NCT00689104|100786121|FG003|Overall Study|Eligibility criterion not met|4|||
33241560|NCT00689104|100786118|FG000|Overall Study|Adverse Event|13|||
33241561|NCT00689104|100786119|FG001|Overall Study|Adverse Event|25|||
33241562|NCT00689104|100786120|FG002|Overall Study|Adverse Event|16|||
33241563|NCT00689104|100786121|FG003|Overall Study|Adverse Event|24|||
33241564|NCT00689104|100786118|FG000|Overall Study|Lack of Efficacy|5|||
33241565|NCT00689104|100786119|FG001|Overall Study|Lack of Efficacy|6|||
33241566|NCT00689104|100786120|FG002|Overall Study|Lack of Efficacy|2|||
33241567|NCT00689104|100786121|FG003|Overall Study|Lack of Efficacy|3|||
33241568|NCT00689104|100786118|FG000|Overall Study|Withdrawal by Subject|12|||
33241569|NCT00689104|100786119|FG001|Overall Study|Withdrawal by Subject|11|||
33241570|NCT00689104|100786120|FG002|Overall Study|Withdrawal by Subject|18|||
33241571|NCT00689104|100786121|FG003|Overall Study|Withdrawal by Subject|11|||
33241572|NCT00689104|100786118|FG000|Overall Study|Lost to Follow-up|4|||
33241573|NCT00689104|100786119|FG001|Overall Study|Lost to Follow-up|3|||
33241574|NCT00689104|100786120|FG002|Overall Study|Lost to Follow-up|2|||
33370967|NCT05142332|101243582|FG002|Overall Study|Physician Decision|2|||
33370968|NCT05142332|101243583|FG003|Overall Study|Physician Decision|1|||
33241575|NCT00689104|100786121|FG003|Overall Study|Lost to Follow-up|5|||
33241576|NCT00689104|100786118|FG000|Overall Study|Protocol Violation|2|||
33241577|NCT00689104|100786119|FG001|Overall Study|Protocol Violation|3|||
33241578|NCT00689104|100786120|FG002|Overall Study|Protocol Violation|5|||
33241579|NCT00689104|100786121|FG003|Overall Study|Protocol Violation|3|||
33241580|NCT00689104|100786118|FG000|Overall Study|Randomized but never received study drug|2|||
33241581|NCT00689104|100786119|FG001|Overall Study|Randomized but never received study drug|1|||
33370969|NCT05142332|101243584|FG004|Overall Study|Physician Decision|0|||
33370970|NCT05142332|101243585|FG005|Overall Study|Physician Decision|0|||
33370971|NCT05142332|101243586|FG006|Overall Study|Physician Decision|3|||
33370972|NCT05142332|101243580|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
33370973|NCT05142332|101243581|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
33370974|NCT05142332|101243582|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
33370975|NCT05142332|101243583|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
33370976|NCT05142332|101243584|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
33370977|NCT05142332|101243585|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
33241582|NCT00689104|100786120|FG002|Overall Study|Randomized but never received study drug|1|||
33241583|NCT00689104|100786121|FG003|Overall Study|Randomized but never received study drug|0|||
33241584|NCT00689104|100786118|FG000|Overall Study|Physician Decision|1|||
33241585|NCT00689104|100786119|FG001|Overall Study|Physician Decision|0|||
33241586|NCT00689104|100786120|FG002|Overall Study|Physician Decision|0|||
33241587|NCT00689104|100786121|FG003|Overall Study|Physician Decision|0|||
33241588|NCT00689104|100786118|FG000|Overall Study|Non-compliance with study procedures|0|||
33241589|NCT00689104|100786119|FG001|Overall Study|Non-compliance with study procedures|0|||
33241590|NCT00689104|100786120|FG002|Overall Study|Non-compliance with study procedures|1|||
33241591|NCT00689104|100786121|FG003|Overall Study|Non-compliance with study procedures|0|||
33370978|NCT05142332|101243586|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
33370979|NCT00524316|101243592|FG000|Overall Study|Withdrawal by Subject|2|||
33421414|NCT03276962|101434771|FG002|Overall Study|Protocol Deviation|1|||
33641401|NCT02736578|102236714|FG001|Overall Study|Adverse Event|0|||
33241592|NCT00224133|100786122|FG000|Overall Study|Adverse Event|93|||
33241593|NCT00224133|100786122|FG000|Overall Study|Protocol Violation|6|||
33241594|NCT00224133|100786122|FG000|Overall Study|Withdrawal by Subject|33|||
33241595|NCT00224133|100786122|FG000|Overall Study|Lack of Efficacy|58|||
33241596|NCT00224133|100786122|FG000|Overall Study|Lost to Follow-up|21|||
33241597|NCT00224133|100786122|FG000|Overall Study|Physician Decision|1|||
33241598|NCT00224133|100786122|FG000|Overall Study|Other|14|||
33241599|NCT02459587|100786123|FG000|3-Month Follow-up Assessment|Death|0|||
33241600|NCT02459587|100786124|FG001|3-Month Follow-up Assessment|Death|2|||
33241601|NCT02459587|100786123|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
33241602|NCT02459587|100786124|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
33241603|NCT02459587|100786123|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
33241604|NCT02459587|100786124|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
33241605|NCT02459587|100786123|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
33241606|NCT02459587|100786124|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
33241607|NCT02459587|100786123|FG000|6-month Follow-up Assessment|Death|2|||
33241608|NCT02459587|100786124|FG001|6-month Follow-up Assessment|Death|1|||
33241609|NCT02459587|100786123|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
33241610|NCT02459587|100786124|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
33241611|NCT02459587|100786123|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
33241612|NCT02459587|100786124|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
33241613|NCT02459587|100786123|FG000|12-month Follow-up Assessment|Death|2|||
33241614|NCT02459587|100786124|FG001|12-month Follow-up Assessment|Death|0|||
33241615|NCT02459587|100786123|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
33241616|NCT02459587|100786124|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
33641402|NCT03636893|102236715|FG000|Overall Study|Death|0|||
33241617|NCT02459587|100786123|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
33641403|NCT03636893|102236716|FG001|Overall Study|Death|1|||
33641404|NCT03636893|102236715|FG000|Overall Study|Protocol Violation|0|||
33641405|NCT03636893|102236716|FG001|Overall Study|Protocol Violation|3|||
33641406|NCT03636893|102236715|FG000|Overall Study|Withdrawal by Subject|1|||
33641407|NCT03636893|102236716|FG001|Overall Study|Withdrawal by Subject|2|||
33641408|NCT03636893|102236715|FG000|Overall Study|Refusal to surgery|4|||
33241618|NCT02459587|100786124|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
33241619|NCT02459587|100786123|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
33241620|NCT02459587|100786124|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
33241621|NCT02401529|100786127|FG000|Overall Study|Lost to Follow-up|2|||
33241622|NCT02401529|100786128|FG001|Overall Study|Lost to Follow-up|1|||
33241623|NCT02401529|100786127|FG000|Overall Study|Physician Decision|2|||
33241624|NCT02401529|100786128|FG001|Overall Study|Physician Decision|6|||
33241625|NCT02401529|100786127|FG000|Overall Study|Protocol Violation|5|||
33241626|NCT02401529|100786128|FG001|Overall Study|Protocol Violation|0|||
33241627|NCT00318656|100786129|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
33241628|NCT00318656|100786130|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
33241629|NCT00318656|100786129|FG000|Overall Study|Did not receive any treatment|0|||
33241630|NCT00318656|100786130|FG001|Overall Study|Did not receive any treatment|1|||
33241631|NCT00940017|100786135|FG000|Overall Study|did not meet entrance criteria|3|||
33241632|NCT00940017|100786135|FG000|Overall Study|Adverse Event|1|||
33241633|NCT04776213|100786136|FG000|Overall Study|Other|1|||
33241634|NCT04776213|100786136|FG000|Overall Study|Withdrawal by Subject|7|||
33241635|NCT04776213|100786136|FG000|Overall Study|Protocol Violation|1|||
33241636|NCT04776213|100786136|FG000|Overall Study|Lost to Follow-up|2|||
33241637|NCT02335268|100786137|FG000|Overall Study|Physician Decision|5|||
33241638|NCT02335268|100786138|FG001|Overall Study|Physician Decision|1|||
33241639|NCT02335268|100786137|FG000|Overall Study|Lack of Efficacy|2|||
33241640|NCT02335268|100786138|FG001|Overall Study|Lack of Efficacy|1|||
33241641|NCT02335268|100786137|FG000|Overall Study|Adverse Event|5|||
33241642|NCT02335268|100786138|FG001|Overall Study|Adverse Event|2|||
33641409|NCT03636893|102236716|FG001|Overall Study|Refusal to surgery|3|||
33241643|NCT02335268|100786137|FG000|Overall Study|increase blasts|2|||
33241644|NCT02335268|100786138|FG001|Overall Study|increase blasts|0|||
33241645|NCT02335268|100786137|FG000|Overall Study|Withdrawal by Subject|3|||
33241646|NCT02335268|100786138|FG001|Overall Study|Withdrawal by Subject|2|||
33241647|NCT00162942|100786139|FG000|Overall Study|Adverse Event|10|||
33142681|NCT02353143|100434960|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
33241648|NCT00162942|100786140|FG001|Overall Study|Adverse Event|6|||
33241649|NCT00162942|100786139|FG000|Overall Study|Death|1|||
33241650|NCT00162942|100786140|FG001|Overall Study|Death|0|||
33241651|NCT00162942|100786139|FG000|Overall Study|Withdrawal by Subject|3|||
33241652|NCT00162942|100786140|FG001|Overall Study|Withdrawal by Subject|6|||
33370980|NCT00524316|101243592|FG000|Overall Study|Adverse Event|7|||
33370981|NCT00524316|101243592|FG000|Overall Study|Disease Progression|7|||
33641410|NCT03636893|102236715|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
33641411|NCT03636893|102236716|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
33241653|NCT00162942|100786139|FG000|Overall Study|Physician Decision|1|||
33241654|NCT00162942|100786140|FG001|Overall Study|Physician Decision|0|||
33241655|NCT00162942|100786139|FG000|Overall Study|Enter Open-Label Study|76|||
33241656|NCT00162942|100786140|FG001|Overall Study|Enter Open-Label Study|35|||
33241657|NCT00162942|100786139|FG000|Overall Study|Alternate Therapy|6|||
33241658|NCT00162942|100786140|FG001|Overall Study|Alternate Therapy|2|||
33241659|NCT00162942|100786139|FG000|Overall Study|Lack of Efficacy|1|||
33241660|NCT00162942|100786140|FG001|Overall Study|Lack of Efficacy|0|||
33241661|NCT00162942|100786139|FG000|Overall Study|Flare During Active Treatment|7|||
33241662|NCT00162942|100786140|FG001|Overall Study|Flare During Active Treatment|3|||
33241663|NCT00162942|100786139|FG000|Overall Study|2 or more consecutive treatments missed|1|||
33241664|NCT00162942|100786140|FG001|Overall Study|2 or more consecutive treatments missed|0|||
33241665|NCT03003962|100786141|FG000|Overall Study|Withdrawal by Subject|5|||
33241666|NCT03003962|100786142|FG001|Overall Study|Withdrawal by Subject|17|||
33241667|NCT03003962|100786141|FG000|Overall Study|Death|274|||
33241668|NCT03003962|100786142|FG001|Overall Study|Death|277|||
33241669|NCT03003962|100786141|FG000|Overall Study|Participants ongoing at DCO|55|||
33241670|NCT03003962|100786142|FG001|Overall Study|Participants ongoing at DCO|40|||
33241671|NCT02561455|100786143|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
33241672|NCT02561455|100786144|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
33241673|NCT02561455|100786145|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
33241674|NCT02561455|100786146|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
33241675|NCT02561455|100786143|FG000|Overall Study|Withdrawal by Subject|1|||
33241676|NCT02561455|100786144|FG001|Overall Study|Withdrawal by Subject|0|||
33241677|NCT02561455|100786145|FG002|Overall Study|Withdrawal by Subject|1|||
33241678|NCT02561455|100786146|FG003|Overall Study|Withdrawal by Subject|0|||
33241679|NCT02561455|100786143|FG000|Overall Study|Disease Progression|0|||
33241680|NCT02561455|100786144|FG001|Overall Study|Disease Progression|1|||
33241681|NCT02561455|100786145|FG002|Overall Study|Disease Progression|0|||
33241682|NCT02561455|100786146|FG003|Overall Study|Disease Progression|0|||
33241683|NCT03282123|100786147|FG000|Overall Study|Withdrawal by Subject|5|||
33241684|NCT00708097|100786149|FG000|Period 1|Protocol Violation|0|||
33641412|NCT03636893|102236715|FG000|Overall Study|Adverse Event|1|||
33641413|NCT03636893|102236716|FG001|Overall Study|Adverse Event|1|||
33641414|NCT01918306|102236719|FG000|Overall Study|progresive disease|4|||
33241685|NCT00708097|100786150|FG001|Period 1|Protocol Violation|1|||
33241686|NCT00708097|100786151|FG002|Period 1|Protocol Violation|0|||
33241687|NCT00708097|100786152|FG003|Period 1|Protocol Violation|2|||
33241688|NCT00708097|100786153|FG004|Period 1|Protocol Violation|0|||
33241689|NCT00708097|100786149|FG000|Period 1|Other Reason|0|||
33241690|NCT00708097|100786150|FG001|Period 1|Other Reason|0|||
33241691|NCT00708097|100786151|FG002|Period 1|Other Reason|0|||
33241692|NCT00708097|100786152|FG003|Period 1|Other Reason|0|||
33241693|NCT00708097|100786153|FG004|Period 1|Other Reason|1|||
33241694|NCT00708097|100786149|FG000|Period 2|Protocol Violation|0|||
33241695|NCT00708097|100786150|FG001|Period 2|Protocol Violation|1|||
33370982|NCT00303108|101243595|FG000|Overall Study|Adverse Event|5|||
33581067|NCT02567799|102017063|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
33581068|NCT02567799|102017061|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
33641415|NCT01918306|102236720|FG001|Overall Study|progresive disease|0|||
33641416|NCT01918306|102236721|FG002|Overall Study|progresive disease|1|||
33641417|NCT01918306|102236722|FG003|Overall Study|progresive disease|1|||
33641418|NCT01918306|102236719|FG000|Overall Study|Withdrawal by Subject|0|||
33241696|NCT00708097|100786151|FG002|Period 2|Protocol Violation|1|||
33241697|NCT00708097|100786152|FG003|Period 2|Protocol Violation|1|||
33241698|NCT00708097|100786153|FG004|Period 2|Protocol Violation|0|||
33241699|NCT03176134|100786155|FG000|Overall Study|Lost to Follow-up|0|||
33581069|NCT02567799|102017062|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
33581070|NCT02567799|102017063|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
33581071|NCT02567799|102017061|FG000|Follow-up|Death|1|||
33581072|NCT02567799|102017062|FG001|Follow-up|Death|0|||
33581073|NCT02567799|102017063|FG002|Follow-up|Death|1|||
33581074|NCT02567799|102017061|FG000|Follow-up|Progressive Disease|1|||
33581075|NCT02567799|102017062|FG001|Follow-up|Progressive Disease|1|||
33581076|NCT02567799|102017063|FG002|Follow-up|Progressive Disease|3|||
33581077|NCT02524145|102017065|FG000|Overall Study|Withdrawal by Subject|2|||
33581078|NCT02524145|102017066|FG001|Overall Study|Withdrawal by Subject|2|||
33581079|NCT02524145|102017067|FG002|Overall Study|Withdrawal by Subject|3|||
33241700|NCT03176134|100786156|FG001|Overall Study|Lost to Follow-up|2|||
33241701|NCT03176134|100786157|FG002|Overall Study|Lost to Follow-up|0|||
33241702|NCT03176134|100786158|FG003|Overall Study|Lost to Follow-up|0|||
33241703|NCT03176134|100786159|FG004|Overall Study|Lost to Follow-up|0|||
33241704|NCT03176134|100786160|FG005|Overall Study|Lost to Follow-up|0|||
33241705|NCT03176134|100786161|FG006|Overall Study|Lost to Follow-up|0|||
33641419|NCT01918306|102236720|FG001|Overall Study|Withdrawal by Subject|0|||
33241706|NCT03176134|100786162|FG007|Overall Study|Lost to Follow-up|0|||
33370983|NCT00303108|101243596|FG001|Overall Study|Adverse Event|6|||
33641420|NCT01918306|102236721|FG002|Overall Study|Withdrawal by Subject|0|||
33142682|NCT02353143|100434961|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
33142683|NCT02353143|100434962|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
33142684|NCT02380690|100434963|FG000|Overall Study|Lost to Follow-up|14|||
33142685|NCT02380690|100434964|FG001|Overall Study|Lost to Follow-up|4|||
33142686|NCT02380690|100434963|FG000|Overall Study|Withdrawal by Subject|20|||
33142687|NCT02380690|100434964|FG001|Overall Study|Withdrawal by Subject|8|||
33142688|NCT01426789|100434965|FG000|Part 1|Protocol deviation|0|||
33142689|NCT01426789|100434966|FG001|Part 1|Protocol deviation|1|||
33142690|NCT01426789|100434967|FG002|Part 1|Protocol deviation|0|||
33142691|NCT01426789|100434968|FG003|Part 1|Protocol deviation|0|||
33142692|NCT01426789|100434969|FG004|Part 1|Protocol deviation|0|||
33142693|NCT01426789|100434970|FG005|Part 1|Protocol deviation|0|||
33241707|NCT03176134|100786155|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
33241708|NCT03176134|100786156|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33142694|NCT01426789|100434965|FG000|Part 1|Lost to Follow-up|1|||
33581080|NCT03335150|102017068|FG000|Overall Study|Withdrawal by Subject|10|||
33142695|NCT01426789|100434966|FG001|Part 1|Lost to Follow-up|2|||
33142696|NCT01426789|100434967|FG002|Part 1|Lost to Follow-up|0|||
33241709|NCT03176134|100786157|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
33241710|NCT03176134|100786158|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
33241711|NCT03176134|100786159|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
33241712|NCT03176134|100786160|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
33241713|NCT03176134|100786161|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
33142697|NCT01426789|100434968|FG003|Part 1|Lost to Follow-up|0|||
33142698|NCT01426789|100434969|FG004|Part 1|Lost to Follow-up|0|||
33142699|NCT01426789|100434970|FG005|Part 1|Lost to Follow-up|0|||
33142700|NCT01426789|100434965|FG000|Part 1|Lack of Efficacy|2|||
33142701|NCT01426789|100434966|FG001|Part 1|Lack of Efficacy|1|||
33142702|NCT01426789|100434967|FG002|Part 1|Lack of Efficacy|0|||
33142703|NCT01426789|100434968|FG003|Part 1|Lack of Efficacy|0|||
33142704|NCT01426789|100434969|FG004|Part 1|Lack of Efficacy|0|||
33142705|NCT01426789|100434970|FG005|Part 1|Lack of Efficacy|0|||
33142706|NCT01426789|100434965|FG000|Part 1|Adverse Event|3|||
33142707|NCT01426789|100434966|FG001|Part 1|Adverse Event|0|||
33241714|NCT03176134|100786162|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
33370984|NCT00303108|101243597|FG002|Overall Study|Adverse Event|7|||
33370985|NCT00303108|101243595|FG000|Overall Study|Patient Request|4|||
33370986|NCT00303108|101243596|FG001|Overall Study|Patient Request|2|||
33370987|NCT00303108|101243597|FG002|Overall Study|Patient Request|8|||
33370988|NCT00303108|101243595|FG000|Overall Study|Failed Entry|1|||
33370989|NCT00303108|101243596|FG001|Overall Study|Failed Entry|0|||
33370990|NCT00303108|101243597|FG002|Overall Study|Failed Entry|1|||
33370991|NCT00303108|101243595|FG000|Overall Study|ineligible|2|||
33370992|NCT00303108|101243596|FG001|Overall Study|ineligible|1|||
33370993|NCT00303108|101243597|FG002|Overall Study|ineligible|0|||
33370994|NCT02184143|101243598|FG000|Overall Study|Withdrawal by Subject|4|||
33370995|NCT02184143|101243599|FG001|Overall Study|Withdrawal by Subject|4|||
33370996|NCT02184143|101243598|FG000|Overall Study|Lost to Follow-up|5|||
33370997|NCT02184143|101243599|FG001|Overall Study|Lost to Follow-up|3|||
33370998|NCT02184143|101243598|FG000|Overall Study|Death|1|||
33370999|NCT02184143|101243599|FG001|Overall Study|Death|0|||
33371000|NCT03539458|101243600|FG000|Overall Study|Death|1|||
33371001|NCT00952289|101243601|FG000|All Participants|Death|9|||
33581081|NCT03335150|102017069|FG001|Overall Study|Withdrawal by Subject|4|||
33581082|NCT03335150|102017068|FG000|Overall Study|Adverse Event|0|||
33581083|NCT03335150|102017069|FG001|Overall Study|Adverse Event|1|||
33581084|NCT01898286|102017073|FG000|Overall Study|Withdrawal by Subject|1|||
33581085|NCT01898286|102017073|FG000|Overall Study|Protocol Violation|1|||
33581086|NCT01898286|102017073|FG000|Overall Study|Lost to Follow-up|1|||
33581087|NCT02517398|102017080|FG000|Overall Study|Death|2|||
33581088|NCT02517398|102017081|FG001|Overall Study|Death|3|||
33581089|NCT02517398|102017082|FG002|Overall Study|Death|4|||
33581090|NCT02517398|102017083|FG003|Overall Study|Death|2|||
33581091|NCT02517398|102017084|FG004|Overall Study|Death|3|||
33142708|NCT01426789|100434967|FG002|Part 1|Adverse Event|0|||
33142709|NCT01426789|100434968|FG003|Part 1|Adverse Event|0|||
33142710|NCT01426789|100434969|FG004|Part 1|Adverse Event|0|||
33142711|NCT01426789|100434970|FG005|Part 1|Adverse Event|0|||
33241715|NCT00859014|100786167|FG000|Overall Study|Death|4|||
33241716|NCT00859014|100786167|FG000|Overall Study|Lost to Follow-up|1|||
33371002|NCT00952289|101243602|FG001|All Participants|Death|9|||
33371003|NCT00952289|101243601|FG000|All Participants|Adverse Event|8|||
33581092|NCT02517398|102017085|FG005|Overall Study|Death|8|||
33142712|NCT01426789|100434965|FG000|Part 2|Protocol deviation|0|||
33371004|NCT00952289|101243602|FG001|All Participants|Adverse Event|8|||
33371005|NCT00952289|101243601|FG000|All Participants|Disease progression|3|||
33371006|NCT00952289|101243602|FG001|All Participants|Disease progression|12|||
33142713|NCT01426789|100434966|FG001|Part 2|Protocol deviation|0|||
33142714|NCT01426789|100434967|FG002|Part 2|Protocol deviation|1|||
33142715|NCT01426789|100434968|FG003|Part 2|Protocol deviation|0|||
33371007|NCT00952289|101243601|FG000|All Participants|Withdrawal by Subject|1|||
33581093|NCT02517398|102017086|FG006|Overall Study|Death|3|||
33241717|NCT02368886|100786170|FG000|Overall Study|Cancel|1|||
33241718|NCT02368886|100786171|FG001|Overall Study|Cancel|1|||
33241719|NCT02368886|100786172|FG002|Overall Study|Cancel|1|||
33241720|NCT02368886|100786173|FG003|Overall Study|Cancel|3|||
33241721|NCT02368886|100786170|FG000|Overall Study|Ineligible|0|||
33241722|NCT02368886|100786171|FG001|Overall Study|Ineligible|0|||
33241723|NCT02368886|100786172|FG002|Overall Study|Ineligible|0|||
33241724|NCT02368886|100786173|FG003|Overall Study|Ineligible|1|||
33241725|NCT01140347|100786175|FG000|Overall Study|Lost to Follow-up|5|||
33241726|NCT01140347|100786176|FG001|Overall Study|Lost to Follow-up|6|||
33241727|NCT01140347|100786175|FG000|Overall Study|Withdrawal by Subject|13|||
33241728|NCT01140347|100786176|FG001|Overall Study|Withdrawal by Subject|8|||
33241729|NCT03582137|100786177|FG000|Overall Study|Adverse Event|1|||
33241730|NCT03582137|100786178|FG001|Overall Study|Adverse Event|0|||
33581094|NCT02517398|102017087|FG007|Overall Study|Death|2|||
33581095|NCT02517398|102017088|FG008|Overall Study|Death|6|||
33581096|NCT02517398|102017089|FG009|Overall Study|Death|24|||
33581097|NCT02517398|102017090|FG010|Overall Study|Death|53|||
33581098|NCT02517398|102017091|FG011|Overall Study|Death|25|||
33581099|NCT02517398|102017092|FG012|Overall Study|Death|73|||
33581100|NCT02517398|102017093|FG013|Overall Study|Death|29|||
33581101|NCT02517398|102017094|FG014|Overall Study|Death|26|||
33581102|NCT02517398|102017095|FG015|Overall Study|Death|23|||
33581103|NCT02517398|102017096|FG016|Overall Study|Death|26|||
33581104|NCT02517398|102017097|FG017|Overall Study|Death|25|||
33641421|NCT01918306|102236722|FG003|Overall Study|Withdrawal by Subject|2|||
33641422|NCT01918306|102236719|FG000|Overall Study|neutropenia|1|||
33641423|NCT01918306|102236720|FG001|Overall Study|neutropenia|0|||
33241731|NCT05750745|100786184|FG000|Overall Study|Adverse Event|1|||
33371008|NCT00952289|101243602|FG001|All Participants|Withdrawal by Subject|10|||
33371009|NCT00952289|101243601|FG000|All Participants|Data lost during site relocation|0|||
33641424|NCT01918306|102236721|FG002|Overall Study|neutropenia|0|||
33142716|NCT01426789|100434969|FG004|Part 2|Protocol deviation|0|||
33142717|NCT01426789|100434970|FG005|Part 2|Protocol deviation|0|||
33142718|NCT01426789|100434965|FG000|Part 2|Death|0|||
33142719|NCT01426789|100434966|FG001|Part 2|Death|0|||
33142720|NCT01426789|100434967|FG002|Part 2|Death|1|||
33241732|NCT05750745|100786185|FG001|Overall Study|Adverse Event|0|||
33371010|NCT00952289|101243602|FG001|All Participants|Data lost during site relocation|1|||
33371011|NCT00952289|101243601|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
33371012|NCT00952289|101243602|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
33371013|NCT00952289|101243601|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
33371014|NCT00952289|101243602|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
33371015|NCT00952289|101243601|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
33581105|NCT02517398|102017098|FG018|Overall Study|Death|22|||
33581106|NCT02517398|102017099|FG019|Overall Study|Death|7|||
33581107|NCT02517398|102017100|FG020|Overall Study|Death|26|||
33581108|NCT02517398|102017101|FG021|Overall Study|Death|30|||
33581109|NCT02517398|102017102|FG022|Overall Study|Death|20|||
33581110|NCT02517398|102017080|FG000|Overall Study|Other|0|||
33581111|NCT02517398|102017081|FG001|Overall Study|Other|0|||
33581112|NCT02517398|102017082|FG002|Overall Study|Other|0|||
33641425|NCT01918306|102236722|FG003|Overall Study|neutropenia|0|||
33641426|NCT01918306|102236719|FG000|Overall Study|Lack of Efficacy|1|||
33371016|NCT00952289|101243602|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
33371017|NCT00952289|101243601|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
33371018|NCT00952289|101243602|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
33371019|NCT00952289|101243601|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
33371020|NCT00952289|101243602|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
33581113|NCT02517398|102017083|FG003|Overall Study|Other|1|||
33581114|NCT02517398|102017084|FG004|Overall Study|Other|0|||
33581115|NCT02517398|102017085|FG005|Overall Study|Other|0|||
33641427|NCT01918306|102236720|FG001|Overall Study|Lack of Efficacy|0|||
33641428|NCT01918306|102236721|FG002|Overall Study|Lack of Efficacy|0|||
33641429|NCT01918306|102236722|FG003|Overall Study|Lack of Efficacy|0|||
33142721|NCT01426789|100434968|FG003|Part 2|Death|0|||
33241733|NCT05750745|100786186|FG002|Overall Study|Adverse Event|0|||
33241734|NCT05750745|100786184|FG000|Overall Study|Protocol Violation|1|||
33241735|NCT05750745|100786185|FG001|Overall Study|Protocol Violation|0|||
33641430|NCT01918306|102236719|FG000|Overall Study|progress disease, crossover|0|||
33641431|NCT01918306|102236720|FG001|Overall Study|progress disease, crossover|0|||
33142722|NCT01426789|100434969|FG004|Part 2|Death|1|||
33241736|NCT05750745|100786186|FG002|Overall Study|Protocol Violation|0|||
33241737|NCT05750745|100786184|FG000|Overall Study|Withdrawal by Subject|0|||
33241738|NCT05750745|100786185|FG001|Overall Study|Withdrawal by Subject|1|||
33371021|NCT00786838|101243603|FG000|Overall Study|Physician Decision|4|||
33581116|NCT02517398|102017086|FG006|Overall Study|Other|0|||
33581117|NCT02517398|102017087|FG007|Overall Study|Other|0|||
33581118|NCT02517398|102017088|FG008|Overall Study|Other|0|||
33581119|NCT02517398|102017089|FG009|Overall Study|Other|1|||
33581120|NCT02517398|102017090|FG010|Overall Study|Other|0|||
33641432|NCT01918306|102236721|FG002|Overall Study|progress disease, crossover|1|||
33641433|NCT01918306|102236722|FG003|Overall Study|progress disease, crossover|0|||
33641434|NCT01626872|102240040|FG000|Overall Study|Physician Decision|13|||
33641435|NCT01626872|102240041|FG001|Overall Study|Physician Decision|9|||
33641436|NCT01626872|102240042|FG002|Overall Study|Physician Decision|6|||
33641437|NCT01626872|102240040|FG000|Overall Study|Withdrawal by Subject|19|||
33641438|NCT01626872|102240041|FG001|Overall Study|Withdrawal by Subject|27|||
33641439|NCT01626872|102240042|FG002|Overall Study|Withdrawal by Subject|8|||
33641440|NCT01626872|102240040|FG000|Overall Study|Adverse Event (including Death)|20|||
33641441|NCT01626872|102240041|FG001|Overall Study|Adverse Event (including Death)|28|||
33641442|NCT01626872|102240042|FG002|Overall Study|Adverse Event (including Death)|8|||
33641443|NCT01626872|102240040|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
33641444|NCT01626872|102240041|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
33641445|NCT01626872|102240042|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
33641446|NCT01605799|102240043|FG000|Overall Study|Withdrawal by Subject|2|||
33641447|NCT01605799|102240044|FG001|Overall Study|Withdrawal by Subject|1|||
33641448|NCT03241368|102240047|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
33641449|NCT03241368|102240047|FG000|Overall Study|Lost to Follow-up|1|||
33641450|NCT03241368|102240047|FG000|Overall Study|Physician Decision|6|||
33421415|NCT03276962|101434772|FG003|Overall Study|Protocol Deviation|2|||
33421416|NCT03276962|101434773|FG004|Overall Study|Protocol Deviation|1|||
33421417|NCT03276962|101434769|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
33581121|NCT02517398|102017091|FG011|Overall Study|Other|0|||
33581122|NCT02517398|102017092|FG012|Overall Study|Other|0|||
33581123|NCT02517398|102017093|FG013|Overall Study|Other|1|||
33581124|NCT02517398|102017094|FG014|Overall Study|Other|0|||
33581125|NCT02517398|102017095|FG015|Overall Study|Other|1|||
33581126|NCT02517398|102017096|FG016|Overall Study|Other|1|||
33581127|NCT02517398|102017097|FG017|Overall Study|Other|0|||
33581128|NCT02517398|102017098|FG018|Overall Study|Other|0|||
33581129|NCT02517398|102017099|FG019|Overall Study|Other|1|||
33581130|NCT02517398|102017100|FG020|Overall Study|Other|0|||
33581131|NCT02517398|102017101|FG021|Overall Study|Other|0|||
33641451|NCT03241368|102240047|FG000|Overall Study|Withdrawal by Subject|6|||
33641452|NCT03241368|102240047|FG000|Overall Study|Protocol Violation|1|||
33641453|NCT01528969|102240051|FG000|Overall Study|absent from the school at baseline|2|||
33641454|NCT01528969|102240052|FG001|Overall Study|absent from the school at baseline|0|||
33641455|NCT01276054|102240053|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
33241739|NCT05750745|100786186|FG002|Overall Study|Withdrawal by Subject|0|||
33241740|NCT03168438|100786188|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
33241741|NCT03168438|100786189|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
33241742|NCT00798265|100786192|FG000|Overall Study|Lost to Follow-up|1|||
33241743|NCT00798265|100786193|FG001|Overall Study|Lost to Follow-up|10|||
33241744|NCT00798265|100786192|FG000|Overall Study|Study closing|7|||
33241745|NCT00798265|100786193|FG001|Overall Study|Study closing|6|||
33241746|NCT00798265|100786192|FG000|Overall Study|Withdrawal by Subject|0|||
33371022|NCT00786838|101243603|FG000|Overall Study|Death|4|||
33371023|NCT00786838|101243603|FG000|Overall Study|Adverse Event|6|||
33581132|NCT02517398|102017102|FG022|Overall Study|Other|0|||
33581133|NCT02517398|102017080|FG000|Overall Study|Lost to Follow-up|0|||
33581134|NCT02517398|102017081|FG001|Overall Study|Lost to Follow-up|0|||
33581135|NCT02517398|102017082|FG002|Overall Study|Lost to Follow-up|0|||
33581136|NCT02517398|102017083|FG003|Overall Study|Lost to Follow-up|0|||
33581137|NCT02517398|102017084|FG004|Overall Study|Lost to Follow-up|0|||
33371024|NCT00786838|101243603|FG000|Overall Study|Progressive disease|31|||
33371025|NCT00786838|101243603|FG000|Overall Study|Withdrawal by Subject|4|||
33371026|NCT01193348|101243612|FG000|Screening Period|Screen Failure|5|||
33371027|NCT01193348|101243612|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
33371028|NCT01193348|101243612|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
33371029|NCT01193348|101243612|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
33371030|NCT01193348|101243612|FG000|Extension Treatment Period|Physician Decision|1|||
33581138|NCT02517398|102017085|FG005|Overall Study|Lost to Follow-up|0|||
33581139|NCT02517398|102017086|FG006|Overall Study|Lost to Follow-up|0|||
33581140|NCT02517398|102017087|FG007|Overall Study|Lost to Follow-up|0|||
33641456|NCT01276054|102240054|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
33641457|NCT00993148|102240055|FG000|Overall Study|Lost to Follow-up|2|||
33641458|NCT00993148|102240055|FG000|Overall Study|never initiated treatment|1|||
33641459|NCT01716052|102240059|FG000|Overall Study|Withdrawal of funding|1|||
33641460|NCT01716052|102240060|FG001|Overall Study|Withdrawal of funding|1|||
33241747|NCT00798265|100786193|FG001|Overall Study|Withdrawal by Subject|1|||
33371031|NCT01193348|101243612|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
33581141|NCT02517398|102017088|FG008|Overall Study|Lost to Follow-up|0|||
33581142|NCT02517398|102017089|FG009|Overall Study|Lost to Follow-up|1|||
33581143|NCT02517398|102017090|FG010|Overall Study|Lost to Follow-up|0|||
33581144|NCT02517398|102017091|FG011|Overall Study|Lost to Follow-up|2|||
33581145|NCT02517398|102017092|FG012|Overall Study|Lost to Follow-up|2|||
33241748|NCT00798265|100786192|FG000|Overall Study|Screen failure|0|||
33581146|NCT02517398|102017093|FG013|Overall Study|Lost to Follow-up|0|||
33581147|NCT02517398|102017094|FG014|Overall Study|Lost to Follow-up|1|||
33241749|NCT00798265|100786193|FG001|Overall Study|Screen failure|1|||
33241750|NCT05177848|100786194|FG000|Overall Study|Lost to Follow-up|1|||
33241751|NCT05177848|100786195|FG001|Overall Study|Lost to Follow-up|4|||
33241752|NCT05177848|100786194|FG000|Overall Study|Discontinued|2|||
33241753|NCT05177848|100786195|FG001|Overall Study|Discontinued|1|||
33241754|NCT05008224|100786202|FG000|Overall Study|Death|3|||
33241755|NCT05008224|100786202|FG000|Overall Study|Lost to Follow-up|2|||
33241756|NCT05008224|100786202|FG000|Overall Study|Did Not Continue on Extension Study|39|||
33241757|NCT05008224|100786202|FG000|Overall Study|Transferred to Extension Study|100|||
33241758|NCT05008224|100786202|FG000|Overall Study|Withdrawal by Subject|2|||
33241759|NCT01556243|100786203|FG000|Overall Study|Ineligible|34|||
33241760|NCT01556243|100786203|FG000|Overall Study|Converted to mastectomy|14|||
33241761|NCT01556243|100786203|FG000|Overall Study|Unable to achieve negative margins|2|||
33241762|NCT01556243|100786203|FG000|Overall Study|Withdrawal by Subject|16|||
33241763|NCT04794179|100786204|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
33241764|NCT04794179|100786205|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
33241765|NCT01764386|100786206|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
33241766|NCT01764386|100786207|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
33371032|NCT02566525|101243613|FG000|Overall Study|Protocol Violation|3|||
33371033|NCT02566525|101243614|FG001|Overall Study|Protocol Violation|5|||
33581148|NCT02517398|102017095|FG015|Overall Study|Lost to Follow-up|1|||
33581149|NCT02517398|102017096|FG016|Overall Study|Lost to Follow-up|0|||
33581150|NCT02517398|102017097|FG017|Overall Study|Lost to Follow-up|3|||
33581151|NCT02517398|102017098|FG018|Overall Study|Lost to Follow-up|1|||
33581152|NCT02517398|102017099|FG019|Overall Study|Lost to Follow-up|0|||
33581153|NCT02517398|102017100|FG020|Overall Study|Lost to Follow-up|1|||
33581154|NCT02517398|102017101|FG021|Overall Study|Lost to Follow-up|0|||
33581155|NCT02517398|102017102|FG022|Overall Study|Lost to Follow-up|2|||
33581156|NCT02517398|102017080|FG000|Overall Study|Withdrew Consent|0|||
33581157|NCT02517398|102017081|FG001|Overall Study|Withdrew Consent|0|||
33581158|NCT02517398|102017082|FG002|Overall Study|Withdrew Consent|0|||
33581159|NCT02517398|102017083|FG003|Overall Study|Withdrew Consent|0|||
33581160|NCT02517398|102017084|FG004|Overall Study|Withdrew Consent|0|||
33581161|NCT02517398|102017085|FG005|Overall Study|Withdrew Consent|0|||
33581162|NCT02517398|102017086|FG006|Overall Study|Withdrew Consent|1|||
33142723|NCT01426789|100434970|FG005|Part 2|Death|0|||
33142724|NCT01426789|100434965|FG000|Part 2|Administrative problems|0|||
33142725|NCT01426789|100434966|FG001|Part 2|Administrative problems|0|||
33142726|NCT01426789|100434967|FG002|Part 2|Administrative problems|2|||
33142727|NCT01426789|100434968|FG003|Part 2|Administrative problems|0|||
33142728|NCT01426789|100434969|FG004|Part 2|Administrative problems|1|||
33142729|NCT01426789|100434970|FG005|Part 2|Administrative problems|0|||
33142730|NCT01426789|100434965|FG000|Part 2|Lost to Follow-up|0|||
33142731|NCT01426789|100434966|FG001|Part 2|Lost to Follow-up|0|||
33142732|NCT01426789|100434967|FG002|Part 2|Lost to Follow-up|4|||
33142733|NCT01426789|100434968|FG003|Part 2|Lost to Follow-up|0|||
33142734|NCT01426789|100434969|FG004|Part 2|Lost to Follow-up|1|||
33142735|NCT01426789|100434970|FG005|Part 2|Lost to Follow-up|0|||
33142736|NCT01426789|100434965|FG000|Part 2|Withdrawal by Subject|0|||
33142737|NCT01426789|100434966|FG001|Part 2|Withdrawal by Subject|0|||
33142738|NCT01426789|100434967|FG002|Part 2|Withdrawal by Subject|0|||
33142739|NCT01426789|100434968|FG003|Part 2|Withdrawal by Subject|1|||
33142740|NCT01426789|100434969|FG004|Part 2|Withdrawal by Subject|2|||
33142741|NCT01426789|100434970|FG005|Part 2|Withdrawal by Subject|0|||
33142742|NCT01426789|100434965|FG000|Part 2|Lack of Efficacy|0|||
33142743|NCT01426789|100434966|FG001|Part 2|Lack of Efficacy|0|||
33142744|NCT01426789|100434967|FG002|Part 2|Lack of Efficacy|5|||
33142745|NCT01426789|100434968|FG003|Part 2|Lack of Efficacy|0|||
33142746|NCT01426789|100434969|FG004|Part 2|Lack of Efficacy|2|||
33142747|NCT01426789|100434970|FG005|Part 2|Lack of Efficacy|0|||
33142748|NCT01426789|100434965|FG000|Part 2|Adverse Event|0|||
33142749|NCT01426789|100434966|FG001|Part 2|Adverse Event|0|||
33142750|NCT01426789|100434967|FG002|Part 2|Adverse Event|2|||
33142751|NCT01426789|100434968|FG003|Part 2|Adverse Event|0|||
33142752|NCT01426789|100434969|FG004|Part 2|Adverse Event|1|||
33142753|NCT01426789|100434970|FG005|Part 2|Adverse Event|0|||
33142754|NCT00089674|100438256|FG000|Overall Study|Physician Decision|4|||
33142755|NCT00089674|100438257|FG001|Overall Study|Physician Decision|2|||
33142756|NCT00089674|100438256|FG000|Overall Study|Adverse Event|23|||
33142757|NCT00089674|100438257|FG001|Overall Study|Adverse Event|29|||
33142758|NCT00089674|100438256|FG000|Overall Study|Withdrawal by Subject|143|||
33142759|NCT00089674|100438257|FG001|Overall Study|Withdrawal by Subject|127|||
33142760|NCT00089674|100438256|FG000|Overall Study|Death|43|||
33142761|NCT00089674|100438257|FG001|Overall Study|Death|43|||
33142762|NCT00089674|100438256|FG000|Overall Study|Disease progression|21|||
33142763|NCT00089674|100438257|FG001|Overall Study|Disease progression|23|||
33142764|NCT00089674|100438256|FG000|Overall Study|Ineligibility determined|8|||
33142765|NCT00089674|100438257|FG001|Overall Study|Ineligibility determined|10|||
33241767|NCT01764386|100786206|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
33241768|NCT01764386|100786207|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
33241769|NCT01764386|100786206|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
33241770|NCT01764386|100786207|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
33241771|NCT01764386|100786206|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
33241772|NCT01764386|100786207|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
33241773|NCT01764386|100786206|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
33241774|NCT01764386|100786207|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
33371034|NCT01079962|101243621|FG000|Overall Study|Adverse Event|2|||
33371035|NCT01079962|101243622|FG001|Overall Study|Adverse Event|2|||
33371036|NCT01079962|101243621|FG000|Overall Study|Withdrawal by Subject|5|||
33371037|NCT01079962|101243622|FG001|Overall Study|Withdrawal by Subject|7|||
33371038|NCT01079962|101243621|FG000|Overall Study|Protocol Violation|2|||
33371039|NCT01079962|101243622|FG001|Overall Study|Protocol Violation|2|||
33371040|NCT01079962|101243621|FG000|Overall Study|No blood pressure (BP) control|3|||
33371041|NCT01079962|101243622|FG001|Overall Study|No blood pressure (BP) control|0|||
33371042|NCT01079962|101243621|FG000|Overall Study|Inclusion/exclusion criteria|1|||
33371043|NCT01079962|101243622|FG001|Overall Study|Inclusion/exclusion criteria|3|||
33371044|NCT01079962|101243621|FG000|Overall Study|Participant not returning for next visit|1|||
33371045|NCT01079962|101243622|FG001|Overall Study|Participant not returning for next visit|0|||
33371046|NCT01079962|101243621|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
33371047|NCT01079962|101243622|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
33142766|NCT00089674|100438256|FG000|Overall Study|Lost to Follow-up|21|||
33142767|NCT00089674|100438257|FG001|Overall Study|Lost to Follow-up|17|||
33142768|NCT00089674|100438256|FG000|Overall Study|Noncompliance|7|||
33142769|NCT00089674|100438257|FG001|Overall Study|Noncompliance|3|||
33142770|NCT00089674|100438256|FG000|Overall Study|Other|5|||
33142771|NCT00089674|100438257|FG001|Overall Study|Other|9|||
33142772|NCT00089674|100438256|FG000|Overall Study|Requirement for alternative therapy|14|||
33142773|NCT00089674|100438257|FG001|Overall Study|Requirement for alternative therapy|4|||
33142774|NCT01011478|100438258|FG000|Overall Study|No follow up data|12|||
33142775|NCT01011478|100438259|FG001|Overall Study|No follow up data|7|||
33142776|NCT03123185|100438260|FG000|Overall Study|Withdrawal by Subject|0|||
33142777|NCT03123185|100438261|FG001|Overall Study|Withdrawal by Subject|0|||
33142778|NCT03123185|100438262|FG002|Overall Study|Withdrawal by Subject|0|||
33142779|NCT03123185|100438263|FG003|Overall Study|Withdrawal by Subject|0|||
33142780|NCT03123185|100438264|FG004|Overall Study|Withdrawal by Subject|0|||
33142781|NCT03123185|100438265|FG005|Overall Study|Withdrawal by Subject|0|||
33142782|NCT03123185|100438266|FG006|Overall Study|Withdrawal by Subject|0|||
33142783|NCT03123185|100438267|FG007|Overall Study|Withdrawal by Subject|0|||
33142784|NCT03123185|100438268|FG008|Overall Study|Withdrawal by Subject|0|||
33142785|NCT03123185|100438269|FG009|Overall Study|Withdrawal by Subject|0|||
33142786|NCT03123185|100438270|FG010|Overall Study|Withdrawal by Subject|0|||
33142787|NCT03123185|100438271|FG011|Overall Study|Withdrawal by Subject|0|||
33142788|NCT03123185|100438272|FG012|Overall Study|Withdrawal by Subject|1|||
33142789|NCT03123185|100438273|FG013|Overall Study|Withdrawal by Subject|0|||
33142790|NCT00667446|100438274|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
33142791|NCT00667446|100438275|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
33142792|NCT00667446|100438274|FG000|Treatment Period (36 Months)|Other|2|||
33142793|NCT00667446|100438275|FG001|Treatment Period (36 Months)|Other|2|||
33142794|NCT00667446|100438274|FG000|Treatment Period (36 Months)|Personal reasons|2|||
33142795|NCT00667446|100438275|FG001|Treatment Period (36 Months)|Personal reasons|2|||
33142796|NCT00667446|100438274|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
33142797|NCT00667446|100438275|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
33142798|NCT00667446|100438274|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
33142799|NCT00667446|100438275|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
33142800|NCT00667446|100438274|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
33142801|NCT00667446|100438275|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
33142802|NCT00667446|100438274|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
33142803|NCT00667446|100438275|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
33142804|NCT00667446|100438274|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
33142805|NCT00667446|100438275|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
33142806|NCT00667446|100438274|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
33142807|NCT00667446|100438275|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
33142808|NCT02101112|100438276|FG000|Overall Study|Adverse Event|0|||
33142809|NCT02101112|100438277|FG001|Overall Study|Adverse Event|0|||
33142810|NCT02101112|100438278|FG002|Overall Study|Adverse Event|1|||
33142811|NCT02101112|100438279|FG003|Overall Study|Adverse Event|0|||
33142812|NCT02101112|100438280|FG004|Overall Study|Adverse Event|0|||
33241775|NCT01764386|100786206|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
33241776|NCT01764386|100786207|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
33241777|NCT01764386|100786206|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
33241778|NCT01764386|100786207|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
33241779|NCT01764386|100786206|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
33241780|NCT01764386|100786207|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
33241781|NCT01167023|100786210|FG000|Overall Study|Lost to Follow-up|0|||
33241782|NCT01167023|100786211|FG001|Overall Study|Lost to Follow-up|1|||
33241783|NCT01167023|100786212|FG002|Overall Study|Lost to Follow-up|1|||
33241784|NCT01167023|100786210|FG000|Overall Study|Screen Failure|0|||
33241785|NCT01167023|100786211|FG001|Overall Study|Screen Failure|1|||
33241786|NCT01167023|100786212|FG002|Overall Study|Screen Failure|0|||
33241787|NCT01167023|100786210|FG000|Overall Study|Sponsor Decision|0|||
33241788|NCT01167023|100786211|FG001|Overall Study|Sponsor Decision|1|||
33241789|NCT01167023|100786212|FG002|Overall Study|Sponsor Decision|0|||
33241790|NCT01167023|100786210|FG000|Overall Study|Withdrawal by Subject|0|||
33581163|NCT02517398|102017087|FG007|Overall Study|Withdrew Consent|0|||
33581164|NCT02517398|102017088|FG008|Overall Study|Withdrew Consent|0|||
33581165|NCT02517398|102017089|FG009|Overall Study|Withdrew Consent|2|||
33581166|NCT02517398|102017090|FG010|Overall Study|Withdrew Consent|7|||
33241791|NCT01167023|100786211|FG001|Overall Study|Withdrawal by Subject|0|||
33241792|NCT01167023|100786212|FG002|Overall Study|Withdrawal by Subject|1|||
33241793|NCT03432533|100786215|FG000|Overall Study|Lost to Follow-up|1|||
33241794|NCT03432533|100786216|FG001|Overall Study|Lost to Follow-up|2|||
33241795|NCT03432533|100786215|FG000|Overall Study|Withdrawal by Subject|14|||
33241796|NCT03432533|100786216|FG001|Overall Study|Withdrawal by Subject|9|||
33241797|NCT01094171|100786217|FG000|Overall Study|Lost to Follow-up|2|||
33241798|NCT01094171|100786217|FG000|Overall Study|Informed consent withdrawal|4|||
33241799|NCT01094171|100786217|FG000|Overall Study|Migration from the study area|3|||
33241800|NCT01094171|100786217|FG000|Overall Study|Other|1|||
33241801|NCT03568461|100786220|FG000|Overall Study|Death|7|||
33241802|NCT03568461|100786220|FG000|Overall Study|Physician Decision|5|||
33241803|NCT03568461|100786220|FG000|Overall Study|Subject decision|5|||
33241804|NCT03568461|100786220|FG000|Overall Study|Lost to Follow-up|1|||
33241805|NCT01687270|100786222|FG000|Overall Study|Lack of Efficacy|11|||
33241806|NCT01687270|100786222|FG000|Overall Study|Lost to Follow-up|1|||
33241807|NCT01575860|100786223|FG000|Overall Study|Withdrawal by Subject|1|||
33241808|NCT01575860|100786223|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
33371048|NCT00603980|101243624|FG000|Study Qualification|Protocol Violation|3|||
33371049|NCT00603980|101243624|FG000|Study Qualification|Inconsistent data reporting|13|||
33371050|NCT00603980|101243624|FG000|Main Study|14th subject completed trial|1|||
33371051|NCT01952834|101243629|FG000|Overall Study|Adverse Event|1|||
33371052|NCT02427477|101243630|FG000|Period 1|Adverse Event|1|||
33371053|NCT02427477|101243631|FG001|Period 1|Adverse Event|0|||
33371054|NCT01258348|101243634|FG000|Overall Study|Adverse Event|1|||
33581167|NCT02517398|102017091|FG011|Overall Study|Withdrew Consent|1|||
33142813|NCT02101112|100438281|FG005|Overall Study|Adverse Event|0|||
33581168|NCT02517398|102017092|FG012|Overall Study|Withdrew Consent|5|||
33581169|NCT02517398|102017093|FG013|Overall Study|Withdrew Consent|4|||
33142814|NCT02101112|100438276|FG000|Overall Study|Withdrawal by Subject|0|||
33142815|NCT02101112|100438277|FG001|Overall Study|Withdrawal by Subject|0|||
33142816|NCT02101112|100438278|FG002|Overall Study|Withdrawal by Subject|0|||
33142817|NCT02101112|100438279|FG003|Overall Study|Withdrawal by Subject|0|||
33142818|NCT02101112|100438280|FG004|Overall Study|Withdrawal by Subject|1|||
33142819|NCT02101112|100438281|FG005|Overall Study|Withdrawal by Subject|0|||
33142820|NCT01350544|100438282|FG000|Overall Study|Administrative Withdrawal|0|||
33142821|NCT01350544|100438283|FG001|Overall Study|Administrative Withdrawal|1|||
33142822|NCT01350544|100438282|FG000|Overall Study|Death|1|||
33142823|NCT01350544|100438283|FG001|Overall Study|Death|2|||
33142824|NCT01350544|100438282|FG000|Overall Study|Moved out of LA County|2|||
33142825|NCT01350544|100438283|FG001|Overall Study|Moved out of LA County|2|||
33142826|NCT01350544|100438282|FG000|Overall Study|Medical Issues|1|||
33142827|NCT01350544|100438283|FG001|Overall Study|Medical Issues|1|||
33371055|NCT01258348|101243635|FG001|Overall Study|Adverse Event|1|||
33581170|NCT02517398|102017094|FG014|Overall Study|Withdrew Consent|2|||
33241809|NCT01890967|100786224|FG000|Overall Study|Adverse Event|3|||
33241810|NCT01890967|100786225|FG001|Overall Study|Adverse Event|3|||
33241811|NCT01890967|100786226|FG002|Overall Study|Adverse Event|3|||
33241812|NCT01890967|100786227|FG003|Overall Study|Adverse Event|2|||
33581171|NCT02517398|102017095|FG015|Overall Study|Withdrew Consent|5|||
33241813|NCT01890967|100786228|FG004|Overall Study|Adverse Event|1|||
33371056|NCT01258348|101243636|FG002|Overall Study|Adverse Event|3|||
33371057|NCT01258348|101243637|FG003|Overall Study|Adverse Event|2|||
33581172|NCT02517398|102017096|FG016|Overall Study|Withdrew Consent|4|||
33581173|NCT02517398|102017097|FG017|Overall Study|Withdrew Consent|2|||
33142828|NCT01350544|100438282|FG000|Overall Study|Withdrawal by Subject|0|||
33241814|NCT01890967|100786229|FG005|Overall Study|Adverse Event|7|||
33581174|NCT02517398|102017098|FG018|Overall Study|Withdrew Consent|3|||
33581175|NCT02517398|102017099|FG019|Overall Study|Withdrew Consent|2|||
33581176|NCT02517398|102017100|FG020|Overall Study|Withdrew Consent|9|||
33581177|NCT02517398|102017101|FG021|Overall Study|Withdrew Consent|3|||
33581178|NCT02517398|102017102|FG022|Overall Study|Withdrew Consent|1|||
33581179|NCT02122146|102017103|FG000|Part 1: Dose Escalation|Death|0|||
33581180|NCT02122146|102017104|FG001|Part 1: Dose Escalation|Death|1|||
33581181|NCT02122146|102017105|FG002|Part 1: Dose Escalation|Death|1|||
33581182|NCT02122146|102017106|FG003|Part 1: Dose Escalation|Death|0|||
33581183|NCT02122146|102017107|FG004|Part 1: Dose Escalation|Death|0|||
33581184|NCT02122146|102017108|FG005|Part 1: Dose Escalation|Death|0|||
33581185|NCT02122146|102017109|FG006|Part 1: Dose Escalation|Death|0|||
33581186|NCT02122146|102017110|FG007|Part 1: Dose Escalation|Death|0|||
33581187|NCT02122146|102017103|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
33581188|NCT02122146|102017104|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
33581189|NCT02122146|102017105|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
33581190|NCT02122146|102017106|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
33581191|NCT02122146|102017107|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
33581192|NCT02122146|102017108|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
33581193|NCT02122146|102017109|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
33581194|NCT02122146|102017110|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
33641461|NCT02223858|102240061|FG000|Overall Study|Death|1|||
33641462|NCT02223858|102240062|FG001|Overall Study|Death|1|||
33641463|NCT02223858|102240061|FG000|Overall Study|Lost to Follow-up|6|||
33641464|NCT02223858|102240062|FG001|Overall Study|Lost to Follow-up|11|||
33641465|NCT02223858|102240061|FG000|Overall Study|Withdrawal by Subject|8|||
33641466|NCT02223858|102240062|FG001|Overall Study|Withdrawal by Subject|5|||
33641467|NCT02223858|102240061|FG000|Overall Study|Refused|9|||
33641468|NCT02223858|102240062|FG001|Overall Study|Refused|9|||
33641469|NCT02379637|102240063|FG000|Overall Study|Protocol Violation|0|||
33641470|NCT02379637|102240064|FG001|Overall Study|Protocol Violation|1|||
33641471|NCT02379637|102240063|FG000|Overall Study|Adverse Event|1|||
33641472|NCT02379637|102240064|FG001|Overall Study|Adverse Event|0|||
33641473|NCT02379637|102240063|FG000|Overall Study|Withdrawal by Subject|1|||
33641474|NCT02379637|102240064|FG001|Overall Study|Withdrawal by Subject|0|||
33641475|NCT03599089|102240065|FG000|Overall Study|Lost to Follow-up|1|||
33641476|NCT03599089|102240066|FG001|Overall Study|Lost to Follow-up|0|||
33641477|NCT03599089|102240067|FG002|Overall Study|Lost to Follow-up|0|||
33641478|NCT03599089|102240068|FG003|Overall Study|Lost to Follow-up|0|||
33641479|NCT03599089|102240065|FG000|Overall Study|Withdrawal by Subject|2|||
33641480|NCT03599089|102240066|FG001|Overall Study|Withdrawal by Subject|1|||
33641481|NCT03599089|102240067|FG002|Overall Study|Withdrawal by Subject|0|||
33641482|NCT03599089|102240068|FG003|Overall Study|Withdrawal by Subject|0|||
33641483|NCT03599089|102240065|FG000|Overall Study|Lack of Efficacy|0|||
33641484|NCT03599089|102240066|FG001|Overall Study|Lack of Efficacy|0|||
33641485|NCT03599089|102240067|FG002|Overall Study|Lack of Efficacy|1|||
33641486|NCT03599089|102240068|FG003|Overall Study|Lack of Efficacy|2|||
33641487|NCT01011309|102240069|FG000|Overall Study|Adverse Event|2|||
33641488|NCT01011309|102240070|FG001|Overall Study|Adverse Event|1|||
33641489|NCT01011309|102240071|FG002|Overall Study|Adverse Event|2|||
33641490|NCT01011309|102240069|FG000|Overall Study|Lack of Efficacy|0|||
33641491|NCT01011309|102240070|FG001|Overall Study|Lack of Efficacy|1|||
33142829|NCT01350544|100438283|FG001|Overall Study|Withdrawal by Subject|1|||
33142830|NCT01350544|100438282|FG000|Overall Study|Incarceration|1|||
33142831|NCT01350544|100438283|FG001|Overall Study|Incarceration|0|||
33142832|NCT01350544|100438282|FG000|Overall Study|Lost to Follow-up|18|||
33142833|NCT01350544|100438283|FG001|Overall Study|Lost to Follow-up|15|||
33142834|NCT01461057|100438286|FG000|Overall Study|Death|10|||
33142835|NCT01461057|100438287|FG001|Overall Study|Death|9|||
33371058|NCT01258348|101243638|FG004|Overall Study|Adverse Event|4|||
33371059|NCT01258348|101243634|FG000|Overall Study|Progressive Disease|0|||
33371060|NCT01258348|101243635|FG001|Overall Study|Progressive Disease|3|||
33581195|NCT02122146|102017103|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33581196|NCT02122146|102017104|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33581197|NCT02122146|102017105|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33581198|NCT02122146|102017106|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
33581199|NCT02122146|102017107|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33581200|NCT02122146|102017108|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33581201|NCT02122146|102017109|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33581202|NCT02122146|102017110|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33641492|NCT01011309|102240071|FG002|Overall Study|Lack of Efficacy|0|||
33641493|NCT01011309|102240069|FG000|Overall Study|Protocol Violation|0|||
33641494|NCT01011309|102240070|FG001|Overall Study|Protocol Violation|1|||
33641495|NCT01011309|102240071|FG002|Overall Study|Protocol Violation|3|||
33641496|NCT02904954|102240072|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
33641497|NCT02904954|102240073|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
33142836|NCT01461057|100438286|FG000|Overall Study|Withdrawal by Subject|2|||
33641498|NCT02904954|102240072|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
33421418|NCT03276962|101434770|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
33421419|NCT03276962|101434771|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
33421420|NCT03276962|101434772|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
33421421|NCT03276962|101434773|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
33421422|NCT03276962|101434769|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
33421423|NCT03276962|101434770|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
33421424|NCT03276962|101434771|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
33421425|NCT03276962|101434772|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
33421426|NCT03276962|101434773|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
33421427|NCT03276962|101434769|FG000|Overall Study|Lost to Follow-up|10|||
33421428|NCT03276962|101434770|FG001|Overall Study|Lost to Follow-up|10|||
33421429|NCT03276962|101434771|FG002|Overall Study|Lost to Follow-up|4|||
33421430|NCT03276962|101434772|FG003|Overall Study|Lost to Follow-up|6|||
33421431|NCT03276962|101434773|FG004|Overall Study|Lost to Follow-up|10|||
33421432|NCT03276962|101434769|FG000|Overall Study|Other|0|||
33421433|NCT03276962|101434770|FG001|Overall Study|Other|2|||
33421434|NCT03276962|101434771|FG002|Overall Study|Other|0|||
33421435|NCT03276962|101434772|FG003|Overall Study|Other|2|||
33421436|NCT03276962|101434773|FG004|Overall Study|Other|1|||
33421437|NCT00068445|101434774|FG000|Randomization|Cancel|1|||
33421438|NCT00068445|101434775|FG001|Randomization|Cancel|3|||
33421439|NCT00068445|101434774|FG000|Randomization|Ineligible|1|||
33421440|NCT00068445|101434775|FG001|Randomization|Ineligible|1|||
33421441|NCT00068445|101434774|FG000|Treatment|Refused Further Treatment|13|||
33421442|NCT00068445|101434775|FG001|Treatment|Refused Further Treatment|10|||
33421443|NCT00068445|101434774|FG000|Treatment|Adverse Event|7|||
33421444|NCT00068445|101434775|FG001|Treatment|Adverse Event|1|||
33421445|NCT00068445|101434774|FG000|Treatment|Other (Specifics not available)|9|||
33421446|NCT00068445|101434775|FG001|Treatment|Other (Specifics not available)|5|||
33421447|NCT02237118|101434776|FG000|Overall Study|Protocol Violation|0|||
33421448|NCT02237118|101434777|FG001|Overall Study|Protocol Violation|1|||
33421449|NCT02237118|101434776|FG000|Overall Study|consent withdrawn|1|||
33421450|NCT02237118|101434777|FG001|Overall Study|consent withdrawn|0|||
33421451|NCT04701658|101434778|FG000|Overall Study|Lost to Follow-up|6|||
33421452|NCT00990093|101434779|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
33421453|NCT00990093|101434780|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
33641499|NCT02904954|102240073|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
33641500|NCT02904954|102240072|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
33641501|NCT02904954|102240073|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
33371061|NCT01258348|101243636|FG002|Overall Study|Progressive Disease|0|||
33371062|NCT01258348|101243637|FG003|Overall Study|Progressive Disease|2|||
33371063|NCT01258348|101243638|FG004|Overall Study|Progressive Disease|2|||
33371064|NCT01258348|101243634|FG000|Overall Study|Physician Decision|0|||
33371065|NCT01258348|101243635|FG001|Overall Study|Physician Decision|0|||
33371066|NCT01258348|101243636|FG002|Overall Study|Physician Decision|0|||
33371067|NCT01258348|101243637|FG003|Overall Study|Physician Decision|2|||
33371068|NCT01258348|101243638|FG004|Overall Study|Physician Decision|0|||
33371069|NCT01258348|101243634|FG000|Overall Study|Withdrawal by Subject|0|||
33371070|NCT01258348|101243635|FG001|Overall Study|Withdrawal by Subject|1|||
33371071|NCT01258348|101243636|FG002|Overall Study|Withdrawal by Subject|0|||
33371072|NCT01258348|101243637|FG003|Overall Study|Withdrawal by Subject|0|||
33371073|NCT01258348|101243638|FG004|Overall Study|Withdrawal by Subject|0|||
33371074|NCT02417233|101243639|FG000|Overall Study|Death|4|||
33371075|NCT02417233|101243640|FG001|Overall Study|Death|10|||
33371076|NCT02417233|101243641|FG002|Overall Study|Death|14|||
33371077|NCT02417233|101243639|FG000|Overall Study|Lost to Follow-up|27|||
33371078|NCT02417233|101243640|FG001|Overall Study|Lost to Follow-up|39|||
33371079|NCT02417233|101243641|FG002|Overall Study|Lost to Follow-up|34|||
33421454|NCT00990093|101434779|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
33421455|NCT00990093|101434780|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
33421456|NCT00990093|101434779|FG000|Test Period 1 (1-14 Days)|Other|1|||
33421457|NCT00990093|101434780|FG001|Test Period 1 (1-14 Days)|Other|0|||
33421458|NCT00990093|101434779|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
33421459|NCT00990093|101434780|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
33641502|NCT02904954|102240072|FG000|Adjuvant Durvalumab|Recurrence|2|||
33641503|NCT02904954|102240073|FG001|Adjuvant Durvalumab|Recurrence|0|||
33142837|NCT01461057|100438287|FG001|Overall Study|Withdrawal by Subject|3|||
33421460|NCT00990093|101434779|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
33421461|NCT00990093|101434780|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
33641504|NCT02904954|102240072|FG000|Adjuvant Durvalumab|Adverse Event|2|||
33371080|NCT02417233|101243639|FG000|Overall Study|Protocol Violation|2|||
33371081|NCT02417233|101243640|FG001|Overall Study|Protocol Violation|0|||
33371082|NCT02417233|101243641|FG002|Overall Study|Protocol Violation|2|||
33371083|NCT02417233|101243639|FG000|Overall Study|Withdrawal by Subject|2|||
33371084|NCT02417233|101243640|FG001|Overall Study|Withdrawal by Subject|1|||
33371085|NCT02417233|101243641|FG002|Overall Study|Withdrawal by Subject|8|||
33421462|NCT00990093|101434779|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
33421463|NCT00990093|101434780|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
33421464|NCT00990093|101434779|FG000|Test Period 2 (15-28 Days)|Other|0|||
33421465|NCT00990093|101434780|FG001|Test Period 2 (15-28 Days)|Other|1|||
33421466|NCT00068406|101434787|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
33421467|NCT00068406|101434787|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
33581203|NCT02122146|102017103|FG000|Part 1: Dose Escalation|Other|1|||
33641505|NCT02904954|102240073|FG001|Adjuvant Durvalumab|Adverse Event|6|||
33641506|NCT02904954|102240072|FG000|Adjuvant Durvalumab|Participant wishes|12|||
33641507|NCT02904954|102240073|FG001|Adjuvant Durvalumab|Participant wishes|7|||
33641508|NCT02904954|102240072|FG000|Adjuvant Durvalumab|Physician Decision|2|||
33641509|NCT02904954|102240073|FG001|Adjuvant Durvalumab|Physician Decision|1|||
33641510|NCT02904954|102240072|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
33641511|NCT02904954|102240073|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
33641512|NCT02904954|102240072|FG000|Adjuvant Durvalumab|Death|0|||
33641513|NCT02904954|102240073|FG001|Adjuvant Durvalumab|Death|1|||
33641514|NCT02904954|102240072|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
33641515|NCT02904954|102240073|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
33142838|NCT01461057|100438286|FG000|Overall Study|Physician Decision|0|||
33142839|NCT01461057|100438287|FG001|Overall Study|Physician Decision|2|||
33142840|NCT01461057|100438286|FG000|Overall Study|Adverse Event|0|||
33142841|NCT01461057|100438287|FG001|Overall Study|Adverse Event|1|||
33142842|NCT01461057|100438286|FG000|Overall Study|Progression of Disease|1|||
33142843|NCT01461057|100438287|FG001|Overall Study|Progression of Disease|0|||
33142844|NCT01461057|100438286|FG000|Overall Study|Study Terminated by Sponsor|2|||
33142845|NCT01461057|100438287|FG001|Overall Study|Study Terminated by Sponsor|0|||
33142846|NCT00397943|100438288|FG000|Overall Study|Unspecified reasons|12|||
33142847|NCT00397943|100438289|FG001|Overall Study|Unspecified reasons|9|||
33142848|NCT00397943|100438290|FG002|Overall Study|Unspecified reasons|0|||
33142849|NCT00397943|100438291|FG003|Overall Study|Unspecified reasons|0|||
33142850|NCT00397943|100438292|FG004|Overall Study|Unspecified reasons|0|||
33142851|NCT03188042|100438293|FG000|Overall Study|Withdrawal by Subject|1|||
33142852|NCT03188042|100438294|FG001|Overall Study|Withdrawal by Subject|1|||
33241815|NCT01890967|100786224|FG000|Overall Study|Death|1|||
33241816|NCT01890967|100786225|FG001|Overall Study|Death|0|||
33241817|NCT01890967|100786226|FG002|Overall Study|Death|0|||
33241818|NCT01890967|100786227|FG003|Overall Study|Death|0|||
33241819|NCT01890967|100786228|FG004|Overall Study|Death|0|||
33241820|NCT01890967|100786229|FG005|Overall Study|Death|0|||
33241821|NCT01890967|100786224|FG000|Overall Study|Lost to Follow-up|1|||
33241822|NCT01890967|100786225|FG001|Overall Study|Lost to Follow-up|1|||
33241823|NCT01890967|100786226|FG002|Overall Study|Lost to Follow-up|1|||
33241824|NCT01890967|100786227|FG003|Overall Study|Lost to Follow-up|1|||
33371086|NCT02417233|101243639|FG000|Overall Study|Relocation out of study area|1|||
33371087|NCT02417233|101243640|FG001|Overall Study|Relocation out of study area|0|||
33371088|NCT02417233|101243641|FG002|Overall Study|Relocation out of study area|1|||
33371089|NCT02417233|101243639|FG000|Overall Study|Mentally unstable|0|||
33371090|NCT02417233|101243640|FG001|Overall Study|Mentally unstable|1|||
33371091|NCT02417233|101243641|FG002|Overall Study|Mentally unstable|0|||
33371092|NCT03599141|101243644|FG000|Overall Study|Lost to Follow-up|3|||
33371093|NCT03599141|101243645|FG001|Overall Study|Lost to Follow-up|1|||
33371094|NCT05373706|101243650|FG000|Overall Study|Lost to Follow-up|2|||
33371095|NCT05373706|101243651|FG001|Overall Study|Lost to Follow-up|2|||
33371096|NCT01468909|101243652|FG000|Overall Study|Never Treated|2|||
33371097|NCT01468909|101243653|FG001|Overall Study|Never Treated|2|||
33371098|NCT01187901|101243654|FG000|Overall Study|Protocol Violation|1|||
33371099|NCT01187901|101243655|FG001|Overall Study|Protocol Violation|0|||
33371100|NCT01187901|101243654|FG000|Overall Study|Lost to Follow-up|1|||
33371101|NCT01187901|101243655|FG001|Overall Study|Lost to Follow-up|2|||
33371102|NCT01187901|101243654|FG000|Overall Study|Unrelated Health Reasons|1|||
33371103|NCT01187901|101243655|FG001|Overall Study|Unrelated Health Reasons|2|||
33371104|NCT01187901|101243654|FG000|Overall Study|Suspected Allergic Reaction|1|||
33371105|NCT01187901|101243655|FG001|Overall Study|Suspected Allergic Reaction|1|||
33371106|NCT01187901|101243654|FG000|Overall Study|Adverse Event|3|||
33371107|NCT01187901|101243655|FG001|Overall Study|Adverse Event|0|||
33371108|NCT01187901|101243654|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
33371109|NCT01187901|101243655|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
33371110|NCT01187901|101243654|FG000|Overall Study|Pregnancy|0|||
33371111|NCT01187901|101243655|FG001|Overall Study|Pregnancy|2|||
33241825|NCT01890967|100786228|FG004|Overall Study|Lost to Follow-up|0|||
33371112|NCT01165021|101243656|FG000|Overall Study|Death|1|||
33371113|NCT00430521|101243660|FG000|Overall Study|Adverse Event|0|||
33371114|NCT00430521|101243661|FG001|Overall Study|Adverse Event|0|||
33371115|NCT00430521|101243662|FG002|Overall Study|Adverse Event|0|||
33371116|NCT00430521|101243663|FG003|Overall Study|Adverse Event|0|||
33371117|NCT00430521|101243664|FG004|Overall Study|Adverse Event|0|||
33641516|NCT02998268|102240079|FG000|Overall Study|Adverse Event|0|||
33641517|NCT02998268|102240080|FG001|Overall Study|Adverse Event|2|||
33371118|NCT00430521|101243665|FG005|Overall Study|Adverse Event|2|||
33641518|NCT02998268|102240079|FG000|Overall Study|Withdrawal by Subject|0|||
33641519|NCT02998268|102240080|FG001|Overall Study|Withdrawal by Subject|1|||
33641520|NCT00948441|102240083|FG000|Overall Study|no longer meet inclusion criteria|1|||
33641521|NCT00948441|102240084|FG001|Overall Study|no longer meet inclusion criteria|4|||
33641522|NCT02792829|102240087|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
33641523|NCT02792829|102240088|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
33641524|NCT02792829|102240089|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
33641525|NCT02792829|102240090|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
33641526|NCT02792829|102240091|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
33641527|NCT02792829|102240092|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
33641528|NCT02792829|102240093|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
33641529|NCT02792829|102240094|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
33641530|NCT02792829|102240087|FG000|Treatment Period 2|Adverse Event|0|||
33641531|NCT02792829|102240088|FG001|Treatment Period 2|Adverse Event|0|||
33641532|NCT02792829|102240089|FG002|Treatment Period 2|Adverse Event|0|||
33581204|NCT02122146|102017104|FG001|Part 1: Dose Escalation|Other|0|||
33581205|NCT02122146|102017105|FG002|Part 1: Dose Escalation|Other|0|||
33581206|NCT02122146|102017106|FG003|Part 1: Dose Escalation|Other|0|||
33581207|NCT02122146|102017107|FG004|Part 1: Dose Escalation|Other|0|||
33581208|NCT02122146|102017108|FG005|Part 1: Dose Escalation|Other|1|||
33581209|NCT02122146|102017109|FG006|Part 1: Dose Escalation|Other|1|||
33581210|NCT02122146|102017110|FG007|Part 1: Dose Escalation|Other|2|||
33581211|NCT00625586|102017114|FG000|Overall Study|Adverse Event|1|||
33581212|NCT00625586|102017114|FG000|Overall Study|Progressive disease|1|||
33581213|NCT00131352|102017115|FG000|Initial Treatment Period|Adverse Event|1|||
33581214|NCT00131352|102017116|FG001|Initial Treatment Period|Adverse Event|3|||
33581215|NCT00131352|102017115|FG000|Initial Treatment Period|Non-compliant|1|||
33241826|NCT01890967|100786229|FG005|Overall Study|Lost to Follow-up|1|||
33241827|NCT01890967|100786224|FG000|Overall Study|Protocol Violation|0|||
33241828|NCT01890967|100786225|FG001|Overall Study|Protocol Violation|3|||
33241829|NCT01890967|100786226|FG002|Overall Study|Protocol Violation|3|||
33581216|NCT00131352|102017116|FG001|Initial Treatment Period|Non-compliant|2|||
33241830|NCT01890967|100786227|FG003|Overall Study|Protocol Violation|2|||
33241831|NCT01890967|100786228|FG004|Overall Study|Protocol Violation|4|||
33241832|NCT01890967|100786229|FG005|Overall Study|Protocol Violation|1|||
33241833|NCT01890967|100786224|FG000|Overall Study|Sponsor Decision|2|||
33241834|NCT01890967|100786225|FG001|Overall Study|Sponsor Decision|0|||
33641533|NCT02792829|102240090|FG003|Treatment Period 2|Adverse Event|0|||
33641534|NCT02792829|102240091|FG004|Treatment Period 2|Adverse Event|1|||
33641535|NCT02792829|102240092|FG005|Treatment Period 2|Adverse Event|0|||
33142853|NCT04473482|100438295|FG000|Overall Study|Death|0|||
33142854|NCT04473482|100438296|FG001|Overall Study|Death|3|||
33142855|NCT04473482|100438295|FG000|Overall Study|Lost to Follow-up|9|||
33142856|NCT04473482|100438296|FG001|Overall Study|Lost to Follow-up|7|||
33142857|NCT04473482|100438295|FG000|Overall Study|Withdrawal by Subject|2|||
33142858|NCT04473482|100438296|FG001|Overall Study|Withdrawal by Subject|1|||
33142859|NCT04590248|100438297|FG000|Overall Study|Lost to Follow-up|1|||
33142860|NCT04590248|100438297|FG000|Overall Study|Withdrawal by Subject|16|||
33241835|NCT01890967|100786226|FG002|Overall Study|Sponsor Decision|1|||
33641536|NCT02792829|102240093|FG006|Treatment Period 2|Adverse Event|1|||
33641537|NCT02792829|102240094|FG007|Treatment Period 2|Adverse Event|1|||
33641538|NCT02792829|102240087|FG000|Treatment Period 2|Use of proscribed medications|0|||
33641539|NCT02792829|102240088|FG001|Treatment Period 2|Use of proscribed medications|0|||
33641540|NCT02792829|102240089|FG002|Treatment Period 2|Use of proscribed medications|0|||
33641541|NCT02792829|102240090|FG003|Treatment Period 2|Use of proscribed medications|0|||
33641542|NCT02792829|102240091|FG004|Treatment Period 2|Use of proscribed medications|0|||
33641543|NCT02792829|102240092|FG005|Treatment Period 2|Use of proscribed medications|0|||
33641544|NCT02792829|102240093|FG006|Treatment Period 2|Use of proscribed medications|0|||
33641545|NCT02792829|102240094|FG007|Treatment Period 2|Use of proscribed medications|1|||
33641546|NCT01339052|102240098|FG000|Overall Study|Disease progression|13|||
33641547|NCT01339052|102240099|FG001|Overall Study|Disease progression|46|||
33142861|NCT04590248|100438297|FG000|Overall Study|Other|2|||
33142862|NCT02764190|100438298|FG000|Overall Study|Lost to Follow-up|17|||
33241836|NCT01890967|100786227|FG003|Overall Study|Sponsor Decision|3|||
33142863|NCT02764190|100438299|FG001|Overall Study|Lost to Follow-up|13|||
33142864|NCT00450385|100438302|FG000|Overall Study|Death|3|||
33241837|NCT01890967|100786228|FG004|Overall Study|Sponsor Decision|2|||
33241838|NCT01890967|100786229|FG005|Overall Study|Sponsor Decision|3|||
33641548|NCT01339052|102240098|FG000|Overall Study|Adverse Event|1|||
33641549|NCT01339052|102240099|FG001|Overall Study|Adverse Event|1|||
33371119|NCT00430521|101243666|FG006|Overall Study|Adverse Event|1|||
33581217|NCT00131352|102017115|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
33581218|NCT00131352|102017116|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
33581219|NCT00131352|102017115|FG000|Initial Treatment Period|Lack of Efficacy|6|||
33641550|NCT01339052|102240098|FG000|Overall Study|Withdrawal by Subject|0|||
33371120|NCT00430521|101243667|FG007|Overall Study|Adverse Event|0|||
33641551|NCT01339052|102240099|FG001|Overall Study|Withdrawal by Subject|3|||
33641552|NCT01339052|102240098|FG000|Overall Study|Physician Decision|1|||
33641553|NCT01339052|102240099|FG001|Overall Study|Physician Decision|0|||
33641554|NCT03819114|102240100|FG000|Overall Study|Protocol Violation|0|||
33641555|NCT03819114|102240101|FG001|Overall Study|Protocol Violation|1|||
33641556|NCT03819114|102240102|FG002|Overall Study|Protocol Violation|1|||
33641557|NCT03819114|102240103|FG003|Overall Study|Protocol Violation|0|||
33641558|NCT03819114|102240100|FG000|Overall Study|Lost to Follow-up|0|||
33641559|NCT03819114|102240101|FG001|Overall Study|Lost to Follow-up|0|||
33641560|NCT03819114|102240102|FG002|Overall Study|Lost to Follow-up|1|||
33641561|NCT03819114|102240103|FG003|Overall Study|Lost to Follow-up|0|||
33641562|NCT03436082|102240108|FG000|Overall Study|Did not undergo procedure|1|||
33641563|NCT03436082|102240109|FG001|Overall Study|Did not undergo procedure|0|||
33641564|NCT02948634|102240114|FG000|Overall Study|Lack of efficacy and study suspended|10|||
33641565|NCT02948634|102240115|FG001|Overall Study|Lack of efficacy and study suspended|2|||
33641566|NCT01583296|102240122|FG000|Overall Study|Withdrawal by Subject|11|||
33641567|NCT01583296|102240123|FG001|Overall Study|Withdrawal by Subject|10|||
33641568|NCT00241839|102240127|FG000|Overall Study|Withdrawal by Subject|18|||
33641569|NCT00241839|102240128|FG001|Overall Study|Withdrawal by Subject|17|||
33641570|NCT00241839|102240127|FG000|Overall Study|Adverse Event|1|||
33641571|NCT00241839|102240128|FG001|Overall Study|Adverse Event|1|||
33641572|NCT01033448|102240129|FG000|Overall Study|Withdrawal by Subject|4|||
33641573|NCT01033448|102240129|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
33641574|NCT01033448|102240129|FG000|Overall Study|Lost to Follow-up|3|||
33641575|NCT01033448|102240129|FG000|Overall Study|Withdrew due to other reasons|3|||
33641576|NCT01033448|102240129|FG000|Overall Study|Unknown disposition|1|||
33641577|NCT00834093|102240132|FG000|Overall Study|Progressive Disease|3|||
33641578|NCT00834093|102240132|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
33641579|NCT01524796|102240134|FG000|Overall Study|Adverse Event|13|||
33641580|NCT01524796|102240134|FG000|Overall Study|Lack of Efficacy|3|||
33641581|NCT01524796|102240134|FG000|Overall Study|Lost to Follow-up|1|||
33641582|NCT01524796|102240134|FG000|Overall Study|The price|1|||
33641583|NCT01524796|102240134|FG000|Overall Study|Withdrawal by Subject|4|||
33641584|NCT01524796|102240134|FG000|Overall Study|Move|1|||
33641585|NCT01524796|102240134|FG000|Overall Study|Deterioration of pains|1|||
33641586|NCT01524796|102240134|FG000|Overall Study|Gall stone surgery|1|||
33641587|NCT01524796|102240134|FG000|Overall Study|Nervous about confidentiality|1|||
33641588|NCT01524796|102240134|FG000|Overall Study|Switch to carbamazapine|1|||
33641589|NCT01524796|102240134|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
33641590|NCT00594815|102240135|FG000|Overall Study|Never Treated|3|||
33641591|NCT00594815|102240135|FG000|Overall Study|Withdrawal by Subject|2|||
33641592|NCT00594815|102240135|FG000|Overall Study|Toxicity|4|||
33641593|NCT03179319|102240136|FG000|Overall Study|Lost to Follow-up|6|||
33641594|NCT03179319|102240137|FG001|Overall Study|Lost to Follow-up|0|||
33641595|NCT04455815|102240138|FG000|Randomisation Phase|Adverse Event|1|||
33641596|NCT04455815|102240139|FG001|Randomisation Phase|Adverse Event|0|||
33641597|NCT04455815|102240138|FG000|Treatment Phase|Adverse Event|0|||
33641598|NCT04455815|102240139|FG001|Treatment Phase|Adverse Event|1|||
33641599|NCT04455815|102240138|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
33641600|NCT04455815|102240139|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
33641601|NCT04455815|102240138|FG000|Treatment Phase|Withdrawal by Subject|1|||
33142865|NCT00450385|100438302|FG000|Overall Study|Protocol Violation|1|||
33641602|NCT04455815|102240139|FG001|Treatment Phase|Withdrawal by Subject|1|||
33641603|NCT03339219|102240140|FG000|Overall Study|Death|12|||
33641604|NCT03339219|102240140|FG000|Overall Study|Site Terminated by Sponsor|22|||
33142866|NCT00450385|100438302|FG000|Overall Study|Withdrawal by Subject|2|||
33142867|NCT00450385|100438302|FG000|Overall Study|Lack of Efficacy|2|||
33241839|NCT01890967|100786224|FG000|Overall Study|Withdrawal by Subject|3|||
33241840|NCT01890967|100786225|FG001|Overall Study|Withdrawal by Subject|4|||
33421468|NCT02018042|101434791|FG000|Overall Study|Withdrawal by Subject|1|||
33421469|NCT01246986|101434794|FG000|Overall Study|Lost to Follow-up|0|||
33641605|NCT03339219|102240140|FG000|Overall Study|Withdrawal by Subject|1|||
33641606|NCT03212144|102240141|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
33641607|NCT03212144|102240142|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
33641608|NCT03212144|102240141|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
33641609|NCT03212144|102240142|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
33641610|NCT02721966|102240143|FG000|Overall Study|Protocol Violation|1|||
33641611|NCT02721966|102240144|FG001|Overall Study|Protocol Violation|0|||
33641612|NCT02721966|102240145|FG002|Overall Study|Protocol Violation|0|||
33641613|NCT02721966|102240146|FG003|Overall Study|Protocol Violation|0|||
33641614|NCT02721966|102240147|FG004|Overall Study|Protocol Violation|0|||
33641615|NCT02721966|102240143|FG000|Overall Study|Withdrawal by Subject|9|||
33641616|NCT02721966|102240144|FG001|Overall Study|Withdrawal by Subject|2|||
33641617|NCT02721966|102240145|FG002|Overall Study|Withdrawal by Subject|3|||
33641618|NCT02721966|102240146|FG003|Overall Study|Withdrawal by Subject|7|||
33641619|NCT02721966|102240147|FG004|Overall Study|Withdrawal by Subject|0|||
33641620|NCT02721966|102240143|FG000|Overall Study|Adverse Event|4|||
33641621|NCT02721966|102240144|FG001|Overall Study|Adverse Event|4|||
33641622|NCT02721966|102240145|FG002|Overall Study|Adverse Event|3|||
33641623|NCT02721966|102240146|FG003|Overall Study|Adverse Event|0|||
33641624|NCT02721966|102240147|FG004|Overall Study|Adverse Event|0|||
33641625|NCT02721966|102240143|FG000|Overall Study|Death|1|||
33641626|NCT02721966|102240144|FG001|Overall Study|Death|0|||
33641627|NCT02721966|102240145|FG002|Overall Study|Death|0|||
33641628|NCT02721966|102240146|FG003|Overall Study|Death|0|||
33641629|NCT02721966|102240147|FG004|Overall Study|Death|0|||
33641630|NCT02721966|102240143|FG000|Overall Study|Lack of Efficacy|7|||
33641631|NCT02721966|102240144|FG001|Overall Study|Lack of Efficacy|4|||
33641632|NCT02721966|102240145|FG002|Overall Study|Lack of Efficacy|0|||
33641633|NCT02721966|102240146|FG003|Overall Study|Lack of Efficacy|0|||
33641634|NCT02721966|102240147|FG004|Overall Study|Lack of Efficacy|0|||
33641635|NCT02721966|102240143|FG000|Overall Study|Lost to Follow-up|0|||
33641636|NCT02721966|102240144|FG001|Overall Study|Lost to Follow-up|0|||
33641637|NCT02721966|102240145|FG002|Overall Study|Lost to Follow-up|3|||
33641638|NCT02721966|102240146|FG003|Overall Study|Lost to Follow-up|0|||
33641639|NCT02721966|102240147|FG004|Overall Study|Lost to Follow-up|0|||
33641640|NCT02721966|102240143|FG000|Overall Study|Physician Decision|1|||
33641641|NCT02721966|102240144|FG001|Overall Study|Physician Decision|1|||
33641642|NCT02721966|102240145|FG002|Overall Study|Physician Decision|0|||
33641643|NCT02721966|102240146|FG003|Overall Study|Physician Decision|0|||
33641644|NCT02721966|102240147|FG004|Overall Study|Physician Decision|0|||
33641645|NCT02721966|102240143|FG000|Overall Study|Pregnancy|1|||
33641646|NCT02721966|102240144|FG001|Overall Study|Pregnancy|0|||
33641647|NCT02721966|102240145|FG002|Overall Study|Pregnancy|0|||
33641648|NCT02721966|102240146|FG003|Overall Study|Pregnancy|0|||
33581220|NCT00131352|102017116|FG001|Initial Treatment Period|Lack of Efficacy|4|||
33581221|NCT00131352|102017115|FG000|Initial Treatment Period|Other|0|||
33581222|NCT00131352|102017116|FG001|Initial Treatment Period|Other|2|||
33581223|NCT00131352|102017115|FG000|Repeat Treatment Period|Adverse Event|1|||
33581224|NCT00131352|102017116|FG001|Repeat Treatment Period|Adverse Event|0|||
33581225|NCT00131352|102017115|FG000|Repeat Treatment Period|Other|1|||
33581226|NCT00131352|102017116|FG001|Repeat Treatment Period|Other|0|||
33581227|NCT03008070|102017117|FG000|Overall Study|Adverse Event|3|||
33581228|NCT03008070|102017118|FG001|Overall Study|Adverse Event|3|||
33581229|NCT03008070|102017119|FG002|Overall Study|Adverse Event|3|||
33581230|NCT03008070|102017117|FG000|Overall Study|Lost to Follow-up|1|||
33581231|NCT03008070|102017118|FG001|Overall Study|Lost to Follow-up|1|||
33581232|NCT03008070|102017119|FG002|Overall Study|Lost to Follow-up|0|||
33581233|NCT03008070|102017117|FG000|Overall Study|Non compliance|0|||
33581234|NCT03008070|102017118|FG001|Overall Study|Non compliance|1|||
33581235|NCT03008070|102017119|FG002|Overall Study|Non compliance|1|||
33581236|NCT03008070|102017117|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
33581237|NCT03008070|102017118|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
33581238|NCT03008070|102017119|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
33581239|NCT03008070|102017117|FG000|Overall Study|Withdrawal by Subject|2|||
33581240|NCT03008070|102017118|FG001|Overall Study|Withdrawal by Subject|0|||
33581241|NCT03008070|102017119|FG002|Overall Study|Withdrawal by Subject|1|||
33581242|NCT03008070|102017117|FG000|Overall Study|Use of prohibited drug|0|||
33581243|NCT03008070|102017118|FG001|Overall Study|Use of prohibited drug|0|||
33581244|NCT03008070|102017119|FG002|Overall Study|Use of prohibited drug|2|||
33581245|NCT02735421|102017122|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
33581246|NCT02735421|102017122|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
33581247|NCT02735421|102017122|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
33581248|NCT02735421|102017122|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
33581249|NCT02735421|102017122|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
33581250|NCT02735421|102017122|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
33581251|NCT02735421|102017122|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
33581252|NCT00420381|102017123|FG000|Overall Study|Protocol Violation|1|||
33581253|NCT03549338|102017124|FG000|Overall Study|Progressive Disease|1|||
33581254|NCT03549338|102017125|FG001|Overall Study|Progressive Disease|0|||
33581255|NCT03549338|102017126|FG002|Overall Study|Progressive Disease|0|||
33641649|NCT02721966|102240147|FG004|Overall Study|Pregnancy|0|||
33641650|NCT02721966|102240143|FG000|Overall Study|Did not continue to period 2|5|||
33641651|NCT02721966|102240144|FG001|Overall Study|Did not continue to period 2|12|||
33641652|NCT02721966|102240145|FG002|Overall Study|Did not continue to period 2|0|||
33641653|NCT02721966|102240146|FG003|Overall Study|Did not continue to period 2|0|||
33581256|NCT03549338|102017124|FG000|Overall Study|Clinical Progression|0|||
33581257|NCT03549338|102017125|FG001|Overall Study|Clinical Progression|1|||
33581258|NCT03549338|102017126|FG002|Overall Study|Clinical Progression|0|||
33581259|NCT02528942|102017129|FG000|Overall Study|Did not meet imaging criteria|9|||
33581260|NCT02528942|102017129|FG000|Overall Study|Lost to Follow-up|25|||
33641654|NCT02721966|102240147|FG004|Overall Study|Did not continue to period 2|5|||
33641655|NCT00035932|102240148|FG000|Overall Study|Adverse Event|10|||
33641656|NCT00035932|102240149|FG001|Overall Study|Adverse Event|9|||
33641657|NCT00035932|102240150|FG002|Overall Study|Adverse Event|9|||
33641658|NCT00035932|102240148|FG000|Overall Study|Death|0|||
33641659|NCT00035932|102240149|FG001|Overall Study|Death|0|||
33641660|NCT00035932|102240150|FG002|Overall Study|Death|1|||
33641661|NCT00035932|102240148|FG000|Overall Study|Disease Progression / Relapse|1|||
33641662|NCT00035932|102240149|FG001|Overall Study|Disease Progression / Relapse|1|||
33641663|NCT00035932|102240150|FG002|Overall Study|Disease Progression / Relapse|0|||
33641664|NCT00035932|102240148|FG000|Overall Study|Lost to Follow-up|4|||
33641665|NCT00035932|102240149|FG001|Overall Study|Lost to Follow-up|4|||
33641666|NCT00035932|102240150|FG002|Overall Study|Lost to Follow-up|3|||
33641667|NCT00035932|102240148|FG000|Overall Study|Noncompliance|6|||
33641668|NCT00035932|102240149|FG001|Overall Study|Noncompliance|7|||
33641669|NCT00035932|102240150|FG002|Overall Study|Noncompliance|6|||
33641670|NCT00035932|102240148|FG000|Overall Study|Protocol Violation While on Study|0|||
33641671|NCT00035932|102240149|FG001|Overall Study|Protocol Violation While on Study|1|||
33641672|NCT00035932|102240150|FG002|Overall Study|Protocol Violation While on Study|2|||
33641673|NCT00035932|102240148|FG000|Overall Study|Withdrawal by Subject|1|||
33641674|NCT00035932|102240149|FG001|Overall Study|Withdrawal by Subject|5|||
33641675|NCT00035932|102240150|FG002|Overall Study|Withdrawal by Subject|0|||
33641676|NCT00035932|102240148|FG000|Overall Study|Study Termination by Sponsor|1|||
33641677|NCT00035932|102240149|FG001|Overall Study|Study Termination by Sponsor|0|||
33641678|NCT00035932|102240150|FG002|Overall Study|Study Termination by Sponsor|0|||
33641679|NCT00035932|102240148|FG000|Overall Study|Lack of Efficacy|33|||
33641680|NCT00035932|102240149|FG001|Overall Study|Lack of Efficacy|33|||
33641681|NCT00035932|102240150|FG002|Overall Study|Lack of Efficacy|28|||
33641682|NCT02541604|102240161|FG000|Overall Study|Death|6|||
33641683|NCT02541604|102240162|FG001|Overall Study|Death|5|||
33641684|NCT02541604|102240163|FG002|Overall Study|Death|7|||
33641685|NCT02541604|102240164|FG003|Overall Study|Death|2|||
33641686|NCT02541604|102240165|FG004|Overall Study|Death|9|||
33641687|NCT02541604|102240166|FG005|Overall Study|Death|8|||
33641688|NCT02541604|102240167|FG006|Overall Study|Death|9|||
33641689|NCT02541604|102240168|FG007|Overall Study|Death|9|||
33641690|NCT02541604|102240169|FG008|Overall Study|Death|3|||
33641691|NCT02541604|102240170|FG009|Overall Study|Death|4|||
33641692|NCT02541604|102240171|FG010|Overall Study|Death|2|||
33641693|NCT02541604|102240172|FG011|Overall Study|Death|3|||
33641694|NCT02541604|102240161|FG000|Overall Study|Lost to Follow-up|2|||
33641695|NCT02541604|102240162|FG001|Overall Study|Lost to Follow-up|0|||
33641696|NCT02541604|102240163|FG002|Overall Study|Lost to Follow-up|1|||
33641697|NCT02541604|102240164|FG003|Overall Study|Lost to Follow-up|0|||
33641698|NCT02541604|102240165|FG004|Overall Study|Lost to Follow-up|0|||
33641699|NCT02541604|102240166|FG005|Overall Study|Lost to Follow-up|1|||
33142868|NCT00450385|100438302|FG000|Overall Study|Adverse Event|1|||
33142869|NCT00450385|100438302|FG000|Overall Study|Physician Decision|1|||
33142870|NCT00450385|100438302|FG000|Overall Study|Other|3|||
33142871|NCT01089361|100438303|FG000|Overall Study|Death|1|||
33142872|NCT01089361|100438304|FG001|Overall Study|Death|0|||
33142873|NCT01307020|100438305|FG000|Overall Study|Lost to Follow-up|0|||
33142874|NCT01307020|100438306|FG001|Overall Study|Lost to Follow-up|0|||
33142875|NCT01307020|100438307|FG002|Overall Study|Lost to Follow-up|1|||
33142876|NCT01307020|100438308|FG003|Overall Study|Lost to Follow-up|1|||
33142877|NCT01307020|100438309|FG004|Overall Study|Lost to Follow-up|0|||
33142878|NCT01307020|100438310|FG005|Overall Study|Lost to Follow-up|0|||
33142879|NCT01307020|100438311|FG006|Overall Study|Lost to Follow-up|1|||
33142880|NCT01307020|100438312|FG007|Overall Study|Lost to Follow-up|0|||
33142881|NCT01307020|100438313|FG008|Overall Study|Lost to Follow-up|0|||
33142882|NCT01307020|100438314|FG009|Overall Study|Lost to Follow-up|0|||
33421470|NCT01246986|101434795|FG001|Overall Study|Lost to Follow-up|1|||
33142883|NCT01307020|100438305|FG000|Overall Study|Electronic data capture failure|0|||
33142884|NCT01307020|100438306|FG001|Overall Study|Electronic data capture failure|1|||
33142885|NCT01307020|100438307|FG002|Overall Study|Electronic data capture failure|0|||
33142886|NCT01307020|100438308|FG003|Overall Study|Electronic data capture failure|0|||
33142887|NCT01307020|100438309|FG004|Overall Study|Electronic data capture failure|0|||
33371121|NCT00430521|101243660|FG000|Overall Study|Lost to Follow-up|7|||
33421471|NCT01246986|101434796|FG002|Overall Study|Lost to Follow-up|3|||
33421472|NCT01246986|101434797|FG003|Overall Study|Lost to Follow-up|0|||
33641700|NCT02541604|102240167|FG006|Overall Study|Lost to Follow-up|1|||
33641701|NCT02541604|102240168|FG007|Overall Study|Lost to Follow-up|0|||
33641702|NCT02541604|102240169|FG008|Overall Study|Lost to Follow-up|0|||
33641703|NCT02541604|102240170|FG009|Overall Study|Lost to Follow-up|0|||
33641704|NCT02541604|102240171|FG010|Overall Study|Lost to Follow-up|0|||
33142888|NCT01307020|100438310|FG005|Overall Study|Electronic data capture failure|0|||
33241841|NCT01890967|100786226|FG002|Overall Study|Withdrawal by Subject|2|||
33371122|NCT00430521|101243661|FG001|Overall Study|Lost to Follow-up|8|||
33641705|NCT02541604|102240172|FG011|Overall Study|Lost to Follow-up|0|||
33641706|NCT02541604|102240161|FG000|Overall Study|Withdrawal by Subject|2|||
33641707|NCT02541604|102240162|FG001|Overall Study|Withdrawal by Subject|0|||
33641708|NCT02541604|102240163|FG002|Overall Study|Withdrawal by Subject|1|||
33641709|NCT02541604|102240164|FG003|Overall Study|Withdrawal by Subject|0|||
33371123|NCT00430521|101243662|FG002|Overall Study|Lost to Follow-up|3|||
33371124|NCT00430521|101243663|FG003|Overall Study|Lost to Follow-up|5|||
33371125|NCT00430521|101243664|FG004|Overall Study|Lost to Follow-up|5|||
33371126|NCT00430521|101243665|FG005|Overall Study|Lost to Follow-up|2|||
33371127|NCT00430521|101243666|FG006|Overall Study|Lost to Follow-up|8|||
33371128|NCT00430521|101243667|FG007|Overall Study|Lost to Follow-up|10|||
33371129|NCT00430521|101243660|FG000|Overall Study|Pregnancy|0|||
33371130|NCT00430521|101243661|FG001|Overall Study|Pregnancy|0|||
33371131|NCT00430521|101243662|FG002|Overall Study|Pregnancy|0|||
33371132|NCT00430521|101243663|FG003|Overall Study|Pregnancy|0|||
33371133|NCT00430521|101243664|FG004|Overall Study|Pregnancy|0|||
33371134|NCT00430521|101243665|FG005|Overall Study|Pregnancy|0|||
33371135|NCT00430521|101243666|FG006|Overall Study|Pregnancy|1|||
33371136|NCT00430521|101243667|FG007|Overall Study|Pregnancy|0|||
33371137|NCT00430521|101243660|FG000|Overall Study|Vaccine Expired|0|||
33421473|NCT01246986|101434798|FG004|Overall Study|Lost to Follow-up|0|||
33641710|NCT02541604|102240165|FG004|Overall Study|Withdrawal by Subject|1|||
33641711|NCT02541604|102240166|FG005|Overall Study|Withdrawal by Subject|1|||
33641712|NCT02541604|102240167|FG006|Overall Study|Withdrawal by Subject|0|||
33641713|NCT02541604|102240168|FG007|Overall Study|Withdrawal by Subject|0|||
33641714|NCT02541604|102240169|FG008|Overall Study|Withdrawal by Subject|1|||
33641715|NCT02541604|102240170|FG009|Overall Study|Withdrawal by Subject|0|||
33641716|NCT02541604|102240171|FG010|Overall Study|Withdrawal by Subject|0|||
33641717|NCT02541604|102240172|FG011|Overall Study|Withdrawal by Subject|0|||
33641718|NCT02541604|102240161|FG000|Overall Study|Study Terminated by Sponsor|1|||
33641719|NCT02541604|102240162|FG001|Overall Study|Study Terminated by Sponsor|4|||
33641720|NCT02541604|102240163|FG002|Overall Study|Study Terminated by Sponsor|2|||
33641721|NCT02541604|102240164|FG003|Overall Study|Study Terminated by Sponsor|1|||
33641722|NCT02541604|102240165|FG004|Overall Study|Study Terminated by Sponsor|0|||
33641723|NCT02541604|102240166|FG005|Overall Study|Study Terminated by Sponsor|0|||
33641724|NCT02541604|102240167|FG006|Overall Study|Study Terminated by Sponsor|0|||
33641725|NCT02541604|102240168|FG007|Overall Study|Study Terminated by Sponsor|0|||
33641726|NCT02541604|102240169|FG008|Overall Study|Study Terminated by Sponsor|0|||
33641727|NCT02541604|102240170|FG009|Overall Study|Study Terminated by Sponsor|0|||
33641728|NCT02541604|102240171|FG010|Overall Study|Study Terminated by Sponsor|0|||
33641729|NCT02541604|102240172|FG011|Overall Study|Study Terminated by Sponsor|0|||
33641730|NCT02541604|102240161|FG000|Overall Study|Medical condition may jeopardize safety|0|||
33641731|NCT02541604|102240162|FG001|Overall Study|Medical condition may jeopardize safety|0|||
33641732|NCT02541604|102240163|FG002|Overall Study|Medical condition may jeopardize safety|0|||
33641733|NCT02541604|102240164|FG003|Overall Study|Medical condition may jeopardize safety|0|||
33641734|NCT02541604|102240165|FG004|Overall Study|Medical condition may jeopardize safety|0|||
33641735|NCT02541604|102240166|FG005|Overall Study|Medical condition may jeopardize safety|0|||
33641736|NCT02541604|102240167|FG006|Overall Study|Medical condition may jeopardize safety|0|||
33641737|NCT02541604|102240168|FG007|Overall Study|Medical condition may jeopardize safety|1|||
33641738|NCT02541604|102240169|FG008|Overall Study|Medical condition may jeopardize safety|0|||
33641739|NCT02541604|102240170|FG009|Overall Study|Medical condition may jeopardize safety|0|||
33641740|NCT02541604|102240171|FG010|Overall Study|Medical condition may jeopardize safety|0|||
33641741|NCT02541604|102240172|FG011|Overall Study|Medical condition may jeopardize safety|0|||
33641742|NCT02350478|102240173|FG000|Overall Study|Lost to Follow-up|5|||
33641743|NCT02350478|102240174|FG001|Overall Study|Lost to Follow-up|1|||
33641744|NCT01869764|102240178|FG000|Overall Study|Withdrawal by Subject|0|||
33641745|NCT01869764|102240179|FG001|Overall Study|Withdrawal by Subject|2|||
33641746|NCT01077050|102240183|FG000|Overall Study|Subjects signed ICF could not be located|1|||
33641747|NCT01077050|102240183|FG000|Overall Study|Screen failure|8|||
33641748|NCT00092443|102240186|FG000|Overall Study|Adverse Event|9|||
33641749|NCT00092443|102240187|FG001|Overall Study|Adverse Event|13|||
33641750|NCT00092443|102240186|FG000|Overall Study|Lost to Follow-up|7|||
33641751|NCT00092443|102240187|FG001|Overall Study|Lost to Follow-up|3|||
33371138|NCT00430521|101243661|FG001|Overall Study|Vaccine Expired|0|||
33371139|NCT00430521|101243662|FG002|Overall Study|Vaccine Expired|0|||
33371140|NCT00430521|101243663|FG003|Overall Study|Vaccine Expired|0|||
33371141|NCT00430521|101243664|FG004|Overall Study|Vaccine Expired|0|||
33421474|NCT01246986|101434799|FG005|Overall Study|Lost to Follow-up|1|||
33641752|NCT00092443|102240186|FG000|Overall Study|Protocol Violation|11|||
33641753|NCT00092443|102240187|FG001|Overall Study|Protocol Violation|9|||
33641754|NCT00092443|102240186|FG000|Overall Study|Withdrawal by Subject|9|||
33641755|NCT00092443|102240187|FG001|Overall Study|Withdrawal by Subject|11|||
33371142|NCT00430521|101243665|FG005|Overall Study|Vaccine Expired|1|||
33371143|NCT00430521|101243666|FG006|Overall Study|Vaccine Expired|0|||
33371144|NCT00430521|101243667|FG007|Overall Study|Vaccine Expired|0|||
33371145|NCT00430521|101243660|FG000|Overall Study|Protocol Violation|1|||
33641756|NCT00092443|102240186|FG000|Overall Study|Moved|5|||
33641757|NCT00092443|102240187|FG001|Overall Study|Moved|5|||
33641758|NCT00092443|102240186|FG000|Overall Study|Other|17|||
33641759|NCT00092443|102240187|FG001|Overall Study|Other|13|||
33641760|NCT02876601|102240188|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
33641761|NCT02876601|102240189|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
33142889|NCT01307020|100438311|FG006|Overall Study|Electronic data capture failure|0|||
33142890|NCT01307020|100438312|FG007|Overall Study|Electronic data capture failure|0|||
33142891|NCT01307020|100438313|FG008|Overall Study|Electronic data capture failure|0|||
33142892|NCT01307020|100438314|FG009|Overall Study|Electronic data capture failure|0|||
33142893|NCT00548405|100438318|FG000|Overall Study|Adverse Event|6|||
33142894|NCT00548405|100438319|FG001|Overall Study|Adverse Event|2|||
33142895|NCT00548405|100438320|FG002|Overall Study|Adverse Event|0|||
33142896|NCT00548405|100438318|FG000|Overall Study|Lack of Efficacy|6|||
33142897|NCT00548405|100438319|FG001|Overall Study|Lack of Efficacy|0|||
33142898|NCT00548405|100438320|FG002|Overall Study|Lack of Efficacy|0|||
33142899|NCT00548405|100438318|FG000|Overall Study|Physician Decision|3|||
33142900|NCT00548405|100438319|FG001|Overall Study|Physician Decision|4|||
33142901|NCT00548405|100438320|FG002|Overall Study|Physician Decision|1|||
33142902|NCT00548405|100438318|FG000|Overall Study|Pregnancy|1|||
33142903|NCT00548405|100438319|FG001|Overall Study|Pregnancy|0|||
33142904|NCT00548405|100438320|FG002|Overall Study|Pregnancy|0|||
33142905|NCT00548405|100438318|FG000|Overall Study|Protocol Violation|1|||
33142906|NCT00548405|100438319|FG001|Overall Study|Protocol Violation|0|||
33142907|NCT00548405|100438320|FG002|Overall Study|Protocol Violation|0|||
33142908|NCT00548405|100438318|FG000|Overall Study|Withdrawal by Subject|36|||
33142909|NCT00548405|100438319|FG001|Overall Study|Withdrawal by Subject|12|||
33142910|NCT00548405|100438320|FG002|Overall Study|Withdrawal by Subject|5|||
33142911|NCT00548405|100438318|FG000|Overall Study|Lost to Follow-up|1|||
33142912|NCT00548405|100438319|FG001|Overall Study|Lost to Follow-up|1|||
33142913|NCT00548405|100438320|FG002|Overall Study|Lost to Follow-up|2|||
33142914|NCT00548405|100438318|FG000|Overall Study|Death|0|||
33142915|NCT00548405|100438319|FG001|Overall Study|Death|1|||
33641762|NCT02876601|102240190|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
33641763|NCT02876601|102240191|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
33641764|NCT01696188|102240194|FG000|Overall Study|Protocol Violation|1|||
33641765|NCT01696188|102240195|FG001|Overall Study|Protocol Violation|1|||
33641766|NCT00566696|102240196|FG000|Overall Study|Met Exclusion Criteria|2|||
33641767|NCT00566696|102240196|FG000|Overall Study|Muromonab not available|1|||
33142916|NCT00548405|100438320|FG002|Overall Study|Death|1|||
33142917|NCT00548405|100438318|FG000|Overall Study|Sponsor decision|1|||
33142918|NCT00548405|100438319|FG001|Overall Study|Sponsor decision|0|||
33581261|NCT01244035|102017133|FG000|Part 1: Period 1|Adverse Event|0|||
33581262|NCT01244035|102017134|FG001|Part 1: Period 1|Adverse Event|0|||
33581263|NCT01244035|102017135|FG002|Part 1: Period 1|Adverse Event|0|||
33581264|NCT01244035|102017136|FG003|Part 1: Period 1|Adverse Event|0|||
33581265|NCT01244035|102017137|FG004|Part 1: Period 1|Adverse Event|0|||
33581266|NCT01244035|102017138|FG005|Part 1: Period 1|Adverse Event|1|||
33581267|NCT01244035|102017133|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
33581268|NCT01244035|102017134|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
33581269|NCT01244035|102017135|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
33581270|NCT01244035|102017136|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
33581271|NCT01244035|102017137|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
33581272|NCT01244035|102017138|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
33581273|NCT01244035|102017133|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
33581274|NCT01244035|102017134|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
33581275|NCT01244035|102017135|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
33581276|NCT01244035|102017136|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
33641768|NCT00566696|102240196|FG000|Overall Study|Health Status Change|1|||
33641769|NCT00566696|102240196|FG000|Overall Study|Physician Decision|1|||
33142919|NCT00548405|100438320|FG002|Overall Study|Sponsor decision|0|||
33142920|NCT00548405|100438318|FG000|Overall Study|Randomized but not treated|1|||
33142921|NCT00548405|100438319|FG001|Overall Study|Randomized but not treated|0|||
33142922|NCT00548405|100438320|FG002|Overall Study|Randomized but not treated|0|||
33142923|NCT02292784|100438321|FG000|Overall Study|Lost to Follow-up|1|||
33421475|NCT01246986|101434800|FG006|Overall Study|Lost to Follow-up|0|||
33421476|NCT01246986|101434794|FG000|Overall Study|Withdrawal by Subject|3|||
33421477|NCT01246986|101434795|FG001|Overall Study|Withdrawal by Subject|4|||
33421478|NCT01246986|101434796|FG002|Overall Study|Withdrawal by Subject|3|||
33421479|NCT01246986|101434797|FG003|Overall Study|Withdrawal by Subject|0|||
33421480|NCT01246986|101434798|FG004|Overall Study|Withdrawal by Subject|4|||
33421481|NCT01246986|101434799|FG005|Overall Study|Withdrawal by Subject|0|||
33421482|NCT01246986|101434800|FG006|Overall Study|Withdrawal by Subject|0|||
33421483|NCT01697449|101434801|FG000|Overall Study|Disease progression|47|||
33142924|NCT02292784|100438322|FG001|Overall Study|Lost to Follow-up|17|||
33142925|NCT02292784|100438323|FG002|Overall Study|Lost to Follow-up|18|||
33421484|NCT01697449|101434801|FG000|Overall Study|Adverse Event|7|||
33581277|NCT01244035|102017137|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
33581278|NCT01244035|102017138|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
33641770|NCT00566696|102240196|FG000|Overall Study|Non-Patient Donors|37|||
33142926|NCT02292784|100438321|FG000|Overall Study|Withdrawal by Subject|0|||
33142927|NCT02292784|100438322|FG001|Overall Study|Withdrawal by Subject|3|||
33142928|NCT02292784|100438323|FG002|Overall Study|Withdrawal by Subject|3|||
33421485|NCT01697449|101434801|FG000|Overall Study|Lost to Follow-up|5|||
33421486|NCT01697449|101434801|FG000|Overall Study|Withdrawal by Subject|2|||
33421487|NCT01697449|101434801|FG000|Overall Study|Physician Decision|1|||
33421488|NCT01697449|101434801|FG000|Overall Study|Death|2|||
33421489|NCT01697449|101434801|FG000|Overall Study|Other|1|||
33421490|NCT01697449|101434801|FG000|Overall Study|Missing|25|||
33421491|NCT03550794|101434802|FG000|Overall Study|No longer met inclusion criteria|1|||
33581279|NCT01244035|102017133|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
33581280|NCT01244035|102017134|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
33581281|NCT01244035|102017135|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
33581282|NCT01244035|102017136|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
33581283|NCT01244035|102017137|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
33581284|NCT01244035|102017138|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
33581285|NCT01244035|102017133|FG000|Part 1: Period 3|Adverse Event|0|||
33581286|NCT01244035|102017134|FG001|Part 1: Period 3|Adverse Event|0|||
33581287|NCT01244035|102017135|FG002|Part 1: Period 3|Adverse Event|0|||
33581288|NCT01244035|102017136|FG003|Part 1: Period 3|Adverse Event|0|||
33581289|NCT01244035|102017137|FG004|Part 1: Period 3|Adverse Event|0|||
33142929|NCT03324581|100438326|FG000|Overall Study|Adverse Event|18|||
33142930|NCT03324581|100438327|FG001|Overall Study|Adverse Event|11|||
33142931|NCT03324581|100438328|FG002|Overall Study|Adverse Event|7|||
33142932|NCT03324581|100438326|FG000|Overall Study|Lack of Efficacy|0|||
33142933|NCT03324581|100438327|FG001|Overall Study|Lack of Efficacy|1|||
33142934|NCT03324581|100438328|FG002|Overall Study|Lack of Efficacy|0|||
33142935|NCT03324581|100438326|FG000|Overall Study|Lost to Follow-up|5|||
33142936|NCT03324581|100438327|FG001|Overall Study|Lost to Follow-up|3|||
33142937|NCT03324581|100438328|FG002|Overall Study|Lost to Follow-up|6|||
33371146|NCT00430521|101243661|FG001|Overall Study|Protocol Violation|0|||
33371147|NCT00430521|101243662|FG002|Overall Study|Protocol Violation|0|||
33371148|NCT00430521|101243663|FG003|Overall Study|Protocol Violation|0|||
33371149|NCT00430521|101243664|FG004|Overall Study|Protocol Violation|0|||
33371150|NCT00430521|101243665|FG005|Overall Study|Protocol Violation|0|||
33371151|NCT00430521|101243666|FG006|Overall Study|Protocol Violation|0|||
33371152|NCT00430521|101243667|FG007|Overall Study|Protocol Violation|0|||
33581290|NCT01244035|102017138|FG005|Part 1: Period 3|Adverse Event|1|||
33581291|NCT01244035|102017133|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
33581292|NCT01244035|102017134|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
33581293|NCT01244035|102017135|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
33581294|NCT01244035|102017136|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
33581295|NCT01244035|102017137|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
33581296|NCT01244035|102017138|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
33581297|NCT01244035|102017133|FG000|Part 1: Period 3|Protocol Deviation|0|||
33581298|NCT01244035|102017134|FG001|Part 1: Period 3|Protocol Deviation|1|||
33581299|NCT01244035|102017135|FG002|Part 1: Period 3|Protocol Deviation|0|||
33581300|NCT01244035|102017136|FG003|Part 1: Period 3|Protocol Deviation|0|||
33581301|NCT01244035|102017137|FG004|Part 1: Period 3|Protocol Deviation|0|||
33641771|NCT04154189|102240197|FG000|Overall Study|Withdrawal by Subject|4|||
33641772|NCT04154189|102240198|FG001|Overall Study|Withdrawal by Subject|6|||
33641773|NCT04154189|102240197|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
33641774|NCT04154189|102240198|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
33641775|NCT04154189|102240197|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
33641776|NCT04154189|102240198|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
33142938|NCT03324581|100438326|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
33142939|NCT03324581|100438327|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
33142940|NCT03324581|100438328|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
33241842|NCT01890967|100786227|FG003|Overall Study|Withdrawal by Subject|3|||
33241843|NCT01890967|100786228|FG004|Overall Study|Withdrawal by Subject|3|||
33371153|NCT00430521|101243660|FG000|Overall Study|Withdrawal by Subject|3|||
33371154|NCT00430521|101243661|FG001|Overall Study|Withdrawal by Subject|1|||
33371155|NCT00430521|101243662|FG002|Overall Study|Withdrawal by Subject|0|||
33371156|NCT00430521|101243663|FG003|Overall Study|Withdrawal by Subject|3|||
33371157|NCT00430521|101243664|FG004|Overall Study|Withdrawal by Subject|0|||
33371158|NCT00430521|101243665|FG005|Overall Study|Withdrawal by Subject|0|||
33371159|NCT00430521|101243666|FG006|Overall Study|Withdrawal by Subject|0|||
33371160|NCT00430521|101243667|FG007|Overall Study|Withdrawal by Subject|2|||
33371161|NCT03116399|101243668|FG000|Overall Study|Death|8|||
33371162|NCT03116399|101243669|FG001|Overall Study|Death|3|||
33371163|NCT03116399|101243668|FG000|Overall Study|Lost to Follow-up|7|||
33581302|NCT01244035|102017138|FG005|Part 1: Period 3|Protocol Deviation|0|||
33581303|NCT01484496|102017141|FG000|Period 1|Protocol Violation|3|||
33581304|NCT01484496|102017142|FG001|Period 1|Protocol Violation|4|||
33581305|NCT01484496|102017143|FG002|Period 1|Protocol Violation|0|||
33581306|NCT01484496|102017144|FG003|Period 1|Protocol Violation|0|||
33371164|NCT03116399|101243669|FG001|Overall Study|Lost to Follow-up|11|||
33142941|NCT03324581|100438326|FG000|Overall Study|Physician Decision|0|||
33142942|NCT03324581|100438327|FG001|Overall Study|Physician Decision|1|||
33421492|NCT03550794|101434803|FG001|Overall Study|No longer met inclusion criteria|2|||
33142943|NCT03324581|100438328|FG002|Overall Study|Physician Decision|2|||
33142944|NCT03324581|100438326|FG000|Overall Study|Protocol Deviation|8|||
33142945|NCT03324581|100438327|FG001|Overall Study|Protocol Deviation|9|||
33142946|NCT03324581|100438328|FG002|Overall Study|Protocol Deviation|4|||
33142947|NCT03324581|100438326|FG000|Overall Study|Withdrawal by Subject|6|||
33142948|NCT03324581|100438327|FG001|Overall Study|Withdrawal by Subject|8|||
33142949|NCT03324581|100438328|FG002|Overall Study|Withdrawal by Subject|6|||
33142950|NCT03324581|100438326|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
33142951|NCT03324581|100438327|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
33142952|NCT03324581|100438328|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
33142953|NCT00895011|100438329|FG000|Overall Study|Withdrawal by Subject|14|||
33142954|NCT00895011|100438330|FG001|Overall Study|Withdrawal by Subject|7|||
33142955|NCT00895011|100438331|FG002|Overall Study|Withdrawal by Subject|2|||
33142956|NCT00895011|100438329|FG000|Overall Study|Lost to Follow-up|5|||
33142957|NCT00895011|100438330|FG001|Overall Study|Lost to Follow-up|4|||
33142958|NCT00895011|100438331|FG002|Overall Study|Lost to Follow-up|1|||
33142959|NCT00895011|100438329|FG000|Overall Study|Protocol Violation|3|||
33142960|NCT00895011|100438330|FG001|Overall Study|Protocol Violation|1|||
33142961|NCT00895011|100438331|FG002|Overall Study|Protocol Violation|3|||
33142962|NCT00895011|100438329|FG000|Overall Study|Adverse Event|1|||
33142963|NCT00895011|100438330|FG001|Overall Study|Adverse Event|2|||
33142964|NCT00895011|100438331|FG002|Overall Study|Adverse Event|2|||
33142965|NCT00895011|100438329|FG000|Overall Study|schedule conflict|1|||
33142966|NCT00895011|100438330|FG001|Overall Study|schedule conflict|0|||
33142967|NCT00895011|100438331|FG002|Overall Study|schedule conflict|0|||
33142968|NCT01002820|100438332|FG000|Overall Study|Adverse Event|1|||
33241844|NCT01890967|100786229|FG005|Overall Study|Withdrawal by Subject|1|||
33241845|NCT04541186|100786230|FG000|Main Study|Adverse Event|0|||
33142969|NCT01002820|100438332|FG000|Overall Study|Withdrawal by Subject|2|||
33581307|NCT01484496|102017141|FG000|Period 1|Physician Decision|5|||
33581308|NCT01484496|102017142|FG001|Period 1|Physician Decision|1|||
33142970|NCT01002820|100438332|FG000|Overall Study|Lack of Efficacy|1|||
33142971|NCT02456103|100438333|FG000|Overall Study|Study Closure|207|||
33142972|NCT02456103|100438333|FG000|Overall Study|Physician Decision|1|||
33142973|NCT02456103|100438333|FG000|Overall Study|Required prohibited medications|5|||
33142974|NCT02456103|100438333|FG000|Overall Study|Protocol Violation|1|||
33241846|NCT04541186|100786231|FG001|Main Study|Adverse Event|0|||
33241847|NCT04541186|100786232|FG002|Main Study|Adverse Event|4|||
33241848|NCT04541186|100786233|FG003|Main Study|Adverse Event|0|||
33241849|NCT04541186|100786234|FG004|Main Study|Adverse Event|0|||
33241850|NCT04541186|100786230|FG000|Main Study|Investigator Decision|0|||
33241851|NCT04541186|100786231|FG001|Main Study|Investigator Decision|0|||
33241852|NCT04541186|100786232|FG002|Main Study|Investigator Decision|1|||
33241853|NCT04541186|100786233|FG003|Main Study|Investigator Decision|1|||
33241854|NCT04541186|100786234|FG004|Main Study|Investigator Decision|0|||
33581309|NCT01484496|102017143|FG002|Period 1|Physician Decision|0|||
33581310|NCT01484496|102017144|FG003|Period 1|Physician Decision|0|||
33581311|NCT01484496|102017141|FG000|Period 1|Lack of Efficacy|10|||
33581312|NCT01484496|102017142|FG001|Period 1|Lack of Efficacy|15|||
33581313|NCT01484496|102017143|FG002|Period 1|Lack of Efficacy|0|||
33581314|NCT01484496|102017144|FG003|Period 1|Lack of Efficacy|0|||
33142975|NCT02456103|100438333|FG000|Overall Study|Adverse Event|5|||
33142976|NCT02456103|100438333|FG000|Overall Study|Abnormal Laboratory Value|2|||
33142977|NCT02456103|100438333|FG000|Overall Study|Lost to Follow-up|1|||
33142978|NCT02456103|100438333|FG000|Overall Study|Withdrawal by Subject|24|||
33142979|NCT02047318|100438334|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
33142980|NCT02047318|100438334|FG000|Core Study Period|Adverse Event|1|||
33142981|NCT02047318|100438334|FG000|Core Study Period|Withdrawal by caregiver|3|||
33241855|NCT04541186|100786230|FG000|Main Study|Withdrawal by Subject|1|||
33581315|NCT01484496|102017141|FG000|Period 1|Adverse Event|25|||
33581316|NCT01484496|102017142|FG001|Period 1|Adverse Event|40|||
33581317|NCT01484496|102017143|FG002|Period 1|Adverse Event|0|||
33581318|NCT01484496|102017144|FG003|Period 1|Adverse Event|0|||
33142982|NCT02047318|100438334|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
33142983|NCT01133990|100438335|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
33142984|NCT01133990|100438336|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33142985|NCT01133990|100438337|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33241856|NCT04541186|100786231|FG001|Main Study|Withdrawal by Subject|1|||
33581319|NCT01484496|102017141|FG000|Period 1|Withdrawal by Subject|15|||
33581320|NCT01484496|102017142|FG001|Period 1|Withdrawal by Subject|12|||
33581321|NCT01484496|102017143|FG002|Period 1|Withdrawal by Subject|0|||
33581322|NCT01484496|102017144|FG003|Period 1|Withdrawal by Subject|0|||
33581323|NCT01484496|102017141|FG000|Period 1|Lost to Follow-up|2|||
33581324|NCT01484496|102017142|FG001|Period 1|Lost to Follow-up|6|||
33581325|NCT01484496|102017143|FG002|Period 1|Lost to Follow-up|0|||
33241857|NCT04541186|100786232|FG002|Main Study|Withdrawal by Subject|0|||
33241858|NCT04541186|100786233|FG003|Main Study|Withdrawal by Subject|0|||
33241859|NCT04541186|100786234|FG004|Main Study|Withdrawal by Subject|0|||
33241860|NCT04541186|100786230|FG000|Main Study|COVID-19-related Dose Interruption|0|||
33641777|NCT04154189|102240197|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
33641778|NCT04154189|102240198|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
33641779|NCT04154189|102240197|FG000|Overall Study|Death|25|||
33641780|NCT04154189|102240198|FG001|Overall Study|Death|25|||
33641781|NCT01938716|102240199|FG000|Overall Study|Physician Decision|2|||
33641782|NCT01938716|102240199|FG000|Overall Study|Withdrawal by Subject|2|||
33641783|NCT00068419|102240202|FG000|Overall Study|Adverse Event|3|||
33641784|NCT00068419|102240202|FG000|Overall Study|Lack of Efficacy|24|||
33241861|NCT04541186|100786231|FG001|Main Study|COVID-19-related Dose Interruption|0|||
33241862|NCT04541186|100786232|FG002|Main Study|COVID-19-related Dose Interruption|0|||
33241863|NCT04541186|100786233|FG003|Main Study|COVID-19-related Dose Interruption|0|||
33241864|NCT04541186|100786234|FG004|Main Study|COVID-19-related Dose Interruption|1|||
33241865|NCT04541186|100786230|FG000|Main Study|Randomized in Error Not Treated|0|||
33241866|NCT04541186|100786231|FG001|Main Study|Randomized in Error Not Treated|0|||
33241867|NCT04541186|100786232|FG002|Main Study|Randomized in Error Not Treated|1|||
33241868|NCT04541186|100786233|FG003|Main Study|Randomized in Error Not Treated|0|||
33241869|NCT04541186|100786234|FG004|Main Study|Randomized in Error Not Treated|0|||
33241870|NCT04541186|100786230|FG000|Fibrate Expansion Study|Other than Specified|0|||
33241871|NCT04541186|100786231|FG001|Fibrate Expansion Study|Other than Specified|0|||
33241872|NCT04541186|100786232|FG002|Fibrate Expansion Study|Other than Specified|0|||
33241873|NCT04541186|100786233|FG003|Fibrate Expansion Study|Other than Specified|0|||
33241874|NCT04541186|100786234|FG004|Fibrate Expansion Study|Other than Specified|1|||
33241875|NCT01388543|100786237|FG000|Day 14|Adverse Event|1|||
33241876|NCT01388543|100786238|FG001|Day 14|Adverse Event|4|||
33241877|NCT00335153|100786239|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
33241878|NCT00335153|100786239|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
33241879|NCT00335153|100786239|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
33241880|NCT00335153|100786239|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
33581326|NCT01484496|102017144|FG003|Period 1|Lost to Follow-up|0|||
33581327|NCT01484496|102017141|FG000|Period 1|Positive Pregnancy|1|||
33581328|NCT01484496|102017142|FG001|Period 1|Positive Pregnancy|6|||
33581329|NCT01484496|102017143|FG002|Period 1|Positive Pregnancy|0|||
33581330|NCT01484496|102017144|FG003|Period 1|Positive Pregnancy|0|||
33581331|NCT01484496|102017141|FG000|Period 1|Treatment Failure|3|||
33641785|NCT00068419|102240202|FG000|Overall Study|Lost to Follow-up|1|||
33241881|NCT00335153|100786239|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
33241882|NCT00335153|100786239|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
33241883|NCT00335153|100786239|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
33241884|NCT00335153|100786239|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
33241885|NCT00335153|100786239|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
33581332|NCT01484496|102017142|FG001|Period 1|Treatment Failure|6|||
33581333|NCT01484496|102017143|FG002|Period 1|Treatment Failure|0|||
33581334|NCT01484496|102017144|FG003|Period 1|Treatment Failure|0|||
33581335|NCT01484496|102017141|FG000|Period 1|Lack of Compliance|2|||
33581336|NCT01484496|102017142|FG001|Period 1|Lack of Compliance|1|||
33581337|NCT01484496|102017143|FG002|Period 1|Lack of Compliance|0|||
33581338|NCT01484496|102017144|FG003|Period 1|Lack of Compliance|0|||
33581339|NCT01484496|102017141|FG000|Period 1|Unable to Visit Site|0|||
33581340|NCT01484496|102017142|FG001|Period 1|Unable to Visit Site|2|||
33581341|NCT01484496|102017143|FG002|Period 1|Unable to Visit Site|0|||
33581342|NCT01484496|102017144|FG003|Period 1|Unable to Visit Site|0|||
33641786|NCT00068419|102240202|FG000|Overall Study|Physician Decision|7|||
33641787|NCT00068419|102240202|FG000|Overall Study|Withdrawal by Subject|14|||
33641788|NCT00068419|102240202|FG000|Overall Study|Ineligible|11|||
33371165|NCT03116399|101243668|FG000|Overall Study|Investigator Decision|1|||
33371166|NCT03116399|101243669|FG001|Overall Study|Investigator Decision|1|||
33641789|NCT02283762|102240205|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
33142986|NCT01133990|100438338|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33241886|NCT00335153|100786239|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
33371167|NCT03116399|101243668|FG000|Overall Study|Withdrawal by Subject|24|||
33371168|NCT03116399|101243669|FG001|Overall Study|Withdrawal by Subject|9|||
33371169|NCT01457118|101243670|FG000|Overall Study|Adverse Event|1|||
33371170|NCT01457118|101243671|FG001|Overall Study|Adverse Event|0|||
33421493|NCT03550794|101434802|FG000|Overall Study|Goals of care changed|1|||
33581343|NCT01484496|102017141|FG000|Period 2|Lack of Efficacy|0|||
33241887|NCT03289455|100786240|FG000|Overall Study|Death|1|||
33241888|NCT03289455|100786241|FG001|Overall Study|Death|0|||
33241889|NCT03289455|100786242|FG002|Overall Study|Death|0|||
33371171|NCT01457118|101243672|FG002|Overall Study|Adverse Event|0|||
33581344|NCT01484496|102017142|FG001|Period 2|Lack of Efficacy|0|||
33371172|NCT01457118|101243673|FG003|Overall Study|Adverse Event|1|||
33581345|NCT01484496|102017143|FG002|Period 2|Lack of Efficacy|1|||
33581346|NCT01484496|102017144|FG003|Period 2|Lack of Efficacy|3|||
33581347|NCT01484496|102017141|FG000|Period 2|Adverse Event|0|||
33581348|NCT01484496|102017142|FG001|Period 2|Adverse Event|0|||
33641790|NCT02283762|102240206|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
33241890|NCT03289455|100786240|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
33241891|NCT03289455|100786241|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
33241892|NCT03289455|100786242|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
33241893|NCT03289455|100786240|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
33241894|NCT03289455|100786241|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
33241895|NCT03289455|100786242|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
33241896|NCT03289455|100786240|FG000|Overall Study|Progressive disease|3|||
33241897|NCT03289455|100786241|FG001|Overall Study|Progressive disease|4|||
33241898|NCT03289455|100786242|FG002|Overall Study|Progressive disease|5|||
33421494|NCT03550794|101434803|FG001|Overall Study|Goals of care changed|0|||
33421495|NCT03550794|101434802|FG000|Overall Study|Withdrawal by Subject|2|||
33241899|NCT00953160|100786246|FG000|Overall Study|Lost to Follow-up|23|||
33241900|NCT00953160|100786246|FG000|Overall Study|Withdrawal by Subject|4|||
33241901|NCT00814489|100786247|FG000|Overall Study|Other|2|||
33241902|NCT00814489|100786248|FG001|Overall Study|Other|0|||
33241903|NCT00814489|100786249|FG002|Overall Study|Other|1|||
33241904|NCT01642186|100786255|FG000|Overall Study|Death|0|||
33241905|NCT01642186|100786256|FG001|Overall Study|Death|2|||
33241906|NCT01642186|100786257|FG002|Overall Study|Death|2|||
33241907|NCT01642186|100786255|FG000|Overall Study|Lost to Follow-up|0|||
33241908|NCT01642186|100786256|FG001|Overall Study|Lost to Follow-up|0|||
33241909|NCT01642186|100786257|FG002|Overall Study|Lost to Follow-up|1|||
33241910|NCT00662909|100786258|FG000|Overall Study|Adverse Event|17|||
33241911|NCT00662909|100786259|FG001|Overall Study|Adverse Event|18|||
33241912|NCT00662909|100786260|FG002|Overall Study|Adverse Event|19|||
33241913|NCT00662909|100786258|FG000|Overall Study|Lack of Efficacy|9|||
33241914|NCT00662909|100786259|FG001|Overall Study|Lack of Efficacy|1|||
33241915|NCT00662909|100786260|FG002|Overall Study|Lack of Efficacy|5|||
33241916|NCT00662909|100786258|FG000|Overall Study|Withdrawal by Subject|29|||
33241917|NCT00662909|100786259|FG001|Overall Study|Withdrawal by Subject|22|||
33241918|NCT00662909|100786260|FG002|Overall Study|Withdrawal by Subject|16|||
33241919|NCT00662909|100786258|FG000|Overall Study|Lost to Follow-up|2|||
33241920|NCT00662909|100786259|FG001|Overall Study|Lost to Follow-up|9|||
33241921|NCT00662909|100786260|FG002|Overall Study|Lost to Follow-up|3|||
33241922|NCT00662909|100786258|FG000|Overall Study|Protocol Violation|7|||
33421496|NCT03550794|101434803|FG001|Overall Study|Withdrawal by Subject|0|||
33421497|NCT03550794|101434802|FG000|Overall Study|Death|0|||
33421498|NCT03550794|101434803|FG001|Overall Study|Death|1|||
33421499|NCT03876873|101434804|FG000|Overall Study|Physician Decision|0|||
33421500|NCT03876873|101434805|FG001|Overall Study|Physician Decision|1|||
33421501|NCT00640614|101434806|FG000|Overall Study|Lost to Follow-up|1|||
33421502|NCT00640614|101434807|FG001|Overall Study|Lost to Follow-up|0|||
33421503|NCT01835470|101434808|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
33421504|NCT01835470|101434808|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
33421505|NCT00566631|101434811|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
33421506|NCT00566631|101434811|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
33421507|NCT00566631|101434811|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
33421508|NCT00566631|101434811|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
33421509|NCT00566631|101434811|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
33421510|NCT00566631|101434811|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
33421511|NCT00566631|101434811|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
33421512|NCT00566631|101434811|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
33581349|NCT01484496|102017143|FG002|Period 2|Adverse Event|5|||
33241923|NCT00662909|100786259|FG001|Overall Study|Protocol Violation|4|||
33241924|NCT00662909|100786260|FG002|Overall Study|Protocol Violation|5|||
33241925|NCT00662909|100786258|FG000|Overall Study|Randomized- never received study drug|1|||
33241926|NCT00662909|100786259|FG001|Overall Study|Randomized- never received study drug|0|||
33241927|NCT00662909|100786260|FG002|Overall Study|Randomized- never received study drug|0|||
33241928|NCT00662909|100786258|FG000|Overall Study|Non-compliance with study procedures|3|||
33241929|NCT00662909|100786259|FG001|Overall Study|Non-compliance with study procedures|3|||
33241930|NCT00662909|100786260|FG002|Overall Study|Non-compliance with study procedures|2|||
33241931|NCT00662909|100786258|FG000|Overall Study|Physician Decision|1|||
33241932|NCT00662909|100786259|FG001|Overall Study|Physician Decision|1|||
33241933|NCT00662909|100786260|FG002|Overall Study|Physician Decision|2|||
33641791|NCT02283762|102240205|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
33241934|NCT00662909|100786258|FG000|Overall Study|Eligibility criterion not met|0|||
33241935|NCT00662909|100786259|FG001|Overall Study|Eligibility criterion not met|1|||
33241936|NCT00662909|100786260|FG002|Overall Study|Eligibility criterion not met|1|||
33241937|NCT04011384|100786261|FG000|Overall Study|Withdrawal by Subject|2|||
33241938|NCT04011384|100786262|FG001|Overall Study|Withdrawal by Subject|0|||
33241939|NCT01598987|100786265|FG000|Baseline to Month 12|Administrative problems|2|||
33421513|NCT00566631|101434811|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
33421514|NCT00566631|101434811|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
33641792|NCT02283762|102240206|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
33241940|NCT01598987|100786265|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
33241941|NCT01598987|100786265|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
33241942|NCT01598987|100786265|FG000|Baseline to 24 Month|Administrative problems|2|||
33241943|NCT01598987|100786265|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
33241944|NCT01268059|100786269|FG000|Overall Study|Lost to Follow-up|0|||
33241945|NCT01268059|100786270|FG001|Overall Study|Lost to Follow-up|1|||
33241946|NCT01268059|100786271|FG002|Overall Study|Lost to Follow-up|0|||
33241947|NCT01268059|100786272|FG003|Overall Study|Lost to Follow-up|0|||
33241948|NCT01268059|100786269|FG000|Overall Study|Withdrawal by Subject|7|||
33241949|NCT01268059|100786270|FG001|Overall Study|Withdrawal by Subject|4|||
33241950|NCT01268059|100786271|FG002|Overall Study|Withdrawal by Subject|0|||
33241951|NCT01268059|100786272|FG003|Overall Study|Withdrawal by Subject|0|||
33241952|NCT01268059|100786269|FG000|Overall Study|Death|20|||
33241953|NCT01268059|100786270|FG001|Overall Study|Death|30|||
33241954|NCT01268059|100786271|FG002|Overall Study|Death|3|||
33241955|NCT01268059|100786272|FG003|Overall Study|Death|5|||
33241956|NCT01268059|100786269|FG000|Overall Study|Progression of disease|1|||
33241957|NCT01268059|100786270|FG001|Overall Study|Progression of disease|0|||
33241958|NCT01268059|100786271|FG002|Overall Study|Progression of disease|0|||
33241959|NCT01268059|100786272|FG003|Overall Study|Progression of disease|0|||
33241960|NCT00550732|100786275|FG000|Overall Study|Death|4|||
33241961|NCT00550732|100786275|FG000|Overall Study|Withdrawal by Subject|2|||
33241962|NCT00550732|100786275|FG000|Overall Study|Physician Decision|2|||
33241963|NCT00550732|100786275|FG000|Overall Study|Lost to Follow-up|1|||
33241964|NCT00550732|100786275|FG000|Overall Study|Palliative care|1|||
33241965|NCT00550732|100786275|FG000|Overall Study|Adverse Event|1|||
33641793|NCT02283762|102240205|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
33641794|NCT02283762|102240206|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
33641795|NCT02283762|102240205|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
33641796|NCT02283762|102240206|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
33641797|NCT02283762|102240205|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
33241966|NCT01027871|100786279|FG000|Overall Study|Physician Decision|1|||
33241967|NCT01027871|100786280|FG001|Overall Study|Physician Decision|5|||
33241968|NCT01027871|100786281|FG002|Overall Study|Physician Decision|0|||
33241969|NCT01027871|100786279|FG000|Overall Study|Protocol Violation|0|||
33241970|NCT01027871|100786280|FG001|Overall Study|Protocol Violation|2|||
33241971|NCT01027871|100786281|FG002|Overall Study|Protocol Violation|2|||
33241972|NCT01027871|100786279|FG000|Overall Study|Withdrawal by Subject|1|||
33241973|NCT01027871|100786280|FG001|Overall Study|Withdrawal by Subject|2|||
33241974|NCT01027871|100786281|FG002|Overall Study|Withdrawal by Subject|2|||
33241975|NCT01027871|100786279|FG000|Overall Study|Adverse Event|0|||
33241976|NCT01027871|100786280|FG001|Overall Study|Adverse Event|2|||
33241977|NCT01027871|100786281|FG002|Overall Study|Adverse Event|2|||
33241978|NCT01027871|100786279|FG000|Overall Study|Sponsor Decision|0|||
33241979|NCT01027871|100786280|FG001|Overall Study|Sponsor Decision|2|||
33241980|NCT01027871|100786281|FG002|Overall Study|Sponsor Decision|0|||
33241981|NCT01027871|100786279|FG000|Overall Study|Discontinued Prior to Treatment|0|||
33581350|NCT01484496|102017144|FG003|Period 2|Adverse Event|13|||
33581351|NCT01484496|102017141|FG000|Period 2|Other|0|||
33581352|NCT01484496|102017142|FG001|Period 2|Other|0|||
33581353|NCT01484496|102017143|FG002|Period 2|Other|9|||
33581354|NCT01484496|102017144|FG003|Period 2|Other|6|||
33581355|NCT01479764|102020033|FG000|Randomized|Adverse Event|1|||
33581356|NCT01479764|102020034|FG001|Randomized|Adverse Event|1|||
33581357|NCT01479764|102020033|FG000|Randomized|Withdrawal by Subject|1|||
33581358|NCT01479764|102020034|FG001|Randomized|Withdrawal by Subject|0|||
33581359|NCT01479764|102020033|FG000|Treated|Lost to Follow-up|0|||
33581360|NCT01479764|102020034|FG001|Treated|Lost to Follow-up|2|||
33581361|NCT02477527|102020037|FG000|Overall Study|Lost to Follow-up|2|||
33581362|NCT02477527|102020037|FG000|Overall Study|Withdrawal by Subject|1|||
33641798|NCT02283762|102240206|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
33641799|NCT02283762|102240205|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
33241982|NCT01027871|100786280|FG001|Overall Study|Discontinued Prior to Treatment|0|||
33241983|NCT01027871|100786281|FG002|Overall Study|Discontinued Prior to Treatment|1|||
33241984|NCT01348854|100786282|FG000|Overall Study|Lost to Follow-up|2|||
33241985|NCT01348854|100786283|FG001|Overall Study|Lost to Follow-up|1|||
33371173|NCT01457118|101243670|FG000|Overall Study|Clinical Progression|0|||
33241986|NCT01348854|100786282|FG000|Overall Study|Withdrawal by Subject|1|||
33241987|NCT01348854|100786283|FG001|Overall Study|Withdrawal by Subject|0|||
33241988|NCT01555762|100786289|FG000|Overall Study|No information on Bevacizumab intake|11|||
33241989|NCT01555762|100786289|FG000|Overall Study|Missing start date of infusion|8|||
33581363|NCT02477527|102020037|FG000|Overall Study|Screen Failure|3|||
33581364|NCT00809926|102020041|FG000|Overall Study|Adverse Event|18|||
33241990|NCT01555762|100786289|FG000|Overall Study|75 years old or more ticked No|1|||
33371174|NCT01457118|101243671|FG001|Overall Study|Clinical Progression|1|||
33581365|NCT00809926|102020042|FG001|Overall Study|Adverse Event|10|||
33581366|NCT00809926|102020041|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
33581367|NCT00809926|102020042|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33581368|NCT00809926|102020041|FG000|Overall Study|Patient withdrew consent|8|||
33581369|NCT00809926|102020042|FG001|Overall Study|Patient withdrew consent|6|||
33581370|NCT00809926|102020041|FG000|Overall Study|Lost to Follow-up|2|||
33581371|NCT00809926|102020042|FG001|Overall Study|Lost to Follow-up|1|||
33581372|NCT00809926|102020041|FG000|Overall Study|Administrative Problems|0|||
33581373|NCT00809926|102020042|FG001|Overall Study|Administrative Problems|1|||
33581374|NCT00809926|102020041|FG000|Overall Study|Protocol deviation|0|||
33581375|NCT00809926|102020042|FG001|Overall Study|Protocol deviation|2|||
33581376|NCT01977898|102020043|FG000|Overall Study|Non functioning catheter|1|||
33581377|NCT01977898|102020044|FG001|Overall Study|Non functioning catheter|1|||
33581378|NCT02931838|102020045|FG000|Overall Study|Reason not provided by investigator|1|||
33581379|NCT02931838|102020046|FG001|Overall Study|Reason not provided by investigator|0|||
33581380|NCT02931838|102020047|FG002|Overall Study|Reason not provided by investigator|1|||
33581381|NCT02931838|102020048|FG003|Overall Study|Reason not provided by investigator|0|||
33581382|NCT02931838|102020049|FG004|Overall Study|Reason not provided by investigator|0|||
33581383|NCT02931838|102020050|FG005|Overall Study|Reason not provided by investigator|0|||
33581384|NCT02931838|102020045|FG000|Overall Study|Poor/non-compliance|0|||
33581385|NCT02931838|102020046|FG001|Overall Study|Poor/non-compliance|0|||
33581386|NCT02931838|102020047|FG002|Overall Study|Poor/non-compliance|1|||
33581387|NCT02931838|102020048|FG003|Overall Study|Poor/non-compliance|0|||
33581388|NCT02931838|102020049|FG004|Overall Study|Poor/non-compliance|0|||
33581389|NCT02931838|102020050|FG005|Overall Study|Poor/non-compliance|0|||
33581390|NCT02931838|102020045|FG000|Overall Study|Lack of Efficacy|5|||
33581391|NCT02931838|102020046|FG001|Overall Study|Lack of Efficacy|4|||
33581392|NCT02931838|102020047|FG002|Overall Study|Lack of Efficacy|0|||
33581393|NCT02931838|102020048|FG003|Overall Study|Lack of Efficacy|0|||
33581394|NCT02931838|102020049|FG004|Overall Study|Lack of Efficacy|0|||
33581395|NCT02931838|102020050|FG005|Overall Study|Lack of Efficacy|1|||
33581396|NCT02931838|102020045|FG000|Overall Study|Lost to Follow-up|1|||
33581397|NCT02931838|102020046|FG001|Overall Study|Lost to Follow-up|0|||
33241991|NCT01555762|100786289|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
33241992|NCT01555762|100786289|FG000|Overall Study|Death linked to progression of disease|165|||
33241993|NCT01555762|100786289|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
33241994|NCT01555762|100786289|FG000|Overall Study|Investigator's decision|10|||
33241995|NCT01555762|100786289|FG000|Overall Study|Participant not wishing to continue|5|||
33241996|NCT01555762|100786289|FG000|Overall Study|Missing data|1|||
33241997|NCT01555762|100786289|FG000|Overall Study|Death linked to an adverse event|14|||
33241998|NCT04530344|100786290|FG000|Overall Study|Lost to Follow-up|3|||
33241999|NCT04530344|100786291|FG001|Overall Study|Lost to Follow-up|3|||
33242000|NCT04530344|100786292|FG002|Overall Study|Lost to Follow-up|3|||
33242001|NCT04530344|100786293|FG003|Overall Study|Lost to Follow-up|10|||
33242002|NCT04530344|100786290|FG000|Overall Study|Withdrawal by Subject|14|||
33371175|NCT01457118|101243672|FG002|Overall Study|Clinical Progression|0|||
33371176|NCT01457118|101243673|FG003|Overall Study|Clinical Progression|1|||
33371177|NCT01457118|101243670|FG000|Overall Study|Physician Decision|2|||
33371178|NCT01457118|101243671|FG001|Overall Study|Physician Decision|0|||
33371179|NCT01457118|101243672|FG002|Overall Study|Physician Decision|0|||
33371180|NCT01457118|101243673|FG003|Overall Study|Physician Decision|0|||
33371181|NCT01457118|101243670|FG000|Overall Study|Progressive Disease by RECIST|12|||
33371182|NCT01457118|101243671|FG001|Overall Study|Progressive Disease by RECIST|3|||
33371183|NCT01457118|101243672|FG002|Overall Study|Progressive Disease by RECIST|1|||
33371184|NCT01457118|101243673|FG003|Overall Study|Progressive Disease by RECIST|0|||
33371185|NCT01457118|101243670|FG000|Overall Study|Withdrawal by Subject|5|||
33371186|NCT01457118|101243671|FG001|Overall Study|Withdrawal by Subject|0|||
33371187|NCT01457118|101243672|FG002|Overall Study|Withdrawal by Subject|0|||
33371188|NCT01457118|101243673|FG003|Overall Study|Withdrawal by Subject|0|||
33371189|NCT00915005|101243676|FG000|Overall Study|Withdrawal by Subject|4|||
33371190|NCT00915005|101243677|FG001|Overall Study|Withdrawal by Subject|4|||
33371191|NCT00915005|101243676|FG000|Overall Study|Patient preferred protons therapy|6|||
33371192|NCT00915005|101243677|FG001|Overall Study|Patient preferred protons therapy|0|||
33371193|NCT00915005|101243676|FG000|Overall Study|Insurance denial|3|||
33641800|NCT02283762|102240206|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
33641801|NCT02283762|102240205|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
33641802|NCT02283762|102240206|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
33242003|NCT04530344|100786291|FG001|Overall Study|Withdrawal by Subject|5|||
33242004|NCT04530344|100786292|FG002|Overall Study|Withdrawal by Subject|18|||
33371194|NCT00915005|101243677|FG001|Overall Study|Insurance denial|15|||
33371195|NCT03260205|101243678|FG000|Overall Study|Adverse Event|2|||
33371196|NCT03260205|101243679|FG001|Overall Study|Adverse Event|0|||
33371197|NCT03260205|101243680|FG002|Overall Study|Adverse Event|2|||
33581398|NCT02931838|102020047|FG002|Overall Study|Lost to Follow-up|1|||
33581399|NCT02931838|102020048|FG003|Overall Study|Lost to Follow-up|1|||
33581400|NCT02931838|102020049|FG004|Overall Study|Lost to Follow-up|2|||
33581401|NCT02931838|102020050|FG005|Overall Study|Lost to Follow-up|0|||
33581402|NCT02931838|102020045|FG000|Overall Study|Subject request to discontinue treatment|4|||
33581403|NCT02931838|102020046|FG001|Overall Study|Subject request to discontinue treatment|3|||
33371198|NCT03260205|101243681|FG003|Overall Study|Adverse Event|2|||
33371199|NCT03260205|101243682|FG004|Overall Study|Adverse Event|4|||
33371200|NCT03260205|101243678|FG000|Overall Study|Lost to Follow-up|2|||
33371201|NCT03260205|101243679|FG001|Overall Study|Lost to Follow-up|2|||
33371202|NCT03260205|101243680|FG002|Overall Study|Lost to Follow-up|1|||
33371203|NCT03260205|101243681|FG003|Overall Study|Lost to Follow-up|1|||
33242005|NCT04530344|100786293|FG003|Overall Study|Withdrawal by Subject|33|||
33242006|NCT04530344|100786290|FG000|Overall Study|Adverse Event|0|||
33242007|NCT04530344|100786291|FG001|Overall Study|Adverse Event|0|||
33242008|NCT04530344|100786292|FG002|Overall Study|Adverse Event|0|||
33242009|NCT04530344|100786293|FG003|Overall Study|Adverse Event|1|||
33242010|NCT04530344|100786290|FG000|Overall Study|Lack of Efficacy|0|||
33242011|NCT04530344|100786291|FG001|Overall Study|Lack of Efficacy|0|||
33242012|NCT04530344|100786292|FG002|Overall Study|Lack of Efficacy|0|||
33242013|NCT04530344|100786293|FG003|Overall Study|Lack of Efficacy|1|||
33242014|NCT04530344|100786290|FG000|Overall Study|Physician Decision|0|||
33242015|NCT04530344|100786291|FG001|Overall Study|Physician Decision|0|||
33242016|NCT04530344|100786292|FG002|Overall Study|Physician Decision|1|||
33242017|NCT04530344|100786293|FG003|Overall Study|Physician Decision|1|||
33242018|NCT04530344|100786290|FG000|Overall Study|Pregnancy|0|||
33242019|NCT04530344|100786291|FG001|Overall Study|Pregnancy|0|||
33242020|NCT04530344|100786292|FG002|Overall Study|Pregnancy|2|||
33242021|NCT04530344|100786293|FG003|Overall Study|Pregnancy|1|||
33242022|NCT04530344|100786290|FG000|Overall Study|Protocol Violation|0|||
33371204|NCT03260205|101243682|FG004|Overall Study|Lost to Follow-up|5|||
33371205|NCT03260205|101243678|FG000|Overall Study|Protocol Violation|0|||
33371206|NCT03260205|101243679|FG001|Overall Study|Protocol Violation|0|||
33371207|NCT03260205|101243680|FG002|Overall Study|Protocol Violation|2|||
33371208|NCT03260205|101243681|FG003|Overall Study|Protocol Violation|0|||
33371209|NCT03260205|101243682|FG004|Overall Study|Protocol Violation|1|||
33371210|NCT03260205|101243678|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
33371211|NCT03260205|101243679|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
33371212|NCT03260205|101243680|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
33371213|NCT03260205|101243681|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
33421515|NCT00566631|101434811|FG000|Part 2: Extension Phase|Adverse Event|11|||
33421516|NCT00566631|101434811|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
33641803|NCT02283762|102240205|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
33641804|NCT02283762|102240206|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
33641805|NCT02283762|102240205|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
33641806|NCT02283762|102240206|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
33641807|NCT02283762|102240205|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
33142987|NCT01133990|100438339|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33142988|NCT01133990|100438340|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
33142989|NCT01133990|100438335|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
33142990|NCT01133990|100438336|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
33142991|NCT01133990|100438337|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
33142992|NCT01133990|100438338|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
33142993|NCT01133990|100438339|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
33142994|NCT01133990|100438340|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
33142995|NCT01133990|100438335|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
33142996|NCT01133990|100438336|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
33142997|NCT01133990|100438337|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
33142998|NCT01133990|100438338|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
33142999|NCT01133990|100438339|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
33143000|NCT01133990|100438340|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
33143001|NCT01133990|100438335|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
33143002|NCT01133990|100438336|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
33143003|NCT01133990|100438337|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
33143004|NCT01133990|100438338|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
33143005|NCT01133990|100438339|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
33143006|NCT01133990|100438340|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
33143007|NCT00420641|100438341|FG000|Overall Study|Adverse Event|3|||
33143008|NCT00420641|100438342|FG001|Overall Study|Adverse Event|25|||
33143009|NCT00420641|100438343|FG002|Overall Study|Adverse Event|10|||
33143010|NCT00420641|100438341|FG000|Overall Study|Lost to Follow-up|2|||
33143011|NCT00420641|100438342|FG001|Overall Study|Lost to Follow-up|4|||
33143012|NCT00420641|100438343|FG002|Overall Study|Lost to Follow-up|2|||
33143013|NCT00420641|100438341|FG000|Overall Study|Protocol Violation|8|||
33143014|NCT00420641|100438342|FG001|Overall Study|Protocol Violation|8|||
33143015|NCT00420641|100438343|FG002|Overall Study|Protocol Violation|7|||
33143016|NCT00420641|100438341|FG000|Overall Study|Withdrawal by Subject|15|||
33143017|NCT00420641|100438342|FG001|Overall Study|Withdrawal by Subject|21|||
33143018|NCT00420641|100438343|FG002|Overall Study|Withdrawal by Subject|14|||
33242023|NCT04530344|100786291|FG001|Overall Study|Protocol Violation|0|||
33242024|NCT04530344|100786292|FG002|Overall Study|Protocol Violation|0|||
33242025|NCT04530344|100786293|FG003|Overall Study|Protocol Violation|1|||
33242026|NCT04530344|100786290|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
33242027|NCT04530344|100786291|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
33242028|NCT04530344|100786292|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
33242029|NCT04530344|100786293|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
33242030|NCT04530344|100786290|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
33242031|NCT04530344|100786291|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
33242032|NCT04530344|100786292|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
33242033|NCT04530344|100786293|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
33242034|NCT04530344|100786290|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
33242035|NCT04530344|100786291|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
33242036|NCT04530344|100786292|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
33242037|NCT04530344|100786293|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
33242038|NCT04530344|100786290|FG000|Overall Study|Personal Reasons|0|||
33242039|NCT04530344|100786291|FG001|Overall Study|Personal Reasons|0|||
33242040|NCT04530344|100786292|FG002|Overall Study|Personal Reasons|0|||
33242041|NCT04530344|100786293|FG003|Overall Study|Personal Reasons|1|||
33242042|NCT04530344|100786290|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
33242043|NCT04530344|100786291|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
33242044|NCT04530344|100786292|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
33242045|NCT04530344|100786293|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
33242046|NCT00551213|100786294|FG000|Overall Study|Adverse Event|6|||
33242047|NCT00551213|100786295|FG001|Overall Study|Adverse Event|3|||
33242048|NCT00551213|100786294|FG000|Overall Study|Progressive Disease|41|||
33641808|NCT02283762|102240206|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
33641809|NCT02283762|102240205|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
33641810|NCT02283762|102240206|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
33641811|NCT02283762|102240205|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
33641812|NCT02283762|102240206|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
33641813|NCT04328077|102240209|FG000|Overall Study|Lost to Follow-up|0|||
33641814|NCT04328077|102240210|FG001|Overall Study|Lost to Follow-up|1|||
33641815|NCT04328077|102240211|FG002|Overall Study|Lost to Follow-up|0|||
33242049|NCT00551213|100786295|FG001|Overall Study|Progressive Disease|12|||
33641816|NCT04328077|102240212|FG003|Overall Study|Lost to Follow-up|0|||
33641817|NCT04328077|102240209|FG000|Overall Study|Withdrawal by Subject|0|||
33641818|NCT04328077|102240210|FG001|Overall Study|Withdrawal by Subject|1|||
33641819|NCT04328077|102240211|FG002|Overall Study|Withdrawal by Subject|1|||
33641820|NCT04328077|102240212|FG003|Overall Study|Withdrawal by Subject|3|||
33641821|NCT00387790|102240213|FG000|Overall Study|Adverse Event|5|||
33641822|NCT00387790|102240213|FG000|Overall Study|Lack of Efficacy|2|||
33641823|NCT00387790|102240213|FG000|Overall Study|Physician Decision|2|||
33641824|NCT00387790|102240213|FG000|Overall Study|Withdrawal by Subject|3|||
33641825|NCT00387790|102240213|FG000|Overall Study|Ineligible for study|2|||
33641826|NCT03070964|102240214|FG000|Overall Study|Progressive disease|8|||
33641827|NCT03070964|102240214|FG000|Overall Study|Treatment-unrelated adverse event|2|||
33641828|NCT03070964|102240214|FG000|Overall Study|Never treated|1|||
33641829|NCT03070964|102240214|FG000|Overall Study|Physician Decision|1|||
33641830|NCT03070964|102240214|FG000|Overall Study|Withdrawal by Subject|1|||
33242050|NCT00551213|100786294|FG000|Overall Study|Withdrawal by Subject|2|||
33242051|NCT00551213|100786295|FG001|Overall Study|Withdrawal by Subject|0|||
33242052|NCT00551213|100786294|FG000|Overall Study|Not Treated|1|||
33242053|NCT00551213|100786295|FG001|Overall Study|Not Treated|2|||
33242054|NCT02179918|100786296|FG000|Overall Study|Death|0|||
33242055|NCT02179918|100786297|FG001|Overall Study|Death|0|||
33242056|NCT02179918|100786298|FG002|Overall Study|Death|0|||
33242057|NCT02179918|100786299|FG003|Overall Study|Death|1|||
33371214|NCT03260205|101243682|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
33371215|NCT03260205|101243678|FG000|Overall Study|Other: Unspecified|0|||
33641831|NCT03070964|102240214|FG000|Overall Study|Adverse Event|1|||
33242058|NCT02179918|100786300|FG004|Overall Study|Death|0|||
33242059|NCT02179918|100786296|FG000|Overall Study|Lost to Follow-up|0|||
33242060|NCT02179918|100786297|FG001|Overall Study|Lost to Follow-up|0|||
33242061|NCT02179918|100786298|FG002|Overall Study|Lost to Follow-up|1|||
33242062|NCT02179918|100786299|FG003|Overall Study|Lost to Follow-up|0|||
33242063|NCT02179918|100786300|FG004|Overall Study|Lost to Follow-up|0|||
33242064|NCT02179918|100786296|FG000|Overall Study|Progressive Disease|4|||
33242065|NCT02179918|100786297|FG001|Overall Study|Progressive Disease|1|||
33242066|NCT02179918|100786298|FG002|Overall Study|Progressive Disease|1|||
33242067|NCT02179918|100786299|FG003|Overall Study|Progressive Disease|2|||
33641832|NCT00392769|102240215|FG000|Overall Study|Clinical Deterioration|9|||
33641833|NCT00392769|102240215|FG000|Overall Study|Adverse Event|1|||
33641834|NCT01160822|102240216|FG000|Overall Study|Adverse Event|0|||
33641835|NCT01160822|102240217|FG001|Overall Study|Adverse Event|0|||
33641836|NCT01160822|102240218|FG002|Overall Study|Adverse Event|0|||
33242068|NCT02179918|100786300|FG004|Overall Study|Progressive Disease|6|||
33242069|NCT02179918|100786296|FG000|Overall Study|Other|0|||
33242070|NCT02179918|100786297|FG001|Overall Study|Other|1|||
33242071|NCT02179918|100786298|FG002|Overall Study|Other|0|||
33242072|NCT02179918|100786299|FG003|Overall Study|Other|0|||
33371216|NCT03260205|101243679|FG001|Overall Study|Other: Unspecified|0|||
33581404|NCT02931838|102020047|FG002|Overall Study|Subject request to discontinue treatment|3|||
33581405|NCT02931838|102020048|FG003|Overall Study|Subject request to discontinue treatment|0|||
33371217|NCT03260205|101243680|FG002|Overall Study|Other: Unspecified|3|||
33371218|NCT03260205|101243681|FG003|Overall Study|Other: Unspecified|1|||
33371219|NCT03260205|101243682|FG004|Overall Study|Other: Unspecified|1|||
33242073|NCT02179918|100786300|FG004|Overall Study|Other|1|||
33371220|NCT03260205|101243678|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
33371221|NCT03260205|101243679|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
33371222|NCT03260205|101243680|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
33371223|NCT03260205|101243681|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
33371224|NCT03260205|101243682|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
33371225|NCT00118482|101243683|FG000|Overall Study|Lost to Follow-up|7|||
33371226|NCT00118482|101243684|FG001|Overall Study|Lost to Follow-up|7|||
33371227|NCT00118482|101243683|FG000|Overall Study|Withdrawal by Subject|23|||
33371228|NCT00118482|101243684|FG001|Overall Study|Withdrawal by Subject|22|||
33371229|NCT01856595|101243685|FG000|Overall Study|Withdrawal by Subject|0|||
33371230|NCT01856595|101243686|FG001|Overall Study|Withdrawal by Subject|1|||
33371231|NCT01856595|101243687|FG002|Overall Study|Withdrawal by Subject|0|||
33371232|NCT01856595|101243688|FG003|Overall Study|Withdrawal by Subject|0|||
33371233|NCT01856595|101243689|FG004|Overall Study|Withdrawal by Subject|0|||
33371234|NCT01856595|101243690|FG005|Overall Study|Withdrawal by Subject|0|||
33371235|NCT01856595|101243691|FG006|Overall Study|Withdrawal by Subject|1|||
33371236|NCT01856595|101243692|FG007|Overall Study|Withdrawal by Subject|0|||
33371237|NCT01856595|101243693|FG008|Overall Study|Withdrawal by Subject|0|||
33371238|NCT02196038|101243694|FG000|Overall Study|Death|16|||
33371239|NCT02196038|101243695|FG001|Overall Study|Death|21|||
33371240|NCT02196038|101243694|FG000|Overall Study|Withdrawal by Subject|0|||
33371241|NCT02196038|101243695|FG001|Overall Study|Withdrawal by Subject|1|||
33371242|NCT02196038|101243694|FG000|Overall Study|Lost to Follow-up|1|||
33371243|NCT02196038|101243695|FG001|Overall Study|Lost to Follow-up|0|||
33371244|NCT03255291|101243696|FG000|Overall Study|Determined to be ineligible|10|||
33371245|NCT03255291|101243697|FG001|Overall Study|Determined to be ineligible|12|||
33371246|NCT03255291|101243698|FG002|Overall Study|Determined to be ineligible|6|||
33371247|NCT03255291|101243699|FG003|Overall Study|Determined to be ineligible|6|||
33371248|NCT03255291|101243700|FG004|Overall Study|Determined to be ineligible|5|||
33371249|NCT03255291|101243701|FG005|Overall Study|Determined to be ineligible|10|||
33371250|NCT03255291|101243696|FG000|Overall Study|Baseline data collection issues|3|||
33371251|NCT03255291|101243697|FG001|Overall Study|Baseline data collection issues|0|||
33371252|NCT03255291|101243698|FG002|Overall Study|Baseline data collection issues|0|||
33371253|NCT03255291|101243699|FG003|Overall Study|Baseline data collection issues|0|||
33371254|NCT03255291|101243700|FG004|Overall Study|Baseline data collection issues|2|||
33371255|NCT03255291|101243701|FG005|Overall Study|Baseline data collection issues|0|||
33371256|NCT02202031|101243702|FG000|Overall Study|Lost to Follow-up|1|||
33371257|NCT02202031|101243703|FG001|Overall Study|Lost to Follow-up|0|||
33371258|NCT02202031|101243702|FG000|Overall Study|Too Busy|1|||
33371259|NCT02202031|101243703|FG001|Overall Study|Too Busy|3|||
33371260|NCT02202031|101243702|FG000|Overall Study|Illness/Medical Reason|0|||
33371261|NCT02202031|101243703|FG001|Overall Study|Illness/Medical Reason|2|||
33421517|NCT00566631|101434811|FG000|Part 2: Extension Phase|Death|1|||
33421518|NCT00566631|101434811|FG000|Part 2: Extension Phase|Other|5|||
33421519|NCT02441179|101434813|FG000|Overall Study|Withdrawal by Subject|1|||
33421520|NCT02441179|101434814|FG001|Overall Study|Withdrawal by Subject|1|||
33421521|NCT03940586|101434815|FG000|Overall Study|Death|3|||
33421522|NCT03940586|101434816|FG001|Overall Study|Death|2|||
33421523|NCT03940586|101434817|FG002|Overall Study|Death|0|||
33371262|NCT02202031|101243702|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
33371263|NCT02202031|101243703|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
33371264|NCT02849990|101243704|FG000|Overall Study|Adverse Event|1|||
33371265|NCT02849990|101243704|FG000|Overall Study|Withdrawal by Subject|1|||
33371266|NCT00069576|101243705|FG000|Original Trial|Lost to Follow-up|25|||
33371267|NCT00069576|101243706|FG001|Original Trial|Lost to Follow-up|33|||
33421524|NCT03940586|101434815|FG000|Overall Study|Physician Decision|1|||
33641837|NCT01160822|102240219|FG003|Overall Study|Adverse Event|0|||
33371268|NCT00069576|101243705|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
33371269|NCT00069576|101243706|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
33371270|NCT00316303|101243707|FG000|Overall Study|Lost to Follow-up|11|||
33421525|NCT03940586|101434816|FG001|Overall Study|Physician Decision|0|||
33421526|NCT03940586|101434817|FG002|Overall Study|Physician Decision|1|||
33421527|NCT03940586|101434815|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
33242074|NCT02179918|100786296|FG000|Overall Study|Subject refused further follow-up|0|||
33371271|NCT00316303|101243708|FG001|Overall Study|Lost to Follow-up|16|||
33371272|NCT01029002|101243710|FG000|Overall Study|Lost to Follow-up|2|||
33371273|NCT01029002|101243711|FG001|Overall Study|Lost to Follow-up|4|||
33371274|NCT02361762|101243713|FG000|Overall Study|Withdrawal by Subject|0|||
33371275|NCT02361762|101243714|FG001|Overall Study|Withdrawal by Subject|1|||
33371276|NCT02361762|101243713|FG000|Overall Study|Lost to Follow-up|0|||
33371277|NCT02361762|101243714|FG001|Overall Study|Lost to Follow-up|1|||
33371278|NCT01419665|101243715|FG000|Combination Treatment|Adverse Event|7|||
33371279|NCT01419665|101243716|FG001|Combination Treatment|Adverse Event|10|||
33371280|NCT01419665|101243715|FG000|Combination Treatment|Physician Decision|5|||
33371281|NCT01419665|101243716|FG001|Combination Treatment|Physician Decision|8|||
33371282|NCT01419665|101243715|FG000|Combination Treatment|Protocol Violation|6|||
33371283|NCT01419665|101243716|FG001|Combination Treatment|Protocol Violation|2|||
33371284|NCT01419665|101243715|FG000|Combination Treatment|disease progression|10|||
33371285|NCT01419665|101243716|FG001|Combination Treatment|disease progression|9|||
33371286|NCT01419665|101243715|FG000|Combination Treatment|Death|5|||
33371287|NCT01419665|101243716|FG001|Combination Treatment|Death|7|||
33371288|NCT01419665|101243715|FG000|Combination Treatment|administrative problems|0|||
33371289|NCT01419665|101243716|FG001|Combination Treatment|administrative problems|1|||
33371290|NCT01419665|101243715|FG000|Combination Treatment|Withdrawal by Subject|5|||
33371291|NCT01419665|101243716|FG001|Combination Treatment|Withdrawal by Subject|4|||
33371292|NCT01419665|101243715|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
33371293|NCT01419665|101243716|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
33371294|NCT01419665|101243715|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
33371295|NCT01419665|101243716|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
33371296|NCT01419665|101243715|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
33371297|NCT01419665|101243716|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
33371298|NCT01419665|101243715|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
33371299|NCT01419665|101243716|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
33371300|NCT01419665|101243715|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
33371301|NCT01419665|101243716|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
33371302|NCT01419665|101243715|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
33371303|NCT01419665|101243716|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
33371304|NCT01419665|101243715|FG000|Maintenance Treatment and/or Follow up|Death|1|||
33371305|NCT01419665|101243716|FG001|Maintenance Treatment and/or Follow up|Death|2|||
33371306|NCT01419665|101243715|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
33371307|NCT01419665|101243716|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
33371308|NCT01419665|101243715|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
33371309|NCT01419665|101243716|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
33371310|NCT01419665|101243715|FG000|Open Label Phase|Death|1|||
33371311|NCT01419665|101243716|FG001|Open Label Phase|Death|0|||
33371312|NCT01419665|101243715|FG000|Open Label Phase|disease progression|0|||
33371313|NCT01419665|101243716|FG001|Open Label Phase|disease progression|1|||
33371314|NCT00943319|101243719|FG000|Overall Study|Death|1|||
33371315|NCT04369430|101243728|FG000|Overall Study|Adverse Event|2|||
33371316|NCT04369430|101243729|FG001|Overall Study|Adverse Event|3|||
33371317|NCT04369430|101243728|FG000|Overall Study|Death|1|||
33371318|NCT04369430|101243729|FG001|Overall Study|Death|0|||
33371319|NCT04369430|101243728|FG000|Overall Study|Withdrawal by Subject|4|||
33371320|NCT04369430|101243729|FG001|Overall Study|Withdrawal by Subject|3|||
33371321|NCT04369430|101243728|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
33371322|NCT04369430|101243729|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
33371323|NCT04369430|101243728|FG000|Overall Study|Lost to Follow-up|0|||
33371324|NCT04369430|101243729|FG001|Overall Study|Lost to Follow-up|1|||
33371325|NCT01474746|101243733|FG000|Overall Study|Lost to Follow-up|1|||
33371326|NCT01474746|101243734|FG001|Overall Study|Lost to Follow-up|1|||
33371327|NCT01474746|101243733|FG000|Overall Study|Withdrawal by Subject|2|||
33371328|NCT01474746|101243734|FG001|Overall Study|Withdrawal by Subject|1|||
33371329|NCT00913978|101243735|FG000|Overall Study|Surgeon choice|1|||
33371330|NCT00913978|101243736|FG001|Overall Study|Surgeon choice|3|||
33371331|NCT02678741|101243737|FG000|Overall Study|Death|4|||
33371332|NCT02678741|101243737|FG000|Overall Study|Withdrawal by Subject|1|||
33371333|NCT02678741|101243737|FG000|Overall Study|ineligible|3|||
33371334|NCT02678741|101243737|FG000|Overall Study|Not RECIST Measurable|2|||
33421528|NCT03940586|101434816|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
33371335|NCT02678741|101243737|FG000|Overall Study|Lack of Efficacy|10|||
33371336|NCT00372190|101243738|FG000|Overall Study|Lost to Follow-up|3|||
33371337|NCT00372190|101243739|FG001|Overall Study|Lost to Follow-up|1|||
33371338|NCT02998554|101243740|FG000|Overall Study|Adverse Event|8|||
33371339|NCT02998554|101243741|FG001|Overall Study|Adverse Event|3|||
33371340|NCT02998554|101243740|FG000|Overall Study|Protocol deviation|1|||
33371341|NCT02998554|101243741|FG001|Overall Study|Protocol deviation|0|||
33371342|NCT02998554|101243740|FG000|Overall Study|Withdrawal by Subject|2|||
33371343|NCT02998554|101243741|FG001|Overall Study|Withdrawal by Subject|6|||
33371344|NCT02998554|101243740|FG000|Overall Study|Lost to Follow-up|0|||
33371345|NCT02998554|101243741|FG001|Overall Study|Lost to Follow-up|1|||
33421529|NCT03940586|101434817|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
33421530|NCT03940586|101434815|FG000|Overall Study|Not Treated|0|||
33143019|NCT00420641|100438341|FG000|Overall Study|Lack of Efficacy|6|||
33143020|NCT00420641|100438342|FG001|Overall Study|Lack of Efficacy|5|||
33143021|NCT00420641|100438343|FG002|Overall Study|Lack of Efficacy|4|||
33371346|NCT02998554|101243740|FG000|Overall Study|Lack of Efficacy|0|||
33371347|NCT02998554|101243741|FG001|Overall Study|Lack of Efficacy|1|||
33371348|NCT01930799|101243746|FG000|Overall Study|Withdrawal by Subject|3|||
33371349|NCT01930799|101243746|FG000|Overall Study|Lost to Follow-up|5|||
33371350|NCT01228071|101243749|FG000|Overall Study|Protocol Violation|1|||
33371351|NCT01228071|101243749|FG000|Overall Study|Withdrawal by Subject|1|||
33371352|NCT02435277|101243754|FG000|Overall Study|Adverse Event|1|||
33371353|NCT02435277|101243755|FG001|Overall Study|Adverse Event|1|||
33371354|NCT02435277|101243756|FG002|Overall Study|Adverse Event|0|||
33421531|NCT03940586|101434816|FG001|Overall Study|Not Treated|2|||
33421532|NCT03940586|101434817|FG002|Overall Study|Not Treated|0|||
33421533|NCT01020773|101434820|FG000|Overall Study|Withdrawal by Subject|4|||
33421534|NCT01020773|101434821|FG001|Overall Study|Withdrawal by Subject|3|||
33421535|NCT02295280|101434822|FG000|Overall Study|Adverse Event|0|||
33421536|NCT02295280|101434823|FG001|Overall Study|Adverse Event|1|||
33421537|NCT00665626|101434828|FG000|Overall Study|Lack of Efficacy|8|||
33421538|NCT00665626|101434829|FG001|Overall Study|Lack of Efficacy|5|||
33143022|NCT00420641|100438341|FG000|Overall Study|Non-compliance|7|||
33143023|NCT00420641|100438342|FG001|Overall Study|Non-compliance|5|||
33143024|NCT00420641|100438343|FG002|Overall Study|Non-compliance|4|||
33143025|NCT00420641|100438341|FG000|Overall Study|Other|4|||
33143026|NCT00420641|100438342|FG001|Overall Study|Other|4|||
33143027|NCT00420641|100438343|FG002|Overall Study|Other|3|||
33143028|NCT03533686|100438344|FG000|Overall Study|Withdrawal by Subject|1|||
33143029|NCT03533686|100438345|FG001|Overall Study|Withdrawal by Subject|0|||
33143030|NCT03533686|100438346|FG002|Overall Study|Withdrawal by Subject|0|||
33143031|NCT03533686|100438347|FG003|Overall Study|Withdrawal by Subject|3|||
33143032|NCT03533686|100438348|FG004|Overall Study|Withdrawal by Subject|5|||
33143033|NCT03533686|100438349|FG005|Overall Study|Withdrawal by Subject|1|||
33143034|NCT03533686|100438344|FG000|Overall Study|Lost to Follow-up|0|||
33143035|NCT03533686|100438345|FG001|Overall Study|Lost to Follow-up|1|||
33143036|NCT03533686|100438346|FG002|Overall Study|Lost to Follow-up|0|||
33143037|NCT03533686|100438347|FG003|Overall Study|Lost to Follow-up|0|||
33143038|NCT03533686|100438348|FG004|Overall Study|Lost to Follow-up|2|||
33143039|NCT03533686|100438349|FG005|Overall Study|Lost to Follow-up|0|||
33143040|NCT03533686|100438344|FG000|Overall Study|Screen Failure|0|||
33143041|NCT03533686|100438345|FG001|Overall Study|Screen Failure|0|||
33143042|NCT03533686|100438346|FG002|Overall Study|Screen Failure|0|||
33143043|NCT03533686|100438347|FG003|Overall Study|Screen Failure|2|||
33143044|NCT03533686|100438348|FG004|Overall Study|Screen Failure|0|||
33143045|NCT03533686|100438349|FG005|Overall Study|Screen Failure|0|||
33421539|NCT00665626|101434828|FG000|Overall Study|Lost to Follow-up|0|||
33421540|NCT00665626|101434829|FG001|Overall Study|Lost to Follow-up|2|||
33421541|NCT00665626|101434828|FG000|Overall Study|Withdrawal by Subject|0|||
33581406|NCT02931838|102020049|FG004|Overall Study|Subject request to discontinue treatment|1|||
33581407|NCT02931838|102020050|FG005|Overall Study|Subject request to discontinue treatment|0|||
33581408|NCT02931838|102020045|FG000|Overall Study|Withdrawal by Subject|1|||
33581409|NCT02931838|102020046|FG001|Overall Study|Withdrawal by Subject|2|||
33581410|NCT02931838|102020047|FG002|Overall Study|Withdrawal by Subject|0|||
33581411|NCT02931838|102020048|FG003|Overall Study|Withdrawal by Subject|1|||
33581412|NCT02931838|102020049|FG004|Overall Study|Withdrawal by Subject|0|||
33581413|NCT02931838|102020050|FG005|Overall Study|Withdrawal by Subject|0|||
33581414|NCT02931838|102020045|FG000|Overall Study|Adverse Event|2|||
33581415|NCT02931838|102020046|FG001|Overall Study|Adverse Event|1|||
33581416|NCT02931838|102020047|FG002|Overall Study|Adverse Event|2|||
33641838|NCT01160822|102240220|FG004|Overall Study|Adverse Event|1|||
33641839|NCT01160822|102240221|FG005|Overall Study|Adverse Event|2|||
33143046|NCT03915860|100438351|FG000|Overall Study|Adverse Event|3|||
33143047|NCT03915860|100438351|FG000|Overall Study|Withdrawal by Subject|6|||
33143048|NCT03915860|100438351|FG000|Overall Study|Lost to Follow-up|2|||
33143049|NCT03915860|100438351|FG000|Overall Study|Other than specified|3|||
33143050|NCT00622739|100438352|FG000|Overall Study|Physician Decision|1|||
33143051|NCT00622739|100438353|FG001|Overall Study|Physician Decision|0|||
33143052|NCT00622739|100438352|FG000|Overall Study|Adverse Event|1|||
33371355|NCT02435277|101243757|FG003|Overall Study|Adverse Event|0|||
33371356|NCT02435277|101243754|FG000|Overall Study|Withdrawal by Subject|1|||
33371357|NCT02435277|101243755|FG001|Overall Study|Withdrawal by Subject|0|||
33421542|NCT00665626|101434829|FG001|Overall Study|Withdrawal by Subject|1|||
33421543|NCT00665626|101434828|FG000|Overall Study|Protocol Violation|0|||
33581417|NCT02931838|102020048|FG003|Overall Study|Adverse Event|1|||
33581418|NCT02931838|102020049|FG004|Overall Study|Adverse Event|3|||
33371358|NCT02435277|101243756|FG002|Overall Study|Withdrawal by Subject|0|||
33641840|NCT01160822|102240222|FG006|Overall Study|Adverse Event|5|||
33641841|NCT01160822|102240216|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33641842|NCT01160822|102240217|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33641843|NCT01160822|102240218|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33143053|NCT00622739|100438353|FG001|Overall Study|Adverse Event|2|||
33143054|NCT00622739|100438352|FG000|Overall Study|Lack of Efficacy|0|||
33143055|NCT00622739|100438353|FG001|Overall Study|Lack of Efficacy|2|||
33143056|NCT00622739|100438352|FG000|Overall Study|Withdrawal by Subject|0|||
33143057|NCT00622739|100438353|FG001|Overall Study|Withdrawal by Subject|1|||
33143058|NCT00622739|100438352|FG000|Overall Study|Lost to Follow-up|0|||
33641844|NCT01160822|102240219|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
33641845|NCT01160822|102240220|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
33641846|NCT01160822|102240221|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
33641847|NCT01160822|102240222|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
33641848|NCT01160822|102240216|FG000|Overall Study|Withdrawal by Subject|0|||
33641849|NCT01160822|102240217|FG001|Overall Study|Withdrawal by Subject|0|||
33641850|NCT01160822|102240218|FG002|Overall Study|Withdrawal by Subject|0|||
33641851|NCT01160822|102240219|FG003|Overall Study|Withdrawal by Subject|0|||
33143059|NCT00622739|100438353|FG001|Overall Study|Lost to Follow-up|1|||
33143060|NCT01233687|100438354|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
33143061|NCT01233687|100438354|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
33143062|NCT01233687|100438354|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
33143063|NCT00171054|100438355|FG000|Overall Study|Protocol Violation|1|||
33143064|NCT00171054|100438356|FG001|Overall Study|Protocol Violation|2|||
33143065|NCT00171054|100438355|FG000|Overall Study|Patient withdrew consent|1|||
33143066|NCT00171054|100438356|FG001|Overall Study|Patient withdrew consent|0|||
33143067|NCT00171054|100438355|FG000|Overall Study|Lost to Follow-up|0|||
33143068|NCT00171054|100438356|FG001|Overall Study|Lost to Follow-up|1|||
33143069|NCT00171054|100438355|FG000|Overall Study|Adverse Event|8|||
33143070|NCT00171054|100438356|FG001|Overall Study|Adverse Event|8|||
33143071|NCT00171054|100438355|FG000|Overall Study|Condition no longer required study drug|0|||
33242075|NCT02179918|100786297|FG001|Overall Study|Subject refused further follow-up|1|||
33242076|NCT02179918|100786298|FG002|Overall Study|Subject refused further follow-up|0|||
33242077|NCT02179918|100786299|FG003|Overall Study|Subject refused further follow-up|0|||
33242078|NCT02179918|100786300|FG004|Overall Study|Subject refused further follow-up|1|||
33242079|NCT02362035|100786303|FG000|Overall Study|Death|67|||
33242080|NCT02362035|100786303|FG000|Overall Study|Lost to Follow-up|3|||
33242081|NCT02362035|100786303|FG000|Overall Study|Adverse Event|1|||
33242082|NCT02362035|100786303|FG000|Overall Study|Physician Decision|1|||
33242083|NCT02362035|100786303|FG000|Overall Study|Subject started another cancer therapy|10|||
33242084|NCT02362035|100786303|FG000|Overall Study|Study terminated by sponsor|45|||
33242085|NCT02362035|100786303|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
33242086|NCT02362035|100786303|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
33242087|NCT02362035|100786303|FG000|Overall Study|Disease progression|11|||
33242088|NCT02362035|100786303|FG000|Overall Study|Withdrawal by Subject|20|||
33242089|NCT02788656|100786304|FG000|Overall Study|Withdrawal by Subject|1|||
33242090|NCT02788656|100786305|FG001|Overall Study|Withdrawal by Subject|0|||
33371359|NCT02435277|101243757|FG003|Overall Study|Withdrawal by Subject|0|||
33371360|NCT00089843|101243764|FG000|Overall Study|Withdrawal by Subject|1|||
33371361|NCT00089843|101243765|FG001|Overall Study|Withdrawal by Subject|4|||
33371362|NCT00089843|101243766|FG002|Overall Study|Withdrawal by Subject|5|||
33581419|NCT02931838|102020050|FG005|Overall Study|Adverse Event|1|||
33581420|NCT02829996|102020056|FG000|Overall Study|Withdrawal by Subject|1|||
33581421|NCT02829996|102020057|FG001|Overall Study|Withdrawal by Subject|0|||
33581422|NCT02829996|102020058|FG002|Overall Study|Withdrawal by Subject|0|||
33581423|NCT02829996|102020059|FG003|Overall Study|Withdrawal by Subject|0|||
33581424|NCT02829996|102020060|FG004|Overall Study|Withdrawal by Subject|0|||
33581425|NCT04263766|102020061|FG000|Overall Study|Withdrawal by Subject|6|||
33581426|NCT04263766|102020062|FG001|Overall Study|Withdrawal by Subject|4|||
33581427|NCT04263766|102020061|FG000|Overall Study|Lack of Efficacy|1|||
33581428|NCT04263766|102020062|FG001|Overall Study|Lack of Efficacy|3|||
33581429|NCT03810014|102020067|FG000|Overall Study|Pregnancy|2|||
33581430|NCT03810014|102020068|FG001|Overall Study|Pregnancy|2|||
33581431|NCT03810014|102020069|FG002|Overall Study|Pregnancy|0|||
33641852|NCT01160822|102240220|FG004|Overall Study|Withdrawal by Subject|0|||
33143072|NCT00171054|100438356|FG001|Overall Study|Condition no longer required study drug|1|||
33143073|NCT01975831|100438357|FG000|Overall Study|Adverse Event|1|||
33143074|NCT01975831|100438358|FG001|Overall Study|Adverse Event|2|||
33371363|NCT00089843|101243767|FG003|Overall Study|Withdrawal by Subject|6|||
33581432|NCT03810014|102020070|FG003|Overall Study|Pregnancy|2|||
33143075|NCT01975831|100438359|FG002|Overall Study|Adverse Event|2|||
33143076|NCT01975831|100438360|FG003|Overall Study|Adverse Event|0|||
33641853|NCT01160822|102240221|FG005|Overall Study|Withdrawal by Subject|0|||
33242091|NCT00335556|100786308|FG000|Overall Study|Death|0|||
33242092|NCT00335556|100786309|FG001|Overall Study|Death|5|||
33581433|NCT01575808|102020071|FG000|Overall Study|Death|2|||
33143077|NCT01975831|100438361|FG004|Overall Study|Adverse Event|1|||
33143078|NCT01975831|100438362|FG005|Overall Study|Adverse Event|1|||
33143079|NCT01975831|100438363|FG006|Overall Study|Adverse Event|3|||
33143080|NCT01975831|100438364|FG007|Overall Study|Adverse Event|4|||
33143081|NCT01975831|100438365|FG008|Overall Study|Adverse Event|1|||
33242093|NCT00335556|100786310|FG002|Overall Study|Death|0|||
33581434|NCT01575808|102020072|FG001|Overall Study|Death|0|||
33581435|NCT01575808|102020071|FG000|Overall Study|Withdrawal by Subject|1|||
33581436|NCT01575808|102020072|FG001|Overall Study|Withdrawal by Subject|0|||
33581437|NCT01162473|102020073|FG000|Overall Study|Adverse Event|2|||
33581438|NCT01162473|102020074|FG001|Overall Study|Adverse Event|1|||
33581439|NCT01162473|102020073|FG000|Overall Study|Withdrawal by Subject|0|||
33581440|NCT01162473|102020074|FG001|Overall Study|Withdrawal by Subject|4|||
33581441|NCT00690794|102020075|FG000|Overall Study|Adverse Event|12|||
33581442|NCT00690794|102020076|FG001|Overall Study|Adverse Event|10|||
33581443|NCT00690794|102020075|FG000|Overall Study|Lost to Follow-up|1|||
33581444|NCT00690794|102020076|FG001|Overall Study|Lost to Follow-up|4|||
33641854|NCT01160822|102240222|FG006|Overall Study|Withdrawal by Subject|1|||
33641855|NCT01160822|102240216|FG000|Overall Study|Lost to Follow-up|0|||
33641856|NCT01160822|102240217|FG001|Overall Study|Lost to Follow-up|0|||
33641857|NCT01160822|102240218|FG002|Overall Study|Lost to Follow-up|0|||
33641858|NCT01160822|102240219|FG003|Overall Study|Lost to Follow-up|0|||
33641859|NCT01160822|102240220|FG004|Overall Study|Lost to Follow-up|1|||
33641860|NCT01160822|102240221|FG005|Overall Study|Lost to Follow-up|0|||
33641861|NCT01160822|102240222|FG006|Overall Study|Lost to Follow-up|0|||
33641862|NCT01160822|102240216|FG000|Overall Study|Administrative problems|0|||
33641863|NCT01160822|102240217|FG001|Overall Study|Administrative problems|0|||
33641864|NCT01160822|102240218|FG002|Overall Study|Administrative problems|0|||
33641865|NCT01160822|102240219|FG003|Overall Study|Administrative problems|0|||
33641866|NCT01160822|102240220|FG004|Overall Study|Administrative problems|1|||
33641867|NCT01160822|102240221|FG005|Overall Study|Administrative problems|0|||
33641868|NCT01160822|102240222|FG006|Overall Study|Administrative problems|0|||
33641869|NCT01160822|102240216|FG000|Overall Study|Protocol deviation|0|||
33641870|NCT01160822|102240217|FG001|Overall Study|Protocol deviation|0|||
33641871|NCT01160822|102240218|FG002|Overall Study|Protocol deviation|0|||
33641872|NCT01160822|102240219|FG003|Overall Study|Protocol deviation|0|||
33641873|NCT01160822|102240220|FG004|Overall Study|Protocol deviation|2|||
33143082|NCT01975831|100438357|FG000|Overall Study|Death|1|||
33242094|NCT00335556|100786311|FG003|Overall Study|Death|0|||
33242095|NCT00335556|100786312|FG004|Overall Study|Death|1|||
33242096|NCT00335556|100786313|FG005|Overall Study|Death|0|||
33242097|NCT00335556|100786308|FG000|Overall Study|Lack of Efficacy|0|||
33242098|NCT00335556|100786309|FG001|Overall Study|Lack of Efficacy|19|||
33242099|NCT00335556|100786310|FG002|Overall Study|Lack of Efficacy|3|||
33242100|NCT00335556|100786311|FG003|Overall Study|Lack of Efficacy|3|||
33371364|NCT00089843|101243764|FG000|Overall Study|Physician Decision|1|||
33371365|NCT00089843|101243765|FG001|Overall Study|Physician Decision|0|||
33371366|NCT00089843|101243766|FG002|Overall Study|Physician Decision|0|||
33371367|NCT00089843|101243767|FG003|Overall Study|Physician Decision|1|||
33371368|NCT04964063|101243768|FG000|Overall Study|Adverse Event|4|||
33371369|NCT04964063|101243768|FG000|Overall Study|Lost to Follow-up|47|||
33371370|NCT04964063|101243768|FG000|Overall Study|Withdrawal by Subject|5|||
33371371|NCT04964063|101243768|FG000|Overall Study|Baseline Tasks Expired|41|||
33371372|NCT04964063|101243768|FG000|Overall Study|Participant withdrawn in error|1|||
33371373|NCT04544709|101247424|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
33371374|NCT02531373|101247425|FG000|Overall Study|Lack of Efficacy|0|||
33371375|NCT02531373|101247426|FG001|Overall Study|Lack of Efficacy|0|||
33371376|NCT02531373|101247427|FG002|Overall Study|Lack of Efficacy|0|||
33371377|NCT02531373|101247428|FG003|Overall Study|Lack of Efficacy|0|||
33371378|NCT02531373|101247429|FG004|Overall Study|Lack of Efficacy|3|||
33371379|NCT02531373|101247430|FG005|Overall Study|Lack of Efficacy|2|||
33371380|NCT02531373|101247431|FG006|Overall Study|Lack of Efficacy|4|||
33581445|NCT00690794|102020075|FG000|Overall Study|Withdrawal by Subject|0|||
33143083|NCT01975831|100438358|FG001|Overall Study|Death|1|||
33143084|NCT01975831|100438359|FG002|Overall Study|Death|0|||
33242101|NCT00335556|100786312|FG004|Overall Study|Lack of Efficacy|0|||
33242102|NCT00335556|100786313|FG005|Overall Study|Lack of Efficacy|1|||
33371381|NCT02531373|101247432|FG007|Overall Study|Lack of Efficacy|8|||
33371382|NCT02531373|101247433|FG008|Overall Study|Lack of Efficacy|5|||
33641874|NCT01160822|102240221|FG005|Overall Study|Protocol deviation|0|||
33641875|NCT01160822|102240222|FG006|Overall Study|Protocol deviation|0|||
33641876|NCT00123422|102240226|FG000|Overall Study|Physician Decision|2|||
33641877|NCT00123422|102240227|FG001|Overall Study|Physician Decision|2|||
33143085|NCT01975831|100438360|FG003|Overall Study|Death|0|||
33143086|NCT01975831|100438361|FG004|Overall Study|Death|1|||
33371383|NCT02531373|101247425|FG000|Overall Study|Lost to Follow-up|0|||
33371384|NCT02531373|101247426|FG001|Overall Study|Lost to Follow-up|0|||
33242103|NCT00335556|100786308|FG000|Overall Study|Physician Decision|0|||
33242104|NCT00335556|100786309|FG001|Overall Study|Physician Decision|6|||
33641878|NCT00123422|102240228|FG002|Overall Study|Physician Decision|6|||
33581446|NCT00690794|102020076|FG001|Overall Study|Withdrawal by Subject|9|||
33581447|NCT00690794|102020075|FG000|Overall Study|Protocol Violation|6|||
33581448|NCT00690794|102020076|FG001|Overall Study|Protocol Violation|7|||
33581449|NCT00690794|102020075|FG000|Overall Study|Noncompliance|1|||
33581450|NCT00690794|102020076|FG001|Overall Study|Noncompliance|2|||
33581451|NCT00690794|102020075|FG000|Overall Study|Other not specified|1|||
33581452|NCT00690794|102020076|FG001|Overall Study|Other not specified|3|||
33581453|NCT01198574|102020077|FG000|Overall Study|Resigned from schools|4|||
33581454|NCT01198574|102020078|FG001|Overall Study|Resigned from schools|1|||
33581455|NCT01198574|102020079|FG002|Overall Study|Resigned from schools|1|||
33581456|NCT01198574|102020080|FG003|Overall Study|Resigned from schools|4|||
33581457|NCT02776683|102020083|FG000|Pre-switch Period|Protocol Violation|1|||
33581458|NCT02776683|102020084|FG001|Pre-switch Period|Protocol Violation|0|||
33581459|NCT02776683|102020083|FG000|Pre-switch Period|Adverse Event|21|||
33581460|NCT02776683|102020084|FG001|Pre-switch Period|Adverse Event|0|||
33581461|NCT02776683|102020083|FG000|Pre-switch Period|Withdrawal by Subject|9|||
33581462|NCT02776683|102020084|FG001|Pre-switch Period|Withdrawal by Subject|0|||
33581463|NCT02776683|102020083|FG000|Pre-switch Period|Physician Decision|7|||
33581464|NCT02776683|102020084|FG001|Pre-switch Period|Physician Decision|0|||
33581465|NCT02776683|102020083|FG000|Pre-switch Period|Progressive disease|39|||
33641879|NCT00123422|102240226|FG000|Overall Study|Withdrawal by Subject|1|||
33641880|NCT00123422|102240227|FG001|Overall Study|Withdrawal by Subject|2|||
33641881|NCT00123422|102240228|FG002|Overall Study|Withdrawal by Subject|2|||
33641882|NCT00123422|102240226|FG000|Overall Study|Lost to Follow-up|1|||
33421544|NCT00665626|101434829|FG001|Overall Study|Protocol Violation|2|||
33421545|NCT00665626|101434828|FG000|Overall Study|Adverse Event|1|||
33641883|NCT00123422|102240227|FG001|Overall Study|Lost to Follow-up|2|||
33641884|NCT00123422|102240228|FG002|Overall Study|Lost to Follow-up|2|||
33143087|NCT01975831|100438362|FG005|Overall Study|Death|0|||
33143088|NCT01975831|100438363|FG006|Overall Study|Death|1|||
33143089|NCT01975831|100438364|FG007|Overall Study|Death|0|||
33143090|NCT01975831|100438365|FG008|Overall Study|Death|0|||
33143091|NCT01975831|100438357|FG000|Overall Study|Progressive Disease|1|||
33143092|NCT01975831|100438358|FG001|Overall Study|Progressive Disease|3|||
33143093|NCT01975831|100438359|FG002|Overall Study|Progressive Disease|2|||
33143094|NCT01975831|100438360|FG003|Overall Study|Progressive Disease|4|||
33143095|NCT01975831|100438361|FG004|Overall Study|Progressive Disease|13|||
33143096|NCT01975831|100438362|FG005|Overall Study|Progressive Disease|9|||
33143097|NCT01975831|100438363|FG006|Overall Study|Progressive Disease|10|||
33641885|NCT01047553|102240229|FG000|Overall Study|Adverse Event|10|||
33641886|NCT01047553|102240230|FG001|Overall Study|Adverse Event|5|||
33641887|NCT01047553|102240229|FG000|Overall Study|Withdrawal by Subject|4|||
33641888|NCT01047553|102240230|FG001|Overall Study|Withdrawal by Subject|2|||
33641889|NCT01047553|102240229|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
33641890|NCT01047553|102240230|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
33641891|NCT01047553|102240229|FG000|Overall Study|Lost to Follow-up|1|||
33641892|NCT01047553|102240230|FG001|Overall Study|Lost to Follow-up|0|||
33641893|NCT01047553|102240229|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
33641894|NCT01047553|102240230|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
33641895|NCT01047553|102240229|FG000|Overall Study|PI's decision|0|||
33641896|NCT01047553|102240230|FG001|Overall Study|PI's decision|1|||
33641897|NCT01623050|102240231|FG000|Overall Study|Lost to Follow-up|9|||
33641898|NCT02425943|102240232|FG000|Overall Study|Adverse Event|3|||
33641899|NCT02425943|102240233|FG001|Overall Study|Adverse Event|1|||
33641900|NCT02425943|102240232|FG000|Overall Study|Lost to Follow-up|59|||
33641901|NCT02425943|102240233|FG001|Overall Study|Lost to Follow-up|37|||
33641902|NCT02425943|102240232|FG000|Overall Study|Protocol Violation|4|||
33641903|NCT02425943|102240233|FG001|Overall Study|Protocol Violation|1|||
33641904|NCT02425943|102240232|FG000|Overall Study|Withdrawal by Subject|64|||
33641905|NCT02425943|102240233|FG001|Overall Study|Withdrawal by Subject|31|||
33641906|NCT02425943|102240232|FG000|Overall Study|Other|6|||
33143098|NCT01975831|100438364|FG007|Overall Study|Progressive Disease|8|||
33143099|NCT01975831|100438365|FG008|Overall Study|Progressive Disease|10|||
33143100|NCT01975831|100438357|FG000|Overall Study|Withdrawal by Subject|0|||
33371385|NCT02531373|101247427|FG002|Overall Study|Lost to Follow-up|0|||
33143101|NCT01975831|100438358|FG001|Overall Study|Withdrawal by Subject|3|||
33421546|NCT00665626|101434829|FG001|Overall Study|Adverse Event|9|||
33581466|NCT02776683|102020084|FG001|Pre-switch Period|Progressive disease|0|||
33581467|NCT02776683|102020083|FG000|Pre-switch Period|Other than listed|3|||
33581468|NCT02776683|102020084|FG001|Pre-switch Period|Other than listed|0|||
33641907|NCT02425943|102240233|FG001|Overall Study|Other|0|||
33641908|NCT02745080|102240234|FG000|Overall Study|Adverse Event|13|||
33641909|NCT02745080|102240235|FG001|Overall Study|Adverse Event|21|||
33641910|NCT02745080|102240234|FG000|Overall Study|Lack of Efficacy|11|||
33641911|NCT02745080|102240235|FG001|Overall Study|Lack of Efficacy|23|||
33641912|NCT02745080|102240234|FG000|Overall Study|Lost to Follow-up|3|||
33641913|NCT02745080|102240235|FG001|Overall Study|Lost to Follow-up|3|||
33143102|NCT01975831|100438359|FG002|Overall Study|Withdrawal by Subject|0|||
33143103|NCT01975831|100438360|FG003|Overall Study|Withdrawal by Subject|0|||
33641914|NCT02745080|102240234|FG000|Overall Study|Physician Decision|3|||
33641915|NCT02745080|102240235|FG001|Overall Study|Physician Decision|0|||
33641916|NCT02745080|102240234|FG000|Overall Study|Protocol Violation|3|||
33641917|NCT02745080|102240235|FG001|Overall Study|Protocol Violation|1|||
33641918|NCT02745080|102240234|FG000|Overall Study|Withdrawal by Subject|22|||
33641919|NCT02745080|102240235|FG001|Overall Study|Withdrawal by Subject|41|||
33641920|NCT01976741|102240236|FG000|Overall Study|Withdrawal by Subject|1|||
33641921|NCT01976741|102240237|FG001|Overall Study|Withdrawal by Subject|0|||
33641922|NCT01976741|102240238|FG002|Overall Study|Withdrawal by Subject|1|||
33641923|NCT01976741|102240239|FG003|Overall Study|Withdrawal by Subject|1|||
33641924|NCT01976741|102240240|FG004|Overall Study|Withdrawal by Subject|0|||
33641925|NCT01976741|102240241|FG005|Overall Study|Withdrawal by Subject|0|||
33143104|NCT01975831|100438361|FG004|Overall Study|Withdrawal by Subject|3|||
33143105|NCT01975831|100438362|FG005|Overall Study|Withdrawal by Subject|1|||
33143106|NCT01975831|100438363|FG006|Overall Study|Withdrawal by Subject|1|||
33143107|NCT01975831|100438364|FG007|Overall Study|Withdrawal by Subject|0|||
33143108|NCT01975831|100438365|FG008|Overall Study|Withdrawal by Subject|0|||
33143109|NCT01975831|100438357|FG000|Overall Study|Physician Decision|0|||
33143110|NCT01975831|100438358|FG001|Overall Study|Physician Decision|0|||
33143111|NCT01975831|100438359|FG002|Overall Study|Physician Decision|0|||
33143112|NCT01975831|100438360|FG003|Overall Study|Physician Decision|0|||
33143113|NCT01975831|100438361|FG004|Overall Study|Physician Decision|0|||
33143114|NCT01975831|100438362|FG005|Overall Study|Physician Decision|1|||
33143115|NCT01975831|100438363|FG006|Overall Study|Physician Decision|0|||
33143116|NCT01975831|100438364|FG007|Overall Study|Physician Decision|1|||
33143117|NCT01975831|100438365|FG008|Overall Study|Physician Decision|0|||
33143118|NCT01975831|100438357|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
33143119|NCT01975831|100438358|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
33143120|NCT01975831|100438359|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
33581469|NCT02776683|102020083|FG000|Post-switch Period|Adverse Event|0|||
33581470|NCT02776683|102020084|FG001|Post-switch Period|Adverse Event|3|||
33581471|NCT02776683|102020083|FG000|Post-switch Period|Withdrawal by Subject|0|||
33581472|NCT02776683|102020084|FG001|Post-switch Period|Withdrawal by Subject|2|||
33581473|NCT02776683|102020083|FG000|Post-switch Period|Physician Decision|0|||
33581474|NCT02776683|102020084|FG001|Post-switch Period|Physician Decision|3|||
33581475|NCT02776683|102020083|FG000|Post-switch Period|Progressive disease|0|||
33581476|NCT02776683|102020084|FG001|Post-switch Period|Progressive disease|20|||
33581477|NCT02776683|102020083|FG000|Post-switch Period|Other than listed|0|||
33581478|NCT02776683|102020084|FG001|Post-switch Period|Other than listed|15|||
33581479|NCT00049322|102020092|FG000|Overall Study|disease burden|0|||
33581480|NCT00049322|102020093|FG001|Overall Study|disease burden|3|||
33581481|NCT00049322|102020092|FG000|Overall Study|Adverse Event|1|||
33581482|NCT00049322|102020093|FG001|Overall Study|Adverse Event|0|||
33581483|NCT00049322|102020092|FG000|Overall Study|refused angio|0|||
33581484|NCT00049322|102020093|FG001|Overall Study|refused angio|3|||
33581485|NCT03338400|102020100|FG000|Overall Study|Lost to Follow-up|1|||
33581486|NCT03338400|102020101|FG001|Overall Study|Lost to Follow-up|2|||
33581487|NCT00856635|102020105|FG000|Overall Study|Lost to Follow-up|2|||
33581488|NCT00856635|102020106|FG001|Overall Study|Lost to Follow-up|5|||
33581489|NCT00856635|102020105|FG000|Overall Study|Pregnancy|1|||
33581490|NCT00856635|102020106|FG001|Overall Study|Pregnancy|0|||
33581491|NCT00856635|102020105|FG000|Overall Study|Withdrawal by Subject|3|||
33581492|NCT00856635|102020106|FG001|Overall Study|Withdrawal by Subject|1|||
33581493|NCT00856635|102020105|FG000|Overall Study|Serious Adverse Event|1|||
33581494|NCT00856635|102020106|FG001|Overall Study|Serious Adverse Event|0|||
33581495|NCT00856635|102020105|FG000|Overall Study|Other|1|||
33581496|NCT00856635|102020106|FG001|Overall Study|Other|0|||
33581497|NCT00856635|102020105|FG000|Overall Study|Discontinued at Randomization|2|||
33581498|NCT00856635|102020106|FG001|Overall Study|Discontinued at Randomization|2|||
33581499|NCT03072043|102020107|FG000|Overall Study|Death|0|||
33581500|NCT03072043|102020108|FG001|Overall Study|Death|0|||
33581501|NCT03072043|102020109|FG002|Overall Study|Death|3|||
33581502|NCT03072043|102020107|FG000|Overall Study|Adverse Event|0|||
33581503|NCT03072043|102020108|FG001|Overall Study|Adverse Event|0|||
33581504|NCT03072043|102020109|FG002|Overall Study|Adverse Event|2|||
33581505|NCT03072043|102020107|FG000|Overall Study|Withdrawal by Subject|0|||
33581506|NCT03072043|102020108|FG001|Overall Study|Withdrawal by Subject|0|||
33581507|NCT03072043|102020109|FG002|Overall Study|Withdrawal by Subject|4|||
33581508|NCT01016067|102020110|FG000|Overall Study|Lost to Follow-up|1|||
33581509|NCT01016067|102020111|FG001|Overall Study|Lost to Follow-up|2|||
33581510|NCT01016067|102020110|FG000|Overall Study|Physician Decision|1|||
33242105|NCT00335556|100786310|FG002|Overall Study|Physician Decision|2|||
33581511|NCT01016067|102020111|FG001|Overall Study|Physician Decision|1|||
33581512|NCT01016067|102020110|FG000|Overall Study|Withdrew due to Relocation|0|||
33581513|NCT01016067|102020111|FG001|Overall Study|Withdrew due to Relocation|1|||
33641926|NCT01976741|102240242|FG006|Overall Study|Withdrawal by Subject|1|||
33641927|NCT01976741|102240243|FG007|Overall Study|Withdrawal by Subject|4|||
33641928|NCT01976741|102240244|FG008|Overall Study|Withdrawal by Subject|0|||
33143121|NCT01975831|100438360|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
33143122|NCT01975831|100438361|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
33581514|NCT00540592|102020112|FG000|Overall Study|Adverse Event|0|||
33143123|NCT01975831|100438362|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
33143124|NCT01975831|100438363|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
33143125|NCT01975831|100438364|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
33143126|NCT01975831|100438365|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
33143127|NCT01975831|100438357|FG000|Overall Study|Entered Hospice|0|||
33421547|NCT00665626|101434828|FG000|Overall Study|Due to exclusion criteria|0|||
33143128|NCT01975831|100438358|FG001|Overall Study|Entered Hospice|0|||
33143129|NCT01975831|100438359|FG002|Overall Study|Entered Hospice|0|||
33143130|NCT01975831|100438360|FG003|Overall Study|Entered Hospice|0|||
33143131|NCT01975831|100438361|FG004|Overall Study|Entered Hospice|0|||
33143132|NCT01975831|100438362|FG005|Overall Study|Entered Hospice|1|||
33143133|NCT01975831|100438363|FG006|Overall Study|Entered Hospice|0|||
33143134|NCT01975831|100438364|FG007|Overall Study|Entered Hospice|0|||
33143135|NCT01975831|100438365|FG008|Overall Study|Entered Hospice|0|||
33143136|NCT01975831|100438357|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
33143137|NCT01975831|100438358|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
33143138|NCT01975831|100438359|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
33143139|NCT01975831|100438360|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
33143140|NCT01975831|100438361|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
33143141|NCT01975831|100438362|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
33143142|NCT01975831|100438363|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
33143143|NCT01975831|100438364|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
33143144|NCT01975831|100438365|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
33143145|NCT03963401|100438366|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
33143146|NCT03963401|100438367|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
33143147|NCT03963401|100438368|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
33143148|NCT03963401|100438369|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
33143149|NCT03963401|100438370|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
33143150|NCT03963401|100438371|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
33143151|NCT03963401|100438366|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
33143152|NCT03963401|100438367|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
33143153|NCT03963401|100438368|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
33143154|NCT03963401|100438369|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
33143155|NCT03963401|100438370|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
33143156|NCT03963401|100438371|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
33143157|NCT03963401|100438366|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
33143158|NCT03963401|100438367|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
33143159|NCT03963401|100438368|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
33143160|NCT03963401|100438369|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
33143161|NCT03963401|100438370|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
33143162|NCT03963401|100438371|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
33143163|NCT03963401|100438366|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
33143164|NCT03963401|100438367|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
33143165|NCT03963401|100438368|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
33143166|NCT03963401|100438369|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
33143167|NCT03963401|100438370|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
33143168|NCT03963401|100438371|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
33143169|NCT03963401|100438366|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
33143170|NCT03963401|100438367|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
33143171|NCT03963401|100438368|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
33143172|NCT03963401|100438369|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
33143173|NCT03963401|100438370|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
33143174|NCT03963401|100438371|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
33143175|NCT03963401|100438366|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
33143176|NCT03963401|100438367|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
33143177|NCT03963401|100438368|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
33143178|NCT03963401|100438369|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
33421548|NCT00665626|101434829|FG001|Overall Study|Due to exclusion criteria|1|||
33421549|NCT00665626|101434828|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
33421550|NCT00665626|101434829|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
33581515|NCT00540592|102020113|FG001|Overall Study|Adverse Event|1|||
33581516|NCT00540592|102020114|FG002|Overall Study|Adverse Event|0|||
33581517|NCT00540592|102020115|FG003|Overall Study|Adverse Event|0|||
33581518|NCT00540592|102020116|FG004|Overall Study|Adverse Event|1|||
33143179|NCT03963401|100438370|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
33143180|NCT03963401|100438371|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
33242106|NCT00335556|100786311|FG003|Overall Study|Physician Decision|1|||
33242107|NCT00335556|100786312|FG004|Overall Study|Physician Decision|0|||
33242108|NCT00335556|100786313|FG005|Overall Study|Physician Decision|0|||
33242109|NCT00335556|100786308|FG000|Overall Study|Ineligible|2|||
33242110|NCT00335556|100786309|FG001|Overall Study|Ineligible|0|||
33581519|NCT00540592|102020117|FG005|Overall Study|Adverse Event|0|||
33581520|NCT00540592|102020118|FG006|Overall Study|Adverse Event|0|||
33242111|NCT00335556|100786310|FG002|Overall Study|Ineligible|0|||
33242112|NCT00335556|100786311|FG003|Overall Study|Ineligible|0|||
33581521|NCT00540592|102020119|FG007|Overall Study|Adverse Event|1|||
33581522|NCT00540592|102020120|FG008|Overall Study|Adverse Event|1|||
33581523|NCT00540592|102020121|FG009|Overall Study|Adverse Event|2|||
33581524|NCT00540592|102020112|FG000|Overall Study|Lost to Follow-up|2|||
33581525|NCT00540592|102020113|FG001|Overall Study|Lost to Follow-up|0|||
33581526|NCT00540592|102020114|FG002|Overall Study|Lost to Follow-up|0|||
33581527|NCT00540592|102020115|FG003|Overall Study|Lost to Follow-up|0|||
33581528|NCT00540592|102020116|FG004|Overall Study|Lost to Follow-up|0|||
33581529|NCT00540592|102020117|FG005|Overall Study|Lost to Follow-up|0|||
33581530|NCT00540592|102020118|FG006|Overall Study|Lost to Follow-up|0|||
33581531|NCT00540592|102020119|FG007|Overall Study|Lost to Follow-up|0|||
33641929|NCT01976741|102240245|FG009|Overall Study|Withdrawal by Subject|0|||
33641930|NCT01976741|102240236|FG000|Overall Study|Adverse Event|0|||
33641931|NCT01976741|102240237|FG001|Overall Study|Adverse Event|0|||
33641932|NCT01976741|102240238|FG002|Overall Study|Adverse Event|2|||
33641933|NCT01976741|102240239|FG003|Overall Study|Adverse Event|0|||
33641934|NCT01976741|102240240|FG004|Overall Study|Adverse Event|0|||
33641935|NCT01976741|102240241|FG005|Overall Study|Adverse Event|0|||
33242113|NCT00335556|100786312|FG004|Overall Study|Ineligible|0|||
33242114|NCT00335556|100786313|FG005|Overall Study|Ineligible|0|||
33242115|NCT00335556|100786308|FG000|Overall Study|Refusal of further protocol therapy|0|||
33242116|NCT00335556|100786309|FG001|Overall Study|Refusal of further protocol therapy|4|||
33242117|NCT00335556|100786310|FG002|Overall Study|Refusal of further protocol therapy|0|||
33242118|NCT00335556|100786311|FG003|Overall Study|Refusal of further protocol therapy|1|||
33242119|NCT00335556|100786312|FG004|Overall Study|Refusal of further protocol therapy|0|||
33242120|NCT00335556|100786313|FG005|Overall Study|Refusal of further protocol therapy|0|||
33242121|NCT03283553|100786314|FG000|Patient Participant Flow|Death|5|||
33242122|NCT03283553|100786315|FG001|Patient Participant Flow|Death|10|||
33242123|NCT03283553|100786314|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
33242124|NCT03283553|100786315|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
33242125|NCT03283553|100786314|FG000|Patient Participant Flow|Lost to Follow-up|1|||
33242126|NCT03283553|100786315|FG001|Patient Participant Flow|Lost to Follow-up|1|||
33242127|NCT03283553|100786314|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
33242128|NCT03283553|100786315|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
33242129|NCT03283553|100786314|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
33242130|NCT03283553|100786315|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
33242131|NCT03283553|100786314|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
33242132|NCT03283553|100786315|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
33242133|NCT00594932|100786316|FG000|First 3 Months|Withdrawal by Subject|1|||
33242134|NCT00594932|100786317|FG001|First 3 Months|Withdrawal by Subject|3|||
33242135|NCT00594932|100786316|FG000|Final 3 Months|Withdrawal by Subject|4|||
33242136|NCT00594932|100786317|FG001|Final 3 Months|Withdrawal by Subject|3|||
33242137|NCT01008748|100786323|FG000|Overall Study|Lost to Follow-up|80|||
33242138|NCT01008748|100786323|FG000|Overall Study|Other|1|||
33242139|NCT02320253|100788952|FG000|Overall Study|Withdrawal by Subject|3|||
33242140|NCT02320253|100788953|FG001|Overall Study|Withdrawal by Subject|0|||
33242141|NCT02320253|100788954|FG002|Overall Study|Withdrawal by Subject|0|||
33242142|NCT02320253|100788952|FG000|Overall Study|Lost to Follow-up|2|||
33242143|NCT02320253|100788953|FG001|Overall Study|Lost to Follow-up|2|||
33242144|NCT02320253|100788954|FG002|Overall Study|Lost to Follow-up|1|||
33581532|NCT00540592|102020120|FG008|Overall Study|Lost to Follow-up|0|||
33641936|NCT01976741|102240242|FG006|Overall Study|Adverse Event|3|||
33641937|NCT01976741|102240243|FG007|Overall Study|Adverse Event|8|||
33641938|NCT01976741|102240244|FG008|Overall Study|Adverse Event|1|||
33641939|NCT01976741|102240245|FG009|Overall Study|Adverse Event|4|||
33581533|NCT00540592|102020121|FG009|Overall Study|Lost to Follow-up|0|||
33581534|NCT00540592|102020112|FG000|Overall Study|Withdrawal by Subject|0|||
33242145|NCT02320253|100788952|FG000|Overall Study|Death|1|||
33581535|NCT00540592|102020113|FG001|Overall Study|Withdrawal by Subject|0|||
33581536|NCT00540592|102020114|FG002|Overall Study|Withdrawal by Subject|1|||
33641940|NCT02167139|102240249|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
33641941|NCT02167139|102240250|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
33641942|NCT02167139|102240251|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
33242146|NCT02320253|100788953|FG001|Overall Study|Death|0|||
33242147|NCT02320253|100788954|FG002|Overall Study|Death|1|||
33242148|NCT01653743|100788956|FG000|Overall Study|Withdrawal by Subject|1|||
33242149|NCT01653743|100788957|FG001|Overall Study|Withdrawal by Subject|0|||
33581537|NCT00540592|102020115|FG003|Overall Study|Withdrawal by Subject|1|||
33143181|NCT03963401|100438366|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
33143182|NCT03963401|100438367|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
33143183|NCT03963401|100438368|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
33143184|NCT03963401|100438369|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
33143185|NCT03963401|100438370|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
33143186|NCT03963401|100438371|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
33143187|NCT03963401|100438366|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
33143188|NCT03963401|100438367|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
33143189|NCT03963401|100438368|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
33143190|NCT03963401|100438369|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
33143191|NCT03963401|100438370|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
33143192|NCT03963401|100438371|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
33143193|NCT03963401|100438366|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
33143194|NCT03963401|100438367|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
33143195|NCT03963401|100438368|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
33143196|NCT03963401|100438369|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
33143197|NCT03963401|100438370|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
33143198|NCT03963401|100438371|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
33143199|NCT03963401|100438366|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
33143200|NCT03963401|100438367|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
33143201|NCT03963401|100438368|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
33143202|NCT03963401|100438369|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
33143203|NCT03963401|100438370|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
33143204|NCT03963401|100438371|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
33143205|NCT03963401|100438366|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
33143206|NCT03963401|100438367|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
33143207|NCT03963401|100438368|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
33143208|NCT03963401|100438369|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
33143209|NCT03963401|100438370|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
33143210|NCT03963401|100438371|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
33143211|NCT01330017|100438374|FG000|Overall Study|Adverse Event|0|||
33143212|NCT01330017|100438375|FG001|Overall Study|Adverse Event|1|||
33143213|NCT01330017|100438376|FG002|Overall Study|Adverse Event|1|||
33143214|NCT01330017|100438377|FG003|Overall Study|Adverse Event|4|||
33143215|NCT01330017|100438378|FG004|Overall Study|Adverse Event|0|||
33143216|NCT01330017|100438374|FG000|Overall Study|Withdrawal by Subject|0|||
33143217|NCT01330017|100438375|FG001|Overall Study|Withdrawal by Subject|0|||
33143218|NCT01330017|100438376|FG002|Overall Study|Withdrawal by Subject|1|||
33143219|NCT01330017|100438377|FG003|Overall Study|Withdrawal by Subject|0|||
33143220|NCT01330017|100438378|FG004|Overall Study|Withdrawal by Subject|1|||
33143221|NCT01330017|100438374|FG000|Overall Study|Lost to Follow-up|0|||
33143222|NCT01330017|100438375|FG001|Overall Study|Lost to Follow-up|0|||
33143223|NCT01330017|100438376|FG002|Overall Study|Lost to Follow-up|1|||
33143224|NCT01330017|100438377|FG003|Overall Study|Lost to Follow-up|0|||
33143225|NCT01330017|100438378|FG004|Overall Study|Lost to Follow-up|0|||
33143226|NCT01330017|100438374|FG000|Overall Study|Protocol Violation|0|||
33143227|NCT01330017|100438375|FG001|Overall Study|Protocol Violation|0|||
33143228|NCT01330017|100438376|FG002|Overall Study|Protocol Violation|0|||
33143229|NCT01330017|100438377|FG003|Overall Study|Protocol Violation|1|||
33143230|NCT01330017|100438378|FG004|Overall Study|Protocol Violation|0|||
33143231|NCT01330017|100438374|FG000|Overall Study|Unknown Reason|5|||
33143232|NCT01330017|100438375|FG001|Overall Study|Unknown Reason|3|||
33143233|NCT01330017|100438376|FG002|Overall Study|Unknown Reason|5|||
33143234|NCT01330017|100438377|FG003|Overall Study|Unknown Reason|7|||
33143235|NCT01330017|100438378|FG004|Overall Study|Unknown Reason|2|||
33143236|NCT03945175|100438379|FG000|Overall Study|Did not meet inclusion criteria|31|||
33143237|NCT03945175|100438379|FG000|Overall Study|Withdrew consent|2|||
33143238|NCT03945175|100438379|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
33143239|NCT03945175|100438379|FG000|Overall Study|Early termination during Mydayis treatment|1|||
33143240|NCT00645788|100438382|FG000|Overall Study|Did not receive study drug|1|||
33143241|NCT00645788|100438383|FG001|Overall Study|Did not receive study drug|1|||
33143242|NCT00645788|100438384|FG002|Overall Study|Did not receive study drug|0|||
33143243|NCT00645788|100438385|FG003|Overall Study|Did not receive study drug|0|||
33242150|NCT01653743|100788956|FG000|Overall Study|Investigator discretion|3|||
33242151|NCT01653743|100788957|FG001|Overall Study|Investigator discretion|0|||
33242152|NCT00688688|100788958|FG000|Overall Study|Eligibility criterion not met|7|||
33143244|NCT00645788|100438382|FG000|Overall Study|Adverse Event|4|||
33143245|NCT00645788|100438383|FG001|Overall Study|Adverse Event|9|||
33143246|NCT00645788|100438384|FG002|Overall Study|Adverse Event|5|||
33143247|NCT00645788|100438385|FG003|Overall Study|Adverse Event|3|||
33143248|NCT00645788|100438382|FG000|Overall Study|Lost to Follow-up|1|||
33143249|NCT00645788|100438383|FG001|Overall Study|Lost to Follow-up|0|||
33143250|NCT00645788|100438384|FG002|Overall Study|Lost to Follow-up|0|||
33143251|NCT00645788|100438385|FG003|Overall Study|Lost to Follow-up|0|||
33143252|NCT00645788|100438382|FG000|Overall Study|Protocol Violation|1|||
33143253|NCT00645788|100438383|FG001|Overall Study|Protocol Violation|0|||
33143254|NCT00645788|100438384|FG002|Overall Study|Protocol Violation|2|||
33143255|NCT00645788|100438385|FG003|Overall Study|Protocol Violation|0|||
33143256|NCT00645788|100438382|FG000|Overall Study|Withdrawal by Subject|0|||
33143257|NCT00645788|100438383|FG001|Overall Study|Withdrawal by Subject|1|||
33143258|NCT00645788|100438384|FG002|Overall Study|Withdrawal by Subject|0|||
33143259|NCT00645788|100438385|FG003|Overall Study|Withdrawal by Subject|2|||
33143260|NCT00645788|100438382|FG000|Overall Study|Pulmonary exacerbation|13|||
33143261|NCT00645788|100438383|FG001|Overall Study|Pulmonary exacerbation|16|||
33143262|NCT00645788|100438384|FG002|Overall Study|Pulmonary exacerbation|11|||
33143263|NCT00645788|100438385|FG003|Overall Study|Pulmonary exacerbation|9|||
33143264|NCT04706416|100438386|FG000|Overall Study|Lost to Follow-up|2|||
33143265|NCT04706416|100438387|FG001|Overall Study|Lost to Follow-up|0|||
33143266|NCT02119676|100438388|FG000|Overall Study|Adverse Event|9|||
33143267|NCT02119676|100438389|FG001|Overall Study|Adverse Event|17|||
33143268|NCT02119676|100438390|FG002|Overall Study|Adverse Event|10|||
33143269|NCT02119676|100438391|FG003|Overall Study|Adverse Event|10|||
33143270|NCT02119676|100438388|FG000|Overall Study|Disease progression|53|||
33143271|NCT02119676|100438389|FG001|Overall Study|Disease progression|55|||
33143272|NCT02119676|100438390|FG002|Overall Study|Disease progression|68|||
33143273|NCT02119676|100438391|FG003|Overall Study|Disease progression|73|||
33143274|NCT02119676|100438388|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
33143275|NCT02119676|100438389|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
33143276|NCT02119676|100438390|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
33143277|NCT02119676|100438391|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
33143278|NCT02119676|100438388|FG000|Overall Study|Physician Decision|4|||
33143279|NCT02119676|100438389|FG001|Overall Study|Physician Decision|2|||
33143280|NCT02119676|100438390|FG002|Overall Study|Physician Decision|3|||
33143281|NCT02119676|100438391|FG003|Overall Study|Physician Decision|2|||
33143282|NCT02119676|100438388|FG000|Overall Study|Death|9|||
33143283|NCT02119676|100438389|FG001|Overall Study|Death|3|||
33143284|NCT02119676|100438390|FG002|Overall Study|Death|2|||
33143285|NCT02119676|100438391|FG003|Overall Study|Death|1|||
33143286|NCT02119676|100438388|FG000|Overall Study|Noncompliance|0|||
33143287|NCT02119676|100438389|FG001|Overall Study|Noncompliance|1|||
33143288|NCT02119676|100438390|FG002|Overall Study|Noncompliance|0|||
33143289|NCT02119676|100438391|FG003|Overall Study|Noncompliance|0|||
33143290|NCT02119676|100438388|FG000|Overall Study|Lost to Follow-up|0|||
33143291|NCT02119676|100438389|FG001|Overall Study|Lost to Follow-up|0|||
33143292|NCT02119676|100438390|FG002|Overall Study|Lost to Follow-up|1|||
33143293|NCT02119676|100438391|FG003|Overall Study|Lost to Follow-up|0|||
33143294|NCT02119676|100438388|FG000|Overall Study|Protocol deviation|0|||
33143295|NCT02119676|100438389|FG001|Overall Study|Protocol deviation|0|||
33143296|NCT02119676|100438390|FG002|Overall Study|Protocol deviation|1|||
33143297|NCT02119676|100438391|FG003|Overall Study|Protocol deviation|0|||
33143298|NCT02119676|100438388|FG000|Overall Study|Other, unspecified|2|||
33143299|NCT02119676|100438389|FG001|Overall Study|Other, unspecified|1|||
33143300|NCT02119676|100438390|FG002|Overall Study|Other, unspecified|3|||
33143301|NCT02119676|100438391|FG003|Overall Study|Other, unspecified|4|||
33143302|NCT02119676|100438388|FG000|Overall Study|Did not receive study med|2|||
33143303|NCT02119676|100438389|FG001|Overall Study|Did not receive study med|2|||
33143304|NCT02119676|100438390|FG002|Overall Study|Did not receive study med|4|||
33143305|NCT02119676|100438391|FG003|Overall Study|Did not receive study med|5|||
33143306|NCT02677324|100438398|FG000|Overall Study|Disease Progression|6|||
33143307|NCT02677324|100438398|FG000|Overall Study|Inability to Swallow pills|1|||
33242153|NCT00688688|100788959|FG001|Overall Study|Eligibility criterion not met|7|||
33371386|NCT02531373|101247428|FG003|Overall Study|Lost to Follow-up|0|||
33371387|NCT02531373|101247429|FG004|Overall Study|Lost to Follow-up|0|||
33371388|NCT02531373|101247430|FG005|Overall Study|Lost to Follow-up|2|||
33371389|NCT02531373|101247431|FG006|Overall Study|Lost to Follow-up|2|||
33143308|NCT02677324|100438398|FG000|Overall Study|Non-compliance|1|||
33143309|NCT02677324|100438398|FG000|Overall Study|Lack of Efficacy|1|||
33143310|NCT02677324|100438398|FG000|Overall Study|Medical insurance coverage|1|||
33143311|NCT02677324|100438398|FG000|Overall Study|Adverse Event|1|||
33143312|NCT02677324|100438398|FG000|Overall Study|IgM Myeloma diagnosis|1|||
33143313|NCT03234881|100438399|FG000|Overall Study|Lost to Follow-up|9|||
33143314|NCT03234881|100438400|FG001|Overall Study|Lost to Follow-up|3|||
33143315|NCT01401959|100438401|FG000|Enrolled|Withdrawal by Subject|1|||
33143316|NCT01401959|100438402|FG001|Enrolled|Withdrawal by Subject|0|||
33143317|NCT01401959|100438403|FG002|Enrolled|Withdrawal by Subject|0|||
33143318|NCT01401959|100438401|FG000|Treated|Disease Progression|2|||
33143319|NCT01401959|100438402|FG001|Treated|Disease Progression|2|||
33371390|NCT02531373|101247432|FG007|Overall Study|Lost to Follow-up|0|||
33371391|NCT02531373|101247433|FG008|Overall Study|Lost to Follow-up|0|||
33371392|NCT02531373|101247425|FG000|Overall Study|Physician Decision|0|||
33371393|NCT02531373|101247426|FG001|Overall Study|Physician Decision|0|||
33143320|NCT01401959|100438403|FG002|Treated|Disease Progression|1|||
33143321|NCT01401959|100438401|FG000|Treated|Adverse Event|4|||
33143322|NCT01401959|100438402|FG001|Treated|Adverse Event|3|||
33143323|NCT01401959|100438403|FG002|Treated|Adverse Event|2|||
33143324|NCT01401959|100438401|FG000|Treated|Withdrawal by Subject|1|||
33143325|NCT01401959|100438402|FG001|Treated|Withdrawal by Subject|2|||
33143326|NCT01401959|100438403|FG002|Treated|Withdrawal by Subject|2|||
33143327|NCT01401959|100438401|FG000|Treated|Protocol Violation|0|||
33143328|NCT01401959|100438402|FG001|Treated|Protocol Violation|1|||
33143329|NCT01401959|100438403|FG002|Treated|Protocol Violation|0|||
33143330|NCT01585584|100438406|FG000|Overall Study|Lack of Efficacy|1|||
33143331|NCT01585584|100438406|FG000|Overall Study|Withdrawal by Subject|1|||
33143332|NCT01585584|100438406|FG000|Overall Study|Physician Decision|2|||
33143333|NCT01547780|100438407|FG000|Baseline PET Scan|Physician Decision|1|||
33143334|NCT01547780|100438408|FG001|Baseline PET Scan|Physician Decision|0|||
33143335|NCT01547780|100438409|FG002|Baseline PET Scan|Physician Decision|1|||
33143336|NCT01547780|100438410|FG003|Baseline PET Scan|Physician Decision|0|||
33143337|NCT01547780|100438407|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
33143338|NCT01547780|100438408|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
33143339|NCT01547780|100438409|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
33143340|NCT01547780|100438410|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
33143341|NCT02522871|100438411|FG000|Overall Study|Protocol Violation|1|||
33143342|NCT02522871|100438412|FG001|Overall Study|Protocol Violation|4|||
33143343|NCT02522871|100438411|FG000|Overall Study|Treated without randomization|1|||
33143344|NCT02522871|100438412|FG001|Overall Study|Treated without randomization|0|||
33143345|NCT02522871|100438411|FG000|Overall Study|Death|9|||
33143346|NCT02522871|100438412|FG001|Overall Study|Death|9|||
33143347|NCT02522871|100438411|FG000|Overall Study|Died in operating room prior to transplant|0|||
33143348|NCT02522871|100438412|FG001|Overall Study|Died in operating room prior to transplant|1|||
33143349|NCT00636987|100438414|FG000|Overall Study|Death|44|||
33143350|NCT00636987|100438414|FG000|Overall Study|Explanted|13|||
33143351|NCT00636987|100438414|FG000|Overall Study|Lost to Follow-up|63|||
33143352|NCT00636987|100438414|FG000|Overall Study|5 year visit window not complete|69|||
33143353|NCT00393042|100438417|FG000|First Intervention|Withdrawal by Subject|1|||
33143354|NCT00393042|100438418|FG001|First Intervention|Withdrawal by Subject|2|||
33143355|NCT00393042|100438417|FG000|First Intervention|Lost to Follow-up|3|||
33143356|NCT00393042|100438418|FG001|First Intervention|Lost to Follow-up|3|||
33143357|NCT00393042|100438417|FG000|First Intervention|Protocol Violation|1|||
33143358|NCT00393042|100438418|FG001|First Intervention|Protocol Violation|0|||
33143359|NCT00393042|100438417|FG000|First Intervention|Adverse Event|0|||
33143360|NCT00393042|100438418|FG001|First Intervention|Adverse Event|1|||
33143361|NCT00393042|100438417|FG000|Second Intervetion|Adverse Event|0|||
33143362|NCT00393042|100438418|FG001|Second Intervetion|Adverse Event|3|||
33143363|NCT00393042|100438417|FG000|Second Intervetion|Withdrawal by Subject|0|||
33143364|NCT00393042|100438418|FG001|Second Intervetion|Withdrawal by Subject|2|||
33143365|NCT00393042|100438417|FG000|Second Intervetion|Lack of Efficacy|1|||
33143366|NCT00393042|100438418|FG001|Second Intervetion|Lack of Efficacy|0|||
33143367|NCT00393042|100438417|FG000|Second Intervetion|Lost to Follow-up|0|||
33143368|NCT00393042|100438418|FG001|Second Intervetion|Lost to Follow-up|2|||
33143369|NCT00393042|100438417|FG000|Second Intervetion|Protocol Violation|1|||
33143370|NCT00393042|100438418|FG001|Second Intervetion|Protocol Violation|1|||
33242154|NCT00688688|100788960|FG002|Overall Study|Eligibility criterion not met|10|||
33371394|NCT02531373|101247427|FG002|Overall Study|Physician Decision|0|||
33371395|NCT02531373|101247428|FG003|Overall Study|Physician Decision|0|||
33581538|NCT00540592|102020116|FG004|Overall Study|Withdrawal by Subject|0|||
33581539|NCT00540592|102020117|FG005|Overall Study|Withdrawal by Subject|0|||
33581540|NCT00540592|102020118|FG006|Overall Study|Withdrawal by Subject|0|||
33581541|NCT00540592|102020119|FG007|Overall Study|Withdrawal by Subject|0|||
33581542|NCT00540592|102020120|FG008|Overall Study|Withdrawal by Subject|0|||
33581543|NCT00540592|102020121|FG009|Overall Study|Withdrawal by Subject|0|||
33581544|NCT03456700|102020122|FG000|Overall Study|Withdrawal by Subject|1|||
33242155|NCT00688688|100788958|FG000|Overall Study|Adverse Event|52|||
33143371|NCT00704522|100438421|FG000|Overall Study|Lack of Efficacy|65|||
33143372|NCT00704522|100438422|FG001|Overall Study|Lack of Efficacy|17|||
33143373|NCT00704522|100438421|FG000|Overall Study|Failure to appear again at hospital|56|||
33143374|NCT00704522|100438422|FG001|Overall Study|Failure to appear again at hospital|10|||
33143375|NCT00704522|100438421|FG000|Overall Study|Withdrawal by Subject|17|||
33143376|NCT00704522|100438422|FG001|Overall Study|Withdrawal by Subject|8|||
33143377|NCT00704522|100438421|FG000|Overall Study|Adverse Event|9|||
33143378|NCT00704522|100438422|FG001|Overall Study|Adverse Event|1|||
33371396|NCT02531373|101247429|FG004|Overall Study|Physician Decision|2|||
33143379|NCT00704522|100438421|FG000|Overall Study|Undefined causes|9|||
33143380|NCT00704522|100438422|FG001|Overall Study|Undefined causes|7|||
33143381|NCT00704522|100438421|FG000|Overall Study|No information on therapy end|27|||
33242156|NCT00688688|100788959|FG001|Overall Study|Adverse Event|51|||
33371397|NCT02531373|101247430|FG005|Overall Study|Physician Decision|1|||
33371398|NCT02531373|101247431|FG006|Overall Study|Physician Decision|0|||
33371399|NCT02531373|101247432|FG007|Overall Study|Physician Decision|0|||
33371400|NCT02531373|101247433|FG008|Overall Study|Physician Decision|0|||
33371401|NCT02531373|101247425|FG000|Overall Study|Protocol Violation|0|||
33371402|NCT02531373|101247426|FG001|Overall Study|Protocol Violation|0|||
33371403|NCT02531373|101247427|FG002|Overall Study|Protocol Violation|0|||
33371404|NCT02531373|101247428|FG003|Overall Study|Protocol Violation|0|||
33421551|NCT00665626|101434828|FG000|Overall Study|Unably to comply with dosing regimen|0|||
33421552|NCT00665626|101434829|FG001|Overall Study|Unably to comply with dosing regimen|1|||
33421553|NCT00665626|101434828|FG000|Overall Study|Death|1|||
33421554|NCT00665626|101434829|FG001|Overall Study|Death|0|||
33421555|NCT02875067|101434830|FG000|Overall Study|Withdrawal by Subject|1|||
33421556|NCT02875067|101434830|FG000|Overall Study|Withdrawal by Termination of Study|5|||
33421557|NCT00886782|101434833|FG000|Overall Study|Disease progression|3|||
33421558|NCT00886782|101434834|FG001|Overall Study|Disease progression|3|||
33421559|NCT00886782|101434835|FG002|Overall Study|Disease progression|3|||
33421560|NCT00886782|101434833|FG000|Overall Study|Study drug toxicity|0|||
33421561|NCT00886782|101434834|FG001|Overall Study|Study drug toxicity|0|||
33421562|NCT00886782|101434835|FG002|Overall Study|Study drug toxicity|1|||
33421563|NCT00886782|101434833|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
33421564|NCT00886782|101434834|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
33641943|NCT02167139|102240252|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
33641944|NCT02167139|102240249|FG000|Randomised, Double-blind|Adverse Event|2|||
33641945|NCT02167139|102240250|FG001|Randomised, Double-blind|Adverse Event|9|||
33641946|NCT02167139|102240251|FG002|Randomised, Double-blind|Adverse Event|0|||
33641947|NCT02167139|102240252|FG003|Randomised, Double-blind|Adverse Event|0|||
33641948|NCT02167139|102240249|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
33641949|NCT02167139|102240250|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
33641950|NCT02167139|102240251|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
33641951|NCT02167139|102240252|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
33641952|NCT02167139|102240249|FG000|Randomised, Double-blind|Other|3|||
33641953|NCT02167139|102240250|FG001|Randomised, Double-blind|Other|0|||
33641954|NCT02167139|102240251|FG002|Randomised, Double-blind|Other|0|||
33641955|NCT02167139|102240252|FG003|Randomised, Double-blind|Other|0|||
33143382|NCT00704522|100438422|FG001|Overall Study|No information on therapy end|2|||
33143383|NCT04535167|100438423|FG000|Treatment|Adverse Event|0|||
33143384|NCT04535167|100438424|FG001|Treatment|Adverse Event|0|||
33143385|NCT04535167|100438425|FG002|Treatment|Adverse Event|0|||
33143386|NCT04535167|100438426|FG003|Treatment|Adverse Event|0|||
33143387|NCT04535167|100438427|FG004|Treatment|Adverse Event|0|||
33143388|NCT04535167|100438428|FG005|Treatment|Adverse Event|0|||
33143389|NCT04535167|100438429|FG006|Treatment|Adverse Event|1|||
33143390|NCT04535167|100438423|FG000|Follow-Up|Death|0|||
33143391|NCT04535167|100438424|FG001|Follow-Up|Death|0|||
33143392|NCT04535167|100438425|FG002|Follow-Up|Death|0|||
33143393|NCT04535167|100438426|FG003|Follow-Up|Death|0|||
33143394|NCT04535167|100438427|FG004|Follow-Up|Death|0|||
33143395|NCT04535167|100438428|FG005|Follow-Up|Death|0|||
33143396|NCT04535167|100438429|FG006|Follow-Up|Death|1|||
33143397|NCT04535167|100438423|FG000|Follow-Up|Lost to Follow-up|0|||
33143398|NCT04535167|100438424|FG001|Follow-Up|Lost to Follow-up|0|||
33371405|NCT02531373|101247429|FG004|Overall Study|Protocol Violation|0|||
33371406|NCT02531373|101247430|FG005|Overall Study|Protocol Violation|1|||
33421565|NCT00886782|101434835|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
33421566|NCT01890109|101434836|FG000|Overall Study|Withdrawal by Subject|0|||
33421567|NCT01890109|101434837|FG001|Overall Study|Withdrawal by Subject|3|||
33421568|NCT01890109|101434836|FG000|Overall Study|Lost to Follow-up|1|||
33421569|NCT01890109|101434837|FG001|Overall Study|Lost to Follow-up|2|||
33421570|NCT03547531|101434844|FG000|Overall Study|not coming in data collection : sick|2|||
33641956|NCT02167139|102240249|FG000|Transition-extension|Adverse Event|2|||
33641957|NCT02167139|102240250|FG001|Transition-extension|Adverse Event|0|||
33641958|NCT02167139|102240251|FG002|Transition-extension|Adverse Event|2|||
33641959|NCT02167139|102240252|FG003|Transition-extension|Adverse Event|3|||
33143399|NCT04535167|100438425|FG002|Follow-Up|Lost to Follow-up|0|||
33143400|NCT04535167|100438426|FG003|Follow-Up|Lost to Follow-up|1|||
33143401|NCT04535167|100438427|FG004|Follow-Up|Lost to Follow-up|0|||
33143402|NCT04535167|100438428|FG005|Follow-Up|Lost to Follow-up|0|||
33143403|NCT04535167|100438429|FG006|Follow-Up|Lost to Follow-up|0|||
33143404|NCT00476047|100438431|FG000|Overall Study|Lost to Follow-up|1|||
33143405|NCT05093790|100438432|FG000|Overall Study|Failure to meet continuation criteria|0|||
33143406|NCT05093790|100438433|FG001|Overall Study|Failure to meet continuation criteria|0|||
33143407|NCT05093790|100438434|FG002|Overall Study|Failure to meet continuation criteria|1|||
33143408|NCT05093790|100438435|FG003|Overall Study|Failure to meet continuation criteria|0|||
33143409|NCT05093790|100438432|FG000|Overall Study|Adverse Event|1|||
33143410|NCT05093790|100438433|FG001|Overall Study|Adverse Event|0|||
33143411|NCT05093790|100438434|FG002|Overall Study|Adverse Event|0|||
33143412|NCT05093790|100438435|FG003|Overall Study|Adverse Event|0|||
33371407|NCT02531373|101247431|FG006|Overall Study|Protocol Violation|1|||
33371408|NCT02531373|101247432|FG007|Overall Study|Protocol Violation|0|||
33242157|NCT00688688|100788960|FG002|Overall Study|Adverse Event|50|||
33242158|NCT00688688|100788958|FG000|Overall Study|Lack of Efficacy|34|||
33242159|NCT00688688|100788959|FG001|Overall Study|Lack of Efficacy|25|||
33242160|NCT00688688|100788960|FG002|Overall Study|Lack of Efficacy|45|||
33242161|NCT00688688|100788958|FG000|Overall Study|Withdrawal by Subject|66|||
33242162|NCT00688688|100788959|FG001|Overall Study|Withdrawal by Subject|75|||
33242163|NCT00688688|100788960|FG002|Overall Study|Withdrawal by Subject|65|||
33242164|NCT00688688|100788958|FG000|Overall Study|Lost to Follow-up|14|||
33242165|NCT00688688|100788959|FG001|Overall Study|Lost to Follow-up|7|||
33242166|NCT00688688|100788960|FG002|Overall Study|Lost to Follow-up|7|||
33242167|NCT00688688|100788958|FG000|Overall Study|Protocol Violation|6|||
33242168|NCT00688688|100788959|FG001|Overall Study|Protocol Violation|9|||
33242169|NCT00688688|100788960|FG002|Overall Study|Protocol Violation|11|||
33242170|NCT00688688|100788958|FG000|Overall Study|Randomized but never received study drug|1|||
33371409|NCT02531373|101247433|FG008|Overall Study|Protocol Violation|1|||
33371410|NCT02531373|101247425|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33371411|NCT02531373|101247426|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33371412|NCT02531373|101247427|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
33371413|NCT02531373|101247428|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
33371414|NCT02531373|101247429|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
33371415|NCT02531373|101247430|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
33371416|NCT02531373|101247431|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
33371417|NCT02531373|101247432|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
33371418|NCT02531373|101247433|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
33371419|NCT02531373|101247425|FG000|Overall Study|Withdrawal by Subject|0|||
33371420|NCT02531373|101247426|FG001|Overall Study|Withdrawal by Subject|0|||
33371421|NCT02531373|101247427|FG002|Overall Study|Withdrawal by Subject|0|||
33371422|NCT02531373|101247428|FG003|Overall Study|Withdrawal by Subject|0|||
33371423|NCT02531373|101247429|FG004|Overall Study|Withdrawal by Subject|3|||
33371424|NCT02531373|101247430|FG005|Overall Study|Withdrawal by Subject|0|||
33371425|NCT02531373|101247431|FG006|Overall Study|Withdrawal by Subject|0|||
33371426|NCT02531373|101247432|FG007|Overall Study|Withdrawal by Subject|0|||
33371427|NCT02531373|101247433|FG008|Overall Study|Withdrawal by Subject|0|||
33371428|NCT03738566|101247434|FG000|Initial Study Phase|Withdrawal by Subject|1|||
33371429|NCT03738566|101247435|FG001|Initial Study Phase|Withdrawal by Subject|1|||
33421571|NCT03547531|101434845|FG001|Overall Study|not coming in data collection : sick|2|||
33421572|NCT03547531|101434844|FG000|Overall Study|having family occasion|0|||
33421573|NCT03547531|101434845|FG001|Overall Study|having family occasion|2|||
33421574|NCT03118765|101434850|FG000|Overall Study|Withdrawal by Subject|0|||
33421575|NCT03118765|101434851|FG001|Overall Study|Withdrawal by Subject|0|||
33421576|NCT03118765|101434852|FG002|Overall Study|Withdrawal by Subject|1|||
33421577|NCT03118765|101434853|FG003|Overall Study|Withdrawal by Subject|0|||
33421578|NCT03118765|101434854|FG004|Overall Study|Withdrawal by Subject|0|||
33421579|NCT03118765|101434850|FG000|Overall Study|Adverse Event|1|||
33421580|NCT03118765|101434851|FG001|Overall Study|Adverse Event|1|||
33421581|NCT03118765|101434852|FG002|Overall Study|Adverse Event|1|||
33421582|NCT03118765|101434853|FG003|Overall Study|Adverse Event|1|||
33421583|NCT03118765|101434854|FG004|Overall Study|Adverse Event|1|||
33421584|NCT03118765|101434850|FG000|Overall Study|Non compliance with Study Procedures|0|||
33421585|NCT03118765|101434851|FG001|Overall Study|Non compliance with Study Procedures|0|||
33421586|NCT03118765|101434852|FG002|Overall Study|Non compliance with Study Procedures|0|||
33421587|NCT03118765|101434853|FG003|Overall Study|Non compliance with Study Procedures|1|||
33421588|NCT03118765|101434854|FG004|Overall Study|Non compliance with Study Procedures|0|||
33421589|NCT03118765|101434850|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
33421590|NCT03118765|101434851|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
33421591|NCT03118765|101434852|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
33421592|NCT03118765|101434853|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
33641960|NCT02167139|102240249|FG000|Transition-extension|Withdrawal by Subject|2|||
33641961|NCT02167139|102240250|FG001|Transition-extension|Withdrawal by Subject|0|||
33641962|NCT02167139|102240251|FG002|Transition-extension|Withdrawal by Subject|4|||
33242171|NCT00688688|100788959|FG001|Overall Study|Randomized but never received study drug|0|||
33242172|NCT00688688|100788960|FG002|Overall Study|Randomized but never received study drug|0|||
33242173|NCT00688688|100788958|FG000|Overall Study|Non-compliance with study procedures|5|||
33242174|NCT00688688|100788959|FG001|Overall Study|Non-compliance with study procedures|3|||
33421593|NCT03118765|101434854|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
33421594|NCT03118765|101434850|FG000|Overall Study|COPD Exacerbation|1|||
33421595|NCT03118765|101434851|FG001|Overall Study|COPD Exacerbation|0|||
33421596|NCT03118765|101434852|FG002|Overall Study|COPD Exacerbation|0|||
33242175|NCT00688688|100788960|FG002|Overall Study|Non-compliance with study procedures|4|||
33242176|NCT00688688|100788958|FG000|Overall Study|Taking exclusionary medications|1|||
33242177|NCT00688688|100788959|FG001|Overall Study|Taking exclusionary medications|0|||
33371430|NCT03738566|101247436|FG002|Initial Study Phase|Withdrawal by Subject|2|||
33371431|NCT03738566|101247437|FG003|Initial Study Phase|Withdrawal by Subject|0|||
33641963|NCT02167139|102240252|FG003|Transition-extension|Withdrawal by Subject|1|||
33641964|NCT02167139|102240249|FG000|Transition-extension|Lack of Efficacy|0|||
33641965|NCT02167139|102240250|FG001|Transition-extension|Lack of Efficacy|0|||
33641966|NCT02167139|102240251|FG002|Transition-extension|Lack of Efficacy|1|||
33641967|NCT02167139|102240252|FG003|Transition-extension|Lack of Efficacy|1|||
33641968|NCT02167139|102240249|FG000|Transition-extension|Other|1|||
33641969|NCT02167139|102240250|FG001|Transition-extension|Other|0|||
33641970|NCT02167139|102240251|FG002|Transition-extension|Other|1|||
33641971|NCT02167139|102240252|FG003|Transition-extension|Other|0|||
33641972|NCT02167139|102240249|FG000|Transition-extension|Lost to Follow-up|1|||
33641973|NCT02167139|102240250|FG001|Transition-extension|Lost to Follow-up|0|||
33143413|NCT00251004|100438436|FG000|Overall Study|Withdrawal by Subject|23|||
33143414|NCT00251004|100438437|FG001|Overall Study|Withdrawal by Subject|16|||
33143415|NCT00251004|100438438|FG002|Overall Study|Withdrawal by Subject|14|||
33143416|NCT00251004|100438436|FG000|Overall Study|Death|9|||
33143417|NCT00251004|100438437|FG001|Overall Study|Death|10|||
33143418|NCT00251004|100438438|FG002|Overall Study|Death|8|||
33143419|NCT00251004|100438436|FG000|Overall Study|Lost to Follow-up|1|||
33641974|NCT02167139|102240251|FG002|Transition-extension|Lost to Follow-up|0|||
33641975|NCT02167139|102240252|FG003|Transition-extension|Lost to Follow-up|0|||
33641976|NCT03048578|102240253|FG000|Overall Study|Withdrawal by Subject|5|||
33143420|NCT00251004|100438437|FG001|Overall Study|Lost to Follow-up|2|||
33143421|NCT00251004|100438438|FG002|Overall Study|Lost to Follow-up|1|||
33143422|NCT00251004|100438436|FG000|Overall Study|Graft Loss|12|||
33143423|NCT00251004|100438437|FG001|Overall Study|Graft Loss|13|||
33143424|NCT00251004|100438438|FG002|Overall Study|Graft Loss|8|||
33421597|NCT03118765|101434853|FG003|Overall Study|COPD Exacerbation|1|||
33421598|NCT03118765|101434854|FG004|Overall Study|COPD Exacerbation|0|||
33421599|NCT03118765|101434850|FG000|Overall Study|Lost to Follow-up|1|||
33421600|NCT03118765|101434851|FG001|Overall Study|Lost to Follow-up|0|||
33143425|NCT01288976|100438439|FG000|Overall Study|Withdrawal by Subject|58|||
33143426|NCT01288976|100438440|FG001|Overall Study|Withdrawal by Subject|12|||
33421601|NCT03118765|101434852|FG002|Overall Study|Lost to Follow-up|1|||
33421602|NCT03118765|101434853|FG003|Overall Study|Lost to Follow-up|0|||
33143427|NCT01288976|100438441|FG002|Overall Study|Withdrawal by Subject|9|||
33143428|NCT01288976|100438439|FG000|Overall Study|Death|98|||
33143429|NCT01288976|100438440|FG001|Overall Study|Death|6|||
33143430|NCT01288976|100438441|FG002|Overall Study|Death|4|||
33143431|NCT01288976|100438439|FG000|Overall Study|Data unavailable|22|||
33143432|NCT01288976|100438440|FG001|Overall Study|Data unavailable|9|||
33143433|NCT01288976|100438441|FG002|Overall Study|Data unavailable|7|||
33143434|NCT02742246|100438442|FG000|Overall Study|Never initiated treatment|5|||
33421603|NCT03118765|101434854|FG004|Overall Study|Lost to Follow-up|0|||
33421604|NCT03118765|101434850|FG000|Overall Study|Sponsor Decision|1|||
33421605|NCT03118765|101434851|FG001|Overall Study|Sponsor Decision|0|||
33421606|NCT03118765|101434852|FG002|Overall Study|Sponsor Decision|1|||
33421607|NCT03118765|101434853|FG003|Overall Study|Sponsor Decision|0|||
33421608|NCT03118765|101434854|FG004|Overall Study|Sponsor Decision|1|||
33421609|NCT01392170|101434855|FG000|Overall Study|Withdrawal by Subject|1|||
33421610|NCT01392170|101434855|FG000|Overall Study|Ineligible|1|||
33421611|NCT03959137|101434856|FG000|Overall Study|Protocol Violation|6|||
33421612|NCT02476851|101434857|FG000|Overall Study|Protocol Violation|1|||
33143435|NCT02742246|100438443|FG001|Overall Study|Never initiated treatment|3|||
33242178|NCT00688688|100788960|FG002|Overall Study|Taking exclusionary medications|0|||
33242179|NCT00688688|100788958|FG000|Overall Study|Site closure|0|||
33421613|NCT02476851|101434858|FG001|Overall Study|Protocol Violation|1|||
33421614|NCT00829439|101434861|FG000|Overall Study|Adverse Event|0|||
33421615|NCT00829439|101434862|FG001|Overall Study|Adverse Event|0|||
33421616|NCT00829439|101434863|FG002|Overall Study|Adverse Event|1|||
33421617|NCT00829439|101434864|FG003|Overall Study|Adverse Event|0|||
33581545|NCT00912782|102020123|FG000|Overall Study|Death|2|||
33581546|NCT00912782|102020124|FG001|Overall Study|Death|1|||
33581547|NCT00912782|102020123|FG000|Overall Study|Lost to Follow-up|0|||
33581548|NCT00912782|102020124|FG001|Overall Study|Lost to Follow-up|1|||
33581549|NCT00912782|102020123|FG000|Overall Study|Did not receive vascular access type|1|||
33581550|NCT00912782|102020124|FG001|Overall Study|Did not receive vascular access type|2|||
33581551|NCT00912782|102020123|FG000|Overall Study|Relocated before study completion|0|||
33581552|NCT00912782|102020124|FG001|Overall Study|Relocated before study completion|1|||
33581553|NCT01558115|102020128|FG000|Overall Study|Withdrawal by Subject|3|||
33641977|NCT03048578|102240254|FG001|Overall Study|Withdrawal by Subject|6|||
33641978|NCT03048578|102240253|FG000|Overall Study|Lost to Follow-up|22|||
33641979|NCT03048578|102240254|FG001|Overall Study|Lost to Follow-up|10|||
33143436|NCT02742246|100438444|FG002|Overall Study|Never initiated treatment|1|||
33143437|NCT02742246|100438442|FG000|Overall Study|dropped out during treatment|7|||
33143438|NCT02742246|100438443|FG001|Overall Study|dropped out during treatment|13|||
33143439|NCT02742246|100438444|FG002|Overall Study|dropped out during treatment|10|||
33143440|NCT02742246|100438442|FG000|Overall Study|Death|1|||
33143441|NCT02742246|100438443|FG001|Overall Study|Death|0|||
33421618|NCT02862535|101434865|FG000|Overall Study|Death|7|||
33143442|NCT02742246|100438444|FG002|Overall Study|Death|0|||
33143443|NCT03745820|100438445|FG000|Overall Study|Adverse Event|0|||
33143444|NCT03745820|100438446|FG001|Overall Study|Adverse Event|3|||
33143445|NCT03745820|100438447|FG002|Overall Study|Adverse Event|2|||
33143446|NCT03745820|100438445|FG000|Overall Study|Non-Compliance with Study Drug|4|||
33143447|NCT03745820|100438446|FG001|Overall Study|Non-Compliance with Study Drug|3|||
33143448|NCT03745820|100438447|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33143449|NCT03745820|100438445|FG000|Overall Study|Withdrawal by Subject|4|||
33143450|NCT03745820|100438446|FG001|Overall Study|Withdrawal by Subject|4|||
33143451|NCT03745820|100438447|FG002|Overall Study|Withdrawal by Subject|4|||
33143452|NCT03745820|100438445|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
33143453|NCT03745820|100438446|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
33143454|NCT03745820|100438447|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
33143455|NCT03745820|100438445|FG000|Overall Study|Lost to Follow-up|2|||
33143456|NCT03745820|100438446|FG001|Overall Study|Lost to Follow-up|0|||
33143457|NCT03745820|100438447|FG002|Overall Study|Lost to Follow-up|3|||
33143458|NCT03745820|100438445|FG000|Overall Study|Reason not Specified|2|||
33143459|NCT03745820|100438446|FG001|Overall Study|Reason not Specified|4|||
33143460|NCT03745820|100438447|FG002|Overall Study|Reason not Specified|1|||
33143461|NCT01209832|100438454|FG000|Period 1|Sponsor Decision and was not dosed|1|||
33143462|NCT01209832|100438454|FG000|Period 2|Sponsor Decision|1|||
33143463|NCT02045303|100438463|FG000|Overall Study|Protocol Violation|2|||
33143464|NCT02045303|100438464|FG001|Overall Study|Protocol Violation|1|||
33143465|NCT02045303|100438465|FG002|Overall Study|Protocol Violation|0|||
33143466|NCT02045303|100438463|FG000|Overall Study|Withdrawal by Subject|0|||
33143467|NCT02045303|100438464|FG001|Overall Study|Withdrawal by Subject|2|||
33143468|NCT02045303|100438465|FG002|Overall Study|Withdrawal by Subject|0|||
33242180|NCT00688688|100788959|FG001|Overall Study|Site closure|1|||
33242181|NCT00688688|100788960|FG002|Overall Study|Site closure|0|||
33242182|NCT00688688|100788958|FG000|Overall Study|Violation of exclusion criterion|0|||
33242183|NCT00688688|100788959|FG001|Overall Study|Violation of exclusion criterion|1|||
33371432|NCT03738566|101247434|FG000|Initial Study Phase|Death|0|||
33371433|NCT03738566|101247435|FG001|Initial Study Phase|Death|1|||
33641980|NCT03048578|102240253|FG000|Overall Study|Adverse Event|1|||
33641981|NCT03048578|102240254|FG001|Overall Study|Adverse Event|2|||
33641982|NCT03048578|102240253|FG000|Overall Study|Terminated|3|||
33641983|NCT03048578|102240254|FG001|Overall Study|Terminated|2|||
33641984|NCT04195893|102240255|FG000|Second Intervention|Withdrawal by Subject|1|||
33641985|NCT04195893|102240256|FG001|Second Intervention|Withdrawal by Subject|0|||
33641986|NCT01010867|102240257|FG000|Overall Study|< 50% adherence to probiotic|1|||
33641987|NCT04953728|102240258|FG000|Overall Study|Withdrawal by Subject|3|||
33641988|NCT04953728|102240258|FG000|Overall Study|Physician Decision|1|||
33641989|NCT04080167|102240259|FG000|Overall Study|Lost to Follow-up-Patients|7|||
33641990|NCT04080167|102240260|FG001|Overall Study|Lost to Follow-up-Patients|14|||
33641991|NCT04080167|102240261|FG002|Overall Study|Lost to Follow-up-Patients|0|||
33143469|NCT03614975|100438466|FG000|Overall Study|Physician Decision|7|||
33143470|NCT03614975|100438467|FG001|Overall Study|Physician Decision|5|||
33371434|NCT03738566|101247436|FG002|Initial Study Phase|Death|0|||
33371435|NCT03738566|101247437|FG003|Initial Study Phase|Death|0|||
33371436|NCT03738566|101247434|FG000|Initial Study Phase|Treatment failure|5|||
33371437|NCT03738566|101247435|FG001|Initial Study Phase|Treatment failure|0|||
33371438|NCT03738566|101247436|FG002|Initial Study Phase|Treatment failure|0|||
33371439|NCT03738566|101247437|FG003|Initial Study Phase|Treatment failure|0|||
33371440|NCT03738566|101247434|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
33581554|NCT01558115|102020128|FG000|Overall Study|Study closed due to poor enrollment|4|||
33581555|NCT00881530|102020129|FG000|Overall Study|Adverse Event|5|||
33581556|NCT00881530|102020130|FG001|Overall Study|Adverse Event|1|||
33581557|NCT00881530|102020131|FG002|Overall Study|Adverse Event|1|||
33581558|NCT00881530|102020132|FG003|Overall Study|Adverse Event|4|||
33581559|NCT00881530|102020133|FG004|Overall Study|Adverse Event|10|||
33581560|NCT00881530|102020134|FG005|Overall Study|Adverse Event|2|||
33581561|NCT00881530|102020129|FG000|Overall Study|Lack of Efficacy|1|||
33641992|NCT04080167|102240259|FG000|Overall Study|Lost to Follow-up-Providers|2|||
33641993|NCT04080167|102240260|FG001|Overall Study|Lost to Follow-up-Providers|2|||
33143471|NCT03614975|100438466|FG000|Overall Study|Withdrawal by Subject|2|||
33242184|NCT00688688|100788960|FG002|Overall Study|Violation of exclusion criterion|0|||
33371441|NCT03738566|101247435|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
33641994|NCT04080167|102240261|FG002|Overall Study|Lost to Follow-up-Providers|0|||
33641995|NCT04080167|102240259|FG000|Overall Study|Withdrawal by Subject|1|||
33143472|NCT03614975|100438467|FG001|Overall Study|Withdrawal by Subject|2|||
33143473|NCT03614975|100438466|FG000|Overall Study|Specimens not in lab batch shipment|1|||
33143474|NCT03614975|100438467|FG001|Overall Study|Specimens not in lab batch shipment|1|||
33143475|NCT03036800|100438468|FG000|Overall Study|Protocol Violation|1|||
33143476|NCT03036800|100438469|FG001|Overall Study|Protocol Violation|0|||
33143477|NCT03036800|100438468|FG000|Overall Study|Non-compliance|1|||
33581562|NCT00881530|102020130|FG001|Overall Study|Lack of Efficacy|0|||
33641996|NCT04080167|102240260|FG001|Overall Study|Withdrawal by Subject|2|||
33641997|NCT04080167|102240261|FG002|Overall Study|Withdrawal by Subject|0|||
33641998|NCT04080167|102240259|FG000|Overall Study|Withdrawal by Provider|0|||
33641999|NCT04080167|102240260|FG001|Overall Study|Withdrawal by Provider|0|||
33642000|NCT04080167|102240261|FG002|Overall Study|Withdrawal by Provider|4|||
33642001|NCT04080167|102240259|FG000|Overall Study|Death-Patient|2|||
33642002|NCT04080167|102240260|FG001|Overall Study|Death-Patient|1|||
33642003|NCT04080167|102240261|FG002|Overall Study|Death-Patient|0|||
33642004|NCT04080167|102240259|FG000|Overall Study|Hydroxyurea New Starts|0|||
33143478|NCT03036800|100438469|FG001|Overall Study|Non-compliance|0|||
33143479|NCT03036800|100438468|FG000|Overall Study|Lost to Follow-up|1|||
33143480|NCT03036800|100438469|FG001|Overall Study|Lost to Follow-up|0|||
33143481|NCT03036800|100438468|FG000|Overall Study|Death|1|||
33143482|NCT03036800|100438469|FG001|Overall Study|Death|0|||
33143483|NCT03036800|100438468|FG000|Overall Study|Tolerance|5|||
33143484|NCT03036800|100438469|FG001|Overall Study|Tolerance|0|||
33143485|NCT03036800|100438468|FG000|Overall Study|Unknown/no reason given|50|||
33143486|NCT03036800|100438469|FG001|Overall Study|Unknown/no reason given|39|||
33143487|NCT02829944|100438470|FG000|Overall Study|Physician Decision|0|||
33143488|NCT02829944|100438471|FG001|Overall Study|Physician Decision|1|||
33143489|NCT02829944|100438470|FG000|Overall Study|Screen Failure|2|||
33143490|NCT02829944|100438471|FG001|Overall Study|Screen Failure|2|||
33143491|NCT02829944|100438470|FG000|Overall Study|Inadequate Neuraxial Block|1|||
33143492|NCT02829944|100438471|FG001|Overall Study|Inadequate Neuraxial Block|1|||
33143493|NCT02829944|100438470|FG000|Overall Study|Withdrawal by Subject|2|||
33143494|NCT02829944|100438471|FG001|Overall Study|Withdrawal by Subject|1|||
33143495|NCT02829944|100438470|FG000|Overall Study|Catheter Displacement|1|||
33143496|NCT02829944|100438471|FG001|Overall Study|Catheter Displacement|0|||
33143497|NCT02829944|100438470|FG000|Overall Study|Catheter broke|0|||
33143498|NCT02829944|100438471|FG001|Overall Study|Catheter broke|1|||
33143499|NCT02829944|100438470|FG000|Overall Study|Staff unavailable|0|||
33143500|NCT02829944|100438471|FG001|Overall Study|Staff unavailable|1|||
33143501|NCT03328182|100438478|FG000|Overall Study|Withdrawal by Subject|1|||
33143502|NCT03328182|100438478|FG000|Overall Study|Protocol Violation|2|||
33143503|NCT03328182|100438478|FG000|Overall Study|No Product Evaluated|1|||
33242185|NCT00121199|100788963|FG000|Overall Study|Adverse Event|11|||
33242186|NCT00121199|100788963|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
33242187|NCT00121199|100788963|FG000|Overall Study|Progression/Relapse|1|||
33242188|NCT00121199|100788963|FG000|Overall Study|Death|3|||
33242189|NCT00121199|100788963|FG000|Overall Study|Other - Not Protocol Specified|3|||
33371442|NCT03738566|101247436|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
33371443|NCT03738566|101247437|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
33371444|NCT01253421|101247438|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
33371445|NCT01253421|101247439|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
33371446|NCT01253421|101247440|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
33371447|NCT01253421|101247441|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
33371448|NCT01253421|101247442|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
33371449|NCT01253421|101247438|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
33371450|NCT01253421|101247439|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
33371451|NCT01253421|101247440|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
33371452|NCT01253421|101247441|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
33371453|NCT01253421|101247442|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
33371454|NCT01253421|101247438|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
33371455|NCT01253421|101247439|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
33371456|NCT01253421|101247440|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
33371457|NCT01253421|101247441|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
33371458|NCT01253421|101247442|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
33371459|NCT01253421|101247438|FG000|Assessment and Scheduling|Physician Decision|1|||
33371460|NCT01253421|101247439|FG001|Assessment and Scheduling|Physician Decision|0|||
33371461|NCT01253421|101247440|FG002|Assessment and Scheduling|Physician Decision|0|||
33642005|NCT04080167|102240260|FG001|Overall Study|Hydroxyurea New Starts|0|||
33642006|NCT04080167|102240261|FG002|Overall Study|Hydroxyurea New Starts|1|||
33642007|NCT04080167|102240259|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
33642008|NCT04080167|102240260|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
33143504|NCT01551420|100438483|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
33242190|NCT00121199|100788963|FG000|Overall Study|Ineligible|9|||
33242191|NCT00367237|100788970|FG000|Overall Study|Adverse Event|7|||
33143505|NCT01551420|100438484|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
33143506|NCT01551420|100438483|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
33143507|NCT01551420|100438484|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
33143508|NCT01551420|100438483|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
33371462|NCT01253421|101247441|FG003|Assessment and Scheduling|Physician Decision|0|||
33371463|NCT01253421|101247442|FG004|Assessment and Scheduling|Physician Decision|0|||
33371464|NCT01253421|101247438|FG000|Drug+Scanning Visit|Physician Decision|0|||
33143509|NCT01551420|100438484|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
33642009|NCT04080167|102240261|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
33642010|NCT05343624|102240264|FG000|Overall Study|Chart review not completed|1|||
33642011|NCT02597478|102240272|FG000|Overall Study|Withdrawal by Subject|2|||
33642012|NCT02597478|102240273|FG001|Overall Study|Withdrawal by Subject|0|||
33642013|NCT02597478|102240272|FG000|Overall Study|Change of opioid dose|1|||
33642014|NCT02597478|102240273|FG001|Overall Study|Change of opioid dose|0|||
33642015|NCT02597478|102240272|FG000|Overall Study|Insufficient exertional dyspnea|0|||
33642016|NCT02597478|102240273|FG001|Overall Study|Insufficient exertional dyspnea|1|||
33642017|NCT02118961|102240286|FG000|Overall Study|Withdrawal by Subject|1|||
33642018|NCT02118961|102240287|FG001|Overall Study|Withdrawal by Subject|0|||
33642019|NCT01781299|102240288|FG000|Overall Study|Withdrawal by Subject|0|||
33642020|NCT01781299|102240289|FG001|Overall Study|Withdrawal by Subject|1|||
33642021|NCT00557856|102240290|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
33642022|NCT00557856|102240291|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
33642023|NCT00557856|102240292|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
33642024|NCT00557856|102240293|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
33642025|NCT00557856|102240294|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
33642026|NCT00557856|102240295|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
33642027|NCT00557856|102240296|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
33642028|NCT00557856|102240297|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
33642029|NCT00557856|102240298|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
33642030|NCT00557856|102240290|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
33642031|NCT00557856|102240291|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
33642032|NCT00557856|102240292|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
33642033|NCT00557856|102240293|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
33642034|NCT00557856|102240294|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
33642035|NCT00557856|102240295|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
33642036|NCT00557856|102240296|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
33642037|NCT00557856|102240297|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
33642038|NCT00557856|102240298|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
33642039|NCT00557856|102240290|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
33642040|NCT00557856|102240291|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
33642041|NCT00557856|102240292|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
33642042|NCT00557856|102240293|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
33642043|NCT00557856|102240294|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
33642044|NCT00557856|102240295|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
33642045|NCT00557856|102240296|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
33642046|NCT00557856|102240297|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
33642047|NCT00557856|102240298|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
33642048|NCT00557856|102240290|FG000|Part 1: Dose Escalation Phase|Other|0|||
33642049|NCT00557856|102240291|FG001|Part 1: Dose Escalation Phase|Other|0|||
33642050|NCT00557856|102240292|FG002|Part 1: Dose Escalation Phase|Other|1|||
33642051|NCT00557856|102240293|FG003|Part 1: Dose Escalation Phase|Other|1|||
33642052|NCT00557856|102240294|FG004|Part 1: Dose Escalation Phase|Other|0|||
33642053|NCT00557856|102240295|FG005|Part 1: Dose Escalation Phase|Other|0|||
33642054|NCT00557856|102240296|FG006|Part 1: Dose Escalation Phase|Other|0|||
33642055|NCT00557856|102240297|FG007|Part 1: Dose Escalation Phase|Other|1|||
33642056|NCT00557856|102240298|FG008|Part 1: Dose Escalation Phase|Other|0|||
33642057|NCT00557856|102240290|FG000|Part 1: Dose Escalation Phase|Death|0|||
33642058|NCT00557856|102240291|FG001|Part 1: Dose Escalation Phase|Death|0|||
33642059|NCT00557856|102240292|FG002|Part 1: Dose Escalation Phase|Death|0|||
33642060|NCT00557856|102240293|FG003|Part 1: Dose Escalation Phase|Death|0|||
33642061|NCT00557856|102240294|FG004|Part 1: Dose Escalation Phase|Death|0|||
33642062|NCT00557856|102240295|FG005|Part 1: Dose Escalation Phase|Death|1|||
33642063|NCT00557856|102240296|FG006|Part 1: Dose Escalation Phase|Death|0|||
33642064|NCT00557856|102240297|FG007|Part 1: Dose Escalation Phase|Death|0|||
33143510|NCT01551420|100438483|FG000|Screened for Part B Eligibility|Declined participation|8|||
33371465|NCT01253421|101247439|FG001|Drug+Scanning Visit|Physician Decision|0|||
33143511|NCT01551420|100438484|FG001|Screened for Part B Eligibility|Declined participation|1|||
33371466|NCT01253421|101247440|FG002|Drug+Scanning Visit|Physician Decision|0|||
33371467|NCT01253421|101247441|FG003|Drug+Scanning Visit|Physician Decision|0|||
33642065|NCT00557856|102240298|FG008|Part 1: Dose Escalation Phase|Death|0|||
33642066|NCT00557856|102240290|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
33642067|NCT00557856|102240291|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
33242192|NCT00367237|100788971|FG001|Overall Study|Adverse Event|2|||
33242193|NCT00367237|100788970|FG000|Overall Study|Lost to Follow-up|1|||
33642068|NCT00557856|102240292|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
33242194|NCT00367237|100788971|FG001|Overall Study|Lost to Follow-up|0|||
33242195|NCT00367237|100788970|FG000|Overall Study|Withdrawal by Subject|0|||
33371468|NCT01253421|101247442|FG004|Drug+Scanning Visit|Physician Decision|1|||
33143512|NCT01551420|100438483|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
33143513|NCT01551420|100438484|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
33143514|NCT01551420|100438483|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
33143515|NCT01551420|100438484|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
33143516|NCT01551420|100438483|FG000|Home Use (Part B)|Withdrawal by staff|0|||
33143517|NCT01551420|100438484|FG001|Home Use (Part B)|Withdrawal by staff|1|||
33143518|NCT00245583|100438485|FG000|Overall Study|Lost to Follow-up|1|||
33143519|NCT00245583|100438486|FG001|Overall Study|Lost to Follow-up|5|||
33143520|NCT00245583|100438485|FG000|Overall Study|Adverse Event|2|||
33143521|NCT00245583|100438486|FG001|Overall Study|Adverse Event|1|||
33143522|NCT00245583|100438485|FG000|Overall Study|Lack of Efficacy|1|||
33143523|NCT00245583|100438486|FG001|Overall Study|Lack of Efficacy|0|||
33143524|NCT00245583|100438485|FG000|Overall Study|Withdrawal by Subject|2|||
33143525|NCT00245583|100438486|FG001|Overall Study|Withdrawal by Subject|3|||
33143526|NCT02220998|100438487|FG000|Overall Study|Randomized but Never Treated|1|||
33143527|NCT02220998|100438488|FG001|Overall Study|Randomized but Never Treated|2|||
33143528|NCT02220998|100438487|FG000|Overall Study|Death|2|||
33143529|NCT02220998|100438488|FG001|Overall Study|Death|0|||
33143530|NCT02220998|100438487|FG000|Overall Study|Lack of Efficacy|0|||
33143531|NCT02220998|100438488|FG001|Overall Study|Lack of Efficacy|5|||
33143532|NCT02220998|100438487|FG000|Overall Study|Lost to Follow-up|4|||
33143533|NCT02220998|100438488|FG001|Overall Study|Lost to Follow-up|4|||
33143534|NCT01142089|100438491|FG000|Overall Study|Physician Decision|1|||
33143535|NCT01142089|100438492|FG001|Overall Study|Physician Decision|0|||
33143536|NCT01142089|100438491|FG000|Overall Study|Withdrawal by Subject|1|||
33143537|NCT01142089|100438492|FG001|Overall Study|Withdrawal by Subject|2|||
33143538|NCT01142089|100438491|FG000|Overall Study|Use of prohibited medications|0|||
33143539|NCT01142089|100438492|FG001|Overall Study|Use of prohibited medications|1|||
33143540|NCT01142089|100438491|FG000|Overall Study|Noncompliance with study procedures|2|||
33143541|NCT01142089|100438492|FG001|Overall Study|Noncompliance with study procedures|1|||
33143542|NCT01142089|100438491|FG000|Overall Study|Patient required rescue medication|8|||
33143543|NCT01142089|100438492|FG001|Overall Study|Patient required rescue medication|17|||
33143544|NCT00812487|100438495|FG000|Overall Study|Lost to Follow-up|2|||
33143545|NCT00812487|100438496|FG001|Overall Study|Lost to Follow-up|0|||
33143546|NCT00812487|100438495|FG000|Overall Study|Withdrawal by Subject|3|||
33143547|NCT00812487|100438496|FG001|Overall Study|Withdrawal by Subject|2|||
33143548|NCT00812487|100438495|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
33143549|NCT00812487|100438496|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
33143550|NCT00812487|100438495|FG000|Overall Study|Protocol Violation|0|||
33143551|NCT00812487|100438496|FG001|Overall Study|Protocol Violation|1|||
33143552|NCT00206076|100438499|FG000|Overall Study|Physician Decision|2|||
33143553|NCT00206076|100438500|FG001|Overall Study|Physician Decision|0|||
33143554|NCT00206076|100438499|FG000|Overall Study|Withdrawal by Subject|1|||
33143555|NCT00206076|100438500|FG001|Overall Study|Withdrawal by Subject|1|||
33143556|NCT03560739|100438505|FG000|Overall Study|Adverse Event|0|||
33143557|NCT03560739|100438506|FG001|Overall Study|Adverse Event|1|||
33143558|NCT03560739|100438507|FG002|Overall Study|Adverse Event|0|||
33143559|NCT03560739|100438508|FG003|Overall Study|Adverse Event|0|||
33143560|NCT02486627|100438509|FG000|Overall Study|Death|1|||
33143561|NCT02486627|100438510|FG001|Overall Study|Death|0|||
33143562|NCT02486627|100438509|FG000|Overall Study|Other Unspecified|0|||
33143563|NCT02486627|100438510|FG001|Overall Study|Other Unspecified|2|||
33143564|NCT02486627|100438509|FG000|Overall Study|Consent Withdrawn by Participant|4|||
33371469|NCT01005732|101247443|FG000|Overall Study|Lost to Follow-up|10|||
33371470|NCT01005732|101247443|FG000|Overall Study|Death|1|||
33371471|NCT01240811|101247446|FG000|Overall Study|Physician Decision|0|||
33371472|NCT01240811|101247447|FG001|Overall Study|Physician Decision|1|||
33371473|NCT01240811|101247448|FG002|Overall Study|Physician Decision|0|||
33371474|NCT01240811|101247446|FG000|Overall Study|Withdrawal by Subject|0|||
33371475|NCT01240811|101247447|FG001|Overall Study|Withdrawal by Subject|0|||
33371476|NCT01240811|101247448|FG002|Overall Study|Withdrawal by Subject|1|||
33371477|NCT00414310|101247449|FG000|Overall Study|Not treated|1|||
33642069|NCT00557856|102240293|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
33143565|NCT02486627|100438510|FG001|Overall Study|Consent Withdrawn by Participant|3|||
33143566|NCT02486627|100438509|FG000|Overall Study|Significant Participant Noncompliance|1|||
33143567|NCT02486627|100438510|FG001|Overall Study|Significant Participant Noncompliance|1|||
33143568|NCT02486627|100438509|FG000|Overall Study|Lost to Follow-up|1|||
33143569|NCT02486627|100438510|FG001|Overall Study|Lost to Follow-up|3|||
33143570|NCT01974765|100438512|FG000|Overall Study|Withdrawal by Subject|1|||
33143571|NCT01974765|100438512|FG000|Overall Study|Death|1|||
33143572|NCT01974765|100438512|FG000|Overall Study|Adverse Event|2|||
33143573|NCT01609478|100438513|FG000|Overall Study|Adverse Event|3|||
33143574|NCT01609478|100438514|FG001|Overall Study|Adverse Event|1|||
33242196|NCT00367237|100788971|FG001|Overall Study|Withdrawal by Subject|4|||
33371478|NCT00414310|101247450|FG001|Overall Study|Not treated|0|||
33371479|NCT02020031|101247452|FG000|Overall Study|Physician Decision|1|||
33143575|NCT01609478|100438515|FG002|Overall Study|Adverse Event|5|||
33143576|NCT01609478|100438513|FG000|Overall Study|Protocol Deviation|0|||
33143577|NCT01609478|100438514|FG001|Overall Study|Protocol Deviation|1|||
33143578|NCT01609478|100438515|FG002|Overall Study|Protocol Deviation|1|||
33143579|NCT01609478|100438513|FG000|Overall Study|Non-Compliance with study treatment|1|||
33143580|NCT01609478|100438514|FG001|Overall Study|Non-Compliance with study treatment|0|||
33143581|NCT01609478|100438515|FG002|Overall Study|Non-Compliance with study treatment|0|||
33143582|NCT01609478|100438513|FG000|Overall Study|Physician Decision|1|||
33143583|NCT01609478|100438514|FG001|Overall Study|Physician Decision|0|||
33143584|NCT01609478|100438515|FG002|Overall Study|Physician Decision|1|||
33143585|NCT01609478|100438513|FG000|Overall Study|Withdrawal by Subject|2|||
33143586|NCT01609478|100438514|FG001|Overall Study|Withdrawal by Subject|0|||
33143587|NCT01609478|100438515|FG002|Overall Study|Withdrawal by Subject|2|||
33143588|NCT03490981|100438518|FG000|Overall Study|Lost to Follow-up|1|||
33143589|NCT03490981|100438519|FG001|Overall Study|Lost to Follow-up|2|||
33143590|NCT01074047|100438520|FG000|Treatment Phase|Adverse Event|89|||
33143591|NCT01074047|100438521|FG001|Treatment Phase|Adverse Event|66|||
33143592|NCT01074047|100438520|FG000|Treatment Phase|Disease Progression|16|||
33143593|NCT01074047|100438521|FG001|Treatment Phase|Disease Progression|21|||
33143594|NCT01074047|100438520|FG000|Treatment Phase|Withdrawal by Subject|27|||
33143595|NCT01074047|100438521|FG001|Treatment Phase|Withdrawal by Subject|48|||
33143596|NCT01074047|100438520|FG000|Treatment Phase|Death|53|||
33143597|NCT01074047|100438521|FG001|Treatment Phase|Death|58|||
33143598|NCT01074047|100438520|FG000|Treatment Phase|Lost to Follow-up|0|||
33143599|NCT01074047|100438521|FG001|Treatment Phase|Lost to Follow-up|1|||
33143600|NCT01074047|100438520|FG000|Treatment Phase|Protocol Violation|0|||
33143601|NCT01074047|100438521|FG001|Treatment Phase|Protocol Violation|1|||
33143602|NCT01074047|100438520|FG000|Treatment Phase|Miscellaneous|32|||
33143603|NCT01074047|100438521|FG001|Treatment Phase|Miscellaneous|39|||
33371480|NCT02020031|101247453|FG001|Overall Study|Physician Decision|1|||
33371481|NCT02164513|101247456|FG000|Overall Study|Adverse Event|162|||
33371482|NCT02164513|101247457|FG001|Overall Study|Adverse Event|180|||
33371483|NCT02164513|101247458|FG002|Overall Study|Adverse Event|111|||
33371484|NCT02164513|101247456|FG000|Overall Study|Other: Study Closed or terminated|5|||
33143604|NCT01074047|100438520|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
33143605|NCT01074047|100438521|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
33143606|NCT01074047|100438520|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
33143607|NCT01074047|100438521|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
33143608|NCT01074047|100438520|FG000|Survival Follow-Up Phase|Death|116|||
33143609|NCT01074047|100438521|FG001|Survival Follow-Up Phase|Death|124|||
33143610|NCT01074047|100438520|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
33143611|NCT01074047|100438521|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
33143612|NCT01074047|100438520|FG000|Extension Phase|Physician Decision|1|||
33143613|NCT01074047|100438521|FG001|Extension Phase|Physician Decision|0|||
33143614|NCT01074047|100438520|FG000|Extension Phase|Adverse Event|5|||
33143615|NCT01074047|100438521|FG001|Extension Phase|Adverse Event|0|||
33143616|NCT01074047|100438520|FG000|Extension Phase|Disease Progression|9|||
33143617|NCT01074047|100438521|FG001|Extension Phase|Disease Progression|0|||
33143618|NCT01074047|100438520|FG000|Extension Phase|Withdrawal by Subject|2|||
33143619|NCT01074047|100438521|FG001|Extension Phase|Withdrawal by Subject|0|||
33143620|NCT01074047|100438520|FG000|Extension Phase|Death|5|||
33143621|NCT01074047|100438521|FG001|Extension Phase|Death|0|||
33143622|NCT03112590|100438522|FG000|Overall Study|Adverse Event|0|||
33143623|NCT03112590|100438523|FG001|Overall Study|Adverse Event|1|||
33143624|NCT03112590|100438524|FG002|Overall Study|Adverse Event|0|||
33143625|NCT00290407|100438525|FG000|Overall Study|Physician Decision|2|||
33143626|NCT03584373|100438528|FG000|Overall Study|Lost to Follow-up|7|||
33143627|NCT03584373|100438529|FG001|Overall Study|Lost to Follow-up|8|||
33143628|NCT01007253|100438530|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
33143629|NCT01007253|100438531|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
33143630|NCT01007253|100438532|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
33371485|NCT02164513|101247457|FG001|Overall Study|Other: Study Closed or terminated|2|||
33143631|NCT01007253|100438533|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
33371486|NCT02164513|101247458|FG002|Overall Study|Other: Study Closed or terminated|4|||
33371487|NCT02164513|101247456|FG000|Overall Study|Lost to Follow-up|30|||
33143632|NCT02632838|100438536|FG000|Overall Study|Withdrawal by Subject|3|||
33143633|NCT02632838|100438537|FG001|Overall Study|Withdrawal by Subject|0|||
33143634|NCT02632838|100438536|FG000|Overall Study|Lost to Follow-up|0|||
33143635|NCT02632838|100438537|FG001|Overall Study|Lost to Follow-up|2|||
33143636|NCT00993044|100438545|FG000|Irinotecan 50 mg|Physician Decision|1|||
33143637|NCT04449029|100438546|FG000|Overall Study|Adverse Event|0|||
33143638|NCT04449029|100438547|FG001|Overall Study|Adverse Event|1|||
33143639|NCT04449029|100438548|FG002|Overall Study|Adverse Event|1|||
33371488|NCT02164513|101247457|FG001|Overall Study|Lost to Follow-up|36|||
33143640|NCT04449029|100438549|FG003|Overall Study|Adverse Event|0|||
33143641|NCT04449029|100438550|FG004|Overall Study|Adverse Event|1|||
33143642|NCT04449029|100438551|FG005|Overall Study|Adverse Event|0|||
33143643|NCT04449029|100438552|FG006|Overall Study|Adverse Event|1|||
33143644|NCT04449029|100438553|FG007|Overall Study|Adverse Event|0|||
33143645|NCT04449029|100438546|FG000|Overall Study|Lost to Follow-up|0|||
33143646|NCT04449029|100438547|FG001|Overall Study|Lost to Follow-up|1|||
33143647|NCT04449029|100438548|FG002|Overall Study|Lost to Follow-up|0|||
33143648|NCT04449029|100438549|FG003|Overall Study|Lost to Follow-up|0|||
33143649|NCT04449029|100438550|FG004|Overall Study|Lost to Follow-up|0|||
33143650|NCT04449029|100438551|FG005|Overall Study|Lost to Follow-up|0|||
33143651|NCT04449029|100438552|FG006|Overall Study|Lost to Follow-up|0|||
33143652|NCT04449029|100438553|FG007|Overall Study|Lost to Follow-up|0|||
33143653|NCT04449029|100438546|FG000|Overall Study|Protocol Violation|0|||
33143654|NCT04449029|100438547|FG001|Overall Study|Protocol Violation|1|||
33143655|NCT04449029|100438548|FG002|Overall Study|Protocol Violation|0|||
33143656|NCT04449029|100438549|FG003|Overall Study|Protocol Violation|0|||
33143657|NCT04449029|100438550|FG004|Overall Study|Protocol Violation|0|||
33143658|NCT04449029|100438551|FG005|Overall Study|Protocol Violation|0|||
33143659|NCT04449029|100438552|FG006|Overall Study|Protocol Violation|0|||
33143660|NCT04449029|100438553|FG007|Overall Study|Protocol Violation|0|||
33143661|NCT04449029|100438546|FG000|Overall Study|Physician Decision|0|||
33143662|NCT04449029|100438547|FG001|Overall Study|Physician Decision|0|||
33143663|NCT04449029|100438548|FG002|Overall Study|Physician Decision|0|||
33143664|NCT04449029|100438549|FG003|Overall Study|Physician Decision|0|||
33143665|NCT04449029|100438550|FG004|Overall Study|Physician Decision|0|||
33143666|NCT04449029|100438551|FG005|Overall Study|Physician Decision|1|||
33143667|NCT04449029|100438552|FG006|Overall Study|Physician Decision|0|||
33143668|NCT04449029|100438553|FG007|Overall Study|Physician Decision|0|||
33143669|NCT04449029|100438546|FG000|Overall Study|Withdrawal by Subject|3|||
33143670|NCT04449029|100438547|FG001|Overall Study|Withdrawal by Subject|0|||
33143671|NCT04449029|100438548|FG002|Overall Study|Withdrawal by Subject|1|||
33143672|NCT04449029|100438549|FG003|Overall Study|Withdrawal by Subject|1|||
33421619|NCT02862535|101434866|FG001|Overall Study|Death|3|||
33143673|NCT04449029|100438550|FG004|Overall Study|Withdrawal by Subject|5|||
33143674|NCT04449029|100438551|FG005|Overall Study|Withdrawal by Subject|1|||
33143675|NCT04449029|100438552|FG006|Overall Study|Withdrawal by Subject|4|||
33143676|NCT04449029|100438553|FG007|Overall Study|Withdrawal by Subject|0|||
33143677|NCT00924781|100438554|FG000|Overall Study|Study terminated by sponsor|12|||
33143678|NCT00924781|100438555|FG001|Overall Study|Study terminated by sponsor|10|||
33143679|NCT00868517|100438556|FG000|Overall Study|Withdrawal by Subject|3|||
33143680|NCT00868517|100438557|FG001|Overall Study|Withdrawal by Subject|3|||
33143681|NCT00868517|100438558|FG002|Overall Study|Withdrawal by Subject|2|||
33143682|NCT00868517|100438556|FG000|Overall Study|Protocol Violation|1|||
33143683|NCT00868517|100438557|FG001|Overall Study|Protocol Violation|1|||
33143684|NCT00868517|100438558|FG002|Overall Study|Protocol Violation|0|||
33143685|NCT02282345|100438559|FG000|Overall Study|Progression|0|||
33143686|NCT02282345|100438560|FG001|Overall Study|Progression|1|||
33143687|NCT02478398|100438561|FG000|Overall Study|Adverse Event|20|||
33143688|NCT02478398|100438562|FG001|Overall Study|Adverse Event|5|||
33143689|NCT02478398|100438561|FG000|Overall Study|Lost to Follow-up|5|||
33143690|NCT02478398|100438562|FG001|Overall Study|Lost to Follow-up|4|||
33143691|NCT02478398|100438561|FG000|Overall Study|Non-Compliance With Study Drug|5|||
33143692|NCT02478398|100438562|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33143693|NCT02478398|100438561|FG000|Overall Study|Protocol Violation|3|||
33143694|NCT02478398|100438562|FG001|Overall Study|Protocol Violation|1|||
33143695|NCT02478398|100438561|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
33143696|NCT02478398|100438562|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
33242197|NCT00367237|100788970|FG000|Overall Study|Protocol Violation|2|||
33242198|NCT00367237|100788971|FG001|Overall Study|Protocol Violation|5|||
33371489|NCT02164513|101247458|FG002|Overall Study|Lost to Follow-up|22|||
33371490|NCT02164513|101247456|FG000|Overall Study|Physician Decision|47|||
33371491|NCT02164513|101247457|FG001|Overall Study|Physician Decision|57|||
33371492|NCT02164513|101247458|FG002|Overall Study|Physician Decision|28|||
33371493|NCT02164513|101247456|FG000|Overall Study|Withdrawal by Subject|192|||
33371494|NCT02164513|101247457|FG001|Overall Study|Withdrawal by Subject|261|||
33371495|NCT02164513|101247458|FG002|Overall Study|Withdrawal by Subject|130|||
33371496|NCT02164513|101247456|FG000|Overall Study|Other: Reason not provided by site|1|||
33371497|NCT02164513|101247457|FG001|Overall Study|Other: Reason not provided by site|0|||
33143697|NCT02478398|100438561|FG000|Overall Study|Withdrawal By Participant|10|||
33143698|NCT02478398|100438562|FG001|Overall Study|Withdrawal By Participant|4|||
33143699|NCT02195687|100438563|FG000|Overall Study|Personal Reasons|1|||
33143700|NCT02195687|100438564|FG001|Overall Study|Personal Reasons|1|||
33143701|NCT02195687|100438563|FG000|Overall Study|Lost to Follow-up|4|||
33143702|NCT02195687|100438564|FG001|Overall Study|Lost to Follow-up|1|||
33143703|NCT01095094|100438565|FG000|Overall Study|Withdrawal by Subject|1|||
33143704|NCT01095094|100438565|FG000|Overall Study|Death|1|||
33143705|NCT01095094|100438565|FG000|Overall Study|Physician Decision|1|||
33143706|NCT00768469|100441537|FG000|Overall Study|Adverse Event|0|||
33143707|NCT00768469|100441538|FG001|Overall Study|Adverse Event|2|||
33371498|NCT02164513|101247458|FG002|Overall Study|Other: Reason not provided by site|0|||
33371499|NCT01746732|101247459|FG000|Lead-In Period|Withdrawal by Subject|1|||
33581563|NCT00881530|102020131|FG002|Overall Study|Lack of Efficacy|0|||
33581564|NCT00881530|102020132|FG003|Overall Study|Lack of Efficacy|0|||
33581565|NCT00881530|102020133|FG004|Overall Study|Lack of Efficacy|1|||
33581566|NCT00881530|102020134|FG005|Overall Study|Lack of Efficacy|1|||
33581567|NCT00881530|102020129|FG000|Overall Study|Not compliant with the protocol|0|||
33581568|NCT00881530|102020130|FG001|Overall Study|Not compliant with the protocol|0|||
33581569|NCT00881530|102020131|FG002|Overall Study|Not compliant with the protocol|0|||
33642070|NCT00557856|102240294|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
33642071|NCT00557856|102240295|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
33642072|NCT00557856|102240296|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
33642073|NCT00557856|102240297|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
33642074|NCT00557856|102240298|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
33143708|NCT00768469|100441537|FG000|Overall Study|Disease Progression|3|||
33143709|NCT00768469|100441538|FG001|Overall Study|Disease Progression|4|||
33143710|NCT00768469|100441537|FG000|Overall Study|Withdrawal by Subject|0|||
33143711|NCT00768469|100441538|FG001|Overall Study|Withdrawal by Subject|1|||
33143712|NCT02718300|100441539|FG000|Overall Study|Death|4|||
33143713|NCT02718300|100441540|FG001|Overall Study|Death|5|||
33143714|NCT02718300|100441541|FG002|Overall Study|Death|17|||
33143715|NCT02718300|100441539|FG000|Overall Study|Lost to Follow-up|1|||
33143716|NCT02718300|100441540|FG001|Overall Study|Lost to Follow-up|0|||
33143717|NCT02718300|100441541|FG002|Overall Study|Lost to Follow-up|2|||
33143718|NCT02718300|100441539|FG000|Overall Study|Physician Decision|1|||
33143719|NCT02718300|100441540|FG001|Overall Study|Physician Decision|0|||
33143720|NCT02718300|100441541|FG002|Overall Study|Physician Decision|2|||
33143721|NCT02718300|100441539|FG000|Overall Study|Study Terminated by Sponsor|6|||
33143722|NCT02718300|100441540|FG001|Overall Study|Study Terminated by Sponsor|3|||
33143723|NCT02718300|100441541|FG002|Overall Study|Study Terminated by Sponsor|4|||
33143724|NCT02718300|100441539|FG000|Overall Study|Withdrawal by Subject|0|||
33143725|NCT02718300|100441540|FG001|Overall Study|Withdrawal by Subject|4|||
33143726|NCT02718300|100441541|FG002|Overall Study|Withdrawal by Subject|3|||
33143727|NCT02718300|100441539|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
33143728|NCT02718300|100441540|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
33143729|NCT02718300|100441541|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
33143730|NCT00769483|100441542|FG000|Overall Study|Withdrawal by Subject|0|||
33371500|NCT01746732|101247460|FG001|Lead-In Period|Withdrawal by Subject|0|||
33371501|NCT01746732|101247461|FG002|Lead-In Period|Withdrawal by Subject|0|||
33371502|NCT01746732|101247459|FG000|Period 1|Physician Decision|0|||
33371503|NCT01746732|101247460|FG001|Period 1|Physician Decision|1|||
33371504|NCT01746732|101247461|FG002|Period 1|Physician Decision|0|||
33371505|NCT01746732|101247459|FG000|Period 2|Withdrawal by Subject|0|||
33581570|NCT00881530|102020132|FG003|Overall Study|Not compliant with the protocol|0|||
33581571|NCT00881530|102020133|FG004|Overall Study|Not compliant with the protocol|2|||
33581572|NCT00881530|102020134|FG005|Overall Study|Not compliant with the protocol|0|||
33581573|NCT00881530|102020129|FG000|Overall Study|Lost to Follow-up|0|||
33581574|NCT00881530|102020130|FG001|Overall Study|Lost to Follow-up|1|||
33581575|NCT00881530|102020131|FG002|Overall Study|Lost to Follow-up|1|||
33581576|NCT00881530|102020132|FG003|Overall Study|Lost to Follow-up|3|||
33581577|NCT00881530|102020133|FG004|Overall Study|Lost to Follow-up|1|||
33581578|NCT00881530|102020134|FG005|Overall Study|Lost to Follow-up|0|||
33581579|NCT00881530|102020129|FG000|Overall Study|Refused to continue medication|7|||
33371506|NCT01746732|101247460|FG001|Period 2|Withdrawal by Subject|0|||
33371507|NCT01746732|101247461|FG002|Period 2|Withdrawal by Subject|2|||
33371508|NCT01746732|101247459|FG000|Period 2|Adverse Event|0|||
33581580|NCT00881530|102020130|FG001|Overall Study|Refused to continue medication|2|||
33581581|NCT00881530|102020131|FG002|Overall Study|Refused to continue medication|1|||
33581582|NCT00881530|102020132|FG003|Overall Study|Refused to continue medication|2|||
33581583|NCT00881530|102020133|FG004|Overall Study|Refused to continue medication|0|||
33581584|NCT00881530|102020134|FG005|Overall Study|Refused to continue medication|0|||
33581585|NCT00881530|102020129|FG000|Overall Study|Other reason not defined above|1|||
33581586|NCT00881530|102020130|FG001|Overall Study|Other reason not defined above|1|||
33581587|NCT00881530|102020131|FG002|Overall Study|Other reason not defined above|2|||
33642075|NCT00557856|102240290|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
33642076|NCT00557856|102240291|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33143731|NCT00769483|100441543|FG001|Overall Study|Withdrawal by Subject|1|||
33143732|NCT00769483|100441544|FG002|Overall Study|Withdrawal by Subject|0|||
33143733|NCT00769483|100441545|FG003|Overall Study|Withdrawal by Subject|0|||
33143734|NCT00769483|100441546|FG004|Overall Study|Withdrawal by Subject|1|||
33371509|NCT01746732|101247460|FG001|Period 2|Adverse Event|0|||
33371510|NCT01746732|101247461|FG002|Period 2|Adverse Event|1|||
33371511|NCT01746732|101247459|FG000|Period 2|Lost to Follow-up|0|||
33371512|NCT01746732|101247460|FG001|Period 2|Lost to Follow-up|0|||
33581588|NCT00881530|102020132|FG003|Overall Study|Other reason not defined above|0|||
33581589|NCT00881530|102020133|FG004|Overall Study|Other reason not defined above|0|||
33242199|NCT00811187|100788982|FG000|Overall Study|Unable to place device / procedure abort|3|||
33242200|NCT00811187|100788983|FG001|Overall Study|Unable to place device / procedure abort|3|||
33371513|NCT01746732|101247461|FG002|Period 2|Lost to Follow-up|1|||
33371514|NCT03314519|101247462|FG000|Overall Study|Protocol Violation|3|||
33421620|NCT02862535|101434867|FG002|Overall Study|Death|2|||
33421621|NCT02862535|101434868|FG003|Overall Study|Death|5|||
33421622|NCT02862535|101434865|FG000|Overall Study|Study Terminated by Sponsor|1|||
33421623|NCT02862535|101434866|FG001|Overall Study|Study Terminated by Sponsor|3|||
33421624|NCT02862535|101434867|FG002|Overall Study|Study Terminated by Sponsor|8|||
33421625|NCT02862535|101434868|FG003|Overall Study|Study Terminated by Sponsor|5|||
33421626|NCT02862535|101434865|FG000|Overall Study|Enrolled, not Treated|1|||
33421627|NCT02862535|101434866|FG001|Overall Study|Enrolled, not Treated|0|||
33421628|NCT02862535|101434867|FG002|Overall Study|Enrolled, not Treated|0|||
33421629|NCT02862535|101434868|FG003|Overall Study|Enrolled, not Treated|1|||
33371515|NCT03314519|101247463|FG001|Overall Study|Protocol Violation|2|||
33371516|NCT03554005|101247464|FG000|Overall Study|Not in participant's best interest|0|||
33371517|NCT03554005|101247465|FG001|Overall Study|Not in participant's best interest|0|||
33371518|NCT03554005|101247466|FG002|Overall Study|Not in participant's best interest|0|||
33371519|NCT03554005|101247467|FG003|Overall Study|Not in participant's best interest|0|||
33371520|NCT03554005|101247468|FG004|Overall Study|Not in participant's best interest|0|||
33371521|NCT03554005|101247469|FG005|Overall Study|Not in participant's best interest|1|||
33371522|NCT03554005|101247464|FG000|Overall Study|Disease Progression|1|||
33371523|NCT03554005|101247465|FG001|Overall Study|Disease Progression|1|||
33371524|NCT03554005|101247466|FG002|Overall Study|Disease Progression|1|||
33371525|NCT03554005|101247467|FG003|Overall Study|Disease Progression|1|||
33371526|NCT03554005|101247468|FG004|Overall Study|Disease Progression|5|||
33421630|NCT03840135|101434874|FG000|Overall Study|Protocol Violation|6|||
33421631|NCT03840135|101434875|FG001|Overall Study|Protocol Violation|1|||
33421632|NCT03840135|101434874|FG000|Overall Study|Withdrawal by Subject|1|||
33421633|NCT03840135|101434875|FG001|Overall Study|Withdrawal by Subject|0|||
33421634|NCT02176642|101434876|FG000|Overall Study|Withdrawal by Subject|0|||
33421635|NCT02176642|101434877|FG001|Overall Study|Withdrawal by Subject|1|||
33421636|NCT01174368|101434878|FG000|Overall Study|Withdrawal by Subject|1|||
33421637|NCT04088734|101434879|FG000|Overall Study|Other, Not Specified|5|||
33421638|NCT01678924|101434880|FG000|Overall Study|Adverse Event|1|||
33421639|NCT01678924|101434881|FG001|Overall Study|Adverse Event|1|||
33421640|NCT01678924|101434882|FG002|Overall Study|Adverse Event|0|||
33421641|NCT01678924|101434883|FG003|Overall Study|Adverse Event|1|||
33642077|NCT00557856|102240292|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33642078|NCT00557856|102240293|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33642079|NCT00557856|102240294|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33642080|NCT00557856|102240295|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33642081|NCT00557856|102240296|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33642082|NCT00557856|102240297|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33642083|NCT00557856|102240298|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
33642084|NCT00557856|102240290|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
33371527|NCT03554005|101247469|FG005|Overall Study|Disease Progression|6|||
33371528|NCT03554005|101247464|FG000|Overall Study|Adverse Event|0|||
33371529|NCT03554005|101247465|FG001|Overall Study|Adverse Event|0|||
33371530|NCT03554005|101247466|FG002|Overall Study|Adverse Event|0|||
33371531|NCT03554005|101247467|FG003|Overall Study|Adverse Event|0|||
33371532|NCT03554005|101247468|FG004|Overall Study|Adverse Event|0|||
33371533|NCT03554005|101247469|FG005|Overall Study|Adverse Event|3|||
33371534|NCT03554005|101247464|FG000|Overall Study|Physician Decision|0|||
33371535|NCT03554005|101247465|FG001|Overall Study|Physician Decision|0|||
33371536|NCT03554005|101247466|FG002|Overall Study|Physician Decision|0|||
33371537|NCT03554005|101247467|FG003|Overall Study|Physician Decision|0|||
33371538|NCT03554005|101247468|FG004|Overall Study|Physician Decision|1|||
33371539|NCT03554005|101247469|FG005|Overall Study|Physician Decision|0|||
33642085|NCT00557856|102240291|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
33371540|NCT03554005|101247464|FG000|Overall Study|Other|0|||
33421642|NCT01678924|101434880|FG000|Overall Study|Lack of Efficacy|7|||
33421643|NCT01678924|101434881|FG001|Overall Study|Lack of Efficacy|2|||
33421644|NCT01678924|101434882|FG002|Overall Study|Lack of Efficacy|0|||
33421645|NCT01678924|101434883|FG003|Overall Study|Lack of Efficacy|5|||
33421646|NCT01678924|101434880|FG000|Overall Study|Lost to Follow-up|0|||
33421647|NCT01678924|101434881|FG001|Overall Study|Lost to Follow-up|4|||
33421648|NCT01678924|101434882|FG002|Overall Study|Lost to Follow-up|0|||
33371541|NCT03554005|101247465|FG001|Overall Study|Other|0|||
33371542|NCT03554005|101247466|FG002|Overall Study|Other|0|||
33371543|NCT03554005|101247467|FG003|Overall Study|Other|0|||
33371544|NCT03554005|101247468|FG004|Overall Study|Other|0|||
33371545|NCT03554005|101247469|FG005|Overall Study|Other|1|||
33371546|NCT01934192|101247470|FG000|Overall Study|Protocol Violation|0|||
33371547|NCT01934192|101247471|FG001|Overall Study|Protocol Violation|0|||
33371548|NCT01934192|101247472|FG002|Overall Study|Protocol Violation|0|||
33421649|NCT01678924|101434883|FG003|Overall Study|Lost to Follow-up|2|||
33242201|NCT00561574|100788987|FG000|Overall Study|Adverse Event|21|||
33242202|NCT00561574|100788988|FG001|Overall Study|Adverse Event|24|||
33242203|NCT00561574|100788987|FG000|Overall Study|Lack of Efficacy|11|||
33242204|NCT00561574|100788988|FG001|Overall Study|Lack of Efficacy|21|||
33242205|NCT00561574|100788987|FG000|Overall Study|Withdrawal by Subject|4|||
33242206|NCT00561574|100788988|FG001|Overall Study|Withdrawal by Subject|4|||
33242207|NCT00561574|100788987|FG000|Overall Study|Reason Unrelated to Trial|6|||
33242208|NCT00561574|100788988|FG001|Overall Study|Reason Unrelated to Trial|2|||
33242209|NCT00561574|100788987|FG000|Overall Study|Lost to Follow-up|1|||
33242210|NCT00561574|100788988|FG001|Overall Study|Lost to Follow-up|0|||
33242211|NCT00561574|100788987|FG000|Overall Study|Other|5|||
33242212|NCT00561574|100788988|FG001|Overall Study|Other|7|||
33242213|NCT02065245|100788994|FG000|Infusion 1|Lost to Follow-up|0|||
33242214|NCT02065245|100788995|FG001|Infusion 1|Lost to Follow-up|0|||
33242215|NCT02065245|100788996|FG002|Infusion 1|Lost to Follow-up|0|||
33242216|NCT02065245|100788997|FG003|Infusion 1|Lost to Follow-up|0|||
33242217|NCT02065245|100788998|FG004|Infusion 1|Lost to Follow-up|0|||
33242218|NCT02065245|100788999|FG005|Infusion 1|Lost to Follow-up|0|||
33242219|NCT02065245|100789000|FG006|Infusion 1|Lost to Follow-up|1|||
33242220|NCT02065245|100788994|FG000|Infusion 1|Death|0|||
33242221|NCT02065245|100788995|FG001|Infusion 1|Death|0|||
33242222|NCT02065245|100788996|FG002|Infusion 1|Death|1|||
33242223|NCT02065245|100788997|FG003|Infusion 1|Death|0|||
33242224|NCT02065245|100788998|FG004|Infusion 1|Death|1|||
33242225|NCT02065245|100788999|FG005|Infusion 1|Death|0|||
33242226|NCT02065245|100789000|FG006|Infusion 1|Death|0|||
33242227|NCT02065245|100788994|FG000|Infusion 2|Death|0|||
33242228|NCT02065245|100788995|FG001|Infusion 2|Death|0|||
33242229|NCT02065245|100788996|FG002|Infusion 2|Death|0|||
33242230|NCT02065245|100788997|FG003|Infusion 2|Death|0|||
33242231|NCT02065245|100788998|FG004|Infusion 2|Death|0|||
33242232|NCT02065245|100788999|FG005|Infusion 2|Death|0|||
33242233|NCT02065245|100789000|FG006|Infusion 2|Death|1|||
33242234|NCT02065245|100788994|FG000|Infusion 3|Lost to Follow-up|1|||
33242235|NCT02065245|100788995|FG001|Infusion 3|Lost to Follow-up|1|||
33242236|NCT02065245|100788996|FG002|Infusion 3|Lost to Follow-up|0|||
33242237|NCT02065245|100788997|FG003|Infusion 3|Lost to Follow-up|0|||
33242238|NCT02065245|100788998|FG004|Infusion 3|Lost to Follow-up|0|||
33242239|NCT02065245|100788999|FG005|Infusion 3|Lost to Follow-up|0|||
33242240|NCT02065245|100789000|FG006|Infusion 3|Lost to Follow-up|0|||
33242241|NCT01876043|100789001|FG000|Overall Study|Death|1|||
33242242|NCT01876043|100789001|FG000|Overall Study|Withdrawal by Subject|1|||
33242243|NCT01929993|100789005|FG000|Overall Study|Protocol Violation|4|||
33242244|NCT01929993|100789006|FG001|Overall Study|Protocol Violation|6|||
33242245|NCT01929993|100789005|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
33242246|NCT01929993|100789006|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
33242247|NCT00836810|100789007|FG000|Overall Study|New diagnosis|1|||
33242248|NCT00836810|100789008|FG001|Overall Study|New diagnosis|0|||
33242249|NCT02491411|100789009|FG000|Overall Study|Physician Decision|4|||
33242250|NCT00079937|100789020|FG000|Overall Study|Adverse Event|2|||
33242251|NCT00079937|100789021|FG001|Overall Study|Adverse Event|1|||
33242252|NCT00079937|100789020|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33242253|NCT00079937|100789021|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33242254|NCT00079937|100789020|FG000|Overall Study|Subject no longer requires study drug|3|||
33242255|NCT00079937|100789021|FG001|Overall Study|Subject no longer requires study drug|0|||
33242256|NCT00079937|100789020|FG000|Overall Study|Protocol Violation|8|||
33242257|NCT00079937|100789021|FG001|Overall Study|Protocol Violation|6|||
33242258|NCT00079937|100789020|FG000|Overall Study|Withdrawal by Subject|21|||
33242259|NCT00079937|100789021|FG001|Overall Study|Withdrawal by Subject|7|||
33242260|NCT00079937|100789020|FG000|Overall Study|Lost to Follow-up|12|||
33242261|NCT00079937|100789021|FG001|Overall Study|Lost to Follow-up|5|||
33242262|NCT00079937|100789020|FG000|Overall Study|Administrative problems|22|||
33242263|NCT00079937|100789021|FG001|Overall Study|Administrative problems|11|||
33242264|NCT01518257|100789029|FG000|Overall Study|Lost to Follow-up|1|||
33242265|NCT01518257|100789030|FG001|Overall Study|Lost to Follow-up|0|||
33242266|NCT01518257|100789029|FG000|Overall Study|Other Miscellaneous Reason|1|||
33242267|NCT01518257|100789030|FG001|Overall Study|Other Miscellaneous Reason|0|||
33242268|NCT00764868|100789031|FG000|Overall Study|Adverse Event|18|||
33242269|NCT00764868|100789031|FG000|Overall Study|Withdrawal by Subject|31|||
33242270|NCT00764868|100789031|FG000|Overall Study|Non-compliance|16|||
33242271|NCT00764868|100789031|FG000|Overall Study|Lost to Follow-up|25|||
33242272|NCT00764868|100789031|FG000|Overall Study|Lack of Efficacy|5|||
33242273|NCT00764868|100789031|FG000|Overall Study|Subject moved|7|||
33242274|NCT00764868|100789031|FG000|Overall Study|Pregnancy|3|||
33242275|NCT00764868|100789031|FG000|Overall Study|Prohibited medication|1|||
33242276|NCT00764868|100789031|FG000|Overall Study|Out of town|1|||
33242277|NCT00764868|100789031|FG000|Overall Study|Misuse and compliance of study drug|1|||
33242278|NCT00764868|100789031|FG000|Overall Study|Subject sent to boarding school|1|||
33242279|NCT00764868|100789031|FG000|Overall Study|Met an exclusion criteria|1|||
33242280|NCT00764868|100789031|FG000|Overall Study|Positive drug screen|2|||
33242281|NCT00764868|100789031|FG000|Overall Study|Sponsor requested withdrawal|1|||
33242282|NCT01734811|100789032|FG000|Overall Study|Lost to Follow-up|2|||
33242283|NCT01734811|100789033|FG001|Overall Study|Lost to Follow-up|3|||
33242284|NCT01734811|100789032|FG000|Overall Study|Withdrawal by Subject|2|||
33242285|NCT01734811|100789033|FG001|Overall Study|Withdrawal by Subject|0|||
33242286|NCT02373813|100789035|FG000|Run-In Period|Other, Not Specified|5|||
33242287|NCT02373813|100789036|FG001|Run-In Period|Other, Not Specified|0|||
33242288|NCT02373813|100789037|FG002|Run-In Period|Other, Not Specified|0|||
33242289|NCT02373813|100789038|FG003|Run-In Period|Other, Not Specified|0|||
33242290|NCT02373813|100789035|FG000|Run-In Period|Withdrawal by Subject|16|||
33242291|NCT02373813|100789036|FG001|Run-In Period|Withdrawal by Subject|0|||
33242292|NCT02373813|100789037|FG002|Run-In Period|Withdrawal by Subject|0|||
33242293|NCT02373813|100789038|FG003|Run-In Period|Withdrawal by Subject|0|||
33242294|NCT02373813|100789035|FG000|Run-In Period|Decision by Sponsor|11|||
33242295|NCT02373813|100789036|FG001|Run-In Period|Decision by Sponsor|0|||
33242296|NCT02373813|100789037|FG002|Run-In Period|Decision by Sponsor|0|||
33242297|NCT02373813|100789038|FG003|Run-In Period|Decision by Sponsor|0|||
33242298|NCT02373813|100789035|FG000|Run-In Period|Protocol Violation|75|||
33242299|NCT02373813|100789036|FG001|Run-In Period|Protocol Violation|0|||
33242300|NCT02373813|100789037|FG002|Run-In Period|Protocol Violation|0|||
33242301|NCT02373813|100789038|FG003|Run-In Period|Protocol Violation|0|||
33242302|NCT02373813|100789035|FG000|Run-In Period|Lost to Follow-up|2|||
33242303|NCT02373813|100789036|FG001|Run-In Period|Lost to Follow-up|0|||
33242304|NCT02373813|100789037|FG002|Run-In Period|Lost to Follow-up|0|||
33242305|NCT02373813|100789038|FG003|Run-In Period|Lost to Follow-up|0|||
33242306|NCT02373813|100789035|FG000|Run-In Period|Adverse Event|3|||
33242307|NCT02373813|100789036|FG001|Run-In Period|Adverse Event|0|||
33242308|NCT02373813|100789037|FG002|Run-In Period|Adverse Event|0|||
33242309|NCT02373813|100789038|FG003|Run-In Period|Adverse Event|0|||
33242310|NCT02373813|100789035|FG000|Run-In Period|Noncompliance|1|||
33242311|NCT02373813|100789036|FG001|Run-In Period|Noncompliance|0|||
33242312|NCT02373813|100789037|FG002|Run-In Period|Noncompliance|0|||
33242313|NCT02373813|100789038|FG003|Run-In Period|Noncompliance|0|||
33242314|NCT02373813|100789035|FG000|Run-In Period|Ineligibility Determined|3|||
33242315|NCT02373813|100789036|FG001|Run-In Period|Ineligibility Determined|0|||
33242316|NCT02373813|100789037|FG002|Run-In Period|Ineligibility Determined|0|||
33242317|NCT02373813|100789038|FG003|Run-In Period|Ineligibility Determined|0|||
33242318|NCT02373813|100789035|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
33242319|NCT02373813|100789036|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
33242320|NCT02373813|100789037|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
33242321|NCT02373813|100789038|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
33242322|NCT02373813|100789035|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
33242323|NCT02373813|100789036|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
33242324|NCT02373813|100789037|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
33242325|NCT02373813|100789038|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
33242326|NCT02373813|100789035|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33242327|NCT02373813|100789036|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
33242328|NCT02373813|100789037|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
33242329|NCT02373813|100789038|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
33242330|NCT02373813|100789035|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33242331|NCT02373813|100789036|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
33242332|NCT02373813|100789037|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
33242333|NCT02373813|100789038|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
33242334|NCT01369355|100789039|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
33642086|NCT00557856|102240292|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
33642087|NCT00557856|102240293|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
33642088|NCT00557856|102240294|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
33642089|NCT00557856|102240295|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
33642090|NCT00557856|102240296|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
33642091|NCT00557856|102240297|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
33642092|NCT00557856|102240298|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
33642093|NCT00557856|102240290|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33642094|NCT00557856|102240291|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33642095|NCT00557856|102240292|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33642096|NCT00557856|102240293|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33242335|NCT01369355|100789040|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
33242336|NCT01369355|100789041|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
33242337|NCT01369355|100789042|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
33242338|NCT01369355|100789043|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
33242339|NCT01369355|100789044|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
33242340|NCT01369355|100789045|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
33242341|NCT01369355|100789046|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
33242342|NCT01369355|100789047|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
33242343|NCT01369355|100789039|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
33242344|NCT01369355|100789040|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
33242345|NCT01369355|100789041|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
33242346|NCT01369355|100789042|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
33242347|NCT01369355|100789043|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
33242348|NCT01369355|100789044|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
33242349|NCT01369355|100789045|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
33642097|NCT00557856|102240294|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33642098|NCT00557856|102240295|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33642099|NCT00557856|102240296|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33642100|NCT00557856|102240297|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
33642101|NCT00557856|102240298|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
33642102|NCT00557856|102240290|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
33642103|NCT00557856|102240291|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
33642104|NCT00557856|102240292|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
33642105|NCT00557856|102240293|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
33242350|NCT01369355|100789046|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
33242351|NCT01369355|100789047|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
33242352|NCT01369355|100789039|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
33242353|NCT01369355|100789040|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
33242354|NCT01369355|100789041|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
33242355|NCT01369355|100789042|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
33242356|NCT01369355|100789043|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
33242357|NCT01369355|100789044|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
33242358|NCT01369355|100789045|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
33371549|NCT01934192|101247473|FG003|Overall Study|Protocol Violation|1|||
33371550|NCT01934192|101247470|FG000|Overall Study|Other: reached stopping criteria|6|||
33371551|NCT01934192|101247471|FG001|Overall Study|Other: reached stopping criteria|5|||
33371552|NCT01934192|101247472|FG002|Overall Study|Other: reached stopping criteria|1|||
33371553|NCT01934192|101247473|FG003|Overall Study|Other: reached stopping criteria|0|||
33371554|NCT01934192|101247470|FG000|Overall Study|Physician Decision|3|||
33371555|NCT01934192|101247471|FG001|Overall Study|Physician Decision|2|||
33371556|NCT01934192|101247472|FG002|Overall Study|Physician Decision|0|||
33371557|NCT01934192|101247473|FG003|Overall Study|Physician Decision|0|||
33371558|NCT00417976|101247474|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
33371559|NCT00417976|101247474|FG000|Overall Study|Treatment -related toxicity|2|||
33371560|NCT00339183|101247475|FG000|Overall Study|Adverse Event|5|||
33371561|NCT00339183|101247476|FG001|Overall Study|Adverse Event|3|||
33371562|NCT00339183|101247475|FG000|Overall Study|Withdrawal by Subject|16|||
33371563|NCT00339183|101247476|FG001|Overall Study|Withdrawal by Subject|19|||
33371564|NCT00339183|101247475|FG000|Overall Study|Physician Decision|2|||
33371565|NCT00339183|101247476|FG001|Overall Study|Physician Decision|4|||
33371566|NCT00339183|101247475|FG000|Overall Study|Lost to Follow-up|17|||
33421650|NCT01678924|101434880|FG000|Overall Study|Personal Reasons|2|||
33421651|NCT01678924|101434881|FG001|Overall Study|Personal Reasons|2|||
33421652|NCT01678924|101434882|FG002|Overall Study|Personal Reasons|2|||
33581590|NCT00881530|102020134|FG005|Overall Study|Other reason not defined above|2|||
33581591|NCT03122145|102020135|FG000|Overall Study|Concurrent respiratory disease|3|||
33581592|NCT03122145|102020136|FG001|Overall Study|Concurrent respiratory disease|0|||
33581593|NCT02151786|102020141|FG000|Overall Study|Unavailability of Case Report Form|26|||
33581594|NCT02151786|102020141|FG000|Overall Study|Outside the Contract Period|1|||
33581595|NCT02151786|102020141|FG000|Overall Study|Randomized, not Treated|1|||
33581596|NCT02151786|102020141|FG000|Overall Study|Unavailability of Information|8|||
33581597|NCT01815424|102020146|FG000|Week 0 to 16|Adverse Event|1|||
33581598|NCT01815424|102020147|FG001|Week 0 to 16|Adverse Event|3|||
33581599|NCT01815424|102020148|FG002|Week 0 to 16|Adverse Event|3|||
33581600|NCT01815424|102020149|FG003|Week 0 to 16|Adverse Event|0|||
33581601|NCT01815424|102020150|FG004|Week 0 to 16|Adverse Event|0|||
33581602|NCT01815424|102020146|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
33581603|NCT01815424|102020147|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
33581604|NCT01815424|102020148|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
33581605|NCT01815424|102020149|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
33581606|NCT01815424|102020150|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
33581607|NCT01815424|102020146|FG000|Week 0 to 16|Lost to Follow-up|0|||
33371567|NCT00339183|101247476|FG001|Overall Study|Lost to Follow-up|17|||
33581608|NCT01815424|102020147|FG001|Week 0 to 16|Lost to Follow-up|1|||
33642106|NCT00557856|102240294|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
33642107|NCT00557856|102240295|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
33371568|NCT00339183|101247475|FG000|Overall Study|Protocol-specified criteria|12|||
33371569|NCT00339183|101247476|FG001|Overall Study|Protocol-specified criteria|8|||
33371570|NCT00339183|101247475|FG000|Overall Study|Missing reason|3|||
33371571|NCT00339183|101247476|FG001|Overall Study|Missing reason|1|||
33371572|NCT00339183|101247475|FG000|Overall Study|Other|46|||
33371573|NCT00339183|101247476|FG001|Overall Study|Other|40|||
33581609|NCT01815424|102020148|FG002|Week 0 to 16|Lost to Follow-up|0|||
33642108|NCT00557856|102240296|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
33421653|NCT01678924|101434883|FG003|Overall Study|Personal Reasons|7|||
33421654|NCT01678924|101434880|FG000|Overall Study|Withdrawal by Subject|0|||
33581610|NCT01815424|102020149|FG003|Week 0 to 16|Lost to Follow-up|0|||
33581611|NCT01815424|102020150|FG004|Week 0 to 16|Lost to Follow-up|0|||
33581612|NCT01815424|102020146|FG000|Week 0 to 16|Withdrawal by Subject|0|||
33581613|NCT01815424|102020147|FG001|Week 0 to 16|Withdrawal by Subject|0|||
33581614|NCT01815424|102020148|FG002|Week 0 to 16|Withdrawal by Subject|1|||
33581615|NCT01815424|102020149|FG003|Week 0 to 16|Withdrawal by Subject|0|||
33581616|NCT01815424|102020150|FG004|Week 0 to 16|Withdrawal by Subject|0|||
33581617|NCT01815424|102020146|FG000|Week 0 to 16|Other|1|||
33581618|NCT01815424|102020147|FG001|Week 0 to 16|Other|0|||
33581619|NCT01815424|102020148|FG002|Week 0 to 16|Other|3|||
33581620|NCT01815424|102020149|FG003|Week 0 to 16|Other|0|||
33581621|NCT01815424|102020150|FG004|Week 0 to 16|Other|0|||
33581622|NCT01815424|102020146|FG000|Week 0 to 16|Protocol Violation|1|||
33581623|NCT01815424|102020147|FG001|Week 0 to 16|Protocol Violation|0|||
33581624|NCT01815424|102020148|FG002|Week 0 to 16|Protocol Violation|0|||
33242359|NCT01369355|100789046|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
33242360|NCT01369355|100789047|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
33242361|NCT01369355|100789039|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
33242362|NCT01369355|100789040|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
33242363|NCT01369355|100789041|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
33242364|NCT01369355|100789042|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
33242365|NCT01369355|100789043|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
33242366|NCT01369355|100789044|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
33242367|NCT01369355|100789045|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
33242368|NCT01369355|100789046|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
33242369|NCT01369355|100789047|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
33242370|NCT01369355|100789039|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
33242371|NCT01369355|100789040|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
33242372|NCT01369355|100789041|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
33242373|NCT01369355|100789042|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
33242374|NCT01369355|100789043|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
33371574|NCT00339183|101247475|FG000|Overall Study|Ongoing|20|||
33371575|NCT00339183|101247476|FG001|Overall Study|Ongoing|13|||
33371576|NCT00411788|101247477|FG000|Overall Study|Protocol Violation|1|||
33371577|NCT00411788|101247477|FG000|Overall Study|Adverse Event|1|||
33371578|NCT01808118|101247478|FG000|Period 1|Adverse Event|15|||
33371579|NCT01808118|101247479|FG001|Period 1|Adverse Event|0|||
33371580|NCT01808118|101247480|FG002|Period 1|Adverse Event|0|||
33371581|NCT01808118|101247478|FG000|Period 1|Withdrew consent|24|||
33371582|NCT01808118|101247479|FG001|Period 1|Withdrew consent|0|||
33371583|NCT01808118|101247480|FG002|Period 1|Withdrew consent|0|||
33371584|NCT01808118|101247478|FG000|Period 1|Lost to Follow-up|9|||
33371585|NCT01808118|101247479|FG001|Period 1|Lost to Follow-up|0|||
33371586|NCT01808118|101247480|FG002|Period 1|Lost to Follow-up|0|||
33371587|NCT01808118|101247478|FG000|Period 1|Did not meet criteria for remission|303|||
33371588|NCT01808118|101247479|FG001|Period 1|Did not meet criteria for remission|0|||
33371589|NCT01808118|101247480|FG002|Period 1|Did not meet criteria for remission|0|||
33371590|NCT01808118|101247478|FG000|Period 1|Enrolled in error|7|||
33371591|NCT01808118|101247479|FG001|Period 1|Enrolled in error|0|||
33371592|NCT01808118|101247480|FG002|Period 1|Enrolled in error|0|||
33371593|NCT01808118|101247478|FG000|Period 1|Did not meet inclusion criteria|3|||
33371594|NCT01808118|101247479|FG001|Period 1|Did not meet inclusion criteria|0|||
33371595|NCT01808118|101247480|FG002|Period 1|Did not meet inclusion criteria|0|||
33371596|NCT01808118|101247478|FG000|Period 1|Non-conformance with inclusion criteria|3|||
33371597|NCT01808118|101247479|FG001|Period 1|Non-conformance with inclusion criteria|0|||
33371598|NCT01808118|101247480|FG002|Period 1|Non-conformance with inclusion criteria|0|||
33371599|NCT01808118|101247478|FG000|Period 1|Investigator decision: site closure|2|||
33371600|NCT01808118|101247479|FG001|Period 1|Investigator decision: site closure|0|||
33371601|NCT01808118|101247480|FG002|Period 1|Investigator decision: site closure|0|||
33371602|NCT01808118|101247478|FG000|Period 1|Non-compliance per sponsor|1|||
33371603|NCT01808118|101247479|FG001|Period 1|Non-compliance per sponsor|0|||
33371604|NCT01808118|101247480|FG002|Period 1|Non-compliance per sponsor|0|||
33371605|NCT01808118|101247478|FG000|Period 1|Lack of Efficacy|1|||
33371606|NCT01808118|101247479|FG001|Period 1|Lack of Efficacy|0|||
33421655|NCT01678924|101434881|FG001|Overall Study|Withdrawal by Subject|3|||
33642109|NCT00557856|102240297|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
33371607|NCT01808118|101247480|FG002|Period 1|Lack of Efficacy|0|||
33371608|NCT01808118|101247478|FG000|Period 2|Adverse Event|0|||
33371609|NCT01808118|101247479|FG001|Period 2|Adverse Event|4|||
33371610|NCT01808118|101247480|FG002|Period 2|Adverse Event|0|||
33421656|NCT01678924|101434882|FG002|Overall Study|Withdrawal by Subject|0|||
33581625|NCT01815424|102020149|FG003|Week 0 to 16|Protocol Violation|0|||
33371611|NCT01808118|101247478|FG000|Period 2|Withdrew consent|0|||
33581626|NCT01815424|102020150|FG004|Week 0 to 16|Protocol Violation|0|||
33581627|NCT01815424|102020146|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
33581628|NCT01815424|102020147|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
33581629|NCT01815424|102020148|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
33581630|NCT01815424|102020149|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
33581631|NCT01815424|102020150|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
33581632|NCT01815424|102020146|FG000|Week 16 to 52|Other|0|||
33581633|NCT01815424|102020147|FG001|Week 16 to 52|Other|1|||
33581634|NCT01815424|102020148|FG002|Week 16 to 52|Other|0|||
33581635|NCT01815424|102020149|FG003|Week 16 to 52|Other|0|||
33242375|NCT01369355|100789044|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
33242376|NCT01369355|100789045|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
33242377|NCT01369355|100789046|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
33242378|NCT01369355|100789047|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
33242379|NCT01369355|100789039|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
33242380|NCT01369355|100789040|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
33242381|NCT01369355|100789041|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
33242382|NCT01369355|100789042|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
33242383|NCT01369355|100789043|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
33242384|NCT01369355|100789044|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
33242385|NCT01369355|100789045|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
33242386|NCT01369355|100789046|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
33242387|NCT01369355|100789047|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
33242388|NCT01369355|100789039|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
33242389|NCT01369355|100789040|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
33242390|NCT01369355|100789041|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
33242391|NCT01369355|100789042|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
33242392|NCT01369355|100789043|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
33242393|NCT01369355|100789044|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
33242394|NCT01369355|100789045|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
33242395|NCT01369355|100789046|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
33242396|NCT01369355|100789047|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
33242397|NCT01369355|100789039|FG000|Long-term Extension (Week 44-272)|Death|0|||
33242398|NCT01369355|100789040|FG001|Long-term Extension (Week 44-272)|Death|0|||
33242399|NCT01369355|100789041|FG002|Long-term Extension (Week 44-272)|Death|0|||
33242400|NCT01369355|100789042|FG003|Long-term Extension (Week 44-272)|Death|0|||
33242401|NCT01369355|100789043|FG004|Long-term Extension (Week 44-272)|Death|0|||
33242402|NCT01369355|100789044|FG005|Long-term Extension (Week 44-272)|Death|0|||
33242403|NCT01369355|100789045|FG006|Long-term Extension (Week 44-272)|Death|0|||
33242404|NCT01369355|100789046|FG007|Long-term Extension (Week 44-272)|Death|1|||
33242405|NCT01369355|100789047|FG008|Long-term Extension (Week 44-272)|Death|3|||
33242406|NCT01369355|100789039|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
33242407|NCT01369355|100789040|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
33242408|NCT01369355|100789041|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
33242409|NCT01369355|100789042|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
33242410|NCT01369355|100789043|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
33242411|NCT01369355|100789044|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
33242412|NCT01369355|100789045|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
33242413|NCT01369355|100789046|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
33242414|NCT01369355|100789047|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
33242415|NCT01369355|100789039|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
33242416|NCT01369355|100789040|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
33242417|NCT01369355|100789041|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
33242418|NCT01369355|100789042|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
33242419|NCT01369355|100789043|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
33242420|NCT01369355|100789044|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
33242421|NCT01369355|100789045|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
33242422|NCT01369355|100789046|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
33242423|NCT01369355|100789047|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
33242424|NCT01369355|100789039|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
33371612|NCT01808118|101247479|FG001|Period 2|Withdrew consent|7|||
33371613|NCT01808118|101247480|FG002|Period 2|Withdrew consent|6|||
33371614|NCT01808118|101247478|FG000|Period 2|Lost to Follow-up|0|||
33421657|NCT01678924|101434883|FG003|Overall Study|Withdrawal by Subject|2|||
33421658|NCT01678924|101434880|FG000|Overall Study|Unable to attend scheduled visits|0|||
33242425|NCT01369355|100789040|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
33242426|NCT01369355|100789041|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
33242427|NCT01369355|100789042|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
33371615|NCT01808118|101247479|FG001|Period 2|Lost to Follow-up|0|||
33371616|NCT01808118|101247480|FG002|Period 2|Lost to Follow-up|2|||
33421659|NCT01678924|101434881|FG001|Overall Study|Unable to attend scheduled visits|0|||
33581636|NCT01815424|102020150|FG004|Week 16 to 52|Other|0|||
33581637|NCT01815424|102020146|FG000|Week 16 to 52|Adverse Event|0|||
33581638|NCT01815424|102020147|FG001|Week 16 to 52|Adverse Event|0|||
33143735|NCT00769483|100441547|FG005|Overall Study|Withdrawal by Subject|0|||
33143736|NCT03603509|100441548|FG000|Overall Study|Lost to Follow-up|3|||
33143737|NCT03603509|100441549|FG001|Overall Study|Lost to Follow-up|4|||
33143738|NCT04010539|100441554|FG000|Overall Study|Withdrawal by Subject|4|||
33143739|NCT04010539|100441555|FG001|Overall Study|Withdrawal by Subject|1|||
33143740|NCT04010539|100441554|FG000|Overall Study|Physician Decision|0|||
33143741|NCT04010539|100441555|FG001|Overall Study|Physician Decision|2|||
33143742|NCT04010539|100441554|FG000|Overall Study|Lost to Follow-up|10|||
33143743|NCT04010539|100441555|FG001|Overall Study|Lost to Follow-up|14|||
33143744|NCT04010539|100441554|FG000|Overall Study|Adverse Event|3|||
33143745|NCT04010539|100441555|FG001|Overall Study|Adverse Event|0|||
33143746|NCT04010539|100441554|FG000|Overall Study|Participant Did Not Receive IP|0|||
33143747|NCT04010539|100441555|FG001|Overall Study|Participant Did Not Receive IP|1|||
33143748|NCT04010539|100441554|FG000|Overall Study|Protocol Deviation|0|||
33143749|NCT04010539|100441555|FG001|Overall Study|Protocol Deviation|1|||
33143750|NCT04010539|100441554|FG000|Overall Study|Randomized in Error/ Mistake|2|||
33143751|NCT04010539|100441555|FG001|Overall Study|Randomized in Error/ Mistake|0|||
33143752|NCT04010539|100441554|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
33143753|NCT04010539|100441555|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
33143754|NCT00137839|100441556|FG000|Overall Study|Adverse Event|7|||
33143755|NCT00137839|100441556|FG000|Overall Study|Physician Decision|7|||
33143756|NCT00137839|100441556|FG000|Overall Study|Death|8|||
33143757|NCT00137839|100441556|FG000|Overall Study|Disease Progression|60|||
33581639|NCT01815424|102020148|FG002|Week 16 to 52|Adverse Event|0|||
33581640|NCT01815424|102020149|FG003|Week 16 to 52|Adverse Event|0|||
33581641|NCT01815424|102020150|FG004|Week 16 to 52|Adverse Event|1|||
33581642|NCT01815424|102020146|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
33581643|NCT01815424|102020147|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
33581644|NCT01815424|102020148|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
33581645|NCT01815424|102020149|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
33581646|NCT01815424|102020150|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
33642110|NCT00557856|102240298|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
33642111|NCT00557856|102240290|FG000|Part 2: Exploratory Phase|Other|0|||
33642112|NCT00557856|102240291|FG001|Part 2: Exploratory Phase|Other|0|||
33642113|NCT00557856|102240292|FG002|Part 2: Exploratory Phase|Other|0|||
33642114|NCT00557856|102240293|FG003|Part 2: Exploratory Phase|Other|0|||
33642115|NCT00557856|102240294|FG004|Part 2: Exploratory Phase|Other|0|||
33642116|NCT00557856|102240295|FG005|Part 2: Exploratory Phase|Other|0|||
33642117|NCT00557856|102240296|FG006|Part 2: Exploratory Phase|Other|0|||
33642118|NCT00557856|102240297|FG007|Part 2: Exploratory Phase|Other|0|||
33642119|NCT00557856|102240298|FG008|Part 2: Exploratory Phase|Other|1|||
33642120|NCT00557856|102240290|FG000|Part 2: Exploratory Phase|Death|0|||
33642121|NCT00557856|102240291|FG001|Part 2: Exploratory Phase|Death|0|||
33642122|NCT00557856|102240292|FG002|Part 2: Exploratory Phase|Death|0|||
33642123|NCT00557856|102240293|FG003|Part 2: Exploratory Phase|Death|0|||
33642124|NCT00557856|102240294|FG004|Part 2: Exploratory Phase|Death|0|||
33642125|NCT00557856|102240295|FG005|Part 2: Exploratory Phase|Death|0|||
33642126|NCT00557856|102240296|FG006|Part 2: Exploratory Phase|Death|0|||
33642127|NCT00557856|102240297|FG007|Part 2: Exploratory Phase|Death|0|||
33642128|NCT00557856|102240298|FG008|Part 2: Exploratory Phase|Death|2|||
33642129|NCT00557856|102240290|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
33642130|NCT00557856|102240291|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
33642131|NCT00557856|102240292|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
33642132|NCT00557856|102240293|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
33642133|NCT00557856|102240294|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
33642134|NCT00557856|102240295|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
33642135|NCT00557856|102240296|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
33642136|NCT00557856|102240297|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
33642137|NCT00557856|102240298|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
33642138|NCT00419952|102240301|FG000|Overall Study|Adverse Event|8|||
33642139|NCT00419952|102240302|FG001|Overall Study|Adverse Event|10|||
33642140|NCT00419952|102240301|FG000|Overall Study|Withdrawal by Subject|44|||
33143758|NCT00137839|100441556|FG000|Overall Study|Not Start Treatment|1|||
33143759|NCT00137839|100441556|FG000|Overall Study|Prolonged Treatment Delay|1|||
33143760|NCT01423604|100441557|FG000|Safety Run-In|Adverse Event|3|||
33143761|NCT01423604|100441558|FG001|Safety Run-In|Adverse Event|0|||
33143762|NCT01423604|100441557|FG000|Safety Run-In|Death|1|||
33143763|NCT01423604|100441558|FG001|Safety Run-In|Death|0|||
33143764|NCT01423604|100441557|FG000|Safety Run-In|Physician Decision|1|||
33143765|NCT01423604|100441558|FG001|Safety Run-In|Physician Decision|0|||
33581647|NCT01815424|102020146|FG000|Week 16 to 52|Lost to Follow-up|0|||
33642141|NCT00419952|102240302|FG001|Overall Study|Withdrawal by Subject|43|||
33642142|NCT00419952|102240301|FG000|Overall Study|Lost to Follow-up|43|||
33642143|NCT00419952|102240302|FG001|Overall Study|Lost to Follow-up|34|||
33642144|NCT00419952|102240301|FG000|Overall Study|Protocol Violation|32|||
33642145|NCT00419952|102240302|FG001|Overall Study|Protocol Violation|24|||
33242428|NCT01369355|100789043|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
33242429|NCT01369355|100789044|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
33242430|NCT01369355|100789045|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
33242431|NCT01369355|100789046|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
33242432|NCT01369355|100789047|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
33242433|NCT01369355|100789039|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
33242434|NCT01369355|100789040|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
33581648|NCT01815424|102020147|FG001|Week 16 to 52|Lost to Follow-up|2|||
33581649|NCT01815424|102020148|FG002|Week 16 to 52|Lost to Follow-up|0|||
33581650|NCT01815424|102020149|FG003|Week 16 to 52|Lost to Follow-up|2|||
33581651|NCT01815424|102020150|FG004|Week 16 to 52|Lost to Follow-up|1|||
33581652|NCT01815424|102020146|FG000|Week 16 to 52|Withdrawal by Subject|1|||
33581653|NCT01815424|102020147|FG001|Week 16 to 52|Withdrawal by Subject|2|||
33581654|NCT01815424|102020148|FG002|Week 16 to 52|Withdrawal by Subject|0|||
33581655|NCT01815424|102020149|FG003|Week 16 to 52|Withdrawal by Subject|0|||
33242435|NCT01369355|100789041|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
33242436|NCT01369355|100789042|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
33242437|NCT01369355|100789043|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
33242438|NCT01369355|100789044|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
33242439|NCT01369355|100789045|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
33242440|NCT01369355|100789046|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
33242441|NCT01369355|100789047|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
33242442|NCT01369355|100789039|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
33371617|NCT01808118|101247478|FG000|Period 2|Investigator no longer conducting trials|0|||
33371618|NCT01808118|101247479|FG001|Period 2|Investigator no longer conducting trials|1|||
33581656|NCT01815424|102020150|FG004|Week 16 to 52|Withdrawal by Subject|0|||
33642146|NCT00419952|102240301|FG000|Overall Study|Pregnancy|4|||
33642147|NCT00419952|102240302|FG001|Overall Study|Pregnancy|2|||
33642148|NCT00419952|102240301|FG000|Overall Study|Physician Decision|1|||
33642149|NCT00419952|102240302|FG001|Overall Study|Physician Decision|3|||
33642150|NCT00419952|102240301|FG000|Overall Study|Incorrectly enrolled|10|||
33642151|NCT00419952|102240302|FG001|Overall Study|Incorrectly enrolled|3|||
33642152|NCT00419952|102240301|FG000|Overall Study|Intake of prohibited medication|2|||
33642153|NCT00419952|102240302|FG001|Overall Study|Intake of prohibited medication|2|||
33642154|NCT00419952|102240301|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
33642155|NCT00419952|102240302|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
33642156|NCT00419952|102240301|FG000|Overall Study|Diary or medication non-compliance|2|||
33642157|NCT00419952|102240302|FG001|Overall Study|Diary or medication non-compliance|4|||
33642158|NCT00419952|102240301|FG000|Overall Study|Abnormal ECG|1|||
33581657|NCT01295944|102020151|FG000|Overall Study|Switched to alternative treatment|1|||
33581658|NCT01295944|102020151|FG000|Overall Study|Ineligible|9|||
33581659|NCT01295944|102020151|FG000|Overall Study|Withdrawal by Subject|4|||
33581660|NCT01295944|102020151|FG000|Overall Study|Participant chose to be treated in Peru|1|||
33581661|NCT01295944|102020151|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
33581662|NCT01295944|102020151|FG000|Overall Study|Participant was diagnosed with stage 1 infiltrated ductal carcinoma of the right breast(10/03/2013).|1|||
33581663|NCT01295944|102020151|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
33581664|NCT02725476|102020159|FG000|Overall Study|Physician Decision|2|||
33642159|NCT00419952|102240302|FG001|Overall Study|Abnormal ECG|0|||
33642160|NCT01255436|102240303|FG000|Overall Study|Lost to Follow-up|178|||
33642161|NCT01255436|102240304|FG001|Overall Study|Lost to Follow-up|191|||
33642162|NCT01255436|102240303|FG000|Overall Study|Death, stroke, or MI|4|||
33642163|NCT01255436|102240304|FG001|Overall Study|Death, stroke, or MI|3|||
33642164|NCT02930018|102240305|FG000|Overall Study|Lost to Follow-up|1|||
33642165|NCT02930018|102240306|FG001|Overall Study|Lost to Follow-up|1|||
33642166|NCT02930018|102240305|FG000|Overall Study|Withdrawal by Subject|5|||
33143766|NCT01423604|100441557|FG000|Safety Run-In|Disease progression|3|||
33143767|NCT01423604|100441558|FG001|Safety Run-In|Disease progression|0|||
33371619|NCT01808118|101247480|FG002|Period 2|Investigator no longer conducting trials|0|||
33371620|NCT01808118|101247478|FG000|Period 2|Switched to other therapy|0|||
33371621|NCT01808118|101247479|FG001|Period 2|Switched to other therapy|1|||
33642167|NCT02930018|102240306|FG001|Overall Study|Withdrawal by Subject|2|||
33143768|NCT01423604|100441557|FG000|Safety Run-In|Patient decision|1|||
33371622|NCT01808118|101247480|FG002|Period 2|Switched to other therapy|0|||
33371623|NCT01763905|101247481|FG000|Overall Study|Withdrawal by Subject|1|||
33371624|NCT01763905|101247482|FG001|Overall Study|Withdrawal by Subject|1|||
33371625|NCT01763905|101247483|FG002|Overall Study|Withdrawal by Subject|0|||
33581665|NCT02725476|102020160|FG001|Overall Study|Physician Decision|0|||
33581666|NCT02725476|102020159|FG000|Overall Study|Adverse Event|1|||
33642168|NCT04413617|102240308|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
33642169|NCT04413617|102240309|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
33642170|NCT04413617|102240310|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
33371626|NCT01763905|101247484|FG003|Overall Study|Withdrawal by Subject|1|||
33371627|NCT01763905|101247481|FG000|Overall Study|Decision by sponsor|5|||
33371628|NCT01763905|101247482|FG001|Overall Study|Decision by sponsor|0|||
33371629|NCT01763905|101247483|FG002|Overall Study|Decision by sponsor|8|||
33371630|NCT01763905|101247484|FG003|Overall Study|Decision by sponsor|0|||
33371631|NCT01763905|101247481|FG000|Overall Study|Lost to Follow-up|0|||
33581667|NCT02725476|102020160|FG001|Overall Study|Adverse Event|1|||
33581668|NCT02549989|102020162|FG000|Overall Study|Adverse Event|4|||
33581669|NCT02549989|102020162|FG000|Overall Study|Death|1|||
33581670|NCT02549989|102020162|FG000|Overall Study|Lack of Efficacy|19|||
33581671|NCT02549989|102020162|FG000|Overall Study|Withdrawal by Subject|3|||
33581672|NCT03902392|102020164|FG000|Overall Study|Lost to Follow-up|7|||
33581673|NCT03902392|102020165|FG001|Overall Study|Lost to Follow-up|7|||
33642171|NCT04413617|102240311|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
33371632|NCT01763905|101247482|FG001|Overall Study|Lost to Follow-up|0|||
33371633|NCT01763905|101247483|FG002|Overall Study|Lost to Follow-up|1|||
33371634|NCT01763905|101247484|FG003|Overall Study|Lost to Follow-up|0|||
33371635|NCT01863849|101247485|FG000|Overall Study|Lost to Follow-up|1|||
33371636|NCT01863849|101247486|FG001|Overall Study|Lost to Follow-up|0|||
33371637|NCT00142519|101247490|FG000|Overall Study|Not Treated|7|||
33371638|NCT00142519|101247491|FG001|Overall Study|Not Treated|9|||
33371639|NCT00142519|101247490|FG000|Overall Study|Protocol Violation|1|||
33371640|NCT00142519|101247491|FG001|Overall Study|Protocol Violation|0|||
33371641|NCT00142519|101247490|FG000|Overall Study|Withdrawal by Subject|10|||
33371642|NCT00142519|101247491|FG001|Overall Study|Withdrawal by Subject|7|||
33371643|NCT02819310|101247492|FG000|Overall Study|Withdrawal by Subject|37|||
33371644|NCT02819310|101247492|FG000|Overall Study|Lost to Follow-up|16|||
33371645|NCT02819310|101247492|FG000|Overall Study|Adverse Event|13|||
33371646|NCT02819310|101247492|FG000|Overall Study|Lack of Efficacy|5|||
33371647|NCT02819310|101247492|FG000|Overall Study|Physician Decision|8|||
33371648|NCT02819310|101247492|FG000|Overall Study|Protocol Violation|30|||
33371649|NCT04439838|101247493|FG000|Overall Study|Withdrawal by Subject|0|||
33371650|NCT04439838|101247494|FG001|Overall Study|Withdrawal by Subject|0|||
33371651|NCT04439838|101247495|FG002|Overall Study|Withdrawal by Subject|0|||
33371652|NCT04439838|101247496|FG003|Overall Study|Withdrawal by Subject|0|||
33371653|NCT04439838|101247497|FG004|Overall Study|Withdrawal by Subject|0|||
33371654|NCT04439838|101247498|FG005|Overall Study|Withdrawal by Subject|0|||
33371655|NCT04439838|101247499|FG006|Overall Study|Withdrawal by Subject|0|||
33371656|NCT04439838|101247500|FG007|Overall Study|Withdrawal by Subject|0|||
33371657|NCT04439838|101247501|FG008|Overall Study|Withdrawal by Subject|1|||
33371658|NCT02116660|101247502|FG000|Overall Study|Deteriorating renal function|0|||
33371659|NCT02116660|101247503|FG001|Overall Study|Deteriorating renal function|1|||
33371660|NCT02116660|101247502|FG000|Overall Study|Adverse Event|1|||
33371661|NCT02116660|101247503|FG001|Overall Study|Adverse Event|1|||
33371662|NCT02116660|101247502|FG000|Overall Study|Withdrawal by Subject|0|||
33371663|NCT02116660|101247503|FG001|Overall Study|Withdrawal by Subject|2|||
33371664|NCT02116660|101247502|FG000|Overall Study|Organization reason|1|||
33371665|NCT02116660|101247503|FG001|Overall Study|Organization reason|0|||
33371666|NCT01345123|101247504|FG000|Overall Study|participants no longer with health plan|79|||
33371667|NCT01345123|101247505|FG001|Overall Study|participants no longer with health plan|85|||
33371668|NCT01345123|101247506|FG002|Overall Study|participants no longer with health plan|88|||
33371669|NCT02145156|101247509|FG000|Overall Study|No match to vaccination records|60|||
33371670|NCT02145156|101247510|FG001|Overall Study|No match to vaccination records|52|||
33371671|NCT02145156|101247511|FG002|Overall Study|No match to vaccination records|41|||
33371672|NCT00752609|101247524|FG000|Overall Study|Adverse Event|2|||
33371673|NCT00752609|101247525|FG001|Overall Study|Adverse Event|2|||
33371674|NCT00752609|101247524|FG000|Overall Study|Withdrawal by Subject|3|||
33371675|NCT00752609|101247525|FG001|Overall Study|Withdrawal by Subject|0|||
33371676|NCT00752609|101247524|FG000|Overall Study|Physician Decision|1|||
33371677|NCT00752609|101247525|FG001|Overall Study|Physician Decision|0|||
33371678|NCT00752609|101247524|FG000|Overall Study|Death|1|||
33371679|NCT00752609|101247525|FG001|Overall Study|Death|0|||
33371680|NCT00752609|101247524|FG000|Overall Study|Met exclusion criteria|1|||
33371681|NCT00752609|101247525|FG001|Overall Study|Met exclusion criteria|0|||
33371682|NCT00752609|101247524|FG000|Overall Study|Received Aranesp in error|1|||
33371683|NCT00752609|101247525|FG001|Overall Study|Received Aranesp in error|0|||
33371684|NCT00905021|101247526|FG000|Overall Study|Adverse Event|2|||
33371685|NCT03439748|101247528|FG000|Overall Study|Withdrawal by Subject|11|||
33371686|NCT03439748|101247529|FG001|Overall Study|Withdrawal by Subject|17|||
33371687|NCT00789477|101247535|FG000|Overall Study|Withdrawal by Subject|2|||
33371688|NCT00789477|101247536|FG001|Overall Study|Withdrawal by Subject|1|||
33371689|NCT00789477|101247537|FG002|Overall Study|Withdrawal by Subject|3|||
33371690|NCT00789477|101247538|FG003|Overall Study|Withdrawal by Subject|2|||
33581674|NCT01926444|102020166|FG000|Overall Study|Colonoscopy not performed|0|||
33581675|NCT01926444|102020167|FG001|Overall Study|Colonoscopy not performed|0|||
33371691|NCT00789477|101247539|FG004|Overall Study|Withdrawal by Subject|3|||
33371692|NCT00789477|101247535|FG000|Overall Study|Protocol Violation|1|||
33371693|NCT00789477|101247536|FG001|Overall Study|Protocol Violation|0|||
33371694|NCT00789477|101247537|FG002|Overall Study|Protocol Violation|0|||
33371695|NCT00789477|101247538|FG003|Overall Study|Protocol Violation|1|||
33371696|NCT00789477|101247539|FG004|Overall Study|Protocol Violation|0|||
33371697|NCT00789477|101247535|FG000|Overall Study|Adverse Event|3|||
33371698|NCT00789477|101247536|FG001|Overall Study|Adverse Event|3|||
33371699|NCT00789477|101247537|FG002|Overall Study|Adverse Event|1|||
33371700|NCT00789477|101247538|FG003|Overall Study|Adverse Event|0|||
33371701|NCT00789477|101247539|FG004|Overall Study|Adverse Event|0|||
33371702|NCT00789477|101247535|FG000|Overall Study|Death|1|||
33371703|NCT00789477|101247536|FG001|Overall Study|Death|1|||
33371704|NCT00789477|101247537|FG002|Overall Study|Death|2|||
33371705|NCT00789477|101247538|FG003|Overall Study|Death|2|||
33371706|NCT00789477|101247539|FG004|Overall Study|Death|0|||
33371707|NCT00789477|101247535|FG000|Overall Study|Lost to Follow-up|0|||
33371708|NCT00789477|101247536|FG001|Overall Study|Lost to Follow-up|1|||
33371709|NCT00789477|101247537|FG002|Overall Study|Lost to Follow-up|4|||
33371710|NCT00789477|101247538|FG003|Overall Study|Lost to Follow-up|2|||
33371711|NCT00789477|101247539|FG004|Overall Study|Lost to Follow-up|4|||
33371712|NCT00789477|101247535|FG000|Overall Study|Lack of Efficacy|2|||
33371713|NCT00789477|101247536|FG001|Overall Study|Lack of Efficacy|0|||
33371714|NCT00789477|101247537|FG002|Overall Study|Lack of Efficacy|0|||
33371715|NCT00789477|101247538|FG003|Overall Study|Lack of Efficacy|0|||
33371716|NCT00789477|101247539|FG004|Overall Study|Lack of Efficacy|0|||
33371717|NCT00789477|101247535|FG000|Overall Study|Other|2|||
33371718|NCT00789477|101247536|FG001|Overall Study|Other|0|||
33371719|NCT00789477|101247537|FG002|Overall Study|Other|1|||
33371720|NCT00789477|101247538|FG003|Overall Study|Other|3|||
33371721|NCT00789477|101247539|FG004|Overall Study|Other|0|||
33371722|NCT01716533|101247540|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
33371723|NCT01716533|101247541|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
33371724|NCT01716533|101247542|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
33371725|NCT01716533|101247543|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
33371726|NCT01716533|101247540|FG000|Overall Study|Withdrawal by Subject|0|||
33371727|NCT01716533|101247541|FG001|Overall Study|Withdrawal by Subject|0|||
33371728|NCT01716533|101247542|FG002|Overall Study|Withdrawal by Subject|0|||
33371729|NCT01716533|101247543|FG003|Overall Study|Withdrawal by Subject|5|||
33371730|NCT01716533|101247540|FG000|Overall Study|Death|0|||
33371731|NCT01716533|101247541|FG001|Overall Study|Death|0|||
33371732|NCT01716533|101247542|FG002|Overall Study|Death|0|||
33421660|NCT01678924|101434882|FG002|Overall Study|Unable to attend scheduled visits|0|||
33421661|NCT01678924|101434883|FG003|Overall Study|Unable to attend scheduled visits|1|||
33421662|NCT04288115|101434885|FG000|Overall Study|Withdrawal by Subject|0|||
33421663|NCT04288115|101434886|FG001|Overall Study|Withdrawal by Subject|1|||
33421664|NCT04288115|101434885|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
33642172|NCT04413617|102240312|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
33642173|NCT04413617|102240308|FG000|Overall Study|Protocol Violation|0|||
33642174|NCT04413617|102240309|FG001|Overall Study|Protocol Violation|1|||
33642175|NCT04413617|102240310|FG002|Overall Study|Protocol Violation|0|||
33371733|NCT01716533|101247543|FG003|Overall Study|Death|2|||
33421665|NCT04288115|101434886|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
33421666|NCT00479401|101434887|FG000|Overall Study|Adverse Event|24|||
33421667|NCT00479401|101434888|FG001|Overall Study|Adverse Event|20|||
33421668|NCT00479401|101434889|FG002|Overall Study|Adverse Event|4|||
33421669|NCT00479401|101434887|FG000|Overall Study|Lack of Efficacy|2|||
33421670|NCT00479401|101434888|FG001|Overall Study|Lack of Efficacy|2|||
33421671|NCT00479401|101434889|FG002|Overall Study|Lack of Efficacy|4|||
33421672|NCT00479401|101434887|FG000|Overall Study|Protocol Violation|2|||
33421673|NCT00479401|101434888|FG001|Overall Study|Protocol Violation|1|||
33421674|NCT00479401|101434889|FG002|Overall Study|Protocol Violation|1|||
33421675|NCT00479401|101434887|FG000|Overall Study|Lost to Follow-up|1|||
33421676|NCT00479401|101434888|FG001|Overall Study|Lost to Follow-up|1|||
33421677|NCT00479401|101434889|FG002|Overall Study|Lost to Follow-up|1|||
33371734|NCT01716533|101247540|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
33371735|NCT01716533|101247541|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
33371736|NCT01716533|101247542|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
33371737|NCT01716533|101247543|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
33371738|NCT00321984|101247544|FG000|Overall Study|Adverse Event|9|||
33371739|NCT00321984|101247545|FG001|Overall Study|Adverse Event|6|||
33371740|NCT00321984|101247546|FG002|Overall Study|Adverse Event|8|||
33371741|NCT00321984|101247544|FG000|Overall Study|Protocol Violation|0|||
33371742|NCT00321984|101247545|FG001|Overall Study|Protocol Violation|1|||
33371743|NCT00321984|101247546|FG002|Overall Study|Protocol Violation|1|||
33421678|NCT00479401|101434887|FG000|Overall Study|Withdrawal by Subject|16|||
33371744|NCT00321984|101247544|FG000|Overall Study|Lost to Follow-up|2|||
33371745|NCT00321984|101247545|FG001|Overall Study|Lost to Follow-up|4|||
33642176|NCT04413617|102240311|FG003|Overall Study|Protocol Violation|0|||
33371746|NCT00321984|101247546|FG002|Overall Study|Lost to Follow-up|2|||
33642177|NCT04413617|102240312|FG004|Overall Study|Protocol Violation|1|||
33371747|NCT00321984|101247544|FG000|Overall Study|Withdrawal by Subject|8|||
33642178|NCT04413617|102240308|FG000|Overall Study|Lack of Efficacy|2|||
33642179|NCT04413617|102240309|FG001|Overall Study|Lack of Efficacy|0|||
33143769|NCT01423604|100441558|FG001|Safety Run-In|Patient decision|0|||
33143770|NCT01423604|100441557|FG000|Randomized|Adverse Event|4|||
33143771|NCT01423604|100441558|FG001|Randomized|Adverse Event|10|||
33143772|NCT01423604|100441557|FG000|Randomized|Death|1|||
33143773|NCT01423604|100441558|FG001|Randomized|Death|0|||
33143774|NCT01423604|100441557|FG000|Randomized|Physician Decision|16|||
33143775|NCT01423604|100441558|FG001|Randomized|Physician Decision|13|||
33143776|NCT01423604|100441557|FG000|Randomized|Other - unspecified|37|||
33143777|NCT01423604|100441558|FG001|Randomized|Other - unspecified|31|||
33143778|NCT01423604|100441557|FG000|Randomized|Patient decision|5|||
33143779|NCT01423604|100441558|FG001|Randomized|Patient decision|9|||
33143780|NCT01634178|100441559|FG000|Treatment Period 1|Adverse Event|0|||
33143781|NCT01634178|100441560|FG001|Treatment Period 1|Adverse Event|1|||
33143782|NCT01634178|100441559|FG000|Treatment Period 2|Adverse Event|1|||
33143783|NCT01634178|100441560|FG001|Treatment Period 2|Adverse Event|0|||
33143784|NCT01099709|100441561|FG000|Period 1|Withdrawal by Subject|0|||
33143785|NCT01099709|100441562|FG001|Period 1|Withdrawal by Subject|1|||
33143786|NCT01099709|100441561|FG000|Period 1|Positive cotinine test|0|||
33143787|NCT01099709|100441562|FG001|Period 1|Positive cotinine test|1|||
33143788|NCT01099709|100441561|FG000|Period 1|Adverse Event|1|||
33143789|NCT01099709|100441562|FG001|Period 1|Adverse Event|0|||
33143790|NCT00542451|100441563|FG000|Overall Study|Adverse Event|31|||
33143791|NCT00542451|100441563|FG000|Overall Study|Withdrawal by Subject|30|||
33143792|NCT00542451|100441563|FG000|Overall Study|Physician Decision|4|||
33143793|NCT00542451|100441563|FG000|Overall Study|Recurrent disease|1|||
33642180|NCT04413617|102240310|FG002|Overall Study|Lack of Efficacy|2|||
33642181|NCT04413617|102240311|FG003|Overall Study|Lack of Efficacy|1|||
33642182|NCT04413617|102240312|FG004|Overall Study|Lack of Efficacy|0|||
33642183|NCT04413617|102240308|FG000|Overall Study|Withdrawal by Subject|3|||
33143794|NCT00542451|100441563|FG000|Overall Study|unknown reason|1|||
33143795|NCT00542451|100441563|FG000|Overall Study|Death|2|||
33143796|NCT00542451|100441563|FG000|Overall Study|Lost to Follow-up|10|||
33143797|NCT01362595|100441566|FG000|Overall Study|Screen failure|10|||
33143798|NCT01362595|100441566|FG000|Overall Study|Withdrawal by Subject|2|||
33143799|NCT03361176|100441568|FG000|Overall Study|Lost to Follow-up|1|||
33143800|NCT03361176|100441569|FG001|Overall Study|Lost to Follow-up|2|||
33143801|NCT03361176|100441568|FG000|Overall Study|Adverse Event|0|||
33143802|NCT03361176|100441569|FG001|Overall Study|Adverse Event|2|||
33143803|NCT03361176|100441568|FG000|Overall Study|Withdrawal by Subject|0|||
33143804|NCT03361176|100441569|FG001|Overall Study|Withdrawal by Subject|1|||
33143805|NCT04369924|100441570|FG000|Overall Study|Lost to Follow-up|302|||
33143806|NCT04369924|100441571|FG001|Overall Study|Lost to Follow-up|339|||
33143807|NCT02925793|100441576|FG000|Overall Study|Adverse Event|3|||
33143808|NCT02925793|100441577|FG001|Overall Study|Adverse Event|3|||
33143809|NCT02925793|100441578|FG002|Overall Study|Adverse Event|6|||
33143810|NCT02925793|100441576|FG000|Overall Study|Withdrawal by Subject|16|||
33143811|NCT02925793|100441577|FG001|Overall Study|Withdrawal by Subject|15|||
33143812|NCT02925793|100441578|FG002|Overall Study|Withdrawal by Subject|13|||
33143813|NCT02925793|100441576|FG000|Overall Study|Investigator Discretion|0|||
33143814|NCT02925793|100441577|FG001|Overall Study|Investigator Discretion|1|||
33143815|NCT02925793|100441578|FG002|Overall Study|Investigator Discretion|1|||
33143816|NCT02925793|100441576|FG000|Overall Study|Lost to Follow-up|2|||
33143817|NCT02925793|100441577|FG001|Overall Study|Lost to Follow-up|3|||
33143818|NCT02925793|100441578|FG002|Overall Study|Lost to Follow-up|1|||
33371748|NCT00321984|101247545|FG001|Overall Study|Withdrawal by Subject|6|||
33371749|NCT00321984|101247546|FG002|Overall Study|Withdrawal by Subject|5|||
33371750|NCT00321984|101247544|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
33371751|NCT00321984|101247545|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
33642184|NCT04413617|102240309|FG001|Overall Study|Withdrawal by Subject|4|||
33642185|NCT04413617|102240310|FG002|Overall Study|Withdrawal by Subject|2|||
33143819|NCT02925793|100441576|FG000|Overall Study|Lack of Efficacy|2|||
33143820|NCT02925793|100441577|FG001|Overall Study|Lack of Efficacy|6|||
33143821|NCT02925793|100441578|FG002|Overall Study|Lack of Efficacy|4|||
33143822|NCT02925793|100441576|FG000|Overall Study|Other:|2|||
33143823|NCT02925793|100441577|FG001|Overall Study|Other:|1|||
33143824|NCT02925793|100441578|FG002|Overall Study|Other:|3|||
33143825|NCT02628769|100441580|FG000|First Intervention|Adverse Event|1|||
33143826|NCT02628769|100441581|FG001|First Intervention|Adverse Event|0|||
33143827|NCT02628769|100441580|FG000|First Intervention|Withdrawal by Subject|0|||
33143828|NCT02628769|100441581|FG001|First Intervention|Withdrawal by Subject|1|||
33143829|NCT02628769|100441580|FG000|Second Intervention|Adverse Event|2|||
33143830|NCT02628769|100441581|FG001|Second Intervention|Adverse Event|0|||
33143831|NCT02628769|100441580|FG000|Second Intervention|Physician Decision|0|||
33143832|NCT02628769|100441581|FG001|Second Intervention|Physician Decision|1|||
33371752|NCT00321984|101247546|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
33642186|NCT04413617|102240311|FG003|Overall Study|Withdrawal by Subject|5|||
33143833|NCT00136604|100441583|FG000|Overall Study|Lost to Follow-up|1|||
33143834|NCT00136604|100441584|FG001|Overall Study|Lost to Follow-up|0|||
33143835|NCT00136604|100441585|FG002|Overall Study|Lost to Follow-up|0|||
33143836|NCT00136604|100441586|FG003|Overall Study|Lost to Follow-up|0|||
33143837|NCT00136604|100441587|FG004|Overall Study|Lost to Follow-up|1|||
33143838|NCT00136604|100441583|FG000|Overall Study|Migrated/moved from study area|0|||
33143839|NCT00136604|100441584|FG001|Overall Study|Migrated/moved from study area|1|||
33143840|NCT00136604|100441585|FG002|Overall Study|Migrated/moved from study area|0|||
33143841|NCT00136604|100441586|FG003|Overall Study|Migrated/moved from study area|0|||
33642187|NCT04413617|102240312|FG004|Overall Study|Withdrawal by Subject|3|||
33642188|NCT04413617|102240308|FG000|Overall Study|Death|1|||
33642189|NCT04413617|102240309|FG001|Overall Study|Death|0|||
33642190|NCT04413617|102240310|FG002|Overall Study|Death|0|||
33642191|NCT04413617|102240311|FG003|Overall Study|Death|0|||
33143842|NCT00136604|100441587|FG004|Overall Study|Migrated/moved from study area|0|||
33143843|NCT00327470|100441593|FG000|Overall Study|Randomized, but not treated|0|||
33143844|NCT00327470|100441594|FG001|Overall Study|Randomized, but not treated|2|||
33143845|NCT00327470|100441593|FG000|Overall Study|Adverse Event|9|||
33143846|NCT00327470|100441594|FG001|Overall Study|Adverse Event|14|||
33143847|NCT00327470|100441593|FG000|Overall Study|Lack of Efficacy|7|||
33143848|NCT00327470|100441594|FG001|Overall Study|Lack of Efficacy|19|||
33143849|NCT00327470|100441593|FG000|Overall Study|Other|5|||
33143850|NCT00327470|100441594|FG001|Overall Study|Other|9|||
33371753|NCT00321984|101247544|FG000|Overall Study|Lack of Efficacy|3|||
33371754|NCT00321984|101247545|FG001|Overall Study|Lack of Efficacy|1|||
33421679|NCT00479401|101434888|FG001|Overall Study|Withdrawal by Subject|10|||
33581676|NCT01926444|102020168|FG002|Overall Study|Colonoscopy not performed|4|||
33581677|NCT01926444|102020169|FG003|Overall Study|Colonoscopy not performed|2|||
33581678|NCT00078806|102020176|FG000|Part 1A|Adverse Event|2|||
33581679|NCT00078806|102020177|FG001|Part 1A|Adverse Event|0|||
33581680|NCT00078806|102020178|FG002|Part 1A|Adverse Event|0|||
33581681|NCT00078806|102020179|FG003|Part 1A|Adverse Event|0|||
33581682|NCT00078806|102020176|FG000|Part 1A|Lack of Efficacy|7|||
33581683|NCT00078806|102020177|FG001|Part 1A|Lack of Efficacy|0|||
33581684|NCT00078806|102020178|FG002|Part 1A|Lack of Efficacy|0|||
33581685|NCT00078806|102020179|FG003|Part 1A|Lack of Efficacy|0|||
33581686|NCT00078806|102020176|FG000|Part 1A|Other|1|||
33581687|NCT00078806|102020177|FG001|Part 1A|Other|0|||
33581688|NCT00078806|102020178|FG002|Part 1A|Other|0|||
33581689|NCT00078806|102020179|FG003|Part 1A|Other|0|||
33581690|NCT00078806|102020176|FG000|Part 1B|Adverse Event|1|||
33581691|NCT00078806|102020177|FG001|Part 1B|Adverse Event|0|||
33581692|NCT00078806|102020178|FG002|Part 1B|Adverse Event|0|||
33581693|NCT00078806|102020179|FG003|Part 1B|Adverse Event|0|||
33581694|NCT00078806|102020176|FG000|Part 1B|Lack of Efficacy|7|||
33581695|NCT00078806|102020177|FG001|Part 1B|Lack of Efficacy|0|||
33581696|NCT00078806|102020178|FG002|Part 1B|Lack of Efficacy|0|||
33642192|NCT04413617|102240312|FG004|Overall Study|Death|0|||
33642193|NCT04413617|102240308|FG000|Overall Study|Adverse Event|1|||
33642194|NCT04413617|102240309|FG001|Overall Study|Adverse Event|0|||
33642195|NCT04413617|102240310|FG002|Overall Study|Adverse Event|0|||
33642196|NCT04413617|102240311|FG003|Overall Study|Adverse Event|1|||
33642197|NCT04413617|102240312|FG004|Overall Study|Adverse Event|1|||
33642198|NCT04413617|102240308|FG000|Overall Study|COVID-19|0|||
33642199|NCT04413617|102240309|FG001|Overall Study|COVID-19|1|||
33642200|NCT04413617|102240310|FG002|Overall Study|COVID-19|0|||
33642201|NCT04413617|102240311|FG003|Overall Study|COVID-19|0|||
33642202|NCT04413617|102240312|FG004|Overall Study|COVID-19|0|||
33642203|NCT00372593|102240317|FG000|Overall Study|Adverse Event|43|||
33642204|NCT00372593|102240318|FG001|Overall Study|Adverse Event|45|||
33642205|NCT00372593|102240319|FG002|Overall Study|Adverse Event|0|||
33642206|NCT00372593|102240317|FG000|Overall Study|Death|16|||
33642207|NCT00372593|102240318|FG001|Overall Study|Death|20|||
33642208|NCT00372593|102240319|FG002|Overall Study|Death|1|||
33642209|NCT00372593|102240317|FG000|Overall Study|Lack of Efficacy|82|||
33642210|NCT00372593|102240318|FG001|Overall Study|Lack of Efficacy|71|||
33581697|NCT00078806|102020179|FG003|Part 1B|Lack of Efficacy|0|||
33581698|NCT00078806|102020176|FG000|Part 2|Adverse Event|0|||
33581699|NCT00078806|102020177|FG001|Part 2|Adverse Event|1|||
33642211|NCT00372593|102240319|FG002|Overall Study|Lack of Efficacy|2|||
33143851|NCT00327470|100441593|FG000|Overall Study|Lost to Follow-up|1|||
33143852|NCT00327470|100441594|FG001|Overall Study|Lost to Follow-up|3|||
33143853|NCT00327470|100441593|FG000|Overall Study|Withdrawal by Subject|6|||
33143854|NCT00327470|100441594|FG001|Overall Study|Withdrawal by Subject|12|||
33143855|NCT00327470|100441593|FG000|Overall Study|Death|1|||
33581700|NCT00078806|102020178|FG002|Part 2|Adverse Event|0|||
33581701|NCT00078806|102020179|FG003|Part 2|Adverse Event|0|||
33581702|NCT01340664|102020180|FG000|Overall Study|Adverse Event|0|||
33642212|NCT00372593|102240317|FG000|Overall Study|Lost to Follow-up|1|||
33642213|NCT00372593|102240318|FG001|Overall Study|Lost to Follow-up|0|||
33642214|NCT00372593|102240319|FG002|Overall Study|Lost to Follow-up|0|||
33642215|NCT00372593|102240317|FG000|Overall Study|Physician Decision|42|||
33642216|NCT00372593|102240318|FG001|Overall Study|Physician Decision|41|||
33642217|NCT00372593|102240319|FG002|Overall Study|Physician Decision|0|||
33642218|NCT00372593|102240317|FG000|Overall Study|Ineligible|20|||
33642219|NCT00372593|102240318|FG001|Overall Study|Ineligible|21|||
33642220|NCT00372593|102240319|FG002|Overall Study|Ineligible|1|||
33642221|NCT01750229|102240323|FG000|Randomized Crossover Phase|Adverse Event|1|||
33642222|NCT01750229|102240323|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
33642223|NCT01750229|102240323|FG000|Long-term Follow-up Phase|Adverse Event|2|||
33642224|NCT01750229|102240323|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
33642225|NCT01469377|102240324|FG000|Overall Study|Protocol Deviation|7|||
33642226|NCT01469377|102240325|FG001|Overall Study|Protocol Deviation|10|||
33642227|NCT01469377|102240326|FG002|Overall Study|Protocol Deviation|10|||
33642228|NCT01469377|102240324|FG000|Overall Study|Lost to Follow-up|3|||
33642229|NCT01469377|102240325|FG001|Overall Study|Lost to Follow-up|2|||
33642230|NCT01469377|102240326|FG002|Overall Study|Lost to Follow-up|5|||
33143856|NCT00327470|100441594|FG001|Overall Study|Death|4|||
33143857|NCT01895361|100441595|FG000|Overall Study|Adverse Event|1|||
33143858|NCT01895361|100441596|FG001|Overall Study|Adverse Event|1|||
33143859|NCT01895361|100441597|FG002|Overall Study|Adverse Event|3|||
33143860|NCT01895361|100441595|FG000|Overall Study|Death|2|||
33143861|NCT01895361|100441596|FG001|Overall Study|Death|1|||
33143862|NCT01895361|100441597|FG002|Overall Study|Death|2|||
33143863|NCT01895361|100441595|FG000|Overall Study|Lost to Follow-up|4|||
33143864|NCT01895361|100441596|FG001|Overall Study|Lost to Follow-up|4|||
33143865|NCT01895361|100441597|FG002|Overall Study|Lost to Follow-up|6|||
33143866|NCT01895361|100441595|FG000|Overall Study|Non-compliance with study|1|||
33143867|NCT01895361|100441596|FG001|Overall Study|Non-compliance with study|3|||
33143868|NCT01895361|100441597|FG002|Overall Study|Non-compliance with study|1|||
33143869|NCT01895361|100441595|FG000|Overall Study|Physician Decision|2|||
33143870|NCT01895361|100441596|FG001|Overall Study|Physician Decision|2|||
33143871|NCT01895361|100441597|FG002|Overall Study|Physician Decision|2|||
33143872|NCT01895361|100441595|FG000|Overall Study|Withdrawal by Subject|7|||
33143873|NCT01895361|100441596|FG001|Overall Study|Withdrawal by Subject|6|||
33143874|NCT01895361|100441597|FG002|Overall Study|Withdrawal by Subject|6|||
33143875|NCT01895361|100441595|FG000|Overall Study|Lack of Efficacy|0|||
33143876|NCT01895361|100441596|FG001|Overall Study|Lack of Efficacy|1|||
33143877|NCT01895361|100441597|FG002|Overall Study|Lack of Efficacy|0|||
33143878|NCT01895361|100441595|FG000|Overall Study|Reasons different from categories above|7|||
33143879|NCT01895361|100441596|FG001|Overall Study|Reasons different from categories above|3|||
33143880|NCT01895361|100441597|FG002|Overall Study|Reasons different from categories above|4|||
33143881|NCT00887744|100441598|FG000|Overall Study|Adverse Event|3|||
33143882|NCT00887744|100441598|FG000|Overall Study|Death|1|||
33143883|NCT00887744|100441598|FG000|Overall Study|Lost to Follow-up|3|||
33143884|NCT00887744|100441598|FG000|Overall Study|Withdrawal by Subject|18|||
33143885|NCT00887744|100441598|FG000|Overall Study|Various reasons|9|||
33143886|NCT01275339|100441599|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
33143887|NCT01275339|100441600|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
33143888|NCT01275339|100441601|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
33143889|NCT01275339|100441602|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
33642231|NCT01469377|102240324|FG000|Overall Study|Withdrawal of Consent|12|||
33642232|NCT01469377|102240325|FG001|Overall Study|Withdrawal of Consent|14|||
33642233|NCT01469377|102240326|FG002|Overall Study|Withdrawal of Consent|15|||
33642234|NCT01469377|102240324|FG000|Overall Study|Adverse Event|8|||
33642235|NCT01469377|102240325|FG001|Overall Study|Adverse Event|18|||
33642236|NCT01469377|102240326|FG002|Overall Study|Adverse Event|36|||
33642237|NCT01469377|102240324|FG000|Overall Study|Insufficient Therapeutic Response|3|||
33642238|NCT01469377|102240325|FG001|Overall Study|Insufficient Therapeutic Response|4|||
33642239|NCT01469377|102240326|FG002|Overall Study|Insufficient Therapeutic Response|0|||
33642240|NCT01469377|102240324|FG000|Overall Study|Other Miscellaneous Reasons|2|||
33642241|NCT01469377|102240325|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33642242|NCT01469377|102240326|FG002|Overall Study|Other Miscellaneous Reasons|0|||
33642243|NCT00101452|102240328|FG000|Overall Study|Adverse Event|2|||
33143890|NCT01275339|100441599|FG000|Overall Study|Withdrawal by Subject|0|||
33642244|NCT00101452|102240329|FG001|Overall Study|Adverse Event|0|||
33143891|NCT01275339|100441600|FG001|Overall Study|Withdrawal by Subject|0|||
33143892|NCT01275339|100441601|FG002|Overall Study|Withdrawal by Subject|1|||
33143893|NCT01275339|100441602|FG003|Overall Study|Withdrawal by Subject|0|||
33143894|NCT02314143|100441603|FG000|Overall Study|Adverse Event|0|||
33143895|NCT02314143|100441604|FG001|Overall Study|Adverse Event|6|||
33143896|NCT02314143|100441605|FG002|Overall Study|Adverse Event|4|||
33143897|NCT02314143|100441603|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
33143898|NCT02314143|100441604|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
33143899|NCT02314143|100441605|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
33642245|NCT00101452|102240330|FG002|Overall Study|Adverse Event|1|||
33642246|NCT00101452|102240328|FG000|Overall Study|Lost to Follow-up|13|||
33642247|NCT00101452|102240329|FG001|Overall Study|Lost to Follow-up|8|||
33642248|NCT00101452|102240330|FG002|Overall Study|Lost to Follow-up|14|||
33642249|NCT00101452|102240328|FG000|Overall Study|Withdrawal by Subject|10|||
33143900|NCT02314143|100441603|FG000|Overall Study|Physician Decision|2|||
33143901|NCT02314143|100441604|FG001|Overall Study|Physician Decision|1|||
33143902|NCT02314143|100441605|FG002|Overall Study|Physician Decision|0|||
33143903|NCT02314143|100441603|FG000|Overall Study|Withdrawal by Subject|1|||
33143904|NCT02314143|100441604|FG001|Overall Study|Withdrawal by Subject|0|||
33143905|NCT02314143|100441605|FG002|Overall Study|Withdrawal by Subject|1|||
33143906|NCT00321893|100441606|FG000|Overall Study|Non-Compliance/Refusal|16|||
33143907|NCT00321893|100441607|FG001|Overall Study|Non-Compliance/Refusal|10|||
33143908|NCT00321893|100441606|FG000|Overall Study|Lost to Follow-up|2|||
33143909|NCT00321893|100441607|FG001|Overall Study|Lost to Follow-up|1|||
33371755|NCT00321984|101247546|FG002|Overall Study|Lack of Efficacy|3|||
33371756|NCT00321984|101247544|FG000|Overall Study|Noncompliant|0|||
33371757|NCT00321984|101247545|FG001|Overall Study|Noncompliant|0|||
33421680|NCT00479401|101434889|FG002|Overall Study|Withdrawal by Subject|2|||
33143910|NCT00321893|100441606|FG000|Overall Study|Adverse Event|6|||
33143911|NCT00321893|100441607|FG001|Overall Study|Adverse Event|3|||
33143912|NCT05498701|100441608|FG000|Period 3|Adverse Event|1|||
33143913|NCT05498701|100441609|FG001|Period 3|Adverse Event|0|||
33143914|NCT00829283|100441610|FG000|Overall Study|Lost to Follow-up|7|||
33143915|NCT00829283|100441611|FG001|Overall Study|Lost to Follow-up|25|||
33143916|NCT00998764|100441612|FG000|Overall Study|Lack of Efficacy|3|||
33143917|NCT00998764|100441613|FG001|Overall Study|Lack of Efficacy|6|||
33143918|NCT00998764|100441612|FG000|Overall Study|Adverse Event|17|||
33143919|NCT00998764|100441613|FG001|Overall Study|Adverse Event|12|||
33143920|NCT00998764|100441612|FG000|Overall Study|Withdrawal by Subject|19|||
33143921|NCT00998764|100441613|FG001|Overall Study|Withdrawal by Subject|25|||
33143922|NCT00998764|100441612|FG000|Overall Study|Physician Decision|3|||
33143923|NCT00998764|100441613|FG001|Overall Study|Physician Decision|3|||
33143924|NCT00998764|100441612|FG000|Overall Study|Death|3|||
33371758|NCT00321984|101247546|FG002|Overall Study|Noncompliant|2|||
33371759|NCT00321984|101247544|FG000|Overall Study|Pregnancy|0|||
33371760|NCT00321984|101247545|FG001|Overall Study|Pregnancy|1|||
33371761|NCT00321984|101247546|FG002|Overall Study|Pregnancy|0|||
33371762|NCT00321984|101247544|FG000|Overall Study|Per Subject Request|1|||
33371763|NCT00321984|101247545|FG001|Overall Study|Per Subject Request|0|||
33371764|NCT00321984|101247546|FG002|Overall Study|Per Subject Request|0|||
33371765|NCT00321984|101247544|FG000|Overall Study|Per Investigator Request|1|||
33371766|NCT00321984|101247545|FG001|Overall Study|Per Investigator Request|0|||
33371767|NCT00321984|101247546|FG002|Overall Study|Per Investigator Request|0|||
33371768|NCT00321984|101247544|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
33421681|NCT00479401|101434887|FG000|Overall Study|Exclusion criteria, relocation|4|||
33421682|NCT00479401|101434888|FG001|Overall Study|Exclusion criteria, relocation|3|||
33421683|NCT00479401|101434889|FG002|Overall Study|Exclusion criteria, relocation|0|||
33421684|NCT02953262|101434890|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
33421685|NCT02953262|101434891|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
33421686|NCT02953262|101434892|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
33421687|NCT02953262|101434893|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
33421688|NCT00725725|101434894|FG000|Overall Study|Adverse Event|1|||
33421689|NCT00725725|101434895|FG001|Overall Study|Adverse Event|3|||
33421690|NCT00725725|101434896|FG002|Overall Study|Adverse Event|2|||
33421691|NCT00725725|101434894|FG000|Overall Study|Lost to Follow-up|2|||
33421692|NCT00725725|101434895|FG001|Overall Study|Lost to Follow-up|0|||
33421693|NCT00725725|101434896|FG002|Overall Study|Lost to Follow-up|2|||
33421694|NCT00725725|101434894|FG000|Overall Study|Withdrawal by Subject|1|||
33421695|NCT00725725|101434895|FG001|Overall Study|Withdrawal by Subject|0|||
33421696|NCT00725725|101434896|FG002|Overall Study|Withdrawal by Subject|1|||
33371769|NCT00321984|101247545|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
33371770|NCT00321984|101247546|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
33421697|NCT00725725|101434894|FG000|Overall Study|Protocol Violation|0|||
33421698|NCT00725725|101434895|FG001|Overall Study|Protocol Violation|1|||
33421699|NCT00725725|101434896|FG002|Overall Study|Protocol Violation|0|||
33421700|NCT02030834|101434900|FG000|Overall Study|Death|4|||
33581703|NCT01340664|102020181|FG001|Overall Study|Adverse Event|1|||
33581704|NCT01340664|102020182|FG002|Overall Study|Adverse Event|7|||
33143925|NCT00998764|100441613|FG001|Overall Study|Death|1|||
33143926|NCT00998764|100441612|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
33143927|NCT00998764|100441613|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
33143928|NCT00998764|100441612|FG000|Overall Study|Protocol Violation|0|||
33143929|NCT00998764|100441613|FG001|Overall Study|Protocol Violation|1|||
33143930|NCT00998764|100441612|FG000|Overall Study|Failed to Return|1|||
33143931|NCT00998764|100441613|FG001|Overall Study|Failed to Return|1|||
33371771|NCT02632110|101247547|FG000|Overall Study|Withdrawal by Subject|1|||
33371772|NCT02632110|101247548|FG001|Overall Study|Withdrawal by Subject|1|||
33421701|NCT02030834|101434901|FG001|Overall Study|Death|0|||
33421702|NCT02030834|101434902|FG002|Overall Study|Death|0|||
33421703|NCT02030834|101434900|FG000|Overall Study|Manufacturing failure|2|||
33421704|NCT02030834|101434901|FG001|Overall Study|Manufacturing failure|0|||
33421705|NCT02030834|101434902|FG002|Overall Study|Manufacturing failure|1|||
33143932|NCT00998764|100441612|FG000|Overall Study|Lost to Follow-up|1|||
33143933|NCT00998764|100441613|FG001|Overall Study|Lost to Follow-up|1|||
33143934|NCT00998764|100441612|FG000|Overall Study|Loss of Caregiver|0|||
33143935|NCT00998764|100441613|FG001|Overall Study|Loss of Caregiver|3|||
33143936|NCT00998764|100441612|FG000|Overall Study|Other|4|||
33143937|NCT00998764|100441613|FG001|Overall Study|Other|4|||
33143938|NCT00998764|100441612|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
33143939|NCT00998764|100441613|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
33143940|NCT03269552|100441614|FG000|Overall Study|Adverse Event|2|||
33143941|NCT01736657|100441615|FG000|Overall Study|insufficient vascular access|1|||
33143942|NCT03729362|100441620|FG000|Overall Study|Withdrawal by Subject|2|||
33143943|NCT03729362|100441621|FG001|Overall Study|Withdrawal by Subject|0|||
33143944|NCT03729362|100441620|FG000|Overall Study|Physician Decision|1|||
33143945|NCT03729362|100441621|FG001|Overall Study|Physician Decision|0|||
33143946|NCT03729362|100441620|FG000|Overall Study|COVID-19 Pandemic|1|||
33143947|NCT03729362|100441621|FG001|Overall Study|COVID-19 Pandemic|0|||
33143948|NCT03729362|100441620|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
33143949|NCT03729362|100441621|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
33143950|NCT03729362|100441620|FG000|Overall Study|Adverse Event|0|||
33143951|NCT03729362|100441621|FG001|Overall Study|Adverse Event|1|||
33143952|NCT03729362|100441620|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
33143953|NCT03729362|100441621|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
33143954|NCT03355664|100441622|FG000|Overall Study|Adverse Event|1|||
33143955|NCT03355664|100441623|FG001|Overall Study|Adverse Event|2|||
33143956|NCT03355664|100441622|FG000|Overall Study|Lost to Follow-up|11|||
33143957|NCT03355664|100441623|FG001|Overall Study|Lost to Follow-up|7|||
33143958|NCT03355664|100441622|FG000|Overall Study|Protocol Violation|1|||
33143959|NCT03355664|100441623|FG001|Overall Study|Protocol Violation|2|||
33143960|NCT03355664|100441622|FG000|Overall Study|Withdrawal by Subject|2|||
33143961|NCT03355664|100441623|FG001|Overall Study|Withdrawal by Subject|1|||
33143962|NCT00249288|100441624|FG000|Overall Study|Lost to Follow-up|3|||
33143963|NCT00249288|100441625|FG001|Overall Study|Lost to Follow-up|3|||
33143964|NCT00249288|100441624|FG000|Overall Study|Withdrawal by Subject|2|||
33143965|NCT00249288|100441625|FG001|Overall Study|Withdrawal by Subject|2|||
33143966|NCT02325791|100441632|FG000|Overall Study|Adverse Event|0|||
33143967|NCT02325791|100441633|FG001|Overall Study|Adverse Event|1|||
33143968|NCT02325791|100441634|FG002|Overall Study|Adverse Event|1|||
33143969|NCT02325791|100441635|FG003|Overall Study|Adverse Event|0|||
33143970|NCT02325791|100441632|FG000|Overall Study|Death|0|||
33143971|NCT02325791|100441633|FG001|Overall Study|Death|3|||
33143972|NCT02325791|100441634|FG002|Overall Study|Death|0|||
33143973|NCT02325791|100441635|FG003|Overall Study|Death|1|||
33143974|NCT02325791|100441632|FG000|Overall Study|Lost to Follow-up|0|||
33143975|NCT02325791|100441633|FG001|Overall Study|Lost to Follow-up|15|||
33143976|NCT02325791|100441634|FG002|Overall Study|Lost to Follow-up|14|||
33143977|NCT02325791|100441635|FG003|Overall Study|Lost to Follow-up|9|||
33143978|NCT02325791|100441632|FG000|Overall Study|Physician Decision|0|||
33143979|NCT02325791|100441633|FG001|Overall Study|Physician Decision|1|||
33143980|NCT02325791|100441634|FG002|Overall Study|Physician Decision|1|||
33143981|NCT02325791|100441635|FG003|Overall Study|Physician Decision|0|||
33143982|NCT02325791|100441632|FG000|Overall Study|Protocol Violation|0|||
33143983|NCT02325791|100441633|FG001|Overall Study|Protocol Violation|0|||
33143984|NCT02325791|100441634|FG002|Overall Study|Protocol Violation|1|||
33143985|NCT02325791|100441635|FG003|Overall Study|Protocol Violation|0|||
33143986|NCT02325791|100441632|FG000|Overall Study|Withdrawal by Subject|0|||
33143987|NCT02325791|100441633|FG001|Overall Study|Withdrawal by Subject|5|||
33421706|NCT02030834|101434900|FG000|Overall Study|Disease progression|2|||
33421707|NCT02030834|101434901|FG001|Overall Study|Disease progression|0|||
33421708|NCT02030834|101434902|FG002|Overall Study|Disease progression|2|||
33421709|NCT02030834|101434900|FG000|Overall Study|Lost to Follow-up|1|||
33421710|NCT02030834|101434901|FG001|Overall Study|Lost to Follow-up|0|||
33143988|NCT02325791|100441634|FG002|Overall Study|Withdrawal by Subject|8|||
33143989|NCT02325791|100441635|FG003|Overall Study|Withdrawal by Subject|16|||
33143990|NCT01117792|100441641|FG000|Overall Study|Death|1|||
33143991|NCT01117792|100441641|FG000|Overall Study|Adverse Event|3|||
33143992|NCT00814879|100441642|FG000|By Week 24|Cancer Diagnosis|1|||
33143993|NCT00814879|100441643|FG001|By Week 24|Cancer Diagnosis|0|||
33143994|NCT00814879|100441642|FG000|By Week 24|Incarceration|0|||
33143995|NCT00814879|100441643|FG001|By Week 24|Incarceration|1|||
33421711|NCT02030834|101434902|FG002|Overall Study|Lost to Follow-up|0|||
33143996|NCT00814879|100441642|FG000|By Week 48|Lost to Follow-up|2|||
33143997|NCT00814879|100441643|FG001|By Week 48|Lost to Follow-up|2|||
33143998|NCT00814879|100441642|FG000|By Week 48|Death|0|||
33143999|NCT00814879|100441643|FG001|By Week 48|Death|1|||
33144000|NCT00910247|100441644|FG000|Overall Study|Adverse Event|15|||
33144001|NCT00910247|100441644|FG000|Overall Study|Death|2|||
33144002|NCT00910247|100441644|FG000|Overall Study|Lost to Follow-up|10|||
33421712|NCT02030834|101434900|FG000|Overall Study|Withdrawal by Subject|1|||
33421713|NCT02030834|101434901|FG001|Overall Study|Withdrawal by Subject|0|||
33144003|NCT00910247|100441644|FG000|Overall Study|Physician Decision|3|||
33144004|NCT00910247|100441644|FG000|Overall Study|Protocol Violation|10|||
33144005|NCT00910247|100441644|FG000|Overall Study|Withdrawal by Subject|25|||
33144006|NCT00910247|100441644|FG000|Overall Study|Not collected|4|||
33144007|NCT04322539|100441646|FG000|Overall Study|Withdrawal of consent|14|||
33144008|NCT04322539|100441647|FG001|Overall Study|Withdrawal of consent|8|||
33144009|NCT04322539|100441646|FG000|Overall Study|Death|317|||
33144010|NCT04322539|100441647|FG001|Overall Study|Death|173|||
33371773|NCT02632110|101247549|FG002|Overall Study|Withdrawal by Subject|0|||
33371774|NCT02632110|101247550|FG003|Overall Study|Withdrawal by Subject|0|||
33371775|NCT02632110|101247551|FG004|Overall Study|Withdrawal by Subject|1|||
33371776|NCT02632110|101247552|FG005|Overall Study|Withdrawal by Subject|1|||
33371777|NCT02632110|101247553|FG006|Overall Study|Withdrawal by Subject|3|||
33642250|NCT00101452|102240329|FG001|Overall Study|Withdrawal by Subject|14|||
33642251|NCT00101452|102240330|FG002|Overall Study|Withdrawal by Subject|9|||
33642252|NCT00101452|102240328|FG000|Overall Study|Baseline Fail|2|||
33642253|NCT00101452|102240329|FG001|Overall Study|Baseline Fail|1|||
33642254|NCT00101452|102240330|FG002|Overall Study|Baseline Fail|2|||
33642255|NCT00101452|102240328|FG000|Overall Study|Physician Decision|0|||
33642256|NCT00101452|102240329|FG001|Overall Study|Physician Decision|3|||
33642257|NCT00101452|102240330|FG002|Overall Study|Physician Decision|2|||
33642258|NCT00101452|102240328|FG000|Overall Study|Protocol Violation|2|||
33642259|NCT00101452|102240329|FG001|Overall Study|Protocol Violation|1|||
33642260|NCT00101452|102240330|FG002|Overall Study|Protocol Violation|3|||
33642261|NCT00101452|102240328|FG000|Overall Study|Other|15|||
33642262|NCT00101452|102240329|FG001|Overall Study|Other|16|||
33642263|NCT00101452|102240330|FG002|Overall Study|Other|12|||
33642264|NCT00774566|102240331|FG000|Overall Study|Protocol Violation|18|||
33642265|NCT00774566|102240332|FG001|Overall Study|Protocol Violation|15|||
33642266|NCT02974543|102240333|FG000|Overall Study|Withdrawal by Subject|1|||
33642267|NCT02974543|102240334|FG001|Overall Study|Withdrawal by Subject|0|||
33642268|NCT00865280|102240337|FG000|Overall Study|Withdrawal by Subject|4|||
33642269|NCT00865280|102240338|FG001|Overall Study|Withdrawal by Subject|1|||
33642270|NCT00865280|102240337|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
33642271|NCT00865280|102240338|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
33642272|NCT00865280|102240337|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
33642273|NCT00865280|102240338|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
33642274|NCT00865280|102240337|FG000|Overall Study|Exclusion Condition|1|||
33642275|NCT00865280|102240338|FG001|Overall Study|Exclusion Condition|0|||
33642276|NCT00865280|102240337|FG000|Overall Study|Adverse Event|0|||
33642277|NCT00865280|102240338|FG001|Overall Study|Adverse Event|1|||
33642278|NCT01411891|102240347|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
33642279|NCT01411891|102240348|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
33642280|NCT03313037|102240349|FG000|Overall Study|Protocol Violation|4|||
33642281|NCT03313037|102240350|FG001|Overall Study|Protocol Violation|1|||
33642282|NCT03313037|102240349|FG000|Overall Study|Other|1|||
33642283|NCT03313037|102240350|FG001|Overall Study|Other|1|||
33642284|NCT03313037|102240349|FG000|Overall Study|Withdrawal by Subject|4|||
33642285|NCT03313037|102240350|FG001|Overall Study|Withdrawal by Subject|3|||
33642286|NCT03313037|102240349|FG000|Overall Study|No longer meets eligibility criteria|1|||
33642287|NCT03313037|102240350|FG001|Overall Study|No longer meets eligibility criteria|7|||
33642288|NCT03313037|102240349|FG000|Overall Study|Lost to Follow-up|9|||
33642289|NCT03313037|102240350|FG001|Overall Study|Lost to Follow-up|8|||
33642290|NCT03313037|102240349|FG000|Overall Study|Randomized but not treated|1|||
33642291|NCT03313037|102240350|FG001|Overall Study|Randomized but not treated|0|||
33642292|NCT00975780|102240351|FG000|Follow Up|Death|88|||
33642293|NCT00975780|102240352|FG001|Follow Up|Death|122|||
33144011|NCT04322539|100441646|FG000|Overall Study|Adverse Event|1|||
33144012|NCT04322539|100441647|FG001|Overall Study|Adverse Event|0|||
33144013|NCT04322539|100441646|FG000|Overall Study|Lost to Follow-up|3|||
33371778|NCT02632110|101247554|FG007|Overall Study|Withdrawal by Subject|3|||
33642294|NCT00975780|102240351|FG000|Follow Up|Facility Withdrawal|7|||
33642295|NCT00975780|102240352|FG001|Follow Up|Facility Withdrawal|23|||
33642296|NCT00975780|102240351|FG000|Follow Up|Discharged from Facility|7|||
33642297|NCT00975780|102240352|FG001|Follow Up|Discharged from Facility|12|||
33642298|NCT01500720|102240353|FG000|Overall Study|Randomized But Not Treated|1|||
33371779|NCT02632110|101247555|FG008|Overall Study|Withdrawal by Subject|1|||
33642299|NCT01500720|102240354|FG001|Overall Study|Randomized But Not Treated|1|||
33642300|NCT01500720|102240353|FG000|Overall Study|Other|4|||
33371780|NCT02632110|101247556|FG009|Overall Study|Withdrawal by Subject|1|||
33642301|NCT01500720|102240354|FG001|Overall Study|Other|8|||
33642302|NCT03037580|102244013|FG000|Overall Study|Withdrawal by Subject|3|||
33642303|NCT03037580|102244014|FG001|Overall Study|Withdrawal by Subject|0|||
33642304|NCT03037580|102244013|FG000|Overall Study|Adverse Event|1|||
33642305|NCT03037580|102244014|FG001|Overall Study|Adverse Event|0|||
33642306|NCT03037580|102244013|FG000|Overall Study|Study Terminated by Sponsor|12|||
33642307|NCT03037580|102244014|FG001|Overall Study|Study Terminated by Sponsor|15|||
33642308|NCT03037580|102244013|FG000|Overall Study|Death|0|||
33144014|NCT04322539|100441647|FG001|Overall Study|Lost to Follow-up|0|||
33144015|NCT04322539|100441646|FG000|Overall Study|Other|2|||
33144016|NCT04322539|100441647|FG001|Overall Study|Other|3|||
33144017|NCT04322539|100441646|FG000|Overall Study|Ongoing|124|||
33144018|NCT04322539|100441647|FG001|Overall Study|Ongoing|46|||
33144019|NCT03860935|100441649|FG000|Overall Study|Withdrawal of Consent|15|||
33144020|NCT03860935|100441650|FG001|Overall Study|Withdrawal of Consent|6|||
33144021|NCT03860935|100441649|FG000|Overall Study|Death|75|||
33144022|NCT03860935|100441650|FG001|Overall Study|Death|51|||
33144023|NCT02054481|100441655|FG000|Overall Study|Adverse Event|1|||
33144024|NCT02054481|100441656|FG001|Overall Study|Adverse Event|1|||
33144025|NCT02054481|100441657|FG002|Overall Study|Adverse Event|0|||
33144026|NCT02054481|100441658|FG003|Overall Study|Adverse Event|1|||
33144027|NCT02054481|100441655|FG000|Overall Study|Lost to Follow-up|1|||
33144028|NCT02054481|100441656|FG001|Overall Study|Lost to Follow-up|0|||
33144029|NCT02054481|100441657|FG002|Overall Study|Lost to Follow-up|0|||
33144030|NCT02054481|100441658|FG003|Overall Study|Lost to Follow-up|0|||
33144031|NCT02054481|100441655|FG000|Overall Study|Other reason|2|||
33144032|NCT02054481|100441656|FG001|Overall Study|Other reason|1|||
33144033|NCT02054481|100441657|FG002|Overall Study|Other reason|2|||
33144034|NCT02054481|100441658|FG003|Overall Study|Other reason|0|||
33144035|NCT01347580|100441659|FG000|Overall Study|Withdrawal by Subject|13|||
33144036|NCT01347580|100441660|FG001|Overall Study|Withdrawal by Subject|23|||
33144037|NCT01347580|100441659|FG000|Overall Study|Death|30|||
33144038|NCT01347580|100441660|FG001|Overall Study|Death|19|||
33144039|NCT01347580|100441659|FG000|Overall Study|Protocol Violation|10|||
33144040|NCT01347580|100441660|FG001|Overall Study|Protocol Violation|7|||
33144041|NCT01347580|100441659|FG000|Overall Study|Lost to Follow-up|3|||
33144042|NCT01347580|100441660|FG001|Overall Study|Lost to Follow-up|1|||
33144043|NCT01347580|100441659|FG000|Overall Study|Had other reason|9|||
33144044|NCT01347580|100441660|FG001|Overall Study|Had other reason|6|||
33144045|NCT02093026|100441661|FG000|Overall Study|Adverse Event|26|||
33144046|NCT02093026|100441661|FG000|Overall Study|Death|10|||
33144047|NCT02093026|100441661|FG000|Overall Study|Other|157|||
33144048|NCT00366340|100441662|FG000|Infant Series|Protocol Violation|3|||
33144049|NCT00366340|100441663|FG001|Infant Series|Protocol Violation|4|||
33144050|NCT00366340|100441662|FG000|Infant Series|Withdrawal by Subject|3|||
33144051|NCT00366340|100441663|FG001|Infant Series|Withdrawal by Subject|3|||
33144052|NCT00366340|100441662|FG000|Infant Series|Adverse Event|0|||
33144053|NCT00366340|100441663|FG001|Infant Series|Adverse Event|2|||
33144054|NCT00366340|100441662|FG000|Infant Series|Lost to Follow-up|1|||
33144055|NCT00366340|100441663|FG001|Infant Series|Lost to Follow-up|1|||
33144056|NCT00366340|100441662|FG000|Infant Series|Failure to return|1|||
33144057|NCT00366340|100441663|FG001|Infant Series|Failure to return|0|||
33144058|NCT00366340|100441662|FG000|After the Infant Series|Parent/legal guardian request|1|||
33144059|NCT00366340|100441663|FG001|After the Infant Series|Parent/legal guardian request|1|||
33144060|NCT00366340|100441662|FG000|After the Infant Series|Failed to return|0|||
33144061|NCT00366340|100441663|FG001|After the Infant Series|Failed to return|1|||
33144062|NCT00366340|100441662|FG000|After the Infant Series|Protocol Violation|2|||
33144063|NCT00366340|100441663|FG001|After the Infant Series|Protocol Violation|2|||
33144064|NCT00366340|100441662|FG000|After the Infant Series|Adverse Event|0|||
33144065|NCT00366340|100441663|FG001|After the Infant Series|Adverse Event|1|||
33144066|NCT00366340|100441662|FG000|After the Infant Series|Lost to Follow-up|0|||
33144067|NCT00366340|100441663|FG001|After the Infant Series|Lost to Follow-up|1|||
33144068|NCT00366340|100441662|FG000|Toddler Dose|Failed to return|1|||
33144069|NCT00366340|100441663|FG001|Toddler Dose|Failed to return|0|||
33144070|NCT00366340|100441662|FG000|Toddler Dose|Parent/legal guardian request|0|||
33144071|NCT00366340|100441663|FG001|Toddler Dose|Parent/legal guardian request|1|||
33144072|NCT00873860|100441664|FG000|Overall Study|Lost to Follow-up|1|||
33144073|NCT00873860|100441665|FG001|Overall Study|Lost to Follow-up|0|||
33144074|NCT00873860|100441666|FG002|Overall Study|Lost to Follow-up|0|||
33144075|NCT00873860|100441667|FG003|Overall Study|Lost to Follow-up|1|||
33144076|NCT00873860|100441664|FG000|Overall Study|Withdrawal by Subject|1|||
33371781|NCT02596711|101247557|FG000|Overall Study|Lost to Follow-up|1|||
33371782|NCT02596711|101247558|FG001|Overall Study|Lost to Follow-up|2|||
33144077|NCT00873860|100441665|FG001|Overall Study|Withdrawal by Subject|0|||
33242443|NCT01369355|100789040|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
33371783|NCT02596711|101247559|FG002|Overall Study|Lost to Follow-up|3|||
33371784|NCT00408421|101247560|FG000|Treatment Initial Randomization|Adverse Event|5|||
33371785|NCT00408421|101247561|FG001|Treatment Initial Randomization|Adverse Event|9|||
33144078|NCT00873860|100441666|FG002|Overall Study|Withdrawal by Subject|2|||
33144079|NCT00873860|100441667|FG003|Overall Study|Withdrawal by Subject|0|||
33144080|NCT00873860|100441664|FG000|Overall Study|Death|1|||
33144081|NCT00873860|100441665|FG001|Overall Study|Death|0|||
33242444|NCT01369355|100789041|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
33144082|NCT00873860|100441666|FG002|Overall Study|Death|0|||
33144083|NCT00873860|100441667|FG003|Overall Study|Death|0|||
33144084|NCT00873860|100441664|FG000|Overall Study|Other|1|||
33144085|NCT00873860|100441665|FG001|Overall Study|Other|0|||
33421714|NCT02030834|101434902|FG002|Overall Study|Withdrawal by Subject|0|||
33421715|NCT02030834|101434900|FG000|Overall Study|Lack of funding|1|||
33421716|NCT02030834|101434901|FG001|Overall Study|Lack of funding|0|||
33421717|NCT02030834|101434902|FG002|Overall Study|Lack of funding|0|||
33421718|NCT00103259|101434905|FG000|Overall Study|Death|3|||
33421719|NCT00103259|101434906|FG001|Overall Study|Death|2|||
33421720|NCT00103259|101434905|FG000|Overall Study|Withdrawal by Subject|2|||
33642309|NCT03037580|102244014|FG001|Overall Study|Death|1|||
33642310|NCT03083873|102244015|FG000|Overall Study|Death|6|||
33642311|NCT03083873|102244016|FG001|Overall Study|Death|15|||
33642312|NCT03083873|102244017|FG002|Overall Study|Death|13|||
33642313|NCT03083873|102244018|FG003|Overall Study|Death|9|||
33642314|NCT03083873|102244019|FG004|Overall Study|Death|0|||
33642315|NCT03083873|102244015|FG000|Overall Study|Sponsor Terminated Study|0|||
33642316|NCT03083873|102244016|FG001|Overall Study|Sponsor Terminated Study|1|||
33642317|NCT03083873|102244017|FG002|Overall Study|Sponsor Terminated Study|2|||
33642318|NCT03083873|102244018|FG003|Overall Study|Sponsor Terminated Study|3|||
33642319|NCT03083873|102244019|FG004|Overall Study|Sponsor Terminated Study|0|||
33642320|NCT03083873|102244015|FG000|Overall Study|Lost to Follow-up|0|||
33642321|NCT03083873|102244016|FG001|Overall Study|Lost to Follow-up|1|||
33642322|NCT03083873|102244017|FG002|Overall Study|Lost to Follow-up|1|||
33642323|NCT03083873|102244018|FG003|Overall Study|Lost to Follow-up|0|||
33642324|NCT03083873|102244019|FG004|Overall Study|Lost to Follow-up|0|||
33642325|NCT03083873|102244015|FG000|Overall Study|Withdrawal by Subject|2|||
33642326|NCT03083873|102244016|FG001|Overall Study|Withdrawal by Subject|0|||
33642327|NCT03083873|102244017|FG002|Overall Study|Withdrawal by Subject|0|||
33642328|NCT03083873|102244018|FG003|Overall Study|Withdrawal by Subject|0|||
33642329|NCT03083873|102244019|FG004|Overall Study|Withdrawal by Subject|0|||
33642330|NCT03083873|102244015|FG000|Overall Study|Did Not Receive TIL|2|||
33642331|NCT03083873|102244016|FG001|Overall Study|Did Not Receive TIL|5|||
33642332|NCT03083873|102244017|FG002|Overall Study|Did Not Receive TIL|3|||
33642333|NCT03083873|102244018|FG003|Overall Study|Did Not Receive TIL|1|||
33642334|NCT03083873|102244019|FG004|Overall Study|Did Not Receive TIL|0|||
33642335|NCT02280408|102244020|FG000|Overall Study|Lost to Follow-up|0|||
33642336|NCT02280408|102244021|FG001|Overall Study|Lost to Follow-up|2|||
33642337|NCT02280408|102244022|FG002|Overall Study|Lost to Follow-up|0|||
33642338|NCT02280408|102244023|FG003|Overall Study|Lost to Follow-up|0|||
33642339|NCT02533453|102244024|FG000|Overall Study|Adverse Event|6|||
33642340|NCT02533453|102244024|FG000|Overall Study|Protocol Violation|1|||
33642341|NCT02533453|102244024|FG000|Overall Study|Withdrawal by Subject|2|||
33642342|NCT00074490|102244026|FG000|Overall Study|Progressive malignancy|0|||
33642343|NCT00074490|102244027|FG001|Overall Study|Progressive malignancy|7|||
33642344|NCT00074490|102244028|FG002|Overall Study|Progressive malignancy|0|||
33642345|NCT00074490|102244029|FG003|Overall Study|Progressive malignancy|0|||
33642346|NCT00074490|102244030|FG004|Overall Study|Progressive malignancy|3|||
33642347|NCT00074490|102244031|FG005|Overall Study|Progressive malignancy|0|||
33642348|NCT00787267|102244032|FG000|Overall Study|Screen failure/Ineligible|10|||
33642349|NCT00787267|102244032|FG000|Overall Study|No Reason Provided|1|||
33642350|NCT00787267|102244032|FG000|Overall Study|Withdrawal by Subject|1|||
33642351|NCT02888119|102244033|FG000|Overall Study|Lost to Follow-up|5|||
33642352|NCT02888119|102244034|FG001|Overall Study|Lost to Follow-up|4|||
33642353|NCT02888119|102244035|FG002|Overall Study|Lost to Follow-up|0|||
33642354|NCT01621802|102244041|FG000|Overall Study|Protocol Violation|0|||
33642355|NCT01621802|102244042|FG001|Overall Study|Protocol Violation|0|||
33642356|NCT01621802|102244043|FG002|Overall Study|Protocol Violation|0|||
33642357|NCT01621802|102244044|FG003|Overall Study|Protocol Violation|0|||
33642358|NCT01621802|102244045|FG004|Overall Study|Protocol Violation|0|||
33642359|NCT01621802|102244046|FG005|Overall Study|Protocol Violation|1|||
33642360|NCT01621802|102244041|FG000|Overall Study|Withdrawal by Subject|8|||
33642361|NCT01621802|102244042|FG001|Overall Study|Withdrawal by Subject|4|||
33421721|NCT00103259|101434906|FG001|Overall Study|Withdrawal by Subject|3|||
33421722|NCT00103259|101434905|FG000|Overall Study|alternative therapy|1|||
33421723|NCT00103259|101434906|FG001|Overall Study|alternative therapy|0|||
33642362|NCT01621802|102244043|FG002|Overall Study|Withdrawal by Subject|4|||
33642363|NCT01621802|102244044|FG003|Overall Study|Withdrawal by Subject|2|||
33421724|NCT00103259|101434905|FG000|Overall Study|other (reasons were not specified)|2|||
33421725|NCT00103259|101434906|FG001|Overall Study|other (reasons were not specified)|1|||
33642364|NCT01621802|102244045|FG004|Overall Study|Withdrawal by Subject|2|||
33642365|NCT01621802|102244046|FG005|Overall Study|Withdrawal by Subject|0|||
33642366|NCT01621802|102244041|FG000|Overall Study|Migrated/moved from study area|0|||
33642367|NCT01621802|102244042|FG001|Overall Study|Migrated/moved from study area|0|||
33642368|NCT01621802|102244043|FG002|Overall Study|Migrated/moved from study area|2|||
33642369|NCT01621802|102244044|FG003|Overall Study|Migrated/moved from study area|0|||
33642370|NCT01621802|102244045|FG004|Overall Study|Migrated/moved from study area|1|||
33642371|NCT01621802|102244046|FG005|Overall Study|Migrated/moved from study area|0|||
33642372|NCT01621802|102244041|FG000|Overall Study|Others|3|||
33642373|NCT01621802|102244042|FG001|Overall Study|Others|3|||
33642374|NCT01621802|102244043|FG002|Overall Study|Others|3|||
33642375|NCT01621802|102244044|FG003|Overall Study|Others|2|||
33421726|NCT00103259|101434905|FG000|Overall Study|ineligible/no protocol therapy|4|||
33421727|NCT00103259|101434906|FG001|Overall Study|ineligible/no protocol therapy|6|||
33421728|NCT04098068|101434907|FG000|Overall Study|Disease Progression|7|||
33421729|NCT04098068|101434907|FG000|Overall Study|Withdrawal by Subject|2|||
33421730|NCT04098068|101434907|FG000|Overall Study|New Cancer Diagnosis|1|||
33421731|NCT03078192|101434908|FG000|Overall Study|Withdrawal by Subject|2|||
33144086|NCT00873860|100441666|FG002|Overall Study|Other|1|||
33144087|NCT00873860|100441667|FG003|Overall Study|Other|0|||
33144088|NCT01850602|100441668|FG000|Overall Study|Adverse Event|7|||
33144089|NCT01850602|100441669|FG001|Overall Study|Adverse Event|10|||
33144090|NCT01850602|100441668|FG000|Overall Study|Physician Decision|2|||
33144091|NCT01850602|100441669|FG001|Overall Study|Physician Decision|1|||
33144092|NCT01850602|100441668|FG000|Overall Study|Withdrawal by Subject|2|||
33144093|NCT01850602|100441669|FG001|Overall Study|Withdrawal by Subject|4|||
33144094|NCT01850602|100441668|FG000|Overall Study|Decrease in serum calcium|2|||
33144095|NCT01850602|100441669|FG001|Overall Study|Decrease in serum calcium|3|||
33144096|NCT01850602|100441668|FG000|Overall Study|Increase in serum ferritin|1|||
33144097|NCT01850602|100441669|FG001|Overall Study|Increase in serum ferritin|0|||
33421732|NCT03078192|101434909|FG001|Overall Study|Withdrawal by Subject|1|||
33421733|NCT03078192|101434908|FG000|Overall Study|screen failure|0|||
33421734|NCT03078192|101434909|FG001|Overall Study|screen failure|3|||
33144098|NCT00378079|100441671|FG000|Overall Study|Lost to Follow-up|6|||
33421735|NCT02623426|101434910|FG000|Overall Study|Lost to Follow-up|0|||
33421736|NCT02623426|101434911|FG001|Overall Study|Lost to Follow-up|0|||
33421737|NCT02623426|101434912|FG002|Overall Study|Lost to Follow-up|1|||
33421738|NCT02623426|101434910|FG000|Overall Study|Withdrawal by Subject|1|||
33421739|NCT02623426|101434911|FG001|Overall Study|Withdrawal by Subject|2|||
33421740|NCT02623426|101434912|FG002|Overall Study|Withdrawal by Subject|2|||
33421741|NCT01585831|101434913|FG000|Overall Study|Physician Decision|0|||
33421742|NCT01585831|101434914|FG001|Overall Study|Physician Decision|1|||
33581705|NCT01340664|102020180|FG000|Overall Study|Lost to Follow-up|2|||
33581706|NCT01340664|102020181|FG001|Overall Study|Lost to Follow-up|0|||
33581707|NCT01340664|102020182|FG002|Overall Study|Lost to Follow-up|2|||
33581708|NCT01340664|102020180|FG000|Overall Study|Withdrawal by Subject|2|||
33581709|NCT01340664|102020181|FG001|Overall Study|Withdrawal by Subject|4|||
33581710|NCT01340664|102020182|FG002|Overall Study|Withdrawal by Subject|0|||
33581711|NCT01340664|102020180|FG000|Overall Study|Glycemic withdrawal criteria|2|||
33581712|NCT01340664|102020181|FG001|Overall Study|Glycemic withdrawal criteria|0|||
33581713|NCT01340664|102020182|FG002|Overall Study|Glycemic withdrawal criteria|0|||
33581714|NCT01340664|102020180|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
33144099|NCT00378079|100441672|FG001|Overall Study|Lost to Follow-up|1|||
33144100|NCT00378079|100441673|FG002|Overall Study|Lost to Follow-up|0|||
33144101|NCT00718081|100441674|FG000|Overall Study|Adverse Event|0|||
33581715|NCT01340664|102020181|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
33144102|NCT00718081|100441675|FG001|Overall Study|Adverse Event|1|||
33144103|NCT00718081|100441676|FG002|Overall Study|Adverse Event|0|||
33581716|NCT01340664|102020182|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
33581717|NCT01340664|102020180|FG000|Overall Study|Other|1|||
33581718|NCT01340664|102020181|FG001|Overall Study|Other|2|||
33581719|NCT01340664|102020182|FG002|Overall Study|Other|2|||
33581720|NCT01119443|102020183|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
33581721|NCT01119443|102020184|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
33581722|NCT01635998|102020188|FG000|Overall Study|Death|1|||
33581723|NCT01635998|102020189|FG001|Overall Study|Death|1|||
33581724|NCT01635998|102020188|FG000|Overall Study|Lost to Follow-up|2|||
33144104|NCT00718081|100441674|FG000|Overall Study|Lack of Efficacy|7|||
33144105|NCT00718081|100441675|FG001|Overall Study|Lack of Efficacy|3|||
33144106|NCT00718081|100441676|FG002|Overall Study|Lack of Efficacy|21|||
33421743|NCT01585831|101434913|FG000|Overall Study|Withdrawal by Subject|2|||
33421744|NCT01585831|101434914|FG001|Overall Study|Withdrawal by Subject|1|||
33421745|NCT02602080|101434929|FG000|Overall Study|Protocol Violation|6|||
33421746|NCT02602080|101434930|FG001|Overall Study|Protocol Violation|1|||
33421747|NCT02602080|101434931|FG002|Overall Study|Protocol Violation|3|||
33421748|NCT03216954|101434932|FG000|Overall Study|Adverse Event|0|||
33421749|NCT03216954|101434933|FG001|Overall Study|Adverse Event|0|||
33421750|NCT03216954|101434934|FG002|Overall Study|Adverse Event|1|||
33421751|NCT03216954|101434935|FG003|Overall Study|Adverse Event|0|||
33144107|NCT01056380|100441677|FG000|Overall Study|Lost to Follow-up|2|||
33144108|NCT01056380|100441678|FG001|Overall Study|Lost to Follow-up|3|||
33421752|NCT03216954|101434936|FG004|Overall Study|Adverse Event|1|||
33421753|NCT03216954|101434932|FG000|Overall Study|Withdrawal by Subject|2|||
33581725|NCT01635998|102020189|FG001|Overall Study|Lost to Follow-up|1|||
33144109|NCT04352127|100441680|FG000|Overall Study|Unable to obtain readings|4|||
33144110|NCT04352127|100441681|FG001|Overall Study|Unable to obtain readings|1|||
33144111|NCT01017575|100441682|FG000|Overall Study|Lack of Efficacy|0|||
33144112|NCT01017575|100441683|FG001|Overall Study|Lack of Efficacy|1|||
33581726|NCT01635998|102020188|FG000|Overall Study|Withdrawal by Subject|1|||
33144113|NCT01017575|100441684|FG002|Overall Study|Lack of Efficacy|0|||
33144114|NCT01017575|100441685|FG003|Overall Study|Lack of Efficacy|1|||
33144115|NCT01017575|100441686|FG004|Overall Study|Lack of Efficacy|1|||
33144116|NCT01017575|100441682|FG000|Overall Study|Adverse Event|0|||
33144117|NCT01017575|100441683|FG001|Overall Study|Adverse Event|1|||
33144118|NCT01017575|100441684|FG002|Overall Study|Adverse Event|0|||
33144119|NCT01017575|100441685|FG003|Overall Study|Adverse Event|0|||
33144120|NCT01017575|100441686|FG004|Overall Study|Adverse Event|2|||
33144121|NCT01017575|100441682|FG000|Overall Study|Withdrawal by Subject|1|||
33144122|NCT01017575|100441683|FG001|Overall Study|Withdrawal by Subject|0|||
33144123|NCT01017575|100441684|FG002|Overall Study|Withdrawal by Subject|0|||
33144124|NCT01017575|100441685|FG003|Overall Study|Withdrawal by Subject|0|||
33144125|NCT01017575|100441686|FG004|Overall Study|Withdrawal by Subject|0|||
33144126|NCT03891667|100441687|FG000|Overall Study|Physician Decision|1|||
33144127|NCT03891667|100441688|FG001|Overall Study|Physician Decision|0|||
33144128|NCT03891667|100441687|FG000|Overall Study|COVID related pause|1|||
33144129|NCT03891667|100441688|FG001|Overall Study|COVID related pause|1|||
33144130|NCT03891667|100441687|FG000|Overall Study|Withdrawal by Subject|0|||
33144131|NCT03891667|100441688|FG001|Overall Study|Withdrawal by Subject|1|||
33144132|NCT03891667|100441687|FG000|Overall Study|Adverse Event|0|||
33144133|NCT03891667|100441688|FG001|Overall Study|Adverse Event|1|||
33144134|NCT01467427|100441694|FG000|Overall Study|Withdrawal by Subject|1|||
33144135|NCT01467427|100441695|FG001|Overall Study|Withdrawal by Subject|0|||
33144136|NCT01467427|100441694|FG000|Overall Study|Entered extension phase|11|||
33144137|NCT01467427|100441695|FG001|Overall Study|Entered extension phase|11|||
33144138|NCT01467427|100441694|FG000|Overall Study|Not continuing in extension phase|0|||
33144139|NCT01467427|100441695|FG001|Overall Study|Not continuing in extension phase|2|||
33144140|NCT02446743|100441702|FG000|Overall Study|Withdrawal by Subject|1|||
33144141|NCT02446743|100441703|FG001|Overall Study|Withdrawal by Subject|1|||
33144142|NCT02446743|100441702|FG000|Overall Study|Lost to Follow-up|1|||
33144143|NCT02446743|100441703|FG001|Overall Study|Lost to Follow-up|0|||
33144144|NCT02446743|100441702|FG000|Overall Study|Adverse Event|1|||
33144145|NCT02446743|100441703|FG001|Overall Study|Adverse Event|1|||
33144146|NCT02446743|100441702|FG000|Overall Study|Other|2|||
33144147|NCT02446743|100441703|FG001|Overall Study|Other|3|||
33144148|NCT05342532|100441706|FG000|Overall Study|Adverse Event|5|||
33144149|NCT05342532|100441707|FG001|Overall Study|Adverse Event|20|||
33144150|NCT05342532|100441706|FG000|Overall Study|Lost to Follow-up|10|||
33144151|NCT05342532|100441707|FG001|Overall Study|Lost to Follow-up|15|||
33144152|NCT01476644|100441710|FG000|Overall Study|Death|5|||
33144153|NCT01476644|100441710|FG000|Overall Study|moved to another state|2|||
33144154|NCT01476644|100441710|FG000|Overall Study|Lost to Follow-up|19|||
33144155|NCT01476644|100441710|FG000|Overall Study|Withdrawal by Subject|13|||
33144156|NCT03500679|100441711|FG000|Overall Study|Lost to Follow-up|6|||
33144157|NCT03500679|100441712|FG001|Overall Study|Lost to Follow-up|3|||
33144158|NCT03500679|100441711|FG000|Overall Study|Withdrawal by Subject|3|||
33144159|NCT03500679|100441712|FG001|Overall Study|Withdrawal by Subject|0|||
33144160|NCT01514370|100441719|FG000|Overall Study|Protocol Violation|2|||
33144161|NCT01514370|100441720|FG001|Overall Study|Protocol Violation|3|||
33144162|NCT01514370|100441719|FG000|Overall Study|Lost to Follow-up|0|||
33242445|NCT01369355|100789042|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
33144163|NCT01514370|100441720|FG001|Overall Study|Lost to Follow-up|2|||
33144164|NCT01514370|100441719|FG000|Overall Study|Withdrawal by Subject|2|||
33144165|NCT01514370|100441720|FG001|Overall Study|Withdrawal by Subject|1|||
33144166|NCT01514370|100441719|FG000|Overall Study|Adverse Event|1|||
33144167|NCT01514370|100441720|FG001|Overall Study|Adverse Event|3|||
33144168|NCT01514370|100441719|FG000|Overall Study|Other|6|||
33144169|NCT01514370|100441720|FG001|Overall Study|Other|7|||
33144170|NCT00761150|100441721|FG000|Open-label Period|Adverse Event|36|||
33144171|NCT00761150|100441722|FG001|Open-label Period|Adverse Event|0|||
33144172|NCT00761150|100441723|FG002|Open-label Period|Adverse Event|0|||
33144173|NCT00761150|100441721|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
33144174|NCT00761150|100441722|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
33144175|NCT00761150|100441723|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
33242446|NCT01369355|100789043|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
33371786|NCT00408421|101247562|FG002|Treatment Initial Randomization|Adverse Event|0|||
33371787|NCT00408421|101247560|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
33371788|NCT00408421|101247561|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
33371789|NCT00408421|101247562|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
33144176|NCT00761150|100441721|FG000|Open-label Period|Lost to Follow-up|7|||
33144177|NCT00761150|100441722|FG001|Open-label Period|Lost to Follow-up|0|||
33144178|NCT00761150|100441723|FG002|Open-label Period|Lost to Follow-up|0|||
33144179|NCT00761150|100441721|FG000|Open-label Period|Lack of Efficacy|4|||
33144180|NCT00761150|100441722|FG001|Open-label Period|Lack of Efficacy|0|||
33144181|NCT00761150|100441723|FG002|Open-label Period|Lack of Efficacy|0|||
33242447|NCT01369355|100789044|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
33144182|NCT00761150|100441721|FG000|Open-label Period|Withdrawal by Subject|5|||
33242448|NCT01369355|100789045|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
33642376|NCT01621802|102244045|FG004|Overall Study|Others|1|||
33642377|NCT01621802|102244046|FG005|Overall Study|Others|0|||
33642378|NCT01621802|102244041|FG000|Overall Study|Lost to Follow-up|36|||
33642379|NCT01621802|102244042|FG001|Overall Study|Lost to Follow-up|16|||
33642380|NCT01621802|102244043|FG002|Overall Study|Lost to Follow-up|24|||
33642381|NCT01621802|102244044|FG003|Overall Study|Lost to Follow-up|7|||
33642382|NCT01621802|102244045|FG004|Overall Study|Lost to Follow-up|31|||
33642383|NCT01621802|102244046|FG005|Overall Study|Lost to Follow-up|11|||
33642384|NCT03894813|102244047|FG000|Overall Study|Adverse Event|1|||
33642385|NCT03894813|102244048|FG001|Overall Study|Adverse Event|1|||
33642386|NCT03894813|102244047|FG000|Overall Study|Lack of Efficacy|3|||
33642387|NCT03894813|102244048|FG001|Overall Study|Lack of Efficacy|3|||
33642388|NCT03894813|102244047|FG000|Overall Study|Lost to Follow-up|1|||
33642389|NCT03894813|102244048|FG001|Overall Study|Lost to Follow-up|0|||
33642390|NCT03894813|102244047|FG000|Overall Study|Pregnancy|2|||
33642391|NCT03894813|102244048|FG001|Overall Study|Pregnancy|1|||
33642392|NCT03894813|102244047|FG000|Overall Study|Protocol Violation|3|||
33642393|NCT03894813|102244048|FG001|Overall Study|Protocol Violation|7|||
33642394|NCT03894813|102244047|FG000|Overall Study|Withdrawal by Subject|1|||
33642395|NCT03894813|102244048|FG001|Overall Study|Withdrawal by Subject|3|||
33642396|NCT03894813|102244047|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
33144183|NCT00761150|100441722|FG001|Open-label Period|Withdrawal by Subject|0|||
33144184|NCT00761150|100441723|FG002|Open-label Period|Withdrawal by Subject|0|||
33144185|NCT00761150|100441721|FG000|Open-label Period|Noncompliance|2|||
33144186|NCT00761150|100441722|FG001|Open-label Period|Noncompliance|0|||
33144187|NCT00761150|100441723|FG002|Open-label Period|Noncompliance|0|||
33144188|NCT00761150|100441721|FG000|Open-label Period|Other|5|||
33144189|NCT00761150|100441722|FG001|Open-label Period|Other|0|||
33144190|NCT00761150|100441723|FG002|Open-label Period|Other|0|||
33144191|NCT00761150|100441721|FG000|Double-blind Period|Lack of Efficacy|0|||
33144192|NCT00761150|100441722|FG001|Double-blind Period|Lack of Efficacy|2|||
33144193|NCT00761150|100441723|FG002|Double-blind Period|Lack of Efficacy|19|||
33144194|NCT00761150|100441721|FG000|Double-blind Period|Adverse Event|0|||
33144195|NCT00761150|100441722|FG001|Double-blind Period|Adverse Event|3|||
33144196|NCT00761150|100441723|FG002|Double-blind Period|Adverse Event|3|||
33144197|NCT00761150|100441721|FG000|Double-blind Period|Withdrawal by Subject|0|||
33144198|NCT00761150|100441722|FG001|Double-blind Period|Withdrawal by Subject|3|||
33144199|NCT00761150|100441723|FG002|Double-blind Period|Withdrawal by Subject|2|||
33144200|NCT00761150|100441721|FG000|Double-blind Period|Lost to Follow-up|0|||
33144201|NCT00761150|100441722|FG001|Double-blind Period|Lost to Follow-up|2|||
33144202|NCT00761150|100441723|FG002|Double-blind Period|Lost to Follow-up|1|||
33144203|NCT00761150|100441721|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
33144204|NCT00761150|100441722|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
33144205|NCT00761150|100441723|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
33144206|NCT00761150|100441721|FG000|Double-blind Period|Noncompliance|0|||
33144207|NCT00761150|100441722|FG001|Double-blind Period|Noncompliance|1|||
33371790|NCT00408421|101247560|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
33371791|NCT00408421|101247561|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
33371792|NCT00408421|101247562|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
33371793|NCT00408421|101247560|FG000|Treatment Initial Randomization|Physician Decision|1|||
33371794|NCT00408421|101247561|FG001|Treatment Initial Randomization|Physician Decision|0|||
33371795|NCT00408421|101247562|FG002|Treatment Initial Randomization|Physician Decision|0|||
33371796|NCT00408421|101247560|FG000|Treatment Initial Randomization|Protocol Violation|0|||
33371797|NCT00408421|101247561|FG001|Treatment Initial Randomization|Protocol Violation|1|||
33371798|NCT00408421|101247562|FG002|Treatment Initial Randomization|Protocol Violation|0|||
33371799|NCT00408421|101247560|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
33371800|NCT00408421|101247561|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
33371801|NCT00408421|101247562|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
33581727|NCT01635998|102020189|FG001|Overall Study|Withdrawal by Subject|5|||
33642397|NCT03894813|102244048|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
33642398|NCT02399163|102244049|FG000|Overall Study|Adverse Event|2|||
33642399|NCT02399163|102244049|FG000|Overall Study|Protocol Deviation|2|||
33642400|NCT02399163|102244049|FG000|Overall Study|Withdrawal by Participant|5|||
33144208|NCT00761150|100441723|FG002|Double-blind Period|Noncompliance|0|||
33144209|NCT00761150|100441721|FG000|Double-blind Period|Other|0|||
33144210|NCT00761150|100441722|FG001|Double-blind Period|Other|3|||
33144211|NCT00761150|100441723|FG002|Double-blind Period|Other|3|||
33581728|NCT00161616|102020190|FG000|Overall Study|Withdrawal by Subject|6|||
33144212|NCT00879879|100441724|FG000|Overall Study|Death|1|||
33144213|NCT00879879|100441724|FG000|Overall Study|Withdrawal by Subject|1|||
33642401|NCT02509026|102244050|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
33642402|NCT02509026|102244050|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
33642403|NCT02509026|102244050|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
33642404|NCT02509026|102244050|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
33642405|NCT02509026|102244050|FG000|Induction Period (24 Weeks)|Other|2|||
33421754|NCT03216954|101434933|FG001|Overall Study|Withdrawal by Subject|0|||
33421755|NCT03216954|101434934|FG002|Overall Study|Withdrawal by Subject|0|||
33421756|NCT03216954|101434935|FG003|Overall Study|Withdrawal by Subject|0|||
33421757|NCT03216954|101434936|FG004|Overall Study|Withdrawal by Subject|0|||
33421758|NCT03216954|101434932|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
33421759|NCT03216954|101434933|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
33421760|NCT03216954|101434934|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
33421761|NCT03216954|101434935|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
33421762|NCT03216954|101434936|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
33581729|NCT00161616|102020191|FG001|Overall Study|Withdrawal by Subject|5|||
33581730|NCT00161616|102020190|FG000|Overall Study|Physician Decision|1|||
33581731|NCT00161616|102020191|FG001|Overall Study|Physician Decision|0|||
33581732|NCT00161616|102020190|FG000|Overall Study|Death|1|||
33581733|NCT00161616|102020191|FG001|Overall Study|Death|1|||
33581734|NCT00161616|102020190|FG000|Overall Study|Lost to Follow-up|17|||
33581735|NCT00161616|102020191|FG001|Overall Study|Lost to Follow-up|13|||
33581736|NCT00161616|102020190|FG000|Overall Study|Protocol deviation|1|||
33371802|NCT00408421|101247560|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
33371803|NCT00408421|101247561|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
33371804|NCT00408421|101247562|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
33371805|NCT00408421|101247560|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
33371806|NCT00408421|101247561|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
33371807|NCT00408421|101247562|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
33371808|NCT00408421|101247560|FG000|Treatment Re-Randomization|Adverse Event|2|||
33371809|NCT00408421|101247561|FG001|Treatment Re-Randomization|Adverse Event|2|||
33371810|NCT00408421|101247562|FG002|Treatment Re-Randomization|Adverse Event|4|||
33371811|NCT00408421|101247560|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
33371812|NCT00408421|101247561|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
33371813|NCT00408421|101247562|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
33371814|NCT00408421|101247560|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
33371815|NCT00408421|101247561|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
33371816|NCT00408421|101247562|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
33371817|NCT00408421|101247560|FG000|Treatment Re-Randomization|Physician Decision|1|||
33581737|NCT00161616|102020191|FG001|Overall Study|Protocol deviation|0|||
33581738|NCT02623205|102020194|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
33371818|NCT00408421|101247561|FG001|Treatment Re-Randomization|Physician Decision|3|||
33371819|NCT00408421|101247562|FG002|Treatment Re-Randomization|Physician Decision|0|||
33371820|NCT00408421|101247560|FG000|Treatment Re-Randomization|Protocol Violation|1|||
33581739|NCT02623205|102020195|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
33144214|NCT00879879|100441724|FG000|Overall Study|Physician Decision|1|||
33144215|NCT00384111|100441725|FG000|Overall Study|Disease Progression|3|||
33144216|NCT00384111|100441725|FG000|Overall Study|Adverse Event|1|||
33144217|NCT00384111|100441725|FG000|Overall Study|Investigator Decision|3|||
33144218|NCT00384111|100441725|FG000|Overall Study|Study Terminated by the Sponsor|19|||
33144219|NCT01289782|100441728|FG000|Overall Study|Lost to Follow-up|14|||
33144220|NCT01289782|100441729|FG001|Overall Study|Lost to Follow-up|7|||
33144221|NCT01289782|100441728|FG000|Overall Study|Protocol Violation|1|||
33144222|NCT01289782|100441729|FG001|Overall Study|Protocol Violation|1|||
33144223|NCT01289782|100441728|FG000|Overall Study|Withdrawal by Subject|8|||
33144224|NCT01289782|100441729|FG001|Overall Study|Withdrawal by Subject|2|||
33371821|NCT00408421|101247561|FG001|Treatment Re-Randomization|Protocol Violation|1|||
33371822|NCT00408421|101247562|FG002|Treatment Re-Randomization|Protocol Violation|0|||
33371823|NCT00408421|101247560|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
33421763|NCT01896700|101434938|FG000|Overall Study|Adverse Event|4|||
33421764|NCT01896700|101434939|FG001|Overall Study|Adverse Event|5|||
33421765|NCT01896700|101434938|FG000|Overall Study|Withdrawal by Subject|0|||
33421766|NCT01896700|101434939|FG001|Overall Study|Withdrawal by Subject|1|||
33144225|NCT01289782|100441728|FG000|Overall Study|Sponsor's Decision|1|||
33144226|NCT01289782|100441729|FG001|Overall Study|Sponsor's Decision|0|||
33421767|NCT01185639|101434942|FG000|Overall Study|Progressed and didn't receive therapy|2|||
33421768|NCT02038959|101434947|FG000|Overall Study|Withdrawal by Subject|6|||
33421769|NCT02038959|101434948|FG001|Overall Study|Withdrawal by Subject|8|||
33581740|NCT01672879|102020196|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
33581741|NCT01672879|102020197|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
33144227|NCT01289782|100441728|FG000|Overall Study|Reason not specified|1|||
33144228|NCT01289782|100441729|FG001|Overall Study|Reason not specified|2|||
33144229|NCT01445886|100441730|FG000|Overall Study|Lost to Follow-up|2|||
33144230|NCT01445886|100441730|FG000|Overall Study|Protocol Violation|3|||
33144231|NCT02652767|100441739|FG000|Overall Study|Death|2|||
33144232|NCT02652767|100441739|FG000|Overall Study|Lost to Follow-up|1|||
33371824|NCT00408421|101247561|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
33371825|NCT00408421|101247562|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
33144233|NCT02652767|100441739|FG000|Overall Study|Withdrawal by Subject|1|||
33144234|NCT00194675|100441743|FG000|Overall Study|Lost to Follow-up|1|||
33144235|NCT00194675|100441744|FG001|Overall Study|Lost to Follow-up|1|||
33144236|NCT00194675|100441743|FG000|Overall Study|lack of interest|1|||
33144237|NCT00194675|100441744|FG001|Overall Study|lack of interest|1|||
33144238|NCT00194675|100441743|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
33144239|NCT00194675|100441744|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
33144240|NCT00194675|100441743|FG000|Overall Study|Protocol Violation|1|||
33144241|NCT00194675|100441744|FG001|Overall Study|Protocol Violation|0|||
33144242|NCT00194675|100441743|FG000|Overall Study|Death|1|||
33242449|NCT01369355|100789046|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
33242450|NCT01369355|100789047|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
33242451|NCT01369355|100789039|FG000|Long-term Extension (Week 44-272)|Other|0|||
33242452|NCT01369355|100789040|FG001|Long-term Extension (Week 44-272)|Other|0|||
33242453|NCT01369355|100789041|FG002|Long-term Extension (Week 44-272)|Other|0|||
33242454|NCT01369355|100789042|FG003|Long-term Extension (Week 44-272)|Other|0|||
33581742|NCT01672879|102020198|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
33581743|NCT01672879|102020196|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
33581744|NCT01672879|102020197|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
33581745|NCT01672879|102020198|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
33581746|NCT01672879|102020196|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
33581747|NCT01672879|102020197|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
33581748|NCT01672879|102020198|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
33581749|NCT01672879|102020196|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
33581750|NCT01672879|102020197|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
33242455|NCT01369355|100789043|FG004|Long-term Extension (Week 44-272)|Other|0|||
33242456|NCT01369355|100789044|FG005|Long-term Extension (Week 44-272)|Other|0|||
33242457|NCT01369355|100789045|FG006|Long-term Extension (Week 44-272)|Other|110|||
33242458|NCT01369355|100789046|FG007|Long-term Extension (Week 44-272)|Other|9|||
33242459|NCT01369355|100789047|FG008|Long-term Extension (Week 44-272)|Other|17|||
33242460|NCT01101165|100789048|FG000|Period 1|Adverse Event|1|||
33242461|NCT01101165|100789049|FG001|Period 1|Adverse Event|2|||
33581751|NCT01672879|102020198|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
33581752|NCT01672879|102020196|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
33581753|NCT01672879|102020197|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
33581754|NCT01672879|102020198|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
33581755|NCT01672879|102020196|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
33581756|NCT01672879|102020197|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
33581757|NCT01672879|102020198|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
33581758|NCT01672879|102020196|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
33581759|NCT01672879|102020197|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
33581760|NCT01672879|102020198|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
33581761|NCT01672879|102020196|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
33581762|NCT01672879|102020197|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
33581763|NCT01672879|102020198|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
33581764|NCT01672879|102020196|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
33581765|NCT01672879|102020197|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
33581766|NCT01672879|102020198|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
33581767|NCT01672879|102020196|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
33581768|NCT01672879|102020197|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
33581769|NCT01672879|102020198|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
33581770|NCT01672879|102020196|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
33581771|NCT01672879|102020197|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
33581772|NCT01672879|102020198|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
33581773|NCT01672879|102020196|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
33581774|NCT01672879|102020197|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
33581775|NCT01672879|102020198|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
33581776|NCT01672879|102020196|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
33581777|NCT01672879|102020197|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
33581778|NCT01672879|102020198|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
33581779|NCT00451958|102020199|FG000|CS21A (NCT00451958)|Adverse Event|21|||
33242462|NCT01101165|100789048|FG000|Period 1|Withdrawal by Subject|0|||
33242463|NCT01101165|100789049|FG001|Period 1|Withdrawal by Subject|2|||
33242464|NCT01101165|100789048|FG000|Period 1|Positive Drug Screen|0|||
33421770|NCT03467971|101434951|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33144243|NCT00194675|100441744|FG001|Overall Study|Death|0|||
33144244|NCT01150474|100441745|FG000|Overall Study|Withdrawal by Subject|5|||
33144245|NCT01150474|100441746|FG001|Overall Study|Withdrawal by Subject|2|||
33242465|NCT01101165|100789049|FG001|Period 1|Positive Drug Screen|1|||
33242466|NCT01101165|100789048|FG000|Period 1|Lost to Follow-up|1|||
33144246|NCT01150474|100441745|FG000|Overall Study|Cancer found|1|||
33642406|NCT02509026|102244050|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
33642407|NCT02509026|102244050|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
33642408|NCT02509026|102244050|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
33642409|NCT02509026|102244050|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
33642410|NCT02509026|102244050|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
33642411|NCT02509026|102244050|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
33642412|NCT02509026|102244050|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
33642413|NCT02509026|102244050|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
33642414|NCT00845897|102244052|FG000|Overall Study|Lost to Follow-up|1|||
33642415|NCT00845897|102244053|FG001|Overall Study|Lost to Follow-up|1|||
33642416|NCT00845897|102244054|FG002|Overall Study|Lost to Follow-up|0|||
33642417|NCT00845897|102244052|FG000|Overall Study|Withdrawal by Subject|0|||
33642418|NCT00845897|102244053|FG001|Overall Study|Withdrawal by Subject|3|||
33642419|NCT00845897|102244054|FG002|Overall Study|Withdrawal by Subject|2|||
33642420|NCT00845897|102244052|FG000|Overall Study|Ulcer did not heal|1|||
33642421|NCT00845897|102244053|FG001|Overall Study|Ulcer did not heal|0|||
33144247|NCT01150474|100441746|FG001|Overall Study|Cancer found|0|||
33144248|NCT01150474|100441745|FG000|Overall Study|Multiple Studies|0|||
33144249|NCT01150474|100441746|FG001|Overall Study|Multiple Studies|1|||
33144250|NCT01150474|100441745|FG000|Overall Study|Rectotomy|1|||
33144251|NCT01150474|100441746|FG001|Overall Study|Rectotomy|0|||
33144252|NCT01150474|100441745|FG000|Overall Study|Drug did not arrive in time|1|||
33144253|NCT01150474|100441746|FG001|Overall Study|Drug did not arrive in time|0|||
33144254|NCT01150474|100441745|FG000|Overall Study|Drug not administered|1|||
33144255|NCT01150474|100441746|FG001|Overall Study|Drug not administered|0|||
33144256|NCT01150474|100441745|FG000|Overall Study|Surgery Changed|1|||
33144257|NCT01150474|100441746|FG001|Overall Study|Surgery Changed|0|||
33144258|NCT00973349|100441749|FG000|Overall Study|Adverse Event|0|||
33144259|NCT00973349|100441750|FG001|Overall Study|Adverse Event|0|||
33144260|NCT00973349|100441751|FG002|Overall Study|Adverse Event|0|||
33144261|NCT00973349|100441752|FG003|Overall Study|Adverse Event|0|||
33144262|NCT00973349|100441753|FG004|Overall Study|Adverse Event|1|||
33144263|NCT00973349|100441754|FG005|Overall Study|Adverse Event|0|||
33144264|NCT00973349|100441755|FG006|Overall Study|Adverse Event|0|||
33144265|NCT00973349|100441756|FG007|Overall Study|Adverse Event|0|||
33144266|NCT00973349|100441757|FG008|Overall Study|Adverse Event|1|||
33144267|NCT00973349|100441758|FG009|Overall Study|Adverse Event|0|||
33144268|NCT00973349|100441759|FG010|Overall Study|Adverse Event|0|||
33144269|NCT00973349|100441760|FG011|Overall Study|Adverse Event|0|||
33144270|NCT00973349|100441761|FG012|Overall Study|Adverse Event|0|||
33144271|NCT00973349|100441762|FG013|Overall Study|Adverse Event|0|||
33144272|NCT00973349|100441763|FG014|Overall Study|Adverse Event|1|||
33144273|NCT00973349|100441764|FG015|Overall Study|Adverse Event|0|||
33144274|NCT00973349|100441749|FG000|Overall Study|Withdrawal by Subject|1|||
33144275|NCT00973349|100441750|FG001|Overall Study|Withdrawal by Subject|2|||
33144276|NCT00973349|100441751|FG002|Overall Study|Withdrawal by Subject|2|||
33144277|NCT00973349|100441752|FG003|Overall Study|Withdrawal by Subject|3|||
33144278|NCT00973349|100441753|FG004|Overall Study|Withdrawal by Subject|2|||
33144279|NCT00973349|100441754|FG005|Overall Study|Withdrawal by Subject|0|||
33144280|NCT00973349|100441755|FG006|Overall Study|Withdrawal by Subject|2|||
33144281|NCT00973349|100441756|FG007|Overall Study|Withdrawal by Subject|2|||
33144282|NCT00973349|100441757|FG008|Overall Study|Withdrawal by Subject|0|||
33144283|NCT00973349|100441758|FG009|Overall Study|Withdrawal by Subject|2|||
33144284|NCT00973349|100441759|FG010|Overall Study|Withdrawal by Subject|0|||
33144285|NCT00973349|100441760|FG011|Overall Study|Withdrawal by Subject|1|||
33144286|NCT00973349|100441761|FG012|Overall Study|Withdrawal by Subject|0|||
33144287|NCT00973349|100441762|FG013|Overall Study|Withdrawal by Subject|0|||
33144288|NCT00973349|100441763|FG014|Overall Study|Withdrawal by Subject|0|||
33242467|NCT01101165|100789049|FG001|Period 1|Lost to Follow-up|0|||
33242468|NCT01101165|100789048|FG000|Period 2|Withdrawal by Subject|3|||
33642422|NCT00845897|102244054|FG002|Overall Study|Ulcer did not heal|1|||
33642423|NCT00845897|102244052|FG000|Overall Study|Too ill to participate|0|||
33642424|NCT00845897|102244053|FG001|Overall Study|Too ill to participate|1|||
33144289|NCT00973349|100441764|FG015|Overall Study|Withdrawal by Subject|0|||
33144290|NCT00973349|100441749|FG000|Overall Study|Lost to Follow-up|3|||
33144291|NCT00973349|100441750|FG001|Overall Study|Lost to Follow-up|1|||
33144292|NCT00973349|100441751|FG002|Overall Study|Lost to Follow-up|2|||
33242469|NCT01101165|100789049|FG001|Period 2|Withdrawal by Subject|1|||
33144293|NCT00973349|100441752|FG003|Overall Study|Lost to Follow-up|2|||
33144294|NCT00973349|100441753|FG004|Overall Study|Lost to Follow-up|1|||
33144295|NCT00973349|100441754|FG005|Overall Study|Lost to Follow-up|3|||
33144296|NCT00973349|100441755|FG006|Overall Study|Lost to Follow-up|0|||
33144297|NCT00973349|100441756|FG007|Overall Study|Lost to Follow-up|1|||
33144298|NCT00973349|100441757|FG008|Overall Study|Lost to Follow-up|2|||
33144299|NCT00973349|100441758|FG009|Overall Study|Lost to Follow-up|1|||
33642425|NCT00845897|102244054|FG002|Overall Study|Too ill to participate|0|||
33642426|NCT00934362|102244056|FG000|Overall Study|Adverse Event|1|||
33642427|NCT00934362|102244057|FG001|Overall Study|Adverse Event|0|||
33144300|NCT00973349|100441759|FG010|Overall Study|Lost to Follow-up|0|||
33144301|NCT00973349|100441760|FG011|Overall Study|Lost to Follow-up|1|||
33144302|NCT00973349|100441761|FG012|Overall Study|Lost to Follow-up|0|||
33144303|NCT00973349|100441762|FG013|Overall Study|Lost to Follow-up|0|||
33144304|NCT00973349|100441763|FG014|Overall Study|Lost to Follow-up|0|||
33144305|NCT00973349|100441764|FG015|Overall Study|Lost to Follow-up|1|||
33144306|NCT00973349|100441749|FG000|Overall Study|Inappropriate enrolment|0|||
33144307|NCT00973349|100441750|FG001|Overall Study|Inappropriate enrolment|0|||
33144308|NCT00973349|100441751|FG002|Overall Study|Inappropriate enrolment|1|||
33144309|NCT00973349|100441752|FG003|Overall Study|Inappropriate enrolment|0|||
33144310|NCT00973349|100441753|FG004|Overall Study|Inappropriate enrolment|0|||
33144311|NCT00973349|100441754|FG005|Overall Study|Inappropriate enrolment|0|||
33144312|NCT00973349|100441755|FG006|Overall Study|Inappropriate enrolment|0|||
33144313|NCT00973349|100441756|FG007|Overall Study|Inappropriate enrolment|0|||
33642428|NCT03763877|102244058|FG000|Overall Study|Withdrawal by Subject|3|||
33642429|NCT03763877|102244059|FG001|Overall Study|Withdrawal by Subject|1|||
33642430|NCT03763877|102244060|FG002|Overall Study|Withdrawal by Subject|3|||
33642431|NCT03763877|102244061|FG003|Overall Study|Withdrawal by Subject|4|||
33642432|NCT03763877|102244058|FG000|Overall Study|Adverse Event|1|||
33642433|NCT03763877|102244059|FG001|Overall Study|Adverse Event|1|||
33642434|NCT03763877|102244060|FG002|Overall Study|Adverse Event|3|||
33642435|NCT03763877|102244061|FG003|Overall Study|Adverse Event|1|||
33642436|NCT03763877|102244058|FG000|Overall Study|Protocol Violation|1|||
33642437|NCT03763877|102244059|FG001|Overall Study|Protocol Violation|1|||
33642438|NCT03763877|102244060|FG002|Overall Study|Protocol Violation|0|||
33642439|NCT03763877|102244061|FG003|Overall Study|Protocol Violation|0|||
33642440|NCT03763877|102244058|FG000|Overall Study|Lost to Follow-up|0|||
33642441|NCT03763877|102244059|FG001|Overall Study|Lost to Follow-up|1|||
33642442|NCT03763877|102244060|FG002|Overall Study|Lost to Follow-up|1|||
33642443|NCT03763877|102244061|FG003|Overall Study|Lost to Follow-up|0|||
33642444|NCT02640508|102244062|FG000|Overall Study|Death|19|||
33642445|NCT02640508|102244062|FG000|Overall Study|Withdrawal by Subject|8|||
33642446|NCT02640508|102244062|FG000|Overall Study|Physician Decision|1|||
33642447|NCT02640508|102244062|FG000|Overall Study|Lost to Follow-up|1|||
33642448|NCT01733680|102244066|FG000|Overall Study|Withdrawal by Subject|0|||
33642449|NCT01733680|102244067|FG001|Overall Study|Withdrawal by Subject|1|||
33642450|NCT04200352|102244074|FG000|Overall Study|Death|1|||
33642451|NCT04200352|102244074|FG000|Overall Study|Adverse Event|6|||
33642452|NCT04200352|102244074|FG000|Overall Study|Withdrawal by parent/guardian|6|||
33642453|NCT04200352|102244074|FG000|Overall Study|Lack of Efficacy|1|||
33642454|NCT04200352|102244074|FG000|Overall Study|Other than specified|6|||
33144314|NCT00973349|100441757|FG008|Overall Study|Inappropriate enrolment|0|||
33144315|NCT00973349|100441758|FG009|Overall Study|Inappropriate enrolment|2|||
33144316|NCT00973349|100441759|FG010|Overall Study|Inappropriate enrolment|0|||
33144317|NCT00973349|100441760|FG011|Overall Study|Inappropriate enrolment|0|||
33144318|NCT00973349|100441761|FG012|Overall Study|Inappropriate enrolment|1|||
33144319|NCT00973349|100441762|FG013|Overall Study|Inappropriate enrolment|0|||
33144320|NCT00973349|100441763|FG014|Overall Study|Inappropriate enrolment|1|||
33144321|NCT00973349|100441764|FG015|Overall Study|Inappropriate enrolment|1|||
33144322|NCT00973349|100441749|FG000|Overall Study|Protocol Violation|0|||
33144323|NCT00973349|100441750|FG001|Overall Study|Protocol Violation|0|||
33144324|NCT00973349|100441751|FG002|Overall Study|Protocol Violation|0|||
33144325|NCT00973349|100441752|FG003|Overall Study|Protocol Violation|0|||
33144326|NCT00973349|100441753|FG004|Overall Study|Protocol Violation|0|||
33421771|NCT03467971|101434952|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33642455|NCT02537015|102244075|FG000|Overall Study|Adverse Event|3|||
33642456|NCT02537015|102244075|FG000|Overall Study|Withdrawal by Subject|2|||
33642457|NCT02537015|102244075|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33642458|NCT01262989|102244082|FG000|Period 1|Lost to Follow-up|1|||
33642459|NCT01262989|102244083|FG001|Period 1|Lost to Follow-up|1|||
33642460|NCT01262989|102244082|FG000|Period 1|Intercurrent disease|0|||
33642461|NCT01262989|102244083|FG001|Period 1|Intercurrent disease|1|||
33642462|NCT01262989|102244082|FG000|Period 1|Positive answer for exclusion criteria|0|||
33642463|NCT01262989|102244083|FG001|Period 1|Positive answer for exclusion criteria|1|||
33642464|NCT01262989|102244082|FG000|Period 2|Intercurrent disease|0|||
33642465|NCT01262989|102244083|FG001|Period 2|Intercurrent disease|1|||
33642466|NCT02722304|102244087|FG000|Overall Study|Study Terminated by Sponsor|1|||
33144327|NCT00973349|100441754|FG005|Overall Study|Protocol Violation|0|||
33242470|NCT01101165|100789048|FG000|Period 2|Adverse Event|1|||
33144328|NCT00973349|100441755|FG006|Overall Study|Protocol Violation|0|||
33242471|NCT01101165|100789049|FG001|Period 2|Adverse Event|0|||
33642467|NCT02722304|102244088|FG001|Overall Study|Study Terminated by Sponsor|0|||
33642468|NCT02722304|102244089|FG002|Overall Study|Study Terminated by Sponsor|2|||
33642469|NCT02722304|102244090|FG003|Overall Study|Study Terminated by Sponsor|1|||
33144329|NCT00973349|100441756|FG007|Overall Study|Protocol Violation|0|||
33144330|NCT00973349|100441757|FG008|Overall Study|Protocol Violation|1|||
33642470|NCT02722304|102244091|FG004|Overall Study|Study Terminated by Sponsor|1|||
33642471|NCT02722304|102244087|FG000|Overall Study|Other|0|||
33642472|NCT02722304|102244088|FG001|Overall Study|Other|0|||
33642473|NCT02722304|102244089|FG002|Overall Study|Other|0|||
33642474|NCT02722304|102244090|FG003|Overall Study|Other|1|||
33642475|NCT02722304|102244091|FG004|Overall Study|Other|1|||
33642476|NCT03962504|102244092|FG000|Overall Study|Other|11|||
33642477|NCT03962504|102244093|FG001|Overall Study|Other|32|||
33642478|NCT02637037|102244094|FG000|Overall Study|Positive drug screen at admission|1|||
33642479|NCT02637037|102244095|FG001|Overall Study|Positive drug screen at admission|0|||
33642480|NCT02637037|102244094|FG000|Overall Study|Withdrawal by Subject|2|||
33642481|NCT02637037|102244095|FG001|Overall Study|Withdrawal by Subject|1|||
33642482|NCT02637037|102244094|FG000|Overall Study|Adverse Event|1|||
33642483|NCT02637037|102244095|FG001|Overall Study|Adverse Event|0|||
33642484|NCT02970942|102244096|FG000|Overall Study|Death|0|||
33642485|NCT02970942|102244097|FG001|Overall Study|Death|1|||
33642486|NCT02970942|102244098|FG002|Overall Study|Death|0|||
33642487|NCT02970942|102244099|FG003|Overall Study|Death|0|||
33642488|NCT02970942|102244096|FG000|Overall Study|Lost to Follow-up|1|||
33642489|NCT02970942|102244097|FG001|Overall Study|Lost to Follow-up|0|||
33642490|NCT02970942|102244098|FG002|Overall Study|Lost to Follow-up|2|||
33642491|NCT02970942|102244099|FG003|Overall Study|Lost to Follow-up|1|||
33642492|NCT02970942|102244096|FG000|Overall Study|Withdrawal by Subject|3|||
33642493|NCT02970942|102244097|FG001|Overall Study|Withdrawal by Subject|5|||
33642494|NCT02970942|102244098|FG002|Overall Study|Withdrawal by Subject|3|||
33642495|NCT02970942|102244099|FG003|Overall Study|Withdrawal by Subject|2|||
33642496|NCT02803580|102244100|FG000|Overall Study|Death|13|||
33642497|NCT02803580|102244100|FG000|Overall Study|Lost to Follow-up|19|||
33642498|NCT02803580|102244100|FG000|Overall Study|Withdrawal by Subject|3|||
33642499|NCT02803580|102244100|FG000|Overall Study|Inclusion in clinical trial|1|||
33642500|NCT00981058|102244101|FG000|Overall Study|Adverse Event|1|||
33581780|NCT00451958|102020200|FG001|CS21A (NCT00451958)|Adverse Event|34|||
33581781|NCT00451958|102020201|FG002|CS21A (NCT00451958)|Adverse Event|14|||
33581782|NCT00451958|102020202|FG003|CS21A (NCT00451958)|Adverse Event|17|||
33581783|NCT00451958|102020203|FG004|CS21A (NCT00451958)|Adverse Event|0|||
33581784|NCT00451958|102020199|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
33581785|NCT00451958|102020200|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
33581786|NCT00451958|102020201|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
33581787|NCT00451958|102020202|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
33581788|NCT00451958|102020203|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
33581789|NCT00451958|102020199|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
33581790|NCT00451958|102020200|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
33581791|NCT00451958|102020201|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
33581792|NCT00451958|102020202|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
33581793|NCT00451958|102020203|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
33581794|NCT00451958|102020199|FG000|CS21A (NCT00451958)|Physician Decision|2|||
33581795|NCT00451958|102020200|FG001|CS21A (NCT00451958)|Physician Decision|4|||
33581796|NCT00451958|102020201|FG002|CS21A (NCT00451958)|Physician Decision|4|||
33581797|NCT00451958|102020202|FG003|CS21A (NCT00451958)|Physician Decision|4|||
33581798|NCT00451958|102020203|FG004|CS21A (NCT00451958)|Physician Decision|0|||
33581799|NCT00451958|102020199|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
33581800|NCT00451958|102020200|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
33581801|NCT00451958|102020201|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
33581802|NCT00451958|102020202|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
33581803|NCT00451958|102020203|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
33581804|NCT00451958|102020199|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
33581805|NCT00451958|102020200|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
33581806|NCT00451958|102020201|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
33581807|NCT00451958|102020202|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
33581808|NCT00451958|102020203|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
33581809|NCT00211172|102020204|FG000|Overall Study|Died or lost health plan eligibility|39|||
33581810|NCT00211172|102020205|FG001|Overall Study|Died or lost health plan eligibility|32|||
33581811|NCT03462641|102020208|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
33581812|NCT03462641|102020209|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
33581813|NCT03462641|102020208|FG000|Visit 2|Withdrawal by Subject|0|||
33581814|NCT03462641|102020209|FG001|Visit 2|Withdrawal by Subject|1|||
33642501|NCT00981058|102244102|FG001|Overall Study|Adverse Event|1|||
33642502|NCT00981058|102244101|FG000|Overall Study|Progressive Disease|61|||
33581815|NCT01119066|102020210|FG000|Overall Study|Withdrawal by Subject|4|||
33581816|NCT01119066|102020211|FG001|Overall Study|Withdrawal by Subject|6|||
33581817|NCT01119066|102020212|FG002|Overall Study|Withdrawal by Subject|0|||
33581818|NCT01119066|102020213|FG003|Overall Study|Withdrawal by Subject|0|||
33581819|NCT01119066|102020210|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
33581820|NCT01119066|102020211|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
33642503|NCT00981058|102244102|FG001|Overall Study|Progressive Disease|49|||
33642504|NCT00981058|102244101|FG000|Overall Study|Lost to Follow-up|16|||
33642505|NCT00981058|102244102|FG001|Overall Study|Lost to Follow-up|15|||
33642506|NCT00981058|102244101|FG000|Overall Study|New Anticancer Therapy|6|||
33642507|NCT00981058|102244102|FG001|Overall Study|New Anticancer Therapy|6|||
33642508|NCT00981058|102244101|FG000|Overall Study|Noncompliance|1|||
33642509|NCT00981058|102244102|FG001|Overall Study|Noncompliance|0|||
33642510|NCT00981058|102244101|FG000|Overall Study|Radiologist Error|0|||
33642511|NCT00981058|102244102|FG001|Overall Study|Radiologist Error|1|||
33144331|NCT00973349|100441758|FG009|Overall Study|Protocol Violation|0|||
33144332|NCT00973349|100441759|FG010|Overall Study|Protocol Violation|0|||
33144333|NCT00973349|100441760|FG011|Overall Study|Protocol Violation|0|||
33144334|NCT00973349|100441761|FG012|Overall Study|Protocol Violation|0|||
33144335|NCT00973349|100441762|FG013|Overall Study|Protocol Violation|0|||
33144336|NCT00973349|100441763|FG014|Overall Study|Protocol Violation|0|||
33144337|NCT00973349|100441764|FG015|Overall Study|Protocol Violation|0|||
33144338|NCT00973349|100441749|FG000|Overall Study|Unable to classify|0|||
33144339|NCT00973349|100441750|FG001|Overall Study|Unable to classify|0|||
33144340|NCT00973349|100441751|FG002|Overall Study|Unable to classify|0|||
33144341|NCT00973349|100441752|FG003|Overall Study|Unable to classify|0|||
33144342|NCT00973349|100441753|FG004|Overall Study|Unable to classify|1|||
33144343|NCT00973349|100441754|FG005|Overall Study|Unable to classify|1|||
33144344|NCT00973349|100441755|FG006|Overall Study|Unable to classify|0|||
33144345|NCT00973349|100441756|FG007|Overall Study|Unable to classify|0|||
33144346|NCT00973349|100441757|FG008|Overall Study|Unable to classify|0|||
33144347|NCT00973349|100441758|FG009|Overall Study|Unable to classify|1|||
33144348|NCT00973349|100441759|FG010|Overall Study|Unable to classify|0|||
33144349|NCT00973349|100441760|FG011|Overall Study|Unable to classify|0|||
33144350|NCT00973349|100441761|FG012|Overall Study|Unable to classify|0|||
33144351|NCT00973349|100441762|FG013|Overall Study|Unable to classify|0|||
33144352|NCT00973349|100441763|FG014|Overall Study|Unable to classify|0|||
33144353|NCT00973349|100441764|FG015|Overall Study|Unable to classify|0|||
33144354|NCT03631355|100441765|FG000|Overall Study|Lost to Follow-up|1|||
33144355|NCT03631355|100441766|FG001|Overall Study|Lost to Follow-up|2|||
33144356|NCT00323869|100441768|FG000|Overall Study|Death|1|||
33144357|NCT01101191|100441773|FG000|Period 1|Withdrawal by Subject|1|||
33144358|NCT01101191|100441774|FG001|Period 1|Withdrawal by Subject|0|||
33144359|NCT01101191|100441773|FG000|Period 1|Adverse Event|1|||
33144360|NCT01101191|100441774|FG001|Period 1|Adverse Event|2|||
33371826|NCT02322892|101247565|FG000|Overall Study|Surgery cancelled|1|||
33371827|NCT02322892|101247566|FG001|Overall Study|Surgery cancelled|2|||
33371828|NCT02322892|101247565|FG000|Overall Study|Met exclusion criteria|0|||
33581821|NCT01119066|102020212|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
33581822|NCT01119066|102020213|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
33581823|NCT01119066|102020210|FG000|Overall Study|Relapse identified before transplant|1|||
33581824|NCT01119066|102020211|FG001|Overall Study|Relapse identified before transplant|0|||
33581825|NCT01119066|102020212|FG002|Overall Study|Relapse identified before transplant|0|||
33581826|NCT01119066|102020213|FG003|Overall Study|Relapse identified before transplant|0|||
33581827|NCT01119066|102020210|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
33581828|NCT01119066|102020211|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
33581829|NCT01119066|102020212|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
33581830|NCT01119066|102020213|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
33581831|NCT01119066|102020210|FG000|Overall Study|Relapse identified before transplant|0|||
33581832|NCT01119066|102020211|FG001|Overall Study|Relapse identified before transplant|4|||
33581833|NCT01119066|102020212|FG002|Overall Study|Relapse identified before transplant|0|||
33581834|NCT01119066|102020213|FG003|Overall Study|Relapse identified before transplant|0|||
33581835|NCT01333722|102020214|FG000|Overall Study|Lack of Efficacy|0|||
33581836|NCT01333722|102020215|FG001|Overall Study|Lack of Efficacy|2|||
33581837|NCT01333722|102020214|FG000|Overall Study|Withdrawal by Subject|0|||
33581838|NCT01333722|102020215|FG001|Overall Study|Withdrawal by Subject|1|||
33581839|NCT01804049|102020217|FG000|Overall Study|Adverse Event|2|||
33581840|NCT01804049|102020218|FG001|Overall Study|Adverse Event|10|||
33642512|NCT00981058|102244101|FG000|Overall Study|Randomization Error|1|||
33642513|NCT00981058|102244102|FG001|Overall Study|Randomization Error|2|||
33642514|NCT00981058|102244101|FG000|Overall Study|Withdrawal by Subject|25|||
33642515|NCT00981058|102244102|FG001|Overall Study|Withdrawal by Subject|23|||
33642516|NCT00981058|102244101|FG000|Overall Study|On study treatment at conclusion|9|||
33642517|NCT00981058|102244102|FG001|Overall Study|On study treatment at conclusion|0|||
33144361|NCT04571515|100441775|FG000|Overall Study|Physician Decision|0|||
33144362|NCT04571515|100441776|FG001|Overall Study|Physician Decision|0|||
33144363|NCT04571515|100441777|FG002|Overall Study|Physician Decision|0|||
33144364|NCT04571515|100441778|FG003|Overall Study|Physician Decision|0|||
33144365|NCT04571515|100441779|FG004|Overall Study|Physician Decision|1|||
33581841|NCT01804049|102020217|FG000|Overall Study|Lost to Follow-up|2|||
33144366|NCT04571515|100441775|FG000|Overall Study|Withdrawal by Subject|0|||
33144367|NCT04571515|100441776|FG001|Overall Study|Withdrawal by Subject|0|||
33144368|NCT04571515|100441777|FG002|Overall Study|Withdrawal by Subject|0|||
33144369|NCT04571515|100441778|FG003|Overall Study|Withdrawal by Subject|0|||
33144370|NCT04571515|100441779|FG004|Overall Study|Withdrawal by Subject|1|||
33144371|NCT04571515|100441775|FG000|Overall Study|insufficient pain|1|||
33371829|NCT02322892|101247566|FG001|Overall Study|Met exclusion criteria|1|||
33371830|NCT02322892|101247565|FG000|Overall Study|Protocol Violation|1|||
33371831|NCT02322892|101247566|FG001|Overall Study|Protocol Violation|0|||
33371832|NCT00138151|101247567|FG000|Overall Study|Withdrawal by Subject|3|||
33144372|NCT04571515|100441776|FG001|Overall Study|insufficient pain|0|||
33144373|NCT04571515|100441777|FG002|Overall Study|insufficient pain|0|||
33144374|NCT04571515|100441778|FG003|Overall Study|insufficient pain|0|||
33144375|NCT04571515|100441779|FG004|Overall Study|insufficient pain|1|||
33144376|NCT00821327|100441780|FG000|Overall Study|Adverse Event|13|||
33144377|NCT00821327|100441780|FG000|Overall Study|Patient Request|1|||
33144378|NCT00821327|100441780|FG000|Overall Study|Investigator Request|2|||
33144379|NCT00821327|100441780|FG000|Overall Study|Sponsor Request|1|||
33144380|NCT00821327|100441780|FG000|Overall Study|Disease Progression|13|||
33144381|NCT00821327|100441780|FG000|Overall Study|Other/Unknown|5|||
33144382|NCT02604017|100441781|FG000|Overall Study|Withdrew Consent|0|||
33144383|NCT02604017|100441782|FG001|Overall Study|Withdrew Consent|2|||
33144384|NCT02604017|100441781|FG000|Overall Study|Lost to Follow-up|5|||
33144385|NCT02604017|100441782|FG001|Overall Study|Lost to Follow-up|6|||
33371833|NCT00138151|101247567|FG000|Overall Study|Physician Decision|1|||
33371834|NCT01115569|101247568|FG000|Conversion/Titration Phase|Adverse Event|59|||
33371835|NCT01115569|101247569|FG001|Conversion/Titration Phase|Adverse Event|0|||
33642518|NCT01146795|102244107|FG000|Overall Study|Withdrawal by Subject|4|||
33642519|NCT01146795|102244107|FG000|Overall Study|Adverse Event|6|||
33642520|NCT01146795|102244107|FG000|Overall Study|Still in treatment at study closure|10|||
33642521|NCT03534180|102244108|FG000|Overall Study|Withdrawal by Subject|1|||
33642522|NCT01544335|102244113|FG000|Overall Study|Lost to Follow-up|27|||
33642523|NCT01544335|102244113|FG000|Overall Study|Death|4|||
33642524|NCT01544335|102244113|FG000|Overall Study|Disease progression|3|||
33642525|NCT01544335|102244113|FG000|Overall Study|Baseline Measurements not Available|19|||
33642526|NCT00611026|102244114|FG000|Randomized to Double-blind Treatment|Not treated|2|||
33144386|NCT02604017|100441781|FG000|Overall Study|Other|1|||
33144387|NCT02604017|100441782|FG001|Overall Study|Other|0|||
33144388|NCT02398227|100441783|FG000|Overall Study|Lost to Follow-up|21|||
33144389|NCT02398227|100441784|FG001|Overall Study|Lost to Follow-up|12|||
33144390|NCT02398227|100441783|FG000|Overall Study|Withdrawal by Subject|5|||
33371836|NCT01115569|101247568|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
33371837|NCT01115569|101247569|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
33371838|NCT01115569|101247568|FG000|Conversion/Titration Phase|Physician Decision|5|||
33371839|NCT01115569|101247569|FG001|Conversion/Titration Phase|Physician Decision|0|||
33371840|NCT01115569|101247568|FG000|Conversion/Titration Phase|Protocol Violation|68|||
33371841|NCT01115569|101247569|FG001|Conversion/Titration Phase|Protocol Violation|0|||
33371842|NCT01115569|101247568|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
33371843|NCT01115569|101247569|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
33371844|NCT01115569|101247568|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
33371845|NCT01115569|101247569|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
33371846|NCT01115569|101247568|FG000|Maintenance Phase|Adverse Event|0|||
33371847|NCT01115569|101247569|FG001|Maintenance Phase|Adverse Event|43|||
33371848|NCT01115569|101247568|FG000|Maintenance Phase|Lost to Follow-up|0|||
33371849|NCT01115569|101247569|FG001|Maintenance Phase|Lost to Follow-up|8|||
33371850|NCT01115569|101247568|FG000|Maintenance Phase|Physician Decision|0|||
33371851|NCT01115569|101247569|FG001|Maintenance Phase|Physician Decision|3|||
33371852|NCT01115569|101247568|FG000|Maintenance Phase|Protocol Violation|0|||
33371853|NCT01115569|101247569|FG001|Maintenance Phase|Protocol Violation|9|||
33371854|NCT01115569|101247568|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33371855|NCT01115569|101247569|FG001|Maintenance Phase|Withdrawal by Subject|27|||
33371856|NCT01115569|101247568|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
33371857|NCT01115569|101247569|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
33371858|NCT01115569|101247568|FG000|Maintenance Phase|Administrative|0|||
33371859|NCT01115569|101247569|FG001|Maintenance Phase|Administrative|1|||
33371860|NCT02773238|101247573|FG000|Overall Study|Lack of Efficacy|4|||
33421772|NCT03797222|101434957|FG000|Overall Study|Withdrawal by Subject|1|||
33144391|NCT02398227|100441784|FG001|Overall Study|Withdrawal by Subject|6|||
33371861|NCT00115349|101247574|FG000|Overall Study|Study closed due to low enrollment.|11|||
33371862|NCT00115349|101247575|FG001|Overall Study|Study closed due to low enrollment.|9|||
33371863|NCT02399813|101247576|FG000|Overall Study|Progressive Disease-Radiographic|2|||
33421773|NCT02643394|101434958|FG000|Overall Study|Protocol Violation|4|||
33421774|NCT02643394|101434959|FG001|Overall Study|Protocol Violation|5|||
33581842|NCT01804049|102020218|FG001|Overall Study|Lost to Follow-up|1|||
33581843|NCT01804049|102020217|FG000|Overall Study|Decreased interest/personal|4|||
33581844|NCT01804049|102020218|FG001|Overall Study|Decreased interest/personal|5|||
33642527|NCT00611026|102244115|FG001|Randomized to Double-blind Treatment|Not treated|1|||
33144392|NCT02398227|100441783|FG000|Overall Study|Removed from treatment and dropped out|1|||
33144393|NCT02398227|100441784|FG001|Overall Study|Removed from treatment and dropped out|0|||
33144394|NCT02793128|100441785|FG000|Overall Study|Death|4|||
33371864|NCT02399813|101247576|FG000|Overall Study|Death|20|||
33371865|NCT02399813|101247576|FG000|Overall Study|Withdrawal by Subject|3|||
33371866|NCT02399813|101247576|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
33144395|NCT02793128|100441785|FG000|Overall Study|Withdrawal by Subject|2|||
33144396|NCT02793128|100441785|FG000|Overall Study|Physician Decision|1|||
33144397|NCT02793128|100441785|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
33144398|NCT02793128|100441785|FG000|Overall Study|Patient elected nephroureterectomy|1|||
33144399|NCT00686998|100441786|FG000|Overall Study|Adverse Event|3|||
33144400|NCT00686998|100441787|FG001|Overall Study|Adverse Event|2|||
33642528|NCT00611026|102244116|FG002|Randomized to Double-blind Treatment|Not treated|3|||
33642529|NCT00611026|102244114|FG000|Double-blind Treatment Period|Death|1|||
33581845|NCT01804049|102020217|FG000|Overall Study|Other health concerns|2|||
33581846|NCT01804049|102020218|FG001|Overall Study|Other health concerns|7|||
33581847|NCT01804049|102020217|FG000|Overall Study|Moved out of area|0|||
33581848|NCT01804049|102020218|FG001|Overall Study|Moved out of area|7|||
33642530|NCT00611026|102244115|FG001|Double-blind Treatment Period|Death|0|||
33642531|NCT00611026|102244116|FG002|Double-blind Treatment Period|Death|0|||
33642532|NCT00611026|102244114|FG000|Double-blind Treatment Period|Adverse Event|9|||
33642533|NCT00611026|102244115|FG001|Double-blind Treatment Period|Adverse Event|28|||
33642534|NCT00611026|102244116|FG002|Double-blind Treatment Period|Adverse Event|46|||
33642535|NCT00611026|102244114|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
33642536|NCT00611026|102244115|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
33642537|NCT00611026|102244116|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
33642538|NCT00611026|102244114|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
33642539|NCT00611026|102244115|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
33642540|NCT00611026|102244116|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
33642541|NCT00611026|102244114|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
33642542|NCT00611026|102244115|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
33642543|NCT00611026|102244116|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
33642544|NCT00611026|102244114|FG000|Double-blind Treatment Period|Other|13|||
33642545|NCT00611026|102244115|FG001|Double-blind Treatment Period|Other|20|||
33642546|NCT00611026|102244116|FG002|Double-blind Treatment Period|Other|18|||
33642547|NCT02023697|102244117|FG000|Treatment Period|Radiological progression|13|||
33642548|NCT02023697|102244118|FG001|Treatment Period|Radiological progression|17|||
33642549|NCT02023697|102244119|FG002|Treatment Period|Radiological progression|26|||
33642550|NCT02023697|102244117|FG000|Treatment Period|Never Treated|5|||
33642551|NCT02023697|102244118|FG001|Treatment Period|Never Treated|6|||
33642552|NCT02023697|102244119|FG002|Treatment Period|Never Treated|10|||
33642553|NCT02023697|102244117|FG000|Treatment Period|Adverse Event|13|||
33642554|NCT02023697|102244118|FG001|Treatment Period|Adverse Event|25|||
33642555|NCT02023697|102244119|FG002|Treatment Period|Adverse Event|23|||
33642556|NCT02023697|102244117|FG000|Treatment Period|Logistical difficulties|1|||
33642557|NCT02023697|102244118|FG001|Treatment Period|Logistical difficulties|1|||
33642558|NCT02023697|102244119|FG002|Treatment Period|Logistical difficulties|1|||
33642559|NCT02023697|102244117|FG000|Treatment Period|Clinical progression|10|||
33144401|NCT00686998|100441788|FG002|Overall Study|Adverse Event|1|||
33144402|NCT00686998|100441786|FG000|Overall Study|Withdrawal by Subject|2|||
33144403|NCT00686998|100441787|FG001|Overall Study|Withdrawal by Subject|1|||
33242472|NCT00248287|100789051|FG000|Overall Study|Adverse Event|11|||
33581849|NCT01804049|102020217|FG000|Overall Study|other MD recommended|1|||
33581850|NCT01804049|102020218|FG001|Overall Study|other MD recommended|1|||
33581851|NCT01804049|102020217|FG000|Overall Study|Enrollment in dual studies|0|||
33581852|NCT01804049|102020218|FG001|Overall Study|Enrollment in dual studies|1|||
33581853|NCT03896477|102020219|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
33581854|NCT03896477|102020220|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
33581855|NCT03896477|102020221|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
33581856|NCT03896477|102020219|FG000|Overall Study|Parent Requested Withdrawal|8|||
33581857|NCT03896477|102020220|FG001|Overall Study|Parent Requested Withdrawal|12|||
33642560|NCT02023697|102244118|FG001|Treatment Period|Clinical progression|8|||
33642561|NCT02023697|102244119|FG002|Treatment Period|Clinical progression|28|||
33642562|NCT02023697|102244117|FG000|Treatment Period|Withdrawal by Subject|4|||
33642563|NCT02023697|102244118|FG001|Treatment Period|Withdrawal by Subject|5|||
33144404|NCT00686998|100441788|FG002|Overall Study|Withdrawal by Subject|2|||
33242473|NCT00248287|100789052|FG001|Overall Study|Adverse Event|10|||
33581858|NCT03896477|102020221|FG002|Overall Study|Parent Requested Withdrawal|9|||
33581859|NCT03896477|102020219|FG000|Overall Study|Adverse Event|0|||
33642564|NCT02023697|102244119|FG002|Treatment Period|Withdrawal by Subject|13|||
33642565|NCT02023697|102244117|FG000|Treatment Period|Safety outcome reached|0|||
33642566|NCT02023697|102244118|FG001|Treatment Period|Safety outcome reached|1|||
33642567|NCT02023697|102244119|FG002|Treatment Period|Safety outcome reached|0|||
33144405|NCT00686998|100441786|FG000|Overall Study|Lack of Efficacy|7|||
33581860|NCT03896477|102020220|FG001|Overall Study|Adverse Event|0|||
33581861|NCT03896477|102020221|FG002|Overall Study|Adverse Event|1|||
33581862|NCT03896477|102020219|FG000|Overall Study|Death|1|||
33642568|NCT02023697|102244117|FG000|Treatment Period|Physician Decision|0|||
33642569|NCT02023697|102244118|FG001|Treatment Period|Physician Decision|0|||
33642570|NCT02023697|102244119|FG002|Treatment Period|Physician Decision|1|||
33642571|NCT02023697|102244117|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
33581863|NCT03896477|102020220|FG001|Overall Study|Death|0|||
33581864|NCT03896477|102020221|FG002|Overall Study|Death|0|||
33581865|NCT03896477|102020219|FG000|Overall Study|Other|5|||
33581866|NCT03896477|102020220|FG001|Overall Study|Other|6|||
33581867|NCT03896477|102020221|FG002|Overall Study|Other|7|||
33581868|NCT03896477|102020219|FG000|Overall Study|Lost to Follow-up|2|||
33581869|NCT03896477|102020220|FG001|Overall Study|Lost to Follow-up|1|||
33581870|NCT03896477|102020221|FG002|Overall Study|Lost to Follow-up|1|||
33581871|NCT02257242|102020224|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
33581872|NCT02257242|102020225|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33581873|NCT02257242|102020226|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33581874|NCT02257242|102020227|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33581875|NCT02257242|102020228|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33581876|NCT02257242|102020229|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33581877|NCT02257242|102020230|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33581878|NCT02257242|102020231|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33581879|NCT02257242|102020232|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
33581880|NCT00334737|102020235|FG000|Hospital Phase|Death|1|||
33581881|NCT00334737|102020236|FG001|Hospital Phase|Death|2|||
33581882|NCT00334737|102020237|FG002|Hospital Phase|Death|3|||
33581883|NCT00334737|102020235|FG000|Hospital Phase|Withdrawal by Subject|0|||
33581884|NCT00334737|102020236|FG001|Hospital Phase|Withdrawal by Subject|0|||
33581885|NCT00334737|102020237|FG002|Hospital Phase|Withdrawal by Subject|1|||
33581886|NCT00334737|102020235|FG000|Hospital Phase|Did not receive study drug|1|||
33581887|NCT00334737|102020236|FG001|Hospital Phase|Did not receive study drug|0|||
33581888|NCT00334737|102020237|FG002|Hospital Phase|Did not receive study drug|0|||
33581889|NCT00334737|102020235|FG000|Follow up Phase|Lost to Follow-up|5|||
33581890|NCT00334737|102020236|FG001|Follow up Phase|Lost to Follow-up|3|||
33581891|NCT00334737|102020237|FG002|Follow up Phase|Lost to Follow-up|6|||
33581892|NCT02820844|102020239|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
33581893|NCT02820844|102020240|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
33581894|NCT02820844|102020241|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
33642572|NCT02023697|102244118|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
33642573|NCT02023697|102244119|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
33642574|NCT02023697|102244117|FG000|Active Follow-up Period|Lost to Follow-up|1|||
33642575|NCT02023697|102244118|FG001|Active Follow-up Period|Lost to Follow-up|1|||
33642576|NCT02023697|102244119|FG002|Active Follow-up Period|Lost to Follow-up|1|||
33642577|NCT02023697|102244117|FG000|Active Follow-up Period|Deterioration of general condition|1|||
33642578|NCT02023697|102244118|FG001|Active Follow-up Period|Deterioration of general condition|1|||
33642579|NCT02023697|102244119|FG002|Active Follow-up Period|Deterioration of general condition|1|||
33642580|NCT02023697|102244117|FG000|Active Follow-up Period|Other unspecified|2|||
33642581|NCT02023697|102244118|FG001|Active Follow-up Period|Other unspecified|0|||
33642582|NCT02023697|102244119|FG002|Active Follow-up Period|Other unspecified|1|||
33642583|NCT02023697|102244117|FG000|Active Follow-up Period|Clinical progression|0|||
33642584|NCT02023697|102244118|FG001|Active Follow-up Period|Clinical progression|2|||
33642585|NCT02023697|102244119|FG002|Active Follow-up Period|Clinical progression|1|||
33642586|NCT02023697|102244117|FG000|Active Follow-up Period|Radiological progression|0|||
33642587|NCT02023697|102244118|FG001|Active Follow-up Period|Radiological progression|0|||
33642588|NCT02023697|102244119|FG002|Active Follow-up Period|Radiological progression|1|||
33642589|NCT02023697|102244117|FG000|Active Follow-up Period|Death|83|||
33642590|NCT02023697|102244118|FG001|Active Follow-up Period|Death|82|||
33642591|NCT02023697|102244119|FG002|Active Follow-up Period|Death|87|||
33642592|NCT02023697|102244117|FG000|Long-term Follow-up Period|Death|9|||
33642593|NCT02023697|102244118|FG001|Long-term Follow-up Period|Death|6|||
33642594|NCT02023697|102244119|FG002|Long-term Follow-up Period|Death|4|||
33642595|NCT02023697|102244117|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
33642596|NCT02023697|102244118|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
33642597|NCT02023697|102244119|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
33642598|NCT02023697|102244117|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
33642599|NCT02023697|102244118|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
33642600|NCT02023697|102244119|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
33642601|NCT02023697|102244117|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
33642602|NCT02023697|102244118|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
33642603|NCT02023697|102244119|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
33642604|NCT02023697|102244117|FG000|Long-term Follow-up Period|Technical problems|0|||
33642605|NCT02023697|102244118|FG001|Long-term Follow-up Period|Technical problems|0|||
33642606|NCT02023697|102244119|FG002|Long-term Follow-up Period|Technical problems|1|||
33642607|NCT02023697|102244117|FG000|Long-term Follow-up Period|Other unspecified|6|||
33144406|NCT00686998|100441787|FG001|Overall Study|Lack of Efficacy|5|||
33144407|NCT00686998|100441788|FG002|Overall Study|Lack of Efficacy|0|||
33144408|NCT00686998|100441786|FG000|Overall Study|Other|0|||
33144409|NCT00686998|100441787|FG001|Overall Study|Other|0|||
33144410|NCT00686998|100441788|FG002|Overall Study|Other|1|||
33144411|NCT00686998|100441786|FG000|Overall Study|Safety Reasons|1|||
33642608|NCT02023697|102244118|FG001|Long-term Follow-up Period|Other unspecified|3|||
33642609|NCT02023697|102244119|FG002|Long-term Follow-up Period|Other unspecified|5|||
33642610|NCT01519869|102244122|FG000|Overall Study|Lost to Follow-up|1|||
33642611|NCT00607373|102244123|FG000|Treatment Period|Adverse Event|0|||
33642612|NCT00607373|102244124|FG001|Treatment Period|Adverse Event|4|||
33642613|NCT00607373|102244123|FG000|Treatment Period|Physician Decision|0|||
33642614|NCT00607373|102244124|FG001|Treatment Period|Physician Decision|1|||
33642615|NCT00607373|102244123|FG000|Treatment Period|Withdrawal by Subject|0|||
33242474|NCT00248287|100789051|FG000|Overall Study|Death|1|||
33242475|NCT00248287|100789052|FG001|Overall Study|Death|0|||
33242476|NCT00248287|100789051|FG000|Overall Study|Lost to Follow-up|0|||
33242477|NCT00248287|100789052|FG001|Overall Study|Lost to Follow-up|1|||
33242478|NCT00248287|100789051|FG000|Overall Study|Investigator Request|4|||
33242479|NCT00248287|100789052|FG001|Overall Study|Investigator Request|3|||
33242480|NCT00248287|100789051|FG000|Overall Study|Patient Request|5|||
33242481|NCT00248287|100789052|FG001|Overall Study|Patient Request|3|||
33242482|NCT00248287|100789051|FG000|Overall Study|Other|3|||
33242483|NCT00248287|100789052|FG001|Overall Study|Other|2|||
33242484|NCT01878890|100789053|FG000|Overall Study|Protocol Violation|0|||
33242485|NCT01878890|100789054|FG001|Overall Study|Protocol Violation|1|||
33242486|NCT01878890|100789055|FG002|Overall Study|Protocol Violation|0|||
33242487|NCT01878890|100789056|FG003|Overall Study|Protocol Violation|0|||
33242488|NCT00748969|100789059|FG000|Overall Study|Withdrawal by Subject|1|||
33242489|NCT00748969|100789060|FG001|Overall Study|Withdrawal by Subject|0|||
33242490|NCT00748969|100789059|FG000|Overall Study|Withdrawal by Subject|0|||
33242491|NCT00748969|100789060|FG001|Overall Study|Withdrawal by Subject|1|||
33242492|NCT01101542|100789061|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
33242493|NCT01101542|100789061|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
33242494|NCT01101542|100789061|FG000|Year 4 Surveillance Period|Other|287|||
33242495|NCT01101542|100789061|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
33242496|NCT01101542|100789061|FG000|Year 5 Surveillance Period|Pregnancy|1|||
33242497|NCT01101542|100789061|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
33242498|NCT01101542|100789061|FG000|Year 6 Surveillance Period|Pregnancy|1|||
33242499|NCT01101542|100789061|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
33242500|NCT02692235|100789062|FG000|Overall Study|Withdrawal by Subject|2|||
33242501|NCT02692235|100789063|FG001|Overall Study|Withdrawal by Subject|1|||
33242502|NCT02692235|100789062|FG000|Overall Study|Adverse Event|1|||
33242503|NCT02692235|100789063|FG001|Overall Study|Adverse Event|2|||
33242504|NCT00797225|100789064|FG000|Weeks 1 to 12|Adverse Event|0|||
33242505|NCT00797225|100789065|FG001|Weeks 1 to 12|Adverse Event|0|||
33242506|NCT00797225|100789066|FG002|Weeks 1 to 12|Adverse Event|1|||
33242507|NCT00797225|100789067|FG003|Weeks 1 to 12|Adverse Event|0|||
33371867|NCT02399813|101247576|FG000|Overall Study|Lost to Follow-up|2|||
33371868|NCT02399813|101247576|FG000|Overall Study|Other than specified|5|||
33371869|NCT01008995|101247579|FG000|Controlled Period|Adverse Event|1|||
33371870|NCT01008995|101247580|FG001|Controlled Period|Adverse Event|2|||
33421775|NCT00563524|101434960|FG000|Overall Study|Adverse Event|0|||
33642616|NCT00607373|102244124|FG001|Treatment Period|Withdrawal by Subject|1|||
33144412|NCT00686998|100441787|FG001|Overall Study|Safety Reasons|0|||
33371871|NCT01008995|101247581|FG002|Controlled Period|Adverse Event|0|||
33371872|NCT01008995|101247582|FG003|Controlled Period|Adverse Event|0|||
33371873|NCT01008995|101247579|FG000|Controlled Period|Other|2|||
33371874|NCT01008995|101247580|FG001|Controlled Period|Other|1|||
33371875|NCT01008995|101247581|FG002|Controlled Period|Other|0|||
33371876|NCT01008995|101247582|FG003|Controlled Period|Other|0|||
33371877|NCT01008995|101247579|FG000|After Controlled Period|Adverse Event|0|||
33371878|NCT01008995|101247580|FG001|After Controlled Period|Adverse Event|0|||
33421776|NCT00563524|101434961|FG001|Overall Study|Adverse Event|1|||
33642617|NCT00607373|102244123|FG000|Follow-up Period|Other|0|||
33144413|NCT00686998|100441788|FG002|Overall Study|Safety Reasons|0|||
33144414|NCT00999921|100441791|FG000|Overall Study|Lost to Follow-up|10|||
33242508|NCT00797225|100789068|FG004|Weeks 1 to 12|Adverse Event|0|||
33242509|NCT00797225|100789069|FG005|Weeks 1 to 12|Adverse Event|0|||
33242510|NCT00797225|100789070|FG006|Weeks 1 to 12|Adverse Event|0|||
33242511|NCT00797225|100789071|FG007|Weeks 1 to 12|Adverse Event|0|||
33242512|NCT00797225|100789064|FG000|Weeks 1 to 12|Non-compliance|0|||
33642618|NCT00607373|102244124|FG001|Follow-up Period|Other|1|||
33642619|NCT00607373|102244123|FG000|Follow-up Period|Protocol Violation|0|||
33144415|NCT00999921|100441792|FG001|Overall Study|Lost to Follow-up|19|||
33242513|NCT00797225|100789065|FG001|Weeks 1 to 12|Non-compliance|1|||
33371879|NCT01008995|101247581|FG002|After Controlled Period|Adverse Event|1|||
33144416|NCT02582255|100441793|FG000|Overall Study|Protocol Violation|0|||
33371880|NCT01008995|101247582|FG003|After Controlled Period|Adverse Event|1|||
33242514|NCT00797225|100789066|FG002|Weeks 1 to 12|Non-compliance|0|||
33242515|NCT00797225|100789067|FG003|Weeks 1 to 12|Non-compliance|0|||
33242516|NCT00797225|100789068|FG004|Weeks 1 to 12|Non-compliance|0|||
33242517|NCT00797225|100789069|FG005|Weeks 1 to 12|Non-compliance|0|||
33242518|NCT00797225|100789070|FG006|Weeks 1 to 12|Non-compliance|0|||
33242519|NCT00797225|100789071|FG007|Weeks 1 to 12|Non-compliance|0|||
33242520|NCT00797225|100789064|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
33242521|NCT00797225|100789065|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
33242522|NCT00797225|100789066|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
33242523|NCT00797225|100789067|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
33242524|NCT00797225|100789068|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
33242525|NCT00797225|100789069|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
33242526|NCT00797225|100789070|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
33242527|NCT00797225|100789071|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
33242528|NCT00797225|100789064|FG000|Weeks 1 to 12|Sponsor Decision|1|||
33242529|NCT00797225|100789065|FG001|Weeks 1 to 12|Sponsor Decision|0|||
33242530|NCT00797225|100789066|FG002|Weeks 1 to 12|Sponsor Decision|0|||
33242531|NCT00797225|100789067|FG003|Weeks 1 to 12|Sponsor Decision|0|||
33242532|NCT00797225|100789068|FG004|Weeks 1 to 12|Sponsor Decision|0|||
33242533|NCT00797225|100789069|FG005|Weeks 1 to 12|Sponsor Decision|0|||
33242534|NCT00797225|100789070|FG006|Weeks 1 to 12|Sponsor Decision|0|||
33242535|NCT00797225|100789071|FG007|Weeks 1 to 12|Sponsor Decision|0|||
33242536|NCT00797225|100789064|FG000|Weeks 13 to 24|Non-compliance|0|||
33242537|NCT00797225|100789065|FG001|Weeks 13 to 24|Non-compliance|2|||
33242538|NCT00797225|100789066|FG002|Weeks 13 to 24|Non-compliance|0|||
33242539|NCT00797225|100789067|FG003|Weeks 13 to 24|Non-compliance|0|||
33242540|NCT00797225|100789068|FG004|Weeks 13 to 24|Non-compliance|0|||
33242541|NCT00797225|100789069|FG005|Weeks 13 to 24|Non-compliance|0|||
33242542|NCT00797225|100789070|FG006|Weeks 13 to 24|Non-compliance|0|||
33242543|NCT00797225|100789071|FG007|Weeks 13 to 24|Non-compliance|0|||
33242544|NCT00797225|100789064|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
33242545|NCT00797225|100789065|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
33242546|NCT00797225|100789066|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
33242547|NCT00797225|100789067|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
33242548|NCT00797225|100789068|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
33242549|NCT00797225|100789069|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
33242550|NCT00797225|100789070|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
33242551|NCT00797225|100789071|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
33242552|NCT00797225|100789064|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
33242553|NCT00797225|100789065|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
33242554|NCT00797225|100789066|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
33242555|NCT00797225|100789067|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
33242556|NCT00797225|100789068|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
33242557|NCT00797225|100789069|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
33242558|NCT00797225|100789070|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
33242559|NCT00797225|100789071|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
33371881|NCT01008995|101247579|FG000|After Controlled Period|Other|0|||
33371882|NCT01008995|101247580|FG001|After Controlled Period|Other|0|||
33371883|NCT01008995|101247581|FG002|After Controlled Period|Other|1|||
33371884|NCT01008995|101247582|FG003|After Controlled Period|Other|0|||
33371885|NCT01514188|101247583|FG000|Overall Study|Adverse Event|3|||
33371886|NCT01514188|101247584|FG001|Overall Study|Adverse Event|5|||
33371887|NCT01514188|101247583|FG000|Overall Study|Withdrawal by Subject|2|||
33371888|NCT01514188|101247584|FG001|Overall Study|Withdrawal by Subject|4|||
33371889|NCT01514188|101247583|FG000|Overall Study|Protocol Violation|2|||
33371890|NCT01514188|101247584|FG001|Overall Study|Protocol Violation|4|||
33371891|NCT01514188|101247583|FG000|Overall Study|Physician Decision|0|||
33371892|NCT01514188|101247584|FG001|Overall Study|Physician Decision|2|||
33371893|NCT01514188|101247583|FG000|Overall Study|Disease Progression|13|||
33371894|NCT01514188|101247584|FG001|Overall Study|Disease Progression|14|||
33371895|NCT01514188|101247583|FG000|Overall Study|Death|1|||
33421777|NCT00563524|101434962|FG002|Overall Study|Adverse Event|0|||
33421778|NCT00563524|101434963|FG003|Overall Study|Adverse Event|0|||
33421779|NCT00563524|101434964|FG004|Overall Study|Adverse Event|2|||
33242560|NCT00797225|100789064|FG000|Weeks 13 to 24|Adverse Event|0|||
33242561|NCT00797225|100789065|FG001|Weeks 13 to 24|Adverse Event|1|||
33242562|NCT00797225|100789066|FG002|Weeks 13 to 24|Adverse Event|0|||
33242563|NCT00797225|100789067|FG003|Weeks 13 to 24|Adverse Event|0|||
33242564|NCT00797225|100789068|FG004|Weeks 13 to 24|Adverse Event|0|||
33242565|NCT00797225|100789069|FG005|Weeks 13 to 24|Adverse Event|0|||
33242566|NCT00797225|100789070|FG006|Weeks 13 to 24|Adverse Event|1|||
33242567|NCT00797225|100789071|FG007|Weeks 13 to 24|Adverse Event|0|||
33242568|NCT00797225|100789064|FG000|Weeks 13 to 24|Sponsor Decision|0|||
33242569|NCT00797225|100789065|FG001|Weeks 13 to 24|Sponsor Decision|0|||
33242570|NCT00797225|100789066|FG002|Weeks 13 to 24|Sponsor Decision|0|||
33242571|NCT00797225|100789067|FG003|Weeks 13 to 24|Sponsor Decision|0|||
33242572|NCT00797225|100789068|FG004|Weeks 13 to 24|Sponsor Decision|0|||
33371896|NCT01514188|101247584|FG001|Overall Study|Death|3|||
33371897|NCT01514188|101247583|FG000|Overall Study|Other|2|||
33371898|NCT01514188|101247584|FG001|Overall Study|Other|1|||
33421780|NCT00563524|101434965|FG005|Overall Study|Adverse Event|0|||
33242573|NCT00797225|100789069|FG005|Weeks 13 to 24|Sponsor Decision|0|||
33242574|NCT00797225|100789070|FG006|Weeks 13 to 24|Sponsor Decision|1|||
33371899|NCT00926796|101247585|FG000|Overall Study|Did not receive randomized treatment|4|||
33581895|NCT02820844|102020242|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
33371900|NCT00926796|101247586|FG001|Overall Study|Did not receive randomized treatment|7|||
33371901|NCT00926796|101247585|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
33371902|NCT00926796|101247586|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
33371903|NCT00926796|101247585|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
33371904|NCT00926796|101247586|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
33581896|NCT02820844|102020243|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
33581897|NCT02820844|102020244|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
33242575|NCT00797225|100789071|FG007|Weeks 13 to 24|Sponsor Decision|0|||
33242576|NCT02424344|100789072|FG000|Overall Study|Lack of Efficacy|0|||
33242577|NCT02424344|100789073|FG001|Overall Study|Lack of Efficacy|1|||
33242578|NCT02424344|100789072|FG000|Overall Study|Withdrawal by Subject|2|||
33242579|NCT02424344|100789073|FG001|Overall Study|Withdrawal by Subject|1|||
33242580|NCT02424344|100789072|FG000|Overall Study|Lost to Follow-up|1|||
33242581|NCT02424344|100789073|FG001|Overall Study|Lost to Follow-up|0|||
33242582|NCT02424344|100789072|FG000|Overall Study|Adverse Event|4|||
33242583|NCT02424344|100789073|FG001|Overall Study|Adverse Event|8|||
33242584|NCT04034238|100789074|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
33242585|NCT04034238|100789075|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
33242586|NCT04034238|100789076|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
33242587|NCT04034238|100789077|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
33242588|NCT04034238|100789074|FG000|Dose Escalation Phase|Screen failures|0|||
33242589|NCT04034238|100789075|FG001|Dose Escalation Phase|Screen failures|0|||
33242590|NCT04034238|100789076|FG002|Dose Escalation Phase|Screen failures|0|||
33242591|NCT04034238|100789077|FG003|Dose Escalation Phase|Screen failures|2|||
33242592|NCT04034238|100789074|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
33242593|NCT04034238|100789075|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
33242594|NCT04034238|100789076|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
33242595|NCT04034238|100789077|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
33242596|NCT04034238|100789074|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
33242597|NCT04034238|100789075|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
33242598|NCT04034238|100789076|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
33242599|NCT04034238|100789077|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
33242600|NCT04610684|100789079|FG000|Study Treatment|Withdrawal by Subject|1|||
33242601|NCT04610684|100789079|FG000|Study Treatment|Disease Progression|2|||
33242602|NCT04610684|100789079|FG000|Follow up|Death|2|||
33242603|NCT04610684|100789079|FG000|Follow up|Withdrawal by Subject|1|||
33242604|NCT01941316|100789081|FG000|Overall Study|Adverse Event|0|||
33242605|NCT01941316|100789082|FG001|Overall Study|Adverse Event|1|||
33242606|NCT01941316|100789083|FG002|Overall Study|Adverse Event|0|||
33242607|NCT01941316|100789084|FG003|Overall Study|Adverse Event|7|||
33242608|NCT01941316|100789081|FG000|Overall Study|Progressive Disease|3|||
33242609|NCT01941316|100789082|FG001|Overall Study|Progressive Disease|6|||
33242610|NCT01941316|100789083|FG002|Overall Study|Progressive Disease|2|||
33242611|NCT01941316|100789084|FG003|Overall Study|Progressive Disease|29|||
33242612|NCT01941316|100789081|FG000|Overall Study|Withdrawal by Subject|0|||
33242613|NCT01941316|100789082|FG001|Overall Study|Withdrawal by Subject|2|||
33242614|NCT01941316|100789083|FG002|Overall Study|Withdrawal by Subject|1|||
33242615|NCT01941316|100789084|FG003|Overall Study|Withdrawal by Subject|8|||
33242616|NCT01941316|100789081|FG000|Overall Study|Death|0|||
33242617|NCT01941316|100789082|FG001|Overall Study|Death|0|||
33242618|NCT01941316|100789083|FG002|Overall Study|Death|0|||
33242619|NCT01941316|100789084|FG003|Overall Study|Death|3|||
33242620|NCT01941316|100789081|FG000|Overall Study|Physician Decision|0|||
33242621|NCT01941316|100789082|FG001|Overall Study|Physician Decision|0|||
33242622|NCT01941316|100789083|FG002|Overall Study|Physician Decision|0|||
33242623|NCT01941316|100789084|FG003|Overall Study|Physician Decision|3|||
33242624|NCT01941316|100789081|FG000|Overall Study|Protocol Violation|0|||
33242625|NCT01941316|100789082|FG001|Overall Study|Protocol Violation|0|||
33242626|NCT01941316|100789083|FG002|Overall Study|Protocol Violation|0|||
33242627|NCT01941316|100789084|FG003|Overall Study|Protocol Violation|3|||
33242628|NCT01941316|100789081|FG000|Overall Study|Intercurrent illness|0|||
33242629|NCT01941316|100789082|FG001|Overall Study|Intercurrent illness|0|||
33242630|NCT01941316|100789083|FG002|Overall Study|Intercurrent illness|0|||
33242631|NCT01941316|100789084|FG003|Overall Study|Intercurrent illness|1|||
33242632|NCT01941316|100789081|FG000|Overall Study|Other, not specified|0|||
33242633|NCT01941316|100789082|FG001|Overall Study|Other, not specified|0|||
33242634|NCT01941316|100789083|FG002|Overall Study|Other, not specified|0|||
33371905|NCT00926796|101247585|FG000|Overall Study|Adverse Event|7|||
33242635|NCT01941316|100789084|FG003|Overall Study|Other, not specified|1|||
33242636|NCT04730947|100789085|FG000|Overall Study|Withdrawal by Subject|0|||
33421781|NCT00563524|101434960|FG000|Overall Study|Lost to Follow-up|1|||
33421782|NCT00563524|101434961|FG001|Overall Study|Lost to Follow-up|0|||
33421783|NCT00563524|101434962|FG002|Overall Study|Lost to Follow-up|0|||
33421784|NCT00563524|101434963|FG003|Overall Study|Lost to Follow-up|0|||
33421785|NCT00563524|101434964|FG004|Overall Study|Lost to Follow-up|0|||
33421786|NCT00563524|101434965|FG005|Overall Study|Lost to Follow-up|0|||
33421787|NCT00563524|101434960|FG000|Overall Study|Protocol Violation|0|||
33242637|NCT04730947|100789086|FG001|Overall Study|Withdrawal by Subject|1|||
33242638|NCT02263885|100789087|FG000|Overall Study|Withdrawal by Subject|7|||
33242639|NCT02263885|100789087|FG000|Overall Study|Alternative Treatment|3|||
33242640|NCT00578227|100789094|FG000|Overall Study|Lost to Follow-up|0|||
33242641|NCT00578227|100789095|FG001|Overall Study|Lost to Follow-up|1|||
33242642|NCT00578227|100789096|FG002|Overall Study|Lost to Follow-up|1|||
33242643|NCT00578227|100789094|FG000|Overall Study|Withdrawal by Subject|5|||
33242644|NCT00578227|100789095|FG001|Overall Study|Withdrawal by Subject|1|||
33371906|NCT00926796|101247586|FG001|Overall Study|Adverse Event|14|||
33371907|NCT00926796|101247585|FG000|Overall Study|Lost to Follow-up|22|||
33371908|NCT00926796|101247586|FG001|Overall Study|Lost to Follow-up|13|||
33371909|NCT00926796|101247585|FG000|Overall Study|Protocol Violation|15|||
33371910|NCT00926796|101247586|FG001|Overall Study|Protocol Violation|11|||
33371911|NCT00926796|101247585|FG000|Overall Study|Withdrawal by Subject|1|||
33371912|NCT00926796|101247586|FG001|Overall Study|Withdrawal by Subject|0|||
33371913|NCT03126539|101247587|FG000|Overall Study|Lost to Follow-up|1|||
33371914|NCT03126539|101247588|FG001|Overall Study|Lost to Follow-up|1|||
33371915|NCT03126539|101247589|FG002|Overall Study|Lost to Follow-up|1|||
33371916|NCT03126539|101247590|FG003|Overall Study|Lost to Follow-up|0|||
33371917|NCT03126539|101247591|FG004|Overall Study|Lost to Follow-up|0|||
33371918|NCT02128763|101247598|FG000|Overall Study|Death|1|||
33371919|NCT02128763|101247599|FG001|Overall Study|Death|0|||
33371920|NCT02128763|101247598|FG000|Overall Study|Lost to Follow-up|19|||
33371921|NCT02128763|101247599|FG001|Overall Study|Lost to Follow-up|16|||
33371922|NCT00632463|101247600|FG000|Overall Study|Adverse Event|0|||
33371923|NCT00632463|101247601|FG001|Overall Study|Adverse Event|1|||
33371924|NCT00632463|101247602|FG002|Overall Study|Adverse Event|0|||
33371925|NCT03855137|101247603|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
33371926|NCT03855137|101247604|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
33371927|NCT03855137|101247605|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
33371928|NCT03855137|101247603|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
33371929|NCT03855137|101247604|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
33371930|NCT03855137|101247605|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
33371931|NCT03855137|101247603|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
33371932|NCT03855137|101247604|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
33371933|NCT03855137|101247605|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
33371934|NCT03855137|101247603|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
33371935|NCT03855137|101247604|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
33371936|NCT03855137|101247605|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
33371937|NCT03855137|101247603|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
33371938|NCT03855137|101247604|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
33371939|NCT03855137|101247605|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
33371940|NCT03855137|101247603|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
33371941|NCT03855137|101247604|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
33371942|NCT03855137|101247605|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
33371943|NCT03855137|101247603|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
33371944|NCT03855137|101247604|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
33371945|NCT03855137|101247605|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
33371946|NCT03855137|101247603|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
33371947|NCT03855137|101247604|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
33371948|NCT03855137|101247605|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
33371949|NCT03855137|101247603|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
33371950|NCT03855137|101247604|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
33371951|NCT03855137|101247605|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
33371952|NCT03855137|101247603|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
33371953|NCT03855137|101247604|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
33371954|NCT03855137|101247605|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
33371955|NCT05836818|101247606|FG000|Overall Study|Physician Decision|1|||
33371956|NCT05836818|101247607|FG001|Overall Study|Physician Decision|1|||
33371957|NCT05836818|101247608|FG002|Overall Study|Physician Decision|0|||
33371958|NCT05836818|101247606|FG000|Overall Study|Withdrawal by Subject|0|||
33371959|NCT05836818|101247607|FG001|Overall Study|Withdrawal by Subject|0|||
33371960|NCT05836818|101247608|FG002|Overall Study|Withdrawal by Subject|1|||
33421788|NCT00563524|101434961|FG001|Overall Study|Protocol Violation|1|||
33421789|NCT00563524|101434962|FG002|Overall Study|Protocol Violation|0|||
33242645|NCT00578227|100789096|FG002|Overall Study|Withdrawal by Subject|3|||
33242646|NCT05489224|100789097|FG000|Treatment Period I|Withdrawal by Subject|6|||
33242647|NCT05489224|100789098|FG001|Treatment Period I|Withdrawal by Subject|5|||
33242648|NCT05489224|100789099|FG002|Treatment Period I|Withdrawal by Subject|0|||
33242649|NCT05489224|100789097|FG000|Treatment Period I|Adverse Event|3|||
33642620|NCT00607373|102244124|FG001|Follow-up Period|Protocol Violation|1|||
33642621|NCT00607373|102244123|FG000|Follow-up Period|Withdrawal by Subject|1|||
33642622|NCT00607373|102244124|FG001|Follow-up Period|Withdrawal by Subject|3|||
33642623|NCT00334113|102244127|FG000|Overall Study|Lost to Follow-up|2|||
33642624|NCT00334113|102244128|FG001|Overall Study|Lost to Follow-up|2|||
33642625|NCT00334113|102244127|FG000|Overall Study|Withdrawal by Subject|0|||
33642626|NCT00334113|102244128|FG001|Overall Study|Withdrawal by Subject|1|||
33642627|NCT00867815|102244129|FG000|Overall Study|Lost to Follow-up|1|||
33642628|NCT02872935|102244131|FG000|Overall Study|Other|0|||
33642629|NCT02872935|102244132|FG001|Overall Study|Other|1|||
33642630|NCT00006289|102244133|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
33642631|NCT00006289|102244134|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
33642632|NCT00006289|102244133|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
33642633|NCT00006289|102244134|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
33642634|NCT01229267|102244136|FG000|Overall Study|Adverse Event|4|||
33642635|NCT01229267|102244137|FG001|Overall Study|Adverse Event|6|||
33642636|NCT01229267|102244138|FG002|Overall Study|Adverse Event|3|||
33642637|NCT01229267|102244139|FG003|Overall Study|Adverse Event|2|||
33642638|NCT01229267|102244140|FG004|Overall Study|Adverse Event|10|||
33642639|NCT01229267|102244136|FG000|Overall Study|Death|40|||
33642640|NCT01229267|102244137|FG001|Overall Study|Death|37|||
33642641|NCT01229267|102244138|FG002|Overall Study|Death|35|||
33642642|NCT01229267|102244139|FG003|Overall Study|Death|13|||
33642643|NCT01229267|102244140|FG004|Overall Study|Death|103|||
33642644|NCT01229267|102244136|FG000|Overall Study|Withdrawal by Subject|23|||
33642645|NCT01229267|102244137|FG001|Overall Study|Withdrawal by Subject|22|||
33642646|NCT01229267|102244138|FG002|Overall Study|Withdrawal by Subject|32|||
33642647|NCT01229267|102244139|FG003|Overall Study|Withdrawal by Subject|14|||
33642648|NCT01229267|102244140|FG004|Overall Study|Withdrawal by Subject|59|||
33642649|NCT01229267|102244136|FG000|Overall Study|Protocol Violation|0|||
33642650|NCT01229267|102244137|FG001|Overall Study|Protocol Violation|1|||
33642651|NCT01229267|102244138|FG002|Overall Study|Protocol Violation|0|||
33642652|NCT01229267|102244139|FG003|Overall Study|Protocol Violation|0|||
33642653|NCT01229267|102244140|FG004|Overall Study|Protocol Violation|0|||
33642654|NCT01229267|102244136|FG000|Overall Study|Progressive disease|0|||
33642655|NCT01229267|102244137|FG001|Overall Study|Progressive disease|0|||
33642656|NCT01229267|102244138|FG002|Overall Study|Progressive disease|0|||
33642657|NCT01229267|102244139|FG003|Overall Study|Progressive disease|0|||
33642658|NCT01229267|102244140|FG004|Overall Study|Progressive disease|1|||
33642659|NCT01229267|102244136|FG000|Overall Study|Physician Decision|8|||
33642660|NCT01229267|102244137|FG001|Overall Study|Physician Decision|11|||
33642661|NCT01229267|102244138|FG002|Overall Study|Physician Decision|8|||
33642662|NCT01229267|102244139|FG003|Overall Study|Physician Decision|3|||
33642663|NCT01229267|102244140|FG004|Overall Study|Physician Decision|25|||
33642664|NCT01229267|102244136|FG000|Overall Study|Lost to Follow-up|6|||
33642665|NCT01229267|102244137|FG001|Overall Study|Lost to Follow-up|5|||
33642666|NCT01229267|102244138|FG002|Overall Study|Lost to Follow-up|8|||
33642667|NCT01229267|102244139|FG003|Overall Study|Lost to Follow-up|3|||
33642668|NCT01229267|102244140|FG004|Overall Study|Lost to Follow-up|22|||
33642669|NCT00899431|102244141|FG000|Overall Study|Physician Decision|1|||
33642670|NCT00899431|102244142|FG001|Overall Study|Physician Decision|0|||
33642671|NCT00899431|102244143|FG002|Overall Study|Physician Decision|0|||
33642672|NCT00423917|102244145|FG000|Overall Study|Cancel|2|||
33642673|NCT00423917|102244145|FG000|Overall Study|Ineligible|1|||
33642674|NCT01039376|102244154|FG000|Overall Study|Lost to Follow-up|5|||
33642675|NCT01039376|102244155|FG001|Overall Study|Lost to Follow-up|12|||
33642676|NCT01039376|102244154|FG000|Overall Study|Physician Decision|15|||
33642677|NCT01039376|102244155|FG001|Overall Study|Physician Decision|10|||
33642678|NCT01039376|102244154|FG000|Overall Study|Withdrawal by Subject|20|||
33642679|NCT01039376|102244155|FG001|Overall Study|Withdrawal by Subject|32|||
33642680|NCT01039376|102244154|FG000|Overall Study|Study terminated by Sponsor|90|||
33642681|NCT01039376|102244155|FG001|Overall Study|Study terminated by Sponsor|72|||
33242650|NCT05489224|100789098|FG001|Treatment Period I|Adverse Event|11|||
33642682|NCT04816669|102244156|FG000|Part 1|Adverse Event|1|||
33642683|NCT04816669|102244157|FG001|Part 1|Adverse Event|1|||
33642684|NCT04816669|102244158|FG002|Part 1|Adverse Event|0|||
33642685|NCT04816669|102244159|FG003|Part 1|Adverse Event|0|||
33642686|NCT04816669|102244156|FG000|Part 1|Lost to Follow-up|2|||
33642687|NCT04816669|102244157|FG001|Part 1|Lost to Follow-up|2|||
33642688|NCT04816669|102244158|FG002|Part 1|Lost to Follow-up|0|||
33642689|NCT04816669|102244159|FG003|Part 1|Lost to Follow-up|0|||
33642690|NCT04816669|102244156|FG000|Part 1|Protocol Violation|0|||
33642691|NCT04816669|102244157|FG001|Part 1|Protocol Violation|1|||
33242651|NCT05489224|100789099|FG002|Treatment Period I|Adverse Event|0|||
33421790|NCT00563524|101434963|FG003|Overall Study|Protocol Violation|0|||
33642692|NCT04816669|102244158|FG002|Part 1|Protocol Violation|0|||
33642693|NCT04816669|102244159|FG003|Part 1|Protocol Violation|0|||
33642694|NCT04816669|102244156|FG000|Part 1|Withdrawal by Subject|1|||
33642695|NCT04816669|102244157|FG001|Part 1|Withdrawal by Subject|2|||
33642696|NCT04816669|102244158|FG002|Part 1|Withdrawal by Subject|0|||
33642697|NCT04816669|102244159|FG003|Part 1|Withdrawal by Subject|0|||
33642698|NCT04816669|102244156|FG000|Part 2|Other|0|||
33642699|NCT04816669|102244157|FG001|Part 2|Other|0|||
33642700|NCT04816669|102244158|FG002|Part 2|Other|1|||
33642701|NCT04816669|102244159|FG003|Part 2|Other|0|||
33642702|NCT04816669|102244156|FG000|Part 2|Withdrawal by Subject|0|||
33642703|NCT04816669|102244157|FG001|Part 2|Withdrawal by Subject|0|||
33642704|NCT04816669|102244158|FG002|Part 2|Withdrawal by Subject|0|||
33642705|NCT04816669|102244159|FG003|Part 2|Withdrawal by Subject|1|||
33642706|NCT04816669|102244156|FG000|Part 2|Lost to Follow-up|0|||
33642707|NCT04816669|102244157|FG001|Part 2|Lost to Follow-up|0|||
33642708|NCT04816669|102244158|FG002|Part 2|Lost to Follow-up|1|||
33144417|NCT02582255|100441794|FG001|Overall Study|Protocol Violation|3|||
33144418|NCT03783702|100441795|FG000|Overall Study|Lost to Follow-up|6|||
33144419|NCT03783702|100441796|FG001|Overall Study|Lost to Follow-up|8|||
33144420|NCT03783702|100441795|FG000|Overall Study|Protocol Violation|1|||
33144421|NCT03783702|100441796|FG001|Overall Study|Protocol Violation|3|||
33144422|NCT00730028|100441803|FG000|Overall Study|Adverse Event|23|||
33144423|NCT00730028|100441804|FG001|Overall Study|Adverse Event|26|||
33144424|NCT00730028|100441805|FG002|Overall Study|Adverse Event|16|||
33144425|NCT00730028|100441806|FG003|Overall Study|Adverse Event|20|||
33144426|NCT00730028|100441807|FG004|Overall Study|Adverse Event|43|||
33642709|NCT04816669|102244159|FG003|Part 2|Lost to Follow-up|0|||
33642710|NCT04173494|102244162|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
33642711|NCT04173494|102244163|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
33642712|NCT04173494|102244162|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
33144427|NCT00730028|100441803|FG000|Overall Study|Lost to Follow-up|13|||
33144428|NCT00730028|100441804|FG001|Overall Study|Lost to Follow-up|26|||
33144429|NCT00730028|100441805|FG002|Overall Study|Lost to Follow-up|22|||
33144430|NCT00730028|100441806|FG003|Overall Study|Lost to Follow-up|26|||
33144431|NCT00730028|100441807|FG004|Overall Study|Lost to Follow-up|25|||
33144432|NCT00730028|100441803|FG000|Overall Study|Protocol Violation|6|||
33144433|NCT00730028|100441804|FG001|Overall Study|Protocol Violation|1|||
33144434|NCT00730028|100441805|FG002|Overall Study|Protocol Violation|1|||
33144435|NCT00730028|100441806|FG003|Overall Study|Protocol Violation|2|||
33144436|NCT00730028|100441807|FG004|Overall Study|Protocol Violation|0|||
33144437|NCT00730028|100441803|FG000|Overall Study|Withdrawal by Subject|9|||
33144438|NCT00730028|100441804|FG001|Overall Study|Withdrawal by Subject|5|||
33144439|NCT00730028|100441805|FG002|Overall Study|Withdrawal by Subject|4|||
33144440|NCT00730028|100441806|FG003|Overall Study|Withdrawal by Subject|5|||
33144441|NCT00730028|100441807|FG004|Overall Study|Withdrawal by Subject|9|||
33144442|NCT00730028|100441803|FG000|Overall Study|Physician Decision|3|||
33144443|NCT00730028|100441804|FG001|Overall Study|Physician Decision|3|||
33144444|NCT00730028|100441805|FG002|Overall Study|Physician Decision|2|||
33144445|NCT00730028|100441806|FG003|Overall Study|Physician Decision|3|||
33144446|NCT00730028|100441807|FG004|Overall Study|Physician Decision|2|||
33642713|NCT04173494|102244163|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
33642714|NCT04173494|102244162|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
33642715|NCT04173494|102244163|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
33642716|NCT04173494|102244162|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
33642717|NCT04173494|102244163|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
33642718|NCT04173494|102244162|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
33642719|NCT04173494|102244163|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
33144447|NCT00730028|100441803|FG000|Overall Study|Treatment Failure|5|||
33144448|NCT00730028|100441804|FG001|Overall Study|Treatment Failure|5|||
33144449|NCT00730028|100441805|FG002|Overall Study|Treatment Failure|0|||
33144450|NCT00730028|100441806|FG003|Overall Study|Treatment Failure|0|||
33144451|NCT00730028|100441807|FG004|Overall Study|Treatment Failure|1|||
33144452|NCT00730028|100441803|FG000|Overall Study|Randomization Error|1|||
33421791|NCT00563524|101434964|FG004|Overall Study|Protocol Violation|0|||
33144453|NCT00730028|100441804|FG001|Overall Study|Randomization Error|0|||
33144454|NCT00730028|100441805|FG002|Overall Study|Randomization Error|0|||
33144455|NCT00730028|100441806|FG003|Overall Study|Randomization Error|0|||
33144456|NCT00730028|100441807|FG004|Overall Study|Randomization Error|2|||
33144457|NCT01854944|100441808|FG000|Overall Study|Withdrawal by Subject|0|||
33144458|NCT01854944|100441809|FG001|Overall Study|Withdrawal by Subject|0|||
33144459|NCT01854944|100441810|FG002|Overall Study|Withdrawal by Subject|1|||
33144460|NCT00395538|100441811|FG000|Overall Study|Did not re-consent to revised protocol|1|||
33144461|NCT00395538|100441812|FG001|Overall Study|Did not re-consent to revised protocol|10|||
33144462|NCT00395538|100441813|FG002|Overall Study|Did not re-consent to revised protocol|0|||
33642720|NCT04173494|102244162|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
33642721|NCT04173494|102244163|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
33144463|NCT00395538|100441811|FG000|Overall Study|FDA partial hold on PTH|0|||
33144464|NCT00395538|100441812|FG001|Overall Study|FDA partial hold on PTH|0|||
33642722|NCT04173494|102244162|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
33144465|NCT00395538|100441813|FG002|Overall Study|FDA partial hold on PTH|11|||
33144466|NCT00395538|100441811|FG000|Overall Study|Failed screening|0|||
33144467|NCT00395538|100441812|FG001|Overall Study|Failed screening|0|||
33144468|NCT00395538|100441813|FG002|Overall Study|Failed screening|4|||
33144469|NCT00395538|100441811|FG000|Overall Study|Switch to Natpara|0|||
33144470|NCT00395538|100441812|FG001|Overall Study|Switch to Natpara|0|||
33144471|NCT00395538|100441813|FG002|Overall Study|Switch to Natpara|3|||
33144472|NCT00395538|100441811|FG000|Overall Study|Adverse Event|1|||
33144473|NCT00395538|100441812|FG001|Overall Study|Adverse Event|0|||
33144474|NCT00395538|100441813|FG002|Overall Study|Adverse Event|2|||
33144475|NCT00395538|100441811|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
33144476|NCT00395538|100441812|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
33144477|NCT00395538|100441813|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
33144478|NCT00395538|100441811|FG000|Overall Study|Non-compliance with study protocol|0|||
33144479|NCT00395538|100441812|FG001|Overall Study|Non-compliance with study protocol|1|||
33144480|NCT00395538|100441813|FG002|Overall Study|Non-compliance with study protocol|0|||
33144481|NCT00395538|100441811|FG000|Overall Study|PTH resistance|0|||
33144482|NCT00395538|100441812|FG001|Overall Study|PTH resistance|0|||
33144483|NCT00395538|100441813|FG002|Overall Study|PTH resistance|1|||
33144484|NCT00395538|100441811|FG000|Overall Study|Pregnancy|1|||
33144485|NCT00395538|100441812|FG001|Overall Study|Pregnancy|0|||
33144486|NCT00395538|100441813|FG002|Overall Study|Pregnancy|0|||
33144487|NCT00395538|100441811|FG000|Overall Study|Partial recovery of parathyroid function|0|||
33144488|NCT00395538|100441812|FG001|Overall Study|Partial recovery of parathyroid function|0|||
33144489|NCT00395538|100441813|FG002|Overall Study|Partial recovery of parathyroid function|1|||
33144490|NCT00395538|100441811|FG000|Overall Study|Participant elected to discontinue|0|||
33242652|NCT05489224|100789097|FG000|Treatment Period I|Lost to Follow-up|0|||
33242653|NCT05489224|100789098|FG001|Treatment Period I|Lost to Follow-up|1|||
33242654|NCT05489224|100789099|FG002|Treatment Period I|Lost to Follow-up|0|||
33242655|NCT05489224|100789097|FG000|Treatment Period I|Physician Decision|0|||
33242656|NCT05489224|100789098|FG001|Treatment Period I|Physician Decision|1|||
33242657|NCT05489224|100789099|FG002|Treatment Period I|Physician Decision|0|||
33242658|NCT05489224|100789097|FG000|Treatment Period II up to Week 32|Ongoing|222|||
33242659|NCT05489224|100789098|FG001|Treatment Period II up to Week 32|Ongoing|107|||
33242660|NCT05489224|100789099|FG002|Treatment Period II up to Week 32|Ongoing|107|||
33581898|NCT02820844|102020239|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
33581899|NCT02820844|102020240|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
33581900|NCT02820844|102020241|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
33581901|NCT02820844|102020242|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
33581902|NCT02820844|102020243|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
33581903|NCT02820844|102020244|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
33581904|NCT02820844|102020239|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
33581905|NCT02820844|102020240|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
33581906|NCT02820844|102020241|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
33581907|NCT02820844|102020242|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
33581908|NCT02820844|102020243|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
33581909|NCT02820844|102020244|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
33581910|NCT02820844|102020239|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
33581911|NCT02820844|102020240|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
33581912|NCT02820844|102020241|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
33581913|NCT02820844|102020242|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
33581914|NCT02820844|102020243|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
33581915|NCT02820844|102020244|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
33581916|NCT02820844|102020239|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
33581917|NCT02820844|102020240|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
33581918|NCT02820844|102020241|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
33581919|NCT02820844|102020242|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
33581920|NCT02820844|102020243|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
33581921|NCT02820844|102020244|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
33581922|NCT02820844|102020239|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
33581923|NCT02820844|102020240|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
33581924|NCT02820844|102020241|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
33581925|NCT02820844|102020242|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
33581926|NCT02820844|102020243|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
33581927|NCT02820844|102020244|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
33144491|NCT00395538|100441812|FG001|Overall Study|Participant elected to discontinue|0|||
33144492|NCT00395538|100441813|FG002|Overall Study|Participant elected to discontinue|1|||
33144493|NCT03021564|100441814|FG000|Overall Study|Death|84|||
33144494|NCT03021564|100441815|FG001|Overall Study|Death|466|||
33144495|NCT03021564|100441814|FG000|Overall Study|Lost to Follow-up|0|||
33242661|NCT05489224|100789097|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
33642723|NCT04173494|102244163|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
33642724|NCT04173494|102244162|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
33642725|NCT04173494|102244163|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
33642726|NCT04173494|102244162|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
33642727|NCT04173494|102244163|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
33642728|NCT04173494|102244162|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
33642729|NCT04173494|102244163|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
33642730|NCT04173494|102244162|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
33642731|NCT04173494|102244163|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
33642732|NCT04173494|102244162|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
33642733|NCT04173494|102244163|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
33642734|NCT04173494|102244162|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
33642735|NCT04173494|102244163|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
33642736|NCT04173494|102244162|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
33642737|NCT04173494|102244163|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
33642738|NCT04173494|102244162|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
33144496|NCT03021564|100441815|FG001|Overall Study|Lost to Follow-up|2|||
33144497|NCT03455764|100441816|FG000|Overall Study|Adverse Event|1|||
33421792|NCT00563524|101434965|FG005|Overall Study|Protocol Violation|0|||
33421793|NCT00563524|101434960|FG000|Overall Study|Withdrawal by Subject|1|||
33642739|NCT04173494|102244163|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
33642740|NCT04173494|102244162|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
33642741|NCT04173494|102244163|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
33642742|NCT00990704|102244164|FG000|Overall Study|Adverse Event|1|||
33642743|NCT00990704|102244165|FG001|Overall Study|Adverse Event|1|||
33642744|NCT00990704|102244164|FG000|Overall Study|Physician Decision|0|||
33642745|NCT00990704|102244165|FG001|Overall Study|Physician Decision|1|||
33642746|NCT00808080|102244169|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
33144498|NCT03455764|100441817|FG001|Overall Study|Adverse Event|0|||
33144499|NCT03455764|100441818|FG002|Overall Study|Adverse Event|0|||
33421794|NCT00563524|101434961|FG001|Overall Study|Withdrawal by Subject|1|||
33421795|NCT00563524|101434962|FG002|Overall Study|Withdrawal by Subject|3|||
33421796|NCT00563524|101434963|FG003|Overall Study|Withdrawal by Subject|0|||
33421797|NCT00563524|101434964|FG004|Overall Study|Withdrawal by Subject|0|||
33581928|NCT02820844|102020239|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
33581929|NCT02820844|102020240|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
33581930|NCT02820844|102020241|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
33581931|NCT02820844|102020242|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
33581932|NCT02820844|102020243|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
33581933|NCT02820844|102020244|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
33581934|NCT02820844|102020239|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33581935|NCT02820844|102020240|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33581936|NCT02820844|102020241|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
33581937|NCT02820844|102020242|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
33581938|NCT02820844|102020243|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33581939|NCT02820844|102020244|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33581940|NCT02820844|102020239|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
33581941|NCT02820844|102020240|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
33581942|NCT02820844|102020241|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
33581943|NCT02820844|102020242|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
33581944|NCT02820844|102020243|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
33581945|NCT02820844|102020244|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
33581946|NCT02820844|102020239|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33581947|NCT02820844|102020240|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33581948|NCT02820844|102020241|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33581949|NCT02820844|102020242|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33581950|NCT02820844|102020243|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
33581951|NCT02820844|102020244|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
33642747|NCT02660983|102244174|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
33642748|NCT02660983|102244175|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
33144500|NCT03455764|100441819|FG003|Overall Study|Adverse Event|0|||
33144501|NCT03455764|100441820|FG004|Overall Study|Adverse Event|0|||
33144502|NCT03455764|100441816|FG000|Overall Study|Disease Progression|4|||
33144503|NCT03455764|100441817|FG001|Overall Study|Disease Progression|0|||
33144504|NCT03455764|100441818|FG002|Overall Study|Disease Progression|0|||
33421798|NCT00563524|101434965|FG005|Overall Study|Withdrawal by Subject|1|||
33642749|NCT02660983|102244174|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
33642750|NCT02660983|102244175|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
33642751|NCT02660983|102244174|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
33642752|NCT02660983|102244175|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
33642753|NCT02660983|102244174|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
33642754|NCT02660983|102244175|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
33642755|NCT02660983|102244174|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
33642756|NCT02660983|102244175|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
33642757|NCT02660983|102244174|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
33642758|NCT02660983|102244175|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
33642759|NCT02660983|102244174|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
33642760|NCT02660983|102244175|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
33642761|NCT01075685|102244176|FG000|Overall Study|Protocol Violation|9|||
33642762|NCT01075685|102244177|FG001|Overall Study|Protocol Violation|1|||
33642763|NCT01075685|102244176|FG000|Overall Study|Withdrawal by Subject|20|||
33642764|NCT01075685|102244177|FG001|Overall Study|Withdrawal by Subject|5|||
33642765|NCT01075685|102244176|FG000|Overall Study|Lost to Follow-up|563|||
33642766|NCT01075685|102244177|FG001|Overall Study|Lost to Follow-up|220|||
33642767|NCT02527421|102244178|FG000|Overall Study|Withdrawal by Subject|1|||
33642768|NCT02527421|102244179|FG001|Overall Study|Withdrawal by Subject|0|||
33642769|NCT00114517|102244180|FG000|Overall Study|Adverse Event|6|||
33642770|NCT00114517|102244181|FG001|Overall Study|Adverse Event|1|||
33642771|NCT00114517|102244182|FG002|Overall Study|Adverse Event|6|||
33642772|NCT00114517|102244183|FG003|Overall Study|Adverse Event|3|||
33642773|NCT00114517|102244180|FG000|Overall Study|Lost to Follow-up|2|||
33642774|NCT00114517|102244181|FG001|Overall Study|Lost to Follow-up|2|||
33642775|NCT00114517|102244182|FG002|Overall Study|Lost to Follow-up|2|||
33642776|NCT00114517|102244183|FG003|Overall Study|Lost to Follow-up|1|||
33642777|NCT00114517|102244180|FG000|Overall Study|Too busy|3|||
33642778|NCT00114517|102244181|FG001|Overall Study|Too busy|1|||
33642779|NCT00114517|102244182|FG002|Overall Study|Too busy|1|||
33642780|NCT00114517|102244183|FG003|Overall Study|Too busy|2|||
33642781|NCT00114517|102244180|FG000|Overall Study|Moved from area|0|||
33642782|NCT00114517|102244181|FG001|Overall Study|Moved from area|3|||
33642783|NCT00114517|102244182|FG002|Overall Study|Moved from area|2|||
33642784|NCT00114517|102244183|FG003|Overall Study|Moved from area|1|||
33642785|NCT00114517|102244180|FG000|Overall Study|Did not want estradiol|1|||
33642786|NCT00114517|102244181|FG001|Overall Study|Did not want estradiol|1|||
33642787|NCT00114517|102244182|FG002|Overall Study|Did not want estradiol|0|||
33642788|NCT00114517|102244183|FG003|Overall Study|Did not want estradiol|0|||
33642789|NCT00114517|102244180|FG000|Overall Study|Armed-services duty|0|||
33642790|NCT00114517|102244181|FG001|Overall Study|Armed-services duty|1|||
33642791|NCT00114517|102244182|FG002|Overall Study|Armed-services duty|0|||
33642792|NCT00114517|102244183|FG003|Overall Study|Armed-services duty|1|||
33421799|NCT00627458|101434966|FG000|Overall Study|Migrated from study area|1|||
33421800|NCT00627458|101434967|FG001|Overall Study|Migrated from study area|0|||
33371961|NCT05836818|101247606|FG000|Overall Study|Later found to be previously vaccinated|0|||
33371962|NCT05836818|101247607|FG001|Overall Study|Later found to be previously vaccinated|1|||
33371963|NCT05836818|101247608|FG002|Overall Study|Later found to be previously vaccinated|3|||
33371964|NCT05836818|101247606|FG000|Overall Study|Pregnancy|0|||
33371965|NCT05836818|101247607|FG001|Overall Study|Pregnancy|1|||
33371966|NCT05836818|101247608|FG002|Overall Study|Pregnancy|0|||
33371967|NCT05836818|101247606|FG000|Overall Study|Allergic to vaccines|0|||
33371968|NCT05836818|101247607|FG001|Overall Study|Allergic to vaccines|1|||
33371969|NCT05836818|101247608|FG002|Overall Study|Allergic to vaccines|0|||
33371970|NCT02993224|101247611|FG000|Core Phase - Period 1|Adverse Event|4|||
33371971|NCT02993224|101247611|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
33371972|NCT02993224|101247611|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
33371973|NCT02993224|101247611|FG000|Core Phase- Period 2|Adverse Event|1|||
33371974|NCT02993224|101247611|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
33371975|NCT02993224|101247611|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
33371976|NCT02993224|101247611|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
33371977|NCT02993224|101247611|FG000|Extension Phase|Adverse Event|3|||
33371978|NCT02993224|101247611|FG000|Extension Phase|Withdrawal by Subject|3|||
33642793|NCT00114517|102244180|FG000|Overall Study|Competing family issue|0|||
33371979|NCT02993224|101247611|FG000|Extension Phase|Lost to Follow-up|2|||
33371980|NCT02993224|101247611|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
33371981|NCT00702052|101247612|FG000|Overall Study|Adverse Event|23|||
33642794|NCT00114517|102244181|FG001|Overall Study|Competing family issue|1|||
33642795|NCT00114517|102244182|FG002|Overall Study|Competing family issue|0|||
33642796|NCT00114517|102244183|FG003|Overall Study|Competing family issue|1|||
33642797|NCT00114517|102244180|FG000|Overall Study|Physician Decision|0|||
33642798|NCT00114517|102244181|FG001|Overall Study|Physician Decision|1|||
33642799|NCT00114517|102244182|FG002|Overall Study|Physician Decision|0|||
33642800|NCT00114517|102244183|FG003|Overall Study|Physician Decision|0|||
33642801|NCT00114517|102244180|FG000|Overall Study|Lost interest|0|||
33642802|NCT00114517|102244181|FG001|Overall Study|Lost interest|0|||
33642803|NCT00114517|102244182|FG002|Overall Study|Lost interest|1|||
33642804|NCT00114517|102244183|FG003|Overall Study|Lost interest|0|||
33642805|NCT00114517|102244180|FG000|Overall Study|Weight increase|0|||
33642806|NCT00114517|102244181|FG001|Overall Study|Weight increase|0|||
33642807|NCT00114517|102244182|FG002|Overall Study|Weight increase|1|||
33642808|NCT00114517|102244183|FG003|Overall Study|Weight increase|0|||
33642809|NCT00114517|102244180|FG000|Overall Study|Concern about blood clots|0|||
33642810|NCT00114517|102244181|FG001|Overall Study|Concern about blood clots|0|||
33642811|NCT00114517|102244182|FG002|Overall Study|Concern about blood clots|1|||
33642812|NCT00114517|102244183|FG003|Overall Study|Concern about blood clots|0|||
33642813|NCT00114517|102244180|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
33642814|NCT00114517|102244181|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
33642815|NCT00114517|102244182|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
33642816|NCT00114517|102244183|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
33642817|NCT03052426|102244184|FG000|Overall Study|Withdrawal by Subject|0|||
33642818|NCT03052426|102244185|FG001|Overall Study|Withdrawal by Subject|1|||
33642819|NCT03052426|102244186|FG002|Overall Study|Withdrawal by Subject|0|||
33642820|NCT03052426|102244184|FG000|Overall Study|Lost to Follow-up|2|||
33642821|NCT03052426|102244185|FG001|Overall Study|Lost to Follow-up|0|||
33642822|NCT03052426|102244186|FG002|Overall Study|Lost to Follow-up|1|||
33642823|NCT00363480|102244187|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
33642824|NCT00363480|102244187|FG000|Overall Study|Adverse Event|4|||
33642825|NCT00363480|102244187|FG000|Overall Study|Lost to Follow-up|5|||
33642826|NCT00363480|102244187|FG000|Overall Study|Withdrawal by Subject|5|||
33642827|NCT00363480|102244187|FG000|Overall Study|Non-compliance of subject|1|||
33642828|NCT00363480|102244187|FG000|Overall Study|Participant discontinued on its own|1|||
33642829|NCT03214666|102244188|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
33642830|NCT03214666|102244189|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
33642831|NCT03214666|102244190|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
33642832|NCT03214666|102244191|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
33642833|NCT03214666|102244192|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
33642834|NCT03214666|102244193|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
33642835|NCT03500224|102244198|FG000|Overall Study|Withdrawal by Subject|2|||
33642836|NCT00706342|102244205|FG000|Overall Study|Adverse Event|3|||
33642837|NCT00706342|102244205|FG000|Overall Study|Not responding to treatment|2|||
33642838|NCT00706342|102244205|FG000|Overall Study|Withdrawn due to failure to respond|1|||
33642839|NCT00706342|102244205|FG000|Overall Study|Death|1|||
33642840|NCT00706342|102244205|FG000|Overall Study|Withdrew from the study on his own.|1|||
33642841|NCT00706342|102244205|FG000|Overall Study|Investigator discretion|2|||
33642842|NCT00706342|102244205|FG000|Overall Study|Non-responder Week 12|1|||
33642843|NCT00706342|102244205|FG000|Overall Study|Ongoing|6|||
33642844|NCT00706342|102244205|FG000|Overall Study|WIthdrawal of consent|1|||
33642845|NCT00643162|102244206|FG000|Overall Study|Withdrawal by Subject|1|||
33642846|NCT00643162|102244207|FG001|Overall Study|Withdrawal by Subject|1|||
33242662|NCT05489224|100789098|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
33242663|NCT05489224|100789099|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
33581952|NCT03497039|102020246|FG000|Overall Study|Withdrawal by Subject|1|||
33581953|NCT03497039|102020247|FG001|Overall Study|Withdrawal by Subject|0|||
33581954|NCT03497039|102020246|FG000|Overall Study|Protocol Violation|0|||
33581955|NCT03497039|102020247|FG001|Overall Study|Protocol Violation|1|||
33581956|NCT01694433|102020251|FG000|Overall Study|Adverse Event|7|||
33581957|NCT01694433|102020252|FG001|Overall Study|Adverse Event|0|||
33581958|NCT01694433|102020251|FG000|Overall Study|Physician Decision|1|||
33581959|NCT01694433|102020252|FG001|Overall Study|Physician Decision|0|||
33581960|NCT01694433|102020251|FG000|Overall Study|Withdrawal by Subject|3|||
33581961|NCT01694433|102020252|FG001|Overall Study|Withdrawal by Subject|4|||
33581962|NCT01871545|102020253|FG000|Overall Study|Death|2|||
33581963|NCT01871545|102020254|FG001|Overall Study|Death|0|||
33581964|NCT01871545|102020253|FG000|Overall Study|Lack of Efficacy|11|||
33581965|NCT01871545|102020254|FG001|Overall Study|Lack of Efficacy|2|||
33581966|NCT01871545|102020253|FG000|Overall Study|Physician Decision|4|||
33581967|NCT01871545|102020254|FG001|Overall Study|Physician Decision|0|||
33581968|NCT01871545|102020253|FG000|Overall Study|Withdrawal by Subject|0|||
33642847|NCT00947882|102244209|FG000|Overall Study|Adverse Event|0|||
33642848|NCT00947882|102244210|FG001|Overall Study|Adverse Event|1|||
33642849|NCT00947882|102244211|FG002|Overall Study|Adverse Event|4|||
33642850|NCT00947882|102244212|FG003|Overall Study|Adverse Event|4|||
33581969|NCT01871545|102020254|FG001|Overall Study|Withdrawal by Subject|1|||
33642851|NCT00947882|102244209|FG000|Overall Study|Withdrawal by Subject|2|||
33642852|NCT00947882|102244210|FG001|Overall Study|Withdrawal by Subject|0|||
33144505|NCT03455764|100441819|FG003|Overall Study|Disease Progression|0|||
33144506|NCT03455764|100441820|FG004|Overall Study|Disease Progression|0|||
33144507|NCT03455764|100441816|FG000|Overall Study|On Treatment|1|||
33642853|NCT00947882|102244211|FG002|Overall Study|Withdrawal by Subject|8|||
33642854|NCT00947882|102244212|FG003|Overall Study|Withdrawal by Subject|2|||
33642855|NCT00947882|102244209|FG000|Overall Study|Protocol Violation|0|||
33642856|NCT00947882|102244210|FG001|Overall Study|Protocol Violation|0|||
33642857|NCT00947882|102244211|FG002|Overall Study|Protocol Violation|1|||
33642858|NCT00947882|102244212|FG003|Overall Study|Protocol Violation|0|||
33642859|NCT00947882|102244209|FG000|Overall Study|Lost to Follow-up|0|||
33642860|NCT00947882|102244210|FG001|Overall Study|Lost to Follow-up|2|||
33421801|NCT00627458|101434968|FG002|Overall Study|Migrated from study area|1|||
33421802|NCT00627458|101434966|FG000|Overall Study|Withdrawal by Subject|2|||
33421803|NCT00627458|101434967|FG001|Overall Study|Withdrawal by Subject|6|||
33642861|NCT00947882|102244211|FG002|Overall Study|Lost to Follow-up|1|||
33642862|NCT00947882|102244212|FG003|Overall Study|Lost to Follow-up|0|||
33421804|NCT00627458|101434968|FG002|Overall Study|Withdrawal by Subject|5|||
33421805|NCT00627458|101434966|FG000|Overall Study|Lost to Follow-up|1|||
33642863|NCT00947882|102244209|FG000|Overall Study|Other/Unknown|10|||
33642864|NCT00947882|102244210|FG001|Overall Study|Other/Unknown|13|||
33642865|NCT00947882|102244211|FG002|Overall Study|Other/Unknown|3|||
33421806|NCT00627458|101434967|FG001|Overall Study|Lost to Follow-up|1|||
33421807|NCT00627458|101434968|FG002|Overall Study|Lost to Follow-up|0|||
33421808|NCT01766310|101434969|FG000|Overall Study|Lost to Follow-up|1|||
33421809|NCT01766310|101434970|FG001|Overall Study|Lost to Follow-up|3|||
33421810|NCT00127192|101434974|FG000|Overall Study|Adverse Event|0|||
33421811|NCT00127192|101434975|FG001|Overall Study|Adverse Event|1|||
33421812|NCT00127192|101434976|FG002|Overall Study|Adverse Event|1|||
33421813|NCT00127192|101434977|FG003|Overall Study|Adverse Event|1|||
33421814|NCT00127192|101434978|FG004|Overall Study|Adverse Event|0|||
33642866|NCT00947882|102244212|FG003|Overall Study|Other/Unknown|6|||
33642867|NCT00947882|102244209|FG000|Overall Study|Trial Terminated by Sponsor|62|||
33642868|NCT00947882|102244210|FG001|Overall Study|Trial Terminated by Sponsor|61|||
33642869|NCT00947882|102244211|FG002|Overall Study|Trial Terminated by Sponsor|62|||
33642870|NCT00947882|102244212|FG003|Overall Study|Trial Terminated by Sponsor|70|||
33642871|NCT03436290|102244213|FG000|Overall Study|Post-randomization Exclusion|1|||
33642872|NCT03436290|102244214|FG001|Overall Study|Post-randomization Exclusion|0|||
33642873|NCT03436290|102244213|FG000|Overall Study|Death|6|||
33642874|NCT03436290|102244214|FG001|Overall Study|Death|0|||
33642875|NCT03436290|102244213|FG000|Overall Study|Withdrawal by Subject|4|||
33642876|NCT03436290|102244214|FG001|Overall Study|Withdrawal by Subject|0|||
33642877|NCT03436290|102244213|FG000|Overall Study|Protocol Violation|30|||
33642878|NCT03436290|102244214|FG001|Overall Study|Protocol Violation|0|||
33642879|NCT01317277|102244215|FG000|Overall Study|Lost to Follow-up|3|||
33642880|NCT01317277|102244216|FG001|Overall Study|Lost to Follow-up|1|||
33642881|NCT01317277|102244215|FG000|Overall Study|Lost MEMS|1|||
33642882|NCT01317277|102244216|FG001|Overall Study|Lost MEMS|1|||
33642883|NCT01317277|102244215|FG000|Overall Study|Unable to comply with intervention|1|||
33642884|NCT01317277|102244216|FG001|Overall Study|Unable to comply with intervention|0|||
33642885|NCT01317277|102244215|FG000|Overall Study|Withdrawal by Subject|1|||
33642886|NCT01317277|102244216|FG001|Overall Study|Withdrawal by Subject|0|||
33642887|NCT01317277|102244215|FG000|Overall Study|Adverse Event|1|||
33642888|NCT01317277|102244216|FG001|Overall Study|Adverse Event|0|||
33642889|NCT02624986|102244218|FG000|Overall Study|Death|0|||
33642890|NCT02624986|102244219|FG001|Overall Study|Death|1|||
33642891|NCT02624986|102244220|FG002|Overall Study|Death|2|||
33642892|NCT02624986|102244221|FG003|Overall Study|Death|2|||
33371982|NCT00702052|101247612|FG000|Overall Study|Disease Progression|30|||
33371983|NCT00702052|101247612|FG000|Overall Study|Withdrawal by Subject|5|||
33371984|NCT03670641|101247621|FG000|Overall Study|Lost to Follow-up|3|||
33371985|NCT03011034|101247622|FG000|Overall Study|Adverse Event|1|||
33371986|NCT03011034|101247623|FG001|Overall Study|Adverse Event|0|||
33371987|NCT02340819|101247627|FG000|Overall Study|Adverse Event|1|||
33371988|NCT02340819|101247627|FG000|Overall Study|Withdrawal by Subject|2|||
33371989|NCT02340819|101247627|FG000|Overall Study|Discontinued with other reason|1|||
33371990|NCT02389816|101247633|FG000|Overall Study|Randomized but Not Treated|1|||
33371991|NCT02389816|101247634|FG001|Overall Study|Randomized but Not Treated|0|||
33371992|NCT02389816|101247635|FG002|Overall Study|Randomized but Not Treated|0|||
33371993|NCT02389816|101247633|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
33421815|NCT00127192|101434974|FG000|Overall Study|Lack of Efficacy|2|||
33421816|NCT00127192|101434975|FG001|Overall Study|Lack of Efficacy|0|||
33421817|NCT00127192|101434976|FG002|Overall Study|Lack of Efficacy|0|||
33642893|NCT02624986|102244222|FG004|Overall Study|Death|2|||
33642894|NCT02624986|102244223|FG005|Overall Study|Death|0|||
33642895|NCT02624986|102244224|FG006|Overall Study|Death|0|||
33642896|NCT02624986|102244225|FG007|Overall Study|Death|1|||
33642897|NCT02624986|102244218|FG000|Overall Study|Study Terminated by Sponsor|1|||
33642898|NCT02624986|102244219|FG001|Overall Study|Study Terminated by Sponsor|1|||
33642899|NCT02624986|102244220|FG002|Overall Study|Study Terminated by Sponsor|0|||
33421818|NCT00127192|101434977|FG003|Overall Study|Lack of Efficacy|0|||
33421819|NCT00127192|101434978|FG004|Overall Study|Lack of Efficacy|2|||
33642900|NCT02624986|102244221|FG003|Overall Study|Study Terminated by Sponsor|1|||
33642901|NCT02624986|102244222|FG004|Overall Study|Study Terminated by Sponsor|2|||
33371994|NCT02389816|101247634|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
33371995|NCT02389816|101247635|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
33371996|NCT02389816|101247633|FG000|Overall Study|Major Protocol Deviation|1|||
33371997|NCT02389816|101247634|FG001|Overall Study|Major Protocol Deviation|0|||
33371998|NCT02389816|101247635|FG002|Overall Study|Major Protocol Deviation|0|||
33371999|NCT02389816|101247633|FG000|Overall Study|Lost to Follow-up|1|||
33372000|NCT02389816|101247634|FG001|Overall Study|Lost to Follow-up|0|||
33372001|NCT02389816|101247635|FG002|Overall Study|Lost to Follow-up|0|||
33372002|NCT02389816|101247633|FG000|Overall Study|Withdrawal of Consent|6|||
33372003|NCT02389816|101247634|FG001|Overall Study|Withdrawal of Consent|4|||
33372004|NCT02389816|101247635|FG002|Overall Study|Withdrawal of Consent|4|||
33372005|NCT02389816|101247633|FG000|Overall Study|Lack of Efficacy|1|||
33372006|NCT02389816|101247634|FG001|Overall Study|Lack of Efficacy|0|||
33372007|NCT02389816|101247635|FG002|Overall Study|Lack of Efficacy|0|||
33372008|NCT02389816|101247633|FG000|Overall Study|Non Compliance with Study Drug|1|||
33372009|NCT02389816|101247634|FG001|Overall Study|Non Compliance with Study Drug|1|||
33372010|NCT02389816|101247635|FG002|Overall Study|Non Compliance with Study Drug|1|||
33372011|NCT02389816|101247633|FG000|Overall Study|Reason not Specified|0|||
33372012|NCT02389816|101247634|FG001|Overall Study|Reason not Specified|2|||
33372013|NCT02389816|101247635|FG002|Overall Study|Reason not Specified|0|||
33372014|NCT02108600|101247636|FG000|Overall Study|Withdrawal by Subject|2|||
33372015|NCT02108600|101247637|FG001|Overall Study|Withdrawal by Subject|0|||
33372016|NCT02108600|101247636|FG000|Overall Study|Lost to Follow-up|1|||
33372017|NCT02108600|101247637|FG001|Overall Study|Lost to Follow-up|1|||
33372018|NCT00986258|101247638|FG000|Observation Period|Not eligible to be dosed|11|||
33372019|NCT00986258|101247638|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
33372020|NCT00986258|101247638|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
33372021|NCT00986258|101247638|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
33372022|NCT00986258|101247638|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
33372023|NCT00986258|101247638|FG000|Titration and Optimal Dose Period|Other|1|||
33372024|NCT00986258|101247638|FG000|Maintenance Period|Adverse Event|5|||
33421820|NCT00127192|101434974|FG000|Overall Study|Withdrawal by Subject|0|||
33421821|NCT00127192|101434975|FG001|Overall Study|Withdrawal by Subject|0|||
33421822|NCT00127192|101434976|FG002|Overall Study|Withdrawal by Subject|1|||
33421823|NCT00127192|101434977|FG003|Overall Study|Withdrawal by Subject|0|||
33421824|NCT00127192|101434978|FG004|Overall Study|Withdrawal by Subject|3|||
33421825|NCT00127192|101434974|FG000|Overall Study|Adverse event in pre-treatment period|1|||
33421826|NCT00127192|101434975|FG001|Overall Study|Adverse event in pre-treatment period|0|||
33421827|NCT00127192|101434976|FG002|Overall Study|Adverse event in pre-treatment period|0|||
33421828|NCT00127192|101434977|FG003|Overall Study|Adverse event in pre-treatment period|0|||
33421829|NCT00127192|101434978|FG004|Overall Study|Adverse event in pre-treatment period|0|||
33421830|NCT02156466|101434981|FG000|Overall Study|Adverse Event|0|||
33421831|NCT02156466|101434982|FG001|Overall Study|Adverse Event|0|||
33421832|NCT02156466|101434983|FG002|Overall Study|Adverse Event|1|||
33421833|NCT02156466|101434984|FG003|Overall Study|Adverse Event|1|||
33421834|NCT02156466|101434985|FG004|Overall Study|Adverse Event|0|||
33421835|NCT02156466|101434981|FG000|Overall Study|Quantiferon Positivity|0|||
33421836|NCT02156466|101434982|FG001|Overall Study|Quantiferon Positivity|0|||
33421837|NCT02156466|101434983|FG002|Overall Study|Quantiferon Positivity|0|||
33421838|NCT02156466|101434984|FG003|Overall Study|Quantiferon Positivity|1|||
33421839|NCT02156466|101434985|FG004|Overall Study|Quantiferon Positivity|0|||
33421840|NCT00479765|101434992|FG000|Overall Study|study terminated|4|||
33421841|NCT00295620|101434996|FG000|Overall Study|Lost to Follow-up|9|||
33421842|NCT00295620|101434997|FG001|Overall Study|Lost to Follow-up|5|||
33421843|NCT00295620|101434996|FG000|Overall Study|Withdrawal by Subject|37|||
33421844|NCT00295620|101434997|FG001|Overall Study|Withdrawal by Subject|50|||
33421845|NCT00295620|101434996|FG000|Overall Study|Death|206|||
33421846|NCT00295620|101434997|FG001|Overall Study|Death|207|||
33421847|NCT00295620|101434996|FG000|Overall Study|Other reasons|10|||
33372025|NCT00986258|101247638|FG000|Maintenance Period|Lack of Efficacy|2|||
33372026|NCT00986258|101247638|FG000|Maintenance Period|Withdrawal by Subject|2|||
33372027|NCT00516269|101247640|FG000|Overall Study|Adverse Event|2|||
33421848|NCT00295620|101434997|FG001|Overall Study|Other reasons|9|||
33421849|NCT00295620|101434996|FG000|Overall Study|Discontinuation by sponsor|580|||
33421850|NCT00295620|101434997|FG001|Overall Study|Discontinuation by sponsor|593|||
33421851|NCT00295620|101434996|FG000|Overall Study|Protocol Violation|30|||
33421852|NCT00295620|101434997|FG001|Overall Study|Protocol Violation|32|||
33421853|NCT00972153|101434998|FG000|Overall Study|Equipment malfunction during case|0|||
33421854|NCT00972153|101434999|FG001|Overall Study|Equipment malfunction during case|1|||
33421855|NCT00972153|101435000|FG002|Overall Study|Equipment malfunction during case|0|||
33421856|NCT04318535|101435001|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
33421857|NCT04318535|101435002|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
33372028|NCT00516269|101247641|FG001|Overall Study|Adverse Event|1|||
33372029|NCT00516269|101247640|FG000|Overall Study|Lost to Follow-up|0|||
33372030|NCT00516269|101247641|FG001|Overall Study|Lost to Follow-up|1|||
33421858|NCT04318535|101435003|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
33421859|NCT04556838|101435004|FG000|Overall Study|Withdrawal by Subject|3|||
33421860|NCT04556838|101435005|FG001|Overall Study|Withdrawal by Subject|1|||
33421861|NCT04556838|101435006|FG002|Overall Study|Withdrawal by Subject|2|||
33421862|NCT04556838|101435004|FG000|Overall Study|Adverse Event|0|||
33372031|NCT00516269|101247640|FG000|Overall Study|Protocol Violation|0|||
33372032|NCT00516269|101247641|FG001|Overall Study|Protocol Violation|1|||
33372033|NCT01426425|101247645|FG000|Overall Study|Exited prior to EP study|22|||
33372034|NCT01426425|101247645|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
33372035|NCT01426425|101247645|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
33372036|NCT03350750|101247648|FG000|Overall Study|Death|1|||
33372037|NCT03350750|101247649|FG001|Overall Study|Death|1|||
33372038|NCT03691610|101247652|FG000|Overall Study|Adverse Event|0|||
33372039|NCT03691610|101247653|FG001|Overall Study|Adverse Event|1|||
33372040|NCT03691610|101247654|FG002|Overall Study|Adverse Event|0|||
33372041|NCT03691610|101247655|FG003|Overall Study|Adverse Event|0|||
33372042|NCT03691610|101247652|FG000|Overall Study|Protocol Deviation|15|||
33372043|NCT03691610|101247653|FG001|Overall Study|Protocol Deviation|8|||
33372044|NCT03691610|101247654|FG002|Overall Study|Protocol Deviation|1|||
33372045|NCT03691610|101247655|FG003|Overall Study|Protocol Deviation|2|||
33372046|NCT03691610|101247652|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
33372047|NCT03691610|101247653|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
33372048|NCT03691610|101247654|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
33372049|NCT03691610|101247655|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
33372050|NCT03691610|101247652|FG000|Overall Study|Lost to Follow-up|20|||
33372051|NCT03691610|101247653|FG001|Overall Study|Lost to Follow-up|11|||
33372052|NCT03691610|101247654|FG002|Overall Study|Lost to Follow-up|5|||
33372053|NCT03691610|101247655|FG003|Overall Study|Lost to Follow-up|2|||
33372054|NCT00615290|101247656|FG000|Overall Study|Adverse Event|2|||
33372055|NCT00615290|101247656|FG000|Overall Study|Lost to Follow-up|3|||
33372056|NCT00615290|101247656|FG000|Overall Study|Withdrawal by Subject|1|||
33372057|NCT00615290|101247656|FG000|Overall Study|Other|2|||
33372058|NCT03294681|101247657|FG000|Overall Study|Withdrawal by Subject|1|||
33372059|NCT02112994|101247662|FG000|Overall Study|Progressive Disease|0|||
33372060|NCT02112994|101247663|FG001|Overall Study|Progressive Disease|0|||
33372061|NCT02112994|101247664|FG002|Overall Study|Progressive Disease|1|||
33372062|NCT02112994|101247662|FG000|Overall Study|Pregnancy|0|||
33372063|NCT02112994|101247663|FG001|Overall Study|Pregnancy|1|||
33372064|NCT02112994|101247664|FG002|Overall Study|Pregnancy|1|||
33372065|NCT02112994|101247662|FG000|Overall Study|Liver Transplant|0|||
33372066|NCT02112994|101247663|FG001|Overall Study|Liver Transplant|1|||
33372067|NCT02112994|101247664|FG002|Overall Study|Liver Transplant|0|||
33372068|NCT02112994|101247662|FG000|Overall Study|Withdrawal by Subject|0|||
33372069|NCT02112994|101247663|FG001|Overall Study|Withdrawal by Subject|0|||
33372070|NCT02112994|101247664|FG002|Overall Study|Withdrawal by Subject|1|||
33372071|NCT04146467|101247665|FG000|Overall Study|Adverse Event|0|||
33372072|NCT04146467|101247666|FG001|Overall Study|Adverse Event|1|||
33372073|NCT04146467|101247665|FG000|Overall Study|Lost to Follow-up|0|||
33372074|NCT04146467|101247666|FG001|Overall Study|Lost to Follow-up|2|||
33372075|NCT00620321|101247667|FG000|Overall Study|Adverse Event|1|||
33372076|NCT00620321|101247668|FG001|Overall Study|Adverse Event|1|||
33372077|NCT00620321|101247667|FG000|Overall Study|Death|1|||
33372078|NCT00620321|101247668|FG001|Overall Study|Death|1|||
33372079|NCT00620321|101247667|FG000|Overall Study|Physician Decision|0|||
33372080|NCT00620321|101247668|FG001|Overall Study|Physician Decision|7|||
33372081|NCT00620321|101247667|FG000|Overall Study|Progressive Disease|5|||
33372082|NCT00620321|101247668|FG001|Overall Study|Progressive Disease|5|||
33372083|NCT00620321|101247667|FG000|Overall Study|Sponsor Decision|0|||
33372084|NCT00620321|101247668|FG001|Overall Study|Sponsor Decision|1|||
33372085|NCT00620321|101247667|FG000|Overall Study|Withdrawal by Subject|1|||
33372086|NCT00620321|101247668|FG001|Overall Study|Withdrawal by Subject|1|||
33372087|NCT03165721|101247669|FG000|Overall Study|Refused further treatment|3|||
33372088|NCT03165721|101247670|FG001|Overall Study|Refused further treatment|0|||
33372089|NCT03165721|101247671|FG002|Overall Study|Refused further treatment|0|||
33372090|NCT03165721|101247669|FG000|Overall Study|Physician Decision|1|||
33372091|NCT03165721|101247670|FG001|Overall Study|Physician Decision|0|||
33372092|NCT03165721|101247671|FG002|Overall Study|Physician Decision|0|||
33581970|NCT01206140|102020262|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
33372093|NCT00995345|101247675|FG000|Overall Study|Withdrawal by Subject|4|||
33372094|NCT00995345|101247676|FG001|Overall Study|Withdrawal by Subject|2|||
33372095|NCT00995345|101247677|FG002|Overall Study|Withdrawal by Subject|1|||
33372096|NCT00995345|101247678|FG003|Overall Study|Withdrawal by Subject|3|||
33372097|NCT00995345|101247679|FG004|Overall Study|Withdrawal by Subject|1|||
33372098|NCT00995345|101247675|FG000|Overall Study|Adverse Event|3|||
33372099|NCT00995345|101247676|FG001|Overall Study|Adverse Event|1|||
33372100|NCT00995345|101247677|FG002|Overall Study|Adverse Event|2|||
33421863|NCT04556838|101435005|FG001|Overall Study|Adverse Event|1|||
33372101|NCT00995345|101247678|FG003|Overall Study|Adverse Event|0|||
33421864|NCT04556838|101435006|FG002|Overall Study|Adverse Event|1|||
33421865|NCT04556838|101435004|FG000|Overall Study|Lost to Follow-up|0|||
33421866|NCT04556838|101435005|FG001|Overall Study|Lost to Follow-up|0|||
33421867|NCT04556838|101435006|FG002|Overall Study|Lost to Follow-up|2|||
33421868|NCT04556838|101435004|FG000|Overall Study|Subject travel|0|||
33421869|NCT04556838|101435005|FG001|Overall Study|Subject travel|1|||
33421870|NCT04556838|101435006|FG002|Overall Study|Subject travel|0|||
33421871|NCT04556838|101435004|FG000|Overall Study|Physician Decision|1|||
33421872|NCT04556838|101435005|FG001|Overall Study|Physician Decision|0|||
33421873|NCT04556838|101435006|FG002|Overall Study|Physician Decision|0|||
33421874|NCT00297492|101436904|FG000|Set Quit Date|Lost to Follow-up|7|||
33421875|NCT00297492|101436905|FG001|Set Quit Date|Lost to Follow-up|13|||
33421876|NCT00297492|101436906|FG002|Set Quit Date|Lost to Follow-up|5|||
33421877|NCT00297492|101436904|FG000|6 Month Follow-up|Lost to Follow-up|63|||
33421878|NCT00297492|101436905|FG001|6 Month Follow-up|Lost to Follow-up|49|||
33421879|NCT00297492|101436906|FG002|6 Month Follow-up|Lost to Follow-up|27|||
33421880|NCT00021229|101436911|FG000|Overall Study|Adverse Event|10|||
33421881|NCT00021229|101436912|FG001|Overall Study|Adverse Event|5|||
33421882|NCT00021229|101436913|FG002|Overall Study|Adverse Event|2|||
33421883|NCT00021229|101436911|FG000|Overall Study|Death|0|||
33421884|NCT00021229|101436912|FG001|Overall Study|Death|1|||
33421885|NCT00021229|101436913|FG002|Overall Study|Death|0|||
33421886|NCT00021229|101436911|FG000|Overall Study|Withdrawal by Subject|7|||
33421887|NCT00021229|101436912|FG001|Overall Study|Withdrawal by Subject|7|||
33421888|NCT00021229|101436913|FG002|Overall Study|Withdrawal by Subject|1|||
33421889|NCT00021229|101436911|FG000|Overall Study|Progressive Disease|15|||
33421890|NCT00021229|101436912|FG001|Overall Study|Progressive Disease|19|||
33421891|NCT00021229|101436913|FG002|Overall Study|Progressive Disease|12|||
33421892|NCT00021229|101436911|FG000|Overall Study|Protocol Violation|1|||
33421893|NCT00021229|101436912|FG001|Overall Study|Protocol Violation|1|||
33421894|NCT00021229|101436913|FG002|Overall Study|Protocol Violation|0|||
33421895|NCT00021229|101436911|FG000|Overall Study|Physician Decision|0|||
33421896|NCT00021229|101436912|FG001|Overall Study|Physician Decision|0|||
33421897|NCT00021229|101436913|FG002|Overall Study|Physician Decision|1|||
33421898|NCT00021229|101436911|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
33421899|NCT00021229|101436912|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
33421900|NCT00021229|101436913|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
33421901|NCT00738920|101436914|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
33421902|NCT00738920|101436915|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
33144508|NCT03455764|100441817|FG001|Overall Study|On Treatment|0|||
33144509|NCT03455764|100441818|FG002|Overall Study|On Treatment|0|||
33242664|NCT05489224|100789097|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
33242665|NCT05489224|100789098|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
33242666|NCT05489224|100789099|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
33242667|NCT00087490|100789100|FG000|Overall Study|Death|6|||
33242668|NCT00087490|100789101|FG001|Overall Study|Death|4|||
33242669|NCT00087490|100789100|FG000|Overall Study|Adverse Event|3|||
33242670|NCT00087490|100789101|FG001|Overall Study|Adverse Event|8|||
33242671|NCT00087490|100789100|FG000|Overall Study|Lack of Efficacy|0|||
33242672|NCT00087490|100789101|FG001|Overall Study|Lack of Efficacy|2|||
33242673|NCT00087490|100789100|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
33242674|NCT00087490|100789101|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
33242675|NCT00087490|100789100|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
33372102|NCT00995345|101247679|FG004|Overall Study|Adverse Event|1|||
33421903|NCT00738920|101436916|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
33421904|NCT00738920|101436914|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
33421905|NCT00738920|101436915|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
33421906|NCT00738920|101436916|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
33421907|NCT00738920|101436914|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
33144510|NCT03455764|100441819|FG003|Overall Study|On Treatment|0|||
33144511|NCT03455764|100441820|FG004|Overall Study|On Treatment|0|||
33144512|NCT02536833|100444983|FG000|Overall Study|Discontinued Before Treatment|0|||
33144513|NCT02536833|100444984|FG001|Overall Study|Discontinued Before Treatment|0|||
33144514|NCT02536833|100444985|FG002|Overall Study|Discontinued Before Treatment|1|||
33144515|NCT02536833|100444986|FG003|Overall Study|Discontinued Before Treatment|2|||
33144516|NCT02536833|100444983|FG000|Overall Study|Adverse Event|1|||
33144517|NCT02536833|100444984|FG001|Overall Study|Adverse Event|3|||
33144518|NCT02536833|100444985|FG002|Overall Study|Adverse Event|4|||
33144519|NCT02536833|100444986|FG003|Overall Study|Adverse Event|1|||
33144520|NCT02536833|100444983|FG000|Overall Study|Lost to Follow-up|2|||
33144521|NCT02536833|100444984|FG001|Overall Study|Lost to Follow-up|1|||
33144522|NCT02536833|100444985|FG002|Overall Study|Lost to Follow-up|2|||
33144523|NCT02536833|100444986|FG003|Overall Study|Lost to Follow-up|2|||
33144524|NCT02536833|100444983|FG000|Overall Study|Physician Decision|0|||
33144525|NCT02536833|100444984|FG001|Overall Study|Physician Decision|0|||
33144526|NCT02536833|100444985|FG002|Overall Study|Physician Decision|0|||
33144527|NCT02536833|100444986|FG003|Overall Study|Physician Decision|1|||
33581971|NCT01206140|102020263|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
33581972|NCT05010070|102020264|FG000|Overall Study|Lost to Follow-up|1|||
33581973|NCT05010070|102020264|FG000|Overall Study|Withdrawal by Subject|1|||
33581974|NCT01696773|102020265|FG000|Days 15-27, Washout|Adverse Event|1|||
33581975|NCT01696773|102020266|FG001|Days 15-27, Washout|Adverse Event|0|||
33144528|NCT02536833|100444983|FG000|Overall Study|Site Terminated by Sponsor|2|||
33144529|NCT02536833|100444984|FG001|Overall Study|Site Terminated by Sponsor|2|||
33144530|NCT02536833|100444985|FG002|Overall Study|Site Terminated by Sponsor|2|||
33372103|NCT00995345|101247675|FG000|Overall Study|Lost to Follow-up|2|||
33372104|NCT00995345|101247676|FG001|Overall Study|Lost to Follow-up|2|||
33372105|NCT00995345|101247677|FG002|Overall Study|Lost to Follow-up|2|||
33144531|NCT02536833|100444986|FG003|Overall Study|Site Terminated by Sponsor|2|||
33144532|NCT02536833|100444983|FG000|Overall Study|Subject Non-Compliance|0|||
33144533|NCT02536833|100444984|FG001|Overall Study|Subject Non-Compliance|1|||
33144534|NCT02536833|100444985|FG002|Overall Study|Subject Non-Compliance|1|||
33144535|NCT02536833|100444986|FG003|Overall Study|Subject Non-Compliance|0|||
33144536|NCT02536833|100444983|FG000|Overall Study|Withdrawal by Subject|4|||
33144537|NCT02536833|100444984|FG001|Overall Study|Withdrawal by Subject|3|||
33144538|NCT02536833|100444985|FG002|Overall Study|Withdrawal by Subject|5|||
33144539|NCT02536833|100444986|FG003|Overall Study|Withdrawal by Subject|11|||
33144540|NCT00588952|100444991|FG000|Overall Study|Adverse Event|0|||
33144541|NCT00588952|100444992|FG001|Overall Study|Adverse Event|2|||
33144542|NCT00588952|100444991|FG000|Overall Study|Withdrawal by Subject|3|||
33144543|NCT00588952|100444992|FG001|Overall Study|Withdrawal by Subject|5|||
33144544|NCT01484938|100444993|FG000|Overall Study|Adverse Event|2|||
33144545|NCT01484938|100444993|FG000|Overall Study|Lost to Follow-up|1|||
33144546|NCT01484938|100444993|FG000|Overall Study|Noncompliance|1|||
33144547|NCT01475071|100444996|FG000|Overall Study|Physician Decision|1|||
33144548|NCT01475071|100444996|FG000|Overall Study|Withdrawal by Subject|6|||
33144549|NCT01475071|100444996|FG000|Overall Study|Lost to Follow-up|1|||
33144550|NCT02021656|100444997|FG000|Overall Study|Adverse Event|1|||
33144551|NCT02021656|100444997|FG000|Overall Study|Lack of Efficacy|2|||
33144552|NCT02021656|100444997|FG000|Overall Study|Lost to Follow-up|1|||
33144553|NCT02021656|100444997|FG000|Overall Study|Withdrew Consent|2|||
33144554|NCT03475875|100444998|FG000|Period 1|Lost to Follow-up|1|||
33144555|NCT03475875|100444999|FG001|Period 1|Lost to Follow-up|0|||
33144556|NCT03475875|100444998|FG000|Period 1|Adverse Event|2|||
33144557|NCT03475875|100444999|FG001|Period 1|Adverse Event|1|||
33144558|NCT03475875|100444998|FG000|Period 2|Adverse Event|3|||
33144559|NCT03475875|100444999|FG001|Period 2|Adverse Event|0|||
33144560|NCT03475875|100444998|FG000|Period 2|Protocol Violation|0|||
33144561|NCT03475875|100444999|FG001|Period 2|Protocol Violation|1|||
33144562|NCT01369485|100445000|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
33144563|NCT01369485|100445001|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
33144564|NCT01369485|100445000|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
33144565|NCT01369485|100445001|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
33144566|NCT01369485|100445000|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
33144567|NCT01369485|100445001|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
33144568|NCT01369485|100445000|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
33144569|NCT01369485|100445001|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
33144570|NCT01369485|100445000|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
33144571|NCT01369485|100445001|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
33144572|NCT01369485|100445000|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
33372106|NCT00995345|101247678|FG003|Overall Study|Lost to Follow-up|1|||
33372107|NCT00995345|101247679|FG004|Overall Study|Lost to Follow-up|0|||
33372108|NCT00995345|101247675|FG000|Overall Study|all other reasons combined|2|||
33372109|NCT00995345|101247676|FG001|Overall Study|all other reasons combined|2|||
33372110|NCT00995345|101247677|FG002|Overall Study|all other reasons combined|2|||
33372111|NCT00995345|101247678|FG003|Overall Study|all other reasons combined|1|||
33372112|NCT00995345|101247679|FG004|Overall Study|all other reasons combined|3|||
33372113|NCT01201798|101247680|FG000|Overall Study|Adverse Event|2|||
33372114|NCT01201798|101247681|FG001|Overall Study|Adverse Event|0|||
33372115|NCT01201798|101247680|FG000|Overall Study|Lost to Follow-up|3|||
33372116|NCT01201798|101247681|FG001|Overall Study|Lost to Follow-up|5|||
33144573|NCT01369485|100445001|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
33144574|NCT01369485|100445000|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
33144575|NCT01369485|100445001|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
33144576|NCT01369485|100445000|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
33144577|NCT01369485|100445001|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
33144578|NCT01369485|100445000|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
33144579|NCT01369485|100445001|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
33242676|NCT00087490|100789101|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
33372117|NCT01201798|101247680|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
33581976|NCT02103062|102020267|FG000|Overall Study|Adverse Event|1|||
33581977|NCT02103062|102020268|FG001|Overall Study|Adverse Event|2|||
33144580|NCT01369485|100445000|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
33144581|NCT01369485|100445001|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
33144582|NCT00214500|100445002|FG000|Treatment Period|Adverse Event|1|||
33144583|NCT00214500|100445002|FG000|Extension Period|Withdrawal by Subject|2|||
33144584|NCT01527357|100445003|FG000|Overall Study|Death|8|||
33144585|NCT01527357|100445004|FG001|Overall Study|Death|2|||
33144586|NCT01527357|100445003|FG000|Overall Study|Lost to Follow-up|6|||
33144587|NCT01527357|100445004|FG001|Overall Study|Lost to Follow-up|4|||
33144588|NCT01527357|100445003|FG000|Overall Study|Withdrew Consent|1|||
33144589|NCT01527357|100445004|FG001|Overall Study|Withdrew Consent|1|||
33144590|NCT01527357|100445003|FG000|Overall Study|Non-compliance|0|||
33144591|NCT01527357|100445004|FG001|Overall Study|Non-compliance|1|||
33144592|NCT01527357|100445003|FG000|Overall Study|No Day 29 Visit|0|||
33242677|NCT00087490|100789100|FG000|Overall Study|Randomized but not treated|7|||
33242678|NCT00087490|100789101|FG001|Overall Study|Randomized but not treated|18|||
33242679|NCT04939428|100789105|FG000|Overall Study|Death|0|||
33242680|NCT04939428|100789106|FG001|Overall Study|Death|1|||
33242681|NCT04939428|100789107|FG002|Overall Study|Death|0|||
33242682|NCT04939428|100789105|FG000|Overall Study|Lost to Follow-up|0|||
33242683|NCT04939428|100789106|FG001|Overall Study|Lost to Follow-up|5|||
33421908|NCT00738920|101436915|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
33421909|NCT00738920|101436916|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
33421910|NCT00738920|101436914|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
33421911|NCT00738920|101436915|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
33421912|NCT00738920|101436916|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
33421913|NCT00738920|101436914|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
33421914|NCT00738920|101436915|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
33421915|NCT00738920|101436916|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
33421916|NCT00738920|101436914|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
33421917|NCT00738920|101436915|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
33421918|NCT00738920|101436916|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
33421919|NCT00738920|101436914|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
33581978|NCT02103062|102020267|FG000|Overall Study|Progressive Disease|17|||
33581979|NCT02103062|102020268|FG001|Overall Study|Progressive Disease|20|||
33581980|NCT02103062|102020267|FG000|Overall Study|Death|0|||
33581981|NCT02103062|102020268|FG001|Overall Study|Death|1|||
33242684|NCT04939428|100789107|FG002|Overall Study|Lost to Follow-up|0|||
33242685|NCT04939428|100789105|FG000|Overall Study|Physician Decision|1|||
33242686|NCT04939428|100789106|FG001|Overall Study|Physician Decision|0|||
33242687|NCT04939428|100789107|FG002|Overall Study|Physician Decision|0|||
33242688|NCT04939428|100789105|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
33242689|NCT04939428|100789106|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33581982|NCT00292045|102020270|FG000|Core Study (Through Week 13)|Adverse Event|1|||
33581983|NCT00292045|102020270|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
33581984|NCT00400517|102020271|FG000|Overall Study|Withdrawal by Subject|1|||
33581985|NCT00400517|102020271|FG000|Overall Study|Physician Decision|1|||
33581986|NCT00703963|102020272|FG000|Overall Study|Withdrawal by Subject|7|||
33581987|NCT00703963|102020273|FG001|Overall Study|Withdrawal by Subject|13|||
33581988|NCT00703963|102020272|FG000|Overall Study|Physician Decision|0|||
33581989|NCT00703963|102020273|FG001|Overall Study|Physician Decision|1|||
33581990|NCT04721158|102020276|FG000|Overall Study|Lost to Follow-up|4|||
33581991|NCT04721158|102020276|FG000|Overall Study|Device did not connect|1|||
33581992|NCT00326001|102020277|FG000|Overall Study|Adverse Event|4|||
33581993|NCT00326001|102020278|FG001|Overall Study|Adverse Event|5|||
33581994|NCT00326001|102020277|FG000|Overall Study|Physician Decision|3|||
33581995|NCT00326001|102020278|FG001|Overall Study|Physician Decision|3|||
33581996|NCT01170273|102020284|FG000|Overall Study|Lost to Follow-up|6|||
33581997|NCT01170273|102020285|FG001|Overall Study|Lost to Follow-up|8|||
33581998|NCT01170273|102020284|FG000|Overall Study|Protocol Violation|1|||
33581999|NCT01170273|102020285|FG001|Overall Study|Protocol Violation|0|||
33242690|NCT04939428|100789107|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33242691|NCT04939428|100789105|FG000|Overall Study|Withdrawal by Subject|10|||
33242692|NCT04939428|100789106|FG001|Overall Study|Withdrawal by Subject|11|||
33372118|NCT01201798|101247681|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
33582000|NCT01170273|102020284|FG000|Overall Study|Death|1|||
33582001|NCT01170273|102020285|FG001|Overall Study|Death|0|||
33582002|NCT01170273|102020284|FG000|Overall Study|Adverse Event|0|||
33582003|NCT01170273|102020285|FG001|Overall Study|Adverse Event|1|||
33144593|NCT01527357|100445004|FG001|Overall Study|No Day 29 Visit|1|||
33242693|NCT04939428|100789107|FG002|Overall Study|Withdrawal by Subject|0|||
33582004|NCT03183063|102020286|FG000|Overall Study|Withdrawal by Subject|2|||
33582005|NCT03183063|102020287|FG001|Overall Study|Withdrawal by Subject|0|||
33582006|NCT03183063|102020288|FG002|Overall Study|Withdrawal by Subject|0|||
33582007|NCT03183063|102020286|FG000|Overall Study|Physician Decision|3|||
33582008|NCT03183063|102020287|FG001|Overall Study|Physician Decision|4|||
33372119|NCT01201798|101247680|FG000|Overall Study|Noncompliance|1|||
33372120|NCT01201798|101247681|FG001|Overall Study|Noncompliance|0|||
33372121|NCT01201798|101247680|FG000|Overall Study|Protocol Violation|1|||
33372122|NCT01201798|101247681|FG001|Overall Study|Protocol Violation|1|||
33372123|NCT01201798|101247680|FG000|Overall Study|Treatment Failure|1|||
33372124|NCT01201798|101247681|FG001|Overall Study|Treatment Failure|8|||
33372125|NCT02433379|101247684|FG000|Overall Study|Screen Failures|55|||
33372126|NCT02433379|101247684|FG000|Overall Study|Death|57|||
33372127|NCT02433379|101247684|FG000|Overall Study|Total Withdrawals|209|||
33372128|NCT01774344|101247685|FG000|Overall Study|Withdrawal by Subject|3|||
33242694|NCT04939428|100789105|FG000|Overall Study|Unkown|6|||
33242695|NCT04939428|100789106|FG001|Overall Study|Unkown|3|||
33372129|NCT01774344|101247686|FG001|Overall Study|Withdrawal by Subject|10|||
33372130|NCT01774344|101247685|FG000|Overall Study|Protocol Violation|0|||
33372131|NCT01774344|101247686|FG001|Overall Study|Protocol Violation|1|||
33372132|NCT01774344|101247685|FG000|Overall Study|Lost to Follow-up|4|||
33372133|NCT01774344|101247686|FG001|Overall Study|Lost to Follow-up|10|||
33372134|NCT01774344|101247685|FG000|Overall Study|End of survival follow-up not available|2|||
33372135|NCT01774344|101247686|FG001|Overall Study|End of survival follow-up not available|2|||
33421920|NCT00738920|101436915|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
33421921|NCT00738920|101436916|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
33421922|NCT00738920|101436914|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
33582009|NCT03183063|102020288|FG002|Overall Study|Physician Decision|4|||
33582010|NCT02923531|102020289|FG000|Overall Study|Adverse Event|4|||
33582011|NCT02923531|102020289|FG000|Overall Study|Clinical Deterioration|1|||
33582012|NCT02923531|102020289|FG000|Overall Study|Disease Progression|3|||
33582013|NCT02923531|102020289|FG000|Overall Study|Study Termination|1|||
33582014|NCT00466947|102020292|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
33582015|NCT00466947|102020293|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
33582016|NCT00466947|102020292|FG000|Study End Analysis Period|Adverse Event|35|||
33582017|NCT00466947|102020293|FG001|Study End Analysis Period|Adverse Event|43|||
33582018|NCT00466947|102020292|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
33582019|NCT00466947|102020293|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
33582020|NCT00466947|102020292|FG000|Study End Analysis Period|Physician Decision|29|||
33582021|NCT00466947|102020293|FG001|Study End Analysis Period|Physician Decision|29|||
33582022|NCT00466947|102020292|FG000|Study End Analysis Period|Protocol Violation|9|||
33582023|NCT00466947|102020293|FG001|Study End Analysis Period|Protocol Violation|17|||
33582024|NCT00466947|102020292|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
33582025|NCT00466947|102020293|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
33582026|NCT00466947|102020292|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
33582027|NCT00466947|102020293|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
33582028|NCT00466947|102020292|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
33582029|NCT00466947|102020293|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
33582030|NCT00466947|102020292|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
33582031|NCT00466947|102020293|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
33582032|NCT00590122|102020295|FG000|Overall Study|swallowed oral dissolving dose|1|||
33582033|NCT00590122|102020296|FG001|Overall Study|swallowed oral dissolving dose|0|||
33582034|NCT00430989|102020298|FG000|Overall Study|Lost to Follow-up|2|||
33582035|NCT00430989|102020299|FG001|Overall Study|Lost to Follow-up|3|||
33582036|NCT00430989|102020298|FG000|Overall Study|Withdrawal by Subject|15|||
33582037|NCT00430989|102020299|FG001|Overall Study|Withdrawal by Subject|14|||
33582038|NCT00430989|102020298|FG000|Overall Study|Protocol Violation|30|||
33582039|NCT00430989|102020299|FG001|Overall Study|Protocol Violation|37|||
33582040|NCT00430989|102020298|FG000|Overall Study|Not eligible|13|||
33582041|NCT00430989|102020299|FG001|Overall Study|Not eligible|6|||
33582042|NCT00532129|102020300|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
33582043|NCT00532129|102020300|FG000|Treatment Period|Physician Decision|15|||
33582044|NCT00532129|102020300|FG000|Treatment Period|Disease progression|3|||
33582045|NCT00532129|102020300|FG000|Treatment Period|Protocol Violation|1|||
33582046|NCT00532129|102020300|FG000|Treatment Period|Other|5|||
33582047|NCT00532129|102020300|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
33582048|NCT00532129|102020300|FG000|Follow-up Period|Disease progression|57|||
33144594|NCT01527357|100445003|FG000|Overall Study|Did Not Receive Treatment|2|||
33144595|NCT01527357|100445004|FG001|Overall Study|Did Not Receive Treatment|0|||
33144596|NCT02017171|100445005|FG000|Overall Study|Death|10|||
33144597|NCT02017171|100445006|FG001|Overall Study|Death|4|||
33144598|NCT02017171|100445005|FG000|Overall Study|Withdrawal by Subject|23|||
33144599|NCT02017171|100445006|FG001|Overall Study|Withdrawal by Subject|17|||
33144600|NCT02017171|100445005|FG000|Overall Study|Lost to Follow-up|21|||
33144601|NCT02017171|100445006|FG001|Overall Study|Lost to Follow-up|20|||
33144602|NCT02017171|100445005|FG000|Overall Study|ESKD|6|||
33144603|NCT02017171|100445006|FG001|Overall Study|ESKD|2|||
33144604|NCT02017171|100445005|FG000|Overall Study|Miscellaneous|2|||
33144605|NCT02017171|100445006|FG001|Overall Study|Miscellaneous|3|||
33582049|NCT00532129|102020300|FG000|Follow-up Period|Lost to Follow-up|1|||
33582050|NCT00532129|102020300|FG000|Follow-up Period|Other|6|||
33582051|NCT01492426|102020301|FG000|Treatment|Death|0|||
33582052|NCT01492426|102020302|FG001|Treatment|Death|1|||
33582053|NCT01492426|102020301|FG000|Treatment|Other|1|||
33582054|NCT01492426|102020302|FG001|Treatment|Other|0|||
33582055|NCT01492426|102020301|FG000|Treatment|Adverse Event|25|||
33582056|NCT01492426|102020302|FG001|Treatment|Adverse Event|25|||
33242696|NCT04939428|100789107|FG002|Overall Study|Unkown|0|||
33242697|NCT04939428|100789105|FG000|Overall Study|Discotinued per protocol|0|||
33242698|NCT04939428|100789106|FG001|Overall Study|Discotinued per protocol|0|||
33242699|NCT04939428|100789107|FG002|Overall Study|Discotinued per protocol|902|||
33242700|NCT03415022|100789109|FG000|Overall Study|Withdrawal by Subject|1|||
33242701|NCT03415022|100789110|FG001|Overall Study|Withdrawal by Subject|2|||
33242702|NCT03415022|100789109|FG000|Overall Study|COVID-19 Suspension|2|||
33242703|NCT03415022|100789110|FG001|Overall Study|COVID-19 Suspension|3|||
33242704|NCT03415022|100789109|FG000|Overall Study|Lost to Follow-up|2|||
33242705|NCT03415022|100789110|FG001|Overall Study|Lost to Follow-up|0|||
33242706|NCT02825043|100789116|FG000|Overall Study|Lost to Follow-up|4|||
33242707|NCT00558753|100789121|FG000|Overall Study|Lost to Follow-up|5|||
33242708|NCT00558753|100789122|FG001|Overall Study|Lost to Follow-up|7|||
33242709|NCT02498613|100789123|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
33242710|NCT02498613|100789124|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
33242711|NCT02498613|100789125|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
33242712|NCT02498613|100789126|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
33242713|NCT02498613|100789123|FG000|Overall Study|Withdrawal by Subject|3|||
33242714|NCT02498613|100789124|FG001|Overall Study|Withdrawal by Subject|1|||
33242715|NCT02498613|100789125|FG002|Overall Study|Withdrawal by Subject|0|||
33242716|NCT02498613|100789126|FG003|Overall Study|Withdrawal by Subject|0|||
33242717|NCT01192295|100789127|FG000|Overall Study|Adverse Event|3|||
33242718|NCT01192295|100789128|FG001|Overall Study|Adverse Event|7|||
33242719|NCT01192295|100789127|FG000|Overall Study|Withdrawal by Subject|3|||
33242720|NCT01192295|100789128|FG001|Overall Study|Withdrawal by Subject|4|||
33242721|NCT01192295|100789127|FG000|Overall Study|Lost to Follow-up|0|||
33242722|NCT01192295|100789128|FG001|Overall Study|Lost to Follow-up|1|||
33242723|NCT01192295|100789127|FG000|Overall Study|Lack of Efficacy|0|||
33582057|NCT01492426|102020301|FG000|Treatment|Lack of Efficacy|38|||
33582058|NCT01492426|102020302|FG001|Treatment|Lack of Efficacy|5|||
33582059|NCT01492426|102020301|FG000|Treatment|Participant withdrew consent|1|||
33242724|NCT01192295|100789128|FG001|Overall Study|Lack of Efficacy|5|||
33372136|NCT01774344|101247685|FG000|Overall Study|Data collection finished|4|||
33372137|NCT01774344|101247686|FG001|Overall Study|Data collection finished|14|||
33372138|NCT01774344|101247685|FG000|Overall Study|Other|0|||
33372139|NCT01774344|101247686|FG001|Overall Study|Other|1|||
33242725|NCT01192295|100789127|FG000|Overall Study|Administrative|4|||
33242726|NCT01192295|100789128|FG001|Overall Study|Administrative|6|||
33372140|NCT01774344|101247685|FG000|Overall Study|Did not enter Survival Follow up|49|||
33242727|NCT04956692|100789129|FG000|Overall Study|Death|115|||
33242728|NCT04956692|100789130|FG001|Overall Study|Death|47|||
33242729|NCT04956692|100789129|FG000|Overall Study|Lost to Follow-up|0|||
33242730|NCT04956692|100789130|FG001|Overall Study|Lost to Follow-up|1|||
33242731|NCT04956692|100789129|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
33242732|NCT04956692|100789130|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33242733|NCT04956692|100789129|FG000|Overall Study|Withdrawal by Subject|5|||
33242734|NCT04956692|100789130|FG001|Overall Study|Withdrawal by Subject|2|||
33242735|NCT04956692|100789129|FG000|Overall Study|Ongoing in Study|236|||
33242736|NCT04956692|100789130|FG001|Overall Study|Ongoing in Study|123|||
33242737|NCT01124617|100789131|FG000|Overall Study|Adverse Event|5|||
33242738|NCT01124617|100789132|FG001|Overall Study|Adverse Event|2|||
33242739|NCT01124617|100789131|FG000|Overall Study|Lack of Efficacy|2|||
33242740|NCT01124617|100789132|FG001|Overall Study|Lack of Efficacy|1|||
33242741|NCT01124617|100789131|FG000|Overall Study|Protocol Violation|1|||
33242742|NCT01124617|100789132|FG001|Overall Study|Protocol Violation|1|||
33372141|NCT01774344|101247686|FG001|Overall Study|Did not enter Survival Follow up|83|||
33372142|NCT01252134|101247691|FG000|Period 1, 8 Hours|Personal Reasons|0|||
33372143|NCT01252134|101247692|FG001|Period 1, 8 Hours|Personal Reasons|1|||
33372144|NCT01252134|101247693|FG002|Period 1, 8 Hours|Personal Reasons|1|||
33372145|NCT01252134|101247694|FG003|Period 1, 8 Hours|Personal Reasons|0|||
33372146|NCT01252134|101247695|FG004|Period 1, 8 Hours|Personal Reasons|0|||
33372147|NCT01252134|101247696|FG005|Period 1, 8 Hours|Personal Reasons|0|||
33372148|NCT01651052|101247697|FG000|Overall Study|Death|21|||
33372149|NCT01651052|101247697|FG000|Overall Study|Explant|1|||
33372150|NCT01651052|101247697|FG000|Overall Study|Withdrawal by Subject|1|||
33582060|NCT01492426|102020302|FG001|Treatment|Participant withdrew consent|2|||
33582061|NCT01492426|102020301|FG000|Treatment|Poor compliance/noncompliance|1|||
33372151|NCT01651052|101247697|FG000|Overall Study|Lost to Follow-up|3|||
33242743|NCT01124617|100789131|FG000|Overall Study|Withdrawal by Subject|9|||
33582062|NCT01492426|102020302|FG001|Treatment|Poor compliance/noncompliance|0|||
33242744|NCT01124617|100789132|FG001|Overall Study|Withdrawal by Subject|1|||
33242745|NCT01124617|100789131|FG000|Overall Study|Other|2|||
33242746|NCT01124617|100789132|FG001|Overall Study|Other|1|||
33242747|NCT04672460|100789143|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
33242748|NCT04672460|100789144|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
33242749|NCT04672460|100789143|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
33242750|NCT04672460|100789144|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
33242751|NCT04672460|100789143|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
33242752|NCT04672460|100789144|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
33242753|NCT04672460|100789143|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
33242754|NCT04672460|100789144|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
33242755|NCT04672460|100789143|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
33242756|NCT04672460|100789144|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
33242757|NCT04672460|100789143|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
33242758|NCT04672460|100789144|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
33242759|NCT04672460|100789143|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
33242760|NCT04672460|100789144|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
33372152|NCT00137436|101247706|FG000|Overall Study|Adverse Event|13|||
33372153|NCT00137436|101247706|FG000|Overall Study|Death|2|||
33372154|NCT00137436|101247706|FG000|Overall Study|Lack of Efficacy|17|||
33372155|NCT00137436|101247706|FG000|Overall Study|Withdrawal by Subject|6|||
33372156|NCT00137436|101247706|FG000|Overall Study|Other|5|||
33372157|NCT04657016|101247707|FG000|Overall Study|Adverse Event|2|||
33372158|NCT04657016|101247708|FG001|Overall Study|Adverse Event|4|||
33372159|NCT04657016|101247707|FG000|Overall Study|Death|1|||
33372160|NCT04657016|101247708|FG001|Overall Study|Death|1|||
33372161|NCT04657016|101247707|FG000|Overall Study|Lost to Follow-up|24|||
33372162|NCT04657016|101247708|FG001|Overall Study|Lost to Follow-up|12|||
33372163|NCT04657016|101247707|FG000|Overall Study|Physician Decision|1|||
33372164|NCT04657016|101247708|FG001|Overall Study|Physician Decision|2|||
33582063|NCT01492426|102020301|FG000|Treatment|Subject requested discontinue study drug|7|||
33582064|NCT01492426|102020302|FG001|Treatment|Subject requested discontinue study drug|3|||
33582065|NCT01492426|102020301|FG000|Treatment|Lost to Follow-up|9|||
33582066|NCT01492426|102020302|FG001|Treatment|Lost to Follow-up|4|||
33582067|NCT01492426|102020301|FG000|Treatment|Participant does not meet study criteria|1|||
33582068|NCT01492426|102020302|FG001|Treatment|Participant does not meet study criteria|0|||
33582069|NCT01492426|102020301|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
33582070|NCT01492426|102020302|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
33582071|NCT01492426|102020301|FG000|Follow-Up|Death|1|||
33582072|NCT01492426|102020302|FG001|Follow-Up|Death|0|||
33582073|NCT01492426|102020301|FG000|Follow-Up|Other|4|||
33582074|NCT01492426|102020302|FG001|Follow-Up|Other|2|||
33372165|NCT04657016|101247707|FG000|Overall Study|Pregnancy|2|||
33372166|NCT04657016|101247708|FG001|Overall Study|Pregnancy|2|||
33372167|NCT04657016|101247707|FG000|Overall Study|Protocol Deviation|1|||
33372168|NCT04657016|101247708|FG001|Overall Study|Protocol Deviation|0|||
33372169|NCT04657016|101247707|FG000|Overall Study|Withdrawal by Subject|28|||
33582075|NCT01492426|102020301|FG000|Follow-Up|Participant Withdrew Consent|6|||
33372170|NCT04657016|101247708|FG001|Overall Study|Withdrawal by Subject|14|||
33372171|NCT04657016|101247707|FG000|Overall Study|Other - as reported by the investigator|6|||
33372172|NCT04657016|101247708|FG001|Overall Study|Other - as reported by the investigator|0|||
33144606|NCT01611454|100445009|FG000|Overall Study|Lack of Efficacy|18|||
33372173|NCT00912015|101247720|FG000|Overall Study|Lack of Efficacy|1|||
33372174|NCT00912015|101247721|FG001|Overall Study|Lack of Efficacy|0|||
33372175|NCT00912015|101247722|FG002|Overall Study|Lack of Efficacy|0|||
33421923|NCT00738920|101436915|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
33582076|NCT01492426|102020302|FG001|Follow-Up|Participant Withdrew Consent|1|||
33582077|NCT01492426|102020301|FG000|Follow-Up|Lost to Follow-up|12|||
33582078|NCT01492426|102020302|FG001|Follow-Up|Lost to Follow-up|6|||
33144607|NCT01611454|100445010|FG001|Overall Study|Lack of Efficacy|10|||
33144608|NCT02117414|100445011|FG000|Overall Study|Death|5|||
33144609|NCT02117414|100445012|FG001|Overall Study|Death|2|||
33144610|NCT02117414|100445011|FG000|Overall Study|Withdrawal by Subject|10|||
33144611|NCT02117414|100445012|FG001|Overall Study|Withdrawal by Subject|4|||
33144612|NCT01931670|100445015|FG000|Treatment Period|Exclusionary Medication Received|1|||
33144613|NCT01931670|100445016|FG001|Treatment Period|Exclusionary Medication Received|1|||
33144614|NCT01931670|100445017|FG002|Treatment Period|Exclusionary Medication Received|1|||
33144615|NCT01931670|100445015|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
33144616|NCT01931670|100445016|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
33144617|NCT01931670|100445017|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
33144618|NCT01931670|100445015|FG000|Treatment Period|Subject Noncompliant|4|||
33144619|NCT01931670|100445016|FG001|Treatment Period|Subject Noncompliant|9|||
33144620|NCT01931670|100445017|FG002|Treatment Period|Subject Noncompliant|5|||
33144621|NCT01931670|100445015|FG000|Treatment Period|Adverse Event|19|||
33372176|NCT00912015|101247723|FG003|Overall Study|Lack of Efficacy|0|||
33372177|NCT00912015|101247720|FG000|Overall Study|Withdrawal by Subject|8|||
33242761|NCT04672460|100789143|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
33242762|NCT04672460|100789144|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
33242763|NCT04672460|100789143|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
33242764|NCT04672460|100789144|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
33242765|NCT04672460|100789143|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
33242766|NCT04672460|100789144|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
33242767|NCT04672460|100789143|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
33242768|NCT04672460|100789144|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
33242769|NCT04672460|100789143|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
33242770|NCT04672460|100789144|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
33242771|NCT04672460|100789143|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
33242772|NCT04672460|100789144|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
33242773|NCT04672460|100789143|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
33242774|NCT04672460|100789144|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
33242775|NCT04672460|100789143|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
33242776|NCT04672460|100789144|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
33242777|NCT04672460|100789143|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
33242778|NCT04672460|100789144|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
33242779|NCT04672460|100789143|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
33242780|NCT04672460|100789144|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
33242781|NCT00519779|100789145|FG000|Overall Study|Withdrawal by Subject|0|||
33242782|NCT00519779|100789146|FG001|Overall Study|Withdrawal by Subject|1|||
33242783|NCT01244984|100789149|FG000|Overall Study|Adverse Event|2|||
33242784|NCT01244984|100789150|FG001|Overall Study|Adverse Event|11|||
33242785|NCT01244984|100789151|FG002|Overall Study|Adverse Event|2|||
33242786|NCT01244984|100789149|FG000|Overall Study|Protocol Violation|1|||
33242787|NCT01244984|100789150|FG001|Overall Study|Protocol Violation|0|||
33242788|NCT01244984|100789151|FG002|Overall Study|Protocol Violation|0|||
33242789|NCT01244984|100789149|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
33242790|NCT01244984|100789150|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
33242791|NCT01244984|100789151|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
33242792|NCT01244984|100789149|FG000|Overall Study|Withdrawal by Subject|1|||
33242793|NCT01244984|100789150|FG001|Overall Study|Withdrawal by Subject|2|||
33242794|NCT01244984|100789151|FG002|Overall Study|Withdrawal by Subject|2|||
33242795|NCT03850444|100789152|FG000|Overall Study|Adverse Event|16|||
33242796|NCT03850444|100789153|FG001|Overall Study|Adverse Event|10|||
33242797|NCT03850444|100789152|FG000|Overall Study|Death|87|||
33242798|NCT03850444|100789153|FG001|Overall Study|Death|107|||
33242799|NCT03850444|100789152|FG000|Overall Study|Lost to Follow-up|1|||
33242800|NCT03850444|100789153|FG001|Overall Study|Lost to Follow-up|1|||
33242801|NCT03850444|100789152|FG000|Overall Study|Withdrawal by Subject|1|||
33242802|NCT03850444|100789153|FG001|Overall Study|Withdrawal by Subject|5|||
33242803|NCT03850444|100789152|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
33242804|NCT03850444|100789153|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
33242805|NCT05027971|100789154|FG000|Overall Study|Physician Decision|7|||
33242806|NCT05027971|100789155|FG001|Overall Study|Physician Decision|3|||
33242807|NCT05027971|100789154|FG000|Overall Study|Lost to Follow-up|1|||
33242808|NCT05027971|100789155|FG001|Overall Study|Lost to Follow-up|1|||
33242809|NCT05027971|100789154|FG000|Overall Study|Withdrawal by Subject|0|||
33242810|NCT05027971|100789155|FG001|Overall Study|Withdrawal by Subject|2|||
33242811|NCT05027971|100789154|FG000|Overall Study|Non-study fiber used.|0|||
33242812|NCT05027971|100789155|FG001|Overall Study|Non-study fiber used.|1|||
33242813|NCT05027971|100789154|FG000|Overall Study|Protocol Violation|0|||
33242814|NCT05027971|100789155|FG001|Overall Study|Protocol Violation|2|||
33242815|NCT02321540|100789156|FG000|Overall Study|Death|0|||
33242816|NCT02321540|100789157|FG001|Overall Study|Death|1|||
33242817|NCT02321540|100789156|FG000|Overall Study|Progression|3|||
33242818|NCT02321540|100789157|FG001|Overall Study|Progression|9|||
33242819|NCT04550039|100789158|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
33242820|NCT04550039|100789159|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
33242821|NCT04550039|100789158|FG000|Overall Study|patient self-withdrew from study|0|||
33242822|NCT04550039|100789159|FG001|Overall Study|patient self-withdrew from study|1|||
33242823|NCT03246672|100789162|FG000|Overall Study|Lost to Follow-up|2|||
33242824|NCT02939183|100789163|FG000|Overall Study|Death|0|||
33242825|NCT02939183|100789164|FG001|Overall Study|Death|0|||
33242826|NCT02939183|100789165|FG002|Overall Study|Death|1|||
33242827|NCT02939183|100789166|FG003|Overall Study|Death|0|||
33242828|NCT02939183|100789167|FG004|Overall Study|Death|0|||
33242829|NCT02939183|100789168|FG005|Overall Study|Death|2|||
33242830|NCT02939183|100789169|FG006|Overall Study|Death|1|||
33242831|NCT02939183|100789170|FG007|Overall Study|Death|0|||
33242832|NCT02939183|100789171|FG008|Overall Study|Death|0|||
33242833|NCT02939183|100789163|FG000|Overall Study|Sponsor decision|0|||
33242834|NCT02939183|100789164|FG001|Overall Study|Sponsor decision|1|||
33242835|NCT02939183|100789165|FG002|Overall Study|Sponsor decision|0|||
33242836|NCT02939183|100789166|FG003|Overall Study|Sponsor decision|1|||
33242837|NCT02939183|100789167|FG004|Overall Study|Sponsor decision|2|||
33642902|NCT02624986|102244223|FG005|Overall Study|Study Terminated by Sponsor|2|||
33642903|NCT02624986|102244224|FG006|Overall Study|Study Terminated by Sponsor|4|||
33642904|NCT02624986|102244225|FG007|Overall Study|Study Terminated by Sponsor|3|||
33642905|NCT02624986|102244218|FG000|Overall Study|Progressive Disease|0|||
33642906|NCT02624986|102244219|FG001|Overall Study|Progressive Disease|1|||
33642907|NCT02624986|102244220|FG002|Overall Study|Progressive Disease|0|||
33642908|NCT02624986|102244221|FG003|Overall Study|Progressive Disease|0|||
33642909|NCT02624986|102244222|FG004|Overall Study|Progressive Disease|0|||
33642910|NCT02624986|102244223|FG005|Overall Study|Progressive Disease|0|||
33642911|NCT02624986|102244224|FG006|Overall Study|Progressive Disease|0|||
33642912|NCT02624986|102244225|FG007|Overall Study|Progressive Disease|0|||
33642913|NCT02624986|102244218|FG000|Overall Study|Protocol Violation|1|||
33642914|NCT02624986|102244219|FG001|Overall Study|Protocol Violation|0|||
33642915|NCT02624986|102244220|FG002|Overall Study|Protocol Violation|0|||
33642916|NCT02624986|102244221|FG003|Overall Study|Protocol Violation|0|||
33642917|NCT02624986|102244222|FG004|Overall Study|Protocol Violation|0|||
33642918|NCT02624986|102244223|FG005|Overall Study|Protocol Violation|0|||
33642919|NCT02624986|102244224|FG006|Overall Study|Protocol Violation|0|||
33642920|NCT02624986|102244225|FG007|Overall Study|Protocol Violation|0|||
33642921|NCT02624986|102244218|FG000|Overall Study|Withdrawal by Subject|0|||
33642922|NCT02624986|102244219|FG001|Overall Study|Withdrawal by Subject|0|||
33642923|NCT02624986|102244220|FG002|Overall Study|Withdrawal by Subject|0|||
33642924|NCT02624986|102244221|FG003|Overall Study|Withdrawal by Subject|0|||
33642925|NCT02624986|102244222|FG004|Overall Study|Withdrawal by Subject|0|||
33642926|NCT02624986|102244223|FG005|Overall Study|Withdrawal by Subject|0|||
33242838|NCT02939183|100789168|FG005|Overall Study|Sponsor decision|0|||
33242839|NCT02939183|100789169|FG006|Overall Study|Sponsor decision|3|||
33242840|NCT02939183|100789170|FG007|Overall Study|Sponsor decision|1|||
33242841|NCT02939183|100789171|FG008|Overall Study|Sponsor decision|4|||
33242842|NCT02939183|100789163|FG000|Overall Study|Withdrawal by Subject|0|||
33242843|NCT02939183|100789164|FG001|Overall Study|Withdrawal by Subject|2|||
33242844|NCT02939183|100789165|FG002|Overall Study|Withdrawal by Subject|0|||
33242845|NCT02939183|100789166|FG003|Overall Study|Withdrawal by Subject|1|||
33242846|NCT02939183|100789167|FG004|Overall Study|Withdrawal by Subject|0|||
33242847|NCT02939183|100789168|FG005|Overall Study|Withdrawal by Subject|0|||
33242848|NCT02939183|100789169|FG006|Overall Study|Withdrawal by Subject|2|||
33242849|NCT02939183|100789170|FG007|Overall Study|Withdrawal by Subject|2|||
33242850|NCT02939183|100789171|FG008|Overall Study|Withdrawal by Subject|2|||
33242851|NCT02939183|100789163|FG000|Overall Study|Not treated due to adverse event|0|||
33242852|NCT02939183|100789164|FG001|Overall Study|Not treated due to adverse event|0|||
33242853|NCT02939183|100789165|FG002|Overall Study|Not treated due to adverse event|0|||
33242854|NCT02939183|100789166|FG003|Overall Study|Not treated due to adverse event|1|||
33242855|NCT02939183|100789167|FG004|Overall Study|Not treated due to adverse event|0|||
33242856|NCT02939183|100789168|FG005|Overall Study|Not treated due to adverse event|0|||
33242857|NCT02939183|100789169|FG006|Overall Study|Not treated due to adverse event|1|||
33242858|NCT02939183|100789170|FG007|Overall Study|Not treated due to adverse event|0|||
33242859|NCT02939183|100789171|FG008|Overall Study|Not treated due to adverse event|0|||
33242860|NCT02926937|100789172|FG000|Overall Study|Adverse Event|0|||
33242861|NCT02926937|100789173|FG001|Overall Study|Adverse Event|1|||
33242862|NCT02926937|100789174|FG002|Overall Study|Adverse Event|1|||
33242863|NCT02926937|100789172|FG000|Overall Study|Poor Compliance to Protocol|1|||
33242864|NCT02926937|100789173|FG001|Overall Study|Poor Compliance to Protocol|0|||
33242865|NCT02926937|100789174|FG002|Overall Study|Poor Compliance to Protocol|0|||
33242866|NCT02926937|100789172|FG000|Overall Study|Lost to Follow-up|4|||
33242867|NCT02926937|100789173|FG001|Overall Study|Lost to Follow-up|5|||
33242868|NCT02926937|100789174|FG002|Overall Study|Lost to Follow-up|0|||
33242869|NCT02926937|100789172|FG000|Overall Study|At the Participant's own Request|11|||
33242870|NCT02926937|100789173|FG001|Overall Study|At the Participant's own Request|5|||
33242871|NCT02926937|100789174|FG002|Overall Study|At the Participant's own Request|8|||
33242872|NCT02926937|100789172|FG000|Overall Study|Reason not Specified|3|||
33242873|NCT02926937|100789173|FG001|Overall Study|Reason not Specified|4|||
33242874|NCT02926937|100789174|FG002|Overall Study|Reason not Specified|2|||
33642927|NCT02624986|102244224|FG006|Overall Study|Withdrawal by Subject|0|||
33242875|NCT04305912|100789175|FG000|First Intervention|COVID-19 Suspension|2|||
33242876|NCT04305912|100789176|FG001|First Intervention|COVID-19 Suspension|0|||
33242877|NCT04305912|100789175|FG000|First Intervention|Withdrawal by Subject|0|||
33242878|NCT04305912|100789176|FG001|First Intervention|Withdrawal by Subject|1|||
33242879|NCT04305912|100789175|FG000|Second Intervention|Adverse Event|0|||
33242880|NCT04305912|100789176|FG001|Second Intervention|Adverse Event|1|||
33242881|NCT01354938|100789181|FG000|Overall Study|Lost to Follow-up|1|||
33642928|NCT02624986|102244225|FG007|Overall Study|Withdrawal by Subject|1|||
33642929|NCT01742286|102244226|FG000|Escalation Phase|Administrative problems|1|||
33642930|NCT01742286|102244227|FG001|Escalation Phase|Administrative problems|1|||
33642931|NCT01742286|102244228|FG002|Escalation Phase|Administrative problems|0|||
33642932|NCT01742286|102244229|FG003|Escalation Phase|Administrative problems|0|||
33642933|NCT01742286|102244230|FG004|Escalation Phase|Administrative problems|0|||
33642934|NCT01742286|102244231|FG005|Escalation Phase|Administrative problems|0|||
33642935|NCT01742286|102244232|FG006|Escalation Phase|Administrative problems|2|||
33642936|NCT01742286|102244226|FG000|Escalation Phase|Adverse Event|0|||
33642937|NCT01742286|102244227|FG001|Escalation Phase|Adverse Event|1|||
33642938|NCT01742286|102244228|FG002|Escalation Phase|Adverse Event|2|||
33642939|NCT01742286|102244229|FG003|Escalation Phase|Adverse Event|0|||
33642940|NCT01742286|102244230|FG004|Escalation Phase|Adverse Event|0|||
33642941|NCT01742286|102244231|FG005|Escalation Phase|Adverse Event|1|||
33642942|NCT01742286|102244232|FG006|Escalation Phase|Adverse Event|0|||
33242882|NCT04438785|100789187|FG000|Overall Study|change of weight, give up intervention|2|||
33242883|NCT04438785|100789188|FG001|Overall Study|change of weight, give up intervention|10|||
33242884|NCT02206685|100789189|FG000|Overall Study|Surgery cancelled/changed|2|||
33242885|NCT02206685|100789190|FG001|Overall Study|Surgery cancelled/changed|3|||
33242886|NCT02206685|100789189|FG000|Overall Study|Withdrawal by Subject|1|||
33242887|NCT02206685|100789190|FG001|Overall Study|Withdrawal by Subject|2|||
33242888|NCT02206685|100789189|FG000|Overall Study|Protocol Violation|2|||
33242889|NCT02206685|100789190|FG001|Overall Study|Protocol Violation|2|||
33242890|NCT00783692|100789191|FG000|Induction Phase|Adverse Event|7|||
33242891|NCT00783692|100789192|FG001|Induction Phase|Adverse Event|9|||
33242892|NCT00783692|100789193|FG002|Induction Phase|Adverse Event|24|||
33242893|NCT00783692|100789194|FG003|Induction Phase|Adverse Event|0|||
33242894|NCT00783692|100789195|FG004|Induction Phase|Adverse Event|0|||
33242895|NCT00783692|100789196|FG005|Induction Phase|Adverse Event|0|||
33242896|NCT00783692|100789197|FG006|Induction Phase|Adverse Event|0|||
33242897|NCT00783692|100789191|FG000|Induction Phase|Protocol Violation|0|||
33242898|NCT00783692|100789192|FG001|Induction Phase|Protocol Violation|0|||
33242899|NCT00783692|100789193|FG002|Induction Phase|Protocol Violation|1|||
33242900|NCT00783692|100789194|FG003|Induction Phase|Protocol Violation|0|||
33242901|NCT00783692|100789195|FG004|Induction Phase|Protocol Violation|0|||
33242902|NCT00783692|100789196|FG005|Induction Phase|Protocol Violation|0|||
33242903|NCT00783692|100789197|FG006|Induction Phase|Protocol Violation|0|||
33242904|NCT00783692|100789191|FG000|Induction Phase|Lack of Efficacy|1|||
33242905|NCT00783692|100789192|FG001|Induction Phase|Lack of Efficacy|3|||
33242906|NCT00783692|100789193|FG002|Induction Phase|Lack of Efficacy|28|||
33242907|NCT00783692|100789194|FG003|Induction Phase|Lack of Efficacy|0|||
33242908|NCT00783692|100789195|FG004|Induction Phase|Lack of Efficacy|0|||
33242909|NCT00783692|100789196|FG005|Induction Phase|Lack of Efficacy|0|||
33242910|NCT00783692|100789197|FG006|Induction Phase|Lack of Efficacy|0|||
33242911|NCT00783692|100789191|FG000|Induction Phase|Withdrawal by Subject|3|||
33242912|NCT00783692|100789192|FG001|Induction Phase|Withdrawal by Subject|9|||
33242913|NCT00783692|100789193|FG002|Induction Phase|Withdrawal by Subject|16|||
33242914|NCT00783692|100789194|FG003|Induction Phase|Withdrawal by Subject|0|||
33642943|NCT01742286|102244226|FG000|Escalation Phase|Disease progression|3|||
33642944|NCT01742286|102244227|FG001|Escalation Phase|Disease progression|7|||
33642945|NCT01742286|102244228|FG002|Escalation Phase|Disease progression|4|||
33642946|NCT01742286|102244229|FG003|Escalation Phase|Disease progression|1|||
33242915|NCT00783692|100789195|FG004|Induction Phase|Withdrawal by Subject|0|||
33242916|NCT00783692|100789196|FG005|Induction Phase|Withdrawal by Subject|0|||
33242917|NCT00783692|100789197|FG006|Induction Phase|Withdrawal by Subject|0|||
33242918|NCT00783692|100789191|FG000|Induction Phase|Lost to Follow-up|0|||
33242919|NCT00783692|100789192|FG001|Induction Phase|Lost to Follow-up|0|||
33242920|NCT00783692|100789193|FG002|Induction Phase|Lost to Follow-up|3|||
33242921|NCT00783692|100789194|FG003|Induction Phase|Lost to Follow-up|0|||
33242922|NCT00783692|100789195|FG004|Induction Phase|Lost to Follow-up|0|||
33242923|NCT00783692|100789196|FG005|Induction Phase|Lost to Follow-up|0|||
33242924|NCT00783692|100789197|FG006|Induction Phase|Lost to Follow-up|0|||
33642947|NCT01742286|102244230|FG004|Escalation Phase|Disease progression|4|||
33642948|NCT01742286|102244231|FG005|Escalation Phase|Disease progression|3|||
33642949|NCT01742286|102244232|FG006|Escalation Phase|Disease progression|2|||
33642950|NCT01742286|102244226|FG000|Escalation Phase|Death|0|||
33642951|NCT01742286|102244227|FG001|Escalation Phase|Death|0|||
33242925|NCT00783692|100789191|FG000|Induction Phase|Other|0|||
33242926|NCT00783692|100789192|FG001|Induction Phase|Other|0|||
33242927|NCT00783692|100789193|FG002|Induction Phase|Other|2|||
33242928|NCT00783692|100789194|FG003|Induction Phase|Other|0|||
33242929|NCT00783692|100789195|FG004|Induction Phase|Other|0|||
33242930|NCT00783692|100789196|FG005|Induction Phase|Other|0|||
33242931|NCT00783692|100789197|FG006|Induction Phase|Other|0|||
33242932|NCT00783692|100789191|FG000|Maintenance Phase|Adverse Event|7|||
33242933|NCT00783692|100789192|FG001|Maintenance Phase|Adverse Event|0|||
33242934|NCT00783692|100789193|FG002|Maintenance Phase|Adverse Event|0|||
33242935|NCT00783692|100789194|FG003|Maintenance Phase|Adverse Event|15|||
33242936|NCT00783692|100789195|FG004|Maintenance Phase|Adverse Event|12|||
33242937|NCT00783692|100789196|FG005|Maintenance Phase|Adverse Event|9|||
33642952|NCT01742286|102244228|FG002|Escalation Phase|Death|0|||
33642953|NCT01742286|102244229|FG003|Escalation Phase|Death|0|||
33242938|NCT00783692|100789197|FG006|Maintenance Phase|Adverse Event|38|||
33642954|NCT01742286|102244230|FG004|Escalation Phase|Death|0|||
33642955|NCT01742286|102244231|FG005|Escalation Phase|Death|1|||
33642956|NCT01742286|102244232|FG006|Escalation Phase|Death|0|||
33642957|NCT01742286|102244226|FG000|Escalation Phase|Physician Decision|0|||
33642958|NCT01742286|102244227|FG001|Escalation Phase|Physician Decision|3|||
33642959|NCT01742286|102244228|FG002|Escalation Phase|Physician Decision|0|||
33642960|NCT01742286|102244229|FG003|Escalation Phase|Physician Decision|1|||
33642961|NCT01742286|102244230|FG004|Escalation Phase|Physician Decision|0|||
33642962|NCT01742286|102244231|FG005|Escalation Phase|Physician Decision|0|||
33642963|NCT01742286|102244232|FG006|Escalation Phase|Physician Decision|2|||
33642964|NCT01742286|102244226|FG000|Escalation Phase|Subject/guardian decision|1|||
33642965|NCT01742286|102244227|FG001|Escalation Phase|Subject/guardian decision|0|||
33642966|NCT01742286|102244228|FG002|Escalation Phase|Subject/guardian decision|0|||
33642967|NCT01742286|102244229|FG003|Escalation Phase|Subject/guardian decision|0|||
33642968|NCT01742286|102244230|FG004|Escalation Phase|Subject/guardian decision|0|||
33642969|NCT01742286|102244231|FG005|Escalation Phase|Subject/guardian decision|0|||
33642970|NCT01742286|102244232|FG006|Escalation Phase|Subject/guardian decision|0|||
33642971|NCT01742286|102244226|FG000|Expansion Phase|Administrative problems|0|||
33642972|NCT01742286|102244227|FG001|Expansion Phase|Administrative problems|0|||
33642973|NCT01742286|102244228|FG002|Expansion Phase|Administrative problems|0|||
33642974|NCT01742286|102244229|FG003|Expansion Phase|Administrative problems|0|||
33642975|NCT01742286|102244230|FG004|Expansion Phase|Administrative problems|0|||
33642976|NCT01742286|102244231|FG005|Expansion Phase|Administrative problems|0|||
33642977|NCT01742286|102244232|FG006|Expansion Phase|Administrative problems|5|||
33642978|NCT01742286|102244226|FG000|Expansion Phase|Physician Decision|0|||
33144622|NCT01931670|100445016|FG001|Treatment Period|Adverse Event|8|||
33144623|NCT01931670|100445017|FG002|Treatment Period|Adverse Event|21|||
33144624|NCT01931670|100445015|FG000|Treatment Period|Lack of Efficacy|11|||
33144625|NCT01931670|100445016|FG001|Treatment Period|Lack of Efficacy|2|||
33144626|NCT01931670|100445017|FG002|Treatment Period|Lack of Efficacy|2|||
33144627|NCT01931670|100445015|FG000|Treatment Period|Pregnancy|7|||
33144628|NCT01931670|100445016|FG001|Treatment Period|Pregnancy|2|||
33144629|NCT01931670|100445017|FG002|Treatment Period|Pregnancy|0|||
33144630|NCT01931670|100445015|FG000|Treatment Period|Other|8|||
33144631|NCT01931670|100445016|FG001|Treatment Period|Other|7|||
33144632|NCT01931670|100445017|FG002|Treatment Period|Other|2|||
33144633|NCT01931670|100445015|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
33144634|NCT01931670|100445016|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
33144635|NCT01931670|100445017|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
33144636|NCT01931670|100445015|FG000|Treatment Period|Lost to Follow-up|19|||
33144637|NCT01931670|100445016|FG001|Treatment Period|Lost to Follow-up|5|||
33144638|NCT01931670|100445017|FG002|Treatment Period|Lost to Follow-up|7|||
33144639|NCT01931670|100445015|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
33144640|NCT01931670|100445016|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
33144641|NCT01931670|100445017|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
33144642|NCT01931670|100445015|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
33144643|NCT01931670|100445016|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
33144644|NCT01931670|100445017|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
33144645|NCT01931670|100445015|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
33144646|NCT01931670|100445016|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
33242939|NCT00783692|100789191|FG000|Maintenance Phase|Protocol Violation|0|||
33582079|NCT02375373|102020310|FG000|Overall Study|Withdrawal by Subject|11|||
33582080|NCT01945996|102020311|FG000|Overall Study|Lost to Follow-up|3|||
33582081|NCT01945996|102020312|FG001|Overall Study|Lost to Follow-up|5|||
33582082|NCT01194219|102020313|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
33582083|NCT01194219|102020314|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
33582084|NCT01194219|102020315|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33582085|NCT01194219|102020316|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33582086|NCT01194219|102020317|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33582087|NCT01194219|102020318|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33582088|NCT01194219|102020319|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33582089|NCT01194219|102020320|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33642979|NCT01742286|102244227|FG001|Expansion Phase|Physician Decision|0|||
33642980|NCT01742286|102244228|FG002|Expansion Phase|Physician Decision|4|||
33642981|NCT01742286|102244229|FG003|Expansion Phase|Physician Decision|0|||
33642982|NCT01742286|102244230|FG004|Expansion Phase|Physician Decision|0|||
33642983|NCT01742286|102244231|FG005|Expansion Phase|Physician Decision|0|||
33144647|NCT01931670|100445017|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
33144648|NCT01931670|100445015|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
33144649|NCT01931670|100445016|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
33421924|NCT00738920|101436916|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
33582090|NCT01194219|102020321|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33642984|NCT01742286|102244232|FG006|Expansion Phase|Physician Decision|9|||
33642985|NCT01742286|102244226|FG000|Expansion Phase|Adverse Event|0|||
33642986|NCT01742286|102244227|FG001|Expansion Phase|Adverse Event|0|||
33642987|NCT01742286|102244228|FG002|Expansion Phase|Adverse Event|0|||
33642988|NCT01742286|102244229|FG003|Expansion Phase|Adverse Event|0|||
33642989|NCT01742286|102244230|FG004|Expansion Phase|Adverse Event|0|||
33642990|NCT01742286|102244231|FG005|Expansion Phase|Adverse Event|0|||
33144650|NCT01931670|100445017|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
33144651|NCT01931670|100445015|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
33144652|NCT01931670|100445016|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
33144653|NCT01931670|100445017|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
33144654|NCT01931670|100445015|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
33144655|NCT01931670|100445016|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
33144656|NCT01931670|100445017|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
33144657|NCT01465191|100445021|FG000|Overall Study|Protocol Violation|6|||
33144658|NCT01465191|100445022|FG001|Overall Study|Protocol Violation|3|||
33144659|NCT01465191|100445023|FG002|Overall Study|Protocol Violation|3|||
33144660|NCT01465191|100445021|FG000|Overall Study|Lost to Follow-up|3|||
33144661|NCT01465191|100445022|FG001|Overall Study|Lost to Follow-up|6|||
33144662|NCT01465191|100445023|FG002|Overall Study|Lost to Follow-up|4|||
33642991|NCT01742286|102244232|FG006|Expansion Phase|Adverse Event|6|||
33642992|NCT01742286|102244226|FG000|Expansion Phase|Disease progression|0|||
33642993|NCT01742286|102244227|FG001|Expansion Phase|Disease progression|0|||
33642994|NCT01742286|102244228|FG002|Expansion Phase|Disease progression|3|||
33642995|NCT01742286|102244229|FG003|Expansion Phase|Disease progression|0|||
33642996|NCT01742286|102244230|FG004|Expansion Phase|Disease progression|0|||
33642997|NCT01742286|102244231|FG005|Expansion Phase|Disease progression|0|||
33642998|NCT01742286|102244232|FG006|Expansion Phase|Disease progression|15|||
33642999|NCT01742286|102244226|FG000|Expansion Phase|Withdrawal by Subject|0|||
33643000|NCT01742286|102244227|FG001|Expansion Phase|Withdrawal by Subject|0|||
33643001|NCT01742286|102244228|FG002|Expansion Phase|Withdrawal by Subject|0|||
33643002|NCT01742286|102244229|FG003|Expansion Phase|Withdrawal by Subject|0|||
33643003|NCT01742286|102244230|FG004|Expansion Phase|Withdrawal by Subject|0|||
33643004|NCT01742286|102244231|FG005|Expansion Phase|Withdrawal by Subject|0|||
33643005|NCT01742286|102244232|FG006|Expansion Phase|Withdrawal by Subject|1|||
33643006|NCT00635999|102244238|FG000|Overall Study|Withdrawal by Subject|4|||
33643007|NCT00635999|102244239|FG001|Overall Study|Withdrawal by Subject|2|||
33643008|NCT00635999|102244240|FG002|Overall Study|Withdrawal by Subject|1|||
33643009|NCT05366738|102244246|FG000|Overall Study|Adverse Event|0|||
33643010|NCT05366738|102244247|FG001|Overall Study|Adverse Event|1|||
33643011|NCT05366738|102244248|FG002|Overall Study|Adverse Event|0|||
33643012|NCT01063283|102244251|FG000|Cycle 1|Adverse Event|2|||
33643013|NCT01063283|102244252|FG001|Cycle 1|Adverse Event|0|||
33643014|NCT01063283|102244253|FG002|Cycle 1|Adverse Event|0|||
33643015|NCT01063283|102244251|FG000|Cycle 1|Technical failure in data collection|1|||
33643016|NCT01063283|102244252|FG001|Cycle 1|Technical failure in data collection|0|||
33643017|NCT01063283|102244253|FG002|Cycle 1|Technical failure in data collection|0|||
33643018|NCT00539864|102244254|FG000|Overall Study|Lost to Follow-up|0|||
33144663|NCT03055858|100445025|FG000|Overall Study|Death|9|||
33144664|NCT03055858|100445025|FG000|Overall Study|Withdrawal by Subject|11|||
33144665|NCT03055858|100445025|FG000|Overall Study|Lost to Follow-up|6|||
33144666|NCT03055858|100445025|FG000|Overall Study|Missed Follow-Up Visits|18|||
33144667|NCT00719264|100445026|FG000|Overall Study|Adverse Event|41|||
33144668|NCT00719264|100445027|FG001|Overall Study|Adverse Event|49|||
33144669|NCT00719264|100445026|FG000|Overall Study|Death|13|||
33144670|NCT00719264|100445027|FG001|Overall Study|Death|10|||
33144671|NCT00719264|100445026|FG000|Overall Study|Administrative Problems|6|||
33144672|NCT00719264|100445027|FG001|Overall Study|Administrative Problems|4|||
33144673|NCT00719264|100445026|FG000|Overall Study|Lost to Follow-up|1|||
33144674|NCT00719264|100445027|FG001|Overall Study|Lost to Follow-up|1|||
33242940|NCT00783692|100789192|FG001|Maintenance Phase|Protocol Violation|0|||
33242941|NCT00783692|100789193|FG002|Maintenance Phase|Protocol Violation|0|||
33242942|NCT00783692|100789194|FG003|Maintenance Phase|Protocol Violation|1|||
33242943|NCT00783692|100789195|FG004|Maintenance Phase|Protocol Violation|2|||
33643019|NCT00539864|102244255|FG001|Overall Study|Lost to Follow-up|1|||
33643020|NCT00539864|102244254|FG000|Overall Study|Withdrawal by Subject|1|||
33643021|NCT00539864|102244255|FG001|Overall Study|Withdrawal by Subject|1|||
33643022|NCT01069900|102244258|FG000|Overall Study|Technical problems|0|||
33643023|NCT01069900|102244259|FG001|Overall Study|Technical problems|1|||
33144675|NCT00719264|100445026|FG000|Overall Study|Withdrawal by Subject|12|||
33144676|NCT00719264|100445027|FG001|Overall Study|Withdrawal by Subject|7|||
33144677|NCT00719264|100445026|FG000|Overall Study|Protocol Deviation|1|||
33144678|NCT00719264|100445027|FG001|Overall Study|Protocol Deviation|3|||
33643024|NCT01069900|102244258|FG000|Overall Study|Lost to Follow-up|7|||
33144679|NCT00719264|100445026|FG000|Overall Study|New Cancer Therapy|4|||
33144680|NCT00719264|100445027|FG001|Overall Study|New Cancer Therapy|2|||
33643025|NCT01069900|102244259|FG001|Overall Study|Lost to Follow-up|1|||
33643026|NCT01069900|102244258|FG000|Overall Study|Withdrawal by Subject|6|||
33144681|NCT00719264|100445026|FG000|Overall Study|Disease Progression|104|||
33144682|NCT00719264|100445027|FG001|Overall Study|Disease Progression|107|||
33144683|NCT01172275|100445028|FG000|Overall Study|Lost to Follow-up|1|||
33144684|NCT01172275|100445029|FG001|Overall Study|Lost to Follow-up|0|||
33144685|NCT01172275|100445028|FG000|Overall Study|Protocol Violation|1|||
33144686|NCT01172275|100445029|FG001|Overall Study|Protocol Violation|0|||
33144687|NCT00459979|100445038|FG000|Overall Study|Withdrawal by Subject|1|||
33144688|NCT00459979|100445038|FG000|Overall Study|Protocol Violation|1|||
33144689|NCT01251146|100445039|FG000|Overall Study|Lost to Follow-up|3|||
33144690|NCT01251146|100445040|FG001|Overall Study|Lost to Follow-up|10|||
33144691|NCT04761627|100445041|FG000|Run-in Period|Death|1|||
33144692|NCT04761627|100445042|FG001|Run-in Period|Death|0|||
33242944|NCT00783692|100789196|FG005|Maintenance Phase|Protocol Violation|3|||
33242945|NCT00783692|100789197|FG006|Maintenance Phase|Protocol Violation|4|||
33421925|NCT00738920|101436914|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
33421926|NCT00738920|101436915|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
33421927|NCT00738920|101436916|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
33421928|NCT00738920|101436914|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
33421929|NCT00738920|101436915|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
33421930|NCT00738920|101436916|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
33421931|NCT01418352|101436920|FG000|Overall Study|Lost to Follow-up|2|||
33421932|NCT01418352|101436921|FG001|Overall Study|Lost to Follow-up|0|||
33421933|NCT01418352|101436922|FG002|Overall Study|Lost to Follow-up|0|||
33421934|NCT01418352|101436923|FG003|Overall Study|Lost to Follow-up|0|||
33421935|NCT01418352|101436920|FG000|Overall Study|Adverse Event|0|||
33421936|NCT01418352|101436921|FG001|Overall Study|Adverse Event|1|||
33421937|NCT01418352|101436922|FG002|Overall Study|Adverse Event|0|||
33242946|NCT00783692|100789191|FG000|Maintenance Phase|Lack of Efficacy|79|||
33242947|NCT00783692|100789192|FG001|Maintenance Phase|Lack of Efficacy|0|||
33242948|NCT00783692|100789193|FG002|Maintenance Phase|Lack of Efficacy|0|||
33242949|NCT00783692|100789194|FG003|Maintenance Phase|Lack of Efficacy|64|||
33242950|NCT00783692|100789195|FG004|Maintenance Phase|Lack of Efficacy|58|||
33242951|NCT00783692|100789196|FG005|Maintenance Phase|Lack of Efficacy|48|||
33242952|NCT00783692|100789197|FG006|Maintenance Phase|Lack of Efficacy|177|||
33242953|NCT00783692|100789191|FG000|Maintenance Phase|Withdrawal by Subject|7|||
33242954|NCT00783692|100789192|FG001|Maintenance Phase|Withdrawal by Subject|0|||
33242955|NCT00783692|100789193|FG002|Maintenance Phase|Withdrawal by Subject|0|||
33242956|NCT00783692|100789194|FG003|Maintenance Phase|Withdrawal by Subject|7|||
33242957|NCT00783692|100789195|FG004|Maintenance Phase|Withdrawal by Subject|6|||
33242958|NCT00783692|100789196|FG005|Maintenance Phase|Withdrawal by Subject|9|||
33242959|NCT00783692|100789197|FG006|Maintenance Phase|Withdrawal by Subject|24|||
33242960|NCT00783692|100789191|FG000|Maintenance Phase|Lost to Follow-up|2|||
33242961|NCT00783692|100789192|FG001|Maintenance Phase|Lost to Follow-up|0|||
33242962|NCT00783692|100789193|FG002|Maintenance Phase|Lost to Follow-up|0|||
33242963|NCT00783692|100789194|FG003|Maintenance Phase|Lost to Follow-up|1|||
33242964|NCT00783692|100789195|FG004|Maintenance Phase|Lost to Follow-up|3|||
33242965|NCT00783692|100789196|FG005|Maintenance Phase|Lost to Follow-up|2|||
33242966|NCT00783692|100789197|FG006|Maintenance Phase|Lost to Follow-up|5|||
33242967|NCT00783692|100789191|FG000|Maintenance Phase|Other|0|||
33372178|NCT00912015|101247721|FG001|Overall Study|Withdrawal by Subject|8|||
33242968|NCT00783692|100789192|FG001|Maintenance Phase|Other|0|||
33242969|NCT00783692|100789193|FG002|Maintenance Phase|Other|0|||
33242970|NCT00783692|100789194|FG003|Maintenance Phase|Other|1|||
33242971|NCT00783692|100789195|FG004|Maintenance Phase|Other|0|||
33372179|NCT00912015|101247722|FG002|Overall Study|Withdrawal by Subject|3|||
33372180|NCT00912015|101247723|FG003|Overall Study|Withdrawal by Subject|0|||
33372181|NCT00912015|101247720|FG000|Overall Study|Protocol Violation|1|||
33372182|NCT00912015|101247721|FG001|Overall Study|Protocol Violation|0|||
33372183|NCT00912015|101247722|FG002|Overall Study|Protocol Violation|0|||
33372184|NCT00912015|101247723|FG003|Overall Study|Protocol Violation|1|||
33372185|NCT00912015|101247720|FG000|Overall Study|Adverse Event|6|||
33372186|NCT00912015|101247721|FG001|Overall Study|Adverse Event|0|||
33421938|NCT01418352|101436923|FG003|Overall Study|Adverse Event|0|||
33421939|NCT01418352|101436920|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
33421940|NCT01418352|101436921|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
33421941|NCT01418352|101436922|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
33421942|NCT01418352|101436923|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
33421943|NCT01418352|101436920|FG000|Overall Study|Subject Withdrew Consent|0|||
33144693|NCT04761627|100445043|FG002|Run-in Period|Death|0|||
33242972|NCT00783692|100789196|FG005|Maintenance Phase|Other|1|||
33144694|NCT04761627|100445041|FG000|Run-in Period|Required alternative therapy|2|||
33242973|NCT00783692|100789197|FG006|Maintenance Phase|Other|1|||
33242974|NCT01141660|100789198|FG000|Overall Study|Physician Decision|0|||
33242975|NCT01141660|100789199|FG001|Overall Study|Physician Decision|12|||
33144695|NCT04761627|100445042|FG001|Run-in Period|Required alternative therapy|0|||
33242976|NCT02099539|100789200|FG000|Overall Study|Progressive Disease|3|||
33372187|NCT00912015|101247722|FG002|Overall Study|Adverse Event|0|||
33144696|NCT04761627|100445043|FG002|Run-in Period|Required alternative therapy|0|||
33144697|NCT04761627|100445041|FG000|Run-in Period|Lost to Follow-up|2|||
33144698|NCT04761627|100445042|FG001|Run-in Period|Lost to Follow-up|0|||
33144699|NCT04761627|100445043|FG002|Run-in Period|Lost to Follow-up|0|||
33144700|NCT04761627|100445041|FG000|Run-in Period|Protocol Violation|3|||
33144701|NCT04761627|100445042|FG001|Run-in Period|Protocol Violation|0|||
33144702|NCT04761627|100445043|FG002|Run-in Period|Protocol Violation|0|||
33144703|NCT04761627|100445041|FG000|Run-in Period|Abnormal liver function|1|||
33144704|NCT04761627|100445042|FG001|Run-in Period|Abnormal liver function|0|||
33144705|NCT04761627|100445043|FG002|Run-in Period|Abnormal liver function|0|||
33144706|NCT04761627|100445041|FG000|Run-in Period|Adverse Event|6|||
33144707|NCT04761627|100445042|FG001|Run-in Period|Adverse Event|0|||
33144708|NCT04761627|100445043|FG002|Run-in Period|Adverse Event|0|||
33144709|NCT04761627|100445041|FG000|Run-in Period|Withdrawal by Subject|7|||
33144710|NCT04761627|100445042|FG001|Run-in Period|Withdrawal by Subject|0|||
33144711|NCT04761627|100445043|FG002|Run-in Period|Withdrawal by Subject|0|||
33144712|NCT04761627|100445041|FG000|Run-in Period|Did not meet PASI 50|15|||
33144713|NCT04761627|100445042|FG001|Run-in Period|Did not meet PASI 50|0|||
33144714|NCT04761627|100445043|FG002|Run-in Period|Did not meet PASI 50|0|||
33144715|NCT04761627|100445041|FG000|Run-in Period|Study site closure|2|||
33144716|NCT04761627|100445042|FG001|Run-in Period|Study site closure|0|||
33144717|NCT04761627|100445043|FG002|Run-in Period|Study site closure|0|||
33421944|NCT01418352|101436921|FG001|Overall Study|Subject Withdrew Consent|1|||
33421945|NCT01418352|101436922|FG002|Overall Study|Subject Withdrew Consent|2|||
33421946|NCT01418352|101436923|FG003|Overall Study|Subject Withdrew Consent|1|||
33421947|NCT01418352|101436920|FG000|Overall Study|Protocol Deviation|0|||
33421948|NCT01418352|101436921|FG001|Overall Study|Protocol Deviation|0|||
33144718|NCT04761627|100445041|FG000|Run-in Period|Pregnancy|2|||
33144719|NCT04761627|100445042|FG001|Run-in Period|Pregnancy|0|||
33144720|NCT04761627|100445043|FG002|Run-in Period|Pregnancy|0|||
33421949|NCT01418352|101436922|FG002|Overall Study|Protocol Deviation|1|||
33643027|NCT01069900|102244259|FG001|Overall Study|Withdrawal by Subject|1|||
33643028|NCT01069900|102244258|FG000|Overall Study|Protocol Violation|4|||
33144721|NCT04761627|100445041|FG000|Post-randomization Period|Military service|0|||
33144722|NCT04761627|100445042|FG001|Post-randomization Period|Military service|1|||
33144723|NCT04761627|100445043|FG002|Post-randomization Period|Military service|0|||
33144724|NCT04761627|100445041|FG000|Post-randomization Period|Adverse Event|0|||
33144725|NCT04761627|100445042|FG001|Post-randomization Period|Adverse Event|4|||
33144726|NCT04761627|100445043|FG002|Post-randomization Period|Adverse Event|2|||
33144727|NCT04761627|100445041|FG000|Post-randomization Period|Lost to Follow-up|0|||
33144728|NCT04761627|100445042|FG001|Post-randomization Period|Lost to Follow-up|6|||
33144729|NCT04761627|100445043|FG002|Post-randomization Period|Lost to Follow-up|6|||
33144730|NCT04761627|100445041|FG000|Post-randomization Period|Withdrawal by Subject|0|||
33144731|NCT04761627|100445042|FG001|Post-randomization Period|Withdrawal by Subject|7|||
33144732|NCT04761627|100445043|FG002|Post-randomization Period|Withdrawal by Subject|6|||
33144733|NCT04761627|100445041|FG000|Post-randomization Period|Pregnancy|0|||
33144734|NCT04761627|100445042|FG001|Post-randomization Period|Pregnancy|0|||
33144735|NCT04761627|100445043|FG002|Post-randomization Period|Pregnancy|1|||
33144736|NCT04761627|100445041|FG000|Post-randomization Period|Study site closure|0|||
33144737|NCT04761627|100445042|FG001|Post-randomization Period|Study site closure|0|||
33144738|NCT04761627|100445043|FG002|Post-randomization Period|Study site closure|1|||
33144739|NCT04761627|100445041|FG000|Post-randomization Period|Family planning|0|||
33144740|NCT04761627|100445042|FG001|Post-randomization Period|Family planning|1|||
33144741|NCT04761627|100445043|FG002|Post-randomization Period|Family planning|0|||
33144742|NCT03828370|100445045|FG000|3 Month Follow-up|Lost to Follow-up|4|||
33372188|NCT00912015|101247723|FG003|Overall Study|Adverse Event|1|||
33372189|NCT02918266|101247724|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
33372190|NCT02918266|101247725|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33372191|NCT02918266|101247726|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33372192|NCT02918266|101247727|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33372193|NCT02918266|101247728|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33372194|NCT02918266|101247729|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33372195|NCT02918266|101247730|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
33372196|NCT02918266|101247731|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33372197|NCT02918266|101247732|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
33643029|NCT01069900|102244259|FG001|Overall Study|Protocol Violation|1|||
33144743|NCT03828370|100445046|FG001|3 Month Follow-up|Lost to Follow-up|12|||
33144744|NCT03828370|100445045|FG000|9 Month Follow up|Lost to Follow-up|12|||
33144745|NCT03828370|100445046|FG001|9 Month Follow up|Lost to Follow-up|20|||
33372198|NCT02918266|101247733|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33421950|NCT01418352|101436923|FG003|Overall Study|Protocol Deviation|0|||
33144746|NCT04179890|100445047|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
33144747|NCT04179890|100445048|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
33421951|NCT01418352|101436920|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
33144748|NCT04179890|100445047|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
33144749|NCT04179890|100445048|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
33144750|NCT04179890|100445047|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
33144751|NCT04179890|100445048|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
33144752|NCT04179890|100445047|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
33144753|NCT04179890|100445048|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
33144754|NCT04179890|100445047|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
33144755|NCT04179890|100445048|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
33144756|NCT04179890|100445047|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
33144757|NCT04179890|100445048|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
33144758|NCT04179890|100445047|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
33144759|NCT04179890|100445048|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
33144760|NCT04179890|100445047|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
33144761|NCT04179890|100445048|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
33144762|NCT04179890|100445047|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
33144763|NCT04179890|100445048|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
33144764|NCT02663687|100445049|FG000|Overall Study|Adverse Event|1|||
33144765|NCT02663687|100445050|FG001|Overall Study|Adverse Event|0|||
33144766|NCT02663687|100445051|FG002|Overall Study|Adverse Event|0|||
33144767|NCT02663687|100445052|FG003|Overall Study|Adverse Event|0|||
33144768|NCT02663687|100445053|FG004|Overall Study|Adverse Event|0|||
33144769|NCT02663687|100445049|FG000|Overall Study|Other|1|||
33144770|NCT02663687|100445050|FG001|Overall Study|Other|0|||
33144771|NCT02663687|100445051|FG002|Overall Study|Other|1|||
33144772|NCT02663687|100445052|FG003|Overall Study|Other|0|||
33144773|NCT02663687|100445053|FG004|Overall Study|Other|0|||
33144774|NCT02987660|100445056|FG000|Overall Study|Study terminated by sponsor|10|||
33144775|NCT02987660|100445057|FG001|Overall Study|Study terminated by sponsor|10|||
33144776|NCT00058539|100445058|FG000|Overall Study|Disease progression|24|||
33144777|NCT00058539|100445058|FG000|Overall Study|Adverse Event|3|||
33144778|NCT00058539|100445058|FG000|Overall Study|Withdrawal by Subject|5|||
33144779|NCT00058539|100445058|FG000|Overall Study|Physician Decision|9|||
33144780|NCT00058539|100445058|FG000|Overall Study|Death|1|||
33144781|NCT01574079|100445059|FG000|Overall Study|Physician Decision|0|||
33144782|NCT01574079|100445060|FG001|Overall Study|Physician Decision|2|||
33144783|NCT01574079|100445059|FG000|Overall Study|Lost to Follow-up|1|||
33144784|NCT01574079|100445060|FG001|Overall Study|Lost to Follow-up|0|||
33144785|NCT00814801|100445064|FG000|Overall Study|Adverse Event|15|||
33144786|NCT00814801|100445065|FG001|Overall Study|Adverse Event|16|||
33144787|NCT00814801|100445066|FG002|Overall Study|Adverse Event|19|||
33144788|NCT00814801|100445064|FG000|Overall Study|Withdrawal by Subject|9|||
33144789|NCT00814801|100445065|FG001|Overall Study|Withdrawal by Subject|11|||
33144790|NCT00814801|100445066|FG002|Overall Study|Withdrawal by Subject|14|||
33144791|NCT00814801|100445064|FG000|Overall Study|Inappropriate as a subject|1|||
33144792|NCT00814801|100445065|FG001|Overall Study|Inappropriate as a subject|1|||
33144793|NCT00814801|100445066|FG002|Overall Study|Inappropriate as a subject|1|||
33144794|NCT00814801|100445064|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
33144795|NCT00814801|100445065|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
33144796|NCT00814801|100445066|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
33144797|NCT00814801|100445064|FG000|Overall Study|Missing or change of caregiver|6|||
33144798|NCT00814801|100445065|FG001|Overall Study|Missing or change of caregiver|2|||
33144799|NCT00814801|100445066|FG002|Overall Study|Missing or change of caregiver|4|||
33144800|NCT00814801|100445064|FG000|Overall Study|Non-compliance|0|||
33582091|NCT01194219|102020322|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
33582092|NCT01194219|102020313|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
33582093|NCT01194219|102020314|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
33582094|NCT01194219|102020315|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33582095|NCT01194219|102020316|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33582096|NCT01194219|102020317|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33582097|NCT01194219|102020318|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33582098|NCT01194219|102020319|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33582099|NCT01194219|102020320|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33582100|NCT01194219|102020321|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33144801|NCT00814801|100445065|FG001|Overall Study|Non-compliance|1|||
33144802|NCT00814801|100445066|FG002|Overall Study|Non-compliance|1|||
33144803|NCT00814801|100445064|FG000|Overall Study|Other|2|||
33582101|NCT01194219|102020322|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
33643030|NCT01069900|102244258|FG000|Overall Study|Insufficient Therapeutic effect|1|||
33643031|NCT01069900|102244259|FG001|Overall Study|Insufficient Therapeutic effect|0|||
33643032|NCT03583385|102244260|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33144804|NCT00814801|100445065|FG001|Overall Study|Other|6|||
33144805|NCT00814801|100445066|FG002|Overall Study|Other|4|||
33144806|NCT00609362|100445069|FG000|Overall Study|Withdrawal by Subject|2|||
33144807|NCT00609362|100445070|FG001|Overall Study|Withdrawal by Subject|1|||
33144808|NCT00609362|100445069|FG000|Overall Study|Adverse Event|1|||
33144809|NCT00609362|100445070|FG001|Overall Study|Adverse Event|0|||
33144810|NCT03312751|100445071|FG000|Overall Study|Death|7|||
33144811|NCT03312751|100445072|FG001|Overall Study|Death|9|||
33144812|NCT03312751|100445071|FG000|Overall Study|Study discontinuation due to other reason|0|||
33144813|NCT03312751|100445072|FG001|Overall Study|Study discontinuation due to other reason|1|||
33144814|NCT02414139|100445073|FG000|Treatment Period|Adverse Event|11|||
33144815|NCT02414139|100445074|FG001|Treatment Period|Adverse Event|6|||
33144816|NCT02414139|100445075|FG002|Treatment Period|Adverse Event|8|||
33144817|NCT02414139|100445076|FG003|Treatment Period|Adverse Event|5|||
33144818|NCT02414139|100445077|FG004|Treatment Period|Adverse Event|14|||
33144819|NCT02414139|100445078|FG005|Treatment Period|Adverse Event|3|||
33144820|NCT02414139|100445079|FG006|Treatment Period|Adverse Event|6|||
33144821|NCT02414139|100445080|FG007|Treatment Period|Adverse Event|1|||
33144822|NCT02414139|100445081|FG008|Treatment Period|Adverse Event|6|||
33144823|NCT02414139|100445082|FG009|Treatment Period|Adverse Event|8|||
33144824|NCT02414139|100445073|FG000|Treatment Period|Death|0|||
33144825|NCT02414139|100445074|FG001|Treatment Period|Death|0|||
33144826|NCT02414139|100445075|FG002|Treatment Period|Death|1|||
33144827|NCT02414139|100445076|FG003|Treatment Period|Death|1|||
33144828|NCT02414139|100445077|FG004|Treatment Period|Death|0|||
33144829|NCT02414139|100445078|FG005|Treatment Period|Death|0|||
33144830|NCT02414139|100445079|FG006|Treatment Period|Death|0|||
33144831|NCT02414139|100445080|FG007|Treatment Period|Death|0|||
33144832|NCT02414139|100445081|FG008|Treatment Period|Death|0|||
33144833|NCT02414139|100445082|FG009|Treatment Period|Death|1|||
33144834|NCT02414139|100445073|FG000|Treatment Period|Physician Decision|5|||
33144835|NCT02414139|100445074|FG001|Treatment Period|Physician Decision|4|||
33144836|NCT02414139|100445075|FG002|Treatment Period|Physician Decision|6|||
33144837|NCT02414139|100445076|FG003|Treatment Period|Physician Decision|1|||
33144838|NCT02414139|100445077|FG004|Treatment Period|Physician Decision|4|||
33144839|NCT02414139|100445078|FG005|Treatment Period|Physician Decision|0|||
33144840|NCT02414139|100445079|FG006|Treatment Period|Physician Decision|2|||
33144841|NCT02414139|100445080|FG007|Treatment Period|Physician Decision|0|||
33144842|NCT02414139|100445081|FG008|Treatment Period|Physician Decision|1|||
33144843|NCT02414139|100445082|FG009|Treatment Period|Physician Decision|4|||
33144844|NCT02414139|100445073|FG000|Treatment Period|Progressive disease|48|||
33242977|NCT02099539|100789201|FG001|Overall Study|Progressive Disease|2|||
33643033|NCT03583385|102244261|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33643034|NCT03583385|102244260|FG000|Treatment Period 2|Adverse Event|1|||
33643035|NCT03583385|102244261|FG001|Treatment Period 2|Adverse Event|0|||
33643036|NCT02446899|102244262|FG000|Overall Study|Adverse Event|4|||
33643037|NCT02446899|102244263|FG001|Overall Study|Adverse Event|7|||
33643038|NCT02446899|102244262|FG000|Overall Study|Condition Under Investigation Worsened|1|||
33643039|NCT02446899|102244263|FG001|Overall Study|Condition Under Investigation Worsened|4|||
33643040|NCT02446899|102244262|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
33643041|NCT02446899|102244263|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
33643042|NCT02446899|102244262|FG000|Overall Study|Lack of Efficacy|2|||
33643043|NCT02446899|102244263|FG001|Overall Study|Lack of Efficacy|8|||
33643044|NCT02446899|102244262|FG000|Overall Study|Lost to Follow-up|1|||
33643045|NCT02446899|102244263|FG001|Overall Study|Lost to Follow-up|3|||
33643046|NCT02446899|102244262|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
33643047|NCT02446899|102244263|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
33643048|NCT02446899|102244262|FG000|Overall Study|Withdrawal by Subject|11|||
33643049|NCT02446899|102244263|FG001|Overall Study|Withdrawal by Subject|19|||
33643050|NCT02446899|102244262|FG000|Overall Study|Miscellaneous|5|||
33643051|NCT02446899|102244263|FG001|Overall Study|Miscellaneous|4|||
33643052|NCT02446899|102244262|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
33643053|NCT02446899|102244263|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
33643054|NCT01026324|102244264|FG000|Follow up/Survival|Withdrawal by Subject|1|||
33643055|NCT01026324|102244265|FG001|Follow up/Survival|Withdrawal by Subject|0|||
33144845|NCT02414139|100445074|FG001|Treatment Period|Progressive disease|31|||
33144846|NCT02414139|100445075|FG002|Treatment Period|Progressive disease|37|||
33144847|NCT02414139|100445076|FG003|Treatment Period|Progressive disease|21|||
33144848|NCT02414139|100445077|FG004|Treatment Period|Progressive disease|43|||
33144849|NCT02414139|100445078|FG005|Treatment Period|Progressive disease|12|||
33144850|NCT02414139|100445079|FG006|Treatment Period|Progressive disease|16|||
33144851|NCT02414139|100445080|FG007|Treatment Period|Progressive disease|2|||
33144852|NCT02414139|100445081|FG008|Treatment Period|Progressive disease|20|||
33144853|NCT02414139|100445082|FG009|Treatment Period|Progressive disease|14|||
33144854|NCT02414139|100445073|FG000|Treatment Period|Protocol deviation|0|||
33144855|NCT02414139|100445074|FG001|Treatment Period|Protocol deviation|0|||
33144856|NCT02414139|100445075|FG002|Treatment Period|Protocol deviation|1|||
33144857|NCT02414139|100445076|FG003|Treatment Period|Protocol deviation|0|||
33144858|NCT02414139|100445077|FG004|Treatment Period|Protocol deviation|0|||
33144859|NCT02414139|100445078|FG005|Treatment Period|Protocol deviation|0|||
33144860|NCT02414139|100445079|FG006|Treatment Period|Protocol deviation|0|||
33144861|NCT02414139|100445080|FG007|Treatment Period|Protocol deviation|0|||
33144862|NCT02414139|100445081|FG008|Treatment Period|Protocol deviation|0|||
33144863|NCT02414139|100445082|FG009|Treatment Period|Protocol deviation|0|||
33144864|NCT02414139|100445073|FG000|Treatment Period|Subject/Guardian decision|5|||
33144865|NCT02414139|100445074|FG001|Treatment Period|Subject/Guardian decision|1|||
33144866|NCT02414139|100445075|FG002|Treatment Period|Subject/Guardian decision|1|||
33144867|NCT02414139|100445076|FG003|Treatment Period|Subject/Guardian decision|2|||
33643056|NCT01026324|102244266|FG002|Follow up/Survival|Withdrawal by Subject|0|||
33643057|NCT01262820|102244267|FG000|Overall Study|Adverse Event|5|||
33643058|NCT01262820|102244267|FG000|Overall Study|Lack of Efficacy|9|||
33643059|NCT01262820|102244267|FG000|Overall Study|Drug held for 21+ days|1|||
33643060|NCT00280748|102244270|FG000|Overall Study|Decline in performance|3|||
33643061|NCT00280748|102244270|FG000|Overall Study|Extra-cranial disease progression|1|||
33144868|NCT02414139|100445077|FG004|Treatment Period|Subject/Guardian decision|5|||
33144869|NCT02414139|100445078|FG005|Treatment Period|Subject/Guardian decision|0|||
33144870|NCT02414139|100445079|FG006|Treatment Period|Subject/Guardian decision|2|||
33144871|NCT02414139|100445080|FG007|Treatment Period|Subject/Guardian decision|0|||
33144872|NCT02414139|100445081|FG008|Treatment Period|Subject/Guardian decision|1|||
33144873|NCT02414139|100445082|FG009|Treatment Period|Subject/Guardian decision|1|||
33421952|NCT01418352|101436921|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
33421953|NCT01418352|101436922|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
33421954|NCT01418352|101436923|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
33421955|NCT02983227|101436929|FG000|Overall Study|Adverse Event|21|||
33421956|NCT02983227|101436930|FG001|Overall Study|Adverse Event|3|||
33421957|NCT02983227|101436929|FG000|Overall Study|Death|3|||
33421958|NCT02983227|101436930|FG001|Overall Study|Death|0|||
33421959|NCT02983227|101436929|FG000|Overall Study|Lack of Efficacy|8|||
33421960|NCT02983227|101436930|FG001|Overall Study|Lack of Efficacy|1|||
33421961|NCT02983227|101436929|FG000|Overall Study|Lost to Follow-up|3|||
33421962|NCT02983227|101436930|FG001|Overall Study|Lost to Follow-up|0|||
33421963|NCT02983227|101436929|FG000|Overall Study|Multiple Reasons|2|||
33421964|NCT02983227|101436930|FG001|Overall Study|Multiple Reasons|1|||
33421965|NCT02983227|101436929|FG000|Overall Study|Physician Decision|3|||
33643062|NCT00080899|102244271|FG000|Overall Study|Adverse Event|1|||
33643063|NCT03116152|102244272|FG000|Overall Study|Disease Progression|49|||
33643064|NCT03116152|102244273|FG001|Overall Study|Disease Progression|47|||
33643065|NCT03116152|102244272|FG000|Overall Study|Death|5|||
33643066|NCT03116152|102244273|FG001|Overall Study|Death|2|||
33643067|NCT03116152|102244272|FG000|Overall Study|Adverse Event|21|||
33144874|NCT02414139|100445073|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
33144875|NCT02414139|100445074|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
33144876|NCT02414139|100445075|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
33144877|NCT02414139|100445076|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
33144878|NCT02414139|100445077|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
33144879|NCT02414139|100445078|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
33643068|NCT03116152|102244273|FG001|Overall Study|Adverse Event|7|||
33643069|NCT03116152|102244272|FG000|Overall Study|Protocol Violation|2|||
33643070|NCT03116152|102244273|FG001|Overall Study|Protocol Violation|2|||
33643071|NCT03116152|102244272|FG000|Overall Study|Withdrawal by Subject|0|||
33643072|NCT03116152|102244273|FG001|Overall Study|Withdrawal by Subject|1|||
33242978|NCT02099539|100789202|FG002|Overall Study|Progressive Disease|2|||
33242979|NCT02099539|100789203|FG003|Overall Study|Progressive Disease|1|||
33421966|NCT02983227|101436930|FG001|Overall Study|Physician Decision|1|||
33421967|NCT02983227|101436929|FG000|Overall Study|Withdrawal by Subject|19|||
33421968|NCT02983227|101436930|FG001|Overall Study|Withdrawal by Subject|8|||
33421969|NCT01825876|101436932|FG000|Period 2|Withdrawal by Subject|0|||
33643073|NCT03116152|102244272|FG000|Overall Study|Physician Decision|3|||
33643074|NCT03116152|102244273|FG001|Overall Study|Physician Decision|2|||
33643075|NCT03116152|102244272|FG000|Overall Study|other|11|||
33643076|NCT03116152|102244273|FG001|Overall Study|other|34|||
33144880|NCT02414139|100445079|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
33144881|NCT02414139|100445080|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
33242980|NCT02099539|100789204|FG004|Overall Study|Progressive Disease|4|||
33421970|NCT01825876|101436933|FG001|Period 2|Withdrawal by Subject|1|||
33421971|NCT01963676|101436936|FG000|Overall Study|Withdrawal by Subject|1|||
33643077|NCT02840799|102244274|FG000|Phase 1|Physician Decision|1|||
33643078|NCT02840799|102244275|FG001|Phase 1|Physician Decision|3|||
33643079|NCT02840799|102244274|FG000|Phase 1|Withdrawal by Subject|4|||
33144882|NCT02414139|100445081|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
33144883|NCT02414139|100445082|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
33144884|NCT02414139|100445073|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
33144885|NCT02414139|100445074|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
33144886|NCT02414139|100445075|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
33144887|NCT02414139|100445076|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
33144888|NCT02414139|100445077|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
33144889|NCT02414139|100445078|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
33144890|NCT02414139|100445079|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
33144891|NCT02414139|100445080|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
33144892|NCT02414139|100445081|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
33144893|NCT02414139|100445082|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
33144894|NCT02414139|100445073|FG000|Post-treatment Efficacy Follow-up|Death|0|||
33643080|NCT02840799|102244275|FG001|Phase 1|Withdrawal by Subject|0|||
33643081|NCT02840799|102244274|FG000|Phase 2 (Crossover)|Adverse Event|0|||
33643082|NCT02840799|102244275|FG001|Phase 2 (Crossover)|Adverse Event|1|||
33643083|NCT02840799|102244274|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
33643084|NCT02840799|102244275|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
33643085|NCT01657019|102244278|FG000|Overall Study|Withdrawal by Subject|65|||
33643086|NCT01657019|102244278|FG000|Overall Study|Adverse Event|55|||
33643087|NCT01657019|102244278|FG000|Overall Study|Lost to Follow-up|48|||
33643088|NCT01657019|102244278|FG000|Overall Study|Protocol Violation|6|||
33643089|NCT01657019|102244278|FG000|Overall Study|Lack of Efficacy|3|||
33643090|NCT01657019|102244278|FG000|Overall Study|Other|58|||
33144895|NCT02414139|100445074|FG001|Post-treatment Efficacy Follow-up|Death|1|||
33144896|NCT02414139|100445075|FG002|Post-treatment Efficacy Follow-up|Death|0|||
33643091|NCT00393861|102244279|FG000|Overall Study|Adverse Event|2|||
33643092|NCT00393861|102244279|FG000|Overall Study|Disease Progression|24|||
33643093|NCT01474018|102244280|FG000|Overall Study|Lost to Follow-up|0|||
33242981|NCT02099539|100789205|FG005|Overall Study|Progressive Disease|2|||
33242982|NCT02099539|100789206|FG006|Overall Study|Progressive Disease|0|||
33242983|NCT02099539|100789200|FG000|Overall Study|Adverse Event|0|||
33242984|NCT02099539|100789201|FG001|Overall Study|Adverse Event|0|||
33242985|NCT02099539|100789202|FG002|Overall Study|Adverse Event|1|||
33582102|NCT01194219|102020313|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
33582103|NCT01194219|102020314|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33582104|NCT01194219|102020315|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33582105|NCT01194219|102020316|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33582106|NCT01194219|102020317|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33582107|NCT01194219|102020318|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33582108|NCT01194219|102020319|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33582109|NCT01194219|102020320|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33582110|NCT01194219|102020321|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33582111|NCT01194219|102020322|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
33582112|NCT01194219|102020313|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
33582113|NCT01194219|102020314|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
33582114|NCT01194219|102020315|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33582115|NCT01194219|102020316|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33582116|NCT01194219|102020317|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33582117|NCT01194219|102020318|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33643094|NCT01474018|102244281|FG001|Overall Study|Lost to Follow-up|1|||
33643095|NCT01474018|102244280|FG000|Overall Study|Withdrawal by Subject|0|||
33643096|NCT01474018|102244281|FG001|Overall Study|Withdrawal by Subject|2|||
33643097|NCT05334212|102244282|FG000|Overall Study|Study terminated prematurely|7|||
33144897|NCT02414139|100445076|FG003|Post-treatment Efficacy Follow-up|Death|0|||
33144898|NCT02414139|100445077|FG004|Post-treatment Efficacy Follow-up|Death|1|||
33144899|NCT02414139|100445078|FG005|Post-treatment Efficacy Follow-up|Death|0|||
33144900|NCT02414139|100445079|FG006|Post-treatment Efficacy Follow-up|Death|0|||
33144901|NCT02414139|100445080|FG007|Post-treatment Efficacy Follow-up|Death|0|||
33242986|NCT02099539|100789203|FG003|Overall Study|Adverse Event|1|||
33242987|NCT02099539|100789204|FG004|Overall Study|Adverse Event|0|||
33242988|NCT02099539|100789205|FG005|Overall Study|Adverse Event|0|||
33242989|NCT02099539|100789206|FG006|Overall Study|Adverse Event|0|||
33582118|NCT01194219|102020319|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33144902|NCT02414139|100445081|FG008|Post-treatment Efficacy Follow-up|Death|0|||
33242990|NCT02099539|100789200|FG000|Overall Study|Physician Decision|0|||
33242991|NCT02099539|100789201|FG001|Overall Study|Physician Decision|0|||
33643098|NCT00554216|102244283|FG000|Overall Study|Lost to Follow-up|92|||
33643099|NCT00554216|102244284|FG001|Overall Study|Lost to Follow-up|31|||
33643100|NCT00554216|102244285|FG002|Overall Study|Lost to Follow-up|63|||
33144903|NCT02414139|100445082|FG009|Post-treatment Efficacy Follow-up|Death|1|||
33242992|NCT02099539|100789202|FG002|Overall Study|Physician Decision|0|||
33242993|NCT02099539|100789203|FG003|Overall Study|Physician Decision|0|||
33582119|NCT01194219|102020320|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33582120|NCT01194219|102020321|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33582121|NCT01194219|102020322|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
33582122|NCT01194219|102020313|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33582123|NCT01194219|102020314|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
33582124|NCT01194219|102020315|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33582125|NCT01194219|102020316|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33144904|NCT02414139|100445073|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
33144905|NCT02414139|100445074|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
33144906|NCT02414139|100445075|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
33144907|NCT02414139|100445076|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
33582126|NCT01194219|102020317|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33582127|NCT01194219|102020318|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33582128|NCT01194219|102020319|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33582129|NCT01194219|102020320|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33582130|NCT01194219|102020321|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33582131|NCT01194219|102020322|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
33582132|NCT01194219|102020313|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
33582133|NCT01194219|102020314|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
33582134|NCT01194219|102020315|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33421972|NCT01963676|101436937|FG001|Overall Study|Withdrawal by Subject|0|||
33372199|NCT02918266|101247734|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
33372200|NCT00543569|101247735|FG000|Overall Study|Death|2|||
33372201|NCT00543569|101247736|FG001|Overall Study|Death|2|||
33372202|NCT00543569|101247737|FG002|Overall Study|Death|3|||
33372203|NCT00543569|101247738|FG003|Overall Study|Death|1|||
33372204|NCT00543569|101247735|FG000|Overall Study|Lost to Follow-up|0|||
33421973|NCT02239692|101436938|FG000|Overall Study|Incomplete colonoscopy|1|||
33421974|NCT02239692|101436939|FG001|Overall Study|Incomplete colonoscopy|2|||
33421975|NCT02239692|101436938|FG000|Overall Study|Adverse Event|0|||
33421976|NCT02239692|101436939|FG001|Overall Study|Adverse Event|1|||
33421977|NCT02239692|101436938|FG000|Overall Study|Physician Decision|0|||
33421978|NCT02239692|101436939|FG001|Overall Study|Physician Decision|1|||
33421979|NCT02239692|101436938|FG000|Overall Study|Lost to Follow-up|1|||
33421980|NCT02239692|101436939|FG001|Overall Study|Lost to Follow-up|4|||
33421981|NCT02239692|101436938|FG000|Overall Study|Withdrawal by Subject|3|||
33421982|NCT02239692|101436939|FG001|Overall Study|Withdrawal by Subject|5|||
33421983|NCT02239692|101436938|FG000|Overall Study|Other reason|1|||
33421984|NCT02239692|101436939|FG001|Overall Study|Other reason|0|||
33421985|NCT01467570|101436942|FG000|Overall Study|Lost to Follow-up|8|||
33582135|NCT01194219|102020316|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33582136|NCT01194219|102020317|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33144908|NCT02414139|100445077|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
33144909|NCT02414139|100445078|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
33144910|NCT02414139|100445079|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
33242994|NCT02099539|100789204|FG004|Overall Study|Physician Decision|0|||
33242995|NCT02099539|100789205|FG005|Overall Study|Physician Decision|1|||
33242996|NCT02099539|100789206|FG006|Overall Study|Physician Decision|0|||
33242997|NCT00916006|100789207|FG000|Overall Study|Adverse Event|1|||
33372205|NCT00543569|101247736|FG001|Overall Study|Lost to Follow-up|0|||
33421986|NCT01467570|101436943|FG001|Overall Study|Lost to Follow-up|9|||
33421987|NCT02956005|101436946|FG000|Overall Study|Not eligible|1|||
33643101|NCT00554216|102244283|FG000|Overall Study|Adverse Event|16|||
33643102|NCT00554216|102244284|FG001|Overall Study|Adverse Event|16|||
33643103|NCT00554216|102244285|FG002|Overall Study|Adverse Event|36|||
33643104|NCT00554216|102244283|FG000|Overall Study|Withdrawal by Subject|92|||
33643105|NCT00554216|102244284|FG001|Overall Study|Withdrawal by Subject|31|||
33643106|NCT00554216|102244285|FG002|Overall Study|Withdrawal by Subject|43|||
33643107|NCT00554216|102244283|FG000|Overall Study|Non compliance|10|||
33643108|NCT00554216|102244284|FG001|Overall Study|Non compliance|4|||
33643109|NCT00554216|102244285|FG002|Overall Study|Non compliance|5|||
33582137|NCT01194219|102020318|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33643110|NCT00554216|102244283|FG000|Overall Study|Pregnancy|2|||
33643111|NCT00554216|102244284|FG001|Overall Study|Pregnancy|1|||
33582138|NCT01194219|102020319|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33582139|NCT01194219|102020320|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33372206|NCT00543569|101247737|FG002|Overall Study|Lost to Follow-up|1|||
33582140|NCT01194219|102020321|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33643112|NCT00554216|102244285|FG002|Overall Study|Pregnancy|14|||
33372207|NCT00543569|101247738|FG003|Overall Study|Lost to Follow-up|1|||
33421988|NCT02956005|101436946|FG000|Overall Study|Withdrawal by Subject|3|||
33421989|NCT02956005|101436946|FG000|Overall Study|Physician Decision|12|||
33421990|NCT01399125|101436948|FG000|Overall Study|Adverse Event|32|||
33643113|NCT00554216|102244283|FG000|Overall Study|Restricted med|3|||
33643114|NCT00554216|102244284|FG001|Overall Study|Restricted med|1|||
33643115|NCT00554216|102244285|FG002|Overall Study|Restricted med|1|||
33582141|NCT01194219|102020322|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
33582142|NCT01194219|102020313|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
33582143|NCT01194219|102020314|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
33582144|NCT01194219|102020315|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33582145|NCT01194219|102020316|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33582146|NCT01194219|102020317|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33582147|NCT01194219|102020318|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33582148|NCT01194219|102020319|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33144911|NCT02414139|100445080|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
33144912|NCT02414139|100445081|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
33643116|NCT00554216|102244283|FG000|Overall Study|Other|12|||
33643117|NCT00554216|102244284|FG001|Overall Study|Other|7|||
33643118|NCT00554216|102244285|FG002|Overall Study|Other|10|||
33421991|NCT01399125|101436949|FG001|Overall Study|Adverse Event|30|||
33421992|NCT01399125|101436948|FG000|Overall Study|Abnormal Lab values|0|||
33421993|NCT01399125|101436949|FG001|Overall Study|Abnormal Lab values|1|||
33421994|NCT01399125|101436948|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33421995|NCT01399125|101436949|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
33421996|NCT01399125|101436948|FG000|Overall Study|Withdrawal by Subject|5|||
33144913|NCT02414139|100445082|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
33421997|NCT01399125|101436949|FG001|Overall Study|Withdrawal by Subject|8|||
33421998|NCT01399125|101436948|FG000|Overall Study|Lost to Follow-up|2|||
33421999|NCT01399125|101436949|FG001|Overall Study|Lost to Follow-up|3|||
33422000|NCT01399125|101436948|FG000|Overall Study|Administrative Problems|7|||
33422001|NCT01399125|101436949|FG001|Overall Study|Administrative Problems|11|||
33422002|NCT01399125|101436948|FG000|Overall Study|Death|0|||
33422003|NCT01399125|101436949|FG001|Overall Study|Death|1|||
33422004|NCT01399125|101436948|FG000|Overall Study|Protocol Deviation|5|||
33422005|NCT01399125|101436949|FG001|Overall Study|Protocol Deviation|2|||
33422006|NCT03001011|101436952|FG000|Overall Study|Adverse Event|9|||
33422007|NCT03001011|101436953|FG001|Overall Study|Adverse Event|3|||
33422008|NCT03001011|101436952|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
33422009|NCT03001011|101436953|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
33422010|NCT03001011|101436952|FG000|Overall Study|Other than specified above|3|||
33422011|NCT03001011|101436953|FG001|Overall Study|Other than specified above|8|||
33422012|NCT01858558|101436956|FG000|Overall Study|Death|1|||
33422013|NCT01858558|101436957|FG001|Overall Study|Death|1|||
33422014|NCT01858558|101436956|FG000|Overall Study|Lost to Follow-up|1|||
33582149|NCT01194219|102020320|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33242998|NCT00916006|100789208|FG001|Overall Study|Adverse Event|1|||
33242999|NCT00916006|100789207|FG000|Overall Study|Withdrawal by Subject|2|||
33243000|NCT00916006|100789208|FG001|Overall Study|Withdrawal by Subject|5|||
33243001|NCT00916006|100789207|FG000|Overall Study|Protocol Violation|0|||
33243002|NCT00916006|100789208|FG001|Overall Study|Protocol Violation|1|||
33243003|NCT05576662|100789212|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
33243004|NCT05576662|100789213|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
33243005|NCT05576662|100789212|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
33243006|NCT05576662|100789213|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
33243007|NCT05576662|100789212|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
33243008|NCT05576662|100789213|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
33243009|NCT05576662|100789212|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
33243010|NCT05576662|100789213|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
33243011|NCT05780047|100789219|FG000|Overall Study|Did not submit baseline urine test kit|226|||
33243012|NCT05780047|100789219|FG000|Overall Study|Lost to Follow-up|34|||
33422015|NCT01858558|101436957|FG001|Overall Study|Lost to Follow-up|0|||
33144914|NCT02414139|100445073|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
33144915|NCT02414139|100445074|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
33144916|NCT02414139|100445075|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
33144917|NCT02414139|100445076|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
33144918|NCT02414139|100445077|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
33144919|NCT02414139|100445078|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
33144920|NCT02414139|100445079|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
33144921|NCT02414139|100445080|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
33144922|NCT02414139|100445081|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
33144923|NCT02414139|100445082|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
33144924|NCT02414139|100445073|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
33144925|NCT02414139|100445074|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
33144926|NCT02414139|100445075|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
33144927|NCT02414139|100445076|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
33582150|NCT01194219|102020321|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33582151|NCT01194219|102020322|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
33582152|NCT01194219|102020313|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
33582153|NCT01194219|102020314|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
33582154|NCT01194219|102020315|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33582155|NCT01194219|102020316|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33582156|NCT01194219|102020317|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33582157|NCT01194219|102020318|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33582158|NCT01194219|102020319|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33582159|NCT01194219|102020320|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33582160|NCT01194219|102020321|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33582161|NCT01194219|102020322|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
33582162|NCT01194219|102020313|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
33582163|NCT01194219|102020314|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
33582164|NCT01194219|102020315|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
33582165|NCT01194219|102020316|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
33582166|NCT01194219|102020317|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
33582167|NCT01194219|102020318|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
33243013|NCT05780047|100789219|FG000|Overall Study|Did not submit second urine test kit|124|||
33243014|NCT00448864|100789220|FG000|Overall Study|Death|1|||
33243015|NCT00448864|100789221|FG001|Overall Study|Death|0|||
33243016|NCT00448864|100789222|FG002|Overall Study|Death|0|||
33243017|NCT00448864|100789220|FG000|Overall Study|Lost to Follow-up|3|||
33243018|NCT00448864|100789221|FG001|Overall Study|Lost to Follow-up|1|||
33243019|NCT00448864|100789222|FG002|Overall Study|Lost to Follow-up|0|||
33243020|NCT00448864|100789220|FG000|Overall Study|Physician Decision|1|||
33243021|NCT00448864|100789221|FG001|Overall Study|Physician Decision|0|||
33243022|NCT00448864|100789222|FG002|Overall Study|Physician Decision|1|||
33243023|NCT00448864|100789220|FG000|Overall Study|Withdrawal by Subject|0|||
33243024|NCT00448864|100789221|FG001|Overall Study|Withdrawal by Subject|2|||
33243025|NCT00448864|100789222|FG002|Overall Study|Withdrawal by Subject|0|||
33243026|NCT00448864|100789220|FG000|Overall Study|Protocol Violation|0|||
33243027|NCT00448864|100789221|FG001|Overall Study|Protocol Violation|2|||
33243028|NCT00448864|100789222|FG002|Overall Study|Protocol Violation|0|||
33243029|NCT01616563|100789225|FG000|Overall Study|Lost to Follow-up|40|||
33243030|NCT02347943|100789231|FG000|Overall Study|Study was cancelled|140|||
33243031|NCT02347943|100789232|FG001|Overall Study|Study was cancelled|67|||
33243032|NCT02347943|100789233|FG002|Overall Study|Study was cancelled|45|||
33243033|NCT03836664|100789239|FG000|Overall Study|Didn't complete forms and lost drug|3|||
33243034|NCT03836664|100789240|FG001|Overall Study|Didn't complete forms and lost drug|3|||
33243035|NCT02531438|100789243|FG000|Overall Study|Adverse Event|7|||
33372208|NCT00543569|101247735|FG000|Overall Study|Miscellaneous Reasons|7|||
33372209|NCT00543569|101247736|FG001|Overall Study|Miscellaneous Reasons|3|||
33372210|NCT00543569|101247737|FG002|Overall Study|Miscellaneous Reasons|11|||
33372211|NCT00543569|101247738|FG003|Overall Study|Miscellaneous Reasons|4|||
33372212|NCT00543569|101247735|FG000|Overall Study|Randomized but never received study drug|3|||
33372213|NCT00543569|101247736|FG001|Overall Study|Randomized but never received study drug|3|||
33372214|NCT00543569|101247737|FG002|Overall Study|Randomized but never received study drug|5|||
33372215|NCT00543569|101247738|FG003|Overall Study|Randomized but never received study drug|3|||
33372216|NCT03141086|101247739|FG000|Overall Study|Study Terminated By Sponsor|1|||
33372217|NCT03141086|101247740|FG001|Overall Study|Study Terminated By Sponsor|1|||
33372218|NCT03141086|101247739|FG000|Overall Study|Withdrawal by Subject|0|||
33372219|NCT03141086|101247740|FG001|Overall Study|Withdrawal by Subject|1|||
33372220|NCT03141086|101247739|FG000|Overall Study|Protocol Violation|0|||
33372221|NCT03141086|101247740|FG001|Overall Study|Protocol Violation|1|||
33372222|NCT03141086|101247739|FG000|Overall Study|Adverse Event|0|||
33372223|NCT03141086|101247740|FG001|Overall Study|Adverse Event|2|||
33372224|NCT02044159|101247741|FG000|Overall Study|Consent declined (deferred consent)|2|||
33372225|NCT02044159|101247742|FG001|Overall Study|Consent declined (deferred consent)|4|||
33372226|NCT02044159|101247741|FG000|Overall Study|No longer eligible, drug not given|1|||
33372227|NCT02044159|101247742|FG001|Overall Study|No longer eligible, drug not given|0|||
33372228|NCT02044159|101247741|FG000|Overall Study|Nurse declined to give study drug|1|||
33372229|NCT02044159|101247742|FG001|Overall Study|Nurse declined to give study drug|0|||
33372230|NCT00771030|101247743|FG000|Overall Study|Adverse Event|0|||
33582168|NCT01194219|102020319|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
33582169|NCT01194219|102020320|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
33643119|NCT00554216|102244283|FG000|Overall Study|Lack of Efficacy|15|||
33643120|NCT00554216|102244284|FG001|Overall Study|Lack of Efficacy|3|||
33243036|NCT02531438|100789244|FG001|Overall Study|Adverse Event|9|||
33243037|NCT02531438|100789243|FG000|Overall Study|Lost to Follow-up|0|||
33243038|NCT02531438|100789244|FG001|Overall Study|Lost to Follow-up|3|||
33243039|NCT02531438|100789243|FG000|Overall Study|Withdrawal by Subject|7|||
33372231|NCT00771030|101247744|FG001|Overall Study|Adverse Event|1|||
33243040|NCT02531438|100789244|FG001|Overall Study|Withdrawal by Subject|8|||
33422016|NCT01858558|101436956|FG000|Overall Study|Disease progression|3|||
33422017|NCT01858558|101436957|FG001|Overall Study|Disease progression|1|||
33422018|NCT01858558|101436956|FG000|Overall Study|Product contamination|2|||
33422019|NCT01858558|101436957|FG001|Overall Study|Product contamination|0|||
33422020|NCT01858558|101436956|FG000|Overall Study|Failed expansion of cell product|2|||
33422021|NCT01858558|101436957|FG001|Overall Study|Failed expansion of cell product|0|||
33422022|NCT01335399|101436960|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
33422023|NCT01335399|101436961|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
33422024|NCT01335399|101436960|FG000|Pre-treatment Period|Participant request to discontinue|0|||
33422025|NCT01335399|101436961|FG001|Pre-treatment Period|Participant request to discontinue|1|||
33422026|NCT01335399|101436960|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
33422027|NCT01335399|101436961|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
33422028|NCT01335399|101436960|FG000|Pre-treatment Period|Consent withdrawal|3|||
33422029|NCT01335399|101436961|FG001|Pre-treatment Period|Consent withdrawal|0|||
33422030|NCT01335399|101436960|FG000|Treatment Period|Disease progression|117|||
33422031|NCT01335399|101436961|FG001|Treatment Period|Disease progression|145|||
33422032|NCT01335399|101436960|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
33422033|NCT01335399|101436961|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
33422034|NCT01335399|101436960|FG000|Treatment Period|Study drug toxicity|52|||
33422035|NCT01335399|101436961|FG001|Treatment Period|Study drug toxicity|64|||
33422036|NCT01335399|101436960|FG000|Treatment Period|Participant request to discontinue|30|||
33422037|NCT01335399|101436961|FG001|Treatment Period|Participant request to discontinue|22|||
33422038|NCT01335399|101436960|FG000|Treatment Period|Other reasons|30|||
33422039|NCT01335399|101436961|FG001|Treatment Period|Other reasons|30|||
33422040|NCT01335399|101436960|FG000|Treatment Period|Consent withdrawal|10|||
33422041|NCT01335399|101436961|FG001|Treatment Period|Consent withdrawal|7|||
33422042|NCT01335399|101436960|FG000|Treatment Period|Death|7|||
33422043|NCT01335399|101436961|FG001|Treatment Period|Death|6|||
33422044|NCT01335399|101436960|FG000|Treatment Period|Poor/Non-compliance|3|||
33422045|NCT01335399|101436961|FG001|Treatment Period|Poor/Non-compliance|4|||
33422046|NCT01335399|101436960|FG000|Treatment Period|Lost to Follow-up|2|||
33422047|NCT01335399|101436961|FG001|Treatment Period|Lost to Follow-up|2|||
33422048|NCT01335399|101436960|FG000|Treatment Period|Maximum clinical benefit|1|||
33372232|NCT00771030|101247745|FG002|Overall Study|Adverse Event|0|||
33372233|NCT00771030|101247746|FG003|Overall Study|Adverse Event|0|||
33372234|NCT00771030|101247747|FG004|Overall Study|Adverse Event|0|||
33643121|NCT00554216|102244285|FG002|Overall Study|Lack of Efficacy|0|||
33643122|NCT00330967|102244286|FG000|Overall Study|Withdrawal by Subject|0|||
33643123|NCT00330967|102244287|FG001|Overall Study|Withdrawal by Subject|5|||
33643124|NCT00330967|102244286|FG000|Overall Study|Physician Decision|0|||
33643125|NCT00330967|102244287|FG001|Overall Study|Physician Decision|9|||
33643126|NCT01561313|102244288|FG000|Overall Study|Withdrawal by Subject|1|||
33643127|NCT01561313|102244289|FG001|Overall Study|Withdrawal by Subject|0|||
33643128|NCT01561313|102244288|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
33643129|NCT01561313|102244289|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
33243041|NCT02531438|100789243|FG000|Overall Study|Physician Decision|0|||
33372235|NCT00771030|101247748|FG005|Overall Study|Adverse Event|0|||
33372236|NCT00771030|101247749|FG006|Overall Study|Adverse Event|0|||
33372237|NCT02651194|101247750|FG000|Overall Study|Lost to Follow-up|3|||
33372238|NCT02651194|101247750|FG000|Overall Study|Other|2|||
33372239|NCT01745393|101247751|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
33372240|NCT01745393|101247752|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
33372241|NCT01745393|101247751|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
33372242|NCT01745393|101247752|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
33372243|NCT01745393|101247751|FG000|12-month Follow-up|Lost to Follow-up|6|||
33422049|NCT01335399|101436961|FG001|Treatment Period|Maximum clinical benefit|1|||
33372244|NCT01745393|101247752|FG001|12-month Follow-up|Lost to Follow-up|5|||
33372245|NCT01871896|101247753|FG000|Overall Study|Lost to Follow-up|1|||
33372246|NCT00905307|101247756|FG000|Overall Study|Switched to Open Label Rescue|7|||
33372247|NCT00905307|101247757|FG001|Overall Study|Switched to Open Label Rescue|17|||
33372248|NCT00905307|101247758|FG002|Overall Study|Switched to Open Label Rescue|11|||
33422050|NCT01335399|101436960|FG000|Treatment Period|No longer meet study criteria|1|||
33372249|NCT00905307|101247759|FG003|Overall Study|Switched to Open Label Rescue|11|||
33243042|NCT02531438|100789244|FG001|Overall Study|Physician Decision|1|||
33372250|NCT00905307|101247760|FG004|Overall Study|Switched to Open Label Rescue|4|||
33422051|NCT01335399|101436961|FG001|Treatment Period|No longer meet study criteria|1|||
33422052|NCT01335399|101436960|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
33422053|NCT01335399|101436961|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
33422054|NCT01784419|101436965|FG000|Overall Study|Adverse Event|3|||
33422055|NCT02162511|101436969|FG000|Overall Study|Lack of Efficacy|0|||
33422056|NCT02162511|101436970|FG001|Overall Study|Lack of Efficacy|0|||
33422057|NCT02162511|101436971|FG002|Overall Study|Lack of Efficacy|2|||
33372251|NCT00905307|101247761|FG005|Overall Study|Switched to Open Label Rescue|15|||
33582170|NCT01194219|102020321|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
33582171|NCT01194219|102020322|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
33582172|NCT01194219|102020313|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33582173|NCT01194219|102020314|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33582174|NCT01194219|102020315|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
33582175|NCT01194219|102020316|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
33582176|NCT01194219|102020317|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33643130|NCT00734539|102244293|FG000|Main Study|Death|33|||
33144928|NCT02414139|100445077|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
33144929|NCT02414139|100445078|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
33144930|NCT02414139|100445079|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
33144931|NCT02414139|100445080|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
33144932|NCT02414139|100445081|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
33144933|NCT02414139|100445082|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
33144934|NCT02414139|100445073|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
33144935|NCT02414139|100445074|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
33144936|NCT02414139|100445075|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
33144937|NCT02414139|100445076|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
33144938|NCT02414139|100445077|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
33144939|NCT02414139|100445078|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
33144940|NCT02414139|100445079|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
33144941|NCT02414139|100445080|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
33144942|NCT02414139|100445081|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
33372252|NCT00905307|101247756|FG000|Overall Study|Lost to Follow-up|0|||
33372253|NCT00905307|101247757|FG001|Overall Study|Lost to Follow-up|0|||
33372254|NCT00905307|101247758|FG002|Overall Study|Lost to Follow-up|0|||
33372255|NCT00905307|101247759|FG003|Overall Study|Lost to Follow-up|0|||
33372256|NCT00905307|101247760|FG004|Overall Study|Lost to Follow-up|1|||
33372257|NCT00905307|101247761|FG005|Overall Study|Lost to Follow-up|1|||
33372258|NCT00905307|101247756|FG000|Overall Study|Adverse Event|3|||
33372259|NCT00905307|101247757|FG001|Overall Study|Adverse Event|4|||
33372260|NCT00905307|101247758|FG002|Overall Study|Adverse Event|5|||
33422058|NCT00267007|101436972|FG000|Overall Study|Withdrawal by Subject|6|||
33422059|NCT00267007|101436973|FG001|Overall Study|Withdrawal by Subject|0|||
33422060|NCT00267007|101436972|FG000|Overall Study|Lost to Follow-up|1|||
33582177|NCT01194219|102020318|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33582178|NCT01194219|102020319|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33643131|NCT00734539|102244294|FG001|Main Study|Death|32|||
33643132|NCT00734539|102244293|FG000|Main Study|Physician Decision|2|||
33643133|NCT00734539|102244294|FG001|Main Study|Physician Decision|0|||
33643134|NCT00734539|102244293|FG000|Main Study|Withdrawal by Subject|1|||
33643135|NCT00734539|102244294|FG001|Main Study|Withdrawal by Subject|3|||
33643136|NCT00734539|102244293|FG000|Main Study|Enrolled in error; ineligible|1|||
33643137|NCT00734539|102244294|FG001|Main Study|Enrolled in error; ineligible|0|||
33643138|NCT03566485|102244295|FG000|Overall Study|Disease progression|5|||
33643139|NCT03566485|102244296|FG001|Overall Study|Disease progression|4|||
33643140|NCT03566485|102244295|FG000|Overall Study|Clinical progression|0|||
33643141|NCT03566485|102244296|FG001|Overall Study|Clinical progression|1|||
33643142|NCT03566485|102244295|FG000|Overall Study|Toxicity|0|||
33643143|NCT03566485|102244296|FG001|Overall Study|Toxicity|2|||
33643144|NCT01134705|102244305|FG000|Overall Study|Adverse Event|1|||
33243043|NCT02531438|100789243|FG000|Overall Study|Death|6|||
33243044|NCT02531438|100789244|FG001|Overall Study|Death|3|||
33372261|NCT00905307|101247759|FG003|Overall Study|Adverse Event|11|||
33582179|NCT01194219|102020320|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33582180|NCT01194219|102020321|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33582181|NCT01194219|102020322|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
33582182|NCT01194219|102020313|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33582183|NCT01194219|102020314|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33582184|NCT01194219|102020315|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
33582185|NCT01194219|102020316|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
33582186|NCT01194219|102020317|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33582187|NCT01194219|102020318|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33582188|NCT01194219|102020319|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33582189|NCT01194219|102020320|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33582190|NCT01194219|102020321|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33643145|NCT01134705|102244306|FG001|Overall Study|Adverse Event|7|||
33643146|NCT01134705|102244305|FG000|Overall Study|Withdrawal by Subject|6|||
33643147|NCT01134705|102244306|FG001|Overall Study|Withdrawal by Subject|6|||
33643148|NCT01134705|102244305|FG000|Overall Study|Pregnancy|1|||
33372262|NCT00905307|101247760|FG004|Overall Study|Adverse Event|3|||
33372263|NCT00905307|101247761|FG005|Overall Study|Adverse Event|5|||
33144943|NCT02414139|100445082|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
33144944|NCT02414139|100445073|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
33144945|NCT02414139|100445074|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
33243045|NCT02531438|100789243|FG000|Overall Study|Randomized, but Not Treated|4|||
33243046|NCT02531438|100789244|FG001|Overall Study|Randomized, but Not Treated|0|||
33243047|NCT02531438|100789243|FG000|Overall Study|Missed EOT/PTE Visit|5|||
33243048|NCT02531438|100789244|FG001|Overall Study|Missed EOT/PTE Visit|2|||
33243049|NCT02531438|100789243|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
33243050|NCT02531438|100789244|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
33243051|NCT01268566|100789245|FG000|Overall Study|Lost to Follow-up|1|||
33243052|NCT01268566|100789245|FG000|Overall Study|Withdrawal by Subject|12|||
33372264|NCT00905307|101247756|FG000|Overall Study|Withdrawal by Subject|5|||
33372265|NCT00905307|101247757|FG001|Overall Study|Withdrawal by Subject|13|||
33372266|NCT00905307|101247758|FG002|Overall Study|Withdrawal by Subject|15|||
33372267|NCT00905307|101247759|FG003|Overall Study|Withdrawal by Subject|11|||
33582191|NCT01194219|102020322|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
33372268|NCT00905307|101247760|FG004|Overall Study|Withdrawal by Subject|4|||
33582192|NCT01194219|102020313|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33582193|NCT01194219|102020314|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33582194|NCT01194219|102020315|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
33582195|NCT01194219|102020316|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
33582196|NCT01194219|102020317|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33582197|NCT01194219|102020318|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33582198|NCT01194219|102020319|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33582199|NCT01194219|102020320|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33582200|NCT01194219|102020321|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33582201|NCT01194219|102020322|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
33372269|NCT00905307|101247761|FG005|Overall Study|Withdrawal by Subject|13|||
33372270|NCT00905307|101247756|FG000|Overall Study|Protocol Violation|1|||
33372271|NCT00905307|101247757|FG001|Overall Study|Protocol Violation|0|||
33372272|NCT00905307|101247758|FG002|Overall Study|Protocol Violation|1|||
33372273|NCT00905307|101247759|FG003|Overall Study|Protocol Violation|0|||
33582202|NCT01194219|102020313|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33582203|NCT01194219|102020314|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33582204|NCT01194219|102020315|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
33582205|NCT01194219|102020316|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33582206|NCT01194219|102020317|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33144946|NCT02414139|100445075|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
33144947|NCT02414139|100445076|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
33144948|NCT02414139|100445077|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
33422061|NCT00267007|101436973|FG001|Overall Study|Lost to Follow-up|0|||
33422062|NCT00267007|101436972|FG000|Overall Study|Non-compliance|0|||
33422063|NCT00267007|101436973|FG001|Overall Study|Non-compliance|1|||
33422064|NCT00267007|101436972|FG000|Overall Study|Adverse Event|1|||
33422065|NCT00267007|101436973|FG001|Overall Study|Adverse Event|0|||
33144949|NCT02414139|100445078|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
33144950|NCT02414139|100445079|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
33144951|NCT02414139|100445080|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
33144952|NCT02414139|100445081|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
33144953|NCT02414139|100445082|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
33144954|NCT01992159|100445083|FG000|Overall Study|Withdrawal by Subject|4|||
33144955|NCT01992159|100445084|FG001|Overall Study|Withdrawal by Subject|7|||
33144956|NCT01992159|100445085|FG002|Overall Study|Withdrawal by Subject|0|||
33144957|NCT01992159|100445086|FG003|Overall Study|Withdrawal by Subject|3|||
33144958|NCT01992159|100445083|FG000|Overall Study|Adverse Event|0|||
33144959|NCT01992159|100445084|FG001|Overall Study|Adverse Event|1|||
33144960|NCT01992159|100445085|FG002|Overall Study|Adverse Event|0|||
33144961|NCT01992159|100445086|FG003|Overall Study|Adverse Event|1|||
33144962|NCT01992159|100445083|FG000|Overall Study|Death|0|||
33144963|NCT01992159|100445084|FG001|Overall Study|Death|0|||
33144964|NCT01992159|100445085|FG002|Overall Study|Death|1|||
33144965|NCT01992159|100445086|FG003|Overall Study|Death|0|||
33243053|NCT01268566|100789245|FG000|Overall Study|Death|30|||
33372274|NCT00905307|101247760|FG004|Overall Study|Protocol Violation|0|||
33422066|NCT01155284|101436976|FG000|Overall Study|Withdrawal by Subject|4|||
33422067|NCT01155284|101436977|FG001|Overall Study|Withdrawal by Subject|3|||
33422068|NCT01155284|101436976|FG000|Overall Study|Lost to Follow-up|1|||
33243054|NCT00495469|100791416|FG000|Overall Study|Adverse Event|0|||
33422069|NCT01155284|101436977|FG001|Overall Study|Lost to Follow-up|2|||
33422070|NCT01155284|101436976|FG000|Overall Study|Physician Decision|1|||
33422071|NCT01155284|101436977|FG001|Overall Study|Physician Decision|0|||
33582207|NCT01194219|102020318|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33372275|NCT00905307|101247761|FG005|Overall Study|Protocol Violation|0|||
33422072|NCT01155284|101436976|FG000|Overall Study|Adverse Event|1|||
33422073|NCT01155284|101436977|FG001|Overall Study|Adverse Event|0|||
33422074|NCT03031431|101436978|FG000|Overall Study|Infant removed by maternal request|1|||
33422075|NCT01600014|101436980|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
33243055|NCT00495469|100791417|FG001|Overall Study|Adverse Event|1|||
33243056|NCT00495469|100791418|FG002|Overall Study|Adverse Event|3|||
33243057|NCT00495469|100791419|FG003|Overall Study|Adverse Event|0|||
33243058|NCT00495469|100791420|FG004|Overall Study|Adverse Event|1|||
33243059|NCT00495469|100791421|FG005|Overall Study|Adverse Event|1|||
33243060|NCT00495469|100791422|FG006|Overall Study|Adverse Event|1|||
33243061|NCT00495469|100791416|FG000|Overall Study|Lost to Follow-up|1|||
33243062|NCT00495469|100791417|FG001|Overall Study|Lost to Follow-up|1|||
33243063|NCT00495469|100791418|FG002|Overall Study|Lost to Follow-up|3|||
33243064|NCT00495469|100791419|FG003|Overall Study|Lost to Follow-up|1|||
33243065|NCT00495469|100791420|FG004|Overall Study|Lost to Follow-up|0|||
33243066|NCT00495469|100791421|FG005|Overall Study|Lost to Follow-up|0|||
33243067|NCT00495469|100791422|FG006|Overall Study|Lost to Follow-up|0|||
33243068|NCT00495469|100791416|FG000|Overall Study|Protocol Violation|0|||
33243069|NCT00495469|100791417|FG001|Overall Study|Protocol Violation|0|||
33582208|NCT01194219|102020319|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33582209|NCT01194219|102020320|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33582210|NCT01194219|102020321|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33582211|NCT01194219|102020322|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
33582212|NCT01194219|102020313|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33582213|NCT01194219|102020314|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33582214|NCT01194219|102020315|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33582215|NCT01194219|102020316|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
33582216|NCT01194219|102020317|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33144966|NCT01721577|100445091|FG000|Overall Study|Lack of Efficacy|1|||
33144967|NCT01721577|100445092|FG001|Overall Study|Lack of Efficacy|0|||
33144968|NCT01721577|100445091|FG000|Overall Study|Death|1|||
33144969|NCT01721577|100445092|FG001|Overall Study|Death|0|||
33144970|NCT01721577|100445091|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
33144971|NCT01721577|100445092|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
33144972|NCT01721577|100445091|FG000|Overall Study|Adverse Event|0|||
33144973|NCT01721577|100445092|FG001|Overall Study|Adverse Event|2|||
33144974|NCT03523000|100445093|FG000|Overall Study|Withdrawal by Subject|3|||
33144975|NCT03523000|100445094|FG001|Overall Study|Withdrawal by Subject|0|||
33144976|NCT03523000|100445093|FG000|Overall Study|Unsuccessful trial|2|||
33144977|NCT03523000|100445094|FG001|Overall Study|Unsuccessful trial|0|||
33144978|NCT01214174|100445098|FG000|Overall Study|Withdrawal by Subject|0|||
33144979|NCT01214174|100445099|FG001|Overall Study|Withdrawal by Subject|0|||
33144980|NCT01214174|100445100|FG002|Overall Study|Withdrawal by Subject|1|||
33144981|NCT00470184|100445103|FG000|Overall Study|Not Treated(became ineligible)|4|||
33144982|NCT00470184|100445103|FG000|Overall Study|Not treated (other)|1|||
33144983|NCT00470184|100445103|FG000|Overall Study|disease Progression|4|||
33144984|NCT00470184|100445103|FG000|Overall Study|Adverse Event|3|||
33144985|NCT00470184|100445103|FG000|Overall Study|Withdrawal by Subject|4|||
33144986|NCT00470184|100445103|FG000|Overall Study|other|5|||
33144987|NCT00470184|100445103|FG000|Overall Study|recurrence|1|||
33144988|NCT03345342|100445104|FG000|Open-Label Phase|Adverse Event|30|||
33144989|NCT03345342|100445105|FG001|Open-Label Phase|Adverse Event|0|||
33144990|NCT03345342|100445106|FG002|Open-Label Phase|Adverse Event|0|||
33144991|NCT03345342|100445107|FG003|Open-Label Phase|Adverse Event|0|||
33144992|NCT03345342|100445108|FG004|Open-Label Phase|Adverse Event|0|||
33144993|NCT03345342|100445104|FG000|Open-Label Phase|Death|1|||
33144994|NCT03345342|100445105|FG001|Open-Label Phase|Death|0|||
33144995|NCT03345342|100445106|FG002|Open-Label Phase|Death|0|||
33144996|NCT03345342|100445107|FG003|Open-Label Phase|Death|0|||
33144997|NCT03345342|100445108|FG004|Open-Label Phase|Death|0|||
33144998|NCT03345342|100445104|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
33144999|NCT03345342|100445105|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
33145000|NCT03345342|100445106|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
33145001|NCT03345342|100445107|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
33145002|NCT03345342|100445108|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
33145003|NCT03345342|100445104|FG000|Open-Label Phase|Lack of Efficacy|6|||
33145004|NCT03345342|100445105|FG001|Open-Label Phase|Lack of Efficacy|0|||
33145005|NCT03345342|100445106|FG002|Open-Label Phase|Lack of Efficacy|0|||
33145006|NCT03345342|100445107|FG003|Open-Label Phase|Lack of Efficacy|0|||
33145007|NCT03345342|100445108|FG004|Open-Label Phase|Lack of Efficacy|0|||
33145008|NCT03345342|100445104|FG000|Open-Label Phase|Lost to Follow-up|9|||
33145009|NCT03345342|100445105|FG001|Open-Label Phase|Lost to Follow-up|0|||
33145010|NCT03345342|100445106|FG002|Open-Label Phase|Lost to Follow-up|0|||
33145011|NCT03345342|100445107|FG003|Open-Label Phase|Lost to Follow-up|0|||
33145012|NCT03345342|100445108|FG004|Open-Label Phase|Lost to Follow-up|0|||
33145013|NCT03345342|100445104|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
33243070|NCT00495469|100791418|FG002|Overall Study|Protocol Violation|0|||
33243071|NCT00495469|100791419|FG003|Overall Study|Protocol Violation|0|||
33243072|NCT00495469|100791420|FG004|Overall Study|Protocol Violation|1|||
33243073|NCT00495469|100791421|FG005|Overall Study|Protocol Violation|2|||
33243074|NCT00495469|100791422|FG006|Overall Study|Protocol Violation|0|||
33243075|NCT00495469|100791416|FG000|Overall Study|Withdrawal by Subject|5|||
33243076|NCT00495469|100791417|FG001|Overall Study|Withdrawal by Subject|3|||
33243077|NCT00495469|100791418|FG002|Overall Study|Withdrawal by Subject|1|||
33243078|NCT00495469|100791419|FG003|Overall Study|Withdrawal by Subject|3|||
33243079|NCT00495469|100791420|FG004|Overall Study|Withdrawal by Subject|3|||
33243080|NCT00495469|100791421|FG005|Overall Study|Withdrawal by Subject|2|||
33243081|NCT00495469|100791422|FG006|Overall Study|Withdrawal by Subject|3|||
33243082|NCT00495469|100791416|FG000|Overall Study|Lack of Efficacy|0|||
33243083|NCT00495469|100791417|FG001|Overall Study|Lack of Efficacy|0|||
33243084|NCT00495469|100791418|FG002|Overall Study|Lack of Efficacy|0|||
33243085|NCT00495469|100791419|FG003|Overall Study|Lack of Efficacy|0|||
33243086|NCT00495469|100791420|FG004|Overall Study|Lack of Efficacy|0|||
33243087|NCT00495469|100791421|FG005|Overall Study|Lack of Efficacy|0|||
33243088|NCT00495469|100791422|FG006|Overall Study|Lack of Efficacy|1|||
33243089|NCT00495469|100791416|FG000|Overall Study|Liver function test abnormality|0|||
33243090|NCT00495469|100791417|FG001|Overall Study|Liver function test abnormality|1|||
33243091|NCT00495469|100791418|FG002|Overall Study|Liver function test abnormality|0|||
33243092|NCT00495469|100791419|FG003|Overall Study|Liver function test abnormality|0|||
33243093|NCT00495469|100791420|FG004|Overall Study|Liver function test abnormality|0|||
33243094|NCT00495469|100791421|FG005|Overall Study|Liver function test abnormality|0|||
33243095|NCT00495469|100791422|FG006|Overall Study|Liver function test abnormality|0|||
33243096|NCT00495469|100791416|FG000|Overall Study|ST depression at randomisation in ECG|0|||
33243097|NCT00495469|100791417|FG001|Overall Study|ST depression at randomisation in ECG|1|||
33243098|NCT00495469|100791418|FG002|Overall Study|ST depression at randomisation in ECG|0|||
33243099|NCT00495469|100791419|FG003|Overall Study|ST depression at randomisation in ECG|0|||
33243100|NCT00495469|100791420|FG004|Overall Study|ST depression at randomisation in ECG|0|||
33243101|NCT00495469|100791421|FG005|Overall Study|ST depression at randomisation in ECG|0|||
33243102|NCT00495469|100791422|FG006|Overall Study|ST depression at randomisation in ECG|0|||
33243103|NCT00530777|100791428|FG000|Overall Study|Lost to Follow-up|0|||
33243104|NCT00530777|100791429|FG001|Overall Study|Lost to Follow-up|1|||
33243105|NCT00530777|100791428|FG000|Overall Study|Death|1|||
33243106|NCT00530777|100791429|FG001|Overall Study|Death|2|||
33243107|NCT00530777|100791428|FG000|Overall Study|Physician Decision|1|||
33243108|NCT00530777|100791429|FG001|Overall Study|Physician Decision|0|||
33243109|NCT00530777|100791428|FG000|Overall Study|Withdrawal by Subject|0|||
33243110|NCT00530777|100791429|FG001|Overall Study|Withdrawal by Subject|1|||
33243111|NCT00530777|100791428|FG000|Overall Study|Unable to adhere to visit schedule|5|||
33243112|NCT00530777|100791429|FG001|Overall Study|Unable to adhere to visit schedule|1|||
33243113|NCT00051311|100791430|FG000|Overall Study|Starting new study|0|||
33243114|NCT00051311|100791431|FG001|Overall Study|Starting new study|1|||
33243115|NCT00051311|100791430|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
33243116|NCT00051311|100791431|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
33243117|NCT00051311|100791430|FG000|Overall Study|Death of recipient|8|||
33243118|NCT00051311|100791431|FG001|Overall Study|Death of recipient|8|||
33243119|NCT00051311|100791430|FG000|Overall Study|Recipient taken off study|4|||
33243120|NCT00051311|100791431|FG001|Overall Study|Recipient taken off study|4|||
33243121|NCT04391309|100791432|FG000|Overall Study|Death|1|||
33243122|NCT04391309|100791433|FG001|Overall Study|Death|1|||
33243123|NCT04391309|100791432|FG000|Overall Study|Lost to Follow-up|3|||
33243124|NCT04391309|100791433|FG001|Overall Study|Lost to Follow-up|2|||
33243125|NCT04391309|100791432|FG000|Overall Study|Withdrawal by Subject|2|||
33243126|NCT04391309|100791433|FG001|Overall Study|Withdrawal by Subject|2|||
33372276|NCT00905307|101247756|FG000|Overall Study|Lack of Efficacy|6|||
33372277|NCT00905307|101247757|FG001|Overall Study|Lack of Efficacy|3|||
33372278|NCT00905307|101247758|FG002|Overall Study|Lack of Efficacy|5|||
33372279|NCT00905307|101247759|FG003|Overall Study|Lack of Efficacy|4|||
33372280|NCT00905307|101247760|FG004|Overall Study|Lack of Efficacy|4|||
33372281|NCT00905307|101247761|FG005|Overall Study|Lack of Efficacy|8|||
33372282|NCT02577406|101247762|FG000|Randomized Period|Death|1|||
33422076|NCT01600014|101436981|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
33243127|NCT00601640|100791442|FG000|Overall Study|Withdrawal by Subject|3|||
33243128|NCT00601640|100791443|FG001|Overall Study|Withdrawal by Subject|0|||
33243129|NCT00601640|100791444|FG002|Overall Study|Withdrawal by Subject|7|||
33243130|NCT00601640|100791442|FG000|Overall Study|Death|1|||
33243131|NCT00601640|100791443|FG001|Overall Study|Death|0|||
33243132|NCT00601640|100791444|FG002|Overall Study|Death|0|||
33243133|NCT00601640|100791442|FG000|Overall Study|Adverse Event|0|||
33243134|NCT00601640|100791443|FG001|Overall Study|Adverse Event|4|||
33243135|NCT00601640|100791444|FG002|Overall Study|Adverse Event|2|||
33372283|NCT02577406|101247763|FG001|Randomized Period|Death|0|||
33372284|NCT02577406|101247762|FG000|Randomized Period|Other reasons|0|||
33643149|NCT01134705|102244306|FG001|Overall Study|Pregnancy|0|||
33243136|NCT00601640|100791442|FG000|Overall Study|intercurrent illness|1|||
33243137|NCT00601640|100791443|FG001|Overall Study|intercurrent illness|0|||
33243138|NCT00601640|100791444|FG002|Overall Study|intercurrent illness|0|||
33243139|NCT00601640|100791442|FG000|Overall Study|change in eligibility status|0|||
33243140|NCT00601640|100791443|FG001|Overall Study|change in eligibility status|1|||
33243141|NCT00601640|100791444|FG002|Overall Study|change in eligibility status|1|||
33243142|NCT01649427|100791447|FG000|Overall Study|Adverse Event|1|||
33243143|NCT01649427|100791448|FG001|Overall Study|Adverse Event|1|||
33243144|NCT01649427|100791447|FG000|Overall Study|Withdrawal by Subject|8|||
33243145|NCT01649427|100791448|FG001|Overall Study|Withdrawal by Subject|7|||
33243146|NCT01649427|100791447|FG000|Overall Study|Lost to Follow-up|0|||
33243147|NCT01649427|100791448|FG001|Overall Study|Lost to Follow-up|1|||
33243148|NCT01649427|100791447|FG000|Overall Study|Graft loss|0|||
33243149|NCT01649427|100791448|FG001|Overall Study|Graft loss|1|||
33243150|NCT01649427|100791447|FG000|Overall Study|Surgical problems during nephrectomy|2|||
33243151|NCT01649427|100791448|FG001|Overall Study|Surgical problems during nephrectomy|2|||
33243152|NCT02096003|100791450|FG000|Overall Study|Protocol Violation|0|||
33243153|NCT02096003|100791451|FG001|Overall Study|Protocol Violation|2|||
33243154|NCT02096003|100791450|FG000|Overall Study|additional surgery|2|||
33243155|NCT02096003|100791451|FG001|Overall Study|additional surgery|1|||
33243156|NCT00577629|100791456|FG000|Treatment Period|Death|1|||
33243157|NCT00577629|100791456|FG000|Long Term Follow-Up|Death|15|||
33243158|NCT00577629|100791456|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
33243159|NCT00577629|100791456|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
33243160|NCT00577629|100791456|FG000|Long Term Follow-Up|Physician Decision|1|||
33243161|NCT03971357|100791461|FG000|Overall Study|Lack of Efficacy|0|||
33243162|NCT03971357|100791462|FG001|Overall Study|Lack of Efficacy|1|||
33243163|NCT04978363|100791463|FG000|Overall Study|Other medical issues unrelated to the study|0|||
33243164|NCT04978363|100791464|FG001|Overall Study|Other medical issues unrelated to the study|0|||
33243165|NCT04978363|100791465|FG002|Overall Study|Other medical issues unrelated to the study|0|||
33243166|NCT04978363|100791466|FG003|Overall Study|Other medical issues unrelated to the study|0|||
33243167|NCT04978363|100791467|FG004|Overall Study|Other medical issues unrelated to the study|1|||
33243168|NCT04978363|100791468|FG005|Overall Study|Other medical issues unrelated to the study|0|||
33372285|NCT02577406|101247763|FG001|Randomized Period|Other reasons|20|||
33372286|NCT02577406|101247762|FG000|Treatment Period|Transition to commercially available treatment|1|||
33372287|NCT02577406|101247763|FG001|Treatment Period|Transition to commercially available treatment|0|||
33372288|NCT02577406|101247762|FG000|Treatment Period|Progressive disease|47|||
33372289|NCT02577406|101247763|FG001|Treatment Period|Progressive disease|36|||
33372290|NCT02577406|101247762|FG000|Treatment Period|Death|36|||
33372291|NCT02577406|101247763|FG001|Treatment Period|Death|23|||
33372292|NCT02577406|101247762|FG000|Treatment Period|Other reasons|3|||
33372293|NCT02577406|101247763|FG001|Treatment Period|Other reasons|37|||
33372294|NCT02577406|101247762|FG000|Treatment Period|Withdrawal by Subject|10|||
33372295|NCT02577406|101247763|FG001|Treatment Period|Withdrawal by Subject|24|||
33372296|NCT02577406|101247762|FG000|Treatment Period|Adverse Event|17|||
33582217|NCT01194219|102020318|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33643150|NCT01134705|102244305|FG000|Overall Study|Lost to Follow-up|5|||
33243169|NCT04978363|100791469|FG006|Overall Study|Other medical issues unrelated to the study|0|||
33243170|NCT04978363|100791470|FG007|Overall Study|Other medical issues unrelated to the study|0|||
33243171|NCT04978363|100791471|FG008|Overall Study|Other medical issues unrelated to the study|0|||
33243172|NCT04978363|100791472|FG009|Overall Study|Other medical issues unrelated to the study|0|||
33243173|NCT04978363|100791473|FG010|Overall Study|Other medical issues unrelated to the study|0|||
33243174|NCT04978363|100791463|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
33243175|NCT04978363|100791464|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
33243176|NCT04978363|100791465|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
33243177|NCT04978363|100791466|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
33582218|NCT01194219|102020319|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33582219|NCT01194219|102020320|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33582220|NCT01194219|102020321|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33582221|NCT01194219|102020322|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
33582222|NCT01194219|102020313|FG000|Maintenance Phase Weeks16-32|Other|0|||
33582223|NCT01194219|102020314|FG001|Maintenance Phase Weeks16-32|Other|0|||
33372297|NCT02577406|101247763|FG001|Treatment Period|Adverse Event|12|||
33582224|NCT01194219|102020315|FG002|Maintenance Phase Weeks16-32|Other|2|||
33582225|NCT01194219|102020316|FG003|Maintenance Phase Weeks16-32|Other|1|||
33643151|NCT01134705|102244306|FG001|Overall Study|Lost to Follow-up|2|||
33643152|NCT01134705|102244305|FG000|Overall Study|Protocol Violation|1|||
33243178|NCT04978363|100791467|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
33243179|NCT04978363|100791468|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
33243180|NCT04978363|100791469|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
33372298|NCT02577406|101247762|FG000|Treatment Period|Disease relapse|27|||
33372299|NCT02577406|101247763|FG001|Treatment Period|Disease relapse|1|||
33643153|NCT01134705|102244306|FG001|Overall Study|Protocol Violation|1|||
33582226|NCT01194219|102020317|FG004|Maintenance Phase Weeks16-32|Other|0|||
33582227|NCT01194219|102020318|FG005|Maintenance Phase Weeks16-32|Other|0|||
33582228|NCT01194219|102020319|FG006|Maintenance Phase Weeks16-32|Other|0|||
33582229|NCT01194219|102020320|FG007|Maintenance Phase Weeks16-32|Other|0|||
33582230|NCT01194219|102020321|FG008|Maintenance Phase Weeks16-32|Other|0|||
33582231|NCT01194219|102020322|FG009|Maintenance Phase Weeks16-32|Other|0|||
33582232|NCT01194219|102020313|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
33582233|NCT01194219|102020314|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
33582234|NCT01194219|102020315|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
33582235|NCT01194219|102020316|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
33582236|NCT01194219|102020317|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
33582237|NCT01194219|102020318|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
33582238|NCT01194219|102020319|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
33582239|NCT01194219|102020320|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
33643154|NCT01134705|102244305|FG000|Overall Study|Other|1|||
33372300|NCT02577406|101247762|FG000|Treatment Period|HSCT|6|||
33643155|NCT01134705|102244306|FG001|Overall Study|Other|6|||
33643156|NCT00126490|102244317|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
33643157|NCT03275350|102244318|FG000|Overall Study|Lost to Follow-up|4|||
33643158|NCT03275350|102244319|FG001|Overall Study|Lost to Follow-up|6|||
33643159|NCT03275350|102244318|FG000|Overall Study|Death|2|||
33643160|NCT03275350|102244319|FG001|Overall Study|Death|1|||
33643161|NCT03275350|102244318|FG000|Overall Study|Physician Decision|1|||
33643162|NCT03275350|102244319|FG001|Overall Study|Physician Decision|0|||
33643163|NCT03275350|102244318|FG000|Overall Study|Incarcerated|1|||
33643164|NCT03275350|102244319|FG001|Overall Study|Incarcerated|1|||
33643165|NCT00233064|102244320|FG000|Overall Study|Lost to Follow-up|7|||
33643166|NCT00233064|102244321|FG001|Overall Study|Lost to Follow-up|7|||
33643167|NCT00233064|102244320|FG000|Overall Study|Withdrawal by Subject|5|||
33643168|NCT00233064|102244321|FG001|Overall Study|Withdrawal by Subject|3|||
33643169|NCT00233064|102244320|FG000|Overall Study|Death|0|||
33643170|NCT00233064|102244321|FG001|Overall Study|Death|1|||
33145014|NCT03345342|100445105|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
33145015|NCT03345342|100445106|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
33145016|NCT03345342|100445107|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
33372301|NCT02577406|101247763|FG001|Treatment Period|HSCT|2|||
33145017|NCT03345342|100445108|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
33145018|NCT03345342|100445104|FG000|Open-Label Phase|Physician Decision|4|||
33145019|NCT03345342|100445105|FG001|Open-Label Phase|Physician Decision|0|||
33145020|NCT03345342|100445106|FG002|Open-Label Phase|Physician Decision|0|||
33145021|NCT03345342|100445107|FG003|Open-Label Phase|Physician Decision|0|||
33145022|NCT03345342|100445108|FG004|Open-Label Phase|Physician Decision|0|||
33145023|NCT03345342|100445104|FG000|Open-Label Phase|Protocol Violation|8|||
33145024|NCT03345342|100445105|FG001|Open-Label Phase|Protocol Violation|0|||
33145025|NCT03345342|100445106|FG002|Open-Label Phase|Protocol Violation|0|||
33145026|NCT03345342|100445107|FG003|Open-Label Phase|Protocol Violation|0|||
33145027|NCT03345342|100445108|FG004|Open-Label Phase|Protocol Violation|0|||
33145028|NCT03345342|100445104|FG000|Open-Label Phase|Withdrawal by Subject|57|||
33372302|NCT02577406|101247762|FG000|Treatment Period|Lost to Follow-up|0|||
33372303|NCT02577406|101247763|FG001|Treatment Period|Lost to Follow-up|1|||
33372304|NCT02577406|101247762|FG000|Treatment Period|Protocol Violation|0|||
33372305|NCT02577406|101247763|FG001|Treatment Period|Protocol Violation|1|||
33372306|NCT03504774|101247764|FG000|Overall Study|Adverse Event|2|||
33145029|NCT03345342|100445105|FG001|Open-Label Phase|Withdrawal by Subject|0|||
33145030|NCT03345342|100445106|FG002|Open-Label Phase|Withdrawal by Subject|0|||
33372307|NCT03504774|101247765|FG001|Overall Study|Adverse Event|0|||
33372308|NCT03504774|101247764|FG000|Overall Study|Lost to Follow-up|0|||
33372309|NCT03504774|101247765|FG001|Overall Study|Lost to Follow-up|1|||
33372310|NCT03504774|101247764|FG000|Overall Study|Protocol Violation|11|||
33372311|NCT03504774|101247765|FG001|Overall Study|Protocol Violation|3|||
33372312|NCT03504774|101247764|FG000|Overall Study|failed wk 52 DBPCFC|1|||
33372313|NCT03504774|101247765|FG001|Overall Study|failed wk 52 DBPCFC|0|||
33372314|NCT00578864|101247768|FG000|Overall Study|Death|1|||
33582240|NCT01194219|102020321|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
33582241|NCT01194219|102020322|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
33643171|NCT00233064|102244320|FG000|Overall Study|Relocation|0|||
33145031|NCT03345342|100445107|FG003|Open-Label Phase|Withdrawal by Subject|0|||
33145032|NCT03345342|100445108|FG004|Open-Label Phase|Withdrawal by Subject|0|||
33372315|NCT00578864|101247769|FG001|Overall Study|Death|0|||
33643172|NCT00233064|102244321|FG001|Overall Study|Relocation|1|||
33145033|NCT03345342|100445104|FG000|Open-Label Phase|Other|15|||
33582242|NCT01194219|102020313|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
33372316|NCT03703375|101247770|FG000|Randomization Period|Withdrawal by Subject|0|||
33582243|NCT01194219|102020314|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
33643173|NCT00233064|102244320|FG000|Overall Study|Protocol Violation|1|||
33372317|NCT03703375|101247771|FG001|Randomization Period|Withdrawal by Subject|0|||
33145034|NCT03345342|100445105|FG001|Open-Label Phase|Other|0|||
33145035|NCT03345342|100445106|FG002|Open-Label Phase|Other|0|||
33145036|NCT03345342|100445107|FG003|Open-Label Phase|Other|0|||
33145037|NCT03345342|100445108|FG004|Open-Label Phase|Other|0|||
33145038|NCT03345342|100445104|FG000|Double-Blind Phase|Adverse Event|0|||
33145039|NCT03345342|100445105|FG001|Double-Blind Phase|Adverse Event|1|||
33145040|NCT03345342|100445106|FG002|Double-Blind Phase|Adverse Event|6|||
33145041|NCT03345342|100445107|FG003|Double-Blind Phase|Adverse Event|0|||
33145042|NCT03345342|100445108|FG004|Double-Blind Phase|Adverse Event|0|||
33145043|NCT03345342|100445104|FG000|Double-Blind Phase|Death|0|||
33145044|NCT03345342|100445105|FG001|Double-Blind Phase|Death|2|||
33145045|NCT03345342|100445106|FG002|Double-Blind Phase|Death|1|||
33145046|NCT03345342|100445107|FG003|Double-Blind Phase|Death|0|||
33145047|NCT03345342|100445108|FG004|Double-Blind Phase|Death|0|||
33145048|NCT03345342|100445104|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
33145049|NCT03345342|100445105|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
33145050|NCT03345342|100445106|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
33145051|NCT03345342|100445107|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
33582244|NCT01194219|102020315|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
33582245|NCT01194219|102020316|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
33582246|NCT01194219|102020317|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
33582247|NCT01194219|102020318|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
33582248|NCT01194219|102020319|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
33582249|NCT01194219|102020320|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
33582250|NCT01194219|102020321|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
33582251|NCT01194219|102020322|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
33582252|NCT01194219|102020313|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33582253|NCT01194219|102020314|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33582254|NCT01194219|102020315|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33582255|NCT01194219|102020316|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33582256|NCT01194219|102020317|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
33582257|NCT01194219|102020318|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33582258|NCT01194219|102020319|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
33582259|NCT01194219|102020320|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33582260|NCT01194219|102020321|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33582261|NCT01194219|102020322|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
33582262|NCT01194219|102020313|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
33582263|NCT01194219|102020314|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
33582264|NCT01194219|102020315|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
33582265|NCT01194219|102020316|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
33582266|NCT01194219|102020317|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
33582267|NCT01194219|102020318|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
33582268|NCT01194219|102020319|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
33582269|NCT01194219|102020320|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
33582270|NCT01194219|102020321|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
33582271|NCT01194219|102020322|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
33582272|NCT01194219|102020313|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
33582273|NCT01194219|102020314|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
33582274|NCT01194219|102020315|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
33582275|NCT01194219|102020316|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
33582276|NCT01194219|102020317|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
33582277|NCT01194219|102020318|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
33582278|NCT01194219|102020319|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
33582279|NCT01194219|102020320|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
33582280|NCT01194219|102020321|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
33582281|NCT01194219|102020322|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
33582282|NCT01194219|102020313|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33582283|NCT01194219|102020314|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33582284|NCT01194219|102020315|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33582285|NCT01194219|102020316|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33582286|NCT01194219|102020317|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33582287|NCT01194219|102020318|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33145052|NCT03345342|100445108|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
33145053|NCT03345342|100445104|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33145054|NCT03345342|100445105|FG001|Double-Blind Phase|Lost to Follow-up|1|||
33145055|NCT03345342|100445106|FG002|Double-Blind Phase|Lost to Follow-up|7|||
33145056|NCT03345342|100445107|FG003|Double-Blind Phase|Lost to Follow-up|0|||
33145057|NCT03345342|100445108|FG004|Double-Blind Phase|Lost to Follow-up|0|||
33145058|NCT03345342|100445104|FG000|Double-Blind Phase|Physician Decision|0|||
33145059|NCT03345342|100445105|FG001|Double-Blind Phase|Physician Decision|1|||
33145060|NCT03345342|100445106|FG002|Double-Blind Phase|Physician Decision|4|||
33145061|NCT03345342|100445107|FG003|Double-Blind Phase|Physician Decision|0|||
33145062|NCT03345342|100445108|FG004|Double-Blind Phase|Physician Decision|0|||
33145063|NCT03345342|100445104|FG000|Double-Blind Phase|Protocol Violation|0|||
33145064|NCT03345342|100445105|FG001|Double-Blind Phase|Protocol Violation|0|||
33145065|NCT03345342|100445106|FG002|Double-Blind Phase|Protocol Violation|1|||
33145066|NCT03345342|100445107|FG003|Double-Blind Phase|Protocol Violation|0|||
33145067|NCT03345342|100445108|FG004|Double-Blind Phase|Protocol Violation|0|||
33145068|NCT03345342|100445104|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
33582288|NCT01194219|102020319|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33582289|NCT01194219|102020320|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
33582290|NCT01194219|102020321|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33582291|NCT01194219|102020322|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
33582292|NCT01194219|102020313|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33582293|NCT01194219|102020314|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33582294|NCT01194219|102020315|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33145069|NCT03345342|100445105|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
33145070|NCT03345342|100445106|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
33145071|NCT03345342|100445107|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
33145072|NCT03345342|100445108|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
33145073|NCT03345342|100445104|FG000|Double-Blind Phase|Other|0|||
33145074|NCT03345342|100445105|FG001|Double-Blind Phase|Other|1|||
33145075|NCT03345342|100445106|FG002|Double-Blind Phase|Other|3|||
33145076|NCT03345342|100445107|FG003|Double-Blind Phase|Other|0|||
33145077|NCT03345342|100445108|FG004|Double-Blind Phase|Other|0|||
33145078|NCT03345342|100445104|FG000|Follow-Up Phase|Adverse Event|0|||
33145079|NCT03345342|100445105|FG001|Follow-Up Phase|Adverse Event|0|||
33145080|NCT03345342|100445106|FG002|Follow-Up Phase|Adverse Event|0|||
33145081|NCT03345342|100445107|FG003|Follow-Up Phase|Adverse Event|0|||
33145082|NCT03345342|100445108|FG004|Follow-Up Phase|Adverse Event|4|||
33145083|NCT03345342|100445104|FG000|Follow-Up Phase|Lost to Follow-up|0|||
33145084|NCT03345342|100445105|FG001|Follow-Up Phase|Lost to Follow-up|0|||
33422077|NCT01600014|101436980|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
33422078|NCT01600014|101436981|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
33422079|NCT01600014|101436980|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
33422080|NCT01600014|101436981|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
33422081|NCT01600014|101436980|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
33422082|NCT01600014|101436981|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
33582295|NCT01194219|102020316|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33582296|NCT01194219|102020317|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33582297|NCT01194219|102020318|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33582298|NCT01194219|102020319|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
33582299|NCT01194219|102020320|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33582300|NCT01194219|102020321|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33582301|NCT01194219|102020322|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
33582302|NCT01194219|102020313|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33582303|NCT01194219|102020314|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33582304|NCT01194219|102020315|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33582305|NCT01194219|102020316|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33582306|NCT01194219|102020317|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33582307|NCT01194219|102020318|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33582308|NCT01194219|102020319|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33582309|NCT01194219|102020320|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
33582310|NCT01194219|102020321|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
33582311|NCT01194219|102020322|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
33582312|NCT01194219|102020313|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33582313|NCT01194219|102020314|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33582314|NCT01194219|102020315|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33582315|NCT01194219|102020316|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33582316|NCT01194219|102020317|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33582317|NCT01194219|102020318|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33145085|NCT03345342|100445106|FG002|Follow-Up Phase|Lost to Follow-up|0|||
33145086|NCT03345342|100445107|FG003|Follow-Up Phase|Lost to Follow-up|0|||
33145087|NCT03345342|100445108|FG004|Follow-Up Phase|Lost to Follow-up|6|||
33145088|NCT03345342|100445104|FG000|Follow-Up Phase|Physician Decision|0|||
33372318|NCT03703375|101247772|FG002|Randomization Period|Withdrawal by Subject|0|||
33145089|NCT03345342|100445105|FG001|Follow-Up Phase|Physician Decision|0|||
33145090|NCT03345342|100445106|FG002|Follow-Up Phase|Physician Decision|0|||
33145091|NCT03345342|100445107|FG003|Follow-Up Phase|Physician Decision|0|||
33145092|NCT03345342|100445108|FG004|Follow-Up Phase|Physician Decision|5|||
33145093|NCT03345342|100445104|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
33145094|NCT03345342|100445105|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
33145095|NCT03345342|100445106|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
33145096|NCT03345342|100445107|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
33145097|NCT03345342|100445108|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
33145098|NCT03345342|100445104|FG000|Follow-Up Phase|Other|0|||
33145099|NCT03345342|100445105|FG001|Follow-Up Phase|Other|0|||
33145100|NCT03345342|100445106|FG002|Follow-Up Phase|Other|0|||
33145101|NCT03345342|100445107|FG003|Follow-Up Phase|Other|3|||
33145102|NCT03345342|100445108|FG004|Follow-Up Phase|Other|1|||
33145103|NCT01487577|100445117|FG000|Overall Study|Became ineligible after signing consent|1|||
33145104|NCT01439347|100445118|FG000|Overall Study|Death|10|||
33145105|NCT01439347|100445119|FG001|Overall Study|Death|9|||
33145106|NCT01439347|100445118|FG000|Overall Study|Withdrawal by Subject|0|||
33145107|NCT01439347|100445119|FG001|Overall Study|Withdrawal by Subject|1|||
33145108|NCT01439347|100445118|FG000|Overall Study|Physician Decision|1|||
33145109|NCT01439347|100445119|FG001|Overall Study|Physician Decision|0|||
33145110|NCT01439347|100445118|FG000|Overall Study|Sponsor Terminated Study|2|||
33145111|NCT01439347|100445119|FG001|Overall Study|Sponsor Terminated Study|3|||
33145112|NCT00371761|100445120|FG000|Overall Study|Adverse Event|1|||
33145113|NCT00371761|100445121|FG001|Overall Study|Adverse Event|1|||
33145114|NCT00371761|100445120|FG000|Overall Study|Withdrawal by Subject|1|||
33145115|NCT00371761|100445121|FG001|Overall Study|Withdrawal by Subject|3|||
33145116|NCT00371761|100445120|FG000|Overall Study|Investigator Judgment|2|||
33145117|NCT00371761|100445121|FG001|Overall Study|Investigator Judgment|3|||
33145118|NCT00371761|100445120|FG000|Overall Study|Study termination|4|||
33145119|NCT00371761|100445121|FG001|Overall Study|Study termination|3|||
33145120|NCT01249118|100445122|FG000|First Washout Period|Physician Decision|0|||
33145121|NCT01249118|100445123|FG001|First Washout Period|Physician Decision|1|||
33145122|NCT01249118|100445124|FG002|First Washout Period|Physician Decision|0|||
33145123|NCT03194490|100445125|FG000|Overall Study|Lost to Follow-up|1|||
33145124|NCT03194490|100445126|FG001|Overall Study|Lost to Follow-up|3|||
33145125|NCT03194490|100445125|FG000|Overall Study|participant developed specific neck pain|1|||
33145126|NCT03194490|100445126|FG001|Overall Study|participant developed specific neck pain|0|||
33145127|NCT02117427|100445130|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
33145128|NCT02117427|100445131|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
33145129|NCT02117427|100445132|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
33145130|NCT02117427|100445130|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
33145131|NCT02117427|100445131|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
33145132|NCT02117427|100445132|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
33145133|NCT02117427|100445130|FG000|Overall Study|Physician Decision|0|||
33145134|NCT02117427|100445131|FG001|Overall Study|Physician Decision|2|||
33145135|NCT02117427|100445132|FG002|Overall Study|Physician Decision|0|||
33145136|NCT02117427|100445130|FG000|Overall Study|No longer meets inclusion criteria|0|||
33145137|NCT02117427|100445131|FG001|Overall Study|No longer meets inclusion criteria|1|||
33145138|NCT02117427|100445132|FG002|Overall Study|No longer meets inclusion criteria|0|||
33145139|NCT02117427|100445130|FG000|Overall Study|Death|0|||
33145140|NCT02117427|100445131|FG001|Overall Study|Death|1|||
33422083|NCT01600014|101436980|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
33422084|NCT01600014|101436981|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
33582318|NCT01194219|102020319|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33582319|NCT01194219|102020320|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
33582320|NCT01194219|102020321|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
33582321|NCT01194219|102020322|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
33582322|NCT01194219|102020313|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33582323|NCT01194219|102020314|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33582324|NCT01194219|102020315|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33582325|NCT01194219|102020316|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33582326|NCT01194219|102020317|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33145141|NCT02117427|100445132|FG002|Overall Study|Death|0|||
33145142|NCT01856023|100445136|FG000|Overall Study|Death|1|||
33145143|NCT01856023|100445137|FG001|Overall Study|Death|2|||
33145144|NCT01856023|100445136|FG000|Overall Study|Adverse Event|2|||
33145145|NCT01856023|100445137|FG001|Overall Study|Adverse Event|1|||
33145146|NCT01856023|100445136|FG000|Overall Study|Lack of Efficacy|5|||
33145147|NCT01856023|100445137|FG001|Overall Study|Lack of Efficacy|5|||
33145148|NCT01856023|100445136|FG000|Overall Study|non compliance, study closure|1|||
33582327|NCT01194219|102020318|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33145149|NCT01856023|100445137|FG001|Overall Study|non compliance, study closure|3|||
33145150|NCT01856023|100445136|FG000|Overall Study|Withdrawal by Subject|1|||
33145151|NCT01856023|100445137|FG001|Overall Study|Withdrawal by Subject|1|||
33145152|NCT01888003|100445138|FG000|Overall Study|Study Terminated|5|||
33145153|NCT01888003|100445139|FG001|Overall Study|Study Terminated|6|||
33145154|NCT01888003|100445140|FG002|Overall Study|Study Terminated|40|||
33145155|NCT00473746|100445141|FG000|Period 1 (Phase 1)|Adverse Event|1|||
33145156|NCT00473746|100445142|FG001|Period 1 (Phase 1)|Adverse Event|0|||
33145157|NCT00473746|100445143|FG002|Period 1 (Phase 1)|Adverse Event|0|||
33145158|NCT00473746|100445144|FG003|Period 1 (Phase 1)|Adverse Event|0|||
33145159|NCT00473746|100445145|FG004|Period 1 (Phase 1)|Adverse Event|0|||
33145160|NCT00473746|100445141|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
33145161|NCT00473746|100445142|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
33145162|NCT00473746|100445143|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
33145163|NCT00473746|100445144|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
33145164|NCT00473746|100445145|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
33145165|NCT00473746|100445141|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
33145166|NCT00473746|100445142|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
33145167|NCT00473746|100445143|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
33145168|NCT00473746|100445144|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
33145169|NCT00473746|100445145|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
33145170|NCT00473746|100445141|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
33145171|NCT00473746|100445142|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
33145172|NCT00473746|100445143|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
33145173|NCT00473746|100445144|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
33145174|NCT00473746|100445145|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
33145175|NCT00473746|100445141|FG000|Period 1 (Phase 1)|Reason not specified|0|||
33145176|NCT00473746|100445142|FG001|Period 1 (Phase 1)|Reason not specified|1|||
33145177|NCT00473746|100445143|FG002|Period 1 (Phase 1)|Reason not specified|0|||
33145178|NCT00473746|100445144|FG003|Period 1 (Phase 1)|Reason not specified|0|||
33145179|NCT00473746|100445145|FG004|Period 1 (Phase 1)|Reason not specified|0|||
33145180|NCT00473746|100445141|FG000|Period 2 (Phase 2)|Adverse Event|0|||
33145181|NCT00473746|100445142|FG001|Period 2 (Phase 2)|Adverse Event|0|||
33145182|NCT00473746|100445143|FG002|Period 2 (Phase 2)|Adverse Event|0|||
33145183|NCT00473746|100445144|FG003|Period 2 (Phase 2)|Adverse Event|0|||
33145184|NCT00473746|100445145|FG004|Period 2 (Phase 2)|Adverse Event|3|||
33145185|NCT00473746|100445141|FG000|Period 2 (Phase 2)|Death|0|||
33145186|NCT00473746|100445142|FG001|Period 2 (Phase 2)|Death|0|||
33145187|NCT00473746|100445143|FG002|Period 2 (Phase 2)|Death|0|||
33145188|NCT00473746|100445144|FG003|Period 2 (Phase 2)|Death|0|||
33145189|NCT00473746|100445145|FG004|Period 2 (Phase 2)|Death|1|||
33145190|NCT00473746|100445141|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
33145191|NCT00473746|100445142|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
33145192|NCT00473746|100445143|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
33145193|NCT00473746|100445144|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
33145194|NCT00473746|100445145|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
33145195|NCT00473746|100445141|FG000|Period 2 (Phase 2)|Reason not specified|0|||
33145196|NCT00473746|100445142|FG001|Period 2 (Phase 2)|Reason not specified|0|||
33145197|NCT00473746|100445143|FG002|Period 2 (Phase 2)|Reason not specified|0|||
33145198|NCT00473746|100445144|FG003|Period 2 (Phase 2)|Reason not specified|0|||
33145199|NCT00473746|100445145|FG004|Period 2 (Phase 2)|Reason not specified|3|||
33145200|NCT01466595|100445152|FG000|Overall Study|Withdrawal by Subject|0|||
33145201|NCT01466595|100445153|FG001|Overall Study|Withdrawal by Subject|1|||
33145202|NCT01151098|100445156|FG000|Overall Study|Adverse Event|82|||
33145203|NCT01151098|100445156|FG000|Overall Study|Lost to Follow-up|6|||
33145204|NCT01151098|100445156|FG000|Overall Study|Lack of Efficacy|15|||
33145205|NCT01151098|100445156|FG000|Overall Study|Protocol Violation|1|||
33145206|NCT01151098|100445156|FG000|Overall Study|Miscellaneous|13|||
33145207|NCT02233946|100445157|FG000|Baseline|Withdrawal by Subject|2|||
33145208|NCT02233946|100445158|FG001|Baseline|Withdrawal by Subject|0|||
33145209|NCT02233946|100445157|FG000|3-months Follow-up|Lost to Follow-up|53|||
33145210|NCT02233946|100445158|FG001|3-months Follow-up|Lost to Follow-up|29|||
33145211|NCT02233946|100445157|FG000|6-months Follow-up|Lost to Follow-up|21|||
33145212|NCT02233946|100445158|FG001|6-months Follow-up|Lost to Follow-up|2|||
33145213|NCT02233946|100445157|FG000|9-month Follow-up|Lost to Follow-up|20|||
33145214|NCT02233946|100445158|FG001|9-month Follow-up|Lost to Follow-up|11|||
33145215|NCT02233946|100445157|FG000|12-month Follow-up|Lost to Follow-up|28|||
33145216|NCT02233946|100445158|FG001|12-month Follow-up|Lost to Follow-up|11|||
33145217|NCT00739596|100445159|FG000|Overall Study|Adverse Event|12|||
33422085|NCT01600014|101436980|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
33145218|NCT00739596|100445160|FG001|Overall Study|Adverse Event|6|||
33145219|NCT00739596|100445159|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
33145220|NCT00739596|100445160|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33145221|NCT00739596|100445159|FG000|Overall Study|Patient Withdrew Consent|8|||
33145222|NCT00739596|100445160|FG001|Overall Study|Patient Withdrew Consent|8|||
33422086|NCT01600014|101436981|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
33145223|NCT00739596|100445159|FG000|Overall Study|Lost to Follow-up|0|||
33145224|NCT00739596|100445160|FG001|Overall Study|Lost to Follow-up|2|||
33145225|NCT00739596|100445159|FG000|Overall Study|Protocol Deviation|1|||
33145226|NCT00739596|100445160|FG001|Overall Study|Protocol Deviation|1|||
33145227|NCT02361580|100445161|FG000|Overall Study|Lost to Follow-up|6|||
33145228|NCT02361580|100445162|FG001|Overall Study|Lost to Follow-up|3|||
33145229|NCT01306877|100445163|FG000|Overall Study|Lost to Follow-up|3|||
33422087|NCT01600014|101436980|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
33422088|NCT01600014|101436981|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
33422089|NCT01600014|101436980|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
33422090|NCT01600014|101436981|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
33422091|NCT01600014|101436980|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
33422092|NCT01600014|101436981|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
33422093|NCT01600014|101436980|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
33422094|NCT01600014|101436981|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
33422095|NCT01600014|101436980|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
33422096|NCT01600014|101436981|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
33422097|NCT01600014|101436980|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
33422098|NCT01600014|101436981|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
33422099|NCT01600014|101436980|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
33422100|NCT01600014|101436981|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
33422101|NCT01600014|101436980|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
33422102|NCT01600014|101436981|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
33422103|NCT01600014|101436980|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
33422104|NCT01600014|101436981|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
33422105|NCT01600014|101436980|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
33422106|NCT01600014|101436981|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
33422107|NCT01600014|101436980|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
33422108|NCT01600014|101436981|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
33422109|NCT00667719|101436982|FG000|Overall Study|Adverse Event|39|||
33422110|NCT00667719|101436982|FG000|Overall Study|Abnormal Test Procedure|1|||
33422111|NCT00667719|101436982|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
33422112|NCT00667719|101436982|FG000|Overall Study|Protocol Violation|3|||
33422113|NCT00667719|101436982|FG000|Overall Study|Withdrawal by Subject|17|||
33422114|NCT00667719|101436982|FG000|Overall Study|Lost to Follow-up|8|||
33422115|NCT02253654|101436984|FG000|Overall Study|Withdrawal by Subject|12|||
33422116|NCT02253654|101436985|FG001|Overall Study|Withdrawal by Subject|4|||
33422117|NCT02253654|101436984|FG000|Overall Study|Decision by Sponsor|1|||
33422118|NCT02253654|101436985|FG001|Overall Study|Decision by Sponsor|1|||
33422119|NCT02253654|101436984|FG000|Overall Study|Lost to Follow-up|2|||
33243181|NCT04978363|100791470|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
33243182|NCT04978363|100791471|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
33243183|NCT04978363|100791472|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
33243184|NCT04978363|100791473|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
33243185|NCT04978363|100791463|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33243186|NCT04978363|100791464|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
33243187|NCT04978363|100791465|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33243188|NCT04978363|100791466|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33243189|NCT04978363|100791467|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33243190|NCT04978363|100791468|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33243191|NCT04978363|100791469|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33243192|NCT04978363|100791470|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33243193|NCT04978363|100791471|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33243194|NCT04978363|100791472|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33243195|NCT04978363|100791473|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
33243196|NCT02138916|100791477|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
33243197|NCT02138916|100791478|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
33243198|NCT02138916|100791479|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
33243199|NCT02138916|100791477|FG000|Overall Study|Death|14|||
33372319|NCT03703375|101247773|FG003|Randomization Period|Withdrawal by Subject|1|||
33372320|NCT03703375|101247770|FG000|Randomization Period|Completed safety run-in treatment|7|||
33372321|NCT03703375|101247771|FG001|Randomization Period|Completed safety run-in treatment|0|||
33372322|NCT03703375|101247772|FG002|Randomization Period|Completed safety run-in treatment|0|||
33372323|NCT03703375|101247773|FG003|Randomization Period|Completed safety run-in treatment|0|||
33372324|NCT03703375|101247770|FG000|Treatment Period|Other Reasons|0|||
33372325|NCT03703375|101247771|FG001|Treatment Period|Other Reasons|1|||
33372326|NCT03703375|101247772|FG002|Treatment Period|Other Reasons|0|||
33372327|NCT03703375|101247773|FG003|Treatment Period|Other Reasons|3|||
33422120|NCT02253654|101436985|FG001|Overall Study|Lost to Follow-up|5|||
33422121|NCT02253654|101436984|FG000|Overall Study|Death|4|||
33422122|NCT02253654|101436985|FG001|Overall Study|Death|7|||
33422123|NCT02253654|101436984|FG000|Overall Study|Did Not Receive Study Treatment|4|||
33422124|NCT02253654|101436985|FG001|Overall Study|Did Not Receive Study Treatment|1|||
33643174|NCT00233064|102244321|FG001|Overall Study|Protocol Violation|0|||
33643175|NCT00233064|102244320|FG000|Overall Study|Moved to Dom. Republic|1|||
33643176|NCT00233064|102244321|FG001|Overall Study|Moved to Dom. Republic|0|||
33643177|NCT00806819|102244322|FG000|Overall Study|progressive disease (modified RECIST )|217|||
33643178|NCT00806819|102244323|FG001|Overall Study|progressive disease (modified RECIST )|216|||
33643179|NCT00806819|102244322|FG000|Overall Study|Worsening or AE of underlying disease|18|||
33145230|NCT01306877|100445164|FG001|Overall Study|Lost to Follow-up|3|||
33145231|NCT01306877|100445163|FG000|Overall Study|Physician Decision|0|||
33145232|NCT01306877|100445164|FG001|Overall Study|Physician Decision|1|||
33145233|NCT02497976|100445172|FG000|Overall Study|Withdrawal by Subject|2|||
33145234|NCT02497976|100445173|FG001|Overall Study|Withdrawal by Subject|0|||
33145235|NCT02497976|100445172|FG000|Overall Study|Moved out of area|0|||
33145236|NCT02497976|100445173|FG001|Overall Study|Moved out of area|1|||
33145237|NCT02283177|100445180|FG000|Overall Study|Withdrawal by Subject|1|||
33145238|NCT02283177|100445181|FG001|Overall Study|Withdrawal by Subject|1|||
33145239|NCT00938964|100445182|FG000|Overall Study|Death|3|||
33145240|NCT00938964|100445183|FG001|Overall Study|Death|3|||
33145241|NCT00938964|100445182|FG000|Overall Study|Lost to Follow-up|2|||
33145242|NCT00938964|100445183|FG001|Overall Study|Lost to Follow-up|3|||
33145243|NCT00938964|100445182|FG000|Overall Study|Withdrawal by Subject|22|||
33145244|NCT00938964|100445183|FG001|Overall Study|Withdrawal by Subject|18|||
33145245|NCT00938964|100445182|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
33145246|NCT00938964|100445183|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
33145247|NCT00760084|100445184|FG000|Overall Study|Physician Decision|5|||
33145248|NCT00760084|100445184|FG000|Overall Study|Withdrawal by Subject|2|||
33145249|NCT00760084|100445184|FG000|Overall Study|Progressive Disease|3|||
33145250|NCT01933789|100445185|FG000|Overall Study|Death|0|||
33582328|NCT01194219|102020319|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33643180|NCT00806819|102244323|FG001|Overall Study|Worsening or AE of underlying disease|25|||
33145251|NCT01933789|100445186|FG001|Overall Study|Death|0|||
33145252|NCT01933789|100445187|FG002|Overall Study|Death|0|||
33145253|NCT01933789|100445188|FG003|Overall Study|Death|0|||
33372328|NCT03703375|101247770|FG000|Treatment Period|Consent Withdrawal|0|||
33372329|NCT03703375|101247771|FG001|Treatment Period|Consent Withdrawal|0|||
33582329|NCT01194219|102020320|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
33582330|NCT01194219|102020321|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
33582331|NCT01194219|102020322|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
33582332|NCT01194219|102020313|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33582333|NCT01194219|102020314|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33582334|NCT01194219|102020315|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33582335|NCT01194219|102020316|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33582336|NCT01194219|102020317|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33582337|NCT01194219|102020318|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33582338|NCT01194219|102020319|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33582339|NCT01194219|102020320|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
33582340|NCT01194219|102020321|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
33582341|NCT01194219|102020322|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
33582342|NCT01194219|102020313|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
33582343|NCT01194219|102020314|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
33582344|NCT01194219|102020315|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
33582345|NCT01194219|102020316|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
33582346|NCT01194219|102020317|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
33582347|NCT01194219|102020318|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
33582348|NCT01194219|102020319|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
33582349|NCT01194219|102020320|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
33582350|NCT01194219|102020321|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
33582351|NCT01194219|102020322|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
33582352|NCT01194219|102020313|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33582353|NCT01194219|102020314|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33582354|NCT01194219|102020315|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33582355|NCT01194219|102020316|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33582356|NCT01194219|102020317|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33582357|NCT01194219|102020318|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33582358|NCT01194219|102020319|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33582359|NCT01194219|102020320|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
33582360|NCT01194219|102020321|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
33582361|NCT01194219|102020322|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
33582362|NCT01194219|102020313|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33582363|NCT01194219|102020314|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33582364|NCT01194219|102020315|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33643181|NCT00806819|102244322|FG000|Overall Study|Other AE|38|||
33145254|NCT01933789|100445189|FG004|Overall Study|Death|21|||
33145255|NCT01933789|100445190|FG005|Overall Study|Death|32|||
33145256|NCT01933789|100445191|FG006|Overall Study|Death|0|||
33145257|NCT01933789|100445192|FG007|Overall Study|Death|0|||
33145258|NCT01933789|100445193|FG008|Overall Study|Death|0|||
33145259|NCT01933789|100445185|FG000|Overall Study|Lost to Follow-up|0|||
33145260|NCT01933789|100445186|FG001|Overall Study|Lost to Follow-up|0|||
33145261|NCT01933789|100445187|FG002|Overall Study|Lost to Follow-up|0|||
33145262|NCT01933789|100445188|FG003|Overall Study|Lost to Follow-up|1|||
33145263|NCT01933789|100445189|FG004|Overall Study|Lost to Follow-up|8|||
33145264|NCT01933789|100445190|FG005|Overall Study|Lost to Follow-up|9|||
33145265|NCT01933789|100445191|FG006|Overall Study|Lost to Follow-up|1|||
33145266|NCT01933789|100445192|FG007|Overall Study|Lost to Follow-up|4|||
33145267|NCT01933789|100445193|FG008|Overall Study|Lost to Follow-up|0|||
33145268|NCT01933789|100445185|FG000|Overall Study|Withdrawal by Subject|2|||
33145269|NCT01933789|100445186|FG001|Overall Study|Withdrawal by Subject|1|||
33145270|NCT01933789|100445187|FG002|Overall Study|Withdrawal by Subject|0|||
33145271|NCT01933789|100445188|FG003|Overall Study|Withdrawal by Subject|0|||
33145272|NCT01933789|100445189|FG004|Overall Study|Withdrawal by Subject|17|||
33145273|NCT01933789|100445190|FG005|Overall Study|Withdrawal by Subject|16|||
33145274|NCT01933789|100445191|FG006|Overall Study|Withdrawal by Subject|1|||
33145275|NCT01933789|100445192|FG007|Overall Study|Withdrawal by Subject|4|||
33145276|NCT01933789|100445193|FG008|Overall Study|Withdrawal by Subject|0|||
33145277|NCT01933789|100445185|FG000|Overall Study|Became Ineligible|4|||
33145278|NCT01933789|100445186|FG001|Overall Study|Became Ineligible|0|||
33145279|NCT01933789|100445187|FG002|Overall Study|Became Ineligible|0|||
33145280|NCT01933789|100445188|FG003|Overall Study|Became Ineligible|0|||
33145281|NCT01933789|100445189|FG004|Overall Study|Became Ineligible|13|||
33145282|NCT01933789|100445190|FG005|Overall Study|Became Ineligible|10|||
33145283|NCT01933789|100445191|FG006|Overall Study|Became Ineligible|13|||
33145284|NCT01933789|100445192|FG007|Overall Study|Became Ineligible|6|||
33422125|NCT02595528|101436986|FG000|Overall Study|Withdrawal by Subject|1|||
33145285|NCT01933789|100445193|FG008|Overall Study|Became Ineligible|0|||
33145286|NCT01525901|100445196|FG000|Period 2: 12 Weeks|Adverse Event|0|||
33145287|NCT01525901|100445197|FG001|Period 2: 12 Weeks|Adverse Event|1|||
33145288|NCT01525901|100445198|FG002|Period 2: 12 Weeks|Adverse Event|0|||
33145289|NCT01525901|100445199|FG003|Period 2: 12 Weeks|Adverse Event|0|||
33145290|NCT04271280|100445204|FG000|Overall Study|Lost to Follow-up|300|||
33145291|NCT04271280|100445204|FG000|Overall Study|Death|153|||
33145292|NCT04271280|100445204|FG000|Overall Study|Withdrawal of consent by patient|59|||
33145293|NCT04271280|100445204|FG000|Overall Study|Other|51|||
33145294|NCT04271280|100445204|FG000|Overall Study|No end of study information|42|||
33145295|NCT01860846|100445207|FG000|Overall Study|Lost to Follow-up|33|||
33145296|NCT01285960|100445210|FG000|Overall Study|Withdrawal by Subject|2|||
33145297|NCT01285960|100445210|FG000|Overall Study|Lost to Follow-up|2|||
33145298|NCT01285960|100445210|FG000|Overall Study|2 subjects received less 10 sonications|2|||
33145299|NCT03309046|100445213|FG000|Overall Study|Withdrawal by Subject|4|||
33145300|NCT03309046|100445214|FG001|Overall Study|Withdrawal by Subject|17|||
33145301|NCT00880165|100445215|FG000|Overall Study|Withdrawal by Subject|27|||
33145302|NCT00880165|100445216|FG001|Overall Study|Withdrawal by Subject|23|||
33145303|NCT00880165|100445215|FG000|Overall Study|Not diagnosed with OSA|14|||
33145304|NCT00880165|100445216|FG001|Overall Study|Not diagnosed with OSA|8|||
33145305|NCT00880165|100445215|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
33145306|NCT00880165|100445216|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
33145307|NCT00880165|100445215|FG000|Overall Study|Lost to follow|9|||
33422126|NCT02595528|101436987|FG001|Overall Study|Withdrawal by Subject|2|||
33422127|NCT02595528|101436988|FG002|Overall Study|Withdrawal by Subject|1|||
33643182|NCT00806819|102244323|FG001|Overall Study|Other AE|40|||
33643183|NCT00806819|102244322|FG000|Overall Study|Protocol Violation|9|||
33643184|NCT00806819|102244323|FG001|Overall Study|Protocol Violation|4|||
33145308|NCT00880165|100445216|FG001|Overall Study|Lost to follow|15|||
33145309|NCT00908011|100445217|FG000|Overall Study|Withdrawal by Subject|2|||
33145310|NCT00908011|100445218|FG001|Overall Study|Withdrawal by Subject|2|||
33145311|NCT01562873|100445228|FG000|Overall Study|Disease Progression per RECIST|10|||
33145312|NCT01562873|100445229|FG001|Overall Study|Disease Progression per RECIST|0|||
33145313|NCT01562873|100445228|FG000|Overall Study|Adverse Event|1|||
33145314|NCT01562873|100445229|FG001|Overall Study|Adverse Event|0|||
33145315|NCT01562873|100445228|FG000|Overall Study|Clinical Disease Progression|9|||
33145316|NCT01562873|100445229|FG001|Overall Study|Clinical Disease Progression|0|||
33145317|NCT01562873|100445228|FG000|Overall Study|Clinical PD and adverse event|1|||
33145318|NCT01562873|100445229|FG001|Overall Study|Clinical PD and adverse event|0|||
33145319|NCT01205581|100445231|FG000|Overall Study|Withdrawal by Subject|1|||
33145320|NCT01205581|100445232|FG001|Overall Study|Withdrawal by Subject|0|||
33145321|NCT01205581|100445233|FG002|Overall Study|Withdrawal by Subject|0|||
33145322|NCT01205581|100445234|FG003|Overall Study|Withdrawal by Subject|0|||
33145323|NCT01205581|100445235|FG004|Overall Study|Withdrawal by Subject|0|||
33145324|NCT01205581|100445236|FG005|Overall Study|Withdrawal by Subject|0|||
33145325|NCT02898116|100445237|FG000|Overall Study|Adverse Event|1|||
33145326|NCT02898116|100445237|FG000|Overall Study|Progressive disease|1|||
33145327|NCT00322153|100445240|FG000|Overall Study|Adverse Event|21|||
33145328|NCT00322153|100445241|FG001|Overall Study|Adverse Event|34|||
33145329|NCT00322153|100445240|FG000|Overall Study|Protocol Violation|6|||
33145330|NCT00322153|100445241|FG001|Overall Study|Protocol Violation|14|||
33145331|NCT00322153|100445240|FG000|Overall Study|Withdrawal by Subject|18|||
33145332|NCT00322153|100445241|FG001|Overall Study|Withdrawal by Subject|10|||
33145333|NCT00322153|100445240|FG000|Overall Study|Lack of Efficacy|8|||
33145334|NCT00322153|100445241|FG001|Overall Study|Lack of Efficacy|3|||
33145335|NCT00322153|100445240|FG000|Overall Study|Lost to Follow-up|5|||
33145336|NCT00322153|100445241|FG001|Overall Study|Lost to Follow-up|4|||
33145337|NCT00322153|100445240|FG000|Overall Study|Withdrawn for other reasons|5|||
33145338|NCT00322153|100445241|FG001|Overall Study|Withdrawn for other reasons|4|||
33145339|NCT01280955|100445253|FG000|Overall Study|Death|2|||
33145340|NCT01280955|100445253|FG000|Overall Study|Withdrawal by Subject|1|||
33145341|NCT01727700|100445254|FG000|Overall Study|Adverse Event|0|||
33145342|NCT01727700|100445255|FG001|Overall Study|Adverse Event|7|||
33145343|NCT01727700|100445256|FG002|Overall Study|Adverse Event|1|||
33145344|NCT01727700|100445254|FG000|Overall Study|Particpant withdrew consent|0|||
33145345|NCT01727700|100445255|FG001|Overall Study|Particpant withdrew consent|3|||
33145346|NCT01727700|100445256|FG002|Overall Study|Particpant withdrew consent|1|||
33145347|NCT01727700|100445254|FG000|Overall Study|Protocol Violation|2|||
33145348|NCT01727700|100445255|FG001|Overall Study|Protocol Violation|0|||
33145349|NCT01727700|100445256|FG002|Overall Study|Protocol Violation|0|||
33145350|NCT01009281|100445257|FG000|Overall Study|Administrative problems|7|||
33145351|NCT02431247|100445258|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
33145352|NCT02431247|100445259|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
33145353|NCT02431247|100445260|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
33145354|NCT02431247|100445258|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
33145355|NCT02431247|100445259|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
33145356|NCT02431247|100445260|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
33145357|NCT02431247|100445258|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
33145358|NCT02431247|100445259|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
33145359|NCT02431247|100445260|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
33145360|NCT02431247|100445258|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
33145361|NCT02431247|100445259|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
33145362|NCT02431247|100445260|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
33145363|NCT02431247|100445258|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
33145364|NCT02431247|100445259|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
33145365|NCT02431247|100445260|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
33145366|NCT02431247|100445258|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
33372330|NCT03703375|101247772|FG002|Treatment Period|Consent Withdrawal|0|||
33372331|NCT03703375|101247773|FG003|Treatment Period|Consent Withdrawal|1|||
33372332|NCT03703375|101247770|FG000|Treatment Period|Death|1|||
33372333|NCT03703375|101247771|FG001|Treatment Period|Death|0|||
33372334|NCT03703375|101247772|FG002|Treatment Period|Death|1|||
33582365|NCT01194219|102020316|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33582366|NCT01194219|102020317|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33582367|NCT01194219|102020318|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33582368|NCT01194219|102020319|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33582369|NCT01194219|102020320|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33582370|NCT01194219|102020321|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
33582371|NCT01194219|102020322|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
33582372|NCT01194219|102020313|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33145367|NCT02431247|100445259|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
33145368|NCT02431247|100445260|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
33145369|NCT02431247|100445258|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
33145370|NCT02431247|100445259|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
33145371|NCT02431247|100445260|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
33145372|NCT02431247|100445258|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
33145373|NCT02431247|100445259|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
33145374|NCT02431247|100445260|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
33145375|NCT02431247|100445258|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
33145376|NCT02431247|100445259|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
33145377|NCT02431247|100445260|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
33145378|NCT02431247|100445258|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
33145379|NCT02431247|100445259|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
33145380|NCT02431247|100445260|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
33243200|NCT02138916|100791478|FG001|Overall Study|Death|11|||
33372335|NCT03703375|101247773|FG003|Treatment Period|Death|2|||
33372336|NCT03703375|101247770|FG000|Treatment Period|Toxicity of Study Treatment|2|||
33372337|NCT03703375|101247771|FG001|Treatment Period|Toxicity of Study Treatment|0|||
33422128|NCT02595528|101436989|FG003|Overall Study|Withdrawal by Subject|3|||
33643185|NCT00806819|102244322|FG000|Overall Study|Lost to Follow-up|1|||
33243201|NCT02138916|100791479|FG002|Overall Study|Death|12|||
33243202|NCT02138916|100791477|FG000|Overall Study|Withdrawal by Subject|27|||
33243203|NCT02138916|100791478|FG001|Overall Study|Withdrawal by Subject|31|||
33243204|NCT02138916|100791479|FG002|Overall Study|Withdrawal by Subject|32|||
33243205|NCT02138916|100791477|FG000|Overall Study|Study specific withdrawal criteria|0|||
33243206|NCT02138916|100791478|FG001|Overall Study|Study specific withdrawal criteria|0|||
33243207|NCT02138916|100791479|FG002|Overall Study|Study specific withdrawal criteria|1|||
33243208|NCT02138916|100791477|FG000|Overall Study|incorrect enrolment|1|||
33243209|NCT02138916|100791478|FG001|Overall Study|incorrect enrolment|1|||
33243210|NCT02138916|100791479|FG002|Overall Study|incorrect enrolment|0|||
33243211|NCT02138916|100791477|FG000|Overall Study|Severe non-compliance|1|||
33243212|NCT02138916|100791478|FG001|Overall Study|Severe non-compliance|2|||
33243213|NCT02138916|100791479|FG002|Overall Study|Severe non-compliance|1|||
33243214|NCT02138916|100791477|FG000|Overall Study|Lost to Follow-up|4|||
33243215|NCT02138916|100791478|FG001|Overall Study|Lost to Follow-up|2|||
33243216|NCT02138916|100791479|FG002|Overall Study|Lost to Follow-up|3|||
33643186|NCT00806819|102244323|FG001|Overall Study|Lost to Follow-up|0|||
33582373|NCT01194219|102020314|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33582374|NCT01194219|102020315|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33582375|NCT01194219|102020316|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33582376|NCT01194219|102020317|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33582377|NCT01194219|102020318|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33582378|NCT01194219|102020319|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33582379|NCT01194219|102020320|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
33582380|NCT01194219|102020321|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
33582381|NCT01194219|102020322|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
33582382|NCT03276728|102020325|FG000|Overall Study|Lost to Follow-up|0|||
33582383|NCT03276728|102020326|FG001|Overall Study|Lost to Follow-up|0|||
33582384|NCT03276728|102020327|FG002|Overall Study|Lost to Follow-up|2|||
33643187|NCT00806819|102244322|FG000|Overall Study|Withdrawal by Subject|32|||
33643188|NCT00806819|102244323|FG001|Overall Study|Withdrawal by Subject|29|||
33243217|NCT02138916|100791477|FG000|Overall Study|Adverse Event|4|||
33243218|NCT02138916|100791478|FG001|Overall Study|Adverse Event|4|||
33243219|NCT02138916|100791479|FG002|Overall Study|Adverse Event|3|||
33243220|NCT02153788|100791480|FG000|Overall Study|Physician Decision|2|||
33243221|NCT02153788|100791481|FG001|Overall Study|Physician Decision|1|||
33243222|NCT00797862|100791482|FG000|Overall Study|Adverse Event|86|||
33243223|NCT00797862|100791483|FG001|Overall Study|Adverse Event|44|||
33243224|NCT00797862|100791484|FG002|Overall Study|Adverse Event|58|||
33243225|NCT00797862|100791482|FG000|Overall Study|Abnormal Test Procedure Result|0|||
33243226|NCT00797862|100791483|FG001|Overall Study|Abnormal Test Procedure Result|1|||
33243227|NCT00797862|100791484|FG002|Overall Study|Abnormal Test Procedure Result|1|||
33243228|NCT00797862|100791482|FG000|Overall Study|Lack of Efficacy|1|||
33243229|NCT00797862|100791483|FG001|Overall Study|Lack of Efficacy|7|||
33372338|NCT03703375|101247772|FG002|Treatment Period|Toxicity of Study Treatment|4|||
33372339|NCT03703375|101247773|FG003|Treatment Period|Toxicity of Study Treatment|1|||
33372340|NCT03703375|101247770|FG000|Treatment Period|Progression|32|||
33582385|NCT03276728|102020328|FG003|Overall Study|Lost to Follow-up|2|||
33643189|NCT00806819|102244322|FG000|Overall Study|Not treated|6|||
33643190|NCT00806819|102244323|FG001|Overall Study|Not treated|3|||
33643191|NCT00806819|102244322|FG000|Overall Study|Reasons other than stated above|25|||
33643192|NCT00806819|102244323|FG001|Overall Study|Reasons other than stated above|41|||
33643193|NCT01379508|102244324|FG000|Treatment to Week 104|Adverse Event|2|||
33643194|NCT01379508|102244325|FG001|Treatment to Week 104|Adverse Event|0|||
33643195|NCT01379508|102244326|FG002|Treatment to Week 104|Adverse Event|5|||
33643196|NCT01379508|102244327|FG003|Treatment to Week 104|Adverse Event|0|||
33643197|NCT01379508|102244324|FG000|Treatment to Week 104|Abnormal lab value|1|||
33643198|NCT01379508|102244325|FG001|Treatment to Week 104|Abnormal lab value|0|||
33643199|NCT01379508|102244326|FG002|Treatment to Week 104|Abnormal lab value|0|||
33643200|NCT01379508|102244327|FG003|Treatment to Week 104|Abnormal lab value|0|||
33643201|NCT01379508|102244324|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
33582386|NCT03276728|102020329|FG004|Overall Study|Lost to Follow-up|0|||
33643202|NCT01379508|102244325|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
33145381|NCT02431247|100445258|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
33243230|NCT00797862|100791484|FG002|Overall Study|Lack of Efficacy|6|||
33243231|NCT00797862|100791482|FG000|Overall Study|No longer required study medication|1|||
33243232|NCT00797862|100791483|FG001|Overall Study|No longer required study medication|0|||
33243233|NCT00797862|100791484|FG002|Overall Study|No longer required study medication|0|||
33243234|NCT00797862|100791482|FG000|Overall Study|Withdrawal by Subject|14|||
33243235|NCT00797862|100791483|FG001|Overall Study|Withdrawal by Subject|7|||
33243236|NCT00797862|100791484|FG002|Overall Study|Withdrawal by Subject|7|||
33243237|NCT00797862|100791482|FG000|Overall Study|Lost to Follow-up|11|||
33243238|NCT00797862|100791483|FG001|Overall Study|Lost to Follow-up|0|||
33243239|NCT00797862|100791484|FG002|Overall Study|Lost to Follow-up|5|||
33243240|NCT00797862|100791482|FG000|Overall Study|Administrative Problem|4|||
33243241|NCT00797862|100791483|FG001|Overall Study|Administrative Problem|0|||
33243242|NCT00797862|100791484|FG002|Overall Study|Administrative Problem|0|||
33243243|NCT00797862|100791482|FG000|Overall Study|Protocol Violation|4|||
33243244|NCT00797862|100791483|FG001|Overall Study|Protocol Violation|6|||
33243245|NCT00797862|100791484|FG002|Overall Study|Protocol Violation|8|||
33243246|NCT00797862|100791482|FG000|Overall Study|Mis-randomized|3|||
33243247|NCT00797862|100791483|FG001|Overall Study|Mis-randomized|3|||
33243248|NCT00797862|100791484|FG002|Overall Study|Mis-randomized|1|||
33243249|NCT00462943|100791485|FG000|Overall Study|Failure to achieve a response|5|||
33243250|NCT00462943|100791486|FG001|Overall Study|Failure to achieve a response|5|||
33243251|NCT00462943|100791487|FG002|Overall Study|Failure to achieve a response|1|||
33243252|NCT00462943|100791485|FG000|Overall Study|Adverse Event|6|||
33243253|NCT00462943|100791486|FG001|Overall Study|Adverse Event|4|||
33243254|NCT00462943|100791487|FG002|Overall Study|Adverse Event|1|||
33243255|NCT00462943|100791485|FG000|Overall Study|Protocol Violation|1|||
33243256|NCT00462943|100791486|FG001|Overall Study|Protocol Violation|0|||
33243257|NCT00462943|100791487|FG002|Overall Study|Protocol Violation|0|||
33243258|NCT00462943|100791485|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
33243259|NCT00462943|100791486|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
33243260|NCT00462943|100791487|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
33243261|NCT00462943|100791485|FG000|Overall Study|Disease Progression|15|||
33243262|NCT00462943|100791486|FG001|Overall Study|Disease Progression|15|||
33243263|NCT00462943|100791487|FG002|Overall Study|Disease Progression|9|||
33243264|NCT00462943|100791485|FG000|Overall Study|Death|5|||
33243265|NCT00462943|100791486|FG001|Overall Study|Death|2|||
33243266|NCT00462943|100791487|FG002|Overall Study|Death|7|||
33243267|NCT00462943|100791485|FG000|Overall Study|Stem Cell Transplant|1|||
33243268|NCT00462943|100791486|FG001|Overall Study|Stem Cell Transplant|1|||
33243269|NCT00462943|100791487|FG002|Overall Study|Stem Cell Transplant|0|||
33243270|NCT00462943|100791485|FG000|Overall Study|Bone Marrow Transplant|1|||
33243271|NCT00462943|100791486|FG001|Overall Study|Bone Marrow Transplant|0|||
33243272|NCT00462943|100791487|FG002|Overall Study|Bone Marrow Transplant|0|||
33243273|NCT00462943|100791485|FG000|Overall Study|Required Lymphocyte Infusion|1|||
33243274|NCT00462943|100791486|FG001|Overall Study|Required Lymphocyte Infusion|0|||
33243275|NCT00462943|100791487|FG002|Overall Study|Required Lymphocyte Infusion|0|||
33243276|NCT00462943|100791485|FG000|Overall Study|Transplant - not specified|1|||
33243277|NCT00462943|100791486|FG001|Overall Study|Transplant - not specified|0|||
33243278|NCT00462943|100791487|FG002|Overall Study|Transplant - not specified|1|||
33243279|NCT00462943|100791485|FG000|Overall Study|Physician Decision|1|||
33243280|NCT00462943|100791486|FG001|Overall Study|Physician Decision|0|||
33243281|NCT00462943|100791487|FG002|Overall Study|Physician Decision|0|||
33243282|NCT00462943|100791485|FG000|Overall Study|Withdrawal by Subject|0|||
33243283|NCT00462943|100791486|FG001|Overall Study|Withdrawal by Subject|1|||
33243284|NCT00462943|100791487|FG002|Overall Study|Withdrawal by Subject|0|||
33243285|NCT00630864|100791499|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
33243286|NCT00630864|100791499|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
33243287|NCT01872611|100791500|FG000|Overall Study|Adverse Event|3|||
33243288|NCT01872611|100791501|FG001|Overall Study|Adverse Event|1|||
33243289|NCT01872611|100791500|FG000|Overall Study|Adverse Event, prior to treatment|0|||
33243290|NCT01872611|100791501|FG001|Overall Study|Adverse Event, prior to treatment|1|||
33243291|NCT01872611|100791500|FG000|Overall Study|Death|0|||
33243292|NCT01872611|100791501|FG001|Overall Study|Death|1|||
33243293|NCT01872611|100791500|FG000|Overall Study|Death, prior to treatment|0|||
33243294|NCT01872611|100791501|FG001|Overall Study|Death, prior to treatment|1|||
33243295|NCT01872611|100791500|FG000|Overall Study|Lost to Follow-up|8|||
33243296|NCT01872611|100791501|FG001|Overall Study|Lost to Follow-up|1|||
33243297|NCT01872611|100791500|FG000|Overall Study|Physician Decision|1|||
33243298|NCT01872611|100791501|FG001|Overall Study|Physician Decision|0|||
33243299|NCT01872611|100791500|FG000|Overall Study|Withdrawal by Subject|6|||
33243300|NCT01872611|100791501|FG001|Overall Study|Withdrawal by Subject|1|||
33243301|NCT01872611|100791500|FG000|Overall Study|Reason not provided|6|||
33243302|NCT01872611|100791501|FG001|Overall Study|Reason not provided|6|||
33243303|NCT00852475|100791505|FG000|Overall Study|Lost to Follow-up|3|||
33243304|NCT00852475|100791506|FG001|Overall Study|Lost to Follow-up|4|||
33372341|NCT03703375|101247771|FG001|Treatment Period|Progression|1|||
33372342|NCT03703375|101247772|FG002|Treatment Period|Progression|7|||
33372343|NCT03703375|101247773|FG003|Treatment Period|Progression|11|||
33372344|NCT03703375|101247770|FG000|Treatment Period|Completed treatment|7|||
33372345|NCT03703375|101247771|FG001|Treatment Period|Completed treatment|2|||
33372346|NCT03703375|101247772|FG002|Treatment Period|Completed treatment|0|||
33422129|NCT02595528|101436986|FG000|Overall Study|Lost to Follow-up|1|||
33243305|NCT00828945|100791508|FG000|Overall Study|Death|4|||
33243306|NCT00828945|100791508|FG000|Overall Study|Participant was missing|1|||
33243307|NCT00828945|100791508|FG000|Overall Study|Other|36|||
33243308|NCT01304147|100791519|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
33372347|NCT03703375|101247773|FG003|Treatment Period|Completed treatment|0|||
33243309|NCT01304147|100791520|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
33243310|NCT03487666|100791532|FG000|Overall Study|Disease progression|4|||
33243311|NCT03487666|100791533|FG001|Overall Study|Disease progression|2|||
33243312|NCT03487666|100791534|FG002|Overall Study|Disease progression|0|||
33243313|NCT03487666|100791532|FG000|Overall Study|Adverse Event|0|||
33243314|NCT03487666|100791533|FG001|Overall Study|Adverse Event|0|||
33243315|NCT03487666|100791534|FG002|Overall Study|Adverse Event|1|||
33243316|NCT02967692|100791535|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|3|||
33243317|NCT02967692|100791536|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|1|||
33243318|NCT02967692|100791537|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|86|||
33243319|NCT02967692|100791538|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date of 01-Jul-2020|82|||
33243320|NCT02967692|100791535|FG000|Overall Study|Progressive disease|3|||
33243321|NCT02967692|100791536|FG001|Overall Study|Progressive disease|15|||
33243322|NCT02967692|100791537|FG002|Overall Study|Progressive disease|99|||
33243323|NCT02967692|100791538|FG003|Overall Study|Progressive disease|128|||
33243324|NCT02967692|100791535|FG000|Overall Study|Subject/guardian decision|1|||
33243325|NCT02967692|100791536|FG001|Overall Study|Subject/guardian decision|1|||
33243326|NCT02967692|100791537|FG002|Overall Study|Subject/guardian decision|6|||
33243327|NCT02967692|100791538|FG003|Overall Study|Subject/guardian decision|13|||
33243328|NCT02967692|100791535|FG000|Overall Study|Death|0|||
33243329|NCT02967692|100791536|FG001|Overall Study|Death|1|||
33243330|NCT02967692|100791537|FG002|Overall Study|Death|10|||
33243331|NCT02967692|100791538|FG003|Overall Study|Death|9|||
33243332|NCT02967692|100791535|FG000|Overall Study|Protocol deviation|1|||
33243333|NCT02967692|100791536|FG001|Overall Study|Protocol deviation|0|||
33243334|NCT02967692|100791537|FG002|Overall Study|Protocol deviation|1|||
33243335|NCT02967692|100791538|FG003|Overall Study|Protocol deviation|1|||
33243336|NCT02967692|100791535|FG000|Overall Study|Lost to Follow-up|0|||
33243337|NCT02967692|100791536|FG001|Overall Study|Lost to Follow-up|0|||
33243338|NCT02967692|100791537|FG002|Overall Study|Lost to Follow-up|1|||
33243339|NCT02967692|100791538|FG003|Overall Study|Lost to Follow-up|0|||
33243340|NCT02967692|100791535|FG000|Overall Study|Physician Decision|0|||
33243341|NCT02967692|100791536|FG001|Overall Study|Physician Decision|0|||
33243342|NCT02967692|100791537|FG002|Overall Study|Physician Decision|13|||
33243343|NCT02967692|100791538|FG003|Overall Study|Physician Decision|9|||
33243344|NCT02967692|100791535|FG000|Overall Study|Adverse Event|1|||
33243345|NCT02967692|100791536|FG001|Overall Study|Adverse Event|9|||
33243346|NCT02967692|100791537|FG002|Overall Study|Adverse Event|51|||
33243347|NCT02967692|100791538|FG003|Overall Study|Adverse Event|23|||
33243348|NCT00832780|100791541|FG000|Overall Study|Death|16|||
33243349|NCT00832780|100791541|FG000|Overall Study|Lost to Follow-up|4|||
33243350|NCT00832780|100791541|FG000|Overall Study|no reason given|2|||
33243351|NCT00832780|100791541|FG000|Overall Study|other complicating condition|2|||
33243352|NCT00832780|100791541|FG000|Overall Study|Physician Decision|1|||
33243353|NCT05015478|100791545|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
33243354|NCT05015478|100791546|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
33243355|NCT05015478|100791547|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
33372348|NCT00305006|101247776|FG000|Overall Study|Withdrawal by Subject|1|||
33582387|NCT03276728|102020330|FG005|Overall Study|Lost to Follow-up|0|||
33582388|NCT03276728|102020331|FG006|Overall Study|Lost to Follow-up|0|||
33582389|NCT03276728|102020332|FG007|Overall Study|Lost to Follow-up|0|||
33582390|NCT03276728|102020325|FG000|Overall Study|Withdrawal by Subject|0|||
33582391|NCT03276728|102020326|FG001|Overall Study|Withdrawal by Subject|0|||
33582392|NCT03276728|102020327|FG002|Overall Study|Withdrawal by Subject|0|||
33582393|NCT03276728|102020328|FG003|Overall Study|Withdrawal by Subject|3|||
33582394|NCT03276728|102020329|FG004|Overall Study|Withdrawal by Subject|0|||
33582395|NCT03276728|102020330|FG005|Overall Study|Withdrawal by Subject|0|||
33582396|NCT03276728|102020331|FG006|Overall Study|Withdrawal by Subject|0|||
33582397|NCT03276728|102020332|FG007|Overall Study|Withdrawal by Subject|0|||
33582398|NCT03276728|102020325|FG000|Overall Study|Decision by sponsor|0|||
33582399|NCT03276728|102020326|FG001|Overall Study|Decision by sponsor|0|||
33582400|NCT03276728|102020327|FG002|Overall Study|Decision by sponsor|0|||
33243356|NCT05015478|100791548|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
33243357|NCT03115346|100791549|FG000|Overall Study|Did not have AAA surgery|28|||
33372349|NCT00305006|101247777|FG001|Overall Study|Withdrawal by Subject|0|||
33582401|NCT03276728|102020328|FG003|Overall Study|Decision by sponsor|0|||
33582402|NCT03276728|102020329|FG004|Overall Study|Decision by sponsor|1|||
33643203|NCT01379508|102244326|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
33582403|NCT03276728|102020330|FG005|Overall Study|Decision by sponsor|0|||
33243358|NCT03115346|100791550|FG001|Overall Study|Did not have AAA surgery|15|||
33243359|NCT03115346|100791549|FG000|Overall Study|Death|3|||
33243360|NCT03115346|100791550|FG001|Overall Study|Death|1|||
33243361|NCT03115346|100791549|FG000|Overall Study|Withdrawal by Subject|0|||
33243362|NCT03115346|100791550|FG001|Overall Study|Withdrawal by Subject|3|||
33243363|NCT03115346|100791549|FG000|Overall Study|Lost to Follow-up|0|||
33243364|NCT03115346|100791550|FG001|Overall Study|Lost to Follow-up|3|||
33422130|NCT02595528|101436987|FG001|Overall Study|Lost to Follow-up|1|||
33243365|NCT02256969|100791551|FG000|Overall Study|Screenfailed or withdrew|2|||
33243366|NCT02256969|100791552|FG001|Overall Study|Screenfailed or withdrew|1|||
33243367|NCT02256969|100791553|FG002|Overall Study|Screenfailed or withdrew|1|||
33243368|NCT04863898|100791555|FG000|Overall Study|Away from study clinic during intervention training period|2|||
33243369|NCT04863898|100791555|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
33243370|NCT04863898|100791555|FG000|Overall Study|Lost to Follow-up|3|||
33243371|NCT04863898|100791555|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
33243372|NCT04863898|100791555|FG000|Overall Study|No longer employed at clinic|3|||
33243373|NCT01093534|100791557|FG000|Overall Study|Adverse Event|2|||
33243374|NCT01093534|100791558|FG001|Overall Study|Adverse Event|5|||
33243375|NCT01093534|100791559|FG002|Overall Study|Adverse Event|2|||
33243376|NCT01093534|100791557|FG000|Overall Study|Lack of Efficacy|2|||
33243377|NCT01093534|100791558|FG001|Overall Study|Lack of Efficacy|1|||
33243378|NCT01093534|100791559|FG002|Overall Study|Lack of Efficacy|1|||
33243379|NCT01093534|100791557|FG000|Overall Study|Withdrawal by Subject|5|||
33243380|NCT01093534|100791558|FG001|Overall Study|Withdrawal by Subject|7|||
33243381|NCT01093534|100791559|FG002|Overall Study|Withdrawal by Subject|2|||
33243382|NCT01093534|100791557|FG000|Overall Study|Other|1|||
33243383|NCT01093534|100791558|FG001|Overall Study|Other|3|||
33243384|NCT01093534|100791559|FG002|Overall Study|Other|4|||
33243385|NCT01789203|100791560|FG000|Overall Study|Adverse Event|2|||
33243386|NCT01789203|100791561|FG001|Overall Study|Adverse Event|2|||
33243387|NCT01789203|100791560|FG000|Overall Study|Withdrawal by Subject|1|||
33243388|NCT01789203|100791561|FG001|Overall Study|Withdrawal by Subject|0|||
33243389|NCT01789203|100791560|FG000|Overall Study|Death|1|||
33243390|NCT01789203|100791561|FG001|Overall Study|Death|0|||
33243391|NCT01789203|100791560|FG000|Overall Study|Protocol Violation|2|||
33243392|NCT01789203|100791561|FG001|Overall Study|Protocol Violation|1|||
33243393|NCT01789203|100791560|FG000|Overall Study|Other|1|||
33243394|NCT01789203|100791561|FG001|Overall Study|Other|1|||
33243395|NCT01789203|100791560|FG000|Overall Study|patient non-adherent|2|||
33243396|NCT01789203|100791561|FG001|Overall Study|patient non-adherent|0|||
33243397|NCT04523181|100791562|FG000|Overall Study|Withdrawal by Subject|4|||
33243398|NCT04523181|100791563|FG001|Overall Study|Withdrawal by Subject|5|||
33243399|NCT04523181|100791562|FG000|Overall Study|Lost to Follow-up|2|||
33243400|NCT04523181|100791563|FG001|Overall Study|Lost to Follow-up|3|||
33243401|NCT04523181|100791562|FG000|Overall Study|Physician Decision|1|||
33243402|NCT04523181|100791563|FG001|Overall Study|Physician Decision|0|||
33243403|NCT04523181|100791562|FG000|Overall Study|Transferred to external facility.|1|||
33243404|NCT04523181|100791563|FG001|Overall Study|Transferred to external facility.|1|||
33243405|NCT00052962|100791566|FG000|Overall Study|Not evaluable|0|||
33243406|NCT00052962|100791567|FG001|Overall Study|Not evaluable|2|||
33243407|NCT00052962|100791566|FG000|Overall Study|Not randomized/not evaluable|1|||
33243408|NCT00052962|100791567|FG001|Overall Study|Not randomized/not evaluable|0|||
33243409|NCT00490555|100791572|FG000|Overall Study|noncompliant with drug administration|0|||
33243410|NCT00490555|100791573|FG001|Overall Study|noncompliant with drug administration|0|||
33243411|NCT00490555|100791574|FG002|Overall Study|noncompliant with drug administration|2|||
33243412|NCT00490555|100791575|FG003|Overall Study|noncompliant with drug administration|0|||
33243413|NCT02616263|100791577|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
33243414|NCT02616263|100791578|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
33243415|NCT02616263|100791577|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
33243416|NCT02616263|100791578|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
33422131|NCT02595528|101436988|FG002|Overall Study|Lost to Follow-up|0|||
33422132|NCT02595528|101436989|FG003|Overall Study|Lost to Follow-up|1|||
33422133|NCT02072174|101436990|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
33422134|NCT02072174|101436991|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
33582404|NCT03276728|102020331|FG006|Overall Study|Decision by sponsor|2|||
33145382|NCT02431247|100445259|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
33582405|NCT03276728|102020332|FG007|Overall Study|Decision by sponsor|1|||
33582406|NCT03981744|102022605|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
33582407|NCT03981744|102022606|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
33582408|NCT03981744|102022607|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
33145383|NCT02431247|100445260|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
33243417|NCT02616263|100791577|FG000|6 Month to 1.5 Year|Death|1|||
33243418|NCT02616263|100791578|FG001|6 Month to 1.5 Year|Death|0|||
33422135|NCT02072174|101436990|FG000|Overall Study|Protocol Violation|16|||
33422136|NCT02072174|101436991|FG001|Overall Study|Protocol Violation|23|||
33145384|NCT02431247|100445258|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
33145385|NCT02431247|100445259|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
33145386|NCT02431247|100445260|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
33243419|NCT02616263|100791577|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
33243420|NCT02616263|100791578|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
33243421|NCT02616263|100791577|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
33422137|NCT02072174|101436990|FG000|Overall Study|Physician Decision|0|||
33422138|NCT02072174|101436991|FG001|Overall Study|Physician Decision|1|||
33422139|NCT02072174|101436990|FG000|Overall Study|Non-compliance with protocol requirement|2|||
33422140|NCT02072174|101436991|FG001|Overall Study|Non-compliance with protocol requirement|0|||
33422141|NCT01355523|101436992|FG000|Overall Study|Withdrawal by Subject|1|||
33243422|NCT02616263|100791578|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
33243423|NCT02616263|100791577|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
33243424|NCT02616263|100791578|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
33422142|NCT01355523|101436993|FG001|Overall Study|Withdrawal by Subject|4|||
33582409|NCT03981744|102022608|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
33582410|NCT03981744|102022605|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
33582411|NCT03981744|102022606|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
33582412|NCT03981744|102022607|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
33582413|NCT03981744|102022608|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
33582414|NCT03981744|102022605|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
33582415|NCT03981744|102022606|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
33582416|NCT03981744|102022607|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
33582417|NCT03981744|102022608|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
33243425|NCT01636362|100791579|FG000|Overall Study|Physician Decision|6|||
33243426|NCT01636362|100791579|FG000|Overall Study|Subject healed, not returning|1|||
33243427|NCT01636362|100791579|FG000|Overall Study|Withdrawal by Subject|1|||
33243428|NCT04213846|100791580|FG000|Overall Study|Withdrawal by Subject|7|||
33243429|NCT04213846|100791581|FG001|Overall Study|Withdrawal by Subject|6|||
33582418|NCT02413996|102022609|FG000|Overall Study|not comfortable with the intervention|9|||
33582419|NCT02413996|102022610|FG001|Overall Study|not comfortable with the intervention|2|||
33582420|NCT06164691|102022612|FG000|Overall Study|Withdrawal by Subject|2|||
33582421|NCT06164691|102022613|FG001|Overall Study|Withdrawal by Subject|0|||
33243430|NCT04213846|100791580|FG000|Overall Study|Lost to Follow-up|15|||
33243431|NCT04213846|100791581|FG001|Overall Study|Lost to Follow-up|21|||
33243432|NCT03905135|100791584|FG000|Dose Escalation|Adverse Event|1|||
33243433|NCT03905135|100791585|FG001|Dose Escalation|Adverse Event|1|||
33243434|NCT03905135|100791584|FG000|Dose Escalation|Progressive disease|3|||
33243435|NCT03905135|100791585|FG001|Dose Escalation|Progressive disease|1|||
33243436|NCT03905135|100791584|FG000|Dose Escalation|Intercurrent illness|1|||
33243437|NCT03905135|100791585|FG001|Dose Escalation|Intercurrent illness|0|||
33243438|NCT03566680|100791586|FG000|Overall Study|Pregnancy|1|||
33243439|NCT03566680|100791586|FG000|Overall Study|Lost to Follow-up|13|||
33243440|NCT03566680|100791586|FG000|Overall Study|Withdrawal by Subject|3|||
33243441|NCT02775435|100791587|FG000|Overall Study|Adverse Event|32|||
33243442|NCT02775435|100791588|FG001|Overall Study|Adverse Event|27|||
33243443|NCT02775435|100791587|FG000|Overall Study|Lost to Follow-up|2|||
33243444|NCT02775435|100791588|FG001|Overall Study|Lost to Follow-up|2|||
33243445|NCT02775435|100791587|FG000|Overall Study|Sponsor decision|44|||
33243446|NCT02775435|100791588|FG001|Overall Study|Sponsor decision|19|||
33243447|NCT02775435|100791587|FG000|Overall Study|Withdrawal by Subject|4|||
33243448|NCT02775435|100791588|FG001|Overall Study|Withdrawal by Subject|9|||
33243449|NCT02775435|100791587|FG000|Overall Study|Death|196|||
33243450|NCT02775435|100791588|FG001|Overall Study|Death|224|||
33243451|NCT00945477|100791590|FG000|Overall Study|Adverse Event|3|||
33243452|NCT00945477|100791590|FG000|Overall Study|Lack of Efficacy|2|||
33243453|NCT00945477|100791590|FG000|Overall Study|Withdrawal by Subject|1|||
33243454|NCT05567159|100791591|FG000|Overall Study|Adverse Event|4|||
33372350|NCT00305006|101247776|FG000|Overall Study|Failure to complete pretest|0|||
33372351|NCT00305006|101247777|FG001|Overall Study|Failure to complete pretest|1|||
33372352|NCT00101192|101247778|FG000|Overall Study|Ineligible|6|||
33372353|NCT00101192|101247778|FG000|Overall Study|Inevaluable|1|||
33372354|NCT01423617|101251812|FG000|Overall Study|Lost to Follow-up|0|||
33372355|NCT01423617|101251813|FG001|Overall Study|Lost to Follow-up|1|||
33372356|NCT01005719|101251816|FG000|Period 1|Adverse Event|0|||
33372357|NCT01005719|101251817|FG001|Period 1|Adverse Event|0|||
33372358|NCT01005719|101251818|FG002|Period 1|Adverse Event|0|||
33372359|NCT01005719|101251819|FG003|Period 1|Adverse Event|1|||
33372360|NCT01005719|101251820|FG004|Period 1|Adverse Event|0|||
33372361|NCT01005719|101251821|FG005|Period 1|Adverse Event|0|||
33372362|NCT01005719|101251816|FG000|Period 1|Delay in completing study procedures|0|||
33372363|NCT01005719|101251817|FG001|Period 1|Delay in completing study procedures|0|||
33422143|NCT01355523|101436992|FG000|Overall Study|Lost to Follow-up|0|||
33243455|NCT05567159|100791591|FG000|Overall Study|Physician Decision|3|||
33243456|NCT05567159|100791591|FG000|Overall Study|Protocol deviation|1|||
33372364|NCT01005719|101251818|FG002|Period 1|Delay in completing study procedures|0|||
33422144|NCT01355523|101436993|FG001|Overall Study|Lost to Follow-up|2|||
33243457|NCT01174550|100791592|FG000|Overall Study|Death|75|||
33243458|NCT01174550|100791593|FG001|Overall Study|Death|74|||
33582422|NCT06164691|102022614|FG002|Overall Study|Withdrawal by Subject|0|||
33243459|NCT01174550|100791592|FG000|Overall Study|Lost to Follow-up|652|||
33372365|NCT01005719|101251819|FG003|Period 1|Delay in completing study procedures|0|||
33243460|NCT01174550|100791593|FG001|Overall Study|Lost to Follow-up|510|||
33243461|NCT01174550|100791592|FG000|Overall Study|Withdrawal by Subject|543|||
33582423|NCT00984594|102022616|FG000|Overall Study|Lost to Follow-up|1|||
33582424|NCT00984594|102022617|FG001|Overall Study|Lost to Follow-up|0|||
33582425|NCT00984594|102022616|FG000|Overall Study|Withdrawal by Subject|0|||
33582426|NCT00984594|102022617|FG001|Overall Study|Withdrawal by Subject|1|||
33582427|NCT00709319|102022623|FG000|Overall Study|Death|4|||
33582428|NCT00709319|102022623|FG000|Overall Study|Withdrawal by Subject|2|||
33422145|NCT01355523|101436992|FG000|Overall Study|Protocol Violation|0|||
33422146|NCT01355523|101436993|FG001|Overall Study|Protocol Violation|2|||
33422147|NCT01355523|101436992|FG000|Overall Study|Adverse Event|0|||
33422148|NCT01355523|101436993|FG001|Overall Study|Adverse Event|2|||
33422149|NCT00084617|101436994|FG000|Overall Study|Withdrawal by Subject|7|||
33422150|NCT00084617|101436994|FG000|Overall Study|Lack of Efficacy|1|||
33422151|NCT00084617|101436994|FG000|Overall Study|Protocol Violation|1|||
33422152|NCT03634488|101436995|FG000|Overall Study|Death|1|||
33422153|NCT03634488|101436996|FG001|Overall Study|Death|0|||
33422154|NCT03634488|101436997|FG002|Overall Study|Death|0|||
33422155|NCT03634488|101436995|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
33422156|NCT03634488|101436996|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
33422157|NCT03634488|101436997|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
33422158|NCT01749033|101437001|FG000|Overall Study|Did not receive allocated intervention|3|||
33422159|NCT01749033|101437002|FG001|Overall Study|Did not receive allocated intervention|3|||
33422160|NCT01749033|101437003|FG002|Overall Study|Did not receive allocated intervention|0|||
33422161|NCT01749033|101437001|FG000|Overall Study|Lost to Follow-up|0|||
33422162|NCT01749033|101437002|FG001|Overall Study|Lost to Follow-up|2|||
33422163|NCT01749033|101437003|FG002|Overall Study|Lost to Follow-up|1|||
33422164|NCT04247594|101437004|FG000|Overall Study|Withdrawal by Subject|4|||
33243462|NCT01174550|100791593|FG001|Overall Study|Withdrawal by Subject|289|||
33243463|NCT02892409|100791594|FG000|Overall Study|Adverse Event|1|||
33243464|NCT02892409|100791595|FG001|Overall Study|Adverse Event|0|||
33243465|NCT02892409|100791594|FG000|Overall Study|Withdrawal by Subject|2|||
33243466|NCT02892409|100791595|FG001|Overall Study|Withdrawal by Subject|1|||
33243467|NCT01648283|100791596|FG000|Overall Study|Withdrawal by Subject|14|||
33243468|NCT01143077|100791602|FG000|Overall Study|Lack of Efficacy|0|||
33243469|NCT01143077|100791603|FG001|Overall Study|Lack of Efficacy|2|||
33422165|NCT00569231|101437007|FG000|Overall Study|Study unrelated surgery|1|||
33422166|NCT00569231|101437007|FG000|Overall Study|Airfare expense|2|||
33582429|NCT03472495|102022625|FG000|Overall Study|Treatment no longer indicated|1|||
33582430|NCT03472495|102022626|FG001|Overall Study|Treatment no longer indicated|2|||
33582431|NCT03472495|102022625|FG000|Overall Study|Physician Decision|0|||
33582432|NCT03472495|102022626|FG001|Overall Study|Physician Decision|2|||
33582433|NCT02151903|102022629|FG000|Overall Study|Withdrawal by Subject|1|||
33582434|NCT02151903|102022630|FG001|Overall Study|Withdrawal by Subject|0|||
33582435|NCT02151903|102022629|FG000|Overall Study|Progressive disease|2|||
33582436|NCT02151903|102022630|FG001|Overall Study|Progressive disease|1|||
33582437|NCT00690430|102022631|FG000|Core Phase|Abnormal Laboratory value|0|||
33582438|NCT00690430|102022632|FG001|Core Phase|Abnormal Laboratory value|1|||
33582439|NCT00690430|102022633|FG002|Core Phase|Abnormal Laboratory value|0|||
33582440|NCT00690430|102022631|FG000|Core Phase|Adverse Event|5|||
33145387|NCT02431247|100445258|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
33243470|NCT01143077|100791604|FG002|Overall Study|Lack of Efficacy|1|||
33243471|NCT01143077|100791602|FG000|Overall Study|Adverse Event|5|||
33243472|NCT01143077|100791603|FG001|Overall Study|Adverse Event|6|||
33243473|NCT01143077|100791604|FG002|Overall Study|Adverse Event|5|||
33243474|NCT01143077|100791602|FG000|Overall Study|Lost to Follow-up|2|||
33243475|NCT01143077|100791603|FG001|Overall Study|Lost to Follow-up|3|||
33243476|NCT01143077|100791604|FG002|Overall Study|Lost to Follow-up|4|||
33243477|NCT01143077|100791602|FG000|Overall Study|Protocol Violation|2|||
33243478|NCT01143077|100791603|FG001|Overall Study|Protocol Violation|0|||
33243479|NCT01143077|100791604|FG002|Overall Study|Protocol Violation|0|||
33243480|NCT01143077|100791602|FG000|Overall Study|Withdrawal by Subject|4|||
33243481|NCT01143077|100791603|FG001|Overall Study|Withdrawal by Subject|3|||
33243482|NCT01143077|100791604|FG002|Overall Study|Withdrawal by Subject|3|||
33243483|NCT01143077|100791602|FG000|Overall Study|Non-compliance with study drug|0|||
33422167|NCT00569231|101437007|FG000|Overall Study|Withdrawal by Subject|1|||
33422168|NCT00569231|101437007|FG000|Overall Study|Car accident injury|1|||
33422169|NCT00569231|101437007|FG000|Overall Study|Non-compliance|2|||
33582441|NCT00690430|102022632|FG001|Core Phase|Adverse Event|1|||
33243484|NCT01143077|100791603|FG001|Overall Study|Non-compliance with study drug|1|||
33582442|NCT00690430|102022633|FG002|Core Phase|Adverse Event|0|||
33582443|NCT00690430|102022631|FG000|Core Phase|Death|0|||
33582444|NCT00690430|102022632|FG001|Core Phase|Death|2|||
33582445|NCT00690430|102022633|FG002|Core Phase|Death|0|||
33582446|NCT00690430|102022631|FG000|Core Phase|Protocol Violation|1|||
33243485|NCT01143077|100791604|FG002|Overall Study|Non-compliance with study drug|1|||
33582447|NCT00690430|102022632|FG001|Core Phase|Protocol Violation|0|||
33422170|NCT00931385|101437013|FG000|Overall Study|Adverse Event|2|||
33422171|NCT00931385|101437014|FG001|Overall Study|Adverse Event|1|||
33422172|NCT00931385|101437015|FG002|Overall Study|Adverse Event|0|||
33422173|NCT00931385|101437016|FG003|Overall Study|Adverse Event|3|||
33422174|NCT00931385|101437013|FG000|Overall Study|Protocol Violation|0|||
33643204|NCT01379508|102244327|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
33422175|NCT00931385|101437014|FG001|Overall Study|Protocol Violation|0|||
33422176|NCT00931385|101437015|FG002|Overall Study|Protocol Violation|1|||
33422177|NCT00931385|101437016|FG003|Overall Study|Protocol Violation|0|||
33422178|NCT00931385|101437013|FG000|Overall Study|Withdrawal by Subject|0|||
33422179|NCT00931385|101437014|FG001|Overall Study|Withdrawal by Subject|1|||
33422180|NCT00931385|101437015|FG002|Overall Study|Withdrawal by Subject|0|||
33422181|NCT00931385|101437016|FG003|Overall Study|Withdrawal by Subject|1|||
33422182|NCT00931385|101437013|FG000|Overall Study|Lost to Follow-up|0|||
33422183|NCT00931385|101437014|FG001|Overall Study|Lost to Follow-up|0|||
33422184|NCT00931385|101437015|FG002|Overall Study|Lost to Follow-up|0|||
33422185|NCT00931385|101437016|FG003|Overall Study|Lost to Follow-up|1|||
33422186|NCT04056299|101437017|FG000|Overall Study|Sponsor discontinued study|3|||
33422187|NCT04056299|101437018|FG001|Overall Study|Sponsor discontinued study|3|||
33422188|NCT04385199|101437019|FG000|Overall Study|Withdrawal by Subject|1|||
33422189|NCT04385199|101437020|FG001|Overall Study|Withdrawal by Subject|0|||
33422190|NCT01358708|101437021|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
33643205|NCT01379508|102244324|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
33643206|NCT01379508|102244325|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
33643207|NCT01379508|102244326|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
33643208|NCT01379508|102244327|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
33643209|NCT01379508|102244324|FG000|Treatment to Week 104|Lost to Follow-up|5|||
33643210|NCT01379508|102244325|FG001|Treatment to Week 104|Lost to Follow-up|0|||
33243486|NCT01143077|100791602|FG000|Overall Study|Administrative|1|||
33243487|NCT01143077|100791603|FG001|Overall Study|Administrative|0|||
33243488|NCT01143077|100791604|FG002|Overall Study|Administrative|0|||
33243489|NCT01143077|100791602|FG000|Overall Study|Principal Investigator Decision|2|||
33243490|NCT01143077|100791603|FG001|Overall Study|Principal Investigator Decision|0|||
33243491|NCT01143077|100791604|FG002|Overall Study|Principal Investigator Decision|1|||
33243492|NCT04739423|100791605|FG000|Overall Study|Protocol Violation|0|||
33243493|NCT04739423|100791606|FG001|Overall Study|Protocol Violation|1|||
33243494|NCT04739423|100791607|FG002|Overall Study|Protocol Violation|0|||
33243495|NCT04739423|100791608|FG003|Overall Study|Protocol Violation|0|||
33243496|NCT04739423|100791609|FG004|Overall Study|Protocol Violation|0|||
33243497|NCT04739423|100791610|FG005|Overall Study|Protocol Violation|0|||
33243498|NCT04739423|100791605|FG000|Overall Study|Adverse Event|0|||
33243499|NCT04739423|100791606|FG001|Overall Study|Adverse Event|0|||
33243500|NCT04739423|100791607|FG002|Overall Study|Adverse Event|1|||
33243501|NCT04739423|100791608|FG003|Overall Study|Adverse Event|0|||
33243502|NCT04739423|100791609|FG004|Overall Study|Adverse Event|1|||
33243503|NCT04739423|100791610|FG005|Overall Study|Adverse Event|0|||
33243504|NCT04739423|100791605|FG000|Overall Study|Withdrawal by Subject|0|||
33243505|NCT04739423|100791606|FG001|Overall Study|Withdrawal by Subject|0|||
33243506|NCT04739423|100791607|FG002|Overall Study|Withdrawal by Subject|0|||
33243507|NCT04739423|100791608|FG003|Overall Study|Withdrawal by Subject|0|||
33243508|NCT04739423|100791609|FG004|Overall Study|Withdrawal by Subject|0|||
33243509|NCT04739423|100791610|FG005|Overall Study|Withdrawal by Subject|1|||
33243510|NCT04580407|100791611|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
33243511|NCT02790606|100791612|FG000|Overall Study|Death|27|||
33243512|NCT02790606|100791612|FG000|Overall Study|Lost to Follow-up|4|||
33243513|NCT02790606|100791612|FG000|Overall Study|Physician Decision|3|||
33243514|NCT02790606|100791612|FG000|Overall Study|Withdrawal by Subject|1|||
33243515|NCT05355805|100791613|FG000|Overall Study|Lost to Follow-up|6|||
33243516|NCT05355805|100791614|FG001|Overall Study|Lost to Follow-up|5|||
33243517|NCT05355805|100791615|FG002|Overall Study|Lost to Follow-up|6|||
33243518|NCT05355805|100791616|FG003|Overall Study|Lost to Follow-up|2|||
33243519|NCT05355805|100791613|FG000|Overall Study|Decision by Sponsor|0|||
33643211|NCT01379508|102244326|FG002|Treatment to Week 104|Lost to Follow-up|3|||
33243520|NCT05355805|100791614|FG001|Overall Study|Decision by Sponsor|0|||
33243521|NCT05355805|100791615|FG002|Overall Study|Decision by Sponsor|0|||
33243522|NCT05355805|100791616|FG003|Overall Study|Decision by Sponsor|1|||
33243523|NCT05355805|100791613|FG000|Overall Study|Withdrawal by Subject|7|||
33243524|NCT05355805|100791614|FG001|Overall Study|Withdrawal by Subject|10|||
33243525|NCT05355805|100791615|FG002|Overall Study|Withdrawal by Subject|9|||
33643212|NCT01379508|102244327|FG003|Treatment to Week 104|Lost to Follow-up|0|||
33243526|NCT05355805|100791616|FG003|Overall Study|Withdrawal by Subject|2|||
33243527|NCT05355805|100791613|FG000|Overall Study|Missing|0|||
33243528|NCT05355805|100791614|FG001|Overall Study|Missing|0|||
33422191|NCT01358708|101437022|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33422192|NCT01358708|101437021|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
33422193|NCT01358708|101437022|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
33422194|NCT03471182|101437025|FG000|Overall Study|Withdrawal by Subject|1|||
33145388|NCT02431247|100445259|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
33145389|NCT02431247|100445260|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
33145390|NCT02431247|100445258|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
33145391|NCT02431247|100445259|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
33145392|NCT02431247|100445260|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
33145393|NCT01569464|100445264|FG000|Overall Study|Adverse Event|4|||
33145394|NCT01569464|100445265|FG001|Overall Study|Adverse Event|0|||
33145395|NCT01569464|100445264|FG000|Overall Study|Lack of Efficacy|1|||
33145396|NCT01569464|100445265|FG001|Overall Study|Lack of Efficacy|0|||
33145397|NCT01569464|100445264|FG000|Overall Study|Protocol Violation|1|||
33145398|NCT01569464|100445265|FG001|Overall Study|Protocol Violation|0|||
33145399|NCT01569464|100445264|FG000|Overall Study|Lost to Follow-up|2|||
33145400|NCT01569464|100445265|FG001|Overall Study|Lost to Follow-up|3|||
33145401|NCT01569464|100445264|FG000|Overall Study|Withdrawal by Subject|1|||
33145402|NCT01569464|100445265|FG001|Overall Study|Withdrawal by Subject|1|||
33145403|NCT01569464|100445264|FG000|Overall Study|Other|1|||
33145404|NCT01569464|100445265|FG001|Overall Study|Other|1|||
33145405|NCT01255787|100445266|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
33145406|NCT01255787|100445267|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
33145407|NCT01255787|100445268|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
33145408|NCT01255787|100445269|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
33145409|NCT01255787|100445266|FG000|Overall Study|Major Protocol Deviation|1|||
33145410|NCT01255787|100445267|FG001|Overall Study|Major Protocol Deviation|1|||
33145411|NCT01255787|100445268|FG002|Overall Study|Major Protocol Deviation|0|||
33145412|NCT01255787|100445269|FG003|Overall Study|Major Protocol Deviation|4|||
33145413|NCT01255787|100445266|FG000|Overall Study|Lost to Follow-up|1|||
33145414|NCT01255787|100445267|FG001|Overall Study|Lost to Follow-up|2|||
33145415|NCT01255787|100445268|FG002|Overall Study|Lost to Follow-up|4|||
33145416|NCT01255787|100445269|FG003|Overall Study|Lost to Follow-up|2|||
33145417|NCT01255787|100445266|FG000|Overall Study|Withdrawal of Consent|3|||
33145418|NCT01255787|100445267|FG001|Overall Study|Withdrawal of Consent|9|||
33145419|NCT01255787|100445268|FG002|Overall Study|Withdrawal of Consent|3|||
33145420|NCT01255787|100445269|FG003|Overall Study|Withdrawal of Consent|4|||
33145421|NCT01255787|100445266|FG000|Overall Study|Pregnancy|0|||
33243529|NCT05355805|100791615|FG002|Overall Study|Missing|1|||
33243530|NCT05355805|100791616|FG003|Overall Study|Missing|0|||
33582448|NCT00690430|102022633|FG002|Core Phase|Protocol Violation|0|||
33582449|NCT00690430|102022631|FG000|Core Phase|Withdrawal by Subject|3|||
33582450|NCT00690430|102022632|FG001|Core Phase|Withdrawal by Subject|3|||
33582451|NCT00690430|102022633|FG002|Core Phase|Withdrawal by Subject|0|||
33582452|NCT00690430|102022631|FG000|Core Phase|Subject no longer requires study drug|1|||
33582453|NCT00690430|102022632|FG001|Core Phase|Subject no longer requires study drug|0|||
33582454|NCT00690430|102022633|FG002|Core Phase|Subject no longer requires study drug|0|||
33582455|NCT00690430|102022631|FG000|Core Phase|Lack of Efficacy|8|||
33582456|NCT00690430|102022632|FG001|Core Phase|Lack of Efficacy|10|||
33582457|NCT00690430|102022633|FG002|Core Phase|Lack of Efficacy|0|||
33582458|NCT00690430|102022631|FG000|Core Phase|Administrative Problems|0|||
33582459|NCT00690430|102022632|FG001|Core Phase|Administrative Problems|1|||
33582460|NCT00690430|102022633|FG002|Core Phase|Administrative Problems|0|||
33582461|NCT00690430|102022631|FG000|Core Phase|Early Termination|0|||
33582462|NCT00690430|102022632|FG001|Core Phase|Early Termination|5|||
33582463|NCT00690430|102022633|FG002|Core Phase|Early Termination|0|||
33582464|NCT00690430|102022631|FG000|Extension Phase|Lack of Efficacy|3|||
33582465|NCT00690430|102022632|FG001|Extension Phase|Lack of Efficacy|1|||
33582466|NCT00690430|102022633|FG002|Extension Phase|Lack of Efficacy|4|||
33582467|NCT00690430|102022631|FG000|Extension Phase|Abnormal Lab Values|1|||
33582468|NCT00690430|102022632|FG001|Extension Phase|Abnormal Lab Values|0|||
33582469|NCT00690430|102022633|FG002|Extension Phase|Abnormal Lab Values|0|||
33582470|NCT00690430|102022631|FG000|Extension Phase|Abnormal test procedure results|1|||
33582471|NCT00690430|102022632|FG001|Extension Phase|Abnormal test procedure results|0|||
33582472|NCT00690430|102022633|FG002|Extension Phase|Abnormal test procedure results|0|||
33582473|NCT00690430|102022631|FG000|Extension Phase|Administrative Problems|0|||
33582474|NCT00690430|102022632|FG001|Extension Phase|Administrative Problems|1|||
33582475|NCT00690430|102022633|FG002|Extension Phase|Administrative Problems|1|||
33582476|NCT00690430|102022631|FG000|Extension Phase|Adverse Event|2|||
33582477|NCT00690430|102022632|FG001|Extension Phase|Adverse Event|1|||
33145422|NCT01255787|100445267|FG001|Overall Study|Pregnancy|0|||
33145423|NCT01255787|100445268|FG002|Overall Study|Pregnancy|0|||
33145424|NCT01255787|100445269|FG003|Overall Study|Pregnancy|1|||
33145425|NCT01255787|100445266|FG000|Overall Study|Lack of Efficacy|2|||
33145426|NCT01255787|100445267|FG001|Overall Study|Lack of Efficacy|2|||
33145427|NCT01255787|100445268|FG002|Overall Study|Lack of Efficacy|2|||
33145428|NCT01255787|100445269|FG003|Overall Study|Lack of Efficacy|2|||
33145429|NCT01255787|100445266|FG000|Overall Study|Noncompliance with Study Drug|3|||
33145430|NCT01255787|100445267|FG001|Overall Study|Noncompliance with Study Drug|1|||
33243531|NCT05355805|100791613|FG000|Overall Study|Ongoing|0|||
33582478|NCT00690430|102022633|FG002|Extension Phase|Adverse Event|2|||
33422195|NCT03471182|101437026|FG001|Overall Study|Withdrawal by Subject|1|||
33643213|NCT01379508|102244324|FG000|Treatment to Week 104|Administrative problems|3|||
33643214|NCT01379508|102244325|FG001|Treatment to Week 104|Administrative problems|1|||
33372366|NCT01005719|101251820|FG004|Period 1|Delay in completing study procedures|0|||
33145431|NCT01255787|100445268|FG002|Overall Study|Noncompliance with Study Drug|0|||
33145432|NCT01255787|100445269|FG003|Overall Study|Noncompliance with Study Drug|0|||
33145433|NCT00745615|100445271|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
33145434|NCT00745615|100445272|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
33145435|NCT00745615|100445273|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
33145436|NCT00745615|100445274|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
33145437|NCT00745615|100445275|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
33145438|NCT00745615|100445276|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
33145439|NCT00745615|100445271|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
33145440|NCT00745615|100445272|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
33145441|NCT00745615|100445273|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
33145442|NCT00745615|100445274|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
33145443|NCT00745615|100445275|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
33145444|NCT00745615|100445276|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
33145445|NCT00745615|100445271|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
33145446|NCT00745615|100445272|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
33145447|NCT00745615|100445273|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
33145448|NCT00745615|100445274|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
33145449|NCT00745615|100445275|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
33145450|NCT00745615|100445276|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
33145451|NCT00745615|100445271|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
33145452|NCT00745615|100445272|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
33145453|NCT00745615|100445273|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
33145454|NCT00745615|100445274|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
33145455|NCT00745615|100445275|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
33145456|NCT00745615|100445276|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
33145457|NCT00745615|100445271|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
33145458|NCT00745615|100445272|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
33372367|NCT01005719|101251821|FG005|Period 1|Delay in completing study procedures|1|||
33372368|NCT01005719|101251816|FG000|Period 2|Adverse Event|0|||
33372369|NCT01005719|101251817|FG001|Period 2|Adverse Event|0|||
33372370|NCT01005719|101251818|FG002|Period 2|Adverse Event|0|||
33372371|NCT01005719|101251819|FG003|Period 2|Adverse Event|0|||
33372372|NCT01005719|101251820|FG004|Period 2|Adverse Event|1|||
33372373|NCT01005719|101251821|FG005|Period 2|Adverse Event|1|||
33582479|NCT00690430|102022631|FG000|Extension Phase|Death|1|||
33582480|NCT00690430|102022632|FG001|Extension Phase|Death|1|||
33582481|NCT00690430|102022633|FG002|Extension Phase|Death|1|||
33582482|NCT00690430|102022631|FG000|Extension Phase|Withdrawal by Subject|0|||
33582483|NCT00690430|102022632|FG001|Extension Phase|Withdrawal by Subject|0|||
33582484|NCT00690430|102022633|FG002|Extension Phase|Withdrawal by Subject|2|||
33582485|NCT00690430|102022631|FG000|Extension Phase|Early Termination|10|||
33643215|NCT01379508|102244326|FG002|Treatment to Week 104|Administrative problems|0|||
33643216|NCT01379508|102244327|FG003|Treatment to Week 104|Administrative problems|0|||
33643217|NCT01379508|102244324|FG000|Treatment to Week 104|Protocol Violation|1|||
33582486|NCT00690430|102022632|FG001|Extension Phase|Early Termination|1|||
33582487|NCT00690430|102022633|FG002|Extension Phase|Early Termination|3|||
33582488|NCT01253369|102022634|FG000|Overall Study|Adverse Event|4|||
33582489|NCT01253369|102022634|FG000|Overall Study|Withdrawal by Subject|2|||
33582490|NCT01253369|102022634|FG000|Overall Study|Death|1|||
33582491|NCT01253369|102022634|FG000|Overall Study|Progressive disease|23|||
33582492|NCT01253369|102022634|FG000|Overall Study|Not Evaluable|3|||
33582493|NCT05005273|102022635|FG000|Overall Study|Study Terminated|1|||
33582494|NCT05005273|102022636|FG001|Overall Study|Study Terminated|0|||
33582495|NCT00603941|102022637|FG000|Overall Study|Disease progression|6|||
33582496|NCT00603941|102022638|FG001|Overall Study|Disease progression|7|||
33582497|NCT00603941|102022639|FG002|Overall Study|Disease progression|1|||
33582498|NCT00603941|102022637|FG000|Overall Study|Adverse Event|1|||
33582499|NCT00603941|102022638|FG001|Overall Study|Adverse Event|0|||
33643218|NCT01379508|102244325|FG001|Treatment to Week 104|Protocol Violation|1|||
33643219|NCT01379508|102244326|FG002|Treatment to Week 104|Protocol Violation|1|||
33372374|NCT02841787|101251825|FG000|Overall Study|Lost to Follow-up|1|||
33145459|NCT00745615|100445273|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
33145460|NCT00745615|100445274|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
33372375|NCT02841787|101251826|FG001|Overall Study|Lost to Follow-up|0|||
33372376|NCT02841787|101251827|FG002|Overall Study|Lost to Follow-up|0|||
33372377|NCT02841787|101251825|FG000|Overall Study|Symptoms dropped below threshold|1|||
33422196|NCT03471182|101437027|FG002|Overall Study|Withdrawal by Subject|0|||
33582500|NCT00603941|102022639|FG002|Overall Study|Adverse Event|1|||
33582501|NCT00603941|102022637|FG000|Overall Study|Physician Decision|0|||
33145461|NCT00745615|100445275|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
33422197|NCT03471182|101437025|FG000|Overall Study|Technical failure|2|||
33422198|NCT03471182|101437026|FG001|Overall Study|Technical failure|0|||
33422199|NCT03471182|101437027|FG002|Overall Study|Technical failure|0|||
33422200|NCT00802529|101437028|FG000|Overall Study|Lost to Follow-up|0|||
33422201|NCT00802529|101437029|FG001|Overall Study|Lost to Follow-up|1|||
33422202|NCT00849524|101437030|FG000|Overall Study|Lack of Efficacy|3|||
33422203|NCT00481871|101437033|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
33422204|NCT00481871|101437034|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
33422205|NCT00481871|101437035|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
33422206|NCT00481871|101437036|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
33422207|NCT00481871|101437037|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
33422208|NCT01964898|101437038|FG000|Overall Study|ineligible post-randomization|1|||
33422209|NCT01964898|101437039|FG001|Overall Study|ineligible post-randomization|1|||
33422210|NCT01964898|101437038|FG000|Overall Study|did not receive the allocated interventi|2|||
33582502|NCT00603941|102022638|FG001|Overall Study|Physician Decision|1|||
33582503|NCT00603941|102022639|FG002|Overall Study|Physician Decision|0|||
33582504|NCT00603941|102022637|FG000|Overall Study|Withdrawal by Subject|0|||
33582505|NCT00603941|102022638|FG001|Overall Study|Withdrawal by Subject|2|||
33145462|NCT00745615|100445276|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
33145463|NCT00745615|100445271|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
33145464|NCT00745615|100445272|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
33582506|NCT00603941|102022639|FG002|Overall Study|Withdrawal by Subject|0|||
33582507|NCT04703192|102022641|FG000|Overall Study|Withdrawal by Subject|2|||
33582508|NCT04703192|102022642|FG001|Overall Study|Withdrawal by Subject|0|||
33145465|NCT00745615|100445273|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
33372378|NCT02841787|101251826|FG001|Overall Study|Symptoms dropped below threshold|0|||
33372379|NCT02841787|101251827|FG002|Overall Study|Symptoms dropped below threshold|0|||
33372380|NCT02841787|101251825|FG000|Overall Study|Withdrawal by Subject|1|||
33372381|NCT02841787|101251826|FG001|Overall Study|Withdrawal by Subject|4|||
33422211|NCT01964898|101437039|FG001|Overall Study|did not receive the allocated interventi|1|||
33422212|NCT01964898|101437038|FG000|Overall Study|Lost to Follow-up|3|||
33422213|NCT01964898|101437039|FG001|Overall Study|Lost to Follow-up|5|||
33422214|NCT01964898|101437038|FG000|Overall Study|Withdrawal by Subject|1|||
33422215|NCT01964898|101437039|FG001|Overall Study|Withdrawal by Subject|0|||
33422216|NCT03611751|101437040|FG000|Pre-treatment|Randomized but not treated|1|||
33422217|NCT03611751|101437041|FG001|Pre-treatment|Randomized but not treated|1|||
33422218|NCT03611751|101437042|FG002|Pre-treatment|Randomized but not treated|0|||
33422219|NCT03611751|101437040|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
33422220|NCT03611751|101437041|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
33422221|NCT03611751|101437042|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
33422222|NCT03611751|101437040|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
33422223|NCT03611751|101437041|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
33422224|NCT03611751|101437042|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
33422225|NCT03611751|101437040|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
33422226|NCT03611751|101437041|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
33422227|NCT03611751|101437042|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
33422228|NCT03611751|101437040|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
33422229|NCT03611751|101437041|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
33372382|NCT02841787|101251827|FG002|Overall Study|Withdrawal by Subject|0|||
33372383|NCT01515306|101251828|FG000|Overall Study|Adverse Event|3|||
33372384|NCT01515306|101251829|FG001|Overall Study|Adverse Event|2|||
33372385|NCT01515306|101251828|FG000|Overall Study|Progressive Disease|19|||
33372386|NCT01515306|101251829|FG001|Overall Study|Progressive Disease|9|||
33422230|NCT03611751|101437042|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
33422231|NCT03611751|101437040|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
33422232|NCT03611751|101437041|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
33422233|NCT03611751|101437042|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
33582509|NCT04703192|102022641|FG000|Overall Study|Death|3|||
33643220|NCT01379508|102244327|FG003|Treatment to Week 104|Protocol Violation|0|||
33145466|NCT00745615|100445274|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
33243532|NCT05355805|100791614|FG001|Overall Study|Ongoing|41|||
33422234|NCT03611751|101437040|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
33422235|NCT03611751|101437041|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
33422236|NCT03611751|101437042|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
33582510|NCT04703192|102022642|FG001|Overall Study|Death|1|||
33582511|NCT04703192|102022641|FG000|Overall Study|Adverse Event|13|||
33582512|NCT04703192|102022642|FG001|Overall Study|Adverse Event|2|||
33372387|NCT01515306|101251828|FG000|Overall Study|Withdrawal by Subject|1|||
33372388|NCT01515306|101251829|FG001|Overall Study|Withdrawal by Subject|2|||
33372389|NCT01515306|101251828|FG000|Overall Study|Physician Decision|1|||
33372390|NCT01515306|101251829|FG001|Overall Study|Physician Decision|1|||
33582513|NCT04703192|102022641|FG000|Overall Study|Progressive or Relapsed Disease|46|||
33145467|NCT00745615|100445275|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
33145468|NCT00745615|100445276|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
33145469|NCT00745615|100445271|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
33145470|NCT00745615|100445272|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
33145471|NCT00745615|100445273|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
33145472|NCT00745615|100445274|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
33145473|NCT00745615|100445275|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
33145474|NCT00745615|100445276|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
33145475|NCT00745615|100445271|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
33145476|NCT00745615|100445272|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
33145477|NCT00745615|100445273|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
33145478|NCT00745615|100445274|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
33145479|NCT00745615|100445275|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
33145480|NCT00745615|100445276|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
33145481|NCT00745615|100445271|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
33145482|NCT00745615|100445272|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
33145483|NCT00745615|100445273|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
33145484|NCT00745615|100445274|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
33145485|NCT00745615|100445275|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
33145486|NCT00745615|100445276|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
33145487|NCT00745615|100445271|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
33145488|NCT00745615|100445272|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
33145489|NCT00745615|100445273|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
33243533|NCT05355805|100791615|FG002|Overall Study|Ongoing|38|||
33243534|NCT05355805|100791616|FG003|Overall Study|Ongoing|48|||
33243535|NCT03239210|100791617|FG000|Overall Study|Lost to Follow-up|2|||
33243536|NCT03239210|100791618|FG001|Overall Study|Lost to Follow-up|2|||
33372391|NCT01341652|101251832|FG000|Overall Study|Incorrect Random Assignment|0|||
33372392|NCT01341652|101251833|FG001|Overall Study|Incorrect Random Assignment|1|||
33643221|NCT01379508|102244324|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
33643222|NCT01379508|102244325|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
33643223|NCT01379508|102244326|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
33643224|NCT01379508|102244327|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
33643225|NCT01379508|102244324|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
33643226|NCT01379508|102244325|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
33643227|NCT01379508|102244326|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
33643228|NCT01379508|102244327|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
33643229|NCT01379508|102244324|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
33643230|NCT01379508|102244325|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
33643231|NCT01379508|102244326|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
33643232|NCT01379508|102244327|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
33643233|NCT01379508|102244324|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
33643234|NCT01379508|102244325|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
33643235|NCT01379508|102244326|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
33643236|NCT01379508|102244327|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
33643237|NCT02920242|102244328|FG000|Overall Study|Withdrawal by Subject|1|||
33643238|NCT02920242|102244329|FG001|Overall Study|Withdrawal by Subject|0|||
33643239|NCT02920242|102244330|FG002|Overall Study|Withdrawal by Subject|1|||
33643240|NCT02920242|102244328|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
33643241|NCT02920242|102244329|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
33643242|NCT02920242|102244330|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
33643243|NCT00939393|102248261|FG000|Overall Study|Withdrawal by Subject|1|||
33643244|NCT00939393|102248262|FG001|Overall Study|Withdrawal by Subject|0|||
33643245|NCT00939393|102248261|FG000|Overall Study|Lost to Follow-up|3|||
33643246|NCT00939393|102248262|FG001|Overall Study|Lost to Follow-up|0|||
33643247|NCT01519167|102248263|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
33643248|NCT01519167|102248264|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
33643249|NCT01519167|102248263|FG000|Overall Study|Adverse Event|0|||
33643250|NCT01519167|102248264|FG001|Overall Study|Adverse Event|1|||
33643251|NCT01519167|102248263|FG000|Overall Study|Lack of Efficacy|0|||
33643252|NCT01519167|102248264|FG001|Overall Study|Lack of Efficacy|1|||
33372393|NCT01341652|101251832|FG000|Overall Study|ineligible; presence metastatic disease|0|||
33643253|NCT01519167|102248263|FG000|Overall Study|Medical condition changes&deep sedation|0|||
33372394|NCT01341652|101251833|FG001|Overall Study|ineligible; presence metastatic disease|1|||
33372395|NCT03491553|101251835|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
33372396|NCT03491553|101251836|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
33643254|NCT01519167|102248264|FG001|Overall Study|Medical condition changes&deep sedation|2|||
33643255|NCT01519167|102248263|FG000|Overall Study|Physician Decision|0|||
33372397|NCT03491553|101251837|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
33422237|NCT03611751|101437040|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
33422238|NCT03611751|101437041|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
33422239|NCT03611751|101437042|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
33422240|NCT03611751|101437040|FG000|Treatment Week 0 - Week 16|Death|0|||
33422241|NCT03611751|101437041|FG001|Treatment Week 0 - Week 16|Death|0|||
33422242|NCT03611751|101437042|FG002|Treatment Week 0 - Week 16|Death|1|||
33422243|NCT03611751|101437040|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
33422244|NCT03611751|101437041|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
33422245|NCT03611751|101437042|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
33372398|NCT03491553|101251838|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
33372399|NCT03491553|101251839|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
33372400|NCT03491553|101251840|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
33372401|NCT03491553|101251835|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
33372402|NCT03491553|101251836|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
33372403|NCT03491553|101251837|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
33372404|NCT03491553|101251838|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
33372405|NCT03491553|101251839|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
33372406|NCT03491553|101251840|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
33372407|NCT02546674|101251841|FG000|Overall Study|Adverse Event|19|||
33372408|NCT02546674|101251841|FG000|Overall Study|Death|1|||
33372409|NCT02546674|101251841|FG000|Overall Study|Lost to Follow-up|1|||
33372410|NCT02546674|101251841|FG000|Overall Study|Physician Decision|13|||
33372411|NCT02546674|101251841|FG000|Overall Study|Pregnancy|1|||
33372412|NCT02546674|101251841|FG000|Overall Study|Progressive Disease|2|||
33372413|NCT02546674|101251841|FG000|Overall Study|Protocol Deviation|2|||
33372414|NCT02546674|101251841|FG000|Overall Study|Subject/Guardian Decision|6|||
33372415|NCT02546674|101251841|FG000|Overall Study|Withdrawal of Informed Consent|3|||
33372416|NCT00256867|101251852|FG000|Overall Study|Adverse Event|0|||
33372417|NCT00256867|101251853|FG001|Overall Study|Adverse Event|1|||
33372418|NCT00256867|101251854|FG002|Overall Study|Adverse Event|1|||
33422246|NCT03611751|101437040|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
33422247|NCT03611751|101437041|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
33422248|NCT03611751|101437042|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
33422249|NCT03611751|101437040|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
33422250|NCT03611751|101437041|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
33422251|NCT03611751|101437042|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
33422252|NCT03611751|101437040|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
33422253|NCT03611751|101437041|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
33422254|NCT03611751|101437042|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
33422255|NCT03611751|101437040|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
33422256|NCT03611751|101437041|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
33422257|NCT03611751|101437042|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
33422258|NCT03611751|101437040|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
33422259|NCT03611751|101437041|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
33422260|NCT03611751|101437042|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
33422261|NCT03611751|101437040|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
33422262|NCT03611751|101437041|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
33422263|NCT03611751|101437042|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
33422264|NCT03611751|101437040|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
33422265|NCT03611751|101437041|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
33582514|NCT04703192|102022642|FG001|Overall Study|Progressive or Relapsed Disease|7|||
33582515|NCT04703192|102022641|FG000|Overall Study|Clinical Progression|19|||
33582516|NCT04703192|102022642|FG001|Overall Study|Clinical Progression|8|||
33582517|NCT04703192|102022641|FG000|Overall Study|Lost to Follow-up|1|||
33582518|NCT04703192|102022642|FG001|Overall Study|Lost to Follow-up|0|||
33582519|NCT04703192|102022641|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
33582520|NCT04703192|102022642|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
33582521|NCT04703192|102022641|FG000|Overall Study|Other|5|||
33582522|NCT04703192|102022642|FG001|Overall Study|Other|1|||
33582523|NCT03462758|102022646|FG000|Overall Study|Chose no or other method of contraception|20|||
33582524|NCT03462758|102022647|FG001|Overall Study|Chose no or other method of contraception|23|||
33582525|NCT03462758|102022646|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
33582526|NCT03462758|102022647|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
33582527|NCT03462758|102022646|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
33582528|NCT03462758|102022647|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
33372419|NCT00256867|101251855|FG003|Overall Study|Adverse Event|1|||
33372420|NCT00256867|101251856|FG004|Overall Study|Adverse Event|2|||
33643256|NCT01519167|102248264|FG001|Overall Study|Physician Decision|1|||
33422266|NCT03611751|101437042|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
33422267|NCT03611751|101437040|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
33372421|NCT00256867|101251857|FG005|Overall Study|Adverse Event|2|||
33372422|NCT00256867|101251858|FG006|Overall Study|Adverse Event|1|||
33372423|NCT00256867|101251859|FG007|Overall Study|Adverse Event|4|||
33372424|NCT00256867|101251852|FG000|Overall Study|Lost to Follow-up|2|||
33372425|NCT00256867|101251853|FG001|Overall Study|Lost to Follow-up|2|||
33582529|NCT03462758|102022646|FG000|Overall Study|Medical contraindication|2|||
33582530|NCT03462758|102022647|FG001|Overall Study|Medical contraindication|2|||
33582531|NCT03462758|102022646|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
33582532|NCT03462758|102022647|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
33582533|NCT01970241|102022648|FG000|Overall Study|Withdrawal by Subject|2|||
33582534|NCT01970241|102022649|FG001|Overall Study|Withdrawal by Subject|0|||
33582535|NCT01970241|102022648|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
33582536|NCT01970241|102022649|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
33582537|NCT01059864|102022653|FG000|Open-Label Run-In Phase|Adverse Event|7|||
33582538|NCT01059864|102022654|FG001|Open-Label Run-In Phase|Adverse Event|0|||
33243537|NCT03239210|100791617|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
33243538|NCT03239210|100791618|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
33243539|NCT03239210|100791617|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
33243540|NCT03239210|100791618|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
33243541|NCT04831775|100791621|FG000|Overall Study|Lost to Follow-up|11|||
33243542|NCT04831775|100791622|FG001|Overall Study|Lost to Follow-up|13|||
33243543|NCT03686384|100791623|FG000|Overall Study|Lack of Efficacy|4|||
33243544|NCT03686384|100791624|FG001|Overall Study|Lack of Efficacy|13|||
33422268|NCT03611751|101437041|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
33422269|NCT03611751|101437042|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
33422270|NCT03611751|101437040|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
33422271|NCT03611751|101437041|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
33422272|NCT03611751|101437042|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
33422273|NCT03611751|101437040|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
33422274|NCT03611751|101437041|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
33422275|NCT03611751|101437042|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
33422276|NCT03611751|101437040|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
33582539|NCT01059864|102022655|FG002|Open-Label Run-In Phase|Adverse Event|0|||
33582540|NCT01059864|102022653|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
33582541|NCT01059864|102022654|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
33582542|NCT01059864|102022655|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
33582543|NCT01059864|102022653|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
33582544|NCT01059864|102022654|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
33582545|NCT01059864|102022655|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
33243545|NCT03686384|100791623|FG000|Overall Study|Lost to Follow-up|3|||
33243546|NCT03686384|100791624|FG001|Overall Study|Lost to Follow-up|0|||
33582546|NCT01059864|102022653|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
33582547|NCT01059864|102022654|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
33582548|NCT01059864|102022655|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
33582549|NCT01059864|102022653|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
33582550|NCT01059864|102022654|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
33582551|NCT01059864|102022655|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
33582552|NCT01059864|102022653|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
33582553|NCT01059864|102022654|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
33582554|NCT01059864|102022655|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
33582555|NCT03230318|102022660|FG000|Overall Study|Radiographic disease progression|72|||
33582556|NCT03230318|102022661|FG001|Overall Study|Radiographic disease progression|19|||
33582557|NCT03230318|102022660|FG000|Overall Study|Clinical progression|17|||
33582558|NCT03230318|102022661|FG001|Overall Study|Clinical progression|7|||
33582559|NCT03230318|102022660|FG000|Overall Study|Adverse Event|5|||
33582560|NCT03230318|102022661|FG001|Overall Study|Adverse Event|3|||
33582561|NCT03230318|102022660|FG000|Overall Study|Physician Decision|2|||
33582562|NCT03230318|102022661|FG001|Overall Study|Physician Decision|3|||
33582563|NCT03230318|102022660|FG000|Overall Study|Death|3|||
33582564|NCT03230318|102022661|FG001|Overall Study|Death|2|||
33582565|NCT03230318|102022660|FG000|Overall Study|Lost to Follow-up|1|||
33582566|NCT03230318|102022661|FG001|Overall Study|Lost to Follow-up|0|||
33582567|NCT03230318|102022660|FG000|Overall Study|Withdrawal by Subject|1|||
33243547|NCT03686384|100791623|FG000|Overall Study|Physician Decision|0|||
33243548|NCT03686384|100791624|FG001|Overall Study|Physician Decision|1|||
33243549|NCT03686384|100791623|FG000|Overall Study|Took prohibited medication|0|||
33243550|NCT03686384|100791624|FG001|Overall Study|Took prohibited medication|1|||
33243551|NCT04159506|100791627|FG000|Overall Study|Lost to Follow-up|2|||
33243552|NCT04159506|100791628|FG001|Overall Study|Lost to Follow-up|5|||
33243553|NCT02949271|100791629|FG000|Overall Study|Lack of Efficacy|5|||
33243554|NCT02949271|100791630|FG001|Overall Study|Lack of Efficacy|4|||
33422277|NCT03611751|101437041|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
33422278|NCT03611751|101437042|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
33243555|NCT02949271|100791629|FG000|Overall Study|Lost to Follow-up|3|||
33243556|NCT02949271|100791630|FG001|Overall Study|Lost to Follow-up|6|||
33243557|NCT02949271|100791629|FG000|Overall Study|Physician Decision|5|||
33582568|NCT03230318|102022661|FG001|Overall Study|Withdrawal by Subject|3|||
33243558|NCT02949271|100791630|FG001|Overall Study|Physician Decision|5|||
33243559|NCT02949271|100791629|FG000|Overall Study|Protocol Violation|6|||
33243560|NCT02949271|100791630|FG001|Overall Study|Protocol Violation|3|||
33243561|NCT02949271|100791629|FG000|Overall Study|Withdrawal by Subject|1|||
33243562|NCT02949271|100791630|FG001|Overall Study|Withdrawal by Subject|0|||
33582569|NCT03230318|102022660|FG000|Overall Study|Other|3|||
33582570|NCT03230318|102022661|FG001|Overall Study|Other|7|||
33582571|NCT03374358|102022662|FG000|Overall Study|Withdrawal by Subject|0|||
33582572|NCT03374358|102022663|FG001|Overall Study|Withdrawal by Subject|2|||
33582573|NCT00886769|102022664|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
33582574|NCT00886769|102022665|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
33582575|NCT01973231|102022666|FG000|Overall Study|Protocol Violation|1|||
33582576|NCT01973231|102022667|FG001|Overall Study|Protocol Violation|1|||
33582577|NCT01973231|102022666|FG000|Overall Study|Lost to Follow-up|1|||
33243563|NCT02949271|100791629|FG000|Overall Study|Delivered prior to intervention|7|||
33243564|NCT02949271|100791630|FG001|Overall Study|Delivered prior to intervention|9|||
33243565|NCT02949271|100791629|FG000|Overall Study|Outside the window for cervical dilation|2|||
33243566|NCT02949271|100791630|FG001|Overall Study|Outside the window for cervical dilation|3|||
33243567|NCT01688973|100791633|FG000|Overall Study|Ineligible|2|||
33243568|NCT01688973|100791634|FG001|Overall Study|Ineligible|3|||
33243569|NCT05273801|100791639|FG000|Overall Study|Physician Decision|1|||
33243570|NCT03861273|100791640|FG000|Screening Phase (3 Weeks)|Other|1|||
33243571|NCT03861273|100791640|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
33243572|NCT03861273|100791640|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
33243573|NCT03861273|100791640|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
33243574|NCT03861273|100791640|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
33243575|NCT01417000|100791642|FG000|Overall Study|Death|59|||
33243576|NCT01417000|100791643|FG001|Overall Study|Death|28|||
33243577|NCT01417000|100791642|FG000|Overall Study|Lost to Follow-up|1|||
33243578|NCT01417000|100791643|FG001|Overall Study|Lost to Follow-up|0|||
33243579|NCT01417000|100791642|FG000|Overall Study|Study Terminated by Sponsor|1|||
33243580|NCT01417000|100791643|FG001|Overall Study|Study Terminated by Sponsor|1|||
33243581|NCT02049437|100791644|FG000|Period 1|Adverse Event|1|||
33243582|NCT02049437|100791645|FG001|Period 1|Adverse Event|1|||
33243583|NCT02049437|100791644|FG000|Period 1|Adverse Event|1|||
33243584|NCT02049437|100791645|FG001|Period 1|Adverse Event|0|||
33243585|NCT04476043|100791646|FG000|Overall Study|Withdrawal by Subject|1|||
33243586|NCT04476043|100791647|FG001|Overall Study|Withdrawal by Subject|3|||
33243587|NCT04476043|100791648|FG002|Overall Study|Withdrawal by Subject|4|||
33243588|NCT04476043|100791649|FG003|Overall Study|Withdrawal by Subject|1|||
33243589|NCT04476043|100791646|FG000|Overall Study|Lost to Follow-up|1|||
33243590|NCT04476043|100791647|FG001|Overall Study|Lost to Follow-up|1|||
33243591|NCT04476043|100791648|FG002|Overall Study|Lost to Follow-up|2|||
33243592|NCT04476043|100791649|FG003|Overall Study|Lost to Follow-up|1|||
33243593|NCT04476043|100791646|FG000|Overall Study|Adverse Event|2|||
33243594|NCT04476043|100791647|FG001|Overall Study|Adverse Event|0|||
33243595|NCT04476043|100791648|FG002|Overall Study|Adverse Event|1|||
33243596|NCT04476043|100791649|FG003|Overall Study|Adverse Event|0|||
33243597|NCT04476043|100791646|FG000|Overall Study|Protocol Violation|0|||
33243598|NCT04476043|100791647|FG001|Overall Study|Protocol Violation|1|||
33243599|NCT04476043|100791648|FG002|Overall Study|Protocol Violation|0|||
33243600|NCT04476043|100791649|FG003|Overall Study|Protocol Violation|0|||
33243601|NCT01838551|100791652|FG000|Overall Study|Adverse Event|16|||
33243602|NCT01838551|100791652|FG000|Overall Study|Death|1|||
33422279|NCT03611751|101437040|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
33422280|NCT03611751|101437041|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
33422281|NCT03611751|101437042|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
33422282|NCT03611751|101437040|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
33422283|NCT03611751|101437041|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
33422284|NCT03611751|101437042|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
33422285|NCT01715415|101437043|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
33422286|NCT01715415|101437044|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
33422287|NCT01715415|101437043|FG000|Double-blind Treatment|Adverse Event|3|||
33422288|NCT01715415|101437044|FG001|Double-blind Treatment|Adverse Event|0|||
33422289|NCT01715415|101437043|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
33582578|NCT01973231|102022667|FG001|Overall Study|Lost to Follow-up|1|||
33582579|NCT01973231|102022666|FG000|Overall Study|unclassified|2|||
33582580|NCT01973231|102022667|FG001|Overall Study|unclassified|1|||
33582581|NCT01973231|102022666|FG000|Overall Study|Withdrawal by Subject|7|||
33243603|NCT01838551|100791652|FG000|Overall Study|Lack of Efficacy|10|||
33243604|NCT01838551|100791652|FG000|Overall Study|Physician Decision|4|||
33243605|NCT01838551|100791652|FG000|Overall Study|Withdrawal by Subject|10|||
33243606|NCT01838551|100791652|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
33422290|NCT01715415|101437044|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
33422291|NCT01715415|101437043|FG000|Double-blind Treatment|Other|1|||
33582582|NCT01973231|102022667|FG001|Overall Study|Withdrawal by Subject|9|||
33582583|NCT00470262|102022668|FG000|Overall Study|Withdrawal by Subject|2|||
33582584|NCT00470262|102022669|FG001|Overall Study|Withdrawal by Subject|0|||
33243607|NCT02459964|100791653|FG000|Overall Study|Withdrawal by Subject|0|||
33582585|NCT01721486|102022672|FG000|Overall Study|Protocol Violation|1|||
33582586|NCT01721486|102022673|FG001|Overall Study|Protocol Violation|0|||
33582587|NCT01721486|102022672|FG000|Overall Study|Physician Decision|0|||
33582588|NCT01721486|102022673|FG001|Overall Study|Physician Decision|1|||
33582589|NCT00556439|102022675|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
33582590|NCT00556439|102022676|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
33582591|NCT00556439|102022677|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
33582592|NCT00556439|102022678|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
33582593|NCT00556439|102022675|FG000|Study Entry to Week 12|Physician Decision|1|||
33582594|NCT00556439|102022676|FG001|Study Entry to Week 12|Physician Decision|0|||
33582595|NCT00556439|102022677|FG002|Study Entry to Week 12|Physician Decision|0|||
33582596|NCT00556439|102022678|FG003|Study Entry to Week 12|Physician Decision|0|||
33582597|NCT00556439|102022675|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
33582598|NCT00556439|102022676|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
33372426|NCT00256867|101251854|FG002|Overall Study|Lost to Follow-up|2|||
33372427|NCT00256867|101251855|FG003|Overall Study|Lost to Follow-up|3|||
33372428|NCT00256867|101251856|FG004|Overall Study|Lost to Follow-up|2|||
33372429|NCT00256867|101251857|FG005|Overall Study|Lost to Follow-up|0|||
33372430|NCT00256867|101251858|FG006|Overall Study|Lost to Follow-up|1|||
33372431|NCT00256867|101251859|FG007|Overall Study|Lost to Follow-up|2|||
33372432|NCT00256867|101251852|FG000|Overall Study|Protocol Violation|0|||
33643257|NCT02228980|102248265|FG000|Overall Study|Adverse Event|14|||
33643258|NCT02228980|102248266|FG001|Overall Study|Adverse Event|0|||
33643259|NCT02228980|102248267|FG002|Overall Study|Adverse Event|0|||
33643260|NCT02228980|102248268|FG003|Overall Study|Adverse Event|0|||
33643261|NCT02228980|102248265|FG000|Overall Study|Protocol Violation|7|||
33643262|NCT02228980|102248266|FG001|Overall Study|Protocol Violation|0|||
33643263|NCT02228980|102248267|FG002|Overall Study|Protocol Violation|0|||
33145490|NCT00745615|100445274|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
33145491|NCT00745615|100445275|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
33145492|NCT00745615|100445276|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
33582599|NCT00556439|102022677|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
33582600|NCT00556439|102022678|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
33582601|NCT00556439|102022675|FG000|Study Entry to Week 12|Recurrent infection|1|||
33643264|NCT02228980|102248268|FG003|Overall Study|Protocol Violation|0|||
33145493|NCT00745615|100445271|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
33145494|NCT00745615|100445272|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
33145495|NCT00745615|100445273|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
33372433|NCT00256867|101251853|FG001|Overall Study|Protocol Violation|0|||
33372434|NCT00256867|101251854|FG002|Overall Study|Protocol Violation|0|||
33372435|NCT00256867|101251855|FG003|Overall Study|Protocol Violation|1|||
33372436|NCT00256867|101251856|FG004|Overall Study|Protocol Violation|0|||
33372437|NCT00256867|101251857|FG005|Overall Study|Protocol Violation|1|||
33372438|NCT00256867|101251858|FG006|Overall Study|Protocol Violation|0|||
33372439|NCT00256867|101251859|FG007|Overall Study|Protocol Violation|1|||
33372440|NCT00256867|101251852|FG000|Overall Study|Withdrawal by Subject|0|||
33372441|NCT00256867|101251853|FG001|Overall Study|Withdrawal by Subject|0|||
33372442|NCT00256867|101251854|FG002|Overall Study|Withdrawal by Subject|1|||
33372443|NCT00256867|101251855|FG003|Overall Study|Withdrawal by Subject|1|||
33372444|NCT00256867|101251856|FG004|Overall Study|Withdrawal by Subject|2|||
33372445|NCT00256867|101251857|FG005|Overall Study|Withdrawal by Subject|2|||
33372446|NCT00256867|101251858|FG006|Overall Study|Withdrawal by Subject|3|||
33372447|NCT00256867|101251859|FG007|Overall Study|Withdrawal by Subject|2|||
33372448|NCT00256867|101251852|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
33372449|NCT00256867|101251853|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
33372450|NCT00256867|101251854|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
33372451|NCT00256867|101251855|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
33372452|NCT00256867|101251856|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
33372453|NCT00256867|101251857|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
33372454|NCT00256867|101251858|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
33372455|NCT00256867|101251859|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
33372456|NCT00256867|101251852|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
33372457|NCT00256867|101251853|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
33372458|NCT00256867|101251854|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
33372459|NCT00256867|101251855|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
33372460|NCT00256867|101251856|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
33422292|NCT01715415|101437044|FG001|Double-blind Treatment|Other|0|||
33372461|NCT00256867|101251857|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
33582602|NCT00556439|102022676|FG001|Study Entry to Week 12|Recurrent infection|0|||
33643265|NCT02228980|102248265|FG000|Overall Study|Withdrawal by Subject|3|||
33372462|NCT00256867|101251858|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
33582603|NCT00556439|102022677|FG002|Study Entry to Week 12|Recurrent infection|0|||
33582604|NCT00556439|102022678|FG003|Study Entry to Week 12|Recurrent infection|0|||
33582605|NCT00556439|102022675|FG000|Study Entry to Week 12|Malignancy|0|||
33582606|NCT00556439|102022676|FG001|Study Entry to Week 12|Malignancy|0|||
33582607|NCT00556439|102022677|FG002|Study Entry to Week 12|Malignancy|1|||
33582608|NCT00556439|102022678|FG003|Study Entry to Week 12|Malignancy|0|||
33243608|NCT02459964|100791654|FG001|Overall Study|Withdrawal by Subject|0|||
33243609|NCT02459964|100791655|FG002|Overall Study|Withdrawal by Subject|1|||
33243610|NCT02459964|100791653|FG000|Overall Study|Abnormal EKG changes|0|||
33243611|NCT02459964|100791654|FG001|Overall Study|Abnormal EKG changes|0|||
33243612|NCT02459964|100791655|FG002|Overall Study|Abnormal EKG changes|1|||
33243613|NCT04639947|100791656|FG000|Overall Study|Screen fail|1|||
33643266|NCT02228980|102248266|FG001|Overall Study|Withdrawal by Subject|3|||
33643267|NCT02228980|102248267|FG002|Overall Study|Withdrawal by Subject|2|||
33643268|NCT02228980|102248268|FG003|Overall Study|Withdrawal by Subject|3|||
33643269|NCT02424578|102248271|FG000|Overall Study|Withdrawal by Subject|0|||
33643270|NCT02424578|102248272|FG001|Overall Study|Withdrawal by Subject|1|||
33643271|NCT04270370|102248274|FG000|Overall Study|Lost to Follow-up|1|||
33643272|NCT04270370|102248275|FG001|Overall Study|Lost to Follow-up|0|||
33643273|NCT04270370|102248276|FG002|Overall Study|Lost to Follow-up|0|||
33582609|NCT00556439|102022675|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
33582610|NCT00556439|102022676|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
33582611|NCT00556439|102022677|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
33582612|NCT00556439|102022678|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
33582613|NCT00556439|102022675|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
33582614|NCT00556439|102022676|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
33582615|NCT00556439|102022677|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
33582616|NCT00556439|102022678|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
33643274|NCT04270370|102248277|FG003|Overall Study|Lost to Follow-up|0|||
33643275|NCT04270370|102248278|FG004|Overall Study|Lost to Follow-up|0|||
33286410|NCT00092521|100943970|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
33286411|NCT00092521|100943971|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
33286412|NCT00092521|100943968|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
33286413|NCT00092521|100943969|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
33286414|NCT00092521|100943970|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
33286415|NCT00092521|100943971|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
33286416|NCT00092521|100943968|FG000|Follow-Up (After Month 7)|Moved|32|||
33286417|NCT00092521|100943969|FG001|Follow-Up (After Month 7)|Moved|2|||
33286418|NCT00092521|100943970|FG002|Follow-Up (After Month 7)|Moved|28|||
33286419|NCT00092521|100943971|FG003|Follow-Up (After Month 7)|Moved|0|||
33286420|NCT00092521|100943968|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
33286421|NCT00092521|100943969|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
33286422|NCT00092521|100943970|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
33286423|NCT00092521|100943971|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
33286424|NCT00092521|100943968|FG000|Follow-Up (After Month 7)|Travel|2|||
33286425|NCT00092521|100943969|FG001|Follow-Up (After Month 7)|Travel|0|||
33286426|NCT00092521|100943970|FG002|Follow-Up (After Month 7)|Travel|0|||
33286427|NCT00092521|100943971|FG003|Follow-Up (After Month 7)|Travel|0|||
33286428|NCT00092521|100943968|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
33286429|NCT00092521|100943969|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
33286430|NCT00092521|100943970|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
33286431|NCT00092521|100943971|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
33286432|NCT00092521|100943968|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
33286433|NCT00092521|100943969|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
33286434|NCT00092521|100943970|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
33286435|NCT00092521|100943971|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
33286436|NCT00092521|100943968|FG000|Extension Study (Group 4)|Adverse Event|0|||
33286437|NCT00092521|100943969|FG001|Extension Study (Group 4)|Adverse Event|0|||
33286438|NCT00092521|100943970|FG002|Extension Study (Group 4)|Adverse Event|0|||
33286439|NCT00092521|100943971|FG003|Extension Study (Group 4)|Adverse Event|2|||
33286440|NCT00092521|100943968|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
33286441|NCT00092521|100943969|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
33286442|NCT00092521|100943970|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
33286443|NCT00092521|100943971|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
33286444|NCT00092521|100943968|FG000|Extension Study (Group 4)|Pregnancy|0|||
33372463|NCT00256867|101251859|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
33372464|NCT00256867|101251852|FG000|Overall Study|Investigator's Decision|0|||
33286445|NCT00092521|100943969|FG001|Extension Study (Group 4)|Pregnancy|0|||
33286446|NCT00092521|100943970|FG002|Extension Study (Group 4)|Pregnancy|0|||
33286447|NCT00092521|100943971|FG003|Extension Study (Group 4)|Pregnancy|4|||
33372465|NCT00256867|101251853|FG001|Overall Study|Investigator's Decision|0|||
33286448|NCT00092521|100943968|FG000|Extension Study (Group 4)|Protocol Violation|0|||
33286449|NCT00092521|100943969|FG001|Extension Study (Group 4)|Protocol Violation|0|||
33372466|NCT00256867|101251854|FG002|Overall Study|Investigator's Decision|0|||
33643276|NCT04270370|102248279|FG005|Overall Study|Lost to Follow-up|0|||
33643277|NCT04270370|102248280|FG006|Overall Study|Lost to Follow-up|0|||
33243614|NCT03686683|100793961|FG000|Overall Study|Withdrawal by Subject|52|||
33243615|NCT03686683|100793962|FG001|Overall Study|Withdrawal by Subject|32|||
33243616|NCT03686683|100793961|FG000|Overall Study|Lost to Follow-up|23|||
33243617|NCT03686683|100793962|FG001|Overall Study|Lost to Follow-up|19|||
33243618|NCT03686683|100793961|FG000|Overall Study|Adverse Event|1|||
33243619|NCT03686683|100793962|FG001|Overall Study|Adverse Event|0|||
33243620|NCT03686683|100793961|FG000|Overall Study|Death|10|||
33243621|NCT03686683|100793962|FG001|Overall Study|Death|5|||
33243622|NCT03686683|100793961|FG000|Overall Study|Progressive Disease|1|||
33243623|NCT03686683|100793962|FG001|Overall Study|Progressive Disease|1|||
33243624|NCT03686683|100793961|FG000|Overall Study|Noncompliance|1|||
33243625|NCT03686683|100793962|FG001|Overall Study|Noncompliance|0|||
33243626|NCT03686683|100793961|FG000|Overall Study|Physician Decision|1|||
33243627|NCT03686683|100793962|FG001|Overall Study|Physician Decision|1|||
33243628|NCT03686683|100793961|FG000|Overall Study|Screen fail post-randomization|1|||
33243629|NCT03686683|100793962|FG001|Overall Study|Screen fail post-randomization|0|||
33243630|NCT03686683|100793961|FG000|Overall Study|Protocol Violation|3|||
33243631|NCT03686683|100793962|FG001|Overall Study|Protocol Violation|0|||
33243632|NCT03686683|100793961|FG000|Overall Study|No data available|1|||
33243633|NCT03686683|100793962|FG001|Overall Study|No data available|0|||
33243634|NCT00819234|100793965|FG000|Overall Study|Withdrawal by Subject|8|||
33243635|NCT00819234|100793966|FG001|Overall Study|Withdrawal by Subject|13|||
33243636|NCT00819234|100793967|FG002|Overall Study|Withdrawal by Subject|6|||
33243637|NCT00819234|100793968|FG003|Overall Study|Withdrawal by Subject|3|||
33243638|NCT00819234|100793969|FG004|Overall Study|Withdrawal by Subject|0|||
33243639|NCT00819234|100793970|FG005|Overall Study|Withdrawal by Subject|4|||
33243640|NCT00819234|100793971|FG006|Overall Study|Withdrawal by Subject|4|||
33243641|NCT00819234|100793972|FG007|Overall Study|Withdrawal by Subject|8|||
33243642|NCT00819234|100793973|FG008|Overall Study|Withdrawal by Subject|5|||
33243643|NCT00819234|100793974|FG009|Overall Study|Withdrawal by Subject|3|||
33243644|NCT00819234|100793965|FG000|Overall Study|Adverse Event|0|||
33243645|NCT00819234|100793966|FG001|Overall Study|Adverse Event|0|||
33243646|NCT00819234|100793967|FG002|Overall Study|Adverse Event|1|||
33372467|NCT00256867|101251855|FG003|Overall Study|Investigator's Decision|0|||
33582617|NCT00556439|102022675|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
33582618|NCT00556439|102022676|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
33582619|NCT00556439|102022677|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
33582620|NCT00556439|102022678|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
33582621|NCT00556439|102022675|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
33582622|NCT00556439|102022676|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
33582623|NCT00556439|102022677|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
33582624|NCT00556439|102022678|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
33582625|NCT01766037|102022679|FG000|Overall Study|Adverse Event|1|||
33582626|NCT01766037|102022680|FG001|Overall Study|Adverse Event|0|||
33582627|NCT01766037|102022679|FG000|Overall Study|Lack of Efficacy|1|||
33582628|NCT01766037|102022680|FG001|Overall Study|Lack of Efficacy|0|||
33582629|NCT01766037|102022679|FG000|Overall Study|Lost to Follow-up|0|||
33582630|NCT01766037|102022680|FG001|Overall Study|Lost to Follow-up|10|||
33582631|NCT01766037|102022679|FG000|Overall Study|Physician Decision|0|||
33582632|NCT01766037|102022680|FG001|Overall Study|Physician Decision|1|||
33582633|NCT01766037|102022679|FG000|Overall Study|Withdrawal by Subject|18|||
33582634|NCT01766037|102022680|FG001|Overall Study|Withdrawal by Subject|16|||
33582635|NCT01766037|102022679|FG000|Overall Study|Moved from area|5|||
33582636|NCT01766037|102022680|FG001|Overall Study|Moved from area|0|||
33582637|NCT01766037|102022679|FG000|Overall Study|medical - unrelated|1|||
33643278|NCT04270370|102248281|FG007|Overall Study|Lost to Follow-up|0|||
33643279|NCT04270370|102248282|FG008|Overall Study|Lost to Follow-up|1|||
33243647|NCT00819234|100793968|FG003|Overall Study|Adverse Event|0|||
33372468|NCT00256867|101251856|FG004|Overall Study|Investigator's Decision|1|||
33372469|NCT00256867|101251857|FG005|Overall Study|Investigator's Decision|0|||
33372470|NCT00256867|101251858|FG006|Overall Study|Investigator's Decision|0|||
33372471|NCT00256867|101251859|FG007|Overall Study|Investigator's Decision|0|||
33372472|NCT00256867|101251852|FG000|Overall Study|Non-compliance with study medication|0|||
33372473|NCT00256867|101251853|FG001|Overall Study|Non-compliance with study medication|0|||
33582638|NCT01766037|102022680|FG001|Overall Study|medical - unrelated|2|||
33582639|NCT01766037|102022679|FG000|Overall Study|nausea / discomfort|3|||
33243648|NCT00819234|100793969|FG004|Overall Study|Adverse Event|0|||
33243649|NCT00819234|100793970|FG005|Overall Study|Adverse Event|2|||
33243650|NCT00819234|100793971|FG006|Overall Study|Adverse Event|0|||
33243651|NCT00819234|100793972|FG007|Overall Study|Adverse Event|0|||
33582640|NCT01766037|102022680|FG001|Overall Study|nausea / discomfort|0|||
33582641|NCT04194944|102022681|FG000|Overall Study|Lost to Follow-up|3|||
33243652|NCT00819234|100793973|FG008|Overall Study|Adverse Event|0|||
33243653|NCT00819234|100793974|FG009|Overall Study|Adverse Event|0|||
33243654|NCT00819234|100793965|FG000|Overall Study|Physician Decision|0|||
33243655|NCT00819234|100793966|FG001|Overall Study|Physician Decision|0|||
33243656|NCT00819234|100793967|FG002|Overall Study|Physician Decision|0|||
33372474|NCT00256867|101251854|FG002|Overall Study|Non-compliance with study medication|0|||
33372475|NCT00256867|101251855|FG003|Overall Study|Non-compliance with study medication|0|||
33372476|NCT00256867|101251856|FG004|Overall Study|Non-compliance with study medication|0|||
33372477|NCT00256867|101251857|FG005|Overall Study|Non-compliance with study medication|0|||
33372478|NCT00256867|101251858|FG006|Overall Study|Non-compliance with study medication|0|||
33372479|NCT00256867|101251859|FG007|Overall Study|Non-compliance with study medication|1|||
33372480|NCT00256867|101251852|FG000|Overall Study|Participant travelled Overseas|0|||
33372481|NCT00256867|101251853|FG001|Overall Study|Participant travelled Overseas|1|||
33372482|NCT00256867|101251854|FG002|Overall Study|Participant travelled Overseas|0|||
33422293|NCT01715415|101437043|FG000|Open-label Treatment|Adverse Event|0|||
33422294|NCT01715415|101437044|FG001|Open-label Treatment|Adverse Event|1|||
33422295|NCT01715415|101437043|FG000|Open-label Treatment|Subject Noncompliant|0|||
33422296|NCT01715415|101437044|FG001|Open-label Treatment|Subject Noncompliant|1|||
33643280|NCT04270370|102248283|FG009|Overall Study|Lost to Follow-up|0|||
33422297|NCT01246973|101437048|FG000|Overall Study|Other|38|||
33422298|NCT01246973|101437049|FG001|Overall Study|Other|25|||
33422299|NCT01246973|101437048|FG000|Overall Study|Adverse Event|16|||
33422300|NCT01246973|101437049|FG001|Overall Study|Adverse Event|9|||
33422301|NCT01246973|101437048|FG000|Overall Study|Withdrawal by Subject|7|||
33422302|NCT01246973|101437049|FG001|Overall Study|Withdrawal by Subject|13|||
33422303|NCT00751998|101437052|FG000|Overall Study|Lost to Follow-up|7|||
33422304|NCT00751998|101437052|FG000|Overall Study|Death|11|||
33422305|NCT00751998|101437052|FG000|Overall Study|Withdrawal by Subject|2|||
33422306|NCT00520494|101437055|FG000|Overall Study|Withdrawal by Subject|1|||
33422307|NCT03372083|101437061|FG000|Overall Study|Adverse Event|3|||
33422308|NCT03372083|101437061|FG000|Overall Study|Physician Decision|1|||
33422309|NCT03372083|101437061|FG000|Overall Study|Withdrawal by Subject|1|||
33422310|NCT01039584|101437062|FG000|Overall Study|Withdrawal by Subject|4|||
33422311|NCT01039584|101437063|FG001|Overall Study|Withdrawal by Subject|2|||
33582642|NCT04194944|102022682|FG001|Overall Study|Lost to Follow-up|0|||
33582643|NCT04194944|102022681|FG000|Overall Study|Withdrawal by Subject|2|||
33582644|NCT04194944|102022682|FG001|Overall Study|Withdrawal by Subject|2|||
33582645|NCT04194944|102022681|FG000|Overall Study|On Treatment|93|||
33582646|NCT04194944|102022682|FG001|Overall Study|On Treatment|30|||
33582647|NCT03799952|102022689|FG000|Overall Study|Program was too easy, discontinued|1|||
33582648|NCT03799952|102022690|FG001|Overall Study|Program was too easy, discontinued|0|||
33582649|NCT03799952|102022689|FG000|Overall Study|Lost to Follow-up|0|||
33582650|NCT03799952|102022690|FG001|Overall Study|Lost to Follow-up|2|||
33582651|NCT03083665|102022695|FG000|Double-Blind Period|Adverse Event|5|||
33582652|NCT03083665|102022696|FG001|Double-Blind Period|Adverse Event|4|||
33582653|NCT03083665|102022697|FG002|Double-Blind Period|Adverse Event|5|||
33582654|NCT03083665|102022698|FG003|Double-Blind Period|Adverse Event|0|||
33582655|NCT03083665|102022699|FG004|Double-Blind Period|Adverse Event|0|||
33582656|NCT03083665|102022700|FG005|Double-Blind Period|Adverse Event|0|||
33582657|NCT03083665|102022695|FG000|Double-Blind Period|Lack of Efficacy|0|||
33582658|NCT03083665|102022696|FG001|Double-Blind Period|Lack of Efficacy|0|||
33582659|NCT03083665|102022697|FG002|Double-Blind Period|Lack of Efficacy|1|||
33582660|NCT03083665|102022698|FG003|Double-Blind Period|Lack of Efficacy|0|||
33582661|NCT03083665|102022699|FG004|Double-Blind Period|Lack of Efficacy|0|||
33582662|NCT03083665|102022700|FG005|Double-Blind Period|Lack of Efficacy|0|||
33582663|NCT03083665|102022695|FG000|Double-Blind Period|Protocol Violation|1|||
33582664|NCT03083665|102022696|FG001|Double-Blind Period|Protocol Violation|0|||
33582665|NCT03083665|102022697|FG002|Double-Blind Period|Protocol Violation|1|||
33582666|NCT03083665|102022698|FG003|Double-Blind Period|Protocol Violation|0|||
33582667|NCT03083665|102022699|FG004|Double-Blind Period|Protocol Violation|0|||
33582668|NCT03083665|102022700|FG005|Double-Blind Period|Protocol Violation|0|||
33582669|NCT03083665|102022695|FG000|Double-Blind Period|Lost to Follow-up|1|||
33582670|NCT03083665|102022696|FG001|Double-Blind Period|Lost to Follow-up|0|||
33582671|NCT03083665|102022697|FG002|Double-Blind Period|Lost to Follow-up|1|||
33582672|NCT03083665|102022698|FG003|Double-Blind Period|Lost to Follow-up|0|||
33582673|NCT03083665|102022699|FG004|Double-Blind Period|Lost to Follow-up|0|||
33582674|NCT03083665|102022700|FG005|Double-Blind Period|Lost to Follow-up|0|||
33582675|NCT03083665|102022695|FG000|Double-Blind Period|Withdrawal by Subject|3|||
33582676|NCT03083665|102022696|FG001|Double-Blind Period|Withdrawal by Subject|0|||
33582677|NCT03083665|102022697|FG002|Double-Blind Period|Withdrawal by Subject|0|||
33582678|NCT03083665|102022698|FG003|Double-Blind Period|Withdrawal by Subject|0|||
33582679|NCT03083665|102022699|FG004|Double-Blind Period|Withdrawal by Subject|0|||
33582680|NCT03083665|102022700|FG005|Double-Blind Period|Withdrawal by Subject|0|||
33582681|NCT03083665|102022695|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
33582682|NCT03083665|102022696|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
33582683|NCT03083665|102022697|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
33643281|NCT04270370|102248284|FG010|Overall Study|Lost to Follow-up|0|||
33643282|NCT04270370|102248285|FG011|Overall Study|Lost to Follow-up|0|||
33422312|NCT01039584|101437064|FG002|Overall Study|Withdrawal by Subject|1|||
33422313|NCT01039584|101437062|FG000|Overall Study|Protocol Violation|10|||
33422314|NCT01039584|101437063|FG001|Overall Study|Protocol Violation|4|||
33422315|NCT01039584|101437064|FG002|Overall Study|Protocol Violation|6|||
33422316|NCT01039584|101437062|FG000|Overall Study|Lost to Follow-up|5|||
33422317|NCT01039584|101437063|FG001|Overall Study|Lost to Follow-up|3|||
33422318|NCT01039584|101437064|FG002|Overall Study|Lost to Follow-up|4|||
33422319|NCT01039584|101437062|FG000|Overall Study|Negative Baseline culture for Candida|59|||
33422320|NCT01039584|101437063|FG001|Overall Study|Negative Baseline culture for Candida|59|||
33422321|NCT01039584|101437064|FG002|Overall Study|Negative Baseline culture for Candida|24|||
33422322|NCT01039584|101437062|FG000|Overall Study|Lack of Efficacy|7|||
33422323|NCT01039584|101437063|FG001|Overall Study|Lack of Efficacy|6|||
33422324|NCT01039584|101437064|FG002|Overall Study|Lack of Efficacy|10|||
33422325|NCT01039584|101437062|FG000|Overall Study|other|1|||
33422326|NCT01039584|101437063|FG001|Overall Study|other|3|||
33422327|NCT01039584|101437064|FG002|Overall Study|other|1|||
33422328|NCT01039584|101437062|FG000|Overall Study|Pap smear with significant pathology|10|||
33422329|NCT01039584|101437063|FG001|Overall Study|Pap smear with significant pathology|10|||
33422330|NCT01039584|101437064|FG002|Overall Study|Pap smear with significant pathology|3|||
33422331|NCT01039584|101437062|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
33422332|NCT01039584|101437063|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
33422333|NCT01039584|101437064|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
33422334|NCT01656967|101437067|FG000|Overall Study|faulty monitor|1|||
33422335|NCT01656967|101437068|FG001|Overall Study|faulty monitor|0|||
33422336|NCT01656967|101437067|FG000|Overall Study|unsuccessful ETT insertion|3|||
33422337|NCT01656967|101437068|FG001|Overall Study|unsuccessful ETT insertion|2|||
33422338|NCT01453374|101437069|FG000|Overall Study|Adverse Event|7|||
33422339|NCT01453374|101437069|FG000|Overall Study|Lack of Efficacy|1|||
33422340|NCT01453374|101437069|FG000|Overall Study|Lost to Follow-up|3|||
33422341|NCT01453374|101437069|FG000|Overall Study|Withdrawal by Subject|5|||
33422342|NCT01453374|101437069|FG000|Overall Study|Incarcerated|2|||
33372483|NCT00256867|101251855|FG003|Overall Study|Participant travelled Overseas|0|||
33372484|NCT00256867|101251856|FG004|Overall Study|Participant travelled Overseas|0|||
33372485|NCT00256867|101251857|FG005|Overall Study|Participant travelled Overseas|0|||
33372486|NCT00256867|101251858|FG006|Overall Study|Participant travelled Overseas|0|||
33372487|NCT00256867|101251859|FG007|Overall Study|Participant travelled Overseas|0|||
33372488|NCT00256867|101251852|FG000|Overall Study|Participant out of assessment window|0|||
33372489|NCT00256867|101251853|FG001|Overall Study|Participant out of assessment window|0|||
33372490|NCT00256867|101251854|FG002|Overall Study|Participant out of assessment window|1|||
33422343|NCT00267020|101437072|FG000|Overall Study|Adverse Event|22|||
33422344|NCT00267020|101437073|FG001|Overall Study|Adverse Event|5|||
33422345|NCT00267020|101437072|FG000|Overall Study|Death|2|||
33422346|NCT00267020|101437073|FG001|Overall Study|Death|1|||
33422347|NCT00267020|101437072|FG000|Overall Study|Withdrawal by Subject|17|||
33582684|NCT03083665|102022698|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
33643283|NCT01209325|102248287|FG000|Overall Study|Lost to Follow-up|24|||
33643284|NCT01209325|102248287|FG000|Overall Study|Adverse Event|1|||
33643285|NCT01209325|102248287|FG000|Overall Study|Relocated|3|||
33643286|NCT01209325|102248287|FG000|Overall Study|Refusal after starting therapy|8|||
33643287|NCT01209325|102248287|FG000|Overall Study|Protocol Violation|4|||
33643288|NCT01209325|102248287|FG000|Overall Study|Refusal prior to therapy|1|||
33643289|NCT01209325|102248287|FG000|Overall Study|Incarceration|2|||
33643290|NCT02404025|102248288|FG000|Overall Study|Adverse Event|1|||
33643291|NCT02404025|102248288|FG000|Overall Study|Lack of Efficacy|3|||
33643292|NCT00329797|102248289|FG000|Overall Study|Protocol Violation|1|||
33643293|NCT00329797|102248290|FG001|Overall Study|Protocol Violation|0|||
33643294|NCT00329797|102248289|FG000|Overall Study|Withdrawal by Subject|6|||
33643295|NCT00329797|102248290|FG001|Overall Study|Withdrawal by Subject|6|||
33643296|NCT03926611|102248291|FG000|Overall Study|Adverse Event|0|||
33643297|NCT03926611|102248292|FG001|Overall Study|Adverse Event|0|||
33643298|NCT03926611|102248293|FG002|Overall Study|Adverse Event|0|||
33643299|NCT03926611|102248294|FG003|Overall Study|Adverse Event|3|||
33643300|NCT03926611|102248295|FG004|Overall Study|Adverse Event|1|||
33643301|NCT03926611|102248296|FG005|Overall Study|Adverse Event|3|||
33643302|NCT03926611|102248297|FG006|Overall Study|Adverse Event|0|||
33643303|NCT03926611|102248291|FG000|Overall Study|Lack of Efficacy|1|||
33643304|NCT03926611|102248292|FG001|Overall Study|Lack of Efficacy|2|||
33643305|NCT03926611|102248293|FG002|Overall Study|Lack of Efficacy|0|||
33643306|NCT03926611|102248294|FG003|Overall Study|Lack of Efficacy|0|||
33643307|NCT03926611|102248295|FG004|Overall Study|Lack of Efficacy|1|||
33643308|NCT03926611|102248296|FG005|Overall Study|Lack of Efficacy|0|||
33643309|NCT03926611|102248297|FG006|Overall Study|Lack of Efficacy|1|||
33643310|NCT03926611|102248291|FG000|Overall Study|Physician Decision|0|||
33643311|NCT03926611|102248292|FG001|Overall Study|Physician Decision|0|||
33643312|NCT03926611|102248293|FG002|Overall Study|Physician Decision|0|||
33643313|NCT03926611|102248294|FG003|Overall Study|Physician Decision|0|||
33643314|NCT03926611|102248295|FG004|Overall Study|Physician Decision|0|||
33643315|NCT03926611|102248296|FG005|Overall Study|Physician Decision|1|||
33643316|NCT03926611|102248297|FG006|Overall Study|Physician Decision|0|||
33145496|NCT00745615|100445274|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
33145497|NCT00745615|100445275|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
33145498|NCT00745615|100445276|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
33145499|NCT00745615|100445271|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
33145500|NCT00745615|100445272|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
33145501|NCT00745615|100445273|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
33145502|NCT00745615|100445274|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
33145503|NCT00745615|100445275|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
33145504|NCT00745615|100445276|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
33145505|NCT00745615|100445271|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
33145506|NCT00745615|100445272|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
33145507|NCT00745615|100445273|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
33145508|NCT00745615|100445274|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
33145509|NCT00745615|100445275|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
33145510|NCT00745615|100445276|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
33145511|NCT00745615|100445271|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
33145512|NCT00745615|100445272|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
33145513|NCT00745615|100445273|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
33145514|NCT00745615|100445274|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
33145515|NCT00745615|100445275|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
33145516|NCT00745615|100445276|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
33145517|NCT02025556|100445278|FG000|Overall Study|Adverse Event|0|||
33582685|NCT03083665|102022699|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
33582686|NCT03083665|102022700|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
33582687|NCT03083665|102022695|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
33582688|NCT03083665|102022696|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
33582689|NCT03083665|102022697|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
33145518|NCT02025556|100445279|FG001|Overall Study|Adverse Event|4|||
33145519|NCT02025556|100445280|FG002|Overall Study|Adverse Event|2|||
33145520|NCT02025556|100445278|FG000|Overall Study|Lack of Efficacy|2|||
33145521|NCT02025556|100445279|FG001|Overall Study|Lack of Efficacy|1|||
33145522|NCT02025556|100445280|FG002|Overall Study|Lack of Efficacy|0|||
33145523|NCT02025556|100445278|FG000|Overall Study|Protocol Violation|2|||
33145524|NCT02025556|100445279|FG001|Overall Study|Protocol Violation|1|||
33145525|NCT02025556|100445280|FG002|Overall Study|Protocol Violation|0|||
33145526|NCT02025556|100445278|FG000|Overall Study|Withdrawal by Subject|0|||
33145527|NCT02025556|100445279|FG001|Overall Study|Withdrawal by Subject|3|||
33145528|NCT02025556|100445280|FG002|Overall Study|Withdrawal by Subject|6|||
33145529|NCT02025556|100445278|FG000|Overall Study|Lost to Follow-up|2|||
33145530|NCT02025556|100445279|FG001|Overall Study|Lost to Follow-up|4|||
33145531|NCT02025556|100445280|FG002|Overall Study|Lost to Follow-up|0|||
33145532|NCT02025556|100445278|FG000|Overall Study|Reason not reported|0|||
33145533|NCT02025556|100445279|FG001|Overall Study|Reason not reported|0|||
33145534|NCT02025556|100445280|FG002|Overall Study|Reason not reported|1|||
33145535|NCT00510952|100445282|FG000|Overall Study|Adverse Event|1|||
33145536|NCT00510952|100445283|FG001|Overall Study|Adverse Event|0|||
33145537|NCT00510952|100445282|FG000|Overall Study|Entry Criteria Not Met|3|||
33582690|NCT03083665|102022698|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
33582691|NCT03083665|102022699|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
33582692|NCT03083665|102022700|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
33582693|NCT03083665|102022695|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
33643317|NCT03926611|102248291|FG000|Overall Study|Protocol Violation|1|||
33643318|NCT03926611|102248292|FG001|Overall Study|Protocol Violation|0|||
33643319|NCT03926611|102248293|FG002|Overall Study|Protocol Violation|0|||
33643320|NCT03926611|102248294|FG003|Overall Study|Protocol Violation|1|||
33582694|NCT03083665|102022696|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
33582695|NCT03083665|102022697|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
33582696|NCT03083665|102022698|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
33643321|NCT03926611|102248295|FG004|Overall Study|Protocol Violation|1|||
33643322|NCT03926611|102248296|FG005|Overall Study|Protocol Violation|1|||
33643323|NCT03926611|102248297|FG006|Overall Study|Protocol Violation|1|||
33643324|NCT03926611|102248291|FG000|Overall Study|Technical problems|0|||
33643325|NCT03926611|102248292|FG001|Overall Study|Technical problems|0|||
33145538|NCT00510952|100445283|FG001|Overall Study|Entry Criteria Not Met|1|||
33145539|NCT00510952|100445282|FG000|Overall Study|Lost to Follow-up|5|||
33145540|NCT00510952|100445283|FG001|Overall Study|Lost to Follow-up|3|||
33145541|NCT00510952|100445282|FG000|Overall Study|Physician Decision|1|||
33145542|NCT00510952|100445283|FG001|Overall Study|Physician Decision|1|||
33145543|NCT00510952|100445282|FG000|Overall Study|Protocol Violation|7|||
33145544|NCT00510952|100445283|FG001|Overall Study|Protocol Violation|4|||
33145545|NCT00510952|100445282|FG000|Overall Study|Sponsor Decision|1|||
33643326|NCT03926611|102248293|FG002|Overall Study|Technical problems|0|||
33643327|NCT03926611|102248294|FG003|Overall Study|Technical problems|0|||
33643328|NCT03926611|102248295|FG004|Overall Study|Technical problems|0|||
33643329|NCT03926611|102248296|FG005|Overall Study|Technical problems|1|||
33643330|NCT03926611|102248297|FG006|Overall Study|Technical problems|0|||
33643331|NCT03926611|102248291|FG000|Overall Study|Withdrawal by Subject|1|||
33643332|NCT03926611|102248292|FG001|Overall Study|Withdrawal by Subject|1|||
33643333|NCT03926611|102248293|FG002|Overall Study|Withdrawal by Subject|1|||
33643334|NCT03926611|102248294|FG003|Overall Study|Withdrawal by Subject|0|||
33643335|NCT03926611|102248295|FG004|Overall Study|Withdrawal by Subject|0|||
33643336|NCT03926611|102248296|FG005|Overall Study|Withdrawal by Subject|1|||
33643337|NCT03926611|102248297|FG006|Overall Study|Withdrawal by Subject|3|||
33643338|NCT03926611|102248291|FG000|Overall Study|Covid-19 pandemic|0|||
33643339|NCT03926611|102248292|FG001|Overall Study|Covid-19 pandemic|0|||
33643340|NCT03926611|102248293|FG002|Overall Study|Covid-19 pandemic|1|||
33643341|NCT03926611|102248294|FG003|Overall Study|Covid-19 pandemic|0|||
33643342|NCT03926611|102248295|FG004|Overall Study|Covid-19 pandemic|1|||
33643343|NCT03926611|102248296|FG005|Overall Study|Covid-19 pandemic|2|||
33643344|NCT03926611|102248297|FG006|Overall Study|Covid-19 pandemic|0|||
33643345|NCT02331277|102248298|FG000|Overall Study|Withdrawal by Subject|1|||
33643346|NCT02331277|102248299|FG001|Overall Study|Withdrawal by Subject|0|||
33643347|NCT01417377|102248300|FG000|Overall Study|Lost to Follow-up|12|||
33643348|NCT01417377|102248300|FG000|Overall Study|Enrolled, but not treated|1|||
33643349|NCT01235741|102248301|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
33643350|NCT01235741|102248302|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
33643351|NCT01235741|102248303|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
33643352|NCT01235741|102248301|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
33643353|NCT01235741|102248302|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
33372491|NCT00256867|101251855|FG003|Overall Study|Participant out of assessment window|0|||
33372492|NCT00256867|101251856|FG004|Overall Study|Participant out of assessment window|0|||
33372493|NCT00256867|101251857|FG005|Overall Study|Participant out of assessment window|0|||
33372494|NCT00256867|101251858|FG006|Overall Study|Participant out of assessment window|0|||
33372495|NCT00256867|101251859|FG007|Overall Study|Participant out of assessment window|0|||
33372496|NCT00256867|101251852|FG000|Overall Study|Withdrawal by participant|0|||
33372497|NCT00256867|101251853|FG001|Overall Study|Withdrawal by participant|0|||
33582697|NCT03083665|102022699|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
33582698|NCT03083665|102022700|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
33582699|NCT03083665|102022695|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
33582700|NCT03083665|102022696|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
33582701|NCT03083665|102022697|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
33582702|NCT03083665|102022698|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
33582703|NCT03083665|102022699|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
33582704|NCT03083665|102022700|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
33582705|NCT03083665|102022695|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
33582706|NCT03083665|102022696|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
33582707|NCT03083665|102022697|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
33582708|NCT03083665|102022698|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
33582709|NCT03083665|102022699|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
33582710|NCT03083665|102022700|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
33582711|NCT03083665|102022695|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
33582712|NCT03083665|102022696|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
33582713|NCT03083665|102022697|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
33582714|NCT03083665|102022698|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
33582715|NCT03083665|102022699|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
33582716|NCT03083665|102022700|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
33582717|NCT03083665|102022695|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
33582718|NCT03083665|102022696|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
33372498|NCT00256867|101251854|FG002|Overall Study|Withdrawal by participant|0|||
33372499|NCT00256867|101251855|FG003|Overall Study|Withdrawal by participant|0|||
33372500|NCT00256867|101251856|FG004|Overall Study|Withdrawal by participant|0|||
33372501|NCT00256867|101251857|FG005|Overall Study|Withdrawal by participant|1|||
33372502|NCT00256867|101251858|FG006|Overall Study|Withdrawal by participant|0|||
33372503|NCT00256867|101251859|FG007|Overall Study|Withdrawal by participant|0|||
33372504|NCT01496430|101251861|FG000|Overall Study|Adverse Event|0|||
33372505|NCT01496430|101251862|FG001|Overall Study|Adverse Event|0|||
33372506|NCT01496430|101251863|FG002|Overall Study|Adverse Event|1|||
33372507|NCT01496430|101251861|FG000|Overall Study|Major Protocol Deviation|0|||
33643354|NCT01235741|102248303|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
33643355|NCT01235741|102248301|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
33643356|NCT01235741|102248302|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
33643357|NCT01235741|102248303|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
33643358|NCT01235741|102248301|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
33643359|NCT01235741|102248302|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
33643360|NCT01235741|102248303|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
33643361|NCT01235741|102248301|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
33643362|NCT01235741|102248302|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
33643363|NCT01235741|102248303|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
33643364|NCT01235741|102248301|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
33643365|NCT01235741|102248302|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
33643366|NCT01235741|102248303|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
33643367|NCT01235741|102248301|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
33643368|NCT01235741|102248302|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
33643369|NCT01235741|102248303|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
33643370|NCT01235741|102248301|FG000|Randomized to Treatment|Adverse Event|0|||
33643371|NCT01235741|102248302|FG001|Randomized to Treatment|Adverse Event|1|||
33643372|NCT01235741|102248303|FG002|Randomized to Treatment|Adverse Event|1|||
33643373|NCT01235741|102248301|FG000|Randomized to Treatment|Sponsor terminated study|0|||
33643374|NCT01235741|102248302|FG001|Randomized to Treatment|Sponsor terminated study|35|||
33643375|NCT01235741|102248303|FG002|Randomized to Treatment|Sponsor terminated study|34|||
33643376|NCT01235741|102248301|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
33643377|NCT01235741|102248302|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
33643378|NCT01235741|102248303|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
33643379|NCT01235741|102248301|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
33643380|NCT01235741|102248302|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
33643381|NCT01235741|102248303|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
33643382|NCT01235741|102248301|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
33643383|NCT01235741|102248302|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
33643384|NCT01235741|102248303|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
33643385|NCT02175030|102248313|FG000|Overall Study|Failed screen after consent|7|||
33643386|NCT02175030|102248314|FG001|Overall Study|Failed screen after consent|6|||
33643387|NCT02175030|102248313|FG000|Overall Study|Failed IUD Insertion|20|||
33643388|NCT02175030|102248314|FG001|Overall Study|Failed IUD Insertion|21|||
33643389|NCT02175030|102248313|FG000|Overall Study|Physician Decision|1|||
33643390|NCT02175030|102248314|FG001|Overall Study|Physician Decision|1|||
33643391|NCT02175030|102248313|FG000|Overall Study|Lost to Follow-up|6|||
33643392|NCT02175030|102248314|FG001|Overall Study|Lost to Follow-up|6|||
33643393|NCT02175030|102248313|FG000|Overall Study|Withdrawal by Subject|1|||
33643394|NCT02175030|102248314|FG001|Overall Study|Withdrawal by Subject|4|||
33643395|NCT00220636|102248315|FG000|Overall Study|Withdrawal by Subject|4|||
33643396|NCT01148979|102248316|FG000|Overall Study|Lost to Follow-up|0|||
33643397|NCT01148979|102248317|FG001|Overall Study|Lost to Follow-up|1|||
33643398|NCT03196349|102248318|FG000|Overall Study|Did not receive study drug|0|||
33643399|NCT03196349|102248319|FG001|Overall Study|Did not receive study drug|1|||
33643400|NCT03196349|102248320|FG002|Overall Study|Did not receive study drug|2|||
33643401|NCT03196349|102248318|FG000|Overall Study|No data entered|2|||
33643402|NCT03196349|102248319|FG001|Overall Study|No data entered|4|||
33643403|NCT03196349|102248320|FG002|Overall Study|No data entered|0|||
33145546|NCT00510952|100445283|FG001|Overall Study|Sponsor Decision|0|||
33145547|NCT00510952|100445282|FG000|Overall Study|Withdrawal by Subject|6|||
33145548|NCT00510952|100445283|FG001|Overall Study|Withdrawal by Subject|7|||
33243657|NCT00819234|100793968|FG003|Overall Study|Physician Decision|1|||
33243658|NCT00819234|100793969|FG004|Overall Study|Physician Decision|0|||
33243659|NCT00819234|100793970|FG005|Overall Study|Physician Decision|0|||
33243660|NCT00819234|100793971|FG006|Overall Study|Physician Decision|0|||
33372508|NCT01496430|101251862|FG001|Overall Study|Major Protocol Deviation|0|||
33582719|NCT03083665|102022697|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
33582720|NCT03083665|102022698|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
33582721|NCT03083665|102022699|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
33582722|NCT03083665|102022700|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
33582723|NCT03083665|102022695|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
33582724|NCT03083665|102022696|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
33582725|NCT03083665|102022697|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
33582726|NCT03083665|102022698|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
33582727|NCT03083665|102022699|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
33582728|NCT03083665|102022700|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
33582729|NCT03083665|102022695|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
33582730|NCT03083665|102022696|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
33582731|NCT03083665|102022697|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
33145549|NCT00510952|100445282|FG000|Overall Study|Did Not Receive Study Drug|2|||
33145550|NCT00510952|100445283|FG001|Overall Study|Did Not Receive Study Drug|0|||
33145551|NCT01277042|100445284|FG000|Overall Study|Adverse Event|4|||
33145552|NCT01277042|100445285|FG001|Overall Study|Adverse Event|3|||
33145553|NCT01277042|100445284|FG000|Overall Study|Lost to Follow-up|2|||
33422348|NCT00267020|101437073|FG001|Overall Study|Withdrawal by Subject|7|||
33422349|NCT00267020|101437072|FG000|Overall Study|Physician Decision|3|||
33643404|NCT03196349|102248318|FG000|Overall Study|Study Terminated early|15|||
33643405|NCT03196349|102248319|FG001|Overall Study|Study Terminated early|9|||
33643406|NCT03196349|102248320|FG002|Overall Study|Study Terminated early|11|||
33643407|NCT00509145|102248321|FG000|Overall Study|Death|0|||
33643408|NCT00509145|102248322|FG001|Overall Study|Death|2|||
33643409|NCT00509145|102248321|FG000|Overall Study|Adverse Event|42|||
33643410|NCT00509145|102248322|FG001|Overall Study|Adverse Event|28|||
33643411|NCT00509145|102248321|FG000|Overall Study|Withdrawal by Subject|32|||
33643412|NCT00509145|102248322|FG001|Overall Study|Withdrawal by Subject|38|||
33643413|NCT00509145|102248321|FG000|Overall Study|Physician Decision|11|||
33643414|NCT00509145|102248322|FG001|Overall Study|Physician Decision|14|||
33643415|NCT00509145|102248321|FG000|Overall Study|Protocol Violation|1|||
33643416|NCT00509145|102248322|FG001|Overall Study|Protocol Violation|6|||
33643417|NCT00509145|102248321|FG000|Overall Study|Pregnancy|3|||
33643418|NCT00509145|102248322|FG001|Overall Study|Pregnancy|8|||
33643419|NCT00509145|102248321|FG000|Overall Study|Lost to Follow-up|6|||
33643420|NCT00509145|102248322|FG001|Overall Study|Lost to Follow-up|5|||
33643421|NCT00509145|102248321|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
33643422|NCT00509145|102248322|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
33643423|NCT00509145|102248321|FG000|Overall Study|Other|6|||
33643424|NCT00509145|102248322|FG001|Overall Study|Other|6|||
33643425|NCT01677377|102248323|FG000|Overall Study|Protocol Violation|1|||
33643426|NCT01677377|102248324|FG001|Overall Study|Protocol Violation|0|||
33643427|NCT01677377|102248325|FG002|Overall Study|Protocol Violation|0|||
33643428|NCT01677377|102248323|FG000|Overall Study|Lost to Follow-up|0|||
33643429|NCT01677377|102248324|FG001|Overall Study|Lost to Follow-up|1|||
33643430|NCT01677377|102248325|FG002|Overall Study|Lost to Follow-up|1|||
33643431|NCT01677377|102248323|FG000|Overall Study|Withdrawal by Subject|0|||
33643432|NCT01677377|102248324|FG001|Overall Study|Withdrawal by Subject|0|||
33643433|NCT01677377|102248325|FG002|Overall Study|Withdrawal by Subject|3|||
33643434|NCT01677377|102248323|FG000|Overall Study|Lack of Efficacy|0|||
33643435|NCT01677377|102248324|FG001|Overall Study|Lack of Efficacy|0|||
33643436|NCT01677377|102248325|FG002|Overall Study|Lack of Efficacy|1|||
33643437|NCT01677377|102248323|FG000|Overall Study|Pregnancy|0|||
33643438|NCT01677377|102248324|FG001|Overall Study|Pregnancy|0|||
33643439|NCT01677377|102248325|FG002|Overall Study|Pregnancy|1|||
33643440|NCT00473382|102248326|FG000|Core Study|Adverse Event|3|||
33643441|NCT00473382|102248327|FG001|Core Study|Adverse Event|1|||
33643442|NCT00473382|102248328|FG002|Core Study|Adverse Event|1|||
33643443|NCT00473382|102248326|FG000|Core Study|Death|3|||
33643444|NCT00473382|102248327|FG001|Core Study|Death|5|||
33643445|NCT00473382|102248328|FG002|Core Study|Death|10|||
33643446|NCT00473382|102248326|FG000|Core Study|Lost to Follow-up|3|||
33643447|NCT00473382|102248327|FG001|Core Study|Lost to Follow-up|3|||
33643448|NCT00473382|102248328|FG002|Core Study|Lost to Follow-up|3|||
33643449|NCT00473382|102248326|FG000|Core Study|Physician Decision|1|||
33422350|NCT00267020|101437073|FG001|Overall Study|Physician Decision|2|||
33643450|NCT00473382|102248327|FG001|Core Study|Physician Decision|2|||
33643451|NCT00473382|102248328|FG002|Core Study|Physician Decision|2|||
33643452|NCT00473382|102248326|FG000|Core Study|Subject non-compliance|5|||
33643453|NCT00473382|102248327|FG001|Core Study|Subject non-compliance|2|||
33643454|NCT00473382|102248328|FG002|Core Study|Subject non-compliance|1|||
33643455|NCT00473382|102248326|FG000|Core Study|Subject needed other treatment|1|||
33643456|NCT00473382|102248327|FG001|Core Study|Subject needed other treatment|3|||
33643457|NCT00473382|102248328|FG002|Core Study|Subject needed other treatment|2|||
33643458|NCT00473382|102248326|FG000|Core Study|Subject's decision|12|||
33643459|NCT00473382|102248327|FG001|Core Study|Subject's decision|11|||
33643460|NCT00473382|102248328|FG002|Core Study|Subject's decision|10|||
33643461|NCT00473382|102248326|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
33643462|NCT00473382|102248327|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
33643463|NCT00473382|102248328|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
33643464|NCT00473382|102248326|FG000|Open-label Extension Through Month 48|Death|1|||
33643465|NCT00473382|102248327|FG001|Open-label Extension Through Month 48|Death|3|||
33643466|NCT00473382|102248328|FG002|Open-label Extension Through Month 48|Death|3|||
33643467|NCT00473382|102248326|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
33643468|NCT00473382|102248327|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
33643469|NCT00473382|102248328|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
33643470|NCT00473382|102248326|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
33643471|NCT00473382|102248327|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
33145554|NCT01277042|100445285|FG001|Overall Study|Lost to Follow-up|2|||
33422351|NCT00267020|101437072|FG000|Overall Study|Disease Progression|39|||
33643472|NCT00473382|102248328|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
33643473|NCT00473382|102248326|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
33643474|NCT00473382|102248327|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
33643475|NCT00473382|102248328|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
33643476|NCT00473382|102248326|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
33643477|NCT00473382|102248327|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
33643478|NCT00473382|102248328|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
33643479|NCT00473382|102248326|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
33643480|NCT00473382|102248327|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
33643481|NCT00473382|102248328|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
33643482|NCT00473382|102248326|FG000|Open-label Extension Through Month 60|Death|1|||
33643483|NCT00473382|102248327|FG001|Open-label Extension Through Month 60|Death|7|||
33643484|NCT00473382|102248328|FG002|Open-label Extension Through Month 60|Death|4|||
33643485|NCT00473382|102248326|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
33643486|NCT00473382|102248327|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
33643487|NCT00473382|102248328|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
33643488|NCT00473382|102248326|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
33145555|NCT01277042|100445284|FG000|Overall Study|Withdrawal by Subject|2|||
33145556|NCT01277042|100445285|FG001|Overall Study|Withdrawal by Subject|0|||
33145557|NCT00596362|100445288|FG000|Overall Study|Progressive Disease|1|||
33145558|NCT04285580|100445289|FG000|Overall Study|Protocol Violation|0|||
33145559|NCT04285580|100445290|FG001|Overall Study|Protocol Violation|1|||
33643489|NCT00473382|102248327|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
33643490|NCT00473382|102248328|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
33643491|NCT00473382|102248326|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
33643492|NCT00473382|102248327|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
33145560|NCT01055496|100448226|FG000|Overall Study|Withdrawal by Subject|2|||
33145561|NCT01055496|100448227|FG001|Overall Study|Withdrawal by Subject|4|||
33145562|NCT01055496|100448226|FG000|Overall Study|Death|13|||
33145563|NCT01055496|100448227|FG001|Overall Study|Death|23|||
33145564|NCT01055496|100448226|FG000|Overall Study|Lost to Follow-up|0|||
33145565|NCT01055496|100448227|FG001|Overall Study|Lost to Follow-up|2|||
33145566|NCT01055496|100448226|FG000|Overall Study|Other - Unspecified|0|||
33145567|NCT01055496|100448227|FG001|Overall Study|Other - Unspecified|1|||
33145568|NCT01163032|100448232|FG000|Randomization Phase|Withdrawal by Subject|2|||
33145569|NCT01163032|100448233|FG001|Randomization Phase|Withdrawal by Subject|3|||
33145570|NCT01163032|100448234|FG002|Randomization Phase|Withdrawal by Subject|0|||
33145571|NCT01163032|100448232|FG000|Randomization Phase|Adverse Event|3|||
33145572|NCT01163032|100448233|FG001|Randomization Phase|Adverse Event|3|||
33145573|NCT01163032|100448234|FG002|Randomization Phase|Adverse Event|0|||
33145574|NCT01163032|100448232|FG000|Randomization Phase|Protocol Violation|0|||
33145575|NCT01163032|100448233|FG001|Randomization Phase|Protocol Violation|1|||
33145576|NCT01163032|100448234|FG002|Randomization Phase|Protocol Violation|0|||
33145577|NCT01163032|100448232|FG000|Randomization Phase|Various*|5|||
33145578|NCT01163032|100448233|FG001|Randomization Phase|Various*|4|||
33145579|NCT01163032|100448234|FG002|Randomization Phase|Various*|0|||
33145580|NCT01163032|100448232|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
33145581|NCT01163032|100448233|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
33145582|NCT01163032|100448234|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
33145583|NCT01163032|100448232|FG000|Open Label Extension Phase|Adverse Event|0|||
33145584|NCT01163032|100448233|FG001|Open Label Extension Phase|Adverse Event|0|||
33145585|NCT01163032|100448234|FG002|Open Label Extension Phase|Adverse Event|3|||
33145586|NCT01163032|100448232|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
33145587|NCT01163032|100448233|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
33145588|NCT01163032|100448234|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
33643493|NCT00473382|102248328|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
33643494|NCT00473382|102248326|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
33643495|NCT00473382|102248327|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
33145589|NCT01163032|100448232|FG000|Open Label Extension Phase|Protocol Violation|0|||
33145590|NCT01163032|100448233|FG001|Open Label Extension Phase|Protocol Violation|0|||
33145591|NCT01163032|100448234|FG002|Open Label Extension Phase|Protocol Violation|1|||
33145592|NCT01163032|100448232|FG000|Open Label Extension Phase|Study Termination|0|||
33145593|NCT01163032|100448233|FG001|Open Label Extension Phase|Study Termination|0|||
33145594|NCT01163032|100448234|FG002|Open Label Extension Phase|Study Termination|7|||
33145595|NCT01163032|100448232|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
33145596|NCT01163032|100448233|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
33422352|NCT00267020|101437073|FG001|Overall Study|Disease Progression|25|||
33643496|NCT00473382|102248328|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
33145597|NCT01163032|100448234|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
33643497|NCT03181529|102248329|FG000|Overall Study|Withdrawal by Subject|1|||
33643498|NCT03181529|102248330|FG001|Overall Study|Withdrawal by Subject|1|||
33643499|NCT03181529|102248329|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
33145598|NCT03442764|100448239|FG000|Overall Study|Adverse Event|1|||
33145599|NCT03442764|100448240|FG001|Overall Study|Adverse Event|0|||
33145600|NCT03442764|100448241|FG002|Overall Study|Adverse Event|0|||
33145601|NCT03119701|100448242|FG000|6-day Dosing|Death|4|||
33145602|NCT03119701|100448243|FG001|6-day Dosing|Death|1|||
33145603|NCT03119701|100448242|FG000|6-day Dosing|Adverse Event|3|||
33145604|NCT03119701|100448243|FG001|6-day Dosing|Adverse Event|0|||
33145605|NCT03119701|100448242|FG000|6-day Dosing|Physician Decision|0|||
33145606|NCT03119701|100448243|FG001|6-day Dosing|Physician Decision|1|||
33145607|NCT03119701|100448242|FG000|6-day Dosing|Withdrawal by Subject|0|||
33145608|NCT03119701|100448243|FG001|6-day Dosing|Withdrawal by Subject|1|||
33145609|NCT03119701|100448242|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
33145610|NCT03119701|100448243|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
33145611|NCT01314911|100448244|FG000|Overall Study|Lost to Follow-up|3|||
33145612|NCT01314911|100448245|FG001|Overall Study|Lost to Follow-up|2|||
33145613|NCT01314911|100448244|FG000|Overall Study|Withdrawal by Subject|1|||
33145614|NCT01314911|100448245|FG001|Overall Study|Withdrawal by Subject|3|||
33145615|NCT01314911|100448244|FG000|Overall Study|Received Non-randomized Study Drug|0|||
33145616|NCT01314911|100448245|FG001|Overall Study|Received Non-randomized Study Drug|1|||
33145617|NCT01314911|100448244|FG000|Overall Study|Never Started Treatment|1|||
33145618|NCT01314911|100448245|FG001|Overall Study|Never Started Treatment|0|||
33145619|NCT02280473|100448246|FG000|Overall Study|Adverse Event|1|||
33145620|NCT02280473|100448247|FG001|Overall Study|Adverse Event|1|||
33582732|NCT03083665|102022698|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
33643500|NCT03181529|102248330|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
33643501|NCT02100696|102248331|FG000|Induction Phase|Adverse Event|0|||
33643502|NCT02100696|102248332|FG001|Induction Phase|Adverse Event|0|||
33643503|NCT02100696|102248333|FG002|Induction Phase|Adverse Event|1|||
33643504|NCT02100696|102248334|FG003|Induction Phase|Adverse Event|0|||
33643505|NCT02100696|102248335|FG004|Induction Phase|Adverse Event|0|||
33643506|NCT02100696|102248336|FG005|Induction Phase|Adverse Event|0|||
33643507|NCT02100696|102248331|FG000|Induction Phase|Lost to Follow-up|1|||
33643508|NCT02100696|102248332|FG001|Induction Phase|Lost to Follow-up|0|||
33643509|NCT02100696|102248333|FG002|Induction Phase|Lost to Follow-up|1|||
33643510|NCT02100696|102248334|FG003|Induction Phase|Lost to Follow-up|0|||
33145621|NCT02280473|100448246|FG000|Overall Study|Lack of Efficacy|0|||
33145622|NCT02280473|100448247|FG001|Overall Study|Lack of Efficacy|1|||
33145623|NCT02280473|100448246|FG000|Overall Study|Lost to Follow-up|0|||
33145624|NCT02280473|100448247|FG001|Overall Study|Lost to Follow-up|1|||
33145625|NCT01315236|100448248|FG000|Double-blind Phase|Death|1|||
33372509|NCT01496430|101251863|FG002|Overall Study|Major Protocol Deviation|1|||
33582733|NCT03083665|102022699|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
33582734|NCT03083665|102022700|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
33582735|NCT00579553|102022701|FG000|Overall Study|Lost to Follow-up|16|||
33582736|NCT00579553|102022702|FG001|Overall Study|Lost to Follow-up|13|||
33582737|NCT03783962|102022703|FG000|Overall Study|Lost to Follow-up|3|||
33582738|NCT03783962|102022704|FG001|Overall Study|Lost to Follow-up|6|||
33582739|NCT03783962|102022703|FG000|Overall Study|Protocol Violation|0|||
33582740|NCT03783962|102022704|FG001|Overall Study|Protocol Violation|1|||
33582741|NCT02954887|102022711|FG000|Overall Study|Withdrawal by Subject|3|||
33582742|NCT02954887|102022711|FG000|Overall Study|Lack of Efficacy|3|||
33582743|NCT02954887|102022711|FG000|Overall Study|Other|1|||
33582744|NCT00383331|102022712|FG000|Overall Study|Protocol Violation|0|||
33582745|NCT00383331|102022713|FG001|Overall Study|Protocol Violation|1|||
33582746|NCT01693250|102022717|FG000|Overall Study|Lost to Follow-up|2|||
33582747|NCT01693250|102022718|FG001|Overall Study|Lost to Follow-up|2|||
33582748|NCT03542266|102022721|FG000|Treatment Phase|Withdrawal by Subject|1|||
33582749|NCT03542266|102022721|FG000|Treatment Phase|Adverse Event|1|||
33582750|NCT03542266|102022721|FG000|Treatment Phase|PD|1|||
33582751|NCT02391311|102022722|FG000|Overall Study|Lost to Follow-up|2|||
33582752|NCT02391311|102022723|FG001|Overall Study|Lost to Follow-up|1|||
33582753|NCT02391311|102022722|FG000|Overall Study|deemed ineligible after baseline|1|||
33582754|NCT02391311|102022723|FG001|Overall Study|deemed ineligible after baseline|1|||
33582755|NCT02364037|102022724|FG000|Overall Study|Withdrawal by Subject|7|||
33582756|NCT02364037|102022725|FG001|Overall Study|Withdrawal by Subject|4|||
33582757|NCT02364037|102022724|FG000|Overall Study|Lost to Follow-up|37|||
33582758|NCT02364037|102022725|FG001|Overall Study|Lost to Follow-up|49|||
33582759|NCT01232127|102022726|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
33582760|NCT01232127|102022727|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
33643511|NCT02100696|102248335|FG004|Induction Phase|Lost to Follow-up|0|||
33643512|NCT02100696|102248336|FG005|Induction Phase|Lost to Follow-up|0|||
33145626|NCT01315236|100448249|FG001|Double-blind Phase|Death|0|||
33145627|NCT01315236|100448248|FG000|Double-blind Phase|Adverse Event|1|||
33422353|NCT00267020|101437072|FG000|Overall Study|Unrelated Complication|1|||
33422354|NCT00267020|101437073|FG001|Overall Study|Unrelated Complication|1|||
33422355|NCT00267020|101437072|FG000|Overall Study|Sponsor Request|1|||
33422356|NCT00267020|101437073|FG001|Overall Study|Sponsor Request|0|||
33422357|NCT00267020|101437072|FG000|Overall Study|Other|1|||
33422358|NCT00267020|101437073|FG001|Overall Study|Other|2|||
33422359|NCT02475980|101437076|FG000|Overall Study|Lost to Follow-up|4|||
33422360|NCT02475980|101437076|FG000|Overall Study|Withdrawal by Subject|1|||
33422361|NCT00033631|101437077|FG000|Overall Study|Protocol Violation|14|||
33422362|NCT00033631|101437078|FG001|Overall Study|Protocol Violation|11|||
33422363|NCT00033631|101437077|FG000|Overall Study|Withdrawal by Subject|4|||
33422364|NCT00033631|101437078|FG001|Overall Study|Withdrawal by Subject|4|||
33422365|NCT02059187|101437079|FG000|Overall Study|Adverse Event|0|||
33422366|NCT02059187|101437080|FG001|Overall Study|Adverse Event|3|||
33422367|NCT02059187|101437079|FG000|Overall Study|Death|1|||
33422368|NCT02059187|101437080|FG001|Overall Study|Death|1|||
33422369|NCT02059187|101437079|FG000|Overall Study|Lost to Follow-up|9|||
33422370|NCT02059187|101437080|FG001|Overall Study|Lost to Follow-up|8|||
33422371|NCT02059187|101437079|FG000|Overall Study|Non-compliance with study drug|1|||
33422372|NCT02059187|101437080|FG001|Overall Study|Non-compliance with study drug|0|||
33422373|NCT02059187|101437079|FG000|Overall Study|Physician Decision|1|||
33422374|NCT02059187|101437080|FG001|Overall Study|Physician Decision|2|||
33422375|NCT02059187|101437079|FG000|Overall Study|Protocol Violation|1|||
33582761|NCT01232127|102022728|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
33582762|NCT00771927|102022729|FG000|Overall Study|Adverse Event|100|||
33582763|NCT00771927|102022730|FG001|Overall Study|Adverse Event|105|||
33582764|NCT00771927|102022729|FG000|Overall Study|Lack of Efficacy|70|||
33422376|NCT02059187|101437080|FG001|Overall Study|Protocol Violation|0|||
33422377|NCT02059187|101437079|FG000|Overall Study|Withdrawal by Subject|12|||
33422378|NCT02059187|101437080|FG001|Overall Study|Withdrawal by Subject|8|||
33582765|NCT00771927|102022730|FG001|Overall Study|Lack of Efficacy|42|||
33582766|NCT00771927|102022729|FG000|Overall Study|Lost to Follow-up|46|||
33582767|NCT00771927|102022730|FG001|Overall Study|Lost to Follow-up|46|||
33582768|NCT00771927|102022729|FG000|Overall Study|Withdrawal by Subject|16|||
33582769|NCT00771927|102022730|FG001|Overall Study|Withdrawal by Subject|17|||
33582770|NCT00771927|102022729|FG000|Overall Study|Other reason|23|||
33582771|NCT00771927|102022730|FG001|Overall Study|Other reason|27|||
33582772|NCT00833469|102022731|FG000|Overall Study|Withdrawal by Subject|1|||
33582773|NCT00833469|102022731|FG000|Overall Study|Lost to Follow-up|1|||
33582774|NCT00739310|102022736|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
33582775|NCT00739310|102022736|FG000|Overall Study|Withdrawal by Subject|1|||
33582776|NCT00739310|102022736|FG000|Overall Study|Lost to Follow-up|2|||
33582777|NCT04776161|102022742|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
33582778|NCT04776161|102022743|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
33582779|NCT04776161|102022744|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
33582780|NCT04776161|102022742|FG000|Overall Study|Withdrawal by Subject|1|||
33643513|NCT02100696|102248331|FG000|Induction Phase|Protocol Violation|0|||
33643514|NCT02100696|102248332|FG001|Induction Phase|Protocol Violation|1|||
33643515|NCT02100696|102248333|FG002|Induction Phase|Protocol Violation|1|||
33643516|NCT02100696|102248334|FG003|Induction Phase|Protocol Violation|0|||
33643517|NCT02100696|102248335|FG004|Induction Phase|Protocol Violation|0|||
33643518|NCT02100696|102248336|FG005|Induction Phase|Protocol Violation|0|||
33643519|NCT02100696|102248331|FG000|Induction Phase|Withdrawal by Subject|8|||
33582781|NCT04776161|102022743|FG001|Overall Study|Withdrawal by Subject|0|||
33582782|NCT04776161|102022744|FG002|Overall Study|Withdrawal by Subject|1|||
33643520|NCT02100696|102248332|FG001|Induction Phase|Withdrawal by Subject|2|||
33643521|NCT02100696|102248333|FG002|Induction Phase|Withdrawal by Subject|13|||
33643522|NCT02100696|102248334|FG003|Induction Phase|Withdrawal by Subject|0|||
33643523|NCT02100696|102248335|FG004|Induction Phase|Withdrawal by Subject|0|||
33643524|NCT02100696|102248336|FG005|Induction Phase|Withdrawal by Subject|0|||
33643525|NCT02100696|102248331|FG000|Induction Phase|Physician Decision|1|||
33643526|NCT02100696|102248332|FG001|Induction Phase|Physician Decision|0|||
33643527|NCT02100696|102248333|FG002|Induction Phase|Physician Decision|2|||
33643528|NCT02100696|102248334|FG003|Induction Phase|Physician Decision|0|||
33643529|NCT02100696|102248335|FG004|Induction Phase|Physician Decision|0|||
33643530|NCT02100696|102248336|FG005|Induction Phase|Physician Decision|0|||
33643531|NCT02100696|102248331|FG000|Induction Phase|Multiple Reasons|5|||
33643532|NCT02100696|102248332|FG001|Induction Phase|Multiple Reasons|2|||
33643533|NCT02100696|102248333|FG002|Induction Phase|Multiple Reasons|8|||
33643534|NCT02100696|102248334|FG003|Induction Phase|Multiple Reasons|0|||
33643535|NCT02100696|102248335|FG004|Induction Phase|Multiple Reasons|0|||
33643536|NCT02100696|102248336|FG005|Induction Phase|Multiple Reasons|0|||
33643537|NCT02100696|102248331|FG000|Maintenance Phase|Adverse Event|0|||
33643538|NCT02100696|102248332|FG001|Maintenance Phase|Adverse Event|0|||
33643539|NCT02100696|102248333|FG002|Maintenance Phase|Adverse Event|0|||
33643540|NCT02100696|102248334|FG003|Maintenance Phase|Adverse Event|0|||
33643541|NCT02100696|102248335|FG004|Maintenance Phase|Adverse Event|0|||
33643542|NCT02100696|102248336|FG005|Maintenance Phase|Adverse Event|2|||
33643543|NCT02100696|102248331|FG000|Maintenance Phase|Lost to Follow-up|0|||
33643544|NCT02100696|102248332|FG001|Maintenance Phase|Lost to Follow-up|0|||
33643545|NCT02100696|102248333|FG002|Maintenance Phase|Lost to Follow-up|0|||
33643546|NCT02100696|102248334|FG003|Maintenance Phase|Lost to Follow-up|0|||
33643547|NCT02100696|102248335|FG004|Maintenance Phase|Lost to Follow-up|1|||
33643548|NCT02100696|102248336|FG005|Maintenance Phase|Lost to Follow-up|0|||
33243661|NCT00819234|100793972|FG007|Overall Study|Physician Decision|0|||
33243662|NCT00819234|100793973|FG008|Overall Study|Physician Decision|0|||
33243663|NCT00819234|100793974|FG009|Overall Study|Physician Decision|2|||
33243664|NCT00819234|100793965|FG000|Overall Study|Protocol Violation|0|||
33582783|NCT04776161|102022742|FG000|Overall Study|Adverse Event|0|||
33582784|NCT04776161|102022743|FG001|Overall Study|Adverse Event|1|||
33582785|NCT04776161|102022744|FG002|Overall Study|Adverse Event|1|||
33243665|NCT00819234|100793966|FG001|Overall Study|Protocol Violation|0|||
33243666|NCT00819234|100793967|FG002|Overall Study|Protocol Violation|1|||
33243667|NCT00819234|100793968|FG003|Overall Study|Protocol Violation|0|||
33243668|NCT00819234|100793969|FG004|Overall Study|Protocol Violation|0|||
33243669|NCT00819234|100793970|FG005|Overall Study|Protocol Violation|0|||
33243670|NCT00819234|100793971|FG006|Overall Study|Protocol Violation|0|||
33243671|NCT00819234|100793972|FG007|Overall Study|Protocol Violation|0|||
33243672|NCT00819234|100793973|FG008|Overall Study|Protocol Violation|0|||
33243673|NCT00819234|100793974|FG009|Overall Study|Protocol Violation|0|||
33243674|NCT00819234|100793965|FG000|Overall Study|Lost to Follow-up|2|||
33243675|NCT00819234|100793966|FG001|Overall Study|Lost to Follow-up|2|||
33243676|NCT00819234|100793967|FG002|Overall Study|Lost to Follow-up|0|||
33582786|NCT01648023|102022745|FG000|Overall Study|Screen Fail Post Randomization|1|||
33582787|NCT01648023|102022746|FG001|Overall Study|Screen Fail Post Randomization|2|||
33243677|NCT00819234|100793968|FG003|Overall Study|Lost to Follow-up|2|||
33243678|NCT00819234|100793969|FG004|Overall Study|Lost to Follow-up|1|||
33243679|NCT00819234|100793970|FG005|Overall Study|Lost to Follow-up|1|||
33243680|NCT00819234|100793971|FG006|Overall Study|Lost to Follow-up|1|||
33243681|NCT00819234|100793972|FG007|Overall Study|Lost to Follow-up|1|||
33243682|NCT00819234|100793973|FG008|Overall Study|Lost to Follow-up|1|||
33243683|NCT00819234|100793974|FG009|Overall Study|Lost to Follow-up|2|||
33243684|NCT02485353|100793979|FG000|Overall Study|Death|1|||
33243685|NCT02485353|100793979|FG000|Overall Study|Disease Progression|1|||
33243686|NCT02846415|100793980|FG000|Overall Study|Lost to Follow-up|2|||
33243687|NCT02846415|100793981|FG001|Overall Study|Lost to Follow-up|0|||
33243688|NCT02846415|100793980|FG000|Overall Study|Withdrawal by Subject|1|||
33243689|NCT02846415|100793981|FG001|Overall Study|Withdrawal by Subject|1|||
33243690|NCT01729871|100793983|FG000|Overall Study|Adverse Event|7|||
33243691|NCT01729871|100793984|FG001|Overall Study|Adverse Event|7|||
33243692|NCT01729871|100793983|FG000|Overall Study|Death|0|||
33243693|NCT01729871|100793984|FG001|Overall Study|Death|1|||
33243694|NCT01729871|100793983|FG000|Overall Study|Lack of Efficacy|0|||
33243695|NCT01729871|100793984|FG001|Overall Study|Lack of Efficacy|1|||
33243696|NCT01729871|100793983|FG000|Overall Study|Physician Decision|0|||
33243697|NCT01729871|100793984|FG001|Overall Study|Physician Decision|2|||
33243698|NCT01729871|100793983|FG000|Overall Study|Protocol Violation|1|||
33243699|NCT01729871|100793984|FG001|Overall Study|Protocol Violation|0|||
33243700|NCT01729871|100793983|FG000|Overall Study|Withdrawal by Subject|0|||
33243701|NCT01729871|100793984|FG001|Overall Study|Withdrawal by Subject|3|||
33243702|NCT01729871|100793983|FG000|Overall Study|Other|4|||
33582788|NCT00040742|102022750|FG000|Overall Study|Death|0|||
33582789|NCT00040742|102022751|FG001|Overall Study|Death|0|||
33643549|NCT02100696|102248331|FG000|Maintenance Phase|Protocol Violation|0|||
33643550|NCT02100696|102248332|FG001|Maintenance Phase|Protocol Violation|0|||
33643551|NCT02100696|102248333|FG002|Maintenance Phase|Protocol Violation|0|||
33643552|NCT02100696|102248334|FG003|Maintenance Phase|Protocol Violation|0|||
33582790|NCT00040742|102022752|FG002|Overall Study|Death|1|||
33582791|NCT00040742|102022753|FG003|Overall Study|Death|0|||
33582792|NCT00040742|102022750|FG000|Overall Study|Adverse Event|15|||
33582793|NCT00040742|102022751|FG001|Overall Study|Adverse Event|16|||
33582794|NCT00040742|102022752|FG002|Overall Study|Adverse Event|21|||
33582795|NCT00040742|102022753|FG003|Overall Study|Adverse Event|9|||
33582796|NCT00040742|102022750|FG000|Overall Study|Withdrawal by Subject|7|||
33643553|NCT02100696|102248335|FG004|Maintenance Phase|Protocol Violation|1|||
33582797|NCT00040742|102022751|FG001|Overall Study|Withdrawal by Subject|15|||
33243703|NCT01729871|100793984|FG001|Overall Study|Other|9|||
33243704|NCT03820986|100793985|FG000|Overall Study|Death|177|||
33243705|NCT03820986|100793986|FG001|Overall Study|Death|156|||
33243706|NCT03820986|100793985|FG000|Overall Study|Lost to Follow-up|0|||
33243707|NCT03820986|100793986|FG001|Overall Study|Lost to Follow-up|1|||
33243708|NCT03820986|100793985|FG000|Overall Study|Withdrawal by Subject|8|||
33243709|NCT03820986|100793986|FG001|Overall Study|Withdrawal by Subject|3|||
33243710|NCT03820986|100793985|FG000|Overall Study|Ongoing|149|||
33582798|NCT00040742|102022752|FG002|Overall Study|Withdrawal by Subject|10|||
33643554|NCT02100696|102248336|FG005|Maintenance Phase|Protocol Violation|0|||
33643555|NCT02100696|102248331|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33243711|NCT03820986|100793986|FG001|Overall Study|Ongoing|180|||
33243712|NCT00871429|100793987|FG000|Overall Study|Lost to Follow-up|6|||
33243713|NCT00871429|100793987|FG000|Overall Study|Withdrawal by Subject|17|||
33243714|NCT00871429|100793987|FG000|Overall Study|Questionnaire not completed|1|||
33243715|NCT00354029|100793989|FG000|Overall Study|Protocol Violation|4|||
33243716|NCT00354029|100793990|FG001|Overall Study|Protocol Violation|2|||
33243717|NCT00731042|100793992|FG000|Second Intervention|Did not meet inclusion criteria|0|||
33243718|NCT00731042|100793993|FG001|Second Intervention|Did not meet inclusion criteria|2|||
33243719|NCT01097655|100793995|FG000|Overall Study|Withdrawal by Subject|1|||
33243720|NCT01097655|100793995|FG000|Overall Study|Subject Documented Twice|1|||
33243721|NCT01097655|100793995|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
33243722|NCT05343455|100793996|FG000|Overall Study|Withdrawal by Subject|4|||
33243723|NCT05343455|100793997|FG001|Overall Study|Withdrawal by Subject|9|||
33243724|NCT05343455|100793998|FG002|Overall Study|Withdrawal by Subject|7|||
33243725|NCT05343455|100793996|FG000|Overall Study|Adverse Event|2|||
33243726|NCT05343455|100793997|FG001|Overall Study|Adverse Event|1|||
33243727|NCT05343455|100793998|FG002|Overall Study|Adverse Event|2|||
33243728|NCT05343455|100793996|FG000|Overall Study|Lost to Follow-up|1|||
33243729|NCT05343455|100793997|FG001|Overall Study|Lost to Follow-up|1|||
33243730|NCT05343455|100793998|FG002|Overall Study|Lost to Follow-up|3|||
33243731|NCT05343455|100793996|FG000|Overall Study|Pregnancy|1|||
33243732|NCT05343455|100793997|FG001|Overall Study|Pregnancy|0|||
33243733|NCT05343455|100793998|FG002|Overall Study|Pregnancy|0|||
33243734|NCT05343455|100793996|FG000|Overall Study|Physician Decision|0|||
33243735|NCT05343455|100793997|FG001|Overall Study|Physician Decision|0|||
33243736|NCT05343455|100793998|FG002|Overall Study|Physician Decision|1|||
33243737|NCT05343455|100793996|FG000|Overall Study|Protocol Violation|0|||
33582799|NCT00040742|102022753|FG003|Overall Study|Withdrawal by Subject|13|||
33582800|NCT00040742|102022750|FG000|Overall Study|Chemotoxicity|4|||
33243738|NCT05343455|100793997|FG001|Overall Study|Protocol Violation|1|||
33243739|NCT05343455|100793998|FG002|Overall Study|Protocol Violation|1|||
33243740|NCT02042443|100794001|FG000|Overall Study|Adverse Event|2|||
33243741|NCT02042443|100794002|FG001|Overall Study|Adverse Event|1|||
33243742|NCT02042443|100794001|FG000|Overall Study|Withdrawal by Subject|0|||
33243743|NCT02042443|100794002|FG001|Overall Study|Withdrawal by Subject|1|||
33243744|NCT02042443|100794001|FG000|Overall Study|Progression|21|||
33243745|NCT02042443|100794002|FG001|Overall Study|Progression|17|||
33243746|NCT02042443|100794001|FG000|Overall Study|not protocol specified|1|||
33243747|NCT02042443|100794002|FG001|Overall Study|not protocol specified|1|||
33243748|NCT02042443|100794001|FG000|Overall Study|Not eligible/not analyzable|3|||
33243749|NCT02042443|100794002|FG001|Overall Study|Not eligible/not analyzable|6|||
33243750|NCT04887285|100794005|FG000|Overall Study|Lost to Follow-up|0|||
33243751|NCT04887285|100794006|FG001|Overall Study|Lost to Follow-up|2|||
33243752|NCT04887285|100794007|FG002|Overall Study|Lost to Follow-up|3|||
33243753|NCT01919619|100794008|FG000|Overall Study|Physician Decision|1|||
33243754|NCT01919619|100794009|FG001|Overall Study|Physician Decision|1|||
33243755|NCT05484726|100794010|FG000|Overall Study|Protocol Violation|3|||
33243756|NCT05484726|100794011|FG001|Overall Study|Protocol Violation|3|||
33243757|NCT05484726|100794010|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
33243758|NCT05484726|100794011|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
33243759|NCT05484726|100794010|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
33582801|NCT00040742|102022751|FG001|Overall Study|Chemotoxicity|3|||
33582802|NCT00040742|102022752|FG002|Overall Study|Chemotoxicity|5|||
33582803|NCT00040742|102022753|FG003|Overall Study|Chemotoxicity|2|||
33643556|NCT02100696|102248332|FG001|Maintenance Phase|Withdrawal by Subject|0|||
33643557|NCT02100696|102248333|FG002|Maintenance Phase|Withdrawal by Subject|0|||
33643558|NCT02100696|102248334|FG003|Maintenance Phase|Withdrawal by Subject|1|||
33243760|NCT05484726|100794011|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
33243761|NCT05484726|100794010|FG000|Overall Study|continued need of mechanical ventilation|2|||
33243762|NCT05484726|100794011|FG001|Overall Study|continued need of mechanical ventilation|3|||
33243763|NCT05484726|100794010|FG000|Overall Study|Withdrawal by Subject|2|||
33243764|NCT05484726|100794011|FG001|Overall Study|Withdrawal by Subject|3|||
33243765|NCT05484726|100794010|FG000|Overall Study|IVH (G III & IV)|2|||
33243766|NCT05484726|100794011|FG001|Overall Study|IVH (G III & IV)|1|||
33243767|NCT05484726|100794010|FG000|Overall Study|NEC (stage II & III)|2|||
33243768|NCT05484726|100794011|FG001|Overall Study|NEC (stage II & III)|3|||
33582804|NCT00040742|102022750|FG000|Overall Study|Incomplete Forms|6|||
33582805|NCT00040742|102022751|FG001|Overall Study|Incomplete Forms|10|||
33582806|NCT00040742|102022752|FG002|Overall Study|Incomplete Forms|4|||
33643559|NCT02100696|102248335|FG004|Maintenance Phase|Withdrawal by Subject|4|||
33643560|NCT02100696|102248336|FG005|Maintenance Phase|Withdrawal by Subject|2|||
33643561|NCT02100696|102248331|FG000|Maintenance Phase|Physician Decision|0|||
33643562|NCT02100696|102248332|FG001|Maintenance Phase|Physician Decision|0|||
33643563|NCT02100696|102248333|FG002|Maintenance Phase|Physician Decision|0|||
33643564|NCT02100696|102248334|FG003|Maintenance Phase|Physician Decision|0|||
33643565|NCT02100696|102248335|FG004|Maintenance Phase|Physician Decision|1|||
33643566|NCT02100696|102248336|FG005|Maintenance Phase|Physician Decision|0|||
33582807|NCT00040742|102022753|FG003|Overall Study|Incomplete Forms|5|||
33582808|NCT00040742|102022750|FG000|Overall Study|Other medical|7|||
33643567|NCT02100696|102248331|FG000|Maintenance Phase|Multiple Reasons|0|||
33243769|NCT04248829|100794013|FG000|Overall Study|Disease progression|44|||
33243770|NCT04248829|100794014|FG001|Overall Study|Disease progression|109|||
33243771|NCT04248829|100794013|FG000|Overall Study|Adverse Event|19|||
33243772|NCT04248829|100794014|FG001|Overall Study|Adverse Event|18|||
33243773|NCT04248829|100794013|FG000|Overall Study|Withdrawal by Subject|11|||
33243774|NCT04248829|100794014|FG001|Overall Study|Withdrawal by Subject|2|||
33243775|NCT04248829|100794013|FG000|Overall Study|Lost to Follow-up|0|||
33243776|NCT04248829|100794014|FG001|Overall Study|Lost to Follow-up|1|||
33243777|NCT04248829|100794013|FG000|Overall Study|Death|12|||
33243778|NCT04248829|100794014|FG001|Overall Study|Death|14|||
33243779|NCT04248829|100794013|FG000|Overall Study|Physician Decision|2|||
33243780|NCT04248829|100794014|FG001|Overall Study|Physician Decision|4|||
33243781|NCT04248829|100794013|FG000|Overall Study|Any reason not specifically recorded|0|||
33243782|NCT04248829|100794014|FG001|Overall Study|Any reason not specifically recorded|2|||
33243783|NCT03070392|100794020|FG000|Overall Study|Not Treated|7|||
33243784|NCT03070392|100794021|FG001|Overall Study|Not Treated|0|||
33243785|NCT03070392|100794022|FG002|Overall Study|Not Treated|3|||
33243786|NCT03070392|100794023|FG003|Overall Study|Not Treated|12|||
33243787|NCT03070392|100794020|FG000|Overall Study|Death|3|||
33243788|NCT03070392|100794021|FG001|Overall Study|Death|0|||
33243789|NCT03070392|100794022|FG002|Overall Study|Death|0|||
33243790|NCT03070392|100794023|FG003|Overall Study|Death|1|||
33643568|NCT02100696|102248332|FG001|Maintenance Phase|Multiple Reasons|0|||
33643569|NCT02100696|102248333|FG002|Maintenance Phase|Multiple Reasons|0|||
33243791|NCT03070392|100794020|FG000|Overall Study|Withdrawal by Subject|7|||
33243792|NCT03070392|100794021|FG001|Overall Study|Withdrawal by Subject|0|||
33243793|NCT03070392|100794022|FG002|Overall Study|Withdrawal by Subject|0|||
33243794|NCT03070392|100794023|FG003|Overall Study|Withdrawal by Subject|3|||
33243795|NCT03070392|100794020|FG000|Overall Study|Physician Decision|1|||
33243796|NCT03070392|100794021|FG001|Overall Study|Physician Decision|0|||
33243797|NCT03070392|100794022|FG002|Overall Study|Physician Decision|0|||
33243798|NCT03070392|100794023|FG003|Overall Study|Physician Decision|2|||
33243799|NCT03070392|100794020|FG000|Overall Study|Progressive Disease|154|||
33243800|NCT03070392|100794021|FG001|Overall Study|Progressive Disease|6|||
33243801|NCT03070392|100794022|FG002|Overall Study|Progressive Disease|2|||
33243802|NCT03070392|100794023|FG003|Overall Study|Progressive Disease|70|||
33243803|NCT03070392|100794020|FG000|Overall Study|Adverse Event|6|||
33243804|NCT03070392|100794021|FG001|Overall Study|Adverse Event|1|||
33243805|NCT03070392|100794022|FG002|Overall Study|Adverse Event|1|||
33243806|NCT03070392|100794023|FG003|Overall Study|Adverse Event|3|||
33243807|NCT03070392|100794020|FG000|Overall Study|Alternate anticancer treatment|1|||
33243808|NCT03070392|100794021|FG001|Overall Study|Alternate anticancer treatment|0|||
33243809|NCT03070392|100794022|FG002|Overall Study|Alternate anticancer treatment|0|||
33243810|NCT03070392|100794023|FG003|Overall Study|Alternate anticancer treatment|1|||
33243811|NCT03070392|100794020|FG000|Overall Study|Ongoing|73|||
33243812|NCT03070392|100794021|FG001|Overall Study|Ongoing|0|||
33243813|NCT03070392|100794022|FG002|Overall Study|Ongoing|0|||
33243814|NCT03070392|100794023|FG003|Overall Study|Ongoing|11|||
33582809|NCT00040742|102022751|FG001|Overall Study|Other medical|5|||
33582810|NCT00040742|102022752|FG002|Overall Study|Other medical|5|||
33582811|NCT00040742|102022753|FG003|Overall Study|Other medical|5|||
33582812|NCT01643408|102022754|FG000|Overall Study|Adverse Event|12|||
33582813|NCT01643408|102022754|FG000|Overall Study|Other|2|||
33582814|NCT01102491|102022755|FG000|Overall Study|Protocol Violation|11|||
33582815|NCT01102491|102022756|FG001|Overall Study|Protocol Violation|12|||
33582816|NCT02100423|102022757|FG000|Overall Study|Death|1|||
33582817|NCT02100423|102022757|FG000|Overall Study|Withdrawal by Subject|3|||
33582818|NCT02100423|102022757|FG000|Overall Study|Adverse Event|1|||
33582819|NCT02100423|102022757|FG000|Overall Study|Physician Decision|1|||
33582820|NCT02779777|102022758|FG000|Overall Study|Disease Progression|1|||
33372510|NCT01496430|101251861|FG000|Overall Study|Lost to Follow-up|2|||
33582821|NCT02779777|102022759|FG001|Overall Study|Disease Progression|0|||
33582822|NCT02779777|102022760|FG002|Overall Study|Disease Progression|0|||
33643570|NCT02100696|102248334|FG003|Maintenance Phase|Multiple Reasons|0|||
33243815|NCT02820051|100794025|FG000|Overall Study|Lost to Follow-up|7|||
33243816|NCT02820051|100794026|FG001|Overall Study|Lost to Follow-up|4|||
33243817|NCT04889118|100794027|FG000|Overall Study|Death|33|||
33243818|NCT04889118|100794028|FG001|Overall Study|Death|37|||
33243819|NCT04889118|100794027|FG000|Overall Study|Ongoing in Study|31|||
33243820|NCT04889118|100794028|FG001|Overall Study|Ongoing in Study|30|||
33243821|NCT01304706|100794031|FG000|Overall Study|Adverse Event|2|||
33243822|NCT01304706|100794031|FG000|Overall Study|Lack of Efficacy|1|||
33243823|NCT01304706|100794031|FG000|Overall Study|Death|3|||
33243824|NCT01304706|100794031|FG000|Overall Study|Withdrawal by Subject|3|||
33243825|NCT01304706|100794031|FG000|Overall Study|Lost to Follow-up|7|||
33243826|NCT01304706|100794031|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
33582823|NCT02779777|102022758|FG000|Overall Study|Adverse Event|3|||
33243827|NCT05310084|100794036|FG000|Overall Study|Withdrawal by Subject|2|||
33243828|NCT05310084|100794037|FG001|Overall Study|Withdrawal by Subject|3|||
33243829|NCT05310084|100794036|FG000|Overall Study|Participant availability|0|||
33243830|NCT05310084|100794037|FG001|Overall Study|Participant availability|4|||
33243831|NCT05310084|100794036|FG000|Overall Study|Lost to Follow-up|1|||
33243832|NCT05310084|100794037|FG001|Overall Study|Lost to Follow-up|1|||
33243833|NCT05310084|100794036|FG000|Overall Study|Adverse Event|1|||
33243834|NCT05310084|100794037|FG001|Overall Study|Adverse Event|1|||
33243835|NCT05310084|100794036|FG000|Overall Study|Randomized but not vaccinated|4|||
33243836|NCT05310084|100794037|FG001|Overall Study|Randomized but not vaccinated|2|||
33243837|NCT03111095|100794038|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
33243838|NCT03111095|100794039|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
33243839|NCT03111095|100794038|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
33243840|NCT03111095|100794039|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
33243841|NCT01106287|100794040|FG000|Overall Study|Adverse Event|1|||
33243842|NCT01106287|100794041|FG001|Overall Study|Adverse Event|0|||
33243843|NCT01106287|100794042|FG002|Overall Study|Adverse Event|0|||
33243844|NCT01106287|100794043|FG003|Overall Study|Adverse Event|0|||
33243845|NCT04531540|100794048|FG000|Overall Study|Adverse Event|1|||
33243846|NCT04531540|100794048|FG000|Overall Study|Protocol Violation|3|||
33243847|NCT04531540|100794048|FG000|Overall Study|Withdrawal by Subject|4|||
33243848|NCT04531540|100794048|FG000|Overall Study|Found to be Ineligible|1|||
33243849|NCT03199469|100794055|FG000|Overall Study|Randomized, not treated|0|||
33243850|NCT03199469|100794056|FG001|Overall Study|Randomized, not treated|3|||
33243851|NCT03199469|100794055|FG000|Overall Study|Withdrawal by Subject|1|||
33243852|NCT03199469|100794056|FG001|Overall Study|Withdrawal by Subject|0|||
33243853|NCT03199469|100794055|FG000|Overall Study|Death|1|||
33243854|NCT03199469|100794056|FG001|Overall Study|Death|3|||
33243855|NCT03199469|100794055|FG000|Overall Study|Ongoing|5|||
33243856|NCT03199469|100794056|FG001|Overall Study|Ongoing|14|||
33243857|NCT04736056|100794057|FG000|Overall Study|Death|0|||
33372511|NCT01496430|101251862|FG001|Overall Study|Lost to Follow-up|3|||
33372512|NCT01496430|101251863|FG002|Overall Study|Lost to Follow-up|1|||
33372513|NCT01496430|101251861|FG000|Overall Study|Voluntary Withdrawal|2|||
33372514|NCT01496430|101251862|FG001|Overall Study|Voluntary Withdrawal|1|||
33372515|NCT01496430|101251863|FG002|Overall Study|Voluntary Withdrawal|6|||
33372516|NCT01496430|101251861|FG000|Overall Study|Principal Investigator Discretion|0|||
33372517|NCT01496430|101251862|FG001|Overall Study|Principal Investigator Discretion|1|||
33372518|NCT01496430|101251863|FG002|Overall Study|Principal Investigator Discretion|1|||
33372519|NCT01496430|101251861|FG000|Overall Study|Other|2|||
33372520|NCT01496430|101251862|FG001|Overall Study|Other|0|||
33372521|NCT01496430|101251863|FG002|Overall Study|Other|0|||
33372522|NCT01627067|101251865|FG000|Overall Study|Screen Failure|1|||
33372523|NCT01996904|101251866|FG000|Overall Study|Lost to Follow-up|38|||
33372524|NCT01996904|101251867|FG001|Overall Study|Lost to Follow-up|27|||
33372525|NCT01361009|101251871|FG000|Overall Study|Protocol Violation|116|||
33372526|NCT01263691|101251872|FG000|Overall Study|Lost to Follow-up|1|||
33372527|NCT01263691|101251873|FG001|Overall Study|Lost to Follow-up|0|||
33372528|NCT01263691|101251874|FG002|Overall Study|Lost to Follow-up|1|||
33372529|NCT01263691|101251875|FG003|Overall Study|Lost to Follow-up|1|||
33372530|NCT01263691|101251876|FG004|Overall Study|Lost to Follow-up|0|||
33372531|NCT01263691|101251877|FG005|Overall Study|Lost to Follow-up|0|||
33372532|NCT01263691|101251872|FG000|Overall Study|Withdrawal by Subject|1|||
33372533|NCT01263691|101251873|FG001|Overall Study|Withdrawal by Subject|0|||
33372534|NCT01263691|101251874|FG002|Overall Study|Withdrawal by Subject|0|||
33372535|NCT01263691|101251875|FG003|Overall Study|Withdrawal by Subject|0|||
33372536|NCT01263691|101251876|FG004|Overall Study|Withdrawal by Subject|0|||
33372537|NCT01263691|101251877|FG005|Overall Study|Withdrawal by Subject|0|||
33372538|NCT01263691|101251872|FG000|Overall Study|Adverse Event|1|||
33372539|NCT01263691|101251873|FG001|Overall Study|Adverse Event|0|||
33372540|NCT01263691|101251874|FG002|Overall Study|Adverse Event|0|||
33372541|NCT01263691|101251875|FG003|Overall Study|Adverse Event|0|||
33372542|NCT01263691|101251876|FG004|Overall Study|Adverse Event|0|||
33145628|NCT01315236|100448249|FG001|Double-blind Phase|Adverse Event|0|||
33145629|NCT01315236|100448248|FG000|Double-blind Phase|Withdrawal of Consent|1|||
33243858|NCT04736056|100794058|FG001|Overall Study|Death|0|||
33243859|NCT04736056|100794059|FG002|Overall Study|Death|0|||
33243860|NCT04736056|100794060|FG003|Overall Study|Death|1|||
33243861|NCT04736056|100794057|FG000|Overall Study|Lost to Follow-up|1|||
33243862|NCT04736056|100794058|FG001|Overall Study|Lost to Follow-up|0|||
33243863|NCT04736056|100794059|FG002|Overall Study|Lost to Follow-up|1|||
33372543|NCT01263691|101251877|FG005|Overall Study|Adverse Event|0|||
33145630|NCT01315236|100448249|FG001|Double-blind Phase|Withdrawal of Consent|0|||
33243864|NCT04736056|100794060|FG003|Overall Study|Lost to Follow-up|1|||
33145631|NCT01315236|100448248|FG000|Double-blind Phase|Lost to Follow-up|1|||
33372544|NCT01687413|101251885|FG000|Overall Study|Withdrawal by Subject|0|||
33372545|NCT01687413|101251886|FG001|Overall Study|Withdrawal by Subject|2|||
33372546|NCT01687413|101251885|FG000|Overall Study|Not eligible|0|||
33372547|NCT01687413|101251886|FG001|Overall Study|Not eligible|2|||
33372548|NCT01687413|101251885|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
33372549|NCT01687413|101251886|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
33243865|NCT04736056|100794057|FG000|Overall Study|Withdrawal by Subject|2|||
33243866|NCT04736056|100794058|FG001|Overall Study|Withdrawal by Subject|0|||
33243867|NCT04736056|100794059|FG002|Overall Study|Withdrawal by Subject|0|||
33243868|NCT04736056|100794060|FG003|Overall Study|Withdrawal by Subject|0|||
33243869|NCT04736056|100794057|FG000|Overall Study|Physician Decision|1|||
33243870|NCT04736056|100794058|FG001|Overall Study|Physician Decision|0|||
33243871|NCT04736056|100794059|FG002|Overall Study|Physician Decision|1|||
33243872|NCT04736056|100794060|FG003|Overall Study|Physician Decision|0|||
33243873|NCT02929108|100794061|FG000|Overall Study|Hospice patient death|100|||
33243874|NCT02929108|100794062|FG001|Overall Study|Hospice patient death|64|||
33243875|NCT02929108|100794063|FG002|Overall Study|Hospice patient death|28|||
33243876|NCT02929108|100794064|FG003|Overall Study|Hospice patient death|46|||
33243877|NCT02929108|100794065|FG004|Overall Study|Hospice patient death|55|||
33243878|NCT02929108|100794066|FG005|Overall Study|Hospice patient death|28|||
33243879|NCT02929108|100794067|FG006|Overall Study|Hospice patient death|78|||
33243880|NCT02812966|100794068|FG000|Overall Study|Death|1|||
33243881|NCT02812966|100794069|FG001|Overall Study|Death|0|||
33243882|NCT04771273|100794070|FG000|Dose Escalation Period|Not treated with trial medication|0|||
33243883|NCT04771273|100794071|FG001|Dose Escalation Period|Not treated with trial medication|1|||
33243884|NCT04771273|100794072|FG002|Dose Escalation Period|Not treated with trial medication|1|||
33243885|NCT04771273|100794073|FG003|Dose Escalation Period|Not treated with trial medication|0|||
33243886|NCT04771273|100794070|FG000|Dose Escalation Period|Other reasons than listed|2|||
33243887|NCT04771273|100794071|FG001|Dose Escalation Period|Other reasons than listed|0|||
33243888|NCT04771273|100794072|FG002|Dose Escalation Period|Other reasons than listed|2|||
33243889|NCT04771273|100794073|FG003|Dose Escalation Period|Other reasons than listed|1|||
33243890|NCT04771273|100794070|FG000|Dose Escalation Period|Protocol Violation|0|||
33243891|NCT04771273|100794071|FG001|Dose Escalation Period|Protocol Violation|0|||
33243892|NCT04771273|100794072|FG002|Dose Escalation Period|Protocol Violation|3|||
33243893|NCT04771273|100794073|FG003|Dose Escalation Period|Protocol Violation|1|||
33243894|NCT04771273|100794070|FG000|Dose Escalation Period|Burden of study procedures|1|||
33243895|NCT04771273|100794071|FG001|Dose Escalation Period|Burden of study procedures|0|||
33243896|NCT04771273|100794072|FG002|Dose Escalation Period|Burden of study procedures|0|||
33243897|NCT04771273|100794073|FG003|Dose Escalation Period|Burden of study procedures|0|||
33243898|NCT04771273|100794070|FG000|Dose Escalation Period|Change of residence|0|||
33243899|NCT04771273|100794071|FG001|Dose Escalation Period|Change of residence|0|||
33243900|NCT04771273|100794072|FG002|Dose Escalation Period|Change of residence|0|||
33243901|NCT04771273|100794073|FG003|Dose Escalation Period|Change of residence|1|||
33243902|NCT04771273|100794070|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
33145632|NCT01315236|100448249|FG001|Double-blind Phase|Lost to Follow-up|0|||
33145633|NCT01315236|100448248|FG000|Open-label Phase|Death|1|||
33145634|NCT01315236|100448249|FG001|Open-label Phase|Death|0|||
33145635|NCT01315236|100448248|FG000|Open-label Phase|Adverse Event|0|||
33145636|NCT01315236|100448249|FG001|Open-label Phase|Adverse Event|1|||
33145637|NCT01315236|100448248|FG000|Open-label Phase|Other|0|||
33243903|NCT04771273|100794071|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
33243904|NCT04771273|100794072|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
33243905|NCT04771273|100794073|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
33243906|NCT04771273|100794070|FG000|Dose Escalation Period|Adverse Event|8|||
33243907|NCT04771273|100794071|FG001|Dose Escalation Period|Adverse Event|9|||
33243908|NCT04771273|100794072|FG002|Dose Escalation Period|Adverse Event|12|||
33372550|NCT00403559|101251887|FG000|Overall Study|Adverse Event|0|||
33372551|NCT00403559|101251888|FG001|Overall Study|Adverse Event|1|||
33372552|NCT00403559|101251887|FG000|Overall Study|Lost to Follow-up|3|||
33372553|NCT00403559|101251888|FG001|Overall Study|Lost to Follow-up|3|||
33372554|NCT00403559|101251887|FG000|Overall Study|Withdrawal by Subject|1|||
33422379|NCT01586624|101437086|FG000|Overall Study|Adverse Event|3|||
33243909|NCT04771273|100794073|FG003|Dose Escalation Period|Adverse Event|2|||
33243910|NCT04771273|100794070|FG000|Maintenance Period|Other than listed|4|||
33243911|NCT04771273|100794071|FG001|Maintenance Period|Other than listed|2|||
33422380|NCT01586624|101437087|FG001|Overall Study|Adverse Event|0|||
33422381|NCT01586624|101437088|FG002|Overall Study|Adverse Event|2|||
33422382|NCT01586624|101437089|FG003|Overall Study|Adverse Event|1|||
33422383|NCT01586624|101437090|FG004|Overall Study|Adverse Event|3|||
33243912|NCT04771273|100794072|FG002|Maintenance Period|Other than listed|0|||
33243913|NCT04771273|100794073|FG003|Maintenance Period|Other than listed|3|||
33422384|NCT01586624|101437091|FG005|Overall Study|Adverse Event|3|||
33422385|NCT01586624|101437092|FG006|Overall Study|Adverse Event|2|||
33145638|NCT01315236|100448249|FG001|Open-label Phase|Other|1|||
33145639|NCT01315236|100448248|FG000|12-Month Follow-up Period|Death|0|||
33243914|NCT04771273|100794070|FG000|Maintenance Period|Burden of study procedures|1|||
33243915|NCT04771273|100794071|FG001|Maintenance Period|Burden of study procedures|0|||
33372555|NCT00403559|101251888|FG001|Overall Study|Withdrawal by Subject|0|||
33145640|NCT01315236|100448249|FG001|12-Month Follow-up Period|Death|1|||
33372556|NCT02410902|101251889|FG000|Overall Study|Adverse Event|2|||
33372557|NCT02410902|101251890|FG001|Overall Study|Adverse Event|3|||
33372558|NCT02410902|101251889|FG000|Overall Study|Lost to Follow-up|4|||
33372559|NCT02410902|101251890|FG001|Overall Study|Lost to Follow-up|1|||
33372560|NCT02410902|101251889|FG000|Overall Study|Protocol Violation|1|||
33372561|NCT02410902|101251890|FG001|Overall Study|Protocol Violation|4|||
33372562|NCT02410902|101251889|FG000|Overall Study|Withdrawal by Subject|6|||
33372563|NCT02410902|101251890|FG001|Overall Study|Withdrawal by Subject|8|||
33372564|NCT02410902|101251889|FG000|Overall Study|Non-Compliance|8|||
33372565|NCT02410902|101251890|FG001|Overall Study|Non-Compliance|2|||
33372566|NCT02750800|101251893|FG000|Overall Study|Adverse Event|18|||
33372567|NCT02750800|101251893|FG000|Overall Study|Lost to Follow-up|12|||
33422386|NCT01586624|101437093|FG007|Overall Study|Adverse Event|3|||
33372568|NCT02750800|101251893|FG000|Overall Study|Investigator decision|53|||
33372569|NCT02750800|101251893|FG000|Overall Study|Patient request|12|||
33372570|NCT02750800|101251893|FG000|Overall Study|Other, not specified|3|||
33372571|NCT01675011|101251894|FG000|Overall Study|Trial terminated by Sponsor|3|||
33372572|NCT01675011|101251895|FG001|Overall Study|Trial terminated by Sponsor|1|||
33372573|NCT03456713|101251897|FG000|Overall Study|Lost to Follow-up|1|||
33372574|NCT03456713|101251898|FG001|Overall Study|Lost to Follow-up|0|||
33372575|NCT03456713|101251899|FG002|Overall Study|Lost to Follow-up|0|||
33372576|NCT03456713|101251900|FG003|Overall Study|Lost to Follow-up|0|||
33372577|NCT04799405|101251901|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
33372578|NCT03007953|101251903|FG000|Overall Study|Withdrawal by Subject|5|||
33372579|NCT03007953|101251904|FG001|Overall Study|Withdrawal by Subject|2|||
33372580|NCT03007953|101251903|FG000|Overall Study|Death|5|||
33372581|NCT03007953|101251904|FG001|Overall Study|Death|7|||
33372582|NCT03007953|101251903|FG000|Overall Study|Lost to Follow-up|3|||
33372583|NCT03007953|101251904|FG001|Overall Study|Lost to Follow-up|2|||
33372584|NCT03007953|101251903|FG000|Overall Study|Enrolled in Hospice|3|||
33372585|NCT03007953|101251904|FG001|Overall Study|Enrolled in Hospice|2|||
33372586|NCT03650452|101251905|FG000|Overall Study|Physician Decision|1|||
33372587|NCT03650452|101251906|FG001|Overall Study|Physician Decision|0|||
33372588|NCT03650452|101251905|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
33372589|NCT03650452|101251906|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33372590|NCT03650452|101251905|FG000|Overall Study|Adverse Event|3|||
33372591|NCT03650452|101251906|FG001|Overall Study|Adverse Event|4|||
33372592|NCT03650452|101251905|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
33372593|NCT03650452|101251906|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
33372594|NCT01994226|101251907|FG000|Overall Study|Protocol Violation|13|||
33372595|NCT01994226|101251908|FG001|Overall Study|Protocol Violation|10|||
33372596|NCT01994226|101251907|FG000|Overall Study|Early Cessation of treatment|6|||
33372597|NCT01994226|101251908|FG001|Overall Study|Early Cessation of treatment|11|||
33372598|NCT04321252|101251912|FG000|Overall Study|Withdrawal by Subject|0|||
33372599|NCT04321252|101251913|FG001|Overall Study|Withdrawal by Subject|0|||
33372600|NCT04321252|101251914|FG002|Overall Study|Withdrawal by Subject|0|||
33372601|NCT04321252|101251915|FG003|Overall Study|Withdrawal by Subject|0|||
33372602|NCT04321252|101251916|FG004|Overall Study|Withdrawal by Subject|0|||
33372603|NCT04321252|101251917|FG005|Overall Study|Withdrawal by Subject|1|||
33372604|NCT04321252|101251918|FG006|Overall Study|Withdrawal by Subject|0|||
33372605|NCT04321252|101251919|FG007|Overall Study|Withdrawal by Subject|0|||
33372606|NCT04321252|101251920|FG008|Overall Study|Withdrawal by Subject|0|||
33372607|NCT01753076|101251921|FG000|Overall Study|Adverse Event|17|||
33372608|NCT01753076|101251922|FG001|Overall Study|Adverse Event|18|||
33372609|NCT01753076|101251921|FG000|Overall Study|Lack of Efficacy|3|||
33372610|NCT01753076|101251922|FG001|Overall Study|Lack of Efficacy|1|||
33372611|NCT01753076|101251921|FG000|Overall Study|Lost to Follow-up|2|||
33372612|NCT01753076|101251922|FG001|Overall Study|Lost to Follow-up|1|||
33372613|NCT01753076|101251921|FG000|Overall Study|Physician Decision|4|||
33372614|NCT01753076|101251922|FG001|Overall Study|Physician Decision|2|||
33372615|NCT01753076|101251921|FG000|Overall Study|Withdrawal by Subject|14|||
33372616|NCT01753076|101251922|FG001|Overall Study|Withdrawal by Subject|24|||
33372617|NCT01753076|101251921|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
33372618|NCT01753076|101251922|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
33372619|NCT01331239|101251923|FG000|Part II: Core Study|Adverse Event|0|||
33372620|NCT01331239|101251924|FG001|Part II: Core Study|Adverse Event|3|||
33372621|NCT01331239|101251925|FG002|Part II: Core Study|Adverse Event|0|||
33372622|NCT01331239|101251923|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
33372623|NCT01331239|101251924|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
33372624|NCT01331239|101251925|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
33372625|NCT01331239|101251923|FG000|Part II: Core Study|Withdrawal by Subject|0|||
33372626|NCT01331239|101251924|FG001|Part II: Core Study|Withdrawal by Subject|2|||
33372627|NCT01331239|101251925|FG002|Part II: Core Study|Withdrawal by Subject|0|||
33372628|NCT01331239|101251923|FG000|Part II: Core Study|Administrative problems|0|||
33372629|NCT01331239|101251924|FG001|Part II: Core Study|Administrative problems|1|||
33422387|NCT01586624|101437086|FG000|Overall Study|Physician Decision|0|||
33372630|NCT01331239|101251925|FG002|Part II: Core Study|Administrative problems|0|||
33372631|NCT00008138|101251926|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
33372632|NCT00008138|101251926|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
33372633|NCT00008138|101251926|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
33372634|NCT00008138|101251926|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
33372635|NCT00008138|101251926|FG000|Interval Debulking|Withdrawal by Subject|2|||
33372636|NCT00008138|101251926|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
33372637|NCT00008138|101251926|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
33372638|NCT00008138|101251926|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
33372639|NCT00366548|101251927|FG000|Infant Series|Adverse Event|1|||
33372640|NCT00366548|101251928|FG001|Infant Series|Adverse Event|3|||
33372641|NCT00366548|101251927|FG000|Infant Series|Protocol Violation|0|||
33372642|NCT00366548|101251928|FG001|Infant Series|Protocol Violation|1|||
33372643|NCT00366548|101251927|FG000|Infant Series|Withdrawal by Subject|3|||
33372644|NCT00366548|101251928|FG001|Infant Series|Withdrawal by Subject|1|||
33372645|NCT00366548|101251927|FG000|After Infant Series|Withdrawal by Subject|3|||
33372646|NCT00366548|101251928|FG001|After Infant Series|Withdrawal by Subject|1|||
33372647|NCT00366548|101251927|FG000|After Infant Series|Adverse Event|2|||
33372648|NCT00366548|101251928|FG001|After Infant Series|Adverse Event|0|||
33372649|NCT00366548|101251927|FG000|After Infant Series|Lost to Follow-up|1|||
33372650|NCT00366548|101251928|FG001|After Infant Series|Lost to Follow-up|0|||
33372651|NCT02935634|101251931|FG000|Randomization|Participant withdrew consent|0|||
33372652|NCT02935634|101251932|FG001|Randomization|Participant withdrew consent|1|||
33372653|NCT02935634|101251933|FG002|Randomization|Participant withdrew consent|0|||
33372654|NCT02935634|101251934|FG003|Randomization|Participant withdrew consent|0|||
33372655|NCT02935634|101251935|FG004|Randomization|Participant withdrew consent|0|||
33372656|NCT02935634|101251936|FG005|Randomization|Participant withdrew consent|0|||
33372657|NCT02935634|101251931|FG000|Randomization|Death|2|||
33372658|NCT02935634|101251932|FG001|Randomization|Death|1|||
33372659|NCT02935634|101251933|FG002|Randomization|Death|1|||
33372660|NCT02935634|101251934|FG003|Randomization|Death|0|||
33372661|NCT02935634|101251935|FG004|Randomization|Death|0|||
33372662|NCT02935634|101251936|FG005|Randomization|Death|0|||
33372663|NCT02935634|101251931|FG000|Randomization|Other reasons|0|||
33372664|NCT02935634|101251932|FG001|Randomization|Other reasons|2|||
33372665|NCT02935634|101251933|FG002|Randomization|Other reasons|2|||
33372666|NCT02935634|101251934|FG003|Randomization|Other reasons|0|||
33372667|NCT02935634|101251935|FG004|Randomization|Other reasons|0|||
33372668|NCT02935634|101251936|FG005|Randomization|Other reasons|0|||
33372669|NCT02935634|101251931|FG000|Treatment: Track 1|Disease progression|15|||
33372670|NCT02935634|101251932|FG001|Treatment: Track 1|Disease progression|17|||
33372671|NCT02935634|101251933|FG002|Treatment: Track 1|Disease progression|28|||
33422388|NCT01586624|101437087|FG001|Overall Study|Physician Decision|1|||
33422389|NCT01586624|101437088|FG002|Overall Study|Physician Decision|1|||
33422390|NCT01586624|101437089|FG003|Overall Study|Physician Decision|0|||
33422391|NCT01586624|101437090|FG004|Overall Study|Physician Decision|2|||
33422392|NCT01586624|101437091|FG005|Overall Study|Physician Decision|0|||
33422393|NCT01586624|101437092|FG006|Overall Study|Physician Decision|1|||
33422394|NCT01586624|101437093|FG007|Overall Study|Physician Decision|1|||
33422395|NCT01586624|101437086|FG000|Overall Study|Withdrawal by Subject|0|||
33422396|NCT01586624|101437087|FG001|Overall Study|Withdrawal by Subject|0|||
33422397|NCT01586624|101437088|FG002|Overall Study|Withdrawal by Subject|0|||
33422398|NCT01586624|101437089|FG003|Overall Study|Withdrawal by Subject|1|||
33422399|NCT01586624|101437090|FG004|Overall Study|Withdrawal by Subject|0|||
33422400|NCT01586624|101437091|FG005|Overall Study|Withdrawal by Subject|0|||
33422401|NCT01586624|101437092|FG006|Overall Study|Withdrawal by Subject|0|||
33422402|NCT01586624|101437093|FG007|Overall Study|Withdrawal by Subject|0|||
33422403|NCT01586624|101437086|FG000|Overall Study|Evidence of disease progression|1|||
33422404|NCT01586624|101437087|FG001|Overall Study|Evidence of disease progression|3|||
33422405|NCT01586624|101437088|FG002|Overall Study|Evidence of disease progression|2|||
33422406|NCT01586624|101437089|FG003|Overall Study|Evidence of disease progression|5|||
33422407|NCT01586624|101437090|FG004|Overall Study|Evidence of disease progression|3|||
33422408|NCT01586624|101437091|FG005|Overall Study|Evidence of disease progression|5|||
33422409|NCT01586624|101437092|FG006|Overall Study|Evidence of disease progression|4|||
33372672|NCT02935634|101251934|FG003|Treatment: Track 1|Disease progression|4|||
33372673|NCT02935634|101251935|FG004|Treatment: Track 1|Disease progression|6|||
33372674|NCT02935634|101251936|FG005|Treatment: Track 1|Disease progression|2|||
33372675|NCT02935634|101251931|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
33372676|NCT02935634|101251932|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
33372677|NCT02935634|101251933|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
33372678|NCT02935634|101251934|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
33372679|NCT02935634|101251935|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
33372680|NCT02935634|101251936|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
33372681|NCT02935634|101251931|FG000|Treatment: Track 1|Lost to Follow-up|1|||
33422410|NCT01586624|101437093|FG007|Overall Study|Evidence of disease progression|6|||
33643571|NCT02100696|102248335|FG004|Maintenance Phase|Multiple Reasons|2|||
33643572|NCT02100696|102248336|FG005|Maintenance Phase|Multiple Reasons|1|||
33643573|NCT01711216|102248340|FG000|Overall Study|Adverse Event|4|||
33643574|NCT01711216|102248340|FG000|Overall Study|Pregnancy|56|||
33643575|NCT01711216|102248340|FG000|Overall Study|Withdrawal by Subject|6|||
33643576|NCT01711216|102248340|FG000|Overall Study|Lost to Follow-up|46|||
33643577|NCT01711216|102248340|FG000|Overall Study|variety of other minor reasons|83|||
33643578|NCT01711216|102248340|FG000|Overall Study|no reason specified|22|||
33643579|NCT02252939|102248341|FG000|Overall Study|Lost to Follow-up|3|||
33643580|NCT02969655|102248342|FG000|Overall Study|Withdrawal by Subject|3|||
33643581|NCT02969655|102248343|FG001|Overall Study|Withdrawal by Subject|2|||
33643582|NCT02969655|102248342|FG000|Overall Study|Physician Decision|4|||
33145641|NCT01315236|100448248|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
33145642|NCT01315236|100448249|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
33145643|NCT02011893|100448250|FG000|Enrollment to Randomization|Adverse Event|2|||
33145644|NCT02011893|100448251|FG001|Enrollment to Randomization|Adverse Event|0|||
33145645|NCT02011893|100448252|FG002|Enrollment to Randomization|Adverse Event|0|||
33145646|NCT02011893|100448250|FG000|Enrollment to Randomization|Physician Decision|10|||
33145647|NCT02011893|100448251|FG001|Enrollment to Randomization|Physician Decision|0|||
33145648|NCT02011893|100448252|FG002|Enrollment to Randomization|Physician Decision|0|||
33145649|NCT02011893|100448250|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
33145650|NCT02011893|100448251|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
33145651|NCT02011893|100448252|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
33145652|NCT02011893|100448250|FG000|Enrollment to Randomization|Screening Failure|29|||
33145653|NCT02011893|100448251|FG001|Enrollment to Randomization|Screening Failure|0|||
33145654|NCT02011893|100448252|FG002|Enrollment to Randomization|Screening Failure|0|||
33145655|NCT02011893|100448250|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
33145656|NCT02011893|100448251|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
33145657|NCT02011893|100448252|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
33145658|NCT02011893|100448250|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
33145659|NCT02011893|100448251|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
33145660|NCT02011893|100448252|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
33145661|NCT02011893|100448250|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
33145662|NCT02011893|100448251|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
33372682|NCT02935634|101251932|FG001|Treatment: Track 1|Lost to Follow-up|0|||
33372683|NCT02935634|101251933|FG002|Treatment: Track 1|Lost to Follow-up|0|||
33582824|NCT02779777|102022759|FG001|Overall Study|Adverse Event|1|||
33582825|NCT02779777|102022760|FG002|Overall Study|Adverse Event|0|||
33582826|NCT02779777|102022758|FG000|Overall Study|Physician Decision|9|||
33582827|NCT02779777|102022759|FG001|Overall Study|Physician Decision|0|||
33582828|NCT02779777|102022760|FG002|Overall Study|Physician Decision|1|||
33582829|NCT02779777|102022758|FG000|Overall Study|Withdrawal by Subject|1|||
33582830|NCT02779777|102022759|FG001|Overall Study|Withdrawal by Subject|0|||
33582831|NCT02779777|102022760|FG002|Overall Study|Withdrawal by Subject|0|||
33582832|NCT03326063|102022761|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
33582833|NCT03326063|102022762|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
33643583|NCT02969655|102248343|FG001|Overall Study|Physician Decision|3|||
33643584|NCT02969655|102248342|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
33643585|NCT02969655|102248343|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
33643586|NCT02969655|102248342|FG000|Overall Study|Adverse Event|10|||
33643587|NCT02969655|102248343|FG001|Overall Study|Adverse Event|8|||
33643588|NCT03158285|102248344|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
33643589|NCT03158285|102248345|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
33643590|NCT03158285|102248346|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
33643591|NCT03158285|102248344|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
33643592|NCT03158285|102248345|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
33145663|NCT02011893|100448252|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
33145664|NCT02011893|100448250|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
33372684|NCT02935634|101251934|FG003|Treatment: Track 1|Lost to Follow-up|0|||
33372685|NCT02935634|101251935|FG004|Treatment: Track 1|Lost to Follow-up|0|||
33372686|NCT02935634|101251936|FG005|Treatment: Track 1|Lost to Follow-up|0|||
33422411|NCT01586624|101437086|FG000|Overall Study|Screen failure (no treatment received)|0|||
33582834|NCT03046446|102022763|FG000|Overall Study|Lack of Efficacy|7|||
33582835|NCT03046446|102022763|FG000|Overall Study|Adverse Event|6|||
33582836|NCT03046446|102022763|FG000|Overall Study|Lost to Follow-up|3|||
33582837|NCT03046446|102022763|FG000|Overall Study|Withdrawal by Subject|14|||
33145665|NCT02011893|100448251|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
33145666|NCT02011893|100448252|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
33145667|NCT02011893|100448250|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
33643593|NCT03158285|102248346|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
33643594|NCT03158285|102248344|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
33643595|NCT03158285|102248345|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
33643596|NCT03158285|102248346|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
33422412|NCT01586624|101437087|FG001|Overall Study|Screen failure (no treatment received)|0|||
33422413|NCT01586624|101437088|FG002|Overall Study|Screen failure (no treatment received)|0|||
33422414|NCT01586624|101437089|FG003|Overall Study|Screen failure (no treatment received)|0|||
33422415|NCT01586624|101437090|FG004|Overall Study|Screen failure (no treatment received)|0|||
33422416|NCT01586624|101437091|FG005|Overall Study|Screen failure (no treatment received)|0|||
33422417|NCT01586624|101437092|FG006|Overall Study|Screen failure (no treatment received)|1|||
33422418|NCT01586624|101437093|FG007|Overall Study|Screen failure (no treatment received)|0|||
33582838|NCT03046446|102022763|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
33582839|NCT03046446|102022763|FG000|Overall Study|Disease Progression (see caveats)|25|||
33582840|NCT03046446|102022763|FG000|Overall Study|Non OA related knee surgery|1|||
33582841|NCT04512001|102022764|FG000|Week 0 to Week 24|Adverse Event|14|||
33582842|NCT04512001|102022765|FG001|Week 0 to Week 24|Adverse Event|10|||
33582843|NCT04512001|102022766|FG002|Week 0 to Week 24|Adverse Event|0|||
33582844|NCT04512001|102022767|FG003|Week 0 to Week 24|Adverse Event|0|||
33582845|NCT04512001|102022768|FG004|Week 0 to Week 24|Adverse Event|0|||
33582846|NCT04512001|102022764|FG000|Week 0 to Week 24|Death|0|||
33582847|NCT04512001|102022765|FG001|Week 0 to Week 24|Death|2|||
33582848|NCT04512001|102022766|FG002|Week 0 to Week 24|Death|0|||
33643597|NCT03158285|102248344|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
33643598|NCT03158285|102248345|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
33145668|NCT02011893|100448251|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
33145669|NCT02011893|100448252|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
33145670|NCT01142128|100448255|FG000|Overall Study|Physician Decision|1|||
33145671|NCT01142128|100448255|FG000|Overall Study|Lost to Follow-up|1|||
33145672|NCT01142128|100448255|FG000|Overall Study|Withdrawal by Subject|2|||
33372687|NCT02935634|101251931|FG000|Treatment: Track 1|Study drug toxicity|2|||
33372688|NCT02935634|101251932|FG001|Treatment: Track 1|Study drug toxicity|1|||
33372689|NCT02935634|101251933|FG002|Treatment: Track 1|Study drug toxicity|3|||
33582849|NCT04512001|102022767|FG003|Week 0 to Week 24|Death|0|||
33582850|NCT04512001|102022768|FG004|Week 0 to Week 24|Death|0|||
33582851|NCT04512001|102022764|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
33582852|NCT04512001|102022765|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
33582853|NCT04512001|102022766|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
33582854|NCT04512001|102022767|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
33643599|NCT03158285|102248346|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
33643600|NCT03158285|102248344|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
33643601|NCT03158285|102248345|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
33643602|NCT03158285|102248346|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
33643603|NCT03158285|102248344|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
33643604|NCT03158285|102248345|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
33643605|NCT03158285|102248346|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
33643606|NCT03158285|102248344|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
33643607|NCT03158285|102248345|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
33643608|NCT03158285|102248346|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
33643609|NCT03158285|102248344|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
33643610|NCT03158285|102248345|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
33372690|NCT02935634|101251934|FG003|Treatment: Track 1|Study drug toxicity|0|||
33372691|NCT02935634|101251935|FG004|Treatment: Track 1|Study drug toxicity|0|||
33372692|NCT02935634|101251936|FG005|Treatment: Track 1|Study drug toxicity|1|||
33372693|NCT02935634|101251931|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
33372694|NCT02935634|101251932|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
33372695|NCT02935634|101251933|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
33372696|NCT02935634|101251934|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
33372697|NCT02935634|101251935|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
33422419|NCT01984229|101437094|FG000|Safety Follow-up Period|Adverse Event|1|||
33582855|NCT04512001|102022768|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
33582856|NCT04512001|102022764|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
33582857|NCT04512001|102022765|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
33582858|NCT04512001|102022766|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
33582859|NCT04512001|102022767|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
33582860|NCT04512001|102022768|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
33582861|NCT04512001|102022764|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
33643611|NCT03158285|102248346|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
33643612|NCT03158285|102248344|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
33643613|NCT03158285|102248345|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
33643614|NCT03158285|102248346|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
33643615|NCT03158285|102248344|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
33643616|NCT03158285|102248345|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
33422420|NCT01984229|101437095|FG001|Safety Follow-up Period|Adverse Event|1|||
33422421|NCT01984229|101437094|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
33422422|NCT01984229|101437095|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
33422423|NCT01364298|101437096|FG000|Overall Study|Adverse Event|3|||
33422424|NCT01364298|101437097|FG001|Overall Study|Adverse Event|4|||
33643617|NCT03158285|102248346|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
33643618|NCT03158285|102248344|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
33643619|NCT03158285|102248345|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
33643620|NCT03158285|102248346|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
33643621|NCT03158285|102248344|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
33643622|NCT03158285|102248345|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
33643623|NCT03158285|102248346|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
33643624|NCT03158285|102248344|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
33643625|NCT03158285|102248345|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
33145673|NCT01962922|100448259|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
33145674|NCT01962922|100448260|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
33145675|NCT01962922|100448259|FG000|PK Portion Day 7|non-compliance|1|||
33145676|NCT01962922|100448260|FG001|PK Portion Day 7|non-compliance|0|||
33145677|NCT01962922|100448259|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
33145678|NCT01962922|100448260|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
33145679|NCT01962922|100448259|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
33145680|NCT01962922|100448260|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
33145681|NCT01082640|100448262|FG000|Overall Study|Adverse Event|9|||
33145682|NCT01082640|100448263|FG001|Overall Study|Adverse Event|5|||
33145683|NCT01082640|100448264|FG002|Overall Study|Adverse Event|3|||
33145684|NCT01082640|100448262|FG000|Overall Study|Withdrawal by Subject|3|||
33145685|NCT01082640|100448263|FG001|Overall Study|Withdrawal by Subject|3|||
33145686|NCT01082640|100448264|FG002|Overall Study|Withdrawal by Subject|2|||
33145687|NCT01082640|100448262|FG000|Overall Study|Major protocol deviation|3|||
33145688|NCT01082640|100448263|FG001|Overall Study|Major protocol deviation|3|||
33145689|NCT01082640|100448264|FG002|Overall Study|Major protocol deviation|0|||
33145690|NCT01082640|100448262|FG000|Overall Study|Lost to Follow-up|0|||
33145691|NCT01082640|100448263|FG001|Overall Study|Lost to Follow-up|3|||
33145692|NCT01082640|100448264|FG002|Overall Study|Lost to Follow-up|0|||
33145693|NCT01082640|100448262|FG000|Overall Study|Other|2|||
33145694|NCT01082640|100448263|FG001|Overall Study|Other|1|||
33145695|NCT01082640|100448264|FG002|Overall Study|Other|3|||
33145696|NCT01115803|100448265|FG000|Overall Study|Withdrawal by Subject|0|||
33145697|NCT01115803|100448266|FG001|Overall Study|Withdrawal by Subject|0|||
33145698|NCT01115803|100448267|FG002|Overall Study|Withdrawal by Subject|0|||
33145699|NCT01115803|100448268|FG003|Overall Study|Withdrawal by Subject|0|||
33145700|NCT01115803|100448269|FG004|Overall Study|Withdrawal by Subject|0|||
33145701|NCT01115803|100448270|FG005|Overall Study|Withdrawal by Subject|0|||
33145702|NCT01115803|100448271|FG006|Overall Study|Withdrawal by Subject|1|||
33145703|NCT01115803|100448265|FG000|Overall Study|Lost to Follow-up|0|||
33145704|NCT01115803|100448266|FG001|Overall Study|Lost to Follow-up|0|||
33145705|NCT01115803|100448267|FG002|Overall Study|Lost to Follow-up|1|||
33145706|NCT01115803|100448268|FG003|Overall Study|Lost to Follow-up|0|||
33145707|NCT01115803|100448269|FG004|Overall Study|Lost to Follow-up|0|||
33145708|NCT01115803|100448270|FG005|Overall Study|Lost to Follow-up|0|||
33145709|NCT01115803|100448271|FG006|Overall Study|Lost to Follow-up|0|||
33145710|NCT01115803|100448265|FG000|Overall Study|Progressive Disease during Cycle1|0|||
33145711|NCT01115803|100448266|FG001|Overall Study|Progressive Disease during Cycle1|0|||
33145712|NCT01115803|100448267|FG002|Overall Study|Progressive Disease during Cycle1|0|||
33145713|NCT01115803|100448268|FG003|Overall Study|Progressive Disease during Cycle1|0|||
33145714|NCT01115803|100448269|FG004|Overall Study|Progressive Disease during Cycle1|0|||
33145715|NCT01115803|100448270|FG005|Overall Study|Progressive Disease during Cycle1|0|||
33145716|NCT01115803|100448271|FG006|Overall Study|Progressive Disease during Cycle1|1|||
33145717|NCT02514473|100448275|FG000|Overall Study|Adverse Event|0|||
33145718|NCT02514473|100448276|FG001|Overall Study|Adverse Event|2|||
33145719|NCT02514473|100448275|FG000|Overall Study|Withdrawal by Subject|2|||
33145720|NCT02514473|100448276|FG001|Overall Study|Withdrawal by Subject|1|||
33145721|NCT02514473|100448275|FG000|Overall Study|Lost to Follow-up|0|||
33145722|NCT02514473|100448276|FG001|Overall Study|Lost to Follow-up|1|||
33145723|NCT02514473|100448275|FG000|Overall Study|Other|1|||
33145724|NCT02514473|100448276|FG001|Overall Study|Other|1|||
33145725|NCT02605837|100448277|FG000|Overall Study|Adverse Event|3|||
33145726|NCT02605837|100448278|FG001|Overall Study|Adverse Event|1|||
33145727|NCT02605837|100448277|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33145728|NCT02605837|100448278|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33145729|NCT02605837|100448277|FG000|Overall Study|Withdrawal by Subject|8|||
33145730|NCT02605837|100448278|FG001|Overall Study|Withdrawal by Subject|8|||
33145731|NCT02605837|100448277|FG000|Overall Study|Physician Decision|0|||
33145732|NCT02605837|100448278|FG001|Overall Study|Physician Decision|1|||
33582862|NCT04512001|102022765|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
33643626|NCT03158285|102248346|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
33643627|NCT03158285|102248344|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
33643628|NCT03158285|102248345|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
33643629|NCT03158285|102248346|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
33643630|NCT03158285|102248344|FG000|Active Treatment Period: Week 52-100|Death|1|||
33643631|NCT03158285|102248345|FG001|Active Treatment Period: Week 52-100|Death|0|||
33643632|NCT03158285|102248346|FG002|Active Treatment Period: Week 52-100|Death|0|||
33643633|NCT03158285|102248344|FG000|Active Treatment Period: Week 52-100|Other|4|||
33643634|NCT03158285|102248345|FG001|Active Treatment Period: Week 52-100|Other|1|||
33643635|NCT03158285|102248346|FG002|Active Treatment Period: Week 52-100|Other|0|||
33643636|NCT00312195|102248348|FG000|Overall Study|Adverse Event|4|||
33643637|NCT00312195|102248349|FG001|Overall Study|Adverse Event|6|||
33643638|NCT00312195|102248348|FG000|Overall Study|Lost to Follow-up|1|||
33643639|NCT00312195|102248349|FG001|Overall Study|Lost to Follow-up|0|||
33643640|NCT00312195|102248348|FG000|Overall Study|Protocol Violation|1|||
33643641|NCT00312195|102248349|FG001|Overall Study|Protocol Violation|0|||
33643642|NCT00916929|102248350|FG000|Overall Study|Lost to Follow-up|1|||
33643643|NCT00916929|102248351|FG001|Overall Study|Lost to Follow-up|3|||
33643644|NCT00916929|102248350|FG000|Overall Study|Death|5|||
33643645|NCT00916929|102248351|FG001|Overall Study|Death|10|||
33643646|NCT00916929|102248350|FG000|Overall Study|Withdrawal by Subject|1|||
33145733|NCT00708201|100448282|FG000|Overall Study|Adverse Event|4|||
33422425|NCT01364298|101437096|FG000|Overall Study|Lack of adherence to treatment|1|||
33422426|NCT01364298|101437097|FG001|Overall Study|Lack of adherence to treatment|3|||
33422427|NCT01364298|101437096|FG000|Overall Study|Lack of Efficacy|1|||
33145734|NCT00708201|100448283|FG001|Overall Study|Adverse Event|4|||
33145735|NCT00708201|100448282|FG000|Overall Study|Withdrawal by Subject|1|||
33145736|NCT00708201|100448283|FG001|Overall Study|Withdrawal by Subject|1|||
33145737|NCT00708201|100448282|FG000|Overall Study|Lost to Follow-up|2|||
33145738|NCT00708201|100448283|FG001|Overall Study|Lost to Follow-up|0|||
33145739|NCT00708201|100448282|FG000|Overall Study|Protocol Violation|0|||
33372698|NCT02935634|101251936|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
33372699|NCT02935634|101251931|FG000|Treatment: Track 1|Participant withdrew consent|2|||
33422428|NCT01364298|101437097|FG001|Overall Study|Lack of Efficacy|0|||
33422429|NCT01364298|101437096|FG000|Overall Study|Lost to Follow-up|5|||
33422430|NCT01364298|101437097|FG001|Overall Study|Lost to Follow-up|10|||
33422431|NCT01364298|101437096|FG000|Overall Study|Withdrawal by Subject|3|||
33422432|NCT01364298|101437097|FG001|Overall Study|Withdrawal by Subject|3|||
33422433|NCT01364298|101437096|FG000|Overall Study|Other|1|||
33422434|NCT01364298|101437097|FG001|Overall Study|Other|3|||
33422435|NCT04444752|101437098|FG000|Overall Study|Adverse Event|1|||
33582863|NCT04512001|102022766|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
33582864|NCT04512001|102022767|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
33582865|NCT04512001|102022768|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
33582866|NCT04512001|102022764|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
33582867|NCT04512001|102022765|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
33582868|NCT04512001|102022766|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
33643647|NCT00916929|102248351|FG001|Overall Study|Withdrawal by Subject|5|||
33145740|NCT00708201|100448283|FG001|Overall Study|Protocol Violation|1|||
33145741|NCT02942576|100448288|FG000|Overall Study|Adverse Event|28|||
33145742|NCT02942576|100448289|FG001|Overall Study|Adverse Event|6|||
33145743|NCT02942576|100448288|FG000|Overall Study|Withdrawal by Subject|7|||
33243916|NCT04771273|100794072|FG002|Maintenance Period|Burden of study procedures|0|||
33372700|NCT02935634|101251932|FG001|Treatment: Track 1|Participant withdrew consent|0|||
33372701|NCT02935634|101251933|FG002|Treatment: Track 1|Participant withdrew consent|1|||
33372702|NCT02935634|101251934|FG003|Treatment: Track 1|Participant withdrew consent|0|||
33372703|NCT02935634|101251935|FG004|Treatment: Track 1|Participant withdrew consent|1|||
33372704|NCT02935634|101251936|FG005|Treatment: Track 1|Participant withdrew consent|0|||
33372705|NCT02935634|101251931|FG000|Treatment: Track 1|Other reasons|0|||
33372706|NCT02935634|101251932|FG001|Treatment: Track 1|Other reasons|0|||
33372707|NCT02935634|101251933|FG002|Treatment: Track 1|Other reasons|2|||
33372708|NCT02935634|101251934|FG003|Treatment: Track 1|Other reasons|0|||
33372709|NCT02935634|101251935|FG004|Treatment: Track 1|Other reasons|0|||
33372710|NCT02935634|101251936|FG005|Treatment: Track 1|Other reasons|0|||
33372711|NCT02935634|101251931|FG000|Treatment: Track 2|Disease progression|13|||
33422436|NCT04444752|101437099|FG001|Overall Study|Adverse Event|0|||
33643648|NCT00916929|102248350|FG000|Overall Study|Left ventricular epicardial lead|1|||
33145744|NCT02942576|100448289|FG001|Overall Study|Withdrawal by Subject|5|||
33145745|NCT02942576|100448288|FG000|Overall Study|Physician Decision|1|||
33145746|NCT02942576|100448289|FG001|Overall Study|Physician Decision|4|||
33372712|NCT02935634|101251932|FG001|Treatment: Track 2|Disease progression|26|||
33422437|NCT04444752|101437100|FG002|Overall Study|Adverse Event|0|||
33422438|NCT04444752|101437101|FG003|Overall Study|Adverse Event|2|||
33643649|NCT00916929|102248351|FG001|Overall Study|Left ventricular epicardial lead|2|||
33643650|NCT00916929|102248350|FG000|Overall Study|Transferred to hospice care|1|||
33643651|NCT00916929|102248351|FG001|Overall Study|Transferred to hospice care|1|||
33643652|NCT00916929|102248350|FG000|Overall Study|System explant|1|||
33643653|NCT00916929|102248351|FG001|Overall Study|System explant|0|||
33643654|NCT00916929|102248350|FG000|Overall Study|Moved to another state|0|||
33643655|NCT00916929|102248351|FG001|Overall Study|Moved to another state|1|||
33643656|NCT00916929|102248350|FG000|Overall Study|Device unable to process impedance data|0|||
33643657|NCT00916929|102248351|FG001|Overall Study|Device unable to process impedance data|7|||
33643658|NCT02427464|102248355|FG000|Overall Study|Adverse Event|6|||
33643659|NCT02427464|102248356|FG001|Overall Study|Adverse Event|1|||
33643660|NCT02427464|102248355|FG000|Overall Study|Lost to Follow-up|16|||
33643661|NCT02427464|102248356|FG001|Overall Study|Lost to Follow-up|5|||
33643662|NCT02427464|102248355|FG000|Overall Study|Physician Decision|2|||
33643663|NCT02427464|102248356|FG001|Overall Study|Physician Decision|0|||
33643664|NCT02427464|102248355|FG000|Overall Study|Withdrawal by Subject|10|||
33643665|NCT02427464|102248356|FG001|Overall Study|Withdrawal by Subject|8|||
33643666|NCT02427464|102248355|FG000|Overall Study|Noncompliance|16|||
33643667|NCT02427464|102248356|FG001|Overall Study|Noncompliance|10|||
33643668|NCT02139592|102248361|FG000|Overall Study|Case Report Forms Uncollected|8|||
33643669|NCT02269267|102248362|FG000|Overall Study|Death|5|||
33643670|NCT00499083|102248365|FG000|Overall Study|Not evaluable|3|||
33643671|NCT00436345|102248372|FG000|Overall Study|ICU resident beyond follow-up period|3|||
33643672|NCT00436345|102248373|FG001|Overall Study|ICU resident beyond follow-up period|0|||
33643673|NCT02873702|102248379|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
33643674|NCT02873702|102248380|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
33643675|NCT02873702|102248381|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
33643676|NCT02873702|102248382|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
33643677|NCT02873702|102248379|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
33643678|NCT02873702|102248380|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
33643679|NCT02873702|102248381|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
33643680|NCT02873702|102248382|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
33643681|NCT02873702|102248379|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
33643682|NCT02873702|102248380|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
33643683|NCT02873702|102248381|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
33643684|NCT02873702|102248382|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
33643685|NCT02873702|102248379|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
33643686|NCT02873702|102248380|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
33643687|NCT02873702|102248381|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
33643688|NCT02873702|102248382|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
33643689|NCT02873702|102248379|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
33643690|NCT02873702|102248380|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
33643691|NCT02873702|102248381|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
33643692|NCT02873702|102248382|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
33643693|NCT00433004|102248396|FG000|Overall Study|Lost to Follow-up|5|||
33643694|NCT00433004|102248397|FG001|Overall Study|Lost to Follow-up|7|||
33643695|NCT05083585|102248398|FG000|Overall Study|Death|1|||
33643696|NCT05083585|102248399|FG001|Overall Study|Death|1|||
33643697|NCT05083585|102248398|FG000|Overall Study|Lost to Follow-up|1|||
33643698|NCT05083585|102248399|FG001|Overall Study|Lost to Follow-up|1|||
33643699|NCT05083585|102248398|FG000|Overall Study|Withdrawal by Subject|2|||
33643700|NCT05083585|102248399|FG001|Overall Study|Withdrawal by Subject|0|||
33643701|NCT05083585|102248398|FG000|Overall Study|Randomized but not vaccinated|2|||
33643702|NCT05083585|102248399|FG001|Overall Study|Randomized but not vaccinated|0|||
33643703|NCT02474069|102248404|FG000|Selection Phase (SP)|Adverse Event|8|||
33643704|NCT02474069|102248405|FG001|Selection Phase (SP)|Adverse Event|0|||
33643705|NCT02474069|102248406|FG002|Selection Phase (SP)|Adverse Event|0|||
33643706|NCT02474069|102248404|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
33643707|NCT02474069|102248405|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
33643708|NCT02474069|102248406|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
33643709|NCT02474069|102248404|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
33643710|NCT02474069|102248405|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
33643711|NCT02474069|102248406|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
33643712|NCT02474069|102248404|FG000|Selection Phase (SP)|Physician Decision|1|||
33643713|NCT02474069|102248405|FG001|Selection Phase (SP)|Physician Decision|0|||
33643714|NCT02474069|102248406|FG002|Selection Phase (SP)|Physician Decision|0|||
33643715|NCT02474069|102248404|FG000|Selection Phase (SP)|Protocol Violation|1|||
33643716|NCT02474069|102248405|FG001|Selection Phase (SP)|Protocol Violation|0|||
33643717|NCT02474069|102248406|FG002|Selection Phase (SP)|Protocol Violation|0|||
33643718|NCT02474069|102248404|FG000|Selection Phase (SP)|No longer requires treatment|1|||
33643719|NCT02474069|102248405|FG001|Selection Phase (SP)|No longer requires treatment|0|||
33643720|NCT02474069|102248406|FG002|Selection Phase (SP)|No longer requires treatment|0|||
33643721|NCT02474069|102248404|FG000|Selection Phase (SP)|Technical Problem|1|||
33643722|NCT02474069|102248405|FG001|Selection Phase (SP)|Technical Problem|0|||
33643723|NCT02474069|102248406|FG002|Selection Phase (SP)|Technical Problem|0|||
33145747|NCT02942576|100448288|FG000|Overall Study|Other|10|||
33145748|NCT02942576|100448289|FG001|Overall Study|Other|8|||
33145749|NCT01565499|100448290|FG000|Overall Study|Physician Decision|1|||
33145750|NCT01565499|100448290|FG000|Overall Study|Adverse Event|5|||
33145751|NCT01565499|100448290|FG000|Overall Study|Withdrawal by Subject|2|||
33145752|NCT01653782|100448291|FG000|Overall Study|Withdrawal by Subject|9|||
33145753|NCT01653782|100448292|FG001|Overall Study|Withdrawal by Subject|15|||
33145754|NCT01653782|100448293|FG002|Overall Study|Withdrawal by Subject|4|||
33145755|NCT01653782|100448291|FG000|Overall Study|Lost to Follow-up|7|||
33145756|NCT01653782|100448292|FG001|Overall Study|Lost to Follow-up|3|||
33145757|NCT01653782|100448293|FG002|Overall Study|Lost to Follow-up|2|||
33145758|NCT00510874|100448294|FG000|Overall Study|Withdrawal by Subject|1|||
33145759|NCT00510874|100448295|FG001|Overall Study|Withdrawal by Subject|1|||
33145760|NCT00510874|100448296|FG002|Overall Study|Withdrawal by Subject|0|||
33145761|NCT00510874|100448297|FG003|Overall Study|Withdrawal by Subject|0|||
33145762|NCT00510874|100448298|FG004|Overall Study|Withdrawal by Subject|3|||
33145763|NCT00510874|100448299|FG005|Overall Study|Withdrawal by Subject|0|||
33145764|NCT00510874|100448300|FG006|Overall Study|Withdrawal by Subject|0|||
33145765|NCT00510874|100448294|FG000|Overall Study|Lost to Follow-up|2|||
33145766|NCT00510874|100448295|FG001|Overall Study|Lost to Follow-up|3|||
33145767|NCT00510874|100448296|FG002|Overall Study|Lost to Follow-up|1|||
33145768|NCT00510874|100448297|FG003|Overall Study|Lost to Follow-up|3|||
33145769|NCT00510874|100448298|FG004|Overall Study|Lost to Follow-up|4|||
33145770|NCT00510874|100448299|FG005|Overall Study|Lost to Follow-up|0|||
33145771|NCT00510874|100448300|FG006|Overall Study|Lost to Follow-up|1|||
33145772|NCT04389970|100448302|FG000|Overall Study|Lost to Follow-up|1|||
33145773|NCT02734433|100448303|FG000|Overall Study|Disease progression|1|||
33145774|NCT02734433|100448304|FG001|Overall Study|Disease progression|5|||
33145775|NCT02734433|100448303|FG000|Overall Study|Clinical progression|0|||
33145776|NCT02734433|100448304|FG001|Overall Study|Clinical progression|1|||
33145777|NCT02734433|100448303|FG000|Overall Study|Withdrawal by Subject|1|||
33145778|NCT02734433|100448304|FG001|Overall Study|Withdrawal by Subject|2|||
33145779|NCT01028378|100448305|FG000|Overall Study|Lost to Follow-up|12|||
33145780|NCT01028378|100448305|FG000|Overall Study|Withdrawal by Subject|1|||
33145781|NCT01028378|100448305|FG000|Overall Study|Adminstrative Reasons|4|||
33372713|NCT02935634|101251933|FG002|Treatment: Track 2|Disease progression|20|||
33372714|NCT02935634|101251934|FG003|Treatment: Track 2|Disease progression|5|||
33372715|NCT02935634|101251935|FG004|Treatment: Track 2|Disease progression|1|||
33372716|NCT02935634|101251936|FG005|Treatment: Track 2|Disease progression|4|||
33582869|NCT04512001|102022767|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
33582870|NCT04512001|102022768|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
33582871|NCT04512001|102022764|FG000|Week 24 to Week 63|Adverse Event|0|||
33582872|NCT04512001|102022765|FG001|Week 24 to Week 63|Adverse Event|0|||
33582873|NCT04512001|102022766|FG002|Week 24 to Week 63|Adverse Event|13|||
33582874|NCT04512001|102022767|FG003|Week 24 to Week 63|Adverse Event|8|||
33582875|NCT04512001|102022768|FG004|Week 24 to Week 63|Adverse Event|6|||
33582876|NCT04512001|102022764|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
33582877|NCT04512001|102022765|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
33582878|NCT04512001|102022766|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
33582879|NCT04512001|102022767|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
33582880|NCT04512001|102022768|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
33582881|NCT04512001|102022764|FG000|Week 24 to Week 63|Death|0|||
33582882|NCT04512001|102022765|FG001|Week 24 to Week 63|Death|0|||
33582883|NCT04512001|102022766|FG002|Week 24 to Week 63|Death|0|||
33582884|NCT04512001|102022767|FG003|Week 24 to Week 63|Death|1|||
33582885|NCT04512001|102022768|FG004|Week 24 to Week 63|Death|1|||
33582886|NCT04512001|102022764|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
33582887|NCT04512001|102022765|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
33582888|NCT04512001|102022766|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
33582889|NCT04512001|102022767|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
33582890|NCT04512001|102022768|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
33145782|NCT00976573|100448306|FG000|Overall Study|Ineligible|0|||
33145783|NCT00976573|100448307|FG001|Overall Study|Ineligible|1|||
33243917|NCT04771273|100794073|FG003|Maintenance Period|Burden of study procedures|0|||
33243918|NCT04771273|100794070|FG000|Maintenance Period|Change of residence|0|||
33372717|NCT02935634|101251931|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
33372718|NCT02935634|101251932|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
33582891|NCT04512001|102022764|FG000|Week 24 to Week 63|Miscellaneous|0|||
33582892|NCT04512001|102022765|FG001|Week 24 to Week 63|Miscellaneous|0|||
33582893|NCT04512001|102022766|FG002|Week 24 to Week 63|Miscellaneous|3|||
33145784|NCT00976573|100448306|FG000|Overall Study|Cancel prior to receiving treatment|4|||
33145785|NCT00976573|100448307|FG001|Overall Study|Cancel prior to receiving treatment|2|||
33145786|NCT02992132|100448308|FG000|Overall Study|Adverse Event|4|||
33145787|NCT02992132|100448309|FG001|Overall Study|Adverse Event|1|||
33145788|NCT02992132|100448310|FG002|Overall Study|Adverse Event|3|||
33145789|NCT02992132|100448308|FG000|Overall Study|Lack of Efficacy|2|||
33582894|NCT04512001|102022767|FG003|Week 24 to Week 63|Miscellaneous|2|||
33582895|NCT04512001|102022768|FG004|Week 24 to Week 63|Miscellaneous|1|||
33145790|NCT02992132|100448309|FG001|Overall Study|Lack of Efficacy|0|||
33145791|NCT02992132|100448310|FG002|Overall Study|Lack of Efficacy|0|||
33145792|NCT02992132|100448308|FG000|Overall Study|Non-compliance with study drug|2|||
33145793|NCT02992132|100448309|FG001|Overall Study|Non-compliance with study drug|0|||
33145794|NCT02992132|100448310|FG002|Overall Study|Non-compliance with study drug|0|||
33145795|NCT02992132|100448308|FG000|Overall Study|Progressive disease|1|||
33145796|NCT02992132|100448309|FG001|Overall Study|Progressive disease|0|||
33145797|NCT02992132|100448310|FG002|Overall Study|Progressive disease|0|||
33145798|NCT02992132|100448308|FG000|Overall Study|Protocol Violation|2|||
33145799|NCT02992132|100448309|FG001|Overall Study|Protocol Violation|2|||
33145800|NCT02992132|100448310|FG002|Overall Study|Protocol Violation|0|||
33145801|NCT02992132|100448308|FG000|Overall Study|Caregiver withdrew consent|2|||
33145802|NCT02992132|100448309|FG001|Overall Study|Caregiver withdrew consent|3|||
33422439|NCT04444752|101437098|FG000|Overall Study|Lost to Follow-up|2|||
33422440|NCT04444752|101437099|FG001|Overall Study|Lost to Follow-up|6|||
33422441|NCT04444752|101437100|FG002|Overall Study|Lost to Follow-up|2|||
33422442|NCT04444752|101437101|FG003|Overall Study|Lost to Follow-up|5|||
33422443|NCT04444752|101437098|FG000|Overall Study|Physician Decision|0|||
33422444|NCT04444752|101437099|FG001|Overall Study|Physician Decision|0|||
33643724|NCT02474069|102248404|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
33643725|NCT02474069|102248405|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
33643726|NCT02474069|102248406|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
33643727|NCT02474069|102248404|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
33643728|NCT02474069|102248405|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
33643729|NCT02474069|102248406|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
33643730|NCT02474069|102248404|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
33643731|NCT02474069|102248405|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
33643732|NCT02474069|102248406|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
33643733|NCT02474069|102248404|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
33643734|NCT02474069|102248405|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
33643735|NCT02474069|102248406|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
33643736|NCT02474069|102248404|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
33643737|NCT02474069|102248405|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
33643738|NCT02474069|102248406|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
33643739|NCT02474069|102248404|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
33643740|NCT02474069|102248405|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
33643741|NCT02474069|102248406|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
33643742|NCT01330108|102248407|FG000|Overall Study|Withdrawal by Subject|4|||
33643743|NCT01821560|102248409|FG000|Overall Study|Lost to Follow-up|5|||
33643744|NCT01821560|102248410|FG001|Overall Study|Lost to Follow-up|5|||
33643745|NCT01821560|102248409|FG000|Overall Study|Withdrawal by Subject|1|||
33643746|NCT01821560|102248410|FG001|Overall Study|Withdrawal by Subject|1|||
33643747|NCT01821560|102248409|FG000|Overall Study|Protocol Violation|0|||
33643748|NCT01821560|102248410|FG001|Overall Study|Protocol Violation|1|||
33643749|NCT01646125|102248414|FG000|Overall Study|Untreated|2|||
33643750|NCT01646125|102248415|FG001|Overall Study|Untreated|5|||
33643751|NCT01646125|102248414|FG000|Overall Study|Adverse Event|2|||
33643752|NCT01646125|102248415|FG001|Overall Study|Adverse Event|1|||
33422445|NCT04444752|101437100|FG002|Overall Study|Physician Decision|0|||
33422446|NCT04444752|101437101|FG003|Overall Study|Physician Decision|2|||
33422447|NCT04444752|101437098|FG000|Overall Study|Pregnancy|0|||
33422448|NCT04444752|101437099|FG001|Overall Study|Pregnancy|0|||
33422449|NCT04444752|101437100|FG002|Overall Study|Pregnancy|0|||
33422450|NCT04444752|101437101|FG003|Overall Study|Pregnancy|1|||
33422451|NCT04444752|101437098|FG000|Overall Study|Withdrawal by Subject|6|||
33422452|NCT04444752|101437099|FG001|Overall Study|Withdrawal by Subject|5|||
33422453|NCT04444752|101437100|FG002|Overall Study|Withdrawal by Subject|3|||
33422454|NCT04444752|101437101|FG003|Overall Study|Withdrawal by Subject|4|||
33422455|NCT04444752|101437098|FG000|Overall Study|Protocol Violation|1|||
33422456|NCT04444752|101437099|FG001|Overall Study|Protocol Violation|1|||
33422457|NCT04444752|101437100|FG002|Overall Study|Protocol Violation|0|||
33643753|NCT01646125|102248414|FG000|Overall Study|Death|1|||
33643754|NCT01646125|102248415|FG001|Overall Study|Death|1|||
33422458|NCT04444752|101437101|FG003|Overall Study|Protocol Violation|0|||
33422459|NCT04444752|101437098|FG000|Overall Study|Patient moving out of town|1|||
33145803|NCT02992132|100448310|FG002|Overall Study|Caregiver withdrew consent|2|||
33145804|NCT02992132|100448308|FG000|Overall Study|Withdrawal by Subject|0|||
33145805|NCT02992132|100448309|FG001|Overall Study|Withdrawal by Subject|2|||
33145806|NCT02992132|100448310|FG002|Overall Study|Withdrawal by Subject|1|||
33145807|NCT02992132|100448308|FG000|Overall Study|Physician Decision|0|||
33145808|NCT02992132|100448309|FG001|Overall Study|Physician Decision|0|||
33145809|NCT02992132|100448310|FG002|Overall Study|Physician Decision|1|||
33145810|NCT03091777|100448311|FG000|Overall Study|Pregnancy|2|||
33422460|NCT04444752|101437099|FG001|Overall Study|Patient moving out of town|0|||
33422461|NCT04444752|101437100|FG002|Overall Study|Patient moving out of town|0|||
33422462|NCT04444752|101437101|FG003|Overall Study|Patient moving out of town|1|||
33422463|NCT04444752|101437098|FG000|Overall Study|Lack of Efficacy|0|||
33422464|NCT04444752|101437099|FG001|Overall Study|Lack of Efficacy|0|||
33422465|NCT04444752|101437100|FG002|Overall Study|Lack of Efficacy|0|||
33422466|NCT04444752|101437101|FG003|Overall Study|Lack of Efficacy|1|||
33422467|NCT04444752|101437098|FG000|Overall Study|Death|0|||
33422468|NCT04444752|101437099|FG001|Overall Study|Death|0|||
33422469|NCT04444752|101437100|FG002|Overall Study|Death|1|||
33422470|NCT04444752|101437101|FG003|Overall Study|Death|0|||
33422471|NCT00575328|101437102|FG000|Overall Study|Adverse Event|1|||
33422472|NCT00575328|101437103|FG001|Overall Study|Adverse Event|1|||
33422473|NCT00575328|101437102|FG000|Overall Study|Lost to Follow-up|2|||
33422474|NCT00575328|101437103|FG001|Overall Study|Lost to Follow-up|1|||
33422475|NCT00449930|101437104|FG000|Overall Study|Adverse Event|9|||
33422476|NCT00449930|101437105|FG001|Overall Study|Adverse Event|19|||
33422477|NCT00449930|101437104|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
33422478|NCT00449930|101437105|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
33422479|NCT00449930|101437104|FG000|Overall Study|Lack of Efficacy|10|||
33422480|NCT00449930|101437105|FG001|Overall Study|Lack of Efficacy|1|||
33422481|NCT00449930|101437104|FG000|Overall Study|Lost to Follow-up|9|||
33422482|NCT00449930|101437105|FG001|Overall Study|Lost to Follow-up|14|||
33422483|NCT00449930|101437104|FG000|Overall Study|Physician Decision|1|||
33422484|NCT00449930|101437105|FG001|Overall Study|Physician Decision|2|||
33422485|NCT00449930|101437104|FG000|Overall Study|Protocol Violation|14|||
33422486|NCT00449930|101437105|FG001|Overall Study|Protocol Violation|15|||
33422487|NCT00449930|101437104|FG000|Overall Study|Withdrawal by Subject|16|||
33422488|NCT00449930|101437105|FG001|Overall Study|Withdrawal by Subject|23|||
33422489|NCT00449930|101437104|FG000|Overall Study|Glycemic discontinuation criteria|1|||
33422490|NCT00449930|101437105|FG001|Overall Study|Glycemic discontinuation criteria|1|||
33422491|NCT03707522|101437106|FG000|Overall Study|Lost to Follow-up|24|||
33422492|NCT03707522|101437107|FG001|Overall Study|Lost to Follow-up|27|||
33422493|NCT03707522|101437108|FG002|Overall Study|Lost to Follow-up|41|||
33422494|NCT03707522|101437109|FG003|Overall Study|Lost to Follow-up|36|||
33422495|NCT02576054|101437110|FG000|Overall Study|Withdrawal by Subject|1|||
33422496|NCT02482571|101437111|FG000|Overall Study|Adverse Event|1|||
33422497|NCT02482571|101437111|FG000|Overall Study|Scanner or Respiract failure|3|||
33422498|NCT02482571|101437111|FG000|Overall Study|Withdrawal by Subject|4|||
33422499|NCT01296152|101437116|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
33422500|NCT05016765|101437117|FG000|Overall Study|Lost to Follow-up|4|||
33422501|NCT00681824|101439656|FG000|Overall Study|withdrawn by investigator|0|||
33422502|NCT00681824|101439657|FG001|Overall Study|withdrawn by investigator|0|||
33422503|NCT00681824|101439658|FG002|Overall Study|withdrawn by investigator|1|||
33582896|NCT01104545|102022777|FG000|Overall Study|Adverse Event|0|||
33582897|NCT01104545|102022778|FG001|Overall Study|Adverse Event|1|||
33582898|NCT01104545|102022779|FG002|Overall Study|Adverse Event|2|||
33582899|NCT01772550|102022780|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
33582900|NCT01772550|102022781|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
33582901|NCT01772550|102022782|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
33582902|NCT01772550|102022780|FG000|Overall Study|Adverse Event|0|||
33582903|NCT01772550|102022781|FG001|Overall Study|Adverse Event|0|||
33582904|NCT01772550|102022782|FG002|Overall Study|Adverse Event|1|||
33643755|NCT01646125|102248414|FG000|Overall Study|Physician Decision|1|||
33643756|NCT01646125|102248415|FG001|Overall Study|Physician Decision|3|||
33643757|NCT01646125|102248414|FG000|Overall Study|Progressive disease|22|||
33643758|NCT01646125|102248415|FG001|Overall Study|Progressive disease|16|||
33422504|NCT00681824|101439656|FG000|Overall Study|scheduling conflict|1|||
33422505|NCT00681824|101439657|FG001|Overall Study|scheduling conflict|0|||
33422506|NCT00681824|101439658|FG002|Overall Study|scheduling conflict|0|||
33422507|NCT00681824|101439656|FG000|Overall Study|Death|0|||
33422508|NCT00681824|101439657|FG001|Overall Study|Death|1|||
33643759|NCT01646125|102248414|FG000|Overall Study|Study terminated by sponsor|2|||
33643760|NCT01646125|102248415|FG001|Overall Study|Study terminated by sponsor|1|||
33422509|NCT00681824|101439658|FG002|Overall Study|Death|0|||
33422510|NCT02419469|101439660|FG000|Overall Study|Withdrawal by Subject|1|||
33422511|NCT01542736|101439661|FG000|Overall Study|Death|1|||
33422512|NCT01027884|101439662|FG000|Overall Study|Adverse Event|2|||
33422513|NCT01027884|101439663|FG001|Overall Study|Adverse Event|1|||
33422514|NCT01027884|101439662|FG000|Overall Study|Protocol Violation|1|||
33422515|NCT01027884|101439663|FG001|Overall Study|Protocol Violation|0|||
33422516|NCT01027884|101439662|FG000|Overall Study|Non-compliance|1|||
33643761|NCT01646125|102248414|FG000|Overall Study|Subject/Guardian decision|1|||
33643762|NCT01646125|102248415|FG001|Overall Study|Subject/Guardian decision|1|||
33422517|NCT01027884|101439663|FG001|Overall Study|Non-compliance|1|||
33422518|NCT01027884|101439662|FG000|Overall Study|Withdrawal by Subject|0|||
33422519|NCT01027884|101439663|FG001|Overall Study|Withdrawal by Subject|1|||
33422520|NCT01027884|101439662|FG000|Overall Study|Lost to Follow-up|0|||
33422521|NCT01027884|101439663|FG001|Overall Study|Lost to Follow-up|1|||
33422522|NCT01027884|101439662|FG000|Overall Study|Spinal fixation surgery|0|||
33643763|NCT00853567|102248416|FG000|Overall Study|Study prematurely terminated|71|||
33422523|NCT01027884|101439663|FG001|Overall Study|Spinal fixation surgery|3|||
33145811|NCT03091777|100448312|FG001|Overall Study|Pregnancy|1|||
33145812|NCT03091777|100448313|FG002|Overall Study|Pregnancy|0|||
33243919|NCT04771273|100794071|FG001|Maintenance Period|Change of residence|1|||
33243920|NCT04771273|100794072|FG002|Maintenance Period|Change of residence|3|||
33243921|NCT04771273|100794073|FG003|Maintenance Period|Change of residence|0|||
33243922|NCT04771273|100794070|FG000|Maintenance Period|Perceived lack of efficacy|0|||
33243923|NCT04771273|100794071|FG001|Maintenance Period|Perceived lack of efficacy|0|||
33243924|NCT04771273|100794072|FG002|Maintenance Period|Perceived lack of efficacy|0|||
33243925|NCT04771273|100794073|FG003|Maintenance Period|Perceived lack of efficacy|1|||
33243926|NCT04771273|100794070|FG000|Maintenance Period|Adverse Event|4|||
33243927|NCT04771273|100794071|FG001|Maintenance Period|Adverse Event|5|||
33243928|NCT04771273|100794072|FG002|Maintenance Period|Adverse Event|5|||
33243929|NCT04771273|100794073|FG003|Maintenance Period|Adverse Event|0|||
33145813|NCT03091777|100448311|FG000|Overall Study|Adverse Event|2|||
33145814|NCT03091777|100448312|FG001|Overall Study|Adverse Event|1|||
33243930|NCT01456780|100794074|FG000|Overall Study|Lost to Follow-up|3|||
33243931|NCT01456780|100794075|FG001|Overall Study|Lost to Follow-up|3|||
33243932|NCT01456780|100794076|FG002|Overall Study|Lost to Follow-up|0|||
33243933|NCT01723774|100794077|FG000|Neoadjuvant|Ki67 > 10%|4|||
33243934|NCT01723774|100794078|FG001|Neoadjuvant|Ki67 > 10%|0|||
33243935|NCT01723774|100794079|FG002|Neoadjuvant|Ki67 > 10%|10|||
33243936|NCT01723774|100794080|FG003|Neoadjuvant|Ki67 > 10%|0|||
33243937|NCT01723774|100794077|FG000|Neoadjuvant|Withdrawal by Subject|3|||
33243938|NCT01723774|100794078|FG001|Neoadjuvant|Withdrawal by Subject|1|||
33243939|NCT01723774|100794079|FG002|Neoadjuvant|Withdrawal by Subject|0|||
33243940|NCT01723774|100794080|FG003|Neoadjuvant|Withdrawal by Subject|0|||
33243941|NCT01723774|100794077|FG000|Neoadjuvant|Disease progression|0|||
33243942|NCT01723774|100794078|FG001|Neoadjuvant|Disease progression|1|||
33243943|NCT01723774|100794079|FG002|Neoadjuvant|Disease progression|1|||
33243944|NCT01723774|100794080|FG003|Neoadjuvant|Disease progression|0|||
33243945|NCT01723774|100794077|FG000|Neoadjuvant|Adverse Event|0|||
33243946|NCT01723774|100794078|FG001|Neoadjuvant|Adverse Event|1|||
33243947|NCT01723774|100794079|FG002|Neoadjuvant|Adverse Event|2|||
33243948|NCT01723774|100794080|FG003|Neoadjuvant|Adverse Event|0|||
33243949|NCT01723774|100794077|FG000|Neoadjuvant|High estradiol|0|||
33243950|NCT01723774|100794078|FG001|Neoadjuvant|High estradiol|1|||
33243951|NCT01723774|100794079|FG002|Neoadjuvant|High estradiol|0|||
33243952|NCT01723774|100794080|FG003|Neoadjuvant|High estradiol|0|||
33243953|NCT01123161|100794081|FG000|Overall Study|Lost to Follow-up|1|||
33243954|NCT01123161|100794082|FG001|Overall Study|Lost to Follow-up|0|||
33243955|NCT01123161|100794081|FG000|Overall Study|Withdrawal by Subject|1|||
33243956|NCT01123161|100794082|FG001|Overall Study|Withdrawal by Subject|0|||
33243957|NCT03681639|100794085|FG000|Overall Study|Death|4|||
33243958|NCT03681639|100794085|FG000|Overall Study|Lost to Follow-up|2|||
33243959|NCT03681639|100794085|FG000|Overall Study|Withdrawal by Subject|1|||
33243960|NCT03681639|100794085|FG000|Overall Study|Adverse Event|2|||
33243961|NCT01390857|100794086|FG000|Overall Study|Protocol Violation|2|||
33243962|NCT01390857|100794086|FG000|Overall Study|Lost to Follow-up|1|||
33243963|NCT01390857|100794086|FG000|Overall Study|No Visit after the First Visit|7|||
33243964|NCT02652130|100794087|FG000|Overall Study|Death|1|||
33243965|NCT00991276|100794088|FG000|First Intervention Period|Adverse Event|0|||
33243966|NCT00991276|100794089|FG001|First Intervention Period|Adverse Event|1|||
33243967|NCT00991276|100794090|FG002|First Intervention Period|Adverse Event|0|||
33243968|NCT00991276|100794091|FG003|First Intervention Period|Adverse Event|1|||
33243969|NCT00991276|100794092|FG004|First Intervention Period|Adverse Event|0|||
33582905|NCT03146663|102022785|FG000|Overall Study|Did not receive study treatment|1|||
33145815|NCT03091777|100448313|FG002|Overall Study|Adverse Event|4|||
33145816|NCT03091777|100448311|FG000|Overall Study|Withdrawal by Subject|4|||
33145817|NCT03091777|100448312|FG001|Overall Study|Withdrawal by Subject|2|||
33145818|NCT03091777|100448313|FG002|Overall Study|Withdrawal by Subject|6|||
33145819|NCT03091777|100448311|FG000|Overall Study|Protocol Violation|2|||
33145820|NCT03091777|100448312|FG001|Overall Study|Protocol Violation|1|||
33145821|NCT03091777|100448313|FG002|Overall Study|Protocol Violation|1|||
33145822|NCT03091777|100448311|FG000|Overall Study|Lost to Follow-up|12|||
33145823|NCT03091777|100448312|FG001|Overall Study|Lost to Follow-up|14|||
33145824|NCT03091777|100448313|FG002|Overall Study|Lost to Follow-up|7|||
33145825|NCT03091777|100448311|FG000|Overall Study|Lack of Efficacy|0|||
33145826|NCT03091777|100448312|FG001|Overall Study|Lack of Efficacy|0|||
33145827|NCT03091777|100448313|FG002|Overall Study|Lack of Efficacy|5|||
33145828|NCT03091777|100448311|FG000|Overall Study|Noncompliance with study drug|2|||
33145829|NCT03091777|100448312|FG001|Overall Study|Noncompliance with study drug|3|||
33145830|NCT03091777|100448313|FG002|Overall Study|Noncompliance with study drug|1|||
33145831|NCT03091777|100448311|FG000|Overall Study|Physician Decision|1|||
33243970|NCT00991276|100794093|FG005|First Intervention Period|Adverse Event|0|||
33243971|NCT00991276|100794088|FG000|First Intervention Period|Protocol Violation|0|||
33145832|NCT03091777|100448312|FG001|Overall Study|Physician Decision|0|||
33243972|NCT00991276|100794089|FG001|First Intervention Period|Protocol Violation|0|||
33243973|NCT00991276|100794090|FG002|First Intervention Period|Protocol Violation|0|||
33243974|NCT00991276|100794091|FG003|First Intervention Period|Protocol Violation|0|||
33243975|NCT00991276|100794092|FG004|First Intervention Period|Protocol Violation|2|||
33243976|NCT00991276|100794093|FG005|First Intervention Period|Protocol Violation|0|||
33243977|NCT00991276|100794088|FG000|First Intervention Period|Insufficient clinical response|0|||
33243978|NCT00991276|100794089|FG001|First Intervention Period|Insufficient clinical response|0|||
33243979|NCT00991276|100794090|FG002|First Intervention Period|Insufficient clinical response|0|||
33243980|NCT00991276|100794091|FG003|First Intervention Period|Insufficient clinical response|0|||
33243981|NCT00991276|100794092|FG004|First Intervention Period|Insufficient clinical response|1|||
33243982|NCT00991276|100794093|FG005|First Intervention Period|Insufficient clinical response|0|||
33372719|NCT02935634|101251933|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
33372720|NCT02935634|101251934|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
33372721|NCT02935634|101251935|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
33372722|NCT02935634|101251936|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
33372723|NCT02935634|101251931|FG000|Treatment: Track 2|Study drug toxicity|7|||
33372724|NCT02935634|101251932|FG001|Treatment: Track 2|Study drug toxicity|3|||
33372725|NCT02935634|101251933|FG002|Treatment: Track 2|Study drug toxicity|0|||
33372726|NCT02935634|101251934|FG003|Treatment: Track 2|Study drug toxicity|0|||
33372727|NCT02935634|101251935|FG004|Treatment: Track 2|Study drug toxicity|0|||
33372728|NCT02935634|101251936|FG005|Treatment: Track 2|Study drug toxicity|0|||
33372729|NCT02935634|101251931|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
33372730|NCT02935634|101251932|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
33372731|NCT02935634|101251933|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
33372732|NCT02935634|101251934|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
33372733|NCT02935634|101251935|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
33372734|NCT02935634|101251936|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
33372735|NCT02935634|101251931|FG000|Treatment: Track 2|Participant withdrew consent|0|||
33372736|NCT02935634|101251932|FG001|Treatment: Track 2|Participant withdrew consent|1|||
33372737|NCT02935634|101251933|FG002|Treatment: Track 2|Participant withdrew consent|1|||
33372738|NCT02935634|101251934|FG003|Treatment: Track 2|Participant withdrew consent|0|||
33372739|NCT02935634|101251935|FG004|Treatment: Track 2|Participant withdrew consent|1|||
33372740|NCT02935634|101251936|FG005|Treatment: Track 2|Participant withdrew consent|0|||
33372741|NCT02108951|101251943|FG000|Overall Study|Lost to Follow-up|1|||
33372742|NCT02108951|101251943|FG000|Overall Study|Patient's/guardian's decision|1|||
33372743|NCT02108951|101251943|FG000|Overall Study|Study Terminated by Sponsor|14|||
33372744|NCT03471767|101251947|FG000|Overall Study|Withdrawal by Subject|3|||
33372745|NCT03471767|101251948|FG001|Overall Study|Withdrawal by Subject|1|||
33372746|NCT03471767|101251947|FG000|Overall Study|Adverse Event|1|||
33372747|NCT03471767|101251948|FG001|Overall Study|Adverse Event|0|||
33372748|NCT03471767|101251947|FG000|Overall Study|Lost to Follow-up|1|||
33372749|NCT03471767|101251948|FG001|Overall Study|Lost to Follow-up|0|||
33372750|NCT03471767|101251947|FG000|Overall Study|PI Withdrawal|1|||
33372751|NCT03471767|101251948|FG001|Overall Study|PI Withdrawal|3|||
33372752|NCT03298412|101251951|FG000|Run-in Period|Other, Not Specified|1|||
33372753|NCT03298412|101251951|FG000|Run-in Period|Disease Progression|1|||
33372754|NCT03298412|101251951|FG000|Run-in Period|Ineligibility Determined|1|||
33372755|NCT03298412|101251951|FG000|Run-in Period|Decision by Sponsor|6|||
33372756|NCT00051558|101251952|FG000|Overall Study|Adverse Event|30|||
33372757|NCT00051558|101251953|FG001|Overall Study|Adverse Event|18|||
33372758|NCT00051558|101251952|FG000|Overall Study|Withdrawal by Subject|29|||
33372759|NCT00051558|101251953|FG001|Overall Study|Withdrawal by Subject|42|||
33372760|NCT00051558|101251952|FG000|Overall Study|Death|9|||
33372761|NCT00051558|101251953|FG001|Overall Study|Death|15|||
33422524|NCT02643966|101439664|FG000|First Screening Round|ineligible|1|||
33422525|NCT02643966|101439664|FG000|First Screening Round|excluded from analysis|2|||
33422526|NCT02643966|101439664|FG000|First Screening Round|Lost to Follow-up|56|||
33422527|NCT02643966|101439664|FG000|First Screening Round|Withdrawal by Subject|28|||
33422528|NCT02643966|101439664|FG000|First Screening Round|Death|1|||
33422529|NCT02643966|101439664|FG000|Between First and Second Screening|Lost to Follow-up|65|||
33582906|NCT03146663|102022786|FG001|Overall Study|Did not receive study treatment|1|||
33582907|NCT03835481|102022787|FG000|Double-blind Period|Other not stated below|0|||
33582908|NCT03835481|102022788|FG001|Double-blind Period|Other not stated below|0|||
33582909|NCT03835481|102022789|FG002|Double-blind Period|Other not stated below|0|||
33243983|NCT00991276|100794088|FG000|First Intervention Period|Other|0|||
33372762|NCT00051558|101251952|FG000|Overall Study|Lost to Follow-up|4|||
33372763|NCT00051558|101251953|FG001|Overall Study|Lost to Follow-up|13|||
33372764|NCT00051558|101251952|FG000|Overall Study|Protocol Violation|3|||
33372765|NCT00051558|101251953|FG001|Overall Study|Protocol Violation|4|||
33372766|NCT00051558|101251952|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
33372767|NCT00051558|101251953|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
33422530|NCT02643966|101439664|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
33372768|NCT00051558|101251952|FG000|Overall Study|Sponsor Decision|6|||
33372769|NCT00051558|101251953|FG001|Overall Study|Sponsor Decision|1|||
33422531|NCT02643966|101439664|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
33243984|NCT00991276|100794089|FG001|First Intervention Period|Other|0|||
33243985|NCT00991276|100794090|FG002|First Intervention Period|Other|0|||
33243986|NCT00991276|100794091|FG003|First Intervention Period|Other|1|||
33243987|NCT00991276|100794092|FG004|First Intervention Period|Other|1|||
33243988|NCT00991276|100794093|FG005|First Intervention Period|Other|0|||
33243989|NCT00991276|100794088|FG000|First Intervention Period|Withdrawal by Subject|0|||
33243990|NCT00991276|100794089|FG001|First Intervention Period|Withdrawal by Subject|1|||
33243991|NCT00991276|100794090|FG002|First Intervention Period|Withdrawal by Subject|0|||
33243992|NCT00991276|100794091|FG003|First Intervention Period|Withdrawal by Subject|1|||
33243993|NCT00991276|100794092|FG004|First Intervention Period|Withdrawal by Subject|0|||
33243994|NCT00991276|100794093|FG005|First Intervention Period|Withdrawal by Subject|1|||
33243995|NCT00991276|100794088|FG000|First Intervention Period|Lost to Follow-up|0|||
33372770|NCT00051558|101251952|FG000|Overall Study|Other|2|||
33372771|NCT00051558|101251953|FG001|Overall Study|Other|1|||
33372772|NCT00051558|101251952|FG000|Overall Study|Significant Lab Value|2|||
33372773|NCT00051558|101251953|FG001|Overall Study|Significant Lab Value|0|||
33372774|NCT00051558|101251952|FG000|Overall Study|Physician Decision|5|||
33372775|NCT00051558|101251953|FG001|Overall Study|Physician Decision|0|||
33372776|NCT02115815|101251954|FG000|Overall Study|Withdrawal by Subject|2|||
33372777|NCT02115815|101251955|FG001|Overall Study|Withdrawal by Subject|0|||
33582910|NCT03835481|102022790|FG003|Double-blind Period|Other not stated below|1|||
33582911|NCT03835481|102022791|FG004|Double-blind Period|Other not stated below|1|||
33582912|NCT03835481|102022787|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
33582913|NCT03835481|102022788|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
33582914|NCT03835481|102022789|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
33582915|NCT03835481|102022790|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
33582916|NCT03835481|102022791|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
33582917|NCT03835481|102022787|FG000|Double-blind Period|Withdrawal by Subject|0|||
33582918|NCT03835481|102022788|FG001|Double-blind Period|Withdrawal by Subject|0|||
33582919|NCT03835481|102022789|FG002|Double-blind Period|Withdrawal by Subject|1|||
33582920|NCT03835481|102022790|FG003|Double-blind Period|Withdrawal by Subject|0|||
33582921|NCT03835481|102022791|FG004|Double-blind Period|Withdrawal by Subject|5|||
33582922|NCT03835481|102022787|FG000|Double-blind Period|Lost to Follow-up|0|||
33582923|NCT03835481|102022788|FG001|Double-blind Period|Lost to Follow-up|0|||
33582924|NCT03835481|102022789|FG002|Double-blind Period|Lost to Follow-up|0|||
33582925|NCT03835481|102022790|FG003|Double-blind Period|Lost to Follow-up|1|||
33582926|NCT03835481|102022791|FG004|Double-blind Period|Lost to Follow-up|0|||
33582927|NCT03835481|102022787|FG000|Double-blind Period|Protocol Violation|0|||
33582928|NCT03835481|102022788|FG001|Double-blind Period|Protocol Violation|2|||
33582929|NCT03835481|102022789|FG002|Double-blind Period|Protocol Violation|0|||
33643764|NCT01908803|102248417|FG000|Overall Study|Adverse Event|1|||
33643765|NCT01908803|102248418|FG001|Overall Study|Adverse Event|0|||
33643766|NCT01908803|102248417|FG000|Overall Study|Physician Decision|0|||
33643767|NCT01908803|102248418|FG001|Overall Study|Physician Decision|1|||
33643768|NCT01908803|102248417|FG000|Overall Study|Withdrawal by Subject|1|||
33643769|NCT01908803|102248418|FG001|Overall Study|Withdrawal by Subject|0|||
33643770|NCT01908803|102248417|FG000|Overall Study|Randomization Error|1|||
33643771|NCT01908803|102248418|FG001|Overall Study|Randomization Error|0|||
33643772|NCT01908803|102248417|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
33643773|NCT01908803|102248418|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
33643774|NCT00282308|102248428|FG000|Treatment Period|Lost to Follow-up|1|||
33643775|NCT00282308|102248429|FG001|Treatment Period|Lost to Follow-up|0|||
33643776|NCT00282308|102248430|FG002|Treatment Period|Lost to Follow-up|0|||
33643777|NCT00282308|102248428|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
33145833|NCT03091777|100448313|FG002|Overall Study|Physician Decision|1|||
33145834|NCT03091777|100448311|FG000|Overall Study|Abnormal Laboratory Value|7|||
33145835|NCT03091777|100448312|FG001|Overall Study|Abnormal Laboratory Value|11|||
33145836|NCT03091777|100448313|FG002|Overall Study|Abnormal Laboratory Value|12|||
33145837|NCT02862600|100448315|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
33145838|NCT02862600|100448315|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
33145839|NCT02862600|100448315|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
33145840|NCT02862600|100448315|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
33145841|NCT00930982|100448316|FG000|Overall Study|Adverse Event|19|||
33145842|NCT00930982|100448317|FG001|Overall Study|Adverse Event|23|||
33145843|NCT00930982|100448316|FG000|Overall Study|Protocol Violation|1|||
33145844|NCT00930982|100448317|FG001|Overall Study|Protocol Violation|5|||
33145845|NCT00930982|100448316|FG000|Overall Study|Withdrawal by Subject|1|||
33145846|NCT00930982|100448317|FG001|Overall Study|Withdrawal by Subject|1|||
33145847|NCT01751802|100448318|FG000|Overall Study|Adverse Event|4|||
33145848|NCT01751802|100448319|FG001|Overall Study|Adverse Event|2|||
33145849|NCT01739400|100448325|FG000|Overall Study|Physician Decision|3|||
33145850|NCT01739400|100448326|FG001|Overall Study|Physician Decision|0|||
33145851|NCT01739400|100448325|FG000|Overall Study|Lost to Follow-up|2|||
33243996|NCT00991276|100794089|FG001|First Intervention Period|Lost to Follow-up|1|||
33372778|NCT02115815|101251956|FG002|Overall Study|Withdrawal by Subject|0|||
33582930|NCT03835481|102022790|FG003|Double-blind Period|Protocol Violation|1|||
33582931|NCT03835481|102022791|FG004|Double-blind Period|Protocol Violation|0|||
33582932|NCT03835481|102022787|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
33145852|NCT01739400|100448326|FG001|Overall Study|Lost to Follow-up|0|||
33145853|NCT01739400|100448325|FG000|Overall Study|Death|5|||
33243997|NCT00991276|100794090|FG002|First Intervention Period|Lost to Follow-up|0|||
33243998|NCT00991276|100794091|FG003|First Intervention Period|Lost to Follow-up|1|||
33243999|NCT00991276|100794092|FG004|First Intervention Period|Lost to Follow-up|0|||
33244000|NCT00991276|100794093|FG005|First Intervention Period|Lost to Follow-up|0|||
33244001|NCT00991276|100794088|FG000|Second Intervention Period|Adverse Event|0|||
33244002|NCT00991276|100794089|FG001|Second Intervention Period|Adverse Event|2|||
33244003|NCT00991276|100794090|FG002|Second Intervention Period|Adverse Event|0|||
33244004|NCT00991276|100794091|FG003|Second Intervention Period|Adverse Event|1|||
33244005|NCT00991276|100794092|FG004|Second Intervention Period|Adverse Event|1|||
33244006|NCT00991276|100794093|FG005|Second Intervention Period|Adverse Event|0|||
33244007|NCT00991276|100794088|FG000|Second Intervention Period|Protocol Violation|1|||
33244008|NCT00991276|100794089|FG001|Second Intervention Period|Protocol Violation|0|||
33244009|NCT00991276|100794090|FG002|Second Intervention Period|Protocol Violation|0|||
33244010|NCT00991276|100794091|FG003|Second Intervention Period|Protocol Violation|0|||
33244011|NCT00991276|100794092|FG004|Second Intervention Period|Protocol Violation|0|||
33244012|NCT00991276|100794093|FG005|Second Intervention Period|Protocol Violation|0|||
33244013|NCT00991276|100794088|FG000|Second Intervention Period|Other|0|||
33244014|NCT00991276|100794089|FG001|Second Intervention Period|Other|0|||
33244015|NCT00991276|100794090|FG002|Second Intervention Period|Other|0|||
33244016|NCT00991276|100794091|FG003|Second Intervention Period|Other|1|||
33244017|NCT00991276|100794092|FG004|Second Intervention Period|Other|0|||
33244018|NCT00991276|100794093|FG005|Second Intervention Period|Other|1|||
33372779|NCT02115815|101251957|FG003|Overall Study|Withdrawal by Subject|0|||
33372780|NCT02115815|101251958|FG004|Overall Study|Withdrawal by Subject|0|||
33372781|NCT02115815|101251959|FG005|Overall Study|Withdrawal by Subject|0|||
33372782|NCT02115815|101251960|FG006|Overall Study|Withdrawal by Subject|0|||
33372783|NCT02115815|101251954|FG000|Overall Study|Not enough drug to dose participant|0|||
33372784|NCT02115815|101251955|FG001|Overall Study|Not enough drug to dose participant|0|||
33372785|NCT02115815|101251956|FG002|Overall Study|Not enough drug to dose participant|0|||
33372786|NCT02115815|101251957|FG003|Overall Study|Not enough drug to dose participant|0|||
33372787|NCT02115815|101251958|FG004|Overall Study|Not enough drug to dose participant|0|||
33582933|NCT03835481|102022788|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
33145854|NCT01739400|100448326|FG001|Overall Study|Death|2|||
33145855|NCT01739400|100448325|FG000|Overall Study|Withdrawal by Subject|7|||
33145856|NCT01739400|100448326|FG001|Overall Study|Withdrawal by Subject|7|||
33145857|NCT01624870|100448327|FG000|Overall Study|Death|19|||
33145858|NCT01624870|100448327|FG000|Overall Study|Withdrawal by Subject|1|||
33145859|NCT01624870|100448327|FG000|Overall Study|CoreValve not implanted|6|||
33145860|NCT01624870|100448327|FG000|Overall Study|Lost to follow up|1|||
33145861|NCT03612856|100448328|FG000|Pre-dose Period|Physician Decision|0|||
33145862|NCT03612856|100448329|FG001|Pre-dose Period|Physician Decision|1|||
33145863|NCT03612856|100448330|FG002|Pre-dose Period|Physician Decision|1|||
33145864|NCT03612856|100448328|FG000|Pre-dose Period|Withdrawal by Subject|0|||
33145865|NCT03612856|100448329|FG001|Pre-dose Period|Withdrawal by Subject|1|||
33145866|NCT03612856|100448330|FG002|Pre-dose Period|Withdrawal by Subject|0|||
33145867|NCT00586326|100448331|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
33145868|NCT00586326|100448331|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
33145869|NCT00586326|100448331|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
33145870|NCT00586326|100448331|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
33145871|NCT00586326|100448331|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
33145872|NCT00586326|100448331|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
33145873|NCT00586326|100448331|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
33145874|NCT00586326|100448331|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
33145875|NCT00586326|100448331|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
33145876|NCT00586326|100448331|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
33145877|NCT00586326|100448331|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
33145878|NCT00586326|100448331|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
33145879|NCT00586326|100448331|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
33145880|NCT00586326|100448331|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
33145881|NCT00586326|100448331|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
33145882|NCT00586326|100448331|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
33145883|NCT00586326|100448331|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
33145884|NCT00521001|100448333|FG000|Overall Study|Ineligible|1|||
33244019|NCT00991276|100794088|FG000|Third Intervention Period|Protocol Violation|1|||
33244020|NCT00991276|100794089|FG001|Third Intervention Period|Protocol Violation|0|||
33244021|NCT00991276|100794090|FG002|Third Intervention Period|Protocol Violation|0|||
33244022|NCT00991276|100794091|FG003|Third Intervention Period|Protocol Violation|0|||
33244023|NCT00991276|100794092|FG004|Third Intervention Period|Protocol Violation|0|||
33244024|NCT00991276|100794093|FG005|Third Intervention Period|Protocol Violation|0|||
33244025|NCT00991276|100794088|FG000|Third Intervention Period|Other|0|||
33244026|NCT00991276|100794089|FG001|Third Intervention Period|Other|0|||
33244027|NCT00991276|100794090|FG002|Third Intervention Period|Other|0|||
33244028|NCT00991276|100794091|FG003|Third Intervention Period|Other|0|||
33244029|NCT00991276|100794092|FG004|Third Intervention Period|Other|0|||
33244030|NCT00991276|100794093|FG005|Third Intervention Period|Other|1|||
33244031|NCT00991276|100794088|FG000|Third Intervention Period|Adverse Event|0|||
33244032|NCT00991276|100794089|FG001|Third Intervention Period|Adverse Event|0|||
33244033|NCT00991276|100794090|FG002|Third Intervention Period|Adverse Event|1|||
33244034|NCT00991276|100794091|FG003|Third Intervention Period|Adverse Event|0|||
33244035|NCT00991276|100794092|FG004|Third Intervention Period|Adverse Event|0|||
33244036|NCT00991276|100794093|FG005|Third Intervention Period|Adverse Event|0|||
33244037|NCT00991276|100794088|FG000|Third Intervention Period|Withdrawal by Subject|0|||
33244038|NCT00991276|100794089|FG001|Third Intervention Period|Withdrawal by Subject|0|||
33244039|NCT00991276|100794090|FG002|Third Intervention Period|Withdrawal by Subject|0|||
33244040|NCT00991276|100794091|FG003|Third Intervention Period|Withdrawal by Subject|1|||
33244041|NCT00991276|100794092|FG004|Third Intervention Period|Withdrawal by Subject|0|||
33244042|NCT00991276|100794093|FG005|Third Intervention Period|Withdrawal by Subject|0|||
33244043|NCT00946192|100794094|FG000|Overall Study|Lost to Follow-up|6|||
33244044|NCT00946192|100794095|FG001|Overall Study|Lost to Follow-up|11|||
33244045|NCT00946192|100794096|FG002|Overall Study|Lost to Follow-up|9|||
33244046|NCT00946192|100794094|FG000|Overall Study|Withdrawal by Subject|10|||
33244047|NCT00946192|100794095|FG001|Overall Study|Withdrawal by Subject|7|||
33244048|NCT00946192|100794096|FG002|Overall Study|Withdrawal by Subject|3|||
33244049|NCT00946192|100794094|FG000|Overall Study|Did not start medication|2|||
33244050|NCT00946192|100794095|FG001|Overall Study|Did not start medication|0|||
33244051|NCT00946192|100794096|FG002|Overall Study|Did not start medication|0|||
33244052|NCT00819910|100794097|FG000|Overall Study|Adverse Event|0|||
33244053|NCT00819910|100794098|FG001|Overall Study|Adverse Event|0|||
33244054|NCT00819910|100794099|FG002|Overall Study|Adverse Event|2|||
33244055|NCT00819910|100794100|FG003|Overall Study|Adverse Event|1|||
33422532|NCT02643966|101439664|FG000|Second Screening Round|Withdrawal by Subject|20|||
33422533|NCT02643966|101439664|FG000|Second Screening Round|Lost to Follow-up|57|||
33422534|NCT02643966|101439664|FG000|Second Screening Round|Physician Decision|2|||
33422535|NCT02643966|101439664|FG000|Second Screening Round|Death|4|||
33422536|NCT02643966|101439664|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
33422537|NCT02643966|101439664|FG000|Between Second and Third Screening|Death|1|||
33422538|NCT02643966|101439664|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
33422539|NCT02643966|101439664|FG000|Third Screening Round|PI excluded|2|||
33422540|NCT02643966|101439664|FG000|Third Screening Round|Lost to Follow-up|241|||
33422541|NCT01154127|101439665|FG000|Period 1 (21 Days)|Adverse Event|3|||
33422542|NCT01154127|101439666|FG001|Period 1 (21 Days)|Adverse Event|4|||
33422543|NCT01154127|101439665|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
33422544|NCT01154127|101439666|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
33422545|NCT01154127|101439665|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
33422546|NCT01154127|101439666|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
33422547|NCT01154127|101439665|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
33422548|NCT01154127|101439666|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
33422549|NCT01154127|101439665|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
33422550|NCT01154127|101439666|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
33422551|NCT00383019|101439667|FG000|Overall Study|Adverse Event|5|||
33422552|NCT00383019|101439668|FG001|Overall Study|Adverse Event|1|||
33244056|NCT00819910|100794097|FG000|Overall Study|Withdrawal by Subject|1|||
33244057|NCT00819910|100794098|FG001|Overall Study|Withdrawal by Subject|1|||
33244058|NCT00819910|100794099|FG002|Overall Study|Withdrawal by Subject|1|||
33244059|NCT00819910|100794100|FG003|Overall Study|Withdrawal by Subject|0|||
33244060|NCT00819910|100794097|FG000|Overall Study|Lost to Follow-up|1|||
33244061|NCT00819910|100794098|FG001|Overall Study|Lost to Follow-up|0|||
33244062|NCT00819910|100794099|FG002|Overall Study|Lost to Follow-up|0|||
33244063|NCT00819910|100794100|FG003|Overall Study|Lost to Follow-up|0|||
33244064|NCT04423393|100794101|FG000|Overall Study|Withdrawal by Subject|0|||
33244065|NCT04423393|100794102|FG001|Overall Study|Withdrawal by Subject|0|||
33422553|NCT00383019|101439667|FG000|Overall Study|Withdrawal by Subject|0|||
33244066|NCT04423393|100794103|FG002|Overall Study|Withdrawal by Subject|0|||
33244067|NCT04423393|100794104|FG003|Overall Study|Withdrawal by Subject|0|||
33244068|NCT04423393|100794105|FG004|Overall Study|Withdrawal by Subject|0|||
33244069|NCT04423393|100794106|FG005|Overall Study|Withdrawal by Subject|1|||
33244070|NCT04423393|100794107|FG006|Overall Study|Withdrawal by Subject|0|||
33244071|NCT04423393|100794108|FG007|Overall Study|Withdrawal by Subject|0|||
33244072|NCT04423393|100794109|FG008|Overall Study|Withdrawal by Subject|0|||
33244073|NCT04423393|100794110|FG009|Overall Study|Withdrawal by Subject|0|||
33422554|NCT00383019|101439668|FG001|Overall Study|Withdrawal by Subject|1|||
33422555|NCT01977352|101439669|FG000|Overall Study|Lost to Follow-up|1|||
33422556|NCT01977352|101439670|FG001|Overall Study|Lost to Follow-up|2|||
33244074|NCT04423393|100794111|FG010|Overall Study|Withdrawal by Subject|0|||
33244075|NCT04423393|100794112|FG011|Overall Study|Withdrawal by Subject|0|||
33372788|NCT02115815|101251959|FG005|Overall Study|Not enough drug to dose participant|1|||
33372789|NCT02115815|101251960|FG006|Overall Study|Not enough drug to dose participant|0|||
33582934|NCT03835481|102022789|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
33582935|NCT03835481|102022790|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
33582936|NCT03835481|102022791|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
33582937|NCT03835481|102022787|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
33582938|NCT03835481|102022788|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
33582939|NCT03835481|102022789|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
33582940|NCT03835481|102022790|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
33582941|NCT03835481|102022791|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
33582942|NCT03835481|102022787|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
33582943|NCT03835481|102022788|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
33582944|NCT03835481|102022789|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
33582945|NCT03835481|102022790|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
33582946|NCT03835481|102022791|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
33582947|NCT03835481|102022787|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
33582948|NCT03835481|102022788|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
33582949|NCT03835481|102022789|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
33582950|NCT03835481|102022790|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
33582951|NCT03835481|102022791|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
33582952|NCT03835481|102022787|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
33582953|NCT03835481|102022788|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
33582954|NCT03835481|102022789|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
33582955|NCT03835481|102022790|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
33582956|NCT03835481|102022791|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
33582957|NCT03835481|102022787|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
33582958|NCT03835481|102022788|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
33582959|NCT03835481|102022789|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
33582960|NCT03835481|102022790|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
33582961|NCT03835481|102022791|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
33582962|NCT00792740|102022792|FG000|Overall Study|Disease Worsening|3|||
33582963|NCT00792740|102022793|FG001|Overall Study|Disease Worsening|2|||
33145885|NCT02301988|100448334|FG000|Overall Study|Withdrawal by Subject|2|||
33145886|NCT02301988|100448335|FG001|Overall Study|Withdrawal by Subject|1|||
33145887|NCT02301988|100448334|FG000|Overall Study|Physician Decision|2|||
33145888|NCT02301988|100448335|FG001|Overall Study|Physician Decision|2|||
33145889|NCT02301988|100448334|FG000|Overall Study|Unknown Reason|1|||
33145890|NCT02301988|100448335|FG001|Overall Study|Unknown Reason|3|||
33145891|NCT02301988|100448334|FG000|Overall Study|Lack of Efficacy|3|||
33145892|NCT02301988|100448335|FG001|Overall Study|Lack of Efficacy|2|||
33145893|NCT02301988|100448334|FG000|Overall Study|Death|1|||
33145894|NCT02301988|100448335|FG001|Overall Study|Death|0|||
33145895|NCT02301988|100448334|FG000|Overall Study|Adverse Event|1|||
33145896|NCT02301988|100448335|FG001|Overall Study|Adverse Event|1|||
33145897|NCT01076075|100448336|FG000|Overall Study|Adverse Event|3|||
33145898|NCT01076075|100448337|FG001|Overall Study|Adverse Event|9|||
33145899|NCT01076075|100448336|FG000|Overall Study|Lack of Efficacy|5|||
33145900|NCT01076075|100448337|FG001|Overall Study|Lack of Efficacy|4|||
33145901|NCT01076075|100448336|FG000|Overall Study|Lost to Follow-up|6|||
33145902|NCT01076075|100448337|FG001|Overall Study|Lost to Follow-up|5|||
33145903|NCT01076075|100448336|FG000|Overall Study|other|19|||
33145904|NCT01076075|100448337|FG001|Overall Study|other|9|||
33145905|NCT01076075|100448336|FG000|Overall Study|Protocol Violation|0|||
33145906|NCT01076075|100448337|FG001|Overall Study|Protocol Violation|1|||
33145907|NCT01076075|100448336|FG000|Overall Study|Withdrawal by Subject|8|||
33145908|NCT01076075|100448337|FG001|Overall Study|Withdrawal by Subject|19|||
33145909|NCT00442468|100448338|FG000|Overall Study|Adverse Event|4|||
33145910|NCT00442468|100448338|FG000|Overall Study|Withdrawal by Subject|91|||
33145911|NCT00442468|100448338|FG000|Overall Study|Did not complete all study procedures|88|||
33145912|NCT02448680|100448340|FG000|Overall Study|Physician Decision|1|||
33145913|NCT02448680|100448341|FG001|Overall Study|Physician Decision|1|||
33145914|NCT02448680|100448340|FG000|Overall Study|Withdrawal by Subject|0|||
33145915|NCT02448680|100448341|FG001|Overall Study|Withdrawal by Subject|2|||
33145916|NCT00761748|100448342|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
33145917|NCT00761748|100448343|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
33145918|NCT00761748|100448342|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
33145919|NCT00761748|100448343|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
33145920|NCT05108922|100448344|FG000|Overall Study|Adverse Event|2|||
33372790|NCT02115815|101251954|FG000|Overall Study|Missed appointment, randomized in error|0|||
33582964|NCT00792740|102022792|FG000|Overall Study|Personal Reason|1|||
33582965|NCT00792740|102022793|FG001|Overall Study|Personal Reason|0|||
33422557|NCT00051636|101439671|FG000|Period 1 - Core|Adverse Event|2|||
33422558|NCT00051636|101439672|FG001|Period 1 - Core|Adverse Event|2|||
33422559|NCT00051636|101439671|FG000|Period 1 - Core|Protocol Violation|1|||
33422560|NCT00051636|101439672|FG001|Period 1 - Core|Protocol Violation|0|||
33422561|NCT00051636|101439671|FG000|Period 1 - Core|Withdrawal by Subject|1|||
33422562|NCT00051636|101439672|FG001|Period 1 - Core|Withdrawal by Subject|2|||
33422563|NCT00051636|101439671|FG000|Period 1 - Core|Lost to Follow-up|0|||
33422564|NCT00051636|101439672|FG001|Period 1 - Core|Lost to Follow-up|2|||
33422565|NCT00051636|101439671|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
33422566|NCT00051636|101439672|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
33422567|NCT00051636|101439671|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
33422568|NCT00051636|101439672|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
33422569|NCT00051636|101439671|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
33422570|NCT00051636|101439672|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
33422571|NCT00051636|101439671|FG000|Period 2- Extended Observation Period|Death|4|||
33422572|NCT00051636|101439672|FG001|Period 2- Extended Observation Period|Death|5|||
33422573|NCT00051636|101439671|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
33422574|NCT00051636|101439672|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
33422575|NCT03182686|101439673|FG000|Overall Study|Lost to Follow-up|2|||
33422576|NCT03182686|101439674|FG001|Overall Study|Lost to Follow-up|0|||
33422577|NCT03182686|101439673|FG000|Overall Study|Adverse Event|2|||
33422578|NCT03182686|101439674|FG001|Overall Study|Adverse Event|0|||
33422579|NCT03182686|101439673|FG000|Overall Study|Withdrawal by Subject|3|||
33422580|NCT03182686|101439674|FG001|Overall Study|Withdrawal by Subject|0|||
33422581|NCT00833547|101439677|FG000|Overall Study|Withdrawal by Subject|2|||
33582966|NCT00792740|102022792|FG000|Overall Study|Adverse Event|1|||
33582967|NCT00792740|102022793|FG001|Overall Study|Adverse Event|3|||
33582968|NCT00792740|102022792|FG000|Overall Study|Patient's withdrawal of consent|0|||
33582969|NCT00792740|102022793|FG001|Overall Study|Patient's withdrawal of consent|1|||
33582970|NCT00792740|102022792|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
33582971|NCT00792740|102022793|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
33582972|NCT00792740|102022792|FG000|Overall Study|Other reasons|0|||
33582973|NCT00792740|102022793|FG001|Overall Study|Other reasons|1|||
33582974|NCT02443337|102022795|FG000|Overall Study|Adverse Event|0|||
33582975|NCT02443337|102022796|FG001|Overall Study|Adverse Event|1|||
33582976|NCT02443337|102022795|FG000|Overall Study|Clinical Progressive Disease|3|||
33582977|NCT02443337|102022796|FG001|Overall Study|Clinical Progressive Disease|0|||
33582978|NCT02443337|102022795|FG000|Overall Study|Withdrawal by Subject|2|||
33582979|NCT02443337|102022796|FG001|Overall Study|Withdrawal by Subject|1|||
33582980|NCT01309204|102022797|FG000|Overall Study|Adverse Event|48|||
33582981|NCT01309204|102022798|FG001|Overall Study|Adverse Event|58|||
33582982|NCT01309204|102022797|FG000|Overall Study|Lost to Follow-up|2|||
33582983|NCT01309204|102022798|FG001|Overall Study|Lost to Follow-up|2|||
33582984|NCT01309204|102022797|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
33582985|NCT01309204|102022798|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
33582986|NCT01309204|102022797|FG000|Overall Study|Inadequate control of IOP|4|||
33582987|NCT01309204|102022798|FG001|Overall Study|Inadequate control of IOP|4|||
33582988|NCT01309204|102022797|FG000|Overall Study|Other|4|||
33582989|NCT01309204|102022798|FG001|Overall Study|Other|1|||
33582990|NCT02997865|102022799|FG000|Overall Study|Death|2|||
33422582|NCT00833547|101439678|FG001|Overall Study|Withdrawal by Subject|2|||
33582991|NCT02997865|102022800|FG001|Overall Study|Death|1|||
33582992|NCT02997865|102022799|FG000|Overall Study|Lost to Follow-up|6|||
33582993|NCT02997865|102022800|FG001|Overall Study|Lost to Follow-up|3|||
33582994|NCT02997865|102022799|FG000|Overall Study|Withdrawal by Subject|5|||
33582995|NCT02997865|102022800|FG001|Overall Study|Withdrawal by Subject|0|||
33582996|NCT01127633|102022801|FG000|Overall Study|Adverse Event|74|||
33582997|NCT01127633|102022802|FG001|Overall Study|Adverse Event|73|||
33582998|NCT01127633|102022801|FG000|Overall Study|Death|40|||
33422583|NCT00344305|101439679|FG000|Overall Study|Lost to Follow-up|2|||
33422584|NCT00344305|101439680|FG001|Overall Study|Lost to Follow-up|0|||
33643778|NCT00282308|102248429|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
33422585|NCT00344305|101439679|FG000|Overall Study|Participant was not contacted in window|0|||
33422586|NCT00344305|101439680|FG001|Overall Study|Participant was not contacted in window|1|||
33582999|NCT01127633|102022802|FG001|Overall Study|Death|43|||
33583000|NCT01127633|102022801|FG000|Overall Study|Lost to Follow-up|4|||
33583001|NCT01127633|102022802|FG001|Overall Study|Lost to Follow-up|0|||
33583002|NCT01127633|102022801|FG000|Overall Study|Parent/Caregiver Decision|246|||
33583003|NCT01127633|102022802|FG001|Overall Study|Parent/Caregiver Decision|228|||
33583004|NCT01127633|102022801|FG000|Overall Study|Physician Decision|60|||
33583005|NCT01127633|102022802|FG001|Overall Study|Physician Decision|45|||
33583006|NCT01127633|102022801|FG000|Overall Study|Withdrawal by Subject|57|||
33583007|NCT01127633|102022802|FG001|Overall Study|Withdrawal by Subject|72|||
33583008|NCT01127633|102022801|FG000|Overall Study|Sponsor Decision|163|||
33583009|NCT01127633|102022802|FG001|Overall Study|Sponsor Decision|195|||
33583010|NCT01127633|102022801|FG000|Overall Study|Protocol Violation|8|||
33583011|NCT01127633|102022802|FG001|Overall Study|Protocol Violation|16|||
33583012|NCT01127633|102022801|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
33583013|NCT01127633|102022802|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
33583014|NCT01127633|102022801|FG000|Overall Study|Not treated|1|||
33583015|NCT01127633|102022802|FG001|Overall Study|Not treated|0|||
33583016|NCT02236572|102022806|FG000|Overall Study|Withdrawal by Subject|1|||
33583017|NCT02236572|102022806|FG000|Overall Study|Protocol Violation|1|||
33583018|NCT02236572|102022806|FG000|Overall Study|Lost to Follow-up|1|||
33145921|NCT05108922|100448345|FG001|Overall Study|Adverse Event|3|||
33422587|NCT00827359|101439681|FG000|Overall Study|Progressive Diseas|19|||
33422588|NCT00827359|101439681|FG000|Overall Study|Unacceptable Toxicity|5|||
33422589|NCT00827359|101439681|FG000|Overall Study|Ineligible|1|||
33422590|NCT02766088|101439684|FG000|Overall Study|Sponsor study termination|498|||
33422591|NCT02766088|101439684|FG000|Overall Study|Migrated/moved from the study area|1|||
33422592|NCT02766088|101439684|FG000|Overall Study|Lost to Follow-up|5|||
33422593|NCT02766088|101439684|FG000|Overall Study|Other|1|||
33422594|NCT02766088|101439684|FG000|Overall Study|Death|1|||
33583019|NCT01673854|102022807|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
33643779|NCT00282308|102248430|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
33145922|NCT05108922|100448344|FG000|Overall Study|Lost to Follow-up|2|||
33145923|NCT05108922|100448345|FG001|Overall Study|Lost to Follow-up|1|||
33145924|NCT05108922|100448344|FG000|Overall Study|Inadvertent enrollment|0|||
33145925|NCT05108922|100448345|FG001|Overall Study|Inadvertent enrollment|1|||
33145926|NCT05108922|100448344|FG000|Overall Study|Physician Decision|2|||
33145927|NCT05108922|100448345|FG001|Overall Study|Physician Decision|3|||
33145928|NCT05108922|100448344|FG000|Overall Study|Protocol deviation|1|||
33145929|NCT05108922|100448345|FG001|Overall Study|Protocol deviation|0|||
33145930|NCT05108922|100448344|FG000|Overall Study|Screen failure|1|||
33145931|NCT05108922|100448345|FG001|Overall Study|Screen failure|0|||
33145932|NCT05108922|100448344|FG000|Overall Study|Withdrawal by Subject|11|||
33145933|NCT05108922|100448345|FG001|Overall Study|Withdrawal by Subject|8|||
33145934|NCT05867342|100448346|FG000|Overall Study|Investigator Decision|3|||
33145935|NCT05867342|100448347|FG001|Overall Study|Investigator Decision|3|||
33145936|NCT02360605|100448348|FG000|Overall Study|Withdrawal by Subject|4|||
33145937|NCT02360605|100448349|FG001|Overall Study|Withdrawal by Subject|9|||
33145938|NCT02360605|100448348|FG000|Overall Study|Lost to Follow-up|7|||
33145939|NCT02360605|100448349|FG001|Overall Study|Lost to Follow-up|8|||
33145940|NCT02360605|100448348|FG000|Overall Study|Death|0|||
33145941|NCT02360605|100448349|FG001|Overall Study|Death|1|||
33145942|NCT00076024|100448350|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
33145943|NCT00076024|100448351|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
33145944|NCT00076024|100448352|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
33145945|NCT00076024|100448353|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
33145946|NCT00076024|100448350|FG000|Phase 1, Lead-in|Adverse Event|1|||
33145947|NCT00076024|100448351|FG001|Phase 1, Lead-in|Adverse Event|0|||
33145948|NCT00076024|100448352|FG002|Phase 1, Lead-in|Adverse Event|0|||
33145949|NCT00076024|100448353|FG003|Phase 1, Lead-in|Adverse Event|0|||
33145950|NCT00076024|100448350|FG000|Phase 1, Lead-in|Clinical progression|1|||
33145951|NCT00076024|100448351|FG001|Phase 1, Lead-in|Clinical progression|0|||
33145952|NCT00076024|100448352|FG002|Phase 1, Lead-in|Clinical progression|0|||
33145953|NCT00076024|100448353|FG003|Phase 1, Lead-in|Clinical progression|0|||
33145954|NCT00076024|100448350|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
33145955|NCT00076024|100448351|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
33145956|NCT00076024|100448352|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
33145957|NCT00076024|100448353|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
33145958|NCT00076024|100448350|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
33145959|NCT00076024|100448351|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
33422595|NCT01120600|101439685|FG000|Overall Study|Adverse Event|7|||
33145960|NCT00076024|100448352|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
33145961|NCT00076024|100448353|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
33145962|NCT00076024|100448350|FG000|Phase 2, Double-blind|Adverse Event|0|||
33145963|NCT00076024|100448351|FG001|Phase 2, Double-blind|Adverse Event|25|||
33145964|NCT00076024|100448352|FG002|Phase 2, Double-blind|Adverse Event|6|||
33422596|NCT01120600|101439686|FG001|Overall Study|Adverse Event|7|||
33422597|NCT01120600|101439685|FG000|Overall Study|Excessive Bone Loss|0|||
33583020|NCT01673854|102022807|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
33145965|NCT00076024|100448353|FG003|Phase 2, Double-blind|Adverse Event|0|||
33145966|NCT00076024|100448350|FG000|Phase 2, Double-blind|Un-specified|0|||
33145967|NCT00076024|100448351|FG001|Phase 2, Double-blind|Un-specified|14|||
33145968|NCT00076024|100448352|FG002|Phase 2, Double-blind|Un-specified|6|||
33145969|NCT00076024|100448353|FG003|Phase 2, Double-blind|Un-specified|0|||
33145970|NCT00076024|100448350|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
33422598|NCT01120600|101439686|FG001|Overall Study|Excessive Bone Loss|4|||
33422599|NCT01120600|101439685|FG000|Overall Study|Lost to Follow-up|1|||
33422600|NCT01120600|101439686|FG001|Overall Study|Lost to Follow-up|3|||
33422601|NCT01120600|101439685|FG000|Overall Study|Physician Decision|1|||
33422602|NCT01120600|101439686|FG001|Overall Study|Physician Decision|3|||
33422603|NCT01120600|101439685|FG000|Overall Study|Protocol Violation|0|||
33422604|NCT01120600|101439686|FG001|Overall Study|Protocol Violation|4|||
33422605|NCT01120600|101439685|FG000|Overall Study|Withdrawal by Subject|10|||
33422606|NCT01120600|101439686|FG001|Overall Study|Withdrawal by Subject|11|||
33422607|NCT02766400|101439691|FG000|Overall Study|Death|1|||
33422608|NCT02766400|101439692|FG001|Overall Study|Death|2|||
33422609|NCT02766400|101439691|FG000|Overall Study|Withdrawal by Subject|1|||
33422610|NCT02766400|101439692|FG001|Overall Study|Withdrawal by Subject|0|||
33422611|NCT02280356|101439693|FG000|Overall Study|Not Treated|2|||
33422612|NCT02280356|101439693|FG000|Overall Study|Withdrawal by Subject|1|||
33422613|NCT02280356|101439693|FG000|Overall Study|Not evaluable|2|||
33422614|NCT03724968|101439694|FG000|Overall Study|Insurance issues|0|||
33422615|NCT03724968|101439695|FG001|Overall Study|Insurance issues|1|||
33422616|NCT03724968|101439694|FG000|Overall Study|Study closed|0|||
33422617|NCT03724968|101439695|FG001|Overall Study|Study closed|1|||
33422618|NCT00366678|101439696|FG000|Infant Series|Withdrawal by Subject|8|||
33422619|NCT00366678|101439697|FG001|Infant Series|Withdrawal by Subject|6|||
33422620|NCT00366678|101439698|FG002|Infant Series|Withdrawal by Subject|0|||
33422621|NCT00366678|101439696|FG000|Infant Series|Protocol Violation|4|||
33422622|NCT00366678|101439697|FG001|Infant Series|Protocol Violation|3|||
33422623|NCT00366678|101439698|FG002|Infant Series|Protocol Violation|0|||
33422624|NCT00366678|101439696|FG000|Infant Series|Failed to return|1|||
33422625|NCT00366678|101439697|FG001|Infant Series|Failed to return|1|||
33422626|NCT00366678|101439698|FG002|Infant Series|Failed to return|0|||
33422627|NCT00366678|101439696|FG000|Infant Series|Adverse Event|1|||
33422628|NCT00366678|101439697|FG001|Infant Series|Adverse Event|0|||
33422629|NCT00366678|101439698|FG002|Infant Series|Adverse Event|0|||
33422630|NCT00366678|101439696|FG000|After Infant|Withdrawal by Subject|8|||
33422631|NCT00366678|101439697|FG001|After Infant|Withdrawal by Subject|4|||
33422632|NCT00366678|101439698|FG002|After Infant|Withdrawal by Subject|0|||
33422633|NCT00366678|101439696|FG000|After Infant|Lost to Follow-up|2|||
33422634|NCT00366678|101439697|FG001|After Infant|Lost to Follow-up|1|||
33422635|NCT00366678|101439698|FG002|After Infant|Lost to Follow-up|0|||
33422636|NCT00366678|101439696|FG000|After Infant|Failed to return|5|||
33422637|NCT00366678|101439697|FG001|After Infant|Failed to return|5|||
33422638|NCT00366678|101439698|FG002|After Infant|Failed to return|0|||
33422639|NCT00366678|101439696|FG000|After Infant|Adverse Event|1|||
33422640|NCT00366678|101439697|FG001|After Infant|Adverse Event|0|||
33422641|NCT00366678|101439698|FG002|After Infant|Adverse Event|0|||
33422642|NCT00366678|101439696|FG000|After Infant|Protocol Violation|1|||
33422643|NCT00366678|101439697|FG001|After Infant|Protocol Violation|0|||
33422644|NCT00366678|101439698|FG002|After Infant|Protocol Violation|0|||
33422645|NCT00366678|101439696|FG000|Toddler Dose|Protocol Violation|2|||
33422646|NCT00366678|101439697|FG001|Toddler Dose|Protocol Violation|1|||
33422647|NCT00366678|101439698|FG002|Toddler Dose|Protocol Violation|0|||
33422648|NCT00366678|101439696|FG000|Toddler Dose|Failed to return|1|||
33422649|NCT00366678|101439697|FG001|Toddler Dose|Failed to return|0|||
33422650|NCT00366678|101439698|FG002|Toddler Dose|Failed to return|0|||
33422651|NCT00366678|101439696|FG000|Toddler Dose|Withdrawal by Subject|1|||
33422652|NCT00366678|101439697|FG001|Toddler Dose|Withdrawal by Subject|0|||
33422653|NCT00366678|101439698|FG002|Toddler Dose|Withdrawal by Subject|0|||
33422654|NCT00366678|101439696|FG000|Toddler Dose|protocol deviation|1|||
33422655|NCT00366678|101439697|FG001|Toddler Dose|protocol deviation|0|||
33422656|NCT00366678|101439698|FG002|Toddler Dose|protocol deviation|0|||
33422657|NCT03125629|101439701|FG000|Overall Study|Withdrawal by Subject|2|||
33422658|NCT03125629|101439701|FG000|Overall Study|Equipment malfunction|1|||
33422659|NCT03264066|101439705|FG000|Overall Study|Adverse Event|1|||
33422660|NCT03264066|101439706|FG001|Overall Study|Adverse Event|1|||
33422661|NCT03264066|101439707|FG002|Overall Study|Adverse Event|0|||
33422662|NCT03264066|101439708|FG003|Overall Study|Adverse Event|0|||
33583021|NCT01673854|102022807|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
33422663|NCT03264066|101439709|FG004|Overall Study|Adverse Event|0|||
33422664|NCT03264066|101439710|FG005|Overall Study|Adverse Event|0|||
33422665|NCT03264066|101439705|FG000|Overall Study|Death|12|||
33422666|NCT03264066|101439706|FG001|Overall Study|Death|12|||
33422667|NCT03264066|101439707|FG002|Overall Study|Death|8|||
33422668|NCT03264066|101439708|FG003|Overall Study|Death|10|||
33422669|NCT03264066|101439709|FG004|Overall Study|Death|6|||
33422670|NCT03264066|101439710|FG005|Overall Study|Death|1|||
33422671|NCT03264066|101439705|FG000|Overall Study|Lost to Follow-up|1|||
33422672|NCT03264066|101439706|FG001|Overall Study|Lost to Follow-up|0|||
33422673|NCT03264066|101439707|FG002|Overall Study|Lost to Follow-up|0|||
33422674|NCT03264066|101439708|FG003|Overall Study|Lost to Follow-up|0|||
33422675|NCT03264066|101439709|FG004|Overall Study|Lost to Follow-up|0|||
33422676|NCT03264066|101439710|FG005|Overall Study|Lost to Follow-up|0|||
33583022|NCT01673854|102022807|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
33422677|NCT03264066|101439705|FG000|Overall Study|Progressive Disease|0|||
33422678|NCT03264066|101439706|FG001|Overall Study|Progressive Disease|2|||
33422679|NCT03264066|101439707|FG002|Overall Study|Progressive Disease|1|||
33422680|NCT03264066|101439708|FG003|Overall Study|Progressive Disease|0|||
33422681|NCT03264066|101439709|FG004|Overall Study|Progressive Disease|0|||
33422682|NCT03264066|101439710|FG005|Overall Study|Progressive Disease|0|||
33422683|NCT03264066|101439705|FG000|Overall Study|Study Terminated by Sponsor|5|||
33422684|NCT03264066|101439706|FG001|Overall Study|Study Terminated by Sponsor|5|||
33422685|NCT03264066|101439707|FG002|Overall Study|Study Terminated by Sponsor|8|||
33422686|NCT03264066|101439708|FG003|Overall Study|Study Terminated by Sponsor|5|||
33422687|NCT03264066|101439709|FG004|Overall Study|Study Terminated by Sponsor|1|||
33422688|NCT03264066|101439710|FG005|Overall Study|Study Terminated by Sponsor|2|||
33422689|NCT03264066|101439705|FG000|Overall Study|Withdrawal by Subject|1|||
33422690|NCT03264066|101439706|FG001|Overall Study|Withdrawal by Subject|0|||
33422691|NCT03264066|101439707|FG002|Overall Study|Withdrawal by Subject|0|||
33422692|NCT03264066|101439708|FG003|Overall Study|Withdrawal by Subject|5|||
33422693|NCT03264066|101439709|FG004|Overall Study|Withdrawal by Subject|0|||
33422694|NCT03264066|101439710|FG005|Overall Study|Withdrawal by Subject|0|||
33422695|NCT01074307|101439711|FG000|Overall Study|No primary endpoint evaluation|14|||
33422696|NCT01074307|101439712|FG001|Overall Study|No primary endpoint evaluation|6|||
33422697|NCT01074307|101439711|FG000|Overall Study|Exclusion criterion|0|||
33422698|NCT01074307|101439712|FG001|Overall Study|Exclusion criterion|1|||
33422699|NCT01074307|101439711|FG000|Overall Study|Protocol Violation|8|||
33422700|NCT01074307|101439712|FG001|Overall Study|Protocol Violation|5|||
33422701|NCT01422720|101439714|FG000|Overall Study|Adverse Event|16|||
33422702|NCT01422720|101439714|FG000|Overall Study|Lack of Efficacy|1|||
33422703|NCT01422720|101439714|FG000|Overall Study|Withdrawal by Subject|4|||
33422704|NCT01422720|101439714|FG000|Overall Study|Ineligibility|1|||
33422705|NCT00457665|101439715|FG000|12 Months|Drug allergy|1|||
33422706|NCT00457665|101439716|FG001|12 Months|Drug allergy|1|||
33422707|NCT00457665|101439715|FG000|12 Months|High HIV viral load|5|||
33422708|NCT00457665|101439716|FG001|12 Months|High HIV viral load|1|||
33422709|NCT00457665|101439715|FG000|12 Months|Lipodystrophy|2|||
33422710|NCT00457665|101439716|FG001|12 Months|Lipodystrophy|0|||
33422711|NCT00457665|101439715|FG000|12 Months|Withdrawal by Subject|0|||
33422712|NCT00457665|101439716|FG001|12 Months|Withdrawal by Subject|2|||
33422713|NCT00457665|101439715|FG000|12 Months|Abnormal Liver function tests|0|||
33422714|NCT00457665|101439716|FG001|12 Months|Abnormal Liver function tests|5|||
33422715|NCT00457665|101439715|FG000|24 Months|Withdrawal by Subject|3|||
33422716|NCT00457665|101439716|FG001|24 Months|Withdrawal by Subject|2|||
33422717|NCT00457665|101439715|FG000|24 Months|Lipodystrophy|1|||
33422718|NCT00457665|101439716|FG001|24 Months|Lipodystrophy|1|||
33422719|NCT00457665|101439715|FG000|24 Months|Abnormal liver function tests|1|||
33422720|NCT00457665|101439716|FG001|24 Months|Abnormal liver function tests|5|||
33422721|NCT04147611|101439717|FG000|Overall Study|Physician Decision|0|||
33422722|NCT04147611|101439718|FG001|Overall Study|Physician Decision|1|||
33422723|NCT00123487|101439719|FG000|Randomized|Death prior to starting treatment|0|||
33422724|NCT00123487|101439720|FG001|Randomized|Death prior to starting treatment|1|||
33422725|NCT00123487|101439719|FG000|Randomized|SAE prior to starting treatment|1|||
33422726|NCT00123487|101439720|FG001|Randomized|SAE prior to starting treatment|0|||
33583023|NCT01673854|102022807|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
33583024|NCT01673854|102022807|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
33583025|NCT01673854|102022807|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
33583026|NCT01673854|102022807|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
33244076|NCT04423393|100794113|FG012|Overall Study|Withdrawal by Subject|0|||
33244077|NCT04423393|100794114|FG013|Overall Study|Withdrawal by Subject|1|||
33244078|NCT04423393|100794115|FG014|Overall Study|Withdrawal by Subject|0|||
33244079|NCT04423393|100794116|FG015|Overall Study|Withdrawal by Subject|0|||
33244080|NCT04423393|100794117|FG016|Overall Study|Withdrawal by Subject|0|||
33244081|NCT04423393|100794118|FG017|Overall Study|Withdrawal by Subject|0|||
33244082|NCT04423393|100794101|FG000|Overall Study|Sponsor Decision|0|||
33244083|NCT04423393|100794102|FG001|Overall Study|Sponsor Decision|0|||
33643780|NCT00282308|102248428|FG000|Treatment Period|Adverse Event|0|||
33643781|NCT00282308|102248429|FG001|Treatment Period|Adverse Event|2|||
33244084|NCT04423393|100794103|FG002|Overall Study|Sponsor Decision|0|||
33244085|NCT04423393|100794104|FG003|Overall Study|Sponsor Decision|0|||
33244086|NCT04423393|100794105|FG004|Overall Study|Sponsor Decision|0|||
33422727|NCT00123487|101439719|FG000|Treated With Study Drug|Adverse Event|23|||
33244087|NCT04423393|100794106|FG005|Overall Study|Sponsor Decision|0|||
33244088|NCT04423393|100794107|FG006|Overall Study|Sponsor Decision|0|||
33422728|NCT00123487|101439720|FG001|Treated With Study Drug|Adverse Event|22|||
33422729|NCT00123487|101439719|FG000|Treated With Study Drug|Disease Progression|141|||
33422730|NCT00123487|101439720|FG001|Treated With Study Drug|Disease Progression|122|||
33422731|NCT00123487|101439719|FG000|Treated With Study Drug|Physician Decision|8|||
33422732|NCT00123487|101439720|FG001|Treated With Study Drug|Physician Decision|9|||
33422733|NCT00123487|101439719|FG000|Treated With Study Drug|Other|59|||
33583027|NCT01673854|102022807|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
33643782|NCT00282308|102248430|FG002|Treatment Period|Adverse Event|0|||
33643783|NCT00282308|102248428|FG000|Treatment Period|Not Treated with Study Drug|1|||
33643784|NCT00282308|102248429|FG001|Treatment Period|Not Treated with Study Drug|0|||
33643785|NCT00282308|102248430|FG002|Treatment Period|Not Treated with Study Drug|0|||
33643786|NCT00282308|102248428|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
33643787|NCT00282308|102248429|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
33643788|NCT00282308|102248430|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
33643789|NCT00282308|102248428|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
33643790|NCT00282308|102248429|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
33583028|NCT01673854|102022807|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
33583029|NCT01673854|102022807|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
33583030|NCT01673854|102022807|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
33583031|NCT01135459|102022809|FG000|Overall Study|Adverse Event|8|||
33583032|NCT01135459|102022810|FG001|Overall Study|Adverse Event|10|||
33583033|NCT01135459|102022809|FG000|Overall Study|Lack of Efficacy|3|||
33583034|NCT01135459|102022810|FG001|Overall Study|Lack of Efficacy|1|||
33583035|NCT01135459|102022809|FG000|Overall Study|Withdrawal by Subject|2|||
33583036|NCT01135459|102022810|FG001|Overall Study|Withdrawal by Subject|3|||
33583037|NCT01135459|102022809|FG000|Overall Study|Protocol Violation|5|||
33583038|NCT01135459|102022810|FG001|Overall Study|Protocol Violation|3|||
33583039|NCT01135459|102022809|FG000|Overall Study|Lost to Follow-up|2|||
33583040|NCT01135459|102022810|FG001|Overall Study|Lost to Follow-up|1|||
33583041|NCT01135459|102022809|FG000|Overall Study|Non-compliance to study procedures|0|||
33583042|NCT01135459|102022810|FG001|Overall Study|Non-compliance to study procedures|1|||
33583043|NCT01135459|102022809|FG000|Overall Study|Other than specified|1|||
33583044|NCT01135459|102022810|FG001|Overall Study|Other than specified|1|||
33583045|NCT00803738|102022811|FG000|Overall Study|Adverse Event|3|||
33583046|NCT00803738|102022812|FG001|Overall Study|Adverse Event|5|||
33643791|NCT00282308|102248430|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
33643792|NCT00282308|102248428|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
33643793|NCT00282308|102248429|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
33643794|NCT00282308|102248430|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
33643795|NCT00282308|102248428|FG000|Safety Follow-up Period|Adverse Event|0|||
33643796|NCT00282308|102248429|FG001|Safety Follow-up Period|Adverse Event|0|||
33643797|NCT00282308|102248430|FG002|Safety Follow-up Period|Adverse Event|1|||
33643798|NCT00282308|102248428|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
33643799|NCT00282308|102248429|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
33643800|NCT00282308|102248430|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
33643801|NCT00282308|102248428|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
33643802|NCT00282308|102248429|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
33643803|NCT00282308|102248430|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
33422734|NCT00123487|101439720|FG001|Treated With Study Drug|Other|58|||
33422735|NCT00123487|101439719|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
33422736|NCT00123487|101439720|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
33422737|NCT00123487|101439719|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
33422738|NCT00123487|101439720|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
33422739|NCT00123487|101439719|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
33422740|NCT00123487|101439720|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
33422741|NCT03726437|101439724|FG000|Overall Study|Lost to Follow-up|85|||
33422742|NCT03726437|101439725|FG001|Overall Study|Lost to Follow-up|76|||
33422743|NCT02402933|101439728|FG000|Overall Study|Withdrawal by Subject|4|||
33643804|NCT00282308|102248428|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
33643805|NCT00282308|102248429|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
33643806|NCT00282308|102248430|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
33643807|NCT03565497|102248433|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
33643808|NCT03565497|102248434|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
33643809|NCT03565497|102248435|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
33643810|NCT03565497|102248433|FG000|Overall Study|Lost to Follow-up|1|||
33643811|NCT03565497|102248434|FG001|Overall Study|Lost to Follow-up|1|||
33145971|NCT00076024|100448351|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
33145972|NCT00076024|100448352|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
33372791|NCT02115815|101251955|FG001|Overall Study|Missed appointment, randomized in error|0|||
33422744|NCT02402933|101439728|FG000|Overall Study|Discontinued; Site Termination|10|||
33422745|NCT00729365|101439729|FG000|Overall Study|Physician Decision|33|||
33422746|NCT00729365|101439730|FG001|Overall Study|Physician Decision|6|||
33643812|NCT03565497|102248435|FG002|Overall Study|Lost to Follow-up|2|||
33583047|NCT00803738|102022811|FG000|Overall Study|Lost to Follow-up|4|||
33583048|NCT00803738|102022812|FG001|Overall Study|Lost to Follow-up|4|||
33583049|NCT00803738|102022811|FG000|Overall Study|Protocol Violation|18|||
33583050|NCT00803738|102022812|FG001|Overall Study|Protocol Violation|10|||
33583051|NCT00803738|102022811|FG000|Overall Study|Withdrawal by Subject|1|||
33244089|NCT04423393|100794108|FG007|Overall Study|Sponsor Decision|0|||
33244090|NCT04423393|100794109|FG008|Overall Study|Sponsor Decision|0|||
33643813|NCT03565497|102248433|FG000|Overall Study|Withdrawal by Subject|1|||
33643814|NCT03565497|102248434|FG001|Overall Study|Withdrawal by Subject|1|||
33643815|NCT03565497|102248435|FG002|Overall Study|Withdrawal by Subject|1|||
33643816|NCT00098813|102248439|FG000|Overall Study|Death|8|||
33643817|NCT00098813|102248439|FG000|Overall Study|Protocol Violation|1|||
33643818|NCT00098813|102248439|FG000|Overall Study|Withdrawal by Subject|7|||
33643819|NCT00098813|102248439|FG000|Overall Study|Progression of Disease|1|||
33643820|NCT00098813|102248439|FG000|Overall Study|Other complicating disease|1|||
33643821|NCT00098813|102248439|FG000|Overall Study|Reversal of RAI resistance|1|||
33643822|NCT03983317|102248440|FG000|Overall Study|Physician Decision|5|||
33643823|NCT01525225|102248441|FG000|Enrollment|No longer met study criteria|1|||
33643824|NCT01525225|102248441|FG000|Enrollment|Other|1|||
33643825|NCT01761240|102248442|FG000|Overall Study|Progressive disease:radiology assessment|3|||
33643826|NCT01761240|102248443|FG001|Overall Study|Progressive disease:radiology assessment|3|||
33643827|NCT01761240|102248444|FG002|Overall Study|Progressive disease:radiology assessment|0|||
33643828|NCT01761240|102248445|FG003|Overall Study|Progressive disease:radiology assessment|0|||
33643829|NCT01761240|102248446|FG004|Overall Study|Progressive disease:radiology assessment|0|||
33643830|NCT01761240|102248442|FG000|Overall Study|Progressive disease:clinical assessment|0|||
33244091|NCT04423393|100794110|FG009|Overall Study|Sponsor Decision|0|||
33244092|NCT04423393|100794111|FG010|Overall Study|Sponsor Decision|0|||
33422747|NCT00729365|101439731|FG002|Overall Study|Physician Decision|7|||
33422748|NCT02713243|101439734|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
33422749|NCT02713243|101439735|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
33422750|NCT02713243|101439734|FG000|Overall Study|Administrative problems|0|||
33422751|NCT02713243|101439735|FG001|Overall Study|Administrative problems|1|||
33422752|NCT02713243|101439734|FG000|Overall Study|Protocol deviation|0|||
33422753|NCT02713243|101439735|FG001|Overall Study|Protocol deviation|1|||
33422754|NCT00283686|101439736|FG000|Overall Study|Death|1|||
33422755|NCT00283686|101439737|FG001|Overall Study|Death|1|||
33422756|NCT00283686|101439738|FG002|Overall Study|Death|1|||
33422757|NCT00283686|101439739|FG003|Overall Study|Death|0|||
33422758|NCT00283686|101439736|FG000|Overall Study|Lost to Follow-up|21|||
33422759|NCT00283686|101439737|FG001|Overall Study|Lost to Follow-up|31|||
33422760|NCT00283686|101439738|FG002|Overall Study|Lost to Follow-up|26|||
33244093|NCT04423393|100794112|FG011|Overall Study|Sponsor Decision|0|||
33244094|NCT04423393|100794113|FG012|Overall Study|Sponsor Decision|0|||
33244095|NCT04423393|100794114|FG013|Overall Study|Sponsor Decision|1|||
33244096|NCT04423393|100794115|FG014|Overall Study|Sponsor Decision|0|||
33372792|NCT02115815|101251956|FG002|Overall Study|Missed appointment, randomized in error|0|||
33372793|NCT02115815|101251957|FG003|Overall Study|Missed appointment, randomized in error|0|||
33372794|NCT02115815|101251958|FG004|Overall Study|Missed appointment, randomized in error|0|||
33372795|NCT02115815|101251959|FG005|Overall Study|Missed appointment, randomized in error|1|||
33372796|NCT02115815|101251960|FG006|Overall Study|Missed appointment, randomized in error|0|||
33372797|NCT01551758|101251962|FG000|Overall Study|Adverse Event|29|||
33372798|NCT01551758|101251963|FG001|Overall Study|Adverse Event|43|||
33372799|NCT01551758|101251962|FG000|Overall Study|Lack of Efficacy|0|||
33244097|NCT04423393|100794116|FG015|Overall Study|Sponsor Decision|0|||
33244098|NCT04423393|100794117|FG016|Overall Study|Sponsor Decision|0|||
33244099|NCT04423393|100794118|FG017|Overall Study|Sponsor Decision|0|||
33244100|NCT05305040|100794119|FG000|Overall Study|Not Dosed|37|||
33244101|NCT05305040|100794120|FG001|Overall Study|Not Dosed|37|||
33244102|NCT05305040|100794119|FG000|Overall Study|Study Closure|34|||
33244103|NCT05305040|100794120|FG001|Overall Study|Study Closure|46|||
33244104|NCT05305040|100794119|FG000|Overall Study|Death|14|||
33244105|NCT05305040|100794120|FG001|Overall Study|Death|13|||
33244106|NCT05305040|100794119|FG000|Overall Study|Withdrawal by Subject|15|||
33244107|NCT05305040|100794120|FG001|Overall Study|Withdrawal by Subject|10|||
33372800|NCT01551758|101251963|FG001|Overall Study|Lack of Efficacy|1|||
33372801|NCT01551758|101251962|FG000|Overall Study|Protocol Violation|5|||
33422761|NCT00283686|101439739|FG003|Overall Study|Lost to Follow-up|20|||
33422762|NCT00283686|101439736|FG000|Overall Study|Less than full participation|7|||
33643831|NCT01761240|102248443|FG001|Overall Study|Progressive disease:clinical assessment|0|||
33643832|NCT01761240|102248444|FG002|Overall Study|Progressive disease:clinical assessment|3|||
33643833|NCT01761240|102248445|FG003|Overall Study|Progressive disease:clinical assessment|1|||
33643834|NCT01761240|102248446|FG004|Overall Study|Progressive disease:clinical assessment|0|||
33643835|NCT01761240|102248442|FG000|Overall Study|Withdrawal by Subject|0|||
33244108|NCT05305040|100794119|FG000|Overall Study|Other|13|||
33244109|NCT05305040|100794120|FG001|Overall Study|Other|10|||
33244110|NCT05305040|100794119|FG000|Overall Study|Primary Malignancy Relapse|3|||
33244111|NCT05305040|100794120|FG001|Overall Study|Primary Malignancy Relapse|4|||
33372802|NCT01551758|101251963|FG001|Overall Study|Protocol Violation|6|||
33422763|NCT00283686|101439737|FG001|Overall Study|Less than full participation|9|||
33422764|NCT00283686|101439738|FG002|Overall Study|Less than full participation|6|||
33244112|NCT05305040|100794119|FG000|Overall Study|Adverse Event|3|||
33244113|NCT05305040|100794120|FG001|Overall Study|Adverse Event|3|||
33643836|NCT01761240|102248443|FG001|Overall Study|Withdrawal by Subject|0|||
33643837|NCT01761240|102248444|FG002|Overall Study|Withdrawal by Subject|0|||
33643838|NCT01761240|102248445|FG003|Overall Study|Withdrawal by Subject|3|||
33643839|NCT01761240|102248446|FG004|Overall Study|Withdrawal by Subject|1|||
33643840|NCT01761240|102248442|FG000|Overall Study|Adverse Event|0|||
33643841|NCT01761240|102248443|FG001|Overall Study|Adverse Event|0|||
33643842|NCT01761240|102248444|FG002|Overall Study|Adverse Event|0|||
33643843|NCT01761240|102248445|FG003|Overall Study|Adverse Event|1|||
33643844|NCT01761240|102248446|FG004|Overall Study|Adverse Event|6|||
33643845|NCT01761240|102248442|FG000|Overall Study|Death|0|||
33643846|NCT01761240|102248443|FG001|Overall Study|Death|1|||
33643847|NCT01761240|102248444|FG002|Overall Study|Death|1|||
33643848|NCT01761240|102248445|FG003|Overall Study|Death|2|||
33643849|NCT01761240|102248446|FG004|Overall Study|Death|1|||
33643850|NCT01761240|102248442|FG000|Overall Study|Non-compliance|0|||
33643851|NCT01761240|102248443|FG001|Overall Study|Non-compliance|0|||
33643852|NCT01761240|102248444|FG002|Overall Study|Non-compliance|1|||
33643853|NCT01761240|102248445|FG003|Overall Study|Non-compliance|0|||
33643854|NCT01761240|102248446|FG004|Overall Study|Non-compliance|0|||
33643855|NCT00567398|102248447|FG000|Overall Study|Adverse Event|6|||
33643856|NCT00567398|102248448|FG001|Overall Study|Adverse Event|14|||
33643857|NCT00567398|102248447|FG000|Overall Study|Physician Decision|0|||
33643858|NCT00567398|102248448|FG001|Overall Study|Physician Decision|4|||
33643859|NCT00567398|102248447|FG000|Overall Study|Withdrawal by Subject|0|||
33643860|NCT00567398|102248448|FG001|Overall Study|Withdrawal by Subject|2|||
33643861|NCT00567398|102248447|FG000|Overall Study|Renal Transplantation|0|||
33643862|NCT00567398|102248448|FG001|Overall Study|Renal Transplantation|3|||
33643863|NCT00567398|102248447|FG000|Overall Study|Other|1|||
33643864|NCT00567398|102248448|FG001|Overall Study|Other|0|||
33643865|NCT00884741|102248449|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
33643866|NCT00884741|102248450|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
33643867|NCT00884741|102248451|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
33643868|NCT00884741|102248452|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
33643869|NCT00884741|102248449|FG000|Step 1 Registration: Tissue Screening|Death|3|||
33643870|NCT00884741|102248450|FG001|Step 1 Registration: Tissue Screening|Death|0|||
33643871|NCT00884741|102248451|FG002|Step 1 Registration: Tissue Screening|Death|0|||
33643872|NCT00884741|102248452|FG003|Step 1 Registration: Tissue Screening|Death|0|||
33643873|NCT00884741|102248449|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
33643874|NCT00884741|102248450|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
33372803|NCT01551758|101251962|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
33372804|NCT01551758|101251963|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
33372805|NCT01551758|101251962|FG000|Overall Study|Lost to Follow-up|29|||
33372806|NCT01551758|101251963|FG001|Overall Study|Lost to Follow-up|25|||
33372807|NCT01551758|101251962|FG000|Overall Study|Physician Decision|9|||
33372808|NCT01551758|101251963|FG001|Overall Study|Physician Decision|3|||
33372809|NCT01551758|101251962|FG000|Overall Study|Withdrawal by Subject|14|||
33372810|NCT01551758|101251963|FG001|Overall Study|Withdrawal by Subject|17|||
33372811|NCT01395368|101251964|FG000|Overall Study|Physician Decision|14|||
33372812|NCT01395368|101251964|FG000|Overall Study|Withdrawal by Subject|2|||
33372813|NCT02488759|101251967|FG000|Overall Study|Disease progression|73|||
33372814|NCT02488759|101251968|FG001|Overall Study|Disease progression|111|||
33372815|NCT02488759|101251969|FG002|Overall Study|Disease progression|62|||
33372816|NCT02488759|101251970|FG003|Overall Study|Disease progression|7|||
33372817|NCT02488759|101251971|FG004|Overall Study|Disease progression|4|||
33372818|NCT02488759|101251972|FG005|Overall Study|Disease progression|2|||
33372819|NCT02488759|101251967|FG000|Overall Study|Study drug toxicity|11|||
33372820|NCT02488759|101251968|FG001|Overall Study|Study drug toxicity|33|||
33372821|NCT02488759|101251969|FG002|Overall Study|Study drug toxicity|31|||
33372822|NCT02488759|101251970|FG003|Overall Study|Study drug toxicity|0|||
33372823|NCT02488759|101251971|FG004|Overall Study|Study drug toxicity|0|||
33643875|NCT00884741|102248451|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
33643876|NCT00884741|102248452|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
33643877|NCT00884741|102248449|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
33643878|NCT00884741|102248450|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
33643879|NCT00884741|102248451|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
33643880|NCT00884741|102248452|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
33643881|NCT00884741|102248449|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
33643882|NCT00884741|102248450|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
33372824|NCT02488759|101251972|FG005|Overall Study|Study drug toxicity|2|||
33372825|NCT02488759|101251967|FG000|Overall Study|Adverse event unrelated to study drug|9|||
33372826|NCT02488759|101251968|FG001|Overall Study|Adverse event unrelated to study drug|11|||
33372827|NCT02488759|101251969|FG002|Overall Study|Adverse event unrelated to study drug|7|||
33372828|NCT02488759|101251970|FG003|Overall Study|Adverse event unrelated to study drug|0|||
33372829|NCT02488759|101251971|FG004|Overall Study|Adverse event unrelated to study drug|1|||
33244114|NCT05305040|100794119|FG000|Overall Study|Lost to Follow-up|2|||
33145973|NCT00076024|100448353|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
33145974|NCT00076024|100448350|FG000|Phase 2, Open-label|Adverse Event|0|||
33145975|NCT00076024|100448351|FG001|Phase 2, Open-label|Adverse Event|0|||
33145976|NCT00076024|100448352|FG002|Phase 2, Open-label|Adverse Event|0|||
33145977|NCT00076024|100448353|FG003|Phase 2, Open-label|Adverse Event|2|||
33145978|NCT00076024|100448350|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
33145979|NCT00076024|100448351|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
33145980|NCT00076024|100448352|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
33145981|NCT00076024|100448353|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
33145982|NCT00076024|100448350|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
33145983|NCT00076024|100448351|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
33145984|NCT00076024|100448352|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
33145985|NCT00076024|100448353|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
33145986|NCT00076024|100448350|FG000|Phase 2, Open-label|Other|0|||
33145987|NCT00076024|100448351|FG001|Phase 2, Open-label|Other|0|||
33145988|NCT00076024|100448352|FG002|Phase 2, Open-label|Other|0|||
33145989|NCT00076024|100448353|FG003|Phase 2, Open-label|Other|2|||
33145990|NCT00640835|100448354|FG000|Overall Study|Adverse Event|5|||
33145991|NCT00640835|100448355|FG001|Overall Study|Adverse Event|3|||
33145992|NCT00640835|100448354|FG000|Overall Study|Withdrawal by Subject|12|||
33145993|NCT00640835|100448355|FG001|Overall Study|Withdrawal by Subject|14|||
33145994|NCT00640835|100448354|FG000|Overall Study|Physician Decision|10|||
33145995|NCT00640835|100448355|FG001|Overall Study|Physician Decision|14|||
33145996|NCT00640835|100448354|FG000|Overall Study|Sponsor's Decision|11|||
33145997|NCT00640835|100448355|FG001|Overall Study|Sponsor's Decision|7|||
33145998|NCT00640835|100448354|FG000|Overall Study|Protocol Violation|2|||
33145999|NCT00640835|100448355|FG001|Overall Study|Protocol Violation|2|||
33146000|NCT00640835|100448354|FG000|Overall Study|Lost to Follow-up|17|||
33146001|NCT00640835|100448355|FG001|Overall Study|Lost to Follow-up|13|||
33146002|NCT00640835|100448354|FG000|Overall Study|Other Reason|19|||
33643883|NCT00884741|102248451|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
33643884|NCT00884741|102248452|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
33146003|NCT00640835|100448355|FG001|Overall Study|Other Reason|4|||
33146004|NCT01757691|100448356|FG000|Overall Study|Administrative problems|2|||
33146005|NCT01757691|100448357|FG001|Overall Study|Administrative problems|0|||
33146006|NCT02284178|100448363|FG000|Overall Study|Met exclusion criteria|49|||
33146007|NCT02284178|100448364|FG001|Overall Study|Met exclusion criteria|54|||
33146008|NCT00920829|100448365|FG000|Allocation|No post randomization data|3|||
33146009|NCT00920829|100448366|FG001|Allocation|No post randomization data|1|||
33372830|NCT02488759|101251972|FG005|Overall Study|Adverse event unrelated to study drug|0|||
33422765|NCT00283686|101439739|FG003|Overall Study|Less than full participation|12|||
33643885|NCT00884741|102248449|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
33643886|NCT00884741|102248450|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
33643887|NCT00884741|102248451|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
33643888|NCT00884741|102248452|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
33643889|NCT00884741|102248449|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
33643890|NCT00884741|102248450|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
33643891|NCT00884741|102248451|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
33643892|NCT00884741|102248452|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
33643893|NCT00884741|102248449|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
33643894|NCT00884741|102248450|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
33643895|NCT00884741|102248451|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
33643896|NCT00884741|102248452|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
33643897|NCT00884741|102248449|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
33643898|NCT00884741|102248450|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
33643899|NCT00884741|102248451|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
33643900|NCT00884741|102248452|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
33146010|NCT00920829|100448367|FG002|Allocation|No post randomization data|0|||
33146011|NCT00920829|100448368|FG003|Allocation|No post randomization data|2|||
33146012|NCT00920829|100448365|FG000|Available for Analysis|Withdrawal by Subject|6|||
33146013|NCT00920829|100448366|FG001|Available for Analysis|Withdrawal by Subject|6|||
33146014|NCT00920829|100448367|FG002|Available for Analysis|Withdrawal by Subject|6|||
33146015|NCT00920829|100448368|FG003|Available for Analysis|Withdrawal by Subject|10|||
33146016|NCT00920829|100448365|FG000|Available for Analysis|Required Medical Treatment|0|||
33146017|NCT00920829|100448366|FG001|Available for Analysis|Required Medical Treatment|1|||
33146018|NCT00920829|100448367|FG002|Available for Analysis|Required Medical Treatment|2|||
33146019|NCT00920829|100448368|FG003|Available for Analysis|Required Medical Treatment|0|||
33146020|NCT00920829|100448365|FG000|Available for Analysis|Adverse Event|1|||
33146021|NCT00920829|100448366|FG001|Available for Analysis|Adverse Event|2|||
33146022|NCT00920829|100448367|FG002|Available for Analysis|Adverse Event|1|||
33146023|NCT00920829|100448368|FG003|Available for Analysis|Adverse Event|0|||
33146024|NCT00920829|100448365|FG000|Available for Analysis|Death|1|||
33146025|NCT00920829|100448366|FG001|Available for Analysis|Death|0|||
33146026|NCT00920829|100448367|FG002|Available for Analysis|Death|0|||
33244115|NCT05305040|100794120|FG001|Overall Study|Lost to Follow-up|1|||
33244116|NCT05305040|100794119|FG000|Overall Study|Graft versus host disease|2|||
33244117|NCT05305040|100794120|FG001|Overall Study|Graft versus host disease|0|||
33244118|NCT05305040|100794119|FG000|Overall Study|Investigator's Decision|1|||
33244119|NCT05305040|100794120|FG001|Overall Study|Investigator's Decision|1|||
33244120|NCT05305040|100794119|FG000|Overall Study|COVID-19 Reasons|1|||
33244121|NCT05305040|100794120|FG001|Overall Study|COVID-19 Reasons|0|||
33244122|NCT04577183|100794124|FG000|Overall Study|Death|1|||
33244123|NCT04577183|100794124|FG000|Overall Study|Withdrawal by Subject|3|||
33244124|NCT04577183|100794124|FG000|Overall Study|Early termination|2|||
33372831|NCT02488759|101251967|FG000|Overall Study|Participant request to discontinue study treatment|6|||
33372832|NCT02488759|101251968|FG001|Overall Study|Participant request to discontinue study treatment|8|||
33372833|NCT02488759|101251969|FG002|Overall Study|Participant request to discontinue study treatment|4|||
33244125|NCT01928940|100794127|FG000|Overall Study|Adverse Event|0|||
33372834|NCT02488759|101251970|FG003|Overall Study|Participant request to discontinue study treatment|0|||
33372835|NCT02488759|101251971|FG004|Overall Study|Participant request to discontinue study treatment|0|||
33372836|NCT02488759|101251972|FG005|Overall Study|Participant request to discontinue study treatment|0|||
33372837|NCT02488759|101251967|FG000|Overall Study|Withdrawal by Subject|4|||
33372838|NCT02488759|101251968|FG001|Overall Study|Withdrawal by Subject|0|||
33372839|NCT02488759|101251969|FG002|Overall Study|Withdrawal by Subject|3|||
33583052|NCT00803738|102022812|FG001|Overall Study|Withdrawal by Subject|4|||
33583053|NCT00803738|102022811|FG000|Overall Study|Lack of Efficacy|10|||
33583054|NCT00803738|102022812|FG001|Overall Study|Lack of Efficacy|16|||
33583055|NCT00803738|102022811|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
33583056|NCT00803738|102022812|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
33583057|NCT00803738|102022811|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
33583058|NCT00803738|102022812|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
33583059|NCT02936869|102022813|FG000|Overall Study|Lost to Follow-up|1|||
33583060|NCT02936869|102022814|FG001|Overall Study|Lost to Follow-up|3|||
33583061|NCT02936869|102022813|FG000|Overall Study|Death|0|||
33583062|NCT02936869|102022814|FG001|Overall Study|Death|1|||
33583063|NCT02936869|102022813|FG000|Overall Study|Legal Case|0|||
33583064|NCT02936869|102022814|FG001|Overall Study|Legal Case|1|||
33583065|NCT02936869|102022813|FG000|Overall Study|Protocol Violation|1|||
33643901|NCT00884741|102248449|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
33643902|NCT00884741|102248450|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
33643903|NCT00884741|102248451|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
33643904|NCT00884741|102248452|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
33643905|NCT00884741|102248449|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
33244126|NCT01928940|100794128|FG001|Overall Study|Adverse Event|1|||
33244127|NCT01257503|100794129|FG000|Overall Study|Lost to Follow-up|7|||
33244128|NCT01257503|100794130|FG001|Overall Study|Lost to Follow-up|10|||
33244129|NCT01257503|100794129|FG000|Overall Study|Over 5 years old at enrollment|0|||
33244130|NCT01257503|100794130|FG001|Overall Study|Over 5 years old at enrollment|1|||
33372840|NCT02488759|101251970|FG003|Overall Study|Withdrawal by Subject|0|||
33372841|NCT02488759|101251971|FG004|Overall Study|Withdrawal by Subject|0|||
33372842|NCT02488759|101251972|FG005|Overall Study|Withdrawal by Subject|2|||
33372843|NCT02488759|101251967|FG000|Overall Study|Lost to Follow-up|0|||
33372844|NCT02488759|101251968|FG001|Overall Study|Lost to Follow-up|0|||
33372845|NCT02488759|101251969|FG002|Overall Study|Lost to Follow-up|2|||
33372846|NCT02488759|101251970|FG003|Overall Study|Lost to Follow-up|0|||
33372847|NCT02488759|101251971|FG004|Overall Study|Lost to Follow-up|0|||
33372848|NCT02488759|101251972|FG005|Overall Study|Lost to Follow-up|0|||
33372849|NCT02488759|101251967|FG000|Overall Study|Maximum clinical benefit|3|||
33372850|NCT02488759|101251968|FG001|Overall Study|Maximum clinical benefit|0|||
33372851|NCT02488759|101251969|FG002|Overall Study|Maximum clinical benefit|1|||
33583066|NCT02936869|102022814|FG001|Overall Study|Protocol Violation|0|||
33643906|NCT00884741|102248450|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
33583067|NCT00923351|102022815|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
33583068|NCT00923351|102022816|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
33583069|NCT00923351|102022817|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
33583070|NCT01582009|102022822|FG000|Overall Study|Withdrawal by Subject|1|||
33583071|NCT01582009|102022822|FG000|Overall Study|Physician Decision|1|||
33643907|NCT00884741|102248451|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
33244131|NCT01257503|100794129|FG000|Overall Study|strep culture positive at enrollment|1|||
33244132|NCT01257503|100794130|FG001|Overall Study|strep culture positive at enrollment|0|||
33244133|NCT01251614|100794131|FG000|Overall Study|Adverse Event|1|||
33244134|NCT01251614|100794132|FG001|Overall Study|Adverse Event|0|||
33372852|NCT02488759|101251970|FG003|Overall Study|Maximum clinical benefit|0|||
33372853|NCT02488759|101251971|FG004|Overall Study|Maximum clinical benefit|0|||
33372854|NCT02488759|101251972|FG005|Overall Study|Maximum clinical benefit|0|||
33372855|NCT02488759|101251967|FG000|Overall Study|Other reasons|7|||
33372856|NCT02488759|101251968|FG001|Overall Study|Other reasons|32|||
33583072|NCT00325130|102022823|FG000|Overall Study|Lost to Follow-up|6|||
33146027|NCT00920829|100448368|FG003|Available for Analysis|Death|0|||
33146028|NCT00920829|100448365|FG000|Available for Analysis|Protocol Violation|0|||
33583073|NCT00325130|102022824|FG001|Overall Study|Lost to Follow-up|14|||
33583074|NCT00325130|102022823|FG000|Overall Study|Withdrawal by Subject|12|||
33583075|NCT00325130|102022824|FG001|Overall Study|Withdrawal by Subject|14|||
33583076|NCT00325130|102022823|FG000|Overall Study|Protocol Deviation|0|||
33146029|NCT00920829|100448366|FG001|Available for Analysis|Protocol Violation|0|||
33146030|NCT00920829|100448367|FG002|Available for Analysis|Protocol Violation|1|||
33146031|NCT00920829|100448368|FG003|Available for Analysis|Protocol Violation|0|||
33146032|NCT00920829|100448365|FG000|Available for Analysis|Required more treatment|0|||
33146033|NCT00920829|100448366|FG001|Available for Analysis|Required more treatment|2|||
33146034|NCT00920829|100448367|FG002|Available for Analysis|Required more treatment|0|||
33146035|NCT00920829|100448368|FG003|Available for Analysis|Required more treatment|1|||
33146036|NCT01227564|100448369|FG000|Overall Study|No Longer Willing to Participate|4|||
33146037|NCT01227564|100448370|FG001|Overall Study|No Longer Willing to Participate|2|||
33146038|NCT01227564|100448371|FG002|Overall Study|No Longer Willing to Participate|5|||
33146039|NCT01227564|100448369|FG000|Overall Study|Participant moved to another town|0|||
33146040|NCT01227564|100448370|FG001|Overall Study|Participant moved to another town|0|||
33146041|NCT01227564|100448371|FG002|Overall Study|Participant moved to another town|1|||
33244135|NCT01251614|100794133|FG002|Overall Study|Adverse Event|1|||
33583077|NCT00325130|102022824|FG001|Overall Study|Protocol Deviation|1|||
33583078|NCT00325130|102022823|FG000|Overall Study|Moved|0|||
33583079|NCT00325130|102022824|FG001|Overall Study|Moved|1|||
33583080|NCT00325130|102022823|FG000|Overall Study|Patient Discontinued for Other|1|||
33583081|NCT00325130|102022824|FG001|Overall Study|Patient Discontinued for Other|0|||
33583082|NCT02819297|102022825|FG000|Overall Study|Withdrawal by Subject|25|||
33583083|NCT02819297|102022826|FG001|Overall Study|Withdrawal by Subject|13|||
33583084|NCT02819297|102022825|FG000|Overall Study|Lost to Follow-up|12|||
33583085|NCT02819297|102022826|FG001|Overall Study|Lost to Follow-up|14|||
33583086|NCT02819297|102022825|FG000|Overall Study|Adverse Event|12|||
33583087|NCT02819297|102022826|FG001|Overall Study|Adverse Event|10|||
33583088|NCT02819297|102022825|FG000|Overall Study|Physician Decision|5|||
33583089|NCT02819297|102022826|FG001|Overall Study|Physician Decision|5|||
33583090|NCT02819297|102022825|FG000|Overall Study|Lack of Efficacy|5|||
33583091|NCT02819297|102022826|FG001|Overall Study|Lack of Efficacy|8|||
33583092|NCT02819297|102022825|FG000|Overall Study|Protocol Violation|1|||
33643908|NCT00884741|102248452|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
33643909|NCT00884741|102248449|FG000|Randomization|Protocol Violation|0|||
33643910|NCT00884741|102248450|FG001|Randomization|Protocol Violation|0|||
33643911|NCT00884741|102248451|FG002|Randomization|Protocol Violation|8|||
33643912|NCT00884741|102248452|FG003|Randomization|Protocol Violation|8|||
33643913|NCT01754727|102248453|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
33643914|NCT02605122|102248454|FG000|Overall Study|Withdrawal by Subject|4|||
33643915|NCT02605122|102248455|FG001|Overall Study|Withdrawal by Subject|1|||
33643916|NCT02605122|102248454|FG000|Overall Study|Lost to Follow-up|1|||
33643917|NCT02605122|102248455|FG001|Overall Study|Lost to Follow-up|1|||
33643918|NCT02703337|102248458|FG000|Period One (Part A)|Withdrawal by Subject|0|||
33643919|NCT02703337|102248459|FG001|Period One (Part A)|Withdrawal by Subject|0|||
33643920|NCT02703337|102248460|FG002|Period One (Part A)|Withdrawal by Subject|0|||
33643921|NCT02703337|102248461|FG003|Period One (Part A)|Withdrawal by Subject|0|||
33643922|NCT02703337|102248462|FG004|Period One (Part A)|Withdrawal by Subject|1|||
33643923|NCT02703337|102248463|FG005|Period One (Part A)|Withdrawal by Subject|0|||
33643924|NCT02703337|102248464|FG006|Period One (Part A)|Withdrawal by Subject|0|||
33643925|NCT02703337|102248465|FG007|Period One (Part A)|Withdrawal by Subject|0|||
33643926|NCT02695420|102248472|FG000|Overall Study|Death|0|||
33643927|NCT02695420|102248473|FG001|Overall Study|Death|1|||
33643928|NCT02695420|102248474|FG002|Overall Study|Death|0|||
33643929|NCT02695420|102248475|FG003|Overall Study|Death|0|||
33643930|NCT03110770|102248476|FG000|Overall Study|Death|1|||
33643931|NCT03110770|102248477|FG001|Overall Study|Death|0|||
33643932|NCT03110770|102248478|FG002|Overall Study|Death|0|||
33643933|NCT03110770|102248479|FG003|Overall Study|Death|1|||
33643934|NCT03110770|102248480|FG004|Overall Study|Death|0|||
33146042|NCT03901456|100448373|FG000|Overall Study|Withdrawal by Subject|0|||
33422766|NCT00964223|101439740|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
33643935|NCT03110770|102248476|FG000|Overall Study|Enrolled but did not receive product|0|||
33244136|NCT01251614|100794131|FG000|Overall Study|Lack of Efficacy|1|||
33643936|NCT03110770|102248477|FG001|Overall Study|Enrolled but did not receive product|0|||
33583093|NCT02819297|102022826|FG001|Overall Study|Protocol Violation|2|||
33583094|NCT00910910|102022827|FG000|Overall Study|Adverse Event|63|||
33583095|NCT00910910|102022828|FG001|Overall Study|Adverse Event|35|||
33583096|NCT00910910|102022827|FG000|Overall Study|PD without histologic change|27|||
33583097|NCT00910910|102022828|FG001|Overall Study|PD without histologic change|23|||
33583098|NCT00910910|102022827|FG000|Overall Study|PD with histologic change|0|||
33583099|NCT00910910|102022828|FG001|Overall Study|PD with histologic change|2|||
33643937|NCT03110770|102248478|FG002|Overall Study|Enrolled but did not receive product|0|||
33583100|NCT00910910|102022827|FG000|Overall Study|Withdrawal by Subject|7|||
33583101|NCT00910910|102022828|FG001|Overall Study|Withdrawal by Subject|5|||
33583102|NCT00910910|102022827|FG000|Overall Study|Lost to Follow-up|2|||
33583103|NCT00910910|102022828|FG001|Overall Study|Lost to Follow-up|2|||
33583104|NCT00910910|102022827|FG000|Overall Study|Death|9|||
33583105|NCT00910910|102022828|FG001|Overall Study|Death|3|||
33583106|NCT00910910|102022827|FG000|Overall Study|Protocol Violation|2|||
33583107|NCT00910910|102022828|FG001|Overall Study|Protocol Violation|2|||
33583108|NCT00910910|102022827|FG000|Overall Study|Completed 13 cycles of treatment|0|||
33422767|NCT02124746|101439747|FG000|Overall Study|Adverse Event|2|||
33422768|NCT02124746|101439748|FG001|Overall Study|Adverse Event|1|||
33422769|NCT02124746|101439749|FG002|Overall Study|Adverse Event|2|||
33583109|NCT00910910|102022828|FG001|Overall Study|Completed 13 cycles of treatment|118|||
33583110|NCT00910910|102022827|FG000|Overall Study|Other|114|||
33583111|NCT00910910|102022828|FG001|Overall Study|Other|32|||
33583112|NCT00910910|102022827|FG000|Overall Study|Untreated before cycle 1|1|||
33583113|NCT00910910|102022828|FG001|Overall Study|Untreated before cycle 1|2|||
33643938|NCT03110770|102248479|FG003|Overall Study|Enrolled but did not receive product|8|||
33583114|NCT00255723|102022833|FG000|Overall Study|Adverse Event|1|||
33583115|NCT00255723|102022834|FG001|Overall Study|Adverse Event|1|||
33583116|NCT00255723|102022833|FG000|Overall Study|Death|0|||
33583117|NCT00255723|102022834|FG001|Overall Study|Death|1|||
33583118|NCT00255723|102022833|FG000|Overall Study|Response Data Not Available|1|||
33643939|NCT03110770|102248480|FG004|Overall Study|Enrolled but did not receive product|7|||
33643940|NCT03110770|102248476|FG000|Overall Study|Lost to Follow-up|0|||
33643941|NCT03110770|102248477|FG001|Overall Study|Lost to Follow-up|0|||
33643942|NCT03110770|102248478|FG002|Overall Study|Lost to Follow-up|0|||
33643943|NCT03110770|102248479|FG003|Overall Study|Lost to Follow-up|53|||
33643944|NCT03110770|102248480|FG004|Overall Study|Lost to Follow-up|45|||
33643945|NCT03110770|102248476|FG000|Overall Study|Investigator Decision|0|||
33643946|NCT03110770|102248477|FG001|Overall Study|Investigator Decision|0|||
33643947|NCT03110770|102248478|FG002|Overall Study|Investigator Decision|0|||
33643948|NCT03110770|102248479|FG003|Overall Study|Investigator Decision|5|||
33643949|NCT03110770|102248480|FG004|Overall Study|Investigator Decision|3|||
33643950|NCT03110770|102248476|FG000|Overall Study|Withdrawal by Subject|0|||
33643951|NCT03110770|102248477|FG001|Overall Study|Withdrawal by Subject|0|||
33643952|NCT03110770|102248478|FG002|Overall Study|Withdrawal by Subject|0|||
33643953|NCT03110770|102248479|FG003|Overall Study|Withdrawal by Subject|24|||
33643954|NCT03110770|102248480|FG004|Overall Study|Withdrawal by Subject|24|||
33643955|NCT03110770|102248476|FG000|Overall Study|Moved from area|5|||
33643956|NCT03110770|102248477|FG001|Overall Study|Moved from area|0|||
33643957|NCT03110770|102248478|FG002|Overall Study|Moved from area|2|||
33643958|NCT03110770|102248479|FG003|Overall Study|Moved from area|42|||
33643959|NCT03110770|102248480|FG004|Overall Study|Moved from area|43|||
33643960|NCT03110770|102248476|FG000|Overall Study|Illness/Injury unrelated to product|0|||
33643961|NCT03110770|102248477|FG001|Overall Study|Illness/Injury unrelated to product|0|||
33643962|NCT03110770|102248478|FG002|Overall Study|Illness/Injury unrelated to product|0|||
33643963|NCT03110770|102248479|FG003|Overall Study|Illness/Injury unrelated to product|0|||
33643964|NCT03110770|102248480|FG004|Overall Study|Illness/Injury unrelated to product|1|||
33643965|NCT01296672|102248483|FG000|Overall Study|Lost to Follow-up|73|||
33643966|NCT01296672|102248484|FG001|Overall Study|Lost to Follow-up|18|||
33643967|NCT00479687|102248485|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
33643968|NCT00479687|102248486|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
33643969|NCT00479687|102248487|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
33643970|NCT00479687|102248485|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
33643971|NCT00479687|102248486|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
33643972|NCT00479687|102248487|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
33643973|NCT00479687|102248485|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
33643974|NCT00479687|102248486|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
33643975|NCT00479687|102248487|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
33643976|NCT00479687|102248485|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
33643977|NCT00479687|102248486|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
33244137|NCT01251614|100794132|FG001|Overall Study|Lack of Efficacy|9|||
33422770|NCT02124746|101439747|FG000|Overall Study|Death|2|||
33583119|NCT00255723|102022834|FG001|Overall Study|Response Data Not Available|0|||
33583120|NCT01803880|102022835|FG000|Overall Study|Adverse Event|1|||
33583121|NCT01803880|102022836|FG001|Overall Study|Adverse Event|0|||
33583122|NCT01803880|102022837|FG002|Overall Study|Adverse Event|0|||
33643978|NCT00479687|102248487|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
33643979|NCT00479687|102248485|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
33422771|NCT02124746|101439748|FG001|Overall Study|Death|1|||
33422772|NCT02124746|101439749|FG002|Overall Study|Death|3|||
33583123|NCT01803880|102022835|FG000|Overall Study|Withdrawal by Subject|1|||
33583124|NCT01803880|102022836|FG001|Overall Study|Withdrawal by Subject|1|||
33643980|NCT00479687|102248486|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
33583125|NCT01803880|102022837|FG002|Overall Study|Withdrawal by Subject|4|||
33583126|NCT01803880|102022835|FG000|Overall Study|Physician Decision|0|||
33583127|NCT01803880|102022836|FG001|Overall Study|Physician Decision|0|||
33146043|NCT03901456|100448374|FG001|Overall Study|Withdrawal by Subject|0|||
33146044|NCT03901456|100448375|FG002|Overall Study|Withdrawal by Subject|1|||
33146045|NCT03901456|100448373|FG000|Overall Study|Lost to Follow-up|0|||
33146046|NCT03901456|100448374|FG001|Overall Study|Lost to Follow-up|1|||
33146047|NCT03901456|100448375|FG002|Overall Study|Lost to Follow-up|0|||
33146048|NCT02927067|100448376|FG000|Overall Study|Withdrawn Consent|20|||
33146049|NCT02927067|100448377|FG001|Overall Study|Withdrawn Consent|12|||
33146050|NCT02927067|100448376|FG000|Overall Study|Death|18|||
33146051|NCT02927067|100448377|FG001|Overall Study|Death|31|||
33146052|NCT02927067|100448376|FG000|Overall Study|Adverse Event|13|||
33146053|NCT02927067|100448377|FG001|Overall Study|Adverse Event|10|||
33146054|NCT02927067|100448376|FG000|Overall Study|Noncompliance|5|||
33146055|NCT02927067|100448377|FG001|Overall Study|Noncompliance|2|||
33146056|NCT02927067|100448376|FG000|Overall Study|Reason not Specified|4|||
33146057|NCT02927067|100448377|FG001|Overall Study|Reason not Specified|6|||
33422773|NCT02124746|101439747|FG000|Overall Study|Lack of Efficacy|3|||
33422774|NCT02124746|101439748|FG001|Overall Study|Lack of Efficacy|2|||
33422775|NCT02124746|101439749|FG002|Overall Study|Lack of Efficacy|2|||
33422776|NCT02124746|101439747|FG000|Overall Study|Physician Decision|6|||
33422777|NCT02124746|101439748|FG001|Overall Study|Physician Decision|4|||
33422778|NCT02124746|101439749|FG002|Overall Study|Physician Decision|5|||
33422779|NCT02124746|101439747|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33422780|NCT02124746|101439748|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33146058|NCT01629706|100448380|FG000|Phase 1 PureVision|Screen Failure|4|||
33146059|NCT01629706|100448380|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
33244138|NCT01251614|100794133|FG002|Overall Study|Lack of Efficacy|4|||
33244139|NCT01251614|100794131|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
33244140|NCT01251614|100794132|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
33244141|NCT01251614|100794133|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
33244142|NCT01251614|100794131|FG000|Overall Study|Pregnancy|0|||
33244143|NCT01251614|100794132|FG001|Overall Study|Pregnancy|0|||
33244144|NCT01251614|100794133|FG002|Overall Study|Pregnancy|2|||
33244145|NCT01251614|100794131|FG000|Overall Study|Loss of Disease Control|0|||
33244146|NCT01251614|100794132|FG001|Overall Study|Loss of Disease Control|1|||
33422781|NCT02124746|101439749|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33422782|NCT02124746|101439747|FG000|Overall Study|Withdrawal by Subject|3|||
33422783|NCT02124746|101439748|FG001|Overall Study|Withdrawal by Subject|3|||
33422784|NCT02124746|101439749|FG002|Overall Study|Withdrawal by Subject|0|||
33422785|NCT02124746|101439747|FG000|Overall Study|Study Terminated by Sponsor|0|||
33422786|NCT02124746|101439748|FG001|Overall Study|Study Terminated by Sponsor|0|||
33422787|NCT02124746|101439749|FG002|Overall Study|Study Terminated by Sponsor|6|||
33422788|NCT02124746|101439747|FG000|Overall Study|Disease Progression|3|||
33422789|NCT02124746|101439748|FG001|Overall Study|Disease Progression|6|||
33422790|NCT02124746|101439749|FG002|Overall Study|Disease Progression|4|||
33422791|NCT01160198|101439750|FG000|Overall Study|Withdrawal by Subject|2|||
33422792|NCT01160198|101439751|FG001|Overall Study|Withdrawal by Subject|1|||
33422793|NCT01160198|101439752|FG002|Overall Study|Withdrawal by Subject|0|||
33583128|NCT01803880|102022837|FG002|Overall Study|Physician Decision|1|||
33583129|NCT01803880|102022835|FG000|Overall Study|Unable to return for follow-up visits|0|||
33583130|NCT01803880|102022836|FG001|Overall Study|Unable to return for follow-up visits|1|||
33583131|NCT01803880|102022837|FG002|Overall Study|Unable to return for follow-up visits|2|||
33583132|NCT01803880|102022835|FG000|Overall Study|Lost to Follow-up|1|||
33583133|NCT01803880|102022836|FG001|Overall Study|Lost to Follow-up|2|||
33583134|NCT01803880|102022837|FG002|Overall Study|Lost to Follow-up|3|||
33583135|NCT01803880|102022835|FG000|Overall Study|Protocol Violation|1|||
33583136|NCT01803880|102022836|FG001|Overall Study|Protocol Violation|0|||
33583137|NCT01803880|102022837|FG002|Overall Study|Protocol Violation|0|||
33583138|NCT01803880|102022835|FG000|Overall Study|Early study termination|0|||
33146060|NCT01629706|100448380|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
33146061|NCT01629706|100448380|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
33146062|NCT01629706|100448380|FG000|Phase 2 Habitual|Screen Failure|6|||
33583139|NCT01803880|102022836|FG001|Overall Study|Early study termination|6|||
33146063|NCT01629706|100448380|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
33146064|NCT01629706|100448380|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
33146065|NCT01629706|100448380|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
33146066|NCT01629706|100448380|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
33146067|NCT01858636|100448383|FG000|Overall Study|No Device Deployment Attempted|24|||
33583140|NCT01803880|102022837|FG002|Overall Study|Early study termination|5|||
33244147|NCT01251614|100794133|FG002|Overall Study|Loss of Disease Control|0|||
33422794|NCT01160198|101439750|FG000|Overall Study|Adverse Event|0|||
33422795|NCT01160198|101439751|FG001|Overall Study|Adverse Event|1|||
33422796|NCT01160198|101439752|FG002|Overall Study|Adverse Event|0|||
33583141|NCT01803880|102022835|FG000|Overall Study|Incomplete data entry by sites|2|||
33583142|NCT01803880|102022836|FG001|Overall Study|Incomplete data entry by sites|0|||
33583143|NCT01803880|102022837|FG002|Overall Study|Incomplete data entry by sites|0|||
33583144|NCT03367403|102022840|FG000|Overall Study|Adverse Event|20|||
33583145|NCT03367403|102022841|FG001|Overall Study|Adverse Event|6|||
33583146|NCT03367403|102022842|FG002|Overall Study|Adverse Event|2|||
33583147|NCT03367403|102022840|FG000|Overall Study|Withdrawal by Subject|12|||
33583148|NCT03367403|102022841|FG001|Overall Study|Withdrawal by Subject|13|||
33643981|NCT00479687|102248487|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
33643982|NCT00479687|102248485|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
33244148|NCT01251614|100794131|FG000|Overall Study|Withdrawal by Subject|0|||
33244149|NCT01251614|100794132|FG001|Overall Study|Withdrawal by Subject|2|||
33244150|NCT01251614|100794133|FG002|Overall Study|Withdrawal by Subject|1|||
33244151|NCT01251614|100794131|FG000|Overall Study|Lost to Follow-up|0|||
33244152|NCT01251614|100794132|FG001|Overall Study|Lost to Follow-up|1|||
33244153|NCT01251614|100794133|FG002|Overall Study|Lost to Follow-up|0|||
33244154|NCT01021332|100794135|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
33244155|NCT01021332|100794135|FG000|Overall Study|Adverse Event|43|||
33244156|NCT01021332|100794135|FG000|Overall Study|Lack of Efficacy|19|||
33244157|NCT01021332|100794135|FG000|Overall Study|Withdrawal of Consent|23|||
33244158|NCT01021332|100794135|FG000|Overall Study|Lost to Follow-up|4|||
33244159|NCT01021332|100794135|FG000|Overall Study|Protocol Violation|9|||
33244160|NCT01021332|100794135|FG000|Overall Study|Miscellaneous|3|||
33244161|NCT00088465|100794136|FG000|Overall Study|Withdrawal by Subject|290|||
33244162|NCT00088465|100794136|FG000|Overall Study|Adverse Event|77|||
33244163|NCT00088465|100794136|FG000|Overall Study|Lost to Follow-up|57|||
33244164|NCT00088465|100794136|FG000|Overall Study|Physician Decision|45|||
33244165|NCT00088465|100794136|FG000|Overall Study|Sponsor Decision|37|||
33244166|NCT00088465|100794136|FG000|Overall Study|Lack of Efficacy|27|||
33244167|NCT00088465|100794136|FG000|Overall Study|Protocol Violation|17|||
33244168|NCT00088465|100794136|FG000|Overall Study|Death|11|||
33643983|NCT00479687|102248486|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
33643984|NCT00479687|102248487|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
33643985|NCT00479687|102248485|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
33643986|NCT00479687|102248486|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
33244169|NCT02734004|100794137|FG000|Overall Study|Death|36|||
33244170|NCT02734004|100794138|FG001|Overall Study|Death|24|||
33244171|NCT02734004|100794139|FG002|Overall Study|Death|26|||
33244172|NCT02734004|100794140|FG003|Overall Study|Death|35|||
33244173|NCT02734004|100794141|FG004|Overall Study|Death|13|||
33244174|NCT02734004|100794142|FG005|Overall Study|Death|17|||
33244175|NCT02734004|100794143|FG006|Overall Study|Death|20|||
33643987|NCT00479687|102248487|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
33643988|NCT00479687|102248485|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
33643989|NCT00479687|102248486|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
33643990|NCT00479687|102248487|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
33643991|NCT00479687|102248485|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
33643992|NCT00479687|102248486|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
33643993|NCT00479687|102248487|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
33643994|NCT01396070|102248497|FG000|Overall Study|Withdrawal by Subject|2|||
33643995|NCT01396070|102248497|FG000|Overall Study|Death|2|||
33643996|NCT01396070|102248497|FG000|Overall Study|Adverse Event|8|||
33244176|NCT02734004|100794137|FG000|Overall Study|Lost to Follow-up|1|||
33244177|NCT02734004|100794138|FG001|Overall Study|Lost to Follow-up|1|||
33244178|NCT02734004|100794139|FG002|Overall Study|Lost to Follow-up|0|||
33244179|NCT02734004|100794140|FG003|Overall Study|Lost to Follow-up|0|||
33244180|NCT02734004|100794141|FG004|Overall Study|Lost to Follow-up|1|||
33244181|NCT02734004|100794142|FG005|Overall Study|Lost to Follow-up|0|||
33244182|NCT02734004|100794143|FG006|Overall Study|Lost to Follow-up|0|||
33244183|NCT02734004|100794137|FG000|Overall Study|Withdrawal by Subject|3|||
33244184|NCT02734004|100794138|FG001|Overall Study|Withdrawal by Subject|1|||
33422797|NCT01160198|101439750|FG000|Overall Study|Lost to Follow-up|0|||
33422798|NCT01160198|101439751|FG001|Overall Study|Lost to Follow-up|1|||
33583149|NCT03367403|102022842|FG002|Overall Study|Withdrawal by Subject|1|||
33583150|NCT03367403|102022840|FG000|Overall Study|Death|1|||
33583151|NCT03367403|102022841|FG001|Overall Study|Death|2|||
33244185|NCT02734004|100794139|FG002|Overall Study|Withdrawal by Subject|1|||
33583152|NCT03367403|102022842|FG002|Overall Study|Death|0|||
33643997|NCT01396070|102248497|FG000|Overall Study|Physician Decision|3|||
33643998|NCT01396070|102248497|FG000|Overall Study|Lack of Efficacy|4|||
33643999|NCT00499590|102248498|FG000|Overall Study|Study Terminated|112|||
33644000|NCT00499590|102248499|FG001|Overall Study|Study Terminated|112|||
33644001|NCT00499590|102248500|FG002|Overall Study|Study Terminated|112|||
33244186|NCT02734004|100794140|FG003|Overall Study|Withdrawal by Subject|1|||
33244187|NCT02734004|100794141|FG004|Overall Study|Withdrawal by Subject|3|||
33244188|NCT02734004|100794142|FG005|Overall Study|Withdrawal by Subject|0|||
33244189|NCT02734004|100794143|FG006|Overall Study|Withdrawal by Subject|2|||
33583153|NCT03367403|102022840|FG000|Overall Study|Physician Decision|0|||
33244190|NCT02734004|100794137|FG000|Overall Study|Other|0|||
33244191|NCT02734004|100794138|FG001|Overall Study|Other|8|||
33244192|NCT02734004|100794139|FG002|Overall Study|Other|7|||
33372857|NCT02488759|101251969|FG002|Overall Study|Other reasons|23|||
33372858|NCT02488759|101251970|FG003|Overall Study|Other reasons|1|||
33372859|NCT02488759|101251971|FG004|Overall Study|Other reasons|1|||
33372860|NCT02488759|101251972|FG005|Overall Study|Other reasons|1|||
33583154|NCT03367403|102022841|FG001|Overall Study|Physician Decision|1|||
33583155|NCT03367403|102022842|FG002|Overall Study|Physician Decision|0|||
33644002|NCT00499590|102248498|FG000|Overall Study|Not treated|1|||
33644003|NCT00499590|102248499|FG001|Overall Study|Not treated|0|||
33644004|NCT00499590|102248500|FG002|Overall Study|Not treated|1|||
33644005|NCT02656693|102248501|FG000|Overall Study|Pregnancy|1|||
33644006|NCT02656693|102248502|FG001|Overall Study|Pregnancy|1|||
33644007|NCT02656693|102248503|FG002|Overall Study|Pregnancy|1|||
33644008|NCT02656693|102248501|FG000|Overall Study|Bariatric surgery|0|||
33644009|NCT02656693|102248502|FG001|Overall Study|Bariatric surgery|1|||
33644010|NCT02656693|102248503|FG002|Overall Study|Bariatric surgery|2|||
33644011|NCT00452361|102248504|FG000|Overall Study|Adverse Event|8|||
33644012|NCT00452361|102248505|FG001|Overall Study|Adverse Event|0|||
33644013|NCT00452361|102248504|FG000|Overall Study|Withdrawal by Subject|0|||
33644014|NCT00452361|102248505|FG001|Overall Study|Withdrawal by Subject|1|||
33644015|NCT00452361|102248504|FG000|Overall Study|Premature termination|13|||
33644016|NCT00452361|102248505|FG001|Overall Study|Premature termination|9|||
33644017|NCT01798849|102248506|FG000|Overall Study|Physician Decision|0|||
33644018|NCT01798849|102248507|FG001|Overall Study|Physician Decision|0|||
33644019|NCT01798849|102248508|FG002|Overall Study|Physician Decision|1|||
33644020|NCT02657408|102248509|FG000|Overall Study|Adverse Event|3|||
33644021|NCT02657408|102248510|FG001|Overall Study|Adverse Event|7|||
33644022|NCT02152956|102248511|FG000|Overall Study|Adverse Event|0|||
33644023|NCT02152956|102248512|FG001|Overall Study|Adverse Event|0|||
33644024|NCT02152956|102248513|FG002|Overall Study|Adverse Event|0|||
33644025|NCT02152956|102248514|FG003|Overall Study|Adverse Event|0|||
33644026|NCT02152956|102248515|FG004|Overall Study|Adverse Event|0|||
33644027|NCT02152956|102248516|FG005|Overall Study|Adverse Event|0|||
33644028|NCT02152956|102248517|FG006|Overall Study|Adverse Event|0|||
33644029|NCT02152956|102248518|FG007|Overall Study|Adverse Event|0|||
33644030|NCT02152956|102248519|FG008|Overall Study|Adverse Event|0|||
33644031|NCT02152956|102248520|FG009|Overall Study|Adverse Event|0|||
33644032|NCT02152956|102248521|FG010|Overall Study|Adverse Event|0|||
33644033|NCT02152956|102248522|FG011|Overall Study|Adverse Event|4|||
33644034|NCT02152956|102248523|FG012|Overall Study|Adverse Event|0|||
33644035|NCT02152956|102248511|FG000|Overall Study|Death|0|||
33644036|NCT02152956|102248512|FG001|Overall Study|Death|3|||
33644037|NCT02152956|102248513|FG002|Overall Study|Death|3|||
33372861|NCT02273752|101251973|FG000|Overall Study|Trial was terminated early|2|||
33372862|NCT01204658|101251982|FG000|Primary Phase|Adverse Event|0|||
33372863|NCT01204658|101251983|FG001|Primary Phase|Adverse Event|0|||
33372864|NCT01204658|101251984|FG002|Primary Phase|Adverse Event|1|||
33372865|NCT01204658|101251985|FG003|Primary Phase|Adverse Event|0|||
33372866|NCT00937768|101251986|FG000|Overall Study|Refused Further Treatment|3|||
33372867|NCT00937768|101251987|FG001|Overall Study|Refused Further Treatment|2|||
33583156|NCT03367403|102022840|FG000|Overall Study|Protocol Violation|1|||
33583157|NCT03367403|102022841|FG001|Overall Study|Protocol Violation|1|||
33583158|NCT03367403|102022842|FG002|Overall Study|Protocol Violation|0|||
33583159|NCT03367403|102022840|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
33583160|NCT03367403|102022841|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
33583161|NCT03367403|102022842|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
33583162|NCT03367403|102022840|FG000|Overall Study|COVID-19|3|||
33583163|NCT03367403|102022841|FG001|Overall Study|COVID-19|6|||
33583164|NCT03367403|102022842|FG002|Overall Study|COVID-19|0|||
33583165|NCT03367403|102022840|FG000|Overall Study|Abuse of Alcohol Intake|0|||
33583166|NCT03367403|102022841|FG001|Overall Study|Abuse of Alcohol Intake|1|||
33583167|NCT03367403|102022842|FG002|Overall Study|Abuse of Alcohol Intake|0|||
33644038|NCT02152956|102248514|FG003|Overall Study|Death|4|||
33644039|NCT02152956|102248515|FG004|Overall Study|Death|1|||
33644040|NCT02152956|102248516|FG005|Overall Study|Death|2|||
33644041|NCT02152956|102248517|FG006|Overall Study|Death|6|||
33644042|NCT02152956|102248518|FG007|Overall Study|Death|6|||
33644043|NCT02152956|102248519|FG008|Overall Study|Death|4|||
33644044|NCT02152956|102248520|FG009|Overall Study|Death|5|||
33244193|NCT02734004|100794140|FG003|Overall Study|Other|4|||
33244194|NCT02734004|100794141|FG004|Overall Study|Other|34|||
33244195|NCT02734004|100794142|FG005|Overall Study|Other|14|||
33372868|NCT00937768|101251986|FG000|Overall Study|Disease Progression|1|||
33644045|NCT02152956|102248521|FG010|Overall Study|Death|3|||
33372869|NCT00937768|101251987|FG001|Overall Study|Disease Progression|1|||
33644046|NCT02152956|102248522|FG011|Overall Study|Death|143|||
33644047|NCT02152956|102248523|FG012|Overall Study|Death|12|||
33644048|NCT02152956|102248511|FG000|Overall Study|Lost to Follow-up|0|||
33644049|NCT02152956|102248512|FG001|Overall Study|Lost to Follow-up|1|||
33644050|NCT02152956|102248513|FG002|Overall Study|Lost to Follow-up|0|||
33583168|NCT03367403|102022840|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
33583169|NCT03367403|102022841|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
33583170|NCT03367403|102022842|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
33583171|NCT04396795|102022845|FG000|Month 1|Lost to Follow-up|2|||
33583172|NCT04396795|102022846|FG001|Month 1|Lost to Follow-up|3|||
33583173|NCT04396795|102022845|FG000|Month 3|Lost to Follow-up|1|||
33244196|NCT02734004|100794143|FG006|Overall Study|Other|10|||
33244197|NCT02197234|100794147|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
33244198|NCT02197234|100794147|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
33244199|NCT02197234|100794147|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
33244200|NCT02197234|100794147|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
33244201|NCT02197234|100794147|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
33244202|NCT02197234|100794147|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
33244203|NCT00531479|100794148|FG000|Overall Study|Death|68|||
33244204|NCT00531479|100794149|FG001|Overall Study|Death|71|||
33244205|NCT00531479|100794148|FG000|Overall Study|Lost to Follow-up|0|||
33244206|NCT00531479|100794149|FG001|Overall Study|Lost to Follow-up|2|||
33583174|NCT04396795|102022846|FG001|Month 3|Lost to Follow-up|3|||
33583175|NCT04396795|102022845|FG000|Month 6|Lost to Follow-up|3|||
33146068|NCT01858636|100448383|FG000|Overall Study|Physician Decision|1|||
33146069|NCT01858636|100448383|FG000|Overall Study|Death|1|||
33146070|NCT01858636|100448383|FG000|Overall Study|Lost to Follow-up|1|||
33146071|NCT01858636|100448383|FG000|Overall Study|Withdrawal by Subject|1|||
33146072|NCT02775903|100448390|FG000|Overall Study|Death|7|||
33146073|NCT02775903|100448391|FG001|Overall Study|Death|11|||
33146074|NCT02775903|100448392|FG002|Overall Study|Death|12|||
33146075|NCT02775903|100448393|FG003|Overall Study|Death|11|||
33146076|NCT02775903|100448390|FG000|Overall Study|Adverse Event|0|||
33244207|NCT00531479|100794148|FG000|Overall Study|Other|0|||
33244208|NCT00531479|100794149|FG001|Overall Study|Other|1|||
33244209|NCT00531479|100794148|FG000|Overall Study|Withdrawal by Subject|6|||
33583176|NCT04396795|102022846|FG001|Month 6|Lost to Follow-up|3|||
33244210|NCT00531479|100794149|FG001|Overall Study|Withdrawal by Subject|6|||
33244211|NCT00531479|100794148|FG000|Overall Study|Did not receive treatment|2|||
33244212|NCT00531479|100794149|FG001|Overall Study|Did not receive treatment|3|||
33244213|NCT04824131|100794159|FG000|CAB LA Oral Phase|Adverse Event|1|||
33244214|NCT04824131|100794159|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
33244215|NCT04824131|100794159|FG000|Step 3|Withdrawal by Subject|2|||
33244216|NCT05458102|100794160|FG000|Overall Study|Withdrew consent|2|||
33244217|NCT05458102|100794161|FG001|Overall Study|Withdrew consent|0|||
33244218|NCT05458102|100794160|FG000|Overall Study|Adverse Event|1|||
33244219|NCT05458102|100794161|FG001|Overall Study|Adverse Event|0|||
33244220|NCT05458102|100794160|FG000|Overall Study|Enrolled but never treated|1|||
33244221|NCT05458102|100794161|FG001|Overall Study|Enrolled but never treated|0|||
33244222|NCT05458102|100794160|FG000|Overall Study|Protocol Violation|1|||
33244223|NCT05458102|100794161|FG001|Overall Study|Protocol Violation|0|||
33244224|NCT01021878|100794162|FG000|Overall Study|Lost to Follow-up|4|||
33244225|NCT01021878|100794163|FG001|Overall Study|Lost to Follow-up|3|||
33244226|NCT01021878|100794162|FG000|Overall Study|Death|0|||
33244227|NCT01021878|100794163|FG001|Overall Study|Death|1|||
33244228|NCT01021878|100794162|FG000|Overall Study|Adverse Event|6|||
33244229|NCT01021878|100794163|FG001|Overall Study|Adverse Event|5|||
33244230|NCT01021878|100794162|FG000|Overall Study|Transplantation|6|||
33244231|NCT01021878|100794163|FG001|Overall Study|Transplantation|1|||
33244232|NCT00477412|100796887|FG000|Overall Study|Death|0|||
33583177|NCT01833494|102022847|FG000|Overall Study|Adverse Event|24|||
33583178|NCT01833494|102022847|FG000|Overall Study|Physician Decision|6|||
33583179|NCT01833494|102022847|FG000|Overall Study|Withdrawal by Subject|6|||
33583180|NCT01833494|102022847|FG000|Overall Study|Decrease in serum phosphorus|4|||
33583181|NCT01833494|102022847|FG000|Overall Study|Decrease in serum calcium|4|||
33244233|NCT00477412|100796888|FG001|Overall Study|Death|0|||
33244234|NCT00477412|100796889|FG002|Overall Study|Death|0|||
33244235|NCT00477412|100796890|FG003|Overall Study|Death|4|||
33244236|NCT00477412|100796887|FG000|Overall Study|Lost to Follow-up|0|||
33244237|NCT00477412|100796888|FG001|Overall Study|Lost to Follow-up|0|||
33583182|NCT01833494|102022847|FG000|Overall Study|Increase in serum ferritin|1|||
33146077|NCT02775903|100448391|FG001|Overall Study|Adverse Event|1|||
33146078|NCT02775903|100448392|FG002|Overall Study|Adverse Event|12|||
33583183|NCT01650831|102022848|FG000|Overall Study|Screen failure|1|||
33583184|NCT01467466|102022849|FG000|Overall Study|Withdrawal by Subject|15|||
33244238|NCT00477412|100796889|FG002|Overall Study|Lost to Follow-up|0|||
33244239|NCT00477412|100796890|FG003|Overall Study|Lost to Follow-up|1|||
33244240|NCT00477412|100796887|FG000|Overall Study|Withdrawal by Subject|0|||
33244241|NCT00477412|100796888|FG001|Overall Study|Withdrawal by Subject|0|||
33146079|NCT02775903|100448393|FG003|Overall Study|Adverse Event|3|||
33244242|NCT00477412|100796889|FG002|Overall Study|Withdrawal by Subject|0|||
33244243|NCT00477412|100796890|FG003|Overall Study|Withdrawal by Subject|2|||
33244244|NCT00477412|100796887|FG000|Overall Study|Second Malignancy|0|||
33244245|NCT00477412|100796888|FG001|Overall Study|Second Malignancy|0|||
33244246|NCT00477412|100796889|FG002|Overall Study|Second Malignancy|0|||
33244247|NCT00477412|100796890|FG003|Overall Study|Second Malignancy|1|||
33244248|NCT00477412|100796887|FG000|Overall Study|Adverse Event|1|||
33244249|NCT00477412|100796888|FG001|Overall Study|Adverse Event|0|||
33244250|NCT00477412|100796889|FG002|Overall Study|Adverse Event|1|||
33244251|NCT00477412|100796890|FG003|Overall Study|Adverse Event|0|||
33244252|NCT01096056|100796896|FG000|Overall Study|Lost to Follow-up|0|||
33244253|NCT01096056|100796897|FG001|Overall Study|Lost to Follow-up|1|||
33244254|NCT02921230|100796898|FG000|Overall Study|Withdrawal by Subject|20|||
33244255|NCT02921230|100796899|FG001|Overall Study|Withdrawal by Subject|8|||
33244256|NCT02921230|100796898|FG000|Overall Study|Death|12|||
33244257|NCT02921230|100796899|FG001|Overall Study|Death|3|||
33244258|NCT02921230|100796898|FG000|Overall Study|Protocol Violation|17|||
33244259|NCT02921230|100796899|FG001|Overall Study|Protocol Violation|6|||
33244260|NCT02921230|100796898|FG000|Overall Study|Early completion|5|||
33244261|NCT02921230|100796899|FG001|Overall Study|Early completion|1|||
33244262|NCT02921230|100796898|FG000|Overall Study|Pending data entry|1|||
33244263|NCT02921230|100796899|FG001|Overall Study|Pending data entry|0|||
33244264|NCT01268891|100796900|FG000|Overall Study|Adverse Event|3|||
33244265|NCT01268891|100796901|FG001|Overall Study|Adverse Event|7|||
33244266|NCT01268891|100796900|FG000|Overall Study|Lack of Efficacy|1|||
33244267|NCT01268891|100796901|FG001|Overall Study|Lack of Efficacy|0|||
33244268|NCT01268891|100796900|FG000|Overall Study|Withdrawal of Consent|3|||
33244269|NCT01268891|100796901|FG001|Overall Study|Withdrawal of Consent|1|||
33244270|NCT01268891|100796900|FG000|Overall Study|Administrative or other reason(s)|1|||
33244271|NCT01268891|100796901|FG001|Overall Study|Administrative or other reason(s)|0|||
33244272|NCT02931396|100796907|FG000|Overall Study|Lost to Follow-up|3|||
33244273|NCT02931396|100796908|FG001|Overall Study|Lost to Follow-up|0|||
33244274|NCT02931396|100796907|FG000|Overall Study|Withdrawal by Subject|2|||
33244275|NCT02931396|100796908|FG001|Overall Study|Withdrawal by Subject|0|||
33244276|NCT00049517|100796911|FG000|Induction|Disease progression|0|||
33244277|NCT00049517|100796912|FG001|Induction|Disease progression|0|||
33244278|NCT00049517|100796913|FG002|Induction|Disease progression|0|||
33244279|NCT00049517|100796914|FG003|Induction|Disease progression|0|||
33244280|NCT00049517|100796915|FG004|Induction|Disease progression|18|||
33244281|NCT00049517|100796916|FG005|Induction|Disease progression|11|||
33244282|NCT00049517|100796911|FG000|Induction|Adverse Event|0|||
33244283|NCT00049517|100796912|FG001|Induction|Adverse Event|0|||
33244284|NCT00049517|100796913|FG002|Induction|Adverse Event|0|||
33244285|NCT00049517|100796914|FG003|Induction|Adverse Event|0|||
33244286|NCT00049517|100796915|FG004|Induction|Adverse Event|5|||
33372870|NCT00937768|101251986|FG000|Overall Study|Alternate Treatment|0|||
33372871|NCT00937768|101251987|FG001|Overall Study|Alternate Treatment|1|||
33583185|NCT01467466|102022850|FG001|Overall Study|Withdrawal by Subject|18|||
33583186|NCT01467466|102022851|FG002|Overall Study|Withdrawal by Subject|13|||
33146080|NCT02775903|100448390|FG000|Overall Study|Progressive disease|15|||
33146081|NCT02775903|100448391|FG001|Overall Study|Progressive disease|14|||
33583187|NCT01467466|102022852|FG003|Overall Study|Withdrawal by Subject|11|||
33583188|NCT01467466|102022849|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
33583189|NCT01467466|102022850|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
33583190|NCT01467466|102022851|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
33583191|NCT01467466|102022852|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
33583192|NCT01467466|102022849|FG000|Overall Study|Procedure Cancelled|46|||
33583193|NCT01467466|102022850|FG001|Overall Study|Procedure Cancelled|45|||
33583194|NCT01467466|102022851|FG002|Overall Study|Procedure Cancelled|25|||
33583195|NCT01467466|102022852|FG003|Overall Study|Procedure Cancelled|29|||
33583196|NCT01467466|102022849|FG000|Overall Study|No Endpoint Blood Draw|38|||
33583197|NCT01467466|102022850|FG001|Overall Study|No Endpoint Blood Draw|32|||
33583198|NCT01467466|102022851|FG002|Overall Study|No Endpoint Blood Draw|51|||
33583199|NCT01467466|102022852|FG003|Overall Study|No Endpoint Blood Draw|43|||
33583200|NCT03592771|102025750|FG000|Overall Study|Adverse Event|2|||
33583201|NCT03592771|102025751|FG001|Overall Study|Adverse Event|0|||
33583202|NCT03592771|102025752|FG002|Overall Study|Adverse Event|1|||
33146082|NCT02775903|100448392|FG002|Overall Study|Progressive disease|30|||
33146083|NCT02775903|100448393|FG003|Overall Study|Progressive disease|20|||
33146084|NCT02775903|100448390|FG000|Overall Study|Lack of Efficacy|2|||
33146085|NCT02775903|100448391|FG001|Overall Study|Lack of Efficacy|2|||
33146086|NCT02775903|100448392|FG002|Overall Study|Lack of Efficacy|2|||
33146087|NCT02775903|100448393|FG003|Overall Study|Lack of Efficacy|6|||
33146088|NCT02775903|100448390|FG000|Overall Study|Withdrawal by Subject|7|||
33146089|NCT02775903|100448391|FG001|Overall Study|Withdrawal by Subject|5|||
33146090|NCT02775903|100448392|FG002|Overall Study|Withdrawal by Subject|5|||
33146091|NCT02775903|100448393|FG003|Overall Study|Withdrawal by Subject|8|||
33146092|NCT02775903|100448390|FG000|Overall Study|Other reasons|7|||
33146093|NCT02775903|100448391|FG001|Overall Study|Other reasons|8|||
33146094|NCT02775903|100448392|FG002|Overall Study|Other reasons|2|||
33146095|NCT02775903|100448393|FG003|Overall Study|Other reasons|12|||
33644051|NCT02152956|102248514|FG003|Overall Study|Lost to Follow-up|0|||
33644052|NCT02152956|102248515|FG004|Overall Study|Lost to Follow-up|0|||
33644053|NCT02152956|102248516|FG005|Overall Study|Lost to Follow-up|0|||
33644054|NCT02152956|102248517|FG006|Overall Study|Lost to Follow-up|0|||
33644055|NCT02152956|102248518|FG007|Overall Study|Lost to Follow-up|0|||
33644056|NCT02152956|102248519|FG008|Overall Study|Lost to Follow-up|0|||
33644057|NCT02152956|102248520|FG009|Overall Study|Lost to Follow-up|0|||
33644058|NCT02152956|102248521|FG010|Overall Study|Lost to Follow-up|0|||
33644059|NCT02152956|102248522|FG011|Overall Study|Lost to Follow-up|3|||
33644060|NCT02152956|102248523|FG012|Overall Study|Lost to Follow-up|0|||
33644061|NCT02152956|102248511|FG000|Overall Study|Withdrawal by Subject|1|||
33644062|NCT02152956|102248512|FG001|Overall Study|Withdrawal by Subject|0|||
33644063|NCT02152956|102248513|FG002|Overall Study|Withdrawal by Subject|1|||
33644064|NCT02152956|102248514|FG003|Overall Study|Withdrawal by Subject|0|||
33644065|NCT02152956|102248515|FG004|Overall Study|Withdrawal by Subject|2|||
33644066|NCT02152956|102248516|FG005|Overall Study|Withdrawal by Subject|2|||
33644067|NCT02152956|102248517|FG006|Overall Study|Withdrawal by Subject|0|||
33644068|NCT02152956|102248518|FG007|Overall Study|Withdrawal by Subject|0|||
33644069|NCT02152956|102248519|FG008|Overall Study|Withdrawal by Subject|1|||
33644070|NCT02152956|102248520|FG009|Overall Study|Withdrawal by Subject|0|||
33644071|NCT02152956|102248521|FG010|Overall Study|Withdrawal by Subject|0|||
33644072|NCT02152956|102248522|FG011|Overall Study|Withdrawal by Subject|4|||
33644073|NCT02152956|102248523|FG012|Overall Study|Withdrawal by Subject|0|||
33644074|NCT02152956|102248511|FG000|Overall Study|Physician Decision|0|||
33644075|NCT02152956|102248512|FG001|Overall Study|Physician Decision|0|||
33644076|NCT02152956|102248513|FG002|Overall Study|Physician Decision|0|||
33644077|NCT02152956|102248514|FG003|Overall Study|Physician Decision|0|||
33372872|NCT00937768|101251986|FG000|Overall Study|No Further Funding|4|||
33372873|NCT00937768|101251987|FG001|Overall Study|No Further Funding|4|||
33372874|NCT02509598|101251988|FG000|Overall Study|Withdrawal by Subject|1|||
33372875|NCT00525148|101251989|FG000|Overall Study|Other Adverse Event|3|||
33372876|NCT00525148|101251990|FG001|Overall Study|Other Adverse Event|5|||
33372877|NCT00525148|101251991|FG002|Overall Study|Other Adverse Event|1|||
33372878|NCT00525148|101251992|FG003|Overall Study|Other Adverse Event|8|||
33372879|NCT00525148|101251989|FG000|Overall Study|Progressive disease|18|||
33372880|NCT00525148|101251990|FG001|Overall Study|Progressive disease|30|||
33372881|NCT00525148|101251991|FG002|Overall Study|Progressive disease|6|||
33372882|NCT00525148|101251992|FG003|Overall Study|Progressive disease|49|||
33644078|NCT02152956|102248515|FG004|Overall Study|Physician Decision|0|||
33644079|NCT02152956|102248516|FG005|Overall Study|Physician Decision|0|||
33644080|NCT02152956|102248517|FG006|Overall Study|Physician Decision|0|||
33146096|NCT02716896|100448398|FG000|Overall Study|Physician Decision|0|||
33244287|NCT00049517|100796916|FG005|Induction|Adverse Event|7|||
33244288|NCT00049517|100796911|FG000|Induction|Death|0|||
33244289|NCT00049517|100796912|FG001|Induction|Death|0|||
33244290|NCT00049517|100796913|FG002|Induction|Death|0|||
33372883|NCT00525148|101251989|FG000|Overall Study|Refused continuation of study medication|0|||
33583203|NCT03592771|102025750|FG000|Overall Study|Death|0|||
33583204|NCT03592771|102025751|FG001|Overall Study|Death|1|||
33583205|NCT03592771|102025752|FG002|Overall Study|Death|1|||
33583206|NCT03592771|102025750|FG000|Overall Study|Lost to Follow-up|5|||
33644081|NCT02152956|102248518|FG007|Overall Study|Physician Decision|0|||
33644082|NCT02152956|102248519|FG008|Overall Study|Physician Decision|0|||
33644083|NCT02152956|102248520|FG009|Overall Study|Physician Decision|0|||
33644084|NCT02152956|102248521|FG010|Overall Study|Physician Decision|0|||
33146097|NCT02716896|100448399|FG001|Overall Study|Physician Decision|1|||
33146098|NCT00667420|100448402|FG000|Overall Study|Adverse Event|2|||
33146099|NCT00667420|100448402|FG000|Overall Study|Lack of Efficacy|5|||
33146100|NCT00667420|100448402|FG000|Overall Study|Physician Decision|1|||
33146101|NCT00667420|100448402|FG000|Overall Study|Withdrawal by Subject|2|||
33146102|NCT00989573|100448415|FG000|Overall Study|Adverse Event|8|||
33146103|NCT00989573|100448416|FG001|Overall Study|Adverse Event|12|||
33146104|NCT00989573|100448417|FG002|Overall Study|Adverse Event|4|||
33146105|NCT00989573|100448415|FG000|Overall Study|Physician Decision|0|||
33146106|NCT00989573|100448416|FG001|Overall Study|Physician Decision|2|||
33146107|NCT00989573|100448417|FG002|Overall Study|Physician Decision|0|||
33146108|NCT00989573|100448415|FG000|Overall Study|Protocol Violation|1|||
33146109|NCT00989573|100448416|FG001|Overall Study|Protocol Violation|1|||
33146110|NCT00989573|100448417|FG002|Overall Study|Protocol Violation|1|||
33146111|NCT00989573|100448415|FG000|Overall Study|Withdrawal by Subject|4|||
33146112|NCT00989573|100448416|FG001|Overall Study|Withdrawal by Subject|7|||
33146113|NCT00989573|100448417|FG002|Overall Study|Withdrawal by Subject|3|||
33146114|NCT04626310|100448418|FG000|Overall Study|4-miss from treatment|6|||
33146115|NCT04626310|100448419|FG001|Overall Study|4-miss from treatment|5|||
33244291|NCT00049517|100796914|FG003|Induction|Death|0|||
33372884|NCT00525148|101251990|FG001|Overall Study|Refused continuation of study medication|2|||
33583207|NCT03592771|102025751|FG001|Overall Study|Lost to Follow-up|11|||
33583208|NCT03592771|102025752|FG002|Overall Study|Lost to Follow-up|15|||
33583209|NCT03592771|102025750|FG000|Overall Study|Withdrawal by Subject|0|||
33583210|NCT03592771|102025751|FG001|Overall Study|Withdrawal by Subject|2|||
33244292|NCT00049517|100796915|FG004|Induction|Death|9|||
33372885|NCT00525148|101251991|FG002|Overall Study|Refused continuation of study medication|0|||
33372886|NCT00525148|101251992|FG003|Overall Study|Refused continuation of study medication|1|||
33372887|NCT00525148|101251989|FG000|Overall Study|Other than stated|2|||
33583211|NCT03592771|102025752|FG002|Overall Study|Withdrawal by Subject|0|||
33583212|NCT00075764|102025753|FG000|Overall Study|Adverse Event|5|||
33583213|NCT00075764|102025754|FG001|Overall Study|Adverse Event|12|||
33583214|NCT00075764|102025753|FG000|Overall Study|Death|4|||
33583215|NCT00075764|102025754|FG001|Overall Study|Death|8|||
33583216|NCT00075764|102025753|FG000|Overall Study|Withdrawal by Subject|28|||
33583217|NCT00075764|102025754|FG001|Overall Study|Withdrawal by Subject|18|||
33583218|NCT00075764|102025753|FG000|Overall Study|Progression|269|||
33583219|NCT00075764|102025754|FG001|Overall Study|Progression|274|||
33583220|NCT00075764|102025753|FG000|Overall Study|Still on treatment|8|||
33583221|NCT00075764|102025754|FG001|Overall Study|Still on treatment|15|||
33372888|NCT00525148|101251990|FG001|Overall Study|Other than stated|1|||
33372889|NCT00525148|101251991|FG002|Overall Study|Other than stated|0|||
33372890|NCT00525148|101251992|FG003|Overall Study|Other than stated|3|||
33372891|NCT01683071|101251993|FG000|Part 1|Lack of Efficacy|1|||
33372892|NCT01683071|101251994|FG001|Part 1|Lack of Efficacy|0|||
33372893|NCT01683071|101251995|FG002|Part 1|Lack of Efficacy|0|||
33372894|NCT01683071|101251996|FG003|Part 1|Lack of Efficacy|3|||
33372895|NCT01683071|101251997|FG004|Part 1|Lack of Efficacy|0|||
33372896|NCT01683071|101251998|FG005|Part 1|Lack of Efficacy|0|||
33372897|NCT01683071|101251993|FG000|Part 1|Withdrawal by Subject|1|||
33372898|NCT01683071|101251994|FG001|Part 1|Withdrawal by Subject|2|||
33372899|NCT01683071|101251995|FG002|Part 1|Withdrawal by Subject|2|||
33372900|NCT01683071|101251996|FG003|Part 1|Withdrawal by Subject|1|||
33372901|NCT01683071|101251997|FG004|Part 1|Withdrawal by Subject|0|||
33372902|NCT01683071|101251998|FG005|Part 1|Withdrawal by Subject|0|||
33372903|NCT01683071|101251993|FG000|Part 1|Surgery Cancelled|1|||
33372904|NCT01683071|101251994|FG001|Part 1|Surgery Cancelled|0|||
33372905|NCT01683071|101251995|FG002|Part 1|Surgery Cancelled|0|||
33372906|NCT01683071|101251996|FG003|Part 1|Surgery Cancelled|0|||
33372907|NCT01683071|101251997|FG004|Part 1|Surgery Cancelled|0|||
33372908|NCT01683071|101251998|FG005|Part 1|Surgery Cancelled|0|||
33372909|NCT01683071|101251993|FG000|Part 1|Did not receive study drug|1|||
33372910|NCT01683071|101251994|FG001|Part 1|Did not receive study drug|0|||
33372911|NCT01683071|101251995|FG002|Part 1|Did not receive study drug|0|||
33372912|NCT01683071|101251996|FG003|Part 1|Did not receive study drug|1|||
33372913|NCT01683071|101251997|FG004|Part 1|Did not receive study drug|0|||
33372914|NCT01683071|101251998|FG005|Part 1|Did not receive study drug|0|||
33372915|NCT01683071|101251993|FG000|Part 1|Early termination; met exclusion criteria|0|||
33372916|NCT01683071|101251994|FG001|Part 1|Early termination; met exclusion criteria|2|||
33372917|NCT01683071|101251995|FG002|Part 1|Early termination; met exclusion criteria|1|||
33372918|NCT01683071|101251996|FG003|Part 1|Early termination; met exclusion criteria|0|||
33372919|NCT01683071|101251997|FG004|Part 1|Early termination; met exclusion criteria|0|||
33372920|NCT01683071|101251998|FG005|Part 1|Early termination; met exclusion criteria|0|||
33372921|NCT01683071|101251993|FG000|Part 2|Lack of Efficacy|0|||
33372922|NCT01683071|101251994|FG001|Part 2|Lack of Efficacy|0|||
33372923|NCT01683071|101251995|FG002|Part 2|Lack of Efficacy|0|||
33372924|NCT01683071|101251996|FG003|Part 2|Lack of Efficacy|0|||
33422799|NCT01160198|101439752|FG002|Overall Study|Lost to Follow-up|0|||
33422800|NCT01160198|101439750|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
33583222|NCT00075764|102025753|FG000|Overall Study|Delinquent|4|||
33583223|NCT00075764|102025754|FG001|Overall Study|Delinquent|2|||
33583224|NCT00075764|102025753|FG000|Overall Study|Not protocol specified|27|||
33583225|NCT00075764|102025754|FG001|Overall Study|Not protocol specified|19|||
33583226|NCT00075764|102025753|FG000|Overall Study|Under review|0|||
33583227|NCT00075764|102025754|FG001|Overall Study|Under review|1|||
33146116|NCT04626310|100448420|FG002|Overall Study|4-miss from treatment|5|||
33146117|NCT04626310|100448418|FG000|Overall Study|Withdrawal by Subject|1|||
33146118|NCT04626310|100448419|FG001|Overall Study|Withdrawal by Subject|0|||
33146119|NCT04626310|100448420|FG002|Overall Study|Withdrawal by Subject|3|||
33146120|NCT01117051|100448421|FG000|Overall Study|Withdrawal by Subject|5|||
33146121|NCT01117051|100448422|FG001|Overall Study|Withdrawal by Subject|3|||
33146122|NCT01117051|100448421|FG000|Overall Study|Adverse Event|4|||
33146123|NCT01117051|100448422|FG001|Overall Study|Adverse Event|3|||
33146124|NCT01117051|100448421|FG000|Overall Study|Lost to Follow-up|0|||
33146125|NCT01117051|100448422|FG001|Overall Study|Lost to Follow-up|1|||
33146126|NCT01117051|100448421|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
33146127|NCT01117051|100448422|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
33146128|NCT01117051|100448421|FG000|Overall Study|Sponsor's decision|3|||
33146129|NCT01117051|100448422|FG001|Overall Study|Sponsor's decision|1|||
33372925|NCT01683071|101251997|FG004|Part 2|Lack of Efficacy|3|||
33372926|NCT01683071|101251998|FG005|Part 2|Lack of Efficacy|4|||
33372927|NCT01683071|101251993|FG000|Part 2|Lost to Follow-up|0|||
33372928|NCT01683071|101251994|FG001|Part 2|Lost to Follow-up|0|||
33372929|NCT01683071|101251995|FG002|Part 2|Lost to Follow-up|0|||
33372930|NCT01683071|101251996|FG003|Part 2|Lost to Follow-up|0|||
33583228|NCT03900728|102025757|FG000|Overall Study|No text responses|0|||
33244293|NCT00049517|100796916|FG005|Induction|Death|6|||
33244294|NCT00049517|100796911|FG000|Induction|Withdrawal by Subject|0|||
33244295|NCT00049517|100796912|FG001|Induction|Withdrawal by Subject|0|||
33244296|NCT00049517|100796913|FG002|Induction|Withdrawal by Subject|0|||
33244297|NCT00049517|100796914|FG003|Induction|Withdrawal by Subject|0|||
33244298|NCT00049517|100796915|FG004|Induction|Withdrawal by Subject|1|||
33244299|NCT00049517|100796916|FG005|Induction|Withdrawal by Subject|3|||
33244300|NCT00049517|100796911|FG000|Induction|Alternative therapy|0|||
33244301|NCT00049517|100796912|FG001|Induction|Alternative therapy|0|||
33244302|NCT00049517|100796913|FG002|Induction|Alternative therapy|0|||
33244303|NCT00049517|100796914|FG003|Induction|Alternative therapy|0|||
33244304|NCT00049517|100796915|FG004|Induction|Alternative therapy|2|||
33244305|NCT00049517|100796916|FG005|Induction|Alternative therapy|2|||
33244306|NCT00049517|100796911|FG000|Induction|Other complicating disease|0|||
33244307|NCT00049517|100796912|FG001|Induction|Other complicating disease|0|||
33244308|NCT00049517|100796913|FG002|Induction|Other complicating disease|0|||
33244309|NCT00049517|100796914|FG003|Induction|Other complicating disease|0|||
33244310|NCT00049517|100796915|FG004|Induction|Other complicating disease|3|||
33244311|NCT00049517|100796916|FG005|Induction|Other complicating disease|0|||
33244312|NCT00049517|100796911|FG000|Induction|Reasons not reported|0|||
33244313|NCT00049517|100796912|FG001|Induction|Reasons not reported|0|||
33244314|NCT00049517|100796913|FG002|Induction|Reasons not reported|0|||
33244315|NCT00049517|100796914|FG003|Induction|Reasons not reported|0|||
33244316|NCT00049517|100796915|FG004|Induction|Reasons not reported|22|||
33244317|NCT00049517|100796916|FG005|Induction|Reasons not reported|25|||
33244318|NCT00049517|100796911|FG000|Conditioning/Transplant|Disease progression|14|||
33244319|NCT00049517|100796912|FG001|Conditioning/Transplant|Disease progression|6|||
33244320|NCT00049517|100796913|FG002|Conditioning/Transplant|Disease progression|10|||
33244321|NCT00049517|100796914|FG003|Conditioning/Transplant|Disease progression|6|||
33244322|NCT00049517|100796915|FG004|Conditioning/Transplant|Disease progression|0|||
33244323|NCT00049517|100796916|FG005|Conditioning/Transplant|Disease progression|0|||
33244324|NCT00049517|100796911|FG000|Conditioning/Transplant|Adverse Event|2|||
33583229|NCT03900728|102025758|FG001|Overall Study|No text responses|0|||
33583230|NCT03900728|102025759|FG002|Overall Study|No text responses|4|||
33583231|NCT02689206|102025760|FG000|Overall Study|Adverse Event|0|||
33146130|NCT01117051|100448421|FG000|Overall Study|Surgical procedure|0|||
33244325|NCT00049517|100796912|FG001|Conditioning/Transplant|Adverse Event|1|||
33244326|NCT00049517|100796913|FG002|Conditioning/Transplant|Adverse Event|4|||
33244327|NCT00049517|100796914|FG003|Conditioning/Transplant|Adverse Event|8|||
33244328|NCT00049517|100796915|FG004|Conditioning/Transplant|Adverse Event|0|||
33244329|NCT00049517|100796916|FG005|Conditioning/Transplant|Adverse Event|0|||
33244330|NCT00049517|100796911|FG000|Conditioning/Transplant|Death|1|||
33244331|NCT00049517|100796912|FG001|Conditioning/Transplant|Death|0|||
33244332|NCT00049517|100796913|FG002|Conditioning/Transplant|Death|0|||
33244333|NCT00049517|100796914|FG003|Conditioning/Transplant|Death|2|||
33244334|NCT00049517|100796915|FG004|Conditioning/Transplant|Death|0|||
33244335|NCT00049517|100796916|FG005|Conditioning/Transplant|Death|0|||
33244336|NCT00049517|100796911|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
33244337|NCT00049517|100796912|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
33244338|NCT00049517|100796913|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
33244339|NCT00049517|100796914|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
33244340|NCT00049517|100796915|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
33244341|NCT00049517|100796916|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
33244342|NCT00049517|100796911|FG000|Conditioning/Transplant|Alternative therapy|4|||
33244343|NCT00049517|100796912|FG001|Conditioning/Transplant|Alternative therapy|4|||
33244344|NCT00049517|100796913|FG002|Conditioning/Transplant|Alternative therapy|2|||
33244345|NCT00049517|100796914|FG003|Conditioning/Transplant|Alternative therapy|1|||
33244346|NCT00049517|100796915|FG004|Conditioning/Transplant|Alternative therapy|1|||
33244347|NCT00049517|100796916|FG005|Conditioning/Transplant|Alternative therapy|0|||
33146131|NCT01117051|100448422|FG001|Overall Study|Surgical procedure|1|||
33146132|NCT01117051|100448421|FG000|Overall Study|Randomized by mistake|0|||
33146133|NCT01117051|100448422|FG001|Overall Study|Randomized by mistake|1|||
33244348|NCT00049517|100796911|FG000|Conditioning/Transplant|Other complicating disease|2|||
33244349|NCT00049517|100796912|FG001|Conditioning/Transplant|Other complicating disease|0|||
33244350|NCT00049517|100796913|FG002|Conditioning/Transplant|Other complicating disease|0|||
33244351|NCT00049517|100796914|FG003|Conditioning/Transplant|Other complicating disease|4|||
33244352|NCT00049517|100796915|FG004|Conditioning/Transplant|Other complicating disease|0|||
33244353|NCT00049517|100796916|FG005|Conditioning/Transplant|Other complicating disease|1|||
33244354|NCT00049517|100796911|FG000|Conditioning/Transplant|Reasons not reported|25|||
33583232|NCT02689206|102025761|FG001|Overall Study|Adverse Event|0|||
33146134|NCT01117051|100448421|FG000|Overall Study|Convenience issue|1|||
33644085|NCT02152956|102248522|FG011|Overall Study|Physician Decision|1|||
33146135|NCT01117051|100448422|FG001|Overall Study|Convenience issue|0|||
33146136|NCT05014412|100448426|FG000|Overall Study|Death|11|||
33146137|NCT05014412|100448427|FG001|Overall Study|Death|7|||
33146138|NCT05014412|100448428|FG002|Overall Study|Death|4|||
33244355|NCT00049517|100796912|FG001|Conditioning/Transplant|Reasons not reported|31|||
33244356|NCT00049517|100796913|FG002|Conditioning/Transplant|Reasons not reported|18|||
33244357|NCT00049517|100796914|FG003|Conditioning/Transplant|Reasons not reported|15|||
33244358|NCT00049517|100796915|FG004|Conditioning/Transplant|Reasons not reported|5|||
33244359|NCT00049517|100796916|FG005|Conditioning/Transplant|Reasons not reported|5|||
33244360|NCT00881335|100796917|FG000|Overall Study|Lost to Follow-up|3|||
33244361|NCT00881335|100796918|FG001|Overall Study|Lost to Follow-up|2|||
33244362|NCT01264718|100796919|FG000|Overall Study|Lost to Follow-up|3|||
33244363|NCT01264718|100796920|FG001|Overall Study|Lost to Follow-up|2|||
33244364|NCT01264718|100796919|FG000|Overall Study|Withdrawal by Subject|9|||
33244365|NCT01264718|100796920|FG001|Overall Study|Withdrawal by Subject|15|||
33244366|NCT01264718|100796919|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
33244367|NCT01264718|100796920|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
33244368|NCT05296629|100796922|FG000|Overall Study|Withdrawal by Subject|3|||
33244369|NCT05296629|100796923|FG001|Overall Study|Withdrawal by Subject|10|||
33583233|NCT02689206|102025762|FG002|Overall Study|Adverse Event|1|||
33583234|NCT02689206|102025763|FG003|Overall Study|Adverse Event|0|||
33583235|NCT02689206|102025764|FG004|Overall Study|Adverse Event|2|||
33583236|NCT02689206|102025760|FG000|Overall Study|Protocol Violation|1|||
33583237|NCT02689206|102025761|FG001|Overall Study|Protocol Violation|0|||
33583238|NCT02689206|102025762|FG002|Overall Study|Protocol Violation|0|||
33583239|NCT02689206|102025763|FG003|Overall Study|Protocol Violation|1|||
33583240|NCT02689206|102025764|FG004|Overall Study|Protocol Violation|2|||
33644086|NCT02152956|102248523|FG012|Overall Study|Physician Decision|0|||
33644087|NCT02152956|102248511|FG000|Overall Study|Study terminated by sponsor|0|||
33644088|NCT02152956|102248512|FG001|Overall Study|Study terminated by sponsor|0|||
33244370|NCT05296629|100796924|FG002|Overall Study|Withdrawal by Subject|4|||
33244371|NCT05296629|100796922|FG000|Overall Study|Lost to Follow-up|2|||
33244372|NCT05296629|100796923|FG001|Overall Study|Lost to Follow-up|7|||
33244373|NCT05296629|100796924|FG002|Overall Study|Lost to Follow-up|1|||
33244374|NCT05296629|100796922|FG000|Overall Study|Adverse Event|0|||
33244375|NCT05296629|100796923|FG001|Overall Study|Adverse Event|4|||
33244376|NCT05296629|100796924|FG002|Overall Study|Adverse Event|2|||
33372931|NCT01683071|101251997|FG004|Part 2|Lost to Follow-up|2|||
33372932|NCT01683071|101251998|FG005|Part 2|Lost to Follow-up|0|||
33372933|NCT01683071|101251993|FG000|Part 2|Withdrawal by Subject|0|||
33372934|NCT01683071|101251994|FG001|Part 2|Withdrawal by Subject|0|||
33583241|NCT02689206|102025760|FG000|Overall Study|Other: Reached stopping criteria|0|||
33583242|NCT02689206|102025761|FG001|Overall Study|Other: Reached stopping criteria|1|||
33583243|NCT02689206|102025762|FG002|Overall Study|Other: Reached stopping criteria|2|||
33644089|NCT02152956|102248513|FG002|Overall Study|Study terminated by sponsor|0|||
33644090|NCT02152956|102248514|FG003|Overall Study|Study terminated by sponsor|0|||
33644091|NCT02152956|102248515|FG004|Overall Study|Study terminated by sponsor|0|||
33644092|NCT02152956|102248516|FG005|Overall Study|Study terminated by sponsor|0|||
33244377|NCT05296629|100796922|FG000|Overall Study|Protocol Violation|0|||
33244378|NCT05296629|100796923|FG001|Overall Study|Protocol Violation|2|||
33372935|NCT01683071|101251995|FG002|Part 2|Withdrawal by Subject|0|||
33372936|NCT01683071|101251996|FG003|Part 2|Withdrawal by Subject|0|||
33372937|NCT01683071|101251997|FG004|Part 2|Withdrawal by Subject|3|||
33372938|NCT01683071|101251998|FG005|Part 2|Withdrawal by Subject|3|||
33372939|NCT01683071|101251993|FG000|Part 2|Surgery cancelled|0|||
33372940|NCT01683071|101251994|FG001|Part 2|Surgery cancelled|0|||
33372941|NCT01683071|101251995|FG002|Part 2|Surgery cancelled|0|||
33372942|NCT01683071|101251996|FG003|Part 2|Surgery cancelled|0|||
33372943|NCT01683071|101251997|FG004|Part 2|Surgery cancelled|4|||
33372944|NCT01683071|101251998|FG005|Part 2|Surgery cancelled|2|||
33372945|NCT01683071|101251993|FG000|Part 2|Did not receive study drug|0|||
33372946|NCT01683071|101251994|FG001|Part 2|Did not receive study drug|0|||
33372947|NCT01683071|101251995|FG002|Part 2|Did not receive study drug|0|||
33372948|NCT01683071|101251996|FG003|Part 2|Did not receive study drug|0|||
33372949|NCT01683071|101251997|FG004|Part 2|Did not receive study drug|2|||
33372950|NCT01683071|101251998|FG005|Part 2|Did not receive study drug|1|||
33372951|NCT01683071|101251993|FG000|Part 2|Met exclusion criterion|0|||
33372952|NCT01683071|101251994|FG001|Part 2|Met exclusion criterion|0|||
33372953|NCT01683071|101251995|FG002|Part 2|Met exclusion criterion|0|||
33372954|NCT01683071|101251996|FG003|Part 2|Met exclusion criterion|0|||
33372955|NCT01683071|101251997|FG004|Part 2|Met exclusion criterion|1|||
33372956|NCT01683071|101251998|FG005|Part 2|Met exclusion criterion|1|||
33372957|NCT01683071|101251993|FG000|Part 2|Protocol deviation|0|||
33244379|NCT05296629|100796924|FG002|Overall Study|Protocol Violation|0|||
33244380|NCT03531905|100796925|FG000|Overall Study|Withdrawal by Subject|3|||
33372958|NCT01683071|101251994|FG001|Part 2|Protocol deviation|0|||
33372959|NCT01683071|101251995|FG002|Part 2|Protocol deviation|0|||
33372960|NCT01683071|101251996|FG003|Part 2|Protocol deviation|0|||
33372961|NCT01683071|101251997|FG004|Part 2|Protocol deviation|1|||
33372962|NCT01683071|101251998|FG005|Part 2|Protocol deviation|2|||
33372963|NCT01683071|101251993|FG000|Part 2|Withdrawal by investigator decision|0|||
33372964|NCT01683071|101251994|FG001|Part 2|Withdrawal by investigator decision|0|||
33583244|NCT02689206|102025763|FG003|Overall Study|Other: Reached stopping criteria|3|||
33644093|NCT02152956|102248517|FG006|Overall Study|Study terminated by sponsor|0|||
33146139|NCT05014412|100448429|FG003|Overall Study|Death|7|||
33146140|NCT05014412|100448426|FG000|Overall Study|Withdrawal by Subject|1|||
33146141|NCT05014412|100448427|FG001|Overall Study|Withdrawal by Subject|1|||
33146142|NCT05014412|100448428|FG002|Overall Study|Withdrawal by Subject|1|||
33146143|NCT05014412|100448429|FG003|Overall Study|Withdrawal by Subject|2|||
33146144|NCT05014412|100448426|FG000|Overall Study|Ongoing|21|||
33146145|NCT05014412|100448427|FG001|Overall Study|Ongoing|4|||
33146146|NCT05014412|100448428|FG002|Overall Study|Ongoing|6|||
33146147|NCT05014412|100448429|FG003|Overall Study|Ongoing|20|||
33146148|NCT00589784|100448430|FG000|Overall Study|Withdrawal by Subject|0|||
33146149|NCT00589784|100448431|FG001|Overall Study|Withdrawal by Subject|6|||
33146150|NCT00589784|100448430|FG000|Overall Study|Patient inevaluable|1|||
33422801|NCT01160198|101439751|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
33422802|NCT01160198|101439752|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
33422803|NCT03811249|101439753|FG000|Overall Study|Withdrawal by Subject|44|||
33422804|NCT03811249|101439753|FG000|Overall Study|Missed Visit|24|||
33422805|NCT01829295|101439754|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
33644094|NCT02152956|102248518|FG007|Overall Study|Study terminated by sponsor|0|||
33644095|NCT02152956|102248519|FG008|Overall Study|Study terminated by sponsor|0|||
33644096|NCT02152956|102248520|FG009|Overall Study|Study terminated by sponsor|0|||
33644097|NCT02152956|102248521|FG010|Overall Study|Study terminated by sponsor|0|||
33644098|NCT02152956|102248522|FG011|Overall Study|Study terminated by sponsor|29|||
33644099|NCT02152956|102248523|FG012|Overall Study|Study terminated by sponsor|0|||
33644100|NCT02152956|102248511|FG000|Overall Study|progressive disease|0|||
33644101|NCT02152956|102248512|FG001|Overall Study|progressive disease|0|||
33644102|NCT02152956|102248513|FG002|Overall Study|progressive disease|0|||
33644103|NCT02152956|102248514|FG003|Overall Study|progressive disease|0|||
33644104|NCT02152956|102248515|FG004|Overall Study|progressive disease|0|||
33644105|NCT02152956|102248516|FG005|Overall Study|progressive disease|0|||
33644106|NCT02152956|102248517|FG006|Overall Study|progressive disease|0|||
33644107|NCT02152956|102248518|FG007|Overall Study|progressive disease|0|||
33644108|NCT02152956|102248519|FG008|Overall Study|progressive disease|1|||
33644109|NCT02152956|102248520|FG009|Overall Study|progressive disease|0|||
33644110|NCT02152956|102248521|FG010|Overall Study|progressive disease|0|||
33644111|NCT02152956|102248522|FG011|Overall Study|progressive disease|1|||
33644112|NCT02152956|102248523|FG012|Overall Study|progressive disease|0|||
33644113|NCT00862082|102248524|FG000|Overall Study|Sponsor decision to terminate the study|5|||
33644114|NCT00862082|102248525|FG001|Overall Study|Sponsor decision to terminate the study|0|||
33644115|NCT00862082|102248524|FG000|Overall Study|Withdrawal by Subject|0|||
33644116|NCT00862082|102248525|FG001|Overall Study|Withdrawal by Subject|1|||
33644117|NCT01942733|102248526|FG000|Overall Study|Lost to Follow-up|1|||
33644118|NCT01942733|102248526|FG000|Overall Study|Non-compliance with IMP|1|||
33644119|NCT01942733|102248526|FG000|Overall Study|Administrative|1|||
33644120|NCT02116205|102248527|FG000|Overall Study|Withdrawal by Subject|2|||
33644121|NCT02116205|102248528|FG001|Overall Study|Withdrawal by Subject|4|||
33644122|NCT02116205|102248529|FG002|Overall Study|Withdrawal by Subject|1|||
33644123|NCT02116205|102248530|FG003|Overall Study|Withdrawal by Subject|3|||
33644124|NCT02116205|102248527|FG000|Overall Study|Lost to Follow-up|0|||
33644125|NCT02116205|102248528|FG001|Overall Study|Lost to Follow-up|2|||
33644126|NCT02116205|102248529|FG002|Overall Study|Lost to Follow-up|1|||
33644127|NCT02116205|102248530|FG003|Overall Study|Lost to Follow-up|2|||
33644128|NCT02116205|102248527|FG000|Overall Study|Physician Decision|0|||
33644129|NCT02116205|102248528|FG001|Overall Study|Physician Decision|1|||
33644130|NCT02116205|102248529|FG002|Overall Study|Physician Decision|1|||
33644131|NCT02116205|102248530|FG003|Overall Study|Physician Decision|1|||
33644132|NCT02116205|102248527|FG000|Overall Study|Exclusion criteria|0|||
33644133|NCT02116205|102248528|FG001|Overall Study|Exclusion criteria|0|||
33644134|NCT02116205|102248529|FG002|Overall Study|Exclusion criteria|1|||
33644135|NCT02116205|102248530|FG003|Overall Study|Exclusion criteria|0|||
33644136|NCT03198507|102248531|FG000|Overall Study|Withdrawal by Subject|1|||
33644137|NCT03198507|102248532|FG001|Overall Study|Withdrawal by Subject|0|||
33644138|NCT04254913|102248537|FG000|Overall Study|Adverse Event|1|||
33644139|NCT01227018|102248540|FG000|Overall Study|Disease progression|9|||
33146151|NCT00589784|100448431|FG001|Overall Study|Patient inevaluable|0|||
33146152|NCT00589784|100448430|FG000|Overall Study|Adverse Event|0|||
33146153|NCT00589784|100448431|FG001|Overall Study|Adverse Event|4|||
33644140|NCT01227018|102248540|FG000|Overall Study|Toxicity|2|||
33644141|NCT01227018|102248540|FG000|Overall Study|Withdrew after beginning treatment|4|||
33644142|NCT00740857|102248544|FG000|Overall Study|Withdrawal by Subject|1|||
33644143|NCT00740857|102248545|FG001|Overall Study|Withdrawal by Subject|0|||
33644144|NCT00740857|102248546|FG002|Overall Study|Withdrawal by Subject|0|||
33644145|NCT00476229|102248551|FG000|Overall Study|Progressive shortness of breath|1|||
33146154|NCT00417482|100448432|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
33146155|NCT00417482|100448433|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
33146156|NCT00417482|100448434|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
33146157|NCT00417482|100448432|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
33644146|NCT00145158|102248552|FG000|Overall Study|premature withdrawal|2|||
33146158|NCT00417482|100448433|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
33146159|NCT00417482|100448434|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
33146160|NCT00417482|100448432|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
33146161|NCT00417482|100448433|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
33146162|NCT00417482|100448434|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
33146163|NCT00417482|100448432|FG000|Phase B 1st 16 Weeks|Death|1|||
33146164|NCT00417482|100448433|FG001|Phase B 1st 16 Weeks|Death|0|||
33146165|NCT00417482|100448434|FG002|Phase B 1st 16 Weeks|Death|0|||
33146166|NCT00417482|100448432|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
33146167|NCT00417482|100448433|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
33146168|NCT00417482|100448434|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
33146169|NCT00417482|100448432|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
33146170|NCT00417482|100448433|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
33146171|NCT00417482|100448434|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
33146172|NCT00417482|100448432|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
33146173|NCT00417482|100448433|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
33146174|NCT00417482|100448434|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
33146175|NCT00417482|100448432|FG000|Phase B 2nd 16 Weeks|Death|1|||
33146176|NCT00417482|100448433|FG001|Phase B 2nd 16 Weeks|Death|1|||
33146177|NCT00417482|100448434|FG002|Phase B 2nd 16 Weeks|Death|0|||
33146178|NCT00543855|100448435|FG000|Overall Study|Adverse Event|3|||
33146179|NCT00543855|100448436|FG001|Overall Study|Adverse Event|1|||
33146180|NCT00543855|100448437|FG002|Overall Study|Adverse Event|3|||
33146181|NCT00543855|100448438|FG003|Overall Study|Adverse Event|4|||
33146182|NCT00543855|100448435|FG000|Overall Study|Lost to Follow-up|0|||
33146183|NCT00543855|100448436|FG001|Overall Study|Lost to Follow-up|0|||
33146184|NCT00543855|100448437|FG002|Overall Study|Lost to Follow-up|1|||
33146185|NCT00543855|100448438|FG003|Overall Study|Lost to Follow-up|0|||
33146186|NCT00543855|100448435|FG000|Overall Study|Withdrawal by Subject|0|||
33146187|NCT00543855|100448436|FG001|Overall Study|Withdrawal by Subject|1|||
33644147|NCT00145158|102248553|FG001|Overall Study|premature withdrawal|3|||
33644148|NCT05300763|102248554|FG000|Overall Study|Adverse Event|0|||
33644149|NCT05300763|102248555|FG001|Overall Study|Adverse Event|1|||
33644150|NCT05300763|102248554|FG000|Overall Study|Major Protocol Deviation|1|||
33644151|NCT05300763|102248555|FG001|Overall Study|Major Protocol Deviation|0|||
33644152|NCT05300763|102248554|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
33644153|NCT05300763|102248555|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
33644154|NCT00946153|102248563|FG000|Phase 2|Adverse Event|0|||
33644155|NCT00946153|102248564|FG001|Phase 2|Adverse Event|0|||
33644156|NCT00946153|102248565|FG002|Phase 2|Adverse Event|0|||
33644157|NCT00946153|102248566|FG003|Phase 2|Adverse Event|0|||
33644158|NCT00946153|102248567|FG004|Phase 2|Adverse Event|6|||
33644159|NCT00946153|102248563|FG000|Phase 2|Need more reduction of dose|0|||
33644160|NCT00946153|102248564|FG001|Phase 2|Need more reduction of dose|0|||
33644161|NCT00946153|102248565|FG002|Phase 2|Need more reduction of dose|0|||
33644162|NCT00946153|102248566|FG003|Phase 2|Need more reduction of dose|0|||
33644163|NCT00946153|102248567|FG004|Phase 2|Need more reduction of dose|2|||
33644164|NCT00946153|102248563|FG000|Phase 2|Physician Decision|0|||
33644165|NCT00946153|102248564|FG001|Phase 2|Physician Decision|0|||
33644166|NCT00946153|102248565|FG002|Phase 2|Physician Decision|0|||
33644167|NCT00946153|102248566|FG003|Phase 2|Physician Decision|0|||
33644168|NCT00946153|102248567|FG004|Phase 2|Physician Decision|1|||
33644169|NCT00946153|102248563|FG000|Phase 2|14 days washout for recovery due to AE|0|||
33644170|NCT00946153|102248564|FG001|Phase 2|14 days washout for recovery due to AE|0|||
33644171|NCT00946153|102248565|FG002|Phase 2|14 days washout for recovery due to AE|0|||
33644172|NCT00946153|102248566|FG003|Phase 2|14 days washout for recovery due to AE|0|||
33644173|NCT00946153|102248567|FG004|Phase 2|14 days washout for recovery due to AE|4|||
33372965|NCT01683071|101251995|FG002|Part 2|Withdrawal by investigator decision|0|||
33372966|NCT01683071|101251996|FG003|Part 2|Withdrawal by investigator decision|0|||
33372967|NCT01683071|101251997|FG004|Part 2|Withdrawal by investigator decision|1|||
33372968|NCT01683071|101251998|FG005|Part 2|Withdrawal by investigator decision|2|||
33422806|NCT01829295|101439755|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
33644174|NCT02249832|102248570|FG000|Overall Study|Withdrawal by Subject|3|||
33644175|NCT02249832|102248570|FG000|Overall Study|Lost to Follow-up|10|||
33146188|NCT00543855|100448437|FG002|Overall Study|Withdrawal by Subject|2|||
33644176|NCT00463567|102248571|FG000|Overall Study|Adverse Event|29|||
33644177|NCT00463567|102248572|FG001|Overall Study|Adverse Event|26|||
33644178|NCT00463567|102248573|FG002|Overall Study|Adverse Event|17|||
33146189|NCT00543855|100448438|FG003|Overall Study|Withdrawal by Subject|0|||
33146190|NCT00543855|100448435|FG000|Overall Study|Protocol Violation|1|||
33146191|NCT00543855|100448436|FG001|Overall Study|Protocol Violation|0|||
33146192|NCT00543855|100448437|FG002|Overall Study|Protocol Violation|0|||
33146193|NCT00543855|100448438|FG003|Overall Study|Protocol Violation|0|||
33146194|NCT03416374|100448439|FG000|Between Treatment Period I and II|Other|0|||
33146195|NCT03416374|100448440|FG001|Between Treatment Period I and II|Other|9|||
33372969|NCT01251276|101251999|FG000|Overall Study|Protocol Violation|1|||
33644179|NCT00463567|102248574|FG003|Overall Study|Adverse Event|46|||
33644180|NCT00463567|102248575|FG004|Overall Study|Adverse Event|10|||
33644181|NCT00463567|102248576|FG005|Overall Study|Adverse Event|10|||
33644182|NCT00463567|102248577|FG006|Overall Study|Adverse Event|4|||
33644183|NCT00463567|102248571|FG000|Overall Study|Withdrawal by Subject|29|||
33644184|NCT00463567|102248572|FG001|Overall Study|Withdrawal by Subject|22|||
33644185|NCT00463567|102248573|FG002|Overall Study|Withdrawal by Subject|20|||
33644186|NCT00463567|102248574|FG003|Overall Study|Withdrawal by Subject|37|||
33644187|NCT00463567|102248575|FG004|Overall Study|Withdrawal by Subject|6|||
33644188|NCT00463567|102248576|FG005|Overall Study|Withdrawal by Subject|5|||
33644189|NCT00463567|102248577|FG006|Overall Study|Withdrawal by Subject|1|||
33644190|NCT00463567|102248571|FG000|Overall Study|Protocol Deviation|13|||
33644191|NCT00463567|102248572|FG001|Overall Study|Protocol Deviation|9|||
33644192|NCT00463567|102248573|FG002|Overall Study|Protocol Deviation|14|||
33644193|NCT00463567|102248574|FG003|Overall Study|Protocol Deviation|11|||
33644194|NCT00463567|102248575|FG004|Overall Study|Protocol Deviation|1|||
33644195|NCT00463567|102248576|FG005|Overall Study|Protocol Deviation|1|||
33644196|NCT00463567|102248577|FG006|Overall Study|Protocol Deviation|2|||
33644197|NCT00463567|102248571|FG000|Overall Study|Lost to Follow-up|12|||
33644198|NCT00463567|102248572|FG001|Overall Study|Lost to Follow-up|6|||
33644199|NCT00463567|102248573|FG002|Overall Study|Lost to Follow-up|13|||
33644200|NCT00463567|102248574|FG003|Overall Study|Lost to Follow-up|8|||
33644201|NCT00463567|102248575|FG004|Overall Study|Lost to Follow-up|1|||
33644202|NCT00463567|102248576|FG005|Overall Study|Lost to Follow-up|1|||
33644203|NCT00463567|102248577|FG006|Overall Study|Lost to Follow-up|1|||
33644204|NCT00463567|102248571|FG000|Overall Study|Administrative problems|5|||
33644205|NCT00463567|102248572|FG001|Overall Study|Administrative problems|3|||
33644206|NCT00463567|102248573|FG002|Overall Study|Administrative problems|6|||
33644207|NCT00463567|102248574|FG003|Overall Study|Administrative problems|9|||
33644208|NCT00463567|102248575|FG004|Overall Study|Administrative problems|3|||
33644209|NCT00463567|102248576|FG005|Overall Study|Administrative problems|2|||
33644210|NCT00463567|102248577|FG006|Overall Study|Administrative problems|2|||
33644211|NCT00463567|102248571|FG000|Overall Study|Lack of Efficacy|4|||
33644212|NCT00463567|102248572|FG001|Overall Study|Lack of Efficacy|9|||
33644213|NCT00463567|102248573|FG002|Overall Study|Lack of Efficacy|9|||
33644214|NCT00463567|102248574|FG003|Overall Study|Lack of Efficacy|17|||
33644215|NCT00463567|102248575|FG004|Overall Study|Lack of Efficacy|1|||
33644216|NCT00463567|102248576|FG005|Overall Study|Lack of Efficacy|0|||
33644217|NCT00463567|102248577|FG006|Overall Study|Lack of Efficacy|1|||
33644218|NCT00463567|102248571|FG000|Overall Study|Abnormal lab value(s)|1|||
33644219|NCT00463567|102248572|FG001|Overall Study|Abnormal lab value(s)|1|||
33644220|NCT00463567|102248573|FG002|Overall Study|Abnormal lab value(s)|2|||
33644221|NCT00463567|102248574|FG003|Overall Study|Abnormal lab value(s)|1|||
33644222|NCT00463567|102248575|FG004|Overall Study|Abnormal lab value(s)|1|||
33644223|NCT00463567|102248576|FG005|Overall Study|Abnormal lab value(s)|0|||
33644224|NCT00463567|102248577|FG006|Overall Study|Abnormal lab value(s)|0|||
33644225|NCT00463567|102248571|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33644226|NCT00463567|102248572|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33644227|NCT00463567|102248573|FG002|Overall Study|Abnormal test procedure result(s)|6|||
33644228|NCT00463567|102248574|FG003|Overall Study|Abnormal test procedure result(s)|2|||
33644229|NCT00463567|102248575|FG004|Overall Study|Abnormal test procedure result(s)|0|||
33644230|NCT00463567|102248576|FG005|Overall Study|Abnormal test procedure result(s)|2|||
33644231|NCT00463567|102248577|FG006|Overall Study|Abnormal test procedure result(s)|0|||
33644232|NCT00463567|102248571|FG000|Overall Study|Death|1|||
33644233|NCT00463567|102248572|FG001|Overall Study|Death|0|||
33644234|NCT00463567|102248573|FG002|Overall Study|Death|2|||
33644235|NCT00463567|102248574|FG003|Overall Study|Death|0|||
33644236|NCT00463567|102248575|FG004|Overall Study|Death|0|||
33644237|NCT00463567|102248576|FG005|Overall Study|Death|0|||
33644238|NCT00463567|102248577|FG006|Overall Study|Death|0|||
33644239|NCT01818752|102252436|FG000|Overall Study|Adverse Event|64|||
33644240|NCT01818752|102252437|FG001|Overall Study|Adverse Event|74|||
33644241|NCT01818752|102252436|FG000|Overall Study|Death|14|||
33644242|NCT01818752|102252437|FG001|Overall Study|Death|18|||
33644243|NCT01818752|102252436|FG000|Overall Study|Non-compliance|16|||
33644244|NCT01818752|102252437|FG001|Overall Study|Non-compliance|20|||
33644245|NCT01818752|102252436|FG000|Overall Study|Withdrawal by Subject|15|||
33372970|NCT01251276|101252000|FG001|Overall Study|Protocol Violation|0|||
33372971|NCT01251276|101251999|FG000|Overall Study|Lost to Follow-up|0|||
33644246|NCT01818752|102252437|FG001|Overall Study|Withdrawal by Subject|14|||
33372972|NCT01251276|101252000|FG001|Overall Study|Lost to Follow-up|1|||
33644247|NCT01818752|102252436|FG000|Overall Study|Physician Decision|9|||
33644248|NCT01818752|102252437|FG001|Overall Study|Physician Decision|8|||
33644249|NCT01818752|102252436|FG000|Overall Study|Disease Progression|54|||
33644250|NCT01818752|102252437|FG001|Overall Study|Disease Progression|48|||
33644251|NCT01818752|102252436|FG000|Overall Study|Other|7|||
33644252|NCT01818752|102252437|FG001|Overall Study|Other|8|||
33644253|NCT01818752|102252436|FG000|Overall Study|Continuing Treatment|1|||
33644254|NCT01818752|102252437|FG001|Overall Study|Continuing Treatment|4|||
33146196|NCT03416374|100448439|FG000|Treatment Period II|Lack of Efficacy|3|||
33146197|NCT03416374|100448440|FG001|Treatment Period II|Lack of Efficacy|11|||
33146198|NCT03416374|100448439|FG000|Treatment Period II|Adverse Event|1|||
33146199|NCT03416374|100448440|FG001|Treatment Period II|Adverse Event|4|||
33146200|NCT03416374|100448439|FG000|Treatment Period II|Death|0|||
33146201|NCT03416374|100448440|FG001|Treatment Period II|Death|1|||
33422807|NCT01829295|101439756|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
33422808|NCT01829295|101439757|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
33422809|NCT01829295|101439754|FG000|6-12 Months|Adverse Event|0|||
33422810|NCT01829295|101439755|FG001|6-12 Months|Adverse Event|0|||
33422811|NCT01829295|101439756|FG002|6-12 Months|Adverse Event|3|||
33422812|NCT01829295|101439757|FG003|6-12 Months|Adverse Event|2|||
33422813|NCT01829295|101439754|FG000|6-12 Months|Lost to Follow-up|2|||
33422814|NCT01829295|101439755|FG001|6-12 Months|Lost to Follow-up|0|||
33422815|NCT01829295|101439756|FG002|6-12 Months|Lost to Follow-up|0|||
33422816|NCT01829295|101439757|FG003|6-12 Months|Lost to Follow-up|0|||
33422817|NCT01829295|101439754|FG000|6-12 Months|Withdrawal by Subject|2|||
33422818|NCT01829295|101439755|FG001|6-12 Months|Withdrawal by Subject|2|||
33422819|NCT01829295|101439756|FG002|6-12 Months|Withdrawal by Subject|0|||
33422820|NCT01829295|101439757|FG003|6-12 Months|Withdrawal by Subject|0|||
33422821|NCT01901146|101439759|FG000|Neoadjuvant Phase|Death|1|||
33422822|NCT01901146|101439760|FG001|Neoadjuvant Phase|Death|2|||
33422823|NCT01901146|101439761|FG002|Neoadjuvant Phase|Death|0|||
33422824|NCT01901146|101439762|FG003|Neoadjuvant Phase|Death|0|||
33583245|NCT02689206|102025764|FG004|Overall Study|Other: Reached stopping criteria|4|||
33583246|NCT02689206|102025760|FG000|Overall Study|Physician Decision|1|||
33583247|NCT02689206|102025761|FG001|Overall Study|Physician Decision|0|||
33583248|NCT02689206|102025762|FG002|Overall Study|Physician Decision|0|||
33583249|NCT02689206|102025763|FG003|Overall Study|Physician Decision|0|||
33644255|NCT01818752|102252436|FG000|Overall Study|Randomized but not Dosed|7|||
33644256|NCT01818752|102252437|FG001|Overall Study|Randomized but not Dosed|4|||
33644257|NCT03773796|102252439|FG000|Overall Study|Adverse Event|1|||
33644258|NCT03773796|102252439|FG000|Overall Study|Withdrawal by Subject|1|||
33644259|NCT03773796|102252439|FG000|Overall Study|Lack of Efficacy|1|||
33644260|NCT01509053|102252444|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
33644261|NCT01509053|102252444|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
33644262|NCT01509053|102252444|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
33644263|NCT01509053|102252444|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
33644264|NCT01509053|102252444|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
33644265|NCT01509053|102252444|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
33644266|NCT00441064|102252445|FG000|Overall Study|Adverse Event|1|||
33644267|NCT00441064|102252446|FG001|Overall Study|Adverse Event|0|||
33644268|NCT00441064|102252445|FG000|Overall Study|Abnormal laboratory values|0|||
33644269|NCT00441064|102252446|FG001|Overall Study|Abnormal laboratory values|2|||
33644270|NCT00441064|102252445|FG000|Overall Study|Abnormal test procedure results|0|||
33644271|NCT00441064|102252446|FG001|Overall Study|Abnormal test procedure results|1|||
33644272|NCT00441064|102252445|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33644273|NCT00441064|102252446|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33644274|NCT00441064|102252445|FG000|Overall Study|Protocol Deviation|3|||
33644275|NCT00441064|102252446|FG001|Overall Study|Protocol Deviation|2|||
33644276|NCT00441064|102252445|FG000|Overall Study|Patient withdrew consent|5|||
33644277|NCT00441064|102252446|FG001|Overall Study|Patient withdrew consent|2|||
33644278|NCT03710083|102252448|FG000|Overall Study|Withdrawal by Subject|2|||
33644279|NCT03710083|102252448|FG000|Overall Study|Unsuccessful Procedure|1|||
33644280|NCT00796419|102252454|FG000|Overall Study|Death|0|||
33583250|NCT02689206|102025764|FG004|Overall Study|Physician Decision|0|||
33583251|NCT02689206|102025760|FG000|Overall Study|Withdrawal by Subject|1|||
33583252|NCT02689206|102025761|FG001|Overall Study|Withdrawal by Subject|0|||
33583253|NCT02689206|102025762|FG002|Overall Study|Withdrawal by Subject|1|||
33583254|NCT02689206|102025763|FG003|Overall Study|Withdrawal by Subject|0|||
33583255|NCT02689206|102025764|FG004|Overall Study|Withdrawal by Subject|0|||
33583256|NCT00661726|102025765|FG000|Overall Study|Adverse Event|1|||
33583257|NCT01107392|102025766|FG000|Overall Study|Adverse Event|2|||
33583258|NCT01107392|102025767|FG001|Overall Study|Adverse Event|0|||
33583259|NCT01107392|102025766|FG000|Overall Study|Personal Reasons|2|||
33583260|NCT01107392|102025767|FG001|Overall Study|Personal Reasons|3|||
33422825|NCT01901146|101439763|FG004|Neoadjuvant Phase|Death|0|||
33422826|NCT01901146|101439759|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
33422827|NCT01901146|101439760|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
33583261|NCT01107392|102025766|FG000|Overall Study|Administrative decision|1|||
33644281|NCT00796419|102252455|FG001|Overall Study|Death|1|||
33644282|NCT02504216|102252456|FG000|Overall Study|Lost to Follow-up|3|||
33146202|NCT03416374|100448439|FG000|Treatment Period II|Other|0|||
33422828|NCT01901146|101439761|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
33422829|NCT01901146|101439762|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
33422830|NCT01901146|101439763|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
33644283|NCT02504216|102252457|FG001|Overall Study|Lost to Follow-up|3|||
33644284|NCT02504216|102252456|FG000|Overall Study|Withdrawal by Subject|8|||
33644285|NCT02504216|102252457|FG001|Overall Study|Withdrawal by Subject|12|||
33644286|NCT00661427|102252458|FG000|Overall Study|Adverse Event|5|||
33644287|NCT00661427|102252459|FG001|Overall Study|Adverse Event|5|||
33644288|NCT00661427|102252458|FG000|Overall Study|Patient not treated|0|||
33644289|NCT00661427|102252459|FG001|Overall Study|Patient not treated|2|||
33644290|NCT01712399|102252460|FG000|Overall Study|Lost to Follow-up|1|||
33644291|NCT01712399|102252460|FG000|Overall Study|Withdrawal by Subject|39|||
33644292|NCT01712399|102252460|FG000|Overall Study|Death|1|||
33644293|NCT01712399|102252460|FG000|Overall Study|Adverse Event|11|||
33644294|NCT01712399|102252460|FG000|Overall Study|Study closure|345|||
33644295|NCT03091348|102252463|FG000|Overall Study|Lost to Follow-up|2|||
33644296|NCT03091348|102252464|FG001|Overall Study|Lost to Follow-up|1|||
33644297|NCT00486291|102252477|FG000|Overall Study|Adverse Event|3|||
33644298|NCT00486291|102252478|FG001|Overall Study|Adverse Event|4|||
33644299|NCT00486291|102252477|FG000|Overall Study|Lost to Follow-up|3|||
33644300|NCT00486291|102252478|FG001|Overall Study|Lost to Follow-up|7|||
33644301|NCT00486291|102252477|FG000|Overall Study|protocol non-compliance|10|||
33644302|NCT00486291|102252478|FG001|Overall Study|protocol non-compliance|15|||
33644303|NCT00486291|102252477|FG000|Overall Study|requirement for restricted medication|0|||
33644304|NCT00486291|102252478|FG001|Overall Study|requirement for restricted medication|3|||
33644305|NCT04040933|102252480|FG000|Overall Study|Protocol Violation|1|||
33644306|NCT04040933|102252480|FG000|Overall Study|Withdrawal by Subject|2|||
33644307|NCT01419197|102252485|FG000|Overall Study|Death|247|||
33644308|NCT01419197|102252486|FG001|Overall Study|Death|122|||
33644309|NCT01419197|102252485|FG000|Overall Study|Physician Decision|4|||
33644310|NCT01419197|102252486|FG001|Overall Study|Physician Decision|4|||
33644311|NCT01419197|102252485|FG000|Overall Study|Non-compliance|3|||
33644312|NCT01419197|102252486|FG001|Overall Study|Non-compliance|1|||
33644313|NCT01419197|102252485|FG000|Overall Study|Withdrawal by Subject|33|||
33644314|NCT01419197|102252486|FG001|Overall Study|Withdrawal by Subject|32|||
33644315|NCT01419197|102252485|FG000|Overall Study|Study Completed by Sponsor|103|||
33644316|NCT01419197|102252486|FG001|Overall Study|Study Completed by Sponsor|34|||
33644317|NCT01419197|102252485|FG000|Overall Study|Reason Not Specified|0|||
33644318|NCT01419197|102252486|FG001|Overall Study|Reason Not Specified|1|||
33644319|NCT01419197|102252485|FG000|Overall Study|Lost to Follow-up|14|||
33644320|NCT01419197|102252486|FG001|Overall Study|Lost to Follow-up|4|||
33644321|NCT01474239|102252491|FG000|Overall Study|Disease Progression|37|||
33644322|NCT01474239|102252492|FG001|Overall Study|Disease Progression|25|||
33244381|NCT03531905|100796926|FG001|Overall Study|Withdrawal by Subject|3|||
33244382|NCT03531905|100796927|FG002|Overall Study|Withdrawal by Subject|2|||
33244383|NCT03531905|100796925|FG000|Overall Study|Lost to Follow-up|2|||
33244384|NCT03531905|100796926|FG001|Overall Study|Lost to Follow-up|2|||
33244385|NCT03531905|100796927|FG002|Overall Study|Lost to Follow-up|1|||
33372973|NCT05674344|101252003|FG000|Overall Study|Screen Fail|21|||
33372974|NCT05674344|101252003|FG000|Overall Study|Incomplete study procedures|3|||
33372975|NCT01189435|101252004|FG000|Overall Study|Withdrawal by Subject|1|||
33372976|NCT01189435|101252004|FG000|Overall Study|Physician Decision|1|||
33372977|NCT02130427|101252005|FG000|Overall Study|Imaging results not interpretable|30|||
33372978|NCT03628508|101252013|FG000|Overall Study|Lost to Follow-up|1|||
33372979|NCT02985450|101252016|FG000|Overall Study|Lost to Follow-up|7|||
33372980|NCT03430245|101252017|FG000|Overall Study|Withdrawal by Subject|6|||
33372981|NCT03430245|101252017|FG000|Overall Study|Lost to Follow-up|1|||
33372982|NCT03622593|101252018|FG000|Overall Study|Withdrawal by Subject|11|||
33372983|NCT03622593|101252019|FG001|Overall Study|Withdrawal by Subject|9|||
33372984|NCT03622593|101252020|FG002|Overall Study|Withdrawal by Subject|13|||
33372985|NCT03622593|101252018|FG000|Overall Study|Death|12|||
33372986|NCT03622593|101252019|FG001|Overall Study|Death|9|||
33372987|NCT03622593|101252020|FG002|Overall Study|Death|10|||
33372988|NCT03622593|101252018|FG000|Overall Study|Lost to Follow-up|11|||
33372989|NCT03622593|101252019|FG001|Overall Study|Lost to Follow-up|5|||
33372990|NCT03622593|101252020|FG002|Overall Study|Lost to Follow-up|8|||
33372991|NCT03622593|101252018|FG000|Overall Study|Adverse Event|4|||
33372992|NCT03622593|101252019|FG001|Overall Study|Adverse Event|5|||
33372993|NCT03622593|101252020|FG002|Overall Study|Adverse Event|6|||
33372994|NCT03622593|101252018|FG000|Overall Study|Physician Decision|2|||
33644323|NCT01474239|102252491|FG000|Overall Study|Adverse Event|12|||
33644324|NCT01474239|102252492|FG001|Overall Study|Adverse Event|3|||
33644325|NCT01474239|102252491|FG000|Overall Study|Withdrawal by Subject|1|||
33644326|NCT01474239|102252492|FG001|Overall Study|Withdrawal by Subject|2|||
33244386|NCT03531905|100796925|FG000|Overall Study|Participant was out of town|1|||
33372995|NCT03622593|101252019|FG001|Overall Study|Physician Decision|1|||
33372996|NCT03622593|101252020|FG002|Overall Study|Physician Decision|6|||
33372997|NCT03622593|101252018|FG000|Overall Study|Other|2|||
33644327|NCT01474239|102252491|FG000|Overall Study|Death|1|||
33644328|NCT01474239|102252492|FG001|Overall Study|Death|1|||
33644329|NCT01474239|102252491|FG000|Overall Study|Clinical Disease Progression|7|||
33644330|NCT01474239|102252492|FG001|Overall Study|Clinical Disease Progression|1|||
33422831|NCT01901146|101439759|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
33422832|NCT01901146|101439760|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
33583262|NCT01107392|102025767|FG001|Overall Study|Administrative decision|0|||
33583263|NCT00938912|102025769|FG000|Overall Study|Withdrawal by Subject|28|||
33583264|NCT00938912|102025769|FG000|Overall Study|Lost to Follow-up|4|||
33583265|NCT00938912|102025769|FG000|Overall Study|Lack of Efficacy|43|||
33583266|NCT00938912|102025769|FG000|Overall Study|Adverse event, non-fatal|24|||
33583267|NCT00938912|102025769|FG000|Overall Study|Adverse event, fatal|1|||
33644331|NCT01474239|102252491|FG000|Overall Study|Withdrawal for Economic Reason|1|||
33644332|NCT01474239|102252492|FG001|Overall Study|Withdrawal for Economic Reason|0|||
33644333|NCT02779556|102252493|FG000|Baseline|Partial baseline interview completed|1|||
33372998|NCT03622593|101252019|FG001|Overall Study|Other|2|||
33372999|NCT03622593|101252020|FG002|Overall Study|Other|3|||
33373000|NCT03622593|101252018|FG000|Overall Study|Protocol Violation|0|||
33373001|NCT03622593|101252019|FG001|Overall Study|Protocol Violation|0|||
33146203|NCT03416374|100448440|FG001|Treatment Period II|Other|2|||
33146204|NCT02889562|100448443|FG000|Overall Study|Physician Decision|0|||
33244387|NCT03531905|100796926|FG001|Overall Study|Participant was out of town|0|||
33244388|NCT03531905|100796927|FG002|Overall Study|Participant was out of town|0|||
33244389|NCT03531905|100796925|FG000|Overall Study|Could not speak with the participant|1|||
33244390|NCT03531905|100796926|FG001|Overall Study|Could not speak with the participant|0|||
33244391|NCT03531905|100796927|FG002|Overall Study|Could not speak with the participant|0|||
33244392|NCT00723294|100796928|FG000|Overall Study|Lobular histology|2|||
33244393|NCT00723294|100796928|FG000|Overall Study|>25% intraductal component|1|||
33244394|NCT00723294|100796928|FG000|Overall Study|No MRI tumor enhancement|1|||
33244395|NCT00723294|100796928|FG000|Overall Study|1.0-Tesla MRI|1|||
33244396|NCT00723294|100796928|FG000|Overall Study|No cryoabalation|2|||
33644334|NCT02779556|102252494|FG001|Baseline|Partial baseline interview completed|0|||
33644335|NCT02779556|102252493|FG000|3 Months|Lost to Follow-up|40|||
33644336|NCT02779556|102252494|FG001|3 Months|Lost to Follow-up|29|||
33644337|NCT02779556|102252493|FG000|3 Months|Missed 3 month clinic visit|27|||
33644338|NCT02779556|102252494|FG001|3 Months|Missed 3 month clinic visit|19|||
33244397|NCT00723294|100796928|FG000|Overall Study|Did not undergo surgery|1|||
33244398|NCT00723294|100796928|FG000|Overall Study|Treated prior to registration|1|||
33373002|NCT03622593|101252020|FG002|Overall Study|Protocol Violation|1|||
33373003|NCT03622593|101252018|FG000|Overall Study|Pregnancy|0|||
33644339|NCT02779556|102252493|FG000|6 Month|Lost to Follow-up|33|||
33644340|NCT02779556|102252494|FG001|6 Month|Lost to Follow-up|39|||
33644341|NCT02779556|102252493|FG000|6 Month HbA1c|No value collected during window|69|||
33644342|NCT02779556|102252494|FG001|6 Month HbA1c|No value collected during window|50|||
33644343|NCT02779556|102252493|FG000|12 Month HbA1c|No value collected during window|138|||
33644344|NCT02779556|102252494|FG001|12 Month HbA1c|No value collected during window|102|||
33644345|NCT01071798|102252496|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
33644346|NCT01071798|102252496|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
33644347|NCT01071798|102252496|FG000|Participants Who Received One Cycle|Patient requirement|20|||
33644348|NCT01071798|102252496|FG000|Participants Who Received One Cycle|Death|5|||
33644349|NCT01071798|102252496|FG000|Participants Who Received One Cycle|Change of therapy|6|||
33644350|NCT01071798|102252496|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
33644351|NCT01071798|102252496|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
33644352|NCT01071798|102252496|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
33644353|NCT01071798|102252496|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
33644354|NCT01071798|102252496|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
33644355|NCT02442804|102252497|FG000|Overall Study|Withdrawal by Subject|0|||
33644356|NCT02442804|102252498|FG001|Overall Study|Withdrawal by Subject|1|||
33644357|NCT02442804|102252497|FG000|Overall Study|Adverse Event|1|||
33644358|NCT02442804|102252498|FG001|Overall Study|Adverse Event|0|||
33644359|NCT01590888|102252499|FG000|Overall Study|Adverse Event|3|||
33146205|NCT02889562|100448444|FG001|Overall Study|Physician Decision|1|||
33244399|NCT00723294|100796928|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
33373004|NCT03622593|101252019|FG001|Overall Study|Pregnancy|0|||
33373005|NCT03622593|101252020|FG002|Overall Study|Pregnancy|1|||
33373006|NCT02683525|101252022|FG000|Overall Study|Lost to Follow-up|1|||
33373007|NCT02683525|101252022|FG000|Overall Study|Physician Decision|1|||
33373008|NCT02683525|101252022|FG000|Overall Study|Disease Progression|6|||
33373009|NCT01067508|101252023|FG000|Overall Study|Physician Decision|0|||
33583268|NCT00938912|102025769|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
33583269|NCT00938912|102025769|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
33583270|NCT00938912|102025769|FG000|Overall Study|Participant needed prohibit medication|1|||
33644360|NCT01590888|102252500|FG001|Overall Study|Adverse Event|0|||
33644361|NCT01590888|102252501|FG002|Overall Study|Adverse Event|1|||
33146206|NCT02889562|100448443|FG000|Overall Study|Withdrawal by Subject|0|||
33244400|NCT00723294|100796928|FG000|Overall Study|Benign lesion|1|||
33244401|NCT00723294|100796928|FG000|Overall Study|Withdrawal by Subject|1|||
33373010|NCT01067508|101252024|FG001|Overall Study|Physician Decision|1|||
33373011|NCT01067508|101252023|FG000|Overall Study|Withdrawal by Subject|0|||
33146207|NCT02889562|100448444|FG001|Overall Study|Withdrawal by Subject|1|||
33146208|NCT00773383|100448446|FG000|Overall Study|Adverse Event|4|||
33146209|NCT00773383|100448446|FG000|Overall Study|Death|1|||
33146210|NCT00773383|100448446|FG000|Overall Study|Progression of Disease|23|||
33146211|NCT00773383|100448446|FG000|Overall Study|Other|2|||
33146212|NCT00773383|100448446|FG000|Overall Study|No study dose received|1|||
33146213|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
33146214|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
33146215|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
33146216|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
33146217|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
33146218|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
33146219|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
33146220|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
33146221|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
33146222|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
33146223|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
33146224|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
33146225|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
33146226|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
33146227|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
33146228|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
33146229|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Program Termination|3|||
33146230|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Program Termination|0|||
33146231|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Program Termination|1|||
33146232|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Program Termination|1|||
33146233|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
33146234|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
33146235|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
33146236|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
33146237|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
33146238|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
33146239|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
33146240|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
33146241|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
33422833|NCT01901146|101439761|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
33583271|NCT00938912|102025769|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
33583272|NCT00938912|102025769|FG000|Overall Study|Did not meet Eligibility criteria|1|||
33583273|NCT00938912|102025769|FG000|Overall Study|Participant relocated not related to AE|1|||
33583274|NCT00938912|102025769|FG000|Overall Study|Participant moved to another city|1|||
33583275|NCT00938912|102025769|FG000|Overall Study|Participant experienced break through seizures|1|||
33583276|NCT00938912|102025769|FG000|Overall Study|No longer wished to participate in the study|1|||
33583277|NCT00938912|102025769|FG000|Overall Study|Protocol Deviation|2|||
33583278|NCT00620373|102025770|FG000|Overall Study|Unverified cancer status|33|||
33583279|NCT01978145|102025771|FG000|Treatment Period 1|Adverse Event|1|||
33583280|NCT01978145|102025772|FG001|Treatment Period 1|Adverse Event|9|||
33583281|NCT01978145|102025771|FG000|Treatment Period 1|Physician Decision|1|||
33583282|NCT01978145|102025772|FG001|Treatment Period 1|Physician Decision|0|||
33583283|NCT01978145|102025771|FG000|Treatment Period 1|Withdrawal by Subject|5|||
33583284|NCT01978145|102025772|FG001|Treatment Period 1|Withdrawal by Subject|4|||
33583285|NCT01978145|102025771|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
33583286|NCT01978145|102025772|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
33583287|NCT01978145|102025771|FG000|Washout Period 1|Adverse Event|0|||
33583288|NCT01978145|102025772|FG001|Washout Period 1|Adverse Event|1|||
33583289|NCT01978145|102025771|FG000|Washout Period 1|Withdrawal by Subject|1|||
33583290|NCT01978145|102025772|FG001|Washout Period 1|Withdrawal by Subject|1|||
33583291|NCT01978145|102025771|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
33583292|NCT01978145|102025772|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
33583293|NCT01978145|102025771|FG000|Treatment Period 2|Adverse Event|3|||
33583294|NCT01978145|102025772|FG001|Treatment Period 2|Adverse Event|3|||
33583295|NCT01978145|102025771|FG000|Treatment Period 2|Protocol Violation|0|||
33583296|NCT01978145|102025772|FG001|Treatment Period 2|Protocol Violation|1|||
33583297|NCT01978145|102025771|FG000|Treatment Period 2|Lost to Follow-up|1|||
33583298|NCT01978145|102025772|FG001|Treatment Period 2|Lost to Follow-up|1|||
33583299|NCT01978145|102025771|FG000|Treatment Period 2|Withdrawal by Subject|7|||
33644362|NCT01590888|102252499|FG000|Overall Study|Lost to Follow-up|1|||
33146242|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
33146243|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
33422834|NCT01901146|101439762|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
33583300|NCT01978145|102025772|FG001|Treatment Period 2|Withdrawal by Subject|4|||
33583301|NCT01978145|102025771|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
33583302|NCT01978145|102025772|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
33146244|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
33146245|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
33146246|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
33146247|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
33146248|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
33146249|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
33146250|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
33146251|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
33146252|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
33146253|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
33146254|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
33146255|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
33146256|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
33146257|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
33146258|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
33146259|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
33146260|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
33146261|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
33146262|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
33146263|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
33644363|NCT01590888|102252500|FG001|Overall Study|Lost to Follow-up|0|||
33644364|NCT01590888|102252501|FG002|Overall Study|Lost to Follow-up|0|||
33644365|NCT02722499|102252509|FG000|Overall Study|Lost to Follow-up|2|||
33644366|NCT02722499|102252510|FG001|Overall Study|Lost to Follow-up|0|||
33644367|NCT02722499|102252511|FG002|Overall Study|Lost to Follow-up|1|||
33644368|NCT01006291|102252512|FG000|Overall Study|Adverse Event|2|||
33644369|NCT01006291|102252513|FG001|Overall Study|Adverse Event|1|||
33644370|NCT01006291|102252514|FG002|Overall Study|Adverse Event|2|||
33146264|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
33146265|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
33146266|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
33146267|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
33146268|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
33146269|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
33146270|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
33146271|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
33146272|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
33146273|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
33146274|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
33146275|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
33644371|NCT01006291|102252512|FG000|Overall Study|Lack of Efficacy|2|||
33644372|NCT01006291|102252513|FG001|Overall Study|Lack of Efficacy|2|||
33644373|NCT01006291|102252514|FG002|Overall Study|Lack of Efficacy|1|||
33644374|NCT01006291|102252512|FG000|Overall Study|Protocol Violation|3|||
33644375|NCT01006291|102252513|FG001|Overall Study|Protocol Violation|3|||
33644376|NCT01006291|102252514|FG002|Overall Study|Protocol Violation|3|||
33644377|NCT01006291|102252512|FG000|Overall Study|Withdrawal criteria|5|||
33644378|NCT01006291|102252513|FG001|Overall Study|Withdrawal criteria|4|||
33644379|NCT01006291|102252514|FG002|Overall Study|Withdrawal criteria|4|||
33644380|NCT01006291|102252512|FG000|Overall Study|Other|14|||
33644381|NCT01006291|102252513|FG001|Overall Study|Other|14|||
33644382|NCT01006291|102252514|FG002|Overall Study|Other|17|||
33644383|NCT00441116|102252515|FG000|Overall Study|Adverse Event|1|||
33644384|NCT00441116|102252516|FG001|Overall Study|Adverse Event|1|||
33644385|NCT00441116|102252515|FG000|Overall Study|Withdrawal by Subject|1|||
33146276|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
33146277|NCT03739840|100448447|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
33244402|NCT00723294|100796928|FG000|Overall Study|No treatment due to probe failure|1|||
33373012|NCT01067508|101252024|FG001|Overall Study|Withdrawal by Subject|1|||
33373013|NCT02273050|101252025|FG000|Overall Study|Adverse Event|4|||
33373014|NCT02273050|101252026|FG001|Overall Study|Adverse Event|3|||
33644386|NCT00441116|102252516|FG001|Overall Study|Withdrawal by Subject|0|||
33644387|NCT00441116|102252515|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
33644388|NCT00441116|102252516|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
33146278|NCT03739840|100448448|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
33373015|NCT02273050|101252027|FG002|Overall Study|Adverse Event|3|||
33644389|NCT02105961|102252517|FG000|Overall Study|Adverse Event|18|||
33644390|NCT02105961|102252518|FG001|Overall Study|Adverse Event|7|||
33644391|NCT02105961|102252519|FG002|Overall Study|Adverse Event|13|||
33644392|NCT02105961|102252517|FG000|Overall Study|Lack of Efficacy|3|||
33146279|NCT03739840|100448449|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
33244403|NCT01065454|100796931|FG000|Treatment|Adverse Event|7|||
33644393|NCT02105961|102252518|FG001|Overall Study|Lack of Efficacy|0|||
33244404|NCT01065454|100796932|FG001|Treatment|Adverse Event|4|||
33244405|NCT01065454|100796933|FG002|Treatment|Adverse Event|3|||
33244406|NCT01065454|100796934|FG003|Treatment|Adverse Event|6|||
33244407|NCT01065454|100796931|FG000|Treatment|Death|1|||
33244408|NCT01065454|100796932|FG001|Treatment|Death|0|||
33244409|NCT01065454|100796933|FG002|Treatment|Death|0|||
33244410|NCT01065454|100796934|FG003|Treatment|Death|0|||
33244411|NCT01065454|100796931|FG000|Treatment|Non-compliance|1|||
33244412|NCT01065454|100796932|FG001|Treatment|Non-compliance|0|||
33244413|NCT01065454|100796933|FG002|Treatment|Non-compliance|0|||
33244414|NCT01065454|100796934|FG003|Treatment|Non-compliance|1|||
33244415|NCT01065454|100796931|FG000|Treatment|Protocol Decision|0|||
33244416|NCT01065454|100796932|FG001|Treatment|Protocol Decision|0|||
33244417|NCT01065454|100796933|FG002|Treatment|Protocol Decision|3|||
33244418|NCT01065454|100796934|FG003|Treatment|Protocol Decision|2|||
33244419|NCT01065454|100796931|FG000|Treatment|Protocol Violation|1|||
33244420|NCT01065454|100796932|FG001|Treatment|Protocol Violation|0|||
33244421|NCT01065454|100796933|FG002|Treatment|Protocol Violation|1|||
33244422|NCT01065454|100796934|FG003|Treatment|Protocol Violation|0|||
33373016|NCT02273050|101252025|FG000|Overall Study|Death|0|||
33373017|NCT02273050|101252026|FG001|Overall Study|Death|0|||
33373018|NCT02273050|101252027|FG002|Overall Study|Death|1|||
33422835|NCT01901146|101439763|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
33422836|NCT01901146|101439759|FG000|Neoadjuvant Phase|Physician Decision|1|||
33644394|NCT02105961|102252519|FG002|Overall Study|Lack of Efficacy|3|||
33644395|NCT02105961|102252517|FG000|Overall Study|Lost to Follow-up|2|||
33644396|NCT02105961|102252518|FG001|Overall Study|Lost to Follow-up|0|||
33644397|NCT02105961|102252519|FG002|Overall Study|Lost to Follow-up|1|||
33644398|NCT02105961|102252517|FG000|Overall Study|Physician Decision|3|||
33644399|NCT02105961|102252518|FG001|Overall Study|Physician Decision|3|||
33644400|NCT02105961|102252519|FG002|Overall Study|Physician Decision|2|||
33644401|NCT02105961|102252517|FG000|Overall Study|Withdrawal by Subject|15|||
33644402|NCT02105961|102252518|FG001|Overall Study|Withdrawal by Subject|7|||
33644403|NCT02105961|102252519|FG002|Overall Study|Withdrawal by Subject|11|||
33644404|NCT00485134|102252520|FG000|Overall Study|Lost to Follow-up|1|||
33644405|NCT00485134|102252521|FG001|Overall Study|Lost to Follow-up|0|||
33644406|NCT00485134|102252522|FG002|Overall Study|Lost to Follow-up|0|||
33644407|NCT00485134|102252523|FG003|Overall Study|Lost to Follow-up|0|||
33644408|NCT00485134|102252524|FG004|Overall Study|Lost to Follow-up|0|||
33644409|NCT00485134|102252525|FG005|Overall Study|Lost to Follow-up|0|||
33644410|NCT00485134|102252526|FG006|Overall Study|Lost to Follow-up|0|||
33644411|NCT00485134|102252527|FG007|Overall Study|Lost to Follow-up|0|||
33644412|NCT00485134|102252520|FG000|Overall Study|Withdrawal by Subject|0|||
33644413|NCT00485134|102252521|FG001|Overall Study|Withdrawal by Subject|1|||
33644414|NCT00485134|102252522|FG002|Overall Study|Withdrawal by Subject|0|||
33644415|NCT00485134|102252523|FG003|Overall Study|Withdrawal by Subject|0|||
33644416|NCT00485134|102252524|FG004|Overall Study|Withdrawal by Subject|0|||
33644417|NCT00485134|102252525|FG005|Overall Study|Withdrawal by Subject|0|||
33644418|NCT00485134|102252526|FG006|Overall Study|Withdrawal by Subject|0|||
33644419|NCT00485134|102252527|FG007|Overall Study|Withdrawal by Subject|0|||
33244423|NCT01065454|100796931|FG000|Treatment|Withdrawal by Subject|3|||
33244424|NCT01065454|100796932|FG001|Treatment|Withdrawal by Subject|1|||
33244425|NCT01065454|100796933|FG002|Treatment|Withdrawal by Subject|2|||
33244426|NCT01065454|100796934|FG003|Treatment|Withdrawal by Subject|3|||
33373019|NCT02273050|101252025|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
33373020|NCT02273050|101252026|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
33373021|NCT02273050|101252027|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
33373022|NCT02273050|101252025|FG000|Overall Study|Lack of Efficacy|0|||
33373023|NCT02273050|101252026|FG001|Overall Study|Lack of Efficacy|1|||
33373024|NCT02273050|101252027|FG002|Overall Study|Lack of Efficacy|1|||
33373025|NCT02273050|101252025|FG000|Overall Study|Withdrawal by Subject|17|||
33373026|NCT02273050|101252026|FG001|Overall Study|Withdrawal by Subject|14|||
33373027|NCT02273050|101252027|FG002|Overall Study|Withdrawal by Subject|16|||
33373028|NCT02273050|101252025|FG000|Overall Study|Lost to Follow-up|0|||
33373029|NCT02273050|101252026|FG001|Overall Study|Lost to Follow-up|2|||
33373030|NCT02273050|101252027|FG002|Overall Study|Lost to Follow-up|3|||
33244427|NCT01065454|100796931|FG000|Follow up|Adverse Event|1|||
33644420|NCT00485134|102252520|FG000|Overall Study|Change in health status|0|||
33644421|NCT00485134|102252521|FG001|Overall Study|Change in health status|1|||
33644422|NCT00485134|102252522|FG002|Overall Study|Change in health status|2|||
33244428|NCT01065454|100796932|FG001|Follow up|Adverse Event|0|||
33244429|NCT01065454|100796933|FG002|Follow up|Adverse Event|0|||
33244430|NCT01065454|100796934|FG003|Follow up|Adverse Event|1|||
33244431|NCT01065454|100796931|FG000|Follow up|Death|0|||
33244432|NCT01065454|100796932|FG001|Follow up|Death|1|||
33244433|NCT01065454|100796933|FG002|Follow up|Death|1|||
33373031|NCT02273050|101252025|FG000|Overall Study|Protocol Violation|3|||
33644423|NCT00485134|102252523|FG003|Overall Study|Change in health status|1|||
33644424|NCT00485134|102252524|FG004|Overall Study|Change in health status|0|||
33644425|NCT00485134|102252525|FG005|Overall Study|Change in health status|1|||
33644426|NCT00485134|102252526|FG006|Overall Study|Change in health status|0|||
33644427|NCT00485134|102252527|FG007|Overall Study|Change in health status|0|||
33644428|NCT00485134|102252520|FG000|Overall Study|Withdrew for adverse event|0|||
33644429|NCT00485134|102252521|FG001|Overall Study|Withdrew for adverse event|0|||
33644430|NCT00485134|102252522|FG002|Overall Study|Withdrew for adverse event|1|||
33644431|NCT00485134|102252523|FG003|Overall Study|Withdrew for adverse event|0|||
33644432|NCT00485134|102252524|FG004|Overall Study|Withdrew for adverse event|0|||
33644433|NCT00485134|102252525|FG005|Overall Study|Withdrew for adverse event|0|||
33644434|NCT00485134|102252526|FG006|Overall Study|Withdrew for adverse event|0|||
33644435|NCT00485134|102252527|FG007|Overall Study|Withdrew for adverse event|0|||
33644436|NCT00485134|102252520|FG000|Overall Study|Positive drug test|0|||
33644437|NCT00485134|102252521|FG001|Overall Study|Positive drug test|0|||
33644438|NCT00485134|102252522|FG002|Overall Study|Positive drug test|0|||
33644439|NCT00485134|102252523|FG003|Overall Study|Positive drug test|0|||
33146280|NCT03739840|100448450|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
33146281|NCT03739840|100448447|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
33146282|NCT03739840|100448448|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
33146283|NCT03739840|100448449|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
33146284|NCT03739840|100448450|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
33146285|NCT03739840|100448447|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
33146286|NCT03739840|100448448|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
33146287|NCT03739840|100448449|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
33146288|NCT03739840|100448450|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
33146289|NCT03739840|100448447|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
33146290|NCT03739840|100448448|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
33146291|NCT03739840|100448449|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
33146292|NCT03739840|100448450|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
33146293|NCT03739840|100448447|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
33146294|NCT03739840|100448448|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
33146295|NCT03739840|100448449|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
33146296|NCT03739840|100448450|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
33146297|NCT03739840|100448447|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
33146298|NCT03739840|100448448|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
33146299|NCT03739840|100448449|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
33146300|NCT03739840|100448450|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
33146301|NCT03739840|100448447|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
33146302|NCT03739840|100448448|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
33146303|NCT03739840|100448449|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
33146304|NCT03739840|100448450|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
33146305|NCT03739840|100448447|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
33146306|NCT03739840|100448448|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
33146307|NCT03739840|100448449|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
33146308|NCT03739840|100448450|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
33244434|NCT01065454|100796934|FG003|Follow up|Death|0|||
33422837|NCT01901146|101439760|FG001|Neoadjuvant Phase|Physician Decision|2|||
33422838|NCT01901146|101439761|FG002|Neoadjuvant Phase|Physician Decision|0|||
33422839|NCT01901146|101439762|FG003|Neoadjuvant Phase|Physician Decision|0|||
33422840|NCT01901146|101439763|FG004|Neoadjuvant Phase|Physician Decision|0|||
33422841|NCT01901146|101439759|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
33422842|NCT01901146|101439760|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
33422843|NCT01901146|101439761|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
33422844|NCT01901146|101439762|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
33422845|NCT01901146|101439763|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
33422846|NCT01901146|101439759|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
33422847|NCT01901146|101439760|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
33422848|NCT01901146|101439761|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
33422849|NCT01901146|101439762|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
33422850|NCT01901146|101439763|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
33422851|NCT01901146|101439759|FG000|Adjuvant Phase|Other|0|||
33422852|NCT01901146|101439760|FG001|Adjuvant Phase|Other|0|||
33422853|NCT01901146|101439761|FG002|Adjuvant Phase|Other|1|||
33422854|NCT01901146|101439762|FG003|Adjuvant Phase|Other|0|||
33422855|NCT01901146|101439763|FG004|Adjuvant Phase|Other|0|||
33422856|NCT01901146|101439759|FG000|Adjuvant Phase|Death|0|||
33422857|NCT01901146|101439760|FG001|Adjuvant Phase|Death|0|||
33422858|NCT01901146|101439761|FG002|Adjuvant Phase|Death|0|||
33644440|NCT00485134|102252524|FG004|Overall Study|Positive drug test|2|||
33422859|NCT01901146|101439762|FG003|Adjuvant Phase|Death|0|||
33422860|NCT01901146|101439763|FG004|Adjuvant Phase|Death|3|||
33644441|NCT00485134|102252525|FG005|Overall Study|Positive drug test|1|||
33644442|NCT00485134|102252526|FG006|Overall Study|Positive drug test|0|||
33644443|NCT00485134|102252527|FG007|Overall Study|Positive drug test|0|||
33644444|NCT00485134|102252520|FG000|Overall Study|Non-compliance|0|||
33244435|NCT01065454|100796931|FG000|Follow up|Lost to Follow-up|0|||
33244436|NCT01065454|100796932|FG001|Follow up|Lost to Follow-up|0|||
33244437|NCT01065454|100796933|FG002|Follow up|Lost to Follow-up|0|||
33244438|NCT01065454|100796934|FG003|Follow up|Lost to Follow-up|1|||
33244439|NCT01065454|100796931|FG000|Follow up|Progressive disease|0|||
33244440|NCT01065454|100796932|FG001|Follow up|Progressive disease|0|||
33244441|NCT01065454|100796933|FG002|Follow up|Progressive disease|0|||
33244442|NCT01065454|100796934|FG003|Follow up|Progressive disease|1|||
33244443|NCT01065454|100796931|FG000|Follow up|Withdrawal by Subject|1|||
33244444|NCT01065454|100796932|FG001|Follow up|Withdrawal by Subject|1|||
33244445|NCT01065454|100796933|FG002|Follow up|Withdrawal by Subject|1|||
33244446|NCT01065454|100796934|FG003|Follow up|Withdrawal by Subject|0|||
33244447|NCT01065454|100796931|FG000|Follow up|study ongoing|37|||
33244448|NCT01065454|100796932|FG001|Follow up|study ongoing|22|||
33244449|NCT01065454|100796933|FG002|Follow up|study ongoing|15|||
33244450|NCT01065454|100796934|FG003|Follow up|study ongoing|41|||
33244451|NCT00303303|100796935|FG000|Overall Study|Withdrawal by Subject|0|||
33244452|NCT00303303|100796936|FG001|Overall Study|Withdrawal by Subject|0|||
33244453|NCT00303303|100796937|FG002|Overall Study|Withdrawal by Subject|1|||
33244454|NCT04582877|100796957|FG000|Overall Study|Did not use device measurement|5|||
33244455|NCT04582877|100796957|FG000|Overall Study|No fractional flow reserve test results|2|||
33244456|NCT04582877|100796957|FG000|Overall Study|Protocol Violation|1|||
33244457|NCT01772719|100796958|FG000|Overall Study|Withdrawal by Subject|3|||
33244458|NCT01772719|100796958|FG000|Overall Study|Adverse Event|2|||
33244459|NCT01772719|100796958|FG000|Overall Study|Protocol Violation|1|||
33244460|NCT01772719|100796958|FG000|Overall Study|Lost to Follow-up|1|||
33244461|NCT00826280|100796959|FG000|Overall Study|Randomized but drug not received|1|||
33244462|NCT00826280|100796960|FG001|Overall Study|Randomized but drug not received|0|||
33244463|NCT00826280|100796961|FG002|Overall Study|Randomized but drug not received|1|||
33244464|NCT00826280|100796959|FG000|Overall Study|Adverse Event|1|||
33244465|NCT00826280|100796960|FG001|Overall Study|Adverse Event|3|||
33244466|NCT00826280|100796961|FG002|Overall Study|Adverse Event|0|||
33244467|NCT00826280|100796959|FG000|Overall Study|Lost to Follow-up|0|||
33244468|NCT00826280|100796960|FG001|Overall Study|Lost to Follow-up|1|||
33244469|NCT00826280|100796961|FG002|Overall Study|Lost to Follow-up|0|||
33244470|NCT00826280|100796959|FG000|Overall Study|Sponsor discontinued subject or study|1|||
33244471|NCT00826280|100796960|FG001|Overall Study|Sponsor discontinued subject or study|0|||
33244472|NCT00826280|100796961|FG002|Overall Study|Sponsor discontinued subject or study|0|||
33244473|NCT00826280|100796959|FG000|Overall Study|Reversible ischemic defect not present|43|||
33244474|NCT00826280|100796960|FG001|Overall Study|Reversible ischemic defect not present|40|||
33244475|NCT00826280|100796961|FG002|Overall Study|Reversible ischemic defect not present|44|||
33244476|NCT00826280|100796959|FG000|Overall Study|Interpretation Failure|1|||
33244477|NCT00826280|100796960|FG001|Overall Study|Interpretation Failure|0|||
33244478|NCT00826280|100796961|FG002|Overall Study|Interpretation Failure|0|||
33244479|NCT00826280|100796959|FG000|Overall Study|Machine Failure|1|||
33244480|NCT00826280|100796960|FG001|Overall Study|Machine Failure|1|||
33244481|NCT00826280|100796961|FG002|Overall Study|Machine Failure|0|||
33244482|NCT00826280|100796959|FG000|Overall Study|One or more non-interpretable scan|0|||
33244483|NCT00826280|100796960|FG001|Overall Study|One or more non-interpretable scan|1|||
33244484|NCT00826280|100796961|FG002|Overall Study|One or more non-interpretable scan|1|||
33244485|NCT03201809|100796964|FG000|Overall Study|Lost to Follow-up|2|||
33244486|NCT03201809|100796965|FG001|Overall Study|Lost to Follow-up|0|||
33244487|NCT00506519|100796966|FG000|Overall Study|Death|4|||
33244488|NCT00506519|100796967|FG001|Overall Study|Death|6|||
33244489|NCT00506519|100796968|FG002|Overall Study|Death|0|||
33244490|NCT00506519|100796966|FG000|Overall Study|Adverse Event|1|||
33244491|NCT00506519|100796967|FG001|Overall Study|Adverse Event|0|||
33244492|NCT00506519|100796968|FG002|Overall Study|Adverse Event|0|||
33244493|NCT02223793|100796969|FG000|Overall Study|Lost to Follow-up|10|||
33244494|NCT02223793|100796970|FG001|Overall Study|Lost to Follow-up|1|||
33244495|NCT02223793|100796971|FG002|Overall Study|Lost to Follow-up|2|||
33244496|NCT02223793|100796969|FG000|Overall Study|Withdrawal by Subject|3|||
33373032|NCT02273050|101252026|FG001|Overall Study|Protocol Violation|1|||
33244497|NCT02223793|100796970|FG001|Overall Study|Withdrawal by Subject|2|||
33373033|NCT02273050|101252027|FG002|Overall Study|Protocol Violation|4|||
33583303|NCT00402324|102025773|FG000|Overall Study|Lost to Follow-up|11|||
33244498|NCT02223793|100796971|FG002|Overall Study|Withdrawal by Subject|3|||
33244499|NCT02223793|100796969|FG000|Overall Study|Moved/studycenter unable to participate|4|||
33244500|NCT02223793|100796970|FG001|Overall Study|Moved/studycenter unable to participate|6|||
33244501|NCT02223793|100796971|FG002|Overall Study|Moved/studycenter unable to participate|8|||
33244502|NCT05705167|100796973|FG000|Overall Study|Randomised but not Treated|0|||
33244503|NCT05705167|100796974|FG001|Overall Study|Randomised but not Treated|2|||
33244504|NCT05705167|100796975|FG002|Overall Study|Randomised but not Treated|0|||
33244505|NCT05705167|100796976|FG003|Overall Study|Randomised but not Treated|7|||
33244506|NCT05705167|100796977|FG004|Overall Study|Randomised but not Treated|0|||
33244507|NCT05705167|100796978|FG005|Overall Study|Randomised but not Treated|0|||
33373034|NCT00862849|101252028|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
33244508|NCT05705167|100796979|FG006|Overall Study|Randomised but not Treated|0|||
33244509|NCT05705167|100796973|FG000|Overall Study|Death|0|||
33244510|NCT05705167|100796974|FG001|Overall Study|Death|0|||
33244511|NCT05705167|100796975|FG002|Overall Study|Death|3|||
33244512|NCT05705167|100796976|FG003|Overall Study|Death|0|||
33244513|NCT05705167|100796977|FG004|Overall Study|Death|1|||
33244514|NCT05705167|100796978|FG005|Overall Study|Death|1|||
33244515|NCT05705167|100796979|FG006|Overall Study|Death|1|||
33244516|NCT05705167|100796973|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
33244517|NCT05705167|100796974|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
33244518|NCT05705167|100796975|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
33244519|NCT05705167|100796976|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
33244520|NCT05705167|100796977|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
33244521|NCT05705167|100796978|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
33244522|NCT05705167|100796979|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
33244523|NCT00389519|100796981|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
33244524|NCT00389519|100796982|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
33244525|NCT00389519|100796983|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
33244526|NCT00389519|100796984|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
33244527|NCT00389519|100796981|FG000|Placebo Run-In|Withdrawal by Subject|19|||
33244528|NCT00389519|100796982|FG001|Placebo Run-In|Withdrawal by Subject|0|||
33244529|NCT00389519|100796983|FG002|Placebo Run-In|Withdrawal by Subject|0|||
33244530|NCT00389519|100796984|FG003|Placebo Run-In|Withdrawal by Subject|0|||
33244531|NCT00389519|100796981|FG000|Placebo Run-In|Reason not specified|40|||
33244532|NCT00389519|100796982|FG001|Placebo Run-In|Reason not specified|0|||
33244533|NCT00389519|100796983|FG002|Placebo Run-In|Reason not specified|0|||
33244534|NCT00389519|100796984|FG003|Placebo Run-In|Reason not specified|0|||
33244535|NCT00389519|100796981|FG000|Randomized|Did not receive study drug|2|||
33244536|NCT00389519|100796982|FG001|Randomized|Did not receive study drug|0|||
33244537|NCT00389519|100796983|FG002|Randomized|Did not receive study drug|0|||
33244538|NCT00389519|100796984|FG003|Randomized|Did not receive study drug|0|||
33244539|NCT00389519|100796981|FG000|Treated|Adverse Event|1|||
33244540|NCT00389519|100796982|FG001|Treated|Adverse Event|0|||
33244541|NCT00389519|100796983|FG002|Treated|Adverse Event|0|||
33244542|NCT00389519|100796984|FG003|Treated|Adverse Event|2|||
33244543|NCT00389519|100796981|FG000|Treated|Reason not specified|1|||
33244544|NCT00389519|100796982|FG001|Treated|Reason not specified|1|||
33244545|NCT00389519|100796983|FG002|Treated|Reason not specified|0|||
33244546|NCT00389519|100796984|FG003|Treated|Reason not specified|2|||
33244547|NCT00241644|100796985|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
33244548|NCT00241644|100796986|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
33244549|NCT00241644|100796987|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
33244550|NCT00241644|100796988|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
33244551|NCT00241644|100796985|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
33244552|NCT00241644|100796986|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
33244553|NCT00241644|100796987|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
33244554|NCT00241644|100796988|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
33244555|NCT00241644|100796985|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
33244556|NCT00241644|100796986|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
33244557|NCT00241644|100796987|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
33244558|NCT00241644|100796988|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
33244559|NCT00241644|100796985|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
33244560|NCT00241644|100796986|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
33244561|NCT00241644|100796987|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
33244562|NCT00241644|100796988|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
33244563|NCT00241644|100796985|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
33244564|NCT00241644|100796986|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
33244565|NCT00241644|100796987|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
33244566|NCT00241644|100796988|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
33244567|NCT00241644|100796985|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
33244568|NCT00241644|100796986|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
33422861|NCT01901146|101439759|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
33422862|NCT01901146|101439760|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
33422863|NCT01901146|101439761|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
33422864|NCT01901146|101439762|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
33244569|NCT00241644|100796987|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
33244570|NCT00241644|100796988|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
33244571|NCT00241644|100796985|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
33244572|NCT00241644|100796986|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
33244573|NCT00241644|100796987|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
33244574|NCT00241644|100796988|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
33244575|NCT00241644|100796985|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
33244576|NCT00241644|100796986|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
33244577|NCT00241644|100796987|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
33244578|NCT00241644|100796988|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
33244579|NCT00241644|100796985|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
33244580|NCT00241644|100796986|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
33244581|NCT00241644|100796987|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
33244582|NCT00241644|100796988|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
33244583|NCT00241644|100796985|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
33244584|NCT00241644|100796986|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
33244585|NCT00241644|100796987|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
33244586|NCT00241644|100796988|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
33244587|NCT00241644|100796985|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
33244588|NCT00241644|100796986|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
33244589|NCT00241644|100796987|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
33244590|NCT00241644|100796988|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
33244591|NCT00241644|100796985|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
33244592|NCT00241644|100796986|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
33244593|NCT00241644|100796987|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
33244594|NCT00241644|100796988|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
33244595|NCT00241644|100796985|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
33244596|NCT00241644|100796986|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
33244597|NCT00241644|100796987|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
33244598|NCT00241644|100796988|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
33244599|NCT05052983|100796991|FG000|Overall Study|Lack of Efficacy|3|||
33244600|NCT05052983|100796992|FG001|Overall Study|Lack of Efficacy|12|||
33244601|NCT05052983|100796991|FG000|Overall Study|Adverse Event|1|||
33244602|NCT05052983|100796992|FG001|Overall Study|Adverse Event|0|||
33244603|NCT03178201|100796998|FG000|Overall Study|Off study|5|||
33244604|NCT03829332|100797001|FG000|Overall Study|Death|145|||
33244605|NCT03829332|100797002|FG001|Overall Study|Death|135|||
33244606|NCT03829332|100797001|FG000|Overall Study|Withdrawal by Subject|10|||
33244607|NCT03829332|100797002|FG001|Overall Study|Withdrawal by Subject|4|||
33244608|NCT03829332|100797001|FG000|Overall Study|Ongoing in Study|154|||
33644445|NCT00485134|102252521|FG001|Overall Study|Non-compliance|0|||
33644446|NCT00485134|102252522|FG002|Overall Study|Non-compliance|0|||
33644447|NCT00485134|102252523|FG003|Overall Study|Non-compliance|0|||
33644448|NCT00485134|102252524|FG004|Overall Study|Non-compliance|1|||
33244609|NCT03829332|100797002|FG001|Overall Study|Ongoing in Study|175|||
33583304|NCT00402324|102025774|FG001|Overall Study|Lost to Follow-up|11|||
33583305|NCT00402324|102025773|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
33373035|NCT00862849|101252029|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
33583306|NCT00402324|102025774|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
33583307|NCT00402324|102025773|FG000|Overall Study|Protocol Violation|8|||
33583308|NCT00402324|102025774|FG001|Overall Study|Protocol Violation|7|||
33583309|NCT00402324|102025773|FG000|Overall Study|Withdrawal by Subject|5|||
33583310|NCT00402324|102025774|FG001|Overall Study|Withdrawal by Subject|2|||
33583311|NCT00402324|102025773|FG000|Overall Study|Physician Decision|2|||
33583312|NCT00402324|102025774|FG001|Overall Study|Physician Decision|4|||
33583313|NCT00402324|102025773|FG000|Overall Study|Sponsor Decision|4|||
33644449|NCT00485134|102252525|FG005|Overall Study|Non-compliance|2|||
33644450|NCT00485134|102252526|FG006|Overall Study|Non-compliance|2|||
33644451|NCT00485134|102252527|FG007|Overall Study|Non-compliance|0|||
33644452|NCT00485134|102252520|FG000|Overall Study|Unable to comply with study schedule|0|||
33644453|NCT00485134|102252521|FG001|Overall Study|Unable to comply with study schedule|0|||
33644454|NCT00485134|102252522|FG002|Overall Study|Unable to comply with study schedule|0|||
33244610|NCT01763047|100797005|FG000|Period 1|Test Article Not Available|4|||
33244611|NCT01763047|100797006|FG001|Period 1|Test Article Not Available|1|||
33244612|NCT01763047|100797005|FG000|Period 1|Protocol Violation|4|||
33244613|NCT01763047|100797006|FG001|Period 1|Protocol Violation|4|||
33244614|NCT01763047|100797005|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
33244615|NCT01763047|100797006|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
33244616|NCT01763047|100797005|FG000|Period 1|Adverse Event|0|||
33244617|NCT01763047|100797006|FG001|Period 1|Adverse Event|1|||
33244618|NCT01763047|100797005|FG000|Period 1|Unsatisfactory Visual Response|0|||
33373036|NCT00862849|101252030|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
33244619|NCT01763047|100797006|FG001|Period 1|Unsatisfactory Visual Response|3|||
33244620|NCT01763047|100797005|FG000|Period 1|Lens Power Not Available|0|||
33244621|NCT01763047|100797006|FG001|Period 1|Lens Power Not Available|1|||
33244622|NCT01763047|100797005|FG000|Period 1|Study Site office Closed|0|||
33244623|NCT01763047|100797006|FG001|Period 1|Study Site office Closed|1|||
33373037|NCT00862849|101252031|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
33583314|NCT00402324|102025774|FG001|Overall Study|Sponsor Decision|5|||
33644455|NCT00485134|102252523|FG003|Overall Study|Unable to comply with study schedule|0|||
33244624|NCT01763047|100797005|FG000|Period 2|Lens Discomfort|1|||
33244625|NCT01763047|100797006|FG001|Period 2|Lens Discomfort|0|||
33244626|NCT01763047|100797005|FG000|Period 2|No longer meets Eligibility Criteria|1|||
33244627|NCT01763047|100797006|FG001|Period 2|No longer meets Eligibility Criteria|0|||
33244628|NCT01763047|100797005|FG000|Period 2|Study Site office Closed|1|||
33244629|NCT01763047|100797006|FG001|Period 2|Study Site office Closed|1|||
33244630|NCT01763047|100797005|FG000|Period 2|Unsatisfactory Visual Response|1|||
33244631|NCT01763047|100797006|FG001|Period 2|Unsatisfactory Visual Response|1|||
33244632|NCT01763047|100797005|FG000|Period 2|Protocol Violation|0|||
33244633|NCT01763047|100797006|FG001|Period 2|Protocol Violation|2|||
33244634|NCT01763047|100797005|FG000|Period 2|Unsatisfactory lens Fitting|0|||
33244635|NCT01763047|100797006|FG001|Period 2|Unsatisfactory lens Fitting|1|||
33244636|NCT04436120|100797007|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
33244637|NCT04436120|100797008|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
33244638|NCT04436120|100797009|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
33244639|NCT04436120|100797010|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
33244640|NCT04436120|100797011|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
33244641|NCT04436120|100797012|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
33244642|NCT04436120|100797013|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
33244643|NCT05328973|100797014|FG000|Overall Study|Withdrawal by Subject|0|||
33244644|NCT05328973|100797015|FG001|Overall Study|Withdrawal by Subject|1|||
33244645|NCT02219490|100797016|FG000|Overall Study|Adverse Event|24|||
33244646|NCT02219490|100797016|FG000|Overall Study|Withdrew consent|96|||
33244647|NCT02219490|100797016|FG000|Overall Study|Lost to Follow-up|126|||
33244648|NCT02219490|100797016|FG000|Overall Study|COVID-19 infection|2|||
33244649|NCT02219490|100797016|FG000|Overall Study|COVID-19 logistical restrictions|33|||
33244650|NCT02219490|100797016|FG000|Overall Study|Other, not specified|57|||
33244651|NCT01313182|100797019|FG000|Overall Study|Protocol Violation|66|||
33244652|NCT01313182|100797020|FG001|Overall Study|Protocol Violation|92|||
33244653|NCT03404960|100797021|FG000|Overall Study|Adverse Event|0|||
33244654|NCT03404960|100797022|FG001|Overall Study|Adverse Event|2|||
33244655|NCT03404960|100797021|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
33244656|NCT03404960|100797022|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
33244657|NCT03404960|100797021|FG000|Overall Study|Bowel obstruction|0|||
33244658|NCT03404960|100797022|FG001|Overall Study|Bowel obstruction|1|||
33244659|NCT03404960|100797021|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
33244660|NCT03404960|100797022|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
33244661|NCT01460381|100797023|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
33244662|NCT01460381|100797024|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
33244663|NCT05826431|100797025|FG000|Overall Study|Withdrawal by Subject|1|||
33244664|NCT01120275|100797026|FG000|Overall Study|Adverse Event|3|||
33244665|NCT01120275|100797026|FG000|Overall Study|Progression|27|||
33244666|NCT01120275|100797026|FG000|Overall Study|Ineligible|3|||
33244667|NCT01120275|100797026|FG000|Overall Study|Withdrawal by Subject|1|||
33244668|NCT01120275|100797026|FG000|Overall Study|Refusal|1|||
33244669|NCT01120275|100797026|FG000|Overall Study|Not specific|1|||
33244670|NCT02365298|100797029|FG000|Period 2|incorrect Rx dispensed|1|||
33244671|NCT02365298|100797030|FG001|Period 2|incorrect Rx dispensed|0|||
33244672|NCT02365298|100797029|FG000|Period 2|Discontinued at request of Sponsor|1|||
33244673|NCT02365298|100797030|FG001|Period 2|Discontinued at request of Sponsor|0|||
33244674|NCT02365298|100797029|FG000|Period 2|Test Article longer available|0|||
33244675|NCT02365298|100797030|FG001|Period 2|Test Article longer available|1|||
33244676|NCT02365298|100797029|FG000|Period 2|Protocol Violation|0|||
33244677|NCT02365298|100797030|FG001|Period 2|Protocol Violation|1|||
33244678|NCT05030311|100797031|FG000|Overall Study|Technical problems|0|||
33244679|NCT05030311|100797032|FG001|Overall Study|Technical problems|1|||
33244680|NCT05030311|100797031|FG000|Overall Study|Withdrawal by Subject|31|||
33244681|NCT05030311|100797032|FG001|Overall Study|Withdrawal by Subject|17|||
33244682|NCT05030311|100797031|FG000|Overall Study|Adverse Event|13|||
33244683|NCT05030311|100797032|FG001|Overall Study|Adverse Event|5|||
33422865|NCT01901146|101439763|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
33244684|NCT05030311|100797031|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33244685|NCT05030311|100797032|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33244686|NCT05030311|100797031|FG000|Overall Study|Physician Decision|5|||
33244687|NCT05030311|100797032|FG001|Overall Study|Physician Decision|2|||
33244688|NCT05030311|100797031|FG000|Overall Study|Lost to Follow-up|5|||
33244689|NCT05030311|100797032|FG001|Overall Study|Lost to Follow-up|1|||
33244690|NCT05030311|100797031|FG000|Overall Study|Protocol Violation|4|||
33244691|NCT05030311|100797032|FG001|Overall Study|Protocol Violation|4|||
33244692|NCT01720043|100797035|FG000|Overall Study|Withdrawal by Subject|1|||
33244693|NCT02014558|100797039|FG000|Overall Study|Never Received Study Drug|0|||
33244694|NCT02014558|100797040|FG001|Overall Study|Never Received Study Drug|0|||
33244695|NCT02014558|100797041|FG002|Overall Study|Never Received Study Drug|0|||
33244696|NCT02014558|100797042|FG003|Overall Study|Never Received Study Drug|0|||
33244697|NCT02014558|100797043|FG004|Overall Study|Never Received Study Drug|1|||
33244698|NCT02014558|100797044|FG005|Overall Study|Never Received Study Drug|0|||
33244699|NCT02014558|100797045|FG006|Overall Study|Never Received Study Drug|1|||
33244700|NCT02014558|100797046|FG007|Overall Study|Never Received Study Drug|0|||
33244701|NCT02014558|100797047|FG008|Overall Study|Never Received Study Drug|2|||
33244702|NCT02014558|100797048|FG009|Overall Study|Never Received Study Drug|0|||
33244703|NCT02014558|100797049|FG010|Overall Study|Never Received Study Drug|2|||
33583315|NCT00402324|102025773|FG000|Overall Study|Lack of Efficacy|1|||
33583316|NCT00402324|102025774|FG001|Overall Study|Lack of Efficacy|4|||
33244704|NCT02014558|100797050|FG011|Overall Study|Never Received Study Drug|2|||
33244705|NCT02014558|100797051|FG012|Overall Study|Never Received Study Drug|0|||
33244706|NCT02014558|100797039|FG000|Overall Study|Adverse Event|0|||
33244707|NCT02014558|100797040|FG001|Overall Study|Adverse Event|0|||
33244708|NCT02014558|100797041|FG002|Overall Study|Adverse Event|0|||
33244709|NCT02014558|100797042|FG003|Overall Study|Adverse Event|0|||
33244710|NCT02014558|100797043|FG004|Overall Study|Adverse Event|1|||
33244711|NCT02014558|100797044|FG005|Overall Study|Adverse Event|0|||
33244712|NCT02014558|100797045|FG006|Overall Study|Adverse Event|0|||
33644456|NCT00485134|102252524|FG004|Overall Study|Unable to comply with study schedule|0|||
33644457|NCT00485134|102252525|FG005|Overall Study|Unable to comply with study schedule|0|||
33644458|NCT00485134|102252526|FG006|Overall Study|Unable to comply with study schedule|0|||
33644459|NCT00485134|102252527|FG007|Overall Study|Unable to comply with study schedule|1|||
33644460|NCT00485134|102252520|FG000|Overall Study|Pregnancy|0|||
33644461|NCT00485134|102252521|FG001|Overall Study|Pregnancy|0|||
33644462|NCT00485134|102252522|FG002|Overall Study|Pregnancy|0|||
33644463|NCT00485134|102252523|FG003|Overall Study|Pregnancy|0|||
33644464|NCT00485134|102252524|FG004|Overall Study|Pregnancy|0|||
33146309|NCT03739840|100448447|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
33146310|NCT03739840|100448448|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
33146311|NCT03739840|100448449|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
33244713|NCT02014558|100797046|FG007|Overall Study|Adverse Event|0|||
33373038|NCT00862849|101252032|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
33373039|NCT00862849|101252033|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
33373040|NCT00862849|101252028|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
33583317|NCT00402324|102025773|FG000|Overall Study|Adverse Event|6|||
33583318|NCT00402324|102025774|FG001|Overall Study|Adverse Event|4|||
33583319|NCT00402324|102025773|FG000|Overall Study|Death|1|||
33583320|NCT00402324|102025774|FG001|Overall Study|Death|0|||
33583321|NCT03559517|102025778|FG000|Overall Study|Withdrawal by Subject|1|||
33583322|NCT03559517|102025779|FG001|Overall Study|Withdrawal by Subject|0|||
33583323|NCT03559517|102025780|FG002|Overall Study|Withdrawal by Subject|0|||
33583324|NCT01901614|102025789|FG000|Overall Study|Adverse Event|0|||
33583325|NCT01901614|102025790|FG001|Overall Study|Adverse Event|1|||
33583326|NCT01901614|102025789|FG000|Overall Study|Lost to Follow-up|1|||
33583327|NCT01901614|102025790|FG001|Overall Study|Lost to Follow-up|0|||
33583328|NCT01901614|102025789|FG000|Overall Study|Screen Fail|1|||
33583329|NCT01901614|102025790|FG001|Overall Study|Screen Fail|0|||
33583330|NCT02522429|102025791|FG000|Overall Study|Lost to Follow-up|8|||
33583331|NCT02522429|102025791|FG000|Overall Study|Adverse Event|2|||
33583332|NCT02522429|102025791|FG000|Overall Study|Death|1|||
33583333|NCT02522429|102025791|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
33583334|NCT00787839|102025792|FG000|Overall Study|Failure to have the OGTT was most common|404|||
33583335|NCT00135330|102025807|FG000|Overall Study|Adverse Event|2|||
33583336|NCT00135330|102025808|FG001|Overall Study|Adverse Event|5|||
33644465|NCT00485134|102252525|FG005|Overall Study|Pregnancy|0|||
33146312|NCT03739840|100448450|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
33146313|NCT04251156|100448451|FG000|Overall Study|Lost to Follow-up|1|||
33146314|NCT04251156|100448452|FG001|Overall Study|Lost to Follow-up|1|||
33146315|NCT04251156|100448451|FG000|Overall Study|Withdrawal by Subject|4|||
33146316|NCT04251156|100448452|FG001|Overall Study|Withdrawal by Subject|4|||
33146317|NCT03481660|100448453|FG000|Overall Study|Adverse Event|5|||
33146318|NCT03481660|100448454|FG001|Overall Study|Adverse Event|4|||
33146319|NCT03481660|100448453|FG000|Overall Study|Death|13|||
33146320|NCT03481660|100448454|FG001|Overall Study|Death|9|||
33146321|NCT03481660|100448453|FG000|Overall Study|Lost to Follow-up|2|||
33146322|NCT03481660|100448454|FG001|Overall Study|Lost to Follow-up|2|||
33146323|NCT03481660|100448453|FG000|Overall Study|Physician Decision|2|||
33146324|NCT03481660|100448454|FG001|Overall Study|Physician Decision|3|||
33146325|NCT03481660|100448453|FG000|Overall Study|Withdrawal by Subject|14|||
33146326|NCT03481660|100448454|FG001|Overall Study|Withdrawal by Subject|7|||
33146327|NCT01367119|100448455|FG000|Overall Study|Adverse Event|1|||
33146328|NCT01367119|100448456|FG001|Overall Study|Adverse Event|0|||
33146329|NCT01367119|100448455|FG000|Overall Study|Withdrawal by Subject|1|||
33146330|NCT01367119|100448456|FG001|Overall Study|Withdrawal by Subject|1|||
33146331|NCT03718299|100448457|FG000|Overall Study|Adverse Event|1|||
33146332|NCT03718299|100448457|FG000|Overall Study|Withdrawal by Subject|6|||
33146333|NCT03718299|100448457|FG000|Overall Study|Physician Decision|2|||
33244714|NCT02014558|100797047|FG008|Overall Study|Adverse Event|2|||
33244715|NCT02014558|100797048|FG009|Overall Study|Adverse Event|2|||
33244716|NCT02014558|100797049|FG010|Overall Study|Adverse Event|5|||
33244717|NCT02014558|100797050|FG011|Overall Study|Adverse Event|21|||
33244718|NCT02014558|100797051|FG012|Overall Study|Adverse Event|3|||
33244719|NCT02014558|100797039|FG000|Overall Study|Death|1|||
33244720|NCT02014558|100797040|FG001|Overall Study|Death|0|||
33644466|NCT00485134|102252526|FG006|Overall Study|Pregnancy|1|||
33644467|NCT00485134|102252527|FG007|Overall Study|Pregnancy|0|||
33644468|NCT00634101|102252530|FG000|Overall Study|Study Terminated|3|||
33146334|NCT03718299|100448457|FG000|Overall Study|Lost to Follow-up|1|||
33244721|NCT02014558|100797041|FG002|Overall Study|Death|0|||
33244722|NCT02014558|100797042|FG003|Overall Study|Death|0|||
33244723|NCT02014558|100797043|FG004|Overall Study|Death|0|||
33244724|NCT02014558|100797044|FG005|Overall Study|Death|0|||
33244725|NCT02014558|100797045|FG006|Overall Study|Death|1|||
33244726|NCT02014558|100797046|FG007|Overall Study|Death|1|||
33244727|NCT02014558|100797047|FG008|Overall Study|Death|2|||
33244728|NCT02014558|100797048|FG009|Overall Study|Death|5|||
33244729|NCT02014558|100797049|FG010|Overall Study|Death|5|||
33244730|NCT02014558|100797050|FG011|Overall Study|Death|19|||
33244731|NCT02014558|100797051|FG012|Overall Study|Death|2|||
33244732|NCT02014558|100797039|FG000|Overall Study|Lack of Efficacy|1|||
33244733|NCT02014558|100797040|FG001|Overall Study|Lack of Efficacy|2|||
33244734|NCT02014558|100797041|FG002|Overall Study|Lack of Efficacy|1|||
33244735|NCT02014558|100797042|FG003|Overall Study|Lack of Efficacy|1|||
33244736|NCT02014558|100797043|FG004|Overall Study|Lack of Efficacy|0|||
33244737|NCT02014558|100797044|FG005|Overall Study|Lack of Efficacy|0|||
33244738|NCT02014558|100797045|FG006|Overall Study|Lack of Efficacy|1|||
33244739|NCT02014558|100797046|FG007|Overall Study|Lack of Efficacy|3|||
33422866|NCT01901146|101439759|FG000|Adjuvant Phase|Physician Decision|0|||
33583337|NCT00135330|102025809|FG002|Overall Study|Adverse Event|1|||
33583338|NCT00135330|102025807|FG000|Overall Study|Lost to Follow-up|0|||
33583339|NCT00135330|102025808|FG001|Overall Study|Lost to Follow-up|2|||
33583340|NCT00135330|102025809|FG002|Overall Study|Lost to Follow-up|3|||
33583341|NCT00135330|102025807|FG000|Overall Study|Physician Decision|1|||
33583342|NCT00135330|102025808|FG001|Overall Study|Physician Decision|1|||
33583343|NCT00135330|102025809|FG002|Overall Study|Physician Decision|0|||
33583344|NCT00135330|102025807|FG000|Overall Study|Protocol Violation|4|||
33583345|NCT00135330|102025808|FG001|Overall Study|Protocol Violation|3|||
33583346|NCT00135330|102025809|FG002|Overall Study|Protocol Violation|3|||
33583347|NCT00135330|102025807|FG000|Overall Study|Patient Decision|5|||
33583348|NCT00135330|102025808|FG001|Overall Study|Patient Decision|1|||
33583349|NCT00135330|102025809|FG002|Overall Study|Patient Decision|4|||
33583350|NCT00135330|102025807|FG000|Overall Study|Sponsor Decision|0|||
33583351|NCT00135330|102025808|FG001|Overall Study|Sponsor Decision|1|||
33583352|NCT00135330|102025809|FG002|Overall Study|Sponsor Decision|0|||
33583353|NCT05559905|102025810|FG000|Overall Study|Withdrawal by Subject|1|||
33583354|NCT05559905|102025811|FG001|Overall Study|Withdrawal by Subject|0|||
33583355|NCT05559905|102025812|FG002|Overall Study|Withdrawal by Subject|0|||
33583356|NCT05559905|102025810|FG000|Overall Study|Not Reported|1|||
33583357|NCT05559905|102025811|FG001|Overall Study|Not Reported|0|||
33644469|NCT00634101|102252531|FG001|Overall Study|Study Terminated|3|||
33146335|NCT00772070|100448458|FG000|Overall Study|Lost to Follow-up|0|||
33146336|NCT00772070|100448459|FG001|Overall Study|Lost to Follow-up|8|||
33146337|NCT00772070|100448458|FG000|Overall Study|Withdrawal by Subject|0|||
33146338|NCT00772070|100448459|FG001|Overall Study|Withdrawal by Subject|2|||
33146339|NCT00772070|100448458|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
33146340|NCT00772070|100448459|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
33146341|NCT02469038|100448460|FG000|Overall Study|Physician Decision|4|||
33146342|NCT02469038|100448461|FG001|Overall Study|Physician Decision|5|||
33146343|NCT00336583|100448464|FG000|Overall Study|Lost to Follow-up|1|||
33146344|NCT00336583|100448464|FG000|Overall Study|Death|1|||
33146345|NCT03116347|100448465|FG000|Overall Study|Withdrawal by Subject|1|||
33146346|NCT03116347|100448466|FG001|Overall Study|Withdrawal by Subject|2|||
33146347|NCT03059446|100448467|FG000|Overall Study|Adverse Event|11|||
33146348|NCT03059446|100448467|FG000|Overall Study|Withdrawal of Consent|16|||
33146349|NCT03059446|100448467|FG000|Overall Study|Lost to Follow-up|3|||
33146350|NCT03059446|100448467|FG000|Overall Study|Protocol Violation|1|||
33146351|NCT03059446|100448467|FG000|Overall Study|Study Terminated by Sponsor|131|||
33146352|NCT03059446|100448467|FG000|Overall Study|Reason not Specified|5|||
33146353|NCT03131453|100451553|FG000|Overall Study|Study terminated by Sponsor|424|||
33146354|NCT03131453|100451554|FG001|Overall Study|Study terminated by Sponsor|222|||
33146355|NCT03131453|100451555|FG002|Overall Study|Study terminated by Sponsor|438|||
33146356|NCT03131453|100451553|FG000|Overall Study|Withdrawal by Subject|18|||
33146357|NCT03131453|100451554|FG001|Overall Study|Withdrawal by Subject|7|||
33146358|NCT03131453|100451555|FG002|Overall Study|Withdrawal by Subject|13|||
33146359|NCT03131453|100451553|FG000|Overall Study|Adverse Event|10|||
33146360|NCT03131453|100451554|FG001|Overall Study|Adverse Event|3|||
33146361|NCT03131453|100451555|FG002|Overall Study|Adverse Event|3|||
33373041|NCT00862849|101252029|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
33373042|NCT00862849|101252030|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
33373043|NCT00862849|101252031|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
33373044|NCT00862849|101252032|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
33373045|NCT00862849|101252033|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
33373046|NCT00788775|101252034|FG000|Overall Study|Progressive Disease|8|||
33373047|NCT00788775|101252035|FG001|Overall Study|Progressive Disease|6|||
33373048|NCT00788775|101252034|FG000|Overall Study|Withdrawal by Subject|0|||
33373049|NCT00788775|101252035|FG001|Overall Study|Withdrawal by Subject|2|||
33373050|NCT00788775|101252034|FG000|Overall Study|Patient Non-Compliance|1|||
33373051|NCT00788775|101252035|FG001|Overall Study|Patient Non-Compliance|0|||
33373052|NCT00788775|101252034|FG000|Overall Study|Patient's measurable disease resected.|1|||
33373053|NCT00788775|101252035|FG001|Overall Study|Patient's measurable disease resected.|0|||
33373054|NCT00882999|101252038|FG000|Overall Study|Adverse Event|0|||
33373055|NCT00882999|101252039|FG001|Overall Study|Adverse Event|0|||
33583358|NCT05559905|102025812|FG002|Overall Study|Not Reported|0|||
33583359|NCT03226249|102025813|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
33583360|NCT03226249|102025813|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
33583361|NCT03226249|102025813|FG000|Survival Follow-up|Patients still in follow-up.|30|||
33583362|NCT03098433|102025814|FG000|Overall Study|Withdrawal by Subject|10|||
33583363|NCT01390298|102025817|FG000|Overall Study|Death|1|||
33583364|NCT01390298|102025817|FG000|Overall Study|long term ICU admission|1|||
33583365|NCT01390298|102025817|FG000|Overall Study|Withdrawal by Subject|14|||
33583366|NCT01390298|102025817|FG000|Overall Study|Lost to Follow-up|7|||
33583367|NCT01390298|102025817|FG000|Overall Study|Surgery cancelled|1|||
33583368|NCT03748706|102025818|FG000|Overall Study|Lost to Follow-up|1|||
33583369|NCT01220401|102025825|FG000|Overall Study|Withdrawal by Subject|2|||
33583370|NCT01220401|102025825|FG000|Overall Study|Protocol Violation|1|||
33583371|NCT02370368|102025826|FG000|Overall Study|Adverse Event|1|||
33644470|NCT00634101|102252530|FG000|Overall Study|Lost to Follow-up|2|||
33644471|NCT00634101|102252531|FG001|Overall Study|Lost to Follow-up|0|||
33373056|NCT00882999|101252040|FG002|Overall Study|Adverse Event|0|||
33373057|NCT00882999|101252041|FG003|Overall Study|Adverse Event|0|||
33373058|NCT00882999|101252042|FG004|Overall Study|Adverse Event|1|||
33373059|NCT00882999|101252043|FG005|Overall Study|Adverse Event|0|||
33373060|NCT00882999|101252044|FG006|Overall Study|Adverse Event|0|||
33373061|NCT00882999|101252038|FG000|Overall Study|Death|0|||
33373062|NCT00882999|101252039|FG001|Overall Study|Death|1|||
33373063|NCT00882999|101252040|FG002|Overall Study|Death|0|||
33373064|NCT00882999|101252041|FG003|Overall Study|Death|0|||
33373065|NCT00882999|101252042|FG004|Overall Study|Death|0|||
33373066|NCT00882999|101252043|FG005|Overall Study|Death|0|||
33373067|NCT00882999|101252044|FG006|Overall Study|Death|0|||
33373068|NCT00882999|101252038|FG000|Overall Study|Withdrawal by Subject|7|||
33373069|NCT00882999|101252039|FG001|Overall Study|Withdrawal by Subject|6|||
33373070|NCT00882999|101252040|FG002|Overall Study|Withdrawal by Subject|3|||
33373071|NCT00882999|101252041|FG003|Overall Study|Withdrawal by Subject|3|||
33373072|NCT00882999|101252042|FG004|Overall Study|Withdrawal by Subject|6|||
33373073|NCT00882999|101252043|FG005|Overall Study|Withdrawal by Subject|5|||
33373074|NCT00882999|101252044|FG006|Overall Study|Withdrawal by Subject|5|||
33373075|NCT00882999|101252038|FG000|Overall Study|Lost to Follow-up|0|||
33583372|NCT02370368|102025827|FG001|Overall Study|Adverse Event|2|||
33644472|NCT00775593|102252533|FG000|Overall Study|Unmet eligibility criteria|6|||
33644473|NCT00775593|102252533|FG000|Overall Study|Death|1|||
33644474|NCT00771953|102252542|FG000|Overall Study|Adverse Event|5|||
33644475|NCT00771953|102252543|FG001|Overall Study|Adverse Event|3|||
33644476|NCT00771953|102252542|FG000|Overall Study|Death|2|||
33644477|NCT00771953|102252543|FG001|Overall Study|Death|2|||
33644478|NCT00771953|102252542|FG000|Overall Study|Progression before active Tx|1|||
33644479|NCT00771953|102252543|FG001|Overall Study|Progression before active Tx|2|||
33644480|NCT00771953|102252542|FG000|Overall Study|Sponsor decision|1|||
33644481|NCT00771953|102252543|FG001|Overall Study|Sponsor decision|0|||
33644482|NCT00771953|102252542|FG000|Overall Study|Other complicating disease|1|||
33644483|NCT00771953|102252543|FG001|Overall Study|Other complicating disease|0|||
33644484|NCT00771953|102252542|FG000|Overall Study|Withdrawal by Subject|0|||
33644485|NCT00771953|102252543|FG001|Overall Study|Withdrawal by Subject|3|||
33373076|NCT00882999|101252039|FG001|Overall Study|Lost to Follow-up|1|||
33373077|NCT00882999|101252040|FG002|Overall Study|Lost to Follow-up|1|||
33373078|NCT00882999|101252041|FG003|Overall Study|Lost to Follow-up|2|||
33373079|NCT00882999|101252042|FG004|Overall Study|Lost to Follow-up|1|||
33373080|NCT00882999|101252043|FG005|Overall Study|Lost to Follow-up|1|||
33373081|NCT00882999|101252044|FG006|Overall Study|Lost to Follow-up|2|||
33373082|NCT00882999|101252038|FG000|Overall Study|Physician Decision|1|||
33373083|NCT00882999|101252039|FG001|Overall Study|Physician Decision|0|||
33373084|NCT00882999|101252040|FG002|Overall Study|Physician Decision|0|||
33373085|NCT00882999|101252041|FG003|Overall Study|Physician Decision|0|||
33373086|NCT00882999|101252042|FG004|Overall Study|Physician Decision|0|||
33373087|NCT00882999|101252043|FG005|Overall Study|Physician Decision|1|||
33373088|NCT00882999|101252044|FG006|Overall Study|Physician Decision|1|||
33373089|NCT03799718|101252045|FG000|Overall Study|Adverse Event|2|||
33373090|NCT01163253|101252046|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
33373091|NCT01163253|101252047|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
33373092|NCT01163253|101252046|FG000|Overall Study|Study Terminated by Sponsor|978|||
33373093|NCT01163253|101252047|FG001|Overall Study|Study Terminated by Sponsor|349|||
33373094|NCT01163253|101252046|FG000|Overall Study|Protocol Violation|43|||
33373095|NCT01163253|101252047|FG001|Overall Study|Protocol Violation|12|||
33373096|NCT01163253|101252046|FG000|Overall Study|Withdrawal by Subject|199|||
33373097|NCT01163253|101252047|FG001|Overall Study|Withdrawal by Subject|50|||
33373098|NCT01163253|101252046|FG000|Overall Study|Medication Error|1|||
33373099|NCT01163253|101252047|FG001|Overall Study|Medication Error|0|||
33373100|NCT01163253|101252046|FG000|Overall Study|Lost to Follow-up|125|||
33373101|NCT01163253|101252047|FG001|Overall Study|Lost to Follow-up|23|||
33373102|NCT01163253|101252046|FG000|Overall Study|Insufficient Clinical Response|423|||
33373103|NCT01163253|101252047|FG001|Overall Study|Insufficient Clinical Response|29|||
33373104|NCT01163253|101252046|FG000|Overall Study|Adverse Event|300|||
33422867|NCT01901146|101439760|FG001|Adjuvant Phase|Physician Decision|0|||
33644486|NCT02744040|102252544|FG000|Overall Study|Withdrawal by Subject|3|||
33422868|NCT01901146|101439761|FG002|Adjuvant Phase|Physician Decision|9|||
33422869|NCT01901146|101439762|FG003|Adjuvant Phase|Physician Decision|2|||
33422870|NCT01901146|101439763|FG004|Adjuvant Phase|Physician Decision|4|||
33422871|NCT01901146|101439759|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
33422872|NCT01901146|101439760|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
33422873|NCT01901146|101439761|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
33422874|NCT01901146|101439762|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
33644487|NCT02744040|102252545|FG001|Overall Study|Withdrawal by Subject|2|||
33644488|NCT02744040|102252546|FG002|Overall Study|Withdrawal by Subject|2|||
33644489|NCT02744040|102252544|FG000|Overall Study|Physician Decision|0|||
33644490|NCT02744040|102252545|FG001|Overall Study|Physician Decision|8|||
33644491|NCT02744040|102252546|FG002|Overall Study|Physician Decision|13|||
33644492|NCT02744040|102252544|FG000|Overall Study|Lost to Follow-up|3|||
33644493|NCT02744040|102252545|FG001|Overall Study|Lost to Follow-up|1|||
33644494|NCT02744040|102252546|FG002|Overall Study|Lost to Follow-up|7|||
33644495|NCT01864603|102252551|FG000|Stage 2|DSMB design modification|86056|||
33644496|NCT01864603|102252552|FG001|Stage 2|DSMB design modification|92558|||
33422875|NCT01901146|101439763|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
33422876|NCT00568776|101439764|FG000|Overall Study|Adverse Event|8|||
33422877|NCT00568776|101439765|FG001|Overall Study|Adverse Event|8|||
33422878|NCT00568776|101439766|FG002|Overall Study|Adverse Event|10|||
33422879|NCT00568776|101439767|FG003|Overall Study|Adverse Event|8|||
33422880|NCT00568776|101439764|FG000|Overall Study|Death|0|||
33422881|NCT00568776|101439765|FG001|Overall Study|Death|1|||
33422882|NCT00568776|101439766|FG002|Overall Study|Death|4|||
33422883|NCT00568776|101439767|FG003|Overall Study|Death|3|||
33422884|NCT00568776|101439764|FG000|Overall Study|Physician Decision|0|||
33422885|NCT00568776|101439765|FG001|Overall Study|Physician Decision|2|||
33422886|NCT00568776|101439766|FG002|Overall Study|Physician Decision|0|||
33422887|NCT00568776|101439767|FG003|Overall Study|Physician Decision|0|||
33422888|NCT00568776|101439764|FG000|Overall Study|Lack of Efficacy|2|||
33422889|NCT00568776|101439765|FG001|Overall Study|Lack of Efficacy|2|||
33422890|NCT00568776|101439766|FG002|Overall Study|Lack of Efficacy|2|||
33422891|NCT00568776|101439767|FG003|Overall Study|Lack of Efficacy|4|||
33644497|NCT02791763|102252553|FG000|Overall Study|Protocol Violation|0|||
33644498|NCT02791763|102252554|FG001|Overall Study|Protocol Violation|0|||
33644499|NCT02791763|102252555|FG002|Overall Study|Protocol Violation|1|||
33644500|NCT02791763|102252553|FG000|Overall Study|Withdrawal by Subject|5|||
33644501|NCT02791763|102252554|FG001|Overall Study|Withdrawal by Subject|1|||
33644502|NCT02791763|102252555|FG002|Overall Study|Withdrawal by Subject|0|||
33644503|NCT02791763|102252553|FG000|Overall Study|Physician Decision|0|||
33644504|NCT02791763|102252554|FG001|Overall Study|Physician Decision|1|||
33644505|NCT02791763|102252555|FG002|Overall Study|Physician Decision|0|||
33644506|NCT02791763|102252553|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
33373105|NCT01163253|101252047|FG001|Overall Study|Adverse Event|78|||
33373106|NCT01163253|101252046|FG000|Overall Study|Death|17|||
33373107|NCT01163253|101252047|FG001|Overall Study|Death|5|||
33422892|NCT00568776|101439764|FG000|Overall Study|Lost to Follow-up|1|||
33422893|NCT00568776|101439765|FG001|Overall Study|Lost to Follow-up|1|||
33373108|NCT01163253|101252046|FG000|Overall Study|Ongoing|13|||
33422894|NCT00568776|101439766|FG002|Overall Study|Lost to Follow-up|1|||
33644507|NCT02791763|102252554|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
33644508|NCT02791763|102252555|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
33373109|NCT01163253|101252047|FG001|Overall Study|Ongoing|4|||
33422895|NCT00568776|101439767|FG003|Overall Study|Lost to Follow-up|1|||
33422896|NCT00568776|101439764|FG000|Overall Study|Protocol Violation|1|||
33422897|NCT00568776|101439765|FG001|Overall Study|Protocol Violation|0|||
33373110|NCT01163253|101252046|FG000|Overall Study|Other Unspecified|170|||
33373111|NCT01163253|101252047|FG001|Overall Study|Other Unspecified|34|||
33422898|NCT00568776|101439766|FG002|Overall Study|Protocol Violation|1|||
33422899|NCT00568776|101439767|FG003|Overall Study|Protocol Violation|1|||
33422900|NCT00568776|101439764|FG000|Overall Study|Withdrawal by Subject|13|||
33422901|NCT00568776|101439765|FG001|Overall Study|Withdrawal by Subject|15|||
33422902|NCT00568776|101439766|FG002|Overall Study|Withdrawal by Subject|13|||
33422903|NCT00568776|101439767|FG003|Overall Study|Withdrawal by Subject|7|||
33422904|NCT00568776|101439764|FG000|Overall Study|Loss of Caregiver|0|||
33422905|NCT00568776|101439765|FG001|Overall Study|Loss of Caregiver|2|||
33422906|NCT00568776|101439766|FG002|Overall Study|Loss of Caregiver|1|||
33422907|NCT00568776|101439767|FG003|Overall Study|Loss of Caregiver|2|||
33422908|NCT00568776|101439764|FG000|Overall Study|Sponsor Decision|2|||
33422909|NCT00568776|101439765|FG001|Overall Study|Sponsor Decision|2|||
33422910|NCT00568776|101439766|FG002|Overall Study|Sponsor Decision|41|||
33422911|NCT00568776|101439767|FG003|Overall Study|Sponsor Decision|42|||
33422912|NCT00568776|101439764|FG000|Overall Study|Miscellaeneous|3|||
33422913|NCT00568776|101439765|FG001|Overall Study|Miscellaeneous|3|||
33422914|NCT00568776|101439766|FG002|Overall Study|Miscellaeneous|1|||
33422915|NCT00568776|101439767|FG003|Overall Study|Miscellaeneous|4|||
33422916|NCT01142466|101439770|FG000|Overall Study|Adverse Event|2|||
33422917|NCT01142466|101439771|FG001|Overall Study|Adverse Event|1|||
33422918|NCT01142466|101439770|FG000|Overall Study|Withdrawal by Subject|1|||
33422919|NCT01142466|101439771|FG001|Overall Study|Withdrawal by Subject|1|||
33422920|NCT01625286|101439775|FG000|Overall Study|Adverse Event|0|||
33422921|NCT01625286|101439776|FG001|Overall Study|Adverse Event|0|||
33422922|NCT01625286|101439777|FG002|Overall Study|Adverse Event|0|||
33422923|NCT01625286|101439778|FG003|Overall Study|Adverse Event|0|||
33422924|NCT01625286|101439779|FG004|Overall Study|Adverse Event|1|||
33422925|NCT01625286|101439780|FG005|Overall Study|Adverse Event|2|||
33422926|NCT01625286|101439781|FG006|Overall Study|Adverse Event|1|||
33422927|NCT01625286|101439775|FG000|Overall Study|Death|0|||
33422928|NCT01625286|101439776|FG001|Overall Study|Death|0|||
33422929|NCT01625286|101439777|FG002|Overall Study|Death|1|||
33422930|NCT01625286|101439778|FG003|Overall Study|Death|1|||
33422931|NCT01625286|101439779|FG004|Overall Study|Death|0|||
33422932|NCT01625286|101439780|FG005|Overall Study|Death|11|||
33422933|NCT01625286|101439781|FG006|Overall Study|Death|16|||
33422934|NCT01625286|101439775|FG000|Overall Study|Withdrawal by Subject|0|||
33422935|NCT01625286|101439776|FG001|Overall Study|Withdrawal by Subject|1|||
33422936|NCT01625286|101439777|FG002|Overall Study|Withdrawal by Subject|0|||
33422937|NCT01625286|101439778|FG003|Overall Study|Withdrawal by Subject|1|||
33422938|NCT01625286|101439779|FG004|Overall Study|Withdrawal by Subject|0|||
33422939|NCT01625286|101439780|FG005|Overall Study|Withdrawal by Subject|0|||
33422940|NCT01625286|101439781|FG006|Overall Study|Withdrawal by Subject|1|||
33422941|NCT01625286|101439775|FG000|Overall Study|Any reason not specifically recorded|0|||
33422942|NCT01625286|101439776|FG001|Overall Study|Any reason not specifically recorded|0|||
33422943|NCT01625286|101439777|FG002|Overall Study|Any reason not specifically recorded|0|||
33422944|NCT01625286|101439778|FG003|Overall Study|Any reason not specifically recorded|0|||
33422945|NCT01625286|101439779|FG004|Overall Study|Any reason not specifically recorded|0|||
33422946|NCT01625286|101439780|FG005|Overall Study|Any reason not specifically recorded|1|||
33146362|NCT03131453|100451553|FG000|Overall Study|Lost to Follow-up|1|||
33146363|NCT03131453|100451554|FG001|Overall Study|Lost to Follow-up|0|||
33146364|NCT03131453|100451555|FG002|Overall Study|Lost to Follow-up|1|||
33146365|NCT03131453|100451553|FG000|Overall Study|Physician Decision|1|||
33146366|NCT03131453|100451554|FG001|Overall Study|Physician Decision|0|||
33146367|NCT03131453|100451555|FG002|Overall Study|Physician Decision|1|||
33146368|NCT03131453|100451553|FG000|Overall Study|Non-compliance with study treatment|1|||
33146369|NCT03131453|100451554|FG001|Overall Study|Non-compliance with study treatment|0|||
33146370|NCT03131453|100451555|FG002|Overall Study|Non-compliance with study treatment|0|||
33146371|NCT03131453|100451553|FG000|Overall Study|Technical problems|1|||
33146372|NCT03131453|100451554|FG001|Overall Study|Technical problems|0|||
33244740|NCT02014558|100797047|FG008|Overall Study|Lack of Efficacy|3|||
33422947|NCT01625286|101439781|FG006|Overall Study|Any reason not specifically recorded|0|||
33422948|NCT01625286|101439775|FG000|Overall Study|Progressive disease|6|||
33422949|NCT01625286|101439776|FG001|Overall Study|Progressive disease|3|||
33422950|NCT01625286|101439777|FG002|Overall Study|Progressive disease|4|||
33422951|NCT01625286|101439778|FG003|Overall Study|Progressive disease|5|||
33422952|NCT01625286|101439779|FG004|Overall Study|Progressive disease|5|||
33422953|NCT01625286|101439780|FG005|Overall Study|Progressive disease|0|||
33422954|NCT01625286|101439781|FG006|Overall Study|Progressive disease|0|||
33422955|NCT01625286|101439775|FG000|Overall Study|Lost to Follow-up|0|||
33422956|NCT01625286|101439776|FG001|Overall Study|Lost to Follow-up|0|||
33422957|NCT01625286|101439777|FG002|Overall Study|Lost to Follow-up|0|||
33422958|NCT01625286|101439778|FG003|Overall Study|Lost to Follow-up|0|||
33422959|NCT01625286|101439779|FG004|Overall Study|Lost to Follow-up|0|||
33146373|NCT03131453|100451555|FG002|Overall Study|Technical problems|0|||
33146374|NCT03131453|100451553|FG000|Overall Study|Protocol deviation|0|||
33244741|NCT02014558|100797048|FG009|Overall Study|Lack of Efficacy|3|||
33422960|NCT01625286|101439780|FG005|Overall Study|Lost to Follow-up|0|||
33422961|NCT01625286|101439781|FG006|Overall Study|Lost to Follow-up|1|||
33644509|NCT02791763|102252553|FG000|Overall Study|Cancer event|1|||
33146375|NCT03131453|100451554|FG001|Overall Study|Protocol deviation|1|||
33146376|NCT03131453|100451555|FG002|Overall Study|Protocol deviation|0|||
33146377|NCT03435640|100451559|FG000|Overall Study|Withdrawal by Subject|0|||
33644510|NCT02791763|102252554|FG001|Overall Study|Cancer event|3|||
33644511|NCT02791763|102252555|FG002|Overall Study|Cancer event|0|||
33644512|NCT02791763|102252553|FG000|Overall Study|Participant had renal transplant|3|||
33644513|NCT02791763|102252554|FG001|Overall Study|Participant had renal transplant|0|||
33644514|NCT02791763|102252555|FG002|Overall Study|Participant had renal transplant|0|||
33644515|NCT02791763|102252553|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
33644516|NCT02791763|102252554|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
33644517|NCT02791763|102252555|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
33644518|NCT02791763|102252553|FG000|Overall Study|Adverse Event|12|||
33644519|NCT02791763|102252554|FG001|Overall Study|Adverse Event|13|||
33644520|NCT02791763|102252555|FG002|Overall Study|Adverse Event|7|||
33644521|NCT00001213|102252556|FG000|Overall Study|Death|18|||
33644522|NCT03237286|102252561|FG000|Overall Study|Withdrawal by Subject|1|||
33644523|NCT03237286|102252562|FG001|Overall Study|Withdrawal by Subject|0|||
33644524|NCT03237286|102252563|FG002|Overall Study|Withdrawal by Subject|2|||
33644525|NCT03237286|102252561|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
33644526|NCT03237286|102252562|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
33644527|NCT03237286|102252563|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
33644528|NCT00742235|102252567|FG000|Overall Study|Lost to Follow-up|0|||
33644529|NCT00742235|102252568|FG001|Overall Study|Lost to Follow-up|31|||
33644530|NCT01950013|102252569|FG000|Overall Study|Withdrawal by Subject|0|||
33644531|NCT01950013|102252570|FG001|Overall Study|Withdrawal by Subject|2|||
33644532|NCT01950013|102252571|FG002|Overall Study|Withdrawal by Subject|0|||
33644533|NCT04629066|102252572|FG000|Overall Study|Lost to Follow-up|3|||
33644534|NCT04629066|102252573|FG001|Overall Study|Lost to Follow-up|2|||
33644535|NCT01763996|102252574|FG000|Treatment Period 2|Adverse Event|0|||
33644536|NCT01763996|102252575|FG001|Treatment Period 2|Adverse Event|1|||
33644537|NCT01088048|102252576|FG000|Overall Study|Adverse Event|7|||
33644538|NCT01088048|102252577|FG001|Overall Study|Adverse Event|9|||
33644539|NCT01088048|102252578|FG002|Overall Study|Adverse Event|7|||
33644540|NCT01088048|102252579|FG003|Overall Study|Adverse Event|5|||
33644541|NCT01088048|102252580|FG004|Overall Study|Adverse Event|6|||
33644542|NCT01088048|102252581|FG005|Overall Study|Adverse Event|3|||
33644543|NCT01088048|102252582|FG006|Overall Study|Adverse Event|3|||
33373112|NCT01043185|101252048|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
33373113|NCT01043185|101252049|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
33373114|NCT01043185|101252050|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
33373115|NCT01043185|101252051|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
33373116|NCT01043185|101252052|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
33373117|NCT01043185|101252053|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
33373118|NCT01043185|101252054|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
33373119|NCT01043185|101252055|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
33373120|NCT01043185|101252056|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
33373121|NCT01043185|101252057|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
33644544|NCT01088048|102252583|FG007|Overall Study|Adverse Event|0|||
33644545|NCT01088048|102252584|FG008|Overall Study|Adverse Event|2|||
33644546|NCT01088048|102252585|FG009|Overall Study|Adverse Event|2|||
33644547|NCT01088048|102252576|FG000|Overall Study|Withdrew Consent|1|||
33644548|NCT01088048|102252577|FG001|Overall Study|Withdrew Consent|1|||
33644549|NCT01088048|102252578|FG002|Overall Study|Withdrew Consent|1|||
33644550|NCT01088048|102252579|FG003|Overall Study|Withdrew Consent|1|||
33644551|NCT01088048|102252580|FG004|Overall Study|Withdrew Consent|2|||
33644552|NCT01088048|102252581|FG005|Overall Study|Withdrew Consent|1|||
33644553|NCT01088048|102252582|FG006|Overall Study|Withdrew Consent|0|||
33644554|NCT01088048|102252583|FG007|Overall Study|Withdrew Consent|2|||
33146378|NCT03435640|100451560|FG001|Overall Study|Withdrawal by Subject|1|||
33146379|NCT03435640|100451561|FG002|Overall Study|Withdrawal by Subject|0|||
33146380|NCT03435640|100451562|FG003|Overall Study|Withdrawal by Subject|2|||
33146381|NCT03435640|100451563|FG004|Overall Study|Withdrawal by Subject|0|||
33644555|NCT01088048|102252584|FG008|Overall Study|Withdrew Consent|2|||
33644556|NCT01088048|102252585|FG009|Overall Study|Withdrew Consent|1|||
33644557|NCT01088048|102252576|FG000|Overall Study|Concomitant Medication Prohibited|1|||
33644558|NCT01088048|102252577|FG001|Overall Study|Concomitant Medication Prohibited|0|||
33146382|NCT03435640|100451564|FG005|Overall Study|Withdrawal by Subject|0|||
33146383|NCT03435640|100451565|FG006|Overall Study|Withdrawal by Subject|3|||
33146384|NCT03435640|100451566|FG007|Overall Study|Withdrawal by Subject|0|||
33146385|NCT03435640|100451567|FG008|Overall Study|Withdrawal by Subject|0|||
33644559|NCT01088048|102252578|FG002|Overall Study|Concomitant Medication Prohibited|0|||
33644560|NCT01088048|102252579|FG003|Overall Study|Concomitant Medication Prohibited|0|||
33146386|NCT03435640|100451568|FG009|Overall Study|Withdrawal by Subject|2|||
33644561|NCT01088048|102252580|FG004|Overall Study|Concomitant Medication Prohibited|0|||
33146387|NCT03435640|100451569|FG010|Overall Study|Withdrawal by Subject|3|||
33146388|NCT03435640|100451559|FG000|Overall Study|Lost to Follow-up|0|||
33146389|NCT03435640|100451560|FG001|Overall Study|Lost to Follow-up|0|||
33146390|NCT03435640|100451561|FG002|Overall Study|Lost to Follow-up|1|||
33146391|NCT03435640|100451562|FG003|Overall Study|Lost to Follow-up|0|||
33146392|NCT03435640|100451563|FG004|Overall Study|Lost to Follow-up|0|||
33146393|NCT03435640|100451564|FG005|Overall Study|Lost to Follow-up|0|||
33146394|NCT03435640|100451565|FG006|Overall Study|Lost to Follow-up|0|||
33146395|NCT03435640|100451566|FG007|Overall Study|Lost to Follow-up|0|||
33146396|NCT03435640|100451567|FG008|Overall Study|Lost to Follow-up|0|||
33644562|NCT01088048|102252581|FG005|Overall Study|Concomitant Medication Prohibited|0|||
33644563|NCT01088048|102252582|FG006|Overall Study|Concomitant Medication Prohibited|0|||
33644564|NCT01088048|102252583|FG007|Overall Study|Concomitant Medication Prohibited|0|||
33644565|NCT01088048|102252584|FG008|Overall Study|Concomitant Medication Prohibited|0|||
33644566|NCT01088048|102252585|FG009|Overall Study|Concomitant Medication Prohibited|0|||
33644567|NCT01088048|102252576|FG000|Overall Study|Investigator Request|2|||
33644568|NCT01088048|102252577|FG001|Overall Study|Investigator Request|2|||
33644569|NCT01088048|102252578|FG002|Overall Study|Investigator Request|0|||
33644570|NCT01088048|102252579|FG003|Overall Study|Investigator Request|0|||
33644571|NCT01088048|102252580|FG004|Overall Study|Investigator Request|3|||
33644572|NCT01088048|102252581|FG005|Overall Study|Investigator Request|1|||
33644573|NCT01088048|102252582|FG006|Overall Study|Investigator Request|1|||
33644574|NCT01088048|102252583|FG007|Overall Study|Investigator Request|0|||
33644575|NCT01088048|102252584|FG008|Overall Study|Investigator Request|0|||
33644576|NCT01088048|102252585|FG009|Overall Study|Investigator Request|0|||
33644577|NCT01088048|102252576|FG000|Overall Study|Patient Non-compliance|0|||
33644578|NCT01088048|102252577|FG001|Overall Study|Patient Non-compliance|1|||
33644579|NCT01088048|102252578|FG002|Overall Study|Patient Non-compliance|0|||
33644580|NCT01088048|102252579|FG003|Overall Study|Patient Non-compliance|0|||
33644581|NCT01088048|102252580|FG004|Overall Study|Patient Non-compliance|0|||
33644582|NCT01088048|102252581|FG005|Overall Study|Patient Non-compliance|0|||
33644583|NCT01088048|102252582|FG006|Overall Study|Patient Non-compliance|0|||
33644584|NCT01088048|102252583|FG007|Overall Study|Patient Non-compliance|0|||
33583373|NCT02370368|102025826|FG000|Overall Study|Withdrawal by Subject|5|||
33583374|NCT02370368|102025827|FG001|Overall Study|Withdrawal by Subject|4|||
33583375|NCT01925768|102025831|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
33583376|NCT01925768|102025832|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33644585|NCT01088048|102252584|FG008|Overall Study|Patient Non-compliance|0|||
33644586|NCT01088048|102252585|FG009|Overall Study|Patient Non-compliance|0|||
33644587|NCT01088048|102252576|FG000|Overall Study|Disease Progression|7|||
33644588|NCT01088048|102252577|FG001|Overall Study|Disease Progression|4|||
33146397|NCT03435640|100451568|FG009|Overall Study|Lost to Follow-up|0|||
33146398|NCT03435640|100451569|FG010|Overall Study|Lost to Follow-up|0|||
33146399|NCT00367770|100451570|FG000|Overall Study|Adverse Event|1|||
33583377|NCT01925768|102025831|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
33583378|NCT01925768|102025832|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
33583379|NCT01925768|102025831|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
33583380|NCT01925768|102025832|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
33583381|NCT01925768|102025831|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
33583382|NCT01925768|102025832|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
33583383|NCT01925768|102025831|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
33583384|NCT01925768|102025832|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
33583385|NCT01925768|102025831|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
33583386|NCT01925768|102025832|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
33583387|NCT01925768|102025831|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
33583388|NCT01925768|102025832|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
33583389|NCT01925768|102025831|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
33583390|NCT01925768|102025832|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
33583391|NCT01925768|102025831|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
33583392|NCT01925768|102025832|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
33583393|NCT01925768|102025831|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
33583394|NCT01925768|102025832|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
33146400|NCT00367770|100451570|FG000|Overall Study|Withdrawal by Subject|1|||
33583395|NCT01925768|102025831|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
33583396|NCT01925768|102025832|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
33644589|NCT01088048|102252578|FG002|Overall Study|Disease Progression|3|||
33644590|NCT01088048|102252579|FG003|Overall Study|Disease Progression|5|||
33644591|NCT01088048|102252580|FG004|Overall Study|Disease Progression|3|||
33146401|NCT00381381|100451571|FG000|Overall Study|Adverse Event|3|||
33146402|NCT00381381|100451571|FG000|Overall Study|Lost to Follow-up|52|||
33146403|NCT00381381|100451571|FG000|Overall Study|Withdrawal by Subject|9|||
33146404|NCT03463031|100451572|FG000|Overall Study|Withdrawal by Subject|4|||
33146405|NCT03463031|100451573|FG001|Overall Study|Withdrawal by Subject|2|||
33146406|NCT03463031|100451572|FG000|Overall Study|Investigator/Sponsor Decision|0|||
33146407|NCT03463031|100451573|FG001|Overall Study|Investigator/Sponsor Decision|1|||
33146408|NCT03463031|100451572|FG000|Overall Study|Lost to Follow-up|1|||
33146409|NCT03463031|100451573|FG001|Overall Study|Lost to Follow-up|1|||
33146410|NCT03463031|100451572|FG000|Overall Study|Adverse Event|4|||
33146411|NCT03463031|100451573|FG001|Overall Study|Adverse Event|1|||
33146412|NCT03463031|100451572|FG000|Overall Study|Use of prohibited medication by subject|1|||
33146413|NCT03463031|100451573|FG001|Overall Study|Use of prohibited medication by subject|0|||
33146414|NCT01390220|100451574|FG000|Test Dose Phase|Adverse Event|17|||
33146415|NCT01390220|100451575|FG001|Test Dose Phase|Adverse Event|0|||
33146416|NCT01390220|100451576|FG002|Test Dose Phase|Adverse Event|0|||
33146417|NCT01390220|100451574|FG000|Test Dose Phase|Withdrawal by Subject|8|||
33146418|NCT01390220|100451575|FG001|Test Dose Phase|Withdrawal by Subject|0|||
33644592|NCT01088048|102252581|FG005|Overall Study|Disease Progression|3|||
33644593|NCT01088048|102252582|FG006|Overall Study|Disease Progression|2|||
33644594|NCT01088048|102252583|FG007|Overall Study|Disease Progression|1|||
33644595|NCT01088048|102252584|FG008|Overall Study|Disease Progression|0|||
33644596|NCT01088048|102252585|FG009|Overall Study|Disease Progression|0|||
33644597|NCT01088048|102252576|FG000|Overall Study|Death|1|||
33644598|NCT01088048|102252577|FG001|Overall Study|Death|5|||
33644599|NCT01088048|102252578|FG002|Overall Study|Death|3|||
33644600|NCT01088048|102252579|FG003|Overall Study|Death|3|||
33644601|NCT01088048|102252580|FG004|Overall Study|Death|1|||
33644602|NCT01088048|102252581|FG005|Overall Study|Death|3|||
33644603|NCT01088048|102252582|FG006|Overall Study|Death|0|||
33644604|NCT01088048|102252583|FG007|Overall Study|Death|0|||
33644605|NCT01088048|102252584|FG008|Overall Study|Death|3|||
33644606|NCT01088048|102252585|FG009|Overall Study|Death|1|||
33644607|NCT01088048|102252576|FG000|Overall Study|Other|3|||
33644608|NCT01088048|102252577|FG001|Overall Study|Other|5|||
33644609|NCT01088048|102252578|FG002|Overall Study|Other|0|||
33644610|NCT01088048|102252579|FG003|Overall Study|Other|0|||
33644611|NCT01088048|102252580|FG004|Overall Study|Other|2|||
33644612|NCT01088048|102252581|FG005|Overall Study|Other|0|||
33644613|NCT01088048|102252582|FG006|Overall Study|Other|0|||
33644614|NCT01088048|102252583|FG007|Overall Study|Other|2|||
33644615|NCT01088048|102252584|FG008|Overall Study|Other|0|||
33644616|NCT01088048|102252585|FG009|Overall Study|Other|0|||
33644617|NCT04463069|102252586|FG000|Overall Study|Withdrawal by Subject|2|||
33644618|NCT04463069|102252587|FG001|Overall Study|Withdrawal by Subject|10|||
33644619|NCT04463069|102252586|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
33644620|NCT04463069|102252587|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
33644621|NCT00122980|102252588|FG000|Overall Study|Death|0|||
33644622|NCT00122980|102252589|FG001|Overall Study|Death|1|||
33644623|NCT00122980|102252588|FG000|Overall Study|Physician Decision|2|||
33644624|NCT00122980|102252589|FG001|Overall Study|Physician Decision|0|||
33644625|NCT00122980|102252588|FG000|Overall Study|Protocol Violation|5|||
33644626|NCT00122980|102252589|FG001|Overall Study|Protocol Violation|1|||
33644627|NCT00122980|102252588|FG000|Overall Study|Withdrawal by Subject|2|||
33644628|NCT00122980|102252589|FG001|Overall Study|Withdrawal by Subject|3|||
33644629|NCT00122980|102252588|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
33644630|NCT00122980|102252589|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
33644631|NCT00122980|102252588|FG000|Overall Study|Study termination|27|||
33644632|NCT00122980|102252589|FG001|Overall Study|Study termination|35|||
33644633|NCT03554486|102252590|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
33644634|NCT03554486|102252591|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
33644635|NCT03554486|102252592|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
33644636|NCT03554486|102252590|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
33644637|NCT03554486|102252591|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
33644638|NCT03554486|102252592|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
33644639|NCT03554486|102252590|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
33644640|NCT03554486|102252591|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
33644641|NCT03554486|102252592|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
33644642|NCT03783078|102252593|FG000|Overall Study|Participants Ongoing|29|||
33644643|NCT03783078|102252593|FG000|Overall Study|Death|26|||
33146419|NCT01390220|100451576|FG002|Test Dose Phase|Withdrawal by Subject|0|||
33146420|NCT01390220|100451574|FG000|Test Dose Phase|Lost to Follow-up|2|||
33644644|NCT01358721|102252594|FG000|Overall Study|Withdrawal by Subject|0|||
33644645|NCT01358721|102252595|FG001|Overall Study|Withdrawal by Subject|0|||
33644646|NCT01358721|102252596|FG002|Overall Study|Withdrawal by Subject|0|||
33146421|NCT01390220|100451575|FG001|Test Dose Phase|Lost to Follow-up|0|||
33644647|NCT01358721|102252597|FG003|Overall Study|Withdrawal by Subject|1|||
33644648|NCT01358721|102252594|FG000|Overall Study|Death|0|||
33644649|NCT01358721|102252595|FG001|Overall Study|Death|2|||
33644650|NCT01358721|102252596|FG002|Overall Study|Death|0|||
33644651|NCT01358721|102252597|FG003|Overall Study|Death|0|||
33644652|NCT01358721|102252594|FG000|Overall Study|Study Drug Toxicity|1|||
33583397|NCT00282087|102025835|FG000|Overall Study|Death|1|||
33583398|NCT02674464|102025836|FG000|Overall Study|Death|10|||
33583399|NCT02674464|102025837|FG001|Overall Study|Death|21|||
33583400|NCT02674464|102025836|FG000|Overall Study|Withdrawal by Subject|24|||
33583401|NCT02674464|102025837|FG001|Overall Study|Withdrawal by Subject|44|||
33583402|NCT02674464|102025836|FG000|Overall Study|Lost to Follow-up|97|||
33583403|NCT02674464|102025837|FG001|Overall Study|Lost to Follow-up|92|||
33583404|NCT02674464|102025836|FG000|Overall Study|Outside survey window|6|||
33583405|NCT02674464|102025837|FG001|Overall Study|Outside survey window|3|||
33583406|NCT02079909|102025840|FG000|Overall Study|Adverse Event|23|||
33583407|NCT02079909|102025841|FG001|Overall Study|Adverse Event|23|||
33583408|NCT02079909|102025842|FG002|Overall Study|Adverse Event|7|||
33583409|NCT02079909|102025840|FG000|Overall Study|Withdrawal by Subject|9|||
33583410|NCT02079909|102025841|FG001|Overall Study|Withdrawal by Subject|17|||
33583411|NCT02079909|102025842|FG002|Overall Study|Withdrawal by Subject|4|||
33583412|NCT02079909|102025840|FG000|Overall Study|Lost to Follow-up|2|||
33583413|NCT02079909|102025841|FG001|Overall Study|Lost to Follow-up|3|||
33583414|NCT02079909|102025842|FG002|Overall Study|Lost to Follow-up|1|||
33583415|NCT02079909|102025840|FG000|Overall Study|Death|2|||
33583416|NCT02079909|102025841|FG001|Overall Study|Death|2|||
33583417|NCT02079909|102025842|FG002|Overall Study|Death|0|||
33583418|NCT02079909|102025840|FG000|Overall Study|Lack of Efficacy|0|||
33583419|NCT02079909|102025841|FG001|Overall Study|Lack of Efficacy|0|||
33583420|NCT02079909|102025842|FG002|Overall Study|Lack of Efficacy|1|||
33583421|NCT02079909|102025840|FG000|Overall Study|Protocol Violation|0|||
33583422|NCT02079909|102025841|FG001|Overall Study|Protocol Violation|1|||
33583423|NCT02079909|102025842|FG002|Overall Study|Protocol Violation|1|||
33583424|NCT02079909|102025840|FG000|Overall Study|Physician Decision|0|||
33583425|NCT02079909|102025841|FG001|Overall Study|Physician Decision|1|||
33583426|NCT02079909|102025842|FG002|Overall Study|Physician Decision|1|||
33583427|NCT02079909|102025840|FG000|Overall Study|Relocation etc.|2|||
33583428|NCT02079909|102025841|FG001|Overall Study|Relocation etc.|2|||
33583429|NCT02079909|102025842|FG002|Overall Study|Relocation etc.|3|||
33583430|NCT02446769|102025843|FG000|Screening Period|Screen Failure|11|||
33583431|NCT02446769|102025844|FG001|Screening Period|Screen Failure|0|||
33583432|NCT02446769|102025845|FG002|Screening Period|Screen Failure|0|||
33583433|NCT02446769|102025843|FG000|Study Period|Randomized in Error|0|||
33583434|NCT02446769|102025844|FG001|Study Period|Randomized in Error|2|||
33583435|NCT02446769|102025845|FG002|Study Period|Randomized in Error|0|||
33583436|NCT01279044|102025852|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
33583437|NCT01279044|102025853|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
33583438|NCT01279044|102025854|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
33583439|NCT01279044|102025852|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
33583440|NCT01279044|102025853|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
33583441|NCT01279044|102025854|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
33583442|NCT01279044|102025852|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
33583443|NCT01279044|102025853|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
33583444|NCT01279044|102025854|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
33583445|NCT03663569|102025855|FG000|Overall Study|Discontinuation of study|11|||
33583446|NCT03663569|102025855|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
33583447|NCT03663569|102025855|FG000|Overall Study|Deceased patient|6|||
33583448|NCT03663569|102025855|FG000|Overall Study|Lost to Follow-up|18|||
33583449|NCT03663569|102025855|FG000|Overall Study|Withdrawal of consent|5|||
33583450|NCT03663569|102025855|FG000|Overall Study|Patient's request|11|||
33583451|NCT03663569|102025855|FG000|Overall Study|Adverse Event|4|||
33583452|NCT03663569|102025855|FG000|Overall Study|Not come to second visit|3|||
33583453|NCT03663569|102025855|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
33583454|NCT03663569|102025855|FG000|Overall Study|Serious adverse event|1|||
33583455|NCT01901289|102025856|FG000|Overall Study|Death|32|||
33583456|NCT01901289|102025856|FG000|Overall Study|Lost to Follow-up|16|||
33583457|NCT01901289|102025856|FG000|Overall Study|Withdrawal by Subject|35|||
33583458|NCT01901289|102025856|FG000|Overall Study|Other type of endpoint met|2|||
33583459|NCT00288015|102025857|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
33583460|NCT00288015|102025857|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
33583461|NCT00288015|102025857|FG000|First Response Assessment|Withdrawal by Subject|1|||
33583462|NCT00288015|102025857|FG000|First Response Assessment|Death|1|||
33583463|NCT00288015|102025857|FG000|First Response Assessment|Physician Decision|2|||
33583464|NCT00288015|102025857|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
33583465|NCT00288015|102025857|FG000|Follow up for Survival x 2 Years|Death|13|||
33583466|NCT00288015|102025857|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
33583467|NCT00288015|102025857|FG000|Follow up for Survival x 2 Years|Other|9|||
33583468|NCT02526212|102025858|FG000|Overall Study|Incarceration|1|||
33583469|NCT02526212|102025859|FG001|Overall Study|Incarceration|0|||
33583470|NCT02526212|102025858|FG000|Overall Study|Lost to Follow-up|1|||
33583471|NCT02526212|102025859|FG001|Overall Study|Lost to Follow-up|0|||
33583472|NCT02526212|102025858|FG000|Overall Study|Death|0|||
33583473|NCT02526212|102025859|FG001|Overall Study|Death|1|||
33146422|NCT01390220|100451576|FG002|Test Dose Phase|Lost to Follow-up|0|||
33146423|NCT01390220|100451574|FG000|Test Dose Phase|Protocol Violation|8|||
33146424|NCT01390220|100451575|FG001|Test Dose Phase|Protocol Violation|0|||
33146425|NCT01390220|100451576|FG002|Test Dose Phase|Protocol Violation|0|||
33146426|NCT01390220|100451574|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
33146427|NCT01390220|100451575|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
33146428|NCT01390220|100451576|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
33146429|NCT01390220|100451574|FG000|Test Dose Phase|Study/Site closure|6|||
33644653|NCT01358721|102252595|FG001|Overall Study|Study Drug Toxicity|3|||
33644654|NCT01358721|102252596|FG002|Overall Study|Study Drug Toxicity|4|||
33644655|NCT01358721|102252597|FG003|Overall Study|Study Drug Toxicity|5|||
33644656|NCT01358721|102252594|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
33644657|NCT01358721|102252595|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
33644658|NCT01358721|102252596|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
33644659|NCT01358721|102252597|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
33644660|NCT01358721|102252594|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
33644661|NCT01358721|102252595|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
33644662|NCT01358721|102252596|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
33644663|NCT01358721|102252597|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
33644664|NCT01358721|102252594|FG000|Overall Study|Adverse Event related to study drug|1|||
33644665|NCT01358721|102252595|FG001|Overall Study|Adverse Event related to study drug|0|||
33644666|NCT01358721|102252596|FG002|Overall Study|Adverse Event related to study drug|0|||
33644667|NCT01358721|102252597|FG003|Overall Study|Adverse Event related to study drug|1|||
33644668|NCT01358721|102252594|FG000|Overall Study|Disease Progression|19|||
33644669|NCT01358721|102252595|FG001|Overall Study|Disease Progression|15|||
33644670|NCT01358721|102252596|FG002|Overall Study|Disease Progression|17|||
33644671|NCT01358721|102252597|FG003|Overall Study|Disease Progression|15|||
33644672|NCT01358721|102252594|FG000|Overall Study|Out of State/Unmet Criteria|0|||
33644673|NCT01358721|102252595|FG001|Overall Study|Out of State/Unmet Criteria|0|||
33644674|NCT01358721|102252596|FG002|Overall Study|Out of State/Unmet Criteria|1|||
33644675|NCT01358721|102252597|FG003|Overall Study|Out of State/Unmet Criteria|0|||
33644676|NCT01215097|102252599|FG000|Overall Study|Adverse Event|1|||
33644677|NCT01215097|102252600|FG001|Overall Study|Adverse Event|3|||
33644678|NCT01215097|102252599|FG000|Overall Study|Protocol Violation|0|||
33644679|NCT01215097|102252600|FG001|Overall Study|Protocol Violation|2|||
33644680|NCT01215097|102252599|FG000|Overall Study|Lost to Follow-up|2|||
33644681|NCT01215097|102252600|FG001|Overall Study|Lost to Follow-up|0|||
33644682|NCT01215097|102252599|FG000|Overall Study|Withdrawal by Subject|6|||
33644683|NCT01215097|102252600|FG001|Overall Study|Withdrawal by Subject|3|||
33644684|NCT01215097|102252599|FG000|Overall Study|Lack of Efficacy|0|||
33644685|NCT01215097|102252600|FG001|Overall Study|Lack of Efficacy|3|||
33146430|NCT01390220|100451575|FG001|Test Dose Phase|Study/Site closure|0|||
33146431|NCT01390220|100451576|FG002|Test Dose Phase|Study/Site closure|0|||
33146432|NCT01390220|100451574|FG000|Test Dose Phase|Caregiver no longer available|5|||
33146433|NCT01390220|100451575|FG001|Test Dose Phase|Caregiver no longer available|0|||
33146434|NCT01390220|100451576|FG002|Test Dose Phase|Caregiver no longer available|0|||
33146435|NCT01390220|100451574|FG000|Test Dose Phase|Noncompliance|2|||
33146436|NCT01390220|100451575|FG001|Test Dose Phase|Noncompliance|0|||
33146437|NCT01390220|100451576|FG002|Test Dose Phase|Noncompliance|0|||
33146438|NCT01390220|100451574|FG000|Test Dose Phase|Logistical|6|||
33146439|NCT01390220|100451575|FG001|Test Dose Phase|Logistical|0|||
33146440|NCT01390220|100451576|FG002|Test Dose Phase|Logistical|0|||
33146441|NCT01390220|100451574|FG000|Comparative Phase|Withdrawal by Subject|0|||
33146442|NCT01390220|100451575|FG001|Comparative Phase|Withdrawal by Subject|1|||
33146443|NCT01390220|100451576|FG002|Comparative Phase|Withdrawal by Subject|0|||
33146444|NCT02140775|100451577|FG000|Overall Study|Withdrawal by Subject|30|||
33146445|NCT02140775|100451578|FG001|Overall Study|Withdrawal by Subject|7|||
33146446|NCT03023046|100451582|FG000|Overall Study|Withdrawal by Subject|1|||
33146447|NCT00937391|100451583|FG000|Stage 2|Withdrawal by Subject|1|||
33146448|NCT02480712|100451584|FG000|Overall Study|Enrolled but Never Treated|1|||
33373122|NCT01401010|101252058|FG000|Overall Study|Could not interpret assay results|1|||
33373123|NCT01401010|101252059|FG001|Overall Study|Could not interpret assay results|0|||
33644686|NCT01215097|102252599|FG000|Overall Study|patient's refusal to come|2|||
33644687|NCT01215097|102252600|FG001|Overall Study|patient's refusal to come|2|||
33644688|NCT01215097|102252599|FG000|Overall Study|patient's private reason|1|||
33644689|NCT01215097|102252600|FG001|Overall Study|patient's private reason|1|||
33146449|NCT02480712|100451584|FG000|Overall Study|Lost to Follow-up|5|||
33644690|NCT02644109|102252601|FG000|Overall Study|Adverse Event|0|||
33146450|NCT02480712|100451584|FG000|Overall Study|Withdrew Consent|3|||
33146451|NCT02480712|100451584|FG000|Overall Study|Death|1|||
33583474|NCT00175916|102025860|FG000|Overall Study|Death|19|||
33146452|NCT02480712|100451584|FG000|Overall Study|Lack of Efficacy|1|||
33146453|NCT04618770|100451588|FG000|Overall Study|Censored from Analysis|12|||
33644691|NCT02644109|102252602|FG001|Overall Study|Adverse Event|4|||
33644692|NCT00202878|102252605|FG000|Overall Study|Death|964|||
33644693|NCT00202878|102252606|FG001|Overall Study|Death|968|||
33644694|NCT00202878|102252605|FG000|Overall Study|Only Vital Status Known|357|||
33644695|NCT00202878|102252606|FG001|Overall Study|Only Vital Status Known|356|||
33644696|NCT00202878|102252605|FG000|Overall Study|Lost to Follow-up|44|||
33146454|NCT04618770|100451588|FG000|Overall Study|Early Termination|25|||
33146455|NCT02581943|100451591|FG000|Overall Study|Death|5|||
33146456|NCT02581943|100451592|FG001|Overall Study|Death|2|||
33146457|NCT02581943|100451591|FG000|Overall Study|Disease Progression|12|||
33146458|NCT02581943|100451592|FG001|Overall Study|Disease Progression|15|||
33146459|NCT02581943|100451591|FG000|Overall Study|Withdrawal by Subject|1|||
33146460|NCT02581943|100451592|FG001|Overall Study|Withdrawal by Subject|2|||
33146461|NCT03468543|100451597|FG000|Overall Study|Protocol stopping rules met|3|||
33146462|NCT02038829|100451598|FG000|Washout Period 1|Death|0|||
33422962|NCT00096486|101439782|FG000|Overall Study|Withdrawal by Subject|0|||
33644697|NCT00202878|102252606|FG001|Overall Study|Lost to Follow-up|49|||
33644698|NCT00202878|102252605|FG000|Overall Study|Site Closure|39|||
33644699|NCT00202878|102252606|FG001|Overall Study|Site Closure|36|||
33644700|NCT00202878|102252605|FG000|Overall Study|Withdrawal by Subject|795|||
33644701|NCT00202878|102252606|FG001|Overall Study|Withdrawal by Subject|808|||
33644702|NCT00950859|102252607|FG000|Overall Study|Adverse Event|3|||
33644703|NCT00950859|102252608|FG001|Overall Study|Adverse Event|3|||
33644704|NCT00950859|102252607|FG000|Overall Study|Insufficient Viral Load Response|12|||
33644705|NCT00950859|102252608|FG001|Overall Study|Insufficient Viral Load Response|3|||
33644706|NCT00950859|102252607|FG000|Overall Study|Protocol Violation|1|||
33644707|NCT00950859|102252608|FG001|Overall Study|Protocol Violation|1|||
33644708|NCT00950859|102252607|FG000|Overall Study|Lost to Follow-up|0|||
33644709|NCT00950859|102252608|FG001|Overall Study|Lost to Follow-up|3|||
33644710|NCT04343235|102252610|FG000|Overall Study|Lost to Follow-up|3|||
33644711|NCT04343235|102252611|FG001|Overall Study|Lost to Follow-up|2|||
33644712|NCT00467753|102252612|FG000|Overall Study|Lost to Follow-up|1|||
33644713|NCT00467753|102252613|FG001|Overall Study|Lost to Follow-up|2|||
33644714|NCT00467753|102252612|FG000|Overall Study|Adverse Event|2|||
33644715|NCT00467753|102252613|FG001|Overall Study|Adverse Event|0|||
33644716|NCT00960570|102252615|FG000|21 Day Washout Period|Adverse Event|1|||
33644717|NCT00960570|102252615|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
33644718|NCT00960570|102252615|FG000|1 Day Period Between Dosing|Adverse Event|2|||
33644719|NCT00960570|102252615|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
33644720|NCT01032889|102252619|FG000|Overall Study|Adverse Event|2|||
33644721|NCT01032889|102252620|FG001|Overall Study|Adverse Event|2|||
33644722|NCT01032889|102252621|FG002|Overall Study|Adverse Event|0|||
33644723|NCT01032889|102252619|FG000|Overall Study|Withdrawal of Consent|1|||
33644724|NCT01032889|102252620|FG001|Overall Study|Withdrawal of Consent|2|||
33644725|NCT01032889|102252621|FG002|Overall Study|Withdrawal of Consent|1|||
33644726|NCT01032889|102252619|FG000|Overall Study|Patient Request|0|||
33644727|NCT01032889|102252620|FG001|Overall Study|Patient Request|1|||
33644728|NCT01032889|102252621|FG002|Overall Study|Patient Request|0|||
33644729|NCT01032889|102252619|FG000|Overall Study|Lost to Follow-up|1|||
33644730|NCT01032889|102252620|FG001|Overall Study|Lost to Follow-up|1|||
33644731|NCT01032889|102252621|FG002|Overall Study|Lost to Follow-up|0|||
33644732|NCT01032889|102252619|FG000|Overall Study|Lack of Submental Fat|2|||
33422963|NCT00096486|101439783|FG001|Overall Study|Withdrawal by Subject|0|||
33583475|NCT00175916|102025860|FG000|Overall Study|Adverse Event|81|||
33583476|NCT00175916|102025860|FG000|Overall Study|Lack of Efficacy|354|||
33583477|NCT00175916|102025860|FG000|Overall Study|Lost to Follow-up|17|||
33583478|NCT00175916|102025860|FG000|Overall Study|Subject Choice|98|||
33583479|NCT00175916|102025860|FG000|Overall Study|Lack of compliance|8|||
33583480|NCT00175916|102025860|FG000|Overall Study|Patient cannot record seizures|1|||
33583481|NCT00175916|102025860|FG000|Overall Study|Sponsor decision|17|||
33583482|NCT00175916|102025860|FG000|Overall Study|Vigabatrin intake|1|||
33583483|NCT00175916|102025860|FG000|Overall Study|Suicidal behaviour|1|||
33583484|NCT00175916|102025860|FG000|Overall Study|Withdrawal by Subject|1|||
33583485|NCT00175916|102025860|FG000|Overall Study|Seizure - free|4|||
33644733|NCT01032889|102252620|FG001|Overall Study|Lack of Submental Fat|8|||
33644734|NCT01032889|102252621|FG002|Overall Study|Lack of Submental Fat|1|||
33146463|NCT02038829|100451599|FG001|Washout Period 1|Death|0|||
33583486|NCT00175916|102025860|FG000|Overall Study|Administrative reason|1|||
33583487|NCT00175916|102025860|FG000|Overall Study|Pregnancy|1|||
33583488|NCT00175916|102025860|FG000|Overall Study|Patient's request|2|||
33644735|NCT01032889|102252619|FG000|Overall Study|Miscellaneous Reasons|2|||
33644736|NCT01032889|102252620|FG001|Overall Study|Miscellaneous Reasons|1|||
33644737|NCT01032889|102252621|FG002|Overall Study|Miscellaneous Reasons|1|||
33644738|NCT00684060|102252622|FG000|Overall Study|Lost to Follow-up|1|||
33146464|NCT02038829|100451600|FG002|Washout Period 1|Death|0|||
33146465|NCT02038829|100451601|FG003|Washout Period 1|Death|0|||
33146466|NCT02038829|100451602|FG004|Washout Period 1|Death|1|||
33146467|NCT02038829|100451603|FG005|Washout Period 1|Death|0|||
33583489|NCT00175916|102025860|FG000|Overall Study|Treating physiciant's choice|1|||
33583490|NCT00175916|102025860|FG000|Overall Study|Moved overseas|1|||
33644739|NCT00684060|102252623|FG001|Overall Study|Lost to Follow-up|0|||
33644740|NCT00684060|102252622|FG000|Overall Study|New stenosis identified|1|||
33146468|NCT02038829|100451604|FG006|Washout Period 1|Death|0|||
33146469|NCT02038829|100451605|FG007|Washout Period 1|Death|0|||
33146470|NCT02038829|100451606|FG008|Washout Period 1|Death|0|||
33146471|NCT02038829|100451607|FG009|Washout Period 1|Death|0|||
33146472|NCT02038829|100451608|FG010|Washout Period 1|Death|0|||
33146473|NCT02038829|100451609|FG011|Washout Period 1|Death|0|||
33146474|NCT02038829|100451598|FG000|Treatment Period 2|Adverse Event|0|||
33146475|NCT02038829|100451599|FG001|Treatment Period 2|Adverse Event|0|||
33146476|NCT02038829|100451600|FG002|Treatment Period 2|Adverse Event|0|||
33146477|NCT02038829|100451601|FG003|Treatment Period 2|Adverse Event|0|||
33146478|NCT02038829|100451602|FG004|Treatment Period 2|Adverse Event|0|||
33146479|NCT02038829|100451603|FG005|Treatment Period 2|Adverse Event|0|||
33146480|NCT02038829|100451604|FG006|Treatment Period 2|Adverse Event|0|||
33146481|NCT02038829|100451605|FG007|Treatment Period 2|Adverse Event|0|||
33146482|NCT02038829|100451606|FG008|Treatment Period 2|Adverse Event|0|||
33422964|NCT00096486|101439784|FG002|Overall Study|Withdrawal by Subject|1|||
33422965|NCT00096486|101439785|FG003|Overall Study|Withdrawal by Subject|1|||
33422966|NCT00096486|101439782|FG000|Overall Study|Not Treated|0|||
33422967|NCT00096486|101439783|FG001|Overall Study|Not Treated|0|||
33422968|NCT00096486|101439784|FG002|Overall Study|Not Treated|1|||
33422969|NCT00096486|101439785|FG003|Overall Study|Not Treated|1|||
33422970|NCT00331773|101439786|FG000|Overall Study|Withdrawal by Subject|6|||
33422971|NCT00331773|101439787|FG001|Overall Study|Withdrawal by Subject|4|||
33422972|NCT00331773|101439786|FG000|Overall Study|Protocol Violation|10|||
33422973|NCT00331773|101439787|FG001|Overall Study|Protocol Violation|3|||
33422974|NCT02164539|101439788|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
33422975|NCT02164539|101439789|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
33422976|NCT02164539|101439790|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
33422977|NCT02164539|101439791|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
33422978|NCT02164539|101439792|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
33422979|NCT02164539|101439793|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
33422980|NCT02164539|101439794|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
33422981|NCT02164539|101439788|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
33422982|NCT02164539|101439789|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
33422983|NCT02164539|101439790|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
33422984|NCT02164539|101439791|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
33422985|NCT02164539|101439792|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
33583491|NCT00175916|102025860|FG000|Overall Study|Loss of job and economic burden|1|||
33583492|NCT00175916|102025860|FG000|Overall Study|Site was closed|9|||
33583493|NCT00175916|102025860|FG000|Overall Study|Patient went to prison|1|||
33583494|NCT00711594|102025861|FG000|Overall Study|Progressive disease|2|||
33583495|NCT00711594|102025862|FG001|Overall Study|Progressive disease|2|||
33583496|NCT00711594|102025863|FG002|Overall Study|Progressive disease|6|||
33583497|NCT00711594|102025864|FG003|Overall Study|Progressive disease|44|||
33583498|NCT00711594|102025861|FG000|Overall Study|Other Adverse Event|1|||
33583499|NCT00711594|102025862|FG001|Overall Study|Other Adverse Event|0|||
33583500|NCT00711594|102025863|FG002|Overall Study|Other Adverse Event|0|||
33583501|NCT00711594|102025864|FG003|Overall Study|Other Adverse Event|16|||
33583502|NCT00711594|102025861|FG000|Overall Study|Withdrawal by Subject|0|||
33644741|NCT00684060|102252623|FG001|Overall Study|New stenosis identified|0|||
33644742|NCT00684060|102252622|FG000|Overall Study|Unable to collect MRI|1|||
33644743|NCT00684060|102252623|FG001|Overall Study|Unable to collect MRI|2|||
33644744|NCT00684060|102252622|FG000|Overall Study|Death|0|||
33644745|NCT00684060|102252623|FG001|Overall Study|Death|1|||
33644746|NCT02405442|102252624|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
33644747|NCT02405442|102252625|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
33146483|NCT02038829|100451607|FG009|Treatment Period 2|Adverse Event|0|||
33146484|NCT02038829|100451608|FG010|Treatment Period 2|Adverse Event|1|||
33146485|NCT02038829|100451609|FG011|Treatment Period 2|Adverse Event|0|||
33373124|NCT03649321|101252060|FG000|Overall Study|Withdrawal by Subject|1|||
33373125|NCT03649321|101252061|FG001|Overall Study|Withdrawal by Subject|0|||
33373126|NCT03649321|101252060|FG000|Overall Study|Death|1|||
33373127|NCT03649321|101252061|FG001|Overall Study|Death|0|||
33373128|NCT00696657|101252062|FG000|Overall Study|Protocol Violation|0|||
33373129|NCT00696657|101252063|FG001|Overall Study|Protocol Violation|0|||
33373130|NCT00696657|101252064|FG002|Overall Study|Protocol Violation|0|||
33583503|NCT00711594|102025862|FG001|Overall Study|Withdrawal by Subject|1|||
33146486|NCT02038829|100451598|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33146487|NCT02038829|100451599|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33146488|NCT02038829|100451600|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33146489|NCT02038829|100451601|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33146490|NCT02038829|100451602|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33373131|NCT00696657|101252065|FG003|Overall Study|Protocol Violation|0|||
33373132|NCT00696657|101252066|FG004|Overall Study|Protocol Violation|0|||
33422986|NCT02164539|101439793|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
33422987|NCT02164539|101439794|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
33422988|NCT02164539|101439788|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
33422989|NCT02164539|101439789|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
33644748|NCT02405442|102252626|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
33146491|NCT02038829|100451603|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33244742|NCT02014558|100797049|FG010|Overall Study|Lack of Efficacy|16|||
33373133|NCT00696657|101252067|FG005|Overall Study|Protocol Violation|1|||
33373134|NCT00696657|101252068|FG006|Overall Study|Protocol Violation|0|||
33373135|NCT00696657|101252069|FG007|Overall Study|Protocol Violation|0|||
33373136|NCT00696657|101252070|FG008|Overall Study|Protocol Violation|1|||
33373137|NCT00696657|101252062|FG000|Overall Study|Lack of Efficacy|0|||
33373138|NCT00696657|101252063|FG001|Overall Study|Lack of Efficacy|1|||
33373139|NCT00696657|101252064|FG002|Overall Study|Lack of Efficacy|0|||
33373140|NCT00696657|101252065|FG003|Overall Study|Lack of Efficacy|0|||
33373141|NCT00696657|101252066|FG004|Overall Study|Lack of Efficacy|0|||
33373142|NCT00696657|101252067|FG005|Overall Study|Lack of Efficacy|0|||
33373143|NCT00696657|101252068|FG006|Overall Study|Lack of Efficacy|0|||
33373144|NCT00696657|101252069|FG007|Overall Study|Lack of Efficacy|0|||
33373145|NCT00696657|101252070|FG008|Overall Study|Lack of Efficacy|0|||
33373146|NCT00696657|101252062|FG000|Overall Study|Withdrawal criteria|1|||
33373147|NCT00696657|101252063|FG001|Overall Study|Withdrawal criteria|3|||
33373148|NCT00696657|101252064|FG002|Overall Study|Withdrawal criteria|2|||
33373149|NCT00696657|101252065|FG003|Overall Study|Withdrawal criteria|2|||
33373150|NCT00696657|101252066|FG004|Overall Study|Withdrawal criteria|0|||
33373151|NCT00696657|101252067|FG005|Overall Study|Withdrawal criteria|0|||
33373152|NCT00696657|101252068|FG006|Overall Study|Withdrawal criteria|1|||
33373153|NCT00696657|101252069|FG007|Overall Study|Withdrawal criteria|1|||
33373154|NCT00696657|101252070|FG008|Overall Study|Withdrawal criteria|2|||
33373155|NCT00696657|101252062|FG000|Overall Study|Unclassified|0|||
33373156|NCT00696657|101252063|FG001|Overall Study|Unclassified|1|||
33373157|NCT00696657|101252064|FG002|Overall Study|Unclassified|3|||
33373158|NCT00696657|101252065|FG003|Overall Study|Unclassified|2|||
33373159|NCT00696657|101252066|FG004|Overall Study|Unclassified|4|||
33373160|NCT00696657|101252067|FG005|Overall Study|Unclassified|2|||
33373161|NCT00696657|101252068|FG006|Overall Study|Unclassified|0|||
33373162|NCT00696657|101252069|FG007|Overall Study|Unclassified|0|||
33373163|NCT00696657|101252070|FG008|Overall Study|Unclassified|1|||
33373164|NCT00696657|101252062|FG000|Overall Study|Adverse Event|0|||
33422990|NCT02164539|101439790|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
33583504|NCT00711594|102025863|FG002|Overall Study|Withdrawal by Subject|0|||
33583505|NCT00711594|102025864|FG003|Overall Study|Withdrawal by Subject|2|||
33583506|NCT02466425|102025870|FG000|Overall Study|Adverse Event|3|||
33583507|NCT02466425|102025871|FG001|Overall Study|Adverse Event|11|||
33583508|NCT02466425|102025870|FG000|Overall Study|Lack of Efficacy|4|||
33583509|NCT02466425|102025871|FG001|Overall Study|Lack of Efficacy|1|||
33583510|NCT02466425|102025870|FG000|Overall Study|Lost to Follow-up|3|||
33583511|NCT02466425|102025871|FG001|Overall Study|Lost to Follow-up|0|||
33583512|NCT02466425|102025870|FG000|Overall Study|Protocol Violation|1|||
33583513|NCT02466425|102025871|FG001|Overall Study|Protocol Violation|0|||
33583514|NCT02466425|102025870|FG000|Overall Study|Withdrawal by Subject|0|||
33583515|NCT02466425|102025871|FG001|Overall Study|Withdrawal by Subject|1|||
33583516|NCT02466425|102025870|FG000|Overall Study|Other|1|||
33583517|NCT02466425|102025871|FG001|Overall Study|Other|3|||
33583518|NCT02466425|102025870|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
33583519|NCT02466425|102025871|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33583520|NCT00335738|102025881|FG000|Overall Study|Physician Decision|6|||
33583521|NCT00335738|102025882|FG001|Overall Study|Physician Decision|0|||
33583522|NCT00335738|102025881|FG000|Overall Study|Withdrawal by Subject|2|||
33583523|NCT00335738|102025882|FG001|Overall Study|Withdrawal by Subject|0|||
33583524|NCT00335738|102025881|FG000|Overall Study|Ineligible|3|||
33583525|NCT00335738|102025882|FG001|Overall Study|Ineligible|4|||
33583526|NCT02036580|102025883|FG000|Overall Study|Withdrawal by Subject|0|||
33583527|NCT02036580|102025884|FG001|Overall Study|Withdrawal by Subject|1|||
33583528|NCT02036580|102025885|FG002|Overall Study|Withdrawal by Subject|0|||
33583529|NCT02036580|102025883|FG000|Overall Study|Adverse Event|1|||
33583530|NCT02036580|102025884|FG001|Overall Study|Adverse Event|0|||
33583531|NCT02036580|102025885|FG002|Overall Study|Adverse Event|0|||
33583532|NCT00735553|102025886|FG000|Overall Study|Study prematurely terminated|77|||
33583533|NCT02318368|102025892|FG000|Overall Study|Withdrawal by Subject|2|||
33583534|NCT02318368|102025893|FG001|Overall Study|Withdrawal by Subject|0|||
33583535|NCT02318368|102025892|FG000|Overall Study|Study terminated by the sponsor|5|||
33583536|NCT02318368|102025893|FG001|Overall Study|Study terminated by the sponsor|2|||
33583537|NCT02318368|102025892|FG000|Overall Study|Death|0|||
33583538|NCT02318368|102025893|FG001|Overall Study|Death|1|||
33583539|NCT03162796|102025894|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
33244743|NCT02014558|100797050|FG011|Overall Study|Lack of Efficacy|8|||
33583540|NCT03162796|102025895|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
33583541|NCT03162796|102025896|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
33583542|NCT03162796|102025894|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
33583543|NCT03162796|102025895|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
33583544|NCT03162796|102025896|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
33644749|NCT02405442|102252627|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
33644750|NCT02405442|102252624|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
33644751|NCT02405442|102252625|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
33644752|NCT02405442|102252626|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
33644753|NCT02405442|102252627|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
33644754|NCT02405442|102252624|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
33583545|NCT03162796|102025894|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
33583546|NCT03162796|102025895|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
33583547|NCT03162796|102025896|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
33583548|NCT03162796|102025894|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
33644755|NCT02405442|102252625|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
33644756|NCT02405442|102252626|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
33644757|NCT02405442|102252627|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
33644758|NCT02405442|102252624|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
33644759|NCT02405442|102252625|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
33644760|NCT02405442|102252626|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
33644761|NCT02405442|102252627|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
33644762|NCT02405442|102252624|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
33644763|NCT02405442|102252625|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
33644764|NCT02405442|102252626|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
33146492|NCT02038829|100451604|FG006|Treatment Period 2|Withdrawal by Subject|0|||
33146493|NCT02038829|100451605|FG007|Treatment Period 2|Withdrawal by Subject|0|||
33146494|NCT02038829|100451606|FG008|Treatment Period 2|Withdrawal by Subject|0|||
33373165|NCT00696657|101252063|FG001|Overall Study|Adverse Event|0|||
33583549|NCT03162796|102025895|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
33583550|NCT03162796|102025896|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
33583551|NCT03162796|102025894|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
33583552|NCT03162796|102025895|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
33583553|NCT03162796|102025896|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
33583554|NCT03162796|102025894|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
33583555|NCT03162796|102025895|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
33583556|NCT03162796|102025896|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
33583557|NCT03162796|102025894|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
33583558|NCT03162796|102025895|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
33583559|NCT03162796|102025896|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
33583560|NCT03162796|102025894|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
33583561|NCT03162796|102025895|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
33583562|NCT03162796|102025896|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
33583563|NCT03162796|102025894|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
33583564|NCT03162796|102025895|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
33644765|NCT02405442|102252627|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
33644766|NCT02405442|102252624|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
33644767|NCT02405442|102252625|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
33644768|NCT02405442|102252626|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
33583565|NCT03162796|102025896|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
33583566|NCT03162796|102025894|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
33583567|NCT03162796|102025895|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
33583568|NCT03162796|102025896|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
33583569|NCT03162796|102025894|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
33583570|NCT03162796|102025895|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
33583571|NCT03162796|102025896|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
33583572|NCT00819156|102025897|FG000|Overall Study|Adverse Event|1|||
33583573|NCT00819156|102025898|FG001|Overall Study|Adverse Event|4|||
33583574|NCT00819156|102025899|FG002|Overall Study|Adverse Event|2|||
33644769|NCT02405442|102252627|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
33644770|NCT02405442|102252624|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
33644771|NCT02405442|102252625|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
33644772|NCT02405442|102252626|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
33146495|NCT02038829|100451607|FG009|Treatment Period 2|Withdrawal by Subject|0|||
33146496|NCT02038829|100451608|FG010|Treatment Period 2|Withdrawal by Subject|0|||
33146497|NCT02038829|100451609|FG011|Treatment Period 2|Withdrawal by Subject|0|||
33373166|NCT00696657|101252064|FG002|Overall Study|Adverse Event|3|||
33373167|NCT00696657|101252065|FG003|Overall Study|Adverse Event|7|||
33583575|NCT00819156|102025900|FG003|Overall Study|Adverse Event|1|||
33583576|NCT00819156|102025901|FG004|Overall Study|Adverse Event|2|||
33373168|NCT00696657|101252066|FG004|Overall Study|Adverse Event|6|||
33146498|NCT02038829|100451598|FG000|Washout Period 2|Adverse Event|0|||
33146499|NCT02038829|100451599|FG001|Washout Period 2|Adverse Event|0|||
33146500|NCT02038829|100451600|FG002|Washout Period 2|Adverse Event|0|||
33146501|NCT02038829|100451601|FG003|Washout Period 2|Adverse Event|0|||
33146502|NCT02038829|100451602|FG004|Washout Period 2|Adverse Event|0|||
33146503|NCT02038829|100451603|FG005|Washout Period 2|Adverse Event|0|||
33146504|NCT02038829|100451604|FG006|Washout Period 2|Adverse Event|0|||
33146505|NCT02038829|100451605|FG007|Washout Period 2|Adverse Event|0|||
33146506|NCT02038829|100451606|FG008|Washout Period 2|Adverse Event|1|||
33146507|NCT02038829|100451607|FG009|Washout Period 2|Adverse Event|0|||
33146508|NCT02038829|100451608|FG010|Washout Period 2|Adverse Event|0|||
33146509|NCT02038829|100451609|FG011|Washout Period 2|Adverse Event|0|||
33146510|NCT02038829|100451598|FG000|Washout Period 2|Withdrawal by Subject|0|||
33146511|NCT02038829|100451599|FG001|Washout Period 2|Withdrawal by Subject|0|||
33146512|NCT02038829|100451600|FG002|Washout Period 2|Withdrawal by Subject|0|||
33146513|NCT02038829|100451601|FG003|Washout Period 2|Withdrawal by Subject|0|||
33146514|NCT02038829|100451602|FG004|Washout Period 2|Withdrawal by Subject|0|||
33146515|NCT02038829|100451603|FG005|Washout Period 2|Withdrawal by Subject|1|||
33146516|NCT02038829|100451604|FG006|Washout Period 2|Withdrawal by Subject|0|||
33146517|NCT02038829|100451605|FG007|Washout Period 2|Withdrawal by Subject|0|||
33146518|NCT02038829|100451606|FG008|Washout Period 2|Withdrawal by Subject|0|||
33146519|NCT02038829|100451607|FG009|Washout Period 2|Withdrawal by Subject|0|||
33146520|NCT02038829|100451608|FG010|Washout Period 2|Withdrawal by Subject|0|||
33146521|NCT02038829|100451609|FG011|Washout Period 2|Withdrawal by Subject|0|||
33146522|NCT02038829|100451598|FG000|Treatment Period 4|Adverse Event|0|||
33146523|NCT02038829|100451599|FG001|Treatment Period 4|Adverse Event|1|||
33146524|NCT02038829|100451600|FG002|Treatment Period 4|Adverse Event|0|||
33146525|NCT02038829|100451601|FG003|Treatment Period 4|Adverse Event|0|||
33146526|NCT02038829|100451602|FG004|Treatment Period 4|Adverse Event|0|||
33244744|NCT02014558|100797051|FG012|Overall Study|Lack of Efficacy|5|||
33244745|NCT02014558|100797039|FG000|Overall Study|Lost to Follow-up|0|||
33244746|NCT02014558|100797040|FG001|Overall Study|Lost to Follow-up|0|||
33244747|NCT02014558|100797041|FG002|Overall Study|Lost to Follow-up|0|||
33244748|NCT02014558|100797042|FG003|Overall Study|Lost to Follow-up|0|||
33244749|NCT02014558|100797043|FG004|Overall Study|Lost to Follow-up|0|||
33244750|NCT02014558|100797044|FG005|Overall Study|Lost to Follow-up|0|||
33244751|NCT02014558|100797045|FG006|Overall Study|Lost to Follow-up|0|||
33244752|NCT02014558|100797046|FG007|Overall Study|Lost to Follow-up|0|||
33244753|NCT02014558|100797047|FG008|Overall Study|Lost to Follow-up|0|||
33244754|NCT02014558|100797048|FG009|Overall Study|Lost to Follow-up|0|||
33244755|NCT02014558|100797049|FG010|Overall Study|Lost to Follow-up|1|||
33244756|NCT02014558|100797050|FG011|Overall Study|Lost to Follow-up|0|||
33244757|NCT02014558|100797051|FG012|Overall Study|Lost to Follow-up|0|||
33244758|NCT02014558|100797039|FG000|Overall Study|Progressive Disease|1|||
33244759|NCT02014558|100797040|FG001|Overall Study|Progressive Disease|0|||
33244760|NCT02014558|100797041|FG002|Overall Study|Progressive Disease|1|||
33244761|NCT02014558|100797042|FG003|Overall Study|Progressive Disease|1|||
33244762|NCT02014558|100797043|FG004|Overall Study|Progressive Disease|1|||
33373169|NCT00696657|101252067|FG005|Overall Study|Adverse Event|9|||
33373170|NCT00696657|101252068|FG006|Overall Study|Adverse Event|14|||
33373171|NCT00696657|101252069|FG007|Overall Study|Adverse Event|2|||
33373172|NCT00696657|101252070|FG008|Overall Study|Adverse Event|5|||
33373173|NCT02006667|101252071|FG000|Overall Study|Adverse Event|3|||
33373174|NCT02006667|101252071|FG000|Overall Study|Death|2|||
33373175|NCT02006667|101252071|FG000|Overall Study|Withdrawal by Subject|1|||
33373176|NCT01111539|101252078|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
33373177|NCT01111539|101252079|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33373178|NCT01111539|101252080|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33373179|NCT01111539|101252081|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33373180|NCT01111539|101252082|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
33146527|NCT02038829|100451603|FG005|Treatment Period 4|Adverse Event|0|||
33146528|NCT02038829|100451604|FG006|Treatment Period 4|Adverse Event|0|||
33146529|NCT02038829|100451605|FG007|Treatment Period 4|Adverse Event|0|||
33146530|NCT02038829|100451606|FG008|Treatment Period 4|Adverse Event|0|||
33244763|NCT02014558|100797044|FG005|Overall Study|Progressive Disease|2|||
33244764|NCT02014558|100797045|FG006|Overall Study|Progressive Disease|1|||
33373181|NCT01111539|101252078|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
33146531|NCT02038829|100451607|FG009|Treatment Period 4|Adverse Event|0|||
33146532|NCT02038829|100451608|FG010|Treatment Period 4|Adverse Event|0|||
33146533|NCT02038829|100451609|FG011|Treatment Period 4|Adverse Event|0|||
33146534|NCT02038829|100451598|FG000|Washout Period 4|Adverse Event|0|||
33244765|NCT02014558|100797046|FG007|Overall Study|Progressive Disease|6|||
33244766|NCT02014558|100797047|FG008|Overall Study|Progressive Disease|5|||
33146535|NCT02038829|100451599|FG001|Washout Period 4|Adverse Event|0|||
33146536|NCT02038829|100451600|FG002|Washout Period 4|Adverse Event|0|||
33244767|NCT02014558|100797048|FG009|Overall Study|Progressive Disease|6|||
33244768|NCT02014558|100797049|FG010|Overall Study|Progressive Disease|22|||
33244769|NCT02014558|100797050|FG011|Overall Study|Progressive Disease|31|||
33244770|NCT02014558|100797051|FG012|Overall Study|Progressive Disease|6|||
33244771|NCT02014558|100797039|FG000|Overall Study|Withdrawal by Subject|0|||
33244772|NCT02014558|100797040|FG001|Overall Study|Withdrawal by Subject|0|||
33244773|NCT02014558|100797041|FG002|Overall Study|Withdrawal by Subject|0|||
33244774|NCT02014558|100797042|FG003|Overall Study|Withdrawal by Subject|0|||
33244775|NCT02014558|100797043|FG004|Overall Study|Withdrawal by Subject|1|||
33244776|NCT02014558|100797044|FG005|Overall Study|Withdrawal by Subject|0|||
33244777|NCT02014558|100797045|FG006|Overall Study|Withdrawal by Subject|0|||
33244778|NCT02014558|100797046|FG007|Overall Study|Withdrawal by Subject|0|||
33244779|NCT02014558|100797047|FG008|Overall Study|Withdrawal by Subject|0|||
33244780|NCT02014558|100797048|FG009|Overall Study|Withdrawal by Subject|2|||
33244781|NCT02014558|100797049|FG010|Overall Study|Withdrawal by Subject|6|||
33244782|NCT02014558|100797050|FG011|Overall Study|Withdrawal by Subject|10|||
33244783|NCT02014558|100797051|FG012|Overall Study|Withdrawal by Subject|0|||
33244784|NCT02014558|100797039|FG000|Overall Study|Miscellaneous|2|||
33244785|NCT02014558|100797040|FG001|Overall Study|Miscellaneous|1|||
33244786|NCT02014558|100797041|FG002|Overall Study|Miscellaneous|1|||
33244787|NCT02014558|100797042|FG003|Overall Study|Miscellaneous|1|||
33244788|NCT02014558|100797043|FG004|Overall Study|Miscellaneous|0|||
33244789|NCT02014558|100797044|FG005|Overall Study|Miscellaneous|1|||
33244790|NCT02014558|100797045|FG006|Overall Study|Miscellaneous|0|||
33244791|NCT02014558|100797046|FG007|Overall Study|Miscellaneous|1|||
33244792|NCT02014558|100797047|FG008|Overall Study|Miscellaneous|1|||
33244793|NCT02014558|100797048|FG009|Overall Study|Miscellaneous|3|||
33244794|NCT02014558|100797049|FG010|Overall Study|Miscellaneous|12|||
33244795|NCT02014558|100797050|FG011|Overall Study|Miscellaneous|11|||
33244796|NCT02014558|100797051|FG012|Overall Study|Miscellaneous|1|||
33244797|NCT00256308|100797052|FG000|Overall Study|Death|2|||
33244798|NCT03441984|100797053|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33244799|NCT03441984|100797054|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33244800|NCT03441984|100797055|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
33244801|NCT03441984|100797056|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33244802|NCT03441984|100797057|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33244803|NCT03441984|100797058|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33244804|NCT03441984|100797059|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33244805|NCT03441984|100797060|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33244806|NCT03441984|100797061|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33244807|NCT03441984|100797062|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33244808|NCT03441984|100797063|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33244809|NCT03441984|100797064|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
33244810|NCT03141788|100797065|FG000|Overall Study|Lost to Follow-up|1|||
33244811|NCT03141788|100797065|FG000|Overall Study|Protocol Violation|3|||
33244812|NCT03141788|100797065|FG000|Overall Study|Withdrawal by Subject|4|||
33244813|NCT03303105|100797066|FG000|Overall Study|Adverse Event|0|||
33244814|NCT03303105|100797067|FG001|Overall Study|Adverse Event|2|||
33244815|NCT03303105|100797066|FG000|Overall Study|Lack of Efficacy|1|||
33244816|NCT03303105|100797067|FG001|Overall Study|Lack of Efficacy|0|||
33244817|NCT03303105|100797066|FG000|Overall Study|Protocol Violation|1|||
33244818|NCT03303105|100797067|FG001|Overall Study|Protocol Violation|0|||
33244819|NCT03303105|100797066|FG000|Overall Study|Withdrawal by Subject|0|||
33244820|NCT03303105|100797067|FG001|Overall Study|Withdrawal by Subject|2|||
33244821|NCT01278862|100797068|FG000|Overall Study|Lost to Follow-up|1|||
33244822|NCT01278862|100797069|FG001|Overall Study|Lost to Follow-up|1|||
33244823|NCT02403323|100797070|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
33244824|NCT02403323|100797071|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
33244825|NCT02403323|100797072|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
33244826|NCT02403323|100797070|FG000|Part 1: Open Label Extension Period|Death|3|||
33244827|NCT02403323|100797071|FG001|Part 1: Open Label Extension Period|Death|0|||
33244828|NCT02403323|100797072|FG002|Part 1: Open Label Extension Period|Death|0|||
33373182|NCT01111539|101252079|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33373183|NCT01111539|101252080|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33422991|NCT02164539|101439791|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
33422992|NCT02164539|101439792|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
33422993|NCT02164539|101439793|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
33373184|NCT01111539|101252081|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33422994|NCT02164539|101439794|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
33422995|NCT02164539|101439788|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
33146537|NCT02038829|100451601|FG003|Washout Period 4|Adverse Event|0|||
33244829|NCT02403323|100797070|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
33244830|NCT02403323|100797071|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
33244831|NCT02403323|100797072|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
33244832|NCT02403323|100797070|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
33244833|NCT02403323|100797071|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
33244834|NCT02403323|100797072|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
33244835|NCT02403323|100797070|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
33244836|NCT02403323|100797071|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
33244837|NCT02403323|100797072|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
33244838|NCT02403323|100797070|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
33244839|NCT02403323|100797071|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
33244840|NCT02403323|100797072|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
33244841|NCT02403323|100797070|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
33244842|NCT02403323|100797071|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
33244843|NCT02403323|100797072|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
33244844|NCT02403323|100797070|FG000|Part 1: Open Label Extension Period|Other|1|||
33244845|NCT02403323|100797071|FG001|Part 1: Open Label Extension Period|Other|0|||
33244846|NCT02403323|100797072|FG002|Part 1: Open Label Extension Period|Other|0|||
33244847|NCT02403323|100797070|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
33244848|NCT02403323|100797071|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
33244849|NCT02403323|100797072|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
33244850|NCT02403323|100797070|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
33244851|NCT02403323|100797071|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
33244852|NCT02403323|100797072|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
33244853|NCT02403323|100797070|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
33244854|NCT02403323|100797071|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
33244855|NCT02403323|100797072|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
33244856|NCT02403323|100797070|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
33244857|NCT02403323|100797071|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
33244858|NCT02403323|100797072|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
33244859|NCT02403323|100797070|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
33244860|NCT02403323|100797071|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
33244861|NCT02403323|100797072|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
33244862|NCT02403323|100797070|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
33244863|NCT02403323|100797071|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
33244864|NCT02403323|100797072|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
33244865|NCT02403323|100797070|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
33244866|NCT02403323|100797071|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
33244867|NCT02403323|100797072|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
33244868|NCT02403323|100797070|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
33244869|NCT02403323|100797071|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
33244870|NCT02403323|100797072|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
33244871|NCT02403323|100797070|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
33244872|NCT02403323|100797071|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
33244873|NCT02403323|100797072|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
33244874|NCT02403323|100797070|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
33244875|NCT02403323|100797071|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
33244876|NCT02403323|100797072|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
33244877|NCT03120676|100797073|FG000|Overall Study|Not treated|1|||
33244878|NCT00672256|100797076|FG000|Overall Study|PI dropped, bad data|44|||
33244879|NCT01833065|100797077|FG000|Overall Study|Adverse Event|6|||
33244880|NCT01833065|100797078|FG001|Overall Study|Adverse Event|1|||
33244881|NCT01833065|100797079|FG002|Overall Study|Adverse Event|0|||
33244882|NCT01833065|100797080|FG003|Overall Study|Adverse Event|2|||
33244883|NCT01833065|100797081|FG004|Overall Study|Adverse Event|3|||
33244884|NCT01833065|100797077|FG000|Overall Study|Protocol Violation|1|||
33244885|NCT01833065|100797078|FG001|Overall Study|Protocol Violation|0|||
33244886|NCT01833065|100797079|FG002|Overall Study|Protocol Violation|0|||
33244887|NCT01833065|100797080|FG003|Overall Study|Protocol Violation|0|||
33244888|NCT01833065|100797081|FG004|Overall Study|Protocol Violation|2|||
33244889|NCT01833065|100797077|FG000|Overall Study|Lost to Follow-up|1|||
33244890|NCT01833065|100797078|FG001|Overall Study|Lost to Follow-up|0|||
33244891|NCT01833065|100797079|FG002|Overall Study|Lost to Follow-up|0|||
33373185|NCT01111539|101252082|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
33583577|NCT00819156|102025902|FG005|Overall Study|Adverse Event|3|||
33146538|NCT02038829|100451602|FG004|Washout Period 4|Adverse Event|0|||
33146539|NCT02038829|100451603|FG005|Washout Period 4|Adverse Event|0|||
33146540|NCT02038829|100451604|FG006|Washout Period 4|Adverse Event|1|||
33244892|NCT01833065|100797080|FG003|Overall Study|Lost to Follow-up|0|||
33244893|NCT01833065|100797081|FG004|Overall Study|Lost to Follow-up|3|||
33244894|NCT01833065|100797077|FG000|Overall Study|Withdrawal by Subject|6|||
33244895|NCT01833065|100797078|FG001|Overall Study|Withdrawal by Subject|2|||
33244896|NCT01833065|100797079|FG002|Overall Study|Withdrawal by Subject|4|||
33244897|NCT01833065|100797080|FG003|Overall Study|Withdrawal by Subject|3|||
33244898|NCT01833065|100797081|FG004|Overall Study|Withdrawal by Subject|11|||
33244899|NCT01833065|100797077|FG000|Overall Study|Subject's substantial non-compliance|0|||
33244900|NCT01833065|100797078|FG001|Overall Study|Subject's substantial non-compliance|1|||
33244901|NCT01833065|100797079|FG002|Overall Study|Subject's substantial non-compliance|0|||
33244902|NCT01833065|100797080|FG003|Overall Study|Subject's substantial non-compliance|0|||
33244903|NCT01833065|100797081|FG004|Overall Study|Subject's substantial non-compliance|0|||
33373186|NCT01111539|101252078|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
33373187|NCT01111539|101252079|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33373188|NCT01111539|101252080|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33373189|NCT01111539|101252081|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33373190|NCT01111539|101252082|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
33373191|NCT01111539|101252078|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
33373192|NCT01111539|101252079|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
33373193|NCT01111539|101252080|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
33373194|NCT01111539|101252081|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
33373195|NCT01111539|101252082|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
33373196|NCT01111539|101252078|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
33373197|NCT01111539|101252079|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
33373198|NCT01111539|101252080|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
33373199|NCT01111539|101252081|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
33373200|NCT01111539|101252082|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
33373201|NCT01111539|101252078|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
33373202|NCT01111539|101252079|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33373203|NCT01111539|101252080|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33583578|NCT00819156|102025897|FG000|Overall Study|Withdrawal by Subject|0|||
33583579|NCT00819156|102025898|FG001|Overall Study|Withdrawal by Subject|3|||
33244904|NCT01833065|100797077|FG000|Overall Study|Trial terminated by sponsor|8|||
33244905|NCT01833065|100797078|FG001|Overall Study|Trial terminated by sponsor|8|||
33244906|NCT01833065|100797079|FG002|Overall Study|Trial terminated by sponsor|7|||
33244907|NCT01833065|100797080|FG003|Overall Study|Trial terminated by sponsor|3|||
33244908|NCT01833065|100797081|FG004|Overall Study|Trial terminated by sponsor|13|||
33244909|NCT01833065|100797077|FG000|Overall Study|Others|2|||
33244910|NCT01833065|100797078|FG001|Overall Study|Others|1|||
33244911|NCT01833065|100797079|FG002|Overall Study|Others|1|||
33244912|NCT01833065|100797080|FG003|Overall Study|Others|1|||
33244913|NCT01833065|100797081|FG004|Overall Study|Others|4|||
33244914|NCT02306161|100797082|FG000|Overall Study|Death|1|||
33244915|NCT02306161|100797083|FG001|Overall Study|Death|3|||
33244916|NCT02306161|100797082|FG000|Overall Study|Lack of Efficacy|20|||
33244917|NCT02306161|100797083|FG001|Overall Study|Lack of Efficacy|43|||
33244918|NCT02306161|100797082|FG000|Overall Study|Physician Decision|30|||
33244919|NCT02306161|100797083|FG001|Overall Study|Physician Decision|18|||
33244920|NCT02306161|100797082|FG000|Overall Study|Withdrawal by Subject|4|||
33244921|NCT02306161|100797083|FG001|Overall Study|Withdrawal by Subject|0|||
33244922|NCT02306161|100797082|FG000|Overall Study|Ineligible|9|||
33244923|NCT02306161|100797083|FG001|Overall Study|Ineligible|5|||
33244924|NCT00868231|100797084|FG000|Treatment Period 1|Adverse Event|0|||
33244925|NCT00868231|100797085|FG001|Treatment Period 1|Adverse Event|0|||
33244926|NCT00868231|100797086|FG002|Treatment Period 1|Adverse Event|0|||
33244927|NCT00868231|100797087|FG003|Treatment Period 1|Adverse Event|0|||
33244928|NCT00868231|100797088|FG004|Treatment Period 1|Adverse Event|1|||
33244929|NCT00868231|100797089|FG005|Treatment Period 1|Adverse Event|0|||
33244930|NCT00868231|100797084|FG000|Treatment Period 2|Adverse Event|1|||
33244931|NCT00868231|100797085|FG001|Treatment Period 2|Adverse Event|0|||
33244932|NCT00868231|100797086|FG002|Treatment Period 2|Adverse Event|0|||
33244933|NCT00868231|100797087|FG003|Treatment Period 2|Adverse Event|0|||
33244934|NCT00868231|100797088|FG004|Treatment Period 2|Adverse Event|0|||
33244935|NCT00868231|100797089|FG005|Treatment Period 2|Adverse Event|0|||
33244936|NCT00868231|100797084|FG000|Treatment Period 3|Adverse Event|0|||
33244937|NCT00868231|100797085|FG001|Treatment Period 3|Adverse Event|0|||
33244938|NCT00868231|100797086|FG002|Treatment Period 3|Adverse Event|1|||
33244939|NCT00868231|100797087|FG003|Treatment Period 3|Adverse Event|0|||
33244940|NCT00868231|100797088|FG004|Treatment Period 3|Adverse Event|0|||
33583580|NCT00819156|102025899|FG002|Overall Study|Withdrawal by Subject|2|||
33583581|NCT00819156|102025900|FG003|Overall Study|Withdrawal by Subject|0|||
33373204|NCT01111539|101252081|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33373205|NCT01111539|101252082|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
33244941|NCT00868231|100797089|FG005|Treatment Period 3|Adverse Event|0|||
33244942|NCT01684046|100797094|FG000|Period 1, First 30 Days|Adverse Event|0|||
33244943|NCT01684046|100797095|FG001|Period 1, First 30 Days|Adverse Event|2|||
33244944|NCT02040844|100797100|FG000|Overall Study|Adverse Event|0|||
33244945|NCT02040844|100797101|FG001|Overall Study|Adverse Event|0|||
33244946|NCT02040844|100797102|FG002|Overall Study|Adverse Event|1|||
33244947|NCT02040844|100797100|FG000|Overall Study|Withdrawal by Subject|16|||
33244948|NCT02040844|100797101|FG001|Overall Study|Withdrawal by Subject|22|||
33244949|NCT02040844|100797102|FG002|Overall Study|Withdrawal by Subject|25|||
33244950|NCT02040844|100797100|FG000|Overall Study|Lost to Follow-up|12|||
33373206|NCT01111539|101252078|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
33373207|NCT01111539|101252079|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
33373208|NCT01111539|101252080|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
33373209|NCT01111539|101252081|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
33373210|NCT01111539|101252082|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
33373211|NCT01111539|101252078|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
33373212|NCT01111539|101252079|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
33373213|NCT01111539|101252080|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
33373214|NCT01111539|101252081|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
33373215|NCT01111539|101252082|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
33373216|NCT01111539|101252078|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33373217|NCT01111539|101252079|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33373218|NCT01111539|101252080|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
33373219|NCT01111539|101252081|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
33373220|NCT01111539|101252082|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
33373221|NCT01111539|101252078|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
33373222|NCT01111539|101252079|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
33373223|NCT01111539|101252080|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
33373224|NCT01111539|101252081|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
33373225|NCT01111539|101252082|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
33373226|NCT01111539|101252078|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
33373227|NCT01111539|101252079|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
33583582|NCT00819156|102025901|FG004|Overall Study|Withdrawal by Subject|1|||
33583583|NCT00819156|102025902|FG005|Overall Study|Withdrawal by Subject|0|||
33146541|NCT02038829|100451605|FG007|Washout Period 4|Adverse Event|0|||
33146542|NCT02038829|100451606|FG008|Washout Period 4|Adverse Event|0|||
33146543|NCT02038829|100451607|FG009|Washout Period 4|Adverse Event|0|||
33146544|NCT02038829|100451608|FG010|Washout Period 4|Adverse Event|0|||
33146545|NCT02038829|100451609|FG011|Washout Period 4|Adverse Event|0|||
33146546|NCT02038829|100451598|FG000|Treatment Period 6|Adverse Event|0|||
33146547|NCT02038829|100451599|FG001|Treatment Period 6|Adverse Event|0|||
33146548|NCT02038829|100451600|FG002|Treatment Period 6|Adverse Event|1|||
33146549|NCT02038829|100451601|FG003|Treatment Period 6|Adverse Event|0|||
33146550|NCT02038829|100451602|FG004|Treatment Period 6|Adverse Event|0|||
33146551|NCT02038829|100451603|FG005|Treatment Period 6|Adverse Event|0|||
33146552|NCT02038829|100451604|FG006|Treatment Period 6|Adverse Event|0|||
33146553|NCT02038829|100451605|FG007|Treatment Period 6|Adverse Event|0|||
33146554|NCT02038829|100451606|FG008|Treatment Period 6|Adverse Event|0|||
33146555|NCT02038829|100451607|FG009|Treatment Period 6|Adverse Event|0|||
33146556|NCT02038829|100451608|FG010|Treatment Period 6|Adverse Event|0|||
33146557|NCT02038829|100451609|FG011|Treatment Period 6|Adverse Event|0|||
33146558|NCT01931202|100451611|FG000|Overall Study|Withdrawal by Subject|0|||
33146559|NCT01931202|100451612|FG001|Overall Study|Withdrawal by Subject|0|||
33146560|NCT01931202|100451613|FG002|Overall Study|Withdrawal by Subject|2|||
33146561|NCT01931202|100451611|FG000|Overall Study|Lost to Follow-up|0|||
33146562|NCT01931202|100451612|FG001|Overall Study|Lost to Follow-up|5|||
33146563|NCT01931202|100451613|FG002|Overall Study|Lost to Follow-up|2|||
33146564|NCT03687970|100451614|FG000|Overall Study|visit scheduling conflicts|2|||
33146565|NCT03687970|100451615|FG001|Overall Study|visit scheduling conflicts|0|||
33146566|NCT04041700|100451626|FG000|Overall Study|Pregnancy|1|||
33146567|NCT04041700|100451626|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
33146568|NCT02359851|100451632|FG000|Overall Study|Death|1|||
33146569|NCT02359851|100451632|FG000|Overall Study|Disease progression|1|||
33146570|NCT04085367|100451633|FG000|Overall Study|Adverse Event|1|||
33146571|NCT04085367|100451634|FG001|Overall Study|Adverse Event|1|||
33146572|NCT04085367|100451633|FG000|Overall Study|Withdrawal by Subject|13|||
33146573|NCT04085367|100451634|FG001|Overall Study|Withdrawal by Subject|4|||
33146574|NCT04085367|100451633|FG000|Overall Study|Lost to Follow-up|3|||
33146575|NCT04085367|100451634|FG001|Overall Study|Lost to Follow-up|1|||
33146576|NCT04085367|100451633|FG000|Overall Study|Other unspecified|2|||
33583584|NCT00819156|102025897|FG000|Overall Study|Protocol Violation|1|||
33583585|NCT00819156|102025898|FG001|Overall Study|Protocol Violation|0|||
33583586|NCT00819156|102025899|FG002|Overall Study|Protocol Violation|1|||
33583587|NCT00819156|102025900|FG003|Overall Study|Protocol Violation|0|||
33583588|NCT00819156|102025901|FG004|Overall Study|Protocol Violation|0|||
33583589|NCT00819156|102025902|FG005|Overall Study|Protocol Violation|1|||
33146577|NCT04085367|100451634|FG001|Overall Study|Other unspecified|1|||
33146578|NCT04085367|100451633|FG000|Overall Study|Status Unknown|1|||
33146579|NCT04085367|100451634|FG001|Overall Study|Status Unknown|1|||
33146580|NCT02730208|100451635|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
33146581|NCT02730208|100451636|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
33244951|NCT02040844|100797101|FG001|Overall Study|Lost to Follow-up|9|||
33373228|NCT01111539|101252080|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
33373229|NCT01111539|101252081|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
33373230|NCT01111539|101252082|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
33373231|NCT01111539|101252078|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
33373232|NCT01111539|101252079|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
33373233|NCT01111539|101252080|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
33373234|NCT01111539|101252081|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
33422996|NCT02164539|101439789|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
33583590|NCT00819156|102025897|FG000|Overall Study|Lost to Follow-up|0|||
33583591|NCT00819156|102025898|FG001|Overall Study|Lost to Follow-up|1|||
33583592|NCT00819156|102025899|FG002|Overall Study|Lost to Follow-up|0|||
33244952|NCT02040844|100797102|FG002|Overall Study|Lost to Follow-up|13|||
33244953|NCT02040844|100797100|FG000|Overall Study|Missing|13|||
33244954|NCT02040844|100797101|FG001|Overall Study|Missing|3|||
33244955|NCT02040844|100797102|FG002|Overall Study|Missing|2|||
33244956|NCT02040844|100797100|FG000|Overall Study|Non-specified|8|||
33244957|NCT02040844|100797101|FG001|Overall Study|Non-specified|2|||
33244958|NCT02040844|100797102|FG002|Overall Study|Non-specified|5|||
33244959|NCT02040844|100797100|FG000|Overall Study|Concomitant medication|1|||
33244960|NCT02040844|100797101|FG001|Overall Study|Concomitant medication|3|||
33244961|NCT02040844|100797102|FG002|Overall Study|Concomitant medication|1|||
33244962|NCT02374957|100797103|FG000|Overall Study|Patient did not complete forms correctly|1|||
33244963|NCT02374957|100797104|FG001|Overall Study|Patient did not complete forms correctly|0|||
33244964|NCT04269889|100797105|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|1|||
33244965|NCT04269889|100797105|FG000|Extended Phase (6 Months to Year 3)|Lack of Efficacy|13|||
33244966|NCT00498186|100797106|FG000|Overall Study|Protocol Violation|10|||
33244967|NCT00498186|100797106|FG000|Overall Study|Lack of Efficacy|31|||
33244968|NCT00498186|100797106|FG000|Overall Study|Adverse Event|89|||
33244969|NCT00498186|100797106|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
33244970|NCT00498186|100797106|FG000|Overall Study|Withdrawal by Subject|18|||
33244971|NCT00498186|100797106|FG000|Overall Study|Lost to Follow-up|3|||
33244972|NCT00498186|100797106|FG000|Overall Study|Other|10|||
33244973|NCT03425643|100797107|FG000|Overall Study|Withdrawal by Subject|10|||
33244974|NCT03425643|100797108|FG001|Overall Study|Withdrawal by Subject|12|||
33244975|NCT03425643|100797107|FG000|Overall Study|Lost to Follow-up|2|||
33244976|NCT03425643|100797108|FG001|Overall Study|Lost to Follow-up|0|||
33244977|NCT03425643|100797107|FG000|Overall Study|Death|109|||
33244978|NCT03425643|100797108|FG001|Overall Study|Death|141|||
33244979|NCT03425643|100797107|FG000|Overall Study|Ongoing in study|276|||
33244980|NCT03425643|100797108|FG001|Overall Study|Ongoing in study|247|||
33244981|NCT00828919|100797114|FG000|Overall Study|Death|0|||
33244982|NCT00828919|100797115|FG001|Overall Study|Death|1|||
33244983|NCT00828919|100797116|FG002|Overall Study|Death|2|||
33244984|NCT00828919|100797117|FG003|Overall Study|Death|0|||
33244985|NCT00828919|100797118|FG004|Overall Study|Death|0|||
33422997|NCT02164539|101439790|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
33422998|NCT02164539|101439791|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
33583593|NCT00819156|102025900|FG003|Overall Study|Lost to Follow-up|0|||
33583594|NCT00819156|102025901|FG004|Overall Study|Lost to Follow-up|0|||
33583595|NCT00819156|102025902|FG005|Overall Study|Lost to Follow-up|2|||
33583596|NCT00819156|102025897|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
33583597|NCT00819156|102025898|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
33583598|NCT00819156|102025899|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
33583599|NCT00819156|102025900|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
33583600|NCT00819156|102025901|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
33583601|NCT00819156|102025902|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
33583602|NCT00819156|102025897|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
33583603|NCT00819156|102025898|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
33583604|NCT00819156|102025899|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
33583605|NCT00819156|102025900|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
33583606|NCT00819156|102025901|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
33583607|NCT00819156|102025902|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
33583608|NCT00819156|102025897|FG000|Overall Study|Prostate-specific antigen progression|0|||
33583609|NCT00819156|102025898|FG001|Overall Study|Prostate-specific antigen progression|0|||
33583610|NCT00819156|102025899|FG002|Overall Study|Prostate-specific antigen progression|0|||
33244986|NCT00828919|100797114|FG000|Overall Study|Adverse Event|2|||
33244987|NCT00828919|100797115|FG001|Overall Study|Adverse Event|2|||
33244988|NCT00828919|100797116|FG002|Overall Study|Adverse Event|2|||
33244989|NCT00828919|100797117|FG003|Overall Study|Adverse Event|1|||
33244990|NCT00828919|100797118|FG004|Overall Study|Adverse Event|3|||
33244991|NCT00828919|100797114|FG000|Overall Study|Objective progression or relapse|4|||
33244992|NCT00828919|100797115|FG001|Overall Study|Objective progression or relapse|4|||
33244993|NCT00828919|100797116|FG002|Overall Study|Objective progression or relapse|11|||
33244994|NCT00828919|100797117|FG003|Overall Study|Objective progression or relapse|0|||
33373235|NCT01111539|101252082|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
33373236|NCT01111539|101252078|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
33373237|NCT01111539|101252079|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
33373238|NCT01111539|101252080|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
33583611|NCT00819156|102025900|FG003|Overall Study|Prostate-specific antigen progression|0|||
33644773|NCT02405442|102252627|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
33644774|NCT02405442|102252624|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
33644775|NCT02405442|102252625|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
33644776|NCT02405442|102252626|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
33644777|NCT02405442|102252627|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
33644778|NCT02405442|102252624|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
33644779|NCT02405442|102252625|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
33644780|NCT02405442|102252626|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
33644781|NCT02405442|102252627|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
33373239|NCT01111539|101252081|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
33583612|NCT00819156|102025901|FG004|Overall Study|Prostate-specific antigen progression|1|||
33583613|NCT00819156|102025902|FG005|Overall Study|Prostate-specific antigen progression|0|||
33583614|NCT02229825|102025907|FG000|Overall Study|Personal Reasons|0|||
33583615|NCT02229825|102025908|FG001|Overall Study|Personal Reasons|1|||
33583616|NCT02229825|102025907|FG000|Overall Study|Refused continuing medication|7|||
33583617|NCT02229825|102025908|FG001|Overall Study|Refused continuing medication|6|||
33583618|NCT02229825|102025907|FG000|Overall Study|Lost to Follow-up|1|||
33583619|NCT02229825|102025908|FG001|Overall Study|Lost to Follow-up|2|||
33583620|NCT02229825|102025907|FG000|Overall Study|Protocol Violation|1|||
33583621|NCT02229825|102025908|FG001|Overall Study|Protocol Violation|1|||
33583622|NCT02229825|102025907|FG000|Overall Study|Lack of Efficacy|4|||
33583623|NCT02229825|102025908|FG001|Overall Study|Lack of Efficacy|10|||
33583624|NCT02229825|102025907|FG000|Overall Study|Adverse Event|11|||
33583625|NCT02229825|102025908|FG001|Overall Study|Adverse Event|9|||
33583626|NCT02229825|102025907|FG000|Overall Study|Not treated|0|||
33583627|NCT02229825|102025908|FG001|Overall Study|Not treated|1|||
33583628|NCT02595866|102025909|FG000|Overall Study|Adverse Event|2|||
33583629|NCT02595866|102025910|FG001|Overall Study|Adverse Event|5|||
33583630|NCT02595866|102025909|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
33583631|NCT02595866|102025910|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
33583632|NCT02595866|102025909|FG000|Overall Study|Death|0|||
33583633|NCT02595866|102025910|FG001|Overall Study|Death|1|||
33583634|NCT02595866|102025909|FG000|Overall Study|Incarceration|1|||
33583635|NCT02595866|102025910|FG001|Overall Study|Incarceration|0|||
33583636|NCT02595866|102025909|FG000|Overall Study|Lack of Efficacy|17|||
33583637|NCT02595866|102025910|FG001|Overall Study|Lack of Efficacy|7|||
33583638|NCT02595866|102025909|FG000|Overall Study|Physician Decision|4|||
33583639|NCT02595866|102025910|FG001|Overall Study|Physician Decision|3|||
33583640|NCT02595866|102025909|FG000|Overall Study|Switched to Alternative Treatment|1|||
33583641|NCT02595866|102025910|FG001|Overall Study|Switched to Alternative Treatment|0|||
33583642|NCT02595866|102025909|FG000|Overall Study|Study Terminated|0|||
33583643|NCT02595866|102025910|FG001|Overall Study|Study Terminated|4|||
33583644|NCT02595866|102025909|FG000|Overall Study|Withdrawal by Subject|6|||
33583645|NCT02595866|102025910|FG001|Overall Study|Withdrawal by Subject|1|||
33583646|NCT02201329|102025911|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
33583647|NCT02201329|102025911|FG000|Overall Study|Withdrawal by Subject|2|||
33583648|NCT00861692|102025915|FG000|Overall Study|Death|6|||
33583649|NCT00269087|102025918|FG000|Overall Study|Adverse Event|20|||
33583650|NCT00269087|102025918|FG000|Overall Study|Withdrawal by Subject|1|||
33583651|NCT00269087|102025918|FG000|Overall Study|Exacerbation of COPD|13|||
33583652|NCT01047007|102025919|FG000|Overall Study|Adverse Event|0|||
33583653|NCT01047007|102025920|FG001|Overall Study|Adverse Event|2|||
33583654|NCT01047007|102025921|FG002|Overall Study|Adverse Event|1|||
33583655|NCT01047007|102025922|FG003|Overall Study|Adverse Event|0|||
33583656|NCT01047007|102025919|FG000|Overall Study|Progressive Disease|2|||
33583657|NCT01047007|102025920|FG001|Overall Study|Progressive Disease|4|||
33583658|NCT01047007|102025921|FG002|Overall Study|Progressive Disease|1|||
33583659|NCT01047007|102025922|FG003|Overall Study|Progressive Disease|0|||
33583660|NCT03423238|102025923|FG000|Overall Study|Lost to Follow-up|1|||
33583661|NCT03423238|102025924|FG001|Overall Study|Lost to Follow-up|0|||
33583662|NCT03423238|102025923|FG000|Overall Study|Withdrawal by Subject|1|||
33583663|NCT03423238|102025924|FG001|Overall Study|Withdrawal by Subject|0|||
33583664|NCT00887159|102025925|FG000|Overall Study|Disease progression|6|||
33583665|NCT00887159|102025926|FG001|Overall Study|Disease progression|39|||
33583666|NCT00887159|102025927|FG002|Overall Study|Disease progression|33|||
33583667|NCT00887159|102025925|FG000|Overall Study|Adverse Event|3|||
33583668|NCT00887159|102025926|FG001|Overall Study|Adverse Event|4|||
33583669|NCT00887159|102025927|FG002|Overall Study|Adverse Event|17|||
33583670|NCT00887159|102025925|FG000|Overall Study|Death|2|||
33583671|NCT00887159|102025926|FG001|Overall Study|Death|2|||
33644782|NCT02405442|102252624|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
33644783|NCT02405442|102252625|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
33644784|NCT02405442|102252626|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
33644785|NCT02405442|102252627|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
33644786|NCT02405442|102252624|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
33644787|NCT02405442|102252625|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
33146582|NCT00920907|100451641|FG000|Induction Period|Adverse Event|0|||
33146583|NCT00920907|100451642|FG001|Induction Period|Adverse Event|2|||
33146584|NCT00920907|100451641|FG000|Induction Period|Death|1|||
33146585|NCT00920907|100451642|FG001|Induction Period|Death|1|||
33146586|NCT00920907|100451641|FG000|Induction Period|Disease Progression|12|||
33146587|NCT00920907|100451642|FG001|Induction Period|Disease Progression|11|||
33146588|NCT00920907|100451641|FG000|Induction Period|Study Drug Toxicity|8|||
33146589|NCT00920907|100451642|FG001|Induction Period|Study Drug Toxicity|6|||
33146590|NCT00920907|100451641|FG000|Induction Period|No longer meets study criteria|0|||
33146591|NCT00920907|100451642|FG001|Induction Period|No longer meets study criteria|1|||
33146592|NCT00920907|100451641|FG000|Induction Period|Withdrawal by Subject|1|||
33146593|NCT00920907|100451642|FG001|Induction Period|Withdrawal by Subject|1|||
33146594|NCT00920907|100451641|FG000|Maintenance Period|Disease Progression|3|||
33146595|NCT00920907|100451642|FG001|Maintenance Period|Disease Progression|7|||
33146596|NCT00920907|100451641|FG000|Maintenance Period|Administrative (study closure)|7|||
33146597|NCT00920907|100451642|FG001|Maintenance Period|Administrative (study closure)|2|||
33146598|NCT00920907|100451641|FG000|Maintenance Period|Study Drug Toxicity|0|||
33244995|NCT00828919|100797118|FG004|Overall Study|Objective progression or relapse|5|||
33244996|NCT00828919|100797114|FG000|Overall Study|No longer willing to participate in study|0|||
33244997|NCT00828919|100797115|FG001|Overall Study|No longer willing to participate in study|0|||
33244998|NCT00828919|100797116|FG002|Overall Study|No longer willing to participate in study|2|||
33244999|NCT00828919|100797117|FG003|Overall Study|No longer willing to participate in study|0|||
33245000|NCT00828919|100797118|FG004|Overall Study|No longer willing to participate in study|0|||
33245001|NCT00828919|100797114|FG000|Overall Study|Insufficient Clinical Response|0|||
33245002|NCT00828919|100797115|FG001|Overall Study|Insufficient Clinical Response|1|||
33245003|NCT00828919|100797116|FG002|Overall Study|Insufficient Clinical Response|2|||
33245004|NCT00828919|100797117|FG003|Overall Study|Insufficient Clinical Response|0|||
33245005|NCT00828919|100797118|FG004|Overall Study|Insufficient Clinical Response|0|||
33245006|NCT00828919|100797114|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
33245007|NCT00828919|100797115|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
33245008|NCT00828919|100797116|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
33245009|NCT00828919|100797117|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
33245010|NCT00828919|100797118|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
33245011|NCT00828919|100797114|FG000|Overall Study|Other|1|||
33245012|NCT00828919|100797115|FG001|Overall Study|Other|0|||
33245013|NCT00828919|100797116|FG002|Overall Study|Other|1|||
33245014|NCT00828919|100797117|FG003|Overall Study|Other|1|||
33245015|NCT00828919|100797118|FG004|Overall Study|Other|0|||
33245016|NCT00828919|100797114|FG000|Overall Study|Lost to Follow-up|0|||
33245017|NCT00828919|100797115|FG001|Overall Study|Lost to Follow-up|1|||
33245018|NCT00828919|100797116|FG002|Overall Study|Lost to Follow-up|0|||
33245019|NCT00828919|100797117|FG003|Overall Study|Lost to Follow-up|0|||
33644788|NCT02405442|102252626|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
33644789|NCT02405442|102252627|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
33644790|NCT02405442|102252624|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
33644791|NCT02405442|102252625|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
33644792|NCT02405442|102252626|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
33644793|NCT02405442|102252627|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
33644794|NCT02405442|102252624|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
33644795|NCT02405442|102252625|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
33644796|NCT02405442|102252626|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
33644797|NCT02405442|102252627|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
33644798|NCT02405442|102252624|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
33644799|NCT02405442|102252625|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
33644800|NCT02405442|102252626|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
33245020|NCT00828919|100797118|FG004|Overall Study|Lost to Follow-up|0|||
33146599|NCT00920907|100451642|FG001|Maintenance Period|Study Drug Toxicity|2|||
33146600|NCT00920907|100451641|FG000|Maintenance Period|Death|1|||
33146601|NCT00920907|100451642|FG001|Maintenance Period|Death|1|||
33146602|NCT00920907|100451641|FG000|Maintenance Period|Withdrawal by Subject|1|||
33146603|NCT00920907|100451642|FG001|Maintenance Period|Withdrawal by Subject|0|||
33245021|NCT03354390|100797119|FG000|Level 1|Death|2|||
33245022|NCT03354390|100797120|FG001|Level 1|Death|0|||
33245023|NCT03354390|100797121|FG002|Level 1|Death|0|||
33146604|NCT00920907|100451641|FG000|Maintenance Period|Adverse Event|0|||
33146605|NCT00920907|100451642|FG001|Maintenance Period|Adverse Event|1|||
33146606|NCT01336569|100451648|FG000|Overall Study|Lost to Follow-up|4|||
33146607|NCT02028871|100451649|FG000|Overall Study|Positive urine drug screen|1|||
33146608|NCT02028871|100451650|FG001|Overall Study|Positive urine drug screen|1|||
33146609|NCT02028871|100451649|FG000|Overall Study|Withdrawal by Subject|1|||
33146610|NCT02028871|100451650|FG001|Overall Study|Withdrawal by Subject|2|||
33146611|NCT02028871|100451649|FG000|Overall Study|IV placement difficulty|1|||
33146612|NCT02028871|100451650|FG001|Overall Study|IV placement difficulty|0|||
33146613|NCT02028871|100451649|FG000|Overall Study|Current Illness|1|||
33146614|NCT02028871|100451650|FG001|Overall Study|Current Illness|0|||
33146615|NCT03350984|100451651|FG000|Overall Study|Death|1|||
33146616|NCT03350984|100451652|FG001|Overall Study|Death|0|||
33146617|NCT03350984|100451651|FG000|Overall Study|Lost to Follow-up|5|||
33146618|NCT03350984|100451652|FG001|Overall Study|Lost to Follow-up|6|||
33146619|NCT03350984|100451651|FG000|Overall Study|Protocol Violation|1|||
33146620|NCT03350984|100451652|FG001|Overall Study|Protocol Violation|2|||
33146621|NCT03350984|100451651|FG000|Overall Study|Physician Decision|1|||
33146622|NCT03350984|100451652|FG001|Overall Study|Physician Decision|0|||
33146623|NCT02537574|100451653|FG000|Overall Study|Adverse Event|1|||
33146624|NCT02537574|100451654|FG001|Overall Study|Adverse Event|3|||
33146625|NCT02537574|100451655|FG002|Overall Study|Adverse Event|2|||
33146626|NCT02537574|100451653|FG000|Overall Study|Lost to Follow-up|40|||
33146627|NCT02537574|100451654|FG001|Overall Study|Lost to Follow-up|51|||
33146628|NCT02537574|100451655|FG002|Overall Study|Lost to Follow-up|55|||
33644801|NCT02405442|102252627|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
33644802|NCT03304249|102252638|FG000|Overall Study|Lost to Follow-up|8|||
33644803|NCT03304249|102252639|FG001|Overall Study|Lost to Follow-up|10|||
33644804|NCT03304249|102252638|FG000|Overall Study|Withdrawal by Subject|12|||
33644805|NCT03304249|102252639|FG001|Overall Study|Withdrawal by Subject|2|||
33644806|NCT03304249|102252638|FG000|Overall Study|Moved Out of District|4|||
33644807|NCT03304249|102252639|FG001|Overall Study|Moved Out of District|2|||
33644808|NCT04849559|102252641|FG000|Overall Study|Withdrawal by Subject|2|||
33644809|NCT04849559|102252642|FG001|Overall Study|Withdrawal by Subject|1|||
33644810|NCT01536067|102252643|FG000|Overall Study|Disease Progression|1|||
33644811|NCT01994889|102252644|FG000|Overall Study|Adverse Event|5|||
33644812|NCT01994889|102252645|FG001|Overall Study|Adverse Event|12|||
33644813|NCT01994889|102252646|FG002|Overall Study|Adverse Event|11|||
33644814|NCT01994889|102252644|FG000|Overall Study|Cardiac Device Implantation|0|||
33644815|NCT01994889|102252645|FG001|Overall Study|Cardiac Device Implantation|2|||
33644816|NCT01994889|102252646|FG002|Overall Study|Cardiac Device Implantation|0|||
33644817|NCT01994889|102252644|FG000|Overall Study|Organ Transplantation|1|||
33644818|NCT01994889|102252645|FG001|Overall Study|Organ Transplantation|5|||
33644819|NCT01994889|102252646|FG002|Overall Study|Organ Transplantation|5|||
33644820|NCT01994889|102252644|FG000|Overall Study|No longer willing to participate|8|||
33644821|NCT01994889|102252645|FG001|Overall Study|No longer willing to participate|17|||
33644822|NCT01994889|102252646|FG002|Overall Study|No longer willing to participate|37|||
33644823|NCT01994889|102252644|FG000|Overall Study|Lost to Follow-up|0|||
33644824|NCT01994889|102252645|FG001|Overall Study|Lost to Follow-up|1|||
33644825|NCT01994889|102252646|FG002|Overall Study|Lost to Follow-up|0|||
33644826|NCT01994889|102252644|FG000|Overall Study|Protocol Violation|0|||
33644827|NCT01994889|102252645|FG001|Overall Study|Protocol Violation|1|||
33644828|NCT01994889|102252646|FG002|Overall Study|Protocol Violation|1|||
33644829|NCT01994889|102252644|FG000|Overall Study|Death|14|||
33644830|NCT01994889|102252645|FG001|Overall Study|Death|25|||
33644831|NCT01994889|102252646|FG002|Overall Study|Death|38|||
33644832|NCT02059291|102252650|FG000|Epoch 2|Lack of Efficacy|0|||
33644833|NCT02059291|102252651|FG001|Epoch 2|Lack of Efficacy|0|||
33644834|NCT02059291|102252652|FG002|Epoch 2|Lack of Efficacy|0|||
33644835|NCT02059291|102252653|FG003|Epoch 2|Lack of Efficacy|1|||
33644836|NCT02059291|102252654|FG004|Epoch 2|Lack of Efficacy|0|||
33644837|NCT02059291|102252655|FG005|Epoch 2|Lack of Efficacy|1|||
33644838|NCT02059291|102252656|FG006|Epoch 2|Lack of Efficacy|0|||
33644839|NCT02059291|102252657|FG007|Epoch 2|Lack of Efficacy|0|||
33644840|NCT02059291|102252658|FG008|Epoch 2|Lack of Efficacy|0|||
33146629|NCT02537574|100451653|FG000|Overall Study|Noncompliance with study drug|0|||
33644841|NCT02059291|102252659|FG009|Epoch 2|Lack of Efficacy|0|||
33644842|NCT02059291|102252660|FG010|Epoch 2|Lack of Efficacy|0|||
33644843|NCT02059291|102252661|FG011|Epoch 2|Lack of Efficacy|0|||
33146630|NCT02537574|100451654|FG001|Overall Study|Noncompliance with study drug|1|||
33373240|NCT01111539|101252082|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
33644844|NCT02059291|102252662|FG012|Epoch 2|Lack of Efficacy|0|||
33644845|NCT02059291|102252663|FG013|Epoch 2|Lack of Efficacy|0|||
33644846|NCT02059291|102252664|FG014|Epoch 2|Lack of Efficacy|0|||
33644847|NCT02059291|102252665|FG015|Epoch 2|Lack of Efficacy|0|||
33644848|NCT02059291|102252666|FG016|Epoch 2|Lack of Efficacy|0|||
33146631|NCT02537574|100451655|FG002|Overall Study|Noncompliance with study drug|1|||
33146632|NCT02537574|100451653|FG000|Overall Study|Physician Decision|2|||
33644849|NCT02059291|102252667|FG017|Epoch 2|Lack of Efficacy|0|||
33644850|NCT02059291|102252668|FG018|Epoch 2|Lack of Efficacy|0|||
33146633|NCT02537574|100451654|FG001|Overall Study|Physician Decision|0|||
33146634|NCT02537574|100451655|FG002|Overall Study|Physician Decision|0|||
33146635|NCT02537574|100451653|FG000|Overall Study|Protocol Violation|4|||
33146636|NCT02537574|100451654|FG001|Overall Study|Protocol Violation|2|||
33146637|NCT02537574|100451655|FG002|Overall Study|Protocol Violation|3|||
33146638|NCT02537574|100451653|FG000|Overall Study|Withdrawal by Subject|37|||
33146639|NCT02537574|100451654|FG001|Overall Study|Withdrawal by Subject|27|||
33146640|NCT02537574|100451655|FG002|Overall Study|Withdrawal by Subject|29|||
33146641|NCT02537574|100451653|FG000|Overall Study|Lack of Efficacy|14|||
33146642|NCT02537574|100451654|FG001|Overall Study|Lack of Efficacy|16|||
33146643|NCT02537574|100451655|FG002|Overall Study|Lack of Efficacy|15|||
33146644|NCT02537574|100451653|FG000|Overall Study|Duplicate Patient|1|||
33146645|NCT02537574|100451654|FG001|Overall Study|Duplicate Patient|0|||
33146646|NCT02537574|100451655|FG002|Overall Study|Duplicate Patient|0|||
33146647|NCT02537574|100451653|FG000|Overall Study|Patient not Stable|0|||
33146648|NCT02537574|100451654|FG001|Overall Study|Patient not Stable|1|||
33146649|NCT02537574|100451655|FG002|Overall Study|Patient not Stable|0|||
33146650|NCT02537574|100451653|FG000|Overall Study|Incarceration|0|||
33146651|NCT02537574|100451654|FG001|Overall Study|Incarceration|1|||
33146652|NCT02537574|100451655|FG002|Overall Study|Incarceration|0|||
33146653|NCT02537574|100451653|FG000|Overall Study|Failed Naloxone Challenge|0|||
33146654|NCT02537574|100451654|FG001|Overall Study|Failed Naloxone Challenge|1|||
33146655|NCT02537574|100451655|FG002|Overall Study|Failed Naloxone Challenge|0|||
33644851|NCT02059291|102252669|FG019|Epoch 2|Lack of Efficacy|0|||
33146656|NCT02537574|100451653|FG000|Overall Study|Transportation Issues|0|||
33146657|NCT02537574|100451654|FG001|Overall Study|Transportation Issues|0|||
33146658|NCT02537574|100451655|FG002|Overall Study|Transportation Issues|1|||
33146659|NCT02537574|100451653|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
33146660|NCT02537574|100451654|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
33373241|NCT01111539|101252078|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33373242|NCT01111539|101252079|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33373243|NCT01111539|101252080|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33373244|NCT01111539|101252081|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
33146661|NCT02537574|100451655|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
33146662|NCT02537574|100451653|FG000|Overall Study|Noncompliance with Protocol|0|||
33146663|NCT02537574|100451654|FG001|Overall Study|Noncompliance with Protocol|0|||
33146664|NCT02537574|100451655|FG002|Overall Study|Noncompliance with Protocol|1|||
33373245|NCT01111539|101252082|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
33373246|NCT02855411|101252096|FG000|Overall Study|Study terminated by sponsor|21|||
33373247|NCT02855411|101252096|FG000|Overall Study|Does not meet entrance criteria|14|||
33373248|NCT01830543|101252100|FG000|Overall Study|Subject Decision|19|||
33373249|NCT01830543|101252101|FG001|Overall Study|Subject Decision|21|||
33583672|NCT00887159|102025927|FG002|Overall Study|Death|0|||
33146665|NCT02711345|100451656|FG000|Overall Study|Adverse Event|0|||
33146666|NCT02711345|100451657|FG001|Overall Study|Adverse Event|0|||
33146667|NCT02711345|100451658|FG002|Overall Study|Adverse Event|0|||
33146668|NCT02711345|100451659|FG003|Overall Study|Adverse Event|1|||
33146669|NCT02711345|100451660|FG004|Overall Study|Adverse Event|1|||
33146670|NCT02711345|100451661|FG005|Overall Study|Adverse Event|2|||
33146671|NCT02711345|100451662|FG006|Overall Study|Adverse Event|1|||
33146672|NCT02711345|100451663|FG007|Overall Study|Adverse Event|0|||
33146673|NCT02711345|100451664|FG008|Overall Study|Adverse Event|0|||
33146674|NCT02711345|100451665|FG009|Overall Study|Adverse Event|2|||
33146675|NCT02711345|100451656|FG000|Overall Study|Physician Decision|0|||
33245024|NCT03354390|100797122|FG003|Level 1|Death|0|||
33245025|NCT03354390|100797119|FG000|Level 1|Physician Decision|1|||
33245026|NCT03354390|100797120|FG001|Level 1|Physician Decision|0|||
33373250|NCT01830543|101252102|FG002|Overall Study|Subject Decision|57|||
33373251|NCT01830543|101252100|FG000|Overall Study|Adverse Event|91|||
33583673|NCT00887159|102025925|FG000|Overall Study|Withdrawal by Subject|4|||
33583674|NCT00887159|102025926|FG001|Overall Study|Withdrawal by Subject|4|||
33583675|NCT00887159|102025927|FG002|Overall Study|Withdrawal by Subject|2|||
33583676|NCT00887159|102025925|FG000|Overall Study|Alternative therapy|2|||
33583677|NCT00887159|102025926|FG001|Overall Study|Alternative therapy|0|||
33583678|NCT00887159|102025927|FG002|Overall Study|Alternative therapy|0|||
33583679|NCT00887159|102025925|FG000|Overall Study|Physician Decision|1|||
33583680|NCT00887159|102025926|FG001|Overall Study|Physician Decision|1|||
33583681|NCT00887159|102025927|FG002|Overall Study|Physician Decision|0|||
33583682|NCT00887159|102025925|FG000|Overall Study|Sympomatic deterioration|1|||
33146676|NCT02711345|100451657|FG001|Overall Study|Physician Decision|0|||
33583683|NCT00887159|102025926|FG001|Overall Study|Sympomatic deterioration|0|||
33146677|NCT02711345|100451658|FG002|Overall Study|Physician Decision|1|||
33245027|NCT03354390|100797121|FG002|Level 1|Physician Decision|0|||
33245028|NCT03354390|100797122|FG003|Level 1|Physician Decision|0|||
33583684|NCT00887159|102025927|FG002|Overall Study|Sympomatic deterioration|0|||
33146678|NCT02711345|100451659|FG003|Overall Study|Physician Decision|0|||
33146679|NCT02711345|100451660|FG004|Overall Study|Physician Decision|0|||
33146680|NCT02711345|100451661|FG005|Overall Study|Physician Decision|0|||
33146681|NCT02711345|100451662|FG006|Overall Study|Physician Decision|0|||
33146682|NCT02711345|100451663|FG007|Overall Study|Physician Decision|0|||
33146683|NCT02711345|100451664|FG008|Overall Study|Physician Decision|1|||
33146684|NCT02711345|100451665|FG009|Overall Study|Physician Decision|0|||
33146685|NCT02711345|100451656|FG000|Overall Study|Progressive disease|1|||
33146686|NCT02711345|100451657|FG001|Overall Study|Progressive disease|3|||
33373252|NCT01830543|101252101|FG001|Overall Study|Adverse Event|77|||
33373253|NCT01830543|101252102|FG002|Overall Study|Adverse Event|76|||
33373254|NCT01830543|101252100|FG000|Overall Study|Death|20|||
33373255|NCT01830543|101252101|FG001|Overall Study|Death|22|||
33373256|NCT01830543|101252102|FG002|Overall Study|Death|22|||
33373257|NCT01830543|101252100|FG000|Overall Study|Protocol Violation|3|||
33373258|NCT01830543|101252101|FG001|Overall Study|Protocol Violation|7|||
33146687|NCT02711345|100451658|FG002|Overall Study|Progressive disease|5|||
33146688|NCT02711345|100451659|FG003|Overall Study|Progressive disease|3|||
33146689|NCT02711345|100451660|FG004|Overall Study|Progressive disease|7|||
33146690|NCT02711345|100451661|FG005|Overall Study|Progressive disease|2|||
33146691|NCT02711345|100451662|FG006|Overall Study|Progressive disease|8|||
33146692|NCT02711345|100451663|FG007|Overall Study|Progressive disease|4|||
33146693|NCT02711345|100451664|FG008|Overall Study|Progressive disease|5|||
33146694|NCT02711345|100451665|FG009|Overall Study|Progressive disease|6|||
33146695|NCT02711345|100451656|FG000|Overall Study|Subject/guardian decision|0|||
33146696|NCT02711345|100451657|FG001|Overall Study|Subject/guardian decision|0|||
33146697|NCT02711345|100451658|FG002|Overall Study|Subject/guardian decision|0|||
33146698|NCT02711345|100451659|FG003|Overall Study|Subject/guardian decision|0|||
33146699|NCT02711345|100451660|FG004|Overall Study|Subject/guardian decision|0|||
33146700|NCT02711345|100451661|FG005|Overall Study|Subject/guardian decision|2|||
33146701|NCT02711345|100451662|FG006|Overall Study|Subject/guardian decision|3|||
33146702|NCT02711345|100451663|FG007|Overall Study|Subject/guardian decision|1|||
33146703|NCT02711345|100451664|FG008|Overall Study|Subject/guardian decision|0|||
33146704|NCT02711345|100451665|FG009|Overall Study|Subject/guardian decision|4|||
33146705|NCT02711345|100451656|FG000|Overall Study|Death|1|||
33146706|NCT02711345|100451657|FG001|Overall Study|Death|0|||
33146707|NCT02711345|100451658|FG002|Overall Study|Death|0|||
33146708|NCT02711345|100451659|FG003|Overall Study|Death|0|||
33146709|NCT02711345|100451660|FG004|Overall Study|Death|0|||
33146710|NCT02711345|100451661|FG005|Overall Study|Death|0|||
33146711|NCT02711345|100451662|FG006|Overall Study|Death|0|||
33146712|NCT02711345|100451663|FG007|Overall Study|Death|1|||
33146713|NCT02711345|100451664|FG008|Overall Study|Death|0|||
33146714|NCT02711345|100451665|FG009|Overall Study|Death|0|||
33146715|NCT01222403|100451666|FG000|Overall Study|Inappropriate enrollment|0|||
33146716|NCT01222403|100451667|FG001|Overall Study|Inappropriate enrollment|2|||
33146717|NCT01709578|100451668|FG000|Overall Study|Rescued and entered in long term safety|63|||
33146718|NCT01709578|100451669|FG001|Overall Study|Rescued and entered in long term safety|25|||
33146719|NCT01709578|100451670|FG002|Overall Study|Rescued and entered in long term safety|26|||
33146720|NCT01709578|100451668|FG000|Overall Study|Adverse Event|9|||
33146721|NCT01709578|100451669|FG001|Overall Study|Adverse Event|18|||
33146722|NCT01709578|100451670|FG002|Overall Study|Adverse Event|17|||
33146723|NCT01709578|100451668|FG000|Overall Study|Lack of Efficacy|5|||
33146724|NCT01709578|100451669|FG001|Overall Study|Lack of Efficacy|4|||
33146725|NCT01709578|100451670|FG002|Overall Study|Lack of Efficacy|2|||
33146726|NCT01709578|100451668|FG000|Overall Study|Poor compliance to protocol|1|||
33146727|NCT01709578|100451669|FG001|Overall Study|Poor compliance to protocol|2|||
33146728|NCT01709578|100451670|FG002|Overall Study|Poor compliance to protocol|1|||
33146729|NCT01709578|100451668|FG000|Overall Study|Other, not related to safety or efficacy|2|||
33146730|NCT01709578|100451669|FG001|Overall Study|Other, not related to safety or efficacy|7|||
33146731|NCT01709578|100451670|FG002|Overall Study|Other, not related to safety or efficacy|5|||
33373259|NCT01830543|101252102|FG002|Overall Study|Protocol Violation|7|||
33373260|NCT01830543|101252100|FG000|Overall Study|Physician Decision|11|||
33373261|NCT01830543|101252101|FG001|Overall Study|Physician Decision|5|||
33373262|NCT01830543|101252102|FG002|Overall Study|Physician Decision|12|||
33146732|NCT02821910|100451671|FG000|Overall Study|Withdrawal by Subject|0|||
33146733|NCT02821910|100451672|FG001|Overall Study|Withdrawal by Subject|0|||
33146734|NCT02821910|100451673|FG002|Overall Study|Withdrawal by Subject|1|||
33373263|NCT01830543|101252100|FG000|Overall Study|Withdrawal by consent|3|||
33373264|NCT01830543|101252101|FG001|Overall Study|Withdrawal by consent|3|||
33373265|NCT01830543|101252102|FG002|Overall Study|Withdrawal by consent|3|||
33146735|NCT02821910|100451674|FG003|Overall Study|Withdrawal by Subject|0|||
33146736|NCT02821910|100451675|FG004|Overall Study|Withdrawal by Subject|0|||
33146737|NCT02821910|100451676|FG005|Overall Study|Withdrawal by Subject|1|||
33146738|NCT02821910|100451671|FG000|Overall Study|Other than specified|1|||
33146739|NCT02821910|100451672|FG001|Overall Study|Other than specified|0|||
33146740|NCT02821910|100451673|FG002|Overall Study|Other than specified|1|||
33146741|NCT02821910|100451674|FG003|Overall Study|Other than specified|0|||
33146742|NCT02821910|100451675|FG004|Overall Study|Other than specified|0|||
33146743|NCT02821910|100451676|FG005|Overall Study|Other than specified|0|||
33146744|NCT01298193|100451677|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
33146745|NCT01298193|100451677|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
33146746|NCT01298193|100451677|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
33146747|NCT01298193|100451677|FG000|Efficacy Phase (Second Cycle)|Death|1|||
33146748|NCT00566501|100451678|FG000|Overall Study|Adverse Event|68|||
33146749|NCT00566501|100451679|FG001|Overall Study|Adverse Event|59|||
33146750|NCT00566501|100451678|FG000|Overall Study|Medication Non-compliance|5|||
33146751|NCT00566501|100451679|FG001|Overall Study|Medication Non-compliance|0|||
33146752|NCT00566501|100451678|FG000|Overall Study|Protocol Violation|2|||
33146753|NCT00566501|100451679|FG001|Overall Study|Protocol Violation|2|||
33146754|NCT00566501|100451678|FG000|Overall Study|Request of Investigator or Sponsor|6|||
33146755|NCT00566501|100451679|FG001|Overall Study|Request of Investigator or Sponsor|7|||
33146756|NCT00566501|100451678|FG000|Overall Study|Withdrawal by Subject|33|||
33146757|NCT00566501|100451679|FG001|Overall Study|Withdrawal by Subject|30|||
33146758|NCT00566501|100451678|FG000|Overall Study|Lack of Efficacy|8|||
33146759|NCT00566501|100451679|FG001|Overall Study|Lack of Efficacy|3|||
33644852|NCT02059291|102252670|FG020|Epoch 2|Lack of Efficacy|0|||
33644853|NCT02059291|102252671|FG021|Epoch 2|Lack of Efficacy|0|||
33146760|NCT00566501|100451678|FG000|Overall Study|Other|25|||
33146761|NCT00566501|100451679|FG001|Overall Study|Other|21|||
33146762|NCT02278471|100451680|FG000|Overall Study|Lost to Follow-up|6|||
33146763|NCT02278471|100451681|FG001|Overall Study|Lost to Follow-up|15|||
33644854|NCT02059291|102252672|FG022|Epoch 2|Lack of Efficacy|0|||
33644855|NCT02059291|102252673|FG023|Epoch 2|Lack of Efficacy|0|||
33644856|NCT02059291|102252674|FG024|Epoch 2|Lack of Efficacy|0|||
33644857|NCT02059291|102252650|FG000|Epoch 2|Adverse Event|0|||
33644858|NCT02059291|102252651|FG001|Epoch 2|Adverse Event|0|||
33644859|NCT02059291|102252652|FG002|Epoch 2|Adverse Event|1|||
33644860|NCT02059291|102252653|FG003|Epoch 2|Adverse Event|1|||
33644861|NCT02059291|102252654|FG004|Epoch 2|Adverse Event|0|||
33644862|NCT02059291|102252655|FG005|Epoch 2|Adverse Event|0|||
33644863|NCT02059291|102252656|FG006|Epoch 2|Adverse Event|0|||
33644864|NCT02059291|102252657|FG007|Epoch 2|Adverse Event|1|||
33644865|NCT02059291|102252658|FG008|Epoch 2|Adverse Event|1|||
33644866|NCT02059291|102252659|FG009|Epoch 2|Adverse Event|0|||
33644867|NCT02059291|102252660|FG010|Epoch 2|Adverse Event|0|||
33644868|NCT02059291|102252661|FG011|Epoch 2|Adverse Event|0|||
33644869|NCT02059291|102252662|FG012|Epoch 2|Adverse Event|0|||
33644870|NCT02059291|102252663|FG013|Epoch 2|Adverse Event|0|||
33644871|NCT02059291|102252664|FG014|Epoch 2|Adverse Event|0|||
33644872|NCT02059291|102252665|FG015|Epoch 2|Adverse Event|0|||
33644873|NCT02059291|102252666|FG016|Epoch 2|Adverse Event|0|||
33644874|NCT02059291|102252667|FG017|Epoch 2|Adverse Event|0|||
33644875|NCT02059291|102252668|FG018|Epoch 2|Adverse Event|0|||
33644876|NCT02059291|102252669|FG019|Epoch 2|Adverse Event|0|||
33644877|NCT02059291|102252670|FG020|Epoch 2|Adverse Event|0|||
33644878|NCT02059291|102252671|FG021|Epoch 2|Adverse Event|0|||
33644879|NCT02059291|102252672|FG022|Epoch 2|Adverse Event|0|||
33644880|NCT02059291|102252673|FG023|Epoch 2|Adverse Event|0|||
33644881|NCT02059291|102252674|FG024|Epoch 2|Adverse Event|0|||
33644882|NCT02059291|102252650|FG000|Epoch 2|Withdrawal by Subject|0|||
33644883|NCT02059291|102252651|FG001|Epoch 2|Withdrawal by Subject|1|||
33644884|NCT02059291|102252652|FG002|Epoch 2|Withdrawal by Subject|0|||
33644885|NCT02059291|102252653|FG003|Epoch 2|Withdrawal by Subject|0|||
33644886|NCT02059291|102252654|FG004|Epoch 2|Withdrawal by Subject|0|||
33644887|NCT02059291|102252655|FG005|Epoch 2|Withdrawal by Subject|1|||
33146764|NCT02278471|100451680|FG000|Overall Study|Death|2|||
33146765|NCT02278471|100451681|FG001|Overall Study|Death|2|||
33146766|NCT02278471|100451680|FG000|Overall Study|Withdrawal by Subject|0|||
33146767|NCT02278471|100451681|FG001|Overall Study|Withdrawal by Subject|3|||
33146768|NCT03960554|100451682|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
33644888|NCT02059291|102252656|FG006|Epoch 2|Withdrawal by Subject|0|||
33644889|NCT02059291|102252657|FG007|Epoch 2|Withdrawal by Subject|0|||
33146769|NCT03960554|100451683|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
33644890|NCT02059291|102252658|FG008|Epoch 2|Withdrawal by Subject|1|||
33644891|NCT02059291|102252659|FG009|Epoch 2|Withdrawal by Subject|0|||
33644892|NCT02059291|102252660|FG010|Epoch 2|Withdrawal by Subject|0|||
33644893|NCT02059291|102252661|FG011|Epoch 2|Withdrawal by Subject|0|||
33644894|NCT02059291|102252662|FG012|Epoch 2|Withdrawal by Subject|0|||
33644895|NCT02059291|102252663|FG013|Epoch 2|Withdrawal by Subject|0|||
33146770|NCT00470158|100451684|FG000|Overall Study|Death|0|||
33373266|NCT01830543|101252100|FG000|Overall Study|Other|12|||
33644896|NCT02059291|102252664|FG014|Epoch 2|Withdrawal by Subject|0|||
33644897|NCT02059291|102252665|FG015|Epoch 2|Withdrawal by Subject|0|||
33644898|NCT02059291|102252666|FG016|Epoch 2|Withdrawal by Subject|0|||
33644899|NCT02059291|102252667|FG017|Epoch 2|Withdrawal by Subject|0|||
33644900|NCT02059291|102252668|FG018|Epoch 2|Withdrawal by Subject|0|||
33644901|NCT02059291|102252669|FG019|Epoch 2|Withdrawal by Subject|0|||
33644902|NCT02059291|102252670|FG020|Epoch 2|Withdrawal by Subject|0|||
33644903|NCT02059291|102252671|FG021|Epoch 2|Withdrawal by Subject|0|||
33146771|NCT00470158|100451685|FG001|Overall Study|Death|0|||
33644904|NCT02059291|102252672|FG022|Epoch 2|Withdrawal by Subject|0|||
33644905|NCT02059291|102252673|FG023|Epoch 2|Withdrawal by Subject|0|||
33245029|NCT03354390|100797119|FG000|Level 2|Physician Decision|0|||
33245030|NCT03354390|100797120|FG001|Level 2|Physician Decision|2|||
33245031|NCT03354390|100797121|FG002|Level 2|Physician Decision|0|||
33245032|NCT03354390|100797122|FG003|Level 2|Physician Decision|0|||
33245033|NCT03354390|100797119|FG000|Level 2|Lack of Efficacy|0|||
33245034|NCT03354390|100797120|FG001|Level 2|Lack of Efficacy|1|||
33245035|NCT03354390|100797121|FG002|Level 2|Lack of Efficacy|0|||
33245036|NCT03354390|100797122|FG003|Level 2|Lack of Efficacy|0|||
33422999|NCT02164539|101439792|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
33423000|NCT02164539|101439793|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
33423001|NCT02164539|101439794|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
33644906|NCT02059291|102252674|FG024|Epoch 2|Withdrawal by Subject|0|||
33245037|NCT03354390|100797119|FG000|Level 2|Lost to Follow-up|0|||
33373267|NCT01830543|101252101|FG001|Overall Study|Other|17|||
33373268|NCT01830543|101252102|FG002|Overall Study|Other|37|||
33373269|NCT02345252|101252103|FG000|Double-Blind Phase|Adverse Event|2|||
33373270|NCT02345252|101252104|FG001|Double-Blind Phase|Adverse Event|3|||
33373271|NCT02345252|101252103|FG000|Double-Blind Phase|Death|1|||
33373272|NCT02345252|101252104|FG001|Double-Blind Phase|Death|2|||
33373273|NCT02345252|101252103|FG000|Double-Blind Phase|Lack of Efficacy|1|||
33373274|NCT02345252|101252104|FG001|Double-Blind Phase|Lack of Efficacy|0|||
33373275|NCT02345252|101252103|FG000|Double-Blind Phase|Investigator's Discretion|4|||
33373276|NCT02345252|101252104|FG001|Double-Blind Phase|Investigator's Discretion|6|||
33373277|NCT02345252|101252103|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
33373278|NCT02345252|101252104|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
33373279|NCT02345252|101252103|FG000|Double-Blind Phase|Protocol Violation|2|||
33373280|NCT02345252|101252104|FG001|Double-Blind Phase|Protocol Violation|1|||
33373281|NCT02345252|101252103|FG000|Double-Blind Phase|Withdrew Consent|21|||
33373282|NCT02345252|101252104|FG001|Double-Blind Phase|Withdrew Consent|23|||
33373283|NCT02345252|101252103|FG000|Double-Blind Phase|Lost to Follow-up|8|||
33373284|NCT02345252|101252104|FG001|Double-Blind Phase|Lost to Follow-up|10|||
33373285|NCT02345252|101252103|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
33373286|NCT02345252|101252104|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
33373287|NCT00195260|101252116|FG000|Part 1: Dose Escalation|Adverse Event|0|||
33373288|NCT00195260|101252117|FG001|Part 1: Dose Escalation|Adverse Event|1|||
33373289|NCT00195260|101252118|FG002|Part 1: Dose Escalation|Adverse Event|0|||
33373290|NCT00195260|101252119|FG003|Part 1: Dose Escalation|Adverse Event|1|||
33373291|NCT00195260|101252120|FG004|Part 1: Dose Escalation|Adverse Event|1|||
33373292|NCT00195260|101252121|FG005|Part 1: Dose Escalation|Adverse Event|0|||
33373293|NCT00195260|101252122|FG006|Part 1: Dose Escalation|Adverse Event|3|||
33373294|NCT00195260|101252123|FG007|Part 1: Dose Escalation|Adverse Event|0|||
33373295|NCT00195260|101252124|FG008|Part 1: Dose Escalation|Adverse Event|0|||
33373296|NCT00195260|101252125|FG009|Part 1: Dose Escalation|Adverse Event|0|||
33373297|NCT00195260|101252126|FG010|Part 1: Dose Escalation|Adverse Event|0|||
33644907|NCT02059291|102252650|FG000|Epoch 3|Physician Decision|0|||
33644908|NCT02059291|102252651|FG001|Epoch 3|Physician Decision|0|||
33644909|NCT02059291|102252652|FG002|Epoch 3|Physician Decision|0|||
33644910|NCT02059291|102252653|FG003|Epoch 3|Physician Decision|0|||
33373298|NCT00195260|101252116|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33373299|NCT00195260|101252117|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33373300|NCT00195260|101252118|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33373301|NCT00195260|101252119|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33373302|NCT00195260|101252120|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
33373303|NCT00195260|101252121|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33373304|NCT00195260|101252122|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33373305|NCT00195260|101252123|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
33373306|NCT00195260|101252124|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33373307|NCT00195260|101252125|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33373308|NCT00195260|101252126|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
33373309|NCT00195260|101252116|FG000|Part 1: Dose Escalation|Death|0|||
33373310|NCT00195260|101252117|FG001|Part 1: Dose Escalation|Death|0|||
33373311|NCT00195260|101252118|FG002|Part 1: Dose Escalation|Death|0|||
33373312|NCT00195260|101252119|FG003|Part 1: Dose Escalation|Death|0|||
33373313|NCT00195260|101252120|FG004|Part 1: Dose Escalation|Death|0|||
33373314|NCT00195260|101252121|FG005|Part 1: Dose Escalation|Death|0|||
33423002|NCT02164539|101439788|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
33644911|NCT02059291|102252654|FG004|Epoch 3|Physician Decision|0|||
33373315|NCT00195260|101252122|FG006|Part 1: Dose Escalation|Death|0|||
33373316|NCT00195260|101252123|FG007|Part 1: Dose Escalation|Death|1|||
33373317|NCT00195260|101252124|FG008|Part 1: Dose Escalation|Death|0|||
33373318|NCT00195260|101252125|FG009|Part 1: Dose Escalation|Death|0|||
33644912|NCT02059291|102252655|FG005|Epoch 3|Physician Decision|0|||
33245038|NCT03354390|100797120|FG001|Level 2|Lost to Follow-up|1|||
33245039|NCT03354390|100797121|FG002|Level 2|Lost to Follow-up|0|||
33245040|NCT03354390|100797122|FG003|Level 2|Lost to Follow-up|0|||
33245041|NCT03354390|100797119|FG000|Level 3|Death|0|||
33245042|NCT03354390|100797120|FG001|Level 3|Death|0|||
33373319|NCT00195260|101252126|FG010|Part 1: Dose Escalation|Death|0|||
33146772|NCT00470158|100451686|FG002|Overall Study|Death|0|||
33146773|NCT00470158|100451687|FG003|Overall Study|Death|0|||
33146774|NCT00470158|100451688|FG004|Overall Study|Death|2|||
33146775|NCT00470158|100451684|FG000|Overall Study|Lost to Follow-up|7|||
33146776|NCT00470158|100451685|FG001|Overall Study|Lost to Follow-up|8|||
33146777|NCT00470158|100451686|FG002|Overall Study|Lost to Follow-up|8|||
33146778|NCT00470158|100451687|FG003|Overall Study|Lost to Follow-up|5|||
33146779|NCT00470158|100451688|FG004|Overall Study|Lost to Follow-up|4|||
33146780|NCT00470158|100451684|FG000|Overall Study|Protocol Violation|1|||
33146781|NCT00470158|100451685|FG001|Overall Study|Protocol Violation|0|||
33146782|NCT00470158|100451686|FG002|Overall Study|Protocol Violation|0|||
33146783|NCT00470158|100451687|FG003|Overall Study|Protocol Violation|0|||
33146784|NCT00470158|100451688|FG004|Overall Study|Protocol Violation|0|||
33146785|NCT01178073|100451691|FG000|Overall Study|Adverse Event|34|||
33146786|NCT01178073|100451692|FG001|Overall Study|Adverse Event|27|||
33146787|NCT01178073|100451693|FG002|Overall Study|Adverse Event|24|||
33644913|NCT02059291|102252656|FG006|Epoch 3|Physician Decision|0|||
33644914|NCT02059291|102252657|FG007|Epoch 3|Physician Decision|0|||
33644915|NCT02059291|102252658|FG008|Epoch 3|Physician Decision|0|||
33644916|NCT02059291|102252659|FG009|Epoch 3|Physician Decision|0|||
33644917|NCT02059291|102252660|FG010|Epoch 3|Physician Decision|0|||
33644918|NCT02059291|102252661|FG011|Epoch 3|Physician Decision|0|||
33644919|NCT02059291|102252662|FG012|Epoch 3|Physician Decision|0|||
33644920|NCT02059291|102252663|FG013|Epoch 3|Physician Decision|1|||
33644921|NCT02059291|102252664|FG014|Epoch 3|Physician Decision|0|||
33644922|NCT02059291|102252665|FG015|Epoch 3|Physician Decision|1|||
33644923|NCT02059291|102252666|FG016|Epoch 3|Physician Decision|0|||
33644924|NCT02059291|102252667|FG017|Epoch 3|Physician Decision|0|||
33644925|NCT02059291|102252668|FG018|Epoch 3|Physician Decision|0|||
33644926|NCT02059291|102252669|FG019|Epoch 3|Physician Decision|0|||
33146788|NCT01178073|100451691|FG000|Overall Study|Protocol Violation|1|||
33146789|NCT01178073|100451692|FG001|Overall Study|Protocol Violation|1|||
33146790|NCT01178073|100451693|FG002|Overall Study|Protocol Violation|1|||
33146791|NCT01178073|100451691|FG000|Overall Study|Lost to Follow-up|2|||
33146792|NCT01178073|100451692|FG001|Overall Study|Lost to Follow-up|0|||
33146793|NCT01178073|100451693|FG002|Overall Study|Lost to Follow-up|3|||
33146794|NCT01178073|100451691|FG000|Overall Study|Physician Decision|14|||
33146795|NCT01178073|100451692|FG001|Overall Study|Physician Decision|10|||
33146796|NCT01178073|100451693|FG002|Overall Study|Physician Decision|10|||
33146797|NCT01178073|100451691|FG000|Overall Study|Withdrawal by Subject|10|||
33146798|NCT01178073|100451692|FG001|Overall Study|Withdrawal by Subject|6|||
33146799|NCT01178073|100451693|FG002|Overall Study|Withdrawal by Subject|8|||
33146800|NCT01178073|100451691|FG000|Overall Study|Missing Completion Status|1|||
33146801|NCT01178073|100451692|FG001|Overall Study|Missing Completion Status|0|||
33146802|NCT01178073|100451693|FG002|Overall Study|Missing Completion Status|0|||
33146803|NCT03505671|100451694|FG000|Overall Study|Withdrawal by Subject|2|||
33146804|NCT03505671|100451695|FG001|Overall Study|Withdrawal by Subject|1|||
33146805|NCT03505671|100451694|FG000|Overall Study|Lost to Follow-up|1|||
33146806|NCT03505671|100451695|FG001|Overall Study|Lost to Follow-up|0|||
33146807|NCT03206073|100451696|FG000|Overall Study|Participant Noncompliance|0|||
33146808|NCT03206073|100451697|FG001|Overall Study|Participant Noncompliance|1|||
33146809|NCT03206073|100451698|FG002|Overall Study|Participant Noncompliance|0|||
33146810|NCT03206073|100451699|FG003|Overall Study|Participant Noncompliance|0|||
33146811|NCT03206073|100451696|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
33146812|NCT03206073|100451697|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
33146813|NCT03206073|100451698|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
33146814|NCT03206073|100451699|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
33146815|NCT03206073|100451696|FG000|Overall Study|Death|0|||
33146816|NCT03206073|100451697|FG001|Overall Study|Death|0|||
33146817|NCT03206073|100451698|FG002|Overall Study|Death|1|||
33146818|NCT03206073|100451699|FG003|Overall Study|Death|0|||
33146819|NCT03206073|100451696|FG000|Overall Study|Taken off active treatment|0|||
33146820|NCT03206073|100451697|FG001|Overall Study|Taken off active treatment|0|||
33146821|NCT03206073|100451698|FG002|Overall Study|Taken off active treatment|3|||
33146822|NCT03206073|100451699|FG003|Overall Study|Taken off active treatment|0|||
33146823|NCT00046891|100451700|FG000|Overall Study|Cancels|5|||
33146824|NCT00046891|100451701|FG001|Overall Study|Cancels|9|||
33146825|NCT00046891|100451700|FG000|Overall Study|Ineligible|1|||
33146826|NCT00046891|100451701|FG001|Overall Study|Ineligible|1|||
33644927|NCT02059291|102252670|FG020|Epoch 3|Physician Decision|0|||
33644928|NCT02059291|102252671|FG021|Epoch 3|Physician Decision|0|||
33146827|NCT00046891|100451700|FG000|Overall Study|Withdrawal by Subject|18|||
33146828|NCT00046891|100451701|FG001|Overall Study|Withdrawal by Subject|15|||
33146829|NCT00046891|100451700|FG000|Overall Study|Adverse Event|5|||
33146830|NCT00046891|100451701|FG001|Overall Study|Adverse Event|5|||
33146831|NCT01903525|100451702|FG000|Overall Study|Lost to Follow-up|5|||
33146832|NCT01903525|100451703|FG001|Overall Study|Lost to Follow-up|9|||
33644929|NCT02059291|102252672|FG022|Epoch 3|Physician Decision|0|||
33644930|NCT02059291|102252673|FG023|Epoch 3|Physician Decision|0|||
33146833|NCT01903525|100451702|FG000|Overall Study|Adverse Event|0|||
33146834|NCT01903525|100451703|FG001|Overall Study|Adverse Event|1|||
33146835|NCT00450112|100451704|FG000|Overall Study|Other Treatment Required|5|||
33146836|NCT00450112|100451705|FG001|Overall Study|Other Treatment Required|1|||
33146837|NCT00450112|100451704|FG000|Overall Study|Withdrawal by Subject|4|||
33146838|NCT00450112|100451705|FG001|Overall Study|Withdrawal by Subject|1|||
33146839|NCT00450112|100451704|FG000|Overall Study|Lost to Follow-up|2|||
33146840|NCT00450112|100451705|FG001|Overall Study|Lost to Follow-up|1|||
33146841|NCT00450112|100451704|FG000|Overall Study|Others|2|||
33146842|NCT00450112|100451705|FG001|Overall Study|Others|3|||
33146843|NCT03224546|100451708|FG000|Overall Study|Lost to Follow-up|9|||
33146844|NCT03224546|100451709|FG001|Overall Study|Lost to Follow-up|8|||
33146845|NCT03224546|100451710|FG002|Overall Study|Lost to Follow-up|3|||
33146846|NCT03224546|100451708|FG000|Overall Study|Withdrawal by Subject|7|||
33146847|NCT03224546|100451709|FG001|Overall Study|Withdrawal by Subject|14|||
33146848|NCT03224546|100451710|FG002|Overall Study|Withdrawal by Subject|12|||
33146849|NCT02310321|100451725|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
33146850|NCT02310321|100451726|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
33146851|NCT02310321|100451727|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
33146852|NCT02310321|100451725|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
33146853|NCT02310321|100451726|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
33146854|NCT02310321|100451727|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
33146855|NCT02310321|100451725|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
33146856|NCT02310321|100451726|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
33146857|NCT02310321|100451727|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
33146858|NCT02310321|100451725|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
33146859|NCT02310321|100451726|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
33146860|NCT02310321|100451727|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
33146861|NCT02310321|100451725|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
33146862|NCT02310321|100451726|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
33146863|NCT02310321|100451727|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
33146864|NCT02310321|100451725|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
33146865|NCT02310321|100451726|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
33146866|NCT02310321|100451727|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
33146867|NCT02310321|100451725|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
33146868|NCT02310321|100451726|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
33146869|NCT02310321|100451727|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
33146870|NCT02310321|100451725|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
33146871|NCT02310321|100451726|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
33146872|NCT02310321|100451727|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
33146873|NCT02310321|100451725|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
33583685|NCT00887159|102025925|FG000|Overall Study|Treatment delayed|1|||
33644931|NCT02059291|102252674|FG024|Epoch 3|Physician Decision|0|||
33644932|NCT02059291|102252650|FG000|Epoch 3|Adverse Event|0|||
33644933|NCT02059291|102252651|FG001|Epoch 3|Adverse Event|0|||
33644934|NCT02059291|102252652|FG002|Epoch 3|Adverse Event|0|||
33146874|NCT02310321|100451726|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
33146875|NCT02310321|100451727|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
33146876|NCT02310321|100451725|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
33146877|NCT02310321|100451726|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
33583686|NCT00887159|102025926|FG001|Overall Study|Treatment delayed|1|||
33583687|NCT00887159|102025927|FG002|Overall Study|Treatment delayed|0|||
33583688|NCT00887159|102025925|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
33583689|NCT00887159|102025926|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
33583690|NCT00887159|102025927|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
33583691|NCT00887159|102025925|FG000|Overall Study|Received more tx instead of observation|1|||
33583692|NCT00887159|102025926|FG001|Overall Study|Received more tx instead of observation|0|||
33583693|NCT00887159|102025927|FG002|Overall Study|Received more tx instead of observation|0|||
33583694|NCT00887159|102025925|FG000|Overall Study|Ineligible|5|||
33583695|NCT00887159|102025926|FG001|Overall Study|Ineligible|1|||
33583696|NCT00887159|102025927|FG002|Overall Study|Ineligible|0|||
33583697|NCT00887159|102025925|FG000|Overall Study|Never started assigned therapy|3|||
33583698|NCT00887159|102025926|FG001|Overall Study|Never started assigned therapy|3|||
33583699|NCT00887159|102025927|FG002|Overall Study|Never started assigned therapy|4|||
33583700|NCT00851890|102025928|FG000|Overall Study|Lost to Follow-up|0|||
33583701|NCT00851890|102025929|FG001|Overall Study|Lost to Follow-up|1|||
33583702|NCT00851890|102025930|FG002|Overall Study|Lost to Follow-up|0|||
33583703|NCT00851890|102025931|FG003|Overall Study|Lost to Follow-up|1|||
33583704|NCT00703846|102025937|FG000|Overall Study|Adverse Event|8|||
33583705|NCT00703846|102025937|FG000|Overall Study|Lost to Follow-up|55|||
33583706|NCT00703846|102025937|FG000|Overall Study|Lack of Efficacy|15|||
33146878|NCT02310321|100451727|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
33146879|NCT02310321|100451725|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
33146880|NCT02310321|100451726|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
33146881|NCT02310321|100451727|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
33146882|NCT02310321|100451725|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
33146883|NCT02310321|100451726|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
33146884|NCT02310321|100451727|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
33146885|NCT02310321|100451725|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
33146886|NCT02310321|100451726|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
33146887|NCT02310321|100451727|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
33146888|NCT02310321|100451725|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
33644935|NCT02059291|102252653|FG003|Epoch 3|Adverse Event|0|||
33644936|NCT02059291|102252654|FG004|Epoch 3|Adverse Event|0|||
33644937|NCT02059291|102252655|FG005|Epoch 3|Adverse Event|0|||
33644938|NCT02059291|102252656|FG006|Epoch 3|Adverse Event|0|||
33644939|NCT02059291|102252657|FG007|Epoch 3|Adverse Event|0|||
33644940|NCT02059291|102252658|FG008|Epoch 3|Adverse Event|0|||
33644941|NCT02059291|102252659|FG009|Epoch 3|Adverse Event|0|||
33644942|NCT02059291|102252660|FG010|Epoch 3|Adverse Event|0|||
33644943|NCT02059291|102252661|FG011|Epoch 3|Adverse Event|0|||
33644944|NCT02059291|102252662|FG012|Epoch 3|Adverse Event|0|||
33644945|NCT02059291|102252663|FG013|Epoch 3|Adverse Event|0|||
33644946|NCT02059291|102252664|FG014|Epoch 3|Adverse Event|0|||
33644947|NCT02059291|102252665|FG015|Epoch 3|Adverse Event|1|||
33644948|NCT02059291|102252666|FG016|Epoch 3|Adverse Event|0|||
33644949|NCT02059291|102252667|FG017|Epoch 3|Adverse Event|0|||
33644950|NCT02059291|102252668|FG018|Epoch 3|Adverse Event|0|||
33644951|NCT02059291|102252669|FG019|Epoch 3|Adverse Event|0|||
33644952|NCT02059291|102252670|FG020|Epoch 3|Adverse Event|0|||
33644953|NCT02059291|102252671|FG021|Epoch 3|Adverse Event|0|||
33644954|NCT02059291|102252672|FG022|Epoch 3|Adverse Event|0|||
33644955|NCT02059291|102252673|FG023|Epoch 3|Adverse Event|0|||
33146889|NCT02310321|100451726|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
33146890|NCT02310321|100451727|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
33146891|NCT02310321|100451725|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
33146892|NCT02310321|100451726|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
33146893|NCT02310321|100451727|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
33146894|NCT02310321|100451725|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
33146895|NCT02310321|100451726|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|0|||
33146896|NCT02310321|100451727|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Missing|16|||
33146897|NCT02310321|100451725|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
33146898|NCT02310321|100451726|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
33146899|NCT02310321|100451727|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|3|||
33146900|NCT02310321|100451725|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
33146901|NCT02310321|100451726|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
33146902|NCT02310321|100451727|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|3|||
33146903|NCT02310321|100451725|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
33146904|NCT02310321|100451726|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
33146905|NCT02310321|100451727|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|3|||
33146906|NCT02310321|100451725|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
33146907|NCT02310321|100451726|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|0|||
33373320|NCT00195260|101252116|FG000|Part 1: Dose Escalation|Disease Progression|3|||
33373321|NCT00195260|101252117|FG001|Part 1: Dose Escalation|Disease Progression|2|||
33373322|NCT00195260|101252118|FG002|Part 1: Dose Escalation|Disease Progression|5|||
33373323|NCT00195260|101252119|FG003|Part 1: Dose Escalation|Disease Progression|6|||
33373324|NCT00195260|101252120|FG004|Part 1: Dose Escalation|Disease Progression|4|||
33373325|NCT00195260|101252121|FG005|Part 1: Dose Escalation|Disease Progression|6|||
33373326|NCT00195260|101252122|FG006|Part 1: Dose Escalation|Disease Progression|7|||
33373327|NCT00195260|101252123|FG007|Part 1: Dose Escalation|Disease Progression|4|||
33644956|NCT02059291|102252674|FG024|Epoch 3|Adverse Event|0|||
33644957|NCT02059291|102252650|FG000|Epoch 3|Lack of Efficacy|0|||
33644958|NCT02059291|102252651|FG001|Epoch 3|Lack of Efficacy|0|||
33644959|NCT02059291|102252652|FG002|Epoch 3|Lack of Efficacy|0|||
33644960|NCT02059291|102252653|FG003|Epoch 3|Lack of Efficacy|0|||
33644961|NCT02059291|102252654|FG004|Epoch 3|Lack of Efficacy|0|||
33644962|NCT02059291|102252655|FG005|Epoch 3|Lack of Efficacy|0|||
33644963|NCT02059291|102252656|FG006|Epoch 3|Lack of Efficacy|0|||
33146908|NCT02310321|100451727|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Missing|26|||
33146909|NCT02310321|100451725|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
33644964|NCT02059291|102252657|FG007|Epoch 3|Lack of Efficacy|0|||
33644965|NCT02059291|102252658|FG008|Epoch 3|Lack of Efficacy|0|||
33644966|NCT02059291|102252659|FG009|Epoch 3|Lack of Efficacy|0|||
33644967|NCT02059291|102252660|FG010|Epoch 3|Lack of Efficacy|0|||
33644968|NCT02059291|102252661|FG011|Epoch 3|Lack of Efficacy|0|||
33644969|NCT02059291|102252662|FG012|Epoch 3|Lack of Efficacy|0|||
33583707|NCT00703846|102025937|FG000|Overall Study|Noncompliance with Study Treatment|2|||
33583708|NCT00703846|102025937|FG000|Overall Study|Withdrawal by Subject|40|||
33644970|NCT02059291|102252663|FG013|Epoch 3|Lack of Efficacy|0|||
33644971|NCT02059291|102252664|FG014|Epoch 3|Lack of Efficacy|0|||
33146910|NCT02310321|100451726|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
33146911|NCT02310321|100451727|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|1|||
33146912|NCT02310321|100451725|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
33146913|NCT02310321|100451726|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
33146914|NCT02310321|100451727|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|1|||
33146915|NCT03418571|100451728|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
33146916|NCT03418571|100451729|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
33146917|NCT02452697|100451730|FG000|Overall Study|Physician Decision|4|||
33146918|NCT02452697|100451731|FG001|Overall Study|Physician Decision|4|||
33146919|NCT02452697|100451732|FG002|Overall Study|Physician Decision|3|||
33146920|NCT02452697|100451733|FG003|Overall Study|Physician Decision|2|||
33146921|NCT02452697|100451730|FG000|Overall Study|Withdrawal by Subject|1|||
33146922|NCT02452697|100451731|FG001|Overall Study|Withdrawal by Subject|0|||
33146923|NCT02452697|100451732|FG002|Overall Study|Withdrawal by Subject|0|||
33146924|NCT02452697|100451733|FG003|Overall Study|Withdrawal by Subject|0|||
33644972|NCT02059291|102252665|FG015|Epoch 3|Lack of Efficacy|3|||
33644973|NCT02059291|102252666|FG016|Epoch 3|Lack of Efficacy|0|||
33644974|NCT02059291|102252667|FG017|Epoch 3|Lack of Efficacy|0|||
33644975|NCT02059291|102252668|FG018|Epoch 3|Lack of Efficacy|0|||
33644976|NCT02059291|102252669|FG019|Epoch 3|Lack of Efficacy|0|||
33644977|NCT02059291|102252670|FG020|Epoch 3|Lack of Efficacy|0|||
33644978|NCT02059291|102252671|FG021|Epoch 3|Lack of Efficacy|0|||
33644979|NCT02059291|102252672|FG022|Epoch 3|Lack of Efficacy|0|||
33644980|NCT02059291|102252673|FG023|Epoch 3|Lack of Efficacy|0|||
33644981|NCT02059291|102252674|FG024|Epoch 3|Lack of Efficacy|0|||
33644982|NCT02059291|102252650|FG000|Epoch 3|Withdrawal by Subject|0|||
33644983|NCT02059291|102252651|FG001|Epoch 3|Withdrawal by Subject|0|||
33644984|NCT02059291|102252652|FG002|Epoch 3|Withdrawal by Subject|0|||
33644985|NCT02059291|102252653|FG003|Epoch 3|Withdrawal by Subject|0|||
33644986|NCT02059291|102252654|FG004|Epoch 3|Withdrawal by Subject|0|||
33644987|NCT02059291|102252655|FG005|Epoch 3|Withdrawal by Subject|0|||
33644988|NCT02059291|102252656|FG006|Epoch 3|Withdrawal by Subject|0|||
33644989|NCT02059291|102252657|FG007|Epoch 3|Withdrawal by Subject|0|||
33644990|NCT02059291|102252658|FG008|Epoch 3|Withdrawal by Subject|0|||
33644991|NCT02059291|102252659|FG009|Epoch 3|Withdrawal by Subject|0|||
33644992|NCT02059291|102252660|FG010|Epoch 3|Withdrawal by Subject|0|||
33644993|NCT02059291|102252661|FG011|Epoch 3|Withdrawal by Subject|0|||
33644994|NCT02059291|102252662|FG012|Epoch 3|Withdrawal by Subject|0|||
33644995|NCT02059291|102252663|FG013|Epoch 3|Withdrawal by Subject|0|||
33644996|NCT02059291|102252664|FG014|Epoch 3|Withdrawal by Subject|0|||
33644997|NCT02059291|102252665|FG015|Epoch 3|Withdrawal by Subject|1|||
33644998|NCT02059291|102252666|FG016|Epoch 3|Withdrawal by Subject|0|||
33644999|NCT02059291|102252667|FG017|Epoch 3|Withdrawal by Subject|0|||
33645000|NCT02059291|102252668|FG018|Epoch 3|Withdrawal by Subject|0|||
33645001|NCT02059291|102252669|FG019|Epoch 3|Withdrawal by Subject|0|||
33645002|NCT02059291|102252670|FG020|Epoch 3|Withdrawal by Subject|0|||
33645003|NCT02059291|102252671|FG021|Epoch 3|Withdrawal by Subject|0|||
33645004|NCT02059291|102252672|FG022|Epoch 3|Withdrawal by Subject|0|||
33645005|NCT02059291|102252673|FG023|Epoch 3|Withdrawal by Subject|0|||
33645006|NCT02059291|102252674|FG024|Epoch 3|Withdrawal by Subject|0|||
33645007|NCT02059291|102252650|FG000|Epoch 4|Adverse Event|0|||
33645008|NCT02059291|102252651|FG001|Epoch 4|Adverse Event|0|||
33645009|NCT02059291|102252652|FG002|Epoch 4|Adverse Event|0|||
33645010|NCT02059291|102252653|FG003|Epoch 4|Adverse Event|0|||
33645011|NCT02059291|102252654|FG004|Epoch 4|Adverse Event|0|||
33645012|NCT02059291|102252655|FG005|Epoch 4|Adverse Event|0|||
33645013|NCT02059291|102252656|FG006|Epoch 4|Adverse Event|0|||
33245043|NCT03354390|100797121|FG002|Level 3|Death|1|||
33583709|NCT00703846|102025937|FG000|Overall Study|Death|1|||
33645014|NCT02059291|102252657|FG007|Epoch 4|Adverse Event|0|||
33146925|NCT02452697|100451730|FG000|Overall Study|still in follow-up|2|||
33146926|NCT02452697|100451731|FG001|Overall Study|still in follow-up|2|||
33146927|NCT02452697|100451732|FG002|Overall Study|still in follow-up|1|||
33583710|NCT00703846|102025937|FG000|Overall Study|Other|14|||
33583711|NCT00703846|102025937|FG000|Overall Study|Did Not Receive Study Drug|2|||
33645015|NCT02059291|102252658|FG008|Epoch 4|Adverse Event|0|||
33645016|NCT02059291|102252659|FG009|Epoch 4|Adverse Event|0|||
33645017|NCT02059291|102252660|FG010|Epoch 4|Adverse Event|0|||
33645018|NCT02059291|102252661|FG011|Epoch 4|Adverse Event|0|||
33583712|NCT01496287|102025939|FG000|Overall Study|Lost to Follow-up|1|||
33583713|NCT01496287|102025939|FG000|Overall Study|Incomplete anesthesia|5|||
33645019|NCT02059291|102252662|FG012|Epoch 4|Adverse Event|0|||
33583714|NCT00375505|102025941|FG000|Overall Study|Adverse Event|1|||
33583715|NCT00375505|102025942|FG001|Overall Study|Adverse Event|2|||
33645020|NCT02059291|102252663|FG013|Epoch 4|Adverse Event|0|||
33645021|NCT02059291|102252664|FG014|Epoch 4|Adverse Event|0|||
33645022|NCT02059291|102252665|FG015|Epoch 4|Adverse Event|0|||
33645023|NCT02059291|102252666|FG016|Epoch 4|Adverse Event|1|||
33146928|NCT02452697|100451733|FG003|Overall Study|still in follow-up|3|||
33146929|NCT00427960|100451736|FG000|Overall Study|Adverse Event|2|||
33146930|NCT00427960|100451737|FG001|Overall Study|Adverse Event|0|||
33146931|NCT00427960|100451736|FG000|Overall Study|Withdrawal by Subject|0|||
33146932|NCT00427960|100451737|FG001|Overall Study|Withdrawal by Subject|3|||
33146933|NCT00427960|100451736|FG000|Overall Study|Other|0|||
33146934|NCT00427960|100451737|FG001|Overall Study|Other|1|||
33146935|NCT01711879|100451738|FG000|Overall Study|Death|1|||
33146936|NCT01711879|100451739|FG001|Overall Study|Death|0|||
33146937|NCT05442775|100451743|FG000|Overall Study|Trial terminated|61|||
33146938|NCT05442775|100451743|FG000|Overall Study|Lack of Efficacy|4|||
33146939|NCT05442775|100451743|FG000|Overall Study|Withdrawal by Subject|4|||
33146940|NCT05442775|100451743|FG000|Overall Study|Death|1|||
33146941|NCT05442775|100451743|FG000|Overall Study|Participant removed at Sponsor request|1|||
33146942|NCT00679055|100451744|FG000|Overall Study|Adverse Event|0|||
33146943|NCT00679055|100451745|FG001|Overall Study|Adverse Event|1|||
33583716|NCT02702609|102025943|FG000|Overall Study|Lost to Follow-up|8|||
33583717|NCT02702609|102025944|FG001|Overall Study|Lost to Follow-up|4|||
33583718|NCT02702609|102025943|FG000|Overall Study|Physician Decision|1|||
33583719|NCT02702609|102025944|FG001|Overall Study|Physician Decision|0|||
33583720|NCT01014767|102025945|FG000|Overall Study|PI left institution, data unavailable|12|||
33645024|NCT02059291|102252667|FG017|Epoch 4|Adverse Event|0|||
33645025|NCT02059291|102252668|FG018|Epoch 4|Adverse Event|0|||
33645026|NCT02059291|102252669|FG019|Epoch 4|Adverse Event|0|||
33645027|NCT02059291|102252670|FG020|Epoch 4|Adverse Event|0|||
33645028|NCT02059291|102252671|FG021|Epoch 4|Adverse Event|0|||
33645029|NCT02059291|102252672|FG022|Epoch 4|Adverse Event|1|||
33583721|NCT01014767|102025946|FG001|Overall Study|PI left institution, data unavailable|1|||
33583722|NCT01014767|102025947|FG002|Overall Study|PI left institution, data unavailable|4|||
33583723|NCT01014767|102025948|FG003|Overall Study|PI left institution, data unavailable|1|||
33583724|NCT01453036|102025949|FG000|Overall Study|Lost to Follow-up|26|||
33583725|NCT01453036|102025950|FG001|Overall Study|Lost to Follow-up|115|||
33583726|NCT01453036|102025951|FG002|Overall Study|Lost to Follow-up|31|||
33645030|NCT02059291|102252673|FG023|Epoch 4|Adverse Event|0|||
33645031|NCT02059291|102252674|FG024|Epoch 4|Adverse Event|0|||
33645032|NCT02059291|102252650|FG000|Epoch 4|Pregnancy|0|||
33645033|NCT02059291|102252651|FG001|Epoch 4|Pregnancy|0|||
33645034|NCT02059291|102252652|FG002|Epoch 4|Pregnancy|0|||
33645035|NCT02059291|102252653|FG003|Epoch 4|Pregnancy|0|||
33645036|NCT02059291|102252654|FG004|Epoch 4|Pregnancy|0|||
33645037|NCT02059291|102252655|FG005|Epoch 4|Pregnancy|0|||
33645038|NCT02059291|102252656|FG006|Epoch 4|Pregnancy|0|||
33645039|NCT02059291|102252657|FG007|Epoch 4|Pregnancy|0|||
33645040|NCT02059291|102252658|FG008|Epoch 4|Pregnancy|0|||
33645041|NCT02059291|102252659|FG009|Epoch 4|Pregnancy|0|||
33645042|NCT02059291|102252660|FG010|Epoch 4|Pregnancy|0|||
33645043|NCT02059291|102252661|FG011|Epoch 4|Pregnancy|0|||
33645044|NCT02059291|102252662|FG012|Epoch 4|Pregnancy|0|||
33645045|NCT02059291|102252663|FG013|Epoch 4|Pregnancy|0|||
33645046|NCT02059291|102252664|FG014|Epoch 4|Pregnancy|0|||
33645047|NCT02059291|102252665|FG015|Epoch 4|Pregnancy|0|||
33245044|NCT03354390|100797122|FG003|Level 3|Death|0|||
33245045|NCT03354390|100797119|FG000|Level 3|Physician Decision|0|||
33373328|NCT00195260|101252124|FG008|Part 1: Dose Escalation|Disease Progression|0|||
33373329|NCT00195260|101252125|FG009|Part 1: Dose Escalation|Disease Progression|0|||
33373330|NCT00195260|101252126|FG010|Part 1: Dose Escalation|Disease Progression|0|||
33373331|NCT00195260|101252116|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
33373332|NCT00195260|101252117|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
33373333|NCT00195260|101252118|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
33373334|NCT00195260|101252119|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
33373335|NCT00195260|101252120|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
33423003|NCT02164539|101439789|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
33583727|NCT01169701|102025954|FG000|Overall Study|Lost to Follow-up|1|||
33583728|NCT01169701|102025955|FG001|Overall Study|Lost to Follow-up|1|||
33583729|NCT01169701|102025954|FG000|Overall Study|Withdrawal by Subject|1|||
33583730|NCT01169701|102025955|FG001|Overall Study|Withdrawal by Subject|3|||
33645048|NCT02059291|102252666|FG016|Epoch 4|Pregnancy|1|||
33645049|NCT02059291|102252667|FG017|Epoch 4|Pregnancy|0|||
33645050|NCT02059291|102252668|FG018|Epoch 4|Pregnancy|0|||
33645051|NCT02059291|102252669|FG019|Epoch 4|Pregnancy|0|||
33645052|NCT02059291|102252670|FG020|Epoch 4|Pregnancy|0|||
33645053|NCT02059291|102252671|FG021|Epoch 4|Pregnancy|0|||
33645054|NCT02059291|102252672|FG022|Epoch 4|Pregnancy|0|||
33645055|NCT02059291|102252673|FG023|Epoch 4|Pregnancy|0|||
33645056|NCT02059291|102252674|FG024|Epoch 4|Pregnancy|0|||
33146944|NCT00679055|100451744|FG000|Overall Study|Other|0|||
33146945|NCT00679055|100451745|FG001|Overall Study|Other|3|||
33146946|NCT00679055|100451744|FG000|Overall Study|Study Terminated|2|||
33245046|NCT03354390|100797120|FG001|Level 3|Physician Decision|0|||
33645057|NCT02059291|102252650|FG000|Epoch 4|Withdrawal by Subject|0|||
33645058|NCT02059291|102252651|FG001|Epoch 4|Withdrawal by Subject|0|||
33645059|NCT02059291|102252652|FG002|Epoch 4|Withdrawal by Subject|0|||
33645060|NCT02059291|102252653|FG003|Epoch 4|Withdrawal by Subject|0|||
33645061|NCT02059291|102252654|FG004|Epoch 4|Withdrawal by Subject|0|||
33583731|NCT01169701|102025954|FG000|Overall Study|Adverse Event|1|||
33583732|NCT01169701|102025955|FG001|Overall Study|Adverse Event|2|||
33146947|NCT00679055|100451745|FG001|Overall Study|Study Terminated|1|||
33146948|NCT02445391|100451746|FG000|Overall Study|No active protocol treatment|3|||
33583733|NCT01169701|102025954|FG000|Overall Study|Exclusion criteria|2|||
33146949|NCT02445391|100451747|FG001|Overall Study|No active protocol treatment|0|||
33146950|NCT02445391|100451748|FG002|Overall Study|No active protocol treatment|0|||
33146951|NCT02445391|100451746|FG000|Overall Study|Adverse Event|0|||
33146952|NCT02445391|100451747|FG001|Overall Study|Adverse Event|21|||
33146953|NCT02445391|100451748|FG002|Overall Study|Adverse Event|12|||
33146954|NCT02445391|100451746|FG000|Overall Study|Alternative therapy|0|||
33146955|NCT02445391|100451747|FG001|Overall Study|Alternative therapy|0|||
33146956|NCT02445391|100451748|FG002|Overall Study|Alternative therapy|1|||
33146957|NCT02445391|100451746|FG000|Overall Study|Disease progression|0|||
33146958|NCT02445391|100451747|FG001|Overall Study|Disease progression|7|||
33146959|NCT02445391|100451748|FG002|Overall Study|Disease progression|22|||
33146960|NCT02445391|100451746|FG000|Overall Study|Complicating disease|0|||
33146961|NCT02445391|100451747|FG001|Overall Study|Complicating disease|2|||
33146962|NCT02445391|100451748|FG002|Overall Study|Complicating disease|1|||
33146963|NCT02445391|100451746|FG000|Overall Study|Withdrawal by Subject|0|||
33146964|NCT02445391|100451747|FG001|Overall Study|Withdrawal by Subject|4|||
33146965|NCT02445391|100451748|FG002|Overall Study|Withdrawal by Subject|9|||
33146966|NCT02445391|100451746|FG000|Overall Study|Financial issue|0|||
33146967|NCT02445391|100451747|FG001|Overall Study|Financial issue|0|||
33146968|NCT02445391|100451748|FG002|Overall Study|Financial issue|2|||
33423004|NCT02164539|101439790|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
33423005|NCT02164539|101439791|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
33423006|NCT02164539|101439792|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
33423007|NCT02164539|101439793|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
33423008|NCT02164539|101439794|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
33423009|NCT02164539|101439788|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
33423010|NCT02164539|101439789|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
33423011|NCT02164539|101439790|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
33146969|NCT02445391|100451746|FG000|Overall Study|Still on treatment|0|||
33146970|NCT02445391|100451747|FG001|Overall Study|Still on treatment|7|||
33146971|NCT02445391|100451748|FG002|Overall Study|Still on treatment|16|||
33146972|NCT02445391|100451746|FG000|Overall Study|Not start protocol therapy|0|||
33146973|NCT02445391|100451747|FG001|Overall Study|Not start protocol therapy|12|||
33146974|NCT02445391|100451748|FG002|Overall Study|Not start protocol therapy|9|||
33146975|NCT00901927|100451752|FG000|Overall Study|Lack of Efficacy|1|||
33146976|NCT00901927|100451752|FG000|Overall Study|Protocol Violation|3|||
33146977|NCT00901927|100451752|FG000|Overall Study|Withdrawal by Subject|2|||
33146978|NCT00568685|100451754|FG000|Overall Study|Adverse Event|2|||
33146979|NCT00568685|100451755|FG001|Overall Study|Adverse Event|3|||
33146980|NCT00568685|100451756|FG002|Overall Study|Adverse Event|3|||
33423012|NCT02164539|101439791|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
33423013|NCT02164539|101439792|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
33423014|NCT02164539|101439793|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
33423015|NCT02164539|101439794|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
33423016|NCT03296553|101439798|FG000|Overall Study|Withdrawal by Subject|1|||
33423017|NCT03296553|101439799|FG001|Overall Study|Withdrawal by Subject|1|||
33423018|NCT03296553|101439798|FG000|Overall Study|Death|1|||
33423019|NCT03296553|101439799|FG001|Overall Study|Death|0|||
33423020|NCT00619619|101439803|FG000|Overall Study|Physician Decision|0|||
33423021|NCT00619619|101439804|FG001|Overall Study|Physician Decision|0|||
33583734|NCT01169701|102025955|FG001|Overall Study|Exclusion criteria|0|||
33583735|NCT01169701|102025954|FG000|Overall Study|Death|0|||
33146981|NCT00568685|100451754|FG000|Overall Study|Withdrawal by Subject|7|||
33146982|NCT00568685|100451755|FG001|Overall Study|Withdrawal by Subject|2|||
33146983|NCT00568685|100451756|FG002|Overall Study|Withdrawal by Subject|2|||
33146984|NCT00568685|100451754|FG000|Overall Study|Protocol Violation|1|||
33423022|NCT00619619|101439805|FG002|Overall Study|Physician Decision|1|||
33583736|NCT01169701|102025955|FG001|Overall Study|Death|1|||
33583737|NCT01169701|102025954|FG000|Overall Study|Administrative problems|0|||
33146985|NCT00568685|100451755|FG001|Overall Study|Protocol Violation|0|||
33146986|NCT00568685|100451756|FG002|Overall Study|Protocol Violation|0|||
33146987|NCT00301821|100451761|FG000|Overall Study|Ineligible|25|||
33146988|NCT00301821|100451761|FG000|Overall Study|Cancel|1|||
33146989|NCT00597701|100451763|FG000|Overall Study|Withdrawal by Subject|5|||
33146990|NCT00597701|100451764|FG001|Overall Study|Withdrawal by Subject|5|||
33146991|NCT00597701|100451763|FG000|Overall Study|Death|0|||
33146992|NCT00597701|100451764|FG001|Overall Study|Death|1|||
33146993|NCT00597701|100451763|FG000|Overall Study|Physician Decision|2|||
33146994|NCT00597701|100451764|FG001|Overall Study|Physician Decision|0|||
33423023|NCT00619619|101439806|FG003|Overall Study|Physician Decision|0|||
33423024|NCT00619619|101439807|FG004|Overall Study|Physician Decision|0|||
33423025|NCT00619619|101439808|FG005|Overall Study|Physician Decision|0|||
33423026|NCT00619619|101439809|FG006|Overall Study|Physician Decision|0|||
33245047|NCT03354390|100797121|FG002|Level 3|Physician Decision|2|||
33245048|NCT03354390|100797122|FG003|Level 3|Physician Decision|0|||
33245049|NCT03354390|100797119|FG000|Level 4|Death|0|||
33245050|NCT03354390|100797120|FG001|Level 4|Death|0|||
33245051|NCT03354390|100797121|FG002|Level 4|Death|0|||
33245052|NCT03354390|100797122|FG003|Level 4|Death|3|||
33245053|NCT02397889|100797123|FG000|Overall Study|Physician Decision|1|||
33245054|NCT02397889|100797124|FG001|Overall Study|Physician Decision|0|||
33245055|NCT05824351|100797128|FG000|Overall Study|Adverse Event|6|||
33245056|NCT05096884|100797129|FG000|Overall Study|Excluded based on negative tilt table test|4|||
33245057|NCT01744691|100797133|FG000|Overall Study|Progressive Disease|18|||
33245058|NCT01744691|100797133|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
33245059|NCT01744691|100797133|FG000|Overall Study|Withdrawal of consent for treatment|3|||
33245060|NCT01744691|100797133|FG000|Overall Study|Physician Decision|4|||
33245061|NCT02501629|100797136|FG000|Overall Study|Death|0|||
33245062|NCT02501629|100797137|FG001|Overall Study|Death|1|||
33245063|NCT02501629|100797136|FG000|Overall Study|Withdrawn from study by sponsor|1|||
33245064|NCT02501629|100797137|FG001|Overall Study|Withdrawn from study by sponsor|0|||
33245065|NCT02501629|100797136|FG000|Overall Study|Early termination by sponsor|1|||
33245066|NCT02501629|100797137|FG001|Overall Study|Early termination by sponsor|0|||
33245067|NCT02501629|100797136|FG000|Overall Study|Withdrawal by Subject|3|||
33245068|NCT02501629|100797137|FG001|Overall Study|Withdrawal by Subject|5|||
33423027|NCT00619619|101439810|FG007|Overall Study|Physician Decision|0|||
33423028|NCT00619619|101439803|FG000|Overall Study|Protocol Violation|0|||
33423029|NCT00619619|101439804|FG001|Overall Study|Protocol Violation|0|||
33423030|NCT00619619|101439805|FG002|Overall Study|Protocol Violation|0|||
33423031|NCT00619619|101439806|FG003|Overall Study|Protocol Violation|1|||
33423032|NCT00619619|101439807|FG004|Overall Study|Protocol Violation|0|||
33423033|NCT00619619|101439808|FG005|Overall Study|Protocol Violation|0|||
33423034|NCT00619619|101439809|FG006|Overall Study|Protocol Violation|1|||
33423035|NCT00619619|101439810|FG007|Overall Study|Protocol Violation|1|||
33423036|NCT00619619|101439803|FG000|Overall Study|Adverse Event|0|||
33423037|NCT00619619|101439804|FG001|Overall Study|Adverse Event|0|||
33423038|NCT00619619|101439805|FG002|Overall Study|Adverse Event|0|||
33423039|NCT00619619|101439806|FG003|Overall Study|Adverse Event|0|||
33423040|NCT00619619|101439807|FG004|Overall Study|Adverse Event|2|||
33423041|NCT00619619|101439808|FG005|Overall Study|Adverse Event|0|||
33423042|NCT00619619|101439809|FG006|Overall Study|Adverse Event|0|||
33423043|NCT00619619|101439810|FG007|Overall Study|Adverse Event|2|||
33423044|NCT03056352|101439811|FG000|Overall Study|Lost to Follow-up|1|||
33423045|NCT01493531|101439813|FG000|Overall Study|Adverse Event|4|||
33423046|NCT01493531|101439814|FG001|Overall Study|Adverse Event|12|||
33423047|NCT01493531|101439815|FG002|Overall Study|Adverse Event|9|||
33423048|NCT01493531|101439813|FG000|Overall Study|Gout flare|3|||
33423049|NCT01493531|101439814|FG001|Overall Study|Gout flare|0|||
33423050|NCT01493531|101439815|FG002|Overall Study|Gout flare|2|||
33423051|NCT01493531|101439813|FG000|Overall Study|Protocol Violation|8|||
33423052|NCT01493531|101439814|FG001|Overall Study|Protocol Violation|15|||
33423053|NCT01493531|101439815|FG002|Overall Study|Protocol Violation|12|||
33423054|NCT01493531|101439813|FG000|Overall Study|Sponsor terminated study|5|||
33423055|NCT01493531|101439814|FG001|Overall Study|Sponsor terminated study|2|||
33423056|NCT01493531|101439815|FG002|Overall Study|Sponsor terminated study|3|||
33423057|NCT01493531|101439813|FG000|Overall Study|Lost to Follow-up|5|||
33423058|NCT01493531|101439814|FG001|Overall Study|Lost to Follow-up|7|||
33423059|NCT01493531|101439815|FG002|Overall Study|Lost to Follow-up|11|||
33423060|NCT01493531|101439813|FG000|Overall Study|Withdrawal by Subject|16|||
33423061|NCT01493531|101439814|FG001|Overall Study|Withdrawal by Subject|13|||
33423062|NCT01493531|101439815|FG002|Overall Study|Withdrawal by Subject|11|||
33423063|NCT01493531|101439813|FG000|Overall Study|Death|0|||
33645062|NCT02059291|102252655|FG005|Epoch 4|Withdrawal by Subject|0|||
33645063|NCT02059291|102252656|FG006|Epoch 4|Withdrawal by Subject|0|||
33423064|NCT01493531|101439814|FG001|Overall Study|Death|1|||
33423065|NCT01493531|101439815|FG002|Overall Study|Death|0|||
33423066|NCT02017535|101439816|FG000|Overall Study|Withdrawal by Subject|1|||
33645064|NCT02059291|102252657|FG007|Epoch 4|Withdrawal by Subject|0|||
33245069|NCT02501629|100797136|FG000|Overall Study|Subject did not return to site|0|||
33245070|NCT02501629|100797137|FG001|Overall Study|Subject did not return to site|1|||
33245071|NCT01474538|100797138|FG000|Treatment Period 1|Death|1|||
33245072|NCT01474538|100797139|FG001|Treatment Period 1|Death|0|||
33245073|NCT01474538|100797138|FG000|Treatment Period 1|Physician Decision|1|||
33245074|NCT01474538|100797139|FG001|Treatment Period 1|Physician Decision|0|||
33423067|NCT02017535|101439817|FG001|Overall Study|Withdrawal by Subject|0|||
33423068|NCT02017535|101439818|FG002|Overall Study|Withdrawal by Subject|0|||
33423069|NCT02017535|101439819|FG003|Overall Study|Withdrawal by Subject|0|||
33423070|NCT00789828|101439825|FG000|Core Period (48 Weeks)|Administrative problems|0|||
33423071|NCT00789828|101439826|FG001|Core Period (48 Weeks)|Administrative problems|1|||
33423072|NCT00789828|101439825|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
33423073|NCT00789828|101439826|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
33423074|NCT00789828|101439825|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
33245075|NCT01474538|100797138|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33245076|NCT01474538|100797139|FG001|Treatment Period 1|Withdrawal by Subject|3|||
33245077|NCT01474538|100797138|FG000|Treatment Period 1|Protocol Violation|0|||
33245078|NCT01474538|100797139|FG001|Treatment Period 1|Protocol Violation|1|||
33245079|NCT01474538|100797138|FG000|Treatment Period 2|Death|1|||
33245080|NCT01474538|100797139|FG001|Treatment Period 2|Death|0|||
33245081|NCT01474538|100797138|FG000|Treatment Period 2|Adverse Event|1|||
33245082|NCT01474538|100797139|FG001|Treatment Period 2|Adverse Event|1|||
33245083|NCT01474538|100797138|FG000|Treatment Period 2|Withdrawal by Subject|2|||
33245084|NCT01474538|100797139|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33245085|NCT01474538|100797138|FG000|Treatment Period 2|Sponsor decision|1|||
33245086|NCT01474538|100797139|FG001|Treatment Period 2|Sponsor decision|0|||
33245087|NCT01474538|100797138|FG000|Treatment Period 2|Physician Decision|0|||
33245088|NCT01474538|100797139|FG001|Treatment Period 2|Physician Decision|1|||
33245089|NCT01474538|100797138|FG000|Treatment Period 2|Protocol Violation|1|||
33245090|NCT01474538|100797139|FG001|Treatment Period 2|Protocol Violation|0|||
33245091|NCT01773122|100797140|FG000|Overall Study|Due to amended age eligibility criteria|3|||
33245092|NCT01773122|100797141|FG001|Overall Study|Due to amended age eligibility criteria|1|||
33245093|NCT01773122|100797142|FG002|Overall Study|Due to amended age eligibility criteria|0|||
33245094|NCT01773122|100797143|FG003|Overall Study|Due to amended age eligibility criteria|1|||
33245095|NCT01018511|100797144|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
33245096|NCT01018511|100797145|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
33245097|NCT01018511|100797146|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
33245098|NCT01018511|100797147|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
33245099|NCT01018511|100797144|FG000|Overall Study|Adverse Event|5|||
33245100|NCT01018511|100797145|FG001|Overall Study|Adverse Event|9|||
33245101|NCT01018511|100797146|FG002|Overall Study|Adverse Event|13|||
33245102|NCT01018511|100797147|FG003|Overall Study|Adverse Event|10|||
33245103|NCT01018511|100797144|FG000|Overall Study|Lack of Efficacy|4|||
33245104|NCT01018511|100797145|FG001|Overall Study|Lack of Efficacy|1|||
33245105|NCT01018511|100797146|FG002|Overall Study|Lack of Efficacy|1|||
33245106|NCT01018511|100797147|FG003|Overall Study|Lack of Efficacy|2|||
33245107|NCT01018511|100797144|FG000|Overall Study|Withdrawal by Subject|6|||
33245108|NCT01018511|100797145|FG001|Overall Study|Withdrawal by Subject|5|||
33245109|NCT01018511|100797146|FG002|Overall Study|Withdrawal by Subject|11|||
33245110|NCT01018511|100797147|FG003|Overall Study|Withdrawal by Subject|9|||
33245111|NCT01018511|100797144|FG000|Overall Study|Lost to Follow-up|0|||
33245112|NCT01018511|100797145|FG001|Overall Study|Lost to Follow-up|0|||
33245113|NCT01018511|100797146|FG002|Overall Study|Lost to Follow-up|1|||
33245114|NCT01018511|100797147|FG003|Overall Study|Lost to Follow-up|0|||
33245115|NCT01018511|100797144|FG000|Overall Study|Protocol Violation|5|||
33245116|NCT01018511|100797145|FG001|Overall Study|Protocol Violation|8|||
33245117|NCT01018511|100797146|FG002|Overall Study|Protocol Violation|7|||
33245118|NCT01018511|100797147|FG003|Overall Study|Protocol Violation|9|||
33245119|NCT01018511|100797144|FG000|Overall Study|Miscellaneous|0|||
33245120|NCT01018511|100797145|FG001|Overall Study|Miscellaneous|2|||
33245121|NCT01018511|100797146|FG002|Overall Study|Miscellaneous|0|||
33245122|NCT01018511|100797147|FG003|Overall Study|Miscellaneous|0|||
33245123|NCT02465359|100797148|FG000|Overall Study|Lack of Efficacy|1|||
33245124|NCT02465359|100797148|FG000|Overall Study|Withdrawal by Subject|1|||
33245125|NCT02465359|100797148|FG000|Overall Study|Adverse Event|1|||
33245126|NCT00072475|100800067|FG000|Overall Study|Adverse Event|44|||
33245127|NCT00072475|100800067|FG000|Overall Study|Death|3|||
33245128|NCT00072475|100800067|FG000|Overall Study|Withdrawal by Subject|46|||
33245129|NCT00072475|100800067|FG000|Overall Study|Patient/Investigator Decision|4|||
33245130|NCT01674569|100800070|FG000|Overall Study|Adverse Event|0|||
33373336|NCT00195260|101252121|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
33373337|NCT00195260|101252122|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
33373338|NCT00195260|101252123|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
33373339|NCT00195260|101252124|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
33373340|NCT00195260|101252125|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
33373341|NCT00195260|101252126|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
33373342|NCT00195260|101252116|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33645065|NCT02059291|102252658|FG008|Epoch 4|Withdrawal by Subject|0|||
33245131|NCT01674569|100800071|FG001|Overall Study|Adverse Event|2|||
33245132|NCT01674569|100800072|FG002|Overall Study|Adverse Event|0|||
33373343|NCT00195260|101252117|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33373344|NCT00195260|101252118|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33245133|NCT01674569|100800073|FG003|Overall Study|Adverse Event|1|||
33245134|NCT01674569|100800074|FG004|Overall Study|Adverse Event|2|||
33245135|NCT01674569|100800075|FG005|Overall Study|Adverse Event|2|||
33245136|NCT01674569|100800070|FG000|Overall Study|Protocol Violation|0|||
33245137|NCT01674569|100800071|FG001|Overall Study|Protocol Violation|1|||
33245138|NCT01674569|100800072|FG002|Overall Study|Protocol Violation|1|||
33245139|NCT01674569|100800073|FG003|Overall Study|Protocol Violation|0|||
33245140|NCT01674569|100800074|FG004|Overall Study|Protocol Violation|0|||
33245141|NCT01674569|100800075|FG005|Overall Study|Protocol Violation|0|||
33245142|NCT01674569|100800070|FG000|Overall Study|Withdrawal by Subject|0|||
33245143|NCT01674569|100800071|FG001|Overall Study|Withdrawal by Subject|0|||
33245144|NCT01674569|100800072|FG002|Overall Study|Withdrawal by Subject|1|||
33245145|NCT01674569|100800073|FG003|Overall Study|Withdrawal by Subject|0|||
33423075|NCT00789828|101439826|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
33423076|NCT00789828|101439825|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
33423077|NCT00789828|101439826|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
33423078|NCT00789828|101439825|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
33583738|NCT01169701|102025955|FG001|Overall Study|Administrative problems|1|||
33583739|NCT01169701|102025954|FG000|Overall Study|Serious adverse event|0|||
33583740|NCT01169701|102025955|FG001|Overall Study|Serious adverse event|1|||
33423079|NCT00789828|101439826|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
33423080|NCT00789828|101439825|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
33423081|NCT00789828|101439826|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
33423082|NCT00789828|101439825|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
33423083|NCT00789828|101439826|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
33423084|NCT00789828|101439825|FG000|Open-label Extension Period (4 Years)|Death|1|||
33423085|NCT00789828|101439826|FG001|Open-label Extension Period (4 Years)|Death|0|||
33423086|NCT00789828|101439825|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
33423087|NCT00789828|101439826|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
33423088|NCT00789828|101439825|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
33423089|NCT00789828|101439826|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
33423090|NCT01559818|101439828|FG000|Overall Study|Physician Decision|1|||
33423091|NCT01559818|101439828|FG000|Overall Study|Pregnancy|1|||
33423092|NCT01559818|101439828|FG000|Overall Study|Study terminated by Sponsor|4|||
33423093|NCT01559818|101439828|FG000|Overall Study|Withdrawal by Subject|1|||
33423094|NCT01336608|101439829|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
33423095|NCT01336608|101439830|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33423096|NCT01336608|101439831|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33423097|NCT01336608|101439832|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
33423098|NCT01336608|101439829|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
33423099|NCT01336608|101439830|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33423100|NCT01336608|101439831|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33423101|NCT01336608|101439832|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
33423102|NCT01336608|101439829|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
33423103|NCT01336608|101439830|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
33423104|NCT01336608|101439831|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
33423105|NCT01336608|101439832|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
33423106|NCT01336608|101439829|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
33423107|NCT01336608|101439830|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
33423108|NCT01336608|101439831|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
33423109|NCT01336608|101439832|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
33423110|NCT01336608|101439829|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
33423111|NCT01336608|101439830|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33423112|NCT01336608|101439831|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33423113|NCT01336608|101439832|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
33423114|NCT01336608|101439829|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
33423115|NCT01336608|101439830|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
33423116|NCT01336608|101439831|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
33423117|NCT01336608|101439832|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
33423118|NCT01336608|101439829|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33423119|NCT01336608|101439830|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
33423120|NCT01336608|101439831|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33423121|NCT01336608|101439832|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
33423122|NCT01336608|101439829|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
33423123|NCT01336608|101439830|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
33423124|NCT01336608|101439831|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
33423125|NCT01336608|101439832|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
33583741|NCT01169701|102025954|FG000|Overall Study|Sponsor decision|0|||
33583742|NCT01169701|102025955|FG001|Overall Study|Sponsor decision|1|||
33583743|NCT00460655|102025956|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
33583744|NCT00460655|102025957|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33583745|NCT00460655|102025958|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33423126|NCT01336608|101439829|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
33245146|NCT01674569|100800074|FG004|Overall Study|Withdrawal by Subject|0|||
33245147|NCT01674569|100800075|FG005|Overall Study|Withdrawal by Subject|0|||
33373345|NCT00195260|101252119|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33373346|NCT00195260|101252120|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33373347|NCT00195260|101252121|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33373348|NCT00195260|101252122|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33373349|NCT00195260|101252123|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
33373350|NCT00195260|101252124|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
33373351|NCT00195260|101252125|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
33373352|NCT00195260|101252126|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
33373353|NCT00195260|101252116|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33373354|NCT00195260|101252117|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33373355|NCT00195260|101252118|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33373356|NCT00195260|101252119|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33373357|NCT00195260|101252120|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33373358|NCT00195260|101252121|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33373359|NCT00195260|101252122|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33373360|NCT00195260|101252123|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
33373361|NCT00195260|101252124|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
33373362|NCT00195260|101252125|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
33373363|NCT00195260|101252126|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
33373364|NCT00195260|101252116|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33373365|NCT00195260|101252117|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33373366|NCT00195260|101252118|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33373367|NCT00195260|101252119|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33373368|NCT00195260|101252120|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33373369|NCT00195260|101252121|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33373370|NCT00195260|101252122|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33373371|NCT00195260|101252123|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
33373372|NCT00195260|101252124|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
33423127|NCT01336608|101439830|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
33423128|NCT01336608|101439831|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
33423129|NCT01336608|101439832|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
33423130|NCT01336608|101439829|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
33423131|NCT01336608|101439830|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
33146995|NCT00597701|100451763|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
33146996|NCT00597701|100451764|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
33146997|NCT00144027|100451765|FG000|Overall Study|Lost to Follow-up|1|||
33146998|NCT00144027|100451766|FG001|Overall Study|Lost to Follow-up|3|||
33146999|NCT00144027|100451765|FG000|Overall Study|Withdrawal by Subject|2|||
33147000|NCT00144027|100451766|FG001|Overall Study|Withdrawal by Subject|2|||
33147001|NCT00144027|100451765|FG000|Overall Study|did not complete baseline assessment|0|||
33147002|NCT00144027|100451766|FG001|Overall Study|did not complete baseline assessment|6|||
33147003|NCT03101267|100451768|FG000|Primary Study Period|Withdrawal by Subject|1|||
33147004|NCT03101267|100451769|FG001|Primary Study Period|Withdrawal by Subject|2|||
33147005|NCT03101267|100451770|FG002|Primary Study Period|Withdrawal by Subject|3|||
33147006|NCT03101267|100451768|FG000|Primary Study Period|Miscellaneous|2|||
33147007|NCT03101267|100451769|FG001|Primary Study Period|Miscellaneous|0|||
33147008|NCT03101267|100451770|FG002|Primary Study Period|Miscellaneous|0|||
33147009|NCT00997438|100451775|FG000|Overall Study|Blood draw difficulty|2|||
33147010|NCT00997438|100451776|FG001|Overall Study|Blood draw difficulty|0|||
33147011|NCT00997438|100451777|FG002|Overall Study|Blood draw difficulty|1|||
33147012|NCT00997438|100451775|FG000|Overall Study|Withdrawal by Subject|1|||
33147013|NCT00997438|100451776|FG001|Overall Study|Withdrawal by Subject|1|||
33147014|NCT00997438|100451777|FG002|Overall Study|Withdrawal by Subject|0|||
33147015|NCT00997438|100451775|FG000|Overall Study|Exclusion criteria at visit 1|2|||
33147016|NCT00997438|100451776|FG001|Overall Study|Exclusion criteria at visit 1|2|||
33147017|NCT00997438|100451777|FG002|Overall Study|Exclusion criteria at visit 1|3|||
33147018|NCT00560885|100451778|FG000|Overall Study|Death|7|||
33147019|NCT00560885|100451778|FG000|Overall Study|Withdrawal by Subject|1|||
33147020|NCT02567552|100451779|FG000|Overall Study|Adverse Event|0|||
33147021|NCT02567552|100451780|FG001|Overall Study|Adverse Event|1|||
33147022|NCT01857310|100451781|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
33147023|NCT01857310|100451782|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
33147024|NCT00744471|100451784|FG000|Overall Study|Randomized but not treated|1|||
33373373|NCT00195260|101252125|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
33373374|NCT00195260|101252126|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
33423132|NCT01336608|101439831|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
33423133|NCT01336608|101439832|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
33147025|NCT00744471|100451785|FG001|Overall Study|Randomized but not treated|1|||
33583746|NCT00460655|102025959|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33583747|NCT00460655|102025956|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
33583748|NCT00460655|102025957|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33583749|NCT00460655|102025958|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33583750|NCT00460655|102025959|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33583751|NCT00460655|102025956|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
33583752|NCT00460655|102025957|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
33583753|NCT00460655|102025958|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
33583754|NCT00460655|102025959|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
33583755|NCT00460655|102025956|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
33583756|NCT00460655|102025957|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
33583757|NCT00460655|102025958|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
33583758|NCT00460655|102025959|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
33583759|NCT00460655|102025956|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33583760|NCT00460655|102025957|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33583761|NCT00460655|102025958|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
33583762|NCT00460655|102025959|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
33583763|NCT00460655|102025956|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
33583764|NCT00460655|102025957|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
33583765|NCT00460655|102025958|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
33583766|NCT00460655|102025959|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
33583767|NCT02998671|102025960|FG000|Period 1|Study Terminated By Sponsor|2|||
33245148|NCT03675737|100800078|FG000|Overall Study|Death|593|||
33245149|NCT03675737|100800079|FG001|Overall Study|Death|660|||
33245150|NCT03675737|100800078|FG000|Overall Study|Lost to Follow-up|1|||
33245151|NCT03675737|100800079|FG001|Overall Study|Lost to Follow-up|5|||
33245152|NCT03675737|100800078|FG000|Overall Study|Physician Decision|1|||
33245153|NCT03675737|100800079|FG001|Overall Study|Physician Decision|0|||
33245154|NCT03675737|100800078|FG000|Overall Study|Withdrawal by Subject|14|||
33245155|NCT03675737|100800079|FG001|Overall Study|Withdrawal by Subject|12|||
33245156|NCT03675737|100800078|FG000|Overall Study|Ongoing in Study|181|||
33245157|NCT03675737|100800079|FG001|Overall Study|Ongoing in Study|112|||
33245158|NCT00543725|100800083|FG000|Overall Study|Adverse Event|18|||
33245159|NCT00543725|100800084|FG001|Overall Study|Adverse Event|27|||
33245160|NCT00543725|100800083|FG000|Overall Study|Sponsor's Decision|0|||
33245161|NCT00543725|100800084|FG001|Overall Study|Sponsor's Decision|1|||
33245162|NCT00543725|100800083|FG000|Overall Study|Subject Non-Compliant|4|||
33245163|NCT00543725|100800084|FG001|Overall Study|Subject Non-Compliant|4|||
33245164|NCT00543725|100800083|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
33245165|NCT00543725|100800084|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
33245166|NCT00543725|100800083|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
33245167|NCT00543725|100800084|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
33245168|NCT00543725|100800083|FG000|Overall Study|Protocol Violation|0|||
33245169|NCT00543725|100800084|FG001|Overall Study|Protocol Violation|1|||
33245170|NCT00543725|100800083|FG000|Overall Study|Withdrawal by Subject|4|||
33245171|NCT00543725|100800084|FG001|Overall Study|Withdrawal by Subject|13|||
33245172|NCT00543725|100800083|FG000|Overall Study|Lost to Follow-up|15|||
33245173|NCT00543725|100800084|FG001|Overall Study|Lost to Follow-up|11|||
33245174|NCT00543725|100800083|FG000|Overall Study|Other|3|||
33245175|NCT00543725|100800084|FG001|Overall Study|Other|3|||
33245176|NCT04511650|100800088|FG000|Overall Study|Lost to Follow-up|1|||
33245177|NCT04511650|100800089|FG001|Overall Study|Lost to Follow-up|0|||
33245178|NCT04511650|100800090|FG002|Overall Study|Lost to Follow-up|0|||
33245179|NCT04511650|100800088|FG000|Overall Study|Withdrawal by Subject|1|||
33245180|NCT04511650|100800089|FG001|Overall Study|Withdrawal by Subject|0|||
33245181|NCT04511650|100800090|FG002|Overall Study|Withdrawal by Subject|0|||
33245182|NCT04511650|100800088|FG000|Overall Study|reason not provided|0|||
33245183|NCT04511650|100800089|FG001|Overall Study|reason not provided|0|||
33245184|NCT04511650|100800090|FG002|Overall Study|reason not provided|1|||
33245185|NCT04511650|100800088|FG000|Overall Study|Death|1|||
33245186|NCT04511650|100800089|FG001|Overall Study|Death|1|||
33245187|NCT04511650|100800090|FG002|Overall Study|Death|1|||
33245188|NCT02028884|100800091|FG000|Double-blind Period|Adverse Event|5|||
33245189|NCT02028884|100800092|FG001|Double-blind Period|Adverse Event|3|||
33245190|NCT02028884|100800093|FG002|Double-blind Period|Adverse Event|0|||
33245191|NCT02028884|100800091|FG000|Double-blind Period|Eligibility Violation|1|||
33245192|NCT02028884|100800092|FG001|Double-blind Period|Eligibility Violation|0|||
33245193|NCT02028884|100800093|FG002|Double-blind Period|Eligibility Violation|0|||
33245194|NCT02028884|100800091|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
33245195|NCT02028884|100800092|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
33245196|NCT02028884|100800093|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
33245197|NCT02028884|100800091|FG000|Double-blind Period|Withdrawal by Subject|2|||
33583768|NCT02998671|102025961|FG001|Period 1|Study Terminated By Sponsor|1|||
33583769|NCT02998671|102025962|FG002|Period 1|Study Terminated By Sponsor|0|||
33583770|NCT02998671|102025963|FG003|Period 1|Study Terminated By Sponsor|0|||
33423134|NCT01336608|101439829|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33423135|NCT01336608|101439830|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
33423136|NCT01336608|101439831|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33423137|NCT01336608|101439832|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33423138|NCT01336608|101439829|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
33423139|NCT01336608|101439830|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
33423140|NCT01336608|101439831|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
33147026|NCT00744471|100451786|FG002|Overall Study|Randomized but not treated|4|||
33147027|NCT00744471|100451787|FG003|Overall Study|Randomized but not treated|0|||
33147028|NCT00744471|100451784|FG000|Overall Study|Death|0|||
33147029|NCT00744471|100451785|FG001|Overall Study|Death|0|||
33147030|NCT00744471|100451786|FG002|Overall Study|Death|0|||
33147031|NCT00744471|100451787|FG003|Overall Study|Death|1|||
33147032|NCT00744471|100451784|FG000|Overall Study|Adverse Event|6|||
33147033|NCT00744471|100451785|FG001|Overall Study|Adverse Event|7|||
33147034|NCT00744471|100451786|FG002|Overall Study|Adverse Event|5|||
33147035|NCT00744471|100451787|FG003|Overall Study|Adverse Event|9|||
33147036|NCT00744471|100451784|FG000|Overall Study|Withdrawal by Subject|9|||
33147037|NCT00744471|100451785|FG001|Overall Study|Withdrawal by Subject|9|||
33147038|NCT00744471|100451786|FG002|Overall Study|Withdrawal by Subject|15|||
33373375|NCT00195260|101252116|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33373376|NCT00195260|101252117|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33373377|NCT00195260|101252118|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33373378|NCT00195260|101252119|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33373379|NCT00195260|101252120|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33373380|NCT00195260|101252121|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33373381|NCT00195260|101252122|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33373382|NCT00195260|101252123|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
33373383|NCT00195260|101252124|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
33373384|NCT00195260|101252125|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
33373385|NCT00195260|101252126|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
33373386|NCT03509207|101252127|FG000|Overall Study|Death|2|||
33373387|NCT00782418|101252128|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
33373388|NCT00782418|101252129|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
33373389|NCT00782418|101252130|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
33373390|NCT00782418|101252131|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
33373391|NCT00782418|101252132|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
33373392|NCT00782418|101252133|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
33373393|NCT00782418|101252134|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
33373394|NCT00782418|101252128|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
33373395|NCT00782418|101252129|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
33373396|NCT00782418|101252130|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
33373397|NCT00782418|101252131|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
33373398|NCT00782418|101252132|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
33373399|NCT00782418|101252133|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
33373400|NCT00782418|101252134|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
33373401|NCT00436566|101252135|FG000|Overall Study|Withdrawal by Subject|2|||
33373402|NCT00436566|101252135|FG000|Overall Study|Protocol Violation|1|||
33373403|NCT01740440|101252136|FG000|Overall Study|Lost to Follow-up|3|||
33373404|NCT00471445|101252138|FG000|Overall Study|Withdrawal by Subject|1|||
33373405|NCT00471445|101252139|FG001|Overall Study|Withdrawal by Subject|1|||
33373406|NCT00471445|101252138|FG000|Overall Study|Ineligible|1|||
33373407|NCT00471445|101252139|FG001|Overall Study|Ineligible|0|||
33373408|NCT00471445|101252138|FG000|Overall Study|Protocol Violation|0|||
33373409|NCT00471445|101252139|FG001|Overall Study|Protocol Violation|1|||
33373410|NCT01810042|101252140|FG000|Overall Study|Lost to Follow-up|10|||
33373411|NCT00777491|101252141|FG000|Overall Study|Protocol Violation|0|||
33373412|NCT00777491|101252142|FG001|Overall Study|Protocol Violation|2|||
33373413|NCT00777491|101252141|FG000|Overall Study|Did not receive any protocol treatment|2|||
33373414|NCT00777491|101252142|FG001|Overall Study|Did not receive any protocol treatment|0|||
33423141|NCT01336608|101439832|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
33423142|NCT01336608|101439829|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
33583771|NCT02998671|102025964|FG004|Period 1|Study Terminated By Sponsor|1|||
33147039|NCT00744471|100451787|FG003|Overall Study|Withdrawal by Subject|12|||
33147040|NCT00744471|100451784|FG000|Overall Study|Protocol Violation|1|||
33147041|NCT00744471|100451785|FG001|Overall Study|Protocol Violation|4|||
33147042|NCT00744471|100451786|FG002|Overall Study|Protocol Violation|1|||
33147043|NCT00744471|100451787|FG003|Overall Study|Protocol Violation|2|||
33373415|NCT02491073|101252149|FG000|Overall Study|screen failure|1|||
33373416|NCT02491073|101252150|FG001|Overall Study|screen failure|0|||
33373417|NCT00879814|101252151|FG000|Overall Study|Adverse Event|0|||
33423143|NCT01336608|101439830|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
33423144|NCT01336608|101439831|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
33423145|NCT01336608|101439832|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
33423146|NCT00078819|101439833|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
33423147|NCT00078819|101439834|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
33423148|NCT00078819|101439835|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
33423149|NCT00078819|101439836|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
33423150|NCT00078819|101439833|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
33423151|NCT00078819|101439834|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
33423152|NCT00078819|101439835|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
33423153|NCT00078819|101439836|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
33423154|NCT00078819|101439833|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
33423155|NCT00078819|101439834|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
33423156|NCT00078819|101439835|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
33423157|NCT00078819|101439836|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
33423158|NCT00078819|101439833|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
33423159|NCT00078819|101439834|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
33423160|NCT00078819|101439835|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
33423161|NCT00078819|101439836|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
33423162|NCT00078819|101439833|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
33423163|NCT00078819|101439834|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
33423164|NCT00078819|101439835|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
33423165|NCT00078819|101439836|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
33423166|NCT00078819|101439833|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
33423167|NCT00078819|101439834|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
33583772|NCT02998671|102025960|FG000|Period 1|Withdrawal by Subject|1|||
33583773|NCT02998671|102025961|FG001|Period 1|Withdrawal by Subject|2|||
33147044|NCT00744471|100451784|FG000|Overall Study|Entered extension study|41|||
33147045|NCT00744471|100451785|FG001|Overall Study|Entered extension study|84|||
33147046|NCT00744471|100451786|FG002|Overall Study|Entered extension study|100|||
33147047|NCT00744471|100451787|FG003|Overall Study|Entered extension study|91|||
33147048|NCT00744471|100451784|FG000|Overall Study|Other|2|||
33147049|NCT00744471|100451785|FG001|Overall Study|Other|3|||
33147050|NCT00744471|100451786|FG002|Overall Study|Other|6|||
33147051|NCT00744471|100451787|FG003|Overall Study|Other|2|||
33147052|NCT00744471|100451784|FG000|Overall Study|Lack of Efficacy|83|||
33147053|NCT00744471|100451785|FG001|Overall Study|Lack of Efficacy|37|||
33147054|NCT00744471|100451786|FG002|Overall Study|Lack of Efficacy|19|||
33147055|NCT00744471|100451787|FG003|Overall Study|Lack of Efficacy|31|||
33147056|NCT00744471|100451784|FG000|Overall Study|Lost to Follow-up|0|||
33147057|NCT00744471|100451785|FG001|Overall Study|Lost to Follow-up|0|||
33147058|NCT00744471|100451786|FG002|Overall Study|Lost to Follow-up|2|||
33147059|NCT00744471|100451787|FG003|Overall Study|Lost to Follow-up|0|||
33147060|NCT03707184|100451789|FG000|Overall Study|Withdrawal by Subject|2|||
33147061|NCT02376829|100451791|FG000|Overall Study|Withdrawal by Subject|27|||
33147062|NCT02376829|100451792|FG001|Overall Study|Withdrawal by Subject|44|||
33147063|NCT03052764|100451793|FG000|Double-Blind Treatment Period|Adverse Event|2|||
33147064|NCT03052764|100451794|FG001|Double-Blind Treatment Period|Adverse Event|0|||
33147065|NCT03052764|100451793|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
33147066|NCT03052764|100451794|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
33147067|NCT03052764|100451793|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
33147068|NCT03052764|100451794|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
33147069|NCT03052764|100451793|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
33147070|NCT03052764|100451794|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33147071|NCT03052764|100451793|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
33147072|NCT03052764|100451794|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
33147073|NCT00495131|100451802|FG000|Overall Study|Adverse Event|6|||
33147074|NCT00495131|100451803|FG001|Overall Study|Adverse Event|2|||
33147075|NCT00495131|100451802|FG000|Overall Study|Lack of Efficacy|0|||
33147076|NCT00495131|100451803|FG001|Overall Study|Lack of Efficacy|2|||
33147077|NCT00495131|100451802|FG000|Overall Study|Lost to Follow-up|0|||
33147078|NCT00495131|100451803|FG001|Overall Study|Lost to Follow-up|2|||
33147079|NCT00495131|100451802|FG000|Overall Study|Withdrawal by Subject|1|||
33147080|NCT00495131|100451803|FG001|Overall Study|Withdrawal by Subject|0|||
33245198|NCT02028884|100800092|FG001|Double-blind Period|Withdrawal by Subject|0|||
33583774|NCT02998671|102025962|FG002|Period 1|Withdrawal by Subject|0|||
33147081|NCT03026088|100451804|FG000|Overall Study|Study termination|20|||
33147082|NCT00084838|100451805|FG000|Overall Study|Death|1|||
33147083|NCT00084838|100451805|FG000|Overall Study|Adverse Event|2|||
33147084|NCT00084838|100451805|FG000|Overall Study|Withdrawal by Subject|1|||
33147085|NCT00084838|100451805|FG000|Overall Study|Progressive Disease|4|||
33373418|NCT00879814|101252152|FG001|Overall Study|Adverse Event|1|||
33583775|NCT02998671|102025963|FG003|Period 1|Withdrawal by Subject|0|||
33147086|NCT00084838|100451805|FG000|Overall Study|Pt Non-Compliance|1|||
33147087|NCT00084838|100451805|FG000|Overall Study|Ineligible|4|||
33147088|NCT00815516|100451808|FG000|Overall Study|Death|3|||
33147089|NCT00815516|100451809|FG001|Overall Study|Death|1|||
33147090|NCT00815516|100451808|FG000|Overall Study|Physician Decision|1|||
33147091|NCT00815516|100451809|FG001|Overall Study|Physician Decision|0|||
33147092|NCT04050371|100451810|FG000|Overall Study|Withdrawal by Subject|1|||
33147093|NCT04050371|100451811|FG001|Overall Study|Withdrawal by Subject|0|||
33147094|NCT03509467|100451812|FG000|Overall Study|Withdrawal by Subject|5|||
33147095|NCT03509467|100451813|FG001|Overall Study|Withdrawal by Subject|1|||
33147096|NCT03509467|100451814|FG002|Overall Study|Withdrawal by Subject|6|||
33147097|NCT03509467|100451815|FG003|Overall Study|Withdrawal by Subject|7|||
33147098|NCT03509467|100451816|FG004|Overall Study|Withdrawal by Subject|10|||
33147099|NCT03509467|100451817|FG005|Overall Study|Withdrawal by Subject|10|||
33147100|NCT03509467|100451818|FG006|Overall Study|Withdrawal by Subject|10|||
33147101|NCT03509467|100451819|FG007|Overall Study|Withdrawal by Subject|10|||
33147102|NCT03509467|100451812|FG000|Overall Study|Death|0|||
33147103|NCT03509467|100451813|FG001|Overall Study|Death|0|||
33147104|NCT03509467|100451814|FG002|Overall Study|Death|2|||
33147105|NCT03509467|100451815|FG003|Overall Study|Death|2|||
33147106|NCT03509467|100451816|FG004|Overall Study|Death|1|||
33147107|NCT03509467|100451817|FG005|Overall Study|Death|0|||
33147108|NCT03509467|100451818|FG006|Overall Study|Death|1|||
33147109|NCT03509467|100451819|FG007|Overall Study|Death|0|||
33147110|NCT03509467|100451812|FG000|Overall Study|Proxy Withdrawal|0|||
33373419|NCT00879814|101252153|FG002|Overall Study|Adverse Event|0|||
33373420|NCT00879814|101252154|FG003|Overall Study|Adverse Event|0|||
33373421|NCT00879814|101252151|FG000|Overall Study|Lost to Follow-up|1|||
33373422|NCT00879814|101252152|FG001|Overall Study|Lost to Follow-up|0|||
33373423|NCT00879814|101252153|FG002|Overall Study|Lost to Follow-up|0|||
33373424|NCT00879814|101252154|FG003|Overall Study|Lost to Follow-up|2|||
33373425|NCT00879814|101252151|FG000|Overall Study|Participant Failed to Return|0|||
33373426|NCT00879814|101252152|FG001|Overall Study|Participant Failed to Return|0|||
33373427|NCT00879814|101252153|FG002|Overall Study|Participant Failed to Return|0|||
33373428|NCT00879814|101252154|FG003|Overall Study|Participant Failed to Return|1|||
33373429|NCT00879814|101252151|FG000|Overall Study|Withdrawal by Subject|3|||
33373430|NCT00879814|101252152|FG001|Overall Study|Withdrawal by Subject|1|||
33373431|NCT00879814|101252153|FG002|Overall Study|Withdrawal by Subject|1|||
33373432|NCT00879814|101252154|FG003|Overall Study|Withdrawal by Subject|2|||
33373433|NCT00879814|101252151|FG000|Overall Study|Physician Decision|0|||
33373434|NCT00879814|101252152|FG001|Overall Study|Physician Decision|0|||
33373435|NCT00879814|101252153|FG002|Overall Study|Physician Decision|1|||
33373436|NCT00879814|101252154|FG003|Overall Study|Physician Decision|0|||
33373437|NCT00879814|101252151|FG000|Overall Study|Other|0|||
33373438|NCT00879814|101252152|FG001|Overall Study|Other|0|||
33373439|NCT00879814|101252153|FG002|Overall Study|Other|1|||
33373440|NCT00879814|101252154|FG003|Overall Study|Other|0|||
33373441|NCT01260467|101252155|FG000|Overall Study|Withdrawal by Subject|2|||
33423168|NCT00078819|101439835|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
33423169|NCT00078819|101439836|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
33423170|NCT00078819|101439833|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
33423171|NCT00078819|101439834|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
33423172|NCT00078819|101439835|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
33423173|NCT00078819|101439836|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
33423174|NCT00078819|101439833|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
33423175|NCT00078819|101439834|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
33423176|NCT00078819|101439835|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
33423177|NCT00078819|101439836|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
33423178|NCT03156270|101439837|FG000|Overall Study|Failed pre-treatment screening|1|||
33423179|NCT03156270|101439837|FG000|Overall Study|Lost to Follow-up|1|||
33423180|NCT02464059|101439838|FG000|Overall Study|Lost to Follow-up|6|||
33423181|NCT03302299|101439839|FG000|Overall Study|Protocol Violation|1|||
33423182|NCT00869089|101439840|FG000|Overall Study|Lost to Follow-up|1|||
33423183|NCT00869089|101439840|FG000|Overall Study|Withdrawal by Subject|1|||
33423184|NCT00869089|101439840|FG000|Overall Study|Screen Fail|1|||
33423185|NCT00272961|101439843|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
33423186|NCT00272961|101439844|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
33423187|NCT00272961|101439845|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
33423188|NCT00272961|101439846|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
33423189|NCT00272961|101439847|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
33147111|NCT03509467|100451813|FG001|Overall Study|Proxy Withdrawal|0|||
33147112|NCT03509467|100451814|FG002|Overall Study|Proxy Withdrawal|0|||
33423190|NCT00272961|101439843|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
33583776|NCT02998671|102025964|FG004|Period 1|Withdrawal by Subject|2|||
33147113|NCT03509467|100451815|FG003|Overall Study|Proxy Withdrawal|0|||
33147114|NCT03509467|100451816|FG004|Overall Study|Proxy Withdrawal|0|||
33147115|NCT03509467|100451817|FG005|Overall Study|Proxy Withdrawal|0|||
33147116|NCT03509467|100451818|FG006|Overall Study|Proxy Withdrawal|0|||
33147117|NCT03509467|100451819|FG007|Overall Study|Proxy Withdrawal|1|||
33147118|NCT00723203|100451820|FG000|Overall Study|Withdrawal by Subject|3|||
33147119|NCT03977454|100451824|FG000|Overall Study|immediate postoperative revision|2|||
33147120|NCT03977454|100451825|FG001|Overall Study|immediate postoperative revision|2|||
33147121|NCT04163718|100451826|FG000|Overall Study|Study terminated|12|||
33147122|NCT04099251|100454224|FG000|Pre-Treatment|Other reasons|1|||
33147123|NCT04099251|100454225|FG001|Pre-Treatment|Other reasons|0|||
33147124|NCT04099251|100454224|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
33147125|NCT04099251|100454225|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
33147126|NCT04099251|100454224|FG000|Blinded Treatment Phase|Other reasons|16|||
33373442|NCT00547378|101255858|FG000|Randomized Cohort|Withdrawal by Subject|7|||
33373443|NCT00547378|101255859|FG001|Randomized Cohort|Withdrawal by Subject|5|||
33583777|NCT02998671|102025960|FG000|Period 1|Pregnancy|1|||
33583778|NCT02998671|102025961|FG001|Period 1|Pregnancy|0|||
33583779|NCT02998671|102025962|FG002|Period 1|Pregnancy|0|||
33583780|NCT02998671|102025963|FG003|Period 1|Pregnancy|0|||
33583781|NCT02998671|102025964|FG004|Period 1|Pregnancy|0|||
33583782|NCT02998671|102025960|FG000|Period 1|Adverse Event|0|||
33583783|NCT02998671|102025961|FG001|Period 1|Adverse Event|0|||
33583784|NCT02998671|102025962|FG002|Period 1|Adverse Event|0|||
33583785|NCT02998671|102025963|FG003|Period 1|Adverse Event|0|||
33583786|NCT02998671|102025964|FG004|Period 1|Adverse Event|1|||
33583787|NCT02998671|102025960|FG000|Period 2|Adverse Event|0|||
33583788|NCT02998671|102025961|FG001|Period 2|Adverse Event|1|||
33583789|NCT02998671|102025962|FG002|Period 2|Adverse Event|0|||
33583790|NCT02998671|102025963|FG003|Period 2|Adverse Event|0|||
33583791|NCT02998671|102025964|FG004|Period 2|Adverse Event|0|||
33583792|NCT02998671|102025960|FG000|Period 2|Study Terminated By Sponsor|3|||
33583793|NCT02998671|102025961|FG001|Period 2|Study Terminated By Sponsor|5|||
33583794|NCT02998671|102025962|FG002|Period 2|Study Terminated By Sponsor|1|||
33583795|NCT02998671|102025963|FG003|Period 2|Study Terminated By Sponsor|3|||
33583796|NCT02998671|102025964|FG004|Period 2|Study Terminated By Sponsor|0|||
33583797|NCT02998671|102025960|FG000|Period 2|Withdrawal by Subject|0|||
33583798|NCT02998671|102025961|FG001|Period 2|Withdrawal by Subject|1|||
33583799|NCT02998671|102025962|FG002|Period 2|Withdrawal by Subject|0|||
33583800|NCT02998671|102025963|FG003|Period 2|Withdrawal by Subject|0|||
33583801|NCT02998671|102025964|FG004|Period 2|Withdrawal by Subject|0|||
33583802|NCT02998671|102025960|FG000|Period 2|Lost to Follow-up|0|||
33583803|NCT02998671|102025961|FG001|Period 2|Lost to Follow-up|0|||
33583804|NCT02998671|102025962|FG002|Period 2|Lost to Follow-up|0|||
33583805|NCT02998671|102025963|FG003|Period 2|Lost to Follow-up|1|||
33583806|NCT02998671|102025964|FG004|Period 2|Lost to Follow-up|0|||
33583807|NCT03012828|102025965|FG000|Overall Study|Lost to Follow-up|1|||
33583808|NCT03012828|102025966|FG001|Overall Study|Lost to Follow-up|0|||
33583809|NCT03012828|102025967|FG002|Overall Study|Lost to Follow-up|1|||
33583810|NCT03012828|102025968|FG003|Overall Study|Lost to Follow-up|0|||
33645066|NCT02059291|102252659|FG009|Epoch 4|Withdrawal by Subject|0|||
33645067|NCT02059291|102252660|FG010|Epoch 4|Withdrawal by Subject|0|||
33645068|NCT02059291|102252661|FG011|Epoch 4|Withdrawal by Subject|0|||
33645069|NCT02059291|102252662|FG012|Epoch 4|Withdrawal by Subject|0|||
33583811|NCT03012828|102025969|FG004|Overall Study|Lost to Follow-up|1|||
33583812|NCT03012828|102025970|FG005|Overall Study|Lost to Follow-up|0|||
33583813|NCT03012828|102025965|FG000|Overall Study|Withdrawal by Subject|0|||
33583814|NCT03012828|102025966|FG001|Overall Study|Withdrawal by Subject|0|||
33583815|NCT03012828|102025967|FG002|Overall Study|Withdrawal by Subject|1|||
33583816|NCT03012828|102025968|FG003|Overall Study|Withdrawal by Subject|0|||
33645070|NCT02059291|102252663|FG013|Epoch 4|Withdrawal by Subject|0|||
33645071|NCT02059291|102252664|FG014|Epoch 4|Withdrawal by Subject|0|||
33645072|NCT02059291|102252665|FG015|Epoch 4|Withdrawal by Subject|0|||
33147127|NCT04099251|100454225|FG001|Blinded Treatment Phase|Other reasons|7|||
33147128|NCT04099251|100454224|FG000|Blinded Treatment Phase|Disease recurrence|26|||
33147129|NCT04099251|100454225|FG001|Blinded Treatment Phase|Disease recurrence|41|||
33147130|NCT04099251|100454224|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
33373444|NCT00547378|101255860|FG002|Randomized Cohort|Withdrawal by Subject|0|||
33583817|NCT03012828|102025969|FG004|Overall Study|Withdrawal by Subject|0|||
33583818|NCT03012828|102025970|FG005|Overall Study|Withdrawal by Subject|1|||
33583819|NCT03012828|102025965|FG000|Overall Study|Non-compliance with protocol|0|||
33583820|NCT03012828|102025966|FG001|Overall Study|Non-compliance with protocol|0|||
33583821|NCT03012828|102025967|FG002|Overall Study|Non-compliance with protocol|0|||
33583822|NCT03012828|102025968|FG003|Overall Study|Non-compliance with protocol|0|||
33583823|NCT03012828|102025969|FG004|Overall Study|Non-compliance with protocol|1|||
33645073|NCT02059291|102252666|FG016|Epoch 4|Withdrawal by Subject|0|||
33147131|NCT04099251|100454225|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
33373445|NCT00547378|101255858|FG000|Randomized Cohort|Death|0|||
33583824|NCT03012828|102025970|FG005|Overall Study|Non-compliance with protocol|0|||
33583825|NCT03012828|102025965|FG000|Overall Study|Delay to last visit would delay DBL|0|||
33645074|NCT02059291|102252667|FG017|Epoch 4|Withdrawal by Subject|0|||
33583826|NCT03012828|102025966|FG001|Overall Study|Delay to last visit would delay DBL|0|||
33583827|NCT03012828|102025967|FG002|Overall Study|Delay to last visit would delay DBL|0|||
33583828|NCT03012828|102025968|FG003|Overall Study|Delay to last visit would delay DBL|0|||
33583829|NCT03012828|102025969|FG004|Overall Study|Delay to last visit would delay DBL|0|||
33583830|NCT03012828|102025970|FG005|Overall Study|Delay to last visit would delay DBL|1|||
33583831|NCT00615719|102025975|FG000|Overall Study|Physician Decision|5|||
33583832|NCT03525600|102025976|FG000|Overall Study|Adverse Event|9|||
33583833|NCT03525600|102025977|FG001|Overall Study|Adverse Event|6|||
33583834|NCT03525600|102025978|FG002|Overall Study|Adverse Event|5|||
33583835|NCT03525600|102025979|FG003|Overall Study|Adverse Event|3|||
33583836|NCT03525600|102025976|FG000|Overall Study|Lost to Follow-up|2|||
33583837|NCT03525600|102025977|FG001|Overall Study|Lost to Follow-up|4|||
33583838|NCT03525600|102025978|FG002|Overall Study|Lost to Follow-up|4|||
33583839|NCT03525600|102025979|FG003|Overall Study|Lost to Follow-up|0|||
33583840|NCT03525600|102025976|FG000|Overall Study|Physician Decision|1|||
33583841|NCT03525600|102025977|FG001|Overall Study|Physician Decision|0|||
33583842|NCT03525600|102025978|FG002|Overall Study|Physician Decision|2|||
33583843|NCT03525600|102025979|FG003|Overall Study|Physician Decision|0|||
33583844|NCT03525600|102025976|FG000|Overall Study|Consent withdrawal|36|||
33583845|NCT03525600|102025977|FG001|Overall Study|Consent withdrawal|20|||
33583846|NCT03525600|102025978|FG002|Overall Study|Consent withdrawal|6|||
33583847|NCT03525600|102025979|FG003|Overall Study|Consent withdrawal|13|||
33583848|NCT03525600|102025976|FG000|Overall Study|Death|7|||
33583849|NCT03525600|102025977|FG001|Overall Study|Death|6|||
33583850|NCT03525600|102025978|FG002|Overall Study|Death|4|||
33583851|NCT03525600|102025979|FG003|Overall Study|Death|3|||
33583852|NCT03525600|102025976|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
33583853|NCT03525600|102025977|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
33583854|NCT03525600|102025978|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
33583855|NCT03525600|102025979|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
33583856|NCT03525600|102025976|FG000|Overall Study|Other|0|||
33583857|NCT03525600|102025977|FG001|Overall Study|Other|1|||
33583858|NCT03525600|102025978|FG002|Overall Study|Other|0|||
33583859|NCT03525600|102025979|FG003|Overall Study|Other|0|||
33583860|NCT00582712|102025980|FG000|Overall Study|Adverse Event|1|||
33583861|NCT00582712|102025980|FG000|Overall Study|Lack of Efficacy|1|||
33583862|NCT00582712|102025980|FG000|Overall Study|Withdrawal by Subject|1|||
33583863|NCT00582712|102025980|FG000|Overall Study|Complicating disease requiring treatment|1|||
33583864|NCT02705105|102025981|FG000|Treatment|Objective Disease Progression|1|||
33583865|NCT02705105|102025982|FG001|Treatment|Objective Disease Progression|50|||
33583866|NCT02705105|102025981|FG000|Treatment|Withdrawal by Subject|3|||
33583867|NCT02705105|102025982|FG001|Treatment|Withdrawal by Subject|5|||
33583868|NCT02705105|102025981|FG000|Treatment|Adverse Event|0|||
33583869|NCT02705105|102025982|FG001|Treatment|Adverse Event|17|||
33583870|NCT02705105|102025981|FG000|Treatment|Clinical Disease Progression|0|||
33583871|NCT02705105|102025982|FG001|Treatment|Clinical Disease Progression|32|||
33583872|NCT02705105|102025981|FG000|Treatment|Physician Decision|0|||
33583873|NCT02705105|102025982|FG001|Treatment|Physician Decision|3|||
33583874|NCT02705105|102025981|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
33583875|NCT02705105|102025982|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
33645075|NCT02059291|102252668|FG018|Epoch 4|Withdrawal by Subject|0|||
33423191|NCT00272961|101439844|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
33423192|NCT00272961|101439845|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
33423193|NCT00272961|101439846|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
33423194|NCT00272961|101439847|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
33423195|NCT00272961|101439843|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
33423196|NCT00272961|101439844|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
33423197|NCT00272961|101439845|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
33423198|NCT00272961|101439846|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
33423199|NCT00272961|101439847|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
33645076|NCT02059291|102252669|FG019|Epoch 4|Withdrawal by Subject|0|||
33245199|NCT02028884|100800093|FG002|Double-blind Period|Withdrawal by Subject|0|||
33645077|NCT02059291|102252670|FG020|Epoch 4|Withdrawal by Subject|1|||
33245200|NCT02028884|100800091|FG000|Open-label Extension Period|Adverse Event|3|||
33245201|NCT02028884|100800092|FG001|Open-label Extension Period|Adverse Event|1|||
33583876|NCT02705105|102025981|FG000|Follow-Up|Death|3|||
33583877|NCT02705105|102025982|FG001|Follow-Up|Death|68|||
33583878|NCT02705105|102025981|FG000|Follow-Up|Withdrawal by Subject|1|||
33583879|NCT02705105|102025982|FG001|Follow-Up|Withdrawal by Subject|14|||
33583880|NCT02705105|102025981|FG000|Follow-Up|Study Terminated|0|||
33583881|NCT02705105|102025982|FG001|Follow-Up|Study Terminated|26|||
33583882|NCT02705105|102025981|FG000|Follow-Up|Discontinued per Amendment 3|0|||
33583883|NCT02705105|102025982|FG001|Follow-Up|Discontinued per Amendment 3|2|||
33583884|NCT01773967|102025983|FG000|Overall Study|Lost to Follow-up|15|||
33583885|NCT01773967|102025984|FG001|Overall Study|Lost to Follow-up|13|||
33583886|NCT00880269|102025985|FG000|Overall Study|Protocol Violation|1|||
33645078|NCT02059291|102252671|FG021|Epoch 4|Withdrawal by Subject|0|||
33583887|NCT00880269|102025986|FG001|Overall Study|Protocol Violation|0|||
33583888|NCT00880269|102025985|FG000|Overall Study|Disease Progression|13|||
33583889|NCT00880269|102025986|FG001|Overall Study|Disease Progression|11|||
33645079|NCT02059291|102252672|FG022|Epoch 4|Withdrawal by Subject|0|||
33645080|NCT02059291|102252673|FG023|Epoch 4|Withdrawal by Subject|0|||
33645081|NCT02059291|102252674|FG024|Epoch 4|Withdrawal by Subject|0|||
33645082|NCT02059291|102252650|FG000|Epoch 4|Lack of Efficacy|0|||
33645083|NCT02059291|102252651|FG001|Epoch 4|Lack of Efficacy|0|||
33645084|NCT02059291|102252652|FG002|Epoch 4|Lack of Efficacy|0|||
33645085|NCT02059291|102252653|FG003|Epoch 4|Lack of Efficacy|0|||
33645086|NCT02059291|102252654|FG004|Epoch 4|Lack of Efficacy|0|||
33645087|NCT02059291|102252655|FG005|Epoch 4|Lack of Efficacy|0|||
33645088|NCT02059291|102252656|FG006|Epoch 4|Lack of Efficacy|0|||
33645089|NCT02059291|102252657|FG007|Epoch 4|Lack of Efficacy|0|||
33645090|NCT02059291|102252658|FG008|Epoch 4|Lack of Efficacy|0|||
33645091|NCT02059291|102252659|FG009|Epoch 4|Lack of Efficacy|0|||
33645092|NCT02059291|102252660|FG010|Epoch 4|Lack of Efficacy|0|||
33645093|NCT02059291|102252661|FG011|Epoch 4|Lack of Efficacy|0|||
33645094|NCT02059291|102252662|FG012|Epoch 4|Lack of Efficacy|0|||
33245202|NCT02028884|100800093|FG002|Open-label Extension Period|Adverse Event|0|||
33645095|NCT02059291|102252663|FG013|Epoch 4|Lack of Efficacy|0|||
33245203|NCT02028884|100800091|FG000|Open-label Extension Period|Lack of Efficacy|3|||
33245204|NCT02028884|100800092|FG001|Open-label Extension Period|Lack of Efficacy|0|||
33245205|NCT02028884|100800093|FG002|Open-label Extension Period|Lack of Efficacy|0|||
33583890|NCT00880269|102025985|FG000|Overall Study|New Cancer Therapy|1|||
33583891|NCT00880269|102025986|FG001|Overall Study|New Cancer Therapy|0|||
33583892|NCT00880269|102025985|FG000|Overall Study|Death|4|||
33583893|NCT00880269|102025986|FG001|Overall Study|Death|2|||
33583894|NCT00880269|102025985|FG000|Overall Study|Lost to Follow-up|0|||
33583895|NCT00880269|102025986|FG001|Overall Study|Lost to Follow-up|1|||
33583896|NCT00880269|102025985|FG000|Overall Study|Withdrawal by Subject|3|||
33583897|NCT00880269|102025986|FG001|Overall Study|Withdrawal by Subject|4|||
33245206|NCT02028884|100800091|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
33245207|NCT02028884|100800092|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
33245208|NCT02028884|100800093|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
33373446|NCT00547378|101255859|FG001|Randomized Cohort|Death|1|||
33373447|NCT00547378|101255860|FG002|Randomized Cohort|Death|0|||
33583898|NCT00880269|102025985|FG000|Overall Study|Adverse Event|10|||
33583899|NCT00880269|102025986|FG001|Overall Study|Adverse Event|9|||
33583900|NCT00500357|102025989|FG000|Overall Study|Death|1|||
33583901|NCT00770562|102025991|FG000|Overall Study|Did not take treatment|1|||
33583902|NCT00770562|102025992|FG001|Overall Study|Did not take treatment|1|||
33583903|NCT04482439|102025993|FG000|Overall Study|Lost to Follow-up|1|||
33583904|NCT04482439|102025993|FG000|Overall Study|Unrelated illness|1|||
33583905|NCT03458325|102025994|FG000|Overall Study|Withdrawal by Subject|1|||
33583906|NCT00758069|102025995|FG000|Overall Study|Lack of Efficacy|0|||
33583907|NCT00758069|102025996|FG001|Overall Study|Lack of Efficacy|0|||
33583908|NCT00758069|102025997|FG002|Overall Study|Lack of Efficacy|1|||
33583909|NCT00758069|102025995|FG000|Overall Study|Incorrect Study Drug|1|||
33583910|NCT00758069|102025996|FG001|Overall Study|Incorrect Study Drug|0|||
33583911|NCT00758069|102025997|FG002|Overall Study|Incorrect Study Drug|0|||
33583912|NCT02676895|102026000|FG000|Overall Study|Administrative reason|1|||
33583913|NCT02676895|102026001|FG001|Overall Study|Administrative reason|0|||
33645096|NCT02059291|102252664|FG014|Epoch 4|Lack of Efficacy|0|||
33645097|NCT02059291|102252665|FG015|Epoch 4|Lack of Efficacy|0|||
33645098|NCT02059291|102252666|FG016|Epoch 4|Lack of Efficacy|0|||
33245209|NCT02028884|100800091|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
33373448|NCT00547378|101255858|FG000|Randomized Cohort|Lost to Follow-up|1|||
33373449|NCT00547378|101255859|FG001|Randomized Cohort|Lost to Follow-up|0|||
33373450|NCT00547378|101255860|FG002|Randomized Cohort|Lost to Follow-up|0|||
33373451|NCT00547378|101255858|FG000|Randomized Cohort|Adverse Event|1|||
33373452|NCT00547378|101255859|FG001|Randomized Cohort|Adverse Event|0|||
33373453|NCT00547378|101255860|FG002|Randomized Cohort|Adverse Event|0|||
33583914|NCT02676895|102026002|FG002|Overall Study|Administrative reason|0|||
33583915|NCT02676895|102026000|FG000|Overall Study|Protocol Violation|1|||
33645099|NCT02059291|102252667|FG017|Epoch 4|Lack of Efficacy|0|||
33245210|NCT02028884|100800092|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
33245211|NCT02028884|100800093|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
33245212|NCT02028884|100800091|FG000|Open-label Extension Period|Switched to another treatment option|3|||
33645100|NCT02059291|102252668|FG018|Epoch 4|Lack of Efficacy|0|||
33645101|NCT02059291|102252669|FG019|Epoch 4|Lack of Efficacy|0|||
33645102|NCT02059291|102252670|FG020|Epoch 4|Lack of Efficacy|0|||
33373454|NCT00547378|101255858|FG000|Randomized Cohort|Other reasons|2|||
33373455|NCT00547378|101255859|FG001|Randomized Cohort|Other reasons|0|||
33583916|NCT02676895|102026001|FG001|Overall Study|Protocol Violation|0|||
33583917|NCT02676895|102026002|FG002|Overall Study|Protocol Violation|0|||
33583918|NCT02676895|102026000|FG000|Overall Study|Adverse Event|0|||
33645103|NCT02059291|102252671|FG021|Epoch 4|Lack of Efficacy|0|||
33645104|NCT02059291|102252672|FG022|Epoch 4|Lack of Efficacy|0|||
33645105|NCT02059291|102252673|FG023|Epoch 4|Lack of Efficacy|1|||
33423200|NCT00272961|101439843|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
33423201|NCT00272961|101439844|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
33423202|NCT00272961|101439845|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
33423203|NCT00272961|101439846|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
33583919|NCT02676895|102026001|FG001|Overall Study|Adverse Event|3|||
33583920|NCT02676895|102026002|FG002|Overall Study|Adverse Event|1|||
33645106|NCT02059291|102252674|FG024|Epoch 4|Lack of Efficacy|0|||
33645107|NCT01324401|102252675|FG000|Overall Study|Withdrawn before any treatment|0|||
33645108|NCT01324401|102252676|FG001|Overall Study|Withdrawn before any treatment|3|||
33645109|NCT01324401|102252675|FG000|Overall Study|Adverse Event|1|||
33645110|NCT01324401|102252676|FG001|Overall Study|Adverse Event|3|||
33645111|NCT00578292|102252679|FG000|Overall Study|Death|1|||
33645112|NCT00578292|102252679|FG000|Overall Study|Graft failure|2|||
33245213|NCT02028884|100800092|FG001|Open-label Extension Period|Switched to another treatment option|0|||
33583921|NCT02676895|102026000|FG000|Overall Study|Lost to Follow-up|0|||
33583922|NCT02676895|102026001|FG001|Overall Study|Lost to Follow-up|0|||
33583923|NCT02676895|102026002|FG002|Overall Study|Lost to Follow-up|1|||
33583924|NCT02676895|102026000|FG000|Overall Study|Withdrawal by Subject|0|||
33583925|NCT02676895|102026001|FG001|Overall Study|Withdrawal by Subject|0|||
33583926|NCT02676895|102026002|FG002|Overall Study|Withdrawal by Subject|1|||
33583927|NCT00289289|102026003|FG000|Overall Study|Withdrawal by Subject|5|||
33583928|NCT00289289|102026004|FG001|Overall Study|Withdrawal by Subject|3|||
33583929|NCT00289289|102026005|FG002|Overall Study|Withdrawal by Subject|15|||
33583930|NCT00289289|102026003|FG000|Overall Study|Lost to Follow-up|1|||
33583931|NCT00289289|102026004|FG001|Overall Study|Lost to Follow-up|0|||
33583932|NCT00289289|102026005|FG002|Overall Study|Lost to Follow-up|1|||
33583933|NCT00289289|102026003|FG000|Overall Study|Death|4|||
33583934|NCT00289289|102026004|FG001|Overall Study|Death|2|||
33583935|NCT00289289|102026005|FG002|Overall Study|Death|5|||
33583936|NCT00289289|102026003|FG000|Overall Study|No implant attempted|0|||
33583937|NCT00289289|102026004|FG001|Overall Study|No implant attempted|0|||
33583938|NCT00289289|102026005|FG002|Overall Study|No implant attempted|1|||
33583939|NCT00289289|102026003|FG000|Overall Study|Physician Decision|1|||
33583940|NCT00289289|102026004|FG001|Overall Study|Physician Decision|0|||
33583941|NCT00289289|102026005|FG002|Overall Study|Physician Decision|6|||
33583942|NCT00289289|102026003|FG000|Overall Study|Non-study device implanted|2|||
33583943|NCT00289289|102026004|FG001|Overall Study|Non-study device implanted|1|||
33583944|NCT00289289|102026005|FG002|Overall Study|Non-study device implanted|3|||
33583945|NCT00289289|102026003|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
33583946|NCT00289289|102026004|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
33583947|NCT00289289|102026005|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
33583948|NCT00289289|102026003|FG000|Overall Study|Other Exit Reason|6|||
33583949|NCT00289289|102026004|FG001|Overall Study|Other Exit Reason|4|||
33583950|NCT00289289|102026005|FG002|Overall Study|Other Exit Reason|12|||
33583951|NCT00244725|102026006|FG000|Overall Study|Lost to Follow-up|3|||
33583952|NCT00244725|102026007|FG001|Overall Study|Lost to Follow-up|4|||
33583953|NCT00244725|102026008|FG002|Overall Study|Lost to Follow-up|9|||
33583954|NCT00244725|102026009|FG003|Overall Study|Lost to Follow-up|2|||
33583955|NCT00244725|102026006|FG000|Overall Study|Withdrawal by Subject|9|||
33583956|NCT00244725|102026007|FG001|Overall Study|Withdrawal by Subject|7|||
33583957|NCT00244725|102026008|FG002|Overall Study|Withdrawal by Subject|7|||
33583958|NCT00244725|102026009|FG003|Overall Study|Withdrawal by Subject|8|||
33583959|NCT00244725|102026006|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
33583960|NCT00244725|102026007|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
33583961|NCT00244725|102026008|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
33583962|NCT00244725|102026009|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
33583963|NCT00244725|102026006|FG000|Overall Study|Physician Decision|3|||
33583964|NCT00244725|102026007|FG001|Overall Study|Physician Decision|0|||
33583965|NCT00244725|102026008|FG002|Overall Study|Physician Decision|1|||
33583966|NCT00244725|102026009|FG003|Overall Study|Physician Decision|2|||
33583967|NCT00244725|102026006|FG000|Overall Study|Adverse Events|3|||
33583968|NCT00244725|102026007|FG001|Overall Study|Adverse Events|1|||
33583969|NCT00244725|102026008|FG002|Overall Study|Adverse Events|4|||
33583970|NCT00244725|102026009|FG003|Overall Study|Adverse Events|4|||
33245214|NCT02028884|100800093|FG002|Open-label Extension Period|Switched to another treatment option|0|||
33583971|NCT00244725|102026006|FG000|Overall Study|Withdrwal by participant|1|||
33583972|NCT00244725|102026007|FG001|Overall Study|Withdrwal by participant|0|||
33583973|NCT00244725|102026008|FG002|Overall Study|Withdrwal by participant|0|||
33583974|NCT00244725|102026009|FG003|Overall Study|Withdrwal by participant|1|||
33583975|NCT00244725|102026006|FG000|Overall Study|Liver function test abnormality|2|||
33583976|NCT00244725|102026007|FG001|Overall Study|Liver function test abnormality|0|||
33583977|NCT00244725|102026008|FG002|Overall Study|Liver function test abnormality|0|||
33583978|NCT00244725|102026009|FG003|Overall Study|Liver function test abnormality|1|||
33645113|NCT00711477|102252680|FG000|Overall Study|Adverse Event|3|||
33645114|NCT00711477|102252681|FG001|Overall Study|Adverse Event|1|||
33583979|NCT00244725|102026006|FG000|Overall Study|Sponsor withdrew the participant|1|||
33583980|NCT00244725|102026007|FG001|Overall Study|Sponsor withdrew the participant|0|||
33583981|NCT00244725|102026008|FG002|Overall Study|Sponsor withdrew the participant|0|||
33583982|NCT00244725|102026009|FG003|Overall Study|Sponsor withdrew the participant|1|||
33583983|NCT00244725|102026006|FG000|Overall Study|Mediciation Error|0|||
33583984|NCT00244725|102026007|FG001|Overall Study|Mediciation Error|1|||
33583985|NCT00244725|102026008|FG002|Overall Study|Mediciation Error|0|||
33583986|NCT00244725|102026009|FG003|Overall Study|Mediciation Error|0|||
33583987|NCT00244725|102026006|FG000|Overall Study|Rehab Refused to allow participantion|0|||
33583988|NCT00244725|102026007|FG001|Overall Study|Rehab Refused to allow participantion|1|||
33583989|NCT00244725|102026008|FG002|Overall Study|Rehab Refused to allow participantion|0|||
33583990|NCT00244725|102026009|FG003|Overall Study|Rehab Refused to allow participantion|0|||
33583991|NCT00244725|102026006|FG000|Overall Study|Headache|0|||
33583992|NCT00244725|102026007|FG001|Overall Study|Headache|1|||
33583993|NCT00244725|102026008|FG002|Overall Study|Headache|0|||
33583994|NCT00244725|102026009|FG003|Overall Study|Headache|0|||
33583995|NCT00244725|102026006|FG000|Overall Study|Received prohibited medication|0|||
33583996|NCT00244725|102026007|FG001|Overall Study|Received prohibited medication|1|||
33583997|NCT00244725|102026008|FG002|Overall Study|Received prohibited medication|0|||
33583998|NCT00244725|102026009|FG003|Overall Study|Received prohibited medication|1|||
33583999|NCT00244725|102026006|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
33584000|NCT00244725|102026007|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
33584001|NCT00244725|102026008|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
33584002|NCT00244725|102026009|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
33584003|NCT00244725|102026006|FG000|Overall Study|Administrative reason|0|||
33584004|NCT00244725|102026007|FG001|Overall Study|Administrative reason|0|||
33584005|NCT00244725|102026008|FG002|Overall Study|Administrative reason|1|||
33584006|NCT00244725|102026009|FG003|Overall Study|Administrative reason|0|||
33584007|NCT00244725|102026006|FG000|Overall Study|Vomit|0|||
33584008|NCT00244725|102026007|FG001|Overall Study|Vomit|0|||
33584009|NCT00244725|102026008|FG002|Overall Study|Vomit|1|||
33584010|NCT00244725|102026009|FG003|Overall Study|Vomit|0|||
33584011|NCT00244725|102026006|FG000|Overall Study|Failed to follow-up|0|||
33584012|NCT00244725|102026007|FG001|Overall Study|Failed to follow-up|0|||
33584013|NCT00244725|102026008|FG002|Overall Study|Failed to follow-up|1|||
33147132|NCT04099251|100454224|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
33147133|NCT04099251|100454225|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
33147134|NCT04099251|100454224|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
33147135|NCT04099251|100454225|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
33147136|NCT04099251|100454224|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
33147137|NCT04099251|100454225|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
33147138|NCT04099251|100454224|FG000|Blinded Treatment Phase|Death|6|||
33147139|NCT04099251|100454225|FG001|Blinded Treatment Phase|Death|2|||
33147140|NCT04099251|100454224|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
33147141|NCT04099251|100454225|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
33147142|NCT04099251|100454224|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
33147143|NCT04099251|100454225|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
33147144|NCT04099251|100454224|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
33147145|NCT04099251|100454225|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
33147146|NCT04099251|100454224|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
33147147|NCT04099251|100454225|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
33147148|NCT04099251|100454224|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
33147149|NCT04099251|100454225|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
33147150|NCT04099251|100454224|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
33147151|NCT04099251|100454225|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
33147152|NCT04099251|100454224|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
33147153|NCT04099251|100454225|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
33147154|NCT04099251|100454224|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
33245215|NCT00536380|100800097|FG000|Overall Study|Adverse Event|0|||
33584014|NCT00244725|102026009|FG003|Overall Study|Failed to follow-up|1|||
33584015|NCT01268046|102026010|FG000|Overall Study|Withdrawal by Subject|1|||
33584016|NCT01268046|102026011|FG001|Overall Study|Withdrawal by Subject|0|||
33584017|NCT01268046|102026012|FG002|Overall Study|Withdrawal by Subject|0|||
33584018|NCT01268046|102026013|FG003|Overall Study|Withdrawal by Subject|1|||
33584019|NCT01268046|102026010|FG000|Overall Study|Lost to Follow-up|0|||
33584020|NCT01268046|102026011|FG001|Overall Study|Lost to Follow-up|0|||
33645115|NCT00711477|102252680|FG000|Overall Study|Lost to Follow-up|0|||
33584021|NCT01268046|102026012|FG002|Overall Study|Lost to Follow-up|1|||
33584022|NCT01268046|102026013|FG003|Overall Study|Lost to Follow-up|0|||
33584023|NCT03265145|102026016|FG000|Overall Study|Protocol Violation|2|||
33584024|NCT03265145|102026017|FG001|Overall Study|Protocol Violation|0|||
33645116|NCT00711477|102252681|FG001|Overall Study|Lost to Follow-up|1|||
33584025|NCT03265145|102026016|FG000|Overall Study|Adverse Event|1|||
33584026|NCT03265145|102026017|FG001|Overall Study|Adverse Event|0|||
33584027|NCT03265145|102026016|FG000|Overall Study|Withdrawal by Subject|23|||
33423204|NCT00272961|101439847|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
33423205|NCT00272961|101439843|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
33423206|NCT00272961|101439844|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
33423207|NCT00272961|101439845|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
33423208|NCT00272961|101439846|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
33423209|NCT00272961|101439847|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
33423210|NCT00272961|101439843|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
33423211|NCT00272961|101439844|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
33423212|NCT00272961|101439845|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
33423213|NCT00272961|101439846|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
33423214|NCT00272961|101439847|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
33423215|NCT00272961|101439843|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
33423216|NCT00272961|101439844|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
33423217|NCT00272961|101439845|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
33423218|NCT00272961|101439846|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
33423219|NCT00272961|101439847|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
33423220|NCT00272961|101439843|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
33423221|NCT00272961|101439844|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
33423222|NCT00272961|101439845|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
33423223|NCT00272961|101439846|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
33423224|NCT00272961|101439847|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
33423225|NCT01612702|101439848|FG000|Overall Study|Protocol Violation|11|||
33423226|NCT01612702|101439849|FG001|Overall Study|Protocol Violation|11|||
33423227|NCT05028751|101439852|FG000|Overall Study|Study Terminated by Sponsor|3|||
33423228|NCT05028751|101439853|FG001|Overall Study|Study Terminated by Sponsor|0|||
33423229|NCT05028751|101439854|FG002|Overall Study|Study Terminated by Sponsor|0|||
33423230|NCT05028751|101439855|FG003|Overall Study|Study Terminated by Sponsor|0|||
33423231|NCT05028751|101439852|FG000|Overall Study|Death|9|||
33423232|NCT05028751|101439853|FG001|Overall Study|Death|3|||
33423233|NCT05028751|101439854|FG002|Overall Study|Death|2|||
33423234|NCT05028751|101439855|FG003|Overall Study|Death|4|||
33423235|NCT05028751|101439852|FG000|Overall Study|Withdrawal by Subject|0|||
33423236|NCT05028751|101439853|FG001|Overall Study|Withdrawal by Subject|0|||
33423237|NCT05028751|101439854|FG002|Overall Study|Withdrawal by Subject|1|||
33423238|NCT05028751|101439855|FG003|Overall Study|Withdrawal by Subject|0|||
33423239|NCT05028751|101439852|FG000|Overall Study|Miscellaneous|2|||
33423240|NCT05028751|101439853|FG001|Overall Study|Miscellaneous|0|||
33423241|NCT05028751|101439854|FG002|Overall Study|Miscellaneous|0|||
33423242|NCT05028751|101439855|FG003|Overall Study|Miscellaneous|0|||
33423243|NCT03044431|101439866|FG000|Overall Study|Lost to Follow-up|59|||
33423244|NCT04347161|101439867|FG000|Overall Study|Death|0|||
33423245|NCT04347161|101439868|FG001|Overall Study|Death|2|||
33423246|NCT04347161|101439867|FG000|Overall Study|Withdrawal by Subject|1|||
33423247|NCT04347161|101439868|FG001|Overall Study|Withdrawal by Subject|0|||
33423248|NCT04347161|101439867|FG000|Overall Study|Lost to Follow-up|0|||
33423249|NCT04347161|101439868|FG001|Overall Study|Lost to Follow-up|1|||
33423250|NCT04347161|101439867|FG000|Overall Study|No longer on study medication|1|||
33423251|NCT04347161|101439868|FG001|Overall Study|No longer on study medication|1|||
33423252|NCT02290028|101439869|FG000|Overall Study|Death|217|||
33423253|NCT02290028|101439869|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
33423254|NCT02290028|101439869|FG000|Overall Study|No longer under care of study physician|76|||
33423255|NCT02290028|101439869|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
33423256|NCT02290028|101439869|FG000|Overall Study|Withdrawal by Subject|52|||
33423257|NCT02290028|101439869|FG000|Overall Study|Study site closure|44|||
33423258|NCT02290028|101439869|FG000|Overall Study|Lost to Follow-up|34|||
33423259|NCT02290028|101439869|FG000|Overall Study|Miscellaneous|10|||
33423260|NCT02290028|101439869|FG000|Overall Study|Transition to EP PASSION|1295|||
33423261|NCT02290028|101439869|FG000|Overall Study|Planned study completion at 12 months|257|||
33423262|NCT00420849|101439872|FG000|Overall Study|Lack of Efficacy|154|||
33423263|NCT00420849|101439872|FG000|Overall Study|Adverse Event|107|||
33423264|NCT00420849|101439872|FG000|Overall Study|Withdrawal by Subject|28|||
33423265|NCT00420849|101439872|FG000|Overall Study|Death|18|||
33584028|NCT03265145|102026017|FG001|Overall Study|Withdrawal by Subject|19|||
33584029|NCT03265145|102026016|FG000|Overall Study|Death|12|||
33584030|NCT03265145|102026017|FG001|Overall Study|Death|12|||
33584031|NCT03265145|102026016|FG000|Overall Study|Lost to Follow-up|13|||
33584032|NCT03265145|102026017|FG001|Overall Study|Lost to Follow-up|9|||
33423266|NCT00420849|101439872|FG000|Overall Study|Other|14|||
33423267|NCT00420849|101439872|FG000|Overall Study|Transplant|8|||
33423268|NCT00420849|101439872|FG000|Overall Study|Protocol Violation|1|||
33423269|NCT00420849|101439872|FG000|Overall Study|Lost to Follow-up|1|||
33423270|NCT00986154|101439873|FG000|Overall Study|Death|136|||
33584033|NCT03265145|102026016|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
33584034|NCT03265145|102026017|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
33584035|NCT03265145|102026016|FG000|Overall Study|Switched back to previous medication|1|||
33584036|NCT03265145|102026017|FG001|Overall Study|Switched back to previous medication|0|||
33645117|NCT00711477|102252680|FG000|Overall Study|Noncompliance|0|||
33645118|NCT00711477|102252681|FG001|Overall Study|Noncompliance|1|||
33645119|NCT01497366|102252684|FG000|Overall Study|Virologic failure|2|||
33645120|NCT01497366|102252685|FG001|Overall Study|Virologic failure|50|||
33645121|NCT01497366|102252684|FG000|Overall Study|Lost to Follow-up|11|||
33645122|NCT01497366|102252685|FG001|Overall Study|Lost to Follow-up|10|||
33645123|NCT01497366|102252684|FG000|Overall Study|Withdrawal by Subject|6|||
33645124|NCT01497366|102252685|FG001|Overall Study|Withdrawal by Subject|6|||
33645125|NCT01497366|102252684|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
33645126|NCT01497366|102252685|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
33147155|NCT04099251|100454225|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
33147156|NCT04099251|100454224|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
33147157|NCT04099251|100454225|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
33147158|NCT01058265|100454226|FG000|Overall Study|Lost to Follow-up|11|||
33147159|NCT01058265|100454227|FG001|Overall Study|Lost to Follow-up|12|||
33147160|NCT02435069|100454232|FG000|Dose Response - First Intervention|Adverse Event|0|||
33584037|NCT03265145|102026016|FG000|Overall Study|Did not want to take medication|1|||
33584038|NCT03265145|102026017|FG001|Overall Study|Did not want to take medication|0|||
33584039|NCT03265145|102026016|FG000|Overall Study|Subject could not afford medication|0|||
33584040|NCT03265145|102026017|FG001|Overall Study|Subject could not afford medication|1|||
33584041|NCT03265145|102026016|FG000|Overall Study|Site closed|2|||
33584042|NCT03265145|102026017|FG001|Overall Study|Site closed|3|||
33584043|NCT03265145|102026016|FG000|Overall Study|Incorrectly randomized|16|||
33584044|NCT03265145|102026017|FG001|Overall Study|Incorrectly randomized|6|||
33584045|NCT03265145|102026016|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
33584046|NCT03265145|102026017|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
33584047|NCT03265145|102026016|FG000|Overall Study|Physician Decision|0|||
33584048|NCT03265145|102026017|FG001|Overall Study|Physician Decision|3|||
33584049|NCT03265145|102026016|FG000|Overall Study|Subject transferred to another facility|0|||
33584050|NCT03265145|102026017|FG001|Overall Study|Subject transferred to another facility|1|||
33584051|NCT01637584|102026022|FG000|Overall Study|Withdrawal by Subject|1|||
33584052|NCT01637584|102026023|FG001|Overall Study|Withdrawal by Subject|3|||
33584053|NCT04262882|102026024|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
33584054|NCT04262882|102026025|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
33584055|NCT04262882|102026024|FG000|Overall Study|Lost to Follow-up|1|||
33584056|NCT04262882|102026025|FG001|Overall Study|Lost to Follow-up|0|||
33584057|NCT02467192|102028831|FG000|Overall Study|Death|1|||
33584058|NCT02467192|102028831|FG000|Overall Study|revealed to have pneumonia before|2|||
33584059|NCT02195700|102028832|FG000|Overall Study|Protocol Violation|0|||
33584060|NCT02195700|102028833|FG001|Overall Study|Protocol Violation|2|||
33584061|NCT02195700|102028832|FG000|Overall Study|Noncompliance|1|||
33584062|NCT02195700|102028833|FG001|Overall Study|Noncompliance|0|||
33584063|NCT02195700|102028832|FG000|Overall Study|Adverse Event|1|||
33584064|NCT02195700|102028833|FG001|Overall Study|Adverse Event|2|||
33584065|NCT02195700|102028832|FG000|Overall Study|Withdrawal by Subject|3|||
33584066|NCT02195700|102028833|FG001|Overall Study|Withdrawal by Subject|2|||
33645127|NCT01497366|102252684|FG000|Overall Study|Other|5|||
33645128|NCT01497366|102252685|FG001|Overall Study|Other|0|||
33645129|NCT01497366|102252684|FG000|Overall Study|Death|1|||
33147161|NCT02435069|100454233|FG001|Dose Response - First Intervention|Adverse Event|1|||
33147162|NCT02435069|100454234|FG002|Dose Response - First Intervention|Adverse Event|1|||
33147163|NCT02435069|100454235|FG003|Dose Response - First Intervention|Adverse Event|0|||
33147164|NCT02435069|100454236|FG004|Dose Response - First Intervention|Adverse Event|0|||
33147165|NCT02435069|100454232|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
33147166|NCT02435069|100454233|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
33147167|NCT02435069|100454234|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
33373456|NCT00547378|101255860|FG002|Randomized Cohort|Other reasons|0|||
33373457|NCT00547378|101255858|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
33373458|NCT00547378|101255859|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
33373459|NCT00547378|101255860|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
33373460|NCT00547378|101255858|FG000|All Implanted Cohort|Adverse Event|4|||
33373461|NCT00547378|101255859|FG001|All Implanted Cohort|Adverse Event|10|||
33373462|NCT00547378|101255860|FG002|All Implanted Cohort|Adverse Event|17|||
33373463|NCT00547378|101255858|FG000|All Implanted Cohort|Lost to Follow-up|0|||
33373464|NCT00547378|101255859|FG001|All Implanted Cohort|Lost to Follow-up|1|||
33373465|NCT00547378|101255860|FG002|All Implanted Cohort|Lost to Follow-up|14|||
33373466|NCT00547378|101255858|FG000|All Implanted Cohort|Death|3|||
33645130|NCT01497366|102252685|FG001|Overall Study|Death|1|||
33245216|NCT00536380|100800098|FG001|Overall Study|Adverse Event|2|||
33245217|NCT00536380|100800099|FG002|Overall Study|Adverse Event|2|||
33245218|NCT00536380|100800097|FG000|Overall Study|Lost to Follow-up|0|||
33245219|NCT00536380|100800098|FG001|Overall Study|Lost to Follow-up|0|||
33245220|NCT00536380|100800099|FG002|Overall Study|Lost to Follow-up|1|||
33245221|NCT00536380|100800097|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
33245222|NCT00536380|100800098|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
33245223|NCT00536380|100800099|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
33245224|NCT00536380|100800097|FG000|Overall Study|Withdrawal related to study drug|7|||
33245225|NCT00536380|100800098|FG001|Overall Study|Withdrawal related to study drug|5|||
33245226|NCT00536380|100800099|FG002|Overall Study|Withdrawal related to study drug|2|||
33245227|NCT00536380|100800097|FG000|Overall Study|Noncompliance with protocol|3|||
33245228|NCT00536380|100800098|FG001|Overall Study|Noncompliance with protocol|2|||
33245229|NCT00536380|100800099|FG002|Overall Study|Noncompliance with protocol|2|||
33373467|NCT00547378|101255859|FG001|All Implanted Cohort|Death|1|||
33373468|NCT00547378|101255860|FG002|All Implanted Cohort|Death|4|||
33373469|NCT00547378|101255858|FG000|All Implanted Cohort|Physician Decision|0|||
33373470|NCT00547378|101255859|FG001|All Implanted Cohort|Physician Decision|2|||
33373471|NCT00547378|101255860|FG002|All Implanted Cohort|Physician Decision|6|||
33373472|NCT00547378|101255858|FG000|All Implanted Cohort|Site closure|2|||
33373473|NCT00547378|101255859|FG001|All Implanted Cohort|Site closure|0|||
33373474|NCT00547378|101255860|FG002|All Implanted Cohort|Site closure|1|||
33645131|NCT01497366|102252684|FG000|Overall Study|Randomized but not treated|7|||
33645132|NCT01497366|102252685|FG001|Overall Study|Randomized but not treated|21|||
33645133|NCT00715910|102252687|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
33645134|NCT00715910|102252688|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
33645135|NCT00715910|102252689|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
33645136|NCT00715910|102252690|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
33645137|NCT00715910|102252691|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
33645138|NCT00715910|102252692|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
33645139|NCT00715910|102252687|FG000|Booster and ESFU Phase|Other|0|||
33645140|NCT00715910|102252688|FG001|Booster and ESFU Phase|Other|0|||
33645141|NCT00715910|102252689|FG002|Booster and ESFU Phase|Other|0|||
33645142|NCT00715910|102252690|FG003|Booster and ESFU Phase|Other|5|||
33645143|NCT00715910|102252691|FG004|Booster and ESFU Phase|Other|1|||
33645144|NCT00715910|102252692|FG005|Booster and ESFU Phase|Other|0|||
33645145|NCT02604160|102252695|FG000|Overall Study|Protocol Violation|0|||
33645146|NCT02604160|102252696|FG001|Overall Study|Protocol Violation|1|||
33645147|NCT02604160|102252695|FG000|Overall Study|Physician Decision|0|||
33645148|NCT02604160|102252696|FG001|Overall Study|Physician Decision|1|||
33584067|NCT02195700|102028832|FG000|Overall Study|Lost to Follow-up|1|||
33584068|NCT02195700|102028833|FG001|Overall Study|Lost to Follow-up|1|||
33584069|NCT00995436|102028836|FG000|Overall Study|Withdrawal by Subject|2|||
33584070|NCT00995436|102028837|FG001|Overall Study|Withdrawal by Subject|5|||
33584071|NCT00995436|102028838|FG002|Overall Study|Withdrawal by Subject|0|||
33584072|NCT05141175|102028839|FG000|Overall Study|Withdrawal by Subject|1|||
33584073|NCT00070109|102028840|FG000|Overall Study|Death|1|||
33584074|NCT00070109|102028841|FG001|Overall Study|Death|1|||
33584075|NCT00070109|102028842|FG002|Overall Study|Death|0|||
33584076|NCT00070109|102028843|FG003|Overall Study|Death|0|||
33584077|NCT00070109|102028844|FG004|Overall Study|Death|1|||
33584078|NCT00070109|102028840|FG000|Overall Study|Lack of Efficacy|6|||
33645149|NCT04074161|102252697|FG000|Overall Study|Withdrawal by Subject|2|||
33645150|NCT04074161|102252698|FG001|Overall Study|Withdrawal by Subject|4|||
33645151|NCT04074161|102252699|FG002|Overall Study|Withdrawal by Subject|1|||
33645152|NCT04074161|102252697|FG000|Overall Study|Lost to Follow-up|4|||
33645153|NCT04074161|102252698|FG001|Overall Study|Lost to Follow-up|5|||
33645154|NCT04074161|102252699|FG002|Overall Study|Lost to Follow-up|3|||
33373475|NCT00547378|101255858|FG000|All Implanted Cohort|Other reasons|1|||
33373476|NCT00547378|101255859|FG001|All Implanted Cohort|Other reasons|0|||
33373477|NCT00547378|101255860|FG002|All Implanted Cohort|Other reasons|1|||
33584079|NCT00070109|102028841|FG001|Overall Study|Lack of Efficacy|4|||
33645155|NCT00555061|102252700|FG000|Overall Study|Adverse Event|3|||
33645156|NCT00555061|102252700|FG000|Overall Study|Protocol Violation|1|||
33645157|NCT00555061|102252700|FG000|Overall Study|Lost to Follow-up|2|||
33645158|NCT00555061|102252700|FG000|Overall Study|Withdrawal by Subject|2|||
33645159|NCT00555061|102252700|FG000|Overall Study|Participant enrolled, but never treated|1|||
33645160|NCT01191762|102252701|FG000|Overall Study|Adverse Event|1|||
33645161|NCT01191762|102252702|FG001|Overall Study|Adverse Event|0|||
33245230|NCT00536380|100800097|FG000|Overall Study|Did not meet protocol eligibility|0|||
33245231|NCT00536380|100800098|FG001|Overall Study|Did not meet protocol eligibility|0|||
33245232|NCT00536380|100800099|FG002|Overall Study|Did not meet protocol eligibility|1|||
33245233|NCT00536380|100800097|FG000|Overall Study|Administrative|0|||
33245234|NCT00536380|100800098|FG001|Overall Study|Administrative|0|||
33584080|NCT00070109|102028842|FG002|Overall Study|Lack of Efficacy|5|||
33245235|NCT00536380|100800099|FG002|Overall Study|Administrative|1|||
33245236|NCT01656304|100800100|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
33584081|NCT00070109|102028843|FG003|Overall Study|Lack of Efficacy|15|||
33423271|NCT00986154|101439874|FG001|Overall Study|Death|127|||
33423272|NCT00986154|101439873|FG000|Overall Study|Lost to Follow-up|7|||
33423273|NCT00986154|101439874|FG001|Overall Study|Lost to Follow-up|4|||
33423274|NCT00986154|101439873|FG000|Overall Study|Withdrawal by Subject|32|||
33423275|NCT00986154|101439874|FG001|Overall Study|Withdrawal by Subject|33|||
33423276|NCT00986154|101439873|FG000|Overall Study|investigator/subject decide not continue|6|||
33423277|NCT00986154|101439874|FG001|Overall Study|investigator/subject decide not continue|3|||
33423278|NCT00986154|101439873|FG000|Overall Study|never received study drug|25|||
33423279|NCT00986154|101439874|FG001|Overall Study|never received study drug|27|||
33423280|NCT00659581|101439875|FG000|Overall Study|Adverse Event|1006|||
33423281|NCT00659581|101439875|FG000|Overall Study|Lack of Efficacy|1183|||
33423282|NCT00659581|101439875|FG000|Overall Study|Other|6393|||
33423283|NCT00871728|101439881|FG000|Overall Study|Adverse Event|1|||
33423284|NCT00871728|101439881|FG000|Overall Study|Protocol Violation|7|||
33584082|NCT00070109|102028844|FG004|Overall Study|Lack of Efficacy|5|||
33584083|NCT00070109|102028840|FG000|Overall Study|Physician Decision|1|||
33584084|NCT00070109|102028841|FG001|Overall Study|Physician Decision|0|||
33584085|NCT00070109|102028842|FG002|Overall Study|Physician Decision|0|||
33245237|NCT01168401|100800101|FG000|Overall Study|Lost to Follow-up|1|||
33245238|NCT01168401|100800102|FG001|Overall Study|Lost to Follow-up|1|||
33373478|NCT00645567|101255861|FG000|Overall Study|Adverse Event|1|||
33373479|NCT02436577|101255862|FG000|Overall Study|Protocol Deviation|0|||
33373480|NCT02436577|101255863|FG001|Overall Study|Protocol Deviation|1|||
33373481|NCT02436577|101255864|FG002|Overall Study|Protocol Deviation|0|||
33373482|NCT02436577|101255865|FG003|Overall Study|Protocol Deviation|0|||
33373483|NCT02436577|101255866|FG004|Overall Study|Protocol Deviation|0|||
33373484|NCT02436577|101255867|FG005|Overall Study|Protocol Deviation|0|||
33373485|NCT00121992|101255868|FG000|Overall Study|Treatment not received|2|||
33373486|NCT00121992|101255869|FG001|Overall Study|Treatment not received|11|||
33373487|NCT00074412|101255870|FG000|Overall Study|Death|30|||
33373488|NCT00074412|101255871|FG001|Overall Study|Death|26|||
33373489|NCT00074412|101255870|FG000|Overall Study|Lost to Follow-up|52|||
33373490|NCT00074412|101255871|FG001|Overall Study|Lost to Follow-up|58|||
33373491|NCT00585923|101255872|FG000|Overall Study|Physician decided not to continue|31|||
33373492|NCT00585923|101255873|FG001|Overall Study|Physician decided not to continue|33|||
33373493|NCT04056455|101255880|FG000|Overall Study|Adverse Event|1|||
33373494|NCT04056455|101255881|FG001|Overall Study|Adverse Event|0|||
33373495|NCT02023164|101255882|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
33373496|NCT02023164|101255883|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
33373497|NCT03521687|101255884|FG000|Overall Study|Adverse Event|4|||
33373498|NCT03521687|101255884|FG000|Overall Study|Physician Decision|1|||
33373499|NCT01944969|101255885|FG000|Overall Study|Adverse Event|1|||
33373500|NCT01944969|101255885|FG000|Overall Study|Lack of Efficacy|1|||
33373501|NCT01944969|101255885|FG000|Overall Study|Non-compliance with IMP|1|||
33373502|NCT01944969|101255885|FG000|Overall Study|Administrative or other reasons|23|||
33373503|NCT01725152|101255886|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
33373504|NCT01725152|101255887|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
33373505|NCT01725152|101255886|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
33373506|NCT01725152|101255887|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
33373507|NCT01725152|101255886|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
33373508|NCT01725152|101255887|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
33373509|NCT01725152|101255886|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
33373510|NCT01725152|101255887|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
33584086|NCT00070109|102028843|FG003|Overall Study|Physician Decision|0|||
33584087|NCT00070109|102028844|FG004|Overall Study|Physician Decision|0|||
33584088|NCT00070109|102028840|FG000|Overall Study|Withdrawal by Subject|0|||
33584089|NCT00070109|102028841|FG001|Overall Study|Withdrawal by Subject|1|||
33584090|NCT00070109|102028842|FG002|Overall Study|Withdrawal by Subject|1|||
33584091|NCT00070109|102028843|FG003|Overall Study|Withdrawal by Subject|0|||
33584092|NCT00070109|102028844|FG004|Overall Study|Withdrawal by Subject|0|||
33584093|NCT00070109|102028840|FG000|Overall Study|Adverse Event|0|||
33584094|NCT00070109|102028841|FG001|Overall Study|Adverse Event|0|||
33584095|NCT00070109|102028842|FG002|Overall Study|Adverse Event|2|||
33584096|NCT00070109|102028843|FG003|Overall Study|Adverse Event|4|||
33584097|NCT00070109|102028844|FG004|Overall Study|Adverse Event|2|||
33584098|NCT00070109|102028840|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
33245239|NCT01168401|100800103|FG002|Overall Study|Lost to Follow-up|2|||
33245240|NCT01168401|100800104|FG003|Overall Study|Lost to Follow-up|1|||
33245241|NCT01168401|100800105|FG004|Overall Study|Lost to Follow-up|0|||
33373511|NCT00446446|101255888|FG000|Overall Study|Death|10|||
33373512|NCT00446446|101255888|FG000|Overall Study|Withdrawal by Subject|6|||
33423285|NCT00871728|101439881|FG000|Overall Study|Lost to Follow-up|2|||
33423286|NCT00871728|101439881|FG000|Overall Study|Failed to Visit Hospital|4|||
33584099|NCT00070109|102028841|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
33584100|NCT00070109|102028842|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
33584101|NCT00070109|102028843|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
33423287|NCT00871728|101439881|FG000|Overall Study|Participant Non-compliance|1|||
33423288|NCT00871728|101439881|FG000|Overall Study|Withdrawal of Informed Consent|5|||
33423289|NCT00597207|101439882|FG000|Overall Study|Lost to Follow-up|5|||
33423290|NCT00597207|101439883|FG001|Overall Study|Lost to Follow-up|7|||
33423291|NCT01255722|101439884|FG000|Overall Study|Adverse Event|0|||
33423292|NCT01255722|101439885|FG001|Overall Study|Adverse Event|1|||
33645162|NCT02039843|102252703|FG000|Randomization and Observation Period|Adverse Event|2|||
33645163|NCT02039843|102252704|FG001|Randomization and Observation Period|Adverse Event|0|||
33645164|NCT02039843|102252703|FG000|Randomization and Observation Period|Death|1|||
33645165|NCT02039843|102252704|FG001|Randomization and Observation Period|Death|0|||
33645166|NCT02039843|102252703|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
33645167|NCT02039843|102252704|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
33423293|NCT01255722|101439886|FG002|Overall Study|Adverse Event|1|||
33645168|NCT02039843|102252703|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
33645169|NCT02039843|102252704|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
33645170|NCT02039843|102252703|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
33645171|NCT02039843|102252704|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
33645172|NCT02039843|102252703|FG000|Pairing With a Study Dog|Death|1|||
33645173|NCT02039843|102252704|FG001|Pairing With a Study Dog|Death|0|||
33645174|NCT02039843|102252703|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
33645175|NCT02039843|102252704|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
33645176|NCT02039843|102252703|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
33645177|NCT02039843|102252704|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
33645178|NCT02039843|102252703|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
33645179|NCT02039843|102252704|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
33645180|NCT02563067|102252705|FG000|Overall Study|Subject/guardian decision|14|||
33645181|NCT02563067|102252706|FG001|Overall Study|Subject/guardian decision|20|||
33645182|NCT02563067|102252707|FG002|Overall Study|Subject/guardian decision|16|||
33645183|NCT02563067|102252705|FG000|Overall Study|Physician Decision|0|||
33645184|NCT02563067|102252706|FG001|Overall Study|Physician Decision|1|||
33645185|NCT02563067|102252707|FG002|Overall Study|Physician Decision|3|||
33645186|NCT02563067|102252705|FG000|Overall Study|Lost to Follow-up|1|||
33645187|NCT02563067|102252706|FG001|Overall Study|Lost to Follow-up|2|||
33645188|NCT02563067|102252707|FG002|Overall Study|Lost to Follow-up|0|||
33645189|NCT02563067|102252705|FG000|Overall Study|Technical problems|0|||
33645190|NCT02563067|102252706|FG001|Overall Study|Technical problems|1|||
33645191|NCT02563067|102252707|FG002|Overall Study|Technical problems|0|||
33645192|NCT02563067|102252705|FG000|Overall Study|Lack of Efficacy|1|||
33245242|NCT01168401|100800106|FG005|Overall Study|Lost to Follow-up|0|||
33423294|NCT01255722|101439884|FG000|Overall Study|asymptomatic patient|1|||
33423295|NCT01255722|101439885|FG001|Overall Study|asymptomatic patient|0|||
33423296|NCT01255722|101439886|FG002|Overall Study|asymptomatic patient|0|||
33423297|NCT01255722|101439884|FG000|Overall Study|beta-blocker contraindicated|2|||
33423298|NCT01255722|101439885|FG001|Overall Study|beta-blocker contraindicated|0|||
33423299|NCT01255722|101439886|FG002|Overall Study|beta-blocker contraindicated|0|||
33423300|NCT04128696|101439887|FG000|Overall Study|Lost to Follow-up|3|||
33645193|NCT02563067|102252706|FG001|Overall Study|Lack of Efficacy|0|||
33645194|NCT02563067|102252707|FG002|Overall Study|Lack of Efficacy|0|||
33645195|NCT02563067|102252705|FG000|Overall Study|Death|0|||
33645196|NCT02563067|102252706|FG001|Overall Study|Death|1|||
33245243|NCT01168401|100800107|FG006|Overall Study|Lost to Follow-up|0|||
33245244|NCT01168401|100800108|FG007|Overall Study|Lost to Follow-up|0|||
33373513|NCT00446446|101255888|FG000|Overall Study|Other|4|||
33373514|NCT00446446|101255888|FG000|Overall Study|Disease Progession|2|||
33373515|NCT00446446|101255888|FG000|Overall Study|Adverse Event|1|||
33373516|NCT00446446|101255888|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
33373517|NCT01860534|101255891|FG000|ROP #1|Needed treatment for ROP|0|||
33373518|NCT01860534|101255892|FG001|ROP #1|Needed treatment for ROP|1|||
33373519|NCT01860534|101255891|FG000|ROP #2|discharged prior to ROP #2|1|||
33373520|NCT01860534|101255892|FG001|ROP #2|discharged prior to ROP #2|0|||
33373521|NCT01151579|101255893|FG000|Overall Study|Physician Decision|3|||
33373522|NCT01151579|101255894|FG001|Overall Study|Physician Decision|1|||
33373523|NCT01151579|101255893|FG000|Overall Study|Withdrawal by Subject|3|||
33373524|NCT01151579|101255894|FG001|Overall Study|Withdrawal by Subject|2|||
33373525|NCT01151579|101255893|FG000|Overall Study|Not meet inclusion criteria|6|||
33373526|NCT01151579|101255894|FG001|Overall Study|Not meet inclusion criteria|4|||
33373527|NCT01737840|101255895|FG000|Overall Study|Diagnosed with an other pathology|2|||
33373528|NCT01737840|101255896|FG001|Overall Study|Diagnosed with an other pathology|2|||
33373529|NCT01586156|101255907|FG000|Overall Study|Pregnancy|0|||
33373530|NCT01586156|101255908|FG001|Overall Study|Pregnancy|1|||
33373531|NCT01586156|101255909|FG002|Overall Study|Pregnancy|0|||
33373532|NCT02104804|101255915|FG000|Overall Study|Did not take study medication|0|||
33423301|NCT04128696|101439888|FG001|Overall Study|Lost to Follow-up|7|||
33423302|NCT04128696|101439887|FG000|Overall Study|Withdrawal by Subject|12|||
33423303|NCT04128696|101439888|FG001|Overall Study|Withdrawal by Subject|11|||
33245245|NCT01168401|100800109|FG008|Overall Study|Lost to Follow-up|0|||
33245246|NCT01168401|100800110|FG009|Overall Study|Lost to Follow-up|0|||
33245247|NCT01168401|100800111|FG010|Overall Study|Lost to Follow-up|0|||
33245248|NCT01168401|100800101|FG000|Overall Study|Withdrawal by Subject|0|||
33245249|NCT01168401|100800102|FG001|Overall Study|Withdrawal by Subject|0|||
33245250|NCT01168401|100800103|FG002|Overall Study|Withdrawal by Subject|0|||
33245251|NCT01168401|100800104|FG003|Overall Study|Withdrawal by Subject|1|||
33245252|NCT01168401|100800105|FG004|Overall Study|Withdrawal by Subject|0|||
33245253|NCT01168401|100800106|FG005|Overall Study|Withdrawal by Subject|0|||
33245254|NCT01168401|100800107|FG006|Overall Study|Withdrawal by Subject|0|||
33245255|NCT01168401|100800108|FG007|Overall Study|Withdrawal by Subject|0|||
33245256|NCT01168401|100800109|FG008|Overall Study|Withdrawal by Subject|0|||
33245257|NCT01168401|100800110|FG009|Overall Study|Withdrawal by Subject|0|||
33245258|NCT01168401|100800111|FG010|Overall Study|Withdrawal by Subject|0|||
33245259|NCT04888585|100800112|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
33245260|NCT04888585|100800113|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
33245261|NCT04888585|100800114|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
33245262|NCT04888585|100800115|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
33245263|NCT04888585|100800116|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
33245264|NCT04888585|100800117|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
33245265|NCT04888585|100800118|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
33245266|NCT04888585|100800119|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
33245267|NCT04888585|100800120|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
33245268|NCT04888585|100800121|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
33245269|NCT04888585|100800122|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
33245270|NCT04888585|100800112|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
33245271|NCT04888585|100800113|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
33245272|NCT04888585|100800114|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
33245273|NCT04888585|100800115|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
33147168|NCT02435069|100454235|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
33147169|NCT02435069|100454236|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
33147170|NCT01916967|100454237|FG000|Overall Study|Adverse Event|0|||
33147171|NCT01916967|100454238|FG001|Overall Study|Adverse Event|0|||
33147172|NCT01916967|100454239|FG002|Overall Study|Adverse Event|2|||
33147173|NCT01916967|100454237|FG000|Overall Study|Lack of Efficacy|0|||
33147174|NCT01916967|100454238|FG001|Overall Study|Lack of Efficacy|0|||
33147175|NCT01916967|100454239|FG002|Overall Study|Lack of Efficacy|6|||
33147176|NCT01916967|100454237|FG000|Overall Study|Physician Decision|0|||
33245274|NCT04888585|100800116|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
33245275|NCT04888585|100800117|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
33245276|NCT04888585|100800118|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
33245277|NCT04888585|100800119|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
33245278|NCT04888585|100800120|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
33245279|NCT04888585|100800121|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
33245280|NCT04888585|100800122|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
33245281|NCT04888585|100800112|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
33245282|NCT04888585|100800113|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
33245283|NCT04888585|100800114|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
33147177|NCT01916967|100454238|FG001|Overall Study|Physician Decision|0|||
33147178|NCT01916967|100454239|FG002|Overall Study|Physician Decision|1|||
33147179|NCT01916967|100454237|FG000|Overall Study|Protocol Violation|0|||
33147180|NCT01916967|100454238|FG001|Overall Study|Protocol Violation|1|||
33147181|NCT01916967|100454239|FG002|Overall Study|Protocol Violation|0|||
33147182|NCT01606254|100454240|FG000|Overall Study|Withdrawal by Subject|1|||
33147183|NCT01606254|100454241|FG001|Overall Study|Withdrawal by Subject|3|||
33147184|NCT01606254|100454242|FG002|Overall Study|Withdrawal by Subject|0|||
33147185|NCT01606254|100454243|FG003|Overall Study|Withdrawal by Subject|2|||
33147186|NCT01606254|100454240|FG000|Overall Study|Adverse Event|1|||
33147187|NCT01606254|100454241|FG001|Overall Study|Adverse Event|1|||
33373533|NCT02104804|101255916|FG001|Overall Study|Did not take study medication|1|||
33147188|NCT01606254|100454242|FG002|Overall Study|Adverse Event|0|||
33147189|NCT01606254|100454243|FG003|Overall Study|Adverse Event|1|||
33147190|NCT01912963|100454244|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
33147191|NCT01912963|100454245|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
33147192|NCT01912963|100454246|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
33245284|NCT04888585|100800115|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
33245285|NCT04888585|100800116|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
33245286|NCT04888585|100800117|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
33245287|NCT04888585|100800118|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
33245288|NCT04888585|100800119|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
33245289|NCT04888585|100800120|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
33245290|NCT04888585|100800121|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
33245291|NCT04888585|100800122|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
33245292|NCT04888585|100800112|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
33245293|NCT04888585|100800113|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
33245294|NCT04888585|100800114|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
33245295|NCT04888585|100800115|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
33245296|NCT04888585|100800116|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
33245297|NCT04888585|100800117|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
33245298|NCT04888585|100800118|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
33245299|NCT04888585|100800119|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
33373534|NCT02104804|101255915|FG000|Overall Study|Study specific discontinuation criteria|6|||
33373535|NCT02104804|101255916|FG001|Overall Study|Study specific discontinuation criteria|1|||
33373536|NCT02104804|101255915|FG000|Overall Study|Other listed|2|||
33373537|NCT02104804|101255916|FG001|Overall Study|Other listed|1|||
33373538|NCT02104804|101255915|FG000|Overall Study|Protocol Violation|0|||
33373539|NCT02104804|101255916|FG001|Overall Study|Protocol Violation|1|||
33373540|NCT02104804|101255915|FG000|Overall Study|Adverse Event|4|||
33245300|NCT04888585|100800120|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
33245301|NCT04888585|100800121|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
33245302|NCT04888585|100800122|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
33245303|NCT04888585|100800112|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
33245304|NCT04888585|100800113|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
33245305|NCT04888585|100800114|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
33245306|NCT04888585|100800115|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
33245307|NCT04888585|100800116|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
33245308|NCT04888585|100800117|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
33245309|NCT04888585|100800118|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
33245310|NCT04888585|100800119|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
33245311|NCT04888585|100800120|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
33245312|NCT04888585|100800121|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
33245313|NCT04888585|100800122|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
33245314|NCT04888585|100800112|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
33245315|NCT04888585|100800113|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
33245316|NCT04888585|100800114|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
33245317|NCT04888585|100800115|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
33245318|NCT04888585|100800116|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
33373541|NCT02104804|101255916|FG001|Overall Study|Adverse Event|3|||
33373542|NCT02104804|101255915|FG000|Overall Study|Withdrawal by Subject|4|||
33373543|NCT02104804|101255916|FG001|Overall Study|Withdrawal by Subject|12|||
33373544|NCT03806179|101255917|FG000|Overall Study|Progressive disease|0|||
33373545|NCT03806179|101255918|FG001|Overall Study|Progressive disease|2|||
33373546|NCT00745368|101255919|FG000|Overall Study|Unable to provide sample|3|||
33373547|NCT00986427|101255920|FG000|Overall Study|Lost to Follow-up|2|||
33373548|NCT00986427|101255921|FG001|Overall Study|Lost to Follow-up|0|||
33373549|NCT00986427|101255920|FG000|Overall Study|Lack of Efficacy|1|||
33373550|NCT00986427|101255921|FG001|Overall Study|Lack of Efficacy|0|||
33373551|NCT00986427|101255920|FG000|Overall Study|Withdrawal by Subject|1|||
33373552|NCT00986427|101255921|FG001|Overall Study|Withdrawal by Subject|0|||
33373553|NCT00115804|101255924|FG000|Overall Study|Adverse Event|2|||
33373554|NCT01104584|101255925|FG000|Overall Study|Study drug never administered|21|||
33373555|NCT01104584|101255925|FG000|Overall Study|Study prematurely discontinued|2|||
33373556|NCT01525849|101255929|FG000|Overall Study|Lost to Follow-up|3|||
33373557|NCT01525849|101255930|FG001|Overall Study|Lost to Follow-up|2|||
33373558|NCT01525849|101255929|FG000|Overall Study|Withdrawal by Subject|1|||
33373559|NCT01525849|101255930|FG001|Overall Study|Withdrawal by Subject|9|||
33373560|NCT01525849|101255929|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
33373561|NCT01525849|101255930|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
33373562|NCT01525849|101255929|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
33373563|NCT01525849|101255930|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
33373564|NCT00848549|101255931|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
33373565|NCT00848549|101255932|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
33373566|NCT00848549|101255931|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
33373567|NCT00848549|101255932|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
33373568|NCT00848549|101255931|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
33373569|NCT00848549|101255932|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
33373570|NCT00848549|101255931|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
33423304|NCT04128696|101439887|FG000|Overall Study|Study Closed/Terminated|26|||
33245319|NCT04888585|100800117|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
33423305|NCT04128696|101439888|FG001|Overall Study|Study Closed/Terminated|38|||
33245320|NCT04888585|100800118|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
33245321|NCT04888585|100800119|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
33245322|NCT04888585|100800120|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
33245323|NCT04888585|100800121|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
33245324|NCT04888585|100800122|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
33245325|NCT04888585|100800112|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
33245326|NCT04888585|100800113|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
33245327|NCT04888585|100800114|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
33245328|NCT04888585|100800115|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
33245329|NCT04888585|100800116|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
33245330|NCT04888585|100800117|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
33245331|NCT04888585|100800118|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
33245332|NCT04888585|100800119|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
33245333|NCT04888585|100800120|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
33245334|NCT04888585|100800121|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
33245335|NCT04888585|100800122|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
33245336|NCT04888585|100800112|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
33245337|NCT04888585|100800113|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
33245338|NCT04888585|100800114|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
33245339|NCT04888585|100800115|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
33245340|NCT04888585|100800116|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
33245341|NCT04888585|100800117|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
33245342|NCT04888585|100800118|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
33245343|NCT04888585|100800119|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
33245344|NCT04888585|100800120|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
33245345|NCT04888585|100800121|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
33584102|NCT00070109|102028844|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
33584103|NCT03941964|102028845|FG000|Overall Study|Adverse Event|1|||
33584104|NCT03941964|102028846|FG001|Overall Study|Adverse Event|8|||
33584105|NCT03941964|102028845|FG000|Overall Study|Progressive disease|7|||
33584106|NCT03941964|102028846|FG001|Overall Study|Progressive disease|3|||
33584107|NCT03941964|102028845|FG000|Overall Study|Lack of Efficacy|0|||
33584108|NCT03941964|102028846|FG001|Overall Study|Lack of Efficacy|1|||
33584109|NCT03941964|102028845|FG000|Overall Study|Death|3|||
33584110|NCT03941964|102028846|FG001|Overall Study|Death|1|||
33584111|NCT03941964|102028845|FG000|Overall Study|Withdrew consent|1|||
33584112|NCT03941964|102028846|FG001|Overall Study|Withdrew consent|3|||
33584113|NCT03941964|102028845|FG000|Overall Study|Physician Decision|9|||
33245346|NCT04888585|100800122|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
33245347|NCT04759131|100800123|FG000|Overall Study|Investigator's discretion|1|||
33245348|NCT04759131|100800124|FG001|Overall Study|Investigator's discretion|0|||
33245349|NCT04759131|100800123|FG000|Overall Study|Subject withdrawal|1|||
33245350|NCT04759131|100800124|FG001|Overall Study|Subject withdrawal|0|||
33245351|NCT01599325|100800125|FG000|Primary Parent Phase|Adverse Event|5|||
33245352|NCT01599325|100800125|FG000|Primary Parent Phase|Disease Progression|7|||
33245353|NCT01599325|100800125|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
33245354|NCT01599325|100800125|FG000|Primary Parent Phase|Death|13|||
33245355|NCT01599325|100800125|FG000|Primary Parent Phase|Protocol Violation|1|||
33245356|NCT01599325|100800125|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
33245357|NCT01599325|100800125|FG000|Primary Parent Phase|Other|2|||
33245358|NCT01599325|100800125|FG000|Extension Phase|Study Closure|1|||
33584114|NCT03941964|102028846|FG001|Overall Study|Physician Decision|2|||
33584115|NCT03941964|102028845|FG000|Overall Study|Other, not specified|2|||
33584116|NCT03941964|102028846|FG001|Overall Study|Other, not specified|1|||
33645197|NCT02563067|102252707|FG002|Overall Study|Death|1|||
33245359|NCT01599325|100800125|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
33245360|NCT01599325|100800125|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
33245361|NCT01599325|100800125|FG000|Extension Phase|Disease Progression|1|||
33245362|NCT01599325|100800125|FG000|Extension Phase|Withdrawal by Subject|8|||
33645198|NCT02563067|102252705|FG000|Overall Study|Adverse Event|2|||
33245363|NCT00906698|100800126|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
33245364|NCT00906698|100800127|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
33245365|NCT00906698|100800128|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
33245366|NCT00906698|100800129|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
33245367|NCT00906698|100800130|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
33245368|NCT00906698|100800131|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
33245369|NCT00906698|100800126|FG000|Overall Study|Adverse Event|0|||
33245370|NCT00906698|100800127|FG001|Overall Study|Adverse Event|0|||
33245371|NCT00906698|100800128|FG002|Overall Study|Adverse Event|2|||
33245372|NCT00906698|100800129|FG003|Overall Study|Adverse Event|0|||
33584117|NCT02016716|102028851|FG000|Overall Study|Withdrawal by Subject|5|||
33245373|NCT00906698|100800130|FG004|Overall Study|Adverse Event|4|||
33245374|NCT00906698|100800131|FG005|Overall Study|Adverse Event|1|||
33245375|NCT00906698|100800126|FG000|Overall Study|Disease progression|3|||
33245376|NCT00906698|100800127|FG001|Overall Study|Disease progression|12|||
33245377|NCT00906698|100800128|FG002|Overall Study|Disease progression|4|||
33245378|NCT00906698|100800129|FG003|Overall Study|Disease progression|4|||
33245379|NCT00906698|100800130|FG004|Overall Study|Disease progression|12|||
33245380|NCT00906698|100800131|FG005|Overall Study|Disease progression|4|||
33245381|NCT00906698|100800126|FG000|Overall Study|Withdrawal by Subject|0|||
33245382|NCT00906698|100800127|FG001|Overall Study|Withdrawal by Subject|0|||
33373571|NCT00848549|101255932|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
33373572|NCT00848549|101255931|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
33373573|NCT00848549|101255932|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
33373574|NCT00848549|101255931|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
33373575|NCT00848549|101255932|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
33373576|NCT00848549|101255931|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
33373577|NCT00848549|101255932|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
33373578|NCT00848549|101255931|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
33373579|NCT00848549|101255932|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
33373580|NCT00848549|101255931|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
33373581|NCT00848549|101255932|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
33373582|NCT00848549|101255931|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
33373583|NCT00848549|101255932|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
33373584|NCT00848549|101255931|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
33373585|NCT00848549|101255932|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
33373586|NCT00848549|101255931|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
33373587|NCT00848549|101255932|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
33373588|NCT00848549|101255931|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
33373589|NCT00848549|101255932|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
33373590|NCT00848549|101255931|FG000|E2090-E044-314 (Extension Study)|Other|5|||
33373591|NCT00848549|101255932|FG001|E2090-E044-314 (Extension Study)|Other|6|||
33373592|NCT02364947|101255933|FG000|Overall Study|Withdrawal by Subject|10|||
33373593|NCT02364947|101255934|FG001|Overall Study|Withdrawal by Subject|8|||
33373594|NCT02364947|101255935|FG002|Overall Study|Withdrawal by Subject|9|||
33373595|NCT02364947|101255933|FG000|Overall Study|Adverse Event|45|||
33373596|NCT02364947|101255934|FG001|Overall Study|Adverse Event|33|||
33423306|NCT04128696|101439887|FG000|Overall Study|Physician Decision|2|||
33423307|NCT04128696|101439888|FG001|Overall Study|Physician Decision|3|||
33423308|NCT00579254|101439889|FG000|Overall Study|Lost to Follow-up|39|||
33645199|NCT02563067|102252706|FG001|Overall Study|Adverse Event|1|||
33147193|NCT01912963|100454244|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
33147194|NCT01912963|100454245|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
33373597|NCT02364947|101255935|FG002|Overall Study|Adverse Event|11|||
33147195|NCT01912963|100454246|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
33147196|NCT01912963|100454244|FG000|Overall Study|Adverse Event|0|||
33147197|NCT01912963|100454245|FG001|Overall Study|Adverse Event|1|||
33147198|NCT01912963|100454246|FG002|Overall Study|Adverse Event|1|||
33147199|NCT01912963|100454244|FG000|Overall Study|Withdrawal by Subject|0|||
33147200|NCT01912963|100454245|FG001|Overall Study|Withdrawal by Subject|1|||
33147201|NCT01912963|100454246|FG002|Overall Study|Withdrawal by Subject|0|||
33147202|NCT01912963|100454244|FG000|Overall Study|Sought treatment locally|0|||
33147203|NCT01912963|100454245|FG001|Overall Study|Sought treatment locally|1|||
33147204|NCT01912963|100454246|FG002|Overall Study|Sought treatment locally|0|||
33147205|NCT01479985|100454248|FG000|Overall Study|Tablet malfunction, no data saved|1|||
33147206|NCT01479985|100454249|FG001|Overall Study|Tablet malfunction, no data saved|1|||
33147207|NCT01479985|100454248|FG000|Overall Study|No decisional conflict scale responses|0|||
33147208|NCT01479985|100454249|FG001|Overall Study|No decisional conflict scale responses|2|||
33147209|NCT01479985|100454248|FG000|Overall Study|No post-visit survey|5|||
33147210|NCT01479985|100454249|FG001|Overall Study|No post-visit survey|3|||
33245383|NCT00906698|100800128|FG002|Overall Study|Withdrawal by Subject|0|||
33373598|NCT02364947|101255933|FG000|Overall Study|Protocol Violation|1|||
33373599|NCT02364947|101255934|FG001|Overall Study|Protocol Violation|1|||
33373600|NCT02364947|101255935|FG002|Overall Study|Protocol Violation|1|||
33645200|NCT02563067|102252707|FG002|Overall Study|Adverse Event|0|||
33373601|NCT02364947|101255933|FG000|Overall Study|Physician Decision|3|||
33147211|NCT00072176|100454250|FG000|Overall Study|Withdrawal by Subject|1|||
33147212|NCT00072176|100454251|FG001|Overall Study|Withdrawal by Subject|0|||
33147213|NCT00072176|100454250|FG000|Overall Study|Protocol Violation|0|||
33245384|NCT00906698|100800129|FG003|Overall Study|Withdrawal by Subject|0|||
33373602|NCT02364947|101255934|FG001|Overall Study|Physician Decision|2|||
33373603|NCT02364947|101255935|FG002|Overall Study|Physician Decision|5|||
33373604|NCT02364947|101255933|FG000|Overall Study|Death|0|||
33373605|NCT02364947|101255934|FG001|Overall Study|Death|1|||
33423309|NCT00579254|101439889|FG000|Overall Study|Discontinued when study terminated|73|||
33245385|NCT00906698|100800130|FG004|Overall Study|Withdrawal by Subject|1|||
33245386|NCT00906698|100800131|FG005|Overall Study|Withdrawal by Subject|0|||
33245387|NCT00906698|100800126|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
33147214|NCT00072176|100454251|FG001|Overall Study|Protocol Violation|1|||
33245388|NCT00906698|100800127|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
33245389|NCT00906698|100800128|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
33245390|NCT00906698|100800129|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
33245391|NCT00906698|100800130|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
33245392|NCT00906698|100800131|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
33245393|NCT01124162|100800132|FG000|First Intervention|Adverse Event|2|||
33245394|NCT01124162|100800133|FG001|First Intervention|Adverse Event|0|||
33245395|NCT01124162|100800132|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
33147215|NCT04263454|100454258|FG000|Overall Study|Adverse Event|0|||
33147216|NCT04263454|100454259|FG001|Overall Study|Adverse Event|2|||
33245396|NCT01124162|100800133|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
33245397|NCT01670019|100800134|FG000|Overall Study|Adverse Event|3|||
33245398|NCT01670019|100800135|FG001|Overall Study|Adverse Event|0|||
33245399|NCT01670019|100800134|FG000|Overall Study|Withdrawal by Subject|6|||
33245400|NCT01670019|100800135|FG001|Overall Study|Withdrawal by Subject|0|||
33245401|NCT01414166|100800136|FG000|Overall Study|Adverse Event|10|||
33245402|NCT01414166|100800137|FG001|Overall Study|Adverse Event|2|||
33245403|NCT01414166|100800136|FG000|Overall Study|Lost to Follow-up|4|||
33245404|NCT01414166|100800137|FG001|Overall Study|Lost to Follow-up|1|||
33245405|NCT01414166|100800136|FG000|Overall Study|Non-compliance with study drug|2|||
33245406|NCT01414166|100800137|FG001|Overall Study|Non-compliance with study drug|0|||
33245407|NCT01414166|100800136|FG000|Overall Study|Physician Decision|2|||
33245408|NCT01414166|100800137|FG001|Overall Study|Physician Decision|0|||
33245409|NCT01414166|100800136|FG000|Overall Study|Protocol Violation|2|||
33245410|NCT01414166|100800137|FG001|Overall Study|Protocol Violation|0|||
33245411|NCT01414166|100800136|FG000|Overall Study|Study terminated by Sponsor|68|||
33245412|NCT01414166|100800137|FG001|Overall Study|Study terminated by Sponsor|75|||
33147217|NCT04263454|100454258|FG000|Overall Study|Physician Decision|3|||
33147218|NCT04263454|100454259|FG001|Overall Study|Physician Decision|5|||
33147219|NCT04263454|100454258|FG000|Overall Study|Poor Data Quality|0|||
33147220|NCT04263454|100454259|FG001|Overall Study|Poor Data Quality|1|||
33147221|NCT01898494|100454260|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
33147222|NCT01898494|100454261|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
33147223|NCT01898494|100454262|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
33147224|NCT01898494|100454263|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
33147225|NCT01898494|100454264|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
33147226|NCT01898494|100454260|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
33147227|NCT01898494|100454261|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
33147228|NCT01898494|100454262|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
33147229|NCT01898494|100454263|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
33147230|NCT01898494|100454264|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
33147231|NCT01898494|100454260|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
33147232|NCT01898494|100454261|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
33147233|NCT01898494|100454262|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
33147234|NCT01898494|100454263|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
33147235|NCT01898494|100454264|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
33147236|NCT01898494|100454260|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
33245413|NCT01414166|100800136|FG000|Overall Study|Withdrawal by Subject|3|||
33245414|NCT01414166|100800137|FG001|Overall Study|Withdrawal by Subject|5|||
33245415|NCT00603447|100800138|FG000|Overall Study|Adverse Event|0|||
33245416|NCT00603447|100800139|FG001|Overall Study|Adverse Event|1|||
33245417|NCT00603447|100800140|FG002|Overall Study|Adverse Event|1|||
33245418|NCT00603447|100800141|FG003|Overall Study|Adverse Event|2|||
33245419|NCT00603447|100800142|FG004|Overall Study|Adverse Event|1|||
33245420|NCT00603447|100800143|FG005|Overall Study|Adverse Event|2|||
33245421|NCT00603447|100800144|FG006|Overall Study|Adverse Event|10|||
33423310|NCT01890785|101439892|FG000|Third Intervention|Withdrawal by Subject|0|||
33423311|NCT01890785|101439893|FG001|Third Intervention|Withdrawal by Subject|1|||
33147237|NCT01898494|100454261|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
33147238|NCT01898494|100454262|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
33245422|NCT00603447|100800138|FG000|Overall Study|Other|0|||
33245423|NCT00603447|100800139|FG001|Overall Study|Other|0|||
33245424|NCT00603447|100800140|FG002|Overall Study|Other|1|||
33245425|NCT00603447|100800141|FG003|Overall Study|Other|0|||
33245426|NCT00603447|100800142|FG004|Overall Study|Other|3|||
33245427|NCT00603447|100800143|FG005|Overall Study|Other|0|||
33245428|NCT00603447|100800144|FG006|Overall Study|Other|13|||
33245429|NCT00603447|100800138|FG000|Overall Study|Withdrew Consent|0|||
33245430|NCT00603447|100800139|FG001|Overall Study|Withdrew Consent|2|||
33245431|NCT00603447|100800140|FG002|Overall Study|Withdrew Consent|0|||
33245432|NCT00603447|100800141|FG003|Overall Study|Withdrew Consent|0|||
33147239|NCT01898494|100454263|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
33147240|NCT01898494|100454264|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
33147241|NCT01898494|100454260|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
33147242|NCT01898494|100454261|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
33147243|NCT01898494|100454262|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
33147244|NCT01898494|100454263|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
33147245|NCT01898494|100454264|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
33147246|NCT01898494|100454260|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
33147247|NCT01898494|100454261|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
33147248|NCT01898494|100454262|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
33147249|NCT01898494|100454263|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
33147250|NCT01898494|100454264|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
33147251|NCT01898494|100454260|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
33147252|NCT01898494|100454261|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
33147253|NCT01898494|100454262|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
33147254|NCT01898494|100454263|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
33147255|NCT01898494|100454264|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
33147256|NCT01898494|100454260|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
33147257|NCT01898494|100454261|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
33147258|NCT01898494|100454262|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
33147259|NCT01898494|100454263|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
33147260|NCT01898494|100454264|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
33147261|NCT01898494|100454260|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
33147262|NCT01898494|100454261|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
33147263|NCT01898494|100454262|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
33147264|NCT01898494|100454263|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
33147265|NCT01898494|100454264|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
33147266|NCT01898494|100454260|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
33147267|NCT01898494|100454261|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
33147268|NCT01898494|100454262|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
33147269|NCT01898494|100454263|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
33147270|NCT01898494|100454264|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
33147271|NCT01898494|100454260|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
33147272|NCT01898494|100454261|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
33147273|NCT01898494|100454262|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
33147274|NCT01898494|100454263|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
33147275|NCT01898494|100454264|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
33147276|NCT01898494|100454260|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
33147277|NCT01898494|100454261|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
33147278|NCT01898494|100454262|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
33147279|NCT01898494|100454263|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
33147280|NCT01898494|100454264|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
33147281|NCT01898494|100454260|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
33147282|NCT01898494|100454261|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
33147283|NCT01898494|100454262|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
33245433|NCT00603447|100800142|FG004|Overall Study|Withdrew Consent|1|||
33245434|NCT00603447|100800143|FG005|Overall Study|Withdrew Consent|0|||
33245435|NCT00603447|100800144|FG006|Overall Study|Withdrew Consent|1|||
33245436|NCT02359435|100800151|FG000|Overall Study|Lost to Follow-up|4|||
33245437|NCT02359435|100800152|FG001|Overall Study|Lost to Follow-up|4|||
33245438|NCT05526911|100800153|FG000|Overall Study|Adverse Event|2|||
33245439|NCT03568162|100800154|FG000|Overall Study|Adverse Event|0|||
33245440|NCT03568162|100800155|FG001|Overall Study|Adverse Event|1|||
33245441|NCT03568162|100800156|FG002|Overall Study|Adverse Event|2|||
33245442|NCT03568162|100800157|FG003|Overall Study|Adverse Event|0|||
33245443|NCT03568162|100800158|FG004|Overall Study|Adverse Event|0|||
33245444|NCT03568162|100800159|FG005|Overall Study|Adverse Event|1|||
33245445|NCT03568162|100800154|FG000|Overall Study|Death|0|||
33245446|NCT03568162|100800155|FG001|Overall Study|Death|0|||
33245447|NCT03568162|100800156|FG002|Overall Study|Death|0|||
33245448|NCT03568162|100800157|FG003|Overall Study|Death|0|||
33245449|NCT03568162|100800158|FG004|Overall Study|Death|1|||
33245450|NCT03568162|100800159|FG005|Overall Study|Death|0|||
33245451|NCT03568162|100800154|FG000|Overall Study|Lost to Follow-up|3|||
33147284|NCT01898494|100454263|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
33147285|NCT01898494|100454264|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
33147286|NCT01898494|100454260|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
33245452|NCT03568162|100800155|FG001|Overall Study|Lost to Follow-up|2|||
33245453|NCT03568162|100800156|FG002|Overall Study|Lost to Follow-up|4|||
33245454|NCT03568162|100800157|FG003|Overall Study|Lost to Follow-up|2|||
33245455|NCT03568162|100800158|FG004|Overall Study|Lost to Follow-up|3|||
33245456|NCT03568162|100800159|FG005|Overall Study|Lost to Follow-up|2|||
33245457|NCT03568162|100800154|FG000|Overall Study|Physician Decision|0|||
33245458|NCT03568162|100800155|FG001|Overall Study|Physician Decision|1|||
33245459|NCT03568162|100800156|FG002|Overall Study|Physician Decision|1|||
33245460|NCT03568162|100800157|FG003|Overall Study|Physician Decision|0|||
33245461|NCT03568162|100800158|FG004|Overall Study|Physician Decision|1|||
33245462|NCT03568162|100800159|FG005|Overall Study|Physician Decision|0|||
33245463|NCT03568162|100800154|FG000|Overall Study|Pregnancy|0|||
33245464|NCT03568162|100800155|FG001|Overall Study|Pregnancy|0|||
33245465|NCT03568162|100800156|FG002|Overall Study|Pregnancy|0|||
33245466|NCT03568162|100800157|FG003|Overall Study|Pregnancy|1|||
33245467|NCT03568162|100800158|FG004|Overall Study|Pregnancy|0|||
33245468|NCT03568162|100800159|FG005|Overall Study|Pregnancy|0|||
33245469|NCT03568162|100800154|FG000|Overall Study|Protocol Violation|1|||
33245470|NCT03568162|100800155|FG001|Overall Study|Protocol Violation|0|||
33245471|NCT03568162|100800156|FG002|Overall Study|Protocol Violation|1|||
33245472|NCT03568162|100800157|FG003|Overall Study|Protocol Violation|1|||
33245473|NCT03568162|100800158|FG004|Overall Study|Protocol Violation|1|||
33245474|NCT03568162|100800159|FG005|Overall Study|Protocol Violation|1|||
33245475|NCT03568162|100800154|FG000|Overall Study|Withdrawal by Subject|15|||
33245476|NCT03568162|100800155|FG001|Overall Study|Withdrawal by Subject|15|||
33245477|NCT03568162|100800156|FG002|Overall Study|Withdrawal by Subject|26|||
33245478|NCT03568162|100800157|FG003|Overall Study|Withdrawal by Subject|22|||
33245479|NCT03568162|100800158|FG004|Overall Study|Withdrawal by Subject|6|||
33245480|NCT03568162|100800159|FG005|Overall Study|Withdrawal by Subject|9|||
33245481|NCT03568162|100800154|FG000|Overall Study|Others|3|||
33245482|NCT03568162|100800155|FG001|Overall Study|Others|4|||
33245483|NCT03568162|100800156|FG002|Overall Study|Others|1|||
33245484|NCT03568162|100800157|FG003|Overall Study|Others|4|||
33245485|NCT03568162|100800158|FG004|Overall Study|Others|2|||
33245486|NCT03568162|100800159|FG005|Overall Study|Others|1|||
33245487|NCT00751036|100800160|FG000|Overall Study|Disease Progression|28|||
33245488|NCT00751036|100800161|FG001|Overall Study|Disease Progression|29|||
33245489|NCT00751036|100800160|FG000|Overall Study|Adverse Event|6|||
33245490|NCT00751036|100800161|FG001|Overall Study|Adverse Event|4|||
33245491|NCT00751036|100800160|FG000|Overall Study|Administrative Problems|3|||
33245492|NCT00751036|100800161|FG001|Overall Study|Administrative Problems|4|||
33245493|NCT00751036|100800160|FG000|Overall Study|Withdrawal by Subject|5|||
33245494|NCT00751036|100800161|FG001|Overall Study|Withdrawal by Subject|2|||
33245495|NCT00751036|100800160|FG000|Overall Study|Death|3|||
33245496|NCT00751036|100800161|FG001|Overall Study|Death|3|||
33245497|NCT00751036|100800160|FG000|Overall Study|Lost to Follow-up|0|||
33245498|NCT00751036|100800161|FG001|Overall Study|Lost to Follow-up|1|||
33245499|NCT00751036|100800160|FG000|Overall Study|Protocol Violation|1|||
33245500|NCT00751036|100800161|FG001|Overall Study|Protocol Violation|0|||
33245501|NCT00751036|100800160|FG000|Overall Study|Missing end of Treatment Page|2|||
33245502|NCT00751036|100800161|FG001|Overall Study|Missing end of Treatment Page|3|||
33245503|NCT03532178|100800162|FG000|First Period|Withdrawal by Subject|1|||
33245504|NCT03532178|100800163|FG001|First Period|Withdrawal by Subject|3|||
33245505|NCT03532178|100800162|FG000|First Period|technical issues in data collection Technical issues|0|||
33245506|NCT03532178|100800163|FG001|First Period|technical issues in data collection Technical issues|1|||
33245507|NCT03532178|100800162|FG000|Second Period|Withdrawal by Subject|1|||
33245508|NCT03532178|100800163|FG001|Second Period|Withdrawal by Subject|1|||
33245509|NCT03532178|100800162|FG000|Second Period|Technical issues|0|||
33245510|NCT03532178|100800163|FG001|Second Period|Technical issues|1|||
33245511|NCT00151996|100800164|FG000|Overall Study|Adverse Event|3|||
33245512|NCT00151996|100800165|FG001|Overall Study|Adverse Event|2|||
33245513|NCT00151996|100800164|FG000|Overall Study|Withdrawal by Subject|1|||
33245514|NCT00151996|100800165|FG001|Overall Study|Withdrawal by Subject|1|||
33245515|NCT00151996|100800164|FG000|Overall Study|Protocol Violation|1|||
33245516|NCT00151996|100800165|FG001|Overall Study|Protocol Violation|2|||
33245517|NCT00151996|100800164|FG000|Overall Study|Sponsor's decision|0|||
33245518|NCT00151996|100800165|FG001|Overall Study|Sponsor's decision|2|||
33245519|NCT00941031|100800166|FG000|Induction Period|Lack of Efficacy|2|||
33245520|NCT00941031|100800167|FG001|Induction Period|Lack of Efficacy|1|||
33645201|NCT02563067|102252705|FG000|Overall Study|Death post Treatment/safety period|1|||
33245521|NCT00941031|100800168|FG002|Induction Period|Lack of Efficacy|0|||
33245522|NCT00941031|100800169|FG003|Induction Period|Lack of Efficacy|5|||
33245523|NCT00941031|100800170|FG004|Induction Period|Lack of Efficacy|0|||
33245524|NCT00941031|100800171|FG005|Induction Period|Lack of Efficacy|0|||
33245525|NCT00941031|100800172|FG006|Induction Period|Lack of Efficacy|0|||
33245526|NCT00941031|100800166|FG000|Induction Period|Withdrawal by Subject|1|||
33245527|NCT00941031|100800167|FG001|Induction Period|Withdrawal by Subject|2|||
33245528|NCT00941031|100800168|FG002|Induction Period|Withdrawal by Subject|2|||
33245529|NCT00941031|100800169|FG003|Induction Period|Withdrawal by Subject|2|||
33245530|NCT00941031|100800170|FG004|Induction Period|Withdrawal by Subject|0|||
33245531|NCT00941031|100800171|FG005|Induction Period|Withdrawal by Subject|0|||
33245532|NCT00941031|100800172|FG006|Induction Period|Withdrawal by Subject|0|||
33245533|NCT00941031|100800166|FG000|Induction Period|Adminstative Problems|1|||
33245534|NCT00941031|100800167|FG001|Induction Period|Adminstative Problems|1|||
33245535|NCT00941031|100800168|FG002|Induction Period|Adminstative Problems|1|||
33147287|NCT01898494|100454261|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
33147288|NCT01898494|100454262|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
33147289|NCT01898494|100454263|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
33147290|NCT01898494|100454264|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
33147291|NCT01920555|100454265|FG000|Overall Study|Physician Decision|1|||
33147292|NCT01920555|100454266|FG001|Overall Study|Physician Decision|2|||
33147293|NCT01920555|100454267|FG002|Overall Study|Physician Decision|1|||
33147294|NCT01920555|100454268|FG003|Overall Study|Physician Decision|2|||
33147295|NCT01920555|100454269|FG004|Overall Study|Physician Decision|0|||
33147296|NCT01920555|100454265|FG000|Overall Study|Lack of Efficacy|2|||
33147297|NCT01920555|100454266|FG001|Overall Study|Lack of Efficacy|0|||
33147298|NCT01920555|100454267|FG002|Overall Study|Lack of Efficacy|0|||
33147299|NCT01920555|100454268|FG003|Overall Study|Lack of Efficacy|0|||
33147300|NCT01920555|100454269|FG004|Overall Study|Lack of Efficacy|0|||
33147301|NCT01920555|100454265|FG000|Overall Study|Travel Difficulties|1|||
33147302|NCT01920555|100454266|FG001|Overall Study|Travel Difficulties|1|||
33147303|NCT01920555|100454267|FG002|Overall Study|Travel Difficulties|0|||
33147304|NCT01920555|100454268|FG003|Overall Study|Travel Difficulties|0|||
33147305|NCT01920555|100454269|FG004|Overall Study|Travel Difficulties|1|||
33147306|NCT01920555|100454265|FG000|Overall Study|Lost to Follow-up|0|||
33147307|NCT01920555|100454266|FG001|Overall Study|Lost to Follow-up|1|||
33147308|NCT01920555|100454267|FG002|Overall Study|Lost to Follow-up|0|||
33147309|NCT01920555|100454268|FG003|Overall Study|Lost to Follow-up|1|||
33147310|NCT01920555|100454269|FG004|Overall Study|Lost to Follow-up|0|||
33147311|NCT00107952|100454270|FG000|Overall Study|Death|75|||
33147312|NCT00107952|100454271|FG001|Overall Study|Death|61|||
33147313|NCT00107952|100454270|FG000|Overall Study|Lost to Follow-up|0|||
33147314|NCT00107952|100454271|FG001|Overall Study|Lost to Follow-up|3|||
33147315|NCT00107952|100454270|FG000|Overall Study|Withdrawal by Subject|9|||
33147316|NCT00107952|100454271|FG001|Overall Study|Withdrawal by Subject|6|||
33147317|NCT00107952|100454270|FG000|Overall Study|Other|2|||
33147318|NCT00107952|100454271|FG001|Overall Study|Other|5|||
33147319|NCT00107952|100454270|FG000|Overall Study|Never received study treatment|9|||
33147320|NCT00107952|100454271|FG001|Overall Study|Never received study treatment|6|||
33147321|NCT02923427|100454272|FG000|Overall Study|convert to laparatomy|2|||
33147322|NCT02923427|100454273|FG001|Overall Study|convert to laparatomy|2|||
33147323|NCT02923427|100454272|FG000|Overall Study|destaturation|1|||
33147324|NCT02923427|100454273|FG001|Overall Study|destaturation|0|||
33147325|NCT02923427|100454272|FG000|Overall Study|can not replace LMA|1|||
33147326|NCT02923427|100454273|FG001|Overall Study|can not replace LMA|0|||
33147327|NCT04656275|100454275|FG000|Overall Study|Study terminated by sponsor|2|||
33147328|NCT04656275|100454276|FG001|Overall Study|Study terminated by sponsor|4|||
33147329|NCT02579928|100454286|FG000|Overall Study|Withdrawal by Subject|1|||
33147330|NCT02579928|100454287|FG001|Overall Study|Withdrawal by Subject|0|||
33147331|NCT03823378|100454292|FG000|Overall Study|Adverse Event|2|||
33147332|NCT03823378|100454293|FG001|Overall Study|Adverse Event|2|||
33147333|NCT03823378|100454294|FG002|Overall Study|Adverse Event|0|||
33147334|NCT03823378|100454295|FG003|Overall Study|Adverse Event|0|||
33147335|NCT03823378|100454296|FG004|Overall Study|Adverse Event|0|||
33147336|NCT03823378|100454297|FG005|Overall Study|Adverse Event|0|||
33147337|NCT03823378|100454292|FG000|Overall Study|Lost to Follow-up|0|||
33147338|NCT03823378|100454293|FG001|Overall Study|Lost to Follow-up|1|||
33147339|NCT03823378|100454294|FG002|Overall Study|Lost to Follow-up|0|||
33147340|NCT03823378|100454295|FG003|Overall Study|Lost to Follow-up|0|||
33147341|NCT03823378|100454296|FG004|Overall Study|Lost to Follow-up|1|||
33147342|NCT03823378|100454297|FG005|Overall Study|Lost to Follow-up|0|||
33147343|NCT03823378|100454292|FG000|Overall Study|Withdrawal by Subject|0|||
33147344|NCT03823378|100454293|FG001|Overall Study|Withdrawal by Subject|1|||
33147345|NCT03823378|100454294|FG002|Overall Study|Withdrawal by Subject|4|||
33147346|NCT03823378|100454295|FG003|Overall Study|Withdrawal by Subject|2|||
33147347|NCT03823378|100454296|FG004|Overall Study|Withdrawal by Subject|0|||
33147348|NCT03823378|100454297|FG005|Overall Study|Withdrawal by Subject|1|||
33147349|NCT03823378|100454292|FG000|Overall Study|Other, not specified|19|||
33147350|NCT03823378|100454293|FG001|Overall Study|Other, not specified|12|||
33147351|NCT03823378|100454294|FG002|Overall Study|Other, not specified|6|||
33147352|NCT03823378|100454295|FG003|Overall Study|Other, not specified|8|||
33147353|NCT03823378|100454296|FG004|Overall Study|Other, not specified|17|||
33147354|NCT03823378|100454297|FG005|Overall Study|Other, not specified|7|||
33147355|NCT00006389|100454299|FG000|Overall Study|Adverse Event|1|||
33373606|NCT02364947|101255935|FG002|Overall Study|Death|0|||
33147356|NCT02059005|100454304|FG000|Overall Study|Death|1|||
33147357|NCT02059005|100454305|FG001|Overall Study|Death|3|||
33373607|NCT02280291|101255936|FG000|Overall Study|Lost to Follow-up|2|||
33373608|NCT02280291|101255937|FG001|Overall Study|Lost to Follow-up|1|||
33147358|NCT02059005|100454304|FG000|Overall Study|Lost to Follow-up|19|||
33147359|NCT02059005|100454305|FG001|Overall Study|Lost to Follow-up|19|||
33147360|NCT02059005|100454304|FG000|Overall Study|Incarceration|0|||
33373609|NCT02280291|101255938|FG002|Overall Study|Lost to Follow-up|3|||
33373610|NCT02280291|101255939|FG003|Overall Study|Lost to Follow-up|8|||
33147361|NCT02059005|100454305|FG001|Overall Study|Incarceration|1|||
33147362|NCT02059005|100454304|FG000|Overall Study|Inpatient|0|||
33147363|NCT02059005|100454305|FG001|Overall Study|Inpatient|1|||
33147364|NCT01278160|100454308|FG000|Overall Study|Adverse Event|1|||
33147365|NCT01278160|100454309|FG001|Overall Study|Adverse Event|1|||
33147366|NCT01278160|100454308|FG000|Overall Study|Lost to Follow-up|0|||
33147367|NCT01278160|100454309|FG001|Overall Study|Lost to Follow-up|1|||
33147368|NCT01278160|100454308|FG000|Overall Study|Withdrawal by Subject|3|||
33147369|NCT01278160|100454309|FG001|Overall Study|Withdrawal by Subject|2|||
33147370|NCT01278160|100454308|FG000|Overall Study|Unclassified|1|||
33147371|NCT01278160|100454309|FG001|Overall Study|Unclassified|2|||
33147372|NCT00433654|100454310|FG000|Overall Study|Death|4|||
33147373|NCT00433654|100454311|FG001|Overall Study|Death|0|||
33147374|NCT00433654|100454310|FG000|Overall Study|Missed visit|6|||
33147375|NCT00433654|100454311|FG001|Overall Study|Missed visit|3|||
33373611|NCT02280291|101255936|FG000|Overall Study|Protocol Violation|1|||
33373612|NCT02280291|101255937|FG001|Overall Study|Protocol Violation|0|||
33373613|NCT02280291|101255938|FG002|Overall Study|Protocol Violation|0|||
33373614|NCT02280291|101255939|FG003|Overall Study|Protocol Violation|0|||
33373615|NCT02280291|101255936|FG000|Overall Study|Other|1|||
33373616|NCT02280291|101255937|FG001|Overall Study|Other|1|||
33245536|NCT00941031|100800169|FG003|Induction Period|Adminstative Problems|0|||
33245537|NCT00941031|100800170|FG004|Induction Period|Adminstative Problems|0|||
33245538|NCT00941031|100800171|FG005|Induction Period|Adminstative Problems|0|||
33245539|NCT00941031|100800172|FG006|Induction Period|Adminstative Problems|0|||
33245540|NCT00941031|100800166|FG000|Induction Period|Adverse Event|1|||
33245541|NCT00941031|100800167|FG001|Induction Period|Adverse Event|0|||
33245542|NCT00941031|100800168|FG002|Induction Period|Adverse Event|3|||
33245543|NCT00941031|100800169|FG003|Induction Period|Adverse Event|2|||
33147376|NCT00433654|100454310|FG000|Overall Study|Subject not yet due for visit|4|||
33147377|NCT00433654|100454311|FG001|Overall Study|Subject not yet due for visit|0|||
33147378|NCT00433654|100454310|FG000|Overall Study|Withdrawal by Subject|1|||
33147379|NCT00433654|100454311|FG001|Overall Study|Withdrawal by Subject|2|||
33147380|NCT00364130|100454313|FG000|Intervention Period|Lost to Follow-up|4|||
33147381|NCT00364130|100454314|FG001|Intervention Period|Lost to Follow-up|3|||
33147382|NCT00364130|100454313|FG000|Intervention Period|Pregnancy|1|||
33147383|NCT00364130|100454314|FG001|Intervention Period|Pregnancy|0|||
33147384|NCT00364130|100454313|FG000|Intervention Period|Withdrawal by Subject|4|||
33147385|NCT00364130|100454314|FG001|Intervention Period|Withdrawal by Subject|5|||
33147386|NCT00364130|100454313|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
33147387|NCT00364130|100454314|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
33147388|NCT04059185|100454330|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
33147389|NCT04059185|100454331|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
33147390|NCT04059185|100454332|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
33147391|NCT04059185|100454330|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
33147392|NCT04059185|100454331|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
33147393|NCT04059185|100454332|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
33147394|NCT04059185|100454330|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
33147395|NCT04059185|100454331|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
33147396|NCT04059185|100454332|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
33245544|NCT00941031|100800170|FG004|Induction Period|Adverse Event|0|||
33245545|NCT00941031|100800171|FG005|Induction Period|Adverse Event|0|||
33245546|NCT00941031|100800172|FG006|Induction Period|Adverse Event|0|||
33245547|NCT00941031|100800166|FG000|Maintenance Period|Withdrawal by Subject|0|||
33373617|NCT02280291|101255938|FG002|Overall Study|Other|0|||
33147397|NCT04059185|100454330|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
33373618|NCT02280291|101255939|FG003|Overall Study|Other|0|||
33373619|NCT04387136|101255945|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
33645202|NCT02563067|102252706|FG001|Overall Study|Death post Treatment/safety period|0|||
33645203|NCT02563067|102252707|FG002|Overall Study|Death post Treatment/safety period|0|||
33645204|NCT01402102|102252708|FG000|Overall Study|Protocol Violation|1|||
33373620|NCT04387136|101255946|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
33245548|NCT00941031|100800167|FG001|Maintenance Period|Withdrawal by Subject|0|||
33245549|NCT00941031|100800168|FG002|Maintenance Period|Withdrawal by Subject|0|||
33245550|NCT00941031|100800169|FG003|Maintenance Period|Withdrawal by Subject|0|||
33373621|NCT01025817|101255947|FG000|Completed Study Medication|Adverse Event|66|||
33645205|NCT01402102|102252709|FG001|Overall Study|Protocol Violation|0|||
33147398|NCT04059185|100454331|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
33147399|NCT04059185|100454332|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
33147400|NCT04059185|100454330|FG000|Longitudinal Assessment-Adults Only|Death|4|||
33147401|NCT04059185|100454331|FG001|Longitudinal Assessment-Adults Only|Death|4|||
33245551|NCT00941031|100800170|FG004|Maintenance Period|Withdrawal by Subject|6|||
33373622|NCT01025817|101255948|FG001|Completed Study Medication|Adverse Event|39|||
33373623|NCT01025817|101255947|FG000|Completed Study Medication|Protocol Deviation|9|||
33373624|NCT01025817|101255948|FG001|Completed Study Medication|Protocol Deviation|8|||
33645206|NCT01402102|102252708|FG000|Overall Study|Insufficiency of compliance|1|||
33645207|NCT01402102|102252709|FG001|Overall Study|Insufficiency of compliance|1|||
33645208|NCT01402102|102252708|FG000|Overall Study|Withdrawal by Subject|0|||
33645209|NCT01402102|102252709|FG001|Overall Study|Withdrawal by Subject|2|||
33645210|NCT00552188|102252710|FG000|Overall Study|Adverse Event|0|||
33645211|NCT00552188|102252711|FG001|Overall Study|Adverse Event|2|||
33645212|NCT00552188|102252710|FG000|Overall Study|Lost to Follow-up|2|||
33645213|NCT00552188|102252711|FG001|Overall Study|Lost to Follow-up|1|||
33645214|NCT00552188|102252710|FG000|Overall Study|Withdrawal of consent|0|||
33645215|NCT00552188|102252711|FG001|Overall Study|Withdrawal of consent|1|||
33645216|NCT00552188|102252710|FG000|Overall Study|Subject returned to home country|0|||
33645217|NCT00552188|102252711|FG001|Overall Study|Subject returned to home country|1|||
33645218|NCT01640314|102252712|FG000|Overall Study|Protocol Violation|0|||
33645219|NCT01640314|102252713|FG001|Overall Study|Protocol Violation|1|||
33645220|NCT00104520|102252720|FG000|Overall Study|Unrelated adverse event|34|||
33147402|NCT04059185|100454332|FG002|Longitudinal Assessment-Adults Only|Death|3|||
33147403|NCT00400946|100454333|FG000|Overall Study|Ineligible|0|||
33147404|NCT00400946|100454334|FG001|Overall Study|Ineligible|0|||
33147405|NCT00400946|100454335|FG002|Overall Study|Ineligible|0|||
33147406|NCT00400946|100454336|FG003|Overall Study|Ineligible|5|||
33147407|NCT00400946|100454337|FG004|Overall Study|Ineligible|1|||
33147408|NCT00400946|100454333|FG000|Overall Study|Induction Failure|0|||
33147409|NCT00400946|100454334|FG001|Overall Study|Induction Failure|0|||
33147410|NCT00400946|100454335|FG002|Overall Study|Induction Failure|0|||
33147411|NCT00400946|100454336|FG003|Overall Study|Induction Failure|11|||
33147412|NCT00400946|100454337|FG004|Overall Study|Induction Failure|8|||
33147413|NCT00400946|100454333|FG000|Overall Study|Induction Death|0|||
33147414|NCT00400946|100454334|FG001|Overall Study|Induction Death|0|||
33147415|NCT00400946|100454335|FG002|Overall Study|Induction Death|0|||
33147416|NCT00400946|100454336|FG003|Overall Study|Induction Death|13|||
33147417|NCT00400946|100454337|FG004|Overall Study|Induction Death|3|||
33147418|NCT00400946|100454333|FG000|Overall Study|Lost to Follow-up|1|||
33147419|NCT00400946|100454334|FG001|Overall Study|Lost to Follow-up|1|||
33147420|NCT00400946|100454335|FG002|Overall Study|Lost to Follow-up|0|||
33147421|NCT00400946|100454336|FG003|Overall Study|Lost to Follow-up|0|||
33147422|NCT00400946|100454337|FG004|Overall Study|Lost to Follow-up|1|||
33147423|NCT00400946|100454333|FG000|Overall Study|Remission Death|1|||
33147424|NCT00400946|100454334|FG001|Overall Study|Remission Death|1|||
33147425|NCT00400946|100454335|FG002|Overall Study|Remission Death|0|||
33147426|NCT00400946|100454336|FG003|Overall Study|Remission Death|0|||
33147427|NCT00400946|100454337|FG004|Overall Study|Remission Death|1|||
33147428|NCT00400946|100454333|FG000|Overall Study|Relapse|9|||
33147429|NCT00400946|100454334|FG001|Overall Study|Relapse|2|||
33147430|NCT00400946|100454335|FG002|Overall Study|Relapse|1|||
33147431|NCT00400946|100454336|FG003|Overall Study|Relapse|1|||
33147432|NCT00400946|100454337|FG004|Overall Study|Relapse|5|||
33147433|NCT00400946|100454333|FG000|Overall Study|Transplant in CR1|0|||
33147434|NCT00400946|100454334|FG001|Overall Study|Transplant in CR1|0|||
33147435|NCT00400946|100454335|FG002|Overall Study|Transplant in CR1|0|||
33423312|NCT01890785|101439894|FG002|Third Intervention|Withdrawal by Subject|0|||
33584118|NCT02016716|102028852|FG001|Overall Study|Withdrawal by Subject|5|||
33584119|NCT02016716|102028853|FG002|Overall Study|Withdrawal by Subject|5|||
33584120|NCT02016716|102028851|FG000|Overall Study|Protocol-specified Criteria|0|||
33584121|NCT02016716|102028852|FG001|Overall Study|Protocol-specified Criteria|1|||
33584122|NCT02016716|102028853|FG002|Overall Study|Protocol-specified Criteria|0|||
33584123|NCT02016716|102028851|FG000|Overall Study|Lost to Follow-up|1|||
33584124|NCT02016716|102028852|FG001|Overall Study|Lost to Follow-up|2|||
33584125|NCT02016716|102028853|FG002|Overall Study|Lost to Follow-up|1|||
33584126|NCT01063062|102028858|FG000|Overall Study|Patient withdrew consent|0|||
33584127|NCT01063062|102028859|FG001|Overall Study|Patient withdrew consent|1|||
33584128|NCT01063062|102028858|FG000|Overall Study|Adverse Event|2|||
33584129|NCT01063062|102028859|FG001|Overall Study|Adverse Event|4|||
33584130|NCT01063062|102028858|FG000|Overall Study|Protocol Violation|5|||
33584131|NCT01063062|102028859|FG001|Overall Study|Protocol Violation|4|||
33645221|NCT00104520|102252721|FG001|Overall Study|Unrelated adverse event|47|||
33147436|NCT00400946|100454336|FG003|Overall Study|Transplant in CR1|10|||
33147437|NCT00400946|100454337|FG004|Overall Study|Transplant in CR1|1|||
33147438|NCT00400946|100454333|FG000|Overall Study|Withdrawal by Subject|2|||
33147439|NCT00400946|100454334|FG001|Overall Study|Withdrawal by Subject|5|||
33147440|NCT00400946|100454335|FG002|Overall Study|Withdrawal by Subject|1|||
33147441|NCT00400946|100454336|FG003|Overall Study|Withdrawal by Subject|5|||
33147442|NCT00400946|100454337|FG004|Overall Study|Withdrawal by Subject|8|||
33147443|NCT00400946|100454333|FG000|Overall Study|Clinical|1|||
33147444|NCT00400946|100454334|FG001|Overall Study|Clinical|2|||
33147445|NCT00400946|100454335|FG002|Overall Study|Clinical|0|||
33147446|NCT00400946|100454336|FG003|Overall Study|Clinical|2|||
33584132|NCT01063062|102028858|FG000|Overall Study|Investigator's request|1|||
33584133|NCT01063062|102028859|FG001|Overall Study|Investigator's request|0|||
33584134|NCT01063062|102028858|FG000|Overall Study|Lost to Follow-up|0|||
33584135|NCT01063062|102028859|FG001|Overall Study|Lost to Follow-up|2|||
33245552|NCT00941031|100800171|FG005|Maintenance Period|Withdrawal by Subject|2|||
33245553|NCT00941031|100800172|FG006|Maintenance Period|Withdrawal by Subject|13|||
33245554|NCT00941031|100800166|FG000|Maintenance Period|Administrative Problems|0|||
33245555|NCT00941031|100800167|FG001|Maintenance Period|Administrative Problems|0|||
33245556|NCT00941031|100800168|FG002|Maintenance Period|Administrative Problems|0|||
33245557|NCT00941031|100800169|FG003|Maintenance Period|Administrative Problems|0|||
33245558|NCT00941031|100800170|FG004|Maintenance Period|Administrative Problems|1|||
33245559|NCT00941031|100800171|FG005|Maintenance Period|Administrative Problems|0|||
33245560|NCT00941031|100800172|FG006|Maintenance Period|Administrative Problems|1|||
33245561|NCT00941031|100800166|FG000|Maintenance Period|Protocol Violation|0|||
33245562|NCT00941031|100800167|FG001|Maintenance Period|Protocol Violation|0|||
33245563|NCT00941031|100800168|FG002|Maintenance Period|Protocol Violation|0|||
33245564|NCT00941031|100800169|FG003|Maintenance Period|Protocol Violation|0|||
33245565|NCT00941031|100800170|FG004|Maintenance Period|Protocol Violation|0|||
33245566|NCT00941031|100800171|FG005|Maintenance Period|Protocol Violation|0|||
33245567|NCT00941031|100800172|FG006|Maintenance Period|Protocol Violation|1|||
33245568|NCT00941031|100800166|FG000|Maintenance Period|Adverse Event|0|||
33245569|NCT00941031|100800167|FG001|Maintenance Period|Adverse Event|0|||
33245570|NCT00941031|100800168|FG002|Maintenance Period|Adverse Event|0|||
33245571|NCT00941031|100800169|FG003|Maintenance Period|Adverse Event|0|||
33245572|NCT00941031|100800170|FG004|Maintenance Period|Adverse Event|0|||
33245573|NCT00941031|100800171|FG005|Maintenance Period|Adverse Event|2|||
33245574|NCT00941031|100800172|FG006|Maintenance Period|Adverse Event|8|||
33245575|NCT00941031|100800166|FG000|Maintenance Period|Lost to Follow-up|0|||
33245576|NCT00941031|100800167|FG001|Maintenance Period|Lost to Follow-up|0|||
33245577|NCT00941031|100800168|FG002|Maintenance Period|Lost to Follow-up|0|||
33245578|NCT00941031|100800169|FG003|Maintenance Period|Lost to Follow-up|0|||
33245579|NCT00941031|100800170|FG004|Maintenance Period|Lost to Follow-up|2|||
33245580|NCT00941031|100800171|FG005|Maintenance Period|Lost to Follow-up|2|||
33245581|NCT00941031|100800172|FG006|Maintenance Period|Lost to Follow-up|7|||
33245582|NCT00941031|100800166|FG000|Maintenance Period|Lack of Efficacy|0|||
33245583|NCT00941031|100800167|FG001|Maintenance Period|Lack of Efficacy|0|||
33245584|NCT00941031|100800168|FG002|Maintenance Period|Lack of Efficacy|0|||
33245585|NCT00941031|100800169|FG003|Maintenance Period|Lack of Efficacy|0|||
33245586|NCT00941031|100800170|FG004|Maintenance Period|Lack of Efficacy|0|||
33245587|NCT00941031|100800171|FG005|Maintenance Period|Lack of Efficacy|0|||
33245588|NCT00941031|100800172|FG006|Maintenance Period|Lack of Efficacy|13|||
33245589|NCT03586167|100800173|FG000|Overall Study|Other|1|||
33245590|NCT03586167|100800174|FG001|Overall Study|Other|0|||
33245591|NCT00984282|100800177|FG000|Double Blind Treatment|Adverse Event|40|||
33245592|NCT00984282|100800178|FG001|Double Blind Treatment|Adverse Event|6|||
33245593|NCT00984282|100800177|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
33245594|NCT00984282|100800178|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
33245595|NCT00984282|100800177|FG000|Double Blind Treatment|Physician Decision|1|||
33245596|NCT00984282|100800178|FG001|Double Blind Treatment|Physician Decision|2|||
33245597|NCT00984282|100800177|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
33245598|NCT00984282|100800178|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
33245599|NCT00984282|100800177|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
33245600|NCT00984282|100800178|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
33245601|NCT00984282|100800177|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
33245602|NCT00984282|100800178|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
33245603|NCT00984282|100800177|FG000|Double Blind Treatment|Lost to Follow-up|3|||
33245604|NCT00984282|100800178|FG001|Double Blind Treatment|Lost to Follow-up|0|||
33245605|NCT00984282|100800177|FG000|Double Blind Treatment|Death|8|||
33245606|NCT00984282|100800178|FG001|Double Blind Treatment|Death|4|||
33245607|NCT00984282|100800177|FG000|Double Blind Treatment|Not treated|0|||
33245608|NCT00984282|100800178|FG001|Double Blind Treatment|Not treated|1|||
33245609|NCT00984282|100800177|FG000|Double Blind Treatment|Switched to commercial drug|6|||
33423313|NCT01890785|101439895|FG003|Third Intervention|Withdrawal by Subject|0|||
33423314|NCT01890785|101439896|FG004|Third Intervention|Withdrawal by Subject|0|||
33245610|NCT00984282|100800178|FG001|Double Blind Treatment|Switched to commercial drug|1|||
33245611|NCT00984282|100800177|FG000|Double Blind Treatment|protocol driven decision point|1|||
33245612|NCT00984282|100800178|FG001|Double Blind Treatment|protocol driven decision point|1|||
33245613|NCT00984282|100800177|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
33423315|NCT01890785|101439897|FG005|Third Intervention|Withdrawal by Subject|0|||
33423316|NCT03412019|101439898|FG000|Overall Study|Withdrawal by Subject|1|||
33245614|NCT00984282|100800178|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
33245615|NCT00984282|100800177|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
33245616|NCT00984282|100800178|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
33245617|NCT00984282|100800177|FG000|Open-label Treatment|Adverse Event|20|||
33245618|NCT00984282|100800178|FG001|Open-label Treatment|Adverse Event|30|||
33245619|NCT00984282|100800177|FG000|Open-label Treatment|Withdrawal by Subject|6|||
33245620|NCT00984282|100800178|FG001|Open-label Treatment|Withdrawal by Subject|21|||
33147447|NCT00400946|100454337|FG004|Overall Study|Clinical|9|||
33147448|NCT00400946|100454333|FG000|Overall Study|Other|0|||
33147449|NCT00400946|100454334|FG001|Overall Study|Other|0|||
33147450|NCT00400946|100454335|FG002|Overall Study|Other|0|||
33147451|NCT00400946|100454336|FG003|Overall Study|Other|0|||
33147452|NCT00400946|100454337|FG004|Overall Study|Other|1|||
33147453|NCT05868382|100454338|FG000|Overall Study|Lost to Follow-up|5|||
33147454|NCT05868382|100454339|FG001|Overall Study|Lost to Follow-up|0|||
33147455|NCT05868382|100454340|FG002|Overall Study|Lost to Follow-up|6|||
33147456|NCT05868382|100454341|FG003|Overall Study|Lost to Follow-up|4|||
33147457|NCT05868382|100454342|FG004|Overall Study|Lost to Follow-up|2|||
33147458|NCT05868382|100454343|FG005|Overall Study|Lost to Follow-up|6|||
33147459|NCT05868382|100454338|FG000|Overall Study|Withdrawal by Subject|1|||
33147460|NCT05868382|100454339|FG001|Overall Study|Withdrawal by Subject|0|||
33147461|NCT05868382|100454340|FG002|Overall Study|Withdrawal by Subject|0|||
33147462|NCT05868382|100454341|FG003|Overall Study|Withdrawal by Subject|0|||
33147463|NCT05868382|100454342|FG004|Overall Study|Withdrawal by Subject|1|||
33147464|NCT05868382|100454343|FG005|Overall Study|Withdrawal by Subject|0|||
33147465|NCT02829918|100454344|FG000|Overall Study|Death|2|||
33147466|NCT02829918|100454344|FG000|Overall Study|Withdrawal by Subject|4|||
33147467|NCT02829918|100454344|FG000|Overall Study|Adverse Event|1|||
33147468|NCT02829918|100454344|FG000|Overall Study|Progression|1|||
33147469|NCT01674634|100454347|FG000|Overall Study|Withdrawal by Subject|3|||
33147470|NCT01674634|100454347|FG000|Overall Study|Lost to Follow-up|3|||
33147471|NCT01236118|100454348|FG000|Overall Study|Adverse Event|2|||
33147472|NCT01236118|100454349|FG001|Overall Study|Adverse Event|0|||
33147473|NCT01236118|100454350|FG002|Overall Study|Adverse Event|2|||
33147474|NCT01236118|100454348|FG000|Overall Study|Physician Decision|0|||
33245621|NCT00984282|100800177|FG000|Open-label Treatment|Death|7|||
33245622|NCT00984282|100800178|FG001|Open-label Treatment|Death|15|||
33245623|NCT00984282|100800177|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
33245624|NCT00984282|100800178|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
33245625|NCT00984282|100800177|FG000|Open-label Treatment|Lost to Follow-up|1|||
33245626|NCT00984282|100800178|FG001|Open-label Treatment|Lost to Follow-up|1|||
33245627|NCT00984282|100800177|FG000|Open-label Treatment|Patient convenience|1|||
33245628|NCT00984282|100800178|FG001|Open-label Treatment|Patient convenience|0|||
33245629|NCT00984282|100800177|FG000|Open-label Treatment|Non-compliant with study medication|1|||
33245630|NCT00984282|100800178|FG001|Open-label Treatment|Non-compliant with study medication|0|||
33245631|NCT00984282|100800177|FG000|Open-label Treatment|Target lesion removed|0|||
33245632|NCT00984282|100800178|FG001|Open-label Treatment|Target lesion removed|1|||
33245633|NCT00984282|100800177|FG000|Open-label Treatment|Protocol driven decision point|1|||
33245634|NCT00984282|100800178|FG001|Open-label Treatment|Protocol driven decision point|1|||
33245635|NCT00984282|100800177|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
33245636|NCT00984282|100800178|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
33245637|NCT00984282|100800177|FG000|Open-label Treatment|Switched to commercial drug|6|||
33245638|NCT00984282|100800178|FG001|Open-label Treatment|Switched to commercial drug|7|||
33245639|NCT00984282|100800177|FG000|Open-label Treatment|Physician Decision|1|||
33245640|NCT00984282|100800178|FG001|Open-label Treatment|Physician Decision|0|||
33245641|NCT00984282|100800177|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
33245642|NCT00984282|100800178|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
33245643|NCT00984282|100800177|FG000|Long Term Follow-up|Death|27|||
33245644|NCT00984282|100800178|FG001|Long Term Follow-up|Death|68|||
33245645|NCT00984282|100800177|FG000|Long Term Follow-up|Lost to Follow-up|3|||
33245646|NCT00984282|100800178|FG001|Long Term Follow-up|Lost to Follow-up|6|||
33245647|NCT00984282|100800177|FG000|Long Term Follow-up|Protocol driven decision point|25|||
33245648|NCT00984282|100800178|FG001|Long Term Follow-up|Protocol driven decision point|26|||
33245649|NCT00984282|100800177|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
33245650|NCT00984282|100800178|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
33245651|NCT00984282|100800177|FG000|Long Term Follow-up|Switched to commercial drug|4|||
33584136|NCT01063062|102028858|FG000|Overall Study|Miscellaneous reason|0|||
33584137|NCT01063062|102028859|FG001|Overall Study|Miscellaneous reason|1|||
33584138|NCT01248728|102028862|FG000|Overall Study|Adverse Event|1|||
33584139|NCT01248728|102028863|FG001|Overall Study|Adverse Event|1|||
33584140|NCT01248728|102028862|FG000|Overall Study|Withdrawal by Subject|2|||
33584141|NCT01248728|102028863|FG001|Overall Study|Withdrawal by Subject|1|||
33584142|NCT01248728|102028862|FG000|Overall Study|Lack of Efficacy|1|||
33584143|NCT01248728|102028863|FG001|Overall Study|Lack of Efficacy|0|||
33584144|NCT01030952|102028864|FG000|Overall Study|Protocol Violation|0|||
33147475|NCT01236118|100454349|FG001|Overall Study|Physician Decision|1|||
33147476|NCT01236118|100454350|FG002|Overall Study|Physician Decision|0|||
33147477|NCT01236118|100454348|FG000|Overall Study|Withdrawal by Subject|0|||
33147478|NCT01236118|100454349|FG001|Overall Study|Withdrawal by Subject|0|||
33147479|NCT01236118|100454350|FG002|Overall Study|Withdrawal by Subject|1|||
33147480|NCT01002482|100454351|FG000|Overall Study|Withdrawal by Subject|14|||
33147481|NCT01002482|100454352|FG001|Overall Study|Withdrawal by Subject|21|||
33147482|NCT01002482|100454351|FG000|Overall Study|Included twice|1|||
33147483|NCT01002482|100454352|FG001|Overall Study|Included twice|0|||
33147484|NCT01467583|100454353|FG000|Overall Study|Death|1|||
33147485|NCT01467583|100454354|FG001|Overall Study|Death|1|||
33147486|NCT01467583|100454355|FG002|Overall Study|Death|0|||
33147487|NCT01467583|100454353|FG000|Overall Study|Withdrawal by Subject|1|||
33147488|NCT01467583|100454354|FG001|Overall Study|Withdrawal by Subject|0|||
33147489|NCT01467583|100454355|FG002|Overall Study|Withdrawal by Subject|0|||
33245652|NCT00984282|100800178|FG001|Long Term Follow-up|Switched to commercial drug|2|||
33245653|NCT00984282|100800177|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
33245654|NCT00984282|100800178|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
33245655|NCT02757885|100800179|FG000|Overall Study|Screen Failures|4|||
33245656|NCT00515086|100800180|FG000|Overall Study|Adverse Event|1|||
33245657|NCT00515086|100800181|FG001|Overall Study|Adverse Event|1|||
33245658|NCT00515086|100800182|FG002|Overall Study|Adverse Event|2|||
33245659|NCT00515086|100800183|FG003|Overall Study|Adverse Event|3|||
33245660|NCT00515086|100800180|FG000|Overall Study|Administrative|1|||
33245661|NCT00515086|100800181|FG001|Overall Study|Administrative|1|||
33245662|NCT00515086|100800182|FG002|Overall Study|Administrative|0|||
33245663|NCT00515086|100800183|FG003|Overall Study|Administrative|0|||
33245664|NCT00515086|100800180|FG000|Overall Study|Withdrawal by Subject|1|||
33245665|NCT00515086|100800181|FG001|Overall Study|Withdrawal by Subject|0|||
33245666|NCT00515086|100800182|FG002|Overall Study|Withdrawal by Subject|0|||
33245667|NCT00515086|100800183|FG003|Overall Study|Withdrawal by Subject|1|||
33245668|NCT00515086|100800180|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
33245669|NCT00515086|100800181|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33245670|NCT00515086|100800182|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
33245671|NCT00515086|100800183|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
33245672|NCT00515086|100800180|FG000|Overall Study|Lost to Follow-up|1|||
33245673|NCT00515086|100800181|FG001|Overall Study|Lost to Follow-up|0|||
33245674|NCT00515086|100800182|FG002|Overall Study|Lost to Follow-up|0|||
33245675|NCT00515086|100800183|FG003|Overall Study|Lost to Follow-up|0|||
33245676|NCT00515086|100800180|FG000|Overall Study|Study drug no longer required|0|||
33245677|NCT00515086|100800181|FG001|Overall Study|Study drug no longer required|1|||
33245678|NCT00515086|100800182|FG002|Overall Study|Study drug no longer required|0|||
33245679|NCT00515086|100800183|FG003|Overall Study|Study drug no longer required|0|||
33245680|NCT00515086|100800180|FG000|Overall Study|Death|2|||
33245681|NCT00515086|100800181|FG001|Overall Study|Death|0|||
33245682|NCT00515086|100800182|FG002|Overall Study|Death|0|||
33245683|NCT00515086|100800183|FG003|Overall Study|Death|0|||
33245684|NCT04886596|100800189|FG000|Overall Study|Adverse Event|73|||
33245685|NCT04886596|100800190|FG001|Overall Study|Adverse Event|78|||
33245686|NCT04886596|100800189|FG000|Overall Study|Lost to Follow-up|104|||
33245687|NCT04886596|100800190|FG001|Overall Study|Lost to Follow-up|104|||
33245688|NCT04886596|100800189|FG000|Overall Study|Ongoing|12095|||
33245689|NCT04886596|100800190|FG001|Overall Study|Ongoing|12107|||
33245690|NCT04886596|100800189|FG000|Overall Study|Consent withdrawal, not due to an (S)AE|162|||
33245691|NCT04886596|100800190|FG001|Overall Study|Consent withdrawal, not due to an (S)AE|173|||
33245692|NCT04886596|100800189|FG000|Overall Study|Migrated / Moved from the study area|17|||
33147490|NCT01467583|100454353|FG000|Overall Study|Protocol Violation|0|||
33245693|NCT04886596|100800190|FG001|Overall Study|Migrated / Moved from the study area|14|||
33245694|NCT04886596|100800189|FG000|Overall Study|Unknown reason|16|||
33245695|NCT04886596|100800190|FG001|Overall Study|Unknown reason|23|||
33245696|NCT00823979|100800191|FG000|Overall Study|Lack of Efficacy|13|||
33245697|NCT00823979|100800192|FG001|Overall Study|Lack of Efficacy|16|||
33245698|NCT00823979|100800193|FG002|Overall Study|Lack of Efficacy|9|||
33245699|NCT00823979|100800191|FG000|Overall Study|Lost to Follow-up|2|||
33245700|NCT00823979|100800192|FG001|Overall Study|Lost to Follow-up|1|||
33423317|NCT03412019|101439899|FG001|Overall Study|Withdrawal by Subject|1|||
33423318|NCT00736099|101439904|FG000|Overall Study|Adverse Event|61|||
33423319|NCT00736099|101439905|FG001|Overall Study|Adverse Event|18|||
33423320|NCT00736099|101439904|FG000|Overall Study|Protocol Violation|10|||
33423321|NCT00736099|101439905|FG001|Overall Study|Protocol Violation|4|||
33147491|NCT01467583|100454354|FG001|Overall Study|Protocol Violation|0|||
33147492|NCT01467583|100454355|FG002|Overall Study|Protocol Violation|2|||
33147493|NCT00055471|100454362|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
33245701|NCT00823979|100800193|FG002|Overall Study|Lost to Follow-up|0|||
33245702|NCT00823979|100800191|FG000|Overall Study|Withdrawal by Subject|2|||
33245703|NCT00823979|100800192|FG001|Overall Study|Withdrawal by Subject|3|||
33245704|NCT00823979|100800193|FG002|Overall Study|Withdrawal by Subject|2|||
33245705|NCT00823979|100800191|FG000|Overall Study|Protocol Violation|1|||
33245706|NCT00823979|100800192|FG001|Overall Study|Protocol Violation|1|||
33245707|NCT00823979|100800193|FG002|Overall Study|Protocol Violation|0|||
33245708|NCT00823979|100800191|FG000|Overall Study|Pregnancy|0|||
33245709|NCT00823979|100800192|FG001|Overall Study|Pregnancy|1|||
33245710|NCT00823979|100800193|FG002|Overall Study|Pregnancy|0|||
33423322|NCT00736099|101439904|FG000|Overall Study|Lost to Follow-up|12|||
33147494|NCT00055471|100454363|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
33147495|NCT00055471|100454364|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
33245711|NCT00823979|100800191|FG000|Overall Study|Adverse Event|0|||
33245712|NCT00823979|100800192|FG001|Overall Study|Adverse Event|2|||
33245713|NCT00823979|100800193|FG002|Overall Study|Adverse Event|4|||
33245714|NCT00823979|100800191|FG000|Overall Study|Other|2|||
33245715|NCT00823979|100800192|FG001|Overall Study|Other|0|||
33245716|NCT00823979|100800193|FG002|Overall Study|Other|1|||
33245717|NCT00823979|100800191|FG000|Overall Study|Randomized but not Treated|4|||
33245718|NCT00823979|100800192|FG001|Overall Study|Randomized but not Treated|3|||
33584145|NCT01030952|102028865|FG001|Overall Study|Protocol Violation|1|||
33645222|NCT00104520|102252720|FG000|Overall Study|Study drug intolerance|0|||
33645223|NCT00104520|102252721|FG001|Overall Study|Study drug intolerance|1|||
33645224|NCT00104520|102252720|FG000|Overall Study|Related adverse event|13|||
33147496|NCT00055471|100454362|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
33147497|NCT00055471|100454363|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
33147498|NCT00055471|100454364|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
33147499|NCT00055471|100454362|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
33147500|NCT00055471|100454363|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
33147501|NCT00055471|100454364|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
33147502|NCT03370289|100454365|FG000|Overall Study|Screen Failure|1|||
33147503|NCT03370289|100454365|FG000|Overall Study|Sample Size Sufficient|4|||
33147504|NCT05128773|100454366|FG000|Overall Study|Sponsor decision to terminate study|3|||
33147505|NCT01756300|100454367|FG000|Overall Study|Death|1|||
33147506|NCT01756300|100454367|FG000|Overall Study|Withdrawal by Subject|1|||
33147507|NCT03868124|100454368|FG000|Overall Study|Withdrawal by Subject|4|||
33147508|NCT03868124|100454369|FG001|Overall Study|Withdrawal by Subject|0|||
33147509|NCT03868124|100454370|FG002|Overall Study|Withdrawal by Subject|1|||
33147510|NCT03868124|100454368|FG000|Overall Study|Physician Decision|1|||
33147511|NCT03868124|100454369|FG001|Overall Study|Physician Decision|0|||
33147512|NCT03868124|100454370|FG002|Overall Study|Physician Decision|1|||
33147513|NCT03868124|100454368|FG000|Overall Study|Lost to Follow-up|1|||
33147514|NCT03868124|100454369|FG001|Overall Study|Lost to Follow-up|1|||
33147515|NCT03868124|100454370|FG002|Overall Study|Lost to Follow-up|2|||
33147516|NCT03868124|100454368|FG000|Overall Study|Death|1|||
33147517|NCT03868124|100454369|FG001|Overall Study|Death|1|||
33147518|NCT03868124|100454370|FG002|Overall Study|Death|2|||
33147519|NCT03868124|100454368|FG000|Overall Study|Adverse Event|0|||
33147520|NCT03868124|100454369|FG001|Overall Study|Adverse Event|0|||
33147521|NCT03868124|100454370|FG002|Overall Study|Adverse Event|3|||
33147522|NCT03868124|100454368|FG000|Overall Study|Explanted|2|||
33147523|NCT03868124|100454369|FG001|Overall Study|Explanted|1|||
33147524|NCT03868124|100454370|FG002|Overall Study|Explanted|0|||
33147525|NCT03868124|100454368|FG000|Overall Study|Ongoing in study|176|||
33147526|NCT03868124|100454369|FG001|Overall Study|Ongoing in study|180|||
33147527|NCT03868124|100454370|FG002|Overall Study|Ongoing in study|183|||
33147528|NCT03822468|100454371|FG000|Treatment Period|Treatment on-going at the data cut-off date (11-Jun-2021)|110|||
33147529|NCT03822468|100454372|FG001|Treatment Period|Treatment on-going at the data cut-off date (11-Jun-2021)|107|||
33147530|NCT03822468|100454371|FG000|Treatment Period|Progressive disease|50|||
33147531|NCT03822468|100454372|FG001|Treatment Period|Progressive disease|51|||
33147532|NCT03822468|100454371|FG000|Treatment Period|Adverse Event|16|||
33147533|NCT03822468|100454372|FG001|Treatment Period|Adverse Event|18|||
33245719|NCT00823979|100800193|FG002|Overall Study|Randomized but not Treated|1|||
33245720|NCT00823979|100800191|FG000|Overall Study|Study Terminated by Sponsor|5|||
33245721|NCT00823979|100800192|FG001|Overall Study|Study Terminated by Sponsor|5|||
33373625|NCT01025817|101255947|FG000|Completed Study Medication|Withdrawal by Subject|8|||
33584146|NCT01030952|102028864|FG000|Overall Study|Informed consent withdrawal|1|||
33584147|NCT01030952|102028865|FG001|Overall Study|Informed consent withdrawal|0|||
33584148|NCT01030952|102028864|FG000|Overall Study|Lost to Follow-up|0|||
33584149|NCT01030952|102028865|FG001|Overall Study|Lost to Follow-up|1|||
33584150|NCT01030952|102028864|FG000|Overall Study|Unexplained|1|||
33584151|NCT01030952|102028865|FG001|Overall Study|Unexplained|1|||
33584152|NCT00194077|102028872|FG000|Overall Study|Lack of Efficacy|22|||
33584153|NCT00194077|102028873|FG001|Overall Study|Lack of Efficacy|29|||
33584154|NCT00194077|102028872|FG000|Overall Study|Study nonadherence|1|||
33584155|NCT00194077|102028873|FG001|Overall Study|Study nonadherence|0|||
33584156|NCT00194077|102028872|FG000|Overall Study|Withdrawal by Subject|1|||
33584157|NCT00194077|102028873|FG001|Overall Study|Withdrawal by Subject|1|||
33584158|NCT01262560|102028874|FG000|Overall Study|Protocol Violation|0|||
33584159|NCT01262560|102028875|FG001|Overall Study|Protocol Violation|1|||
33584160|NCT01262560|102028876|FG002|Overall Study|Protocol Violation|2|||
33584161|NCT05059301|102028884|FG000|Overall Study|Adverse Event|0|||
33645225|NCT00104520|102252721|FG001|Overall Study|Related adverse event|15|||
33147534|NCT03822468|100454371|FG000|Treatment Period|Patient decision|4|||
33245722|NCT00823979|100800193|FG002|Overall Study|Study Terminated by Sponsor|7|||
33245723|NCT04984876|100800194|FG000|Overall Study|Subject decision|2|||
33584162|NCT05059301|102028885|FG001|Overall Study|Adverse Event|2|||
33584163|NCT05059301|102028886|FG002|Overall Study|Adverse Event|2|||
33584164|NCT05059301|102028884|FG000|Overall Study|Lost to Follow-up|2|||
33645226|NCT00104520|102252720|FG000|Overall Study|Lost to Follow-up|1|||
33645227|NCT00104520|102252721|FG001|Overall Study|Lost to Follow-up|0|||
33645228|NCT00104520|102252720|FG000|Overall Study|Noncompliance|0|||
33645229|NCT00104520|102252721|FG001|Overall Study|Noncompliance|2|||
33645230|NCT00104520|102252720|FG000|Overall Study|Personal/administrative|1|||
33645231|NCT00104520|102252721|FG001|Overall Study|Personal/administrative|1|||
33645232|NCT00104520|102252720|FG000|Overall Study|Other|1|||
33645233|NCT00104520|102252721|FG001|Overall Study|Other|5|||
33645234|NCT01120717|102252722|FG000|Overall Study|Withdrawal by Subject|11|||
33645235|NCT01120717|102252723|FG001|Overall Study|Withdrawal by Subject|6|||
33645236|NCT01120717|102252722|FG000|Overall Study|Adverse Event|10|||
33645237|NCT01120717|102252723|FG001|Overall Study|Adverse Event|6|||
33645238|NCT01120717|102252722|FG000|Overall Study|Protocol Deviation|2|||
33645239|NCT01120717|102252723|FG001|Overall Study|Protocol Deviation|5|||
33645240|NCT01120717|102252722|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
33645241|NCT01120717|102252723|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
33645242|NCT01120717|102252722|FG000|Overall Study|Lost to Follow-up|2|||
33645243|NCT01120717|102252723|FG001|Overall Study|Lost to Follow-up|3|||
33645244|NCT01120717|102252722|FG000|Overall Study|Death|3|||
33584165|NCT05059301|102028885|FG001|Overall Study|Lost to Follow-up|3|||
33584166|NCT05059301|102028886|FG002|Overall Study|Lost to Follow-up|3|||
33584167|NCT02707965|102028887|FG000|Overall Study|Withdrawal by Subject|0|||
33584168|NCT02707965|102028888|FG001|Overall Study|Withdrawal by Subject|0|||
33584169|NCT02707965|102028889|FG002|Overall Study|Withdrawal by Subject|1|||
33584170|NCT02707965|102028890|FG003|Overall Study|Withdrawal by Subject|0|||
33584171|NCT02707965|102028891|FG004|Overall Study|Withdrawal by Subject|0|||
33584172|NCT02707965|102028892|FG005|Overall Study|Withdrawal by Subject|0|||
33584173|NCT02707965|102028893|FG006|Overall Study|Withdrawal by Subject|0|||
33584174|NCT02707965|102028894|FG007|Overall Study|Withdrawal by Subject|2|||
33584175|NCT02707965|102028895|FG008|Overall Study|Withdrawal by Subject|0|||
33584176|NCT02707965|102028896|FG009|Overall Study|Withdrawal by Subject|0|||
33584177|NCT02707965|102028897|FG010|Overall Study|Withdrawal by Subject|0|||
33584178|NCT02707965|102028898|FG011|Overall Study|Withdrawal by Subject|0|||
33584179|NCT02707965|102028899|FG012|Overall Study|Withdrawal by Subject|0|||
33584180|NCT02707965|102028900|FG013|Overall Study|Withdrawal by Subject|0|||
33584181|NCT02707965|102028901|FG014|Overall Study|Withdrawal by Subject|0|||
33584182|NCT02707965|102028902|FG015|Overall Study|Withdrawal by Subject|0|||
33584183|NCT02707965|102028887|FG000|Overall Study|PI decisions|0|||
33584184|NCT02707965|102028888|FG001|Overall Study|PI decisions|0|||
33584185|NCT02707965|102028889|FG002|Overall Study|PI decisions|0|||
33584186|NCT02707965|102028890|FG003|Overall Study|PI decisions|0|||
33584187|NCT02707965|102028891|FG004|Overall Study|PI decisions|0|||
33584188|NCT02707965|102028892|FG005|Overall Study|PI decisions|0|||
33584189|NCT02707965|102028893|FG006|Overall Study|PI decisions|0|||
33584190|NCT02707965|102028894|FG007|Overall Study|PI decisions|0|||
33584191|NCT02707965|102028895|FG008|Overall Study|PI decisions|0|||
33584192|NCT02707965|102028896|FG009|Overall Study|PI decisions|0|||
33584193|NCT02707965|102028897|FG010|Overall Study|PI decisions|0|||
33584194|NCT02707965|102028898|FG011|Overall Study|PI decisions|0|||
33584195|NCT02707965|102028899|FG012|Overall Study|PI decisions|0|||
33584196|NCT02707965|102028900|FG013|Overall Study|PI decisions|0|||
33584197|NCT02707965|102028901|FG014|Overall Study|PI decisions|2|||
33584198|NCT02707965|102028902|FG015|Overall Study|PI decisions|0|||
33584199|NCT02707965|102028887|FG000|Overall Study|Protocol deviation|1|||
33584200|NCT02707965|102028888|FG001|Overall Study|Protocol deviation|1|||
33584201|NCT02707965|102028889|FG002|Overall Study|Protocol deviation|0|||
33584202|NCT02707965|102028890|FG003|Overall Study|Protocol deviation|0|||
33584203|NCT02707965|102028891|FG004|Overall Study|Protocol deviation|0|||
33584204|NCT02707965|102028892|FG005|Overall Study|Protocol deviation|0|||
33584205|NCT02707965|102028893|FG006|Overall Study|Protocol deviation|0|||
33584206|NCT02707965|102028894|FG007|Overall Study|Protocol deviation|1|||
33584207|NCT02707965|102028895|FG008|Overall Study|Protocol deviation|0|||
33584208|NCT02707965|102028896|FG009|Overall Study|Protocol deviation|0|||
33584209|NCT02707965|102028897|FG010|Overall Study|Protocol deviation|0|||
33584210|NCT02707965|102028898|FG011|Overall Study|Protocol deviation|0|||
33584211|NCT02707965|102028899|FG012|Overall Study|Protocol deviation|0|||
33584212|NCT02707965|102028900|FG013|Overall Study|Protocol deviation|0|||
33645245|NCT01120717|102252723|FG001|Overall Study|Death|1|||
33645246|NCT01120717|102252722|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
33645247|NCT01120717|102252723|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
33645248|NCT00782834|102252724|FG000|Treatment Phase|fibrous tumor not GIST|1|||
33584213|NCT02707965|102028901|FG014|Overall Study|Protocol deviation|0|||
33584214|NCT02707965|102028902|FG015|Overall Study|Protocol deviation|0|||
33584215|NCT03028129|102028905|FG000|Overall Study|Adverse Event|13|||
33584216|NCT03028129|102028906|FG001|Overall Study|Adverse Event|2|||
33584217|NCT03028129|102028905|FG000|Overall Study|Lost to Follow-up|50|||
33584218|NCT03028129|102028906|FG001|Overall Study|Lost to Follow-up|38|||
33584219|NCT03028129|102028905|FG000|Overall Study|Physician Decision|0|||
33584220|NCT03028129|102028906|FG001|Overall Study|Physician Decision|1|||
33245724|NCT04984876|100800195|FG001|Overall Study|Subject decision|10|||
33245725|NCT04984876|100800196|FG002|Overall Study|Subject decision|3|||
33245726|NCT04984876|100800197|FG003|Overall Study|Subject decision|3|||
33245727|NCT04984876|100800198|FG004|Overall Study|Subject decision|3|||
33245728|NCT04984876|100800199|FG005|Overall Study|Subject decision|0|||
33245729|NCT04984876|100800194|FG000|Overall Study|Guardian decision|0|||
33245730|NCT04984876|100800195|FG001|Overall Study|Guardian decision|1|||
33245731|NCT04984876|100800196|FG002|Overall Study|Guardian decision|0|||
33245732|NCT04984876|100800197|FG003|Overall Study|Guardian decision|2|||
33245733|NCT04984876|100800198|FG004|Overall Study|Guardian decision|0|||
33245734|NCT04984876|100800199|FG005|Overall Study|Guardian decision|1|||
33423323|NCT00736099|101439905|FG001|Overall Study|Lost to Follow-up|5|||
33245735|NCT04984876|100800194|FG000|Overall Study|Lost to Follow-up|0|||
33245736|NCT04984876|100800195|FG001|Overall Study|Lost to Follow-up|0|||
33245737|NCT04984876|100800196|FG002|Overall Study|Lost to Follow-up|1|||
33245738|NCT04984876|100800197|FG003|Overall Study|Lost to Follow-up|1|||
33245739|NCT04984876|100800198|FG004|Overall Study|Lost to Follow-up|0|||
33245740|NCT04984876|100800199|FG005|Overall Study|Lost to Follow-up|0|||
33245741|NCT04984876|100800194|FG000|Overall Study|Physician Decision|1|||
33245742|NCT04984876|100800195|FG001|Overall Study|Physician Decision|0|||
33245743|NCT04984876|100800196|FG002|Overall Study|Physician Decision|0|||
33245744|NCT04984876|100800197|FG003|Overall Study|Physician Decision|1|||
33245745|NCT04984876|100800198|FG004|Overall Study|Physician Decision|0|||
33245746|NCT04984876|100800199|FG005|Overall Study|Physician Decision|0|||
33245747|NCT04984876|100800194|FG000|Overall Study|Adverse Event|0|||
33245748|NCT04984876|100800195|FG001|Overall Study|Adverse Event|0|||
33245749|NCT04984876|100800196|FG002|Overall Study|Adverse Event|1|||
33245750|NCT04984876|100800197|FG003|Overall Study|Adverse Event|0|||
33245751|NCT04984876|100800198|FG004|Overall Study|Adverse Event|0|||
33245752|NCT04984876|100800199|FG005|Overall Study|Adverse Event|0|||
33245753|NCT01240356|100800202|FG000|Overall Study|Withdrawal by Subject|2|||
33245754|NCT01240356|100800203|FG001|Overall Study|Withdrawal by Subject|0|||
33245755|NCT01240356|100800202|FG000|Overall Study|MRI contraindication|1|||
33373626|NCT01025817|101255948|FG001|Completed Study Medication|Withdrawal by Subject|9|||
33373627|NCT01025817|101255947|FG000|Completed Study Medication|Administrative problems|7|||
33373628|NCT01025817|101255948|FG001|Completed Study Medication|Administrative problems|5|||
33373629|NCT01025817|101255947|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
33373630|NCT01025817|101255948|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
33373631|NCT01025817|101255947|FG000|Completed Study Medication|Abnormal test procedure|4|||
33373632|NCT01025817|101255948|FG001|Completed Study Medication|Abnormal test procedure|0|||
33373633|NCT01025817|101255947|FG000|Completed Study Medication|Graft loss|2|||
33373634|NCT01025817|101255948|FG001|Completed Study Medication|Graft loss|5|||
33373635|NCT01025817|101255947|FG000|Completed Study Medication|Death|2|||
33373636|NCT01025817|101255948|FG001|Completed Study Medication|Death|2|||
33373637|NCT01025817|101255947|FG000|Completed Study Medication|Abnormal lab values|0|||
33373638|NCT01025817|101255948|FG001|Completed Study Medication|Abnormal lab values|2|||
33373639|NCT01025817|101255947|FG000|Completed Study Medication|Subject no longer required study drug|0|||
33373640|NCT01025817|101255948|FG001|Completed Study Medication|Subject no longer required study drug|1|||
33373641|NCT01025817|101255947|FG000|Completed Study Medication|Lost to Follow-up|0|||
33373642|NCT01025817|101255948|FG001|Completed Study Medication|Lost to Follow-up|1|||
33423324|NCT00736099|101439904|FG000|Overall Study|Withdrawal by Subject|42|||
33423325|NCT00736099|101439905|FG001|Overall Study|Withdrawal by Subject|13|||
33423326|NCT00736099|101439904|FG000|Overall Study|Lack of Efficacy|15|||
33423327|NCT00736099|101439905|FG001|Overall Study|Lack of Efficacy|8|||
33423328|NCT00736099|101439904|FG000|Overall Study|Other reason|43|||
33423329|NCT00736099|101439905|FG001|Overall Study|Other reason|10|||
33423330|NCT00895583|101439908|FG000|Overall Study|Adverse Event|28|||
33423331|NCT00895583|101439909|FG001|Overall Study|Adverse Event|4|||
33423332|NCT00895583|101439908|FG000|Overall Study|Death|2|||
33423333|NCT00895583|101439909|FG001|Overall Study|Death|1|||
33423334|NCT00895583|101439908|FG000|Overall Study|Physician Decision|3|||
33423335|NCT00895583|101439909|FG001|Overall Study|Physician Decision|1|||
33423336|NCT00895583|101439908|FG000|Overall Study|Lost to Follow-up|1|||
33423337|NCT00895583|101439909|FG001|Overall Study|Lost to Follow-up|3|||
33423338|NCT00895583|101439908|FG000|Overall Study|Protocol Violation|1|||
33245756|NCT01240356|100800203|FG001|Overall Study|MRI contraindication|0|||
33245757|NCT02242942|100800204|FG000|Overall Study|Death|17|||
33373643|NCT01025817|101255947|FG000|Completed Study|Withdrawal by Subject|8|||
33373644|NCT01025817|101255948|FG001|Completed Study|Withdrawal by Subject|16|||
33245758|NCT02242942|100800205|FG001|Overall Study|Death|20|||
33245759|NCT02242942|100800206|FG002|Overall Study|Death|2|||
33245760|NCT02242942|100800204|FG000|Overall Study|Physician Decision|1|||
33245761|NCT02242942|100800205|FG001|Overall Study|Physician Decision|0|||
33245762|NCT02242942|100800206|FG002|Overall Study|Physician Decision|0|||
33373645|NCT01025817|101255947|FG000|Completed Study|Death|6|||
33423339|NCT00895583|101439909|FG001|Overall Study|Protocol Violation|0|||
33423340|NCT00895583|101439908|FG000|Overall Study|Withdrawal by Subject|4|||
33423341|NCT00895583|101439909|FG001|Overall Study|Withdrawal by Subject|2|||
33245763|NCT02242942|100800204|FG000|Overall Study|Withdrawal by Subject|8|||
33245764|NCT02242942|100800205|FG001|Overall Study|Withdrawal by Subject|10|||
33245765|NCT02242942|100800206|FG002|Overall Study|Withdrawal by Subject|0|||
33423342|NCT00895583|101439908|FG000|Overall Study|Lack of Efficacy|5|||
33423343|NCT00895583|101439909|FG001|Overall Study|Lack of Efficacy|0|||
33423344|NCT00895583|101439908|FG000|Overall Study|Other|0|||
33423345|NCT00895583|101439909|FG001|Overall Study|Other|1|||
33423346|NCT02496221|101439910|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
33423347|NCT02496221|101439911|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
33423348|NCT02496221|101439910|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
33423349|NCT02496221|101439911|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
33423350|NCT02496221|101439910|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
33423351|NCT02496221|101439911|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
33423352|NCT01946282|101439912|FG000|Year 1|Did not return FIT kit|4186|||
33423353|NCT01946282|101439913|FG001|Year 1|Did not return FIT kit|608|||
33423354|NCT01946282|101439914|FG002|Year 1|Did not return FIT kit|654|||
33423355|NCT01946282|101439912|FG000|Year 2|Did not return FIT kit|803|||
33423356|NCT01946282|101439913|FG001|Year 2|Did not return FIT kit|131|||
33423357|NCT01946282|101439914|FG002|Year 2|Did not return FIT kit|115|||
33423358|NCT01946282|101439912|FG000|Year 3|Did not return FIT kit|288|||
33423359|NCT01946282|101439913|FG001|Year 3|Did not return FIT kit|43|||
33423360|NCT01946282|101439914|FG002|Year 3|Did not return FIT kit|30|||
33423361|NCT01614925|101439915|FG000|Overall Study|Withdrawal by Subject|1|||
33423362|NCT01614925|101439916|FG001|Overall Study|Withdrawal by Subject|0|||
33423363|NCT01614925|101439915|FG000|Overall Study|Protocol Violation|3|||
33423364|NCT01614925|101439916|FG001|Overall Study|Protocol Violation|2|||
33423365|NCT01011907|101439918|FG000|Overall Study|Withdrawal by Subject|13|||
33423366|NCT01011907|101439919|FG001|Overall Study|Withdrawal by Subject|11|||
33423367|NCT01011907|101439918|FG000|Overall Study|Adverse Event|1|||
33423368|NCT01011907|101439919|FG001|Overall Study|Adverse Event|4|||
33423369|NCT01619085|101439920|FG000|Overall Study|Adverse Event|231|||
33423370|NCT01619085|101439920|FG000|Overall Study|Protocol Violation|4|||
33423371|NCT01619085|101439920|FG000|Overall Study|Lost to Follow-up|3|||
33423372|NCT01619085|101439920|FG000|Overall Study|Withdrawal by Subject|45|||
33423373|NCT01619085|101439920|FG000|Overall Study|Other than specified|96|||
33423374|NCT01619085|101439920|FG000|Overall Study|Not treated|1|||
33423375|NCT01619085|101439920|FG000|Overall Study|Death|145|||
33423376|NCT01201356|101439922|FG000|Overall Study|Adverse Event|170|||
33584221|NCT03028129|102028905|FG000|Overall Study|Protocol Violation|1|||
33584222|NCT03028129|102028906|FG001|Overall Study|Protocol Violation|1|||
33584223|NCT03028129|102028905|FG000|Overall Study|Withdrawal by Subject|62|||
33584224|NCT03028129|102028906|FG001|Overall Study|Withdrawal by Subject|45|||
33584225|NCT04830215|102028907|FG000|Overall Study|Adverse Event|6|||
33645249|NCT00862641|102252725|FG000|Overall Study|Randomized, but drug not received|1|||
33245766|NCT02242942|100800204|FG000|Overall Study|On-going in Study|190|||
33245767|NCT02242942|100800205|FG001|Overall Study|On-going in Study|186|||
33245768|NCT02242942|100800206|FG002|Overall Study|On-going in Study|11|||
33245769|NCT04109118|100800210|FG000|Overall Study|Lost to Follow-up|3|||
33245770|NCT05074498|100800211|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
33245771|NCT05074498|100800212|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
33245772|NCT05074498|100800213|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
33245773|NCT05074498|100800214|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
33245774|NCT05074498|100800215|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
33373646|NCT01025817|101255948|FG001|Completed Study|Death|5|||
33373647|NCT01025817|101255947|FG000|Completed Study|Missing|2|||
33373648|NCT01025817|101255948|FG001|Completed Study|Missing|0|||
33373649|NCT01025817|101255947|FG000|Completed Study|Lost to Follow-up|0|||
33373650|NCT01025817|101255948|FG001|Completed Study|Lost to Follow-up|1|||
33373651|NCT00632541|101255949|FG000|Overall Study|Adverse Event|7|||
33373652|NCT03699631|101255950|FG000|Overall Study|Adverse Event|3|||
33373653|NCT04863014|101255951|FG000|Overall Study|Lost to Follow-up|3|||
33373654|NCT04863014|101255952|FG001|Overall Study|Lost to Follow-up|2|||
33373655|NCT04863014|101255951|FG000|Overall Study|Subject Decision|0|||
33373656|NCT04863014|101255952|FG001|Overall Study|Subject Decision|4|||
33245775|NCT05074498|100800216|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
33245776|NCT05074498|100800211|FG000|Part 1 (Upto Day 104)|Other|1|||
33245777|NCT05074498|100800212|FG001|Part 1 (Upto Day 104)|Other|0|||
33373657|NCT04263142|101255955|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
33373658|NCT04263142|101255956|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
33373659|NCT04263142|101255957|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
33423377|NCT01201356|101439922|FG000|Overall Study|Abnormal laboratory value(s)|51|||
33423378|NCT01201356|101439922|FG000|Overall Study|Abnormal test procedure result(s)|3|||
33423379|NCT01201356|101439922|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
33373660|NCT04263142|101255958|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
33423380|NCT01201356|101439922|FG000|Overall Study|Condition no longer requires study drug|12|||
33423381|NCT01201356|101439922|FG000|Overall Study|Withdrawal by Subject|144|||
33423382|NCT01201356|101439922|FG000|Overall Study|Lost to Follow-up|50|||
33584226|NCT04830215|102028907|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
33645250|NCT00862641|102252726|FG001|Overall Study|Randomized, but drug not received|4|||
33645251|NCT00862641|102252727|FG002|Overall Study|Randomized, but drug not received|1|||
33645252|NCT00862641|102252728|FG003|Overall Study|Randomized, but drug not received|4|||
33645253|NCT00796991|102252729|FG000|Overall Study|Adverse Event|0|||
33645254|NCT00796991|102252730|FG001|Overall Study|Adverse Event|0|||
33645255|NCT00796991|102252731|FG002|Overall Study|Adverse Event|1|||
33645256|NCT00796991|102252729|FG000|Overall Study|Death|2|||
33645257|NCT00796991|102252730|FG001|Overall Study|Death|0|||
33645258|NCT00796991|102252731|FG002|Overall Study|Death|0|||
33645259|NCT00796991|102252729|FG000|Overall Study|Disease Progression|10|||
33645260|NCT00796991|102252730|FG001|Overall Study|Disease Progression|9|||
33645261|NCT00796991|102252731|FG002|Overall Study|Disease Progression|7|||
33645262|NCT00796991|102252729|FG000|Overall Study|Study Drug Toxicity|3|||
33645263|NCT00796991|102252730|FG001|Overall Study|Study Drug Toxicity|3|||
33645264|NCT00796991|102252731|FG002|Overall Study|Study Drug Toxicity|5|||
33645265|NCT00796991|102252729|FG000|Overall Study|Withdrawal by Subject|0|||
33645266|NCT00796991|102252730|FG001|Overall Study|Withdrawal by Subject|0|||
33645267|NCT00796991|102252731|FG002|Overall Study|Withdrawal by Subject|1|||
33645268|NCT02032238|102252734|FG000|Overall Study|Lost to Follow-up|2|||
33645269|NCT02032238|102252735|FG001|Overall Study|Lost to Follow-up|0|||
33645270|NCT03544333|102252744|FG000|Overall Study|Withdrawal by Subject|1|||
33645271|NCT03544333|102252745|FG001|Overall Study|Withdrawal by Subject|0|||
33645272|NCT03865381|102252747|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
33645273|NCT03865381|102252747|FG000|Overall Study|Withdrawal by Subject|2|||
33645274|NCT02067676|102252750|FG000|Overall Study|Withdrawal by Subject|1|||
33645275|NCT02067676|102252751|FG001|Overall Study|Withdrawal by Subject|0|||
33645276|NCT02067676|102252752|FG002|Overall Study|Withdrawal by Subject|0|||
33645277|NCT02067676|102252753|FG003|Overall Study|Withdrawal by Subject|0|||
33645278|NCT02067676|102252754|FG004|Overall Study|Withdrawal by Subject|0|||
33645279|NCT02067676|102252755|FG005|Overall Study|Withdrawal by Subject|0|||
33645280|NCT00314795|102252756|FG000|Overall Study|Adverse Event|8|||
33645281|NCT00314795|102252756|FG000|Overall Study|Death|4|||
33645282|NCT00314795|102252756|FG000|Overall Study|Reason not Specified|3|||
33645283|NCT00314795|102252756|FG000|Overall Study|Renal Transplant|3|||
33645284|NCT00314795|102252756|FG000|Overall Study|Participants Withdrew Consent|2|||
33645285|NCT03672097|102252757|FG000|Period 1|Withdrawal by Subject|2|||
33645286|NCT03672097|102252757|FG000|Period 1|Adverse Event|1|||
33645287|NCT03672097|102252757|FG000|Period 1|Did not receive treatment|1|||
33645288|NCT03672097|102252757|FG000|Period 2|Withdrawal by Subject|3|||
33645289|NCT03672097|102252757|FG000|Period 2|Other|1|||
33645290|NCT02978781|102252758|FG000|Part A|Adverse Event|1|||
33645291|NCT02978781|102252759|FG001|Part A|Adverse Event|1|||
33645292|NCT02978781|102252760|FG002|Part A|Adverse Event|0|||
33645293|NCT02978781|102252761|FG003|Part A|Adverse Event|0|||
33645294|NCT02978781|102252762|FG004|Part A|Adverse Event|0|||
33645295|NCT02978781|102252758|FG000|Part A|Withdrawal by Subject|0|||
33645296|NCT02978781|102252759|FG001|Part A|Withdrawal by Subject|1|||
33645297|NCT02978781|102252760|FG002|Part A|Withdrawal by Subject|0|||
33645298|NCT02978781|102252761|FG003|Part A|Withdrawal by Subject|0|||
33645299|NCT02978781|102252762|FG004|Part A|Withdrawal by Subject|0|||
33645300|NCT02978781|102252758|FG000|Part B|Withdrawal by Subject|0|||
33645301|NCT02978781|102252759|FG001|Part B|Withdrawal by Subject|0|||
33645302|NCT02978781|102252760|FG002|Part B|Withdrawal by Subject|0|||
33645303|NCT02978781|102252761|FG003|Part B|Withdrawal by Subject|1|||
33645304|NCT02978781|102252762|FG004|Part B|Withdrawal by Subject|0|||
33645305|NCT02978781|102252758|FG000|Part C|Adverse Event|0|||
33645306|NCT02978781|102252759|FG001|Part C|Adverse Event|0|||
33147535|NCT03822468|100454372|FG001|Treatment Period|Patient decision|5|||
33147536|NCT03822468|100454371|FG000|Treatment Period|Physician Decision|4|||
33245778|NCT05074498|100800213|FG002|Part 1 (Upto Day 104)|Other|0|||
33423383|NCT01201356|101439922|FG000|Overall Study|administrative problems|74|||
33645307|NCT02978781|102252760|FG002|Part C|Adverse Event|0|||
33645308|NCT02978781|102252761|FG003|Part C|Adverse Event|0|||
33645309|NCT02978781|102252762|FG004|Part C|Adverse Event|2|||
33147537|NCT03822468|100454372|FG001|Treatment Period|Physician Decision|5|||
33423384|NCT01201356|101439922|FG000|Overall Study|Death|16|||
33645310|NCT02978781|102252758|FG000|Part C|Withdrawal by Subject|0|||
33645311|NCT02978781|102252759|FG001|Part C|Withdrawal by Subject|0|||
33645312|NCT02978781|102252760|FG002|Part C|Withdrawal by Subject|0|||
33645313|NCT02978781|102252761|FG003|Part C|Withdrawal by Subject|0|||
33645314|NCT02978781|102252762|FG004|Part C|Withdrawal by Subject|1|||
33645315|NCT02978781|102252758|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
33645316|NCT02978781|102252759|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
33645317|NCT02978781|102252760|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
33147538|NCT03822468|100454371|FG000|Treatment Period|Protocol deviation|2|||
33645318|NCT02978781|102252761|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
33645319|NCT02978781|102252762|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
33645320|NCT02314637|102252770|FG000|Overall Study|Adverse Event|4|||
33645321|NCT02314637|102252771|FG001|Overall Study|Adverse Event|8|||
33147539|NCT03822468|100454372|FG001|Treatment Period|Protocol deviation|1|||
33147540|NCT03822468|100454371|FG000|Treatment Period|Death|1|||
33147541|NCT03822468|100454372|FG001|Treatment Period|Death|1|||
33147542|NCT03822468|100454371|FG000|Treatment Period|Lost to Follow-up|1|||
33147543|NCT03822468|100454372|FG001|Treatment Period|Lost to Follow-up|0|||
33147544|NCT03822468|100454371|FG000|Post-treatment Efficacy Follow-up|Continue to be followed in post-treatment efficacy follow-up at the data cut-off date (11-Jun-2021)|12|||
33147545|NCT03822468|100454372|FG001|Post-treatment Efficacy Follow-up|Continue to be followed in post-treatment efficacy follow-up at the data cut-off date (11-Jun-2021)|13|||
33147546|NCT03822468|100454371|FG000|Post-treatment Efficacy Follow-up|Progressive disease|3|||
33147547|NCT03822468|100454372|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
33147548|NCT03822468|100454371|FG000|Post-treatment Efficacy Follow-up|Patient decision|3|||
33147549|NCT03822468|100454372|FG001|Post-treatment Efficacy Follow-up|Patient decision|1|||
33147550|NCT03822468|100454371|FG000|Post-treatment Efficacy Follow-up|Death|1|||
33147551|NCT03822468|100454372|FG001|Post-treatment Efficacy Follow-up|Death|0|||
33147552|NCT03822468|100454371|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
33147553|NCT03822468|100454372|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
33147554|NCT01041495|100454382|FG000|Overall Study|Withdrawal by Subject|2|||
33147555|NCT01041495|100454383|FG001|Overall Study|Withdrawal by Subject|5|||
33147556|NCT01041495|100454382|FG000|Overall Study|Adverse Event|2|||
33147557|NCT01041495|100454383|FG001|Overall Study|Adverse Event|1|||
33147558|NCT01041495|100454382|FG000|Overall Study|Lost to Follow-up|0|||
33147559|NCT01041495|100454383|FG001|Overall Study|Lost to Follow-up|1|||
33147560|NCT02278341|100454385|FG000|Overall Study|Randomized but never received study drug|1|||
33147561|NCT02278341|100454386|FG001|Overall Study|Randomized but never received study drug|1|||
33147562|NCT02278341|100454385|FG000|Overall Study|Adverse Event|3|||
33147563|NCT02278341|100454386|FG001|Overall Study|Adverse Event|0|||
33147564|NCT02278341|100454385|FG000|Overall Study|Death|68|||
33147565|NCT02278341|100454386|FG001|Overall Study|Death|56|||
33147566|NCT02278341|100454385|FG000|Overall Study|Withdrawal by Subject|30|||
33147567|NCT02278341|100454386|FG001|Overall Study|Withdrawal by Subject|19|||
33147568|NCT02278341|100454385|FG000|Overall Study|Lost to Follow-up|0|||
33147569|NCT02278341|100454386|FG001|Overall Study|Lost to Follow-up|1|||
33147570|NCT02278341|100454385|FG000|Overall Study|Physician Decision|1|||
33147571|NCT02278341|100454386|FG001|Overall Study|Physician Decision|1|||
33147572|NCT02278341|100454385|FG000|Overall Study|Miscellaneous|15|||
33147573|NCT02278341|100454386|FG001|Overall Study|Miscellaneous|14|||
33147574|NCT04982588|100454387|FG000|Overall Study|Withdrawal by Subject|2|||
33147575|NCT03882008|100454391|FG000|Overall Study|Withdrawal by Subject|1|||
33245779|NCT05074498|100800214|FG003|Part 1 (Upto Day 104)|Other|0|||
33245780|NCT05074498|100800215|FG004|Part 1 (Upto Day 104)|Other|0|||
33245781|NCT05074498|100800216|FG005|Part 1 (Upto Day 104)|Other|0|||
33584227|NCT04830215|102028907|FG000|Overall Study|Withdrawal by Subject|3|||
33584228|NCT04830215|102028907|FG000|Overall Study|Protocol Deviation|1|||
33584229|NCT02316353|102028908|FG000|Overall Study|Pregnancy|1|||
33584230|NCT02316353|102028909|FG001|Overall Study|Pregnancy|3|||
33584231|NCT02316353|102028908|FG000|Overall Study|Adverse Event|1|||
33584232|NCT02316353|102028909|FG001|Overall Study|Adverse Event|3|||
33584233|NCT02316353|102028908|FG000|Overall Study|Withdrawal by Subject|6|||
33584234|NCT02316353|102028909|FG001|Overall Study|Withdrawal by Subject|2|||
33584235|NCT01048242|102028916|FG000|Overall Study|See study flow chart|4|||
33584236|NCT01048242|102028917|FG001|Overall Study|See study flow chart|2|||
33584237|NCT01916824|102028918|FG000|Overall Study|Lost to Follow-up|3|||
33584238|NCT01916824|102028919|FG001|Overall Study|Lost to Follow-up|6|||
33584239|NCT01916824|102028918|FG000|Overall Study|Physician Decision|2|||
33645322|NCT02314637|102252770|FG000|Overall Study|Lack of Efficacy|1|||
33645323|NCT02314637|102252771|FG001|Overall Study|Lack of Efficacy|0|||
33645324|NCT02314637|102252770|FG000|Overall Study|Physician Decision|5|||
33645325|NCT02314637|102252771|FG001|Overall Study|Physician Decision|2|||
33645326|NCT02314637|102252770|FG000|Overall Study|Withdrawal by Subject|5|||
33645327|NCT02314637|102252771|FG001|Overall Study|Withdrawal by Subject|4|||
33645328|NCT02314637|102252770|FG000|Overall Study|Other Reason|1|||
33645329|NCT02314637|102252771|FG001|Overall Study|Other Reason|0|||
33645330|NCT00790088|102252772|FG000|Overall Study|Protocol Violation|11|||
33645331|NCT00790088|102252772|FG000|Overall Study|Withdrawal by Subject|17|||
33645332|NCT00790088|102252772|FG000|Overall Study|Lost to Follow-up|7|||
33645333|NCT00790088|102252772|FG000|Overall Study|Physician Decision|4|||
33645334|NCT03180840|102252773|FG000|Overall Study|Withdrawal by Subject|1|||
33645335|NCT01601652|102252774|FG000|Overall Study|Death|1|||
33645336|NCT01837823|102252776|FG000|Overall Study|Lost to Follow-up|6|||
33645337|NCT01802073|102252782|FG000|Overall Study|Lost to Follow-up|0|||
33147576|NCT03882008|100454391|FG000|Overall Study|Lost to Follow-up|1|||
33645338|NCT01802073|102252783|FG001|Overall Study|Lost to Follow-up|1|||
33584240|NCT01916824|102028919|FG001|Overall Study|Physician Decision|0|||
33645339|NCT01802073|102252782|FG000|Overall Study|Non-compliant|4|||
33645340|NCT01802073|102252783|FG001|Overall Study|Non-compliant|2|||
33584241|NCT01916824|102028918|FG000|Overall Study|Withdrawal by Subject|2|||
33645341|NCT01802073|102252782|FG000|Overall Study|Withdrawal by Subject|1|||
33645342|NCT01802073|102252783|FG001|Overall Study|Withdrawal by Subject|1|||
33645343|NCT01802073|102252782|FG000|Overall Study|Physician Decision|0|||
33645344|NCT01802073|102252783|FG001|Overall Study|Physician Decision|7|||
33645345|NCT00481091|102252784|FG000|Overall Study|Withdrawal by Subject|0|||
33645346|NCT00481091|102252785|FG001|Overall Study|Withdrawal by Subject|1|||
33645347|NCT00481091|102252786|FG002|Overall Study|Withdrawal by Subject|1|||
33645348|NCT00481091|102252787|FG003|Overall Study|Withdrawal by Subject|0|||
33645349|NCT00481091|102252788|FG004|Overall Study|Withdrawal by Subject|0|||
33645350|NCT00481091|102252789|FG005|Overall Study|Withdrawal by Subject|0|||
33645351|NCT00481091|102252790|FG006|Overall Study|Withdrawal by Subject|0|||
33645352|NCT00481091|102252791|FG007|Overall Study|Withdrawal by Subject|0|||
33645353|NCT00481091|102252792|FG008|Overall Study|Withdrawal by Subject|1|||
33645354|NCT00481091|102252793|FG009|Overall Study|Withdrawal by Subject|6|||
33645355|NCT00481091|102252784|FG000|Overall Study|Other, Not Specified|0|||
33645356|NCT00481091|102252785|FG001|Overall Study|Other, Not Specified|1|||
33645357|NCT00481091|102252786|FG002|Overall Study|Other, Not Specified|1|||
33645358|NCT00481091|102252787|FG003|Overall Study|Other, Not Specified|0|||
33645359|NCT00481091|102252788|FG004|Overall Study|Other, Not Specified|0|||
33645360|NCT00481091|102252789|FG005|Overall Study|Other, Not Specified|1|||
33645361|NCT00481091|102252790|FG006|Overall Study|Other, Not Specified|0|||
33645362|NCT00481091|102252791|FG007|Overall Study|Other, Not Specified|0|||
33645363|NCT00481091|102252792|FG008|Overall Study|Other, Not Specified|0|||
33645364|NCT00481091|102252793|FG009|Overall Study|Other, Not Specified|4|||
33147577|NCT03187756|100454392|FG000|Overall Study|Termination of study|4|||
33147578|NCT00995865|100454394|FG000|Overall Study|Protocol Violation|2|||
33423385|NCT01201356|101439922|FG000|Overall Study|Protocol Violation|12|||
33584242|NCT01916824|102028919|FG001|Overall Study|Withdrawal by Subject|3|||
33584243|NCT03782259|102028920|FG000|Overall Study|Lost to Follow-up|1|||
33584244|NCT03782259|102028921|FG001|Overall Study|Lost to Follow-up|1|||
33584245|NCT03782259|102028920|FG000|Overall Study|Moved out of state|0|||
33584246|NCT03782259|102028921|FG001|Overall Study|Moved out of state|2|||
33584247|NCT03782259|102028920|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
33584248|NCT03782259|102028921|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
33584249|NCT03782259|102028920|FG000|Overall Study|Subject discontinued intervention|1|||
33584250|NCT03782259|102028921|FG001|Overall Study|Subject discontinued intervention|0|||
33584251|NCT02366923|102028922|FG000|Overall Study|Withdrawal by Subject|1|||
33584252|NCT02366923|102028922|FG000|Overall Study|Positive Slit Lamp Findings|2|||
33584253|NCT02366923|102028922|FG000|Overall Study|High Astigmatism|3|||
33584254|NCT02038946|102028923|FG000|Overall Study|Death|5|||
33584255|NCT02038946|102028923|FG000|Overall Study|Withdrawal by Subject|3|||
33584256|NCT02038946|102028923|FG000|Overall Study|Lost to Follow-up|2|||
33584257|NCT02038946|102028923|FG000|Overall Study|Other reasons|2|||
33584258|NCT03050450|102028924|FG000|Overall Study|Physician Decision|1|||
33584259|NCT03050450|102028925|FG001|Overall Study|Physician Decision|0|||
33584260|NCT03050450|102028926|FG002|Overall Study|Physician Decision|0|||
33584261|NCT03050450|102028927|FG003|Overall Study|Physician Decision|0|||
33584262|NCT03050450|102028928|FG004|Overall Study|Physician Decision|0|||
33584263|NCT00322049|102028929|FG000|Overall Study|Moved out of area|0|||
33584264|NCT00322049|102028930|FG001|Overall Study|Moved out of area|0|||
33584265|NCT00322049|102028931|FG002|Overall Study|Moved out of area|0|||
33584266|NCT00322049|102028932|FG003|Overall Study|Moved out of area|1|||
33584267|NCT00322049|102028929|FG000|Overall Study|Infected with Dengue during study|0|||
33584268|NCT00322049|102028930|FG001|Overall Study|Infected with Dengue during study|1|||
33584269|NCT00322049|102028931|FG002|Overall Study|Infected with Dengue during study|0|||
33584270|NCT00322049|102028932|FG003|Overall Study|Infected with Dengue during study|0|||
33584271|NCT04245449|102028935|FG000|Overall Study|COVID shutdown|7|||
33584272|NCT03299244|102028938|FG000|Overall Study|Withdrawal by Subject|34|||
33584273|NCT03299244|102028939|FG001|Overall Study|Withdrawal by Subject|29|||
33584274|NCT03299244|102028938|FG000|Overall Study|Decision by Sponsor|4|||
33584275|NCT03299244|102028939|FG001|Overall Study|Decision by Sponsor|5|||
33584276|NCT03299244|102028938|FG000|Overall Study|Death|9|||
33584277|NCT03299244|102028939|FG001|Overall Study|Death|4|||
33584278|NCT01823198|102028940|FG000|Overall Study|Physician Decision|0|||
33584279|NCT01823198|102028941|FG001|Overall Study|Physician Decision|1|||
33584280|NCT01823198|102028942|FG002|Overall Study|Physician Decision|0|||
33584281|NCT01823198|102028943|FG003|Overall Study|Physician Decision|0|||
33584282|NCT01823198|102028944|FG004|Overall Study|Physician Decision|0|||
33584283|NCT01823198|102028945|FG005|Overall Study|Physician Decision|3|||
33645365|NCT00481091|102252784|FG000|Overall Study|Adverse Event|1|||
33147579|NCT00995865|100454395|FG001|Overall Study|Protocol Violation|0|||
33584284|NCT01823198|102028946|FG006|Overall Study|Physician Decision|3|||
33584285|NCT01061723|102028958|FG000|Overall Study|Adverse Event|0|||
33584286|NCT01061723|102028959|FG001|Overall Study|Adverse Event|2|||
33584287|NCT01061723|102028960|FG002|Overall Study|Adverse Event|5|||
33584288|NCT01061723|102028961|FG003|Overall Study|Adverse Event|5|||
33584289|NCT01061723|102028962|FG004|Overall Study|Adverse Event|2|||
33584290|NCT01061723|102028963|FG005|Overall Study|Adverse Event|6|||
33423386|NCT01375010|101439923|FG000|Overall Study|Lost to Follow-up|8|||
33423387|NCT01375010|101439924|FG001|Overall Study|Lost to Follow-up|2|||
33423388|NCT01375010|101439923|FG000|Overall Study|Withdrawal by Subject|4|||
33423389|NCT01375010|101439924|FG001|Overall Study|Withdrawal by Subject|2|||
33423390|NCT02236754|101439925|FG000|Overall Study|Withdrawal by Subject|1|||
33423391|NCT02236754|101439926|FG001|Overall Study|Withdrawal by Subject|0|||
33423392|NCT00678379|101439927|FG000|Overall Study|Injection performed after tonsillectomy|2|||
33423393|NCT00678379|101439928|FG001|Overall Study|Injection performed after tonsillectomy|0|||
33423394|NCT00678379|101439929|FG002|Overall Study|Injection performed after tonsillectomy|1|||
33423395|NCT00678379|101439927|FG000|Overall Study|Incomplete Data|4|||
33423396|NCT00678379|101439928|FG001|Overall Study|Incomplete Data|3|||
33423397|NCT00678379|101439929|FG002|Overall Study|Incomplete Data|3|||
33423398|NCT04071626|101439942|FG000|Overall Study|Withdrawal by Subject|1|||
33423399|NCT04071626|101439943|FG001|Overall Study|Withdrawal by Subject|1|||
33423400|NCT04071626|101439942|FG000|Overall Study|Protocol Violation|0|||
33423401|NCT04071626|101439943|FG001|Overall Study|Protocol Violation|1|||
33584291|NCT01061723|102028958|FG000|Overall Study|Lack of Efficacy|2|||
33584292|NCT01061723|102028959|FG001|Overall Study|Lack of Efficacy|3|||
33645366|NCT00481091|102252785|FG001|Overall Study|Adverse Event|2|||
33645367|NCT00481091|102252786|FG002|Overall Study|Adverse Event|0|||
33584293|NCT01061723|102028960|FG002|Overall Study|Lack of Efficacy|4|||
33584294|NCT01061723|102028961|FG003|Overall Study|Lack of Efficacy|2|||
33584295|NCT01061723|102028962|FG004|Overall Study|Lack of Efficacy|1|||
33584296|NCT01061723|102028963|FG005|Overall Study|Lack of Efficacy|1|||
33584297|NCT01061723|102028958|FG000|Overall Study|Randomized but not treated|0|||
33584298|NCT01061723|102028959|FG001|Overall Study|Randomized but not treated|0|||
33584299|NCT01061723|102028960|FG002|Overall Study|Randomized but not treated|0|||
33645368|NCT00481091|102252787|FG003|Overall Study|Adverse Event|1|||
33645369|NCT00481091|102252788|FG004|Overall Study|Adverse Event|1|||
33645370|NCT00481091|102252789|FG005|Overall Study|Adverse Event|1|||
33645371|NCT00481091|102252790|FG006|Overall Study|Adverse Event|2|||
33645372|NCT00481091|102252791|FG007|Overall Study|Adverse Event|1|||
33645373|NCT00481091|102252792|FG008|Overall Study|Adverse Event|1|||
33645374|NCT00481091|102252793|FG009|Overall Study|Adverse Event|6|||
33645375|NCT00481091|102252784|FG000|Overall Study|Progressive disease clinical|0|||
33245782|NCT05074498|100800211|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
33373661|NCT04263142|101255959|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
33373662|NCT04263142|101255955|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
33373663|NCT04263142|101255956|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
33373664|NCT04263142|101255957|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
33373665|NCT04263142|101255958|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
33373666|NCT04263142|101255959|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
33373667|NCT02142894|101255960|FG000|Overall Study|Protocol Violation|8|||
33373668|NCT03282357|101255971|FG000|Overall Study|Lost to Follow-up|3|||
33373669|NCT03282357|101255971|FG000|Overall Study|Withdrawal by Subject|4|||
33373670|NCT03282357|101255971|FG000|Overall Study|Adverse Event|1|||
33373671|NCT03282357|101255971|FG000|Overall Study|Other|9|||
33373672|NCT03136185|101255975|FG000|Overall Study|Adverse Event|0|||
33373673|NCT03136185|101255976|FG001|Overall Study|Adverse Event|1|||
33373674|NCT03136185|101255977|FG002|Overall Study|Adverse Event|3|||
33373675|NCT03136185|101255978|FG003|Overall Study|Adverse Event|1|||
33373676|NCT03136185|101255979|FG004|Overall Study|Adverse Event|2|||
33373677|NCT03136185|101255980|FG005|Overall Study|Adverse Event|2|||
33373678|NCT03136185|101255981|FG006|Overall Study|Adverse Event|5|||
33373679|NCT03136185|101255982|FG007|Overall Study|Adverse Event|1|||
33373680|NCT03136185|101255983|FG008|Overall Study|Adverse Event|1|||
33373681|NCT03136185|101255975|FG000|Overall Study|Death|0|||
33373682|NCT03136185|101255976|FG001|Overall Study|Death|0|||
33373683|NCT03136185|101255977|FG002|Overall Study|Death|0|||
33373684|NCT03136185|101255978|FG003|Overall Study|Death|1|||
33373685|NCT03136185|101255979|FG004|Overall Study|Death|1|||
33373686|NCT03136185|101255980|FG005|Overall Study|Death|0|||
33373687|NCT03136185|101255981|FG006|Overall Study|Death|1|||
33373688|NCT03136185|101255982|FG007|Overall Study|Death|0|||
33645376|NCT00481091|102252785|FG001|Overall Study|Progressive disease clinical|0|||
33645377|NCT00481091|102252786|FG002|Overall Study|Progressive disease clinical|0|||
33645378|NCT00481091|102252787|FG003|Overall Study|Progressive disease clinical|0|||
33373689|NCT03136185|101255983|FG008|Overall Study|Death|0|||
33373690|NCT03136185|101255975|FG000|Overall Study|Physician Decision|3|||
33373691|NCT03136185|101255976|FG001|Overall Study|Physician Decision|1|||
33423402|NCT03812679|101439944|FG000|Overall Study|Adverse Event|2|||
33373692|NCT03136185|101255977|FG002|Overall Study|Physician Decision|1|||
33373693|NCT03136185|101255978|FG003|Overall Study|Physician Decision|2|||
33373694|NCT03136185|101255979|FG004|Overall Study|Physician Decision|1|||
33373695|NCT03136185|101255980|FG005|Overall Study|Physician Decision|2|||
33373696|NCT03136185|101255981|FG006|Overall Study|Physician Decision|1|||
33373697|NCT03136185|101255982|FG007|Overall Study|Physician Decision|0|||
33423403|NCT03812679|101439944|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
33147580|NCT00995865|100454396|FG002|Overall Study|Protocol Violation|0|||
33147581|NCT00995865|100454394|FG000|Overall Study|Lost to Follow-up|0|||
33147582|NCT00995865|100454395|FG001|Overall Study|Lost to Follow-up|0|||
33147583|NCT00995865|100454396|FG002|Overall Study|Lost to Follow-up|1|||
33147584|NCT00880685|100454401|FG000|Memantine 10mg|Lost to Follow-up|2|||
33147585|NCT00880685|100454401|FG000|Memantine 20mg|Withdrawal by Subject|1|||
33147586|NCT04647253|100454402|FG000|Overall Study|Death ≤ 365 Days|16|||
33147587|NCT04647253|100454403|FG001|Overall Study|Death ≤ 365 Days|7|||
33147588|NCT04647253|100454402|FG000|Overall Study|Physician Decision|0|||
33147589|NCT04647253|100454403|FG001|Overall Study|Physician Decision|1|||
33147590|NCT04647253|100454402|FG000|Overall Study|Withdrawal by Subject|7|||
33147591|NCT04647253|100454403|FG001|Overall Study|Withdrawal by Subject|2|||
33147592|NCT04647253|100454402|FG000|Overall Study|Missed 12-Month Visit|9|||
33147593|NCT04647253|100454403|FG001|Overall Study|Missed 12-Month Visit|7|||
33147594|NCT04647253|100454402|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
33147595|NCT04647253|100454403|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
33147596|NCT04972630|100454407|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
33147597|NCT04972630|100454408|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
33147598|NCT04972630|100454409|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
33147599|NCT05291689|100454411|FG000|Overall Study|Adverse Event|3|||
33147600|NCT05291689|100454411|FG000|Overall Study|Lack of Efficacy|10|||
33147601|NCT05291689|100454411|FG000|Overall Study|Withdrawal by Subject|4|||
33147602|NCT03381274|100454414|FG000|Overall Study|Death|2|||
33147603|NCT03381274|100454415|FG001|Overall Study|Death|9|||
33147604|NCT03381274|100454416|FG002|Overall Study|Death|3|||
33147605|NCT03381274|100454417|FG003|Overall Study|Death|2|||
33373698|NCT03136185|101255983|FG008|Overall Study|Physician Decision|1|||
33147606|NCT03381274|100454418|FG004|Overall Study|Death|3|||
33147607|NCT03381274|100454414|FG000|Overall Study|Lost to Follow-up|0|||
33147608|NCT03381274|100454415|FG001|Overall Study|Lost to Follow-up|0|||
33147609|NCT03381274|100454416|FG002|Overall Study|Lost to Follow-up|0|||
33147610|NCT03381274|100454417|FG003|Overall Study|Lost to Follow-up|1|||
33147611|NCT03381274|100454418|FG004|Overall Study|Lost to Follow-up|0|||
33147612|NCT03381274|100454414|FG000|Overall Study|Withdrawal by Subject|2|||
33147613|NCT03381274|100454415|FG001|Overall Study|Withdrawal by Subject|1|||
33147614|NCT03381274|100454416|FG002|Overall Study|Withdrawal by Subject|3|||
33147615|NCT03381274|100454417|FG003|Overall Study|Withdrawal by Subject|1|||
33147616|NCT03381274|100454418|FG004|Overall Study|Withdrawal by Subject|0|||
33147617|NCT03381274|100454414|FG000|Overall Study|Other|1|||
33147618|NCT03381274|100454415|FG001|Overall Study|Other|11|||
33147619|NCT03381274|100454416|FG002|Overall Study|Other|0|||
33147620|NCT03381274|100454417|FG003|Overall Study|Other|2|||
33147621|NCT03381274|100454418|FG004|Overall Study|Other|2|||
33147622|NCT04597918|100454419|FG000|Overall Study|Withdrawal by Subject|6|||
33147623|NCT04597918|100454419|FG000|Overall Study|Lost to Follow-up|3|||
33147624|NCT04597918|100454419|FG000|Overall Study|Death|1|||
33147625|NCT01272661|100454424|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
33147626|NCT01272661|100454425|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
33147627|NCT01272661|100454426|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
33147628|NCT03410823|100454432|FG000|Overall Study|Death|1|||
33147629|NCT03410823|100454432|FG000|Overall Study|Withdrawal by Subject|2|||
33147630|NCT03410823|100454432|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
33147631|NCT01982331|100454433|FG000|Received Vaccination 2|Adverse Event|1|||
33147632|NCT01982331|100454434|FG001|Received Vaccination 2|Adverse Event|2|||
33147633|NCT01982331|100454433|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
33147634|NCT01982331|100454434|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
33147635|NCT01982331|100454433|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
33147636|NCT01982331|100454434|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
33147637|NCT02779855|100454435|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
33147638|NCT02779855|100454436|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
33147639|NCT02779855|100454437|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
33147640|NCT01483690|100454438|FG000|Overall Study|Adverse Event|1|||
33147641|NCT01483690|100454439|FG001|Overall Study|Adverse Event|2|||
33147642|NCT01483690|100454438|FG000|Overall Study|clinical deterioration|1|||
33147643|NCT01483690|100454439|FG001|Overall Study|clinical deterioration|0|||
33147644|NCT01483690|100454438|FG000|Overall Study|Physician Decision|0|||
33147645|NCT01483690|100454439|FG001|Overall Study|Physician Decision|2|||
33373699|NCT03136185|101255975|FG000|Overall Study|Protocol Defined Disease Progression|0|||
33373700|NCT03136185|101255976|FG001|Overall Study|Protocol Defined Disease Progression|0|||
33147646|NCT01483690|100454438|FG000|Overall Study|exclusionary procedure|0|||
33147647|NCT01483690|100454439|FG001|Overall Study|exclusionary procedure|1|||
33147648|NCT00749580|100454440|FG000|Overall Study|Lost to Follow-up|4|||
33147649|NCT00749580|100454441|FG001|Overall Study|Lost to Follow-up|8|||
33147650|NCT00749580|100454440|FG000|Overall Study|Adverse Event|0|||
33245783|NCT05074498|100800212|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
33147651|NCT00749580|100454441|FG001|Overall Study|Adverse Event|1|||
33147652|NCT03150810|100454442|FG000|Overall Study|Death|4|||
33147653|NCT03150810|100454443|FG001|Overall Study|Death|8|||
33147654|NCT03150810|100454444|FG002|Overall Study|Death|7|||
33423404|NCT03812679|101439944|FG000|Overall Study|Renal transplant|1|||
33423405|NCT03812679|101439944|FG000|Overall Study|Withdrawal by Subject|1|||
33423406|NCT03812679|101439944|FG000|Overall Study|Termination of study|2|||
33423407|NCT03812679|101439944|FG000|Overall Study|Water device replacement|1|||
33584300|NCT01061723|102028961|FG003|Overall Study|Randomized but not treated|0|||
33147655|NCT03150810|100454445|FG003|Overall Study|Death|2|||
33147656|NCT03150810|100454446|FG004|Overall Study|Death|2|||
33147657|NCT03150810|100454447|FG005|Overall Study|Death|10|||
33147658|NCT03150810|100454448|FG006|Overall Study|Death|8|||
33147659|NCT03150810|100454449|FG007|Overall Study|Death|6|||
33147660|NCT03150810|100454450|FG008|Overall Study|Death|18|||
33147661|NCT03150810|100454451|FG009|Overall Study|Death|3|||
33147662|NCT03150810|100454452|FG010|Overall Study|Death|19|||
33147663|NCT03150810|100454453|FG011|Overall Study|Death|1|||
33147664|NCT03150810|100454454|FG012|Overall Study|Death|19|||
33147665|NCT03150810|100454442|FG000|Overall Study|Withdrawal by Subject|0|||
33147666|NCT03150810|100454443|FG001|Overall Study|Withdrawal by Subject|1|||
33147667|NCT03150810|100454444|FG002|Overall Study|Withdrawal by Subject|1|||
33147668|NCT03150810|100454445|FG003|Overall Study|Withdrawal by Subject|1|||
33147669|NCT03150810|100454446|FG004|Overall Study|Withdrawal by Subject|0|||
33147670|NCT03150810|100454447|FG005|Overall Study|Withdrawal by Subject|0|||
33147671|NCT03150810|100454448|FG006|Overall Study|Withdrawal by Subject|2|||
33147672|NCT03150810|100454449|FG007|Overall Study|Withdrawal by Subject|0|||
33147673|NCT03150810|100454450|FG008|Overall Study|Withdrawal by Subject|2|||
33147674|NCT03150810|100454451|FG009|Overall Study|Withdrawal by Subject|0|||
33147675|NCT03150810|100454452|FG010|Overall Study|Withdrawal by Subject|1|||
33147676|NCT03150810|100454453|FG011|Overall Study|Withdrawal by Subject|0|||
33147677|NCT03150810|100454454|FG012|Overall Study|Withdrawal by Subject|1|||
33147678|NCT03150810|100454442|FG000|Overall Study|Sponsor Decision|0|||
33147679|NCT03150810|100454443|FG001|Overall Study|Sponsor Decision|2|||
33147680|NCT03150810|100454444|FG002|Overall Study|Sponsor Decision|0|||
33147681|NCT03150810|100454445|FG003|Overall Study|Sponsor Decision|0|||
33147682|NCT03150810|100454446|FG004|Overall Study|Sponsor Decision|1|||
33147683|NCT03150810|100454447|FG005|Overall Study|Sponsor Decision|1|||
33147684|NCT03150810|100454448|FG006|Overall Study|Sponsor Decision|0|||
33147685|NCT03150810|100454449|FG007|Overall Study|Sponsor Decision|0|||
33147686|NCT03150810|100454450|FG008|Overall Study|Sponsor Decision|1|||
33147687|NCT03150810|100454451|FG009|Overall Study|Sponsor Decision|0|||
33147688|NCT03150810|100454452|FG010|Overall Study|Sponsor Decision|0|||
33147689|NCT03150810|100454453|FG011|Overall Study|Sponsor Decision|0|||
33373701|NCT03136185|101255977|FG002|Overall Study|Protocol Defined Disease Progression|1|||
33373702|NCT03136185|101255978|FG003|Overall Study|Protocol Defined Disease Progression|0|||
33373703|NCT03136185|101255979|FG004|Overall Study|Protocol Defined Disease Progression|0|||
33373704|NCT03136185|101255980|FG005|Overall Study|Protocol Defined Disease Progression|1|||
33373705|NCT03136185|101255981|FG006|Overall Study|Protocol Defined Disease Progression|0|||
33373706|NCT03136185|101255982|FG007|Overall Study|Protocol Defined Disease Progression|1|||
33373707|NCT03136185|101255983|FG008|Overall Study|Protocol Defined Disease Progression|1|||
33373708|NCT03136185|101255975|FG000|Overall Study|Withdrawal by Subject|1|||
33584301|NCT01061723|102028962|FG004|Overall Study|Randomized but not treated|0|||
33584302|NCT01061723|102028963|FG005|Overall Study|Randomized but not treated|1|||
33584303|NCT01061723|102028958|FG000|Overall Study|Other than specified above|2|||
33584304|NCT01061723|102028959|FG001|Overall Study|Other than specified above|1|||
33584305|NCT01061723|102028960|FG002|Overall Study|Other than specified above|1|||
33584306|NCT01061723|102028961|FG003|Overall Study|Other than specified above|1|||
33584307|NCT01061723|102028962|FG004|Overall Study|Other than specified above|0|||
33584308|NCT01061723|102028963|FG005|Overall Study|Other than specified above|1|||
33584309|NCT02010593|102028966|FG000|Overall Study|Lost to Follow-up|1|||
33584310|NCT02010593|102028967|FG001|Overall Study|Lost to Follow-up|0|||
33584311|NCT02010593|102028966|FG000|Overall Study|Physician Decision|1|||
33584312|NCT02010593|102028967|FG001|Overall Study|Physician Decision|0|||
33584313|NCT02010593|102028966|FG000|Overall Study|Unable to adhere to visit schedule|0|||
33147690|NCT03150810|100454454|FG012|Overall Study|Sponsor Decision|5|||
33147691|NCT03150810|100454442|FG000|Overall Study|Lost to Follow-up|0|||
33147692|NCT03150810|100454443|FG001|Overall Study|Lost to Follow-up|1|||
33147693|NCT03150810|100454444|FG002|Overall Study|Lost to Follow-up|1|||
33147694|NCT03150810|100454445|FG003|Overall Study|Lost to Follow-up|0|||
33373709|NCT03136185|101255976|FG001|Overall Study|Withdrawal by Subject|0|||
33423408|NCT01964105|101439946|FG000|Overall Study|Lost to Follow-up|2|||
33147695|NCT03150810|100454446|FG004|Overall Study|Lost to Follow-up|0|||
33147696|NCT03150810|100454447|FG005|Overall Study|Lost to Follow-up|0|||
33147697|NCT03150810|100454448|FG006|Overall Study|Lost to Follow-up|1|||
33147698|NCT03150810|100454449|FG007|Overall Study|Lost to Follow-up|0|||
33147699|NCT03150810|100454450|FG008|Overall Study|Lost to Follow-up|0|||
33147700|NCT03150810|100454451|FG009|Overall Study|Lost to Follow-up|0|||
33584314|NCT02010593|102028967|FG001|Overall Study|Unable to adhere to visit schedule|2|||
33584315|NCT04560816|102028968|FG000|Overall Study|Withdrawal by Subject|1|||
33584316|NCT04560816|102028969|FG001|Overall Study|Withdrawal by Subject|1|||
33584317|NCT04560816|102028970|FG002|Overall Study|Withdrawal by Subject|1|||
33584318|NCT04560816|102028971|FG003|Overall Study|Withdrawal by Subject|0|||
33584319|NCT04560816|102028972|FG004|Overall Study|Withdrawal by Subject|3|||
33584320|NCT04560816|102028973|FG005|Overall Study|Withdrawal by Subject|0|||
33584321|NCT04560816|102028968|FG000|Overall Study|Lost to Follow-up|1|||
33584322|NCT04560816|102028969|FG001|Overall Study|Lost to Follow-up|0|||
33584323|NCT04560816|102028970|FG002|Overall Study|Lost to Follow-up|0|||
33584324|NCT04560816|102028971|FG003|Overall Study|Lost to Follow-up|0|||
33584325|NCT04560816|102028972|FG004|Overall Study|Lost to Follow-up|0|||
33584326|NCT04560816|102028973|FG005|Overall Study|Lost to Follow-up|0|||
33584327|NCT04560816|102028968|FG000|Overall Study|Protocol Violation|1|||
33584328|NCT04560816|102028969|FG001|Overall Study|Protocol Violation|0|||
33584329|NCT04560816|102028970|FG002|Overall Study|Protocol Violation|0|||
33584330|NCT04560816|102028971|FG003|Overall Study|Protocol Violation|0|||
33373710|NCT03136185|101255977|FG002|Overall Study|Withdrawal by Subject|1|||
33373711|NCT03136185|101255978|FG003|Overall Study|Withdrawal by Subject|1|||
33373712|NCT03136185|101255979|FG004|Overall Study|Withdrawal by Subject|1|||
33373713|NCT03136185|101255980|FG005|Overall Study|Withdrawal by Subject|1|||
33373714|NCT03136185|101255981|FG006|Overall Study|Withdrawal by Subject|2|||
33373715|NCT03136185|101255982|FG007|Overall Study|Withdrawal by Subject|3|||
33584331|NCT04560816|102028972|FG004|Overall Study|Protocol Violation|0|||
33584332|NCT04560816|102028973|FG005|Overall Study|Protocol Violation|0|||
33584333|NCT02565147|102028974|FG000|Overall Study|Withdrawal by Subject|5|||
33584334|NCT02565147|102028975|FG001|Overall Study|Withdrawal by Subject|1|||
33584335|NCT02565147|102028974|FG000|Overall Study|Lost to Follow-up|0|||
33584336|NCT02565147|102028975|FG001|Overall Study|Lost to Follow-up|1|||
33584337|NCT02565147|102028974|FG000|Overall Study|Death|1|||
33584338|NCT02565147|102028975|FG001|Overall Study|Death|1|||
33584339|NCT00935493|102028976|FG000|Overall Study|Lost to Follow-up|1|||
33584340|NCT00935493|102028977|FG001|Overall Study|Lost to Follow-up|1|||
33584341|NCT00935493|102028978|FG002|Overall Study|Lost to Follow-up|1|||
33645379|NCT00481091|102252788|FG004|Overall Study|Progressive disease clinical|0|||
33645380|NCT00481091|102252789|FG005|Overall Study|Progressive disease clinical|0|||
33645381|NCT00481091|102252790|FG006|Overall Study|Progressive disease clinical|0|||
33645382|NCT00481091|102252791|FG007|Overall Study|Progressive disease clinical|0|||
33584342|NCT00935493|102028976|FG000|Overall Study|Treatment Discontinued|0|||
33584343|NCT00935493|102028977|FG001|Overall Study|Treatment Discontinued|1|||
33584344|NCT00935493|102028978|FG002|Overall Study|Treatment Discontinued|0|||
33584345|NCT00269113|102028979|FG000|Overall Study|Adverse Event|14|||
33584346|NCT00269113|102028980|FG001|Overall Study|Adverse Event|7|||
33584347|NCT00269113|102028979|FG000|Overall Study|Lack of Efficacy|35|||
33645383|NCT00481091|102252792|FG008|Overall Study|Progressive disease clinical|1|||
33645384|NCT00481091|102252793|FG009|Overall Study|Progressive disease clinical|7|||
33645385|NCT00481091|102252784|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
33645386|NCT00481091|102252785|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
33645387|NCT00481091|102252786|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
33645388|NCT00481091|102252787|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
33645389|NCT00481091|102252788|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
33645390|NCT00481091|102252789|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
33645391|NCT00481091|102252790|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
33645392|NCT00481091|102252791|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
33645393|NCT00481091|102252792|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
33645394|NCT00481091|102252793|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
33645395|NCT00481091|102252784|FG000|Overall Study|Progressive disease other|1|||
33645396|NCT00481091|102252785|FG001|Overall Study|Progressive disease other|1|||
33645397|NCT00481091|102252786|FG002|Overall Study|Progressive disease other|0|||
33645398|NCT00481091|102252787|FG003|Overall Study|Progressive disease other|1|||
33645399|NCT00481091|102252788|FG004|Overall Study|Progressive disease other|1|||
33645400|NCT00481091|102252789|FG005|Overall Study|Progressive disease other|1|||
33645401|NCT00481091|102252790|FG006|Overall Study|Progressive disease other|0|||
33584348|NCT00269113|102028980|FG001|Overall Study|Lack of Efficacy|18|||
33645402|NCT00481091|102252791|FG007|Overall Study|Progressive disease other|2|||
33584349|NCT00269113|102028979|FG000|Overall Study|Early Improvement|2|||
33584350|NCT00269113|102028980|FG001|Overall Study|Early Improvement|0|||
33584351|NCT00269113|102028979|FG000|Overall Study|Withdrawal by Subject|0|||
33584352|NCT00269113|102028980|FG001|Overall Study|Withdrawal by Subject|2|||
33584353|NCT00269113|102028979|FG000|Overall Study|Death|6|||
33584354|NCT00269113|102028980|FG001|Overall Study|Death|2|||
33373716|NCT03136185|101255983|FG008|Overall Study|Withdrawal by Subject|3|||
33373717|NCT03136185|101255975|FG000|Overall Study|Not Reported|4|||
33584355|NCT00269113|102028979|FG000|Overall Study|Lost to Follow-up|2|||
33584356|NCT00269113|102028980|FG001|Overall Study|Lost to Follow-up|1|||
33584357|NCT00269113|102028979|FG000|Overall Study|Protocol Violation|15|||
33584358|NCT00269113|102028980|FG001|Overall Study|Protocol Violation|5|||
33584359|NCT00269113|102028979|FG000|Overall Study|Other|0|||
33584360|NCT00269113|102028980|FG001|Overall Study|Other|2|||
33584361|NCT03035864|102028984|FG000|Treatment Period|Adverse Event|1|||
33584362|NCT03035864|102028985|FG001|Treatment Period|Adverse Event|0|||
33584363|NCT03035864|102028984|FG000|Treatment Period|Other|3|||
33584364|NCT03035864|102028985|FG001|Treatment Period|Other|1|||
33147701|NCT03150810|100454452|FG010|Overall Study|Lost to Follow-up|1|||
33147702|NCT03150810|100454453|FG011|Overall Study|Lost to Follow-up|0|||
33147703|NCT03150810|100454454|FG012|Overall Study|Lost to Follow-up|0|||
33147704|NCT03150810|100454442|FG000|Overall Study|Physician Decision|0|||
33147705|NCT03150810|100454443|FG001|Overall Study|Physician Decision|0|||
33147706|NCT03150810|100454444|FG002|Overall Study|Physician Decision|0|||
33584365|NCT03035864|102028984|FG000|Follow-up Period|Adverse Event|1|||
33584366|NCT03035864|102028985|FG001|Follow-up Period|Adverse Event|0|||
33584367|NCT03035864|102028984|FG000|Follow-up Period|Lost to Follow-up|6|||
33584368|NCT03035864|102028985|FG001|Follow-up Period|Lost to Follow-up|2|||
33584369|NCT03035864|102028984|FG000|Follow-up Period|Physician Decision|1|||
33584370|NCT03035864|102028985|FG001|Follow-up Period|Physician Decision|0|||
33584371|NCT03035864|102028984|FG000|Follow-up Period|Other|3|||
33584372|NCT03035864|102028985|FG001|Follow-up Period|Other|2|||
33584373|NCT03275246|102028988|FG000|Overall Study|Protocol Violation|5|||
33584374|NCT03275246|102028988|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
33147707|NCT03150810|100454445|FG003|Overall Study|Physician Decision|0|||
33147708|NCT03150810|100454446|FG004|Overall Study|Physician Decision|0|||
33147709|NCT03150810|100454447|FG005|Overall Study|Physician Decision|1|||
33147710|NCT03150810|100454448|FG006|Overall Study|Physician Decision|1|||
33147711|NCT03150810|100454449|FG007|Overall Study|Physician Decision|0|||
33147712|NCT03150810|100454450|FG008|Overall Study|Physician Decision|0|||
33147713|NCT03150810|100454451|FG009|Overall Study|Physician Decision|0|||
33147714|NCT03150810|100454452|FG010|Overall Study|Physician Decision|0|||
33147715|NCT03150810|100454453|FG011|Overall Study|Physician Decision|0|||
33147716|NCT03150810|100454454|FG012|Overall Study|Physician Decision|0|||
33147717|NCT03150810|100454442|FG000|Overall Study|Site withdrawal from study|0|||
33147718|NCT03150810|100454443|FG001|Overall Study|Site withdrawal from study|1|||
33147719|NCT03150810|100454444|FG002|Overall Study|Site withdrawal from study|0|||
33147720|NCT03150810|100454445|FG003|Overall Study|Site withdrawal from study|0|||
33147721|NCT03150810|100454446|FG004|Overall Study|Site withdrawal from study|0|||
33584375|NCT02125838|102028989|FG000|Overall Study|Lost to Follow-up|4|||
33645403|NCT00481091|102252792|FG008|Overall Study|Progressive disease other|0|||
33645404|NCT00481091|102252793|FG009|Overall Study|Progressive disease other|0|||
33645405|NCT00481091|102252784|FG000|Overall Study|No reason given|0|||
33645406|NCT00481091|102252785|FG001|Overall Study|No reason given|0|||
33645407|NCT00481091|102252786|FG002|Overall Study|No reason given|1|||
33645408|NCT00481091|102252787|FG003|Overall Study|No reason given|1|||
33645409|NCT00481091|102252788|FG004|Overall Study|No reason given|1|||
33245784|NCT05074498|100800213|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
33245785|NCT05074498|100800214|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
33245786|NCT05074498|100800215|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
33645410|NCT00481091|102252789|FG005|Overall Study|No reason given|0|||
33645411|NCT00481091|102252790|FG006|Overall Study|No reason given|1|||
33645412|NCT00481091|102252791|FG007|Overall Study|No reason given|1|||
33645413|NCT00481091|102252792|FG008|Overall Study|No reason given|1|||
33645414|NCT00481091|102252793|FG009|Overall Study|No reason given|4|||
33645415|NCT00373113|102252794|FG000|Overall Study|Death|1|||
33645416|NCT00373113|102252795|FG001|Overall Study|Death|7|||
33147722|NCT03150810|100454447|FG005|Overall Study|Site withdrawal from study|0|||
33147723|NCT03150810|100454448|FG006|Overall Study|Site withdrawal from study|0|||
33245787|NCT05074498|100800216|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
33245788|NCT05074498|100800211|FG000|Part 2 (Upto Day 104)|Death|0|||
33245789|NCT05074498|100800212|FG001|Part 2 (Upto Day 104)|Death|0|||
33245790|NCT05074498|100800213|FG002|Part 2 (Upto Day 104)|Death|0|||
33645417|NCT00373113|102252794|FG000|Overall Study|Adverse Event|38|||
33645418|NCT00373113|102252795|FG001|Overall Study|Adverse Event|24|||
33147724|NCT03150810|100454449|FG007|Overall Study|Site withdrawal from study|0|||
33147725|NCT03150810|100454450|FG008|Overall Study|Site withdrawal from study|0|||
33245791|NCT05074498|100800214|FG003|Part 2 (Upto Day 104)|Death|0|||
33584376|NCT02125838|102028990|FG001|Overall Study|Lost to Follow-up|4|||
33584377|NCT02298868|102028994|FG000|Overall Study|Adverse Event|1|||
33584378|NCT02298868|102028994|FG000|Overall Study|Death|1|||
33584379|NCT02298868|102028994|FG000|Overall Study|Patient underwent transplant|1|||
33147726|NCT03150810|100454451|FG009|Overall Study|Site withdrawal from study|1|||
33147727|NCT03150810|100454452|FG010|Overall Study|Site withdrawal from study|1|||
33147728|NCT03150810|100454453|FG011|Overall Study|Site withdrawal from study|0|||
33147729|NCT03150810|100454454|FG012|Overall Study|Site withdrawal from study|0|||
33584380|NCT01897727|102028995|FG000|Overall Study|Exclusion: central sleep apnea|0|||
33645419|NCT00373113|102252794|FG000|Overall Study|Study terminated by sponsor|9|||
33245792|NCT05074498|100800215|FG004|Part 2 (Upto Day 104)|Death|1|||
33245793|NCT05074498|100800216|FG005|Part 2 (Upto Day 104)|Death|0|||
33245794|NCT05074498|100800211|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
33245795|NCT05074498|100800212|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
33245796|NCT05074498|100800213|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
33245797|NCT05074498|100800214|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
33245798|NCT05074498|100800215|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
33584381|NCT01897727|102028996|FG001|Overall Study|Exclusion: central sleep apnea|1|||
33584382|NCT02266147|102029003|FG000|PART 1: Dose Escalation|Physician Decision|0|||
33584383|NCT02266147|102029004|FG001|PART 1: Dose Escalation|Physician Decision|0|||
33584384|NCT02266147|102029005|FG002|PART 1: Dose Escalation|Physician Decision|1|||
33584385|NCT02266147|102029006|FG003|PART 1: Dose Escalation|Physician Decision|0|||
33584386|NCT02266147|102029003|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
33584387|NCT02266147|102029004|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
33584388|NCT02266147|102029005|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
33584389|NCT02266147|102029006|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
33584390|NCT02266147|102029003|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
33584391|NCT02266147|102029004|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
33584392|NCT02266147|102029005|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
33584393|NCT02266147|102029006|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
33584394|NCT02266147|102029003|FG000|PART 1: Dose Escalation|Other|1|||
33584395|NCT02266147|102029004|FG001|PART 1: Dose Escalation|Other|1|||
33645420|NCT00373113|102252795|FG001|Overall Study|Study terminated by sponsor|1|||
33645421|NCT00373113|102252794|FG000|Overall Study|Global deterioration of health status|10|||
33645422|NCT00373113|102252795|FG001|Overall Study|Global deterioration of health status|7|||
33645423|NCT00373113|102252794|FG000|Overall Study|Lost to Follow-up|1|||
33645424|NCT00373113|102252795|FG001|Overall Study|Lost to Follow-up|3|||
33645425|NCT00373113|102252794|FG000|Overall Study|Objective progression or relapse|150|||
33645426|NCT00373113|102252795|FG001|Overall Study|Objective progression or relapse|169|||
33645427|NCT00373113|102252794|FG000|Overall Study|Other|14|||
33645428|NCT00373113|102252795|FG001|Overall Study|Other|17|||
33645429|NCT00373113|102252794|FG000|Overall Study|Protocol Violation|5|||
33645430|NCT00373113|102252795|FG001|Overall Study|Protocol Violation|1|||
33645431|NCT00373113|102252794|FG000|Overall Study|Withdrawal by Subject|10|||
33645432|NCT00373113|102252795|FG001|Overall Study|Withdrawal by Subject|15|||
33645433|NCT02934503|102252796|FG000|Overall Study|progression of disease|3|||
33645434|NCT02934503|102252796|FG000|Overall Study|Withdrawal by Subject|1|||
33645435|NCT01309282|102252797|FG000|Overall Study|Lost to Follow-up|1|||
33147730|NCT03150810|100454442|FG000|Overall Study|Hospice|0|||
33147731|NCT03150810|100454443|FG001|Overall Study|Hospice|0|||
33147732|NCT03150810|100454444|FG002|Overall Study|Hospice|0|||
33147733|NCT03150810|100454445|FG003|Overall Study|Hospice|0|||
33147734|NCT03150810|100454446|FG004|Overall Study|Hospice|0|||
33147735|NCT03150810|100454447|FG005|Overall Study|Hospice|1|||
33147736|NCT03150810|100454448|FG006|Overall Study|Hospice|0|||
33147737|NCT03150810|100454449|FG007|Overall Study|Hospice|0|||
33147738|NCT03150810|100454450|FG008|Overall Study|Hospice|0|||
33147739|NCT03150810|100454451|FG009|Overall Study|Hospice|0|||
33147740|NCT03150810|100454452|FG010|Overall Study|Hospice|0|||
33147741|NCT03150810|100454453|FG011|Overall Study|Hospice|0|||
33147742|NCT03150810|100454454|FG012|Overall Study|Hospice|0|||
33147743|NCT03150810|100454442|FG000|Overall Study|Participant relocated abroad.|0|||
33147744|NCT03150810|100454443|FG001|Overall Study|Participant relocated abroad.|0|||
33147745|NCT03150810|100454444|FG002|Overall Study|Participant relocated abroad.|0|||
33147746|NCT03150810|100454445|FG003|Overall Study|Participant relocated abroad.|0|||
33147747|NCT03150810|100454446|FG004|Overall Study|Participant relocated abroad.|0|||
33147748|NCT03150810|100454447|FG005|Overall Study|Participant relocated abroad.|1|||
33147749|NCT03150810|100454448|FG006|Overall Study|Participant relocated abroad.|0|||
33147750|NCT03150810|100454449|FG007|Overall Study|Participant relocated abroad.|0|||
33147751|NCT03150810|100454450|FG008|Overall Study|Participant relocated abroad.|0|||
33147752|NCT03150810|100454451|FG009|Overall Study|Participant relocated abroad.|0|||
33147753|NCT03150810|100454452|FG010|Overall Study|Participant relocated abroad.|0|||
33147754|NCT03150810|100454453|FG011|Overall Study|Participant relocated abroad.|0|||
33147755|NCT03150810|100454454|FG012|Overall Study|Participant relocated abroad.|0|||
33147756|NCT03150810|100454442|FG000|Overall Study|Transferred care to oncologist|0|||
33147757|NCT03150810|100454443|FG001|Overall Study|Transferred care to oncologist|0|||
33147758|NCT03150810|100454444|FG002|Overall Study|Transferred care to oncologist|0|||
33147759|NCT03150810|100454445|FG003|Overall Study|Transferred care to oncologist|0|||
33147760|NCT03150810|100454446|FG004|Overall Study|Transferred care to oncologist|0|||
33147761|NCT03150810|100454447|FG005|Overall Study|Transferred care to oncologist|0|||
33147762|NCT03150810|100454448|FG006|Overall Study|Transferred care to oncologist|2|||
33147763|NCT03150810|100454449|FG007|Overall Study|Transferred care to oncologist|0|||
33147764|NCT03150810|100454450|FG008|Overall Study|Transferred care to oncologist|0|||
33147765|NCT03150810|100454451|FG009|Overall Study|Transferred care to oncologist|0|||
33584396|NCT02266147|102029005|FG002|PART 1: Dose Escalation|Other|0|||
33584397|NCT02266147|102029006|FG003|PART 1: Dose Escalation|Other|0|||
33584398|NCT02266147|102029003|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
33584399|NCT02266147|102029004|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
33584400|NCT02266147|102029005|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
33584401|NCT02266147|102029006|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
33584402|NCT02266147|102029003|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
33584403|NCT02266147|102029004|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
33584404|NCT02266147|102029005|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
33584405|NCT02266147|102029006|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
33584406|NCT03198767|102029009|FG000|Overall Study|Protocol Violation|0|||
33584407|NCT03198767|102029010|FG001|Overall Study|Protocol Violation|0|||
33584408|NCT03198767|102029011|FG002|Overall Study|Protocol Violation|0|||
33584409|NCT03198767|102029012|FG003|Overall Study|Protocol Violation|6|||
33584410|NCT03198767|102029013|FG004|Overall Study|Protocol Violation|0|||
33584411|NCT03198767|102029014|FG005|Overall Study|Protocol Violation|0|||
33584412|NCT03198767|102029015|FG006|Overall Study|Protocol Violation|0|||
33584413|NCT02096952|102029019|FG000|Overall Study|Adverse Event|1|||
33245799|NCT05074498|100800216|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
33245800|NCT05074498|100800211|FG000|Part 2 (Upto Day 104)|Other|0|||
33245801|NCT05074498|100800212|FG001|Part 2 (Upto Day 104)|Other|0|||
33245802|NCT05074498|100800213|FG002|Part 2 (Upto Day 104)|Other|0|||
33245803|NCT05074498|100800214|FG003|Part 2 (Upto Day 104)|Other|0|||
33245804|NCT05074498|100800215|FG004|Part 2 (Upto Day 104)|Other|1|||
33245805|NCT05074498|100800216|FG005|Part 2 (Upto Day 104)|Other|0|||
33245806|NCT01450943|100800223|FG000|Overall Study|Screen failure, loss to follow-up|2|||
33245807|NCT01450943|100800224|FG001|Overall Study|Screen failure, loss to follow-up|7|||
33245808|NCT01450943|100800225|FG002|Overall Study|Screen failure, loss to follow-up|6|||
33245809|NCT00938340|100800226|FG000|Overall Study|Withdrawal by Subject|3|||
33245810|NCT00938340|100800226|FG000|Overall Study|Protocol Violation|1|||
33245811|NCT00938340|100800226|FG000|Overall Study|Adverse Event|1|||
33245812|NCT02027935|100800228|FG000|Overall Study|Death|1|||
33245813|NCT02027935|100800228|FG000|Overall Study|Lack of Efficacy|5|||
33245814|NCT02027935|100800228|FG000|Overall Study|Study Closure|1|||
33584414|NCT01831466|102029020|FG000|Overall Study|Protocol Violation|1|||
33584415|NCT01831466|102029021|FG001|Overall Study|Protocol Violation|1|||
33584416|NCT01831466|102029022|FG002|Overall Study|Protocol Violation|2|||
33245815|NCT02334306|100800229|FG000|Double-blind Period|Adverse Event|0|||
33245816|NCT02334306|100800230|FG001|Double-blind Period|Adverse Event|1|||
33245817|NCT02334306|100800229|FG000|Double-blind Period|Withdrawal by Subject|1|||
33245818|NCT02334306|100800230|FG001|Double-blind Period|Withdrawal by Subject|1|||
33373718|NCT03136185|101255976|FG001|Overall Study|Not Reported|1|||
33373719|NCT03136185|101255977|FG002|Overall Study|Not Reported|0|||
33373720|NCT03136185|101255978|FG003|Overall Study|Not Reported|1|||
33373721|NCT03136185|101255979|FG004|Overall Study|Not Reported|0|||
33373722|NCT03136185|101255980|FG005|Overall Study|Not Reported|2|||
33373723|NCT03136185|101255981|FG006|Overall Study|Not Reported|1|||
33373724|NCT03136185|101255982|FG007|Overall Study|Not Reported|1|||
33373725|NCT03136185|101255983|FG008|Overall Study|Not Reported|0|||
33373726|NCT01035255|101255989|FG000|Overall Study|Death|724|||
33373727|NCT01035255|101255990|FG001|Overall Study|Death|844|||
33373728|NCT01035255|101255989|FG000|Overall Study|Lost to Follow-up|2|||
33373729|NCT01035255|101255990|FG001|Overall Study|Lost to Follow-up|5|||
33373730|NCT01035255|101255989|FG000|Overall Study|patient's request|15|||
33423409|NCT01964105|101439947|FG001|Overall Study|Lost to Follow-up|13|||
33423410|NCT01964105|101439948|FG002|Overall Study|Lost to Follow-up|0|||
33423411|NCT00811070|101443467|FG000|Overall Study|Death|0|||
33423412|NCT00811070|101443468|FG001|Overall Study|Death|0|||
33423413|NCT00811070|101443469|FG002|Overall Study|Death|0|||
33245819|NCT02430532|100800231|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
33245820|NCT02430532|100800232|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
33245821|NCT02430532|100800231|FG000|Overall Study|Consent Withdrawn|0|||
33423414|NCT00811070|101443470|FG003|Overall Study|Death|2|||
33423415|NCT00811070|101443471|FG004|Overall Study|Death|5|||
33245822|NCT02430532|100800232|FG001|Overall Study|Consent Withdrawn|2|||
33245823|NCT02430532|100800231|FG000|Overall Study|Adverse Event|0|||
33245824|NCT02430532|100800232|FG001|Overall Study|Adverse Event|1|||
33245825|NCT01333514|100800243|FG000|Overall Study|Withdrawal by Subject|1|||
33584417|NCT01831466|102029023|FG003|Overall Study|Protocol Violation|0|||
33645436|NCT01675167|102252798|FG000|Open-label Titration Phase|Adverse Event|81|||
33373731|NCT01035255|101255990|FG001|Overall Study|patient's request|13|||
33373732|NCT00678587|101255998|FG000|Overall Study|Adverse Event|3|||
33373733|NCT00678587|101255999|FG001|Overall Study|Adverse Event|3|||
33373734|NCT00678587|101255998|FG000|Overall Study|Lack of Efficacy|1|||
33423416|NCT00811070|101443472|FG005|Overall Study|Death|0|||
33423417|NCT00811070|101443467|FG000|Overall Study|Other|1|||
33584418|NCT01831466|102029024|FG004|Overall Study|Protocol Violation|0|||
33584419|NCT01831466|102029025|FG005|Overall Study|Protocol Violation|1|||
33584420|NCT01831466|102029026|FG006|Overall Study|Protocol Violation|0|||
33245826|NCT01333514|100800244|FG001|Overall Study|Withdrawal by Subject|0|||
33245827|NCT03310983|100800247|FG000|Overall Study|Lost to Follow-up|15|||
33245828|NCT03310983|100800248|FG001|Overall Study|Lost to Follow-up|17|||
33245829|NCT01605136|100800249|FG000|Study Period|Withdrawal by Subject|2|||
33245830|NCT01605136|100800250|FG001|Study Period|Withdrawal by Subject|0|||
33245831|NCT01605136|100800249|FG000|Study Period|Physician Decision|1|||
33245832|NCT01605136|100800250|FG001|Study Period|Physician Decision|1|||
33245833|NCT01605136|100800249|FG000|Study Period|Lost to Follow-up|0|||
33245834|NCT01605136|100800250|FG001|Study Period|Lost to Follow-up|2|||
33245835|NCT01605136|100800249|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
33245836|NCT01605136|100800250|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
33245837|NCT00886613|100800251|FG000|Overall Study|Protocol deviation (Part B)|1|||
33245838|NCT00886613|100800252|FG001|Overall Study|Protocol deviation (Part B)|0|||
33245839|NCT00886613|100800253|FG002|Overall Study|Protocol deviation (Part B)|0|||
33245840|NCT00886613|100800251|FG000|Overall Study|Lost to follow-up (Part B)|1|||
33245841|NCT00886613|100800252|FG001|Overall Study|Lost to follow-up (Part B)|0|||
33245842|NCT00886613|100800253|FG002|Overall Study|Lost to follow-up (Part B)|1|||
33245843|NCT00886613|100800251|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
33245844|NCT00886613|100800252|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
33245845|NCT00886613|100800253|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
33245846|NCT03368001|100800258|FG000|Allocation|Lost to Pretest|16|||
33245847|NCT03368001|100800259|FG001|Allocation|Lost to Pretest|25|||
33245848|NCT03368001|100800258|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
33245849|NCT03368001|100800259|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
33245850|NCT03368001|100800258|FG000|Posttest|Lost to Posttest|7|||
33245851|NCT03368001|100800259|FG001|Posttest|Lost to Posttest|11|||
33245852|NCT03368001|100800258|FG000|Posttest|Discontinued Intervention|6|||
33245853|NCT03368001|100800259|FG001|Posttest|Discontinued Intervention|19|||
33245854|NCT03368001|100800258|FG000|Follow-up|Lost to Follow-up|6|||
33245855|NCT03368001|100800259|FG001|Follow-up|Lost to Follow-up|3|||
33245856|NCT02624778|100800262|FG000|Overall Study|Lost to Follow-up|0|||
33245857|NCT02624778|100800263|FG001|Overall Study|Lost to Follow-up|0|||
33245858|NCT02624778|100800264|FG002|Overall Study|Lost to Follow-up|1|||
33245859|NCT02624778|100800265|FG003|Overall Study|Lost to Follow-up|0|||
33245860|NCT02624778|100800266|FG004|Overall Study|Lost to Follow-up|0|||
33245861|NCT02624778|100800267|FG005|Overall Study|Lost to Follow-up|0|||
33245862|NCT02624778|100800268|FG006|Overall Study|Lost to Follow-up|0|||
33245863|NCT02624778|100800269|FG007|Overall Study|Lost to Follow-up|0|||
33373735|NCT00678587|101255999|FG001|Overall Study|Lack of Efficacy|0|||
33373736|NCT00678587|101255998|FG000|Overall Study|Protocol Violation|2|||
33373737|NCT00678587|101255999|FG001|Overall Study|Protocol Violation|1|||
33373738|NCT00678587|101255998|FG000|Overall Study|Study Closed/Terminated|1|||
33373739|NCT00678587|101255999|FG001|Overall Study|Study Closed/Terminated|0|||
33373740|NCT00678587|101255998|FG000|Overall Study|Lost to Follow-up|3|||
33645437|NCT01675167|102252799|FG001|Open-label Titration Phase|Adverse Event|0|||
33245864|NCT02624778|100800270|FG008|Overall Study|Lost to Follow-up|0|||
33373741|NCT00678587|101255999|FG001|Overall Study|Lost to Follow-up|5|||
33373742|NCT00678587|101255998|FG000|Overall Study|Investigator Discretion|2|||
33423418|NCT00811070|101443468|FG001|Overall Study|Other|0|||
33423419|NCT00811070|101443469|FG002|Overall Study|Other|0|||
33423420|NCT00811070|101443470|FG003|Overall Study|Other|0|||
33423421|NCT00811070|101443471|FG004|Overall Study|Other|0|||
33584421|NCT01831466|102029027|FG007|Overall Study|Protocol Violation|0|||
33584422|NCT01831466|102029028|FG008|Overall Study|Protocol Violation|0|||
33584423|NCT01831466|102029029|FG009|Overall Study|Protocol Violation|0|||
33584424|NCT01831466|102029030|FG010|Overall Study|Protocol Violation|0|||
33584425|NCT01831466|102029031|FG011|Overall Study|Protocol Violation|0|||
33584426|NCT01831466|102029020|FG000|Overall Study|Other|2|||
33584427|NCT01831466|102029021|FG001|Overall Study|Other|3|||
33584428|NCT01831466|102029022|FG002|Overall Study|Other|2|||
33584429|NCT01831466|102029023|FG003|Overall Study|Other|2|||
33584430|NCT01831466|102029024|FG004|Overall Study|Other|2|||
33645438|NCT01675167|102252800|FG002|Open-label Titration Phase|Adverse Event|0|||
33245865|NCT02624778|100800262|FG000|Overall Study|Withdrawal by Subject|0|||
33245866|NCT02624778|100800263|FG001|Overall Study|Withdrawal by Subject|1|||
33245867|NCT02624778|100800264|FG002|Overall Study|Withdrawal by Subject|0|||
33245868|NCT02624778|100800265|FG003|Overall Study|Withdrawal by Subject|0|||
33245869|NCT02624778|100800266|FG004|Overall Study|Withdrawal by Subject|0|||
33245870|NCT02624778|100800267|FG005|Overall Study|Withdrawal by Subject|1|||
33245871|NCT02624778|100800268|FG006|Overall Study|Withdrawal by Subject|1|||
33245872|NCT02624778|100800269|FG007|Overall Study|Withdrawal by Subject|1|||
33245873|NCT02624778|100800270|FG008|Overall Study|Withdrawal by Subject|1|||
33373743|NCT00678587|101255999|FG001|Overall Study|Investigator Discretion|6|||
33373744|NCT00678587|101255998|FG000|Overall Study|Withdrew Consent|8|||
33423422|NCT00811070|101443472|FG005|Overall Study|Other|0|||
33584431|NCT01831466|102029025|FG005|Overall Study|Other|1|||
33584432|NCT01831466|102029026|FG006|Overall Study|Other|0|||
33584433|NCT01831466|102029027|FG007|Overall Study|Other|0|||
33584434|NCT01831466|102029028|FG008|Overall Study|Other|0|||
33373745|NCT00678587|101255999|FG001|Overall Study|Withdrew Consent|3|||
33373746|NCT04426825|101256000|FG000|Overall Study|Death|17|||
33373747|NCT04426825|101256000|FG000|Overall Study|Lost to Follow-up|1|||
33373748|NCT04426825|101256000|FG000|Overall Study|Study terminated by sponsor|5|||
33373749|NCT00502307|101256003|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
33373750|NCT00502307|101256004|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
33373751|NCT00502307|101256005|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
33373752|NCT00502307|101256003|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
33373753|NCT00502307|101256004|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
33373754|NCT00502307|101256005|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
33373755|NCT00502307|101256003|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
33373756|NCT00502307|101256004|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
33373757|NCT00502307|101256005|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
33373758|NCT00502307|101256003|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
33423423|NCT00811070|101443467|FG000|Overall Study|Withdrawal by Subject|0|||
33423424|NCT00811070|101443468|FG001|Overall Study|Withdrawal by Subject|1|||
33147766|NCT03150810|100454452|FG010|Overall Study|Transferred care to oncologist|0|||
33147767|NCT03150810|100454453|FG011|Overall Study|Transferred care to oncologist|0|||
33147768|NCT03150810|100454454|FG012|Overall Study|Transferred care to oncologist|0|||
33147769|NCT03845296|100454455|FG000|Overall Study|On Treatment|2|||
33423425|NCT00811070|101443469|FG002|Overall Study|Withdrawal by Subject|0|||
33423426|NCT00811070|101443470|FG003|Overall Study|Withdrawal by Subject|0|||
33423427|NCT00811070|101443471|FG004|Overall Study|Withdrawal by Subject|0|||
33423428|NCT00811070|101443472|FG005|Overall Study|Withdrawal by Subject|0|||
33423429|NCT00811070|101443467|FG000|Overall Study|Physician Decision|0|||
33423430|NCT00811070|101443468|FG001|Overall Study|Physician Decision|0|||
33423431|NCT00811070|101443469|FG002|Overall Study|Physician Decision|0|||
33423432|NCT00811070|101443470|FG003|Overall Study|Physician Decision|0|||
33423433|NCT00811070|101443471|FG004|Overall Study|Physician Decision|0|||
33423434|NCT00811070|101443472|FG005|Overall Study|Physician Decision|1|||
33423435|NCT04428502|101443473|FG000|Overall Study|Did not meet entrance criteria|14|||
33423436|NCT00529568|101443474|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
33423437|NCT00529568|101443475|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
33423438|NCT00529568|101443476|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
33584435|NCT01831466|102029029|FG009|Overall Study|Other|0|||
33584436|NCT01831466|102029030|FG010|Overall Study|Other|0|||
33373759|NCT00502307|101256004|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
33373760|NCT00502307|101256005|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
33373761|NCT00502307|101256003|FG000|Maintenance Period|Progressive disease|80|||
33373762|NCT00502307|101256004|FG001|Maintenance Period|Progressive disease|0|||
33373763|NCT00502307|101256005|FG002|Maintenance Period|Progressive disease|0|||
33423439|NCT00529568|101443474|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
33423440|NCT00529568|101443475|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
33423441|NCT00529568|101443476|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
33423442|NCT00529568|101443474|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
33584437|NCT01831466|102029031|FG011|Overall Study|Other|0|||
33584438|NCT01831466|102029020|FG000|Overall Study|Non-compliance with study treatment|2|||
33584439|NCT01831466|102029021|FG001|Overall Study|Non-compliance with study treatment|1|||
33584440|NCT01831466|102029022|FG002|Overall Study|Non-compliance with study treatment|1|||
33423443|NCT00529568|101443475|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
33423444|NCT00529568|101443476|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
33423445|NCT00529568|101443474|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
33423446|NCT00529568|101443475|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
33423447|NCT00529568|101443476|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
33423448|NCT00529568|101443474|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
33423449|NCT00529568|101443475|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
33423450|NCT00529568|101443476|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
33423451|NCT00529568|101443474|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
33423452|NCT00529568|101443475|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
33423453|NCT00529568|101443476|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
33423454|NCT00529568|101443474|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
33645439|NCT01675167|102252798|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
33245874|NCT02624778|100800262|FG000|Overall Study|Adverse Event|0|||
33373764|NCT00502307|101256003|FG000|Maintenance Period|Discontinued due to other reasons|68|||
33245875|NCT02624778|100800263|FG001|Overall Study|Adverse Event|0|||
33373765|NCT00502307|101256004|FG001|Maintenance Period|Discontinued due to other reasons|0|||
33373766|NCT00502307|101256005|FG002|Maintenance Period|Discontinued due to other reasons|0|||
33423455|NCT00529568|101443475|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
33584441|NCT01831466|102029023|FG003|Overall Study|Non-compliance with study treatment|0|||
33373767|NCT02808312|101256011|FG000|Overall Study|Enrolled but Never Treated|0|||
33373768|NCT02808312|101256012|FG001|Overall Study|Enrolled but Never Treated|0|||
33373769|NCT02808312|101256013|FG002|Overall Study|Enrolled but Never Treated|1|||
33373770|NCT02808312|101256014|FG003|Overall Study|Enrolled but Never Treated|0|||
33373771|NCT02808312|101256015|FG004|Overall Study|Enrolled but Never Treated|0|||
33373772|NCT00701727|101256017|FG000|First Treatment Period|Adverse Event|0|||
33373773|NCT00701727|101256018|FG001|First Treatment Period|Adverse Event|0|||
33373774|NCT00701727|101256017|FG000|First Treatment Period|Withdrawal by Subject|1|||
33373775|NCT00701727|101256018|FG001|First Treatment Period|Withdrawal by Subject|0|||
33373776|NCT00701727|101256017|FG000|First Treatment Period|sponsor decision|0|||
33373777|NCT00701727|101256018|FG001|First Treatment Period|sponsor decision|1|||
33373778|NCT00701727|101256017|FG000|First Treatment Period|Lost to Follow-up|0|||
33373779|NCT00701727|101256018|FG001|First Treatment Period|Lost to Follow-up|1|||
33373780|NCT00701727|101256017|FG000|Second Treatment Period|Withdrawal by Subject|2|||
33373781|NCT00701727|101256018|FG001|Second Treatment Period|Withdrawal by Subject|0|||
33373782|NCT02149836|101256019|FG000|Overall Study|Withdrawal by Subject|1|||
33373783|NCT03591146|101256020|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
33373784|NCT03591146|101256021|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
33373785|NCT03591146|101256022|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
33373786|NCT03591146|101256023|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
33373787|NCT03591146|101256024|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
33373788|NCT03591146|101256020|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
33373789|NCT03591146|101256021|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
33373790|NCT03591146|101256022|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
33373791|NCT03591146|101256023|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
33373792|NCT03591146|101256024|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
33373793|NCT03591146|101256020|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
33373794|NCT03591146|101256021|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
33373795|NCT03591146|101256022|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
33373796|NCT03591146|101256023|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
33373797|NCT03591146|101256024|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
33373798|NCT03591146|101256020|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
33373799|NCT03591146|101256021|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
33373800|NCT03591146|101256022|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
33373801|NCT03591146|101256023|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
33373802|NCT03591146|101256024|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
33373803|NCT01104558|101256027|FG000|Overall Study|Protocol Violation|6|||
33373804|NCT01104558|101256027|FG000|Overall Study|Missing of primary efficacy assessment|10|||
33373805|NCT01104558|101256027|FG000|Overall Study|Missing of genetic analysis results|1|||
33373806|NCT01232894|101256029|FG000|Overall Study|Lost to Follow-up|0|||
33373807|NCT01232894|101256030|FG001|Overall Study|Lost to Follow-up|1|||
33373808|NCT01232894|101256029|FG000|Overall Study|Death|1|||
33373809|NCT01232894|101256030|FG001|Overall Study|Death|0|||
33373810|NCT01232894|101256029|FG000|Overall Study|Protocol Violation|1|||
33147770|NCT03845296|100454456|FG001|Overall Study|On Treatment|1|||
33147771|NCT03845296|100454455|FG000|Overall Study|Adverse Event|4|||
33147772|NCT03845296|100454456|FG001|Overall Study|Adverse Event|11|||
33373811|NCT01232894|101256030|FG001|Overall Study|Protocol Violation|1|||
33373812|NCT01232894|101256029|FG000|Overall Study|Withdrawal by Subject|8|||
33373813|NCT01232894|101256030|FG001|Overall Study|Withdrawal by Subject|5|||
33373814|NCT01232894|101256029|FG000|Overall Study|Physician Decision|2|||
33373815|NCT01232894|101256030|FG001|Overall Study|Physician Decision|1|||
33373816|NCT04501679|101256034|FG000|Overall Study|Pregnancy|0|||
33373817|NCT04501679|101256035|FG001|Overall Study|Pregnancy|1|||
33373818|NCT04501679|101256034|FG000|Overall Study|Adverse Event|4|||
33373819|NCT04501679|101256035|FG001|Overall Study|Adverse Event|2|||
33373820|NCT04501679|101256034|FG000|Overall Study|Withdrawal by Subject|2|||
33423456|NCT00529568|101443476|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
33147773|NCT03845296|100454455|FG000|Overall Study|Refusal unrelated to adverse event|0|||
33245876|NCT02624778|100800264|FG002|Overall Study|Adverse Event|0|||
33373821|NCT04501679|101256035|FG001|Overall Study|Withdrawal by Subject|0|||
33373822|NCT04501679|101256034|FG000|Overall Study|Physician Decision|1|||
33373823|NCT04501679|101256035|FG001|Overall Study|Physician Decision|0|||
33373824|NCT04501679|101256034|FG000|Overall Study|Lost to Follow-up|2|||
33373825|NCT04501679|101256035|FG001|Overall Study|Lost to Follow-up|0|||
33373826|NCT01259856|101256036|FG000|Overall Study|Adverse Event|12|||
33373827|NCT01259856|101256037|FG001|Overall Study|Adverse Event|9|||
33373828|NCT01259856|101256036|FG000|Overall Study|Death|0|||
33373829|NCT01259856|101256037|FG001|Overall Study|Death|1|||
33373830|NCT01259856|101256036|FG000|Overall Study|Lack of Efficacy|3|||
33373831|NCT01259856|101256037|FG001|Overall Study|Lack of Efficacy|1|||
33373832|NCT01259856|101256036|FG000|Overall Study|Lost to Follow-up|1|||
33373833|NCT01259856|101256037|FG001|Overall Study|Lost to Follow-up|1|||
33147774|NCT03845296|100454456|FG001|Overall Study|Refusal unrelated to adverse event|1|||
33373834|NCT01259856|101256036|FG000|Overall Study|Physician Decision|2|||
33147775|NCT03845296|100454455|FG000|Overall Study|Progression/relapse|14|||
33147776|NCT03845296|100454456|FG001|Overall Study|Progression/relapse|18|||
33147777|NCT03845296|100454455|FG000|Overall Study|Death|4|||
33147778|NCT03845296|100454456|FG001|Overall Study|Death|0|||
33147779|NCT03845296|100454455|FG000|Overall Study|Other - not protocol specified|1|||
33147780|NCT03845296|100454456|FG001|Overall Study|Other - not protocol specified|3|||
33147781|NCT01152450|100454458|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
33147782|NCT01152450|100454459|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
33147783|NCT01152450|100454460|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
33147784|NCT01152450|100454461|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
33147785|NCT01152450|100454462|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
33147786|NCT01152450|100454463|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
33147787|NCT01152450|100454458|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
33147788|NCT01152450|100454459|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
33147789|NCT01152450|100454460|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
33147790|NCT01152450|100454461|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
33147791|NCT01152450|100454462|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
33147792|NCT01152450|100454463|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
33147793|NCT01152450|100454458|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33147794|NCT01152450|100454459|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
33147795|NCT01152450|100454460|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
33147796|NCT01152450|100454461|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33147797|NCT01152450|100454462|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33147798|NCT01152450|100454463|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
33147799|NCT03953183|100454469|FG000|Overall Study|Physician Decision|0|||
33147800|NCT03953183|100454470|FG001|Overall Study|Physician Decision|1|||
33147801|NCT03953183|100454469|FG000|Overall Study|Withdrawal by Subject|0|||
33147802|NCT03953183|100454470|FG001|Overall Study|Withdrawal by Subject|1|||
33147803|NCT00737464|100454475|FG000|Overall Study|Adverse Event|1|||
33147804|NCT00737464|100454475|FG000|Overall Study|Death|6|||
33147805|NCT00737464|100454475|FG000|Overall Study|Other - Failure to Return|1|||
33147806|NCT00737464|100454475|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
33147807|NCT00737464|100454475|FG000|Overall Study|Other reasons|4|||
33147808|NCT04622735|100454476|FG000|Overall Study|Lost to Follow-up|1|||
33147809|NCT04622735|100454477|FG001|Overall Study|Lost to Follow-up|2|||
33147810|NCT04622735|100454478|FG002|Overall Study|Lost to Follow-up|1|||
33147811|NCT04622735|100454476|FG000|Overall Study|Adverse Event|0|||
33147812|NCT04622735|100454477|FG001|Overall Study|Adverse Event|0|||
33147813|NCT04622735|100454478|FG002|Overall Study|Adverse Event|1|||
33147814|NCT04622735|100454476|FG000|Overall Study|Protocol Violation|1|||
33147815|NCT04622735|100454477|FG001|Overall Study|Protocol Violation|0|||
33147816|NCT04622735|100454478|FG002|Overall Study|Protocol Violation|0|||
33147817|NCT04690582|100454491|FG000|Overall Study|Withdrawal by Subject|6|||
33147818|NCT04690582|100454492|FG001|Overall Study|Withdrawal by Subject|4|||
33147819|NCT00843726|100456087|FG000|Overall Study|Death|1|||
33147820|NCT00843726|100456088|FG001|Overall Study|Death|0|||
33147821|NCT00843726|100456087|FG000|Overall Study|Withdrawal by Subject|0|||
33147822|NCT00843726|100456088|FG001|Overall Study|Withdrawal by Subject|1|||
33147823|NCT02425644|100456089|FG000|Overall Study|Lost to Follow-up|2|||
33147824|NCT02425644|100456090|FG001|Overall Study|Lost to Follow-up|3|||
33423457|NCT00529568|101443474|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
33423458|NCT00529568|101443475|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
33423459|NCT00529568|101443476|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
33423460|NCT00529568|101443474|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
33423461|NCT00529568|101443475|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
33423462|NCT00529568|101443476|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
33423463|NCT00529568|101443474|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
33423464|NCT00529568|101443475|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
33423465|NCT00529568|101443476|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
33423466|NCT00529568|101443474|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
33423467|NCT00529568|101443475|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
33147825|NCT02425644|100456089|FG000|Overall Study|Withdrawal by Subject|41|||
33584442|NCT01831466|102029024|FG004|Overall Study|Non-compliance with study treatment|0|||
33584443|NCT01831466|102029025|FG005|Overall Study|Non-compliance with study treatment|1|||
33147826|NCT02425644|100456090|FG001|Overall Study|Withdrawal by Subject|36|||
33147827|NCT02425644|100456089|FG000|Overall Study|Lack of Efficacy|3|||
33147828|NCT02425644|100456090|FG001|Overall Study|Lack of Efficacy|10|||
33147829|NCT02425644|100456089|FG000|Overall Study|Adverse Event|13|||
33147830|NCT02425644|100456090|FG001|Overall Study|Adverse Event|3|||
33147831|NCT02425644|100456089|FG000|Overall Study|Death|0|||
33147832|NCT02425644|100456090|FG001|Overall Study|Death|2|||
33147833|NCT02425644|100456089|FG000|Overall Study|Other|18|||
33147834|NCT02425644|100456090|FG001|Overall Study|Other|17|||
33147835|NCT04612790|100456098|FG000|DB Period (Up to 36 Weeks)|Death|1|||
33147836|NCT04612790|100456099|FG001|DB Period (Up to 36 Weeks)|Death|1|||
33147837|NCT04612790|100456100|FG002|DB Period (Up to 36 Weeks)|Death|0|||
33373835|NCT01259856|101256037|FG001|Overall Study|Physician Decision|1|||
33373836|NCT01259856|101256036|FG000|Overall Study|Withdrawal by Subject|9|||
33373837|NCT01259856|101256037|FG001|Overall Study|Withdrawal by Subject|10|||
33373838|NCT01259856|101256036|FG000|Overall Study|Treatment never started|0|||
33373839|NCT01259856|101256037|FG001|Overall Study|Treatment never started|6|||
33373840|NCT01259856|101256036|FG000|Overall Study|Study closure by sponsor|40|||
33373841|NCT01259856|101256037|FG001|Overall Study|Study closure by sponsor|41|||
33373842|NCT01259856|101256036|FG000|Overall Study|Patient developed other disease|0|||
33373843|NCT01259856|101256037|FG001|Overall Study|Patient developed other disease|1|||
33373844|NCT01259856|101256036|FG000|Overall Study|Transfer to another study|0|||
33373845|NCT01259856|101256037|FG001|Overall Study|Transfer to another study|1|||
33373846|NCT01259856|101256036|FG000|Overall Study|Unknown/missing|2|||
33373847|NCT01259856|101256037|FG001|Overall Study|Unknown/missing|2|||
33373848|NCT01795898|101256038|FG000|Overall Study|Adverse Event|27|||
33373849|NCT01795898|101256038|FG000|Overall Study|Lost to Follow-up|20|||
33373850|NCT01795898|101256038|FG000|Overall Study|Withdrawal of consent|6|||
33373851|NCT01795898|101256038|FG000|Overall Study|Diagnosed with metastasis|1|||
33373852|NCT01795898|101256038|FG000|Overall Study|No pain|1|||
33373853|NCT01795898|101256038|FG000|Overall Study|Death|1|||
33373854|NCT01795898|101256038|FG000|Overall Study|Withdrew consent & had adverse events|3|||
33373855|NCT01795898|101256038|FG000|Overall Study|Physician Decision|1|||
33373856|NCT02605447|101256041|FG000|Overall Study|Death|66|||
33373857|NCT02605447|101256041|FG000|Overall Study|Physician Decision|1|||
33373858|NCT02605447|101256041|FG000|Overall Study|Lost to Follow-up|24|||
33373859|NCT02605447|101256041|FG000|Overall Study|Withdrawal by Subject|10|||
33373860|NCT02605447|101256041|FG000|Overall Study|Not disclosed|1|||
33373861|NCT00960934|101256044|FG000|Overall Study|Adverse Event|2|||
33373862|NCT00960934|101256045|FG001|Overall Study|Adverse Event|3|||
33373863|NCT00960934|101256046|FG002|Overall Study|Adverse Event|3|||
33373864|NCT00960934|101256047|FG003|Overall Study|Adverse Event|2|||
33373865|NCT00960934|101256048|FG004|Overall Study|Adverse Event|4|||
33373866|NCT00960934|101256049|FG005|Overall Study|Adverse Event|3|||
33373867|NCT00960934|101256044|FG000|Overall Study|Lack of Efficacy|1|||
33373868|NCT00960934|101256045|FG001|Overall Study|Lack of Efficacy|0|||
33373869|NCT00960934|101256046|FG002|Overall Study|Lack of Efficacy|0|||
33373870|NCT00960934|101256047|FG003|Overall Study|Lack of Efficacy|0|||
33373871|NCT00960934|101256048|FG004|Overall Study|Lack of Efficacy|0|||
33373872|NCT00960934|101256049|FG005|Overall Study|Lack of Efficacy|0|||
33373873|NCT00960934|101256044|FG000|Overall Study|Lost to Follow-up|0|||
33373874|NCT00960934|101256045|FG001|Overall Study|Lost to Follow-up|1|||
33373875|NCT00960934|101256046|FG002|Overall Study|Lost to Follow-up|0|||
33373876|NCT00960934|101256047|FG003|Overall Study|Lost to Follow-up|0|||
33373877|NCT00960934|101256048|FG004|Overall Study|Lost to Follow-up|0|||
33373878|NCT00960934|101256049|FG005|Overall Study|Lost to Follow-up|0|||
33373879|NCT00960934|101256044|FG000|Overall Study|Other|2|||
33373880|NCT00960934|101256045|FG001|Overall Study|Other|1|||
33373881|NCT00960934|101256046|FG002|Overall Study|Other|5|||
33373882|NCT00960934|101256047|FG003|Overall Study|Other|4|||
33373883|NCT00960934|101256048|FG004|Overall Study|Other|2|||
33373884|NCT00960934|101256049|FG005|Overall Study|Other|2|||
33373885|NCT00960934|101256044|FG000|Overall Study|Physician Decision|0|||
33373886|NCT00960934|101256045|FG001|Overall Study|Physician Decision|1|||
33373887|NCT00960934|101256046|FG002|Overall Study|Physician Decision|0|||
33373888|NCT00960934|101256047|FG003|Overall Study|Physician Decision|0|||
33373889|NCT00960934|101256048|FG004|Overall Study|Physician Decision|0|||
33373890|NCT00960934|101256049|FG005|Overall Study|Physician Decision|0|||
33373891|NCT00960934|101256044|FG000|Overall Study|Progressive Disease|1|||
33373892|NCT00960934|101256045|FG001|Overall Study|Progressive Disease|1|||
33373893|NCT00960934|101256046|FG002|Overall Study|Progressive Disease|0|||
33373894|NCT00960934|101256047|FG003|Overall Study|Progressive Disease|0|||
33373895|NCT00960934|101256048|FG004|Overall Study|Progressive Disease|1|||
33373896|NCT00960934|101256049|FG005|Overall Study|Progressive Disease|1|||
33373897|NCT00960934|101256044|FG000|Overall Study|Protocol Violation|3|||
33373898|NCT00960934|101256045|FG001|Overall Study|Protocol Violation|4|||
33373899|NCT00960934|101256046|FG002|Overall Study|Protocol Violation|0|||
33373900|NCT00960934|101256047|FG003|Overall Study|Protocol Violation|3|||
33373901|NCT00960934|101256048|FG004|Overall Study|Protocol Violation|3|||
33373902|NCT00960934|101256049|FG005|Overall Study|Protocol Violation|2|||
33373903|NCT00960934|101256044|FG000|Overall Study|Withdrawal by Subject|5|||
33373904|NCT00960934|101256045|FG001|Overall Study|Withdrawal by Subject|6|||
33373905|NCT00960934|101256046|FG002|Overall Study|Withdrawal by Subject|4|||
33373906|NCT00960934|101256047|FG003|Overall Study|Withdrawal by Subject|5|||
33373907|NCT00960934|101256048|FG004|Overall Study|Withdrawal by Subject|5|||
33373908|NCT00960934|101256049|FG005|Overall Study|Withdrawal by Subject|7|||
33373909|NCT00960934|101256044|FG000|Overall Study|Study Terminated by Sponsor|50|||
33373910|NCT00960934|101256045|FG001|Overall Study|Study Terminated by Sponsor|46|||
33373911|NCT00960934|101256046|FG002|Overall Study|Study Terminated by Sponsor|52|||
33373912|NCT00960934|101256047|FG003|Overall Study|Study Terminated by Sponsor|50|||
33373913|NCT00960934|101256048|FG004|Overall Study|Study Terminated by Sponsor|49|||
33373914|NCT00960934|101256049|FG005|Overall Study|Study Terminated by Sponsor|49|||
33423468|NCT00529568|101443476|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
33423469|NCT03548207|101443477|FG000|Overall Study|Death|10|||
33423470|NCT03548207|101443478|FG001|Overall Study|Death|23|||
33423471|NCT03548207|101443479|FG002|Overall Study|Death|3|||
33423472|NCT03548207|101443477|FG000|Overall Study|Lost to Follow-up|0|||
33423473|NCT03548207|101443478|FG001|Overall Study|Lost to Follow-up|2|||
33423474|NCT03548207|101443479|FG002|Overall Study|Lost to Follow-up|0|||
33423475|NCT03548207|101443477|FG000|Overall Study|Withdrawal by Subject|0|||
33423476|NCT03548207|101443478|FG001|Overall Study|Withdrawal by Subject|3|||
33423477|NCT03548207|101443479|FG002|Overall Study|Withdrawal by Subject|0|||
33584444|NCT01831466|102029026|FG006|Overall Study|Non-compliance with study treatment|0|||
33147838|NCT04612790|100456101|FG003|DB Period (Up to 36 Weeks)|Death|0|||
33147839|NCT04612790|100456098|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
33245877|NCT02624778|100800265|FG003|Overall Study|Adverse Event|0|||
33245878|NCT02624778|100800266|FG004|Overall Study|Adverse Event|0|||
33245879|NCT02624778|100800267|FG005|Overall Study|Adverse Event|0|||
33245880|NCT02624778|100800268|FG006|Overall Study|Adverse Event|0|||
33245881|NCT02624778|100800269|FG007|Overall Study|Adverse Event|0|||
33423478|NCT03548207|101443477|FG000|Overall Study|Sponsor decision|19|||
33423479|NCT03548207|101443478|FG001|Overall Study|Sponsor decision|40|||
33584445|NCT01831466|102029027|FG007|Overall Study|Non-compliance with study treatment|0|||
33584446|NCT01831466|102029028|FG008|Overall Study|Non-compliance with study treatment|0|||
33147840|NCT04612790|100456099|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
33147841|NCT04612790|100456100|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
33147842|NCT04612790|100456101|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
33147843|NCT04612790|100456098|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
33147844|NCT04612790|100456099|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
33147845|NCT04612790|100456100|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
33147846|NCT04612790|100456101|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
33147847|NCT04612790|100456098|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
33147848|NCT04612790|100456099|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
33584447|NCT01831466|102029029|FG009|Overall Study|Non-compliance with study treatment|0|||
33584448|NCT01831466|102029030|FG010|Overall Study|Non-compliance with study treatment|0|||
33584449|NCT01831466|102029031|FG011|Overall Study|Non-compliance with study treatment|0|||
33584450|NCT01831466|102029020|FG000|Overall Study|Death|0|||
33584451|NCT01831466|102029021|FG001|Overall Study|Death|1|||
33584452|NCT01831466|102029022|FG002|Overall Study|Death|0|||
33147849|NCT04612790|100456100|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
33147850|NCT04612790|100456101|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
33147851|NCT04612790|100456098|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
33147852|NCT04612790|100456099|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
33147853|NCT04612790|100456100|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
33147854|NCT04612790|100456101|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
33147855|NCT04612790|100456098|FG000|DB Period (Up to 36 Weeks)|Other|1|||
33147856|NCT04612790|100456099|FG001|DB Period (Up to 36 Weeks)|Other|0|||
33147857|NCT04612790|100456100|FG002|DB Period (Up to 36 Weeks)|Other|0|||
33147858|NCT04612790|100456101|FG003|DB Period (Up to 36 Weeks)|Other|0|||
33147859|NCT04612790|100456098|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
33147860|NCT04612790|100456099|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
33147861|NCT04612790|100456100|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
33147862|NCT04612790|100456101|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
33147863|NCT04612790|100456098|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
33147864|NCT04612790|100456099|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
33147865|NCT04612790|100456100|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
33147866|NCT04612790|100456101|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
33147867|NCT04612790|100456098|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
33147868|NCT04612790|100456099|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
33147869|NCT04612790|100456100|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
33147870|NCT04612790|100456101|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
33147871|NCT04612790|100456098|FG000|OLE Period (Up to 1 Year)|Other|0|||
33147872|NCT04612790|100456099|FG001|OLE Period (Up to 1 Year)|Other|0|||
33147873|NCT04612790|100456100|FG002|OLE Period (Up to 1 Year)|Other|0|||
33147874|NCT04612790|100456101|FG003|OLE Period (Up to 1 Year)|Other|1|||
33147875|NCT03981822|100456102|FG000|Overall Study|Lost to Follow-up|0|||
33147876|NCT03981822|100456103|FG001|Overall Study|Lost to Follow-up|1|||
33147877|NCT03981822|100456104|FG002|Overall Study|Lost to Follow-up|1|||
33147878|NCT03981822|100456105|FG003|Overall Study|Lost to Follow-up|0|||
33147879|NCT03981822|100456106|FG004|Overall Study|Lost to Follow-up|6|||
33147880|NCT03981822|100456107|FG005|Overall Study|Lost to Follow-up|4|||
33147881|NCT03981822|100456108|FG006|Overall Study|Lost to Follow-up|4|||
33147882|NCT03981822|100456109|FG007|Overall Study|Lost to Follow-up|2|||
33147883|NCT03981822|100456102|FG000|Overall Study|Withdrawal by Subject|0|||
33147884|NCT03981822|100456103|FG001|Overall Study|Withdrawal by Subject|1|||
33423480|NCT03548207|101443479|FG002|Overall Study|Sponsor decision|6|||
33584453|NCT01831466|102029023|FG003|Overall Study|Death|0|||
33373915|NCT01253044|101256050|FG000|Overall Study|Lost to Follow-up|38|||
33373916|NCT01253044|101256051|FG001|Overall Study|Lost to Follow-up|29|||
33373917|NCT02045212|101256052|FG000|Overall Study|Adverse Event|0|||
33373918|NCT02045212|101256053|FG001|Overall Study|Adverse Event|1|||
33373919|NCT02045212|101256052|FG000|Overall Study|Withdrawal by Subject|1|||
33373920|NCT02045212|101256053|FG001|Overall Study|Withdrawal by Subject|0|||
33373921|NCT02045212|101256052|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
33373922|NCT02045212|101256053|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
33373923|NCT01640925|101256054|FG000|Overall Study|Withdrawal by Subject|1|||
33373924|NCT01640925|101256055|FG001|Overall Study|Withdrawal by Subject|0|||
33373925|NCT01640925|101256054|FG000|Overall Study|Previously enrolled in this trial|13|||
33373926|NCT01640925|101256055|FG001|Overall Study|Previously enrolled in this trial|11|||
33373927|NCT01328249|101256056|FG000|Overall Study|Adverse Event|3|||
33373928|NCT01328249|101256057|FG001|Overall Study|Adverse Event|0|||
33373929|NCT01328249|101256056|FG000|Overall Study|Disease progression|1|||
33373930|NCT01328249|101256057|FG001|Overall Study|Disease progression|0|||
33584454|NCT01831466|102029024|FG004|Overall Study|Death|0|||
33584455|NCT01831466|102029025|FG005|Overall Study|Death|0|||
33584456|NCT01831466|102029026|FG006|Overall Study|Death|0|||
33584457|NCT01831466|102029027|FG007|Overall Study|Death|0|||
33373931|NCT01328249|101256056|FG000|Overall Study|Withdrawal by Subject|1|||
33373932|NCT01328249|101256057|FG001|Overall Study|Withdrawal by Subject|1|||
33373933|NCT01328249|101256056|FG000|Overall Study|Moved before end of treatment visit|1|||
33373934|NCT01328249|101256057|FG001|Overall Study|Moved before end of treatment visit|0|||
33373935|NCT01328249|101256056|FG000|Overall Study|Subject choice|1|||
33373936|NCT01328249|101256057|FG001|Overall Study|Subject choice|1|||
33373937|NCT01328249|101256056|FG000|Overall Study|Protocol Violation|0|||
33373938|NCT01328249|101256057|FG001|Overall Study|Protocol Violation|1|||
33373939|NCT00028002|101256076|FG000|Overall Study|Withdrawal by Subject|3|||
33373940|NCT00028002|101256076|FG000|Overall Study|Ineligible|8|||
33373941|NCT01276457|101256079|FG000|Core Study|Adverse Event|6|||
33373942|NCT01276457|101256080|FG001|Core Study|Adverse Event|3|||
33373943|NCT01276457|101256079|FG000|Core Study|Lost to Follow-up|1|||
33373944|NCT01276457|101256080|FG001|Core Study|Lost to Follow-up|2|||
33373945|NCT01276457|101256079|FG000|Core Study|Administrative problems|1|||
33373946|NCT01276457|101256080|FG001|Core Study|Administrative problems|1|||
33373947|NCT01276457|101256079|FG000|Core Study|Death|2|||
33373948|NCT01276457|101256080|FG001|Core Study|Death|2|||
33373949|NCT01276457|101256079|FG000|Core Study|Lack of Efficacy|3|||
33373950|NCT01276457|101256080|FG001|Core Study|Lack of Efficacy|12|||
33373951|NCT01276457|101256079|FG000|Extension Study|Lost to Follow-up|3|||
33373952|NCT01276457|101256080|FG001|Extension Study|Lost to Follow-up|0|||
33373953|NCT01276457|101256079|FG000|Extension Study|Death|0|||
33373954|NCT01276457|101256080|FG001|Extension Study|Death|1|||
33373955|NCT01276457|101256079|FG000|Extension Study|Lack of Efficacy|3|||
33373956|NCT01276457|101256080|FG001|Extension Study|Lack of Efficacy|1|||
33373957|NCT01293032|101256081|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
33373958|NCT01293032|101256082|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
33373959|NCT01293032|101256083|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
33373960|NCT01293032|101256084|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
33373961|NCT01293032|101256081|FG000|Treatment|Adverse Event|0|||
33373962|NCT01293032|101256082|FG001|Treatment|Adverse Event|0|||
33373963|NCT01293032|101256083|FG002|Treatment|Adverse Event|1|||
33373964|NCT01293032|101256084|FG003|Treatment|Adverse Event|1|||
33373965|NCT01293032|101256081|FG000|Treatment|Withdrawal by Subject|2|||
33373966|NCT01293032|101256082|FG001|Treatment|Withdrawal by Subject|4|||
33373967|NCT01293032|101256083|FG002|Treatment|Withdrawal by Subject|0|||
33373968|NCT01293032|101256084|FG003|Treatment|Withdrawal by Subject|0|||
33373969|NCT01293032|101256081|FG000|Treatment|Disease Progression, relapse|0|||
33373970|NCT01293032|101256082|FG001|Treatment|Disease Progression, relapse|1|||
33373971|NCT01293032|101256083|FG002|Treatment|Disease Progression, relapse|0|||
33584458|NCT01831466|102029028|FG008|Overall Study|Death|0|||
33584459|NCT01831466|102029029|FG009|Overall Study|Death|0|||
33584460|NCT01831466|102029030|FG010|Overall Study|Death|0|||
33584461|NCT01831466|102029031|FG011|Overall Study|Death|0|||
33373972|NCT01293032|101256084|FG003|Treatment|Disease Progression, relapse|0|||
33373973|NCT01096849|101256085|FG000|Overall Study|Consent Withdrawn|1|||
33373974|NCT01096849|101256086|FG001|Overall Study|Consent Withdrawn|4|||
33245882|NCT02624778|100800270|FG008|Overall Study|Adverse Event|2|||
33373975|NCT01096849|101256087|FG002|Overall Study|Consent Withdrawn|2|||
33584462|NCT01831466|102029020|FG000|Overall Study|Withdrawal by Subject|6|||
33645440|NCT01675167|102252799|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
33373976|NCT01096849|101256085|FG000|Overall Study|Lack of Efficacy|0|||
33373977|NCT01096849|101256086|FG001|Overall Study|Lack of Efficacy|2|||
33584463|NCT01831466|102029021|FG001|Overall Study|Withdrawal by Subject|3|||
33373978|NCT01096849|101256087|FG002|Overall Study|Lack of Efficacy|0|||
33373979|NCT01096849|101256085|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
33584464|NCT01831466|102029022|FG002|Overall Study|Withdrawal by Subject|3|||
33584465|NCT01831466|102029023|FG003|Overall Study|Withdrawal by Subject|3|||
33373980|NCT01096849|101256086|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
33373981|NCT01096849|101256087|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
33373982|NCT01096849|101256085|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
33373983|NCT01096849|101256086|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
33373984|NCT01096849|101256087|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
33373985|NCT01096849|101256085|FG000|Overall Study|Administrative Reasons|0|||
33373986|NCT01096849|101256086|FG001|Overall Study|Administrative Reasons|1|||
33373987|NCT01096849|101256087|FG002|Overall Study|Administrative Reasons|2|||
33423481|NCT03548207|101443477|FG000|Overall Study|Randomized but not treated|6|||
33423482|NCT03548207|101443478|FG001|Overall Study|Randomized but not treated|10|||
33147885|NCT03981822|100456104|FG002|Overall Study|Withdrawal by Subject|0|||
33147886|NCT03981822|100456105|FG003|Overall Study|Withdrawal by Subject|0|||
33423483|NCT03548207|101443479|FG002|Overall Study|Randomized but not treated|4|||
33423484|NCT02657356|101443482|FG000|Overall Study|Death|1|||
33423485|NCT02657356|101443483|FG001|Overall Study|Death|0|||
33147887|NCT03981822|100456106|FG004|Overall Study|Withdrawal by Subject|0|||
33147888|NCT03981822|100456107|FG005|Overall Study|Withdrawal by Subject|1|||
33423486|NCT02657356|101443482|FG000|Overall Study|Withdrawal by Subject|5|||
33423487|NCT02657356|101443483|FG001|Overall Study|Withdrawal by Subject|6|||
33423488|NCT02657356|101443482|FG000|Overall Study|Terminated by Sponsor|8|||
33147889|NCT03981822|100456108|FG006|Overall Study|Withdrawal by Subject|0|||
33147890|NCT03981822|100456109|FG007|Overall Study|Withdrawal by Subject|2|||
33423489|NCT02657356|101443483|FG001|Overall Study|Terminated by Sponsor|5|||
33423490|NCT02657356|101443482|FG000|Overall Study|Rolled over to EAP study|6|||
33423491|NCT02657356|101443483|FG001|Overall Study|Rolled over to EAP study|4|||
33423492|NCT00950599|101443484|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33423493|NCT00950599|101443485|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33423494|NCT00950599|101443486|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33423495|NCT00950599|101443487|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
33147891|NCT03981822|100456102|FG000|Overall Study|COVID-19 Related|0|||
33147892|NCT03981822|100456103|FG001|Overall Study|COVID-19 Related|0|||
33147893|NCT03981822|100456104|FG002|Overall Study|COVID-19 Related|0|||
33147894|NCT03981822|100456105|FG003|Overall Study|COVID-19 Related|0|||
33373988|NCT01096849|101256085|FG000|Overall Study|Lost to Follow-up|1|||
33423496|NCT00950599|101443488|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33423497|NCT00950599|101443489|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33423498|NCT00950599|101443490|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33423499|NCT00950599|101443491|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33423500|NCT00950599|101443492|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33423501|NCT00950599|101443493|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
33423502|NCT00950599|101443484|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33423503|NCT00950599|101443485|FG001|Double-Blind Treatment Period|Adverse Event|1|||
33423504|NCT00950599|101443486|FG002|Double-Blind Treatment Period|Adverse Event|1|||
33423505|NCT00950599|101443487|FG003|Double-Blind Treatment Period|Adverse Event|1|||
33423506|NCT00950599|101443488|FG004|Double-Blind Treatment Period|Adverse Event|1|||
33423507|NCT00950599|101443489|FG005|Double-Blind Treatment Period|Adverse Event|1|||
33584466|NCT01831466|102029024|FG004|Overall Study|Withdrawal by Subject|3|||
33645441|NCT01675167|102252800|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
33245883|NCT02624778|100800262|FG000|Overall Study|Death|0|||
33423508|NCT00950599|101443490|FG006|Double-Blind Treatment Period|Adverse Event|0|||
33423509|NCT00950599|101443491|FG007|Double-Blind Treatment Period|Adverse Event|0|||
33584467|NCT01831466|102029025|FG005|Overall Study|Withdrawal by Subject|5|||
33584468|NCT01831466|102029026|FG006|Overall Study|Withdrawal by Subject|0|||
33584469|NCT01831466|102029027|FG007|Overall Study|Withdrawal by Subject|0|||
33584470|NCT01831466|102029028|FG008|Overall Study|Withdrawal by Subject|0|||
33584471|NCT01831466|102029029|FG009|Overall Study|Withdrawal by Subject|1|||
33584472|NCT01831466|102029030|FG010|Overall Study|Withdrawal by Subject|0|||
33584473|NCT01831466|102029031|FG011|Overall Study|Withdrawal by Subject|1|||
33584474|NCT01831466|102029020|FG000|Overall Study|Lost to Follow-up|0|||
33584475|NCT01831466|102029021|FG001|Overall Study|Lost to Follow-up|1|||
33584476|NCT01831466|102029022|FG002|Overall Study|Lost to Follow-up|4|||
33584477|NCT01831466|102029023|FG003|Overall Study|Lost to Follow-up|2|||
33584478|NCT01831466|102029024|FG004|Overall Study|Lost to Follow-up|0|||
33584479|NCT01831466|102029025|FG005|Overall Study|Lost to Follow-up|3|||
33245884|NCT02624778|100800263|FG001|Overall Study|Death|0|||
33373989|NCT01096849|101256086|FG001|Overall Study|Lost to Follow-up|3|||
33584480|NCT01831466|102029026|FG006|Overall Study|Lost to Follow-up|0|||
33584481|NCT01831466|102029027|FG007|Overall Study|Lost to Follow-up|0|||
33645442|NCT01675167|102252798|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
33147895|NCT03981822|100456106|FG004|Overall Study|COVID-19 Related|2|||
33245885|NCT02624778|100800264|FG002|Overall Study|Death|0|||
33245886|NCT02624778|100800265|FG003|Overall Study|Death|0|||
33373990|NCT01096849|101256087|FG002|Overall Study|Lost to Follow-up|1|||
33147896|NCT03981822|100456107|FG005|Overall Study|COVID-19 Related|1|||
33147897|NCT03981822|100456108|FG006|Overall Study|COVID-19 Related|2|||
33147898|NCT03981822|100456109|FG007|Overall Study|COVID-19 Related|1|||
33147899|NCT00117286|100456110|FG000|Overall Study|Adverse Event|12|||
33147900|NCT00117286|100456111|FG001|Overall Study|Adverse Event|6|||
33147901|NCT00117286|100456110|FG000|Overall Study|Lost to Follow-up|2|||
33147902|NCT00117286|100456111|FG001|Overall Study|Lost to Follow-up|0|||
33147903|NCT00117286|100456110|FG000|Overall Study|Protocol Violation|3|||
33147904|NCT00117286|100456111|FG001|Overall Study|Protocol Violation|3|||
33147905|NCT00117286|100456110|FG000|Overall Study|Withdrawal by Subject|6|||
33147906|NCT00117286|100456111|FG001|Overall Study|Withdrawal by Subject|2|||
33147907|NCT00117286|100456110|FG000|Overall Study|Physician Decision|3|||
33147908|NCT00117286|100456111|FG001|Overall Study|Physician Decision|7|||
33147909|NCT00117286|100456110|FG000|Overall Study|Lack of Efficacy|2|||
33147910|NCT00117286|100456111|FG001|Overall Study|Lack of Efficacy|1|||
33147911|NCT00117286|100456110|FG000|Overall Study|Research site closing|0|||
33147912|NCT00117286|100456111|FG001|Overall Study|Research site closing|2|||
33147913|NCT01155219|100456112|FG000|Overall Study|Adverse Event|3|||
33147914|NCT01155219|100456113|FG001|Overall Study|Adverse Event|1|||
33147915|NCT01155219|100456112|FG000|Overall Study|non-medical reason|1|||
33147916|NCT01155219|100456113|FG001|Overall Study|non-medical reason|2|||
33147917|NCT02495233|100456114|FG000|Overall Study|Miscellaneous|0|||
33147918|NCT02495233|100456115|FG001|Overall Study|Miscellaneous|1|||
33147919|NCT04423939|100456116|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
33147920|NCT04423939|100456117|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
33147921|NCT04423939|100456116|FG000|Overall Study|Death|3|||
33147922|NCT04423939|100456117|FG001|Overall Study|Death|0|||
33147923|NCT04423939|100456116|FG000|Overall Study|Withdrawal by Subject|3|||
33147924|NCT04423939|100456117|FG001|Overall Study|Withdrawal by Subject|0|||
33147925|NCT04423939|100456116|FG000|Overall Study|Caregiver to patient who died|0|||
33147926|NCT04423939|100456117|FG001|Overall Study|Caregiver to patient who died|3|||
33147927|NCT04423939|100456116|FG000|Overall Study|Caregiver to patient who withdrew|0|||
33147928|NCT04423939|100456117|FG001|Overall Study|Caregiver to patient who withdrew|3|||
33147929|NCT06010836|100456118|FG000|Overall Study|Lost to Follow-up|2|||
33147930|NCT06010836|100456119|FG001|Overall Study|Lost to Follow-up|2|||
33147931|NCT06010836|100456118|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
33147932|NCT06010836|100456119|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
33147933|NCT06010836|100456118|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
33147934|NCT06010836|100456119|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
33147935|NCT06010836|100456118|FG000|Overall Study|Did not receive intervention discussion|0|||
33147936|NCT06010836|100456119|FG001|Overall Study|Did not receive intervention discussion|4|||
33147937|NCT01638819|100456120|FG000|Overall Study|Lost to Follow-up|1|||
33147938|NCT01638819|100456121|FG001|Overall Study|Lost to Follow-up|0|||
33147939|NCT00095628|100456122|FG000|Overall Study|Disease progression prior to treatment|1|||
33147940|NCT02962765|100456125|FG000|Overall Study|Protocol Violation|9|||
33147941|NCT02962765|100456125|FG000|Overall Study|Withdrawal by Subject|3|||
33147942|NCT02962765|100456125|FG000|Overall Study|Lost to Follow-up|1|||
33147943|NCT02962765|100456125|FG000|Overall Study|Death|1|||
33147944|NCT02962765|100456125|FG000|Overall Study|Limited access to study medication|3|||
33147945|NCT02105766|100456127|FG000|Overall Study|Physician Decision|1|||
33147946|NCT02105766|100456128|FG001|Overall Study|Physician Decision|1|||
33147947|NCT02105766|100456129|FG002|Overall Study|Physician Decision|0|||
33147948|NCT02105766|100456127|FG000|Overall Study|Lost to Follow-up|2|||
33147949|NCT02105766|100456128|FG001|Overall Study|Lost to Follow-up|0|||
33147950|NCT02105766|100456129|FG002|Overall Study|Lost to Follow-up|0|||
33245887|NCT02624778|100800266|FG004|Overall Study|Death|0|||
33245888|NCT02624778|100800267|FG005|Overall Study|Death|0|||
33245889|NCT02624778|100800268|FG006|Overall Study|Death|1|||
33245890|NCT02624778|100800269|FG007|Overall Study|Death|0|||
33245891|NCT02624778|100800270|FG008|Overall Study|Death|0|||
33423510|NCT00950599|101443492|FG008|Double-Blind Treatment Period|Adverse Event|0|||
33423511|NCT00950599|101443493|FG009|Double-Blind Treatment Period|Adverse Event|0|||
33423512|NCT00950599|101443484|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
33147951|NCT02105766|100456127|FG000|Overall Study|Death|1|||
33147952|NCT02105766|100456128|FG001|Overall Study|Death|1|||
33147953|NCT02105766|100456129|FG002|Overall Study|Death|0|||
33373991|NCT00625365|101256089|FG000|Overall Study|Withdrawal by Subject|1|||
33147954|NCT04123665|100456131|FG000|Overall Study|Withdrawal by Subject|7|||
33147955|NCT04123665|100456132|FG001|Overall Study|Withdrawal by Subject|0|||
33147956|NCT04123665|100456131|FG000|Overall Study|Lost to Follow-up|1|||
33245892|NCT02624778|100800262|FG000|Overall Study|Physician Decision|0|||
33147957|NCT04123665|100456132|FG001|Overall Study|Lost to Follow-up|0|||
33147958|NCT05153473|100456133|FG000|Overall Study|Death|46|||
33147959|NCT05153473|100456133|FG000|Overall Study|Lost to Follow-up|3|||
33245893|NCT02624778|100800263|FG001|Overall Study|Physician Decision|0|||
33245894|NCT02624778|100800264|FG002|Overall Study|Physician Decision|0|||
33147960|NCT04490109|100456135|FG000|Overall Study|Lost to Follow-up|3|||
33645443|NCT01675167|102252799|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
33423513|NCT00950599|101443485|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
33423514|NCT00950599|101443486|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
33423515|NCT00950599|101443487|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
33423516|NCT00950599|101443488|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
33423517|NCT00950599|101443489|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
33423518|NCT00950599|101443490|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
33423519|NCT00950599|101443491|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
33423520|NCT00950599|101443492|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
33423521|NCT00950599|101443493|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
33645444|NCT01675167|102252800|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
33645445|NCT01675167|102252798|FG000|Open-label Titration Phase|Protocol Violation|43|||
33147961|NCT04490109|100456136|FG001|Overall Study|Lost to Follow-up|10|||
33147962|NCT04490109|100456137|FG002|Overall Study|Lost to Follow-up|4|||
33147963|NCT04490109|100456135|FG000|Overall Study|Withdrawal by Subject|8|||
33245895|NCT02624778|100800265|FG003|Overall Study|Physician Decision|0|||
33245896|NCT02624778|100800266|FG004|Overall Study|Physician Decision|0|||
33245897|NCT02624778|100800267|FG005|Overall Study|Physician Decision|0|||
33245898|NCT02624778|100800268|FG006|Overall Study|Physician Decision|0|||
33245899|NCT02624778|100800269|FG007|Overall Study|Physician Decision|3|||
33245900|NCT02624778|100800270|FG008|Overall Study|Physician Decision|3|||
33245901|NCT00926393|100800271|FG000|Overall Study|Withdrawal by Subject|1|||
33245902|NCT00926393|100800272|FG001|Overall Study|Withdrawal by Subject|2|||
33373992|NCT00625365|101256089|FG000|Overall Study|No IV access|5|||
33373993|NCT00625365|101256089|FG000|Overall Study|VSD|1|||
33373994|NCT03453151|101256090|FG000|Overall Study|Withdrawal by Subject|1|||
33373995|NCT03453151|101256090|FG000|Overall Study|Physician Decision|3|||
33373996|NCT00364845|101256091|FG000|Overall Study|Adverse Event|1|||
33373997|NCT00364845|101256092|FG001|Overall Study|Adverse Event|0|||
33373998|NCT00364845|101256091|FG000|Overall Study|Withdrawal by Subject|2|||
33373999|NCT00364845|101256092|FG001|Overall Study|Withdrawal by Subject|1|||
33374000|NCT00364845|101256091|FG000|Overall Study|Physician Decision|8|||
33374001|NCT00364845|101256092|FG001|Overall Study|Physician Decision|8|||
33374002|NCT00364845|101256091|FG000|Overall Study|Lost to Follow-up|0|||
33374003|NCT00364845|101256092|FG001|Overall Study|Lost to Follow-up|1|||
33374004|NCT00364845|101256091|FG000|Overall Study|Death|0|||
33374005|NCT00364845|101256092|FG001|Overall Study|Death|1|||
33374006|NCT02653976|101256093|FG000|Overall Study|Withdrawal by Subject|5|||
33374007|NCT02653976|101256093|FG000|Overall Study|Death|4|||
33374008|NCT02940626|101256094|FG000|Overall Study|Death|40|||
33374009|NCT02940626|101256095|FG001|Overall Study|Death|32|||
33374010|NCT02940626|101256094|FG000|Overall Study|Lost to Follow-up|5|||
33374011|NCT02940626|101256095|FG001|Overall Study|Lost to Follow-up|2|||
33374012|NCT02940626|101256094|FG000|Overall Study|Withdrawal by Subject|1|||
33374013|NCT02940626|101256095|FG001|Overall Study|Withdrawal by Subject|0|||
33374014|NCT02940626|101256094|FG000|Overall Study|Transfer to Hospice Care|1|||
33374015|NCT02940626|101256095|FG001|Overall Study|Transfer to Hospice Care|0|||
33374016|NCT02940626|101256094|FG000|Overall Study|Prohibited Concomitant Medication|0|||
33374017|NCT02940626|101256095|FG001|Overall Study|Prohibited Concomitant Medication|1|||
33374018|NCT02938585|101256097|FG000|Overall Study|Withdrawal by parent or guardian|0|||
33374019|NCT02938585|101256098|FG001|Overall Study|Withdrawal by parent or guardian|1|||
33374020|NCT02938585|101256099|FG002|Overall Study|Withdrawal by parent or guardian|0|||
33374021|NCT02938585|101256100|FG003|Overall Study|Withdrawal by parent or guardian|0|||
33374022|NCT02938585|101256097|FG000|Overall Study|Withdrawal by Subject|0|||
33374023|NCT02938585|101256098|FG001|Overall Study|Withdrawal by Subject|0|||
33374024|NCT02938585|101256099|FG002|Overall Study|Withdrawal by Subject|0|||
33374025|NCT02938585|101256100|FG003|Overall Study|Withdrawal by Subject|5|||
33374026|NCT02330549|101256101|FG000|Overall Study|Adverse Event|1|||
33374027|NCT02330549|101256102|FG001|Overall Study|Adverse Event|0|||
33374028|NCT02330549|101256101|FG000|Overall Study|Subject withdrew consent|2|||
33374029|NCT02330549|101256102|FG001|Overall Study|Subject withdrew consent|1|||
33374030|NCT02330549|101256101|FG000|Overall Study|Failure to meet randomization criteria|1|||
33374031|NCT02330549|101256102|FG001|Overall Study|Failure to meet randomization criteria|0|||
33374032|NCT00786032|101256104|FG000|Overall Study|Death|4|||
33374033|NCT00786032|101256104|FG000|Overall Study|Withdrawal by Subject|14|||
33374034|NCT00786032|101256104|FG000|Overall Study|Did not complete in the timeframe|6|||
33374035|NCT02720016|101256107|FG000|Overall Study|Separation of couple|6|||
33374036|NCT02720016|101256108|FG001|Overall Study|Separation of couple|8|||
33374037|NCT02720016|101256109|FG002|Overall Study|Separation of couple|2|||
33374038|NCT02720016|101256107|FG000|Overall Study|Withdrawal by Subject|6|||
33423522|NCT00950599|101443484|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33584482|NCT01831466|102029028|FG008|Overall Study|Lost to Follow-up|0|||
33245903|NCT00926393|100800271|FG000|Overall Study|Adverse Event|1|||
33374039|NCT02720016|101256108|FG001|Overall Study|Withdrawal by Subject|6|||
33374040|NCT02720016|101256109|FG002|Overall Study|Withdrawal by Subject|4|||
33374041|NCT02720016|101256107|FG000|Overall Study|Scheduling issues|2|||
33147964|NCT04490109|100456136|FG001|Overall Study|Withdrawal by Subject|6|||
33147965|NCT04490109|100456137|FG002|Overall Study|Withdrawal by Subject|9|||
33147966|NCT04490109|100456135|FG000|Overall Study|Physician Decision|0|||
33147967|NCT04490109|100456136|FG001|Overall Study|Physician Decision|2|||
33147968|NCT04490109|100456137|FG002|Overall Study|Physician Decision|3|||
33147969|NCT04490109|100456135|FG000|Overall Study|Adverse Event|2|||
33147970|NCT04490109|100456136|FG001|Overall Study|Adverse Event|1|||
33147971|NCT04490109|100456137|FG002|Overall Study|Adverse Event|0|||
33147972|NCT04490109|100456135|FG000|Overall Study|Significant Non-Compliance|2|||
33147973|NCT04490109|100456136|FG001|Overall Study|Significant Non-Compliance|4|||
33147974|NCT04490109|100456137|FG002|Overall Study|Significant Non-Compliance|4|||
33423523|NCT00950599|101443485|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
33423524|NCT00950599|101443486|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
33423525|NCT00950599|101443487|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
33423526|NCT00950599|101443488|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
33423527|NCT00950599|101443489|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
33423528|NCT00950599|101443490|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
33147975|NCT04490109|100456135|FG000|Overall Study|Significant Clinical Event|0|||
33147976|NCT04490109|100456136|FG001|Overall Study|Significant Clinical Event|1|||
33147977|NCT04490109|100456137|FG002|Overall Study|Significant Clinical Event|0|||
33423529|NCT00950599|101443491|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
33147978|NCT04490109|100456135|FG000|Overall Study|Other Reason|4|||
33147979|NCT04490109|100456136|FG001|Overall Study|Other Reason|1|||
33147980|NCT04490109|100456137|FG002|Overall Study|Other Reason|1|||
33147981|NCT02961218|100456138|FG000|Overall Study|Lost to Follow-up|0|||
33147982|NCT02961218|100456139|FG001|Overall Study|Lost to Follow-up|2|||
33147983|NCT02961218|100456138|FG000|Overall Study|Physician Decision|0|||
33147984|NCT02961218|100456139|FG001|Overall Study|Physician Decision|2|||
33147985|NCT02961218|100456138|FG000|Overall Study|Subject/Guardian Decision|3|||
33147986|NCT02961218|100456139|FG001|Overall Study|Subject/Guardian Decision|1|||
33147987|NCT00625742|100456140|FG000|Overall Study|Disease Progression|2|||
33147988|NCT00625742|100456140|FG000|Overall Study|Withdrawal by Subject|1|||
33147989|NCT00625742|100456140|FG000|Overall Study|Adverse Event|4|||
33147990|NCT00625742|100456140|FG000|Overall Study|Lost to Follow-up|4|||
33147991|NCT00625742|100456140|FG000|Overall Study|Ineligible|1|||
33147992|NCT02675231|100456145|FG000|Overall Study|Withdrawal by Subject|2|||
33147993|NCT02675231|100456146|FG001|Overall Study|Withdrawal by Subject|4|||
33147994|NCT02675231|100456147|FG002|Overall Study|Withdrawal by Subject|2|||
33147995|NCT02675231|100456145|FG000|Overall Study|Lost to Follow-up|3|||
33147996|NCT02675231|100456146|FG001|Overall Study|Lost to Follow-up|4|||
33147997|NCT02675231|100456147|FG002|Overall Study|Lost to Follow-up|3|||
33147998|NCT00174291|100456150|FG000|Overall Study|Lost to Follow-up|1|||
33147999|NCT00174291|100456151|FG001|Overall Study|Lost to Follow-up|1|||
33148000|NCT00174291|100456150|FG000|Overall Study|Protocol Violation|0|||
33148001|NCT00174291|100456151|FG001|Overall Study|Protocol Violation|2|||
33148002|NCT00174291|100456150|FG000|Overall Study|Study terminated by sponsor|1|||
33148003|NCT00174291|100456151|FG001|Overall Study|Study terminated by sponsor|0|||
33148004|NCT00174291|100456150|FG000|Overall Study|Withdrawal by Subject|3|||
33148005|NCT00174291|100456151|FG001|Overall Study|Withdrawal by Subject|3|||
33423530|NCT00950599|101443492|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
33584483|NCT01831466|102029029|FG009|Overall Study|Lost to Follow-up|1|||
33584484|NCT01831466|102029030|FG010|Overall Study|Lost to Follow-up|0|||
33584485|NCT01831466|102029031|FG011|Overall Study|Lost to Follow-up|1|||
33584486|NCT01831466|102029020|FG000|Overall Study|Lack of Efficacy|5|||
33584487|NCT01831466|102029021|FG001|Overall Study|Lack of Efficacy|8|||
33584488|NCT01831466|102029022|FG002|Overall Study|Lack of Efficacy|7|||
33584489|NCT01831466|102029023|FG003|Overall Study|Lack of Efficacy|6|||
33584490|NCT01831466|102029024|FG004|Overall Study|Lack of Efficacy|9|||
33584491|NCT01831466|102029025|FG005|Overall Study|Lack of Efficacy|8|||
33584492|NCT01831466|102029026|FG006|Overall Study|Lack of Efficacy|1|||
33584493|NCT01831466|102029027|FG007|Overall Study|Lack of Efficacy|1|||
33584494|NCT01831466|102029028|FG008|Overall Study|Lack of Efficacy|2|||
33584495|NCT01831466|102029029|FG009|Overall Study|Lack of Efficacy|2|||
33148006|NCT00048061|100456158|FG000|Overall Study|Adverse Event|41|||
33148007|NCT00048061|100456159|FG001|Overall Study|Adverse Event|32|||
33148008|NCT00048061|100456160|FG002|Overall Study|Adverse Event|44|||
33148009|NCT00048061|100456161|FG003|Overall Study|Adverse Event|37|||
33148010|NCT00048061|100456158|FG000|Overall Study|Lost to Follow-up|3|||
33148011|NCT00048061|100456159|FG001|Overall Study|Lost to Follow-up|2|||
33148012|NCT00048061|100456160|FG002|Overall Study|Lost to Follow-up|4|||
33148013|NCT00048061|100456161|FG003|Overall Study|Lost to Follow-up|5|||
33148014|NCT00048061|100456158|FG000|Overall Study|Withdrawal by Subject|20|||
33148015|NCT00048061|100456159|FG001|Overall Study|Withdrawal by Subject|29|||
33584496|NCT01831466|102029030|FG010|Overall Study|Lack of Efficacy|2|||
33584497|NCT01831466|102029031|FG011|Overall Study|Lack of Efficacy|0|||
33148016|NCT00048061|100456160|FG002|Overall Study|Withdrawal by Subject|29|||
33148017|NCT00048061|100456161|FG003|Overall Study|Withdrawal by Subject|32|||
33584498|NCT01831466|102029020|FG000|Overall Study|Adverse Event|0|||
33148018|NCT00048061|100456158|FG000|Overall Study|Did not follow-up|5|||
33148019|NCT00048061|100456159|FG001|Overall Study|Did not follow-up|5|||
33148020|NCT00048061|100456160|FG002|Overall Study|Did not follow-up|4|||
33148021|NCT00048061|100456161|FG003|Overall Study|Did not follow-up|5|||
33148022|NCT00048061|100456158|FG000|Overall Study|Early improvement|6|||
33148023|NCT00048061|100456159|FG001|Overall Study|Early improvement|5|||
33148024|NCT00048061|100456160|FG002|Overall Study|Early improvement|3|||
33148025|NCT00048061|100456161|FG003|Overall Study|Early improvement|0|||
33148026|NCT04854642|100456162|FG000|Overall Study|Adverse Event|1|||
33148027|NCT04854642|100456163|FG001|Overall Study|Adverse Event|2|||
33148028|NCT04854642|100456162|FG000|Overall Study|Withdrawal by Subject|0|||
33148029|NCT04854642|100456163|FG001|Overall Study|Withdrawal by Subject|1|||
33148030|NCT05008055|100456164|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
33148031|NCT05008055|100456165|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
33148032|NCT05008055|100456166|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
33148033|NCT00504582|100456171|FG000|Overall Study|Lost to Follow-up|1|||
33148034|NCT00504582|100456172|FG001|Overall Study|Lost to Follow-up|0|||
33148035|NCT00504582|100456173|FG002|Overall Study|Lost to Follow-up|0|||
33423531|NCT00950599|101443493|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
33423532|NCT00950599|101443484|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
33423533|NCT00950599|101443485|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
33423534|NCT00950599|101443486|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
33423535|NCT00950599|101443487|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
33423536|NCT00950599|101443488|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
33423537|NCT00950599|101443489|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
33423538|NCT00950599|101443490|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
33423539|NCT00950599|101443491|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
33645446|NCT01675167|102252799|FG001|Open-label Titration Phase|Protocol Violation|0|||
33645447|NCT01675167|102252800|FG002|Open-label Titration Phase|Protocol Violation|0|||
33645448|NCT01675167|102252798|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
33245904|NCT00926393|100800272|FG001|Overall Study|Adverse Event|1|||
33423540|NCT00950599|101443492|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
33423541|NCT00950599|101443493|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
33423542|NCT00950599|101443484|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33423543|NCT00950599|101443485|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33423544|NCT00950599|101443486|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33423545|NCT00950599|101443487|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33423546|NCT00950599|101443488|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
33423547|NCT00950599|101443489|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
33423548|NCT00950599|101443490|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33423549|NCT00950599|101443491|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33423550|NCT00950599|101443492|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33584499|NCT01831466|102029021|FG001|Overall Study|Adverse Event|0|||
33584500|NCT01831466|102029022|FG002|Overall Study|Adverse Event|4|||
33584501|NCT01831466|102029023|FG003|Overall Study|Adverse Event|6|||
33584502|NCT01831466|102029024|FG004|Overall Study|Adverse Event|3|||
33584503|NCT01831466|102029025|FG005|Overall Study|Adverse Event|7|||
33584504|NCT01831466|102029026|FG006|Overall Study|Adverse Event|0|||
33584505|NCT01831466|102029027|FG007|Overall Study|Adverse Event|1|||
33584506|NCT01831466|102029028|FG008|Overall Study|Adverse Event|1|||
33584507|NCT01831466|102029029|FG009|Overall Study|Adverse Event|1|||
33584508|NCT01831466|102029030|FG010|Overall Study|Adverse Event|0|||
33584509|NCT01831466|102029031|FG011|Overall Study|Adverse Event|2|||
33584510|NCT02147197|102029036|FG000|Overall Study|Adverse Event|1|||
33584511|NCT02147197|102029037|FG001|Overall Study|Adverse Event|0|||
33584512|NCT02147197|102029038|FG002|Overall Study|Adverse Event|0|||
33584513|NCT02147197|102029036|FG000|Overall Study|Withdrawal of Consent|4|||
33584514|NCT02147197|102029037|FG001|Overall Study|Withdrawal of Consent|3|||
33584515|NCT02147197|102029038|FG002|Overall Study|Withdrawal of Consent|2|||
33584516|NCT02147197|102029036|FG000|Overall Study|Lost to Follow-up|2|||
33584517|NCT02147197|102029037|FG001|Overall Study|Lost to Follow-up|3|||
33584518|NCT02147197|102029038|FG002|Overall Study|Lost to Follow-up|1|||
33645449|NCT01675167|102252799|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
33645450|NCT01675167|102252800|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
33645451|NCT01675167|102252798|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
33584519|NCT02147197|102029036|FG000|Overall Study|Protocol Violation|1|||
33584520|NCT02147197|102029037|FG001|Overall Study|Protocol Violation|0|||
33584521|NCT02147197|102029038|FG002|Overall Study|Protocol Violation|3|||
33148036|NCT05409183|100456174|FG000|Complete Study|Adverse Event|1|||
33148037|NCT05409183|100456175|FG001|Complete Study|Adverse Event|2|||
33148038|NCT05409183|100456174|FG000|Complete Study|Withdrawal by Subject|3|||
33584522|NCT02147197|102029036|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33584523|NCT02147197|102029037|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33645452|NCT01675167|102252799|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
33645453|NCT01675167|102252800|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
33645454|NCT01675167|102252798|FG000|Open-label Titration Phase|Other|55|||
33645455|NCT01675167|102252799|FG001|Open-label Titration Phase|Other|0|||
33645456|NCT01675167|102252800|FG002|Open-label Titration Phase|Other|0|||
33645457|NCT01675167|102252798|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
33645458|NCT01675167|102252799|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
33148039|NCT05409183|100456175|FG001|Complete Study|Withdrawal by Subject|0|||
33148040|NCT06106022|100456176|FG000|Overall Study|Lost to Follow-up|1|||
33148041|NCT06106022|100456177|FG001|Overall Study|Lost to Follow-up|0|||
33148042|NCT06106022|100456176|FG000|Overall Study|Voluntary Withdrawal|0|||
33148043|NCT06106022|100456177|FG001|Overall Study|Voluntary Withdrawal|2|||
33148044|NCT05273749|100456179|FG000|Overall Study|Adverse Event|14|||
33148045|NCT05273749|100456180|FG001|Overall Study|Adverse Event|8|||
33148046|NCT05273749|100456179|FG000|Overall Study|Lack of Efficacy|2|||
33148047|NCT05273749|100456180|FG001|Overall Study|Lack of Efficacy|8|||
33148048|NCT05273749|100456179|FG000|Overall Study|Physician Decision|0|||
33148049|NCT05273749|100456180|FG001|Overall Study|Physician Decision|2|||
33148050|NCT05273749|100456179|FG000|Overall Study|Withdrawal by Subject|14|||
33148051|NCT05273749|100456180|FG001|Overall Study|Withdrawal by Subject|16|||
33148052|NCT05273749|100456179|FG000|Overall Study|Lost to Follow-up|10|||
33148053|NCT05273749|100456180|FG001|Overall Study|Lost to Follow-up|10|||
33148054|NCT05273749|100456179|FG000|Overall Study|Pregnancy|1|||
33148055|NCT05273749|100456180|FG001|Overall Study|Pregnancy|0|||
33148056|NCT05273749|100456179|FG000|Overall Study|Non-Compliance|3|||
33148057|NCT05273749|100456180|FG001|Overall Study|Non-Compliance|2|||
33148058|NCT05273749|100456179|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
33148059|NCT05273749|100456180|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
33148060|NCT02257736|100456181|FG000|Overall Study|Progressive disease|365|||
33148061|NCT02257736|100456182|FG001|Overall Study|Progressive disease|327|||
33148062|NCT02257736|100456181|FG000|Overall Study|Adverse Event|45|||
33148063|NCT02257736|100456182|FG001|Overall Study|Adverse Event|56|||
33148064|NCT02257736|100456181|FG000|Overall Study|Withdrawal by Subject|21|||
33148065|NCT02257736|100456182|FG001|Overall Study|Withdrawal by Subject|38|||
33148066|NCT02257736|100456181|FG000|Overall Study|Death|11|||
33148067|NCT02257736|100456182|FG001|Overall Study|Death|6|||
33148068|NCT02257736|100456181|FG000|Overall Study|Physician Decision|5|||
33148069|NCT02257736|100456182|FG001|Overall Study|Physician Decision|9|||
33148070|NCT02257736|100456181|FG000|Overall Study|Non-Compliance with study drug|1|||
33148071|NCT02257736|100456182|FG001|Overall Study|Non-Compliance with study drug|2|||
33148072|NCT02257736|100456181|FG000|Overall Study|Protocol Violation|1|||
33148073|NCT02257736|100456182|FG001|Overall Study|Protocol Violation|0|||
33148074|NCT02257736|100456181|FG000|Overall Study|Other|1|||
33148075|NCT02257736|100456182|FG001|Overall Study|Other|7|||
33148076|NCT02257736|100456181|FG000|Overall Study|Randomized, not treated|1|||
33148077|NCT02257736|100456182|FG001|Overall Study|Randomized, not treated|2|||
33148078|NCT04541706|100456185|FG000|Overall Study|Withdrawal by Subject|3|||
33148079|NCT04541706|100456185|FG000|Overall Study|Progressive disease|33|||
33148080|NCT04541706|100456185|FG000|Overall Study|Physician Decision|1|||
33148081|NCT04541706|100456185|FG000|Overall Study|Lost to Follow-up|2|||
33148082|NCT04541706|100456185|FG000|Overall Study|Death|5|||
33148083|NCT04541706|100456185|FG000|Overall Study|Adverse Event|1|||
33148084|NCT03524092|100456186|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
33148085|NCT03524092|100456187|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
33148086|NCT03524092|100456188|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
33148087|NCT03524092|100456189|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
33148088|NCT03524092|100456190|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
33148089|NCT03524092|100456191|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
33148090|NCT03524092|100456186|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
33148091|NCT03524092|100456187|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
33148092|NCT03524092|100456188|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
33148093|NCT03524092|100456189|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
33148094|NCT03524092|100456190|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
33245905|NCT02534896|100800273|FG000|Overall Study|Adverse Event|2|||
33245906|NCT02534896|100800274|FG001|Overall Study|Adverse Event|1|||
33423551|NCT00950599|101443493|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
33423552|NCT00950599|101443484|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
33148095|NCT03524092|100456191|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
33148096|NCT03524092|100456186|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
33148097|NCT03524092|100456187|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
33148098|NCT03524092|100456188|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
33148099|NCT03524092|100456189|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
33148100|NCT03524092|100456190|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
33148101|NCT03524092|100456191|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
33148102|NCT03524092|100456186|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
33148103|NCT03524092|100456187|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
33148104|NCT03524092|100456188|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
33148105|NCT03524092|100456189|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
33148106|NCT03524092|100456190|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
33148107|NCT03524092|100456191|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
33148108|NCT03524092|100456186|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
33148109|NCT03524092|100456187|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
33148110|NCT03524092|100456188|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
33148111|NCT03524092|100456189|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
33148112|NCT03524092|100456190|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
33148113|NCT03524092|100456191|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
33148114|NCT03524092|100456186|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
33148115|NCT03524092|100456187|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
33148116|NCT03524092|100456188|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
33148117|NCT03524092|100456189|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
33148118|NCT03524092|100456190|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
33148119|NCT03524092|100456191|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
33148120|NCT03524092|100456186|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
33148121|NCT03524092|100456187|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
33148122|NCT03524092|100456188|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
33148123|NCT03524092|100456189|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
33148124|NCT03524092|100456190|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
33148125|NCT03524092|100456191|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
33148126|NCT03524092|100456186|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
33148127|NCT03524092|100456187|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
33148128|NCT03524092|100456188|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
33148129|NCT03524092|100456189|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
33148130|NCT03524092|100456190|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
33148131|NCT03524092|100456191|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
33148132|NCT03524092|100456186|FG000|Loss of Response Rescue Period|Adverse Event|0|||
33148133|NCT03524092|100456187|FG001|Loss of Response Rescue Period|Adverse Event|0|||
33148134|NCT03524092|100456188|FG002|Loss of Response Rescue Period|Adverse Event|0|||
33148135|NCT03524092|100456189|FG003|Loss of Response Rescue Period|Adverse Event|2|||
33148136|NCT03524092|100456190|FG004|Loss of Response Rescue Period|Adverse Event|0|||
33148137|NCT03524092|100456191|FG005|Loss of Response Rescue Period|Adverse Event|0|||
33148138|NCT03524092|100456186|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
33148139|NCT03524092|100456187|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
33148140|NCT03524092|100456188|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
33148141|NCT03524092|100456189|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
33148142|NCT03524092|100456190|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
33148143|NCT03524092|100456191|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
33645459|NCT01675167|102252800|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
33645460|NCT01675167|102252798|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33645461|NCT01675167|102252799|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
33645462|NCT01675167|102252800|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
33645463|NCT01675167|102252798|FG000|Double-blind Treatment Phase|Adverse Event|0|||
33645464|NCT01675167|102252799|FG001|Double-blind Treatment Phase|Adverse Event|5|||
33645465|NCT01675167|102252800|FG002|Double-blind Treatment Phase|Adverse Event|13|||
33645466|NCT01675167|102252798|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
33645467|NCT01675167|102252799|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
33645468|NCT01675167|102252800|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
33645469|NCT01675167|102252798|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
33645470|NCT01675167|102252799|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
33645471|NCT01675167|102252800|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
33645472|NCT01675167|102252798|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
33645473|NCT01675167|102252799|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
33645474|NCT01675167|102252800|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
33645475|NCT01675167|102252798|FG000|Double-blind Treatment Phase|Other|0|||
33645476|NCT01675167|102252799|FG001|Double-blind Treatment Phase|Other|7|||
33645477|NCT01675167|102252800|FG002|Double-blind Treatment Phase|Other|5|||
33645478|NCT03337490|102252801|FG000|Overall Study|Withdrawal by Subject|1|||
33645479|NCT03337490|102252802|FG001|Overall Study|Withdrawal by Subject|0|||
33645480|NCT03337490|102252803|FG002|Overall Study|Withdrawal by Subject|0|||
33645481|NCT03337490|102252801|FG000|Overall Study|Lack of Efficacy|10|||
33148144|NCT03524092|100456186|FG000|Loss of Response Rescue Period|Pregnancy|0|||
33148145|NCT03524092|100456187|FG001|Loss of Response Rescue Period|Pregnancy|0|||
33148146|NCT03524092|100456188|FG002|Loss of Response Rescue Period|Pregnancy|0|||
33148147|NCT03524092|100456189|FG003|Loss of Response Rescue Period|Pregnancy|1|||
33148148|NCT03524092|100456190|FG004|Loss of Response Rescue Period|Pregnancy|0|||
33148149|NCT03524092|100456191|FG005|Loss of Response Rescue Period|Pregnancy|0|||
33148150|NCT03524092|100456186|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
33148151|NCT03524092|100456187|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
33148152|NCT03524092|100456188|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
33148153|NCT03524092|100456189|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
33148154|NCT03524092|100456190|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
33148155|NCT03524092|100456191|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
33148156|NCT03524092|100456186|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
33148157|NCT03524092|100456187|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
33148158|NCT03524092|100456188|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
33148159|NCT03524092|100456189|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
33148160|NCT03524092|100456190|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
33148161|NCT03524092|100456191|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
33148162|NCT03524092|100456186|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
33148163|NCT03524092|100456187|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
33148164|NCT03524092|100456188|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
33148165|NCT03524092|100456189|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
33148166|NCT03524092|100456190|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
33148167|NCT03524092|100456191|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
33148168|NCT03524092|100456186|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
33148169|NCT03524092|100456187|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
33148170|NCT03524092|100456188|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
33148171|NCT03524092|100456189|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
33148172|NCT03524092|100456190|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
33423553|NCT00950599|101443485|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
33423554|NCT00950599|101443486|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
33423555|NCT00950599|101443487|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
33423556|NCT00950599|101443488|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
33423557|NCT00950599|101443489|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
33423558|NCT00950599|101443490|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
33423559|NCT00950599|101443491|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
33423560|NCT00950599|101443492|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
33148173|NCT03524092|100456191|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
33148174|NCT03524092|100456186|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
33245907|NCT02534896|100800275|FG002|Overall Study|Adverse Event|1|||
33374042|NCT02720016|101256108|FG001|Overall Study|Scheduling issues|4|||
33374043|NCT02720016|101256109|FG002|Overall Study|Scheduling issues|7|||
33374044|NCT02720016|101256107|FG000|Overall Study|Childcare|2|||
33374045|NCT02720016|101256108|FG001|Overall Study|Childcare|0|||
33374046|NCT02720016|101256109|FG002|Overall Study|Childcare|2|||
33374047|NCT02720016|101256107|FG000|Overall Study|Withdrawal by PI|2|||
33374048|NCT02720016|101256108|FG001|Overall Study|Withdrawal by PI|2|||
33374049|NCT02720016|101256109|FG002|Overall Study|Withdrawal by PI|0|||
33374050|NCT02720016|101256107|FG000|Overall Study|Moved away|2|||
33374051|NCT02720016|101256108|FG001|Overall Study|Moved away|0|||
33374052|NCT02720016|101256109|FG002|Overall Study|Moved away|0|||
33374053|NCT02720016|101256107|FG000|Overall Study|Not Primary Health Concern|0|||
33374054|NCT02720016|101256108|FG001|Overall Study|Not Primary Health Concern|0|||
33423561|NCT00950599|101443493|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
33374055|NCT02720016|101256109|FG002|Overall Study|Not Primary Health Concern|2|||
33374056|NCT02720016|101256107|FG000|Overall Study|Transportation issues|0|||
33374057|NCT02720016|101256108|FG001|Overall Study|Transportation issues|0|||
33374058|NCT02720016|101256109|FG002|Overall Study|Transportation issues|1|||
33374059|NCT02720016|101256107|FG000|Overall Study|Other|0|||
33374060|NCT02720016|101256108|FG001|Overall Study|Other|0|||
33374061|NCT02720016|101256109|FG002|Overall Study|Other|2|||
33148175|NCT03524092|100456187|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
33148176|NCT03524092|100456188|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
33148177|NCT03524092|100456189|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
33374062|NCT00568958|101256110|FG000|Allocation|Withdrawal by Subject|7|||
33374063|NCT00568958|101256111|FG001|Allocation|Withdrawal by Subject|3|||
33374064|NCT00568958|101256110|FG000|Allocation|Physician Decision|2|||
33374065|NCT00568958|101256111|FG001|Allocation|Physician Decision|0|||
33423562|NCT00950599|101443484|FG000|Follow-Up Period|Adverse Event|0|||
33374066|NCT00568958|101256110|FG000|Follow-Up|Withdrawal by Subject|6|||
33374067|NCT00568958|101256111|FG001|Follow-Up|Withdrawal by Subject|6|||
33374068|NCT00568958|101256110|FG000|Follow-Up|Physician Decision|1|||
33584524|NCT02147197|102029038|FG002|Overall Study|Other Miscellaneous Reasons|3|||
33584525|NCT02482298|102029042|FG000|Overall Study|Withdrawal by Subject|2|||
33584526|NCT02482298|102029043|FG001|Overall Study|Withdrawal by Subject|1|||
33584527|NCT02482298|102029044|FG002|Overall Study|Withdrawal by Subject|2|||
33584528|NCT02482298|102029042|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
33584529|NCT02482298|102029043|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
33584530|NCT02482298|102029044|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
33584531|NCT02482298|102029042|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
33584532|NCT02482298|102029043|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
33584533|NCT02482298|102029044|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
33584534|NCT02482298|102029042|FG000|Overall Study|Lost to Follow-up|0|||
33584535|NCT02482298|102029043|FG001|Overall Study|Lost to Follow-up|1|||
33584536|NCT02482298|102029044|FG002|Overall Study|Lost to Follow-up|0|||
33584537|NCT01823107|102029045|FG000|Overall Study|Withdrawal by Subject|1|||
33584538|NCT00124072|102029048|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
33584539|NCT00124072|102029049|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
33584540|NCT00124072|102029050|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
33584541|NCT00124072|102029051|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
33584542|NCT00124072|102029048|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
33584543|NCT00124072|102029049|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
33584544|NCT00124072|102029050|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
33584545|NCT00124072|102029051|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
33584546|NCT00124072|102029048|FG000|Overall Study|Death|499|||
33584547|NCT00124072|102029049|FG001|Overall Study|Death|484|||
33584548|NCT00124072|102029050|FG002|Overall Study|Death|471|||
33584549|NCT00124072|102029051|FG003|Overall Study|Death|480|||
33584550|NCT00260832|102029054|FG000|Overall Study|Adverse Event|26|||
33584551|NCT00260832|102029055|FG001|Overall Study|Adverse Event|19|||
33584552|NCT00260832|102029054|FG000|Overall Study|Progression|116|||
33584553|NCT00260832|102029055|FG001|Overall Study|Progression|96|||
33584554|NCT00260832|102029054|FG000|Overall Study|Withdrawal by Subject|15|||
33584555|NCT00260832|102029055|FG001|Overall Study|Withdrawal by Subject|17|||
33423563|NCT00950599|101443485|FG001|Follow-Up Period|Adverse Event|0|||
33423564|NCT00950599|101443486|FG002|Follow-Up Period|Adverse Event|0|||
33423565|NCT00950599|101443487|FG003|Follow-Up Period|Adverse Event|0|||
33423566|NCT00950599|101443488|FG004|Follow-Up Period|Adverse Event|0|||
33423567|NCT00950599|101443489|FG005|Follow-Up Period|Adverse Event|0|||
33423568|NCT00950599|101443490|FG006|Follow-Up Period|Adverse Event|0|||
33423569|NCT00950599|101443491|FG007|Follow-Up Period|Adverse Event|0|||
33423570|NCT00950599|101443492|FG008|Follow-Up Period|Adverse Event|1|||
33423571|NCT00950599|101443493|FG009|Follow-Up Period|Adverse Event|0|||
33423572|NCT00950599|101443484|FG000|Follow-Up Period|Lack of Efficacy|0|||
33423573|NCT00950599|101443485|FG001|Follow-Up Period|Lack of Efficacy|0|||
33423574|NCT00950599|101443486|FG002|Follow-Up Period|Lack of Efficacy|0|||
33423575|NCT00950599|101443487|FG003|Follow-Up Period|Lack of Efficacy|0|||
33423576|NCT00950599|101443488|FG004|Follow-Up Period|Lack of Efficacy|0|||
33423577|NCT00950599|101443489|FG005|Follow-Up Period|Lack of Efficacy|0|||
33423578|NCT00950599|101443490|FG006|Follow-Up Period|Lack of Efficacy|0|||
33423579|NCT00950599|101443491|FG007|Follow-Up Period|Lack of Efficacy|0|||
33423580|NCT00950599|101443492|FG008|Follow-Up Period|Lack of Efficacy|3|||
33423581|NCT00950599|101443493|FG009|Follow-Up Period|Lack of Efficacy|0|||
33423582|NCT00950599|101443484|FG000|Follow-Up Period|Lost to Follow-up|0|||
33423583|NCT00950599|101443485|FG001|Follow-Up Period|Lost to Follow-up|0|||
33423584|NCT00950599|101443486|FG002|Follow-Up Period|Lost to Follow-up|0|||
33423585|NCT00950599|101443487|FG003|Follow-Up Period|Lost to Follow-up|0|||
33584556|NCT00260832|102029054|FG000|Overall Study|Physician Decision|15|||
33584557|NCT00260832|102029055|FG001|Overall Study|Physician Decision|9|||
33584558|NCT00260832|102029054|FG000|Overall Study|Death|43|||
33584559|NCT00260832|102029055|FG001|Overall Study|Death|62|||
33423586|NCT00950599|101443488|FG004|Follow-Up Period|Lost to Follow-up|0|||
33423587|NCT00950599|101443489|FG005|Follow-Up Period|Lost to Follow-up|0|||
33423588|NCT00950599|101443490|FG006|Follow-Up Period|Lost to Follow-up|0|||
33423589|NCT00950599|101443491|FG007|Follow-Up Period|Lost to Follow-up|0|||
33423590|NCT00950599|101443492|FG008|Follow-Up Period|Lost to Follow-up|5|||
33423591|NCT00950599|101443493|FG009|Follow-Up Period|Lost to Follow-up|1|||
33423592|NCT00950599|101443484|FG000|Follow-Up Period|Physician Decision|0|||
33423593|NCT00950599|101443485|FG001|Follow-Up Period|Physician Decision|0|||
33584560|NCT00260832|102029054|FG000|Overall Study|Other|10|||
33584561|NCT00260832|102029055|FG001|Overall Study|Other|7|||
33584562|NCT00260832|102029054|FG000|Overall Study|Protocol Violation|3|||
33584563|NCT00260832|102029055|FG001|Overall Study|Protocol Violation|1|||
33584564|NCT01498692|102029059|FG000|Overall Study|Death|4|||
33584565|NCT01498692|102029059|FG000|Overall Study|Withdrawal by Subject|1|||
33584566|NCT01498692|102029059|FG000|Overall Study|Missed 12-month visit|3|||
33584567|NCT01336712|102029060|FG000|Overall Study|Death|2|||
33584568|NCT01336712|102029060|FG000|Overall Study|Lack of Efficacy|1|||
33584569|NCT00456755|102029061|FG000|Overall Study|Lost to Follow-up|2|||
33584570|NCT00456755|102029062|FG001|Overall Study|Lost to Follow-up|1|||
33584571|NCT00652743|102029063|FG000|Months 12-18|Lost to Follow-up|1|||
33584572|NCT00652743|102029064|FG001|Months 12-18|Lost to Follow-up|2|||
33584573|NCT00652743|102029065|FG002|Months 12-18|Lost to Follow-up|7|||
33584574|NCT00652743|102029063|FG000|Months 24-30|Other|5|||
33584575|NCT00652743|102029064|FG001|Months 24-30|Other|1|||
33584576|NCT00652743|102029065|FG002|Months 24-30|Other|11|||
33584577|NCT00652743|102029063|FG000|Months 36-42|Serious Adverse Events|0|||
33584578|NCT00652743|102029064|FG001|Months 36-42|Serious Adverse Events|1|||
33584579|NCT00652743|102029065|FG002|Months 36-42|Serious Adverse Events|1|||
33584580|NCT00652743|102029063|FG000|Months 36-42|Withdrawal by Subject|1|||
33645482|NCT03337490|102252802|FG001|Overall Study|Lack of Efficacy|12|||
33645483|NCT03337490|102252803|FG002|Overall Study|Lack of Efficacy|35|||
33645484|NCT03337490|102252801|FG000|Overall Study|Physician Decision|0|||
33584581|NCT00652743|102029064|FG001|Months 36-42|Withdrawal by Subject|1|||
33584582|NCT00652743|102029065|FG002|Months 36-42|Withdrawal by Subject|0|||
33584583|NCT00652743|102029063|FG000|Months 36-42|Lost to Follow-up|0|||
33584584|NCT00652743|102029064|FG001|Months 36-42|Lost to Follow-up|1|||
33584585|NCT00652743|102029065|FG002|Months 36-42|Lost to Follow-up|0|||
33584586|NCT00652743|102029063|FG000|Months 36-42|Migrated/moved from study area|1|||
33584587|NCT00652743|102029064|FG001|Months 36-42|Migrated/moved from study area|0|||
33584588|NCT00652743|102029065|FG002|Months 36-42|Migrated/moved from study area|0|||
33584589|NCT00652743|102029063|FG000|Months 36-42|Other|4|||
33584590|NCT00652743|102029064|FG001|Months 36-42|Other|2|||
33584591|NCT00652743|102029065|FG002|Months 36-42|Other|8|||
33584592|NCT03951766|102029066|FG000|Treatment Phase|Lost to Follow-up|1|||
33584593|NCT03951766|102029066|FG000|Follow-up Phase|Lost to Follow-up|10|||
33584594|NCT02243371|102029067|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
33584595|NCT02243371|102029068|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
33584596|NCT02243371|102029067|FG000|Overall Study|Death (unrelated)|2|||
33584597|NCT02243371|102029068|FG001|Overall Study|Death (unrelated)|4|||
33645485|NCT03337490|102252802|FG001|Overall Study|Physician Decision|1|||
33645486|NCT03337490|102252803|FG002|Overall Study|Physician Decision|0|||
33645487|NCT03337490|102252801|FG000|Overall Study|Lost to Follow-up|0|||
33645488|NCT03337490|102252802|FG001|Overall Study|Lost to Follow-up|1|||
33645489|NCT03337490|102252803|FG002|Overall Study|Lost to Follow-up|0|||
33645490|NCT00459186|102252804|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
33645491|NCT00459186|102252804|FG000|PET Imaging and Assessment|Adverse Event|3|||
33645492|NCT04145219|102252805|FG000|Overall Study|Adverse Event|18|||
33645493|NCT04145219|102252806|FG001|Overall Study|Adverse Event|6|||
33645494|NCT04145219|102252805|FG000|Overall Study|Lost to Follow-up|2|||
33645495|NCT04145219|102252806|FG001|Overall Study|Lost to Follow-up|3|||
33645496|NCT04145219|102252805|FG000|Overall Study|Physician Decision|0|||
33645497|NCT04145219|102252806|FG001|Overall Study|Physician Decision|2|||
33645498|NCT04145219|102252805|FG000|Overall Study|Withdrawal by Subject|12|||
33645499|NCT04145219|102252806|FG001|Overall Study|Withdrawal by Subject|8|||
33645500|NCT04145219|102252805|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
33645501|NCT04145219|102252806|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
33645502|NCT00947193|102252807|FG000|Overall Study|Lost to Follow-up|1|||
33645503|NCT00947193|102252808|FG001|Overall Study|Lost to Follow-up|0|||
33645504|NCT00947193|102252807|FG000|Overall Study|Withdrawal by Subject|1|||
33645505|NCT00947193|102252808|FG001|Overall Study|Withdrawal by Subject|0|||
33645506|NCT00947193|102252807|FG000|Overall Study|Factor VIII >1%|1|||
33645507|NCT00947193|102252808|FG001|Overall Study|Factor VIII >1%|0|||
33645508|NCT02238080|102252809|FG000|Overall Study|Death|13|||
33645509|NCT02238080|102252809|FG000|Overall Study|Treatment interrupted|6|||
33645510|NCT02238080|102252809|FG000|Overall Study|Withdrawal by Subject|2|||
33645511|NCT02238080|102252809|FG000|Overall Study|Other|4|||
33645512|NCT00823615|102252810|FG000|Period 2|Lost to Follow-up|2|||
33645513|NCT00823615|102252811|FG001|Period 2|Lost to Follow-up|0|||
33645514|NCT00823615|102252810|FG000|Period 2|Time/Job Conflict|1|||
33645515|NCT00823615|102252811|FG001|Period 2|Time/Job Conflict|2|||
33645516|NCT01587014|102252812|FG000|Overall Study|Death|2|||
33374069|NCT00568958|101256111|FG001|Follow-Up|Physician Decision|1|||
33423594|NCT00950599|101443486|FG002|Follow-Up Period|Physician Decision|0|||
33423595|NCT00950599|101443487|FG003|Follow-Up Period|Physician Decision|0|||
33423596|NCT00950599|101443488|FG004|Follow-Up Period|Physician Decision|0|||
33584598|NCT02243371|102029067|FG000|Overall Study|Adverse Event (unrelated)|0|||
33584599|NCT02243371|102029068|FG001|Overall Study|Adverse Event (unrelated)|1|||
33584600|NCT02243371|102029067|FG000|Overall Study|Lack of Clinical Benefit|0|||
33584601|NCT02243371|102029068|FG001|Overall Study|Lack of Clinical Benefit|1|||
33584602|NCT02243371|102029067|FG000|Overall Study|Withdrawal by Subject|0|||
33584603|NCT02243371|102029068|FG001|Overall Study|Withdrawal by Subject|2|||
33584604|NCT00082368|102029069|FG000|Overall Study|Not treated-pt had poor IV access|1|||
33584605|NCT02720523|102029070|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
33645517|NCT01354899|102256117|FG000|Overall Study|discharge from the hospital|2|||
33645518|NCT01354899|102256117|FG000|Overall Study|Protocol Violation|1|||
33645519|NCT01297491|102256118|FG000|Overall Study|Adverse Event|11|||
33645520|NCT01297491|102256119|FG001|Overall Study|Adverse Event|6|||
33374070|NCT00568958|101256110|FG000|Follow-Up|Family Emergency|1|||
33374071|NCT00568958|101256111|FG001|Follow-Up|Family Emergency|0|||
33374072|NCT00568958|101256110|FG000|Follow-Up|Adverse Event|1|||
33374073|NCT00568958|101256111|FG001|Follow-Up|Adverse Event|0|||
33374074|NCT00418834|101256112|FG000|Overall Study|Adverse Event|16|||
33374075|NCT00418834|101256113|FG001|Overall Study|Adverse Event|9|||
33374076|NCT00418834|101256112|FG000|Overall Study|Lost to Follow-up|0|||
33374077|NCT00418834|101256113|FG001|Overall Study|Lost to Follow-up|1|||
33374078|NCT00418834|101256112|FG000|Overall Study|Protocol Violation|4|||
33374079|NCT00418834|101256113|FG001|Overall Study|Protocol Violation|3|||
33374080|NCT00418834|101256112|FG000|Overall Study|Withdrawal by Subject|3|||
33374081|NCT00418834|101256113|FG001|Overall Study|Withdrawal by Subject|7|||
33374082|NCT00125190|101256116|FG000|Overall Study|Subject/Parent Decision|7|||
33374083|NCT00125190|101256116|FG000|Overall Study|Non-compliance|2|||
33374084|NCT00125190|101256116|FG000|Overall Study|Adverse Event|1|||
33374085|NCT00125190|101256116|FG000|Overall Study|Other|1|||
33374086|NCT00125190|101256116|FG000|Overall Study|Lost to Follow-up|4|||
33374087|NCT01208038|101256119|FG000|Overall Study|Withdrawal by Subject|1|||
33423597|NCT00950599|101443489|FG005|Follow-Up Period|Physician Decision|0|||
33423598|NCT00950599|101443490|FG006|Follow-Up Period|Physician Decision|0|||
33423599|NCT00950599|101443491|FG007|Follow-Up Period|Physician Decision|0|||
33584606|NCT02720523|102029071|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
33374088|NCT01533935|101256120|FG000|Overall Study|Adverse Event|5|||
33374089|NCT01533935|101256121|FG001|Overall Study|Adverse Event|7|||
33374090|NCT01533935|101256122|FG002|Overall Study|Adverse Event|1|||
33374091|NCT01533935|101256123|FG003|Overall Study|Adverse Event|5|||
33374092|NCT01533935|101256124|FG004|Overall Study|Adverse Event|3|||
33374093|NCT01533935|101256120|FG000|Overall Study|Protocol Violation|0|||
33374094|NCT01533935|101256121|FG001|Overall Study|Protocol Violation|2|||
33374095|NCT01533935|101256122|FG002|Overall Study|Protocol Violation|0|||
33374096|NCT01533935|101256123|FG003|Overall Study|Protocol Violation|0|||
33374097|NCT01533935|101256124|FG004|Overall Study|Protocol Violation|0|||
33374098|NCT01533935|101256120|FG000|Overall Study|Lost to Follow-up|0|||
33374099|NCT01533935|101256121|FG001|Overall Study|Lost to Follow-up|0|||
33374100|NCT01533935|101256122|FG002|Overall Study|Lost to Follow-up|1|||
33374101|NCT01533935|101256123|FG003|Overall Study|Lost to Follow-up|0|||
33374102|NCT01533935|101256124|FG004|Overall Study|Lost to Follow-up|0|||
33374103|NCT01533935|101256120|FG000|Overall Study|Withdrawal by Subject|0|||
33374104|NCT01533935|101256121|FG001|Overall Study|Withdrawal by Subject|4|||
33374105|NCT01533935|101256122|FG002|Overall Study|Withdrawal by Subject|5|||
33374106|NCT01533935|101256123|FG003|Overall Study|Withdrawal by Subject|2|||
33374107|NCT01533935|101256124|FG004|Overall Study|Withdrawal by Subject|4|||
33374108|NCT01533935|101256120|FG000|Overall Study|Other reason not defined above|1|||
33374109|NCT01533935|101256121|FG001|Overall Study|Other reason not defined above|0|||
33374110|NCT01533935|101256122|FG002|Overall Study|Other reason not defined above|1|||
33374111|NCT01533935|101256123|FG003|Overall Study|Other reason not defined above|0|||
33374112|NCT01533935|101256124|FG004|Overall Study|Other reason not defined above|1|||
33374113|NCT02457182|101256125|FG000|Overall Study|Lost to Follow-up|1|||
33374114|NCT02457182|101256126|FG001|Overall Study|Lost to Follow-up|0|||
33584607|NCT02720523|102029072|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
33584608|NCT02720523|102029073|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
33584609|NCT02720523|102029074|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
33584610|NCT02720523|102029075|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
33584611|NCT02720523|102029076|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
33584612|NCT02720523|102029070|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
33584613|NCT02720523|102029071|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33148178|NCT03524092|100456190|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
33148179|NCT03524092|100456191|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
33148180|NCT03524092|100456186|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
33148181|NCT03524092|100456187|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
33148182|NCT03524092|100456188|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
33148183|NCT03524092|100456189|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
33374115|NCT02370498|101256127|FG000|Overall Study|Adverse Event|10|||
33374116|NCT02370498|101256128|FG001|Overall Study|Adverse Event|8|||
33374117|NCT02370498|101256127|FG000|Overall Study|Death|263|||
33374118|NCT02370498|101256128|FG001|Overall Study|Death|265|||
33423600|NCT00950599|101443492|FG008|Follow-Up Period|Physician Decision|1|||
33374119|NCT02370498|101256127|FG000|Overall Study|Protocol Violation|1|||
33374120|NCT02370498|101256128|FG001|Overall Study|Protocol Violation|2|||
33374121|NCT02370498|101256127|FG000|Overall Study|Withdrawal by Subject|7|||
33374122|NCT02370498|101256128|FG001|Overall Study|Withdrawal by Subject|12|||
33374123|NCT02370498|101256127|FG000|Overall Study|Sponsor's decision|15|||
33374124|NCT02370498|101256128|FG001|Overall Study|Sponsor's decision|9|||
33374125|NCT03105700|101256129|FG000|Overall Study|screen fail|3|||
33374126|NCT03105700|101256129|FG000|Overall Study|Lost to Follow-up|4|||
33374127|NCT01702363|101256136|FG000|Overall Study|Adverse Event|14|||
33148184|NCT03524092|100456190|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
33148185|NCT03524092|100456191|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
33148186|NCT03524092|100456186|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
33148187|NCT03524092|100456187|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
33148188|NCT03524092|100456188|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
33148189|NCT03524092|100456189|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
33148190|NCT03524092|100456190|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
33148191|NCT03524092|100456191|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
33148192|NCT03524092|100456186|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
33148193|NCT03524092|100456187|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
33148194|NCT03524092|100456188|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
33245908|NCT02534896|100800273|FG000|Overall Study|Insufficient therapeutic response|2|||
33245909|NCT02534896|100800274|FG001|Overall Study|Insufficient therapeutic response|0|||
33245910|NCT02534896|100800275|FG002|Overall Study|Insufficient therapeutic response|0|||
33245911|NCT02540213|100800276|FG000|Overall Study|Death/adverse event|18|||
33584614|NCT02720523|102029072|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33584615|NCT02720523|102029073|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33584616|NCT02720523|102029074|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33645521|NCT01297491|102256118|FG000|Overall Study|Physician Decision|3|||
33645522|NCT01297491|102256119|FG001|Overall Study|Physician Decision|2|||
33645523|NCT01297491|102256118|FG000|Overall Study|Progressive disease|11|||
33645524|NCT01297491|102256119|FG001|Overall Study|Progressive disease|20|||
33645525|NCT01297491|102256118|FG000|Overall Study|Patient/Guardian decision|3|||
33645526|NCT01297491|102256119|FG001|Overall Study|Patient/Guardian decision|4|||
33645527|NCT01297491|102256118|FG000|Overall Study|Death|2|||
33645528|NCT01297491|102256119|FG001|Overall Study|Death|1|||
33584617|NCT02720523|102029075|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33584618|NCT02720523|102029076|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33584619|NCT02720523|102029070|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
33645529|NCT02834793|102256121|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
33245912|NCT02540213|100800276|FG000|Overall Study|Administrative reasons|3|||
33245913|NCT02540213|100800276|FG000|Overall Study|Kidney transplant|3|||
33245914|NCT02540213|100800276|FG000|Overall Study|Lack of Efficacy|6|||
33245915|NCT02540213|100800276|FG000|Overall Study|Consent withdrawn|7|||
33245916|NCT02540213|100800276|FG000|Overall Study|Enrolled but not treated|2|||
33245917|NCT03201757|100800277|FG000|Overall Study|Withdrawal by Subject|133|||
33245918|NCT03201757|100800277|FG000|Overall Study|Adverse Event|44|||
33245919|NCT03201757|100800277|FG000|Overall Study|Lost to Follow-up|37|||
33245920|NCT03201757|100800277|FG000|Overall Study|Pregnancy|2|||
33245921|NCT03201757|100800277|FG000|Overall Study|Lack of Efficacy|1|||
33245922|NCT03201757|100800277|FG000|Overall Study|Protocol Violation|20|||
33584620|NCT02720523|102029071|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
33584621|NCT02720523|102029072|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
33245923|NCT03201757|100800277|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
33245924|NCT03201757|100800277|FG000|Overall Study|Not Yet Determined|5|||
33245925|NCT03201757|100800277|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
33245926|NCT03201757|100800277|FG000|Overall Study|Other|20|||
33245927|NCT04454567|100800278|FG000|Overall Study|Study Terminated by Sponsor|1|||
33245928|NCT04454567|100800279|FG001|Overall Study|Study Terminated by Sponsor|1|||
33245929|NCT01823341|100800280|FG000|Overall Study|Failed run-in|7|||
33245930|NCT01823341|100800280|FG000|Overall Study|Withdrawal by Subject|7|||
33245931|NCT01823341|100800280|FG000|Overall Study|Adverse Event|1|||
33584622|NCT02720523|102029073|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
33584623|NCT02720523|102029074|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
33584624|NCT02720523|102029075|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
33645530|NCT02834793|102256122|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
33645531|NCT02834793|102256123|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
33148195|NCT03524092|100456189|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
33245932|NCT03158948|100800281|FG000|Overall Study|Death|1|||
33245933|NCT03158948|100800282|FG001|Overall Study|Death|1|||
33245934|NCT03158948|100800283|FG002|Overall Study|Death|3|||
33245935|NCT03158948|100800284|FG003|Overall Study|Death|2|||
33245936|NCT03158948|100800281|FG000|Overall Study|Physician Decision|0|||
33245937|NCT03158948|100800282|FG001|Overall Study|Physician Decision|0|||
33245938|NCT03158948|100800283|FG002|Overall Study|Physician Decision|0|||
33245939|NCT03158948|100800284|FG003|Overall Study|Physician Decision|1|||
33245940|NCT00864682|100800289|FG000|Overall Study|Protocol Violation|2|||
33245941|NCT00864682|100800290|FG001|Overall Study|Protocol Violation|1|||
33374128|NCT01702363|101256136|FG000|Overall Study|Lack of Efficacy|4|||
33584625|NCT02720523|102029076|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
33645532|NCT02834793|102256124|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
33645533|NCT02834793|102256121|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
33245942|NCT00864682|100800291|FG002|Overall Study|Protocol Violation|2|||
33245943|NCT01311713|100800294|FG000|Overall Study|Death|0|||
33584626|NCT02720523|102029070|FG000|Period 1: Placebo-controlled Period|Other|0|||
33584627|NCT02720523|102029071|FG001|Period 1: Placebo-controlled Period|Other|0|||
33584628|NCT02720523|102029072|FG002|Period 1: Placebo-controlled Period|Other|1|||
33584629|NCT02720523|102029073|FG003|Period 1: Placebo-controlled Period|Other|1|||
33584630|NCT02720523|102029074|FG004|Period 1: Placebo-controlled Period|Other|0|||
33584631|NCT02720523|102029075|FG005|Period 1: Placebo-controlled Period|Other|0|||
33584632|NCT02720523|102029076|FG006|Period 1: Placebo-controlled Period|Other|0|||
33584633|NCT02720523|102029070|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
33584634|NCT02720523|102029071|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
33584635|NCT02720523|102029072|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
33584636|NCT02720523|102029073|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
33584637|NCT02720523|102029074|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
33245944|NCT01311713|100800295|FG001|Overall Study|Death|0|||
33245945|NCT01311713|100800296|FG002|Overall Study|Death|1|||
33245946|NCT01311713|100800297|FG003|Overall Study|Death|1|||
33245947|NCT01311713|100800298|FG004|Overall Study|Death|0|||
33245948|NCT01311713|100800299|FG005|Overall Study|Death|1|||
33245949|NCT01311713|100800300|FG006|Overall Study|Death|0|||
33245950|NCT01311713|100800294|FG000|Overall Study|Adverse Event|0|||
33245951|NCT01311713|100800295|FG001|Overall Study|Adverse Event|1|||
33245952|NCT01311713|100800296|FG002|Overall Study|Adverse Event|0|||
33584638|NCT02720523|102029075|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
33584639|NCT02720523|102029076|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
33584640|NCT02720523|102029070|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
33584641|NCT02720523|102029071|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
33584642|NCT02720523|102029072|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
33584643|NCT02720523|102029073|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
33584644|NCT02720523|102029074|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
33584645|NCT02720523|102029075|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
33645534|NCT02834793|102256122|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
33645535|NCT02834793|102256123|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
33645536|NCT02834793|102256124|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
33645537|NCT02834793|102256121|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
33645538|NCT02834793|102256122|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
33645539|NCT02834793|102256123|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
33645540|NCT02834793|102256124|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
33245953|NCT01311713|100800297|FG003|Overall Study|Adverse Event|2|||
33584646|NCT02720523|102029076|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
33584647|NCT02720523|102029070|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
33584648|NCT02720523|102029071|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
33584649|NCT02720523|102029072|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
33584650|NCT02720523|102029073|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
33148196|NCT03524092|100456190|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
33245954|NCT01311713|100800298|FG004|Overall Study|Adverse Event|0|||
33245955|NCT01311713|100800299|FG005|Overall Study|Adverse Event|0|||
33245956|NCT01311713|100800300|FG006|Overall Study|Adverse Event|2|||
33245957|NCT01311713|100800294|FG000|Overall Study|Withdrawal by Subject|0|||
33245958|NCT01311713|100800295|FG001|Overall Study|Withdrawal by Subject|1|||
33148197|NCT03524092|100456191|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
33245959|NCT01311713|100800296|FG002|Overall Study|Withdrawal by Subject|1|||
33374129|NCT01702363|101256136|FG000|Overall Study|Withdrawal by Subject|2|||
33374130|NCT04715230|101256138|FG000|Overall Study|Withdrawal by Subject|1|||
33374131|NCT04715230|101256139|FG001|Overall Study|Withdrawal by Subject|0|||
33374132|NCT04715230|101256140|FG002|Overall Study|Withdrawal by Subject|0|||
33374133|NCT04715230|101256138|FG000|Overall Study|Lost to Follow-up|0|||
33374134|NCT04715230|101256139|FG001|Overall Study|Lost to Follow-up|5|||
33374135|NCT04715230|101256140|FG002|Overall Study|Lost to Follow-up|1|||
33374136|NCT01511419|101256141|FG000|Dose 2|Physician Decision|1|||
33374137|NCT01511419|101256142|FG001|Dose 2|Physician Decision|0|||
33374138|NCT02121756|101256143|FG000|Overall Study|Adverse Event|3|||
33423601|NCT00950599|101443493|FG009|Follow-Up Period|Physician Decision|0|||
33584651|NCT02720523|102029074|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
33423602|NCT00950599|101443484|FG000|Follow-Up Period|Poor/Noncompliance|0|||
33423603|NCT00950599|101443485|FG001|Follow-Up Period|Poor/Noncompliance|0|||
33423604|NCT00950599|101443486|FG002|Follow-Up Period|Poor/Noncompliance|0|||
33645541|NCT02834793|102256121|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
33245960|NCT01311713|100800297|FG003|Overall Study|Withdrawal by Subject|0|||
33245961|NCT01311713|100800298|FG004|Overall Study|Withdrawal by Subject|0|||
33245962|NCT01311713|100800299|FG005|Overall Study|Withdrawal by Subject|1|||
33245963|NCT01311713|100800300|FG006|Overall Study|Withdrawal by Subject|2|||
33374139|NCT02121756|101256144|FG001|Overall Study|Adverse Event|0|||
33374140|NCT02121756|101256143|FG000|Overall Study|Protocol Violation|1|||
33245964|NCT01311713|100800294|FG000|Overall Study|Disease progression|3|||
33245965|NCT01311713|100800295|FG001|Overall Study|Disease progression|4|||
33423605|NCT00950599|101443487|FG003|Follow-Up Period|Poor/Noncompliance|0|||
33423606|NCT00950599|101443488|FG004|Follow-Up Period|Poor/Noncompliance|0|||
33423607|NCT00950599|101443489|FG005|Follow-Up Period|Poor/Noncompliance|0|||
33423608|NCT00950599|101443490|FG006|Follow-Up Period|Poor/Noncompliance|0|||
33423609|NCT00950599|101443491|FG007|Follow-Up Period|Poor/Noncompliance|0|||
33423610|NCT00950599|101443492|FG008|Follow-Up Period|Poor/Noncompliance|1|||
33423611|NCT00950599|101443493|FG009|Follow-Up Period|Poor/Noncompliance|0|||
33423612|NCT00950599|101443484|FG000|Follow-Up Period|Subject withdrew Consent|0|||
33423613|NCT00950599|101443485|FG001|Follow-Up Period|Subject withdrew Consent|0|||
33148198|NCT03524092|100456186|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
33148199|NCT03524092|100456187|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
33148200|NCT03524092|100456188|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
33148201|NCT03524092|100456189|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
33148202|NCT03524092|100456190|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
33148203|NCT03524092|100456191|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
33148204|NCT03524092|100456186|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
33148205|NCT03524092|100456187|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
33148206|NCT03524092|100456188|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
33148207|NCT03524092|100456189|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
33148208|NCT03524092|100456190|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
33148209|NCT03524092|100456191|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
33148210|NCT03524092|100456186|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
33148211|NCT03524092|100456187|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
33148212|NCT03524092|100456188|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
33148213|NCT03524092|100456189|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
33423614|NCT00950599|101443486|FG002|Follow-Up Period|Subject withdrew Consent|0|||
33423615|NCT00950599|101443487|FG003|Follow-Up Period|Subject withdrew Consent|0|||
33423616|NCT00950599|101443488|FG004|Follow-Up Period|Subject withdrew Consent|0|||
33423617|NCT00950599|101443489|FG005|Follow-Up Period|Subject withdrew Consent|0|||
33423618|NCT00950599|101443490|FG006|Follow-Up Period|Subject withdrew Consent|0|||
33423619|NCT00950599|101443491|FG007|Follow-Up Period|Subject withdrew Consent|0|||
33584652|NCT02720523|102029075|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
33148214|NCT03524092|100456190|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
33584653|NCT02720523|102029076|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
33584654|NCT02720523|102029070|FG000|Period 2: Long-term Extension Period|Other|0|||
33584655|NCT02720523|102029071|FG001|Period 2: Long-term Extension Period|Other|0|||
33584656|NCT02720523|102029072|FG002|Period 2: Long-term Extension Period|Other|0|||
33584657|NCT02720523|102029073|FG003|Period 2: Long-term Extension Period|Other|0|||
33584658|NCT02720523|102029074|FG004|Period 2: Long-term Extension Period|Other|2|||
33584659|NCT02720523|102029075|FG005|Period 2: Long-term Extension Period|Other|0|||
33584660|NCT02720523|102029076|FG006|Period 2: Long-term Extension Period|Other|3|||
33584661|NCT02342288|102029077|FG000|Overall Study|no protocol anesthesiologist available|3|||
33584662|NCT02342288|102029078|FG001|Overall Study|no protocol anesthesiologist available|2|||
33584663|NCT02342288|102029077|FG000|Overall Study|anesthesia leak in system|1|||
33584664|NCT02342288|102029078|FG001|Overall Study|anesthesia leak in system|0|||
33584665|NCT02342288|102029077|FG000|Overall Study|Withdrawal by Subject|1|||
33148215|NCT03524092|100456191|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
33148216|NCT03524092|100456186|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
33148217|NCT03524092|100456187|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
33148218|NCT03524092|100456188|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
33148219|NCT03524092|100456189|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
33148220|NCT03524092|100456190|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
33148221|NCT03524092|100456191|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
33148222|NCT05691309|100456192|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
33148223|NCT05691309|100456192|FG000|Overall Study|vancomycin levels not evaluable|2|||
33148224|NCT05710107|100456193|FG000|Overall Study|Withdrawal by Subject|1|||
33245966|NCT01311713|100800296|FG002|Overall Study|Disease progression|3|||
33245967|NCT01311713|100800297|FG003|Overall Study|Disease progression|2|||
33245968|NCT01311713|100800298|FG004|Overall Study|Disease progression|4|||
33245969|NCT01311713|100800299|FG005|Overall Study|Disease progression|4|||
33245970|NCT01311713|100800300|FG006|Overall Study|Disease progression|5|||
33423620|NCT00950599|101443492|FG008|Follow-Up Period|Subject withdrew Consent|2|||
33423621|NCT00950599|101443493|FG009|Follow-Up Period|Subject withdrew Consent|1|||
33423622|NCT00606801|101443494|FG000|Intervention|Protocol Violation|3|||
33423623|NCT00606801|101443495|FG001|Intervention|Protocol Violation|3|||
33423624|NCT00543439|101443496|FG000|Period 1|Adverse Event|0|||
33584666|NCT02342288|102029078|FG001|Overall Study|Withdrawal by Subject|0|||
33584667|NCT02342288|102029077|FG000|Overall Study|coordinator contaminated with blood|0|||
33584668|NCT02342288|102029078|FG001|Overall Study|coordinator contaminated with blood|1|||
33584669|NCT02342288|102029077|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
33584670|NCT02342288|102029078|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
33584671|NCT02342288|102029077|FG000|Overall Study|coordinator not available|0|||
33584672|NCT02342288|102029078|FG001|Overall Study|coordinator not available|2|||
33584673|NCT02277691|102029080|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
33584674|NCT02277691|102029080|FG000|Overall Study|Voluntary Withdrawal|7|||
33584675|NCT02277691|102029080|FG000|Overall Study|Lack of Efficacy|5|||
33584676|NCT02277691|102029080|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
33584677|NCT00182078|102029081|FG000|Overall Study|Withdrawal by Subject|1|||
33584678|NCT00182078|102029082|FG001|Overall Study|Withdrawal by Subject|0|||
33584679|NCT00588237|102029083|FG000|Overall Study|Evaluable for toxicity only|3|||
33584680|NCT00588237|102029083|FG000|Overall Study|Patien not treated|1|||
33584681|NCT01846299|102029084|FG000|Overall Study|Physician Decision|4|||
33584682|NCT01846299|102029085|FG001|Overall Study|Physician Decision|2|||
33584683|NCT01846299|102029084|FG000|Overall Study|Protocol deviation|1|||
33584684|NCT01846299|102029085|FG001|Overall Study|Protocol deviation|0|||
33584685|NCT01846299|102029084|FG000|Overall Study|Death|1|||
33584686|NCT01846299|102029085|FG001|Overall Study|Death|2|||
33584687|NCT01846299|102029084|FG000|Overall Study|Lost to Follow-up|3|||
33584688|NCT01846299|102029085|FG001|Overall Study|Lost to Follow-up|0|||
33584689|NCT01846299|102029084|FG000|Overall Study|Withdrawal by Subject|1|||
33584690|NCT01846299|102029085|FG001|Overall Study|Withdrawal by Subject|6|||
33584691|NCT01846299|102029084|FG000|Overall Study|Adverse Event|2|||
33245971|NCT01311713|100800294|FG000|Overall Study|Lost to Follow-up|0|||
33245972|NCT01311713|100800295|FG001|Overall Study|Lost to Follow-up|0|||
33374141|NCT02121756|101256144|FG001|Overall Study|Protocol Violation|1|||
33374142|NCT02121756|101256143|FG000|Overall Study|Physician Decision|2|||
33374143|NCT02121756|101256144|FG001|Overall Study|Physician Decision|1|||
33374144|NCT00712322|101256145|FG000|Overall Study|Protocol deviation|0|||
33374145|NCT00712322|101256146|FG001|Overall Study|Protocol deviation|1|||
33374146|NCT00712322|101256147|FG002|Overall Study|Protocol deviation|0|||
33374147|NCT03009539|101256148|FG000|Overall Study|Lost to Follow-up|132|||
33374148|NCT03009539|101256149|FG001|Overall Study|Lost to Follow-up|113|||
33374149|NCT03009539|101256150|FG002|Overall Study|Lost to Follow-up|132|||
33374150|NCT03009539|101256151|FG003|Overall Study|Lost to Follow-up|113|||
33374151|NCT02125331|101256152|FG000|Overall Study|Protocol Violation|1|||
33374152|NCT02125331|101256153|FG001|Overall Study|Protocol Violation|0|||
33374153|NCT02125331|101256152|FG000|Overall Study|technical problem|2|||
33374154|NCT02125331|101256153|FG001|Overall Study|technical problem|0|||
33374155|NCT02125331|101256152|FG000|Overall Study|screen failure|2|||
33374156|NCT02125331|101256153|FG001|Overall Study|screen failure|0|||
33374157|NCT02953782|101256154|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
33245973|NCT01311713|100800296|FG002|Overall Study|Lost to Follow-up|1|||
33245974|NCT01311713|100800297|FG003|Overall Study|Lost to Follow-up|0|||
33245975|NCT01311713|100800298|FG004|Overall Study|Lost to Follow-up|0|||
33245976|NCT01311713|100800299|FG005|Overall Study|Lost to Follow-up|0|||
33245977|NCT01311713|100800300|FG006|Overall Study|Lost to Follow-up|0|||
33245978|NCT01311713|100800294|FG000|Overall Study|Stopped taking study medication|0|||
33245979|NCT01311713|100800295|FG001|Overall Study|Stopped taking study medication|0|||
33245980|NCT01311713|100800296|FG002|Overall Study|Stopped taking study medication|0|||
33245981|NCT01311713|100800297|FG003|Overall Study|Stopped taking study medication|1|||
33245982|NCT01311713|100800298|FG004|Overall Study|Stopped taking study medication|1|||
33245983|NCT01311713|100800299|FG005|Overall Study|Stopped taking study medication|0|||
33245984|NCT01311713|100800300|FG006|Overall Study|Stopped taking study medication|0|||
33245985|NCT01311713|100800294|FG000|Overall Study|Enrolled but not treated|0|||
33245986|NCT01311713|100800295|FG001|Overall Study|Enrolled but not treated|0|||
33245987|NCT01311713|100800296|FG002|Overall Study|Enrolled but not treated|1|||
33245988|NCT01311713|100800297|FG003|Overall Study|Enrolled but not treated|0|||
33245989|NCT01311713|100800298|FG004|Overall Study|Enrolled but not treated|0|||
33245990|NCT01311713|100800299|FG005|Overall Study|Enrolled but not treated|0|||
33245991|NCT01311713|100800300|FG006|Overall Study|Enrolled but not treated|0|||
33245992|NCT01311713|100800294|FG000|Overall Study|Other than specified|0|||
33374158|NCT02953782|101256155|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
33374159|NCT02953782|101256156|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
33374160|NCT02953782|101256157|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
33374161|NCT02953782|101256158|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
33374162|NCT02953782|101256159|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
33423625|NCT00543439|101443497|FG001|Period 1|Adverse Event|2|||
33584692|NCT01846299|102029085|FG001|Overall Study|Adverse Event|0|||
33584693|NCT00902850|102029086|FG000|Overall Study|Physician Decision|2|||
33584694|NCT00902850|102029087|FG001|Overall Study|Physician Decision|2|||
33584695|NCT00656058|102029088|FG000|Overall Study|Withdrawal by Subject|2|||
33584696|NCT00656058|102029088|FG000|Overall Study|Withdrawal by Subject|4|||
33584697|NCT00682929|102029089|FG000|Overall Study|Adverse Event|4|||
33374163|NCT02953782|101256160|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
33374164|NCT02953782|101256161|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
33374165|NCT02953782|101256154|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
33374166|NCT02953782|101256155|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
33374167|NCT02953782|101256156|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
33374168|NCT02953782|101256157|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
33584698|NCT00682929|102029090|FG001|Overall Study|Adverse Event|1|||
33584699|NCT00682929|102029091|FG002|Overall Study|Adverse Event|1|||
33374169|NCT02953782|101256158|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
33374170|NCT02953782|101256159|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
33374171|NCT02953782|101256160|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
33374172|NCT02953782|101256161|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
33584700|NCT00682929|102029089|FG000|Overall Study|Withdrawal by Subject|1|||
33584701|NCT00682929|102029090|FG001|Overall Study|Withdrawal by Subject|2|||
33584702|NCT00682929|102029091|FG002|Overall Study|Withdrawal by Subject|1|||
33584703|NCT00682929|102029089|FG000|Overall Study|dosing compliance < 80%|0|||
33584704|NCT00682929|102029090|FG001|Overall Study|dosing compliance < 80%|2|||
33584705|NCT00682929|102029091|FG002|Overall Study|dosing compliance < 80%|0|||
33584706|NCT00682929|102029089|FG000|Overall Study|lag in DEA renewal|1|||
33584707|NCT00682929|102029090|FG001|Overall Study|lag in DEA renewal|0|||
33584708|NCT00682929|102029091|FG002|Overall Study|lag in DEA renewal|0|||
33584709|NCT00851552|102029094|FG000|Overall Study|Death|2|||
33584710|NCT00851552|102029094|FG000|Overall Study|Adverse Event|1|||
33584711|NCT00851552|102029094|FG000|Overall Study|Disease Progression|4|||
33584712|NCT00688467|102029096|FG000|Treatment Period 1|Adverse Event|2|||
33584713|NCT00688467|102029097|FG001|Treatment Period 1|Adverse Event|1|||
33584714|NCT00688467|102029096|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
33584715|NCT00688467|102029097|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
33584716|NCT00688467|102029096|FG000|Treatment Period 2|Protocol Violation|0|||
33584717|NCT00688467|102029097|FG001|Treatment Period 2|Protocol Violation|1|||
33584718|NCT00688467|102029096|FG000|Treatment Period 2|Adverse Event|0|||
33584719|NCT00688467|102029097|FG001|Treatment Period 2|Adverse Event|1|||
33584720|NCT02964273|102029098|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
33584721|NCT02964273|102029099|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
33584722|NCT02964273|102029100|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
33584723|NCT02964273|102029101|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
33584724|NCT02964273|102029098|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
33584725|NCT02964273|102029099|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
33584726|NCT02964273|102029100|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
33584727|NCT02964273|102029101|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
33584728|NCT02964273|102029098|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
33584729|NCT02964273|102029099|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
33584730|NCT02964273|102029100|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
33584731|NCT02964273|102029101|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
33584732|NCT02964273|102029098|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
33584733|NCT02964273|102029099|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
33584734|NCT02964273|102029100|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
33584735|NCT02964273|102029101|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
33584736|NCT02964273|102029098|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
33584737|NCT02964273|102029099|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
33584738|NCT02964273|102029100|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
33584739|NCT02964273|102029101|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
33584740|NCT02964273|102029098|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
33584741|NCT02964273|102029099|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
33584742|NCT02964273|102029100|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
33584743|NCT02964273|102029101|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
33584744|NCT03583359|102029102|FG000|Overall Study|Withdrawal by Subject|15|||
33584745|NCT03583359|102029103|FG001|Overall Study|Withdrawal by Subject|6|||
33584746|NCT03583359|102029102|FG000|Overall Study|Lost to Follow-up|12|||
33584747|NCT03583359|102029103|FG001|Overall Study|Lost to Follow-up|3|||
33584748|NCT03583359|102029102|FG000|Overall Study|Adverse Event|0|||
33584749|NCT03583359|102029103|FG001|Overall Study|Adverse Event|1|||
33645542|NCT02834793|102256122|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
33645543|NCT02834793|102256123|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
33148225|NCT05710107|100456194|FG001|Overall Study|Withdrawal by Subject|1|||
33148226|NCT05710107|100456193|FG000|Overall Study|Lost to Follow-up|8|||
33584750|NCT03583359|102029102|FG000|Overall Study|Protocol Violation|0|||
33584751|NCT03583359|102029103|FG001|Overall Study|Protocol Violation|1|||
33584752|NCT03583359|102029102|FG000|Overall Study|Other|2|||
33148227|NCT05710107|100456194|FG001|Overall Study|Lost to Follow-up|9|||
33584753|NCT03583359|102029103|FG001|Overall Study|Other|1|||
33584754|NCT01995526|102029104|FG000|Overall Study|Physician Decision|1|||
33584755|NCT01144416|102029105|FG000|Intervention Period|Adverse Event|5|||
33584756|NCT01144416|102029106|FG001|Intervention Period|Adverse Event|6|||
33584757|NCT01144416|102029105|FG000|Intervention Period|Insufficient ovarian response|11|||
33584758|NCT01144416|102029106|FG001|Intervention Period|Insufficient ovarian response|17|||
33645544|NCT02834793|102256124|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
33645545|NCT02834793|102256121|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
33645546|NCT02834793|102256122|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
33645547|NCT02834793|102256123|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
33645548|NCT02834793|102256124|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
33645549|NCT02834793|102256121|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
33645550|NCT02834793|102256122|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
33584759|NCT01144416|102029105|FG000|Intervention Period|Risk of OHSS|0|||
33584760|NCT01144416|102029106|FG001|Intervention Period|Risk of OHSS|1|||
33584761|NCT01144416|102029105|FG000|Intervention Period|Too high ovarian response|4|||
33584762|NCT01144416|102029106|FG001|Intervention Period|Too high ovarian response|2|||
33645551|NCT02834793|102256123|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
33645552|NCT02834793|102256124|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
33645553|NCT02834793|102256121|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
33645554|NCT02834793|102256122|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
33645555|NCT02834793|102256123|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
33645556|NCT02834793|102256124|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
33645557|NCT02834793|102256121|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
33645558|NCT02834793|102256122|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
33245993|NCT01311713|100800295|FG001|Overall Study|Other than specified|1|||
33245994|NCT01311713|100800296|FG002|Overall Study|Other than specified|2|||
33245995|NCT01311713|100800297|FG003|Overall Study|Other than specified|0|||
33245996|NCT01311713|100800298|FG004|Overall Study|Other than specified|0|||
33245997|NCT01311713|100800299|FG005|Overall Study|Other than specified|0|||
33245998|NCT01311713|100800300|FG006|Overall Study|Other than specified|0|||
33245999|NCT02062827|100800301|FG000|Overall Study|Death|1|||
33246000|NCT02062827|100800302|FG001|Overall Study|Death|0|||
33246001|NCT02062827|100800303|FG002|Overall Study|Death|0|||
33246002|NCT02062827|100800304|FG003|Overall Study|Death|0|||
33246003|NCT02062827|100800305|FG004|Overall Study|Death|0|||
33374173|NCT02953782|101256154|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
33374174|NCT02953782|101256155|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
33374175|NCT02953782|101256156|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
33374176|NCT02953782|101256157|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
33374177|NCT02953782|101256158|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
33584763|NCT01144416|102029105|FG000|Intervention Period|No/too few/bad oocytes|7|||
33584764|NCT01144416|102029106|FG001|Intervention Period|No/too few/bad oocytes|5|||
33645559|NCT02834793|102256123|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
33645560|NCT02834793|102256124|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
33645561|NCT02834793|102256121|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
33645562|NCT02834793|102256122|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
33645563|NCT02834793|102256123|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
33645564|NCT02834793|102256124|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
33645565|NCT02834793|102256121|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
33645566|NCT02834793|102256122|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
33645567|NCT02834793|102256123|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
33645568|NCT02834793|102256124|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
33645569|NCT02834793|102256121|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
33645570|NCT02834793|102256122|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
33645571|NCT02834793|102256123|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
33645572|NCT02834793|102256124|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
33645573|NCT02834793|102256121|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
33645574|NCT02834793|102256122|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
33645575|NCT02834793|102256123|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
33645576|NCT02834793|102256124|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
33645577|NCT02834793|102256121|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
33246004|NCT02062827|100800306|FG005|Overall Study|Death|0|||
33246005|NCT02062827|100800307|FG006|Overall Study|Death|0|||
33374178|NCT02953782|101256159|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
33584765|NCT01144416|102029105|FG000|Intervention Period|No or abnormal fertilization|25|||
33246006|NCT02062827|100800308|FG007|Overall Study|Death|0|||
33246007|NCT02062827|100800301|FG000|Overall Study|Withdrawal by Subject|3|||
33246008|NCT02062827|100800302|FG001|Overall Study|Withdrawal by Subject|1|||
33584766|NCT01144416|102029106|FG001|Intervention Period|No or abnormal fertilization|10|||
33645578|NCT02834793|102256122|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
33645579|NCT02834793|102256123|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
33374179|NCT02953782|101256160|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
33374180|NCT02953782|101256161|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
33374181|NCT02953782|101256154|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
33374182|NCT02953782|101256155|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
33374183|NCT02953782|101256156|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
33374184|NCT02953782|101256157|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
33374185|NCT02953782|101256158|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
33374186|NCT02953782|101256159|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
33374187|NCT02953782|101256160|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
33374188|NCT02953782|101256161|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
33374189|NCT02953782|101256154|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
33374190|NCT02953782|101256155|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
33374191|NCT02953782|101256156|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
33374192|NCT02953782|101256157|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
33374193|NCT02953782|101256158|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
33374194|NCT02953782|101256159|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
33374195|NCT02953782|101256160|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
33374196|NCT02953782|101256161|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
33374197|NCT02953782|101256154|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
33374198|NCT02953782|101256155|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
33374199|NCT02953782|101256156|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
33374200|NCT02953782|101256157|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
33374201|NCT02953782|101256158|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
33374202|NCT02953782|101256159|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
33374203|NCT02953782|101256160|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
33374204|NCT02953782|101256161|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
33374205|NCT02953782|101256154|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
33374206|NCT02953782|101256155|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
33374207|NCT02953782|101256156|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
33374208|NCT02953782|101256157|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
33374209|NCT02953782|101256158|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
33374210|NCT02953782|101256159|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
33374211|NCT02953782|101256160|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
33374212|NCT02953782|101256161|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
33374213|NCT02953782|101256154|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
33374214|NCT02953782|101256155|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
33374215|NCT02953782|101256156|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
33374216|NCT02953782|101256157|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
33584767|NCT01144416|102029105|FG000|Intervention Period|No/too few/bad quality embryos|3|||
33246009|NCT02062827|100800303|FG002|Overall Study|Withdrawal by Subject|1|||
33246010|NCT02062827|100800304|FG003|Overall Study|Withdrawal by Subject|2|||
33246011|NCT02062827|100800305|FG004|Overall Study|Withdrawal by Subject|6|||
33246012|NCT02062827|100800306|FG005|Overall Study|Withdrawal by Subject|0|||
33246013|NCT02062827|100800307|FG006|Overall Study|Withdrawal by Subject|5|||
33246014|NCT02062827|100800308|FG007|Overall Study|Withdrawal by Subject|0|||
33246015|NCT02062827|100800301|FG000|Overall Study|Screen Fail|0|||
33246016|NCT02062827|100800302|FG001|Overall Study|Screen Fail|0|||
33246017|NCT02062827|100800303|FG002|Overall Study|Screen Fail|0|||
33246018|NCT02062827|100800304|FG003|Overall Study|Screen Fail|0|||
33246019|NCT02062827|100800305|FG004|Overall Study|Screen Fail|0|||
33246020|NCT02062827|100800306|FG005|Overall Study|Screen Fail|0|||
33246021|NCT02062827|100800307|FG006|Overall Study|Screen Fail|0|||
33246022|NCT02062827|100800308|FG007|Overall Study|Screen Fail|8|||
33246023|NCT03732820|100800313|FG000|Overall Study|Death|168|||
33246024|NCT03732820|100800314|FG001|Overall Study|Death|203|||
33246025|NCT03732820|100800313|FG000|Overall Study|Other|2|||
33246026|NCT03732820|100800314|FG001|Overall Study|Other|2|||
33246027|NCT03732820|100800313|FG000|Overall Study|Failure to meet randomisation criteria|1|||
33246028|NCT03732820|100800314|FG001|Overall Study|Failure to meet randomisation criteria|1|||
33246029|NCT03732820|100800313|FG000|Overall Study|Patient decision|14|||
33246030|NCT03732820|100800314|FG001|Overall Study|Patient decision|10|||
33246031|NCT03732820|100800313|FG000|Overall Study|Screen failure|0|||
33246032|NCT03732820|100800314|FG001|Overall Study|Screen failure|1|||
33246033|NCT03732820|100800313|FG000|Overall Study|Patients ongoing study at data cut off|210|||
33246034|NCT03732820|100800314|FG001|Overall Study|Patients ongoing study at data cut off|178|||
33374217|NCT02953782|101256158|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
33374218|NCT02953782|101256159|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
33374219|NCT02953782|101256160|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
33374220|NCT02953782|101256161|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
33374221|NCT03151148|101256162|FG000|Overall Study|Lost to Follow-up|1|||
33374222|NCT03151148|101256163|FG001|Overall Study|Lost to Follow-up|0|||
33374223|NCT03151148|101256162|FG000|Overall Study|Withdrawal by Subject|1|||
33374224|NCT03151148|101256163|FG001|Overall Study|Withdrawal by Subject|0|||
33374225|NCT01842308|101256165|FG000|Overall Study|Withdrawal by Subject|0|||
33374226|NCT01842308|101256166|FG001|Overall Study|Withdrawal by Subject|0|||
33374227|NCT01842308|101256167|FG002|Overall Study|Withdrawal by Subject|0|||
33374228|NCT01842308|101256168|FG003|Overall Study|Withdrawal by Subject|0|||
33374229|NCT01842308|101256169|FG004|Overall Study|Withdrawal by Subject|1|||
33374230|NCT00471536|101256170|FG000|Overall Study|Withdrawal by Subject|1|||
33374231|NCT04494633|101258475|FG000|Overall Study|Lost to Follow-up|5|||
33374232|NCT04494633|101258476|FG001|Overall Study|Lost to Follow-up|3|||
33374233|NCT04494633|101258475|FG000|Overall Study|Protocol Violation|1|||
33374234|NCT04494633|101258476|FG001|Overall Study|Protocol Violation|1|||
33374235|NCT00608530|101258477|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
33374236|NCT00608530|101258478|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
33374237|NCT00608530|101258479|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
33374238|NCT00608530|101258480|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
33374239|NCT00608530|101258477|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
33374240|NCT00608530|101258478|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
33374241|NCT00608530|101258479|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
33374242|NCT00608530|101258480|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
33374243|NCT00608530|101258477|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
33374244|NCT00608530|101258478|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
33374245|NCT00608530|101258479|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
33374246|NCT00608530|101258480|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
33374247|NCT00608530|101258477|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
33374248|NCT00608530|101258478|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
33374249|NCT00608530|101258479|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
33374250|NCT00608530|101258480|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
33374251|NCT00608530|101258477|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
33374252|NCT00608530|101258478|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
33374253|NCT00608530|101258479|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
33374254|NCT00608530|101258480|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
33374255|NCT00608530|101258477|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
33374256|NCT00608530|101258478|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
33374257|NCT00608530|101258479|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
33374258|NCT00608530|101258480|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
33374259|NCT04737031|101258483|FG000|Overall Study|Patients who did not have a treatment visit|0|||
33374260|NCT04737031|101258484|FG001|Overall Study|Patients who did not have a treatment visit|31|||
33374261|NCT04737031|101258485|FG002|Overall Study|Patients who did not have a treatment visit|93|||
33374262|NCT04737031|101258486|FG003|Overall Study|Patients who did not have a treatment visit|227|||
33374263|NCT03029650|101258489|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
33374264|NCT03029650|101258490|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
33374265|NCT03029650|101258489|FG000|Washout (1 Week)|Physician Decision|0|||
33374266|NCT03029650|101258490|FG001|Washout (1 Week)|Physician Decision|1|||
33374267|NCT01626352|101258494|FG000|Overall Study|Disease Progression|3|||
33374268|NCT01626352|101258494|FG000|Overall Study|Intercurrent Illness|2|||
33374269|NCT01626352|101258494|FG000|Overall Study|Death|2|||
33374270|NCT01626352|101258494|FG000|Overall Study|Withdrawal by Subject|1|||
33374271|NCT01626352|101258494|FG000|Overall Study|Non-Compliance|1|||
33374272|NCT01626352|101258494|FG000|Overall Study|Never Treated|1|||
33374273|NCT01449682|101258495|FG000|Overall Study|Death|0|||
33374274|NCT01449682|101258496|FG001|Overall Study|Death|1|||
33374275|NCT01449682|101258495|FG000|Overall Study|Adverse Event|1|||
33374276|NCT01449682|101258496|FG001|Overall Study|Adverse Event|0|||
33374277|NCT02078713|101258500|FG000|Overall Study|Lost to Follow-up|49|||
33374278|NCT02078713|101258501|FG001|Overall Study|Lost to Follow-up|55|||
33374279|NCT02078713|101258502|FG002|Overall Study|Lost to Follow-up|0|||
33374280|NCT02078713|101258503|FG003|Overall Study|Lost to Follow-up|0|||
33374281|NCT02078713|101258500|FG000|Overall Study|Pregnant at baseline|3|||
33374282|NCT02078713|101258501|FG001|Overall Study|Pregnant at baseline|5|||
33374283|NCT02078713|101258502|FG002|Overall Study|Pregnant at baseline|0|||
33423626|NCT00543439|101443498|FG002|Period 1|Adverse Event|1|||
33374284|NCT02078713|101258503|FG003|Overall Study|Pregnant at baseline|0|||
33374285|NCT02078713|101258500|FG000|Overall Study|Enrolled twice|0|||
33374286|NCT02078713|101258501|FG001|Overall Study|Enrolled twice|1|||
33246035|NCT03732820|100800313|FG000|Overall Study|Lost to Follow-up|4|||
33374287|NCT02078713|101258502|FG002|Overall Study|Enrolled twice|0|||
33374288|NCT02078713|101258503|FG003|Overall Study|Enrolled twice|0|||
33374289|NCT00937560|101258509|FG000|Initial Treatment|Death|6|||
33374290|NCT00937560|101258509|FG000|Initial Treatment|Withdraw consent|3|||
33374291|NCT00937560|101258509|FG000|Initial Treatment|Adverse Event|1|||
33374292|NCT00937560|101258509|FG000|Initial Treatment|Lost to Follow-up|1|||
33374293|NCT00937560|101258509|FG000|Initial Treatment|No end of study page|10|||
33374294|NCT00937560|101258509|FG000|Maintenance Treatment|Death|12|||
33374295|NCT00937560|101258509|FG000|Maintenance Treatment|Withdraw consent|5|||
33374296|NCT00937560|101258509|FG000|Maintenance Treatment|According to protocol|1|||
33374297|NCT01202227|101258511|FG000|Overall Study|Adverse Event|16|||
33374298|NCT01202227|101258511|FG000|Overall Study|Withdrawal by Subject|2|||
33374299|NCT01202227|101258511|FG000|Overall Study|Lack of Efficacy|1|||
33374300|NCT00099359|101258512|FG000|Overall Study|Death|11|||
33374301|NCT00099359|101258513|FG001|Overall Study|Death|15|||
33374302|NCT00099359|101258514|FG002|Overall Study|Death|17|||
33374303|NCT00099359|101258512|FG000|Overall Study|Withdrawal by Subject|19|||
33374304|NCT00099359|101258513|FG001|Overall Study|Withdrawal by Subject|19|||
33374305|NCT00099359|101258514|FG002|Overall Study|Withdrawal by Subject|23|||
33374306|NCT00099359|101258512|FG000|Overall Study|Lost to Follow-up|15|||
33374307|NCT00099359|101258513|FG001|Overall Study|Lost to Follow-up|24|||
33374308|NCT00099359|101258514|FG002|Overall Study|Lost to Follow-up|24|||
33374309|NCT00099359|101258512|FG000|Overall Study|moved out of area|9|||
33374310|NCT00099359|101258513|FG001|Overall Study|moved out of area|7|||
33374311|NCT00099359|101258514|FG002|Overall Study|moved out of area|4|||
33374312|NCT01606761|101258515|FG000|Prior to Week 24|Lost to Follow-up|0|||
33374313|NCT01606761|101258516|FG001|Prior to Week 24|Lost to Follow-up|3|||
33374314|NCT01606761|101258517|FG002|Prior to Week 24|Lost to Follow-up|2|||
33374315|NCT01606761|101258518|FG003|Prior to Week 24|Lost to Follow-up|0|||
33374316|NCT01606761|101258519|FG004|Prior to Week 24|Lost to Follow-up|0|||
33374317|NCT01606761|101258515|FG000|Prior to Week 24|Withdrawal by Subject|12|||
33374318|NCT01606761|101258516|FG001|Prior to Week 24|Withdrawal by Subject|10|||
33374319|NCT01606761|101258517|FG002|Prior to Week 24|Withdrawal by Subject|9|||
33584768|NCT01144416|102029106|FG001|Intervention Period|No/too few/bad quality embryos|3|||
33584769|NCT01144416|102029105|FG000|Intervention Period|Other|7|||
33148228|NCT05710107|100456193|FG000|Overall Study|Unable to place assigned block|2|||
33148229|NCT05710107|100456194|FG001|Overall Study|Unable to place assigned block|0|||
33148230|NCT05710107|100456193|FG000|Overall Study|Withdrawn by study team|0|||
33148231|NCT05710107|100456194|FG001|Overall Study|Withdrawn by study team|1|||
33148232|NCT00764504|100456195|FG000|Overall Study|Death|12|||
33148233|NCT00764504|100456196|FG001|Overall Study|Death|6|||
33148234|NCT00764504|100456197|FG002|Overall Study|Death|13|||
33148235|NCT00764504|100456195|FG000|Overall Study|Revision of Device|12|||
33148236|NCT00764504|100456196|FG001|Overall Study|Revision of Device|23|||
33148237|NCT00764504|100456197|FG002|Overall Study|Revision of Device|14|||
33148238|NCT00764504|100456195|FG000|Overall Study|Physician Decision|1|||
33148239|NCT00764504|100456196|FG001|Overall Study|Physician Decision|0|||
33148240|NCT00764504|100456197|FG002|Overall Study|Physician Decision|0|||
33148241|NCT00764504|100456195|FG000|Overall Study|Withdrawal by Subject|1|||
33148242|NCT00764504|100456196|FG001|Overall Study|Withdrawal by Subject|7|||
33148243|NCT00764504|100456197|FG002|Overall Study|Withdrawal by Subject|4|||
33148244|NCT00764504|100456195|FG000|Overall Study|Lost to Follow-up|40|||
33148245|NCT00764504|100456196|FG001|Overall Study|Lost to Follow-up|34|||
33148246|NCT00764504|100456197|FG002|Overall Study|Lost to Follow-up|72|||
33148247|NCT04902326|100456198|FG000|Overall Study|Withdrawal by Subject|1|||
33148248|NCT04902326|100456199|FG001|Overall Study|Withdrawal by Subject|3|||
33374320|NCT01606761|101258518|FG003|Prior to Week 24|Withdrawal by Subject|0|||
33374321|NCT01606761|101258519|FG004|Prior to Week 24|Withdrawal by Subject|0|||
33374322|NCT01606761|101258515|FG000|Prior to Week 24|Adverse Event|11|||
33584770|NCT01144416|102029106|FG001|Intervention Period|Other|5|||
33584771|NCT01977729|102029107|FG000|Overall Study|Study terminated|1|||
33584772|NCT04474197|102029108|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
33584773|NCT04474197|102029109|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
33584774|NCT04474197|102029110|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
33584775|NCT04474197|102029111|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
33584776|NCT01057693|102029112|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
33374323|NCT01606761|101258516|FG001|Prior to Week 24|Adverse Event|18|||
33584777|NCT01057693|102029113|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
33148249|NCT04902326|100456200|FG002|Overall Study|Withdrawal by Subject|0|||
33148250|NCT04902326|100456201|FG003|Overall Study|Withdrawal by Subject|1|||
33374324|NCT01606761|101258517|FG002|Prior to Week 24|Adverse Event|22|||
33374325|NCT01606761|101258518|FG003|Prior to Week 24|Adverse Event|0|||
33374326|NCT01606761|101258519|FG004|Prior to Week 24|Adverse Event|0|||
33374327|NCT01606761|101258515|FG000|Prior to Week 24|Lack of Efficacy|15|||
33374328|NCT01606761|101258516|FG001|Prior to Week 24|Lack of Efficacy|14|||
33374329|NCT01606761|101258517|FG002|Prior to Week 24|Lack of Efficacy|8|||
33374330|NCT01606761|101258518|FG003|Prior to Week 24|Lack of Efficacy|0|||
33148251|NCT04902326|100456198|FG000|Overall Study|Lost to Follow-up|14|||
33148252|NCT04902326|100456199|FG001|Overall Study|Lost to Follow-up|14|||
33148253|NCT04902326|100456200|FG002|Overall Study|Lost to Follow-up|14|||
33148254|NCT04902326|100456201|FG003|Overall Study|Lost to Follow-up|6|||
33148255|NCT00267189|100456206|FG000|Overall Study|Patient withdrew consent|1|||
33148256|NCT00267189|100456207|FG001|Overall Study|Patient withdrew consent|1|||
33148257|NCT00267189|100456206|FG000|Overall Study|Death|1|||
33148258|NCT00267189|100456207|FG001|Overall Study|Death|0|||
33148259|NCT00267189|100456206|FG000|Overall Study|Missing|3|||
33148260|NCT00267189|100456207|FG001|Overall Study|Missing|0|||
33148261|NCT01809691|100456208|FG000|Overall Study|Currently on Treatment|192|||
33148262|NCT01809691|100456209|FG001|Overall Study|Currently on Treatment|100|||
33148263|NCT01809691|100456208|FG000|Overall Study|No Protocol Treatment|10|||
33148264|NCT01809691|100456209|FG001|Overall Study|No Protocol Treatment|11|||
33148265|NCT01809691|100456208|FG000|Overall Study|Adverse Event|80|||
33645580|NCT02834793|102256124|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
33645581|NCT02834793|102256121|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
33645582|NCT02834793|102256122|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
33645583|NCT02834793|102256123|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
33645584|NCT02834793|102256124|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
33645585|NCT02834793|102256121|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
33645586|NCT02834793|102256122|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
33645587|NCT02834793|102256123|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
33645588|NCT02834793|102256124|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
33645589|NCT00348881|102256125|FG000|Overall Study|Lost to Follow-up|12|||
33645590|NCT00348881|102256126|FG001|Overall Study|Lost to Follow-up|6|||
33645591|NCT00348881|102256125|FG000|Overall Study|Withdrawal by Subject|3|||
33645592|NCT00348881|102256126|FG001|Overall Study|Withdrawal by Subject|4|||
33645593|NCT00348881|102256125|FG000|Overall Study|Adverse Event|2|||
33645594|NCT00348881|102256126|FG001|Overall Study|Adverse Event|0|||
33645595|NCT00348881|102256125|FG000|Overall Study|Serious Adverse Event|0|||
33645596|NCT00348881|102256126|FG001|Overall Study|Serious Adverse Event|2|||
33645597|NCT00838513|102256127|FG000|Screening Period|Screen Failure|3|||
33645598|NCT00838513|102256127|FG000|Extension Treatment Period|Death|1|||
33645599|NCT00838513|102256127|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
33645600|NCT00929643|102256129|FG000|Overall Study|Protocol Violation|2|||
33645601|NCT00539188|102256130|FG000|Overall Study|Withdrawal by Subject|1|||
33645602|NCT00539188|102256131|FG001|Overall Study|Withdrawal by Subject|0|||
33645603|NCT00539188|102256130|FG000|Overall Study|Lost to Follow-up|2|||
33645604|NCT00539188|102256131|FG001|Overall Study|Lost to Follow-up|1|||
33645605|NCT03023813|102256132|FG000|Overall Study|Lost to Follow-up|1|||
33645606|NCT03023813|102256133|FG001|Overall Study|Lost to Follow-up|2|||
33645607|NCT03023813|102256134|FG002|Overall Study|Lost to Follow-up|0|||
33645608|NCT01616693|102256135|FG000|Evaluated for Safety|Physician Decision|1|||
33645609|NCT01616693|102256136|FG001|Evaluated for Safety|Physician Decision|0|||
33645610|NCT01616693|102256137|FG002|Evaluated for Safety|Physician Decision|1|||
33645611|NCT01616693|102256138|FG003|Evaluated for Safety|Physician Decision|0|||
33645612|NCT01616693|102256135|FG000|Received Both Vaccines|Adverse Event|2|||
33645613|NCT01616693|102256136|FG001|Received Both Vaccines|Adverse Event|0|||
33645614|NCT01616693|102256137|FG002|Received Both Vaccines|Adverse Event|0|||
33645615|NCT01616693|102256138|FG003|Received Both Vaccines|Adverse Event|0|||
33645616|NCT01616693|102256135|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
33645617|NCT01616693|102256136|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
33645618|NCT01616693|102256137|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
33645619|NCT01616693|102256138|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
33645620|NCT01616693|102256135|FG000|Received Both Vaccines|Lost to Follow-up|4|||
33645621|NCT01616693|102256136|FG001|Received Both Vaccines|Lost to Follow-up|3|||
33645622|NCT01616693|102256137|FG002|Received Both Vaccines|Lost to Follow-up|4|||
33645623|NCT01616693|102256138|FG003|Received Both Vaccines|Lost to Follow-up|4|||
33645624|NCT01616693|102256135|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
33645625|NCT01616693|102256136|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
33645626|NCT01616693|102256137|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
33148266|NCT01809691|100456209|FG001|Overall Study|Adverse Event|21|||
33148267|NCT01809691|100456208|FG000|Overall Study|Disease Progression|226|||
33148268|NCT01809691|100456209|FG001|Overall Study|Disease Progression|372|||
33148269|NCT01809691|100456208|FG000|Overall Study|Death|26|||
33148270|NCT01809691|100456209|FG001|Overall Study|Death|13|||
33148271|NCT01809691|100456208|FG000|Overall Study|Participant Refusal|70|||
33148272|NCT01809691|100456209|FG001|Overall Study|Participant Refusal|72|||
33148273|NCT01809691|100456208|FG000|Overall Study|Other, Not Specified|34|||
33645627|NCT01616693|102256138|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
33645628|NCT00145119|102256139|FG000|Overall Study|Death|45|||
33645629|NCT01510769|102256140|FG000|Overall Study|Adverse Event|7|||
33645630|NCT01510769|102256141|FG001|Overall Study|Adverse Event|6|||
33645631|NCT01510769|102256142|FG002|Overall Study|Adverse Event|4|||
33645632|NCT01510769|102256140|FG000|Overall Study|Gout Flare|0|||
33645633|NCT01510769|102256141|FG001|Overall Study|Gout Flare|3|||
33374331|NCT01606761|101258519|FG004|Prior to Week 24|Lack of Efficacy|0|||
33374332|NCT01606761|101258515|FG000|Prior to Week 24|Physician Decision|0|||
33374333|NCT01606761|101258516|FG001|Prior to Week 24|Physician Decision|3|||
33374334|NCT01606761|101258517|FG002|Prior to Week 24|Physician Decision|1|||
33374335|NCT01606761|101258518|FG003|Prior to Week 24|Physician Decision|0|||
33374336|NCT01606761|101258519|FG004|Prior to Week 24|Physician Decision|0|||
33423627|NCT00543439|101443496|FG000|Period 1|Withdrawal by Subject|1|||
33423628|NCT00543439|101443497|FG001|Period 1|Withdrawal by Subject|1|||
33423629|NCT00543439|101443498|FG002|Period 1|Withdrawal by Subject|0|||
33584778|NCT01057693|102029114|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
33645634|NCT01510769|102256142|FG002|Overall Study|Gout Flare|1|||
33645635|NCT01510769|102256140|FG000|Overall Study|Protocol Violation|11|||
33645636|NCT01510769|102256141|FG001|Overall Study|Protocol Violation|10|||
33645637|NCT01510769|102256142|FG002|Overall Study|Protocol Violation|9|||
33645638|NCT01510769|102256140|FG000|Overall Study|Lost to Follow-up|5|||
33645639|NCT01510769|102256141|FG001|Overall Study|Lost to Follow-up|1|||
33645640|NCT01510769|102256142|FG002|Overall Study|Lost to Follow-up|5|||
33645641|NCT01510769|102256140|FG000|Overall Study|Withdrawal by Subject|3|||
33584779|NCT01057693|102029112|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
33584780|NCT01057693|102029113|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
33645642|NCT01510769|102256141|FG001|Overall Study|Withdrawal by Subject|4|||
33645643|NCT01510769|102256142|FG002|Overall Study|Withdrawal by Subject|3|||
33645644|NCT01510769|102256140|FG000|Overall Study|Death|1|||
33645645|NCT01510769|102256141|FG001|Overall Study|Death|1|||
33645646|NCT01510769|102256142|FG002|Overall Study|Death|0|||
33645647|NCT03052400|102256144|FG000|Overall Study|Lost to Follow-up|1|||
33645648|NCT03052400|102256145|FG001|Overall Study|Lost to Follow-up|0|||
33645649|NCT03052400|102256144|FG000|Overall Study|Withdrawal by Subject|0|||
33645650|NCT03052400|102256145|FG001|Overall Study|Withdrawal by Subject|1|||
33645651|NCT00763698|102256146|FG000|Overall Study|Unsuccessful Implant|5|||
33645652|NCT00763698|102256146|FG000|Overall Study|Death|4|||
33645653|NCT00763698|102256146|FG000|Overall Study|Withdrawal by Subject|1|||
33645654|NCT01598129|102256147|FG000|Overall Study|Disease progression|6|||
33645655|NCT01598129|102256147|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
33374337|NCT01606761|101258515|FG000|Prior to Week 24|Other|4|||
33374338|NCT01606761|101258516|FG001|Prior to Week 24|Other|7|||
33374339|NCT01606761|101258517|FG002|Prior to Week 24|Other|5|||
33374340|NCT01606761|101258518|FG003|Prior to Week 24|Other|0|||
33374341|NCT01606761|101258519|FG004|Prior to Week 24|Other|0|||
33584781|NCT01057693|102029114|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
33584782|NCT01057693|102029112|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
33584783|NCT01057693|102029113|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
33584784|NCT01057693|102029114|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
33584785|NCT01057693|102029112|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
33584786|NCT01057693|102029113|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
33584787|NCT01057693|102029114|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
33584788|NCT01057693|102029112|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
33584789|NCT01057693|102029113|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
33584790|NCT01057693|102029114|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
33584791|NCT01057693|102029112|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
33584792|NCT01057693|102029113|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
33584793|NCT01057693|102029114|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
33584794|NCT01057693|102029112|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
33584795|NCT01057693|102029113|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
33584796|NCT01057693|102029114|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
33584797|NCT01057693|102029112|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
33584798|NCT01057693|102029113|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
33645656|NCT01598129|102256147|FG000|Overall Study|Withdrawal by Subject|1|||
33645657|NCT02762370|102256148|FG000|Overall Study|Protocol Violation|1|||
33645658|NCT02762370|102256149|FG001|Overall Study|Protocol Violation|0|||
33374342|NCT01606761|101258515|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
33374343|NCT01606761|101258516|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
33374344|NCT01606761|101258517|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
33374345|NCT01606761|101258518|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
33374346|NCT01606761|101258519|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
33374347|NCT01606761|101258515|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
33374348|NCT01606761|101258516|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
33645659|NCT02954172|102256150|FG000|Overall Study|Protocol Violation|3|||
33645660|NCT02954172|102256151|FG001|Overall Study|Protocol Violation|0|||
33645661|NCT02954172|102256150|FG000|Overall Study|allergic reaction|2|||
33246036|NCT03732820|100800314|FG001|Overall Study|Lost to Follow-up|2|||
33374349|NCT01606761|101258517|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
33374350|NCT01606761|101258518|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
33374351|NCT01606761|101258519|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
33423630|NCT00543439|101443496|FG000|Period 1|Physician Decision|0|||
33645662|NCT02954172|102256151|FG001|Overall Study|allergic reaction|1|||
33645663|NCT02954172|102256150|FG000|Overall Study|non-measurable lesions at baseline|1|||
33645664|NCT02954172|102256151|FG001|Overall Study|non-measurable lesions at baseline|2|||
33645665|NCT01092117|102256152|FG000|Index Procedure to 1 Month|Death|1|||
33645666|NCT01092117|102256152|FG000|1 Month|Death|1|||
33645667|NCT01092117|102256152|FG000|1 Month|Withdrawal by Subject|1|||
33645668|NCT01092117|102256152|FG000|1 Month|Lost to Follow-up|1|||
33645669|NCT01092117|102256152|FG000|6 Months|Death|2|||
33645670|NCT01092117|102256152|FG000|6 Months|Withdrawal by Subject|3|||
33645671|NCT01092117|102256152|FG000|12 Month|Death|11|||
33645672|NCT01092117|102256152|FG000|12 Month|Withdrawal by Subject|2|||
33645673|NCT01092117|102256152|FG000|12 Month|Lost to Follow-up|1|||
33645674|NCT01092117|102256152|FG000|Year 2|Death|5|||
33645675|NCT01092117|102256152|FG000|Year 2|Withdrawal by Subject|4|||
33645676|NCT01092117|102256152|FG000|Year 2|Lost to Follow-up|1|||
33645677|NCT01092117|102256152|FG000|Year 3|Death|7|||
33645678|NCT01092117|102256152|FG000|Year 3|Withdrawal by Subject|9|||
33645679|NCT01092117|102256152|FG000|Year 3|Lost to Follow-up|3|||
33645680|NCT01092117|102256152|FG000|Year 4|Death|8|||
33645681|NCT01092117|102256152|FG000|Year 4|Withdrawal by Subject|4|||
33645682|NCT01092117|102256152|FG000|Year 4|Lost to Follow-up|4|||
33645683|NCT02704143|102256155|FG000|Overall Study|disease progression|10|||
33645684|NCT02433080|102256156|FG000|Overall Study|Lost to Follow-up|1|||
33645685|NCT02433080|102256157|FG001|Overall Study|Lost to Follow-up|2|||
33148274|NCT01809691|100456209|FG001|Overall Study|Other, Not Specified|52|||
33148275|NCT02421939|100456210|FG000|Overall Study|Progressive disease|70|||
33148276|NCT02421939|100456211|FG001|Overall Study|Progressive disease|16|||
33148277|NCT02421939|100456210|FG000|Overall Study|Lack of Efficacy|21|||
33645686|NCT02433080|102256156|FG000|Overall Study|Withdrawal by Subject|0|||
33645687|NCT02433080|102256157|FG001|Overall Study|Withdrawal by Subject|2|||
33148278|NCT02421939|100456211|FG001|Overall Study|Lack of Efficacy|31|||
33148279|NCT02421939|100456210|FG000|Overall Study|Death|36|||
33148280|NCT02421939|100456211|FG001|Overall Study|Death|10|||
33148281|NCT02421939|100456210|FG000|Overall Study|Disease relapse|33|||
33148282|NCT02421939|100456211|FG001|Overall Study|Disease relapse|2|||
33148283|NCT02421939|100456210|FG000|Overall Study|Adverse Event|28|||
33148284|NCT02421939|100456211|FG001|Overall Study|Adverse Event|5|||
33148285|NCT02421939|100456210|FG000|Overall Study|Withdrawal by Subject|5|||
33148286|NCT02421939|100456211|FG001|Overall Study|Withdrawal by Subject|24|||
33148287|NCT02421939|100456210|FG000|Overall Study|Physician Decision|11|||
33148288|NCT02421939|100456211|FG001|Overall Study|Physician Decision|11|||
33148289|NCT02421939|100456210|FG000|Overall Study|Completed 1 or 2 chemo cycles with CRs|0|||
33148290|NCT02421939|100456211|FG001|Overall Study|Completed 1 or 2 chemo cycles with CRs|19|||
33148291|NCT02421939|100456210|FG000|Overall Study|Miscellaneous|4|||
33148292|NCT02421939|100456211|FG001|Overall Study|Miscellaneous|5|||
33148293|NCT02421939|100456210|FG000|Overall Study|Protocol deviation|1|||
33374352|NCT01606761|101258515|FG000|Week 24 to Week 52|Adverse Event|0|||
33374353|NCT01606761|101258516|FG001|Week 24 to Week 52|Adverse Event|11|||
33374354|NCT01606761|101258517|FG002|Week 24 to Week 52|Adverse Event|14|||
33374355|NCT01606761|101258518|FG003|Week 24 to Week 52|Adverse Event|3|||
33374356|NCT01606761|101258519|FG004|Week 24 to Week 52|Adverse Event|15|||
33374357|NCT01606761|101258515|FG000|Week 24 to Week 52|Death|0|||
33374358|NCT01606761|101258516|FG001|Week 24 to Week 52|Death|0|||
33374359|NCT01606761|101258517|FG002|Week 24 to Week 52|Death|2|||
33374360|NCT01606761|101258518|FG003|Week 24 to Week 52|Death|1|||
33374361|NCT01606761|101258519|FG004|Week 24 to Week 52|Death|0|||
33374362|NCT01606761|101258515|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
33374363|NCT01606761|101258516|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
33374364|NCT01606761|101258517|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
33374365|NCT01606761|101258518|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
33374366|NCT01606761|101258519|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
33374367|NCT01606761|101258515|FG000|Week 24 to Week 52|Physician Decision|0|||
33374368|NCT01606761|101258516|FG001|Week 24 to Week 52|Physician Decision|1|||
33374369|NCT01606761|101258517|FG002|Week 24 to Week 52|Physician Decision|1|||
33645688|NCT01765218|102256160|FG000|Overall Study|Protocol Violation|1|||
33645689|NCT01765218|102256161|FG001|Overall Study|Protocol Violation|2|||
33645690|NCT02267317|102256162|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
33645691|NCT02267317|102256163|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
33645692|NCT02267317|102256164|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
33645693|NCT02267317|102256165|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
33645694|NCT02267317|102256166|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
33645695|NCT02267317|102256167|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
33148294|NCT02421939|100456211|FG001|Overall Study|Protocol deviation|1|||
33148295|NCT03315754|100456219|FG000|Overall Study|COVID-19 complications leading to death|1|||
33148296|NCT03315754|100456219|FG000|Overall Study|insurance coverage issue|1|||
33148297|NCT04029688|100456220|FG000|Overall Study|Death|8|||
33374370|NCT01606761|101258518|FG003|Week 24 to Week 52|Physician Decision|0|||
33374371|NCT01606761|101258519|FG004|Week 24 to Week 52|Physician Decision|0|||
33148298|NCT04029688|100456221|FG001|Overall Study|Death|3|||
33645696|NCT02267317|102256162|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
33645697|NCT02267317|102256163|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
33246037|NCT05419557|100800320|FG000|Overall Study|Lost to Follow-up|11|||
33246038|NCT05419557|100800321|FG001|Overall Study|Lost to Follow-up|4|||
33246039|NCT01119703|100800322|FG000|Overall Study|Adverse Event|0|||
33246040|NCT01119703|100800323|FG001|Overall Study|Adverse Event|1|||
33246041|NCT02952261|100800324|FG000|Overall Study|Withdrawal by Subject|4|||
33246042|NCT02952261|100800325|FG001|Overall Study|Withdrawal by Subject|5|||
33246043|NCT02952261|100800324|FG000|Overall Study|Protocol Violation|1|||
33246044|NCT02952261|100800325|FG001|Overall Study|Protocol Violation|0|||
33246045|NCT02781584|100800327|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
33246046|NCT02781584|100800328|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
33246047|NCT02781584|100800329|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
33246048|NCT02781584|100800330|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
33246049|NCT02781584|100800331|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
33246050|NCT02781584|100800332|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
33246051|NCT02781584|100800333|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
33246052|NCT02781584|100800334|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
33246053|NCT02781584|100800335|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
33246054|NCT02781584|100800336|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
33246055|NCT02781584|100800337|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
33246056|NCT02781584|100800338|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
33246057|NCT02781584|100800339|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
33246058|NCT02781584|100800327|FG000|Pre-treatment Phase|Adverse Event|0|||
33246059|NCT02781584|100800328|FG001|Pre-treatment Phase|Adverse Event|0|||
33246060|NCT02781584|100800329|FG002|Pre-treatment Phase|Adverse Event|0|||
33246061|NCT02781584|100800330|FG003|Pre-treatment Phase|Adverse Event|0|||
33246062|NCT02781584|100800331|FG004|Pre-treatment Phase|Adverse Event|0|||
33246063|NCT02781584|100800332|FG005|Pre-treatment Phase|Adverse Event|0|||
33584799|NCT01057693|102029114|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
33584800|NCT01057693|102029112|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
33584801|NCT01057693|102029113|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
33584802|NCT01057693|102029114|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
33584803|NCT01057693|102029112|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
33584804|NCT01057693|102029113|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
33584805|NCT01057693|102029114|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
33584806|NCT01057693|102029112|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
33584807|NCT01057693|102029113|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
33584808|NCT01057693|102029114|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
33584809|NCT01057693|102029112|FG000|Between Single-Blind and Double-Blind|Other|6|||
33584810|NCT01057693|102029113|FG001|Between Single-Blind and Double-Blind|Other|0|||
33584811|NCT01057693|102029114|FG002|Between Single-Blind and Double-Blind|Other|0|||
33584812|NCT01057693|102029112|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
33584813|NCT01057693|102029113|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
33584814|NCT01057693|102029114|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
33584815|NCT01057693|102029112|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
33584816|NCT01057693|102029113|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
33584817|NCT01057693|102029114|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
33584818|NCT01057693|102029112|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
33584819|NCT01057693|102029113|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
33584820|NCT01057693|102029114|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
33584821|NCT01057693|102029112|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
33584822|NCT01057693|102029113|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
33584823|NCT01057693|102029114|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
33584824|NCT01057693|102029112|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
33584825|NCT01057693|102029113|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
33584826|NCT01057693|102029114|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
33584827|NCT01057693|102029112|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
33584828|NCT01057693|102029113|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
33584829|NCT01057693|102029114|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
33584830|NCT01057693|102029112|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
33584831|NCT01057693|102029113|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
33246064|NCT02781584|100800333|FG006|Pre-treatment Phase|Adverse Event|0|||
33246065|NCT02781584|100800334|FG007|Pre-treatment Phase|Adverse Event|0|||
33246066|NCT02781584|100800335|FG008|Pre-treatment Phase|Adverse Event|0|||
33246067|NCT02781584|100800336|FG009|Pre-treatment Phase|Adverse Event|0|||
33246068|NCT02781584|100800337|FG010|Pre-treatment Phase|Adverse Event|0|||
33584832|NCT01057693|102029114|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
33584833|NCT01802580|102029115|FG000|Overall Study|Physician Decision|1|||
33584834|NCT01802580|102029116|FG001|Overall Study|Physician Decision|0|||
33645698|NCT02267317|102256164|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
33645699|NCT02267317|102256165|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
33645700|NCT02267317|102256166|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
33645701|NCT02267317|102256167|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
33645702|NCT01387542|102256168|FG000|Overall Study|Adverse Event|3|||
33645703|NCT01387542|102256168|FG000|Overall Study|Withdrawal by Subject|1|||
33645704|NCT01387542|102256168|FG000|Overall Study|Changed diagnosis|1|||
33645705|NCT01387542|102256168|FG000|Overall Study|Insufficient response|1|||
33645706|NCT01387542|102256168|FG000|Overall Study|Non-compliant|1|||
33645707|NCT01387542|102256168|FG000|Overall Study|Lost to Follow-up|1|||
33645708|NCT02036853|102256169|FG000|Overall Study|Adverse Event|0|||
33645709|NCT02036853|102256170|FG001|Overall Study|Adverse Event|2|||
33645710|NCT02036853|102256169|FG000|Overall Study|Lack of Efficacy|0|||
33584835|NCT01802580|102029115|FG000|Overall Study|Protocol Violation|2|||
33584836|NCT01802580|102029116|FG001|Overall Study|Protocol Violation|0|||
33584837|NCT01802580|102029115|FG000|Overall Study|Withdrawal by Subject|5|||
33584838|NCT01802580|102029116|FG001|Overall Study|Withdrawal by Subject|6|||
33584839|NCT01802580|102029115|FG000|Overall Study|Other|1|||
33584840|NCT01802580|102029116|FG001|Overall Study|Other|3|||
33584841|NCT01802580|102029115|FG000|Overall Study|Lack of Efficacy|0|||
33584842|NCT01802580|102029116|FG001|Overall Study|Lack of Efficacy|2|||
33584843|NCT01732510|102029117|FG000|Overall Study|Adverse Event|0|||
33584844|NCT01732510|102029118|FG001|Overall Study|Adverse Event|1|||
33584845|NCT01732510|102029119|FG002|Overall Study|Adverse Event|1|||
33584846|NCT01732510|102029120|FG003|Overall Study|Adverse Event|0|||
33584847|NCT01732510|102029121|FG004|Overall Study|Adverse Event|0|||
33584848|NCT01732510|102029122|FG005|Overall Study|Adverse Event|0|||
33584849|NCT01732510|102029123|FG006|Overall Study|Adverse Event|1|||
33584850|NCT01732510|102029117|FG000|Overall Study|Protocol Violation|0|||
33584851|NCT01732510|102029118|FG001|Overall Study|Protocol Violation|0|||
33584852|NCT01732510|102029119|FG002|Overall Study|Protocol Violation|0|||
33584853|NCT01732510|102029120|FG003|Overall Study|Protocol Violation|1|||
33584854|NCT01732510|102029121|FG004|Overall Study|Protocol Violation|0|||
33584855|NCT01732510|102029122|FG005|Overall Study|Protocol Violation|0|||
33584856|NCT01732510|102029123|FG006|Overall Study|Protocol Violation|0|||
33584857|NCT01732510|102029117|FG000|Overall Study|Withdrawal by Subject|1|||
33584858|NCT01732510|102029118|FG001|Overall Study|Withdrawal by Subject|3|||
33584859|NCT01732510|102029119|FG002|Overall Study|Withdrawal by Subject|2|||
33584860|NCT01732510|102029120|FG003|Overall Study|Withdrawal by Subject|1|||
33584861|NCT01732510|102029121|FG004|Overall Study|Withdrawal by Subject|5|||
33584862|NCT01732510|102029122|FG005|Overall Study|Withdrawal by Subject|0|||
33584863|NCT01732510|102029123|FG006|Overall Study|Withdrawal by Subject|1|||
33584864|NCT01732510|102029117|FG000|Overall Study|Lost to Follow-up|0|||
33584865|NCT01732510|102029118|FG001|Overall Study|Lost to Follow-up|0|||
33584866|NCT01732510|102029119|FG002|Overall Study|Lost to Follow-up|1|||
33584867|NCT01732510|102029120|FG003|Overall Study|Lost to Follow-up|1|||
33584868|NCT01732510|102029121|FG004|Overall Study|Lost to Follow-up|0|||
33584869|NCT01732510|102029122|FG005|Overall Study|Lost to Follow-up|1|||
33584870|NCT01732510|102029123|FG006|Overall Study|Lost to Follow-up|0|||
33584871|NCT01732510|102029117|FG000|Overall Study|Physician Decision|0|||
33584872|NCT01732510|102029118|FG001|Overall Study|Physician Decision|1|||
33584873|NCT01732510|102029119|FG002|Overall Study|Physician Decision|0|||
33584874|NCT01732510|102029120|FG003|Overall Study|Physician Decision|0|||
33584875|NCT01732510|102029121|FG004|Overall Study|Physician Decision|0|||
33584876|NCT01732510|102029122|FG005|Overall Study|Physician Decision|0|||
33584877|NCT01732510|102029123|FG006|Overall Study|Physician Decision|0|||
33584878|NCT01732510|102029117|FG000|Overall Study|Pregnancy|0|||
33584879|NCT01732510|102029118|FG001|Overall Study|Pregnancy|0|||
33584880|NCT01732510|102029119|FG002|Overall Study|Pregnancy|0|||
33584881|NCT01732510|102029120|FG003|Overall Study|Pregnancy|1|||
33584882|NCT01732510|102029121|FG004|Overall Study|Pregnancy|0|||
33584883|NCT01732510|102029122|FG005|Overall Study|Pregnancy|0|||
33645711|NCT02036853|102256170|FG001|Overall Study|Lack of Efficacy|2|||
33645712|NCT02036853|102256169|FG000|Overall Study|Physician Decision|0|||
33645713|NCT02036853|102256170|FG001|Overall Study|Physician Decision|1|||
33584884|NCT01732510|102029123|FG006|Overall Study|Pregnancy|0|||
33584885|NCT01732510|102029117|FG000|Overall Study|Study Terminated By Sponsor|0|||
33584886|NCT01732510|102029118|FG001|Overall Study|Study Terminated By Sponsor|0|||
33584887|NCT01732510|102029119|FG002|Overall Study|Study Terminated By Sponsor|0|||
33584888|NCT01732510|102029120|FG003|Overall Study|Study Terminated By Sponsor|1|||
33584889|NCT01732510|102029121|FG004|Overall Study|Study Terminated By Sponsor|0|||
33584890|NCT01732510|102029122|FG005|Overall Study|Study Terminated By Sponsor|12|||
33584891|NCT01732510|102029123|FG006|Overall Study|Study Terminated By Sponsor|6|||
33584892|NCT02263326|102029124|FG000|Overall Study|Lost to Follow-up|1|||
33584893|NCT02263326|102029125|FG001|Overall Study|Lost to Follow-up|1|||
33584894|NCT04294459|102029126|FG000|Overall Study|Adverse Event|0|||
33584895|NCT04294459|102029127|FG001|Overall Study|Adverse Event|1|||
33584896|NCT01822899|102029129|FG000|Overall Study|Adverse Event|6|||
33584897|NCT01822899|102029130|FG001|Overall Study|Adverse Event|5|||
33584898|NCT01822899|102029129|FG000|Overall Study|Lack of Efficacy|6|||
33584899|NCT01822899|102029130|FG001|Overall Study|Lack of Efficacy|3|||
33584900|NCT01822899|102029129|FG000|Overall Study|Protocol Violation|6|||
33584901|NCT01822899|102029130|FG001|Overall Study|Protocol Violation|3|||
33584902|NCT01822899|102029129|FG000|Overall Study|Lost to Follow-up|1|||
33645714|NCT02036853|102256169|FG000|Overall Study|Withdrawal by Subject|0|||
33645715|NCT02036853|102256170|FG001|Overall Study|Withdrawal by Subject|1|||
33645716|NCT00084136|102256171|FG000|PI Comparison|Death|10|||
33645717|NCT00084136|102256172|FG001|PI Comparison|Death|9|||
33645718|NCT00084136|102256173|FG002|PI Comparison|Death|0|||
33645719|NCT00084136|102256171|FG000|PI Comparison|Lost to Follow-up|11|||
33645720|NCT00084136|102256172|FG001|PI Comparison|Lost to Follow-up|8|||
33148299|NCT04029688|100456222|FG002|Overall Study|Death|6|||
33148300|NCT04029688|100456223|FG003|Overall Study|Death|2|||
33148301|NCT04029688|100456224|FG004|Overall Study|Death|5|||
33148302|NCT04029688|100456225|FG005|Overall Study|Death|0|||
33148303|NCT04029688|100456226|FG006|Overall Study|Death|2|||
33148304|NCT04029688|100456227|FG007|Overall Study|Death|3|||
33148305|NCT04029688|100456220|FG000|Overall Study|Study Terminated by Sponsor|0|||
33148306|NCT04029688|100456221|FG001|Overall Study|Study Terminated by Sponsor|0|||
33148307|NCT04029688|100456222|FG002|Overall Study|Study Terminated by Sponsor|0|||
33148308|NCT04029688|100456223|FG003|Overall Study|Study Terminated by Sponsor|0|||
33148309|NCT04029688|100456224|FG004|Overall Study|Study Terminated by Sponsor|1|||
33148310|NCT04029688|100456225|FG005|Overall Study|Study Terminated by Sponsor|3|||
33148311|NCT04029688|100456226|FG006|Overall Study|Study Terminated by Sponsor|1|||
33148312|NCT04029688|100456227|FG007|Overall Study|Study Terminated by Sponsor|3|||
33148313|NCT04029688|100456220|FG000|Overall Study|Withdrawal by Subject|0|||
33148314|NCT04029688|100456221|FG001|Overall Study|Withdrawal by Subject|0|||
33423631|NCT00543439|101443497|FG001|Period 1|Physician Decision|0|||
33584903|NCT01822899|102029130|FG001|Overall Study|Lost to Follow-up|0|||
33584904|NCT01822899|102029129|FG000|Overall Study|Withdrawal by Subject|5|||
33584905|NCT01822899|102029130|FG001|Overall Study|Withdrawal by Subject|7|||
33584906|NCT01667133|102029131|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
33584907|NCT01667133|102029132|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
33584908|NCT01667133|102029133|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
33584909|NCT01667133|102029134|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
33584910|NCT01667133|102029135|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
33584911|NCT01667133|102029136|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
33584912|NCT01667133|102029137|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
33645721|NCT00084136|102256173|FG002|PI Comparison|Lost to Follow-up|0|||
33148315|NCT04029688|100456222|FG002|Overall Study|Withdrawal by Subject|0|||
33148316|NCT04029688|100456223|FG003|Overall Study|Withdrawal by Subject|1|||
33148317|NCT04029688|100456224|FG004|Overall Study|Withdrawal by Subject|0|||
33148318|NCT04029688|100456225|FG005|Overall Study|Withdrawal by Subject|0|||
33148319|NCT04029688|100456226|FG006|Overall Study|Withdrawal by Subject|0|||
33148320|NCT04029688|100456227|FG007|Overall Study|Withdrawal by Subject|0|||
33148321|NCT01946204|100456230|FG000|Overall Study|Death|38|||
33148322|NCT01946204|100456231|FG001|Overall Study|Death|59|||
33148323|NCT01946204|100456230|FG000|Overall Study|Withdrawal by Subject|37|||
33148324|NCT01946204|100456231|FG001|Overall Study|Withdrawal by Subject|50|||
33148325|NCT01946204|100456230|FG000|Overall Study|Lost to Follow-up|3|||
33246069|NCT02781584|100800338|FG011|Pre-treatment Phase|Adverse Event|1|||
33374372|NCT01606761|101258515|FG000|Week 24 to Week 52|Other|0|||
33374373|NCT01606761|101258516|FG001|Week 24 to Week 52|Other|1|||
33374374|NCT01606761|101258517|FG002|Week 24 to Week 52|Other|5|||
33374375|NCT01606761|101258518|FG003|Week 24 to Week 52|Other|2|||
33374376|NCT01606761|101258519|FG004|Week 24 to Week 52|Other|2|||
33374377|NCT01606761|101258515|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
33374378|NCT01606761|101258516|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
33374379|NCT01606761|101258517|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
33374380|NCT01606761|101258518|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
33374381|NCT01606761|101258519|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
33374382|NCT01606761|101258515|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
33374383|NCT01606761|101258516|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
33374384|NCT01606761|101258517|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
33374385|NCT01606761|101258518|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
33374386|NCT01606761|101258519|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
33148326|NCT01946204|100456231|FG001|Overall Study|Lost to Follow-up|7|||
33148327|NCT01946204|100456230|FG000|Overall Study|Ongoing|316|||
33148328|NCT01946204|100456231|FG001|Overall Study|Ongoing|687|||
33148329|NCT01946204|100456230|FG000|Overall Study|Other|7|||
33423632|NCT00543439|101443498|FG002|Period 1|Physician Decision|1|||
33584913|NCT01667133|102029138|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
33584914|NCT01667133|102029139|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
33584915|NCT01667133|102029140|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
33584916|NCT01667133|102029141|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
33645722|NCT00084136|102256171|FG000|PI Comparison|Withdrawal by Subject|33|||
33584917|NCT01667133|102029142|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
33584918|NCT01667133|102029131|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33584919|NCT01667133|102029132|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33584920|NCT01667133|102029133|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
33584921|NCT01667133|102029134|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33584922|NCT01667133|102029135|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33584923|NCT01667133|102029136|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33584924|NCT01667133|102029137|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33584925|NCT01667133|102029138|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33584926|NCT01667133|102029139|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33584927|NCT01667133|102029140|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33584928|NCT01667133|102029141|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33584929|NCT01667133|102029142|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
33584930|NCT01667133|102029131|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
33645723|NCT00084136|102256172|FG001|PI Comparison|Withdrawal by Subject|30|||
33645724|NCT00084136|102256173|FG002|PI Comparison|Withdrawal by Subject|0|||
33246070|NCT02781584|100800339|FG012|Pre-treatment Phase|Adverse Event|0|||
33246071|NCT02781584|100800327|FG000|Treatment Phase|Withdrew Consent|0|||
33246072|NCT02781584|100800328|FG001|Treatment Phase|Withdrew Consent|0|||
33246073|NCT02781584|100800329|FG002|Treatment Phase|Withdrew Consent|0|||
33246074|NCT02781584|100800330|FG003|Treatment Phase|Withdrew Consent|0|||
33246075|NCT02781584|100800331|FG004|Treatment Phase|Withdrew Consent|0|||
33246076|NCT02781584|100800332|FG005|Treatment Phase|Withdrew Consent|1|||
33246077|NCT02781584|100800333|FG006|Treatment Phase|Withdrew Consent|0|||
33246078|NCT02781584|100800334|FG007|Treatment Phase|Withdrew Consent|0|||
33246079|NCT02781584|100800335|FG008|Treatment Phase|Withdrew Consent|0|||
33246080|NCT02781584|100800336|FG009|Treatment Phase|Withdrew Consent|0|||
33246081|NCT02781584|100800337|FG010|Treatment Phase|Withdrew Consent|1|||
33645725|NCT00084136|102256171|FG000|PI Comparison|Clinic site closed|1|||
33645726|NCT00084136|102256172|FG001|PI Comparison|Clinic site closed|0|||
33645727|NCT00084136|102256173|FG002|PI Comparison|Clinic site closed|0|||
33645728|NCT00084136|102256171|FG000|NRTI Comparison|Death|20|||
33645729|NCT00084136|102256172|FG001|NRTI Comparison|Death|0|||
33374387|NCT01606761|101258515|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
33374388|NCT01606761|101258516|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
33374389|NCT01606761|101258517|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
33374390|NCT01606761|101258518|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
33374391|NCT01606761|101258519|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
33374392|NCT01606761|101258515|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
33374393|NCT01606761|101258516|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
33374394|NCT01606761|101258517|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
33374395|NCT01606761|101258518|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
33374396|NCT01606761|101258519|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
33374397|NCT03442829|101258520|FG000|Overall Study|Scheduling clash|3|||
33374398|NCT03442829|101258521|FG001|Overall Study|Scheduling clash|1|||
33374399|NCT03442829|101258520|FG000|Overall Study|Illness unrelated to study|1|||
33374400|NCT03442829|101258521|FG001|Overall Study|Illness unrelated to study|1|||
33423633|NCT00543439|101443496|FG000|Period 2|Protocol Violation|1|||
33423634|NCT00543439|101443497|FG001|Period 2|Protocol Violation|0|||
33423635|NCT00543439|101443498|FG002|Period 2|Protocol Violation|1|||
33423636|NCT00543439|101443496|FG000|Period 2|Adverse Event|0|||
33423637|NCT00543439|101443497|FG001|Period 2|Adverse Event|1|||
33645730|NCT00084136|102256173|FG002|NRTI Comparison|Death|18|||
33374401|NCT01051986|101258522|FG000|Overall Study|Death|1|||
33374402|NCT01051986|101258523|FG001|Overall Study|Death|0|||
33374403|NCT01051986|101258522|FG000|Overall Study|Withdrawal by Subject|2|||
33645731|NCT00084136|102256171|FG000|NRTI Comparison|Lost to Follow-up|14|||
33645732|NCT00084136|102256172|FG001|NRTI Comparison|Lost to Follow-up|0|||
33645733|NCT00084136|102256173|FG002|NRTI Comparison|Lost to Follow-up|12|||
33645734|NCT00084136|102256171|FG000|NRTI Comparison|Withdrawal by Subject|54|||
33645735|NCT00084136|102256172|FG001|NRTI Comparison|Withdrawal by Subject|0|||
33645736|NCT00084136|102256173|FG002|NRTI Comparison|Withdrawal by Subject|38|||
33645737|NCT00084136|102256171|FG000|NRTI Comparison|Clinic site closed|12|||
33148330|NCT01946204|100456231|FG001|Overall Study|Other|3|||
33148331|NCT02252172|100456234|FG000|Overall Study|Lost to Follow-up|3|||
33246082|NCT02781584|100800338|FG011|Treatment Phase|Withdrew Consent|2|||
33246083|NCT02781584|100800339|FG012|Treatment Phase|Withdrew Consent|0|||
33246084|NCT02781584|100800327|FG000|Treatment Phase|Adverse Event|0|||
33246085|NCT02781584|100800328|FG001|Treatment Phase|Adverse Event|0|||
33374404|NCT01051986|101258523|FG001|Overall Study|Withdrawal by Subject|1|||
33423638|NCT00543439|101443498|FG002|Period 2|Adverse Event|1|||
33645738|NCT00084136|102256172|FG001|NRTI Comparison|Clinic site closed|0|||
33645739|NCT00084136|102256173|FG002|NRTI Comparison|Clinic site closed|14|||
33246086|NCT02781584|100800329|FG002|Treatment Phase|Adverse Event|0|||
33423639|NCT01169987|101443499|FG000|Overall Study|Withdrawal by Subject|3|||
33423640|NCT01169987|101443499|FG000|Overall Study|Lost to Follow-up|24|||
33584931|NCT01667133|102029132|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
33584932|NCT01667133|102029133|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
33148332|NCT02252172|100456235|FG001|Overall Study|Lost to Follow-up|1|||
33148333|NCT02252172|100456234|FG000|Overall Study|Ongoing|276|||
33148334|NCT02252172|100456235|FG001|Overall Study|Ongoing|298|||
33148335|NCT04551066|100456238|FG000|Overall Study|Death|5|||
33148336|NCT04551066|100456239|FG001|Overall Study|Death|3|||
33246087|NCT02781584|100800330|FG003|Treatment Phase|Adverse Event|0|||
33246088|NCT02781584|100800331|FG004|Treatment Phase|Adverse Event|0|||
33246089|NCT02781584|100800332|FG005|Treatment Phase|Adverse Event|0|||
33645740|NCT00084136|102256171|FG000|NRTI Comparison|Not reason above|1|||
33645741|NCT00084136|102256172|FG001|NRTI Comparison|Not reason above|0|||
33645742|NCT00084136|102256173|FG002|NRTI Comparison|Not reason above|0|||
33645743|NCT01396447|102256174|FG000|Overall Study|Did Not Receive Treatment|3|||
33645744|NCT01396447|102256175|FG001|Overall Study|Did Not Receive Treatment|2|||
33645745|NCT01396447|102256176|FG002|Overall Study|Did Not Receive Treatment|1|||
33645746|NCT01396447|102256177|FG003|Overall Study|Did Not Receive Treatment|0|||
33645747|NCT01396447|102256174|FG000|Overall Study|Adverse Event|15|||
33645748|NCT01396447|102256175|FG001|Overall Study|Adverse Event|12|||
33645749|NCT01396447|102256176|FG002|Overall Study|Adverse Event|12|||
33645750|NCT01396447|102256177|FG003|Overall Study|Adverse Event|17|||
33645751|NCT01396447|102256174|FG000|Overall Study|Insufficient Therapeutic Response|5|||
33645752|NCT01396447|102256175|FG001|Overall Study|Insufficient Therapeutic Response|5|||
33645753|NCT01396447|102256176|FG002|Overall Study|Insufficient Therapeutic Response|2|||
33645754|NCT01396447|102256177|FG003|Overall Study|Insufficient Therapeutic Response|4|||
33645755|NCT01396447|102256174|FG000|Overall Study|Protocol Violation|5|||
33645756|NCT01396447|102256175|FG001|Overall Study|Protocol Violation|2|||
33645757|NCT01396447|102256176|FG002|Overall Study|Protocol Violation|3|||
33645758|NCT01396447|102256177|FG003|Overall Study|Protocol Violation|7|||
33246090|NCT02781584|100800333|FG006|Treatment Phase|Adverse Event|0|||
33584933|NCT01667133|102029134|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
33584934|NCT01667133|102029135|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
33584935|NCT01667133|102029136|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
33584936|NCT01667133|102029137|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
33584937|NCT01667133|102029138|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
33584938|NCT01667133|102029139|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
33584939|NCT01667133|102029140|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
33584940|NCT01667133|102029141|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
33584941|NCT01667133|102029142|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
33584942|NCT01667133|102029131|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33584943|NCT01667133|102029132|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33584944|NCT01667133|102029133|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33584945|NCT01667133|102029134|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
33584946|NCT01667133|102029135|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33584947|NCT01667133|102029136|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33584948|NCT01667133|102029137|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33584949|NCT01667133|102029138|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33584950|NCT01667133|102029139|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33584951|NCT01667133|102029140|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33584952|NCT01667133|102029141|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33584953|NCT01667133|102029142|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
33584954|NCT01667133|102029131|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
33584955|NCT01667133|102029132|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
33584956|NCT01667133|102029133|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
33584957|NCT01667133|102029134|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
33584958|NCT01667133|102029135|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
33584959|NCT01667133|102029136|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
33584960|NCT01667133|102029137|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
33584961|NCT01667133|102029138|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
33584962|NCT01667133|102029139|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
33584963|NCT01667133|102029140|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
33584964|NCT01667133|102029141|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
33584965|NCT01667133|102029142|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
33584966|NCT01667133|102029131|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33645759|NCT01396447|102256174|FG000|Overall Study|Withdrawal of Consent|11|||
33645760|NCT01396447|102256175|FG001|Overall Study|Withdrawal of Consent|9|||
33645761|NCT01396447|102256176|FG002|Overall Study|Withdrawal of Consent|4|||
33645762|NCT01396447|102256177|FG003|Overall Study|Withdrawal of Consent|15|||
33645763|NCT01396447|102256174|FG000|Overall Study|Lost to Follow-up|4|||
33645764|NCT01396447|102256175|FG001|Overall Study|Lost to Follow-up|8|||
33246091|NCT02781584|100800334|FG007|Treatment Phase|Adverse Event|1|||
33246092|NCT02781584|100800335|FG008|Treatment Phase|Adverse Event|0|||
33584967|NCT01667133|102029132|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33584968|NCT01667133|102029133|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33584969|NCT01667133|102029134|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33148337|NCT04551066|100456238|FG000|Overall Study|Lost to Follow-up|1|||
33374405|NCT01051986|101258522|FG000|Overall Study|Protocol Violation|2|||
33374406|NCT01051986|101258523|FG001|Overall Study|Protocol Violation|3|||
33374407|NCT05216406|101258524|FG000|Overall Study|Lost to Follow-up|8|||
33374408|NCT05216406|101258525|FG001|Overall Study|Lost to Follow-up|9|||
33374409|NCT04937816|101258526|FG000|Overall Study|Study drug stopped, reason missing|5|||
33374410|NCT04937816|101258527|FG001|Overall Study|Study drug stopped, reason missing|3|||
33374411|NCT04937816|101258528|FG002|Overall Study|Study drug stopped, reason missing|4|||
33374412|NCT04937816|101258529|FG003|Overall Study|Study drug stopped, reason missing|6|||
33374413|NCT04937816|101258530|FG004|Overall Study|Study drug stopped, reason missing|1|||
33374414|NCT04937816|101258531|FG005|Overall Study|Study drug stopped, reason missing|0|||
33374415|NCT04937816|101258532|FG006|Overall Study|Study drug stopped, reason missing|0|||
33374416|NCT04937816|101258526|FG000|Overall Study|Other than stated below|173|||
33374417|NCT04937816|101258527|FG001|Overall Study|Other than stated below|143|||
33374418|NCT04937816|101258528|FG002|Overall Study|Other than stated below|125|||
33374419|NCT04937816|101258529|FG003|Overall Study|Other than stated below|44|||
33374420|NCT04937816|101258530|FG004|Overall Study|Other than stated below|45|||
33374421|NCT04937816|101258531|FG005|Overall Study|Other than stated below|28|||
33374422|NCT04937816|101258532|FG006|Overall Study|Other than stated below|31|||
33374423|NCT04937816|101258526|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
33374424|NCT04937816|101258527|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
33148338|NCT04551066|100456239|FG001|Overall Study|Lost to Follow-up|0|||
33148339|NCT04551066|100456238|FG000|Overall Study|Sponsor Decision|103|||
33148340|NCT04551066|100456239|FG001|Overall Study|Sponsor Decision|117|||
33148341|NCT04551066|100456238|FG000|Overall Study|Withdrawal by Subject|8|||
33148342|NCT04551066|100456239|FG001|Overall Study|Withdrawal by Subject|2|||
33148343|NCT04551066|100456238|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
33246093|NCT02781584|100800336|FG009|Treatment Phase|Adverse Event|0|||
33246094|NCT02781584|100800337|FG010|Treatment Phase|Adverse Event|0|||
33374425|NCT04937816|101258528|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
33374426|NCT04937816|101258529|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
33374427|NCT04937816|101258530|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
33374428|NCT04937816|101258531|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
33374429|NCT04937816|101258532|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
33374430|NCT04937816|101258526|FG000|Overall Study|Lost to Follow-up|15|||
33374431|NCT04937816|101258527|FG001|Overall Study|Lost to Follow-up|9|||
33374432|NCT04937816|101258528|FG002|Overall Study|Lost to Follow-up|6|||
33374433|NCT04937816|101258529|FG003|Overall Study|Lost to Follow-up|6|||
33374434|NCT04937816|101258530|FG004|Overall Study|Lost to Follow-up|16|||
33148344|NCT04551066|100456239|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
33148345|NCT04551066|100456238|FG000|Overall Study|Adverse Event|2|||
33148346|NCT04551066|100456239|FG001|Overall Study|Adverse Event|0|||
33148347|NCT04551066|100456238|FG000|Overall Study|Physician Decision|2|||
33148348|NCT04551066|100456239|FG001|Overall Study|Physician Decision|0|||
33148349|NCT04551066|100456238|FG000|Overall Study|Protocol Violation|1|||
33148350|NCT04551066|100456239|FG001|Overall Study|Protocol Violation|0|||
33148351|NCT04551066|100456238|FG000|Overall Study|Lack of Efficacy|0|||
33374435|NCT04937816|101258531|FG005|Overall Study|Lost to Follow-up|11|||
33374436|NCT04937816|101258532|FG006|Overall Study|Lost to Follow-up|17|||
33374437|NCT04937816|101258526|FG000|Overall Study|Protocol Violation|15|||
33374438|NCT04937816|101258527|FG001|Overall Study|Protocol Violation|15|||
33374439|NCT04937816|101258528|FG002|Overall Study|Protocol Violation|12|||
33374440|NCT04937816|101258529|FG003|Overall Study|Protocol Violation|30|||
33584970|NCT01667133|102029135|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33584971|NCT01667133|102029136|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33584972|NCT01667133|102029137|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33584973|NCT01667133|102029138|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33584974|NCT01667133|102029139|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33584975|NCT01667133|102029140|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
33584976|NCT01667133|102029141|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33584977|NCT01667133|102029142|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
33584978|NCT01667133|102029131|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
33584979|NCT01667133|102029132|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
33584980|NCT01667133|102029133|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
33584981|NCT01667133|102029134|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
33584982|NCT01667133|102029135|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
33584983|NCT01667133|102029136|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
33148352|NCT04551066|100456239|FG001|Overall Study|Lack of Efficacy|1|||
33246095|NCT02781584|100800338|FG011|Treatment Phase|Adverse Event|0|||
33374441|NCT04937816|101258530|FG004|Overall Study|Protocol Violation|24|||
33374442|NCT04937816|101258531|FG005|Overall Study|Protocol Violation|5|||
33374443|NCT04937816|101258532|FG006|Overall Study|Protocol Violation|5|||
33374444|NCT04937816|101258526|FG000|Overall Study|Adverse Event|303|||
33374445|NCT04937816|101258527|FG001|Overall Study|Adverse Event|267|||
33584984|NCT01667133|102029137|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
33645765|NCT01396447|102256176|FG002|Overall Study|Lost to Follow-up|7|||
33148353|NCT04551066|100456238|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
33645766|NCT01396447|102256177|FG003|Overall Study|Lost to Follow-up|9|||
33645767|NCT01396447|102256174|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33645768|NCT01396447|102256175|FG001|Overall Study|Other Miscellaneous Reasons|2|||
33645769|NCT01396447|102256176|FG002|Overall Study|Other Miscellaneous Reasons|1|||
33645770|NCT01396447|102256177|FG003|Overall Study|Other Miscellaneous Reasons|0|||
33645771|NCT01590758|102256178|FG000|Overall Study|Withdrawal by Subject|0|||
33645772|NCT01590758|102256179|FG001|Overall Study|Withdrawal by Subject|3|||
33645773|NCT01590758|102256178|FG000|Overall Study|Physician Decision|1|||
33645774|NCT01590758|102256179|FG001|Overall Study|Physician Decision|2|||
33645775|NCT01590758|102256178|FG000|Overall Study|Lost to Follow-up|4|||
33645776|NCT01590758|102256179|FG001|Overall Study|Lost to Follow-up|2|||
33645777|NCT01705509|102256180|FG000|Inclusion CPET|Screen Failure|5|||
33645778|NCT01705509|102256180|FG000|Inclusion CPET|Withdrawal by Subject|2|||
33645779|NCT01705509|102256180|FG000|CPET w/ Ranexa|Screen Failure|2|||
33645780|NCT02164461|102256181|FG000|Overall Study|Adverse Event|0|||
33645781|NCT02164461|102256182|FG001|Overall Study|Adverse Event|0|||
33645782|NCT02164461|102256183|FG002|Overall Study|Adverse Event|1|||
33645783|NCT02164461|102256181|FG000|Overall Study|Disease Progression|1|||
33645784|NCT02164461|102256182|FG001|Overall Study|Disease Progression|3|||
33645785|NCT02164461|102256183|FG002|Overall Study|Disease Progression|4|||
33645786|NCT02164461|102256181|FG000|Overall Study|Withdrawal by Subject|0|||
33645787|NCT02164461|102256182|FG001|Overall Study|Withdrawal by Subject|3|||
33645788|NCT02164461|102256183|FG002|Overall Study|Withdrawal by Subject|0|||
33645789|NCT04335136|102256184|FG000|Overall Study|Death|8|||
33645790|NCT04335136|102256185|FG001|Overall Study|Death|4|||
33645791|NCT04335136|102256184|FG000|Overall Study|Lost to Follow-up|2|||
33645792|NCT04335136|102256185|FG001|Overall Study|Lost to Follow-up|0|||
33645793|NCT04335136|102256184|FG000|Overall Study|Protocol Violation|1|||
33645794|NCT04335136|102256185|FG001|Overall Study|Protocol Violation|0|||
33645795|NCT04335136|102256184|FG000|Overall Study|Withdrawal by Subject|1|||
33374446|NCT04937816|101258528|FG002|Overall Study|Adverse Event|273|||
33374447|NCT04937816|101258529|FG003|Overall Study|Adverse Event|553|||
33374448|NCT04937816|101258530|FG004|Overall Study|Adverse Event|575|||
33374449|NCT04937816|101258531|FG005|Overall Study|Adverse Event|343|||
33374450|NCT04937816|101258532|FG006|Overall Study|Adverse Event|337|||
33374451|NCT04937816|101258526|FG000|Overall Study|Not treated|4|||
33374452|NCT04937816|101258527|FG001|Overall Study|Not treated|2|||
33584985|NCT01667133|102029138|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
33584986|NCT01667133|102029139|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
33584987|NCT01667133|102029140|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
33584988|NCT01667133|102029141|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
33584989|NCT01667133|102029142|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
33584990|NCT01667133|102029131|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33584991|NCT01667133|102029132|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33584992|NCT01667133|102029133|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33584993|NCT01667133|102029134|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33584994|NCT01667133|102029135|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33584995|NCT01667133|102029136|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33584996|NCT01667133|102029137|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33584997|NCT01667133|102029138|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33584998|NCT01667133|102029139|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33584999|NCT01667133|102029140|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
33585000|NCT01667133|102029141|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33585001|NCT01667133|102029142|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
33585002|NCT01667133|102029131|FG000|Phase 2: Dose-expansion|Death|0|||
33585003|NCT01667133|102029132|FG001|Phase 2: Dose-expansion|Death|0|||
33585004|NCT01667133|102029133|FG002|Phase 2: Dose-expansion|Death|0|||
33585005|NCT01667133|102029134|FG003|Phase 2: Dose-expansion|Death|0|||
33585006|NCT01667133|102029135|FG004|Phase 2: Dose-expansion|Death|0|||
33585007|NCT01667133|102029136|FG005|Phase 2: Dose-expansion|Death|0|||
33585008|NCT01667133|102029137|FG006|Phase 2: Dose-expansion|Death|0|||
33645796|NCT04335136|102256185|FG001|Overall Study|Withdrawal by Subject|1|||
33645797|NCT04335136|102256184|FG000|Overall Study|Health-threatening condition|0|||
33645798|NCT04335136|102256185|FG001|Overall Study|Health-threatening condition|1|||
33645799|NCT04335136|102256184|FG000|Overall Study|Adverse Event|0|||
33374453|NCT04937816|101258528|FG002|Overall Study|Not treated|2|||
33645800|NCT04335136|102256185|FG001|Overall Study|Adverse Event|1|||
33645801|NCT04335136|102256184|FG000|Overall Study|Erroneously randomized|2|||
33374454|NCT04937816|101258529|FG003|Overall Study|Not treated|2|||
33374455|NCT04937816|101258530|FG004|Overall Study|Not treated|1|||
33585009|NCT01667133|102029138|FG007|Phase 2: Dose-expansion|Death|0|||
33585010|NCT01667133|102029139|FG008|Phase 2: Dose-expansion|Death|0|||
33585011|NCT01667133|102029140|FG009|Phase 2: Dose-expansion|Death|1|||
33585012|NCT01667133|102029141|FG010|Phase 2: Dose-expansion|Death|0|||
33585013|NCT01667133|102029142|FG011|Phase 2: Dose-expansion|Death|0|||
33645802|NCT04335136|102256185|FG001|Overall Study|Erroneously randomized|0|||
33645803|NCT01137604|102256187|FG000|Overall Study|Adverse Event|3|||
33374456|NCT04937816|101258531|FG005|Overall Study|Not treated|4|||
33374457|NCT04937816|101258532|FG006|Overall Study|Not treated|0|||
33374458|NCT04507867|101258533|FG000|Overall Study|Death|7|||
33374459|NCT04507867|101258534|FG001|Overall Study|Death|1|||
33374460|NCT04664855|101258535|FG000|Overall Study|Withdrawal by Subject|0|||
33374461|NCT04664855|101258536|FG001|Overall Study|Withdrawal by Subject|2|||
33374462|NCT02768194|101258541|FG000|Period 1|Adverse Event|0|||
33374463|NCT02768194|101258542|FG001|Period 1|Adverse Event|0|||
33374464|NCT02768194|101258543|FG002|Period 1|Adverse Event|0|||
33148354|NCT04551066|100456239|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
33148355|NCT03898960|100458135|FG000|Overall Study|Death|10|||
33148356|NCT02969707|100458139|FG000|Overall Study|Withdrawal by Subject|6|||
33148357|NCT02969707|100458140|FG001|Overall Study|Withdrawal by Subject|5|||
33148358|NCT02969707|100458139|FG000|Overall Study|Severe anxiety|0|||
33148359|NCT02969707|100458140|FG001|Overall Study|Severe anxiety|1|||
33148360|NCT02969707|100458139|FG000|Overall Study|Positive toxicology screen|0|||
33148361|NCT02969707|100458140|FG001|Overall Study|Positive toxicology screen|2|||
33148362|NCT02969707|100458139|FG000|Overall Study|Claustrophobia|2|||
33148363|NCT02969707|100458140|FG001|Overall Study|Claustrophobia|2|||
33148364|NCT02969707|100458139|FG000|Overall Study|Non-compliance|1|||
33148365|NCT02969707|100458140|FG001|Overall Study|Non-compliance|2|||
33148366|NCT02910583|100458141|FG000|Overall Study|Death|7|||
33148367|NCT02910583|100458142|FG001|Overall Study|Death|3|||
33148368|NCT02910583|100458141|FG000|Overall Study|Lost to Follow-up|1|||
33148369|NCT02910583|100458142|FG001|Overall Study|Lost to Follow-up|0|||
33148370|NCT02910583|100458141|FG000|Overall Study|Withdrawal by Subject|12|||
33148371|NCT02910583|100458142|FG001|Overall Study|Withdrawal by Subject|8|||
33148372|NCT02910583|100458141|FG000|Overall Study|Other, Not Specified|6|||
33148373|NCT02910583|100458142|FG001|Overall Study|Other, Not Specified|3|||
33148374|NCT04544956|100458143|FG000|Overall Study|Withdrawal by Subject|1|||
33148375|NCT05070728|100458144|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
33148376|NCT05070728|100458145|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
33148377|NCT03213457|100458146|FG000|Screening Period|Withdrawal by Subject|0|||
33148378|NCT03213457|100458147|FG001|Screening Period|Withdrawal by Subject|1|||
33148379|NCT03213457|100458148|FG002|Screening Period|Withdrawal by Subject|0|||
33148380|NCT03213457|100458146|FG000|Screening Period|Other|1|||
33585014|NCT01667133|102029131|FG000|Phase 2: Dose-expansion|Other|0|||
33585015|NCT01667133|102029132|FG001|Phase 2: Dose-expansion|Other|0|||
33585016|NCT01667133|102029133|FG002|Phase 2: Dose-expansion|Other|0|||
33148381|NCT03213457|100458147|FG001|Screening Period|Other|0|||
33148382|NCT03213457|100458148|FG002|Screening Period|Other|0|||
33148383|NCT03213457|100458146|FG000|Double-Blind Period|Adverse Event|3|||
33148384|NCT03213457|100458147|FG001|Double-Blind Period|Adverse Event|2|||
33148385|NCT03213457|100458148|FG002|Double-Blind Period|Adverse Event|7|||
33148386|NCT03213457|100458146|FG000|Double-Blind Period|Withdrawal by Subject|14|||
33148387|NCT03213457|100458147|FG001|Double-Blind Period|Withdrawal by Subject|2|||
33148388|NCT03213457|100458148|FG002|Double-Blind Period|Withdrawal by Subject|14|||
33148389|NCT03213457|100458146|FG000|Double-Blind Period|Lost to Follow-up|2|||
33148390|NCT03213457|100458147|FG001|Double-Blind Period|Lost to Follow-up|3|||
33148391|NCT03213457|100458148|FG002|Double-Blind Period|Lost to Follow-up|9|||
33148392|NCT03213457|100458146|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
33148393|NCT03213457|100458147|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
33148394|NCT03213457|100458148|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
33148395|NCT03213457|100458146|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
33148396|NCT03213457|100458147|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
33148397|NCT03213457|100458148|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
33148398|NCT03213457|100458146|FG000|Double-Blind Period|Pregnancy|5|||
33148399|NCT03213457|100458147|FG001|Double-Blind Period|Pregnancy|0|||
33148400|NCT03213457|100458148|FG002|Double-Blind Period|Pregnancy|0|||
33148401|NCT03213457|100458146|FG000|Double-Blind Period|Other|10|||
33148402|NCT03213457|100458147|FG001|Double-Blind Period|Other|3|||
33148403|NCT03213457|100458148|FG002|Double-Blind Period|Other|17|||
33148404|NCT03213457|100458146|FG000|Open-Label Period|Adverse Event|1|||
33148405|NCT03213457|100458147|FG001|Open-Label Period|Adverse Event|2|||
33148406|NCT03213457|100458148|FG002|Open-Label Period|Adverse Event|2|||
33585017|NCT01667133|102029134|FG003|Phase 2: Dose-expansion|Other|0|||
33246096|NCT02781584|100800339|FG012|Treatment Phase|Adverse Event|0|||
33246097|NCT01323660|100800340|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
33374465|NCT02768194|101258544|FG003|Period 1|Adverse Event|1|||
33374466|NCT02768194|101258545|FG004|Period 1|Adverse Event|0|||
33148407|NCT03213457|100458146|FG000|Open-Label Period|Withdrawal by Subject|12|||
33374467|NCT02768194|101258546|FG005|Period 1|Adverse Event|0|||
33585018|NCT01667133|102029135|FG004|Phase 2: Dose-expansion|Other|0|||
33148408|NCT03213457|100458147|FG001|Open-Label Period|Withdrawal by Subject|5|||
33246098|NCT01323660|100800341|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
33148409|NCT03213457|100458148|FG002|Open-Label Period|Withdrawal by Subject|24|||
33374468|NCT02768194|101258541|FG000|Period 2|Other (Reason not specified)|1|||
33423641|NCT01169987|101443499|FG000|Overall Study|Other|4|||
33423642|NCT00065065|101443511|FG000|Overall Study|Adverse Event|3|||
33423643|NCT00065065|101443512|FG001|Overall Study|Adverse Event|2|||
33423644|NCT00065065|101443511|FG000|Overall Study|Withdrawal by Subject|1|||
33423645|NCT00065065|101443512|FG001|Overall Study|Withdrawal by Subject|5|||
33423646|NCT00065065|101443511|FG000|Overall Study|Lack of Efficacy|4|||
33423647|NCT00065065|101443512|FG001|Overall Study|Lack of Efficacy|11|||
33423648|NCT00065065|101443511|FG000|Overall Study|Other|2|||
33423649|NCT00065065|101443512|FG001|Overall Study|Other|2|||
33423650|NCT00420290|101443513|FG000|Overall Study|Adverse Event|3|||
33423651|NCT00420290|101443514|FG001|Overall Study|Adverse Event|1|||
33423652|NCT00420290|101443513|FG000|Overall Study|Withdrawal by Subject|0|||
33423653|NCT00420290|101443514|FG001|Overall Study|Withdrawal by Subject|2|||
33423654|NCT00420290|101443513|FG000|Overall Study|did not meet inclusion/exclusion|1|||
33423655|NCT00420290|101443514|FG001|Overall Study|did not meet inclusion/exclusion|1|||
33423656|NCT02063698|101443515|FG000|Overall Study|did not complete booklet for days 2-8|1|||
33423657|NCT02063698|101443516|FG001|Overall Study|did not complete booklet for days 2-8|2|||
33423658|NCT03262233|101443519|FG000|Overall Study|Withdrawal by Subject|12|||
33423659|NCT03262233|101443520|FG001|Overall Study|Withdrawal by Subject|8|||
33423660|NCT03262233|101443521|FG002|Overall Study|Withdrawal by Subject|21|||
33645804|NCT01137604|102256188|FG001|Overall Study|Adverse Event|6|||
33645805|NCT01137604|102256189|FG002|Overall Study|Adverse Event|9|||
33645806|NCT01137604|102256190|FG003|Overall Study|Adverse Event|9|||
33645807|NCT01137604|102256187|FG000|Overall Study|Participant Choice|0|||
33645808|NCT01137604|102256188|FG001|Overall Study|Participant Choice|2|||
33645809|NCT01137604|102256189|FG002|Overall Study|Participant Choice|2|||
33645810|NCT01137604|102256190|FG003|Overall Study|Participant Choice|0|||
33645811|NCT01137604|102256187|FG000|Overall Study|Withdrawal of consent|0|||
33645812|NCT01137604|102256188|FG001|Overall Study|Withdrawal of consent|0|||
33645813|NCT01137604|102256189|FG002|Overall Study|Withdrawal of consent|0|||
33645814|NCT01137604|102256190|FG003|Overall Study|Withdrawal of consent|2|||
33645815|NCT01137604|102256187|FG000|Overall Study|Clinical progression/deterioration|1|||
33645816|NCT01137604|102256188|FG001|Overall Study|Clinical progression/deterioration|2|||
33645817|NCT01137604|102256189|FG002|Overall Study|Clinical progression/deterioration|2|||
33645818|NCT01137604|102256190|FG003|Overall Study|Clinical progression/deterioration|0|||
33645819|NCT04075734|102256193|FG000|Overall Study|Lost to Follow-up|1|||
33645820|NCT04075734|102256194|FG001|Overall Study|Lost to Follow-up|1|||
33645821|NCT04075734|102256195|FG002|Overall Study|Lost to Follow-up|0|||
33645822|NCT04075734|102256193|FG000|Overall Study|Withdrawal by Subject|3|||
33645823|NCT04075734|102256194|FG001|Overall Study|Withdrawal by Subject|0|||
33645824|NCT04075734|102256195|FG002|Overall Study|Withdrawal by Subject|0|||
33645825|NCT01727024|102256204|FG000|Period 1|Lost to Follow-up|1|||
33645826|NCT01727024|102256205|FG001|Period 1|Lost to Follow-up|1|||
33645827|NCT01727024|102256204|FG000|Period 1|Withdrawal by Subject|2|||
33645828|NCT01727024|102256205|FG001|Period 1|Withdrawal by Subject|3|||
33645829|NCT00843284|102256206|FG000|Overall Study|Adverse Event|39|||
33645830|NCT00843284|102256206|FG000|Overall Study|Lack of Efficacy|5|||
33645831|NCT00843284|102256206|FG000|Overall Study|Lost to Follow-up|11|||
33645832|NCT00843284|102256206|FG000|Overall Study|Other|10|||
33645833|NCT00843284|102256206|FG000|Overall Study|Withdrawal by Subject|4|||
33645834|NCT00843284|102256206|FG000|Overall Study|Death|3|||
33645835|NCT01396057|102256207|FG000|Overall Study|Adverse Event|2|||
33645836|NCT01396057|102256208|FG001|Overall Study|Adverse Event|6|||
33645837|NCT01396057|102256207|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33645838|NCT01396057|102256208|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
33645839|NCT01396057|102256207|FG000|Overall Study|Protocol deviation|4|||
33645840|NCT01396057|102256208|FG001|Overall Study|Protocol deviation|4|||
33645841|NCT01396057|102256207|FG000|Overall Study|Consent withdrawn|3|||
33645842|NCT01396057|102256208|FG001|Overall Study|Consent withdrawn|2|||
33645843|NCT00750152|102256209|FG000|Overall Study|Adverse Event|2|||
33148410|NCT03213457|100458146|FG000|Open-Label Period|Lost to Follow-up|1|||
33423661|NCT03262233|101443522|FG003|Overall Study|Withdrawal by Subject|13|||
33423662|NCT03262233|101443519|FG000|Overall Study|Declined due to shock|1|||
33423663|NCT03262233|101443520|FG001|Overall Study|Declined due to shock|2|||
33645844|NCT00750152|102256210|FG001|Overall Study|Adverse Event|1|||
33645845|NCT00750152|102256209|FG000|Overall Study|Lost to Follow-up|8|||
33645846|NCT00750152|102256210|FG001|Overall Study|Lost to Follow-up|13|||
33645847|NCT00750152|102256209|FG000|Overall Study|Withdrawal by Subject|3|||
33645848|NCT00750152|102256210|FG001|Overall Study|Withdrawal by Subject|3|||
33645849|NCT00750152|102256209|FG000|Overall Study|Physician Decision|1|||
33645850|NCT00750152|102256210|FG001|Overall Study|Physician Decision|1|||
33423664|NCT03262233|101443521|FG002|Overall Study|Declined due to shock|2|||
33423665|NCT03262233|101443522|FG003|Overall Study|Declined due to shock|3|||
33423666|NCT03262233|101443519|FG000|Overall Study|Protocol Violation|5|||
33423667|NCT03262233|101443520|FG001|Overall Study|Protocol Violation|10|||
33423668|NCT03262233|101443521|FG002|Overall Study|Protocol Violation|2|||
33645851|NCT00750152|102256209|FG000|Overall Study|Non-compliance|0|||
33645852|NCT00750152|102256210|FG001|Overall Study|Non-compliance|1|||
33148411|NCT03213457|100458147|FG001|Open-Label Period|Lost to Follow-up|2|||
33148412|NCT03213457|100458148|FG002|Open-Label Period|Lost to Follow-up|8|||
33148413|NCT03213457|100458146|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
33148414|NCT03213457|100458147|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
33148415|NCT03213457|100458148|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
33148416|NCT03213457|100458146|FG000|Open-Label Period|Non-compliance with study procedures|1|||
33148417|NCT03213457|100458147|FG001|Open-Label Period|Non-compliance with study procedures|1|||
33148418|NCT03213457|100458148|FG002|Open-Label Period|Non-compliance with study procedures|2|||
33148419|NCT03213457|100458146|FG000|Open-Label Period|Exclusionary medications|0|||
33148420|NCT03213457|100458147|FG001|Open-Label Period|Exclusionary medications|0|||
33148421|NCT03213457|100458148|FG002|Open-Label Period|Exclusionary medications|1|||
33148422|NCT03213457|100458146|FG000|Open-Label Period|Other|1|||
33148423|NCT03213457|100458147|FG001|Open-Label Period|Other|1|||
33148424|NCT03213457|100458148|FG002|Open-Label Period|Other|6|||
33148425|NCT03213457|100458146|FG000|Follow-Up Period|Adverse Event|16|||
33148426|NCT03213457|100458147|FG001|Follow-Up Period|Adverse Event|8|||
33148427|NCT03213457|100458148|FG002|Follow-Up Period|Adverse Event|37|||
33148428|NCT03213457|100458146|FG000|Follow-Up Period|Withdrawal by Subject|18|||
33148429|NCT03213457|100458147|FG001|Follow-Up Period|Withdrawal by Subject|11|||
33148430|NCT03213457|100458148|FG002|Follow-Up Period|Withdrawal by Subject|55|||
33148431|NCT03213457|100458146|FG000|Follow-Up Period|Lost to Follow-up|28|||
33148432|NCT03213457|100458147|FG001|Follow-Up Period|Lost to Follow-up|15|||
33148433|NCT03213457|100458148|FG002|Follow-Up Period|Lost to Follow-up|50|||
33148434|NCT03213457|100458146|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
33148435|NCT03213457|100458147|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
33148436|NCT03213457|100458148|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
33148437|NCT03213457|100458146|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
33148438|NCT03213457|100458147|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
33148439|NCT03213457|100458148|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
33148440|NCT03213457|100458146|FG000|Follow-Up Period|Pregnancy|7|||
33148441|NCT03213457|100458147|FG001|Follow-Up Period|Pregnancy|0|||
33148442|NCT03213457|100458148|FG002|Follow-Up Period|Pregnancy|18|||
33148443|NCT03213457|100458146|FG000|Follow-Up Period|Exclusionary medications|1|||
33148444|NCT03213457|100458147|FG001|Follow-Up Period|Exclusionary medications|1|||
33148445|NCT03213457|100458148|FG002|Follow-Up Period|Exclusionary medications|5|||
33148446|NCT03213457|100458146|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
33148447|NCT03213457|100458147|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
33148448|NCT03213457|100458148|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
33148449|NCT03213457|100458146|FG000|Follow-Up Period|Other|14|||
33148450|NCT03213457|100458147|FG001|Follow-Up Period|Other|10|||
33148451|NCT03213457|100458148|FG002|Follow-Up Period|Other|31|||
33148452|NCT03834493|100458149|FG000|Overall Study|Participants Ongoing|311|||
33148453|NCT03834493|100458150|FG001|Overall Study|Participants Ongoing|324|||
33148454|NCT03834493|100458149|FG000|Overall Study|Withdrawal by Subject|20|||
33148455|NCT03834493|100458150|FG001|Overall Study|Withdrawal by Subject|17|||
33148456|NCT03834493|100458149|FG000|Overall Study|Physician Decision|1|||
33148457|NCT03834493|100458150|FG001|Overall Study|Physician Decision|0|||
33148458|NCT03834493|100458149|FG000|Overall Study|Death|289|||
33148459|NCT03834493|100458150|FG001|Overall Study|Death|282|||
33148460|NCT04567615|100458155|FG000|Randomization|Participant withdrew consent|1|||
33148461|NCT04567615|100458156|FG001|Randomization|Participant withdrew consent|0|||
33148462|NCT04567615|100458157|FG002|Randomization|Participant withdrew consent|0|||
33148463|NCT04567615|100458155|FG000|Randomization|Adverse event unrelated to study drug|0|||
33148464|NCT04567615|100458156|FG001|Randomization|Adverse event unrelated to study drug|1|||
33148465|NCT04567615|100458157|FG002|Randomization|Adverse event unrelated to study drug|0|||
33148466|NCT04567615|100458155|FG000|Treatment Period|Participant Withdrew Consent|2|||
33148467|NCT04567615|100458156|FG001|Treatment Period|Participant Withdrew Consent|5|||
33148468|NCT04567615|100458157|FG002|Treatment Period|Participant Withdrew Consent|1|||
33148469|NCT04567615|100458155|FG000|Treatment Period|Death|1|||
33148470|NCT04567615|100458156|FG001|Treatment Period|Death|2|||
33148471|NCT04567615|100458157|FG002|Treatment Period|Death|0|||
33585019|NCT01667133|102029136|FG005|Phase 2: Dose-expansion|Other|0|||
33148472|NCT04567615|100458155|FG000|Treatment Period|Lost to Follow-up|0|||
33148473|NCT04567615|100458156|FG001|Treatment Period|Lost to Follow-up|1|||
33585020|NCT01667133|102029137|FG006|Phase 2: Dose-expansion|Other|0|||
33148474|NCT04567615|100458157|FG002|Treatment Period|Lost to Follow-up|0|||
33148475|NCT04567615|100458155|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
33148476|NCT04567615|100458156|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
33148477|NCT04567615|100458157|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
33148478|NCT04567615|100458155|FG000|Treatment Period|Disease Progression|85|||
33148479|NCT04567615|100458156|FG001|Treatment Period|Disease Progression|63|||
33423669|NCT03262233|101443522|FG003|Overall Study|Protocol Violation|13|||
33374469|NCT02768194|101258542|FG001|Period 2|Other (Reason not specified)|0|||
33374470|NCT02768194|101258543|FG002|Period 2|Other (Reason not specified)|0|||
33374471|NCT02768194|101258544|FG003|Period 2|Other (Reason not specified)|0|||
33374472|NCT02768194|101258545|FG004|Period 2|Other (Reason not specified)|0|||
33374473|NCT02768194|101258546|FG005|Period 2|Other (Reason not specified)|0|||
33374474|NCT02768194|101258541|FG000|Period 3|Other (Reason not specified)|0|||
33374475|NCT02768194|101258542|FG001|Period 3|Other (Reason not specified)|1|||
33374476|NCT02768194|101258543|FG002|Period 3|Other (Reason not specified)|0|||
33374477|NCT02768194|101258544|FG003|Period 3|Other (Reason not specified)|0|||
33374478|NCT02768194|101258545|FG004|Period 3|Other (Reason not specified)|0|||
33374479|NCT02768194|101258546|FG005|Period 3|Other (Reason not specified)|0|||
33374480|NCT00748553|101258547|FG000|Overall Study|Adverse Event|0|||
33374481|NCT00748553|101258548|FG001|Overall Study|Adverse Event|1|||
33374482|NCT00748553|101258547|FG000|Overall Study|disease progression|2|||
33374483|NCT00748553|101258548|FG001|Overall Study|disease progression|0|||
33374484|NCT00748553|101258547|FG000|Overall Study|noncompliance|1|||
33374485|NCT00748553|101258548|FG001|Overall Study|noncompliance|0|||
33374486|NCT04633473|101258549|FG000|Overall Study|Withdrawal by Subject|6|||
33374487|NCT01727713|101258552|FG000|Overall Study|Lost to Follow-up|5|||
33374488|NCT01727713|101258552|FG000|Overall Study|Adverse Event|10|||
33374489|NCT01727713|101258552|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
33374490|NCT01727713|101258552|FG000|Overall Study|Withdrawal by Subject|13|||
33374491|NCT01727713|101258552|FG000|Overall Study|Protocol Deviation|2|||
33374492|NCT02175771|101258553|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
33374493|NCT02175771|101258554|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33374494|NCT02175771|101258555|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33374495|NCT02175771|101258556|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33374496|NCT02175771|101258557|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33374497|NCT02175771|101258558|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33374498|NCT02175771|101258559|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33374499|NCT02175771|101258560|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33374500|NCT02175771|101258561|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
33374501|NCT02175771|101258553|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
33374502|NCT02175771|101258554|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33374503|NCT02175771|101258555|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33374504|NCT02175771|101258556|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33374505|NCT02175771|101258557|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33374506|NCT02175771|101258558|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33374507|NCT02175771|101258559|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33374508|NCT02175771|101258560|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33374509|NCT02175771|101258561|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
33374510|NCT02175771|101258553|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
33374511|NCT02175771|101258554|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33374512|NCT02175771|101258555|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33374513|NCT02175771|101258556|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33374514|NCT02175771|101258557|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33374515|NCT02175771|101258558|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33374516|NCT02175771|101258559|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33374517|NCT02175771|101258560|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33374518|NCT02175771|101258561|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
33246099|NCT01323660|100800342|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
33246100|NCT01323660|100800343|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
33374519|NCT02175771|101258553|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
33374520|NCT02175771|101258554|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
33374521|NCT02175771|101258555|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
33374522|NCT02175771|101258556|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
33374523|NCT02175771|101258557|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
33148480|NCT04567615|100458157|FG002|Treatment Period|Disease Progression|16|||
33148481|NCT04567615|100458155|FG000|Treatment Period|Study Drug Toxicity|3|||
33148482|NCT04567615|100458156|FG001|Treatment Period|Study Drug Toxicity|10|||
33246101|NCT01323660|100800344|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
33246102|NCT01323660|100800345|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
33374524|NCT02175771|101258558|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
33374525|NCT02175771|101258559|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
33374526|NCT02175771|101258560|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
33374527|NCT02175771|101258561|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
33374528|NCT02175771|101258553|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
33374529|NCT02175771|101258554|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33423670|NCT03262233|101443519|FG000|Overall Study|data collection artifact|0|||
33423671|NCT03262233|101443520|FG001|Overall Study|data collection artifact|1|||
33374530|NCT02175771|101258555|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33374531|NCT02175771|101258556|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33374532|NCT02175771|101258557|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33374533|NCT02175771|101258558|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33374534|NCT02175771|101258559|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33374535|NCT02175771|101258560|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33374536|NCT02175771|101258561|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
33374537|NCT02175771|101258553|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
33374538|NCT02175771|101258554|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33374539|NCT02175771|101258555|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33374540|NCT02175771|101258556|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33374541|NCT02175771|101258557|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33374542|NCT02175771|101258558|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33374543|NCT02175771|101258559|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33374544|NCT02175771|101258560|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33374545|NCT02175771|101258561|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
33374546|NCT02175771|101258553|FG000|Run-In Period (Pre-assignment)|Other|8|||
33374547|NCT02175771|101258554|FG001|Run-In Period (Pre-assignment)|Other|0|||
33374548|NCT02175771|101258555|FG002|Run-In Period (Pre-assignment)|Other|0|||
33374549|NCT02175771|101258556|FG003|Run-In Period (Pre-assignment)|Other|0|||
33374550|NCT02175771|101258557|FG004|Run-In Period (Pre-assignment)|Other|0|||
33374551|NCT02175771|101258558|FG005|Run-In Period (Pre-assignment)|Other|0|||
33374552|NCT02175771|101258559|FG006|Run-In Period (Pre-assignment)|Other|0|||
33374553|NCT02175771|101258560|FG007|Run-In Period (Pre-assignment)|Other|0|||
33374554|NCT02175771|101258561|FG008|Run-In Period (Pre-assignment)|Other|0|||
33374555|NCT02175771|101258553|FG000|Treatment Period|Adverse Event|0|||
33374556|NCT02175771|101258554|FG001|Treatment Period|Adverse Event|2|||
33374557|NCT02175771|101258555|FG002|Treatment Period|Adverse Event|1|||
33374558|NCT02175771|101258556|FG003|Treatment Period|Adverse Event|1|||
33374559|NCT02175771|101258557|FG004|Treatment Period|Adverse Event|1|||
33374560|NCT02175771|101258558|FG005|Treatment Period|Adverse Event|3|||
33374561|NCT02175771|101258559|FG006|Treatment Period|Adverse Event|2|||
33374562|NCT02175771|101258560|FG007|Treatment Period|Adverse Event|0|||
33374563|NCT02175771|101258561|FG008|Treatment Period|Adverse Event|1|||
33148483|NCT04567615|100458157|FG002|Treatment Period|Study Drug Toxicity|4|||
33148484|NCT04567615|100458155|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
33148485|NCT04567615|100458156|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
33374564|NCT02175771|101258553|FG000|Treatment Period|Withdrawal by Subject|0|||
33374565|NCT02175771|101258554|FG001|Treatment Period|Withdrawal by Subject|9|||
33374566|NCT02175771|101258555|FG002|Treatment Period|Withdrawal by Subject|3|||
33148486|NCT04567615|100458157|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
33148487|NCT04567615|100458155|FG000|Treatment Period|Other Reasons|1|||
33148488|NCT04567615|100458156|FG001|Treatment Period|Other Reasons|2|||
33148489|NCT04567615|100458157|FG002|Treatment Period|Other Reasons|0|||
33148490|NCT04567615|100458155|FG000|Treatment Period|Still On-going Treatment|21|||
33148491|NCT04567615|100458156|FG001|Treatment Period|Still On-going Treatment|22|||
33148492|NCT04567615|100458157|FG002|Treatment Period|Still On-going Treatment|2|||
33148493|NCT04024462|100458160|FG000|Overall Study|Withdrawal by Subject|6|||
33148494|NCT04024462|100458161|FG001|Overall Study|Withdrawal by Subject|7|||
33148495|NCT04024462|100458160|FG000|Overall Study|Progressive Disease|0|||
33246103|NCT01323660|100800340|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
33246104|NCT01323660|100800341|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
33148496|NCT04024462|100458161|FG001|Overall Study|Progressive Disease|1|||
33148497|NCT04024462|100458160|FG000|Overall Study|Adverse Event|0|||
33246105|NCT01323660|100800342|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
33374567|NCT02175771|101258556|FG003|Treatment Period|Withdrawal by Subject|6|||
33148498|NCT04024462|100458161|FG001|Overall Study|Adverse Event|1|||
33148499|NCT04024462|100458160|FG000|Overall Study|Death|0|||
33148500|NCT04024462|100458161|FG001|Overall Study|Death|1|||
33148501|NCT04024462|100458160|FG000|Overall Study|Lost to Follow-up|1|||
33148502|NCT04024462|100458161|FG001|Overall Study|Lost to Follow-up|0|||
33148503|NCT04024462|100458160|FG000|Overall Study|Ongoing in the Study|94|||
33148504|NCT04024462|100458161|FG001|Overall Study|Ongoing in the Study|89|||
33148505|NCT00978432|100458163|FG000|Overall Study|Withdrawal by Subject|0|||
33246106|NCT01323660|100800343|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
33148506|NCT00978432|100458164|FG001|Overall Study|Withdrawal by Subject|0|||
33374568|NCT02175771|101258557|FG004|Treatment Period|Withdrawal by Subject|2|||
33374569|NCT02175771|101258558|FG005|Treatment Period|Withdrawal by Subject|4|||
33374570|NCT02175771|101258559|FG006|Treatment Period|Withdrawal by Subject|2|||
33374571|NCT02175771|101258560|FG007|Treatment Period|Withdrawal by Subject|9|||
33374572|NCT02175771|101258561|FG008|Treatment Period|Withdrawal by Subject|2|||
33148507|NCT00978432|100458165|FG002|Overall Study|Withdrawal by Subject|1|||
33148508|NCT00978432|100458163|FG000|Overall Study|Lack of Efficacy|1|||
33148509|NCT00978432|100458164|FG001|Overall Study|Lack of Efficacy|1|||
33374573|NCT02175771|101258553|FG000|Treatment Period|Noncompliance|0|||
33374574|NCT02175771|101258554|FG001|Treatment Period|Noncompliance|1|||
33374575|NCT02175771|101258555|FG002|Treatment Period|Noncompliance|2|||
33374576|NCT02175771|101258556|FG003|Treatment Period|Noncompliance|0|||
33374577|NCT02175771|101258557|FG004|Treatment Period|Noncompliance|0|||
33374578|NCT02175771|101258558|FG005|Treatment Period|Noncompliance|0|||
33374579|NCT02175771|101258559|FG006|Treatment Period|Noncompliance|0|||
33374580|NCT02175771|101258560|FG007|Treatment Period|Noncompliance|0|||
33374581|NCT02175771|101258561|FG008|Treatment Period|Noncompliance|1|||
33374582|NCT02175771|101258553|FG000|Treatment Period|Protocol Violation|0|||
33374583|NCT02175771|101258554|FG001|Treatment Period|Protocol Violation|0|||
33374584|NCT02175771|101258555|FG002|Treatment Period|Protocol Violation|0|||
33374585|NCT02175771|101258556|FG003|Treatment Period|Protocol Violation|0|||
33374586|NCT02175771|101258557|FG004|Treatment Period|Protocol Violation|0|||
33374587|NCT02175771|101258558|FG005|Treatment Period|Protocol Violation|0|||
33374588|NCT02175771|101258559|FG006|Treatment Period|Protocol Violation|0|||
33374589|NCT02175771|101258560|FG007|Treatment Period|Protocol Violation|1|||
33374590|NCT02175771|101258561|FG008|Treatment Period|Protocol Violation|0|||
33374591|NCT02175771|101258553|FG000|Treatment Period|Disease progression|0|||
33374592|NCT02175771|101258554|FG001|Treatment Period|Disease progression|0|||
33374593|NCT02175771|101258555|FG002|Treatment Period|Disease progression|0|||
33374594|NCT02175771|101258556|FG003|Treatment Period|Disease progression|0|||
33374595|NCT02175771|101258557|FG004|Treatment Period|Disease progression|0|||
33374596|NCT02175771|101258558|FG005|Treatment Period|Disease progression|0|||
33374597|NCT02175771|101258559|FG006|Treatment Period|Disease progression|0|||
33374598|NCT02175771|101258560|FG007|Treatment Period|Disease progression|2|||
33374599|NCT02175771|101258561|FG008|Treatment Period|Disease progression|0|||
33374600|NCT02175771|101258553|FG000|Treatment Period|Lost to Follow-up|0|||
33374601|NCT02175771|101258554|FG001|Treatment Period|Lost to Follow-up|3|||
33374602|NCT02175771|101258555|FG002|Treatment Period|Lost to Follow-up|1|||
33374603|NCT02175771|101258556|FG003|Treatment Period|Lost to Follow-up|3|||
33374604|NCT02175771|101258557|FG004|Treatment Period|Lost to Follow-up|1|||
33374605|NCT02175771|101258558|FG005|Treatment Period|Lost to Follow-up|2|||
33374606|NCT02175771|101258559|FG006|Treatment Period|Lost to Follow-up|1|||
33374607|NCT02175771|101258560|FG007|Treatment Period|Lost to Follow-up|2|||
33374608|NCT02175771|101258561|FG008|Treatment Period|Lost to Follow-up|2|||
33374609|NCT02175771|101258553|FG000|Treatment Period|Lack of Efficacy|0|||
33374610|NCT02175771|101258554|FG001|Treatment Period|Lack of Efficacy|0|||
33374611|NCT02175771|101258555|FG002|Treatment Period|Lack of Efficacy|0|||
33374612|NCT02175771|101258556|FG003|Treatment Period|Lack of Efficacy|0|||
33374613|NCT02175771|101258557|FG004|Treatment Period|Lack of Efficacy|0|||
33374614|NCT02175771|101258558|FG005|Treatment Period|Lack of Efficacy|1|||
33374615|NCT02175771|101258559|FG006|Treatment Period|Lack of Efficacy|0|||
33374616|NCT02175771|101258560|FG007|Treatment Period|Lack of Efficacy|1|||
33374617|NCT02175771|101258561|FG008|Treatment Period|Lack of Efficacy|0|||
33374618|NCT02175771|101258553|FG000|Treatment Period|Other|0|||
33374619|NCT02175771|101258554|FG001|Treatment Period|Other|1|||
33374620|NCT02175771|101258555|FG002|Treatment Period|Other|0|||
33374621|NCT02175771|101258556|FG003|Treatment Period|Other|3|||
33374622|NCT02175771|101258557|FG004|Treatment Period|Other|1|||
33374623|NCT02175771|101258558|FG005|Treatment Period|Other|0|||
33374624|NCT02175771|101258559|FG006|Treatment Period|Other|0|||
33374625|NCT02175771|101258560|FG007|Treatment Period|Other|2|||
33374626|NCT02175771|101258561|FG008|Treatment Period|Other|0|||
33374627|NCT03150095|101258564|FG000|Overall Study|Death|0|||
33374628|NCT03150095|101258565|FG001|Overall Study|Death|1|||
33374629|NCT03150095|101258564|FG000|Overall Study|Lost to Follow-up|1|||
33374630|NCT03150095|101258565|FG001|Overall Study|Lost to Follow-up|1|||
33374631|NCT03150095|101258564|FG000|Overall Study|Withdrawal by Subject|4|||
33374632|NCT03150095|101258565|FG001|Overall Study|Withdrawal by Subject|0|||
33374633|NCT03150095|101258564|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
33585021|NCT01667133|102029138|FG007|Phase 2: Dose-expansion|Other|0|||
33374634|NCT03150095|101258565|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
33374635|NCT03364608|101258566|FG000|Overall Study|Withdrawal by Subject|4|||
33374636|NCT03364608|101258566|FG000|Overall Study|Protocol Violation|2|||
33374637|NCT03364608|101258566|FG000|Overall Study|Lost to Follow-up|2|||
33374638|NCT02324842|101258569|FG000|Overall Study|Lost to Follow-up|1|||
33374639|NCT02324842|101258570|FG001|Overall Study|Lost to Follow-up|1|||
33374640|NCT02324842|101258571|FG002|Overall Study|Lost to Follow-up|2|||
33374641|NCT03288493|101258572|FG000|Overall Study|Withdrawal by Subject|4|||
33585022|NCT01667133|102029139|FG008|Phase 2: Dose-expansion|Other|0|||
33585023|NCT01667133|102029140|FG009|Phase 2: Dose-expansion|Other|0|||
33585024|NCT01667133|102029141|FG010|Phase 2: Dose-expansion|Other|0|||
33374642|NCT03288493|101258573|FG001|Overall Study|Withdrawal by Subject|0|||
33374643|NCT03288493|101258574|FG002|Overall Study|Withdrawal by Subject|0|||
33374644|NCT03288493|101258575|FG003|Overall Study|Withdrawal by Subject|0|||
33374645|NCT03288493|101258576|FG004|Overall Study|Withdrawal by Subject|0|||
33374646|NCT03288493|101258577|FG005|Overall Study|Withdrawal by Subject|2|||
33585025|NCT01667133|102029142|FG011|Phase 2: Dose-expansion|Other|1|||
33374647|NCT03288493|101258578|FG006|Overall Study|Withdrawal by Subject|0|||
33374648|NCT03288493|101258572|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
33374649|NCT03288493|101258573|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
33423672|NCT03262233|101443521|FG002|Overall Study|data collection artifact|0|||
33423673|NCT03262233|101443522|FG003|Overall Study|data collection artifact|0|||
33423674|NCT03456726|101443525|FG000|Overall Study|Disease Progression|6|||
33423675|NCT03456726|101443526|FG001|Overall Study|Disease Progression|1|||
33423676|NCT03456726|101443525|FG000|Overall Study|Adverse Event|4|||
33423677|NCT03456726|101443526|FG001|Overall Study|Adverse Event|2|||
33423678|NCT03456726|101443525|FG000|Overall Study|Withdrawal by Subject|1|||
33423679|NCT03456726|101443526|FG001|Overall Study|Withdrawal by Subject|0|||
33423680|NCT03456726|101443525|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
33423681|NCT03456726|101443526|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
33423682|NCT02082262|101443543|FG000|Overall Study|Withdrawal by Subject|3|||
33423683|NCT02082262|101443543|FG000|Overall Study|Adverse Event|48|||
33423684|NCT01416142|101443544|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
33585026|NCT03292874|102029143|FG000|Overall Study|Due to pandemic|5|||
33585027|NCT02943070|102029146|FG000|Overall Study|Physician Decision|1|||
33585028|NCT02943070|102029146|FG000|Overall Study|Adverse Event|2|||
33585029|NCT02943070|102029146|FG000|Overall Study|Death|2|||
33585030|NCT02943070|102029146|FG000|Overall Study|Withdrawal by Subject|3|||
33585031|NCT02943070|102029146|FG000|Overall Study|Lost to Follow-up|4|||
33585032|NCT02943070|102029146|FG000|Overall Study|Retreatment or TURP|13|||
33585033|NCT02943070|102029146|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
33585034|NCT01670279|102029147|FG000|Overall Study|Adverse Event|0|||
33585035|NCT01670279|102029148|FG001|Overall Study|Adverse Event|1|||
33585036|NCT01670279|102029149|FG002|Overall Study|Adverse Event|0|||
33585037|NCT01670279|102029150|FG003|Overall Study|Adverse Event|0|||
33585038|NCT01670279|102029147|FG000|Overall Study|Physician Decision|0|||
33585039|NCT01670279|102029148|FG001|Overall Study|Physician Decision|1|||
33585040|NCT01670279|102029149|FG002|Overall Study|Physician Decision|0|||
33585041|NCT01670279|102029150|FG003|Overall Study|Physician Decision|0|||
33585042|NCT01670279|102029147|FG000|Overall Study|Participant met withdrawal criteria|0|||
33246107|NCT01323660|100800344|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
33246108|NCT01323660|100800345|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
33246109|NCT01323660|100800340|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
33246110|NCT01323660|100800341|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
33246111|NCT01323660|100800342|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
33246112|NCT01323660|100800343|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
33246113|NCT01323660|100800344|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
33374650|NCT03288493|101258574|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
33374651|NCT03288493|101258575|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
33374652|NCT03288493|101258576|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
33374653|NCT03288493|101258577|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
33374654|NCT03288493|101258578|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
33374655|NCT03288493|101258572|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
33374656|NCT03288493|101258573|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
33374657|NCT03288493|101258574|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
33423685|NCT01416142|101443545|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
33423686|NCT01416142|101443546|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
33423687|NCT01580020|101443547|FG000|Overall Study|Lack of Efficacy|0|||
33423688|NCT01580020|101443548|FG001|Overall Study|Lack of Efficacy|5|||
33585043|NCT01670279|102029148|FG001|Overall Study|Participant met withdrawal criteria|0|||
33585044|NCT01670279|102029149|FG002|Overall Study|Participant met withdrawal criteria|0|||
33585045|NCT01670279|102029150|FG003|Overall Study|Participant met withdrawal criteria|1|||
33585046|NCT02520388|102029153|FG000|Overall Study|Physician Decision|1|||
33585047|NCT02520388|102029154|FG001|Overall Study|Physician Decision|0|||
33585048|NCT02520388|102029153|FG000|Overall Study|Subject or parent/guardian request|0|||
33246114|NCT01323660|100800345|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
33246115|NCT01323660|100800340|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33246116|NCT01323660|100800341|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33246117|NCT01323660|100800342|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33246118|NCT01323660|100800343|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33246119|NCT01323660|100800344|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
33246120|NCT01323660|100800345|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
33246121|NCT01323660|100800340|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33585049|NCT02520388|102029154|FG001|Overall Study|Subject or parent/guardian request|6|||
33585050|NCT02520388|102029153|FG000|Overall Study|Adverse Event|1|||
33585051|NCT02520388|102029154|FG001|Overall Study|Adverse Event|4|||
33585052|NCT02520388|102029153|FG000|Overall Study|Lost to Follow-up|3|||
33585053|NCT02520388|102029154|FG001|Overall Study|Lost to Follow-up|2|||
33585054|NCT02520388|102029153|FG000|Overall Study|Other (reason not defined)|4|||
33585055|NCT02520388|102029154|FG001|Overall Study|Other (reason not defined)|4|||
33585056|NCT00720356|102029155|FG000|Registration to Study|Determined to have methylated MGMT|67|||
33585057|NCT00720356|102029155|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
33585058|NCT00720356|102029155|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
33585059|NCT00720356|102029155|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
33585060|NCT00720356|102029155|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
33585061|NCT00720356|102029155|FG000|Follow up Until Death|Withdrawal by Subject|1|||
33585062|NCT00720356|102029155|FG000|Follow up Until Death|Alive at last data collection|4|||
33585063|NCT01864148|102029156|FG000|Overall Study|Other|2|||
33585064|NCT01864148|102029157|FG001|Overall Study|Other|1|||
33585065|NCT01864148|102029158|FG002|Overall Study|Other|1|||
33585066|NCT01864148|102029159|FG003|Overall Study|Other|3|||
33585067|NCT01864148|102029160|FG004|Overall Study|Other|1|||
33585068|NCT01864148|102029156|FG000|Overall Study|Death|0|||
33585069|NCT01864148|102029157|FG001|Overall Study|Death|0|||
33585070|NCT01864148|102029158|FG002|Overall Study|Death|0|||
33585071|NCT01864148|102029159|FG003|Overall Study|Death|1|||
33585072|NCT01864148|102029160|FG004|Overall Study|Death|0|||
33585073|NCT01864148|102029156|FG000|Overall Study|Investigator Decision|5|||
33585074|NCT01864148|102029157|FG001|Overall Study|Investigator Decision|0|||
33585075|NCT01864148|102029158|FG002|Overall Study|Investigator Decision|0|||
33585076|NCT01864148|102029159|FG003|Overall Study|Investigator Decision|4|||
33585077|NCT01864148|102029160|FG004|Overall Study|Investigator Decision|6|||
33585078|NCT01864148|102029156|FG000|Overall Study|Withdrawal by Subject|9|||
33585079|NCT01864148|102029157|FG001|Overall Study|Withdrawal by Subject|2|||
33585080|NCT01864148|102029158|FG002|Overall Study|Withdrawal by Subject|6|||
33585081|NCT01864148|102029159|FG003|Overall Study|Withdrawal by Subject|8|||
33585082|NCT01864148|102029160|FG004|Overall Study|Withdrawal by Subject|8|||
33585083|NCT01864148|102029156|FG000|Overall Study|Lost to Follow-up|0|||
33585084|NCT01864148|102029157|FG001|Overall Study|Lost to Follow-up|0|||
33585085|NCT01864148|102029158|FG002|Overall Study|Lost to Follow-up|0|||
33585086|NCT01864148|102029159|FG003|Overall Study|Lost to Follow-up|2|||
33585087|NCT01864148|102029160|FG004|Overall Study|Lost to Follow-up|1|||
33585088|NCT01864148|102029156|FG000|Overall Study|Adverse Event|4|||
33585089|NCT01864148|102029157|FG001|Overall Study|Adverse Event|2|||
33585090|NCT01864148|102029158|FG002|Overall Study|Adverse Event|4|||
33585091|NCT01864148|102029159|FG003|Overall Study|Adverse Event|7|||
33645853|NCT00750152|102256209|FG000|Overall Study|Termination by sponsor|1|||
33645854|NCT00750152|102256210|FG001|Overall Study|Termination by sponsor|0|||
33645855|NCT00750152|102256209|FG000|Overall Study|Other|7|||
33645856|NCT00750152|102256210|FG001|Overall Study|Other|8|||
33645857|NCT03263702|102256216|FG000|Overall Study|Lost to Follow-up|2|||
33645858|NCT03263702|102256217|FG001|Overall Study|Lost to Follow-up|2|||
33645859|NCT03263702|102256216|FG000|Overall Study|Withdrawal by Subject|1|||
33645860|NCT03263702|102256217|FG001|Overall Study|Withdrawal by Subject|2|||
33645861|NCT00635219|102256218|FG000|Overall Study|Adverse Event|12|||
33645862|NCT00635219|102256219|FG001|Overall Study|Adverse Event|10|||
33645863|NCT00635219|102256220|FG002|Overall Study|Adverse Event|18|||
33645864|NCT00635219|102256221|FG003|Overall Study|Adverse Event|15|||
33645865|NCT00635219|102256222|FG004|Overall Study|Adverse Event|19|||
33645866|NCT00635219|102256218|FG000|Overall Study|Lack of Efficacy|5|||
33645867|NCT00635219|102256219|FG001|Overall Study|Lack of Efficacy|6|||
33645868|NCT00635219|102256220|FG002|Overall Study|Lack of Efficacy|3|||
33645869|NCT00635219|102256221|FG003|Overall Study|Lack of Efficacy|4|||
33645870|NCT00635219|102256222|FG004|Overall Study|Lack of Efficacy|6|||
33645871|NCT00635219|102256218|FG000|Overall Study|Non-compliance With Study Product|0|||
33645872|NCT00635219|102256219|FG001|Overall Study|Non-compliance With Study Product|0|||
33645873|NCT00635219|102256220|FG002|Overall Study|Non-compliance With Study Product|0|||
33645874|NCT00635219|102256221|FG003|Overall Study|Non-compliance With Study Product|2|||
33645875|NCT00635219|102256222|FG004|Overall Study|Non-compliance With Study Product|1|||
33645876|NCT00635219|102256218|FG000|Overall Study|Protocol Violation|0|||
33585092|NCT01864148|102029160|FG004|Overall Study|Adverse Event|7|||
33585093|NCT01864148|102029156|FG000|Overall Study|Not Dosed|0|||
33585094|NCT01864148|102029157|FG001|Overall Study|Not Dosed|0|||
33585095|NCT01864148|102029158|FG002|Overall Study|Not Dosed|0|||
33585096|NCT01864148|102029159|FG003|Overall Study|Not Dosed|1|||
33585097|NCT01864148|102029160|FG004|Overall Study|Not Dosed|0|||
33585098|NCT02455336|102032561|FG000|Overall Study|Withdrawal by Subject|0|||
33585099|NCT02455336|102032562|FG001|Overall Study|Withdrawal by Subject|2|||
33585100|NCT02455336|102032561|FG000|Overall Study|Adverse Event|3|||
33585101|NCT02455336|102032562|FG001|Overall Study|Adverse Event|0|||
33585102|NCT02455336|102032561|FG000|Overall Study|Non-responder to treatment|2|||
33645877|NCT00635219|102256219|FG001|Overall Study|Protocol Violation|2|||
33374658|NCT03288493|101258575|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
33374659|NCT03288493|101258576|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
33374660|NCT03288493|101258577|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
33374661|NCT03288493|101258578|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
33374662|NCT03288493|101258572|FG000|Overall Study|Death|2|||
33374663|NCT03288493|101258573|FG001|Overall Study|Death|0|||
33374664|NCT03288493|101258574|FG002|Overall Study|Death|0|||
33374665|NCT03288493|101258575|FG003|Overall Study|Death|0|||
33374666|NCT03288493|101258576|FG004|Overall Study|Death|0|||
33374667|NCT03288493|101258577|FG005|Overall Study|Death|0|||
33374668|NCT03288493|101258578|FG006|Overall Study|Death|0|||
33374669|NCT03288493|101258572|FG000|Overall Study|other reason not listed above|2|||
33374670|NCT03288493|101258573|FG001|Overall Study|other reason not listed above|0|||
33374671|NCT03288493|101258574|FG002|Overall Study|other reason not listed above|0|||
33374672|NCT03288493|101258575|FG003|Overall Study|other reason not listed above|0|||
33374673|NCT03288493|101258576|FG004|Overall Study|other reason not listed above|0|||
33374674|NCT03288493|101258577|FG005|Overall Study|other reason not listed above|0|||
33374675|NCT03288493|101258578|FG006|Overall Study|other reason not listed above|0|||
33374676|NCT02279524|101258579|FG000|Overall Study|Withdrawal by Subject|3|||
33374677|NCT02279524|101258580|FG001|Overall Study|Withdrawal by Subject|6|||
33374678|NCT02279524|101258581|FG002|Overall Study|Withdrawal by Subject|3|||
33374679|NCT02279524|101258579|FG000|Overall Study|Adverse Event|4|||
33374680|NCT02279524|101258580|FG001|Overall Study|Adverse Event|3|||
33374681|NCT02279524|101258581|FG002|Overall Study|Adverse Event|2|||
33374682|NCT02279524|101258579|FG000|Overall Study|Lost to Follow-up|1|||
33374683|NCT02279524|101258580|FG001|Overall Study|Lost to Follow-up|1|||
33374684|NCT02279524|101258581|FG002|Overall Study|Lost to Follow-up|0|||
33374685|NCT02279524|101258579|FG000|Overall Study|Disallowed medication|1|||
33374686|NCT02279524|101258580|FG001|Overall Study|Disallowed medication|1|||
33374687|NCT02279524|101258581|FG002|Overall Study|Disallowed medication|2|||
33374688|NCT02279524|101258579|FG000|Overall Study|Bariatric surgery|1|||
33374689|NCT02279524|101258580|FG001|Overall Study|Bariatric surgery|0|||
33374690|NCT02279524|101258581|FG002|Overall Study|Bariatric surgery|0|||
33374691|NCT03888391|101258582|FG000|Overall Study|Lost to Follow-up|15|||
33374692|NCT03050359|101258585|FG000|Overall Study|Randomized But Not Treated|2|||
33374693|NCT03050359|101258586|FG001|Overall Study|Randomized But Not Treated|0|||
33374694|NCT03050359|101258585|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
33374695|NCT03050359|101258586|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
33374696|NCT03050359|101258585|FG000|Overall Study|Significant Protocol Deviation|2|||
33374697|NCT03050359|101258586|FG001|Overall Study|Significant Protocol Deviation|3|||
33374698|NCT03050359|101258585|FG000|Overall Study|Lost to Follow-up|2|||
33374699|NCT03050359|101258586|FG001|Overall Study|Lost to Follow-up|1|||
33374700|NCT03050359|101258585|FG000|Overall Study|Voluntary Withdrawal|4|||
33374701|NCT03050359|101258586|FG001|Overall Study|Voluntary Withdrawal|6|||
33374702|NCT03050359|101258585|FG000|Overall Study|Pregnancy|1|||
33374703|NCT03050359|101258586|FG001|Overall Study|Pregnancy|0|||
33374704|NCT03050359|101258585|FG000|Overall Study|Reason Not Specified|1|||
33374705|NCT03050359|101258586|FG001|Overall Study|Reason Not Specified|0|||
33374706|NCT00414960|101258587|FG000|Overall Study|Adverse Event|4|||
33374707|NCT00414960|101258588|FG001|Overall Study|Adverse Event|0|||
33374708|NCT00414960|101258587|FG000|Overall Study|Withdrawal by Subject|3|||
33374709|NCT00414960|101258588|FG001|Overall Study|Withdrawal by Subject|0|||
33374710|NCT00414960|101258587|FG000|Overall Study|Physician Decision|0|||
33374711|NCT00414960|101258588|FG001|Overall Study|Physician Decision|1|||
33374712|NCT04191577|101258595|FG000|Overall Study|Withdrawal by Subject|2|||
33374713|NCT04191577|101258596|FG001|Overall Study|Withdrawal by Subject|2|||
33374714|NCT04191577|101258597|FG002|Overall Study|Withdrawal by Subject|1|||
33374715|NCT04191577|101258595|FG000|Overall Study|Physician Decision|1|||
33374716|NCT04191577|101258596|FG001|Overall Study|Physician Decision|1|||
33374717|NCT04191577|101258597|FG002|Overall Study|Physician Decision|0|||
33374718|NCT04191577|101258595|FG000|Overall Study|Adverse Event|0|||
33374719|NCT04191577|101258596|FG001|Overall Study|Adverse Event|0|||
33374720|NCT04191577|101258597|FG002|Overall Study|Adverse Event|1|||
33374721|NCT04191577|101258595|FG000|Overall Study|Death|0|||
33374722|NCT04191577|101258596|FG001|Overall Study|Death|0|||
33374723|NCT04191577|101258597|FG002|Overall Study|Death|1|||
33585103|NCT02455336|102032562|FG001|Overall Study|Non-responder to treatment|0|||
33374724|NCT02493426|101258598|FG000|Overall Study|Withdrawal by Subject|0|||
33374725|NCT02493426|101258599|FG001|Overall Study|Withdrawal by Subject|1|||
33374726|NCT01781429|101258604|FG000|Overall Study|Death|0|||
33374727|NCT01781429|101258605|FG001|Overall Study|Death|0|||
33374728|NCT01781429|101258606|FG002|Overall Study|Death|0|||
33374729|NCT01781429|101258607|FG003|Overall Study|Death|0|||
33374730|NCT01781429|101258608|FG004|Overall Study|Death|0|||
33374731|NCT01781429|101258609|FG005|Overall Study|Death|0|||
33374732|NCT01781429|101258610|FG006|Overall Study|Death|0|||
33374733|NCT01781429|101258611|FG007|Overall Study|Death|0|||
33374734|NCT01781429|101258612|FG008|Overall Study|Death|0|||
33374735|NCT01781429|101258613|FG009|Overall Study|Death|1|||
33374736|NCT01781429|101258614|FG010|Overall Study|Death|0|||
33374737|NCT01781429|101258615|FG011|Overall Study|Death|0|||
33374738|NCT01781429|101258616|FG012|Overall Study|Death|1|||
33374739|NCT01781429|101258617|FG013|Overall Study|Death|0|||
33374740|NCT01781429|101258618|FG014|Overall Study|Death|1|||
33374741|NCT01781429|101258619|FG015|Overall Study|Death|0|||
33374742|NCT01781429|101258604|FG000|Overall Study|Withdrawal by Subject|0|||
33374743|NCT01781429|101258605|FG001|Overall Study|Withdrawal by Subject|0|||
33374744|NCT01781429|101258606|FG002|Overall Study|Withdrawal by Subject|0|||
33374745|NCT01781429|101258607|FG003|Overall Study|Withdrawal by Subject|0|||
33374746|NCT01781429|101258608|FG004|Overall Study|Withdrawal by Subject|0|||
33374747|NCT01781429|101258609|FG005|Overall Study|Withdrawal by Subject|0|||
33374748|NCT01781429|101258610|FG006|Overall Study|Withdrawal by Subject|0|||
33374749|NCT01781429|101258611|FG007|Overall Study|Withdrawal by Subject|0|||
33374750|NCT01781429|101258612|FG008|Overall Study|Withdrawal by Subject|1|||
33374751|NCT01781429|101258613|FG009|Overall Study|Withdrawal by Subject|3|||
33374752|NCT01781429|101258614|FG010|Overall Study|Withdrawal by Subject|1|||
33374753|NCT01781429|101258615|FG011|Overall Study|Withdrawal by Subject|1|||
33374754|NCT01781429|101258616|FG012|Overall Study|Withdrawal by Subject|5|||
33374755|NCT01781429|101258617|FG013|Overall Study|Withdrawal by Subject|2|||
33374756|NCT01781429|101258618|FG014|Overall Study|Withdrawal by Subject|3|||
33374757|NCT01781429|101258619|FG015|Overall Study|Withdrawal by Subject|0|||
33374758|NCT01781429|101258604|FG000|Overall Study|Disease Progression|1|||
33374759|NCT01781429|101258605|FG001|Overall Study|Disease Progression|0|||
33374760|NCT01781429|101258606|FG002|Overall Study|Disease Progression|1|||
33374761|NCT01781429|101258607|FG003|Overall Study|Disease Progression|1|||
33374762|NCT01781429|101258608|FG004|Overall Study|Disease Progression|1|||
33374763|NCT01781429|101258609|FG005|Overall Study|Disease Progression|4|||
33374764|NCT01781429|101258610|FG006|Overall Study|Disease Progression|7|||
33374765|NCT01781429|101258611|FG007|Overall Study|Disease Progression|4|||
33374766|NCT01781429|101258612|FG008|Overall Study|Disease Progression|6|||
33374767|NCT01781429|101258613|FG009|Overall Study|Disease Progression|15|||
33374768|NCT01781429|101258614|FG010|Overall Study|Disease Progression|15|||
33374769|NCT01781429|101258615|FG011|Overall Study|Disease Progression|15|||
33374770|NCT01781429|101258616|FG012|Overall Study|Disease Progression|15|||
33374771|NCT01781429|101258617|FG013|Overall Study|Disease Progression|4|||
33374772|NCT01781429|101258618|FG014|Overall Study|Disease Progression|11|||
33374773|NCT01781429|101258619|FG015|Overall Study|Disease Progression|0|||
33374774|NCT01781429|101258604|FG000|Overall Study|Unacceptable Toxicity|0|||
33374775|NCT01781429|101258605|FG001|Overall Study|Unacceptable Toxicity|0|||
33374776|NCT01781429|101258606|FG002|Overall Study|Unacceptable Toxicity|0|||
33374777|NCT01781429|101258607|FG003|Overall Study|Unacceptable Toxicity|0|||
33374778|NCT01781429|101258608|FG004|Overall Study|Unacceptable Toxicity|0|||
33374779|NCT01781429|101258609|FG005|Overall Study|Unacceptable Toxicity|0|||
33246122|NCT01323660|100800341|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33246123|NCT01323660|100800342|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33246124|NCT01323660|100800343|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33246125|NCT01323660|100800344|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
33246126|NCT01323660|100800345|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33246127|NCT01323660|100800340|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
33246128|NCT01323660|100800341|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33246129|NCT01323660|100800342|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
33246130|NCT01323660|100800343|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
33246131|NCT01323660|100800344|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
33246132|NCT01323660|100800345|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33246133|NCT01323660|100800340|FG000|Washout Period (14 Days)|Adverse Event|0|||
33246134|NCT01323660|100800341|FG001|Washout Period (14 Days)|Adverse Event|0|||
33246135|NCT01323660|100800342|FG002|Washout Period (14 Days)|Adverse Event|0|||
33246136|NCT01323660|100800343|FG003|Washout Period (14 Days)|Adverse Event|0|||
33246137|NCT01323660|100800344|FG004|Washout Period (14 Days)|Adverse Event|1|||
33585104|NCT02597452|102032563|FG000|Overall Study|testing incomplete|30|||
33585105|NCT04860869|102032564|FG000|Overall Study|Withdrawal by Subject|1|||
33585106|NCT04860869|102032565|FG001|Overall Study|Withdrawal by Subject|0|||
33585107|NCT00349349|102032571|FG000|Overall Study|Adverse Event|5|||
33585108|NCT00349349|102032572|FG001|Overall Study|Adverse Event|6|||
33374780|NCT01781429|101258610|FG006|Overall Study|Unacceptable Toxicity|0|||
33374781|NCT01781429|101258611|FG007|Overall Study|Unacceptable Toxicity|0|||
33374782|NCT01781429|101258612|FG008|Overall Study|Unacceptable Toxicity|0|||
33374783|NCT01781429|101258613|FG009|Overall Study|Unacceptable Toxicity|0|||
33374784|NCT01781429|101258614|FG010|Overall Study|Unacceptable Toxicity|0|||
33374785|NCT01781429|101258615|FG011|Overall Study|Unacceptable Toxicity|2|||
33374786|NCT01781429|101258616|FG012|Overall Study|Unacceptable Toxicity|0|||
33374787|NCT01781429|101258617|FG013|Overall Study|Unacceptable Toxicity|0|||
33585109|NCT00349349|102032573|FG002|Overall Study|Adverse Event|2|||
33374788|NCT01781429|101258618|FG014|Overall Study|Unacceptable Toxicity|0|||
33374789|NCT01781429|101258619|FG015|Overall Study|Unacceptable Toxicity|0|||
33374790|NCT01781429|101258604|FG000|Overall Study|Patient Condition Changed|0|||
33374791|NCT01781429|101258605|FG001|Overall Study|Patient Condition Changed|0|||
33374792|NCT01781429|101258606|FG002|Overall Study|Patient Condition Changed|0|||
33374793|NCT01781429|101258607|FG003|Overall Study|Patient Condition Changed|0|||
33374794|NCT01781429|101258608|FG004|Overall Study|Patient Condition Changed|0|||
33374795|NCT01781429|101258609|FG005|Overall Study|Patient Condition Changed|0|||
33374796|NCT01781429|101258610|FG006|Overall Study|Patient Condition Changed|0|||
33374797|NCT01781429|101258611|FG007|Overall Study|Patient Condition Changed|0|||
33374798|NCT01781429|101258612|FG008|Overall Study|Patient Condition Changed|0|||
33374799|NCT01781429|101258613|FG009|Overall Study|Patient Condition Changed|4|||
33374800|NCT01781429|101258614|FG010|Overall Study|Patient Condition Changed|0|||
33374801|NCT01781429|101258615|FG011|Overall Study|Patient Condition Changed|1|||
33374802|NCT01781429|101258616|FG012|Overall Study|Patient Condition Changed|0|||
33374803|NCT01781429|101258617|FG013|Overall Study|Patient Condition Changed|1|||
33374804|NCT01781429|101258618|FG014|Overall Study|Patient Condition Changed|0|||
33374805|NCT01781429|101258619|FG015|Overall Study|Patient Condition Changed|0|||
33374806|NCT01781429|101258604|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
33374807|NCT01781429|101258605|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
33374808|NCT01781429|101258606|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
33374809|NCT01781429|101258607|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
33374810|NCT01781429|101258608|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
33374811|NCT01781429|101258609|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
33374812|NCT01781429|101258610|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
33374813|NCT01781429|101258611|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
33374814|NCT01781429|101258612|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
33374815|NCT01781429|101258613|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
33374816|NCT01781429|101258614|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
33374817|NCT01781429|101258615|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
33374818|NCT01781429|101258616|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
33374819|NCT01781429|101258617|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
33374820|NCT01781429|101258618|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
33374821|NCT01781429|101258619|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
33374822|NCT01781429|101258604|FG000|Overall Study|Enrolled, but not treated|0|||
33374823|NCT01781429|101258605|FG001|Overall Study|Enrolled, but not treated|0|||
33374824|NCT01781429|101258606|FG002|Overall Study|Enrolled, but not treated|0|||
33374825|NCT01781429|101258607|FG003|Overall Study|Enrolled, but not treated|0|||
33374826|NCT01781429|101258608|FG004|Overall Study|Enrolled, but not treated|0|||
33374827|NCT01781429|101258609|FG005|Overall Study|Enrolled, but not treated|0|||
33374828|NCT01781429|101258610|FG006|Overall Study|Enrolled, but not treated|0|||
33374829|NCT01781429|101258611|FG007|Overall Study|Enrolled, but not treated|0|||
33374830|NCT01781429|101258612|FG008|Overall Study|Enrolled, but not treated|0|||
33374831|NCT01781429|101258613|FG009|Overall Study|Enrolled, but not treated|0|||
33374832|NCT01781429|101258614|FG010|Overall Study|Enrolled, but not treated|1|||
33374833|NCT01781429|101258615|FG011|Overall Study|Enrolled, but not treated|0|||
33374834|NCT01781429|101258616|FG012|Overall Study|Enrolled, but not treated|0|||
33374835|NCT01781429|101258617|FG013|Overall Study|Enrolled, but not treated|0|||
33374836|NCT01781429|101258618|FG014|Overall Study|Enrolled, but not treated|0|||
33374837|NCT01781429|101258619|FG015|Overall Study|Enrolled, but not treated|0|||
33374838|NCT00798694|101258622|FG000|Overall Study|Lost to Follow-up|1|||
33374839|NCT00798694|101258623|FG001|Overall Study|Lost to Follow-up|1|||
33374840|NCT00798694|101258622|FG000|Overall Study|Physician Decision|1|||
33374841|NCT00798694|101258623|FG001|Overall Study|Physician Decision|0|||
33374842|NCT02635737|101258624|FG000|Overall Study|Protocol Violation|1|||
33374843|NCT01603641|101258625|FG000|Overall Study|Did not Receive Treatment|3|||
33374844|NCT01603641|101258625|FG000|Overall Study|Adverse Event|1|||
33374845|NCT01603641|101258625|FG000|Overall Study|Lack of Efficacy|1|||
33374846|NCT01603641|101258625|FG000|Overall Study|Lost to Follow-up|6|||
33374847|NCT01603641|101258625|FG000|Overall Study|Personal Reasons|18|||
33374848|NCT01603641|101258625|FG000|Overall Study|Other Miscellaneous Reasons|6|||
33374849|NCT02756650|101258626|FG000|Overall Study|Physician Decision|1|||
33374850|NCT02756650|101258626|FG000|Overall Study|Adverse Event|1|||
33374851|NCT00487084|101258627|FG000|Overall Study|Did not receive intervention|4|||
33374852|NCT00487084|101258628|FG001|Overall Study|Did not receive intervention|3|||
33374853|NCT00487084|101258629|FG002|Overall Study|Did not receive intervention|5|||
33374854|NCT00492856|101258632|FG000|Induction|Adverse Event|2|||
33374855|NCT00492856|101258633|FG001|Induction|Adverse Event|0|||
33585110|NCT00349349|102032571|FG000|Overall Study|Withdrawal by Subject|5|||
33585111|NCT00349349|102032572|FG001|Overall Study|Withdrawal by Subject|2|||
33585112|NCT00349349|102032573|FG002|Overall Study|Withdrawal by Subject|1|||
33374856|NCT00492856|101258634|FG002|Induction|Adverse Event|0|||
33374857|NCT00492856|101258635|FG003|Induction|Adverse Event|0|||
33374858|NCT00492856|101258632|FG000|Induction|Withdrawal by Subject|1|||
33374859|NCT00492856|101258633|FG001|Induction|Withdrawal by Subject|0|||
33374860|NCT00492856|101258634|FG002|Induction|Withdrawal by Subject|0|||
33374861|NCT00492856|101258635|FG003|Induction|Withdrawal by Subject|0|||
33374862|NCT00492856|101258632|FG000|Induction|Death|3|||
33374863|NCT00492856|101258633|FG001|Induction|Death|0|||
33374864|NCT00492856|101258634|FG002|Induction|Death|0|||
33374865|NCT00492856|101258635|FG003|Induction|Death|0|||
33374866|NCT00492856|101258632|FG000|Consolidation|Adverse Event|6|||
33374867|NCT00492856|101258633|FG001|Consolidation|Adverse Event|0|||
33374868|NCT00492856|101258634|FG002|Consolidation|Adverse Event|0|||
33374869|NCT00492856|101258635|FG003|Consolidation|Adverse Event|0|||
33374870|NCT00492856|101258632|FG000|Consolidation|Not protocol specified|2|||
33374871|NCT00492856|101258633|FG001|Consolidation|Not protocol specified|0|||
33374872|NCT00492856|101258634|FG002|Consolidation|Not protocol specified|0|||
33374873|NCT00492856|101258635|FG003|Consolidation|Not protocol specified|0|||
33374874|NCT00492856|101258632|FG000|Consolidation|Lost to Follow-up|1|||
33374875|NCT00492856|101258633|FG001|Consolidation|Lost to Follow-up|0|||
33374876|NCT00492856|101258634|FG002|Consolidation|Lost to Follow-up|0|||
33374877|NCT00492856|101258635|FG003|Consolidation|Lost to Follow-up|0|||
33374878|NCT00492856|101258632|FG000|Post-consolidation|Adverse Event|0|||
33374879|NCT00492856|101258633|FG001|Post-consolidation|Adverse Event|4|||
33374880|NCT00492856|101258634|FG002|Post-consolidation|Adverse Event|0|||
33374881|NCT00492856|101258635|FG003|Post-consolidation|Adverse Event|1|||
33585113|NCT00349349|102032571|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
33585114|NCT00349349|102032572|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
33585115|NCT00349349|102032573|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
33585116|NCT00349349|102032571|FG000|Overall Study|Death|13|||
33585117|NCT00349349|102032572|FG001|Overall Study|Death|10|||
33585118|NCT00349349|102032573|FG002|Overall Study|Death|1|||
33585119|NCT00349349|102032571|FG000|Overall Study|Other Treatment Selected|2|||
33585120|NCT00349349|102032572|FG001|Overall Study|Other Treatment Selected|0|||
33585121|NCT00349349|102032573|FG002|Overall Study|Other Treatment Selected|0|||
33585122|NCT00349349|102032571|FG000|Overall Study|Participant Reduced General Condition|0|||
33585123|NCT00349349|102032572|FG001|Overall Study|Participant Reduced General Condition|1|||
33585124|NCT00349349|102032573|FG002|Overall Study|Participant Reduced General Condition|0|||
33585125|NCT00349349|102032571|FG000|Overall Study|Physician Decision|1|||
33585126|NCT00349349|102032572|FG001|Overall Study|Physician Decision|2|||
33585127|NCT00349349|102032573|FG002|Overall Study|Physician Decision|1|||
33585128|NCT00349349|102032571|FG000|Overall Study|No Response|0|||
33585129|NCT00349349|102032572|FG001|Overall Study|No Response|3|||
33585130|NCT00349349|102032573|FG002|Overall Study|No Response|0|||
33585131|NCT00349349|102032571|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
33585132|NCT00349349|102032572|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
33585133|NCT00349349|102032573|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
33585134|NCT03292640|102032574|FG000|Overall Study|Withdrawal by Subject|17|||
33585135|NCT03292640|102032575|FG001|Overall Study|Withdrawal by Subject|16|||
33585136|NCT03292640|102032574|FG000|Overall Study|Adverse Event|20|||
33645878|NCT00635219|102256220|FG002|Overall Study|Protocol Violation|3|||
33645879|NCT00635219|102256221|FG003|Overall Study|Protocol Violation|2|||
33148510|NCT00978432|100458165|FG002|Overall Study|Lack of Efficacy|3|||
33246138|NCT01323660|100800345|FG005|Washout Period (14 Days)|Adverse Event|0|||
33246139|NCT01323660|100800340|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
33246140|NCT01323660|100800341|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
33246141|NCT01323660|100800342|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
33246142|NCT01323660|100800343|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
33246143|NCT01323660|100800344|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
33246144|NCT01323660|100800345|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
33246145|NCT01323660|100800340|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
33246146|NCT01323660|100800341|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
33246147|NCT01323660|100800342|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
33246148|NCT01323660|100800343|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
33246149|NCT01323660|100800344|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
33374882|NCT00492856|101258632|FG000|Post-consolidation|Withdrawal by Subject|0|||
33374883|NCT00492856|101258633|FG001|Post-consolidation|Withdrawal by Subject|4|||
33374884|NCT00492856|101258634|FG002|Post-consolidation|Withdrawal by Subject|0|||
33374885|NCT00492856|101258635|FG003|Post-consolidation|Withdrawal by Subject|0|||
33374886|NCT00492856|101258632|FG000|Post-consolidation|Death|0|||
33423689|NCT01580020|101443549|FG002|Overall Study|Lack of Efficacy|0|||
33585137|NCT03292640|102032575|FG001|Overall Study|Adverse Event|2|||
33585138|NCT03292640|102032574|FG000|Overall Study|Lost to Follow-up|24|||
33585139|NCT03292640|102032575|FG001|Overall Study|Lost to Follow-up|24|||
33585140|NCT00861757|102032578|FG000|Overall Study|Adverse Event|1|||
33585141|NCT00861757|102032579|FG001|Overall Study|Adverse Event|5|||
33246150|NCT01323660|100800345|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
33374887|NCT00492856|101258633|FG001|Post-consolidation|Death|1|||
33374888|NCT00492856|101258634|FG002|Post-consolidation|Death|0|||
33374889|NCT00492856|101258635|FG003|Post-consolidation|Death|0|||
33374890|NCT00492856|101258632|FG000|Post-consolidation|Not protocol specified|0|||
33423690|NCT01580020|101443550|FG003|Overall Study|Lack of Efficacy|1|||
33585142|NCT00861757|102032580|FG002|Overall Study|Adverse Event|7|||
33585143|NCT00861757|102032581|FG003|Overall Study|Adverse Event|2|||
33585144|NCT00861757|102032578|FG000|Overall Study|Entry Criteria Not Met|1|||
33585145|NCT00861757|102032579|FG001|Overall Study|Entry Criteria Not Met|2|||
33585146|NCT00861757|102032580|FG002|Overall Study|Entry Criteria Not Met|1|||
33585147|NCT00861757|102032581|FG003|Overall Study|Entry Criteria Not Met|1|||
33585148|NCT00861757|102032578|FG000|Overall Study|Lack of Efficacy|3|||
33585149|NCT00861757|102032579|FG001|Overall Study|Lack of Efficacy|1|||
33585150|NCT00861757|102032580|FG002|Overall Study|Lack of Efficacy|0|||
33585151|NCT00861757|102032581|FG003|Overall Study|Lack of Efficacy|1|||
33585152|NCT00861757|102032578|FG000|Overall Study|Lost to Follow-up|1|||
33585153|NCT00861757|102032579|FG001|Overall Study|Lost to Follow-up|0|||
33585154|NCT00861757|102032580|FG002|Overall Study|Lost to Follow-up|1|||
33585155|NCT00861757|102032581|FG003|Overall Study|Lost to Follow-up|1|||
33374891|NCT00492856|101258633|FG001|Post-consolidation|Not protocol specified|1|||
33374892|NCT00492856|101258634|FG002|Post-consolidation|Not protocol specified|0|||
33374893|NCT00492856|101258635|FG003|Post-consolidation|Not protocol specified|0|||
33374894|NCT00492856|101258632|FG000|Post-consolidation|Lost to Follow-up|0|||
33374895|NCT00492856|101258633|FG001|Post-consolidation|Lost to Follow-up|2|||
33374896|NCT00492856|101258634|FG002|Post-consolidation|Lost to Follow-up|0|||
33374897|NCT00492856|101258635|FG003|Post-consolidation|Lost to Follow-up|0|||
33374898|NCT00492856|101258632|FG000|Post-consolidation|Observation Arm|0|||
33374899|NCT00492856|101258633|FG001|Post-consolidation|Observation Arm|0|||
33374900|NCT00492856|101258634|FG002|Post-consolidation|Observation Arm|27|||
33374901|NCT00492856|101258635|FG003|Post-consolidation|Observation Arm|0|||
33374902|NCT00903032|101258638|FG000|Overall Study|Withdrawal by Subject|5|||
33374903|NCT00903032|101258639|FG001|Overall Study|Withdrawal by Subject|3|||
33374904|NCT00903032|101258638|FG000|Overall Study|Lost to Follow-up|2|||
33374905|NCT00903032|101258639|FG001|Overall Study|Lost to Follow-up|2|||
33374906|NCT00710034|101258640|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
33374907|NCT00710034|101258641|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
33374908|NCT00710034|101258640|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
33374909|NCT00710034|101258641|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
33374910|NCT00710034|101258640|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
33374911|NCT00710034|101258641|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
33374912|NCT00710034|101258640|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
33374913|NCT00710034|101258641|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
33374914|NCT00710034|101258640|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
33374915|NCT00710034|101258641|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
33374916|NCT00710034|101258640|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
33585156|NCT00861757|102032578|FG000|Overall Study|Physician Decision|0|||
33585157|NCT00861757|102032579|FG001|Overall Study|Physician Decision|0|||
33585158|NCT00861757|102032580|FG002|Overall Study|Physician Decision|0|||
33246151|NCT01323660|100800340|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
33246152|NCT01323660|100800341|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
33645880|NCT00635219|102256222|FG004|Overall Study|Protocol Violation|4|||
33645881|NCT00635219|102256218|FG000|Overall Study|Withdrawal of Consent|8|||
33645882|NCT00635219|102256219|FG001|Overall Study|Withdrawal of Consent|6|||
33645883|NCT00635219|102256220|FG002|Overall Study|Withdrawal of Consent|8|||
33645884|NCT00635219|102256221|FG003|Overall Study|Withdrawal of Consent|11|||
33645885|NCT00635219|102256222|FG004|Overall Study|Withdrawal of Consent|8|||
33645886|NCT00635219|102256218|FG000|Overall Study|Lost to Follow-up|0|||
33645887|NCT00635219|102256219|FG001|Overall Study|Lost to Follow-up|0|||
33645888|NCT00635219|102256220|FG002|Overall Study|Lost to Follow-up|2|||
33645889|NCT00635219|102256221|FG003|Overall Study|Lost to Follow-up|0|||
33645890|NCT00635219|102256222|FG004|Overall Study|Lost to Follow-up|3|||
33645891|NCT00635219|102256218|FG000|Overall Study|Administrative or Other Reasons|0|||
33645892|NCT00635219|102256219|FG001|Overall Study|Administrative or Other Reasons|1|||
33246153|NCT01323660|100800342|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
33246154|NCT01323660|100800343|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
33246155|NCT01323660|100800344|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
33246156|NCT01323660|100800345|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
33246157|NCT01323660|100800340|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
33246158|NCT01323660|100800341|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
33246159|NCT01323660|100800342|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
33246160|NCT01323660|100800343|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
33246161|NCT01323660|100800344|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
33246162|NCT01323660|100800345|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
33246163|NCT01323660|100800340|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
33246164|NCT01323660|100800341|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
33246165|NCT01323660|100800342|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
33246166|NCT01323660|100800343|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
33585159|NCT00861757|102032581|FG003|Overall Study|Physician Decision|1|||
33585160|NCT00861757|102032578|FG000|Overall Study|Protocol Violation|2|||
33585161|NCT00861757|102032579|FG001|Overall Study|Protocol Violation|2|||
33585162|NCT00861757|102032580|FG002|Overall Study|Protocol Violation|4|||
33585163|NCT00861757|102032581|FG003|Overall Study|Protocol Violation|1|||
33585164|NCT00861757|102032578|FG000|Overall Study|Withdrawal by Subject|1|||
33585165|NCT00861757|102032579|FG001|Overall Study|Withdrawal by Subject|5|||
33585166|NCT00861757|102032580|FG002|Overall Study|Withdrawal by Subject|5|||
33585167|NCT00861757|102032581|FG003|Overall Study|Withdrawal by Subject|2|||
33585168|NCT03640507|102032582|FG000|Overall Study|Withdrawal by Subject|0|||
33585169|NCT03640507|102032583|FG001|Overall Study|Withdrawal by Subject|0|||
33585170|NCT03640507|102032584|FG002|Overall Study|Withdrawal by Subject|1|||
33585171|NCT00988052|102032585|FG000|Overall Study|Missing|1|||
33585172|NCT00988052|102032586|FG001|Overall Study|Missing|0|||
33585173|NCT00988052|102032585|FG000|Overall Study|Teva requested subject withdrawal|3|||
33585174|NCT00988052|102032586|FG001|Overall Study|Teva requested subject withdrawal|1|||
33585175|NCT00988052|102032585|FG000|Overall Study|Death|1|||
33585176|NCT00988052|102032586|FG001|Overall Study|Death|3|||
33585177|NCT00988052|102032585|FG000|Overall Study|Protocol Violation|6|||
33585178|NCT00988052|102032586|FG001|Overall Study|Protocol Violation|5|||
33585179|NCT00988052|102032585|FG000|Overall Study|Pregnancy|6|||
33585180|NCT00988052|102032586|FG001|Overall Study|Pregnancy|6|||
33585181|NCT00988052|102032585|FG000|Overall Study|Lack of Efficacy|8|||
33585182|NCT00988052|102032586|FG001|Overall Study|Lack of Efficacy|7|||
33585183|NCT00988052|102032585|FG000|Overall Study|Lost to Follow-up|6|||
33585184|NCT00988052|102032586|FG001|Overall Study|Lost to Follow-up|11|||
33585185|NCT00988052|102032585|FG000|Overall Study|Physician Decision|27|||
33585186|NCT00988052|102032586|FG001|Overall Study|Physician Decision|28|||
33585187|NCT00988052|102032585|FG000|Overall Study|Adverse Event|35|||
33585188|NCT00988052|102032586|FG001|Overall Study|Adverse Event|28|||
33585189|NCT00988052|102032585|FG000|Overall Study|Withdrawal by Subject|90|||
33585190|NCT00988052|102032586|FG001|Overall Study|Withdrawal by Subject|91|||
33585191|NCT00988052|102032585|FG000|Overall Study|Study terminated by sponsor|240|||
33585192|NCT00988052|102032586|FG001|Overall Study|Study terminated by sponsor|236|||
33585193|NCT03520920|102032587|FG000|Overall Study|Death|13|||
33585194|NCT03520920|102032588|FG001|Overall Study|Death|1|||
33585195|NCT03520920|102032589|FG002|Overall Study|Death|0|||
33585196|NCT03520920|102032587|FG000|Overall Study|Withdrawal by Subject|2|||
33585197|NCT03520920|102032588|FG001|Overall Study|Withdrawal by Subject|1|||
33645893|NCT00635219|102256220|FG002|Overall Study|Administrative or Other Reasons|1|||
33645894|NCT00635219|102256221|FG003|Overall Study|Administrative or Other Reasons|0|||
33645895|NCT00635219|102256222|FG004|Overall Study|Administrative or Other Reasons|1|||
33645896|NCT00402740|102256223|FG000|Overall Study|Withdrawal by Subject|18|||
33645897|NCT00402740|102256223|FG000|Overall Study|Death|50|||
33645898|NCT00402740|102256223|FG000|Overall Study|Lost to Follow-up|6|||
33148511|NCT00978432|100458163|FG000|Overall Study|Adverse Event|2|||
33148512|NCT00978432|100458164|FG001|Overall Study|Adverse Event|0|||
33148513|NCT00978432|100458165|FG002|Overall Study|Adverse Event|1|||
33148514|NCT00586846|100458166|FG000|Overall Study|Physician Decision|1|||
33148515|NCT00586846|100458166|FG000|Overall Study|Death|1|||
33148516|NCT00586846|100458166|FG000|Overall Study|Evaluable for Toxicity Only|4|||
33148517|NCT03711266|100458167|FG000|Overall Study|Lost to Follow-up|10|||
33148518|NCT00145600|100458168|FG000|Overall Study|Death|1|||
33148519|NCT00145600|100458169|FG001|Overall Study|Death|2|||
33148520|NCT00145600|100458170|FG002|Overall Study|Death|2|||
33148521|NCT00145600|100458171|FG003|Overall Study|Death|6|||
33148522|NCT00145600|100458168|FG000|Overall Study|Ineligible|3|||
33148523|NCT00145600|100458169|FG001|Overall Study|Ineligible|0|||
33148524|NCT00145600|100458170|FG002|Overall Study|Ineligible|1|||
33148525|NCT00145600|100458171|FG003|Overall Study|Ineligible|5|||
33148526|NCT00145600|100458168|FG000|Overall Study|Lost to Follow-up|2|||
33148527|NCT00145600|100458169|FG001|Overall Study|Lost to Follow-up|6|||
33585198|NCT03520920|102032589|FG002|Overall Study|Withdrawal by Subject|0|||
33645899|NCT00402740|102256223|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
33645900|NCT00402740|102256223|FG000|Overall Study|Subject disposition unknown.|1|||
33645901|NCT01388985|102256225|FG000|Overall Study|Death|0|||
33246167|NCT01323660|100800344|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
33374917|NCT00710034|101258641|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
33585199|NCT03520920|102032587|FG000|Overall Study|Study Terminated by the Sponsor|5|||
33585200|NCT03520920|102032588|FG001|Overall Study|Study Terminated by the Sponsor|14|||
33645902|NCT01388985|102256226|FG001|Overall Study|Death|1|||
33148528|NCT00145600|100458170|FG002|Overall Study|Lost to Follow-up|2|||
33148529|NCT00145600|100458171|FG003|Overall Study|Lost to Follow-up|4|||
33148530|NCT00145600|100458168|FG000|Overall Study|Noncompliance|1|||
33148531|NCT00145600|100458169|FG001|Overall Study|Noncompliance|0|||
33148532|NCT00145600|100458170|FG002|Overall Study|Noncompliance|0|||
33585201|NCT03520920|102032589|FG002|Overall Study|Study Terminated by the Sponsor|5|||
33585202|NCT01536561|102032590|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
33585203|NCT01536561|102032590|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
33585204|NCT01536561|102032590|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
33585205|NCT01536561|102032590|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
33374918|NCT00710034|101258640|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
33374919|NCT00710034|101258641|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
33374920|NCT00710034|101258640|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
33374921|NCT00710034|101258641|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
33374922|NCT00710034|101258640|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
33374923|NCT00710034|101258641|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
33374924|NCT00710034|101258640|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
33374925|NCT00710034|101258641|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
33374926|NCT00710034|101258640|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
33374927|NCT00710034|101258641|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
33374928|NCT02939937|101258652|FG000|Overall Study|Adverse Event|5|||
33374929|NCT02939937|101258653|FG001|Overall Study|Adverse Event|0|||
33374930|NCT02939937|101258652|FG000|Overall Study|Lost to Follow-up|1|||
33374931|NCT02939937|101258653|FG001|Overall Study|Lost to Follow-up|3|||
33374932|NCT01767194|101258654|FG000|Overall Study|Adverse Event|1|||
33374933|NCT01767194|101258655|FG001|Overall Study|Adverse Event|1|||
33374934|NCT01767194|101258654|FG000|Overall Study|Death|0|||
33374935|NCT01767194|101258655|FG001|Overall Study|Death|1|||
33374936|NCT01767194|101258654|FG000|Overall Study|Lack of Efficacy|12|||
33374937|NCT01767194|101258655|FG001|Overall Study|Lack of Efficacy|11|||
33374938|NCT01767194|101258654|FG000|Overall Study|Physician Decision|2|||
33374939|NCT01767194|101258655|FG001|Overall Study|Physician Decision|23|||
33374940|NCT01767194|101258654|FG000|Overall Study|Withdrawal by Subject|0|||
33374941|NCT01767194|101258655|FG001|Overall Study|Withdrawal by Subject|1|||
33374942|NCT01767194|101258654|FG000|Overall Study|Ineligible|1|||
33374943|NCT01767194|101258655|FG001|Overall Study|Ineligible|1|||
33374944|NCT01767194|101258654|FG000|Overall Study|Refusal by patient/parent|2|||
33374945|NCT01767194|101258655|FG001|Overall Study|Refusal by patient/parent|4|||
33374946|NCT01767194|101258654|FG000|Overall Study|Criteria not met on time for next cycle|0|||
33374947|NCT01767194|101258655|FG001|Overall Study|Criteria not met on time for next cycle|1|||
33374948|NCT02586233|101258656|FG000|Overall Study|Randomized but did not receive treatment|0|||
33374949|NCT02586233|101258657|FG001|Overall Study|Randomized but did not receive treatment|1|||
33374950|NCT02586233|101258658|FG002|Overall Study|Randomized but did not receive treatment|0|||
33374951|NCT02586233|101258659|FG003|Overall Study|Randomized but did not receive treatment|0|||
33374952|NCT02586233|101258660|FG004|Overall Study|Randomized but did not receive treatment|0|||
33374953|NCT02586233|101258661|FG005|Overall Study|Randomized but did not receive treatment|2|||
33374954|NCT02586233|101258662|FG006|Overall Study|Randomized but did not receive treatment|2|||
33374955|NCT02586233|101258656|FG000|Overall Study|Death|0|||
33374956|NCT02586233|101258657|FG001|Overall Study|Death|1|||
33374957|NCT02586233|101258658|FG002|Overall Study|Death|0|||
33374958|NCT02586233|101258659|FG003|Overall Study|Death|0|||
33374959|NCT02586233|101258660|FG004|Overall Study|Death|2|||
33374960|NCT02586233|101258661|FG005|Overall Study|Death|0|||
33374961|NCT02586233|101258662|FG006|Overall Study|Death|0|||
33374962|NCT02065622|101258663|FG000|Induction Study|Adverse Event|13|||
33374963|NCT02065622|101258664|FG001|Induction Study|Adverse Event|19|||
33374964|NCT02065622|101258665|FG002|Induction Study|Adverse Event|0|||
33374965|NCT02065622|101258666|FG003|Induction Study|Adverse Event|0|||
33374966|NCT02065622|101258667|FG004|Induction Study|Adverse Event|0|||
33374967|NCT02065622|101258663|FG000|Induction Study|Withdrawal by Subject|3|||
33374968|NCT02065622|101258664|FG001|Induction Study|Withdrawal by Subject|5|||
33374969|NCT02065622|101258665|FG002|Induction Study|Withdrawal by Subject|0|||
33374970|NCT02065622|101258666|FG003|Induction Study|Withdrawal by Subject|0|||
33374971|NCT02065622|101258667|FG004|Induction Study|Withdrawal by Subject|0|||
33374972|NCT02065622|101258663|FG000|Induction Study|Lost to Follow-up|1|||
33374973|NCT02065622|101258664|FG001|Induction Study|Lost to Follow-up|0|||
33374974|NCT02065622|101258665|FG002|Induction Study|Lost to Follow-up|0|||
33374975|NCT02065622|101258666|FG003|Induction Study|Lost to Follow-up|0|||
33374976|NCT02065622|101258667|FG004|Induction Study|Lost to Follow-up|0|||
33374977|NCT02065622|101258663|FG000|Induction Study|Lack of Efficacy|22|||
33374978|NCT02065622|101258664|FG001|Induction Study|Lack of Efficacy|27|||
33374979|NCT02065622|101258665|FG002|Induction Study|Lack of Efficacy|0|||
33374980|NCT02065622|101258666|FG003|Induction Study|Lack of Efficacy|0|||
33374981|NCT02065622|101258667|FG004|Induction Study|Lack of Efficacy|0|||
33374982|NCT02065622|101258663|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
33374983|NCT02065622|101258664|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
33374984|NCT02065622|101258665|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
33374985|NCT02065622|101258666|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
33374986|NCT02065622|101258667|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
33374987|NCT02065622|101258663|FG000|Induction Study|Subject Noncompliance|1|||
33374988|NCT02065622|101258664|FG001|Induction Study|Subject Noncompliance|1|||
33374989|NCT02065622|101258665|FG002|Induction Study|Subject Noncompliance|0|||
33374990|NCT02065622|101258666|FG003|Induction Study|Subject Noncompliance|0|||
33374991|NCT02065622|101258667|FG004|Induction Study|Subject Noncompliance|0|||
33374992|NCT02065622|101258663|FG000|Induction Study|Other, Not Specified|3|||
33374993|NCT02065622|101258664|FG001|Induction Study|Other, Not Specified|2|||
33374994|NCT02065622|101258665|FG002|Induction Study|Other, Not Specified|0|||
33374995|NCT02065622|101258666|FG003|Induction Study|Other, Not Specified|0|||
33374996|NCT02065622|101258667|FG004|Induction Study|Other, Not Specified|0|||
33374997|NCT02065622|101258663|FG000|Maintenance Study|Adverse Event|0|||
33374998|NCT02065622|101258664|FG001|Maintenance Study|Adverse Event|0|||
33374999|NCT02065622|101258665|FG002|Maintenance Study|Adverse Event|25|||
33375000|NCT02065622|101258666|FG003|Maintenance Study|Adverse Event|22|||
33375001|NCT02065622|101258667|FG004|Maintenance Study|Adverse Event|11|||
33375002|NCT02065622|101258663|FG000|Maintenance Study|Withdrawal by Subject|0|||
33375003|NCT02065622|101258664|FG001|Maintenance Study|Withdrawal by Subject|0|||
33375004|NCT02065622|101258665|FG002|Maintenance Study|Withdrawal by Subject|11|||
33375005|NCT02065622|101258666|FG003|Maintenance Study|Withdrawal by Subject|5|||
33375006|NCT02065622|101258667|FG004|Maintenance Study|Withdrawal by Subject|7|||
33375007|NCT02065622|101258663|FG000|Maintenance Study|Lost to Follow-up|0|||
33375008|NCT02065622|101258664|FG001|Maintenance Study|Lost to Follow-up|0|||
33375009|NCT02065622|101258665|FG002|Maintenance Study|Lost to Follow-up|4|||
33375010|NCT02065622|101258666|FG003|Maintenance Study|Lost to Follow-up|1|||
33375011|NCT02065622|101258667|FG004|Maintenance Study|Lost to Follow-up|1|||
33375012|NCT02065622|101258663|FG000|Maintenance Study|Lack of Efficacy|0|||
33375013|NCT02065622|101258664|FG001|Maintenance Study|Lack of Efficacy|0|||
33375014|NCT02065622|101258665|FG002|Maintenance Study|Lack of Efficacy|70|||
33375015|NCT02065622|101258666|FG003|Maintenance Study|Lack of Efficacy|55|||
33375016|NCT02065622|101258667|FG004|Maintenance Study|Lack of Efficacy|19|||
33375017|NCT02065622|101258663|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
33375018|NCT02065622|101258664|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
33375019|NCT02065622|101258665|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
33375020|NCT02065622|101258666|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
33375021|NCT02065622|101258667|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
33375022|NCT02065622|101258663|FG000|Maintenance Study|Subject Non-Compliance|0|||
33375023|NCT02065622|101258664|FG001|Maintenance Study|Subject Non-Compliance|0|||
33375024|NCT02065622|101258665|FG002|Maintenance Study|Subject Non-Compliance|1|||
33375025|NCT02065622|101258666|FG003|Maintenance Study|Subject Non-Compliance|3|||
33375026|NCT02065622|101258667|FG004|Maintenance Study|Subject Non-Compliance|2|||
33375027|NCT02065622|101258663|FG000|Maintenance Study|Other, Not Specified|0|||
33375028|NCT02065622|101258664|FG001|Maintenance Study|Other, Not Specified|0|||
33375029|NCT02065622|101258665|FG002|Maintenance Study|Other, Not Specified|6|||
33375030|NCT02065622|101258666|FG003|Maintenance Study|Other, Not Specified|14|||
33375031|NCT02065622|101258667|FG004|Maintenance Study|Other, Not Specified|2|||
33375032|NCT02065622|101258663|FG000|Maintenance Study|Unknown Reason|0|||
33375033|NCT02065622|101258664|FG001|Maintenance Study|Unknown Reason|0|||
33375034|NCT02065622|101258665|FG002|Maintenance Study|Unknown Reason|0|||
33375035|NCT02065622|101258666|FG003|Maintenance Study|Unknown Reason|1|||
33375036|NCT02065622|101258667|FG004|Maintenance Study|Unknown Reason|0|||
33375037|NCT01982773|101258670|FG000|Overall Study|Withdrawal by Subject|1|||
33375038|NCT01982773|101258671|FG001|Overall Study|Withdrawal by Subject|3|||
33375039|NCT01982773|101258670|FG000|Overall Study|Lost to Follow-up|7|||
33375040|NCT01982773|101258671|FG001|Overall Study|Lost to Follow-up|1|||
33375041|NCT03136367|101258672|FG000|T1 Consultation|discontinued mistakenly included|2|||
33375042|NCT03136367|101258673|FG001|T1 Consultation|discontinued mistakenly included|6|||
33375043|NCT03136367|101258674|FG002|T1 Consultation|discontinued mistakenly included|1|||
33375044|NCT03136367|101258672|FG000|T1 Consultation|Discontinued other|0|||
33375045|NCT03136367|101258673|FG001|T1 Consultation|Discontinued other|1|||
33375046|NCT03136367|101258674|FG002|T1 Consultation|Discontinued other|0|||
33375047|NCT03136367|101258672|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
33375048|NCT03136367|101258673|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
33375049|NCT03136367|101258674|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
33375050|NCT03136367|101258672|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
33375051|NCT03136367|101258673|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
33375052|NCT03136367|101258674|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
33375053|NCT03136367|101258672|FG000|T2 Post-consultation|Discontinued other|0|||
33375054|NCT03136367|101258673|FG001|T2 Post-consultation|Discontinued other|2|||
33375055|NCT03136367|101258674|FG002|T2 Post-consultation|Discontinued other|6|||
33375056|NCT03136367|101258672|FG000|T2 Post-consultation|Discontinued transferred care|0|||
33375057|NCT03136367|101258673|FG001|T2 Post-consultation|Discontinued transferred care|0|||
33375058|NCT03136367|101258674|FG002|T2 Post-consultation|Discontinued transferred care|3|||
33375059|NCT03136367|101258672|FG000|T2 Post-consultation|Discontinued lost contact|0|||
33645903|NCT01388985|102256225|FG000|Overall Study|Lost to Follow-up|30|||
33375060|NCT03136367|101258673|FG001|T2 Post-consultation|Discontinued lost contact|1|||
33375061|NCT03136367|101258674|FG002|T2 Post-consultation|Discontinued lost contact|0|||
33246168|NCT01323660|100800345|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
33375062|NCT03136367|101258672|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
33375063|NCT03136367|101258673|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
33375064|NCT03136367|101258674|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
33375065|NCT03136367|101258672|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
33375066|NCT03136367|101258673|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
33375067|NCT03136367|101258674|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
33375068|NCT03136367|101258672|FG000|T3 1 Week After Surgery|other discontinued|2|||
33375069|NCT03136367|101258673|FG001|T3 1 Week After Surgery|other discontinued|4|||
33375070|NCT03136367|101258674|FG002|T3 1 Week After Surgery|other discontinued|3|||
33375071|NCT03136367|101258672|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
33375072|NCT03136367|101258673|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
33375073|NCT03136367|101258674|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
33375074|NCT03136367|101258672|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
33375075|NCT03136367|101258673|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
33375076|NCT03136367|101258674|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
33375077|NCT03136367|101258672|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
33375078|NCT03136367|101258673|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
33375079|NCT03136367|101258674|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
33375080|NCT03136367|101258672|FG000|T4 12 Weeks After Surgery|Death|0|||
33375081|NCT03136367|101258673|FG001|T4 12 Weeks After Surgery|Death|1|||
33375082|NCT03136367|101258674|FG002|T4 12 Weeks After Surgery|Death|3|||
33375083|NCT03136367|101258672|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
33375084|NCT03136367|101258673|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
33375085|NCT03136367|101258674|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
33375086|NCT03136367|101258672|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
33375087|NCT03136367|101258673|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
33375088|NCT03136367|101258674|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
33375089|NCT03136367|101258672|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
33375090|NCT03136367|101258673|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
33375091|NCT03136367|101258674|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
33375092|NCT03136367|101258672|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
33375093|NCT03136367|101258673|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
33375094|NCT03136367|101258674|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
33375095|NCT03136367|101258672|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
33375096|NCT03136367|101258673|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
33375097|NCT03136367|101258674|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
33375098|NCT03136367|101258672|FG000|T5 1 Year After Surgery|Death|0|||
33375099|NCT03136367|101258673|FG001|T5 1 Year After Surgery|Death|0|||
33375100|NCT03136367|101258674|FG002|T5 1 Year After Surgery|Death|1|||
33375101|NCT03136367|101258672|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
33375102|NCT03136367|101258673|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
33375103|NCT03136367|101258674|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
33375104|NCT03136367|101258672|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
33375105|NCT03136367|101258673|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
33375106|NCT03136367|101258674|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
33375107|NCT03136367|101258672|FG000|T5 1 Year After Surgery|study ended before due|31|||
33375108|NCT03136367|101258673|FG001|T5 1 Year After Surgery|study ended before due|103|||
33375109|NCT03136367|101258674|FG002|T5 1 Year After Surgery|study ended before due|110|||
33375110|NCT03136367|101258672|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
33375111|NCT03136367|101258673|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
33585206|NCT01536561|102032590|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
33585207|NCT01536561|102032590|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
33585208|NCT05332392|102032599|FG000|Overall Study|Did not meet inclusion criteria|25|||
33645904|NCT01388985|102256226|FG001|Overall Study|Lost to Follow-up|30|||
33645905|NCT01388985|102256225|FG000|Overall Study|Withdrawal by Subject|13|||
33148533|NCT00145600|100458171|FG003|Overall Study|Noncompliance|0|||
33246169|NCT01323660|100800340|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33375112|NCT03136367|101258674|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
33375113|NCT00793819|101258676|FG000|Overall Study|Adverse Event|8|||
33375114|NCT00793819|101258677|FG001|Overall Study|Adverse Event|4|||
33585209|NCT05332392|102032599|FG000|Overall Study|Principal Investigator's decision|17|||
33585210|NCT05332392|102032599|FG000|Overall Study|Adverse Event|1|||
33585211|NCT05332392|102032599|FG000|Overall Study|Subject's decision|1|||
33585212|NCT00391053|102032600|FG000|Overall Study|Serious Adverse Events|1|||
33585213|NCT00391053|102032601|FG001|Overall Study|Serious Adverse Events|0|||
33585214|NCT00391053|102032602|FG002|Overall Study|Serious Adverse Events|1|||
33585215|NCT00391053|102032603|FG003|Overall Study|Serious Adverse Events|4|||
33585216|NCT00391053|102032600|FG000|Overall Study|Protocol Violation|2|||
33585217|NCT00391053|102032601|FG001|Overall Study|Protocol Violation|0|||
33375115|NCT00793819|101258676|FG000|Overall Study|Lack of Efficacy|1|||
33375116|NCT00793819|101258677|FG001|Overall Study|Lack of Efficacy|1|||
33375117|NCT00793819|101258676|FG000|Overall Study|Withdrawal by Subject|4|||
33585218|NCT00391053|102032602|FG002|Overall Study|Protocol Violation|0|||
33585219|NCT00391053|102032603|FG003|Overall Study|Protocol Violation|0|||
33375118|NCT00793819|101258677|FG001|Overall Study|Withdrawal by Subject|3|||
33375119|NCT00793819|101258676|FG000|Overall Study|Lost to Follow-up|1|||
33375120|NCT00793819|101258677|FG001|Overall Study|Lost to Follow-up|1|||
33375121|NCT02106455|101258678|FG000|Overall Study|Case Report Form Uncollected|6|||
33375122|NCT02106455|101258678|FG000|Overall Study|Protocol Deviation|2|||
33375123|NCT00242580|101258682|FG000|Overall Study|Adverse Event|3|||
33375124|NCT00242580|101258683|FG001|Overall Study|Adverse Event|0|||
33375125|NCT00242580|101258684|FG002|Overall Study|Adverse Event|2|||
33375126|NCT00242580|101258682|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33375127|NCT00242580|101258683|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
33375128|NCT00242580|101258684|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
33375129|NCT00242580|101258682|FG000|Overall Study|Protocol Violation|0|||
33375130|NCT00242580|101258683|FG001|Overall Study|Protocol Violation|0|||
33375131|NCT00242580|101258684|FG002|Overall Study|Protocol Violation|1|||
33375132|NCT00242580|101258682|FG000|Overall Study|Subject withdrew consent|2|||
33375133|NCT00242580|101258683|FG001|Overall Study|Subject withdrew consent|2|||
33375134|NCT00242580|101258684|FG002|Overall Study|Subject withdrew consent|5|||
33375135|NCT00242580|101258682|FG000|Overall Study|Lost to Follow-up|0|||
33375136|NCT00242580|101258683|FG001|Overall Study|Lost to Follow-up|3|||
33375137|NCT00242580|101258684|FG002|Overall Study|Lost to Follow-up|0|||
33375138|NCT00242580|101258682|FG000|Overall Study|Death|1|||
33375139|NCT00242580|101258683|FG001|Overall Study|Death|2|||
33375140|NCT00242580|101258684|FG002|Overall Study|Death|1|||
33375141|NCT04504032|101258685|FG000|Overall Study|Adverse Event|1|||
33375142|NCT04504032|101258686|FG001|Overall Study|Adverse Event|2|||
33375143|NCT04504032|101258685|FG000|Overall Study|Lost to Follow-up|6|||
33375144|NCT04504032|101258686|FG001|Overall Study|Lost to Follow-up|9|||
33375145|NCT04504032|101258685|FG000|Overall Study|Protocol Violation|2|||
33375146|NCT04504032|101258686|FG001|Overall Study|Protocol Violation|0|||
33375147|NCT04504032|101258685|FG000|Overall Study|Study terminated by sponsor|1|||
33375148|NCT04504032|101258686|FG001|Overall Study|Study terminated by sponsor|2|||
33375149|NCT04504032|101258685|FG000|Overall Study|Withdrawal by Subject|9|||
33375150|NCT04504032|101258686|FG001|Overall Study|Withdrawal by Subject|11|||
33375151|NCT04504032|101258685|FG000|Overall Study|Disease progression prior to dosing|15|||
33375152|NCT04504032|101258686|FG001|Overall Study|Disease progression prior to dosing|3|||
33375153|NCT04504032|101258685|FG000|Overall Study|Drug supply issues|1|||
33375154|NCT04504032|101258686|FG001|Overall Study|Drug supply issues|1|||
33375155|NCT04504032|101258685|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
33375156|NCT04504032|101258686|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
33375157|NCT01432262|101258687|FG000|Overall Study|Withdrawal by Subject|2|||
33375158|NCT01432262|101258688|FG001|Overall Study|Withdrawal by Subject|1|||
33375159|NCT00975195|101258689|FG000|Overall Study|Adverse Event|108|||
33375160|NCT00975195|101258690|FG001|Overall Study|Adverse Event|101|||
33375161|NCT00975195|101258689|FG000|Overall Study|Lack of Efficacy|6|||
33375162|NCT00975195|101258690|FG001|Overall Study|Lack of Efficacy|6|||
33375163|NCT00975195|101258689|FG000|Overall Study|Protocol Violation|27|||
33375164|NCT00975195|101258690|FG001|Overall Study|Protocol Violation|23|||
33375165|NCT00975195|101258689|FG000|Overall Study|Lost to Follow-up|9|||
33375166|NCT00975195|101258690|FG001|Overall Study|Lost to Follow-up|7|||
33375167|NCT00975195|101258689|FG000|Overall Study|Withdrawal by Subject|48|||
33375168|NCT00975195|101258690|FG001|Overall Study|Withdrawal by Subject|61|||
33375169|NCT00975195|101258689|FG000|Overall Study|Other reason not defined above|29|||
33375170|NCT00975195|101258690|FG001|Overall Study|Other reason not defined above|33|||
33375171|NCT00975195|101258689|FG000|Overall Study|Not treated|1|||
33375172|NCT00975195|101258690|FG001|Overall Study|Not treated|2|||
33423691|NCT01580020|101443547|FG000|Overall Study|Withdrawal by Subject|0|||
33423692|NCT01580020|101443548|FG001|Overall Study|Withdrawal by Subject|1|||
33423693|NCT01580020|101443549|FG002|Overall Study|Withdrawal by Subject|1|||
33423694|NCT01580020|101443550|FG003|Overall Study|Withdrawal by Subject|0|||
33423695|NCT01580020|101443547|FG000|Overall Study|Adverse Event|1|||
33423696|NCT01580020|101443548|FG001|Overall Study|Adverse Event|1|||
33423697|NCT01580020|101443549|FG002|Overall Study|Adverse Event|1|||
33423698|NCT01580020|101443550|FG003|Overall Study|Adverse Event|1|||
33423699|NCT01580020|101443547|FG000|Overall Study|Administrative Problems|0|||
33423700|NCT01580020|101443548|FG001|Overall Study|Administrative Problems|0|||
33423701|NCT01580020|101443549|FG002|Overall Study|Administrative Problems|1|||
33375173|NCT01778127|101258694|FG000|Overall Study|Lost to Follow-up|5|||
33375174|NCT01778127|101258695|FG001|Overall Study|Lost to Follow-up|1|||
33375175|NCT01778127|101258696|FG002|Overall Study|Lost to Follow-up|2|||
33375176|NCT01778127|101258694|FG000|Overall Study|Withdrawal by Subject|3|||
33375177|NCT01778127|101258695|FG001|Overall Study|Withdrawal by Subject|1|||
33375178|NCT01778127|101258696|FG002|Overall Study|Withdrawal by Subject|4|||
33375179|NCT03259490|101258697|FG000|Period 1|Withdrawal by Subject|0|||
33375180|NCT03259490|101258698|FG001|Period 1|Withdrawal by Subject|1|||
33375181|NCT03259490|101258697|FG000|Period 2|Protocol Violation|1|||
33375182|NCT03259490|101258698|FG001|Period 2|Protocol Violation|0|||
33375183|NCT02492997|101258699|FG000|Overall Study|Withdrawal by Subject|1|||
33423702|NCT01580020|101443550|FG003|Overall Study|Administrative Problems|0|||
33645906|NCT01388985|102256226|FG001|Overall Study|Withdrawal by Subject|4|||
33645907|NCT01388985|102256225|FG000|Overall Study|Subject unavailable|1|||
33645908|NCT01388985|102256226|FG001|Overall Study|Subject unavailable|1|||
33645909|NCT01388985|102256225|FG000|Overall Study|Other (no reason)|0|||
33645910|NCT01388985|102256226|FG001|Overall Study|Other (no reason)|1|||
33645911|NCT01388985|102256225|FG000|Overall Study|Error of nurse|5|||
33645912|NCT01388985|102256226|FG001|Overall Study|Error of nurse|1|||
33148534|NCT00145600|100458168|FG000|Overall Study|Withdrawal by Subject|1|||
33148535|NCT00145600|100458169|FG001|Overall Study|Withdrawal by Subject|2|||
33148536|NCT00145600|100458170|FG002|Overall Study|Withdrawal by Subject|0|||
33375184|NCT02492997|101258700|FG001|Overall Study|Withdrawal by Subject|0|||
33375185|NCT02492997|101258699|FG000|Overall Study|Gained Weight|1|||
33375186|NCT02492997|101258700|FG001|Overall Study|Gained Weight|0|||
33375187|NCT02492997|101258699|FG000|Overall Study|Lost to Follow-up|0|||
33375188|NCT02492997|101258700|FG001|Overall Study|Lost to Follow-up|1|||
33375189|NCT01072539|101258705|FG000|Overall Study|Treated prior to the Site Initiation|1|||
33375190|NCT01072539|101258705|FG000|Overall Study|Protocol Violation|2|||
33375191|NCT02625324|101258706|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
33375192|NCT02625324|101258706|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
33375193|NCT02625324|101258706|FG000|6-Month Follow-up Subject Accountability|Death|5|||
33375194|NCT02625324|101258706|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
33375195|NCT02625324|101258706|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
33375196|NCT02625324|101258706|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
33375197|NCT02625324|101258706|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
33375198|NCT02625324|101258706|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
33375199|NCT02625324|101258706|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
33375200|NCT02625324|101258706|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
33148537|NCT00145600|100458171|FG003|Overall Study|Withdrawal by Subject|1|||
33148538|NCT05128929|100458175|FG000|Overall Study|Adverse Event|0|||
33148539|NCT05128929|100458176|FG001|Overall Study|Adverse Event|1|||
33148540|NCT02038452|100458177|FG000|Overall Study|Withdrawal by Subject|7|||
33148541|NCT02038452|100458178|FG001|Overall Study|Withdrawal by Subject|9|||
33148542|NCT02038452|100458177|FG000|Overall Study|Lost to Follow-up|31|||
33148543|NCT02038452|100458178|FG001|Overall Study|Lost to Follow-up|28|||
33148544|NCT01539317|100458179|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
33148545|NCT01539317|100458180|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
33148546|NCT00846742|100458183|FG000|Overall Study|Withdrawal by Subject|1|||
33148547|NCT02557295|100458184|FG000|Overall Study|Withdrawal by Subject|9|||
33148548|NCT02557295|100458185|FG001|Overall Study|Withdrawal by Subject|2|||
33148549|NCT02557295|100458186|FG002|Overall Study|Withdrawal by Subject|4|||
33148550|NCT02557295|100458187|FG003|Overall Study|Withdrawal by Subject|0|||
33148551|NCT02557295|100458188|FG004|Overall Study|Withdrawal by Subject|0|||
33148552|NCT02557295|100458189|FG005|Overall Study|Withdrawal by Subject|0|||
33148553|NCT02557295|100458190|FG006|Overall Study|Withdrawal by Subject|15|||
33148554|NCT02557295|100458191|FG007|Overall Study|Withdrawal by Subject|1|||
33148555|NCT02557295|100458192|FG008|Overall Study|Withdrawal by Subject|3|||
33148556|NCT02557295|100458184|FG000|Overall Study|Disease Progression|0|||
33148557|NCT02557295|100458185|FG001|Overall Study|Disease Progression|0|||
33148558|NCT02557295|100458186|FG002|Overall Study|Disease Progression|0|||
33148559|NCT02557295|100458187|FG003|Overall Study|Disease Progression|0|||
33148560|NCT02557295|100458188|FG004|Overall Study|Disease Progression|0|||
33148561|NCT02557295|100458189|FG005|Overall Study|Disease Progression|0|||
33148562|NCT02557295|100458190|FG006|Overall Study|Disease Progression|1|||
33148563|NCT02557295|100458191|FG007|Overall Study|Disease Progression|0|||
33148564|NCT02557295|100458192|FG008|Overall Study|Disease Progression|0|||
33148565|NCT02557295|100458184|FG000|Overall Study|Lack of Efficacy|24|||
33246170|NCT01323660|100800341|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33375201|NCT02625324|101258706|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
33375202|NCT02625324|101258706|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
33375203|NCT02625324|101258706|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
33375204|NCT02625324|101258706|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
33375205|NCT02625324|101258706|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
33423703|NCT01580020|101443547|FG000|Overall Study|Lost to Follow-up|0|||
33423704|NCT01580020|101443548|FG001|Overall Study|Lost to Follow-up|0|||
33423705|NCT01580020|101443549|FG002|Overall Study|Lost to Follow-up|1|||
33645913|NCT03085797|102256227|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
33645914|NCT03085797|102256228|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
33148566|NCT02557295|100458185|FG001|Overall Study|Lack of Efficacy|1|||
33148567|NCT02557295|100458186|FG002|Overall Study|Lack of Efficacy|3|||
33148568|NCT02557295|100458187|FG003|Overall Study|Lack of Efficacy|0|||
33148569|NCT02557295|100458188|FG004|Overall Study|Lack of Efficacy|0|||
33148570|NCT02557295|100458189|FG005|Overall Study|Lack of Efficacy|0|||
33148571|NCT02557295|100458190|FG006|Overall Study|Lack of Efficacy|12|||
33148572|NCT02557295|100458191|FG007|Overall Study|Lack of Efficacy|1|||
33375206|NCT02625324|101258706|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
33375207|NCT02625324|101258706|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
33375208|NCT01826422|101258709|FG000|Overall Study|Withdrawal by Subject|1|||
33375209|NCT01826422|101258710|FG001|Overall Study|Withdrawal by Subject|3|||
33375210|NCT00444626|101258713|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
33375211|NCT00444626|101258713|FG000|Initial Treatment Period|Adverse Event|1|||
33375212|NCT00444626|101258713|FG000|Initial Treatment Period|Lost to Follow-up|9|||
33375213|NCT04167306|101258717|FG000|Overall Study|Lost to Follow-up|2|||
33375214|NCT04167306|101258718|FG001|Overall Study|Lost to Follow-up|2|||
33375215|NCT04167306|101258719|FG002|Overall Study|Lost to Follow-up|5|||
33375216|NCT04167306|101258720|FG003|Overall Study|Lost to Follow-up|5|||
33375217|NCT04167306|101258717|FG000|Overall Study|Adverse Event|13|||
33375218|NCT04167306|101258718|FG001|Overall Study|Adverse Event|14|||
33375219|NCT04167306|101258719|FG002|Overall Study|Adverse Event|5|||
33375220|NCT04167306|101258720|FG003|Overall Study|Adverse Event|4|||
33375221|NCT04167306|101258717|FG000|Overall Study|Withdrawal by Subject|4|||
33375222|NCT04167306|101258718|FG001|Overall Study|Withdrawal by Subject|6|||
33375223|NCT04167306|101258719|FG002|Overall Study|Withdrawal by Subject|8|||
33375224|NCT04167306|101258720|FG003|Overall Study|Withdrawal by Subject|3|||
33375225|NCT04167306|101258717|FG000|Overall Study|covid|1|||
33375226|NCT04167306|101258718|FG001|Overall Study|covid|1|||
33375227|NCT04167306|101258719|FG002|Overall Study|covid|2|||
33375228|NCT04167306|101258720|FG003|Overall Study|covid|1|||
33375229|NCT04167306|101258717|FG000|Overall Study|concomitant medication|0|||
33375230|NCT04167306|101258718|FG001|Overall Study|concomitant medication|0|||
33375231|NCT04167306|101258719|FG002|Overall Study|concomitant medication|0|||
33375232|NCT04167306|101258720|FG003|Overall Study|concomitant medication|1|||
33375233|NCT04167306|101258717|FG000|Overall Study|Alcohol treatment|0|||
33375234|NCT04167306|101258718|FG001|Overall Study|Alcohol treatment|4|||
33375235|NCT04167306|101258719|FG002|Overall Study|Alcohol treatment|3|||
33375236|NCT04167306|101258720|FG003|Overall Study|Alcohol treatment|2|||
33375237|NCT04167306|101258717|FG000|Overall Study|non-compliance|0|||
33375238|NCT04167306|101258718|FG001|Overall Study|non-compliance|0|||
33375239|NCT04167306|101258719|FG002|Overall Study|non-compliance|1|||
33375240|NCT04167306|101258720|FG003|Overall Study|non-compliance|0|||
33375241|NCT04167306|101258717|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
33375242|NCT04167306|101258718|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
33375243|NCT04167306|101258719|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
33375244|NCT04167306|101258720|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
33375245|NCT00296725|101258721|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
33375246|NCT00296725|101258721|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
33375247|NCT00296725|101258721|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
33375248|NCT01188564|101258722|FG000|Double-blind Phase|randomized not treated|1|||
33375249|NCT01188564|101258723|FG001|Double-blind Phase|randomized not treated|0|||
33375250|NCT01952730|101258724|FG000|Overall Study|FDA shut down core lab used by study|1|||
33375251|NCT00953043|101258725|FG000|Overall Study|Withdrawal by Subject|4|||
33375252|NCT00953043|101258726|FG001|Overall Study|Withdrawal by Subject|0|||
33375253|NCT00953043|101258725|FG000|Overall Study|Physician Decision|0|||
33375254|NCT00953043|101258726|FG001|Overall Study|Physician Decision|2|||
33375255|NCT00358917|101258727|FG000|Overall Study|Adverse Event|14|||
33375256|NCT00358917|101258728|FG001|Overall Study|Adverse Event|21|||
33375257|NCT00358917|101258727|FG000|Overall Study|Withdrawal by Subject|5|||
33375258|NCT00358917|101258728|FG001|Overall Study|Withdrawal by Subject|7|||
33375259|NCT00358917|101258727|FG000|Overall Study|Lost to Follow-up|20|||
33375260|NCT00358917|101258728|FG001|Overall Study|Lost to Follow-up|17|||
33645915|NCT03085797|102256227|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
33645916|NCT03085797|102256228|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
33645917|NCT03085797|102256227|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
33645918|NCT03085797|102256228|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
33645919|NCT02054104|102256231|FG000|Overall Study|Did not want to continue due to college classes|1|||
33148573|NCT02557295|100458192|FG008|Overall Study|Lack of Efficacy|0|||
33375261|NCT00358917|101258727|FG000|Overall Study|Noncompliance|12|||
33375262|NCT00358917|101258728|FG001|Overall Study|Noncompliance|11|||
33375263|NCT00358917|101258727|FG000|Overall Study|Death|2|||
33375264|NCT00358917|101258728|FG001|Overall Study|Death|3|||
33375265|NCT00358917|101258727|FG000|Overall Study|Virologic failure|11|||
33375266|NCT00358917|101258728|FG001|Overall Study|Virologic failure|8|||
33375267|NCT00358917|101258727|FG000|Overall Study|Unable to Continue Participation|2|||
33375268|NCT00358917|101258728|FG001|Overall Study|Unable to Continue Participation|2|||
33375269|NCT01553916|101258729|FG000|Overall Study|Withdrawal by Subject|2|||
33148574|NCT02557295|100458184|FG000|Overall Study|Adverse Event|16|||
33375270|NCT01553916|101258729|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
33375271|NCT01441115|101258730|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
33375272|NCT01718509|101258731|FG000|Overall Study|Lost to Follow-up|18|||
33375273|NCT01718509|101258732|FG001|Overall Study|Lost to Follow-up|15|||
33585220|NCT00391053|102032600|FG000|Overall Study|Lost to Follow-up|1|||
33585221|NCT00391053|102032601|FG001|Overall Study|Lost to Follow-up|0|||
33585222|NCT00391053|102032602|FG002|Overall Study|Lost to Follow-up|0|||
33585223|NCT00391053|102032603|FG003|Overall Study|Lost to Follow-up|5|||
33585224|NCT00391053|102032600|FG000|Overall Study|Withdrawal by Subject|5|||
33585225|NCT00391053|102032601|FG001|Overall Study|Withdrawal by Subject|1|||
33585226|NCT00391053|102032602|FG002|Overall Study|Withdrawal by Subject|1|||
33585227|NCT00391053|102032603|FG003|Overall Study|Withdrawal by Subject|1|||
33585228|NCT01713582|102032606|FG000|Overall Study|Disease progression|3|||
33585229|NCT01713582|102032607|FG001|Overall Study|Disease progression|3|||
33585230|NCT01713582|102032608|FG002|Overall Study|Disease progression|3|||
33585231|NCT01713582|102032609|FG003|Overall Study|Disease progression|2|||
33585232|NCT01713582|102032610|FG004|Overall Study|Disease progression|3|||
33585233|NCT01713582|102032611|FG005|Overall Study|Disease progression|3|||
33585234|NCT01713582|102032612|FG006|Overall Study|Disease progression|3|||
33585235|NCT01713582|102032613|FG007|Overall Study|Disease progression|3|||
33585236|NCT01713582|102032614|FG008|Overall Study|Disease progression|3|||
33585237|NCT01713582|102032615|FG009|Overall Study|Disease progression|11|||
33585238|NCT01713582|102032616|FG010|Overall Study|Disease progression|10|||
33585239|NCT01713582|102032617|FG011|Overall Study|Disease progression|5|||
33585240|NCT01713582|102032618|FG012|Overall Study|Disease progression|3|||
33585241|NCT01713582|102032619|FG013|Overall Study|Disease progression|3|||
33585242|NCT01713582|102032620|FG014|Overall Study|Disease progression|6|||
33585243|NCT01713582|102032621|FG015|Overall Study|Disease progression|6|||
33585244|NCT01713582|102032622|FG016|Overall Study|Disease progression|5|||
33585245|NCT01713582|102032623|FG017|Overall Study|Disease progression|2|||
33585246|NCT01713582|102032624|FG018|Overall Study|Disease progression|3|||
33585247|NCT01713582|102032625|FG019|Overall Study|Disease progression|5|||
33585248|NCT01713582|102032626|FG020|Overall Study|Disease progression|15|||
33585249|NCT01713582|102032606|FG000|Overall Study|Death|0|||
33585250|NCT01713582|102032607|FG001|Overall Study|Death|0|||
33585251|NCT01713582|102032608|FG002|Overall Study|Death|0|||
33585252|NCT01713582|102032609|FG003|Overall Study|Death|1|||
33585253|NCT01713582|102032610|FG004|Overall Study|Death|1|||
33585254|NCT01713582|102032611|FG005|Overall Study|Death|3|||
33585255|NCT01713582|102032612|FG006|Overall Study|Death|3|||
33585256|NCT01713582|102032613|FG007|Overall Study|Death|2|||
33585257|NCT01713582|102032614|FG008|Overall Study|Death|3|||
33585258|NCT01713582|102032615|FG009|Overall Study|Death|4|||
33585259|NCT01713582|102032616|FG010|Overall Study|Death|3|||
33585260|NCT01713582|102032617|FG011|Overall Study|Death|0|||
33585261|NCT01713582|102032618|FG012|Overall Study|Death|0|||
33585262|NCT01713582|102032619|FG013|Overall Study|Death|0|||
33585263|NCT01713582|102032620|FG014|Overall Study|Death|0|||
33585264|NCT01713582|102032621|FG015|Overall Study|Death|0|||
33585265|NCT01713582|102032622|FG016|Overall Study|Death|0|||
33585266|NCT01713582|102032623|FG017|Overall Study|Death|0|||
33585267|NCT01713582|102032624|FG018|Overall Study|Death|0|||
33585268|NCT01713582|102032625|FG019|Overall Study|Death|0|||
33585269|NCT01713582|102032626|FG020|Overall Study|Death|0|||
33585270|NCT01713582|102032606|FG000|Overall Study|Adverse event-related|0|||
33585271|NCT01713582|102032607|FG001|Overall Study|Adverse event-related|0|||
33585272|NCT01713582|102032608|FG002|Overall Study|Adverse event-related|0|||
33585273|NCT01713582|102032609|FG003|Overall Study|Adverse event-related|0|||
33585274|NCT01713582|102032610|FG004|Overall Study|Adverse event-related|0|||
33585275|NCT01713582|102032611|FG005|Overall Study|Adverse event-related|0|||
33585276|NCT01713582|102032612|FG006|Overall Study|Adverse event-related|0|||
33585277|NCT01713582|102032613|FG007|Overall Study|Adverse event-related|0|||
33585278|NCT01713582|102032614|FG008|Overall Study|Adverse event-related|0|||
33585279|NCT01713582|102032615|FG009|Overall Study|Adverse event-related|1|||
33585280|NCT01713582|102032616|FG010|Overall Study|Adverse event-related|1|||
33585281|NCT01713582|102032617|FG011|Overall Study|Adverse event-related|0|||
33585282|NCT01713582|102032618|FG012|Overall Study|Adverse event-related|0|||
33585283|NCT01713582|102032619|FG013|Overall Study|Adverse event-related|0|||
33585284|NCT01713582|102032620|FG014|Overall Study|Adverse event-related|0|||
33585285|NCT01713582|102032621|FG015|Overall Study|Adverse event-related|0|||
33585286|NCT01713582|102032622|FG016|Overall Study|Adverse event-related|0|||
33585287|NCT01713582|102032623|FG017|Overall Study|Adverse event-related|0|||
33585288|NCT01713582|102032624|FG018|Overall Study|Adverse event-related|1|||
33585289|NCT01713582|102032625|FG019|Overall Study|Adverse event-related|0|||
33585290|NCT01713582|102032626|FG020|Overall Study|Adverse event-related|0|||
33585291|NCT01713582|102032606|FG000|Overall Study|Adverse event-unrelated|0|||
33585292|NCT01713582|102032607|FG001|Overall Study|Adverse event-unrelated|0|||
33585293|NCT01713582|102032608|FG002|Overall Study|Adverse event-unrelated|0|||
33585294|NCT01713582|102032609|FG003|Overall Study|Adverse event-unrelated|0|||
33585295|NCT01713582|102032610|FG004|Overall Study|Adverse event-unrelated|0|||
33585296|NCT01713582|102032611|FG005|Overall Study|Adverse event-unrelated|1|||
33585297|NCT01713582|102032612|FG006|Overall Study|Adverse event-unrelated|1|||
33585298|NCT01713582|102032613|FG007|Overall Study|Adverse event-unrelated|1|||
33585299|NCT01713582|102032614|FG008|Overall Study|Adverse event-unrelated|0|||
33585300|NCT01713582|102032615|FG009|Overall Study|Adverse event-unrelated|0|||
33585301|NCT01713582|102032616|FG010|Overall Study|Adverse event-unrelated|0|||
33585302|NCT01713582|102032617|FG011|Overall Study|Adverse event-unrelated|0|||
33585303|NCT01713582|102032618|FG012|Overall Study|Adverse event-unrelated|0|||
33585304|NCT01713582|102032619|FG013|Overall Study|Adverse event-unrelated|1|||
33585305|NCT01713582|102032620|FG014|Overall Study|Adverse event-unrelated|1|||
33585306|NCT01713582|102032621|FG015|Overall Study|Adverse event-unrelated|0|||
33585307|NCT01713582|102032622|FG016|Overall Study|Adverse event-unrelated|0|||
33585308|NCT01713582|102032623|FG017|Overall Study|Adverse event-unrelated|0|||
33585309|NCT01713582|102032624|FG018|Overall Study|Adverse event-unrelated|0|||
33585310|NCT01713582|102032625|FG019|Overall Study|Adverse event-unrelated|0|||
33585311|NCT01713582|102032626|FG020|Overall Study|Adverse event-unrelated|0|||
33585312|NCT01713582|102032606|FG000|Overall Study|Withdrawal of consent|0|||
33585313|NCT01713582|102032607|FG001|Overall Study|Withdrawal of consent|0|||
33585314|NCT01713582|102032608|FG002|Overall Study|Withdrawal of consent|1|||
33585315|NCT01713582|102032609|FG003|Overall Study|Withdrawal of consent|0|||
33585316|NCT01713582|102032610|FG004|Overall Study|Withdrawal of consent|0|||
33585317|NCT01713582|102032611|FG005|Overall Study|Withdrawal of consent|1|||
33585318|NCT01713582|102032612|FG006|Overall Study|Withdrawal of consent|0|||
33585319|NCT01713582|102032613|FG007|Overall Study|Withdrawal of consent|0|||
33585320|NCT01713582|102032614|FG008|Overall Study|Withdrawal of consent|0|||
33585321|NCT01713582|102032615|FG009|Overall Study|Withdrawal of consent|1|||
33585322|NCT01713582|102032616|FG010|Overall Study|Withdrawal of consent|0|||
33585323|NCT01713582|102032617|FG011|Overall Study|Withdrawal of consent|0|||
33645920|NCT02054104|102256232|FG001|Overall Study|Did not want to continue due to college classes|0|||
33645921|NCT02054104|102256231|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
33645922|NCT02054104|102256232|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
33246171|NCT01323660|100800342|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33246172|NCT01323660|100800343|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33375274|NCT01718509|101258731|FG000|Overall Study|Withdrawal by Subject|7|||
33423706|NCT01580020|101443550|FG003|Overall Study|Lost to Follow-up|0|||
33423707|NCT03835975|101443551|FG000|Overall Study|Lost to Follow-up|1|||
33423708|NCT03835975|101443552|FG001|Overall Study|Lost to Follow-up|1|||
33423709|NCT03835975|101443553|FG002|Overall Study|Lost to Follow-up|0|||
33645923|NCT02054104|102256231|FG000|Overall Study|No evidence of immunologic response|2|||
33645924|NCT02054104|102256232|FG001|Overall Study|No evidence of immunologic response|2|||
33645925|NCT02054104|102256231|FG000|Overall Study|Disease Progression On Study|4|||
33423710|NCT03835975|101443554|FG003|Overall Study|Lost to Follow-up|0|||
33423711|NCT03835975|101443555|FG004|Overall Study|Lost to Follow-up|0|||
33585324|NCT01713582|102032618|FG012|Overall Study|Withdrawal of consent|0|||
33585325|NCT01713582|102032619|FG013|Overall Study|Withdrawal of consent|0|||
33585326|NCT01713582|102032620|FG014|Overall Study|Withdrawal of consent|0|||
33645926|NCT02054104|102256232|FG001|Overall Study|Disease Progression On Study|5|||
33645927|NCT02054104|102256231|FG000|Overall Study|Diagnosis of lymphoma|0|||
33645928|NCT02054104|102256232|FG001|Overall Study|Diagnosis of lymphoma|1|||
33645929|NCT02054104|102256231|FG000|Overall Study|Inconclusive response|0|||
33645930|NCT02054104|102256232|FG001|Overall Study|Inconclusive response|1|||
33645931|NCT02709538|102256233|FG000|Overall Study|Adverse Event|13|||
33645932|NCT02709538|102256234|FG001|Overall Study|Adverse Event|2|||
33645933|NCT02709538|102256235|FG002|Overall Study|Adverse Event|3|||
33375275|NCT01718509|101258732|FG001|Overall Study|Withdrawal by Subject|13|||
33375276|NCT01718509|101258731|FG000|Overall Study|Adverse Event|5|||
33375277|NCT01718509|101258732|FG001|Overall Study|Adverse Event|7|||
33375278|NCT01718509|101258731|FG000|Overall Study|Other|13|||
33375279|NCT01718509|101258732|FG001|Overall Study|Other|11|||
33375280|NCT01718509|101258731|FG000|Overall Study|Protocol Violation|4|||
33375281|NCT01718509|101258732|FG001|Overall Study|Protocol Violation|2|||
33375282|NCT01718509|101258731|FG000|Overall Study|Lack of Efficacy|1|||
33375283|NCT01718509|101258732|FG001|Overall Study|Lack of Efficacy|0|||
33375284|NCT00621855|101258736|FG000|Overall Study|Adverse Event|32|||
33375285|NCT00621855|101258737|FG001|Overall Study|Adverse Event|31|||
33375286|NCT00621855|101258738|FG002|Overall Study|Adverse Event|48|||
33375287|NCT00621855|101258739|FG003|Overall Study|Adverse Event|34|||
33375288|NCT00621855|101258740|FG004|Overall Study|Adverse Event|31|||
33423712|NCT03835975|101443551|FG000|Overall Study|No longer met eligibility criteria|0|||
33645934|NCT02709538|102256233|FG000|Overall Study|Lack of Efficacy|1|||
33645935|NCT02709538|102256234|FG001|Overall Study|Lack of Efficacy|0|||
33645936|NCT02709538|102256235|FG002|Overall Study|Lack of Efficacy|0|||
33645937|NCT02709538|102256233|FG000|Overall Study|Lost to Follow-up|24|||
33148575|NCT02557295|100458185|FG001|Overall Study|Adverse Event|2|||
33375289|NCT00621855|101258736|FG000|Overall Study|Lost to Follow-up|0|||
33585327|NCT01713582|102032621|FG015|Overall Study|Withdrawal of consent|0|||
33585328|NCT01713582|102032622|FG016|Overall Study|Withdrawal of consent|0|||
33585329|NCT01713582|102032623|FG017|Overall Study|Withdrawal of consent|0|||
33585330|NCT01713582|102032624|FG018|Overall Study|Withdrawal of consent|1|||
33585331|NCT01713582|102032625|FG019|Overall Study|Withdrawal of consent|0|||
33246173|NCT01323660|100800344|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
33246174|NCT01323660|100800345|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33246175|NCT04133363|100800346|FG000|Overall Study|Lost to Follow-up|2|||
33246176|NCT04133363|100800347|FG001|Overall Study|Lost to Follow-up|1|||
33246177|NCT04133363|100800348|FG002|Overall Study|Lost to Follow-up|4|||
33246178|NCT04060355|100800351|FG000|Overall Study|Lost to Follow-up|41|||
33246179|NCT05025449|100800352|FG000|Overall Study|Withdrawal by Subject|1|||
33246180|NCT05025449|100800352|FG000|Overall Study|Patient emergently taken to operating room|1|||
33246181|NCT05349864|100800354|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
33246182|NCT05349864|100800355|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
33246183|NCT02377362|100803695|FG000|Part A Second Treatment|Protocol Violation|0|||
33246184|NCT02377362|100803696|FG001|Part A Second Treatment|Protocol Violation|0|||
33148576|NCT02557295|100458186|FG002|Overall Study|Adverse Event|3|||
33148577|NCT02557295|100458187|FG003|Overall Study|Adverse Event|0|||
33148578|NCT02557295|100458188|FG004|Overall Study|Adverse Event|0|||
33148579|NCT02557295|100458189|FG005|Overall Study|Adverse Event|0|||
33148580|NCT02557295|100458190|FG006|Overall Study|Adverse Event|2|||
33148581|NCT02557295|100458191|FG007|Overall Study|Adverse Event|1|||
33246185|NCT02377362|100803697|FG002|Part A Second Treatment|Protocol Violation|0|||
33246186|NCT02377362|100803698|FG003|Part A Second Treatment|Protocol Violation|0|||
33246187|NCT02377362|100803699|FG004|Part A Second Treatment|Protocol Violation|1|||
33246188|NCT02377362|100803700|FG005|Part A Second Treatment|Protocol Violation|0|||
33246189|NCT02377362|100803701|FG006|Part A Second Treatment|Protocol Violation|0|||
33246190|NCT02377362|100803702|FG007|Part A Second Treatment|Protocol Violation|0|||
33246191|NCT02377362|100803703|FG008|Part A Second Treatment|Protocol Violation|0|||
33246192|NCT02377362|100803704|FG009|Part A Second Treatment|Protocol Violation|0|||
33246193|NCT02377362|100803705|FG010|Part A Second Treatment|Protocol Violation|0|||
33246194|NCT02377362|100803706|FG011|Part A Second Treatment|Protocol Violation|0|||
33246195|NCT02377362|100803707|FG012|Part A Second Treatment|Protocol Violation|0|||
33246196|NCT02377362|100803695|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
33246197|NCT02377362|100803696|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
33246198|NCT02377362|100803697|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
33246199|NCT02377362|100803698|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
33246200|NCT02377362|100803699|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
33246201|NCT02377362|100803700|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
33246202|NCT02377362|100803701|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
33246203|NCT02377362|100803702|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
33246204|NCT02377362|100803703|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
33246205|NCT02377362|100803704|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
33585332|NCT01713582|102032626|FG020|Overall Study|Withdrawal of consent|0|||
33246206|NCT02377362|100803705|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
33246207|NCT02377362|100803706|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
33246208|NCT02377362|100803707|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
33246209|NCT02377362|100803695|FG000|Part B Overall|Protocol Violation|0|||
33246210|NCT02377362|100803696|FG001|Part B Overall|Protocol Violation|0|||
33246211|NCT02377362|100803697|FG002|Part B Overall|Protocol Violation|0|||
33246212|NCT02377362|100803698|FG003|Part B Overall|Protocol Violation|0|||
33246213|NCT02377362|100803699|FG004|Part B Overall|Protocol Violation|0|||
33246214|NCT02377362|100803700|FG005|Part B Overall|Protocol Violation|0|||
33246215|NCT02377362|100803701|FG006|Part B Overall|Protocol Violation|0|||
33423713|NCT03835975|101443552|FG001|Overall Study|No longer met eligibility criteria|1|||
33423714|NCT03835975|101443553|FG002|Overall Study|No longer met eligibility criteria|0|||
33585333|NCT01713582|102032606|FG000|Overall Study|Lack of Efficacy|0|||
33585334|NCT01713582|102032607|FG001|Overall Study|Lack of Efficacy|0|||
33585335|NCT01713582|102032608|FG002|Overall Study|Lack of Efficacy|0|||
33148582|NCT02557295|100458192|FG008|Overall Study|Adverse Event|1|||
33148583|NCT02557295|100458184|FG000|Overall Study|Lost to Follow-up|4|||
33148584|NCT02557295|100458185|FG001|Overall Study|Lost to Follow-up|0|||
33148585|NCT02557295|100458186|FG002|Overall Study|Lost to Follow-up|0|||
33148586|NCT02557295|100458187|FG003|Overall Study|Lost to Follow-up|0|||
33148587|NCT02557295|100458188|FG004|Overall Study|Lost to Follow-up|0|||
33148588|NCT02557295|100458189|FG005|Overall Study|Lost to Follow-up|0|||
33148589|NCT02557295|100458190|FG006|Overall Study|Lost to Follow-up|9|||
33148590|NCT02557295|100458191|FG007|Overall Study|Lost to Follow-up|0|||
33148591|NCT02557295|100458192|FG008|Overall Study|Lost to Follow-up|0|||
33148592|NCT02557295|100458184|FG000|Overall Study|Study Close|54|||
33148593|NCT02557295|100458185|FG001|Overall Study|Study Close|3|||
33148594|NCT02557295|100458186|FG002|Overall Study|Study Close|5|||
33148595|NCT02557295|100458187|FG003|Overall Study|Study Close|3|||
33148596|NCT02557295|100458188|FG004|Overall Study|Study Close|0|||
33148597|NCT02557295|100458189|FG005|Overall Study|Study Close|0|||
33148598|NCT02557295|100458190|FG006|Overall Study|Study Close|37|||
33148599|NCT02557295|100458191|FG007|Overall Study|Study Close|3|||
33148600|NCT02557295|100458192|FG008|Overall Study|Study Close|19|||
33375290|NCT00621855|101258737|FG001|Overall Study|Lost to Follow-up|1|||
33375291|NCT00621855|101258738|FG002|Overall Study|Lost to Follow-up|3|||
33375292|NCT00621855|101258739|FG003|Overall Study|Lost to Follow-up|4|||
33375293|NCT00621855|101258740|FG004|Overall Study|Lost to Follow-up|1|||
33375294|NCT00621855|101258736|FG000|Overall Study|Protocol Violation|16|||
33375295|NCT00621855|101258737|FG001|Overall Study|Protocol Violation|8|||
33375296|NCT00621855|101258738|FG002|Overall Study|Protocol Violation|6|||
33375297|NCT00621855|101258739|FG003|Overall Study|Protocol Violation|7|||
33375298|NCT00621855|101258740|FG004|Overall Study|Protocol Violation|8|||
33375299|NCT00621855|101258736|FG000|Overall Study|Withdrawal by Subject|16|||
33148601|NCT02557295|100458184|FG000|Overall Study|except for study close|4|||
33148602|NCT02557295|100458185|FG001|Overall Study|except for study close|0|||
33148603|NCT02557295|100458186|FG002|Overall Study|except for study close|0|||
33148604|NCT02557295|100458187|FG003|Overall Study|except for study close|0|||
33148605|NCT02557295|100458188|FG004|Overall Study|except for study close|0|||
33148606|NCT02557295|100458189|FG005|Overall Study|except for study close|0|||
33148607|NCT02557295|100458190|FG006|Overall Study|except for study close|5|||
33148608|NCT02557295|100458191|FG007|Overall Study|except for study close|1|||
33148609|NCT02557295|100458192|FG008|Overall Study|except for study close|0|||
33148610|NCT00378105|100458195|FG000|Overall Study|Adverse Event|3|||
33148611|NCT00378105|100458196|FG001|Overall Study|Adverse Event|1|||
33148612|NCT00378105|100458195|FG000|Overall Study|Withdrawal by Subject|3|||
33585336|NCT01713582|102032609|FG003|Overall Study|Lack of Efficacy|0|||
33375300|NCT00621855|101258737|FG001|Overall Study|Withdrawal by Subject|11|||
33375301|NCT00621855|101258738|FG002|Overall Study|Withdrawal by Subject|13|||
33375302|NCT00621855|101258739|FG003|Overall Study|Withdrawal by Subject|13|||
33375303|NCT00621855|101258740|FG004|Overall Study|Withdrawal by Subject|9|||
33375304|NCT00621855|101258736|FG000|Overall Study|Other|9|||
33375305|NCT00621855|101258737|FG001|Overall Study|Other|7|||
33375306|NCT00621855|101258738|FG002|Overall Study|Other|6|||
33375307|NCT00621855|101258739|FG003|Overall Study|Other|5|||
33375308|NCT00621855|101258740|FG004|Overall Study|Other|4|||
33375309|NCT00621855|101258736|FG000|Overall Study|Patients did not receive study drug|3|||
33375310|NCT00621855|101258737|FG001|Overall Study|Patients did not receive study drug|3|||
33375311|NCT00621855|101258738|FG002|Overall Study|Patients did not receive study drug|5|||
33375312|NCT00621855|101258739|FG003|Overall Study|Patients did not receive study drug|4|||
33375313|NCT00621855|101258740|FG004|Overall Study|Patients did not receive study drug|2|||
33375314|NCT03666858|101258745|FG000|Cohort 1|Adverse Event|1|||
33375315|NCT03666858|101258746|FG001|Cohort 1|Adverse Event|0|||
33375316|NCT03666858|101258745|FG000|Cohort 2|Adverse Event|0|||
33375317|NCT03666858|101258746|FG001|Cohort 2|Adverse Event|1|||
33375318|NCT03331666|101258747|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
33375319|NCT03331666|101258748|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
33375320|NCT00946530|101261495|FG000|Overall Study|Withdrawal by Subject|0|||
33375321|NCT00946530|101261496|FG001|Overall Study|Withdrawal by Subject|3|||
33375322|NCT00946530|101261497|FG002|Overall Study|Withdrawal by Subject|0|||
33375323|NCT00946530|101261498|FG003|Overall Study|Withdrawal by Subject|3|||
33375324|NCT00946530|101261495|FG000|Overall Study|Physician Decision|1|||
33375325|NCT00946530|101261496|FG001|Overall Study|Physician Decision|1|||
33585337|NCT01713582|102032610|FG004|Overall Study|Lack of Efficacy|0|||
33585338|NCT01713582|102032611|FG005|Overall Study|Lack of Efficacy|0|||
33585339|NCT01713582|102032612|FG006|Overall Study|Lack of Efficacy|0|||
33585340|NCT01713582|102032613|FG007|Overall Study|Lack of Efficacy|0|||
33585341|NCT01713582|102032614|FG008|Overall Study|Lack of Efficacy|0|||
33585342|NCT01713582|102032615|FG009|Overall Study|Lack of Efficacy|1|||
33585343|NCT01713582|102032616|FG010|Overall Study|Lack of Efficacy|2|||
33585344|NCT01713582|102032617|FG011|Overall Study|Lack of Efficacy|0|||
33585345|NCT01713582|102032618|FG012|Overall Study|Lack of Efficacy|0|||
33585346|NCT01713582|102032619|FG013|Overall Study|Lack of Efficacy|0|||
33585347|NCT01713582|102032620|FG014|Overall Study|Lack of Efficacy|0|||
33585348|NCT01713582|102032621|FG015|Overall Study|Lack of Efficacy|0|||
33585349|NCT01713582|102032622|FG016|Overall Study|Lack of Efficacy|0|||
33585350|NCT01713582|102032623|FG017|Overall Study|Lack of Efficacy|0|||
33585351|NCT01713582|102032624|FG018|Overall Study|Lack of Efficacy|0|||
33585352|NCT01713582|102032625|FG019|Overall Study|Lack of Efficacy|0|||
33585353|NCT01713582|102032626|FG020|Overall Study|Lack of Efficacy|0|||
33375326|NCT00946530|101261497|FG002|Overall Study|Physician Decision|1|||
33375327|NCT00946530|101261498|FG003|Overall Study|Physician Decision|1|||
33585354|NCT01713582|102032606|FG000|Overall Study|Withdrawal by Subject|0|||
33585355|NCT01713582|102032607|FG001|Overall Study|Withdrawal by Subject|0|||
33585356|NCT01713582|102032608|FG002|Overall Study|Withdrawal by Subject|0|||
33585357|NCT01713582|102032609|FG003|Overall Study|Withdrawal by Subject|0|||
33585358|NCT01713582|102032610|FG004|Overall Study|Withdrawal by Subject|0|||
33375328|NCT00617409|101261499|FG000|Overall Study|Withdrawal by Subject|4|||
33375329|NCT00617409|101261500|FG001|Overall Study|Withdrawal by Subject|1|||
33375330|NCT00617409|101261501|FG002|Overall Study|Withdrawal by Subject|2|||
33585359|NCT01713582|102032611|FG005|Overall Study|Withdrawal by Subject|0|||
33585360|NCT01713582|102032612|FG006|Overall Study|Withdrawal by Subject|0|||
33375331|NCT00617409|101261499|FG000|Overall Study|Adverse Event|0|||
33375332|NCT00617409|101261500|FG001|Overall Study|Adverse Event|2|||
33375333|NCT00617409|101261501|FG002|Overall Study|Adverse Event|3|||
33375334|NCT00617409|101261499|FG000|Overall Study|Disease Progression|8|||
33375335|NCT00617409|101261500|FG001|Overall Study|Disease Progression|8|||
33375336|NCT00617409|101261501|FG002|Overall Study|Disease Progression|18|||
33375337|NCT00617409|101261499|FG000|Overall Study|Death|3|||
33375338|NCT00617409|101261500|FG001|Overall Study|Death|5|||
33375339|NCT00617409|101261501|FG002|Overall Study|Death|4|||
33375340|NCT00617409|101261499|FG000|Overall Study|Alternative Therapy|1|||
33375341|NCT00617409|101261500|FG001|Overall Study|Alternative Therapy|2|||
33375342|NCT00617409|101261501|FG002|Overall Study|Alternative Therapy|0|||
33375343|NCT02512068|101261502|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
33375344|NCT02512068|101261503|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
33375345|NCT02512068|101261502|FG000|Overall Study|Major Protocol Deviation|1|||
33375346|NCT02512068|101261503|FG001|Overall Study|Major Protocol Deviation|0|||
33375347|NCT02512068|101261502|FG000|Overall Study|Voluntary Withdrawal|0|||
33375348|NCT02512068|101261503|FG001|Overall Study|Voluntary Withdrawal|1|||
33375349|NCT02512068|101261502|FG000|Overall Study|Lack of Efficacy|0|||
33375350|NCT02512068|101261503|FG001|Overall Study|Lack of Efficacy|1|||
33375351|NCT02512068|101261502|FG000|Overall Study|Reason Not Specified|3|||
33585361|NCT01713582|102032613|FG007|Overall Study|Withdrawal by Subject|0|||
33246216|NCT02377362|100803702|FG007|Part B Overall|Protocol Violation|0|||
33246217|NCT02377362|100803703|FG008|Part B Overall|Protocol Violation|0|||
33246218|NCT02377362|100803704|FG009|Part B Overall|Protocol Violation|1|||
33246219|NCT02377362|100803705|FG010|Part B Overall|Protocol Violation|0|||
33246220|NCT02377362|100803706|FG011|Part B Overall|Protocol Violation|0|||
33246221|NCT02377362|100803707|FG012|Part B Overall|Protocol Violation|0|||
33246222|NCT02377362|100803695|FG000|Part B Overall|Adverse Event|0|||
33246223|NCT02377362|100803696|FG001|Part B Overall|Adverse Event|0|||
33246224|NCT02377362|100803697|FG002|Part B Overall|Adverse Event|0|||
33246225|NCT02377362|100803698|FG003|Part B Overall|Adverse Event|0|||
33246226|NCT02377362|100803699|FG004|Part B Overall|Adverse Event|0|||
33246227|NCT02377362|100803700|FG005|Part B Overall|Adverse Event|0|||
33246228|NCT02377362|100803701|FG006|Part B Overall|Adverse Event|1|||
33246229|NCT02377362|100803702|FG007|Part B Overall|Adverse Event|1|||
33246230|NCT02377362|100803703|FG008|Part B Overall|Adverse Event|0|||
33246231|NCT02377362|100803704|FG009|Part B Overall|Adverse Event|0|||
33246232|NCT02377362|100803705|FG010|Part B Overall|Adverse Event|0|||
33246233|NCT02377362|100803706|FG011|Part B Overall|Adverse Event|0|||
33246234|NCT02377362|100803707|FG012|Part B Overall|Adverse Event|0|||
33246235|NCT02377362|100803695|FG000|Part B Overall|Withdrawal by Subject|0|||
33246236|NCT02377362|100803696|FG001|Part B Overall|Withdrawal by Subject|0|||
33246237|NCT02377362|100803697|FG002|Part B Overall|Withdrawal by Subject|0|||
33246238|NCT02377362|100803698|FG003|Part B Overall|Withdrawal by Subject|0|||
33246239|NCT02377362|100803699|FG004|Part B Overall|Withdrawal by Subject|0|||
33246240|NCT02377362|100803700|FG005|Part B Overall|Withdrawal by Subject|0|||
33246241|NCT02377362|100803701|FG006|Part B Overall|Withdrawal by Subject|1|||
33246242|NCT02377362|100803702|FG007|Part B Overall|Withdrawal by Subject|0|||
33246243|NCT02377362|100803703|FG008|Part B Overall|Withdrawal by Subject|0|||
33246244|NCT02377362|100803704|FG009|Part B Overall|Withdrawal by Subject|0|||
33246245|NCT02377362|100803705|FG010|Part B Overall|Withdrawal by Subject|0|||
33246246|NCT02377362|100803706|FG011|Part B Overall|Withdrawal by Subject|1|||
33246247|NCT02377362|100803707|FG012|Part B Overall|Withdrawal by Subject|0|||
33246248|NCT03681691|100803708|FG000|Overall Study|COVID|1|||
33246249|NCT03681691|100803709|FG001|Overall Study|COVID|0|||
33246250|NCT03681691|100803708|FG000|Overall Study|prolonged bleeding|1|||
33375352|NCT02512068|101261503|FG001|Overall Study|Reason Not Specified|5|||
33585362|NCT01713582|102032614|FG008|Overall Study|Withdrawal by Subject|0|||
33585363|NCT01713582|102032615|FG009|Overall Study|Withdrawal by Subject|0|||
33585364|NCT01713582|102032616|FG010|Overall Study|Withdrawal by Subject|0|||
33585365|NCT01713582|102032617|FG011|Overall Study|Withdrawal by Subject|0|||
33585366|NCT01713582|102032618|FG012|Overall Study|Withdrawal by Subject|0|||
33585367|NCT01713582|102032619|FG013|Overall Study|Withdrawal by Subject|0|||
33585368|NCT01713582|102032620|FG014|Overall Study|Withdrawal by Subject|0|||
33585369|NCT01713582|102032621|FG015|Overall Study|Withdrawal by Subject|0|||
33246251|NCT03681691|100803709|FG001|Overall Study|prolonged bleeding|0|||
33246252|NCT03681691|100803708|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
33246253|NCT03681691|100803709|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
33246254|NCT04084769|100803710|FG000|Overall Study|Protocol Violation|1|||
33246255|NCT04084769|100803711|FG001|Overall Study|Protocol Violation|3|||
33246256|NCT04084769|100803712|FG002|Overall Study|Protocol Violation|0|||
33246257|NCT04084769|100803713|FG003|Overall Study|Protocol Violation|1|||
33375353|NCT03629041|101261514|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
33375354|NCT03629041|101261515|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
33585370|NCT01713582|102032622|FG016|Overall Study|Withdrawal by Subject|0|||
33246258|NCT04084769|100803710|FG000|Overall Study|Withdrawal by Subject|0|||
33645938|NCT02709538|102256234|FG001|Overall Study|Lost to Follow-up|8|||
33645939|NCT02709538|102256235|FG002|Overall Study|Lost to Follow-up|4|||
33645940|NCT02709538|102256233|FG000|Overall Study|Physician Decision|1|||
33645941|NCT02709538|102256234|FG001|Overall Study|Physician Decision|0|||
33645942|NCT02709538|102256235|FG002|Overall Study|Physician Decision|0|||
33645943|NCT02709538|102256233|FG000|Overall Study|Withdrawal by Subject|40|||
33645944|NCT02709538|102256234|FG001|Overall Study|Withdrawal by Subject|7|||
33645945|NCT02709538|102256235|FG002|Overall Study|Withdrawal by Subject|4|||
33645946|NCT02709538|102256233|FG000|Overall Study|Non-compliance with study procedures|5|||
33645947|NCT02709538|102256234|FG001|Overall Study|Non-compliance with study procedures|0|||
33645948|NCT02709538|102256235|FG002|Overall Study|Non-compliance with study procedures|0|||
33645949|NCT02709538|102256233|FG000|Overall Study|Non-compliance with study drug|2|||
33645950|NCT02709538|102256234|FG001|Overall Study|Non-compliance with study drug|0|||
33645951|NCT02709538|102256235|FG002|Overall Study|Non-compliance with study drug|0|||
33246259|NCT04084769|100803711|FG001|Overall Study|Withdrawal by Subject|1|||
33246260|NCT04084769|100803712|FG002|Overall Study|Withdrawal by Subject|0|||
33246261|NCT04084769|100803713|FG003|Overall Study|Withdrawal by Subject|0|||
33246262|NCT04084769|100803710|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33246263|NCT04084769|100803711|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33246264|NCT04084769|100803712|FG002|Overall Study|Withdrawal by parent/guardian|0|||
33246265|NCT04084769|100803713|FG003|Overall Study|Withdrawal by parent/guardian|1|||
33246266|NCT04084769|100803710|FG000|Overall Study|Lost to Follow-up|2|||
33246267|NCT04084769|100803711|FG001|Overall Study|Lost to Follow-up|0|||
33246268|NCT04084769|100803712|FG002|Overall Study|Lost to Follow-up|0|||
33246269|NCT04084769|100803713|FG003|Overall Study|Lost to Follow-up|0|||
33246270|NCT00542386|100803715|FG000|Overall Study|Adverse Event|1|||
33246271|NCT00542386|100803716|FG001|Overall Study|Adverse Event|7|||
33246272|NCT00542386|100803717|FG002|Overall Study|Adverse Event|7|||
33246273|NCT00542386|100803718|FG003|Overall Study|Adverse Event|8|||
33246274|NCT00542386|100803719|FG004|Overall Study|Adverse Event|13|||
33246275|NCT00542386|100803720|FG005|Overall Study|Adverse Event|4|||
33246276|NCT00542386|100803715|FG000|Overall Study|Death|0|||
33246277|NCT00542386|100803716|FG001|Overall Study|Death|0|||
33246278|NCT00542386|100803717|FG002|Overall Study|Death|1|||
33246279|NCT00542386|100803718|FG003|Overall Study|Death|2|||
33246280|NCT00542386|100803719|FG004|Overall Study|Death|1|||
33246281|NCT00542386|100803720|FG005|Overall Study|Death|2|||
33246282|NCT00542386|100803715|FG000|Overall Study|Lack of Efficacy|32|||
33246283|NCT00542386|100803716|FG001|Overall Study|Lack of Efficacy|12|||
33246284|NCT00542386|100803717|FG002|Overall Study|Lack of Efficacy|10|||
33246285|NCT00542386|100803718|FG003|Overall Study|Lack of Efficacy|13|||
33246286|NCT00542386|100803719|FG004|Overall Study|Lack of Efficacy|7|||
33246287|NCT00542386|100803720|FG005|Overall Study|Lack of Efficacy|31|||
33246288|NCT00542386|100803715|FG000|Overall Study|Physician Decision|1|||
33246289|NCT00542386|100803716|FG001|Overall Study|Physician Decision|0|||
33246290|NCT00542386|100803717|FG002|Overall Study|Physician Decision|0|||
33246291|NCT00542386|100803718|FG003|Overall Study|Physician Decision|1|||
33246292|NCT00542386|100803719|FG004|Overall Study|Physician Decision|0|||
33246293|NCT00542386|100803720|FG005|Overall Study|Physician Decision|0|||
33246294|NCT00542386|100803715|FG000|Overall Study|Protocol Violation|0|||
33246295|NCT00542386|100803716|FG001|Overall Study|Protocol Violation|0|||
33246296|NCT00542386|100803717|FG002|Overall Study|Protocol Violation|1|||
33246297|NCT00542386|100803718|FG003|Overall Study|Protocol Violation|0|||
33246298|NCT00542386|100803719|FG004|Overall Study|Protocol Violation|0|||
33246299|NCT00542386|100803720|FG005|Overall Study|Protocol Violation|4|||
33246300|NCT00542386|100803715|FG000|Overall Study|Withdrawal by Subject|5|||
33246301|NCT00542386|100803716|FG001|Overall Study|Withdrawal by Subject|8|||
33246302|NCT00542386|100803717|FG002|Overall Study|Withdrawal by Subject|10|||
33246303|NCT00542386|100803718|FG003|Overall Study|Withdrawal by Subject|11|||
33246304|NCT00542386|100803719|FG004|Overall Study|Withdrawal by Subject|15|||
33246305|NCT00542386|100803720|FG005|Overall Study|Withdrawal by Subject|7|||
33246306|NCT00542386|100803715|FG000|Overall Study|Other Reasons|4|||
33246307|NCT00542386|100803716|FG001|Overall Study|Other Reasons|1|||
33246308|NCT00542386|100803717|FG002|Overall Study|Other Reasons|4|||
33246309|NCT00542386|100803718|FG003|Overall Study|Other Reasons|3|||
33246310|NCT00542386|100803719|FG004|Overall Study|Other Reasons|4|||
33246311|NCT00542386|100803720|FG005|Overall Study|Other Reasons|2|||
33246312|NCT01242085|100803721|FG000|Overall Study|Withdrawal by Subject|4|||
33246313|NCT01242085|100803722|FG001|Overall Study|Withdrawal by Subject|2|||
33246314|NCT01242085|100803723|FG002|Overall Study|Withdrawal by Subject|0|||
33246315|NCT01242085|100803721|FG000|Overall Study|medically unable to have surgery|4|||
33246316|NCT01242085|100803722|FG001|Overall Study|medically unable to have surgery|5|||
33246317|NCT01242085|100803723|FG002|Overall Study|medically unable to have surgery|0|||
33246318|NCT00631917|100803729|FG000|Overall Study|Adverse Event|34|||
33246319|NCT00631917|100803730|FG001|Overall Study|Adverse Event|45|||
33246320|NCT00631917|100803729|FG000|Overall Study|Abnormal laboratory value(s)|2|||
33645952|NCT02709538|102256233|FG000|Overall Study|Protocol deviation|10|||
33645953|NCT02709538|102256234|FG001|Overall Study|Protocol deviation|4|||
33375355|NCT03629041|101261516|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
33375356|NCT03629041|101261517|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
33375357|NCT01623531|101261518|FG000|Overall Study|Death|1|||
33375358|NCT01623531|101261519|FG001|Overall Study|Death|0|||
33375359|NCT01623531|101261518|FG000|Overall Study|Protocol Violation|2|||
33375360|NCT01623531|101261519|FG001|Overall Study|Protocol Violation|1|||
33375361|NCT01623531|101261518|FG000|Overall Study|Missing data at primary outcome time poi|1|||
33375362|NCT01623531|101261519|FG001|Overall Study|Missing data at primary outcome time poi|1|||
33375363|NCT01968954|101261520|FG000|Overall Study|Adverse Event|6|||
33375364|NCT01968954|101261521|FG001|Overall Study|Adverse Event|3|||
33375365|NCT01968954|101261520|FG000|Overall Study|Death|1|||
33375366|NCT01968954|101261521|FG001|Overall Study|Death|2|||
33375367|NCT01968954|101261520|FG000|Overall Study|Lost to Follow-up|6|||
33375368|NCT01968954|101261521|FG001|Overall Study|Lost to Follow-up|4|||
33375369|NCT01968954|101261520|FG000|Overall Study|Withdrawal by Subject|20|||
33375370|NCT01968954|101261521|FG001|Overall Study|Withdrawal by Subject|23|||
33375371|NCT01968954|101261520|FG000|Overall Study|Other|7|||
33375372|NCT01968954|101261521|FG001|Overall Study|Other|8|||
33375373|NCT01968954|101261520|FG000|Overall Study|Protocol Violation|0|||
33375374|NCT01968954|101261521|FG001|Overall Study|Protocol Violation|1|||
33375375|NCT01968954|101261520|FG000|Overall Study|Did not met inclusion criteria|0|||
33375376|NCT01968954|101261521|FG001|Overall Study|Did not met inclusion criteria|2|||
33375377|NCT02796391|101261522|FG000|Overall Study|Lost to Follow-up|2|||
33375378|NCT02796391|101261523|FG001|Overall Study|Lost to Follow-up|2|||
33375379|NCT02796391|101261524|FG002|Overall Study|Lost to Follow-up|13|||
33375380|NCT02796391|101261525|FG003|Overall Study|Lost to Follow-up|8|||
33375381|NCT02796391|101261526|FG004|Overall Study|Lost to Follow-up|14|||
33375382|NCT02796391|101261527|FG005|Overall Study|Lost to Follow-up|13|||
33375383|NCT02796391|101261522|FG000|Overall Study|COVID|0|||
33375384|NCT02796391|101261523|FG001|Overall Study|COVID|0|||
33375385|NCT02796391|101261524|FG002|Overall Study|COVID|5|||
33375386|NCT02796391|101261525|FG003|Overall Study|COVID|5|||
33375387|NCT02796391|101261526|FG004|Overall Study|COVID|2|||
33375388|NCT02796391|101261527|FG005|Overall Study|COVID|4|||
33375389|NCT02796391|101261522|FG000|Overall Study|Participant did not like study cigarettes|0|||
33375390|NCT02796391|101261523|FG001|Overall Study|Participant did not like study cigarettes|0|||
33375391|NCT02796391|101261524|FG002|Overall Study|Participant did not like study cigarettes|3|||
33375392|NCT02796391|101261525|FG003|Overall Study|Participant did not like study cigarettes|0|||
33375393|NCT02796391|101261526|FG004|Overall Study|Participant did not like study cigarettes|0|||
33375394|NCT02796391|101261527|FG005|Overall Study|Participant did not like study cigarettes|0|||
33375395|NCT02796391|101261522|FG000|Overall Study|Withdrawal by Subject|1|||
33375396|NCT02796391|101261523|FG001|Overall Study|Withdrawal by Subject|1|||
33375397|NCT02796391|101261524|FG002|Overall Study|Withdrawal by Subject|4|||
33375398|NCT02796391|101261525|FG003|Overall Study|Withdrawal by Subject|3|||
33375399|NCT02796391|101261526|FG004|Overall Study|Withdrawal by Subject|4|||
33423715|NCT03835975|101443554|FG003|Overall Study|No longer met eligibility criteria|0|||
33423716|NCT03835975|101443555|FG004|Overall Study|No longer met eligibility criteria|0|||
33423717|NCT03835975|101443551|FG000|Overall Study|Protocol Violation|1|||
33423718|NCT03835975|101443552|FG001|Overall Study|Protocol Violation|1|||
33423719|NCT03835975|101443553|FG002|Overall Study|Protocol Violation|2|||
33423720|NCT03835975|101443554|FG003|Overall Study|Protocol Violation|0|||
33423721|NCT03835975|101443555|FG004|Overall Study|Protocol Violation|0|||
33423722|NCT03835975|101443551|FG000|Overall Study|Withdrawal by Subject|1|||
33423723|NCT03835975|101443552|FG001|Overall Study|Withdrawal by Subject|0|||
33423724|NCT03835975|101443553|FG002|Overall Study|Withdrawal by Subject|1|||
33423725|NCT03835975|101443554|FG003|Overall Study|Withdrawal by Subject|1|||
33423726|NCT03835975|101443555|FG004|Overall Study|Withdrawal by Subject|0|||
33423727|NCT01222715|101443556|FG000|Overall Study|Adverse Event|0|||
33423728|NCT01222715|101443557|FG001|Overall Study|Adverse Event|4|||
33423729|NCT01222715|101443556|FG000|Overall Study|Death|0|||
33423730|NCT01222715|101443557|FG001|Overall Study|Death|1|||
33423731|NCT01222715|101443556|FG000|Overall Study|Lack of Efficacy|22|||
33423732|NCT01222715|101443557|FG001|Overall Study|Lack of Efficacy|14|||
33423733|NCT01222715|101443556|FG000|Overall Study|Physician Decision|12|||
33423734|NCT01222715|101443557|FG001|Overall Study|Physician Decision|2|||
33423735|NCT01222715|101443556|FG000|Overall Study|Refusal of further protocol therapy|0|||
33423736|NCT01222715|101443557|FG001|Overall Study|Refusal of further protocol therapy|4|||
33423737|NCT01222715|101443556|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
33423738|NCT01222715|101443557|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
33423739|NCT01222715|101443556|FG000|Overall Study|Ineligible|0|||
33375400|NCT02796391|101261527|FG005|Overall Study|Withdrawal by Subject|3|||
33375401|NCT02796391|101261522|FG000|Overall Study|Adverse Event|0|||
33375402|NCT02796391|101261523|FG001|Overall Study|Adverse Event|0|||
33375403|NCT02796391|101261524|FG002|Overall Study|Adverse Event|0|||
33375404|NCT02796391|101261525|FG003|Overall Study|Adverse Event|1|||
33375405|NCT02796391|101261526|FG004|Overall Study|Adverse Event|0|||
33375406|NCT02796391|101261527|FG005|Overall Study|Adverse Event|0|||
33246321|NCT00631917|100803730|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33246322|NCT00631917|100803729|FG000|Overall Study|Abnormal test procedure result(s)|3|||
33246323|NCT00631917|100803730|FG001|Overall Study|Abnormal test procedure result(s)|2|||
33246324|NCT00631917|100803729|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
33246325|NCT00631917|100803730|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
33246326|NCT00631917|100803729|FG000|Overall Study|No longer required study drug|0|||
33246327|NCT00631917|100803730|FG001|Overall Study|No longer required study drug|1|||
33246328|NCT00631917|100803729|FG000|Overall Study|Protocol deviation|6|||
33246329|NCT00631917|100803730|FG001|Overall Study|Protocol deviation|5|||
33246330|NCT00631917|100803729|FG000|Overall Study|Subject withdrew consent|25|||
33246331|NCT00631917|100803730|FG001|Overall Study|Subject withdrew consent|33|||
33246332|NCT00631917|100803729|FG000|Overall Study|Lost to Follow-up|7|||
33246333|NCT00631917|100803730|FG001|Overall Study|Lost to Follow-up|7|||
33246334|NCT00631917|100803729|FG000|Overall Study|Administrative problems|2|||
33246335|NCT00631917|100803730|FG001|Overall Study|Administrative problems|0|||
33246336|NCT00631917|100803729|FG000|Overall Study|Death|1|||
33246337|NCT00631917|100803730|FG001|Overall Study|Death|0|||
33246338|NCT05650333|100803732|FG000|Treatment Period (7 Days)|Adverse Event|1|||
33246339|NCT02095158|100803733|FG000|Overall Study|Adverse Event|14|||
33246340|NCT02095158|100803733|FG000|Overall Study|Lack of Efficacy|3|||
33246341|NCT02095158|100803733|FG000|Overall Study|Pregnancy|1|||
33246342|NCT02095158|100803733|FG000|Overall Study|Lost to Follow-up|20|||
33246343|NCT02095158|100803733|FG000|Overall Study|Personal Reasons|35|||
33246344|NCT02095158|100803733|FG000|Overall Study|Protocol Violation|1|||
33246345|NCT02095158|100803733|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33246346|NCT01311648|100803734|FG000|Main Study|Protocol Violation|0|||
33246347|NCT01311648|100803735|FG001|Main Study|Protocol Violation|1|||
33246348|NCT01311648|100803734|FG000|Main Study|Adverse Event|0|||
33246349|NCT01311648|100803735|FG001|Main Study|Adverse Event|1|||
33246350|NCT01311648|100803734|FG000|Main Study|Inhibitor management|0|||
33246351|NCT01311648|100803735|FG001|Main Study|Inhibitor management|17|||
33246352|NCT01311648|100803734|FG000|Main Study|Withdrawal by Subject|0|||
33246353|NCT01311648|100803735|FG001|Main Study|Withdrawal by Subject|2|||
33246354|NCT01311648|100803734|FG000|Extension Study|Physician Decision|0|||
33246355|NCT01311648|100803735|FG001|Extension Study|Physician Decision|1|||
33246356|NCT01311648|100803734|FG000|Extension Study|ITI therapy with marketed product|0|||
33246357|NCT01311648|100803735|FG001|Extension Study|ITI therapy with marketed product|1|||
33246358|NCT01311648|100803734|FG000|Extension Study|Incorrect visit planning|0|||
33246359|NCT01311648|100803735|FG001|Extension Study|Incorrect visit planning|1|||
33246360|NCT01311648|100803734|FG000|Extension Study|Family's decision|0|||
33246361|NCT01311648|100803735|FG001|Extension Study|Family's decision|1|||
33246362|NCT01311648|100803734|FG000|Extension Study|Failure of ITI therapy|0|||
33246363|NCT01311648|100803735|FG001|Extension Study|Failure of ITI therapy|3|||
33246364|NCT01311648|100803734|FG000|Extension Study|Long travel|0|||
33246365|NCT01311648|100803735|FG001|Extension Study|Long travel|1|||
33246366|NCT01311648|100803734|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
33246367|NCT01311648|100803735|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
33246368|NCT01311648|100803734|FG000|Extension Study|Withdrawal by Subject|0|||
33246369|NCT01311648|100803735|FG001|Extension Study|Withdrawal by Subject|1|||
33246370|NCT01311648|100803734|FG000|Extension Study|Inhibitor management|0|||
33246371|NCT01311648|100803735|FG001|Extension Study|Inhibitor management|2|||
33246372|NCT00567879|100803736|FG000|Overall Study|Adverse Event|2|||
33246373|NCT00567879|100803737|FG001|Overall Study|Adverse Event|0|||
33246374|NCT00567879|100803738|FG002|Overall Study|Adverse Event|1|||
33246375|NCT00567879|100803739|FG003|Overall Study|Adverse Event|0|||
33246376|NCT00567879|100803740|FG004|Overall Study|Adverse Event|1|||
33246377|NCT00567879|100803741|FG005|Overall Study|Adverse Event|0|||
33246378|NCT00567879|100803736|FG000|Overall Study|Abnormal test procedure(s)|0|||
33375407|NCT02796391|101261522|FG000|Overall Study|Protocol Violation|0|||
33375408|NCT02796391|101261523|FG001|Overall Study|Protocol Violation|0|||
33375409|NCT02796391|101261524|FG002|Overall Study|Protocol Violation|0|||
33375410|NCT02796391|101261525|FG003|Overall Study|Protocol Violation|1|||
33246379|NCT00567879|100803737|FG001|Overall Study|Abnormal test procedure(s)|0|||
33246380|NCT00567879|100803738|FG002|Overall Study|Abnormal test procedure(s)|1|||
33246381|NCT00567879|100803739|FG003|Overall Study|Abnormal test procedure(s)|0|||
33246382|NCT00567879|100803740|FG004|Overall Study|Abnormal test procedure(s)|0|||
33246383|NCT00567879|100803741|FG005|Overall Study|Abnormal test procedure(s)|0|||
33246384|NCT00567879|100803736|FG000|Overall Study|Withdrawal by Subject|0|||
33246385|NCT00567879|100803737|FG001|Overall Study|Withdrawal by Subject|0|||
33246386|NCT00567879|100803738|FG002|Overall Study|Withdrawal by Subject|3|||
33246387|NCT00567879|100803739|FG003|Overall Study|Withdrawal by Subject|1|||
33246388|NCT00567879|100803740|FG004|Overall Study|Withdrawal by Subject|0|||
33246389|NCT00567879|100803741|FG005|Overall Study|Withdrawal by Subject|0|||
33246390|NCT00567879|100803736|FG000|Overall Study|New cancer therapy|0|||
33246391|NCT00567879|100803737|FG001|Overall Study|New cancer therapy|0|||
33375411|NCT02796391|101261526|FG004|Overall Study|Protocol Violation|0|||
33375412|NCT02796391|101261527|FG005|Overall Study|Protocol Violation|0|||
33375413|NCT00683475|101261528|FG000|Overall Study|Withdrawal by Subject|1|||
33375414|NCT00683475|101261529|FG001|Overall Study|Withdrawal by Subject|0|||
33375415|NCT00683475|101261528|FG000|Overall Study|Never Treated: Adverse Event|2|||
33375416|NCT00683475|101261529|FG001|Overall Study|Never Treated: Adverse Event|3|||
33375417|NCT00683475|101261528|FG000|Overall Study|Never Treated: Progressive Disease|1|||
33375418|NCT00683475|101261529|FG001|Overall Study|Never Treated: Progressive Disease|0|||
33375419|NCT05294211|101261530|FG000|Overall Study|Withdrawal by Subject|3|||
33375420|NCT05294211|101261530|FG000|Overall Study|Physician Decision|2|||
33375421|NCT05294211|101261530|FG000|Overall Study|Progressed to active labor|1|||
33375422|NCT05294211|101261530|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
33375423|NCT05294211|101261530|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
33375424|NCT02648724|101261531|FG000|Overall Study|Withdrawal by Subject|0|||
33375425|NCT02648724|101261532|FG001|Overall Study|Withdrawal by Subject|1|||
33375426|NCT02648724|101261533|FG002|Overall Study|Withdrawal by Subject|1|||
33375427|NCT02648724|101261534|FG003|Overall Study|Withdrawal by Subject|0|||
33375428|NCT02648724|101261535|FG004|Overall Study|Withdrawal by Subject|1|||
33375429|NCT02648724|101261536|FG005|Overall Study|Withdrawal by Subject|0|||
33375430|NCT02648724|101261537|FG006|Overall Study|Withdrawal by Subject|0|||
33375431|NCT02648724|101261531|FG000|Overall Study|Progressive disease|2|||
33375432|NCT02648724|101261532|FG001|Overall Study|Progressive disease|2|||
33375433|NCT02648724|101261533|FG002|Overall Study|Progressive disease|2|||
33375434|NCT02648724|101261534|FG003|Overall Study|Progressive disease|3|||
33375435|NCT02648724|101261535|FG004|Overall Study|Progressive disease|22|||
33375436|NCT02648724|101261536|FG005|Overall Study|Progressive disease|7|||
33375437|NCT02648724|101261537|FG006|Overall Study|Progressive disease|8|||
33375438|NCT02648724|101261531|FG000|Overall Study|Other reason (unknown)|1|||
33375439|NCT02648724|101261532|FG001|Overall Study|Other reason (unknown)|0|||
33375440|NCT02648724|101261533|FG002|Overall Study|Other reason (unknown)|0|||
33375441|NCT02648724|101261534|FG003|Overall Study|Other reason (unknown)|0|||
33375442|NCT02648724|101261535|FG004|Overall Study|Other reason (unknown)|0|||
33375443|NCT02648724|101261536|FG005|Overall Study|Other reason (unknown)|0|||
33375444|NCT02648724|101261537|FG006|Overall Study|Other reason (unknown)|0|||
33375445|NCT02648724|101261531|FG000|Overall Study|Protocol Violation|0|||
33645954|NCT02709538|102256235|FG002|Overall Study|Protocol deviation|4|||
33645955|NCT02709538|102256233|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
33645956|NCT02709538|102256234|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
33645957|NCT02709538|102256235|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
33645958|NCT02709538|102256233|FG000|Overall Study|Other|16|||
33645959|NCT02709538|102256234|FG001|Overall Study|Other|7|||
33645960|NCT02709538|102256235|FG002|Overall Study|Other|5|||
33375446|NCT02648724|101261532|FG001|Overall Study|Protocol Violation|0|||
33375447|NCT02648724|101261533|FG002|Overall Study|Protocol Violation|0|||
33375448|NCT02648724|101261534|FG003|Overall Study|Protocol Violation|0|||
33375449|NCT02648724|101261535|FG004|Overall Study|Protocol Violation|1|||
33375450|NCT02648724|101261536|FG005|Overall Study|Protocol Violation|0|||
33375451|NCT02648724|101261537|FG006|Overall Study|Protocol Violation|0|||
33375452|NCT02648724|101261531|FG000|Overall Study|Death|0|||
33375453|NCT02648724|101261532|FG001|Overall Study|Death|0|||
33375454|NCT02648724|101261533|FG002|Overall Study|Death|0|||
33375455|NCT02648724|101261534|FG003|Overall Study|Death|0|||
33375456|NCT02648724|101261535|FG004|Overall Study|Death|0|||
33375457|NCT02648724|101261536|FG005|Overall Study|Death|0|||
33375458|NCT02648724|101261537|FG006|Overall Study|Death|3|||
33375459|NCT02648724|101261531|FG000|Overall Study|Physician Decision|0|||
33375460|NCT02648724|101261532|FG001|Overall Study|Physician Decision|0|||
33375461|NCT02648724|101261533|FG002|Overall Study|Physician Decision|0|||
33375462|NCT02648724|101261534|FG003|Overall Study|Physician Decision|0|||
33375463|NCT02648724|101261535|FG004|Overall Study|Physician Decision|1|||
33375464|NCT02648724|101261536|FG005|Overall Study|Physician Decision|0|||
33645961|NCT00942994|102256242|FG000|Overall Study|Adverse Event|7|||
33645962|NCT00942994|102256243|FG001|Overall Study|Adverse Event|4|||
33645963|NCT00942994|102256242|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33645964|NCT00942994|102256243|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33246392|NCT00567879|100803738|FG002|Overall Study|New cancer therapy|1|||
33375465|NCT02648724|101261537|FG006|Overall Study|Physician Decision|1|||
33375466|NCT02648724|101261531|FG000|Overall Study|Transferred to named patient program|0|||
33375467|NCT02648724|101261532|FG001|Overall Study|Transferred to named patient program|0|||
33375468|NCT02648724|101261533|FG002|Overall Study|Transferred to named patient program|0|||
33375469|NCT02648724|101261534|FG003|Overall Study|Transferred to named patient program|0|||
33375470|NCT02648724|101261535|FG004|Overall Study|Transferred to named patient program|0|||
33375471|NCT02648724|101261536|FG005|Overall Study|Transferred to named patient program|1|||
33375472|NCT02648724|101261537|FG006|Overall Study|Transferred to named patient program|0|||
33375473|NCT04017442|101261546|FG000|Overall Study|Withdrawal by Subject|0|||
33375474|NCT04017442|101261547|FG001|Overall Study|Withdrawal by Subject|3|||
33375475|NCT04017442|101261546|FG000|Overall Study|Lost to Follow-up|21|||
33645965|NCT00942994|102256242|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33375476|NCT04017442|101261547|FG001|Overall Study|Lost to Follow-up|19|||
33375477|NCT01911845|101261548|FG000|Overall Study|Adverse Event|2|||
33375478|NCT01911845|101261548|FG000|Overall Study|Lost to Follow-up|1|||
33375479|NCT01911845|101261548|FG000|Overall Study|Other (not specified)|3|||
33375480|NCT00077610|101261549|FG000|Overall Study|Adverse Event|9|||
33645966|NCT00942994|102256243|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33645967|NCT00942994|102256242|FG000|Overall Study|Patient withdrew consent|5|||
33645968|NCT00942994|102256243|FG001|Overall Study|Patient withdrew consent|8|||
33645969|NCT00942994|102256242|FG000|Overall Study|Lost to Follow-up|1|||
33645970|NCT00942994|102256243|FG001|Overall Study|Lost to Follow-up|4|||
33645971|NCT00942994|102256242|FG000|Overall Study|Protocol deviation|1|||
33645972|NCT00942994|102256243|FG001|Overall Study|Protocol deviation|2|||
33645973|NCT00324961|102256244|FG000|Overall Study|Adverse Event|5|||
33645974|NCT00324961|102256244|FG000|Overall Study|Consent Withdrawn|11|||
33645975|NCT00324961|102256244|FG000|Overall Study|Lost to Follow-up|22|||
33645976|NCT00324961|102256244|FG000|Overall Study|Protocol Violation|3|||
33645977|NCT00324961|102256244|FG000|Overall Study|Other|2|||
33246393|NCT00567879|100803739|FG003|Overall Study|New cancer therapy|0|||
33375481|NCT00077610|101261550|FG001|Overall Study|Adverse Event|7|||
33375482|NCT00077610|101261551|FG002|Overall Study|Adverse Event|1|||
33375483|NCT00077610|101261549|FG000|Overall Study|Lost to Follow-up|0|||
33375484|NCT00077610|101261550|FG001|Overall Study|Lost to Follow-up|1|||
33375485|NCT00077610|101261551|FG002|Overall Study|Lost to Follow-up|2|||
33375486|NCT00077610|101261549|FG000|Overall Study|Withdrawal by Subject|4|||
33375487|NCT00077610|101261550|FG001|Overall Study|Withdrawal by Subject|10|||
33375488|NCT00077610|101261551|FG002|Overall Study|Withdrawal by Subject|6|||
33375489|NCT00077610|101261549|FG000|Overall Study|Death|17|||
33375490|NCT00077610|101261550|FG001|Overall Study|Death|13|||
33375491|NCT00077610|101261551|FG002|Overall Study|Death|13|||
33375492|NCT00077610|101261549|FG000|Overall Study|Renal transplant|12|||
33375493|NCT00077610|101261550|FG001|Overall Study|Renal transplant|15|||
33375494|NCT00077610|101261551|FG002|Overall Study|Renal transplant|11|||
33375495|NCT00077610|101261549|FG000|Overall Study|Withdrew from dialysis care|5|||
33375496|NCT00077610|101261550|FG001|Overall Study|Withdrew from dialysis care|0|||
33375497|NCT00077610|101261551|FG002|Overall Study|Withdrew from dialysis care|3|||
33375498|NCT00077610|101261549|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33375499|NCT00077610|101261550|FG001|Overall Study|Insufficient Therapeutic Response|0|||
33375500|NCT00077610|101261551|FG002|Overall Study|Insufficient Therapeutic Response|0|||
33375501|NCT00077610|101261549|FG000|Overall Study|Multiple blood transfusions|0|||
33375502|NCT00077610|101261550|FG001|Overall Study|Multiple blood transfusions|0|||
33375503|NCT00077610|101261551|FG002|Overall Study|Multiple blood transfusions|1|||
33375504|NCT00077610|101261549|FG000|Overall Study|Principal Investigator's decision|1|||
33375505|NCT00077610|101261550|FG001|Overall Study|Principal Investigator's decision|0|||
33375506|NCT00077610|101261551|FG002|Overall Study|Principal Investigator's decision|1|||
33375507|NCT00077610|101261549|FG000|Overall Study|Worsening of health condition|1|||
33375508|NCT00077610|101261550|FG001|Overall Study|Worsening of health condition|1|||
33375509|NCT00077610|101261551|FG002|Overall Study|Worsening of health condition|0|||
33375510|NCT00077610|101261549|FG000|Overall Study|Given Epogen in hospital|1|||
33375511|NCT00077610|101261550|FG001|Overall Study|Given Epogen in hospital|0|||
33375512|NCT00077610|101261551|FG002|Overall Study|Given Epogen in hospital|0|||
33375513|NCT00077610|101261549|FG000|Overall Study|Transferred to other unit|0|||
33375514|NCT00077610|101261550|FG001|Overall Study|Transferred to other unit|0|||
33375515|NCT00077610|101261551|FG002|Overall Study|Transferred to other unit|1|||
33375516|NCT00077610|101261549|FG000|Overall Study|Transferred to nursing home|0|||
33375517|NCT00077610|101261550|FG001|Overall Study|Transferred to nursing home|0|||
33375518|NCT00077610|101261551|FG002|Overall Study|Transferred to nursing home|1|||
33375519|NCT00077610|101261549|FG000|Overall Study|Transfer to satellite unit|1|||
33423740|NCT01222715|101443557|FG001|Overall Study|Ineligible|1|||
33423741|NCT01222715|101443556|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
33423742|NCT01222715|101443557|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
33423743|NCT02598622|101443561|FG000|Overall Study|Withdrawal by Subject|3|||
33585371|NCT01713582|102032623|FG017|Overall Study|Withdrawal by Subject|1|||
33645978|NCT01874340|102256246|FG000|Overall Study|Study terminated by Sponsor|6|||
33246394|NCT00567879|100803740|FG004|Overall Study|New cancer therapy|0|||
33375520|NCT00077610|101261550|FG001|Overall Study|Transfer to satellite unit|0|||
33375521|NCT00077610|101261551|FG002|Overall Study|Transfer to satellite unit|0|||
33375522|NCT00077610|101261549|FG000|Overall Study|Transfer to other center for surgery|1|||
33375523|NCT00077610|101261550|FG001|Overall Study|Transfer to other center for surgery|0|||
33375524|NCT00077610|101261551|FG002|Overall Study|Transfer to other center for surgery|0|||
33375525|NCT00077610|101261549|FG000|Overall Study|Change in dialysis modality|1|||
33375526|NCT00077610|101261550|FG001|Overall Study|Change in dialysis modality|0|||
33375527|NCT00077610|101261551|FG002|Overall Study|Change in dialysis modality|0|||
33375528|NCT00077610|101261549|FG000|Overall Study|Relocation|0|||
33645979|NCT01874340|102256247|FG001|Overall Study|Study terminated by Sponsor|8|||
33645980|NCT01874340|102256248|FG002|Overall Study|Study terminated by Sponsor|8|||
33645981|NCT01874340|102256249|FG003|Overall Study|Study terminated by Sponsor|4|||
33375529|NCT00077610|101261550|FG001|Overall Study|Relocation|8|||
33375530|NCT00077610|101261551|FG002|Overall Study|Relocation|5|||
33375531|NCT00077610|101261549|FG000|Overall Study|Financial issues|0|||
33375532|NCT00077610|101261550|FG001|Overall Study|Financial issues|1|||
33375533|NCT00077610|101261551|FG002|Overall Study|Financial issues|0|||
33375534|NCT00077610|101261549|FG000|Overall Study|Sponsors decision to withdraw|0|||
33375535|NCT00077610|101261550|FG001|Overall Study|Sponsors decision to withdraw|0|||
33375536|NCT00077610|101261551|FG002|Overall Study|Sponsors decision to withdraw|1|||
33375537|NCT00579501|101261560|FG000|Overall Study|Death|1|||
33375538|NCT00579501|101261560|FG000|Overall Study|End of neoadjuvant therapy|25|||
33375539|NCT00579501|101261560|FG000|Overall Study|toxicity|1|||
33375540|NCT00579501|101261560|FG000|Overall Study|Secondary lesion|1|||
33375541|NCT00579501|101261560|FG000|Overall Study|Radiation therapy before surgery|1|||
33375542|NCT02723604|101261561|FG000|Overall Study|ineligible|1|||
33375543|NCT02723604|101261561|FG000|Overall Study|never received treatment|1|||
33375544|NCT00363246|101261567|FG000|Overall Study|Death|40|||
33375545|NCT00363246|101261567|FG000|Overall Study|Withdrawal by Subject|19|||
33375546|NCT00363246|101261567|FG000|Overall Study|Lost to Follow-up|14|||
33375547|NCT00363246|101261567|FG000|Overall Study|Bad health|6|||
33375548|NCT00363246|101261567|FG000|Overall Study|Stopped using wheelchair|11|||
33375549|NCT00363246|101261567|FG000|Overall Study|Subject expressed security concerns|2|||
33375550|NCT00363246|101261567|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
33375551|NCT02504268|101261568|FG000|Overall Study|Adverse Event|18|||
33375552|NCT02504268|101261569|FG001|Overall Study|Adverse Event|8|||
33375553|NCT02504268|101261570|FG002|Overall Study|Adverse Event|14|||
33375554|NCT02504268|101261571|FG003|Overall Study|Adverse Event|0|||
33375555|NCT02504268|101261572|FG004|Overall Study|Adverse Event|0|||
33375556|NCT02504268|101261573|FG005|Overall Study|Adverse Event|0|||
33375557|NCT02504268|101261574|FG006|Overall Study|Adverse Event|0|||
33375558|NCT02504268|101261575|FG007|Overall Study|Adverse Event|0|||
33375559|NCT02504268|101261576|FG008|Overall Study|Adverse Event|0|||
33585372|NCT01713582|102032624|FG018|Overall Study|Withdrawal by Subject|0|||
33585373|NCT01713582|102032625|FG019|Overall Study|Withdrawal by Subject|0|||
33585374|NCT01713582|102032626|FG020|Overall Study|Withdrawal by Subject|0|||
33585375|NCT01713582|102032606|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
33585376|NCT01713582|102032607|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
33585377|NCT01713582|102032608|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
33585378|NCT01713582|102032609|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
33585379|NCT01713582|102032610|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
33246395|NCT00567879|100803741|FG005|Overall Study|New cancer therapy|0|||
33246396|NCT00567879|100803736|FG000|Overall Study|Disease progression|5|||
33246397|NCT00567879|100803737|FG001|Overall Study|Disease progression|7|||
33246398|NCT00567879|100803738|FG002|Overall Study|Disease progression|15|||
33246399|NCT00567879|100803739|FG003|Overall Study|Disease progression|5|||
33246400|NCT00567879|100803740|FG004|Overall Study|Disease progression|11|||
33246401|NCT00567879|100803741|FG005|Overall Study|Disease progression|3|||
33246402|NCT04011033|100803743|FG000|Overall Study|Physician Decision|2|||
33246403|NCT04011033|100803744|FG001|Overall Study|Physician Decision|3|||
33246404|NCT04011033|100803743|FG000|Overall Study|Withdrawal by Subject|1|||
33246405|NCT04011033|100803744|FG001|Overall Study|Withdrawal by Subject|0|||
33246406|NCT00058058|100803745|FG000|Overall Study|Withdrawal by Subject|4|||
33585380|NCT01713582|102032611|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
33585381|NCT01713582|102032612|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
33585382|NCT01713582|102032613|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
33585383|NCT01713582|102032614|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
33585384|NCT01713582|102032615|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
33585385|NCT01713582|102032616|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
33246407|NCT00058058|100803745|FG000|Overall Study|Ineligible|20|||
33246408|NCT00058058|100803745|FG000|Overall Study|Claustrophobic|5|||
33246409|NCT00058058|100803745|FG000|Overall Study|technical issues|6|||
33246410|NCT00058058|100803745|FG000|Overall Study|Poor positioning, illness,pain|3|||
33246411|NCT03643211|100803748|FG000|Overall Study|Contract violation/deficiency|12|||
33246412|NCT03643211|100803748|FG000|Overall Study|Invalid registration|3|||
33246413|NCT03643211|100803748|FG000|Overall Study|No treatment information|2|||
33246414|NCT03643211|100803748|FG000|Overall Study|No adverse event information - No revisit|4|||
33375560|NCT02504268|101261568|FG000|Overall Study|Withdrawal of Consent|11|||
33375561|NCT02504268|101261569|FG001|Overall Study|Withdrawal of Consent|10|||
33375562|NCT02504268|101261570|FG002|Overall Study|Withdrawal of Consent|3|||
33375563|NCT02504268|101261571|FG003|Overall Study|Withdrawal of Consent|0|||
33375564|NCT02504268|101261572|FG004|Overall Study|Withdrawal of Consent|0|||
33375565|NCT02504268|101261573|FG005|Overall Study|Withdrawal of Consent|0|||
33375566|NCT02504268|101261574|FG006|Overall Study|Withdrawal of Consent|0|||
33375567|NCT02504268|101261575|FG007|Overall Study|Withdrawal of Consent|0|||
33585386|NCT01713582|102032617|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
33585387|NCT01713582|102032618|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
33645982|NCT01874340|102256246|FG000|Overall Study|Withdrawal by Subject|0|||
33645983|NCT01874340|102256247|FG001|Overall Study|Withdrawal by Subject|0|||
33645984|NCT01874340|102256248|FG002|Overall Study|Withdrawal by Subject|0|||
33645985|NCT01874340|102256249|FG003|Overall Study|Withdrawal by Subject|1|||
33645986|NCT00831493|102256253|FG000|Overall Study|Intractable nausea and vomiting|1|||
33645987|NCT01057589|102256254|FG000|Overall Study|Disease Progression|35|||
33645988|NCT01057589|102256254|FG000|Overall Study|Adverse Event|10|||
33645989|NCT01057589|102256254|FG000|Overall Study|Physician Decision|8|||
33645990|NCT01057589|102256254|FG000|Overall Study|Withdrawal by Subject|3|||
33645991|NCT01057589|102256254|FG000|Overall Study|Sponsor Decision|1|||
33375568|NCT02504268|101261576|FG008|Overall Study|Withdrawal of Consent|0|||
33375569|NCT02504268|101261568|FG000|Overall Study|Pregnancy|2|||
33375570|NCT02504268|101261569|FG001|Overall Study|Pregnancy|0|||
33375571|NCT02504268|101261570|FG002|Overall Study|Pregnancy|0|||
33375572|NCT02504268|101261571|FG003|Overall Study|Pregnancy|0|||
33375573|NCT02504268|101261572|FG004|Overall Study|Pregnancy|0|||
33375574|NCT02504268|101261573|FG005|Overall Study|Pregnancy|0|||
33375575|NCT02504268|101261574|FG006|Overall Study|Pregnancy|0|||
33375576|NCT02504268|101261575|FG007|Overall Study|Pregnancy|0|||
33375577|NCT02504268|101261576|FG008|Overall Study|Pregnancy|0|||
33375578|NCT02504268|101261568|FG000|Overall Study|Lost to Follow-up|3|||
33375579|NCT02504268|101261569|FG001|Overall Study|Lost to Follow-up|6|||
33375580|NCT02504268|101261570|FG002|Overall Study|Lost to Follow-up|4|||
33375581|NCT02504268|101261571|FG003|Overall Study|Lost to Follow-up|0|||
33375582|NCT02504268|101261572|FG004|Overall Study|Lost to Follow-up|0|||
33375583|NCT02504268|101261573|FG005|Overall Study|Lost to Follow-up|0|||
33375584|NCT02504268|101261574|FG006|Overall Study|Lost to Follow-up|0|||
33375585|NCT02504268|101261575|FG007|Overall Study|Lost to Follow-up|0|||
33375586|NCT02504268|101261576|FG008|Overall Study|Lost to Follow-up|0|||
33375587|NCT02504268|101261568|FG000|Overall Study|Death|1|||
33375588|NCT02504268|101261569|FG001|Overall Study|Death|1|||
33375589|NCT02504268|101261570|FG002|Overall Study|Death|0|||
33375590|NCT02504268|101261571|FG003|Overall Study|Death|0|||
33375591|NCT02504268|101261572|FG004|Overall Study|Death|0|||
33375592|NCT02504268|101261573|FG005|Overall Study|Death|0|||
33375593|NCT02504268|101261574|FG006|Overall Study|Death|0|||
33375594|NCT02504268|101261575|FG007|Overall Study|Death|0|||
33375595|NCT02504268|101261576|FG008|Overall Study|Death|0|||
33375596|NCT02504268|101261568|FG000|Overall Study|Subject Request to Discontinue|11|||
33375597|NCT02504268|101261569|FG001|Overall Study|Subject Request to Discontinue|3|||
33375598|NCT02504268|101261570|FG002|Overall Study|Subject Request to Discontinue|6|||
33375599|NCT02504268|101261571|FG003|Overall Study|Subject Request to Discontinue|0|||
33375600|NCT02504268|101261572|FG004|Overall Study|Subject Request to Discontinue|0|||
33375601|NCT02504268|101261573|FG005|Overall Study|Subject Request to Discontinue|0|||
33645992|NCT01057589|102256254|FG000|Overall Study|Death|8|||
33645993|NCT01057589|102256254|FG000|Overall Study|Lost to Follow-up|1|||
33375602|NCT02504268|101261574|FG006|Overall Study|Subject Request to Discontinue|0|||
33375603|NCT02504268|101261575|FG007|Overall Study|Subject Request to Discontinue|0|||
33375604|NCT02504268|101261576|FG008|Overall Study|Subject Request to Discontinue|0|||
33375605|NCT02504268|101261568|FG000|Overall Study|No Longer Meets Study Criteria|2|||
33375606|NCT02504268|101261569|FG001|Overall Study|No Longer Meets Study Criteria|3|||
33375607|NCT02504268|101261570|FG002|Overall Study|No Longer Meets Study Criteria|0|||
33375608|NCT02504268|101261571|FG003|Overall Study|No Longer Meets Study Criteria|0|||
33375609|NCT02504268|101261572|FG004|Overall Study|No Longer Meets Study Criteria|0|||
33375610|NCT02504268|101261573|FG005|Overall Study|No Longer Meets Study Criteria|0|||
33375611|NCT02504268|101261574|FG006|Overall Study|No Longer Meets Study Criteria|0|||
33375612|NCT02504268|101261575|FG007|Overall Study|No Longer Meets Study Criteria|0|||
33375613|NCT02504268|101261576|FG008|Overall Study|No Longer Meets Study Criteria|0|||
33645994|NCT00295880|102256255|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
33645995|NCT00295880|102256255|FG000|Overall Study|Unit randomization did not occur|1|||
33375614|NCT02504268|101261568|FG000|Overall Study|Lack of Efficacy|11|||
33645996|NCT04359901|102256256|FG000|Overall Study|Withdrawal by Subject|0|||
33375615|NCT02504268|101261569|FG001|Overall Study|Lack of Efficacy|35|||
33375616|NCT02504268|101261570|FG002|Overall Study|Lack of Efficacy|9|||
33375617|NCT02504268|101261571|FG003|Overall Study|Lack of Efficacy|0|||
33375618|NCT02504268|101261572|FG004|Overall Study|Lack of Efficacy|0|||
33375619|NCT02504268|101261573|FG005|Overall Study|Lack of Efficacy|0|||
33375620|NCT02504268|101261574|FG006|Overall Study|Lack of Efficacy|0|||
33375621|NCT02504268|101261575|FG007|Overall Study|Lack of Efficacy|0|||
33375622|NCT02504268|101261576|FG008|Overall Study|Lack of Efficacy|0|||
33375623|NCT02504268|101261568|FG000|Overall Study|Poor/Non-Compliance|3|||
33375624|NCT02504268|101261569|FG001|Overall Study|Poor/Non-Compliance|2|||
33375625|NCT02504268|101261570|FG002|Overall Study|Poor/Non-Compliance|3|||
33375626|NCT02504268|101261571|FG003|Overall Study|Poor/Non-Compliance|0|||
33375627|NCT02504268|101261572|FG004|Overall Study|Poor/Non-Compliance|0|||
33645997|NCT04359901|102256257|FG001|Overall Study|Withdrawal by Subject|1|||
33645998|NCT04359901|102256256|FG000|Overall Study|Death|6|||
33645999|NCT04359901|102256257|FG001|Overall Study|Death|2|||
33646000|NCT00243269|102256258|FG000|Overall Study|Protocol Violation|2|||
33375628|NCT02504268|101261573|FG005|Overall Study|Poor/Non-Compliance|0|||
33375629|NCT02504268|101261574|FG006|Overall Study|Poor/Non-Compliance|0|||
33375630|NCT02504268|101261575|FG007|Overall Study|Poor/Non-Compliance|0|||
33375631|NCT02504268|101261576|FG008|Overall Study|Poor/Non-Compliance|0|||
33375632|NCT02504268|101261568|FG000|Overall Study|Not Disclosed|1|||
33375633|NCT02504268|101261569|FG001|Overall Study|Not Disclosed|0|||
33375634|NCT02504268|101261570|FG002|Overall Study|Not Disclosed|2|||
33375635|NCT02504268|101261571|FG003|Overall Study|Not Disclosed|0|||
33375636|NCT02504268|101261572|FG004|Overall Study|Not Disclosed|0|||
33375637|NCT02504268|101261573|FG005|Overall Study|Not Disclosed|0|||
33375638|NCT02504268|101261574|FG006|Overall Study|Not Disclosed|0|||
33375639|NCT02504268|101261575|FG007|Overall Study|Not Disclosed|0|||
33375640|NCT02504268|101261576|FG008|Overall Study|Not Disclosed|0|||
33375641|NCT02921919|101261586|FG000|Overall Study|Other|5|||
33375642|NCT02921919|101261587|FG001|Overall Study|Other|6|||
33375643|NCT02921919|101261586|FG000|Overall Study|Lost to Follow-up|0|||
33375644|NCT02921919|101261587|FG001|Overall Study|Lost to Follow-up|1|||
33375645|NCT02921919|101261586|FG000|Overall Study|Withdrawal by Subject|5|||
33375646|NCT02921919|101261587|FG001|Overall Study|Withdrawal by Subject|1|||
33375647|NCT02921919|101261586|FG000|Overall Study|Disease Progression|47|||
33375648|NCT02921919|101261587|FG001|Overall Study|Disease Progression|38|||
33375649|NCT02921919|101261586|FG000|Overall Study|Physician Decision|3|||
33375650|NCT02921919|101261587|FG001|Overall Study|Physician Decision|2|||
33375651|NCT02921919|101261586|FG000|Overall Study|Adverse Event|6|||
33375652|NCT02921919|101261587|FG001|Overall Study|Adverse Event|4|||
33375653|NCT01592409|101261590|FG000|Overall Study|Withdrawal by Subject|0|||
33375654|NCT01592409|101261591|FG001|Overall Study|Withdrawal by Subject|1|||
33375655|NCT00819585|101261592|FG000|Core Study|Adverse Event|2|||
33375656|NCT00819585|101261593|FG001|Core Study|Adverse Event|1|||
33375657|NCT00819585|101261594|FG002|Core Study|Adverse Event|1|||
33375658|NCT00819585|101261595|FG003|Core Study|Adverse Event|4|||
33375659|NCT00819585|101261596|FG004|Core Study|Adverse Event|1|||
33375660|NCT00819585|101261597|FG005|Core Study|Adverse Event|0|||
33375661|NCT00819585|101261598|FG006|Core Study|Adverse Event|2|||
33375662|NCT00819585|101261599|FG007|Core Study|Adverse Event|0|||
33375663|NCT00819585|101261600|FG008|Core Study|Adverse Event|0|||
33375664|NCT00819585|101261601|FG009|Core Study|Adverse Event|0|||
33375665|NCT00819585|101261602|FG010|Core Study|Adverse Event|0|||
33375666|NCT00819585|101261592|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
33375667|NCT00819585|101261593|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
33375668|NCT00819585|101261594|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
33375669|NCT00819585|101261595|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
33375670|NCT00819585|101261596|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
33375671|NCT00819585|101261597|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
33375672|NCT00819585|101261598|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
33375673|NCT00819585|101261599|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
33375674|NCT00819585|101261600|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
33375675|NCT00819585|101261601|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
33375676|NCT00819585|101261602|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
33375677|NCT00819585|101261592|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
33375678|NCT00819585|101261593|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
33375679|NCT00819585|101261594|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
33375680|NCT00819585|101261595|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
33646001|NCT00243269|102256259|FG001|Overall Study|Protocol Violation|1|||
33646002|NCT00243269|102256260|FG002|Overall Study|Protocol Violation|0|||
33646003|NCT00243269|102256261|FG003|Overall Study|Protocol Violation|1|||
33646004|NCT00243269|102256258|FG000|Overall Study|Lost to Follow-up|1|||
33646005|NCT00243269|102256259|FG001|Overall Study|Lost to Follow-up|0|||
33646006|NCT00243269|102256260|FG002|Overall Study|Lost to Follow-up|1|||
33646007|NCT00243269|102256261|FG003|Overall Study|Lost to Follow-up|3|||
33375681|NCT00819585|101261596|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
33585388|NCT01713582|102032619|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
33585389|NCT01713582|102032620|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
33375682|NCT00819585|101261597|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
33375683|NCT00819585|101261598|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
33375684|NCT00819585|101261599|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
33375685|NCT00819585|101261600|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
33375686|NCT00819585|101261601|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
33375687|NCT00819585|101261602|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
33375688|NCT00819585|101261592|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
33375689|NCT00819585|101261593|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
33375690|NCT00819585|101261594|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
33375691|NCT00819585|101261595|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
33375692|NCT00819585|101261596|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
33375693|NCT00819585|101261597|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
33375694|NCT00819585|101261598|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
33646008|NCT00029146|102256266|FG000|Overall Study|Lost to Follow-up|2|||
33646009|NCT00029146|102256267|FG001|Overall Study|Lost to Follow-up|1|||
33646010|NCT02636361|102256268|FG000|Period 4|Physician Decision|0|||
33646011|NCT02636361|102256269|FG001|Period 4|Physician Decision|0|||
33646012|NCT02636361|102256270|FG002|Period 4|Physician Decision|0|||
33646013|NCT02636361|102256271|FG003|Period 4|Physician Decision|1|||
33646014|NCT02636361|102256272|FG004|Period 4|Physician Decision|0|||
33646015|NCT01776307|102256273|FG000|Overall Study|Not dosed|0|||
33646016|NCT01776307|102256274|FG001|Overall Study|Not dosed|0|||
33375695|NCT00819585|101261599|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
33375696|NCT00819585|101261600|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
33375697|NCT00819585|101261601|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
33375698|NCT00819585|101261602|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
33375699|NCT00819585|101261592|FG000|Core Study|Subject Withdrew Consent|0|||
33375700|NCT00819585|101261593|FG001|Core Study|Subject Withdrew Consent|3|||
33375701|NCT00819585|101261594|FG002|Core Study|Subject Withdrew Consent|2|||
33375702|NCT00819585|101261595|FG003|Core Study|Subject Withdrew Consent|1|||
33375703|NCT00819585|101261596|FG004|Core Study|Subject Withdrew Consent|0|||
33375704|NCT00819585|101261597|FG005|Core Study|Subject Withdrew Consent|0|||
33375705|NCT00819585|101261598|FG006|Core Study|Subject Withdrew Consent|3|||
33375706|NCT00819585|101261599|FG007|Core Study|Subject Withdrew Consent|0|||
33375707|NCT00819585|101261600|FG008|Core Study|Subject Withdrew Consent|0|||
33375708|NCT00819585|101261601|FG009|Core Study|Subject Withdrew Consent|0|||
33375709|NCT00819585|101261602|FG010|Core Study|Subject Withdrew Consent|0|||
33375710|NCT00819585|101261592|FG000|Core Study|Lost to Follow-up|2|||
33375711|NCT00819585|101261593|FG001|Core Study|Lost to Follow-up|1|||
33375712|NCT00819585|101261594|FG002|Core Study|Lost to Follow-up|2|||
33375713|NCT00819585|101261595|FG003|Core Study|Lost to Follow-up|0|||
33375714|NCT00819585|101261596|FG004|Core Study|Lost to Follow-up|1|||
33375715|NCT00819585|101261597|FG005|Core Study|Lost to Follow-up|1|||
33423744|NCT02598622|101443562|FG001|Overall Study|Withdrawal by Subject|0|||
33423745|NCT02598622|101443561|FG000|Overall Study|Physician Decision|3|||
33423746|NCT02598622|101443562|FG001|Overall Study|Physician Decision|0|||
33423747|NCT00265083|101443563|FG000|Overall Study|Adverse Event|5|||
33423748|NCT00265083|101443564|FG001|Overall Study|Adverse Event|13|||
33423749|NCT00265083|101443565|FG002|Overall Study|Adverse Event|15|||
33423750|NCT00265083|101443563|FG000|Overall Study|Lost to Follow-up|3|||
33423751|NCT00265083|101443564|FG001|Overall Study|Lost to Follow-up|4|||
33423752|NCT00265083|101443565|FG002|Overall Study|Lost to Follow-up|4|||
33423753|NCT00265083|101443563|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
33585390|NCT01713582|102032621|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
33585391|NCT01713582|102032622|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
33585392|NCT01713582|102032623|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
33585393|NCT01713582|102032624|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
33585394|NCT01713582|102032625|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
33585395|NCT01713582|102032626|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
33585396|NCT01713582|102032606|FG000|Overall Study|Disease progression and adverse event|0|||
33585397|NCT01713582|102032607|FG001|Overall Study|Disease progression and adverse event|0|||
33585398|NCT01713582|102032608|FG002|Overall Study|Disease progression and adverse event|0|||
33585399|NCT01713582|102032609|FG003|Overall Study|Disease progression and adverse event|0|||
33585400|NCT01713582|102032610|FG004|Overall Study|Disease progression and adverse event|0|||
33585401|NCT01713582|102032611|FG005|Overall Study|Disease progression and adverse event|0|||
33585402|NCT01713582|102032612|FG006|Overall Study|Disease progression and adverse event|0|||
33585403|NCT01713582|102032613|FG007|Overall Study|Disease progression and adverse event|0|||
33585404|NCT01713582|102032614|FG008|Overall Study|Disease progression and adverse event|0|||
33585405|NCT01713582|102032615|FG009|Overall Study|Disease progression and adverse event|0|||
33585406|NCT01713582|102032616|FG010|Overall Study|Disease progression and adverse event|0|||
33585407|NCT01713582|102032617|FG011|Overall Study|Disease progression and adverse event|0|||
33585408|NCT01713582|102032618|FG012|Overall Study|Disease progression and adverse event|0|||
33585409|NCT01713582|102032619|FG013|Overall Study|Disease progression and adverse event|0|||
33585410|NCT01713582|102032620|FG014|Overall Study|Disease progression and adverse event|0|||
33646017|NCT01776307|102256275|FG002|Overall Study|Not dosed|1|||
33646018|NCT02565784|102256282|FG000|First Treatment|Adverse Event|1|||
33148613|NCT00378105|100458196|FG001|Overall Study|Withdrawal by Subject|3|||
33246415|NCT00777556|100803749|FG000|Overall Study|Inappropriate self-selection|34|||
33585411|NCT01713582|102032621|FG015|Overall Study|Disease progression and adverse event|0|||
33585412|NCT01713582|102032622|FG016|Overall Study|Disease progression and adverse event|1|||
33585413|NCT01713582|102032623|FG017|Overall Study|Disease progression and adverse event|0|||
33246416|NCT00777556|100803749|FG000|Overall Study|Dispensed but did not use product|12|||
33375716|NCT00819585|101261598|FG006|Core Study|Lost to Follow-up|1|||
33375717|NCT00819585|101261599|FG007|Core Study|Lost to Follow-up|0|||
33375718|NCT00819585|101261600|FG008|Core Study|Lost to Follow-up|0|||
33375719|NCT00819585|101261601|FG009|Core Study|Lost to Follow-up|0|||
33423754|NCT00265083|101443564|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
33646019|NCT02565784|102256282|FG000|First Treatment|Withdrawal by Subject|1|||
33375720|NCT00819585|101261602|FG010|Core Study|Lost to Follow-up|0|||
33646020|NCT02565784|102256282|FG000|Second Treatment|Withdrawal by Subject|2|||
33646021|NCT00488683|102256283|FG000|Overall Study|Withdrawal by Subject|1|||
33246417|NCT00777556|100803749|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
33246418|NCT04088188|100803750|FG000|Overall Study|Withdrawal by Subject|2|||
33246419|NCT04088188|100803751|FG001|Overall Study|Withdrawal by Subject|0|||
33246420|NCT04088188|100803750|FG000|Overall Study|Adverse Event|2|||
33246421|NCT04088188|100803751|FG001|Overall Study|Adverse Event|0|||
33246422|NCT03761784|100803752|FG000|Overall Study|Adverse Event|4|||
33246423|NCT03761784|100803753|FG001|Overall Study|Adverse Event|0|||
33246424|NCT03761784|100803752|FG000|Overall Study|Lost to Follow-up|10|||
33246425|NCT03761784|100803753|FG001|Overall Study|Lost to Follow-up|7|||
33246426|NCT03761784|100803752|FG000|Overall Study|Pregnancy|1|||
33246427|NCT03761784|100803753|FG001|Overall Study|Pregnancy|0|||
33246428|NCT03761784|100803752|FG000|Overall Study|Protocol Violation|2|||
33246429|NCT03761784|100803753|FG001|Overall Study|Protocol Violation|0|||
33246430|NCT03761784|100803752|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
33246431|NCT03761784|100803753|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
33246432|NCT03761784|100803752|FG000|Overall Study|Withdrawal by Subject|9|||
33246433|NCT03761784|100803753|FG001|Overall Study|Withdrawal by Subject|4|||
33246434|NCT03761784|100803752|FG000|Overall Study|Physician Decision|1|||
33375721|NCT00819585|101261592|FG000|Core Study|Administrative Problems|0|||
33375722|NCT00819585|101261593|FG001|Core Study|Administrative Problems|0|||
33375723|NCT00819585|101261594|FG002|Core Study|Administrative Problems|0|||
33375724|NCT00819585|101261595|FG003|Core Study|Administrative Problems|0|||
33375725|NCT00819585|101261596|FG004|Core Study|Administrative Problems|0|||
33375726|NCT00819585|101261597|FG005|Core Study|Administrative Problems|0|||
33375727|NCT00819585|101261598|FG006|Core Study|Administrative Problems|2|||
33375728|NCT00819585|101261599|FG007|Core Study|Administrative Problems|0|||
33375729|NCT00819585|101261600|FG008|Core Study|Administrative Problems|0|||
33375730|NCT00819585|101261601|FG009|Core Study|Administrative Problems|0|||
33375731|NCT00819585|101261602|FG010|Core Study|Administrative Problems|0|||
33585414|NCT01713582|102032624|FG018|Overall Study|Disease progression and adverse event|0|||
33646022|NCT00488683|102256284|FG001|Overall Study|Withdrawal by Subject|2|||
33646023|NCT00488683|102256285|FG002|Overall Study|Withdrawal by Subject|2|||
33646024|NCT00488683|102256283|FG000|Overall Study|Lost to Follow-up|5|||
33646025|NCT00488683|102256284|FG001|Overall Study|Lost to Follow-up|3|||
33646026|NCT00488683|102256285|FG002|Overall Study|Lost to Follow-up|0|||
33646027|NCT00488683|102256283|FG000|Overall Study|Protocol Violation|5|||
33646028|NCT00488683|102256284|FG001|Overall Study|Protocol Violation|1|||
33646029|NCT00488683|102256285|FG002|Overall Study|Protocol Violation|0|||
33246435|NCT03761784|100803753|FG001|Overall Study|Physician Decision|0|||
33246436|NCT03761784|100803752|FG000|Overall Study|Other Than Specified|1|||
33246437|NCT03761784|100803753|FG001|Overall Study|Other Than Specified|0|||
33246438|NCT03722446|100803758|FG000|Overall Study|Protocol Violation|15|||
33246439|NCT03722446|100803759|FG001|Overall Study|Protocol Violation|2|||
33246440|NCT05487703|100803760|FG000|Overall Study|Other|19|||
33246441|NCT05487703|100803760|FG000|Overall Study|Participant not well|5|||
33246442|NCT05487703|100803760|FG000|Overall Study|Insurance Reasons|6|||
33375732|NCT00819585|101261592|FG000|Core Study|Death|0|||
33375733|NCT00819585|101261593|FG001|Core Study|Death|0|||
33375734|NCT00819585|101261594|FG002|Core Study|Death|0|||
33375735|NCT00819585|101261595|FG003|Core Study|Death|0|||
33585415|NCT01713582|102032625|FG019|Overall Study|Disease progression and adverse event|0|||
33585416|NCT01713582|102032626|FG020|Overall Study|Disease progression and adverse event|0|||
33585417|NCT02684617|102032631|FG000|Overall Study|Adverse Event|1|||
33585418|NCT02684617|102032632|FG001|Overall Study|Adverse Event|0|||
33585419|NCT02684617|102032633|FG002|Overall Study|Adverse Event|1|||
33585420|NCT02684617|102032631|FG000|Overall Study|Death|8|||
33585421|NCT02684617|102032632|FG001|Overall Study|Death|16|||
33585422|NCT02684617|102032633|FG002|Overall Study|Death|28|||
33585423|NCT02684617|102032631|FG000|Overall Study|Withdrawal by Subject|2|||
33585424|NCT02684617|102032632|FG001|Overall Study|Withdrawal by Subject|0|||
33585425|NCT02684617|102032633|FG002|Overall Study|Withdrawal by Subject|4|||
33585426|NCT02684617|102032631|FG000|Overall Study|Screen Failure|1|||
33585427|NCT02684617|102032632|FG001|Overall Study|Screen Failure|0|||
33585428|NCT02684617|102032633|FG002|Overall Study|Screen Failure|2|||
33585429|NCT02684617|102032631|FG000|Overall Study|Study Terminated by Sponsor|6|||
33585430|NCT02684617|102032632|FG001|Overall Study|Study Terminated by Sponsor|1|||
33585431|NCT02684617|102032633|FG002|Overall Study|Study Terminated by Sponsor|5|||
33585432|NCT02974140|102032634|FG000|Overall Study|Adverse Event|2|||
33585433|NCT02974140|102032634|FG000|Overall Study|Lost to Follow-up|1|||
33585434|NCT02974140|102032634|FG000|Overall Study|Study Terminated by Sponsor|36|||
33585435|NCT00662831|102032636|FG000|Overall Study|Death|4|||
33375736|NCT00819585|101261596|FG004|Core Study|Death|0|||
33585436|NCT00662831|102032637|FG001|Overall Study|Death|1|||
33585437|NCT00662831|102032636|FG000|Overall Study|Lack of Efficacy|6|||
33646030|NCT00488683|102256283|FG000|Overall Study|Unable to Classify|1|||
33646031|NCT00488683|102256284|FG001|Overall Study|Unable to Classify|0|||
33246443|NCT05487703|100803760|FG000|Overall Study|Physician Decision|19|||
33246444|NCT05487703|100803760|FG000|Overall Study|Lack of Efficacy|60|||
33246445|NCT03771898|100803768|FG000|Overall Study|Adverse Event|1|||
33246446|NCT03771898|100803769|FG001|Overall Study|Adverse Event|0|||
33246447|NCT03771898|100803770|FG002|Overall Study|Adverse Event|0|||
33246448|NCT03771898|100803771|FG003|Overall Study|Adverse Event|0|||
33246449|NCT03771898|100803772|FG004|Overall Study|Adverse Event|0|||
33246450|NCT03771898|100803768|FG000|Overall Study|Lost to Follow-up|1|||
33246451|NCT03771898|100803769|FG001|Overall Study|Lost to Follow-up|1|||
33246452|NCT03771898|100803770|FG002|Overall Study|Lost to Follow-up|1|||
33246453|NCT03771898|100803771|FG003|Overall Study|Lost to Follow-up|0|||
33246454|NCT03771898|100803772|FG004|Overall Study|Lost to Follow-up|0|||
33246455|NCT03771898|100803768|FG000|Overall Study|Withdrawal by parent/guardian|1|||
33246456|NCT03771898|100803769|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33246457|NCT03771898|100803770|FG002|Overall Study|Withdrawal by parent/guardian|0|||
33246458|NCT03771898|100803771|FG003|Overall Study|Withdrawal by parent/guardian|0|||
33246459|NCT03771898|100803772|FG004|Overall Study|Withdrawal by parent/guardian|0|||
33246460|NCT03771898|100803768|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
33246461|NCT03771898|100803769|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
33246462|NCT03771898|100803770|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
33246463|NCT03771898|100803771|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
33246464|NCT03771898|100803772|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
33585438|NCT00662831|102032637|FG001|Overall Study|Lack of Efficacy|6|||
33585439|NCT00662831|102032636|FG000|Overall Study|Lost to Follow-up|1|||
33585440|NCT00662831|102032637|FG001|Overall Study|Lost to Follow-up|0|||
33585441|NCT00662831|102032636|FG000|Overall Study|Withdrawal by Subject|2|||
33246465|NCT00849147|100803779|FG000|Overall Study|Withdrawal by Subject|1|||
33246466|NCT00849147|100803779|FG000|Overall Study|Protocol Violation|2|||
33585442|NCT00662831|102032637|FG001|Overall Study|Withdrawal by Subject|1|||
33585443|NCT00662831|102032636|FG000|Overall Study|Other|62|||
33585444|NCT00662831|102032637|FG001|Overall Study|Other|31|||
33585445|NCT00662831|102032636|FG000|Overall Study|Protocol Violation|8|||
33585446|NCT00662831|102032637|FG001|Overall Study|Protocol Violation|4|||
33646032|NCT00488683|102256285|FG002|Overall Study|Unable to Classify|0|||
33646033|NCT01738646|102256289|FG000|Overall Study|Still Receiving Treatment|2|||
33646034|NCT01652469|102256291|FG000|Overall Study|Withdrawal by Subject|1|||
33646035|NCT01652469|102256292|FG001|Overall Study|Withdrawal by Subject|4|||
33646036|NCT01652469|102256291|FG000|Overall Study|Lost to Follow-up|0|||
33246467|NCT00849147|100803779|FG000|Overall Study|Disease Relapse/Progression|2|||
33246468|NCT04927975|100803780|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
33246469|NCT04927975|100803781|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
33246470|NCT04927975|100803782|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
33246471|NCT04927975|100803783|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
33246472|NCT04927975|100803784|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
33246473|NCT04927975|100803785|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
33246474|NCT04927975|100803780|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
33246475|NCT04927975|100803781|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
33246476|NCT04927975|100803782|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
33246477|NCT04927975|100803783|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
33246478|NCT04927975|100803784|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
33246479|NCT04927975|100803785|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
33246480|NCT04927975|100803780|FG000|Period 1 (Baseline-Week 24)|Death|0|||
33246481|NCT04927975|100803781|FG001|Period 1 (Baseline-Week 24)|Death|0|||
33246482|NCT04927975|100803782|FG002|Period 1 (Baseline-Week 24)|Death|0|||
33246483|NCT04927975|100803783|FG003|Period 1 (Baseline-Week 24)|Death|0|||
33246484|NCT04927975|100803784|FG004|Period 1 (Baseline-Week 24)|Death|0|||
33246485|NCT04927975|100803785|FG005|Period 1 (Baseline-Week 24)|Death|1|||
33246486|NCT04927975|100803780|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
33646037|NCT01652469|102256292|FG001|Overall Study|Lost to Follow-up|2|||
33646038|NCT01237899|102256293|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
33646039|NCT01237899|102256294|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
33246487|NCT04927975|100803781|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
33246488|NCT04927975|100803782|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
33246489|NCT04927975|100803783|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
33375737|NCT00819585|101261597|FG005|Core Study|Death|0|||
33646040|NCT01237899|102256295|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
33246490|NCT04927975|100803784|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
33246491|NCT04927975|100803785|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
33246492|NCT04927975|100803780|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
33375738|NCT00819585|101261598|FG006|Core Study|Death|1|||
33375739|NCT00819585|101261599|FG007|Core Study|Death|0|||
33375740|NCT00819585|101261600|FG008|Core Study|Death|0|||
33375741|NCT00819585|101261601|FG009|Core Study|Death|0|||
33585447|NCT00662831|102032636|FG000|Overall Study|Adverse Event|23|||
33585448|NCT00662831|102032637|FG001|Overall Study|Adverse Event|16|||
33375742|NCT00819585|101261602|FG010|Core Study|Death|0|||
33375743|NCT00819585|101261592|FG000|Core Study|Protocol Violation|0|||
33375744|NCT00819585|101261593|FG001|Core Study|Protocol Violation|0|||
33375745|NCT00819585|101261594|FG002|Core Study|Protocol Violation|1|||
33375746|NCT00819585|101261595|FG003|Core Study|Protocol Violation|0|||
33375747|NCT00819585|101261596|FG004|Core Study|Protocol Violation|0|||
33375748|NCT00819585|101261597|FG005|Core Study|Protocol Violation|1|||
33375749|NCT00819585|101261598|FG006|Core Study|Protocol Violation|3|||
33375750|NCT00819585|101261599|FG007|Core Study|Protocol Violation|0|||
33375751|NCT00819585|101261600|FG008|Core Study|Protocol Violation|0|||
33375752|NCT00819585|101261601|FG009|Core Study|Protocol Violation|0|||
33375753|NCT00819585|101261602|FG010|Core Study|Protocol Violation|0|||
33375754|NCT00819585|101261592|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
33375755|NCT00819585|101261593|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
33375756|NCT00819585|101261594|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
33375757|NCT00819585|101261595|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
33375758|NCT00819585|101261596|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
33375759|NCT00819585|101261597|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
33375760|NCT00819585|101261598|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
33375761|NCT00819585|101261599|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
33375762|NCT00819585|101261600|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
33646041|NCT01237899|102256296|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
33646042|NCT01237899|102256297|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
33646043|NCT01237899|102256298|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
33646044|NCT01237899|102256299|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
33646045|NCT01237899|102256300|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
33646046|NCT01237899|102256301|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
33246493|NCT04927975|100803781|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
33375763|NCT00819585|101261601|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
33375764|NCT00819585|101261602|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
33375765|NCT00819585|101261592|FG000|Extension Study|Subject Withdrew Consent|0|||
33375766|NCT00819585|101261593|FG001|Extension Study|Subject Withdrew Consent|0|||
33375767|NCT00819585|101261594|FG002|Extension Study|Subject Withdrew Consent|0|||
33246494|NCT04927975|100803782|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
33246495|NCT04927975|100803783|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
33246496|NCT04927975|100803784|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
33246497|NCT04927975|100803785|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
33246498|NCT00569946|100803786|FG000|Overall Study|Adverse Event|16|||
33246499|NCT00569946|100803786|FG000|Overall Study|Objective Progression or Relapse|42|||
33375768|NCT00819585|101261595|FG003|Extension Study|Subject Withdrew Consent|0|||
33375769|NCT00819585|101261596|FG004|Extension Study|Subject Withdrew Consent|0|||
33375770|NCT00819585|101261597|FG005|Extension Study|Subject Withdrew Consent|0|||
33375771|NCT00819585|101261598|FG006|Extension Study|Subject Withdrew Consent|0|||
33375772|NCT00819585|101261599|FG007|Extension Study|Subject Withdrew Consent|0|||
33375773|NCT00819585|101261600|FG008|Extension Study|Subject Withdrew Consent|3|||
33375774|NCT00819585|101261601|FG009|Extension Study|Subject Withdrew Consent|0|||
33375775|NCT00819585|101261602|FG010|Extension Study|Subject Withdrew Consent|1|||
33375776|NCT00819585|101261592|FG000|Extension Study|Lost to Follow-up|0|||
33375777|NCT00819585|101261593|FG001|Extension Study|Lost to Follow-up|0|||
33375778|NCT00819585|101261594|FG002|Extension Study|Lost to Follow-up|0|||
33246500|NCT00569946|100803786|FG000|Overall Study|Global Deterioration of Health Status|1|||
33246501|NCT02132702|100803787|FG000|Overall Study|Protocol Violation|2|||
33246502|NCT02132702|100803787|FG000|Overall Study|Adverse Event|3|||
33246503|NCT02132702|100803787|FG000|Overall Study|Withdrawal by Subject|3|||
33246504|NCT00502593|100803788|FG000|Overall Study|Withdrawn unspecified reason|1|||
33246505|NCT00502593|100803789|FG001|Overall Study|Withdrawn unspecified reason|1|||
33246506|NCT00502593|100803790|FG002|Overall Study|Withdrawn unspecified reason|3|||
33246507|NCT00502593|100803791|FG003|Overall Study|Withdrawn unspecified reason|1|||
33246508|NCT00502593|100803792|FG004|Overall Study|Withdrawn unspecified reason|2|||
33375779|NCT00819585|101261595|FG003|Extension Study|Lost to Follow-up|0|||
33375780|NCT00819585|101261596|FG004|Extension Study|Lost to Follow-up|0|||
33375781|NCT00819585|101261597|FG005|Extension Study|Lost to Follow-up|0|||
33375782|NCT00819585|101261598|FG006|Extension Study|Lost to Follow-up|0|||
33646047|NCT01237899|102256302|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
33246509|NCT00502593|100803793|FG005|Overall Study|Withdrawn unspecified reason|0|||
33246510|NCT00502593|100803794|FG006|Overall Study|Withdrawn unspecified reason|2|||
33246511|NCT00502593|100803795|FG007|Overall Study|Withdrawn unspecified reason|0|||
33375783|NCT00819585|101261599|FG007|Extension Study|Lost to Follow-up|0|||
33375784|NCT00819585|101261600|FG008|Extension Study|Lost to Follow-up|2|||
33375785|NCT00819585|101261601|FG009|Extension Study|Lost to Follow-up|1|||
33375786|NCT00819585|101261602|FG010|Extension Study|Lost to Follow-up|1|||
33375787|NCT00819585|101261592|FG000|Extension Study|Death|0|||
33375788|NCT00819585|101261593|FG001|Extension Study|Death|0|||
33375789|NCT00819585|101261594|FG002|Extension Study|Death|0|||
33375790|NCT00819585|101261595|FG003|Extension Study|Death|0|||
33375791|NCT00819585|101261596|FG004|Extension Study|Death|0|||
33375792|NCT00819585|101261597|FG005|Extension Study|Death|0|||
33375793|NCT00819585|101261598|FG006|Extension Study|Death|0|||
33375794|NCT00819585|101261599|FG007|Extension Study|Death|0|||
33375795|NCT00819585|101261600|FG008|Extension Study|Death|2|||
33375796|NCT00819585|101261601|FG009|Extension Study|Death|0|||
33375797|NCT00819585|101261602|FG010|Extension Study|Death|0|||
33375798|NCT01029886|101261603|FG000|Overall Study|Adverse Event|12|||
33375799|NCT01029886|101261604|FG001|Overall Study|Adverse Event|25|||
33375800|NCT01029886|101261603|FG000|Overall Study|Lost to Follow-up|1|||
33375801|NCT01029886|101261604|FG001|Overall Study|Lost to Follow-up|0|||
33375802|NCT01029886|101261603|FG000|Overall Study|Physician Decision|2|||
33375803|NCT01029886|101261604|FG001|Overall Study|Physician Decision|6|||
33375804|NCT01029886|101261603|FG000|Overall Study|Protocol Violation|17|||
33375805|NCT01029886|101261604|FG001|Overall Study|Protocol Violation|5|||
33375806|NCT01029886|101261603|FG000|Overall Study|Withdrawal by Subject|8|||
33375807|NCT01029886|101261604|FG001|Overall Study|Withdrawal by Subject|18|||
33246512|NCT00502593|100803796|FG008|Overall Study|Withdrawn unspecified reason|0|||
33246513|NCT00502593|100803797|FG009|Overall Study|Withdrawn unspecified reason|0|||
33246514|NCT00502593|100803798|FG010|Overall Study|Withdrawn unspecified reason|0|||
33246515|NCT00502593|100803799|FG011|Overall Study|Withdrawn unspecified reason|0|||
33246516|NCT00502593|100803788|FG000|Overall Study|Withdrawal by Subject|0|||
33246517|NCT00502593|100803789|FG001|Overall Study|Withdrawal by Subject|0|||
33375808|NCT01029886|101261603|FG000|Overall Study|Entry Criteria Not Met|13|||
33375809|NCT01029886|101261604|FG001|Overall Study|Entry Criteria Not Met|5|||
33375810|NCT01029886|101261603|FG000|Overall Study|Sponsor Decision|1|||
33375811|NCT01029886|101261604|FG001|Overall Study|Sponsor Decision|0|||
33375812|NCT01029886|101261603|FG000|Overall Study|Loss Glucose Control|7|||
33375813|NCT01029886|101261604|FG001|Overall Study|Loss Glucose Control|1|||
33375814|NCT02431468|101261605|FG000|Overall Study|Adverse Event|2|||
33375815|NCT02431468|101261606|FG001|Overall Study|Adverse Event|4|||
33375816|NCT02431468|101261607|FG002|Overall Study|Adverse Event|5|||
33375817|NCT02431468|101261605|FG000|Overall Study|Withdrawal by Subject|4|||
33375818|NCT02431468|101261606|FG001|Overall Study|Withdrawal by Subject|12|||
33375819|NCT02431468|101261607|FG002|Overall Study|Withdrawal by Subject|2|||
33375820|NCT02431468|101261605|FG000|Overall Study|noncompliance, investigator termination,|2|||
33375821|NCT02431468|101261606|FG001|Overall Study|noncompliance, investigator termination,|2|||
33375822|NCT02431468|101261607|FG002|Overall Study|noncompliance, investigator termination,|2|||
33375823|NCT04348591|101261611|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
33375824|NCT04348591|101261612|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
33375825|NCT04348591|101261611|FG000|Imaging Session (120 Min)|Physician Decision|0|||
33375826|NCT04348591|101261612|FG001|Imaging Session (120 Min)|Physician Decision|1|||
33375827|NCT04348591|101261611|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
33375828|NCT04348591|101261612|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
33375829|NCT02509494|101261613|FG000|Overall Study|Lost to Follow-up|8|||
33375830|NCT02509494|101261614|FG001|Overall Study|Lost to Follow-up|47|||
33375831|NCT02509494|101261615|FG002|Overall Study|Lost to Follow-up|19|||
33375832|NCT02509494|101261616|FG003|Overall Study|Lost to Follow-up|6|||
33375833|NCT02509494|101261617|FG004|Overall Study|Lost to Follow-up|3|||
33246518|NCT00502593|100803790|FG002|Overall Study|Withdrawal by Subject|6|||
33246519|NCT00502593|100803791|FG003|Overall Study|Withdrawal by Subject|2|||
33246520|NCT00502593|100803792|FG004|Overall Study|Withdrawal by Subject|2|||
33375834|NCT02509494|101261618|FG005|Overall Study|Lost to Follow-up|3|||
33375835|NCT02509494|101261619|FG006|Overall Study|Lost to Follow-up|1|||
33375836|NCT02509494|101261620|FG007|Overall Study|Lost to Follow-up|3|||
33375837|NCT02509494|101261621|FG008|Overall Study|Lost to Follow-up|1|||
33375838|NCT02509494|101261613|FG000|Overall Study|Physician Decision|2|||
33375839|NCT02509494|101261614|FG001|Overall Study|Physician Decision|1|||
33375840|NCT02509494|101261615|FG002|Overall Study|Physician Decision|0|||
33375841|NCT02509494|101261616|FG003|Overall Study|Physician Decision|0|||
33375842|NCT02509494|101261617|FG004|Overall Study|Physician Decision|0|||
33375843|NCT02509494|101261618|FG005|Overall Study|Physician Decision|0|||
33423755|NCT00265083|101443565|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
33423756|NCT00265083|101443563|FG000|Overall Study|Other|1|||
33423757|NCT00265083|101443564|FG001|Overall Study|Other|12|||
33646048|NCT01237899|102256303|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
33646049|NCT01182844|102256309|FG000|Overall Study|Withdrawal by Subject|0|||
33646050|NCT01182844|102256310|FG001|Overall Study|Withdrawal by Subject|2|||
33646051|NCT00904033|102256311|FG000|Overall Study|Withdrawal by Subject|1|||
33646052|NCT00904033|102256312|FG001|Overall Study|Withdrawal by Subject|1|||
33646053|NCT00904033|102256313|FG002|Overall Study|Withdrawal by Subject|0|||
33375844|NCT02509494|101261619|FG006|Overall Study|Physician Decision|0|||
33375845|NCT02509494|101261620|FG007|Overall Study|Physician Decision|0|||
33375846|NCT02509494|101261621|FG008|Overall Study|Physician Decision|0|||
33375847|NCT02509494|101261613|FG000|Overall Study|Withdrawal by Subject|4|||
33375848|NCT02509494|101261614|FG001|Overall Study|Withdrawal by Subject|17|||
33423758|NCT00265083|101443565|FG002|Overall Study|Other|9|||
33646054|NCT00904033|102256314|FG003|Overall Study|Withdrawal by Subject|0|||
33375849|NCT02509494|101261615|FG002|Overall Study|Withdrawal by Subject|7|||
33375850|NCT02509494|101261616|FG003|Overall Study|Withdrawal by Subject|5|||
33375851|NCT02509494|101261617|FG004|Overall Study|Withdrawal by Subject|0|||
33375852|NCT02509494|101261618|FG005|Overall Study|Withdrawal by Subject|6|||
33375853|NCT02509494|101261619|FG006|Overall Study|Withdrawal by Subject|1|||
33375854|NCT02509494|101261620|FG007|Overall Study|Withdrawal by Subject|2|||
33375855|NCT02509494|101261621|FG008|Overall Study|Withdrawal by Subject|1|||
33375856|NCT02509494|101261613|FG000|Overall Study|Death|0|||
33375857|NCT02509494|101261614|FG001|Overall Study|Death|1|||
33375858|NCT02509494|101261615|FG002|Overall Study|Death|0|||
33375859|NCT02509494|101261616|FG003|Overall Study|Death|0|||
33375860|NCT02509494|101261617|FG004|Overall Study|Death|1|||
33375861|NCT02509494|101261618|FG005|Overall Study|Death|0|||
33375862|NCT02509494|101261619|FG006|Overall Study|Death|0|||
33375863|NCT02509494|101261620|FG007|Overall Study|Death|1|||
33375864|NCT02509494|101261621|FG008|Overall Study|Death|0|||
33375865|NCT02509494|101261613|FG000|Overall Study|Other|0|||
33375866|NCT02509494|101261614|FG001|Overall Study|Other|4|||
33375867|NCT02509494|101261615|FG002|Overall Study|Other|5|||
33375868|NCT02509494|101261616|FG003|Overall Study|Other|0|||
33375869|NCT02509494|101261617|FG004|Overall Study|Other|0|||
33375870|NCT02509494|101261618|FG005|Overall Study|Other|0|||
33375871|NCT02509494|101261619|FG006|Overall Study|Other|0|||
33375872|NCT02509494|101261620|FG007|Overall Study|Other|0|||
33375873|NCT02509494|101261621|FG008|Overall Study|Other|0|||
33375874|NCT02509494|101261613|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33375875|NCT02509494|101261614|FG001|Overall Study|Non-Compliance With Study Drug|11|||
33375876|NCT02509494|101261615|FG002|Overall Study|Non-Compliance With Study Drug|7|||
33375877|NCT02509494|101261616|FG003|Overall Study|Non-Compliance With Study Drug|0|||
33585449|NCT02388165|102032646|FG000|Overall Study|Study terminated by sponsor|5|||
33585450|NCT02388165|102032647|FG001|Overall Study|Study terminated by sponsor|5|||
33246521|NCT00502593|100803793|FG005|Overall Study|Withdrawal by Subject|0|||
33246522|NCT00502593|100803794|FG006|Overall Study|Withdrawal by Subject|3|||
33246523|NCT00502593|100803795|FG007|Overall Study|Withdrawal by Subject|0|||
33246524|NCT00502593|100803796|FG008|Overall Study|Withdrawal by Subject|3|||
33246525|NCT00502593|100803797|FG009|Overall Study|Withdrawal by Subject|0|||
33246526|NCT00502593|100803798|FG010|Overall Study|Withdrawal by Subject|1|||
33246527|NCT00502593|100803799|FG011|Overall Study|Withdrawal by Subject|0|||
33246528|NCT00502593|100803788|FG000|Overall Study|Lost to Follow-up|2|||
33246529|NCT00502593|100803789|FG001|Overall Study|Lost to Follow-up|1|||
33246530|NCT00502593|100803790|FG002|Overall Study|Lost to Follow-up|1|||
33246531|NCT00502593|100803791|FG003|Overall Study|Lost to Follow-up|1|||
33246532|NCT00502593|100803792|FG004|Overall Study|Lost to Follow-up|0|||
33246533|NCT00502593|100803793|FG005|Overall Study|Lost to Follow-up|0|||
33246534|NCT00502593|100803794|FG006|Overall Study|Lost to Follow-up|0|||
33246535|NCT00502593|100803795|FG007|Overall Study|Lost to Follow-up|0|||
33246536|NCT00502593|100803796|FG008|Overall Study|Lost to Follow-up|3|||
33246537|NCT00502593|100803797|FG009|Overall Study|Lost to Follow-up|0|||
33246538|NCT00502593|100803798|FG010|Overall Study|Lost to Follow-up|1|||
33246539|NCT00502593|100803799|FG011|Overall Study|Lost to Follow-up|0|||
33246540|NCT03781804|100803801|FG000|Overall Study|Adverse Event|2|||
33246541|NCT03781804|100803802|FG001|Overall Study|Adverse Event|2|||
33246542|NCT03781804|100803803|FG002|Overall Study|Adverse Event|3|||
33246543|NCT03781804|100803801|FG000|Overall Study|Lost to Follow-up|1|||
33375878|NCT02509494|101261617|FG004|Overall Study|Non-Compliance With Study Drug|1|||
33375879|NCT02509494|101261618|FG005|Overall Study|Non-Compliance With Study Drug|2|||
33375880|NCT02509494|101261619|FG006|Overall Study|Non-Compliance With Study Drug|1|||
33375881|NCT02509494|101261620|FG007|Overall Study|Non-Compliance With Study Drug|1|||
33375882|NCT02509494|101261621|FG008|Overall Study|Non-Compliance With Study Drug|0|||
33585451|NCT02388165|102032646|FG000|Overall Study|Other|11|||
33585452|NCT02388165|102032647|FG001|Overall Study|Other|13|||
33585453|NCT02388165|102032646|FG000|Overall Study|No longer meet eligibility criteria|40|||
33585454|NCT02388165|102032647|FG001|Overall Study|No longer meet eligibility criteria|43|||
33585455|NCT02388165|102032646|FG000|Overall Study|Withdrawal of consent|31|||
33585456|NCT02388165|102032647|FG001|Overall Study|Withdrawal of consent|32|||
33585457|NCT02388165|102032646|FG000|Overall Study|Lost to Follow-up|19|||
33585458|NCT02388165|102032647|FG001|Overall Study|Lost to Follow-up|20|||
33585459|NCT02388165|102032646|FG000|Overall Study|Death|13|||
33246544|NCT03781804|100803802|FG001|Overall Study|Lost to Follow-up|1|||
33246545|NCT03781804|100803803|FG002|Overall Study|Lost to Follow-up|2|||
33246546|NCT03781804|100803801|FG000|Overall Study|Lack of Efficacy|4|||
33585460|NCT02388165|102032647|FG001|Overall Study|Death|10|||
33585461|NCT02388165|102032646|FG000|Overall Study|Adverse Event|3|||
33375883|NCT00622869|101261622|FG000|Overall Study|Subject Withdrew Consent|13|||
33585462|NCT02388165|102032647|FG001|Overall Study|Adverse Event|5|||
33375884|NCT00622869|101261623|FG001|Overall Study|Subject Withdrew Consent|17|||
33375885|NCT00622869|101261624|FG002|Overall Study|Subject Withdrew Consent|11|||
33375886|NCT00622869|101261622|FG000|Overall Study|Administrative Problems|11|||
33375887|NCT00622869|101261623|FG001|Overall Study|Administrative Problems|17|||
33375888|NCT00622869|101261624|FG002|Overall Study|Administrative Problems|13|||
33375889|NCT00622869|101261622|FG000|Overall Study|Death|12|||
33375890|NCT00622869|101261623|FG001|Overall Study|Death|15|||
33375891|NCT00622869|101261624|FG002|Overall Study|Death|10|||
33375892|NCT00622869|101261622|FG000|Overall Study|Lost to Follow-up|2|||
33375893|NCT00622869|101261623|FG001|Overall Study|Lost to Follow-up|4|||
33375894|NCT00622869|101261624|FG002|Overall Study|Lost to Follow-up|2|||
33375895|NCT00622869|101261622|FG000|Overall Study|Graft Loss|5|||
33375896|NCT00622869|101261623|FG001|Overall Study|Graft Loss|3|||
33375897|NCT00622869|101261624|FG002|Overall Study|Graft Loss|2|||
33375898|NCT00622869|101261622|FG000|Overall Study|Missing|0|||
33246547|NCT03781804|100803802|FG001|Overall Study|Lack of Efficacy|2|||
33246548|NCT03781804|100803803|FG002|Overall Study|Lack of Efficacy|9|||
33246549|NCT03781804|100803801|FG000|Overall Study|Protocol Violation|0|||
33246550|NCT03781804|100803802|FG001|Overall Study|Protocol Violation|0|||
33246551|NCT03781804|100803803|FG002|Overall Study|Protocol Violation|1|||
33246552|NCT03781804|100803801|FG000|Overall Study|Withdrawal by Subject|0|||
33246553|NCT03781804|100803802|FG001|Overall Study|Withdrawal by Subject|1|||
33246554|NCT03781804|100803803|FG002|Overall Study|Withdrawal by Subject|1|||
33246555|NCT03781804|100803801|FG000|Overall Study|Reason not provided|2|||
33246556|NCT03781804|100803802|FG001|Overall Study|Reason not provided|2|||
33246557|NCT03781804|100803803|FG002|Overall Study|Reason not provided|0|||
33246558|NCT01913340|100803804|FG000|Overall Study|Death|2|||
33246559|NCT01913340|100803805|FG001|Overall Study|Death|5|||
33246560|NCT01913340|100803804|FG000|Overall Study|Lost to Follow-up|1|||
33246561|NCT01913340|100803805|FG001|Overall Study|Lost to Follow-up|1|||
33246562|NCT03822351|100803807|FG000|Overall Study|Death|27|||
33246563|NCT03822351|100803808|FG001|Overall Study|Death|23|||
33246564|NCT03822351|100803809|FG002|Overall Study|Death|24|||
33246565|NCT03822351|100803807|FG000|Overall Study|Lost to Follow-up|6|||
33246566|NCT03822351|100803808|FG001|Overall Study|Lost to Follow-up|2|||
33246567|NCT03822351|100803809|FG002|Overall Study|Lost to Follow-up|1|||
33246568|NCT03822351|100803807|FG000|Overall Study|Withdrawal by Subject|10|||
33246569|NCT03822351|100803808|FG001|Overall Study|Withdrawal by Subject|4|||
33246570|NCT03822351|100803809|FG002|Overall Study|Withdrawal by Subject|6|||
33246571|NCT03822351|100803807|FG000|Overall Study|Progressive Disease|2|||
33246572|NCT03822351|100803808|FG001|Overall Study|Progressive Disease|1|||
33246573|NCT03822351|100803809|FG002|Overall Study|Progressive Disease|0|||
33246574|NCT03822351|100803807|FG000|Overall Study|Not Treated|1|||
33246575|NCT03822351|100803808|FG001|Overall Study|Not Treated|1|||
33246576|NCT03822351|100803809|FG002|Overall Study|Not Treated|1|||
33246577|NCT03383887|100803810|FG000|Overall Study|Lost to Follow-up|0|||
33246578|NCT03383887|100803811|FG001|Overall Study|Lost to Follow-up|1|||
33246579|NCT01250002|100803812|FG000|Overall Study|Change to open surgical procedure|4|||
33246580|NCT01250002|100803813|FG001|Overall Study|Change to open surgical procedure|3|||
33246581|NCT01740557|100803814|FG000|Overall Study|Ineligible|1|||
33246582|NCT01740557|100803814|FG000|Overall Study|Screen failure|1|||
33246583|NCT04163458|100803816|FG000|Overall Study|Protocol Deviation|7|||
33246584|NCT04163458|100803817|FG001|Overall Study|Protocol Deviation|13|||
33246585|NCT04163458|100803816|FG000|Overall Study|Adverse Event|5|||
33246586|NCT04163458|100803817|FG001|Overall Study|Adverse Event|8|||
33246587|NCT04163458|100803816|FG000|Overall Study|Due to COVID-19 pandemic|4|||
33246588|NCT04163458|100803817|FG001|Overall Study|Due to COVID-19 pandemic|2|||
33246589|NCT04163458|100803816|FG000|Overall Study|Participant withdrew consent|2|||
33246590|NCT04163458|100803817|FG001|Overall Study|Participant withdrew consent|3|||
33246591|NCT04163458|100803816|FG000|Overall Study|Randomization failure|2|||
33246592|NCT04163458|100803817|FG001|Overall Study|Randomization failure|2|||
33246593|NCT04163458|100803816|FG000|Overall Study|Other|4|||
33246594|NCT04163458|100803817|FG001|Overall Study|Other|2|||
33246595|NCT01007149|100803820|FG000|Overall Study|Administrative problems|0|||
33246596|NCT01007149|100803821|FG001|Overall Study|Administrative problems|1|||
33246597|NCT03006341|100803826|FG000|Overall Study|Not linked in the EMR|25069|||
33246598|NCT03006341|100803827|FG001|Overall Study|Not linked in the EMR|67505|||
33246599|NCT03006341|100803828|FG002|Overall Study|Not linked in the EMR|30993|||
33246600|NCT03006341|100803829|FG003|Overall Study|Not linked in the EMR|10685|||
33246601|NCT04697069|100803832|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
33246602|NCT04697069|100803833|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
33246603|NCT04697069|100803832|FG000|Overall Study|Study termination|2|||
33246604|NCT04697069|100803833|FG001|Overall Study|Study termination|1|||
33246605|NCT01704846|100803836|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33246606|NCT01704846|100803837|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33246607|NCT03213678|100803838|FG000|Overall Study|Death|1|||
33246608|NCT03213678|100803838|FG000|Overall Study|Physician Decision|1|||
33246609|NCT03213678|100803838|FG000|Overall Study|Progressive disease|16|||
33246610|NCT03098030|100803842|FG000|Overall Study|Death|10|||
33375899|NCT00622869|101261623|FG001|Overall Study|Missing|1|||
33246611|NCT03098030|100803843|FG001|Overall Study|Death|156|||
33246612|NCT03098030|100803844|FG002|Overall Study|Death|156|||
33246613|NCT03098030|100803845|FG003|Overall Study|Death|82|||
33375900|NCT00622869|101261624|FG002|Overall Study|Missing|1|||
33375901|NCT00138424|101261627|FG000|Overall Study|Physician Decision|0|||
33375902|NCT00138424|101261628|FG001|Overall Study|Physician Decision|1|||
33375903|NCT00138424|101261629|FG002|Overall Study|Physician Decision|0|||
33375904|NCT00138424|101261630|FG003|Overall Study|Physician Decision|0|||
33375905|NCT00165646|101261631|FG000|Overall Study|Adverse Event|1|||
33375906|NCT00165646|101261632|FG001|Overall Study|Adverse Event|1|||
33375907|NCT00165646|101261633|FG002|Overall Study|Adverse Event|1|||
33585463|NCT02388165|102032646|FG000|Overall Study|Did not meet entrance criteria|5|||
33585464|NCT02388165|102032647|FG001|Overall Study|Did not meet entrance criteria|2|||
33246614|NCT03098030|100803842|FG000|Overall Study|Withdrawal by Subject|0|||
33246615|NCT03098030|100803843|FG001|Overall Study|Withdrawal by Subject|7|||
33246616|NCT03098030|100803844|FG002|Overall Study|Withdrawal by Subject|8|||
33246617|NCT03098030|100803845|FG003|Overall Study|Withdrawal by Subject|2|||
33246618|NCT03098030|100803842|FG000|Overall Study|Lost to Follow-up|0|||
33246619|NCT03098030|100803843|FG001|Overall Study|Lost to Follow-up|0|||
33246620|NCT03098030|100803844|FG002|Overall Study|Lost to Follow-up|2|||
33246621|NCT03098030|100803845|FG003|Overall Study|Lost to Follow-up|1|||
33246622|NCT03210402|100803846|FG000|Overall Study|Withdrawal by Subject|0|||
33246623|NCT03210402|100803847|FG001|Overall Study|Withdrawal by Subject|1|||
33246624|NCT02322216|100803848|FG000|Overall Study|Adverse Event|1|||
33246625|NCT02322216|100803849|FG001|Overall Study|Adverse Event|0|||
33246626|NCT02322216|100803848|FG000|Overall Study|Withdrawal by Subject|1|||
33246627|NCT02322216|100803849|FG001|Overall Study|Withdrawal by Subject|4|||
33246628|NCT01560949|100803850|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
33246629|NCT01560949|100803850|FG000|Surgery Phase|Physician Decision|3|||
33246630|NCT01720446|100803859|FG000|Overall Study|Lost to Follow-up|12|||
33246631|NCT01720446|100803860|FG001|Overall Study|Lost to Follow-up|6|||
33246632|NCT01720446|100803861|FG002|Overall Study|Lost to Follow-up|16|||
33246633|NCT01720446|100803862|FG003|Overall Study|Lost to Follow-up|16|||
33246634|NCT01720446|100803859|FG000|Overall Study|Withdrawal by Subject|2|||
33246635|NCT01720446|100803860|FG001|Overall Study|Withdrawal by Subject|5|||
33246636|NCT01720446|100803861|FG002|Overall Study|Withdrawal by Subject|4|||
33246637|NCT01720446|100803862|FG003|Overall Study|Withdrawal by Subject|4|||
33246638|NCT01195675|100803863|FG000|Overall Study|Adverse Event|1|||
33246639|NCT01195675|100803863|FG000|Overall Study|Withdrawal by Subject|2|||
33246640|NCT03721016|100803864|FG000|Overall Study|Adverse Event|0|||
33246641|NCT03721016|100803865|FG001|Overall Study|Adverse Event|1|||
33246642|NCT03721016|100803866|FG002|Overall Study|Adverse Event|1|||
33246643|NCT03721016|100803864|FG000|Overall Study|Withdrawal by Subject|8|||
33246644|NCT03721016|100803865|FG001|Overall Study|Withdrawal by Subject|16|||
33246645|NCT03721016|100803866|FG002|Overall Study|Withdrawal by Subject|13|||
33585465|NCT00958360|102032652|FG000|Overall Study|Withdrawal by Subject|3|||
33585466|NCT00958360|102032653|FG001|Overall Study|Withdrawal by Subject|1|||
33585467|NCT00958360|102032652|FG000|Overall Study|Death|6|||
33585468|NCT00958360|102032653|FG001|Overall Study|Death|7|||
33246646|NCT03721016|100803864|FG000|Overall Study|Lost to Follow-up|4|||
33246647|NCT03721016|100803865|FG001|Overall Study|Lost to Follow-up|6|||
33246648|NCT03721016|100803866|FG002|Overall Study|Lost to Follow-up|5|||
33246649|NCT03721016|100803864|FG000|Overall Study|Physician Decision|0|||
33246650|NCT03721016|100803865|FG001|Overall Study|Physician Decision|1|||
33246651|NCT03721016|100803866|FG002|Overall Study|Physician Decision|2|||
33246652|NCT03721016|100803864|FG000|Overall Study|Protocol Violation|0|||
33246653|NCT03721016|100803865|FG001|Overall Study|Protocol Violation|1|||
33246654|NCT03721016|100803866|FG002|Overall Study|Protocol Violation|0|||
33246655|NCT03721016|100803864|FG000|Overall Study|Site terminated by sponsor|3|||
33246656|NCT03721016|100803865|FG001|Overall Study|Site terminated by sponsor|7|||
33246657|NCT03721016|100803866|FG002|Overall Study|Site terminated by sponsor|6|||
33246658|NCT03721016|100803864|FG000|Overall Study|Subject exited early due to COVID-19|1|||
33246659|NCT03721016|100803865|FG001|Overall Study|Subject exited early due to COVID-19|0|||
33246660|NCT03721016|100803866|FG002|Overall Study|Subject exited early due to COVID-19|0|||
33585469|NCT00958360|102032652|FG000|Overall Study|Physician Decision|2|||
33246661|NCT03593070|100803867|FG000|Overall Study|administrative withdrawal|1|||
33246662|NCT03593070|100803868|FG001|Overall Study|administrative withdrawal|1|||
33246663|NCT03586544|100803869|FG000|First Intervention|Adverse Event|0|||
33246664|NCT03586544|100803870|FG001|First Intervention|Adverse Event|1|||
33246665|NCT03586544|100803869|FG000|Second Intervention|Withdrawal by Subject|0|||
33246666|NCT03586544|100803870|FG001|Second Intervention|Withdrawal by Subject|1|||
33246667|NCT02824432|100803871|FG000|Overall Study|Major Protocol Deviation|1|||
33246668|NCT02824432|100803872|FG001|Overall Study|Major Protocol Deviation|0|||
33246669|NCT02954055|100803875|FG000|Overall Study|Did not initiate therapy|6|||
33246670|NCT02954055|100803876|FG001|Overall Study|Did not initiate therapy|1|||
33375908|NCT00165646|101261631|FG000|Overall Study|Lack of Efficacy|1|||
33246671|NCT02974010|100803877|FG000|Overall Study|Lost to Follow-up|3|||
33246672|NCT02974010|100803878|FG001|Overall Study|Lost to Follow-up|1|||
33246673|NCT02974010|100803879|FG002|Overall Study|Lost to Follow-up|0|||
33585470|NCT00958360|102032653|FG001|Overall Study|Physician Decision|1|||
33585471|NCT00958360|102032652|FG000|Overall Study|Lost to Follow-up|0|||
33585472|NCT00958360|102032653|FG001|Overall Study|Lost to Follow-up|1|||
33246674|NCT02974010|100803880|FG003|Overall Study|Lost to Follow-up|0|||
33246675|NCT02974010|100803877|FG000|Overall Study|Withdrawal by Subject|2|||
33246676|NCT02974010|100803878|FG001|Overall Study|Withdrawal by Subject|1|||
33246677|NCT02974010|100803879|FG002|Overall Study|Withdrawal by Subject|0|||
33423759|NCT01726335|101443567|FG000|Overall Study|Lost to Follow-up|2|||
33423760|NCT01726335|101443567|FG000|Overall Study|Withdrawal by Subject|15|||
33423761|NCT01726335|101443567|FG000|Overall Study|Adverse Event|4|||
33423762|NCT01726335|101443567|FG000|Overall Study|Lost to Follow-up|2|||
33423763|NCT01726335|101443567|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
33423764|NCT01205529|101443568|FG000|Overall Study|Procedure Cancelled|4|||
33423765|NCT01205529|101443568|FG000|Overall Study|Withdrawal by Subject|2|||
33423766|NCT01205529|101443568|FG000|Overall Study|Physician Decision|4|||
33423767|NCT01205529|101443568|FG000|Overall Study|Unstable post op|15|||
33423768|NCT01205529|101443568|FG000|Overall Study|No longer met criteria|30|||
33423769|NCT02230085|101443569|FG000|Overall Study|Physician Decision|1|||
33246678|NCT02974010|100803880|FG003|Overall Study|Withdrawal by Subject|0|||
33246679|NCT02974010|100803877|FG000|Overall Study|Adverse Event|0|||
33423770|NCT02230085|101443569|FG000|Overall Study|Withdrawal by Subject|3|||
33423771|NCT04060654|101443570|FG000|Overall Study|Withdrawal by Subject|1|||
33423772|NCT04060654|101443570|FG000|Overall Study|Lost to Follow-up|5|||
33423773|NCT00363129|101443571|FG000|Overall Study|Withdrawal by Subject|11|||
33423774|NCT00363129|101443572|FG001|Overall Study|Withdrawal by Subject|18|||
33423775|NCT00363129|101443571|FG000|Overall Study|Adverse Event|8|||
33423776|NCT00363129|101443572|FG001|Overall Study|Adverse Event|3|||
33423777|NCT00363129|101443571|FG000|Overall Study|Alternate Treatment|2|||
33423778|NCT00363129|101443572|FG001|Overall Study|Alternate Treatment|4|||
33423779|NCT00363129|101443571|FG000|Overall Study|Other Medical Problems|2|||
33423780|NCT00363129|101443572|FG001|Overall Study|Other Medical Problems|4|||
33423781|NCT00363129|101443571|FG000|Overall Study|Death|0|||
33423782|NCT00363129|101443572|FG001|Overall Study|Death|1|||
33423783|NCT00363129|101443571|FG000|Overall Study|Other Reasons|6|||
33423784|NCT00363129|101443572|FG001|Overall Study|Other Reasons|3|||
33423785|NCT04603937|101443573|FG000|Overall Study|Adverse Event|9|||
33423786|NCT04603937|101443574|FG001|Overall Study|Adverse Event|10|||
33423787|NCT04603937|101443573|FG000|Overall Study|Withdrawal by Subject|7|||
33585473|NCT02397915|102032654|FG000|Period 1|Protocol Violation|0|||
33585474|NCT02397915|102032655|FG001|Period 1|Protocol Violation|1|||
33246680|NCT02974010|100803878|FG001|Overall Study|Adverse Event|1|||
33246681|NCT02974010|100803879|FG002|Overall Study|Adverse Event|0|||
33246682|NCT02974010|100803880|FG003|Overall Study|Adverse Event|0|||
33246683|NCT02974010|100803877|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
33246684|NCT02974010|100803878|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
33246685|NCT02974010|100803879|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
33246686|NCT02974010|100803880|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
33246687|NCT02974010|100803877|FG000|Overall Study|Lack of Efficacy|0|||
33246688|NCT02974010|100803878|FG001|Overall Study|Lack of Efficacy|0|||
33246689|NCT02974010|100803879|FG002|Overall Study|Lack of Efficacy|1|||
33246690|NCT02974010|100803880|FG003|Overall Study|Lack of Efficacy|0|||
33246691|NCT00711646|100803881|FG000|Overall Study|Adverse Event|6|||
33246692|NCT00711646|100803882|FG001|Overall Study|Adverse Event|1|||
33246693|NCT00711646|100803881|FG000|Overall Study|Withdrawal by Subject|4|||
33246694|NCT00711646|100803882|FG001|Overall Study|Withdrawal by Subject|0|||
33246695|NCT00711646|100803881|FG000|Overall Study|Protocol Violation|0|||
33246696|NCT00711646|100803882|FG001|Overall Study|Protocol Violation|1|||
33246697|NCT00711646|100803881|FG000|Overall Study|Lost to Follow-up|1|||
33246698|NCT00711646|100803882|FG001|Overall Study|Lost to Follow-up|0|||
33246699|NCT00711646|100803881|FG000|Overall Study|administrative decision|0|||
33375909|NCT00165646|101261632|FG001|Overall Study|Lack of Efficacy|2|||
33375910|NCT00165646|101261633|FG002|Overall Study|Lack of Efficacy|0|||
33423788|NCT04603937|101443574|FG001|Overall Study|Withdrawal by Subject|6|||
33423789|NCT04603937|101443573|FG000|Overall Study|Lost to Follow-up|5|||
33423790|NCT04603937|101443574|FG001|Overall Study|Lost to Follow-up|6|||
33585475|NCT02397915|102032656|FG002|Period 1|Protocol Violation|0|||
33585476|NCT02397915|102032657|FG003|Period 1|Protocol Violation|0|||
33585477|NCT02397915|102032654|FG000|Period 1|Physician Decision|1|||
33585478|NCT02397915|102032655|FG001|Period 1|Physician Decision|0|||
33585479|NCT02397915|102032656|FG002|Period 1|Physician Decision|0|||
33585480|NCT02397915|102032657|FG003|Period 1|Physician Decision|0|||
33585481|NCT00293813|102032659|FG000|Overall Study|Physician Decision|0|||
33585482|NCT00293813|102032660|FG001|Overall Study|Physician Decision|1|||
33423791|NCT04603937|101443573|FG000|Overall Study|Physician Decision|0|||
33423792|NCT04603937|101443574|FG001|Overall Study|Physician Decision|1|||
33423793|NCT04603937|101443573|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
33585483|NCT00293813|102032661|FG002|Overall Study|Physician Decision|0|||
33585484|NCT00293813|102032659|FG000|Overall Study|Adverse Event|3|||
33585485|NCT00293813|102032660|FG001|Overall Study|Adverse Event|1|||
33423794|NCT04603937|101443574|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
33246700|NCT00711646|100803882|FG001|Overall Study|administrative decision|1|||
33246701|NCT00711646|100803881|FG000|Overall Study|patient non-compliance|1|||
33246702|NCT00711646|100803882|FG001|Overall Study|patient non-compliance|0|||
33246703|NCT03852433|100803883|FG000|Overall Study|Withdrawal of consent|5|||
33246704|NCT03852433|100803884|FG001|Overall Study|Withdrawal of consent|8|||
33246705|NCT03852433|100803885|FG002|Overall Study|Withdrawal of consent|1|||
33246706|NCT03852433|100803886|FG003|Overall Study|Withdrawal of consent|1|||
33246707|NCT03852433|100803883|FG000|Overall Study|Adverse Event|1|||
33246708|NCT03852433|100803884|FG001|Overall Study|Adverse Event|1|||
33423795|NCT01430104|101443575|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
33423796|NCT02444182|101443588|FG000|Overall Study|non-compliance|2|||
33423797|NCT02444182|101443589|FG001|Overall Study|non-compliance|1|||
33423798|NCT02444182|101443588|FG000|Overall Study|Lost to Follow-up|0|||
33423799|NCT02444182|101443589|FG001|Overall Study|Lost to Follow-up|4|||
33423800|NCT03836729|101443594|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
33423801|NCT02209454|101443595|FG000|Second Period|Adverse Event|1|||
33423802|NCT02209454|101443596|FG001|Second Period|Adverse Event|0|||
33423803|NCT01271933|101443597|FG000|Single-Blind Phase|Lack of Efficacy|37|||
33423804|NCT01271933|101443598|FG001|Single-Blind Phase|Lack of Efficacy|0|||
33585486|NCT00293813|102032661|FG002|Overall Study|Adverse Event|1|||
33585487|NCT00293813|102032659|FG000|Overall Study|Withdrawal by Subject|7|||
33585488|NCT00293813|102032660|FG001|Overall Study|Withdrawal by Subject|4|||
33585489|NCT00293813|102032661|FG002|Overall Study|Withdrawal by Subject|4|||
33585490|NCT00293813|102032659|FG000|Overall Study|Lost to Follow-up|3|||
33585491|NCT00293813|102032660|FG001|Overall Study|Lost to Follow-up|2|||
33585492|NCT00293813|102032661|FG002|Overall Study|Lost to Follow-up|3|||
33585493|NCT00293813|102032659|FG000|Overall Study|Noncompliance|0|||
33585494|NCT00293813|102032660|FG001|Overall Study|Noncompliance|1|||
33585495|NCT00293813|102032661|FG002|Overall Study|Noncompliance|0|||
33585496|NCT01208324|102032670|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
33585497|NCT01208324|102032671|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
33585498|NCT01208324|102032672|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
33646055|NCT00904033|102256311|FG000|Overall Study|Physician Decision|0|||
33646056|NCT00904033|102256312|FG001|Overall Study|Physician Decision|0|||
33646057|NCT00904033|102256313|FG002|Overall Study|Physician Decision|1|||
33646058|NCT00904033|102256314|FG003|Overall Study|Physician Decision|0|||
33646059|NCT00904033|102256311|FG000|Overall Study|Unable to obtain final blood draw|0|||
33646060|NCT00904033|102256312|FG001|Overall Study|Unable to obtain final blood draw|0|||
33646061|NCT00904033|102256313|FG002|Overall Study|Unable to obtain final blood draw|0|||
33646062|NCT00904033|102256314|FG003|Overall Study|Unable to obtain final blood draw|2|||
33646063|NCT02175199|102256315|FG000|Overall Study|Withdrawal by Subject|1|||
33646064|NCT02175199|102256316|FG001|Overall Study|Withdrawal by Subject|5|||
33646065|NCT02175199|102256315|FG000|Overall Study|Randomized in Error|1|||
33646066|NCT02175199|102256316|FG001|Overall Study|Randomized in Error|0|||
33646067|NCT02175199|102256315|FG000|Overall Study|Sponsor Decision|1|||
33646068|NCT02175199|102256316|FG001|Overall Study|Sponsor Decision|0|||
33646069|NCT00612807|102256317|FG000|Overall Study|Withdrawal by Subject|2|||
33646070|NCT00612807|102256318|FG001|Overall Study|Withdrawal by Subject|0|||
33646071|NCT01086358|102256319|FG000|First Intervention|Lost to Follow-up|9|||
33646072|NCT01086358|102256320|FG001|First Intervention|Lost to Follow-up|4|||
33646073|NCT01086358|102256319|FG000|First Intervention|Withdrawal by Subject|0|||
33646074|NCT01086358|102256320|FG001|First Intervention|Withdrawal by Subject|1|||
33646075|NCT01086358|102256319|FG000|Second Intervention|Lost to Follow-up|4|||
33646076|NCT01086358|102256320|FG001|Second Intervention|Lost to Follow-up|4|||
33646077|NCT03073733|102256321|FG000|Overall Study|Lost to Follow-up|1|||
33646078|NCT03073733|102256322|FG001|Overall Study|Lost to Follow-up|0|||
33646079|NCT03073733|102256323|FG002|Overall Study|Lost to Follow-up|0|||
33646080|NCT03073733|102256321|FG000|Overall Study|Physician Decision|0|||
33646081|NCT03073733|102256322|FG001|Overall Study|Physician Decision|1|||
33646082|NCT03073733|102256323|FG002|Overall Study|Physician Decision|0|||
33646083|NCT03073733|102256321|FG000|Overall Study|Withdrawal by Subject|0|||
33646084|NCT03073733|102256322|FG001|Overall Study|Withdrawal by Subject|0|||
33148614|NCT00378105|100458195|FG000|Overall Study|Death|1|||
33148615|NCT00378105|100458196|FG001|Overall Study|Death|0|||
33148616|NCT00378105|100458195|FG000|Overall Study|Going to transplant|7|||
33148617|NCT00378105|100458196|FG001|Overall Study|Going to transplant|8|||
33246709|NCT03852433|100803885|FG002|Overall Study|Adverse Event|1|||
33423805|NCT01271933|101443599|FG002|Single-Blind Phase|Lack of Efficacy|0|||
33585499|NCT01208324|102032673|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
33585500|NCT01523743|102032674|FG000|Period 1|Adverse Event|1|||
33585501|NCT01523743|102032675|FG001|Period 1|Adverse Event|0|||
33646085|NCT03073733|102256323|FG002|Overall Study|Withdrawal by Subject|1|||
33646086|NCT00702715|102256324|FG000|Overall Study|Lost to Follow-up|1|||
33646087|NCT00702715|102256325|FG001|Overall Study|Lost to Follow-up|0|||
33646088|NCT01097005|102256326|FG000|Overall Study|Case Report Form not collected|18|||
33646089|NCT01097005|102256326|FG000|Overall Study|Subjects cannot visit the hospital|1|||
33646090|NCT01097005|102256326|FG000|Overall Study|Poor medication compliance|1|||
33585502|NCT01523743|102032674|FG000|Period 1|Withdrawal by Subject|6|||
33585503|NCT01523743|102032675|FG001|Period 1|Withdrawal by Subject|2|||
33585504|NCT01523743|102032674|FG000|Period 1|Lost to Follow-up|1|||
33585505|NCT01523743|102032675|FG001|Period 1|Lost to Follow-up|0|||
33585506|NCT01523743|102032674|FG000|Period 1|Lack of Efficacy|1|||
33585507|NCT01523743|102032675|FG001|Period 1|Lack of Efficacy|0|||
33585508|NCT01523743|102032674|FG000|Period 1|Felt unable to empty bladder|1|||
33585509|NCT01523743|102032675|FG001|Period 1|Felt unable to empty bladder|0|||
33585510|NCT01523743|102032674|FG000|Period 2|Withdrawal by Subject|0|||
33585511|NCT01523743|102032675|FG001|Period 2|Withdrawal by Subject|2|||
33585512|NCT01523743|102032674|FG000|Period 2|Adverse Event|1|||
33585513|NCT01523743|102032675|FG001|Period 2|Adverse Event|0|||
33585514|NCT01645735|102032676|FG000|Overall Study|Physician Decision|2|||
33585515|NCT01645735|102032677|FG001|Overall Study|Physician Decision|0|||
33585516|NCT01645735|102032676|FG000|Overall Study|Withdrawal by Subject|1|||
33585517|NCT01645735|102032677|FG001|Overall Study|Withdrawal by Subject|0|||
33585518|NCT01645735|102032676|FG000|Overall Study|Protocol Violation|1|||
33585519|NCT01645735|102032677|FG001|Overall Study|Protocol Violation|0|||
33585520|NCT01645735|102032676|FG000|Overall Study|Adverse Event|0|||
33585521|NCT01645735|102032677|FG001|Overall Study|Adverse Event|1|||
33585522|NCT03370419|102032686|FG000|Overall Study|Lost to Follow-up|16|||
33585523|NCT01642901|102032687|FG000|12-month Follow-up|Withdrawal by Subject|1|||
33585524|NCT01642901|102032688|FG001|12-month Follow-up|Withdrawal by Subject|0|||
33585525|NCT03846427|102032689|FG000|Overall Study|Death|13|||
33585526|NCT03846427|102032689|FG000|Overall Study|Withdrawal by Subject|3|||
33585527|NCT03846427|102032689|FG000|Overall Study|Physician Decision|1|||
33585528|NCT00635349|102032690|FG000|Overall Study|Other|8|||
33585529|NCT00635349|102032691|FG001|Overall Study|Other|6|||
33585530|NCT00635349|102032690|FG000|Overall Study|Protocol Violation|18|||
33585531|NCT00635349|102032691|FG001|Overall Study|Protocol Violation|22|||
33585532|NCT00635349|102032690|FG000|Overall Study|Withdrawal by Subject|3|||
33585533|NCT00635349|102032691|FG001|Overall Study|Withdrawal by Subject|8|||
33585534|NCT00635349|102032690|FG000|Overall Study|Lost to Follow-up|4|||
33585535|NCT00635349|102032691|FG001|Overall Study|Lost to Follow-up|3|||
33585536|NCT00635349|102032690|FG000|Overall Study|Adverse Event|11|||
33585537|NCT00635349|102032691|FG001|Overall Study|Adverse Event|9|||
33585538|NCT00576628|102032692|FG000|Overall Study|Adverse Event|11|||
33585539|NCT00576628|102032692|FG000|Overall Study|Death|2|||
33585540|NCT00576628|102032692|FG000|Overall Study|Failure to return|1|||
33585541|NCT00576628|102032692|FG000|Overall Study|Refused Treatment|8|||
33585542|NCT00576628|102032692|FG000|Overall Study|Pregnancy|1|||
33585543|NCT00576628|102032692|FG000|Overall Study|RBC transfusion|1|||
33585544|NCT00576628|102032692|FG000|Overall Study|Progression of Kidney Disease|1|||
33585545|NCT00576628|102032692|FG000|Overall Study|Progression of Renal Failure|1|||
33585546|NCT00576628|102032692|FG000|Overall Study|The patient move into other town|1|||
33585547|NCT00576628|102032692|FG000|Overall Study|Transplantation|1|||
33585548|NCT00576628|102032692|FG000|Overall Study|Dialysis|15|||
33585549|NCT03802630|102032696|FG000|Overall Study|Study terminated by sponsor|130|||
33585550|NCT03802630|102032697|FG001|Overall Study|Study terminated by sponsor|134|||
33585551|NCT03802630|102032696|FG000|Overall Study|Subject decision|16|||
33585552|NCT03802630|102032697|FG001|Overall Study|Subject decision|9|||
33585553|NCT03802630|102032696|FG000|Overall Study|Adverse Event|3|||
33585554|NCT03802630|102032697|FG001|Overall Study|Adverse Event|1|||
33585555|NCT03802630|102032696|FG000|Overall Study|Lost to Follow-up|2|||
33585556|NCT03802630|102032697|FG001|Overall Study|Lost to Follow-up|2|||
33585557|NCT03802630|102032696|FG000|Overall Study|Physician Decision|2|||
33585558|NCT03802630|102032697|FG001|Overall Study|Physician Decision|0|||
33585559|NCT03802630|102032696|FG000|Overall Study|Death|0|||
33585560|NCT03802630|102032697|FG001|Overall Study|Death|2|||
33585561|NCT01221753|102032698|FG000|Overall Study|Adverse Event|1|||
33585562|NCT03604172|102032699|FG000|Overall Study|Lost to Follow-up|1|||
33585563|NCT03604172|102032700|FG001|Overall Study|Lost to Follow-up|2|||
33585564|NCT02097719|102032701|FG000|Overall Study|Subject Withdrew Consent|1|||
33585565|NCT02097719|102032702|FG001|Overall Study|Subject Withdrew Consent|0|||
33585566|NCT02097719|102032701|FG000|Overall Study|Lost to Follow-up|0|||
33646091|NCT01097005|102256326|FG000|Overall Study|No examination data available|244|||
33375911|NCT00165646|101261631|FG000|Overall Study|Withdrawal by Subject|0|||
33375912|NCT00165646|101261632|FG001|Overall Study|Withdrawal by Subject|2|||
33375913|NCT00165646|101261633|FG002|Overall Study|Withdrawal by Subject|1|||
33375914|NCT00165646|101261631|FG000|Overall Study|Physician Decision|2|||
33375915|NCT00165646|101261632|FG001|Overall Study|Physician Decision|0|||
33375916|NCT00165646|101261633|FG002|Overall Study|Physician Decision|2|||
33375917|NCT00165646|101261631|FG000|Overall Study|Protocol Violation|1|||
33585567|NCT02097719|102032702|FG001|Overall Study|Lost to Follow-up|1|||
33585568|NCT02097719|102032701|FG000|Overall Study|Adverse Event|2|||
33585569|NCT02097719|102032702|FG001|Overall Study|Adverse Event|0|||
33585570|NCT01701362|102032708|FG000|Overall Study|Adverse events not related to study drug|1|||
33585571|NCT01701362|102032709|FG001|Overall Study|Adverse events not related to study drug|6|||
33585572|NCT01701362|102032708|FG000|Overall Study|Adverse events related to study drug|12|||
33646092|NCT01097005|102256326|FG000|Overall Study|Deviation from exclusion criteria|37|||
33646093|NCT01097005|102256326|FG000|Overall Study|Adverse Event|14|||
33646094|NCT01097005|102256326|FG000|Overall Study|Discontinuance by complication|50|||
33646095|NCT00934440|102256331|FG000|Overall Study|Lost to Follow-up|1|||
33646096|NCT01947855|102256332|FG000|Overall Study|Withdrawal by Subject|1|||
33646097|NCT01947855|102256333|FG001|Overall Study|Withdrawal by Subject|0|||
33646098|NCT01947855|102256334|FG002|Overall Study|Withdrawal by Subject|0|||
33646099|NCT00275340|102256337|FG000|Overall Study|Lost to Follow-up|2|||
33646100|NCT00275340|102256338|FG001|Overall Study|Lost to Follow-up|4|||
33646101|NCT01864005|102256340|FG000|Overall Study|Protocol Violation|0|||
33646102|NCT01864005|102256341|FG001|Overall Study|Protocol Violation|1|||
33646103|NCT01864005|102256340|FG000|Overall Study|Withdrawal by Subject|0|||
33646104|NCT01864005|102256341|FG001|Overall Study|Withdrawal by Subject|1|||
33646105|NCT01864005|102256340|FG000|Overall Study|Incorrect enrolment|1|||
33646106|NCT01864005|102256341|FG001|Overall Study|Incorrect enrolment|0|||
33646107|NCT01864005|102256340|FG000|Overall Study|Disease need|1|||
33646108|NCT01864005|102256341|FG001|Overall Study|Disease need|1|||
33148618|NCT00378105|100458195|FG000|Overall Study|Progressive disease|3|||
33148619|NCT00378105|100458196|FG001|Overall Study|Progressive disease|3|||
33246710|NCT03852433|100803886|FG003|Overall Study|Adverse Event|1|||
33246711|NCT03852433|100803883|FG000|Overall Study|Lost to Follow-up|0|||
33246712|NCT03852433|100803884|FG001|Overall Study|Lost to Follow-up|1|||
33246713|NCT03852433|100803885|FG002|Overall Study|Lost to Follow-up|0|||
33375918|NCT00165646|101261632|FG001|Overall Study|Protocol Violation|0|||
33375919|NCT00165646|101261633|FG002|Overall Study|Protocol Violation|0|||
33375920|NCT00916370|101261639|FG000|Overall Study|Death|3|||
33585573|NCT01701362|102032709|FG001|Overall Study|Adverse events related to study drug|10|||
33585574|NCT01701362|102032708|FG000|Overall Study|Protocol Violation|5|||
33585575|NCT01701362|102032709|FG001|Overall Study|Protocol Violation|3|||
33585576|NCT01701362|102032708|FG000|Overall Study|No longer willing to participate|8|||
33585577|NCT01701362|102032709|FG001|Overall Study|No longer willing to participate|14|||
33585578|NCT01701362|102032708|FG000|Overall Study|Lost to Follow-up|6|||
33585579|NCT01701362|102032709|FG001|Overall Study|Lost to Follow-up|9|||
33585580|NCT01701362|102032708|FG000|Overall Study|Insufficient clinical response|6|||
33585581|NCT01701362|102032709|FG001|Overall Study|Insufficient clinical response|6|||
33585582|NCT01701362|102032708|FG000|Overall Study|Death|0|||
33585583|NCT01701362|102032709|FG001|Overall Study|Death|1|||
33585584|NCT01701362|102032708|FG000|Overall Study|Randomized but not treated|1|||
33585585|NCT01701362|102032709|FG001|Overall Study|Randomized but not treated|2|||
33585586|NCT01701362|102032708|FG000|Overall Study|Reasons other than those mentioned above|3|||
33585587|NCT01701362|102032709|FG001|Overall Study|Reasons other than those mentioned above|5|||
33585588|NCT05002985|102032711|FG000|Overall Study|Withdrawal by Subject|1|||
33585589|NCT01681186|102032712|FG000|Washout Period From Second Intervention|Adverse Event|0|||
33585590|NCT01681186|102032713|FG001|Washout Period From Second Intervention|Adverse Event|0|||
33585591|NCT01681186|102032714|FG002|Washout Period From Second Intervention|Adverse Event|0|||
33585592|NCT01681186|102032715|FG003|Washout Period From Second Intervention|Adverse Event|0|||
33585593|NCT01681186|102032716|FG004|Washout Period From Second Intervention|Adverse Event|0|||
33585594|NCT01681186|102032717|FG005|Washout Period From Second Intervention|Adverse Event|0|||
33585595|NCT01681186|102032718|FG006|Washout Period From Second Intervention|Adverse Event|1|||
33585596|NCT01681186|102032719|FG007|Washout Period From Second Intervention|Adverse Event|0|||
33585597|NCT01681186|102032712|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
33585598|NCT01681186|102032713|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
33585599|NCT01681186|102032714|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
33585600|NCT01681186|102032715|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
33646109|NCT01864005|102256340|FG000|Overall Study|Need GP IIb/IIIa|1|||
33646110|NCT01864005|102256341|FG001|Overall Study|Need GP IIb/IIIa|3|||
33646111|NCT02147561|102256342|FG000|Overall Study|Lost to Follow-up|3|||
33375921|NCT00916370|101261640|FG001|Overall Study|Death|1|||
33375922|NCT00916370|101261639|FG000|Overall Study|Withdrawal by Subject|2|||
33375923|NCT00916370|101261640|FG001|Overall Study|Withdrawal by Subject|0|||
33375924|NCT00916370|101261639|FG000|Overall Study|Physician Decision|0|||
33375925|NCT00916370|101261640|FG001|Overall Study|Physician Decision|1|||
33375926|NCT01346371|101261641|FG000|Overall Study|Lost to Follow-up|2|||
33375927|NCT01346371|101261642|FG001|Overall Study|Lost to Follow-up|0|||
33585601|NCT01681186|102032716|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
33646112|NCT02147561|102256342|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
33646113|NCT01305577|102256343|FG000|Overall Study|Adverse Event|2|||
33646114|NCT01305577|102256344|FG001|Overall Study|Adverse Event|2|||
33646115|NCT01305577|102256345|FG002|Overall Study|Adverse Event|1|||
33646116|NCT01305577|102256343|FG000|Overall Study|Withdrawal by Subject|7|||
33148620|NCT00378105|100458195|FG000|Overall Study|remain on study|3|||
33246714|NCT03852433|100803886|FG003|Overall Study|Lost to Follow-up|1|||
33246715|NCT03852433|100803883|FG000|Overall Study|Pregnancy|0|||
33375928|NCT02554253|101261643|FG000|Overall Study|ineligible after enrollment|1|||
33375929|NCT02554253|101261644|FG001|Overall Study|ineligible after enrollment|0|||
33646117|NCT01305577|102256344|FG001|Overall Study|Withdrawal by Subject|5|||
33646118|NCT01305577|102256345|FG002|Overall Study|Withdrawal by Subject|6|||
33646119|NCT01305577|102256343|FG000|Overall Study|Lost to Follow-up|4|||
33646120|NCT01305577|102256344|FG001|Overall Study|Lost to Follow-up|3|||
33646121|NCT01305577|102256345|FG002|Overall Study|Lost to Follow-up|2|||
33646122|NCT01305577|102256343|FG000|Overall Study|Protocol Deviation|0|||
33646123|NCT01305577|102256344|FG001|Overall Study|Protocol Deviation|1|||
33646124|NCT01305577|102256345|FG002|Overall Study|Protocol Deviation|1|||
33646125|NCT02529553|102256347|FG000|Overall Study|Progressive Disease|1|||
33646126|NCT02529553|102256348|FG001|Overall Study|Progressive Disease|0|||
33646127|NCT02529553|102256349|FG002|Overall Study|Progressive Disease|1|||
33646128|NCT02529553|102256350|FG003|Overall Study|Progressive Disease|3|||
33646129|NCT02529553|102256351|FG004|Overall Study|Progressive Disease|2|||
33646130|NCT02529553|102256352|FG005|Overall Study|Progressive Disease|3|||
33646131|NCT02529553|102256353|FG006|Overall Study|Progressive Disease|3|||
33646132|NCT02529553|102256354|FG007|Overall Study|Progressive Disease|5|||
33646133|NCT02529553|102256355|FG008|Overall Study|Progressive Disease|3|||
33646134|NCT02529553|102256347|FG000|Overall Study|Physician Decision|0|||
33646135|NCT02529553|102256348|FG001|Overall Study|Physician Decision|1|||
33585602|NCT01681186|102032717|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
33585603|NCT01681186|102032718|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
33585604|NCT01681186|102032719|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
33585605|NCT01681186|102032712|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
33585606|NCT01681186|102032713|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
33585607|NCT01681186|102032714|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
33585608|NCT01681186|102032715|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
33585609|NCT01681186|102032716|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
33646136|NCT02529553|102256349|FG002|Overall Study|Physician Decision|0|||
33646137|NCT02529553|102256350|FG003|Overall Study|Physician Decision|0|||
33646138|NCT02529553|102256351|FG004|Overall Study|Physician Decision|1|||
33646139|NCT02529553|102256352|FG005|Overall Study|Physician Decision|0|||
33646140|NCT02529553|102256353|FG006|Overall Study|Physician Decision|0|||
33646141|NCT02529553|102256354|FG007|Overall Study|Physician Decision|0|||
33646142|NCT02529553|102256355|FG008|Overall Study|Physician Decision|0|||
33646143|NCT02529553|102256347|FG000|Overall Study|Withdrawal by Subject|0|||
33646144|NCT02529553|102256348|FG001|Overall Study|Withdrawal by Subject|0|||
33646145|NCT02529553|102256349|FG002|Overall Study|Withdrawal by Subject|0|||
33646146|NCT02529553|102256350|FG003|Overall Study|Withdrawal by Subject|0|||
33646147|NCT02529553|102256351|FG004|Overall Study|Withdrawal by Subject|0|||
33646148|NCT02529553|102256352|FG005|Overall Study|Withdrawal by Subject|1|||
33646149|NCT02529553|102256353|FG006|Overall Study|Withdrawal by Subject|0|||
33646150|NCT02529553|102256354|FG007|Overall Study|Withdrawal by Subject|1|||
33646151|NCT02529553|102256355|FG008|Overall Study|Withdrawal by Subject|0|||
33646152|NCT04530136|102256356|FG000|Overall Study|Lost to Follow-up|2|||
33246716|NCT03852433|100803884|FG001|Overall Study|Pregnancy|1|||
33246717|NCT03852433|100803885|FG002|Overall Study|Pregnancy|1|||
33246718|NCT03852433|100803886|FG003|Overall Study|Pregnancy|0|||
33246719|NCT03852433|100803883|FG000|Overall Study|Protocol Violation|0|||
33246720|NCT03852433|100803884|FG001|Overall Study|Protocol Violation|0|||
33246721|NCT03852433|100803885|FG002|Overall Study|Protocol Violation|1|||
33246722|NCT03852433|100803886|FG003|Overall Study|Protocol Violation|1|||
33246723|NCT03852433|100803883|FG000|Overall Study|Death|0|||
33585610|NCT01681186|102032717|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
33585611|NCT01681186|102032718|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
33246724|NCT03852433|100803884|FG001|Overall Study|Death|0|||
33375930|NCT02554253|101261643|FG000|Overall Study|converted to transcatheter procedure|0|||
33375931|NCT02554253|101261644|FG001|Overall Study|converted to transcatheter procedure|1|||
33375932|NCT02554253|101261643|FG000|Overall Study|received both drugs|0|||
33375933|NCT02554253|101261644|FG001|Overall Study|received both drugs|1|||
33375934|NCT00751114|101261645|FG000|Overall Study|Adverse Event|2|||
33375935|NCT00751114|101261646|FG001|Overall Study|Adverse Event|4|||
33375936|NCT00751114|101261645|FG000|Overall Study|Protocol Violation|8|||
33646153|NCT04530136|102256357|FG001|Overall Study|Lost to Follow-up|3|||
33646154|NCT04530136|102256356|FG000|Overall Study|Withdrawal by Subject|1|||
33646155|NCT04530136|102256357|FG001|Overall Study|Withdrawal by Subject|0|||
33646156|NCT04530136|102256356|FG000|Overall Study|Death|0|||
33646157|NCT04530136|102256357|FG001|Overall Study|Death|1|||
33646158|NCT01516034|102256358|FG000|Overall Study|Physician Decision|1|||
33646159|NCT01516034|102256358|FG000|Overall Study|Lack of Efficacy|7|||
33646160|NCT02560025|102256368|FG000|Overall Study|Ineligible after consent/ registration|3|||
33646161|NCT00856518|102256369|FG000|Overall Study|Lost to Follow-up|4|||
33646162|NCT00856518|102256370|FG001|Overall Study|Lost to Follow-up|2|||
33646163|NCT03698591|102256371|FG000|Overall Study|Withdrawal by Subject|2|||
33246725|NCT03852433|100803885|FG002|Overall Study|Death|1|||
33375937|NCT00751114|101261646|FG001|Overall Study|Protocol Violation|9|||
33246726|NCT03852433|100803886|FG003|Overall Study|Death|0|||
33246727|NCT03852433|100803883|FG000|Overall Study|Lack of Efficacy|0|||
33375938|NCT00751114|101261645|FG000|Overall Study|Withdrawal by Subject|9|||
33375939|NCT00751114|101261646|FG001|Overall Study|Withdrawal by Subject|4|||
33375940|NCT00751114|101261645|FG000|Overall Study|Lost to Follow-up|4|||
33375941|NCT00751114|101261646|FG001|Overall Study|Lost to Follow-up|7|||
33375942|NCT00751114|101261645|FG000|Overall Study|Lack of Efficacy|0|||
33375943|NCT00751114|101261646|FG001|Overall Study|Lack of Efficacy|7|||
33375944|NCT00751114|101261645|FG000|Overall Study|Not Treated|13|||
33375945|NCT00751114|101261646|FG001|Overall Study|Not Treated|1|||
33375946|NCT00751114|101261645|FG000|Overall Study|Out of country for 2 months|1|||
33375947|NCT00751114|101261646|FG001|Overall Study|Out of country for 2 months|0|||
33375948|NCT00751114|101261645|FG000|Overall Study|Move to another city|1|||
33375949|NCT00751114|101261646|FG001|Overall Study|Move to another city|0|||
33375950|NCT01842607|101261647|FG000|Overall Study|Adverse Event|11|||
33375951|NCT01842607|101261647|FG000|Overall Study|Lack of Efficacy|19|||
33375952|NCT01842607|101261647|FG000|Overall Study|Protocol Violation|8|||
33375953|NCT01842607|101261647|FG000|Overall Study|Protocol defined stopping criteria|2|||
33375954|NCT01842607|101261647|FG000|Overall Study|Lost to Follow-up|3|||
33375955|NCT01842607|101261647|FG000|Overall Study|Physician Decision|9|||
33375956|NCT01842607|101261647|FG000|Overall Study|Withdrawal by Subject|14|||
33375957|NCT03731364|101261650|FG000|Overall Study|Adverse Event|0|||
33375958|NCT03731364|101261651|FG001|Overall Study|Adverse Event|0|||
33375959|NCT03731364|101261652|FG002|Overall Study|Adverse Event|1|||
33375960|NCT03731364|101261653|FG003|Overall Study|Adverse Event|2|||
33375961|NCT03731364|101261654|FG004|Overall Study|Adverse Event|1|||
33585612|NCT01681186|102032719|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
33585613|NCT01681186|102032712|FG000|Fourth Intervention|Protocol Violation|0|||
33585614|NCT01681186|102032713|FG001|Fourth Intervention|Protocol Violation|0|||
33585615|NCT01681186|102032714|FG002|Fourth Intervention|Protocol Violation|0|||
33585616|NCT01681186|102032715|FG003|Fourth Intervention|Protocol Violation|0|||
33585617|NCT01681186|102032716|FG004|Fourth Intervention|Protocol Violation|0|||
33585618|NCT01681186|102032717|FG005|Fourth Intervention|Protocol Violation|0|||
33585619|NCT01681186|102032718|FG006|Fourth Intervention|Protocol Violation|0|||
33585620|NCT01681186|102032719|FG007|Fourth Intervention|Protocol Violation|1|||
33585621|NCT04153981|102032721|FG000|Overall Study|Death|1|||
33585622|NCT04153981|102032721|FG000|Overall Study|Withdrawal by Subject|24|||
33585623|NCT04153981|102032721|FG000|Overall Study|Lost to Follow-up|1|||
33585624|NCT04153981|102032721|FG000|Overall Study|Physician Decision|1|||
33585625|NCT04153981|102032721|FG000|Overall Study|Due to Unavailable Glucometer|1|||
33585626|NCT04153981|102032721|FG000|Overall Study|Covid 19|52|||
33585627|NCT04153981|102032721|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
33585628|NCT04153981|102032721|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
33585629|NCT04154293|102032724|FG000|Overall Study|Withdrawal by Subject|2|||
33585630|NCT04154293|102032725|FG001|Overall Study|Withdrawal by Subject|3|||
33585631|NCT04154293|102032726|FG002|Overall Study|Withdrawal by Subject|1|||
33585632|NCT04154293|102032724|FG000|Overall Study|Physician Decision|0|||
33585633|NCT04154293|102032725|FG001|Overall Study|Physician Decision|0|||
33585634|NCT04154293|102032726|FG002|Overall Study|Physician Decision|1|||
33585635|NCT02952313|102032729|FG000|Primary Endpoint|Lost to Follow-up|4|||
33585636|NCT02952313|102032729|FG000|Primary Endpoint|Withdrawal by Subject|1|||
33585637|NCT02952313|102032729|FG000|Primary Endpoint|Lack of Efficacy|1|||
33585638|NCT02952313|102032729|FG000|Primary Endpoint|Missed visit|1|||
33585639|NCT02952313|102032729|FG000|Long-term Follow-up|Lost to Follow-up|12|||
33585640|NCT02952313|102032729|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
33585641|NCT02952313|102032729|FG000|Long-term Follow-up|Lack of Efficacy|6|||
33585642|NCT02952313|102032729|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
33585643|NCT02952313|102032729|FG000|Long-term Follow-up|Physician Decision|1|||
33585644|NCT02952313|102032729|FG000|Long-term Follow-up|Death|1|||
33585645|NCT02644096|102032732|FG000|Overall Study|Withdrawal by Subject|28|||
33585646|NCT02644096|102032733|FG001|Overall Study|Withdrawal by Subject|25|||
33585647|NCT03989349|102032735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
33585648|NCT03989349|102032736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
33585649|NCT03989349|102032737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
33585650|NCT03989349|102032738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
33585651|NCT03989349|102032739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
33585652|NCT03989349|102032740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
33585653|NCT03989349|102032735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
33585654|NCT03989349|102032736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
33585655|NCT03989349|102032737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
33585656|NCT03989349|102032738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
33375962|NCT00592852|101261655|FG000|Overall Study|Non-compliance|1|||
33375963|NCT00592852|101261655|FG000|Overall Study|Adverse Event|3|||
33375964|NCT00592852|101261655|FG000|Overall Study|Found ineligible|1|||
33375965|NCT00592852|101261655|FG000|Overall Study|Withdrawal by Subject|1|||
33375966|NCT02357849|101261658|FG000|Overall Study|Withdrawal by Subject|2|||
33423806|NCT01271933|101443597|FG000|Single-Blind Phase|Lost to Follow-up|10|||
33375967|NCT02357849|101261659|FG001|Overall Study|Withdrawal by Subject|3|||
33375968|NCT04580394|101261662|FG000|First Intervention|Incorrectly Randomized|1|||
33375969|NCT04580394|101261662|FG000|First Intervention|Physician Decision|1|||
33375970|NCT04580394|101261662|FG000|First Intervention|Lost to Follow-up|1|||
33375971|NCT04580394|101261662|FG000|Washout (One Week)|Withdrawal by Subject|1|||
33375972|NCT04580394|101261662|FG000|Washout (One Week)|Adverse Event|1|||
33375973|NCT04580394|101261662|FG000|Washout (One Week)|Withdrawal by Subject|2|||
33375974|NCT04580394|101261662|FG000|Third Intervention|Adverse Event|1|||
33375975|NCT04580394|101261662|FG000|Third Intervention|Withdrawal by Subject|1|||
33375976|NCT04580394|101261662|FG000|Washout (One Week)|Withdrawal by Subject|2|||
33375977|NCT00311181|101261665|FG000|Overall Study|Final DFTs were not obtained|96|||
33375978|NCT03103906|101261667|FG000|Overall Study|Adverse Event|2|||
33375979|NCT03103906|101261668|FG001|Overall Study|Adverse Event|3|||
33375980|NCT03103906|101261667|FG000|Overall Study|Other|2|||
33375981|NCT03103906|101261668|FG001|Overall Study|Other|0|||
33375982|NCT01089582|101261669|FG000|Overall Study|Death|2|||
33423807|NCT01271933|101443598|FG001|Single-Blind Phase|Lost to Follow-up|0|||
33423808|NCT01271933|101443599|FG002|Single-Blind Phase|Lost to Follow-up|0|||
33423809|NCT01271933|101443597|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
33423810|NCT01271933|101443598|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
33423811|NCT01271933|101443599|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
33423812|NCT01271933|101443597|FG000|Single-Blind Phase|Protocol Violation|3|||
33423813|NCT01271933|101443598|FG001|Single-Blind Phase|Protocol Violation|0|||
33585657|NCT03989349|102032739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
33585658|NCT03989349|102032740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
33585659|NCT03989349|102032735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
33585660|NCT03989349|102032736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
33585661|NCT03989349|102032737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
33585662|NCT03989349|102032738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
33585663|NCT03989349|102032739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
33585664|NCT03989349|102032740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
33585665|NCT03989349|102032735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
33585666|NCT03989349|102032736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
33585667|NCT03989349|102032737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
33585668|NCT03989349|102032738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
33585669|NCT03989349|102032739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
33585670|NCT03989349|102032740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
33585671|NCT03989349|102032735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
33585672|NCT03989349|102032736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
33585673|NCT03989349|102032737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
33585674|NCT03989349|102032738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
33585675|NCT03989349|102032739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
33585676|NCT03989349|102032740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
33585677|NCT03989349|102032735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
33585678|NCT03989349|102032736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
33585679|NCT03989349|102032737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
33585680|NCT03989349|102032738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
33585681|NCT03989349|102032739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
33585682|NCT03989349|102032740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
33585683|NCT03989349|102032735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
33585684|NCT03989349|102032736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
33585685|NCT03989349|102032737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
33585686|NCT03989349|102032738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
33585687|NCT03989349|102032739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
33585688|NCT03989349|102032740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
33585689|NCT03989349|102032735|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
33585690|NCT03989349|102032736|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
33585691|NCT03989349|102032737|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
33585692|NCT03989349|102032738|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
33375983|NCT01089582|101261669|FG000|Overall Study|Adverse Event|15|||
33423814|NCT01271933|101443599|FG002|Single-Blind Phase|Protocol Violation|0|||
33246728|NCT03852433|100803884|FG001|Overall Study|Lack of Efficacy|1|||
33375984|NCT01089582|101261669|FG000|Overall Study|Lost to Follow-up|8|||
33375985|NCT01089582|101261669|FG000|Overall Study|Other|4|||
33375986|NCT01089582|101261669|FG000|Overall Study|Withdrawal by Subject|1|||
33423815|NCT01271933|101443597|FG000|Single-Blind Phase|Adverse Event|52|||
33585693|NCT03989349|102032739|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
33585694|NCT03989349|102032740|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
33585695|NCT03989349|102032735|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
33585696|NCT03989349|102032736|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
33585697|NCT03989349|102032737|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
33585698|NCT03989349|102032738|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
33585699|NCT03989349|102032739|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
33585700|NCT03989349|102032740|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
33646164|NCT03698591|102256372|FG001|Overall Study|Withdrawal by Subject|2|||
33646165|NCT03698591|102256371|FG000|Overall Study|Failed drug screen|1|||
33646166|NCT03698591|102256372|FG001|Overall Study|Failed drug screen|1|||
33646167|NCT03698591|102256371|FG000|Overall Study|Failed health screen|0|||
33646168|NCT03698591|102256372|FG001|Overall Study|Failed health screen|1|||
33646169|NCT03698591|102256371|FG000|Overall Study|Ineligible for financial compensation|1|||
33646170|NCT03698591|102256372|FG001|Overall Study|Ineligible for financial compensation|0|||
33646171|NCT03698591|102256371|FG000|Overall Study|Equipment Error|1|||
33646172|NCT03698591|102256372|FG001|Overall Study|Equipment Error|0|||
33646173|NCT03698591|102256371|FG000|Overall Study|Could not establish TMS dosage|0|||
33646174|NCT03698591|102256372|FG001|Overall Study|Could not establish TMS dosage|1|||
33646175|NCT01338298|102256373|FG000|Overall Study|Withdrawal by Subject|1|||
33646176|NCT01338298|102256374|FG001|Overall Study|Withdrawal by Subject|1|||
33646177|NCT01338298|102256373|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
33646178|NCT01338298|102256374|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
33646179|NCT01338298|102256373|FG000|Overall Study|Administrative error|0|||
33646180|NCT01338298|102256374|FG001|Overall Study|Administrative error|1|||
33423816|NCT01271933|101443598|FG001|Single-Blind Phase|Adverse Event|0|||
33585701|NCT03989349|102032735|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
33585702|NCT03989349|102032736|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
33585703|NCT03989349|102032737|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
33585704|NCT03989349|102032738|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
33585705|NCT03989349|102032739|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
33585706|NCT03989349|102032740|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
33585707|NCT03989349|102032735|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33585708|NCT03989349|102032736|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33585709|NCT03989349|102032737|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
33585710|NCT03989349|102032738|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33585711|NCT03989349|102032739|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
33585712|NCT03989349|102032740|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33585713|NCT03989349|102032735|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
33585714|NCT03989349|102032736|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
33585715|NCT03989349|102032737|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
33585716|NCT03989349|102032738|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
33585717|NCT03989349|102032739|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
33585718|NCT03989349|102032740|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
33585719|NCT03989349|102032735|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
33585720|NCT03989349|102032736|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
33585721|NCT03989349|102032737|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
33585722|NCT03989349|102032738|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
33585723|NCT03989349|102032739|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
33585724|NCT03989349|102032740|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
33585725|NCT03989349|102032735|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
33585726|NCT03989349|102032736|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
33585727|NCT03989349|102032737|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
33585728|NCT03989349|102032738|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
33585729|NCT03989349|102032739|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
33585730|NCT03989349|102032740|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
33585731|NCT02628600|102032741|FG000|Overall Study|Death|2|||
33585732|NCT02628600|102032742|FG001|Overall Study|Death|1|||
33646181|NCT01338298|102256373|FG000|Overall Study|Positive symptom worsening|1|||
33646182|NCT01338298|102256374|FG001|Overall Study|Positive symptom worsening|0|||
33646183|NCT01338298|102256373|FG000|Overall Study|Depressive symptoms and nausea|1|||
33646184|NCT01338298|102256374|FG001|Overall Study|Depressive symptoms and nausea|0|||
33423817|NCT01271933|101443599|FG002|Single-Blind Phase|Adverse Event|0|||
33585733|NCT02628600|102032741|FG000|Overall Study|Adverse Event|3|||
33646185|NCT01338298|102256373|FG000|Overall Study|Non-adherence|1|||
33646186|NCT01338298|102256374|FG001|Overall Study|Non-adherence|0|||
33646187|NCT04248491|102256375|FG000|Overall Study|Lost to Follow-up|1|||
33646188|NCT04248491|102256376|FG001|Overall Study|Lost to Follow-up|0|||
33585734|NCT02628600|102032742|FG001|Overall Study|Adverse Event|20|||
33585735|NCT02628600|102032741|FG000|Overall Study|Protocol Violation|0|||
33585736|NCT02628600|102032742|FG001|Overall Study|Protocol Violation|1|||
33585737|NCT02628600|102032741|FG000|Overall Study|Lack of Efficacy|2|||
33585738|NCT02628600|102032742|FG001|Overall Study|Lack of Efficacy|0|||
33585739|NCT02628600|102032741|FG000|Overall Study|Withdrawal by Subject|13|||
33585740|NCT02628600|102032742|FG001|Overall Study|Withdrawal by Subject|8|||
33585741|NCT02628600|102032741|FG000|Overall Study|Lost to Follow-up|1|||
33585742|NCT02628600|102032742|FG001|Overall Study|Lost to Follow-up|0|||
33585743|NCT02628600|102032741|FG000|Overall Study|Physician Decision|2|||
33585744|NCT02628600|102032742|FG001|Overall Study|Physician Decision|2|||
33375987|NCT02159469|101261671|FG000|Overall Study|Missing Completion status|1|||
33375988|NCT02159469|101261671|FG000|Overall Study|Adverse Event|5|||
33375989|NCT02159469|101261671|FG000|Overall Study|Non-compliance|2|||
33375990|NCT02159469|101261671|FG000|Overall Study|Withdrawal by Subject|9|||
33375991|NCT02159469|101261671|FG000|Overall Study|Lost to Follow-up|1|||
33375992|NCT02159469|101261671|FG000|Overall Study|Sponsor's request|2|||
33375993|NCT02159469|101261671|FG000|Overall Study|Met Stopping Criteria|3|||
33375994|NCT02159469|101261671|FG000|Overall Study|Other|1|||
33375995|NCT02159469|101261671|FG000|Overall Study|Multiple|29|||
33375996|NCT00302718|101261673|FG000|Overall Study|Participant left the hospital|1|||
33375997|NCT00302718|101261674|FG001|Overall Study|Participant left the hospital|0|||
33375998|NCT00302718|101261675|FG002|Overall Study|Participant left the hospital|0|||
33375999|NCT00302718|101261676|FG003|Overall Study|Participant left the hospital|1|||
33376000|NCT00302718|101261673|FG000|Overall Study|Withdrawal by Subject|0|||
33585745|NCT02628600|102032741|FG000|Overall Study|Other not specified|1|||
33585746|NCT02628600|102032742|FG001|Overall Study|Other not specified|0|||
33585747|NCT03107052|102032743|FG000|Overall Study|Adverse Event|6|||
33585748|NCT03107052|102032744|FG001|Overall Study|Adverse Event|1|||
33585749|NCT03107052|102032745|FG002|Overall Study|Adverse Event|2|||
33585750|NCT03107052|102032743|FG000|Overall Study|Withdrawal by Subject|9|||
33585751|NCT03107052|102032744|FG001|Overall Study|Withdrawal by Subject|5|||
33585752|NCT03107052|102032745|FG002|Overall Study|Withdrawal by Subject|8|||
33585753|NCT03107052|102032743|FG000|Overall Study|Protocol Violation|6|||
33585754|NCT03107052|102032744|FG001|Overall Study|Protocol Violation|0|||
33585755|NCT03107052|102032745|FG002|Overall Study|Protocol Violation|3|||
33585756|NCT03107052|102032743|FG000|Overall Study|Lost to Follow-up|4|||
33585757|NCT03107052|102032744|FG001|Overall Study|Lost to Follow-up|0|||
33585758|NCT03107052|102032745|FG002|Overall Study|Lost to Follow-up|1|||
33585759|NCT03107052|102032743|FG000|Overall Study|Lack of Efficacy|23|||
33585760|NCT03107052|102032744|FG001|Overall Study|Lack of Efficacy|7|||
33585761|NCT03107052|102032745|FG002|Overall Study|Lack of Efficacy|4|||
33585762|NCT03107052|102032743|FG000|Overall Study|Other than specified|4|||
33585763|NCT03107052|102032744|FG001|Overall Study|Other than specified|2|||
33646189|NCT00899392|102256377|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
33646190|NCT00899392|102256378|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
33646191|NCT00796978|102256379|FG000|Overall Study|Cardiac adverse event|5|||
33646192|NCT00796978|102256379|FG000|Overall Study|Adverse Event|4|||
33646193|NCT00796978|102256379|FG000|Overall Study|Withdrawal by Subject|3|||
33646194|NCT00530816|102256380|FG000|Overall Study|Progressive Disease|16|||
33246729|NCT03852433|100803885|FG002|Overall Study|Lack of Efficacy|0|||
33376001|NCT00302718|101261674|FG001|Overall Study|Withdrawal by Subject|1|||
33423818|NCT01271933|101443597|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
33585764|NCT03107052|102032745|FG002|Overall Study|Other than specified|0|||
33585765|NCT03107052|102032743|FG000|Overall Study|Study terminated due to futility|67|||
33585766|NCT03107052|102032744|FG001|Overall Study|Study terminated due to futility|31|||
33585767|NCT03107052|102032745|FG002|Overall Study|Study terminated due to futility|23|||
33585768|NCT00606411|102032746|FG000|Overall Study|Adverse Event|1|||
33585769|NCT00606411|102032747|FG001|Overall Study|Adverse Event|2|||
33585770|NCT00606411|102032746|FG000|Overall Study|Lack of Adherence|1|||
33585771|NCT00606411|102032747|FG001|Overall Study|Lack of Adherence|1|||
33585772|NCT00606411|102032746|FG000|Overall Study|Lack of Efficacy|1|||
33585773|NCT00606411|102032747|FG001|Overall Study|Lack of Efficacy|1|||
33376002|NCT00302718|101261675|FG002|Overall Study|Withdrawal by Subject|0|||
33585774|NCT00606411|102032746|FG000|Overall Study|Withdrawal by Subject|2|||
33585775|NCT00606411|102032747|FG001|Overall Study|Withdrawal by Subject|0|||
33585776|NCT00606411|102032746|FG000|Overall Study|Lost to Follow-up|1|||
33585777|NCT00606411|102032747|FG001|Overall Study|Lost to Follow-up|2|||
33585778|NCT00606411|102032746|FG000|Overall Study|Move out of state|0|||
33585779|NCT00606411|102032747|FG001|Overall Study|Move out of state|1|||
33585780|NCT02297815|102032748|FG000|Overall Study|Lost to Follow-up|236|||
33585781|NCT02297815|102032749|FG001|Overall Study|Lost to Follow-up|140|||
33585782|NCT04209634|102032757|FG000|Overall Study|Ongoing|10|||
33585783|NCT01700959|102032758|FG000|Overall Study|Adverse Event|0|||
33646195|NCT00530816|102256381|FG001|Overall Study|Progressive Disease|24|||
33376003|NCT00302718|101261676|FG003|Overall Study|Withdrawal by Subject|0|||
33376004|NCT00302718|101261673|FG000|Overall Study|Participant left primary care setting|0|||
33646196|NCT00530816|102256382|FG002|Overall Study|Progressive Disease|24|||
33646197|NCT00530816|102256380|FG000|Overall Study|Adverse Event|6|||
33646198|NCT00530816|102256381|FG001|Overall Study|Adverse Event|13|||
33646199|NCT00530816|102256382|FG002|Overall Study|Adverse Event|7|||
33646200|NCT00530816|102256380|FG000|Overall Study|Other|3|||
33646201|NCT00530816|102256381|FG001|Overall Study|Other|3|||
33646202|NCT00530816|102256382|FG002|Overall Study|Other|4|||
33646203|NCT00530816|102256380|FG000|Overall Study|Withdrawal by Subject|1|||
33646204|NCT00530816|102256381|FG001|Overall Study|Withdrawal by Subject|2|||
33646205|NCT00530816|102256382|FG002|Overall Study|Withdrawal by Subject|6|||
33148621|NCT00378105|100458196|FG001|Overall Study|remain on study|11|||
33148622|NCT00378105|100458195|FG000|Overall Study|Physician Decision|0|||
33148623|NCT00378105|100458196|FG001|Overall Study|Physician Decision|2|||
33376005|NCT00302718|101261674|FG001|Overall Study|Participant left primary care setting|0|||
33376006|NCT00302718|101261675|FG002|Overall Study|Participant left primary care setting|2|||
33376007|NCT00302718|101261676|FG003|Overall Study|Participant left primary care setting|1|||
33376008|NCT01429792|101261682|FG000|Overall Study|Other Reasons|67|||
33376009|NCT01429792|101261682|FG000|Overall Study|Unknown Disposition|94|||
33376010|NCT01429792|101261682|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
33376011|NCT01429792|101261682|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
33376012|NCT01429792|101261682|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
33376013|NCT01429792|101261682|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
33376014|NCT01429792|101261682|FG000|Overall Study|Withdrawal by Subject|70|||
33376015|NCT01429792|101261682|FG000|Overall Study|Lost to Follow-up|88|||
33376016|NCT00352755|101261686|FG000|Overall Study|Physician Decision|1|||
33376017|NCT00352755|101261686|FG000|Overall Study|Adverse Event|1|||
33376018|NCT01409031|101261687|FG000|Overall Study|transferred to other hosp|1|||
33376019|NCT01409031|101261688|FG001|Overall Study|transferred to other hosp|0|||
33376020|NCT01397552|101261689|FG000|Overall Study|Adverse Event|1|||
33376021|NCT01397552|101261690|FG001|Overall Study|Adverse Event|0|||
33376022|NCT01397552|101261689|FG000|Overall Study|Withdrawal by Subject|2|||
33376023|NCT01397552|101261690|FG001|Overall Study|Withdrawal by Subject|1|||
33376024|NCT00948818|101261691|FG000|Overall Study|Adverse Event|10|||
33376025|NCT00948818|101261692|FG001|Overall Study|Adverse Event|32|||
33376026|NCT00948818|101261691|FG000|Overall Study|Protocol Violation|9|||
33376027|NCT00948818|101261692|FG001|Overall Study|Protocol Violation|10|||
33376028|NCT00948818|101261691|FG000|Overall Study|Withdrawal by Subject|25|||
33376029|NCT00948818|101261692|FG001|Overall Study|Withdrawal by Subject|25|||
33376030|NCT00948818|101261691|FG000|Overall Study|Lost to Follow-up|10|||
33376031|NCT00948818|101261692|FG001|Overall Study|Lost to Follow-up|17|||
33376032|NCT00948818|101261691|FG000|Overall Study|Lack of Efficacy|4|||
33376033|NCT00948818|101261692|FG001|Overall Study|Lack of Efficacy|5|||
33376034|NCT00948818|101261691|FG000|Overall Study|Other Reason|4|||
33376035|NCT00948818|101261692|FG001|Overall Study|Other Reason|5|||
33376036|NCT05086289|101261697|FG000|Overall Study|Adverse Event|4|||
33376037|NCT05086289|101261698|FG001|Overall Study|Adverse Event|2|||
33376038|NCT05086289|101261697|FG000|Overall Study|Lost to Follow-up|2|||
33376039|NCT05086289|101261698|FG001|Overall Study|Lost to Follow-up|0|||
33376040|NCT05086289|101261697|FG000|Overall Study|Non-compliance with study drug|2|||
33376041|NCT05086289|101261698|FG001|Overall Study|Non-compliance with study drug|1|||
33376042|NCT05086289|101261697|FG000|Overall Study|Physician Decision|2|||
33376043|NCT05086289|101261698|FG001|Overall Study|Physician Decision|0|||
33376044|NCT05086289|101261697|FG000|Overall Study|Withdrawal by Subject|5|||
33376045|NCT05086289|101261698|FG001|Overall Study|Withdrawal by Subject|2|||
33376046|NCT00434122|101261699|FG000|Overall Study|Non-compliance with protocol|0|||
33376047|NCT00434122|101261700|FG001|Overall Study|Non-compliance with protocol|1|||
33376048|NCT00434122|101261699|FG000|Overall Study|loss of subject contact|1|||
33585784|NCT01700959|102032759|FG001|Overall Study|Adverse Event|1|||
33585785|NCT01700959|102032760|FG002|Overall Study|Adverse Event|1|||
33585786|NCT01700959|102032761|FG003|Overall Study|Adverse Event|2|||
33585787|NCT01700959|102032762|FG004|Overall Study|Adverse Event|0|||
33585788|NCT01700959|102032763|FG005|Overall Study|Adverse Event|2|||
33585789|NCT01700959|102032758|FG000|Overall Study|Withdrawal by Subject|15|||
33585790|NCT01700959|102032759|FG001|Overall Study|Withdrawal by Subject|9|||
33585791|NCT01700959|102032760|FG002|Overall Study|Withdrawal by Subject|12|||
33646206|NCT01124006|102256383|FG000|Overall Study|Withdrawal by Subject|2|||
33148624|NCT00378105|100458195|FG000|Overall Study|Going non-protocol therapy|0|||
33148625|NCT00378105|100458196|FG001|Overall Study|Going non-protocol therapy|1|||
33585792|NCT01700959|102032761|FG003|Overall Study|Withdrawal by Subject|11|||
33585793|NCT01700959|102032762|FG004|Overall Study|Withdrawal by Subject|8|||
33376049|NCT00434122|101261700|FG001|Overall Study|loss of subject contact|1|||
33376050|NCT00434122|101261699|FG000|Overall Study|Personal reasons|1|||
33376051|NCT00434122|101261700|FG001|Overall Study|Personal reasons|1|||
33646207|NCT01124006|102256384|FG001|Overall Study|Withdrawal by Subject|2|||
33148626|NCT00378105|100458195|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
33376052|NCT00434122|101261699|FG000|Overall Study|Large follicle size|2|||
33376053|NCT00434122|101261700|FG001|Overall Study|Large follicle size|2|||
33376054|NCT00434122|101261699|FG000|Overall Study|Low follicular response.|1|||
33376055|NCT00434122|101261700|FG001|Overall Study|Low follicular response.|2|||
33376056|NCT00434122|101261699|FG000|Overall Study|Travelling of subject.|1|||
33376057|NCT00434122|101261700|FG001|Overall Study|Travelling of subject.|0|||
33376058|NCT01822691|101261706|FG000|Overall Study|Withdrawal by Subject|2|||
33376059|NCT03628417|101261707|FG000|Overall Study|Death|1|||
33376060|NCT03628417|101261708|FG001|Overall Study|Death|1|||
33376061|NCT04397718|101261709|FG000|Overall Study|Death|7|||
33376062|NCT04397718|101261710|FG001|Overall Study|Death|11|||
33585794|NCT01700959|102032763|FG005|Overall Study|Withdrawal by Subject|12|||
33585795|NCT01700959|102032758|FG000|Overall Study|Ineligible|2|||
33585796|NCT01700959|102032759|FG001|Overall Study|Ineligible|1|||
33585797|NCT01700959|102032760|FG002|Overall Study|Ineligible|2|||
33585798|NCT01700959|102032761|FG003|Overall Study|Ineligible|0|||
33585799|NCT01700959|102032762|FG004|Overall Study|Ineligible|0|||
33585800|NCT01700959|102032763|FG005|Overall Study|Ineligible|1|||
33646208|NCT01124006|102256385|FG002|Overall Study|Withdrawal by Subject|0|||
33646209|NCT01124006|102256383|FG000|Overall Study|Lost to Follow-up|1|||
33646210|NCT01124006|102256384|FG001|Overall Study|Lost to Follow-up|0|||
33646211|NCT01124006|102256385|FG002|Overall Study|Lost to Follow-up|1|||
33646212|NCT01124006|102256383|FG000|Overall Study|Other|0|||
33646213|NCT01124006|102256384|FG001|Overall Study|Other|0|||
33376063|NCT04397718|101261709|FG000|Overall Study|Lost to Follow-up|0|||
33376064|NCT04397718|101261710|FG001|Overall Study|Lost to Follow-up|4|||
33376065|NCT02237157|101261711|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
33148627|NCT00378105|100458196|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
33148628|NCT01385176|100458197|FG000|Randomization Phase|Death|1|||
33148629|NCT01385176|100458198|FG001|Randomization Phase|Death|2|||
33148630|NCT01385176|100458197|FG000|6-18 Month All VNS Active|Death|1|||
33148631|NCT01385176|100458198|FG001|6-18 Month All VNS Active|Death|2|||
33148632|NCT01385176|100458197|FG000|6-18 Month All VNS Active|Physician Decision|0|||
33148633|NCT01385176|100458198|FG001|6-18 Month All VNS Active|Physician Decision|1|||
33148634|NCT01385176|100458197|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
33148635|NCT01385176|100458198|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
33148636|NCT01385176|100458197|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
33376066|NCT02237157|101261712|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
33376067|NCT02237157|101261713|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
33376068|NCT02237157|101261714|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
33376069|NCT02237157|101261711|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
33376070|NCT02237157|101261712|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
33376071|NCT02237157|101261713|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
33376072|NCT02237157|101261714|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
33376073|NCT04570657|101261715|FG000|Overall Study|Adverse Event|0|||
33376074|NCT04570657|101261716|FG001|Overall Study|Adverse Event|0|||
33376075|NCT04570657|101261717|FG002|Overall Study|Adverse Event|1|||
33376076|NCT04570657|101261715|FG000|Overall Study|Lost to Follow-up|0|||
33585801|NCT01700959|102032758|FG000|Overall Study|Noncompliant|9|||
33585802|NCT01700959|102032759|FG001|Overall Study|Noncompliant|9|||
33585803|NCT01700959|102032760|FG002|Overall Study|Noncompliant|17|||
33585804|NCT01700959|102032761|FG003|Overall Study|Noncompliant|18|||
33585805|NCT01700959|102032762|FG004|Overall Study|Noncompliant|15|||
33585806|NCT01700959|102032763|FG005|Overall Study|Noncompliant|9|||
33585807|NCT01700959|102032758|FG000|Overall Study|Side effects|1|||
33585808|NCT01700959|102032759|FG001|Overall Study|Side effects|4|||
33423819|NCT01271933|101443598|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
33585809|NCT01700959|102032760|FG002|Overall Study|Side effects|8|||
33585810|NCT01700959|102032761|FG003|Overall Study|Side effects|4|||
33585811|NCT01700959|102032762|FG004|Overall Study|Side effects|4|||
33585812|NCT01700959|102032763|FG005|Overall Study|Side effects|1|||
33585813|NCT01234480|102032764|FG000|Overall Study|Pregnancy|88|||
33585814|NCT01234480|102032764|FG000|Overall Study|>36/Normal History|50|||
33585815|NCT01234480|102032764|FG000|Overall Study|Age|3|||
33585816|NCT01234480|102032764|FG000|Overall Study|HPV Vaccine History|28|||
33585817|NCT01234480|102032764|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
33585818|NCT01234480|102032764|FG000|Overall Study|Hysterectomy|2|||
33148637|NCT01385176|100458198|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
33423820|NCT01271933|101443599|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
33585819|NCT01234480|102032764|FG000|Overall Study|Hysterectomy post enrollment|1|||
33585820|NCT01234480|102032764|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
33585821|NCT01234480|102032764|FG000|Overall Study|Informed Consent Form Violation|30|||
33376077|NCT04570657|101261716|FG001|Overall Study|Lost to Follow-up|0|||
33376078|NCT04570657|101261717|FG002|Overall Study|Lost to Follow-up|1|||
33376079|NCT04570657|101261715|FG000|Overall Study|Physician Decision|0|||
33376080|NCT04570657|101261716|FG001|Overall Study|Physician Decision|1|||
33585822|NCT01234480|102032764|FG000|Overall Study|Incorrect Visit|3|||
33585823|NCT01234480|102032764|FG000|Overall Study|No Florida Lab License|20|||
33646214|NCT01124006|102256385|FG002|Overall Study|Other|1|||
33148638|NCT00704808|100458199|FG000|Overall Study|Discontinued prior to starting treatment|14|||
33376081|NCT04570657|101261717|FG002|Overall Study|Physician Decision|0|||
33376082|NCT04570657|101261715|FG000|Overall Study|Withdrawal by Subject|1|||
33376083|NCT04570657|101261716|FG001|Overall Study|Withdrawal by Subject|2|||
33376084|NCT04570657|101261717|FG002|Overall Study|Withdrawal by Subject|2|||
33376085|NCT00618449|101261718|FG000|Overall Study|Lost to Follow-up|98|||
33585824|NCT01234480|102032764|FG000|Overall Study|Out of Window|42|||
33585825|NCT01234480|102032764|FG000|Overall Study|Sample Processing/Storage|92|||
33585826|NCT01234480|102032764|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
33585827|NCT01234480|102032764|FG000|Overall Study|Site/Subject non-compliance|44|||
33585828|NCT01234480|102032764|FG000|Overall Study|Missing Sample|9|||
33585829|NCT01076205|102032765|FG000|Overall Study|Adverse Drug Reaction|299|||
33585830|NCT01076205|102032765|FG000|Overall Study|Lack of Effectiveness|1423|||
33585831|NCT01076205|102032765|FG000|Overall Study|Other Reason|1075|||
33585832|NCT01076205|102032765|FG000|Overall Study|Unknown Reason|71|||
33585833|NCT01076205|102032765|FG000|Overall Study|Lost to Follow-up|3151|||
33585834|NCT00399568|102032766|FG000|Overall Study|Adverse Event|1|||
33585835|NCT00399568|102032767|FG001|Overall Study|Adverse Event|2|||
33585836|NCT00399568|102032766|FG000|Overall Study|Withdrawal by Subject|7|||
33585837|NCT00399568|102032767|FG001|Overall Study|Withdrawal by Subject|3|||
33585838|NCT00399568|102032766|FG000|Overall Study|Protocol non-compliance|2|||
33585839|NCT00399568|102032767|FG001|Overall Study|Protocol non-compliance|2|||
33585840|NCT00399568|102032766|FG000|Overall Study|Lost to Follow-up|2|||
33585841|NCT00399568|102032767|FG001|Overall Study|Lost to Follow-up|2|||
33585842|NCT04660552|102032768|FG000|Overall Study|Withdrawal by Subject|3|||
33585843|NCT04660552|102032769|FG001|Overall Study|Withdrawal by Subject|1|||
33585844|NCT00814580|102032774|FG000|Overall Study|Adverse Event|6|||
33585845|NCT00814580|102032775|FG001|Overall Study|Adverse Event|15|||
33585846|NCT00814580|102032774|FG000|Overall Study|Lack of Efficacy|18|||
33585847|NCT00814580|102032775|FG001|Overall Study|Lack of Efficacy|25|||
33585848|NCT00814580|102032774|FG000|Overall Study|Protocol Violation|2|||
33585849|NCT00814580|102032775|FG001|Overall Study|Protocol Violation|0|||
33585850|NCT00814580|102032774|FG000|Overall Study|Withdrawal by Subject|2|||
33585851|NCT00814580|102032775|FG001|Overall Study|Withdrawal by Subject|2|||
33585852|NCT00814580|102032774|FG000|Overall Study|Other|1|||
33585853|NCT00814580|102032775|FG001|Overall Study|Other|3|||
33585854|NCT00814580|102032774|FG000|Overall Study|Did Not Take Drug|2|||
33585855|NCT00814580|102032775|FG001|Overall Study|Did Not Take Drug|2|||
33585856|NCT01532921|102032776|FG000|Overall Study|Death|3|||
33585857|NCT01532921|102032776|FG000|Overall Study|Withdrawal by Subject|2|||
33585858|NCT01532921|102032776|FG000|Overall Study|Lost to Follow-up|3|||
33585859|NCT01532921|102032776|FG000|Overall Study|Physician Decision|7|||
33585860|NCT01532921|102032776|FG000|Overall Study|Device was explanted during procedure|1|||
33585861|NCT00778336|102032777|FG000|Index Procedure-Discharge|Death|6|||
33585862|NCT00778336|102032778|FG001|Index Procedure-Discharge|Death|3|||
33585863|NCT00778336|102032779|FG002|Index Procedure-Discharge|Death|2|||
33585864|NCT00778336|102032780|FG003|Index Procedure-Discharge|Death|0|||
33585865|NCT00778336|102032777|FG000|3 Month Follow Up|Lost to Follow-up|15|||
33585866|NCT00778336|102032778|FG001|3 Month Follow Up|Lost to Follow-up|20|||
33585867|NCT00778336|102032779|FG002|3 Month Follow Up|Lost to Follow-up|3|||
33585868|NCT00778336|102032780|FG003|3 Month Follow Up|Lost to Follow-up|0|||
33585869|NCT00778336|102032777|FG000|3 Month Follow Up|Death|8|||
33585870|NCT00778336|102032778|FG001|3 Month Follow Up|Death|3|||
33585871|NCT00778336|102032779|FG002|3 Month Follow Up|Death|2|||
33585872|NCT00778336|102032780|FG003|3 Month Follow Up|Death|0|||
33376086|NCT00618449|101261719|FG001|Overall Study|Lost to Follow-up|110|||
33376087|NCT02669862|101261720|FG000|Overall Study|Lost to Follow-up|0|||
33376088|NCT02669862|101261721|FG001|Overall Study|Lost to Follow-up|2|||
33376089|NCT02669862|101261722|FG002|Overall Study|Lost to Follow-up|1|||
33376090|NCT02669862|101261720|FG000|Overall Study|Withdrawal by Subject|2|||
33376091|NCT02669862|101261721|FG001|Overall Study|Withdrawal by Subject|2|||
33376092|NCT02669862|101261722|FG002|Overall Study|Withdrawal by Subject|3|||
33376093|NCT02669862|101261720|FG000|Overall Study|moved|0|||
33376094|NCT02669862|101261721|FG001|Overall Study|moved|1|||
33376095|NCT02669862|101261722|FG002|Overall Study|moved|0|||
33376096|NCT02669862|101261720|FG000|Overall Study|Protocol Violation|0|||
33376097|NCT02669862|101261721|FG001|Overall Study|Protocol Violation|0|||
33376098|NCT02669862|101261722|FG002|Overall Study|Protocol Violation|1|||
33376099|NCT04032171|101261727|FG000|Overall Study|Study Termination|1|||
33376100|NCT04032171|101261728|FG001|Overall Study|Study Termination|0|||
33376101|NCT02034474|101261729|FG000|Overall Study|Adverse Event|3|||
33376102|NCT02034474|101261730|FG001|Overall Study|Adverse Event|2|||
33376103|NCT02034474|101261729|FG000|Overall Study|Withdrawal by Subject|1|||
33376104|NCT02034474|101261730|FG001|Overall Study|Withdrawal by Subject|2|||
33585873|NCT03711370|102032781|FG000|Overall Study|Lost to Follow-up|16|||
33585874|NCT03711370|102032782|FG001|Overall Study|Lost to Follow-up|10|||
33376105|NCT01317615|101261732|FG000|Overall Study|Disease progression|25|||
33376106|NCT01317615|101261732|FG000|Overall Study|New cancer therapy|5|||
33585875|NCT03711370|102032781|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
33585876|NCT03711370|102032782|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
33585877|NCT04072835|102032783|FG000|Overall Study|Overall trial ended|603|||
33585878|NCT04072835|102032783|FG000|Overall Study|Ablation|97|||
33585879|NCT04072835|102032783|FG000|Overall Study|Withdrawal of consent|66|||
33585880|NCT04072835|102032783|FG000|Overall Study|Physician Decision|50|||
33585881|NCT04072835|102032783|FG000|Overall Study|Lost to Follow-up|39|||
33585882|NCT04072835|102032783|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
33585883|NCT04072835|102032783|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
33585884|NCT04072835|102032783|FG000|Overall Study|Adverse Event|25|||
33585885|NCT04072835|102032783|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
33585886|NCT04072835|102032783|FG000|Overall Study|Death|11|||
33585887|NCT04072835|102032783|FG000|Overall Study|Participant felt the drug did not work|8|||
33585888|NCT04072835|102032783|FG000|Overall Study|Participant tolerability|5|||
33585889|NCT04072835|102032783|FG000|Overall Study|Missing|5|||
33585890|NCT04072835|102032783|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
33585891|NCT04072835|102032783|FG000|Overall Study|Pregnancy|3|||
33585892|NCT00342628|102032791|FG000|Overall Study|Withdrawal by Subject|19|||
33585893|NCT00342628|102032792|FG001|Overall Study|Withdrawal by Subject|19|||
33585894|NCT00342628|102032793|FG002|Overall Study|Withdrawal by Subject|18|||
33585895|NCT00342628|102032791|FG000|Overall Study|Death|1|||
33585896|NCT00342628|102032792|FG001|Overall Study|Death|1|||
33585897|NCT00342628|102032793|FG002|Overall Study|Death|0|||
33585898|NCT00342628|102032791|FG000|Overall Study|moved residence|0|||
33585899|NCT00342628|102032792|FG001|Overall Study|moved residence|1|||
33585900|NCT00342628|102032793|FG002|Overall Study|moved residence|1|||
33585901|NCT02013778|102032794|FG000|Overall Study|Death|4|||
33585902|NCT02013778|102032794|FG000|Overall Study|Withdrawal by Subject|1|||
33585903|NCT02013778|102032794|FG000|Overall Study|Physician Decision|1|||
33585904|NCT02013778|102032794|FG000|Overall Study|Adverse Event|1|||
33585905|NCT02038777|102032795|FG000|Overall Study|Death|0|||
33585906|NCT02038777|102032796|FG001|Overall Study|Death|2|||
33585907|NCT02038777|102032797|FG002|Overall Study|Death|0|||
33585908|NCT02038777|102032798|FG003|Overall Study|Death|1|||
33148639|NCT00704808|100458199|FG000|Overall Study|Death|7|||
33246730|NCT03852433|100803886|FG003|Overall Study|Lack of Efficacy|0|||
33246731|NCT03852433|100803883|FG000|Overall Study|Non-compliance with study drug|0|||
33246732|NCT03852433|100803884|FG001|Overall Study|Non-compliance with study drug|0|||
33585909|NCT02038777|102032799|FG004|Overall Study|Death|2|||
33585910|NCT02038777|102032800|FG005|Overall Study|Death|4|||
33585911|NCT02038777|102032801|FG006|Overall Study|Death|0|||
33246733|NCT03852433|100803885|FG002|Overall Study|Non-compliance with study drug|0|||
33246734|NCT03852433|100803886|FG003|Overall Study|Non-compliance with study drug|1|||
33246735|NCT03852433|100803883|FG000|Overall Study|Physician Decision|1|||
33246736|NCT03852433|100803884|FG001|Overall Study|Physician Decision|0|||
33246737|NCT03852433|100803885|FG002|Overall Study|Physician Decision|0|||
33246738|NCT03852433|100803886|FG003|Overall Study|Physician Decision|0|||
33246739|NCT03852433|100803883|FG000|Overall Study|Randomized but never treated|1|||
33246740|NCT03852433|100803884|FG001|Overall Study|Randomized but never treated|0|||
33246741|NCT03852433|100803885|FG002|Overall Study|Randomized but never treated|0|||
33246742|NCT03852433|100803886|FG003|Overall Study|Randomized but never treated|0|||
33246743|NCT00763282|100803887|FG000|Overall Study|Withdrawal by Subject|6|||
33246744|NCT00763282|100803888|FG001|Overall Study|Withdrawal by Subject|5|||
33246745|NCT00763282|100803887|FG000|Overall Study|Death|4|||
33246746|NCT00763282|100803888|FG001|Overall Study|Death|3|||
33246747|NCT00763282|100803887|FG000|Overall Study|Lost to Follow-up|22|||
33246748|NCT00763282|100803888|FG001|Overall Study|Lost to Follow-up|26|||
33246749|NCT01348087|100803893|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
33246750|NCT01348087|100803893|FG000|Overall Study|Administrative problems|79|||
33246751|NCT01348087|100803893|FG000|Overall Study|protocol deviation|1|||
33246752|NCT01348087|100803893|FG000|Overall Study|Lost to Follow-up|1|||
33246753|NCT01348087|100803893|FG000|Overall Study|Subject withdrew consent|7|||
33246754|NCT01348087|100803893|FG000|Overall Study|Adverse Event|25|||
33246755|NCT03503773|100803896|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
33246756|NCT03503773|100803897|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
33246757|NCT03503773|100803896|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
33585912|NCT02038777|102032802|FG007|Overall Study|Death|10|||
33585913|NCT02038777|102032795|FG000|Overall Study|Lost to Follow-up|0|||
33246758|NCT03503773|100803897|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
33585914|NCT02038777|102032796|FG001|Overall Study|Lost to Follow-up|0|||
33585915|NCT02038777|102032797|FG002|Overall Study|Lost to Follow-up|0|||
33585916|NCT02038777|102032798|FG003|Overall Study|Lost to Follow-up|1|||
33246759|NCT03503773|100803896|FG000|Overall Study|Not completing the primary ABPM|3|||
33376107|NCT01317615|101261732|FG000|Overall Study|Death|6|||
33585917|NCT02038777|102032799|FG004|Overall Study|Lost to Follow-up|0|||
33585918|NCT02038777|102032800|FG005|Overall Study|Lost to Follow-up|0|||
33585919|NCT02038777|102032801|FG006|Overall Study|Lost to Follow-up|0|||
33585920|NCT02038777|102032802|FG007|Overall Study|Lost to Follow-up|0|||
33376108|NCT01317615|101261732|FG000|Overall Study|Withdrawal by Subject|5|||
33376109|NCT01317615|101261732|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33376110|NCT01317615|101261732|FG000|Overall Study|Adverse Event|7|||
33376111|NCT03550131|101261733|FG000|Overall Study|Lost to Follow-up|16|||
33376112|NCT03550131|101261734|FG001|Overall Study|Lost to Follow-up|24|||
33376113|NCT03550131|101261733|FG000|Overall Study|Withdrawal by Subject|36|||
33376114|NCT03550131|101261734|FG001|Overall Study|Withdrawal by Subject|28|||
33376115|NCT03550131|101261733|FG000|Overall Study|Illness of dyad member|10|||
33376116|NCT03550131|101261734|FG001|Overall Study|Illness of dyad member|2|||
33376117|NCT03550131|101261733|FG000|Overall Study|Death of person with dementia|4|||
33376118|NCT03550131|101261734|FG001|Overall Study|Death of person with dementia|8|||
33376119|NCT02864940|101261736|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
33376120|NCT02864940|101261737|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
33376121|NCT00495495|101261738|FG000|Overall Study|Protocol Violation|99|||
33376122|NCT00059215|101261743|FG000|Overall Study|Adverse Event|5|||
33376123|NCT00059215|101261744|FG001|Overall Study|Adverse Event|5|||
33376124|NCT00059215|101261745|FG002|Overall Study|Adverse Event|9|||
33376125|NCT00059215|101261746|FG003|Overall Study|Adverse Event|9|||
33376126|NCT00059215|101261743|FG000|Overall Study|Death|0|||
33376127|NCT00059215|101261744|FG001|Overall Study|Death|0|||
33376128|NCT00059215|101261745|FG002|Overall Study|Death|3|||
33376129|NCT00059215|101261746|FG003|Overall Study|Death|0|||
33376130|NCT00059215|101261743|FG000|Overall Study|Lost to Follow-up|1|||
33376131|NCT00059215|101261744|FG001|Overall Study|Lost to Follow-up|2|||
33376132|NCT00059215|101261745|FG002|Overall Study|Lost to Follow-up|0|||
33376133|NCT00059215|101261746|FG003|Overall Study|Lost to Follow-up|0|||
33376134|NCT00059215|101261743|FG000|Overall Study|Withdrawal by Subject|4|||
33376135|NCT00059215|101261744|FG001|Overall Study|Withdrawal by Subject|4|||
33376136|NCT00059215|101261745|FG002|Overall Study|Withdrawal by Subject|1|||
33376137|NCT00059215|101261746|FG003|Overall Study|Withdrawal by Subject|3|||
33376138|NCT00059215|101261743|FG000|Overall Study|Protocol Violation|1|||
33376139|NCT00059215|101261744|FG001|Overall Study|Protocol Violation|0|||
33376140|NCT00059215|101261745|FG002|Overall Study|Protocol Violation|1|||
33376141|NCT00059215|101261746|FG003|Overall Study|Protocol Violation|0|||
33376142|NCT00059215|101261743|FG000|Overall Study|Protocol entry criteria not met|1|||
33376143|NCT00059215|101261744|FG001|Overall Study|Protocol entry criteria not met|1|||
33376144|NCT00059215|101261745|FG002|Overall Study|Protocol entry criteria not met|0|||
33376145|NCT00059215|101261746|FG003|Overall Study|Protocol entry criteria not met|2|||
33376146|NCT00059215|101261743|FG000|Overall Study|Physician Decision|1|||
33376147|NCT00059215|101261744|FG001|Overall Study|Physician Decision|2|||
33376148|NCT00059215|101261745|FG002|Overall Study|Physician Decision|1|||
33376149|NCT00059215|101261746|FG003|Overall Study|Physician Decision|1|||
33376150|NCT03025217|101261747|FG000|Overall Study|Pregnancy|1|||
33376151|NCT03025217|101261747|FG000|Overall Study|Lost to Follow-up|1|||
33376152|NCT03025217|101261747|FG000|Overall Study|Not eligible, poor English|2|||
33376153|NCT01019486|101261749|FG000|Overall Study|Withdrawal by Subject|1|||
33376154|NCT01019486|101261750|FG001|Overall Study|Withdrawal by Subject|1|||
33376155|NCT01019486|101261751|FG002|Overall Study|Withdrawal by Subject|1|||
33376156|NCT02338492|101261752|FG000|Overall Study|Death|32|||
33376157|NCT02338492|101261752|FG000|Overall Study|Adverse Event|3|||
33376158|NCT02338492|101261752|FG000|Overall Study|Lost to Follow-up|4|||
33376159|NCT02338492|101261752|FG000|Overall Study|Reason not captured above|6|||
33376160|NCT01021852|101261755|FG000|Treatment Period 1|Adverse Event|3|||
33376161|NCT01021852|101261756|FG001|Treatment Period 1|Adverse Event|1|||
33376162|NCT01021852|101261757|FG002|Treatment Period 1|Adverse Event|1|||
33376163|NCT01021852|101261758|FG003|Treatment Period 1|Adverse Event|0|||
33376164|NCT01021852|101261759|FG004|Treatment Period 1|Adverse Event|2|||
33376165|NCT01021852|101261760|FG005|Treatment Period 1|Adverse Event|2|||
33376166|NCT01021852|101261761|FG006|Treatment Period 1|Adverse Event|0|||
33376167|NCT01021852|101261762|FG007|Treatment Period 1|Adverse Event|0|||
33376168|NCT01021852|101261755|FG000|Treatment Period 1|Pregnancy|0|||
33376169|NCT01021852|101261756|FG001|Treatment Period 1|Pregnancy|0|||
33376170|NCT01021852|101261757|FG002|Treatment Period 1|Pregnancy|1|||
33376171|NCT01021852|101261758|FG003|Treatment Period 1|Pregnancy|0|||
33376172|NCT01021852|101261759|FG004|Treatment Period 1|Pregnancy|0|||
33376173|NCT01021852|101261760|FG005|Treatment Period 1|Pregnancy|0|||
33376174|NCT01021852|101261761|FG006|Treatment Period 1|Pregnancy|0|||
33376175|NCT01021852|101261762|FG007|Treatment Period 1|Pregnancy|0|||
33585921|NCT02038777|102032795|FG000|Overall Study|Other|0|||
33376176|NCT01021852|101261755|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33376177|NCT01021852|101261756|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33376178|NCT01021852|101261757|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33376179|NCT01021852|101261758|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33376180|NCT01021852|101261759|FG004|Treatment Period 1|Withdrawal by Subject|1|||
33376181|NCT01021852|101261760|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33376182|NCT01021852|101261761|FG006|Treatment Period 1|Withdrawal by Subject|0|||
33376183|NCT01021852|101261762|FG007|Treatment Period 1|Withdrawal by Subject|1|||
33585922|NCT02038777|102032796|FG001|Overall Study|Other|1|||
33376184|NCT01021852|101261755|FG000|Treatment Period 1|Not Treated|0|||
33376185|NCT01021852|101261756|FG001|Treatment Period 1|Not Treated|0|||
33376186|NCT01021852|101261757|FG002|Treatment Period 1|Not Treated|0|||
33376187|NCT01021852|101261758|FG003|Treatment Period 1|Not Treated|2|||
33376188|NCT01021852|101261759|FG004|Treatment Period 1|Not Treated|0|||
33376189|NCT01021852|101261760|FG005|Treatment Period 1|Not Treated|0|||
33376190|NCT01021852|101261761|FG006|Treatment Period 1|Not Treated|0|||
33376191|NCT01021852|101261762|FG007|Treatment Period 1|Not Treated|0|||
33376192|NCT01021852|101261755|FG000|Washout Period-Placebo|Adverse Event|0|||
33376193|NCT01021852|101261756|FG001|Washout Period-Placebo|Adverse Event|0|||
33376194|NCT01021852|101261757|FG002|Washout Period-Placebo|Adverse Event|0|||
33376195|NCT01021852|101261758|FG003|Washout Period-Placebo|Adverse Event|1|||
33376196|NCT01021852|101261759|FG004|Washout Period-Placebo|Adverse Event|0|||
33376197|NCT01021852|101261760|FG005|Washout Period-Placebo|Adverse Event|1|||
33376198|NCT01021852|101261761|FG006|Washout Period-Placebo|Adverse Event|0|||
33376199|NCT01021852|101261762|FG007|Washout Period-Placebo|Adverse Event|0|||
33376200|NCT01021852|101261755|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
33376201|NCT01021852|101261756|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
33376202|NCT01021852|101261757|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
33376203|NCT01021852|101261758|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
33376204|NCT01021852|101261759|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
33376205|NCT01021852|101261760|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
33376206|NCT01021852|101261761|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
33376207|NCT01021852|101261762|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
33376208|NCT01021852|101261755|FG000|Washout Period-Placebo|Protocol Violation|0|||
33376209|NCT01021852|101261756|FG001|Washout Period-Placebo|Protocol Violation|0|||
33376210|NCT01021852|101261757|FG002|Washout Period-Placebo|Protocol Violation|0|||
33376211|NCT01021852|101261758|FG003|Washout Period-Placebo|Protocol Violation|0|||
33376212|NCT01021852|101261759|FG004|Washout Period-Placebo|Protocol Violation|0|||
33376213|NCT01021852|101261760|FG005|Washout Period-Placebo|Protocol Violation|0|||
33376214|NCT01021852|101261761|FG006|Washout Period-Placebo|Protocol Violation|1|||
33376215|NCT01021852|101261762|FG007|Washout Period-Placebo|Protocol Violation|0|||
33376216|NCT01021852|101261755|FG000|Washout Period-No Drug|Adverse Event|1|||
33376217|NCT01021852|101261756|FG001|Washout Period-No Drug|Adverse Event|0|||
33376218|NCT01021852|101261757|FG002|Washout Period-No Drug|Adverse Event|0|||
33376219|NCT01021852|101261758|FG003|Washout Period-No Drug|Adverse Event|0|||
33376220|NCT01021852|101261759|FG004|Washout Period-No Drug|Adverse Event|0|||
33376221|NCT01021852|101261760|FG005|Washout Period-No Drug|Adverse Event|1|||
33376222|NCT01021852|101261761|FG006|Washout Period-No Drug|Adverse Event|0|||
33376223|NCT01021852|101261762|FG007|Washout Period-No Drug|Adverse Event|0|||
33376224|NCT01021852|101261755|FG000|Treatment Period 2|Adverse Event|0|||
33376225|NCT01021852|101261756|FG001|Treatment Period 2|Adverse Event|1|||
33376226|NCT01021852|101261757|FG002|Treatment Period 2|Adverse Event|0|||
33376227|NCT01021852|101261758|FG003|Treatment Period 2|Adverse Event|0|||
33376228|NCT01021852|101261759|FG004|Treatment Period 2|Adverse Event|1|||
33376229|NCT01021852|101261760|FG005|Treatment Period 2|Adverse Event|0|||
33376230|NCT01021852|101261761|FG006|Treatment Period 2|Adverse Event|1|||
33376231|NCT01021852|101261762|FG007|Treatment Period 2|Adverse Event|0|||
33376232|NCT01021852|101261755|FG000|Treatment Period 2|Lack of Efficacy|0|||
33376233|NCT01021852|101261756|FG001|Treatment Period 2|Lack of Efficacy|0|||
33376234|NCT01021852|101261757|FG002|Treatment Period 2|Lack of Efficacy|0|||
33376235|NCT01021852|101261758|FG003|Treatment Period 2|Lack of Efficacy|0|||
33376236|NCT01021852|101261759|FG004|Treatment Period 2|Lack of Efficacy|0|||
33376237|NCT01021852|101261760|FG005|Treatment Period 2|Lack of Efficacy|1|||
33376238|NCT01021852|101261761|FG006|Treatment Period 2|Lack of Efficacy|0|||
33376239|NCT01021852|101261762|FG007|Treatment Period 2|Lack of Efficacy|0|||
33376240|NCT01021852|101261755|FG000|Treatment Period 2|Physician Decision|0|||
33376241|NCT01021852|101261756|FG001|Treatment Period 2|Physician Decision|0|||
33376242|NCT01021852|101261757|FG002|Treatment Period 2|Physician Decision|1|||
33376243|NCT01021852|101261758|FG003|Treatment Period 2|Physician Decision|0|||
33376244|NCT01021852|101261759|FG004|Treatment Period 2|Physician Decision|0|||
33376245|NCT01021852|101261760|FG005|Treatment Period 2|Physician Decision|0|||
33376246|NCT01021852|101261761|FG006|Treatment Period 2|Physician Decision|0|||
33376247|NCT01021852|101261762|FG007|Treatment Period 2|Physician Decision|0|||
33148640|NCT00704808|100458199|FG000|Overall Study|Tumor progression|80|||
33376248|NCT01021852|101261755|FG000|Treatment Period 2|Protocol Violation|0|||
33376249|NCT01021852|101261756|FG001|Treatment Period 2|Protocol Violation|0|||
33376250|NCT01021852|101261757|FG002|Treatment Period 2|Protocol Violation|0|||
33376251|NCT01021852|101261758|FG003|Treatment Period 2|Protocol Violation|0|||
33376252|NCT01021852|101261759|FG004|Treatment Period 2|Protocol Violation|1|||
33585923|NCT02038777|102032797|FG002|Overall Study|Other|0|||
33376253|NCT01021852|101261760|FG005|Treatment Period 2|Protocol Violation|0|||
33376254|NCT01021852|101261761|FG006|Treatment Period 2|Protocol Violation|1|||
33376255|NCT01021852|101261762|FG007|Treatment Period 2|Protocol Violation|0|||
33376256|NCT01021852|101261755|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33376257|NCT01021852|101261756|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33585924|NCT02038777|102032798|FG003|Overall Study|Other|2|||
33376258|NCT01021852|101261757|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33376259|NCT01021852|101261758|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33246760|NCT03503773|100803897|FG001|Overall Study|Not completing the primary ABPM|1|||
33246761|NCT03503773|100803896|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
33246762|NCT03503773|100803897|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
33246763|NCT02317705|100803898|FG000|Overall Study|Withdrawal by Subject|3|||
33246764|NCT02317705|100803898|FG000|Overall Study|Physician Decision|1|||
33246765|NCT02317705|100803898|FG000|Overall Study|Drug not usable|1|||
33246766|NCT01981356|100803900|FG000|Overall Study|Lost to Follow-up|4|||
33246767|NCT01981356|100803901|FG001|Overall Study|Lost to Follow-up|1|||
33246768|NCT01981356|100803900|FG000|Overall Study|Withdrawal by Subject|1|||
33246769|NCT01981356|100803901|FG001|Overall Study|Withdrawal by Subject|1|||
33246770|NCT01981356|100803900|FG000|Overall Study|Protocol Violation|2|||
33246771|NCT01981356|100803901|FG001|Overall Study|Protocol Violation|0|||
33246772|NCT03425539|100803902|FG000|Overall Study|Randomized but not treated|0|||
33246773|NCT03425539|100803903|FG001|Overall Study|Randomized but not treated|1|||
33246774|NCT03425539|100803902|FG000|Overall Study|Adverse Event|2|||
33246775|NCT03425539|100803903|FG001|Overall Study|Adverse Event|2|||
33246776|NCT03425539|100803902|FG000|Overall Study|Withdrawal by Subject|3|||
33246777|NCT03425539|100803903|FG001|Overall Study|Withdrawal by Subject|0|||
33246778|NCT03425539|100803902|FG000|Overall Study|Lost to Follow-up|0|||
33246779|NCT03425539|100803903|FG001|Overall Study|Lost to Follow-up|1|||
33246780|NCT02289560|100803904|FG000|Overall Study|Lost to Follow-up|6|||
33246781|NCT02289560|100803904|FG000|Overall Study|Alternative Treatment|4|||
33246782|NCT02289560|100803904|FG000|Overall Study|Inadequate Treatment|2|||
33246783|NCT02289560|100803904|FG000|Overall Study|Withdrawal by Subject|23|||
33246784|NCT00712166|100803905|FG000|Overall Study|Noncompliance|0|||
33246785|NCT00712166|100803906|FG001|Overall Study|Noncompliance|1|||
33246786|NCT04091672|100803909|FG000|Overall Study|Death|6|||
33246787|NCT04091672|100803910|FG001|Overall Study|Death|6|||
33246788|NCT04091672|100803909|FG000|Overall Study|Lost to Follow-up|7|||
33246789|NCT04091672|100803910|FG001|Overall Study|Lost to Follow-up|7|||
33246790|NCT04091672|100803909|FG000|Overall Study|Withdrawal by Subject|3|||
33246791|NCT04091672|100803910|FG001|Overall Study|Withdrawal by Subject|3|||
33246792|NCT04091672|100803909|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
33246793|NCT04091672|100803910|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
33246794|NCT01867580|100803911|FG000|Overall Study|Withdrawal by Subject|2|||
33376260|NCT01021852|101261759|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33376261|NCT01021852|101261760|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33376262|NCT01021852|101261761|FG006|Treatment Period 2|Withdrawal by Subject|1|||
33376263|NCT01021852|101261762|FG007|Treatment Period 2|Withdrawal by Subject|2|||
33376264|NCT01658579|101261768|FG000|Treatment Period A|Other|0|||
33376265|NCT01658579|101261769|FG001|Treatment Period A|Other|0|||
33376266|NCT01658579|101261770|FG002|Treatment Period A|Other|1|||
33376267|NCT01658579|101261771|FG003|Treatment Period A|Other|1|||
33376268|NCT01658579|101261768|FG000|Treatment Period A|Adverse Event|1|||
33376269|NCT01658579|101261769|FG001|Treatment Period A|Adverse Event|0|||
33376270|NCT01658579|101261770|FG002|Treatment Period A|Adverse Event|0|||
33376271|NCT01658579|101261771|FG003|Treatment Period A|Adverse Event|0|||
33376272|NCT01658579|101261768|FG000|Treatment Period B|Other|0|||
33376273|NCT01658579|101261769|FG001|Treatment Period B|Other|0|||
33376274|NCT01658579|101261770|FG002|Treatment Period B|Other|0|||
33376275|NCT01658579|101261771|FG003|Treatment Period B|Other|1|||
33376276|NCT00910429|101261774|FG000|Overall Study|Death|18|||
33376277|NCT00910429|101261775|FG001|Overall Study|Death|12|||
33376278|NCT00910429|101261774|FG000|Overall Study|Withdrawal by Subject|3|||
33376279|NCT00910429|101261775|FG001|Overall Study|Withdrawal by Subject|2|||
33376280|NCT00910429|101261774|FG000|Overall Study|Protocol Violation|1|||
33376281|NCT00910429|101261775|FG001|Overall Study|Protocol Violation|0|||
33376282|NCT00910429|101261774|FG000|Overall Study|Lost to Follow-up|2|||
33246795|NCT01867580|100803912|FG001|Overall Study|Withdrawal by Subject|3|||
33376283|NCT00910429|101261775|FG001|Overall Study|Lost to Follow-up|1|||
33423821|NCT01271933|101443597|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
33423822|NCT01271933|101443598|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
33246796|NCT01867580|100803911|FG000|Overall Study|Physician Decision|17|||
33246797|NCT01867580|100803912|FG001|Overall Study|Physician Decision|12|||
33423823|NCT01271933|101443599|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
33246798|NCT01867580|100803911|FG000|Overall Study|Lost to Follow-up|3|||
33246799|NCT01867580|100803912|FG001|Overall Study|Lost to Follow-up|5|||
33246800|NCT01867580|100803911|FG000|Overall Study|Sponsor terminated study|1|||
33246801|NCT01867580|100803912|FG001|Overall Study|Sponsor terminated study|0|||
33246802|NCT01867580|100803911|FG000|Overall Study|Missed follow-up assessment|2|||
33246803|NCT01867580|100803912|FG001|Overall Study|Missed follow-up assessment|1|||
33246804|NCT01867580|100803911|FG000|Overall Study|Interruption to therapy|3|||
33376284|NCT00910429|101261774|FG000|Overall Study|Adverse Event|10|||
33376285|NCT00910429|101261775|FG001|Overall Study|Adverse Event|5|||
33376286|NCT00910429|101261774|FG000|Overall Study|Drug non-compliance|1|||
33376287|NCT00910429|101261775|FG001|Overall Study|Drug non-compliance|0|||
33376288|NCT00910429|101261774|FG000|Overall Study|Lack of Efficacy|4|||
33376289|NCT00910429|101261775|FG001|Overall Study|Lack of Efficacy|1|||
33376290|NCT03176277|101261776|FG000|Part A Dose Escalation Study|Adverse Event|1|||
33376291|NCT03176277|101261777|FG001|Part A Dose Escalation Study|Adverse Event|0|||
33376292|NCT03176277|101261778|FG002|Part A Dose Escalation Study|Adverse Event|1|||
33376293|NCT03176277|101261779|FG003|Part A Dose Escalation Study|Adverse Event|0|||
33376294|NCT03176277|101261776|FG000|Part A Dose Escalation Study|Physician Decision|1|||
33376295|NCT03176277|101261777|FG001|Part A Dose Escalation Study|Physician Decision|1|||
33376296|NCT03176277|101261778|FG002|Part A Dose Escalation Study|Physician Decision|2|||
33376297|NCT03176277|101261779|FG003|Part A Dose Escalation Study|Physician Decision|0|||
33376298|NCT03176277|101261776|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
33376299|NCT03176277|101261777|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
33376300|NCT03176277|101261778|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
33376301|NCT03176277|101261779|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
33376302|NCT03176277|101261776|FG000|Part A Dose Escalation Study|Progressive disease|3|||
33376303|NCT03176277|101261777|FG001|Part A Dose Escalation Study|Progressive disease|1|||
33376304|NCT03176277|101261778|FG002|Part A Dose Escalation Study|Progressive disease|3|||
33376305|NCT03176277|101261779|FG003|Part A Dose Escalation Study|Progressive disease|0|||
33376306|NCT00448916|101261784|FG000|Overall Study|Adverse Event|2|||
33376307|NCT00448916|101261785|FG001|Overall Study|Adverse Event|2|||
33376308|NCT00448916|101261786|FG002|Overall Study|Adverse Event|3|||
33376309|NCT00448916|101261787|FG003|Overall Study|Adverse Event|2|||
33376310|NCT00448916|101261784|FG000|Overall Study|Lack of Efficacy|1|||
33376311|NCT00448916|101261785|FG001|Overall Study|Lack of Efficacy|0|||
33376312|NCT00448916|101261786|FG002|Overall Study|Lack of Efficacy|2|||
33376313|NCT00448916|101261787|FG003|Overall Study|Lack of Efficacy|1|||
33376314|NCT00448916|101261784|FG000|Overall Study|Withdrawal by Subject|3|||
33376315|NCT00448916|101261785|FG001|Overall Study|Withdrawal by Subject|3|||
33376316|NCT00448916|101261786|FG002|Overall Study|Withdrawal by Subject|1|||
33376317|NCT00448916|101261787|FG003|Overall Study|Withdrawal by Subject|1|||
33376318|NCT00448916|101261784|FG000|Overall Study|Other|1|||
33376319|NCT00448916|101261785|FG001|Overall Study|Other|0|||
33376320|NCT00448916|101261786|FG002|Overall Study|Other|0|||
33376321|NCT00448916|101261787|FG003|Overall Study|Other|0|||
33376322|NCT00448916|101261784|FG000|Overall Study|Lost to Follow-up|0|||
33376323|NCT00448916|101261785|FG001|Overall Study|Lost to Follow-up|1|||
33376324|NCT00448916|101261786|FG002|Overall Study|Lost to Follow-up|0|||
33376325|NCT00448916|101261787|FG003|Overall Study|Lost to Follow-up|1|||
33376326|NCT00448916|101261784|FG000|Overall Study|Protocol Violation|0|||
33376327|NCT00448916|101261785|FG001|Overall Study|Protocol Violation|0|||
33376328|NCT00448916|101261786|FG002|Overall Study|Protocol Violation|0|||
33376329|NCT00448916|101261787|FG003|Overall Study|Protocol Violation|1|||
33376330|NCT00264849|101261790|FG000|Overall Study|Adverse Event|7|||
33376331|NCT00264849|101261791|FG001|Overall Study|Adverse Event|2|||
33376332|NCT00264849|101261790|FG000|Overall Study|Withdrawal by Subject|7|||
33376333|NCT00264849|101261791|FG001|Overall Study|Withdrawal by Subject|11|||
33376334|NCT00264849|101261790|FG000|Overall Study|Protocol Violation|5|||
33376335|NCT00264849|101261791|FG001|Overall Study|Protocol Violation|3|||
33376336|NCT00264849|101261790|FG000|Overall Study|Lack of Efficacy|1|||
33376337|NCT00264849|101261791|FG001|Overall Study|Lack of Efficacy|6|||
33585925|NCT02038777|102032799|FG004|Overall Study|Other|1|||
33585926|NCT02038777|102032800|FG005|Overall Study|Other|0|||
33585927|NCT02038777|102032801|FG006|Overall Study|Other|0|||
33585928|NCT02038777|102032802|FG007|Overall Study|Other|0|||
33376338|NCT00264849|101261790|FG000|Overall Study|Lost to Follow-up|0|||
33376339|NCT00264849|101261791|FG001|Overall Study|Lost to Follow-up|2|||
33376340|NCT00264849|101261790|FG000|Overall Study|Death|0|||
33376341|NCT00264849|101261791|FG001|Overall Study|Death|1|||
33376342|NCT00264849|101261790|FG000|Overall Study|Administrative Problems|2|||
33376343|NCT00264849|101261791|FG001|Overall Study|Administrative Problems|0|||
33376344|NCT00288860|101261792|FG000|Overall Study|Did not complete intake|4|||
33376345|NCT00288860|101261793|FG001|Overall Study|Did not complete intake|8|||
33585929|NCT02038777|102032795|FG000|Overall Study|Randomized but not treated|0|||
33585930|NCT02038777|102032796|FG001|Overall Study|Randomized but not treated|1|||
33246805|NCT01867580|100803912|FG001|Overall Study|Interruption to therapy|0|||
33376346|NCT00288860|101261792|FG000|Overall Study|Death|4|||
33376347|NCT00288860|101261793|FG001|Overall Study|Death|3|||
33376348|NCT00288860|101261792|FG000|Overall Study|Withdrawal by Subject|20|||
33376349|NCT00288860|101261793|FG001|Overall Study|Withdrawal by Subject|15|||
33376350|NCT00288860|101261792|FG000|Overall Study|Lost to Follow-up|74|||
33376351|NCT00288860|101261793|FG001|Overall Study|Lost to Follow-up|71|||
33376352|NCT04105244|101261794|FG000|Overall Study|Withdrawal by Subject|10|||
33376353|NCT04105244|101261795|FG001|Overall Study|Withdrawal by Subject|12|||
33376354|NCT04105244|101261794|FG000|Overall Study|Lost to Follow-up|20|||
33376355|NCT04105244|101261795|FG001|Overall Study|Lost to Follow-up|15|||
33585931|NCT02038777|102032797|FG002|Overall Study|Randomized but not treated|0|||
33376356|NCT04105244|101261794|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
33376357|NCT04105244|101261795|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
33376358|NCT04105244|101261794|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
33376359|NCT04105244|101261795|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
33376360|NCT02815293|101261796|FG000|Overall Study|Study termination by sponsor|10|||
33376361|NCT02815293|101261797|FG001|Overall Study|Study termination by sponsor|7|||
33376362|NCT02815293|101261798|FG002|Overall Study|Study termination by sponsor|0|||
33376363|NCT02815293|101261796|FG000|Overall Study|Participants not randomized|0|||
33376364|NCT02815293|101261797|FG001|Overall Study|Participants not randomized|0|||
33376365|NCT02815293|101261798|FG002|Overall Study|Participants not randomized|18|||
33376366|NCT02815293|101261796|FG000|Overall Study|Adverse Event|0|||
33376367|NCT02815293|101261797|FG001|Overall Study|Adverse Event|1|||
33376368|NCT02815293|101261798|FG002|Overall Study|Adverse Event|0|||
33376369|NCT00675103|101261799|FG000|Overall Study|Lack of Efficacy|2|||
33376370|NCT00675103|101261799|FG000|Overall Study|Adverse Event|1|||
33376371|NCT00808249|101261800|FG000|Overall Study|Adverse Event|4|||
33376372|NCT00808249|101261801|FG001|Overall Study|Adverse Event|7|||
33376373|NCT00808249|101261802|FG002|Overall Study|Adverse Event|10|||
33376374|NCT00808249|101261803|FG003|Overall Study|Adverse Event|6|||
33376375|NCT00808249|101261800|FG000|Overall Study|Lost to Follow-up|2|||
33376376|NCT00808249|101261801|FG001|Overall Study|Lost to Follow-up|3|||
33376377|NCT00808249|101261802|FG002|Overall Study|Lost to Follow-up|3|||
33376378|NCT00808249|101261803|FG003|Overall Study|Lost to Follow-up|5|||
33376379|NCT00808249|101261800|FG000|Overall Study|Withdrawal by Subject|4|||
33376380|NCT00808249|101261801|FG001|Overall Study|Withdrawal by Subject|0|||
33376381|NCT00808249|101261802|FG002|Overall Study|Withdrawal by Subject|2|||
33376382|NCT00808249|101261803|FG003|Overall Study|Withdrawal by Subject|4|||
33376383|NCT00808249|101261800|FG000|Overall Study|Protocol Violation|3|||
33376384|NCT00808249|101261801|FG001|Overall Study|Protocol Violation|3|||
33376385|NCT00808249|101261802|FG002|Overall Study|Protocol Violation|3|||
33376386|NCT00808249|101261803|FG003|Overall Study|Protocol Violation|0|||
33376387|NCT00808249|101261800|FG000|Overall Study|Lack of Efficacy|1|||
33376388|NCT00808249|101261801|FG001|Overall Study|Lack of Efficacy|1|||
33376389|NCT00808249|101261802|FG002|Overall Study|Lack of Efficacy|0|||
33376390|NCT00808249|101261803|FG003|Overall Study|Lack of Efficacy|0|||
33376391|NCT00808249|101261800|FG000|Overall Study|study specific discontinuation criteria|1|||
33376392|NCT00808249|101261801|FG001|Overall Study|study specific discontinuation criteria|0|||
33376393|NCT00808249|101261802|FG002|Overall Study|study specific discontinuation criteria|1|||
33376394|NCT00808249|101261803|FG003|Overall Study|study specific discontinuation criteria|0|||
33376395|NCT00808249|101261800|FG000|Overall Study|All other reasons|2|||
33376396|NCT00808249|101261801|FG001|Overall Study|All other reasons|1|||
33376397|NCT00808249|101261802|FG002|Overall Study|All other reasons|3|||
33376398|NCT00808249|101261803|FG003|Overall Study|All other reasons|1|||
33376399|NCT02397694|101261809|FG000|Double-Blinded Phase|Adverse Event|1|||
33376400|NCT02397694|101261810|FG001|Double-Blinded Phase|Adverse Event|0|||
33376401|NCT02397694|101261809|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
33376402|NCT02397694|101261810|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
33376403|NCT02397694|101261809|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
33376404|NCT02397694|101261810|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
33376405|NCT02397694|101261809|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
33423824|NCT01271933|101443597|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
33423825|NCT01271933|101443598|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
33585932|NCT02038777|102032798|FG003|Overall Study|Randomized but not treated|0|||
33585933|NCT02038777|102032799|FG004|Overall Study|Randomized but not treated|0|||
33585934|NCT02038777|102032800|FG005|Overall Study|Randomized but not treated|0|||
33585935|NCT02038777|102032801|FG006|Overall Study|Randomized but not treated|0|||
33585936|NCT02038777|102032802|FG007|Overall Study|Randomized but not treated|0|||
33585937|NCT02038777|102032795|FG000|Overall Study|Started Chemotherapy|1|||
33585938|NCT02038777|102032796|FG001|Overall Study|Started Chemotherapy|0|||
33585939|NCT02038777|102032797|FG002|Overall Study|Started Chemotherapy|3|||
33585940|NCT02038777|102032798|FG003|Overall Study|Started Chemotherapy|0|||
33585941|NCT02038777|102032799|FG004|Overall Study|Started Chemotherapy|0|||
33585942|NCT02038777|102032800|FG005|Overall Study|Started Chemotherapy|0|||
33585943|NCT02038777|102032801|FG006|Overall Study|Started Chemotherapy|0|||
33585944|NCT02038777|102032802|FG007|Overall Study|Started Chemotherapy|0|||
33585945|NCT01270880|102032806|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
33585946|NCT02831855|102032809|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
33585947|NCT02831855|102032810|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
33376406|NCT02397694|101261810|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
33585948|NCT02831855|102032811|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
33376407|NCT02397694|101261809|FG000|Open Label Extension Phase|Protocol Violation|1|||
33376408|NCT02397694|101261810|FG001|Open Label Extension Phase|Protocol Violation|0|||
33376409|NCT02397694|101261809|FG000|Open Label Extension Phase|Withdrew Consent|3|||
33376410|NCT02397694|101261810|FG001|Open Label Extension Phase|Withdrew Consent|1|||
33423826|NCT01271933|101443599|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
33376411|NCT02397694|101261809|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
33376412|NCT02397694|101261810|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
33376413|NCT01934894|101261819|FG000|Overall Study|Adverse Event|1|||
33376414|NCT01934894|101261820|FG001|Overall Study|Adverse Event|2|||
33376415|NCT01934894|101261819|FG000|Overall Study|Death|2|||
33376416|NCT01934894|101261820|FG001|Overall Study|Death|0|||
33376417|NCT01934894|101261819|FG000|Overall Study|Withdrawal by Subject|0|||
33376418|NCT01934894|101261820|FG001|Overall Study|Withdrawal by Subject|1|||
33376419|NCT01934894|101261819|FG000|Overall Study|Progressive Disease|3|||
33376420|NCT01934894|101261820|FG001|Overall Study|Progressive Disease|2|||
33376421|NCT02622724|101264976|FG000|Overall Study|Death|51|||
33376422|NCT02622724|101264977|FG001|Overall Study|Death|53|||
33376423|NCT02622724|101264976|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
33376424|NCT02622724|101264977|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
33376425|NCT02622724|101264976|FG000|Overall Study|Early termination of study|38|||
33376426|NCT02622724|101264977|FG001|Overall Study|Early termination of study|43|||
33376427|NCT00717366|101264978|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
33376428|NCT00717366|101264979|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
33376429|NCT00717366|101264978|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
33376430|NCT00717366|101264979|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
33376431|NCT00717366|101264978|FG000|Core Study Period (20 Weeks)|Death|0|||
33376432|NCT00717366|101264979|FG001|Core Study Period (20 Weeks)|Death|1|||
33376433|NCT00717366|101264978|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
33376434|NCT00717366|101264979|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
33376435|NCT00717366|101264978|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
33376436|NCT00717366|101264979|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
33376437|NCT00717366|101264978|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
33376438|NCT00717366|101264979|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
33376439|NCT00717366|101264978|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
33376440|NCT00717366|101264979|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
33376441|NCT03225716|101264984|FG000|Overall Study|Withdrawal by Subject|2|||
33376442|NCT03225716|101264985|FG001|Overall Study|Withdrawal by Subject|2|||
33376443|NCT03225716|101264986|FG002|Overall Study|Withdrawal by Subject|0|||
33376444|NCT03225716|101264984|FG000|Overall Study|Lack of Efficacy|1|||
33376445|NCT03225716|101264985|FG001|Overall Study|Lack of Efficacy|0|||
33376446|NCT03225716|101264986|FG002|Overall Study|Lack of Efficacy|0|||
33376447|NCT03225716|101264984|FG000|Overall Study|Adverse Event|2|||
33376448|NCT03225716|101264985|FG001|Overall Study|Adverse Event|0|||
33376449|NCT03225716|101264986|FG002|Overall Study|Adverse Event|1|||
33376450|NCT03225716|101264984|FG000|Overall Study|Study early termination by Sponsor|0|||
33376451|NCT03225716|101264985|FG001|Overall Study|Study early termination by Sponsor|0|||
33376452|NCT03225716|101264986|FG002|Overall Study|Study early termination by Sponsor|2|||
33376453|NCT02922634|101264987|FG000|Overall Study|Withdrawal by Subject|5|||
33376454|NCT02922634|101264987|FG000|Overall Study|Did not have their surgery|5|||
33376455|NCT03245723|101264988|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
33585949|NCT02831855|102032809|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
33585950|NCT02831855|102032810|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
33585951|NCT02831855|102032811|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
33585952|NCT02831855|102032809|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
33246806|NCT01867580|100803911|FG000|Overall Study|Osteomyelitis|0|||
33246807|NCT01867580|100803912|FG001|Overall Study|Osteomyelitis|1|||
33246808|NCT01867580|100803911|FG000|Overall Study|Continuation of therapy|0|||
33246809|NCT01867580|100803912|FG001|Overall Study|Continuation of therapy|1|||
33246810|NCT01867580|100803911|FG000|Overall Study|Wound recurrence|0|||
33246811|NCT01867580|100803912|FG001|Overall Study|Wound recurrence|1|||
33246812|NCT00404079|100803915|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
33246813|NCT00404079|100803916|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
33246814|NCT03538054|100803917|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
33246815|NCT03538054|100803917|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
33246816|NCT03538054|100803917|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
33246817|NCT00995709|100803918|FG000|Overall Study|Adverse Event|4|||
33246818|NCT00995709|100803919|FG001|Overall Study|Adverse Event|2|||
33246819|NCT00995709|100803920|FG002|Overall Study|Adverse Event|0|||
33246820|NCT00995709|100803918|FG000|Overall Study|Lack of Efficacy|0|||
33246821|NCT00995709|100803919|FG001|Overall Study|Lack of Efficacy|1|||
33246822|NCT00995709|100803920|FG002|Overall Study|Lack of Efficacy|4|||
33376456|NCT03245723|101264989|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
33376457|NCT03245723|101264988|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
33376458|NCT03245723|101264989|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
33585953|NCT02831855|102032810|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
33246823|NCT00995709|100803918|FG000|Overall Study|Withdrawal by Subject|0|||
33246824|NCT00995709|100803919|FG001|Overall Study|Withdrawal by Subject|4|||
33246825|NCT00995709|100803920|FG002|Overall Study|Withdrawal by Subject|1|||
33246826|NCT00995709|100803918|FG000|Overall Study|Lost to Follow-up|1|||
33585954|NCT02831855|102032811|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
33585955|NCT02831855|102032809|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
33585956|NCT02831855|102032810|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
33585957|NCT02831855|102032811|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
33585958|NCT02831855|102032809|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
33585959|NCT02831855|102032810|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
33585960|NCT02831855|102032811|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
33376459|NCT03245723|101264988|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
33585961|NCT02831855|102032809|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
33246827|NCT00995709|100803919|FG001|Overall Study|Lost to Follow-up|0|||
33246828|NCT00995709|100803920|FG002|Overall Study|Lost to Follow-up|0|||
33246829|NCT00995709|100803918|FG000|Overall Study|Death|0|||
33246830|NCT00995709|100803919|FG001|Overall Study|Death|1|||
33246831|NCT00995709|100803920|FG002|Overall Study|Death|0|||
33246832|NCT00995709|100803918|FG000|Overall Study|Protocol Violation|2|||
33246833|NCT00995709|100803919|FG001|Overall Study|Protocol Violation|1|||
33246834|NCT00995709|100803920|FG002|Overall Study|Protocol Violation|0|||
33246835|NCT03768206|100803921|FG000|Overall Study|Lost to Follow-up|2|||
33246836|NCT03768206|100803922|FG001|Overall Study|Lost to Follow-up|1|||
33246837|NCT03768206|100803921|FG000|Overall Study|Withdrawal by Subject|0|||
33246838|NCT03768206|100803922|FG001|Overall Study|Withdrawal by Subject|1|||
33246839|NCT03102242|100803923|FG000|Overall Study|Adverse Event|2|||
33246840|NCT01027286|100803924|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
33246841|NCT01027286|100803925|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
33246842|NCT01027286|100803924|FG000|Overall Study|Lost to Follow-up|0|||
33246843|NCT01027286|100803925|FG001|Overall Study|Lost to Follow-up|1|||
33246844|NCT01211665|100803926|FG000|Overall Study|Withdrawal by Subject|1|||
33246845|NCT01211665|100803927|FG001|Overall Study|Withdrawal by Subject|0|||
33246846|NCT01211665|100803926|FG000|Overall Study|Death|1|||
33246847|NCT01211665|100803927|FG001|Overall Study|Death|0|||
33246848|NCT00425503|100803928|FG000|Overall Study|Adverse Event|2|||
33246849|NCT00425503|100803928|FG000|Overall Study|Protocol Violation|1|||
33246850|NCT03563053|100803929|FG000|Overall Study|Withdrawal by Subject|17|||
33246851|NCT03563053|100803929|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
33246852|NCT03563053|100803929|FG000|Overall Study|Adverse Event|3|||
33246853|NCT03563053|100803929|FG000|Overall Study|Physician Decision|1|||
33246854|NCT03563053|100803929|FG000|Overall Study|study terminated by sponsor|71|||
33246855|NCT03404843|100803930|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
33246856|NCT03404843|100803931|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
33246857|NCT01107626|100803932|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
33246858|NCT01107626|100803933|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
33246859|NCT01107626|100803934|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
33585962|NCT02831855|102032810|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
33585963|NCT02831855|102032811|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
33585964|NCT02831855|102032809|FG000|Open Label Phase (24 Weeks)|Other|4|||
33585965|NCT02831855|102032810|FG001|Open Label Phase (24 Weeks)|Other|0|||
33585966|NCT02831855|102032811|FG002|Open Label Phase (24 Weeks)|Other|0|||
33585967|NCT02831855|102032809|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
33585968|NCT02831855|102032810|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
33585969|NCT02831855|102032811|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
33585970|NCT02831855|102032809|FG000|Double Blind Phase (24 Weeks)|Death|0|||
33585971|NCT02831855|102032810|FG001|Double Blind Phase (24 Weeks)|Death|0|||
33585972|NCT02831855|102032811|FG002|Double Blind Phase (24 Weeks)|Death|2|||
33585973|NCT02831855|102032809|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
33585974|NCT02831855|102032810|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
33585975|NCT02831855|102032811|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
33585976|NCT02831855|102032809|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
33585977|NCT02831855|102032810|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
33585978|NCT02831855|102032811|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
33585979|NCT02831855|102032809|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
33585980|NCT02831855|102032810|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
33585981|NCT02831855|102032811|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
33585982|NCT02831855|102032809|FG000|Double Blind Phase (24 Weeks)|Other|0|||
33585983|NCT02831855|102032810|FG001|Double Blind Phase (24 Weeks)|Other|2|||
33246860|NCT01107626|100803935|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
33246861|NCT01107626|100803932|FG000|Step 1: Induction Therapy|Adverse Event|198|||
33246862|NCT01107626|100803933|FG001|Step 1: Induction Therapy|Adverse Event|0|||
33246863|NCT01107626|100803934|FG002|Step 1: Induction Therapy|Adverse Event|0|||
33246864|NCT01107626|100803935|FG003|Step 1: Induction Therapy|Adverse Event|0|||
33376460|NCT03245723|101264989|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
33376461|NCT03245723|101264988|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
33585984|NCT02831855|102032811|FG002|Double Blind Phase (24 Weeks)|Other|5|||
33585985|NCT02831855|102032809|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
33376462|NCT03245723|101264989|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
33376463|NCT00406783|101264990|FG000|Overall Study|Adverse Event|4|||
33376464|NCT00406783|101264991|FG001|Overall Study|Adverse Event|4|||
33376465|NCT00406783|101264990|FG000|Overall Study|Treatment Failure|2|||
33376466|NCT00406783|101264991|FG001|Overall Study|Treatment Failure|3|||
33376467|NCT00406783|101264990|FG000|Overall Study|Lost to Follow-up|3|||
33376468|NCT00406783|101264991|FG001|Overall Study|Lost to Follow-up|0|||
33376469|NCT00406783|101264990|FG000|Overall Study|Withdrawal by Subject|1|||
33376470|NCT00406783|101264991|FG001|Overall Study|Withdrawal by Subject|4|||
33376471|NCT00406783|101264990|FG000|Overall Study|Protocol Violation|4|||
33376472|NCT00406783|101264991|FG001|Overall Study|Protocol Violation|4|||
33376473|NCT01093755|101264992|FG000|Overall Study|Withdrawal by Subject|3|||
33585986|NCT02831855|102032810|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
33585987|NCT02831855|102032811|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
33585988|NCT02831855|102032809|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
33585989|NCT02831855|102032810|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
33585990|NCT02831855|102032811|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
33585991|NCT02831855|102032809|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
33585992|NCT02831855|102032810|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
33585993|NCT02831855|102032811|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
33585994|NCT05420961|102032812|FG000|Overall Study|Withdrawal by Subject|2|||
33585995|NCT05420961|102032813|FG001|Overall Study|Withdrawal by Subject|1|||
33585996|NCT05420961|102032814|FG002|Overall Study|Withdrawal by Subject|1|||
33585997|NCT05420961|102032815|FG003|Overall Study|Withdrawal by Subject|0|||
33585998|NCT05420961|102032816|FG004|Overall Study|Withdrawal by Subject|0|||
33585999|NCT05420961|102032812|FG000|Overall Study|Lost to Follow-up|0|||
33586000|NCT05420961|102032813|FG001|Overall Study|Lost to Follow-up|0|||
33586001|NCT05420961|102032814|FG002|Overall Study|Lost to Follow-up|1|||
33586002|NCT05420961|102032815|FG003|Overall Study|Lost to Follow-up|0|||
33586003|NCT05420961|102032816|FG004|Overall Study|Lost to Follow-up|0|||
33586004|NCT05420961|102032812|FG000|Overall Study|Randomized by mistake without study treatment|0|||
33586005|NCT05420961|102032813|FG001|Overall Study|Randomized by mistake without study treatment|0|||
33586006|NCT05420961|102032814|FG002|Overall Study|Randomized by mistake without study treatment|1|||
33586007|NCT05420961|102032815|FG003|Overall Study|Randomized by mistake without study treatment|0|||
33586008|NCT05420961|102032816|FG004|Overall Study|Randomized by mistake without study treatment|1|||
33586009|NCT01001767|102032826|FG000|Overall Study|no baseline study performed|1|||
33586010|NCT01001767|102032827|FG001|Overall Study|no baseline study performed|0|||
33586011|NCT01001767|102032826|FG000|Overall Study|Protocol Violation|1|||
33586012|NCT01001767|102032827|FG001|Overall Study|Protocol Violation|0|||
33586013|NCT01001767|102032826|FG000|Overall Study|Lost to Follow-up|1|||
33586014|NCT01001767|102032827|FG001|Overall Study|Lost to Follow-up|0|||
33586015|NCT01001767|102032826|FG000|Overall Study|Physician Decision|1|||
33586016|NCT01001767|102032827|FG001|Overall Study|Physician Decision|0|||
33586017|NCT00783835|102032828|FG000|Overall Study|Adverse Event|3|||
33586018|NCT00783835|102032828|FG000|Overall Study|Medical Criteria|1|||
33646215|NCT01958489|102256386|FG000|Period 2|Adverse Event|0|||
33646216|NCT01958489|102256387|FG001|Period 2|Adverse Event|1|||
33376474|NCT01093755|101264993|FG001|Overall Study|Withdrawal by Subject|4|||
33376475|NCT02561299|101264994|FG000|Overall Study|Death|2|||
33376476|NCT02561299|101264995|FG001|Overall Study|Death|4|||
33376477|NCT02561299|101264994|FG000|Overall Study|Lost to Follow-up|1|||
33376478|NCT02561299|101264995|FG001|Overall Study|Lost to Follow-up|0|||
33376479|NCT02561299|101264994|FG000|Overall Study|Withdrawal by Subject|2|||
33376480|NCT02561299|101264995|FG001|Overall Study|Withdrawal by Subject|2|||
33376481|NCT05554471|101265001|FG000|Overall Study|Physician Decision|2|||
33376482|NCT05554471|101265002|FG001|Overall Study|Physician Decision|1|||
33376483|NCT05554471|101265001|FG000|Overall Study|Lost to Follow-up|2|||
33376484|NCT05554471|101265002|FG001|Overall Study|Lost to Follow-up|1|||
33376485|NCT05554471|101265001|FG000|Overall Study|Death|0|||
33376486|NCT05554471|101265002|FG001|Overall Study|Death|1|||
33376487|NCT00006604|101265003|FG000|Overall Study|Met study objective - no further FU|1|||
33376488|NCT00006604|101265004|FG001|Overall Study|Met study objective - no further FU|0|||
33423827|NCT01271933|101443597|FG000|Double-Blind Phase|Randomized but not treated|0|||
33423828|NCT01271933|101443598|FG001|Double-Blind Phase|Randomized but not treated|0|||
33423829|NCT01271933|101443599|FG002|Double-Blind Phase|Randomized but not treated|1|||
33423830|NCT01271933|101443597|FG000|Double-Blind Phase|Lack of Efficacy|0|||
33423831|NCT01271933|101443598|FG001|Double-Blind Phase|Lack of Efficacy|6|||
33423832|NCT01271933|101443599|FG002|Double-Blind Phase|Lack of Efficacy|9|||
33423833|NCT01271933|101443597|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33423834|NCT01271933|101443598|FG001|Double-Blind Phase|Lost to Follow-up|1|||
33423835|NCT01271933|101443599|FG002|Double-Blind Phase|Lost to Follow-up|1|||
33376489|NCT00006604|101265005|FG002|Overall Study|Met study objective - no further FU|0|||
33376490|NCT00006604|101265006|FG003|Overall Study|Met study objective - no further FU|0|||
33586019|NCT00783835|102032828|FG000|Overall Study|Withdrawal by Subject|2|||
33586020|NCT00783835|102032828|FG000|Overall Study|Lost to Follow-up|1|||
33586021|NCT00783835|102032828|FG000|Overall Study|Participant not Adherent|3|||
33586022|NCT01947283|102032835|FG000|Overall Study|Death|1|||
33586023|NCT01947283|102032836|FG001|Overall Study|Death|1|||
33586024|NCT01947283|102032837|FG002|Overall Study|Death|1|||
33646217|NCT00573144|102256388|FG000|Overall Study|Withdrawal by Subject|2|||
33376491|NCT00006604|101265007|FG004|Overall Study|Met study objective - no further FU|0|||
33376492|NCT00006604|101265008|FG005|Overall Study|Met study objective - no further FU|0|||
33376493|NCT00006604|101265009|FG006|Overall Study|Met study objective - no further FU|0|||
33376494|NCT00006604|101265010|FG007|Overall Study|Met study objective - no further FU|0|||
33376495|NCT00006604|101265011|FG008|Overall Study|Met study objective - no further FU|0|||
33376496|NCT00006604|101265012|FG009|Overall Study|Met study objective - no further FU|0|||
33376497|NCT00006604|101265013|FG010|Overall Study|Met study objective - no further FU|0|||
33423836|NCT01271933|101443597|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
33423837|NCT01271933|101443598|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
33423838|NCT01271933|101443599|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
33586025|NCT01947283|102032838|FG003|Overall Study|Death|0|||
33586026|NCT01947283|102032839|FG004|Overall Study|Death|0|||
33586027|NCT01947283|102032840|FG005|Overall Study|Death|0|||
33586028|NCT01947283|102032841|FG006|Overall Study|Death|0|||
33586029|NCT01947283|102032835|FG000|Overall Study|Lost to Follow-up|4|||
33586030|NCT01947283|102032836|FG001|Overall Study|Lost to Follow-up|6|||
33586031|NCT01947283|102032837|FG002|Overall Study|Lost to Follow-up|5|||
33586032|NCT01947283|102032838|FG003|Overall Study|Lost to Follow-up|5|||
33586033|NCT01947283|102032839|FG004|Overall Study|Lost to Follow-up|0|||
33586034|NCT01947283|102032840|FG005|Overall Study|Lost to Follow-up|2|||
33586035|NCT01947283|102032841|FG006|Overall Study|Lost to Follow-up|5|||
33586036|NCT01947283|102032835|FG000|Overall Study|Withdrawal by Subject|10|||
33586037|NCT01947283|102032836|FG001|Overall Study|Withdrawal by Subject|8|||
33586038|NCT01947283|102032837|FG002|Overall Study|Withdrawal by Subject|4|||
33586039|NCT01947283|102032838|FG003|Overall Study|Withdrawal by Subject|1|||
33423839|NCT01271933|101443597|FG000|Double-Blind Phase|Adverse Event|0|||
33423840|NCT01271933|101443598|FG001|Double-Blind Phase|Adverse Event|3|||
33423841|NCT01271933|101443599|FG002|Double-Blind Phase|Adverse Event|0|||
33423842|NCT01271933|101443597|FG000|Double-Blind Phase|Participant request-personal reason|0|||
33423843|NCT01271933|101443598|FG001|Double-Blind Phase|Participant request-personal reason|1|||
33423844|NCT01271933|101443599|FG002|Double-Blind Phase|Participant request-personal reason|0|||
33423845|NCT03255031|101443600|FG000|Overall Study|Adverse Event|5|||
33423846|NCT03255031|101443601|FG001|Overall Study|Adverse Event|3|||
33423847|NCT03255031|101443600|FG000|Overall Study|Physician Decision|2|||
33423848|NCT03255031|101443601|FG001|Overall Study|Physician Decision|1|||
33423849|NCT03255031|101443600|FG000|Overall Study|Withdrawal by Subject|9|||
33423850|NCT03255031|101443601|FG001|Overall Study|Withdrawal by Subject|3|||
33423851|NCT01309828|101443602|FG000|Overall Study|Adverse Event|10|||
33423852|NCT01309828|101443603|FG001|Overall Study|Adverse Event|11|||
33423853|NCT01309828|101443602|FG000|Overall Study|Voluntary Withdrawal|5|||
33423854|NCT01309828|101443603|FG001|Overall Study|Voluntary Withdrawal|4|||
33423855|NCT01309828|101443602|FG000|Overall Study|Major Protocol Deviation|0|||
33423856|NCT01309828|101443603|FG001|Overall Study|Major Protocol Deviation|1|||
33423857|NCT01309828|101443602|FG000|Overall Study|Other|1|||
33423858|NCT01309828|101443603|FG001|Overall Study|Other|0|||
33423859|NCT00304954|101443604|FG000|Overall Study|Withdrawal by Subject|0|||
33423860|NCT00304954|101443605|FG001|Overall Study|Withdrawal by Subject|0|||
33423861|NCT00304954|101443606|FG002|Overall Study|Withdrawal by Subject|1|||
33423862|NCT00304954|101443607|FG003|Overall Study|Withdrawal by Subject|0|||
33423863|NCT00304954|101443604|FG000|Overall Study|Adverse Event|1|||
33423864|NCT00304954|101443605|FG001|Overall Study|Adverse Event|0|||
33423865|NCT00304954|101443606|FG002|Overall Study|Adverse Event|0|||
33423866|NCT00304954|101443607|FG003|Overall Study|Adverse Event|0|||
33423867|NCT03724916|101443608|FG000|Overall Study|Withdrawal by Subject|0|||
33586040|NCT01947283|102032839|FG004|Overall Study|Withdrawal by Subject|0|||
33586041|NCT01947283|102032840|FG005|Overall Study|Withdrawal by Subject|0|||
33376498|NCT00006604|101265014|FG011|Overall Study|Met study objective - no further FU|0|||
33646218|NCT00573144|102256389|FG001|Overall Study|Withdrawal by Subject|3|||
33586042|NCT01947283|102032841|FG006|Overall Study|Withdrawal by Subject|2|||
33586043|NCT01947283|102032835|FG000|Overall Study|No Clinical Recording|12|||
33586044|NCT01947283|102032836|FG001|Overall Study|No Clinical Recording|6|||
33586045|NCT01947283|102032837|FG002|Overall Study|No Clinical Recording|8|||
33586046|NCT01947283|102032838|FG003|Overall Study|No Clinical Recording|10|||
33423868|NCT03724916|101443609|FG001|Overall Study|Withdrawal by Subject|1|||
33423869|NCT03724916|101443610|FG002|Overall Study|Withdrawal by Subject|1|||
33423870|NCT03724916|101443611|FG003|Overall Study|Withdrawal by Subject|2|||
33586047|NCT01947283|102032839|FG004|Overall Study|No Clinical Recording|0|||
33376499|NCT00006604|101265015|FG012|Overall Study|Met study objective - no further FU|0|||
33423871|NCT03724916|101443608|FG000|Overall Study|Randomized but not Treated|1|||
33423872|NCT03724916|101443609|FG001|Overall Study|Randomized but not Treated|0|||
33423873|NCT03724916|101443610|FG002|Overall Study|Randomized but not Treated|0|||
33586048|NCT01947283|102032840|FG005|Overall Study|No Clinical Recording|0|||
33376500|NCT00006604|101265016|FG013|Overall Study|Met study objective - no further FU|0|||
33376501|NCT00006604|101265017|FG014|Overall Study|Met study objective - no further FU|1|||
33376502|NCT00006604|101265018|FG015|Overall Study|Met study objective - no further FU|1|||
33376503|NCT00006604|101265019|FG016|Overall Study|Met study objective - no further FU|0|||
33376504|NCT00006604|101265003|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
33376505|NCT00006604|101265004|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
33376506|NCT00006604|101265005|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
33376507|NCT00006604|101265006|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
33376508|NCT00006604|101265007|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
33376509|NCT00006604|101265008|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
33376510|NCT00006604|101265009|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
33376511|NCT00006604|101265010|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
33423874|NCT03724916|101443611|FG003|Overall Study|Randomized but not Treated|0|||
33423875|NCT00736333|101443615|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
33423876|NCT00736333|101443615|FG000|Overall Study|Data Missing|2|||
33423877|NCT00736333|101443615|FG000|Overall Study|Tumor Progression|75|||
33423878|NCT00736333|101443615|FG000|Overall Study|Toxicity|6|||
33423879|NCT00736333|101443615|FG000|Overall Study|Withdrawal by Subject|10|||
33423880|NCT00736333|101443615|FG000|Overall Study|Death|7|||
33423881|NCT00736333|101443615|FG000|Overall Study|Other|4|||
33423882|NCT01783730|101443619|FG000|Overall Study|Failed to meet inclusion criteria|6|||
33423883|NCT00305110|101443620|FG000|Overall Study|Missing data|29|||
33423884|NCT02981602|101443645|FG000|Overall Study|Adverse Event|0|||
33423885|NCT02981602|101443646|FG001|Overall Study|Adverse Event|0|||
33423886|NCT02981602|101443647|FG002|Overall Study|Adverse Event|0|||
33423887|NCT02981602|101443648|FG003|Overall Study|Adverse Event|1|||
33423888|NCT02981602|101443649|FG004|Overall Study|Adverse Event|0|||
33423889|NCT03012815|101443651|FG000|Overall Study|Lost to Follow-up|1|||
33423890|NCT03012815|101443652|FG001|Overall Study|Lost to Follow-up|0|||
33423891|NCT03012815|101443651|FG000|Overall Study|Physician Decision|3|||
33423892|NCT03012815|101443652|FG001|Overall Study|Physician Decision|2|||
33586049|NCT01947283|102032841|FG006|Overall Study|No Clinical Recording|0|||
33586050|NCT01947283|102032835|FG000|Overall Study|Non-coding Clinical Recording language|0|||
33586051|NCT01947283|102032836|FG001|Overall Study|Non-coding Clinical Recording language|0|||
33586052|NCT01947283|102032837|FG002|Overall Study|Non-coding Clinical Recording language|0|||
33586053|NCT01947283|102032838|FG003|Overall Study|Non-coding Clinical Recording language|1|||
33646219|NCT00530504|102256390|FG000|Overall Study|Death|54|||
33646220|NCT00530504|102256390|FG000|Overall Study|Lost to Follow-up|26|||
33646221|NCT00530504|102256390|FG000|Overall Study|Withdrawal by Subject|39|||
33646222|NCT00530504|102256390|FG000|Overall Study|Exited study due to other reasons|33|||
33646223|NCT00139477|102256391|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
33646224|NCT00139477|102256392|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
33646225|NCT00139477|102256391|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
33646226|NCT00139477|102256392|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
33646227|NCT00139477|102256391|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
33646228|NCT00139477|102256392|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
33586054|NCT01947283|102032839|FG004|Overall Study|Non-coding Clinical Recording language|0|||
33586055|NCT01947283|102032840|FG005|Overall Study|Non-coding Clinical Recording language|0|||
33586056|NCT01947283|102032841|FG006|Overall Study|Non-coding Clinical Recording language|0|||
33586057|NCT01947283|102032835|FG000|Overall Study|Missing Follow-up Assessment|2|||
33586058|NCT01947283|102032836|FG001|Overall Study|Missing Follow-up Assessment|2|||
33586059|NCT01947283|102032837|FG002|Overall Study|Missing Follow-up Assessment|3|||
33586060|NCT01947283|102032838|FG003|Overall Study|Missing Follow-up Assessment|0|||
33586061|NCT01947283|102032839|FG004|Overall Study|Missing Follow-up Assessment|0|||
33586062|NCT01947283|102032840|FG005|Overall Study|Missing Follow-up Assessment|2|||
33586063|NCT01947283|102032841|FG006|Overall Study|Missing Follow-up Assessment|0|||
33586064|NCT01947283|102032835|FG000|Overall Study|No patients were enrolled in study|0|||
33586065|NCT01947283|102032836|FG001|Overall Study|No patients were enrolled in study|0|||
33586066|NCT01947283|102032837|FG002|Overall Study|No patients were enrolled in study|0|||
33586067|NCT01947283|102032838|FG003|Overall Study|No patients were enrolled in study|0|||
33586068|NCT01947283|102032839|FG004|Overall Study|No patients were enrolled in study|0|||
33586069|NCT01947283|102032840|FG005|Overall Study|No patients were enrolled in study|3|||
33586070|NCT01947283|102032841|FG006|Overall Study|No patients were enrolled in study|1|||
33646229|NCT00139477|102256391|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
33646230|NCT00139477|102256392|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
33376512|NCT00006604|101265011|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
33423893|NCT03012815|101443651|FG000|Overall Study|Adverse Event|1|||
33423894|NCT03012815|101443652|FG001|Overall Study|Adverse Event|0|||
33423895|NCT00766506|101443653|FG000|Overall Study|Use rescue medication after 3 hours|3|||
33423896|NCT00766506|101443654|FG001|Overall Study|Use rescue medication after 3 hours|0|||
33423897|NCT00766506|101443653|FG000|Overall Study|Other|2|||
33246865|NCT01107626|100803932|FG000|Step 1: Induction Therapy|Death|62|||
33246866|NCT01107626|100803933|FG001|Step 1: Induction Therapy|Death|0|||
33246867|NCT01107626|100803934|FG002|Step 1: Induction Therapy|Death|0|||
33246868|NCT01107626|100803935|FG003|Step 1: Induction Therapy|Death|0|||
33246869|NCT01107626|100803932|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
33246870|NCT01107626|100803933|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
33246871|NCT01107626|100803934|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
33246872|NCT01107626|100803935|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
33246873|NCT01107626|100803932|FG000|Step 1: Induction Therapy|Complicating disease|13|||
33246874|NCT01107626|100803933|FG001|Step 1: Induction Therapy|Complicating disease|0|||
33246875|NCT01107626|100803934|FG002|Step 1: Induction Therapy|Complicating disease|0|||
33246876|NCT01107626|100803935|FG003|Step 1: Induction Therapy|Complicating disease|0|||
33246877|NCT01107626|100803932|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
33586071|NCT02314156|102032842|FG000|Overall Study|Adverse Event|1|||
33586072|NCT02314156|102032843|FG001|Overall Study|Adverse Event|0|||
33586073|NCT02314156|102032842|FG000|Overall Study|Withdrawal by Subject|1|||
33586074|NCT02314156|102032843|FG001|Overall Study|Withdrawal by Subject|0|||
33586075|NCT01221623|102032844|FG000|Overall Study|Withdrawal by Subject|19|||
33586076|NCT01221623|102032845|FG001|Overall Study|Withdrawal by Subject|8|||
33586077|NCT01221623|102032844|FG000|Overall Study|Lost to Follow-up|7|||
33246878|NCT01107626|100803933|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
33246879|NCT01107626|100803934|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
33246880|NCT01107626|100803935|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
33246881|NCT01107626|100803932|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
33246882|NCT01107626|100803933|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
33246883|NCT01107626|100803934|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
33246884|NCT01107626|100803935|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
33246885|NCT01107626|100803932|FG000|Step 1: Induction Therapy|Non-compliance|4|||
33246886|NCT01107626|100803933|FG001|Step 1: Induction Therapy|Non-compliance|0|||
33246887|NCT01107626|100803934|FG002|Step 1: Induction Therapy|Non-compliance|0|||
33246888|NCT01107626|100803935|FG003|Step 1: Induction Therapy|Non-compliance|0|||
33246889|NCT01107626|100803932|FG000|Step 1: Induction Therapy|Pain|4|||
33246890|NCT01107626|100803933|FG001|Step 1: Induction Therapy|Pain|0|||
33246891|NCT01107626|100803934|FG002|Step 1: Induction Therapy|Pain|0|||
33246892|NCT01107626|100803935|FG003|Step 1: Induction Therapy|Pain|0|||
33246893|NCT01107626|100803932|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
33246894|NCT01107626|100803933|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
33246895|NCT01107626|100803934|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
33246896|NCT01107626|100803935|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
33246897|NCT01107626|100803932|FG000|Step 1: Induction Therapy|Hospice care|1|||
33246898|NCT01107626|100803933|FG001|Step 1: Induction Therapy|Hospice care|0|||
33246899|NCT01107626|100803934|FG002|Step 1: Induction Therapy|Hospice care|0|||
33246900|NCT01107626|100803935|FG003|Step 1: Induction Therapy|Hospice care|0|||
33246901|NCT01107626|100803932|FG000|Step 1: Induction Therapy|Physician Decision|1|||
33246902|NCT01107626|100803933|FG001|Step 1: Induction Therapy|Physician Decision|0|||
33246903|NCT01107626|100803934|FG002|Step 1: Induction Therapy|Physician Decision|0|||
33246904|NCT01107626|100803935|FG003|Step 1: Induction Therapy|Physician Decision|0|||
33246905|NCT01107626|100803932|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
33246906|NCT01107626|100803933|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
33246907|NCT01107626|100803934|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
33246908|NCT01107626|100803935|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
33246909|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
33246910|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
33586078|NCT01221623|102032845|FG001|Overall Study|Lost to Follow-up|1|||
33246911|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
33246912|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
33246913|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
33246914|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
33246915|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
33246916|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
33646231|NCT00139477|102256391|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
33246917|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Death|0|||
33376513|NCT00006604|101265012|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
33376514|NCT00006604|101265013|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
33246918|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Death|8|||
33376515|NCT00006604|101265014|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
33246919|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Death|2|||
33246920|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Death|13|||
33376516|NCT00006604|101265015|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
33376517|NCT00006604|101265016|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
33586079|NCT01221623|102032844|FG000|Overall Study|Adverse Event|6|||
33586080|NCT01221623|102032845|FG001|Overall Study|Adverse Event|3|||
33646232|NCT00139477|102256392|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
33646233|NCT00139477|102256391|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
33646234|NCT00139477|102256392|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
33646235|NCT00139477|102256391|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
33646236|NCT00139477|102256392|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
33646237|NCT01311024|102256394|FG000|Overall Study|Protocol Violation|35|||
33646238|NCT01311024|102256395|FG001|Overall Study|Protocol Violation|22|||
33646239|NCT01689532|102256396|FG000|Overall Study|Adverse Event|9|||
33646240|NCT01689532|102256397|FG001|Overall Study|Adverse Event|5|||
33646241|NCT01689532|102256396|FG000|Overall Study|Lack of Efficacy|2|||
33646242|NCT01689532|102256397|FG001|Overall Study|Lack of Efficacy|2|||
33376518|NCT00006604|101265017|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
33586081|NCT01221623|102032844|FG000|Overall Study|Death|1|||
33586082|NCT01221623|102032845|FG001|Overall Study|Death|0|||
33586083|NCT01221623|102032844|FG000|Overall Study|Other|5|||
33586084|NCT01221623|102032845|FG001|Overall Study|Other|2|||
33586085|NCT00854724|102032846|FG000|First Intervention|Withdrawal by Subject|1|||
33586086|NCT00854724|102032847|FG001|First Intervention|Withdrawal by Subject|1|||
33586087|NCT00854724|102032846|FG000|Washout|Protocol Violation|1|||
33586088|NCT00854724|102032847|FG001|Washout|Protocol Violation|0|||
33586089|NCT00854724|102032846|FG000|Washout|Withdrawal by Subject|0|||
33586090|NCT00854724|102032847|FG001|Washout|Withdrawal by Subject|1|||
33586091|NCT00854724|102032846|FG000|Second Intervention|Protocol Violation|1|||
33586092|NCT00854724|102032847|FG001|Second Intervention|Protocol Violation|0|||
33586093|NCT00854724|102032846|FG000|Second Intervention|Physician Decision|0|||
33586094|NCT00854724|102032847|FG001|Second Intervention|Physician Decision|1|||
33586095|NCT03333928|102032848|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
33586096|NCT03333928|102032849|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
33586097|NCT03333928|102032850|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
33586098|NCT03333928|102032848|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
33586099|NCT03333928|102032849|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
33586100|NCT03333928|102032850|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
33586101|NCT03333928|102032848|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
33586102|NCT03333928|102032849|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
33586103|NCT03333928|102032850|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
33586104|NCT03333928|102032848|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
33586105|NCT03333928|102032849|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
33586106|NCT03333928|102032850|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
33586107|NCT03333928|102032848|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
33586108|NCT03333928|102032849|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
33586109|NCT03333928|102032850|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
33586110|NCT03333928|102032848|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
33586111|NCT03333928|102032849|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
33586112|NCT03333928|102032850|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
33586113|NCT03333928|102032848|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
33586114|NCT03333928|102032849|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
33586115|NCT03333928|102032850|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
33586116|NCT03333928|102032848|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
33586117|NCT03333928|102032849|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
33586118|NCT03333928|102032850|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
33586119|NCT01891396|102032851|FG000|Overall Study|Withdrawal by Subject|4|||
33586120|NCT01891396|102032852|FG001|Overall Study|Withdrawal by Subject|4|||
33586121|NCT01891396|102032853|FG002|Overall Study|Withdrawal by Subject|3|||
33586122|NCT01891396|102032851|FG000|Overall Study|Lost to Follow-up|0|||
33586123|NCT01891396|102032852|FG001|Overall Study|Lost to Follow-up|1|||
33586124|NCT01891396|102032853|FG002|Overall Study|Lost to Follow-up|0|||
33586125|NCT00830375|102032854|FG000|Overall Study|Lost to Follow-up|1|||
33586126|NCT02574078|102032857|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33586127|NCT02574078|102032858|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33586128|NCT02574078|102032859|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33586129|NCT02574078|102032860|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33586130|NCT02574078|102032861|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33586131|NCT02574078|102032862|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
33586132|NCT02574078|102032863|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
33586133|NCT02574078|102032864|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33376519|NCT00006604|101265018|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
33646243|NCT01689532|102256396|FG000|Overall Study|Withdrawal by Subject|1|||
33646244|NCT01689532|102256397|FG001|Overall Study|Withdrawal by Subject|2|||
33646245|NCT01689532|102256396|FG000|Overall Study|Physician Decision|2|||
33646246|NCT01689532|102256397|FG001|Overall Study|Physician Decision|0|||
33646247|NCT00243841|102256398|FG000|Overall Study|Physician Decision|0|||
33646248|NCT00243841|102256399|FG001|Overall Study|Physician Decision|0|||
33646249|NCT00243841|102256400|FG002|Overall Study|Physician Decision|1|||
33646250|NCT00243841|102256401|FG003|Overall Study|Physician Decision|0|||
33646251|NCT00243841|102256402|FG004|Overall Study|Physician Decision|0|||
33646252|NCT00243841|102256403|FG005|Overall Study|Physician Decision|2|||
33646253|NCT00975689|102256404|FG000|Overall Study|Adverse Event|0|||
33646254|NCT00975689|102256405|FG001|Overall Study|Adverse Event|3|||
33646255|NCT00975689|102256404|FG000|Overall Study|Withdrawal by Subject|1|||
33646256|NCT00975689|102256405|FG001|Overall Study|Withdrawal by Subject|0|||
33646257|NCT00975689|102256404|FG000|Overall Study|Physician Decision|1|||
33646258|NCT00975689|102256405|FG001|Overall Study|Physician Decision|0|||
33646259|NCT02509117|102256407|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33646260|NCT02509117|102256408|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
33646261|NCT02509117|102256409|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33646262|NCT02509117|102256410|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33646263|NCT02509117|102256411|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33646264|NCT02509117|102256412|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33646265|NCT02509117|102256413|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33646266|NCT02509117|102256414|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33646267|NCT02509117|102256415|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33646268|NCT02509117|102256416|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
33646269|NCT02509117|102256407|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33646270|NCT02509117|102256408|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33646271|NCT02509117|102256409|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33646272|NCT02509117|102256410|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33646273|NCT02509117|102256411|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33646274|NCT02509117|102256412|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33646275|NCT02509117|102256413|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33646276|NCT02509117|102256414|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33646277|NCT02509117|102256415|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
33646278|NCT02509117|102256416|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
33646279|NCT02509117|102256407|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33646280|NCT02509117|102256408|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33646281|NCT02509117|102256409|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33646282|NCT02509117|102256410|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33646283|NCT02509117|102256411|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33646284|NCT02509117|102256412|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33646285|NCT02509117|102256413|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33646286|NCT02509117|102256414|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33646287|NCT02509117|102256415|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
33646288|NCT02509117|102256416|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
33646289|NCT03976648|102256417|FG000|Overall Study|Adverse Event|0|||
33646290|NCT03976648|102256418|FG001|Overall Study|Adverse Event|2|||
33646291|NCT03976648|102256417|FG000|Overall Study|Study terminated by sponsor|21|||
33646292|NCT03976648|102256418|FG001|Overall Study|Study terminated by sponsor|8|||
33646293|NCT04535453|102256420|FG000|Overall Study|Death|0|||
33646294|NCT04535453|102256421|FG001|Overall Study|Death|1|||
33646295|NCT04535453|102256422|FG002|Overall Study|Death|0|||
33646296|NCT04535453|102256423|FG003|Overall Study|Death|0|||
33646297|NCT04535453|102256424|FG004|Overall Study|Death|0|||
33646298|NCT04535453|102256425|FG005|Overall Study|Death|0|||
33646299|NCT04535453|102256426|FG006|Overall Study|Death|0|||
33646300|NCT04535453|102256427|FG007|Overall Study|Death|0|||
33646301|NCT04535453|102256428|FG008|Overall Study|Death|0|||
33646302|NCT04535453|102256429|FG009|Overall Study|Death|0|||
33646303|NCT04535453|102256430|FG010|Overall Study|Death|0|||
33376520|NCT00006604|101265019|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
33376521|NCT00006604|101265003|FG000|Overall Study|Death|0|||
33376522|NCT00006604|101265004|FG001|Overall Study|Death|0|||
33376523|NCT00006604|101265005|FG002|Overall Study|Death|0|||
33376524|NCT00006604|101265006|FG003|Overall Study|Death|0|||
33376525|NCT00006604|101265007|FG004|Overall Study|Death|0|||
33423898|NCT00766506|101443654|FG001|Overall Study|Other|2|||
33646304|NCT04535453|102256431|FG011|Overall Study|Death|0|||
33646305|NCT04535453|102256420|FG000|Overall Study|Lost to Follow-up|1|||
33646306|NCT04535453|102256421|FG001|Overall Study|Lost to Follow-up|1|||
33646307|NCT04535453|102256422|FG002|Overall Study|Lost to Follow-up|1|||
33646308|NCT04535453|102256423|FG003|Overall Study|Lost to Follow-up|0|||
33423899|NCT01571635|101443656|FG000|Overall Study|Adverse Event|3|||
33376526|NCT00006604|101265008|FG005|Overall Study|Death|0|||
33376527|NCT00006604|101265009|FG006|Overall Study|Death|0|||
33376528|NCT00006604|101265010|FG007|Overall Study|Death|0|||
33376529|NCT00006604|101265011|FG008|Overall Study|Death|0|||
33376530|NCT00006604|101265012|FG009|Overall Study|Death|1|||
33376531|NCT00006604|101265013|FG010|Overall Study|Death|1|||
33376532|NCT00006604|101265014|FG011|Overall Study|Death|1|||
33376533|NCT00006604|101265015|FG012|Overall Study|Death|0|||
33376534|NCT00006604|101265016|FG013|Overall Study|Death|0|||
33376535|NCT00006604|101265017|FG014|Overall Study|Death|0|||
33376536|NCT00006604|101265018|FG015|Overall Study|Death|0|||
33376537|NCT00006604|101265019|FG016|Overall Study|Death|0|||
33376538|NCT00006604|101265003|FG000|Overall Study|Severe debilitation, unable to continue|0|||
33376539|NCT00006604|101265004|FG001|Overall Study|Severe debilitation, unable to continue|0|||
33376540|NCT00006604|101265005|FG002|Overall Study|Severe debilitation, unable to continue|0|||
33376541|NCT00006604|101265006|FG003|Overall Study|Severe debilitation, unable to continue|0|||
33376542|NCT00006604|101265007|FG004|Overall Study|Severe debilitation, unable to continue|0|||
33376543|NCT00006604|101265008|FG005|Overall Study|Severe debilitation, unable to continue|0|||
33376544|NCT00006604|101265009|FG006|Overall Study|Severe debilitation, unable to continue|3|||
33376545|NCT00006604|101265010|FG007|Overall Study|Severe debilitation, unable to continue|0|||
33376546|NCT00006604|101265011|FG008|Overall Study|Severe debilitation, unable to continue|0|||
33376547|NCT00006604|101265012|FG009|Overall Study|Severe debilitation, unable to continue|5|||
33586134|NCT02574078|102032865|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
33586135|NCT02574078|102032866|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33586136|NCT02574078|102032867|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33586137|NCT02574078|102032868|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33586138|NCT02574078|102032869|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33586139|NCT02574078|102032857|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
33586140|NCT02574078|102032858|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
33586141|NCT02574078|102032859|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
33586142|NCT02574078|102032860|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
33586143|NCT02574078|102032861|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
33246921|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
33246922|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
33246923|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
33246924|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
33246925|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
33246926|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
33246927|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
33246928|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
33246929|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
33246930|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
33246931|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
33246932|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
33246933|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
33246934|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
33246935|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
33246936|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
33246937|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
33246938|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
33246939|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
33246940|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
33246941|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
33246942|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
33246943|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
33246944|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
33246945|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
33246946|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
33246947|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
33246948|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
33246949|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
33246950|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
33246951|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
33376548|NCT00006604|101265013|FG010|Overall Study|Severe debilitation, unable to continue|0|||
33376549|NCT00006604|101265014|FG011|Overall Study|Severe debilitation, unable to continue|2|||
33376550|NCT00006604|101265015|FG012|Overall Study|Severe debilitation, unable to continue|1|||
33376551|NCT00006604|101265016|FG013|Overall Study|Severe debilitation, unable to continue|0|||
33376552|NCT00006604|101265017|FG014|Overall Study|Severe debilitation, unable to continue|2|||
33423900|NCT01571635|101443657|FG001|Overall Study|Adverse Event|0|||
33586144|NCT02574078|102032862|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
33586145|NCT02574078|102032863|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
33586146|NCT02574078|102032864|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
33376553|NCT00006604|101265018|FG015|Overall Study|Severe debilitation, unable to continue|0|||
33376554|NCT00006604|101265019|FG016|Overall Study|Severe debilitation, unable to continue|0|||
33376555|NCT00006604|101265003|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
33376556|NCT00006604|101265004|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
33376557|NCT00006604|101265005|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
33376558|NCT00006604|101265006|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
33376559|NCT00006604|101265007|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
33376560|NCT00006604|101265008|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
33376561|NCT00006604|101265009|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
33376562|NCT00006604|101265010|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
33376563|NCT00006604|101265011|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
33376564|NCT00006604|101265012|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
33376565|NCT00006604|101265013|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
33376566|NCT00006604|101265014|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
33376567|NCT00006604|101265015|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
33423901|NCT01571635|101443658|FG002|Overall Study|Adverse Event|2|||
33423902|NCT01571635|101443659|FG003|Overall Study|Adverse Event|3|||
33423903|NCT01571635|101443660|FG004|Overall Study|Adverse Event|5|||
33423904|NCT01571635|101443656|FG000|Overall Study|Other reasons|2|||
33423905|NCT01571635|101443657|FG001|Overall Study|Other reasons|1|||
33423906|NCT01571635|101443658|FG002|Overall Study|Other reasons|2|||
33423907|NCT01571635|101443659|FG003|Overall Study|Other reasons|2|||
33423908|NCT01571635|101443660|FG004|Overall Study|Other reasons|1|||
33423909|NCT01571635|101443656|FG000|Overall Study|Study terminated by sponsor|0|||
33423910|NCT01571635|101443657|FG001|Overall Study|Study terminated by sponsor|4|||
33423911|NCT01571635|101443658|FG002|Overall Study|Study terminated by sponsor|1|||
33423912|NCT01571635|101443659|FG003|Overall Study|Study terminated by sponsor|3|||
33423913|NCT01571635|101443660|FG004|Overall Study|Study terminated by sponsor|1|||
33423914|NCT01571635|101443656|FG000|Overall Study|Withdrew consent|1|||
33423915|NCT01571635|101443657|FG001|Overall Study|Withdrew consent|1|||
33586147|NCT02574078|102032865|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
33586148|NCT02574078|102032866|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
33586149|NCT02574078|102032867|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
33586150|NCT02574078|102032868|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
33586151|NCT02574078|102032869|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
33586152|NCT02574078|102032857|FG000|Pre-Treatment Period|Other reasons|0|||
33586153|NCT02574078|102032858|FG001|Pre-Treatment Period|Other reasons|0|||
33586154|NCT02574078|102032859|FG002|Pre-Treatment Period|Other reasons|0|||
33586155|NCT02574078|102032860|FG003|Pre-Treatment Period|Other reasons|0|||
33376568|NCT00006604|101265016|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
33376569|NCT00006604|101265017|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
33376570|NCT00006604|101265018|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
33376571|NCT00006604|101265019|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
33376572|NCT00006604|101265003|FG000|Overall Study|Site closing|0|||
33376573|NCT00006604|101265004|FG001|Overall Study|Site closing|0|||
33376574|NCT00006604|101265005|FG002|Overall Study|Site closing|1|||
33586156|NCT02574078|102032861|FG004|Pre-Treatment Period|Other reasons|0|||
33586157|NCT02574078|102032862|FG005|Pre-Treatment Period|Other reasons|0|||
33586158|NCT02574078|102032863|FG006|Pre-Treatment Period|Other reasons|2|||
33586159|NCT02574078|102032864|FG007|Pre-Treatment Period|Other reasons|0|||
33586160|NCT02574078|102032865|FG008|Pre-Treatment Period|Other reasons|0|||
33586161|NCT02574078|102032866|FG009|Pre-Treatment Period|Other reasons|0|||
33586162|NCT02574078|102032867|FG010|Pre-Treatment Period|Other reasons|2|||
33586163|NCT02574078|102032868|FG011|Pre-Treatment Period|Other reasons|0|||
33586164|NCT02574078|102032869|FG012|Pre-Treatment Period|Other reasons|0|||
33586165|NCT02574078|102032857|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
33586166|NCT02574078|102032858|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
33586167|NCT02574078|102032859|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
33586168|NCT02574078|102032860|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
33586169|NCT02574078|102032861|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
33586170|NCT02574078|102032862|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
33586171|NCT02574078|102032863|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
33148641|NCT00704808|100458199|FG000|Overall Study|Patient's decision|11|||
33376575|NCT00006604|101265006|FG003|Overall Study|Site closing|1|||
33423916|NCT01571635|101443658|FG002|Overall Study|Withdrew consent|2|||
33423917|NCT01571635|101443659|FG003|Overall Study|Withdrew consent|3|||
33423918|NCT01571635|101443660|FG004|Overall Study|Withdrew consent|0|||
33423919|NCT01571635|101443656|FG000|Overall Study|Lack of Efficacy|0|||
33423920|NCT01571635|101443657|FG001|Overall Study|Lack of Efficacy|2|||
33423921|NCT01571635|101443658|FG002|Overall Study|Lack of Efficacy|0|||
33586172|NCT02574078|102032864|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
33586173|NCT02574078|102032865|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
33586174|NCT02574078|102032866|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
33586175|NCT02574078|102032867|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
33586176|NCT02574078|102032868|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
33586177|NCT02574078|102032869|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
33586178|NCT02574078|102032857|FG000|Treatment Period|Disease progression|6|||
33586179|NCT02574078|102032858|FG001|Treatment Period|Disease progression|4|||
33376576|NCT00006604|101265007|FG004|Overall Study|Site closing|0|||
33376577|NCT00006604|101265008|FG005|Overall Study|Site closing|0|||
33376578|NCT00006604|101265009|FG006|Overall Study|Site closing|0|||
33376579|NCT00006604|101265010|FG007|Overall Study|Site closing|1|||
33376580|NCT00006604|101265011|FG008|Overall Study|Site closing|0|||
33376581|NCT00006604|101265012|FG009|Overall Study|Site closing|0|||
33376582|NCT00006604|101265013|FG010|Overall Study|Site closing|0|||
33376583|NCT00006604|101265014|FG011|Overall Study|Site closing|1|||
33376584|NCT00006604|101265015|FG012|Overall Study|Site closing|1|||
33376585|NCT00006604|101265016|FG013|Overall Study|Site closing|1|||
33376586|NCT00006604|101265017|FG014|Overall Study|Site closing|0|||
33376587|NCT00006604|101265018|FG015|Overall Study|Site closing|0|||
33376588|NCT00006604|101265019|FG016|Overall Study|Site closing|1|||
33376589|NCT00006604|101265003|FG000|Overall Study|Withdrawal by Subject|1|||
33376590|NCT00006604|101265004|FG001|Overall Study|Withdrawal by Subject|0|||
33376591|NCT00006604|101265005|FG002|Overall Study|Withdrawal by Subject|2|||
33376592|NCT00006604|101265006|FG003|Overall Study|Withdrawal by Subject|0|||
33376593|NCT00006604|101265007|FG004|Overall Study|Withdrawal by Subject|1|||
33376594|NCT00006604|101265008|FG005|Overall Study|Withdrawal by Subject|2|||
33376595|NCT00006604|101265009|FG006|Overall Study|Withdrawal by Subject|2|||
33376596|NCT00006604|101265010|FG007|Overall Study|Withdrawal by Subject|0|||
33376597|NCT00006604|101265011|FG008|Overall Study|Withdrawal by Subject|1|||
33376598|NCT00006604|101265012|FG009|Overall Study|Withdrawal by Subject|3|||
33376599|NCT00006604|101265013|FG010|Overall Study|Withdrawal by Subject|2|||
33423922|NCT01571635|101443659|FG003|Overall Study|Lack of Efficacy|1|||
33423923|NCT01571635|101443660|FG004|Overall Study|Lack of Efficacy|2|||
33423924|NCT01406873|101443661|FG000|Overall Study|Withdrawal by Subject|1|||
33423925|NCT01406873|101443662|FG001|Overall Study|Withdrawal by Subject|1|||
33423926|NCT00771901|101443667|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
33423927|NCT00771901|101443668|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
33376600|NCT00006604|101265014|FG011|Overall Study|Withdrawal by Subject|0|||
33376601|NCT00006604|101265015|FG012|Overall Study|Withdrawal by Subject|1|||
33376602|NCT00006604|101265016|FG013|Overall Study|Withdrawal by Subject|2|||
33376603|NCT00006604|101265017|FG014|Overall Study|Withdrawal by Subject|1|||
33376604|NCT00006604|101265018|FG015|Overall Study|Withdrawal by Subject|0|||
33376605|NCT00006604|101265019|FG016|Overall Study|Withdrawal by Subject|1|||
33376606|NCT00006604|101265003|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
33376607|NCT00006604|101265004|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
33376608|NCT00006604|101265005|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
33376609|NCT00006604|101265006|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
33376610|NCT00006604|101265007|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
33376611|NCT00006604|101265008|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
33376612|NCT00006604|101265009|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
33376613|NCT00006604|101265010|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
33376614|NCT00006604|101265011|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
33376615|NCT00006604|101265012|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
33376616|NCT00006604|101265013|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
33376617|NCT00006604|101265014|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
33376618|NCT00006604|101265015|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
33376619|NCT00006604|101265016|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
33376620|NCT00006604|101265017|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
33376621|NCT00006604|101265018|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
33423928|NCT00771901|101443669|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
33586180|NCT02574078|102032859|FG002|Treatment Period|Disease progression|7|||
33586181|NCT02574078|102032860|FG003|Treatment Period|Disease progression|18|||
33586182|NCT02574078|102032861|FG004|Treatment Period|Disease progression|16|||
33586183|NCT02574078|102032862|FG005|Treatment Period|Disease progression|26|||
33586184|NCT02574078|102032863|FG006|Treatment Period|Disease progression|5|||
33376622|NCT00006604|101265019|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
33423929|NCT01200394|101443670|FG000|Overall Study|Adverse Event|0|||
33423930|NCT01200394|101443671|FG001|Overall Study|Adverse Event|14|||
33376623|NCT00006604|101265003|FG000|Overall Study|Lost to Follow-up|0|||
33423931|NCT01200394|101443670|FG000|Overall Study|Death|1|||
33423932|NCT01200394|101443671|FG001|Overall Study|Death|0|||
33586185|NCT02574078|102032864|FG007|Treatment Period|Disease progression|9|||
33423933|NCT01200394|101443670|FG000|Overall Study|Lost to Follow-up|0|||
33246952|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
33246953|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
33246954|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
33246955|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
33246956|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
33246957|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
33246958|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
33246959|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
33246960|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
33246961|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Pain|0|||
33246962|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Pain|0|||
33646309|NCT04535453|102256424|FG004|Overall Study|Lost to Follow-up|3|||
33646310|NCT04535453|102256425|FG005|Overall Study|Lost to Follow-up|1|||
33646311|NCT04535453|102256426|FG006|Overall Study|Lost to Follow-up|0|||
33646312|NCT04535453|102256427|FG007|Overall Study|Lost to Follow-up|0|||
33646313|NCT04535453|102256428|FG008|Overall Study|Lost to Follow-up|1|||
33646314|NCT04535453|102256429|FG009|Overall Study|Lost to Follow-up|1|||
33246963|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Pain|0|||
33246964|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Pain|1|||
33246965|NCT01107626|100803932|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
33246966|NCT01107626|100803933|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
33246967|NCT01107626|100803934|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
33246968|NCT01107626|100803935|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
33246969|NCT00465985|100803941|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
33246970|NCT00465985|100803942|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
33586186|NCT02574078|102032865|FG008|Treatment Period|Disease progression|8|||
33586187|NCT02574078|102032866|FG009|Treatment Period|Disease progression|5|||
33586188|NCT02574078|102032867|FG010|Treatment Period|Disease progression|20|||
33586189|NCT02574078|102032868|FG011|Treatment Period|Disease progression|29|||
33586190|NCT02574078|102032869|FG012|Treatment Period|Disease progression|2|||
33246971|NCT00465985|100803941|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
33246972|NCT00465985|100803942|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
33246973|NCT00465985|100803941|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
33246974|NCT00465985|100803942|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
33246975|NCT00465985|100803941|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
33246976|NCT00465985|100803942|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
33246977|NCT01345292|100803945|FG000|Overall Study|Withdrawal by Subject|2|||
33246978|NCT01345292|100803946|FG001|Overall Study|Withdrawal by Subject|0|||
33246979|NCT01345292|100803947|FG002|Overall Study|Withdrawal by Subject|1|||
33246980|NCT03396913|100803948|FG000|Overall Study|Lost to Follow-up|0|||
33246981|NCT03396913|100803949|FG001|Overall Study|Lost to Follow-up|6|||
33246982|NCT00567164|100803950|FG000|Overall Study|Withdrawal by Subject|171|||
33246983|NCT00567164|100803951|FG001|Overall Study|Withdrawal by Subject|21|||
33246984|NCT00567164|100803952|FG002|Overall Study|Withdrawal by Subject|17|||
33246985|NCT00567164|100803950|FG000|Overall Study|Protocol Violation|23|||
33246986|NCT00567164|100803951|FG001|Overall Study|Protocol Violation|4|||
33246987|NCT00567164|100803952|FG002|Overall Study|Protocol Violation|2|||
33246988|NCT00567164|100803950|FG000|Overall Study|Adverse Event|92|||
33246989|NCT00567164|100803951|FG001|Overall Study|Adverse Event|13|||
33246990|NCT00567164|100803952|FG002|Overall Study|Adverse Event|9|||
33246991|NCT00567164|100803950|FG000|Overall Study|Death|0|||
33246992|NCT00567164|100803951|FG001|Overall Study|Death|0|||
33246993|NCT00567164|100803952|FG002|Overall Study|Death|1|||
33246994|NCT00567164|100803950|FG000|Overall Study|Lost to Follow-up|202|||
33246995|NCT00567164|100803951|FG001|Overall Study|Lost to Follow-up|23|||
33246996|NCT00567164|100803952|FG002|Overall Study|Lost to Follow-up|21|||
33246997|NCT00567164|100803950|FG000|Overall Study|Pregnancy|20|||
33246998|NCT00567164|100803951|FG001|Overall Study|Pregnancy|4|||
33586191|NCT02574078|102032857|FG000|Treatment Period|Study drug toxicity|1|||
33586192|NCT02574078|102032858|FG001|Treatment Period|Study drug toxicity|1|||
33586193|NCT02574078|102032859|FG002|Treatment Period|Study drug toxicity|0|||
33586194|NCT02574078|102032860|FG003|Treatment Period|Study drug toxicity|5|||
33586195|NCT02574078|102032861|FG004|Treatment Period|Study drug toxicity|3|||
33646315|NCT04535453|102256430|FG010|Overall Study|Lost to Follow-up|0|||
33246999|NCT00567164|100803952|FG002|Overall Study|Pregnancy|6|||
33646316|NCT04535453|102256431|FG011|Overall Study|Lost to Follow-up|0|||
33247000|NCT00567164|100803950|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
33247001|NCT00567164|100803951|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
33646317|NCT04535453|102256420|FG000|Overall Study|Physician Decision|0|||
33247002|NCT00567164|100803952|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
33247003|NCT00567164|100803950|FG000|Overall Study|Missing|1|||
33247004|NCT00567164|100803951|FG001|Overall Study|Missing|0|||
33247005|NCT00567164|100803952|FG002|Overall Study|Missing|0|||
33586196|NCT02574078|102032862|FG005|Treatment Period|Study drug toxicity|1|||
33646318|NCT04535453|102256421|FG001|Overall Study|Physician Decision|0|||
33586197|NCT02574078|102032863|FG006|Treatment Period|Study drug toxicity|2|||
33247006|NCT02701361|100803953|FG000|Overall Study|Lost to Follow-up|5|||
33247007|NCT02701361|100803954|FG001|Overall Study|Lost to Follow-up|2|||
33247008|NCT02701361|100803955|FG002|Overall Study|Lost to Follow-up|1|||
33247009|NCT02701361|100803953|FG000|Overall Study|Withdrawal by Subject|4|||
33247010|NCT02701361|100803954|FG001|Overall Study|Withdrawal by Subject|0|||
33586198|NCT02574078|102032864|FG007|Treatment Period|Study drug toxicity|0|||
33586199|NCT02574078|102032865|FG008|Treatment Period|Study drug toxicity|2|||
33586200|NCT02574078|102032866|FG009|Treatment Period|Study drug toxicity|1|||
33586201|NCT02574078|102032867|FG010|Treatment Period|Study drug toxicity|16|||
33586202|NCT02574078|102032868|FG011|Treatment Period|Study drug toxicity|2|||
33586203|NCT02574078|102032869|FG012|Treatment Period|Study drug toxicity|4|||
33586204|NCT02574078|102032857|FG000|Treatment Period|Death|2|||
33586205|NCT02574078|102032858|FG001|Treatment Period|Death|0|||
33586206|NCT02574078|102032859|FG002|Treatment Period|Death|0|||
33586207|NCT02574078|102032860|FG003|Treatment Period|Death|0|||
33586208|NCT02574078|102032861|FG004|Treatment Period|Death|1|||
33586209|NCT02574078|102032862|FG005|Treatment Period|Death|1|||
33586210|NCT02574078|102032863|FG006|Treatment Period|Death|1|||
33586211|NCT02574078|102032864|FG007|Treatment Period|Death|1|||
33586212|NCT02574078|102032865|FG008|Treatment Period|Death|7|||
33586213|NCT02574078|102032866|FG009|Treatment Period|Death|1|||
33586214|NCT02574078|102032867|FG010|Treatment Period|Death|0|||
33586215|NCT02574078|102032868|FG011|Treatment Period|Death|2|||
33586216|NCT02574078|102032869|FG012|Treatment Period|Death|1|||
33586217|NCT02574078|102032857|FG000|Treatment Period|Adverse event unrelated to drug|0|||
33586218|NCT02574078|102032858|FG001|Treatment Period|Adverse event unrelated to drug|0|||
33586219|NCT02574078|102032859|FG002|Treatment Period|Adverse event unrelated to drug|1|||
33586220|NCT02574078|102032860|FG003|Treatment Period|Adverse event unrelated to drug|0|||
33586221|NCT02574078|102032861|FG004|Treatment Period|Adverse event unrelated to drug|2|||
33586222|NCT02574078|102032862|FG005|Treatment Period|Adverse event unrelated to drug|3|||
33586223|NCT02574078|102032863|FG006|Treatment Period|Adverse event unrelated to drug|0|||
33586224|NCT02574078|102032864|FG007|Treatment Period|Adverse event unrelated to drug|0|||
33586225|NCT02574078|102032865|FG008|Treatment Period|Adverse event unrelated to drug|1|||
33586226|NCT02574078|102032866|FG009|Treatment Period|Adverse event unrelated to drug|2|||
33586227|NCT02574078|102032867|FG010|Treatment Period|Adverse event unrelated to drug|4|||
33646319|NCT04535453|102256422|FG002|Overall Study|Physician Decision|0|||
33646320|NCT04535453|102256423|FG003|Overall Study|Physician Decision|1|||
33247011|NCT02701361|100803955|FG002|Overall Study|Withdrawal by Subject|0|||
33247012|NCT02701361|100803953|FG000|Overall Study|timed out in rehab center|0|||
33646321|NCT04535453|102256424|FG004|Overall Study|Physician Decision|0|||
33646322|NCT04535453|102256425|FG005|Overall Study|Physician Decision|0|||
33646323|NCT04535453|102256426|FG006|Overall Study|Physician Decision|0|||
33646324|NCT04535453|102256427|FG007|Overall Study|Physician Decision|0|||
33646325|NCT04535453|102256428|FG008|Overall Study|Physician Decision|0|||
33646326|NCT04535453|102256429|FG009|Overall Study|Physician Decision|0|||
33247013|NCT02701361|100803954|FG001|Overall Study|timed out in rehab center|1|||
33247014|NCT02701361|100803955|FG002|Overall Study|timed out in rehab center|0|||
33247015|NCT02701361|100803953|FG000|Overall Study|incarceration|0|||
33247016|NCT02701361|100803954|FG001|Overall Study|incarceration|0|||
33247017|NCT02701361|100803955|FG002|Overall Study|incarceration|1|||
33247018|NCT03085017|100803959|FG000|Overall Study|Death|0|||
33586228|NCT02574078|102032868|FG011|Treatment Period|Adverse event unrelated to drug|1|||
33586229|NCT02574078|102032869|FG012|Treatment Period|Adverse event unrelated to drug|0|||
33247019|NCT03085017|100803960|FG001|Overall Study|Death|3|||
33247020|NCT00631475|100803965|FG000|Overall Study|Death|18|||
33376624|NCT00006604|101265004|FG001|Overall Study|Lost to Follow-up|0|||
33646327|NCT04535453|102256430|FG010|Overall Study|Physician Decision|0|||
33646328|NCT04535453|102256431|FG011|Overall Study|Physician Decision|0|||
33376625|NCT00006604|101265005|FG002|Overall Study|Lost to Follow-up|0|||
33586230|NCT02574078|102032857|FG000|Treatment Period|Administrative reason by Sponsor|0|||
33586231|NCT02574078|102032858|FG001|Treatment Period|Administrative reason by Sponsor|1|||
33376626|NCT00006604|101265006|FG003|Overall Study|Lost to Follow-up|0|||
33376627|NCT00006604|101265007|FG004|Overall Study|Lost to Follow-up|0|||
33376628|NCT00006604|101265008|FG005|Overall Study|Lost to Follow-up|0|||
33376629|NCT00006604|101265009|FG006|Overall Study|Lost to Follow-up|0|||
33646329|NCT04535453|102256420|FG000|Overall Study|Withdrawal by Subject|3|||
33646330|NCT04535453|102256421|FG001|Overall Study|Withdrawal by Subject|6|||
33247021|NCT00631475|100803965|FG000|Overall Study|Adverse Event|14|||
33376630|NCT00006604|101265010|FG007|Overall Study|Lost to Follow-up|1|||
33586232|NCT02574078|102032859|FG002|Treatment Period|Administrative reason by Sponsor|0|||
33646331|NCT04535453|102256422|FG002|Overall Study|Withdrawal by Subject|3|||
33646332|NCT04535453|102256423|FG003|Overall Study|Withdrawal by Subject|3|||
33148642|NCT00704808|100458199|FG000|Overall Study|Early therapy discontinuation|16|||
33148643|NCT00704808|100458199|FG000|Overall Study|Adverse Event|1|||
33376631|NCT00006604|101265011|FG008|Overall Study|Lost to Follow-up|0|||
33586233|NCT02574078|102032860|FG003|Treatment Period|Administrative reason by Sponsor|0|||
33646333|NCT04535453|102256424|FG004|Overall Study|Withdrawal by Subject|2|||
33376632|NCT00006604|101265012|FG009|Overall Study|Lost to Follow-up|2|||
33376633|NCT00006604|101265013|FG010|Overall Study|Lost to Follow-up|0|||
33376634|NCT00006604|101265014|FG011|Overall Study|Lost to Follow-up|0|||
33376635|NCT00006604|101265015|FG012|Overall Study|Lost to Follow-up|0|||
33376636|NCT00006604|101265016|FG013|Overall Study|Lost to Follow-up|0|||
33376637|NCT00006604|101265017|FG014|Overall Study|Lost to Follow-up|0|||
33376638|NCT00006604|101265018|FG015|Overall Study|Lost to Follow-up|1|||
33376639|NCT00006604|101265019|FG016|Overall Study|Lost to Follow-up|3|||
33376640|NCT00006604|101265003|FG000|Overall Study|Other Reason|0|||
33376641|NCT00006604|101265004|FG001|Overall Study|Other Reason|0|||
33376642|NCT00006604|101265005|FG002|Overall Study|Other Reason|0|||
33376643|NCT00006604|101265006|FG003|Overall Study|Other Reason|0|||
33376644|NCT00006604|101265007|FG004|Overall Study|Other Reason|0|||
33376645|NCT00006604|101265008|FG005|Overall Study|Other Reason|1|||
33376646|NCT00006604|101265009|FG006|Overall Study|Other Reason|0|||
33376647|NCT00006604|101265010|FG007|Overall Study|Other Reason|0|||
33376648|NCT00006604|101265011|FG008|Overall Study|Other Reason|0|||
33376649|NCT00006604|101265012|FG009|Overall Study|Other Reason|1|||
33376650|NCT00006604|101265013|FG010|Overall Study|Other Reason|0|||
33376651|NCT00006604|101265014|FG011|Overall Study|Other Reason|0|||
33376652|NCT00006604|101265015|FG012|Overall Study|Other Reason|0|||
33376653|NCT00006604|101265016|FG013|Overall Study|Other Reason|0|||
33376654|NCT00006604|101265017|FG014|Overall Study|Other Reason|0|||
33376655|NCT00006604|101265018|FG015|Overall Study|Other Reason|0|||
33376656|NCT00006604|101265019|FG016|Overall Study|Other Reason|0|||
33376657|NCT02156492|101265020|FG000|Period 1|No Reason Given|0|||
33376658|NCT02156492|101265021|FG001|Period 1|No Reason Given|1|||
33376659|NCT02156492|101265022|FG002|Period 1|No Reason Given|0|||
33376660|NCT02156492|101265020|FG000|Period 3|Adverse Event|0|||
33376661|NCT02156492|101265021|FG001|Period 3|Adverse Event|1|||
33376662|NCT02156492|101265022|FG002|Period 3|Adverse Event|0|||
33376663|NCT03115476|101265023|FG000|LP0084-1369|Death|1|||
33376664|NCT03115476|101265024|FG001|LP0084-1369|Death|0|||
33376665|NCT03115476|101265025|FG002|LP0084-1369|Death|2|||
33376666|NCT03115476|101265023|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
33376667|NCT03115476|101265024|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
33376668|NCT03115476|101265025|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
33376669|NCT01265420|101265026|FG000|Overall Study|Lost to Follow-up|1|||
33376670|NCT00343291|101265027|FG000|Overall Study|Adverse Event|13|||
33376671|NCT00343291|101265028|FG001|Overall Study|Adverse Event|13|||
33376672|NCT00343291|101265027|FG000|Overall Study|Death|3|||
33376673|NCT00343291|101265028|FG001|Overall Study|Death|2|||
33376674|NCT00343291|101265027|FG000|Overall Study|Progressive disease|33|||
33376675|NCT00343291|101265028|FG001|Overall Study|Progressive disease|34|||
33376676|NCT00343291|101265027|FG000|Overall Study|Withdrawal by Subject|0|||
33376677|NCT00343291|101265028|FG001|Overall Study|Withdrawal by Subject|2|||
33376678|NCT00343291|101265027|FG000|Overall Study|Other|8|||
33376679|NCT00343291|101265028|FG001|Overall Study|Other|5|||
33376680|NCT03076190|101265029|FG000|Overall Study|Lost to Follow-up|9|||
33376681|NCT03076190|101265030|FG001|Overall Study|Lost to Follow-up|34|||
33376682|NCT03076190|101265029|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
33376683|NCT03076190|101265030|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
33376684|NCT00667251|101265031|FG000|Overall Study|Adverse Event|13|||
33376685|NCT00667251|101265032|FG001|Overall Study|Adverse Event|4|||
33376686|NCT00667251|101265031|FG000|Overall Study|Withdrawal by Subject|6|||
33376687|NCT00667251|101265032|FG001|Overall Study|Withdrawal by Subject|2|||
33376688|NCT00667251|101265031|FG000|Overall Study|Other/missing|46|||
33376689|NCT00667251|101265032|FG001|Overall Study|Other/missing|84|||
33376690|NCT00667251|101265031|FG000|Overall Study|Intercurrent Illness|4|||
33376691|NCT00667251|101265032|FG001|Overall Study|Intercurrent Illness|3|||
33376692|NCT00667251|101265031|FG000|Overall Study|Symptomatic progression|1|||
33376693|NCT00667251|101265032|FG001|Overall Study|Symptomatic progression|2|||
33376694|NCT01069523|101265037|FG000|Overall Study|Withdrawal by Subject|4|||
33376695|NCT01069523|101265038|FG001|Overall Study|Withdrawal by Subject|7|||
33376696|NCT01694420|101265039|FG000|Overall Study|Lost to Follow-up|3|||
33376697|NCT00844649|101265040|FG000|Overall Study|Progressive Disease|196|||
33376698|NCT00844649|101265041|FG001|Overall Study|Progressive Disease|245|||
33376699|NCT00844649|101265040|FG000|Overall Study|Adverse Event|128|||
33376700|NCT00844649|101265041|FG001|Overall Study|Adverse Event|73|||
33376701|NCT00844649|101265040|FG000|Overall Study|Physician Decision|25|||
33586234|NCT02574078|102032861|FG004|Treatment Period|Administrative reason by Sponsor|0|||
33376702|NCT00844649|101265041|FG001|Overall Study|Physician Decision|18|||
33376703|NCT00844649|101265040|FG000|Overall Study|Protocol Violation|10|||
33376704|NCT00844649|101265041|FG001|Overall Study|Protocol Violation|6|||
33376705|NCT00844649|101265040|FG000|Overall Study|Withdrawal by Subject|28|||
33376706|NCT00844649|101265041|FG001|Overall Study|Withdrawal by Subject|39|||
33376707|NCT00844649|101265040|FG000|Overall Study|Other|7|||
33376708|NCT00844649|101265041|FG001|Overall Study|Other|10|||
33376709|NCT00844649|101265040|FG000|Overall Study|Withdrew prior to starting treatment|11|||
33376710|NCT00844649|101265041|FG001|Overall Study|Withdrew prior to starting treatment|27|||
33586235|NCT02574078|102032862|FG005|Treatment Period|Administrative reason by Sponsor|0|||
33646334|NCT04535453|102256425|FG005|Overall Study|Withdrawal by Subject|1|||
33646335|NCT04535453|102256426|FG006|Overall Study|Withdrawal by Subject|1|||
33646336|NCT04535453|102256427|FG007|Overall Study|Withdrawal by Subject|1|||
33646337|NCT04535453|102256428|FG008|Overall Study|Withdrawal by Subject|1|||
33646338|NCT04535453|102256429|FG009|Overall Study|Withdrawal by Subject|1|||
33646339|NCT04535453|102256430|FG010|Overall Study|Withdrawal by Subject|0|||
33646340|NCT04535453|102256431|FG011|Overall Study|Withdrawal by Subject|1|||
33646341|NCT04535453|102256420|FG000|Overall Study|Other|0|||
33646342|NCT04535453|102256421|FG001|Overall Study|Other|0|||
33646343|NCT04535453|102256422|FG002|Overall Study|Other|1|||
33646344|NCT04535453|102256423|FG003|Overall Study|Other|0|||
33646345|NCT04535453|102256424|FG004|Overall Study|Other|1|||
33646346|NCT04535453|102256425|FG005|Overall Study|Other|0|||
33247022|NCT00631475|100803965|FG000|Overall Study|Withdrew consent|5|||
33247023|NCT00631475|100803965|FG000|Overall Study|Preparation for lung transplant|8|||
33247024|NCT04337489|100803966|FG000|Overall Study|Withdrawal by Subject|1|||
33586236|NCT02574078|102032863|FG006|Treatment Period|Administrative reason by Sponsor|1|||
33586237|NCT02574078|102032864|FG007|Treatment Period|Administrative reason by Sponsor|0|||
33586238|NCT02574078|102032865|FG008|Treatment Period|Administrative reason by Sponsor|0|||
33586239|NCT02574078|102032866|FG009|Treatment Period|Administrative reason by Sponsor|0|||
33586240|NCT02574078|102032867|FG010|Treatment Period|Administrative reason by Sponsor|0|||
33586241|NCT02574078|102032868|FG011|Treatment Period|Administrative reason by Sponsor|0|||
33586242|NCT02574078|102032869|FG012|Treatment Period|Administrative reason by Sponsor|3|||
33586243|NCT02574078|102032857|FG000|Treatment Period|Other reasons|1|||
33586244|NCT02574078|102032858|FG001|Treatment Period|Other reasons|0|||
33586245|NCT02574078|102032859|FG002|Treatment Period|Other reasons|1|||
33586246|NCT02574078|102032860|FG003|Treatment Period|Other reasons|3|||
33586247|NCT02574078|102032861|FG004|Treatment Period|Other reasons|3|||
33586248|NCT02574078|102032862|FG005|Treatment Period|Other reasons|1|||
33586249|NCT02574078|102032863|FG006|Treatment Period|Other reasons|2|||
33586250|NCT02574078|102032864|FG007|Treatment Period|Other reasons|1|||
33586251|NCT02574078|102032865|FG008|Treatment Period|Other reasons|3|||
33586252|NCT02574078|102032866|FG009|Treatment Period|Other reasons|1|||
33586253|NCT02574078|102032867|FG010|Treatment Period|Other reasons|1|||
33586254|NCT02574078|102032868|FG011|Treatment Period|Other reasons|3|||
33586255|NCT02574078|102032869|FG012|Treatment Period|Other reasons|1|||
33586256|NCT02574078|102032857|FG000|Treatment Period|Participant request to stop drug|0|||
33586257|NCT02574078|102032858|FG001|Treatment Period|Participant request to stop drug|0|||
33586258|NCT02574078|102032859|FG002|Treatment Period|Participant request to stop drug|0|||
33586259|NCT02574078|102032860|FG003|Treatment Period|Participant request to stop drug|2|||
33586260|NCT02574078|102032861|FG004|Treatment Period|Participant request to stop drug|4|||
33586261|NCT02574078|102032862|FG005|Treatment Period|Participant request to stop drug|0|||
33586262|NCT02574078|102032863|FG006|Treatment Period|Participant request to stop drug|1|||
33586263|NCT02574078|102032864|FG007|Treatment Period|Participant request to stop drug|0|||
33586264|NCT02574078|102032865|FG008|Treatment Period|Participant request to stop drug|3|||
33586265|NCT02574078|102032866|FG009|Treatment Period|Participant request to stop drug|2|||
33586266|NCT02574078|102032867|FG010|Treatment Period|Participant request to stop drug|2|||
33586267|NCT02574078|102032868|FG011|Treatment Period|Participant request to stop drug|4|||
33586268|NCT02574078|102032869|FG012|Treatment Period|Participant request to stop drug|1|||
33586269|NCT02574078|102032857|FG000|Treatment Period|Participant withdrew consent|0|||
33586270|NCT02574078|102032858|FG001|Treatment Period|Participant withdrew consent|0|||
33586271|NCT02574078|102032859|FG002|Treatment Period|Participant withdrew consent|0|||
33586272|NCT02574078|102032860|FG003|Treatment Period|Participant withdrew consent|0|||
33586273|NCT02574078|102032861|FG004|Treatment Period|Participant withdrew consent|1|||
33586274|NCT02574078|102032862|FG005|Treatment Period|Participant withdrew consent|1|||
33586275|NCT02574078|102032863|FG006|Treatment Period|Participant withdrew consent|0|||
33586276|NCT02574078|102032864|FG007|Treatment Period|Participant withdrew consent|1|||
33586277|NCT02574078|102032865|FG008|Treatment Period|Participant withdrew consent|0|||
33646347|NCT04535453|102256426|FG006|Overall Study|Other|1|||
33247025|NCT02140554|100803968|FG000|Overall Study|Withdrawal of consent|1|||
33586278|NCT02574078|102032866|FG009|Treatment Period|Participant withdrew consent|2|||
33247026|NCT02140554|100803969|FG001|Overall Study|Withdrawal of consent|0|||
33646348|NCT04535453|102256427|FG007|Overall Study|Other|1|||
33646349|NCT04535453|102256428|FG008|Overall Study|Other|1|||
33247027|NCT02140554|100803970|FG002|Overall Study|Withdrawal of consent|4|||
33247028|NCT02140554|100803968|FG000|Overall Study|Physician Decision|1|||
33247029|NCT02140554|100803969|FG001|Overall Study|Physician Decision|0|||
33586279|NCT02574078|102032867|FG010|Treatment Period|Participant withdrew consent|1|||
33646350|NCT04535453|102256429|FG009|Overall Study|Other|0|||
33646351|NCT04535453|102256430|FG010|Overall Study|Other|0|||
33148644|NCT00704808|100458199|FG000|Overall Study|Lost to Follow-up|1|||
33586280|NCT02574078|102032868|FG011|Treatment Period|Participant withdrew consent|4|||
33586281|NCT02574078|102032869|FG012|Treatment Period|Participant withdrew consent|1|||
33646352|NCT04535453|102256431|FG011|Overall Study|Other|0|||
33646353|NCT03539549|102256433|FG000|Overall Study|Adverse Event|12|||
33376711|NCT05127421|101265043|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
33376712|NCT05127421|101265044|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
33376713|NCT05127421|101265045|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
33376714|NCT05127421|101265046|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
33376715|NCT05127421|101265043|FG000|4-Week Double-Blind Period|Physician Decision|1|||
33376716|NCT05127421|101265044|FG001|4-Week Double-Blind Period|Physician Decision|0|||
33376717|NCT05127421|101265045|FG002|4-Week Double-Blind Period|Physician Decision|0|||
33376718|NCT05127421|101265046|FG003|4-Week Double-Blind Period|Physician Decision|0|||
33376719|NCT05127421|101265043|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
33376720|NCT05127421|101265044|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
33376721|NCT05127421|101265045|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
33376722|NCT05127421|101265046|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
33376723|NCT05127421|101265043|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
33376724|NCT05127421|101265044|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
33376725|NCT05127421|101265045|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
33376726|NCT05127421|101265046|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
33376727|NCT05127421|101265043|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
33376728|NCT05127421|101265044|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
33376729|NCT05127421|101265045|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
33376730|NCT05127421|101265046|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
33376731|NCT05127421|101265043|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
33376732|NCT05127421|101265044|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
33376733|NCT05127421|101265045|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
33376734|NCT05127421|101265046|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
33376735|NCT05127421|101265043|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
33376736|NCT05127421|101265044|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
33376737|NCT05127421|101265045|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
33376738|NCT05127421|101265046|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
33376739|NCT05127421|101265043|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
33376740|NCT05127421|101265044|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
33376741|NCT05127421|101265045|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
33376742|NCT05127421|101265046|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
33376743|NCT00077376|101265047|FG000|Overall Study|Adverse Event|8|||
33376744|NCT00077376|101265047|FG000|Overall Study|Withdrawal by Subject|2|||
33376745|NCT00077376|101265047|FG000|Overall Study|Death|1|||
33376746|NCT00077376|101265047|FG000|Overall Study|Physician Decision|1|||
33376747|NCT00077376|101265047|FG000|Overall Study|Alternative therapy|5|||
33376748|NCT00077376|101265047|FG000|Overall Study|Complicating disease|1|||
33376749|NCT00077376|101265047|FG000|Overall Study|Still on treatment|1|||
33376750|NCT00077376|101265047|FG000|Overall Study|Symptomatic deterioration|1|||
33376751|NCT00077376|101265047|FG000|Overall Study|Surgery|1|||
33376752|NCT00077376|101265047|FG000|Overall Study|Insurance ran out|1|||
33376753|NCT01755195|101265051|FG000|Overall Study|Participant noncompliance|2|||
33376754|NCT01755195|101265051|FG000|Overall Study|Switched to alternative treatment|4|||
33376755|NCT01755195|101265051|FG000|Overall Study|Withdrawal by Subject|1|||
33376756|NCT01755195|101265051|FG000|Overall Study|Participant refused to start treatment|1|||
33376757|NCT01755195|101265051|FG000|Overall Study|Participant has been consented for another trial|1|||
33376758|NCT01755195|101265051|FG000|Overall Study|Refused further treatment|3|||
33376759|NCT01755195|101265051|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
33376760|NCT01324622|101265052|FG000|Overall Study|Lost to Follow-up|7|||
33376761|NCT01324622|101265053|FG001|Overall Study|Lost to Follow-up|7|||
33376762|NCT01324622|101265052|FG000|Overall Study|Death|1|||
33376763|NCT01324622|101265053|FG001|Overall Study|Death|0|||
33376764|NCT01324622|101265052|FG000|Overall Study|Lack of Efficacy|1|||
33376765|NCT01324622|101265053|FG001|Overall Study|Lack of Efficacy|0|||
33376766|NCT01086150|101265055|FG000|Overall Study|Withdrawal by Subject|0|||
33376767|NCT01086150|101265056|FG001|Overall Study|Withdrawal by Subject|4|||
33376768|NCT01086150|101265057|FG002|Overall Study|Withdrawal by Subject|1|||
33376769|NCT01086150|101265055|FG000|Overall Study|Lost to Follow-up|0|||
33376770|NCT01086150|101265056|FG001|Overall Study|Lost to Follow-up|1|||
33376771|NCT01086150|101265057|FG002|Overall Study|Lost to Follow-up|0|||
33376772|NCT01086150|101265055|FG000|Overall Study|Screen Failure|0|||
33376773|NCT01086150|101265056|FG001|Overall Study|Screen Failure|1|||
33376774|NCT01086150|101265057|FG002|Overall Study|Screen Failure|0|||
33376775|NCT00929734|101265058|FG000|Overall Study|Lost to Follow-up|2|||
33376776|NCT00929734|101265059|FG001|Overall Study|Lost to Follow-up|1|||
33376777|NCT00929734|101265058|FG000|Overall Study|Withdrawal by Subject|0|||
33376778|NCT00929734|101265059|FG001|Overall Study|Withdrawal by Subject|2|||
33376779|NCT00377611|101265062|FG000|Overall Study|Adverse Event|2|||
33376780|NCT00377611|101265063|FG001|Overall Study|Adverse Event|9|||
33376781|NCT00377611|101265062|FG000|Overall Study|Protocol Violation|2|||
33376782|NCT00377611|101265063|FG001|Overall Study|Protocol Violation|0|||
33376783|NCT00377611|101265062|FG000|Overall Study|Withdrawal by Subject|0|||
33376784|NCT00377611|101265063|FG001|Overall Study|Withdrawal by Subject|5|||
33376785|NCT00377611|101265062|FG000|Overall Study|Lost to Follow-up|18|||
33376786|NCT00377611|101265063|FG001|Overall Study|Lost to Follow-up|16|||
33376787|NCT00377611|101265062|FG000|Overall Study|Other|0|||
33376788|NCT00377611|101265063|FG001|Overall Study|Other|3|||
33376789|NCT01115738|101265069|FG000|Overall Study|Death|1|||
33376790|NCT01115738|101265070|FG001|Overall Study|Death|0|||
33376791|NCT01115738|101265071|FG002|Overall Study|Death|0|||
33376792|NCT01115738|101265069|FG000|Overall Study|Lost to Follow-up|0|||
33376793|NCT01115738|101265070|FG001|Overall Study|Lost to Follow-up|0|||
33376794|NCT01115738|101265071|FG002|Overall Study|Lost to Follow-up|1|||
33376795|NCT01115738|101265069|FG000|Overall Study|Physician Decision|18|||
33376796|NCT01115738|101265070|FG001|Overall Study|Physician Decision|15|||
33376797|NCT01115738|101265071|FG002|Overall Study|Physician Decision|17|||
33376798|NCT01115738|101265069|FG000|Overall Study|Withdrawal by Subject|6|||
33376799|NCT01115738|101265070|FG001|Overall Study|Withdrawal by Subject|6|||
33376800|NCT01115738|101265071|FG002|Overall Study|Withdrawal by Subject|9|||
33376801|NCT01973452|101265072|FG000|Overall Study|Lack of Efficacy|0|||
33376802|NCT01973452|101265073|FG001|Overall Study|Lack of Efficacy|1|||
33376803|NCT01973452|101265072|FG000|Overall Study|Lost to Follow-up|1|||
33376804|NCT01973452|101265073|FG001|Overall Study|Lost to Follow-up|0|||
33376805|NCT01973452|101265072|FG000|Overall Study|Withdrawal by Subject|10|||
33376806|NCT01973452|101265073|FG001|Overall Study|Withdrawal by Subject|9|||
33376807|NCT01973452|101265072|FG000|Overall Study|Ineligible|1|||
33376808|NCT01973452|101265073|FG001|Overall Study|Ineligible|1|||
33376809|NCT01973452|101265072|FG000|Overall Study|Surgery canceled by participant|5|||
33376810|NCT01973452|101265073|FG001|Overall Study|Surgery canceled by participant|3|||
33376811|NCT00848250|101265074|FG000|Overall Study|surgery was completed without cardiopulm|0|||
33376812|NCT00848250|101265075|FG001|Overall Study|surgery was completed without cardiopulm|1|||
33376813|NCT02163993|101265076|FG000|Treatment Period|Adverse Event|0|||
33376814|NCT02163993|101265077|FG001|Treatment Period|Adverse Event|1|||
33376815|NCT02163993|101265078|FG002|Treatment Period|Adverse Event|0|||
33376816|NCT02163993|101265079|FG003|Treatment Period|Adverse Event|0|||
33376817|NCT02163993|101265080|FG004|Treatment Period|Adverse Event|1|||
33376818|NCT02163993|101265076|FG000|Treatment Period|Lost to Follow-up|2|||
33376819|NCT02163993|101265077|FG001|Treatment Period|Lost to Follow-up|3|||
33423934|NCT01200394|101443671|FG001|Overall Study|Lost to Follow-up|1|||
33423935|NCT01200394|101443670|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
33423936|NCT01200394|101443671|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
33423937|NCT01200394|101443670|FG000|Overall Study|Protocol Violation|0|||
33423938|NCT01200394|101443671|FG001|Overall Study|Protocol Violation|3|||
33423939|NCT01200394|101443670|FG000|Overall Study|Withdrawal by Subject|0|||
33646354|NCT03539549|102256433|FG000|Overall Study|Lost to Follow-up|1|||
33247030|NCT02140554|100803970|FG002|Overall Study|Physician Decision|2|||
33247031|NCT02140554|100803968|FG000|Overall Study|Death|0|||
33247032|NCT02140554|100803969|FG001|Overall Study|Death|0|||
33247033|NCT02140554|100803970|FG002|Overall Study|Death|1|||
33376820|NCT02163993|101265078|FG002|Treatment Period|Lost to Follow-up|1|||
33376821|NCT02163993|101265079|FG003|Treatment Period|Lost to Follow-up|3|||
33376822|NCT02163993|101265080|FG004|Treatment Period|Lost to Follow-up|1|||
33376823|NCT02163993|101265076|FG000|Treatment Period|Physician Decision|1|||
33376824|NCT02163993|101265077|FG001|Treatment Period|Physician Decision|0|||
33376825|NCT02163993|101265078|FG002|Treatment Period|Physician Decision|0|||
33376826|NCT02163993|101265079|FG003|Treatment Period|Physician Decision|0|||
33376827|NCT02163993|101265080|FG004|Treatment Period|Physician Decision|0|||
33376828|NCT02163993|101265076|FG000|Treatment Period|Protocol Violation|2|||
33423940|NCT01200394|101443671|FG001|Overall Study|Withdrawal by Subject|5|||
33586282|NCT02574078|102032857|FG000|Treatment Period|Participant no longer meets criteria|0|||
33586283|NCT02574078|102032858|FG001|Treatment Period|Participant no longer meets criteria|0|||
33586284|NCT02574078|102032859|FG002|Treatment Period|Participant no longer meets criteria|0|||
33586285|NCT02574078|102032860|FG003|Treatment Period|Participant no longer meets criteria|0|||
33586286|NCT02574078|102032861|FG004|Treatment Period|Participant no longer meets criteria|1|||
33586287|NCT02574078|102032862|FG005|Treatment Period|Participant no longer meets criteria|0|||
33586288|NCT02574078|102032863|FG006|Treatment Period|Participant no longer meets criteria|0|||
33586289|NCT02574078|102032864|FG007|Treatment Period|Participant no longer meets criteria|0|||
33586290|NCT02574078|102032865|FG008|Treatment Period|Participant no longer meets criteria|0|||
33586291|NCT02574078|102032866|FG009|Treatment Period|Participant no longer meets criteria|1|||
33586292|NCT02574078|102032867|FG010|Treatment Period|Participant no longer meets criteria|1|||
33586293|NCT02574078|102032868|FG011|Treatment Period|Participant no longer meets criteria|1|||
33586294|NCT02574078|102032869|FG012|Treatment Period|Participant no longer meets criteria|0|||
33586295|NCT02574078|102032857|FG000|Treatment Period|Lost to Follow-up|0|||
33586296|NCT02574078|102032858|FG001|Treatment Period|Lost to Follow-up|0|||
33586297|NCT02574078|102032859|FG002|Treatment Period|Lost to Follow-up|0|||
33586298|NCT02574078|102032860|FG003|Treatment Period|Lost to Follow-up|0|||
33586299|NCT02574078|102032861|FG004|Treatment Period|Lost to Follow-up|0|||
33247034|NCT02140554|100803968|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
33423941|NCT01200394|101443670|FG000|Overall Study|Other|0|||
33586300|NCT02574078|102032862|FG005|Treatment Period|Lost to Follow-up|0|||
33586301|NCT02574078|102032863|FG006|Treatment Period|Lost to Follow-up|0|||
33586302|NCT02574078|102032864|FG007|Treatment Period|Lost to Follow-up|0|||
33586303|NCT02574078|102032865|FG008|Treatment Period|Lost to Follow-up|0|||
33586304|NCT02574078|102032866|FG009|Treatment Period|Lost to Follow-up|1|||
33586305|NCT02574078|102032867|FG010|Treatment Period|Lost to Follow-up|0|||
33586306|NCT02574078|102032868|FG011|Treatment Period|Lost to Follow-up|1|||
33586307|NCT02574078|102032869|FG012|Treatment Period|Lost to Follow-up|0|||
33586308|NCT02574078|102032857|FG000|Treatment Period|Maximum clinical benefit|0|||
33586309|NCT02574078|102032858|FG001|Treatment Period|Maximum clinical benefit|0|||
33586310|NCT02574078|102032859|FG002|Treatment Period|Maximum clinical benefit|0|||
33586311|NCT02574078|102032860|FG003|Treatment Period|Maximum clinical benefit|0|||
33586312|NCT02574078|102032861|FG004|Treatment Period|Maximum clinical benefit|0|||
33586313|NCT02574078|102032862|FG005|Treatment Period|Maximum clinical benefit|0|||
33586314|NCT02574078|102032863|FG006|Treatment Period|Maximum clinical benefit|0|||
33586315|NCT02574078|102032864|FG007|Treatment Period|Maximum clinical benefit|0|||
33586316|NCT02574078|102032865|FG008|Treatment Period|Maximum clinical benefit|0|||
33586317|NCT02574078|102032866|FG009|Treatment Period|Maximum clinical benefit|1|||
33586318|NCT02574078|102032867|FG010|Treatment Period|Maximum clinical benefit|0|||
33586319|NCT02574078|102032868|FG011|Treatment Period|Maximum clinical benefit|0|||
33586320|NCT02574078|102032869|FG012|Treatment Period|Maximum clinical benefit|0|||
33586321|NCT04188834|102032870|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
33586322|NCT03726658|102032871|FG000|Overall Study|Lost to Follow-up|0|||
33247035|NCT02140554|100803969|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
33247036|NCT02140554|100803970|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
33247037|NCT02282527|100803971|FG000|Overall Study|Lost to Follow-up|0|||
33586323|NCT03726658|102032872|FG001|Overall Study|Lost to Follow-up|0|||
33586324|NCT03726658|102032873|FG002|Overall Study|Lost to Follow-up|2|||
33586325|NCT03726658|102032874|FG003|Overall Study|Lost to Follow-up|0|||
33586326|NCT03726658|102032875|FG004|Overall Study|Lost to Follow-up|0|||
33247038|NCT02282527|100803972|FG001|Overall Study|Lost to Follow-up|1|||
33247039|NCT02282527|100803971|FG000|Overall Study|Lack of home health aid|1|||
33247040|NCT02282527|100803972|FG001|Overall Study|Lack of home health aid|0|||
33247041|NCT00282438|100803973|FG000|Overall Study|Lack of Efficacy|1|||
33247042|NCT00282438|100803974|FG001|Overall Study|Lack of Efficacy|0|||
33247043|NCT00282438|100803973|FG000|Overall Study|Death|0|||
33247044|NCT00282438|100803974|FG001|Overall Study|Death|1|||
33247045|NCT02469064|100803975|FG000|Overall Study|Request not to receive intervention.|1|||
33586327|NCT03726658|102032876|FG005|Overall Study|Lost to Follow-up|1|||
33586328|NCT03726658|102032877|FG006|Overall Study|Lost to Follow-up|1|||
33586329|NCT03726658|102032871|FG000|Overall Study|Withdrawal by Subject|1|||
33586330|NCT03726658|102032872|FG001|Overall Study|Withdrawal by Subject|0|||
33586331|NCT03726658|102032873|FG002|Overall Study|Withdrawal by Subject|0|||
33586332|NCT03726658|102032874|FG003|Overall Study|Withdrawal by Subject|0|||
33148645|NCT00704808|100458199|FG000|Overall Study|Treatment change|1|||
33247046|NCT02469064|100803976|FG001|Overall Study|Request not to receive intervention.|3|||
33247047|NCT03736785|100803977|FG000|Overall Study|Adverse Event|1|||
33247048|NCT03736785|100803978|FG001|Overall Study|Adverse Event|1|||
33247049|NCT03736785|100803979|FG002|Overall Study|Adverse Event|1|||
33247050|NCT03736785|100803977|FG000|Overall Study|Death|1|||
33247051|NCT03736785|100803978|FG001|Overall Study|Death|0|||
33247052|NCT03736785|100803979|FG002|Overall Study|Death|1|||
33247053|NCT03736785|100803977|FG000|Overall Study|Lost to Follow-up|0|||
33247054|NCT03736785|100803978|FG001|Overall Study|Lost to Follow-up|2|||
33586333|NCT03726658|102032875|FG004|Overall Study|Withdrawal by Subject|6|||
33586334|NCT03726658|102032876|FG005|Overall Study|Withdrawal by Subject|4|||
33586335|NCT03726658|102032877|FG006|Overall Study|Withdrawal by Subject|2|||
33586336|NCT03726658|102032871|FG000|Overall Study|Pregnancy|0|||
33586337|NCT03726658|102032872|FG001|Overall Study|Pregnancy|0|||
33148646|NCT01741012|100458200|FG000|Overall Study|Lost to Follow-up|1|||
33148647|NCT01741012|100458200|FG000|Overall Study|Withdrawal by Subject|2|||
33148648|NCT00777205|100458204|FG000|Overall Study|Lost to Follow-up|25|||
33148649|NCT00777205|100458205|FG001|Overall Study|Lost to Follow-up|9|||
33148650|NCT00777205|100458204|FG000|Overall Study|Withdrawal by Subject|6|||
33148651|NCT00777205|100458205|FG001|Overall Study|Withdrawal by Subject|4|||
33148652|NCT00777205|100458204|FG000|Overall Study|Death|0|||
33148653|NCT00777205|100458205|FG001|Overall Study|Death|2|||
33148654|NCT00777205|100458204|FG000|Overall Study|Protocol Violation|0|||
33148655|NCT00777205|100458205|FG001|Overall Study|Protocol Violation|56|||
33148656|NCT01309308|100458206|FG000|Overall Study|Lost to Follow-up|6|||
33148657|NCT01309308|100458207|FG001|Overall Study|Lost to Follow-up|4|||
33148658|NCT01801072|100458213|FG000|Overall Study|Lost to Follow-up|17|||
33247055|NCT03736785|100803979|FG002|Overall Study|Lost to Follow-up|3|||
33247056|NCT03736785|100803977|FG000|Overall Study|Non compliance with study drug|1|||
33247057|NCT03736785|100803978|FG001|Overall Study|Non compliance with study drug|1|||
33247058|NCT03736785|100803979|FG002|Overall Study|Non compliance with study drug|0|||
33586338|NCT03726658|102032873|FG002|Overall Study|Pregnancy|0|||
33376829|NCT02163993|101265077|FG001|Treatment Period|Protocol Violation|1|||
33376830|NCT02163993|101265078|FG002|Treatment Period|Protocol Violation|0|||
33376831|NCT02163993|101265079|FG003|Treatment Period|Protocol Violation|1|||
33376832|NCT02163993|101265080|FG004|Treatment Period|Protocol Violation|2|||
33376833|NCT02163993|101265076|FG000|Treatment Period|Withdrawal by Subject|6|||
33376834|NCT02163993|101265077|FG001|Treatment Period|Withdrawal by Subject|4|||
33376835|NCT02163993|101265078|FG002|Treatment Period|Withdrawal by Subject|1|||
33376836|NCT02163993|101265079|FG003|Treatment Period|Withdrawal by Subject|4|||
33376837|NCT02163993|101265080|FG004|Treatment Period|Withdrawal by Subject|1|||
33376838|NCT02163993|101265076|FG000|Treatment Period|Not treated|1|||
33376839|NCT02163993|101265077|FG001|Treatment Period|Not treated|0|||
33376840|NCT02163993|101265078|FG002|Treatment Period|Not treated|0|||
33376841|NCT02163993|101265079|FG003|Treatment Period|Not treated|1|||
33376842|NCT02163993|101265080|FG004|Treatment Period|Not treated|2|||
33376843|NCT02163993|101265076|FG000|Post-treatment Period|Adverse Event|0|||
33376844|NCT02163993|101265077|FG001|Post-treatment Period|Adverse Event|0|||
33376845|NCT02163993|101265078|FG002|Post-treatment Period|Adverse Event|1|||
33423942|NCT01200394|101443671|FG001|Overall Study|Other|1|||
33423943|NCT02626182|101443672|FG000|Overall Study|Adverse Event|2|||
33423944|NCT02626182|101443673|FG001|Overall Study|Adverse Event|0|||
33423945|NCT04126733|101443674|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
33423946|NCT04126733|101443674|FG000|Treatment Period|Adverse Event|8|||
33423947|NCT04126733|101443674|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
33423948|NCT04126733|101443674|FG000|Treatment Period|Physician Decision|5|||
33423949|NCT04126733|101443674|FG000|Treatment Period|Death|1|||
33423950|NCT04126733|101443674|FG000|Treatment Period|Other Reasons|2|||
33423951|NCT04126733|101443674|FG000|Active Follow-up Period|Death|13|||
33423952|NCT04126733|101443674|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
33423953|NCT04126733|101443674|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
33423954|NCT04126733|101443674|FG000|Active Follow-up Period|Other Reasons|1|||
33423955|NCT04126733|101443674|FG000|Long-term Follow-up Period|Death|22|||
33423956|NCT04126733|101443674|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
33423957|NCT04126733|101443674|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
33423958|NCT02957682|101443675|FG000|Overall Study|Adverse Event|64|||
33586339|NCT03726658|102032874|FG003|Overall Study|Pregnancy|0|||
33586340|NCT03726658|102032875|FG004|Overall Study|Pregnancy|0|||
33586341|NCT03726658|102032876|FG005|Overall Study|Pregnancy|0|||
33586342|NCT03726658|102032877|FG006|Overall Study|Pregnancy|1|||
33586343|NCT03726658|102032871|FG000|Overall Study|Not Reported|0|||
33586344|NCT03726658|102032872|FG001|Overall Study|Not Reported|0|||
33586345|NCT03726658|102032873|FG002|Overall Study|Not Reported|0|||
33586346|NCT03726658|102032874|FG003|Overall Study|Not Reported|0|||
33586347|NCT03726658|102032875|FG004|Overall Study|Not Reported|0|||
33586348|NCT03726658|102032876|FG005|Overall Study|Not Reported|0|||
33586349|NCT03726658|102032877|FG006|Overall Study|Not Reported|1|||
33586350|NCT04532294|102036255|FG000|Overall Study|Withdrawal by Subject|0|||
33586351|NCT04532294|102036256|FG001|Overall Study|Withdrawal by Subject|0|||
33586352|NCT04532294|102036257|FG002|Overall Study|Withdrawal by Subject|1|||
33247059|NCT03736785|100803977|FG000|Overall Study|Physician Decision|0|||
33247060|NCT03736785|100803978|FG001|Overall Study|Physician Decision|1|||
33247061|NCT03736785|100803979|FG002|Overall Study|Physician Decision|1|||
33247062|NCT03736785|100803977|FG000|Overall Study|Protocol Violation|1|||
33247063|NCT03736785|100803978|FG001|Overall Study|Protocol Violation|4|||
33247064|NCT03736785|100803979|FG002|Overall Study|Protocol Violation|3|||
33376846|NCT02163993|101265079|FG003|Post-treatment Period|Adverse Event|0|||
33586353|NCT04532294|102036255|FG000|Overall Study|Participants Not Dosed|0|||
33586354|NCT04532294|102036256|FG001|Overall Study|Participants Not Dosed|0|||
33586355|NCT04532294|102036257|FG002|Overall Study|Participants Not Dosed|2|||
33586356|NCT03470194|102036260|FG000|Overall Study|Lost to Follow-up|11|||
33586357|NCT03470194|102036261|FG001|Overall Study|Lost to Follow-up|17|||
33586358|NCT00104728|102036262|FG000|Overall Study|screen failures|19|||
33586359|NCT01521923|102036265|FG000|Overall Study|AE, serious fatal|1|||
33586360|NCT01521923|102036266|FG001|Overall Study|AE, serious fatal|0|||
33646355|NCT03539549|102256433|FG000|Overall Study|Death|2|||
33247065|NCT03736785|100803977|FG000|Overall Study|Sponsor Decision|1|||
33247066|NCT03736785|100803978|FG001|Overall Study|Sponsor Decision|0|||
33376847|NCT02163993|101265080|FG004|Post-treatment Period|Adverse Event|0|||
33376848|NCT02163993|101265076|FG000|Post-treatment Period|Lost to Follow-up|2|||
33376849|NCT02163993|101265077|FG001|Post-treatment Period|Lost to Follow-up|2|||
33376850|NCT02163993|101265078|FG002|Post-treatment Period|Lost to Follow-up|3|||
33376851|NCT02163993|101265079|FG003|Post-treatment Period|Lost to Follow-up|1|||
33376852|NCT02163993|101265080|FG004|Post-treatment Period|Lost to Follow-up|0|||
33376853|NCT02163993|101265076|FG000|Post-treatment Period|Protocol Violation|0|||
33423959|NCT02957682|101443676|FG001|Overall Study|Adverse Event|67|||
33423960|NCT02957682|101443675|FG000|Overall Study|Poor Compliance to Protocol|30|||
33586361|NCT01521923|102036267|FG002|Overall Study|AE, serious fatal|0|||
33586362|NCT01521923|102036268|FG003|Overall Study|AE, serious fatal|0|||
33586363|NCT01521923|102036265|FG000|Overall Study|SAE, non-fatal|0|||
33646356|NCT03539549|102256433|FG000|Overall Study|Progressive Disease|1|||
33646357|NCT03539549|102256433|FG000|Overall Study|Reason not Specified|1|||
33646358|NCT01587898|102256434|FG000|Overall Study|Adverse Event|1|||
33646359|NCT01587898|102256435|FG001|Overall Study|Adverse Event|1|||
33646360|NCT01587898|102256436|FG002|Overall Study|Adverse Event|0|||
33646361|NCT01587898|102256437|FG003|Overall Study|Adverse Event|0|||
33646362|NCT01587898|102256434|FG000|Overall Study|Protocol Violation|0|||
33646363|NCT01587898|102256435|FG001|Overall Study|Protocol Violation|2|||
33646364|NCT01587898|102256436|FG002|Overall Study|Protocol Violation|1|||
33646365|NCT01587898|102256437|FG003|Overall Study|Protocol Violation|1|||
33646366|NCT01587898|102256434|FG000|Overall Study|Lost to Follow-up|0|||
33646367|NCT01587898|102256435|FG001|Overall Study|Lost to Follow-up|0|||
33646368|NCT01587898|102256436|FG002|Overall Study|Lost to Follow-up|0|||
33646369|NCT01587898|102256437|FG003|Overall Study|Lost to Follow-up|1|||
33646370|NCT01587898|102256434|FG000|Overall Study|Withdrawal by Subject|2|||
33646371|NCT01587898|102256435|FG001|Overall Study|Withdrawal by Subject|1|||
33646372|NCT01587898|102256436|FG002|Overall Study|Withdrawal by Subject|0|||
33646373|NCT01587898|102256437|FG003|Overall Study|Withdrawal by Subject|0|||
33646374|NCT01587898|102256434|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
33646375|NCT01587898|102256435|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
33646376|NCT01587898|102256436|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
33646377|NCT01587898|102256437|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
33646378|NCT01932437|102256438|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
33646379|NCT01932437|102256439|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
33646380|NCT01932437|102256440|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
33646381|NCT01932437|102256441|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
33646382|NCT01932437|102256442|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
33646383|NCT01932437|102256443|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
33646384|NCT02105662|102256444|FG000|Overall Study|Lost to Follow-up|5|||
33646385|NCT02105662|102256444|FG000|Overall Study|Withdrawal by Subject|1|||
33646386|NCT02350764|102256445|FG000|Overall Study|Adverse Event|4|||
33646387|NCT02350764|102256445|FG000|Overall Study|Death|3|||
33646388|NCT02350764|102256445|FG000|Overall Study|Physician Decision|2|||
33646389|NCT02350764|102256445|FG000|Overall Study|Withdrawal by Subject|2|||
33646390|NCT00534599|102256446|FG000|Overall Study|Adverse Event|25|||
33646391|NCT00534599|102256447|FG001|Overall Study|Adverse Event|4|||
33646392|NCT00534599|102256446|FG000|Overall Study|Incorrect enrollment|2|||
33646393|NCT00534599|102256447|FG001|Overall Study|Incorrect enrollment|1|||
33646394|NCT00534599|102256446|FG000|Overall Study|Mis-randomization|2|||
33646395|NCT00534599|102256447|FG001|Overall Study|Mis-randomization|2|||
33646396|NCT00534599|102256446|FG000|Overall Study|Developed study-specific d/c criteria|5|||
33646397|NCT00534599|102256447|FG001|Overall Study|Developed study-specific d/c criteria|0|||
33646398|NCT00534599|102256446|FG000|Overall Study|Lack of Efficacy|0|||
33646399|NCT00534599|102256447|FG001|Overall Study|Lack of Efficacy|1|||
33646400|NCT00534599|102256446|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
33646401|NCT00534599|102256447|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
33646402|NCT00534599|102256446|FG000|Overall Study|Protocol Violation|1|||
33646403|NCT00534599|102256447|FG001|Overall Study|Protocol Violation|3|||
33646404|NCT00534599|102256446|FG000|Overall Study|Lost to Follow-up|11|||
33646405|NCT00534599|102256447|FG001|Overall Study|Lost to Follow-up|14|||
33646406|NCT00534599|102256446|FG000|Overall Study|Withdrawal by Subject|4|||
33646407|NCT00534599|102256447|FG001|Overall Study|Withdrawal by Subject|6|||
33646408|NCT00534599|102256446|FG000|Overall Study|Other|7|||
33646409|NCT00534599|102256447|FG001|Overall Study|Other|0|||
33646410|NCT02872285|102259584|FG000|Overall Study|Withdrawal by Subject|2|||
33646411|NCT02872285|102259585|FG001|Overall Study|Withdrawal by Subject|0|||
33646412|NCT02872285|102259584|FG000|Overall Study|Lost to Follow-up|2|||
33646413|NCT02872285|102259585|FG001|Overall Study|Lost to Follow-up|2|||
33646414|NCT02872285|102259584|FG000|Overall Study|Discontinued due to back surgery|1|||
33646415|NCT02872285|102259585|FG001|Overall Study|Discontinued due to back surgery|0|||
33646416|NCT01290796|102259589|FG000|Overall Study|Lost to Follow-up|21|||
33646417|NCT01290796|102259589|FG000|Overall Study|Withdrawal by Subject|4|||
33646418|NCT01290796|102259589|FG000|Overall Study|Physician Decision|2|||
33376854|NCT02163993|101265077|FG001|Post-treatment Period|Protocol Violation|0|||
33646419|NCT01290796|102259589|FG000|Overall Study|Secondary Surgical Intervention|2|||
33646420|NCT01290796|102259589|FG000|Overall Study|Withdrawal by Sponsor|1|||
33646421|NCT02230670|102259592|FG000|Overall Study|Adverse Event|1|||
33646422|NCT02230670|102259593|FG001|Overall Study|Adverse Event|2|||
33148659|NCT01801072|100458214|FG001|Overall Study|Lost to Follow-up|14|||
33148660|NCT01801072|100458213|FG000|Overall Study|Physician Decision|2|||
33376855|NCT02163993|101265078|FG002|Post-treatment Period|Protocol Violation|0|||
33376856|NCT02163993|101265079|FG003|Post-treatment Period|Protocol Violation|0|||
33646423|NCT02230670|102259592|FG000|Overall Study|Withdrawal by Subject|2|||
33646424|NCT02230670|102259593|FG001|Overall Study|Withdrawal by Subject|2|||
33646425|NCT02230670|102259592|FG000|Overall Study|Physician Decision|0|||
33646426|NCT02230670|102259593|FG001|Overall Study|Physician Decision|1|||
33247067|NCT03736785|100803979|FG002|Overall Study|Sponsor Decision|0|||
33247068|NCT03736785|100803977|FG000|Overall Study|Unknown/Missing data|3|||
33247069|NCT03736785|100803978|FG001|Overall Study|Unknown/Missing data|2|||
33247070|NCT03736785|100803979|FG002|Overall Study|Unknown/Missing data|1|||
33646427|NCT02230670|102259592|FG000|Overall Study|Protocol Violation|0|||
33646428|NCT02230670|102259593|FG001|Overall Study|Protocol Violation|1|||
33247071|NCT03736785|100803977|FG000|Overall Study|Withdrawal by Subject|9|||
33247072|NCT03736785|100803978|FG001|Overall Study|Withdrawal by Subject|6|||
33247073|NCT03736785|100803979|FG002|Overall Study|Withdrawal by Subject|4|||
33247074|NCT01068249|100803980|FG000|Overall Study|Death|1|||
33247075|NCT01068249|100803980|FG000|Overall Study|Withdrawal by Subject|3|||
33247076|NCT01549652|100806537|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
33247077|NCT01549652|100806538|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
33247078|NCT01549652|100806539|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
33247079|NCT01549652|100806540|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
33247080|NCT01549652|100806537|FG000|Overall Study|Study Drug Titration Failure|5|||
33247081|NCT01549652|100806538|FG001|Overall Study|Study Drug Titration Failure|6|||
33247082|NCT01549652|100806539|FG002|Overall Study|Study Drug Titration Failure|0|||
33247083|NCT01549652|100806540|FG003|Overall Study|Study Drug Titration Failure|0|||
33247084|NCT01549652|100806537|FG000|Overall Study|Withdrawal Effect|0|||
33247085|NCT01549652|100806538|FG001|Overall Study|Withdrawal Effect|2|||
33247086|NCT01549652|100806539|FG002|Overall Study|Withdrawal Effect|0|||
33247087|NCT01549652|100806540|FG003|Overall Study|Withdrawal Effect|0|||
33247088|NCT01549652|100806537|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
33247089|NCT01549652|100806538|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
33247090|NCT01549652|100806539|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
33247091|NCT01549652|100806540|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
33247092|NCT01549652|100806537|FG000|Overall Study|Problem with Infusion|1|||
33247093|NCT01549652|100806538|FG001|Overall Study|Problem with Infusion|0|||
33247094|NCT01549652|100806539|FG002|Overall Study|Problem with Infusion|0|||
33247095|NCT01549652|100806540|FG003|Overall Study|Problem with Infusion|0|||
33247096|NCT01549652|100806537|FG000|Overall Study|Titration Non-Compliance|1|||
33247097|NCT01549652|100806538|FG001|Overall Study|Titration Non-Compliance|3|||
33247098|NCT01549652|100806539|FG002|Overall Study|Titration Non-Compliance|4|||
33247099|NCT01549652|100806540|FG003|Overall Study|Titration Non-Compliance|5|||
33247100|NCT01549652|100806537|FG000|Overall Study|Titration Side Effects|0|||
33247101|NCT01549652|100806538|FG001|Overall Study|Titration Side Effects|0|||
33247102|NCT01549652|100806539|FG002|Overall Study|Titration Side Effects|6|||
33247103|NCT01549652|100806540|FG003|Overall Study|Titration Side Effects|3|||
33247104|NCT01549652|100806537|FG000|Overall Study|Withdrawal by Subject|0|||
33247105|NCT01549652|100806538|FG001|Overall Study|Withdrawal by Subject|0|||
33247106|NCT01549652|100806539|FG002|Overall Study|Withdrawal by Subject|5|||
33247107|NCT01549652|100806540|FG003|Overall Study|Withdrawal by Subject|3|||
33247108|NCT03302156|100806541|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
33247109|NCT03302156|100806542|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
33247110|NCT03302156|100806543|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
33247111|NCT01726023|100806544|FG000|Overall Study|Death|1|||
33247112|NCT01726023|100806545|FG001|Overall Study|Death|1|||
33247113|NCT01726023|100806544|FG000|Overall Study|Lost to Follow-up|5|||
33423961|NCT02957682|101443676|FG001|Overall Study|Poor Compliance to Protocol|26|||
33247114|NCT01726023|100806545|FG001|Overall Study|Lost to Follow-up|10|||
33247115|NCT01726023|100806544|FG000|Overall Study|Other Eligibility criteria|7|||
33247116|NCT01726023|100806545|FG001|Overall Study|Other Eligibility criteria|7|||
33247117|NCT01726023|100806544|FG000|Overall Study|Withdrawal by Subject|16|||
33247118|NCT01726023|100806545|FG001|Overall Study|Withdrawal by Subject|8|||
33247119|NCT00099437|100806566|FG000|Overall Study|Lost to Follow-up|30|||
33247120|NCT00099437|100806567|FG001|Overall Study|Lost to Follow-up|33|||
33247121|NCT00099437|100806566|FG000|Overall Study|Death|293|||
33247122|NCT00099437|100806567|FG001|Overall Study|Death|261|||
33247123|NCT00099437|100806566|FG000|Overall Study|Withdrawal by Subject|6|||
33247124|NCT00099437|100806567|FG001|Overall Study|Withdrawal by Subject|10|||
33247125|NCT00099437|100806566|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
33247126|NCT00099437|100806567|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
33247127|NCT04716933|100806568|FG000|Overall Study|Ongoing|46|||
33247128|NCT04716933|100806569|FG001|Overall Study|Ongoing|37|||
33247129|NCT04716933|100806568|FG000|Overall Study|Sponsor Decision|55|||
33247130|NCT04716933|100806569|FG001|Overall Study|Sponsor Decision|63|||
33247131|NCT01280591|100806570|FG000|Overall Study|Withdrawal by Subject|0|||
33247132|NCT01280591|100806571|FG001|Overall Study|Withdrawal by Subject|0|||
33247133|NCT01280591|100806572|FG002|Overall Study|Withdrawal by Subject|0|||
33247134|NCT01280591|100806573|FG003|Overall Study|Withdrawal by Subject|2|||
33247135|NCT01280591|100806570|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
33247136|NCT01280591|100806571|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
33247137|NCT01280591|100806572|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
33423962|NCT02957682|101443675|FG000|Overall Study|Physician Decision|4|||
33646429|NCT02230670|102259592|FG000|Overall Study|Progression to Child-Pugh C|1|||
33646430|NCT02230670|102259593|FG001|Overall Study|Progression to Child-Pugh C|2|||
33148661|NCT01801072|100458214|FG001|Overall Study|Physician Decision|3|||
33586364|NCT01521923|102036266|FG001|Overall Study|SAE, non-fatal|2|||
33586365|NCT01521923|102036267|FG002|Overall Study|SAE, non-fatal|2|||
33376857|NCT02163993|101265080|FG004|Post-treatment Period|Protocol Violation|1|||
33376858|NCT02163993|101265076|FG000|Post-treatment Period|Withdrawal by Subject|2|||
33376859|NCT02163993|101265077|FG001|Post-treatment Period|Withdrawal by Subject|4|||
33376860|NCT02163993|101265078|FG002|Post-treatment Period|Withdrawal by Subject|0|||
33376861|NCT02163993|101265079|FG003|Post-treatment Period|Withdrawal by Subject|1|||
33376862|NCT02163993|101265080|FG004|Post-treatment Period|Withdrawal by Subject|2|||
33376863|NCT02559713|101265081|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
33376864|NCT00383721|101265082|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
33376865|NCT00383721|101265083|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
33376866|NCT00383721|101265084|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
33376867|NCT00383721|101265085|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
33376868|NCT00383721|101265086|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
33376869|NCT00383721|101265082|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
33376870|NCT00383721|101265083|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
33376871|NCT00383721|101265084|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
33376872|NCT00383721|101265085|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
33376873|NCT00383721|101265086|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
33376874|NCT00383721|101265082|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
33423963|NCT02957682|101443676|FG001|Overall Study|Physician Decision|4|||
33423964|NCT02957682|101443675|FG000|Overall Study|Study Terminated by Sponsor|4|||
33423965|NCT02957682|101443676|FG001|Overall Study|Study Terminated by Sponsor|3|||
33423966|NCT02957682|101443675|FG000|Overall Study|Subject Moved|10|||
33423967|NCT02957682|101443676|FG001|Overall Study|Subject Moved|16|||
33423968|NCT02957682|101443675|FG000|Overall Study|Withdrawal by Subject|64|||
33423969|NCT02957682|101443676|FG001|Overall Study|Withdrawal by Subject|33|||
33148662|NCT01801072|100458213|FG000|Overall Study|Withdrawal by Subject|1|||
33148663|NCT01801072|100458214|FG001|Overall Study|Withdrawal by Subject|0|||
33423970|NCT02957682|101443675|FG000|Overall Study|Related to IMP Administration|3|||
33423971|NCT02957682|101443676|FG001|Overall Study|Related to IMP Administration|6|||
33423972|NCT02957682|101443675|FG000|Overall Study|Non-disclosed|16|||
33423973|NCT02957682|101443676|FG001|Overall Study|Non-disclosed|12|||
33423974|NCT02957682|101443675|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
33423975|NCT02957682|101443676|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
33423976|NCT01440595|101443677|FG000|Overall Study|Lost to Follow-up|0|||
33423977|NCT01440595|101443678|FG001|Overall Study|Lost to Follow-up|1|||
33423978|NCT01440595|101443679|FG002|Overall Study|Lost to Follow-up|0|||
33423979|NCT01440595|101443677|FG000|Overall Study|Study terminated by sponsor.|1|||
33423980|NCT01440595|101443678|FG001|Overall Study|Study terminated by sponsor.|2|||
33423981|NCT01440595|101443679|FG002|Overall Study|Study terminated by sponsor.|1|||
33586366|NCT01521923|102036268|FG003|Overall Study|SAE, non-fatal|0|||
33586367|NCT01521923|102036265|FG000|Overall Study|AE, non-serious, non-fatal|1|||
33586368|NCT01521923|102036266|FG001|Overall Study|AE, non-serious, non-fatal|3|||
33586369|NCT01521923|102036267|FG002|Overall Study|AE, non-serious, non-fatal|6|||
33586370|NCT01521923|102036268|FG003|Overall Study|AE, non-serious, non-fatal|2|||
33586371|NCT01521923|102036265|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
33586372|NCT01521923|102036266|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
33586373|NCT01521923|102036267|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
33586374|NCT01521923|102036268|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
33586375|NCT01521923|102036265|FG000|Overall Study|Lack of Efficacy|1|||
33646431|NCT02123472|102259594|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
33646432|NCT02123472|102259595|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
33586376|NCT01521923|102036266|FG001|Overall Study|Lack of Efficacy|1|||
33586377|NCT01521923|102036267|FG002|Overall Study|Lack of Efficacy|0|||
33586378|NCT01521923|102036268|FG003|Overall Study|Lack of Efficacy|0|||
33586379|NCT01521923|102036265|FG000|Overall Study|Protocol Violation|0|||
33586380|NCT01521923|102036266|FG001|Overall Study|Protocol Violation|0|||
33586381|NCT01521923|102036267|FG002|Overall Study|Protocol Violation|1|||
33646433|NCT00918736|102259598|FG000|Overall Study|Withdrawal by Subject|4|||
33376875|NCT00383721|101265083|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
33376876|NCT00383721|101265084|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
33376877|NCT00383721|101265085|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
33423982|NCT03451331|101443680|FG000|Overall Study|Withdrawal by Subject|1|||
33423983|NCT03451331|101443681|FG001|Overall Study|Withdrawal by Subject|0|||
33423984|NCT03451331|101443680|FG000|Overall Study|Unable to start treatment.|1|||
33423985|NCT03451331|101443681|FG001|Overall Study|Unable to start treatment.|1|||
33586382|NCT01521923|102036268|FG003|Overall Study|Protocol Violation|0|||
33586383|NCT01521923|102036265|FG000|Overall Study|Lost to Follow-up|1|||
33646434|NCT00859456|102259599|FG000|Overall Study|Adverse Event|3|||
33247138|NCT01280591|100806573|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
33247139|NCT02512042|100806577|FG000|Overall Study|Adverse Event|0|||
33247140|NCT02512042|100806578|FG001|Overall Study|Adverse Event|4|||
33247141|NCT02512042|100806577|FG000|Overall Study|Withdrawal by Subject|6|||
33247142|NCT02512042|100806578|FG001|Overall Study|Withdrawal by Subject|6|||
33247143|NCT02512042|100806577|FG000|Overall Study|Non-compliance with study drug|1|||
33247144|NCT02512042|100806578|FG001|Overall Study|Non-compliance with study drug|2|||
33247145|NCT02512042|100806577|FG000|Overall Study|Lost to Follow-up|5|||
33247146|NCT02512042|100806578|FG001|Overall Study|Lost to Follow-up|2|||
33247147|NCT02512042|100806577|FG000|Overall Study|Other|11|||
33247148|NCT02512042|100806578|FG001|Overall Study|Other|11|||
33247149|NCT01511250|100806579|FG000|Overall Study|Withdrawal of Consent|1|||
33247150|NCT01511250|100806580|FG001|Overall Study|Withdrawal of Consent|0|||
33247151|NCT01511250|100806581|FG002|Overall Study|Withdrawal of Consent|0|||
33247152|NCT01511250|100806582|FG003|Overall Study|Withdrawal of Consent|0|||
33247153|NCT01511250|100806583|FG004|Overall Study|Withdrawal of Consent|0|||
33247154|NCT01511250|100806584|FG005|Overall Study|Withdrawal of Consent|0|||
33247155|NCT01511250|100806585|FG006|Overall Study|Withdrawal of Consent|0|||
33247156|NCT01511250|100806586|FG007|Overall Study|Withdrawal of Consent|1|||
33247157|NCT01511250|100806587|FG008|Overall Study|Withdrawal of Consent|1|||
33247158|NCT01511250|100806588|FG009|Overall Study|Withdrawal of Consent|0|||
33247159|NCT01511250|100806579|FG000|Overall Study|Sponsor/Investigator Decision|1|||
33247160|NCT01511250|100806580|FG001|Overall Study|Sponsor/Investigator Decision|0|||
33247161|NCT01511250|100806581|FG002|Overall Study|Sponsor/Investigator Decision|0|||
33247162|NCT01511250|100806582|FG003|Overall Study|Sponsor/Investigator Decision|0|||
33247163|NCT01511250|100806583|FG004|Overall Study|Sponsor/Investigator Decision|0|||
33247164|NCT01511250|100806584|FG005|Overall Study|Sponsor/Investigator Decision|0|||
33247165|NCT01511250|100806585|FG006|Overall Study|Sponsor/Investigator Decision|0|||
33247166|NCT01511250|100806586|FG007|Overall Study|Sponsor/Investigator Decision|0|||
33247167|NCT01511250|100806587|FG008|Overall Study|Sponsor/Investigator Decision|0|||
33247168|NCT01511250|100806588|FG009|Overall Study|Sponsor/Investigator Decision|0|||
33247169|NCT01511250|100806579|FG000|Overall Study|Lost to Follow-up|7|||
33247170|NCT01511250|100806580|FG001|Overall Study|Lost to Follow-up|3|||
33247171|NCT01511250|100806581|FG002|Overall Study|Lost to Follow-up|3|||
33247172|NCT01511250|100806582|FG003|Overall Study|Lost to Follow-up|3|||
33247173|NCT01511250|100806583|FG004|Overall Study|Lost to Follow-up|0|||
33247174|NCT01511250|100806584|FG005|Overall Study|Lost to Follow-up|0|||
33247175|NCT01511250|100806585|FG006|Overall Study|Lost to Follow-up|2|||
33247176|NCT01511250|100806586|FG007|Overall Study|Lost to Follow-up|3|||
33376878|NCT00383721|101265086|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
33376879|NCT00383721|101265082|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
33586384|NCT01521923|102036266|FG001|Overall Study|Lost to Follow-up|0|||
33148664|NCT01801072|100458213|FG000|Overall Study|Protocol Violation|2|||
33148665|NCT01801072|100458214|FG001|Overall Study|Protocol Violation|0|||
33148666|NCT01801072|100458213|FG000|Overall Study|Death|7|||
33148667|NCT01801072|100458214|FG001|Overall Study|Death|8|||
33148668|NCT03332771|100458219|FG000|Overall Study|Adverse Event|6|||
33148669|NCT03332771|100458220|FG001|Overall Study|Adverse Event|4|||
33148670|NCT03332771|100458221|FG002|Overall Study|Adverse Event|1|||
33148671|NCT03332771|100458222|FG003|Overall Study|Adverse Event|3|||
33148672|NCT03332771|100458219|FG000|Overall Study|Poor Compliance to Protocol|0|||
33148673|NCT03332771|100458220|FG001|Overall Study|Poor Compliance to Protocol|1|||
33148674|NCT03332771|100458221|FG002|Overall Study|Poor Compliance to Protocol|0|||
33148675|NCT03332771|100458222|FG003|Overall Study|Poor Compliance to Protocol|1|||
33148676|NCT03332771|100458219|FG000|Overall Study|Lost to Follow-up|2|||
33148677|NCT03332771|100458220|FG001|Overall Study|Lost to Follow-up|2|||
33148678|NCT03332771|100458221|FG002|Overall Study|Lost to Follow-up|1|||
33148679|NCT03332771|100458222|FG003|Overall Study|Lost to Follow-up|2|||
33148680|NCT03332771|100458219|FG000|Overall Study|At the Participant's own request|20|||
33148681|NCT03332771|100458220|FG001|Overall Study|At the Participant's own request|26|||
33148682|NCT03332771|100458221|FG002|Overall Study|At the Participant's own request|14|||
33148683|NCT03332771|100458222|FG003|Overall Study|At the Participant's own request|23|||
33148684|NCT03332771|100458219|FG000|Overall Study|Reason Not Specified|6|||
33148685|NCT03332771|100458220|FG001|Overall Study|Reason Not Specified|18|||
33148686|NCT03332771|100458221|FG002|Overall Study|Reason Not Specified|16|||
33148687|NCT03332771|100458222|FG003|Overall Study|Reason Not Specified|19|||
33148688|NCT03150485|100458223|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
33148689|NCT03150485|100458224|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
33148690|NCT03150485|100458225|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
33148691|NCT03150485|100458226|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
33148692|NCT03150485|100458227|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
33148693|NCT03150485|100458228|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
33148694|NCT04711135|100458230|FG000|Overall Study|Physician Decision|0|||
33148695|NCT04711135|100458231|FG001|Overall Study|Physician Decision|1|||
33148696|NCT04711135|100458230|FG000|Overall Study|Ongoing treatment|0|||
33423986|NCT05288673|101443682|FG000|Overall Study|Consent withdrawn by subject|0|||
33423987|NCT05288673|101443683|FG001|Overall Study|Consent withdrawn by subject|0|||
33423988|NCT05288673|101443684|FG002|Overall Study|Consent withdrawn by subject|1|||
33423989|NCT02683187|101443686|FG000|Overall Study|Failed IV access|3|||
33423990|NCT02683187|101443686|FG000|Overall Study|Withdrawal by Subject|5|||
33423991|NCT01463683|101443689|FG000|Overall Study|Adverse Event|2|||
33423992|NCT01463683|101443690|FG001|Overall Study|Adverse Event|0|||
33423993|NCT01463683|101443691|FG002|Overall Study|Adverse Event|0|||
33423994|NCT01463683|101443689|FG000|Overall Study|Lost to Follow-up|10|||
33423995|NCT01463683|101443690|FG001|Overall Study|Lost to Follow-up|9|||
33423996|NCT01463683|101443691|FG002|Overall Study|Lost to Follow-up|7|||
33423997|NCT01463683|101443689|FG000|Overall Study|Physician Decision|0|||
33423998|NCT01463683|101443690|FG001|Overall Study|Physician Decision|3|||
33423999|NCT01463683|101443691|FG002|Overall Study|Physician Decision|1|||
33424000|NCT01463683|101443689|FG000|Overall Study|Pregnancy|2|||
33424001|NCT01463683|101443690|FG001|Overall Study|Pregnancy|2|||
33424002|NCT01463683|101443691|FG002|Overall Study|Pregnancy|1|||
33424003|NCT01463683|101443689|FG000|Overall Study|Withdrawal by Subject|5|||
33424004|NCT01463683|101443690|FG001|Overall Study|Withdrawal by Subject|17|||
33424005|NCT01463683|101443691|FG002|Overall Study|Withdrawal by Subject|2|||
33424006|NCT04130919|101443692|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
33424007|NCT04130919|101443693|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
33424008|NCT04130919|101443694|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
33424009|NCT04130919|101443695|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
33424010|NCT04130919|101443696|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
33424011|NCT04130919|101443697|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
33424012|NCT04130919|101443692|FG000|Blinded Treatment Phase|Adverse Event|0|||
33424013|NCT04130919|101443693|FG001|Blinded Treatment Phase|Adverse Event|0|||
33424014|NCT04130919|101443694|FG002|Blinded Treatment Phase|Adverse Event|1|||
33424015|NCT04130919|101443695|FG003|Blinded Treatment Phase|Adverse Event|0|||
33424016|NCT04130919|101443696|FG004|Blinded Treatment Phase|Adverse Event|0|||
33424017|NCT04130919|101443697|FG005|Blinded Treatment Phase|Adverse Event|0|||
33424018|NCT04130919|101443692|FG000|Blinded Treatment Phase|Disease worsening|0|||
33424019|NCT04130919|101443693|FG001|Blinded Treatment Phase|Disease worsening|0|||
33424020|NCT04130919|101443694|FG002|Blinded Treatment Phase|Disease worsening|1|||
33424021|NCT04130919|101443695|FG003|Blinded Treatment Phase|Disease worsening|0|||
33424022|NCT04130919|101443696|FG004|Blinded Treatment Phase|Disease worsening|0|||
33424023|NCT04130919|101443697|FG005|Blinded Treatment Phase|Disease worsening|0|||
33424024|NCT04130919|101443692|FG000|Blinded Treatment Phase|Investigator's decision|0|||
33424025|NCT04130919|101443693|FG001|Blinded Treatment Phase|Investigator's decision|1|||
33424026|NCT04130919|101443694|FG002|Blinded Treatment Phase|Investigator's decision|0|||
33424027|NCT04130919|101443695|FG003|Blinded Treatment Phase|Investigator's decision|0|||
33424028|NCT04130919|101443696|FG004|Blinded Treatment Phase|Investigator's decision|0|||
33586385|NCT01521923|102036267|FG002|Overall Study|Lost to Follow-up|2|||
33586386|NCT01521923|102036268|FG003|Overall Study|Lost to Follow-up|1|||
33586387|NCT01521923|102036265|FG000|Overall Study|Withdrawal by Subject|1|||
33247177|NCT01511250|100806587|FG008|Overall Study|Lost to Follow-up|13|||
33424029|NCT04130919|101443697|FG005|Blinded Treatment Phase|Investigator's decision|0|||
33424030|NCT04130919|101443692|FG000|Blinded Treatment Phase|Withdrew consent|1|||
33424031|NCT04130919|101443693|FG001|Blinded Treatment Phase|Withdrew consent|0|||
33424032|NCT04130919|101443694|FG002|Blinded Treatment Phase|Withdrew consent|0|||
33424033|NCT04130919|101443695|FG003|Blinded Treatment Phase|Withdrew consent|0|||
33424034|NCT04130919|101443696|FG004|Blinded Treatment Phase|Withdrew consent|0|||
33424035|NCT04130919|101443697|FG005|Blinded Treatment Phase|Withdrew consent|0|||
33424036|NCT04130919|101443692|FG000|Open-label Treatment Phase|Withdrew consent|0|||
33424037|NCT04130919|101443693|FG001|Open-label Treatment Phase|Withdrew consent|0|||
33424038|NCT04130919|101443694|FG002|Open-label Treatment Phase|Withdrew consent|0|||
33424039|NCT04130919|101443695|FG003|Open-label Treatment Phase|Withdrew consent|1|||
33424040|NCT04130919|101443696|FG004|Open-label Treatment Phase|Withdrew consent|1|||
33424041|NCT04130919|101443697|FG005|Open-label Treatment Phase|Withdrew consent|1|||
33424042|NCT04130919|101443692|FG000|Open-label Treatment Phase|Disease worsening|0|||
33424043|NCT04130919|101443693|FG001|Open-label Treatment Phase|Disease worsening|0|||
33424044|NCT04130919|101443694|FG002|Open-label Treatment Phase|Disease worsening|0|||
33424045|NCT04130919|101443695|FG003|Open-label Treatment Phase|Disease worsening|1|||
33424046|NCT04130919|101443696|FG004|Open-label Treatment Phase|Disease worsening|0|||
33424047|NCT04130919|101443697|FG005|Open-label Treatment Phase|Disease worsening|1|||
33424048|NCT04130919|101443692|FG000|Open-label Treatment Phase|Investigator's decision|0|||
33424049|NCT04130919|101443693|FG001|Open-label Treatment Phase|Investigator's decision|0|||
33424050|NCT04130919|101443694|FG002|Open-label Treatment Phase|Investigator's decision|0|||
33424051|NCT04130919|101443695|FG003|Open-label Treatment Phase|Investigator's decision|1|||
33424052|NCT04130919|101443696|FG004|Open-label Treatment Phase|Investigator's decision|0|||
33424053|NCT04130919|101443697|FG005|Open-label Treatment Phase|Investigator's decision|0|||
33424054|NCT04130919|101443692|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
33424055|NCT04130919|101443693|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
33424056|NCT04130919|101443694|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
33424057|NCT04130919|101443695|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
33424058|NCT04130919|101443696|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
33424059|NCT04130919|101443697|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
33424060|NCT04130919|101443692|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
33424061|NCT04130919|101443693|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
33424062|NCT04130919|101443694|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
33424063|NCT04130919|101443695|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
33424064|NCT04130919|101443696|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
33424065|NCT04130919|101443697|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
33424066|NCT03202511|101443700|FG000|Overall Study|Withdrawal by Subject|1|||
33424067|NCT03202511|101443701|FG001|Overall Study|Withdrawal by Subject|0|||
33424068|NCT03053622|101443702|FG000|Overall Study|Lost to Follow-up|0|||
33424069|NCT03053622|101443703|FG001|Overall Study|Lost to Follow-up|0|||
33424070|NCT03053622|101443704|FG002|Overall Study|Lost to Follow-up|0|||
33424071|NCT03053622|101443705|FG003|Overall Study|Lost to Follow-up|1|||
33424072|NCT01328054|101443707|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
33424073|NCT01328054|101443708|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
33424074|NCT01328054|101443707|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
33424075|NCT01328054|101443708|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
33424076|NCT01328054|101443707|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
33424077|NCT01328054|101443708|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
33424078|NCT00616928|101443710|FG000|Overall Study|Adverse Event|6|||
33424079|NCT00616928|101443711|FG001|Overall Study|Adverse Event|3|||
33424080|NCT00616928|101443712|FG002|Overall Study|Adverse Event|2|||
33424081|NCT00616928|101443713|FG003|Overall Study|Adverse Event|2|||
33424082|NCT00616928|101443710|FG000|Overall Study|Other|51|||
33424083|NCT00616928|101443711|FG001|Overall Study|Other|8|||
33424084|NCT00616928|101443712|FG002|Overall Study|Other|15|||
33424085|NCT00616928|101443713|FG003|Overall Study|Other|5|||
33424086|NCT00616928|101443710|FG000|Overall Study|Lost to Follow-up|5|||
33424087|NCT00616928|101443711|FG001|Overall Study|Lost to Follow-up|7|||
33424088|NCT00616928|101443712|FG002|Overall Study|Lost to Follow-up|0|||
33424089|NCT00616928|101443713|FG003|Overall Study|Lost to Follow-up|0|||
33424090|NCT01664494|101443714|FG000|Overall Study|Withdrawal by Subject|27|||
33424091|NCT01664494|101443714|FG000|Overall Study|Death|18|||
33424092|NCT01664494|101443714|FG000|Overall Study|Other|49|||
33586388|NCT01521923|102036266|FG001|Overall Study|Withdrawal by Subject|1|||
33586389|NCT01521923|102036267|FG002|Overall Study|Withdrawal by Subject|1|||
33586390|NCT01521923|102036268|FG003|Overall Study|Withdrawal by Subject|2|||
33586391|NCT01521923|102036265|FG000|Overall Study|Other|2|||
33586392|NCT01521923|102036266|FG001|Overall Study|Other|1|||
33586393|NCT01521923|102036267|FG002|Overall Study|Other|3|||
33148697|NCT04711135|100458231|FG001|Overall Study|Ongoing treatment|1|||
33376880|NCT00383721|101265083|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
33376881|NCT00383721|101265084|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
33376882|NCT00383721|101265085|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
33376883|NCT00383721|101265086|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
33376884|NCT00383721|101265082|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
33376885|NCT00383721|101265083|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
33376886|NCT00383721|101265084|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
33376887|NCT00383721|101265085|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
33376888|NCT00383721|101265086|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
33424093|NCT01664494|101443714|FG000|Overall Study|Lost to Follow-up|99|||
33424094|NCT04470622|101443715|FG000|Overall Study|Withdrawal by Subject|0|||
33424095|NCT04470622|101443716|FG001|Overall Study|Withdrawal by Subject|1|||
33424096|NCT04470622|101443715|FG000|Overall Study|Screen Failure|0|||
33424097|NCT04470622|101443716|FG001|Overall Study|Screen Failure|1|||
33424098|NCT04470622|101443715|FG000|Overall Study|Death|0|||
33148698|NCT02131532|100458232|FG000|Overall Study|Withdrawal by Subject|1|||
33148699|NCT02131532|100458232|FG000|Overall Study|Physician Decision|1|||
33148700|NCT02131532|100458232|FG000|Overall Study|Other health conditions|2|||
33148701|NCT00923936|100458233|FG000|Overall Study|progressive disease on study|2|||
33424099|NCT04470622|101443716|FG001|Overall Study|Death|1|||
33424100|NCT02556632|101443717|FG000|Overall Study|Lost to Follow-up|1|||
33424101|NCT02556632|101443718|FG001|Overall Study|Lost to Follow-up|0|||
33424102|NCT02556632|101443719|FG002|Overall Study|Lost to Follow-up|0|||
33424103|NCT02556632|101443717|FG000|Overall Study|Disliked Intervention|1|||
33424104|NCT02556632|101443718|FG001|Overall Study|Disliked Intervention|1|||
33424105|NCT02556632|101443719|FG002|Overall Study|Disliked Intervention|1|||
33586394|NCT01521923|102036268|FG003|Overall Study|Other|6|||
33148702|NCT00923936|100458234|FG001|Overall Study|progressive disease on study|1|||
33247178|NCT01511250|100806588|FG009|Overall Study|Lost to Follow-up|5|||
33247179|NCT01511250|100806579|FG000|Overall Study|Protocol Violation|0|||
33247180|NCT01511250|100806580|FG001|Overall Study|Protocol Violation|2|||
33247181|NCT01511250|100806581|FG002|Overall Study|Protocol Violation|1|||
33247182|NCT01511250|100806582|FG003|Overall Study|Protocol Violation|0|||
33247183|NCT01511250|100806583|FG004|Overall Study|Protocol Violation|0|||
33247184|NCT01511250|100806584|FG005|Overall Study|Protocol Violation|0|||
33247185|NCT01511250|100806585|FG006|Overall Study|Protocol Violation|0|||
33247186|NCT01511250|100806586|FG007|Overall Study|Protocol Violation|0|||
33247187|NCT01511250|100806587|FG008|Overall Study|Protocol Violation|0|||
33247188|NCT01511250|100806588|FG009|Overall Study|Protocol Violation|0|||
33247189|NCT02759731|100806602|FG000|Overall Study|Did not complete treatment.|8|||
33247190|NCT04310579|100806604|FG000|Overall Study|Adverse Event|0|||
33247191|NCT04310579|100806605|FG001|Overall Study|Adverse Event|0|||
33247192|NCT04310579|100806606|FG002|Overall Study|Adverse Event|0|||
33247193|NCT04310579|100806607|FG003|Overall Study|Adverse Event|0|||
33247194|NCT04310579|100806608|FG004|Overall Study|Adverse Event|0|||
33247195|NCT04310579|100806609|FG005|Overall Study|Adverse Event|0|||
33247196|NCT04310579|100806610|FG006|Overall Study|Adverse Event|2|||
33247197|NCT04310579|100806611|FG007|Overall Study|Adverse Event|0|||
33247198|NCT04310579|100806612|FG008|Overall Study|Adverse Event|1|||
33247199|NCT04310579|100806613|FG009|Overall Study|Adverse Event|1|||
33247200|NCT04310579|100806614|FG010|Overall Study|Adverse Event|0|||
33247201|NCT04310579|100806604|FG000|Overall Study|Withdrawal by Subject|0|||
33247202|NCT04310579|100806605|FG001|Overall Study|Withdrawal by Subject|0|||
33247203|NCT04310579|100806606|FG002|Overall Study|Withdrawal by Subject|0|||
33247204|NCT04310579|100806607|FG003|Overall Study|Withdrawal by Subject|0|||
33247205|NCT04310579|100806608|FG004|Overall Study|Withdrawal by Subject|0|||
33247206|NCT04310579|100806609|FG005|Overall Study|Withdrawal by Subject|1|||
33247207|NCT04310579|100806610|FG006|Overall Study|Withdrawal by Subject|0|||
33247208|NCT04310579|100806611|FG007|Overall Study|Withdrawal by Subject|0|||
33247209|NCT04310579|100806612|FG008|Overall Study|Withdrawal by Subject|0|||
33247210|NCT04310579|100806613|FG009|Overall Study|Withdrawal by Subject|0|||
33247211|NCT04310579|100806614|FG010|Overall Study|Withdrawal by Subject|0|||
33247212|NCT04310579|100806604|FG000|Overall Study|Positive COVID-19 test|0|||
33247213|NCT04310579|100806605|FG001|Overall Study|Positive COVID-19 test|0|||
33247214|NCT04310579|100806606|FG002|Overall Study|Positive COVID-19 test|0|||
33247215|NCT04310579|100806607|FG003|Overall Study|Positive COVID-19 test|0|||
33247216|NCT04310579|100806608|FG004|Overall Study|Positive COVID-19 test|0|||
33247217|NCT04310579|100806609|FG005|Overall Study|Positive COVID-19 test|0|||
33424106|NCT02556632|101443717|FG000|Overall Study|No Reason|1|||
33148703|NCT00923936|100458233|FG000|Overall Study|Adverse Event|2|||
33148704|NCT00923936|100458234|FG001|Overall Study|Adverse Event|1|||
33148705|NCT00923936|100458233|FG000|Overall Study|Lost to follow up|2|||
33148706|NCT00923936|100458234|FG001|Overall Study|Lost to follow up|0|||
33148707|NCT00923936|100458233|FG000|Overall Study|Continuing in follow up period|2|||
33148708|NCT00923936|100458234|FG001|Overall Study|Continuing in follow up period|1|||
33148709|NCT03035409|100458237|FG000|Overall Study|Adverse Event|5|||
33148710|NCT03035409|100458237|FG000|Overall Study|Death|2|||
33148711|NCT03035409|100458237|FG000|Overall Study|Withdrawal by Subject|2|||
33148712|NCT03035409|100458237|FG000|Overall Study|Non compliance|4|||
33148713|NCT03035409|100458237|FG000|Overall Study|Patient was jittery|1|||
33148714|NCT03035409|100458237|FG000|Overall Study|Did not like Questionnaire|1|||
33148715|NCT03035409|100458237|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
33148716|NCT03035409|100458237|FG000|Overall Study|Did not like taking drugs|1|||
33148717|NCT02393690|100458246|FG000|Overall Study|Ineligible|0|||
33148718|NCT02393690|100458247|FG001|Overall Study|Ineligible|1|||
33148719|NCT01437878|100458248|FG000|Overall Study|Withdrawal by Subject|1|||
33148720|NCT01437878|100458249|FG001|Overall Study|Withdrawal by Subject|0|||
33148721|NCT01610271|100458251|FG000|Overall Study|Surgery not complete|0|||
33148722|NCT01610271|100458252|FG001|Overall Study|Surgery not complete|1|||
33148723|NCT01610271|100458251|FG000|Overall Study|Prosthesis not implanted|2|||
33148724|NCT01610271|100458252|FG001|Overall Study|Prosthesis not implanted|3|||
33148725|NCT05896748|100458253|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
33148726|NCT05896748|100458253|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
33148727|NCT05896748|100458253|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
33148728|NCT05896748|100458253|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
33148729|NCT05896748|100458253|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
33148730|NCT02305888|100458256|FG000|Overall Study|Lost to Follow-up|0|||
33148731|NCT02305888|100458257|FG001|Overall Study|Lost to Follow-up|0|||
33148732|NCT02305888|100458258|FG002|Overall Study|Lost to Follow-up|1|||
33148733|NCT02305888|100458256|FG000|Overall Study|Adverse Event|0|||
33148734|NCT02305888|100458257|FG001|Overall Study|Adverse Event|1|||
33148735|NCT02305888|100458258|FG002|Overall Study|Adverse Event|0|||
33148736|NCT00478881|100458259|FG000|Overall Study|Adverse Event|31|||
33424107|NCT02556632|101443718|FG001|Overall Study|No Reason|0|||
33424108|NCT02556632|101443719|FG002|Overall Study|No Reason|1|||
33424109|NCT02556632|101443717|FG000|Overall Study|Personal Issues|0|||
33424110|NCT02556632|101443718|FG001|Overall Study|Personal Issues|1|||
33424111|NCT02556632|101443719|FG002|Overall Study|Personal Issues|1|||
33424112|NCT02556632|101443717|FG000|Overall Study|Changed Mind|0|||
33424113|NCT02556632|101443718|FG001|Overall Study|Changed Mind|1|||
33424114|NCT02556632|101443719|FG002|Overall Study|Changed Mind|0|||
33424115|NCT02556632|101443717|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
33424116|NCT02556632|101443718|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
33424117|NCT02556632|101443719|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
33376889|NCT00383721|101265082|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
33376890|NCT00383721|101265083|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
33376891|NCT00383721|101265084|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
33376892|NCT00383721|101265085|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
33376893|NCT00383721|101265086|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
33376894|NCT00383721|101265082|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
33376895|NCT00383721|101265083|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
33376896|NCT00383721|101265084|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
33376897|NCT00383721|101265085|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
33376898|NCT00383721|101265086|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
33376899|NCT00383721|101265082|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
33376900|NCT00383721|101265083|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
33376901|NCT00383721|101265084|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
33376902|NCT00383721|101265085|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
33376903|NCT00383721|101265086|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
33376904|NCT00383721|101265082|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
33376905|NCT00383721|101265083|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
33376906|NCT00383721|101265084|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
33376907|NCT00383721|101265085|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
33376908|NCT00383721|101265086|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
33376909|NCT00383721|101265082|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
33376910|NCT00383721|101265083|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
33376911|NCT00383721|101265084|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
33376912|NCT00383721|101265085|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
33376913|NCT00383721|101265086|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
33376914|NCT00383721|101265082|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
33376915|NCT00383721|101265083|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
33376916|NCT00383721|101265084|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
33376917|NCT00383721|101265085|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
33424118|NCT02556632|101443717|FG000|Overall Study|Unrelated Adverse Event|1|||
33424119|NCT02556632|101443718|FG001|Overall Study|Unrelated Adverse Event|0|||
33424120|NCT02556632|101443719|FG002|Overall Study|Unrelated Adverse Event|3|||
33424121|NCT02556632|101443717|FG000|Overall Study|Related Adverse Event|0|||
33424122|NCT02556632|101443718|FG001|Overall Study|Related Adverse Event|1|||
33424123|NCT02556632|101443719|FG002|Overall Study|Related Adverse Event|0|||
33424124|NCT02556632|101443717|FG000|Overall Study|Possibly Related Adverse Event|0|||
33424125|NCT02556632|101443718|FG001|Overall Study|Possibly Related Adverse Event|0|||
33424126|NCT02556632|101443719|FG002|Overall Study|Possibly Related Adverse Event|1|||
33424127|NCT02556632|101443717|FG000|Overall Study|Did Not Start RT|0|||
33424128|NCT02556632|101443718|FG001|Overall Study|Did Not Start RT|1|||
33424129|NCT02556632|101443719|FG002|Overall Study|Did Not Start RT|0|||
33424130|NCT02556632|101443717|FG000|Overall Study|Ineligible|0|||
33586395|NCT01521923|102036265|FG000|Overall Study|AE, captured in Period 1|0|||
33586396|NCT01521923|102036266|FG001|Overall Study|AE, captured in Period 1|1|||
33586397|NCT01521923|102036267|FG002|Overall Study|AE, captured in Period 1|0|||
33586398|NCT01521923|102036268|FG003|Overall Study|AE, captured in Period 1|1|||
33586399|NCT00107900|102036269|FG000|Overall Study|Adverse Event|3|||
33586400|NCT00107900|102036270|FG001|Overall Study|Adverse Event|2|||
33586401|NCT00107900|102036271|FG002|Overall Study|Adverse Event|10|||
33148737|NCT00478881|100458260|FG001|Overall Study|Adverse Event|12|||
33376918|NCT00383721|101265086|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
33586402|NCT00107900|102036272|FG003|Overall Study|Adverse Event|3|||
33376919|NCT00383721|101265082|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
33424131|NCT02556632|101443718|FG001|Overall Study|Ineligible|1|||
33424132|NCT02556632|101443719|FG002|Overall Study|Ineligible|0|||
33586403|NCT00107900|102036273|FG004|Overall Study|Adverse Event|5|||
33424133|NCT02556632|101443717|FG000|Overall Study|Disliked Study Procedures|0|||
33424134|NCT02556632|101443718|FG001|Overall Study|Disliked Study Procedures|0|||
33424135|NCT02556632|101443719|FG002|Overall Study|Disliked Study Procedures|1|||
33424136|NCT02556632|101443717|FG000|Overall Study|Treatment or Change Delay|0|||
33424137|NCT02556632|101443718|FG001|Overall Study|Treatment or Change Delay|0|||
33424138|NCT02556632|101443719|FG002|Overall Study|Treatment or Change Delay|1|||
33424139|NCT00700310|101443720|FG000|Overall Study|Adverse Event|6|||
33424140|NCT00700310|101443721|FG001|Overall Study|Adverse Event|10|||
33424141|NCT00700310|101443722|FG002|Overall Study|Adverse Event|5|||
33424142|NCT00700310|101443723|FG003|Overall Study|Adverse Event|11|||
33424143|NCT00700310|101443720|FG000|Overall Study|Lost to Follow-up|4|||
33424144|NCT00700310|101443721|FG001|Overall Study|Lost to Follow-up|1|||
33424145|NCT00700310|101443722|FG002|Overall Study|Lost to Follow-up|0|||
33424146|NCT00700310|101443723|FG003|Overall Study|Lost to Follow-up|1|||
33424147|NCT00700310|101443720|FG000|Overall Study|Withdrawal by Subject|8|||
33424148|NCT00700310|101443721|FG001|Overall Study|Withdrawal by Subject|9|||
33424149|NCT00700310|101443722|FG002|Overall Study|Withdrawal by Subject|8|||
33424150|NCT00700310|101443723|FG003|Overall Study|Withdrawal by Subject|8|||
33424151|NCT00700310|101443720|FG000|Overall Study|Lack of Efficacy|0|||
33424152|NCT00700310|101443721|FG001|Overall Study|Lack of Efficacy|3|||
33424153|NCT00700310|101443722|FG002|Overall Study|Lack of Efficacy|0|||
33424154|NCT00700310|101443723|FG003|Overall Study|Lack of Efficacy|1|||
33424155|NCT00700310|101443720|FG000|Overall Study|Administrative/Other|1|||
33424156|NCT00700310|101443721|FG001|Overall Study|Administrative/Other|3|||
33424157|NCT00700310|101443722|FG002|Overall Study|Administrative/Other|1|||
33424158|NCT00700310|101443723|FG003|Overall Study|Administrative/Other|3|||
33424159|NCT00700310|101443720|FG000|Overall Study|Randomized, Not Treated|2|||
33424160|NCT00700310|101443721|FG001|Overall Study|Randomized, Not Treated|0|||
33424161|NCT00700310|101443722|FG002|Overall Study|Randomized, Not Treated|2|||
33424162|NCT00700310|101443723|FG003|Overall Study|Randomized, Not Treated|2|||
33424163|NCT00527397|101443724|FG000|Overall Study|Adverse Event|3|||
33424164|NCT00527397|101443724|FG000|Overall Study|Lack of Efficacy|1|||
33424165|NCT00527397|101443724|FG000|Overall Study|Protocol Violation|1|||
33586404|NCT00107900|102036274|FG005|Overall Study|Adverse Event|3|||
33586405|NCT00107900|102036269|FG000|Overall Study|Death|0|||
33586406|NCT00107900|102036270|FG001|Overall Study|Death|0|||
33148738|NCT00478881|100458259|FG000|Overall Study|Lack of Efficacy|0|||
33247218|NCT04310579|100806610|FG006|Overall Study|Positive COVID-19 test|0|||
33376920|NCT00383721|101265083|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
33376921|NCT00383721|101265084|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
33376922|NCT00383721|101265085|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
33376923|NCT00383721|101265086|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
33376924|NCT00383721|101265082|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
33376925|NCT00383721|101265083|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
33376926|NCT00383721|101265084|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
33376927|NCT00383721|101265085|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
33376928|NCT00383721|101265086|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
33376929|NCT00383721|101265082|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
33376930|NCT00383721|101265083|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
33376931|NCT00383721|101265084|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
33376932|NCT00383721|101265085|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
33376933|NCT00383721|101265086|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
33376934|NCT00383721|101265082|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
33376935|NCT00383721|101265083|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
33376936|NCT00383721|101265084|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
33376937|NCT00383721|101265085|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
33376938|NCT00383721|101265086|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
33376939|NCT00383721|101265082|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
33376940|NCT00383721|101265083|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
33376941|NCT00383721|101265084|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
33376942|NCT00383721|101265085|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
33376943|NCT00383721|101265086|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
33376944|NCT00383721|101265082|FG000|26-Week Treatment Safety Extension|Administrative|1|||
33376945|NCT00383721|101265083|FG001|26-Week Treatment Safety Extension|Administrative|2|||
33376946|NCT00383721|101265084|FG002|26-Week Treatment Safety Extension|Administrative|3|||
33424166|NCT00527397|101443724|FG000|Overall Study|Withdrawal by Subject|6|||
33247219|NCT04310579|100806611|FG007|Overall Study|Positive COVID-19 test|0|||
33424167|NCT00527397|101443724|FG000|Overall Study|Study terminated by sponsor|13|||
33424168|NCT01347879|101443725|FG000|Overall Study|Adverse Event|0|||
33424169|NCT01347879|101443726|FG001|Overall Study|Adverse Event|12|||
33424170|NCT01347879|101443725|FG000|Overall Study|Lost to Follow-up|2|||
33424171|NCT01347879|101443726|FG001|Overall Study|Lost to Follow-up|0|||
33586407|NCT00107900|102036271|FG002|Overall Study|Death|0|||
33247220|NCT04310579|100806612|FG008|Overall Study|Positive COVID-19 test|0|||
33247221|NCT04310579|100806613|FG009|Overall Study|Positive COVID-19 test|0|||
33376947|NCT00383721|101265085|FG003|26-Week Treatment Safety Extension|Administrative|1|||
33376948|NCT00383721|101265086|FG004|26-Week Treatment Safety Extension|Administrative|0|||
33376949|NCT00434512|101265090|FG000|Overall Study|Migrated/moved from study area|0|||
33376950|NCT00434512|101265091|FG001|Overall Study|Migrated/moved from study area|0|||
33376951|NCT00434512|101265092|FG002|Overall Study|Migrated/moved from study area|0|||
33376952|NCT00434512|101265093|FG003|Overall Study|Migrated/moved from study area|1|||
33376953|NCT00434512|101265094|FG004|Overall Study|Migrated/moved from study area|1|||
33376954|NCT00434512|101265095|FG005|Overall Study|Migrated/moved from study area|1|||
33376955|NCT00434512|101265090|FG000|Overall Study|Other|0|||
33376956|NCT00434512|101265091|FG001|Overall Study|Other|1|||
33376957|NCT00434512|101265092|FG002|Overall Study|Other|0|||
33376958|NCT00434512|101265093|FG003|Overall Study|Other|0|||
33376959|NCT00434512|101265094|FG004|Overall Study|Other|0|||
33376960|NCT00434512|101265095|FG005|Overall Study|Other|0|||
33376961|NCT01000727|101265096|FG000|Overall Study|Lost to Follow-up|41|||
33424172|NCT01347879|101443725|FG000|Overall Study|Withdrawal by Subject|3|||
33424173|NCT01347879|101443726|FG001|Overall Study|Withdrawal by Subject|2|||
33424174|NCT01347879|101443725|FG000|Overall Study|Other|2|||
33424175|NCT01347879|101443726|FG001|Overall Study|Other|3|||
33424176|NCT03712228|101443729|FG000|Treatment Period 1|Lack of Efficacy|0|||
33424177|NCT03712228|101443730|FG001|Treatment Period 1|Lack of Efficacy|0|||
33376962|NCT01000727|101265097|FG001|Overall Study|Lost to Follow-up|43|||
33376963|NCT01000727|101265096|FG000|Overall Study|Withdrawal by Subject|111|||
33376964|NCT01000727|101265097|FG001|Overall Study|Withdrawal by Subject|109|||
33376965|NCT01000727|101265096|FG000|Overall Study|Study closed/terminated|23|||
33376966|NCT01000727|101265097|FG001|Overall Study|Study closed/terminated|24|||
33376967|NCT00262080|101265102|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
33376968|NCT00262080|101265103|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
33376969|NCT00262080|101265104|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
33376970|NCT00262080|101265102|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
33376971|NCT00262080|101265103|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
33376972|NCT00262080|101265104|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
33424178|NCT03712228|101443731|FG002|Treatment Period 1|Lack of Efficacy|0|||
33424179|NCT03712228|101443732|FG003|Treatment Period 1|Lack of Efficacy|0|||
33424180|NCT03712228|101443733|FG004|Treatment Period 1|Lack of Efficacy|0|||
33424181|NCT03712228|101443734|FG005|Treatment Period 1|Lack of Efficacy|1|||
33424182|NCT03712228|101443729|FG000|Treatment Period 2|Pregnancy|0|||
33586408|NCT00107900|102036272|FG003|Overall Study|Death|0|||
33586409|NCT00107900|102036273|FG004|Overall Study|Death|1|||
33586410|NCT00107900|102036274|FG005|Overall Study|Death|0|||
33586411|NCT00107900|102036269|FG000|Overall Study|Lost to Follow-up|4|||
33586412|NCT00107900|102036270|FG001|Overall Study|Lost to Follow-up|1|||
33586413|NCT00107900|102036271|FG002|Overall Study|Lost to Follow-up|3|||
33646435|NCT00859456|102259599|FG000|Overall Study|Progressive disease|2|||
33646436|NCT00859456|102259599|FG000|Overall Study|Non-compliance|3|||
33646437|NCT01731938|102259601|FG000|Preliminary Part I|Withdrawal by Subject|2|||
33646438|NCT01731938|102259602|FG001|Preliminary Part I|Withdrawal by Subject|2|||
33646439|NCT01731938|102259601|FG000|Preliminary Part I|Physician Decision|1|||
33646440|NCT01731938|102259602|FG001|Preliminary Part I|Physician Decision|0|||
33646441|NCT01731938|102259601|FG000|Preliminary Part I|Lost to Follow-up|0|||
33646442|NCT01731938|102259602|FG001|Preliminary Part I|Lost to Follow-up|3|||
33646443|NCT01731938|102259601|FG000|Preliminary Part I|Missed Week 6 visit|0|||
33646444|NCT01731938|102259602|FG001|Preliminary Part I|Missed Week 6 visit|3|||
33646445|NCT01731938|102259601|FG000|Primary Part II|Withdrawal by Subject|5|||
33646446|NCT01731938|102259602|FG001|Primary Part II|Withdrawal by Subject|4|||
33646447|NCT01731938|102259601|FG000|Primary Part II|Lost to Follow-up|4|||
33646448|NCT01731938|102259602|FG001|Primary Part II|Lost to Follow-up|5|||
33646449|NCT01731938|102259601|FG000|Primary Part II|Death|2|||
33376973|NCT00262080|101265102|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
33424183|NCT03712228|101443730|FG001|Treatment Period 2|Pregnancy|0|||
33586414|NCT00107900|102036272|FG003|Overall Study|Lost to Follow-up|2|||
33646450|NCT01731938|102259602|FG001|Primary Part II|Death|1|||
33376974|NCT00262080|101265103|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
33424184|NCT03712228|101443731|FG002|Treatment Period 2|Pregnancy|0|||
33424185|NCT03712228|101443732|FG003|Treatment Period 2|Pregnancy|1|||
33424186|NCT03712228|101443733|FG004|Treatment Period 2|Pregnancy|0|||
33586415|NCT00107900|102036273|FG004|Overall Study|Lost to Follow-up|5|||
33586416|NCT00107900|102036274|FG005|Overall Study|Lost to Follow-up|5|||
33586417|NCT00107900|102036269|FG000|Overall Study|Protocol Violation|1|||
33376975|NCT00262080|101265104|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
33376976|NCT00262080|101265102|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
33424187|NCT03712228|101443734|FG005|Treatment Period 2|Pregnancy|0|||
33424188|NCT03712228|101443729|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33586418|NCT00107900|102036270|FG001|Overall Study|Protocol Violation|0|||
33586419|NCT00107900|102036271|FG002|Overall Study|Protocol Violation|5|||
33646451|NCT01731938|102259601|FG000|Primary Part II|Missed Week 6 visit|2|||
33646452|NCT01731938|102259602|FG001|Primary Part II|Missed Week 6 visit|3|||
33247222|NCT04310579|100806614|FG010|Overall Study|Positive COVID-19 test|1|||
33247223|NCT00751790|100806615|FG000|Overall Study|Lost to Follow-up|1|||
33247224|NCT00751790|100806615|FG000|Overall Study|Death|3|||
33247225|NCT00751790|100806615|FG000|Overall Study|Withdrawal by Subject|1|||
33247226|NCT01227707|100806616|FG000|Overall Study|Adverse Event|10|||
33376977|NCT00262080|101265103|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
33376978|NCT00262080|101265104|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
33376979|NCT00262080|101265102|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
33376980|NCT00262080|101265103|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
33376981|NCT00262080|101265104|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
33376982|NCT00262080|101265102|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
33376983|NCT00262080|101265103|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
33376984|NCT00262080|101265104|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
33376985|NCT03571256|101265105|FG000|Overall Study|Adverse Event|3|||
33376986|NCT03571256|101265106|FG001|Overall Study|Adverse Event|0|||
33376987|NCT03571256|101265107|FG002|Overall Study|Adverse Event|1|||
33376988|NCT03571256|101265105|FG000|Overall Study|Withdrawal by Subject|3|||
33376989|NCT03571256|101265106|FG001|Overall Study|Withdrawal by Subject|1|||
33376990|NCT03571256|101265107|FG002|Overall Study|Withdrawal by Subject|1|||
33376991|NCT03571256|101265105|FG000|Overall Study|Other than specified|0|||
33376992|NCT03571256|101265106|FG001|Overall Study|Other than specified|1|||
33376993|NCT03571256|101265107|FG002|Overall Study|Other than specified|1|||
33376994|NCT03571256|101265105|FG000|Overall Study|Protocol Violation|0|||
33376995|NCT03571256|101265106|FG001|Overall Study|Protocol Violation|1|||
33376996|NCT03571256|101265107|FG002|Overall Study|Protocol Violation|1|||
33376997|NCT00356863|101265108|FG000|Overall Study|Death|16|||
33376998|NCT00356863|101265109|FG001|Overall Study|Death|32|||
33376999|NCT00356863|101265108|FG000|Overall Study|Lost to Follow-up|76|||
33377000|NCT00356863|101265109|FG001|Overall Study|Lost to Follow-up|43|||
33377001|NCT01363713|101265110|FG000|Overall Study|Adverse Event|1|||
33377002|NCT01363713|101265110|FG000|Overall Study|Protocol Violation|3|||
33377003|NCT01363713|101265110|FG000|Overall Study|Withdrawal by Subject|2|||
33377004|NCT01953328|101265111|FG000|Overall Study|Withdrawal by Subject|0|||
33377005|NCT01953328|101265112|FG001|Overall Study|Withdrawal by Subject|0|||
33377006|NCT01953328|101265113|FG002|Overall Study|Withdrawal by Subject|0|||
33377007|NCT01953328|101265114|FG003|Overall Study|Withdrawal by Subject|0|||
33377008|NCT01953328|101265115|FG004|Overall Study|Withdrawal by Subject|1|||
33377009|NCT01953328|101265116|FG005|Overall Study|Withdrawal by Subject|0|||
33377010|NCT01953328|101265117|FG006|Overall Study|Withdrawal by Subject|0|||
33377011|NCT01953328|101265118|FG007|Overall Study|Withdrawal by Subject|0|||
33377012|NCT01953328|101265111|FG000|Overall Study|Lost to Follow-up|0|||
33377013|NCT01953328|101265112|FG001|Overall Study|Lost to Follow-up|0|||
33377014|NCT01953328|101265113|FG002|Overall Study|Lost to Follow-up|0|||
33377015|NCT01953328|101265114|FG003|Overall Study|Lost to Follow-up|0|||
33377016|NCT01953328|101265115|FG004|Overall Study|Lost to Follow-up|1|||
33377017|NCT01953328|101265116|FG005|Overall Study|Lost to Follow-up|0|||
33377018|NCT01953328|101265117|FG006|Overall Study|Lost to Follow-up|0|||
33377019|NCT01953328|101265118|FG007|Overall Study|Lost to Follow-up|0|||
33377020|NCT00254293|101265125|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
33377021|NCT00254293|101265126|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
33424189|NCT03712228|101443730|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33424190|NCT03712228|101443731|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33424191|NCT03712228|101443732|FG003|Treatment Period 2|Withdrawal by Subject|1|||
33586420|NCT00107900|102036272|FG003|Overall Study|Protocol Violation|5|||
33586421|NCT00107900|102036273|FG004|Overall Study|Protocol Violation|7|||
33586422|NCT00107900|102036274|FG005|Overall Study|Protocol Violation|0|||
33586423|NCT00107900|102036269|FG000|Overall Study|Withdrawal by Subject|1|||
33586424|NCT00107900|102036270|FG001|Overall Study|Withdrawal by Subject|0|||
33586425|NCT00107900|102036271|FG002|Overall Study|Withdrawal by Subject|5|||
33586426|NCT00107900|102036272|FG003|Overall Study|Withdrawal by Subject|0|||
33586427|NCT00107900|102036273|FG004|Overall Study|Withdrawal by Subject|1|||
33586428|NCT00107900|102036274|FG005|Overall Study|Withdrawal by Subject|1|||
33586429|NCT00107900|102036269|FG000|Overall Study|Administrative Reasons|1|||
33586430|NCT00107900|102036270|FG001|Overall Study|Administrative Reasons|0|||
33586431|NCT00107900|102036271|FG002|Overall Study|Administrative Reasons|2|||
33586432|NCT00107900|102036272|FG003|Overall Study|Administrative Reasons|2|||
33586433|NCT00107900|102036273|FG004|Overall Study|Administrative Reasons|2|||
33586434|NCT00107900|102036274|FG005|Overall Study|Administrative Reasons|0|||
33586435|NCT00570778|102036275|FG000|Overall Study|Protocol deviation|2|||
33586436|NCT00570778|102036276|FG001|Overall Study|Protocol deviation|1|||
33586437|NCT00570778|102036277|FG002|Overall Study|Protocol deviation|2|||
33586438|NCT00570778|102036278|FG003|Overall Study|Protocol deviation|2|||
33586439|NCT00570778|102036275|FG000|Overall Study|Adverse Event|0|||
33586440|NCT00570778|102036276|FG001|Overall Study|Adverse Event|1|||
33247227|NCT01227707|100806616|FG000|Overall Study|Progression of disease|3|||
33247228|NCT01227707|100806616|FG000|Overall Study|Withdrawal by Subject|1|||
33377022|NCT00254293|101265127|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
33377023|NCT00254293|101265128|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
33377024|NCT00254293|101265129|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
33377025|NCT00254293|101265130|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
33377026|NCT00254293|101265131|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
33377027|NCT00254293|101265125|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
33377028|NCT00254293|101265126|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
33377029|NCT00254293|101265127|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
33377030|NCT00254293|101265128|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
33377031|NCT00254293|101265129|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
33377032|NCT00254293|101265130|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
33377033|NCT00254293|101265131|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
33377034|NCT00254293|101265125|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
33377035|NCT00254293|101265126|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
33377036|NCT00254293|101265127|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
33377037|NCT00254293|101265128|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
33377038|NCT00254293|101265129|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
33377039|NCT00254293|101265130|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
33377040|NCT00254293|101265131|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
33377041|NCT00254293|101265125|FG000|LTE Open Label Variable SC Dosing|Death|0|||
33377042|NCT00254293|101265126|FG001|LTE Open Label Variable SC Dosing|Death|0|||
33377043|NCT00254293|101265127|FG002|LTE Open Label Variable SC Dosing|Death|1|||
33377044|NCT00254293|101265128|FG003|LTE Open Label Variable SC Dosing|Death|0|||
33377045|NCT00254293|101265129|FG004|LTE Open Label Variable SC Dosing|Death|0|||
33377046|NCT00254293|101265130|FG005|LTE Open Label Variable SC Dosing|Death|0|||
33377047|NCT00254293|101265131|FG006|LTE Open Label Variable SC Dosing|Death|0|||
33377048|NCT00254293|101265125|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
33377049|NCT00254293|101265126|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
33377050|NCT00254293|101265127|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
33377051|NCT00254293|101265128|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
33377052|NCT00254293|101265129|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
33377053|NCT00254293|101265130|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
33377054|NCT00254293|101265131|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
33377055|NCT00254293|101265125|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
33377056|NCT00254293|101265126|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
33377057|NCT00254293|101265127|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
33377058|NCT00254293|101265128|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
33377059|NCT00254293|101265129|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
33247229|NCT01227707|100806616|FG000|Overall Study|Patient non-compliance|3|||
33247230|NCT01227707|100806616|FG000|Overall Study|Medical decision|6|||
33247231|NCT01227707|100806616|FG000|Overall Study|Death|1|||
33247232|NCT02380742|100806617|FG000|Overall Study|Withdrawal by Subject|1|||
33247233|NCT02380742|100806618|FG001|Overall Study|Withdrawal by Subject|0|||
33247234|NCT00554801|100806621|FG000|Overall Study|left area before completion|5|||
33247235|NCT00554801|100806622|FG001|Overall Study|left area before completion|0|||
33247236|NCT00554801|100806621|FG000|Overall Study|Withdrawal by Subject|14|||
33247237|NCT00554801|100806622|FG001|Overall Study|Withdrawal by Subject|0|||
33247238|NCT03635567|100806623|FG000|Overall Study|Lost to Follow-up|0|||
33247239|NCT03635567|100806624|FG001|Overall Study|Lost to Follow-up|2|||
33247240|NCT03635567|100806623|FG000|Overall Study|Withdrawal by Subject|9|||
33247241|NCT03635567|100806624|FG001|Overall Study|Withdrawal by Subject|10|||
33247242|NCT03635567|100806623|FG000|Overall Study|Ongoing in Study|125|||
33247243|NCT03635567|100806624|FG001|Overall Study|Ongoing in Study|76|||
33247244|NCT03635567|100806623|FG000|Overall Study|Death|174|||
33247245|NCT03635567|100806624|FG001|Overall Study|Death|221|||
33247246|NCT03784963|100806625|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
33247247|NCT03784963|100806626|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
33247248|NCT03784963|100806627|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
33247249|NCT03784963|100806628|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
33247250|NCT01939158|100806629|FG000|Overall Study|Adverse Event|1|||
33247251|NCT01939158|100806630|FG001|Overall Study|Adverse Event|0|||
33247252|NCT01939158|100806631|FG002|Overall Study|Adverse Event|0|||
33247253|NCT01939158|100806632|FG003|Overall Study|Adverse Event|0|||
33247254|NCT01939158|100806629|FG000|Overall Study|Withdrawal by Subject|22|||
33247255|NCT01939158|100806630|FG001|Overall Study|Withdrawal by Subject|25|||
33377060|NCT00254293|101265130|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
33247256|NCT01939158|100806631|FG002|Overall Study|Withdrawal by Subject|15|||
33247257|NCT01939158|100806632|FG003|Overall Study|Withdrawal by Subject|17|||
33377061|NCT00254293|101265131|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
33377062|NCT00254293|101265125|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
33377063|NCT00254293|101265126|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
33377064|NCT00254293|101265127|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
33377065|NCT00254293|101265128|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
33377066|NCT00254293|101265129|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
33377067|NCT00254293|101265130|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
33377068|NCT00254293|101265131|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
33377069|NCT00254293|101265125|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
33377070|NCT00254293|101265126|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
33377071|NCT00254293|101265127|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
33377072|NCT00254293|101265128|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
33377073|NCT00254293|101265129|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
33377074|NCT00254293|101265130|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
33377075|NCT00254293|101265131|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
33377076|NCT00254293|101265125|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
33377077|NCT00254293|101265126|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
33377078|NCT00254293|101265127|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
33377079|NCT00254293|101265128|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
33377080|NCT00254293|101265129|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
33377081|NCT00254293|101265130|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
33377082|NCT00254293|101265131|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
33377083|NCT00254293|101265125|FG000|LTE Open Label Variable SC Dosing|Other|0|||
33377084|NCT00254293|101265126|FG001|LTE Open Label Variable SC Dosing|Other|0|||
33377085|NCT00254293|101265127|FG002|LTE Open Label Variable SC Dosing|Other|2|||
33377086|NCT00254293|101265128|FG003|LTE Open Label Variable SC Dosing|Other|0|||
33377087|NCT00254293|101265129|FG004|LTE Open Label Variable SC Dosing|Other|0|||
33377088|NCT00254293|101265130|FG005|LTE Open Label Variable SC Dosing|Other|0|||
33377089|NCT00254293|101265131|FG006|LTE Open Label Variable SC Dosing|Other|0|||
33377090|NCT00254293|101265125|FG000|LTE Open Label Fixed Dosing|Death|0|||
33377091|NCT00254293|101265126|FG001|LTE Open Label Fixed Dosing|Death|0|||
33377092|NCT00254293|101265127|FG002|LTE Open Label Fixed Dosing|Death|0|||
33377093|NCT00254293|101265128|FG003|LTE Open Label Fixed Dosing|Death|0|||
33377094|NCT00254293|101265129|FG004|LTE Open Label Fixed Dosing|Death|0|||
33377095|NCT00254293|101265130|FG005|LTE Open Label Fixed Dosing|Death|0|||
33377096|NCT00254293|101265131|FG006|LTE Open Label Fixed Dosing|Death|3|||
33377097|NCT00254293|101265125|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
33377098|NCT00254293|101265126|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
33377099|NCT00254293|101265127|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
33377100|NCT00254293|101265128|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
33377101|NCT00254293|101265129|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
33377102|NCT00254293|101265130|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
33377103|NCT00254293|101265131|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
33377104|NCT00254293|101265125|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
33377105|NCT00254293|101265126|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
33377106|NCT00254293|101265127|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
33377107|NCT00254293|101265128|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
33377108|NCT00254293|101265129|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
33377109|NCT00254293|101265130|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
33377110|NCT00254293|101265131|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
33377111|NCT00254293|101265125|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
33377112|NCT00254293|101265126|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
33377113|NCT00254293|101265127|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
33377114|NCT00254293|101265128|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
33377115|NCT00254293|101265129|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
33377116|NCT00254293|101265130|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
33377117|NCT00254293|101265131|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
33377118|NCT00254293|101265125|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
33377119|NCT00254293|101265126|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
33377120|NCT00254293|101265127|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
33377121|NCT00254293|101265128|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
33377122|NCT00254293|101265129|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
33377123|NCT00254293|101265130|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
33377124|NCT00254293|101265131|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
33377125|NCT00254293|101265125|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
33377126|NCT00254293|101265126|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
33377127|NCT00254293|101265127|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
33377128|NCT00254293|101265128|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
33377129|NCT00254293|101265129|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
33424192|NCT03712228|101443733|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33377130|NCT00254293|101265130|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
33377131|NCT00254293|101265131|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
33377132|NCT00254293|101265125|FG000|LTE Open Label Fixed Dosing|Other|0|||
33377133|NCT00254293|101265126|FG001|LTE Open Label Fixed Dosing|Other|0|||
33377134|NCT00254293|101265127|FG002|LTE Open Label Fixed Dosing|Other|0|||
33377135|NCT00254293|101265128|FG003|LTE Open Label Fixed Dosing|Other|0|||
33377136|NCT00254293|101265129|FG004|LTE Open Label Fixed Dosing|Other|0|||
33377137|NCT00254293|101265130|FG005|LTE Open Label Fixed Dosing|Other|0|||
33377138|NCT00254293|101265131|FG006|LTE Open Label Fixed Dosing|Other|1|||
33377139|NCT01617187|101265132|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
33377140|NCT01617187|101265133|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
33377141|NCT01617187|101265134|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
33377142|NCT01617187|101265135|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
33377143|NCT01617187|101265132|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
33377144|NCT01617187|101265133|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
33377145|NCT01617187|101265134|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
33377146|NCT01617187|101265135|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
33377147|NCT01617187|101265132|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
33377148|NCT01617187|101265133|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
33377149|NCT01617187|101265134|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
33377150|NCT01617187|101265135|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
33377151|NCT01617187|101265132|FG000|Treatment Through Study Completion|Adverse Event|1|||
33377152|NCT01617187|101265133|FG001|Treatment Through Study Completion|Adverse Event|1|||
33377153|NCT01617187|101265134|FG002|Treatment Through Study Completion|Adverse Event|0|||
33377154|NCT01617187|101265135|FG003|Treatment Through Study Completion|Adverse Event|1|||
33377155|NCT01617187|101265132|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
33377156|NCT01617187|101265133|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
33377157|NCT01617187|101265134|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
33377158|NCT01617187|101265135|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
33377159|NCT01617187|101265132|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
33377160|NCT01617187|101265133|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
33377161|NCT01617187|101265134|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
33377162|NCT01617187|101265135|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
33377163|NCT01617187|101265132|FG000|Treatment Through Study Completion|Protocol Violation|1|||
33377164|NCT01617187|101265133|FG001|Treatment Through Study Completion|Protocol Violation|0|||
33377165|NCT01617187|101265134|FG002|Treatment Through Study Completion|Protocol Violation|0|||
33377166|NCT01617187|101265135|FG003|Treatment Through Study Completion|Protocol Violation|1|||
33377167|NCT00393913|101265136|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
33377168|NCT00393913|101265136|FG000|Initial Assessment|Withdrawal by Subject|16|||
33377169|NCT00393913|101265136|FG000|CPAP|Withdrawal by Subject|3|||
33377170|NCT00393913|101265136|FG000|CPAP|Physician Decision|1|||
33377171|NCT00393913|101265136|FG000|CPAP|TEchnical problem with CPAP|3|||
33377172|NCT01357915|101265137|FG000|Overall Study|Lost to Follow-up|3|||
33377173|NCT01357915|101265138|FG001|Overall Study|Lost to Follow-up|0|||
33377174|NCT02702518|101265139|FG000|Overall Study|Lost to Follow-up|3|||
33377175|NCT02702518|101265140|FG001|Overall Study|Lost to Follow-up|4|||
33377176|NCT01996748|101265148|FG000|Overall Study|Personal reason|1|||
33377177|NCT01996748|101265149|FG001|Overall Study|Personal reason|0|||
33377178|NCT01996748|101265148|FG000|Overall Study|Physician Decision|2|||
33377179|NCT01996748|101265149|FG001|Overall Study|Physician Decision|0|||
33377180|NCT01996748|101265148|FG000|Overall Study|Adverse Event|1|||
33377181|NCT01996748|101265149|FG001|Overall Study|Adverse Event|4|||
33377182|NCT01996748|101265148|FG000|Overall Study|Withdrawal by Subject|0|||
33377183|NCT01996748|101265149|FG001|Overall Study|Withdrawal by Subject|1|||
33377184|NCT01996748|101265148|FG000|Overall Study|Lost to Follow-up|4|||
33377185|NCT01996748|101265149|FG001|Overall Study|Lost to Follow-up|1|||
33377186|NCT04191967|101265152|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
33377187|NCT04191967|101265152|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
33377188|NCT01354353|101265153|FG000|Overall Study|Adverse Event|1|||
33377189|NCT01354353|101265154|FG001|Overall Study|Adverse Event|0|||
33377190|NCT01354353|101265155|FG002|Overall Study|Adverse Event|0|||
33377191|NCT01354353|101265156|FG003|Overall Study|Adverse Event|4|||
33377192|NCT01354353|101265157|FG004|Overall Study|Adverse Event|0|||
33377193|NCT01354353|101265158|FG005|Overall Study|Adverse Event|5|||
33424193|NCT03712228|101443734|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33646453|NCT00615901|102259607|FG000|Overall Study|Withdrawal by Subject|2|||
33377194|NCT01354353|101265153|FG000|Overall Study|Entry Criteria Not Met|0|||
33377195|NCT01354353|101265154|FG001|Overall Study|Entry Criteria Not Met|0|||
33377196|NCT01354353|101265155|FG002|Overall Study|Entry Criteria Not Met|0|||
33377197|NCT01354353|101265156|FG003|Overall Study|Entry Criteria Not Met|1|||
33377198|NCT01354353|101265157|FG004|Overall Study|Entry Criteria Not Met|1|||
33377199|NCT01354353|101265158|FG005|Overall Study|Entry Criteria Not Met|0|||
33377200|NCT01354353|101265153|FG000|Overall Study|Physician Decision|0|||
33377201|NCT01354353|101265154|FG001|Overall Study|Physician Decision|1|||
33377202|NCT01354353|101265155|FG002|Overall Study|Physician Decision|1|||
33377203|NCT01354353|101265156|FG003|Overall Study|Physician Decision|0|||
33377204|NCT01354353|101265157|FG004|Overall Study|Physician Decision|0|||
33377205|NCT01354353|101265158|FG005|Overall Study|Physician Decision|0|||
33377206|NCT01354353|101265153|FG000|Overall Study|Withdrawal by Subject|2|||
33377207|NCT01354353|101265154|FG001|Overall Study|Withdrawal by Subject|0|||
33377208|NCT01354353|101265155|FG002|Overall Study|Withdrawal by Subject|1|||
33377209|NCT01354353|101265156|FG003|Overall Study|Withdrawal by Subject|0|||
33377210|NCT01354353|101265157|FG004|Overall Study|Withdrawal by Subject|0|||
33377211|NCT01354353|101265158|FG005|Overall Study|Withdrawal by Subject|1|||
33377212|NCT02695524|101265159|FG000|Overall Study|Lost to Follow-up|3|||
33377213|NCT02695524|101265160|FG001|Overall Study|Lost to Follow-up|2|||
33377214|NCT02695524|101265159|FG000|Overall Study|Death|0|||
33377215|NCT02695524|101265160|FG001|Overall Study|Death|1|||
33377216|NCT00574496|101265161|FG000|Overall Study|Withdrawal by Subject|1|||
33377217|NCT00831441|101265162|FG000|Randomized|Death|82|||
33377218|NCT00831441|101265163|FG001|Randomized|Death|81|||
33377219|NCT00831441|101265162|FG000|Randomized|Adverse Event|248|||
33377220|NCT00831441|101265163|FG001|Randomized|Adverse Event|321|||
33377221|NCT00831441|101265162|FG000|Randomized|Emergency procedure|2|||
33377222|NCT00831441|101265163|FG001|Randomized|Emergency procedure|2|||
33377223|NCT00831441|101265162|FG000|Randomized|Elective procedure|26|||
33377224|NCT00831441|101265163|FG001|Randomized|Elective procedure|25|||
33377225|NCT00831441|101265162|FG000|Randomized|Physician Decision|26|||
33377226|NCT00831441|101265163|FG001|Randomized|Physician Decision|35|||
33377227|NCT00831441|101265162|FG000|Randomized|No longer met criteria|13|||
33377228|NCT00831441|101265163|FG001|Randomized|No longer met criteria|19|||
33377229|NCT00831441|101265162|FG000|Randomized|Withdrawal by Subject|178|||
33377230|NCT00831441|101265163|FG001|Randomized|Withdrawal by Subject|212|||
33377231|NCT00831441|101265162|FG000|Randomized|Lost to Follow-up|26|||
33377232|NCT00831441|101265163|FG001|Randomized|Lost to Follow-up|35|||
33377233|NCT00831441|101265162|FG000|Randomized|Administrative reason by sponsor|2780|||
33377234|NCT00831441|101265163|FG001|Randomized|Administrative reason by sponsor|2671|||
33377235|NCT00831441|101265162|FG000|Randomized|poor/non-compliance|30|||
33377236|NCT00831441|101265163|FG001|Randomized|poor/non-compliance|38|||
33377237|NCT00831441|101265162|FG000|Randomized|non-specified|276|||
33377238|NCT00831441|101265163|FG001|Randomized|non-specified|266|||
33377239|NCT00831441|101265162|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
33377240|NCT00831441|101265163|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
33377241|NCT00831441|101265162|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
33377242|NCT00831441|101265163|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
33377243|NCT00831441|101265162|FG000|Follow Up (30 Days)|Death|63|||
33377244|NCT00831441|101265163|FG001|Follow Up (30 Days)|Death|86|||
33377245|NCT00831441|101265162|FG000|Follow Up (30 Days)|non-specified|16|||
33377246|NCT00831441|101265163|FG001|Follow Up (30 Days)|non-specified|26|||
33377247|NCT00831441|101265162|FG000|Follow Up (30 Days)|missing end of study status|0|||
33377248|NCT00831441|101265163|FG001|Follow Up (30 Days)|missing end of study status|1|||
33377249|NCT00082758|101265167|FG000|Overall Study|Adverse Event|0|||
33377250|NCT00082758|101265168|FG001|Overall Study|Adverse Event|2|||
33377251|NCT00082758|101265169|FG002|Overall Study|Adverse Event|0|||
33377252|NCT00082758|101265167|FG000|Overall Study|Lack of Efficacy|12|||
33377253|NCT00082758|101265168|FG001|Overall Study|Lack of Efficacy|13|||
33377254|NCT00082758|101265169|FG002|Overall Study|Lack of Efficacy|0|||
33377255|NCT00082758|101265167|FG000|Overall Study|Physician Decision|0|||
33377256|NCT00082758|101265168|FG001|Overall Study|Physician Decision|1|||
33377257|NCT00082758|101265169|FG002|Overall Study|Physician Decision|0|||
33377258|NCT00082758|101265167|FG000|Overall Study|Withdrawal by Subject|3|||
33377259|NCT00082758|101265168|FG001|Overall Study|Withdrawal by Subject|0|||
33377260|NCT00082758|101265169|FG002|Overall Study|Withdrawal by Subject|0|||
33377261|NCT00082758|101265167|FG000|Overall Study|Protocol Violation|0|||
33377262|NCT00082758|101265168|FG001|Overall Study|Protocol Violation|1|||
33377263|NCT00082758|101265169|FG002|Overall Study|Protocol Violation|0|||
33377264|NCT01669811|101265172|FG000|Overall Study|Investigator decision|0|||
33377265|NCT01669811|101265173|FG001|Overall Study|Investigator decision|1|||
33377266|NCT01669811|101265172|FG000|Overall Study|Withdrawal by Subject|1|||
33377267|NCT01669811|101265173|FG001|Overall Study|Withdrawal by Subject|2|||
33377268|NCT01669811|101265172|FG000|Overall Study|Adverse Event|2|||
33377269|NCT01669811|101265173|FG001|Overall Study|Adverse Event|6|||
33377270|NCT01669811|101265172|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
33377271|NCT01669811|101265173|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
33377272|NCT03198754|101265177|FG000|Overall Study|Withdrawal by Subject|5|||
33377273|NCT03198754|101265178|FG001|Overall Study|Withdrawal by Subject|4|||
33377274|NCT03198754|101265177|FG000|Overall Study|Lost to Follow-up|4|||
33377275|NCT03198754|101265178|FG001|Overall Study|Lost to Follow-up|3|||
33377276|NCT03198754|101265177|FG000|Overall Study|Ineligible|2|||
33377277|NCT03198754|101265178|FG001|Overall Study|Ineligible|1|||
33377278|NCT01361919|101265179|FG000|Overall Study|technical issues|10|||
33377279|NCT01361919|101265180|FG001|Overall Study|technical issues|12|||
33377280|NCT01361919|101265181|FG002|Overall Study|technical issues|10|||
33377281|NCT00987623|101265182|FG000|Overall Study|Lost to Follow-up|2|||
33377282|NCT00987623|101265183|FG001|Overall Study|Lost to Follow-up|1|||
33377283|NCT00987623|101265182|FG000|Overall Study|Time/job conflict|2|||
33377284|NCT00987623|101265183|FG001|Overall Study|Time/job conflict|0|||
33377285|NCT00987623|101265182|FG000|Overall Study|Discomfort|1|||
33377286|NCT00987623|101265183|FG001|Overall Study|Discomfort|0|||
33377287|NCT00987623|101265182|FG000|Overall Study|Biomicroscopy|0|||
33377288|NCT00987623|101265183|FG001|Overall Study|Biomicroscopy|1|||
33377289|NCT00987623|101265182|FG000|Overall Study|Influenza|0|||
33377290|NCT00987623|101265183|FG001|Overall Study|Influenza|1|||
33377291|NCT03089216|101265184|FG000|Overall Study|Adverse Event|0|||
33377292|NCT03089216|101265185|FG001|Overall Study|Adverse Event|0|||
33377293|NCT03089216|101265186|FG002|Overall Study|Adverse Event|0|||
33377294|NCT03089216|101265187|FG003|Overall Study|Adverse Event|1|||
33377295|NCT00190983|101265189|FG000|Overall Study|Inevaluable (never treated)|2|||
33377296|NCT00853489|101265190|FG000|Overall Study|Lost to Follow-up|5|||
33377297|NCT00853489|101265191|FG001|Overall Study|Lost to Follow-up|2|||
33377298|NCT00441441|101265193|FG000|Overall Study|Adverse Event|2|||
33377299|NCT00441441|101265194|FG001|Overall Study|Adverse Event|1|||
33377300|NCT00441441|101265193|FG000|Overall Study|Protocol Violation|4|||
33377301|NCT00441441|101265194|FG001|Overall Study|Protocol Violation|6|||
33377302|NCT00441441|101265193|FG000|Overall Study|Exacerbation of asthma|1|||
33377303|NCT00441441|101265194|FG001|Overall Study|Exacerbation of asthma|2|||
33377304|NCT00441441|101265193|FG000|Overall Study|Withdrawal by Subject|1|||
33377305|NCT00441441|101265194|FG001|Overall Study|Withdrawal by Subject|2|||
33377306|NCT00441441|101265193|FG000|Overall Study|Other|3|||
33377307|NCT00441441|101265194|FG001|Overall Study|Other|3|||
33377308|NCT03943953|101265198|FG000|Trial of ITG 1|Lost to Follow-up|19|||
33377309|NCT03943953|101265199|FG001|Trial of ITG 1|Lost to Follow-up|1|||
33377310|NCT03943953|101265198|FG000|Trial of ITG 2|Lost to Follow-up|8|||
33377311|NCT03943953|101265199|FG001|Trial of ITG 2|Lost to Follow-up|0|||
33377312|NCT03943953|101265198|FG000|Trial of ITG 3|Lost to Follow-up|2|||
33377313|NCT03943953|101265199|FG001|Trial of ITG 3|Lost to Follow-up|0|||
33377314|NCT03943953|101265198|FG000|Trial of ITG 4|Lost to Follow-up|2|||
33377315|NCT03943953|101265199|FG001|Trial of ITG 4|Lost to Follow-up|0|||
33377316|NCT01956240|101265200|FG000|Overall Study|Lost to Follow-up|6|||
33377317|NCT01956240|101265201|FG001|Overall Study|Lost to Follow-up|20|||
33377318|NCT01956240|101265200|FG000|Overall Study|Adverse Event|17|||
33377319|NCT01956240|101265201|FG001|Overall Study|Adverse Event|4|||
33377320|NCT00642746|101265208|FG000|Overall Study|Patient unevaluable|1|||
33377321|NCT00642746|101265209|FG001|Overall Study|Patient unevaluable|0|||
33377322|NCT00567541|101265210|FG000|Overall Study|Adverse Event|0|||
33377323|NCT00567541|101265211|FG001|Overall Study|Adverse Event|1|||
33377324|NCT04587453|101265212|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
33377325|NCT04587453|101265213|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
33377326|NCT02365584|101265216|FG000|Overall Study|Adverse Event|2|||
33377327|NCT02365584|101265217|FG001|Overall Study|Adverse Event|2|||
33377328|NCT02365584|101265216|FG000|Overall Study|Withdrawal by Subject|1|||
33377329|NCT02365584|101265217|FG001|Overall Study|Withdrawal by Subject|0|||
33377330|NCT02365584|101265216|FG000|Overall Study|Disease Progression|9|||
33377331|NCT02365584|101265217|FG001|Overall Study|Disease Progression|12|||
33377332|NCT01364233|101265220|FG000|Overall Study|Lost to Follow-up|1|||
33377333|NCT02855450|101265223|FG000|Overall Study|Adverse Event|1|||
33377334|NCT02855450|101265224|FG001|Overall Study|Adverse Event|0|||
33377335|NCT02855450|101265223|FG000|Overall Study|Lost to Follow-up|4|||
33377336|NCT02855450|101265224|FG001|Overall Study|Lost to Follow-up|0|||
33377337|NCT03956225|101265227|FG000|Overall Study|Lack of Efficacy|1|||
33377338|NCT03956225|101265228|FG001|Overall Study|Lack of Efficacy|1|||
33377339|NCT03956225|101265227|FG000|Overall Study|Lost to Follow-up|0|||
33377340|NCT03956225|101265228|FG001|Overall Study|Lost to Follow-up|1|||
33377341|NCT03956225|101265227|FG000|Overall Study|Withdrawal by Subject|2|||
33377342|NCT03956225|101265228|FG001|Overall Study|Withdrawal by Subject|1|||
33377343|NCT03956225|101265227|FG000|Overall Study|Other Reasons|2|||
33586441|NCT00570778|102036277|FG002|Overall Study|Adverse Event|4|||
33586442|NCT00570778|102036278|FG003|Overall Study|Adverse Event|1|||
33586443|NCT00570778|102036275|FG000|Overall Study|Subject withdrew consent|0|||
33586444|NCT00570778|102036276|FG001|Overall Study|Subject withdrew consent|1|||
33586445|NCT00570778|102036277|FG002|Overall Study|Subject withdrew consent|0|||
33646454|NCT00615901|102259607|FG000|Overall Study|Adverse Event|7|||
33377344|NCT03956225|101265228|FG001|Overall Study|Other Reasons|1|||
33377345|NCT00084929|101265235|FG000|Overall Study|ineligible - medical contraindication|1|||
33377346|NCT00084929|101265235|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
33377347|NCT00084929|101265235|FG000|Overall Study|Ineligible - Medical history|6|||
33377348|NCT00084929|101265235|FG000|Overall Study|Withdrawal by Subject|10|||
33377349|NCT00084929|101265235|FG000|Overall Study|Missing/incomplete CTC exam|9|||
33377350|NCT00084929|101265235|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
33424194|NCT00860574|101443739|FG000|Overall Study|Death|2|||
33424195|NCT00860574|101443739|FG000|Overall Study|Relapse|1|||
33424196|NCT01408576|101443740|FG000|Overall Study|Lack of Efficacy|17|||
33424197|NCT01408576|101443741|FG001|Overall Study|Lack of Efficacy|30|||
33424198|NCT01408576|101443742|FG002|Overall Study|Lack of Efficacy|48|||
33424199|NCT01408576|101443740|FG000|Overall Study|Protocol Violation|1|||
33424200|NCT01408576|101443741|FG001|Overall Study|Protocol Violation|2|||
33424201|NCT01408576|101443742|FG002|Overall Study|Protocol Violation|2|||
33424202|NCT01408576|101443740|FG000|Overall Study|Lost to Follow-up|10|||
33424203|NCT01408576|101443741|FG001|Overall Study|Lost to Follow-up|9|||
33424204|NCT01408576|101443742|FG002|Overall Study|Lost to Follow-up|17|||
33424205|NCT01408576|101443740|FG000|Overall Study|Withdrawal by Subject|34|||
33424206|NCT01408576|101443741|FG001|Overall Study|Withdrawal by Subject|60|||
33424207|NCT01408576|101443742|FG002|Overall Study|Withdrawal by Subject|66|||
33424208|NCT01408576|101443740|FG000|Overall Study|Sponsor terminated study|89|||
33424209|NCT01408576|101443741|FG001|Overall Study|Sponsor terminated study|333|||
33424210|NCT01408576|101443742|FG002|Overall Study|Sponsor terminated study|330|||
33424211|NCT01408576|101443740|FG000|Overall Study|AE, serious fatal|4|||
33424212|NCT01408576|101443741|FG001|Overall Study|AE, serious fatal|4|||
33424213|NCT01408576|101443742|FG002|Overall Study|AE, serious fatal|1|||
33424214|NCT01408576|101443740|FG000|Overall Study|SAE, non-fatal|11|||
33424215|NCT01408576|101443741|FG001|Overall Study|SAE, non-fatal|23|||
33424216|NCT01408576|101443742|FG002|Overall Study|SAE, non-fatal|14|||
33646455|NCT02078960|102259608|FG000|Treatment Period|Other|0|||
33646456|NCT02078960|102259609|FG001|Treatment Period|Other|0|||
33646457|NCT02078960|102259610|FG002|Treatment Period|Other|1|||
33377351|NCT00798655|101265243|FG000|Overall Study|Did not receive at least one dose of pan|2|||
33377352|NCT04402008|101265244|FG000|Overall Study|Adverse Event|0|||
33377353|NCT04402008|101265245|FG001|Overall Study|Adverse Event|0|||
33377354|NCT04402008|101265246|FG002|Overall Study|Adverse Event|0|||
33377355|NCT04402008|101265247|FG003|Overall Study|Adverse Event|1|||
33377356|NCT04402008|101265248|FG004|Overall Study|Adverse Event|0|||
33377357|NCT04402008|101265249|FG005|Overall Study|Adverse Event|0|||
33377358|NCT04402008|101265250|FG006|Overall Study|Adverse Event|0|||
33377359|NCT04402008|101265244|FG000|Overall Study|Disease Progression|3|||
33377360|NCT04402008|101265245|FG001|Overall Study|Disease Progression|2|||
33377361|NCT04402008|101265246|FG002|Overall Study|Disease Progression|3|||
33377362|NCT04402008|101265247|FG003|Overall Study|Disease Progression|3|||
33377363|NCT04402008|101265248|FG004|Overall Study|Disease Progression|4|||
33377364|NCT04402008|101265249|FG005|Overall Study|Disease Progression|3|||
33377365|NCT04402008|101265250|FG006|Overall Study|Disease Progression|10|||
33377366|NCT04402008|101265244|FG000|Overall Study|Withdrawal by Subject|0|||
33377367|NCT04402008|101265245|FG001|Overall Study|Withdrawal by Subject|1|||
33377368|NCT04402008|101265246|FG002|Overall Study|Withdrawal by Subject|0|||
33377369|NCT04402008|101265247|FG003|Overall Study|Withdrawal by Subject|0|||
33377370|NCT04402008|101265248|FG004|Overall Study|Withdrawal by Subject|1|||
33377371|NCT04402008|101265249|FG005|Overall Study|Withdrawal by Subject|0|||
33377372|NCT04402008|101265250|FG006|Overall Study|Withdrawal by Subject|0|||
33377373|NCT04402008|101265244|FG000|Overall Study|Sponsor Decision|0|||
33377374|NCT04402008|101265245|FG001|Overall Study|Sponsor Decision|0|||
33377375|NCT04402008|101265246|FG002|Overall Study|Sponsor Decision|0|||
33377376|NCT04402008|101265247|FG003|Overall Study|Sponsor Decision|0|||
33377377|NCT04402008|101265248|FG004|Overall Study|Sponsor Decision|0|||
33377378|NCT04402008|101265249|FG005|Overall Study|Sponsor Decision|0|||
33377379|NCT04402008|101265250|FG006|Overall Study|Sponsor Decision|3|||
33377380|NCT04402008|101265244|FG000|Overall Study|Death|0|||
33377381|NCT04402008|101265245|FG001|Overall Study|Death|0|||
33377382|NCT04402008|101265246|FG002|Overall Study|Death|0|||
33377383|NCT04402008|101265247|FG003|Overall Study|Death|0|||
33377384|NCT04402008|101265248|FG004|Overall Study|Death|1|||
33377385|NCT04402008|101265249|FG005|Overall Study|Death|0|||
33424217|NCT01408576|101443740|FG000|Overall Study|AE, non-serious non-fatal|12|||
33424218|NCT01408576|101443741|FG001|Overall Study|AE, non-serious non-fatal|19|||
33646458|NCT02078960|102259608|FG000|Treatment Period|Lack of Efficacy|0|||
33646459|NCT02078960|102259609|FG001|Treatment Period|Lack of Efficacy|1|||
33377386|NCT04402008|101265250|FG006|Overall Study|Death|2|||
33377387|NCT04402008|101265244|FG000|Overall Study|Other|0|||
33377388|NCT04402008|101265245|FG001|Overall Study|Other|0|||
33377389|NCT04402008|101265246|FG002|Overall Study|Other|0|||
33377390|NCT04402008|101265247|FG003|Overall Study|Other|0|||
33377391|NCT04402008|101265248|FG004|Overall Study|Other|0|||
33377392|NCT04402008|101265249|FG005|Overall Study|Other|0|||
33377393|NCT04402008|101265250|FG006|Overall Study|Other|5|||
33377394|NCT02349789|101265251|FG000|Overall Study|Withdrawal by Subject|2|||
33377395|NCT00980980|101265252|FG000|Overall Study|Withdrawal by Hospital|0|||
33424219|NCT01408576|101443742|FG002|Overall Study|AE, non-serious non-fatal|11|||
33424220|NCT01408576|101443740|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
33424221|NCT01408576|101443741|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33646460|NCT02078960|102259610|FG002|Treatment Period|Lack of Efficacy|0|||
33646461|NCT02078960|102259608|FG000|Treatment Period|Disease progression - accelerated phase|0|||
33377396|NCT00980980|101265253|FG001|Overall Study|Withdrawal by Hospital|1|||
33377397|NCT00980980|101265254|FG002|Overall Study|Withdrawal by Hospital|0|||
33377398|NCT01303380|101265255|FG000|Overall Study|Lack of compliance to study procedures|1|||
33377399|NCT04465396|101265258|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
33377400|NCT04465396|101265259|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
33377401|NCT04465396|101265260|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
33377402|NCT04465396|101265261|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
33377403|NCT04543955|101265262|FG000|Overall Study|Company cancelled study|1|||
33377404|NCT04543955|101265263|FG001|Overall Study|Company cancelled study|0|||
33377405|NCT04311177|101265264|FG000|Overall Study|Adverse Event|3|||
33377406|NCT04311177|101265265|FG001|Overall Study|Adverse Event|1|||
33377407|NCT04311177|101265264|FG000|Overall Study|Physician Decision|4|||
33377408|NCT04311177|101265265|FG001|Overall Study|Physician Decision|3|||
33377409|NCT04311177|101265264|FG000|Overall Study|Withdrawal by Subject|1|||
33377410|NCT04311177|101265265|FG001|Overall Study|Withdrawal by Subject|0|||
33377411|NCT01348425|101265266|FG000|Overall Study|Imaging was not taken.|1|||
33377412|NCT01348425|101265267|FG001|Overall Study|Imaging was not taken.|1|||
33377413|NCT03580382|101265268|FG000|Overall Study|Early Termination of Study|0|||
33377414|NCT03580382|101265269|FG001|Overall Study|Early Termination of Study|3|||
33377415|NCT01980706|101265270|FG000|Overall Study|Withdrawal by Subject|9|||
33377416|NCT01980706|101265271|FG001|Overall Study|Withdrawal by Subject|6|||
33377417|NCT01980706|101265272|FG002|Overall Study|Withdrawal by Subject|2|||
33377418|NCT01980706|101265270|FG000|Overall Study|Adverse Event|1|||
33377419|NCT01980706|101265271|FG001|Overall Study|Adverse Event|2|||
33377420|NCT01980706|101265272|FG002|Overall Study|Adverse Event|5|||
33377421|NCT01980706|101265270|FG000|Overall Study|Lost to Follow-up|3|||
33377422|NCT01980706|101265271|FG001|Overall Study|Lost to Follow-up|4|||
33377423|NCT01980706|101265272|FG002|Overall Study|Lost to Follow-up|3|||
33377424|NCT01980706|101265270|FG000|Overall Study|miscellaneous|4|||
33377425|NCT01980706|101265271|FG001|Overall Study|miscellaneous|5|||
33377426|NCT01980706|101265272|FG002|Overall Study|miscellaneous|3|||
33377427|NCT02358369|101265273|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
33377428|NCT02358369|101265274|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
33377429|NCT02358369|101265275|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
33377430|NCT02358369|101265276|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
33377431|NCT02358369|101265277|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
33377432|NCT02358369|101265273|FG000|Treatment Period A/B|Adverse Event|0|||
33377433|NCT02358369|101265274|FG001|Treatment Period A/B|Adverse Event|0|||
33377434|NCT02358369|101265275|FG002|Treatment Period A/B|Adverse Event|1|||
33377435|NCT02358369|101265276|FG003|Treatment Period A/B|Adverse Event|2|||
33377436|NCT02358369|101265277|FG004|Treatment Period A/B|Adverse Event|0|||
33377437|NCT02358369|101265273|FG000|Treatment Period A/B|Death|0|||
33377438|NCT02358369|101265274|FG001|Treatment Period A/B|Death|0|||
33377439|NCT02358369|101265275|FG002|Treatment Period A/B|Death|1|||
33377440|NCT02358369|101265276|FG003|Treatment Period A/B|Death|0|||
33377441|NCT02358369|101265277|FG004|Treatment Period A/B|Death|0|||
33377442|NCT02358369|101265273|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
33377443|NCT02358369|101265274|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
33377444|NCT02358369|101265275|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
33377445|NCT02358369|101265276|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
33377446|NCT02358369|101265277|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
33377447|NCT02358369|101265273|FG000|Treatment Period C|Adverse Event|0|||
33377448|NCT02358369|101265274|FG001|Treatment Period C|Adverse Event|0|||
33377449|NCT02358369|101265275|FG002|Treatment Period C|Adverse Event|0|||
33377450|NCT02358369|101265276|FG003|Treatment Period C|Adverse Event|0|||
33377451|NCT02358369|101265277|FG004|Treatment Period C|Adverse Event|7|||
33377452|NCT00413062|101265282|FG000|Overall Study|Adverse event/serious adverse event|289|||
33377453|NCT00413062|101265283|FG001|Overall Study|Adverse event/serious adverse event|56|||
33377454|NCT00413062|101265282|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
33377455|NCT00413062|101265283|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
33377456|NCT00413062|101265282|FG000|Overall Study|Withdrawal of informed consent|111|||
33377457|NCT00413062|101265283|FG001|Overall Study|Withdrawal of informed consent|36|||
33586446|NCT00570778|102036278|FG003|Overall Study|Subject withdrew consent|1|||
33377458|NCT00413062|101265282|FG000|Overall Study|Pregnancy|15|||
33377459|NCT00413062|101265283|FG001|Overall Study|Pregnancy|5|||
33377460|NCT00413062|101265282|FG000|Overall Study|Pregnancy wish|17|||
33377461|NCT00413062|101265283|FG001|Overall Study|Pregnancy wish|6|||
33377462|NCT00413062|101265282|FG000|Overall Study|Lost to Follow-up|175|||
33377463|NCT00413062|101265283|FG001|Overall Study|Lost to Follow-up|73|||
33377464|NCT00413062|101265282|FG000|Overall Study|Other reason|70|||
33377465|NCT00413062|101265283|FG001|Overall Study|Other reason|34|||
33377466|NCT00650091|101265284|FG000|Amended Study Design|Withdrawal by Subject|12|||
33377467|NCT00650091|101265285|FG001|Amended Study Design|Withdrawal by Subject|11|||
33586447|NCT00570778|102036275|FG000|Overall Study|Abnormal test procedure|1|||
33646462|NCT02078960|102259609|FG001|Treatment Period|Disease progression - accelerated phase|1|||
33424222|NCT01408576|101443742|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33424223|NCT01408576|101443740|FG000|Overall Study|AE, unknown type|0|||
33424224|NCT01408576|101443741|FG001|Overall Study|AE, unknown type|1|||
33424225|NCT01408576|101443742|FG002|Overall Study|AE, unknown type|0|||
33424226|NCT01408576|101443740|FG000|Overall Study|Other|10|||
33377468|NCT00650091|101265286|FG002|Amended Study Design|Withdrawal by Subject|0|||
33377469|NCT00650091|101265284|FG000|Amended Study Design|Physician Decision|5|||
33377470|NCT00650091|101265285|FG001|Amended Study Design|Physician Decision|0|||
33377471|NCT00650091|101265286|FG002|Amended Study Design|Physician Decision|0|||
33377472|NCT00650091|101265284|FG000|Amended Study Design|Adverse Event|1|||
33377473|NCT00650091|101265285|FG001|Amended Study Design|Adverse Event|4|||
33377474|NCT00650091|101265286|FG002|Amended Study Design|Adverse Event|0|||
33377475|NCT00650091|101265284|FG000|Amended Study Design|Lung transplantation|4|||
33377476|NCT00650091|101265285|FG001|Amended Study Design|Lung transplantation|2|||
33377477|NCT00650091|101265286|FG002|Amended Study Design|Lung transplantation|0|||
33586448|NCT00570778|102036276|FG001|Overall Study|Abnormal test procedure|0|||
33586449|NCT00570778|102036277|FG002|Overall Study|Abnormal test procedure|0|||
33586450|NCT00570778|102036278|FG003|Overall Study|Abnormal test procedure|0|||
33586451|NCT00570778|102036275|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33586452|NCT00570778|102036276|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33586453|NCT00570778|102036277|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33377478|NCT00650091|101265284|FG000|Amended Study Design|Other|1|||
33424227|NCT01408576|101443741|FG001|Overall Study|Other|16|||
33424228|NCT01408576|101443742|FG002|Overall Study|Other|18|||
33424229|NCT03877237|101443744|FG000|Overall Study|Adverse Event|1|||
33424230|NCT03877237|101443745|FG001|Overall Study|Adverse Event|2|||
33424231|NCT03877237|101443744|FG000|Overall Study|Death|3|||
33424232|NCT03877237|101443745|FG001|Overall Study|Death|2|||
33424233|NCT03877237|101443744|FG000|Overall Study|Physician Decision|1|||
33424234|NCT03877237|101443745|FG001|Overall Study|Physician Decision|0|||
33424235|NCT03877237|101443744|FG000|Overall Study|Withdrawal by Subject|0|||
33424236|NCT03877237|101443745|FG001|Overall Study|Withdrawal by Subject|2|||
33424237|NCT00345683|101443746|FG000|Overall Study|Lost to Follow-up|19|||
33424238|NCT00345683|101443747|FG001|Overall Study|Lost to Follow-up|7|||
33424239|NCT00345683|101443746|FG000|Overall Study|Other|6|||
33424240|NCT00345683|101443747|FG001|Overall Study|Other|2|||
33424241|NCT01335464|101443748|FG000|Overall Study|Adverse Event|15|||
33424242|NCT01335464|101443749|FG001|Overall Study|Adverse Event|25|||
33424243|NCT01335464|101443748|FG000|Overall Study|Non compliant with protocol|2|||
33424244|NCT01335464|101443749|FG001|Overall Study|Non compliant with protocol|0|||
33424245|NCT01335464|101443748|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
33424246|NCT01335464|101443749|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
33424247|NCT01335464|101443748|FG000|Overall Study|Not treated|2|||
33424248|NCT01335464|101443749|FG001|Overall Study|Not treated|0|||
33424249|NCT01335464|101443748|FG000|Overall Study|Reason other than those stated above|1|||
33424250|NCT01335464|101443749|FG001|Overall Study|Reason other than those stated above|1|||
33424251|NCT01440647|101443750|FG000|Overall Study|Death|2|||
33424252|NCT01440647|101443751|FG001|Overall Study|Death|3|||
33586454|NCT00570778|102036278|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
33586455|NCT00570778|102036275|FG000|Overall Study|Lost to Follow-up|0|||
33586456|NCT00570778|102036276|FG001|Overall Study|Lost to Follow-up|0|||
33586457|NCT00570778|102036277|FG002|Overall Study|Lost to Follow-up|1|||
33586458|NCT00570778|102036278|FG003|Overall Study|Lost to Follow-up|0|||
33586459|NCT00570778|102036275|FG000|Overall Study|Subject no longer requires study drug|0|||
33586460|NCT00570778|102036276|FG001|Overall Study|Subject no longer requires study drug|1|||
33586461|NCT00570778|102036277|FG002|Overall Study|Subject no longer requires study drug|0|||
33247258|NCT01939158|100806629|FG000|Overall Study|Migrated/moved from study area|5|||
33247259|NCT01939158|100806630|FG001|Overall Study|Migrated/moved from study area|7|||
33247260|NCT01939158|100806631|FG002|Overall Study|Migrated/moved from study area|3|||
33247261|NCT01939158|100806632|FG003|Overall Study|Migrated/moved from study area|6|||
33247262|NCT01939158|100806629|FG000|Overall Study|Lost to Follow-up|18|||
33377479|NCT00650091|101265285|FG001|Amended Study Design|Other|3|||
33377480|NCT00650091|101265286|FG002|Amended Study Design|Other|0|||
33424253|NCT02323295|101443759|FG000|Overall Study|Adverse Event|0|||
33424254|NCT02323295|101443760|FG001|Overall Study|Adverse Event|1|||
33586462|NCT00570778|102036278|FG003|Overall Study|Subject no longer requires study drug|0|||
33424255|NCT02323295|101443759|FG000|Overall Study|Withdrawal by Subject|0|||
33424256|NCT02323295|101443760|FG001|Overall Study|Withdrawal by Subject|1|||
33424257|NCT02323295|101443759|FG000|Overall Study|Patient did not have surgery as planned.|0|||
33424258|NCT02323295|101443760|FG001|Overall Study|Patient did not have surgery as planned.|1|||
33424259|NCT03636542|101446310|FG000|Overall Study|Lost to Follow-up|1|||
33247263|NCT01939158|100806630|FG001|Overall Study|Lost to Follow-up|17|||
33424260|NCT03636542|101446311|FG001|Overall Study|Lost to Follow-up|1|||
33586463|NCT01500252|102036280|FG000|Overall Study|Death|4|||
33586464|NCT01500252|102036281|FG001|Overall Study|Death|2|||
33586465|NCT01500252|102036280|FG000|Overall Study|Lost to Follow-up|5|||
33424261|NCT03636542|101446310|FG000|Overall Study|Physician Decision|0|||
33377481|NCT02486952|101265287|FG000|Overall Study|Not Started Induction Therapy|3|||
33377482|NCT02486952|101265287|FG000|Overall Study|Adverse Event|1|||
33377483|NCT02486952|101265287|FG000|Overall Study|Death|15|||
33377484|NCT02486952|101265287|FG000|Overall Study|Lack of Efficacy|3|||
33377485|NCT02486952|101265287|FG000|Overall Study|Lost to Follow-up|26|||
33377486|NCT02486952|101265287|FG000|Overall Study|Other|2|||
33377487|NCT02176291|101265288|FG000|Overall Study|Death|1|||
33377488|NCT02176291|101265289|FG001|Overall Study|Death|0|||
33377489|NCT02176291|101265288|FG000|Overall Study|non compliance with protocol|2|||
33377490|NCT02176291|101265289|FG001|Overall Study|non compliance with protocol|0|||
33377491|NCT02176291|101265288|FG000|Overall Study|Withdrawal by Subject|2|||
33377492|NCT02176291|101265289|FG001|Overall Study|Withdrawal by Subject|0|||
33377493|NCT00574119|101265290|FG000|Overall Study|Adverse Event|1|||
33377494|NCT00574119|101265290|FG000|Overall Study|Protocol Violation|1|||
33377495|NCT00574119|101265290|FG000|Overall Study|Withdrawal by Subject|1|||
33377496|NCT00574119|101265290|FG000|Overall Study|Physician Decision|1|||
33377497|NCT02432040|101265291|FG000|Overall Study|Lack of Efficacy|3|||
33377498|NCT02432040|101265292|FG001|Overall Study|Lack of Efficacy|0|||
33377499|NCT02432040|101265291|FG000|Overall Study|Lost to Follow-up|4|||
33377500|NCT02432040|101265292|FG001|Overall Study|Lost to Follow-up|5|||
33377501|NCT02432040|101265291|FG000|Overall Study|Physician Decision|1|||
33377502|NCT02432040|101265292|FG001|Overall Study|Physician Decision|1|||
33377503|NCT00315705|101265296|FG000|Phase 1|Refused further treatment|1|||
33377504|NCT00315705|101265296|FG000|Phase 1|Failure to achieve response|8|||
33377505|NCT00315705|101265296|FG000|Phase 1|Disease relapse|4|||
33377506|NCT00315705|101265296|FG000|Phase 1|Scheduled for transplant|9|||
33377507|NCT00315705|101265296|FG000|Phase 1|Death|3|||
33377508|NCT00315705|101265296|FG000|Phase 2|Physician Decision|4|||
33377509|NCT00315705|101265296|FG000|Phase 2|Adverse Event|1|||
33377510|NCT00315705|101265296|FG000|Phase 2|Failure to achieve response|3|||
33377511|NCT00315705|101265296|FG000|Phase 2|Disease relapse|1|||
33377512|NCT00315705|101265296|FG000|Phase 2|Scheduled for transplant|8|||
33377513|NCT00315705|101265296|FG000|Phase 2|Other|1|||
33377514|NCT00315705|101265296|FG000|Phase 2|Death|7|||
33377515|NCT03364673|101265299|FG000|Overall Study|Withdrawal by Subject|2|||
33377516|NCT03364673|101265299|FG000|Overall Study|Injury unrelated to study|3|||
33377517|NCT01714817|101269286|FG000|Year 1 Period|Lack of Efficacy|11|||
33377518|NCT01714817|101269287|FG001|Year 1 Period|Lack of Efficacy|9|||
33377519|NCT01714817|101269286|FG000|Year 1 Period|Adverse Event|20|||
33377520|NCT01714817|101269287|FG001|Year 1 Period|Adverse Event|17|||
33377521|NCT01714817|101269286|FG000|Year 1 Period|Withdrawal by Subject|6|||
33377522|NCT01714817|101269287|FG001|Year 1 Period|Withdrawal by Subject|7|||
33377523|NCT01714817|101269286|FG000|Year 1 Period|Death|1|||
33377524|NCT01714817|101269287|FG001|Year 1 Period|Death|1|||
33377525|NCT01714817|101269286|FG000|Year 1 Period|Lost to Follow-up|0|||
33377526|NCT01714817|101269287|FG001|Year 1 Period|Lost to Follow-up|2|||
33377527|NCT01714817|101269286|FG000|Year 1 Period|Poor / non-compliance|0|||
33377528|NCT01714817|101269287|FG001|Year 1 Period|Poor / non-compliance|1|||
33377529|NCT01714817|101269286|FG000|Year 1 Period|Pregnancy|2|||
33377530|NCT01714817|101269287|FG001|Year 1 Period|Pregnancy|0|||
33377531|NCT01714817|101269286|FG000|Year 1 Period|Participant no longer meets criteria|6|||
33377532|NCT01714817|101269287|FG001|Year 1 Period|Participant no longer meets criteria|2|||
33377533|NCT01714817|101269286|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
33377534|NCT01714817|101269287|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
33377535|NCT01714817|101269286|FG000|Year 1 Period|Change in Concomitant Medication|0|||
33377536|NCT01714817|101269287|FG001|Year 1 Period|Change in Concomitant Medication|1|||
33377537|NCT01714817|101269286|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
33377538|NCT01714817|101269287|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
33377539|NCT01714817|101269286|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
33377540|NCT01714817|101269287|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
33377541|NCT01714817|101269286|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
33377542|NCT01714817|101269287|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
33377543|NCT01714817|101269286|FG000|Year 2 Period|Lack of Efficacy|4|||
33377544|NCT01714817|101269287|FG001|Year 2 Period|Lack of Efficacy|12|||
33377545|NCT01714817|101269286|FG000|Year 2 Period|Adverse Event|7|||
33377546|NCT01714817|101269287|FG001|Year 2 Period|Adverse Event|6|||
33377547|NCT01714817|101269286|FG000|Year 2 Period|Participant request to stop treatment|4|||
33424262|NCT03636542|101446311|FG001|Overall Study|Physician Decision|1|||
33377548|NCT01714817|101269287|FG001|Year 2 Period|Participant request to stop treatment|4|||
33377549|NCT01714817|101269286|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
33377550|NCT01714817|101269287|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
33377551|NCT01714817|101269286|FG000|Year 2 Period|Participant withdrew consent|1|||
33377552|NCT01714817|101269287|FG001|Year 2 Period|Participant withdrew consent|5|||
33377553|NCT01714817|101269286|FG000|Year 2 Period|Participant no longer meets criteria|1|||
33377554|NCT01714817|101269287|FG001|Year 2 Period|Participant no longer meets criteria|4|||
33377555|NCT01714817|101269286|FG000|Year 2 Period|Lost to Follow-up|2|||
33377556|NCT01714817|101269287|FG001|Year 2 Period|Lost to Follow-up|0|||
33646463|NCT02078960|102259610|FG002|Treatment Period|Disease progression - accelerated phase|0|||
33646464|NCT02078960|102259608|FG000|Treatment Period|Disease progression - blast phase|1|||
33646465|NCT02078960|102259609|FG001|Treatment Period|Disease progression - blast phase|0|||
33646466|NCT02078960|102259610|FG002|Treatment Period|Disease progression - blast phase|0|||
33646467|NCT02078960|102259608|FG000|Treatment Period|Withdrawal by Subject|0|||
33646468|NCT02078960|102259609|FG001|Treatment Period|Withdrawal by Subject|1|||
33247264|NCT01939158|100806631|FG002|Overall Study|Lost to Follow-up|17|||
33247265|NCT01939158|100806632|FG003|Overall Study|Lost to Follow-up|17|||
33247266|NCT01939158|100806629|FG000|Overall Study|Death|0|||
33247267|NCT01939158|100806630|FG001|Overall Study|Death|0|||
33247268|NCT01939158|100806631|FG002|Overall Study|Death|1|||
33247269|NCT01939158|100806632|FG003|Overall Study|Death|1|||
33247270|NCT01939158|100806629|FG000|Overall Study|No longer meets eligibility criteria|0|||
33247271|NCT01939158|100806630|FG001|Overall Study|No longer meets eligibility criteria|0|||
33247272|NCT01939158|100806631|FG002|Overall Study|No longer meets eligibility criteria|1|||
33247273|NCT01939158|100806632|FG003|Overall Study|No longer meets eligibility criteria|0|||
33247274|NCT01939158|100806629|FG000|Overall Study|Other|1|||
33247275|NCT01939158|100806630|FG001|Overall Study|Other|3|||
33247276|NCT01939158|100806631|FG002|Overall Study|Other|4|||
33247277|NCT01939158|100806632|FG003|Overall Study|Other|3|||
33247278|NCT04565249|100806633|FG000|Overall Study|Death|0|||
33247279|NCT04565249|100806634|FG001|Overall Study|Death|0|||
33247280|NCT04565249|100806635|FG002|Overall Study|Death|0|||
33247281|NCT04565249|100806636|FG003|Overall Study|Death|1|||
33247282|NCT01582945|100806639|FG000|Overall Study|Intolerable side-effects|1|||
33247283|NCT01582945|100806639|FG000|Overall Study|Scheduling conflicts|1|||
33247284|NCT00545844|100806642|FG000|Overall Study|Lost to Follow-up|9|||
33247285|NCT00545844|100806642|FG000|Overall Study|Protocol Violation|1|||
33247286|NCT00545844|100806642|FG000|Overall Study|Withdrawal by Subject|2|||
33247287|NCT00530335|100806644|FG000|Overall Study|Adverse Event|3|||
33247288|NCT00530335|100806644|FG000|Overall Study|Protocol Violation|1|||
33247289|NCT00530335|100806644|FG000|Overall Study|Withdrawal by Subject|1|||
33247290|NCT00530335|100806644|FG000|Overall Study|Physician Decision|1|||
33247291|NCT02680756|100806645|FG000|Overall Study|Adverse Event|10|||
33247292|NCT02680756|100806646|FG001|Overall Study|Adverse Event|2|||
33247293|NCT02680756|100806645|FG000|Overall Study|Lost to Follow-up|7|||
33247294|NCT02680756|100806646|FG001|Overall Study|Lost to Follow-up|6|||
33247295|NCT02680756|100806645|FG000|Overall Study|Withdrawal by Subject|5|||
33247296|NCT02680756|100806646|FG001|Overall Study|Withdrawal by Subject|5|||
33247297|NCT02680756|100806645|FG000|Overall Study|Physician Decision|4|||
33247298|NCT02680756|100806646|FG001|Overall Study|Physician Decision|1|||
33247299|NCT02680756|100806645|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
33247300|NCT02680756|100806646|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
33247301|NCT02680756|100806645|FG000|Overall Study|Blood transfusion for any reason|0|||
33247302|NCT02680756|100806646|FG001|Overall Study|Blood transfusion for any reason|1|||
33247303|NCT02680756|100806645|FG000|Overall Study|Death|1|||
33247304|NCT02680756|100806646|FG001|Overall Study|Death|0|||
33247305|NCT02680756|100806645|FG000|Overall Study|Protocol Violation|1|||
33247306|NCT02680756|100806646|FG001|Overall Study|Protocol Violation|0|||
33247307|NCT02680756|100806645|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
33247308|NCT02680756|100806646|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
33247309|NCT02680756|100806645|FG000|Overall Study|None of above or not recorded|3|||
33247310|NCT02680756|100806646|FG001|Overall Study|None of above or not recorded|2|||
33247311|NCT01249092|100806647|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
33247312|NCT01249092|100806647|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
33646469|NCT02078960|102259610|FG002|Treatment Period|Withdrawal by Subject|1|||
33646470|NCT02078960|102259608|FG000|Treatment Period|Adverse Event|1|||
33247313|NCT01191788|100806650|FG000|Overall Study|Lost to Follow-up|21|||
33247314|NCT01191788|100806651|FG001|Overall Study|Lost to Follow-up|22|||
33247315|NCT01516892|100806652|FG000|Overall Study|Adverse Event|25|||
33247316|NCT01516892|100806652|FG000|Overall Study|Lack of Efficacy|35|||
33247317|NCT01516892|100806652|FG000|Overall Study|Pregnancy|5|||
33247318|NCT01516892|100806652|FG000|Overall Study|Lost to Follow-up|82|||
33247319|NCT01516892|100806652|FG000|Overall Study|Subject Withdrew Consent|92|||
33247320|NCT01516892|100806652|FG000|Overall Study|Protocol Violation|60|||
33247321|NCT01516892|100806652|FG000|Overall Study|Other Miscellaneous Reasons|43|||
33247322|NCT01516892|100806652|FG000|Overall Study|Missing|1|||
33247323|NCT00349908|100806653|FG000|Overall Study|Withdrawal by Subject|0|||
33247324|NCT00349908|100806654|FG001|Overall Study|Withdrawal by Subject|4|||
33247325|NCT01710514|100806658|FG000|Overall Study|Adverse Event|6|||
33247326|NCT01710514|100806659|FG001|Overall Study|Adverse Event|7|||
33247327|NCT01710514|100806658|FG000|Overall Study|Withdrawal by Subject|1|||
33247328|NCT01710514|100806659|FG001|Overall Study|Withdrawal by Subject|0|||
33247329|NCT02735915|100806660|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
33247330|NCT02735915|100806660|FG000|Overall Study|Withdrawal following SAE|2|||
33247331|NCT02735915|100806660|FG000|Overall Study|Withdrawal by Subject|1|||
33646471|NCT02078960|102259609|FG001|Treatment Period|Adverse Event|0|||
33377557|NCT01714817|101269286|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
33377558|NCT01714817|101269287|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
33377559|NCT01714817|101269286|FG000|Year 2 Period|Pregnancy|1|||
33377560|NCT01714817|101269287|FG001|Year 2 Period|Pregnancy|1|||
33377561|NCT01714817|101269286|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
33377562|NCT01714817|101269287|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
33377563|NCT01714817|101269286|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
33377564|NCT01714817|101269287|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
33377565|NCT01714817|101269286|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
33377566|NCT01714817|101269287|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
33377567|NCT01714817|101269286|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
33377568|NCT01714817|101269287|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
33377569|NCT01714817|101269286|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
33377570|NCT01714817|101269287|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
33377571|NCT01714817|101269286|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
33377572|NCT01714817|101269287|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
33377573|NCT01714817|101269286|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
33377574|NCT01714817|101269287|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
33377575|NCT01714817|101269286|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
33377576|NCT01714817|101269287|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
33377577|NCT01714817|101269286|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
33377578|NCT01714817|101269287|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
33377579|NCT01714817|101269286|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
33377580|NCT01714817|101269287|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
33377581|NCT01714817|101269286|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
33377582|NCT01714817|101269287|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
33377583|NCT01714817|101269286|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
33377584|NCT01714817|101269287|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
33377585|NCT01714817|101269286|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
33377586|NCT01714817|101269287|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
33377587|NCT01714817|101269286|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
33377588|NCT01714817|101269287|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
33377589|NCT01714817|101269286|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
33377590|NCT01714817|101269287|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
33377591|NCT01714817|101269286|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
33377592|NCT01714817|101269287|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
33377593|NCT00973921|101269288|FG000|Overall Study|IVUS results were not available|9|||
33377594|NCT01766817|101269291|FG000|Overall Study|Drug-related adverse event|1|||
33377595|NCT01766817|101269292|FG001|Overall Study|Drug-related adverse event|2|||
33377596|NCT01766817|101269293|FG002|Overall Study|Drug-related adverse event|1|||
33377597|NCT01766817|101269291|FG000|Overall Study|Drug-unrelated adverse event|3|||
33377598|NCT01766817|101269292|FG001|Overall Study|Drug-unrelated adverse event|3|||
33377599|NCT01766817|101269293|FG002|Overall Study|Drug-unrelated adverse event|3|||
33377600|NCT01766817|101269291|FG000|Overall Study|Death|1|||
33377601|NCT01766817|101269292|FG001|Overall Study|Death|1|||
33377602|NCT01766817|101269293|FG002|Overall Study|Death|0|||
33377603|NCT01766817|101269291|FG000|Overall Study|Unable to take study drug|0|||
33377604|NCT01766817|101269292|FG001|Overall Study|Unable to take study drug|1|||
33377605|NCT01766817|101269293|FG002|Overall Study|Unable to take study drug|0|||
33377606|NCT01766817|101269291|FG000|Overall Study|Withdrawal by Subject|2|||
33377607|NCT01766817|101269292|FG001|Overall Study|Withdrawal by Subject|0|||
33377608|NCT01766817|101269293|FG002|Overall Study|Withdrawal by Subject|3|||
33377609|NCT01766817|101269291|FG000|Overall Study|Subject non-compliance|0|||
33377610|NCT01766817|101269292|FG001|Overall Study|Subject non-compliance|1|||
33377611|NCT01766817|101269293|FG002|Overall Study|Subject non-compliance|2|||
33377612|NCT01766817|101269291|FG000|Overall Study|Physician Decision|3|||
33377613|NCT01766817|101269292|FG001|Overall Study|Physician Decision|3|||
33377614|NCT01766817|101269293|FG002|Overall Study|Physician Decision|4|||
33377615|NCT01766817|101269291|FG000|Overall Study|Other|1|||
33148739|NCT00478881|100458260|FG001|Overall Study|Lack of Efficacy|3|||
33148740|NCT00478881|100458259|FG000|Overall Study|Lost to Follow-up|0|||
33377616|NCT01766817|101269292|FG001|Overall Study|Other|0|||
33377617|NCT01766817|101269293|FG002|Overall Study|Other|0|||
33377618|NCT02208024|101269294|FG000|Overall Study|Withdrawal by Subject|1|||
33247332|NCT00359619|100806661|FG000|Overall Study|Adverse Event|0|||
33377619|NCT00764478|101269300|FG000|Overall Study|Adverse Event|1|||
33377620|NCT00764478|101269301|FG001|Overall Study|Adverse Event|1|||
33377621|NCT00764478|101269302|FG002|Overall Study|Adverse Event|1|||
33377622|NCT00764478|101269300|FG000|Overall Study|Withdrawal by Subject|7|||
33148741|NCT00478881|100458260|FG001|Overall Study|Lost to Follow-up|1|||
33377623|NCT00764478|101269301|FG001|Overall Study|Withdrawal by Subject|12|||
33247333|NCT00359619|100806662|FG001|Overall Study|Adverse Event|0|||
33247334|NCT00359619|100806663|FG002|Overall Study|Adverse Event|1|||
33247335|NCT00359619|100806664|FG003|Overall Study|Adverse Event|0|||
33247336|NCT00359619|100806665|FG004|Overall Study|Adverse Event|0|||
33247337|NCT00359619|100806666|FG005|Overall Study|Adverse Event|0|||
33247338|NCT00359619|100806667|FG006|Overall Study|Adverse Event|1|||
33247339|NCT00359619|100806661|FG000|Overall Study|Withdrawal by Subject|3|||
33247340|NCT00359619|100806662|FG001|Overall Study|Withdrawal by Subject|1|||
33247341|NCT00359619|100806663|FG002|Overall Study|Withdrawal by Subject|4|||
33247342|NCT00359619|100806664|FG003|Overall Study|Withdrawal by Subject|2|||
33247343|NCT00359619|100806665|FG004|Overall Study|Withdrawal by Subject|2|||
33247344|NCT00359619|100806666|FG005|Overall Study|Withdrawal by Subject|0|||
33377624|NCT00764478|101269302|FG002|Overall Study|Withdrawal by Subject|1|||
33377625|NCT00764478|101269300|FG000|Overall Study|Lost to Follow-up|7|||
33377626|NCT00764478|101269301|FG001|Overall Study|Lost to Follow-up|8|||
33377627|NCT00764478|101269302|FG002|Overall Study|Lost to Follow-up|5|||
33377628|NCT00764478|101269300|FG000|Overall Study|Protocol Violation|0|||
33377629|NCT00764478|101269301|FG001|Overall Study|Protocol Violation|1|||
33424263|NCT03636542|101446310|FG000|Overall Study|Withdrawal by Subject|1|||
33424264|NCT03636542|101446311|FG001|Overall Study|Withdrawal by Subject|0|||
33424265|NCT01637961|101446320|FG000|Overall Study|Ineligible: wrong primary|1|||
33424266|NCT01637961|101446320|FG000|Overall Study|Ineligible: inadequate pathology|1|||
33424267|NCT00558519|101446321|FG000|Overall Study|Ph+|20|||
33424268|NCT00558519|101446321|FG000|Overall Study|Ineligible|1|||
33424269|NCT00558519|101446321|FG000|Overall Study|Insufficient data|1|||
33424270|NCT00558519|101446321|FG000|Overall Study|Never received treatment|1|||
33424271|NCT02133352|101446325|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
33424272|NCT00382291|101446326|FG000|Overall Study|Adverse Event|1|||
33424273|NCT00382291|101446327|FG001|Overall Study|Adverse Event|2|||
33424274|NCT00382291|101446328|FG002|Overall Study|Adverse Event|2|||
33424275|NCT00382291|101446326|FG000|Overall Study|Protocol Violation|1|||
33424276|NCT00382291|101446327|FG001|Overall Study|Protocol Violation|0|||
33424277|NCT00382291|101446328|FG002|Overall Study|Protocol Violation|0|||
33424278|NCT00382291|101446326|FG000|Overall Study|Temporary study suspension|2|||
33586466|NCT01500252|102036281|FG001|Overall Study|Lost to Follow-up|4|||
33586467|NCT01843673|102036282|FG000|Overall Study|Lack of Efficacy|2|||
33586468|NCT01843673|102036282|FG000|Overall Study|Withdrawal by Subject|4|||
33586469|NCT00301262|102036285|FG000|Double Blind Phase (DB)|Adverse Event|1|||
33586470|NCT00301262|102036286|FG001|Double Blind Phase (DB)|Adverse Event|0|||
33586471|NCT00301262|102036285|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
33247345|NCT00359619|100806667|FG006|Overall Study|Withdrawal by Subject|3|||
33377630|NCT00764478|101269302|FG002|Overall Study|Protocol Violation|1|||
33377631|NCT03448224|101269303|FG000|Overall Study|Provided same answer to every question|1|||
33377632|NCT03448224|101269304|FG001|Overall Study|Provided same answer to every question|0|||
33377633|NCT00838916|101269306|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
33424279|NCT00382291|101446327|FG001|Overall Study|Temporary study suspension|2|||
33424280|NCT00382291|101446328|FG002|Overall Study|Temporary study suspension|5|||
33424281|NCT00382291|101446326|FG000|Overall Study|Withdrawal by Subject|0|||
33424282|NCT00382291|101446327|FG001|Overall Study|Withdrawal by Subject|2|||
33424283|NCT00382291|101446328|FG002|Overall Study|Withdrawal by Subject|0|||
33424284|NCT00382291|101446326|FG000|Overall Study|Physician Decision|0|||
33424285|NCT00382291|101446327|FG001|Overall Study|Physician Decision|1|||
33424286|NCT00382291|101446328|FG002|Overall Study|Physician Decision|0|||
33424287|NCT00382291|101446326|FG000|Overall Study|Lack of Efficacy|0|||
33424288|NCT00382291|101446327|FG001|Overall Study|Lack of Efficacy|0|||
33424289|NCT00382291|101446328|FG002|Overall Study|Lack of Efficacy|1|||
33424290|NCT01537549|101446329|FG000|Overall Study|Lost to Follow-up|1|||
33424291|NCT01537549|101446329|FG000|Overall Study|Withdrawal by Subject|2|||
33424292|NCT02629965|101446344|FG000|Period 1|Adverse Event|1|||
33424293|NCT02629965|101446345|FG001|Period 1|Adverse Event|0|||
33424294|NCT02629965|101446344|FG000|Period 1|Unexpected worsening of disease|2|||
33424295|NCT02629965|101446345|FG001|Period 1|Unexpected worsening of disease|0|||
33424296|NCT02629965|101446344|FG000|Period 1|Other than listed above|1|||
33424297|NCT02629965|101446345|FG001|Period 1|Other than listed above|2|||
33424298|NCT02629965|101446344|FG000|Period 2|Adverse Event|1|||
33586472|NCT00301262|102036286|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
33586473|NCT00301262|102036285|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
33586474|NCT00301262|102036286|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
33586475|NCT00301262|102036285|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
33247346|NCT00359619|100806661|FG000|Overall Study|Other|1|||
33247347|NCT00359619|100806662|FG001|Overall Study|Other|0|||
33247348|NCT00359619|100806663|FG002|Overall Study|Other|0|||
33247349|NCT00359619|100806664|FG003|Overall Study|Other|0|||
33377634|NCT00838916|101269307|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
33377635|NCT00838916|101269306|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
33377636|NCT00838916|101269307|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
33424299|NCT02629965|101446345|FG001|Period 2|Adverse Event|0|||
33586476|NCT00301262|102036286|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
33586477|NCT00301262|102036285|FG000|Double Blind Phase (DB)|Other|1|||
33586478|NCT00301262|102036286|FG001|Double Blind Phase (DB)|Other|4|||
33586479|NCT00301262|102036285|FG000|Open Label Phase (OL)|Adverse Event|1|||
33586480|NCT00301262|102036286|FG001|Open Label Phase (OL)|Adverse Event|0|||
33586481|NCT00301262|102036285|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
33586482|NCT00301262|102036286|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
33586483|NCT00301262|102036285|FG000|Open Label Phase (OL)|Other|2|||
33586484|NCT00301262|102036286|FG001|Open Label Phase (OL)|Other|0|||
33586485|NCT01301066|102036290|FG000|Overall Study|Lost to Follow-up|5|||
33586486|NCT01301066|102036291|FG001|Overall Study|Lost to Follow-up|11|||
33586487|NCT01301066|102036290|FG000|Overall Study|Protocol Violation|8|||
33586488|NCT01301066|102036291|FG001|Overall Study|Protocol Violation|7|||
33586489|NCT01301066|102036290|FG000|Overall Study|Withdrawal by Subject|4|||
33586490|NCT01301066|102036291|FG001|Overall Study|Withdrawal by Subject|9|||
33586491|NCT01301066|102036290|FG000|Overall Study|Adverse Event|6|||
33586492|NCT01301066|102036291|FG001|Overall Study|Adverse Event|6|||
33586493|NCT01301066|102036290|FG000|Overall Study|Sponsor Decision|2|||
33586494|NCT01301066|102036291|FG001|Overall Study|Sponsor Decision|1|||
33646472|NCT02078960|102259610|FG002|Treatment Period|Adverse Event|0|||
33646473|NCT02078960|102259608|FG000|Treatment Period|Death|0|||
33646474|NCT02078960|102259609|FG001|Treatment Period|Death|0|||
33646475|NCT02078960|102259610|FG002|Treatment Period|Death|1|||
33646476|NCT02078960|102259608|FG000|Follow-up Period|Death|2|||
33646477|NCT02078960|102259609|FG001|Follow-up Period|Death|0|||
33247350|NCT00359619|100806665|FG004|Overall Study|Other|0|||
33247351|NCT00359619|100806666|FG005|Overall Study|Other|0|||
33247352|NCT00359619|100806667|FG006|Overall Study|Other|0|||
33247353|NCT00359619|100806661|FG000|Overall Study|Lost to Follow-up|4|||
33247354|NCT00359619|100806662|FG001|Overall Study|Lost to Follow-up|4|||
33377637|NCT00838916|101269306|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
33377638|NCT00838916|101269307|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
33377639|NCT00838916|101269306|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
33424300|NCT04006847|101446346|FG000|Overall Study|Product issue|1|||
33424301|NCT00328783|101446349|FG000|Overall Study|Could not tolerate ABC|21|||
33424302|NCT00328783|101446349|FG000|Overall Study|No heart in RT field|4|||
33424303|NCT00328783|101446349|FG000|Overall Study|Withdrawal by Subject|1|||
33424304|NCT01225991|101446350|FG000|Overall Study|Withdrawal by Subject|6|||
33586495|NCT01301066|102036290|FG000|Overall Study|Physician Decision|0|||
33586496|NCT01301066|102036291|FG001|Overall Study|Physician Decision|1|||
33586497|NCT01301066|102036290|FG000|Overall Study|Other|2|||
33377640|NCT00838916|101269307|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
33377641|NCT00838916|101269306|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
33377642|NCT00838916|101269307|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
33377643|NCT00838916|101269306|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
33377644|NCT00838916|101269307|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
33377645|NCT00838916|101269306|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
33377646|NCT00838916|101269307|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
33377647|NCT00838916|101269306|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
33377648|NCT00838916|101269307|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
33377649|NCT00838916|101269306|FG000|Treatment Period (156 Weeks)|Missing|3|||
33377650|NCT00838916|101269307|FG001|Treatment Period (156 Weeks)|Missing|1|||
33377651|NCT00838916|101269306|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
33377652|NCT00838916|101269307|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
33377653|NCT00838916|101269306|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
33377654|NCT00838916|101269307|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
33377655|NCT00838916|101269306|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
33377656|NCT00838916|101269307|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
33377657|NCT00838916|101269306|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
33377658|NCT00838916|101269307|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
33424305|NCT00217971|101446353|FG000|Overall Study|Adverse Event|1|||
33424306|NCT00217971|101446354|FG001|Overall Study|Adverse Event|1|||
33586498|NCT01301066|102036291|FG001|Overall Study|Other|0|||
33586499|NCT02120781|102036292|FG000|Overall Study|Physician Decision|2|||
33586500|NCT02120781|102036293|FG001|Overall Study|Physician Decision|0|||
33586501|NCT02120781|102036292|FG000|Overall Study|Completion not documented|2|||
33247355|NCT00359619|100806663|FG002|Overall Study|Lost to Follow-up|2|||
33247356|NCT00359619|100806664|FG003|Overall Study|Lost to Follow-up|1|||
33646478|NCT02078960|102259610|FG002|Follow-up Period|Death|0|||
33148742|NCT00478881|100458259|FG000|Overall Study|Protocol Violation|2|||
33247357|NCT00359619|100806665|FG004|Overall Study|Lost to Follow-up|1|||
33247358|NCT00359619|100806666|FG005|Overall Study|Lost to Follow-up|5|||
33377659|NCT00838916|101269306|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
33377660|NCT00838916|101269307|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
33377661|NCT00838916|101269306|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
33646479|NCT02078960|102259608|FG000|Follow-up Period|Lost to Follow-up|0|||
33377662|NCT00838916|101269307|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
33377663|NCT00838916|101269306|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
33377664|NCT00838916|101269307|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
33377665|NCT00838916|101269306|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
33377666|NCT00838916|101269307|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
33377667|NCT00838916|101269306|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
33377668|NCT00838916|101269307|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
33377669|NCT00838916|101269306|FG000|Follow-up Period (8 Weeks)|Missing|3|||
33377670|NCT00838916|101269307|FG001|Follow-up Period (8 Weeks)|Missing|0|||
33377671|NCT04093258|101269308|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
33377672|NCT04093258|101269309|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
33377673|NCT01030458|101269312|FG000|Overall Study|Lost to Follow-up|9|||
33377674|NCT01030458|101269313|FG001|Overall Study|Lost to Follow-up|10|||
33377675|NCT01030458|101269312|FG000|Overall Study|Withdrawal by Subject|2|||
33377676|NCT01030458|101269313|FG001|Overall Study|Withdrawal by Subject|3|||
33377677|NCT01030458|101269312|FG000|Overall Study|Logistical reasons|9|||
33646480|NCT02078960|102259609|FG001|Follow-up Period|Lost to Follow-up|1|||
33148743|NCT00478881|100458260|FG001|Overall Study|Protocol Violation|2|||
33377678|NCT01030458|101269313|FG001|Overall Study|Logistical reasons|5|||
33424307|NCT00217971|101446353|FG000|Overall Study|Lost to Follow-up|15|||
33424308|NCT00217971|101446354|FG001|Overall Study|Lost to Follow-up|19|||
33424309|NCT00217971|101446353|FG000|Overall Study|Physician Decision|0|||
33424310|NCT00217971|101446354|FG001|Overall Study|Physician Decision|1|||
33377679|NCT01030458|101269312|FG000|Overall Study|Moved or changed job|6|||
33377680|NCT01030458|101269313|FG001|Overall Study|Moved or changed job|13|||
33377681|NCT01030458|101269312|FG000|Overall Study|Side effect of medication|1|||
33377682|NCT01030458|101269313|FG001|Overall Study|Side effect of medication|1|||
33377683|NCT02662985|101269315|FG000|Treatment Period 1|Adverse Event|0|||
33377684|NCT02662985|101269316|FG001|Treatment Period 1|Adverse Event|2|||
33377685|NCT02662985|101269315|FG000|Treatment Period 1|Protocol Violation|0|||
33377686|NCT02662985|101269316|FG001|Treatment Period 1|Protocol Violation|1|||
33377687|NCT02662985|101269315|FG000|Treatment Period 1|Physician Decision|1|||
33377688|NCT02662985|101269316|FG001|Treatment Period 1|Physician Decision|0|||
33377689|NCT02662985|101269315|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33377690|NCT02662985|101269316|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33377691|NCT02662985|101269315|FG000|Treatment Period 2|Lack of Efficacy|0|||
33377692|NCT02662985|101269316|FG001|Treatment Period 2|Lack of Efficacy|1|||
33377693|NCT02662985|101269315|FG000|Treatment Period 2|Lost to Follow-up|1|||
33377694|NCT02662985|101269316|FG001|Treatment Period 2|Lost to Follow-up|0|||
33377695|NCT02662985|101269315|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
33377696|NCT02662985|101269316|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
33377697|NCT02662985|101269315|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
33377698|NCT02662985|101269316|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
33377699|NCT02662985|101269315|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
33377700|NCT02662985|101269316|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
33377701|NCT02662985|101269315|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
33377702|NCT02662985|101269316|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
33377703|NCT02662985|101269315|FG000|Treatment Period 3 (Extension Period)|Death|0|||
33377704|NCT02662985|101269316|FG001|Treatment Period 3 (Extension Period)|Death|1|||
33377705|NCT03488251|101269317|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
33377706|NCT03488251|101269318|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
33377707|NCT03488251|101269319|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
33377708|NCT03488251|101269320|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
33377709|NCT03488251|101269317|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
33377710|NCT03488251|101269318|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
33377711|NCT03488251|101269319|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
33377712|NCT03488251|101269320|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
33377713|NCT03488251|101269317|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
33377714|NCT03488251|101269318|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
33424311|NCT00217971|101446353|FG000|Overall Study|Withdrawal by Subject|7|||
33424312|NCT00217971|101446354|FG001|Overall Study|Withdrawal by Subject|12|||
33424313|NCT00217971|101446353|FG000|Overall Study|non compliant|1|||
33424314|NCT00217971|101446354|FG001|Overall Study|non compliant|0|||
33424315|NCT01827371|101446355|FG000|Overall Study|Adverse Event|0|||
33424316|NCT01827371|101446356|FG001|Overall Study|Adverse Event|0|||
33377715|NCT03488251|101269319|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
33377716|NCT03488251|101269320|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
33377717|NCT03488251|101269317|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
33377718|NCT03488251|101269318|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
33424317|NCT01827371|101446357|FG002|Overall Study|Adverse Event|4|||
33377719|NCT03488251|101269319|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
33377720|NCT03488251|101269320|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
33377721|NCT03488251|101269317|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
33377722|NCT03488251|101269318|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
33377723|NCT03488251|101269319|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
33377724|NCT03488251|101269320|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
33377725|NCT00992784|101269321|FG000|Overall Study|Adverse Event|2|||
33377726|NCT00992784|101269322|FG001|Overall Study|Adverse Event|1|||
33377727|NCT00992784|101269323|FG002|Overall Study|Adverse Event|0|||
33377728|NCT00992784|101269321|FG000|Overall Study|Withdrawal by Subject|1|||
33377729|NCT00992784|101269322|FG001|Overall Study|Withdrawal by Subject|1|||
33377730|NCT00992784|101269323|FG002|Overall Study|Withdrawal by Subject|1|||
33377731|NCT03337152|101269329|FG000|Overall Study|Physician Decision|1|||
33377732|NCT03337152|101269330|FG001|Overall Study|Physician Decision|0|||
33377733|NCT03337152|101269329|FG000|Overall Study|Lost to Follow-up|1|||
33377734|NCT03337152|101269330|FG001|Overall Study|Lost to Follow-up|3|||
33377735|NCT03337152|101269329|FG000|Overall Study|Adverse Event|3|||
33377736|NCT03337152|101269330|FG001|Overall Study|Adverse Event|1|||
33377737|NCT03337152|101269329|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
33424318|NCT01827371|101446358|FG003|Overall Study|Adverse Event|2|||
33424319|NCT01827371|101446355|FG000|Overall Study|Lost to Follow-up|0|||
33424320|NCT01827371|101446356|FG001|Overall Study|Lost to Follow-up|2|||
33424321|NCT01827371|101446357|FG002|Overall Study|Lost to Follow-up|0|||
33424322|NCT01827371|101446358|FG003|Overall Study|Lost to Follow-up|4|||
33424323|NCT01827371|101446355|FG000|Overall Study|Protocol Violation|1|||
33424324|NCT01827371|101446356|FG001|Overall Study|Protocol Violation|0|||
33424325|NCT01827371|101446357|FG002|Overall Study|Protocol Violation|0|||
33424326|NCT01827371|101446358|FG003|Overall Study|Protocol Violation|0|||
33424327|NCT01827371|101446355|FG000|Overall Study|Withdrawal by Subject|1|||
33424328|NCT01827371|101446356|FG001|Overall Study|Withdrawal by Subject|2|||
33424329|NCT01827371|101446357|FG002|Overall Study|Withdrawal by Subject|2|||
33424330|NCT01827371|101446358|FG003|Overall Study|Withdrawal by Subject|3|||
33424331|NCT01827371|101446355|FG000|Overall Study|Physician Decision|0|||
33424332|NCT01827371|101446356|FG001|Overall Study|Physician Decision|1|||
33424333|NCT01827371|101446357|FG002|Overall Study|Physician Decision|0|||
33424334|NCT01827371|101446358|FG003|Overall Study|Physician Decision|1|||
33424335|NCT01827371|101446355|FG000|Overall Study|Temporary study halt to vaccinations|11|||
33424336|NCT01827371|101446356|FG001|Overall Study|Temporary study halt to vaccinations|2|||
33424337|NCT01827371|101446357|FG002|Overall Study|Temporary study halt to vaccinations|5|||
33424338|NCT01827371|101446358|FG003|Overall Study|Temporary study halt to vaccinations|13|||
33424339|NCT01484028|101446359|FG000|Period 1|Lost to Follow-up|0|||
33424340|NCT01484028|101446360|FG001|Period 1|Lost to Follow-up|1|||
33424341|NCT01484028|101446361|FG002|Period 1|Lost to Follow-up|0|||
33424342|NCT01484028|101446362|FG003|Period 1|Lost to Follow-up|0|||
33424343|NCT01484028|101446359|FG000|Period 1|Non-Compliance to Protocol|0|||
33424344|NCT01484028|101446360|FG001|Period 1|Non-Compliance to Protocol|1|||
33424345|NCT01484028|101446361|FG002|Period 1|Non-Compliance to Protocol|0|||
33424346|NCT01484028|101446362|FG003|Period 1|Non-Compliance to Protocol|1|||
33424347|NCT01484028|101446359|FG000|Period 1|Lens Discomfort|0|||
33424348|NCT01484028|101446360|FG001|Period 1|Lens Discomfort|1|||
33424349|NCT01484028|101446361|FG002|Period 1|Lens Discomfort|0|||
33424350|NCT01484028|101446362|FG003|Period 1|Lens Discomfort|0|||
33424351|NCT02082912|101446364|FG000|Overall Study|Physician Decision|0|||
33424352|NCT02082912|101446365|FG001|Overall Study|Physician Decision|1|||
33424353|NCT00591253|101446376|FG000|Overall Study|Adverse Event|3|||
33424354|NCT00591253|101446377|FG001|Overall Study|Adverse Event|3|||
33424355|NCT00591253|101446378|FG002|Overall Study|Adverse Event|1|||
33424356|NCT00591253|101446376|FG000|Overall Study|Protocol Violation|2|||
33424357|NCT00591253|101446377|FG001|Overall Study|Protocol Violation|2|||
33424358|NCT00591253|101446378|FG002|Overall Study|Protocol Violation|2|||
33424359|NCT00591253|101446376|FG000|Overall Study|Lost to Follow-up|2|||
33424360|NCT00591253|101446377|FG001|Overall Study|Lost to Follow-up|4|||
33424361|NCT00591253|101446378|FG002|Overall Study|Lost to Follow-up|0|||
33424362|NCT00591253|101446376|FG000|Overall Study|Withdrawal by Subject|1|||
33424363|NCT00591253|101446377|FG001|Overall Study|Withdrawal by Subject|7|||
33377738|NCT03337152|101269330|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
33424364|NCT00591253|101446378|FG002|Overall Study|Withdrawal by Subject|6|||
33377739|NCT00772382|101269333|FG000|Overall Study|Adverse Event|19|||
33377740|NCT00772382|101269333|FG000|Overall Study|Death|6|||
33377741|NCT00772382|101269333|FG000|Overall Study|Lack of Efficacy|4|||
33424365|NCT00591253|101446376|FG000|Overall Study|Lack of Efficacy|1|||
33424366|NCT00591253|101446377|FG001|Overall Study|Lack of Efficacy|0|||
33424367|NCT00591253|101446378|FG002|Overall Study|Lack of Efficacy|3|||
33424368|NCT00591253|101446376|FG000|Overall Study|Other|5|||
33377742|NCT00772382|101269333|FG000|Overall Study|Physician Decision|5|||
33424369|NCT00591253|101446377|FG001|Overall Study|Other|5|||
33424370|NCT00591253|101446378|FG002|Overall Study|Other|3|||
33424371|NCT01389024|101446379|FG000|Overall Study|Withdrawal by Subject|0|||
33424372|NCT01389024|101446380|FG001|Overall Study|Withdrawal by Subject|1|||
33424373|NCT01389024|101446379|FG000|Overall Study|Lost to Follow-up|1|||
33424374|NCT01389024|101446380|FG001|Overall Study|Lost to Follow-up|0|||
33424375|NCT02555618|101446381|FG000|Overall Study|Sponsor's Circumstances|1|||
33424376|NCT02555618|101446382|FG001|Overall Study|Sponsor's Circumstances|0|||
33424377|NCT00080288|101446387|FG000|Overall Study|Adverse Event|7|||
33424378|NCT00080288|101446388|FG001|Overall Study|Adverse Event|4|||
33424379|NCT00080288|101446387|FG000|Overall Study|Lost to Follow-up|3|||
33424380|NCT00080288|101446388|FG001|Overall Study|Lost to Follow-up|5|||
33424381|NCT00080288|101446387|FG000|Overall Study|Physician Decision|6|||
33424382|NCT00080288|101446388|FG001|Overall Study|Physician Decision|2|||
33424383|NCT00080288|101446387|FG000|Overall Study|Withdrawal by Subject|3|||
33424384|NCT00080288|101446388|FG001|Overall Study|Withdrawal by Subject|16|||
33424385|NCT00080288|101446387|FG000|Overall Study|Miscellaneous|11|||
33424386|NCT00080288|101446388|FG001|Overall Study|Miscellaneous|11|||
33424387|NCT04292171|101446389|FG000|Overall Study|Pharmacy error|2|||
33424388|NCT04292171|101446390|FG001|Overall Study|Pharmacy error|0|||
33424389|NCT04292171|101446389|FG000|Overall Study|Delivered prior to procedure|0|||
33424390|NCT04292171|101446390|FG001|Overall Study|Delivered prior to procedure|1|||
33424391|NCT02414854|101446391|FG000|Overall Study|Adverse Event|9|||
33424392|NCT02414854|101446392|FG001|Overall Study|Adverse Event|7|||
33424393|NCT02414854|101446393|FG002|Overall Study|Adverse Event|1|||
33424394|NCT02414854|101446394|FG003|Overall Study|Adverse Event|12|||
33424395|NCT02414854|101446391|FG000|Overall Study|Poor compliance to protocol|1|||
33424396|NCT02414854|101446392|FG001|Overall Study|Poor compliance to protocol|1|||
33424397|NCT02414854|101446393|FG002|Overall Study|Poor compliance to protocol|2|||
33424398|NCT02414854|101446394|FG003|Overall Study|Poor compliance to protocol|2|||
33424399|NCT02414854|101446391|FG000|Overall Study|Other than specified above|12|||
33424400|NCT02414854|101446392|FG001|Overall Study|Other than specified above|37|||
33424401|NCT02414854|101446393|FG002|Overall Study|Other than specified above|17|||
33424402|NCT02414854|101446394|FG003|Overall Study|Other than specified above|37|||
33424403|NCT03263819|101446395|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
33424404|NCT03263819|101446396|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
33424405|NCT00597584|101446397|FG000|Overall Study|Adverse Event|4|||
33424406|NCT00597584|101446398|FG001|Overall Study|Adverse Event|2|||
33424407|NCT00597584|101446397|FG000|Overall Study|Death|53|||
33424408|NCT00597584|101446398|FG001|Overall Study|Death|30|||
33424409|NCT00597584|101446397|FG000|Overall Study|Lack of Efficacy|1|||
33424410|NCT00597584|101446398|FG001|Overall Study|Lack of Efficacy|0|||
33424411|NCT00597584|101446397|FG000|Overall Study|Lost to Follow-up|2|||
33424412|NCT00597584|101446398|FG001|Overall Study|Lost to Follow-up|4|||
33424413|NCT00597584|101446397|FG000|Overall Study|Physician Decision|3|||
33424414|NCT00597584|101446398|FG001|Overall Study|Physician Decision|0|||
33424415|NCT00597584|101446397|FG000|Overall Study|Pregnancy|2|||
33424416|NCT00597584|101446398|FG001|Overall Study|Pregnancy|0|||
33424417|NCT00597584|101446397|FG000|Overall Study|Withdrawal by Subject|44|||
33424418|NCT00597584|101446398|FG001|Overall Study|Withdrawal by Subject|12|||
33424419|NCT00597584|101446397|FG000|Overall Study|Discontinued Dialysis|0|||
33586502|NCT02120781|102036293|FG001|Overall Study|Completion not documented|1|||
33377743|NCT00772382|101269333|FG000|Overall Study|Protocol Violation|1|||
33377744|NCT00772382|101269333|FG000|Overall Study|Withdrawal by Subject|10|||
33377745|NCT00772382|101269333|FG000|Overall Study|Other Reasons|10|||
33377746|NCT00229203|101269334|FG000|Overall Study|Progressive disease|18|||
33377747|NCT00229203|101269335|FG001|Overall Study|Progressive disease|9|||
33377748|NCT00229203|101269334|FG000|Overall Study|Toxicity|6|||
33377749|NCT00229203|101269335|FG001|Overall Study|Toxicity|1|||
33377750|NCT00229203|101269334|FG000|Overall Study|Death|4|||
33377751|NCT00229203|101269335|FG001|Overall Study|Death|2|||
33377752|NCT00229203|101269334|FG000|Overall Study|Other|3|||
33377753|NCT00229203|101269335|FG001|Overall Study|Other|3|||
33377754|NCT00229203|101269334|FG000|Overall Study|Withdrawal by Subject|1|||
33424420|NCT00597584|101446398|FG001|Overall Study|Discontinued Dialysis|1|||
33424421|NCT00597584|101446397|FG000|Overall Study|Lost ability to consent|1|||
33424422|NCT00597584|101446398|FG001|Overall Study|Lost ability to consent|1|||
33424423|NCT00597584|101446397|FG000|Overall Study|Never dosed|1|||
33424424|NCT00597584|101446398|FG001|Overall Study|Never dosed|0|||
33424425|NCT00597584|101446397|FG000|Overall Study|Relocation|8|||
33586503|NCT03850093|102036294|FG000|Overall Study|Withdrawal by Subject|1|||
33586504|NCT03850093|102036295|FG001|Overall Study|Withdrawal by Subject|0|||
33586505|NCT03850093|102036296|FG002|Overall Study|Withdrawal by Subject|2|||
33586506|NCT01188551|102036297|FG000|Overall Study|Pharmacy issues|1|||
33377755|NCT00229203|101269335|FG001|Overall Study|Withdrawal by Subject|4|||
33377756|NCT00479557|101269336|FG000|Overall Study|Death|0|||
33424426|NCT00597584|101446398|FG001|Overall Study|Relocation|6|||
33424427|NCT00597584|101446397|FG000|Overall Study|Renal transplant|9|||
33424428|NCT00597584|101446398|FG001|Overall Study|Renal transplant|7|||
33424429|NCT01796860|101446399|FG000|Overall Study|Withdrawal by Subject|3|||
33377757|NCT00479557|101269337|FG001|Overall Study|Death|0|||
33377758|NCT00479557|101269338|FG002|Overall Study|Death|0|||
33377759|NCT00479557|101269339|FG003|Overall Study|Death|0|||
33377760|NCT00479557|101269340|FG004|Overall Study|Death|0|||
33377761|NCT00479557|101269341|FG005|Overall Study|Death|1|||
33377762|NCT00479557|101269342|FG006|Overall Study|Death|0|||
33377763|NCT00479557|101269336|FG000|Overall Study|Lack of Efficacy|1|||
33377764|NCT00479557|101269337|FG001|Overall Study|Lack of Efficacy|0|||
33377765|NCT00479557|101269338|FG002|Overall Study|Lack of Efficacy|0|||
33377766|NCT00479557|101269339|FG003|Overall Study|Lack of Efficacy|0|||
33377767|NCT00479557|101269340|FG004|Overall Study|Lack of Efficacy|0|||
33377768|NCT00479557|101269341|FG005|Overall Study|Lack of Efficacy|0|||
33377769|NCT00479557|101269342|FG006|Overall Study|Lack of Efficacy|0|||
33377770|NCT00479557|101269336|FG000|Overall Study|Lost to Follow-up|0|||
33377771|NCT00479557|101269337|FG001|Overall Study|Lost to Follow-up|2|||
33377772|NCT00479557|101269338|FG002|Overall Study|Lost to Follow-up|0|||
33377773|NCT00479557|101269339|FG003|Overall Study|Lost to Follow-up|2|||
33377774|NCT00479557|101269340|FG004|Overall Study|Lost to Follow-up|0|||
33377775|NCT00479557|101269341|FG005|Overall Study|Lost to Follow-up|0|||
33377776|NCT00479557|101269342|FG006|Overall Study|Lost to Follow-up|0|||
33377777|NCT00479557|101269336|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
33377778|NCT00479557|101269337|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
33377779|NCT00479557|101269338|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
33377780|NCT00479557|101269339|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
33377781|NCT00479557|101269340|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
33424430|NCT00926289|101446400|FG000|Overall Study|Adverse Event|9|||
33424431|NCT00926289|101446401|FG001|Overall Study|Adverse Event|11|||
33377782|NCT00479557|101269341|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
33377783|NCT00479557|101269342|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
33377784|NCT00479557|101269336|FG000|Overall Study|AE not related to Study Drug|1|||
33377785|NCT00479557|101269337|FG001|Overall Study|AE not related to Study Drug|3|||
33377786|NCT00479557|101269338|FG002|Overall Study|AE not related to Study Drug|0|||
33377787|NCT00479557|101269339|FG003|Overall Study|AE not related to Study Drug|0|||
33377788|NCT00479557|101269340|FG004|Overall Study|AE not related to Study Drug|2|||
33377789|NCT00479557|101269341|FG005|Overall Study|AE not related to Study Drug|2|||
33377790|NCT00479557|101269342|FG006|Overall Study|AE not related to Study Drug|1|||
33377791|NCT00479557|101269336|FG000|Overall Study|Caregiver Request|2|||
33377792|NCT00479557|101269337|FG001|Overall Study|Caregiver Request|2|||
33377793|NCT00479557|101269338|FG002|Overall Study|Caregiver Request|2|||
33377794|NCT00479557|101269339|FG003|Overall Study|Caregiver Request|0|||
33377795|NCT00479557|101269340|FG004|Overall Study|Caregiver Request|1|||
33377796|NCT00479557|101269341|FG005|Overall Study|Caregiver Request|2|||
33377797|NCT00479557|101269342|FG006|Overall Study|Caregiver Request|0|||
33377798|NCT00479557|101269336|FG000|Overall Study|Investigator Request|0|||
33377799|NCT00479557|101269337|FG001|Overall Study|Investigator Request|0|||
33377800|NCT00479557|101269338|FG002|Overall Study|Investigator Request|1|||
33377801|NCT00479557|101269339|FG003|Overall Study|Investigator Request|0|||
33377802|NCT00479557|101269340|FG004|Overall Study|Investigator Request|0|||
33377803|NCT00479557|101269341|FG005|Overall Study|Investigator Request|0|||
33377804|NCT00479557|101269342|FG006|Overall Study|Investigator Request|0|||
33377805|NCT00479557|101269336|FG000|Overall Study|Subject Request|3|||
33377806|NCT00479557|101269337|FG001|Overall Study|Subject Request|0|||
33377807|NCT00479557|101269338|FG002|Overall Study|Subject Request|1|||
33377808|NCT00479557|101269339|FG003|Overall Study|Subject Request|1|||
33377809|NCT00479557|101269340|FG004|Overall Study|Subject Request|1|||
33377810|NCT00479557|101269341|FG005|Overall Study|Subject Request|4|||
33377811|NCT00479557|101269342|FG006|Overall Study|Subject Request|1|||
33377812|NCT00479557|101269336|FG000|Overall Study|Other|2|||
33377813|NCT00479557|101269337|FG001|Overall Study|Other|3|||
33424432|NCT00926289|101446400|FG000|Overall Study|Protocol Violation|8|||
33424433|NCT00926289|101446401|FG001|Overall Study|Protocol Violation|12|||
33247359|NCT00359619|100806667|FG006|Overall Study|Lost to Follow-up|0|||
33247360|NCT03601507|100806668|FG000|Overall Study|Adverse Event|1|||
33377814|NCT00479557|101269338|FG002|Overall Study|Other|1|||
33377815|NCT00479557|101269339|FG003|Overall Study|Other|0|||
33377816|NCT00479557|101269340|FG004|Overall Study|Other|0|||
33377817|NCT00479557|101269341|FG005|Overall Study|Other|3|||
33377818|NCT00479557|101269342|FG006|Overall Study|Other|0|||
33586507|NCT01188551|102036298|FG001|Overall Study|Pharmacy issues|0|||
33377819|NCT03814590|101269343|FG000|Overall Study|Adverse Event|0|||
33377820|NCT03814590|101269344|FG001|Overall Study|Adverse Event|0|||
33377821|NCT03814590|101269345|FG002|Overall Study|Adverse Event|0|||
33377822|NCT03814590|101269346|FG003|Overall Study|Adverse Event|0|||
33377823|NCT03814590|101269347|FG004|Overall Study|Adverse Event|0|||
33377824|NCT03814590|101269348|FG005|Overall Study|Adverse Event|1|||
33377825|NCT03814590|101269349|FG006|Overall Study|Adverse Event|1|||
33424434|NCT00926289|101446400|FG000|Overall Study|Lost to Follow-up|3|||
33247361|NCT03113487|100806669|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
33377826|NCT03814590|101269350|FG007|Overall Study|Adverse Event|1|||
33377827|NCT03814590|101269351|FG008|Overall Study|Adverse Event|0|||
33377828|NCT03814590|101269352|FG009|Overall Study|Adverse Event|0|||
33377829|NCT03814590|101269353|FG010|Overall Study|Adverse Event|1|||
33377830|NCT03814590|101269354|FG011|Overall Study|Adverse Event|0|||
33377831|NCT03814590|101269355|FG012|Overall Study|Adverse Event|3|||
33377832|NCT03814590|101269356|FG013|Overall Study|Adverse Event|0|||
33377833|NCT03814590|101269343|FG000|Overall Study|Lost to Follow-up|0|||
33377834|NCT03814590|101269344|FG001|Overall Study|Lost to Follow-up|2|||
33377835|NCT03814590|101269345|FG002|Overall Study|Lost to Follow-up|1|||
33377836|NCT03814590|101269346|FG003|Overall Study|Lost to Follow-up|0|||
33377837|NCT03814590|101269347|FG004|Overall Study|Lost to Follow-up|1|||
33377838|NCT03814590|101269348|FG005|Overall Study|Lost to Follow-up|1|||
33377839|NCT03814590|101269349|FG006|Overall Study|Lost to Follow-up|1|||
33377840|NCT03814590|101269350|FG007|Overall Study|Lost to Follow-up|1|||
33377841|NCT03814590|101269351|FG008|Overall Study|Lost to Follow-up|0|||
33424435|NCT00926289|101446401|FG001|Overall Study|Lost to Follow-up|6|||
33424436|NCT00926289|101446400|FG000|Overall Study|Withdrawal by Subject|4|||
33424437|NCT00926289|101446401|FG001|Overall Study|Withdrawal by Subject|4|||
33424438|NCT00926289|101446400|FG000|Overall Study|Other|1|||
33424439|NCT00926289|101446401|FG001|Overall Study|Other|3|||
33424440|NCT02217345|101446402|FG000|Overall Study|Lost to Follow-up|2|||
33424441|NCT02217345|101446403|FG001|Overall Study|Lost to Follow-up|1|||
33424442|NCT02217345|101446402|FG000|Overall Study|Withdrawal by Subject|3|||
33424443|NCT02217345|101446403|FG001|Overall Study|Withdrawal by Subject|2|||
33424444|NCT02217345|101446402|FG000|Overall Study|Adverse Event|2|||
33424445|NCT02217345|101446403|FG001|Overall Study|Adverse Event|1|||
33424446|NCT02217345|101446402|FG000|Overall Study|Physician Decision|0|||
33424447|NCT02217345|101446403|FG001|Overall Study|Physician Decision|1|||
33586508|NCT01188551|102036299|FG002|Overall Study|Pharmacy issues|0|||
33586509|NCT01188551|102036300|FG003|Overall Study|Pharmacy issues|0|||
33586510|NCT02798315|102036313|FG000|Overall Study|Failure to return|1|||
33586511|NCT04644276|102036315|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
33586512|NCT04644276|102036316|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
33377842|NCT03814590|101269352|FG009|Overall Study|Lost to Follow-up|0|||
33377843|NCT03814590|101269353|FG010|Overall Study|Lost to Follow-up|1|||
33377844|NCT03814590|101269354|FG011|Overall Study|Lost to Follow-up|0|||
33377845|NCT03814590|101269355|FG012|Overall Study|Lost to Follow-up|0|||
33377846|NCT03814590|101269356|FG013|Overall Study|Lost to Follow-up|1|||
33377847|NCT03814590|101269343|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33377848|NCT03814590|101269344|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33377849|NCT03814590|101269345|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33377850|NCT03814590|101269346|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33377851|NCT03814590|101269347|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33377852|NCT03814590|101269348|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33377853|NCT03814590|101269349|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33377854|NCT03814590|101269350|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33377855|NCT03814590|101269351|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33377856|NCT03814590|101269352|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
33377857|NCT03814590|101269353|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33377858|NCT03814590|101269354|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33377859|NCT03814590|101269355|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33377860|NCT03814590|101269356|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
33377861|NCT03814590|101269343|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
33377862|NCT03814590|101269344|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
33377863|NCT03814590|101269345|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
33377864|NCT03814590|101269346|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
33377865|NCT03814590|101269347|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
33424448|NCT04071366|101446404|FG000|Part 1: Open-label (29 Days)|Death|4|||
33586513|NCT04644276|102036317|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
33586514|NCT01437111|102036318|FG000|Overall Study|Adverse Event|2|||
33586515|NCT01437111|102036318|FG000|Overall Study|Withdrawal by Subject|4|||
33586516|NCT01437111|102036318|FG000|Overall Study|Not reported|5|||
33586517|NCT01437111|102036318|FG000|Overall Study|Physician Decision|1|||
33586518|NCT01437111|102036318|FG000|Overall Study|Lost to Follow-up|5|||
33424449|NCT04071366|101446405|FG001|Part 1: Open-label (29 Days)|Death|2|||
33424450|NCT04071366|101446406|FG002|Part 1: Open-label (29 Days)|Death|8|||
33424451|NCT04071366|101446407|FG003|Part 1: Open-label (29 Days)|Death|0|||
33424452|NCT04071366|101446408|FG004|Part 1: Open-label (29 Days)|Death|0|||
33424453|NCT04071366|101446404|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
33424454|NCT04071366|101446405|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
33424455|NCT04071366|101446406|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
33424456|NCT04071366|101446407|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
33424457|NCT04071366|101446408|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
33424458|NCT04071366|101446404|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
33424459|NCT04071366|101446405|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
33424460|NCT04071366|101446406|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
33424461|NCT04071366|101446407|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
33424462|NCT04071366|101446408|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
33646481|NCT02078960|102259610|FG002|Follow-up Period|Lost to Follow-up|0|||
33424463|NCT04071366|101446404|FG000|Part 2: Randomized (29 Days)|Death|0|||
33424464|NCT04071366|101446405|FG001|Part 2: Randomized (29 Days)|Death|0|||
33424465|NCT04071366|101446406|FG002|Part 2: Randomized (29 Days)|Death|0|||
33424466|NCT04071366|101446407|FG003|Part 2: Randomized (29 Days)|Death|2|||
33424467|NCT04071366|101446408|FG004|Part 2: Randomized (29 Days)|Death|2|||
33377866|NCT03814590|101269348|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
33377867|NCT03814590|101269349|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
33377868|NCT03814590|101269350|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
33377869|NCT03814590|101269351|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
33377870|NCT03814590|101269352|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
33377871|NCT03814590|101269353|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
33377872|NCT03814590|101269354|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
33377873|NCT03814590|101269355|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
33377874|NCT03814590|101269356|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
33377875|NCT03814590|101269343|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33424468|NCT04071366|101446404|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
33424469|NCT04071366|101446405|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
33424470|NCT04071366|101446406|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
33424471|NCT04071366|101446407|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
33424472|NCT04071366|101446408|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
33424473|NCT04071366|101446404|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
33424474|NCT04071366|101446405|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
33424475|NCT04071366|101446406|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
33424476|NCT04071366|101446407|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
33424477|NCT04071366|101446408|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
33424478|NCT04071366|101446404|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
33424479|NCT04071366|101446405|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
33377876|NCT03814590|101269344|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33377877|NCT03814590|101269345|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33377878|NCT03814590|101269346|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33377879|NCT03814590|101269347|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33377880|NCT03814590|101269348|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33377881|NCT03814590|101269349|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33377882|NCT03814590|101269350|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33377883|NCT03814590|101269351|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33377884|NCT03814590|101269352|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33377885|NCT03814590|101269353|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33377886|NCT03814590|101269354|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33377887|NCT03814590|101269355|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33424480|NCT04071366|101446406|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
33424481|NCT04071366|101446407|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
33424482|NCT04071366|101446408|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
33424483|NCT04071366|101446404|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
33424484|NCT04071366|101446405|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
33424485|NCT04071366|101446406|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
33424486|NCT04071366|101446407|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
33646482|NCT00653939|102259611|FG000|Overall Study|Adverse Event|1|||
33646483|NCT00653939|102259612|FG001|Overall Study|Adverse Event|3|||
33646484|NCT00653939|102259611|FG000|Overall Study|Withdrawal by Subject|3|||
33424487|NCT04071366|101446408|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
33424488|NCT04071366|101446404|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
33424489|NCT04071366|101446405|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
33586519|NCT01437111|102036318|FG000|Overall Study|Protocol Violation|1|||
33646485|NCT00653939|102259612|FG001|Overall Study|Withdrawal by Subject|3|||
33646486|NCT00653939|102259611|FG000|Overall Study|Physician Decision|4|||
33646487|NCT00653939|102259612|FG001|Overall Study|Physician Decision|0|||
33424490|NCT04071366|101446406|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
33424491|NCT04071366|101446407|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
33424492|NCT04071366|101446408|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
33424493|NCT04071366|101446404|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
33424494|NCT04071366|101446405|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
33424495|NCT04071366|101446406|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
33424496|NCT04071366|101446407|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
33424497|NCT04071366|101446408|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
33424498|NCT00320593|101446409|FG000|Overall Study|Lost to Follow-up|3|||
33424499|NCT00320593|101446410|FG001|Overall Study|Lost to Follow-up|0|||
33424500|NCT00320593|101446409|FG000|Overall Study|Moved to another state|1|||
33586520|NCT02817594|102036319|FG000|Overall Study|Withdrawal by Subject|1|||
33586521|NCT02817594|102036319|FG000|Overall Study|Other|1|||
33586522|NCT02817594|102036319|FG000|Overall Study|Did Not Receive Treatment|1|||
33586523|NCT02858440|102036320|FG000|Overall Study|Lost to Follow-up|3|||
33586524|NCT02858440|102036320|FG000|Overall Study|Protocol Violation|2|||
33586525|NCT02858440|102036320|FG000|Overall Study|Consent withdrawal|3|||
33586526|NCT02858440|102036320|FG000|Overall Study|Migrated/moved from study area|4|||
33586527|NCT00005947|102036323|FG000|Overall Study|Death|54|||
33586528|NCT00005947|102036324|FG001|Overall Study|Death|40|||
33586529|NCT00005947|102036323|FG000|Overall Study|Patient Refused to Continue|2|||
33586530|NCT00005947|102036324|FG001|Overall Study|Patient Refused to Continue|1|||
33247362|NCT04304534|100806670|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
33247363|NCT04304534|100806671|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
33247364|NCT04304534|100806672|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
33247365|NCT04304534|100806673|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
33247366|NCT04304534|100806670|FG000|Overall Study|Non-Compliance with study drug|0|||
33247367|NCT04304534|100806671|FG001|Overall Study|Non-Compliance with study drug|1|||
33247368|NCT04304534|100806672|FG002|Overall Study|Non-Compliance with study drug|1|||
33247369|NCT04304534|100806673|FG003|Overall Study|Non-Compliance with study drug|1|||
33247370|NCT04304534|100806670|FG000|Overall Study|Lost to Follow-up|0|||
33247371|NCT04304534|100806671|FG001|Overall Study|Lost to Follow-up|1|||
33586531|NCT00005947|102036323|FG000|Overall Study|Site Closure|1|||
33586532|NCT00005947|102036324|FG001|Overall Study|Site Closure|0|||
33247372|NCT04304534|100806672|FG002|Overall Study|Lost to Follow-up|2|||
33247373|NCT04304534|100806673|FG003|Overall Study|Lost to Follow-up|3|||
33247374|NCT04304534|100806670|FG000|Overall Study|Unspecific|4|||
33247375|NCT04304534|100806671|FG001|Overall Study|Unspecific|2|||
33247376|NCT04304534|100806672|FG002|Overall Study|Unspecific|2|||
33247377|NCT04304534|100806673|FG003|Overall Study|Unspecific|2|||
33247378|NCT04304534|100806670|FG000|Overall Study|Technical Problems|2|||
33247379|NCT04304534|100806671|FG001|Overall Study|Technical Problems|2|||
33247380|NCT04304534|100806672|FG002|Overall Study|Technical Problems|3|||
33247381|NCT04304534|100806673|FG003|Overall Study|Technical Problems|4|||
33247382|NCT04304534|100806670|FG000|Overall Study|Death|7|||
33247383|NCT04304534|100806671|FG001|Overall Study|Death|2|||
33247384|NCT04304534|100806672|FG002|Overall Study|Death|4|||
33247385|NCT04304534|100806673|FG003|Overall Study|Death|3|||
33247386|NCT04304534|100806670|FG000|Overall Study|Withdrawal by Subject|7|||
33247387|NCT04304534|100806671|FG001|Overall Study|Withdrawal by Subject|2|||
33377888|NCT03814590|101269356|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33377889|NCT03814590|101269343|FG000|Overall Study|UNKNOWN REASON|0|||
33377890|NCT03814590|101269344|FG001|Overall Study|UNKNOWN REASON|0|||
33377891|NCT03814590|101269345|FG002|Overall Study|UNKNOWN REASON|0|||
33377892|NCT03814590|101269346|FG003|Overall Study|UNKNOWN REASON|0|||
33377893|NCT03814590|101269347|FG004|Overall Study|UNKNOWN REASON|0|||
33377894|NCT03814590|101269348|FG005|Overall Study|UNKNOWN REASON|0|||
33377895|NCT03814590|101269349|FG006|Overall Study|UNKNOWN REASON|0|||
33377896|NCT03814590|101269350|FG007|Overall Study|UNKNOWN REASON|1|||
33377897|NCT03814590|101269351|FG008|Overall Study|UNKNOWN REASON|0|||
33377898|NCT03814590|101269352|FG009|Overall Study|UNKNOWN REASON|0|||
33377899|NCT03814590|101269353|FG010|Overall Study|UNKNOWN REASON|0|||
33424501|NCT00320593|101446410|FG001|Overall Study|Moved to another state|0|||
33424502|NCT00320593|101446409|FG000|Overall Study|Withdrawal by Subject|2|||
33586533|NCT03818607|102036325|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
33586534|NCT03818607|102036326|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
33586535|NCT03818607|102036325|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
33586536|NCT03818607|102036326|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
33586537|NCT03818607|102036325|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
33247388|NCT04304534|100806672|FG002|Overall Study|Withdrawal by Subject|7|||
33377900|NCT03814590|101269354|FG011|Overall Study|UNKNOWN REASON|0|||
33247389|NCT04304534|100806673|FG003|Overall Study|Withdrawal by Subject|4|||
33247390|NCT04304534|100806670|FG000|Overall Study|Physician Decision|4|||
33377901|NCT03814590|101269355|FG012|Overall Study|UNKNOWN REASON|0|||
33424503|NCT00320593|101446410|FG001|Overall Study|Withdrawal by Subject|1|||
33377902|NCT03814590|101269356|FG013|Overall Study|UNKNOWN REASON|0|||
33377903|NCT01895452|101269361|FG000|Overall Study|Adverse Event|1|||
33377904|NCT01895452|101269362|FG001|Overall Study|Adverse Event|4|||
33377905|NCT01895452|101269361|FG000|Overall Study|Lost to Follow-up|1|||
33377906|NCT01895452|101269362|FG001|Overall Study|Lost to Follow-up|5|||
33377907|NCT01895452|101269361|FG000|Overall Study|Pregnancy|0|||
33377908|NCT01895452|101269362|FG001|Overall Study|Pregnancy|1|||
33377909|NCT01895452|101269361|FG000|Overall Study|Withdrawal by Subject|2|||
33377910|NCT01895452|101269362|FG001|Overall Study|Withdrawal by Subject|14|||
33377911|NCT01895452|101269361|FG000|Overall Study|Underlying disease|0|||
33377912|NCT01895452|101269362|FG001|Overall Study|Underlying disease|3|||
33377913|NCT01895452|101269361|FG000|Overall Study|Noncompliance with study drug|0|||
33377914|NCT01895452|101269362|FG001|Overall Study|Noncompliance with study drug|1|||
33377915|NCT03137121|101269363|FG000|Overall Study|Withdrawal by Subject|0|||
33377916|NCT03137121|101269364|FG001|Overall Study|Withdrawal by Subject|1|||
33377917|NCT03521193|101269375|FG000|Overall Study|Withdrawal by Subject|8|||
33377918|NCT03521193|101269376|FG001|Overall Study|Withdrawal by Subject|0|||
33377919|NCT03521193|101269375|FG000|Overall Study|non compliant to ASA treatment|8|||
33377920|NCT03521193|101269376|FG001|Overall Study|non compliant to ASA treatment|0|||
33377921|NCT01969799|101269377|FG000|Overall Study|Adverse Event|0|||
33377922|NCT01969799|101269378|FG001|Overall Study|Adverse Event|1|||
33377923|NCT01969799|101269377|FG000|Overall Study|Death|16|||
33377924|NCT01969799|101269378|FG001|Overall Study|Death|11|||
33377925|NCT01969799|101269377|FG000|Overall Study|Lost to Follow-up|0|||
33377926|NCT01969799|101269378|FG001|Overall Study|Lost to Follow-up|2|||
33377927|NCT01969799|101269377|FG000|Overall Study|Physician Decision|1|||
33377928|NCT01969799|101269378|FG001|Overall Study|Physician Decision|0|||
33377929|NCT00305253|101269379|FG000|Overall Study|Withdrawal by Subject|0|||
33377930|NCT00305253|101269380|FG001|Overall Study|Withdrawal by Subject|1|||
33377931|NCT00511342|101269382|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
33377932|NCT00511342|101269383|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
33377933|NCT00511342|101269382|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
33377934|NCT00511342|101269383|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
33377935|NCT00511342|101269382|FG000|Overall Study|Pregnancy|0|||
33377936|NCT00511342|101269383|FG001|Overall Study|Pregnancy|1|||
33377937|NCT00511342|101269382|FG000|Overall Study|Pregnancy wish|0|||
33377938|NCT00511342|101269383|FG001|Overall Study|Pregnancy wish|1|||
33424504|NCT00320593|101446409|FG000|Overall Study|Withdrawal by clinical center|1|||
33424505|NCT00320593|101446410|FG001|Overall Study|Withdrawal by clinical center|0|||
33424506|NCT02746705|101446411|FG000|Overall Study|Physician Decision|1|||
33424507|NCT02746705|101446412|FG001|Overall Study|Physician Decision|1|||
33586538|NCT03818607|102036326|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
33586539|NCT03994211|102036327|FG000|Core Phase|Adverse Event|0|||
33586540|NCT03994211|102036328|FG001|Core Phase|Adverse Event|1|||
33586541|NCT03994211|102036329|FG002|Core Phase|Adverse Event|0|||
33586542|NCT03994211|102036327|FG000|Extension Phase|Adverse Event|0|||
33586543|NCT03994211|102036328|FG001|Extension Phase|Adverse Event|0|||
33586544|NCT03994211|102036329|FG002|Extension Phase|Adverse Event|1|||
33586545|NCT03994211|102036327|FG000|Extension Phase|Physician Decision|0|||
33586546|NCT03994211|102036328|FG001|Extension Phase|Physician Decision|0|||
33586547|NCT03994211|102036329|FG002|Extension Phase|Physician Decision|1|||
33586548|NCT03994211|102036327|FG000|Extension Phase|Progressive Disease|0|||
33586549|NCT03994211|102036328|FG001|Extension Phase|Progressive Disease|0|||
33586550|NCT03994211|102036329|FG002|Extension Phase|Progressive Disease|20|||
33586551|NCT03994211|102036327|FG000|Extension Phase|Withdrawal by Subject|0|||
33586552|NCT03994211|102036328|FG001|Extension Phase|Withdrawal by Subject|0|||
33586553|NCT03994211|102036329|FG002|Extension Phase|Withdrawal by Subject|2|||
33586554|NCT05040971|102036334|FG000|Overall Study|Withdrawal by Subject|0|||
33586555|NCT05040971|102036335|FG001|Overall Study|Withdrawal by Subject|2|||
33148744|NCT00478881|100458259|FG000|Overall Study|Withdrawal by Subject|6|||
33377939|NCT00511342|101269382|FG000|Overall Study|Lost to Follow-up|1|||
33377940|NCT00511342|101269383|FG001|Overall Study|Lost to Follow-up|5|||
33377941|NCT00511342|101269382|FG000|Overall Study|Other Reason|2|||
33377942|NCT00511342|101269383|FG001|Overall Study|Other Reason|2|||
33377943|NCT01114373|101269384|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
33586556|NCT05040971|102036334|FG000|Overall Study|Lost to Follow-up|8|||
33586557|NCT05040971|102036335|FG001|Overall Study|Lost to Follow-up|3|||
33586558|NCT05040971|102036334|FG000|Overall Study|Death|2|||
33586559|NCT05040971|102036335|FG001|Overall Study|Death|0|||
33586560|NCT02091362|102036336|FG000|Period 1|Protocol Violation|1|||
33586561|NCT02091362|102036337|FG001|Period 1|Protocol Violation|0|||
33148745|NCT00478881|100458260|FG001|Overall Study|Withdrawal by Subject|2|||
33377944|NCT01114373|101269385|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
33377945|NCT01114373|101269384|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
33424508|NCT02746705|101446411|FG000|Overall Study|Lost to Follow-up|1|||
33586562|NCT02091362|102036336|FG000|Period 1|Withdrawal by Subject|2|||
33586563|NCT02091362|102036337|FG001|Period 1|Withdrawal by Subject|3|||
33586564|NCT02091362|102036336|FG000|Period 1|Lost to Follow-up|0|||
33424509|NCT02746705|101446412|FG001|Overall Study|Lost to Follow-up|0|||
33424510|NCT02746705|101446411|FG000|Overall Study|outlier scores deemed not valid|0|||
33424511|NCT02746705|101446412|FG001|Overall Study|outlier scores deemed not valid|1|||
33424512|NCT03070431|101446413|FG000|Overall Study|Withdrawal by Subject|2|||
33377946|NCT01114373|101269385|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
33377947|NCT01114373|101269384|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
33377948|NCT01114373|101269385|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
33377949|NCT01114373|101269384|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
33377950|NCT01114373|101269385|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
33377951|NCT01124448|101269390|FG000|Overall Study|Lost to Follow-up|0|||
33424513|NCT03070431|101446413|FG000|Overall Study|Lost to Follow-up|2|||
33424514|NCT01190098|101446416|FG000|Overall Study|Adverse Event|2|||
33424515|NCT01190098|101446417|FG001|Overall Study|Adverse Event|0|||
33424516|NCT01190098|101446416|FG000|Overall Study|Patient coomorbidity|0|||
33424517|NCT01190098|101446417|FG001|Overall Study|Patient coomorbidity|1|||
33424518|NCT01190098|101446416|FG000|Overall Study|Lack of transportation|1|||
33586565|NCT02091362|102036337|FG001|Period 1|Lost to Follow-up|1|||
33586566|NCT02091362|102036336|FG000|Period 1|Adverse Event|2|||
33586567|NCT02091362|102036337|FG001|Period 1|Adverse Event|0|||
33586568|NCT02091362|102036336|FG000|Wash-out|Lost to Follow-up|1|||
33586569|NCT02091362|102036337|FG001|Wash-out|Lost to Follow-up|1|||
33586570|NCT02091362|102036336|FG000|Wash-out|Withdrawal by Subject|0|||
33586571|NCT02091362|102036337|FG001|Wash-out|Withdrawal by Subject|2|||
33586572|NCT02091362|102036336|FG000|Period 2|Adverse Event|1|||
33586573|NCT02091362|102036337|FG001|Period 2|Adverse Event|0|||
33646488|NCT00653939|102259611|FG000|Overall Study|Disease Progression|2|||
33646489|NCT00653939|102259612|FG001|Overall Study|Disease Progression|3|||
33646490|NCT00653939|102259611|FG000|Overall Study|Other|2|||
33646491|NCT00653939|102259612|FG001|Overall Study|Other|6|||
33646492|NCT02034409|102259613|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
33377952|NCT01124448|101269391|FG001|Overall Study|Lost to Follow-up|3|||
33377953|NCT01124448|101269390|FG000|Overall Study|Protocol Violation|2|||
33377954|NCT01124448|101269391|FG001|Overall Study|Protocol Violation|0|||
33377955|NCT01885078|101269392|FG000|Treatment Period|Adverse Event|52|||
33377956|NCT01885078|101269393|FG001|Treatment Period|Adverse Event|136|||
33377957|NCT01885078|101269394|FG002|Treatment Period|Adverse Event|30|||
33377958|NCT01885078|101269395|FG003|Treatment Period|Adverse Event|73|||
33377959|NCT01885078|101269396|FG004|Treatment Period|Adverse Event|17|||
33377960|NCT01885078|101269397|FG005|Treatment Period|Adverse Event|72|||
33377961|NCT01885078|101269398|FG006|Treatment Period|Adverse Event|24|||
33377962|NCT01885078|101269399|FG007|Treatment Period|Adverse Event|5|||
33377963|NCT01885078|101269400|FG008|Treatment Period|Adverse Event|0|||
33377964|NCT01885078|101269401|FG009|Treatment Period|Adverse Event|0|||
33377965|NCT01885078|101269392|FG000|Treatment Period|Death|13|||
33377966|NCT01885078|101269393|FG001|Treatment Period|Death|33|||
33377967|NCT01885078|101269394|FG002|Treatment Period|Death|5|||
33377968|NCT01885078|101269395|FG003|Treatment Period|Death|9|||
33377969|NCT01885078|101269396|FG004|Treatment Period|Death|2|||
33377970|NCT01885078|101269397|FG005|Treatment Period|Death|10|||
33377971|NCT01885078|101269398|FG006|Treatment Period|Death|3|||
33377972|NCT01885078|101269399|FG007|Treatment Period|Death|2|||
33377973|NCT01885078|101269400|FG008|Treatment Period|Death|0|||
33377974|NCT01885078|101269401|FG009|Treatment Period|Death|0|||
33377975|NCT01885078|101269392|FG000|Treatment Period|Lack of Efficacy|12|||
33377976|NCT01885078|101269393|FG001|Treatment Period|Lack of Efficacy|33|||
33377977|NCT01885078|101269394|FG002|Treatment Period|Lack of Efficacy|10|||
33377978|NCT01885078|101269395|FG003|Treatment Period|Lack of Efficacy|23|||
33377979|NCT01885078|101269396|FG004|Treatment Period|Lack of Efficacy|24|||
33377980|NCT01885078|101269397|FG005|Treatment Period|Lack of Efficacy|58|||
33377981|NCT01885078|101269398|FG006|Treatment Period|Lack of Efficacy|9|||
33377982|NCT01885078|101269399|FG007|Treatment Period|Lack of Efficacy|5|||
33586574|NCT02091362|102036336|FG000|Period 2|Lost to Follow-up|0|||
33646493|NCT02034409|102259614|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
33646494|NCT02034409|102259613|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
33377983|NCT01885078|101269400|FG008|Treatment Period|Lack of Efficacy|0|||
33377984|NCT01885078|101269401|FG009|Treatment Period|Lack of Efficacy|0|||
33377985|NCT01885078|101269392|FG000|Treatment Period|Lost to Follow-up|16|||
33377986|NCT01885078|101269393|FG001|Treatment Period|Lost to Follow-up|19|||
33377987|NCT01885078|101269394|FG002|Treatment Period|Lost to Follow-up|7|||
33377988|NCT01885078|101269395|FG003|Treatment Period|Lost to Follow-up|9|||
33377989|NCT01885078|101269396|FG004|Treatment Period|Lost to Follow-up|2|||
33424519|NCT01190098|101446417|FG001|Overall Study|Lack of transportation|0|||
33586575|NCT02091362|102036337|FG001|Period 2|Lost to Follow-up|1|||
33424520|NCT01190098|101446416|FG000|Overall Study|Other|0|||
33586576|NCT02091362|102036336|FG000|Period 2|Withdrawal by Subject|1|||
33377990|NCT01885078|101269397|FG005|Treatment Period|Lost to Follow-up|8|||
33424521|NCT01190098|101446417|FG001|Overall Study|Other|1|||
33586577|NCT02091362|102036337|FG001|Period 2|Withdrawal by Subject|1|||
33646495|NCT02034409|102259614|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
33586578|NCT00889603|102036338|FG000|Overall Study|Adverse Event|7|||
33586579|NCT00889603|102036338|FG000|Overall Study|Death|3|||
33586580|NCT00889603|102036338|FG000|Overall Study|Lost to Follow-up|19|||
33586581|NCT00889603|102036338|FG000|Overall Study|No longer willing to participant in stud|4|||
33586582|NCT00889603|102036338|FG000|Overall Study|Other|4|||
33586583|NCT02438683|102036339|FG000|Overall Study|Adverse Event|1|||
33586584|NCT02438683|102036340|FG001|Overall Study|Adverse Event|0|||
33586585|NCT02438683|102036341|FG002|Overall Study|Adverse Event|0|||
33586586|NCT02438683|102036342|FG003|Overall Study|Adverse Event|0|||
33586587|NCT02438683|102036343|FG004|Overall Study|Adverse Event|0|||
33586588|NCT02438683|102036344|FG005|Overall Study|Adverse Event|0|||
33586589|NCT02253433|102036345|FG000|Overall Study|Unable to Contact|9|||
33586590|NCT02253433|102036346|FG001|Overall Study|Unable to Contact|16|||
33586591|NCT02253433|102036345|FG000|Overall Study|Death|1|||
33586592|NCT02253433|102036346|FG001|Overall Study|Death|1|||
33646496|NCT02034409|102259613|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
33646497|NCT02034409|102259614|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
33646498|NCT02034409|102259613|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
33646499|NCT02034409|102259614|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
33646500|NCT02034409|102259613|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
33646501|NCT02034409|102259614|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
33646502|NCT02034409|102259613|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
33646503|NCT02034409|102259614|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
33646504|NCT00228553|102259617|FG000|Overall Study|Adverse Event|112|||
33646505|NCT00228553|102259617|FG000|Overall Study|Lack of Efficacy|34|||
33646506|NCT00228553|102259617|FG000|Overall Study|Lost to Follow-up|67|||
33646507|NCT00228553|102259617|FG000|Overall Study|Physician Decision|48|||
33646508|NCT00228553|102259617|FG000|Overall Study|Protocol Violation|6|||
33646509|NCT00228553|102259617|FG000|Overall Study|Withdrawal by Subject|115|||
33646510|NCT00228553|102259617|FG000|Overall Study|Pregnancy|2|||
33646511|NCT00228553|102259617|FG000|Overall Study|Miscellaneous|46|||
33646512|NCT00759564|102259618|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
33646513|NCT00759564|102259619|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
33646514|NCT00759564|102259620|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
33646515|NCT00759564|102259621|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
33646516|NCT00759564|102259622|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
33646517|NCT00591318|102259623|FG000|Overall Study|Lack of Efficacy|2|||
33646518|NCT00591318|102259624|FG001|Overall Study|Lack of Efficacy|0|||
33646519|NCT00591318|102259623|FG000|Overall Study|Adverse Event|2|||
33646520|NCT00591318|102259624|FG001|Overall Study|Adverse Event|0|||
33646521|NCT00781885|102259627|FG000|Overall Study|Physician Decision|1|||
33646522|NCT04556383|102259628|FG000|PCP|Lack of Efficacy|28|||
33646523|NCT04556383|102259629|FG001|PCP|Lack of Efficacy|23|||
33646524|NCT04556383|102259630|FG002|PCP|Lack of Efficacy|23|||
33646525|NCT04556383|102259631|FG003|PCP|Lack of Efficacy|0|||
33646526|NCT04556383|102259628|FG000|PCP|Study terminated by sponsor|15|||
33646527|NCT04556383|102259629|FG001|PCP|Study terminated by sponsor|13|||
33646528|NCT04556383|102259630|FG002|PCP|Study terminated by sponsor|16|||
33646529|NCT04556383|102259631|FG003|PCP|Study terminated by sponsor|0|||
33646530|NCT04556383|102259628|FG000|PCP|Withdrawal by Subject|8|||
33646531|NCT04556383|102259629|FG001|PCP|Withdrawal by Subject|6|||
33646532|NCT04556383|102259630|FG002|PCP|Withdrawal by Subject|6|||
33646533|NCT04556383|102259631|FG003|PCP|Withdrawal by Subject|0|||
33646534|NCT04556383|102259628|FG000|PCP|Adverse Event|1|||
33646535|NCT04556383|102259629|FG001|PCP|Adverse Event|7|||
33646536|NCT04556383|102259630|FG002|PCP|Adverse Event|7|||
33646537|NCT04556383|102259631|FG003|PCP|Adverse Event|0|||
33646538|NCT04556383|102259628|FG000|PCP|Other, Not Specified|1|||
33646539|NCT04556383|102259629|FG001|PCP|Other, Not Specified|2|||
33646540|NCT04556383|102259630|FG002|PCP|Other, Not Specified|1|||
33424522|NCT00370396|101446418|FG000|Overall Study|Withdrawal by Subject|0|||
33646541|NCT04556383|102259631|FG003|PCP|Other, Not Specified|0|||
33646542|NCT04556383|102259628|FG000|PCP|Protocol Violation|1|||
33646543|NCT04556383|102259629|FG001|PCP|Protocol Violation|0|||
33646544|NCT04556383|102259630|FG002|PCP|Protocol Violation|1|||
33646545|NCT04556383|102259631|FG003|PCP|Protocol Violation|0|||
33646546|NCT04556383|102259628|FG000|PCP|Lost to Follow-up|1|||
33424523|NCT00370396|101446419|FG001|Overall Study|Withdrawal by Subject|0|||
33424524|NCT00370396|101446420|FG002|Overall Study|Withdrawal by Subject|1|||
33586593|NCT02253433|102036345|FG000|Overall Study|No Longer Interested|3|||
33586594|NCT02253433|102036346|FG001|Overall Study|No Longer Interested|15|||
33586595|NCT02253433|102036345|FG000|Overall Study|Out of Study Area|2|||
33586596|NCT02253433|102036346|FG001|Overall Study|Out of Study Area|7|||
33646547|NCT04556383|102259629|FG001|PCP|Lost to Follow-up|0|||
33586597|NCT02253433|102036345|FG000|Overall Study|Uncomfortable with home visitors|0|||
33646548|NCT04556383|102259630|FG002|PCP|Lost to Follow-up|0|||
33646549|NCT04556383|102259631|FG003|PCP|Lost to Follow-up|0|||
33646550|NCT04556383|102259628|FG000|PCP|Physician Decision|0|||
33646551|NCT04556383|102259629|FG001|PCP|Physician Decision|1|||
33646552|NCT04556383|102259630|FG002|PCP|Physician Decision|0|||
33646553|NCT04556383|102259631|FG003|PCP|Physician Decision|0|||
33586598|NCT02253433|102036346|FG001|Overall Study|Uncomfortable with home visitors|3|||
33586599|NCT02253433|102036345|FG000|Overall Study|Unstable Housing/Homeless|0|||
33586600|NCT02253433|102036346|FG001|Overall Study|Unstable Housing/Homeless|7|||
33586601|NCT02253433|102036345|FG000|Overall Study|Too Busy|0|||
33586602|NCT02253433|102036346|FG001|Overall Study|Too Busy|4|||
33586603|NCT02253433|102036345|FG000|Overall Study|Medical or Other Concerns|1|||
33586604|NCT02253433|102036346|FG001|Overall Study|Medical or Other Concerns|2|||
33586605|NCT02470585|102036350|FG000|Overall Study|Death|224|||
33586606|NCT02470585|102036351|FG001|Overall Study|Death|227|||
33586607|NCT02470585|102036352|FG002|Overall Study|Death|199|||
33586608|NCT02470585|102036350|FG000|Overall Study|Withdrew consent|21|||
33586609|NCT02470585|102036351|FG001|Overall Study|Withdrew consent|22|||
33586610|NCT02470585|102036352|FG002|Overall Study|Withdrew consent|31|||
33377991|NCT01885078|101269398|FG006|Treatment Period|Lost to Follow-up|2|||
33377992|NCT01885078|101269399|FG007|Treatment Period|Lost to Follow-up|0|||
33377993|NCT01885078|101269400|FG008|Treatment Period|Lost to Follow-up|0|||
33377994|NCT01885078|101269401|FG009|Treatment Period|Lost to Follow-up|0|||
33377995|NCT01885078|101269392|FG000|Treatment Period|Physician Decision|19|||
33377996|NCT01885078|101269393|FG001|Treatment Period|Physician Decision|21|||
33377997|NCT01885078|101269394|FG002|Treatment Period|Physician Decision|5|||
33377998|NCT01885078|101269395|FG003|Treatment Period|Physician Decision|12|||
33424525|NCT00370396|101446418|FG000|Overall Study|Lost to Follow-up|11|||
33586611|NCT02470585|102036350|FG000|Overall Study|Lost to Follow-up|8|||
33586612|NCT02470585|102036351|FG001|Overall Study|Lost to Follow-up|15|||
33586613|NCT02470585|102036352|FG002|Overall Study|Lost to Follow-up|13|||
33586614|NCT02470585|102036350|FG000|Overall Study|Sponsor discontinued study|117|||
33646554|NCT04556383|102259628|FG000|PCP|Site terminated by sponsor|0|||
33646555|NCT04556383|102259629|FG001|PCP|Site terminated by sponsor|1|||
33646556|NCT04556383|102259630|FG002|PCP|Site terminated by sponsor|0|||
33646557|NCT04556383|102259631|FG003|PCP|Site terminated by sponsor|0|||
33646558|NCT04556383|102259628|FG000|OLE|Study terminated by sponsor|0|||
33646559|NCT04556383|102259629|FG001|OLE|Study terminated by sponsor|0|||
33377999|NCT01885078|101269396|FG004|Treatment Period|Physician Decision|9|||
33378000|NCT01885078|101269397|FG005|Treatment Period|Physician Decision|24|||
33378001|NCT01885078|101269398|FG006|Treatment Period|Physician Decision|4|||
33378002|NCT01885078|101269399|FG007|Treatment Period|Physician Decision|3|||
33378003|NCT01885078|101269400|FG008|Treatment Period|Physician Decision|0|||
33378004|NCT01885078|101269401|FG009|Treatment Period|Physician Decision|0|||
33378005|NCT01885078|101269392|FG000|Treatment Period|Protocol Violation|3|||
33378006|NCT01885078|101269393|FG001|Treatment Period|Protocol Violation|5|||
33378007|NCT01885078|101269394|FG002|Treatment Period|Protocol Violation|0|||
33378008|NCT01885078|101269395|FG003|Treatment Period|Protocol Violation|3|||
33378009|NCT01885078|101269396|FG004|Treatment Period|Protocol Violation|1|||
33378010|NCT01885078|101269397|FG005|Treatment Period|Protocol Violation|6|||
33378011|NCT01885078|101269398|FG006|Treatment Period|Protocol Violation|0|||
33378012|NCT01885078|101269399|FG007|Treatment Period|Protocol Violation|0|||
33378013|NCT01885078|101269400|FG008|Treatment Period|Protocol Violation|0|||
33378014|NCT01885078|101269401|FG009|Treatment Period|Protocol Violation|0|||
33378015|NCT01885078|101269392|FG000|Treatment Period|Sponsor Decision|245|||
33378016|NCT01885078|101269393|FG001|Treatment Period|Sponsor Decision|648|||
33378017|NCT01885078|101269394|FG002|Treatment Period|Sponsor Decision|49|||
33378018|NCT01885078|101269395|FG003|Treatment Period|Sponsor Decision|90|||
33378019|NCT01885078|101269396|FG004|Treatment Period|Sponsor Decision|20|||
33378020|NCT01885078|101269397|FG005|Treatment Period|Sponsor Decision|38|||
33378021|NCT01885078|101269398|FG006|Treatment Period|Sponsor Decision|162|||
33378022|NCT01885078|101269399|FG007|Treatment Period|Sponsor Decision|3|||
33378023|NCT01885078|101269400|FG008|Treatment Period|Sponsor Decision|0|||
33378024|NCT01885078|101269401|FG009|Treatment Period|Sponsor Decision|0|||
33378025|NCT01885078|101269392|FG000|Treatment Period|Withdrawal by Subject|72|||
33378026|NCT01885078|101269393|FG001|Treatment Period|Withdrawal by Subject|132|||
33378027|NCT01885078|101269394|FG002|Treatment Period|Withdrawal by Subject|25|||
33378028|NCT01885078|101269395|FG003|Treatment Period|Withdrawal by Subject|63|||
33378029|NCT01885078|101269396|FG004|Treatment Period|Withdrawal by Subject|15|||
33378030|NCT01885078|101269397|FG005|Treatment Period|Withdrawal by Subject|34|||
33378031|NCT01885078|101269398|FG006|Treatment Period|Withdrawal by Subject|17|||
33378032|NCT01885078|101269399|FG007|Treatment Period|Withdrawal by Subject|10|||
33378033|NCT01885078|101269400|FG008|Treatment Period|Withdrawal by Subject|0|||
33586615|NCT02470585|102036351|FG001|Overall Study|Sponsor discontinued study|110|||
33586616|NCT02470585|102036352|FG002|Overall Study|Sponsor discontinued study|122|||
33586617|NCT02470585|102036350|FG000|Overall Study|Other, not specified|5|||
33586618|NCT02470585|102036351|FG001|Overall Study|Other, not specified|7|||
33586619|NCT02470585|102036352|FG002|Overall Study|Other, not specified|14|||
33586620|NCT02470585|102036350|FG000|Overall Study|Missing due to site non-compliance|0|||
33148746|NCT00478881|100458259|FG000|Overall Study|Non-Compliance with Study Medication|0|||
33424526|NCT00370396|101446419|FG001|Overall Study|Lost to Follow-up|1|||
33378034|NCT01885078|101269401|FG009|Treatment Period|Withdrawal by Subject|0|||
33586621|NCT02470585|102036351|FG001|Overall Study|Missing due to site non-compliance|2|||
33646560|NCT04556383|102259630|FG002|OLE|Study terminated by sponsor|0|||
33646561|NCT04556383|102259631|FG003|OLE|Study terminated by sponsor|68|||
33646562|NCT04556383|102259628|FG000|OLE|Withdrawal by Subject|0|||
33646563|NCT04556383|102259629|FG001|OLE|Withdrawal by Subject|0|||
33646564|NCT04556383|102259630|FG002|OLE|Withdrawal by Subject|0|||
33646565|NCT04556383|102259631|FG003|OLE|Withdrawal by Subject|10|||
33646566|NCT04556383|102259628|FG000|OLE|Lack of Efficacy|0|||
33646567|NCT04556383|102259629|FG001|OLE|Lack of Efficacy|0|||
33646568|NCT04556383|102259630|FG002|OLE|Lack of Efficacy|0|||
33646569|NCT04556383|102259631|FG003|OLE|Lack of Efficacy|7|||
33646570|NCT04556383|102259628|FG000|OLE|Adverse Event|0|||
33378035|NCT01885078|101269392|FG000|Treatment Period|Other|0|||
33378036|NCT01885078|101269393|FG001|Treatment Period|Other|0|||
33378037|NCT01885078|101269394|FG002|Treatment Period|Other|0|||
33378038|NCT01885078|101269395|FG003|Treatment Period|Other|1|||
33424527|NCT00370396|101446420|FG002|Overall Study|Lost to Follow-up|0|||
33424528|NCT00566098|101446421|FG000|Collection of MILs|Withdrawal by Subject|1|||
33646571|NCT04556383|102259629|FG001|OLE|Adverse Event|0|||
33646572|NCT04556383|102259630|FG002|OLE|Adverse Event|0|||
33646573|NCT04556383|102259631|FG003|OLE|Adverse Event|2|||
33646574|NCT04556383|102259628|FG000|OLE|Other, Not Specified|0|||
33646575|NCT04556383|102259629|FG001|OLE|Other, Not Specified|0|||
33646576|NCT04556383|102259630|FG002|OLE|Other, Not Specified|0|||
33247391|NCT04304534|100806671|FG001|Overall Study|Physician Decision|9|||
33247392|NCT04304534|100806672|FG002|Overall Study|Physician Decision|9|||
33247393|NCT04304534|100806673|FG003|Overall Study|Physician Decision|5|||
33247394|NCT04304534|100806670|FG000|Overall Study|Subject Decision|34|||
33247395|NCT04304534|100806671|FG001|Overall Study|Subject Decision|25|||
33247396|NCT04304534|100806672|FG002|Overall Study|Subject Decision|25|||
33247397|NCT04304534|100806673|FG003|Overall Study|Subject Decision|26|||
33247398|NCT04304534|100806670|FG000|Overall Study|Adverse Event|35|||
33247399|NCT04304534|100806671|FG001|Overall Study|Adverse Event|40|||
33247400|NCT04304534|100806672|FG002|Overall Study|Adverse Event|39|||
33247401|NCT04304534|100806673|FG003|Overall Study|Adverse Event|44|||
33247402|NCT02451943|100806675|FG000|Overall Study|On Treatment|4|||
33247403|NCT02451943|100806676|FG001|Overall Study|On Treatment|4|||
33247404|NCT02451943|100806675|FG000|Overall Study|Withdrawal by Subject|13|||
33247405|NCT02451943|100806676|FG001|Overall Study|Withdrawal by Subject|16|||
33247406|NCT02451943|100806675|FG000|Overall Study|Lost to Follow-up|3|||
33247407|NCT02451943|100806676|FG001|Overall Study|Lost to Follow-up|4|||
33247408|NCT00771667|100806677|FG000|Induction Phase|Adverse Event|5|||
33247409|NCT00771667|100806678|FG001|Induction Phase|Adverse Event|2|||
33247410|NCT00771667|100806679|FG002|Induction Phase|Adverse Event|4|||
33247411|NCT00771667|100806680|FG003|Induction Phase|Adverse Event|1|||
33247412|NCT00771667|100806681|FG004|Induction Phase|Adverse Event|0|||
33247413|NCT00771667|100806682|FG005|Induction Phase|Adverse Event|0|||
33247414|NCT00771667|100806683|FG006|Induction Phase|Adverse Event|0|||
33247415|NCT00771667|100806684|FG007|Induction Phase|Adverse Event|0|||
33247416|NCT00771667|100806685|FG008|Induction Phase|Adverse Event|0|||
33247417|NCT00771667|100806686|FG009|Induction Phase|Adverse Event|0|||
33247418|NCT00771667|100806677|FG000|Induction Phase|Lack of Efficacy|9|||
33247419|NCT00771667|100806678|FG001|Induction Phase|Lack of Efficacy|2|||
33247420|NCT00771667|100806679|FG002|Induction Phase|Lack of Efficacy|4|||
33247421|NCT00771667|100806680|FG003|Induction Phase|Lack of Efficacy|3|||
33247422|NCT00771667|100806681|FG004|Induction Phase|Lack of Efficacy|0|||
33247423|NCT00771667|100806682|FG005|Induction Phase|Lack of Efficacy|0|||
33247424|NCT00771667|100806683|FG006|Induction Phase|Lack of Efficacy|0|||
33247425|NCT00771667|100806684|FG007|Induction Phase|Lack of Efficacy|0|||
33247426|NCT00771667|100806685|FG008|Induction Phase|Lack of Efficacy|0|||
33247427|NCT00771667|100806686|FG009|Induction Phase|Lack of Efficacy|0|||
33247428|NCT00771667|100806677|FG000|Induction Phase|Lost to Follow-up|1|||
33247429|NCT00771667|100806678|FG001|Induction Phase|Lost to Follow-up|0|||
33247430|NCT00771667|100806679|FG002|Induction Phase|Lost to Follow-up|1|||
33247431|NCT00771667|100806680|FG003|Induction Phase|Lost to Follow-up|0|||
33247432|NCT00771667|100806681|FG004|Induction Phase|Lost to Follow-up|0|||
33247433|NCT00771667|100806682|FG005|Induction Phase|Lost to Follow-up|0|||
33247434|NCT00771667|100806683|FG006|Induction Phase|Lost to Follow-up|0|||
33247435|NCT00771667|100806684|FG007|Induction Phase|Lost to Follow-up|0|||
33247436|NCT00771667|100806685|FG008|Induction Phase|Lost to Follow-up|0|||
33247437|NCT00771667|100806686|FG009|Induction Phase|Lost to Follow-up|0|||
33247438|NCT00771667|100806677|FG000|Induction Phase|Other|4|||
33378039|NCT01885078|101269396|FG004|Treatment Period|Other|0|||
33646577|NCT04556383|102259631|FG003|OLE|Other, Not Specified|2|||
33247439|NCT00771667|100806678|FG001|Induction Phase|Other|6|||
33378040|NCT01885078|101269397|FG005|Treatment Period|Other|0|||
33378041|NCT01885078|101269398|FG006|Treatment Period|Other|0|||
33646578|NCT04556383|102259628|FG000|OLE|Death|0|||
33646579|NCT04556383|102259629|FG001|OLE|Death|0|||
33646580|NCT04556383|102259630|FG002|OLE|Death|0|||
33247440|NCT00771667|100806679|FG002|Induction Phase|Other|3|||
33247441|NCT00771667|100806680|FG003|Induction Phase|Other|4|||
33247442|NCT00771667|100806681|FG004|Induction Phase|Other|0|||
33646581|NCT04556383|102259631|FG003|OLE|Death|1|||
33646582|NCT04556383|102259628|FG000|OLE|Lost to Follow-up|0|||
33646583|NCT04556383|102259629|FG001|OLE|Lost to Follow-up|0|||
33247443|NCT00771667|100806682|FG005|Induction Phase|Other|0|||
33247444|NCT00771667|100806683|FG006|Induction Phase|Other|0|||
33247445|NCT00771667|100806684|FG007|Induction Phase|Other|0|||
33247446|NCT00771667|100806685|FG008|Induction Phase|Other|0|||
33247447|NCT00771667|100806686|FG009|Induction Phase|Other|0|||
33247448|NCT00771667|100806677|FG000|Maintenance Phase|Adverse Event|0|||
33247449|NCT00771667|100806678|FG001|Maintenance Phase|Adverse Event|0|||
33247450|NCT00771667|100806679|FG002|Maintenance Phase|Adverse Event|0|||
33247451|NCT00771667|100806680|FG003|Maintenance Phase|Adverse Event|0|||
33247452|NCT00771667|100806681|FG004|Maintenance Phase|Adverse Event|1|||
33247453|NCT00771667|100806682|FG005|Maintenance Phase|Adverse Event|3|||
33247454|NCT00771667|100806683|FG006|Maintenance Phase|Adverse Event|5|||
33247455|NCT00771667|100806684|FG007|Maintenance Phase|Adverse Event|1|||
33247456|NCT00771667|100806685|FG008|Maintenance Phase|Adverse Event|8|||
33247457|NCT00771667|100806686|FG009|Maintenance Phase|Adverse Event|7|||
33247458|NCT00771667|100806677|FG000|Maintenance Phase|Lack of Efficacy|0|||
33247459|NCT00771667|100806678|FG001|Maintenance Phase|Lack of Efficacy|0|||
33247460|NCT00771667|100806679|FG002|Maintenance Phase|Lack of Efficacy|0|||
33247461|NCT00771667|100806680|FG003|Maintenance Phase|Lack of Efficacy|0|||
33247462|NCT00771667|100806681|FG004|Maintenance Phase|Lack of Efficacy|1|||
33247463|NCT00771667|100806682|FG005|Maintenance Phase|Lack of Efficacy|3|||
33247464|NCT00771667|100806683|FG006|Maintenance Phase|Lack of Efficacy|3|||
33247465|NCT00771667|100806684|FG007|Maintenance Phase|Lack of Efficacy|2|||
33247466|NCT00771667|100806685|FG008|Maintenance Phase|Lack of Efficacy|11|||
33247467|NCT00771667|100806686|FG009|Maintenance Phase|Lack of Efficacy|7|||
33247468|NCT00771667|100806677|FG000|Maintenance Phase|Other|0|||
33247469|NCT00771667|100806678|FG001|Maintenance Phase|Other|0|||
33247470|NCT00771667|100806679|FG002|Maintenance Phase|Other|0|||
33247471|NCT00771667|100806680|FG003|Maintenance Phase|Other|0|||
33247472|NCT00771667|100806681|FG004|Maintenance Phase|Other|0|||
33247473|NCT00771667|100806682|FG005|Maintenance Phase|Other|1|||
33247474|NCT00771667|100806683|FG006|Maintenance Phase|Other|2|||
33247475|NCT00771667|100806684|FG007|Maintenance Phase|Other|2|||
33247476|NCT00771667|100806685|FG008|Maintenance Phase|Other|3|||
33247477|NCT00771667|100806686|FG009|Maintenance Phase|Other|3|||
33247478|NCT00608907|100806687|FG000|Overall Study|Adverse Event|6|||
33247479|NCT00608907|100806688|FG001|Overall Study|Adverse Event|0|||
33247480|NCT00608907|100806689|FG002|Overall Study|Adverse Event|1|||
33247481|NCT00608907|100806687|FG000|Overall Study|Death|1|||
33247482|NCT00608907|100806688|FG001|Overall Study|Death|0|||
33247483|NCT00608907|100806689|FG002|Overall Study|Death|0|||
33247484|NCT00608907|100806687|FG000|Overall Study|Withdrawal by Subject|4|||
33247485|NCT00608907|100806688|FG001|Overall Study|Withdrawal by Subject|0|||
33378042|NCT01885078|101269399|FG007|Treatment Period|Other|0|||
33378043|NCT01885078|101269400|FG008|Treatment Period|Other|0|||
33424529|NCT00566098|101446421|FG000|Collection of MILs|Relapsed|1|||
33646584|NCT04556383|102259630|FG002|OLE|Lost to Follow-up|0|||
33646585|NCT04556383|102259631|FG003|OLE|Lost to Follow-up|1|||
33646586|NCT00992589|102259636|FG000|Open-Label Phase|Adverse Event|4|||
33646587|NCT00992589|102259637|FG001|Open-Label Phase|Adverse Event|0|||
33646588|NCT00992589|102259638|FG002|Open-Label Phase|Adverse Event|0|||
33646589|NCT00992589|102259639|FG003|Open-Label Phase|Adverse Event|0|||
33646590|NCT00992589|102259636|FG000|Open-Label Phase|Withdrawal by Subject|20|||
33148747|NCT00478881|100458260|FG001|Overall Study|Non-Compliance with Study Medication|2|||
33148748|NCT04654468|100458261|FG000|Overall Study|Death|1|||
33148749|NCT04654468|100458261|FG000|Overall Study|Ongoing in the Study|50|||
33148750|NCT03487549|100458264|FG000|Overall Study|Protocol Violation|0|||
33148751|NCT03487549|100458265|FG001|Overall Study|Protocol Violation|1|||
33148752|NCT03487549|100458264|FG000|Overall Study|Lost to Follow-up|2|||
33148753|NCT03487549|100458265|FG001|Overall Study|Lost to Follow-up|1|||
33148754|NCT03487549|100458264|FG000|Overall Study|Withdrawal by Subject|2|||
33148755|NCT03487549|100458265|FG001|Overall Study|Withdrawal by Subject|0|||
33148756|NCT03489551|100458271|FG000|Overall Study|Withdrawal by Subject|2|||
33148757|NCT05419908|100458272|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
33148758|NCT05419908|100458273|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
33148759|NCT05419908|100458272|FG000|Overall Study|Serious Adverse Event|0|||
33148760|NCT05419908|100458273|FG001|Overall Study|Serious Adverse Event|2|||
33148761|NCT05419908|100458272|FG000|Overall Study|Withdrawal by Subject|2|||
33148762|NCT05419908|100458273|FG001|Overall Study|Withdrawal by Subject|0|||
33148763|NCT05419908|100458272|FG000|Overall Study|Miscellaneous|1|||
33247486|NCT00608907|100806689|FG002|Overall Study|Withdrawal by Subject|0|||
33247487|NCT00608907|100806687|FG000|Overall Study|Progressive Disease|1|||
33247488|NCT00608907|100806688|FG001|Overall Study|Progressive Disease|0|||
33247489|NCT00608907|100806689|FG002|Overall Study|Progressive Disease|0|||
33247490|NCT01649791|100806692|FG000|Overall Study|Disease Progression|2|||
33247491|NCT01649791|100806692|FG000|Overall Study|Adverse Event|1|||
33247492|NCT02689349|100806693|FG000|Overall Study|Not implanted|4|||
33247493|NCT02689349|100806694|FG001|Overall Study|Not implanted|0|||
33247494|NCT02689349|100806693|FG000|Overall Study|Withdrawal by Subject|9|||
33646591|NCT00992589|102259637|FG001|Open-Label Phase|Withdrawal by Subject|0|||
33378044|NCT01885078|101269401|FG009|Treatment Period|Other|0|||
33378045|NCT01885078|101269392|FG000|Step-down Period|Sponsor Decision|0|||
33378046|NCT01885078|101269393|FG001|Step-down Period|Sponsor Decision|0|||
33378047|NCT01885078|101269394|FG002|Step-down Period|Sponsor Decision|0|||
33378048|NCT01885078|101269395|FG003|Step-down Period|Sponsor Decision|0|||
33378049|NCT01885078|101269396|FG004|Step-down Period|Sponsor Decision|0|||
33378050|NCT01885078|101269397|FG005|Step-down Period|Sponsor Decision|0|||
33378051|NCT01885078|101269398|FG006|Step-down Period|Sponsor Decision|0|||
33378052|NCT01885078|101269399|FG007|Step-down Period|Sponsor Decision|0|||
33378053|NCT01885078|101269400|FG008|Step-down Period|Sponsor Decision|1|||
33378054|NCT01885078|101269401|FG009|Step-down Period|Sponsor Decision|1|||
33378055|NCT01885078|101269392|FG000|Step-down Period|Adverse Event|0|||
33424530|NCT00566098|101446421|FG000|Generation of MILs Product|Relapsed|1|||
33424531|NCT00566098|101446421|FG000|Administration of ASCT+MILs|Death|10|||
33424532|NCT00566098|101446421|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
33424533|NCT01076166|101446422|FG000|Overall Study|Adverse Event|3|||
33424534|NCT01076166|101446422|FG000|Overall Study|Symptoms improved/resolved|6|||
33424535|NCT00399490|101446423|FG000|Overall Study|Adverse Event|19|||
33424536|NCT00399490|101446423|FG000|Overall Study|Lack of Efficacy|31|||
33424537|NCT00399490|101446423|FG000|Overall Study|Lost to Follow-up|5|||
33378056|NCT01885078|101269393|FG001|Step-down Period|Adverse Event|0|||
33378057|NCT01885078|101269394|FG002|Step-down Period|Adverse Event|0|||
33378058|NCT01885078|101269395|FG003|Step-down Period|Adverse Event|0|||
33378059|NCT01885078|101269396|FG004|Step-down Period|Adverse Event|0|||
33378060|NCT01885078|101269397|FG005|Step-down Period|Adverse Event|0|||
33378061|NCT01885078|101269398|FG006|Step-down Period|Adverse Event|0|||
33378062|NCT01885078|101269399|FG007|Step-down Period|Adverse Event|0|||
33378063|NCT01885078|101269400|FG008|Step-down Period|Adverse Event|29|||
33378064|NCT01885078|101269401|FG009|Step-down Period|Adverse Event|38|||
33378065|NCT01885078|101269392|FG000|Step-down Period|Withdrawal by Subject|0|||
33378066|NCT01885078|101269393|FG001|Step-down Period|Withdrawal by Subject|0|||
33378067|NCT01885078|101269394|FG002|Step-down Period|Withdrawal by Subject|0|||
33378068|NCT01885078|101269395|FG003|Step-down Period|Withdrawal by Subject|0|||
33378069|NCT01885078|101269396|FG004|Step-down Period|Withdrawal by Subject|0|||
33378070|NCT01885078|101269397|FG005|Step-down Period|Withdrawal by Subject|0|||
33424538|NCT00399490|101446423|FG000|Overall Study|Withdrawal by Subject|18|||
33378071|NCT01885078|101269398|FG006|Step-down Period|Withdrawal by Subject|0|||
33378072|NCT01885078|101269399|FG007|Step-down Period|Withdrawal by Subject|0|||
33378073|NCT01885078|101269400|FG008|Step-down Period|Withdrawal by Subject|25|||
33378074|NCT01885078|101269401|FG009|Step-down Period|Withdrawal by Subject|15|||
33378075|NCT01885078|101269392|FG000|Step-down Period|Physician Decision|0|||
33424539|NCT00399490|101446423|FG000|Overall Study|Other|25|||
33646592|NCT00992589|102259638|FG002|Open-Label Phase|Withdrawal by Subject|0|||
33646593|NCT00992589|102259639|FG003|Open-Label Phase|Withdrawal by Subject|0|||
33646594|NCT00992589|102259636|FG000|Open-Label Phase|Lost to Follow-up|1|||
33646595|NCT00992589|102259637|FG001|Open-Label Phase|Lost to Follow-up|0|||
33646596|NCT00992589|102259638|FG002|Open-Label Phase|Lost to Follow-up|0|||
33646597|NCT00992589|102259639|FG003|Open-Label Phase|Lost to Follow-up|0|||
33646598|NCT00992589|102259636|FG000|Open-Label Phase|Protocol Violation|3|||
33646599|NCT00992589|102259637|FG001|Open-Label Phase|Protocol Violation|0|||
33646600|NCT00992589|102259638|FG002|Open-Label Phase|Protocol Violation|0|||
33646601|NCT00992589|102259639|FG003|Open-Label Phase|Protocol Violation|0|||
33646602|NCT00992589|102259636|FG000|Open-Label Phase|Physician Decision|4|||
33646603|NCT00992589|102259637|FG001|Open-Label Phase|Physician Decision|0|||
33424540|NCT01092702|101446427|FG000|Overall Study|Withdrawal by Subject|7|||
33424541|NCT01092702|101446427|FG000|Overall Study|Lost to Follow-up|2|||
33646604|NCT00992589|102259638|FG002|Open-Label Phase|Physician Decision|0|||
33646605|NCT00992589|102259639|FG003|Open-Label Phase|Physician Decision|0|||
33646606|NCT00992589|102259636|FG000|Open-Label Phase|Other|45|||
33646607|NCT00992589|102259637|FG001|Open-Label Phase|Other|0|||
33646608|NCT00992589|102259638|FG002|Open-Label Phase|Other|0|||
33646609|NCT00992589|102259639|FG003|Open-Label Phase|Other|0|||
33646610|NCT00992589|102259636|FG000|Double-Blind Phase|Adverse Event|0|||
33646611|NCT00992589|102259637|FG001|Double-Blind Phase|Adverse Event|6|||
33646612|NCT00992589|102259638|FG002|Double-Blind Phase|Adverse Event|2|||
33378076|NCT01885078|101269393|FG001|Step-down Period|Physician Decision|0|||
33378077|NCT01885078|101269394|FG002|Step-down Period|Physician Decision|0|||
33378078|NCT01885078|101269395|FG003|Step-down Period|Physician Decision|0|||
33378079|NCT01885078|101269396|FG004|Step-down Period|Physician Decision|0|||
33378080|NCT01885078|101269397|FG005|Step-down Period|Physician Decision|0|||
33378081|NCT01885078|101269398|FG006|Step-down Period|Physician Decision|0|||
33378082|NCT01885078|101269399|FG007|Step-down Period|Physician Decision|0|||
33424542|NCT00323609|101446428|FG000|Overall Study|Death|16|||
33424543|NCT00323609|101446429|FG001|Overall Study|Death|21|||
33424544|NCT00323609|101446430|FG002|Overall Study|Death|0|||
33378083|NCT01885078|101269400|FG008|Step-down Period|Physician Decision|7|||
33378084|NCT01885078|101269401|FG009|Step-down Period|Physician Decision|2|||
33646613|NCT00992589|102259639|FG003|Double-Blind Phase|Adverse Event|3|||
33646614|NCT00992589|102259636|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
33378085|NCT01885078|101269392|FG000|Step-down Period|Death|0|||
33378086|NCT01885078|101269393|FG001|Step-down Period|Death|0|||
33378087|NCT01885078|101269394|FG002|Step-down Period|Death|0|||
33378088|NCT01885078|101269395|FG003|Step-down Period|Death|0|||
33378089|NCT01885078|101269396|FG004|Step-down Period|Death|0|||
33378090|NCT01885078|101269397|FG005|Step-down Period|Death|0|||
33378091|NCT01885078|101269398|FG006|Step-down Period|Death|0|||
33378092|NCT01885078|101269399|FG007|Step-down Period|Death|0|||
33378093|NCT01885078|101269400|FG008|Step-down Period|Death|4|||
33378094|NCT01885078|101269401|FG009|Step-down Period|Death|3|||
33378095|NCT01885078|101269392|FG000|Step-down Period|Lost to Follow-up|0|||
33378096|NCT01885078|101269393|FG001|Step-down Period|Lost to Follow-up|0|||
33378097|NCT01885078|101269394|FG002|Step-down Period|Lost to Follow-up|0|||
33378098|NCT01885078|101269395|FG003|Step-down Period|Lost to Follow-up|0|||
33378099|NCT01885078|101269396|FG004|Step-down Period|Lost to Follow-up|0|||
33424545|NCT00323609|101446431|FG003|Overall Study|Death|0|||
33424546|NCT00323609|101446428|FG000|Overall Study|Lost to Follow-up|9|||
33424547|NCT00323609|101446429|FG001|Overall Study|Lost to Follow-up|10|||
33424548|NCT00323609|101446430|FG002|Overall Study|Lost to Follow-up|0|||
33424549|NCT00323609|101446431|FG003|Overall Study|Lost to Follow-up|0|||
33424550|NCT00323609|101446428|FG000|Overall Study|Physician Decision|2|||
33424551|NCT00323609|101446429|FG001|Overall Study|Physician Decision|0|||
33424552|NCT00323609|101446430|FG002|Overall Study|Physician Decision|0|||
33424553|NCT00323609|101446431|FG003|Overall Study|Physician Decision|1|||
33424554|NCT00323609|101446428|FG000|Overall Study|Withdrawal by Subject|11|||
33378100|NCT01885078|101269397|FG005|Step-down Period|Lost to Follow-up|0|||
33378101|NCT01885078|101269398|FG006|Step-down Period|Lost to Follow-up|0|||
33378102|NCT01885078|101269399|FG007|Step-down Period|Lost to Follow-up|0|||
33378103|NCT01885078|101269400|FG008|Step-down Period|Lost to Follow-up|1|||
33378104|NCT01885078|101269401|FG009|Step-down Period|Lost to Follow-up|1|||
33378105|NCT01885078|101269392|FG000|Step-down Period|Lack of Efficacy|0|||
33378106|NCT01885078|101269393|FG001|Step-down Period|Lack of Efficacy|0|||
33378107|NCT01885078|101269394|FG002|Step-down Period|Lack of Efficacy|0|||
33378108|NCT01885078|101269395|FG003|Step-down Period|Lack of Efficacy|0|||
33378109|NCT01885078|101269396|FG004|Step-down Period|Lack of Efficacy|0|||
33378110|NCT01885078|101269397|FG005|Step-down Period|Lack of Efficacy|0|||
33378111|NCT01885078|101269398|FG006|Step-down Period|Lack of Efficacy|0|||
33378112|NCT01885078|101269399|FG007|Step-down Period|Lack of Efficacy|0|||
33378113|NCT01885078|101269400|FG008|Step-down Period|Lack of Efficacy|1|||
33378114|NCT01885078|101269401|FG009|Step-down Period|Lack of Efficacy|0|||
33378115|NCT01885078|101269392|FG000|Step-down Period|Protocol Violation|0|||
33378116|NCT01885078|101269393|FG001|Step-down Period|Protocol Violation|0|||
33378117|NCT01885078|101269394|FG002|Step-down Period|Protocol Violation|0|||
33378118|NCT01885078|101269395|FG003|Step-down Period|Protocol Violation|0|||
33378119|NCT01885078|101269396|FG004|Step-down Period|Protocol Violation|0|||
33378120|NCT01885078|101269397|FG005|Step-down Period|Protocol Violation|0|||
33378121|NCT01885078|101269398|FG006|Step-down Period|Protocol Violation|0|||
33378122|NCT01885078|101269399|FG007|Step-down Period|Protocol Violation|0|||
33378123|NCT01885078|101269400|FG008|Step-down Period|Protocol Violation|1|||
33378124|NCT01885078|101269401|FG009|Step-down Period|Protocol Violation|1|||
33378125|NCT01963208|101269404|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
33378126|NCT01963208|101269405|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
33378127|NCT01963208|101269406|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
33378128|NCT01963208|101269407|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
33378129|NCT01963208|101269408|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
33378130|NCT01963208|101269409|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
33378131|NCT01963208|101269404|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
33424555|NCT00323609|101446429|FG001|Overall Study|Withdrawal by Subject|23|||
33424556|NCT00323609|101446430|FG002|Overall Study|Withdrawal by Subject|4|||
33378132|NCT01963208|101269405|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
33378133|NCT01963208|101269406|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
33378134|NCT01963208|101269407|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
33424557|NCT00323609|101446431|FG003|Overall Study|Withdrawal by Subject|4|||
33424558|NCT00323609|101446428|FG000|Overall Study|Other non-VCF-related medical condition|3|||
33378135|NCT01963208|101269408|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
33378136|NCT01963208|101269409|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
33378137|NCT01963208|101269404|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
33378138|NCT01963208|101269405|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
33378139|NCT01963208|101269406|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
33424559|NCT00323609|101446429|FG001|Overall Study|Other non-VCF-related medical condition|2|||
33424560|NCT00323609|101446430|FG002|Overall Study|Other non-VCF-related medical condition|0|||
33378140|NCT01963208|101269407|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
33378141|NCT01963208|101269408|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
33378142|NCT01963208|101269409|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
33378143|NCT01963208|101269404|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
33424561|NCT00323609|101446431|FG003|Overall Study|Other non-VCF-related medical condition|0|||
33378144|NCT01963208|101269405|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
33378145|NCT01963208|101269406|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
33378146|NCT01963208|101269407|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
33424562|NCT00323609|101446428|FG000|Overall Study|Sponsor discontinued trial|29|||
33424563|NCT00323609|101446429|FG001|Overall Study|Sponsor discontinued trial|29|||
33424564|NCT00323609|101446430|FG002|Overall Study|Sponsor discontinued trial|0|||
33424565|NCT00323609|101446431|FG003|Overall Study|Sponsor discontinued trial|0|||
33424566|NCT00323609|101446428|FG000|Overall Study|Unrelenting or severe back pain|1|||
33378147|NCT01963208|101269408|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
33378148|NCT01963208|101269409|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
33378149|NCT01963208|101269404|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
33378150|NCT01963208|101269405|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
33378151|NCT01963208|101269406|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
33378152|NCT01963208|101269407|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
33378153|NCT01963208|101269408|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
33378154|NCT01963208|101269409|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
33378155|NCT01963208|101269404|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
33378156|NCT01963208|101269405|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
33424567|NCT00323609|101446429|FG001|Overall Study|Unrelenting or severe back pain|1|||
33424568|NCT00323609|101446430|FG002|Overall Study|Unrelenting or severe back pain|0|||
33424569|NCT00323609|101446431|FG003|Overall Study|Unrelenting or severe back pain|0|||
33424570|NCT00323609|101446428|FG000|Overall Study|Logistical withdrawal|9|||
33424571|NCT00323609|101446429|FG001|Overall Study|Logistical withdrawal|5|||
33424572|NCT00323609|101446430|FG002|Overall Study|Logistical withdrawal|0|||
33424573|NCT00323609|101446431|FG003|Overall Study|Logistical withdrawal|1|||
33424574|NCT00323609|101446428|FG000|Overall Study|Other reason|11|||
33424575|NCT00323609|101446429|FG001|Overall Study|Other reason|8|||
33424576|NCT00323609|101446430|FG002|Overall Study|Other reason|4|||
33424577|NCT00323609|101446431|FG003|Overall Study|Other reason|9|||
33424578|NCT00066807|101446436|FG000|Overall Study|Study was terminated early|14|||
33646615|NCT00992589|102259637|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
33646616|NCT00992589|102259638|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
33646617|NCT00992589|102259639|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
33646618|NCT00992589|102259636|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33646619|NCT00992589|102259637|FG001|Double-Blind Phase|Lost to Follow-up|0|||
33646620|NCT00992589|102259638|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33646621|NCT00992589|102259639|FG003|Double-Blind Phase|Lost to Follow-up|2|||
33646622|NCT00992589|102259636|FG000|Double-Blind Phase|Other|0|||
33378157|NCT01963208|101269406|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
33378158|NCT01963208|101269407|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
33378159|NCT01963208|101269408|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
33378160|NCT01963208|101269409|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
33378161|NCT01963208|101269404|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
33378162|NCT01963208|101269405|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
33378163|NCT01963208|101269406|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
33378164|NCT01963208|101269407|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
33378165|NCT01963208|101269408|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
33378166|NCT01963208|101269409|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
33424579|NCT00066807|101446437|FG001|Overall Study|Study was terminated early|15|||
33424580|NCT03734679|101446438|FG000|Overall Study|Missed Visit|1|||
33424581|NCT00350519|101446440|FG000|Overall Study|Death|0|||
33424582|NCT00350519|101446441|FG001|Overall Study|Death|1|||
33646623|NCT00992589|102259637|FG001|Double-Blind Phase|Other|1|||
33646624|NCT00992589|102259638|FG002|Double-Blind Phase|Other|6|||
33646625|NCT00992589|102259639|FG003|Double-Blind Phase|Other|3|||
33646626|NCT02238067|102259640|FG000|Overall Study|Not completed survey at Month 6|45|||
33646627|NCT03645434|102259642|FG000|Period 1|Adverse Event|0|||
33646628|NCT03645434|102259643|FG001|Period 1|Adverse Event|0|||
33378167|NCT01963208|101269404|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
33378168|NCT01963208|101269405|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
33378169|NCT01963208|101269406|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
33378170|NCT01963208|101269407|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
33424583|NCT00350519|101446440|FG000|Overall Study|Physician Decision|0|||
33646629|NCT03645434|102259644|FG002|Period 1|Adverse Event|0|||
33646630|NCT03645434|102259645|FG003|Period 1|Adverse Event|1|||
33148764|NCT05419908|100458273|FG001|Overall Study|Miscellaneous|1|||
33378171|NCT01963208|101269408|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
33378172|NCT01963208|101269409|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
33424584|NCT00350519|101446441|FG001|Overall Study|Physician Decision|1|||
33424585|NCT00350519|101446440|FG000|Overall Study|Protocol Violation|1|||
33424586|NCT00350519|101446441|FG001|Overall Study|Protocol Violation|2|||
33148765|NCT04966741|100458274|FG000|Overall Study|Lost to Follow-up|1|||
33424587|NCT00350519|101446440|FG000|Overall Study|Withdrawal by Subject|3|||
33646631|NCT03645434|102259646|FG004|Period 1|Adverse Event|0|||
33378173|NCT01963208|101269404|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
33378174|NCT01963208|101269405|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
33378175|NCT01963208|101269406|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
33378176|NCT01963208|101269407|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
33378177|NCT01963208|101269408|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
33378178|NCT01963208|101269409|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
33378179|NCT01963208|101269404|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
33378180|NCT01963208|101269405|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
33378181|NCT01963208|101269406|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
33378182|NCT01963208|101269407|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
33378183|NCT01963208|101269408|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
33424588|NCT00350519|101446441|FG001|Overall Study|Withdrawal by Subject|2|||
33424589|NCT00854620|101446442|FG000|Overall Study|Adverse Event|1|||
33424590|NCT00409188|101446443|FG000|Overall Study|Ongoing at data cut-off|383|||
33424591|NCT00409188|101446444|FG001|Overall Study|Ongoing at data cut-off|175|||
33424592|NCT01504867|101446451|FG000|Overall Study|Inclusion criteria not met|2|||
33424593|NCT01504867|101446452|FG001|Overall Study|Inclusion criteria not met|2|||
33424594|NCT01504867|101446451|FG000|Overall Study|Consent revoked|5|||
33424595|NCT01504867|101446452|FG001|Overall Study|Consent revoked|1|||
33424596|NCT03439293|101446453|FG000|Overall Study|Death|22|||
33424597|NCT03439293|101446453|FG000|Overall Study|Withdrawal by Subject|8|||
33424598|NCT03439293|101446453|FG000|Overall Study|Lost to Follow-up|2|||
33424599|NCT03439293|101446453|FG000|Overall Study|Reason Not Specified|28|||
33424600|NCT03439293|101446453|FG000|Overall Study|Missing|1|||
33424601|NCT00923195|101446454|FG000|Overall Study|Death|0|||
33424602|NCT00923195|101446455|FG001|Overall Study|Death|1|||
33424603|NCT01706770|101446462|FG000|Overall Study|Lost to Follow-up|1|||
33424604|NCT01706770|101446463|FG001|Overall Study|Lost to Follow-up|0|||
33424605|NCT01706770|101446462|FG000|Overall Study|Physician Decision|1|||
33424606|NCT01706770|101446463|FG001|Overall Study|Physician Decision|0|||
33424607|NCT03670537|101446464|FG000|Overall Study|Protocol Violation|1|||
33424608|NCT01613131|101446465|FG000|Overall Study|Withdrawal by Subject|3|||
33424609|NCT01613131|101446466|FG001|Overall Study|Withdrawal by Subject|5|||
33424610|NCT03627195|101446468|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
33424611|NCT03627195|101446469|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
33424612|NCT03627195|101446470|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
33424613|NCT03627195|101446471|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
33424614|NCT03627195|101446472|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
33424615|NCT03627195|101446473|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
33424616|NCT00686790|101446474|FG000|Overall Study|Adverse Event|2|||
33424617|NCT00686790|101446474|FG000|Overall Study|Withdrawal by Subject|1|||
33424618|NCT00686790|101446474|FG000|Overall Study|Death|1|||
33424619|NCT00686790|101446474|FG000|Overall Study|Lost to Follow-up|12|||
33424620|NCT02328547|101446475|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
33424621|NCT02328547|101446476|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
33424622|NCT02328547|101446475|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
33424623|NCT02328547|101446476|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
33424624|NCT00528879|101446477|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
33424625|NCT00528879|101446478|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
33424626|NCT00528879|101446479|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
33424627|NCT00528879|101446480|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
33424628|NCT00528879|101446477|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
33424629|NCT00528879|101446478|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
33424630|NCT00528879|101446479|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
33424631|NCT00528879|101446480|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
33424632|NCT00528879|101446477|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
33424633|NCT00528879|101446478|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
33424634|NCT00528879|101446479|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
33424635|NCT00528879|101446480|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
33424636|NCT00528879|101446477|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
33424637|NCT00528879|101446478|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
33424638|NCT00528879|101446479|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
33424639|NCT00528879|101446480|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
33424640|NCT00528879|101446477|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
33424641|NCT00528879|101446478|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
33424642|NCT00528879|101446479|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
33424643|NCT00528879|101446480|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
33424644|NCT00528879|101446477|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
33424645|NCT00528879|101446478|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
33586622|NCT02470585|102036352|FG002|Overall Study|Missing due to site non-compliance|3|||
33586623|NCT02248649|102036355|FG000|Overall Study|Death|7|||
33424646|NCT00528879|101446479|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
33424647|NCT00528879|101446480|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
33424648|NCT00528879|101446477|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
33424649|NCT00528879|101446478|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
33424650|NCT00528879|101446479|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
33424651|NCT00528879|101446480|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
33424652|NCT00528879|101446477|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
33424653|NCT00528879|101446478|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
33424654|NCT00528879|101446479|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
33424655|NCT00528879|101446480|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
33424656|NCT00528879|101446477|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
33424657|NCT00528879|101446478|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
33424658|NCT00528879|101446479|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
33424659|NCT00528879|101446480|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
33378184|NCT01963208|101269409|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
33378185|NCT01963208|101269404|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
33378186|NCT01963208|101269405|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
33378187|NCT01963208|101269406|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
33378188|NCT01963208|101269407|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
33378189|NCT01963208|101269408|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
33378190|NCT01963208|101269409|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
33378191|NCT01963208|101269404|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
33378192|NCT01963208|101269405|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
33378193|NCT01963208|101269406|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
33378194|NCT01963208|101269407|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
33378195|NCT01963208|101269408|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
33378196|NCT01963208|101269409|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
33378197|NCT01963208|101269404|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
33378198|NCT01963208|101269405|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
33378199|NCT01963208|101269406|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
33378200|NCT01963208|101269407|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
33378201|NCT01963208|101269408|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
33378202|NCT01963208|101269409|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
33378203|NCT01963208|101269404|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
33378204|NCT01963208|101269405|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
33378205|NCT01963208|101269406|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
33378206|NCT01963208|101269407|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
33378207|NCT01963208|101269408|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
33378208|NCT01963208|101269409|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
33378209|NCT03498287|101269410|FG000|Overall Study|Withdrawal by Subject|3|||
33378210|NCT03498287|101269411|FG001|Overall Study|Withdrawal by Subject|0|||
33378211|NCT03498287|101269410|FG000|Overall Study|Protocol Violation|0|||
33378212|NCT03498287|101269411|FG001|Overall Study|Protocol Violation|4|||
33378213|NCT03498287|101269410|FG000|Overall Study|Adverse Event|0|||
33378214|NCT03498287|101269411|FG001|Overall Study|Adverse Event|1|||
33378215|NCT00165841|101269412|FG000|Overall Study|Adverse Event|2|||
33378216|NCT00165841|101269413|FG001|Overall Study|Adverse Event|3|||
33378217|NCT00165841|101269412|FG000|Overall Study|Lack of Efficacy|6|||
33378218|NCT00165841|101269413|FG001|Overall Study|Lack of Efficacy|33|||
33378219|NCT00165841|101269412|FG000|Overall Study|Lost to Follow-up|4|||
33378220|NCT00165841|101269413|FG001|Overall Study|Lost to Follow-up|4|||
33378221|NCT00165841|101269412|FG000|Overall Study|Withdrawal by Subject|7|||
33378222|NCT00165841|101269413|FG001|Overall Study|Withdrawal by Subject|8|||
33378223|NCT00165841|101269412|FG000|Overall Study|Physician Decision|1|||
33378224|NCT00165841|101269413|FG001|Overall Study|Physician Decision|0|||
33378225|NCT00165841|101269412|FG000|Overall Study|Protocol Violation|6|||
33378226|NCT00165841|101269413|FG001|Overall Study|Protocol Violation|8|||
33378227|NCT00165841|101269412|FG000|Overall Study|Other|3|||
33378228|NCT00165841|101269413|FG001|Overall Study|Other|5|||
33378229|NCT00165841|101269412|FG000|Overall Study|Medication Noncompliance|1|||
33378230|NCT00165841|101269413|FG001|Overall Study|Medication Noncompliance|1|||
33247495|NCT02689349|100806694|FG001|Overall Study|Withdrawal by Subject|0|||
33378231|NCT00259740|101269414|FG000|Overall Study|Physician Decision|1|||
33378232|NCT00259740|101269415|FG001|Overall Study|Physician Decision|1|||
33378233|NCT00259740|101269414|FG000|Overall Study|Adverse Event|0|||
33378234|NCT00259740|101269415|FG001|Overall Study|Adverse Event|2|||
33247496|NCT01664104|100806695|FG000|Overall Study|Adverse Event|6|||
33378235|NCT00259740|101269414|FG000|Overall Study|Withdrawal by Subject|2|||
33378236|NCT00259740|101269415|FG001|Overall Study|Withdrawal by Subject|6|||
33378237|NCT00259740|101269414|FG000|Overall Study|Death|1|||
33378238|NCT00259740|101269415|FG001|Overall Study|Death|1|||
33378239|NCT00259740|101269414|FG000|Overall Study|Disease progression|19|||
33378240|NCT00259740|101269415|FG001|Overall Study|Disease progression|36|||
33378241|NCT00259740|101269414|FG000|Overall Study|Ongoing|17|||
33378242|NCT00259740|101269415|FG001|Overall Study|Ongoing|3|||
33378243|NCT00259740|101269414|FG000|Overall Study|Other|3|||
33378244|NCT00259740|101269415|FG001|Overall Study|Other|0|||
33378245|NCT00259740|101269414|FG000|Overall Study|Requirement for alternative therapy|0|||
33378246|NCT00259740|101269415|FG001|Overall Study|Requirement for alternative therapy|4|||
33378247|NCT03589885|101269416|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
33378248|NCT03589885|101269417|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
33378249|NCT03589885|101269418|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
33378250|NCT03589885|101269419|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
33378251|NCT03589885|101269420|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
33378252|NCT03589885|101269416|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
33378253|NCT03589885|101269417|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
33378254|NCT03589885|101269418|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
33378255|NCT03589885|101269419|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
33424660|NCT00528879|101446477|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
33424661|NCT00528879|101446478|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
33424662|NCT00528879|101446479|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
33424663|NCT00528879|101446480|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
33424664|NCT00528879|101446477|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
33424665|NCT00528879|101446478|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
33424666|NCT00528879|101446479|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
33424667|NCT00528879|101446480|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
33424668|NCT00528879|101446477|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
33424669|NCT00528879|101446478|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
33424670|NCT00528879|101446479|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
33424671|NCT00528879|101446480|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
33424672|NCT00528879|101446477|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
33424673|NCT00528879|101446478|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
33586624|NCT02248649|102036356|FG001|Overall Study|Death|11|||
33586625|NCT02248649|102036355|FG000|Overall Study|Lost to Follow-up|14|||
33586626|NCT02248649|102036356|FG001|Overall Study|Lost to Follow-up|10|||
33586627|NCT00958347|102036357|FG000|Overall Study|Death|43|||
33586628|NCT00958347|102036357|FG000|Overall Study|Withdrawal by Subject|23|||
33586629|NCT00958347|102036357|FG000|Overall Study|Lost to Follow-up|15|||
33586630|NCT00958347|102036357|FG000|Overall Study|revision/removal|10|||
33378256|NCT03589885|101269420|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
33378257|NCT03589885|101269416|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
33378258|NCT03589885|101269417|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
33378259|NCT03589885|101269418|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
33378260|NCT03589885|101269419|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
33424674|NCT00528879|101446479|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
33424675|NCT00528879|101446480|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
33424676|NCT00528879|101446477|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
33424677|NCT00528879|101446478|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
33424678|NCT00528879|101446479|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
33424679|NCT00528879|101446480|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
33424680|NCT00528879|101446477|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
33424681|NCT00528879|101446478|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
33424682|NCT00528879|101446479|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
33424683|NCT00528879|101446480|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
33424684|NCT00528879|101446477|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
33424685|NCT00528879|101446478|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
33424686|NCT00528879|101446479|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
33424687|NCT00528879|101446480|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
33424688|NCT02024698|101446484|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
33586631|NCT00958347|102036357|FG000|Overall Study|study termination|135|||
33586632|NCT04075513|102036360|FG000|Overall Study|Withdrawal by Subject|2|||
33378261|NCT03589885|101269420|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
33378262|NCT03589885|101269416|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
33378263|NCT03589885|101269417|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
33424689|NCT02024698|101446485|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
33424690|NCT02995837|101446486|FG000|Overall Study|Lost to Follow-up|9|||
33586633|NCT04075513|102036361|FG001|Overall Study|Withdrawal by Subject|2|||
33586634|NCT04075513|102036360|FG000|Overall Study|Lack of Efficacy|1|||
33586635|NCT04075513|102036361|FG001|Overall Study|Lack of Efficacy|0|||
33586636|NCT04075513|102036360|FG000|Overall Study|Lost to Follow-up|4|||
33586637|NCT04075513|102036361|FG001|Overall Study|Lost to Follow-up|2|||
33586638|NCT04075513|102036360|FG000|Overall Study|Switch to insulin pump|1|||
33586639|NCT04075513|102036361|FG001|Overall Study|Switch to insulin pump|0|||
33378264|NCT03589885|101269418|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
33378265|NCT03589885|101269419|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
33378266|NCT03589885|101269420|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
33378267|NCT03589885|101269416|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
33378268|NCT03589885|101269417|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
33378269|NCT03589885|101269418|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
33378270|NCT03589885|101269419|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
33378271|NCT03589885|101269420|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
33378272|NCT03589885|101269416|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
33378273|NCT03589885|101269417|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
33378274|NCT03589885|101269418|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
33378275|NCT03589885|101269419|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
33378276|NCT03589885|101269420|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
33378277|NCT03589885|101269416|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
33378278|NCT03589885|101269417|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
33148766|NCT04966741|100458275|FG001|Overall Study|Lost to Follow-up|0|||
33148767|NCT04250714|100458278|FG000|Overall Study|Treatment - withdrawal by subject|14|||
33148768|NCT04250714|100458278|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
33148769|NCT04250714|100458278|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
33148770|NCT04250714|100458278|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
33148771|NCT04250714|100458278|FG000|Overall Study|Treatment - Death|1|||
33148772|NCT04250714|100458278|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
33148773|NCT04250714|100458278|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
33247497|NCT01664104|100806695|FG000|Overall Study|Lack of Efficacy|2|||
33378279|NCT03589885|101269418|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
33378280|NCT03589885|101269419|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
33378281|NCT03589885|101269420|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
33378282|NCT03589885|101269416|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
33378283|NCT03589885|101269417|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
33378284|NCT03589885|101269418|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
33378285|NCT03589885|101269419|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
33378286|NCT03589885|101269420|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
33378287|NCT03970395|101269421|FG000|Overall Study|Withdrawal by Subject|3|||
33378288|NCT03970395|101269422|FG001|Overall Study|Withdrawal by Subject|4|||
33378289|NCT03970395|101269421|FG000|Overall Study|Lost to Follow-up|4|||
33378290|NCT03970395|101269422|FG001|Overall Study|Lost to Follow-up|8|||
33378291|NCT00064350|101269423|FG000|Induction Treatment|Disease Progression|5|||
33378292|NCT00064350|101269424|FG001|Induction Treatment|Disease Progression|1|||
33378293|NCT00064350|101269425|FG002|Induction Treatment|Disease Progression|110|||
33378294|NCT00064350|101269423|FG000|Induction Treatment|Adverse Event|0|||
33378295|NCT00064350|101269424|FG001|Induction Treatment|Adverse Event|2|||
33378296|NCT00064350|101269425|FG002|Induction Treatment|Adverse Event|49|||
33378297|NCT00064350|101269423|FG000|Induction Treatment|Death|0|||
33378298|NCT00064350|101269424|FG001|Induction Treatment|Death|0|||
33378299|NCT00064350|101269425|FG002|Induction Treatment|Death|9|||
33378300|NCT00064350|101269423|FG000|Induction Treatment|Withdrawal by Subject|0|||
33378301|NCT00064350|101269424|FG001|Induction Treatment|Withdrawal by Subject|0|||
33378302|NCT00064350|101269425|FG002|Induction Treatment|Withdrawal by Subject|21|||
33378303|NCT00064350|101269423|FG000|Induction Treatment|Ineligible or never started treatment|3|||
33378304|NCT00064350|101269424|FG001|Induction Treatment|Ineligible or never started treatment|6|||
33378305|NCT00064350|101269425|FG002|Induction Treatment|Ineligible or never started treatment|34|||
33378306|NCT00064350|101269423|FG000|Induction Treatment|Other|0|||
33378307|NCT00064350|101269424|FG001|Induction Treatment|Other|0|||
33646632|NCT03645434|102259647|FG005|Period 1|Adverse Event|0|||
33646633|NCT03645434|102259642|FG000|Period 1|COPD exacerbation|0|||
33646634|NCT03645434|102259643|FG001|Period 1|COPD exacerbation|0|||
33646635|NCT03645434|102259644|FG002|Period 1|COPD exacerbation|0|||
33646636|NCT03645434|102259645|FG003|Period 1|COPD exacerbation|0|||
33646637|NCT03645434|102259646|FG004|Period 1|COPD exacerbation|1|||
33646638|NCT03645434|102259647|FG005|Period 1|COPD exacerbation|0|||
33646639|NCT00160667|102259648|FG000|Overall Study|Adverse Event|3|||
33646640|NCT00160667|102259649|FG001|Overall Study|Adverse Event|1|||
33148774|NCT04250714|100458278|FG000|Overall Study|Attempt|2|||
33247498|NCT01664104|100806695|FG000|Overall Study|Withdrawal by Subject|1|||
33378308|NCT00064350|101269425|FG002|Induction Treatment|Other|13|||
33378309|NCT00064350|101269423|FG000|Randomization|Adverse Event|8|||
33378310|NCT00064350|101269424|FG001|Randomization|Adverse Event|3|||
33378311|NCT00064350|101269425|FG002|Randomization|Adverse Event|0|||
33378312|NCT00064350|101269423|FG000|Randomization|Death|3|||
33378313|NCT00064350|101269424|FG001|Randomization|Death|0|||
33378314|NCT00064350|101269425|FG002|Randomization|Death|0|||
33378315|NCT00064350|101269423|FG000|Randomization|Withdrawal by Subject|1|||
33646641|NCT00160667|102259650|FG002|Overall Study|Adverse Event|4|||
33646642|NCT00160667|102259648|FG000|Overall Study|Withdrawal by Subject|2|||
33378316|NCT00064350|101269424|FG001|Randomization|Withdrawal by Subject|0|||
33378317|NCT00064350|101269425|FG002|Randomization|Withdrawal by Subject|0|||
33378318|NCT00064350|101269423|FG000|Randomization|Ineligible or never started treatment|9|||
33378319|NCT00064350|101269424|FG001|Randomization|Ineligible or never started treatment|15|||
33378320|NCT00064350|101269425|FG002|Randomization|Ineligible or never started treatment|0|||
33378321|NCT00064350|101269423|FG000|Randomization|Other|5|||
33378322|NCT00064350|101269424|FG001|Randomization|Other|0|||
33378323|NCT00064350|101269425|FG002|Randomization|Other|0|||
33378324|NCT00064350|101269423|FG000|Cross-Over|Adverse Event|0|||
33378325|NCT00064350|101269424|FG001|Cross-Over|Adverse Event|1|||
33378326|NCT00064350|101269425|FG002|Cross-Over|Adverse Event|0|||
33378327|NCT00064350|101269423|FG000|Cross-Over|Death|1|||
33378328|NCT00064350|101269424|FG001|Cross-Over|Death|3|||
33378329|NCT00064350|101269425|FG002|Cross-Over|Death|0|||
33378330|NCT00064350|101269423|FG000|Cross-Over|Withdrawal by Subject|2|||
33378331|NCT00064350|101269424|FG001|Cross-Over|Withdrawal by Subject|2|||
33378332|NCT00064350|101269425|FG002|Cross-Over|Withdrawal by Subject|0|||
33424691|NCT02995837|101446487|FG001|Overall Study|Lost to Follow-up|8|||
33424692|NCT01965535|101446490|FG000|Overall Study|Lack of Efficacy|2|||
33424693|NCT01965535|101446491|FG001|Overall Study|Lack of Efficacy|1|||
33424694|NCT02065791|101446492|FG000|Overall Study|Closed Site|1|||
33424695|NCT02065791|101446493|FG001|Overall Study|Closed Site|1|||
33424696|NCT02065791|101446492|FG000|Overall Study|Withdrawal by Subject|11|||
33424697|NCT02065791|101446493|FG001|Overall Study|Withdrawal by Subject|5|||
33424698|NCT02065791|101446492|FG000|Overall Study|Lost to Follow-up|13|||
33424699|NCT02065791|101446493|FG001|Overall Study|Lost to Follow-up|9|||
33646643|NCT00160667|102259649|FG001|Overall Study|Withdrawal by Subject|0|||
33646644|NCT00160667|102259650|FG002|Overall Study|Withdrawal by Subject|1|||
33378333|NCT00064350|101269423|FG000|Cross-Over|Ineligible or never started treatment|3|||
33378334|NCT00064350|101269424|FG001|Cross-Over|Ineligible or never started treatment|6|||
33378335|NCT00064350|101269425|FG002|Cross-Over|Ineligible or never started treatment|0|||
33378336|NCT00064350|101269423|FG000|Cross-Over|Other|0|||
33378337|NCT00064350|101269424|FG001|Cross-Over|Other|2|||
33378338|NCT00064350|101269425|FG002|Cross-Over|Other|0|||
33378339|NCT00789958|101269428|FG000|Overall Study|Adverse Event|3|||
33378340|NCT00789958|101269428|FG000|Overall Study|Withdrawal by Subject|4|||
33378341|NCT00789958|101269428|FG000|Overall Study|Progression|3|||
33378342|NCT00789958|101269428|FG000|Overall Study|not protocol specified|1|||
33378343|NCT00789958|101269428|FG000|Overall Study|Not eligible/not analyzable|26|||
33378344|NCT04550221|101269429|FG000|Overall Study|Lost to Follow-up|0|||
33378345|NCT04550221|101269430|FG001|Overall Study|Lost to Follow-up|4|||
33378346|NCT04550221|101269429|FG000|Overall Study|Withdrawn|3|||
33378347|NCT04550221|101269430|FG001|Overall Study|Withdrawn|0|||
33378348|NCT04550221|101269429|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
33378349|NCT04550221|101269430|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
33378350|NCT01098461|101269431|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
33378351|NCT01098461|101269432|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
33378352|NCT01098461|101269433|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
33378353|NCT01098461|101269434|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
33378354|NCT01098461|101269431|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
33378355|NCT01098461|101269432|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
33378356|NCT01098461|101269433|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
33378357|NCT01098461|101269434|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
33378358|NCT01098461|101269431|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
33378359|NCT01098461|101269432|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
33378360|NCT01098461|101269433|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
33378361|NCT01098461|101269434|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
33378362|NCT01098461|101269431|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
33378363|NCT01098461|101269432|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
33424700|NCT00297479|101446494|FG000|Overall Study|Lost to Follow-up|37|||
33646645|NCT00160667|102259648|FG000|Overall Study|Lack of Efficacy|0|||
33646646|NCT00160667|102259649|FG001|Overall Study|Lack of Efficacy|1|||
33646647|NCT00160667|102259650|FG002|Overall Study|Lack of Efficacy|0|||
33378364|NCT01098461|101269433|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
33378365|NCT01098461|101269434|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
33378366|NCT01098461|101269431|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
33378367|NCT01098461|101269432|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
33378368|NCT01098461|101269433|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
33424701|NCT00297479|101446495|FG001|Overall Study|Lost to Follow-up|54|||
33646648|NCT00160667|102259648|FG000|Overall Study|Protocol Violation|0|||
33378369|NCT01098461|101269434|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
33378370|NCT01098461|101269431|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
33424702|NCT00297479|101446496|FG002|Overall Study|Lost to Follow-up|51|||
33424703|NCT01017029|101446497|FG000|Overall Study|Lost to Follow-up|1|||
33424704|NCT01017029|101446498|FG001|Overall Study|Lost to Follow-up|0|||
33378371|NCT01098461|101269432|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
33424705|NCT01017029|101446497|FG000|Overall Study|Administrative problem|0|||
33424706|NCT01017029|101446498|FG001|Overall Study|Administrative problem|1|||
33378372|NCT01098461|101269433|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
33378373|NCT01098461|101269434|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
33586640|NCT03248167|102036362|FG000|Overall Study|Withdrawal by Subject|2|||
33586641|NCT03248167|102036363|FG001|Overall Study|Withdrawal by Subject|2|||
33586642|NCT03248167|102036362|FG000|Overall Study|Physician Decision|0|||
33586643|NCT03248167|102036363|FG001|Overall Study|Physician Decision|1|||
33378374|NCT01098461|101269431|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
33378375|NCT01098461|101269432|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
33378376|NCT01098461|101269433|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
33378377|NCT01098461|101269434|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
33378378|NCT00976950|101269435|FG000|Overall Study|Adverse Event|3|||
33378379|NCT00976950|101269435|FG000|Overall Study|Events with no relationship to Aptivus|3|||
33378380|NCT05590767|101269442|FG000|Overall Study|Protocol Violation|1|||
33378381|NCT05590767|101269442|FG000|Overall Study|surgery canceled|1|||
33378382|NCT05590767|101269442|FG000|Overall Study|interscalene brachial block not performed|1|||
33378383|NCT00946881|101269443|FG000|First Treatment|Withdrawal by Subject|1|||
33378384|NCT00946881|101269443|FG000|First Treatment|Patient relocated to another state|1|||
33378385|NCT00946881|101269443|FG000|Retreatment|Withdrawal by Subject|1|||
33378386|NCT01575197|101269444|FG000|Overall Study|Migration out of study area|1|||
33378387|NCT01575197|101269445|FG001|Overall Study|Migration out of study area|5|||
33378388|NCT01575197|101269446|FG002|Overall Study|Migration out of study area|4|||
33378389|NCT01575197|101269444|FG000|Overall Study|SAE|0|||
33378390|NCT01575197|101269445|FG001|Overall Study|SAE|1|||
33378391|NCT01575197|101269446|FG002|Overall Study|SAE|0|||
33378392|NCT01575197|101269444|FG000|Overall Study|Lost to Follow-up|0|||
33378393|NCT01575197|101269445|FG001|Overall Study|Lost to Follow-up|1|||
33378394|NCT01575197|101269446|FG002|Overall Study|Lost to Follow-up|0|||
33378395|NCT01575197|101269444|FG000|Overall Study|Withdrawal by Subject|0|||
33378396|NCT01575197|101269445|FG001|Overall Study|Withdrawal by Subject|1|||
33378397|NCT01575197|101269446|FG002|Overall Study|Withdrawal by Subject|1|||
33378398|NCT01575197|101269444|FG000|Overall Study|Protocol Violation|2|||
33378399|NCT01575197|101269445|FG001|Overall Study|Protocol Violation|1|||
33378400|NCT01575197|101269446|FG002|Overall Study|Protocol Violation|1|||
33378401|NCT00668200|101269447|FG000|Overall Study|Withdrawal by Subject|2|||
33378402|NCT00668200|101269447|FG000|Overall Study|Lost to Follow-up|1|||
33378403|NCT00643487|101269449|FG000|Overall Study|Technical difficulty|3|||
33424707|NCT01017029|101446497|FG000|Overall Study|Death|3|||
33586644|NCT03248167|102036362|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
33586645|NCT03248167|102036363|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
33586646|NCT03248167|102036362|FG000|Overall Study|Lost to Follow-up|1|||
33586647|NCT03248167|102036363|FG001|Overall Study|Lost to Follow-up|0|||
33586648|NCT00090779|102036366|FG000|Step 1|Withdrawal by Subject|4|||
33586649|NCT00090779|102036367|FG001|Step 1|Withdrawal by Subject|2|||
33586650|NCT00090779|102036366|FG000|Step 1|Lost to Follow-up|3|||
33586651|NCT00090779|102036367|FG001|Step 1|Lost to Follow-up|2|||
33586652|NCT00090779|102036366|FG000|Step 1|Death|0|||
33586653|NCT00090779|102036367|FG001|Step 1|Death|2|||
33586654|NCT00090779|102036366|FG000|Step 1|Physician Decision|1|||
33586655|NCT00090779|102036367|FG001|Step 1|Physician Decision|0|||
33586656|NCT00090779|102036366|FG000|Step 1|Pregnancy|1|||
33586657|NCT00090779|102036367|FG001|Step 1|Pregnancy|0|||
33586658|NCT00090779|102036366|FG000|Step 1|Non-compliance to study requirements|0|||
33586659|NCT00090779|102036367|FG001|Step 1|Non-compliance to study requirements|1|||
33586660|NCT00090779|102036366|FG000|Step 1|Subject relocated|2|||
33586661|NCT00090779|102036367|FG001|Step 1|Subject relocated|8|||
33586662|NCT00090779|102036366|FG000|Step 2|Off study per study closure|6|||
33586663|NCT00090779|102036367|FG001|Step 2|Off study per study closure|16|||
33586664|NCT00090779|102036366|FG000|Step 2|Subject relocated|0|||
33586665|NCT00090779|102036367|FG001|Step 2|Subject relocated|1|||
33586666|NCT00090779|102036366|FG000|Step 2|Non-compliance to study requirements|0|||
33586667|NCT00090779|102036367|FG001|Step 2|Non-compliance to study requirements|1|||
33586668|NCT00090779|102036366|FG000|Step 3|Initiation of ART and off extended study|3|||
33586669|NCT00090779|102036367|FG001|Step 3|Initiation of ART and off extended study|2|||
33586670|NCT00090779|102036366|FG000|Step 3|Off extended study due to study closure|4|||
33586671|NCT00090779|102036367|FG001|Step 3|Off extended study due to study closure|3|||
33586672|NCT01140867|102036368|FG000|Overall Study|Adverse Event|22|||
33586673|NCT01140867|102036368|FG000|Overall Study|Lack of Efficacy|3|||
33586674|NCT01140867|102036368|FG000|Overall Study|Lost to Follow-up|2|||
33378404|NCT00448760|101269452|FG000|Overall Study|Death|3|||
33378405|NCT00805545|101269456|FG000|Overall Study|Protocol Violation|3|||
33378406|NCT00805545|101269457|FG001|Overall Study|Protocol Violation|2|||
33378407|NCT00805545|101269456|FG000|Overall Study|Protocol Violation|3|||
33378408|NCT00805545|101269457|FG001|Overall Study|Protocol Violation|1|||
33424708|NCT01017029|101446498|FG001|Overall Study|Death|1|||
33378409|NCT00255086|101269458|FG000|Overall Study|Adverse Event|1|||
33378410|NCT00255086|101269459|FG001|Overall Study|Adverse Event|1|||
33378411|NCT00255086|101269458|FG000|Overall Study|Protocol Violation|1|||
33378412|NCT00255086|101269459|FG001|Overall Study|Protocol Violation|1|||
33378413|NCT01740388|101269460|FG000|Overall Study|Withdrawal by Subject|1|||
33378414|NCT01740388|101269461|FG001|Overall Study|Withdrawal by Subject|2|||
33378415|NCT01740388|101269460|FG000|Overall Study|Lost to Follow-up|2|||
33378416|NCT01740388|101269461|FG001|Overall Study|Lost to Follow-up|0|||
33378417|NCT01740388|101269460|FG000|Overall Study|Physician Decision|2|||
33424709|NCT00455533|101446500|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
33424710|NCT00455533|101446501|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
33424711|NCT00455533|101446502|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
33424712|NCT00455533|101446500|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
33424713|NCT00455533|101446501|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
33424714|NCT00455533|101446502|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
33424715|NCT00455533|101446500|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
33424716|NCT00455533|101446501|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
33378418|NCT01740388|101269461|FG001|Overall Study|Physician Decision|6|||
33378419|NCT01740388|101269460|FG000|Overall Study|Subjects missing data, completed|41|||
33378420|NCT01740388|101269461|FG001|Overall Study|Subjects missing data, completed|36|||
33378421|NCT04124692|101269462|FG000|Overall Study|Medical reason|0|||
33378422|NCT04124692|101269463|FG001|Overall Study|Medical reason|1|||
33378423|NCT04124692|101269462|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
33378424|NCT04124692|101269463|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
33378425|NCT04124692|101269462|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
33378426|NCT04124692|101269463|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
33378427|NCT04124692|101269462|FG000|Overall Study|Lost to Follow-up|2|||
33378428|NCT04124692|101269463|FG001|Overall Study|Lost to Follow-up|4|||
33378429|NCT04124692|101269462|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
33378430|NCT04124692|101269463|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
33378431|NCT01185249|101269464|FG000|Overall Study|Patients discharged or change in status|42|||
33378432|NCT02429258|101269477|FG000|Overall Study|Withdrawal by Subject|2|||
33378433|NCT02429258|101269478|FG001|Overall Study|Withdrawal by Subject|0|||
33378434|NCT02429258|101269477|FG000|Overall Study|Protocol Violation|0|||
33378435|NCT02429258|101269478|FG001|Overall Study|Protocol Violation|1|||
33378436|NCT00630812|101269481|FG000|Randomisation to First Dose|Adverse Event|1|||
33378437|NCT00630812|101269482|FG001|Randomisation to First Dose|Adverse Event|1|||
33378438|NCT00630812|101269481|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
33378439|NCT00630812|101269482|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
33378440|NCT00630812|101269481|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
33424717|NCT00455533|101446502|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
33424718|NCT00455533|101446500|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
33424719|NCT00455533|101446501|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
33424720|NCT00455533|101446502|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
33424721|NCT00455533|101446500|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
33646649|NCT00160667|102259649|FG001|Overall Study|Protocol Violation|1|||
33646650|NCT00160667|102259650|FG002|Overall Study|Protocol Violation|0|||
33646651|NCT00160667|102259648|FG000|Overall Study|Patient decision|0|||
33646652|NCT00160667|102259649|FG001|Overall Study|Patient decision|0|||
33646653|NCT00160667|102259650|FG002|Overall Study|Patient decision|1|||
33646654|NCT03805659|102259653|FG000|Overall Study|Withdrawal by Subject|0|||
33646655|NCT03805659|102259654|FG001|Overall Study|Withdrawal by Subject|1|||
33646656|NCT01159431|102259655|FG000|Overall Study|Adverse Event|1|||
33646657|NCT01159431|102259656|FG001|Overall Study|Adverse Event|2|||
33646658|NCT01159431|102259655|FG000|Overall Study|non-compliance|1|||
33646659|NCT01159431|102259656|FG001|Overall Study|non-compliance|1|||
33646660|NCT01159431|102259655|FG000|Overall Study|Lack of Efficacy|0|||
33646661|NCT01159431|102259656|FG001|Overall Study|Lack of Efficacy|3|||
33646662|NCT00943072|102259657|FG000|Overall Study|Adverse Event|0|||
33646663|NCT00943072|102259658|FG001|Overall Study|Adverse Event|3|||
33646664|NCT00943072|102259657|FG000|Overall Study|Death|0|||
33378441|NCT00630812|101269482|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
33378442|NCT00630812|101269481|FG000|Randomisation to First Dose|Protocol Violation|4|||
33646665|NCT00943072|102259658|FG001|Overall Study|Death|2|||
33646666|NCT00943072|102259657|FG000|Overall Study|Withdrawal by Subject|3|||
33646667|NCT00943072|102259658|FG001|Overall Study|Withdrawal by Subject|1|||
33378443|NCT00630812|101269482|FG001|Randomisation to First Dose|Protocol Violation|1|||
33424722|NCT00455533|101446501|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
33646668|NCT00943072|102259657|FG000|Overall Study|Protocol Violation|0|||
33646669|NCT00943072|102259658|FG001|Overall Study|Protocol Violation|1|||
33646670|NCT00943072|102259657|FG000|Overall Study|Lost to Follow-up|1|||
33646671|NCT00943072|102259658|FG001|Overall Study|Lost to Follow-up|2|||
33646672|NCT00943072|102259657|FG000|Overall Study|Lack of Efficacy|0|||
33646673|NCT00943072|102259658|FG001|Overall Study|Lack of Efficacy|4|||
33646674|NCT00943072|102259657|FG000|Overall Study|Other|1|||
33646675|NCT00943072|102259658|FG001|Overall Study|Other|1|||
33646676|NCT00854113|102259659|FG000|Overall Study|Adverse Event|0|||
33378444|NCT00630812|101269481|FG000|Double Blind Treatment Period|Adverse Event|13|||
33378445|NCT00630812|101269482|FG001|Double Blind Treatment Period|Adverse Event|5|||
33378446|NCT00630812|101269481|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
33378447|NCT00630812|101269482|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
33378448|NCT00630812|101269481|FG000|Double Blind Treatment Period|Physician Decision|2|||
33378449|NCT00630812|101269482|FG001|Double Blind Treatment Period|Physician Decision|1|||
33378450|NCT00630812|101269481|FG000|Double Blind Treatment Period|Protocol Violation|1|||
33378451|NCT00630812|101269482|FG001|Double Blind Treatment Period|Protocol Violation|0|||
33378452|NCT00630812|101269481|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
33378453|NCT00630812|101269482|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
33378454|NCT00630812|101269481|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
33378455|NCT00630812|101269482|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
33378456|NCT00630812|101269481|FG000|Double Blind Treatment Period|Non-compliance|0|||
33378457|NCT00630812|101269482|FG001|Double Blind Treatment Period|Non-compliance|1|||
33378458|NCT00424528|101269484|FG000|Overall Study|Adverse Event|2|||
33378459|NCT00424528|101269485|FG001|Overall Study|Adverse Event|1|||
33378460|NCT00424528|101269486|FG002|Overall Study|Adverse Event|2|||
33378461|NCT00424528|101269484|FG000|Overall Study|Protocol Violation|1|||
33378462|NCT00424528|101269485|FG001|Overall Study|Protocol Violation|1|||
33378463|NCT00424528|101269486|FG002|Overall Study|Protocol Violation|0|||
33378464|NCT00424528|101269484|FG000|Overall Study|Lost to Follow-up|0|||
33378465|NCT00424528|101269485|FG001|Overall Study|Lost to Follow-up|1|||
33378466|NCT00424528|101269486|FG002|Overall Study|Lost to Follow-up|0|||
33378467|NCT00424528|101269484|FG000|Overall Study|noncompliance with study requirements|2|||
33378468|NCT00424528|101269485|FG001|Overall Study|noncompliance with study requirements|1|||
33378469|NCT00424528|101269486|FG002|Overall Study|noncompliance with study requirements|2|||
33378470|NCT00239837|101269487|FG000|Overall Study|Lost to Follow-up|3|||
33378471|NCT00239837|101269488|FG001|Overall Study|Lost to Follow-up|7|||
33378472|NCT00738374|101269489|FG000|Induction Treatment Phase|Adverse Event|14|||
33378473|NCT00738374|101269490|FG001|Induction Treatment Phase|Adverse Event|0|||
33378474|NCT00738374|101269491|FG002|Induction Treatment Phase|Adverse Event|0|||
33378475|NCT00738374|101269492|FG003|Induction Treatment Phase|Adverse Event|0|||
33378476|NCT00738374|101269489|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
33378477|NCT00738374|101269490|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
33378478|NCT00738374|101269491|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
33378479|NCT00738374|101269492|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
33378480|NCT00738374|101269489|FG000|Induction Treatment Phase|Physician Decision|2|||
33378481|NCT00738374|101269490|FG001|Induction Treatment Phase|Physician Decision|0|||
33378482|NCT00738374|101269491|FG002|Induction Treatment Phase|Physician Decision|0|||
33378483|NCT00738374|101269492|FG003|Induction Treatment Phase|Physician Decision|0|||
33378484|NCT00738374|101269489|FG000|Induction Treatment Phase|Protocol Violation|2|||
33378485|NCT00738374|101269490|FG001|Induction Treatment Phase|Protocol Violation|0|||
33378486|NCT00738374|101269491|FG002|Induction Treatment Phase|Protocol Violation|0|||
33378487|NCT00738374|101269492|FG003|Induction Treatment Phase|Protocol Violation|0|||
33378488|NCT00738374|101269489|FG000|Induction Treatment Phase|Non-compliance|1|||
33378489|NCT00738374|101269490|FG001|Induction Treatment Phase|Non-compliance|0|||
33378490|NCT00738374|101269491|FG002|Induction Treatment Phase|Non-compliance|0|||
33378491|NCT00738374|101269492|FG003|Induction Treatment Phase|Non-compliance|0|||
33378492|NCT00738374|101269489|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
33378493|NCT00738374|101269490|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
33378494|NCT00738374|101269491|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
33378495|NCT00738374|101269492|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
33378496|NCT00738374|101269489|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
33378497|NCT00738374|101269490|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
33378498|NCT00738374|101269491|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
33378499|NCT00738374|101269492|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
33378500|NCT00738374|101269489|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
33148775|NCT04250714|100458278|FG000|Overall Study|Intent|7|||
33378501|NCT00738374|101269490|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
33378502|NCT00738374|101269491|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
33378503|NCT00738374|101269492|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
33378504|NCT00738374|101269489|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
33378505|NCT00738374|101269490|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
33424723|NCT00455533|101446502|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
33646677|NCT00854113|102259660|FG001|Overall Study|Adverse Event|0|||
33148776|NCT03611010|100458283|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
33378506|NCT00738374|101269491|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
33378507|NCT00738374|101269492|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
33378508|NCT00738374|101269489|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
33378509|NCT00738374|101269490|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
33378510|NCT00738374|101269491|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
33378511|NCT00738374|101269492|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
33378512|NCT00738374|101269489|FG000|Maintenance Treatment/Observation Phase|Other|0|||
33378513|NCT00738374|101269490|FG001|Maintenance Treatment/Observation Phase|Other|1|||
33378514|NCT00738374|101269491|FG002|Maintenance Treatment/Observation Phase|Other|0|||
33378515|NCT00738374|101269492|FG003|Maintenance Treatment/Observation Phase|Other|0|||
33378516|NCT01021813|101269493|FG000|DB Treatment Phase|Adverse Event|60|||
33378517|NCT01021813|101269494|FG001|DB Treatment Phase|Adverse Event|22|||
33378518|NCT01021813|101269495|FG002|DB Treatment Phase|Adverse Event|0|||
33378519|NCT01021813|101269496|FG003|DB Treatment Phase|Adverse Event|0|||
33378520|NCT01021813|101269497|FG004|DB Treatment Phase|Adverse Event|0|||
33378521|NCT01021813|101269493|FG000|DB Treatment Phase|Lack of Efficacy|44|||
33378522|NCT01021813|101269494|FG001|DB Treatment Phase|Lack of Efficacy|28|||
33378523|NCT01021813|101269495|FG002|DB Treatment Phase|Lack of Efficacy|0|||
33378524|NCT01021813|101269496|FG003|DB Treatment Phase|Lack of Efficacy|0|||
33378525|NCT01021813|101269497|FG004|DB Treatment Phase|Lack of Efficacy|0|||
33378526|NCT01021813|101269493|FG000|DB Treatment Phase|Lost to Follow-up|14|||
33378527|NCT01021813|101269494|FG001|DB Treatment Phase|Lost to Follow-up|12|||
33378528|NCT01021813|101269495|FG002|DB Treatment Phase|Lost to Follow-up|0|||
33378529|NCT01021813|101269496|FG003|DB Treatment Phase|Lost to Follow-up|0|||
33378530|NCT01021813|101269497|FG004|DB Treatment Phase|Lost to Follow-up|0|||
33378531|NCT01021813|101269493|FG000|DB Treatment Phase|Physician Decision|17|||
33378532|NCT01021813|101269494|FG001|DB Treatment Phase|Physician Decision|8|||
33378533|NCT01021813|101269495|FG002|DB Treatment Phase|Physician Decision|0|||
33378534|NCT01021813|101269496|FG003|DB Treatment Phase|Physician Decision|0|||
33378535|NCT01021813|101269497|FG004|DB Treatment Phase|Physician Decision|0|||
33378536|NCT01021813|101269493|FG000|DB Treatment Phase|Pregnancy|1|||
33378537|NCT01021813|101269494|FG001|DB Treatment Phase|Pregnancy|0|||
33378538|NCT01021813|101269495|FG002|DB Treatment Phase|Pregnancy|0|||
33424724|NCT00455533|101446500|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
33424725|NCT00455533|101446501|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
33424726|NCT00455533|101446502|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
33424727|NCT00455533|101446500|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
33424728|NCT00455533|101446501|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
33424729|NCT00455533|101446502|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
33424730|NCT00455533|101446500|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
33424731|NCT00455533|101446501|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
33424732|NCT00455533|101446502|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
33424733|NCT00455533|101446500|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
33424734|NCT00455533|101446501|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
33424735|NCT00455533|101446502|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
33424736|NCT00455533|101446500|FG000|Period Two: Randomized Period|Death|0|||
33424737|NCT00455533|101446501|FG001|Period Two: Randomized Period|Death|0|||
33424738|NCT00455533|101446502|FG002|Period Two: Randomized Period|Death|3|||
33424739|NCT00455533|101446500|FG000|Period Two: Randomized Period|Disease Progression|0|||
33424740|NCT00455533|101446501|FG001|Period Two: Randomized Period|Disease Progression|1|||
33424741|NCT00455533|101446502|FG002|Period Two: Randomized Period|Disease Progression|1|||
33424742|NCT00455533|101446500|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
33424743|NCT00455533|101446501|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
33424744|NCT00455533|101446502|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
33424745|NCT00455533|101446500|FG000|Period Two: Randomized Period|Other - need reasons|0|||
33424746|NCT00455533|101446501|FG001|Period Two: Randomized Period|Other - need reasons|1|||
33424747|NCT00455533|101446502|FG002|Period Two: Randomized Period|Other - need reasons|0|||
33424748|NCT00455533|101446500|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
33424749|NCT00455533|101446501|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
33424750|NCT00455533|101446502|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
33586675|NCT01140867|102036368|FG000|Overall Study|Withdrawal by Subject|1|||
33586676|NCT01140867|102036368|FG000|Overall Study|Protocol Violation|1|||
33148777|NCT03611010|100458284|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
33378539|NCT01021813|101269496|FG003|DB Treatment Phase|Pregnancy|0|||
33378540|NCT01021813|101269497|FG004|DB Treatment Phase|Pregnancy|0|||
33378541|NCT01021813|101269493|FG000|DB Treatment Phase|Protocol Violation|4|||
33378542|NCT01021813|101269494|FG001|DB Treatment Phase|Protocol Violation|3|||
33378543|NCT01021813|101269495|FG002|DB Treatment Phase|Protocol Violation|0|||
33378544|NCT01021813|101269496|FG003|DB Treatment Phase|Protocol Violation|0|||
33424751|NCT00455533|101446500|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
33378545|NCT01021813|101269497|FG004|DB Treatment Phase|Protocol Violation|0|||
33378546|NCT01021813|101269493|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
33378547|NCT01021813|101269494|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
33247499|NCT01664104|100806695|FG000|Overall Study|Lost to Follow-up|4|||
33247500|NCT01664104|100806695|FG000|Overall Study|Other|1|||
33247501|NCT01664104|100806695|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
33247502|NCT02013037|100806696|FG000|Overall Study|Death|6|||
33247503|NCT02013037|100806696|FG000|Overall Study|Withdrawal by Subject|1|||
33247504|NCT02013037|100806696|FG000|Overall Study|Awaiting Transplantation|7|||
33247505|NCT02013037|100806696|FG000|Overall Study|Transplanted without DSA|2|||
33247506|NCT02908464|100806697|FG000|Overall Study|Withdrawal by Subject|2|||
33247507|NCT02908464|100806698|FG001|Overall Study|Withdrawal by Subject|1|||
33378548|NCT01021813|101269495|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
33378549|NCT01021813|101269496|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
33378550|NCT01021813|101269497|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
33378551|NCT01021813|101269493|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
33378552|NCT01021813|101269494|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
33378553|NCT01021813|101269495|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
33378554|NCT01021813|101269496|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
33378555|NCT01021813|101269497|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
33378556|NCT01021813|101269493|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
33378557|NCT01021813|101269494|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
33378558|NCT01021813|101269495|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
33378559|NCT01021813|101269496|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
33378560|NCT01021813|101269497|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
33378561|NCT01021813|101269493|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
33378562|NCT01021813|101269494|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
33378563|NCT01021813|101269495|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
33378564|NCT01021813|101269496|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
33378565|NCT01021813|101269497|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
33378566|NCT01021813|101269493|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
33378567|NCT01021813|101269494|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
33378568|NCT01021813|101269495|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
33378569|NCT01021813|101269496|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
33378570|NCT01021813|101269497|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
33378571|NCT01021813|101269493|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
33378572|NCT01021813|101269494|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
33378573|NCT01021813|101269495|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
33378574|NCT01021813|101269496|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
33378575|NCT01021813|101269497|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
33378576|NCT01536119|101269503|FG000|Overall Study|Lost to Follow-up|17|||
33378577|NCT01536119|101269504|FG001|Overall Study|Lost to Follow-up|14|||
33378578|NCT01088438|101269510|FG000|Overall Study|Withdrawal by Subject|11|||
33424752|NCT00455533|101446501|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
33586677|NCT01140867|102036368|FG000|Overall Study|Uncooperative patient|2|||
33586678|NCT01140867|102036368|FG000|Overall Study|Medication Noncompliance|2|||
33148778|NCT03611010|100458285|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
33148779|NCT03611010|100458286|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
33148780|NCT02819518|100458288|FG000|Overall Study|Death|9|||
33148781|NCT02819518|100458289|FG001|Overall Study|Death|12|||
33148782|NCT02819518|100458290|FG002|Overall Study|Death|9|||
33148783|NCT02819518|100458291|FG003|Overall Study|Death|475|||
33148784|NCT02819518|100458292|FG004|Overall Study|Death|244|||
33148785|NCT02819518|100458288|FG000|Overall Study|Withdrawal by Subject|0|||
33148786|NCT02819518|100458289|FG001|Overall Study|Withdrawal by Subject|0|||
33148787|NCT02819518|100458290|FG002|Overall Study|Withdrawal by Subject|0|||
33148788|NCT02819518|100458291|FG003|Overall Study|Withdrawal by Subject|25|||
33148789|NCT02819518|100458292|FG004|Overall Study|Withdrawal by Subject|8|||
33148790|NCT02819518|100458288|FG000|Overall Study|Lost to Follow-up|0|||
33148791|NCT02819518|100458289|FG001|Overall Study|Lost to Follow-up|0|||
33148792|NCT02819518|100458290|FG002|Overall Study|Lost to Follow-up|0|||
33148793|NCT02819518|100458291|FG003|Overall Study|Lost to Follow-up|0|||
33148794|NCT02819518|100458292|FG004|Overall Study|Lost to Follow-up|1|||
33148795|NCT02819518|100458288|FG000|Overall Study|Sponsor Decision|1|||
33148796|NCT02819518|100458289|FG001|Overall Study|Sponsor Decision|1|||
33148797|NCT02819518|100458290|FG002|Overall Study|Sponsor Decision|0|||
33148798|NCT02819518|100458291|FG003|Overall Study|Sponsor Decision|34|||
33148799|NCT02819518|100458292|FG004|Overall Study|Sponsor Decision|17|||
33148800|NCT02819518|100458288|FG000|Overall Study|Transferred to extension study|1|||
33148801|NCT02819518|100458289|FG001|Overall Study|Transferred to extension study|1|||
33148802|NCT02819518|100458290|FG002|Overall Study|Transferred to extension study|1|||
33148803|NCT02819518|100458291|FG003|Overall Study|Transferred to extension study|32|||
33424753|NCT00455533|101446502|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
33424754|NCT02340078|101446504|FG000|Overall Study|Protocol Violation|1|||
33424755|NCT01298596|101446505|FG000|Overall Study|Withdrawal by Subject|1|||
33424756|NCT01298596|101446506|FG001|Overall Study|Withdrawal by Subject|1|||
33424757|NCT01298596|101446505|FG000|Overall Study|Death|5|||
33424758|NCT01298596|101446506|FG001|Overall Study|Death|3|||
33424759|NCT01298596|101446505|FG000|Overall Study|Lost to Follow-up|6|||
33424760|NCT01298596|101446506|FG001|Overall Study|Lost to Follow-up|14|||
33424761|NCT01298596|101446505|FG000|Overall Study|Referred for further management|16|||
33424762|NCT01298596|101446506|FG001|Overall Study|Referred for further management|15|||
33424763|NCT02437890|101446507|FG000|Overall Study|Non-compliance to study drug|0|||
33424764|NCT02437890|101446508|FG001|Overall Study|Non-compliance to study drug|1|||
33424765|NCT02437890|101446509|FG002|Overall Study|Non-compliance to study drug|0|||
33424766|NCT02437890|101446510|FG003|Overall Study|Non-compliance to study drug|0|||
33424767|NCT02437890|101446511|FG004|Overall Study|Non-compliance to study drug|1|||
33424768|NCT02437890|101446507|FG000|Overall Study|Sponsor's decision|1|||
33424769|NCT02437890|101446508|FG001|Overall Study|Sponsor's decision|1|||
33424770|NCT02437890|101446509|FG002|Overall Study|Sponsor's decision|4|||
33424771|NCT02437890|101446510|FG003|Overall Study|Sponsor's decision|0|||
33424772|NCT02437890|101446511|FG004|Overall Study|Sponsor's decision|2|||
33424773|NCT02437890|101446507|FG000|Overall Study|Physician Decision|0|||
33424774|NCT02437890|101446508|FG001|Overall Study|Physician Decision|0|||
33424775|NCT02437890|101446509|FG002|Overall Study|Physician Decision|0|||
33424776|NCT02437890|101446510|FG003|Overall Study|Physician Decision|1|||
33424777|NCT02437890|101446511|FG004|Overall Study|Physician Decision|0|||
33378579|NCT01088438|101269511|FG001|Overall Study|Withdrawal by Subject|6|||
33378580|NCT01088438|101269510|FG000|Overall Study|Lost to Follow-up|18|||
33378581|NCT01088438|101269511|FG001|Overall Study|Lost to Follow-up|30|||
33378582|NCT00171314|101269512|FG000|Overall Study|Adverse Event|44|||
33378583|NCT00171314|101269513|FG001|Overall Study|Adverse Event|41|||
33378584|NCT00171314|101269512|FG000|Overall Study|Lack of Efficacy|19|||
33378585|NCT00171314|101269513|FG001|Overall Study|Lack of Efficacy|14|||
33378586|NCT00171314|101269512|FG000|Overall Study|Withdrawal by Subject|9|||
33378587|NCT00171314|101269513|FG001|Overall Study|Withdrawal by Subject|6|||
33378588|NCT00171314|101269512|FG000|Overall Study|Abnormal Test Procedure Results|9|||
33378589|NCT00171314|101269513|FG001|Overall Study|Abnormal Test Procedure Results|3|||
33378590|NCT00171314|101269512|FG000|Overall Study|Protocol Violation|3|||
33646678|NCT00854113|102259661|FG002|Overall Study|Adverse Event|0|||
33378591|NCT00171314|101269513|FG001|Overall Study|Protocol Violation|7|||
33378592|NCT00171314|101269512|FG000|Overall Study|Administrative Problems|4|||
33378593|NCT00171314|101269513|FG001|Overall Study|Administrative Problems|3|||
33378594|NCT00171314|101269512|FG000|Overall Study|Lost to Follow-up|1|||
33378595|NCT00171314|101269513|FG001|Overall Study|Lost to Follow-up|3|||
33378596|NCT00171314|101269512|FG000|Overall Study|Death|2|||
33378597|NCT00171314|101269513|FG001|Overall Study|Death|1|||
33378598|NCT00747617|101269518|FG000|Overall Study|Lost to Follow-up|3|||
33378599|NCT00747617|101269519|FG001|Overall Study|Lost to Follow-up|1|||
33378600|NCT03987919|101269520|FG000|Overall Study|Adverse Event|1|||
33378601|NCT03987919|101269521|FG001|Overall Study|Adverse Event|4|||
33424778|NCT02437890|101446507|FG000|Overall Study|Unable to attend visit(s)|1|||
33646679|NCT00854113|102259662|FG003|Overall Study|Adverse Event|0|||
33378602|NCT03987919|101269522|FG002|Overall Study|Adverse Event|1|||
33378603|NCT03987919|101269523|FG003|Overall Study|Adverse Event|3|||
33378604|NCT03987919|101269520|FG000|Overall Study|Death|4|||
33378605|NCT03987919|101269521|FG001|Overall Study|Death|4|||
33378606|NCT03987919|101269522|FG002|Overall Study|Death|4|||
33378607|NCT03987919|101269523|FG003|Overall Study|Death|1|||
33378608|NCT03987919|101269520|FG000|Overall Study|Lost to Follow-up|5|||
33378609|NCT03987919|101269521|FG001|Overall Study|Lost to Follow-up|6|||
33424779|NCT02437890|101446508|FG001|Overall Study|Unable to attend visit(s)|0|||
33424780|NCT02437890|101446509|FG002|Overall Study|Unable to attend visit(s)|0|||
33424781|NCT02437890|101446510|FG003|Overall Study|Unable to attend visit(s)|0|||
33424782|NCT02437890|101446511|FG004|Overall Study|Unable to attend visit(s)|0|||
33424783|NCT02437890|101446507|FG000|Overall Study|Lack of Efficacy|1|||
33646680|NCT00854113|102259663|FG004|Overall Study|Adverse Event|0|||
33378610|NCT03987919|101269522|FG002|Overall Study|Lost to Follow-up|8|||
33378611|NCT03987919|101269523|FG003|Overall Study|Lost to Follow-up|12|||
33378612|NCT03987919|101269520|FG000|Overall Study|Physician Decision|0|||
33378613|NCT03987919|101269521|FG001|Overall Study|Physician Decision|2|||
33378614|NCT03987919|101269522|FG002|Overall Study|Physician Decision|0|||
33378615|NCT03987919|101269523|FG003|Overall Study|Physician Decision|4|||
33378616|NCT03987919|101269520|FG000|Overall Study|Pregnancy|1|||
33378617|NCT03987919|101269521|FG001|Overall Study|Pregnancy|0|||
33378618|NCT03987919|101269522|FG002|Overall Study|Pregnancy|1|||
33424784|NCT02437890|101446508|FG001|Overall Study|Lack of Efficacy|3|||
33424785|NCT02437890|101446509|FG002|Overall Study|Lack of Efficacy|0|||
33424786|NCT02437890|101446510|FG003|Overall Study|Lack of Efficacy|3|||
33424787|NCT02437890|101446511|FG004|Overall Study|Lack of Efficacy|1|||
33424788|NCT02437890|101446507|FG000|Overall Study|Adverse Event|4|||
33378619|NCT03987919|101269523|FG003|Overall Study|Pregnancy|1|||
33378620|NCT03987919|101269520|FG000|Overall Study|Protocol Violation|0|||
33378621|NCT03987919|101269521|FG001|Overall Study|Protocol Violation|1|||
33378622|NCT03987919|101269522|FG002|Overall Study|Protocol Violation|0|||
33378623|NCT03987919|101269523|FG003|Overall Study|Protocol Violation|0|||
33378624|NCT03987919|101269520|FG000|Overall Study|Site terminated by Sponsor|0|||
33378625|NCT03987919|101269521|FG001|Overall Study|Site terminated by Sponsor|0|||
33378626|NCT03987919|101269522|FG002|Overall Study|Site terminated by Sponsor|0|||
33586679|NCT01832493|102036369|FG000|Overall Study|Physician Decision|2|||
33646681|NCT00854113|102259664|FG005|Overall Study|Adverse Event|0|||
33646682|NCT00854113|102259665|FG006|Overall Study|Adverse Event|0|||
33646683|NCT00854113|102259666|FG007|Overall Study|Adverse Event|2|||
33646684|NCT00854113|102259667|FG008|Overall Study|Adverse Event|0|||
33646685|NCT00854113|102259668|FG009|Overall Study|Adverse Event|0|||
33646686|NCT00854113|102259669|FG010|Overall Study|Adverse Event|0|||
33646687|NCT00854113|102259659|FG000|Overall Study|Withdrawal by Subject|0|||
33646688|NCT00854113|102259660|FG001|Overall Study|Withdrawal by Subject|0|||
33646689|NCT00854113|102259661|FG002|Overall Study|Withdrawal by Subject|0|||
33586680|NCT01832493|102036369|FG000|Overall Study|Protocol Violation|4|||
33586681|NCT01832493|102036369|FG000|Overall Study|Unable to place LV lead|2|||
33586682|NCT00431444|102036374|FG000|Overall Study|Protocol Violation|1|||
33586683|NCT00431444|102036375|FG001|Overall Study|Protocol Violation|4|||
33586684|NCT00431444|102036374|FG000|Overall Study|Adverse Event|2|||
33586685|NCT00431444|102036375|FG001|Overall Study|Adverse Event|1|||
33586686|NCT00431444|102036374|FG000|Overall Study|Withdrawal by Subject|1|||
33586687|NCT00431444|102036375|FG001|Overall Study|Withdrawal by Subject|1|||
33586688|NCT00431444|102036374|FG000|Overall Study|Lost to Follow-up|1|||
33586689|NCT00431444|102036375|FG001|Overall Study|Lost to Follow-up|0|||
33646690|NCT00854113|102259662|FG003|Overall Study|Withdrawal by Subject|0|||
33646691|NCT00854113|102259663|FG004|Overall Study|Withdrawal by Subject|0|||
33646692|NCT00854113|102259664|FG005|Overall Study|Withdrawal by Subject|0|||
33646693|NCT00854113|102259665|FG006|Overall Study|Withdrawal by Subject|0|||
33646694|NCT00854113|102259666|FG007|Overall Study|Withdrawal by Subject|1|||
33646695|NCT00854113|102259667|FG008|Overall Study|Withdrawal by Subject|1|||
33646696|NCT00854113|102259668|FG009|Overall Study|Withdrawal by Subject|0|||
33646697|NCT00854113|102259669|FG010|Overall Study|Withdrawal by Subject|0|||
33646698|NCT01738477|102259674|FG000|Overall Study|Lost to Follow-up|1|||
33646699|NCT01738477|102259675|FG001|Overall Study|Lost to Follow-up|4|||
33646700|NCT01324141|102259679|FG000|Overall Study|Declined to participate before treatment started|1|||
33646701|NCT01324141|102259679|FG000|Overall Study|Disease progression on study|1|||
33646702|NCT02741518|102259682|FG000|Overall Study|Withdrawal by Subject|1|||
33646703|NCT02741518|102259683|FG001|Overall Study|Withdrawal by Subject|1|||
33646704|NCT00743106|102259685|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
33646705|NCT00743106|102259686|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
33646706|NCT04450381|102259687|FG000|Overall Study|Protocol Violation|4|||
33646707|NCT04450381|102259687|FG000|Overall Study|Wrong device setting|2|||
33247508|NCT02908464|100806697|FG000|Overall Study|Found ineligible after randomization|0|||
33378627|NCT03987919|101269523|FG003|Overall Study|Site terminated by Sponsor|1|||
33378628|NCT03987919|101269520|FG000|Overall Study|Withdrawal by Subject|7|||
33424789|NCT02437890|101446508|FG001|Overall Study|Adverse Event|9|||
33424790|NCT02437890|101446509|FG002|Overall Study|Adverse Event|5|||
33424791|NCT02437890|101446510|FG003|Overall Study|Adverse Event|11|||
33424792|NCT02437890|101446511|FG004|Overall Study|Adverse Event|7|||
33424793|NCT02437890|101446507|FG000|Overall Study|Withdrawal by Subject|1|||
33424794|NCT02437890|101446508|FG001|Overall Study|Withdrawal by Subject|2|||
33424795|NCT02437890|101446509|FG002|Overall Study|Withdrawal by Subject|6|||
33586690|NCT00431444|102036374|FG000|Overall Study|Administrative Problems|0|||
33586691|NCT00431444|102036375|FG001|Overall Study|Administrative Problems|1|||
33586692|NCT03332173|102036378|FG000|Overall Study|Death|7|||
33586693|NCT03332173|102036378|FG000|Overall Study|Withdrawal by Subject|6|||
33586694|NCT03332173|102036378|FG000|Overall Study|Lost to Follow-up|2|||
33586695|NCT03332173|102036378|FG000|Overall Study|Transferred to long-term extension study|29|||
33586696|NCT04723355|102036379|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
33586697|NCT04723355|102036379|FG000|Overall Study|Errors in the informed consent form|2|||
33586698|NCT02249091|102036380|FG000|Overall Study|Lack of Efficacy|8|||
33586699|NCT02249091|102036381|FG001|Overall Study|Lack of Efficacy|3|||
33586700|NCT02249091|102036380|FG000|Overall Study|Physician Decision|4|||
33586701|NCT02249091|102036381|FG001|Overall Study|Physician Decision|1|||
33586702|NCT02249091|102036380|FG000|Overall Study|Withdrawal by Subject|2|||
33586703|NCT02249091|102036381|FG001|Overall Study|Withdrawal by Subject|2|||
33646708|NCT02445794|102259688|FG000|Overall Study|Adverse Event|0|||
33646709|NCT02445794|102259689|FG001|Overall Study|Adverse Event|0|||
33424796|NCT02437890|101446510|FG003|Overall Study|Withdrawal by Subject|5|||
33586704|NCT02249091|102036380|FG000|Overall Study|Death|3|||
33586705|NCT02249091|102036381|FG001|Overall Study|Death|4|||
33646710|NCT02445794|102259690|FG002|Overall Study|Adverse Event|2|||
33424797|NCT02437890|101446511|FG004|Overall Study|Withdrawal by Subject|5|||
33646711|NCT02445794|102259691|FG003|Overall Study|Adverse Event|0|||
33646712|NCT00724867|102259692|FG000|Overall Study|Adverse Event|25|||
33646713|NCT00724867|102259692|FG000|Overall Study|Lack of Efficacy|14|||
33646714|NCT00724867|102259692|FG000|Overall Study|Lost to Follow-up|12|||
33646715|NCT00724867|102259692|FG000|Overall Study|Non-compliance with study drug|6|||
33148804|NCT02819518|100458292|FG004|Overall Study|Transferred to extension study|11|||
33148805|NCT03422627|100458293|FG000|Overall Study|Protocol-specified Criteria|1|||
33148806|NCT03422627|100458294|FG001|Overall Study|Protocol-specified Criteria|1|||
33148807|NCT03422627|100458295|FG002|Overall Study|Protocol-specified Criteria|0|||
33148808|NCT03422627|100458296|FG003|Overall Study|Protocol-specified Criteria|0|||
33148809|NCT03422627|100458297|FG004|Overall Study|Protocol-specified Criteria|2|||
33148810|NCT03422627|100458293|FG000|Overall Study|Requirement for Alternative Therapy|1|||
33148811|NCT03422627|100458294|FG001|Overall Study|Requirement for Alternative Therapy|1|||
33148812|NCT03422627|100458295|FG002|Overall Study|Requirement for Alternative Therapy|2|||
33148813|NCT03422627|100458296|FG003|Overall Study|Requirement for Alternative Therapy|0|||
33148814|NCT03422627|100458297|FG004|Overall Study|Requirement for Alternative Therapy|0|||
33148815|NCT03422627|100458293|FG000|Overall Study|Disease Progression|1|||
33586706|NCT02249091|102036380|FG000|Overall Study|Adverse Event|1|||
33586707|NCT02249091|102036381|FG001|Overall Study|Adverse Event|0|||
33586708|NCT02249091|102036380|FG000|Overall Study|Stable disease with following SCT|0|||
33586709|NCT02249091|102036381|FG001|Overall Study|Stable disease with following SCT|1|||
33586710|NCT02249091|102036380|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
33586711|NCT02249091|102036381|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
33586712|NCT02249091|102036380|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
33586713|NCT02249091|102036381|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
33586714|NCT02249091|102036380|FG000|Overall Study|Refractory AML|1|||
33586715|NCT02249091|102036381|FG001|Overall Study|Refractory AML|1|||
33586716|NCT03053440|102036382|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
33586717|NCT03053440|102036383|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
33586718|NCT03053440|102036382|FG000|Overall Study|Death|18|||
33586719|NCT03053440|102036383|FG001|Overall Study|Death|14|||
33586720|NCT03053440|102036382|FG000|Overall Study|Withdrawal by Subject|9|||
33586721|NCT03053440|102036383|FG001|Overall Study|Withdrawal by Subject|8|||
33586722|NCT03053440|102036382|FG000|Overall Study|Lost to Follow-up|1|||
33586723|NCT03053440|102036383|FG001|Overall Study|Lost to Follow-up|0|||
33586724|NCT03053440|102036382|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
33586725|NCT03053440|102036383|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
33586726|NCT03053440|102036382|FG000|Overall Study|Physician Decision|2|||
33586727|NCT03053440|102036383|FG001|Overall Study|Physician Decision|1|||
33586728|NCT03053440|102036382|FG000|Overall Study|Participant Randomized but died before dosing|1|||
33586729|NCT03053440|102036383|FG001|Overall Study|Participant Randomized but died before dosing|0|||
33586730|NCT02308163|102036384|FG000|Overall Study|Not fulfill eligible criteria|1|||
33586731|NCT02308163|102036385|FG001|Overall Study|Not fulfill eligible criteria|2|||
33586732|NCT02308163|102036386|FG002|Overall Study|Not fulfill eligible criteria|0|||
33586733|NCT02308163|102036387|FG003|Overall Study|Not fulfill eligible criteria|1|||
33586734|NCT02308163|102036388|FG004|Overall Study|Not fulfill eligible criteria|1|||
33586735|NCT02308163|102036384|FG000|Overall Study|Adverse Event|9|||
33586736|NCT02308163|102036385|FG001|Overall Study|Adverse Event|5|||
33586737|NCT02308163|102036386|FG002|Overall Study|Adverse Event|2|||
33586738|NCT02308163|102036387|FG003|Overall Study|Adverse Event|2|||
33586739|NCT02308163|102036388|FG004|Overall Study|Adverse Event|11|||
33586740|NCT02308163|102036384|FG000|Overall Study|Lack of Efficacy|11|||
33586741|NCT02308163|102036385|FG001|Overall Study|Lack of Efficacy|3|||
33586742|NCT02308163|102036386|FG002|Overall Study|Lack of Efficacy|8|||
33586743|NCT02308163|102036387|FG003|Overall Study|Lack of Efficacy|4|||
33586744|NCT02308163|102036388|FG004|Overall Study|Lack of Efficacy|6|||
33586745|NCT02308163|102036384|FG000|Overall Study|Withdrawal of consent|2|||
33586746|NCT02308163|102036385|FG001|Overall Study|Withdrawal of consent|3|||
33586747|NCT02308163|102036386|FG002|Overall Study|Withdrawal of consent|0|||
33586748|NCT02308163|102036387|FG003|Overall Study|Withdrawal of consent|2|||
33586749|NCT02308163|102036388|FG004|Overall Study|Withdrawal of consent|6|||
33586750|NCT02308163|102036384|FG000|Overall Study|Protocol Violation|3|||
33586751|NCT02308163|102036385|FG001|Overall Study|Protocol Violation|3|||
33586752|NCT02308163|102036386|FG002|Overall Study|Protocol Violation|3|||
33586753|NCT02308163|102036387|FG003|Overall Study|Protocol Violation|2|||
33586754|NCT02308163|102036388|FG004|Overall Study|Protocol Violation|5|||
33646716|NCT00724867|102259692|FG000|Overall Study|Physician Decision|17|||
33646717|NCT00724867|102259692|FG000|Overall Study|Protocol Violation|1|||
33646718|NCT00724867|102259692|FG000|Overall Study|Withdrawal by Subject|31|||
33148816|NCT03422627|100458294|FG001|Overall Study|Disease Progression|0|||
33586755|NCT02308163|102036384|FG000|Overall Study|Lab data met discontinuation criteria|3|||
33586756|NCT02308163|102036385|FG001|Overall Study|Lab data met discontinuation criteria|0|||
33586757|NCT02308163|102036386|FG002|Overall Study|Lab data met discontinuation criteria|0|||
33586758|NCT02308163|102036387|FG003|Overall Study|Lab data met discontinuation criteria|2|||
33148817|NCT03422627|100458295|FG002|Overall Study|Disease Progression|1|||
33148818|NCT03422627|100458296|FG003|Overall Study|Disease Progression|2|||
33148819|NCT03422627|100458297|FG004|Overall Study|Disease Progression|0|||
33148820|NCT03422627|100458293|FG000|Overall Study|Adverse Event|2|||
33148821|NCT03422627|100458294|FG001|Overall Study|Adverse Event|1|||
33148822|NCT03422627|100458295|FG002|Overall Study|Adverse Event|0|||
33148823|NCT03422627|100458296|FG003|Overall Study|Adverse Event|0|||
33148824|NCT03422627|100458297|FG004|Overall Study|Adverse Event|2|||
33424798|NCT02437890|101446507|FG000|Overall Study|Death|0|||
33378629|NCT03987919|101269521|FG001|Overall Study|Withdrawal by Subject|7|||
33378630|NCT03987919|101269522|FG002|Overall Study|Withdrawal by Subject|8|||
33378631|NCT03987919|101269523|FG003|Overall Study|Withdrawal by Subject|4|||
33378632|NCT03987919|101269520|FG000|Overall Study|Other - as reported by the investigator|1|||
33378633|NCT03987919|101269521|FG001|Overall Study|Other - as reported by the investigator|3|||
33148825|NCT03422627|100458293|FG000|Overall Study|Ineligibility Determined|0|||
33148826|NCT03422627|100458294|FG001|Overall Study|Ineligibility Determined|1|||
33148827|NCT03422627|100458295|FG002|Overall Study|Ineligibility Determined|0|||
33148828|NCT03422627|100458296|FG003|Overall Study|Ineligibility Determined|0|||
33148829|NCT03422627|100458297|FG004|Overall Study|Ineligibility Determined|0|||
33148830|NCT03422627|100458293|FG000|Overall Study|Death|0|||
33148831|NCT03422627|100458294|FG001|Overall Study|Death|1|||
33148832|NCT03422627|100458295|FG002|Overall Study|Death|1|||
33378634|NCT03987919|101269522|FG002|Overall Study|Other - as reported by the investigator|2|||
33378635|NCT03987919|101269523|FG003|Overall Study|Other - as reported by the investigator|0|||
33378636|NCT03558555|101269524|FG000|Overall Study|Lost to Follow-up|2|||
33378637|NCT03558555|101269525|FG001|Overall Study|Lost to Follow-up|1|||
33424799|NCT02437890|101446508|FG001|Overall Study|Death|0|||
33424800|NCT02437890|101446509|FG002|Overall Study|Death|0|||
33424801|NCT02437890|101446510|FG003|Overall Study|Death|2|||
33424802|NCT02437890|101446511|FG004|Overall Study|Death|0|||
33424803|NCT03101293|101446512|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
33424804|NCT03101293|101446513|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
33424805|NCT01272193|101446514|FG000|Overall Study|Adverse Event|1|||
33424806|NCT01272193|101446515|FG001|Overall Study|Adverse Event|1|||
33424807|NCT01272193|101446514|FG000|Overall Study|Lack of Efficacy|0|||
33424808|NCT01272193|101446515|FG001|Overall Study|Lack of Efficacy|3|||
33424809|NCT01272193|101446514|FG000|Overall Study|Withdrawal Criteria|1|||
33424810|NCT01272193|101446515|FG001|Overall Study|Withdrawal Criteria|1|||
33424811|NCT01272193|101446514|FG000|Overall Study|Unclassified|8|||
33424812|NCT01272193|101446515|FG001|Overall Study|Unclassified|7|||
33424813|NCT01377233|101446516|FG000|Open-label|Adverse Event|1|||
33424814|NCT01377233|101446517|FG001|Open-label|Adverse Event|0|||
33424815|NCT01377233|101446518|FG002|Open-label|Adverse Event|0|||
33424816|NCT01377233|101446519|FG003|Open-label|Adverse Event|0|||
33424817|NCT01377233|101446520|FG004|Open-label|Adverse Event|0|||
33424818|NCT01377233|101446516|FG000|Open-label|Withdrawal by Subject|3|||
33148833|NCT03422627|100458296|FG003|Overall Study|Death|0|||
33378638|NCT02927873|101269529|FG000|Overall Study|Lost to Follow-up|0|||
33378639|NCT02927873|101269530|FG001|Overall Study|Lost to Follow-up|1|||
33378640|NCT02927873|101269531|FG002|Overall Study|Lost to Follow-up|0|||
33378641|NCT02927873|101269532|FG003|Overall Study|Lost to Follow-up|0|||
33378642|NCT02927873|101269533|FG004|Overall Study|Lost to Follow-up|0|||
33424819|NCT01377233|101446517|FG001|Open-label|Withdrawal by Subject|0|||
33424820|NCT01377233|101446518|FG002|Open-label|Withdrawal by Subject|0|||
33424821|NCT01377233|101446519|FG003|Open-label|Withdrawal by Subject|0|||
33424822|NCT01377233|101446520|FG004|Open-label|Withdrawal by Subject|0|||
33424823|NCT01377233|101446516|FG000|Double-blind|Adverse Event|0|||
33424824|NCT01377233|101446517|FG001|Double-blind|Adverse Event|1|||
33424825|NCT01377233|101446518|FG002|Double-blind|Adverse Event|2|||
33424826|NCT01377233|101446519|FG003|Double-blind|Adverse Event|2|||
33148834|NCT03422627|100458297|FG004|Overall Study|Death|0|||
33247509|NCT02908464|100806698|FG001|Overall Study|Found ineligible after randomization|2|||
33378643|NCT02927873|101269534|FG005|Overall Study|Lost to Follow-up|0|||
33424827|NCT01377233|101446520|FG004|Double-blind|Adverse Event|0|||
33424828|NCT01377233|101446516|FG000|Double-blind|Protocol Violation|0|||
33148835|NCT03422627|100458293|FG000|Overall Study|Withdrawal by Subject|0|||
33148836|NCT03422627|100458294|FG001|Overall Study|Withdrawal by Subject|0|||
33148837|NCT03422627|100458295|FG002|Overall Study|Withdrawal by Subject|0|||
33378644|NCT02927873|101269529|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33378645|NCT02927873|101269530|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
33378646|NCT02927873|101269531|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33424829|NCT01377233|101446517|FG001|Double-blind|Protocol Violation|0|||
33247510|NCT00093795|100806699|FG000|Overall Study|No follow up data|20|||
33424830|NCT01377233|101446518|FG002|Double-blind|Protocol Violation|0|||
33424831|NCT01377233|101446519|FG003|Double-blind|Protocol Violation|0|||
33424832|NCT01377233|101446520|FG004|Double-blind|Protocol Violation|1|||
33424833|NCT01377233|101446516|FG000|Double-blind|Withdrawal by Subject|0|||
33424834|NCT01377233|101446517|FG001|Double-blind|Withdrawal by Subject|0|||
33424835|NCT01377233|101446518|FG002|Double-blind|Withdrawal by Subject|0|||
33378647|NCT02927873|101269532|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33378648|NCT02927873|101269533|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33378649|NCT02927873|101269534|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33378650|NCT02927873|101269529|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33378651|NCT02927873|101269530|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33378652|NCT02927873|101269531|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33424836|NCT01377233|101446519|FG003|Double-blind|Withdrawal by Subject|1|||
33424837|NCT01377233|101446520|FG004|Double-blind|Withdrawal by Subject|0|||
33424838|NCT01377233|101446516|FG000|Double-blind|Administrative or other|0|||
33424839|NCT01377233|101446517|FG001|Double-blind|Administrative or other|0|||
33424840|NCT01377233|101446518|FG002|Double-blind|Administrative or other|0|||
33424841|NCT01377233|101446519|FG003|Double-blind|Administrative or other|1|||
33424842|NCT01377233|101446520|FG004|Double-blind|Administrative or other|1|||
33424843|NCT00185211|101446523|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
33586759|NCT02308163|102036388|FG004|Overall Study|Lab data met discontinuation criteria|0|||
33586760|NCT02308163|102036384|FG000|Overall Study|Miscellaneous|2|||
33586761|NCT02308163|102036385|FG001|Overall Study|Miscellaneous|2|||
33586762|NCT02308163|102036386|FG002|Overall Study|Miscellaneous|1|||
33586763|NCT02308163|102036387|FG003|Overall Study|Miscellaneous|0|||
33586764|NCT02308163|102036388|FG004|Overall Study|Miscellaneous|5|||
33586765|NCT00904670|102036389|FG000|Open Label Phase|Withdrawal by Subject|2|||
33586766|NCT00904670|102036390|FG001|Open Label Phase|Withdrawal by Subject|0|||
33586767|NCT00904670|102036389|FG000|Open Label Phase|Adverse Event|2|||
33586768|NCT00904670|102036390|FG001|Open Label Phase|Adverse Event|0|||
33586769|NCT00904670|102036389|FG000|Open Label Phase|Lack of Efficacy|1|||
33247511|NCT00093795|100806700|FG001|Overall Study|No follow up data|16|||
33247512|NCT00093795|100806701|FG002|Overall Study|No follow up data|17|||
33247513|NCT01769391|100806703|FG000|Overall Study|Death|10|||
33247514|NCT01769391|100806704|FG001|Overall Study|Death|1|||
33247515|NCT01769391|100806703|FG000|Overall Study|Adverse Event|0|||
33247516|NCT01769391|100806704|FG001|Overall Study|Adverse Event|3|||
33247517|NCT01769391|100806703|FG000|Overall Study|Progressive Disease|1|||
33247518|NCT01769391|100806704|FG001|Overall Study|Progressive Disease|2|||
33247519|NCT01769391|100806703|FG000|Overall Study|Withdrawal by Subject|4|||
33247520|NCT01769391|100806704|FG001|Overall Study|Withdrawal by Subject|3|||
33247521|NCT01769391|100806703|FG000|Overall Study|Investigator Decision|2|||
33247522|NCT01769391|100806704|FG001|Overall Study|Investigator Decision|0|||
33247523|NCT03523962|100806709|FG000|Closed Fractures|Death|86|||
33247524|NCT03523962|100806710|FG001|Closed Fractures|Death|71|||
33247525|NCT03523962|100806711|FG002|Closed Fractures|Death|0|||
33247526|NCT03523962|100806712|FG003|Closed Fractures|Death|0|||
33247527|NCT03523962|100806709|FG000|Closed Fractures|Lost to Follow-up|62|||
33247528|NCT03523962|100806710|FG001|Closed Fractures|Lost to Follow-up|36|||
33247529|NCT03523962|100806711|FG002|Closed Fractures|Lost to Follow-up|0|||
33247530|NCT03523962|100806712|FG003|Closed Fractures|Lost to Follow-up|0|||
33247531|NCT03523962|100806709|FG000|Closed Fractures|Withdrawal by Subject|19|||
33247532|NCT03523962|100806710|FG001|Closed Fractures|Withdrawal by Subject|29|||
33247533|NCT03523962|100806711|FG002|Closed Fractures|Withdrawal by Subject|0|||
33247534|NCT03523962|100806712|FG003|Closed Fractures|Withdrawal by Subject|0|||
33247535|NCT03523962|100806709|FG000|Closed Fractures|Incarceration|1|||
33247536|NCT03523962|100806710|FG001|Closed Fractures|Incarceration|4|||
33247537|NCT03523962|100806711|FG002|Closed Fractures|Incarceration|0|||
33247538|NCT03523962|100806712|FG003|Closed Fractures|Incarceration|0|||
33247539|NCT03523962|100806709|FG000|Open Fractures|Death|0|||
33247540|NCT03523962|100806710|FG001|Open Fractures|Death|0|||
33247541|NCT03523962|100806711|FG002|Open Fractures|Death|11|||
33378653|NCT02927873|101269532|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33378654|NCT02927873|101269533|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33378655|NCT02927873|101269534|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33378656|NCT02927873|101269529|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
33378657|NCT02927873|101269530|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
33378658|NCT02927873|101269531|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
33378659|NCT02927873|101269532|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
33424844|NCT00185211|101446524|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
33424845|NCT00185211|101446523|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
33424846|NCT00185211|101446524|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
33424847|NCT00185211|101446523|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
33586770|NCT00904670|102036390|FG001|Open Label Phase|Lack of Efficacy|0|||
33586771|NCT00904670|102036389|FG000|Open Label Phase|Lost to Follow-up|1|||
33586772|NCT00904670|102036390|FG001|Open Label Phase|Lost to Follow-up|0|||
33247542|NCT03523962|100806712|FG003|Open Fractures|Death|6|||
33247543|NCT03523962|100806709|FG000|Open Fractures|Lost to Follow-up|0|||
33247544|NCT03523962|100806710|FG001|Open Fractures|Lost to Follow-up|0|||
33247545|NCT03523962|100806711|FG002|Open Fractures|Lost to Follow-up|15|||
33247546|NCT03523962|100806712|FG003|Open Fractures|Lost to Follow-up|8|||
33247547|NCT03523962|100806709|FG000|Open Fractures|Withdrawal by Subject|0|||
33646719|NCT00724867|102259692|FG000|Overall Study|Sponsor decision to end study|14|||
33378660|NCT02927873|101269533|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
33378661|NCT02927873|101269534|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
33378662|NCT02927873|101269529|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
33586773|NCT05069597|102036398|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
33586774|NCT05069597|102036399|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
33586775|NCT02485639|102036400|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
33586776|NCT02485639|102036400|FG000|Overall Study|Early termination|4|||
33586777|NCT02485639|102036400|FG000|Overall Study|Withdrawal by Subject|4|||
33586778|NCT02836717|102036401|FG000|Test Phase|Lack of Efficacy|14|||
33586779|NCT02836717|102036402|FG001|Test Phase|Lack of Efficacy|8|||
33586780|NCT02836717|102036403|FG002|Test Phase|Lack of Efficacy|0|||
33586781|NCT02836717|102036401|FG000|Study Phase|Adverse Event|2|||
33586782|NCT02836717|102036402|FG001|Study Phase|Adverse Event|0|||
33586783|NCT02836717|102036403|FG002|Study Phase|Adverse Event|0|||
33586784|NCT02836717|102036401|FG000|Study Phase|Lack of Efficacy|8|||
33586785|NCT02836717|102036402|FG001|Study Phase|Lack of Efficacy|6|||
33586786|NCT02836717|102036403|FG002|Study Phase|Lack of Efficacy|1|||
33586787|NCT02836717|102036401|FG000|Study Phase|Withdrawal by Subject|1|||
33586788|NCT02836717|102036402|FG001|Study Phase|Withdrawal by Subject|0|||
33586789|NCT02836717|102036403|FG002|Study Phase|Withdrawal by Subject|0|||
33586790|NCT02836717|102036401|FG000|Study Phase|Death|1|||
33586791|NCT02836717|102036402|FG001|Study Phase|Death|0|||
33586792|NCT02836717|102036403|FG002|Study Phase|Death|0|||
33586793|NCT02836717|102036401|FG000|Study Phase|abdominal surgeries|2|||
33586794|NCT02836717|102036402|FG001|Study Phase|abdominal surgeries|1|||
33586795|NCT02836717|102036403|FG002|Study Phase|abdominal surgeries|0|||
33586796|NCT01638013|102036404|FG000|Overall Study|Adverse Event|36|||
33586797|NCT01638013|102036405|FG001|Overall Study|Adverse Event|29|||
33586798|NCT01638013|102036406|FG002|Overall Study|Adverse Event|48|||
33586799|NCT01638013|102036404|FG000|Overall Study|Lack of Efficacy|39|||
33586800|NCT01638013|102036405|FG001|Overall Study|Lack of Efficacy|11|||
33586801|NCT01638013|102036406|FG002|Overall Study|Lack of Efficacy|14|||
33586802|NCT01638013|102036404|FG000|Overall Study|Protocol Violation|10|||
33586803|NCT01638013|102036405|FG001|Overall Study|Protocol Violation|7|||
33586804|NCT01638013|102036406|FG002|Overall Study|Protocol Violation|11|||
33646720|NCT00724867|102259692|FG000|Overall Study|Subject incarcerated|1|||
33378663|NCT02927873|101269530|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
33378664|NCT02927873|101269531|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
33378665|NCT02927873|101269532|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
33378666|NCT02927873|101269533|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
33378667|NCT02927873|101269534|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
33378668|NCT02927873|101269529|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
33378669|NCT02927873|101269530|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
33378670|NCT02927873|101269531|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
33378671|NCT02927873|101269532|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
33378672|NCT02927873|101269533|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
33378673|NCT02927873|101269534|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
33378674|NCT00501046|101269535|FG000|Overall Study|Adverse Event|21|||
33378675|NCT00501046|101269536|FG001|Overall Study|Adverse Event|25|||
33378676|NCT00501046|101269535|FG000|Overall Study|Death|23|||
33378677|NCT00501046|101269536|FG001|Overall Study|Death|30|||
33378678|NCT00501046|101269535|FG000|Overall Study|Lost to Follow-up|14|||
33378679|NCT00501046|101269536|FG001|Overall Study|Lost to Follow-up|13|||
33378680|NCT00501046|101269535|FG000|Overall Study|Physician Decision|7|||
33378681|NCT00501046|101269536|FG001|Overall Study|Physician Decision|2|||
33378682|NCT00501046|101269535|FG000|Overall Study|Pregnancy|0|||
33378683|NCT00501046|101269536|FG001|Overall Study|Pregnancy|3|||
33378684|NCT00501046|101269535|FG000|Overall Study|Protocol Violation|2|||
33378685|NCT00501046|101269536|FG001|Overall Study|Protocol Violation|1|||
33378686|NCT00501046|101269535|FG000|Overall Study|Withdrawal by Subject|84|||
33378687|NCT00501046|101269536|FG001|Overall Study|Withdrawal by Subject|83|||
33378688|NCT00501046|101269535|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
33378689|NCT00501046|101269536|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
33378690|NCT00762372|101269542|FG000|Overall Study|Adverse Event|1|||
33378691|NCT00762372|101269543|FG001|Overall Study|Adverse Event|0|||
33378692|NCT00762372|101269544|FG002|Overall Study|Adverse Event|0|||
33378693|NCT00878215|101269545|FG000|Overall Study|Determined to be ineligible|0|||
33424848|NCT00185211|101446524|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
33586805|NCT01638013|102036404|FG000|Overall Study|Met discontinuation criteria|4|||
33586806|NCT01638013|102036405|FG001|Overall Study|Met discontinuation criteria|0|||
33586807|NCT01638013|102036406|FG002|Overall Study|Met discontinuation criteria|7|||
33586808|NCT01638013|102036404|FG000|Overall Study|Subject Lost to Follow up|1|||
33378694|NCT00878215|101269546|FG001|Overall Study|Determined to be ineligible|10|||
33378695|NCT00878215|101269547|FG002|Overall Study|Determined to be ineligible|0|||
33378696|NCT00878215|101269548|FG003|Overall Study|Determined to be ineligible|0|||
33378697|NCT02785952|101269549|FG000|Overall Study|Adverse Event|31|||
33378698|NCT02785952|101269550|FG001|Overall Study|Adverse Event|19|||
33378699|NCT02785952|101269549|FG000|Overall Study|Refusal unrelated to adverse events|10|||
33378700|NCT02785952|101269550|FG001|Overall Study|Refusal unrelated to adverse events|5|||
33378701|NCT02785952|101269549|FG000|Overall Study|Disease progression/relapse|61|||
33378702|NCT02785952|101269550|FG001|Overall Study|Disease progression/relapse|89|||
33378703|NCT02785952|101269549|FG000|Overall Study|Death|11|||
33378704|NCT02785952|101269550|FG001|Overall Study|Death|7|||
33424849|NCT00185211|101446523|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
33424850|NCT00185211|101446524|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
33424851|NCT00185211|101446523|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
33424852|NCT00185211|101446524|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
33586809|NCT01638013|102036405|FG001|Overall Study|Subject Lost to Follow up|0|||
33586810|NCT01638013|102036406|FG002|Overall Study|Subject Lost to Follow up|1|||
33586811|NCT01638013|102036404|FG000|Overall Study|Miscellaneous|25|||
33586812|NCT01638013|102036405|FG001|Overall Study|Miscellaneous|19|||
33586813|NCT01638013|102036406|FG002|Overall Study|Miscellaneous|23|||
33586814|NCT01638013|102036404|FG000|Overall Study|Withdrawal of Consent|16|||
33586815|NCT01638013|102036405|FG001|Overall Study|Withdrawal of Consent|12|||
33586816|NCT01638013|102036406|FG002|Overall Study|Withdrawal of Consent|16|||
33586817|NCT01638013|102036404|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
33586818|NCT01638013|102036405|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
33586819|NCT01638013|102036406|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
33586820|NCT02982772|102036412|FG000|Intervention|Lost to Follow-up|19|||
33586821|NCT02982772|102036413|FG001|Intervention|Lost to Follow-up|13|||
33586822|NCT02982772|102036412|FG000|1M Follow-Up|Lost to Follow-up|21|||
33586823|NCT02982772|102036413|FG001|1M Follow-Up|Lost to Follow-up|18|||
33586824|NCT02982772|102036412|FG000|3M Follow-Up|Lost to Follow-up|17|||
33586825|NCT02982772|102036413|FG001|3M Follow-Up|Lost to Follow-up|11|||
33586826|NCT02982772|102036412|FG000|6M Follow-Up|Lost to Follow-up|11|||
33586827|NCT02982772|102036413|FG001|6M Follow-Up|Lost to Follow-up|9|||
33646721|NCT00724867|102259692|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
33148838|NCT03422627|100458296|FG003|Overall Study|Withdrawal by Subject|1|||
33148839|NCT03422627|100458297|FG004|Overall Study|Withdrawal by Subject|0|||
33148840|NCT04091750|100458298|FG000|Overall Study|Adverse Event|4|||
33148841|NCT04091750|100458298|FG000|Overall Study|Withdrawal by Subject|1|||
33148842|NCT02750943|100458301|FG000|Overall Study|Lost to Follow-up|1|||
33148843|NCT02750943|100458302|FG001|Overall Study|Lost to Follow-up|2|||
33148844|NCT02750943|100458301|FG000|Overall Study|Withdrawal by Subject|5|||
33247548|NCT03523962|100806710|FG001|Open Fractures|Withdrawal by Subject|0|||
33247549|NCT03523962|100806711|FG002|Open Fractures|Withdrawal by Subject|6|||
33247550|NCT03523962|100806712|FG003|Open Fractures|Withdrawal by Subject|2|||
33247551|NCT03523962|100806709|FG000|Open Fractures|Incarceration|0|||
33247552|NCT03523962|100806710|FG001|Open Fractures|Incarceration|0|||
33247553|NCT03523962|100806711|FG002|Open Fractures|Incarceration|1|||
33247554|NCT03523962|100806712|FG003|Open Fractures|Incarceration|0|||
33247555|NCT00290706|100806713|FG000|Overall Study|Withdrawal by Subject|2|||
33247556|NCT00290706|100806714|FG001|Overall Study|Withdrawal by Subject|0|||
33247557|NCT00290706|100806715|FG002|Overall Study|Withdrawal by Subject|0|||
33247558|NCT00290706|100806716|FG003|Overall Study|Withdrawal by Subject|0|||
33247559|NCT00290706|100806713|FG000|Overall Study|Progressive Disease|3|||
33247560|NCT00290706|100806714|FG001|Overall Study|Progressive Disease|5|||
33247561|NCT00290706|100806715|FG002|Overall Study|Progressive Disease|4|||
33247562|NCT00290706|100806716|FG003|Overall Study|Progressive Disease|10|||
33247563|NCT00290706|100806713|FG000|Overall Study|Adverse Event|0|||
33247564|NCT00290706|100806714|FG001|Overall Study|Adverse Event|1|||
33247565|NCT00290706|100806715|FG002|Overall Study|Adverse Event|2|||
33247566|NCT00290706|100806716|FG003|Overall Study|Adverse Event|0|||
33247567|NCT00290706|100806713|FG000|Overall Study|Receive auto transplant or radiation|0|||
33247568|NCT00290706|100806714|FG001|Overall Study|Receive auto transplant or radiation|0|||
33247569|NCT00290706|100806715|FG002|Overall Study|Receive auto transplant or radiation|0|||
33247570|NCT00290706|100806716|FG003|Overall Study|Receive auto transplant or radiation|1|||
33424853|NCT00185211|101446523|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
33586828|NCT02982772|102036412|FG000|12M Follow-Up|Lost to Follow-up|11|||
33586829|NCT02982772|102036413|FG001|12M Follow-Up|Lost to Follow-up|5|||
33646722|NCT00724867|102259692|FG000|Overall Study|Subject moved out of state|1|||
33148845|NCT02750943|100458302|FG001|Overall Study|Withdrawal by Subject|7|||
33247571|NCT00290706|100806713|FG000|Overall Study|Physician Decision|0|||
33247572|NCT00290706|100806714|FG001|Overall Study|Physician Decision|0|||
33378705|NCT02785952|101269549|FG000|Overall Study|Other- not protocol specified|6|||
33247573|NCT00290706|100806715|FG002|Overall Study|Physician Decision|0|||
33378706|NCT02785952|101269550|FG001|Overall Study|Other- not protocol specified|4|||
33148846|NCT02788474|100458303|FG000|Double Blind Treatment Period|Not treated|1|||
33378707|NCT02785952|101269549|FG000|Overall Study|On protocol treatment|6|||
33378708|NCT02785952|101269550|FG001|Overall Study|On protocol treatment|3|||
33378709|NCT02232087|101269557|FG000|Overall Study|Withdrawal by Subject|2|||
33378710|NCT02232087|101269558|FG001|Overall Study|Withdrawal by Subject|0|||
33378711|NCT02232087|101269559|FG002|Overall Study|Withdrawal by Subject|0|||
33378712|NCT02232087|101269560|FG003|Overall Study|Withdrawal by Subject|0|||
33378713|NCT02232087|101269561|FG004|Overall Study|Withdrawal by Subject|0|||
33378714|NCT02232087|101269562|FG005|Overall Study|Withdrawal by Subject|1|||
33424854|NCT00185211|101446524|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
33424855|NCT00185211|101446523|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
33424856|NCT00185211|101446524|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
33148847|NCT02788474|100458304|FG001|Double Blind Treatment Period|Not treated|0|||
33148848|NCT02788474|100458303|FG000|Double Blind Treatment Period|Patient's refusal|3|||
33148849|NCT02788474|100458304|FG001|Double Blind Treatment Period|Patient's refusal|0|||
33148850|NCT02788474|100458303|FG000|Double Blind Treatment Period|Adverse Event|6|||
33148851|NCT02788474|100458304|FG001|Double Blind Treatment Period|Adverse Event|4|||
33148852|NCT02788474|100458303|FG000|Open Label Treatment Period|Adverse Event|29|||
33148853|NCT02788474|100458304|FG001|Open Label Treatment Period|Adverse Event|9|||
33148854|NCT02788474|100458303|FG000|Open Label Treatment Period|Other than reason specified|1|||
33148855|NCT02788474|100458304|FG001|Open Label Treatment Period|Other than reason specified|0|||
33148856|NCT02788474|100458303|FG000|Open Label Treatment Period|Patient's refusal|1|||
33148857|NCT02788474|100458304|FG001|Open Label Treatment Period|Patient's refusal|3|||
33148858|NCT02788474|100458303|FG000|Open Label Treatment Period|Non-compliance|1|||
33148859|NCT02788474|100458304|FG001|Open Label Treatment Period|Non-compliance|0|||
33148860|NCT03519386|100458305|FG000|Overall Study|Withdrawal by Subject|4|||
33148861|NCT03519386|100458306|FG001|Overall Study|Withdrawal by Subject|1|||
33148862|NCT03519386|100458307|FG002|Overall Study|Withdrawal by Subject|2|||
33148863|NCT03519386|100458305|FG000|Overall Study|Physician Decision|1|||
33148864|NCT03519386|100458306|FG001|Overall Study|Physician Decision|1|||
33148865|NCT03519386|100458307|FG002|Overall Study|Physician Decision|1|||
33148866|NCT03519386|100458305|FG000|Overall Study|Lost to Follow-up|0|||
33148867|NCT03519386|100458306|FG001|Overall Study|Lost to Follow-up|1|||
33148868|NCT03519386|100458307|FG002|Overall Study|Lost to Follow-up|1|||
33148869|NCT03519386|100458305|FG000|Overall Study|Death|1|||
33148870|NCT03519386|100458306|FG001|Overall Study|Death|0|||
33148871|NCT03519386|100458307|FG002|Overall Study|Death|4|||
33148872|NCT03519386|100458305|FG000|Overall Study|Adverse Event|2|||
33148873|NCT03519386|100458306|FG001|Overall Study|Adverse Event|1|||
33148874|NCT03519386|100458307|FG002|Overall Study|Adverse Event|2|||
33148875|NCT03519386|100458305|FG000|Overall Study|Explanted|2|||
33148876|NCT03519386|100458306|FG001|Overall Study|Explanted|1|||
33148877|NCT03519386|100458307|FG002|Overall Study|Explanted|0|||
33148878|NCT03519386|100458305|FG000|Overall Study|Ongoing in study|190|||
33148879|NCT03519386|100458306|FG001|Overall Study|Ongoing in study|192|||
33148880|NCT03519386|100458307|FG002|Overall Study|Ongoing in study|183|||
33148881|NCT00925990|100458308|FG000|Overall Study|Adverse Event|1|||
33148882|NCT00925990|100458309|FG001|Overall Study|Adverse Event|3|||
33148883|NCT00925990|100458308|FG000|Overall Study|Withdrawal by Subject|2|||
33148884|NCT00925990|100458309|FG001|Overall Study|Withdrawal by Subject|2|||
33148885|NCT00925990|100458308|FG000|Overall Study|Lost to Follow-up|1|||
33148886|NCT00925990|100458309|FG001|Overall Study|Lost to Follow-up|3|||
33148887|NCT00925990|100458308|FG000|Overall Study|Physician Decision|1|||
33148888|NCT00925990|100458309|FG001|Overall Study|Physician Decision|1|||
33148889|NCT00925990|100458308|FG000|Overall Study|moved out of state, missed medication|0|||
33148890|NCT00925990|100458309|FG001|Overall Study|moved out of state, missed medication|2|||
33148891|NCT05080660|100458310|FG000|Overall Study|Adverse Event|4|||
33148892|NCT05080660|100458311|FG001|Overall Study|Adverse Event|0|||
33148893|NCT05080660|100458310|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
33148894|NCT05080660|100458311|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
33148895|NCT05080660|100458310|FG000|Overall Study|Physician Decision|1|||
33148896|NCT05080660|100458311|FG001|Overall Study|Physician Decision|0|||
33424857|NCT00185211|101446523|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
33424858|NCT00185211|101446524|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
33424859|NCT00185211|101446523|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
33148897|NCT05080660|100458310|FG000|Overall Study|Protocol Deviation|2|||
33148898|NCT05080660|100458311|FG001|Overall Study|Protocol Deviation|0|||
33148899|NCT05080660|100458310|FG000|Overall Study|Withdrawal by Subject|5|||
33148900|NCT05080660|100458311|FG001|Overall Study|Withdrawal by Subject|2|||
33148901|NCT02204007|100458312|FG000|Overall Study|Surgery Canceled|1|||
33148902|NCT02204007|100458313|FG001|Overall Study|Surgery Canceled|1|||
33148903|NCT00750880|100458314|FG000|Overall Study|Adverse Event|76|||
33148904|NCT00750880|100458314|FG000|Overall Study|Death|4|||
33247574|NCT00290706|100806716|FG003|Overall Study|Physician Decision|1|||
33247575|NCT01695317|100806717|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
33378715|NCT02232087|101269557|FG000|Overall Study|poor inhalation technique|0|||
33424860|NCT00185211|101446524|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
33424861|NCT00185211|101446523|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
33424862|NCT00185211|101446524|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
33424863|NCT00185211|101446523|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
33424864|NCT00185211|101446524|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
33424865|NCT00185211|101446523|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
33424866|NCT00185211|101446524|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
33378716|NCT02232087|101269558|FG001|Overall Study|poor inhalation technique|1|||
33378717|NCT02232087|101269559|FG002|Overall Study|poor inhalation technique|0|||
33378718|NCT02232087|101269560|FG003|Overall Study|poor inhalation technique|0|||
33378719|NCT02232087|101269561|FG004|Overall Study|poor inhalation technique|0|||
33378720|NCT02232087|101269562|FG005|Overall Study|poor inhalation technique|2|||
33378721|NCT02232087|101269557|FG000|Overall Study|protocol stop criteria|0|||
33378722|NCT02232087|101269558|FG001|Overall Study|protocol stop criteria|1|||
33378723|NCT02232087|101269559|FG002|Overall Study|protocol stop criteria|0|||
33378724|NCT02232087|101269560|FG003|Overall Study|protocol stop criteria|1|||
33378725|NCT02232087|101269561|FG004|Overall Study|protocol stop criteria|0|||
33378726|NCT02232087|101269562|FG005|Overall Study|protocol stop criteria|0|||
33378727|NCT02232087|101269557|FG000|Overall Study|Adverse Event|0|||
33378728|NCT02232087|101269558|FG001|Overall Study|Adverse Event|0|||
33378729|NCT02232087|101269559|FG002|Overall Study|Adverse Event|0|||
33378730|NCT02232087|101269560|FG003|Overall Study|Adverse Event|0|||
33378731|NCT02232087|101269561|FG004|Overall Study|Adverse Event|1|||
33378732|NCT02232087|101269562|FG005|Overall Study|Adverse Event|0|||
33378733|NCT02559206|101269563|FG000|Overall Study|Adverse Event|0|||
33378734|NCT02559206|101269564|FG001|Overall Study|Adverse Event|4|||
33378735|NCT02559206|101269565|FG002|Overall Study|Adverse Event|1|||
33378736|NCT02559206|101269566|FG003|Overall Study|Adverse Event|5|||
33378737|NCT02559206|101269567|FG004|Overall Study|Adverse Event|3|||
33378738|NCT02559206|101269568|FG005|Overall Study|Adverse Event|0|||
33378739|NCT02559206|101269569|FG006|Overall Study|Adverse Event|1|||
33378740|NCT02559206|101269570|FG007|Overall Study|Adverse Event|0|||
33378741|NCT02559206|101269563|FG000|Overall Study|Protocol Violation|1|||
33378742|NCT02559206|101269564|FG001|Overall Study|Protocol Violation|0|||
33378743|NCT02559206|101269565|FG002|Overall Study|Protocol Violation|1|||
33378744|NCT02559206|101269566|FG003|Overall Study|Protocol Violation|0|||
33378745|NCT02559206|101269567|FG004|Overall Study|Protocol Violation|0|||
33378746|NCT02559206|101269568|FG005|Overall Study|Protocol Violation|2|||
33378747|NCT02559206|101269569|FG006|Overall Study|Protocol Violation|0|||
33378748|NCT02559206|101269570|FG007|Overall Study|Protocol Violation|0|||
33378749|NCT02559206|101269563|FG000|Overall Study|Withdrawal by Subject|3|||
33378750|NCT02559206|101269564|FG001|Overall Study|Withdrawal by Subject|3|||
33378751|NCT02559206|101269565|FG002|Overall Study|Withdrawal by Subject|1|||
33378752|NCT02559206|101269566|FG003|Overall Study|Withdrawal by Subject|3|||
33378753|NCT02559206|101269567|FG004|Overall Study|Withdrawal by Subject|5|||
33378754|NCT02559206|101269568|FG005|Overall Study|Withdrawal by Subject|4|||
33378755|NCT02559206|101269569|FG006|Overall Study|Withdrawal by Subject|1|||
33378756|NCT02559206|101269570|FG007|Overall Study|Withdrawal by Subject|2|||
33378757|NCT02559206|101269563|FG000|Overall Study|Lost to Follow-up|3|||
33378758|NCT02559206|101269564|FG001|Overall Study|Lost to Follow-up|5|||
33378759|NCT02559206|101269565|FG002|Overall Study|Lost to Follow-up|3|||
33378760|NCT02559206|101269566|FG003|Overall Study|Lost to Follow-up|3|||
33378761|NCT02559206|101269567|FG004|Overall Study|Lost to Follow-up|2|||
33378762|NCT02559206|101269568|FG005|Overall Study|Lost to Follow-up|5|||
33378763|NCT02559206|101269569|FG006|Overall Study|Lost to Follow-up|1|||
33378764|NCT02559206|101269570|FG007|Overall Study|Lost to Follow-up|4|||
33378765|NCT02559206|101269563|FG000|Overall Study|Lack of Efficacy|1|||
33424867|NCT01098240|101446525|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
33378766|NCT02559206|101269564|FG001|Overall Study|Lack of Efficacy|0|||
33378767|NCT02559206|101269565|FG002|Overall Study|Lack of Efficacy|3|||
33378768|NCT02559206|101269566|FG003|Overall Study|Lack of Efficacy|2|||
33424868|NCT01098240|101446526|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
33378769|NCT02559206|101269567|FG004|Overall Study|Lack of Efficacy|2|||
33378770|NCT02559206|101269568|FG005|Overall Study|Lack of Efficacy|3|||
33378771|NCT02559206|101269569|FG006|Overall Study|Lack of Efficacy|3|||
33378772|NCT02559206|101269570|FG007|Overall Study|Lack of Efficacy|3|||
33378773|NCT02559206|101269563|FG000|Overall Study|Other Not Specified|0|||
33378774|NCT02559206|101269564|FG001|Overall Study|Other Not Specified|0|||
33378775|NCT02559206|101269565|FG002|Overall Study|Other Not Specified|0|||
33378776|NCT02559206|101269566|FG003|Overall Study|Other Not Specified|1|||
33424869|NCT01098240|101446527|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
33646723|NCT00724867|102259692|FG000|Overall Study|Elected to exit due to site closure|2|||
33378777|NCT02559206|101269567|FG004|Overall Study|Other Not Specified|0|||
33378778|NCT02559206|101269568|FG005|Overall Study|Other Not Specified|0|||
33378779|NCT02559206|101269569|FG006|Overall Study|Other Not Specified|0|||
33378780|NCT02559206|101269570|FG007|Overall Study|Other Not Specified|0|||
33378781|NCT01094730|101269572|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
33378782|NCT01094730|101269573|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
33378783|NCT01094730|101269572|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
33378784|NCT01094730|101269573|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
33378785|NCT01094730|101269572|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
33378786|NCT01094730|101269573|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
33378787|NCT01094730|101269572|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
33378788|NCT01094730|101269573|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
33378789|NCT01094730|101269572|FG000|Period 2 (14 Days)|Protocol Violation|2|||
33378790|NCT01094730|101269573|FG001|Period 2 (14 Days)|Protocol Violation|0|||
33378791|NCT01094730|101269572|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
33378792|NCT01094730|101269573|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
33378793|NCT01094730|101269572|FG000|Period 2 (14 Days)|Adverse Event|0|||
33378794|NCT01094730|101269573|FG001|Period 2 (14 Days)|Adverse Event|1|||
33378795|NCT01094730|101269572|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
33378796|NCT01094730|101269573|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
33378797|NCT00423085|101269574|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
33378798|NCT00423085|101269575|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
33378799|NCT00423085|101269576|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
33378800|NCT00423085|101269577|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
33378801|NCT00423085|101269574|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
33378802|NCT00423085|101269575|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
33378803|NCT00423085|101269576|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
33378804|NCT00423085|101269577|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
33378805|NCT00423085|101269574|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
33378806|NCT00423085|101269575|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
33378807|NCT00423085|101269576|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
33378808|NCT00423085|101269577|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
33378809|NCT00423085|101269574|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
33378810|NCT00423085|101269575|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
33378811|NCT00423085|101269576|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
33378812|NCT00423085|101269577|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
33378813|NCT00423085|101269574|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
33378814|NCT00423085|101269575|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
33378815|NCT00423085|101269576|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
33378816|NCT00423085|101269577|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
33378817|NCT00423085|101269574|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
33424870|NCT01098240|101446525|FG000|Open-Label Phase|Protocol Violation|4|||
33424871|NCT01098240|101446526|FG001|Open-Label Phase|Protocol Violation|0|||
33424872|NCT01098240|101446527|FG002|Open-Label Phase|Protocol Violation|0|||
33424873|NCT01098240|101446525|FG000|Open-Label Phase|Lost to Follow-up|13|||
33424874|NCT01098240|101446526|FG001|Open-Label Phase|Lost to Follow-up|0|||
33424875|NCT01098240|101446527|FG002|Open-Label Phase|Lost to Follow-up|0|||
33424876|NCT01098240|101446525|FG000|Open-Label Phase|Other|19|||
33424877|NCT01098240|101446526|FG001|Open-Label Phase|Other|0|||
33424878|NCT01098240|101446527|FG002|Open-Label Phase|Other|0|||
33424879|NCT01098240|101446525|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
33378818|NCT00423085|101269575|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
33378819|NCT00423085|101269576|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
33378820|NCT00423085|101269577|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
33378821|NCT00423085|101269574|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
33378822|NCT00423085|101269575|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
33378823|NCT00423085|101269576|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
33378824|NCT00423085|101269577|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
33378825|NCT00423085|101269574|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
33378826|NCT00423085|101269575|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
33378827|NCT00423085|101269576|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
33378828|NCT00423085|101269577|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
33378829|NCT00423085|101269574|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
33378830|NCT00423085|101269575|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
33424880|NCT01098240|101446526|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
33424881|NCT01098240|101446527|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
33646724|NCT00335764|102259698|FG000|Overall Study|wrong histology|1|||
33646725|NCT00335764|102259699|FG001|Overall Study|wrong histology|0|||
33378831|NCT00423085|101269576|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
33424882|NCT01098240|101446525|FG000|Open-Label Phase|Pregnancy|1|||
33424883|NCT01098240|101446526|FG001|Open-Label Phase|Pregnancy|0|||
33424884|NCT01098240|101446527|FG002|Open-Label Phase|Pregnancy|0|||
33424885|NCT01098240|101446525|FG000|Open-Label Phase|Withdrawal by Subject|9|||
33646726|NCT00335764|102259700|FG002|Overall Study|wrong histology|0|||
33378832|NCT00423085|101269577|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
33378833|NCT00423085|101269574|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
33378834|NCT00423085|101269575|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
33378835|NCT00423085|101269576|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
33378836|NCT00423085|101269577|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
33378837|NCT00423085|101269574|FG000|52-Week Open-Label Extension Phase|Death|0|||
33378838|NCT00423085|101269575|FG001|52-Week Open-Label Extension Phase|Death|0|||
33247576|NCT01695317|100806718|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
33247577|NCT01695317|100806717|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
33247578|NCT01695317|100806718|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
33247579|NCT02750709|100806724|FG000|Treatment Period 1|Adverse Event|0|||
33247580|NCT02750709|100806725|FG001|Treatment Period 1|Adverse Event|0|||
33247581|NCT02750709|100806726|FG002|Treatment Period 1|Adverse Event|0|||
33247582|NCT02750709|100806727|FG003|Treatment Period 1|Adverse Event|0|||
33247583|NCT02750709|100806728|FG004|Treatment Period 1|Adverse Event|0|||
33247584|NCT02750709|100806729|FG005|Treatment Period 1|Adverse Event|1|||
33247585|NCT02107014|100806744|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
33247586|NCT00371566|100806747|FG000|Treatment Phase|Withdrawal by Subject|0|||
33247587|NCT00371566|100806748|FG001|Treatment Phase|Withdrawal by Subject|1|||
33247588|NCT00371566|100806747|FG000|Treatment Phase|Adverse Event|0|||
33247589|NCT00371566|100806748|FG001|Treatment Phase|Adverse Event|1|||
33247590|NCT00371566|100806747|FG000|Treatment Phase|Protocol Violation|0|||
33247591|NCT00371566|100806748|FG001|Treatment Phase|Protocol Violation|1|||
33247592|NCT00371566|100806747|FG000|Chemoradiation Phase|Physician Decision|2|||
33247593|NCT00371566|100806748|FG001|Chemoradiation Phase|Physician Decision|0|||
33247594|NCT00371566|100806747|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
33247595|NCT00371566|100806748|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
33247596|NCT00371566|100806747|FG000|Chemoradiation Phase|Non compliant|0|||
33247597|NCT00371566|100806748|FG001|Chemoradiation Phase|Non compliant|1|||
33247598|NCT00371566|100806747|FG000|Chemoradiation Phase|Progressive Disease|1|||
33247599|NCT00371566|100806748|FG001|Chemoradiation Phase|Progressive Disease|1|||
33247600|NCT00371566|100806747|FG000|Chemoradiation Phase|Death|2|||
33247601|NCT00371566|100806748|FG001|Chemoradiation Phase|Death|0|||
33247602|NCT00371566|100806747|FG000|Follow Up Phase|Death|0|||
33247603|NCT00371566|100806748|FG001|Follow Up Phase|Death|5|||
33247604|NCT00371566|100806747|FG000|Follow Up Phase|Disease progression|1|||
33247605|NCT00371566|100806748|FG001|Follow Up Phase|Disease progression|0|||
33247606|NCT00371566|100806747|FG000|Follow Up Phase|Withdrawal by Subject|0|||
33247607|NCT00371566|100806748|FG001|Follow Up Phase|Withdrawal by Subject|1|||
33247608|NCT00371566|100806747|FG000|Follow Up Phase|Physician Decision|1|||
33247609|NCT00371566|100806748|FG001|Follow Up Phase|Physician Decision|1|||
33247610|NCT00371566|100806747|FG000|Follow Up Phase|Lost to Follow-up|1|||
33247611|NCT00371566|100806748|FG001|Follow Up Phase|Lost to Follow-up|0|||
33247612|NCT03124108|100806749|FG000|Overall Study|Adverse Event|0|||
33247613|NCT03124108|100806750|FG001|Overall Study|Adverse Event|1|||
33247614|NCT03124108|100806751|FG002|Overall Study|Adverse Event|0|||
33247615|NCT02057718|100806752|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
33247616|NCT02057718|100806753|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
33247617|NCT02057718|100806752|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
33247618|NCT02057718|100806753|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
33247619|NCT02057718|100806752|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
33247620|NCT02057718|100806753|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
33247621|NCT02057718|100806752|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
33247622|NCT02057718|100806753|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
33247623|NCT02057718|100806752|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
33247624|NCT02057718|100806753|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
33247625|NCT02057718|100806752|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
33247626|NCT02057718|100806753|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
33247627|NCT02057718|100806752|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
33247628|NCT02057718|100806753|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
33247629|NCT02057718|100806752|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
33247630|NCT02057718|100806753|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
33247631|NCT02057718|100806752|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
33247632|NCT02057718|100806753|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
33378839|NCT00423085|101269576|FG002|52-Week Open-Label Extension Phase|Death|0|||
33378840|NCT00423085|101269577|FG003|52-Week Open-Label Extension Phase|Death|2|||
33378841|NCT01182337|101269580|FG000|Overall Study|Withdrawal by Subject|3|||
33378842|NCT01182337|101269581|FG001|Overall Study|Withdrawal by Subject|1|||
33247633|NCT02057718|100806752|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
33378843|NCT01182337|101269580|FG000|Overall Study|Lost to Follow-up|0|||
33378844|NCT01182337|101269581|FG001|Overall Study|Lost to Follow-up|1|||
33378845|NCT02932332|101269582|FG000|Overall Study|Withdrawal by Subject|1|||
33378846|NCT02932332|101269583|FG001|Overall Study|Withdrawal by Subject|1|||
33378847|NCT02932332|101269584|FG002|Overall Study|Withdrawal by Subject|0|||
33378848|NCT02932332|101269585|FG003|Overall Study|Withdrawal by Subject|1|||
33378849|NCT02932332|101269582|FG000|Overall Study|Chest pain|0|||
33378850|NCT02932332|101269583|FG001|Overall Study|Chest pain|0|||
33378851|NCT02932332|101269584|FG002|Overall Study|Chest pain|0|||
33378852|NCT02932332|101269585|FG003|Overall Study|Chest pain|1|||
33378853|NCT02932332|101269582|FG000|Overall Study|Not Dyspneic cough|1|||
33378854|NCT02932332|101269583|FG001|Overall Study|Not Dyspneic cough|2|||
33378855|NCT02932332|101269584|FG002|Overall Study|Not Dyspneic cough|1|||
33378856|NCT02932332|101269585|FG003|Overall Study|Not Dyspneic cough|0|||
33378857|NCT05254613|101269586|FG000|Overall Study|Lost to Follow-up|0|||
33378858|NCT05254613|101269587|FG001|Overall Study|Lost to Follow-up|0|||
33378859|NCT05254613|101269588|FG002|Overall Study|Lost to Follow-up|1|||
33378860|NCT01518244|101269589|FG000|Overall Study|Adverse Event|3|||
33378861|NCT00353496|101269590|FG000|Overall Study|Adverse Event|1|||
33378862|NCT00353496|101269591|FG001|Overall Study|Adverse Event|0|||
33378863|NCT00353496|101269590|FG000|Overall Study|Protocol Violation|2|||
33378864|NCT00353496|101269591|FG001|Overall Study|Protocol Violation|2|||
33378865|NCT00353496|101269590|FG000|Overall Study|Withdrawal by Subject|3|||
33378866|NCT00353496|101269591|FG001|Overall Study|Withdrawal by Subject|4|||
33378867|NCT00353496|101269590|FG000|Overall Study|Physician Decision|6|||
33378868|NCT00353496|101269591|FG001|Overall Study|Physician Decision|9|||
33378869|NCT00353496|101269590|FG000|Overall Study|Not otherwise specified|4|||
33378870|NCT00353496|101269591|FG001|Overall Study|Not otherwise specified|2|||
33378871|NCT01056341|101269592|FG000|Overall Study|Treatment Intolerance|0|||
33378872|NCT01056341|101269593|FG001|Overall Study|Treatment Intolerance|2|||
33378873|NCT01056341|101269594|FG002|Overall Study|Treatment Intolerance|0|||
33378874|NCT01056341|101269595|FG003|Overall Study|Treatment Intolerance|2|||
33378875|NCT01056341|101269596|FG004|Overall Study|Treatment Intolerance|0|||
33586830|NCT00412958|102036414|FG000|Overall Study|Withdrawal by Subject|3|||
33247634|NCT02057718|100806753|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
33247635|NCT02057718|100806752|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
33247636|NCT02057718|100806753|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
33247637|NCT03095508|100806754|FG000|Overall Study|Adverse Event|0|||
33247638|NCT03095508|100806755|FG001|Overall Study|Adverse Event|1|||
33247639|NCT04536077|100806758|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
33247640|NCT04536077|100806759|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
33247641|NCT04536077|100806758|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
33247642|NCT04536077|100806759|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
33247643|NCT01839877|100806760|FG000|Overall Study|Protocol Violation|1|||
33247644|NCT01565928|100806761|FG000|Overall Study|Adverse Event|3|||
33247645|NCT01565928|100806761|FG000|Overall Study|Other|3|||
33247646|NCT01565928|100806761|FG000|Overall Study|Progressive Disease|13|||
33247647|NCT01565928|100806761|FG000|Overall Study|Withdrawal by Subject|1|||
33247648|NCT01565928|100806761|FG000|Overall Study|Death|2|||
33247649|NCT00603538|100806762|FG000|Overall Study|Adverse Event|0|||
33247650|NCT00603538|100806763|FG001|Overall Study|Adverse Event|4|||
33247651|NCT00603538|100806764|FG002|Overall Study|Adverse Event|2|||
33247652|NCT00603538|100806762|FG000|Overall Study|Objective progression or relapse|3|||
33247653|NCT00603538|100806763|FG001|Overall Study|Objective progression or relapse|0|||
33247654|NCT00603538|100806764|FG002|Overall Study|Objective progression or relapse|0|||
33247655|NCT00580801|100806771|FG000|Overall Study|Physician Decision|1|||
33247656|NCT00580801|100806772|FG001|Overall Study|Physician Decision|0|||
33247657|NCT00580801|100806773|FG002|Overall Study|Physician Decision|0|||
33247658|NCT00580801|100806771|FG000|Overall Study|Adverse Event|2|||
33247659|NCT00580801|100806772|FG001|Overall Study|Adverse Event|0|||
33586831|NCT00412958|102036415|FG001|Overall Study|Withdrawal by Subject|0|||
33247660|NCT00580801|100806773|FG002|Overall Study|Adverse Event|0|||
33247661|NCT00580801|100806771|FG000|Overall Study|Lost to Follow-up|2|||
33247662|NCT00580801|100806772|FG001|Overall Study|Lost to Follow-up|0|||
33247663|NCT00580801|100806773|FG002|Overall Study|Lost to Follow-up|0|||
33378876|NCT01056341|101269592|FG000|Overall Study|Lack of Efficacy|32|||
33378877|NCT01056341|101269593|FG001|Overall Study|Lack of Efficacy|30|||
33378878|NCT01056341|101269594|FG002|Overall Study|Lack of Efficacy|7|||
33378879|NCT01056341|101269595|FG003|Overall Study|Lack of Efficacy|25|||
33378880|NCT01056341|101269596|FG004|Overall Study|Lack of Efficacy|9|||
33378881|NCT01056341|101269592|FG000|Overall Study|Other reasons|4|||
33378882|NCT01056341|101269593|FG001|Overall Study|Other reasons|4|||
33586832|NCT00412958|102036416|FG002|Overall Study|Withdrawal by Subject|0|||
33378883|NCT01056341|101269594|FG002|Overall Study|Other reasons|8|||
33378884|NCT01056341|101269595|FG003|Overall Study|Other reasons|9|||
33378885|NCT01056341|101269596|FG004|Overall Study|Other reasons|5|||
33378886|NCT00755846|101269597|FG000|Overall Study|Adverse Event|0|||
33378887|NCT00755846|101269598|FG001|Overall Study|Adverse Event|0|||
33586833|NCT00412958|102036417|FG003|Overall Study|Withdrawal by Subject|1|||
33247664|NCT00580801|100806771|FG000|Overall Study|Reached a virologic endpoint|0|||
33247665|NCT00580801|100806772|FG001|Overall Study|Reached a virologic endpoint|1|||
33247666|NCT00580801|100806773|FG002|Overall Study|Reached a virologic endpoint|2|||
33247667|NCT00580801|100806771|FG000|Overall Study|Participant non-compliant|0|||
33247668|NCT00580801|100806772|FG001|Overall Study|Participant non-compliant|0|||
33247669|NCT00580801|100806773|FG002|Overall Study|Participant non-compliant|1|||
33247670|NCT00580801|100806771|FG000|Overall Study|Travel|1|||
33247671|NCT00580801|100806772|FG001|Overall Study|Travel|0|||
33247672|NCT00580801|100806773|FG002|Overall Study|Travel|0|||
33247673|NCT03256344|100806774|FG000|Overall Study|Death|6|||
33247674|NCT03256344|100806775|FG001|Overall Study|Death|22|||
33247675|NCT03256344|100806774|FG000|Overall Study|Withdrawal by Subject|3|||
33247676|NCT03256344|100806775|FG001|Overall Study|Withdrawal by Subject|3|||
33247677|NCT03256344|100806774|FG000|Overall Study|Sponsor Decision|1|||
33247678|NCT03256344|100806775|FG001|Overall Study|Sponsor Decision|0|||
33247679|NCT03646669|100806778|FG000|Overall Study|Withdrawal by Subject|5|||
33247680|NCT03646669|100806779|FG001|Overall Study|Withdrawal by Subject|0|||
33247681|NCT01645111|100806780|FG000|Overall Study|Did not require Clevidipine|15|||
33247682|NCT03631199|100806781|FG000|Overall Study|Progressive disease|9|||
33247683|NCT03631199|100806782|FG001|Overall Study|Progressive disease|5|||
33247684|NCT03631199|100806783|FG002|Overall Study|Progressive disease|5|||
33247685|NCT03631199|100806784|FG003|Overall Study|Progressive disease|149|||
33247686|NCT03631199|100806785|FG004|Overall Study|Progressive disease|148|||
33247687|NCT03631199|100806781|FG000|Overall Study|Physician Decision|0|||
33247688|NCT03631199|100806782|FG001|Overall Study|Physician Decision|2|||
33247689|NCT03631199|100806783|FG002|Overall Study|Physician Decision|3|||
33247690|NCT03631199|100806784|FG003|Overall Study|Physician Decision|19|||
33247691|NCT03631199|100806785|FG004|Overall Study|Physician Decision|13|||
33378888|NCT00755846|101269599|FG002|Overall Study|Adverse Event|0|||
33378889|NCT00755846|101269600|FG003|Overall Study|Adverse Event|1|||
33378890|NCT00755846|101269601|FG004|Overall Study|Adverse Event|3|||
33378891|NCT00755846|101269602|FG005|Overall Study|Adverse Event|2|||
33378892|NCT00755846|101269597|FG000|Overall Study|Protocol Violation|1|||
33378893|NCT00755846|101269598|FG001|Overall Study|Protocol Violation|1|||
33378894|NCT00755846|101269599|FG002|Overall Study|Protocol Violation|1|||
33378895|NCT00755846|101269600|FG003|Overall Study|Protocol Violation|1|||
33378896|NCT00755846|101269601|FG004|Overall Study|Protocol Violation|1|||
33378897|NCT00755846|101269602|FG005|Overall Study|Protocol Violation|1|||
33378898|NCT00755846|101269597|FG000|Overall Study|Lost to Follow-up|0|||
33378899|NCT00755846|101269598|FG001|Overall Study|Lost to Follow-up|2|||
33378900|NCT00755846|101269599|FG002|Overall Study|Lost to Follow-up|1|||
33378901|NCT00755846|101269600|FG003|Overall Study|Lost to Follow-up|0|||
33378902|NCT00755846|101269601|FG004|Overall Study|Lost to Follow-up|4|||
33378903|NCT00755846|101269602|FG005|Overall Study|Lost to Follow-up|2|||
33378904|NCT00755846|101269597|FG000|Overall Study|Withdrawal by Subject|2|||
33378905|NCT00755846|101269598|FG001|Overall Study|Withdrawal by Subject|3|||
33378906|NCT00755846|101269599|FG002|Overall Study|Withdrawal by Subject|5|||
33378907|NCT00755846|101269600|FG003|Overall Study|Withdrawal by Subject|2|||
33378908|NCT00755846|101269601|FG004|Overall Study|Withdrawal by Subject|0|||
33378909|NCT00755846|101269602|FG005|Overall Study|Withdrawal by Subject|1|||
33424886|NCT01098240|101446526|FG001|Open-Label Phase|Withdrawal by Subject|0|||
33424887|NCT01098240|101446527|FG002|Open-Label Phase|Withdrawal by Subject|0|||
33424888|NCT01098240|101446525|FG000|Open-Label Phase|Adverse Event|12|||
33424889|NCT01098240|101446526|FG001|Open-Label Phase|Adverse Event|0|||
33424890|NCT01098240|101446527|FG002|Open-Label Phase|Adverse Event|0|||
33424891|NCT01098240|101446525|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
33424892|NCT01098240|101446526|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
33424893|NCT01098240|101446527|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
33646727|NCT00335764|102259701|FG003|Overall Study|wrong histology|0|||
33646728|NCT00335764|102259702|FG004|Overall Study|wrong histology|1|||
33247692|NCT03631199|100806781|FG000|Overall Study|Adverse Event|1|||
33247693|NCT03631199|100806782|FG001|Overall Study|Adverse Event|1|||
33247694|NCT03631199|100806783|FG002|Overall Study|Adverse Event|0|||
33247695|NCT03631199|100806784|FG003|Overall Study|Adverse Event|28|||
33247696|NCT03631199|100806785|FG004|Overall Study|Adverse Event|29|||
33247697|NCT03631199|100806781|FG000|Overall Study|Death|0|||
33378910|NCT00755846|101269597|FG000|Overall Study|Hyperglycemic Rescue|21|||
33378911|NCT00755846|101269598|FG001|Overall Study|Hyperglycemic Rescue|7|||
33378912|NCT00755846|101269599|FG002|Overall Study|Hyperglycemic Rescue|5|||
33378913|NCT00755846|101269600|FG003|Overall Study|Hyperglycemic Rescue|8|||
33646729|NCT00475982|102259703|FG000|Overall Study|surgery rescheduled|7|||
33247698|NCT03631199|100806782|FG001|Overall Study|Death|1|||
33378914|NCT00755846|101269601|FG004|Overall Study|Hyperglycemic Rescue|8|||
33378915|NCT00755846|101269602|FG005|Overall Study|Hyperglycemic Rescue|7|||
33247699|NCT03631199|100806783|FG002|Overall Study|Death|0|||
33247700|NCT03631199|100806784|FG003|Overall Study|Death|35|||
33247701|NCT03631199|100806785|FG004|Overall Study|Death|48|||
33247702|NCT03631199|100806781|FG000|Overall Study|Subject decision|0|||
33247703|NCT03631199|100806782|FG001|Overall Study|Subject decision|1|||
33646730|NCT00475982|102259704|FG001|Overall Study|surgery rescheduled|3|||
33646731|NCT02260180|102259710|FG000|Overall Study|Adverse Event|2|||
33646732|NCT02260180|102259711|FG001|Overall Study|Adverse Event|0|||
33646733|NCT02260180|102259712|FG002|Overall Study|Adverse Event|1|||
33148905|NCT00750880|100458314|FG000|Overall Study|Lack of Efficacy|46|||
33378916|NCT00755846|101269597|FG000|Overall Study|Physician Decision|1|||
33378917|NCT00755846|101269598|FG001|Overall Study|Physician Decision|3|||
33378918|NCT00755846|101269599|FG002|Overall Study|Physician Decision|0|||
33378919|NCT00755846|101269600|FG003|Overall Study|Physician Decision|1|||
33378920|NCT00755846|101269601|FG004|Overall Study|Physician Decision|0|||
33378921|NCT00755846|101269602|FG005|Overall Study|Physician Decision|1|||
33378922|NCT00755846|101269597|FG000|Overall Study|Administrative Error|0|||
33378923|NCT00755846|101269598|FG001|Overall Study|Administrative Error|1|||
33378924|NCT00755846|101269599|FG002|Overall Study|Administrative Error|0|||
33378925|NCT00755846|101269600|FG003|Overall Study|Administrative Error|0|||
33378926|NCT00755846|101269601|FG004|Overall Study|Administrative Error|0|||
33378927|NCT00755846|101269602|FG005|Overall Study|Administrative Error|0|||
33378928|NCT00755846|101269597|FG000|Overall Study|Participant Non-compliance|0|||
33378929|NCT00755846|101269598|FG001|Overall Study|Participant Non-compliance|0|||
33378930|NCT00755846|101269599|FG002|Overall Study|Participant Non-compliance|0|||
33378931|NCT00755846|101269600|FG003|Overall Study|Participant Non-compliance|0|||
33378932|NCT00755846|101269601|FG004|Overall Study|Participant Non-compliance|1|||
33586834|NCT00412958|102036414|FG000|Overall Study|Adverse Event|0|||
33586835|NCT00412958|102036415|FG001|Overall Study|Adverse Event|1|||
33586836|NCT00412958|102036416|FG002|Overall Study|Adverse Event|0|||
33586837|NCT00412958|102036417|FG003|Overall Study|Adverse Event|0|||
33586838|NCT00412958|102036414|FG000|Overall Study|Lost to Follow-up|0|||
33148906|NCT00750880|100458314|FG000|Overall Study|Lost to Follow-up|10|||
33148907|NCT00750880|100458314|FG000|Overall Study|Protocol Violation|15|||
33586839|NCT00412958|102036415|FG001|Overall Study|Lost to Follow-up|1|||
33586840|NCT00412958|102036416|FG002|Overall Study|Lost to Follow-up|0|||
33586841|NCT00412958|102036417|FG003|Overall Study|Lost to Follow-up|0|||
33586842|NCT00412958|102036414|FG000|Overall Study|Death|0|||
33586843|NCT00412958|102036415|FG001|Overall Study|Death|1|||
33586844|NCT00412958|102036416|FG002|Overall Study|Death|0|||
33586845|NCT00412958|102036417|FG003|Overall Study|Death|0|||
33586846|NCT00412958|102036414|FG000|Overall Study|Transport issue|0|||
33586847|NCT00412958|102036415|FG001|Overall Study|Transport issue|1|||
33586848|NCT00412958|102036416|FG002|Overall Study|Transport issue|0|||
33586849|NCT00412958|102036417|FG003|Overall Study|Transport issue|0|||
33586850|NCT02923830|102036418|FG000|Overall Study|Physician Decision|13|||
33586851|NCT02923830|102036419|FG001|Overall Study|Physician Decision|15|||
33586852|NCT01309997|102036429|FG000|Overall Study|Adverse Event|1|||
33586853|NCT01309997|102036430|FG001|Overall Study|Adverse Event|0|||
33586854|NCT01309997|102036429|FG000|Overall Study|Death|1|||
33586855|NCT01309997|102036430|FG001|Overall Study|Death|3|||
33586856|NCT01309997|102036429|FG000|Overall Study|Lack of Efficacy|2|||
33586857|NCT01309997|102036430|FG001|Overall Study|Lack of Efficacy|2|||
33586858|NCT01309997|102036429|FG000|Overall Study|Withdrawal by Subject|1|||
33586859|NCT01309997|102036430|FG001|Overall Study|Withdrawal by Subject|1|||
33586860|NCT01905943|102036431|FG000|Overall Study|Withdrawal of consent|90|||
33586861|NCT01905943|102036431|FG000|Overall Study|Lost to Follow-up|16|||
33586862|NCT01905943|102036431|FG000|Overall Study|Investigator discretion|7|||
33586863|NCT01905943|102036431|FG000|Overall Study|Death|186|||
33586864|NCT01905943|102036431|FG000|Overall Study|Adverse Event|3|||
33586865|NCT01905943|102036431|FG000|Overall Study|Other|12|||
33586866|NCT00438360|102036432|FG000|Overall Study|Adverse Event|6|||
33586867|NCT00438360|102036433|FG001|Overall Study|Adverse Event|1|||
33586868|NCT00438360|102036432|FG000|Overall Study|Lack of Efficacy|42|||
33586869|NCT00438360|102036433|FG001|Overall Study|Lack of Efficacy|27|||
33586870|NCT00438360|102036432|FG000|Overall Study|Other|24|||
33586871|NCT00438360|102036433|FG001|Overall Study|Other|15|||
33586872|NCT01939977|102036443|FG000|Overall Study|Adverse Event|4|||
33586873|NCT01939977|102036444|FG001|Overall Study|Adverse Event|3|||
33148908|NCT00750880|100458314|FG000|Overall Study|Withdrawal by Subject|33|||
33378933|NCT00755846|101269602|FG005|Overall Study|Participant Non-compliance|0|||
33378934|NCT01318512|101269608|FG000|Maintenance Period (6 Months)|Death|2|||
33378935|NCT01318512|101269608|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
33586874|NCT01939977|102036443|FG000|Overall Study|Lack of Efficacy|3|||
33586875|NCT01939977|102036444|FG001|Overall Study|Lack of Efficacy|0|||
33586876|NCT01939977|102036443|FG000|Overall Study|Physician Decision|1|||
33586877|NCT01939977|102036444|FG001|Overall Study|Physician Decision|1|||
33586878|NCT01939977|102036443|FG000|Overall Study|Withdrawal by Subject|0|||
33378936|NCT01194804|101269609|FG000|Overall Study|Withdrawal by Subject|1|||
33586879|NCT01939977|102036444|FG001|Overall Study|Withdrawal by Subject|2|||
33378937|NCT00115765|101269610|FG000|Overall Study|Withdrawal by Subject|22|||
33378938|NCT00115765|101269611|FG001|Overall Study|Withdrawal by Subject|53|||
33586880|NCT01939977|102036443|FG000|Overall Study|Did not meet inclusion criteria|1|||
33646734|NCT01214395|102259714|FG000|Overall Study|All patients had infection|5|||
33646735|NCT01409811|102259715|FG000|Overall Study|Insurance denial|1|||
33247704|NCT03631199|100806783|FG002|Overall Study|Subject decision|0|||
33247705|NCT03631199|100806784|FG003|Overall Study|Subject decision|12|||
33247706|NCT03631199|100806785|FG004|Overall Study|Subject decision|12|||
33247707|NCT03631199|100806781|FG000|Overall Study|No treated|0|||
33247708|NCT03631199|100806782|FG001|Overall Study|No treated|0|||
33247709|NCT03631199|100806783|FG002|Overall Study|No treated|0|||
33586881|NCT01939977|102036444|FG001|Overall Study|Did not meet inclusion criteria|0|||
33586882|NCT01939977|102036443|FG000|Overall Study|Did not receive study medication|0|||
33586883|NCT01939977|102036444|FG001|Overall Study|Did not receive study medication|1|||
33586884|NCT02323126|102036445|FG000|Overall Study|Patient / guardian decision|0|||
33586885|NCT02323126|102036446|FG001|Overall Study|Patient / guardian decision|1|||
33586886|NCT02323126|102036447|FG002|Overall Study|Patient / guardian decision|2|||
33586887|NCT02323126|102036445|FG000|Overall Study|Progressive disease|14|||
33586888|NCT02323126|102036446|FG001|Overall Study|Progressive disease|8|||
33586889|NCT02323126|102036447|FG002|Overall Study|Progressive disease|14|||
33586890|NCT02323126|102036445|FG000|Overall Study|Physician Decision|0|||
33586891|NCT02323126|102036446|FG001|Overall Study|Physician Decision|1|||
33586892|NCT02323126|102036447|FG002|Overall Study|Physician Decision|3|||
33586893|NCT02323126|102036445|FG000|Overall Study|Death|1|||
33586894|NCT02323126|102036446|FG001|Overall Study|Death|1|||
33586895|NCT02323126|102036447|FG002|Overall Study|Death|4|||
33586896|NCT02323126|102036445|FG000|Overall Study|Adverse Event|3|||
33586897|NCT02323126|102036446|FG001|Overall Study|Adverse Event|5|||
33586898|NCT02323126|102036447|FG002|Overall Study|Adverse Event|7|||
33586899|NCT04222699|102036452|FG000|Overall Study|Lost to Follow-up|2|||
33586900|NCT04601532|102036455|FG000|Overall Study|Lost to Follow-up|1|||
33586901|NCT04601532|102036456|FG001|Overall Study|Lost to Follow-up|2|||
33646736|NCT02948088|102259716|FG000|Overall Study|Lost to Follow-up|8|||
33646737|NCT02948088|102259716|FG000|Overall Study|Death|1|||
33646738|NCT02948088|102259716|FG000|Overall Study|Withdrawal by Subject|4|||
33646739|NCT02948088|102259716|FG000|Overall Study|Other|2|||
33646740|NCT00223080|102259724|FG000|Overall Study|Withdrawal by Subject|253|||
33646741|NCT00223080|102259725|FG001|Overall Study|Withdrawal by Subject|232|||
33646742|NCT00223080|102259724|FG000|Overall Study|Required contraindicated med|0|||
33646743|NCT00223080|102259725|FG001|Overall Study|Required contraindicated med|1|||
33646744|NCT00223080|102259724|FG000|Overall Study|Non-compliant|7|||
33646745|NCT00223080|102259725|FG001|Overall Study|Non-compliant|7|||
33646746|NCT00223080|102259724|FG000|Overall Study|Moved from study area|37|||
33646747|NCT00223080|102259725|FG001|Overall Study|Moved from study area|47|||
33646748|NCT00223080|102259724|FG000|Overall Study|Lost to Follow-up|259|||
33646749|NCT00223080|102259725|FG001|Overall Study|Lost to Follow-up|284|||
33646750|NCT00223080|102259724|FG000|Overall Study|Death|85|||
33646751|NCT00223080|102259725|FG001|Overall Study|Death|74|||
33646752|NCT00223080|102259724|FG000|Overall Study|Other|14|||
33646753|NCT00223080|102259725|FG001|Overall Study|Other|11|||
33646754|NCT00223080|102259724|FG000|Overall Study|Reason not provided|141|||
33646755|NCT00223080|102259725|FG001|Overall Study|Reason not provided|140|||
33646756|NCT00223080|102259724|FG000|Overall Study|Adverse Event|0|||
33646757|NCT00223080|102259725|FG001|Overall Study|Adverse Event|1|||
33646758|NCT01105767|102259726|FG000|Overall Study|Lost to Follow-up|1160|||
33646759|NCT01105767|102259727|FG001|Overall Study|Lost to Follow-up|1614|||
33646760|NCT01105767|102259728|FG002|Overall Study|Lost to Follow-up|1184|||
33646761|NCT00946985|102259733|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
33646762|NCT00946985|102259733|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
33646763|NCT00946985|102259733|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
33646764|NCT00946985|102259733|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
33646765|NCT00946985|102259733|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
33646766|NCT00946985|102259733|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
33646767|NCT00946985|102259733|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
33646768|NCT00946985|102259733|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
33646769|NCT00946985|102259733|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
33646770|NCT02270944|102259734|FG000|Overall Study|Lost to Follow-up|9|||
33646771|NCT02270944|102259735|FG001|Overall Study|Lost to Follow-up|4|||
33646772|NCT02270944|102259734|FG000|Overall Study|Withdrawal by Subject|2|||
33646773|NCT02270944|102259735|FG001|Overall Study|Withdrawal by Subject|1|||
33586902|NCT04601532|102036455|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
33586903|NCT04601532|102036456|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
33586904|NCT02752633|102036457|FG000|Overall Study|Withdrawal by Subject|1|||
33646774|NCT01456897|102259737|FG000|Overall Study|Adverse Event|19|||
33646775|NCT01456897|102259738|FG001|Overall Study|Adverse Event|22|||
33646776|NCT01456897|102259737|FG000|Overall Study|Protocol Violation|3|||
33247710|NCT03631199|100806784|FG003|Overall Study|No treated|0|||
33646777|NCT01456897|102259738|FG001|Overall Study|Protocol Violation|4|||
33646778|NCT01456897|102259737|FG000|Overall Study|Physician Decision|5|||
33646779|NCT01456897|102259738|FG001|Overall Study|Physician Decision|3|||
33247711|NCT03631199|100806785|FG004|Overall Study|No treated|1|||
33247712|NCT03631199|100806781|FG000|Overall Study|Treatment ongoing|0|||
33586905|NCT01951586|102036460|FG000|Overall Study|Death|61|||
33378939|NCT00115765|101269612|FG002|Overall Study|Withdrawal by Subject|76|||
33378940|NCT00115765|101269613|FG003|Overall Study|Withdrawal by Subject|15|||
33378941|NCT00115765|101269610|FG000|Overall Study|Physician Decision|4|||
33378942|NCT00115765|101269611|FG001|Overall Study|Physician Decision|15|||
33378943|NCT00115765|101269612|FG002|Overall Study|Physician Decision|18|||
33378944|NCT00115765|101269613|FG003|Overall Study|Physician Decision|13|||
33378945|NCT00115765|101269610|FG000|Overall Study|Lost to Follow-up|3|||
33378946|NCT00115765|101269611|FG001|Overall Study|Lost to Follow-up|20|||
33378947|NCT00115765|101269612|FG002|Overall Study|Lost to Follow-up|18|||
33378948|NCT00115765|101269613|FG003|Overall Study|Lost to Follow-up|1|||
33378949|NCT00115765|101269610|FG000|Overall Study|Other|6|||
33378950|NCT00115765|101269611|FG001|Overall Study|Other|12|||
33378951|NCT00115765|101269612|FG002|Overall Study|Other|9|||
33378952|NCT00115765|101269613|FG003|Overall Study|Other|2|||
33378953|NCT01928485|101269614|FG000|Overall Study|Physician Decision|0|||
33378954|NCT01928485|101269615|FG001|Overall Study|Physician Decision|1|||
33378955|NCT03095521|101269616|FG000|Overall Study|Withdrawal by Subject|0|||
33378956|NCT03095521|101269617|FG001|Overall Study|Withdrawal by Subject|1|||
33378957|NCT03095521|101269616|FG000|Overall Study|Lost to Follow-up|0|||
33378958|NCT03095521|101269617|FG001|Overall Study|Lost to Follow-up|1|||
33378959|NCT01608724|101269626|FG000|Overall Study|Withdrawal by Subject|131|||
33378960|NCT01608724|101269626|FG000|Overall Study|Lost to Follow-up|41|||
33378961|NCT01608724|101269626|FG000|Overall Study|Study-specific discontinuation criteria|32|||
33378962|NCT01608724|101269626|FG000|Overall Study|Adverse Event|29|||
33378963|NCT01608724|101269626|FG000|Overall Study|Protocol Violation|6|||
33378964|NCT01608724|101269626|FG000|Overall Study|bood sugar too high, etc.|3|||
33378965|NCT01608724|101269626|FG000|Overall Study|Safety reasons|1|||
33378966|NCT00623467|101269633|FG000|Overall Study|Lost to Follow-up|1|||
33378967|NCT00623467|101269633|FG000|Overall Study|Protocol Violation|4|||
33378968|NCT00623467|101269633|FG000|Overall Study|Withdrawal by Subject|2|||
33378969|NCT04876599|101269634|FG000|Overall Study|Missed|2|||
33378970|NCT04876599|101269635|FG001|Overall Study|Missed|0|||
33378971|NCT04876599|101269634|FG000|Overall Study|Declined|2|||
33378972|NCT04876599|101269635|FG001|Overall Study|Declined|3|||
33378973|NCT01217190|101269638|FG000|Second Dosing|Withdrawal by Subject|0|||
33378974|NCT01217190|101269639|FG001|Second Dosing|Withdrawal by Subject|2|||
33378975|NCT01875367|101269640|FG000|Overall Study|Not complete at least 2 questionaries|4|||
33378976|NCT01875367|101269641|FG001|Overall Study|Not complete at least 2 questionaries|2|||
33378977|NCT01875367|101269640|FG000|Overall Study|Not receive study treatment|1|||
33378978|NCT01875367|101269641|FG001|Overall Study|Not receive study treatment|0|||
33378979|NCT01797965|101269642|FG000|Overall Study|Adverse Event|104|||
33378980|NCT01797965|101269643|FG001|Overall Study|Adverse Event|129|||
33378981|NCT01797965|101269644|FG002|Overall Study|Adverse Event|4|||
33378982|NCT01797965|101269645|FG003|Overall Study|Adverse Event|21|||
33378983|NCT01797965|101269642|FG000|Overall Study|Lost to Follow-up|9|||
33378984|NCT01797965|101269643|FG001|Overall Study|Lost to Follow-up|8|||
33378985|NCT01797965|101269644|FG002|Overall Study|Lost to Follow-up|1|||
33378986|NCT01797965|101269645|FG003|Overall Study|Lost to Follow-up|2|||
33378987|NCT01797965|101269642|FG000|Overall Study|Consent withdrawn|130|||
33378988|NCT01797965|101269643|FG001|Overall Study|Consent withdrawn|117|||
33378989|NCT01797965|101269644|FG002|Overall Study|Consent withdrawn|3|||
33378990|NCT01797965|101269645|FG003|Overall Study|Consent withdrawn|35|||
33378991|NCT01797965|101269642|FG000|Overall Study|Investigator decision|21|||
33378992|NCT01797965|101269643|FG001|Overall Study|Investigator decision|15|||
33378993|NCT01797965|101269644|FG002|Overall Study|Investigator decision|0|||
33378994|NCT01797965|101269645|FG003|Overall Study|Investigator decision|0|||
33378995|NCT01797965|101269642|FG000|Overall Study|Death|2|||
33378996|NCT01797965|101269643|FG001|Overall Study|Death|4|||
33378997|NCT01797965|101269644|FG002|Overall Study|Death|0|||
33378998|NCT01797965|101269645|FG003|Overall Study|Death|0|||
33378999|NCT01797965|101269642|FG000|Overall Study|Disease progression, defined by protocol|3|||
33379000|NCT01797965|101269643|FG001|Overall Study|Disease progression, defined by protocol|1|||
33379001|NCT01797965|101269644|FG002|Overall Study|Disease progression, defined by protocol|0|||
33379002|NCT01797965|101269645|FG003|Overall Study|Disease progression, defined by protocol|0|||
33379003|NCT01797965|101269642|FG000|Overall Study|Reason Not Specified|280|||
33586906|NCT01951586|102036461|FG001|Overall Study|Death|120|||
33586907|NCT01951586|102036460|FG000|Overall Study|Withdrawal by Subject|8|||
33379004|NCT01797965|101269643|FG001|Overall Study|Reason Not Specified|295|||
33586908|NCT01951586|102036461|FG001|Overall Study|Withdrawal by Subject|17|||
33586909|NCT01951586|102036460|FG000|Overall Study|Lost to Follow-up|0|||
33379005|NCT01797965|101269644|FG002|Overall Study|Reason Not Specified|0|||
33379006|NCT01797965|101269645|FG003|Overall Study|Reason Not Specified|15|||
33379007|NCT05319080|101269648|FG000|Overall Study|Withdrawal by Subject|2|||
33379008|NCT05319080|101269648|FG000|Overall Study|Physician Decision|4|||
33379009|NCT02124707|101269649|FG000|Overall Study|Adverse Event|5|||
33379010|NCT02124707|101269649|FG000|Overall Study|Physician Decision|1|||
33379011|NCT02124707|101269649|FG000|Overall Study|Death|1|||
33379012|NCT00310388|101269651|FG000|Primary Reporting Phase|Adverse Event|101|||
33586910|NCT01951586|102036461|FG001|Overall Study|Lost to Follow-up|1|||
33379013|NCT00310388|101269652|FG001|Primary Reporting Phase|Adverse Event|0|||
33379014|NCT00310388|101269651|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
33379015|NCT00310388|101269652|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
33379016|NCT00310388|101269651|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
33379017|NCT00310388|101269652|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
33379018|NCT00310388|101269651|FG000|Primary Reporting Phase|Protocol Violation|10|||
33379019|NCT00310388|101269652|FG001|Primary Reporting Phase|Protocol Violation|0|||
33379020|NCT00310388|101269651|FG000|Primary Reporting Phase|Pregnancy|3|||
33379021|NCT00310388|101269652|FG001|Primary Reporting Phase|Pregnancy|0|||
33379022|NCT00310388|101269651|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
33379023|NCT00310388|101269652|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
33379024|NCT00310388|101269651|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
33379025|NCT00310388|101269652|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
33379026|NCT00310388|101269651|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
33379027|NCT00310388|101269652|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
33379028|NCT00310388|101269651|FG000|Primary Reporting Phase|Physician Decision|2|||
33379029|NCT00310388|101269652|FG001|Primary Reporting Phase|Physician Decision|0|||
33379030|NCT00310388|101269651|FG000|Primary Reporting Phase|Request of the sponsor|19|||
33379031|NCT00310388|101269652|FG001|Primary Reporting Phase|Request of the sponsor|0|||
33586911|NCT01951586|102036460|FG000|Overall Study|Sponsor Decision|9|||
33586912|NCT01951586|102036461|FG001|Overall Study|Sponsor Decision|10|||
33586913|NCT03832322|102036462|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
33586914|NCT03832322|102036463|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
33586915|NCT04599803|102036464|FG000|Overall Study|Withdrawal by Subject|5|||
33586916|NCT04599803|102036464|FG000|Overall Study|Lost to Follow-up|26|||
33586917|NCT03248531|102036467|FG000|Overall Study|Adverse Event|0|||
33586918|NCT03248531|102036468|FG001|Overall Study|Adverse Event|0|||
33586919|NCT03248531|102036469|FG002|Overall Study|Adverse Event|1|||
33586920|NCT03248531|102036467|FG000|Overall Study|Lost to Follow-up|1|||
33586921|NCT03248531|102036468|FG001|Overall Study|Lost to Follow-up|0|||
33586922|NCT03248531|102036469|FG002|Overall Study|Lost to Follow-up|5|||
33586923|NCT03248531|102036467|FG000|Overall Study|Withdrawal by Subject|3|||
33586924|NCT03248531|102036468|FG001|Overall Study|Withdrawal by Subject|3|||
33646780|NCT01456897|102259737|FG000|Overall Study|Withdrawal by Subject|44|||
33646781|NCT01456897|102259738|FG001|Overall Study|Withdrawal by Subject|17|||
33646782|NCT01456897|102259737|FG000|Overall Study|Lack of Efficacy|4|||
33646783|NCT01456897|102259738|FG001|Overall Study|Lack of Efficacy|11|||
33646784|NCT04784442|102259745|FG000|Overall Study|Adverse Event|1|||
33646785|NCT04784442|102259746|FG001|Overall Study|Adverse Event|0|||
33379032|NCT00310388|101269651|FG000|Primary Reporting Phase|Failed to return|8|||
33379033|NCT00310388|101269652|FG001|Primary Reporting Phase|Failed to return|0|||
33379034|NCT00310388|101269651|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
33379035|NCT00310388|101269652|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
33379036|NCT00310388|101269651|FG000|Primary Reporting Phase|Participant request|2|||
33646786|NCT04784442|102259747|FG002|Overall Study|Adverse Event|2|||
33646787|NCT04784442|102259748|FG003|Overall Study|Adverse Event|1|||
33646788|NCT04784442|102259745|FG000|Overall Study|Protocol Violation|1|||
33646789|NCT04784442|102259746|FG001|Overall Study|Protocol Violation|0|||
33646790|NCT04784442|102259747|FG002|Overall Study|Protocol Violation|0|||
33646791|NCT04784442|102259748|FG003|Overall Study|Protocol Violation|0|||
33646792|NCT04784442|102259745|FG000|Overall Study|Non-compliance with study drug|1|||
33646793|NCT04784442|102259746|FG001|Overall Study|Non-compliance with study drug|0|||
33646794|NCT04784442|102259747|FG002|Overall Study|Non-compliance with study drug|0|||
33646795|NCT04784442|102259748|FG003|Overall Study|Non-compliance with study drug|0|||
33379037|NCT00310388|101269652|FG001|Primary Reporting Phase|Participant request|0|||
33424894|NCT01098240|101446525|FG000|Double-Blind Phase|Protocol Violation|0|||
33424895|NCT01098240|101446526|FG001|Double-Blind Phase|Protocol Violation|2|||
33424896|NCT01098240|101446527|FG002|Double-Blind Phase|Protocol Violation|4|||
33424897|NCT01098240|101446525|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33424898|NCT01098240|101446526|FG001|Double-Blind Phase|Lost to Follow-up|2|||
33379038|NCT00310388|101269651|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
33379039|NCT00310388|101269652|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
33379040|NCT00310388|101269651|FG000|Primary Reporting Phase|Discontinuation of study|1|||
33424899|NCT01098240|101446527|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33586925|NCT03248531|102036469|FG002|Overall Study|Withdrawal by Subject|2|||
33586926|NCT03248531|102036467|FG000|Overall Study|Sponsor Request|0|||
33586927|NCT03248531|102036468|FG001|Overall Study|Sponsor Request|2|||
33379041|NCT00310388|101269652|FG001|Primary Reporting Phase|Discontinuation of study|0|||
33586928|NCT03248531|102036469|FG002|Overall Study|Sponsor Request|0|||
33586929|NCT02516982|102036472|FG000|Overall Study|Called in to antenatal appointment|32|||
33586930|NCT02516982|102036473|FG001|Overall Study|Called in to antenatal appointment|35|||
33646796|NCT01499277|102259751|FG000|Overall Study|Adverse Event|3|||
33646797|NCT01499277|102259752|FG001|Overall Study|Adverse Event|6|||
33646798|NCT01499277|102259751|FG000|Overall Study|Death|3|||
33379042|NCT00310388|101269651|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
33424900|NCT01098240|101446525|FG000|Double-Blind Phase|Other|0|||
33424901|NCT01098240|101446526|FG001|Double-Blind Phase|Other|2|||
33424902|NCT01098240|101446527|FG002|Double-Blind Phase|Other|2|||
33424903|NCT01098240|101446525|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
33424904|NCT01098240|101446526|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
33379043|NCT00310388|101269652|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
33379044|NCT00310388|101269651|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
33379045|NCT00310388|101269652|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
33379046|NCT00310388|101269651|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
33379047|NCT00310388|101269652|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
33379048|NCT00310388|101269651|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
33379049|NCT00310388|101269652|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
33379050|NCT00310388|101269651|FG000|Primary Reporting Phase|Participant passed away|1|||
33379051|NCT00310388|101269652|FG001|Primary Reporting Phase|Participant passed away|0|||
33379052|NCT00310388|101269651|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
33379053|NCT00310388|101269652|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
33379054|NCT00310388|101269651|FG000|Primary Reporting Phase|Missing|1|||
33379055|NCT00310388|101269652|FG001|Primary Reporting Phase|Missing|0|||
33379056|NCT00310388|101269651|FG000|Primary Reporting Phase|Other|1|||
33379057|NCT00310388|101269652|FG001|Primary Reporting Phase|Other|0|||
33379058|NCT00310388|101269651|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
33379059|NCT00310388|101269652|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
33379060|NCT00310388|101269651|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
33379061|NCT00310388|101269652|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
33379062|NCT00310388|101269651|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
33379063|NCT00310388|101269652|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
33379064|NCT00310388|101269651|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
33379065|NCT00310388|101269652|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
33379066|NCT01391819|101269653|FG000|Overall Study|Withdrawal by Subject|56|||
33379067|NCT01391819|101269653|FG000|Overall Study|Migrated/moved from study area|82|||
33379068|NCT01391819|101269653|FG000|Overall Study|Lost to Follow-up|252|||
33379069|NCT01391819|101269653|FG000|Overall Study|Death|3|||
33379070|NCT01391819|101269653|FG000|Overall Study|Other|9|||
33379071|NCT00781599|101272717|FG000|Overall Study|Lost to Follow-up|7|||
33379072|NCT00781599|101272718|FG001|Overall Study|Lost to Follow-up|4|||
33379073|NCT01561560|101272720|FG000|First Two Weeks of Wear|Time/job conflict|0|||
33379074|NCT01561560|101272721|FG001|First Two Weeks of Wear|Time/job conflict|1|||
33379075|NCT01561560|101272720|FG000|First Two Weeks of Wear|Adverse Event|0|||
33379076|NCT01561560|101272721|FG001|First Two Weeks of Wear|Adverse Event|1|||
33379077|NCT01561560|101272720|FG000|Second Two Weeks of Wear|Adverse Event|0|||
33379078|NCT01561560|101272721|FG001|Second Two Weeks of Wear|Adverse Event|1|||
33379079|NCT00523341|101272722|FG000|Overall Study|Withdrawal by Subject|399|||
33379080|NCT00523341|101272723|FG001|Overall Study|Withdrawal by Subject|427|||
33379081|NCT00523341|101272722|FG000|Overall Study|Other|181|||
33379082|NCT00523341|101272723|FG001|Overall Study|Other|198|||
33379083|NCT00523341|101272722|FG000|Overall Study|Adverse Event|122|||
33379084|NCT00523341|101272723|FG001|Overall Study|Adverse Event|155|||
33379085|NCT00523341|101272722|FG000|Overall Study|Death|101|||
33379086|NCT00523341|101272723|FG001|Overall Study|Death|110|||
33379087|NCT00523341|101272722|FG000|Overall Study|Lost to Follow-up|73|||
33379088|NCT00523341|101272723|FG001|Overall Study|Lost to Follow-up|61|||
33379089|NCT00523341|101272722|FG000|Overall Study|Non-compliance|20|||
33379090|NCT00523341|101272723|FG001|Overall Study|Non-compliance|13|||
33379091|NCT00523341|101272722|FG000|Overall Study|Physician Decision|14|||
33379092|NCT00523341|101272723|FG001|Overall Study|Physician Decision|13|||
33379093|NCT00523341|101272722|FG000|Overall Study|Requirement for Alternative Therapy|4|||
33379094|NCT00523341|101272723|FG001|Overall Study|Requirement for Alternative Therapy|14|||
33379095|NCT00523341|101272722|FG000|Overall Study|Protocol Deviation|6|||
33379096|NCT00523341|101272723|FG001|Overall Study|Protocol Deviation|5|||
33379097|NCT00523341|101272722|FG000|Overall Study|Ineligibility Determined|3|||
33646799|NCT01499277|102259752|FG001|Overall Study|Death|2|||
33646800|NCT01499277|102259751|FG000|Overall Study|Lost to Follow-up|15|||
33646801|NCT01499277|102259752|FG001|Overall Study|Lost to Follow-up|8|||
33646802|NCT01499277|102259751|FG000|Overall Study|Protocol Violation|2|||
33379098|NCT00523341|101272723|FG001|Overall Study|Ineligibility Determined|4|||
33379099|NCT00523341|101272722|FG000|Overall Study|Disease Progression|1|||
33424905|NCT01098240|101446527|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
33379100|NCT00523341|101272723|FG001|Overall Study|Disease Progression|0|||
33379101|NCT00494871|101272724|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
33379102|NCT00494871|101272725|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
33424906|NCT01098240|101446525|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
33424907|NCT01098240|101446526|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
33646803|NCT01499277|102259752|FG001|Overall Study|Protocol Violation|3|||
33247713|NCT03631199|100806782|FG001|Overall Study|Treatment ongoing|1|||
33247714|NCT03631199|100806783|FG002|Overall Study|Treatment ongoing|1|||
33247715|NCT03631199|100806784|FG003|Overall Study|Treatment ongoing|76|||
33247716|NCT03631199|100806785|FG004|Overall Study|Treatment ongoing|71|||
33247717|NCT03631199|100806781|FG000|Overall Study|Guardian decision|0|||
33247718|NCT03631199|100806782|FG001|Overall Study|Guardian decision|0|||
33247719|NCT03631199|100806783|FG002|Overall Study|Guardian decision|0|||
33247720|NCT03631199|100806784|FG003|Overall Study|Guardian decision|1|||
33247721|NCT03631199|100806785|FG004|Overall Study|Guardian decision|1|||
33247722|NCT04858425|100806786|FG000|Overall Study|Adverse Event|2|||
33247723|NCT04858425|100806787|FG001|Overall Study|Adverse Event|2|||
33247724|NCT04858425|100806786|FG000|Overall Study|Withdrawal by Subject|3|||
33247725|NCT04858425|100806787|FG001|Overall Study|Withdrawal by Subject|1|||
33247726|NCT04858425|100806786|FG000|Overall Study|Lost to Follow-up|4|||
33247727|NCT04858425|100806787|FG001|Overall Study|Lost to Follow-up|2|||
33247728|NCT04858425|100806786|FG000|Overall Study|Lost to Follow-up|1|||
33247729|NCT04858425|100806787|FG001|Overall Study|Lost to Follow-up|0|||
33247730|NCT01155869|100806788|FG000|Overall Study|Lost to Follow-up|3|||
33247731|NCT01155869|100806789|FG001|Overall Study|Lost to Follow-up|1|||
33247732|NCT01972152|100806790|FG000|First Treatment Visit|Lost to Follow-up|0|||
33247733|NCT01972152|100806791|FG001|First Treatment Visit|Lost to Follow-up|1|||
33247734|NCT01972152|100806792|FG002|First Treatment Visit|Lost to Follow-up|0|||
33247735|NCT01972152|100806793|FG003|First Treatment Visit|Lost to Follow-up|0|||
33247736|NCT01972152|100806794|FG004|First Treatment Visit|Lost to Follow-up|0|||
33247737|NCT01972152|100806795|FG005|First Treatment Visit|Lost to Follow-up|0|||
33247738|NCT01972152|100806790|FG000|Second Treatment Visit|Protocol Violation|0|||
33247739|NCT01972152|100806791|FG001|Second Treatment Visit|Protocol Violation|1|||
33247740|NCT01972152|100806792|FG002|Second Treatment Visit|Protocol Violation|0|||
33247741|NCT01972152|100806793|FG003|Second Treatment Visit|Protocol Violation|0|||
33247742|NCT01972152|100806794|FG004|Second Treatment Visit|Protocol Violation|0|||
33247743|NCT01972152|100806795|FG005|Second Treatment Visit|Protocol Violation|0|||
33247744|NCT01494662|100810096|FG000|Overall Study|Withdrawal by Subject|0|||
33247745|NCT01494662|100810097|FG001|Overall Study|Withdrawal by Subject|0|||
33247746|NCT01494662|100810098|FG002|Overall Study|Withdrawal by Subject|1|||
33247747|NCT01494662|100810099|FG003|Overall Study|Withdrawal by Subject|0|||
33247748|NCT01494662|100810100|FG004|Overall Study|Withdrawal by Subject|0|||
33247749|NCT01494662|100810101|FG005|Overall Study|Withdrawal by Subject|0|||
33247750|NCT01494662|100810102|FG006|Overall Study|Withdrawal by Subject|0|||
33247751|NCT01494662|100810096|FG000|Overall Study|Physician Decision|0|||
33247752|NCT01494662|100810097|FG001|Overall Study|Physician Decision|0|||
33247753|NCT01494662|100810098|FG002|Overall Study|Physician Decision|1|||
33247754|NCT01494662|100810099|FG003|Overall Study|Physician Decision|0|||
33247755|NCT01494662|100810100|FG004|Overall Study|Physician Decision|0|||
33247756|NCT01494662|100810101|FG005|Overall Study|Physician Decision|0|||
33247757|NCT01494662|100810102|FG006|Overall Study|Physician Decision|0|||
33247758|NCT03523091|100810103|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
33247759|NCT03523091|100810104|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
33247760|NCT03523091|100810103|FG000|Overall Study|Withdrawal by Subject|0|||
33247761|NCT03523091|100810104|FG001|Overall Study|Withdrawal by Subject|3|||
33247762|NCT03523091|100810103|FG000|Overall Study|Increase Botox dose|0|||
33247763|NCT03523091|100810104|FG001|Overall Study|Increase Botox dose|1|||
33247764|NCT00768066|100810105|FG000|Overall Study|Did not receive study product injection.|3|||
33247765|NCT00768066|100810106|FG001|Overall Study|Did not receive study product injection.|3|||
33247766|NCT00768066|100810107|FG002|Overall Study|Did not receive study product injection.|0|||
33247767|NCT00964366|100810113|FG000|Overall Study|Did not qualify at Day 1|1|||
33247768|NCT00964366|100810114|FG001|Overall Study|Did not qualify at Day 1|0|||
33247769|NCT00964366|100810113|FG000|Overall Study|Withdrawal by Subject|0|||
33247770|NCT00964366|100810114|FG001|Overall Study|Withdrawal by Subject|1|||
33247771|NCT00003656|100810117|FG000|Overall Study|Adverse Event|0|||
33247772|NCT00003656|100810118|FG001|Overall Study|Adverse Event|1|||
33247773|NCT00197015|100810119|FG000|Overall Study|Adverse Event|3|||
33247774|NCT00197015|100810120|FG001|Overall Study|Adverse Event|0|||
33247775|NCT00197015|100810121|FG002|Overall Study|Adverse Event|1|||
33247776|NCT00197015|100810119|FG000|Overall Study|Protocol Violation|0|||
33247777|NCT00197015|100810120|FG001|Overall Study|Protocol Violation|3|||
33247778|NCT00197015|100810121|FG002|Overall Study|Protocol Violation|3|||
33247779|NCT00197015|100810119|FG000|Overall Study|Withdrawal by Subject|17|||
33247780|NCT00197015|100810120|FG001|Overall Study|Withdrawal by Subject|37|||
33247781|NCT00197015|100810121|FG002|Overall Study|Withdrawal by Subject|34|||
33247782|NCT00197015|100810119|FG000|Overall Study|Lost to Follow-up|28|||
33247783|NCT00197015|100810120|FG001|Overall Study|Lost to Follow-up|46|||
33247784|NCT00197015|100810121|FG002|Overall Study|Lost to Follow-up|37|||
33247785|NCT00197015|100810119|FG000|Overall Study|Other|2|||
33247786|NCT00197015|100810120|FG001|Overall Study|Other|3|||
33247787|NCT00197015|100810121|FG002|Overall Study|Other|2|||
33247788|NCT04044664|100810122|FG000|Stage 1|Adverse Event|3|||
33247789|NCT04044664|100810123|FG001|Stage 1|Adverse Event|3|||
33247790|NCT04044664|100810124|FG002|Stage 1|Adverse Event|1|||
33379103|NCT00494871|101272724|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
33379104|NCT00494871|101272725|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
33379105|NCT00494871|101272724|FG000|Double-blind (DB) Treatment Period|Death|8|||
33379106|NCT00494871|101272725|FG001|Double-blind (DB) Treatment Period|Death|3|||
33379107|NCT00494871|101272724|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
33379108|NCT00494871|101272725|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
33379109|NCT00494871|101272724|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
33379110|NCT00494871|101272725|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
33379111|NCT00494871|101272724|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
33379112|NCT00494871|101272725|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
33379113|NCT00494871|101272724|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
33379114|NCT00494871|101272725|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
33379115|NCT00494871|101272724|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
33379116|NCT00494871|101272725|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
33379117|NCT00494871|101272724|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
33379118|NCT00494871|101272725|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
33379119|NCT00494871|101272724|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
33379120|NCT00494871|101272725|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
33379121|NCT00494871|101272724|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
33646804|NCT01499277|102259751|FG000|Overall Study|Withdrawal by Subject|16|||
33646805|NCT01499277|102259752|FG001|Overall Study|Withdrawal by Subject|6|||
33646806|NCT01499277|102259751|FG000|Overall Study|Lack of therapeutic response and other|8|||
33646807|NCT01499277|102259752|FG001|Overall Study|Lack of therapeutic response and other|7|||
33646808|NCT00171834|102259753|FG000|Overall Study|Adverse Event|2|||
33646809|NCT00171834|102259754|FG001|Overall Study|Adverse Event|1|||
33646810|NCT00171834|102259755|FG002|Overall Study|Adverse Event|3|||
33646811|NCT00171834|102259756|FG003|Overall Study|Adverse Event|2|||
33646812|NCT00171834|102259757|FG004|Overall Study|Adverse Event|2|||
33646813|NCT00171834|102259758|FG005|Overall Study|Adverse Event|15|||
33646814|NCT00171834|102259759|FG006|Overall Study|Adverse Event|1|||
33646815|NCT00171834|102259753|FG000|Overall Study|Withdrawal by Subject|0|||
33646816|NCT00171834|102259754|FG001|Overall Study|Withdrawal by Subject|2|||
33646817|NCT00171834|102259755|FG002|Overall Study|Withdrawal by Subject|0|||
33646818|NCT00171834|102259756|FG003|Overall Study|Withdrawal by Subject|1|||
33646819|NCT00171834|102259757|FG004|Overall Study|Withdrawal by Subject|1|||
33646820|NCT00171834|102259758|FG005|Overall Study|Withdrawal by Subject|1|||
33646821|NCT00171834|102259759|FG006|Overall Study|Withdrawal by Subject|0|||
33247791|NCT04044664|100810122|FG000|Stage 1|Lost to Follow-up|3|||
33379122|NCT00494871|101272725|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
33379123|NCT00494871|101272724|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
33379124|NCT00494871|101272725|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
33379125|NCT00494871|101272724|FG000|Follow-up (FU) Period|Adverse Event|1|||
33379126|NCT00494871|101272725|FG001|Follow-up (FU) Period|Adverse Event|1|||
33379127|NCT00494871|101272724|FG000|Follow-up (FU) Period|Death|13|||
33379128|NCT00494871|101272725|FG001|Follow-up (FU) Period|Death|12|||
33379129|NCT00494871|101272724|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
33379130|NCT00494871|101272725|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
33379131|NCT00494871|101272724|FG000|Follow-up (FU) Period|Physician Decision|0|||
33379132|NCT00494871|101272725|FG001|Follow-up (FU) Period|Physician Decision|1|||
33379133|NCT00494871|101272724|FG000|Follow-up (FU) Period|Protocol Violation|1|||
33379134|NCT00494871|101272725|FG001|Follow-up (FU) Period|Protocol Violation|0|||
33379135|NCT00494871|101272724|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
33379136|NCT00494871|101272725|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
33379137|NCT00494871|101272724|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
33586931|NCT02516982|102036474|FG002|Overall Study|Called in to antenatal appointment|0|||
33586932|NCT02516982|102036475|FG003|Overall Study|Called in to antenatal appointment|0|||
33586933|NCT02516982|102036472|FG000|Overall Study|Withdrawal by Subject|0|||
33586934|NCT02516982|102036473|FG001|Overall Study|Withdrawal by Subject|0|||
33586935|NCT02516982|102036474|FG002|Overall Study|Withdrawal by Subject|1|||
33586936|NCT02516982|102036475|FG003|Overall Study|Withdrawal by Subject|2|||
33586937|NCT02516982|102036472|FG000|Overall Study|Protocol Violation|0|||
33586938|NCT02516982|102036473|FG001|Overall Study|Protocol Violation|0|||
33586939|NCT02516982|102036474|FG002|Overall Study|Protocol Violation|1|||
33586940|NCT02516982|102036475|FG003|Overall Study|Protocol Violation|1|||
33586941|NCT02516982|102036472|FG000|Overall Study|Did not install the app|0|||
33586942|NCT02516982|102036473|FG001|Overall Study|Did not install the app|0|||
33586943|NCT02516982|102036474|FG002|Overall Study|Did not install the app|46|||
33586944|NCT02516982|102036475|FG003|Overall Study|Did not install the app|47|||
33586945|NCT00610857|102036477|FG000|Overall Study|Not evaluable for response|2|||
33586946|NCT00559104|102036478|FG000|Overall Study|Lack of Efficacy|9|||
33586947|NCT00559104|102036479|FG001|Overall Study|Lack of Efficacy|0|||
33646822|NCT00171834|102259753|FG000|Overall Study|Death from study indication|0|||
33379138|NCT00494871|101272725|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
33379139|NCT02681055|101272726|FG000|Weeks 5-12|Adverse Event|1|||
33379140|NCT00438399|101272727|FG000|Overall Study|Lost to Follow-up|2|||
33379141|NCT00438399|101272728|FG001|Overall Study|Lost to Follow-up|2|||
33379142|NCT00438399|101272729|FG002|Overall Study|Lost to Follow-up|1|||
33379143|NCT00438399|101272730|FG003|Overall Study|Lost to Follow-up|1|||
33379144|NCT00438399|101272731|FG004|Overall Study|Lost to Follow-up|1|||
33379145|NCT00438399|101272732|FG005|Overall Study|Lost to Follow-up|1|||
33379146|NCT00438399|101272727|FG000|Overall Study|Adverse Event|0|||
33379147|NCT00438399|101272728|FG001|Overall Study|Adverse Event|0|||
33379148|NCT00438399|101272729|FG002|Overall Study|Adverse Event|1|||
33379149|NCT00438399|101272730|FG003|Overall Study|Adverse Event|1|||
33379150|NCT00438399|101272731|FG004|Overall Study|Adverse Event|0|||
33379151|NCT00438399|101272732|FG005|Overall Study|Adverse Event|1|||
33379152|NCT00438399|101272727|FG000|Overall Study|Withdrawal by Subject|5|||
33379153|NCT00438399|101272728|FG001|Overall Study|Withdrawal by Subject|6|||
33379154|NCT00438399|101272729|FG002|Overall Study|Withdrawal by Subject|3|||
33379155|NCT00438399|101272730|FG003|Overall Study|Withdrawal by Subject|2|||
33379156|NCT00438399|101272731|FG004|Overall Study|Withdrawal by Subject|2|||
33379157|NCT00438399|101272732|FG005|Overall Study|Withdrawal by Subject|2|||
33379158|NCT00438399|101272727|FG000|Overall Study|Protocol Violation|0|||
33379159|NCT00438399|101272728|FG001|Overall Study|Protocol Violation|0|||
33379160|NCT00438399|101272729|FG002|Overall Study|Protocol Violation|1|||
33379161|NCT00438399|101272730|FG003|Overall Study|Protocol Violation|0|||
33379162|NCT00438399|101272731|FG004|Overall Study|Protocol Violation|0|||
33379163|NCT00438399|101272732|FG005|Overall Study|Protocol Violation|1|||
33379164|NCT00438399|101272727|FG000|Overall Study|Subje stopped study|0|||
33379165|NCT00438399|101272728|FG001|Overall Study|Subje stopped study|0|||
33379166|NCT00438399|101272729|FG002|Overall Study|Subje stopped study|1|||
33379167|NCT00438399|101272730|FG003|Overall Study|Subje stopped study|0|||
33379168|NCT00438399|101272731|FG004|Overall Study|Subje stopped study|0|||
33379169|NCT00438399|101272732|FG005|Overall Study|Subje stopped study|0|||
33379170|NCT00438399|101272727|FG000|Overall Study|Pregnancy|0|||
33379171|NCT00438399|101272728|FG001|Overall Study|Pregnancy|0|||
33379172|NCT00438399|101272729|FG002|Overall Study|Pregnancy|0|||
33379173|NCT00438399|101272730|FG003|Overall Study|Pregnancy|0|||
33379174|NCT00438399|101272731|FG004|Overall Study|Pregnancy|0|||
33379175|NCT00438399|101272732|FG005|Overall Study|Pregnancy|1|||
33379176|NCT00438399|101272727|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
33379177|NCT00438399|101272728|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
33379178|NCT00438399|101272729|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
33379179|NCT00438399|101272730|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
33379180|NCT00438399|101272731|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
33379181|NCT00438399|101272732|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
33379182|NCT00817206|101272733|FG000|Overall Study|Adverse Event|10|||
33379183|NCT00817206|101272734|FG001|Overall Study|Adverse Event|3|||
33379184|NCT00817206|101272733|FG000|Overall Study|Protocol Violation|0|||
33379185|NCT00817206|101272734|FG001|Overall Study|Protocol Violation|2|||
33586948|NCT03143153|102036480|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
33379186|NCT00817206|101272733|FG000|Overall Study|Lost to Follow-up|0|||
33379187|NCT00817206|101272734|FG001|Overall Study|Lost to Follow-up|1|||
33379188|NCT00817206|101272733|FG000|Overall Study|Death|2|||
33379189|NCT00817206|101272734|FG001|Overall Study|Death|0|||
33379190|NCT00817206|101272733|FG000|Overall Study|Withdrawal by Subject|7|||
33586949|NCT03143153|102036481|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
33586950|NCT03143153|102036482|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
33586951|NCT03143153|102036480|FG000|Pre-Treatment|Participant withdrew consent|0|||
33586952|NCT03143153|102036481|FG001|Pre-Treatment|Participant withdrew consent|1|||
33586953|NCT03143153|102036482|FG002|Pre-Treatment|Participant withdrew consent|12|||
33586954|NCT03143153|102036480|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
33586955|NCT03143153|102036481|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
33586956|NCT03143153|102036482|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
33586957|NCT03143153|102036480|FG000|Pre-Treatment|Other Reasons|1|||
33586958|NCT03143153|102036481|FG001|Pre-Treatment|Other Reasons|2|||
33586959|NCT03143153|102036482|FG002|Pre-Treatment|Other Reasons|1|||
33586960|NCT03143153|102036480|FG000|Pre-Treatment|Disease Progression|1|||
33586961|NCT03143153|102036481|FG001|Pre-Treatment|Disease Progression|1|||
33586962|NCT03143153|102036482|FG002|Pre-Treatment|Disease Progression|2|||
33379191|NCT00817206|101272734|FG001|Overall Study|Withdrawal by Subject|3|||
33379192|NCT00817206|101272733|FG000|Overall Study|Physician Decision|2|||
33379193|NCT00817206|101272734|FG001|Overall Study|Physician Decision|0|||
33379194|NCT00592553|101272739|FG000|Overall Study|Protocol Noncompliance|1|||
33379195|NCT00592553|101272740|FG001|Overall Study|Protocol Noncompliance|0|||
33586963|NCT03143153|102036480|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
33379196|NCT00592553|101272741|FG002|Overall Study|Protocol Noncompliance|0|||
33586964|NCT03143153|102036481|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
33646823|NCT00171834|102259754|FG001|Overall Study|Death from study indication|1|||
33646824|NCT00171834|102259755|FG002|Overall Study|Death from study indication|0|||
33646825|NCT00171834|102259756|FG003|Overall Study|Death from study indication|0|||
33646826|NCT00171834|102259757|FG004|Overall Study|Death from study indication|1|||
33646827|NCT00171834|102259758|FG005|Overall Study|Death from study indication|0|||
33646828|NCT00171834|102259759|FG006|Overall Study|Death from study indication|0|||
33646829|NCT00171834|102259753|FG000|Overall Study|Disease Progression|4|||
33646830|NCT00171834|102259754|FG001|Overall Study|Disease Progression|8|||
33646831|NCT00171834|102259755|FG002|Overall Study|Disease Progression|8|||
33646832|NCT00171834|102259756|FG003|Overall Study|Disease Progression|9|||
33646833|NCT00171834|102259757|FG004|Overall Study|Disease Progression|2|||
33646834|NCT00171834|102259758|FG005|Overall Study|Disease Progression|18|||
33646835|NCT00171834|102259759|FG006|Overall Study|Disease Progression|3|||
33646836|NCT00171834|102259753|FG000|Overall Study|Treatment Duration Completed|0|||
33646837|NCT00171834|102259754|FG001|Overall Study|Treatment Duration Completed|0|||
33646838|NCT00171834|102259755|FG002|Overall Study|Treatment Duration Completed|1|||
33646839|NCT00171834|102259756|FG003|Overall Study|Treatment Duration Completed|0|||
33646840|NCT00171834|102259757|FG004|Overall Study|Treatment Duration Completed|2|||
33646841|NCT00171834|102259758|FG005|Overall Study|Treatment Duration Completed|1|||
33646842|NCT00171834|102259759|FG006|Overall Study|Treatment Duration Completed|0|||
33646843|NCT02813577|102259762|FG000|Overall Study|Study terminated|4|||
33646844|NCT03412565|102259763|FG000|Overall Study|Lost to Follow-up|0|||
33646845|NCT03412565|102259764|FG001|Overall Study|Lost to Follow-up|0|||
33646846|NCT03412565|102259765|FG002|Overall Study|Lost to Follow-up|1|||
33646847|NCT03412565|102259766|FG003|Overall Study|Lost to Follow-up|0|||
33646848|NCT03412565|102259763|FG000|Overall Study|Physician Decision|0|||
33646849|NCT03412565|102259764|FG001|Overall Study|Physician Decision|0|||
33646850|NCT03412565|102259765|FG002|Overall Study|Physician Decision|0|||
33646851|NCT03412565|102259766|FG003|Overall Study|Physician Decision|1|||
33646852|NCT03412565|102259763|FG000|Overall Study|Withdrawal by Subject|0|||
33646853|NCT03412565|102259764|FG001|Overall Study|Withdrawal by Subject|4|||
33646854|NCT03412565|102259765|FG002|Overall Study|Withdrawal by Subject|5|||
33646855|NCT03412565|102259766|FG003|Overall Study|Withdrawal by Subject|5|||
33646856|NCT03412565|102259763|FG000|Overall Study|Death|1|||
33646857|NCT03412565|102259764|FG001|Overall Study|Death|3|||
33646858|NCT03412565|102259765|FG002|Overall Study|Death|4|||
33646859|NCT03412565|102259766|FG003|Overall Study|Death|5|||
33646860|NCT03412565|102259763|FG000|Overall Study|Data collection ended|0|||
33646861|NCT03412565|102259764|FG001|Overall Study|Data collection ended|41|||
33646862|NCT03412565|102259765|FG002|Overall Study|Data collection ended|41|||
33646863|NCT03412565|102259766|FG003|Overall Study|Data collection ended|40|||
33646864|NCT00970684|102259767|FG000|Overall Study|Lack of Efficacy|5|||
33646865|NCT00970684|102259767|FG000|Overall Study|Adverse Event|4|||
33646866|NCT00970684|102259767|FG000|Overall Study|Withdrawal by Subject|1|||
33646867|NCT03844945|102259768|FG000|Overall Study|Adverse Event|1|||
33646868|NCT03844945|102259769|FG001|Overall Study|Adverse Event|1|||
33646869|NCT03844945|102259770|FG002|Overall Study|Adverse Event|4|||
33646870|NCT03844945|102259771|FG003|Overall Study|Adverse Event|0|||
33646871|NCT03844945|102259768|FG000|Overall Study|Withdrawal by Subject|0|||
33646872|NCT03844945|102259769|FG001|Overall Study|Withdrawal by Subject|0|||
33646873|NCT03844945|102259770|FG002|Overall Study|Withdrawal by Subject|1|||
33646874|NCT03844945|102259771|FG003|Overall Study|Withdrawal by Subject|0|||
33646875|NCT03844945|102259768|FG000|Overall Study|Lack of Efficacy|0|||
33646876|NCT03844945|102259769|FG001|Overall Study|Lack of Efficacy|0|||
33646877|NCT03844945|102259770|FG002|Overall Study|Lack of Efficacy|0|||
33646878|NCT03844945|102259771|FG003|Overall Study|Lack of Efficacy|1|||
33646879|NCT02929407|102259777|FG000|Overall Study|Adverse Event|1|||
33646880|NCT00337675|102259778|FG000|Overall Study|Adverse Event|10|||
33646881|NCT00337675|102259779|FG001|Overall Study|Adverse Event|9|||
33646882|NCT00337675|102259780|FG002|Overall Study|Adverse Event|19|||
33646883|NCT00337675|102259778|FG000|Overall Study|Lack of Efficacy|10|||
33646884|NCT00337675|102259779|FG001|Overall Study|Lack of Efficacy|7|||
33646885|NCT00337675|102259780|FG002|Overall Study|Lack of Efficacy|9|||
33646886|NCT00337675|102259778|FG000|Overall Study|Lost to Follow-up|22|||
33646887|NCT00337675|102259779|FG001|Overall Study|Lost to Follow-up|19|||
33646888|NCT00337675|102259780|FG002|Overall Study|Lost to Follow-up|17|||
33646889|NCT00337675|102259778|FG000|Overall Study|Physician Decision|9|||
33379197|NCT00575094|101272742|FG000|Overall Study|Adverse Event|2|||
33646890|NCT00337675|102259779|FG001|Overall Study|Physician Decision|17|||
33646891|NCT00337675|102259780|FG002|Overall Study|Physician Decision|14|||
33646892|NCT00337675|102259778|FG000|Overall Study|Protocol Violation|21|||
33646893|NCT00337675|102259779|FG001|Overall Study|Protocol Violation|24|||
33646894|NCT00337675|102259780|FG002|Overall Study|Protocol Violation|19|||
33646895|NCT00337675|102259778|FG000|Overall Study|Withdrawal by Subject|25|||
33646896|NCT00337675|102259779|FG001|Overall Study|Withdrawal by Subject|25|||
33148909|NCT00750880|100458314|FG000|Overall Study|Physician Decision|20|||
33646897|NCT00337675|102259780|FG002|Overall Study|Withdrawal by Subject|19|||
33646898|NCT00337675|102259778|FG000|Overall Study|Progressive Disease|0|||
33646899|NCT00337675|102259779|FG001|Overall Study|Progressive Disease|2|||
33646900|NCT00337675|102259780|FG002|Overall Study|Progressive Disease|0|||
33646901|NCT00337675|102259778|FG000|Overall Study|Trial Terminated|0|||
33646902|NCT00337675|102259779|FG001|Overall Study|Trial Terminated|0|||
33646903|NCT00337675|102259780|FG002|Overall Study|Trial Terminated|2|||
33646904|NCT01363349|102259790|FG000|Overall Study|Adverse Event|6|||
33646905|NCT01363349|102259791|FG001|Overall Study|Adverse Event|7|||
33646906|NCT01363349|102259790|FG000|Overall Study|Lack of Efficacy|3|||
33646907|NCT01363349|102259791|FG001|Overall Study|Lack of Efficacy|10|||
33646908|NCT01363349|102259790|FG000|Overall Study|Non compliance/Protocol deviations|2|||
33646909|NCT01363349|102259791|FG001|Overall Study|Non compliance/Protocol deviations|2|||
33646910|NCT01363349|102259790|FG000|Overall Study|Withdrawal by Subject|14|||
33646911|NCT01363349|102259791|FG001|Overall Study|Withdrawal by Subject|6|||
33646912|NCT01363349|102259790|FG000|Overall Study|Lost to Follow-up|5|||
33646913|NCT01363349|102259791|FG001|Overall Study|Lost to Follow-up|6|||
33646914|NCT01363349|102259790|FG000|Overall Study|Not reported|36|||
33646915|NCT01363349|102259791|FG001|Overall Study|Not reported|37|||
33646916|NCT01363349|102259790|FG000|Overall Study|missing|1|||
33646917|NCT01363349|102259791|FG001|Overall Study|missing|2|||
33646918|NCT00246740|102259792|FG000|Initial Enrollment|Death|1|||
33646919|NCT00246740|102259793|FG001|Initial Enrollment|Death|0|||
33646920|NCT00246740|102259792|FG000|Initial Enrollment|Additional surgery scheduled|0|||
33646921|NCT00246740|102259793|FG001|Initial Enrollment|Additional surgery scheduled|2|||
33148910|NCT00750880|100458314|FG000|Overall Study|Administrative|11|||
33148911|NCT02676466|100460607|FG000|Overall Study|Death|0|||
33148912|NCT02676466|100460608|FG001|Overall Study|Death|2|||
33148913|NCT02676466|100460609|FG002|Overall Study|Death|1|||
33148914|NCT02676466|100460610|FG003|Overall Study|Death|0|||
33148915|NCT02676466|100460611|FG004|Overall Study|Death|0|||
33148916|NCT02676466|100460612|FG005|Overall Study|Death|0|||
33148917|NCT02676466|100460613|FG006|Overall Study|Death|0|||
33148918|NCT02676466|100460614|FG007|Overall Study|Death|0|||
33148919|NCT02676466|100460607|FG000|Overall Study|Withdrawal by Subject|4|||
33148920|NCT02676466|100460608|FG001|Overall Study|Withdrawal by Subject|3|||
33148921|NCT02676466|100460609|FG002|Overall Study|Withdrawal by Subject|1|||
33148922|NCT02676466|100460610|FG003|Overall Study|Withdrawal by Subject|0|||
33148923|NCT02676466|100460611|FG004|Overall Study|Withdrawal by Subject|3|||
33148924|NCT02676466|100460612|FG005|Overall Study|Withdrawal by Subject|1|||
33148925|NCT02676466|100460613|FG006|Overall Study|Withdrawal by Subject|1|||
33148926|NCT02676466|100460614|FG007|Overall Study|Withdrawal by Subject|1|||
33148927|NCT03290079|100460615|FG000|Overall Study|Death|2|||
33148928|NCT03583164|100460616|FG000|Overall Study|Death in Main Phase|35|||
33148929|NCT03583164|100460616|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
33148930|NCT03583164|100460616|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
33148931|NCT03583164|100460616|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
33148932|NCT03583164|100460616|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
33148933|NCT03583164|100460616|FG000|Overall Study|Physician decision in Main Phase|1|||
33148934|NCT03583164|100460616|FG000|Overall Study|Physician decision in Extended Phase|2|||
33148935|NCT03583164|100460616|FG000|Overall Study|Death in Extended Phase|13|||
33148936|NCT03583164|100460616|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
33148937|NCT03583164|100460616|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
33379198|NCT00575094|101272742|FG000|Overall Study|Withdrawal by Subject|1|||
33379199|NCT03497429|101272743|FG000|Overall Study|Progressive disease|3|||
33379200|NCT03497429|101272744|FG001|Overall Study|Progressive disease|4|||
33379201|NCT03497429|101272743|FG000|Overall Study|Adverse Event|0|||
33148938|NCT03583164|100460616|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
33148939|NCT03583164|100460616|FG000|Overall Study|Treatment failure in Main Phase|2|||
33148940|NCT03583164|100460616|FG000|Overall Study|Treatment failure in Extended Phase|4|||
33148941|NCT03583164|100460616|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
33148942|NCT03583164|100460616|FG000|Overall Study|Other not specified reason in Main Phase|2|||
33379202|NCT03497429|101272744|FG001|Overall Study|Adverse Event|2|||
33148943|NCT01325623|100460619|FG000|Overall Study|Withdrawal by Subject|3|||
33148944|NCT01394718|100460622|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
33379203|NCT01757405|101272748|FG000|Overall Study|Lost to Follow-up|1|||
33379204|NCT01757405|101272749|FG001|Overall Study|Lost to Follow-up|1|||
33379205|NCT01757405|101272748|FG000|Overall Study|Withdrawal by Subject|0|||
33379206|NCT01757405|101272749|FG001|Overall Study|Withdrawal by Subject|1|||
33379207|NCT04900038|101272750|FG000|Overall Study|Adverse Event|1|||
33148945|NCT01394718|100460623|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
33148946|NCT03604692|100460624|FG000|Overall Study|Investigator's Decision|0|||
33379208|NCT04900038|101272751|FG001|Overall Study|Adverse Event|0|||
33379209|NCT04900038|101272752|FG002|Overall Study|Adverse Event|1|||
33646922|NCT00246740|102259792|FG000|Initial Enrollment|Surgery schedule change|4|||
33646923|NCT00246740|102259793|FG001|Initial Enrollment|Surgery schedule change|4|||
33379210|NCT04900038|101272753|FG003|Overall Study|Adverse Event|1|||
33379211|NCT04900038|101272750|FG000|Overall Study|Withdrawal by Subject|0|||
33646924|NCT00246740|102259792|FG000|Initial Enrollment|Other|1|||
33646925|NCT00246740|102259793|FG001|Initial Enrollment|Other|2|||
33379212|NCT04900038|101272751|FG001|Overall Study|Withdrawal by Subject|1|||
33379213|NCT04900038|101272752|FG002|Overall Study|Withdrawal by Subject|0|||
33379214|NCT04900038|101272753|FG003|Overall Study|Withdrawal by Subject|0|||
33379215|NCT04900038|101272750|FG000|Overall Study|Study terminated by sponsor|18|||
33379216|NCT04900038|101272751|FG001|Overall Study|Study terminated by sponsor|15|||
33379217|NCT04900038|101272752|FG002|Overall Study|Study terminated by sponsor|17|||
33379218|NCT04900038|101272753|FG003|Overall Study|Study terminated by sponsor|14|||
33379219|NCT04900038|101272750|FG000|Overall Study|Protocol Deviation|1|||
33379220|NCT04900038|101272751|FG001|Overall Study|Protocol Deviation|1|||
33379221|NCT04900038|101272752|FG002|Overall Study|Protocol Deviation|0|||
33379222|NCT04900038|101272753|FG003|Overall Study|Protocol Deviation|0|||
33379223|NCT04900038|101272750|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
33379224|NCT04900038|101272751|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
33379225|NCT04900038|101272752|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
33379226|NCT04900038|101272753|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
33379227|NCT04900038|101272750|FG000|Overall Study|Lost to Follow-up|0|||
33379228|NCT04900038|101272751|FG001|Overall Study|Lost to Follow-up|0|||
33379229|NCT04900038|101272752|FG002|Overall Study|Lost to Follow-up|0|||
33379230|NCT04900038|101272753|FG003|Overall Study|Lost to Follow-up|1|||
33379231|NCT00012012|101272754|FG000|Overall Study|Protocol Violation|1|||
33379232|NCT00012012|101272755|FG001|Overall Study|Protocol Violation|1|||
33379233|NCT00012012|101272754|FG000|Overall Study|Withdrawal by Subject|0|||
33379234|NCT00012012|101272755|FG001|Overall Study|Withdrawal by Subject|2|||
33379235|NCT03712345|101272765|FG000|Overall Study|Failure to meet randomization criteria|0|||
33379236|NCT03712345|101272766|FG001|Overall Study|Failure to meet randomization criteria|0|||
33379237|NCT03712345|101272767|FG002|Overall Study|Failure to meet randomization criteria|1|||
33379238|NCT04831515|101272769|FG000|First Intervention|Adverse Event|0|||
33379239|NCT04831515|101272770|FG001|First Intervention|Adverse Event|1|||
33379240|NCT01315847|101272771|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
33379241|NCT01315847|101272772|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
33379242|NCT01315847|101272771|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
33379243|NCT01315847|101272772|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
33379244|NCT01295580|101272775|FG000|Overall Study|Protocol Violation|4|||
33379245|NCT01295580|101272776|FG001|Overall Study|Protocol Violation|2|||
33379246|NCT01295580|101272775|FG000|Overall Study|Withdrawal by Subject|1|||
33379247|NCT01295580|101272776|FG001|Overall Study|Withdrawal by Subject|4|||
33379248|NCT01295580|101272775|FG000|Overall Study|Adverse Event|2|||
33379249|NCT01295580|101272776|FG001|Overall Study|Adverse Event|1|||
33379250|NCT01295580|101272775|FG000|Overall Study|Lost to Follow-up|1|||
33148947|NCT03604692|100460625|FG001|Overall Study|Investigator's Decision|0|||
33148948|NCT03604692|100460626|FG002|Overall Study|Investigator's Decision|0|||
33148949|NCT03604692|100460627|FG003|Overall Study|Investigator's Decision|1|||
33148950|NCT03604692|100460628|FG004|Overall Study|Investigator's Decision|0|||
33148951|NCT03604692|100460629|FG005|Overall Study|Investigator's Decision|7|||
33148952|NCT03604692|100460624|FG000|Overall Study|Withdrawal by Subject|0|||
33148953|NCT03604692|100460625|FG001|Overall Study|Withdrawal by Subject|0|||
33148954|NCT03604692|100460626|FG002|Overall Study|Withdrawal by Subject|0|||
33148955|NCT03604692|100460627|FG003|Overall Study|Withdrawal by Subject|0|||
33148956|NCT03604692|100460628|FG004|Overall Study|Withdrawal by Subject|0|||
33148957|NCT03604692|100460629|FG005|Overall Study|Withdrawal by Subject|2|||
33148958|NCT03604692|100460624|FG000|Overall Study|Progressive Disease|1|||
33379251|NCT01295580|101272776|FG001|Overall Study|Lost to Follow-up|0|||
33379252|NCT01295580|101272775|FG000|Overall Study|Lack of Efficacy|1|||
33379253|NCT01295580|101272776|FG001|Overall Study|Lack of Efficacy|0|||
33379254|NCT01295580|101272775|FG000|Overall Study|Other: inconvenience|1|||
33379255|NCT01295580|101272776|FG001|Overall Study|Other: inconvenience|0|||
33379256|NCT01295580|101272775|FG000|Overall Study|Other: family objection|0|||
33379257|NCT01295580|101272776|FG001|Overall Study|Other: family objection|1|||
33586965|NCT03143153|102036482|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
33586966|NCT03143153|102036480|FG000|Treatment|Disease progression|174|||
33148959|NCT03604692|100460625|FG001|Overall Study|Progressive Disease|0|||
33148960|NCT03604692|100460626|FG002|Overall Study|Progressive Disease|1|||
33379258|NCT01999946|101272778|FG000|Overall Study|Participant not released from jail|2|||
33379259|NCT01999946|101272779|FG001|Overall Study|Participant not released from jail|2|||
33379260|NCT01999946|101272780|FG002|Overall Study|Participant not released from jail|0|||
33379261|NCT01999946|101272778|FG000|Overall Study|Not included in primary outcome analysis|0|||
33379262|NCT01999946|101272779|FG001|Overall Study|Not included in primary outcome analysis|0|||
33148961|NCT03604692|100460627|FG003|Overall Study|Progressive Disease|0|||
33148962|NCT03604692|100460628|FG004|Overall Study|Progressive Disease|3|||
33148963|NCT03604692|100460629|FG005|Overall Study|Progressive Disease|4|||
33379263|NCT01999946|101272780|FG002|Overall Study|Not included in primary outcome analysis|79|||
33379264|NCT02807363|101272781|FG000|Dosing Period|Adverse Event|0|||
33379265|NCT02807363|101272782|FG001|Dosing Period|Adverse Event|1|||
33379266|NCT02807363|101272783|FG002|Dosing Period|Adverse Event|0|||
33586967|NCT03143153|102036481|FG001|Treatment|Disease progression|184|||
33247792|NCT04044664|100810123|FG001|Stage 1|Lost to Follow-up|2|||
33247793|NCT04044664|100810124|FG002|Stage 1|Lost to Follow-up|2|||
33247794|NCT04044664|100810122|FG000|Stage 1|Withdrawal by Subject|9|||
33247795|NCT04044664|100810123|FG001|Stage 1|Withdrawal by Subject|1|||
33247796|NCT04044664|100810124|FG002|Stage 1|Withdrawal by Subject|0|||
33247797|NCT04044664|100810122|FG000|Stage 1|noncompliance, personal reason|2|||
33247798|NCT04044664|100810123|FG001|Stage 1|noncompliance, personal reason|0|||
33247799|NCT04044664|100810124|FG002|Stage 1|noncompliance, personal reason|0|||
33247800|NCT04044664|100810122|FG000|Stage 1|randomization error|0|||
33586968|NCT03143153|102036482|FG002|Treatment|Disease progression|193|||
33586969|NCT03143153|102036480|FG000|Treatment|Study drug toxicity|59|||
33586970|NCT03143153|102036481|FG001|Treatment|Study drug toxicity|33|||
33148964|NCT03604692|100460624|FG000|Overall Study|Difficulty Coming into Site.|0|||
33148965|NCT03604692|100460625|FG001|Overall Study|Difficulty Coming into Site.|0|||
33148966|NCT03604692|100460626|FG002|Overall Study|Difficulty Coming into Site.|0|||
33148967|NCT03604692|100460627|FG003|Overall Study|Difficulty Coming into Site.|0|||
33148968|NCT03604692|100460628|FG004|Overall Study|Difficulty Coming into Site.|0|||
33148969|NCT03604692|100460629|FG005|Overall Study|Difficulty Coming into Site.|1|||
33148970|NCT03604692|100460624|FG000|Overall Study|Death|0|||
33148971|NCT03604692|100460625|FG001|Overall Study|Death|0|||
33148972|NCT03604692|100460626|FG002|Overall Study|Death|1|||
33148973|NCT03604692|100460627|FG003|Overall Study|Death|0|||
33148974|NCT03604692|100460628|FG004|Overall Study|Death|0|||
33148975|NCT03604692|100460629|FG005|Overall Study|Death|0|||
33148976|NCT03604692|100460624|FG000|Overall Study|Drug Intolerance|0|||
33148977|NCT03604692|100460625|FG001|Overall Study|Drug Intolerance|0|||
33148978|NCT03604692|100460626|FG002|Overall Study|Drug Intolerance|0|||
33148979|NCT03604692|100460627|FG003|Overall Study|Drug Intolerance|1|||
33148980|NCT03604692|100460628|FG004|Overall Study|Drug Intolerance|0|||
33148981|NCT03604692|100460629|FG005|Overall Study|Drug Intolerance|0|||
33148982|NCT03604692|100460624|FG000|Overall Study|Noncompliance with follow-up visit|0|||
33148983|NCT03604692|100460625|FG001|Overall Study|Noncompliance with follow-up visit|0|||
33148984|NCT03604692|100460626|FG002|Overall Study|Noncompliance with follow-up visit|0|||
33148985|NCT03604692|100460627|FG003|Overall Study|Noncompliance with follow-up visit|1|||
33148986|NCT03604692|100460628|FG004|Overall Study|Noncompliance with follow-up visit|0|||
33148987|NCT03604692|100460629|FG005|Overall Study|Noncompliance with follow-up visit|0|||
33148988|NCT03604692|100460624|FG000|Overall Study|Continuing Treatment/In Follow-Up|0|||
33148989|NCT03604692|100460625|FG001|Overall Study|Continuing Treatment/In Follow-Up|0|||
33148990|NCT03604692|100460626|FG002|Overall Study|Continuing Treatment/In Follow-Up|1|||
33148991|NCT03604692|100460627|FG003|Overall Study|Continuing Treatment/In Follow-Up|1|||
33148992|NCT03604692|100460628|FG004|Overall Study|Continuing Treatment/In Follow-Up|0|||
33148993|NCT03604692|100460629|FG005|Overall Study|Continuing Treatment/In Follow-Up|0|||
33148994|NCT03604692|100460624|FG000|Overall Study|Not Treated|0|||
33148995|NCT03604692|100460625|FG001|Overall Study|Not Treated|0|||
33148996|NCT03604692|100460626|FG002|Overall Study|Not Treated|0|||
33148997|NCT03604692|100460627|FG003|Overall Study|Not Treated|0|||
33148998|NCT03604692|100460628|FG004|Overall Study|Not Treated|1|||
33148999|NCT03604692|100460629|FG005|Overall Study|Not Treated|0|||
33149000|NCT04025710|100460634|FG000|Overall Study|Death|3|||
33149001|NCT04025710|100460634|FG000|Overall Study|Lost to Follow-up|5|||
33149002|NCT04025710|100460634|FG000|Overall Study|Withdrawal by Subject|1|||
33149003|NCT04025710|100460634|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
33149004|NCT04025710|100460634|FG000|Overall Study|Drop-out according to protocol|34|||
33149005|NCT01917929|100460635|FG000|Overall Study|Death|5|||
33149006|NCT01917929|100460635|FG000|Overall Study|Lost to Follow-up|19|||
33149007|NCT01917929|100460635|FG000|Overall Study|Withdrawal by Subject|31|||
33149008|NCT01917929|100460635|FG000|Overall Study|Adverse Event|6|||
33149009|NCT01917929|100460635|FG000|Overall Study|Investigative Site Terminated|11|||
33149010|NCT01917929|100460635|FG000|Overall Study|Censored because study device not implanted|6|||
33149011|NCT01917929|100460635|FG000|Overall Study|Censored because surgery not performed|3|||
33149012|NCT01917929|100460635|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
33149013|NCT01917929|100460635|FG000|Overall Study|No 5 year data|70|||
33149014|NCT01917929|100460635|FG000|Overall Study|Sponsor terminated study|26|||
33149015|NCT01994590|100460636|FG000|Overall Study|Adverse Event|1|||
33149016|NCT01994590|100460636|FG000|Overall Study|Trial Terminated|1|||
33149017|NCT02316548|100460646|FG000|Overall Study|Protocol Violation|0|||
33149018|NCT02316548|100460647|FG001|Overall Study|Protocol Violation|1|||
33149019|NCT03954041|100460648|FG000|Overall Study|Lost to Follow-up|3|||
33149020|NCT03954041|100460649|FG001|Overall Study|Lost to Follow-up|3|||
33149021|NCT03954041|100460650|FG002|Overall Study|Lost to Follow-up|6|||
33149022|NCT03954041|100460648|FG000|Overall Study|Death|4|||
33149023|NCT03954041|100460649|FG001|Overall Study|Death|0|||
33149024|NCT03954041|100460650|FG002|Overall Study|Death|1|||
33149025|NCT03954041|100460648|FG000|Overall Study|Death by neurologic criteria|0|||
33149026|NCT03954041|100460649|FG001|Overall Study|Death by neurologic criteria|0|||
33149027|NCT03954041|100460650|FG002|Overall Study|Death by neurologic criteria|1|||
33247801|NCT04044664|100810123|FG001|Stage 1|randomization error|1|||
33646926|NCT02273596|102259794|FG000|24-Week Treatment Period|Adverse Event|3|||
33646927|NCT02273596|102259794|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
33646928|NCT02273596|102259794|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
33646929|NCT02273596|102259794|FG000|24-Week Treatment Period|Physician Decision|1|||
33646930|NCT02273596|102259794|FG000|24-Week Treatment Period|Protocol Deviation|1|||
33646931|NCT02273596|102259794|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
33646932|NCT02273596|102259794|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
33646933|NCT02273596|102259794|FG000|Extension Period|Lost to Follow-up|1|||
33646934|NCT02273596|102259794|FG000|Extension Period|Protocol Deviation|1|||
33646935|NCT03595228|102259795|FG000|Overall Study|Death|2|||
33247802|NCT04044664|100810124|FG002|Stage 1|randomization error|0|||
33424908|NCT01098240|101446527|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
33424909|NCT01098240|101446525|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
33424910|NCT01098240|101446526|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
33424911|NCT01098240|101446527|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
33424912|NCT01098240|101446525|FG000|Double-Blind Phase|Adverse Event|0|||
33424913|NCT01098240|101446526|FG001|Double-Blind Phase|Adverse Event|3|||
33424914|NCT01098240|101446527|FG002|Double-Blind Phase|Adverse Event|3|||
33424915|NCT01689974|101446528|FG000|Overall Study|Termination of Study|5|||
33424916|NCT01689974|101446529|FG001|Overall Study|Termination of Study|5|||
33424917|NCT03558997|101446530|FG000|Overall Study|Adverse Event|0|||
33424918|NCT03558997|101446531|FG001|Overall Study|Adverse Event|2|||
33424919|NCT03558997|101446532|FG002|Overall Study|Adverse Event|5|||
33424920|NCT03558997|101446533|FG003|Overall Study|Adverse Event|1|||
33424921|NCT03558997|101446530|FG000|Overall Study|Physician Decision|0|||
33424922|NCT03558997|101446531|FG001|Overall Study|Physician Decision|0|||
33424923|NCT03558997|101446532|FG002|Overall Study|Physician Decision|1|||
33424924|NCT03558997|101446533|FG003|Overall Study|Physician Decision|0|||
33424925|NCT03558997|101446530|FG000|Overall Study|Withdrawal by Subject|1|||
33424926|NCT03558997|101446531|FG001|Overall Study|Withdrawal by Subject|0|||
33424927|NCT03558997|101446532|FG002|Overall Study|Withdrawal by Subject|1|||
33379267|NCT02807363|101272784|FG003|Dosing Period|Adverse Event|0|||
33379268|NCT00756886|101272785|FG000|Overall Study|Lost to Follow-up|1|||
33379269|NCT00756886|101272786|FG001|Overall Study|Lost to Follow-up|0|||
33379270|NCT00756886|101272785|FG000|Overall Study|Adverse Event|0|||
33379271|NCT00756886|101272786|FG001|Overall Study|Adverse Event|3|||
33379272|NCT00756886|101272785|FG000|Overall Study|Lack of Efficacy|1|||
33379273|NCT00756886|101272786|FG001|Overall Study|Lack of Efficacy|0|||
33379274|NCT00756886|101272785|FG000|Overall Study|Ineligible|9|||
33379275|NCT00756886|101272786|FG001|Overall Study|Ineligible|4|||
33379276|NCT03446651|101272788|FG000|Overall Study|Lost to Follow-up|4|||
33424928|NCT03558997|101446533|FG003|Overall Study|Withdrawal by Subject|1|||
33424929|NCT03558997|101446530|FG000|Overall Study|Lost to Follow-up|0|||
33424930|NCT03558997|101446531|FG001|Overall Study|Lost to Follow-up|0|||
33424931|NCT03558997|101446532|FG002|Overall Study|Lost to Follow-up|1|||
33424932|NCT03558997|101446533|FG003|Overall Study|Lost to Follow-up|0|||
33424933|NCT01458119|101446534|FG000|Overall Study|Physician Decision|4|||
33379277|NCT03446651|101272789|FG001|Overall Study|Lost to Follow-up|0|||
33379278|NCT03446651|101272788|FG000|Overall Study|Open Label Participants|5|||
33379279|NCT03446651|101272789|FG001|Overall Study|Open Label Participants|0|||
33379280|NCT00238303|101272794|FG000|Overall Study|Withdrawal by Subject|11|||
33379281|NCT00238303|101272795|FG001|Overall Study|Withdrawal by Subject|1|||
33379282|NCT00238303|101272796|FG002|Overall Study|Withdrawal by Subject|2|||
33379283|NCT00238303|101272794|FG000|Overall Study|Death|1|||
33379284|NCT00238303|101272795|FG001|Overall Study|Death|0|||
33379285|NCT00238303|101272796|FG002|Overall Study|Death|1|||
33379286|NCT00238303|101272794|FG000|Overall Study|Other Medical Problems|2|||
33379287|NCT00238303|101272795|FG001|Overall Study|Other Medical Problems|0|||
33379288|NCT00238303|101272796|FG002|Overall Study|Other Medical Problems|2|||
33379289|NCT00238303|101272794|FG000|Overall Study|Poor tolerance of study treatment|1|||
33379290|NCT00238303|101272795|FG001|Overall Study|Poor tolerance of study treatment|0|||
33379291|NCT00238303|101272796|FG002|Overall Study|Poor tolerance of study treatment|1|||
33424934|NCT01458119|101446534|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
33424935|NCT01458119|101446534|FG000|Overall Study|Pregnancy|1|||
33646936|NCT03595228|102259795|FG000|Overall Study|Lack of Efficacy|13|||
33247803|NCT04044664|100810122|FG000|Stage 2|Adverse Event|2|||
33379292|NCT00238303|101272794|FG000|Overall Study|Adverse Event|0|||
33424936|NCT01458119|101446534|FG000|Overall Study|Death|2|||
33424937|NCT01458119|101446534|FG000|Overall Study|Adverse Event|1|||
33424938|NCT01458119|101446534|FG000|Overall Study|Consent Withdrawn by Participant|8|||
33424939|NCT01458119|101446534|FG000|Overall Study|Non-compliance With Study Drug|3|||
33424940|NCT02868281|101446537|FG000|Overall Study|Adverse Event|2|||
33379293|NCT00238303|101272795|FG001|Overall Study|Adverse Event|1|||
33379294|NCT00238303|101272796|FG002|Overall Study|Adverse Event|3|||
33379295|NCT03544268|101272797|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
33379296|NCT03544268|101272798|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
33646937|NCT03595228|102259795|FG000|Overall Study|Withdrawal by Subject|3|||
33379297|NCT01479374|101272807|FG000|Overall Study|Adverse Event|2|||
33379298|NCT01479374|101272808|FG001|Overall Study|Adverse Event|1|||
33379299|NCT01479374|101272809|FG002|Overall Study|Adverse Event|0|||
33379300|NCT01479374|101272807|FG000|Overall Study|Lost to Follow-up|1|||
33379301|NCT01479374|101272808|FG001|Overall Study|Lost to Follow-up|2|||
33379302|NCT01479374|101272809|FG002|Overall Study|Lost to Follow-up|0|||
33379303|NCT01479374|101272807|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
33379304|NCT01479374|101272808|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
33379305|NCT01479374|101272809|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
33379306|NCT01479374|101272807|FG000|Overall Study|Other|0|||
33379307|NCT01479374|101272808|FG001|Overall Study|Other|4|||
33379308|NCT01479374|101272809|FG002|Overall Study|Other|5|||
33379309|NCT00634114|101272810|FG000|Overall Study|Adverse Event|6|||
33379310|NCT00634114|101272811|FG001|Overall Study|Adverse Event|8|||
33379311|NCT00634114|101272812|FG002|Overall Study|Adverse Event|3|||
33379312|NCT00634114|101272810|FG000|Overall Study|Withdrawal by Subject|9|||
33379313|NCT00634114|101272811|FG001|Overall Study|Withdrawal by Subject|6|||
33379314|NCT00634114|101272812|FG002|Overall Study|Withdrawal by Subject|11|||
33379315|NCT00634114|101272810|FG000|Overall Study|Lost to Follow-up|0|||
33379316|NCT00634114|101272811|FG001|Overall Study|Lost to Follow-up|0|||
33379317|NCT00634114|101272812|FG002|Overall Study|Lost to Follow-up|1|||
33379318|NCT00634114|101272810|FG000|Overall Study|Protocol Violation|3|||
33379319|NCT00634114|101272811|FG001|Overall Study|Protocol Violation|3|||
33379320|NCT00634114|101272812|FG002|Overall Study|Protocol Violation|1|||
33379321|NCT00634114|101272810|FG000|Overall Study|Pregnancy|1|||
33379322|NCT00634114|101272811|FG001|Overall Study|Pregnancy|0|||
33379323|NCT00634114|101272812|FG002|Overall Study|Pregnancy|0|||
33379324|NCT00634114|101272810|FG000|Overall Study|Incorrect enrolment|0|||
33379325|NCT00634114|101272811|FG001|Overall Study|Incorrect enrolment|1|||
33379326|NCT00634114|101272812|FG002|Overall Study|Incorrect enrolment|0|||
33424941|NCT02868281|101446538|FG001|Overall Study|Adverse Event|2|||
33424942|NCT02868281|101446537|FG000|Overall Study|Protocol Violation|13|||
33424943|NCT02868281|101446538|FG001|Overall Study|Protocol Violation|10|||
33424944|NCT02868281|101446537|FG000|Overall Study|Lost to Follow-up|3|||
33424945|NCT02868281|101446538|FG001|Overall Study|Lost to Follow-up|6|||
33424946|NCT02868281|101446537|FG000|Overall Study|Withdrawal by Subject|11|||
33424947|NCT02868281|101446538|FG001|Overall Study|Withdrawal by Subject|15|||
33424948|NCT02868281|101446537|FG000|Overall Study|Physician Decision|2|||
33424949|NCT02868281|101446538|FG001|Overall Study|Physician Decision|0|||
33424950|NCT02868281|101446537|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
33424951|NCT02868281|101446538|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
33424952|NCT02868281|101446537|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
33424953|NCT02868281|101446538|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
33424954|NCT02868281|101446537|FG000|Overall Study|Long journey/moving away|1|||
33424955|NCT02868281|101446538|FG001|Overall Study|Long journey/moving away|1|||
33424956|NCT01722266|101446539|FG000|Overall Study|Withdrawal by Subject|1|||
33424957|NCT01722266|101446540|FG001|Overall Study|Withdrawal by Subject|2|||
33424958|NCT01722266|101446541|FG002|Overall Study|Withdrawal by Subject|0|||
33424959|NCT01722266|101446542|FG003|Overall Study|Withdrawal by Subject|0|||
33424960|NCT01722266|101446539|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
33424961|NCT01722266|101446540|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
33424962|NCT01722266|101446541|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
33424963|NCT01722266|101446542|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
33424964|NCT01722266|101446539|FG000|Overall Study|Dropped out due to Nausea|0|||
33646938|NCT03595228|102259795|FG000|Overall Study|Withdrawal by Sponsor|1|||
33247804|NCT04044664|100810123|FG001|Stage 2|Adverse Event|0|||
33379327|NCT00634114|101272810|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
33379328|NCT00634114|101272811|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
33379329|NCT00634114|101272812|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
33379330|NCT00634114|101272810|FG000|Overall Study|Difficult to continue|3|||
33379331|NCT00634114|101272811|FG001|Overall Study|Difficult to continue|1|||
33379332|NCT00634114|101272812|FG002|Overall Study|Difficult to continue|1|||
33379333|NCT00634114|101272810|FG000|Overall Study|Other reason|1|||
33424965|NCT01722266|101446540|FG001|Overall Study|Dropped out due to Nausea|0|||
33424966|NCT01722266|101446541|FG002|Overall Study|Dropped out due to Nausea|2|||
33424967|NCT01722266|101446542|FG003|Overall Study|Dropped out due to Nausea|0|||
33424968|NCT03555890|101446543|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33424969|NCT03555890|101446544|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33424970|NCT03555890|101446545|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33379334|NCT00634114|101272811|FG001|Overall Study|Other reason|1|||
33379335|NCT00634114|101272812|FG002|Overall Study|Other reason|1|||
33379336|NCT02056834|101272815|FG000|Overall Study|Lost to Follow-up|7|||
33379337|NCT03583372|101272816|FG000|Overall Study|Withdrawal by Subject|6|||
33379338|NCT03583372|101272817|FG001|Overall Study|Withdrawal by Subject|11|||
33424971|NCT03555890|101446546|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
33424972|NCT02354976|101446554|FG000|Overall Study|Other - reason not specified|1|||
33247805|NCT04044664|100810124|FG002|Stage 2|Adverse Event|0|||
33247806|NCT04044664|100810122|FG000|Stage 2|Lost to Follow-up|3|||
33247807|NCT04044664|100810123|FG001|Stage 2|Lost to Follow-up|2|||
33247808|NCT04044664|100810124|FG002|Stage 2|Lost to Follow-up|1|||
33247809|NCT04044664|100810122|FG000|Stage 2|Withdrawal by Subject|3|||
33247810|NCT04044664|100810123|FG001|Stage 2|Withdrawal by Subject|0|||
33247811|NCT04044664|100810124|FG002|Stage 2|Withdrawal by Subject|0|||
33247812|NCT04044664|100810122|FG000|Stage 2|protocol deviation|1|||
33247813|NCT04044664|100810123|FG001|Stage 2|protocol deviation|0|||
33247814|NCT04044664|100810124|FG002|Stage 2|protocol deviation|0|||
33247815|NCT03982199|100810129|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
33247816|NCT03982199|100810130|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
33247817|NCT03982199|100810131|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
33247818|NCT03982199|100810132|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
33247819|NCT03982199|100810133|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
33247820|NCT03982199|100810134|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
33247821|NCT03982199|100810135|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
33247822|NCT03982199|100810136|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
33149028|NCT03954041|100460648|FG000|Overall Study|Reason not specified|7|||
33149029|NCT03954041|100460649|FG001|Overall Study|Reason not specified|4|||
33149030|NCT03954041|100460650|FG002|Overall Study|Reason not specified|2|||
33149031|NCT03954041|100460648|FG000|Overall Study|Withdrew prior to dosing|4|||
33149032|NCT03954041|100460649|FG001|Overall Study|Withdrew prior to dosing|2|||
33149033|NCT03954041|100460650|FG002|Overall Study|Withdrew prior to dosing|0|||
33149034|NCT04543409|100460653|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33149035|NCT04543409|100460654|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33149036|NCT04543409|100460653|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
33149037|NCT04543409|100460654|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
33149038|NCT04543409|100460653|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
33149039|NCT04543409|100460654|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
33149040|NCT04543409|100460653|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
33149041|NCT04543409|100460654|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
33149042|NCT04543409|100460653|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
33149043|NCT04543409|100460654|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
33149044|NCT04543409|100460653|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
33149045|NCT04543409|100460654|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
33149046|NCT04543409|100460653|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
33149047|NCT04543409|100460654|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
33149048|NCT04543409|100460653|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
33149049|NCT04543409|100460654|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
33149050|NCT04543409|100460653|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
33149051|NCT04543409|100460654|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
33149052|NCT04543409|100460653|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
33149053|NCT04543409|100460654|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
33149054|NCT04543409|100460653|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
33149055|NCT04543409|100460654|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
33149056|NCT00667602|100460655|FG000|Overall Study|Withdrawal by Subject|4|||
33149057|NCT00667602|100460656|FG001|Overall Study|Withdrawal by Subject|9|||
33149058|NCT00667602|100460657|FG002|Overall Study|Withdrawal by Subject|10|||
33149059|NCT00667602|100460655|FG000|Overall Study|Lost to Follow-up|4|||
33149060|NCT00667602|100460656|FG001|Overall Study|Lost to Follow-up|5|||
33149061|NCT00667602|100460657|FG002|Overall Study|Lost to Follow-up|6|||
33149062|NCT00667602|100460655|FG000|Overall Study|Administrative reason|0|||
33149063|NCT00667602|100460656|FG001|Overall Study|Administrative reason|0|||
33149064|NCT00667602|100460657|FG002|Overall Study|Administrative reason|2|||
33149065|NCT00667602|100460655|FG000|Overall Study|Protocol Violation|0|||
33149066|NCT00667602|100460656|FG001|Overall Study|Protocol Violation|1|||
33149067|NCT00667602|100460657|FG002|Overall Study|Protocol Violation|0|||
33149068|NCT00608543|100460661|FG000|Overall Study|Adverse Event|4|||
33149069|NCT01496976|100460662|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
33149070|NCT00089284|100460663|FG000|Overall Study|Adverse event before starting treatment|0|||
33149071|NCT00089284|100460664|FG001|Overall Study|Adverse event before starting treatment|0|||
33149072|NCT00089284|100460665|FG002|Overall Study|Adverse event before starting treatment|0|||
33149073|NCT00089284|100460666|FG003|Overall Study|Adverse event before starting treatment|0|||
33149074|NCT00089284|100460667|FG004|Overall Study|Adverse event before starting treatment|0|||
33149075|NCT00089284|100460668|FG005|Overall Study|Adverse event before starting treatment|0|||
33149076|NCT00089284|100460669|FG006|Overall Study|Adverse event before starting treatment|1|||
33247823|NCT03982199|100810137|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
33247824|NCT03982199|100810138|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
33586971|NCT03143153|102036482|FG002|Treatment|Study drug toxicity|40|||
33379339|NCT03583372|101272818|FG002|Overall Study|Withdrawal by Subject|7|||
33379340|NCT03583372|101272819|FG003|Overall Study|Withdrawal by Subject|8|||
33379341|NCT03583372|101272816|FG000|Overall Study|Lost to Follow-up|4|||
33379342|NCT03583372|101272817|FG001|Overall Study|Lost to Follow-up|6|||
33379343|NCT03583372|101272818|FG002|Overall Study|Lost to Follow-up|3|||
33379344|NCT03583372|101272819|FG003|Overall Study|Lost to Follow-up|2|||
33379345|NCT03583372|101272816|FG000|Overall Study|Adverse Event|1|||
33379346|NCT03583372|101272817|FG001|Overall Study|Adverse Event|3|||
33379347|NCT03583372|101272818|FG002|Overall Study|Adverse Event|4|||
33379348|NCT03583372|101272819|FG003|Overall Study|Adverse Event|4|||
33379349|NCT03583372|101272816|FG000|Overall Study|Physician Decision|0|||
33379350|NCT03583372|101272817|FG001|Overall Study|Physician Decision|1|||
33379351|NCT03583372|101272818|FG002|Overall Study|Physician Decision|1|||
33379352|NCT03583372|101272819|FG003|Overall Study|Physician Decision|1|||
33379353|NCT03583372|101272816|FG000|Overall Study|Lack of Efficacy|0|||
33379354|NCT03583372|101272817|FG001|Overall Study|Lack of Efficacy|1|||
33379355|NCT03583372|101272818|FG002|Overall Study|Lack of Efficacy|0|||
33379356|NCT03583372|101272819|FG003|Overall Study|Lack of Efficacy|1|||
33379357|NCT03583372|101272816|FG000|Overall Study|Death|1|||
33379358|NCT03583372|101272817|FG001|Overall Study|Death|0|||
33379359|NCT03583372|101272818|FG002|Overall Study|Death|0|||
33379360|NCT03583372|101272819|FG003|Overall Study|Death|0|||
33379361|NCT03583372|101272816|FG000|Overall Study|Protocol Violation|0|||
33379362|NCT03583372|101272817|FG001|Overall Study|Protocol Violation|1|||
33379363|NCT03583372|101272818|FG002|Overall Study|Protocol Violation|0|||
33379364|NCT03583372|101272819|FG003|Overall Study|Protocol Violation|0|||
33379365|NCT03583372|101272816|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
33379366|NCT03583372|101272817|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
33379367|NCT03583372|101272818|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
33379368|NCT03583372|101272819|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
33379369|NCT03583372|101272816|FG000|Overall Study|Did Not Receive Study Drug|0|||
33379370|NCT03583372|101272817|FG001|Overall Study|Did Not Receive Study Drug|1|||
33379371|NCT03583372|101272818|FG002|Overall Study|Did Not Receive Study Drug|0|||
33379372|NCT03583372|101272819|FG003|Overall Study|Did Not Receive Study Drug|0|||
33379373|NCT03583372|101272816|FG000|Overall Study|Captured as Other in the Database|1|||
33379374|NCT03583372|101272817|FG001|Overall Study|Captured as Other in the Database|2|||
33379375|NCT03583372|101272818|FG002|Overall Study|Captured as Other in the Database|4|||
33379376|NCT03583372|101272819|FG003|Overall Study|Captured as Other in the Database|1|||
33379377|NCT03722784|101272823|FG000|Overall Study|Withdrawal by Subject|1|||
33379378|NCT03722784|101272824|FG001|Overall Study|Withdrawal by Subject|0|||
33379379|NCT03722784|101272823|FG000|Overall Study|Physician Decision|1|||
33379380|NCT03722784|101272824|FG001|Overall Study|Physician Decision|1|||
33379381|NCT03722784|101272823|FG000|Overall Study|Protocol Violation|0|||
33379382|NCT03722784|101272824|FG001|Overall Study|Protocol Violation|1|||
33379383|NCT03730194|101272829|FG000|First Stage Treatment|Withdrawal by Subject|1|||
33379384|NCT03730194|101272830|FG001|First Stage Treatment|Withdrawal by Subject|1|||
33379385|NCT03730194|101272831|FG002|First Stage Treatment|Withdrawal by Subject|0|||
33586972|NCT03143153|102036480|FG000|Treatment|Death|5|||
33586973|NCT03143153|102036481|FG001|Treatment|Death|3|||
33586974|NCT03143153|102036482|FG002|Treatment|Death|4|||
33586975|NCT03143153|102036480|FG000|Treatment|Adverse event unrelated to study drug|19|||
33586976|NCT03143153|102036481|FG001|Treatment|Adverse event unrelated to study drug|28|||
33586977|NCT03143153|102036482|FG002|Treatment|Adverse event unrelated to study drug|12|||
33586978|NCT03143153|102036480|FG000|Treatment|Participant request to discontinue study treatment|13|||
33586979|NCT03143153|102036481|FG001|Treatment|Participant request to discontinue study treatment|15|||
33586980|NCT03143153|102036482|FG002|Treatment|Participant request to discontinue study treatment|20|||
33586981|NCT03143153|102036480|FG000|Treatment|Participant withdrew consent|3|||
33586982|NCT03143153|102036481|FG001|Treatment|Participant withdrew consent|4|||
33586983|NCT03143153|102036482|FG002|Treatment|Participant withdrew consent|12|||
33586984|NCT03143153|102036480|FG000|Treatment|Pregnancy|1|||
33586985|NCT03143153|102036481|FG001|Treatment|Pregnancy|0|||
33586986|NCT03143153|102036482|FG002|Treatment|Pregnancy|0|||
33586987|NCT03143153|102036480|FG000|Treatment|Maximum clinical benefit|1|||
33586988|NCT03143153|102036481|FG001|Treatment|Maximum clinical benefit|3|||
33586989|NCT03143153|102036482|FG002|Treatment|Maximum clinical benefit|4|||
33149077|NCT00053365|100460670|FG000|Overall Study|Incorrect cell type|1|||
33586990|NCT03143153|102036480|FG000|Treatment|Completed treatment as per Protocol|13|||
33586991|NCT03143153|102036481|FG001|Treatment|Completed treatment as per Protocol|8|||
33586992|NCT03143153|102036482|FG002|Treatment|Completed treatment as per Protocol|0|||
33379386|NCT03730194|101272832|FG003|First Stage Treatment|Withdrawal by Subject|0|||
33379387|NCT03730194|101272833|FG004|First Stage Treatment|Withdrawal by Subject|0|||
33379388|NCT03730194|101272834|FG005|First Stage Treatment|Withdrawal by Subject|0|||
33379389|NCT03730194|101272829|FG000|First Stage Treatment|Protocol Violation|3|||
33379390|NCT03730194|101272830|FG001|First Stage Treatment|Protocol Violation|3|||
33379391|NCT03730194|101272831|FG002|First Stage Treatment|Protocol Violation|0|||
33379392|NCT03730194|101272832|FG003|First Stage Treatment|Protocol Violation|0|||
33379393|NCT03730194|101272833|FG004|First Stage Treatment|Protocol Violation|0|||
33586993|NCT03143153|102036480|FG000|Treatment|Other reasons|12|||
33586994|NCT03143153|102036481|FG001|Treatment|Other reasons|7|||
33586995|NCT03143153|102036482|FG002|Treatment|Other reasons|15|||
33586996|NCT03143153|102036480|FG000|Treatment|Not reported|1|||
33586997|NCT03143153|102036481|FG001|Treatment|Not reported|0|||
33586998|NCT03143153|102036482|FG002|Treatment|Not reported|0|||
33586999|NCT02222688|102036485|FG000|Overall Study|Withdrawal by Subject|0|||
33587000|NCT02222688|102036486|FG001|Overall Study|Withdrawal by Subject|0|||
33587001|NCT02222688|102036487|FG002|Overall Study|Withdrawal by Subject|0|||
33587002|NCT02222688|102036488|FG003|Overall Study|Withdrawal by Subject|2|||
33587003|NCT02222688|102036489|FG004|Overall Study|Withdrawal by Subject|1|||
33587004|NCT02222688|102036490|FG005|Overall Study|Withdrawal by Subject|0|||
33587005|NCT02222688|102036491|FG006|Overall Study|Withdrawal by Subject|1|||
33587006|NCT02222688|102036485|FG000|Overall Study|Disease progression|1|||
33587007|NCT02222688|102036486|FG001|Overall Study|Disease progression|0|||
33587008|NCT02222688|102036487|FG002|Overall Study|Disease progression|0|||
33587009|NCT02222688|102036488|FG003|Overall Study|Disease progression|0|||
33587010|NCT02222688|102036489|FG004|Overall Study|Disease progression|0|||
33587011|NCT02222688|102036490|FG005|Overall Study|Disease progression|0|||
33587012|NCT02222688|102036491|FG006|Overall Study|Disease progression|0|||
33587013|NCT00405392|102036492|FG000|Overall Study|Adverse Event|15|||
33587014|NCT00405392|102036493|FG001|Overall Study|Adverse Event|14|||
33587015|NCT00405392|102036492|FG000|Overall Study|Did not meet Eligibility criteria|7|||
33587016|NCT00405392|102036493|FG001|Overall Study|Did not meet Eligibility criteria|2|||
33587017|NCT00405392|102036492|FG000|Overall Study|Withdrawal by Subject|4|||
33587018|NCT00405392|102036493|FG001|Overall Study|Withdrawal by Subject|3|||
33587019|NCT00405392|102036492|FG000|Overall Study|Lost to Follow-up|1|||
33587020|NCT00405392|102036493|FG001|Overall Study|Lost to Follow-up|2|||
33587021|NCT00405392|102036492|FG000|Overall Study|Data missing|2|||
33587022|NCT00405392|102036493|FG001|Overall Study|Data missing|0|||
33587023|NCT00405392|102036492|FG000|Overall Study|Non-compliance|0|||
33587024|NCT00405392|102036493|FG001|Overall Study|Non-compliance|1|||
33587025|NCT00405392|102036492|FG000|Overall Study|Other|1|||
33587026|NCT00405392|102036493|FG001|Overall Study|Other|5|||
33587027|NCT00933608|102036494|FG000|Overall Study|Adverse Event|4|||
33587028|NCT00933608|102036495|FG001|Overall Study|Adverse Event|2|||
33587029|NCT00933608|102036494|FG000|Overall Study|Physician Decision|1|||
33587030|NCT00933608|102036495|FG001|Overall Study|Physician Decision|0|||
33587031|NCT00600106|102036496|FG000|Overall Study|Withdrawal by Subject|1|||
33587032|NCT00600106|102036497|FG001|Overall Study|Withdrawal by Subject|1|||
33587033|NCT00224120|102036498|FG000|Overall Study|Adverse Event|10|||
33587034|NCT00224120|102036499|FG001|Overall Study|Adverse Event|4|||
33587035|NCT00224120|102036498|FG000|Overall Study|Protocol Violation|1|||
33587036|NCT00224120|102036499|FG001|Overall Study|Protocol Violation|0|||
33587037|NCT00224120|102036498|FG000|Overall Study|Withdrawal by Subject|5|||
33587038|NCT00224120|102036499|FG001|Overall Study|Withdrawal by Subject|10|||
33587039|NCT00224120|102036498|FG000|Overall Study|Lack of Efficacy|0|||
33587040|NCT00224120|102036499|FG001|Overall Study|Lack of Efficacy|2|||
33587041|NCT00224120|102036498|FG000|Overall Study|Lost to Follow-up|2|||
33587042|NCT00224120|102036499|FG001|Overall Study|Lost to Follow-up|3|||
33587043|NCT00224120|102036498|FG000|Overall Study|Other|4|||
33587044|NCT00224120|102036499|FG001|Overall Study|Other|5|||
33587045|NCT01318135|102036500|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
33587046|NCT01318135|102036501|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33646939|NCT02036970|102259799|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
33646940|NCT02036970|102259800|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
33646941|NCT02036970|102259801|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
33646942|NCT02036970|102259802|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
33646943|NCT02036970|102259803|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
33646944|NCT02036970|102259804|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
33646945|NCT02036970|102259805|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
33646946|NCT02036970|102259806|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
33149078|NCT00053365|100460670|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
33587047|NCT01318135|102036502|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33587048|NCT01318135|102036503|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33587049|NCT01318135|102036504|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33587050|NCT01318135|102036505|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33587051|NCT01318135|102036506|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33587052|NCT01318135|102036507|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33587053|NCT01318135|102036500|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
33587054|NCT01318135|102036501|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
33587055|NCT01318135|102036502|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
33587056|NCT01318135|102036503|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
33587057|NCT01318135|102036504|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
33646947|NCT02036970|102259807|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
33379394|NCT03730194|101272834|FG005|First Stage Treatment|Protocol Violation|0|||
33379395|NCT03334396|101272836|FG000|Overall Study|Adverse Event|1|||
33379396|NCT03334396|101272837|FG001|Overall Study|Adverse Event|0|||
33379397|NCT03334396|101272838|FG002|Overall Study|Adverse Event|1|||
33379398|NCT03334396|101272839|FG003|Overall Study|Adverse Event|0|||
33379399|NCT03334396|101272840|FG004|Overall Study|Adverse Event|0|||
33379400|NCT03334396|101272841|FG005|Overall Study|Adverse Event|0|||
33424973|NCT02354976|101446555|FG001|Overall Study|Other - reason not specified|0|||
33424974|NCT02354976|101446556|FG002|Overall Study|Other - reason not specified|1|||
33424975|NCT02354976|101446554|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
33424976|NCT02354976|101446555|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
33424977|NCT02354976|101446556|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
33587058|NCT01318135|102036505|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
33587059|NCT01318135|102036506|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
33587060|NCT01318135|102036507|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
33587061|NCT01318135|102036500|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
33587062|NCT01318135|102036501|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
33587063|NCT01318135|102036502|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
33587064|NCT01318135|102036503|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
33587065|NCT01318135|102036504|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
33587066|NCT01318135|102036505|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
33587067|NCT01318135|102036506|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
33587068|NCT01318135|102036507|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
33587069|NCT01318135|102036500|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
33587070|NCT01318135|102036501|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
33587071|NCT01318135|102036502|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
33587072|NCT01318135|102036503|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
33587073|NCT01318135|102036504|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
33646948|NCT02036970|102259808|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
33379401|NCT03334396|101272842|FG006|Overall Study|Adverse Event|0|||
33379402|NCT03334396|101272843|FG007|Overall Study|Adverse Event|0|||
33424978|NCT02354976|101446554|FG000|Overall Study|Adverse Event|1|||
33424979|NCT02354976|101446555|FG001|Overall Study|Adverse Event|0|||
33424980|NCT02354976|101446556|FG002|Overall Study|Adverse Event|2|||
33424981|NCT03077828|101446558|FG000|Treatment Cycles|Death|1|||
33424982|NCT03077828|101446558|FG000|Treatment Cycles|Withdrawal by Subject|1|||
33424983|NCT03077828|101446558|FG000|Treatment Cycles|Screen Fail|2|||
33424984|NCT03077828|101446558|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
33424985|NCT03077828|101446558|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
33424986|NCT03077828|101446558|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
33424987|NCT03077828|101446558|FG000|Follow-up|Patients still in follow-up|15|||
33424988|NCT04575038|101446561|FG000|Overall Study|Withdrawal by Subject|1|||
33424989|NCT04575038|101446562|FG001|Overall Study|Withdrawal by Subject|1|||
33424990|NCT01462695|101446563|FG000|Overall Study|Adverse Event|1|||
33424991|NCT01462695|101446564|FG001|Overall Study|Adverse Event|1|||
33424992|NCT01462695|101446563|FG000|Overall Study|Death|2|||
33424993|NCT01462695|101446564|FG001|Overall Study|Death|0|||
33424994|NCT01462695|101446563|FG000|Overall Study|Lack of Efficacy|6|||
33424995|NCT01462695|101446564|FG001|Overall Study|Lack of Efficacy|12|||
33379403|NCT03334396|101272836|FG000|Overall Study|Lack of Efficacy|10|||
33379404|NCT03334396|101272837|FG001|Overall Study|Lack of Efficacy|4|||
33424996|NCT01462695|101446563|FG000|Overall Study|Physician Decision|5|||
33424997|NCT01462695|101446564|FG001|Overall Study|Physician Decision|0|||
33424998|NCT01462695|101446563|FG000|Overall Study|Withdrawal by Subject|2|||
33424999|NCT01462695|101446564|FG001|Overall Study|Withdrawal by Subject|0|||
33425000|NCT01462695|101446563|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
33425001|NCT01462695|101446564|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
33425002|NCT00068237|101446565|FG000|Overall Study|Ineligible|3|||
33587074|NCT01318135|102036505|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
33587075|NCT01318135|102036506|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
33587076|NCT01318135|102036507|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
33587077|NCT01318135|102036500|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33646949|NCT02036970|102259799|FG000|Part 1: Day 1 Through Week 16|Death|0|||
33425003|NCT00068237|101446565|FG000|Overall Study|No protocol treatment received|2|||
33646950|NCT02036970|102259800|FG001|Part 1: Day 1 Through Week 16|Death|0|||
33646951|NCT02036970|102259801|FG002|Part 1: Day 1 Through Week 16|Death|0|||
33379405|NCT03334396|101272838|FG002|Overall Study|Lack of Efficacy|1|||
33379406|NCT03334396|101272839|FG003|Overall Study|Lack of Efficacy|3|||
33379407|NCT03334396|101272840|FG004|Overall Study|Lack of Efficacy|1|||
33425004|NCT00845026|101446566|FG000|Study Period III|Adverse Event|23|||
33425005|NCT00845026|101446567|FG001|Study Period III|Adverse Event|19|||
33425006|NCT00845026|101446566|FG000|Study Period III|Perceived lack of efficacy|27|||
33425007|NCT00845026|101446567|FG001|Study Period III|Perceived lack of efficacy|15|||
33425008|NCT00845026|101446566|FG000|Study Period III|Withdrawal by Subject|19|||
33247825|NCT03982199|100810139|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
33247826|NCT03982199|100810140|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
33587078|NCT01318135|102036501|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33587079|NCT01318135|102036502|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33587080|NCT01318135|102036503|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33587081|NCT01318135|102036504|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33587082|NCT01318135|102036505|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
33587083|NCT01318135|102036506|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
33587084|NCT01318135|102036507|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33587085|NCT01318135|102036500|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
33587086|NCT01318135|102036501|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
33587087|NCT01318135|102036502|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
33587088|NCT01318135|102036503|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
33587089|NCT01318135|102036504|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
33587090|NCT01318135|102036505|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
33587091|NCT01318135|102036506|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
33587092|NCT01318135|102036507|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
33587093|NCT01318135|102036500|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
33587094|NCT01318135|102036501|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
33587095|NCT01318135|102036502|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
33587096|NCT01318135|102036503|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
33587097|NCT01318135|102036504|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
33587098|NCT01318135|102036505|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
33587099|NCT01318135|102036506|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
33587100|NCT01318135|102036507|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
33587101|NCT00361231|102036508|FG000|Overall Study|Physician Decision|3|||
33587102|NCT00361231|102036508|FG000|Overall Study|Symptomatic deterioration|5|||
33587103|NCT00361231|102036508|FG000|Overall Study|Radiographic disease progression|16|||
33587104|NCT00361231|102036508|FG000|Overall Study|Withdrawal by Subject|4|||
33587105|NCT00361231|102036508|FG000|Overall Study|Adverse Event|6|||
33587106|NCT03206918|102036509|FG000|Overall Study|Death|11|||
33587107|NCT03206918|102036509|FG000|Overall Study|Withdrawal by Subject|5|||
33587108|NCT03206918|102036509|FG000|Overall Study|Study terminated by sponsor|12|||
33587109|NCT03206918|102036509|FG000|Overall Study|Lost to Follow-up|3|||
33587110|NCT03206918|102036509|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
33587111|NCT01734785|102036510|FG000|Open-Label Period|Adverse Event|0|||
33587112|NCT01734785|102036511|FG001|Open-Label Period|Adverse Event|0|||
33587113|NCT01734785|102036512|FG002|Open-Label Period|Adverse Event|0|||
33587114|NCT01734785|102036513|FG003|Open-Label Period|Adverse Event|9|||
33587115|NCT01734785|102036510|FG000|Open-Label Period|Lack of Efficacy|0|||
33587116|NCT01734785|102036511|FG001|Open-Label Period|Lack of Efficacy|0|||
33587117|NCT01734785|102036512|FG002|Open-Label Period|Lack of Efficacy|0|||
33587118|NCT01734785|102036513|FG003|Open-Label Period|Lack of Efficacy|1|||
33587119|NCT01734785|102036510|FG000|Open-Label Period|Protocol Violation|0|||
33587120|NCT01734785|102036511|FG001|Open-Label Period|Protocol Violation|0|||
33587121|NCT01734785|102036512|FG002|Open-Label Period|Protocol Violation|0|||
33587122|NCT01734785|102036513|FG003|Open-Label Period|Protocol Violation|13|||
33149079|NCT00053365|100460670|FG000|Overall Study|Never treated|4|||
33149080|NCT04815031|100460671|FG000|Overall Study|No adverse event information (missing information)|33|||
33149081|NCT02319837|100460672|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
33149082|NCT02319837|100460673|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
33149083|NCT02319837|100460674|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
33149084|NCT02319837|100460672|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
33149085|NCT02319837|100460673|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
33379408|NCT03334396|101272841|FG005|Overall Study|Lack of Efficacy|0|||
33379409|NCT03334396|101272842|FG006|Overall Study|Lack of Efficacy|0|||
33379410|NCT03334396|101272843|FG007|Overall Study|Lack of Efficacy|1|||
33379411|NCT03334396|101272836|FG000|Overall Study|Lost to Follow-up|0|||
33379412|NCT03334396|101272837|FG001|Overall Study|Lost to Follow-up|0|||
33425009|NCT00845026|101446567|FG001|Study Period III|Withdrawal by Subject|15|||
33587123|NCT01734785|102036510|FG000|Open-Label Period|Lost to Follow-up|0|||
33587124|NCT01734785|102036511|FG001|Open-Label Period|Lost to Follow-up|0|||
33587125|NCT01734785|102036512|FG002|Open-Label Period|Lost to Follow-up|0|||
33587126|NCT01734785|102036513|FG003|Open-Label Period|Lost to Follow-up|14|||
33587127|NCT01734785|102036510|FG000|Open-Label Period|Withdrawal by Subject|0|||
33587128|NCT01734785|102036511|FG001|Open-Label Period|Withdrawal by Subject|0|||
33587129|NCT01734785|102036512|FG002|Open-Label Period|Withdrawal by Subject|0|||
33587130|NCT01734785|102036513|FG003|Open-Label Period|Withdrawal by Subject|12|||
33587131|NCT01734785|102036510|FG000|Open-Label Period|Other Reasons|0|||
33587132|NCT01734785|102036511|FG001|Open-Label Period|Other Reasons|0|||
33425010|NCT00845026|101446566|FG000|Study Period III|Entry Criteria not met|8|||
33425011|NCT00845026|101446567|FG001|Study Period III|Entry Criteria not met|11|||
33425012|NCT00845026|101446566|FG000|Study Period III|Lost to Follow-up|4|||
33425013|NCT00845026|101446567|FG001|Study Period III|Lost to Follow-up|5|||
33425014|NCT00845026|101446566|FG000|Study Period III|Protocol Violation|8|||
33425015|NCT00845026|101446567|FG001|Study Period III|Protocol Violation|1|||
33425016|NCT00845026|101446566|FG000|Study Period III|Scheduled conflict|3|||
33425017|NCT00845026|101446567|FG001|Study Period III|Scheduled conflict|1|||
33587133|NCT01734785|102036512|FG002|Open-Label Period|Other Reasons|0|||
33587134|NCT01734785|102036513|FG003|Open-Label Period|Other Reasons|224|||
33587135|NCT01734785|102036510|FG000|Double-Blind Period|Adverse Event|0|||
33587136|NCT01734785|102036511|FG001|Double-Blind Period|Adverse Event|3|||
33646952|NCT02036970|102259802|FG003|Part 1: Day 1 Through Week 16|Death|0|||
33379413|NCT03334396|101272838|FG002|Overall Study|Lost to Follow-up|1|||
33646953|NCT02036970|102259803|FG004|Part 1: Day 1 Through Week 16|Death|0|||
33646954|NCT02036970|102259804|FG005|Part 1: Day 1 Through Week 16|Death|0|||
33646955|NCT02036970|102259805|FG006|Part 1: Day 1 Through Week 16|Death|0|||
33646956|NCT02036970|102259806|FG007|Part 1: Day 1 Through Week 16|Death|0|||
33646957|NCT02036970|102259807|FG008|Part 1: Day 1 Through Week 16|Death|1|||
33379414|NCT03334396|101272839|FG003|Overall Study|Lost to Follow-up|0|||
33379415|NCT03334396|101272840|FG004|Overall Study|Lost to Follow-up|0|||
33379416|NCT03334396|101272841|FG005|Overall Study|Lost to Follow-up|0|||
33379417|NCT03334396|101272842|FG006|Overall Study|Lost to Follow-up|1|||
33379418|NCT03334396|101272843|FG007|Overall Study|Lost to Follow-up|0|||
33379419|NCT03334396|101272836|FG000|Overall Study|Physician Decision|1|||
33379420|NCT03334396|101272837|FG001|Overall Study|Physician Decision|0|||
33379421|NCT03334396|101272838|FG002|Overall Study|Physician Decision|0|||
33379422|NCT03334396|101272839|FG003|Overall Study|Physician Decision|0|||
33379423|NCT03334396|101272840|FG004|Overall Study|Physician Decision|0|||
33379424|NCT03334396|101272841|FG005|Overall Study|Physician Decision|0|||
33379425|NCT03334396|101272842|FG006|Overall Study|Physician Decision|0|||
33379426|NCT03334396|101272843|FG007|Overall Study|Physician Decision|0|||
33379427|NCT03334396|101272836|FG000|Overall Study|Withdrawal by Subject|10|||
33379428|NCT03334396|101272837|FG001|Overall Study|Withdrawal by Subject|5|||
33379429|NCT03334396|101272838|FG002|Overall Study|Withdrawal by Subject|7|||
33379430|NCT03334396|101272839|FG003|Overall Study|Withdrawal by Subject|2|||
33379431|NCT03334396|101272840|FG004|Overall Study|Withdrawal by Subject|2|||
33379432|NCT03334396|101272841|FG005|Overall Study|Withdrawal by Subject|1|||
33379433|NCT03334396|101272842|FG006|Overall Study|Withdrawal by Subject|2|||
33379434|NCT03334396|101272843|FG007|Overall Study|Withdrawal by Subject|0|||
33379435|NCT03334396|101272836|FG000|Overall Study|Pregnancy|0|||
33379436|NCT03334396|101272837|FG001|Overall Study|Pregnancy|1|||
33379437|NCT03334396|101272838|FG002|Overall Study|Pregnancy|0|||
33379438|NCT03334396|101272839|FG003|Overall Study|Pregnancy|0|||
33379439|NCT03334396|101272840|FG004|Overall Study|Pregnancy|0|||
33379440|NCT03334396|101272841|FG005|Overall Study|Pregnancy|0|||
33379441|NCT03334396|101272842|FG006|Overall Study|Pregnancy|0|||
33379442|NCT03334396|101272843|FG007|Overall Study|Pregnancy|0|||
33379443|NCT03334396|101272836|FG000|Overall Study|Ineligible|0|||
33379444|NCT03334396|101272837|FG001|Overall Study|Ineligible|1|||
33379445|NCT03334396|101272838|FG002|Overall Study|Ineligible|0|||
33379446|NCT03334396|101272839|FG003|Overall Study|Ineligible|0|||
33379447|NCT03334396|101272840|FG004|Overall Study|Ineligible|0|||
33379448|NCT03334396|101272841|FG005|Overall Study|Ineligible|0|||
33587137|NCT01734785|102036512|FG002|Double-Blind Period|Adverse Event|2|||
33587138|NCT01734785|102036513|FG003|Double-Blind Period|Adverse Event|0|||
33587139|NCT01734785|102036510|FG000|Double-Blind Period|Lack of Efficacy|0|||
33587140|NCT01734785|102036511|FG001|Double-Blind Period|Lack of Efficacy|1|||
33646958|NCT02036970|102259808|FG009|Part 1: Day 1 Through Week 16|Death|0|||
33646959|NCT02036970|102259799|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
33379449|NCT03334396|101272842|FG006|Overall Study|Ineligible|0|||
33379450|NCT03334396|101272843|FG007|Overall Study|Ineligible|0|||
33379451|NCT03334396|101272836|FG000|Overall Study|Started New Job|1|||
33425018|NCT00845026|101446566|FG000|Study Period III|Subject is moving or has moved|2|||
33587141|NCT01734785|102036512|FG002|Double-Blind Period|Lack of Efficacy|0|||
33587142|NCT01734785|102036513|FG003|Double-Blind Period|Lack of Efficacy|0|||
33587143|NCT01734785|102036510|FG000|Double-Blind Period|Protocol Violation|0|||
33379452|NCT03334396|101272837|FG001|Overall Study|Started New Job|0|||
33379453|NCT03334396|101272838|FG002|Overall Study|Started New Job|0|||
33379454|NCT03334396|101272839|FG003|Overall Study|Started New Job|0|||
33379455|NCT03334396|101272840|FG004|Overall Study|Started New Job|0|||
33379456|NCT03334396|101272841|FG005|Overall Study|Started New Job|0|||
33379457|NCT03334396|101272842|FG006|Overall Study|Started New Job|0|||
33379458|NCT03334396|101272843|FG007|Overall Study|Started New Job|0|||
33379459|NCT03337139|101272847|FG000|Phase I|Withdrawal by Subject|10|||
33379460|NCT03337139|101272848|FG001|Phase I|Withdrawal by Subject|0|||
33379461|NCT00174785|101272851|FG000|Overall Study|Adverse Event|293|||
33425019|NCT00845026|101446567|FG001|Study Period III|Subject is moving or has moved|4|||
33646960|NCT02036970|102259800|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
33379462|NCT00174785|101272852|FG001|Overall Study|Adverse Event|191|||
33379463|NCT00174785|101272851|FG000|Overall Study|Protocol Violation|14|||
33379464|NCT00174785|101272852|FG001|Overall Study|Protocol Violation|14|||
33379465|NCT00174785|101272851|FG000|Overall Study|Withdrawal by Subject|173|||
33379466|NCT00174785|101272852|FG001|Overall Study|Withdrawal by Subject|175|||
33379467|NCT00174785|101272851|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
33379468|NCT00174785|101272852|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
33379469|NCT00174785|101272851|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
33379470|NCT00174785|101272852|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
33379471|NCT00174785|101272851|FG000|Overall Study|Other prohibited medication|5|||
33379472|NCT00174785|101272852|FG001|Overall Study|Other prohibited medication|3|||
33379473|NCT00174785|101272851|FG000|Overall Study|Family request|6|||
33379474|NCT00174785|101272852|FG001|Overall Study|Family request|8|||
33379475|NCT00174785|101272851|FG000|Overall Study|Not pre-specified/Not coded|56|||
33379476|NCT00174785|101272852|FG001|Overall Study|Not pre-specified/Not coded|70|||
33379477|NCT00289185|101272853|FG000|Overall Study|Withdrawal by Subject|4|||
33379478|NCT00289185|101272854|FG001|Overall Study|Withdrawal by Subject|8|||
33379479|NCT00289185|101272853|FG000|Overall Study|Lost to Follow-up|23|||
33379480|NCT00289185|101272854|FG001|Overall Study|Lost to Follow-up|17|||
33379481|NCT00289185|101272853|FG000|Overall Study|Death|1|||
33379482|NCT00289185|101272854|FG001|Overall Study|Death|1|||
33379483|NCT02387372|101272855|FG000|Overall Study|Not Treated|1|||
33379484|NCT02387372|101272856|FG001|Overall Study|Not Treated|0|||
33379485|NCT00589979|101272857|FG000|Run-In Period|Adverse Event|5|||
33379486|NCT00589979|101272858|FG001|Run-In Period|Adverse Event|0|||
33379487|NCT00589979|101272859|FG002|Run-In Period|Adverse Event|0|||
33379488|NCT00589979|101272857|FG000|Run-In Period|Protocol Violation|3|||
33379489|NCT00589979|101272858|FG001|Run-In Period|Protocol Violation|0|||
33379490|NCT00589979|101272859|FG002|Run-In Period|Protocol Violation|0|||
33379491|NCT00589979|101272857|FG000|Run-In Period|Did not qualify for randomization|54|||
33379492|NCT00589979|101272858|FG001|Run-In Period|Did not qualify for randomization|0|||
33379493|NCT00589979|101272859|FG002|Run-In Period|Did not qualify for randomization|0|||
33646961|NCT02036970|102259801|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
33646962|NCT02036970|102259802|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
33646963|NCT02036970|102259803|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
33646964|NCT02036970|102259804|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
33646965|NCT02036970|102259805|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
33646966|NCT02036970|102259806|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
33646967|NCT02036970|102259807|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
33646968|NCT02036970|102259808|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
33646969|NCT02036970|102259799|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
33646970|NCT02036970|102259800|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
33646971|NCT02036970|102259801|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
33646972|NCT02036970|102259802|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
33379494|NCT00589979|101272857|FG000|Run-In Period|Withdrawal by Subject|10|||
33379495|NCT00589979|101272858|FG001|Run-In Period|Withdrawal by Subject|0|||
33379496|NCT00589979|101272859|FG002|Run-In Period|Withdrawal by Subject|0|||
33379497|NCT00589979|101272857|FG000|Run-In Period|Informed Consent Withdrawn|4|||
33379498|NCT00589979|101272858|FG001|Run-In Period|Informed Consent Withdrawn|0|||
33379499|NCT00589979|101272859|FG002|Run-In Period|Informed Consent Withdrawn|0|||
33379500|NCT00589979|101272857|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
33379501|NCT00589979|101272858|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
33379502|NCT00589979|101272859|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
33379503|NCT00589979|101272857|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
33379504|NCT00589979|101272858|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
33379505|NCT00589979|101272859|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
33379506|NCT00589979|101272857|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
33379507|NCT00589979|101272858|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
33379508|NCT00589979|101272859|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
33379509|NCT00589979|101272857|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
33379510|NCT00589979|101272858|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
33379511|NCT00589979|101272859|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
33379512|NCT00589979|101272857|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
33379513|NCT00589979|101272858|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
33379514|NCT00589979|101272859|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
33379515|NCT00589979|101272857|FG000|Double-Blind Treatment Period 2|Other|0|||
33379516|NCT00589979|101272858|FG001|Double-Blind Treatment Period 2|Other|0|||
33379517|NCT00589979|101272859|FG002|Double-Blind Treatment Period 2|Other|1|||
33379518|NCT00589979|101272857|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
33379519|NCT00589979|101272858|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
33379520|NCT00589979|101272859|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
33646973|NCT02036970|102259803|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
33247827|NCT03982199|100810141|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
33247828|NCT03982199|100810142|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
33247829|NCT03982199|100810129|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
33247830|NCT03982199|100810130|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
33247831|NCT03982199|100810131|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
33247832|NCT03982199|100810132|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
33247833|NCT03982199|100810133|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
33247834|NCT03982199|100810134|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
33247835|NCT03982199|100810135|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
33247836|NCT03982199|100810136|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
33247837|NCT03982199|100810137|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
33247838|NCT03982199|100810138|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
33247839|NCT03982199|100810139|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
33247840|NCT03982199|100810140|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
33247841|NCT03982199|100810141|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
33247842|NCT03982199|100810142|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
33247843|NCT03982199|100810129|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
33247844|NCT03982199|100810130|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
33247845|NCT03982199|100810131|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
33247846|NCT03982199|100810132|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
33247847|NCT03982199|100810133|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
33247848|NCT03982199|100810134|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
33247849|NCT03982199|100810135|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
33247850|NCT03982199|100810136|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
33247851|NCT03982199|100810137|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
33247852|NCT03982199|100810138|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
33247853|NCT03982199|100810139|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
33425020|NCT00845026|101446566|FG000|Study Period III|Transportation issues|1|||
33425021|NCT00845026|101446567|FG001|Study Period III|Transportation issues|1|||
33425022|NCT00845026|101446566|FG000|Study Period IV|Adverse Event|4|||
33425023|NCT00845026|101446567|FG001|Study Period IV|Adverse Event|0|||
33425024|NCT00845026|101446566|FG000|Study Period IV|Perceived lack of efficacy|2|||
33425025|NCT00845026|101446567|FG001|Study Period IV|Perceived lack of efficacy|1|||
33425026|NCT00845026|101446566|FG000|Study Period IV|Protocol Violation|3|||
33425027|NCT00845026|101446567|FG001|Study Period IV|Protocol Violation|1|||
33425028|NCT00845026|101446566|FG000|Study Period IV|Lost to Follow-up|1|||
33425029|NCT00845026|101446567|FG001|Study Period IV|Lost to Follow-up|0|||
33425030|NCT00845026|101446566|FG000|Study Period IV|Withdrawal by Subject|4|||
33425031|NCT00845026|101446567|FG001|Study Period IV|Withdrawal by Subject|1|||
33425032|NCT00845026|101446566|FG000|Study Period IV|Entry Criteria Not Met|1|||
33425033|NCT00845026|101446567|FG001|Study Period IV|Entry Criteria Not Met|0|||
33425034|NCT00845026|101446566|FG000|Study Period IV|Subject is moving or has moved|0|||
33425035|NCT00845026|101446567|FG001|Study Period IV|Subject is moving or has moved|1|||
33425036|NCT00845026|101446566|FG000|Study Period IV|Scheduling conflict|1|||
33425037|NCT00845026|101446567|FG001|Study Period IV|Scheduling conflict|0|||
33489720|NCT02899962|101686774|FG002|Open-label Phase|Lost to Follow-up|0|||
33489721|NCT02899962|101686772|FG000|Open-label Phase|Other reasons|9|||
33489722|NCT02899962|101686773|FG001|Open-label Phase|Other reasons|0|||
33587144|NCT01734785|102036511|FG001|Double-Blind Period|Protocol Violation|1|||
33587145|NCT01734785|102036512|FG002|Double-Blind Period|Protocol Violation|1|||
33247854|NCT03982199|100810140|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
33247855|NCT03982199|100810141|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
33247856|NCT03982199|100810142|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
33247857|NCT03982199|100810129|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
33247858|NCT03982199|100810130|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
33247859|NCT03982199|100810131|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
33247860|NCT03982199|100810132|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
33247861|NCT03982199|100810133|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
33247862|NCT03982199|100810134|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
33489723|NCT02899962|101686774|FG002|Open-label Phase|Other reasons|0|||
33489724|NCT02899962|101686772|FG000|Open-label Phase|Withdrawal by Subject|7|||
33489725|NCT02899962|101686773|FG001|Open-label Phase|Withdrawal by Subject|0|||
33489726|NCT02899962|101686774|FG002|Open-label Phase|Withdrawal by Subject|0|||
33587146|NCT01734785|102036513|FG003|Double-Blind Period|Protocol Violation|0|||
33489727|NCT02899962|101686772|FG000|Maintenance Phase|Adverse Event|0|||
33489728|NCT02899962|101686773|FG001|Maintenance Phase|Adverse Event|2|||
33489729|NCT02899962|101686774|FG002|Maintenance Phase|Adverse Event|1|||
33489730|NCT02899962|101686772|FG000|Maintenance Phase|Death|0|||
33489731|NCT02899962|101686773|FG001|Maintenance Phase|Death|0|||
33587147|NCT01734785|102036510|FG000|Double-Blind Period|Lost to Follow-up|2|||
33247863|NCT03982199|100810135|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
33379521|NCT00589979|101272857|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
33379522|NCT00589979|101272858|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
33379523|NCT00589979|101272859|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
33379524|NCT01588353|101272860|FG000|Step2|Withdrawal by Subject|0|||
33379525|NCT01588353|101272861|FG001|Step2|Withdrawal by Subject|1|||
33379526|NCT01588353|101272862|FG002|Step2|Withdrawal by Subject|0|||
33379527|NCT01588353|101272860|FG000|Step3|Adverse Event|0|||
33379528|NCT01588353|101272861|FG001|Step3|Adverse Event|0|||
33379529|NCT01588353|101272862|FG002|Step3|Adverse Event|2|||
33379530|NCT01429077|101272863|FG000|Overall Study|Lost to Follow-up|0|||
33379531|NCT01429077|101272864|FG001|Overall Study|Lost to Follow-up|3|||
33379532|NCT04348656|101272865|FG000|Overall Study|Withdrawal by Subject|2|||
33379533|NCT04348656|101272866|FG001|Overall Study|Withdrawal by Subject|0|||
33379534|NCT04348656|101272865|FG000|Overall Study|Lost to Follow-up|11|||
33379535|NCT04348656|101272866|FG001|Overall Study|Lost to Follow-up|6|||
33379536|NCT01927419|101272872|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33379537|NCT01927419|101272873|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
33587148|NCT01734785|102036511|FG001|Double-Blind Period|Lost to Follow-up|4|||
33587149|NCT01734785|102036512|FG002|Double-Blind Period|Lost to Follow-up|2|||
33379538|NCT01927419|101272872|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
33379539|NCT01927419|101272873|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
33149086|NCT02319837|100460674|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
33149087|NCT02319837|100460672|FG000|Study Treatment Phase|Adverse Event|73|||
33149088|NCT02319837|100460673|FG001|Study Treatment Phase|Adverse Event|36|||
33149089|NCT02319837|100460674|FG002|Study Treatment Phase|Adverse Event|63|||
33149090|NCT02319837|100460672|FG000|Study Treatment Phase|Development of castration resistance|0|||
33149091|NCT02319837|100460673|FG001|Study Treatment Phase|Development of castration resistance|2|||
33149092|NCT02319837|100460674|FG002|Study Treatment Phase|Development of castration resistance|0|||
33379540|NCT01927419|101272872|FG000|Treatment Period|Disease progression|17|||
33379541|NCT01927419|101272873|FG001|Treatment Period|Disease progression|20|||
33379542|NCT01927419|101272872|FG000|Treatment Period|Study drug toxicity|48|||
33379543|NCT01927419|101272873|FG001|Treatment Period|Study drug toxicity|10|||
33379544|NCT01927419|101272872|FG000|Treatment Period|Death|0|||
33149093|NCT02319837|100460672|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
33149094|NCT02319837|100460673|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
33149095|NCT02319837|100460674|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
33149096|NCT02319837|100460672|FG000|Study Treatment Phase|Protocol Violation|2|||
33149097|NCT02319837|100460673|FG001|Study Treatment Phase|Protocol Violation|2|||
33149098|NCT02319837|100460674|FG002|Study Treatment Phase|Protocol Violation|1|||
33247864|NCT03982199|100810136|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
33247865|NCT03982199|100810137|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
33247866|NCT03982199|100810138|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
33247867|NCT03982199|100810139|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
33247868|NCT03982199|100810140|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
33247869|NCT03982199|100810141|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
33247870|NCT03982199|100810142|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
33247871|NCT03982199|100810129|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
33247872|NCT03982199|100810130|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
33247873|NCT03982199|100810131|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
33247874|NCT03982199|100810132|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
33247875|NCT03982199|100810133|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
33247876|NCT03982199|100810134|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
33247877|NCT03982199|100810135|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
33247878|NCT03982199|100810136|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
33247879|NCT03982199|100810137|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
33247880|NCT03982199|100810138|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
33379545|NCT01927419|101272873|FG001|Treatment Period|Death|1|||
33587150|NCT01734785|102036513|FG003|Double-Blind Period|Lost to Follow-up|0|||
33587151|NCT01734785|102036510|FG000|Double-Blind Period|Withdrawal by Subject|2|||
33587152|NCT01734785|102036511|FG001|Double-Blind Period|Withdrawal by Subject|0|||
33587153|NCT01734785|102036512|FG002|Double-Blind Period|Withdrawal by Subject|0|||
33587154|NCT01734785|102036513|FG003|Double-Blind Period|Withdrawal by Subject|0|||
33247881|NCT03982199|100810139|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
33247882|NCT03982199|100810140|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
33247883|NCT03982199|100810141|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
33247884|NCT03982199|100810142|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
33247885|NCT03982199|100810129|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
33379546|NCT01927419|101272872|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
33379547|NCT01927419|101272873|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
33587155|NCT01734785|102036510|FG000|Double-Blind Period|Not treated|1|||
33587156|NCT01734785|102036511|FG001|Double-Blind Period|Not treated|0|||
33149099|NCT02319837|100460672|FG000|Study Treatment Phase|Lost to Follow-up|0|||
33149100|NCT02319837|100460673|FG001|Study Treatment Phase|Lost to Follow-up|1|||
33149101|NCT02319837|100460674|FG002|Study Treatment Phase|Lost to Follow-up|0|||
33149102|NCT02319837|100460672|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
33149103|NCT02319837|100460673|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
33149104|NCT02319837|100460674|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
33149105|NCT02319837|100460672|FG000|Study Treatment Phase|Other|0|||
33149106|NCT02319837|100460673|FG001|Study Treatment Phase|Other|1|||
33149107|NCT02319837|100460674|FG002|Study Treatment Phase|Other|0|||
33149108|NCT02319837|100460672|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
33149109|NCT02319837|100460673|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
33149110|NCT02319837|100460674|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
33247886|NCT03982199|100810130|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
33587157|NCT01734785|102036512|FG002|Double-Blind Period|Not treated|0|||
33587158|NCT01734785|102036513|FG003|Double-Blind Period|Not treated|0|||
33587159|NCT00191945|102036514|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
33587160|NCT00191945|102036515|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
33587161|NCT00191945|102036514|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
33379548|NCT01927419|101272872|FG000|Treatment Period|Participant request to discontinue|12|||
33247887|NCT03982199|100810131|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
33247888|NCT03982199|100810132|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
33379549|NCT01927419|101272873|FG001|Treatment Period|Participant request to discontinue|4|||
33379550|NCT01927419|101272872|FG000|Treatment Period|Withdrawal by Subject|1|||
33379551|NCT01927419|101272873|FG001|Treatment Period|Withdrawal by Subject|1|||
33379552|NCT01927419|101272872|FG000|Treatment Period|Maximum Clinical Benefit|6|||
33379553|NCT01927419|101272873|FG001|Treatment Period|Maximum Clinical Benefit|2|||
33379554|NCT01927419|101272872|FG000|Treatment Period|Other reasons|3|||
33379555|NCT01927419|101272873|FG001|Treatment Period|Other reasons|4|||
33379556|NCT01927419|101272872|FG000|Treatment Period|Not Reported|1|||
33379557|NCT01927419|101272873|FG001|Treatment Period|Not Reported|1|||
33379558|NCT01167582|101272874|FG000|Overall Study|Lost to Follow-up|0|||
33379559|NCT01167582|101272875|FG001|Overall Study|Lost to Follow-up|1|||
33379560|NCT01935336|101272876|FG000|Overall Study|Adverse Event|1|||
33379561|NCT01935336|101272877|FG001|Overall Study|Adverse Event|0|||
33379562|NCT01935336|101272878|FG002|Overall Study|Adverse Event|0|||
33379563|NCT01935336|101272879|FG003|Overall Study|Adverse Event|0|||
33379564|NCT01935336|101272876|FG000|Overall Study|Progressive disease|5|||
33379565|NCT01935336|101272877|FG001|Overall Study|Progressive disease|3|||
33379566|NCT01935336|101272878|FG002|Overall Study|Progressive disease|47|||
33379567|NCT01935336|101272879|FG003|Overall Study|Progressive disease|66|||
33379568|NCT00390416|101272880|FG000|Overall Study|Withdrawal by Subject|1|||
33379569|NCT00390416|101272880|FG000|Overall Study|Not treated|3|||
33379570|NCT03600714|101272881|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
33379571|NCT04533815|101272882|FG000|Overall Study|Adverse Event|2|||
33379572|NCT04533815|101272882|FG000|Overall Study|Site withdrew|5|||
33379573|NCT01486784|101272883|FG000|Overall Study|Withdrawal by Subject|0|||
33379574|NCT01486784|101272884|FG001|Overall Study|Withdrawal by Subject|0|||
33379575|NCT01486784|101272885|FG002|Overall Study|Withdrawal by Subject|1|||
33587162|NCT00191945|102036515|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
33587163|NCT00191945|102036514|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
33587164|NCT00191945|102036515|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
33587165|NCT00191945|102036514|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
33587166|NCT00191945|102036515|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
33587167|NCT01703091|102036518|FG000|Overall Study|Adverse Event|5|||
33587168|NCT01703091|102036519|FG001|Overall Study|Adverse Event|3|||
33587169|NCT01703091|102036518|FG000|Overall Study|Physician Decision|2|||
33587170|NCT01703091|102036519|FG001|Overall Study|Physician Decision|1|||
33587171|NCT01703091|102036518|FG000|Overall Study|Withdrawal by Subject|1|||
33587172|NCT01703091|102036519|FG001|Overall Study|Withdrawal by Subject|0|||
33587173|NCT01703091|102036518|FG000|Overall Study|Sponsor Decision|1|||
33587174|NCT01703091|102036519|FG001|Overall Study|Sponsor Decision|0|||
33587175|NCT03490292|102036520|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
33587176|NCT03490292|102036521|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
33379576|NCT01486784|101272886|FG003|Overall Study|Withdrawal by Subject|0|||
33379577|NCT01486784|101272887|FG004|Overall Study|Withdrawal by Subject|1|||
33425038|NCT03769181|101449484|FG000|Overall Study|Adverse Event|1|||
33587177|NCT03490292|102036520|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
33587178|NCT03490292|102036521|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
33587179|NCT03490292|102036520|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
33587180|NCT03490292|102036521|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
33425039|NCT03769181|101449485|FG001|Overall Study|Adverse Event|0|||
33425040|NCT03769181|101449486|FG002|Overall Study|Adverse Event|2|||
33425041|NCT03769181|101449487|FG003|Overall Study|Adverse Event|4|||
33425042|NCT03769181|101449484|FG000|Overall Study|Withdrawal by Subject|1|||
33425043|NCT03769181|101449485|FG001|Overall Study|Withdrawal by Subject|0|||
33425044|NCT03769181|101449486|FG002|Overall Study|Withdrawal by Subject|2|||
33425045|NCT03769181|101449487|FG003|Overall Study|Withdrawal by Subject|1|||
33425046|NCT03769181|101449484|FG000|Overall Study|Progressive disease|9|||
33425047|NCT03769181|101449485|FG001|Overall Study|Progressive disease|7|||
33425048|NCT03769181|101449486|FG002|Overall Study|Progressive disease|13|||
33425049|NCT03769181|101449487|FG003|Overall Study|Progressive disease|6|||
33425050|NCT03769181|101449484|FG000|Overall Study|Other - Unspecified|2|||
33425051|NCT03769181|101449485|FG001|Overall Study|Other - Unspecified|1|||
33425052|NCT03769181|101449486|FG002|Overall Study|Other - Unspecified|0|||
33425053|NCT03769181|101449487|FG003|Overall Study|Other - Unspecified|0|||
33425054|NCT01021137|101449491|FG000|Overall Study|Lost to Follow-up|9|||
33379578|NCT01486784|101272888|FG005|Overall Study|Withdrawal by Subject|2|||
33379579|NCT01486784|101272883|FG000|Overall Study|Subject did not meet entry criteria|0|||
33379580|NCT01486784|101272884|FG001|Overall Study|Subject did not meet entry criteria|0|||
33379581|NCT01486784|101272885|FG002|Overall Study|Subject did not meet entry criteria|0|||
33379582|NCT01486784|101272886|FG003|Overall Study|Subject did not meet entry criteria|0|||
33379583|NCT01486784|101272887|FG004|Overall Study|Subject did not meet entry criteria|1|||
33379584|NCT01486784|101272888|FG005|Overall Study|Subject did not meet entry criteria|0|||
33379585|NCT01486784|101272883|FG000|Overall Study|Death|0|||
33379586|NCT01486784|101272884|FG001|Overall Study|Death|0|||
33379587|NCT01486784|101272885|FG002|Overall Study|Death|0|||
33379588|NCT01486784|101272886|FG003|Overall Study|Death|0|||
33379589|NCT01486784|101272887|FG004|Overall Study|Death|0|||
33425055|NCT01021137|101449492|FG001|Overall Study|Lost to Follow-up|4|||
33425056|NCT01021137|101449493|FG002|Overall Study|Lost to Follow-up|2|||
33425057|NCT01021137|101449494|FG003|Overall Study|Lost to Follow-up|6|||
33425058|NCT01021137|101449491|FG000|Overall Study|Withdrawal by Subject|1|||
33425059|NCT01021137|101449492|FG001|Overall Study|Withdrawal by Subject|0|||
33425060|NCT01021137|101449493|FG002|Overall Study|Withdrawal by Subject|0|||
33425061|NCT01021137|101449494|FG003|Overall Study|Withdrawal by Subject|3|||
33425062|NCT02535000|101449498|FG000|Overall Study|Cancellation of surgery.|1|||
33149111|NCT02319837|100460672|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
33149112|NCT02319837|100460673|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
33149113|NCT02319837|100460674|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
33149114|NCT02319837|100460672|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
33149115|NCT02319837|100460673|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
33149116|NCT02319837|100460674|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
33149117|NCT02319837|100460672|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
33247889|NCT03982199|100810133|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
33425063|NCT02535000|101449499|FG001|Overall Study|Cancellation of surgery.|2|||
33425064|NCT04741503|101449504|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
33425065|NCT04741503|101449505|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
33425066|NCT04741503|101449506|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
33247890|NCT03982199|100810134|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
33379590|NCT01486784|101272888|FG005|Overall Study|Death|1|||
33425067|NCT04741503|101449504|FG000|Initial Enrollment|Overquotas removed|0|||
33425068|NCT04741503|101449505|FG001|Initial Enrollment|Overquotas removed|0|||
33425069|NCT04741503|101449506|FG002|Initial Enrollment|Overquotas removed|186|||
33425070|NCT04741503|101449504|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
33425071|NCT04741503|101449505|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
33425072|NCT04741503|101449506|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
33425073|NCT01015612|101449509|FG000|Overall Study|Death|113|||
33587181|NCT03490292|102036520|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
33587182|NCT03490292|102036521|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
33587183|NCT03490292|102036520|FG000|1 Year Follow Up Post Last Dose|Death|1|||
33587184|NCT03490292|102036521|FG001|1 Year Follow Up Post Last Dose|Death|1|||
33587185|NCT00577707|102036523|FG000|Overall Study|Withdrawal by Subject|3|||
33587186|NCT00841776|102036525|FG000|Overall Study|Lack of Efficacy|0|||
33587187|NCT00841776|102036526|FG001|Overall Study|Lack of Efficacy|1|||
33379591|NCT00111917|101272889|FG000|Overall Study|Withdrawal by Subject|1|||
33379592|NCT00111917|101272890|FG001|Overall Study|Withdrawal by Subject|1|||
33425074|NCT01015612|101449509|FG000|Overall Study|Withdrawal by Subject|40|||
33587188|NCT00841776|102036525|FG000|Overall Study|Lost to Follow-up|2|||
33587189|NCT00841776|102036526|FG001|Overall Study|Lost to Follow-up|1|||
33587190|NCT00841776|102036525|FG000|Overall Study|Withdrawal by Subject|0|||
33379593|NCT01413542|101272893|FG000|Overall Study|Physician Decision|1|||
33379594|NCT01413542|101272894|FG001|Overall Study|Physician Decision|0|||
33379595|NCT01413542|101272895|FG002|Overall Study|Physician Decision|3|||
33379596|NCT01413542|101272896|FG003|Overall Study|Physician Decision|0|||
33379597|NCT01413542|101272893|FG000|Overall Study|Adverse Event|0|||
33379598|NCT01413542|101272894|FG001|Overall Study|Adverse Event|0|||
33379599|NCT01413542|101272895|FG002|Overall Study|Adverse Event|0|||
33379600|NCT01413542|101272896|FG003|Overall Study|Adverse Event|1|||
33379601|NCT01653158|101272907|FG000|Overall Study|Death|0|||
33379602|NCT01653158|101272908|FG001|Overall Study|Death|0|||
33379603|NCT01653158|101272909|FG002|Overall Study|Death|0|||
33379604|NCT01653158|101272910|FG003|Overall Study|Death|1|||
33379605|NCT01653158|101272911|FG004|Overall Study|Death|0|||
33379606|NCT01653158|101272912|FG005|Overall Study|Death|0|||
33379607|NCT01653158|101272913|FG006|Overall Study|Death|0|||
33379608|NCT01653158|101272914|FG007|Overall Study|Death|2|||
33379609|NCT01653158|101272907|FG000|Overall Study|Adverse Event|0|||
33379610|NCT01653158|101272908|FG001|Overall Study|Adverse Event|0|||
33379611|NCT01653158|101272909|FG002|Overall Study|Adverse Event|0|||
33379612|NCT01653158|101272910|FG003|Overall Study|Adverse Event|1|||
33379613|NCT01653158|101272911|FG004|Overall Study|Adverse Event|0|||
33379614|NCT01653158|101272912|FG005|Overall Study|Adverse Event|0|||
33379615|NCT01653158|101272913|FG006|Overall Study|Adverse Event|0|||
33379616|NCT01653158|101272914|FG007|Overall Study|Adverse Event|3|||
33379617|NCT01653158|101272907|FG000|Overall Study|Other|0|||
33247891|NCT03982199|100810135|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
33247892|NCT03982199|100810136|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
33247893|NCT03982199|100810137|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
33379618|NCT01653158|101272908|FG001|Overall Study|Other|0|||
33379619|NCT01653158|101272909|FG002|Overall Study|Other|0|||
33379620|NCT01653158|101272910|FG003|Overall Study|Other|0|||
33379621|NCT01653158|101272911|FG004|Overall Study|Other|0|||
33379622|NCT01653158|101272912|FG005|Overall Study|Other|0|||
33379623|NCT01653158|101272913|FG006|Overall Study|Other|0|||
33379624|NCT01653158|101272914|FG007|Overall Study|Other|1|||
33379625|NCT01653158|101272907|FG000|Overall Study|Progressive disease|0|||
33379626|NCT01653158|101272908|FG001|Overall Study|Progressive disease|0|||
33379627|NCT01653158|101272909|FG002|Overall Study|Progressive disease|0|||
33379628|NCT01653158|101272910|FG003|Overall Study|Progressive disease|0|||
33379629|NCT01653158|101272911|FG004|Overall Study|Progressive disease|1|||
33379630|NCT01653158|101272912|FG005|Overall Study|Progressive disease|1|||
33379631|NCT01653158|101272913|FG006|Overall Study|Progressive disease|2|||
33379632|NCT01653158|101272914|FG007|Overall Study|Progressive disease|9|||
33379633|NCT01653158|101272907|FG000|Overall Study|Withdrawal by Subject|1|||
33379634|NCT01653158|101272908|FG001|Overall Study|Withdrawal by Subject|0|||
33379635|NCT01653158|101272909|FG002|Overall Study|Withdrawal by Subject|0|||
33379636|NCT01653158|101272910|FG003|Overall Study|Withdrawal by Subject|0|||
33379637|NCT01653158|101272911|FG004|Overall Study|Withdrawal by Subject|0|||
33379638|NCT01653158|101272912|FG005|Overall Study|Withdrawal by Subject|0|||
33379639|NCT01653158|101272913|FG006|Overall Study|Withdrawal by Subject|0|||
33379640|NCT01653158|101272914|FG007|Overall Study|Withdrawal by Subject|0|||
33379641|NCT03519516|101272915|FG000|Overall Study|Adverse Event|0|||
33379642|NCT03519516|101272916|FG001|Overall Study|Adverse Event|1|||
33379643|NCT02219087|101272917|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
33425075|NCT03208933|101449510|FG000|Overall Study|Death|3|||
33425076|NCT03208933|101449510|FG000|Overall Study|Withdrawal by Subject|3|||
33425077|NCT03208933|101449510|FG000|Overall Study|Adverse Event|1|||
33425078|NCT03208933|101449510|FG000|Overall Study|Lost to Follow-up|2|||
33425079|NCT03208933|101449510|FG000|Overall Study|Physician Decision|3|||
33379644|NCT02219087|101272918|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
33425080|NCT03208933|101449510|FG000|Overall Study|Protocol Violation|1|||
33425081|NCT00095199|101449511|FG000|Overall Study|Adverse Event|40|||
33425082|NCT00095199|101449512|FG001|Overall Study|Adverse Event|22|||
33425083|NCT00095199|101449513|FG002|Overall Study|Adverse Event|26|||
33425084|NCT00095199|101449514|FG003|Overall Study|Adverse Event|11|||
33425085|NCT00095199|101449511|FG000|Overall Study|Progressive disease|213|||
33247894|NCT03982199|100810138|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
33379645|NCT00964158|101272919|FG000|Overall Study|Lost to Follow-up|0|||
33379646|NCT00964158|101272920|FG001|Overall Study|Lost to Follow-up|1|||
33379647|NCT00964158|101272921|FG002|Overall Study|Lost to Follow-up|2|||
33379648|NCT00964158|101272919|FG000|Overall Study|Withdrawal by Subject|0|||
33379649|NCT00964158|101272920|FG001|Overall Study|Withdrawal by Subject|0|||
33425086|NCT00095199|101449512|FG001|Overall Study|Progressive disease|179|||
33425087|NCT00095199|101449513|FG002|Overall Study|Progressive disease|105|||
33379650|NCT00964158|101272921|FG002|Overall Study|Withdrawal by Subject|6|||
33379651|NCT03247413|101272924|FG000|Overall Study|Lost to Follow-up|28|||
33379652|NCT01681576|101272925|FG000|Period 1|Adverse Event|1|||
33379653|NCT01681576|101272926|FG001|Period 1|Adverse Event|0|||
33379654|NCT01681576|101272925|FG000|Period 1|Protocol Deviation|1|||
33379655|NCT01681576|101272926|FG001|Period 1|Protocol Deviation|0|||
33379656|NCT01681576|101272925|FG000|Period 2|subject/guardian decision|3|||
33379657|NCT01681576|101272926|FG001|Period 2|subject/guardian decision|1|||
33379658|NCT01681576|101272925|FG000|Period 2|Non-compliance with study treatment|1|||
33646974|NCT02036970|102259804|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
33646975|NCT02036970|102259805|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
33646976|NCT02036970|102259806|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
33646977|NCT02036970|102259807|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
33646978|NCT02036970|102259808|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
33646979|NCT02036970|102259799|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33646980|NCT02036970|102259800|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33646981|NCT02036970|102259801|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33646982|NCT02036970|102259802|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
33646983|NCT02036970|102259803|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33646984|NCT02036970|102259804|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33646985|NCT02036970|102259805|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33646986|NCT02036970|102259806|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33646987|NCT02036970|102259807|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33646988|NCT02036970|102259808|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
33646989|NCT02036970|102259799|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
33646990|NCT02036970|102259800|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
33646991|NCT02036970|102259801|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
33646992|NCT02036970|102259802|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
33646993|NCT02036970|102259803|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
33646994|NCT02036970|102259804|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
33646995|NCT02036970|102259805|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
33646996|NCT02036970|102259806|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
33646997|NCT02036970|102259807|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
33646998|NCT02036970|102259808|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
33646999|NCT02036970|102259799|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
33647000|NCT02036970|102259800|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
33647001|NCT02036970|102259801|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
33647002|NCT02036970|102259802|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
33647003|NCT02036970|102259803|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
33647004|NCT02036970|102259804|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
33379659|NCT01681576|101272926|FG001|Period 2|Non-compliance with study treatment|0|||
33379660|NCT01106625|101272927|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
33379661|NCT01106625|101272928|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
33379662|NCT01106625|101272929|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
33379663|NCT01106625|101272927|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
33379664|NCT01106625|101272928|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
33379665|NCT01106625|101272929|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
33379666|NCT01106625|101272927|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
33379667|NCT01106625|101272928|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
33379668|NCT01106625|101272929|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
33379669|NCT01106625|101272927|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
33425088|NCT00095199|101449514|FG003|Overall Study|Progressive disease|98|||
33425089|NCT00095199|101449511|FG000|Overall Study|Death|10|||
33425090|NCT00095199|101449512|FG001|Overall Study|Death|6|||
33425091|NCT00095199|101449513|FG002|Overall Study|Death|11|||
33425092|NCT00095199|101449514|FG003|Overall Study|Death|9|||
33425093|NCT00095199|101449511|FG000|Overall Study|Withdrawal by Subject|21|||
33425094|NCT00095199|101449512|FG001|Overall Study|Withdrawal by Subject|16|||
33379670|NCT01106625|101272928|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
33379671|NCT01106625|101272929|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
33379672|NCT01106625|101272927|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
33379673|NCT01106625|101272928|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
33379674|NCT01106625|101272929|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
33379675|NCT01106625|101272927|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
33379676|NCT01106625|101272928|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
33379677|NCT01106625|101272929|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
33379678|NCT01106625|101272927|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
33425095|NCT00095199|101449513|FG002|Overall Study|Withdrawal by Subject|13|||
33425096|NCT00095199|101449514|FG003|Overall Study|Withdrawal by Subject|22|||
33425097|NCT00095199|101449511|FG000|Overall Study|Protocol Violation|4|||
33425098|NCT00095199|101449512|FG001|Overall Study|Protocol Violation|4|||
33425099|NCT00095199|101449513|FG002|Overall Study|Protocol Violation|2|||
33425100|NCT00095199|101449514|FG003|Overall Study|Protocol Violation|0|||
33489732|NCT02899962|101686774|FG002|Maintenance Phase|Death|1|||
33647005|NCT02036970|102259805|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
33647006|NCT02036970|102259806|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
33647007|NCT02036970|102259807|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
33647008|NCT02036970|102259808|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
33379679|NCT01106625|101272928|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
33379680|NCT01106625|101272929|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
33379681|NCT01106625|101272927|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
33647009|NCT02036970|102259799|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
33379682|NCT01106625|101272928|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
33379683|NCT01106625|101272929|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33379684|NCT01106625|101272927|FG000|Core Period: Baseline to Week 26|Other|8|||
33379685|NCT01106625|101272928|FG001|Core Period: Baseline to Week 26|Other|7|||
33379686|NCT01106625|101272929|FG002|Core Period: Baseline to Week 26|Other|4|||
33379687|NCT01106625|101272927|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
33379688|NCT01106625|101272928|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
33379689|NCT01106625|101272929|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
33379690|NCT01106625|101272927|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
33379691|NCT01106625|101272928|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
33379692|NCT01106625|101272929|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
33379693|NCT01106625|101272927|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
33379694|NCT01106625|101272928|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33379695|NCT01106625|101272929|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
33379696|NCT01106625|101272927|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33379697|NCT01106625|101272928|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
33379698|NCT01106625|101272929|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33379699|NCT01106625|101272927|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
33379700|NCT01106625|101272928|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33379701|NCT01106625|101272929|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33379702|NCT01106625|101272927|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
33379703|NCT01106625|101272928|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
33379704|NCT01106625|101272929|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
33379705|NCT01106625|101272927|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
33379706|NCT01106625|101272928|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
33379707|NCT01106625|101272929|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
33379708|NCT01106625|101272927|FG000|Extension Period: Week 26 to Week 52|Other|5|||
33379709|NCT01106625|101272928|FG001|Extension Period: Week 26 to Week 52|Other|5|||
33379710|NCT01106625|101272929|FG002|Extension Period: Week 26 to Week 52|Other|4|||
33379711|NCT02947022|101272930|FG000|Overall Study|Study Stopped|1|||
33379712|NCT01397448|101272931|FG000|Overall Study|Adverse Event|4|||
33379713|NCT01397448|101272932|FG001|Overall Study|Adverse Event|4|||
33379714|NCT01397448|101272933|FG002|Overall Study|Adverse Event|6|||
33379715|NCT01397448|101272931|FG000|Overall Study|Withdrawal by Subject|4|||
33379716|NCT01397448|101272932|FG001|Overall Study|Withdrawal by Subject|4|||
33379717|NCT01397448|101272933|FG002|Overall Study|Withdrawal by Subject|3|||
33379718|NCT01397448|101272931|FG000|Overall Study|Lack of Efficacy|2|||
33379719|NCT01397448|101272932|FG001|Overall Study|Lack of Efficacy|0|||
33379720|NCT01397448|101272933|FG002|Overall Study|Lack of Efficacy|5|||
33379721|NCT01397448|101272931|FG000|Overall Study|Other|8|||
33379722|NCT01397448|101272932|FG001|Overall Study|Other|7|||
33379723|NCT01397448|101272933|FG002|Overall Study|Other|4|||
33379724|NCT00441103|101272937|FG000|Overall Study|Adverse Event|2|||
33379725|NCT00441103|101272938|FG001|Overall Study|Adverse Event|1|||
33379726|NCT00441103|101272937|FG000|Overall Study|Death|1|||
33379727|NCT00441103|101272938|FG001|Overall Study|Death|0|||
33379728|NCT00441103|101272937|FG000|Overall Study|Disease Progression|2|||
33379729|NCT00441103|101272938|FG001|Overall Study|Disease Progression|0|||
33379730|NCT00441103|101272937|FG000|Overall Study|Lost to Follow-up|1|||
33379731|NCT00441103|101272938|FG001|Overall Study|Lost to Follow-up|0|||
33379732|NCT00441103|101272937|FG000|Overall Study|Protocol Violation|1|||
33379733|NCT00441103|101272938|FG001|Overall Study|Protocol Violation|0|||
33379734|NCT00441103|101272937|FG000|Overall Study|Participant unable to use Rebiject II|1|||
33379735|NCT00441103|101272938|FG001|Overall Study|Participant unable to use Rebiject II|0|||
33379736|NCT00441103|101272937|FG000|Overall Study|Participant refused MRI|1|||
33379737|NCT00441103|101272938|FG001|Overall Study|Participant refused MRI|0|||
33379738|NCT00441103|101272937|FG000|Overall Study|Inclusion criteria absent|1|||
33379739|NCT00441103|101272938|FG001|Overall Study|Inclusion criteria absent|0|||
33379740|NCT00441103|101272937|FG000|Overall Study|Non-compliant|0|||
33647010|NCT02036970|102259800|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
33379741|NCT00441103|101272938|FG001|Overall Study|Non-compliant|1|||
33379742|NCT00441103|101272937|FG000|Overall Study|Participant decided to withdraw|1|||
33379743|NCT00441103|101272938|FG001|Overall Study|Participant decided to withdraw|0|||
33379744|NCT00441103|101272937|FG000|Overall Study|Participant's reason|0|||
33647011|NCT02036970|102259801|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
33647012|NCT02036970|102259802|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
33647013|NCT02036970|102259803|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
33647014|NCT02036970|102259804|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
33647015|NCT02036970|102259805|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
33647016|NCT02036970|102259806|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
33647017|NCT02036970|102259807|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
33647018|NCT02036970|102259808|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
33647019|NCT02036970|102259799|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
33647020|NCT02036970|102259800|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
33647021|NCT02036970|102259801|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
33647022|NCT02036970|102259802|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
33379745|NCT00441103|101272938|FG001|Overall Study|Participant's reason|1|||
33379746|NCT00441103|101272937|FG000|Overall Study|Participant decided to stop|0|||
33379747|NCT00441103|101272938|FG001|Overall Study|Participant decided to stop|1|||
33425101|NCT00095199|101449511|FG000|Overall Study|Liver function test results elevated|0|||
33425102|NCT00095199|101449512|FG001|Overall Study|Liver function test results elevated|0|||
33425103|NCT00095199|101449513|FG002|Overall Study|Liver function test results elevated|1|||
33425104|NCT00095199|101449514|FG003|Overall Study|Liver function test results elevated|1|||
33425105|NCT00095199|101449511|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
33425106|NCT00095199|101449512|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
33425107|NCT00095199|101449513|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
33425108|NCT00095199|101449514|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
33425109|NCT00095199|101449511|FG000|Overall Study|Physician Decision|5|||
33425110|NCT00095199|101449512|FG001|Overall Study|Physician Decision|6|||
33425111|NCT00095199|101449513|FG002|Overall Study|Physician Decision|1|||
33425112|NCT00095199|101449514|FG003|Overall Study|Physician Decision|1|||
33425113|NCT00095199|101449511|FG000|Overall Study|Not eligible|1|||
33425114|NCT00095199|101449512|FG001|Overall Study|Not eligible|7|||
33425115|NCT00095199|101449513|FG002|Overall Study|Not eligible|0|||
33425116|NCT00095199|101449514|FG003|Overall Study|Not eligible|1|||
33425117|NCT00095199|101449511|FG000|Overall Study|Started Palliative Radiotherapy|1|||
33425118|NCT00095199|101449512|FG001|Overall Study|Started Palliative Radiotherapy|0|||
33425119|NCT00095199|101449513|FG002|Overall Study|Started Palliative Radiotherapy|0|||
33425120|NCT00095199|101449514|FG003|Overall Study|Started Palliative Radiotherapy|0|||
33425121|NCT00095199|101449511|FG000|Overall Study|Started radiotherapy regimen|0|||
33425122|NCT00095199|101449512|FG001|Overall Study|Started radiotherapy regimen|1|||
33379748|NCT04096326|101272939|FG000|Overall Study|Withdrawal by Subject|0|||
33425123|NCT00095199|101449513|FG002|Overall Study|Started radiotherapy regimen|0|||
33425124|NCT00095199|101449514|FG003|Overall Study|Started radiotherapy regimen|0|||
33425125|NCT00095199|101449511|FG000|Overall Study|Primary tumor removed in other surgery|0|||
33425126|NCT00095199|101449512|FG001|Overall Study|Primary tumor removed in other surgery|1|||
33425127|NCT00095199|101449513|FG002|Overall Study|Primary tumor removed in other surgery|0|||
33425128|NCT00095199|101449514|FG003|Overall Study|Primary tumor removed in other surgery|0|||
33425129|NCT00095199|101449511|FG000|Overall Study|Data inadvertently lost by site|1|||
33425130|NCT00095199|101449512|FG001|Overall Study|Data inadvertently lost by site|0|||
33425131|NCT00095199|101449513|FG002|Overall Study|Data inadvertently lost by site|0|||
33379749|NCT04096326|101272940|FG001|Overall Study|Withdrawal by Subject|0|||
33379750|NCT04096326|101272941|FG002|Overall Study|Withdrawal by Subject|0|||
33379751|NCT04096326|101272942|FG003|Overall Study|Withdrawal by Subject|0|||
33379752|NCT04096326|101272943|FG004|Overall Study|Withdrawal by Subject|0|||
33379753|NCT04096326|101272944|FG005|Overall Study|Withdrawal by Subject|0|||
33379754|NCT04096326|101272945|FG006|Overall Study|Withdrawal by Subject|1|||
33379755|NCT04096326|101272946|FG007|Overall Study|Withdrawal by Subject|0|||
33379756|NCT04096326|101272947|FG008|Overall Study|Withdrawal by Subject|0|||
33379757|NCT04096326|101272948|FG009|Overall Study|Withdrawal by Subject|0|||
33379758|NCT04096326|101272939|FG000|Overall Study|Lost to Follow-up|0|||
33379759|NCT04096326|101272940|FG001|Overall Study|Lost to Follow-up|1|||
33379760|NCT04096326|101272941|FG002|Overall Study|Lost to Follow-up|0|||
33425132|NCT00095199|101449514|FG003|Overall Study|Data inadvertently lost by site|0|||
33425133|NCT03066440|101449515|FG000|Overall Study|Physician Decision|1|||
33379761|NCT04096326|101272942|FG003|Overall Study|Lost to Follow-up|0|||
33379762|NCT04096326|101272943|FG004|Overall Study|Lost to Follow-up|0|||
33379763|NCT04096326|101272944|FG005|Overall Study|Lost to Follow-up|0|||
33379764|NCT04096326|101272945|FG006|Overall Study|Lost to Follow-up|0|||
33379765|NCT04096326|101272946|FG007|Overall Study|Lost to Follow-up|0|||
33379766|NCT04096326|101272947|FG008|Overall Study|Lost to Follow-up|0|||
33379767|NCT04096326|101272948|FG009|Overall Study|Lost to Follow-up|0|||
33425134|NCT03066440|101449516|FG001|Overall Study|Physician Decision|1|||
33425135|NCT03066440|101449515|FG000|Overall Study|Protocol Violation|0|||
33425136|NCT03066440|101449516|FG001|Overall Study|Protocol Violation|2|||
33647023|NCT02036970|102259803|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
33647024|NCT02036970|102259804|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
33379768|NCT04096326|101272939|FG000|Overall Study|COVID-19-related reasons|0|||
33379769|NCT04096326|101272940|FG001|Overall Study|COVID-19-related reasons|0|||
33379770|NCT04096326|101272941|FG002|Overall Study|COVID-19-related reasons|0|||
33379771|NCT04096326|101272942|FG003|Overall Study|COVID-19-related reasons|0|||
33379772|NCT04096326|101272943|FG004|Overall Study|COVID-19-related reasons|1|||
33379773|NCT04096326|101272944|FG005|Overall Study|COVID-19-related reasons|5|||
33379774|NCT04096326|101272945|FG006|Overall Study|COVID-19-related reasons|0|||
33379775|NCT04096326|101272946|FG007|Overall Study|COVID-19-related reasons|0|||
33379776|NCT04096326|101272947|FG008|Overall Study|COVID-19-related reasons|0|||
33379777|NCT04096326|101272948|FG009|Overall Study|COVID-19-related reasons|0|||
33379778|NCT03341923|101272953|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
33379779|NCT03341923|101272954|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
33379780|NCT00506948|101272955|FG000|Overall Study|Death|4|||
33379781|NCT00506948|101272955|FG000|Overall Study|Adverse Event|5|||
33379782|NCT00506948|101272955|FG000|Overall Study|Physician Decision|1|||
33379783|NCT01120379|101272956|FG000|One Year Timepoint|Withdrawal by Subject|41|||
33379784|NCT01120379|101272956|FG000|One Year Timepoint|Lost to Follow-up|115|||
33379785|NCT01120379|101272956|FG000|One Year Timepoint|Death|108|||
33379786|NCT01120379|101272956|FG000|One Year Timepoint|Physician Decision|9|||
33379787|NCT01120379|101272956|FG000|One Year Timepoint|Any other reason for early termination|5|||
33379788|NCT01120379|101272956|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
33379789|NCT01120379|101272956|FG000|Two Year Timepoint|Lost to Follow-up|87|||
33425137|NCT03578276|101449517|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
33425138|NCT03578276|101449518|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
33587191|NCT00841776|102036526|FG001|Overall Study|Withdrawal by Subject|1|||
33647025|NCT02036970|102259805|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
33647026|NCT02036970|102259806|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
33647027|NCT02036970|102259807|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
33647028|NCT02036970|102259808|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
33647029|NCT02160899|102259809|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
33647030|NCT02160899|102259810|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
33647031|NCT02160899|102259811|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
33647032|NCT02160899|102259812|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
33247895|NCT03982199|100810139|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
33247896|NCT03982199|100810140|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
33379790|NCT01120379|101272956|FG000|Two Year Timepoint|Death|123|||
33379791|NCT01120379|101272956|FG000|Two Year Timepoint|Physician Decision|12|||
33379792|NCT01120379|101272956|FG000|Two Year Timepoint|Any other reason for early termination|4|||
33379793|NCT01120379|101272956|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
33425139|NCT00515073|101449520|FG000|Overall Study|Withdrawal by Subject|1|||
33425140|NCT00515073|101449520|FG000|Overall Study|Physician Decision|1|||
33425141|NCT02191579|101449523|FG000|Treatment 1|Multiple Reasons Specified|27|||
33425142|NCT02191579|101449524|FG001|Treatment 1|Multiple Reasons Specified|58|||
33425143|NCT02191579|101449523|FG000|Treatment 2|Multiple Reasons Specified|0|||
33425144|NCT02191579|101449524|FG001|Treatment 2|Multiple Reasons Specified|25|||
33425145|NCT01427803|101449525|FG000|Overall Study|Lost to Follow-up|32|||
33425146|NCT01427803|101449526|FG001|Overall Study|Lost to Follow-up|26|||
33587192|NCT03308968|102036527|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
33587193|NCT03308968|102036528|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
33587194|NCT03308968|102036529|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
33587195|NCT03308968|102036527|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
33587196|NCT03308968|102036528|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
33587197|NCT03308968|102036529|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
33587198|NCT03308968|102036527|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
33587199|NCT03308968|102036528|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
33587200|NCT03308968|102036529|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
33587201|NCT03308968|102036527|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
33587202|NCT03308968|102036528|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
33587203|NCT03308968|102036529|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
33587204|NCT03308968|102036527|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
33587205|NCT03308968|102036528|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
33587206|NCT03308968|102036529|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
33587207|NCT03308968|102036527|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
33379794|NCT01120379|101272956|FG000|Three Year Timepoint|Lost to Follow-up|43|||
33379795|NCT01120379|101272956|FG000|Three Year Timepoint|Death|120|||
33379796|NCT01120379|101272956|FG000|Three Year Timepoint|Physician Decision|9|||
33379797|NCT01120379|101272956|FG000|Three Year Timepoint|Any other reason for early termination|17|||
33425147|NCT01427803|101449525|FG000|Overall Study|Withdrawal by Subject|20|||
33587208|NCT03308968|102036528|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
33587209|NCT03308968|102036529|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
33587210|NCT03308968|102036527|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
33647033|NCT02160899|102259813|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
33647034|NCT02160899|102259814|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
33379798|NCT01120379|101272956|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
33379799|NCT01120379|101272956|FG000|Four Year Timepoint|Lost to Follow-up|10|||
33425148|NCT01427803|101449526|FG001|Overall Study|Withdrawal by Subject|0|||
33425149|NCT01427803|101449525|FG000|Overall Study|Unable to complete full treatment period|6|||
33425150|NCT01427803|101449526|FG001|Overall Study|Unable to complete full treatment period|0|||
33425151|NCT01427803|101449525|FG000|Overall Study|Protocol Violation|1|||
33425152|NCT01427803|101449526|FG001|Overall Study|Protocol Violation|0|||
33425153|NCT01427803|101449525|FG000|Overall Study|Physician Decision|3|||
33425154|NCT01427803|101449526|FG001|Overall Study|Physician Decision|0|||
33425155|NCT01427803|101449525|FG000|Overall Study|did not take product|1|||
33425156|NCT01427803|101449526|FG001|Overall Study|did not take product|0|||
33425157|NCT00948025|101449531|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
33425158|NCT00948025|101449532|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
33425159|NCT00948025|101449531|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
33425160|NCT00948025|101449532|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
33425161|NCT00948025|101449531|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
33425162|NCT00948025|101449532|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
33425163|NCT01360632|101449533|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
33425164|NCT01360632|101449534|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
33425165|NCT01360632|101449535|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
33425166|NCT01360632|101449536|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
33425167|NCT01360632|101449537|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
33425168|NCT01360632|101449533|FG000|Phase A (8 Weeks)|Adverse Event|60|||
33425169|NCT01360632|101449534|FG001|Phase A (8 Weeks)|Adverse Event|0|||
33425170|NCT01360632|101449535|FG002|Phase A (8 Weeks)|Adverse Event|0|||
33425171|NCT01360632|101449536|FG003|Phase A (8 Weeks)|Adverse Event|0|||
33425172|NCT01360632|101449537|FG004|Phase A (8 Weeks)|Adverse Event|0|||
33425173|NCT01360632|101449533|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
33425174|NCT01360632|101449534|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
33425175|NCT01360632|101449535|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
33425176|NCT01360632|101449536|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
33425177|NCT01360632|101449537|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
33425178|NCT01360632|101449533|FG000|Phase A (8 Weeks)|Physician Decision|10|||
33425179|NCT01360632|101449534|FG001|Phase A (8 Weeks)|Physician Decision|0|||
33425180|NCT01360632|101449535|FG002|Phase A (8 Weeks)|Physician Decision|0|||
33425181|NCT01360632|101449536|FG003|Phase A (8 Weeks)|Physician Decision|0|||
33425182|NCT01360632|101449537|FG004|Phase A (8 Weeks)|Physician Decision|0|||
33425183|NCT01360632|101449533|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
33425184|NCT01360632|101449534|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
33425185|NCT01360632|101449535|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
33425186|NCT01360632|101449536|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
33425187|NCT01360632|101449537|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
33425188|NCT01360632|101449533|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
33425189|NCT01360632|101449534|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
33425190|NCT01360632|101449535|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
33425191|NCT01360632|101449536|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
33425192|NCT01360632|101449537|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
33425193|NCT01360632|101449533|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
33425194|NCT01360632|101449534|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
33425195|NCT01360632|101449535|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
33425196|NCT01360632|101449536|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
33425197|NCT01360632|101449537|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
33425198|NCT01360632|101449533|FG000|Phase B (6 Weeks)|Adverse Event|0|||
33425199|NCT01360632|101449534|FG001|Phase B (6 Weeks)|Adverse Event|3|||
33425200|NCT01360632|101449535|FG002|Phase B (6 Weeks)|Adverse Event|9|||
33425201|NCT01360632|101449536|FG003|Phase B (6 Weeks)|Adverse Event|3|||
33425202|NCT01360632|101449537|FG004|Phase B (6 Weeks)|Adverse Event|0|||
33425203|NCT01360632|101449533|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
33379800|NCT01120379|101272956|FG000|Four Year Timepoint|Death|131|||
33379801|NCT01120379|101272956|FG000|Four Year Timepoint|Physician Decision|5|||
33379802|NCT01120379|101272956|FG000|Four Year Timepoint|Any other reason for early termination|217|||
33379803|NCT02530671|101272959|FG000|Overall Study|Lost to Follow-up|2|||
33379804|NCT02530671|101272960|FG001|Overall Study|Lost to Follow-up|0|||
33379805|NCT02530671|101272959|FG000|Overall Study|Withdrawal by Subject|1|||
33379806|NCT02530671|101272960|FG001|Overall Study|Withdrawal by Subject|0|||
33425204|NCT01360632|101449534|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
33425205|NCT01360632|101449535|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
33425206|NCT01360632|101449536|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
33425207|NCT01360632|101449537|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
33425208|NCT01360632|101449533|FG000|Phase B (6 Weeks)|Physician Decision|0|||
33425209|NCT01360632|101449534|FG001|Phase B (6 Weeks)|Physician Decision|0|||
33647035|NCT01667419|102259815|FG000|Overall Study|Reason Not Specified|1|||
33379807|NCT00423735|101272961|FG000|Overall Study|Ineligible / No protocol treatment|8|||
33425210|NCT01360632|101449535|FG002|Phase B (6 Weeks)|Physician Decision|0|||
33647036|NCT01667419|102259816|FG001|Overall Study|Reason Not Specified|0|||
33425211|NCT01360632|101449536|FG003|Phase B (6 Weeks)|Physician Decision|1|||
33247897|NCT03982199|100810141|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
33247898|NCT03982199|100810142|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
33247899|NCT03982199|100810129|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
33247900|NCT03982199|100810130|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
33247901|NCT03982199|100810131|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
33247902|NCT03982199|100810132|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
33247903|NCT03982199|100810133|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
33247904|NCT03982199|100810134|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
33247905|NCT03982199|100810135|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
33247906|NCT03982199|100810136|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
33247907|NCT03982199|100810137|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
33247908|NCT03982199|100810138|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
33247909|NCT03982199|100810139|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
33247910|NCT03982199|100810140|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
33247911|NCT03982199|100810141|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
33247912|NCT03982199|100810142|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
33247913|NCT03982199|100810129|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
33247914|NCT03982199|100810130|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
33247915|NCT03982199|100810131|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
33247916|NCT03982199|100810132|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
33247917|NCT03982199|100810133|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
33247918|NCT03982199|100810134|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
33247919|NCT03982199|100810135|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
33247920|NCT03982199|100810136|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
33247921|NCT03982199|100810137|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
33247922|NCT03982199|100810138|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
33247923|NCT03982199|100810139|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
33247924|NCT03982199|100810140|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
33247925|NCT03982199|100810141|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
33247926|NCT03982199|100810142|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
33247927|NCT03982199|100810129|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
33247928|NCT03982199|100810130|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
33247929|NCT03982199|100810131|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
33247930|NCT03982199|100810132|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
33247931|NCT03982199|100810133|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
33247932|NCT03982199|100810134|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
33247933|NCT03982199|100810135|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
33247934|NCT03982199|100810136|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
33247935|NCT03982199|100810137|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
33247936|NCT03982199|100810138|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
33247937|NCT03982199|100810139|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
33247938|NCT03982199|100810140|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
33247939|NCT03982199|100810141|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
33247940|NCT03982199|100810142|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
33247941|NCT03982199|100810129|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
33247942|NCT03982199|100810130|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
33247943|NCT03982199|100810131|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
33247944|NCT03982199|100810132|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
33247945|NCT03982199|100810133|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
33247946|NCT03982199|100810134|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
33247947|NCT03982199|100810135|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
33247948|NCT03982199|100810136|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
33247949|NCT03982199|100810137|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
33247950|NCT03982199|100810138|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
33247951|NCT03982199|100810139|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
33247952|NCT03982199|100810140|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
33247953|NCT03982199|100810141|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
33247954|NCT03982199|100810142|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
33247955|NCT03982199|100810129|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
33247956|NCT03982199|100810130|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
33425212|NCT01360632|101449537|FG004|Phase B (6 Weeks)|Physician Decision|0|||
33425213|NCT01360632|101449533|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
33247957|NCT03982199|100810131|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
33247958|NCT03982199|100810132|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
33379808|NCT00423735|101272962|FG001|Overall Study|Ineligible / No protocol treatment|6|||
33379809|NCT00423735|101272963|FG002|Overall Study|Ineligible / No protocol treatment|0|||
33425214|NCT01360632|101449534|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
33425215|NCT01360632|101449535|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
33425216|NCT01360632|101449536|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
33647037|NCT01667419|102259817|FG002|Overall Study|Reason Not Specified|0|||
33647038|NCT01667419|102259818|FG003|Overall Study|Reason Not Specified|0|||
33647039|NCT01667419|102259815|FG000|Overall Study|Withdrawal by Subject|16|||
33647040|NCT01667419|102259816|FG001|Overall Study|Withdrawal by Subject|8|||
33647041|NCT01667419|102259817|FG002|Overall Study|Withdrawal by Subject|9|||
33647042|NCT01667419|102259818|FG003|Overall Study|Withdrawal by Subject|8|||
33647043|NCT01667419|102259815|FG000|Overall Study|Non-compliance|0|||
33379810|NCT04410198|101272964|FG000|Overall Study|Death|10|||
33379811|NCT04410198|101272964|FG000|Overall Study|Withdrawal by Subject|7|||
33379812|NCT04410198|101272964|FG000|Overall Study|Transferred/Relocation|4|||
33647044|NCT01667419|102259816|FG001|Overall Study|Non-compliance|0|||
33647045|NCT01667419|102259817|FG002|Overall Study|Non-compliance|0|||
33647046|NCT01667419|102259818|FG003|Overall Study|Non-compliance|1|||
33647047|NCT01667419|102259815|FG000|Overall Study|Protocol Violation|1|||
33647048|NCT01667419|102259816|FG001|Overall Study|Protocol Violation|0|||
33647049|NCT01667419|102259817|FG002|Overall Study|Protocol Violation|0|||
33647050|NCT01667419|102259818|FG003|Overall Study|Protocol Violation|0|||
33647051|NCT01667419|102259815|FG000|Overall Study|Lost to Follow-up|7|||
33647052|NCT01667419|102259816|FG001|Overall Study|Lost to Follow-up|6|||
33647053|NCT01667419|102259817|FG002|Overall Study|Lost to Follow-up|2|||
33647054|NCT01667419|102259818|FG003|Overall Study|Lost to Follow-up|4|||
33647055|NCT01667419|102259815|FG000|Overall Study|Death|18|||
33647056|NCT01667419|102259816|FG001|Overall Study|Death|33|||
33647057|NCT01667419|102259817|FG002|Overall Study|Death|25|||
33379813|NCT04410198|101272964|FG000|Overall Study|Kidney Transplant|9|||
33379814|NCT04410198|101272964|FG000|Overall Study|Adverse Event|4|||
33379815|NCT04410198|101272964|FG000|Overall Study|Physician Decision|2|||
33379816|NCT04410198|101272964|FG000|Overall Study|Other than specified|1|||
33379817|NCT00980343|101272965|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
33379818|NCT00980343|101272966|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
33379819|NCT02193828|101272967|FG000|Overall Study|Withdrawal by Subject|0|||
33379820|NCT02193828|101272968|FG001|Overall Study|Withdrawal by Subject|0|||
33379821|NCT02193828|101272969|FG002|Overall Study|Withdrawal by Subject|1|||
33379822|NCT02193828|101272970|FG003|Overall Study|Withdrawal by Subject|1|||
33379823|NCT03655717|101272971|FG000|Overall Study|Withdrawal by Subject|4|||
33379824|NCT03655717|101272972|FG001|Overall Study|Withdrawal by Subject|8|||
33379825|NCT03655717|101272973|FG002|Overall Study|Withdrawal by Subject|1|||
33379826|NCT03655717|101272974|FG003|Overall Study|Withdrawal by Subject|0|||
33379827|NCT03655717|101272975|FG004|Overall Study|Withdrawal by Subject|0|||
33379828|NCT03655717|101272976|FG005|Overall Study|Withdrawal by Subject|1|||
33379829|NCT03655717|101272977|FG006|Overall Study|Withdrawal by Subject|3|||
33379830|NCT03655717|101272978|FG007|Overall Study|Withdrawal by Subject|1|||
33379831|NCT03655717|101272979|FG008|Overall Study|Withdrawal by Subject|2|||
33379832|NCT03655717|101272980|FG009|Overall Study|Withdrawal by Subject|0|||
33379833|NCT03655717|101272981|FG010|Overall Study|Withdrawal by Subject|0|||
33379834|NCT03655717|101272982|FG011|Overall Study|Withdrawal by Subject|1|||
33379835|NCT03655717|101272983|FG012|Overall Study|Withdrawal by Subject|0|||
33379836|NCT03655717|101272984|FG013|Overall Study|Withdrawal by Subject|3|||
33379837|NCT03655717|101272985|FG014|Overall Study|Withdrawal by Subject|0|||
33379838|NCT03655717|101272986|FG015|Overall Study|Withdrawal by Subject|1|||
33379839|NCT03655717|101272987|FG016|Overall Study|Withdrawal by Subject|0|||
33379840|NCT03655717|101272988|FG017|Overall Study|Withdrawal by Subject|0|||
33379841|NCT03655717|101272989|FG018|Overall Study|Withdrawal by Subject|1|||
33379842|NCT03655717|101272990|FG019|Overall Study|Withdrawal by Subject|0|||
33379843|NCT03655717|101272991|FG020|Overall Study|Withdrawal by Subject|0|||
33379844|NCT03655717|101272992|FG021|Overall Study|Withdrawal by Subject|1|||
33379845|NCT03655717|101272993|FG022|Overall Study|Withdrawal by Subject|2|||
33379846|NCT03655717|101272994|FG023|Overall Study|Withdrawal by Subject|1|||
33379847|NCT03655717|101272995|FG024|Overall Study|Withdrawal by Subject|1|||
33647058|NCT01667419|102259818|FG003|Overall Study|Death|26|||
33379848|NCT03655717|101272996|FG025|Overall Study|Withdrawal by Subject|0|||
33379849|NCT03655717|101272971|FG000|Overall Study|Physician Decision|3|||
33379850|NCT03655717|101272972|FG001|Overall Study|Physician Decision|3|||
33379851|NCT03655717|101272973|FG002|Overall Study|Physician Decision|0|||
33379852|NCT03655717|101272974|FG003|Overall Study|Physician Decision|0|||
33647059|NCT04380519|102259820|FG000|Overall Study|Withdrawal by Subject|4|||
33647060|NCT04380519|102259821|FG001|Overall Study|Withdrawal by Subject|0|||
33647061|NCT04380519|102259822|FG002|Overall Study|Withdrawal by Subject|1|||
33647062|NCT04380519|102259820|FG000|Overall Study|Death|14|||
33647063|NCT04380519|102259821|FG001|Overall Study|Death|9|||
33379853|NCT03655717|101272975|FG004|Overall Study|Physician Decision|0|||
33379854|NCT03655717|101272976|FG005|Overall Study|Physician Decision|0|||
33379855|NCT03655717|101272977|FG006|Overall Study|Physician Decision|0|||
33647064|NCT04380519|102259822|FG002|Overall Study|Death|6|||
33379856|NCT03655717|101272978|FG007|Overall Study|Physician Decision|0|||
33379857|NCT03655717|101272979|FG008|Overall Study|Physician Decision|0|||
33379858|NCT03655717|101272980|FG009|Overall Study|Physician Decision|1|||
33379859|NCT03655717|101272981|FG010|Overall Study|Physician Decision|0|||
33379860|NCT03655717|101272982|FG011|Overall Study|Physician Decision|0|||
33379861|NCT03655717|101272983|FG012|Overall Study|Physician Decision|0|||
33379862|NCT03655717|101272984|FG013|Overall Study|Physician Decision|0|||
33379863|NCT03655717|101272985|FG014|Overall Study|Physician Decision|0|||
33379864|NCT03655717|101272986|FG015|Overall Study|Physician Decision|0|||
33379865|NCT03655717|101272987|FG016|Overall Study|Physician Decision|0|||
33379866|NCT03655717|101272988|FG017|Overall Study|Physician Decision|0|||
33379867|NCT03655717|101272989|FG018|Overall Study|Physician Decision|0|||
33379868|NCT03655717|101272990|FG019|Overall Study|Physician Decision|1|||
33379869|NCT03655717|101272991|FG020|Overall Study|Physician Decision|0|||
33379870|NCT03655717|101272992|FG021|Overall Study|Physician Decision|0|||
33379871|NCT03655717|101272993|FG022|Overall Study|Physician Decision|0|||
33379872|NCT03655717|101272994|FG023|Overall Study|Physician Decision|1|||
33379873|NCT03655717|101272995|FG024|Overall Study|Physician Decision|0|||
33379874|NCT03655717|101272996|FG025|Overall Study|Physician Decision|0|||
33379875|NCT03655717|101272971|FG000|Overall Study|Lost to Follow-up|3|||
33379876|NCT03655717|101272972|FG001|Overall Study|Lost to Follow-up|1|||
33379877|NCT03655717|101272973|FG002|Overall Study|Lost to Follow-up|0|||
33379878|NCT03655717|101272974|FG003|Overall Study|Lost to Follow-up|1|||
33379879|NCT03655717|101272975|FG004|Overall Study|Lost to Follow-up|0|||
33379880|NCT03655717|101272976|FG005|Overall Study|Lost to Follow-up|1|||
33379881|NCT03655717|101272977|FG006|Overall Study|Lost to Follow-up|0|||
33379882|NCT03655717|101272978|FG007|Overall Study|Lost to Follow-up|0|||
33379883|NCT03655717|101272979|FG008|Overall Study|Lost to Follow-up|0|||
33647065|NCT04380519|102259820|FG000|Overall Study|Adverse Event|0|||
33647066|NCT04380519|102259821|FG001|Overall Study|Adverse Event|1|||
33647067|NCT04380519|102259822|FG002|Overall Study|Adverse Event|0|||
33647068|NCT04380519|102259820|FG000|Overall Study|relatives' decision|0|||
33647069|NCT04380519|102259821|FG001|Overall Study|relatives' decision|1|||
33647070|NCT04380519|102259822|FG002|Overall Study|relatives' decision|0|||
33647071|NCT01808092|102259823|FG000|Overall Study|Death|39|||
33647072|NCT01808092|102259824|FG001|Overall Study|Death|29|||
33647073|NCT01808092|102259823|FG000|Overall Study|Lost to Follow-up|3|||
33647074|NCT01808092|102259824|FG001|Overall Study|Lost to Follow-up|7|||
33647075|NCT01808092|102259823|FG000|Overall Study|Withdrawal by Subject|9|||
33647076|NCT01808092|102259824|FG001|Overall Study|Withdrawal by Subject|4|||
33647077|NCT01808092|102259823|FG000|Overall Study|Other Eligibility criteria|3|||
33647078|NCT01808092|102259824|FG001|Overall Study|Other Eligibility criteria|5|||
33647079|NCT01485172|102259826|FG000|Overall Study|Adverse Event|2|||
33647080|NCT01485172|102259827|FG001|Overall Study|Adverse Event|1|||
33647081|NCT01485172|102259828|FG002|Overall Study|Adverse Event|2|||
33379884|NCT03655717|101272980|FG009|Overall Study|Lost to Follow-up|0|||
33379885|NCT03655717|101272981|FG010|Overall Study|Lost to Follow-up|0|||
33379886|NCT03655717|101272982|FG011|Overall Study|Lost to Follow-up|1|||
33379887|NCT03655717|101272983|FG012|Overall Study|Lost to Follow-up|0|||
33379888|NCT03655717|101272984|FG013|Overall Study|Lost to Follow-up|0|||
33379889|NCT03655717|101272985|FG014|Overall Study|Lost to Follow-up|0|||
33379890|NCT03655717|101272986|FG015|Overall Study|Lost to Follow-up|0|||
33379891|NCT03655717|101272987|FG016|Overall Study|Lost to Follow-up|0|||
33379892|NCT03655717|101272988|FG017|Overall Study|Lost to Follow-up|0|||
33587211|NCT03308968|102036528|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
33587212|NCT03308968|102036529|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
33587213|NCT03308968|102036527|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
33587214|NCT03308968|102036528|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
33587215|NCT03308968|102036529|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
33587216|NCT03308968|102036527|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
33587217|NCT03308968|102036528|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
33587218|NCT03308968|102036529|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
33587219|NCT03308968|102036527|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
33587220|NCT03308968|102036528|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
33587221|NCT03308968|102036529|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
33587222|NCT03308968|102036527|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
33647082|NCT01485172|102259829|FG003|Overall Study|Adverse Event|2|||
33379893|NCT03655717|101272989|FG018|Overall Study|Lost to Follow-up|0|||
33379894|NCT03655717|101272990|FG019|Overall Study|Lost to Follow-up|0|||
33379895|NCT03655717|101272991|FG020|Overall Study|Lost to Follow-up|0|||
33647083|NCT01485172|102259830|FG004|Overall Study|Adverse Event|1|||
33647084|NCT01485172|102259831|FG005|Overall Study|Adverse Event|2|||
33647085|NCT01485172|102259826|FG000|Overall Study|Lack of Efficacy|2|||
33647086|NCT01485172|102259827|FG001|Overall Study|Lack of Efficacy|0|||
33379896|NCT03655717|101272992|FG021|Overall Study|Lost to Follow-up|0|||
33379897|NCT03655717|101272993|FG022|Overall Study|Lost to Follow-up|0|||
33587223|NCT03308968|102036528|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
33587224|NCT03308968|102036529|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
33379898|NCT03655717|101272994|FG023|Overall Study|Lost to Follow-up|0|||
33379899|NCT03655717|101272995|FG024|Overall Study|Lost to Follow-up|0|||
33379900|NCT03655717|101272996|FG025|Overall Study|Lost to Follow-up|0|||
33379901|NCT01844830|101272997|FG000|Overall Study|Withdrawal by Subject|1|||
33379902|NCT01844830|101272998|FG001|Overall Study|Withdrawal by Subject|0|||
33379903|NCT03364335|101272999|FG000|Overall Study|Adverse Event|3|||
33379904|NCT03364335|101273000|FG001|Overall Study|Adverse Event|4|||
33647087|NCT01485172|102259828|FG002|Overall Study|Lack of Efficacy|0|||
33647088|NCT01485172|102259829|FG003|Overall Study|Lack of Efficacy|0|||
33647089|NCT01485172|102259830|FG004|Overall Study|Lack of Efficacy|0|||
33647090|NCT01485172|102259831|FG005|Overall Study|Lack of Efficacy|0|||
33647091|NCT01485172|102259826|FG000|Overall Study|Protocol Violation|0|||
33647092|NCT01485172|102259827|FG001|Overall Study|Protocol Violation|0|||
33647093|NCT01485172|102259828|FG002|Overall Study|Protocol Violation|4|||
33247959|NCT03982199|100810133|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
33247960|NCT03982199|100810134|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
33247961|NCT03982199|100810135|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
33247962|NCT03982199|100810136|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
33247963|NCT03982199|100810137|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
33425217|NCT01360632|101449537|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
33425218|NCT01360632|101449533|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
33425219|NCT01360632|101449534|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
33425220|NCT01360632|101449535|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
33425221|NCT01360632|101449536|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
33425222|NCT01360632|101449537|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
33425223|NCT01360632|101449533|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
33425224|NCT01360632|101449534|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
33425225|NCT01360632|101449535|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
33425226|NCT01360632|101449536|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
33425227|NCT01360632|101449537|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
33425228|NCT01360632|101449533|FG000|Phase A+|Lost to Follow-up|0|||
33425229|NCT01360632|101449534|FG001|Phase A+|Lost to Follow-up|0|||
33247964|NCT03982199|100810138|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
33247965|NCT03982199|100810139|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
33247966|NCT03982199|100810140|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
33247967|NCT03982199|100810141|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
33247968|NCT03982199|100810142|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
33247969|NCT03982199|100810129|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
33247970|NCT03982199|100810130|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
33247971|NCT03982199|100810131|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
33247972|NCT03982199|100810132|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
33247973|NCT03982199|100810133|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
33247974|NCT03982199|100810134|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
33247975|NCT03982199|100810135|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
33247976|NCT03982199|100810136|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
33247977|NCT03982199|100810137|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
33247978|NCT03982199|100810138|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
33247979|NCT03982199|100810139|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
33247980|NCT03982199|100810140|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
33247981|NCT03982199|100810141|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
33247982|NCT03982199|100810142|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
33247983|NCT03982199|100810129|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
33247984|NCT03982199|100810130|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
33247985|NCT03982199|100810131|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
33247986|NCT03982199|100810132|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
33247987|NCT03982199|100810133|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
33247988|NCT03982199|100810134|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
33247989|NCT03982199|100810135|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
33247990|NCT03982199|100810136|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
33247991|NCT03982199|100810137|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
33247992|NCT03982199|100810138|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
33247993|NCT03982199|100810139|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
33379905|NCT03364335|101273001|FG002|Overall Study|Adverse Event|1|||
33379906|NCT03364335|101273002|FG003|Overall Study|Adverse Event|2|||
33379907|NCT03364335|101273003|FG004|Overall Study|Adverse Event|0|||
33379908|NCT03364335|101272999|FG000|Overall Study|Lost to Follow-up|7|||
33425230|NCT01360632|101449535|FG002|Phase A+|Lost to Follow-up|0|||
33425231|NCT01360632|101449536|FG003|Phase A+|Lost to Follow-up|0|||
33647094|NCT01485172|102259829|FG003|Overall Study|Protocol Violation|5|||
33647095|NCT01485172|102259830|FG004|Overall Study|Protocol Violation|1|||
33379909|NCT03364335|101273000|FG001|Overall Study|Lost to Follow-up|7|||
33379910|NCT03364335|101273001|FG002|Overall Study|Lost to Follow-up|10|||
33379911|NCT03364335|101273002|FG003|Overall Study|Lost to Follow-up|11|||
33379912|NCT03364335|101273003|FG004|Overall Study|Lost to Follow-up|11|||
33379913|NCT02157506|101273004|FG000|Overall Study|Adverse Event|0|||
33379914|NCT02157506|101273005|FG001|Overall Study|Adverse Event|1|||
33379915|NCT02157506|101273006|FG002|Overall Study|Adverse Event|0|||
33379916|NCT02157506|101273007|FG003|Overall Study|Adverse Event|0|||
33379917|NCT02157506|101273008|FG004|Overall Study|Adverse Event|0|||
33379918|NCT02157506|101273004|FG000|Overall Study|Lost to Follow-up|0|||
33379919|NCT02157506|101273005|FG001|Overall Study|Lost to Follow-up|0|||
33379920|NCT02157506|101273006|FG002|Overall Study|Lost to Follow-up|1|||
33379921|NCT02157506|101273007|FG003|Overall Study|Lost to Follow-up|0|||
33379922|NCT02157506|101273008|FG004|Overall Study|Lost to Follow-up|0|||
33379923|NCT00594204|101273009|FG000|Overall Study|Adverse Event|15|||
33379924|NCT00594204|101273010|FG001|Overall Study|Adverse Event|3|||
33379925|NCT00594204|101273009|FG000|Overall Study|Lost to Follow-up|9|||
33379926|NCT00594204|101273010|FG001|Overall Study|Lost to Follow-up|5|||
33379927|NCT00594204|101273009|FG000|Overall Study|Withdrawal by Subject|23|||
33379928|NCT00594204|101273010|FG001|Overall Study|Withdrawal by Subject|29|||
33379929|NCT00594204|101273009|FG000|Overall Study|Other|4|||
33379930|NCT00594204|101273010|FG001|Overall Study|Other|3|||
33379931|NCT00594204|101273009|FG000|Overall Study|Lack of Efficacy|3|||
33379932|NCT00594204|101273010|FG001|Overall Study|Lack of Efficacy|4|||
33379933|NCT00594204|101273009|FG000|Overall Study|Randomized but not treated|4|||
33379934|NCT00594204|101273010|FG001|Overall Study|Randomized but not treated|1|||
33379935|NCT03004469|101273011|FG000|Overall Study|Adverse Event|6|||
33379936|NCT03004469|101273012|FG001|Overall Study|Adverse Event|4|||
33379937|NCT03004469|101273013|FG002|Overall Study|Adverse Event|6|||
33647096|NCT01485172|102259831|FG005|Overall Study|Protocol Violation|0|||
33647097|NCT01485172|102259826|FG000|Overall Study|Protocol defined stopping criteria|1|||
33647098|NCT01485172|102259827|FG001|Overall Study|Protocol defined stopping criteria|0|||
33647099|NCT01485172|102259828|FG002|Overall Study|Protocol defined stopping criteria|0|||
33647100|NCT01485172|102259829|FG003|Overall Study|Protocol defined stopping criteria|0|||
33647101|NCT01485172|102259830|FG004|Overall Study|Protocol defined stopping criteria|1|||
33647102|NCT01485172|102259831|FG005|Overall Study|Protocol defined stopping criteria|0|||
33647103|NCT01485172|102259826|FG000|Overall Study|Lost to Follow-up|0|||
33647104|NCT01485172|102259827|FG001|Overall Study|Lost to Follow-up|0|||
33647105|NCT01485172|102259828|FG002|Overall Study|Lost to Follow-up|1|||
33647106|NCT01485172|102259829|FG003|Overall Study|Lost to Follow-up|0|||
33647107|NCT01485172|102259830|FG004|Overall Study|Lost to Follow-up|0|||
33647108|NCT01485172|102259831|FG005|Overall Study|Lost to Follow-up|1|||
33647109|NCT01485172|102259826|FG000|Overall Study|Physician Decision|0|||
33647110|NCT01485172|102259827|FG001|Overall Study|Physician Decision|0|||
33647111|NCT01485172|102259828|FG002|Overall Study|Physician Decision|0|||
33647112|NCT01485172|102259829|FG003|Overall Study|Physician Decision|0|||
33647113|NCT01485172|102259830|FG004|Overall Study|Physician Decision|1|||
33647114|NCT01485172|102259831|FG005|Overall Study|Physician Decision|0|||
33647115|NCT01485172|102259826|FG000|Overall Study|Withdrawal by Subject|2|||
33647116|NCT01485172|102259827|FG001|Overall Study|Withdrawal by Subject|0|||
33647117|NCT01485172|102259828|FG002|Overall Study|Withdrawal by Subject|0|||
33647118|NCT01485172|102259829|FG003|Overall Study|Withdrawal by Subject|1|||
33647119|NCT01485172|102259830|FG004|Overall Study|Withdrawal by Subject|1|||
33647120|NCT01485172|102259831|FG005|Overall Study|Withdrawal by Subject|1|||
33647121|NCT03288142|102259832|FG000|Overall Study|Lost to Follow-up|22|||
33647122|NCT03288142|102259833|FG001|Overall Study|Lost to Follow-up|15|||
33647123|NCT00476008|102259834|FG000|Overall Study|Adverse Event|4|||
33647124|NCT00476008|102259835|FG001|Overall Study|Adverse Event|4|||
33647125|NCT00476008|102259834|FG000|Overall Study|Placebo concerns|2|||
33647126|NCT00476008|102259835|FG001|Overall Study|Placebo concerns|2|||
33647127|NCT00476008|102259834|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
33647128|NCT00476008|102259835|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
33647129|NCT00476008|102259834|FG000|Overall Study|Withdrawal by Subject|0|||
33647130|NCT00476008|102259835|FG001|Overall Study|Withdrawal by Subject|1|||
33647131|NCT00476008|102259834|FG000|Overall Study|Death|1|||
33647132|NCT00476008|102259835|FG001|Overall Study|Death|0|||
33149118|NCT02319837|100460673|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
33647133|NCT00502203|102259838|FG000|Overall Study|Inevaluable|1|||
33379938|NCT03004469|101273011|FG000|Overall Study|Lack of Efficacy|1|||
33647134|NCT02873429|102259844|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
33647135|NCT02873429|102259845|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
33647136|NCT02873429|102259844|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
33647137|NCT02873429|102259845|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
33647138|NCT02873429|102259844|FG000|16 Weeks|Lost to Follow-up|3|||
33379939|NCT03004469|101273012|FG001|Overall Study|Lack of Efficacy|0|||
33379940|NCT03004469|101273013|FG002|Overall Study|Lack of Efficacy|1|||
33379941|NCT03004469|101273011|FG000|Overall Study|Lost to Follow-up|23|||
33379942|NCT03004469|101273012|FG001|Overall Study|Lost to Follow-up|14|||
33379943|NCT03004469|101273013|FG002|Overall Study|Lost to Follow-up|6|||
33379944|NCT03004469|101273011|FG000|Overall Study|Non-Compliance with Study Drug|2|||
33379945|NCT03004469|101273012|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33379946|NCT03004469|101273013|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33379947|NCT03004469|101273011|FG000|Overall Study|Protocol Violation|0|||
33379948|NCT03004469|101273012|FG001|Overall Study|Protocol Violation|0|||
33379949|NCT03004469|101273013|FG002|Overall Study|Protocol Violation|1|||
33379950|NCT03004469|101273011|FG000|Overall Study|Withdrawal by Subject|29|||
33379951|NCT03004469|101273012|FG001|Overall Study|Withdrawal by Subject|27|||
33379952|NCT03004469|101273013|FG002|Overall Study|Withdrawal by Subject|10|||
33379953|NCT03004469|101273011|FG000|Overall Study|Other unspecified reason|0|||
33379954|NCT03004469|101273012|FG001|Overall Study|Other unspecified reason|4|||
33379955|NCT03004469|101273013|FG002|Overall Study|Other unspecified reason|1|||
33379956|NCT03303092|101273016|FG000|Overall Study|Adverse Event|1|||
33379957|NCT03303092|101273017|FG001|Overall Study|Adverse Event|0|||
33379958|NCT03303092|101273018|FG002|Overall Study|Adverse Event|1|||
33379959|NCT03303092|101273016|FG000|Overall Study|Protocol Violation|1|||
33379960|NCT03303092|101273017|FG001|Overall Study|Protocol Violation|5|||
33379961|NCT03303092|101273018|FG002|Overall Study|Protocol Violation|1|||
33379962|NCT03303092|101273016|FG000|Overall Study|Withdrawal by Subject|1|||
33379963|NCT03303092|101273017|FG001|Overall Study|Withdrawal by Subject|1|||
33379964|NCT03303092|101273018|FG002|Overall Study|Withdrawal by Subject|3|||
33379965|NCT00349752|101273019|FG000|Overall Study|Adverse Event|8|||
33379966|NCT00349752|101273020|FG001|Overall Study|Adverse Event|12|||
33379967|NCT00349752|101273019|FG000|Overall Study|Lack of Efficacy|37|||
33379968|NCT00349752|101273020|FG001|Overall Study|Lack of Efficacy|42|||
33379969|NCT00349752|101273019|FG000|Overall Study|Lost to Follow-up|4|||
33379970|NCT00349752|101273020|FG001|Overall Study|Lost to Follow-up|2|||
33379971|NCT00349752|101273019|FG000|Overall Study|Personal reasons|6|||
33379972|NCT00349752|101273020|FG001|Overall Study|Personal reasons|5|||
33379973|NCT00349752|101273019|FG000|Overall Study|Other: Required exclusionary medication|0|||
33379974|NCT00349752|101273020|FG001|Overall Study|Other: Required exclusionary medication|1|||
33379975|NCT00349752|101273019|FG000|Overall Study|Other: Non compliance|0|||
33379976|NCT00349752|101273020|FG001|Overall Study|Other: Non compliance|1|||
33379977|NCT00349752|101273019|FG000|Overall Study|Other: Patient stopped steroids|0|||
33647139|NCT02873429|102259845|FG001|16 Weeks|Lost to Follow-up|0|||
33647140|NCT00647270|102259846|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
33647141|NCT00647270|102259847|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
33647142|NCT00647270|102259848|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
33647143|NCT00647270|102259846|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
33647144|NCT00647270|102259847|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
33647145|NCT00647270|102259848|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
33647146|NCT00647270|102259846|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
33647147|NCT00647270|102259847|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
33647148|NCT00647270|102259848|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
33647149|NCT00647270|102259846|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
33647150|NCT00647270|102259847|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
33647151|NCT00647270|102259848|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
33647152|NCT00647270|102259846|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
33647153|NCT00647270|102259847|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
33647154|NCT00647270|102259848|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
33647155|NCT00647270|102259846|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
33647156|NCT00647270|102259847|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
33647157|NCT00647270|102259848|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
33647158|NCT00647270|102259846|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
33647159|NCT00647270|102259847|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
33647160|NCT00647270|102259848|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
33647161|NCT01433289|102259849|FG000|Overall Study|Pregnancy|0|||
33647162|NCT01433289|102259850|FG001|Overall Study|Pregnancy|1|||
33647163|NCT01433289|102259851|FG002|Overall Study|Pregnancy|0|||
33647164|NCT01433289|102259852|FG003|Overall Study|Pregnancy|0|||
33647165|NCT01008423|102259853|FG000|Overall Study|Adverse Event|13|||
33647166|NCT01008423|102259854|FG001|Overall Study|Adverse Event|6|||
33647167|NCT01008423|102259853|FG000|Overall Study|Withdrawal by Subject|4|||
33647168|NCT01008423|102259854|FG001|Overall Study|Withdrawal by Subject|7|||
33647169|NCT01008423|102259853|FG000|Overall Study|Lost to Follow-up|0|||
33647170|NCT01008423|102259854|FG001|Overall Study|Lost to Follow-up|2|||
33647171|NCT01008423|102259853|FG000|Overall Study|Low Cortisol|0|||
33647172|NCT01008423|102259854|FG001|Overall Study|Low Cortisol|1|||
33379978|NCT00349752|101273020|FG001|Overall Study|Other: Patient stopped steroids|1|||
33379979|NCT00349752|101273019|FG000|Overall Study|Other: Patient's steroid use|1|||
33379980|NCT00349752|101273020|FG001|Overall Study|Other: Patient's steroid use|0|||
33379981|NCT00349752|101273019|FG000|Overall Study|Other: Ineligible|1|||
33379982|NCT00349752|101273020|FG001|Overall Study|Other: Ineligible|0|||
33379983|NCT00349752|101273019|FG000|Overall Study|Other: Inadvertently unblinded|1|||
33379984|NCT00349752|101273020|FG001|Overall Study|Other: Inadvertently unblinded|0|||
33379985|NCT00349752|101273019|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
33379986|NCT00349752|101273020|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
33379987|NCT02716194|101273031|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
33379988|NCT02716194|101273032|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
33379989|NCT02716194|101273033|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
33379990|NCT02670330|101273034|FG000|Overall Study|Protocol Deviation|1|||
33379991|NCT02670330|101273035|FG001|Overall Study|Protocol Deviation|0|||
33379992|NCT02670330|101273034|FG000|Overall Study|Study Terminated By Sponsor|36|||
33379993|NCT02670330|101273035|FG001|Overall Study|Study Terminated By Sponsor|43|||
33379994|NCT02670330|101273034|FG000|Overall Study|Adverse Event|1|||
33379995|NCT02670330|101273035|FG001|Overall Study|Adverse Event|3|||
33379996|NCT02670330|101273034|FG000|Overall Study|Withdrawal by Subject|34|||
33379997|NCT02670330|101273035|FG001|Overall Study|Withdrawal by Subject|29|||
33379998|NCT02670330|101273034|FG000|Overall Study|Lost to Follow-up|3|||
33379999|NCT02670330|101273035|FG001|Overall Study|Lost to Follow-up|2|||
33380000|NCT00507416|101273036|FG000|Overall Study|Adverse Event|58|||
33380001|NCT00507416|101273037|FG001|Overall Study|Adverse Event|67|||
33380002|NCT00507416|101273038|FG002|Overall Study|Adverse Event|65|||
33380003|NCT00507416|101273036|FG000|Overall Study|Protocol Violation|1|||
33380004|NCT00507416|101273037|FG001|Overall Study|Protocol Violation|2|||
33380005|NCT00507416|101273038|FG002|Overall Study|Protocol Violation|0|||
33380006|NCT00507416|101273036|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
33380007|NCT00507416|101273037|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
33380008|NCT00507416|101273038|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
33380009|NCT00507416|101273036|FG000|Overall Study|Progressive Disease|20|||
33380010|NCT00507416|101273037|FG001|Overall Study|Progressive Disease|10|||
33380011|NCT00507416|101273038|FG002|Overall Study|Progressive Disease|13|||
33380012|NCT00507416|101273036|FG000|Overall Study|Patient declined further treatment|18|||
33380013|NCT00507416|101273037|FG001|Overall Study|Patient declined further treatment|14|||
33380014|NCT00507416|101273038|FG002|Overall Study|Patient declined further treatment|11|||
33380015|NCT00507416|101273036|FG000|Overall Study|Other|11|||
33380016|NCT00507416|101273037|FG001|Overall Study|Other|16|||
33380017|NCT00507416|101273038|FG002|Overall Study|Other|13|||
33380018|NCT00507416|101273036|FG000|Overall Study|Did not Receive Study Treatment|3|||
33380019|NCT00507416|101273037|FG001|Overall Study|Did not Receive Study Treatment|9|||
33380020|NCT00507416|101273038|FG002|Overall Study|Did not Receive Study Treatment|4|||
33380021|NCT01958125|101273039|FG000|Overall Study|Missing diary data|2|||
33380022|NCT01958125|101273040|FG001|Overall Study|Missing diary data|6|||
33380023|NCT01958125|101273039|FG000|Overall Study|No headache attacks|0|||
33380024|NCT01958125|101273040|FG001|Overall Study|No headache attacks|2|||
33380025|NCT01529385|101273041|FG000|Overall Study|Lost to Follow-up|2|||
33380026|NCT01529385|101273042|FG001|Overall Study|Lost to Follow-up|1|||
33380027|NCT02062463|101276570|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
33380028|NCT02062463|101276571|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
33380029|NCT02062463|101276572|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
33380030|NCT02062463|101276573|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
33380031|NCT02062463|101276570|FG000|Stage 2|Adverse Event|0|||
33380032|NCT02062463|101276571|FG001|Stage 2|Adverse Event|0|||
33380033|NCT02062463|101276572|FG002|Stage 2|Adverse Event|12|||
33380034|NCT02062463|101276573|FG003|Stage 2|Adverse Event|20|||
33380035|NCT02062463|101276570|FG000|Stage 2|Lack of Efficacy|0|||
33380036|NCT02062463|101276571|FG001|Stage 2|Lack of Efficacy|0|||
33380037|NCT02062463|101276572|FG002|Stage 2|Lack of Efficacy|3|||
33380038|NCT02062463|101276573|FG003|Stage 2|Lack of Efficacy|4|||
33380039|NCT02062463|101276570|FG000|Stage 2|Lost to Follow-up|0|||
33380040|NCT02062463|101276571|FG001|Stage 2|Lost to Follow-up|0|||
33380041|NCT02062463|101276572|FG002|Stage 2|Lost to Follow-up|20|||
33425232|NCT01360632|101449537|FG004|Phase A+|Lost to Follow-up|2|||
33149119|NCT02319837|100460674|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
33380042|NCT02062463|101276573|FG003|Stage 2|Lost to Follow-up|20|||
33380043|NCT02062463|101276570|FG000|Stage 2|Non-Compliance|0|||
33380044|NCT02062463|101276571|FG001|Stage 2|Non-Compliance|0|||
33380045|NCT02062463|101276572|FG002|Stage 2|Non-Compliance|0|||
33380046|NCT02062463|101276573|FG003|Stage 2|Non-Compliance|1|||
33380047|NCT02062463|101276570|FG000|Stage 2|Other than specified|0|||
33380048|NCT02062463|101276571|FG001|Stage 2|Other than specified|0|||
33380049|NCT02062463|101276572|FG002|Stage 2|Other than specified|3|||
33380050|NCT02062463|101276573|FG003|Stage 2|Other than specified|1|||
33380051|NCT02062463|101276570|FG000|Stage 2|Withdrawal by Subject|0|||
33380052|NCT02062463|101276571|FG001|Stage 2|Withdrawal by Subject|0|||
33380053|NCT02062463|101276572|FG002|Stage 2|Withdrawal by Subject|15|||
33425233|NCT01360632|101449533|FG000|Phase A+|Adverse Event|0|||
33425234|NCT01360632|101449534|FG001|Phase A+|Adverse Event|0|||
33425235|NCT01360632|101449535|FG002|Phase A+|Adverse Event|0|||
33380054|NCT02062463|101276573|FG003|Stage 2|Withdrawal by Subject|10|||
33380055|NCT01586806|101276574|FG000|Overall Study|Protocol Violation|0|||
33380056|NCT01586806|101276575|FG001|Overall Study|Protocol Violation|1|||
33380057|NCT01586806|101276576|FG002|Overall Study|Protocol Violation|0|||
33380058|NCT01586806|101276574|FG000|Overall Study|Withdrawal by Subject|1|||
33380059|NCT01586806|101276575|FG001|Overall Study|Withdrawal by Subject|0|||
33380060|NCT01586806|101276576|FG002|Overall Study|Withdrawal by Subject|0|||
33380061|NCT01586806|101276574|FG000|Overall Study|Lost to Follow-up|2|||
33380062|NCT01586806|101276575|FG001|Overall Study|Lost to Follow-up|3|||
33380063|NCT01586806|101276576|FG002|Overall Study|Lost to Follow-up|2|||
33380064|NCT03067129|101276577|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
33380065|NCT03067129|101276578|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
33380066|NCT03067129|101276579|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
33380067|NCT03067129|101276580|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
33380068|NCT03067129|101276577|FG000|Overall Study|Withdrawal by Subject|0|||
33380069|NCT03067129|101276578|FG001|Overall Study|Withdrawal by Subject|0|||
33380070|NCT03067129|101276579|FG002|Overall Study|Withdrawal by Subject|1|||
33380071|NCT03067129|101276580|FG003|Overall Study|Withdrawal by Subject|2|||
33380072|NCT03067129|101276577|FG000|Overall Study|Lost to Follow-up|5|||
33380073|NCT03067129|101276578|FG001|Overall Study|Lost to Follow-up|5|||
33380074|NCT03067129|101276579|FG002|Overall Study|Lost to Follow-up|4|||
33380075|NCT03067129|101276580|FG003|Overall Study|Lost to Follow-up|3|||
33380076|NCT00205699|101276583|FG000|Overall Study|Lost to Follow-up|1|||
33380077|NCT00205699|101276584|FG001|Overall Study|Lost to Follow-up|3|||
33380078|NCT00205699|101276585|FG002|Overall Study|Lost to Follow-up|5|||
33380079|NCT00205699|101276583|FG000|Overall Study|Adverse Event|1|||
33380080|NCT00205699|101276584|FG001|Overall Study|Adverse Event|0|||
33380081|NCT00205699|101276585|FG002|Overall Study|Adverse Event|0|||
33380082|NCT00205699|101276583|FG000|Overall Study|Withdrawal by Subject|1|||
33380083|NCT00205699|101276584|FG001|Overall Study|Withdrawal by Subject|2|||
33380084|NCT00205699|101276585|FG002|Overall Study|Withdrawal by Subject|1|||
33380085|NCT00205699|101276583|FG000|Overall Study|Lack of Efficacy|0|||
33380086|NCT00205699|101276584|FG001|Overall Study|Lack of Efficacy|1|||
33380087|NCT00205699|101276585|FG002|Overall Study|Lack of Efficacy|0|||
33380088|NCT00067470|101276587|FG000|Overall Study|Withdrawal by Subject|0|||
33380089|NCT00067470|101276588|FG001|Overall Study|Withdrawal by Subject|1|||
33380090|NCT04169061|101276589|FG000|Overall Study|Adverse Event|2|||
33380091|NCT04169061|101276589|FG000|Overall Study|Death|1|||
33380092|NCT04169061|101276589|FG000|Overall Study|Withdrawal by Subject|1|||
33380093|NCT04169061|101276589|FG000|Overall Study|Protocol Violation|1|||
33380094|NCT00192036|101276590|FG000|Overall Study|Protocol Violation|3|||
33380095|NCT00192036|101276590|FG000|Overall Study|Adverse Event|6|||
33380096|NCT00192036|101276590|FG000|Overall Study|Patient/Physician Perception|1|||
33380097|NCT00192036|101276590|FG000|Overall Study|Objective Tumor Progression|4|||
33380098|NCT00192036|101276590|FG000|Overall Study|Clinical Disease Progression|1|||
33380099|NCT00192036|101276590|FG000|Overall Study|Death|1|||
33380100|NCT00192036|101276590|FG000|Overall Study|Unknown or Not Specified|5|||
33380101|NCT02701192|101276591|FG000|Overall Study|Protocol Violation|2|||
33380102|NCT02701192|101276591|FG000|Overall Study|Lost to Follow-up|4|||
33380103|NCT01763866|101276592|FG000|Overall Study|Withdrawal by Subject|2|||
33380104|NCT01763866|101276593|FG001|Overall Study|Withdrawal by Subject|1|||
33380105|NCT01763866|101276594|FG002|Overall Study|Withdrawal by Subject|4|||
33380106|NCT01763866|101276595|FG003|Overall Study|Withdrawal by Subject|0|||
33380107|NCT01763866|101276596|FG004|Overall Study|Withdrawal by Subject|0|||
33380108|NCT01763866|101276597|FG005|Overall Study|Withdrawal by Subject|3|||
33380109|NCT01763866|101276598|FG006|Overall Study|Withdrawal by Subject|4|||
33380110|NCT01763866|101276599|FG007|Overall Study|Withdrawal by Subject|0|||
33425236|NCT01360632|101449536|FG003|Phase A+|Adverse Event|0|||
33425237|NCT01360632|101449537|FG004|Phase A+|Adverse Event|2|||
33425238|NCT01360632|101449533|FG000|Phase A+|Met Withdrawal Criteria|0|||
33425239|NCT01360632|101449534|FG001|Phase A+|Met Withdrawal Criteria|0|||
33380111|NCT01763866|101276600|FG008|Overall Study|Withdrawal by Subject|1|||
33380112|NCT01763866|101276601|FG009|Overall Study|Withdrawal by Subject|1|||
33380113|NCT01763866|101276602|FG010|Overall Study|Withdrawal by Subject|2|||
33380114|NCT01763866|101276603|FG011|Overall Study|Withdrawal by Subject|2|||
33380115|NCT01763866|101276604|FG012|Overall Study|Withdrawal by Subject|2|||
33380116|NCT01763866|101276605|FG013|Overall Study|Withdrawal by Subject|0|||
33380117|NCT01763866|101276606|FG014|Overall Study|Withdrawal by Subject|6|||
33380118|NCT01763866|101276607|FG015|Overall Study|Withdrawal by Subject|3|||
33380119|NCT01763866|101276608|FG016|Overall Study|Withdrawal by Subject|0|||
33425240|NCT01360632|101449535|FG002|Phase A+|Met Withdrawal Criteria|0|||
33380120|NCT01763866|101276609|FG017|Overall Study|Withdrawal by Subject|1|||
33380121|NCT01763866|101276610|FG018|Overall Study|Withdrawal by Subject|1|||
33380122|NCT01763866|101276611|FG019|Overall Study|Withdrawal by Subject|1|||
33380123|NCT01763866|101276612|FG020|Overall Study|Withdrawal by Subject|2|||
33380124|NCT01763866|101276613|FG021|Overall Study|Withdrawal by Subject|1|||
33380125|NCT01763866|101276614|FG022|Overall Study|Withdrawal by Subject|2|||
33380126|NCT01763866|101276615|FG023|Overall Study|Withdrawal by Subject|1|||
33425241|NCT01360632|101449536|FG003|Phase A+|Met Withdrawal Criteria|0|||
33380127|NCT01763866|101276592|FG000|Overall Study|Decision by sponsor|0|||
33380128|NCT01763866|101276593|FG001|Overall Study|Decision by sponsor|0|||
33380129|NCT01763866|101276594|FG002|Overall Study|Decision by sponsor|1|||
33380130|NCT01763866|101276595|FG003|Overall Study|Decision by sponsor|0|||
33380131|NCT01763866|101276596|FG004|Overall Study|Decision by sponsor|2|||
33380132|NCT01763866|101276597|FG005|Overall Study|Decision by sponsor|0|||
33380133|NCT01763866|101276598|FG006|Overall Study|Decision by sponsor|2|||
33647173|NCT01008423|102259853|FG000|Overall Study|Lack of Efficacy|0|||
33647174|NCT01008423|102259854|FG001|Overall Study|Lack of Efficacy|5|||
33647175|NCT01008423|102259853|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
33647176|NCT01008423|102259854|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
33647177|NCT01008423|102259853|FG000|Overall Study|Personal Conflict|1|||
33647178|NCT01008423|102259854|FG001|Overall Study|Personal Conflict|0|||
33380134|NCT01763866|101276599|FG007|Overall Study|Decision by sponsor|0|||
33380135|NCT01763866|101276600|FG008|Overall Study|Decision by sponsor|2|||
33380136|NCT01763866|101276601|FG009|Overall Study|Decision by sponsor|0|||
33380137|NCT01763866|101276602|FG010|Overall Study|Decision by sponsor|6|||
33380138|NCT01763866|101276603|FG011|Overall Study|Decision by sponsor|0|||
33380139|NCT01763866|101276604|FG012|Overall Study|Decision by sponsor|1|||
33380140|NCT01763866|101276605|FG013|Overall Study|Decision by sponsor|0|||
33380141|NCT01763866|101276606|FG014|Overall Study|Decision by sponsor|5|||
33380142|NCT01763866|101276607|FG015|Overall Study|Decision by sponsor|0|||
33380143|NCT01763866|101276608|FG016|Overall Study|Decision by sponsor|0|||
33380144|NCT01763866|101276609|FG017|Overall Study|Decision by sponsor|0|||
33380145|NCT01763866|101276610|FG018|Overall Study|Decision by sponsor|4|||
33380146|NCT01763866|101276611|FG019|Overall Study|Decision by sponsor|0|||
33380147|NCT01763866|101276612|FG020|Overall Study|Decision by sponsor|2|||
33380148|NCT01763866|101276613|FG021|Overall Study|Decision by sponsor|0|||
33380149|NCT01763866|101276614|FG022|Overall Study|Decision by sponsor|1|||
33380150|NCT01763866|101276615|FG023|Overall Study|Decision by sponsor|0|||
33380151|NCT01763866|101276592|FG000|Overall Study|Lost to Follow-up|0|||
33380152|NCT01763866|101276593|FG001|Overall Study|Lost to Follow-up|0|||
33380153|NCT01763866|101276594|FG002|Overall Study|Lost to Follow-up|0|||
33380154|NCT01763866|101276595|FG003|Overall Study|Lost to Follow-up|0|||
33380155|NCT01763866|101276596|FG004|Overall Study|Lost to Follow-up|0|||
33380156|NCT01763866|101276597|FG005|Overall Study|Lost to Follow-up|0|||
33380157|NCT01763866|101276598|FG006|Overall Study|Lost to Follow-up|1|||
33380158|NCT01763866|101276599|FG007|Overall Study|Lost to Follow-up|0|||
33380159|NCT01763866|101276600|FG008|Overall Study|Lost to Follow-up|0|||
33380160|NCT01763866|101276601|FG009|Overall Study|Lost to Follow-up|0|||
33380161|NCT01763866|101276602|FG010|Overall Study|Lost to Follow-up|0|||
33380162|NCT01763866|101276603|FG011|Overall Study|Lost to Follow-up|0|||
33380163|NCT01763866|101276604|FG012|Overall Study|Lost to Follow-up|1|||
33380164|NCT01763866|101276605|FG013|Overall Study|Lost to Follow-up|0|||
33380165|NCT01763866|101276606|FG014|Overall Study|Lost to Follow-up|1|||
33380166|NCT01763866|101276607|FG015|Overall Study|Lost to Follow-up|0|||
33380167|NCT01763866|101276608|FG016|Overall Study|Lost to Follow-up|0|||
33380168|NCT01763866|101276609|FG017|Overall Study|Lost to Follow-up|0|||
33380169|NCT01763866|101276610|FG018|Overall Study|Lost to Follow-up|1|||
33380170|NCT01763866|101276611|FG019|Overall Study|Lost to Follow-up|1|||
33425242|NCT01360632|101449537|FG004|Phase A+|Met Withdrawal Criteria|7|||
33425243|NCT01360632|101449533|FG000|Phase A+|Physician Decision|0|||
33425244|NCT01360632|101449534|FG001|Phase A+|Physician Decision|0|||
33425245|NCT01360632|101449535|FG002|Phase A+|Physician Decision|0|||
33425246|NCT01360632|101449536|FG003|Phase A+|Physician Decision|0|||
33425247|NCT01360632|101449537|FG004|Phase A+|Physician Decision|3|||
33425248|NCT01360632|101449533|FG000|Phase A+|Withdrawal by Subject|0|||
33425249|NCT01360632|101449534|FG001|Phase A+|Withdrawal by Subject|0|||
33425250|NCT01360632|101449535|FG002|Phase A+|Withdrawal by Subject|0|||
33425251|NCT01360632|101449536|FG003|Phase A+|Withdrawal by Subject|0|||
33425252|NCT01360632|101449537|FG004|Phase A+|Withdrawal by Subject|8|||
33425253|NCT01360632|101449533|FG000|Phase A+|Protocol Deviation|0|||
33425254|NCT01360632|101449534|FG001|Phase A+|Protocol Deviation|0|||
33425255|NCT01360632|101449535|FG002|Phase A+|Protocol Deviation|0|||
33425256|NCT01360632|101449536|FG003|Phase A+|Protocol Deviation|0|||
33425257|NCT01360632|101449537|FG004|Phase A+|Protocol Deviation|3|||
33647179|NCT01008423|102259853|FG000|Overall Study|Other|0|||
33647180|NCT01008423|102259854|FG001|Overall Study|Other|1|||
33149120|NCT02319837|100460672|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
33380171|NCT01763866|101276612|FG020|Overall Study|Lost to Follow-up|0|||
33380172|NCT01763866|101276613|FG021|Overall Study|Lost to Follow-up|0|||
33380173|NCT01763866|101276614|FG022|Overall Study|Lost to Follow-up|0|||
33380174|NCT01763866|101276615|FG023|Overall Study|Lost to Follow-up|1|||
33380175|NCT01763866|101276592|FG000|Overall Study|Death|0|||
33380176|NCT01763866|101276593|FG001|Overall Study|Death|0|||
33380177|NCT01763866|101276594|FG002|Overall Study|Death|0|||
33380178|NCT01763866|101276595|FG003|Overall Study|Death|0|||
33380179|NCT01763866|101276596|FG004|Overall Study|Death|0|||
33380180|NCT01763866|101276597|FG005|Overall Study|Death|0|||
33380181|NCT01763866|101276598|FG006|Overall Study|Death|0|||
33425258|NCT01086215|101449541|FG000|Overall Study|Death|14|||
33425259|NCT01086215|101449542|FG001|Overall Study|Death|8|||
33425260|NCT01086215|101449543|FG002|Overall Study|Death|8|||
33425261|NCT01086215|101449544|FG003|Overall Study|Death|1|||
33425262|NCT01086215|101449541|FG000|Overall Study|Lost to Follow-up|22|||
33425263|NCT01086215|101449542|FG001|Overall Study|Lost to Follow-up|39|||
33425264|NCT01086215|101449543|FG002|Overall Study|Lost to Follow-up|18|||
33425265|NCT01086215|101449544|FG003|Overall Study|Lost to Follow-up|2|||
33425266|NCT00409578|101449550|FG000|Overall Study|Adverse Event|27|||
33425267|NCT00409578|101449551|FG001|Overall Study|Adverse Event|37|||
33425268|NCT00409578|101449552|FG002|Overall Study|Adverse Event|25|||
33587225|NCT03308968|102036527|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
33587226|NCT03308968|102036528|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
33587227|NCT03308968|102036529|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
33587228|NCT03308968|102036527|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
33587229|NCT03308968|102036528|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
33587230|NCT03308968|102036529|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
33149121|NCT02319837|100460673|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
33149122|NCT02319837|100460674|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
33149123|NCT02319837|100460672|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
33149124|NCT02319837|100460673|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
33149125|NCT02319837|100460674|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
33149126|NCT02319837|100460672|FG000|Long-Term Follow-Up Phase|Death|33|||
33149127|NCT02319837|100460673|FG001|Long-Term Follow-Up Phase|Death|54|||
33149128|NCT02319837|100460674|FG002|Long-Term Follow-Up Phase|Death|42|||
33149129|NCT02254278|100460675|FG000|Overall Study|Protocol Violation|1|||
33149130|NCT02254278|100460676|FG001|Overall Study|Protocol Violation|1|||
33149131|NCT04176705|100460678|FG000|Overall Study|Withdrawal by Subject|4|||
33149132|NCT04176705|100460679|FG001|Overall Study|Withdrawal by Subject|4|||
33149133|NCT04176705|100460678|FG000|Overall Study|Death|1|||
33149134|NCT04176705|100460679|FG001|Overall Study|Death|1|||
33149135|NCT04176705|100460678|FG000|Overall Study|Lost to Follow-up|3|||
33149136|NCT04176705|100460679|FG001|Overall Study|Lost to Follow-up|3|||
33149137|NCT00602667|100460681|FG000|Overall Study|Still on Therapy|0|||
33149138|NCT00602667|100460682|FG001|Overall Study|Still on Therapy|2|||
33149139|NCT00602667|100460683|FG002|Overall Study|Still on Therapy|2|||
33149140|NCT00602667|100460681|FG000|Overall Study|Death|0|||
33149141|NCT00602667|100460682|FG001|Overall Study|Death|1|||
33647181|NCT00640224|102259855|FG000|Overall Study|Lost to Follow-up|5|||
33647182|NCT00640224|102259856|FG001|Overall Study|Lost to Follow-up|2|||
33647183|NCT00640224|102259857|FG002|Overall Study|Lost to Follow-up|0|||
33149142|NCT00602667|100460683|FG002|Overall Study|Death|1|||
33149143|NCT00602667|100460681|FG000|Overall Study|Family request|3|||
33149144|NCT00602667|100460682|FG001|Overall Study|Family request|25|||
33149145|NCT00602667|100460683|FG002|Overall Study|Family request|6|||
33149146|NCT00602667|100460681|FG000|Overall Study|Excessive toxicity|1|||
33149147|NCT00602667|100460682|FG001|Overall Study|Excessive toxicity|1|||
33149148|NCT00602667|100460683|FG002|Overall Study|Excessive toxicity|0|||
33149149|NCT00602667|100460681|FG000|Overall Study|Second malignancy|0|||
33149150|NCT00602667|100460682|FG001|Overall Study|Second malignancy|1|||
33149151|NCT00602667|100460683|FG002|Overall Study|Second malignancy|0|||
33149152|NCT00602667|100460681|FG000|Overall Study|Physician Decision|2|||
33149153|NCT00602667|100460682|FG001|Overall Study|Physician Decision|3|||
33149154|NCT00602667|100460683|FG002|Overall Study|Physician Decision|8|||
33149155|NCT00602667|100460681|FG000|Overall Study|Progressive disease|13|||
33149156|NCT00602667|100460682|FG001|Overall Study|Progressive disease|48|||
33149157|NCT00602667|100460683|FG002|Overall Study|Progressive disease|45|||
33149158|NCT00602667|100460681|FG000|Overall Study|Progressive disease prior to therapy|0|||
33149159|NCT00602667|100460682|FG001|Overall Study|Progressive disease prior to therapy|0|||
33149160|NCT00602667|100460683|FG002|Overall Study|Progressive disease prior to therapy|1|||
33149161|NCT00057876|100460684|FG000|Overall Study|Adverse Event|8|||
33380182|NCT01763866|101276599|FG007|Overall Study|Death|0|||
33425269|NCT00409578|101449553|FG003|Overall Study|Adverse Event|33|||
33425270|NCT00409578|101449550|FG000|Overall Study|Abnormal laboratory value(s)|2|||
33587231|NCT03308968|102036527|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
33647184|NCT00640224|102259858|FG003|Overall Study|Lost to Follow-up|0|||
33647185|NCT00640224|102259855|FG000|Overall Study|Withdrawal by Subject|1|||
33149162|NCT00057876|100460685|FG001|Overall Study|Adverse Event|8|||
33149163|NCT00057876|100460684|FG000|Overall Study|Death|2|||
33149164|NCT00057876|100460685|FG001|Overall Study|Death|1|||
33149165|NCT00057876|100460684|FG000|Overall Study|Withdrawal by Subject|5|||
33149166|NCT00057876|100460685|FG001|Overall Study|Withdrawal by Subject|6|||
33380183|NCT01763866|101276600|FG008|Overall Study|Death|0|||
33149167|NCT00057876|100460684|FG000|Overall Study|Lack of Efficacy|10|||
33149168|NCT00057876|100460685|FG001|Overall Study|Lack of Efficacy|8|||
33149169|NCT00057876|100460684|FG000|Overall Study|Ineligible|1|||
33425271|NCT00409578|101449551|FG001|Overall Study|Abnormal laboratory value(s)|2|||
33149170|NCT00057876|100460685|FG001|Overall Study|Ineligible|2|||
33149171|NCT00057876|100460684|FG000|Overall Study|other reason|2|||
33425272|NCT00409578|101449552|FG002|Overall Study|Abnormal laboratory value(s)|2|||
33425273|NCT00409578|101449553|FG003|Overall Study|Abnormal laboratory value(s)|4|||
33425274|NCT00409578|101449550|FG000|Overall Study|Lack of Efficacy|0|||
33247994|NCT03982199|100810140|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
33247995|NCT03982199|100810141|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
33380184|NCT01763866|101276601|FG009|Overall Study|Death|0|||
33380185|NCT01763866|101276602|FG010|Overall Study|Death|0|||
33380186|NCT01763866|101276603|FG011|Overall Study|Death|0|||
33380187|NCT01763866|101276604|FG012|Overall Study|Death|0|||
33380188|NCT01763866|101276605|FG013|Overall Study|Death|0|||
33380189|NCT01763866|101276606|FG014|Overall Study|Death|0|||
33380190|NCT01763866|101276607|FG015|Overall Study|Death|0|||
33380191|NCT01763866|101276608|FG016|Overall Study|Death|1|||
33380192|NCT01763866|101276609|FG017|Overall Study|Death|0|||
33380193|NCT01763866|101276610|FG018|Overall Study|Death|0|||
33380194|NCT01763866|101276611|FG019|Overall Study|Death|0|||
33380195|NCT01763866|101276612|FG020|Overall Study|Death|0|||
33380196|NCT01763866|101276613|FG021|Overall Study|Death|0|||
33380197|NCT01763866|101276614|FG022|Overall Study|Death|0|||
33380198|NCT01763866|101276615|FG023|Overall Study|Death|0|||
33380199|NCT00599027|101276616|FG000|Overall Study|Withdrawal by Subject|1|||
33425275|NCT00409578|101449551|FG001|Overall Study|Lack of Efficacy|0|||
33587232|NCT03308968|102036528|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
33247996|NCT03982199|100810142|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
33247997|NCT03982199|100810129|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
33247998|NCT03982199|100810130|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
33247999|NCT03982199|100810131|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
33248000|NCT03982199|100810132|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
33248001|NCT03982199|100810133|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
33248002|NCT03982199|100810134|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
33248003|NCT03982199|100810135|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
33248004|NCT03982199|100810136|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
33248005|NCT03982199|100810137|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
33248006|NCT03982199|100810138|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
33248007|NCT03982199|100810139|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
33248008|NCT03982199|100810140|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
33248009|NCT03982199|100810141|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
33248010|NCT03982199|100810142|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
33248011|NCT03982199|100810129|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
33248012|NCT03982199|100810130|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
33248013|NCT03982199|100810131|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
33248014|NCT03982199|100810132|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
33248015|NCT03982199|100810133|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
33248016|NCT03982199|100810134|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
33248017|NCT03982199|100810135|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
33248018|NCT03982199|100810136|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
33248019|NCT03982199|100810137|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
33248020|NCT03982199|100810138|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
33248021|NCT03982199|100810139|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
33248022|NCT03982199|100810140|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
33248023|NCT03982199|100810141|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
33248024|NCT03982199|100810142|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
33248025|NCT03982199|100810129|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
33248026|NCT03982199|100810130|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
33248027|NCT03982199|100810131|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
33248028|NCT03982199|100810132|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
33248029|NCT03982199|100810133|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
33248030|NCT03982199|100810134|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
33248031|NCT03982199|100810135|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
33248032|NCT03982199|100810136|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
33248033|NCT03982199|100810137|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
33248034|NCT03982199|100810138|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
33248035|NCT03982199|100810139|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
33248036|NCT03982199|100810140|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
33248037|NCT03982199|100810141|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
33248038|NCT03982199|100810142|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
33380200|NCT00599027|101276617|FG001|Overall Study|Withdrawal by Subject|1|||
33380201|NCT00599027|101276616|FG000|Overall Study|Adverse Event|0|||
33380202|NCT00599027|101276617|FG001|Overall Study|Adverse Event|1|||
33425276|NCT00409578|101449552|FG002|Overall Study|Lack of Efficacy|0|||
33425277|NCT00409578|101449553|FG003|Overall Study|Lack of Efficacy|2|||
33425278|NCT00409578|101449550|FG000|Overall Study|Subject no longer requires study drug|0|||
33425279|NCT00409578|101449551|FG001|Overall Study|Subject no longer requires study drug|0|||
33425280|NCT00409578|101449552|FG002|Overall Study|Subject no longer requires study drug|0|||
33425281|NCT00409578|101449553|FG003|Overall Study|Subject no longer requires study drug|1|||
33425282|NCT00409578|101449550|FG000|Overall Study|Withdrawal by Subject|8|||
33425283|NCT00409578|101449551|FG001|Overall Study|Withdrawal by Subject|15|||
33425284|NCT00409578|101449552|FG002|Overall Study|Withdrawal by Subject|16|||
33149172|NCT00057876|100460685|FG001|Overall Study|other reason|2|||
33149173|NCT00057876|100460684|FG000|Overall Study|other complicating disease|1|||
33149174|NCT00057876|100460685|FG001|Overall Study|other complicating disease|0|||
33149175|NCT02694523|100460686|FG000|Part A|Adverse Event|7|||
33149176|NCT02694523|100460687|FG001|Part A|Adverse Event|3|||
33425285|NCT00409578|101449553|FG003|Overall Study|Withdrawal by Subject|17|||
33425286|NCT00409578|101449550|FG000|Overall Study|Lost to Follow-up|2|||
33425287|NCT00409578|101449551|FG001|Overall Study|Lost to Follow-up|0|||
33425288|NCT00409578|101449552|FG002|Overall Study|Lost to Follow-up|2|||
33425289|NCT00409578|101449553|FG003|Overall Study|Lost to Follow-up|2|||
33425290|NCT00409578|101449550|FG000|Overall Study|Administrative problems|8|||
33425291|NCT00409578|101449551|FG001|Overall Study|Administrative problems|9|||
33425292|NCT00409578|101449552|FG002|Overall Study|Administrative problems|2|||
33647186|NCT00640224|102259856|FG001|Overall Study|Withdrawal by Subject|0|||
33647187|NCT00640224|102259857|FG002|Overall Study|Withdrawal by Subject|0|||
33647188|NCT00640224|102259858|FG003|Overall Study|Withdrawal by Subject|0|||
33647189|NCT00640224|102259855|FG000|Overall Study|Headaches|0|||
33647190|NCT00640224|102259856|FG001|Overall Study|Headaches|1|||
33647191|NCT00640224|102259857|FG002|Overall Study|Headaches|0|||
33647192|NCT00640224|102259858|FG003|Overall Study|Headaches|0|||
33647193|NCT00636363|102259859|FG000|Overall Study|Conjunctivitis|0|||
33647194|NCT00636363|102259860|FG001|Overall Study|Conjunctivitis|0|||
33647195|NCT00636363|102259861|FG002|Overall Study|Conjunctivitis|1|||
33647196|NCT00636363|102259859|FG000|Overall Study|Adverse Event|0|||
33647197|NCT00636363|102259860|FG001|Overall Study|Adverse Event|0|||
33647198|NCT00636363|102259861|FG002|Overall Study|Adverse Event|1|||
33647199|NCT00636363|102259859|FG000|Overall Study|Positive slit lamp finding|0|||
33647200|NCT00636363|102259860|FG001|Overall Study|Positive slit lamp finding|2|||
33647201|NCT00636363|102259861|FG002|Overall Study|Positive slit lamp finding|1|||
33647202|NCT00636363|102259859|FG000|Overall Study|Study related symptoms/complaints|8|||
33647203|NCT00636363|102259860|FG001|Overall Study|Study related symptoms/complaints|7|||
33647204|NCT00636363|102259861|FG002|Overall Study|Study related symptoms/complaints|4|||
33647205|NCT00636363|102259859|FG000|Overall Study|Met ineligibility criteria|0|||
33647206|NCT00636363|102259860|FG001|Overall Study|Met ineligibility criteria|0|||
33149177|NCT02694523|100460688|FG002|Part A|Adverse Event|0|||
33149178|NCT02694523|100460689|FG003|Part A|Adverse Event|0|||
33149179|NCT02694523|100460690|FG004|Part A|Adverse Event|0|||
33380203|NCT00599027|101276616|FG000|Overall Study|Treatment Failure|0|||
33380204|NCT00599027|101276617|FG001|Overall Study|Treatment Failure|1|||
33380205|NCT03162055|101276626|FG000|Overall Study|Adverse Event|6|||
33380206|NCT03162055|101276627|FG001|Overall Study|Adverse Event|5|||
33380207|NCT03162055|101276626|FG000|Overall Study|Death|3|||
33380208|NCT03162055|101276627|FG001|Overall Study|Death|3|||
33380209|NCT03162055|101276626|FG000|Overall Study|Lost to Follow-up|0|||
33380210|NCT03162055|101276627|FG001|Overall Study|Lost to Follow-up|1|||
33380211|NCT03162055|101276626|FG000|Overall Study|Study-specific withdrawal criteria|22|||
33380212|NCT03162055|101276627|FG001|Overall Study|Study-specific withdrawal criteria|14|||
33380213|NCT03162055|101276626|FG000|Overall Study|Withdrawal by Subject|17|||
33380214|NCT03162055|101276627|FG001|Overall Study|Withdrawal by Subject|2|||
33380215|NCT03162055|101276626|FG000|Overall Study|Did not receive treatment|2|||
33380216|NCT03162055|101276627|FG001|Overall Study|Did not receive treatment|0|||
33380217|NCT03162055|101276626|FG000|Overall Study|Incorrect randomization|4|||
33380218|NCT03162055|101276627|FG001|Overall Study|Incorrect randomization|3|||
33425293|NCT00409578|101449553|FG003|Overall Study|Administrative problems|4|||
33425294|NCT00409578|101449550|FG000|Overall Study|Death|2|||
33425295|NCT00409578|101449551|FG001|Overall Study|Death|4|||
33647207|NCT00636363|102259861|FG002|Overall Study|Met ineligibility criteria|3|||
33149180|NCT02694523|100460691|FG005|Part A|Adverse Event|0|||
33647208|NCT00636363|102259859|FG000|Overall Study|Missed > 1 visit|0|||
33149181|NCT02694523|100460692|FG006|Part A|Adverse Event|0|||
33380219|NCT03162055|101276626|FG000|Overall Study|Other|8|||
33425296|NCT00409578|101449552|FG002|Overall Study|Death|4|||
33647209|NCT00636363|102259860|FG001|Overall Study|Missed > 1 visit|1|||
33380220|NCT03162055|101276627|FG001|Overall Study|Other|15|||
33380221|NCT04511819|101276635|FG000|Overall Study|Non-compliance with study drug|5|||
33380222|NCT04511819|101276636|FG001|Overall Study|Non-compliance with study drug|1|||
33587233|NCT03308968|102036529|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
33647210|NCT00636363|102259861|FG002|Overall Study|Missed > 1 visit|3|||
33647211|NCT00636363|102259859|FG000|Overall Study|Lack of motivation|1|||
33149182|NCT02694523|100460686|FG000|Part A|Protocol Violation|1|||
33380223|NCT04511819|101276635|FG000|Overall Study|Withdrawal by Subject|0|||
33380224|NCT04511819|101276636|FG001|Overall Study|Withdrawal by Subject|3|||
33380225|NCT04511819|101276635|FG000|Overall Study|Adverse Event|0|||
33380226|NCT04511819|101276636|FG001|Overall Study|Adverse Event|1|||
33425297|NCT00409578|101449553|FG003|Overall Study|Death|2|||
33425298|NCT00409578|101449550|FG000|Overall Study|Protocol Violation|3|||
33425299|NCT00409578|101449551|FG001|Overall Study|Protocol Violation|2|||
33425300|NCT00409578|101449552|FG002|Overall Study|Protocol Violation|3|||
33425301|NCT00409578|101449553|FG003|Overall Study|Protocol Violation|1|||
33425302|NCT00409578|101449550|FG000|Overall Study|Missing|0|||
33149183|NCT02694523|100460687|FG001|Part A|Protocol Violation|0|||
33380227|NCT04511819|101276635|FG000|Overall Study|Protocol deviation|1|||
33380228|NCT04511819|101276636|FG001|Overall Study|Protocol deviation|0|||
33380229|NCT01767519|101276637|FG000|Overall Study|Other Reasons|4|||
33380230|NCT01767519|101276638|FG001|Overall Study|Other Reasons|4|||
33380231|NCT01767519|101276639|FG002|Overall Study|Other Reasons|2|||
33380232|NCT01767519|101276637|FG000|Overall Study|Protocol Violation|0|||
33380233|NCT01767519|101276638|FG001|Overall Study|Protocol Violation|3|||
33380234|NCT01767519|101276639|FG002|Overall Study|Protocol Violation|0|||
33380235|NCT01767519|101276637|FG000|Overall Study|Personal Reasons|1|||
33380236|NCT01767519|101276638|FG001|Overall Study|Personal Reasons|0|||
33380237|NCT01767519|101276639|FG002|Overall Study|Personal Reasons|0|||
33380238|NCT01767519|101276637|FG000|Overall Study|Lost to Follow-up|3|||
33380239|NCT01767519|101276638|FG001|Overall Study|Lost to Follow-up|1|||
33380240|NCT01767519|101276639|FG002|Overall Study|Lost to Follow-up|2|||
33380241|NCT01767519|101276637|FG000|Overall Study|Lack of Efficacy|1|||
33380242|NCT01767519|101276638|FG001|Overall Study|Lack of Efficacy|0|||
33380243|NCT01767519|101276639|FG002|Overall Study|Lack of Efficacy|0|||
33380244|NCT01767519|101276637|FG000|Overall Study|Adverse Event|5|||
33380245|NCT01767519|101276638|FG001|Overall Study|Adverse Event|5|||
33380246|NCT01767519|101276639|FG002|Overall Study|Adverse Event|1|||
33380247|NCT03695393|101276645|FG000|Overall Study|Death|3|||
33380248|NCT03695393|101276646|FG001|Overall Study|Death|1|||
33380249|NCT03695393|101276645|FG000|Overall Study|Lost to Follow-up|0|||
33380250|NCT03695393|101276646|FG001|Overall Study|Lost to Follow-up|1|||
33380251|NCT00131664|101276647|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
33380252|NCT00131664|101276648|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
33380253|NCT00131664|101276649|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
33380254|NCT00131664|101276650|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
33380255|NCT00131664|101276651|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
33380256|NCT00131664|101276652|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
33380257|NCT00131664|101276647|FG000|First Period (First 6 Months)|Death|0|||
33380258|NCT00131664|101276648|FG001|First Period (First 6 Months)|Death|1|||
33380259|NCT00131664|101276649|FG002|First Period (First 6 Months)|Death|0|||
33380260|NCT00131664|101276650|FG003|First Period (First 6 Months)|Death|0|||
33380261|NCT00131664|101276651|FG004|First Period (First 6 Months)|Death|0|||
33380262|NCT00131664|101276652|FG005|First Period (First 6 Months)|Death|0|||
33380263|NCT00131664|101276647|FG000|First Period (First 6 Months)|Protocol Violation|2|||
33380264|NCT00131664|101276648|FG001|First Period (First 6 Months)|Protocol Violation|2|||
33380265|NCT00131664|101276649|FG002|First Period (First 6 Months)|Protocol Violation|1|||
33380266|NCT00131664|101276650|FG003|First Period (First 6 Months)|Protocol Violation|0|||
33380267|NCT00131664|101276651|FG004|First Period (First 6 Months)|Protocol Violation|0|||
33380268|NCT00131664|101276652|FG005|First Period (First 6 Months)|Protocol Violation|0|||
33380269|NCT00131664|101276647|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
33380270|NCT00131664|101276648|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
33380271|NCT00131664|101276649|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
33380272|NCT00131664|101276650|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
33380273|NCT00131664|101276651|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
33380274|NCT00131664|101276652|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
33380275|NCT00131664|101276647|FG000|First Period (First 6 Months)|Adverse Event|9|||
33380276|NCT00131664|101276648|FG001|First Period (First 6 Months)|Adverse Event|4|||
33380277|NCT00131664|101276649|FG002|First Period (First 6 Months)|Adverse Event|5|||
33380278|NCT00131664|101276650|FG003|First Period (First 6 Months)|Adverse Event|0|||
33380279|NCT00131664|101276651|FG004|First Period (First 6 Months)|Adverse Event|0|||
33587234|NCT01147250|102036534|FG000|Overall Study|Lost to Follow-up|14|||
33149184|NCT02694523|100460688|FG002|Part A|Protocol Violation|0|||
33380280|NCT00131664|101276652|FG005|First Period (First 6 Months)|Adverse Event|0|||
33380281|NCT00131664|101276647|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
33380282|NCT00131664|101276648|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
33587235|NCT01147250|102036535|FG001|Overall Study|Lost to Follow-up|11|||
33380283|NCT00131664|101276649|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
33380284|NCT00131664|101276650|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
33425303|NCT00409578|101449551|FG001|Overall Study|Missing|1|||
33587236|NCT01147250|102036534|FG000|Overall Study|Withdrawal by Subject|83|||
33149185|NCT02694523|100460689|FG003|Part A|Protocol Violation|0|||
33647212|NCT00636363|102259860|FG001|Overall Study|Lack of motivation|0|||
33647213|NCT00636363|102259861|FG002|Overall Study|Lack of motivation|1|||
33647214|NCT00636363|102259859|FG000|Overall Study|Protocol Violation|0|||
33647215|NCT00636363|102259860|FG001|Overall Study|Protocol Violation|3|||
33647216|NCT00636363|102259861|FG002|Overall Study|Protocol Violation|0|||
33647217|NCT00636363|102259859|FG000|Overall Study|Lost to Follow-up|3|||
33647218|NCT00636363|102259860|FG001|Overall Study|Lost to Follow-up|4|||
33647219|NCT00636363|102259861|FG002|Overall Study|Lost to Follow-up|2|||
33647220|NCT00636363|102259859|FG000|Overall Study|Withdrawal by Subject|1|||
33647221|NCT00636363|102259860|FG001|Overall Study|Withdrawal by Subject|3|||
33647222|NCT00636363|102259861|FG002|Overall Study|Withdrawal by Subject|2|||
33647223|NCT01657461|102259862|FG000|Overall Study|Death|9|||
33647224|NCT01657461|102259863|FG001|Overall Study|Death|12|||
33647225|NCT01657461|102259862|FG000|Overall Study|Lost to Follow-up|0|||
33647226|NCT01657461|102259863|FG001|Overall Study|Lost to Follow-up|3|||
33647227|NCT01657461|102259862|FG000|Overall Study|Physician Decision|0|||
33647228|NCT01657461|102259863|FG001|Overall Study|Physician Decision|2|||
33647229|NCT01657461|102259862|FG000|Overall Study|Withdrawal by Subject|1|||
33647230|NCT01657461|102259863|FG001|Overall Study|Withdrawal by Subject|3|||
33647231|NCT02343549|102259864|FG000|Overall Study|Death|11|||
33647232|NCT02343549|102259864|FG000|Overall Study|Withdrawal by Subject|2|||
33647233|NCT01015638|102259865|FG000|Overall Study|Withdrawal by Subject|1|||
33647234|NCT01015638|102259866|FG001|Overall Study|Withdrawal by Subject|0|||
33647235|NCT01343693|102259867|FG000|Overall Study|Lost to Follow-up|9|||
33647236|NCT01090323|102259871|FG000|Overall Study|Adverse Event|12|||
33647237|NCT01090323|102259872|FG001|Overall Study|Adverse Event|2|||
33647238|NCT01090323|102259871|FG000|Overall Study|Abnormal Lab Values|3|||
33647239|NCT01090323|102259872|FG001|Overall Study|Abnormal Lab Values|1|||
33647240|NCT01090323|102259871|FG000|Overall Study|Abnormal Test Procedure Results|2|||
33647241|NCT01090323|102259872|FG001|Overall Study|Abnormal Test Procedure Results|0|||
33647242|NCT01090323|102259871|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33647243|NCT01090323|102259872|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33647244|NCT01090323|102259871|FG000|Overall Study|Condition no longer requires drug|5|||
33647245|NCT01090323|102259872|FG001|Overall Study|Condition no longer requires drug|4|||
33647246|NCT01090323|102259871|FG000|Overall Study|Protocol Violation|2|||
33647247|NCT01090323|102259872|FG001|Overall Study|Protocol Violation|1|||
33647248|NCT01090323|102259871|FG000|Overall Study|Withdrew consent|33|||
33149186|NCT02694523|100460690|FG004|Part A|Protocol Violation|0|||
33248039|NCT03982199|100810129|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
33248040|NCT03982199|100810130|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
33248041|NCT03982199|100810131|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
33248042|NCT03982199|100810132|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
33248043|NCT03982199|100810133|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
33248044|NCT03982199|100810134|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
33248045|NCT03982199|100810135|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
33248046|NCT03982199|100810136|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
33248047|NCT03982199|100810137|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
33248048|NCT03982199|100810138|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
33248049|NCT03982199|100810139|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
33248050|NCT03982199|100810140|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
33248051|NCT03982199|100810141|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
33248052|NCT03982199|100810142|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
33248053|NCT03982199|100810129|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
33248054|NCT03982199|100810130|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
33248055|NCT03982199|100810131|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
33248056|NCT03982199|100810132|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
33248057|NCT03982199|100810133|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
33248058|NCT03982199|100810134|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
33248059|NCT03982199|100810135|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
33248060|NCT03982199|100810136|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
33248061|NCT03982199|100810137|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
33248062|NCT03982199|100810138|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
33248063|NCT03982199|100810139|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
33380285|NCT00131664|101276651|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
33380286|NCT00131664|101276652|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
33647249|NCT01090323|102259872|FG001|Overall Study|Withdrew consent|11|||
33647250|NCT01090323|102259871|FG000|Overall Study|Lost to Follow-up|11|||
33647251|NCT01090323|102259872|FG001|Overall Study|Lost to Follow-up|6|||
33647252|NCT01090323|102259871|FG000|Overall Study|Administrative problems|6|||
33647253|NCT01090323|102259872|FG001|Overall Study|Administrative problems|4|||
33647254|NCT01090323|102259871|FG000|Overall Study|Death|1|||
33647255|NCT01090323|102259872|FG001|Overall Study|Death|2|||
33248064|NCT03982199|100810140|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
33248065|NCT03982199|100810141|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
33248066|NCT03982199|100810142|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
33248067|NCT03982199|100810129|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
33248068|NCT03982199|100810130|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
33248069|NCT03982199|100810131|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
33248070|NCT03982199|100810132|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
33248071|NCT03982199|100810133|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
33248072|NCT03982199|100810134|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
33248073|NCT03982199|100810135|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
33248074|NCT03982199|100810136|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
33248075|NCT03982199|100810137|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
33248076|NCT03982199|100810138|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
33248077|NCT03982199|100810139|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
33248078|NCT03982199|100810140|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
33248079|NCT03982199|100810141|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
33248080|NCT03982199|100810142|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
33248081|NCT03982199|100810129|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
33248082|NCT03982199|100810130|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
33248083|NCT03982199|100810131|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
33248084|NCT03982199|100810132|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
33248085|NCT03982199|100810133|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
33248086|NCT03982199|100810134|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
33248087|NCT03982199|100810135|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
33248088|NCT03982199|100810136|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
33248089|NCT03982199|100810137|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
33248090|NCT03982199|100810138|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
33248091|NCT03982199|100810139|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
33248092|NCT03982199|100810140|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
33248093|NCT03982199|100810141|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
33248094|NCT03982199|100810142|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
33248095|NCT03982199|100810129|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
33248096|NCT03982199|100810130|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
33248097|NCT03982199|100810131|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
33248098|NCT03982199|100810132|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
33248099|NCT03982199|100810133|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
33248100|NCT03982199|100810134|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
33248101|NCT03982199|100810135|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
33248102|NCT03982199|100810136|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
33248103|NCT03982199|100810137|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
33248104|NCT03982199|100810138|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
33248105|NCT03982199|100810139|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
33248106|NCT03982199|100810140|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
33248107|NCT03982199|100810141|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
33248108|NCT03982199|100810142|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
33248109|NCT03982199|100810129|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
33248110|NCT03982199|100810130|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
33248111|NCT03982199|100810131|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
33248112|NCT03982199|100810132|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
33248113|NCT03982199|100810133|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
33248114|NCT03982199|100810134|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
33248115|NCT03982199|100810135|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
33248116|NCT03982199|100810136|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
33248117|NCT03982199|100810137|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
33248118|NCT03982199|100810138|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
33248119|NCT03982199|100810139|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
33248120|NCT03982199|100810140|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
33248121|NCT03982199|100810141|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
33380287|NCT00131664|101276647|FG000|First Period (First 6 Months)|Administrative reasons|2|||
33380288|NCT00131664|101276648|FG001|First Period (First 6 Months)|Administrative reasons|0|||
33380289|NCT00131664|101276649|FG002|First Period (First 6 Months)|Administrative reasons|5|||
33425304|NCT00409578|101449552|FG002|Overall Study|Missing|0|||
33587237|NCT01147250|102036535|FG001|Overall Study|Withdrawal by Subject|88|||
33587238|NCT01147250|102036534|FG000|Overall Study|Site termination by sponsor|13|||
33647256|NCT01090323|102259871|FG000|Overall Study|Stopped end of core|7|||
33647257|NCT01090323|102259872|FG001|Overall Study|Stopped end of core|0|||
33380290|NCT00131664|101276650|FG003|First Period (First 6 Months)|Administrative reasons|0|||
33380291|NCT00131664|101276651|FG004|First Period (First 6 Months)|Administrative reasons|0|||
33647258|NCT01090323|102259871|FG000|Overall Study|Stopped end of extension 1#|3|||
33380292|NCT00131664|101276652|FG005|First Period (First 6 Months)|Administrative reasons|0|||
33380293|NCT00131664|101276647|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
33380294|NCT00131664|101276648|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
33380295|NCT00131664|101276649|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
33380296|NCT00131664|101276650|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
33380297|NCT00131664|101276651|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
33380298|NCT00131664|101276652|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
33380299|NCT00131664|101276647|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
33425305|NCT00409578|101449553|FG003|Overall Study|Missing|1|||
33425306|NCT03083132|101449554|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
33425307|NCT03083132|101449555|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
33425308|NCT03083132|101449554|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
33425309|NCT03083132|101449555|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
33425310|NCT03083132|101449554|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
33425311|NCT03083132|101449555|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
33425312|NCT02729194|101449556|FG000|Overall Study|Withdrawal by Subject|3|||
33425313|NCT00299728|101449557|FG000|Overall Study|Lost to Follow-up|0|||
33425314|NCT00299728|101449558|FG001|Overall Study|Lost to Follow-up|1|||
33425315|NCT00299728|101449557|FG000|Overall Study|Withdrawal by Subject|0|||
33425316|NCT00299728|101449558|FG001|Overall Study|Withdrawal by Subject|1|||
33425317|NCT00299728|101449557|FG000|Overall Study|Progressive disease|0|||
33425318|NCT00299728|101449558|FG001|Overall Study|Progressive disease|1|||
33647259|NCT01090323|102259872|FG001|Overall Study|Stopped end of extension 1#|1|||
33647260|NCT03615040|102259876|FG000|Overall Study|Withdrawal by Subject|2|||
33647261|NCT03615040|102259877|FG001|Overall Study|Withdrawal by Subject|1|||
33380300|NCT00131664|101276648|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
33380301|NCT00131664|101276649|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
33425319|NCT01473758|101449564|FG000|Cycle 1|Adverse Event|10|||
33425320|NCT01473758|101449565|FG001|Cycle 1|Adverse Event|2|||
33425321|NCT01473758|101449566|FG002|Cycle 1|Adverse Event|0|||
33425322|NCT01473758|101449567|FG003|Cycle 1|Adverse Event|0|||
33425323|NCT01473758|101449564|FG000|Cycle 1|Withdrawal by Subject|1|||
33425324|NCT01473758|101449565|FG001|Cycle 1|Withdrawal by Subject|1|||
33425325|NCT01473758|101449566|FG002|Cycle 1|Withdrawal by Subject|0|||
33425326|NCT01473758|101449567|FG003|Cycle 1|Withdrawal by Subject|0|||
33425327|NCT01473758|101449564|FG000|Cycle 2|Adverse Event|0|||
33425328|NCT01473758|101449565|FG001|Cycle 2|Adverse Event|0|||
33425329|NCT01473758|101449566|FG002|Cycle 2|Adverse Event|5|||
33425330|NCT01473758|101449567|FG003|Cycle 2|Adverse Event|0|||
33425331|NCT00534092|101449571|FG000|Overall Study|Lost to Follow-up|1|||
33425332|NCT00534092|101449572|FG001|Overall Study|Lost to Follow-up|0|||
33425333|NCT00534092|101449571|FG000|Overall Study|personal reasons/family concerns|1|||
33425334|NCT00534092|101449572|FG001|Overall Study|personal reasons/family concerns|0|||
33425335|NCT04023994|101449573|FG000|Overall Study|Lost to Follow-up|0|||
33425336|NCT04023994|101449574|FG001|Overall Study|Lost to Follow-up|1|||
33425337|NCT04023994|101449575|FG002|Overall Study|Lost to Follow-up|2|||
33425338|NCT04023994|101449576|FG003|Overall Study|Lost to Follow-up|0|||
33425339|NCT04023994|101449577|FG004|Overall Study|Lost to Follow-up|0|||
33425340|NCT04023994|101449578|FG005|Overall Study|Lost to Follow-up|0|||
33425341|NCT04023994|101449573|FG000|Overall Study|Withdrawal by Subject|0|||
33425342|NCT04023994|101449574|FG001|Overall Study|Withdrawal by Subject|0|||
33425343|NCT04023994|101449575|FG002|Overall Study|Withdrawal by Subject|0|||
33425344|NCT04023994|101449576|FG003|Overall Study|Withdrawal by Subject|1|||
33425345|NCT04023994|101449577|FG004|Overall Study|Withdrawal by Subject|0|||
33587239|NCT01147250|102036535|FG001|Overall Study|Site termination by sponsor|5|||
33587240|NCT01147250|102036534|FG000|Overall Study|Other than specified|0|||
33587241|NCT01147250|102036535|FG001|Overall Study|Other than specified|1|||
33587242|NCT00700882|102038426|FG000|Overall Study|Never received treatment|6|||
33587243|NCT00700882|102038426|FG000|Overall Study|Ineligible|2|||
33587244|NCT00700882|102038426|FG000|Overall Study|No KIT mutation|51|||
33587245|NCT00624468|102038436|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
33587246|NCT00624468|102038437|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
33587247|NCT00624468|102038438|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
33587248|NCT00624468|102038439|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
33647262|NCT03615040|102259876|FG000|Overall Study|Physician Decision|2|||
33647263|NCT03615040|102259877|FG001|Overall Study|Physician Decision|2|||
33647264|NCT03615040|102259876|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
33647265|NCT03615040|102259877|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
33647266|NCT03615040|102259876|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
33425346|NCT04023994|101449578|FG005|Overall Study|Withdrawal by Subject|0|||
33425347|NCT02378506|101449585|FG000|Overall Study|Lack of Efficacy|3|||
33425348|NCT02378506|101449585|FG000|Overall Study|Withdrawal by Subject|4|||
33425349|NCT02378506|101449585|FG000|Overall Study|Protocol Violation|2|||
33425350|NCT02378506|101449585|FG000|Overall Study|Death|1|||
33425351|NCT02378506|101449585|FG000|Overall Study|Adverse Event|14|||
33425352|NCT02378506|101449585|FG000|Overall Study|Randomized But Not Treated|1|||
33425353|NCT00219557|101449586|FG000|Phase 1|Lack of Efficacy|3|||
33425354|NCT00219557|101449587|FG001|Phase 1|Lack of Efficacy|0|||
33425355|NCT00219557|101449588|FG002|Phase 1|Lack of Efficacy|0|||
33425356|NCT00219557|101449586|FG000|Phase 1|Adverse Event|2|||
33425357|NCT00219557|101449587|FG001|Phase 1|Adverse Event|0|||
33425358|NCT00219557|101449588|FG002|Phase 1|Adverse Event|0|||
33425359|NCT00219557|101449586|FG000|Phase 1|Withdrawal by Subject|1|||
33425360|NCT00219557|101449587|FG001|Phase 1|Withdrawal by Subject|0|||
33425361|NCT00219557|101449588|FG002|Phase 1|Withdrawal by Subject|0|||
33425362|NCT00219557|101449586|FG000|Phase 1|Started chemotherapy at other institute|1|||
33425363|NCT00219557|101449587|FG001|Phase 1|Started chemotherapy at other institute|0|||
33425364|NCT00219557|101449588|FG002|Phase 1|Started chemotherapy at other institute|0|||
33425365|NCT00219557|101449586|FG000|Phase 2|Lack of Efficacy|0|||
33425366|NCT00219557|101449587|FG001|Phase 2|Lack of Efficacy|21|||
33425367|NCT00219557|101449588|FG002|Phase 2|Lack of Efficacy|15|||
33425368|NCT00219557|101449586|FG000|Phase 2|Adverse Event|0|||
33425369|NCT00219557|101449587|FG001|Phase 2|Adverse Event|22|||
33425370|NCT00219557|101449588|FG002|Phase 2|Adverse Event|2|||
33425371|NCT00219557|101449586|FG000|Phase 2|Death|0|||
33425372|NCT00219557|101449587|FG001|Phase 2|Death|8|||
33425373|NCT00219557|101449588|FG002|Phase 2|Death|2|||
33425374|NCT00219557|101449586|FG000|Phase 2|Other|0|||
33425375|NCT00219557|101449587|FG001|Phase 2|Other|8|||
33425376|NCT00219557|101449588|FG002|Phase 2|Other|6|||
33425377|NCT00219557|101449586|FG000|Phase 2|Withdrawal by Subject|0|||
33425378|NCT00219557|101449587|FG001|Phase 2|Withdrawal by Subject|9|||
33425379|NCT00219557|101449588|FG002|Phase 2|Withdrawal by Subject|5|||
33647267|NCT03615040|102259877|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
33647268|NCT03615040|102259876|FG000|Overall Study|Death|0|||
33647269|NCT03615040|102259877|FG001|Overall Study|Death|2|||
33647270|NCT01175083|102259878|FG000|Primary Epoch|Withdrawal by Subject|0|||
33380302|NCT00131664|101276650|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
33380303|NCT00131664|101276651|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
33380304|NCT00131664|101276652|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
33380305|NCT00131664|101276647|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
33380306|NCT00131664|101276648|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
33380307|NCT00131664|101276649|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
33380308|NCT00131664|101276650|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
33380309|NCT00131664|101276651|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
33380310|NCT00131664|101276652|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
33380311|NCT00131664|101276647|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
33380312|NCT00131664|101276648|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
33380313|NCT00131664|101276649|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
33380314|NCT00131664|101276650|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
33380315|NCT00131664|101276651|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
33380316|NCT00131664|101276652|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
33380317|NCT00131664|101276647|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
33380318|NCT00131664|101276648|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
33380319|NCT00131664|101276649|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
33380320|NCT00131664|101276650|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
33425380|NCT00219557|101449586|FG000|Phase 2|Treatment not received|0|||
33425381|NCT00219557|101449587|FG001|Phase 2|Treatment not received|1|||
33647271|NCT01175083|102259879|FG001|Primary Epoch|Withdrawal by Subject|0|||
33647272|NCT01175083|102259880|FG002|Primary Epoch|Withdrawal by Subject|0|||
33647273|NCT01175083|102259881|FG003|Primary Epoch|Withdrawal by Subject|0|||
33425382|NCT00219557|101449588|FG002|Phase 2|Treatment not received|3|||
33425383|NCT01348542|101449589|FG000|Overall Study|Withdrawal by Subject|3|||
33425384|NCT01348542|101449590|FG001|Overall Study|Withdrawal by Subject|0|||
33425385|NCT04313283|101449592|FG000|Overall Study|did not complete intervention|4|||
33425386|NCT02278952|101449593|FG000|Overall Study|Insufficient Sample|6|||
33425387|NCT03586830|101449594|FG000|Overall Study|Site terminated by Sponsor|1|||
33425388|NCT03586830|101449595|FG001|Overall Study|Site terminated by Sponsor|4|||
33425389|NCT03586830|101449596|FG002|Overall Study|Site terminated by Sponsor|3|||
33425390|NCT03586830|101449597|FG003|Overall Study|Site terminated by Sponsor|3|||
33647274|NCT01175083|102259882|FG004|Primary Epoch|Withdrawal by Subject|0|||
33425391|NCT03586830|101449594|FG000|Overall Study|Lost to Follow-up|0|||
33425392|NCT03586830|101449595|FG001|Overall Study|Lost to Follow-up|2|||
33425393|NCT03586830|101449596|FG002|Overall Study|Lost to Follow-up|2|||
33149187|NCT02694523|100460691|FG005|Part A|Protocol Violation|0|||
33149188|NCT02694523|100460692|FG006|Part A|Protocol Violation|0|||
33149189|NCT02694523|100460686|FG000|Part A|Lost to Follow-up|1|||
33149190|NCT02694523|100460687|FG001|Part A|Lost to Follow-up|2|||
33149191|NCT02694523|100460688|FG002|Part A|Lost to Follow-up|0|||
33149192|NCT02694523|100460689|FG003|Part A|Lost to Follow-up|0|||
33149193|NCT02694523|100460690|FG004|Part A|Lost to Follow-up|0|||
33149194|NCT02694523|100460691|FG005|Part A|Lost to Follow-up|0|||
33149195|NCT02694523|100460692|FG006|Part A|Lost to Follow-up|0|||
33149196|NCT02694523|100460686|FG000|Part A|Withdrawal by Subject|3|||
33149197|NCT02694523|100460687|FG001|Part A|Withdrawal by Subject|1|||
33149198|NCT02694523|100460688|FG002|Part A|Withdrawal by Subject|0|||
33149199|NCT02694523|100460689|FG003|Part A|Withdrawal by Subject|0|||
33149200|NCT02694523|100460690|FG004|Part A|Withdrawal by Subject|0|||
33149201|NCT02694523|100460691|FG005|Part A|Withdrawal by Subject|0|||
33149202|NCT02694523|100460692|FG006|Part A|Withdrawal by Subject|0|||
33149203|NCT02694523|100460686|FG000|Part A|Other|1|||
33149204|NCT02694523|100460687|FG001|Part A|Other|1|||
33149205|NCT02694523|100460688|FG002|Part A|Other|0|||
33149206|NCT02694523|100460689|FG003|Part A|Other|0|||
33149207|NCT02694523|100460690|FG004|Part A|Other|0|||
33587249|NCT00624468|102038436|FG000|Double-blind Period|Withdrew Prematurely|1|||
33587250|NCT00624468|102038437|FG001|Double-blind Period|Withdrew Prematurely|1|||
33587251|NCT00624468|102038438|FG002|Double-blind Period|Withdrew Prematurely|0|||
33587252|NCT00624468|102038439|FG003|Double-blind Period|Withdrew Prematurely|0|||
33587253|NCT00624468|102038436|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
33587254|NCT00624468|102038437|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
33587255|NCT00624468|102038438|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
33587256|NCT00624468|102038439|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
33587257|NCT00624468|102038436|FG000|Safety Follow-up (SFU) Period|Other|0|||
33587258|NCT00624468|102038437|FG001|Safety Follow-up (SFU) Period|Other|0|||
33587259|NCT00624468|102038438|FG002|Safety Follow-up (SFU) Period|Other|1|||
33587260|NCT00624468|102038439|FG003|Safety Follow-up (SFU) Period|Other|1|||
33587261|NCT02584452|102038440|FG000|Overall Study|Physician Decision|1|||
33587262|NCT02584452|102038441|FG001|Overall Study|Physician Decision|1|||
33587263|NCT02584452|102038440|FG000|Overall Study|Lost to Follow-up|1|||
33587264|NCT02584452|102038441|FG001|Overall Study|Lost to Follow-up|1|||
33587265|NCT03718884|102038442|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
33587266|NCT03718884|102038443|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
33149208|NCT02694523|100460691|FG005|Part A|Other|0|||
33149209|NCT02694523|100460692|FG006|Part A|Other|0|||
33149210|NCT02694523|100460686|FG000|Part B|Adverse Event|0|||
33149211|NCT02694523|100460687|FG001|Part B|Adverse Event|0|||
33149212|NCT02694523|100460688|FG002|Part B|Adverse Event|7|||
33149213|NCT02694523|100460689|FG003|Part B|Adverse Event|1|||
33149214|NCT02694523|100460690|FG004|Part B|Adverse Event|1|||
33149215|NCT02694523|100460691|FG005|Part B|Adverse Event|2|||
33149216|NCT02694523|100460692|FG006|Part B|Adverse Event|0|||
33149217|NCT02694523|100460686|FG000|Part B|Protocol Violation|0|||
33149218|NCT02694523|100460687|FG001|Part B|Protocol Violation|0|||
33149219|NCT02694523|100460688|FG002|Part B|Protocol Violation|1|||
33149220|NCT02694523|100460689|FG003|Part B|Protocol Violation|0|||
33149221|NCT02694523|100460690|FG004|Part B|Protocol Violation|0|||
33149222|NCT02694523|100460691|FG005|Part B|Protocol Violation|0|||
33149223|NCT02694523|100460692|FG006|Part B|Protocol Violation|0|||
33149224|NCT02694523|100460686|FG000|Part B|Lost to Follow-up|0|||
33149225|NCT02694523|100460687|FG001|Part B|Lost to Follow-up|0|||
33149226|NCT02694523|100460688|FG002|Part B|Lost to Follow-up|2|||
33149227|NCT02694523|100460689|FG003|Part B|Lost to Follow-up|3|||
33149228|NCT02694523|100460690|FG004|Part B|Lost to Follow-up|2|||
33149229|NCT02694523|100460691|FG005|Part B|Lost to Follow-up|0|||
33380321|NCT00131664|101276651|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
33587267|NCT03718884|102038442|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
33149230|NCT02694523|100460692|FG006|Part B|Lost to Follow-up|1|||
33149231|NCT02694523|100460686|FG000|Part B|Withdrawal by Subject|0|||
33587268|NCT03718884|102038443|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
33587269|NCT03427814|102038449|FG000|Overall Study|Withdrawal by Subject|4|||
33149232|NCT02694523|100460687|FG001|Part B|Withdrawal by Subject|0|||
33149233|NCT02694523|100460688|FG002|Part B|Withdrawal by Subject|9|||
33149234|NCT02694523|100460689|FG003|Part B|Withdrawal by Subject|0|||
33149235|NCT02694523|100460690|FG004|Part B|Withdrawal by Subject|1|||
33149236|NCT02694523|100460691|FG005|Part B|Withdrawal by Subject|3|||
33149237|NCT02694523|100460692|FG006|Part B|Withdrawal by Subject|0|||
33149238|NCT02694523|100460686|FG000|Part B|Other|0|||
33149239|NCT02694523|100460687|FG001|Part B|Other|0|||
33425394|NCT03586830|101449597|FG003|Overall Study|Lost to Follow-up|1|||
33149240|NCT02694523|100460688|FG002|Part B|Other|1|||
33149241|NCT02694523|100460689|FG003|Part B|Other|0|||
33149242|NCT02694523|100460690|FG004|Part B|Other|0|||
33149243|NCT02694523|100460691|FG005|Part B|Other|0|||
33149244|NCT02694523|100460692|FG006|Part B|Other|1|||
33149245|NCT02970318|100460693|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
33149246|NCT02970318|100460694|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
33647275|NCT01175083|102259883|FG005|Primary Epoch|Withdrawal by Subject|2|||
33647276|NCT01175083|102259878|FG000|Primary Epoch|Lost to Follow-up|0|||
33647277|NCT01175083|102259879|FG001|Primary Epoch|Lost to Follow-up|0|||
33647278|NCT01175083|102259880|FG002|Primary Epoch|Lost to Follow-up|0|||
33647279|NCT01175083|102259881|FG003|Primary Epoch|Lost to Follow-up|0|||
33647280|NCT01175083|102259882|FG004|Primary Epoch|Lost to Follow-up|0|||
33425395|NCT03586830|101449594|FG000|Overall Study|Withdrawal by Subject|1|||
33425396|NCT03586830|101449595|FG001|Overall Study|Withdrawal by Subject|0|||
33425397|NCT03586830|101449596|FG002|Overall Study|Withdrawal by Subject|3|||
33425398|NCT03586830|101449597|FG003|Overall Study|Withdrawal by Subject|1|||
33425399|NCT04356573|101449611|FG000|Overall Study|Didn't Qualify|1|||
33425400|NCT04356573|101449612|FG001|Overall Study|Didn't Qualify|0|||
33425401|NCT02598193|101449614|FG000|Overall Study|Adverse Event|13|||
33425402|NCT02598193|101449614|FG000|Overall Study|Withdrawal by Subject|1|||
33425403|NCT02598193|101449614|FG000|Overall Study|Listed in active lung transplant list|1|||
33425404|NCT02598193|101449614|FG000|Overall Study|Does not want to take Nintedanib|1|||
33425405|NCT00693784|101449616|FG000|Overall Study|Lost to Follow-up|2|||
33425406|NCT00693784|101449616|FG000|Overall Study|Withdrawal by Subject|2|||
33425407|NCT00971204|101449617|FG000|Overall Study|Did not meet all criteria-not treated|14|||
33425408|NCT00971204|101449617|FG000|Overall Study|Lost to Follow-up|10|||
33425409|NCT01967888|101449618|FG000|Overall Study|Lost to Follow-up|6|||
33425410|NCT01967888|101449619|FG001|Overall Study|Lost to Follow-up|4|||
33425411|NCT01967888|101449618|FG000|Overall Study|Withdrawal by Subject|1|||
33425412|NCT01967888|101449619|FG001|Overall Study|Withdrawal by Subject|1|||
33425413|NCT01967888|101449618|FG000|Overall Study|Did Not Have Transplant|1|||
33425414|NCT01967888|101449619|FG001|Overall Study|Did Not Have Transplant|0|||
33425415|NCT01967888|101449618|FG000|Overall Study|Research visit not done, data recorded|1|||
33425416|NCT01967888|101449619|FG001|Overall Study|Research visit not done, data recorded|0|||
33425417|NCT01967888|101449618|FG000|Overall Study|Subject excluded after randomization|1|||
33425418|NCT01967888|101449619|FG001|Overall Study|Subject excluded after randomization|0|||
33425419|NCT01967888|101449618|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
33425420|NCT01967888|101449619|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
33425421|NCT01967888|101449618|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
33425422|NCT01967888|101449619|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
33425423|NCT00876733|101449620|FG000|Overall Study|Adverse Event|34|||
33425424|NCT00876733|101449621|FG001|Overall Study|Adverse Event|20|||
33425425|NCT00876733|101449622|FG002|Overall Study|Adverse Event|10|||
33425426|NCT00876733|101449623|FG003|Overall Study|Adverse Event|3|||
33380322|NCT00131664|101276652|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
33380323|NCT00131664|101276647|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
33380324|NCT00131664|101276648|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
33380325|NCT00131664|101276649|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
33380326|NCT00131664|101276650|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
33380327|NCT00131664|101276651|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
33380328|NCT00131664|101276652|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
33380329|NCT01360762|101276669|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
33380330|NCT01360762|101276669|FG000|Main Study Period (12-month Treatment)|Death|5|||
33380331|NCT01360762|101276669|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
33380332|NCT01360762|101276669|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
33380333|NCT01360762|101276669|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
33380334|NCT01360762|101276669|FG000|Whole Study Period|Lost to Follow-up|10|||
33380335|NCT01360762|101276669|FG000|Whole Study Period|Death|7|||
33380336|NCT01360762|101276669|FG000|Whole Study Period|Patient relapsed|18|||
33380337|NCT01360762|101276669|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
33380338|NCT00565058|101276674|FG000|Overall Study|Adverse Event|1|||
33380339|NCT00565058|101276675|FG001|Overall Study|Adverse Event|0|||
33380340|NCT01026389|101276676|FG000|Overall Study|Withdrawal by Subject|1|||
33380341|NCT01026389|101276677|FG001|Overall Study|Withdrawal by Subject|3|||
33647281|NCT01175083|102259883|FG005|Primary Epoch|Lost to Follow-up|1|||
33647282|NCT01175083|102259878|FG000|Booster Epoch|Death|0|||
33647283|NCT01175083|102259879|FG001|Booster Epoch|Death|0|||
33647284|NCT01175083|102259880|FG002|Booster Epoch|Death|1|||
33380342|NCT01026389|101276676|FG000|Overall Study|change of treatment, patient moved|4|||
33425427|NCT00876733|101449620|FG000|Overall Study|Lack of Efficacy|17|||
33425428|NCT00876733|101449621|FG001|Overall Study|Lack of Efficacy|9|||
33425429|NCT00876733|101449622|FG002|Overall Study|Lack of Efficacy|10|||
33425430|NCT00876733|101449623|FG003|Overall Study|Lack of Efficacy|1|||
33587270|NCT03427814|102038450|FG001|Overall Study|Withdrawal by Subject|4|||
33647285|NCT01175083|102259881|FG003|Booster Epoch|Death|0|||
33647286|NCT01175083|102259882|FG004|Booster Epoch|Death|0|||
33647287|NCT01175083|102259883|FG005|Booster Epoch|Death|0|||
33647288|NCT01175083|102259878|FG000|Booster Epoch|Withdrawal by Subject|0|||
33647289|NCT01175083|102259879|FG001|Booster Epoch|Withdrawal by Subject|0|||
33425431|NCT00876733|101449620|FG000|Overall Study|Lost to Follow-up|26|||
33425432|NCT00876733|101449621|FG001|Overall Study|Lost to Follow-up|10|||
33425433|NCT00876733|101449622|FG002|Overall Study|Lost to Follow-up|3|||
33425434|NCT00876733|101449623|FG003|Overall Study|Lost to Follow-up|2|||
33425435|NCT00876733|101449620|FG000|Overall Study|Data not available|14|||
33425436|NCT00876733|101449621|FG001|Overall Study|Data not available|3|||
33425437|NCT00876733|101449622|FG002|Overall Study|Data not available|7|||
33425438|NCT00876733|101449623|FG003|Overall Study|Data not available|1|||
33425439|NCT01401478|101449624|FG000|Overall Study|Study drug not available|6|||
33425440|NCT01401478|101449624|FG000|Overall Study|Adverse Event|5|||
33425441|NCT01401478|101449624|FG000|Overall Study|Hyperphosphatemia|5|||
33425442|NCT01401478|101449624|FG000|Overall Study|Lost to Follow-up|5|||
33425443|NCT01401478|101449624|FG000|Overall Study|Kidney transplantation|3|||
33425444|NCT01401478|101449624|FG000|Overall Study|Withdrawal by Subject|3|||
33425445|NCT01401478|101449624|FG000|Overall Study|Blood samples not available|1|||
33425446|NCT01401478|101449624|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
33425447|NCT01401478|101449624|FG000|Overall Study|Low intact parathyroid hormone|1|||
33425448|NCT01401478|101449624|FG000|Overall Study|Serious adverse event|1|||
33425449|NCT02390219|101449626|FG000|Overall Study|Death|1|||
33425450|NCT02390219|101449626|FG000|Overall Study|Physician Decision|1|||
33425451|NCT02390219|101449626|FG000|Overall Study|Adverse Event|6|||
33425452|NCT02390219|101449626|FG000|Overall Study|Withdrawal by Subject|1|||
33425453|NCT02390219|101449626|FG000|Overall Study|Lost to Follow-up|2|||
33425454|NCT02390219|101449626|FG000|Overall Study|Other|2|||
33425455|NCT02094937|101449627|FG000|8 Weeks in Period 1|Adverse Event|9|||
33425456|NCT02094937|101449628|FG001|8 Weeks in Period 1|Adverse Event|0|||
33425457|NCT02094937|101449629|FG002|8 Weeks in Period 1|Adverse Event|0|||
33425458|NCT02094937|101449630|FG003|8 Weeks in Period 1|Adverse Event|0|||
33425459|NCT02094937|101449627|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
33425460|NCT02094937|101449628|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
33425461|NCT02094937|101449629|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
33425462|NCT02094937|101449630|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
33425463|NCT02094937|101449627|FG000|8 Weeks in Period 1|Protocol Violation|2|||
33425464|NCT02094937|101449628|FG001|8 Weeks in Period 1|Protocol Violation|0|||
33425465|NCT02094937|101449629|FG002|8 Weeks in Period 1|Protocol Violation|0|||
33425466|NCT02094937|101449630|FG003|8 Weeks in Period 1|Protocol Violation|0|||
33425467|NCT02094937|101449627|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
33425468|NCT02094937|101449628|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
33425469|NCT02094937|101449629|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
33425470|NCT02094937|101449630|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
33425471|NCT02094937|101449627|FG000|8 Weeks in Period 1|Physician Decision|1|||
33425472|NCT02094937|101449628|FG001|8 Weeks in Period 1|Physician Decision|0|||
33425473|NCT02094937|101449629|FG002|8 Weeks in Period 1|Physician Decision|0|||
33425474|NCT02094937|101449630|FG003|8 Weeks in Period 1|Physician Decision|0|||
33425475|NCT02094937|101449627|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
33425476|NCT02094937|101449628|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
33425477|NCT02094937|101449629|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
33425478|NCT02094937|101449630|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
33425479|NCT02094937|101449627|FG000|12 Weeks in Period 2|Adverse Event|0|||
33425480|NCT02094937|101449628|FG001|12 Weeks in Period 2|Adverse Event|2|||
33425481|NCT02094937|101449629|FG002|12 Weeks in Period 2|Adverse Event|4|||
33425482|NCT02094937|101449630|FG003|12 Weeks in Period 2|Adverse Event|1|||
33425483|NCT02094937|101449627|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
33425484|NCT02094937|101449628|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
33425485|NCT02094937|101449629|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
33425486|NCT02094937|101449630|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
33425487|NCT02094937|101449627|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
33425488|NCT02094937|101449628|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
33425489|NCT02094937|101449629|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
33425490|NCT02094937|101449630|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
33425491|NCT02094937|101449627|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
33425492|NCT02094937|101449628|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
33425493|NCT02094937|101449629|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
33425494|NCT02094937|101449630|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
33425495|NCT02094937|101449627|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
33647290|NCT01175083|102259880|FG002|Booster Epoch|Withdrawal by Subject|0|||
33425496|NCT02094937|101449628|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
33647291|NCT01175083|102259881|FG003|Booster Epoch|Withdrawal by Subject|1|||
33425497|NCT02094937|101449629|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
33425498|NCT02094937|101449630|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
33425499|NCT00936884|101449632|FG000|Double-blind|Withdrawal by Subject|6|||
33425500|NCT00936884|101449633|FG001|Double-blind|Withdrawal by Subject|4|||
33425501|NCT00936884|101449634|FG002|Double-blind|Withdrawal by Subject|0|||
33425502|NCT00936884|101449632|FG000|Double-blind|Death|2|||
33425503|NCT00936884|101449633|FG001|Double-blind|Death|1|||
33425504|NCT00936884|101449634|FG002|Double-blind|Death|0|||
33425505|NCT00936884|101449632|FG000|Double-blind|Lack of Efficacy|1|||
33425506|NCT00936884|101449633|FG001|Double-blind|Lack of Efficacy|1|||
33425507|NCT00936884|101449634|FG002|Double-blind|Lack of Efficacy|0|||
33425508|NCT00936884|101449632|FG000|Double-blind|Adverse Event|1|||
33425509|NCT00936884|101449633|FG001|Double-blind|Adverse Event|0|||
33425510|NCT00936884|101449634|FG002|Double-blind|Adverse Event|0|||
33425511|NCT00936884|101449632|FG000|Double-blind|Physician Decision|1|||
33425512|NCT00936884|101449633|FG001|Double-blind|Physician Decision|0|||
33425513|NCT00936884|101449634|FG002|Double-blind|Physician Decision|0|||
33425514|NCT00936884|101449632|FG000|Double-blind|No post baseline diary entry|1|||
33425515|NCT00936884|101449633|FG001|Double-blind|No post baseline diary entry|0|||
33425516|NCT00936884|101449634|FG002|Double-blind|No post baseline diary entry|0|||
33425517|NCT00936884|101449632|FG000|Double-blind|Did not receive study drug|0|||
33425518|NCT00936884|101449633|FG001|Double-blind|Did not receive study drug|1|||
33425519|NCT00936884|101449634|FG002|Double-blind|Did not receive study drug|0|||
33425520|NCT00856778|101449635|FG000|Overall Study|Adverse Event|7|||
33425521|NCT00856778|101449635|FG000|Overall Study|Withdrawal by Subject|10|||
33425522|NCT00856778|101449635|FG000|Overall Study|Study deviation|2|||
33425523|NCT00856778|101449635|FG000|Overall Study|Lost to Follow-up|5|||
33425524|NCT01326702|101449636|FG000|Overall Study|Other|1|||
33425525|NCT01326702|101449637|FG001|Overall Study|Other|0|||
33425526|NCT01326702|101449638|FG002|Overall Study|Other|0|||
33425527|NCT01326702|101449639|FG003|Overall Study|Other|0|||
33425528|NCT01326702|101449640|FG004|Overall Study|Other|0|||
33425529|NCT01326702|101449641|FG005|Overall Study|Other|1|||
33425530|NCT01326702|101449642|FG006|Overall Study|Other|0|||
33425531|NCT01326702|101449636|FG000|Overall Study|progressive disease|1|||
33425532|NCT01326702|101449637|FG001|Overall Study|progressive disease|1|||
33425533|NCT01326702|101449638|FG002|Overall Study|progressive disease|3|||
33425534|NCT01326702|101449639|FG003|Overall Study|progressive disease|1|||
33425535|NCT01326702|101449640|FG004|Overall Study|progressive disease|3|||
33425536|NCT01326702|101449641|FG005|Overall Study|progressive disease|2|||
33425537|NCT01326702|101449642|FG006|Overall Study|progressive disease|3|||
33425538|NCT01326702|101449636|FG000|Overall Study|Death|0|||
33425539|NCT01326702|101449637|FG001|Overall Study|Death|1|||
33425540|NCT01326702|101449638|FG002|Overall Study|Death|0|||
33425541|NCT01326702|101449639|FG003|Overall Study|Death|0|||
33425542|NCT01326702|101449640|FG004|Overall Study|Death|0|||
33425543|NCT01326702|101449641|FG005|Overall Study|Death|0|||
33425544|NCT01326702|101449642|FG006|Overall Study|Death|0|||
33425545|NCT01326702|101449636|FG000|Overall Study|Adverse Event|0|||
33425546|NCT01326702|101449637|FG001|Overall Study|Adverse Event|0|||
33425547|NCT01326702|101449638|FG002|Overall Study|Adverse Event|1|||
33425548|NCT01326702|101449639|FG003|Overall Study|Adverse Event|1|||
33425549|NCT01326702|101449640|FG004|Overall Study|Adverse Event|0|||
33425550|NCT01326702|101449641|FG005|Overall Study|Adverse Event|3|||
33425551|NCT01326702|101449642|FG006|Overall Study|Adverse Event|1|||
33425552|NCT01326702|101449636|FG000|Overall Study|Withdrawal by Subject|0|||
33425553|NCT01326702|101449637|FG001|Overall Study|Withdrawal by Subject|0|||
33248122|NCT03982199|100810142|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
33248123|NCT03982199|100810129|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
33248124|NCT03982199|100810130|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
33248125|NCT03982199|100810131|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
33248126|NCT03982199|100810132|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
33248127|NCT03982199|100810133|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
33248128|NCT03982199|100810134|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
33248129|NCT03982199|100810135|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
33248130|NCT03982199|100810136|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
33248131|NCT03982199|100810137|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
33248132|NCT03982199|100810138|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
33248133|NCT03982199|100810139|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
33248134|NCT03982199|100810140|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
33248135|NCT03982199|100810141|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
33248136|NCT03982199|100810142|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
33248137|NCT03982199|100810129|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
33248138|NCT03982199|100810130|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
33248139|NCT03982199|100810131|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
33248140|NCT03982199|100810132|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
33425554|NCT01326702|101449638|FG002|Overall Study|Withdrawal by Subject|1|||
33425555|NCT01326702|101449639|FG003|Overall Study|Withdrawal by Subject|0|||
33425556|NCT01326702|101449640|FG004|Overall Study|Withdrawal by Subject|1|||
33425557|NCT01326702|101449641|FG005|Overall Study|Withdrawal by Subject|1|||
33425558|NCT01326702|101449642|FG006|Overall Study|Withdrawal by Subject|3|||
33425559|NCT01326702|101449636|FG000|Overall Study|Not Treated|0|||
33425560|NCT01326702|101449637|FG001|Overall Study|Not Treated|0|||
33425561|NCT01326702|101449638|FG002|Overall Study|Not Treated|0|||
33425562|NCT01326702|101449639|FG003|Overall Study|Not Treated|1|||
33425563|NCT01326702|101449640|FG004|Overall Study|Not Treated|0|||
33425564|NCT01326702|101449641|FG005|Overall Study|Not Treated|1|||
33425565|NCT01326702|101449642|FG006|Overall Study|Not Treated|0|||
33425566|NCT02092961|101449643|FG000|Overall Study|Not reported|1|||
33425567|NCT02092961|101449644|FG001|Overall Study|Not reported|0|||
33425568|NCT02092961|101449645|FG002|Overall Study|Not reported|1|||
33425569|NCT02092961|101449643|FG000|Overall Study|Study stopped|13|||
33425570|NCT02092961|101449644|FG001|Overall Study|Study stopped|9|||
33425571|NCT02092961|101449645|FG002|Overall Study|Study stopped|12|||
33425572|NCT02092961|101449643|FG000|Overall Study|Lack of therapeutic response|2|||
33425573|NCT02092961|101449644|FG001|Overall Study|Lack of therapeutic response|1|||
33425574|NCT02092961|101449645|FG002|Overall Study|Lack of therapeutic response|3|||
33425575|NCT02092961|101449643|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
33425576|NCT02092961|101449644|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
33425577|NCT02092961|101449645|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
33425578|NCT02092961|101449643|FG000|Overall Study|Adverse Event|2|||
33425579|NCT02092961|101449644|FG001|Overall Study|Adverse Event|4|||
33425580|NCT02092961|101449645|FG002|Overall Study|Adverse Event|0|||
33380343|NCT01026389|101276677|FG001|Overall Study|change of treatment, patient moved|2|||
33380344|NCT00280150|101276678|FG000|Overall Study|Adverse Event|0|||
33380345|NCT00280150|101276679|FG001|Overall Study|Adverse Event|1|||
33380346|NCT00280150|101276680|FG002|Overall Study|Adverse Event|2|||
33380347|NCT00280150|101276681|FG003|Overall Study|Adverse Event|3|||
33380348|NCT00280150|101276678|FG000|Overall Study|Lack of Efficacy|0|||
33380349|NCT00280150|101276679|FG001|Overall Study|Lack of Efficacy|0|||
33380350|NCT00280150|101276680|FG002|Overall Study|Lack of Efficacy|0|||
33380351|NCT00280150|101276681|FG003|Overall Study|Lack of Efficacy|3|||
33380352|NCT00280150|101276678|FG000|Overall Study|Physician Decision|0|||
33380353|NCT00280150|101276679|FG001|Overall Study|Physician Decision|0|||
33380354|NCT00280150|101276680|FG002|Overall Study|Physician Decision|0|||
33380355|NCT00280150|101276681|FG003|Overall Study|Physician Decision|1|||
33380356|NCT00280150|101276678|FG000|Overall Study|Protocol Violation|0|||
33425581|NCT01252238|101449648|FG000|Overall Study|Sponsor terminated study|4|||
33425582|NCT01252238|101449649|FG001|Overall Study|Sponsor terminated study|4|||
33425583|NCT01252238|101449650|FG002|Overall Study|Sponsor terminated study|4|||
33425584|NCT01361607|101449651|FG000|Overall Study|Adverse Event|38|||
33425585|NCT01361607|101449652|FG001|Overall Study|Adverse Event|29|||
33425586|NCT01361607|101449651|FG000|Overall Study|Withdrawal by Subject|19|||
33425587|NCT01361607|101449652|FG001|Overall Study|Withdrawal by Subject|8|||
33425588|NCT01361607|101449651|FG000|Overall Study|Withdrawal by Investigator|5|||
33425589|NCT01361607|101449652|FG001|Overall Study|Withdrawal by Investigator|3|||
33425590|NCT01361607|101449651|FG000|Overall Study|Lost to Follow-up|1|||
33425591|NCT01361607|101449652|FG001|Overall Study|Lost to Follow-up|0|||
33425592|NCT01361607|101449651|FG000|Overall Study|Met Withdrawal Criteria|1|||
33425593|NCT01361607|101449652|FG001|Overall Study|Met Withdrawal Criteria|1|||
33425594|NCT01325532|101449653|FG000|Overall Study|Withdrawal by Subject|2|||
33587271|NCT03427814|102038449|FG000|Overall Study|Lost to Follow-up|0|||
33587272|NCT03427814|102038450|FG001|Overall Study|Lost to Follow-up|2|||
33587273|NCT03427814|102038449|FG000|Overall Study|Death|42|||
33587274|NCT03427814|102038450|FG001|Overall Study|Death|31|||
33587275|NCT03427814|102038449|FG000|Overall Study|Sponsor's Decision|1|||
33587276|NCT03427814|102038450|FG001|Overall Study|Sponsor's Decision|0|||
33587277|NCT03427814|102038449|FG000|Overall Study|Investigator's Decision|1|||
33587278|NCT03427814|102038450|FG001|Overall Study|Investigator's Decision|2|||
33587279|NCT03427814|102038449|FG000|Overall Study|Disease progression|1|||
33587280|NCT03427814|102038450|FG001|Overall Study|Disease progression|0|||
33587281|NCT03427814|102038449|FG000|Overall Study|Treatment Completed|0|||
33587282|NCT03427814|102038450|FG001|Overall Study|Treatment Completed|1|||
33587283|NCT03427814|102038449|FG000|Overall Study|Sponsor's Decision to End study|21|||
33587284|NCT03427814|102038450|FG001|Overall Study|Sponsor's Decision to End study|25|||
33587285|NCT03427814|102038449|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
33587286|NCT03427814|102038450|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
33380357|NCT00280150|101276679|FG001|Overall Study|Protocol Violation|0|||
33587287|NCT00443053|102038451|FG000|Overall Study|Adverse Event|2|||
33587288|NCT00443053|102038452|FG001|Overall Study|Adverse Event|1|||
33425595|NCT01325532|101449654|FG001|Overall Study|Withdrawal by Subject|0|||
33425596|NCT03210259|101449655|FG000|12-Week Run-in Period|Adverse Event|1|||
33587289|NCT00443053|102038451|FG000|Overall Study|Withdrawal by Subject|9|||
33647292|NCT01175083|102259882|FG004|Booster Epoch|Withdrawal by Subject|0|||
33587290|NCT00443053|102038452|FG001|Overall Study|Withdrawal by Subject|18|||
33587291|NCT00443053|102038451|FG000|Overall Study|Lost to Follow-up|4|||
33647293|NCT01175083|102259883|FG005|Booster Epoch|Withdrawal by Subject|0|||
33647294|NCT04027608|102259887|FG000|Overall Study|Withdrawal by Subject|13|||
33380358|NCT00280150|101276680|FG002|Overall Study|Protocol Violation|0|||
33380359|NCT00280150|101276681|FG003|Overall Study|Protocol Violation|1|||
33380360|NCT00280150|101276678|FG000|Overall Study|Withdrawal by Subject|0|||
33425597|NCT03210259|101449656|FG001|12-Week Run-in Period|Adverse Event|0|||
33425598|NCT03210259|101449657|FG002|12-Week Run-in Period|Adverse Event|0|||
33425599|NCT03210259|101449655|FG000|12-Week Run-in Period|Death|1|||
33425600|NCT03210259|101449656|FG001|12-Week Run-in Period|Death|0|||
33425601|NCT03210259|101449657|FG002|12-Week Run-in Period|Death|0|||
33425602|NCT03210259|101449655|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
33425603|NCT03210259|101449656|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
33425604|NCT03210259|101449657|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
33587292|NCT00443053|102038452|FG001|Overall Study|Lost to Follow-up|5|||
33587293|NCT00443053|102038451|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
33149247|NCT02970318|100460695|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
33149248|NCT02970318|100460696|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
33149249|NCT02970318|100460693|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
33149250|NCT02970318|100460694|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
33380361|NCT00280150|101276679|FG001|Overall Study|Withdrawal by Subject|0|||
33380362|NCT00280150|101276680|FG002|Overall Study|Withdrawal by Subject|0|||
33380363|NCT00280150|101276681|FG003|Overall Study|Withdrawal by Subject|1|||
33380364|NCT00280150|101276678|FG000|Overall Study|Did not get consolidation therapy|3|||
33380365|NCT00280150|101276679|FG001|Overall Study|Did not get consolidation therapy|0|||
33380366|NCT00280150|101276680|FG002|Overall Study|Did not get consolidation therapy|3|||
33380367|NCT00280150|101276681|FG003|Overall Study|Did not get consolidation therapy|0|||
33380368|NCT00280150|101276678|FG000|Overall Study|Declining Performance Status|0|||
33380369|NCT00280150|101276679|FG001|Overall Study|Declining Performance Status|0|||
33380370|NCT00280150|101276680|FG002|Overall Study|Declining Performance Status|0|||
33380371|NCT00280150|101276681|FG003|Overall Study|Declining Performance Status|1|||
33380372|NCT01764256|101276684|FG000|Received All Vaccinations|Adverse Event|1|||
33380373|NCT01764256|101276685|FG001|Received All Vaccinations|Adverse Event|1|||
33380374|NCT01764256|101276686|FG002|Received All Vaccinations|Adverse Event|0|||
33380375|NCT01764256|101276687|FG003|Received All Vaccinations|Adverse Event|0|||
33380376|NCT01764256|101276684|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
33380377|NCT01764256|101276685|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
33380378|NCT01764256|101276686|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
33380379|NCT01764256|101276687|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
33380380|NCT01764256|101276684|FG000|Received All Vaccinations|Lost to Follow-up|1|||
33380381|NCT01764256|101276685|FG001|Received All Vaccinations|Lost to Follow-up|0|||
33380382|NCT01764256|101276686|FG002|Received All Vaccinations|Lost to Follow-up|0|||
33380383|NCT01764256|101276687|FG003|Received All Vaccinations|Lost to Follow-up|0|||
33380384|NCT01764256|101276684|FG000|Completed Study|Lost to Follow-up|0|||
33380385|NCT01764256|101276685|FG001|Completed Study|Lost to Follow-up|0|||
33380386|NCT01764256|101276686|FG002|Completed Study|Lost to Follow-up|0|||
33380387|NCT01764256|101276687|FG003|Completed Study|Lost to Follow-up|1|||
33380388|NCT01954251|101276688|FG000|Overall Study|Adverse Event|5|||
33380389|NCT01954251|101276689|FG001|Overall Study|Adverse Event|7|||
33380390|NCT01954251|101276688|FG000|Overall Study|Lost to Follow-up|6|||
33380391|NCT01954251|101276689|FG001|Overall Study|Lost to Follow-up|6|||
33380392|NCT01954251|101276688|FG000|Overall Study|Withdrawal by Subject|2|||
33380393|NCT01954251|101276689|FG001|Overall Study|Withdrawal by Subject|6|||
33380394|NCT00194025|101276690|FG000|Overall Study|Adverse Event|1|||
33380395|NCT00194025|101276690|FG000|Overall Study|non-adherence with study medication|4|||
33380396|NCT02475395|101276697|FG000|Overall Study|Protocol Violation|30|||
33380397|NCT02475395|101276698|FG001|Overall Study|Protocol Violation|3|||
33380398|NCT01995136|101276699|FG000|Overall Study|Change in residence|1|||
33380399|NCT01431144|101276703|FG000|Overall Study|Implant mobility and removal|2|||
33380400|NCT01431144|101276704|FG001|Overall Study|Implant mobility and removal|0|||
33380401|NCT04603391|101276705|FG000|First Intervention (4 Days)|Adverse Event|1|||
33380402|NCT04603391|101276706|FG001|First Intervention (4 Days)|Adverse Event|0|||
33380403|NCT04603391|101276705|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
33380404|NCT04603391|101276706|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
33380405|NCT03543358|101276707|FG000|Overall Study|Death|1|||
33380406|NCT03543358|101276708|FG001|Overall Study|Death|0|||
33149251|NCT02970318|100460695|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
33149252|NCT02970318|100460696|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
33248141|NCT03982199|100810133|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
33380407|NCT03543358|101276707|FG000|Overall Study|Disease Progression|1|||
33380408|NCT03543358|101276708|FG001|Overall Study|Disease Progression|0|||
33380409|NCT03543358|101276707|FG000|Overall Study|Parent Study Closure|1|||
33380410|NCT03543358|101276708|FG001|Overall Study|Parent Study Closure|0|||
33380411|NCT00326417|101276709|FG000|Overall Study|Withdrawal by Subject|0|||
33380412|NCT00326417|101276710|FG001|Overall Study|Withdrawal by Subject|0|||
33380413|NCT00326417|101276711|FG002|Overall Study|Withdrawal by Subject|1|||
33380414|NCT00326417|101276712|FG003|Overall Study|Withdrawal by Subject|0|||
33380415|NCT00326417|101276709|FG000|Overall Study|Arm Closed|7|||
33425605|NCT03210259|101449655|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
33425606|NCT03210259|101449656|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
33587294|NCT00443053|102038452|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
33425607|NCT03210259|101449657|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
33425608|NCT03210259|101449655|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
33425609|NCT03210259|101449656|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
33425610|NCT03210259|101449657|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
33425611|NCT03210259|101449655|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
33425612|NCT03210259|101449656|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
33425613|NCT03210259|101449657|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
33425614|NCT03210259|101449655|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
33425615|NCT03210259|101449656|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
33425616|NCT03210259|101449657|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
33425617|NCT03210259|101449655|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
33425618|NCT03210259|101449656|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
33425619|NCT03210259|101449657|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
33425620|NCT03210259|101449655|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
33425621|NCT03210259|101449656|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
33425622|NCT03210259|101449657|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
33425623|NCT03210259|101449655|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
33425624|NCT03210259|101449656|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
33425625|NCT03210259|101449657|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
33425626|NCT03210259|101449655|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
33425627|NCT03210259|101449656|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
33425628|NCT03210259|101449657|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
33425629|NCT00770315|101449658|FG000|Overall Study|Adverse Event|11|||
33425630|NCT00770315|101449659|FG001|Overall Study|Adverse Event|17|||
33425631|NCT00770315|101449660|FG002|Overall Study|Adverse Event|16|||
33425632|NCT00770315|101449661|FG003|Overall Study|Adverse Event|6|||
33425633|NCT00770315|101449658|FG000|Overall Study|Lost to Follow-up|9|||
33425634|NCT00770315|101449659|FG001|Overall Study|Lost to Follow-up|5|||
33425635|NCT00770315|101449660|FG002|Overall Study|Lost to Follow-up|10|||
33425636|NCT00770315|101449661|FG003|Overall Study|Lost to Follow-up|3|||
33647295|NCT04027608|102259888|FG001|Overall Study|Withdrawal by Subject|2|||
33647296|NCT04027608|102259887|FG000|Overall Study|Protocol Violation|2|||
33647297|NCT04027608|102259888|FG001|Overall Study|Protocol Violation|1|||
33647298|NCT04027608|102259887|FG000|Overall Study|Physician Decision|1|||
33647299|NCT04027608|102259888|FG001|Overall Study|Physician Decision|0|||
33380416|NCT00326417|101276710|FG001|Overall Study|Arm Closed|0|||
33380417|NCT00326417|101276711|FG002|Overall Study|Arm Closed|0|||
33380418|NCT00326417|101276712|FG003|Overall Study|Arm Closed|3|||
33380419|NCT00326417|101276709|FG000|Overall Study|Death|7|||
33380420|NCT00326417|101276710|FG001|Overall Study|Death|0|||
33380421|NCT00326417|101276711|FG002|Overall Study|Death|0|||
33380422|NCT00326417|101276712|FG003|Overall Study|Death|0|||
33380423|NCT03454412|101276714|FG000|Baseline Assesment|Physician Decision|12|||
33380424|NCT02721251|101276715|FG000|Overall Study|Withdrawal by Subject|8|||
33380425|NCT02721251|101276716|FG001|Overall Study|Withdrawal by Subject|7|||
33380426|NCT02721251|101276717|FG002|Overall Study|Withdrawal by Subject|9|||
33149253|NCT02970318|100460693|FG000|Overall for Arm A & Main for Arm B|Death|41|||
33149254|NCT02970318|100460694|FG001|Overall for Arm A & Main for Arm B|Death|33|||
33149255|NCT02970318|100460695|FG002|Overall for Arm A & Main for Arm B|Death|0|||
33149256|NCT02970318|100460696|FG003|Overall for Arm A & Main for Arm B|Death|0|||
33149257|NCT02970318|100460693|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
33149258|NCT02970318|100460694|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
33149259|NCT02970318|100460695|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
33248142|NCT03982199|100810134|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
33380427|NCT02721251|101276715|FG000|Overall Study|poor adherence|2|||
33380428|NCT02721251|101276716|FG001|Overall Study|poor adherence|2|||
33380429|NCT02721251|101276717|FG002|Overall Study|poor adherence|2|||
33380430|NCT01670656|101276718|FG000|Overall Study|Non-compliance with study drug|0|||
33380431|NCT01670656|101276719|FG001|Overall Study|Non-compliance with study drug|0|||
33380432|NCT01670656|101276720|FG002|Overall Study|Non-compliance with study drug|3|||
33380433|NCT01670656|101276721|FG003|Overall Study|Non-compliance with study drug|0|||
33380434|NCT01670656|101276722|FG004|Overall Study|Non-compliance with study drug|1|||
33380435|NCT01670656|101276718|FG000|Overall Study|Pregnancy|0|||
33380436|NCT01670656|101276719|FG001|Overall Study|Pregnancy|0|||
33380437|NCT01670656|101276720|FG002|Overall Study|Pregnancy|0|||
33380438|NCT01670656|101276721|FG003|Overall Study|Pregnancy|0|||
33380439|NCT01670656|101276722|FG004|Overall Study|Pregnancy|1|||
33425637|NCT00770315|101449658|FG000|Overall Study|Withdrawal by Subject|13|||
33425638|NCT00770315|101449659|FG001|Overall Study|Withdrawal by Subject|17|||
33425639|NCT00770315|101449660|FG002|Overall Study|Withdrawal by Subject|24|||
33425640|NCT00770315|101449661|FG003|Overall Study|Withdrawal by Subject|20|||
33380440|NCT01670656|101276718|FG000|Overall Study|Withdrawal by Subject|1|||
33380441|NCT01670656|101276719|FG001|Overall Study|Withdrawal by Subject|1|||
33380442|NCT01670656|101276720|FG002|Overall Study|Withdrawal by Subject|0|||
33380443|NCT01670656|101276721|FG003|Overall Study|Withdrawal by Subject|0|||
33380444|NCT01670656|101276722|FG004|Overall Study|Withdrawal by Subject|0|||
33380445|NCT01670656|101276718|FG000|Overall Study|Non-compliance with protocol|0|||
33380446|NCT01670656|101276719|FG001|Overall Study|Non-compliance with protocol|3|||
33380447|NCT01670656|101276720|FG002|Overall Study|Non-compliance with protocol|1|||
33380448|NCT01670656|101276721|FG003|Overall Study|Non-compliance with protocol|1|||
33380449|NCT01670656|101276722|FG004|Overall Study|Non-compliance with protocol|2|||
33380450|NCT01670656|101276718|FG000|Overall Study|Adverse Event|2|||
33380451|NCT01670656|101276719|FG001|Overall Study|Adverse Event|2|||
33380452|NCT01670656|101276720|FG002|Overall Study|Adverse Event|2|||
33380453|NCT01670656|101276721|FG003|Overall Study|Adverse Event|3|||
33380454|NCT01670656|101276722|FG004|Overall Study|Adverse Event|3|||
33380455|NCT01670656|101276718|FG000|Overall Study|Subject withdrew consent|0|||
33380456|NCT01670656|101276719|FG001|Overall Study|Subject withdrew consent|1|||
33380457|NCT01670656|101276720|FG002|Overall Study|Subject withdrew consent|2|||
33380458|NCT01670656|101276721|FG003|Overall Study|Subject withdrew consent|1|||
33380459|NCT01670656|101276722|FG004|Overall Study|Subject withdrew consent|1|||
33380460|NCT01670656|101276718|FG000|Overall Study|Lost to Follow-up|0|||
33380461|NCT01670656|101276719|FG001|Overall Study|Lost to Follow-up|0|||
33380462|NCT01670656|101276720|FG002|Overall Study|Lost to Follow-up|0|||
33380463|NCT01670656|101276721|FG003|Overall Study|Lost to Follow-up|0|||
33380464|NCT01670656|101276722|FG004|Overall Study|Lost to Follow-up|3|||
33425641|NCT00770315|101449658|FG000|Overall Study|Noncompliance with Protocol|7|||
33425642|NCT00770315|101449659|FG001|Overall Study|Noncompliance with Protocol|4|||
33248143|NCT03982199|100810135|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
33425643|NCT00770315|101449660|FG002|Overall Study|Noncompliance with Protocol|7|||
33425644|NCT00770315|101449661|FG003|Overall Study|Noncompliance with Protocol|9|||
33425645|NCT04242186|101449665|FG000|Overall Study|Death|5|||
33425646|NCT04535583|101449669|FG000|Overall Study|Lost to Follow-up|1|||
33425647|NCT04535583|101449669|FG000|Overall Study|Physician Decision|1|||
33425648|NCT04535583|101449669|FG000|Overall Study|Withdrawal by Subject|1|||
33425649|NCT01270841|101449670|FG000|Overall Study|Adverse Event|0|||
33425650|NCT01270841|101449671|FG001|Overall Study|Adverse Event|1|||
33425651|NCT01270841|101449672|FG002|Overall Study|Adverse Event|0|||
33425652|NCT01270841|101449673|FG003|Overall Study|Adverse Event|3|||
33425653|NCT01270841|101449670|FG000|Overall Study|Withdrawal by Subject|3|||
33425654|NCT01270841|101449671|FG001|Overall Study|Withdrawal by Subject|2|||
33425655|NCT01270841|101449672|FG002|Overall Study|Withdrawal by Subject|3|||
33425656|NCT01270841|101449673|FG003|Overall Study|Withdrawal by Subject|3|||
33425657|NCT01270841|101449670|FG000|Overall Study|Lost to Follow-up|3|||
33425658|NCT01270841|101449671|FG001|Overall Study|Lost to Follow-up|1|||
33425659|NCT01270841|101449672|FG002|Overall Study|Lost to Follow-up|4|||
33425660|NCT01270841|101449673|FG003|Overall Study|Lost to Follow-up|2|||
33425661|NCT01270841|101449670|FG000|Overall Study|Physician Decision|0|||
33425662|NCT01270841|101449671|FG001|Overall Study|Physician Decision|1|||
33425663|NCT01270841|101449672|FG002|Overall Study|Physician Decision|0|||
33425664|NCT01270841|101449673|FG003|Overall Study|Physician Decision|0|||
33425665|NCT01270841|101449670|FG000|Overall Study|Did not qualify|6|||
33425666|NCT01270841|101449671|FG001|Overall Study|Did not qualify|3|||
33425667|NCT01270841|101449672|FG002|Overall Study|Did not qualify|4|||
33425668|NCT01270841|101449673|FG003|Overall Study|Did not qualify|5|||
33425669|NCT01270841|101449670|FG000|Overall Study|Protocol Violation|1|||
33425670|NCT01270841|101449671|FG001|Overall Study|Protocol Violation|5|||
33425671|NCT01270841|101449672|FG002|Overall Study|Protocol Violation|0|||
33425672|NCT01270841|101449673|FG003|Overall Study|Protocol Violation|0|||
33425673|NCT01270841|101449670|FG000|Overall Study|Enrolled in error|0|||
33425674|NCT01270841|101449671|FG001|Overall Study|Enrolled in error|1|||
33587295|NCT00443053|102038451|FG000|Overall Study|Noncompliance|2|||
33587296|NCT00443053|102038452|FG001|Overall Study|Noncompliance|1|||
33587297|NCT00443053|102038451|FG000|Overall Study|Other|3|||
33587298|NCT00443053|102038452|FG001|Overall Study|Other|4|||
33587299|NCT00443053|102038451|FG000|Overall Study|Physician Decision|0|||
33587300|NCT00443053|102038452|FG001|Overall Study|Physician Decision|4|||
33587301|NCT00316706|102038463|FG000|Overall Study|Lost to Follow-up|38|||
33380465|NCT01670656|101276718|FG000|Overall Study|Subject moved|0|||
33380466|NCT01670656|101276719|FG001|Overall Study|Subject moved|0|||
33380467|NCT01670656|101276720|FG002|Overall Study|Subject moved|0|||
33380468|NCT01670656|101276721|FG003|Overall Study|Subject moved|1|||
33425675|NCT01270841|101449672|FG002|Overall Study|Enrolled in error|0|||
33425676|NCT01270841|101449673|FG003|Overall Study|Enrolled in error|0|||
33425677|NCT00124449|101449674|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
33425678|NCT00124449|101449675|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
33425679|NCT00124449|101449674|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
33587302|NCT00316706|102038464|FG001|Overall Study|Lost to Follow-up|48|||
33380469|NCT01670656|101276722|FG004|Overall Study|Subject moved|0|||
33380470|NCT01840228|101276727|FG000|Overall Study|Lost to Follow-up|1|||
33425680|NCT00124449|101449675|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
33587303|NCT00632827|102038468|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
33647300|NCT04027608|102259887|FG000|Overall Study|Lost to Follow-up|20|||
33647301|NCT04027608|102259888|FG001|Overall Study|Lost to Follow-up|4|||
33647302|NCT01675544|102259889|FG000|Overall Study|Withdrawal by Subject|2|||
33647303|NCT01068600|102259890|FG000|Overall Study|Withdrawal by Subject|5|||
33647304|NCT01068600|102259891|FG001|Overall Study|Withdrawal by Subject|6|||
33647305|NCT01068600|102259890|FG000|Overall Study|Adverse Event|3|||
33647306|NCT01068600|102259891|FG001|Overall Study|Adverse Event|3|||
33647307|NCT01068600|102259890|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33647308|NCT01068600|102259891|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33647309|NCT01068600|102259890|FG000|Overall Study|Lost to Follow-up|1|||
33647310|NCT01068600|102259891|FG001|Overall Study|Lost to Follow-up|2|||
33647311|NCT01068600|102259890|FG000|Overall Study|Protocol deviation|1|||
33647312|NCT01068600|102259891|FG001|Overall Study|Protocol deviation|1|||
33647313|NCT01068600|102259890|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33647314|NCT01068600|102259891|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
33647315|NCT01068600|102259890|FG000|Overall Study|Administrative problems|0|||
33647316|NCT01068600|102259891|FG001|Overall Study|Administrative problems|1|||
33647317|NCT00776919|102259893|FG000|Overall Study|Withdrawal by Subject|16|||
33647318|NCT00776919|102259894|FG001|Overall Study|Withdrawal by Subject|14|||
33647319|NCT00776919|102259895|FG002|Overall Study|Withdrawal by Subject|15|||
33647320|NCT00776919|102259896|FG003|Overall Study|Withdrawal by Subject|26|||
33647321|NCT00776919|102259893|FG000|Overall Study|Lost to Follow-up|8|||
33647322|NCT00776919|102259894|FG001|Overall Study|Lost to Follow-up|12|||
33647323|NCT00776919|102259895|FG002|Overall Study|Lost to Follow-up|11|||
33647324|NCT00776919|102259896|FG003|Overall Study|Lost to Follow-up|8|||
33647325|NCT00776919|102259893|FG000|Overall Study|Adverse Event|1|||
33647326|NCT00776919|102259894|FG001|Overall Study|Adverse Event|0|||
33647327|NCT00776919|102259895|FG002|Overall Study|Adverse Event|2|||
33647328|NCT00776919|102259896|FG003|Overall Study|Adverse Event|2|||
33647329|NCT00776919|102259893|FG000|Overall Study|Protocol Violation|1|||
33647330|NCT00776919|102259894|FG001|Overall Study|Protocol Violation|2|||
33647331|NCT00776919|102259895|FG002|Overall Study|Protocol Violation|0|||
33647332|NCT00776919|102259896|FG003|Overall Study|Protocol Violation|1|||
33647333|NCT00776919|102259893|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
33647334|NCT00776919|102259894|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
33647335|NCT00776919|102259895|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
33647336|NCT00776919|102259896|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
33647337|NCT04345367|102259900|FG000|Overall Study|Other|3|||
33647338|NCT04345367|102259901|FG001|Overall Study|Other|4|||
33647339|NCT04345367|102259900|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
33647340|NCT04345367|102259901|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
33149260|NCT02970318|100460696|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
33149261|NCT02970318|100460693|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
33380471|NCT01840228|101276728|FG001|Overall Study|Lost to Follow-up|1|||
33380472|NCT00363051|101276729|FG000|Overall Study|Adminstrative problems|1|||
33380473|NCT00363051|101276730|FG001|Overall Study|Adminstrative problems|1|||
33380474|NCT00363051|101276729|FG000|Overall Study|Adverse Event|21|||
33380475|NCT00363051|101276730|FG001|Overall Study|Adverse Event|12|||
33380476|NCT00363051|101276729|FG000|Overall Study|New Cancer Therapy|2|||
33380477|NCT00363051|101276730|FG001|Overall Study|New Cancer Therapy|1|||
33380478|NCT00363051|101276729|FG000|Overall Study|Withdrawal by Subject|11|||
33380479|NCT00363051|101276730|FG001|Overall Study|Withdrawal by Subject|3|||
33380480|NCT00363051|101276729|FG000|Overall Study|Lost to Follow-up|0|||
33380481|NCT00363051|101276730|FG001|Overall Study|Lost to Follow-up|1|||
33380482|NCT00363051|101276729|FG000|Overall Study|Protocol Violation|0|||
33380483|NCT00363051|101276730|FG001|Overall Study|Protocol Violation|2|||
33380484|NCT00363051|101276729|FG000|Overall Study|Death|3|||
33380485|NCT00363051|101276730|FG001|Overall Study|Death|2|||
33380486|NCT00126581|101276733|FG000|Overall Study|Adverse Event|3|||
33380487|NCT00126581|101276734|FG001|Overall Study|Adverse Event|7|||
33380488|NCT00126581|101276733|FG000|Overall Study|Death|3|||
33380489|NCT00126581|101276734|FG001|Overall Study|Death|2|||
33647341|NCT04345367|102259900|FG000|Overall Study|Withdrawal by Subject|11|||
33647342|NCT04345367|102259901|FG001|Overall Study|Withdrawal by Subject|11|||
33647343|NCT04345367|102259900|FG000|Overall Study|Protocol Violation|4|||
33647344|NCT04345367|102259901|FG001|Overall Study|Protocol Violation|3|||
33380490|NCT00126581|101276733|FG000|Overall Study|Withdrawal by Subject|1|||
33380491|NCT00126581|101276734|FG001|Overall Study|Withdrawal by Subject|4|||
33380492|NCT00126581|101276733|FG000|Overall Study|Alternative therapy|3|||
33380493|NCT00126581|101276734|FG001|Overall Study|Alternative therapy|3|||
33380494|NCT00126581|101276733|FG000|Overall Study|Other illness/MD discretion|3|||
33380495|NCT00126581|101276734|FG001|Overall Study|Other illness/MD discretion|4|||
33380496|NCT00729326|101276736|FG000|Overall Study|Lost to Follow-up|2|||
33380497|NCT00729326|101276737|FG001|Overall Study|Lost to Follow-up|0|||
33647345|NCT04345367|102259900|FG000|Overall Study|Lost to Follow-up|2|||
33647346|NCT04345367|102259901|FG001|Overall Study|Lost to Follow-up|4|||
33647347|NCT04345367|102259900|FG000|Overall Study|Lack of Efficacy|2|||
33425681|NCT00124449|101449674|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
33425682|NCT00124449|101449675|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
33425683|NCT00124449|101449674|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
33425684|NCT00124449|101449675|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
33425685|NCT00124449|101449674|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
33425686|NCT00124449|101449675|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
33425687|NCT00124449|101449674|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
33425688|NCT00124449|101449675|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
33425689|NCT00124449|101449674|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
33425690|NCT00124449|101449675|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
33425691|NCT00124449|101449674|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
33425692|NCT00124449|101449675|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
33425693|NCT00124449|101449674|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
33425694|NCT00124449|101449675|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
33425695|NCT00124449|101449674|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
33425696|NCT00124449|101449675|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
33425697|NCT00124449|101449674|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
33425698|NCT00124449|101449675|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
33425699|NCT00124449|101449674|FG000|18-Month Untreated Observation Period|Relocated|1|||
33425700|NCT00124449|101449675|FG001|18-Month Untreated Observation Period|Relocated|0|||
33425701|NCT03568500|101449676|FG000|Overall Study|Lost to Follow-up|1|||
33425702|NCT03568500|101449677|FG001|Overall Study|Lost to Follow-up|1|||
33425703|NCT03568500|101449678|FG002|Overall Study|Lost to Follow-up|2|||
33425704|NCT03568500|101449676|FG000|Overall Study|Adverse Event|1|||
33425705|NCT03568500|101449677|FG001|Overall Study|Adverse Event|1|||
33425706|NCT03568500|101449678|FG002|Overall Study|Adverse Event|2|||
33425707|NCT03568500|101449676|FG000|Overall Study|Physician Decision|1|||
33425708|NCT03568500|101449677|FG001|Overall Study|Physician Decision|0|||
33425709|NCT03568500|101449678|FG002|Overall Study|Physician Decision|0|||
33425710|NCT03568500|101449676|FG000|Overall Study|Withdrawal by Subject|4|||
33425711|NCT03568500|101449677|FG001|Overall Study|Withdrawal by Subject|2|||
33425712|NCT03568500|101449678|FG002|Overall Study|Withdrawal by Subject|0|||
33425713|NCT03568500|101449676|FG000|Overall Study|Technical Problems|2|||
33425714|NCT03568500|101449677|FG001|Overall Study|Technical Problems|1|||
33425715|NCT03568500|101449678|FG002|Overall Study|Technical Problems|0|||
33425716|NCT03568500|101449676|FG000|Overall Study|Participant Noncompliance|1|||
33425717|NCT03568500|101449677|FG001|Overall Study|Participant Noncompliance|1|||
33425718|NCT03568500|101449678|FG002|Overall Study|Participant Noncompliance|0|||
33425719|NCT02270983|101449689|FG000|Overall Study|Adverse Event|3|||
33425720|NCT02270983|101449690|FG001|Overall Study|Adverse Event|2|||
33425721|NCT02270983|101449691|FG002|Overall Study|Adverse Event|6|||
33425722|NCT02270983|101449689|FG000|Overall Study|Lack of Efficacy|2|||
33425723|NCT02270983|101449690|FG001|Overall Study|Lack of Efficacy|1|||
33425724|NCT02270983|101449691|FG002|Overall Study|Lack of Efficacy|1|||
33425725|NCT02270983|101449689|FG000|Overall Study|Withdrawal by Subject|1|||
33425726|NCT02270983|101449690|FG001|Overall Study|Withdrawal by Subject|0|||
33425727|NCT02270983|101449691|FG002|Overall Study|Withdrawal by Subject|2|||
33425728|NCT02270983|101449689|FG000|Overall Study|Lost to Follow-up|1|||
33425729|NCT02270983|101449690|FG001|Overall Study|Lost to Follow-up|1|||
33587304|NCT00632827|102038468|FG000|Overall Study|Death|2|||
33587305|NCT00632827|102038468|FG000|Overall Study|Adverse Event|5|||
33587306|NCT00632827|102038468|FG000|Overall Study|Lost to Follow-up|1|||
33587307|NCT00294671|102038469|FG000|Overall Study|Lack of Efficacy|11|||
33587308|NCT00294671|102038470|FG001|Overall Study|Lack of Efficacy|23|||
33587309|NCT00294671|102038469|FG000|Overall Study|Liver transplant|7|||
33587310|NCT00294671|102038470|FG001|Overall Study|Liver transplant|9|||
33587311|NCT00294671|102038469|FG000|Overall Study|Drug related adverse event (AE)|4|||
33587312|NCT00294671|102038470|FG001|Overall Study|Drug related adverse event (AE)|2|||
33587313|NCT00294671|102038469|FG000|Overall Study|Non-drug related AE|3|||
33587314|NCT00294671|102038470|FG001|Overall Study|Non-drug related AE|2|||
33587315|NCT00294671|102038469|FG000|Overall Study|Lost to Follow-up|1|||
33587316|NCT00294671|102038470|FG001|Overall Study|Lost to Follow-up|3|||
33587317|NCT00294671|102038469|FG000|Overall Study|Non-compliance|1|||
33149262|NCT02970318|100460694|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
33149263|NCT02970318|100460695|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
33149264|NCT02970318|100460696|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
33425730|NCT02270983|101449691|FG002|Overall Study|Lost to Follow-up|2|||
33425731|NCT02270983|101449689|FG000|Overall Study|Protocol Violation|1|||
33425732|NCT02270983|101449690|FG001|Overall Study|Protocol Violation|1|||
33425733|NCT02270983|101449691|FG002|Overall Study|Protocol Violation|1|||
33425734|NCT02270983|101449689|FG000|Overall Study|family emergency|0|||
33425735|NCT02270983|101449690|FG001|Overall Study|family emergency|1|||
33425736|NCT02270983|101449691|FG002|Overall Study|family emergency|0|||
33587318|NCT00294671|102038470|FG001|Overall Study|Non-compliance|0|||
33587319|NCT00294671|102038469|FG000|Overall Study|Death|0|||
33587320|NCT00294671|102038470|FG001|Overall Study|Death|1|||
33587321|NCT02547038|102038471|FG000|Overall Study|Lost to Follow-up|3|||
33587322|NCT02547038|102038472|FG001|Overall Study|Lost to Follow-up|2|||
33587323|NCT01534351|102038473|FG000|Overall Study|Study Terminated Early|1|||
33587324|NCT01534351|102038474|FG001|Overall Study|Study Terminated Early|0|||
33587325|NCT01534351|102038475|FG002|Overall Study|Study Terminated Early|0|||
33587326|NCT03594747|102038476|FG000|Overall Study|Death|78|||
33587327|NCT03594747|102038477|FG001|Overall Study|Death|86|||
33587328|NCT03594747|102038478|FG002|Overall Study|Death|87|||
33587329|NCT03594747|102038476|FG000|Overall Study|Withdrawal by Subject|5|||
33587330|NCT03594747|102038477|FG001|Overall Study|Withdrawal by Subject|2|||
33587331|NCT03594747|102038478|FG002|Overall Study|Withdrawal by Subject|11|||
33587332|NCT03594747|102038476|FG000|Overall Study|Lost to Follow-up|4|||
33149265|NCT02970318|100460693|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
33149266|NCT02970318|100460694|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
33149267|NCT02970318|100460695|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
33425737|NCT02270983|101449689|FG000|Overall Study|study procedure non-compliance|1|||
33425738|NCT02270983|101449690|FG001|Overall Study|study procedure non-compliance|0|||
33425739|NCT02270983|101449691|FG002|Overall Study|study procedure non-compliance|0|||
33425740|NCT02270983|101449689|FG000|Overall Study|moved away from study site|0|||
33587333|NCT03594747|102038477|FG001|Overall Study|Lost to Follow-up|1|||
33587334|NCT03594747|102038478|FG002|Overall Study|Lost to Follow-up|1|||
33587335|NCT03594747|102038476|FG000|Overall Study|Physician Decision|0|||
33587336|NCT03594747|102038477|FG001|Overall Study|Physician Decision|1|||
33587337|NCT03594747|102038478|FG002|Overall Study|Physician Decision|0|||
33587338|NCT03594747|102038476|FG000|Overall Study|Sponsor decision|23|||
33587339|NCT03594747|102038477|FG001|Overall Study|Sponsor decision|17|||
33587340|NCT03594747|102038478|FG002|Overall Study|Sponsor decision|16|||
33149268|NCT02970318|100460696|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
33425741|NCT02270983|101449690|FG001|Overall Study|moved away from study site|1|||
33425742|NCT02270983|101449691|FG002|Overall Study|moved away from study site|0|||
33425743|NCT01902134|101449694|FG000|Overall Study|Adverse Event|3|||
33425744|NCT01902134|101449695|FG001|Overall Study|Adverse Event|1|||
33425745|NCT01902134|101449696|FG002|Overall Study|Adverse Event|2|||
33425746|NCT01902134|101449697|FG003|Overall Study|Adverse Event|1|||
33425747|NCT01902134|101449698|FG004|Overall Study|Adverse Event|1|||
33425748|NCT01902134|101449699|FG005|Overall Study|Adverse Event|3|||
33425749|NCT01902134|101449694|FG000|Overall Study|Lack of Efficacy|0|||
33425750|NCT01902134|101449695|FG001|Overall Study|Lack of Efficacy|0|||
33425751|NCT01902134|101449696|FG002|Overall Study|Lack of Efficacy|2|||
33425752|NCT01902134|101449697|FG003|Overall Study|Lack of Efficacy|0|||
33425753|NCT01902134|101449698|FG004|Overall Study|Lack of Efficacy|0|||
33425754|NCT01902134|101449699|FG005|Overall Study|Lack of Efficacy|1|||
33425755|NCT01902134|101449694|FG000|Overall Study|Physician Decision|0|||
33425756|NCT01902134|101449695|FG001|Overall Study|Physician Decision|1|||
33425757|NCT01902134|101449696|FG002|Overall Study|Physician Decision|0|||
33425758|NCT01902134|101449697|FG003|Overall Study|Physician Decision|0|||
33425759|NCT01902134|101449698|FG004|Overall Study|Physician Decision|0|||
33425760|NCT01902134|101449699|FG005|Overall Study|Physician Decision|0|||
33425761|NCT01902134|101449694|FG000|Overall Study|Protocol Violation|0|||
33425762|NCT01902134|101449695|FG001|Overall Study|Protocol Violation|0|||
33425763|NCT01902134|101449696|FG002|Overall Study|Protocol Violation|0|||
33425764|NCT01902134|101449697|FG003|Overall Study|Protocol Violation|0|||
33425765|NCT01902134|101449698|FG004|Overall Study|Protocol Violation|0|||
33425766|NCT01902134|101449699|FG005|Overall Study|Protocol Violation|1|||
33425767|NCT01902134|101449694|FG000|Overall Study|Withdrawal by Subject|4|||
33425768|NCT01902134|101449695|FG001|Overall Study|Withdrawal by Subject|8|||
33425769|NCT01902134|101449696|FG002|Overall Study|Withdrawal by Subject|9|||
33425770|NCT01902134|101449697|FG003|Overall Study|Withdrawal by Subject|1|||
33425771|NCT01902134|101449698|FG004|Overall Study|Withdrawal by Subject|5|||
33425772|NCT01902134|101449699|FG005|Overall Study|Withdrawal by Subject|4|||
33425773|NCT01902134|101449694|FG000|Overall Study|no compliance|1|||
33425774|NCT01902134|101449695|FG001|Overall Study|no compliance|0|||
33587341|NCT03594747|102038476|FG000|Overall Study|Did not meet inclusion criteria|0|||
33587342|NCT03594747|102038477|FG001|Overall Study|Did not meet inclusion criteria|0|||
33587343|NCT03594747|102038478|FG002|Overall Study|Did not meet inclusion criteria|1|||
33587344|NCT03594747|102038476|FG000|Overall Study|Transfer to long term extension study|10|||
33425775|NCT01902134|101449696|FG002|Overall Study|no compliance|0|||
33425776|NCT01902134|101449697|FG003|Overall Study|no compliance|0|||
33425777|NCT01902134|101449698|FG004|Overall Study|no compliance|0|||
33425778|NCT01902134|101449699|FG005|Overall Study|no compliance|0|||
33425779|NCT01902134|101449694|FG000|Overall Study|Other|0|||
33425780|NCT01902134|101449695|FG001|Overall Study|Other|1|||
33587345|NCT03594747|102038477|FG001|Overall Study|Transfer to long term extension study|12|||
33587346|NCT03594747|102038478|FG002|Overall Study|Transfer to long term extension study|5|||
33587347|NCT02482428|102038479|FG000|Overall Study|Lost to Follow-up|4|||
33425781|NCT01902134|101449696|FG002|Overall Study|Other|2|||
33425782|NCT01902134|101449697|FG003|Overall Study|Other|0|||
33425783|NCT01902134|101449698|FG004|Overall Study|Other|1|||
33425784|NCT01902134|101449699|FG005|Overall Study|Other|0|||
33425785|NCT02117479|101449702|FG000|Overall Study|Death|13|||
33425786|NCT02117479|101449703|FG001|Overall Study|Death|8|||
33425787|NCT02117479|101449702|FG000|Overall Study|Adverse Event|8|||
33425788|NCT02117479|101449703|FG001|Overall Study|Adverse Event|16|||
33425789|NCT02117479|101449702|FG000|Overall Study|Subject decision|8|||
33425790|NCT02117479|101449703|FG001|Overall Study|Subject decision|9|||
33425791|NCT02117479|101449702|FG000|Overall Study|Disease progression|104|||
33425792|NCT02117479|101449703|FG001|Overall Study|Disease progression|108|||
33425793|NCT02117479|101449702|FG000|Overall Study|Noncompliance with study treatment|1|||
33425794|NCT02117479|101449703|FG001|Overall Study|Noncompliance with study treatment|0|||
33425795|NCT02117479|101449702|FG000|Overall Study|Study terminated by the sponsor|4|||
33425796|NCT02117479|101449703|FG001|Overall Study|Study terminated by the sponsor|6|||
33425797|NCT02117479|101449702|FG000|Overall Study|Physician Decision|7|||
33425798|NCT02117479|101449703|FG001|Overall Study|Physician Decision|2|||
33425799|NCT02117479|101449702|FG000|Overall Study|Other unspecified|11|||
33425800|NCT02117479|101449703|FG001|Overall Study|Other unspecified|7|||
33425801|NCT02984683|101449704|FG000|Overall Study|Adverse Event|3|||
33425802|NCT02984683|101449705|FG001|Overall Study|Adverse Event|3|||
33425803|NCT02984683|101449704|FG000|Overall Study|Withdrawal by Subject|1|||
33425804|NCT02984683|101449705|FG001|Overall Study|Withdrawal by Subject|0|||
33425805|NCT02984683|101449704|FG000|Overall Study|Disease progression|7|||
33425806|NCT02984683|101449705|FG001|Overall Study|Disease progression|9|||
33425807|NCT00303316|101449706|FG000|Overall Study|Protocol Violation|1|||
33425808|NCT00303316|101449707|FG001|Overall Study|Protocol Violation|0|||
33425809|NCT00303316|101449706|FG000|Overall Study|Lost to Follow-up|0|||
33425810|NCT00303316|101449707|FG001|Overall Study|Lost to Follow-up|1|||
33425811|NCT00303316|101449706|FG000|Overall Study|Withdrawal by Subject|1|||
33425812|NCT00303316|101449707|FG001|Overall Study|Withdrawal by Subject|2|||
33425813|NCT01208402|101449710|FG000|Overall Study|Withdrawal by Subject|1|||
33425814|NCT01208402|101449711|FG001|Overall Study|Withdrawal by Subject|0|||
33425815|NCT00379587|101449712|FG000|Overall Study|Lost to Follow-up|2|||
33425816|NCT01155063|101449713|FG000|Overall Study|Adverse Event|1|||
33425817|NCT01155063|101449713|FG000|Overall Study|Withdrawal by Subject|1|||
33425818|NCT01155063|101449713|FG000|Overall Study|Study terminated by sponsor|87|||
33425819|NCT01814137|101449714|FG000|Overall Study|Adverse Event|0|||
33425820|NCT01814137|101449715|FG001|Overall Study|Adverse Event|1|||
33425821|NCT01814137|101449714|FG000|Overall Study|Withdrawal by Subject|2|||
33425822|NCT01814137|101449715|FG001|Overall Study|Withdrawal by Subject|2|||
33425823|NCT01814137|101449714|FG000|Overall Study|Physician Decision|1|||
33425824|NCT01814137|101449715|FG001|Overall Study|Physician Decision|1|||
33425825|NCT01814137|101449714|FG000|Overall Study|Unclassified|2|||
33425826|NCT01814137|101449715|FG001|Overall Study|Unclassified|1|||
33425827|NCT02360397|101449722|FG000|Overall Study|Incomplete screening|3|||
33425828|NCT02360397|101449722|FG000|Overall Study|Adverse Event|1|||
33425829|NCT01690520|101449723|FG000|Overall Study|Death|25|||
33425830|NCT01690520|101449724|FG001|Overall Study|Death|21|||
33425831|NCT01690520|101449723|FG000|Overall Study|Lost to Follow-up|2|||
33425832|NCT01690520|101449724|FG001|Overall Study|Lost to Follow-up|3|||
33425833|NCT01690520|101449723|FG000|Overall Study|Withdrawal by Subject|2|||
33425834|NCT01690520|101449724|FG001|Overall Study|Withdrawal by Subject|0|||
33425835|NCT01690520|101449723|FG000|Overall Study|Relapse|0|||
33425836|NCT01690520|101449724|FG001|Overall Study|Relapse|1|||
33425837|NCT01690520|101449723|FG000|Overall Study|Other|0|||
33425838|NCT01690520|101449724|FG001|Overall Study|Other|1|||
33425839|NCT01690520|101449723|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
33149269|NCT02970318|100460693|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
33587348|NCT02482428|102038480|FG001|Overall Study|Lost to Follow-up|9|||
33149270|NCT02970318|100460694|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
33149271|NCT02970318|100460695|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
33149272|NCT02970318|100460696|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
33380498|NCT00729326|101276736|FG000|Overall Study|Physician Decision|0|||
33149273|NCT03053271|100460697|FG000|Overall Study|Did not meet randomization criteria|3|||
33380499|NCT00729326|101276737|FG001|Overall Study|Physician Decision|1|||
33380500|NCT00729326|101276736|FG000|Overall Study|Protocol Violation|3|||
33380501|NCT00729326|101276737|FG001|Overall Study|Protocol Violation|2|||
33380502|NCT00729326|101276736|FG000|Overall Study|Subject Decision|4|||
33380503|NCT00729326|101276737|FG001|Overall Study|Subject Decision|4|||
33380504|NCT00729326|101276736|FG000|Overall Study|Sponsor Decision|1|||
33380505|NCT00729326|101276737|FG001|Overall Study|Sponsor Decision|2|||
33380506|NCT01313208|101276740|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
33380507|NCT01313208|101276741|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
33380508|NCT01313208|101276740|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
33380509|NCT01313208|101276741|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
33380510|NCT01313208|101276740|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
33380511|NCT01313208|101276741|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
33380512|NCT01313208|101276740|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
33380513|NCT01313208|101276741|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
33380514|NCT01313208|101276740|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
33380515|NCT01313208|101276741|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
33380516|NCT01313208|101276740|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
33380517|NCT01313208|101276741|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
33380518|NCT01313208|101276740|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
33380519|NCT01313208|101276741|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
33380520|NCT01313208|101276740|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
33380521|NCT01313208|101276741|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
33380522|NCT01313208|101276740|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
33380523|NCT01313208|101276741|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
33380524|NCT02726113|101276742|FG000|Total Enrollment|Physician Decision|0|||
33380525|NCT02726113|101276743|FG001|Total Enrollment|Physician Decision|1|||
33380526|NCT02726113|101276742|FG000|Total Enrollment|Protocol Violation|1|||
33380527|NCT02726113|101276743|FG001|Total Enrollment|Protocol Violation|0|||
33380528|NCT02726113|101276742|FG000|Total Enrollment|Withdrawal by Subject|2|||
33380529|NCT02726113|101276743|FG001|Total Enrollment|Withdrawal by Subject|1|||
33380530|NCT02726113|101276742|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
33380531|NCT02726113|101276743|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
33380532|NCT02726113|101276742|FG000|Genomic Analysis|Protocol Violation|1|||
33380533|NCT02726113|101276743|FG001|Genomic Analysis|Protocol Violation|0|||
33380534|NCT02726113|101276742|FG000|Genomic Analysis|Withdrawal by Subject|2|||
33380535|NCT02726113|101276743|FG001|Genomic Analysis|Withdrawal by Subject|1|||
33380536|NCT02726113|101276742|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
33380537|NCT02726113|101276743|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
33380538|NCT01009983|101276744|FG000|Overall Study|necessary scans not completed|1|||
33380539|NCT02270684|101276746|FG000|Overall Study|Lost to Follow-up|0|||
33380540|NCT02270684|101276747|FG001|Overall Study|Lost to Follow-up|3|||
33380541|NCT02270684|101276746|FG000|Overall Study|Study terminated|1|||
33380542|NCT02270684|101276747|FG001|Overall Study|Study terminated|0|||
33380543|NCT03196193|101276748|FG000|Overall Study|Adverse Event|1|||
33380544|NCT03196193|101276749|FG001|Overall Study|Adverse Event|0|||
33380545|NCT03196193|101276748|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
33380546|NCT03196193|101276749|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
33380547|NCT02260648|101276750|FG000|Overall Study|Adverse Event|3|||
33380548|NCT02260648|101276751|FG001|Overall Study|Adverse Event|0|||
33380549|NCT02260648|101276752|FG002|Overall Study|Adverse Event|1|||
33380550|NCT02260648|101276750|FG000|Overall Study|Withdrawal by Subject|1|||
33380551|NCT02260648|101276751|FG001|Overall Study|Withdrawal by Subject|1|||
33380552|NCT02260648|101276752|FG002|Overall Study|Withdrawal by Subject|0|||
33380553|NCT02260648|101276750|FG000|Overall Study|Protocol Violation|1|||
33380554|NCT02260648|101276751|FG001|Overall Study|Protocol Violation|0|||
33380555|NCT02260648|101276752|FG002|Overall Study|Protocol Violation|0|||
33380556|NCT02260648|101276750|FG000|Overall Study|Discontinue Due to Study Termination|13|||
33380557|NCT02260648|101276751|FG001|Overall Study|Discontinue Due to Study Termination|12|||
33380558|NCT02260648|101276752|FG002|Overall Study|Discontinue Due to Study Termination|7|||
33380559|NCT04724733|101276755|FG000|Overall Study|Lost to Follow-up|1|||
33380560|NCT04724733|101276756|FG001|Overall Study|Lost to Follow-up|1|||
33380561|NCT04724733|101276757|FG002|Overall Study|Lost to Follow-up|1|||
33380562|NCT01582971|101276760|FG000|Overall Study|Death|2|||
33380563|NCT01582971|101276761|FG001|Overall Study|Death|1|||
33380564|NCT01582971|101276760|FG000|Overall Study|Lost to Follow-up|18|||
33380565|NCT01582971|101276761|FG001|Overall Study|Lost to Follow-up|21|||
33380566|NCT01582971|101276760|FG000|Overall Study|Withdrawal by Subject|4|||
33380567|NCT01582971|101276761|FG001|Overall Study|Withdrawal by Subject|2|||
33380568|NCT01582971|101276760|FG000|Overall Study|Other|15|||
33380569|NCT01582971|101276761|FG001|Overall Study|Other|13|||
33380570|NCT01374217|101276762|FG000|Overall Study|Lack of Efficacy|13|||
33380571|NCT01054976|101276763|FG000|Overall Study|Adverse Event|16|||
33380572|NCT01054976|101276763|FG000|Overall Study|Uncooperative participations to study|7|||
33380573|NCT01054976|101276763|FG000|Overall Study|Withdrawal by Subject|4|||
33380574|NCT01054976|101276763|FG000|Overall Study|Other|8|||
33380575|NCT02310906|101276766|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
33380576|NCT02310906|101276767|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
33380577|NCT02310906|101276768|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
33380578|NCT02310906|101276769|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
33380579|NCT02310906|101276766|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
33380580|NCT02310906|101276767|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
33380581|NCT02310906|101276768|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
33380582|NCT02310906|101276769|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
33380583|NCT02310906|101276766|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
33425840|NCT01690520|101449724|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
33425841|NCT01684722|101449725|FG000|Overall Study|Lost to Follow-up|78|||
33425842|NCT01684722|101449726|FG001|Overall Study|Lost to Follow-up|56|||
33425843|NCT01684722|101449727|FG002|Overall Study|Lost to Follow-up|75|||
33425844|NCT01684722|101449728|FG003|Overall Study|Lost to Follow-up|89|||
33425845|NCT01684722|101449725|FG000|Overall Study|Death|19|||
33425846|NCT01684722|101449726|FG001|Overall Study|Death|21|||
33425847|NCT01684722|101449727|FG002|Overall Study|Death|19|||
33425848|NCT01684722|101449728|FG003|Overall Study|Death|21|||
33425849|NCT01625845|101449729|FG000|Overall Study|Adverse Event|1|||
33425850|NCT01625845|101449730|FG001|Overall Study|Adverse Event|2|||
33425851|NCT01625845|101449729|FG000|Overall Study|Lost to Follow-up|2|||
33425852|NCT01625845|101449730|FG001|Overall Study|Lost to Follow-up|1|||
33425853|NCT01625845|101449729|FG000|Overall Study|Withdrawal by Subject|2|||
33425854|NCT01625845|101449730|FG001|Overall Study|Withdrawal by Subject|0|||
33425855|NCT01663714|101449731|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
33425856|NCT01663714|101449731|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
33425857|NCT01663714|101449731|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
33425858|NCT01663714|101449731|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
33425859|NCT01663714|101449731|FG000|Long-Term Follow-Up|Death|4|||
33425860|NCT01663714|101449731|FG000|Long-Term Follow-Up|Non-compliance|1|||
33425861|NCT04133519|101449735|FG000|Overall Study|Withdrawal by Subject|5|||
33425862|NCT04133519|101449736|FG001|Overall Study|Withdrawal by Subject|4|||
33425863|NCT04133519|101449735|FG000|Overall Study|Protocol Violation|0|||
33425864|NCT04133519|101449736|FG001|Overall Study|Protocol Violation|1|||
33425865|NCT04133519|101449735|FG000|Overall Study|Never started treatment|1|||
33647348|NCT04345367|102259901|FG001|Overall Study|Lack of Efficacy|0|||
33647349|NCT04345367|102259900|FG000|Overall Study|Death|2|||
33647350|NCT04345367|102259901|FG001|Overall Study|Death|0|||
33647351|NCT04345367|102259900|FG000|Overall Study|Adverse Event|10|||
33647352|NCT04345367|102259901|FG001|Overall Study|Adverse Event|9|||
33647353|NCT01578850|102259902|FG000|Period 1|Insufficient Clinical Response|1|||
33647354|NCT01578850|102259903|FG001|Period 1|Insufficient Clinical Response|0|||
33647355|NCT01578850|102259904|FG002|Period 1|Insufficient Clinical Response|0|||
33647356|NCT01578850|102259902|FG000|Period 1|Adverse Event|11|||
33647357|NCT01578850|102259903|FG001|Period 1|Adverse Event|0|||
33647358|NCT01578850|102259904|FG002|Period 1|Adverse Event|0|||
33647359|NCT01578850|102259902|FG000|Period 1|Death|1|||
33647360|NCT01578850|102259903|FG001|Period 1|Death|0|||
33647361|NCT01578850|102259904|FG002|Period 1|Death|0|||
33647362|NCT01578850|102259902|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
33647363|NCT01578850|102259903|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
33647364|NCT01578850|102259904|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
33647365|NCT01578850|102259902|FG000|Period 1|Withdrawal by Subject|9|||
33647366|NCT01578850|102259903|FG001|Period 1|Withdrawal by Subject|0|||
33647367|NCT01578850|102259904|FG002|Period 1|Withdrawal by Subject|0|||
33647368|NCT01578850|102259902|FG000|Period 1|Study Terminated by Sponsor|3|||
33647369|NCT01578850|102259903|FG001|Period 1|Study Terminated by Sponsor|0|||
33647370|NCT01578850|102259904|FG002|Period 1|Study Terminated by Sponsor|0|||
33647371|NCT01578850|102259902|FG000|Period 2|Insufficient Clinical Response|0|||
33647372|NCT01578850|102259903|FG001|Period 2|Insufficient Clinical Response|1|||
33647373|NCT01578850|102259904|FG002|Period 2|Insufficient Clinical Response|0|||
33647374|NCT01578850|102259902|FG000|Period 2|Adverse Event|0|||
33647375|NCT01578850|102259903|FG001|Period 2|Adverse Event|3|||
33149274|NCT03053271|100460697|FG000|Overall Study|Withdrawal by Subject|1|||
33149275|NCT03350620|100460698|FG000|Stage 2|Adverse Event|0|||
33149276|NCT03350620|100460699|FG001|Stage 2|Adverse Event|1|||
33425866|NCT04133519|101449736|FG001|Overall Study|Never started treatment|1|||
33425867|NCT01764854|101449738|FG000|Overall Study|Adverse Event|0|||
33425868|NCT01764854|101449739|FG001|Overall Study|Adverse Event|0|||
33425869|NCT01764854|101449740|FG002|Overall Study|Adverse Event|2|||
33425870|NCT01764854|101449741|FG003|Overall Study|Adverse Event|0|||
33425871|NCT01764854|101449738|FG000|Overall Study|Withdrawal by Subject|0|||
33425872|NCT01764854|101449739|FG001|Overall Study|Withdrawal by Subject|0|||
33425873|NCT01764854|101449740|FG002|Overall Study|Withdrawal by Subject|1|||
33425874|NCT01764854|101449741|FG003|Overall Study|Withdrawal by Subject|0|||
33425875|NCT01764854|101449738|FG000|Overall Study|relocation|0|||
33425876|NCT01764854|101449739|FG001|Overall Study|relocation|0|||
33149277|NCT03350620|100460700|FG002|Stage 2|Adverse Event|1|||
33425877|NCT01764854|101449740|FG002|Overall Study|relocation|2|||
33425878|NCT01764854|101449741|FG003|Overall Study|relocation|0|||
33647376|NCT01578850|102259904|FG002|Period 2|Adverse Event|6|||
33647377|NCT01578850|102259902|FG000|Period 2|Lost to Follow-up|0|||
33647378|NCT01578850|102259903|FG001|Period 2|Lost to Follow-up|1|||
33647379|NCT01578850|102259904|FG002|Period 2|Lost to Follow-up|2|||
33647380|NCT01578850|102259902|FG000|Period 2|Withdrawal by Subject|0|||
33647381|NCT01578850|102259903|FG001|Period 2|Withdrawal by Subject|2|||
33149278|NCT03350620|100460698|FG000|Stage 2|Lack of Efficacy|0|||
33425879|NCT01764854|101449738|FG000|Overall Study|Protocol Violation|0|||
33647382|NCT01578850|102259904|FG002|Period 2|Withdrawal by Subject|2|||
33425880|NCT01764854|101449739|FG001|Overall Study|Protocol Violation|0|||
33425881|NCT01764854|101449740|FG002|Overall Study|Protocol Violation|1|||
33425882|NCT01764854|101449741|FG003|Overall Study|Protocol Violation|2|||
33425883|NCT05476679|101449744|FG000|Overall Study|Withdrawal by Subject|0|||
33425884|NCT05476679|101449745|FG001|Overall Study|Withdrawal by Subject|0|||
33425885|NCT05476679|101449746|FG002|Overall Study|Withdrawal by Subject|0|||
33425886|NCT05476679|101449747|FG003|Overall Study|Withdrawal by Subject|1|||
33425887|NCT05476679|101449748|FG004|Overall Study|Withdrawal by Subject|0|||
33425888|NCT05476679|101449744|FG000|Overall Study|Lost to Follow-up|0|||
33425889|NCT05476679|101449745|FG001|Overall Study|Lost to Follow-up|0|||
33425890|NCT05476679|101449746|FG002|Overall Study|Lost to Follow-up|0|||
33425891|NCT05476679|101449747|FG003|Overall Study|Lost to Follow-up|1|||
33425892|NCT05476679|101449748|FG004|Overall Study|Lost to Follow-up|0|||
33425893|NCT00096382|101449749|FG000|Overall Study|Not treated|1|||
33647383|NCT01578850|102259902|FG000|Period 2|Study Terminated by Sponsor|0|||
33647384|NCT01578850|102259903|FG001|Period 2|Study Terminated by Sponsor|5|||
33647385|NCT01578850|102259904|FG002|Period 2|Study Terminated by Sponsor|4|||
33647386|NCT01578850|102259902|FG000|Period 2|Unspecified Reasons|0|||
33647387|NCT01578850|102259903|FG001|Period 2|Unspecified Reasons|1|||
33647388|NCT01578850|102259904|FG002|Period 2|Unspecified Reasons|0|||
33425894|NCT00096382|101449750|FG001|Overall Study|Not treated|0|||
33425895|NCT00096382|101449749|FG000|Overall Study|Death during treatment|1|||
33425896|NCT00096382|101449750|FG001|Overall Study|Death during treatment|0|||
33425897|NCT03016078|101449755|FG000|Overall Study|Protocol Violation|1|||
33425898|NCT03016078|101449755|FG000|Overall Study|Protocol Violation|1|||
33425899|NCT00446654|101449756|FG000|Overall Study|Withdrawal by Subject|1|||
33647389|NCT04364984|102259905|FG000|Overall Study|Death|2|||
33647390|NCT04364984|102259906|FG001|Overall Study|Death|2|||
33647391|NCT04364984|102259907|FG002|Overall Study|Death|0|||
33647392|NCT03179605|102262708|FG000|Overall Study|Withdrawal by Subject|1|||
33647393|NCT03425253|102262709|FG000|Overall Study|Adverse Event|2|||
33647394|NCT03425253|102262709|FG000|Overall Study|Lost to Follow-up|3|||
33425900|NCT00446654|101449757|FG001|Overall Study|Withdrawal by Subject|0|||
33425901|NCT00446654|101449756|FG000|Overall Study|Adverse Event|1|||
33425902|NCT00446654|101449757|FG001|Overall Study|Adverse Event|0|||
33425903|NCT01489956|101449759|FG000|Overall Study|Lost to Follow-up|1|||
33425904|NCT01489956|101449760|FG001|Overall Study|Lost to Follow-up|0|||
33587349|NCT02482428|102038481|FG002|Overall Study|Lost to Follow-up|1|||
33587350|NCT02482428|102038482|FG003|Overall Study|Lost to Follow-up|2|||
33587351|NCT02482428|102038483|FG004|Overall Study|Lost to Follow-up|4|||
33587352|NCT02482428|102038479|FG000|Overall Study|Physician Decision|0|||
33587353|NCT02482428|102038480|FG001|Overall Study|Physician Decision|0|||
33587354|NCT02482428|102038481|FG002|Overall Study|Physician Decision|0|||
33587355|NCT02482428|102038482|FG003|Overall Study|Physician Decision|0|||
33587356|NCT02482428|102038483|FG004|Overall Study|Physician Decision|1|||
33587357|NCT02482428|102038479|FG000|Overall Study|protocol deviation|1|||
33587358|NCT02482428|102038480|FG001|Overall Study|protocol deviation|1|||
33587359|NCT02482428|102038481|FG002|Overall Study|protocol deviation|0|||
33587360|NCT02482428|102038482|FG003|Overall Study|protocol deviation|0|||
33587361|NCT02482428|102038483|FG004|Overall Study|protocol deviation|0|||
33587362|NCT02482428|102038479|FG000|Overall Study|subject/guardian decision|4|||
33587363|NCT02482428|102038480|FG001|Overall Study|subject/guardian decision|2|||
33587364|NCT02482428|102038481|FG002|Overall Study|subject/guardian decision|0|||
33587365|NCT02482428|102038482|FG003|Overall Study|subject/guardian decision|0|||
33587366|NCT02482428|102038483|FG004|Overall Study|subject/guardian decision|2|||
33587367|NCT04097028|102038486|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
33587368|NCT04097028|102038486|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
33587369|NCT04097028|102038486|FG000|Overall Study|Disease Progression prior to Surgery|2|||
33647395|NCT03425253|102262709|FG000|Overall Study|Withdrew Consent|6|||
33647396|NCT03425253|102262709|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
33425905|NCT01489956|101449761|FG002|Overall Study|Lost to Follow-up|0|||
33425906|NCT01489956|101449759|FG000|Overall Study|Withdrawal by Subject|0|||
33647397|NCT01546623|102262712|FG000|Overall Study|Adverse Event|2|||
33647398|NCT01546623|102262713|FG001|Overall Study|Adverse Event|3|||
33647399|NCT01546623|102262712|FG000|Overall Study|Major Protocol Deviation|1|||
33425907|NCT01489956|101449760|FG001|Overall Study|Withdrawal by Subject|0|||
33425908|NCT01489956|101449761|FG002|Overall Study|Withdrawal by Subject|1|||
33425909|NCT03372369|101449762|FG000|Qualification Period|Withdrawal by Subject|16|||
33425910|NCT03372369|101449763|FG001|Qualification Period|Withdrawal by Subject|13|||
33425911|NCT03372369|101449762|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
33587370|NCT04097028|102038486|FG000|Overall Study|Adverse Event prior to Surgery|1|||
33587371|NCT01238991|102038489|FG000|Overall Study|Adverse Event|1|||
33587372|NCT01238991|102038490|FG001|Overall Study|Adverse Event|0|||
33587373|NCT01238991|102038491|FG002|Overall Study|Adverse Event|3|||
33587374|NCT01238991|102038492|FG003|Overall Study|Adverse Event|1|||
33587375|NCT01238991|102038493|FG004|Overall Study|Adverse Event|1|||
33587376|NCT01238991|102038494|FG005|Overall Study|Adverse Event|0|||
33647400|NCT01546623|102262713|FG001|Overall Study|Major Protocol Deviation|1|||
33647401|NCT01546623|102262712|FG000|Overall Study|High Prostate specific antigen|2|||
33647402|NCT01546623|102262713|FG001|Overall Study|High Prostate specific antigen|1|||
33647403|NCT01546623|102262712|FG000|Overall Study|Did Not Receive Study Drug|1|||
33647404|NCT01546623|102262713|FG001|Overall Study|Did Not Receive Study Drug|1|||
33647405|NCT03083990|102262714|FG000|Overall Study|Adverse Event|1|||
33647406|NCT03083990|102262715|FG001|Overall Study|Adverse Event|0|||
33647407|NCT04093024|102262720|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
33647408|NCT04093024|102262721|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
33647409|NCT04093024|102262720|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
33248144|NCT03982199|100810136|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
33248145|NCT03982199|100810137|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
33647410|NCT04093024|102262721|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
33647411|NCT04093024|102262720|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
33647412|NCT04093024|102262721|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
33647413|NCT04093024|102262720|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
33647414|NCT04093024|102262721|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
33647415|NCT01639729|102262722|FG000|Overall Study|Withdrawal by Subject|1|||
33647416|NCT01639729|102262723|FG001|Overall Study|Withdrawal by Subject|0|||
33647417|NCT01639729|102262724|FG002|Overall Study|Withdrawal by Subject|1|||
33647418|NCT01639729|102262725|FG003|Overall Study|Withdrawal by Subject|1|||
33647419|NCT01639729|102262726|FG004|Overall Study|Withdrawal by Subject|0|||
33647420|NCT01639729|102262727|FG005|Overall Study|Withdrawal by Subject|0|||
33647421|NCT00835211|102262728|FG000|First Intervention|Withdrawal by Subject|0|||
33647422|NCT00835211|102262729|FG001|First Intervention|Withdrawal by Subject|1|||
33647423|NCT00835211|102262728|FG000|Washout: 7 Days|Adverse Event|2|||
33647424|NCT00835211|102262729|FG001|Washout: 7 Days|Adverse Event|1|||
33647425|NCT00835211|102262728|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
33248146|NCT03982199|100810138|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
33248147|NCT03982199|100810139|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
33248148|NCT03982199|100810140|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
33248149|NCT03982199|100810141|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
33248150|NCT03982199|100810142|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
33248151|NCT03982199|100810129|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
33380584|NCT02310906|101276767|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
33587377|NCT01238991|102038495|FG006|Overall Study|Adverse Event|1|||
33248152|NCT03982199|100810130|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
33248153|NCT03982199|100810131|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
33587378|NCT01238991|102038496|FG007|Overall Study|Adverse Event|1|||
33587379|NCT01238991|102038497|FG008|Overall Study|Adverse Event|0|||
33587380|NCT01238991|102038498|FG009|Overall Study|Adverse Event|0|||
33587381|NCT01238991|102038489|FG000|Overall Study|Death|0|||
33587382|NCT01238991|102038490|FG001|Overall Study|Death|0|||
33587383|NCT01238991|102038491|FG002|Overall Study|Death|0|||
33587384|NCT01238991|102038492|FG003|Overall Study|Death|1|||
33587385|NCT01238991|102038493|FG004|Overall Study|Death|0|||
33587386|NCT01238991|102038494|FG005|Overall Study|Death|0|||
33587387|NCT01238991|102038495|FG006|Overall Study|Death|0|||
33587388|NCT01238991|102038496|FG007|Overall Study|Death|0|||
33587389|NCT01238991|102038497|FG008|Overall Study|Death|0|||
33587390|NCT01238991|102038498|FG009|Overall Study|Death|0|||
33587391|NCT01238991|102038489|FG000|Overall Study|Lack of Efficacy|0|||
33587392|NCT01238991|102038490|FG001|Overall Study|Lack of Efficacy|0|||
33587393|NCT01238991|102038491|FG002|Overall Study|Lack of Efficacy|1|||
33587394|NCT01238991|102038492|FG003|Overall Study|Lack of Efficacy|0|||
33587395|NCT01238991|102038493|FG004|Overall Study|Lack of Efficacy|0|||
33587396|NCT01238991|102038494|FG005|Overall Study|Lack of Efficacy|0|||
33587397|NCT01238991|102038495|FG006|Overall Study|Lack of Efficacy|0|||
33587398|NCT01238991|102038496|FG007|Overall Study|Lack of Efficacy|0|||
33587399|NCT01238991|102038497|FG008|Overall Study|Lack of Efficacy|1|||
33587400|NCT01238991|102038498|FG009|Overall Study|Lack of Efficacy|0|||
33587401|NCT01238991|102038489|FG000|Overall Study|Withdrawal by Subject|0|||
33587402|NCT01238991|102038490|FG001|Overall Study|Withdrawal by Subject|0|||
33587403|NCT01238991|102038491|FG002|Overall Study|Withdrawal by Subject|1|||
33587404|NCT01238991|102038492|FG003|Overall Study|Withdrawal by Subject|0|||
33587405|NCT01238991|102038493|FG004|Overall Study|Withdrawal by Subject|0|||
33587406|NCT01238991|102038494|FG005|Overall Study|Withdrawal by Subject|0|||
33587407|NCT01238991|102038495|FG006|Overall Study|Withdrawal by Subject|0|||
33587408|NCT01238991|102038496|FG007|Overall Study|Withdrawal by Subject|0|||
33587409|NCT01238991|102038497|FG008|Overall Study|Withdrawal by Subject|0|||
33587410|NCT01238991|102038498|FG009|Overall Study|Withdrawal by Subject|0|||
33587411|NCT01238991|102038489|FG000|Overall Study|Study Terminated by Sponsor|0|||
33647426|NCT00835211|102262729|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
33647427|NCT02687191|102262730|FG000|Overall Study|Death|0|||
33647428|NCT02687191|102262731|FG001|Overall Study|Death|1|||
33647429|NCT02687191|102262732|FG002|Overall Study|Death|1|||
33647430|NCT02687191|102262733|FG003|Overall Study|Death|0|||
33647431|NCT02687191|102262734|FG004|Overall Study|Death|1|||
33647432|NCT02687191|102262735|FG005|Overall Study|Death|1|||
33647433|NCT02687191|102262730|FG000|Overall Study|Withdrawal by Subject|0|||
33647434|NCT02687191|102262731|FG001|Overall Study|Withdrawal by Subject|0|||
33587412|NCT01238991|102038490|FG001|Overall Study|Study Terminated by Sponsor|0|||
33587413|NCT01238991|102038491|FG002|Overall Study|Study Terminated by Sponsor|0|||
33587414|NCT01238991|102038492|FG003|Overall Study|Study Terminated by Sponsor|0|||
33587415|NCT01238991|102038493|FG004|Overall Study|Study Terminated by Sponsor|1|||
33587416|NCT01238991|102038494|FG005|Overall Study|Study Terminated by Sponsor|0|||
33587417|NCT01238991|102038495|FG006|Overall Study|Study Terminated by Sponsor|7|||
33587418|NCT01238991|102038496|FG007|Overall Study|Study Terminated by Sponsor|4|||
33587419|NCT01238991|102038497|FG008|Overall Study|Study Terminated by Sponsor|2|||
33647435|NCT02687191|102262732|FG002|Overall Study|Withdrawal by Subject|0|||
33647436|NCT02687191|102262733|FG003|Overall Study|Withdrawal by Subject|1|||
33647437|NCT02687191|102262734|FG004|Overall Study|Withdrawal by Subject|0|||
33647438|NCT02687191|102262735|FG005|Overall Study|Withdrawal by Subject|0|||
33647439|NCT01028300|102262736|FG000|Overall Study|Study Terminated|4|||
33587420|NCT01238991|102038498|FG009|Overall Study|Study Terminated by Sponsor|2|||
33647440|NCT00834080|102262737|FG000|Overall Study|Adverse Event|7|||
33248154|NCT03982199|100810132|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
33248155|NCT03982199|100810133|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
33248156|NCT03982199|100810134|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
33248157|NCT03982199|100810135|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
33248158|NCT03982199|100810136|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
33248159|NCT03982199|100810137|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
33380585|NCT02310906|101276768|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
33380586|NCT02310906|101276769|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
33380587|NCT02310906|101276766|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
33380588|NCT02310906|101276767|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
33380589|NCT02310906|101276768|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
33380590|NCT02310906|101276769|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
33380591|NCT01354431|101276770|FG000|Pre-Treatment Period|Not reported|1|||
33380592|NCT01354431|101276771|FG001|Pre-Treatment Period|Not reported|0|||
33380593|NCT01354431|101276772|FG002|Pre-Treatment Period|Not reported|0|||
33380594|NCT01354431|101276770|FG000|Treatment Period|Disease Progression|50|||
33380595|NCT01354431|101276771|FG001|Treatment Period|Disease Progression|40|||
33380596|NCT01354431|101276772|FG002|Treatment Period|Disease Progression|44|||
33380597|NCT01354431|101276770|FG000|Treatment Period|Study Drug Toxicity|5|||
33380598|NCT01354431|101276771|FG001|Treatment Period|Study Drug Toxicity|8|||
33380599|NCT01354431|101276772|FG002|Treatment Period|Study Drug Toxicity|4|||
33380600|NCT01354431|101276770|FG000|Treatment Period|Death|0|||
33380601|NCT01354431|101276771|FG001|Treatment Period|Death|1|||
33380602|NCT01354431|101276772|FG002|Treatment Period|Death|0|||
33380603|NCT01354431|101276770|FG000|Treatment Period|AE unrelated to study drug|1|||
33380604|NCT01354431|101276771|FG001|Treatment Period|AE unrelated to study drug|2|||
33380605|NCT01354431|101276772|FG002|Treatment Period|AE unrelated to study drug|5|||
33380606|NCT01354431|101276770|FG000|Treatment Period|Participant request to discontinue|2|||
33380607|NCT01354431|101276771|FG001|Treatment Period|Participant request to discontinue|2|||
33380608|NCT01354431|101276772|FG002|Treatment Period|Participant request to discontinue|1|||
33380609|NCT01354431|101276770|FG000|Treatment Period|Participant withdrew consent|0|||
33380610|NCT01354431|101276771|FG001|Treatment Period|Participant withdrew consent|1|||
33380611|NCT01354431|101276772|FG002|Treatment Period|Participant withdrew consent|0|||
33380612|NCT01354431|101276770|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
33380613|NCT01354431|101276771|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
33380614|NCT01354431|101276772|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
33380615|NCT00843843|101276773|FG000|Overall Study|Physician Decision|1|||
33380616|NCT00843843|101276774|FG001|Overall Study|Physician Decision|1|||
33380617|NCT00843843|101276773|FG000|Overall Study|Protocol Violation|1|||
33380618|NCT00843843|101276774|FG001|Overall Study|Protocol Violation|1|||
33380619|NCT01594333|101276777|FG000|Overall Study|Death|96|||
33380620|NCT01594333|101276778|FG001|Overall Study|Death|83|||
33380621|NCT01594333|101276777|FG000|Overall Study|Lost to Follow-up|5|||
33587421|NCT01238991|102038489|FG000|Overall Study|Caregiver's request|0|||
33587422|NCT01238991|102038490|FG001|Overall Study|Caregiver's request|0|||
33587423|NCT01238991|102038491|FG002|Overall Study|Caregiver's request|0|||
33587424|NCT01238991|102038492|FG003|Overall Study|Caregiver's request|0|||
33647441|NCT00834080|102262737|FG000|Overall Study|Lost to Follow-up|7|||
33149279|NCT03350620|100460699|FG001|Stage 2|Lack of Efficacy|2|||
33149280|NCT03350620|100460700|FG002|Stage 2|Lack of Efficacy|0|||
33425912|NCT03372369|101449763|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
33425913|NCT03372369|101449762|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
33425914|NCT03372369|101449763|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
33425915|NCT00879970|101449768|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
33425916|NCT00879970|101449769|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
33425917|NCT00879970|101449770|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
33425918|NCT00879970|101449771|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
33425919|NCT00879970|101449772|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
33425920|NCT00879970|101449768|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
33425921|NCT00879970|101449769|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
33425922|NCT00879970|101449770|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
33425923|NCT00879970|101449771|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
33425924|NCT00879970|101449772|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
33425925|NCT00879970|101449768|FG000|Period 1 TZD Randomization|Death|2|||
33425926|NCT00879970|101449769|FG001|Period 1 TZD Randomization|Death|1|||
33425927|NCT00879970|101449770|FG002|Period 1 TZD Randomization|Death|0|||
33425928|NCT00879970|101449771|FG003|Period 1 TZD Randomization|Death|0|||
33425929|NCT00879970|101449772|FG004|Period 1 TZD Randomization|Death|0|||
33425930|NCT00879970|101449768|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
33425931|NCT00879970|101449769|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
33425932|NCT00879970|101449770|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
33425933|NCT00879970|101449771|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
33425934|NCT00879970|101449772|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
33647442|NCT00834080|102262737|FG000|Overall Study|Withdrawal by Subject|5|||
33647443|NCT00834080|102262737|FG000|Overall Study|Other - Pregnancy|1|||
33647444|NCT00834080|102262737|FG000|Overall Study|Other - False positive tests of the UDS|1|||
33647445|NCT00834080|102262737|FG000|Overall Study|Physician Decision|1|||
33647446|NCT00834080|102262737|FG000|Overall Study|Subject Relocated|1|||
33647447|NCT00490529|102262738|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
33647448|NCT00490529|102262738|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
33425935|NCT00879970|101449768|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
33425936|NCT00879970|101449769|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
33425937|NCT00879970|101449770|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
33425938|NCT00879970|101449771|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
33425939|NCT00879970|101449772|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
33425940|NCT00879970|101449768|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
33425941|NCT00879970|101449769|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
33425942|NCT00879970|101449770|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
33425943|NCT00879970|101449771|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
33425944|NCT00879970|101449772|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
33425945|NCT00879970|101449768|FG000|Period 2 Vitamin D Randomization|Death|0|||
33425946|NCT00879970|101449769|FG001|Period 2 Vitamin D Randomization|Death|0|||
33425947|NCT00879970|101449770|FG002|Period 2 Vitamin D Randomization|Death|0|||
33425948|NCT00879970|101449771|FG003|Period 2 Vitamin D Randomization|Death|2|||
33425949|NCT00879970|101449772|FG004|Period 2 Vitamin D Randomization|Death|0|||
33425950|NCT00525031|101449815|FG000|Overall Study|Disease Progression|1|||
33425951|NCT00525031|101449816|FG001|Overall Study|Disease Progression|1|||
33425952|NCT03469271|101449818|FG000|Overall Study|Withdrawal by Subject|2|||
33425953|NCT03469271|101449819|FG001|Overall Study|Withdrawal by Subject|0|||
33425954|NCT03469271|101449820|FG002|Overall Study|Withdrawal by Subject|0|||
33425955|NCT03469271|101449821|FG003|Overall Study|Withdrawal by Subject|1|||
33425956|NCT01792284|101449822|FG000|Lead-in Period|Adverse Event|15|||
33425957|NCT01792284|101449823|FG001|Lead-in Period|Adverse Event|0|||
33425958|NCT01792284|101449824|FG002|Lead-in Period|Adverse Event|0|||
33425959|NCT01792284|101449822|FG000|Lead-in Period|Lost to Follow-up|2|||
33425960|NCT01792284|101449823|FG001|Lead-in Period|Lost to Follow-up|0|||
33425961|NCT01792284|101449824|FG002|Lead-in Period|Lost to Follow-up|0|||
33425962|NCT01792284|101449822|FG000|Lead-in Period|Protocol Violation|1|||
33425963|NCT01792284|101449823|FG001|Lead-in Period|Protocol Violation|0|||
33425964|NCT01792284|101449824|FG002|Lead-in Period|Protocol Violation|0|||
33425965|NCT01792284|101449822|FG000|Lead-in Period|Withdrawal by Subject|10|||
33425966|NCT01792284|101449823|FG001|Lead-in Period|Withdrawal by Subject|0|||
33425967|NCT01792284|101449824|FG002|Lead-in Period|Withdrawal by Subject|0|||
33425968|NCT01792284|101449822|FG000|Lead-in Period|Physician Decision|1|||
33425969|NCT01792284|101449823|FG001|Lead-in Period|Physician Decision|0|||
33425970|NCT01792284|101449824|FG002|Lead-in Period|Physician Decision|0|||
33425971|NCT01792284|101449822|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
33425972|NCT01792284|101449823|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
33425973|NCT01792284|101449824|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
33425974|NCT01792284|101449822|FG000|Randomization Period 1|Withdrawal by Subject|0|||
33647449|NCT00490529|102262738|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
33425975|NCT01792284|101449823|FG001|Randomization Period 1|Withdrawal by Subject|1|||
33425976|NCT01792284|101449824|FG002|Randomization Period 1|Withdrawal by Subject|1|||
33425977|NCT01792284|101449822|FG000|Randomization Period 1|Physician Decision|0|||
33425978|NCT01792284|101449823|FG001|Randomization Period 1|Physician Decision|1|||
33425979|NCT01792284|101449824|FG002|Randomization Period 1|Physician Decision|1|||
33425980|NCT01792284|101449822|FG000|Randomization Period 1|Adverse Event|0|||
33425981|NCT01792284|101449823|FG001|Randomization Period 1|Adverse Event|0|||
33425982|NCT01792284|101449824|FG002|Randomization Period 1|Adverse Event|2|||
33425983|NCT01792284|101449822|FG000|Randomization Period 1|Lost to Follow-up|0|||
33425984|NCT01792284|101449823|FG001|Randomization Period 1|Lost to Follow-up|0|||
33425985|NCT01792284|101449824|FG002|Randomization Period 1|Lost to Follow-up|1|||
33425986|NCT01792284|101449822|FG000|Randomization Period 2|Protocol Violation|0|||
33425987|NCT01792284|101449823|FG001|Randomization Period 2|Protocol Violation|1|||
33425988|NCT01792284|101449824|FG002|Randomization Period 2|Protocol Violation|0|||
33425989|NCT01792284|101449822|FG000|Randomization Period 2|Withdrawal by Subject|0|||
33425990|NCT01792284|101449823|FG001|Randomization Period 2|Withdrawal by Subject|2|||
33425991|NCT01792284|101449824|FG002|Randomization Period 2|Withdrawal by Subject|0|||
33425992|NCT00707174|101449828|FG000|Overall Study|Adverse Event|1|||
33425993|NCT00707174|101449829|FG001|Overall Study|Adverse Event|6|||
33425994|NCT00707174|101449828|FG000|Overall Study|Withdrawal by Subject|4|||
33425995|NCT00707174|101449829|FG001|Overall Study|Withdrawal by Subject|1|||
33425996|NCT01716754|101449830|FG000|Overall Study|Death|0|||
33425997|NCT01716754|101449831|FG001|Overall Study|Death|0|||
33425998|NCT01716754|101449832|FG002|Overall Study|Death|0|||
33425999|NCT01716754|101449833|FG003|Overall Study|Death|1|||
33426000|NCT01716754|101449830|FG000|Overall Study|Protocol deviation|0|||
33426001|NCT01716754|101449831|FG001|Overall Study|Protocol deviation|2|||
33426002|NCT01716754|101449832|FG002|Overall Study|Protocol deviation|7|||
33426003|NCT01716754|101449833|FG003|Overall Study|Protocol deviation|2|||
33426004|NCT01716754|101449830|FG000|Overall Study|Non-compliance with study treatment|0|||
33426005|NCT01716754|101449831|FG001|Overall Study|Non-compliance with study treatment|0|||
33426006|NCT01716754|101449832|FG002|Overall Study|Non-compliance with study treatment|1|||
33426007|NCT01716754|101449833|FG003|Overall Study|Non-compliance with study treatment|0|||
33426008|NCT01716754|101449830|FG000|Overall Study|Physician Decision|1|||
33426009|NCT01716754|101449831|FG001|Overall Study|Physician Decision|0|||
33426010|NCT01716754|101449832|FG002|Overall Study|Physician Decision|0|||
33426011|NCT01716754|101449833|FG003|Overall Study|Physician Decision|0|||
33426012|NCT01716754|101449830|FG000|Overall Study|Lost to Follow-up|1|||
33426013|NCT01716754|101449831|FG001|Overall Study|Lost to Follow-up|0|||
33426014|NCT01716754|101449832|FG002|Overall Study|Lost to Follow-up|0|||
33426015|NCT01716754|101449833|FG003|Overall Study|Lost to Follow-up|1|||
33426016|NCT01716754|101449830|FG000|Overall Study|Adverse Event|4|||
33426017|NCT01716754|101449831|FG001|Overall Study|Adverse Event|2|||
33426018|NCT01716754|101449832|FG002|Overall Study|Adverse Event|2|||
33426019|NCT01716754|101449833|FG003|Overall Study|Adverse Event|1|||
33426020|NCT01716754|101449830|FG000|Overall Study|Withdrawal by Subject|5|||
33426021|NCT01716754|101449831|FG001|Overall Study|Withdrawal by Subject|0|||
33426022|NCT01716754|101449832|FG002|Overall Study|Withdrawal by Subject|4|||
33426023|NCT01716754|101449833|FG003|Overall Study|Withdrawal by Subject|3|||
33426024|NCT04304950|101449834|FG000|Overall Study|Lost to Follow-up|1|||
33426025|NCT04304950|101449835|FG001|Overall Study|Lost to Follow-up|1|||
33426026|NCT02196506|101449836|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
33426027|NCT02196506|101449837|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
33426028|NCT02196506|101449838|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
33426029|NCT02196506|101449839|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
33426030|NCT02196506|101449836|FG000|Phase A|Withdrawal by Subject|34|||
33426031|NCT02196506|101449837|FG001|Phase A|Withdrawal by Subject|0|||
33426032|NCT02196506|101449838|FG002|Phase A|Withdrawal by Subject|0|||
33426033|NCT02196506|101449839|FG003|Phase A|Withdrawal by Subject|0|||
33426034|NCT02196506|101449836|FG000|Phase A|Adverse Event|22|||
33426035|NCT02196506|101449837|FG001|Phase A|Adverse Event|0|||
33426036|NCT02196506|101449838|FG002|Phase A|Adverse Event|0|||
33426037|NCT02196506|101449839|FG003|Phase A|Adverse Event|0|||
33426038|NCT02196506|101449836|FG000|Phase A|Lost to Follow-up|9|||
33426039|NCT02196506|101449837|FG001|Phase A|Lost to Follow-up|0|||
33149281|NCT03350620|100460698|FG000|Stage 2|Lost to Follow-up|1|||
33149282|NCT03350620|100460699|FG001|Stage 2|Lost to Follow-up|2|||
33149283|NCT03350620|100460700|FG002|Stage 2|Lost to Follow-up|2|||
33426040|NCT02196506|101449838|FG002|Phase A|Lost to Follow-up|0|||
33426041|NCT02196506|101449839|FG003|Phase A|Lost to Follow-up|0|||
33426042|NCT02196506|101449836|FG000|Phase A|Protocol deviation|12|||
33426043|NCT02196506|101449837|FG001|Phase A|Protocol deviation|0|||
33426044|NCT02196506|101449838|FG002|Phase A|Protocol deviation|0|||
33426045|NCT02196506|101449839|FG003|Phase A|Protocol deviation|0|||
33426046|NCT02196506|101449836|FG000|Phase A|Participant withdrawn by investigator|10|||
33426047|NCT02196506|101449837|FG001|Phase A|Participant withdrawn by investigator|0|||
33426048|NCT02196506|101449838|FG002|Phase A|Participant withdrawn by investigator|0|||
33426049|NCT02196506|101449839|FG003|Phase A|Participant withdrawn by investigator|0|||
33426050|NCT02196506|101449836|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
33426051|NCT02196506|101449837|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
33426052|NCT02196506|101449838|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
33426053|NCT02196506|101449839|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
33380622|NCT01594333|101276778|FG001|Overall Study|Lost to Follow-up|5|||
33380623|NCT01594333|101276777|FG000|Overall Study|Withdrawal by Subject|60|||
33380624|NCT01594333|101276778|FG001|Overall Study|Withdrawal by Subject|63|||
33380625|NCT02227108|101276781|FG000|Overall Study|Did not receive treatment|2|||
33380626|NCT02227108|101276781|FG000|Overall Study|Other|3|||
33380627|NCT02227108|101276781|FG000|Overall Study|Progressive disease|17|||
33380628|NCT02227108|101276781|FG000|Overall Study|Initiation of alternative therapy|2|||
33380629|NCT02227108|101276781|FG000|Overall Study|Investigator discretion|1|||
33380630|NCT02227108|101276781|FG000|Overall Study|Adverse Event|6|||
33380631|NCT00997321|101276782|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
33380632|NCT00997321|101276783|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
33380633|NCT02247401|101276784|FG000|Overall Study|Adverse Event|1|||
33380634|NCT02247401|101276785|FG001|Overall Study|Adverse Event|0|||
33380635|NCT02247401|101276786|FG002|Overall Study|Adverse Event|0|||
33380636|NCT02247401|101276784|FG000|Overall Study|Withdrawal by Subject|4|||
33380637|NCT02247401|101276785|FG001|Overall Study|Withdrawal by Subject|1|||
33380638|NCT02247401|101276786|FG002|Overall Study|Withdrawal by Subject|1|||
33380639|NCT02247401|101276784|FG000|Overall Study|Lost to Follow-up|1|||
33380640|NCT02247401|101276785|FG001|Overall Study|Lost to Follow-up|1|||
33380641|NCT02247401|101276786|FG002|Overall Study|Lost to Follow-up|1|||
33380642|NCT01890512|101276787|FG000|Overall Study|Physician Decision|1|||
33380643|NCT01890512|101276787|FG000|Overall Study|Withdrawal by Subject|1|||
33380644|NCT01890512|101276787|FG000|Overall Study|Protocol Violation|1|||
33380645|NCT01199055|101276790|FG000|Overall Study|Death|0|||
33380646|NCT01199055|101276791|FG001|Overall Study|Death|1|||
33380647|NCT01199055|101276792|FG002|Overall Study|Death|0|||
33380648|NCT01199055|101276790|FG000|Overall Study|Physician Decision|0|||
33380649|NCT01199055|101276791|FG001|Overall Study|Physician Decision|1|||
33380650|NCT01199055|101276792|FG002|Overall Study|Physician Decision|1|||
33380651|NCT01199055|101276790|FG000|Overall Study|Progressive disease|2|||
33380652|NCT01199055|101276791|FG001|Overall Study|Progressive disease|1|||
33380653|NCT01199055|101276792|FG002|Overall Study|Progressive disease|2|||
33380654|NCT01199055|101276790|FG000|Overall Study|Withdrawal by Subject|0|||
33380655|NCT01199055|101276791|FG001|Overall Study|Withdrawal by Subject|0|||
33380656|NCT01199055|101276792|FG002|Overall Study|Withdrawal by Subject|1|||
33380657|NCT03101514|101276795|FG000|Overall Study|Withdrawal by Subject|4|||
33380658|NCT03101514|101276795|FG000|Overall Study|Protocol Violation|2|||
33380659|NCT03101514|101276795|FG000|Overall Study|patient's information was incomplete|1|||
33380660|NCT01195363|101276796|FG000|Overall Study|Lost to Follow-up|7|||
33380661|NCT01195363|101276797|FG001|Overall Study|Lost to Follow-up|4|||
33380662|NCT01195363|101276796|FG000|Overall Study|Adverse Event|3|||
33380663|NCT01195363|101276797|FG001|Overall Study|Adverse Event|1|||
33380664|NCT01195363|101276796|FG000|Overall Study|Lack of Efficacy|0|||
33380665|NCT01195363|101276797|FG001|Overall Study|Lack of Efficacy|4|||
33380666|NCT01195363|101276796|FG000|Overall Study|incarceration|1|||
33380667|NCT01195363|101276797|FG001|Overall Study|incarceration|0|||
33380668|NCT02294318|101276798|FG000|Overall Study|Worsening of drinking|3|||
33380669|NCT02294318|101276799|FG001|Overall Study|Worsening of drinking|0|||
33380670|NCT02294318|101276798|FG000|Overall Study|Not exposed to intervention|0|||
33380671|NCT02294318|101276799|FG001|Overall Study|Not exposed to intervention|2|||
33380672|NCT02614287|101276800|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
33380673|NCT02614287|101276801|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
33380674|NCT02614287|101276800|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
33380675|NCT02614287|101276801|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
33380676|NCT02614287|101276800|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
33380677|NCT02614287|101276801|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
33380678|NCT02614287|101276800|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
33380679|NCT02614287|101276801|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
33380680|NCT02614287|101276800|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
33380681|NCT02614287|101276801|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
33426054|NCT02196506|101449836|FG000|Phase B|Lack of Efficacy|0|||
33380682|NCT02614287|101276800|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
33380683|NCT02614287|101276801|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
33380684|NCT02614287|101276800|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
33380685|NCT02614287|101276801|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
33426055|NCT02196506|101449837|FG001|Phase B|Lack of Efficacy|1|||
33380686|NCT02614287|101276800|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
33380687|NCT02614287|101276801|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
33248160|NCT03982199|100810138|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
33380688|NCT00664209|101276802|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
33426056|NCT02196506|101449838|FG002|Phase B|Lack of Efficacy|2|||
33426057|NCT02196506|101449839|FG003|Phase B|Lack of Efficacy|0|||
33426058|NCT02196506|101449836|FG000|Phase B|Withdrawal by Participant|0|||
33426059|NCT02196506|101449837|FG001|Phase B|Withdrawal by Participant|8|||
33426060|NCT02196506|101449838|FG002|Phase B|Withdrawal by Participant|1|||
33426061|NCT02196506|101449839|FG003|Phase B|Withdrawal by Participant|0|||
33426062|NCT02196506|101449836|FG000|Phase B|Adverse Event|0|||
33426063|NCT02196506|101449837|FG001|Phase B|Adverse Event|4|||
33426064|NCT02196506|101449838|FG002|Phase B|Adverse Event|1|||
33426065|NCT02196506|101449839|FG003|Phase B|Adverse Event|0|||
33426066|NCT02196506|101449836|FG000|Phase B|Lost to Follow-up|0|||
33426067|NCT02196506|101449837|FG001|Phase B|Lost to Follow-up|2|||
33426068|NCT02196506|101449838|FG002|Phase B|Lost to Follow-up|1|||
33426069|NCT02196506|101449839|FG003|Phase B|Lost to Follow-up|0|||
33426070|NCT02196506|101449836|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
33426071|NCT02196506|101449837|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
33426072|NCT02196506|101449838|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
33426073|NCT02196506|101449839|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
33426074|NCT02196506|101449836|FG000|Phase A+|Withdrawal by Participant|0|||
33426075|NCT02196506|101449837|FG001|Phase A+|Withdrawal by Participant|0|||
33426076|NCT02196506|101449838|FG002|Phase A+|Withdrawal by Participant|0|||
33426077|NCT02196506|101449839|FG003|Phase A+|Withdrawal by Participant|5|||
33426078|NCT02196506|101449836|FG000|Phase A+|Adverse Event|0|||
33426079|NCT02196506|101449837|FG001|Phase A+|Adverse Event|0|||
33426080|NCT02196506|101449838|FG002|Phase A+|Adverse Event|0|||
33426081|NCT02196506|101449839|FG003|Phase A+|Adverse Event|1|||
33149284|NCT03350620|100460698|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
33380689|NCT00664209|101276802|FG000|Study Treatment Period|Physician Decision|4|||
33380690|NCT00664209|101276802|FG000|Study Treatment Period|Withdrawal by Subject|2|||
33380691|NCT01511107|101276803|FG000|Overall Study|Ineligible|3|||
33380692|NCT01511107|101276804|FG001|Overall Study|Ineligible|2|||
33380693|NCT01511107|101276803|FG000|Overall Study|Lost to Follow-up|10|||
33380694|NCT01511107|101276804|FG001|Overall Study|Lost to Follow-up|19|||
33380695|NCT01511107|101276803|FG000|Overall Study|Withdrawal by Subject|9|||
33380696|NCT01511107|101276804|FG001|Overall Study|Withdrawal by Subject|20|||
33380697|NCT01107405|101276806|FG000|Overall Study|Adverse Event|1|||
33380698|NCT01107405|101276807|FG001|Overall Study|Adverse Event|1|||
33380699|NCT01107405|101276808|FG002|Overall Study|Adverse Event|0|||
33380700|NCT01107405|101276809|FG003|Overall Study|Adverse Event|0|||
33380701|NCT01107405|101276810|FG004|Overall Study|Adverse Event|2|||
33380702|NCT01107405|101276806|FG000|Overall Study|Withdrawal by Subject|1|||
33380703|NCT01107405|101276807|FG001|Overall Study|Withdrawal by Subject|0|||
33380704|NCT01107405|101276808|FG002|Overall Study|Withdrawal by Subject|1|||
33380705|NCT01107405|101276809|FG003|Overall Study|Withdrawal by Subject|2|||
33380706|NCT01107405|101276810|FG004|Overall Study|Withdrawal by Subject|1|||
33380707|NCT01107405|101276806|FG000|Overall Study|Protocol Violation|0|||
33380708|NCT01107405|101276807|FG001|Overall Study|Protocol Violation|0|||
33380709|NCT01107405|101276808|FG002|Overall Study|Protocol Violation|1|||
33380710|NCT01107405|101276809|FG003|Overall Study|Protocol Violation|1|||
33380711|NCT01107405|101276810|FG004|Overall Study|Protocol Violation|0|||
33380712|NCT01309841|101276812|FG000|Overall Study|Other|0|||
33380713|NCT01309841|101276813|FG001|Overall Study|Other|1|||
33380714|NCT01309841|101276814|FG002|Overall Study|Other|1|||
33380715|NCT01309841|101276812|FG000|Overall Study|Lost to Follow-up|7|||
33380716|NCT01309841|101276813|FG001|Overall Study|Lost to Follow-up|6|||
33380717|NCT01309841|101276814|FG002|Overall Study|Lost to Follow-up|4|||
33380718|NCT01309841|101276812|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
33380719|NCT01309841|101276813|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
33380720|NCT01309841|101276814|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
33380721|NCT01309841|101276812|FG000|Overall Study|Lack of Efficacy|0|||
33380722|NCT01309841|101276813|FG001|Overall Study|Lack of Efficacy|0|||
33380723|NCT01309841|101276814|FG002|Overall Study|Lack of Efficacy|2|||
33380724|NCT01309841|101276812|FG000|Overall Study|Adverse Event|9|||
33380725|NCT01309841|101276813|FG001|Overall Study|Adverse Event|22|||
33380726|NCT01309841|101276814|FG002|Overall Study|Adverse Event|11|||
33380727|NCT01309841|101276812|FG000|Overall Study|Death|1|||
33380728|NCT01309841|101276813|FG001|Overall Study|Death|0|||
33380729|NCT01309841|101276814|FG002|Overall Study|Death|0|||
33380730|NCT01309841|101276812|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
33380731|NCT01309841|101276813|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
33380732|NCT01309841|101276814|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
33380733|NCT01309841|101276812|FG000|Overall Study|Withdrawal by Subject|17|||
33380734|NCT01309841|101276813|FG001|Overall Study|Withdrawal by Subject|6|||
33380735|NCT01309841|101276814|FG002|Overall Study|Withdrawal by Subject|13|||
33380736|NCT01309841|101276812|FG000|Overall Study|Did Not Receive Treatment|2|||
33380737|NCT01309841|101276813|FG001|Overall Study|Did Not Receive Treatment|0|||
33380738|NCT01309841|101276814|FG002|Overall Study|Did Not Receive Treatment|1|||
33380739|NCT01309841|101276812|FG000|Overall Study|Severe non-compliance with protocol|0|||
33647450|NCT00490529|102262738|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
33647451|NCT00490529|102262738|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
33647452|NCT00490529|102262738|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
33647453|NCT02736890|102262741|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
33647454|NCT02736890|102262742|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
33647455|NCT02736890|102262741|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
33647456|NCT02736890|102262742|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
33647457|NCT03137069|102262743|FG000|Overall Study|Withdrawal by Subject|1|||
33647458|NCT03137069|102262744|FG001|Overall Study|Withdrawal by Subject|2|||
33647459|NCT03137069|102262745|FG002|Overall Study|Withdrawal by Subject|2|||
33426082|NCT02196506|101449836|FG000|Phase A+|Lost to Follow-up|0|||
33426083|NCT02196506|101449837|FG001|Phase A+|Lost to Follow-up|0|||
33426084|NCT02196506|101449838|FG002|Phase A+|Lost to Follow-up|0|||
33426085|NCT02196506|101449839|FG003|Phase A+|Lost to Follow-up|6|||
33426086|NCT02196506|101449836|FG000|Phase A+|Participant withdrawn by investigator|0|||
33426087|NCT02196506|101449837|FG001|Phase A+|Participant withdrawn by investigator|0|||
33426088|NCT02196506|101449838|FG002|Phase A+|Participant withdrawn by investigator|0|||
33426089|NCT02196506|101449839|FG003|Phase A+|Participant withdrawn by investigator|1|||
33426090|NCT01965652|101449840|FG000|Overall Study|Adverse Event|40|||
33426091|NCT01965652|101449841|FG001|Overall Study|Adverse Event|37|||
33426092|NCT01965652|101449840|FG000|Overall Study|Withdrawal by Subject|62|||
33426093|NCT01965652|101449841|FG001|Overall Study|Withdrawal by Subject|69|||
33426094|NCT01965652|101449840|FG000|Overall Study|Lost to Follow-up|53|||
33426095|NCT01965652|101449841|FG001|Overall Study|Lost to Follow-up|40|||
33426096|NCT01965652|101449840|FG000|Overall Study|Protocol Violation|34|||
33426097|NCT01965652|101449841|FG001|Overall Study|Protocol Violation|38|||
33426098|NCT01965652|101449840|FG000|Overall Study|Death|3|||
33426099|NCT01965652|101449841|FG001|Overall Study|Death|4|||
33426100|NCT01965652|101449840|FG000|Overall Study|Other - Miscellaneous|18|||
33426101|NCT01965652|101449841|FG001|Overall Study|Other - Miscellaneous|21|||
33426102|NCT01965652|101449840|FG000|Overall Study|Pregnancy|0|||
33426103|NCT01965652|101449841|FG001|Overall Study|Pregnancy|1|||
33426104|NCT02102490|101449844|FG000|Overall Study|Death|6|||
33426105|NCT02102490|101449844|FG000|Overall Study|Lost to Follow-up|1|||
33426106|NCT01872689|101449847|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
33426107|NCT01872689|101449848|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
33426108|NCT01872689|101449849|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
33426109|NCT01872689|101449850|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
33426110|NCT01872689|101449847|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
33426111|NCT01872689|101449848|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
33426112|NCT01872689|101449849|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
33426113|NCT01872689|101449850|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
33426114|NCT01872689|101449847|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
33426115|NCT01872689|101449848|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
33426116|NCT01872689|101449849|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
33426117|NCT01872689|101449850|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
33426118|NCT01872689|101449847|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
33426119|NCT01872689|101449848|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
33426120|NCT01872689|101449849|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
33248161|NCT03982199|100810139|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
33426121|NCT01872689|101449850|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
33587425|NCT01238991|102038493|FG004|Overall Study|Caregiver's request|0|||
33587426|NCT01238991|102038494|FG005|Overall Study|Caregiver's request|0|||
33380740|NCT01309841|101276813|FG001|Overall Study|Severe non-compliance with protocol|5|||
33587427|NCT01238991|102038495|FG006|Overall Study|Caregiver's request|0|||
33587428|NCT01238991|102038496|FG007|Overall Study|Caregiver's request|0|||
33587429|NCT01238991|102038497|FG008|Overall Study|Caregiver's request|1|||
33587430|NCT01238991|102038498|FG009|Overall Study|Caregiver's request|0|||
33587431|NCT01238991|102038489|FG000|Overall Study|Admission to a nursing home|1|||
33587432|NCT01238991|102038490|FG001|Overall Study|Admission to a nursing home|0|||
33587433|NCT01238991|102038491|FG002|Overall Study|Admission to a nursing home|1|||
33587434|NCT01238991|102038492|FG003|Overall Study|Admission to a nursing home|0|||
33587435|NCT01238991|102038493|FG004|Overall Study|Admission to a nursing home|0|||
33587436|NCT01238991|102038494|FG005|Overall Study|Admission to a nursing home|0|||
33587437|NCT01238991|102038495|FG006|Overall Study|Admission to a nursing home|0|||
33587438|NCT01238991|102038496|FG007|Overall Study|Admission to a nursing home|0|||
33587439|NCT01238991|102038497|FG008|Overall Study|Admission to a nursing home|0|||
33587440|NCT01238991|102038498|FG009|Overall Study|Admission to a nursing home|0|||
33587441|NCT00956007|102038503|FG000|Overall Study|Protocol Violation|27|||
33587442|NCT00956007|102038504|FG001|Overall Study|Protocol Violation|23|||
33587443|NCT00516906|102038505|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
33587444|NCT00516906|102038506|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
33149285|NCT03350620|100460699|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
33149286|NCT03350620|100460700|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
33380741|NCT01309841|101276814|FG002|Overall Study|Severe non-compliance with protocol|2|||
33426122|NCT01872689|101449847|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
33426123|NCT01872689|101449848|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
33426124|NCT01872689|101449849|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
33426125|NCT01872689|101449850|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
33426126|NCT01872689|101449847|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
33426127|NCT01872689|101449848|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
33426128|NCT01872689|101449849|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
33426129|NCT01872689|101449850|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
33426130|NCT01872689|101449847|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
33426131|NCT01872689|101449848|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
33426132|NCT01872689|101449849|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
33426133|NCT01872689|101449850|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
33426134|NCT01872689|101449847|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
33426135|NCT01872689|101449848|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
33426136|NCT01872689|101449849|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
33426137|NCT01872689|101449850|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
33426138|NCT01872689|101449847|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
33426139|NCT01872689|101449848|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
33426140|NCT01872689|101449849|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
33426141|NCT01872689|101449850|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
33426142|NCT01872689|101449847|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
33426143|NCT01872689|101449848|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
33426144|NCT01872689|101449849|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
33426145|NCT01872689|101449850|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
33426146|NCT01872689|101449847|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
33426147|NCT01872689|101449848|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
33587445|NCT03654040|102038507|FG000|Overall Study|Death|1|||
33647460|NCT03137069|102262746|FG003|Overall Study|Withdrawal by Subject|2|||
33149287|NCT01954342|100460701|FG000|Overall Study|Missing data from 13-16week study visit|0|||
33380742|NCT01578785|101276815|FG000|Overall Study|Withdrawal by Subject|0|||
33380743|NCT01578785|101276816|FG001|Overall Study|Withdrawal by Subject|1|||
33380744|NCT01578785|101276815|FG000|Overall Study|Study terminated by sponsor|59|||
33380745|NCT01578785|101276816|FG001|Overall Study|Study terminated by sponsor|118|||
33380746|NCT04354155|101276820|FG000|Overall Study|Withdrawal by Subject|1|||
33380747|NCT04354155|101276820|FG000|Overall Study|Did not meet criteria for study intervention|1|||
33380748|NCT00699842|101276821|FG000|Overall Study|Death|0|||
33380749|NCT00699842|101276822|FG001|Overall Study|Death|1|||
33380750|NCT00699842|101276823|FG002|Overall Study|Death|0|||
33380751|NCT02505542|101276829|FG000|Part A: Open-Label Period|Adverse Event|31|||
33380752|NCT02505542|101276830|FG001|Part A: Open-Label Period|Adverse Event|0|||
33380753|NCT02505542|101276831|FG002|Part A: Open-Label Period|Adverse Event|0|||
33380754|NCT02505542|101276832|FG003|Part A: Open-Label Period|Adverse Event|0|||
33380755|NCT02505542|101276829|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
33380756|NCT02505542|101276830|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
33380757|NCT02505542|101276831|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
33380758|NCT02505542|101276832|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
33380759|NCT02505542|101276829|FG000|Part A: Open-Label Period|Protocol Violation|1|||
33380760|NCT02505542|101276830|FG001|Part A: Open-Label Period|Protocol Violation|0|||
33380761|NCT02505542|101276831|FG002|Part A: Open-Label Period|Protocol Violation|0|||
33380762|NCT02505542|101276832|FG003|Part A: Open-Label Period|Protocol Violation|0|||
33380763|NCT02505542|101276829|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
33380764|NCT02505542|101276830|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
33380765|NCT02505542|101276831|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
33380766|NCT02505542|101276832|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
33380767|NCT02505542|101276829|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
33380768|NCT02505542|101276830|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
33380769|NCT02505542|101276831|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
33380770|NCT02505542|101276832|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
33380771|NCT02505542|101276829|FG000|Part A: Open-Label Period|New medical history available|1|||
33380772|NCT02505542|101276830|FG001|Part A: Open-Label Period|New medical history available|0|||
33380773|NCT02505542|101276831|FG002|Part A: Open-Label Period|New medical history available|0|||
33380774|NCT02505542|101276832|FG003|Part A: Open-Label Period|New medical history available|0|||
33380775|NCT02505542|101276829|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
33380776|NCT02505542|101276830|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
33647461|NCT03137069|102262747|FG004|Overall Study|Withdrawal by Subject|0|||
33426148|NCT01872689|101449849|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
33426149|NCT01872689|101449850|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
33426150|NCT01872689|101449847|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
33426151|NCT01872689|101449848|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
33426152|NCT01872689|101449849|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
33426153|NCT01872689|101449850|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
33426154|NCT01872689|101449847|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
33426155|NCT01872689|101449848|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
33426156|NCT01872689|101449849|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
33426157|NCT01872689|101449850|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
33426158|NCT01872689|101449847|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
33426159|NCT01872689|101449848|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
33426160|NCT01872689|101449849|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
33426161|NCT01872689|101449850|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
33426162|NCT02151461|101453526|FG000|Overall Study|Adverse Event|5|||
33426163|NCT02151461|101453527|FG001|Overall Study|Adverse Event|1|||
33426164|NCT02151461|101453528|FG002|Overall Study|Adverse Event|0|||
33426165|NCT02151461|101453529|FG003|Overall Study|Adverse Event|2|||
33426166|NCT02151461|101453526|FG000|Overall Study|Lost to Follow-up|0|||
33380777|NCT02505542|101276831|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
33380778|NCT02505542|101276832|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
33380779|NCT02505542|101276829|FG000|Part A: Open-Label Period|Pregnancy|2|||
33380780|NCT02505542|101276830|FG001|Part A: Open-Label Period|Pregnancy|0|||
33380781|NCT02505542|101276831|FG002|Part A: Open-Label Period|Pregnancy|0|||
33380782|NCT02505542|101276832|FG003|Part A: Open-Label Period|Pregnancy|0|||
33380783|NCT02505542|101276829|FG000|Part A: Open-Label Period|Sponsor directive|1|||
33380784|NCT02505542|101276830|FG001|Part A: Open-Label Period|Sponsor directive|0|||
33380785|NCT02505542|101276831|FG002|Part A: Open-Label Period|Sponsor directive|0|||
33380786|NCT02505542|101276832|FG003|Part A: Open-Label Period|Sponsor directive|0|||
33380787|NCT02505542|101276829|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
33380788|NCT02505542|101276830|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
33380789|NCT02505542|101276831|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
33380790|NCT02505542|101276832|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
33380791|NCT02505542|101276829|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
33380792|NCT02505542|101276830|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
33380793|NCT02505542|101276831|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
33380794|NCT02505542|101276832|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
33380795|NCT02505542|101276829|FG000|Part A: Open-Label Period|Non-compliance|1|||
33380796|NCT02505542|101276830|FG001|Part A: Open-Label Period|Non-compliance|0|||
33380797|NCT02505542|101276831|FG002|Part A: Open-Label Period|Non-compliance|0|||
33380798|NCT02505542|101276832|FG003|Part A: Open-Label Period|Non-compliance|0|||
33380799|NCT02505542|101276829|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
33380800|NCT02505542|101276830|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
33380801|NCT02505542|101276831|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
33380802|NCT02505542|101276832|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
33380803|NCT02505542|101276829|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
33380804|NCT02505542|101276830|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
33380805|NCT02505542|101276831|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
33380806|NCT02505542|101276832|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
33380807|NCT02505542|101276829|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
33380808|NCT02505542|101276830|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
33380809|NCT02505542|101276831|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
33380810|NCT02505542|101276832|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
33380811|NCT02505542|101276829|FG000|Part B: Double-Blind Period|Adverse Event|0|||
33380812|NCT02505542|101276830|FG001|Part B: Double-Blind Period|Adverse Event|0|||
33380813|NCT02505542|101276831|FG002|Part B: Double-Blind Period|Adverse Event|1|||
33380814|NCT02505542|101276832|FG003|Part B: Double-Blind Period|Adverse Event|3|||
33380815|NCT02505542|101276829|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
33380816|NCT02505542|101276830|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
33380817|NCT02505542|101276831|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
33380818|NCT02505542|101276832|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
33380819|NCT02505542|101276829|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
33380820|NCT02505542|101276830|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
33380821|NCT02505542|101276831|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
33380822|NCT02505542|101276832|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
33380823|NCT02505542|101276829|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
33426167|NCT02151461|101453527|FG001|Overall Study|Lost to Follow-up|0|||
33426168|NCT02151461|101453528|FG002|Overall Study|Lost to Follow-up|1|||
33426169|NCT02151461|101453529|FG003|Overall Study|Lost to Follow-up|1|||
33426170|NCT02151461|101453526|FG000|Overall Study|Withdrawal by Subject|1|||
33426171|NCT02151461|101453527|FG001|Overall Study|Withdrawal by Subject|0|||
33426172|NCT02151461|101453528|FG002|Overall Study|Withdrawal by Subject|1|||
33426173|NCT02151461|101453529|FG003|Overall Study|Withdrawal by Subject|1|||
33426174|NCT02151461|101453526|FG000|Overall Study|Treatment discontinuation|0|||
33426175|NCT02151461|101453527|FG001|Overall Study|Treatment discontinuation|0|||
33426176|NCT02151461|101453528|FG002|Overall Study|Treatment discontinuation|1|||
33426177|NCT02151461|101453529|FG003|Overall Study|Treatment discontinuation|0|||
33426178|NCT02629133|101453539|FG000|Overall Study|Lost to Follow-up|3|||
33426179|NCT02629133|101453540|FG001|Overall Study|Lost to Follow-up|1|||
33426180|NCT02629133|101453539|FG000|Overall Study|Withdrawal by Subject|1|||
33426181|NCT02629133|101453540|FG001|Overall Study|Withdrawal by Subject|1|||
33426182|NCT01862328|101453544|FG000|Overall Study|Progressive Disease|3|||
33426183|NCT01862328|101453545|FG001|Overall Study|Progressive Disease|11|||
33426184|NCT01862328|101453546|FG002|Overall Study|Progressive Disease|5|||
33426185|NCT01862328|101453547|FG003|Overall Study|Progressive Disease|6|||
33426186|NCT01862328|101453548|FG004|Overall Study|Progressive Disease|7|||
33426187|NCT01862328|101453549|FG005|Overall Study|Progressive Disease|4|||
33426188|NCT01862328|101453550|FG006|Overall Study|Progressive Disease|3|||
33426189|NCT01862328|101453544|FG000|Overall Study|Adverse Event|0|||
33426190|NCT01862328|101453545|FG001|Overall Study|Adverse Event|4|||
33426191|NCT01862328|101453546|FG002|Overall Study|Adverse Event|0|||
33426192|NCT01862328|101453547|FG003|Overall Study|Adverse Event|1|||
33426193|NCT01862328|101453548|FG004|Overall Study|Adverse Event|0|||
33426194|NCT01862328|101453549|FG005|Overall Study|Adverse Event|2|||
33426195|NCT01862328|101453550|FG006|Overall Study|Adverse Event|4|||
33426196|NCT01862328|101453544|FG000|Overall Study|Other|0|||
33426197|NCT01862328|101453545|FG001|Overall Study|Other|2|||
33426198|NCT01862328|101453546|FG002|Overall Study|Other|1|||
33426199|NCT01862328|101453547|FG003|Overall Study|Other|0|||
33426200|NCT01862328|101453548|FG004|Overall Study|Other|4|||
33426201|NCT01862328|101453549|FG005|Overall Study|Other|0|||
33426202|NCT01862328|101453550|FG006|Overall Study|Other|1|||
33426203|NCT01862328|101453544|FG000|Overall Study|Withdrawal by Subject|1|||
33426204|NCT01862328|101453545|FG001|Overall Study|Withdrawal by Subject|1|||
33426205|NCT01862328|101453546|FG002|Overall Study|Withdrawal by Subject|0|||
33426206|NCT01862328|101453547|FG003|Overall Study|Withdrawal by Subject|0|||
33426207|NCT01862328|101453548|FG004|Overall Study|Withdrawal by Subject|1|||
33426208|NCT01862328|101453549|FG005|Overall Study|Withdrawal by Subject|1|||
33426209|NCT01862328|101453550|FG006|Overall Study|Withdrawal by Subject|1|||
33426210|NCT01862328|101453544|FG000|Overall Study|Symptomatic Deterioration|0|||
33426211|NCT01862328|101453545|FG001|Overall Study|Symptomatic Deterioration|0|||
33426212|NCT01862328|101453546|FG002|Overall Study|Symptomatic Deterioration|0|||
33426213|NCT01862328|101453547|FG003|Overall Study|Symptomatic Deterioration|0|||
33426214|NCT01862328|101453548|FG004|Overall Study|Symptomatic Deterioration|0|||
33426215|NCT01862328|101453549|FG005|Overall Study|Symptomatic Deterioration|0|||
33426216|NCT01862328|101453550|FG006|Overall Study|Symptomatic Deterioration|1|||
33426217|NCT04363736|101453551|FG000|Overall Study|Withdrawal by Subject|1|||
33426218|NCT04363736|101453552|FG001|Overall Study|Withdrawal by Subject|0|||
33426219|NCT04363736|101453551|FG000|Overall Study|Lost to Follow-up|10|||
33426220|NCT04363736|101453552|FG001|Overall Study|Lost to Follow-up|7|||
33426221|NCT04363736|101453551|FG000|Overall Study|Death|8|||
33426222|NCT04363736|101453552|FG001|Overall Study|Death|6|||
33426223|NCT02418910|101453553|FG000|Overall Study|Lost to Follow-up|3|||
33426224|NCT02418910|101453553|FG000|Overall Study|Withdrawal by Subject|4|||
33426225|NCT00580983|101453554|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
33426226|NCT02791659|101453555|FG000|Overall Study|Protocol Violation|0|||
33426227|NCT02791659|101453556|FG001|Overall Study|Protocol Violation|1|||
33426228|NCT00660790|101453557|FG000|Baseline to 3 Months|Death|1|||
33426229|NCT00660790|101453557|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
33426230|NCT00660790|101453557|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
33426231|NCT00830063|101453558|FG000|Overall Study|Adverse Event|7|||
33587446|NCT03654040|102038508|FG001|Overall Study|Death|0|||
33587447|NCT03654040|102038507|FG000|Overall Study|Withdrawal by Subject|1|||
33587448|NCT03654040|102038508|FG001|Overall Study|Withdrawal by Subject|0|||
33426232|NCT00830063|101453559|FG001|Overall Study|Adverse Event|13|||
33426233|NCT00830063|101453560|FG002|Overall Study|Adverse Event|16|||
33426234|NCT00830063|101453561|FG003|Overall Study|Adverse Event|13|||
33426235|NCT00830063|101453558|FG000|Overall Study|Death|1|||
33426236|NCT00830063|101453559|FG001|Overall Study|Death|0|||
33426237|NCT00830063|101453560|FG002|Overall Study|Death|0|||
33426238|NCT00830063|101453561|FG003|Overall Study|Death|0|||
33426239|NCT00830063|101453558|FG000|Overall Study|Lost to Follow-up|0|||
33587449|NCT03654040|102038507|FG000|Overall Study|Study terminated by sponsor|8|||
33426240|NCT00830063|101453559|FG001|Overall Study|Lost to Follow-up|0|||
33426241|NCT00830063|101453560|FG002|Overall Study|Lost to Follow-up|3|||
33426242|NCT00830063|101453561|FG003|Overall Study|Lost to Follow-up|1|||
33426243|NCT00830063|101453558|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
33426244|NCT00830063|101453559|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
33426245|NCT00830063|101453560|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
33426246|NCT00830063|101453561|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
33426247|NCT00830063|101453558|FG000|Overall Study|Lack of Efficacy|51|||
33426248|NCT00830063|101453559|FG001|Overall Study|Lack of Efficacy|23|||
33426249|NCT00830063|101453560|FG002|Overall Study|Lack of Efficacy|25|||
33426250|NCT00830063|101453561|FG003|Overall Study|Lack of Efficacy|32|||
33426251|NCT00830063|101453558|FG000|Overall Study|Other|5|||
33426252|NCT00830063|101453559|FG001|Overall Study|Other|5|||
33426253|NCT00830063|101453560|FG002|Overall Study|Other|8|||
33426254|NCT00830063|101453561|FG003|Overall Study|Other|6|||
33426255|NCT00830063|101453558|FG000|Overall Study|Withdrawal by Subject|16|||
33426256|NCT00830063|101453559|FG001|Overall Study|Withdrawal by Subject|10|||
33426257|NCT00830063|101453560|FG002|Overall Study|Withdrawal by Subject|16|||
33426258|NCT00830063|101453561|FG003|Overall Study|Withdrawal by Subject|13|||
33426259|NCT00830063|101453558|FG000|Overall Study|Protocol Violation|1|||
33426260|NCT00830063|101453559|FG001|Overall Study|Protocol Violation|0|||
33426261|NCT00830063|101453560|FG002|Overall Study|Protocol Violation|3|||
33426262|NCT00830063|101453561|FG003|Overall Study|Protocol Violation|2|||
33426263|NCT00830063|101453558|FG000|Overall Study|Randomized But Not Treated|0|||
33426264|NCT00830063|101453559|FG001|Overall Study|Randomized But Not Treated|2|||
33426265|NCT00830063|101453560|FG002|Overall Study|Randomized But Not Treated|0|||
33426266|NCT00830063|101453561|FG003|Overall Study|Randomized But Not Treated|2|||
33426267|NCT02971605|101453562|FG000|Overall Study|Withdrawal by Subject|1|||
33587450|NCT03654040|102038508|FG001|Overall Study|Study terminated by sponsor|2|||
33587451|NCT03654040|102038507|FG000|Overall Study|Failure to initiate study therapy|2|||
33587452|NCT03654040|102038508|FG001|Overall Study|Failure to initiate study therapy|0|||
33380824|NCT02505542|101276830|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
33380825|NCT02505542|101276831|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
33380826|NCT02505542|101276832|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
33380827|NCT02505542|101276829|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
33380828|NCT02505542|101276830|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
33380829|NCT02505542|101276831|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
33380830|NCT02505542|101276832|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
33380831|NCT02505542|101276829|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
33380832|NCT02505542|101276830|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
33380833|NCT02505542|101276831|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
33380834|NCT02505542|101276832|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
33380835|NCT02505542|101276829|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
33380836|NCT02505542|101276830|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
33380837|NCT02505542|101276831|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
33380838|NCT02505542|101276832|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
33380839|NCT02505542|101276829|FG000|Part B: Double-Blind Period|Miscalculation|0|||
33380840|NCT02505542|101276830|FG001|Part B: Double-Blind Period|Miscalculation|1|||
33380841|NCT02505542|101276831|FG002|Part B: Double-Blind Period|Miscalculation|0|||
33380842|NCT02505542|101276832|FG003|Part B: Double-Blind Period|Miscalculation|0|||
33380843|NCT02505542|101276829|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
33380844|NCT02505542|101276830|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
33380845|NCT02505542|101276831|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
33380846|NCT02505542|101276832|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
33380847|NCT00673894|101276833|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
33380848|NCT00673894|101276834|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
33380849|NCT00673894|101276833|FG000|First Intervention 4 Weeks|Adverse Event|1|||
33380850|NCT00673894|101276834|FG001|First Intervention 4 Weeks|Adverse Event|0|||
33380851|NCT05631548|101276835|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
33380852|NCT05631548|101276836|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
33380853|NCT02120157|101276837|FG000|Overall Study|Death|8|||
33380854|NCT01401465|101276841|FG000|Treatment Period 1|Adverse Event|4|||
33380855|NCT01401465|101276842|FG001|Treatment Period 1|Adverse Event|1|||
33380856|NCT01401465|101276841|FG000|Treatment Period 1|Pregnancy|0|||
33380857|NCT01401465|101276842|FG001|Treatment Period 1|Pregnancy|1|||
33380858|NCT01401465|101276841|FG000|Treatment Period 1|Protocol Violation|5|||
33587453|NCT03654040|102038507|FG000|Overall Study|Transplanted at another center|2|||
33380859|NCT01401465|101276842|FG001|Treatment Period 1|Protocol Violation|0|||
33380860|NCT01401465|101276841|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33380861|NCT01401465|101276842|FG001|Treatment Period 1|Withdrawal by Subject|4|||
33426268|NCT04409002|101453563|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
33426269|NCT00461500|101453564|FG000|Overall Study|Adverse Event|1|||
33426270|NCT00461500|101453565|FG001|Overall Study|Adverse Event|0|||
33426271|NCT00461500|101453564|FG000|Overall Study|Lack of Efficacy|0|||
33426272|NCT00461500|101453565|FG001|Overall Study|Lack of Efficacy|1|||
33426273|NCT00461500|101453564|FG000|Overall Study|Expired Drug Treatment|1|||
33426274|NCT00461500|101453565|FG001|Overall Study|Expired Drug Treatment|1|||
33426275|NCT00461500|101453564|FG000|Overall Study|Study Stopped|1|||
33426276|NCT00461500|101453565|FG001|Overall Study|Study Stopped|2|||
33426277|NCT00461500|101453564|FG000|Overall Study|Drug Treatment Misuse|1|||
33426278|NCT00461500|101453565|FG001|Overall Study|Drug Treatment Misuse|0|||
33426279|NCT00461500|101453564|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
33426280|NCT00461500|101453565|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
33426281|NCT00461500|101453564|FG000|Overall Study|Lost to Follow-up|2|||
33426282|NCT00461500|101453565|FG001|Overall Study|Lost to Follow-up|2|||
33426283|NCT02370784|101453567|FG000|Overall Study|Patient started prohibited medication|0|||
33426284|NCT02370784|101453568|FG001|Overall Study|Patient started prohibited medication|1|||
33426285|NCT01698320|101453569|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
33426286|NCT01698320|101453570|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
33426287|NCT01698320|101453571|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
33426288|NCT01698320|101453569|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
33426289|NCT01698320|101453570|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
33426290|NCT01698320|101453571|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
33426291|NCT01698320|101453569|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
33426292|NCT01698320|101453570|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
33426293|NCT01698320|101453571|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
33426294|NCT01698320|101453569|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
33426295|NCT01698320|101453570|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
33426296|NCT01698320|101453571|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
33426297|NCT01698320|101453569|FG000|12-Week Double-Blind Period|Adverse Event|0|||
33426298|NCT01698320|101453570|FG001|12-Week Double-Blind Period|Adverse Event|1|||
33426299|NCT01698320|101453571|FG002|12-Week Double-Blind Period|Adverse Event|1|||
33426300|NCT01698320|101453569|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
33426301|NCT01698320|101453570|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
33426302|NCT01698320|101453571|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
33426303|NCT01698320|101453569|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
33426304|NCT01698320|101453570|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
33426305|NCT01698320|101453571|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
33426306|NCT01698320|101453569|FG000|12-Week Double-Blind Period|Pregnancy|0|||
33426307|NCT01698320|101453570|FG001|12-Week Double-Blind Period|Pregnancy|1|||
33426308|NCT01698320|101453571|FG002|12-Week Double-Blind Period|Pregnancy|1|||
33426309|NCT01698320|101453569|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
33380862|NCT01401465|101276841|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
33380863|NCT01401465|101276842|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
33380864|NCT01401465|101276841|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
33380865|NCT01401465|101276842|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
33380866|NCT01401465|101276841|FG000|Treatment Period 1|Scheduling Difficulties|1|||
33380867|NCT01401465|101276842|FG001|Treatment Period 1|Scheduling Difficulties|1|||
33380868|NCT01401465|101276841|FG000|Treatment Period 2|Lost to Follow-up|0|||
33380869|NCT01401465|101276842|FG001|Treatment Period 2|Lost to Follow-up|1|||
33380870|NCT01401465|101276841|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33380871|NCT01401465|101276842|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33380872|NCT05101486|101276843|FG000|Overall Study|Death|1|||
33380873|NCT05101486|101276844|FG001|Overall Study|Death|0|||
33380874|NCT05101486|101276845|FG002|Overall Study|Death|1|||
33380875|NCT05101486|101276843|FG000|Overall Study|Lost to Follow-up|12|||
33380876|NCT05101486|101276844|FG001|Overall Study|Lost to Follow-up|8|||
33380877|NCT05101486|101276845|FG002|Overall Study|Lost to Follow-up|17|||
33380878|NCT05101486|101276843|FG000|Overall Study|Physician Decision|1|||
33380879|NCT05101486|101276844|FG001|Overall Study|Physician Decision|0|||
33380880|NCT05101486|101276845|FG002|Overall Study|Physician Decision|0|||
33380881|NCT05101486|101276843|FG000|Overall Study|Protocol Violation|0|||
33380882|NCT05101486|101276844|FG001|Overall Study|Protocol Violation|0|||
33380883|NCT05101486|101276845|FG002|Overall Study|Protocol Violation|1|||
33380884|NCT05101486|101276843|FG000|Overall Study|Withdrawal by Subject|5|||
33380885|NCT05101486|101276844|FG001|Overall Study|Withdrawal by Subject|2|||
33426310|NCT01698320|101453570|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
33426311|NCT01698320|101453571|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
33380886|NCT05101486|101276845|FG002|Overall Study|Withdrawal by Subject|4|||
33380887|NCT05101486|101276843|FG000|Overall Study|Randomized but not vaccinated|1|||
33380888|NCT05101486|101276844|FG001|Overall Study|Randomized but not vaccinated|1|||
33380889|NCT05101486|101276845|FG002|Overall Study|Randomized but not vaccinated|1|||
33380890|NCT01204697|101276851|FG000|Overall Study|Death|26|||
33380891|NCT01204697|101276852|FG001|Overall Study|Death|27|||
33380892|NCT01204697|101276851|FG000|Overall Study|Lost to Follow-up|3|||
33380893|NCT01204697|101276852|FG001|Overall Study|Lost to Follow-up|4|||
33380894|NCT01204697|101276851|FG000|Overall Study|Withdrawal by Subject|2|||
33248162|NCT03982199|100810140|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
33248163|NCT03982199|100810141|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
33248164|NCT03982199|100810142|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
33248165|NCT03982199|100810129|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
33248166|NCT03982199|100810130|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
33248167|NCT03982199|100810131|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
33248168|NCT03982199|100810132|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
33248169|NCT03982199|100810133|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
33248170|NCT03982199|100810134|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
33248171|NCT03982199|100810135|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
33248172|NCT03982199|100810136|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
33248173|NCT03982199|100810137|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
33248174|NCT03982199|100810138|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
33248175|NCT03982199|100810139|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
33248176|NCT03982199|100810140|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
33248177|NCT03982199|100810141|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
33248178|NCT03982199|100810142|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
33248179|NCT03982199|100810129|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
33248180|NCT03982199|100810130|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
33248181|NCT03982199|100810131|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
33248182|NCT03982199|100810132|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
33248183|NCT03982199|100810133|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
33248184|NCT03982199|100810134|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
33248185|NCT03982199|100810135|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
33248186|NCT03982199|100810136|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
33248187|NCT03982199|100810137|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
33380895|NCT01204697|101276852|FG001|Overall Study|Withdrawal by Subject|4|||
33380896|NCT01204697|101276851|FG000|Overall Study|Randomized, but not treated|0|||
33380897|NCT01204697|101276852|FG001|Overall Study|Randomized, but not treated|1|||
33380898|NCT02326467|101276853|FG000|Overall Study|Withdrawal by Subject|1|||
33380899|NCT00868166|101276857|FG000|Overall Study|Death|58|||
33587454|NCT03654040|102038508|FG001|Overall Study|Transplanted at another center|0|||
33587455|NCT03654040|102038507|FG000|Overall Study|Failure to meet eligibility criteria|14|||
33587456|NCT03654040|102038508|FG001|Overall Study|Failure to meet eligibility criteria|2|||
33587457|NCT03654040|102038507|FG000|Overall Study|No longer transplant candidate|1|||
33587458|NCT03654040|102038508|FG001|Overall Study|No longer transplant candidate|0|||
33149288|NCT01954342|100460702|FG001|Overall Study|Missing data from 13-16week study visit|0|||
33149289|NCT01954342|100460703|FG002|Overall Study|Missing data from 13-16week study visit|0|||
33149290|NCT01954342|100460704|FG003|Overall Study|Missing data from 13-16week study visit|1|||
33149291|NCT01954342|100460701|FG000|Overall Study|Miscarriage|0|||
33149292|NCT01954342|100460702|FG001|Overall Study|Miscarriage|0|||
33149293|NCT01954342|100460703|FG002|Overall Study|Miscarriage|0|||
33149294|NCT01954342|100460704|FG003|Overall Study|Miscarriage|3|||
33149295|NCT01954342|100460701|FG000|Overall Study|Lost to Follow-up|0|||
33149296|NCT01954342|100460702|FG001|Overall Study|Lost to Follow-up|0|||
33149297|NCT01954342|100460703|FG002|Overall Study|Lost to Follow-up|0|||
33149298|NCT01954342|100460704|FG003|Overall Study|Lost to Follow-up|5|||
33149299|NCT01954342|100460701|FG000|Overall Study|Preterm delivery|0|||
33149300|NCT01954342|100460702|FG001|Overall Study|Preterm delivery|0|||
33149301|NCT01954342|100460703|FG002|Overall Study|Preterm delivery|0|||
33149302|NCT01954342|100460704|FG003|Overall Study|Preterm delivery|3|||
33149303|NCT01954342|100460701|FG000|Overall Study|Pre-eclampsia|0|||
33149304|NCT01954342|100460702|FG001|Overall Study|Pre-eclampsia|0|||
33149305|NCT01954342|100460703|FG002|Overall Study|Pre-eclampsia|0|||
33149306|NCT01954342|100460704|FG003|Overall Study|Pre-eclampsia|4|||
33149307|NCT01954342|100460701|FG000|Overall Study|Unreliable Data|0|||
33149308|NCT01954342|100460702|FG001|Overall Study|Unreliable Data|0|||
33149309|NCT01954342|100460703|FG002|Overall Study|Unreliable Data|0|||
33149310|NCT01954342|100460704|FG003|Overall Study|Unreliable Data|2|||
33149311|NCT04365257|100460705|FG000|Overall Study|Physician Decision|1|||
33149312|NCT04365257|100460706|FG001|Overall Study|Physician Decision|0|||
33149313|NCT04365257|100460705|FG000|Overall Study|Patient Noncompliance|1|||
33149314|NCT04365257|100460706|FG001|Overall Study|Patient Noncompliance|0|||
33149315|NCT04365257|100460705|FG000|Overall Study|Withdrawal by Subject|0|||
33149316|NCT04365257|100460706|FG001|Overall Study|Withdrawal by Subject|1|||
33149317|NCT01264016|100460707|FG000|Overall Study|Withdrawal by Subject|1|||
33149318|NCT01264016|100460707|FG000|Overall Study|Felt faint at sight of blood|1|||
33149319|NCT03034200|100460708|FG000|Overall Study|Disease progression|8|||
33149320|NCT03034200|100460709|FG001|Overall Study|Disease progression|10|||
33149321|NCT03034200|100460710|FG002|Overall Study|Disease progression|4|||
33149322|NCT03034200|100460708|FG000|Overall Study|Physician Decision|2|||
33149323|NCT03034200|100460709|FG001|Overall Study|Physician Decision|0|||
33149324|NCT03034200|100460710|FG002|Overall Study|Physician Decision|3|||
33149325|NCT03034200|100460708|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
33149326|NCT03034200|100460709|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
33149327|NCT03034200|100460710|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
33149328|NCT03034200|100460708|FG000|Overall Study|Adjuvant Therapy|0|||
33149329|NCT03034200|100460709|FG001|Overall Study|Adjuvant Therapy|0|||
33149330|NCT03034200|100460710|FG002|Overall Study|Adjuvant Therapy|1|||
33149331|NCT02035475|100460711|FG000|Overall Study|Withdrawal by Subject|4|||
33149332|NCT02035475|100460711|FG000|Overall Study|Physician Decision|1|||
33149333|NCT02035475|100460711|FG000|Overall Study|Equipment Error|1|||
33149334|NCT04718103|100460712|FG000|Overall Study|Adverse Event|1|||
33149335|NCT04718103|100460713|FG001|Overall Study|Adverse Event|1|||
33149336|NCT04718103|100460712|FG000|Overall Study|Lack of Efficacy|4|||
33149337|NCT04718103|100460713|FG001|Overall Study|Lack of Efficacy|1|||
33149338|NCT04718103|100460712|FG000|Overall Study|Lost to Follow-up|2|||
33149339|NCT04718103|100460713|FG001|Overall Study|Lost to Follow-up|2|||
33149340|NCT04718103|100460712|FG000|Overall Study|Physician Decision|2|||
33149341|NCT04718103|100460713|FG001|Overall Study|Physician Decision|0|||
33149342|NCT04718103|100460712|FG000|Overall Study|Pregnancy|0|||
33149343|NCT04718103|100460713|FG001|Overall Study|Pregnancy|1|||
33149344|NCT04718103|100460712|FG000|Overall Study|Withdrawal by Subject|10|||
33149345|NCT04718103|100460713|FG001|Overall Study|Withdrawal by Subject|6|||
33149346|NCT04718103|100460712|FG000|Overall Study|Randomized, not treated|4|||
33149347|NCT04718103|100460713|FG001|Overall Study|Randomized, not treated|1|||
33149348|NCT04718103|100460712|FG000|Overall Study|GCP violations|7|||
33149349|NCT04718103|100460713|FG001|Overall Study|GCP violations|5|||
33149350|NCT05156073|100460717|FG000|Overall Study|Patient canceled appointment with PCP|1|||
33149351|NCT00562627|100460718|FG000|Overall Study|Protocol Violation|1|||
33149352|NCT00562627|100460719|FG001|Overall Study|Protocol Violation|1|||
33149353|NCT00562627|100460720|FG002|Overall Study|Protocol Violation|1|||
33149354|NCT03693170|100460725|FG000|Overall Study|Disease Progression|48|||
33149355|NCT03693170|100460725|FG000|Overall Study|Adverse Event|16|||
33149356|NCT03693170|100460725|FG000|Overall Study|Physician Decision|6|||
33149357|NCT03693170|100460725|FG000|Overall Study|Protocol Violation|2|||
33149358|NCT03693170|100460725|FG000|Overall Study|Death|1|||
33149359|NCT03693170|100460725|FG000|Overall Study|Non compliance with study drug|1|||
33149360|NCT03693170|100460725|FG000|Overall Study|Withdrawal by Subject|1|||
33149361|NCT04478123|100460726|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
33149362|NCT04478123|100460726|FG000|Overall Study|NE|1|||
33149363|NCT01369615|100460727|FG000|Overall Study|Withdrawal by Subject|0|||
33149364|NCT01369615|100460728|FG001|Overall Study|Withdrawal by Subject|1|||
33149365|NCT01369615|100460727|FG000|Overall Study|Lost to Follow-up|0|||
33149366|NCT01369615|100460728|FG001|Overall Study|Lost to Follow-up|1|||
33149367|NCT01226043|100460729|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
33149368|NCT01226043|100460730|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
33149369|NCT01226043|100460731|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
33149370|NCT01226043|100460732|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
33149371|NCT01226043|100460729|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
33149372|NCT01226043|100460730|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
33149373|NCT01226043|100460731|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
33149374|NCT01226043|100460732|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
33587459|NCT03654040|102038507|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
33587460|NCT03654040|102038508|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
33587461|NCT03654040|102038507|FG000|Overall Study|Recipient ineligible|0|||
33587462|NCT03654040|102038508|FG001|Overall Study|Recipient ineligible|2|||
33380900|NCT00868166|101276858|FG001|Overall Study|Death|65|||
33587463|NCT03654040|102038507|FG000|Overall Study|Received deceased liver|0|||
33587464|NCT03654040|102038508|FG001|Overall Study|Received deceased liver|1|||
33587465|NCT01555073|102038509|FG000|Overall Study|Lost to Follow-up|1|||
33149375|NCT01226043|100460729|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
33149376|NCT01226043|100460730|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
33149377|NCT01226043|100460731|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
33149378|NCT01226043|100460732|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
33149379|NCT01226043|100460729|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
33149380|NCT01226043|100460730|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
33149381|NCT01226043|100460731|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
33149382|NCT01226043|100460732|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
33149383|NCT01226043|100460729|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
33380901|NCT00868166|101276857|FG000|Overall Study|Withdrawal by Subject|33|||
33380902|NCT00868166|101276858|FG001|Overall Study|Withdrawal by Subject|25|||
33587466|NCT01555073|102038510|FG001|Overall Study|Lost to Follow-up|2|||
33380903|NCT00868166|101276857|FG000|Overall Study|Protocol Violation|1|||
33426312|NCT01698320|101453569|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
33426313|NCT01698320|101453570|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
33426314|NCT01698320|101453571|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
33426315|NCT01698320|101453569|FG000|40-Week Open-Label Period|Adverse Event|0|||
33426316|NCT01698320|101453570|FG001|40-Week Open-Label Period|Adverse Event|3|||
33426317|NCT01698320|101453571|FG002|40-Week Open-Label Period|Adverse Event|2|||
33426318|NCT01698320|101453569|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
33426319|NCT01698320|101453570|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
33426320|NCT01698320|101453571|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
33426321|NCT01698320|101453569|FG000|40-Week Open-Label Period|Pregnancy|0|||
33426322|NCT01698320|101453570|FG001|40-Week Open-Label Period|Pregnancy|2|||
33426323|NCT01698320|101453571|FG002|40-Week Open-Label Period|Pregnancy|1|||
33426324|NCT01698320|101453569|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
33426325|NCT01698320|101453570|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
33426326|NCT01698320|101453571|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
33426327|NCT01698320|101453569|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
33426328|NCT01698320|101453570|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
33426329|NCT01698320|101453571|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
33426330|NCT00686374|101453572|FG000|Overall Study|Lack of Efficacy|10|||
33426331|NCT00686374|101453572|FG000|Overall Study|Adverse Event|8|||
33426332|NCT00686374|101453572|FG000|Overall Study|Withdrew consent|5|||
33426333|NCT00686374|101453572|FG000|Overall Study|Lost to Follow-up|1|||
33426334|NCT00686374|101453572|FG000|Overall Study|Missing reason|33|||
33426335|NCT00686374|101453572|FG000|Overall Study|Other, not specified|4|||
33426336|NCT00437281|101453577|FG000|Overall Study|Adverse Event|0|||
33426337|NCT00437281|101453578|FG001|Overall Study|Adverse Event|0|||
33426338|NCT00437281|101453579|FG002|Overall Study|Adverse Event|0|||
33426339|NCT00437281|101453580|FG003|Overall Study|Adverse Event|1|||
33426340|NCT00437281|101453581|FG004|Overall Study|Adverse Event|0|||
33426341|NCT00437281|101453582|FG005|Overall Study|Adverse Event|1|||
33426342|NCT00437281|101453583|FG006|Overall Study|Adverse Event|0|||
33426343|NCT00437281|101453584|FG007|Overall Study|Adverse Event|0|||
33426344|NCT00437281|101453585|FG008|Overall Study|Adverse Event|0|||
33426345|NCT00437281|101453586|FG009|Overall Study|Adverse Event|1|||
33426346|NCT00437281|101453587|FG010|Overall Study|Adverse Event|0|||
33426347|NCT00437281|101453588|FG011|Overall Study|Adverse Event|0|||
33426348|NCT00437281|101453589|FG012|Overall Study|Adverse Event|0|||
33426349|NCT00437281|101453590|FG013|Overall Study|Adverse Event|1|||
33426350|NCT00437281|101453591|FG014|Overall Study|Adverse Event|1|||
33426351|NCT00437281|101453592|FG015|Overall Study|Adverse Event|0|||
33426352|NCT00437281|101453593|FG016|Overall Study|Adverse Event|0|||
33426353|NCT00437281|101453594|FG017|Overall Study|Adverse Event|0|||
33426354|NCT00437281|101453595|FG018|Overall Study|Adverse Event|1|||
33426355|NCT00437281|101453596|FG019|Overall Study|Adverse Event|0|||
33426356|NCT00437281|101453577|FG000|Overall Study|Lost to Follow-up|0|||
33426357|NCT00437281|101453578|FG001|Overall Study|Lost to Follow-up|0|||
33426358|NCT00437281|101453579|FG002|Overall Study|Lost to Follow-up|0|||
33426359|NCT00437281|101453580|FG003|Overall Study|Lost to Follow-up|0|||
33426360|NCT00437281|101453581|FG004|Overall Study|Lost to Follow-up|0|||
33426361|NCT00437281|101453582|FG005|Overall Study|Lost to Follow-up|0|||
33426362|NCT00437281|101453583|FG006|Overall Study|Lost to Follow-up|0|||
33426363|NCT00437281|101453584|FG007|Overall Study|Lost to Follow-up|0|||
33426364|NCT00437281|101453585|FG008|Overall Study|Lost to Follow-up|0|||
33426365|NCT00437281|101453586|FG009|Overall Study|Lost to Follow-up|0|||
33426366|NCT00437281|101453587|FG010|Overall Study|Lost to Follow-up|0|||
33426367|NCT00437281|101453588|FG011|Overall Study|Lost to Follow-up|0|||
33426368|NCT00437281|101453589|FG012|Overall Study|Lost to Follow-up|0|||
33426369|NCT00437281|101453590|FG013|Overall Study|Lost to Follow-up|0|||
33426370|NCT00437281|101453591|FG014|Overall Study|Lost to Follow-up|0|||
33426371|NCT00437281|101453592|FG015|Overall Study|Lost to Follow-up|0|||
33426372|NCT00437281|101453593|FG016|Overall Study|Lost to Follow-up|0|||
33426373|NCT00437281|101453594|FG017|Overall Study|Lost to Follow-up|0|||
33426374|NCT00437281|101453595|FG018|Overall Study|Lost to Follow-up|0|||
33426375|NCT00437281|101453596|FG019|Overall Study|Lost to Follow-up|1|||
33426376|NCT00475852|101453597|FG000|Overall Study|Death|444|||
33426377|NCT00475852|101453598|FG001|Overall Study|Death|456|||
33426378|NCT00475852|101453597|FG000|Overall Study|Withdrawal by Subject|19|||
33587467|NCT01555073|102038511|FG002|Overall Study|Lost to Follow-up|0|||
33426379|NCT00475852|101453598|FG001|Overall Study|Withdrawal by Subject|24|||
33426380|NCT00475852|101453597|FG000|Overall Study|Lost to Follow-up|54|||
33426381|NCT00475852|101453598|FG001|Overall Study|Lost to Follow-up|68|||
33426382|NCT05017493|101453599|FG000|Overall Study|Withdrawal by Subject|26|||
33426383|NCT05017493|101453600|FG001|Overall Study|Withdrawal by Subject|0|||
33426384|NCT05017493|101453599|FG000|Overall Study|Physician Decision|15|||
33426385|NCT05017493|101453600|FG001|Overall Study|Physician Decision|0|||
33426386|NCT05017493|101453599|FG000|Overall Study|Protocol Violation|81|||
33426387|NCT05017493|101453600|FG001|Overall Study|Protocol Violation|0|||
33426388|NCT00911859|101453601|FG000|Treatment Period|Adverse Event|3|||
33426389|NCT00911859|101453602|FG001|Treatment Period|Adverse Event|3|||
33426390|NCT00911859|101453603|FG002|Treatment Period|Adverse Event|7|||
33426391|NCT00911859|101453601|FG000|Treatment Period|Death|1|||
33426392|NCT00911859|101453602|FG001|Treatment Period|Death|3|||
33426393|NCT00911859|101453603|FG002|Treatment Period|Death|5|||
33426394|NCT00911859|101453601|FG000|Treatment Period|Lack of Efficacy|1|||
33426395|NCT00911859|101453602|FG001|Treatment Period|Lack of Efficacy|7|||
33426396|NCT00911859|101453603|FG002|Treatment Period|Lack of Efficacy|5|||
33426397|NCT00911859|101453601|FG000|Treatment Period|Physician Decision|3|||
33426398|NCT00911859|101453602|FG001|Treatment Period|Physician Decision|3|||
33426399|NCT00911859|101453603|FG002|Treatment Period|Physician Decision|3|||
33426400|NCT00911859|101453601|FG000|Treatment Period|Withdrawal by Subject|0|||
33426401|NCT00911859|101453602|FG001|Treatment Period|Withdrawal by Subject|4|||
33426402|NCT00911859|101453603|FG002|Treatment Period|Withdrawal by Subject|5|||
33426403|NCT00911859|101453601|FG000|Treatment Period|Did not receive study treatment|0|||
33426404|NCT00911859|101453602|FG001|Treatment Period|Did not receive study treatment|1|||
33426405|NCT00911859|101453603|FG002|Treatment Period|Did not receive study treatment|0|||
33426406|NCT00911859|101453601|FG000|Maintainance Period|Lack of Efficacy|0|||
33426407|NCT00911859|101453602|FG001|Maintainance Period|Lack of Efficacy|0|||
33426408|NCT00911859|101453603|FG002|Maintainance Period|Lack of Efficacy|9|||
33426409|NCT00911859|101453601|FG000|Maintainance Period|Physician Decision|0|||
33426410|NCT00911859|101453602|FG001|Maintainance Period|Physician Decision|0|||
33426411|NCT00911859|101453603|FG002|Maintainance Period|Physician Decision|9|||
33426412|NCT00911859|101453601|FG000|Maintainance Period|Withdrawal by Subject|0|||
33426413|NCT00911859|101453602|FG001|Maintainance Period|Withdrawal by Subject|0|||
33426414|NCT00911859|101453603|FG002|Maintainance Period|Withdrawal by Subject|3|||
33426415|NCT00911859|101453601|FG000|Follow-up Period|Death|5|||
33426416|NCT00911859|101453602|FG001|Follow-up Period|Death|8|||
33426417|NCT00911859|101453603|FG002|Follow-up Period|Death|10|||
33426418|NCT00911859|101453601|FG000|Follow-up Period|Lost to Follow-up|1|||
33587468|NCT01555073|102038512|FG003|Overall Study|Lost to Follow-up|5|||
33587469|NCT03734016|102038513|FG000|Overall Study|Participants Remaining in the Study|260|||
33380904|NCT00868166|101276858|FG001|Overall Study|Protocol Violation|0|||
33380905|NCT00868166|101276857|FG000|Overall Study|Lost to Follow-up|1|||
33380906|NCT00868166|101276858|FG001|Overall Study|Lost to Follow-up|3|||
33380907|NCT00868166|101276857|FG000|Overall Study|Adverse Event|9|||
33380908|NCT00868166|101276858|FG001|Overall Study|Adverse Event|10|||
33380909|NCT00868166|101276857|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
33380910|NCT00868166|101276858|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
33380911|NCT00868166|101276857|FG000|Overall Study|Non-compliance with IMP|1|||
33380912|NCT00868166|101276858|FG001|Overall Study|Non-compliance with IMP|1|||
33380913|NCT02709083|101276861|FG000|Overall Study|Original PI left institution|7|||
33380914|NCT01205451|101279375|FG000|Overall Study|Lost to Follow-up|1|||
33380915|NCT01205451|101279376|FG001|Overall Study|Lost to Follow-up|1|||
33380916|NCT01205451|101279375|FG000|Overall Study|Withdrawal by Subject|5|||
33380917|NCT01205451|101279376|FG001|Overall Study|Withdrawal by Subject|9|||
33380918|NCT02919683|101279377|FG000|Post-Surgery Follow-Up|Death|2|||
33380919|NCT02919683|101279378|FG001|Post-Surgery Follow-Up|Death|2|||
33380920|NCT02919683|101279377|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
33380921|NCT02919683|101279378|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
33380922|NCT02207556|101279379|FG000|Overall Study|Physician Decision|1|||
33380923|NCT02207556|101279380|FG001|Overall Study|Physician Decision|0|||
33380924|NCT02207556|101279379|FG000|Overall Study|Withdrawal by Subject|1|||
33380925|NCT02207556|101279380|FG001|Overall Study|Withdrawal by Subject|0|||
33380926|NCT02207556|101279379|FG000|Overall Study|Death|0|||
33380927|NCT02207556|101279380|FG001|Overall Study|Death|5|||
33380928|NCT03954444|101279383|FG000|Overall Study|Withdrawal by Subject|5|||
33380929|NCT03954444|101279384|FG001|Overall Study|Withdrawal by Subject|5|||
33380930|NCT03954444|101279385|FG002|Overall Study|Withdrawal by Subject|5|||
33380931|NCT03954444|101279383|FG000|Overall Study|Adverse Event|1|||
33380932|NCT03954444|101279384|FG001|Overall Study|Adverse Event|3|||
33380933|NCT03954444|101279385|FG002|Overall Study|Adverse Event|2|||
33426419|NCT00911859|101453602|FG001|Follow-up Period|Lost to Follow-up|1|||
33587470|NCT03734016|102038514|FG001|Overall Study|Participants Remaining in the Study|240|||
33380934|NCT03954444|101279383|FG000|Overall Study|Protocol Violation|0|||
33380935|NCT03954444|101279384|FG001|Overall Study|Protocol Violation|3|||
33380936|NCT03954444|101279385|FG002|Overall Study|Protocol Violation|5|||
33380937|NCT03954444|101279383|FG000|Overall Study|Use of prohibited therapy|1|||
33380938|NCT03954444|101279384|FG001|Overall Study|Use of prohibited therapy|1|||
33380939|NCT03954444|101279385|FG002|Overall Study|Use of prohibited therapy|2|||
33380940|NCT03954444|101279383|FG000|Overall Study|Lost to Follow-up|1|||
33380941|NCT03954444|101279384|FG001|Overall Study|Lost to Follow-up|0|||
33380942|NCT03954444|101279385|FG002|Overall Study|Lost to Follow-up|1|||
33426420|NCT00911859|101453603|FG002|Follow-up Period|Lost to Follow-up|0|||
33426421|NCT00911859|101453601|FG000|Follow-up Period|Withdrawal by Subject|0|||
33426422|NCT00911859|101453602|FG001|Follow-up Period|Withdrawal by Subject|4|||
33426423|NCT00911859|101453603|FG002|Follow-up Period|Withdrawal by Subject|4|||
33426424|NCT00911859|101453601|FG000|Follow-up Period|Study terminated by sponsor|5|||
33426425|NCT00911859|101453602|FG001|Follow-up Period|Study terminated by sponsor|33|||
33426426|NCT00911859|101453603|FG002|Follow-up Period|Study terminated by sponsor|27|||
33426427|NCT01991977|101453604|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
33380943|NCT03954444|101279383|FG000|Overall Study|Non-compliant with study drug application|2|||
33380944|NCT03954444|101279384|FG001|Overall Study|Non-compliant with study drug application|2|||
33380945|NCT03954444|101279385|FG002|Overall Study|Non-compliant with study drug application|0|||
33380946|NCT03954444|101279383|FG000|Overall Study|Administrative reasons|0|||
33380947|NCT03954444|101279384|FG001|Overall Study|Administrative reasons|0|||
33380948|NCT03954444|101279385|FG002|Overall Study|Administrative reasons|1|||
33380949|NCT03954444|101279383|FG000|Overall Study|Miscellaneous|3|||
33380950|NCT03954444|101279384|FG001|Overall Study|Miscellaneous|2|||
33380951|NCT03954444|101279385|FG002|Overall Study|Miscellaneous|1|||
33380952|NCT02180217|101279391|FG000|Overall Study|Adverse Event|3|||
33380953|NCT02180217|101279392|FG001|Overall Study|Adverse Event|2|||
33380954|NCT02180217|101279393|FG002|Overall Study|Adverse Event|22|||
33380955|NCT02180217|101279391|FG000|Overall Study|Death|1|||
33380956|NCT02180217|101279392|FG001|Overall Study|Death|1|||
33380957|NCT02180217|101279393|FG002|Overall Study|Death|0|||
33380958|NCT02180217|101279391|FG000|Overall Study|Withdrawal by Subject|1|||
33380959|NCT02180217|101279392|FG001|Overall Study|Withdrawal by Subject|1|||
33380960|NCT02180217|101279393|FG002|Overall Study|Withdrawal by Subject|4|||
33380961|NCT02180217|101279391|FG000|Overall Study|Subject/Guardian decision|5|||
33380962|NCT02180217|101279392|FG001|Overall Study|Subject/Guardian decision|3|||
33380963|NCT02180217|101279393|FG002|Overall Study|Subject/Guardian decision|6|||
33380964|NCT02180217|101279391|FG000|Overall Study|Physician Decision|1|||
33380965|NCT02180217|101279392|FG001|Overall Study|Physician Decision|1|||
33380966|NCT02180217|101279393|FG002|Overall Study|Physician Decision|6|||
33380967|NCT02180217|101279391|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33380968|NCT02180217|101279392|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33380969|NCT02180217|101279393|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
33380970|NCT01464788|101279394|FG000|Overall Study|Lost to Follow-up|0|||
33380971|NCT01464788|101279395|FG001|Overall Study|Lost to Follow-up|1|||
33380972|NCT01464788|101279396|FG002|Overall Study|Lost to Follow-up|0|||
33380973|NCT01464788|101279394|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
33380974|NCT01464788|101279395|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
33380975|NCT01464788|101279396|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
33380976|NCT02585999|101279399|FG000|Overall Study|Lost to Follow-up|1|||
33380977|NCT02585999|101279399|FG000|Overall Study|Protocol Violation|1|||
33380978|NCT00844285|101279404|FG000|Overall Study|Other|0|||
33380979|NCT00844285|101279405|FG001|Overall Study|Other|1|||
33380980|NCT00844285|101279406|FG002|Overall Study|Other|0|||
33380981|NCT00844285|101279404|FG000|Overall Study|Other than specified|95|||
33380982|NCT00844285|101279405|FG001|Overall Study|Other than specified|129|||
33380983|NCT00844285|101279406|FG002|Overall Study|Other than specified|12|||
33380984|NCT00844285|101279404|FG000|Overall Study|Site closure|256|||
33380985|NCT00844285|101279405|FG001|Overall Study|Site closure|450|||
33380986|NCT00844285|101279406|FG002|Overall Study|Site closure|50|||
33380987|NCT00844285|101279404|FG000|Overall Study|Follow-up < 8 years|16|||
33380988|NCT00844285|101279405|FG001|Overall Study|Follow-up < 8 years|23|||
33380989|NCT00844285|101279406|FG002|Overall Study|Follow-up < 8 years|4|||
33380990|NCT00844285|101279404|FG000|Overall Study|Protocol Violation|26|||
33380991|NCT00844285|101279405|FG001|Overall Study|Protocol Violation|28|||
33380992|NCT00844285|101279406|FG002|Overall Study|Protocol Violation|54|||
33380993|NCT00844285|101279404|FG000|Overall Study|Death|22|||
33380994|NCT00844285|101279405|FG001|Overall Study|Death|21|||
33380995|NCT00844285|101279406|FG002|Overall Study|Death|8|||
33380996|NCT00844285|101279404|FG000|Overall Study|Withdrew Consent|344|||
33380997|NCT00844285|101279405|FG001|Overall Study|Withdrew Consent|466|||
33380998|NCT00844285|101279406|FG002|Overall Study|Withdrew Consent|70|||
33380999|NCT00844285|101279404|FG000|Overall Study|Lost to Follow-up|330|||
33381000|NCT00844285|101279405|FG001|Overall Study|Lost to Follow-up|486|||
33426428|NCT01991977|101453604|FG000|Overall Study|Withdrew after start of treatment|5|||
33426429|NCT02725671|101453608|FG000|Overall Study|Lost to Follow-up|1|||
33426430|NCT02962882|101453609|FG000|Overall Study|Adverse Event|2|||
33587471|NCT03734016|102038513|FG000|Overall Study|Death|48|||
33587472|NCT03734016|102038514|FG001|Overall Study|Death|60|||
33587473|NCT03734016|102038513|FG000|Overall Study|Withdrawal by Subject|14|||
33381001|NCT00844285|101279406|FG002|Overall Study|Lost to Follow-up|74|||
33381002|NCT00433446|101279407|FG000|Overall Study|Adverse Event|4|||
33381003|NCT00433446|101279407|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
33381004|NCT00433446|101279407|FG000|Overall Study|Progression|44|||
33381005|NCT00433446|101279407|FG000|Overall Study|Other - Not Protocol specified|3|||
33381006|NCT00433446|101279407|FG000|Overall Study|Ineligible|9|||
33381007|NCT00862654|101279408|FG000|Overall Study|Lack of Efficacy|1|||
33381008|NCT00862654|101279409|FG001|Overall Study|Lack of Efficacy|0|||
33381009|NCT00862654|101279410|FG002|Overall Study|Lack of Efficacy|1|||
33381010|NCT00862654|101279411|FG003|Overall Study|Lack of Efficacy|0|||
33426431|NCT02962882|101453609|FG000|Overall Study|Withdrawal by Subject|2|||
33426432|NCT02962882|101453609|FG000|Overall Study|Transfer from ICU|32|||
33426433|NCT00544557|101453618|FG000|Overall Study|Adverse Event|140|||
33426434|NCT00544557|101453618|FG000|Overall Study|Lack of Efficacy|196|||
33426435|NCT00544557|101453618|FG000|Overall Study|Other|98|||
33426436|NCT01020305|101453619|FG000|Overall Study|Adverse Event|2|||
33426437|NCT01512979|101453621|FG000|Overall Study|Adverse Event|2|||
33426438|NCT01512979|101453622|FG001|Overall Study|Adverse Event|2|||
33426439|NCT01512979|101453621|FG000|Overall Study|Protocol Violation|1|||
33426440|NCT01512979|101453622|FG001|Overall Study|Protocol Violation|4|||
33426441|NCT01512979|101453621|FG000|Overall Study|Lost to Follow-up|2|||
33426442|NCT01512979|101453622|FG001|Overall Study|Lost to Follow-up|5|||
33426443|NCT01512979|101453621|FG000|Overall Study|Withdrawal by Subject|1|||
33426444|NCT01512979|101453622|FG001|Overall Study|Withdrawal by Subject|2|||
33426445|NCT01512979|101453621|FG000|Overall Study|Reason other than stated above|13|||
33426446|NCT01512979|101453622|FG001|Overall Study|Reason other than stated above|9|||
33426447|NCT01588106|101453623|FG000|Overall Study|Withdrawal by Subject|5|||
33426448|NCT01588106|101453624|FG001|Overall Study|Withdrawal by Subject|4|||
33426449|NCT02675426|101453625|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
33426450|NCT02675426|101453626|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
33426451|NCT02675426|101453627|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
33426452|NCT02675426|101453628|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
33426453|NCT02675426|101453625|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
33426454|NCT02675426|101453626|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
33426455|NCT02675426|101453627|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
33426456|NCT02675426|101453628|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
33426457|NCT02675426|101453625|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
33426458|NCT02675426|101453626|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
33426459|NCT02675426|101453627|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
33426460|NCT02675426|101453628|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
33426461|NCT02675426|101453625|FG000|Period 1: Week 1 to Week 12|Other|2|||
33426462|NCT02675426|101453626|FG001|Period 1: Week 1 to Week 12|Other|1|||
33426463|NCT02675426|101453627|FG002|Period 1: Week 1 to Week 12|Other|0|||
33426464|NCT02675426|101453628|FG003|Period 1: Week 1 to Week 12|Other|2|||
33426465|NCT02675426|101453625|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
33426466|NCT02675426|101453626|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
33426467|NCT02675426|101453627|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
33426468|NCT02675426|101453628|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
33426469|NCT02675426|101453625|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
33426470|NCT02675426|101453626|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
33426471|NCT02675426|101453627|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
33426472|NCT02675426|101453628|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
33426473|NCT02675426|101453625|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
33426474|NCT02675426|101453626|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
33426475|NCT02675426|101453627|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
33426476|NCT02675426|101453628|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
33426477|NCT02675426|101453625|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
33426478|NCT02675426|101453626|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
33426479|NCT02675426|101453627|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
33426480|NCT02675426|101453628|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
33426481|NCT02675426|101453625|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
33426482|NCT02675426|101453626|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
33426483|NCT02675426|101453627|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
33426484|NCT02675426|101453628|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
33426485|NCT02675426|101453625|FG000|Period 2: Week 12 to Week 260|Other|8|||
33426486|NCT02675426|101453626|FG001|Period 2: Week 12 to Week 260|Other|12|||
33426487|NCT02675426|101453627|FG002|Period 2: Week 12 to Week 260|Other|23|||
33426488|NCT02675426|101453628|FG003|Period 2: Week 12 to Week 260|Other|15|||
33426489|NCT00775983|101453631|FG000|Overall Study|Protocol Violation|1|||
33426490|NCT00775983|101453632|FG001|Overall Study|Protocol Violation|2|||
33426491|NCT01165242|101453633|FG000|Overall Study|Unreachable Subjects|1|||
33426492|NCT01165242|101453634|FG001|Overall Study|Unreachable Subjects|0|||
33426493|NCT01165242|101453635|FG002|Overall Study|Unreachable Subjects|0|||
33426494|NCT01165242|101453633|FG000|Overall Study|Incarcerated Subjects|0|||
33426495|NCT01165242|101453634|FG001|Overall Study|Incarcerated Subjects|1|||
33426496|NCT01165242|101453635|FG002|Overall Study|Incarcerated Subjects|0|||
33426497|NCT01165242|101453633|FG000|Overall Study|Visit 2 Declined by Subject|0|||
33426498|NCT01165242|101453634|FG001|Overall Study|Visit 2 Declined by Subject|0|||
33426499|NCT01165242|101453635|FG002|Overall Study|Visit 2 Declined by Subject|1|||
33426500|NCT01165242|101453633|FG000|Overall Study|Withdrawal by Subject|0|||
33426501|NCT01165242|101453634|FG001|Overall Study|Withdrawal by Subject|2|||
33426502|NCT01165242|101453635|FG002|Overall Study|Withdrawal by Subject|2|||
33426503|NCT01165242|101453633|FG000|Overall Study|Extended Holiday|0|||
33426504|NCT01165242|101453634|FG001|Overall Study|Extended Holiday|0|||
33426505|NCT01165242|101453635|FG002|Overall Study|Extended Holiday|1|||
33426506|NCT01165242|101453633|FG000|Overall Study|Lost to Follow-up|9|||
33426507|NCT01165242|101453634|FG001|Overall Study|Lost to Follow-up|7|||
33426508|NCT01165242|101453635|FG002|Overall Study|Lost to Follow-up|10|||
33426509|NCT01859702|101453636|FG000|Overall Study|Protocol deviation|3|||
33426510|NCT01859702|101453636|FG000|Overall Study|Adverse Event|2|||
33426511|NCT01841359|101453637|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
33426512|NCT01841359|101453637|FG000|Overall Study|Concommitant medical issues|2|||
33426513|NCT01841359|101453637|FG000|Overall Study|Adverse Event|3|||
33426514|NCT01841359|101453637|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
33426515|NCT01507831|101453642|FG000|Overall Study|Randomized but not treated|0|||
33426516|NCT01507831|101453643|FG001|Overall Study|Randomized but not treated|3|||
33426517|NCT01507831|101453642|FG000|Overall Study|Adverse Event|48|||
33426518|NCT01507831|101453643|FG001|Overall Study|Adverse Event|113|||
33426519|NCT01507831|101453642|FG000|Overall Study|Death|6|||
33426520|NCT01507831|101453643|FG001|Overall Study|Death|2|||
33426521|NCT01507831|101453642|FG000|Overall Study|Poor compliance to protocol|38|||
33426522|NCT01507831|101453643|FG001|Overall Study|Poor compliance to protocol|60|||
33426523|NCT01507831|101453642|FG000|Overall Study|Physician Decision|0|||
33149384|NCT01226043|100460730|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
33149385|NCT01226043|100460731|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
33248188|NCT03982199|100810138|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
33587474|NCT03734016|102038514|FG001|Overall Study|Withdrawal by Subject|16|||
33587475|NCT03734016|102038513|FG000|Overall Study|Physician Decision|0|||
33587476|NCT03734016|102038514|FG001|Overall Study|Physician Decision|7|||
33587477|NCT03734016|102038513|FG000|Overall Study|Lost to Follow-up|3|||
33587478|NCT03734016|102038514|FG001|Overall Study|Lost to Follow-up|1|||
33587479|NCT03734016|102038513|FG000|Overall Study|Adverse Event|2|||
33587480|NCT03734016|102038514|FG001|Overall Study|Adverse Event|1|||
33248189|NCT03982199|100810139|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
33248190|NCT03982199|100810140|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
33248191|NCT03982199|100810141|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
33248192|NCT03982199|100810142|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
33248193|NCT03982199|100810129|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
33248194|NCT03982199|100810130|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
33248195|NCT03982199|100810131|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
33248196|NCT03982199|100810132|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
33248197|NCT03982199|100810133|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
33248198|NCT03982199|100810134|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
33248199|NCT03982199|100810135|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
33248200|NCT03982199|100810136|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
33248201|NCT03982199|100810137|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
33381011|NCT00862654|101279408|FG000|Overall Study|Lost to Follow-up|1|||
33381012|NCT00862654|101279409|FG001|Overall Study|Lost to Follow-up|2|||
33381013|NCT00862654|101279410|FG002|Overall Study|Lost to Follow-up|1|||
33381014|NCT00862654|101279411|FG003|Overall Study|Lost to Follow-up|3|||
33381015|NCT00862654|101279408|FG000|Overall Study|Adverse Event|0|||
33381016|NCT00862654|101279409|FG001|Overall Study|Adverse Event|1|||
33381017|NCT00862654|101279410|FG002|Overall Study|Adverse Event|1|||
33381018|NCT00862654|101279411|FG003|Overall Study|Adverse Event|0|||
33381019|NCT00862654|101279408|FG000|Overall Study|Pregnancy|1|||
33381020|NCT00862654|101279409|FG001|Overall Study|Pregnancy|1|||
33381021|NCT00862654|101279410|FG002|Overall Study|Pregnancy|0|||
33381022|NCT00862654|101279411|FG003|Overall Study|Pregnancy|0|||
33381023|NCT00862654|101279408|FG000|Overall Study|Withdrawal by Subject|2|||
33381024|NCT00862654|101279409|FG001|Overall Study|Withdrawal by Subject|2|||
33381025|NCT00862654|101279410|FG002|Overall Study|Withdrawal by Subject|2|||
33381026|NCT00862654|101279411|FG003|Overall Study|Withdrawal by Subject|3|||
33381027|NCT00862654|101279408|FG000|Overall Study|Subject mistake|0|||
33381028|NCT00862654|101279409|FG001|Overall Study|Subject mistake|1|||
33381029|NCT00862654|101279410|FG002|Overall Study|Subject mistake|0|||
33381030|NCT00862654|101279411|FG003|Overall Study|Subject mistake|0|||
33381031|NCT00862654|101279408|FG000|Overall Study|Familly constraint|0|||
33381032|NCT00862654|101279409|FG001|Overall Study|Familly constraint|1|||
33381033|NCT00862654|101279410|FG002|Overall Study|Familly constraint|0|||
33426524|NCT01507831|101453643|FG001|Overall Study|Physician Decision|4|||
33426525|NCT01507831|101453642|FG000|Overall Study|Participant moved|5|||
33587481|NCT00778375|102038515|FG000|Overall Study|Ineligible|3|||
33587482|NCT01133756|102038516|FG000|Overall Study|Adverse Event|1|||
33426526|NCT01507831|101453643|FG001|Overall Study|Participant moved|19|||
33426527|NCT01507831|101453642|FG000|Overall Study|Consent withdrawn by participant|34|||
33426528|NCT01507831|101453643|FG001|Overall Study|Consent withdrawn by participant|72|||
33426529|NCT01507831|101453642|FG000|Overall Study|Related to study drug administration|5|||
33426530|NCT01507831|101453643|FG001|Overall Study|Related to study drug administration|14|||
33426531|NCT01507831|101453642|FG000|Overall Study|Last visit outside protocol visit window|51|||
33426532|NCT01507831|101453643|FG001|Overall Study|Last visit outside protocol visit window|143|||
33426533|NCT01507831|101453642|FG000|Overall Study|Selection criteria finally not met|0|||
33426534|NCT01507831|101453643|FG001|Overall Study|Selection criteria finally not met|1|||
33426535|NCT01507831|101453642|FG000|Overall Study|Site closure|0|||
33426536|NCT01507831|101453643|FG001|Overall Study|Site closure|3|||
33426537|NCT01507831|101453642|FG000|Overall Study|Potential lost to follow-up|3|||
33426538|NCT01507831|101453643|FG001|Overall Study|Potential lost to follow-up|0|||
33426539|NCT01507831|101453642|FG000|Overall Study|Other|3|||
33426540|NCT01507831|101453643|FG001|Overall Study|Other|6|||
33426541|NCT00520351|101453654|FG000|First Intervention|Withdrawal by Subject|1|||
33426542|NCT00520351|101453655|FG001|First Intervention|Withdrawal by Subject|1|||
33426543|NCT03760510|101453656|FG000|Overall Study|Not ventilated for 24 hours|105|||
33426544|NCT03760510|101453657|FG001|Overall Study|Not ventilated for 24 hours|97|||
33426545|NCT02280421|101453660|FG000|Washout (2 Weeks)|Adverse Event|0|||
33426546|NCT02280421|101453661|FG001|Washout (2 Weeks)|Adverse Event|1|||
33426547|NCT02280421|101453660|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
33426548|NCT02280421|101453661|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
33426549|NCT03652961|101453665|FG000|Overall Study|Lost to Follow-up|3|||
33426550|NCT03652961|101453665|FG000|Overall Study|Screen Failure|1|||
33426551|NCT01070394|101453667|FG000|Overall Study|Adverse Event|6|||
33426552|NCT01070394|101453667|FG000|Overall Study|Withdrawal by Subject|1|||
33426553|NCT03989115|101453668|FG000|Overall Study|Withdrawal by Subject|2|||
33426554|NCT03989115|101453669|FG001|Overall Study|Withdrawal by Subject|1|||
33426555|NCT03989115|101453670|FG002|Overall Study|Withdrawal by Subject|3|||
33426556|NCT03989115|101453671|FG003|Overall Study|Withdrawal by Subject|0|||
33426557|NCT03989115|101453672|FG004|Overall Study|Withdrawal by Subject|17|||
33426558|NCT03989115|101453673|FG005|Overall Study|Withdrawal by Subject|1|||
33426559|NCT03989115|101453674|FG006|Overall Study|Withdrawal by Subject|0|||
33426560|NCT03989115|101453675|FG007|Overall Study|Withdrawal by Subject|0|||
33426561|NCT03989115|101453668|FG000|Overall Study|Sponsor decision to terminate the study|1|||
33426562|NCT03989115|101453669|FG001|Overall Study|Sponsor decision to terminate the study|1|||
33426563|NCT03989115|101453670|FG002|Overall Study|Sponsor decision to terminate the study|0|||
33426564|NCT03989115|101453671|FG003|Overall Study|Sponsor decision to terminate the study|1|||
33426565|NCT03989115|101453672|FG004|Overall Study|Sponsor decision to terminate the study|11|||
33647462|NCT03137069|102262748|FG005|Overall Study|Withdrawal by Subject|0|||
33647463|NCT03137069|102262743|FG000|Overall Study|Adverse Event|0|||
33647464|NCT03137069|102262744|FG001|Overall Study|Adverse Event|3|||
33647465|NCT03137069|102262745|FG002|Overall Study|Adverse Event|1|||
33426566|NCT03989115|101453673|FG005|Overall Study|Sponsor decision to terminate the study|0|||
33426567|NCT03989115|101453674|FG006|Overall Study|Sponsor decision to terminate the study|2|||
33426568|NCT03989115|101453675|FG007|Overall Study|Sponsor decision to terminate the study|1|||
33426569|NCT03989115|101453668|FG000|Overall Study|Lost to Follow-up|2|||
33426570|NCT03989115|101453669|FG001|Overall Study|Lost to Follow-up|0|||
33426571|NCT03989115|101453670|FG002|Overall Study|Lost to Follow-up|0|||
33426572|NCT03989115|101453671|FG003|Overall Study|Lost to Follow-up|0|||
33426573|NCT03989115|101453672|FG004|Overall Study|Lost to Follow-up|1|||
33426574|NCT03989115|101453673|FG005|Overall Study|Lost to Follow-up|0|||
33426575|NCT03989115|101453674|FG006|Overall Study|Lost to Follow-up|0|||
33426576|NCT03989115|101453675|FG007|Overall Study|Lost to Follow-up|0|||
33426577|NCT03989115|101453668|FG000|Overall Study|Death|2|||
33426578|NCT03989115|101453669|FG001|Overall Study|Death|2|||
33426579|NCT03989115|101453670|FG002|Overall Study|Death|9|||
33426580|NCT03989115|101453671|FG003|Overall Study|Death|6|||
33426581|NCT03989115|101453672|FG004|Overall Study|Death|31|||
33426582|NCT03989115|101453673|FG005|Overall Study|Death|6|||
33426583|NCT03989115|101453674|FG006|Overall Study|Death|2|||
33647466|NCT03137069|102262746|FG003|Overall Study|Adverse Event|1|||
33647467|NCT03137069|102262747|FG004|Overall Study|Adverse Event|0|||
33647468|NCT03137069|102262748|FG005|Overall Study|Adverse Event|1|||
33426584|NCT03989115|101453675|FG007|Overall Study|Death|3|||
33426585|NCT03989115|101453668|FG000|Overall Study|Other|1|||
33426586|NCT03989115|101453669|FG001|Overall Study|Other|2|||
33426587|NCT03989115|101453670|FG002|Overall Study|Other|0|||
33426588|NCT03989115|101453671|FG003|Overall Study|Other|0|||
33426589|NCT03989115|101453672|FG004|Overall Study|Other|5|||
33426590|NCT03989115|101453673|FG005|Overall Study|Other|0|||
33426591|NCT03989115|101453674|FG006|Overall Study|Other|0|||
33647469|NCT03137069|102262743|FG000|Overall Study|Protocol Violation|0|||
33647470|NCT03137069|102262744|FG001|Overall Study|Protocol Violation|1|||
33426592|NCT03989115|101453675|FG007|Overall Study|Other|0|||
33426593|NCT01456052|101453676|FG000|Overall Study|Adverse Event|1|||
33647471|NCT03137069|102262745|FG002|Overall Study|Protocol Violation|0|||
33426594|NCT01456052|101453677|FG001|Overall Study|Adverse Event|1|||
33426595|NCT01456052|101453678|FG002|Overall Study|Adverse Event|2|||
33426596|NCT01456052|101453676|FG000|Overall Study|Consent withdrawn|0|||
33381034|NCT00862654|101279411|FG003|Overall Study|Familly constraint|0|||
33381035|NCT00862654|101279408|FG000|Overall Study|Never used study drugs|1|||
33381036|NCT00862654|101279409|FG001|Overall Study|Never used study drugs|0|||
33381037|NCT00862654|101279410|FG002|Overall Study|Never used study drugs|0|||
33381038|NCT00862654|101279411|FG003|Overall Study|Never used study drugs|0|||
33381039|NCT00862654|101279408|FG000|Overall Study|Included after end of inclusions|0|||
33381040|NCT00862654|101279409|FG001|Overall Study|Included after end of inclusions|0|||
33381041|NCT00862654|101279410|FG002|Overall Study|Included after end of inclusions|1|||
33381042|NCT00862654|101279411|FG003|Overall Study|Included after end of inclusions|0|||
33381043|NCT01409993|101279412|FG000|Overall Study|Adverse Event|4|||
33381044|NCT01409993|101279413|FG001|Overall Study|Adverse Event|4|||
33381045|NCT01409993|101279414|FG002|Overall Study|Adverse Event|3|||
33381046|NCT01409993|101279415|FG003|Overall Study|Adverse Event|1|||
33381047|NCT01409993|101279412|FG000|Overall Study|Withdrawal by Subject|0|||
33381048|NCT01409993|101279413|FG001|Overall Study|Withdrawal by Subject|0|||
33381049|NCT01409993|101279414|FG002|Overall Study|Withdrawal by Subject|0|||
33381050|NCT01409993|101279415|FG003|Overall Study|Withdrawal by Subject|4|||
33381051|NCT01409993|101279412|FG000|Overall Study|Lost to Follow-up|0|||
33381052|NCT01409993|101279413|FG001|Overall Study|Lost to Follow-up|1|||
33381053|NCT01409993|101279414|FG002|Overall Study|Lost to Follow-up|0|||
33381054|NCT01409993|101279415|FG003|Overall Study|Lost to Follow-up|0|||
33381055|NCT02188719|101279416|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
33381056|NCT02188719|101279417|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
33381057|NCT02188719|101279418|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
33381058|NCT02188719|101279419|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
33381059|NCT00426556|101279421|FG000|Phase I - Core Phase|Disease Progression|0|||
33381060|NCT00426556|101279422|FG001|Phase I - Core Phase|Disease Progression|6|||
33381061|NCT00426556|101279423|FG002|Phase I - Core Phase|Disease Progression|2|||
33381062|NCT00426556|101279424|FG003|Phase I - Core Phase|Disease Progression|0|||
33381063|NCT00426556|101279421|FG000|Phase I - Core Phase|Adverse Event|1|||
33381064|NCT00426556|101279422|FG001|Phase I - Core Phase|Adverse Event|3|||
33381065|NCT00426556|101279423|FG002|Phase I - Core Phase|Adverse Event|1|||
33381066|NCT00426556|101279424|FG003|Phase I - Core Phase|Adverse Event|0|||
33381067|NCT00426556|101279421|FG000|Phase I - Core Phase|Death|0|||
33381068|NCT00426556|101279422|FG001|Phase I - Core Phase|Death|1|||
33381069|NCT00426556|101279423|FG002|Phase I - Core Phase|Death|0|||
33381070|NCT00426556|101279424|FG003|Phase I - Core Phase|Death|0|||
33381071|NCT00426556|101279421|FG000|Phase I - Extension Phase|Adverse Event|0|||
33381072|NCT00426556|101279422|FG001|Phase I - Extension Phase|Adverse Event|1|||
33381073|NCT00426556|101279423|FG002|Phase I - Extension Phase|Adverse Event|1|||
33381074|NCT00426556|101279424|FG003|Phase I - Extension Phase|Adverse Event|0|||
33381075|NCT00426556|101279421|FG000|Phase I - Extension Phase|Disease Progression|5|||
33381076|NCT00426556|101279422|FG001|Phase I - Extension Phase|Disease Progression|5|||
33381077|NCT00426556|101279423|FG002|Phase I - Extension Phase|Disease Progression|6|||
33381078|NCT00426556|101279424|FG003|Phase I - Extension Phase|Disease Progression|0|||
33381079|NCT00426556|101279421|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
33381080|NCT00426556|101279422|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
33381081|NCT00426556|101279423|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
33381082|NCT00426556|101279424|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
33381083|NCT00426556|101279421|FG000|Phase II - Core Phase|Disease Progression|0|||
33381084|NCT00426556|101279422|FG001|Phase II - Core Phase|Disease Progression|0|||
33381085|NCT00426556|101279423|FG002|Phase II - Core Phase|Disease Progression|0|||
33381086|NCT00426556|101279424|FG003|Phase II - Core Phase|Disease Progression|16|||
33381087|NCT00426556|101279421|FG000|Phase II - Core Phase|Adverse Event|0|||
33381088|NCT00426556|101279422|FG001|Phase II - Core Phase|Adverse Event|0|||
33381089|NCT00426556|101279423|FG002|Phase II - Core Phase|Adverse Event|0|||
33381090|NCT00426556|101279424|FG003|Phase II - Core Phase|Adverse Event|8|||
33381091|NCT00426556|101279421|FG000|Phase II - Extension Phase|Disease Progression|0|||
33381092|NCT00426556|101279422|FG001|Phase II - Extension Phase|Disease Progression|0|||
33381093|NCT00426556|101279423|FG002|Phase II - Extension Phase|Disease Progression|0|||
33381094|NCT00426556|101279424|FG003|Phase II - Extension Phase|Disease Progression|21|||
33381095|NCT00426556|101279421|FG000|Phase II - Extension Phase|Adverse Event|0|||
33381096|NCT00426556|101279422|FG001|Phase II - Extension Phase|Adverse Event|0|||
33381097|NCT00426556|101279423|FG002|Phase II - Extension Phase|Adverse Event|0|||
33381098|NCT00426556|101279424|FG003|Phase II - Extension Phase|Adverse Event|2|||
33381099|NCT04176445|101279430|FG000|Overall Study|Adverse Event|0|||
33426597|NCT01456052|101453677|FG001|Overall Study|Consent withdrawn|2|||
33381100|NCT04176445|101279431|FG001|Overall Study|Adverse Event|1|||
33381101|NCT04176445|101279430|FG000|Overall Study|change plans weaning after first intervention|0|||
33381102|NCT04176445|101279431|FG001|Overall Study|change plans weaning after first intervention|1|||
33381103|NCT00793182|101279448|FG000|Overall Study|Adverse Event|0|||
33381104|NCT00793182|101279449|FG001|Overall Study|Adverse Event|1|||
33381105|NCT00178464|101279450|FG000|Overall Study|Withdrawal by Subject|1|||
33381106|NCT00178464|101279450|FG000|Overall Study|Physician Decision|1|||
33248202|NCT03982199|100810138|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
33248203|NCT03982199|100810139|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
33248204|NCT03982199|100810140|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
33248205|NCT03982199|100810141|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
33248206|NCT03982199|100810142|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
33248207|NCT03982199|100810129|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
33248208|NCT03982199|100810130|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
33248209|NCT03982199|100810131|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
33248210|NCT03982199|100810132|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
33248211|NCT03982199|100810133|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
33248212|NCT03982199|100810134|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
33248213|NCT03982199|100810135|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
33248214|NCT03982199|100810136|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
33248215|NCT03982199|100810137|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
33248216|NCT03982199|100810138|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
33248217|NCT03982199|100810139|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
33248218|NCT03982199|100810140|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
33248219|NCT03982199|100810141|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
33248220|NCT03982199|100810142|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
33248221|NCT03982199|100810129|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
33248222|NCT03982199|100810130|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
33248223|NCT03982199|100810131|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
33248224|NCT03982199|100810132|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
33248225|NCT03982199|100810133|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
33248226|NCT03982199|100810134|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
33248227|NCT03982199|100810135|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
33248228|NCT03982199|100810136|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
33248229|NCT03982199|100810137|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
33248230|NCT03982199|100810138|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
33248231|NCT03982199|100810139|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
33149386|NCT01226043|100460732|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
33149387|NCT01226043|100460729|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
33248232|NCT03982199|100810140|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
33248233|NCT03982199|100810141|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
33248234|NCT03982199|100810142|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
33381107|NCT00488592|101279451|FG000|Overall Study|Withdrawal by Subject|1|||
33381108|NCT00488592|101279451|FG000|Overall Study|Disease progression|1|||
33381109|NCT00488592|101279451|FG000|Overall Study|Enrolled but not treated|1|||
33381110|NCT03428997|101279452|FG000|Overall Study|Sponsor decision.|1|||
33381111|NCT03428997|101279452|FG000|Overall Study|Withdrawal by Subject|3|||
33381112|NCT03428997|101279452|FG000|Overall Study|Lost to Follow-up|4|||
33381113|NCT00111475|101279456|FG000|Overall Study|Lost to Follow-up|0|||
33381114|NCT00111475|101279457|FG001|Overall Study|Lost to Follow-up|0|||
33381115|NCT00111475|101279458|FG002|Overall Study|Lost to Follow-up|0|||
33381116|NCT00111475|101279459|FG003|Overall Study|Lost to Follow-up|0|||
33381117|NCT00111475|101279460|FG004|Overall Study|Lost to Follow-up|0|||
33381118|NCT00111475|101279461|FG005|Overall Study|Lost to Follow-up|1|||
33381119|NCT00111475|101279462|FG006|Overall Study|Lost to Follow-up|0|||
33381120|NCT00111475|101279463|FG007|Overall Study|Lost to Follow-up|0|||
33381121|NCT00111475|101279464|FG008|Overall Study|Lost to Follow-up|0|||
33381122|NCT00111475|101279465|FG009|Overall Study|Lost to Follow-up|0|||
33381123|NCT04656418|101279470|FG000|Overall Study|Withdrawal by Subject|1|||
33381124|NCT04656418|101279471|FG001|Overall Study|Withdrawal by Subject|3|||
33381125|NCT04092816|101279477|FG000|Overall Study|Lost to Follow-up|1|||
33381126|NCT04092816|101279478|FG001|Overall Study|Lost to Follow-up|2|||
33381127|NCT03325556|101279479|FG000|Open-label Period|Lack of Response in OL period|70|||
33381128|NCT03325556|101279480|FG001|Open-label Period|Lack of Response in OL period|0|||
33381129|NCT03325556|101279481|FG002|Open-label Period|Lack of Response in OL period|0|||
33381130|NCT03325556|101279479|FG000|Open-label Period|Adverse Event|27|||
33381131|NCT03325556|101279480|FG001|Open-label Period|Adverse Event|0|||
33381132|NCT03325556|101279481|FG002|Open-label Period|Adverse Event|0|||
33381133|NCT03325556|101279479|FG000|Open-label Period|Death|1|||
33381134|NCT03325556|101279480|FG001|Open-label Period|Death|0|||
33381135|NCT03325556|101279481|FG002|Open-label Period|Death|0|||
33381136|NCT03325556|101279479|FG000|Open-label Period|Lost to Follow-up|1|||
33381137|NCT03325556|101279480|FG001|Open-label Period|Lost to Follow-up|0|||
33381138|NCT03325556|101279481|FG002|Open-label Period|Lost to Follow-up|0|||
33149388|NCT01226043|100460730|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
33149389|NCT01226043|100460731|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
33149390|NCT01226043|100460732|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
33426598|NCT01456052|101453678|FG002|Overall Study|Consent withdrawn|1|||
33647472|NCT03137069|102262746|FG003|Overall Study|Protocol Violation|1|||
33647473|NCT03137069|102262747|FG004|Overall Study|Protocol Violation|1|||
33647474|NCT03137069|102262748|FG005|Overall Study|Protocol Violation|1|||
33647475|NCT03137069|102262743|FG000|Overall Study|Physician Decision|0|||
33647476|NCT03137069|102262744|FG001|Overall Study|Physician Decision|0|||
33248235|NCT03982199|100810129|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
33248236|NCT03982199|100810130|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
33248237|NCT03982199|100810131|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
33248238|NCT03982199|100810132|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
33248239|NCT03982199|100810133|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
33381139|NCT03325556|101279479|FG000|Open-label Period|Non-compliance with study drug|5|||
33381140|NCT03325556|101279480|FG001|Open-label Period|Non-compliance with study drug|0|||
33381141|NCT03325556|101279481|FG002|Open-label Period|Non-compliance with study drug|0|||
33381142|NCT03325556|101279479|FG000|Open-label Period|Use of prohibited medication|1|||
33381143|NCT03325556|101279480|FG001|Open-label Period|Use of prohibited medication|0|||
33381144|NCT03325556|101279481|FG002|Open-label Period|Use of prohibited medication|0|||
33381145|NCT03325556|101279479|FG000|Open-label Period|Protocol Violation|4|||
33381146|NCT03325556|101279480|FG001|Open-label Period|Protocol Violation|0|||
33381147|NCT03325556|101279481|FG002|Open-label Period|Protocol Violation|0|||
33381148|NCT03325556|101279479|FG000|Open-label Period|Withdrawal by Subject|17|||
33381149|NCT03325556|101279480|FG001|Open-label Period|Withdrawal by Subject|0|||
33381150|NCT03325556|101279481|FG002|Open-label Period|Withdrawal by Subject|0|||
33381151|NCT03325556|101279479|FG000|Open-label Period|Not otherwise specified|8|||
33381152|NCT03325556|101279480|FG001|Open-label Period|Not otherwise specified|0|||
33381153|NCT03325556|101279481|FG002|Open-label Period|Not otherwise specified|0|||
33381154|NCT03325556|101279479|FG000|Open-label Period|Administrative discont. at study termination|41|||
33381155|NCT03325556|101279480|FG001|Open-label Period|Administrative discont. at study termination|0|||
33381156|NCT03325556|101279481|FG002|Open-label Period|Administrative discont. at study termination|0|||
33381157|NCT03325556|101279479|FG000|Double-blind Period|Relapse|0|||
33381158|NCT03325556|101279480|FG001|Double-blind Period|Relapse|15|||
33381159|NCT03325556|101279481|FG002|Double-blind Period|Relapse|34|||
33381160|NCT03325556|101279479|FG000|Double-blind Period|Adverse Event|0|||
33381161|NCT03325556|101279480|FG001|Double-blind Period|Adverse Event|3|||
33381162|NCT03325556|101279481|FG002|Double-blind Period|Adverse Event|1|||
33381163|NCT03325556|101279479|FG000|Double-blind Period|Noncompliance with study drug|0|||
33381164|NCT03325556|101279480|FG001|Double-blind Period|Noncompliance with study drug|0|||
33381165|NCT03325556|101279481|FG002|Double-blind Period|Noncompliance with study drug|1|||
33381166|NCT03325556|101279479|FG000|Double-blind Period|Use of prohibited medication|0|||
33381167|NCT03325556|101279480|FG001|Double-blind Period|Use of prohibited medication|1|||
33381168|NCT03325556|101279481|FG002|Double-blind Period|Use of prohibited medication|0|||
33381169|NCT03325556|101279479|FG000|Double-blind Period|Physician Decision|0|||
33381170|NCT03325556|101279480|FG001|Double-blind Period|Physician Decision|0|||
33381171|NCT03325556|101279481|FG002|Double-blind Period|Physician Decision|1|||
33381172|NCT03325556|101279479|FG000|Double-blind Period|Withdrawal by Subject|0|||
33381173|NCT03325556|101279480|FG001|Double-blind Period|Withdrawal by Subject|6|||
33381174|NCT03325556|101279481|FG002|Double-blind Period|Withdrawal by Subject|4|||
33381175|NCT03325556|101279479|FG000|Double-blind Period|Not otherwise specified|0|||
33381176|NCT03325556|101279480|FG001|Double-blind Period|Not otherwise specified|1|||
33381177|NCT03325556|101279481|FG002|Double-blind Period|Not otherwise specified|5|||
33381178|NCT03325556|101279479|FG000|Double-blind Period|Administrative discont. at study termination|0|||
33381179|NCT03325556|101279480|FG001|Double-blind Period|Administrative discont. at study termination|35|||
33381180|NCT03325556|101279481|FG002|Double-blind Period|Administrative discont. at study termination|31|||
33381181|NCT00600028|101279484|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
33381182|NCT00600028|101279485|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
33381183|NCT00600028|101279484|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
33381184|NCT00600028|101279485|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
33381185|NCT00600028|101279484|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
33381186|NCT00600028|101279485|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
33381187|NCT01736254|101279486|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
33381188|NCT01736254|101279486|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
33381189|NCT00039741|101279490|FG000|Overall Study|Death|0|||
33381190|NCT00039741|101279491|FG001|Overall Study|Death|1|||
33381191|NCT00039741|101279492|FG002|Overall Study|Death|0|||
33426599|NCT01456052|101453676|FG000|Overall Study|Protocol Violation|0|||
33426600|NCT01456052|101453677|FG001|Overall Study|Protocol Violation|1|||
33426601|NCT01456052|101453678|FG002|Overall Study|Protocol Violation|0|||
33426602|NCT01456052|101453676|FG000|Overall Study|Physician Decision|1|||
33647477|NCT03137069|102262745|FG002|Overall Study|Physician Decision|0|||
33381192|NCT00039741|101279493|FG003|Overall Study|Death|0|||
33381193|NCT00039741|101279490|FG000|Overall Study|Lost to Follow-up|3|||
33381194|NCT00039741|101279491|FG001|Overall Study|Lost to Follow-up|1|||
33647478|NCT03137069|102262746|FG003|Overall Study|Physician Decision|1|||
33426603|NCT01456052|101453677|FG001|Overall Study|Physician Decision|0|||
33426604|NCT01456052|101453678|FG002|Overall Study|Physician Decision|1|||
33426605|NCT01456052|101453676|FG000|Overall Study|Treatment Failure|0|||
33426606|NCT01456052|101453677|FG001|Overall Study|Treatment Failure|1|||
33426607|NCT01456052|101453678|FG002|Overall Study|Treatment Failure|1|||
33426608|NCT01259401|101453679|FG000|4-month Follow-up|Death|0|||
33426609|NCT01259401|101453680|FG001|4-month Follow-up|Death|1|||
33426610|NCT01259401|101453679|FG000|4-month Follow-up|Lost to Follow-up|0|||
33426611|NCT01259401|101453680|FG001|4-month Follow-up|Lost to Follow-up|1|||
33426612|NCT01623830|101453689|FG000|Overall Study|Withdrawal by Subject|6|||
33426613|NCT01623830|101453690|FG001|Overall Study|Withdrawal by Subject|7|||
33426614|NCT01623830|101453689|FG000|Overall Study|Exclusion from Study|1|||
33426615|NCT01623830|101453690|FG001|Overall Study|Exclusion from Study|2|||
33426616|NCT00871169|101453691|FG000|Overall Study|Protocol Violation|1|||
33426617|NCT00871169|101453691|FG000|Overall Study|Patient did not receive study treatment|2|||
33426618|NCT03751020|101453704|FG000|Overall Study|Withdrawal by Subject|2|||
33426619|NCT03751020|101453705|FG001|Overall Study|Withdrawal by Subject|0|||
33426620|NCT03751020|101453706|FG002|Overall Study|Withdrawal by Subject|0|||
33426621|NCT03751020|101453704|FG000|Overall Study|Lost to Follow-up|7|||
33426622|NCT03751020|101453705|FG001|Overall Study|Lost to Follow-up|4|||
33426623|NCT03751020|101453706|FG002|Overall Study|Lost to Follow-up|10|||
33426624|NCT04335110|101453707|FG000|Overall Study|Withdrawal by Subject|1|||
33426625|NCT04335110|101453708|FG001|Overall Study|Withdrawal by Subject|1|||
33426626|NCT04335110|101453707|FG000|Overall Study|Death|0|||
33426627|NCT04335110|101453708|FG001|Overall Study|Death|1|||
33426628|NCT02451670|101453709|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
33248240|NCT03982199|100810134|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
33248241|NCT03982199|100810135|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
33426629|NCT02451670|101453710|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
33426630|NCT02410837|101453711|FG000|Overall Study|Death|387|||
33426631|NCT02410837|101453711|FG000|Overall Study|Lost to Follow-up|50|||
33426632|NCT02410837|101453711|FG000|Overall Study|Withdrawal by Subject|44|||
33426633|NCT02410837|101453711|FG000|Overall Study|Physician Decision|6|||
33426634|NCT02410837|101453711|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
33426635|NCT03990389|101453713|FG000|Overall Study|Lost to Follow-up|3|||
33426636|NCT03990389|101453714|FG001|Overall Study|Lost to Follow-up|0|||
33426637|NCT00947011|101453715|FG000|Overall Study|Study was terminated,PI left institution|12|||
33426638|NCT01783496|101453716|FG000|Overall Study|Lost to Follow-up|0|||
33426639|NCT01783496|101453717|FG001|Overall Study|Lost to Follow-up|0|||
33426640|NCT01783496|101453718|FG002|Overall Study|Lost to Follow-up|0|||
33426641|NCT01783496|101453719|FG003|Overall Study|Lost to Follow-up|2|||
33248242|NCT03982199|100810136|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
33248243|NCT03982199|100810137|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
33248244|NCT03982199|100810138|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
33248245|NCT03982199|100810139|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
33248246|NCT03982199|100810140|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
33248247|NCT03982199|100810141|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
33381195|NCT00039741|101279492|FG002|Overall Study|Lost to Follow-up|5|||
33381196|NCT00039741|101279493|FG003|Overall Study|Lost to Follow-up|2|||
33381197|NCT00039741|101279490|FG000|Overall Study|Confounding medical condition|1|||
33381198|NCT00039741|101279491|FG001|Overall Study|Confounding medical condition|0|||
33381199|NCT00039741|101279492|FG002|Overall Study|Confounding medical condition|0|||
33381200|NCT00039741|101279493|FG003|Overall Study|Confounding medical condition|0|||
33381201|NCT00039741|101279490|FG000|Overall Study|Not able to get to clinic|5|||
33381202|NCT00039741|101279491|FG001|Overall Study|Not able to get to clinic|2|||
33381203|NCT00039741|101279492|FG002|Overall Study|Not able to get to clinic|0|||
33381204|NCT00039741|101279493|FG003|Overall Study|Not able to get to clinic|3|||
33381205|NCT00039741|101279490|FG000|Overall Study|Moved|3|||
33381206|NCT00039741|101279491|FG001|Overall Study|Moved|2|||
33381207|NCT00039741|101279492|FG002|Overall Study|Moved|3|||
33381208|NCT00039741|101279493|FG003|Overall Study|Moved|6|||
33381209|NCT00039741|101279490|FG000|Overall Study|Non-compliance with protocol|1|||
33381210|NCT00039741|101279491|FG001|Overall Study|Non-compliance with protocol|0|||
33381211|NCT00039741|101279492|FG002|Overall Study|Non-compliance with protocol|1|||
33381212|NCT00039741|101279493|FG003|Overall Study|Non-compliance with protocol|0|||
33381213|NCT00039741|101279490|FG000|Overall Study|Withdrew consent|0|||
33381214|NCT00039741|101279491|FG001|Overall Study|Withdrew consent|5|||
33426642|NCT01783496|101453720|FG004|Overall Study|Lost to Follow-up|0|||
33426643|NCT01783496|101453721|FG005|Overall Study|Lost to Follow-up|1|||
33426644|NCT01783496|101453716|FG000|Overall Study|Withdrawal by Subject|1|||
33426645|NCT01783496|101453717|FG001|Overall Study|Withdrawal by Subject|0|||
33426646|NCT01783496|101453718|FG002|Overall Study|Withdrawal by Subject|0|||
33426647|NCT01783496|101453719|FG003|Overall Study|Withdrawal by Subject|0|||
33426648|NCT01783496|101453720|FG004|Overall Study|Withdrawal by Subject|0|||
33426649|NCT01783496|101453721|FG005|Overall Study|Withdrawal by Subject|0|||
33426650|NCT03862625|101453722|FG000|Overall Study|Lost to Follow-up|0|||
33426651|NCT03862625|101453723|FG001|Overall Study|Lost to Follow-up|1|||
33426652|NCT03361956|101453724|FG000|Overall Study|Adverse Event|1|||
33426653|NCT03361956|101453725|FG001|Overall Study|Adverse Event|0|||
33426654|NCT03361956|101453726|FG002|Overall Study|Adverse Event|1|||
33426655|NCT03361956|101453727|FG003|Overall Study|Adverse Event|1|||
33426656|NCT03361956|101453728|FG004|Overall Study|Adverse Event|0|||
33426657|NCT03361956|101453724|FG000|Overall Study|Other|0|||
33426658|NCT03361956|101453725|FG001|Overall Study|Other|0|||
33149391|NCT01226043|100460729|FG000|6-week Re-randomization Phase|Adverse Event|0|||
33149392|NCT01226043|100460730|FG001|6-week Re-randomization Phase|Adverse Event|0|||
33149393|NCT01226043|100460731|FG002|6-week Re-randomization Phase|Adverse Event|1|||
33149394|NCT01226043|100460732|FG003|6-week Re-randomization Phase|Adverse Event|1|||
33149395|NCT01226043|100460729|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
33149396|NCT01226043|100460730|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
33149397|NCT01226043|100460731|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
33149398|NCT01226043|100460732|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
33149399|NCT01226043|100460729|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
33149400|NCT01226043|100460730|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
33149401|NCT01226043|100460731|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
33149402|NCT01226043|100460732|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
33149403|NCT01226043|100460729|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
33149404|NCT01226043|100460730|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
33149405|NCT01226043|100460731|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
33381215|NCT00039741|101279492|FG002|Overall Study|Withdrew consent|0|||
33381216|NCT00039741|101279493|FG003|Overall Study|Withdrew consent|1|||
33381217|NCT00039741|101279490|FG000|Overall Study|Missed final visit|2|||
33381218|NCT00039741|101279491|FG001|Overall Study|Missed final visit|1|||
33381219|NCT00039741|101279492|FG002|Overall Study|Missed final visit|2|||
33381220|NCT00039741|101279493|FG003|Overall Study|Missed final visit|2|||
33381221|NCT01610076|101279496|FG000|Overall Study|Technical issue with video|0|||
33381222|NCT01610076|101279497|FG001|Overall Study|Technical issue with video|1|||
33381223|NCT01610076|101279496|FG000|Overall Study|Lost to Follow-up|3|||
33381224|NCT01610076|101279497|FG001|Overall Study|Lost to Follow-up|4|||
33381225|NCT04404010|101279499|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
33381226|NCT04404010|101279500|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
33381227|NCT00293423|101279501|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
33381228|NCT00293423|101279502|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
33381229|NCT00293423|101279501|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
33381230|NCT00293423|101279502|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
33381231|NCT00293423|101279501|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
33381232|NCT00293423|101279502|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
33381233|NCT00293423|101279501|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
33381234|NCT00293423|101279502|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
33381235|NCT00293423|101279501|FG000|Surgical Resection|processing error during surgical resection|1|||
33381236|NCT00293423|101279502|FG001|Surgical Resection|processing error during surgical resection|0|||
33381237|NCT00293423|101279501|FG000|Surgical Resection|Withdrawal by Subject|4|||
33381238|NCT00293423|101279502|FG001|Surgical Resection|Withdrawal by Subject|0|||
33381239|NCT00293423|101279501|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
33381240|NCT00293423|101279502|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
33381241|NCT01244191|101279506|FG000|Overall Study|Progressive disease|295|||
33381242|NCT01244191|101279507|FG001|Overall Study|Progressive disease|350|||
33381243|NCT01244191|101279506|FG000|Overall Study|Clinical disease progression|54|||
33381244|NCT01244191|101279507|FG001|Overall Study|Clinical disease progression|36|||
33381245|NCT01244191|101279506|FG000|Overall Study|Adverse Event|65|||
33381246|NCT01244191|101279507|FG001|Overall Study|Adverse Event|48|||
33381247|NCT01244191|101279506|FG000|Overall Study|Death|22|||
33381248|NCT01244191|101279507|FG001|Overall Study|Death|29|||
33381249|NCT01244191|101279506|FG000|Overall Study|Lost to Follow-up|0|||
33381250|NCT01244191|101279507|FG001|Overall Study|Lost to Follow-up|2|||
33381251|NCT01244191|101279506|FG000|Overall Study|Protocol Violation|1|||
33381252|NCT01244191|101279507|FG001|Overall Study|Protocol Violation|2|||
33381253|NCT01244191|101279506|FG000|Overall Study|Withdrawal by Subject|31|||
33381254|NCT01244191|101279507|FG001|Overall Study|Withdrawal by Subject|23|||
33381255|NCT01244191|101279506|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
33381256|NCT01244191|101279507|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
33381257|NCT01071096|101279508|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
33381258|NCT01071096|101279509|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
33381259|NCT00502320|101279512|FG000|Overall Study|Lost to Follow-up|1|||
33381260|NCT00502320|101279513|FG001|Overall Study|Lost to Follow-up|1|||
33426659|NCT03361956|101453726|FG002|Overall Study|Other|0|||
33426660|NCT03361956|101453727|FG003|Overall Study|Other|1|||
33426661|NCT03361956|101453728|FG004|Overall Study|Other|0|||
33426662|NCT03361956|101453724|FG000|Overall Study|Withdrawal by Subject|2|||
33426663|NCT03361956|101453725|FG001|Overall Study|Withdrawal by Subject|2|||
33426664|NCT03361956|101453726|FG002|Overall Study|Withdrawal by Subject|2|||
33426665|NCT03361956|101453727|FG003|Overall Study|Withdrawal by Subject|0|||
33426666|NCT03361956|101453728|FG004|Overall Study|Withdrawal by Subject|3|||
33426667|NCT03361956|101453724|FG000|Overall Study|Disease Relapse|0|||
33426668|NCT03361956|101453725|FG001|Overall Study|Disease Relapse|0|||
33426669|NCT03361956|101453726|FG002|Overall Study|Disease Relapse|1|||
33426670|NCT03361956|101453727|FG003|Overall Study|Disease Relapse|0|||
33426671|NCT03361956|101453728|FG004|Overall Study|Disease Relapse|0|||
33426672|NCT03361956|101453724|FG000|Overall Study|Physician Decision|0|||
33426673|NCT03361956|101453725|FG001|Overall Study|Physician Decision|2|||
33426674|NCT03361956|101453726|FG002|Overall Study|Physician Decision|0|||
33426675|NCT03361956|101453727|FG003|Overall Study|Physician Decision|1|||
33426676|NCT03361956|101453728|FG004|Overall Study|Physician Decision|0|||
33426677|NCT03361956|101453724|FG000|Overall Study|Lost to Follow-up|0|||
33426678|NCT03361956|101453725|FG001|Overall Study|Lost to Follow-up|0|||
33426679|NCT03361956|101453726|FG002|Overall Study|Lost to Follow-up|1|||
33426680|NCT03361956|101453727|FG003|Overall Study|Lost to Follow-up|1|||
33426681|NCT03361956|101453728|FG004|Overall Study|Lost to Follow-up|2|||
33426682|NCT00814658|101453729|FG000|Overall Study|Lost to Follow-up|0|||
33426683|NCT00814658|101453730|FG001|Overall Study|Lost to Follow-up|1|||
33381261|NCT00502320|101279512|FG000|Overall Study|Withdrew Consent|1|||
33381262|NCT00502320|101279513|FG001|Overall Study|Withdrew Consent|0|||
33381263|NCT00502320|101279512|FG000|Overall Study|No longer met criteria|1|||
33381264|NCT00502320|101279513|FG001|Overall Study|No longer met criteria|0|||
33381265|NCT00502320|101279512|FG000|Overall Study|Screen Failure|0|||
33381266|NCT00502320|101279513|FG001|Overall Study|Screen Failure|1|||
33381267|NCT00502320|101279512|FG000|Overall Study|Adverse Event|3|||
33381268|NCT00502320|101279513|FG001|Overall Study|Adverse Event|5|||
33381269|NCT02133742|101279514|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
33381270|NCT02133742|101279514|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
33381271|NCT02133742|101279514|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
33381272|NCT02133742|101279514|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
33381273|NCT02133742|101279514|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
33381274|NCT03287245|101279517|FG000|Overall Study|Study terminated by sponsor|3|||
33381275|NCT03287245|101279518|FG001|Overall Study|Study terminated by sponsor|0|||
33381276|NCT03287245|101279519|FG002|Overall Study|Study terminated by sponsor|3|||
33381277|NCT03287245|101279520|FG003|Overall Study|Study terminated by sponsor|1|||
33381278|NCT03287245|101279517|FG000|Overall Study|Adverse Event|1|||
33381279|NCT03287245|101279518|FG001|Overall Study|Adverse Event|0|||
33381280|NCT03287245|101279519|FG002|Overall Study|Adverse Event|0|||
33381281|NCT03287245|101279520|FG003|Overall Study|Adverse Event|0|||
33381282|NCT03287245|101279517|FG000|Overall Study|Withdrawal by Subject|8|||
33381283|NCT03287245|101279518|FG001|Overall Study|Withdrawal by Subject|3|||
33381284|NCT03287245|101279519|FG002|Overall Study|Withdrawal by Subject|3|||
33381285|NCT03287245|101279520|FG003|Overall Study|Withdrawal by Subject|0|||
33426684|NCT00814658|101453729|FG000|Overall Study|Physician Decision|1|||
33426685|NCT00814658|101453730|FG001|Overall Study|Physician Decision|0|||
33426686|NCT00814658|101453729|FG000|Overall Study|Adverse Event|3|||
33426687|NCT00814658|101453730|FG001|Overall Study|Adverse Event|3|||
33426688|NCT03705169|101453731|FG000|Overall Study|Lost to Follow-up|0|||
33426689|NCT03705169|101453732|FG001|Overall Study|Lost to Follow-up|0|||
33426690|NCT03705169|101453733|FG002|Overall Study|Lost to Follow-up|0|||
33426691|NCT03705169|101453734|FG003|Overall Study|Lost to Follow-up|2|||
33426692|NCT03705169|101453735|FG004|Overall Study|Lost to Follow-up|0|||
33426693|NCT03705169|101453736|FG005|Overall Study|Lost to Follow-up|2|||
33426694|NCT03705169|101453737|FG006|Overall Study|Lost to Follow-up|1|||
33426695|NCT03705169|101453738|FG007|Overall Study|Lost to Follow-up|0|||
33426696|NCT03705169|101453739|FG008|Overall Study|Lost to Follow-up|0|||
33426697|NCT03705169|101453740|FG009|Overall Study|Lost to Follow-up|1|||
33426698|NCT03705169|101453731|FG000|Overall Study|Adverse Event|0|||
33426699|NCT03705169|101453732|FG001|Overall Study|Adverse Event|0|||
33426700|NCT03705169|101453733|FG002|Overall Study|Adverse Event|0|||
33426701|NCT03705169|101453734|FG003|Overall Study|Adverse Event|1|||
33426702|NCT03705169|101453735|FG004|Overall Study|Adverse Event|0|||
33426703|NCT03705169|101453736|FG005|Overall Study|Adverse Event|0|||
33426704|NCT03705169|101453737|FG006|Overall Study|Adverse Event|0|||
33426705|NCT03705169|101453738|FG007|Overall Study|Adverse Event|0|||
33587483|NCT01133756|102038517|FG001|Overall Study|Adverse Event|2|||
33426706|NCT03705169|101453739|FG008|Overall Study|Adverse Event|0|||
33426707|NCT03705169|101453740|FG009|Overall Study|Adverse Event|0|||
33426708|NCT03705169|101453731|FG000|Overall Study|Site Closure|0|||
33426709|NCT03705169|101453732|FG001|Overall Study|Site Closure|0|||
33149406|NCT01226043|100460732|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
33381286|NCT03287245|101279517|FG000|Overall Study|Physician Decision|3|||
33426710|NCT03705169|101453733|FG002|Overall Study|Site Closure|0|||
33426711|NCT03705169|101453734|FG003|Overall Study|Site Closure|1|||
33426712|NCT03705169|101453735|FG004|Overall Study|Site Closure|0|||
33426713|NCT03705169|101453736|FG005|Overall Study|Site Closure|0|||
33426714|NCT03705169|101453737|FG006|Overall Study|Site Closure|0|||
33426715|NCT03705169|101453738|FG007|Overall Study|Site Closure|0|||
33426716|NCT03705169|101453739|FG008|Overall Study|Site Closure|0|||
33426717|NCT03705169|101453740|FG009|Overall Study|Site Closure|0|||
33426718|NCT03705169|101453731|FG000|Overall Study|Did not receive study treatment|0|||
33426719|NCT03705169|101453732|FG001|Overall Study|Did not receive study treatment|0|||
33426720|NCT03705169|101453733|FG002|Overall Study|Did not receive study treatment|0|||
33426721|NCT03705169|101453734|FG003|Overall Study|Did not receive study treatment|1|||
33426722|NCT03705169|101453735|FG004|Overall Study|Did not receive study treatment|0|||
33426723|NCT03705169|101453736|FG005|Overall Study|Did not receive study treatment|0|||
33426724|NCT03705169|101453737|FG006|Overall Study|Did not receive study treatment|0|||
33426725|NCT03705169|101453738|FG007|Overall Study|Did not receive study treatment|0|||
33426726|NCT03705169|101453739|FG008|Overall Study|Did not receive study treatment|0|||
33426727|NCT03705169|101453740|FG009|Overall Study|Did not receive study treatment|0|||
33426728|NCT03705169|101453731|FG000|Overall Study|Concerns about study visit compliance|0|||
33426729|NCT03705169|101453732|FG001|Overall Study|Concerns about study visit compliance|0|||
33426730|NCT03705169|101453733|FG002|Overall Study|Concerns about study visit compliance|0|||
33426731|NCT03705169|101453734|FG003|Overall Study|Concerns about study visit compliance|1|||
33426732|NCT03705169|101453735|FG004|Overall Study|Concerns about study visit compliance|0|||
33426733|NCT03705169|101453736|FG005|Overall Study|Concerns about study visit compliance|0|||
33426734|NCT03705169|101453737|FG006|Overall Study|Concerns about study visit compliance|0|||
33426735|NCT03705169|101453738|FG007|Overall Study|Concerns about study visit compliance|0|||
33426736|NCT03705169|101453739|FG008|Overall Study|Concerns about study visit compliance|0|||
33426737|NCT03705169|101453740|FG009|Overall Study|Concerns about study visit compliance|0|||
33426738|NCT00787566|101453741|FG000|Overall Study|AE related to chemotherapy|0|||
33426739|NCT00787566|101453742|FG001|Overall Study|AE related to chemotherapy|1|||
33426740|NCT00787566|101453743|FG002|Overall Study|AE related to chemotherapy|0|||
33426741|NCT00003782|101453744|FG000|Overall Study|No follow up data|30|||
33426742|NCT00003782|101453745|FG001|Overall Study|No follow up data|31|||
33426743|NCT00003782|101453746|FG002|Overall Study|No follow up data|26|||
33426744|NCT01154153|101453747|FG000|Overall Study|Poor compliance to protocol|2|||
33426745|NCT01154153|101453748|FG001|Overall Study|Poor compliance to protocol|0|||
33426746|NCT01154153|101453747|FG000|Overall Study|Unable to use labs|2|||
33426747|NCT01154153|101453748|FG001|Overall Study|Unable to use labs|3|||
33426748|NCT01154153|101453747|FG000|Overall Study|Withdrew consent|1|||
33426749|NCT01154153|101453748|FG001|Overall Study|Withdrew consent|0|||
33426750|NCT02308111|101453749|FG000|Overall Study|Adverse Event|31|||
33426751|NCT02308111|101453750|FG001|Overall Study|Adverse Event|19|||
33426752|NCT02308111|101453749|FG000|Overall Study|Death|9|||
33426753|NCT02308111|101453750|FG001|Overall Study|Death|6|||
33426754|NCT02308111|101453749|FG000|Overall Study|Lost to Follow-up|2|||
33426755|NCT02308111|101453750|FG001|Overall Study|Lost to Follow-up|7|||
33426756|NCT02308111|101453749|FG000|Overall Study|Physician Decision|6|||
33426757|NCT02308111|101453750|FG001|Overall Study|Physician Decision|17|||
33426758|NCT02308111|101453749|FG000|Overall Study|Protocol Violation|0|||
33426759|NCT02308111|101453750|FG001|Overall Study|Protocol Violation|1|||
33426760|NCT02308111|101453749|FG000|Overall Study|Withdrawal by Subject|28|||
33426761|NCT02308111|101453750|FG001|Overall Study|Withdrawal by Subject|38|||
33426762|NCT02308111|101453749|FG000|Overall Study|Study Terminated by Sponsor|72|||
33426763|NCT02308111|101453750|FG001|Overall Study|Study Terminated by Sponsor|61|||
33426764|NCT02308111|101453749|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
33426765|NCT02308111|101453750|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
33426766|NCT02308111|101453749|FG000|Overall Study|Site Closure|3|||
33426767|NCT02308111|101453750|FG001|Overall Study|Site Closure|3|||
33426768|NCT02308111|101453749|FG000|Overall Study|Non-compliance with Study Drug|3|||
33426769|NCT02308111|101453750|FG001|Overall Study|Non-compliance with Study Drug|1|||
33426770|NCT02308111|101453749|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
33587484|NCT01133756|102038518|FG002|Overall Study|Adverse Event|1|||
33587485|NCT01133756|102038516|FG000|Overall Study|Investigator Decision|1|||
33587486|NCT01133756|102038517|FG001|Overall Study|Investigator Decision|0|||
33587487|NCT01133756|102038518|FG002|Overall Study|Investigator Decision|0|||
33426771|NCT02308111|101453750|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
33426772|NCT02308111|101453749|FG000|Overall Study|Liver Transplant|3|||
33426773|NCT02308111|101453750|FG001|Overall Study|Liver Transplant|3|||
33587488|NCT01133756|102038516|FG000|Overall Study|Withdrawal by Subject|0|||
33587489|NCT01133756|102038517|FG001|Overall Study|Withdrawal by Subject|1|||
33587490|NCT01133756|102038518|FG002|Overall Study|Withdrawal by Subject|0|||
33587491|NCT01133756|102038516|FG000|Overall Study|Progression of Disease|0|||
33426774|NCT02308111|101453749|FG000|Overall Study|Liver Transplant Waitlist|2|||
33426775|NCT02308111|101453750|FG001|Overall Study|Liver Transplant Waitlist|2|||
33587492|NCT01133756|102038517|FG001|Overall Study|Progression of Disease|0|||
33587493|NCT01133756|102038518|FG002|Overall Study|Progression of Disease|1|||
33426776|NCT02308111|101453749|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
33426777|NCT02308111|101453750|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
33426778|NCT01681771|101453751|FG000|Overall Study|Lost to Follow-up|4|||
33426779|NCT01681771|101453752|FG001|Overall Study|Lost to Follow-up|2|||
33426780|NCT00863057|101453753|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
33426781|NCT00863057|101453754|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
33426782|NCT00863057|101453755|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
33426783|NCT00863057|101453756|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
33426784|NCT00863057|101453753|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
33426785|NCT00863057|101453754|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
33426786|NCT00863057|101453755|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
33426787|NCT00863057|101453756|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
33426788|NCT00863057|101453753|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
33426789|NCT00863057|101453754|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
33426790|NCT00863057|101453755|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
33426791|NCT00863057|101453756|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
33426792|NCT00863057|101453753|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
33426793|NCT00863057|101453754|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
33426794|NCT00863057|101453755|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
33426795|NCT00863057|101453756|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
33426796|NCT00006721|101453757|FG000|Overall Study|Adverse Event|0|||
33426797|NCT00006721|101453758|FG001|Overall Study|Adverse Event|4|||
33426798|NCT00006721|101453759|FG002|Overall Study|Adverse Event|4|||
33426799|NCT00006721|101453757|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
33426800|NCT00006721|101453758|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
33426801|NCT00006721|101453759|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
33426802|NCT00006721|101453757|FG000|Overall Study|Progression/Relapse|0|||
33426803|NCT00006721|101453758|FG001|Overall Study|Progression/Relapse|1|||
33426804|NCT00006721|101453759|FG002|Overall Study|Progression/Relapse|2|||
33426805|NCT00006721|101453757|FG000|Overall Study|Death|0|||
33426806|NCT00006721|101453758|FG001|Overall Study|Death|1|||
33426807|NCT00006721|101453759|FG002|Overall Study|Death|2|||
33426808|NCT00006721|101453757|FG000|Overall Study|Other - Not Protocol Specified|0|||
33426809|NCT00006721|101453758|FG001|Overall Study|Other - Not Protocol Specified|7|||
33426810|NCT00006721|101453759|FG002|Overall Study|Other - Not Protocol Specified|7|||
33426811|NCT00006721|101453757|FG000|Overall Study|Ineligible|2|||
33426812|NCT00006721|101453758|FG001|Overall Study|Ineligible|12|||
33426813|NCT00006721|101453759|FG002|Overall Study|Ineligible|10|||
33426814|NCT00006721|101453757|FG000|Overall Study|Eligible but no Treatment Received|1|||
33426815|NCT00006721|101453758|FG001|Overall Study|Eligible but no Treatment Received|0|||
33426816|NCT00006721|101453759|FG002|Overall Study|Eligible but no Treatment Received|0|||
33426817|NCT01078623|101453764|FG000|Treatment Period 1|Adverse Event|1|||
33426818|NCT01078623|101453765|FG001|Treatment Period 1|Adverse Event|1|||
33426819|NCT01078623|101453766|FG002|Treatment Period 1|Adverse Event|1|||
33426820|NCT01078623|101453767|FG003|Treatment Period 1|Adverse Event|0|||
33426821|NCT01078623|101453768|FG004|Treatment Period 1|Adverse Event|0|||
33426822|NCT01078623|101453769|FG005|Treatment Period 1|Adverse Event|0|||
33426823|NCT01078623|101453770|FG006|Treatment Period 1|Adverse Event|1|||
33426824|NCT01078623|101453771|FG007|Treatment Period 1|Adverse Event|0|||
33426825|NCT01078623|101453772|FG008|Treatment Period 1|Adverse Event|1|||
33426826|NCT01078623|101453773|FG009|Treatment Period 1|Adverse Event|1|||
33426827|NCT01078623|101453774|FG010|Treatment Period 1|Adverse Event|0|||
33426828|NCT01078623|101453775|FG011|Treatment Period 1|Adverse Event|0|||
33426829|NCT01078623|101453776|FG012|Treatment Period 1|Adverse Event|0|||
33426830|NCT01078623|101453777|FG013|Treatment Period 1|Adverse Event|0|||
33426831|NCT01078623|101453778|FG014|Treatment Period 1|Adverse Event|0|||
33426832|NCT01078623|101453779|FG015|Treatment Period 1|Adverse Event|0|||
33426833|NCT01078623|101453780|FG016|Treatment Period 1|Adverse Event|0|||
33426834|NCT01078623|101453781|FG017|Treatment Period 1|Adverse Event|0|||
33426835|NCT01078623|101453782|FG018|Treatment Period 1|Adverse Event|0|||
33426836|NCT01078623|101453783|FG019|Treatment Period 1|Adverse Event|0|||
33426837|NCT01078623|101453764|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33426838|NCT01078623|101453765|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33426839|NCT01078623|101453766|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33426840|NCT01078623|101453767|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33426841|NCT01078623|101453768|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33426842|NCT01078623|101453769|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33426843|NCT01078623|101453770|FG006|Treatment Period 1|Withdrawal by Subject|0|||
33426844|NCT01078623|101453771|FG007|Treatment Period 1|Withdrawal by Subject|1|||
33426845|NCT01078623|101453772|FG008|Treatment Period 1|Withdrawal by Subject|0|||
33426846|NCT01078623|101453773|FG009|Treatment Period 1|Withdrawal by Subject|0|||
33426847|NCT01078623|101453774|FG010|Treatment Period 1|Withdrawal by Subject|1|||
33426848|NCT01078623|101453775|FG011|Treatment Period 1|Withdrawal by Subject|0|||
33426849|NCT01078623|101453776|FG012|Treatment Period 1|Withdrawal by Subject|0|||
33587494|NCT03650413|102038519|FG000|Overall Study|Adverse Event|1|||
33587495|NCT03650413|102038519|FG000|Overall Study|Lack of Efficacy|17|||
33426850|NCT01078623|101453777|FG013|Treatment Period 1|Withdrawal by Subject|0|||
33426851|NCT01078623|101453778|FG014|Treatment Period 1|Withdrawal by Subject|0|||
33426852|NCT01078623|101453779|FG015|Treatment Period 1|Withdrawal by Subject|0|||
33426853|NCT01078623|101453780|FG016|Treatment Period 1|Withdrawal by Subject|0|||
33426854|NCT01078623|101453781|FG017|Treatment Period 1|Withdrawal by Subject|0|||
33426855|NCT01078623|101453782|FG018|Treatment Period 1|Withdrawal by Subject|0|||
33426856|NCT01078623|101453783|FG019|Treatment Period 1|Withdrawal by Subject|0|||
33426857|NCT01078623|101453764|FG000|Treatment Period 1|Protocol Violation|0|||
33426858|NCT01078623|101453765|FG001|Treatment Period 1|Protocol Violation|0|||
33426859|NCT01078623|101453766|FG002|Treatment Period 1|Protocol Violation|0|||
33426860|NCT01078623|101453767|FG003|Treatment Period 1|Protocol Violation|0|||
33426861|NCT01078623|101453768|FG004|Treatment Period 1|Protocol Violation|0|||
33426862|NCT01078623|101453769|FG005|Treatment Period 1|Protocol Violation|1|||
33426863|NCT01078623|101453770|FG006|Treatment Period 1|Protocol Violation|0|||
33426864|NCT01078623|101453771|FG007|Treatment Period 1|Protocol Violation|0|||
33426865|NCT01078623|101453772|FG008|Treatment Period 1|Protocol Violation|0|||
33426866|NCT01078623|101453773|FG009|Treatment Period 1|Protocol Violation|0|||
33426867|NCT01078623|101453774|FG010|Treatment Period 1|Protocol Violation|0|||
33426868|NCT01078623|101453775|FG011|Treatment Period 1|Protocol Violation|0|||
33426869|NCT01078623|101453776|FG012|Treatment Period 1|Protocol Violation|0|||
33426870|NCT01078623|101453777|FG013|Treatment Period 1|Protocol Violation|0|||
33426871|NCT01078623|101453778|FG014|Treatment Period 1|Protocol Violation|0|||
33426872|NCT01078623|101453779|FG015|Treatment Period 1|Protocol Violation|0|||
33426873|NCT01078623|101453780|FG016|Treatment Period 1|Protocol Violation|0|||
33426874|NCT01078623|101453781|FG017|Treatment Period 1|Protocol Violation|0|||
33426875|NCT01078623|101453782|FG018|Treatment Period 1|Protocol Violation|0|||
33426876|NCT01078623|101453783|FG019|Treatment Period 1|Protocol Violation|0|||
33426877|NCT01078623|101453764|FG000|Treatment Period 2|Adverse Event|0|||
33426878|NCT01078623|101453765|FG001|Treatment Period 2|Adverse Event|0|||
33426879|NCT01078623|101453766|FG002|Treatment Period 2|Adverse Event|0|||
33426880|NCT01078623|101453767|FG003|Treatment Period 2|Adverse Event|0|||
33426881|NCT01078623|101453768|FG004|Treatment Period 2|Adverse Event|0|||
33426882|NCT01078623|101453769|FG005|Treatment Period 2|Adverse Event|0|||
33426883|NCT01078623|101453770|FG006|Treatment Period 2|Adverse Event|1|||
33426884|NCT01078623|101453771|FG007|Treatment Period 2|Adverse Event|0|||
33426885|NCT01078623|101453772|FG008|Treatment Period 2|Adverse Event|0|||
33426886|NCT01078623|101453773|FG009|Treatment Period 2|Adverse Event|0|||
33426887|NCT01078623|101453774|FG010|Treatment Period 2|Adverse Event|0|||
33426888|NCT01078623|101453775|FG011|Treatment Period 2|Adverse Event|0|||
33426889|NCT01078623|101453776|FG012|Treatment Period 2|Adverse Event|0|||
33426890|NCT01078623|101453777|FG013|Treatment Period 2|Adverse Event|0|||
33426891|NCT01078623|101453778|FG014|Treatment Period 2|Adverse Event|0|||
33426892|NCT01078623|101453779|FG015|Treatment Period 2|Adverse Event|0|||
33426893|NCT01078623|101453780|FG016|Treatment Period 2|Adverse Event|0|||
33426894|NCT01078623|101453781|FG017|Treatment Period 2|Adverse Event|0|||
33426895|NCT01078623|101453782|FG018|Treatment Period 2|Adverse Event|1|||
33426896|NCT01078623|101453783|FG019|Treatment Period 2|Adverse Event|0|||
33426897|NCT01078623|101453764|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33426898|NCT01078623|101453765|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33426899|NCT01078623|101453766|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33426900|NCT01078623|101453767|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33426901|NCT01078623|101453768|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33426902|NCT01078623|101453769|FG005|Treatment Period 2|Withdrawal by Subject|1|||
33426903|NCT01078623|101453770|FG006|Treatment Period 2|Withdrawal by Subject|0|||
33426904|NCT01078623|101453771|FG007|Treatment Period 2|Withdrawal by Subject|0|||
33426905|NCT01078623|101453772|FG008|Treatment Period 2|Withdrawal by Subject|0|||
33426906|NCT01078623|101453773|FG009|Treatment Period 2|Withdrawal by Subject|0|||
33426907|NCT01078623|101453774|FG010|Treatment Period 2|Withdrawal by Subject|0|||
33426908|NCT01078623|101453775|FG011|Treatment Period 2|Withdrawal by Subject|0|||
33426909|NCT01078623|101453776|FG012|Treatment Period 2|Withdrawal by Subject|0|||
33426910|NCT01078623|101453777|FG013|Treatment Period 2|Withdrawal by Subject|0|||
33426911|NCT01078623|101453778|FG014|Treatment Period 2|Withdrawal by Subject|0|||
33426912|NCT01078623|101453779|FG015|Treatment Period 2|Withdrawal by Subject|0|||
33426913|NCT01078623|101453780|FG016|Treatment Period 2|Withdrawal by Subject|0|||
33426914|NCT01078623|101453781|FG017|Treatment Period 2|Withdrawal by Subject|0|||
33426915|NCT01078623|101453782|FG018|Treatment Period 2|Withdrawal by Subject|0|||
33426916|NCT01078623|101453783|FG019|Treatment Period 2|Withdrawal by Subject|0|||
33426917|NCT01078623|101453764|FG000|Treatment Period 3|Adverse Event|0|||
33426918|NCT01078623|101453765|FG001|Treatment Period 3|Adverse Event|0|||
33426919|NCT01078623|101453766|FG002|Treatment Period 3|Adverse Event|0|||
33426920|NCT01078623|101453767|FG003|Treatment Period 3|Adverse Event|0|||
33426921|NCT01078623|101453768|FG004|Treatment Period 3|Adverse Event|1|||
33647479|NCT03137069|102262747|FG004|Overall Study|Physician Decision|0|||
33426922|NCT01078623|101453769|FG005|Treatment Period 3|Adverse Event|0|||
33426923|NCT01078623|101453770|FG006|Treatment Period 3|Adverse Event|0|||
33426924|NCT01078623|101453771|FG007|Treatment Period 3|Adverse Event|0|||
33426925|NCT01078623|101453772|FG008|Treatment Period 3|Adverse Event|0|||
33426926|NCT01078623|101453773|FG009|Treatment Period 3|Adverse Event|0|||
33426927|NCT01078623|101453774|FG010|Treatment Period 3|Adverse Event|0|||
33426928|NCT01078623|101453775|FG011|Treatment Period 3|Adverse Event|0|||
33426929|NCT01078623|101453776|FG012|Treatment Period 3|Adverse Event|0|||
33426930|NCT01078623|101453777|FG013|Treatment Period 3|Adverse Event|1|||
33426931|NCT01078623|101453778|FG014|Treatment Period 3|Adverse Event|0|||
33426932|NCT01078623|101453779|FG015|Treatment Period 3|Adverse Event|0|||
33426933|NCT01078623|101453780|FG016|Treatment Period 3|Adverse Event|0|||
33426934|NCT01078623|101453781|FG017|Treatment Period 3|Adverse Event|0|||
33426935|NCT01078623|101453782|FG018|Treatment Period 3|Adverse Event|0|||
33426936|NCT01078623|101453783|FG019|Treatment Period 3|Adverse Event|0|||
33426937|NCT01078623|101453764|FG000|Treatment Period 4|Adverse Event|0|||
33426938|NCT01078623|101453765|FG001|Treatment Period 4|Adverse Event|0|||
33426939|NCT01078623|101453766|FG002|Treatment Period 4|Adverse Event|1|||
33647480|NCT03137069|102262748|FG005|Overall Study|Physician Decision|0|||
33647481|NCT03137069|102262743|FG000|Overall Study|Study Terminated by Sponsor|0|||
33647482|NCT03137069|102262744|FG001|Overall Study|Study Terminated by Sponsor|0|||
33647483|NCT03137069|102262745|FG002|Overall Study|Study Terminated by Sponsor|0|||
33647484|NCT03137069|102262746|FG003|Overall Study|Study Terminated by Sponsor|0|||
33647485|NCT03137069|102262747|FG004|Overall Study|Study Terminated by Sponsor|1|||
33647486|NCT03137069|102262748|FG005|Overall Study|Study Terminated by Sponsor|0|||
33647487|NCT03137069|102262743|FG000|Overall Study|Data Entry Error|0|||
33647488|NCT03137069|102262744|FG001|Overall Study|Data Entry Error|0|||
33647489|NCT03137069|102262745|FG002|Overall Study|Data Entry Error|0|||
33647490|NCT03137069|102262746|FG003|Overall Study|Data Entry Error|1|||
33248248|NCT03982199|100810142|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
33248249|NCT03982199|100810129|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
33248250|NCT03982199|100810130|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
33248251|NCT03982199|100810131|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
33248252|NCT03982199|100810132|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
33426940|NCT01078623|101453767|FG003|Treatment Period 4|Adverse Event|0|||
33426941|NCT01078623|101453768|FG004|Treatment Period 4|Adverse Event|0|||
33426942|NCT01078623|101453769|FG005|Treatment Period 4|Adverse Event|0|||
33426943|NCT01078623|101453770|FG006|Treatment Period 4|Adverse Event|0|||
33426944|NCT01078623|101453771|FG007|Treatment Period 4|Adverse Event|0|||
33426945|NCT01078623|101453772|FG008|Treatment Period 4|Adverse Event|0|||
33426946|NCT01078623|101453773|FG009|Treatment Period 4|Adverse Event|0|||
33426947|NCT01078623|101453774|FG010|Treatment Period 4|Adverse Event|0|||
33426948|NCT01078623|101453775|FG011|Treatment Period 4|Adverse Event|0|||
33426949|NCT01078623|101453776|FG012|Treatment Period 4|Adverse Event|0|||
33426950|NCT01078623|101453777|FG013|Treatment Period 4|Adverse Event|0|||
33426951|NCT01078623|101453778|FG014|Treatment Period 4|Adverse Event|0|||
33426952|NCT01078623|101453779|FG015|Treatment Period 4|Adverse Event|0|||
33426953|NCT01078623|101453780|FG016|Treatment Period 4|Adverse Event|0|||
33426954|NCT01078623|101453781|FG017|Treatment Period 4|Adverse Event|0|||
33426955|NCT01078623|101453782|FG018|Treatment Period 4|Adverse Event|0|||
33426956|NCT01078623|101453783|FG019|Treatment Period 4|Adverse Event|0|||
33426957|NCT01078623|101453764|FG000|Treatment Period 4|Withdrawal by Subject|0|||
33426958|NCT01078623|101453765|FG001|Treatment Period 4|Withdrawal by Subject|0|||
33426959|NCT01078623|101453766|FG002|Treatment Period 4|Withdrawal by Subject|0|||
33426960|NCT01078623|101453767|FG003|Treatment Period 4|Withdrawal by Subject|0|||
33426961|NCT01078623|101453768|FG004|Treatment Period 4|Withdrawal by Subject|0|||
33426962|NCT01078623|101453769|FG005|Treatment Period 4|Withdrawal by Subject|0|||
33426963|NCT01078623|101453770|FG006|Treatment Period 4|Withdrawal by Subject|0|||
33426964|NCT01078623|101453771|FG007|Treatment Period 4|Withdrawal by Subject|0|||
33426965|NCT01078623|101453772|FG008|Treatment Period 4|Withdrawal by Subject|0|||
33426966|NCT01078623|101453773|FG009|Treatment Period 4|Withdrawal by Subject|0|||
33426967|NCT01078623|101453774|FG010|Treatment Period 4|Withdrawal by Subject|0|||
33426968|NCT01078623|101453775|FG011|Treatment Period 4|Withdrawal by Subject|0|||
33426969|NCT01078623|101453776|FG012|Treatment Period 4|Withdrawal by Subject|0|||
33647491|NCT03137069|102262747|FG004|Overall Study|Data Entry Error|0|||
33647492|NCT03137069|102262748|FG005|Overall Study|Data Entry Error|0|||
33647493|NCT03753789|102262749|FG000|Overall Study|Withdrawal by Subject|2|||
33647494|NCT00146848|102262752|FG000|Pre-randomization|Death|19|||
33647495|NCT00146848|102262753|FG001|Pre-randomization|Death|0|||
33647496|NCT00146848|102262754|FG002|Pre-randomization|Death|0|||
33426970|NCT01078623|101453777|FG013|Treatment Period 4|Withdrawal by Subject|0|||
33426971|NCT01078623|101453778|FG014|Treatment Period 4|Withdrawal by Subject|0|||
33426972|NCT01078623|101453779|FG015|Treatment Period 4|Withdrawal by Subject|1|||
33426973|NCT01078623|101453780|FG016|Treatment Period 4|Withdrawal by Subject|0|||
33426974|NCT01078623|101453781|FG017|Treatment Period 4|Withdrawal by Subject|0|||
33426975|NCT01078623|101453782|FG018|Treatment Period 4|Withdrawal by Subject|0|||
33426976|NCT01078623|101453783|FG019|Treatment Period 4|Withdrawal by Subject|0|||
33426977|NCT01306253|101453788|FG000|Overall Study|Lost to Follow-up|1|||
33647497|NCT00146848|102262752|FG000|Pre-randomization|Lost to Follow-up|70|||
33647498|NCT00146848|102262753|FG001|Pre-randomization|Lost to Follow-up|0|||
33647499|NCT00146848|102262754|FG002|Pre-randomization|Lost to Follow-up|0|||
33426978|NCT01306253|101453789|FG001|Overall Study|Lost to Follow-up|1|||
33426979|NCT01034137|101453790|FG000|Overall Study|Adverse Event|9|||
33426980|NCT01034137|101453791|FG001|Overall Study|Adverse Event|10|||
33647500|NCT00146848|102262752|FG000|Pre-randomization|Physician Decision|8|||
33647501|NCT00146848|102262753|FG001|Pre-randomization|Physician Decision|0|||
33381287|NCT03287245|101279518|FG001|Overall Study|Physician Decision|2|||
33381288|NCT03287245|101279519|FG002|Overall Study|Physician Decision|0|||
33381289|NCT03287245|101279520|FG003|Overall Study|Physician Decision|0|||
33381290|NCT00318565|101279524|FG000|Overall Study|Excluded per protocol|24|||
33381291|NCT03495817|101279525|FG000|26 Week Open Label|Adverse Event|3|||
33381292|NCT03495817|101279525|FG000|26 Week Open Label|Withdrawal by Subject|4|||
33381293|NCT03495817|101279525|FG000|26 Week Open Label|Lost to Follow-up|1|||
33381294|NCT03495817|101279525|FG000|26 Week Extension|Lost to Follow-up|2|||
33381295|NCT01830816|101279526|FG000|Overall Study|Progressive Disease|12|||
33381296|NCT01830816|101279527|FG001|Overall Study|Progressive Disease|7|||
33381297|NCT01830816|101279528|FG002|Overall Study|Progressive Disease|7|||
33381298|NCT01830816|101279526|FG000|Overall Study|Adverse Event|3|||
33381299|NCT01830816|101279527|FG001|Overall Study|Adverse Event|4|||
33381300|NCT01830816|101279528|FG002|Overall Study|Adverse Event|0|||
33381301|NCT01830816|101279526|FG000|Overall Study|Study Terminated by Sponsor|1|||
33381302|NCT01830816|101279527|FG001|Overall Study|Study Terminated by Sponsor|1|||
33381303|NCT01830816|101279528|FG002|Overall Study|Study Terminated by Sponsor|0|||
33381304|NCT01830816|101279526|FG000|Overall Study|Withdrawal by Subject|1|||
33381305|NCT01830816|101279527|FG001|Overall Study|Withdrawal by Subject|1|||
33381306|NCT01830816|101279528|FG002|Overall Study|Withdrawal by Subject|0|||
33381307|NCT01830816|101279526|FG000|Overall Study|Lost to Follow-up|0|||
33381308|NCT01830816|101279527|FG001|Overall Study|Lost to Follow-up|1|||
33381309|NCT01830816|101279528|FG002|Overall Study|Lost to Follow-up|0|||
33381310|NCT01830816|101279526|FG000|Overall Study|Symptomatic Deterioration|1|||
33381311|NCT01830816|101279527|FG001|Overall Study|Symptomatic Deterioration|0|||
33381312|NCT01830816|101279528|FG002|Overall Study|Symptomatic Deterioration|0|||
33381313|NCT01830816|101279526|FG000|Overall Study|Reason not Specified|2|||
33381314|NCT01830816|101279527|FG001|Overall Study|Reason not Specified|0|||
33381315|NCT01830816|101279528|FG002|Overall Study|Reason not Specified|0|||
33381316|NCT00789191|101279539|FG000|Overall Study|Adverse Event|2|||
33381317|NCT00789191|101279540|FG001|Overall Study|Adverse Event|4|||
33381318|NCT00789191|101279539|FG000|Overall Study|Lack of Efficacy|0|||
33381319|NCT00789191|101279540|FG001|Overall Study|Lack of Efficacy|5|||
33381320|NCT00789191|101279539|FG000|Overall Study|Protocol Violation|5|||
33381321|NCT00789191|101279540|FG001|Overall Study|Protocol Violation|3|||
33381322|NCT00789191|101279539|FG000|Overall Study|Withdrawal Criteria|2|||
33381323|NCT00789191|101279540|FG001|Overall Study|Withdrawal Criteria|4|||
33381324|NCT00789191|101279539|FG000|Overall Study|Unclassified|5|||
33381325|NCT00789191|101279540|FG001|Overall Study|Unclassified|3|||
33381326|NCT02853032|101279541|FG000|Overall Study|Adverse Event|4|||
33381327|NCT02853032|101279542|FG001|Overall Study|Adverse Event|0|||
33381328|NCT02853032|101279541|FG000|Overall Study|Withdrawal by Subject|3|||
33381329|NCT02853032|101279542|FG001|Overall Study|Withdrawal by Subject|1|||
33381330|NCT02853032|101279541|FG000|Overall Study|Requested to withdraw from all treatment|2|||
33381331|NCT02853032|101279542|FG001|Overall Study|Requested to withdraw from all treatment|2|||
33381332|NCT02146248|101279543|FG000|Overall Study|Withdrawal by Subject|2|||
33381333|NCT03833817|101279544|FG000|Overall Study|Withdrawal by Subject|3|||
33381334|NCT03833817|101279545|FG001|Overall Study|Withdrawal by Subject|3|||
33381335|NCT03833817|101279544|FG000|Overall Study|Lost to Follow-up|3|||
33381336|NCT03833817|101279545|FG001|Overall Study|Lost to Follow-up|3|||
33381337|NCT00995670|101279546|FG000|Overall Study|Failed arterial cannulation|1|||
33381338|NCT00995670|101279547|FG001|Overall Study|Failed arterial cannulation|0|||
33381339|NCT00995670|101279548|FG002|Overall Study|Failed arterial cannulation|3|||
33381340|NCT04585451|101279549|FG000|Overall Study|Withdrawal by Subject|26|||
33381341|NCT04585451|101279550|FG001|Overall Study|Withdrawal by Subject|0|||
33426981|NCT01034137|101453792|FG002|Overall Study|Adverse Event|8|||
33381342|NCT02921763|101279551|FG000|Overall Study|Adverse Event|4|||
33381343|NCT02921763|101279551|FG000|Overall Study|Lost to Follow-up|4|||
33381344|NCT02921763|101279551|FG000|Overall Study|Lack of Efficacy|3|||
33381345|NCT02921763|101279551|FG000|Overall Study|Protocol Violation|2|||
33381346|NCT02921763|101279551|FG000|Overall Study|Withdrawal by Subject|2|||
33381347|NCT02921763|101279551|FG000|Overall Study|Physician Decision|1|||
33381348|NCT02921763|101279551|FG000|Overall Study|No data obtained|2|||
33381349|NCT02287402|101279552|FG000|Treatment Period|Adverse Event|17|||
33381350|NCT02287402|101279552|FG000|Treatment Period|Voluntary Withdrawal|10|||
33381351|NCT02287402|101279552|FG000|Follow-up|Lost to Follow-up|1|||
33647502|NCT00146848|102262754|FG002|Pre-randomization|Physician Decision|0|||
33381352|NCT02287402|101279552|FG000|Follow-up|Voluntary Withdrawal|2|||
33381353|NCT00691093|101279553|FG000|Overall Study|Adverse Event|1|||
33381354|NCT00691093|101279553|FG000|Overall Study|Lost to Follow-up|1|||
33381355|NCT00691093|101279553|FG000|Overall Study|Lack of Efficacy|1|||
33426982|NCT01034137|101453790|FG000|Overall Study|Withdrawal by Subject|4|||
33426983|NCT01034137|101453791|FG001|Overall Study|Withdrawal by Subject|3|||
33426984|NCT01034137|101453792|FG002|Overall Study|Withdrawal by Subject|3|||
33426985|NCT01034137|101453790|FG000|Overall Study|Lack of Efficacy|9|||
33426986|NCT01034137|101453791|FG001|Overall Study|Lack of Efficacy|4|||
33426987|NCT01034137|101453792|FG002|Overall Study|Lack of Efficacy|13|||
33426988|NCT01034137|101453790|FG000|Overall Study|Protocol Violation|2|||
33426989|NCT01034137|101453791|FG001|Overall Study|Protocol Violation|2|||
33426990|NCT01034137|101453792|FG002|Overall Study|Protocol Violation|1|||
33426991|NCT01034137|101453790|FG000|Overall Study|Refused treatment or did not cooperate|2|||
33426992|NCT01034137|101453791|FG001|Overall Study|Refused treatment or did not cooperate|0|||
33426993|NCT01034137|101453792|FG002|Overall Study|Refused treatment or did not cooperate|1|||
33426994|NCT01034137|101453790|FG000|Overall Study|Administrative or other|2|||
33426995|NCT01034137|101453791|FG001|Overall Study|Administrative or other|3|||
33426996|NCT01034137|101453792|FG002|Overall Study|Administrative or other|4|||
33426997|NCT02557672|101453798|FG000|Overall Study|Withdrawal by Subject|4|||
33426998|NCT02557672|101453799|FG001|Overall Study|Withdrawal by Subject|2|||
33426999|NCT01159769|101453800|FG000|Overall Study|Adverse Event|1|||
33427000|NCT02110706|101453801|FG000|Overall Study|Adverse Event|2|||
33427001|NCT02110706|101453802|FG001|Overall Study|Adverse Event|3|||
33427002|NCT02110706|101453801|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
33427003|NCT02110706|101453802|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
33427004|NCT04908722|101453803|FG000|Overall Study|Protocol deviation|1|||
33427005|NCT04908722|101453804|FG001|Overall Study|Protocol deviation|0|||
33427006|NCT04908722|101453805|FG002|Overall Study|Protocol deviation|0|||
33427007|NCT04908722|101453806|FG003|Overall Study|Protocol deviation|0|||
33427008|NCT04908722|101453807|FG004|Overall Study|Protocol deviation|0|||
33427009|NCT04908722|101453808|FG005|Overall Study|Protocol deviation|1|||
33427010|NCT04908722|101453803|FG000|Overall Study|Lost to Follow-up|33|||
33427011|NCT04908722|101453804|FG001|Overall Study|Lost to Follow-up|33|||
33427012|NCT04908722|101453805|FG002|Overall Study|Lost to Follow-up|36|||
33427013|NCT04908722|101453806|FG003|Overall Study|Lost to Follow-up|30|||
33427014|NCT04908722|101453807|FG004|Overall Study|Lost to Follow-up|32|||
33427015|NCT04908722|101453808|FG005|Overall Study|Lost to Follow-up|34|||
33587496|NCT03650413|102038519|FG000|Overall Study|Other|9|||
33587497|NCT03650413|102038519|FG000|Overall Study|Physician Decision|2|||
33587498|NCT03650413|102038519|FG000|Overall Study|Study Terminated By Sponsor|16|||
33587499|NCT03650413|102038519|FG000|Overall Study|Withdrawal by Subject|16|||
33587500|NCT03028415|102038520|FG000|Overall Study|Lost to Follow-up|6|||
33587501|NCT03028415|102038521|FG001|Overall Study|Lost to Follow-up|3|||
33248253|NCT03982199|100810133|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
33248254|NCT03982199|100810134|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
33248255|NCT03982199|100810135|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
33248256|NCT03982199|100810136|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
33248257|NCT03982199|100810137|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
33248258|NCT03982199|100810138|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
33248259|NCT03982199|100810139|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
33248260|NCT03982199|100810140|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
33381356|NCT00691093|101279553|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
33587502|NCT03028415|102038520|FG000|Overall Study|Withdrawal by Subject|1|||
33587503|NCT03028415|102038521|FG001|Overall Study|Withdrawal by Subject|0|||
33587504|NCT03028415|102038520|FG000|Overall Study|Discontinued due to COVID-19|1|||
33587505|NCT03028415|102038521|FG001|Overall Study|Discontinued due to COVID-19|0|||
33587506|NCT01581021|102038522|FG000|Overall Study|Lost to Follow-up|4|||
33587507|NCT01581021|102038523|FG001|Overall Study|Lost to Follow-up|6|||
33587508|NCT01581021|102038522|FG000|Overall Study|More than 2 hooks in thoracic|3|||
33587509|NCT01581021|102038523|FG001|Overall Study|More than 2 hooks in thoracic|0|||
33587510|NCT01581021|102038522|FG000|Overall Study|Neuromuscular|2|||
33587511|NCT01581021|102038523|FG001|Overall Study|Neuromuscular|1|||
33587512|NCT01581021|102038522|FG000|Overall Study|Not Randomized|1|||
33587513|NCT01581021|102038523|FG001|Overall Study|Not Randomized|2|||
33587514|NCT01581021|102038522|FG000|Overall Study|Lenke 6 Classification|0|||
33587515|NCT01581021|102038523|FG001|Overall Study|Lenke 6 Classification|1|||
33587516|NCT01581021|102038522|FG000|Overall Study|Lack of Efficacy|0|||
33647503|NCT00146848|102262752|FG000|Pre-randomization|Protocol Violation|172|||
33647504|NCT00146848|102262753|FG001|Pre-randomization|Protocol Violation|0|||
33381357|NCT00405821|101279554|FG000|Overall Study|Death|5|||
33427016|NCT04908722|101453803|FG000|Overall Study|Physician Decision|1|||
33427017|NCT04908722|101453804|FG001|Overall Study|Physician Decision|1|||
33427018|NCT04908722|101453805|FG002|Overall Study|Physician Decision|1|||
33647505|NCT00146848|102262754|FG002|Pre-randomization|Protocol Violation|0|||
33427019|NCT04908722|101453806|FG003|Overall Study|Physician Decision|2|||
33427020|NCT04908722|101453807|FG004|Overall Study|Physician Decision|0|||
33427021|NCT04908722|101453808|FG005|Overall Study|Physician Decision|0|||
33427022|NCT04908722|101453803|FG000|Overall Study|Death|1|||
33587517|NCT01581021|102038523|FG001|Overall Study|Lack of Efficacy|1|||
33587518|NCT02791516|102038541|FG000|Overall Study|Withdrawal by Subject|1|||
33587519|NCT02791516|102038542|FG001|Overall Study|Withdrawal by Subject|1|||
33427023|NCT04908722|101453804|FG001|Overall Study|Death|0|||
33427024|NCT04908722|101453805|FG002|Overall Study|Death|0|||
33427025|NCT04908722|101453806|FG003|Overall Study|Death|0|||
33427026|NCT04908722|101453807|FG004|Overall Study|Death|0|||
33427027|NCT04908722|101453808|FG005|Overall Study|Death|1|||
33427028|NCT04908722|101453803|FG000|Overall Study|Withdrawal by Subject|12|||
33427029|NCT04908722|101453804|FG001|Overall Study|Withdrawal by Subject|8|||
33427030|NCT04908722|101453805|FG002|Overall Study|Withdrawal by Subject|7|||
33427031|NCT04908722|101453806|FG003|Overall Study|Withdrawal by Subject|6|||
33427032|NCT04908722|101453807|FG004|Overall Study|Withdrawal by Subject|12|||
33427033|NCT04908722|101453808|FG005|Overall Study|Withdrawal by Subject|14|||
33427034|NCT04908722|101453803|FG000|Overall Study|Other|3|||
33427035|NCT04908722|101453804|FG001|Overall Study|Other|1|||
33427036|NCT04908722|101453805|FG002|Overall Study|Other|3|||
33427037|NCT04908722|101453806|FG003|Overall Study|Other|2|||
33427038|NCT04908722|101453807|FG004|Overall Study|Other|4|||
33381358|NCT00405821|101279555|FG001|Overall Study|Death|7|||
33381359|NCT00405821|101279554|FG000|Overall Study|Lost to Follow-up|7|||
33381360|NCT00405821|101279555|FG001|Overall Study|Lost to Follow-up|7|||
33381361|NCT00405821|101279554|FG000|Overall Study|Protocol Violation|1|||
33381362|NCT00405821|101279555|FG001|Overall Study|Protocol Violation|0|||
33381363|NCT00405821|101279554|FG000|Overall Study|initiated ART|9|||
33381364|NCT00405821|101279555|FG001|Overall Study|initiated ART|8|||
33381365|NCT00333619|101279558|FG000|Overall Study|Death|12|||
33381366|NCT00333619|101279559|FG001|Overall Study|Death|6|||
33381367|NCT00333619|101279558|FG000|Overall Study|Withdrawal by Subject|6|||
33381368|NCT00333619|101279559|FG001|Overall Study|Withdrawal by Subject|1|||
33381369|NCT00333619|101279558|FG000|Overall Study|Lost to Follow-up|3|||
33381370|NCT00333619|101279559|FG001|Overall Study|Lost to Follow-up|3|||
33381371|NCT00643604|101279560|FG000|Overall Study|Death|1|||
33381372|NCT00881361|101279561|FG000|Overall Study|Terminated prior to surgery|27|||
33381373|NCT00881361|101279562|FG001|Overall Study|Terminated prior to surgery|7|||
33381374|NCT00881361|101279563|FG002|Overall Study|Terminated prior to surgery|0|||
33381375|NCT00881361|101279561|FG000|Overall Study|Ineligible|17|||
33381376|NCT00881361|101279562|FG001|Overall Study|Ineligible|2|||
33381377|NCT00881361|101279563|FG002|Overall Study|Ineligible|2|||
33381378|NCT03728140|101279564|FG000|Overall Study|Abnormal embryo transfer operation|10|||
33381379|NCT03728140|101279565|FG001|Overall Study|Abnormal embryo transfer operation|7|||
33381380|NCT04046341|101279566|FG000|Overall Study|Lost to Follow-up|2|||
33381381|NCT04046341|101279566|FG000|Overall Study|Withdrawal by Subject|1|||
33381382|NCT02420223|101279569|FG000|Overall Study|Adverse Event|1|||
33381383|NCT02420223|101279570|FG001|Overall Study|Adverse Event|0|||
33381384|NCT02420223|101279569|FG000|Overall Study|Physician Decision|0|||
33381385|NCT02420223|101279570|FG001|Overall Study|Physician Decision|2|||
33381386|NCT03654755|101279574|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
33381387|NCT03654755|101279575|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
33381388|NCT03654755|101279576|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
33381389|NCT03654755|101279574|FG000|Overall Study|Withdrawal by Subject|2|||
33381390|NCT03654755|101279575|FG001|Overall Study|Withdrawal by Subject|4|||
33381391|NCT03654755|101279576|FG002|Overall Study|Withdrawal by Subject|8|||
33381392|NCT03654755|101279574|FG000|Overall Study|Lost to Follow-up|1|||
33381393|NCT03654755|101279575|FG001|Overall Study|Lost to Follow-up|3|||
33381394|NCT03654755|101279576|FG002|Overall Study|Lost to Follow-up|7|||
33381395|NCT03654755|101279574|FG000|Overall Study|Physician Decision|0|||
33381396|NCT03654755|101279575|FG001|Overall Study|Physician Decision|1|||
33381397|NCT03654755|101279576|FG002|Overall Study|Physician Decision|0|||
33381398|NCT03654755|101279574|FG000|Overall Study|Adverse Event|0|||
33381399|NCT03654755|101279575|FG001|Overall Study|Adverse Event|0|||
33381400|NCT03654755|101279576|FG002|Overall Study|Adverse Event|4|||
33381401|NCT03654755|101279574|FG000|Overall Study|Lack of Efficacy|0|||
33381402|NCT03654755|101279575|FG001|Overall Study|Lack of Efficacy|0|||
33381403|NCT03654755|101279576|FG002|Overall Study|Lack of Efficacy|1|||
33381404|NCT00282568|101279577|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
33381405|NCT00282568|101279577|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
33381406|NCT00282568|101279577|FG000|Extended Treatment Period|Adverse Event|17|||
33381407|NCT00282568|101279577|FG000|Extended Treatment Period|Non-compliance|4|||
33381408|NCT00282568|101279577|FG000|Extended Treatment Period|Physician Decision|1|||
33381409|NCT00282568|101279577|FG000|Extended Treatment Period|Lost to Follow-up|2|||
33381410|NCT04111107|101279578|FG000|Overall Study|Withdrawal by Subject|6|||
33427039|NCT04908722|101453808|FG005|Overall Study|Other|1|||
33381411|NCT04111107|101279578|FG000|Overall Study|Declining Health|5|||
33381412|NCT04247815|101279579|FG000|Overall Study|Adverse Event|1|||
33381413|NCT04247815|101279580|FG001|Overall Study|Adverse Event|0|||
33381414|NCT04247815|101279579|FG000|Overall Study|Withdrawal by Subject|1|||
33381415|NCT04247815|101279580|FG001|Overall Study|Withdrawal by Subject|0|||
33381416|NCT04247815|101279579|FG000|Overall Study|Protocol Violation|0|||
33381417|NCT04247815|101279580|FG001|Overall Study|Protocol Violation|1|||
33381418|NCT01894477|101279581|FG000|Overall Study|Protocol Violation|0|||
33427040|NCT04908722|101453803|FG000|Overall Study|Initiated prohibited medication|0|||
33587520|NCT03015363|102038543|FG000|Overall Study|Physician Decision|14|||
33587521|NCT03015363|102038543|FG000|Overall Study|Withdrawal by Subject|3|||
33587522|NCT04556591|102038544|FG000|Overall Study|Lost to Follow-up|1|||
33587523|NCT04556591|102038545|FG001|Overall Study|Lost to Follow-up|0|||
33587524|NCT04556591|102038544|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
33587525|NCT04556591|102038545|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
33587526|NCT02569476|102038554|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
33587527|NCT02569476|102038554|FG000|Overall Study|Death|33|||
33381419|NCT01894477|101279582|FG001|Overall Study|Protocol Violation|1|||
33587528|NCT02569476|102038554|FG000|Overall Study|Withdrawal by Subject|9|||
33587529|NCT02569476|102038554|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
33587530|NCT02569476|102038554|FG000|Overall Study|Palliative care|1|||
33587531|NCT02569476|102038554|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
33587532|NCT02569476|102038554|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
33587533|NCT03286543|102038555|FG000|Consented|Screen failure before randomization|2|||
33587534|NCT03286543|102038556|FG001|Consented|Screen failure before randomization|0|||
33587535|NCT03286543|102038557|FG002|Consented|Screen failure before randomization|0|||
33587536|NCT03286543|102038555|FG000|Consented|Screen failure before enrollment|4|||
33587537|NCT03286543|102038556|FG001|Consented|Screen failure before enrollment|0|||
33587538|NCT03286543|102038557|FG002|Consented|Screen failure before enrollment|0|||
33587539|NCT03286543|102038555|FG000|Consented|TKA cancelled after enrollment|1|||
33587540|NCT03286543|102038556|FG001|Consented|TKA cancelled after enrollment|0|||
33587541|NCT03286543|102038557|FG002|Consented|TKA cancelled after enrollment|0|||
33587542|NCT03286543|102038555|FG000|Consented|Withdrawn from study|12|||
33587543|NCT03286543|102038556|FG001|Consented|Withdrawn from study|0|||
33587544|NCT03286543|102038557|FG002|Consented|Withdrawn from study|0|||
33587545|NCT03286543|102038555|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
33587546|NCT03286543|102038556|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
33587547|NCT03286543|102038557|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
33587548|NCT03286543|102038555|FG000|Study Enrollment|Withdrawn from study|0|||
33587549|NCT03286543|102038556|FG001|Study Enrollment|Withdrawn from study|6|||
33587550|NCT03286543|102038557|FG002|Study Enrollment|Withdrawn from study|6|||
33587551|NCT01545934|102038558|FG000|Overall Study|Withdrawal by Subject|4|||
33587552|NCT01545934|102038559|FG001|Overall Study|Withdrawal by Subject|3|||
33587553|NCT01545934|102038558|FG000|Overall Study|Lost to Follow-up|1|||
33587554|NCT01545934|102038559|FG001|Overall Study|Lost to Follow-up|0|||
33587555|NCT00780143|102038560|FG000|Overall Study|Progressive disease|1|||
33587556|NCT00780143|102038560|FG000|Overall Study|Toxicity|1|||
33587557|NCT00780143|102038560|FG000|Overall Study|Adverse Event|1|||
33587558|NCT04908384|102038561|FG000|Overall Study|Lost to Follow-up|4|||
33587559|NCT04908384|102038562|FG001|Overall Study|Lost to Follow-up|4|||
33587560|NCT04908384|102038563|FG002|Overall Study|Lost to Follow-up|0|||
33587561|NCT04908384|102038564|FG003|Overall Study|Lost to Follow-up|0|||
33587562|NCT04004221|102038565|FG000|Overall Study|Death|89|||
33381420|NCT01894477|101279581|FG000|Overall Study|protocol changed due SC changed to cord|0|||
33381421|NCT01894477|101279582|FG001|Overall Study|protocol changed due SC changed to cord|1|||
33381422|NCT02394808|101279586|FG000|Period 1|Unsatisfactory lens fitting|0|||
33381423|NCT02394808|101279587|FG001|Period 1|Unsatisfactory lens fitting|1|||
33381424|NCT02394808|101279586|FG000|Period 2|Lost to Follow-up|1|||
33381425|NCT02394808|101279587|FG001|Period 2|Lost to Follow-up|0|||
33587563|NCT04004221|102038565|FG000|Overall Study|Withdrawal by Subject|5|||
33587564|NCT04004221|102038565|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
33587565|NCT04004221|102038565|FG000|Overall Study|Sponsor Decision|9|||
33587566|NCT04004221|102038565|FG000|Overall Study|Participant refused to enter LTE|1|||
33587567|NCT02680041|102038568|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
33587568|NCT02680041|102038568|FG000|Overall Study|Lost to Follow-up|2|||
33587569|NCT00485758|102038581|FG000|Overall Study|Adverse Event|102|||
33587570|NCT00485758|102038582|FG001|Overall Study|Adverse Event|31|||
33587571|NCT00485758|102038581|FG000|Overall Study|Death|0|||
33381426|NCT00213980|101279588|FG000|Overall Study|Withdrawal by Subject|3|||
33381427|NCT00213980|101279589|FG001|Overall Study|Withdrawal by Subject|1|||
33381428|NCT00213980|101279588|FG000|Overall Study|Adverse Event|1|||
33381429|NCT00213980|101279589|FG001|Overall Study|Adverse Event|1|||
33381430|NCT00213980|101279588|FG000|Overall Study|Disease progression|0|||
33587572|NCT00485758|102038582|FG001|Overall Study|Death|1|||
33587573|NCT00485758|102038581|FG000|Overall Study|Lost to Follow-up|5|||
33587574|NCT00485758|102038582|FG001|Overall Study|Lost to Follow-up|1|||
33587575|NCT00485758|102038581|FG000|Overall Study|Physician Decision|3|||
33587576|NCT00485758|102038582|FG001|Overall Study|Physician Decision|3|||
33587577|NCT00485758|102038581|FG000|Overall Study|Protocol Violation|11|||
33381431|NCT00213980|101279589|FG001|Overall Study|Disease progression|2|||
33381432|NCT00213980|101279588|FG000|Overall Study|Developed ovarian cancer|1|||
33381433|NCT00213980|101279589|FG001|Overall Study|Developed ovarian cancer|0|||
33381434|NCT00213980|101279588|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
33647506|NCT00146848|102262752|FG000|Pre-randomization|Withdrawal by Subject|40|||
33647507|NCT00146848|102262753|FG001|Pre-randomization|Withdrawal by Subject|0|||
33427041|NCT04908722|101453804|FG001|Overall Study|Initiated prohibited medication|0|||
33427042|NCT04908722|101453805|FG002|Overall Study|Initiated prohibited medication|0|||
33427043|NCT04908722|101453806|FG003|Overall Study|Initiated prohibited medication|1|||
33427044|NCT04908722|101453807|FG004|Overall Study|Initiated prohibited medication|0|||
33427045|NCT04908722|101453808|FG005|Overall Study|Initiated prohibited medication|1|||
33427046|NCT04908722|101453803|FG000|Overall Study|Randomized but not vaccinated|3|||
33427047|NCT04908722|101453804|FG001|Overall Study|Randomized but not vaccinated|1|||
33427048|NCT04908722|101453805|FG002|Overall Study|Randomized but not vaccinated|2|||
33427049|NCT04908722|101453806|FG003|Overall Study|Randomized but not vaccinated|2|||
33427050|NCT04908722|101453807|FG004|Overall Study|Randomized but not vaccinated|3|||
33427051|NCT04908722|101453808|FG005|Overall Study|Randomized but not vaccinated|4|||
33427052|NCT01261325|101453809|FG000|Overall Study|Lack of Efficacy|1|||
33427053|NCT01261325|101453810|FG001|Overall Study|Lack of Efficacy|1|||
33427054|NCT01261325|101453811|FG002|Overall Study|Lack of Efficacy|0|||
33427055|NCT01261325|101453809|FG000|Overall Study|Withdrawal by Subject|2|||
33427056|NCT01261325|101453810|FG001|Overall Study|Withdrawal by Subject|2|||
33427057|NCT01261325|101453811|FG002|Overall Study|Withdrawal by Subject|4|||
33427058|NCT01261325|101453809|FG000|Overall Study|SAE, non-fatal|1|||
33427059|NCT01261325|101453810|FG001|Overall Study|SAE, non-fatal|5|||
33427060|NCT01261325|101453811|FG002|Overall Study|SAE, non-fatal|1|||
33427061|NCT01261325|101453809|FG000|Overall Study|AE, non-serious non-fatal|9|||
33427062|NCT01261325|101453810|FG001|Overall Study|AE, non-serious non-fatal|15|||
33427063|NCT01261325|101453811|FG002|Overall Study|AE, non-serious non-fatal|13|||
33427064|NCT01261325|101453809|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
33427065|NCT01261325|101453810|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33427066|NCT01261325|101453811|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33427067|NCT01261325|101453809|FG000|Overall Study|Non Compliance|2|||
33427068|NCT01261325|101453810|FG001|Overall Study|Non Compliance|0|||
33427069|NCT01261325|101453811|FG002|Overall Study|Non Compliance|0|||
33427070|NCT01261325|101453809|FG000|Overall Study|Patient Randomized by Mistake|0|||
33427071|NCT01261325|101453810|FG001|Overall Study|Patient Randomized by Mistake|1|||
33427072|NCT01261325|101453811|FG002|Overall Study|Patient Randomized by Mistake|0|||
33427073|NCT01261325|101453809|FG000|Overall Study|Erroneously Randomized|1|||
33427074|NCT01261325|101453810|FG001|Overall Study|Erroneously Randomized|0|||
33427075|NCT01261325|101453811|FG002|Overall Study|Erroneously Randomized|0|||
33427076|NCT01261325|101453809|FG000|Overall Study|Screen Failure|1|||
33427077|NCT01261325|101453810|FG001|Overall Study|Screen Failure|0|||
33427078|NCT01261325|101453811|FG002|Overall Study|Screen Failure|0|||
33427079|NCT01261325|101453809|FG000|Overall Study|Randomized in Error|0|||
33427080|NCT01261325|101453810|FG001|Overall Study|Randomized in Error|0|||
33427081|NCT01261325|101453811|FG002|Overall Study|Randomized in Error|1|||
33427082|NCT01261325|101453809|FG000|Overall Study|Protocol Violation|0|||
33427083|NCT01261325|101453810|FG001|Overall Study|Protocol Violation|3|||
33427084|NCT01261325|101453811|FG002|Overall Study|Protocol Violation|1|||
33427085|NCT01261325|101453809|FG000|Overall Study|Lost to Follow-up|0|||
33427086|NCT01261325|101453810|FG001|Overall Study|Lost to Follow-up|1|||
33427087|NCT01261325|101453811|FG002|Overall Study|Lost to Follow-up|3|||
33427088|NCT01261325|101453809|FG000|Overall Study|AE, serious fatal|0|||
33427089|NCT01261325|101453810|FG001|Overall Study|AE, serious fatal|0|||
33427090|NCT01261325|101453811|FG002|Overall Study|AE, serious fatal|2|||
33427091|NCT01312779|101453818|FG000|Overall Study|Withdrawal by Subject|2|||
33427092|NCT01312779|101453818|FG000|Overall Study|Death|3|||
33427093|NCT01312779|101453818|FG000|Overall Study|Not Implanted with Device|27|||
33427094|NCT02624518|101453819|FG000|Overall Study|Physician Decision|1|||
33427095|NCT00706706|101453820|FG000|Overall Study|Death|53|||
33427096|NCT00706706|101453820|FG000|Overall Study|Lost to Follow-up|7|||
33427097|NCT00706706|101453820|FG000|Overall Study|Study endpoint had reached|45|||
33427098|NCT02544633|101453821|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
33427099|NCT02544633|101453822|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
33149407|NCT01226043|100460729|FG000|6-week Re-randomization Phase|Physician Decision|0|||
33149408|NCT01226043|100460730|FG001|6-week Re-randomization Phase|Physician Decision|0|||
33149409|NCT01226043|100460731|FG002|6-week Re-randomization Phase|Physician Decision|3|||
33149410|NCT01226043|100460732|FG003|6-week Re-randomization Phase|Physician Decision|2|||
33427100|NCT02544633|101453823|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
33427101|NCT02544633|101453824|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
33427102|NCT02544633|101453821|FG000|Treatment Period|Adverse Event|7|||
33427103|NCT02544633|101453822|FG001|Treatment Period|Adverse Event|4|||
33427104|NCT02544633|101453823|FG002|Treatment Period|Adverse Event|0|||
33149411|NCT01226043|100460729|FG000|6-week Re-randomization Phase|completed in error|0|||
33427105|NCT02544633|101453824|FG003|Treatment Period|Adverse Event|5|||
33427106|NCT02544633|101453821|FG000|Treatment Period|Lack of Efficacy|17|||
33427107|NCT02544633|101453822|FG001|Treatment Period|Lack of Efficacy|11|||
33647508|NCT00146848|102262754|FG002|Pre-randomization|Withdrawal by Subject|0|||
33149412|NCT01226043|100460730|FG001|6-week Re-randomization Phase|completed in error|0|||
33427108|NCT02544633|101453823|FG002|Treatment Period|Lack of Efficacy|5|||
33587578|NCT00485758|102038582|FG001|Overall Study|Protocol Violation|2|||
33587579|NCT00485758|102038581|FG000|Overall Study|Withdrawal by Subject|32|||
33587580|NCT00485758|102038582|FG001|Overall Study|Withdrawal by Subject|27|||
33587581|NCT00485758|102038581|FG000|Overall Study|Study Terminated by Sponsor|3|||
33587582|NCT00485758|102038582|FG001|Overall Study|Study Terminated by Sponsor|0|||
33248261|NCT03982199|100810141|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
33248262|NCT03982199|100810142|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
33248263|NCT03982199|100810129|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
33248264|NCT03982199|100810130|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
33248265|NCT03982199|100810131|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
33248266|NCT03982199|100810132|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
33381435|NCT00213980|101279589|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
33381436|NCT03700736|101279590|FG000|Overall Study|Pregnancy|1|||
33381437|NCT03700736|101279591|FG001|Overall Study|Pregnancy|1|||
33381438|NCT03700736|101279590|FG000|Overall Study|Withdrawal by Subject|2|||
33381439|NCT03700736|101279591|FG001|Overall Study|Withdrawal by Subject|6|||
33381440|NCT01824693|101279592|FG000|Overall Study|Death|0|||
33381441|NCT01824693|101279593|FG001|Overall Study|Death|1|||
33381442|NCT01824693|101279594|FG002|Overall Study|Death|0|||
33381443|NCT01824693|101279592|FG000|Overall Study|Physician Decision|1|||
33381444|NCT01824693|101279593|FG001|Overall Study|Physician Decision|1|||
33381445|NCT01824693|101279594|FG002|Overall Study|Physician Decision|1|||
33381446|NCT01824693|101279592|FG000|Overall Study|Withdrawal by Subject|0|||
33381447|NCT01824693|101279593|FG001|Overall Study|Withdrawal by Subject|0|||
33381448|NCT01824693|101279594|FG002|Overall Study|Withdrawal by Subject|1|||
33381449|NCT01824693|101279592|FG000|Overall Study|Progressive Disease|0|||
33381450|NCT01824693|101279593|FG001|Overall Study|Progressive Disease|5|||
33381451|NCT01824693|101279594|FG002|Overall Study|Progressive Disease|0|||
33381452|NCT01824693|101279592|FG000|Overall Study|Ineligible|0|||
33381453|NCT01824693|101279593|FG001|Overall Study|Ineligible|0|||
33381454|NCT01824693|101279594|FG002|Overall Study|Ineligible|3|||
33381455|NCT01824693|101279592|FG000|Overall Study|No Transplant Planned|0|||
33381456|NCT01824693|101279593|FG001|Overall Study|No Transplant Planned|0|||
33381457|NCT01824693|101279594|FG002|Overall Study|No Transplant Planned|10|||
33381458|NCT02555657|101279599|FG000|Overall Study|Death|274|||
33381459|NCT02555657|101279600|FG001|Overall Study|Death|262|||
33381460|NCT02555657|101279599|FG000|Overall Study|Physician Decision|0|||
33381461|NCT02555657|101279600|FG001|Overall Study|Physician Decision|1|||
33381462|NCT02555657|101279599|FG000|Overall Study|Sponsor Decision|27|||
33381463|NCT02555657|101279600|FG001|Overall Study|Sponsor Decision|15|||
33381464|NCT02555657|101279599|FG000|Overall Study|Withdrawal by Subject|11|||
33381465|NCT02555657|101279600|FG001|Overall Study|Withdrawal by Subject|32|||
33381466|NCT01381718|101279601|FG000|Overall Study|Withdrawal by Subject|2|||
33381467|NCT01381718|101279602|FG001|Overall Study|Withdrawal by Subject|5|||
33381468|NCT01381718|101279601|FG000|Overall Study|Lost to Follow-up|3|||
33381469|NCT01381718|101279602|FG001|Overall Study|Lost to Follow-up|5|||
33381470|NCT01381718|101279601|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
33381471|NCT01381718|101279602|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
33381472|NCT02767856|101279609|FG000|Overall Study|Lost to Follow-up|9|||
33381473|NCT02767856|101279610|FG001|Overall Study|Lost to Follow-up|1|||
33381474|NCT02767856|101279609|FG000|Overall Study|Withdrawal by Subject|2|||
33381475|NCT02767856|101279610|FG001|Overall Study|Withdrawal by Subject|1|||
33381476|NCT00555906|101279611|FG000|Phase 1|Objective Progression or Relapse|3|||
33381477|NCT00555906|101279612|FG001|Phase 1|Objective Progression or Relapse|5|||
33381478|NCT00555906|101279613|FG002|Phase 1|Objective Progression or Relapse|3|||
33381479|NCT00555906|101279614|FG003|Phase 1|Objective Progression or Relapse|1|||
33381480|NCT00555906|101279615|FG004|Phase 1|Objective Progression or Relapse|0|||
33381481|NCT00555906|101279611|FG000|Phase 1|Global Deterioration of Health Status|0|||
33381482|NCT00555906|101279612|FG001|Phase 1|Global Deterioration of Health Status|1|||
33381483|NCT00555906|101279613|FG002|Phase 1|Global Deterioration of Health Status|1|||
33381484|NCT00555906|101279614|FG003|Phase 1|Global Deterioration of Health Status|1|||
33381485|NCT00555906|101279615|FG004|Phase 1|Global Deterioration of Health Status|0|||
33381486|NCT00555906|101279611|FG000|Phase 1|Adverse Event|0|||
33381487|NCT00555906|101279612|FG001|Phase 1|Adverse Event|0|||
33381488|NCT00555906|101279613|FG002|Phase 1|Adverse Event|3|||
33381489|NCT00555906|101279614|FG003|Phase 1|Adverse Event|2|||
33381490|NCT00555906|101279615|FG004|Phase 1|Adverse Event|0|||
33381491|NCT00555906|101279611|FG000|Phase 1|Withdrawal by Subject|0|||
33381492|NCT00555906|101279612|FG001|Phase 1|Withdrawal by Subject|0|||
33381493|NCT00555906|101279613|FG002|Phase 1|Withdrawal by Subject|0|||
33381494|NCT00555906|101279614|FG003|Phase 1|Withdrawal by Subject|1|||
33381495|NCT00555906|101279615|FG004|Phase 1|Withdrawal by Subject|0|||
33381496|NCT00555906|101279611|FG000|Phase 2|Adverse Event|0|||
33381497|NCT00555906|101279612|FG001|Phase 2|Adverse Event|0|||
33381498|NCT00555906|101279613|FG002|Phase 2|Adverse Event|0|||
33381499|NCT00555906|101279614|FG003|Phase 2|Adverse Event|0|||
33381500|NCT00555906|101279615|FG004|Phase 2|Adverse Event|4|||
33427109|NCT02544633|101453824|FG003|Treatment Period|Lack of Efficacy|5|||
33427110|NCT02544633|101453821|FG000|Treatment Period|Global Deterioration of Health|3|||
33427111|NCT02544633|101453822|FG001|Treatment Period|Global Deterioration of Health|3|||
33427112|NCT02544633|101453823|FG002|Treatment Period|Global Deterioration of Health|0|||
33427113|NCT02544633|101453824|FG003|Treatment Period|Global Deterioration of Health|1|||
33427114|NCT02544633|101453821|FG000|Treatment Period|Withdrawal by Subject|1|||
33427115|NCT02544633|101453822|FG001|Treatment Period|Withdrawal by Subject|0|||
33427116|NCT02544633|101453823|FG002|Treatment Period|Withdrawal by Subject|0|||
33427117|NCT02544633|101453824|FG003|Treatment Period|Withdrawal by Subject|0|||
33427118|NCT02544633|101453821|FG000|Treatment Period|Lost to Follow-up|0|||
33427119|NCT02544633|101453822|FG001|Treatment Period|Lost to Follow-up|1|||
33427120|NCT02544633|101453823|FG002|Treatment Period|Lost to Follow-up|0|||
33427121|NCT02544633|101453824|FG003|Treatment Period|Lost to Follow-up|0|||
33427122|NCT02544633|101453821|FG000|Treatment Period|Death|0|||
33427123|NCT02544633|101453822|FG001|Treatment Period|Death|0|||
33427124|NCT02544633|101453823|FG002|Treatment Period|Death|1|||
33427125|NCT02544633|101453824|FG003|Treatment Period|Death|0|||
33427126|NCT02544633|101453821|FG000|Treatment Period|Non-compliance|0|||
33427127|NCT02544633|101453822|FG001|Treatment Period|Non-compliance|0|||
33427128|NCT02544633|101453823|FG002|Treatment Period|Non-compliance|1|||
33427129|NCT02544633|101453824|FG003|Treatment Period|Non-compliance|0|||
33427130|NCT02544633|101453821|FG000|Treatment Period|Clinical Disease Progression|0|||
33427131|NCT02544633|101453822|FG001|Treatment Period|Clinical Disease Progression|0|||
33427132|NCT02544633|101453823|FG002|Treatment Period|Clinical Disease Progression|0|||
33427133|NCT02544633|101453824|FG003|Treatment Period|Clinical Disease Progression|1|||
33427134|NCT02544633|101453821|FG000|Survival Follow-up Period|Death|12|||
33427135|NCT02544633|101453822|FG001|Survival Follow-up Period|Death|14|||
33427136|NCT02544633|101453823|FG002|Survival Follow-up Period|Death|3|||
33427137|NCT02544633|101453824|FG003|Survival Follow-up Period|Death|9|||
33427138|NCT02544633|101453821|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
33427139|NCT02544633|101453822|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
33427140|NCT02544633|101453823|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
33427141|NCT02544633|101453824|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
33427142|NCT02544633|101453821|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
33427143|NCT02544633|101453822|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
33427144|NCT02544633|101453823|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
33427145|NCT02544633|101453824|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
33427146|NCT02544633|101453821|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
33427147|NCT02544633|101453822|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
33427148|NCT02544633|101453823|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
33427149|NCT02544633|101453824|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
33427150|NCT01121900|101453825|FG000|First Intervention Period|Adverse Event|1|||
33427151|NCT01121900|101453826|FG001|First Intervention Period|Adverse Event|1|||
33427152|NCT01121900|101453825|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
33427153|NCT01121900|101453826|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33427154|NCT03493698|101453827|FG000|Treatment Period C|Adverse Event|1|||
33427155|NCT03493698|101453827|FG000|Treatment Period C|Withdrawal by Subject|1|||
33427156|NCT01724359|101453828|FG000|Overall Study|Adverse Event|10|||
33427157|NCT01724359|101453828|FG000|Overall Study|Death|1|||
33427158|NCT01724359|101453828|FG000|Overall Study|Other|20|||
33427159|NCT02436135|101453829|FG000|Overall Study|Progressive Disease|3|||
33427160|NCT02436135|101453830|FG001|Overall Study|Progressive Disease|1|||
33427161|NCT02436135|101453829|FG000|Overall Study|Investigator Discretion|1|||
33427162|NCT02436135|101453830|FG001|Overall Study|Investigator Discretion|2|||
33427163|NCT02436135|101453829|FG000|Overall Study|Adverse Event|1|||
33427164|NCT02436135|101453830|FG001|Overall Study|Adverse Event|0|||
33427165|NCT02436135|101453829|FG000|Overall Study|Withdrawal by Participant|1|||
33427166|NCT02436135|101453830|FG001|Overall Study|Withdrawal by Participant|0|||
33381501|NCT00555906|101279611|FG000|Phase 2|Global Deterioration of Health Status|0|||
33381502|NCT00555906|101279612|FG001|Phase 2|Global Deterioration of Health Status|0|||
33381503|NCT00555906|101279613|FG002|Phase 2|Global Deterioration of Health Status|0|||
33381504|NCT00555906|101279614|FG003|Phase 2|Global Deterioration of Health Status|0|||
33381505|NCT00555906|101279615|FG004|Phase 2|Global Deterioration of Health Status|2|||
33381506|NCT00555906|101279611|FG000|Phase 2|Objective Progression or Relapse|0|||
33427167|NCT02436135|101453829|FG000|Overall Study|Study Terminated By Sponsor|0|||
33427168|NCT02436135|101453830|FG001|Overall Study|Study Terminated By Sponsor|1|||
33427169|NCT02513459|101453837|FG000|Overall Study|Adverse Event|7|||
33587583|NCT02231892|102038583|FG000|Overall Study|Lost to Follow-up|1|||
33149413|NCT01226043|100460731|FG002|6-week Re-randomization Phase|completed in error|0|||
33381507|NCT00555906|101279612|FG001|Phase 2|Objective Progression or Relapse|0|||
33427170|NCT02513459|101453837|FG000|Overall Study|Withdrew consent|5|||
33427171|NCT02513459|101453837|FG000|Overall Study|Loss of efficacy|2|||
33427172|NCT02513459|101453837|FG000|Overall Study|Pregnancy|2|||
33427173|NCT02513459|101453837|FG000|Overall Study|Subject decision|2|||
33427174|NCT02513459|101453837|FG000|Overall Study|Lack of response|1|||
33427175|NCT02513459|101453837|FG000|Overall Study|Reproductive plans|1|||
33427176|NCT02513459|101453837|FG000|Overall Study|Surgery planned-- not done|1|||
33427177|NCT01785875|101453838|FG000|Overall Study|Withdrawal by Subject|41|||
33427178|NCT01785875|101453839|FG001|Overall Study|Withdrawal by Subject|34|||
33427179|NCT01785875|101453840|FG002|Overall Study|Withdrawal by Subject|36|||
33427180|NCT01785875|101453838|FG000|Overall Study|Lost to Follow-up|19|||
33427181|NCT01785875|101453839|FG001|Overall Study|Lost to Follow-up|22|||
33427182|NCT01785875|101453840|FG002|Overall Study|Lost to Follow-up|6|||
33427183|NCT01785875|101453838|FG000|Overall Study|Death|27|||
33427184|NCT01785875|101453839|FG001|Overall Study|Death|16|||
33427185|NCT01785875|101453840|FG002|Overall Study|Death|7|||
33427186|NCT01785875|101453838|FG000|Overall Study|Sponsor Decision|0|||
33427187|NCT01785875|101453839|FG001|Overall Study|Sponsor Decision|2|||
33427188|NCT01785875|101453840|FG002|Overall Study|Sponsor Decision|0|||
33427189|NCT01785875|101453838|FG000|Overall Study|Protocol Specified Criteria|207|||
33427190|NCT01785875|101453839|FG001|Overall Study|Protocol Specified Criteria|214|||
33427191|NCT01785875|101453840|FG002|Overall Study|Protocol Specified Criteria|55|||
33427192|NCT01785875|101453838|FG000|Overall Study|Missing|0|||
33427193|NCT01785875|101453839|FG001|Overall Study|Missing|1|||
33427194|NCT01785875|101453840|FG002|Overall Study|Missing|3|||
33427195|NCT03280537|101453844|FG000|Overall Study|Withdrawal by Subject|2|||
33427196|NCT03280537|101453845|FG001|Overall Study|Withdrawal by Subject|4|||
33427197|NCT02521948|101453862|FG000|Overall Study|Adverse Event|2|||
33427198|NCT02521948|101453862|FG000|Overall Study|Death|4|||
33427199|NCT02521948|101453862|FG000|Overall Study|Lost to Follow-up|1|||
33427200|NCT02521948|101453862|FG000|Overall Study|Did not attend one or both follow-ups|6|||
33427201|NCT01169649|101453863|FG000|Overall Study|Patient Not Treated|3|||
33427202|NCT01783483|101453867|FG000|Overall Study|Death|3|||
33427203|NCT01783483|101453868|FG001|Overall Study|Death|3|||
33427204|NCT01783483|101453867|FG000|Overall Study|Lost to Follow-up|14|||
33427205|NCT01783483|101453868|FG001|Overall Study|Lost to Follow-up|10|||
33427206|NCT01783483|101453867|FG000|Overall Study|Withdrawal by Subject|2|||
33427207|NCT01783483|101453868|FG001|Overall Study|Withdrawal by Subject|1|||
33427208|NCT01783483|101453867|FG000|Overall Study|Physician Decision|1|||
33427209|NCT01783483|101453868|FG001|Overall Study|Physician Decision|1|||
33427210|NCT02762565|101457010|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
33427211|NCT00254397|101457022|FG000|Overall Study|Disease Progression|4|||
33427212|NCT00254397|101457023|FG001|Overall Study|Disease Progression|1|||
33427213|NCT00254397|101457024|FG002|Overall Study|Disease Progression|16|||
33427214|NCT00254397|101457025|FG003|Overall Study|Disease Progression|23|||
33427215|NCT00254397|101457022|FG000|Overall Study|Non-Compliant|0|||
33427216|NCT00254397|101457023|FG001|Overall Study|Non-Compliant|0|||
33427217|NCT00254397|101457024|FG002|Overall Study|Non-Compliant|0|||
33427218|NCT00254397|101457025|FG003|Overall Study|Non-Compliant|1|||
33427219|NCT00254397|101457022|FG000|Overall Study|Adverse Event|2|||
33427220|NCT00254397|101457023|FG001|Overall Study|Adverse Event|0|||
33427221|NCT00254397|101457024|FG002|Overall Study|Adverse Event|3|||
33427222|NCT00254397|101457025|FG003|Overall Study|Adverse Event|1|||
33427223|NCT01102777|101457026|FG000|Overall Study|Death|2|||
33427224|NCT01102777|101457027|FG001|Overall Study|Death|6|||
33427225|NCT01102777|101457026|FG000|Overall Study|Lost to Follow-up|7|||
33427226|NCT01102777|101457027|FG001|Overall Study|Lost to Follow-up|10|||
33427227|NCT03031899|101457028|FG000|Overall Study|Protocol Violation|1|||
33427228|NCT03031899|101457028|FG000|Overall Study|lesion disappeared after stopping habit|1|||
33427229|NCT01835132|101457029|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
33427230|NCT03124381|101457030|FG000|Overall Study|Lost to Follow-up|1|||
33427231|NCT03124381|101457031|FG001|Overall Study|Lost to Follow-up|1|||
33427232|NCT03124381|101457030|FG000|Overall Study|Withdrawal by Subject|6|||
33427233|NCT03124381|101457031|FG001|Overall Study|Withdrawal by Subject|3|||
33427234|NCT03124381|101457030|FG000|Overall Study|Protocol Violation|0|||
33427235|NCT03124381|101457031|FG001|Overall Study|Protocol Violation|1|||
33149414|NCT01226043|100460732|FG003|6-week Re-randomization Phase|completed in error|1|||
33149415|NCT01226043|100460729|FG000|30-week Observational Phase|Adverse Event|0|||
33427236|NCT03124381|101457030|FG000|Overall Study|Adverse Event|1|||
33427237|NCT03124381|101457031|FG001|Overall Study|Adverse Event|1|||
33427238|NCT03124381|101457030|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
33427239|NCT03124381|101457031|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
33427240|NCT01084603|101457040|FG000|Baseline|Withdrawal by Subject|2|||
33427241|NCT01084603|101457040|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
33427242|NCT01084603|101457040|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
33427243|NCT01084603|101457040|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
33427244|NCT01084603|101457040|FG000|Washout Period 4|Adverse Event|1|||
33427245|NCT00481247|101457041|FG000|Overall Study|Death|0|||
33427246|NCT00481247|101457042|FG001|Overall Study|Death|1|||
33427247|NCT00481247|101457041|FG000|Overall Study|Disease progression|18|||
33427248|NCT00481247|101457042|FG001|Overall Study|Disease progression|22|||
33427249|NCT00481247|101457041|FG000|Overall Study|Intolerance|42|||
33427250|NCT00481247|101457042|FG001|Overall Study|Intolerance|17|||
33427251|NCT00481247|101457041|FG000|Overall Study|Treatment failure|10|||
33427252|NCT00481247|101457042|FG001|Overall Study|Treatment failure|14|||
33427253|NCT00481247|101457041|FG000|Overall Study|AE unrelated to study drug|13|||
33427254|NCT00481247|101457042|FG001|Overall Study|AE unrelated to study drug|4|||
33427255|NCT00481247|101457041|FG000|Overall Study|Withdrawal by Subject|8|||
33427256|NCT00481247|101457042|FG001|Overall Study|Withdrawal by Subject|13|||
33427257|NCT00481247|101457041|FG000|Overall Study|Pregnancy|2|||
33427258|NCT00481247|101457042|FG001|Overall Study|Pregnancy|1|||
33427259|NCT00481247|101457041|FG000|Overall Study|Lost to Follow-up|1|||
33427260|NCT00481247|101457042|FG001|Overall Study|Lost to Follow-up|2|||
33427261|NCT00481247|101457041|FG000|Overall Study|Poor compliance/noncompliance|1|||
33427262|NCT00481247|101457042|FG001|Overall Study|Poor compliance/noncompliance|7|||
33427263|NCT00481247|101457041|FG000|Overall Study|Administrative reason by sponsor|157|||
33427264|NCT00481247|101457042|FG001|Overall Study|Administrative reason by sponsor|162|||
33427265|NCT00481247|101457041|FG000|Overall Study|Varied|6|||
33427266|NCT00481247|101457042|FG001|Overall Study|Varied|15|||
33427267|NCT00481247|101457041|FG000|Overall Study|Did not receive treatment|1|||
33427268|NCT00481247|101457042|FG001|Overall Study|Did not receive treatment|2|||
33427269|NCT01605461|101457043|FG000|Overall Study|Lost to Follow-up|3|||
33427270|NCT01605461|101457043|FG000|Overall Study|Withdrawal by Subject|1|||
33427271|NCT02741271|101457044|FG000|Overall Study|Lost to Follow-up|2|||
33427272|NCT02741271|101457045|FG001|Overall Study|Lost to Follow-up|0|||
33427273|NCT02741271|101457044|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33427274|NCT02741271|101457045|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
33427275|NCT01612156|101457048|FG000|Overall Study|Protocol Violation|2|||
33427276|NCT01612156|101457049|FG001|Overall Study|Protocol Violation|0|||
33427277|NCT03237611|101457053|FG000|Overall Study|Withdrawal by Subject|1|||
33427278|NCT03237611|101457053|FG000|Overall Study|Ineligible|1|||
33427279|NCT02257632|101457055|FG000|Overall Study|Withdrawal by Subject|0|||
33427280|NCT02257632|101457056|FG001|Overall Study|Withdrawal by Subject|1|||
33427281|NCT02257632|101457055|FG000|Overall Study|Adverse Event|1|||
33427282|NCT02257632|101457056|FG001|Overall Study|Adverse Event|2|||
33427283|NCT03196791|101457057|FG000|Overall Study|Protocol Violation|7|||
33427284|NCT03196791|101457058|FG001|Overall Study|Protocol Violation|3|||
33381508|NCT00555906|101279613|FG002|Phase 2|Objective Progression or Relapse|0|||
33381509|NCT00555906|101279614|FG003|Phase 2|Objective Progression or Relapse|0|||
33381510|NCT00555906|101279615|FG004|Phase 2|Objective Progression or Relapse|16|||
33381511|NCT00555906|101279611|FG000|Phase 2|Withdrawal by Subject|0|||
33381512|NCT00555906|101279612|FG001|Phase 2|Withdrawal by Subject|0|||
33381513|NCT00555906|101279613|FG002|Phase 2|Withdrawal by Subject|0|||
33381514|NCT00555906|101279614|FG003|Phase 2|Withdrawal by Subject|0|||
33381515|NCT00555906|101279615|FG004|Phase 2|Withdrawal by Subject|2|||
33381516|NCT00555906|101279611|FG000|Phase 2|Other|0|||
33427285|NCT03196791|101457057|FG000|Overall Study|Withdrawal by Subject|3|||
33427286|NCT03196791|101457058|FG001|Overall Study|Withdrawal by Subject|2|||
33587584|NCT02231892|102038584|FG001|Overall Study|Lost to Follow-up|0|||
33587585|NCT02231892|102038585|FG002|Overall Study|Lost to Follow-up|3|||
33587586|NCT02231892|102038583|FG000|Overall Study|Withdrawal by Subject|4|||
33587587|NCT02231892|102038584|FG001|Overall Study|Withdrawal by Subject|3|||
33587588|NCT02231892|102038585|FG002|Overall Study|Withdrawal by Subject|15|||
33587589|NCT02231892|102038583|FG000|Overall Study|Physician Decision|0|||
33587590|NCT02231892|102038584|FG001|Overall Study|Physician Decision|2|||
33587591|NCT02231892|102038585|FG002|Overall Study|Physician Decision|4|||
33587592|NCT02231892|102038583|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
33587593|NCT02231892|102038584|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
33587594|NCT02231892|102038585|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
33587595|NCT02231892|102038583|FG000|Overall Study|Participant motor threshold was >83%|0|||
33587596|NCT02231892|102038584|FG001|Overall Study|Participant motor threshold was >83%|0|||
33587597|NCT02231892|102038585|FG002|Overall Study|Participant motor threshold was >83%|9|||
33587598|NCT02231892|102038583|FG000|Overall Study|Could not find motor threshold|2|||
33587599|NCT02231892|102038584|FG001|Overall Study|Could not find motor threshold|0|||
33587600|NCT02231892|102038585|FG002|Overall Study|Could not find motor threshold|1|||
33587601|NCT02231892|102038583|FG000|Overall Study|Could not find reliable motor hotspot|0|||
33587602|NCT02231892|102038584|FG001|Overall Study|Could not find reliable motor hotspot|0|||
33381517|NCT00555906|101279612|FG001|Phase 2|Other|0|||
33381518|NCT00555906|101279613|FG002|Phase 2|Other|0|||
33381519|NCT00555906|101279614|FG003|Phase 2|Other|0|||
33427287|NCT02622074|101457059|FG000|Overall Study|Death|4|||
33427288|NCT02622074|101457060|FG001|Overall Study|Death|0|||
33427289|NCT02622074|101457061|FG002|Overall Study|Death|0|||
33427290|NCT02622074|101457062|FG003|Overall Study|Death|1|||
33427291|NCT02622074|101457063|FG004|Overall Study|Death|1|||
33381520|NCT00555906|101279615|FG004|Phase 2|Other|6|||
33381521|NCT00555906|101279611|FG000|Phase 2|Randomized but not Treated|0|||
33381522|NCT00555906|101279612|FG001|Phase 2|Randomized but not Treated|0|||
33427292|NCT02622074|101457064|FG005|Overall Study|Death|0|||
33427293|NCT02622074|101457059|FG000|Overall Study|Withdrawal by Subject|0|||
33427294|NCT02622074|101457060|FG001|Overall Study|Withdrawal by Subject|1|||
33427295|NCT02622074|101457061|FG002|Overall Study|Withdrawal by Subject|0|||
33427296|NCT02622074|101457062|FG003|Overall Study|Withdrawal by Subject|0|||
33427297|NCT02622074|101457063|FG004|Overall Study|Withdrawal by Subject|0|||
33427298|NCT02622074|101457064|FG005|Overall Study|Withdrawal by Subject|0|||
33427299|NCT03111147|101457066|FG000|Overall Study|Lost to Follow-up|2|||
33427300|NCT03111147|101457067|FG001|Overall Study|Lost to Follow-up|5|||
33427301|NCT03111147|101457066|FG000|Overall Study|Withdrawal by Subject|4|||
33427302|NCT03111147|101457067|FG001|Overall Study|Withdrawal by Subject|3|||
33427303|NCT03111147|101457066|FG000|Overall Study|Protocol Violation|2|||
33427304|NCT03111147|101457067|FG001|Overall Study|Protocol Violation|1|||
33427305|NCT03111147|101457066|FG000|Overall Study|Death|1|||
33427306|NCT03111147|101457067|FG001|Overall Study|Death|1|||
33427307|NCT01606137|101457070|FG000|Overall Study|Adverse Event|85|||
33427308|NCT01606137|101457070|FG000|Overall Study|Withdrawal by Subject|74|||
33427309|NCT01606137|101457070|FG000|Overall Study|Lack of Efficacy|56|||
33427310|NCT01606137|101457070|FG000|Overall Study|Lost to Follow-up|15|||
33427311|NCT01606137|101457070|FG000|Overall Study|Protocol Violation|1|||
33427312|NCT01606137|101457070|FG000|Overall Study|Patient non-compliance|9|||
33427313|NCT01606137|101457070|FG000|Overall Study|Death|1|||
33427314|NCT01606137|101457070|FG000|Overall Study|Decreased/no pain|4|||
33427315|NCT01606137|101457070|FG000|Overall Study|Issues with driving|4|||
33427316|NCT01606137|101457070|FG000|Overall Study|multiple sclerosis less stable|1|||
33427317|NCT01606137|101457070|FG000|Overall Study|Increased bilirubin|1|||
33427318|NCT01606137|101457070|FG000|Overall Study|Spray causes nausea|1|||
33427319|NCT01606137|101457070|FG000|Overall Study|Not enough improvement|4|||
33427320|NCT01606137|101457070|FG000|Overall Study|Wanted to try another treatment|1|||
33427321|NCT01606137|101457070|FG000|Overall Study|Patient leaving country|1|||
33427322|NCT01606137|101457070|FG000|Overall Study|Personal reasons|1|||
33427323|NCT01606137|101457070|FG000|Overall Study|Unable to tolerate study med. taste|1|||
33427324|NCT01606137|101457070|FG000|Overall Study|Patient moving|1|||
33427325|NCT01606137|101457070|FG000|Overall Study|Unable to collect consistent data|1|||
33427326|NCT01677910|101457071|FG000|Double-Blind Treatment Period|Adverse Event|6|||
33427327|NCT01677910|101457072|FG001|Double-Blind Treatment Period|Adverse Event|2|||
33427328|NCT01677910|101457073|FG002|Double-Blind Treatment Period|Adverse Event|3|||
33427329|NCT01677910|101457074|FG003|Double-Blind Treatment Period|Adverse Event|0|||
33427330|NCT01677910|101457071|FG000|Double-Blind Treatment Period|Physician Decision|0|||
33427331|NCT01677910|101457072|FG001|Double-Blind Treatment Period|Physician Decision|0|||
33427332|NCT01677910|101457073|FG002|Double-Blind Treatment Period|Physician Decision|1|||
33427333|NCT01677910|101457074|FG003|Double-Blind Treatment Period|Physician Decision|0|||
33427334|NCT01677910|101457071|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
33427335|NCT01677910|101457072|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
33427336|NCT01677910|101457073|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
33381523|NCT00555906|101279613|FG002|Phase 2|Randomized but not Treated|0|||
33381524|NCT00555906|101279614|FG003|Phase 2|Randomized but not Treated|0|||
33381525|NCT00555906|101279615|FG004|Phase 2|Randomized but not Treated|2|||
33381526|NCT02115113|101279616|FG000|Participants in Run-in Period|Death|0|||
33381527|NCT02115113|101279617|FG001|Participants in Run-in Period|Death|0|||
33381528|NCT02115113|101279618|FG002|Participants in Run-in Period|Death|1|||
33381529|NCT02115113|101279616|FG000|Participants in Run-in Period|Administrative problems|0|||
33381530|NCT02115113|101279617|FG001|Participants in Run-in Period|Administrative problems|0|||
33381531|NCT02115113|101279618|FG002|Participants in Run-in Period|Administrative problems|1|||
33381532|NCT02115113|101279616|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
33381533|NCT02115113|101279617|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
33381534|NCT02115113|101279618|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
33381535|NCT02115113|101279616|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
33427337|NCT01677910|101457074|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
33427338|NCT01677910|101457071|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
33427339|NCT01677910|101457072|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
33427340|NCT01677910|101457073|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
33427341|NCT01677910|101457074|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
33427342|NCT01677910|101457071|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
33427343|NCT01677910|101457072|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
33427344|NCT01677910|101457073|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
33381536|NCT02115113|101279617|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
33381537|NCT02115113|101279618|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
33381538|NCT02115113|101279616|FG000|Participants Randomized|Lost to Follow-up|1|||
33381539|NCT02115113|101279617|FG001|Participants Randomized|Lost to Follow-up|0|||
33427345|NCT01677910|101457074|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
33427346|NCT01677910|101457071|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
33427347|NCT01677910|101457072|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
33427348|NCT01677910|101457073|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
33427349|NCT01677910|101457074|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
33248267|NCT03982199|100810133|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
33248268|NCT03982199|100810134|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
33248269|NCT03982199|100810135|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
33248270|NCT03982199|100810136|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
33248271|NCT03982199|100810137|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
33248272|NCT03982199|100810138|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
33248273|NCT03982199|100810139|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
33248274|NCT03982199|100810140|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
33248275|NCT03982199|100810141|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
33248276|NCT03982199|100810142|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
33248277|NCT01186848|100810143|FG000|Overall Study|Lost to Follow-up|4|||
33248278|NCT01186848|100810143|FG000|Overall Study|Withdrawal by Subject|2|||
33248279|NCT01186848|100810143|FG000|Overall Study|Adverse Event|2|||
33248280|NCT01193153|100810145|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
33248281|NCT01193153|100810146|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
33248282|NCT01193153|100810145|FG000|Open-label Lead in Period|Pregnancy|1|||
33248283|NCT01193153|100810146|FG001|Open-label Lead in Period|Pregnancy|0|||
33248284|NCT01193153|100810145|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
33248285|NCT01193153|100810146|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
33248286|NCT01193153|100810145|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
33248287|NCT01193153|100810146|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
33248288|NCT01193153|100810145|FG000|Open-label Lead in Period|Other|14|||
33248289|NCT01193153|100810146|FG001|Open-label Lead in Period|Other|0|||
33248290|NCT01193153|100810145|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
33248291|NCT01193153|100810146|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
33248292|NCT01193153|100810145|FG000|Open-label Lead in Period|Adverse Event|41|||
33248293|NCT01193153|100810146|FG001|Open-label Lead in Period|Adverse Event|0|||
33248294|NCT01193153|100810145|FG000|Open-label Lead in Period|Death|1|||
33248295|NCT01193153|100810146|FG001|Open-label Lead in Period|Death|0|||
33248296|NCT01193153|100810145|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
33248297|NCT01193153|100810146|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
33248298|NCT01193153|100810145|FG000|Open-label Stabilization Period|Adverse Event|9|||
33248299|NCT01193153|100810146|FG001|Open-label Stabilization Period|Adverse Event|0|||
33427350|NCT01677910|101457071|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
33647509|NCT00146848|102262752|FG000|Post-randomization|Lost to Follow-up|12|||
33647510|NCT00146848|102262753|FG001|Post-randomization|Lost to Follow-up|15|||
33647511|NCT00146848|102262754|FG002|Post-randomization|Lost to Follow-up|12|||
33647512|NCT00146848|102262752|FG000|Post-randomization|Withdrawn|26|||
33647513|NCT00146848|102262753|FG001|Post-randomization|Withdrawn|32|||
33647514|NCT00146848|102262754|FG002|Post-randomization|Withdrawn|27|||
33647515|NCT01964755|102262757|FG000|Overall Study|Death|2|||
33647516|NCT03120351|102262758|FG000|Overall Study|Physician Decision|1|||
33647517|NCT03120351|102262759|FG001|Overall Study|Physician Decision|1|||
33647518|NCT01870076|102262760|FG000|Overall Study|Withdrawal by Subject|1|||
33647519|NCT01870076|102262761|FG001|Overall Study|Withdrawal by Subject|0|||
33647520|NCT01870076|102262762|FG002|Overall Study|Withdrawal by Subject|1|||
33647521|NCT01870076|102262763|FG003|Overall Study|Withdrawal by Subject|0|||
33647522|NCT04491604|102262764|FG000|Overall Study|Withdrawal by Subject|3|||
33647523|NCT03890666|102262767|FG000|Overall Study|Withdrawal by Subject|0|||
33647524|NCT03890666|102262768|FG001|Overall Study|Withdrawal by Subject|1|||
33647525|NCT03890666|102262767|FG000|Overall Study|Protocol deviation|1|||
33647526|NCT03890666|102262768|FG001|Overall Study|Protocol deviation|4|||
33647527|NCT03890666|102262767|FG000|Overall Study|Lost to Follow-up|2|||
33647528|NCT03890666|102262768|FG001|Overall Study|Lost to Follow-up|5|||
33647529|NCT03890666|102262767|FG000|Overall Study|Other than specified|1|||
33647530|NCT03890666|102262768|FG001|Overall Study|Other than specified|8|||
33647531|NCT01282463|102262769|FG000|Overall Study|Lost to Follow-up|1|||
33647532|NCT01282463|102262770|FG001|Overall Study|Lost to Follow-up|0|||
33149416|NCT01226043|100460730|FG001|30-week Observational Phase|Adverse Event|0|||
33149417|NCT01226043|100460731|FG002|30-week Observational Phase|Adverse Event|1|||
33149418|NCT01226043|100460732|FG003|30-week Observational Phase|Adverse Event|1|||
33149419|NCT01226043|100460729|FG000|30-week Observational Phase|Protocol Violation|0|||
33149420|NCT01226043|100460730|FG001|30-week Observational Phase|Protocol Violation|0|||
33149421|NCT01226043|100460731|FG002|30-week Observational Phase|Protocol Violation|0|||
33149422|NCT01226043|100460732|FG003|30-week Observational Phase|Protocol Violation|1|||
33149423|NCT01226043|100460729|FG000|30-week Observational Phase|Lost to Follow-up|0|||
33149424|NCT01226043|100460730|FG001|30-week Observational Phase|Lost to Follow-up|0|||
33149425|NCT01226043|100460731|FG002|30-week Observational Phase|Lost to Follow-up|2|||
33149426|NCT01226043|100460732|FG003|30-week Observational Phase|Lost to Follow-up|2|||
33149427|NCT01226043|100460729|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
33149428|NCT01226043|100460730|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
33149429|NCT01226043|100460731|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
33149430|NCT01226043|100460732|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
33427351|NCT01677910|101457072|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
33427352|NCT01677910|101457073|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
33427353|NCT01677910|101457074|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
33427354|NCT01677910|101457071|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
33427355|NCT01677910|101457072|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
33427356|NCT01677910|101457073|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
33427357|NCT01677910|101457074|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
33427358|NCT01677910|101457071|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
33427359|NCT01677910|101457072|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
33427360|NCT01677910|101457073|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
33427361|NCT01677910|101457074|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
33427362|NCT01677910|101457071|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
33427363|NCT01677910|101457072|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
33427364|NCT01677910|101457073|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
33427365|NCT01677910|101457074|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
33427366|NCT01875445|101457076|FG000|Overall Study|Lost to Follow-up|5|||
33427367|NCT01875445|101457077|FG001|Overall Study|Lost to Follow-up|0|||
33427368|NCT01875445|101457076|FG000|Overall Study|Withdrawal by Subject|2|||
33427369|NCT01875445|101457077|FG001|Overall Study|Withdrawal by Subject|0|||
33427370|NCT02454972|101457078|FG000|Overall Study|Progressive disease|17|||
33427371|NCT02454972|101457079|FG001|Overall Study|Progressive disease|16|||
33427372|NCT02454972|101457080|FG002|Overall Study|Progressive disease|59|||
33427373|NCT02454972|101457081|FG003|Overall Study|Progressive disease|23|||
33427374|NCT02454972|101457082|FG004|Overall Study|Progressive disease|16|||
33427375|NCT02454972|101457083|FG005|Overall Study|Progressive disease|12|||
33427376|NCT02454972|101457084|FG006|Overall Study|Progressive disease|19|||
33427377|NCT02454972|101457085|FG007|Overall Study|Progressive disease|27|||
33427378|NCT02454972|101457086|FG008|Overall Study|Progressive disease|0|||
33427379|NCT02454972|101457078|FG000|Overall Study|Death|0|||
33427380|NCT02454972|101457079|FG001|Overall Study|Death|0|||
33427381|NCT02454972|101457080|FG002|Overall Study|Death|5|||
33427382|NCT02454972|101457081|FG003|Overall Study|Death|1|||
33427383|NCT02454972|101457082|FG004|Overall Study|Death|0|||
33427384|NCT02454972|101457083|FG005|Overall Study|Death|0|||
33427385|NCT02454972|101457084|FG006|Overall Study|Death|0|||
33427386|NCT02454972|101457085|FG007|Overall Study|Death|0|||
33427387|NCT02454972|101457086|FG008|Overall Study|Death|95|||
33427388|NCT02454972|101457078|FG000|Overall Study|Physician Decision|0|||
33427389|NCT02454972|101457079|FG001|Overall Study|Physician Decision|1|||
33427390|NCT02454972|101457080|FG002|Overall Study|Physician Decision|2|||
33427391|NCT02454972|101457081|FG003|Overall Study|Physician Decision|1|||
33427392|NCT02454972|101457082|FG004|Overall Study|Physician Decision|2|||
33427393|NCT02454972|101457083|FG005|Overall Study|Physician Decision|0|||
33427394|NCT02454972|101457084|FG006|Overall Study|Physician Decision|0|||
33427395|NCT02454972|101457085|FG007|Overall Study|Physician Decision|1|||
33427396|NCT02454972|101457086|FG008|Overall Study|Physician Decision|0|||
33427397|NCT02454972|101457078|FG000|Overall Study|Non treatment-related adverse event|2|||
33427398|NCT02454972|101457079|FG001|Overall Study|Non treatment-related adverse event|0|||
33427399|NCT02454972|101457080|FG002|Overall Study|Non treatment-related adverse event|1|||
33427400|NCT02454972|101457081|FG003|Overall Study|Non treatment-related adverse event|0|||
33427401|NCT02454972|101457082|FG004|Overall Study|Non treatment-related adverse event|0|||
33427402|NCT02454972|101457083|FG005|Overall Study|Non treatment-related adverse event|1|||
33427403|NCT02454972|101457084|FG006|Overall Study|Non treatment-related adverse event|0|||
33647533|NCT01282463|102262771|FG002|Overall Study|Lost to Follow-up|0|||
33647534|NCT01282463|102262769|FG000|Overall Study|Withdrawal by Subject|6|||
33427404|NCT02454972|101457085|FG007|Overall Study|Non treatment-related adverse event|1|||
33427405|NCT02454972|101457086|FG008|Overall Study|Non treatment-related adverse event|0|||
33427406|NCT02454972|101457078|FG000|Overall Study|Treatment-related adverse events|0|||
33427407|NCT02454972|101457079|FG001|Overall Study|Treatment-related adverse events|1|||
33587603|NCT02231892|102038585|FG002|Overall Study|Could not find reliable motor hotspot|1|||
33587604|NCT04470050|102038590|FG000|Double-blind Treatment Phase|Adverse Event|0|||
33587605|NCT04470050|102038591|FG001|Double-blind Treatment Phase|Adverse Event|0|||
33587606|NCT04470050|102038592|FG002|Double-blind Treatment Phase|Adverse Event|0|||
33587607|NCT04470050|102038593|FG003|Double-blind Treatment Phase|Adverse Event|1|||
33587608|NCT04470050|102038594|FG004|Double-blind Treatment Phase|Adverse Event|0|||
33427408|NCT02454972|101457080|FG002|Overall Study|Treatment-related adverse events|1|||
33427409|NCT02454972|101457081|FG003|Overall Study|Treatment-related adverse events|0|||
33587609|NCT04470050|102038595|FG005|Double-blind Treatment Phase|Adverse Event|0|||
33427410|NCT02454972|101457082|FG004|Overall Study|Treatment-related adverse events|2|||
33427411|NCT02454972|101457083|FG005|Overall Study|Treatment-related adverse events|0|||
33427412|NCT02454972|101457084|FG006|Overall Study|Treatment-related adverse events|0|||
33427413|NCT02454972|101457085|FG007|Overall Study|Treatment-related adverse events|2|||
33427414|NCT02454972|101457086|FG008|Overall Study|Treatment-related adverse events|0|||
33427415|NCT02454972|101457078|FG000|Overall Study|Patient moves to compassionate use|0|||
33427416|NCT02454972|101457079|FG001|Overall Study|Patient moves to compassionate use|0|||
33427417|NCT02454972|101457080|FG002|Overall Study|Patient moves to compassionate use|0|||
33427418|NCT02454972|101457081|FG003|Overall Study|Patient moves to compassionate use|0|||
33427419|NCT02454972|101457082|FG004|Overall Study|Patient moves to compassionate use|0|||
33427420|NCT02454972|101457083|FG005|Overall Study|Patient moves to compassionate use|0|||
33427421|NCT02454972|101457084|FG006|Overall Study|Patient moves to compassionate use|2|||
33427422|NCT02454972|101457085|FG007|Overall Study|Patient moves to compassionate use|0|||
33427423|NCT02454972|101457086|FG008|Overall Study|Patient moves to compassionate use|0|||
33427424|NCT02454972|101457078|FG000|Overall Study|Withdrawal by Subject|0|||
33427425|NCT02454972|101457079|FG001|Overall Study|Withdrawal by Subject|1|||
33427426|NCT02454972|101457080|FG002|Overall Study|Withdrawal by Subject|5|||
33427427|NCT02454972|101457081|FG003|Overall Study|Withdrawal by Subject|2|||
33427428|NCT02454972|101457082|FG004|Overall Study|Withdrawal by Subject|3|||
33427429|NCT02454972|101457083|FG005|Overall Study|Withdrawal by Subject|2|||
33427430|NCT02454972|101457084|FG006|Overall Study|Withdrawal by Subject|0|||
33427431|NCT02454972|101457085|FG007|Overall Study|Withdrawal by Subject|1|||
33427432|NCT02454972|101457086|FG008|Overall Study|Withdrawal by Subject|2|||
33427433|NCT02454972|101457078|FG000|Overall Study|Multiple delay/holds on treatment|0|||
33427434|NCT02454972|101457079|FG001|Overall Study|Multiple delay/holds on treatment|0|||
33427435|NCT02454972|101457080|FG002|Overall Study|Multiple delay/holds on treatment|0|||
33427436|NCT02454972|101457081|FG003|Overall Study|Multiple delay/holds on treatment|1|||
33427437|NCT02454972|101457082|FG004|Overall Study|Multiple delay/holds on treatment|0|||
33427438|NCT02454972|101457083|FG005|Overall Study|Multiple delay/holds on treatment|0|||
33427439|NCT02454972|101457084|FG006|Overall Study|Multiple delay/holds on treatment|0|||
33427440|NCT02454972|101457085|FG007|Overall Study|Multiple delay/holds on treatment|0|||
33427441|NCT02454972|101457086|FG008|Overall Study|Multiple delay/holds on treatment|0|||
33427442|NCT02454972|101457078|FG000|Overall Study|Never treated|0|||
33427443|NCT02454972|101457079|FG001|Overall Study|Never treated|0|||
33427444|NCT02454972|101457080|FG002|Overall Study|Never treated|3|||
33427445|NCT02454972|101457081|FG003|Overall Study|Never treated|1|||
33427446|NCT02454972|101457082|FG004|Overall Study|Never treated|1|||
33427447|NCT02454972|101457083|FG005|Overall Study|Never treated|0|||
33427448|NCT02454972|101457084|FG006|Overall Study|Never treated|0|||
33427449|NCT02454972|101457085|FG007|Overall Study|Never treated|0|||
33427450|NCT02454972|101457086|FG008|Overall Study|Never treated|5|||
33427451|NCT02454972|101457078|FG000|Overall Study|Lost to Follow-up|0|||
33427452|NCT02454972|101457079|FG001|Overall Study|Lost to Follow-up|0|||
33427453|NCT02454972|101457080|FG002|Overall Study|Lost to Follow-up|0|||
33427454|NCT02454972|101457081|FG003|Overall Study|Lost to Follow-up|0|||
33427455|NCT02454972|101457082|FG004|Overall Study|Lost to Follow-up|0|||
33427456|NCT02454972|101457083|FG005|Overall Study|Lost to Follow-up|0|||
33427457|NCT02454972|101457084|FG006|Overall Study|Lost to Follow-up|0|||
33427458|NCT02454972|101457085|FG007|Overall Study|Lost to Follow-up|0|||
33427459|NCT02454972|101457086|FG008|Overall Study|Lost to Follow-up|2|||
33427460|NCT02454972|101457078|FG000|Overall Study|Study termination|0|||
33427461|NCT02454972|101457079|FG001|Overall Study|Study termination|0|||
33427462|NCT02454972|101457080|FG002|Overall Study|Study termination|0|||
33427463|NCT02454972|101457081|FG003|Overall Study|Study termination|0|||
33427464|NCT02454972|101457082|FG004|Overall Study|Study termination|0|||
33427465|NCT02454972|101457083|FG005|Overall Study|Study termination|0|||
33427466|NCT02454972|101457084|FG006|Overall Study|Study termination|0|||
33427467|NCT02454972|101457085|FG007|Overall Study|Study termination|0|||
33427468|NCT02454972|101457086|FG008|Overall Study|Study termination|6|||
33427469|NCT00752856|101457087|FG000|Overall Study|randomized but did not do viral kinetics|0|||
33427470|NCT00752856|101457088|FG001|Overall Study|randomized but did not do viral kinetics|1|||
33427471|NCT03763331|101457091|FG000|Overall Study|Lost to Follow-up|1|||
33427472|NCT03763331|101457092|FG001|Overall Study|Lost to Follow-up|0|||
33427473|NCT03763331|101457091|FG000|Overall Study|Withdrawal by Subject|1|||
33427474|NCT03763331|101457092|FG001|Overall Study|Withdrawal by Subject|0|||
33427475|NCT03763331|101457091|FG000|Overall Study|Non-compliance|0|||
33427476|NCT03763331|101457092|FG001|Overall Study|Non-compliance|3|||
33427477|NCT02123459|101457093|FG000|Washout Period (1 Day)|Adverse Event|1|||
33427478|NCT02123459|101457094|FG001|Washout Period (1 Day)|Adverse Event|0|||
33427479|NCT01025193|101457095|FG000|Overall Study|Protocol Violation|1|||
33427480|NCT01025193|101457095|FG000|Overall Study|Adverse Event|3|||
33427481|NCT00003102|101457096|FG000|Overall Study|Physician Decision|1|||
33427482|NCT00003102|101457097|FG001|Overall Study|Physician Decision|1|||
33427483|NCT00003102|101457098|FG002|Overall Study|Physician Decision|0|||
33427484|NCT00003102|101457096|FG000|Overall Study|Progressive Disease|0|||
33427485|NCT00003102|101457097|FG001|Overall Study|Progressive Disease|1|||
33427486|NCT00003102|101457098|FG002|Overall Study|Progressive Disease|0|||
33427487|NCT00003102|101457096|FG000|Overall Study|Adverse Event|0|||
33427488|NCT00003102|101457097|FG001|Overall Study|Adverse Event|1|||
33427489|NCT00003102|101457098|FG002|Overall Study|Adverse Event|1|||
33427490|NCT00003102|101457096|FG000|Overall Study|Death|0|||
33427491|NCT00003102|101457097|FG001|Overall Study|Death|0|||
33427492|NCT00003102|101457098|FG002|Overall Study|Death|1|||
33427493|NCT03521999|101457099|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
33427494|NCT03521999|101457100|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
33427495|NCT03521999|101457099|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
33427496|NCT03521999|101457100|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
33427497|NCT03521999|101457099|FG000|Completed 3 Month Follow up|Death|0|||
33427498|NCT03521999|101457100|FG001|Completed 3 Month Follow up|Death|1|||
33427499|NCT03521999|101457099|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
33427500|NCT03521999|101457100|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
33427501|NCT01223196|101457101|FG000|Overall Study|Lost to Follow-up|2|||
33427502|NCT01223196|101457102|FG001|Overall Study|Lost to Follow-up|0|||
33427503|NCT01223196|101457101|FG000|Overall Study|Physician Decision|1|||
33427504|NCT01223196|101457102|FG001|Overall Study|Physician Decision|0|||
33427505|NCT01223196|101457101|FG000|Overall Study|Withdrawal by Subject|1|||
33427506|NCT01223196|101457102|FG001|Overall Study|Withdrawal by Subject|0|||
33427507|NCT00583596|101457105|FG000|Overall Study|Lost to Follow-up|110|||
33427508|NCT00583596|101457105|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
33427509|NCT00583596|101457105|FG000|Overall Study|Death|2|||
33427510|NCT00583596|101457105|FG000|Overall Study|Withdrawal by Subject|6|||
33427511|NCT00583596|101457105|FG000|Overall Study|Lost to Follow-up|94|||
33427512|NCT00583596|101457105|FG000|Overall Study|Data not complete|1|||
33427513|NCT00583596|101457105|FG000|Overall Study|Not consented|15|||
33427514|NCT00583596|101457105|FG000|Overall Study|Outside f-up window|26|||
33427515|NCT00373685|101457107|FG000|Overall Study|Death|2|||
33427516|NCT00373685|101457108|FG001|Overall Study|Death|1|||
33427517|NCT00373685|101457107|FG000|Overall Study|Adverse Event|278|||
33427518|NCT00373685|101457108|FG001|Overall Study|Adverse Event|253|||
33427519|NCT00373685|101457107|FG000|Overall Study|Insufficient clinical response|169|||
33427520|NCT00373685|101457108|FG001|Overall Study|Insufficient clinical response|119|||
33427521|NCT00373685|101457107|FG000|Overall Study|Did not meet entrance criteria|167|||
33427522|NCT00373685|101457108|FG001|Overall Study|Did not meet entrance criteria|184|||
33427523|NCT00373685|101457107|FG000|Overall Study|Lost to follow up|83|||
33427524|NCT00373685|101457108|FG001|Overall Study|Lost to follow up|103|||
33427525|NCT00373685|101457107|FG000|Overall Study|No longer willing to participate|337|||
33427526|NCT00373685|101457108|FG001|Overall Study|No longer willing to participate|352|||
33427527|NCT00373685|101457107|FG000|Overall Study|Other|149|||
33427528|NCT00373685|101457108|FG001|Overall Study|Other|146|||
33427529|NCT00373685|101457107|FG000|Overall Study|Protocol Violation|191|||
33427530|NCT00373685|101457108|FG001|Overall Study|Protocol Violation|182|||
33427531|NCT00373685|101457107|FG000|Overall Study|Final Status Unknown|12|||
33427532|NCT00373685|101457108|FG001|Overall Study|Final Status Unknown|4|||
33427533|NCT00373685|101457107|FG000|Overall Study|Randomized, not treated|51|||
33647535|NCT01282463|102262770|FG001|Overall Study|Withdrawal by Subject|2|||
33248300|NCT01193153|100810145|FG000|Open-label Stabilization Period|Death|2|||
33248301|NCT01193153|100810146|FG001|Open-label Stabilization Period|Death|0|||
33248302|NCT01193153|100810145|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
33248303|NCT01193153|100810146|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
33248304|NCT01193153|100810145|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
33248305|NCT01193153|100810146|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
33381540|NCT02115113|101279618|FG002|Participants Randomized|Lost to Follow-up|0|||
33381541|NCT02115113|101279616|FG000|Participants Randomized|Death|1|||
33381542|NCT02115113|101279617|FG001|Participants Randomized|Death|0|||
33381543|NCT02115113|101279618|FG002|Participants Randomized|Death|0|||
33381544|NCT01195831|101279625|FG000|Overall Study|Lost to Follow-up|2|||
33381545|NCT01195831|101279626|FG001|Overall Study|Lost to Follow-up|4|||
33381546|NCT01195831|101279625|FG000|Overall Study|Withdrawal by Subject|2|||
33381547|NCT01195831|101279626|FG001|Overall Study|Withdrawal by Subject|2|||
33381548|NCT01195831|101279625|FG000|Overall Study|Adverse Event|4|||
33381549|NCT01195831|101279626|FG001|Overall Study|Adverse Event|2|||
33381550|NCT01195831|101279625|FG000|Overall Study|Protocol Violation|0|||
33381551|NCT01195831|101279626|FG001|Overall Study|Protocol Violation|2|||
33381552|NCT01697267|101279633|FG000|Overall Study|Death|3|||
33381553|NCT01697267|101279634|FG001|Overall Study|Death|1|||
33381554|NCT01697267|101279633|FG000|Overall Study|Withdrawal by Subject|5|||
33427534|NCT00373685|101457108|FG001|Overall Study|Randomized, not treated|77|||
33427535|NCT03840811|101457109|FG000|Overall Study|Lost to Follow-up|0|||
33427536|NCT03840811|101457110|FG001|Overall Study|Lost to Follow-up|0|||
33427537|NCT03840811|101457111|FG002|Overall Study|Lost to Follow-up|1|||
33427538|NCT01806597|101457112|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
33427539|NCT01806597|101457113|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
33587610|NCT04470050|102038596|FG006|Double-blind Treatment Phase|Adverse Event|0|||
33381555|NCT01697267|101279634|FG001|Overall Study|Withdrawal by Subject|5|||
33381556|NCT01697267|101279633|FG000|Overall Study|Adverse Event|2|||
33381557|NCT01697267|101279634|FG001|Overall Study|Adverse Event|1|||
33381558|NCT01697267|101279633|FG000|Overall Study|Lost to Follow-up|2|||
33381559|NCT01697267|101279634|FG001|Overall Study|Lost to Follow-up|4|||
33381560|NCT01697267|101279633|FG000|Overall Study|Physician Decision|2|||
33381561|NCT01697267|101279634|FG001|Overall Study|Physician Decision|4|||
33427540|NCT01806597|101457114|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
33427541|NCT01806597|101457115|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
33427542|NCT01806597|101457116|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
33427543|NCT01806597|101457117|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
33427544|NCT01806597|101457112|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
33427545|NCT01806597|101457113|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
33427546|NCT01806597|101457114|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
33427547|NCT01806597|101457115|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
33427548|NCT01806597|101457116|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
33427549|NCT01806597|101457117|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
33427550|NCT01806597|101457112|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
33427551|NCT01806597|101457113|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
33427552|NCT01806597|101457114|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
33427553|NCT01806597|101457115|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
33427554|NCT01806597|101457116|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
33149431|NCT01226043|100460729|FG000|30-week Observational Phase|Physician Decision|0|||
33149432|NCT01226043|100460730|FG001|30-week Observational Phase|Physician Decision|0|||
33381562|NCT05425719|101279635|FG000|Overall Study|Lost to Follow-up|4|||
33381563|NCT05425719|101279636|FG001|Overall Study|Lost to Follow-up|0|||
33381564|NCT05425719|101279635|FG000|Overall Study|Withdrew consent|1|||
33381565|NCT05425719|101279636|FG001|Overall Study|Withdrew consent|1|||
33381566|NCT01819506|101279643|FG000|Overall Study|Physician Decision|5|||
33381567|NCT01819506|101279644|FG001|Overall Study|Physician Decision|2|||
33381568|NCT01819506|101279643|FG000|Overall Study|Withdrawal by Subject|3|||
33381569|NCT01819506|101279644|FG001|Overall Study|Withdrawal by Subject|3|||
33381570|NCT03094832|101279645|FG000|Overall Study|Lost to Follow-up|0|||
33381571|NCT03094832|101279646|FG001|Overall Study|Lost to Follow-up|0|||
33381572|NCT03094832|101279647|FG002|Overall Study|Lost to Follow-up|0|||
33381573|NCT03094832|101279648|FG003|Overall Study|Lost to Follow-up|1|||
33381574|NCT03094832|101279649|FG004|Overall Study|Lost to Follow-up|1|||
33381575|NCT03094832|101279645|FG000|Overall Study|Death|1|||
33381576|NCT03094832|101279646|FG001|Overall Study|Death|0|||
33381577|NCT03094832|101279647|FG002|Overall Study|Death|0|||
33381578|NCT03094832|101279648|FG003|Overall Study|Death|0|||
33381579|NCT03094832|101279649|FG004|Overall Study|Death|0|||
33381580|NCT03094832|101279645|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
33381581|NCT03094832|101279646|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33381582|NCT03094832|101279647|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
33381583|NCT03094832|101279648|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
33381584|NCT03094832|101279649|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
33381585|NCT03094832|101279645|FG000|Overall Study|Other|13|||
33381586|NCT03094832|101279646|FG001|Overall Study|Other|20|||
33381587|NCT03094832|101279647|FG002|Overall Study|Other|1|||
33381588|NCT03094832|101279648|FG003|Overall Study|Other|7|||
33381589|NCT03094832|101279649|FG004|Overall Study|Other|1|||
33381590|NCT03986190|101279650|FG000|Overall Study|Withdrawal by Subject|12|||
33381591|NCT03986190|101279651|FG001|Overall Study|Withdrawal by Subject|0|||
33381592|NCT01700985|101279652|FG000|Overall Study|Incarcerated|0|||
33381593|NCT01700985|101279653|FG001|Overall Study|Incarcerated|1|||
33381594|NCT02702011|101279654|FG000|Overall Study|Withdrawal by Subject|0|||
33381595|NCT02702011|101279655|FG001|Overall Study|Withdrawal by Subject|1|||
33381596|NCT02702011|101279656|FG002|Overall Study|Withdrawal by Subject|0|||
33381597|NCT02702011|101279657|FG003|Overall Study|Withdrawal by Subject|0|||
33381598|NCT00936117|101279662|FG000|Overall Study|Adverse Event|7|||
33381599|NCT00936117|101279662|FG000|Overall Study|Unable to continue oral medication|3|||
33381600|NCT02168803|101279663|FG000|Overall Study|Lost to Follow-up|1|||
33381601|NCT02168803|101279664|FG001|Overall Study|Lost to Follow-up|0|||
33381602|NCT02168803|101279665|FG002|Overall Study|Lost to Follow-up|1|||
33381603|NCT02168803|101279663|FG000|Overall Study|Withdrawal by Subject|1|||
33381604|NCT02168803|101279664|FG001|Overall Study|Withdrawal by Subject|1|||
33427555|NCT01806597|101457117|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
33427556|NCT01806597|101457112|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
33381605|NCT02168803|101279665|FG002|Overall Study|Withdrawal by Subject|2|||
33381606|NCT02168803|101279663|FG000|Overall Study|Physician Decision|0|||
33381607|NCT02168803|101279664|FG001|Overall Study|Physician Decision|1|||
33381608|NCT02168803|101279665|FG002|Overall Study|Physician Decision|0|||
33381609|NCT02168803|101279663|FG000|Overall Study|Adverse Event|0|||
33381610|NCT02168803|101279664|FG001|Overall Study|Adverse Event|1|||
33381611|NCT02168803|101279665|FG002|Overall Study|Adverse Event|1|||
33381612|NCT02168803|101279663|FG000|Overall Study|Death|0|||
33381613|NCT02168803|101279664|FG001|Overall Study|Death|0|||
33381614|NCT02168803|101279665|FG002|Overall Study|Death|1|||
33381615|NCT02168803|101279663|FG000|Overall Study|Sponsor Decision|0|||
33381616|NCT02168803|101279664|FG001|Overall Study|Sponsor Decision|0|||
33381617|NCT02168803|101279665|FG002|Overall Study|Sponsor Decision|1|||
33381618|NCT03444870|101279666|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
33381619|NCT03444870|101279667|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
33647536|NCT01282463|102262771|FG002|Overall Study|Withdrawal by Subject|3|||
33647537|NCT01282463|102262769|FG000|Overall Study|"Never Treated Death"|0|||
33647538|NCT01282463|102262770|FG001|Overall Study|"Never Treated Death"|1|||
33647539|NCT01282463|102262771|FG002|Overall Study|"Never Treated Death"|0|||
33647540|NCT01282463|102262769|FG000|Overall Study|"Never Treated PD"|0|||
33647541|NCT01282463|102262770|FG001|Overall Study|"Never Treated PD"|1|||
33647542|NCT01282463|102262771|FG002|Overall Study|"Never Treated PD"|0|||
33647543|NCT01282463|102262769|FG000|Overall Study|Protocol Violation|0|||
33248306|NCT01193153|100810145|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
33647544|NCT01282463|102262770|FG001|Overall Study|Protocol Violation|0|||
33647545|NCT01282463|102262771|FG002|Overall Study|Protocol Violation|1|||
33647546|NCT01282463|102262769|FG000|Overall Study|Physician Decision|1|||
33647547|NCT01282463|102262770|FG001|Overall Study|Physician Decision|0|||
33647548|NCT01282463|102262771|FG002|Overall Study|Physician Decision|0|||
33647549|NCT00119678|102262772|FG000|Double-blind Treatment Period|Death|1|||
33647550|NCT00119678|102262773|FG001|Double-blind Treatment Period|Death|0|||
33647551|NCT00119678|102262772|FG000|Double-blind Treatment Period|Adverse Event|7|||
33647552|NCT00119678|102262773|FG001|Double-blind Treatment Period|Adverse Event|1|||
33647553|NCT00119678|102262772|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
33647554|NCT00119678|102262773|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
33647555|NCT00119678|102262772|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
33647556|NCT00119678|102262773|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
33647557|NCT00119678|102262772|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
33647558|NCT00119678|102262773|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
33248307|NCT01193153|100810146|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
33248308|NCT01193153|100810145|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
33248309|NCT01193153|100810146|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
33248310|NCT01193153|100810145|FG000|Open-label Stabilization Period|Other|8|||
33248311|NCT01193153|100810146|FG001|Open-label Stabilization Period|Other|0|||
33248312|NCT01193153|100810145|FG000|Double Blind Relapse Prevention Period|Other|2|||
33248313|NCT01193153|100810146|FG001|Double Blind Relapse Prevention Period|Other|3|||
33248314|NCT01193153|100810145|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
33248315|NCT01193153|100810146|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
33248316|NCT01193153|100810145|FG000|Double Blind Relapse Prevention Period|Death|2|||
33248317|NCT01193153|100810146|FG001|Double Blind Relapse Prevention Period|Death|0|||
33248318|NCT01193153|100810145|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
33248319|NCT01193153|100810146|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
33248320|NCT01193153|100810145|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
33248321|NCT01193153|100810146|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
33248322|NCT01193153|100810145|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
33248323|NCT01193153|100810146|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
33248324|NCT01193153|100810145|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
33248325|NCT01193153|100810146|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
33248326|NCT01193153|100810145|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
33248327|NCT01193153|100810146|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
33248328|NCT00464672|100810148|FG000|Overall Study|withdrawal of consent|0|||
33248329|NCT00464672|100810149|FG001|Overall Study|withdrawal of consent|0|||
33248330|NCT00464672|100810150|FG002|Overall Study|withdrawal of consent|0|||
33248331|NCT00464672|100810151|FG003|Overall Study|withdrawal of consent|1|||
33381620|NCT03444870|101279668|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
33381621|NCT03444870|101279669|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
33381622|NCT03444870|101279670|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
33381623|NCT03444870|101279671|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
33381624|NCT03444870|101279666|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
33381625|NCT03444870|101279667|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
33381626|NCT03444870|101279668|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
33381627|NCT03444870|101279669|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
33381628|NCT03444870|101279670|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
33381629|NCT03444870|101279671|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
33381630|NCT03444870|101279666|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
33381631|NCT03444870|101279667|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
33647559|NCT00119678|102262772|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
33647560|NCT00119678|102262773|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
33647561|NCT00119678|102262772|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
33647562|NCT00119678|102262773|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
33248332|NCT00464672|100810152|FG004|Overall Study|withdrawal of consent|9|||
33248333|NCT00464672|100810153|FG005|Overall Study|withdrawal of consent|4|||
33248334|NCT00464672|100810148|FG000|Overall Study|Lost to Follow-up|25|||
33647563|NCT00119678|102262772|FG000|Double-blind Treatment Period|Pregnancy|0|||
33427557|NCT01806597|101457113|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
33427558|NCT01806597|101457114|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
33427559|NCT01806597|101457115|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
33427560|NCT01806597|101457116|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
33427561|NCT01806597|101457117|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
33427562|NCT01806597|101457112|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
33427563|NCT01806597|101457113|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
33427564|NCT01806597|101457114|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
33427565|NCT01806597|101457115|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
33427566|NCT01806597|101457116|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
33427567|NCT01806597|101457117|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
33427568|NCT01806597|101457112|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
33647564|NCT00119678|102262773|FG001|Double-blind Treatment Period|Pregnancy|2|||
33647565|NCT00119678|102262772|FG000|Double-blind Treatment Period|Not treated|1|||
33647566|NCT00119678|102262773|FG001|Double-blind Treatment Period|Not treated|2|||
33647567|NCT00119678|102262772|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
33647568|NCT00119678|102262773|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
33647569|NCT00119678|102262772|FG000|Open-label Treatment Period|Death|1|||
33647570|NCT00119678|102262773|FG001|Open-label Treatment Period|Death|0|||
33647571|NCT00119678|102262772|FG000|Open-label Treatment Period|Adverse Event|3|||
33647572|NCT00119678|102262773|FG001|Open-label Treatment Period|Adverse Event|0|||
33647573|NCT00119678|102262772|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
33647574|NCT00119678|102262773|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
33647575|NCT00119678|102262772|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
33647576|NCT00119678|102262773|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
33647577|NCT00119678|102262772|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
33647578|NCT00119678|102262773|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
33647579|NCT00119678|102262772|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
33647580|NCT00119678|102262773|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
33647581|NCT00119678|102262772|FG000|Open-label Treatment Period|Pregnancy|1|||
33647582|NCT00119678|102262773|FG001|Open-label Treatment Period|Pregnancy|0|||
33647583|NCT00119678|102262772|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
33647584|NCT00119678|102262773|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
33647585|NCT00375609|102262775|FG000|Overall Study|Did not receive treatment|1|||
33647586|NCT00375609|102262776|FG001|Overall Study|Did not receive treatment|0|||
33647587|NCT00375609|102262777|FG002|Overall Study|Did not receive treatment|0|||
33647588|NCT00375609|102262775|FG000|Overall Study|Adverse Event|0|||
33647589|NCT00375609|102262776|FG001|Overall Study|Adverse Event|3|||
33248335|NCT00464672|100810149|FG001|Overall Study|Lost to Follow-up|10|||
33248336|NCT00464672|100810150|FG002|Overall Study|Lost to Follow-up|0|||
33248337|NCT00464672|100810151|FG003|Overall Study|Lost to Follow-up|0|||
33248338|NCT00464672|100810152|FG004|Overall Study|Lost to Follow-up|1|||
33248339|NCT00464672|100810153|FG005|Overall Study|Lost to Follow-up|0|||
33381632|NCT03444870|101279668|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
33381633|NCT03444870|101279669|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
33381634|NCT03444870|101279670|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
33381635|NCT03444870|101279671|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
33381636|NCT03444870|101279666|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
33381637|NCT03444870|101279667|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
33381638|NCT03444870|101279668|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
33381639|NCT03444870|101279669|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
33381640|NCT03444870|101279670|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
33381641|NCT03444870|101279671|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
33381642|NCT03444870|101279666|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
33381643|NCT03444870|101279667|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
33381644|NCT03444870|101279668|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
33381645|NCT03444870|101279669|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
33381646|NCT03444870|101279670|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
33381647|NCT03444870|101279671|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
33647590|NCT00375609|102262777|FG002|Overall Study|Adverse Event|0|||
33647591|NCT00375609|102262775|FG000|Overall Study|Lost to Follow-up|1|||
33647592|NCT00375609|102262776|FG001|Overall Study|Lost to Follow-up|0|||
33647593|NCT00375609|102262777|FG002|Overall Study|Lost to Follow-up|0|||
33248340|NCT00943605|100810160|FG000|Overall Study|Study termination|30|||
33248341|NCT00943605|100810161|FG001|Overall Study|Study termination|30|||
33248342|NCT01156116|100810162|FG000|Overall Study|Withdrawal by Subject|3|||
33248343|NCT01156116|100810163|FG001|Overall Study|Withdrawal by Subject|1|||
33248344|NCT01156116|100810162|FG000|Overall Study|CPAP intolerance|2|||
33381648|NCT03444870|101279666|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
33381649|NCT03444870|101279667|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
33427569|NCT01806597|101457113|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
33427570|NCT01806597|101457114|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
33427571|NCT01806597|101457115|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
33427572|NCT01806597|101457116|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
33427573|NCT01806597|101457117|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
33427574|NCT01806597|101457112|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
33427575|NCT01806597|101457113|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
33427576|NCT01806597|101457114|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
33427577|NCT01806597|101457115|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
33427578|NCT01806597|101457116|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
33427579|NCT01806597|101457117|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
33427580|NCT01806597|101457112|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
33427581|NCT01806597|101457113|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
33427582|NCT01806597|101457114|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
33427583|NCT01806597|101457115|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
33427584|NCT01806597|101457116|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
33427585|NCT01806597|101457117|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
33427586|NCT01806597|101457112|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
33427587|NCT01806597|101457113|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
33427588|NCT01806597|101457114|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
33427589|NCT01806597|101457115|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
33427590|NCT01806597|101457116|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
33427591|NCT01806597|101457117|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
33427592|NCT01806597|101457112|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
33427593|NCT01806597|101457113|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
33427594|NCT01806597|101457114|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
33427595|NCT01806597|101457115|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
33427596|NCT01806597|101457116|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
33427597|NCT01806597|101457117|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
33427598|NCT01806597|101457112|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
33427599|NCT01806597|101457113|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
33427600|NCT01806597|101457114|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
33427601|NCT01806597|101457115|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
33427602|NCT01806597|101457116|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
33427603|NCT01806597|101457117|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
33427604|NCT01806597|101457112|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
33427605|NCT01806597|101457113|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
33427606|NCT01806597|101457114|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
33427607|NCT01806597|101457115|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
33427608|NCT01806597|101457116|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
33427609|NCT01806597|101457117|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
33427610|NCT01806597|101457112|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
33427611|NCT01806597|101457113|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
33427612|NCT01806597|101457114|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
33427613|NCT01806597|101457115|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
33427614|NCT01806597|101457116|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
33427615|NCT01806597|101457117|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
33427616|NCT01806597|101457112|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
33248345|NCT01156116|100810163|FG001|Overall Study|CPAP intolerance|0|||
33248346|NCT00975806|100810164|FG000|Overall Study|Adverse Event|2|||
33248347|NCT00975806|100810165|FG001|Overall Study|Adverse Event|1|||
33248348|NCT00975806|100810166|FG002|Overall Study|Adverse Event|2|||
33248349|NCT00975806|100810164|FG000|Overall Study|Disease Progression|1|||
33248350|NCT00975806|100810165|FG001|Overall Study|Disease Progression|5|||
33248351|NCT00975806|100810166|FG002|Overall Study|Disease Progression|1|||
33647594|NCT00375609|102262775|FG000|Overall Study|Physician Decision|0|||
33647595|NCT00375609|102262776|FG001|Overall Study|Physician Decision|0|||
33647596|NCT00375609|102262777|FG002|Overall Study|Physician Decision|1|||
33647597|NCT00375609|102262775|FG000|Overall Study|Withdrawal by Subject|1|||
33248352|NCT00975806|100810164|FG000|Overall Study|Withdrawal by Subject|1|||
33248353|NCT00975806|100810165|FG001|Overall Study|Withdrawal by Subject|0|||
33248354|NCT00975806|100810166|FG002|Overall Study|Withdrawal by Subject|0|||
33248355|NCT00975806|100810164|FG000|Overall Study|Death|0|||
33248356|NCT00975806|100810165|FG001|Overall Study|Death|1|||
33248357|NCT00975806|100810166|FG002|Overall Study|Death|0|||
33427617|NCT01806597|101457113|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
33427618|NCT01806597|101457114|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
33427619|NCT01806597|101457115|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
33427620|NCT01806597|101457116|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
33427621|NCT01806597|101457117|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
33427622|NCT01806597|101457112|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
33427623|NCT01806597|101457113|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
33427624|NCT01806597|101457114|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
33427625|NCT01806597|101457115|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
33427626|NCT01806597|101457116|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
33427627|NCT01806597|101457117|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
33427628|NCT01806597|101457112|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
33427629|NCT01806597|101457113|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
33427630|NCT01806597|101457114|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
33427631|NCT01806597|101457115|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
33427632|NCT01806597|101457116|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
33427633|NCT01806597|101457117|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
33427634|NCT01806597|101457112|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
33427635|NCT01806597|101457113|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
33427636|NCT01806597|101457114|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
33427637|NCT01806597|101457115|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
33427638|NCT01806597|101457116|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
33427639|NCT01806597|101457117|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
33427640|NCT01806597|101457112|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
33427641|NCT01806597|101457113|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
33427642|NCT01806597|101457114|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
33427643|NCT01806597|101457115|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
33427644|NCT01806597|101457116|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
33427645|NCT01806597|101457117|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
33427646|NCT01806597|101457112|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
33427647|NCT01806597|101457113|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
33427648|NCT01806597|101457114|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
33427649|NCT01806597|101457115|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
33427650|NCT01806597|101457116|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
33427651|NCT01806597|101457117|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
33427652|NCT02499354|101457118|FG000|Overall Study|Withdrawal by Subject|1|||
33427653|NCT02499354|101457119|FG001|Overall Study|Withdrawal by Subject|0|||
33427654|NCT04274192|101457121|FG000|Overall Study|Protocol Violation|1|||
33427655|NCT04274192|101457122|FG001|Overall Study|Protocol Violation|0|||
33427656|NCT02770716|101457126|FG000|Overall Study|Death|101|||
33427657|NCT02770716|101457127|FG001|Overall Study|Death|45|||
33427658|NCT02770716|101457126|FG000|Overall Study|Withdrawal by Subject|4|||
33427659|NCT02770716|101457127|FG001|Overall Study|Withdrawal by Subject|2|||
33427660|NCT02770716|101457126|FG000|Overall Study|Lost to Follow-up|1|||
33427661|NCT02770716|101457127|FG001|Overall Study|Lost to Follow-up|0|||
33427662|NCT02770716|101457126|FG000|Overall Study|Various reasons|6|||
33427663|NCT02770716|101457127|FG001|Overall Study|Various reasons|2|||
33427664|NCT02040428|101457128|FG000|Overall Study|Death|4|||
33427665|NCT02040428|101457129|FG001|Overall Study|Death|3|||
33427666|NCT02040428|101457128|FG000|Overall Study|Withdrawal by Subject|1|||
33427667|NCT02040428|101457129|FG001|Overall Study|Withdrawal by Subject|1|||
33427668|NCT02468557|101457132|FG000|Overall Study|Adverse Event|1|||
33427669|NCT02468557|101457132|FG000|Overall Study|Death|1|||
33427670|NCT02468557|101457132|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
33427671|NCT02468557|101457132|FG000|Overall Study|All Enrolled but Never Dosed|4|||
33427672|NCT01907737|101457133|FG000|Overall Study|Withdrawal by Subject|1|||
33427673|NCT00571922|101457134|FG000|Overall Study|Completion unknown|36|||
33427674|NCT00571922|101457135|FG001|Overall Study|Completion unknown|36|||
33587611|NCT04470050|102038590|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
33587612|NCT04470050|102038591|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
33427675|NCT02763579|101457136|FG000|Global Period|Death|167|||
33427676|NCT02763579|101457137|FG001|Global Period|Death|151|||
33427677|NCT02763579|101457138|FG002|Global Period|Death|0|||
33427678|NCT02763579|101457139|FG003|Global Period|Death|0|||
33427679|NCT02763579|101457136|FG000|Global Period|Lost to Follow-up|2|||
33427680|NCT02763579|101457137|FG001|Global Period|Lost to Follow-up|4|||
33587613|NCT04470050|102038592|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
33587614|NCT04470050|102038593|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
33587615|NCT04470050|102038594|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
33427681|NCT02763579|101457138|FG002|Global Period|Lost to Follow-up|0|||
33427682|NCT02763579|101457139|FG003|Global Period|Lost to Follow-up|0|||
33248358|NCT00975806|100810164|FG000|Overall Study|Physician decision and disease related|1|||
33248359|NCT00975806|100810165|FG001|Overall Study|Physician decision and disease related|0|||
33248360|NCT00975806|100810166|FG002|Overall Study|Physician decision and disease related|1|||
33248361|NCT05512949|100810167|FG000|Overall Study|Lost to Follow-up|4|||
33248362|NCT05512949|100810168|FG001|Overall Study|Lost to Follow-up|6|||
33248363|NCT05512949|100810169|FG002|Overall Study|Lost to Follow-up|2|||
33248364|NCT05512949|100810167|FG000|Overall Study|Protocol Violation|0|||
33248365|NCT05512949|100810168|FG001|Overall Study|Protocol Violation|0|||
33248366|NCT05512949|100810169|FG002|Overall Study|Protocol Violation|1|||
33248367|NCT05512949|100810167|FG000|Overall Study|Withdrawal by Subject|1|||
33248368|NCT05512949|100810168|FG001|Overall Study|Withdrawal by Subject|1|||
33248369|NCT05512949|100810169|FG002|Overall Study|Withdrawal by Subject|2|||
33248370|NCT05512949|100810167|FG000|Overall Study|Completion status unknown|1|||
33248371|NCT05512949|100810168|FG001|Overall Study|Completion status unknown|3|||
33248372|NCT05512949|100810169|FG002|Overall Study|Completion status unknown|0|||
33248373|NCT01190150|100810170|FG000|First Treatment|Withdrawal by Subject|1|||
33248374|NCT01190150|100810171|FG001|First Treatment|Withdrawal by Subject|0|||
33248375|NCT01190150|100810170|FG000|Washout|Withdrawal by Subject|0|||
33248376|NCT01190150|100810171|FG001|Washout|Withdrawal by Subject|1|||
33248377|NCT01190150|100810170|FG000|Washout|Difficulty in adherence|0|||
33248378|NCT01190150|100810171|FG001|Washout|Difficulty in adherence|1|||
33248379|NCT03942042|100810172|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
33248380|NCT03942042|100810173|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
33248381|NCT03942042|100810172|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
33248382|NCT03942042|100810173|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
33248383|NCT02596035|100810175|FG000|Overall Study|Disease Progression|64|||
33248384|NCT02596035|100810176|FG001|Overall Study|Disease Progression|32|||
33248385|NCT02596035|100810177|FG002|Overall Study|Disease Progression|1|||
33248386|NCT02596035|100810175|FG000|Overall Study|study drug toxicity|12|||
33248387|NCT02596035|100810176|FG001|Overall Study|study drug toxicity|3|||
33248388|NCT02596035|100810177|FG002|Overall Study|study drug toxicity|0|||
33248389|NCT02596035|100810175|FG000|Overall Study|AE unrelated to study drug|5|||
33248390|NCT02596035|100810176|FG001|Overall Study|AE unrelated to study drug|2|||
33248391|NCT02596035|100810177|FG002|Overall Study|AE unrelated to study drug|0|||
33248392|NCT02596035|100810175|FG000|Overall Study|participant request to discontinue study treatment|2|||
33248393|NCT02596035|100810176|FG001|Overall Study|participant request to discontinue study treatment|0|||
33248394|NCT02596035|100810177|FG002|Overall Study|participant request to discontinue study treatment|0|||
33248395|NCT02596035|100810175|FG000|Overall Study|participant withdrew consent|2|||
33248396|NCT02596035|100810176|FG001|Overall Study|participant withdrew consent|2|||
33248397|NCT02596035|100810177|FG002|Overall Study|participant withdrew consent|0|||
33248398|NCT02596035|100810175|FG000|Overall Study|Poor/Non Comlpiance|0|||
33248399|NCT02596035|100810176|FG001|Overall Study|Poor/Non Comlpiance|1|||
33248400|NCT02596035|100810177|FG002|Overall Study|Poor/Non Comlpiance|0|||
33248401|NCT02596035|100810175|FG000|Overall Study|participant no longer meets study criteria|1|||
33248402|NCT02596035|100810176|FG001|Overall Study|participant no longer meets study criteria|0|||
33248403|NCT02596035|100810177|FG002|Overall Study|participant no longer meets study criteria|0|||
33248404|NCT02596035|100810175|FG000|Overall Study|other reasons|11|||
33248405|NCT02596035|100810176|FG001|Overall Study|other reasons|4|||
33248406|NCT02596035|100810177|FG002|Overall Study|other reasons|0|||
33248407|NCT01191086|100810178|FG000|Overall Study|Adverse Event|20|||
33248408|NCT01191086|100810178|FG000|Overall Study|Lack of Efficacy|10|||
33248409|NCT01191086|100810178|FG000|Overall Study|Lost to Follow-up|4|||
33248410|NCT01191086|100810178|FG000|Overall Study|Physician Decision|2|||
33248411|NCT01191086|100810178|FG000|Overall Study|Withdrawal by Subject|24|||
33248412|NCT01191086|100810178|FG000|Overall Study|Discontinuation criterion met|1|||
33248413|NCT01191086|100810178|FG000|Overall Study|Other|1|||
33248414|NCT03613129|100810179|FG000|Pre-treatment Assessment|Protocol Violation|2|||
33248415|NCT03613129|100810180|FG001|Pre-treatment Assessment|Protocol Violation|0|||
33381650|NCT03444870|101279668|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
33587616|NCT04470050|102038595|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
33248416|NCT03613129|100810181|FG002|Pre-treatment Assessment|Protocol Violation|0|||
33248417|NCT03613129|100810182|FG003|Pre-treatment Assessment|Protocol Violation|0|||
33587617|NCT04470050|102038596|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
33587618|NCT04470050|102038590|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
33248418|NCT03613129|100810183|FG004|Pre-treatment Assessment|Protocol Violation|0|||
33248419|NCT03613129|100810179|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
33248420|NCT03613129|100810180|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
33248421|NCT03613129|100810181|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
33248422|NCT03613129|100810182|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
33248423|NCT03613129|100810183|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
33248424|NCT02968004|100810184|FG000|Overall Study|Adverse Event|1|||
33248425|NCT02968004|100810185|FG001|Overall Study|Adverse Event|0|||
33427683|NCT02763579|101457136|FG000|Global Period|Physician Decision|0|||
33248426|NCT02968004|100810184|FG000|Overall Study|Withdrawal by Subject|0|||
33427684|NCT02763579|101457137|FG001|Global Period|Physician Decision|2|||
33427685|NCT02763579|101457138|FG002|Global Period|Physician Decision|0|||
33427686|NCT02763579|101457139|FG003|Global Period|Physician Decision|0|||
33427687|NCT02763579|101457136|FG000|Global Period|Study Terminated By Sponsor|21|||
33427688|NCT02763579|101457137|FG001|Global Period|Study Terminated By Sponsor|26|||
33427689|NCT02763579|101457138|FG002|Global Period|Study Terminated By Sponsor|0|||
33427690|NCT02763579|101457139|FG003|Global Period|Study Terminated By Sponsor|0|||
33427691|NCT02763579|101457136|FG000|Global Period|Withdrawal by Subject|12|||
33427692|NCT02763579|101457137|FG001|Global Period|Withdrawal by Subject|18|||
33427693|NCT02763579|101457138|FG002|Global Period|Withdrawal by Subject|0|||
33427694|NCT02763579|101457139|FG003|Global Period|Withdrawal by Subject|0|||
33427695|NCT02763579|101457136|FG000|China Period|Death|0|||
33427696|NCT02763579|101457137|FG001|China Period|Death|0|||
33427697|NCT02763579|101457138|FG002|China Period|Death|46|||
33427698|NCT02763579|101457139|FG003|China Period|Death|48|||
33427699|NCT02763579|101457136|FG000|China Period|Lost to Follow-up|0|||
33427700|NCT02763579|101457137|FG001|China Period|Lost to Follow-up|0|||
33427701|NCT02763579|101457138|FG002|China Period|Lost to Follow-up|1|||
33427702|NCT02763579|101457139|FG003|China Period|Lost to Follow-up|1|||
33427703|NCT02763579|101457136|FG000|China Period|Physician Decision|0|||
33427704|NCT02763579|101457137|FG001|China Period|Physician Decision|0|||
33427705|NCT02763579|101457138|FG002|China Period|Physician Decision|0|||
33427706|NCT02763579|101457139|FG003|China Period|Physician Decision|1|||
33427707|NCT02763579|101457136|FG000|China Period|Study Terminated By Sponsor|0|||
33427708|NCT02763579|101457137|FG001|China Period|Study Terminated By Sponsor|0|||
33427709|NCT02763579|101457138|FG002|China Period|Study Terminated By Sponsor|3|||
33427710|NCT02763579|101457139|FG003|China Period|Study Terminated By Sponsor|4|||
33427711|NCT02763579|101457136|FG000|China Period|Withdrawal by Subject|0|||
33427712|NCT02763579|101457137|FG001|China Period|Withdrawal by Subject|0|||
33427713|NCT02763579|101457138|FG002|China Period|Withdrawal by Subject|3|||
33427714|NCT02763579|101457139|FG003|China Period|Withdrawal by Subject|3|||
33427715|NCT03740100|101457143|FG000|Overall Study|Adverse Event|1|||
33427716|NCT03740100|101457143|FG000|Overall Study|Death|1|||
33427717|NCT01244815|101457148|FG000|Overall Study|Not Treated|0|||
33427718|NCT01244815|101457149|FG001|Overall Study|Not Treated|1|||
33427719|NCT01244815|101457150|FG002|Overall Study|Not Treated|0|||
33427720|NCT01244815|101457151|FG003|Overall Study|Not Treated|0|||
33427721|NCT01244815|101457148|FG000|Overall Study|Adverse Event|4|||
33427722|NCT01244815|101457149|FG001|Overall Study|Adverse Event|7|||
33427723|NCT01244815|101457150|FG002|Overall Study|Adverse Event|5|||
33427724|NCT01244815|101457151|FG003|Overall Study|Adverse Event|5|||
33427725|NCT01244815|101457148|FG000|Overall Study|Treatment Failure|0|||
33427726|NCT01244815|101457149|FG001|Overall Study|Treatment Failure|0|||
33427727|NCT01244815|101457150|FG002|Overall Study|Treatment Failure|0|||
33427728|NCT01244815|101457151|FG003|Overall Study|Treatment Failure|1|||
33427729|NCT01244815|101457148|FG000|Overall Study|Lost to Follow-up|3|||
33427730|NCT01244815|101457149|FG001|Overall Study|Lost to Follow-up|2|||
33427731|NCT01244815|101457150|FG002|Overall Study|Lost to Follow-up|3|||
33427732|NCT01244815|101457151|FG003|Overall Study|Lost to Follow-up|2|||
33427733|NCT01244815|101457148|FG000|Overall Study|Withdrawal by Subject|0|||
33427734|NCT01244815|101457149|FG001|Overall Study|Withdrawal by Subject|2|||
33427735|NCT01244815|101457150|FG002|Overall Study|Withdrawal by Subject|0|||
33427736|NCT01244815|101457151|FG003|Overall Study|Withdrawal by Subject|3|||
33427737|NCT01244815|101457148|FG000|Overall Study|Protocol Violation|7|||
33427738|NCT01244815|101457149|FG001|Overall Study|Protocol Violation|4|||
33427739|NCT01244815|101457150|FG002|Overall Study|Protocol Violation|3|||
33427740|NCT01244815|101457151|FG003|Overall Study|Protocol Violation|1|||
33427741|NCT01244815|101457148|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
33427742|NCT01244815|101457149|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
33427743|NCT01244815|101457150|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
33427744|NCT01244815|101457151|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
33427745|NCT01042977|101457157|FG000|Overall Study|Adverse Event|4|||
33427746|NCT01042977|101457158|FG001|Overall Study|Adverse Event|12|||
33427747|NCT01042977|101457157|FG000|Overall Study|Death|2|||
33427748|NCT01042977|101457158|FG001|Overall Study|Death|1|||
33427749|NCT01042977|101457157|FG000|Overall Study|Withdrawal by Subject|8|||
33427750|NCT01042977|101457158|FG001|Overall Study|Withdrawal by Subject|16|||
33248427|NCT02968004|100810185|FG001|Overall Study|Withdrawal by Subject|1|||
33248428|NCT01175707|100810192|FG000|Overall Study|Adverse Event|4|||
33427751|NCT01042977|101457157|FG000|Overall Study|Lost to Follow-up|0|||
33427752|NCT01042977|101457158|FG001|Overall Study|Lost to Follow-up|2|||
33427753|NCT01042977|101457157|FG000|Overall Study|Poor/non-compliance|3|||
33427754|NCT01042977|101457158|FG001|Overall Study|Poor/non-compliance|4|||
33248429|NCT01175707|100810193|FG001|Overall Study|Adverse Event|6|||
33427755|NCT01042977|101457157|FG000|Overall Study|Subject no longer meets study criteria|15|||
33427756|NCT01042977|101457158|FG001|Overall Study|Subject no longer meets study criteria|13|||
33427757|NCT01042977|101457157|FG000|Overall Study|Incorrect enrollment|6|||
33427758|NCT01042977|101457158|FG001|Overall Study|Incorrect enrollment|4|||
33427759|NCT01042977|101457157|FG000|Overall Study|Safety|0|||
33427760|NCT01042977|101457158|FG001|Overall Study|Safety|2|||
33427761|NCT01042977|101457157|FG000|Overall Study|Administrative reason by sponsor|0|||
33427762|NCT01042977|101457158|FG001|Overall Study|Administrative reason by sponsor|1|||
33427763|NCT01042977|101457157|FG000|Overall Study|Various|3|||
33427764|NCT01042977|101457158|FG001|Overall Study|Various|0|||
33427765|NCT04317781|101457159|FG000|Overall Study|Adverse Event|1|||
33427766|NCT04317781|101457159|FG000|Overall Study|Disease relapse|1|||
33427767|NCT04317781|101457159|FG000|Overall Study|Withdrawal by Subject|1|||
33427768|NCT02424565|101457161|FG000|Period 1 (D0)|Protocol Violation|0|||
33427769|NCT02424565|101457162|FG001|Period 1 (D0)|Protocol Violation|1|||
33427770|NCT00326885|101457163|FG000|Overall Study|Adverse Event|1|||
33427771|NCT00326885|101457163|FG000|Overall Study|Withdrawal by Subject|3|||
33427772|NCT00326885|101457163|FG000|Overall Study|Physician Decision|1|||
33427773|NCT00326885|101457163|FG000|Overall Study|Hospice withdrew consent|2|||
33427774|NCT03705351|101457166|FG000|Overall Study|Study termination|3|||
33427775|NCT03705351|101457166|FG000|Overall Study|Death|1|||
33427776|NCT03705351|101457166|FG000|Overall Study|Lack of Efficacy|2|||
33427777|NCT03705351|101457166|FG000|Overall Study|Withdrawal by Subject|1|||
33427778|NCT01294592|101457171|FG000|Overall Study|Adverse Event|28|||
33427779|NCT01294592|101457172|FG001|Overall Study|Adverse Event|13|||
33427780|NCT01294592|101457171|FG000|Overall Study|Lack of Efficacy|7|||
33427781|NCT01294592|101457172|FG001|Overall Study|Lack of Efficacy|5|||
33427782|NCT01294592|101457171|FG000|Overall Study|Protocol Violation|1|||
33427783|NCT01294592|101457172|FG001|Overall Study|Protocol Violation|7|||
33427784|NCT01294592|101457171|FG000|Overall Study|Lost to Follow-up|7|||
33427785|NCT01294592|101457172|FG001|Overall Study|Lost to Follow-up|9|||
33427786|NCT01294592|101457171|FG000|Overall Study|Physician Decision|6|||
33427787|NCT01294592|101457172|FG001|Overall Study|Physician Decision|11|||
33427788|NCT01294592|101457171|FG000|Overall Study|Withdrawal by Subject|28|||
33427789|NCT01294592|101457172|FG001|Overall Study|Withdrawal by Subject|28|||
33427790|NCT00593333|101457173|FG000|Overall Study|Lost to Follow-up|10|||
33427791|NCT00593333|101457174|FG001|Overall Study|Lost to Follow-up|11|||
33427792|NCT02265952|101457175|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
33427793|NCT02265952|101457176|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
33427794|NCT02265952|101457175|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
33427795|NCT02265952|101457176|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
33427796|NCT01446913|101457178|FG000|Overall Study|Significant illness|1|||
33427797|NCT01446913|101457179|FG001|Overall Study|Significant illness|1|||
33427798|NCT01446913|101457180|FG002|Overall Study|Significant illness|1|||
33427799|NCT01446913|101457178|FG000|Overall Study|Withdrawal by Subject|5|||
33427800|NCT01446913|101457179|FG001|Overall Study|Withdrawal by Subject|3|||
33427801|NCT01446913|101457180|FG002|Overall Study|Withdrawal by Subject|5|||
33427802|NCT01446913|101457178|FG000|Overall Study|Physician Decision|0|||
33427803|NCT01446913|101457179|FG001|Overall Study|Physician Decision|0|||
33427804|NCT01446913|101457180|FG002|Overall Study|Physician Decision|2|||
33427805|NCT01446913|101457178|FG000|Overall Study|Lost to Follow-up|3|||
33427806|NCT01446913|101457179|FG001|Overall Study|Lost to Follow-up|5|||
33427807|NCT01446913|101457180|FG002|Overall Study|Lost to Follow-up|3|||
33427808|NCT02175966|101457181|FG000|Follow-up Period|Lack of Efficacy|10|||
33427809|NCT02175966|101457182|FG001|Follow-up Period|Lack of Efficacy|6|||
33427810|NCT03063632|101457183|FG000|Overall Study|Death|4|||
33427811|NCT03063632|101457184|FG001|Overall Study|Death|6|||
33427812|NCT03063632|101457183|FG000|Overall Study|Lost to Follow-up|0|||
33427813|NCT03063632|101457184|FG001|Overall Study|Lost to Follow-up|1|||
33427814|NCT03063632|101457183|FG000|Overall Study|Withdrawal by Subject|0|||
33427815|NCT03063632|101457184|FG001|Overall Study|Withdrawal by Subject|2|||
33427816|NCT03063632|101457183|FG000|Overall Study|Physician Decision|2|||
33427817|NCT03063632|101457184|FG001|Overall Study|Physician Decision|0|||
33427818|NCT03063632|101457183|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
33427819|NCT03063632|101457184|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
33427820|NCT02904200|101457185|FG000|Overall Study|Withdrawal by Subject|1|||
33427821|NCT02904200|101457186|FG001|Overall Study|Withdrawal by Subject|0|||
33427822|NCT01113710|101457187|FG000|Overall Study|Adverse Event|64|||
33427823|NCT01113710|101457187|FG000|Overall Study|Lack of Efficacy|41|||
33427824|NCT01113710|101457187|FG000|Overall Study|No Information Available|40|||
33427825|NCT01113710|101457187|FG000|Overall Study|Withdrawal by Subject|28|||
33427826|NCT01113710|101457187|FG000|Overall Study|Lost to Follow-up|20|||
33427827|NCT01113710|101457187|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
33427828|NCT01113710|101457187|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
33647598|NCT00375609|102262776|FG001|Overall Study|Withdrawal by Subject|4|||
33427829|NCT01113710|101457187|FG000|Overall Study|Lack of Patient's Compliance|8|||
33427830|NCT01113710|101457187|FG000|Overall Study|Other|7|||
33427831|NCT01113710|101457187|FG000|Overall Study|Adverse Event/Other|5|||
33427832|NCT01113710|101457187|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
33427833|NCT01113710|101457187|FG000|Overall Study|Lack of Efficacy/Other|4|||
33427834|NCT01113710|101457187|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
33427835|NCT01113710|101457187|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
33381651|NCT03444870|101279669|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
33381652|NCT03444870|101279670|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
33381653|NCT03444870|101279671|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
33381654|NCT03444870|101279666|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
33381655|NCT03444870|101279667|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
33381656|NCT03444870|101279668|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
33381657|NCT03444870|101279669|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
33381658|NCT03444870|101279670|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
33381659|NCT03444870|101279671|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
33381660|NCT03444870|101279666|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
33381661|NCT03444870|101279667|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
33381662|NCT03444870|101279668|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
33381663|NCT03444870|101279669|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
33381664|NCT03444870|101279670|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
33381665|NCT03444870|101279671|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
33381666|NCT03444870|101279666|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
33381667|NCT03444870|101279667|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
33381668|NCT03444870|101279668|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
33381669|NCT03444870|101279669|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
33381670|NCT03444870|101279670|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
33381671|NCT03444870|101279671|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
33381672|NCT03444870|101279666|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
33381673|NCT03444870|101279667|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
33381674|NCT03444870|101279668|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
33381675|NCT03444870|101279669|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
33381676|NCT03444870|101279670|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
33381677|NCT03444870|101279671|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
33381678|NCT03444870|101279666|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
33381679|NCT03444870|101279667|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
33381680|NCT03444870|101279668|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
33381681|NCT03444870|101279669|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
33381682|NCT03444870|101279670|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
33381683|NCT03444870|101279671|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
33381684|NCT03444870|101279666|FG000|Open-Label Extension (OLE) Period|Death|0|||
33381685|NCT03444870|101279667|FG001|Open-Label Extension (OLE) Period|Death|0|||
33381686|NCT03444870|101279668|FG002|Open-Label Extension (OLE) Period|Death|0|||
33381687|NCT03444870|101279669|FG003|Open-Label Extension (OLE) Period|Death|0|||
33381688|NCT03444870|101279670|FG004|Open-Label Extension (OLE) Period|Death|1|||
33381689|NCT03444870|101279671|FG005|Open-Label Extension (OLE) Period|Death|0|||
33381690|NCT02379390|101279676|FG000|Overall Study|Adverse Event|1|||
33381691|NCT02379390|101279677|FG001|Overall Study|Adverse Event|1|||
33381692|NCT02379390|101279676|FG000|Overall Study|Investigator's decision|1|||
33381693|NCT02379390|101279677|FG001|Overall Study|Investigator's decision|0|||
33381694|NCT02379390|101279676|FG000|Overall Study|Study Termination|0|||
33381695|NCT02379390|101279677|FG001|Overall Study|Study Termination|1|||
33381696|NCT00795509|101283315|FG000|Overall Study|Protocol Violation|31|||
33381697|NCT04929613|101283316|FG000|Overall Study|Withdrawal by Subject|12|||
33381698|NCT02293902|101283319|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
33381699|NCT02293902|101283320|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
33381700|NCT02293902|101283321|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
33381701|NCT02293902|101283322|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
33381702|NCT02293902|101283323|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
33381703|NCT02293902|101283319|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
33381704|NCT02293902|101283320|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
33381705|NCT02293902|101283321|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
33381706|NCT02293902|101283322|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
33381707|NCT02293902|101283323|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
33381708|NCT02293902|101283319|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
33381709|NCT02293902|101283320|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
33381710|NCT02293902|101283321|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
33381711|NCT02293902|101283322|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
33381712|NCT02293902|101283323|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
33381713|NCT02293902|101283319|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
33381714|NCT02293902|101283320|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
33381715|NCT02293902|101283321|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
33427836|NCT01113710|101457187|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
33381716|NCT02293902|101283322|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
33427837|NCT01113710|101457187|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
33248430|NCT00315055|100810198|FG000|Overall Study|Protocol Violation|2|||
33248431|NCT00315055|100810199|FG001|Overall Study|Protocol Violation|4|||
33248432|NCT00315055|100810198|FG000|Overall Study|Lost to Follow-up|1|||
33248433|NCT00315055|100810199|FG001|Overall Study|Lost to Follow-up|1|||
33248434|NCT02145182|100810200|FG000|Overall Study|Adverse Event|4|||
33248435|NCT02145182|100810201|FG001|Overall Study|Adverse Event|1|||
33248436|NCT02145182|100810200|FG000|Overall Study|Death|7|||
33248437|NCT02145182|100810201|FG001|Overall Study|Death|7|||
33248438|NCT02145182|100810200|FG000|Overall Study|Lost to Follow-up|2|||
33248439|NCT02145182|100810201|FG001|Overall Study|Lost to Follow-up|2|||
33248440|NCT02145182|100810200|FG000|Overall Study|Pre-transplant Withdrawal|0|||
33248441|NCT02145182|100810201|FG001|Overall Study|Pre-transplant Withdrawal|2|||
33248442|NCT02145182|100810200|FG000|Overall Study|Withdrawal by Subject|5|||
33248443|NCT02145182|100810201|FG001|Overall Study|Withdrawal by Subject|4|||
33248444|NCT01909336|100810202|FG000|Overall Study|Lost to Follow-up|4|||
33248445|NCT01909336|100810203|FG001|Overall Study|Lost to Follow-up|2|||
33248446|NCT01909336|100810204|FG002|Overall Study|Lost to Follow-up|2|||
33248447|NCT01909336|100810202|FG000|Overall Study|Physician Decision|0|||
33248448|NCT01909336|100810203|FG001|Overall Study|Physician Decision|1|||
33248449|NCT01909336|100810204|FG002|Overall Study|Physician Decision|1|||
33248450|NCT01090024|100810205|FG000|Period 1|Met exclusion criteria|0|||
33248451|NCT01090024|100810206|FG001|Period 1|Met exclusion criteria|0|||
33248452|NCT01090024|100810207|FG002|Period 1|Met exclusion criteria|0|||
33248453|NCT01090024|100810208|FG003|Period 1|Met exclusion criteria|0|||
33248454|NCT01090024|100810209|FG004|Period 1|Met exclusion criteria|0|||
33248455|NCT01090024|100810210|FG005|Period 1|Met exclusion criteria|0|||
33248456|NCT01090024|100810211|FG006|Period 1|Met exclusion criteria|0|||
33587619|NCT04470050|102038591|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
33587620|NCT04470050|102038592|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
33587621|NCT04470050|102038593|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
33587622|NCT04470050|102038594|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
33587623|NCT04470050|102038595|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
33587624|NCT04470050|102038596|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
33587625|NCT03783442|102038597|FG000|Overall Study|Remained on study (ongoing at time of DCO)|114|||
33587626|NCT03783442|102038598|FG001|Overall Study|Remained on study (ongoing at time of DCO)|77|||
33149433|NCT01226043|100460731|FG002|30-week Observational Phase|Physician Decision|2|||
33149434|NCT01226043|100460732|FG003|30-week Observational Phase|Physician Decision|2|||
33149435|NCT03387150|100460733|FG000|Overall Study|Withdrawal by Subject|3|||
33149436|NCT03387150|100460734|FG001|Overall Study|Withdrawal by Subject|0|||
33149437|NCT03387150|100460735|FG002|Overall Study|Withdrawal by Subject|3|||
33149438|NCT03387150|100460736|FG003|Overall Study|Withdrawal by Subject|4|||
33149439|NCT03387150|100460737|FG004|Overall Study|Withdrawal by Subject|1|||
33149440|NCT03387150|100460738|FG005|Overall Study|Withdrawal by Subject|2|||
33149441|NCT03387150|100460739|FG006|Overall Study|Withdrawal by Subject|0|||
33149442|NCT03387150|100460733|FG000|Overall Study|Lost to Follow-up|3|||
33149443|NCT03387150|100460734|FG001|Overall Study|Lost to Follow-up|2|||
33149444|NCT03387150|100460735|FG002|Overall Study|Lost to Follow-up|2|||
33149445|NCT03387150|100460736|FG003|Overall Study|Lost to Follow-up|3|||
33149446|NCT03387150|100460737|FG004|Overall Study|Lost to Follow-up|3|||
33149447|NCT03387150|100460738|FG005|Overall Study|Lost to Follow-up|3|||
33149448|NCT03387150|100460739|FG006|Overall Study|Lost to Follow-up|0|||
33149449|NCT03387150|100460733|FG000|Overall Study|Participant unable to adhere to visit|0|||
33149450|NCT03387150|100460734|FG001|Overall Study|Participant unable to adhere to visit|1|||
33149451|NCT03387150|100460735|FG002|Overall Study|Participant unable to adhere to visit|0|||
33149452|NCT03387150|100460736|FG003|Overall Study|Participant unable to adhere to visit|0|||
33149453|NCT03387150|100460737|FG004|Overall Study|Participant unable to adhere to visit|2|||
33149454|NCT03387150|100460738|FG005|Overall Study|Participant unable to adhere to visit|2|||
33149455|NCT03387150|100460739|FG006|Overall Study|Participant unable to adhere to visit|0|||
33149456|NCT00116168|100460740|FG000|Overall Study|Lost to Follow-up|6|||
33149457|NCT00116168|100460741|FG001|Overall Study|Lost to Follow-up|5|||
33149458|NCT00116168|100460742|FG002|Overall Study|Lost to Follow-up|0|||
33149459|NCT00116168|100460743|FG003|Overall Study|Lost to Follow-up|0|||
33149460|NCT03803683|100460744|FG000|Overall Study|Lost to Follow-up|41|||
33149461|NCT03803683|100460745|FG001|Overall Study|Lost to Follow-up|18|||
33149462|NCT03803683|100460746|FG002|Overall Study|Lost to Follow-up|12|||
33149463|NCT03803683|100460744|FG000|Overall Study|Withdrawal by Subject|9|||
33149464|NCT03803683|100460745|FG001|Overall Study|Withdrawal by Subject|1|||
33149465|NCT03803683|100460746|FG002|Overall Study|Withdrawal by Subject|4|||
33149466|NCT03514017|100460747|FG000|Overall Study|Death|1|||
33149467|NCT03514017|100460747|FG000|Overall Study|Adverse Event|1|||
33149468|NCT04508140|100460748|FG000|Overall Study|Adverse Event|2|||
33149469|NCT04508140|100460749|FG001|Overall Study|Adverse Event|2|||
33149470|NCT04508140|100460748|FG000|Overall Study|Withdrawal by Subject|0|||
33248457|NCT01090024|100810212|FG007|Period 1|Met exclusion criteria|0|||
33248458|NCT01090024|100810213|FG008|Period 1|Met exclusion criteria|0|||
33248459|NCT01090024|100810214|FG009|Period 1|Met exclusion criteria|0|||
33248460|NCT01090024|100810215|FG010|Period 1|Met exclusion criteria|0|||
33248461|NCT01090024|100810216|FG011|Period 1|Met exclusion criteria|0|||
33248462|NCT01090024|100810217|FG012|Period 1|Met exclusion criteria|0|||
33248463|NCT01090024|100810218|FG013|Period 1|Met exclusion criteria|0|||
33248464|NCT01090024|100810219|FG014|Period 1|Met exclusion criteria|1|||
33248465|NCT01090024|100810220|FG015|Period 1|Met exclusion criteria|0|||
33248466|NCT01090024|100810221|FG016|Period 1|Met exclusion criteria|0|||
33248467|NCT01090024|100810222|FG017|Period 1|Met exclusion criteria|0|||
33248468|NCT01090024|100810205|FG000|Period 1|Adverse Event|0|||
33248469|NCT01090024|100810206|FG001|Period 1|Adverse Event|0|||
33248470|NCT01090024|100810207|FG002|Period 1|Adverse Event|0|||
33248471|NCT01090024|100810208|FG003|Period 1|Adverse Event|0|||
33248472|NCT01090024|100810209|FG004|Period 1|Adverse Event|0|||
33248473|NCT01090024|100810210|FG005|Period 1|Adverse Event|0|||
33248474|NCT01090024|100810211|FG006|Period 1|Adverse Event|0|||
33248475|NCT01090024|100810212|FG007|Period 1|Adverse Event|0|||
33427838|NCT01113710|101457187|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
33427839|NCT01113710|101457187|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
33427840|NCT01113710|101457187|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
33427841|NCT01113710|101457187|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
33427842|NCT01113710|101457187|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
33427843|NCT01113710|101457187|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
33427844|NCT01113710|101457187|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
33427845|NCT01113710|101457187|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
33427846|NCT01113710|101457187|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
33427847|NCT00770991|101457188|FG000|Overall Study|Physician Decision|2|||
33427848|NCT00770991|101457189|FG001|Overall Study|Physician Decision|0|||
33427849|NCT00770991|101457188|FG000|Overall Study|Withdrawal by Subject|1|||
33427850|NCT00770991|101457189|FG001|Overall Study|Withdrawal by Subject|0|||
33427851|NCT00770991|101457188|FG000|Overall Study|Adverse Event|1|||
33427852|NCT00770991|101457189|FG001|Overall Study|Adverse Event|5|||
33427853|NCT00770991|101457188|FG000|Overall Study|Pregnancy|1|||
33427854|NCT00770991|101457189|FG001|Overall Study|Pregnancy|0|||
33427855|NCT03404206|101457191|FG000|Overall Study|Withdrawal by Subject|1|||
33427856|NCT03404206|101457192|FG001|Overall Study|Withdrawal by Subject|1|||
33427857|NCT03404206|101457193|FG002|Overall Study|Withdrawal by Subject|0|||
33427858|NCT03404206|101457191|FG000|Overall Study|Lost to Follow-up|3|||
33427859|NCT03404206|101457192|FG001|Overall Study|Lost to Follow-up|1|||
33427860|NCT03404206|101457193|FG002|Overall Study|Lost to Follow-up|0|||
33427861|NCT01138150|101457198|FG000|Overall Study|blood unable to be processed|0|||
33427862|NCT01138150|101457199|FG001|Overall Study|blood unable to be processed|1|||
33427863|NCT01138150|101457198|FG000|Overall Study|Physician Decision|1|||
33427864|NCT01138150|101457199|FG001|Overall Study|Physician Decision|0|||
33427865|NCT00207714|101457202|FG000|Overall Study|Adverse Event|6|||
33427866|NCT00207714|101457203|FG001|Overall Study|Adverse Event|2|||
33427867|NCT00207714|101457204|FG002|Overall Study|Adverse Event|4|||
33427868|NCT00207714|101457205|FG003|Overall Study|Adverse Event|3|||
33427869|NCT00207714|101457206|FG004|Overall Study|Adverse Event|1|||
33427870|NCT00207714|101457202|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
33427871|NCT00207714|101457203|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33427872|NCT00207714|101457204|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
33427873|NCT00207714|101457205|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
33427874|NCT00207714|101457206|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
33427875|NCT00207714|101457202|FG000|Overall Study|Other|3|||
33427876|NCT00207714|101457203|FG001|Overall Study|Other|2|||
33427877|NCT00207714|101457204|FG002|Overall Study|Other|5|||
33427878|NCT00207714|101457205|FG003|Overall Study|Other|1|||
33427879|NCT00207714|101457206|FG004|Overall Study|Other|0|||
33427880|NCT00936975|101457207|FG000|Overall Study|Withdrawal by Subject|1|||
33427881|NCT00936975|101457207|FG000|Overall Study|Disease progression|3|||
33427882|NCT00936975|101457207|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
33149471|NCT04508140|100460749|FG001|Overall Study|Withdrawal by Subject|2|||
33248476|NCT01090024|100810213|FG008|Period 1|Adverse Event|0|||
33427883|NCT01381900|101457210|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
33427884|NCT01381900|101457211|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
33427885|NCT01381900|101457212|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
33248477|NCT01090024|100810214|FG009|Period 1|Adverse Event|1|||
33248478|NCT01090024|100810215|FG010|Period 1|Adverse Event|0|||
33248479|NCT01090024|100810216|FG011|Period 1|Adverse Event|1|||
33248480|NCT01090024|100810217|FG012|Period 1|Adverse Event|0|||
33248481|NCT01090024|100810218|FG013|Period 1|Adverse Event|0|||
33248482|NCT01090024|100810219|FG014|Period 1|Adverse Event|0|||
33248483|NCT01090024|100810220|FG015|Period 1|Adverse Event|0|||
33248484|NCT01090024|100810221|FG016|Period 1|Adverse Event|0|||
33248485|NCT01090024|100810222|FG017|Period 1|Adverse Event|1|||
33427886|NCT01381900|101457210|FG000|Overall Study|Adverse Event|4|||
33427887|NCT01381900|101457211|FG001|Overall Study|Adverse Event|6|||
33427888|NCT01381900|101457212|FG002|Overall Study|Adverse Event|7|||
33427889|NCT01381900|101457210|FG000|Overall Study|Noncompliance with study drug|0|||
33427890|NCT01381900|101457211|FG001|Overall Study|Noncompliance with study drug|0|||
33427891|NCT01381900|101457212|FG002|Overall Study|Noncompliance with study drug|1|||
33427892|NCT01381900|101457210|FG000|Overall Study|Physician Decision|0|||
33427893|NCT01381900|101457211|FG001|Overall Study|Physician Decision|1|||
33427894|NCT01381900|101457212|FG002|Overall Study|Physician Decision|1|||
33427895|NCT01381900|101457210|FG000|Overall Study|Protocol Violation|0|||
33427896|NCT01381900|101457211|FG001|Overall Study|Protocol Violation|1|||
33427897|NCT01381900|101457212|FG002|Overall Study|Protocol Violation|1|||
33427898|NCT01381900|101457210|FG000|Overall Study|Withdrawal by Subject|0|||
33587627|NCT03783442|102038597|FG000|Overall Study|Death|196|||
33587628|NCT03783442|102038598|FG001|Overall Study|Death|226|||
33647599|NCT00375609|102262777|FG002|Overall Study|Withdrawal by Subject|0|||
33647600|NCT00375609|102262775|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
33248486|NCT01090024|100810205|FG000|Period 1|Withdrawal by Subject|0|||
33381717|NCT02293902|101283323|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
33381718|NCT02293902|101283319|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
33381719|NCT02293902|101283320|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
33381720|NCT02293902|101283321|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
33381721|NCT02293902|101283322|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
33381722|NCT02293902|101283323|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
33381723|NCT00779324|101283325|FG000|Overall Study|Lost to Follow-up|2|||
33381724|NCT00779324|101283326|FG001|Overall Study|Lost to Follow-up|1|||
33381725|NCT00779324|101283325|FG000|Overall Study|Withdrawal by Subject|4|||
33381726|NCT00779324|101283326|FG001|Overall Study|Withdrawal by Subject|2|||
33381727|NCT00779324|101283325|FG000|Overall Study|Missed visit|1|||
33381728|NCT00779324|101283326|FG001|Overall Study|Missed visit|1|||
33381729|NCT02565615|101283327|FG000|Overall Study|Death|0|||
33381730|NCT02565615|101283328|FG001|Overall Study|Death|1|||
33381731|NCT02565615|101283329|FG002|Overall Study|Death|0|||
33381732|NCT02565615|101283330|FG003|Overall Study|Death|0|||
33381733|NCT02565615|101283331|FG004|Overall Study|Death|4|||
33381734|NCT02565615|101283327|FG000|Overall Study|Not willing to participate in study|2|||
33381735|NCT02565615|101283328|FG001|Overall Study|Not willing to participate in study|21|||
33381736|NCT02565615|101283329|FG002|Overall Study|Not willing to participate in study|0|||
33381737|NCT02565615|101283330|FG003|Overall Study|Not willing to participate in study|1|||
33381738|NCT02565615|101283331|FG004|Overall Study|Not willing to participate in study|169|||
33381739|NCT02565615|101283327|FG000|Overall Study|Lost to Follow-up|0|||
33381740|NCT02565615|101283328|FG001|Overall Study|Lost to Follow-up|4|||
33381741|NCT02565615|101283329|FG002|Overall Study|Lost to Follow-up|0|||
33381742|NCT02565615|101283330|FG003|Overall Study|Lost to Follow-up|1|||
33381743|NCT02565615|101283331|FG004|Overall Study|Lost to Follow-up|765|||
33381744|NCT02565615|101283327|FG000|Overall Study|Not meeting eligibility criteria|0|||
33381745|NCT02565615|101283328|FG001|Overall Study|Not meeting eligibility criteria|7|||
33381746|NCT02565615|101283329|FG002|Overall Study|Not meeting eligibility criteria|0|||
33381747|NCT02565615|101283330|FG003|Overall Study|Not meeting eligibility criteria|0|||
33381748|NCT02565615|101283331|FG004|Overall Study|Not meeting eligibility criteria|25|||
33381749|NCT02565615|101283327|FG000|Overall Study|Reason not defined|0|||
33381750|NCT02565615|101283328|FG001|Overall Study|Reason not defined|2|||
33381751|NCT02565615|101283329|FG002|Overall Study|Reason not defined|0|||
33381752|NCT02565615|101283330|FG003|Overall Study|Reason not defined|1|||
33381753|NCT02565615|101283331|FG004|Overall Study|Reason not defined|62|||
33381754|NCT02565615|101283327|FG000|Overall Study|Adverse Event|1|||
33381755|NCT02565615|101283328|FG001|Overall Study|Adverse Event|1|||
33381756|NCT02565615|101283329|FG002|Overall Study|Adverse Event|0|||
33381757|NCT02565615|101283330|FG003|Overall Study|Adverse Event|0|||
33381758|NCT02565615|101283331|FG004|Overall Study|Adverse Event|9|||
33381759|NCT02565615|101283327|FG000|Overall Study|Untreated|0|||
33381760|NCT02565615|101283328|FG001|Overall Study|Untreated|0|||
33381761|NCT02565615|101283329|FG002|Overall Study|Untreated|0|||
33381762|NCT02565615|101283330|FG003|Overall Study|Untreated|0|||
33381763|NCT02565615|101283331|FG004|Overall Study|Untreated|567|||
33381764|NCT02616185|101283332|FG000|Overall Study|Death|0|||
33381765|NCT02616185|101283333|FG001|Overall Study|Death|0|||
33381766|NCT02616185|101283334|FG002|Overall Study|Death|0|||
33381767|NCT02616185|101283335|FG003|Overall Study|Death|1|||
33381768|NCT02616185|101283336|FG004|Overall Study|Death|2|||
33381769|NCT02616185|101283337|FG005|Overall Study|Death|0|||
33381770|NCT02616185|101283338|FG006|Overall Study|Death|0|||
33381771|NCT02616185|101283339|FG007|Overall Study|Death|2|||
33381772|NCT02616185|101283340|FG008|Overall Study|Death|1|||
33381773|NCT02616185|101283332|FG000|Overall Study|Study terminated by sponsor|0|||
33381774|NCT02616185|101283333|FG001|Overall Study|Study terminated by sponsor|0|||
33381775|NCT02616185|101283334|FG002|Overall Study|Study terminated by sponsor|1|||
33381776|NCT02616185|101283335|FG003|Overall Study|Study terminated by sponsor|0|||
33381777|NCT02616185|101283336|FG004|Overall Study|Study terminated by sponsor|0|||
33381778|NCT02616185|101283337|FG005|Overall Study|Study terminated by sponsor|0|||
33427899|NCT01381900|101457211|FG001|Overall Study|Withdrawal by Subject|0|||
33427900|NCT01381900|101457212|FG002|Overall Study|Withdrawal by Subject|1|||
33427901|NCT01381900|101457210|FG000|Overall Study|Early withdraw|3|||
33427902|NCT01381900|101457211|FG001|Overall Study|Early withdraw|1|||
33427903|NCT01381900|101457212|FG002|Overall Study|Early withdraw|1|||
33427904|NCT03549130|101457213|FG000|Overall Study|Adverse Event|0|||
33427905|NCT03549130|101457214|FG001|Overall Study|Adverse Event|1|||
33427906|NCT03549130|101457213|FG000|Overall Study|Lost to Follow-up|0|||
33427907|NCT03549130|101457214|FG001|Overall Study|Lost to Follow-up|1|||
33427908|NCT01590433|101457220|FG000|Overall Study|Lost to Follow-up|20|||
33427909|NCT01590433|101457221|FG001|Overall Study|Lost to Follow-up|8|||
33427910|NCT01590433|101457220|FG000|Overall Study|Withdrawal by Subject|21|||
33427911|NCT01590433|101457221|FG001|Overall Study|Withdrawal by Subject|11|||
33427912|NCT01590433|101457220|FG000|Overall Study|Adverse Event|11|||
33427913|NCT01590433|101457221|FG001|Overall Study|Adverse Event|3|||
33427914|NCT00618774|101457224|FG000|Overall Study|Adverse Event|5|||
33427915|NCT00618774|101457225|FG001|Overall Study|Adverse Event|3|||
33427916|NCT00618774|101457224|FG000|Overall Study|Withdrawal by Subject|1|||
33427917|NCT00618774|101457225|FG001|Overall Study|Withdrawal by Subject|0|||
33427918|NCT00910858|101457226|FG000|Pharmacokinetic Phase|Adverse Event|1|||
33427919|NCT00910858|101457227|FG001|Pharmacokinetic Phase|Adverse Event|0|||
33427920|NCT00910858|101457228|FG002|Pharmacokinetic Phase|Adverse Event|0|||
33427921|NCT00910858|101457226|FG000|Monotherapy Phase|Adverse Event|3|||
33427922|NCT00910858|101457227|FG001|Monotherapy Phase|Adverse Event|2|||
33149472|NCT04508140|100460748|FG000|Overall Study|progressive disease|9|||
33149473|NCT04508140|100460749|FG001|Overall Study|progressive disease|3|||
33149474|NCT03646643|100460750|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
33149475|NCT03646643|100460751|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
33149476|NCT03646643|100460750|FG000|Overall Study|Lost to Follow-up|0|||
33149477|NCT03646643|100460751|FG001|Overall Study|Lost to Follow-up|1|||
33149478|NCT00191646|100460752|FG000|Overall Study|Toxicity|26|||
33149479|NCT00191646|100460753|FG001|Overall Study|Toxicity|37|||
33149480|NCT00191646|100460752|FG000|Overall Study|Disease Progression|5|||
33149481|NCT00191646|100460753|FG001|Overall Study|Disease Progression|6|||
33381779|NCT02616185|101283338|FG006|Overall Study|Study terminated by sponsor|5|||
33381780|NCT02616185|101283339|FG007|Overall Study|Study terminated by sponsor|2|||
33381781|NCT02616185|101283340|FG008|Overall Study|Study terminated by sponsor|0|||
33381782|NCT02616185|101283332|FG000|Overall Study|Participant refused further follow-up|1|||
33381783|NCT02616185|101283333|FG001|Overall Study|Participant refused further follow-up|1|||
33381784|NCT02616185|101283334|FG002|Overall Study|Participant refused further follow-up|2|||
33381785|NCT02616185|101283335|FG003|Overall Study|Participant refused further follow-up|3|||
33381786|NCT02616185|101283336|FG004|Overall Study|Participant refused further follow-up|4|||
33381787|NCT02616185|101283337|FG005|Overall Study|Participant refused further follow-up|0|||
33381788|NCT02616185|101283338|FG006|Overall Study|Participant refused further follow-up|3|||
33381789|NCT02616185|101283339|FG007|Overall Study|Participant refused further follow-up|4|||
33381790|NCT02616185|101283340|FG008|Overall Study|Participant refused further follow-up|3|||
33381791|NCT02616185|101283332|FG000|Overall Study|Not reported|0|||
33381792|NCT02616185|101283333|FG001|Overall Study|Not reported|0|||
33381793|NCT02616185|101283334|FG002|Overall Study|Not reported|0|||
33381794|NCT02616185|101283335|FG003|Overall Study|Not reported|1|||
33381795|NCT02616185|101283336|FG004|Overall Study|Not reported|3|||
33381796|NCT02616185|101283337|FG005|Overall Study|Not reported|1|||
33381797|NCT02616185|101283338|FG006|Overall Study|Not reported|0|||
33381798|NCT02616185|101283339|FG007|Overall Study|Not reported|5|||
33381799|NCT02616185|101283340|FG008|Overall Study|Not reported|2|||
33381800|NCT01230749|101283341|FG000|Overall Study|Adverse Event|0|||
33381801|NCT01230749|101283342|FG001|Overall Study|Adverse Event|0|||
33381802|NCT01230749|101283343|FG002|Overall Study|Adverse Event|0|||
33381803|NCT01230749|101283344|FG003|Overall Study|Adverse Event|1|||
33381804|NCT01230749|101283341|FG000|Overall Study|Physician Decision|0|||
33381805|NCT01230749|101283342|FG001|Overall Study|Physician Decision|0|||
33381806|NCT01230749|101283343|FG002|Overall Study|Physician Decision|1|||
33381807|NCT01230749|101283344|FG003|Overall Study|Physician Decision|0|||
33381808|NCT01230749|101283341|FG000|Overall Study|Withdrawal by Subject|0|||
33381809|NCT01230749|101283342|FG001|Overall Study|Withdrawal by Subject|1|||
33381810|NCT01230749|101283343|FG002|Overall Study|Withdrawal by Subject|0|||
33381811|NCT01230749|101283344|FG003|Overall Study|Withdrawal by Subject|0|||
33381812|NCT01230749|101283341|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
33381813|NCT01230749|101283342|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
33381814|NCT01230749|101283343|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
33381815|NCT01230749|101283344|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
33427923|NCT00910858|101457228|FG002|Monotherapy Phase|Adverse Event|0|||
33427924|NCT00910858|101457226|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
33427925|NCT00910858|101457227|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
33427926|NCT00910858|101457228|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
33427927|NCT00910858|101457226|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
33427928|NCT00910858|101457227|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
33427929|NCT00910858|101457228|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
33427930|NCT00910858|101457226|FG000|Monotherapy Phase|Protocol Violation|1|||
33427931|NCT00910858|101457227|FG001|Monotherapy Phase|Protocol Violation|0|||
33427932|NCT00910858|101457228|FG002|Monotherapy Phase|Protocol Violation|0|||
33427933|NCT00910858|101457226|FG000|Monotherapy Phase|Other|3|||
33427934|NCT00910858|101457227|FG001|Monotherapy Phase|Other|4|||
33427935|NCT00910858|101457228|FG002|Monotherapy Phase|Other|2|||
33427936|NCT00910858|101457226|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
33647601|NCT00375609|102262776|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
33427937|NCT00910858|101457227|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
33427938|NCT00910858|101457228|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
33427939|NCT00910858|101457226|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
33427940|NCT00910858|101457227|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
33427941|NCT00910858|101457228|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
33427942|NCT00910858|101457226|FG000|Combined Treatment Phase|Protocol Violation|1|||
33427943|NCT00910858|101457227|FG001|Combined Treatment Phase|Protocol Violation|0|||
33427944|NCT00910858|101457228|FG002|Combined Treatment Phase|Protocol Violation|0|||
33427945|NCT00910858|101457226|FG000|Combined Treatment Phase|Other|0|||
33427946|NCT00910858|101457227|FG001|Combined Treatment Phase|Other|2|||
33427947|NCT00910858|101457228|FG002|Combined Treatment Phase|Other|1|||
33427948|NCT02266706|101457231|FG000|Overall Study|Withdrawal by Subject|0|||
33427949|NCT02266706|101457232|FG001|Overall Study|Withdrawal by Subject|1|||
33427950|NCT02266706|101457233|FG002|Overall Study|Withdrawal by Subject|1|||
33427951|NCT02266706|101457234|FG003|Overall Study|Withdrawal by Subject|0|||
33427952|NCT02266706|101457235|FG004|Overall Study|Withdrawal by Subject|0|||
33427953|NCT02266706|101457236|FG005|Overall Study|Withdrawal by Subject|1|||
33427954|NCT02266706|101457237|FG006|Overall Study|Withdrawal by Subject|0|||
33427955|NCT02266706|101457238|FG007|Overall Study|Withdrawal by Subject|0|||
33427956|NCT02266706|101457239|FG008|Overall Study|Withdrawal by Subject|0|||
33427957|NCT02266706|101457231|FG000|Overall Study|Screen failure|0|||
33427958|NCT02266706|101457232|FG001|Overall Study|Screen failure|0|||
33427959|NCT02266706|101457233|FG002|Overall Study|Screen failure|0|||
33427960|NCT02266706|101457234|FG003|Overall Study|Screen failure|0|||
33427961|NCT02266706|101457235|FG004|Overall Study|Screen failure|0|||
33427962|NCT02266706|101457236|FG005|Overall Study|Screen failure|1|||
33427963|NCT02266706|101457237|FG006|Overall Study|Screen failure|1|||
33427964|NCT02266706|101457238|FG007|Overall Study|Screen failure|0|||
33427965|NCT02266706|101457239|FG008|Overall Study|Screen failure|0|||
33427966|NCT02266706|101457231|FG000|Overall Study|Enrollment in another study|0|||
33427967|NCT02266706|101457232|FG001|Overall Study|Enrollment in another study|0|||
33427968|NCT02266706|101457233|FG002|Overall Study|Enrollment in another study|0|||
33427969|NCT02266706|101457234|FG003|Overall Study|Enrollment in another study|1|||
33427970|NCT02266706|101457235|FG004|Overall Study|Enrollment in another study|0|||
33427971|NCT02266706|101457236|FG005|Overall Study|Enrollment in another study|0|||
33587629|NCT03783442|102038597|FG000|Overall Study|Withdrawal by Subject|14|||
33587630|NCT03783442|102038598|FG001|Overall Study|Withdrawal by Subject|17|||
33587631|NCT03783442|102038597|FG000|Overall Study|Lost to Follow-up|2|||
33587632|NCT03783442|102038598|FG001|Overall Study|Lost to Follow-up|3|||
33587633|NCT00309985|102038599|FG000|Overall Study|Disease progression|12|||
33587634|NCT00309985|102038600|FG001|Overall Study|Disease progression|0|||
33587635|NCT00309985|102038599|FG000|Overall Study|Adverse Event|30|||
33587636|NCT00309985|102038600|FG001|Overall Study|Adverse Event|0|||
33587637|NCT00309985|102038599|FG000|Overall Study|Death|2|||
33587638|NCT00309985|102038600|FG001|Overall Study|Death|0|||
33587639|NCT00309985|102038599|FG000|Overall Study|Withdrawal by Subject|5|||
33587640|NCT00309985|102038600|FG001|Overall Study|Withdrawal by Subject|1|||
33587641|NCT00309985|102038599|FG000|Overall Study|Physician Decision|3|||
33587642|NCT00309985|102038600|FG001|Overall Study|Physician Decision|0|||
33587643|NCT00309985|102038599|FG000|Overall Study|Never started treatment|7|||
33587644|NCT00309985|102038600|FG001|Overall Study|Never started treatment|0|||
33587645|NCT00309985|102038599|FG000|Overall Study|Complicating disease|1|||
33587646|NCT00309985|102038600|FG001|Overall Study|Complicating disease|0|||
33587647|NCT00309985|102038599|FG000|Overall Study|Non-compliance|1|||
33587648|NCT00309985|102038600|FG001|Overall Study|Non-compliance|0|||
33587649|NCT00309985|102038599|FG000|Overall Study|Chemotherapy discontinued only|1|||
33427972|NCT02266706|101457237|FG006|Overall Study|Enrollment in another study|0|||
33427973|NCT02266706|101457238|FG007|Overall Study|Enrollment in another study|0|||
33427974|NCT02266706|101457239|FG008|Overall Study|Enrollment in another study|0|||
33587650|NCT00309985|102038600|FG001|Overall Study|Chemotherapy discontinued only|0|||
33647602|NCT00375609|102262777|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
33427975|NCT01851590|101457240|FG000|Overall Study|Withdrawal by Subject|0|||
33427976|NCT01851590|101457241|FG001|Overall Study|Withdrawal by Subject|0|||
33427977|NCT01851590|101457242|FG002|Overall Study|Withdrawal by Subject|1|||
33427978|NCT01851590|101457240|FG000|Overall Study|Adverse Event|0|||
33587651|NCT01814397|102038603|FG000|Overall Study|Adverse Event|7|||
33587652|NCT01814397|102038603|FG000|Overall Study|Withdrawal by Subject|7|||
33427979|NCT01851590|101457241|FG001|Overall Study|Adverse Event|0|||
33427980|NCT01851590|101457242|FG002|Overall Study|Adverse Event|2|||
33427981|NCT01851590|101457240|FG000|Overall Study|Lack of Efficacy|0|||
33427982|NCT01851590|101457241|FG001|Overall Study|Lack of Efficacy|1|||
33427983|NCT01851590|101457242|FG002|Overall Study|Lack of Efficacy|0|||
33427984|NCT00408876|101457244|FG000|Overall Study|Adverse Event|9|||
33427985|NCT00408876|101457245|FG001|Overall Study|Adverse Event|17|||
33427986|NCT00408876|101457246|FG002|Overall Study|Adverse Event|27|||
33427987|NCT00408876|101457247|FG003|Overall Study|Adverse Event|10|||
33427988|NCT00408876|101457244|FG000|Overall Study|Withdrawal by Subject|3|||
33427989|NCT00408876|101457245|FG001|Overall Study|Withdrawal by Subject|6|||
33427990|NCT00408876|101457246|FG002|Overall Study|Withdrawal by Subject|6|||
33427991|NCT00408876|101457247|FG003|Overall Study|Withdrawal by Subject|14|||
33427992|NCT00408876|101457244|FG000|Overall Study|Lack of Efficacy|2|||
33427993|NCT00408876|101457245|FG001|Overall Study|Lack of Efficacy|4|||
33427994|NCT00408876|101457246|FG002|Overall Study|Lack of Efficacy|5|||
33427995|NCT00408876|101457247|FG003|Overall Study|Lack of Efficacy|6|||
33427996|NCT00408876|101457244|FG000|Overall Study|Lost to Follow-up|1|||
33427997|NCT00408876|101457245|FG001|Overall Study|Lost to Follow-up|6|||
33427998|NCT00408876|101457246|FG002|Overall Study|Lost to Follow-up|5|||
33427999|NCT00408876|101457247|FG003|Overall Study|Lost to Follow-up|2|||
33428000|NCT00408876|101457244|FG000|Overall Study|Protocol Violation|0|||
33428001|NCT00408876|101457245|FG001|Overall Study|Protocol Violation|3|||
33428002|NCT00408876|101457246|FG002|Overall Study|Protocol Violation|4|||
33428003|NCT00408876|101457247|FG003|Overall Study|Protocol Violation|3|||
33428004|NCT00408876|101457244|FG000|Overall Study|Physician Decision|1|||
33428005|NCT00408876|101457245|FG001|Overall Study|Physician Decision|0|||
33428006|NCT00408876|101457246|FG002|Overall Study|Physician Decision|3|||
33428007|NCT00408876|101457247|FG003|Overall Study|Physician Decision|0|||
33428008|NCT02006147|101457259|FG000|Overall Study|Protocol Violation|1|||
33428009|NCT02006147|101457260|FG001|Overall Study|Protocol Violation|1|||
33428010|NCT02006147|101457261|FG002|Overall Study|Protocol Violation|0|||
33428011|NCT02006147|101457262|FG003|Overall Study|Protocol Violation|0|||
33428012|NCT02006147|101457259|FG000|Overall Study|Withdrawal by Subject|0|||
33428013|NCT02006147|101457260|FG001|Overall Study|Withdrawal by Subject|1|||
33428014|NCT02006147|101457261|FG002|Overall Study|Withdrawal by Subject|0|||
33428015|NCT02006147|101457262|FG003|Overall Study|Withdrawal by Subject|0|||
33428016|NCT02006147|101457259|FG000|Overall Study|Withdrawal by Sponsor|1|||
33428017|NCT02006147|101457260|FG001|Overall Study|Withdrawal by Sponsor|0|||
33428018|NCT02006147|101457261|FG002|Overall Study|Withdrawal by Sponsor|0|||
33428019|NCT02006147|101457262|FG003|Overall Study|Withdrawal by Sponsor|0|||
33428020|NCT01238822|101457263|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
33428021|NCT01023269|101457270|FG000|Overall Study|early termination of the study|2|||
33587653|NCT03629223|102038604|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
33149482|NCT00191646|100460752|FG000|Overall Study|Physician Decision|20|||
33149483|NCT00191646|100460753|FG001|Overall Study|Physician Decision|11|||
33381816|NCT00617656|101283345|FG000|Overall Study|Inclusion error|4|||
33381817|NCT00617656|101283346|FG001|Overall Study|Inclusion error|4|||
33381818|NCT00617656|101283347|FG002|Overall Study|Inclusion error|0|||
33381819|NCT00617656|101283348|FG003|Overall Study|Inclusion error|0|||
33381820|NCT00617656|101283345|FG000|Overall Study|Missing data|44|||
33381821|NCT00617656|101283346|FG001|Overall Study|Missing data|30|||
33381822|NCT00617656|101283347|FG002|Overall Study|Missing data|13|||
33381823|NCT00617656|101283348|FG003|Overall Study|Missing data|6|||
33381824|NCT00617656|101283345|FG000|Overall Study|Withdrawal by Subject|0|||
33381825|NCT00617656|101283346|FG001|Overall Study|Withdrawal by Subject|2|||
33381826|NCT00617656|101283347|FG002|Overall Study|Withdrawal by Subject|0|||
33381827|NCT00617656|101283348|FG003|Overall Study|Withdrawal by Subject|0|||
33381828|NCT00493974|101283349|FG000|Overall Study|Death|1|||
33381829|NCT00493974|101283350|FG001|Overall Study|Death|2|||
33381830|NCT00493974|101283349|FG000|Overall Study|Withdrawal by Subject|8|||
33381831|NCT00493974|101283350|FG001|Overall Study|Withdrawal by Subject|6|||
33381832|NCT00493974|101283349|FG000|Overall Study|Lost to Follow-up|4|||
33381833|NCT00493974|101283350|FG001|Overall Study|Lost to Follow-up|6|||
33381834|NCT00971425|101283351|FG000|Overall Study|Adverse Event|1|||
33381835|NCT00971425|101283352|FG001|Overall Study|Adverse Event|1|||
33381836|NCT00971425|101283351|FG000|Overall Study|Withdrawal by Subject|0|||
33381837|NCT00971425|101283352|FG001|Overall Study|Withdrawal by Subject|1|||
33381838|NCT00593840|101283353|FG000|Overall Study|Withdrawal by Subject|1|||
33381839|NCT00003476|101283356|FG000|Overall Study|Not evaluable|1|||
33381840|NCT00642018|101283373|FG000|Overall Study|Adverse Event|11|||
33381841|NCT00642018|101283374|FG001|Overall Study|Adverse Event|36|||
33381842|NCT00642018|101283373|FG000|Overall Study|Withdrawal by Subject|4|||
33381843|NCT00642018|101283374|FG001|Overall Study|Withdrawal by Subject|10|||
33381844|NCT00642018|101283373|FG000|Overall Study|Progressive Disease|13|||
33381845|NCT00642018|101283374|FG001|Overall Study|Progressive Disease|18|||
33428022|NCT01023269|101457271|FG001|Overall Study|early termination of the study|0|||
33428023|NCT00979628|101457272|FG000|Overall Study|received regimen < 24 hours|7|||
33381846|NCT00642018|101283373|FG000|Overall Study|Physician Decision|0|||
33428024|NCT00979628|101457273|FG001|Overall Study|received regimen < 24 hours|6|||
33428025|NCT00979628|101457274|FG002|Overall Study|received regimen < 24 hours|5|||
33428026|NCT00979628|101457272|FG000|Overall Study|received steroids|1|||
33428027|NCT00979628|101457273|FG001|Overall Study|received steroids|1|||
33381847|NCT00642018|101283374|FG001|Overall Study|Physician Decision|10|||
33381848|NCT00642018|101283373|FG000|Overall Study|Protocol Violation|0|||
33381849|NCT00642018|101283374|FG001|Overall Study|Protocol Violation|1|||
33381850|NCT00642018|101283373|FG000|Overall Study|Death|0|||
33381851|NCT00642018|101283374|FG001|Overall Study|Death|3|||
33381852|NCT00642018|101283373|FG000|Overall Study|Entry Criteria Not Met|0|||
33381853|NCT00642018|101283374|FG001|Overall Study|Entry Criteria Not Met|1|||
33381854|NCT04682353|101283375|FG000|Overall Study|Lost to Follow-up|0|||
33381855|NCT04682353|101283376|FG001|Overall Study|Lost to Follow-up|1|||
33381856|NCT04682353|101283377|FG002|Overall Study|Lost to Follow-up|0|||
33381857|NCT04682353|101283378|FG003|Overall Study|Lost to Follow-up|1|||
33381858|NCT04682353|101283375|FG000|Overall Study|Personal reasons|0|||
33381859|NCT04682353|101283376|FG001|Overall Study|Personal reasons|1|||
33381860|NCT04682353|101283377|FG002|Overall Study|Personal reasons|0|||
33381861|NCT04682353|101283378|FG003|Overall Study|Personal reasons|0|||
33381862|NCT01117012|101283379|FG000|Overall Study|Adverse Event|0|||
33381863|NCT01117012|101283380|FG001|Overall Study|Adverse Event|1|||
33381864|NCT01117012|101283379|FG000|Overall Study|Death|1|||
33381865|NCT01117012|101283380|FG001|Overall Study|Death|1|||
33381866|NCT01117012|101283379|FG000|Overall Study|Withdrawal by Subject|3|||
33381867|NCT01117012|101283380|FG001|Overall Study|Withdrawal by Subject|0|||
33381868|NCT01117012|101283379|FG000|Overall Study|Undefined|4|||
33381869|NCT01117012|101283380|FG001|Overall Study|Undefined|3|||
33381870|NCT00418379|101283381|FG000|Year 1|Adverse Event|9|||
33381871|NCT00418379|101283382|FG001|Year 1|Adverse Event|15|||
33381872|NCT00418379|101283383|FG002|Year 1|Adverse Event|3|||
33381873|NCT00418379|101283381|FG000|Year 1|Withdrawal by Subject|7|||
33381874|NCT00418379|101283382|FG001|Year 1|Withdrawal by Subject|8|||
33381875|NCT00418379|101283383|FG002|Year 1|Withdrawal by Subject|5|||
33381876|NCT00418379|101283381|FG000|Year 1|Any other reason not above-mentioned|2|||
33381877|NCT00418379|101283382|FG001|Year 1|Any other reason not above-mentioned|5|||
33381878|NCT00418379|101283383|FG002|Year 1|Any other reason not above-mentioned|7|||
33381879|NCT00418379|101283381|FG000|Year 2|Adverse Event|5|||
33381880|NCT00418379|101283382|FG001|Year 2|Adverse Event|2|||
33381881|NCT00418379|101283383|FG002|Year 2|Adverse Event|1|||
33381882|NCT00418379|101283381|FG000|Year 2|Withdrawal by Subject|1|||
33381883|NCT00418379|101283382|FG001|Year 2|Withdrawal by Subject|1|||
33381884|NCT00418379|101283383|FG002|Year 2|Withdrawal by Subject|3|||
33381885|NCT00418379|101283381|FG000|Year 2|Any other reason not above-mentioned|2|||
33381886|NCT00418379|101283382|FG001|Year 2|Any other reason not above-mentioned|1|||
33381887|NCT00418379|101283383|FG002|Year 2|Any other reason not above-mentioned|6|||
33381888|NCT00418379|101283381|FG000|Year 3|Withdrawal by Subject|1|||
33381889|NCT00418379|101283382|FG001|Year 3|Withdrawal by Subject|1|||
33381890|NCT00418379|101283383|FG002|Year 3|Withdrawal by Subject|2|||
33381891|NCT00418379|101283381|FG000|Year 3|Any other reason not above-mentioned|2|||
33381892|NCT00418379|101283382|FG001|Year 3|Any other reason not above-mentioned|1|||
33381893|NCT00418379|101283383|FG002|Year 3|Any other reason not above-mentioned|1|||
33381894|NCT00418379|101283381|FG000|Year 4|Adverse Event|0|||
33381895|NCT00418379|101283382|FG001|Year 4|Adverse Event|1|||
33381896|NCT00418379|101283383|FG002|Year 4|Adverse Event|0|||
33381897|NCT00418379|101283381|FG000|Year 4|Withdrawal by Subject|2|||
33381898|NCT00418379|101283382|FG001|Year 4|Withdrawal by Subject|3|||
33381899|NCT00418379|101283383|FG002|Year 4|Withdrawal by Subject|2|||
33381900|NCT00418379|101283381|FG000|Year 4|Any other reason not above-mentioned|1|||
33381901|NCT00418379|101283382|FG001|Year 4|Any other reason not above-mentioned|1|||
33381902|NCT00418379|101283383|FG002|Year 4|Any other reason not above-mentioned|0|||
33428028|NCT00979628|101457274|FG002|Overall Study|received steroids|0|||
33428029|NCT00979628|101457272|FG000|Overall Study|transferred to ICU|1|||
33381903|NCT00418379|101283381|FG000|Year 5|Adverse Event|0|||
33381904|NCT00418379|101283382|FG001|Year 5|Adverse Event|1|||
33381905|NCT00418379|101283383|FG002|Year 5|Adverse Event|0|||
33428030|NCT00979628|101457273|FG001|Overall Study|transferred to ICU|2|||
33428031|NCT00979628|101457274|FG002|Overall Study|transferred to ICU|1|||
33428032|NCT00549198|101457275|FG000|Overall Study|Adverse Event|28|||
33428033|NCT00549198|101457276|FG001|Overall Study|Adverse Event|26|||
33428034|NCT00549198|101457275|FG000|Overall Study|Insufficient Viral Load Response|4|||
33381906|NCT00418379|101283381|FG000|Year 5|Any other reason not above-mentioned|2|||
33381907|NCT00418379|101283382|FG001|Year 5|Any other reason not above-mentioned|4|||
33381908|NCT00418379|101283383|FG002|Year 5|Any other reason not above-mentioned|3|||
33381909|NCT00377429|101283384|FG000|Overall Study|Withdrawal by Subject|5|||
33381910|NCT00377429|101283384|FG000|Overall Study|Adverse Event|8|||
33381911|NCT00377429|101283384|FG000|Overall Study|Physician Decision|1|||
33381912|NCT00377429|101283384|FG000|Overall Study|Patient non-compliance|1|||
33381913|NCT00475540|101283387|FG000|36 Months|Lost to Follow-up|4|||
33381914|NCT00475540|101283388|FG001|36 Months|Lost to Follow-up|4|||
33381915|NCT00475540|101283387|FG000|36 Months|Death|1|||
33381916|NCT00475540|101283388|FG001|36 Months|Death|2|||
33381917|NCT00475540|101283387|FG000|36 Months|Censored due to reoperation|3|||
33381918|NCT00475540|101283388|FG001|36 Months|Censored due to reoperation|0|||
33381919|NCT00631540|101283390|FG000|Overall Study|Withdrawal by Subject|5|||
33381920|NCT00631540|101283390|FG000|Overall Study|Death|4|||
33381921|NCT00631540|101283390|FG000|Overall Study|Lost to Follow-up|2|||
33381922|NCT00631540|101283390|FG000|Overall Study|Core Lab Data Unavailable|3|||
33381923|NCT03726333|101283395|FG000|Overall Study|Progressive Disease|0|||
33381924|NCT03726333|101283396|FG001|Overall Study|Progressive Disease|0|||
33381925|NCT03726333|101283397|FG002|Overall Study|Progressive Disease|1|||
33381926|NCT03726333|101283398|FG003|Overall Study|Progressive Disease|0|||
33381927|NCT03726333|101283399|FG004|Overall Study|Progressive Disease|0|||
33381928|NCT01654523|101283400|FG000|Overall Study|Withdrawal by Subject|1|||
33381929|NCT02007954|101283401|FG000|Overall Study|Received liver transplant|3|||
33381930|NCT02007954|101283401|FG000|Overall Study|Switch in treatment modality|2|||
33381931|NCT02007954|101283401|FG000|Overall Study|Disease progression and unrelated AE|1|||
33381932|NCT02007954|101283401|FG000|Overall Study|Death|1|||
33381933|NCT00304915|101283402|FG000|Overall Study|Lost to Follow-up|11|||
33381934|NCT00304915|101283403|FG001|Overall Study|Lost to Follow-up|11|||
33381935|NCT00304915|101283402|FG000|Overall Study|Death|4|||
33381936|NCT00304915|101283403|FG001|Overall Study|Death|5|||
33381937|NCT00304915|101283402|FG000|Overall Study|Withdrawal by Subject|3|||
33381938|NCT00304915|101283403|FG001|Overall Study|Withdrawal by Subject|0|||
33381939|NCT00862121|101283405|FG000|Overall Study|Adverse Event|1|||
33381940|NCT00862121|101283406|FG001|Overall Study|Adverse Event|2|||
33381941|NCT00862121|101283405|FG000|Overall Study|Lack of Efficacy|0|||
33381942|NCT00862121|101283406|FG001|Overall Study|Lack of Efficacy|3|||
33381943|NCT00862121|101283405|FG000|Overall Study|Protocol Violation|0|||
33381944|NCT00862121|101283406|FG001|Overall Study|Protocol Violation|1|||
33381945|NCT00862121|101283405|FG000|Overall Study|Exclusion criterion violation|0|||
33381946|NCT00862121|101283406|FG001|Overall Study|Exclusion criterion violation|1|||
33381947|NCT00862121|101283405|FG000|Overall Study|Incorrect randomisation|0|||
33381948|NCT00862121|101283406|FG001|Overall Study|Incorrect randomisation|1|||
33381949|NCT00120289|101283407|FG000|Overall Study|Death|96|||
33381950|NCT00120289|101283408|FG001|Overall Study|Death|82|||
33381951|NCT00120289|101283407|FG000|Overall Study|Lost to Follow-up|11|||
33381952|NCT00120289|101283408|FG001|Overall Study|Lost to Follow-up|14|||
33381953|NCT00120289|101283407|FG000|Overall Study|Withdrawal by Subject|14|||
33381954|NCT00120289|101283408|FG001|Overall Study|Withdrawal by Subject|13|||
33381955|NCT00839423|101283409|FG000|Overall Study|Adverse Event|4|||
33381956|NCT00839423|101283410|FG001|Overall Study|Adverse Event|3|||
33381957|NCT00839423|101283411|FG002|Overall Study|Adverse Event|7|||
33381958|NCT00839423|101283412|FG003|Overall Study|Adverse Event|16|||
33381959|NCT00839423|101283409|FG000|Overall Study|Lack of Efficacy|6|||
33381960|NCT00839423|101283410|FG001|Overall Study|Lack of Efficacy|6|||
33381961|NCT00839423|101283411|FG002|Overall Study|Lack of Efficacy|3|||
33381962|NCT00839423|101283412|FG003|Overall Study|Lack of Efficacy|2|||
33381963|NCT00839423|101283409|FG000|Overall Study|Non-compliance|0|||
33381964|NCT00839423|101283410|FG001|Overall Study|Non-compliance|0|||
33381965|NCT00839423|101283411|FG002|Overall Study|Non-compliance|0|||
33381966|NCT00839423|101283412|FG003|Overall Study|Non-compliance|1|||
33381967|NCT00839423|101283409|FG000|Overall Study|Protocol Violation|0|||
33381968|NCT00839423|101283410|FG001|Overall Study|Protocol Violation|1|||
33381969|NCT00839423|101283411|FG002|Overall Study|Protocol Violation|2|||
33381970|NCT00839423|101283412|FG003|Overall Study|Protocol Violation|0|||
33381971|NCT00839423|101283409|FG000|Overall Study|Withdrawal of consent|4|||
33381972|NCT00839423|101283410|FG001|Overall Study|Withdrawal of consent|0|||
33381973|NCT00839423|101283411|FG002|Overall Study|Withdrawal of consent|4|||
33587654|NCT03629223|102038605|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
33587655|NCT03629223|102038606|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
33381974|NCT00839423|101283412|FG003|Overall Study|Withdrawal of consent|1|||
33381975|NCT00839423|101283409|FG000|Overall Study|Lost to Follow-up|1|||
33428035|NCT00549198|101457276|FG001|Overall Study|Insufficient Viral Load Response|2|||
33428036|NCT00549198|101457275|FG000|Overall Study|Protocol-defined Virological Failure|7|||
33428037|NCT00549198|101457276|FG001|Overall Study|Protocol-defined Virological Failure|0|||
33428038|NCT00549198|101457275|FG000|Overall Study|Non-compliance|2|||
33381976|NCT00839423|101283410|FG001|Overall Study|Lost to Follow-up|0|||
33381977|NCT00839423|101283411|FG002|Overall Study|Lost to Follow-up|1|||
33381978|NCT00839423|101283412|FG003|Overall Study|Lost to Follow-up|0|||
33381979|NCT00839423|101283409|FG000|Overall Study|Administrative or other reasons|3|||
33587656|NCT03629223|102038607|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
33381980|NCT00839423|101283410|FG001|Overall Study|Administrative or other reasons|0|||
33381981|NCT00839423|101283411|FG002|Overall Study|Administrative or other reasons|1|||
33381982|NCT00839423|101283412|FG003|Overall Study|Administrative or other reasons|0|||
33381983|NCT00270998|101283414|FG000|3 Month Follow-up|Adverse Event|1|||
33381984|NCT00270998|101283415|FG001|3 Month Follow-up|Adverse Event|0|||
33381985|NCT00270998|101283416|FG002|3 Month Follow-up|Adverse Event|0|||
33428039|NCT00549198|101457276|FG001|Overall Study|Non-compliance|4|||
33428040|NCT00549198|101457275|FG000|Overall Study|Lost to Follow-up|7|||
33428041|NCT00549198|101457276|FG001|Overall Study|Lost to Follow-up|8|||
33428042|NCT00549198|101457275|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
33428043|NCT00549198|101457276|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
33428044|NCT00549198|101457275|FG000|Overall Study|Protocol Violation|7|||
33428045|NCT00549198|101457276|FG001|Overall Study|Protocol Violation|2|||
33428046|NCT00549198|101457275|FG000|Overall Study|Investigator Decision|4|||
33428047|NCT00549198|101457276|FG001|Overall Study|Investigator Decision|3|||
33428048|NCT00549198|101457275|FG000|Overall Study|Withdrawal by Subject|7|||
33428049|NCT00549198|101457276|FG001|Overall Study|Withdrawal by Subject|7|||
33428050|NCT00549198|101457275|FG000|Overall Study|Disease Progression|1|||
33428051|NCT00549198|101457276|FG001|Overall Study|Disease Progression|0|||
33428052|NCT00549198|101457275|FG000|Overall Study|Participant Moved|2|||
33428053|NCT00549198|101457276|FG001|Overall Study|Participant Moved|0|||
33428054|NCT00549198|101457275|FG000|Overall Study|Participant not able to perform Week 96|1|||
33428055|NCT00549198|101457276|FG001|Overall Study|Participant not able to perform Week 96|0|||
33428056|NCT00549198|101457275|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
33428057|NCT00549198|101457276|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
33428058|NCT00549198|101457275|FG000|Overall Study|Prohibited Medication|1|||
33647603|NCT00470834|102262781|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
33647604|NCT00470834|102262782|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
33647605|NCT00470834|102262781|FG000|Treatment Period (18 Months)|Adverse Event|7|||
33647606|NCT00470834|102262782|FG001|Treatment Period (18 Months)|Adverse Event|6|||
33647607|NCT00470834|102262781|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
33647608|NCT00470834|102262782|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
33647609|NCT00470834|102262781|FG000|Treatment Period (18 Months)|Physician Decision|4|||
33647610|NCT00470834|102262782|FG001|Treatment Period (18 Months)|Physician Decision|4|||
33647611|NCT00470834|102262781|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
33647612|NCT00470834|102262782|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
33647613|NCT00470834|102262781|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
33647614|NCT00470834|102262782|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
33647615|NCT00470834|102262781|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
33647616|NCT00470834|102262782|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
33647617|NCT00470834|102262781|FG000|Treatment Period (18 Months)|Non-compliance|1|||
33647618|NCT00470834|102262782|FG001|Treatment Period (18 Months)|Non-compliance|0|||
33647619|NCT00470834|102262781|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
33647620|NCT00470834|102262782|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
33647621|NCT00470834|102262781|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
33647622|NCT00470834|102262782|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
33647623|NCT00470834|102262781|FG000|Extension Period (24 Months)|Adverse Event|3|||
33647624|NCT00470834|102262782|FG001|Extension Period (24 Months)|Adverse Event|4|||
33647625|NCT00470834|102262781|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
33647626|NCT00470834|102262782|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
33647627|NCT00470834|102262781|FG000|Extension Period (24 Months)|Physician Decision|4|||
33248487|NCT01090024|100810206|FG001|Period 1|Withdrawal by Subject|0|||
33248488|NCT01090024|100810207|FG002|Period 1|Withdrawal by Subject|0|||
33248489|NCT01090024|100810208|FG003|Period 1|Withdrawal by Subject|1|||
33248490|NCT01090024|100810209|FG004|Period 1|Withdrawal by Subject|0|||
33248491|NCT01090024|100810210|FG005|Period 1|Withdrawal by Subject|0|||
33248492|NCT01090024|100810211|FG006|Period 1|Withdrawal by Subject|0|||
33248493|NCT01090024|100810212|FG007|Period 1|Withdrawal by Subject|0|||
33248494|NCT01090024|100810213|FG008|Period 1|Withdrawal by Subject|0|||
33248495|NCT01090024|100810214|FG009|Period 1|Withdrawal by Subject|0|||
33248496|NCT01090024|100810215|FG010|Period 1|Withdrawal by Subject|0|||
33248497|NCT01090024|100810216|FG011|Period 1|Withdrawal by Subject|0|||
33248498|NCT01090024|100810217|FG012|Period 1|Withdrawal by Subject|0|||
33248499|NCT01090024|100810218|FG013|Period 1|Withdrawal by Subject|0|||
33248500|NCT01090024|100810219|FG014|Period 1|Withdrawal by Subject|0|||
33248501|NCT01090024|100810220|FG015|Period 1|Withdrawal by Subject|0|||
33248502|NCT01090024|100810221|FG016|Period 1|Withdrawal by Subject|0|||
33248503|NCT01090024|100810222|FG017|Period 1|Withdrawal by Subject|0|||
33248504|NCT01090024|100810205|FG000|Period 1|Lost to Follow-up|0|||
33428059|NCT00549198|101457276|FG001|Overall Study|Prohibited Medication|2|||
33647628|NCT00470834|102262782|FG001|Extension Period (24 Months)|Physician Decision|3|||
33647629|NCT00470834|102262781|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
33647630|NCT00470834|102262782|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
33428060|NCT00549198|101457275|FG000|Overall Study|Participant planning pregnancy|1|||
33428061|NCT00549198|101457276|FG001|Overall Study|Participant planning pregnancy|0|||
33248505|NCT01090024|100810206|FG001|Period 1|Lost to Follow-up|1|||
33248506|NCT01090024|100810207|FG002|Period 1|Lost to Follow-up|0|||
33248507|NCT01090024|100810208|FG003|Period 1|Lost to Follow-up|0|||
33248508|NCT01090024|100810209|FG004|Period 1|Lost to Follow-up|0|||
33647631|NCT00470834|102262781|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
33647632|NCT00470834|102262782|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
33647633|NCT00470834|102262781|FG000|Extension Period (24 Months)|Non-compliance|0|||
33647634|NCT00470834|102262782|FG001|Extension Period (24 Months)|Non-compliance|1|||
33647635|NCT00470834|102262781|FG000|Extension Period (24 Months)|Disease Progression|0|||
33647636|NCT00470834|102262782|FG001|Extension Period (24 Months)|Disease Progression|1|||
33647637|NCT04050202|102262785|FG000|Overall Study|Lost to Follow-up|2|||
33647638|NCT00388583|102262786|FG000|Overall Study|Protocol Violation|1|||
33647639|NCT00388583|102262787|FG001|Overall Study|Protocol Violation|0|||
33647640|NCT00388583|102262786|FG000|Overall Study|Withdrawal by Subject|3|||
33428062|NCT00549198|101457275|FG000|Overall Study|Participant overweight, no scan possible|1|||
33428063|NCT00549198|101457276|FG001|Overall Study|Participant overweight, no scan possible|0|||
33428064|NCT00549198|101457275|FG000|Overall Study|No scan facilities|0|||
33428065|NCT00549198|101457276|FG001|Overall Study|No scan facilities|2|||
33428066|NCT00549198|101457275|FG000|Overall Study|Pregnancy|0|||
33428067|NCT00549198|101457276|FG001|Overall Study|Pregnancy|3|||
33428068|NCT00549198|101457275|FG000|Overall Study|Not Exposed to Study Drug|3|||
33428069|NCT00549198|101457276|FG001|Overall Study|Not Exposed to Study Drug|4|||
33428070|NCT02139306|101457277|FG000|Overall Study|Withdrawal by Subject|4|||
33428071|NCT02139306|101457278|FG001|Overall Study|Withdrawal by Subject|6|||
33428072|NCT02139306|101457277|FG000|Overall Study|Adverse Event|3|||
33428073|NCT02139306|101457278|FG001|Overall Study|Adverse Event|4|||
33428074|NCT02139306|101457277|FG000|Overall Study|Physician Decision|0|||
33428075|NCT02139306|101457278|FG001|Overall Study|Physician Decision|1|||
33428076|NCT02139306|101457277|FG000|Overall Study|Other Unspecified|2|||
33428077|NCT02139306|101457278|FG001|Overall Study|Other Unspecified|3|||
33428078|NCT02139306|101457277|FG000|Overall Study|Protocol Violation|4|||
33428079|NCT02139306|101457278|FG001|Overall Study|Protocol Violation|0|||
33428080|NCT01314703|101457287|FG000|Overall Study|screen failure and closed enrollment|8|||
33428081|NCT01907087|101457292|FG000|Overall Study|Withdrawal by Subject|1|||
33587657|NCT03629223|102038608|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
33587658|NCT03629223|102038609|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
33587659|NCT03629223|102038604|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
33587660|NCT03629223|102038605|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
33587661|NCT03629223|102038606|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
33587662|NCT03629223|102038607|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
33587663|NCT03629223|102038608|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
33587664|NCT03629223|102038609|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
33587665|NCT03629223|102038604|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
33587666|NCT03629223|102038605|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
33587667|NCT03629223|102038606|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
33587668|NCT03629223|102038607|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
33587669|NCT03629223|102038608|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
33587670|NCT03629223|102038609|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
33587671|NCT03629223|102038604|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
33587672|NCT03629223|102038605|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
33587673|NCT03629223|102038606|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
33587674|NCT03629223|102038607|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
33587675|NCT03629223|102038608|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
33587676|NCT03629223|102038609|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
33587677|NCT03629223|102038604|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
33587678|NCT03629223|102038605|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
33587679|NCT03629223|102038606|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
33587680|NCT03629223|102038607|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
33587681|NCT03629223|102038608|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
33587682|NCT03629223|102038609|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
33587683|NCT00564733|102038616|FG000|Overall Study|Withdrawal by Subject|4|||
33587684|NCT00564733|102038616|FG000|Overall Study|Ineligible|5|||
33587685|NCT03530995|102038617|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
33587686|NCT03530995|102038618|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
33647641|NCT00388583|102262787|FG001|Overall Study|Withdrawal by Subject|3|||
33647642|NCT00388583|102262786|FG000|Overall Study|Serious Adverse Event|2|||
33647643|NCT00388583|102262787|FG001|Overall Study|Serious Adverse Event|0|||
33647644|NCT00388583|102262786|FG000|Overall Study|Did not receive vaccine|0|||
33647645|NCT00388583|102262787|FG001|Overall Study|Did not receive vaccine|1|||
33647646|NCT02654717|102262788|FG000|Overall Study|Adverse Event|2|||
33647647|NCT02654717|102262789|FG001|Overall Study|Adverse Event|2|||
33248509|NCT01090024|100810210|FG005|Period 1|Lost to Follow-up|0|||
33428082|NCT01859390|101457293|FG000|Overall Study|Insufficient Sputum Collected|1|||
33428083|NCT01859390|101457294|FG001|Overall Study|Insufficient Sputum Collected|3|||
33587687|NCT03530995|102038617|FG000|Part 1 Period 3|Protocol Violation|1|||
33587688|NCT03530995|102038618|FG001|Part 1 Period 3|Protocol Violation|0|||
33647648|NCT02654717|102262788|FG000|Overall Study|Protocol Violation|1|||
33428084|NCT01859390|101457293|FG000|Overall Study|Sample Missing Collection Date|0|||
33428085|NCT01859390|101457294|FG001|Overall Study|Sample Missing Collection Date|1|||
33428086|NCT01859390|101457293|FG000|Overall Study|Tube Cracked|0|||
33428087|NCT01859390|101457294|FG001|Overall Study|Tube Cracked|2|||
33428088|NCT01859390|101457293|FG000|Overall Study|Shipment Error|0|||
33428089|NCT01859390|101457294|FG001|Overall Study|Shipment Error|1|||
33428090|NCT02533999|101457301|FG000|Overall Study|Lost to Follow-up|3|||
33428091|NCT02533999|101457302|FG001|Overall Study|Lost to Follow-up|5|||
33428092|NCT02533999|101457301|FG000|Overall Study|Protocol Violation|3|||
33428093|NCT02533999|101457302|FG001|Overall Study|Protocol Violation|0|||
33428094|NCT02533999|101457301|FG000|Overall Study|Adverse Event|0|||
33428095|NCT02533999|101457302|FG001|Overall Study|Adverse Event|1|||
33428096|NCT02533999|101457301|FG000|Overall Study|Randomized but intervention not received|0|||
33428097|NCT02533999|101457302|FG001|Overall Study|Randomized but intervention not received|1|||
33428098|NCT01084005|101459897|FG000|Overall Study|Adverse Event|1|||
33428099|NCT01084005|101459898|FG001|Overall Study|Adverse Event|8|||
33428100|NCT01084005|101459897|FG000|Overall Study|Protocol Violation|3|||
33428101|NCT01084005|101459898|FG001|Overall Study|Protocol Violation|7|||
33428102|NCT01084005|101459897|FG000|Overall Study|Withdrawal by Subject|1|||
33428103|NCT01084005|101459898|FG001|Overall Study|Withdrawal by Subject|1|||
33428104|NCT00463866|101459901|FG000|Overall Study|Adverse Event|70|||
33428105|NCT00463866|101459902|FG001|Overall Study|Adverse Event|93|||
33428106|NCT00463866|101459901|FG000|Overall Study|Withdrawal by Subject|81|||
33428107|NCT00463866|101459902|FG001|Overall Study|Withdrawal by Subject|79|||
33428108|NCT00463866|101459901|FG000|Overall Study|Lost to Follow-up|46|||
33381986|NCT00270998|101283414|FG000|3 Month Follow-up|Lack of Efficacy|1|||
33381987|NCT00270998|101283415|FG001|3 Month Follow-up|Lack of Efficacy|2|||
33381988|NCT00270998|101283416|FG002|3 Month Follow-up|Lack of Efficacy|1|||
33381989|NCT00270998|101283414|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
33381990|NCT00270998|101283415|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
33381991|NCT00270998|101283416|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
33381992|NCT00270998|101283414|FG000|3 Month Follow-up|Pessary did not fit|12|||
33428109|NCT00463866|101459902|FG001|Overall Study|Lost to Follow-up|55|||
33428110|NCT00463866|101459901|FG000|Overall Study|Incorrect Enrolment|64|||
33428111|NCT00463866|101459902|FG001|Overall Study|Incorrect Enrolment|66|||
33428112|NCT00463866|101459901|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
33428113|NCT00463866|101459902|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
33428114|NCT00463866|101459901|FG000|Overall Study|Safety Reason|1|||
33428115|NCT00463866|101459902|FG001|Overall Study|Safety Reason|3|||
33428116|NCT00463866|101459901|FG000|Overall Study|Mis-Randomization of subject|0|||
33428117|NCT00463866|101459902|FG001|Overall Study|Mis-Randomization of subject|1|||
33428118|NCT00463866|101459901|FG000|Overall Study|Other|22|||
33428119|NCT00463866|101459902|FG001|Overall Study|Other|22|||
33428120|NCT01620489|101459904|FG000|Overall Study|Adverse Event|17|||
33428121|NCT01620489|101459905|FG001|Overall Study|Adverse Event|4|||
33428122|NCT01620489|101459904|FG000|Overall Study|Protocol Violation|0|||
33428123|NCT01620489|101459905|FG001|Overall Study|Protocol Violation|3|||
33428124|NCT01620489|101459904|FG000|Overall Study|Withdrawal Criteria|17|||
33428125|NCT01620489|101459905|FG001|Overall Study|Withdrawal Criteria|25|||
33428126|NCT01620489|101459904|FG000|Overall Study|Unclassified|1|||
33428127|NCT01620489|101459905|FG001|Overall Study|Unclassified|2|||
33428128|NCT02143947|101459910|FG000|Overall Study|Lost to Follow-up|4|||
33428129|NCT02143947|101459911|FG001|Overall Study|Lost to Follow-up|2|||
33428130|NCT02970669|101459912|FG000|Double-blind Period|Adverse Event|4|||
33428131|NCT02970669|101459913|FG001|Double-blind Period|Adverse Event|0|||
33428132|NCT02970669|101459912|FG000|Double-blind Period|Death|1|||
33428133|NCT02970669|101459913|FG001|Double-blind Period|Death|0|||
33428134|NCT02970669|101459912|FG000|Double-blind Period|Study terminated by sponsor|1|||
33428135|NCT02970669|101459913|FG001|Double-blind Period|Study terminated by sponsor|2|||
33428136|NCT02970669|101459912|FG000|Double-blind Period|Physician Decision|0|||
33428137|NCT02970669|101459913|FG001|Double-blind Period|Physician Decision|2|||
33428138|NCT02970669|101459912|FG000|Double-blind Period|Withdrawal by Subject|2|||
33428139|NCT02970669|101459913|FG001|Double-blind Period|Withdrawal by Subject|2|||
33647649|NCT02654717|102262789|FG001|Overall Study|Protocol Violation|2|||
33647650|NCT02654717|102262788|FG000|Overall Study|Withdrawal by Subject|0|||
33428140|NCT02970669|101459912|FG000|Open-label Period|Withdrawal by Subject|2|||
33428141|NCT02970669|101459913|FG001|Open-label Period|Withdrawal by Subject|2|||
33428142|NCT02970669|101459912|FG000|Open-label Period|Adverse Event|1|||
33428143|NCT02970669|101459913|FG001|Open-label Period|Adverse Event|0|||
33428144|NCT02970669|101459912|FG000|Open-label Period|Physician Decision|1|||
33381993|NCT00270998|101283415|FG001|3 Month Follow-up|Pessary did not fit|0|||
33428145|NCT02970669|101459913|FG001|Open-label Period|Physician Decision|0|||
33428146|NCT01155583|101459914|FG000|Phase I|Screen failure - did not start treatment|0|||
33428147|NCT01155583|101459915|FG001|Phase I|Screen failure - did not start treatment|0|||
33428148|NCT01155583|101459916|FG002|Phase I|Screen failure - did not start treatment|0|||
33428149|NCT01155583|101459917|FG003|Phase I|Screen failure - did not start treatment|0|||
33248510|NCT01090024|100810211|FG006|Period 1|Lost to Follow-up|0|||
33428150|NCT01155583|101459918|FG004|Phase I|Screen failure - did not start treatment|1|||
33428151|NCT01155583|101459919|FG005|Phase I|Screen failure - did not start treatment|0|||
33428152|NCT01155583|101459920|FG006|Phase I|Screen failure - did not start treatment|0|||
33428153|NCT01155583|101459921|FG007|Phase I|Screen failure - did not start treatment|2|||
33428154|NCT01155583|101459922|FG008|Phase I|Screen failure - did not start treatment|0|||
33428155|NCT01155583|101459914|FG000|Phase I|Withdrawal by Subject|0|||
33428156|NCT01155583|101459915|FG001|Phase I|Withdrawal by Subject|0|||
33428157|NCT01155583|101459916|FG002|Phase I|Withdrawal by Subject|0|||
33428158|NCT01155583|101459917|FG003|Phase I|Withdrawal by Subject|0|||
33428159|NCT01155583|101459918|FG004|Phase I|Withdrawal by Subject|0|||
33428160|NCT01155583|101459919|FG005|Phase I|Withdrawal by Subject|0|||
33428161|NCT01155583|101459920|FG006|Phase I|Withdrawal by Subject|0|||
33428162|NCT01155583|101459921|FG007|Phase I|Withdrawal by Subject|1|||
33428163|NCT01155583|101459922|FG008|Phase I|Withdrawal by Subject|0|||
33428164|NCT04147715|101459923|FG000|Overall Study|Adverse Event|0|||
33428165|NCT04147715|101459924|FG001|Overall Study|Adverse Event|0|||
33428166|NCT04147715|101459925|FG002|Overall Study|Adverse Event|0|||
33428167|NCT04147715|101459926|FG003|Overall Study|Adverse Event|0|||
33428168|NCT04147715|101459927|FG004|Overall Study|Adverse Event|0|||
33428169|NCT04147715|101459928|FG005|Overall Study|Adverse Event|0|||
33428170|NCT04147715|101459929|FG006|Overall Study|Adverse Event|0|||
33428171|NCT04147715|101459930|FG007|Overall Study|Adverse Event|2|||
33428172|NCT04147715|101459931|FG008|Overall Study|Adverse Event|1|||
33428173|NCT04147715|101459932|FG009|Overall Study|Adverse Event|0|||
33428174|NCT04147715|101459933|FG010|Overall Study|Adverse Event|0|||
33428175|NCT04147715|101459934|FG011|Overall Study|Adverse Event|0|||
33428176|NCT03137082|101459939|FG000|Overall Study|Withdrawal by Subject|1|||
33428177|NCT03137082|101459940|FG001|Overall Study|Withdrawal by Subject|1|||
33428178|NCT03137082|101459939|FG000|Overall Study|Lost to Follow-up|1|||
33428179|NCT03137082|101459940|FG001|Overall Study|Lost to Follow-up|0|||
33428180|NCT00490061|101459941|FG000|Overall Study|Physician Decision|1|||
33428181|NCT01952574|101459945|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
33428182|NCT01952574|101459946|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
33428183|NCT01952574|101459947|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
33428184|NCT01952574|101459948|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
33428185|NCT01952574|101459949|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33428186|NCT01952574|101459950|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33428187|NCT01952574|101459951|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33428188|NCT01952574|101459945|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
33428189|NCT01952574|101459946|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
33428190|NCT01952574|101459947|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
33428191|NCT01952574|101459948|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
33428192|NCT01952574|101459949|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
33428193|NCT01952574|101459950|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
33428194|NCT01952574|101459951|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
33428195|NCT01952574|101459945|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
33428196|NCT01952574|101459946|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
33428197|NCT01952574|101459947|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
33428198|NCT01952574|101459948|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
33428199|NCT01952574|101459949|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
33428200|NCT01952574|101459950|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
33428201|NCT01952574|101459951|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
33428202|NCT01952574|101459945|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
33428203|NCT01952574|101459946|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
33428204|NCT01952574|101459947|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
33428205|NCT01952574|101459948|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
33428206|NCT01952574|101459949|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
33428207|NCT01952574|101459950|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
33428208|NCT01952574|101459951|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
33428209|NCT01952574|101459945|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
33428210|NCT01952574|101459946|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
33428211|NCT01952574|101459947|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
33428212|NCT01952574|101459948|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
33428213|NCT01952574|101459949|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
33428214|NCT01952574|101459950|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
33647651|NCT02654717|102262789|FG001|Overall Study|Withdrawal by Subject|1|||
33647652|NCT02654717|102262788|FG000|Overall Study|Non-permitted medication|3|||
33428215|NCT01952574|101459951|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
33428216|NCT01952574|101459945|FG000|Open-label Treatment Phase|Missing|0|||
33428217|NCT01952574|101459946|FG001|Open-label Treatment Phase|Missing|0|||
33428218|NCT01952574|101459947|FG002|Open-label Treatment Phase|Missing|0|||
33428219|NCT01952574|101459948|FG003|Open-label Treatment Phase|Missing|0|||
33428220|NCT01952574|101459949|FG004|Open-label Treatment Phase|Missing|4|||
33428221|NCT01952574|101459950|FG005|Open-label Treatment Phase|Missing|0|||
33428222|NCT01952574|101459951|FG006|Open-label Treatment Phase|Missing|0|||
33428223|NCT01952574|101459945|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
33428224|NCT01952574|101459946|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
33428225|NCT01952574|101459947|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
33428226|NCT01952574|101459948|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
33428227|NCT01952574|101459949|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
33428228|NCT01952574|101459950|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
33428229|NCT01952574|101459951|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
33428230|NCT01952574|101459945|FG000|Open-label Treatment Phase|Death|0|||
33428231|NCT01952574|101459946|FG001|Open-label Treatment Phase|Death|0|||
33428232|NCT01952574|101459947|FG002|Open-label Treatment Phase|Death|0|||
33428233|NCT01952574|101459948|FG003|Open-label Treatment Phase|Death|0|||
33587689|NCT03530995|102038617|FG000|Part 1 Period 4|Physician Decision|1|||
33647653|NCT02654717|102262789|FG001|Overall Study|Non-permitted medication|0|||
33381994|NCT00270998|101283416|FG002|3 Month Follow-up|Pessary did not fit|0|||
33381995|NCT00270998|101283414|FG000|3 Month Follow-up|Personal/family health|1|||
33381996|NCT00270998|101283415|FG001|3 Month Follow-up|Personal/family health|1|||
33381997|NCT00270998|101283416|FG002|3 Month Follow-up|Personal/family health|0|||
33381998|NCT00270998|101283414|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
33381999|NCT00270998|101283415|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
33382000|NCT00270998|101283416|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
33382001|NCT00270998|101283414|FG000|12 Month Follow-up|Lack of Efficacy|5|||
33382002|NCT00270998|101283415|FG001|12 Month Follow-up|Lack of Efficacy|4|||
33382003|NCT00270998|101283416|FG002|12 Month Follow-up|Lack of Efficacy|3|||
33382004|NCT00270998|101283414|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
33382005|NCT00270998|101283415|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
33382006|NCT00270998|101283416|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
33382007|NCT00270998|101283414|FG000|12 Month Follow-up|Pessary did not fit|1|||
33382008|NCT00270998|101283415|FG001|12 Month Follow-up|Pessary did not fit|0|||
33382009|NCT00270998|101283416|FG002|12 Month Follow-up|Pessary did not fit|0|||
33382010|NCT00270998|101283414|FG000|12 Month Follow-up|Personal/family health|0|||
33382011|NCT00270998|101283415|FG001|12 Month Follow-up|Personal/family health|5|||
33382012|NCT00270998|101283416|FG002|12 Month Follow-up|Personal/family health|1|||
33382013|NCT00270998|101283414|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
33382014|NCT00270998|101283415|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
33382015|NCT00270998|101283416|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
33382016|NCT01188096|101283417|FG000|Overall Study|progression of disease|4|||
33382017|NCT01188096|101283417|FG000|Overall Study|Withdrawal by Subject|2|||
33382018|NCT01033487|101283418|FG000|Fourth Intervention Period|Adverse Event|0|||
33382019|NCT01033487|101283419|FG001|Fourth Intervention Period|Adverse Event|0|||
33382020|NCT01033487|101283420|FG002|Fourth Intervention Period|Adverse Event|0|||
33382021|NCT01033487|101283421|FG003|Fourth Intervention Period|Adverse Event|0|||
33382022|NCT01033487|101283422|FG004|Fourth Intervention Period|Adverse Event|0|||
33382023|NCT01033487|101283423|FG005|Fourth Intervention Period|Adverse Event|0|||
33382024|NCT01033487|101283424|FG006|Fourth Intervention Period|Adverse Event|0|||
33382025|NCT01033487|101283425|FG007|Fourth Intervention Period|Adverse Event|0|||
33382026|NCT01033487|101283426|FG008|Fourth Intervention Period|Adverse Event|1|||
33382027|NCT01033487|101283427|FG009|Fourth Intervention Period|Adverse Event|0|||
33382028|NCT01175213|101283435|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
33382029|NCT01175213|101283436|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
33382030|NCT01175213|101283435|FG000|IGSC, 10%/rHuPH20|Death|1|||
33382031|NCT01175213|101283436|FG001|IGSC, 10%/rHuPH20|Death|0|||
33382032|NCT01175213|101283435|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
33382033|NCT01175213|101283436|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
33382034|NCT01175213|101283435|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
33382035|NCT01175213|101283436|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
33382036|NCT01175213|101283435|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
33382037|NCT01175213|101283436|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
33382038|NCT01175213|101283435|FG000|Safety Follow-up|Adverse Event|1|||
33382039|NCT01175213|101283436|FG001|Safety Follow-up|Adverse Event|0|||
33382040|NCT01164865|101283437|FG000|Overall Study|Lost to Follow-up|2|||
33382041|NCT01164865|101283438|FG001|Overall Study|Lost to Follow-up|1|||
33382042|NCT01626989|101283439|FG000|Screening Period|Screen Failure|15|||
33382043|NCT01626989|101283440|FG001|Screening Period|Screen Failure|0|||
33382044|NCT01626989|101283441|FG002|Screening Period|Screen Failure|0|||
33382045|NCT01626989|101283439|FG000|Screening Period|Withdrawal by Subject|2|||
33382046|NCT01626989|101283440|FG001|Screening Period|Withdrawal by Subject|0|||
33382047|NCT01626989|101283441|FG002|Screening Period|Withdrawal by Subject|0|||
33382048|NCT03017846|101283442|FG000|Overall Study|Lost to Follow-up|3|||
33382049|NCT03017846|101283442|FG000|Overall Study|Adverse Event|2|||
33428234|NCT01952574|101459949|FG004|Open-label Treatment Phase|Death|1|||
33428235|NCT01952574|101459950|FG005|Open-label Treatment Phase|Death|0|||
33428236|NCT01952574|101459951|FG006|Open-label Treatment Phase|Death|0|||
33428237|NCT01952574|101459945|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
33382050|NCT02119026|101283444|FG000|1st-line Treatment|Adverse Event|9|||
33248511|NCT01090024|100810212|FG007|Period 1|Lost to Follow-up|0|||
33248512|NCT01090024|100810213|FG008|Period 1|Lost to Follow-up|0|||
33248513|NCT01090024|100810214|FG009|Period 1|Lost to Follow-up|0|||
33248514|NCT01090024|100810215|FG010|Period 1|Lost to Follow-up|0|||
33248515|NCT01090024|100810216|FG011|Period 1|Lost to Follow-up|0|||
33248516|NCT01090024|100810217|FG012|Period 1|Lost to Follow-up|0|||
33248517|NCT01090024|100810218|FG013|Period 1|Lost to Follow-up|0|||
33248518|NCT01090024|100810219|FG014|Period 1|Lost to Follow-up|0|||
33248519|NCT01090024|100810220|FG015|Period 1|Lost to Follow-up|0|||
33248520|NCT01090024|100810221|FG016|Period 1|Lost to Follow-up|0|||
33248521|NCT01090024|100810222|FG017|Period 1|Lost to Follow-up|0|||
33248522|NCT01090024|100810205|FG000|Period 2|Lost to Follow-up|0|||
33248523|NCT01090024|100810206|FG001|Period 2|Lost to Follow-up|0|||
33248524|NCT01090024|100810207|FG002|Period 2|Lost to Follow-up|0|||
33248525|NCT01090024|100810208|FG003|Period 2|Lost to Follow-up|1|||
33248526|NCT01090024|100810209|FG004|Period 2|Lost to Follow-up|0|||
33248527|NCT01090024|100810210|FG005|Period 2|Lost to Follow-up|0|||
33248528|NCT01090024|100810211|FG006|Period 2|Lost to Follow-up|0|||
33248529|NCT01090024|100810212|FG007|Period 2|Lost to Follow-up|0|||
33248530|NCT01090024|100810213|FG008|Period 2|Lost to Follow-up|0|||
33248531|NCT01090024|100810214|FG009|Period 2|Lost to Follow-up|0|||
33248532|NCT01090024|100810215|FG010|Period 2|Lost to Follow-up|0|||
33248533|NCT01090024|100810216|FG011|Period 2|Lost to Follow-up|0|||
33248534|NCT01090024|100810217|FG012|Period 2|Lost to Follow-up|0|||
33248535|NCT01090024|100810218|FG013|Period 2|Lost to Follow-up|0|||
33248536|NCT01090024|100810219|FG014|Period 2|Lost to Follow-up|0|||
33248537|NCT01090024|100810220|FG015|Period 2|Lost to Follow-up|0|||
33248538|NCT01090024|100810221|FG016|Period 2|Lost to Follow-up|0|||
33248539|NCT01090024|100810222|FG017|Period 2|Lost to Follow-up|0|||
33248540|NCT01090024|100810205|FG000|Period 2|Adverse Event|1|||
33248541|NCT01090024|100810206|FG001|Period 2|Adverse Event|0|||
33248542|NCT01090024|100810207|FG002|Period 2|Adverse Event|0|||
33248543|NCT01090024|100810208|FG003|Period 2|Adverse Event|0|||
33248544|NCT01090024|100810209|FG004|Period 2|Adverse Event|0|||
33248545|NCT01090024|100810210|FG005|Period 2|Adverse Event|0|||
33248546|NCT01090024|100810211|FG006|Period 2|Adverse Event|0|||
33248547|NCT01090024|100810212|FG007|Period 2|Adverse Event|0|||
33248548|NCT01090024|100810213|FG008|Period 2|Adverse Event|0|||
33248549|NCT01090024|100810214|FG009|Period 2|Adverse Event|0|||
33248550|NCT01090024|100810215|FG010|Period 2|Adverse Event|0|||
33248551|NCT01090024|100810216|FG011|Period 2|Adverse Event|0|||
33382051|NCT02119026|101283445|FG001|1st-line Treatment|Adverse Event|14|||
33382052|NCT02119026|101283444|FG000|1st-line Treatment|Physician Decision|3|||
33382053|NCT02119026|101283445|FG001|1st-line Treatment|Physician Decision|8|||
33382054|NCT02119026|101283444|FG000|1st-line Treatment|Withdrawal by Subject|4|||
33382055|NCT02119026|101283445|FG001|1st-line Treatment|Withdrawal by Subject|10|||
33382056|NCT02119026|101283444|FG000|1st-line Treatment|Patient condition or compliance|6|||
33382057|NCT02119026|101283445|FG001|1st-line Treatment|Patient condition or compliance|4|||
33382058|NCT02119026|101283444|FG000|1st-line Treatment|Surgery of metastases|2|||
33382059|NCT02119026|101283445|FG001|1st-line Treatment|Surgery of metastases|1|||
33382060|NCT02119026|101283444|FG000|1st-line Treatment|Death|2|||
33382061|NCT02119026|101283445|FG001|1st-line Treatment|Death|1|||
33382062|NCT02119026|101283444|FG000|2nd-line Treatment|Lost to Follow-up|2|||
33382063|NCT02119026|101283445|FG001|2nd-line Treatment|Lost to Follow-up|0|||
33428238|NCT01952574|101459946|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
33428239|NCT01952574|101459947|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
33647654|NCT02874144|102262790|FG000|Overall Study|Lost to Follow-up|3|||
33647655|NCT02874144|102262791|FG001|Overall Study|Lost to Follow-up|5|||
33647656|NCT01250145|102262794|FG000|Overall Study|Adverse Event|2|||
33647657|NCT01250145|102262795|FG001|Overall Study|Adverse Event|1|||
33647658|NCT01250145|102262794|FG000|Overall Study|Withdrawal by Subject|0|||
33647659|NCT01250145|102262795|FG001|Overall Study|Withdrawal by Subject|4|||
33248552|NCT01090024|100810217|FG012|Period 2|Adverse Event|0|||
33248553|NCT01090024|100810218|FG013|Period 2|Adverse Event|0|||
33248554|NCT01090024|100810219|FG014|Period 2|Adverse Event|0|||
33248555|NCT01090024|100810220|FG015|Period 2|Adverse Event|0|||
33248556|NCT01090024|100810221|FG016|Period 2|Adverse Event|0|||
33248557|NCT01090024|100810222|FG017|Period 2|Adverse Event|0|||
33248558|NCT01090024|100810205|FG000|Period 3|Withdrawal by Subject|0|||
33248559|NCT01090024|100810206|FG001|Period 3|Withdrawal by Subject|0|||
33248560|NCT01090024|100810207|FG002|Period 3|Withdrawal by Subject|0|||
33248561|NCT01090024|100810208|FG003|Period 3|Withdrawal by Subject|0|||
33382064|NCT02119026|101283444|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
33647660|NCT03567343|102262796|FG000|Overall Study|Lost to Follow-up|2|||
33248562|NCT01090024|100810209|FG004|Period 3|Withdrawal by Subject|0|||
33248563|NCT01090024|100810210|FG005|Period 3|Withdrawal by Subject|0|||
33248564|NCT01090024|100810211|FG006|Period 3|Withdrawal by Subject|0|||
33382065|NCT02119026|101283445|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
33382066|NCT02119026|101283444|FG000|2nd-line Treatment|Adverse Event|4|||
33382067|NCT02119026|101283445|FG001|2nd-line Treatment|Adverse Event|1|||
33382068|NCT00804843|101283446|FG000|Overall Study|Protocol Violation|1|||
33382069|NCT00804843|101283447|FG001|Overall Study|Protocol Violation|0|||
33382070|NCT00804843|101283446|FG000|Overall Study|Adverse Event|8|||
33382071|NCT00804843|101283447|FG001|Overall Study|Adverse Event|5|||
33382072|NCT00804843|101283446|FG000|Overall Study|Withdrawal by Subject|1|||
33382073|NCT00804843|101283447|FG001|Overall Study|Withdrawal by Subject|2|||
33382074|NCT02293993|101283448|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
33382075|NCT02293993|101283449|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
33382076|NCT02293993|101283450|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
33382077|NCT02293993|101283451|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
33382078|NCT02293993|101283448|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
33382079|NCT02293993|101283449|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
33382080|NCT02293993|101283450|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
33382081|NCT02293993|101283451|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
33382082|NCT02293993|101283448|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
33382083|NCT02293993|101283449|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
33382084|NCT02293993|101283450|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
33382085|NCT02293993|101283451|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
33382086|NCT02293993|101283448|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
33382087|NCT02293993|101283449|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
33382088|NCT02293993|101283450|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
33382089|NCT02293993|101283451|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
33382090|NCT02293993|101283448|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
33382091|NCT02293993|101283449|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
33382092|NCT02293993|101283450|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
33382093|NCT02293993|101283451|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
33382094|NCT01074658|101283452|FG000|Overall Study|No implant attempted|19|||
33382095|NCT01184846|101283453|FG000|Overall Study|Adverse Event|2|||
33382096|NCT01184846|101283453|FG000|Overall Study|Insufficient response|1|||
33382097|NCT03115112|101283457|FG000|Overall Study|Adverse Event|5|||
33382098|NCT03115112|101283458|FG001|Overall Study|Adverse Event|1|||
33382099|NCT03115112|101283457|FG000|Overall Study|Withdrawal by Subject|4|||
33382100|NCT03115112|101283458|FG001|Overall Study|Withdrawal by Subject|2|||
33382101|NCT03115112|101283457|FG000|Overall Study|Lost to Follow-up|0|||
33382102|NCT03115112|101283458|FG001|Overall Study|Lost to Follow-up|1|||
33382103|NCT03115112|101283457|FG000|Overall Study|Death|1|||
33382104|NCT03115112|101283458|FG001|Overall Study|Death|0|||
33382105|NCT03115112|101283457|FG000|Overall Study|Pregnancy|1|||
33428240|NCT01952574|101459948|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
33428241|NCT01952574|101459949|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
33428242|NCT01952574|101459950|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
33428243|NCT01952574|101459951|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
33428244|NCT01952574|101459945|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
33428245|NCT01952574|101459946|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
33428246|NCT01952574|101459947|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
33428247|NCT01952574|101459948|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
33428248|NCT01952574|101459949|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
33428249|NCT01952574|101459950|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
33428250|NCT01952574|101459951|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
33428251|NCT00526890|101459964|FG000|Overall Study|Adverse Event|2|||
33428252|NCT03567057|101459965|FG000|Overall Study|Adverse Event|56|||
33428253|NCT03567057|101459966|FG001|Overall Study|Adverse Event|53|||
33428254|NCT03567057|101459967|FG002|Overall Study|Adverse Event|28|||
33428255|NCT03567057|101459965|FG000|Overall Study|Withdrawal by Subject|22|||
33428256|NCT03567057|101459966|FG001|Overall Study|Withdrawal by Subject|24|||
33428257|NCT03567057|101459967|FG002|Overall Study|Withdrawal by Subject|13|||
33428258|NCT03567057|101459965|FG000|Overall Study|Lost to Follow-up|3|||
33428259|NCT03567057|101459966|FG001|Overall Study|Lost to Follow-up|5|||
33428260|NCT03567057|101459967|FG002|Overall Study|Lost to Follow-up|2|||
33428261|NCT03567057|101459965|FG000|Overall Study|COVID-19 pandemic|4|||
33428262|NCT03567057|101459966|FG001|Overall Study|COVID-19 pandemic|3|||
33428263|NCT03567057|101459967|FG002|Overall Study|COVID-19 pandemic|0|||
33428264|NCT03567057|101459965|FG000|Overall Study|Non-compliance with study drug|4|||
33149484|NCT00191646|100460752|FG000|Overall Study|Withdrawal by Subject|58|||
33428265|NCT03567057|101459966|FG001|Overall Study|Non-compliance with study drug|2|||
33428266|NCT03567057|101459967|FG002|Overall Study|Non-compliance with study drug|0|||
33428267|NCT03567057|101459965|FG000|Overall Study|Lack of Efficacy|3|||
33428268|NCT03567057|101459966|FG001|Overall Study|Lack of Efficacy|0|||
33428269|NCT03567057|101459967|FG002|Overall Study|Lack of Efficacy|1|||
33428270|NCT03567057|101459965|FG000|Overall Study|Death|1|||
33428271|NCT03567057|101459966|FG001|Overall Study|Death|0|||
33428272|NCT03567057|101459967|FG002|Overall Study|Death|0|||
33428273|NCT03567057|101459965|FG000|Overall Study|Physician Decision|1|||
33428274|NCT03567057|101459966|FG001|Overall Study|Physician Decision|0|||
33428275|NCT03567057|101459967|FG002|Overall Study|Physician Decision|0|||
33428276|NCT03567057|101459965|FG000|Overall Study|Unstable medical condition|1|||
33428277|NCT03567057|101459966|FG001|Overall Study|Unstable medical condition|0|||
33428278|NCT03567057|101459967|FG002|Overall Study|Unstable medical condition|0|||
33428279|NCT03567057|101459965|FG000|Overall Study|Medical history event|0|||
33428280|NCT03567057|101459966|FG001|Overall Study|Medical history event|0|||
33428281|NCT03567057|101459967|FG002|Overall Study|Medical history event|1|||
33428282|NCT03567057|101459965|FG000|Overall Study|Other|0|||
33428283|NCT03567057|101459966|FG001|Overall Study|Other|0|||
33428284|NCT03567057|101459967|FG002|Overall Study|Other|1|||
33428285|NCT02058628|101459968|FG000|Overall Study|Adverse Event|1|||
33428286|NCT02058628|101459969|FG001|Overall Study|Adverse Event|0|||
33428287|NCT02058628|101459968|FG000|Overall Study|Withdrawal by Subject|2|||
33428288|NCT02058628|101459969|FG001|Overall Study|Withdrawal by Subject|2|||
33428289|NCT02058628|101459968|FG000|Overall Study|Lost to Follow-up|2|||
33428290|NCT02058628|101459969|FG001|Overall Study|Lost to Follow-up|4|||
33428291|NCT02058628|101459968|FG000|Overall Study|Not in time schedule|0|||
33428292|NCT02058628|101459969|FG001|Overall Study|Not in time schedule|1|||
33428293|NCT02058628|101459968|FG000|Overall Study|The visit date was not in timeline|0|||
33428294|NCT02058628|101459969|FG001|Overall Study|The visit date was not in timeline|1|||
33428295|NCT02058628|101459968|FG000|Overall Study|A lot of time for study for participant|1|||
33428296|NCT02058628|101459969|FG001|Overall Study|A lot of time for study for participant|0|||
33428297|NCT02058628|101459968|FG000|Overall Study|Non compliance|1|||
33428298|NCT02058628|101459969|FG001|Overall Study|Non compliance|0|||
33428299|NCT01070966|101459970|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
33428300|NCT01070966|101459970|FG000|Participants for Safety Evaluation|Off-label use|9|||
33428301|NCT01070966|101459970|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
33428302|NCT01070966|101459970|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
33428303|NCT01070966|101459970|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
33428304|NCT01070966|101459970|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
33428305|NCT01070966|101459970|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
33428306|NCT01070966|101459970|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
33428307|NCT01337050|101459971|FG000|Overall Study|Death|0|||
33428308|NCT01337050|101459972|FG001|Overall Study|Death|0|||
33428309|NCT01337050|101459973|FG002|Overall Study|Death|4|||
33428310|NCT01337050|101459971|FG000|Overall Study|Other|4|||
33428311|NCT01337050|101459972|FG001|Overall Study|Other|6|||
33428312|NCT01337050|101459973|FG002|Overall Study|Other|8|||
33428313|NCT01337050|101459971|FG000|Overall Study|Participants refused further follow-up|0|||
33428314|NCT01337050|101459972|FG001|Overall Study|Participants refused further follow-up|7|||
33428315|NCT01337050|101459973|FG002|Overall Study|Participants refused further follow-up|7|||
33428316|NCT01299038|101459974|FG000|Overall Study|Withdrawal by Subject|1|||
33428317|NCT01299038|101459975|FG001|Overall Study|Withdrawal by Subject|0|||
33428318|NCT00767325|101459976|FG000|Overall Study|Lack of Efficacy|2|||
33428319|NCT00767325|101459976|FG000|Overall Study|Adverse Event|7|||
33428320|NCT00767325|101459976|FG000|Overall Study|Lost to Follow-up|3|||
33428321|NCT00767325|101459976|FG000|Overall Study|No longer met study criteria|2|||
33428322|NCT00767325|101459976|FG000|Overall Study|Missed visit due to family reasons|1|||
33428323|NCT01078090|101459977|FG000|Overall Study|Lost to Follow-up|2363|||
33428324|NCT01078090|101459977|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
33428325|NCT01078090|101459977|FG000|Overall Study|Lack of Efficacy|1193|||
33428326|NCT01078090|101459977|FG000|Overall Study|ADR and lack of efficacy|61|||
33647661|NCT03567343|102262797|FG001|Overall Study|Lost to Follow-up|1|||
33382106|NCT03115112|101283458|FG001|Overall Study|Pregnancy|0|||
33382107|NCT03115112|101283457|FG000|Overall Study|Site closure|1|||
33382108|NCT03115112|101283458|FG001|Overall Study|Site closure|1|||
33382109|NCT00098020|101283459|FG000|Overall Study|Adverse Event|2|||
33382110|NCT00098020|101283459|FG000|Overall Study|Lost to Follow-up|1|||
33382111|NCT00098020|101283459|FG000|Overall Study|elevated liver enzymes|1|||
33382112|NCT00098020|101283459|FG000|Overall Study|Low urine PCR|1|||
33382113|NCT00098020|101283459|FG000|Overall Study|Low epidermal growth factor receptor|1|||
33382114|NCT01151540|101283460|FG000|Overall Study|Other|2|||
33382115|NCT01151540|101283460|FG000|Overall Study|Adverse event, non-fatal|4|||
33382116|NCT01151540|101283460|FG000|Overall Study|Withdrawal by Subject|7|||
33428327|NCT01078090|101459977|FG000|Overall Study|Other|523|||
33428328|NCT01193517|101459978|FG000|Overall Study|Early Progression|1|||
33382117|NCT03846219|101283461|FG000|Overall Study|Withdrawal by Subject|3|||
33382118|NCT03846219|101283462|FG001|Overall Study|Withdrawal by Subject|2|||
33382119|NCT03846219|101283463|FG002|Overall Study|Withdrawal by Subject|2|||
33382120|NCT03846219|101283461|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
33428329|NCT01193517|101459979|FG001|Overall Study|Early Progression|0|||
33428330|NCT01193517|101459980|FG002|Overall Study|Early Progression|0|||
33428331|NCT00417027|101459983|FG000|Overall Study|Protocol Violation|0|||
33428332|NCT00417027|101459984|FG001|Overall Study|Protocol Violation|5|||
33428333|NCT00417027|101459985|FG002|Overall Study|Protocol Violation|5|||
33428334|NCT01904383|101459986|FG000|Overall Study|CRF not collected|117|||
33428335|NCT01904383|101459986|FG000|Overall Study|Reason not listed|147|||
33428336|NCT01904383|101459986|FG000|Overall Study|Lost to Follow-up|674|||
33428337|NCT01904383|101459986|FG000|Overall Study|Lack of Efficacy|370|||
33428338|NCT01904383|101459986|FG000|Overall Study|Improvement|141|||
33428339|NCT01904383|101459986|FG000|Overall Study|Adverse Event|271|||
33428340|NCT01904383|101459986|FG000|Overall Study|No patient visit after entry|54|||
33428341|NCT02444533|101459989|FG000|Overall Study|Not able to complete forms|0|||
33428342|NCT02444533|101459990|FG001|Overall Study|Not able to complete forms|2|||
33428343|NCT02444533|101459989|FG000|Overall Study|Only gave post-procedure complications|2|||
33428344|NCT02444533|101459990|FG001|Overall Study|Only gave post-procedure complications|2|||
33428345|NCT05085964|101460001|FG000|Overall Study|Premature termination of study|21|||
33428346|NCT05085964|101460002|FG001|Overall Study|Premature termination of study|0|||
33428347|NCT00633152|101460005|FG000|Overall Study|Adverse Event|1|||
33428348|NCT00633152|101460006|FG001|Overall Study|Adverse Event|0|||
33428349|NCT00633152|101460005|FG000|Overall Study|Randomized, did not receive study drug|5|||
33428350|NCT00633152|101460006|FG001|Overall Study|Randomized, did not receive study drug|2|||
33428351|NCT00633152|101460005|FG000|Overall Study|Withdrawal by Subject|1|||
33428352|NCT00633152|101460006|FG001|Overall Study|Withdrawal by Subject|1|||
33428353|NCT00633152|101460005|FG000|Overall Study|Lost to Follow-up|4|||
33428354|NCT00633152|101460006|FG001|Overall Study|Lost to Follow-up|1|||
33428355|NCT00633152|101460005|FG000|Overall Study|Miscellaneous Other|3|||
33428356|NCT00633152|101460006|FG001|Overall Study|Miscellaneous Other|2|||
33428357|NCT01889862|101460009|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
33428358|NCT01889862|101460010|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
33428359|NCT01889862|101460011|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
33428360|NCT01889862|101460012|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
33428361|NCT01889862|101460013|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
33428362|NCT01889862|101460009|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
33428363|NCT01889862|101460010|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
33428364|NCT01889862|101460011|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
33428365|NCT01889862|101460012|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
33428366|NCT01889862|101460013|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
33428367|NCT01889862|101460009|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
33428368|NCT01889862|101460010|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
33428369|NCT01889862|101460011|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
33428370|NCT01889862|101460012|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
33428371|NCT01889862|101460013|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
33428372|NCT01889862|101460009|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
33428373|NCT01889862|101460010|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
33428374|NCT01889862|101460011|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
33428375|NCT01889862|101460012|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
33428376|NCT01889862|101460013|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
33428377|NCT01889862|101460009|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
33428378|NCT01889862|101460010|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
33428379|NCT01889862|101460011|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
33428380|NCT01889862|101460012|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
33428381|NCT01889862|101460013|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
33428382|NCT01889862|101460009|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
33428383|NCT01889862|101460010|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
33428384|NCT01889862|101460011|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
33428385|NCT01889862|101460012|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
33428386|NCT01889862|101460013|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
33428387|NCT01889862|101460009|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
33428388|NCT01889862|101460010|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
33428389|NCT01889862|101460011|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
33428390|NCT01889862|101460012|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
33428391|NCT01889862|101460013|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
33428392|NCT01889862|101460009|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
33428393|NCT01889862|101460010|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
33428394|NCT01889862|101460011|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
33428395|NCT01889862|101460012|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
33428396|NCT01889862|101460013|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
33428397|NCT01889862|101460009|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
33428398|NCT01889862|101460010|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
33248565|NCT01090024|100810212|FG007|Period 3|Withdrawal by Subject|0|||
33428399|NCT01889862|101460011|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
33428400|NCT01889862|101460012|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
33428401|NCT01889862|101460013|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
33428402|NCT01889862|101460009|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
33428403|NCT01889862|101460010|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
33428404|NCT01889862|101460011|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
33428405|NCT01889862|101460012|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
33428406|NCT01889862|101460013|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
33428407|NCT04132232|101460014|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
33428408|NCT04132232|101460015|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
33428409|NCT04132232|101460014|FG000|Overall Study|Lost to Follow-up|6|||
33428410|NCT04132232|101460015|FG001|Overall Study|Lost to Follow-up|7|||
33428411|NCT00638157|101460017|FG000|Overall Study|Adverse Event|0|||
33428412|NCT00638157|101460018|FG001|Overall Study|Adverse Event|1|||
33428413|NCT00638157|101460017|FG000|Overall Study|Clinical (symptomatic) failure|1|||
33428414|NCT00638157|101460018|FG001|Overall Study|Clinical (symptomatic) failure|1|||
33428415|NCT00638157|101460017|FG000|Overall Study|Microbiological failure|1|||
33428416|NCT00638157|101460018|FG001|Overall Study|Microbiological failure|0|||
33428417|NCT00638157|101460017|FG000|Overall Study|Lost to Follow-up|1|||
33428418|NCT00638157|101460018|FG001|Overall Study|Lost to Follow-up|0|||
33587690|NCT03530995|102038618|FG001|Part 1 Period 4|Physician Decision|0|||
33587691|NCT03530995|102038617|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
33587692|NCT03530995|102038618|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
33587693|NCT02027311|102038619|FG000|Overall Study|Protocol Violation|3|||
33587694|NCT02027311|102038620|FG001|Overall Study|Protocol Violation|2|||
33587695|NCT04493424|102038623|FG000|Overall Study|Termination of the trial by the sponsor|89|||
33587696|NCT04493424|102038623|FG000|Overall Study|Withdrawal by Subject|9|||
33587697|NCT04493424|102038623|FG000|Overall Study|Lost to Follow-up|2|||
33587698|NCT04493424|102038623|FG000|Overall Study|Lack of Efficacy|3|||
33587699|NCT04493424|102038623|FG000|Overall Study|Adverse Event|5|||
33647662|NCT03567343|102262796|FG000|Overall Study|No longer eligible|2|||
33647663|NCT03567343|102262797|FG001|Overall Study|No longer eligible|1|||
33647664|NCT03567343|102262796|FG000|Overall Study|Adverse Event|1|||
33647665|NCT03567343|102262797|FG001|Overall Study|Adverse Event|0|||
33647666|NCT03567343|102262796|FG000|Overall Study|Protocol Violation|1|||
33647667|NCT03567343|102262797|FG001|Overall Study|Protocol Violation|1|||
33647668|NCT01981551|102262798|FG000|Overall Study|Refused further treatment|8|||
33647669|NCT01981551|102262798|FG000|Overall Study|Adverse Event|1|||
33647670|NCT02547363|102262799|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
33647671|NCT02547363|102262800|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
33647672|NCT02547363|102262799|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
33647673|NCT02547363|102262800|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
33647674|NCT02547363|102262799|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
33647675|NCT02547363|102262800|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
33647676|NCT02547363|102262799|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
33647677|NCT02547363|102262800|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
33647678|NCT02547363|102262799|FG000|12-month Follow-up|Withdrawal by Subject|4|||
33647679|NCT02547363|102262800|FG001|12-month Follow-up|Withdrawal by Subject|3|||
33647680|NCT02547363|102262799|FG000|12-month Follow-up|Lost to Follow-up|4|||
33382121|NCT03846219|101283462|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
33382122|NCT03846219|101283463|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
33382123|NCT03846219|101283461|FG000|Overall Study|Physician Decision|0|||
33382124|NCT03846219|101283462|FG001|Overall Study|Physician Decision|0|||
33382125|NCT03846219|101283463|FG002|Overall Study|Physician Decision|2|||
33382126|NCT02677220|101283464|FG000|Overall Study|Adverse Event|1|||
33382127|NCT00718666|101283465|FG000|Booster Phase Year 5|No active participation request|0|||
33382128|NCT00718666|101283466|FG001|Booster Phase Year 5|No active participation request|0|||
33382129|NCT00718666|101283467|FG002|Booster Phase Year 5|No active participation request|1|||
33382130|NCT00718666|101283465|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
33382131|NCT00718666|101283466|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
33382132|NCT00718666|101283467|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
33382133|NCT00718666|101283465|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
33382134|NCT00718666|101283466|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
33382135|NCT00718666|101283467|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
33382136|NCT00718666|101283465|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
33382137|NCT00718666|101283466|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
33382138|NCT00718666|101283467|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
33382139|NCT00836277|101283468|FG000|Overall Study|Not evaluable for response|6|||
33382140|NCT00870818|101283469|FG000|Overall Study|Lost to Follow-up|3|||
33382141|NCT00870818|101283470|FG001|Overall Study|Lost to Follow-up|2|||
33382142|NCT00870818|101283471|FG002|Overall Study|Lost to Follow-up|1|||
33382143|NCT00870818|101283472|FG003|Overall Study|Lost to Follow-up|0|||
33382144|NCT00870818|101283473|FG004|Overall Study|Lost to Follow-up|0|||
33587700|NCT02237001|102038634|FG000|Overall Study|Lost to Follow-up|2|||
33587701|NCT02237001|102038634|FG000|Overall Study|Withdrawal by Subject|1|||
33587702|NCT02237001|102038634|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
33428419|NCT00638157|101460017|FG000|Overall Study|Physician Decision|1|||
33428420|NCT00638157|101460018|FG001|Overall Study|Physician Decision|0|||
33428421|NCT00638157|101460017|FG000|Overall Study|Other|1|||
33428422|NCT00638157|101460018|FG001|Overall Study|Other|2|||
33428423|NCT00638157|101460017|FG000|Overall Study|Randomized, not treated|2|||
33428424|NCT00638157|101460018|FG001|Overall Study|Randomized, not treated|0|||
33428425|NCT02884206|101460019|FG000|Valsartan Run-in Period|Death|1|||
33428426|NCT02884206|101460020|FG001|Valsartan Run-in Period|Death|0|||
33428427|NCT02884206|101460021|FG002|Valsartan Run-in Period|Death|0|||
33428428|NCT02884206|101460019|FG000|Valsartan Run-in Period|Adverse Event|31|||
33428429|NCT02884206|101460020|FG001|Valsartan Run-in Period|Adverse Event|0|||
33382145|NCT00870818|101283469|FG000|Overall Study|Withdrawal by Subject|0|||
33382146|NCT00870818|101283470|FG001|Overall Study|Withdrawal by Subject|0|||
33382147|NCT00870818|101283471|FG002|Overall Study|Withdrawal by Subject|1|||
33382148|NCT00870818|101283472|FG003|Overall Study|Withdrawal by Subject|2|||
33382149|NCT00870818|101283473|FG004|Overall Study|Withdrawal by Subject|0|||
33382150|NCT00870818|101283469|FG000|Overall Study|Terminated by sponsor|29|||
33382151|NCT00870818|101283470|FG001|Overall Study|Terminated by sponsor|70|||
33382152|NCT00870818|101283471|FG002|Overall Study|Terminated by sponsor|36|||
33382153|NCT00870818|101283472|FG003|Overall Study|Terminated by sponsor|36|||
33382154|NCT00870818|101283473|FG004|Overall Study|Terminated by sponsor|38|||
33382155|NCT00870818|101283469|FG000|Overall Study|Other|0|||
33382156|NCT00870818|101283470|FG001|Overall Study|Other|1|||
33382157|NCT00870818|101283471|FG002|Overall Study|Other|0|||
33382158|NCT00870818|101283472|FG003|Overall Study|Other|0|||
33382159|NCT00870818|101283473|FG004|Overall Study|Other|0|||
33382160|NCT02802878|101283474|FG000|Overall Study|Withdrawal by Subject|3|||
33382161|NCT02802878|101283475|FG001|Overall Study|Withdrawal by Subject|3|||
33382162|NCT02802878|101283474|FG000|Overall Study|Protocol Violation|1|||
33382163|NCT02802878|101283475|FG001|Overall Study|Protocol Violation|0|||
33382164|NCT00405652|101283477|FG000|Overall Study|Adverse Event|4|||
33382165|NCT00453180|101283484|FG000|Overall Study|Lost to Follow-up|2|||
33382166|NCT00453180|101283485|FG001|Overall Study|Lost to Follow-up|1|||
33382167|NCT00453180|101283484|FG000|Overall Study|Adverse Event|1|||
33382168|NCT00453180|101283485|FG001|Overall Study|Adverse Event|2|||
33382169|NCT01993615|101283488|FG000|Overall Study|Death|1|||
33382170|NCT01993615|101283489|FG001|Overall Study|Death|0|||
33382171|NCT02494778|101283490|FG000|Overall Study|Death|3|||
33382172|NCT02494778|101283490|FG000|Overall Study|Other|173|||
33382173|NCT02494778|101283490|FG000|Overall Study|Lack of Efficacy|4|||
33382174|NCT02494778|101283490|FG000|Overall Study|Adverse Event|18|||
33382175|NCT02494778|101283490|FG000|Overall Study|Withdrawal by Subject|20|||
33382176|NCT02494778|101283490|FG000|Overall Study|Lost to Follow-up|2|||
33382177|NCT02494778|101283490|FG000|Overall Study|Noncompliant with study drug admin.|1|||
33382178|NCT00818207|101283494|FG000|Overall Study|Adverse Event|6|||
33382179|NCT00818207|101283495|FG001|Overall Study|Adverse Event|0|||
33382180|NCT00818207|101283494|FG000|Overall Study|Lost to Follow-up|160|||
33382181|NCT00818207|101283495|FG001|Overall Study|Lost to Follow-up|146|||
33428430|NCT02884206|101460021|FG002|Valsartan Run-in Period|Adverse Event|0|||
33428431|NCT02884206|101460019|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
33428432|NCT02884206|101460020|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
33428433|NCT02884206|101460021|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
33428434|NCT02884206|101460019|FG000|Valsartan Run-in Period|Protocol deviation|4|||
33428435|NCT02884206|101460020|FG001|Valsartan Run-in Period|Protocol deviation|0|||
33428436|NCT02884206|101460021|FG002|Valsartan Run-in Period|Protocol deviation|0|||
33428437|NCT02884206|101460019|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
33428438|NCT02884206|101460020|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
33428439|NCT02884206|101460021|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
33428440|NCT02884206|101460019|FG000|Valsartan Run-in Period|Physician Decision|1|||
33428441|NCT02884206|101460020|FG001|Valsartan Run-in Period|Physician Decision|0|||
33428442|NCT02884206|101460021|FG002|Valsartan Run-in Period|Physician Decision|0|||
33428443|NCT02884206|101460019|FG000|LCZ696 Run-in Period|Adverse Event|38|||
33428444|NCT02884206|101460020|FG001|LCZ696 Run-in Period|Adverse Event|0|||
33428445|NCT02884206|101460021|FG002|LCZ696 Run-in Period|Adverse Event|0|||
33428446|NCT02884206|101460019|FG000|LCZ696 Run-in Period|Death|2|||
33428447|NCT02884206|101460020|FG001|LCZ696 Run-in Period|Death|0|||
33428448|NCT02884206|101460021|FG002|LCZ696 Run-in Period|Death|0|||
33248566|NCT01090024|100810213|FG008|Period 3|Withdrawal by Subject|0|||
33587703|NCT02237001|102038634|FG000|Overall Study|Re-operation|4|||
33382182|NCT00818207|101283494|FG000|Overall Study|Multiple reasons|11|||
33382183|NCT00818207|101283495|FG001|Overall Study|Multiple reasons|12|||
33382184|NCT00818207|101283494|FG000|Overall Study|Withdrawal by Subject|42|||
33382185|NCT00818207|101283495|FG001|Overall Study|Withdrawal by Subject|104|||
33382186|NCT00818207|101283494|FG000|Overall Study|Death|3|||
33382187|NCT00818207|101283495|FG001|Overall Study|Death|5|||
33382188|NCT01181102|101283497|FG000|Overall Study|Adverse Event|28|||
33382189|NCT01181102|101283498|FG001|Overall Study|Adverse Event|26|||
33382190|NCT01181102|101283497|FG000|Overall Study|Lack of Efficacy|3|||
33382191|NCT01181102|101283498|FG001|Overall Study|Lack of Efficacy|1|||
33382192|NCT01181102|101283497|FG000|Overall Study|Lost to Follow-up|2|||
33382193|NCT01181102|101283498|FG001|Overall Study|Lost to Follow-up|0|||
33382194|NCT01181102|101283497|FG000|Overall Study|Physician Decision|3|||
33382195|NCT01181102|101283498|FG001|Overall Study|Physician Decision|1|||
33382196|NCT01181102|101283497|FG000|Overall Study|Protocol Violation|5|||
33382197|NCT01181102|101283498|FG001|Overall Study|Protocol Violation|6|||
33382198|NCT01181102|101283497|FG000|Overall Study|Withdrawal by Subject|10|||
33382199|NCT01181102|101283498|FG001|Overall Study|Withdrawal by Subject|12|||
33382200|NCT03074149|101283499|FG000|Overall Study|Reason unknown|22|||
33382201|NCT03074149|101283500|FG001|Overall Study|Reason unknown|35|||
33382202|NCT03074149|101283499|FG000|Overall Study|Death|10|||
33382203|NCT03074149|101283500|FG001|Overall Study|Death|45|||
33382204|NCT03495453|101283501|FG000|Overall Study|Withdrawal by Subject|0|||
33382205|NCT03495453|101283502|FG001|Overall Study|Withdrawal by Subject|1|||
33382206|NCT04142216|101283507|FG000|Overall Study|Hospitalization|0|||
33382207|NCT04142216|101283508|FG001|Overall Study|Hospitalization|2|||
33382208|NCT04142216|101283507|FG000|Overall Study|Death|3|||
33382209|NCT04142216|101283508|FG001|Overall Study|Death|1|||
33382210|NCT04142216|101283507|FG000|Overall Study|Referral to another hemodialysis unit|3|||
33382211|NCT04142216|101283508|FG001|Overall Study|Referral to another hemodialysis unit|2|||
33382212|NCT04142216|101283507|FG000|Overall Study|Use of clove|0|||
33382213|NCT04142216|101283508|FG001|Overall Study|Use of clove|1|||
33382214|NCT04721977|101283509|FG000|Overall Study|Death|15|||
33382215|NCT04721977|101283509|FG000|Overall Study|Ongoing|51|||
33382216|NCT02862548|101283510|FG000|Randomized Phase (Up to Week 48)|Death|0|||
33382217|NCT02862548|101283511|FG001|Randomized Phase (Up to Week 48)|Death|1|||
33382218|NCT02862548|101283510|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
33382219|NCT02862548|101283511|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
33428449|NCT02884206|101460019|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
33428450|NCT02884206|101460020|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
33428451|NCT02884206|101460021|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
33428452|NCT02884206|101460019|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
33428453|NCT02884206|101460020|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
33428454|NCT02884206|101460021|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
33428455|NCT02884206|101460019|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
33428456|NCT02884206|101460020|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
33428457|NCT02884206|101460021|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
33428458|NCT02884206|101460019|FG000|LCZ696 Run-in Period|Physician Decision|1|||
33428459|NCT02884206|101460020|FG001|LCZ696 Run-in Period|Physician Decision|0|||
33428460|NCT02884206|101460021|FG002|LCZ696 Run-in Period|Physician Decision|0|||
33382220|NCT02862548|101283510|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
33382221|NCT02862548|101283511|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
33382222|NCT02862548|101283510|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
33428461|NCT02884206|101460019|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
33428462|NCT02884206|101460020|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
33428463|NCT02884206|101460021|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
33428464|NCT02884206|101460019|FG000|Double-Blind Period|Death|0|||
33428465|NCT02884206|101460020|FG001|Double-Blind Period|Death|28|||
33428466|NCT02884206|101460021|FG002|Double-Blind Period|Death|39|||
33428467|NCT02884206|101460019|FG000|Double-Blind Period|Patient/guardian decision|0|||
33428468|NCT02884206|101460020|FG001|Double-Blind Period|Patient/guardian decision|10|||
33428469|NCT02884206|101460021|FG002|Double-Blind Period|Patient/guardian decision|13|||
33428470|NCT02884206|101460019|FG000|Double-Blind Period|Lost to Follow-up|0|||
33428471|NCT02884206|101460020|FG001|Double-Blind Period|Lost to Follow-up|4|||
33428472|NCT02884206|101460021|FG002|Double-Blind Period|Lost to Follow-up|4|||
33428473|NCT02884206|101460019|FG000|Double-Blind Period|Physician Decision|0|||
33428474|NCT02884206|101460020|FG001|Double-Blind Period|Physician Decision|2|||
33428475|NCT02884206|101460021|FG002|Double-Blind Period|Physician Decision|0|||
33428476|NCT02884206|101460019|FG000|Double-Blind Period|Adverse Event|0|||
33428477|NCT02884206|101460020|FG001|Double-Blind Period|Adverse Event|0|||
33428478|NCT02884206|101460021|FG002|Double-Blind Period|Adverse Event|3|||
33428479|NCT02884206|101460019|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
33428480|NCT02884206|101460020|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
33587704|NCT02237001|102038634|FG000|Overall Study|Incarceration|1|||
33587705|NCT02907216|102038635|FG000|Overall Study|No benefit to be obtained by continuing|0|||
33587706|NCT02907216|102038636|FG001|Overall Study|No benefit to be obtained by continuing|1|||
33382223|NCT02862548|101283511|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
33382224|NCT02475850|101283514|FG000|Overall Study|Death|155|||
33382225|NCT02475850|101283515|FG001|Overall Study|Death|141|||
33382226|NCT02475850|101283514|FG000|Overall Study|Lost to Follow-up|217|||
33382227|NCT02475850|101283515|FG001|Overall Study|Lost to Follow-up|188|||
33382228|NCT02475850|101283514|FG000|Overall Study|Withdrawal by Subject|221|||
33382229|NCT02475850|101283515|FG001|Overall Study|Withdrawal by Subject|155|||
33382230|NCT02322411|101283516|FG000|Overall Study|Lost to Follow-up|4|||
33382231|NCT02322411|101283517|FG001|Overall Study|Lost to Follow-up|7|||
33428481|NCT02884206|101460021|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
33428482|NCT00686920|101460022|FG000|Overall Study|Death|45|||
33428483|NCT00686920|101460023|FG001|Overall Study|Death|14|||
33428484|NCT00686920|101460022|FG000|Overall Study|Liver Transplant|23|||
33428485|NCT00686920|101460023|FG001|Overall Study|Liver Transplant|8|||
33428486|NCT00686920|101460022|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
33428487|NCT00686920|101460023|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
33428488|NCT00686920|101460022|FG000|Overall Study|Withdrawal by Subject|23|||
33428489|NCT00686920|101460023|FG001|Overall Study|Withdrawal by Subject|5|||
33428490|NCT00686920|101460022|FG000|Overall Study|Protocol Violation|2|||
33428491|NCT00686920|101460023|FG001|Overall Study|Protocol Violation|1|||
33428492|NCT00686920|101460022|FG000|Overall Study|Adverse Event|10|||
33428493|NCT00686920|101460023|FG001|Overall Study|Adverse Event|2|||
33428494|NCT00686920|101460022|FG000|Overall Study|Personal Reason|0|||
33428495|NCT00686920|101460023|FG001|Overall Study|Personal Reason|1|||
33428496|NCT00686920|101460022|FG000|Overall Study|Lost to Follow-up|15|||
33428497|NCT00686920|101460023|FG001|Overall Study|Lost to Follow-up|3|||
33428498|NCT00686920|101460022|FG000|Overall Study|Moved to Another State|1|||
33428499|NCT00686920|101460023|FG001|Overall Study|Moved to Another State|0|||
33428500|NCT00686920|101460022|FG000|Overall Study|Transferred to Nursing Home|1|||
33428501|NCT00686920|101460023|FG001|Overall Study|Transferred to Nursing Home|0|||
33428502|NCT00686920|101460022|FG000|Overall Study|Noncompliance|9|||
33382232|NCT02322411|101283516|FG000|Overall Study|Withdrawal by Subject|1|||
33382233|NCT02322411|101283517|FG001|Overall Study|Withdrawal by Subject|0|||
33382234|NCT01406652|101283518|FG000|Overall Study|Lost-to-follow-up|3|||
33382235|NCT01406652|101283519|FG001|Overall Study|Lost-to-follow-up|4|||
33382236|NCT01406652|101283518|FG000|Overall Study|Withdrawal by Subject|2|||
33382237|NCT01406652|101283519|FG001|Overall Study|Withdrawal by Subject|2|||
33382238|NCT01406652|101283518|FG000|Overall Study|Insufficient follow-up|5|||
33382239|NCT01406652|101283519|FG001|Overall Study|Insufficient follow-up|4|||
33382240|NCT01406652|101283518|FG000|Overall Study|Infection not sure|10|||
33382241|NCT01406652|101283519|FG001|Overall Study|Infection not sure|10|||
33382242|NCT02680587|101283523|FG000|Overall Study|Withdrawal by Subject|1|||
33382243|NCT02680587|101283524|FG001|Overall Study|Withdrawal by Subject|0|||
33382244|NCT01815580|101283525|FG000|Overall Study|Lost to Follow-up|4|||
33382245|NCT01815580|101283526|FG001|Overall Study|Lost to Follow-up|7|||
33382246|NCT01815580|101283525|FG000|Overall Study|Withdrawal by Subject|3|||
33382247|NCT01815580|101283526|FG001|Overall Study|Withdrawal by Subject|4|||
33382248|NCT01815580|101283525|FG000|Overall Study|Excluded from analysis|5|||
33382249|NCT01815580|101283526|FG001|Overall Study|Excluded from analysis|4|||
33382250|NCT05200455|101283527|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
33382251|NCT03372603|101283528|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
33382252|NCT03372603|101283529|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
33382253|NCT03372603|101283528|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
33382254|NCT03372603|101283529|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
33382255|NCT02671461|101283531|FG000|Treatment|Adverse Event|0|||
33382256|NCT02671461|101283532|FG001|Treatment|Adverse Event|0|||
33382257|NCT02671461|101283533|FG002|Treatment|Adverse Event|1|||
33382258|NCT02671461|101283531|FG000|Treatment|Administrative Reason by Sponsor|1|||
33382259|NCT02671461|101283532|FG001|Treatment|Administrative Reason by Sponsor|3|||
33382260|NCT02671461|101283533|FG002|Treatment|Administrative Reason by Sponsor|4|||
33382261|NCT02671461|101283531|FG000|Treatment|Randomized, not treated|1|||
33382262|NCT02671461|101283532|FG001|Treatment|Randomized, not treated|0|||
33382263|NCT02671461|101283533|FG002|Treatment|Randomized, not treated|0|||
33382264|NCT02671461|101283531|FG000|Follow-up|Withdrawal by Subject|1|||
33382265|NCT02671461|101283532|FG001|Follow-up|Withdrawal by Subject|0|||
33382266|NCT02671461|101283533|FG002|Follow-up|Withdrawal by Subject|0|||
33382267|NCT02671461|101283531|FG000|Follow-up|Lost to Follow-up|0|||
33382268|NCT02671461|101283532|FG001|Follow-up|Lost to Follow-up|0|||
33382269|NCT02671461|101283533|FG002|Follow-up|Lost to Follow-up|1|||
33382270|NCT02671461|101283531|FG000|Follow-up|Administrative Reason by Sponsor|0|||
33382271|NCT02671461|101283532|FG001|Follow-up|Administrative Reason by Sponsor|1|||
33382272|NCT02671461|101283533|FG002|Follow-up|Administrative Reason by Sponsor|0|||
33428503|NCT00686920|101460023|FG001|Overall Study|Noncompliance|0|||
33248567|NCT01090024|100810214|FG009|Period 3|Withdrawal by Subject|0|||
33248568|NCT01090024|100810215|FG010|Period 3|Withdrawal by Subject|0|||
33382273|NCT02887859|101283534|FG000|Overall Study|Ongoing|6|||
33382274|NCT02887859|101283534|FG000|Overall Study|Adverse Event|7|||
33382275|NCT02887859|101283534|FG000|Overall Study|Death|1|||
33382276|NCT02887859|101283534|FG000|Overall Study|Physician Decision|1|||
33382277|NCT04671342|101283535|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
33382278|NCT04671342|101283535|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
33428504|NCT00686920|101460022|FG000|Overall Study|Principal Investigator Decision|2|||
33428505|NCT00686920|101460023|FG001|Overall Study|Principal Investigator Decision|0|||
33428506|NCT02019979|101460024|FG000|Overall Study|study terminated|14|||
33428507|NCT00289458|101460025|FG000|Overall Study|Death|1|||
33587707|NCT02907216|102038635|FG000|Overall Study|Withdrawal by Subject|1|||
33382279|NCT04671342|101283535|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
33382280|NCT04671342|101283535|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
33382281|NCT04671342|101283535|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
33382282|NCT04671342|101283535|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
33382283|NCT02261883|101283536|FG000|Overall Study|Death|3|||
33382284|NCT02261883|101283537|FG001|Overall Study|Death|2|||
33382285|NCT02261883|101283536|FG000|Overall Study|Physician Decision|1|||
33382286|NCT02261883|101283537|FG001|Overall Study|Physician Decision|0|||
33382287|NCT02261883|101283536|FG000|Overall Study|Protocol Violation|1|||
33382288|NCT02261883|101283537|FG001|Overall Study|Protocol Violation|0|||
33382289|NCT02261883|101283536|FG000|Overall Study|Withdrawal by Subject|0|||
33382290|NCT02261883|101283537|FG001|Overall Study|Withdrawal by Subject|1|||
33382291|NCT02261883|101283536|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
33382292|NCT02261883|101283537|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
33382293|NCT00089479|101283538|FG000|Overall Study|Death|108|||
33382294|NCT00089479|101283539|FG001|Overall Study|Death|75|||
33382295|NCT00089479|101283538|FG000|Overall Study|Withdrawal by Subject|86|||
33382296|NCT00089479|101283539|FG001|Overall Study|Withdrawal by Subject|107|||
33382297|NCT00089479|101283538|FG000|Overall Study|Lost to Follow-up|137|||
33382298|NCT00089479|101283539|FG001|Overall Study|Lost to Follow-up|107|||
33382299|NCT01061736|101283542|FG000|Overall Study|Dose regimen not selected|0|||
33382300|NCT01061736|101283543|FG001|Overall Study|Dose regimen not selected|0|||
33382301|NCT01061736|101283544|FG002|Overall Study|Dose regimen not selected|0|||
33382302|NCT01061736|101283545|FG003|Overall Study|Dose regimen not selected|0|||
33382303|NCT01061736|101283546|FG004|Overall Study|Dose regimen not selected|0|||
33382304|NCT01061736|101283547|FG005|Overall Study|Dose regimen not selected|0|||
33382305|NCT01061736|101283548|FG006|Overall Study|Dose regimen not selected|79|||
33382306|NCT01061736|101283549|FG007|Overall Study|Dose regimen not selected|0|||
33382307|NCT01061736|101283550|FG008|Overall Study|Dose regimen not selected|0|||
33382308|NCT01061736|101283551|FG009|Overall Study|Dose regimen not selected|0|||
33382309|NCT01061736|101283542|FG000|Overall Study|Adverse Event|13|||
33382310|NCT01061736|101283543|FG001|Overall Study|Adverse Event|1|||
33382311|NCT01061736|101283544|FG002|Overall Study|Adverse Event|3|||
33382312|NCT01061736|101283545|FG003|Overall Study|Adverse Event|2|||
33382313|NCT01061736|101283546|FG004|Overall Study|Adverse Event|4|||
33382314|NCT01061736|101283547|FG005|Overall Study|Adverse Event|1|||
33382315|NCT01061736|101283548|FG006|Overall Study|Adverse Event|4|||
33382316|NCT01061736|101283549|FG007|Overall Study|Adverse Event|63|||
33382317|NCT01061736|101283550|FG008|Overall Study|Adverse Event|67|||
33382318|NCT01061736|101283551|FG009|Overall Study|Adverse Event|34|||
33382319|NCT01061736|101283542|FG000|Overall Study|Lack of Efficacy|0|||
33382320|NCT01061736|101283543|FG001|Overall Study|Lack of Efficacy|2|||
33382321|NCT01061736|101283544|FG002|Overall Study|Lack of Efficacy|1|||
33382322|NCT01061736|101283545|FG003|Overall Study|Lack of Efficacy|1|||
33382323|NCT01061736|101283546|FG004|Overall Study|Lack of Efficacy|1|||
33382324|NCT01061736|101283547|FG005|Overall Study|Lack of Efficacy|2|||
33382325|NCT01061736|101283548|FG006|Overall Study|Lack of Efficacy|1|||
33382326|NCT01061736|101283549|FG007|Overall Study|Lack of Efficacy|9|||
33382327|NCT01061736|101283550|FG008|Overall Study|Lack of Efficacy|9|||
33382328|NCT01061736|101283551|FG009|Overall Study|Lack of Efficacy|10|||
33382329|NCT01061736|101283542|FG000|Overall Study|Poor compliance to protocol|0|||
33382330|NCT01061736|101283543|FG001|Overall Study|Poor compliance to protocol|0|||
33382331|NCT01061736|101283544|FG002|Overall Study|Poor compliance to protocol|0|||
33382332|NCT01061736|101283545|FG003|Overall Study|Poor compliance to protocol|0|||
33382333|NCT01061736|101283546|FG004|Overall Study|Poor compliance to protocol|0|||
33382334|NCT01061736|101283547|FG005|Overall Study|Poor compliance to protocol|0|||
33382335|NCT01061736|101283548|FG006|Overall Study|Poor compliance to protocol|0|||
33382336|NCT01061736|101283549|FG007|Overall Study|Poor compliance to protocol|2|||
33382337|NCT01061736|101283550|FG008|Overall Study|Poor compliance to protocol|5|||
33382338|NCT01061736|101283551|FG009|Overall Study|Poor compliance to protocol|9|||
33382339|NCT01061736|101283542|FG000|Overall Study|Not treated|0|||
33382340|NCT01061736|101283543|FG001|Overall Study|Not treated|0|||
33587708|NCT02907216|102038636|FG001|Overall Study|Withdrawal by Subject|0|||
33382341|NCT01061736|101283544|FG002|Overall Study|Not treated|0|||
33382342|NCT01061736|101283545|FG003|Overall Study|Not treated|0|||
33382343|NCT01061736|101283546|FG004|Overall Study|Not treated|1|||
33382344|NCT01061736|101283547|FG005|Overall Study|Not treated|0|||
33382345|NCT01061736|101283548|FG006|Overall Study|Not treated|0|||
33587709|NCT03928418|102038637|FG000|Overall Study|Lost to Follow-up|5|||
33382346|NCT01061736|101283549|FG007|Overall Study|Not treated|2|||
33382347|NCT01061736|101283550|FG008|Overall Study|Not treated|1|||
33382348|NCT01061736|101283551|FG009|Overall Study|Not treated|0|||
33382349|NCT01061736|101283542|FG000|Overall Study|Other than specified above|0|||
33382350|NCT01061736|101283543|FG001|Overall Study|Other than specified above|1|||
33382351|NCT01061736|101283544|FG002|Overall Study|Other than specified above|2|||
33382352|NCT01061736|101283545|FG003|Overall Study|Other than specified above|0|||
33587710|NCT03928418|102038638|FG001|Overall Study|Lost to Follow-up|3|||
33428508|NCT00289458|101460026|FG001|Overall Study|Death|0|||
33428509|NCT00289458|101460027|FG002|Overall Study|Death|0|||
33428510|NCT00289458|101460025|FG000|Overall Study|Physician Decision|3|||
33428511|NCT00289458|101460026|FG001|Overall Study|Physician Decision|4|||
33428512|NCT00289458|101460027|FG002|Overall Study|Physician Decision|2|||
33428513|NCT00289458|101460025|FG000|Overall Study|Withdrawal by Subject|2|||
33428514|NCT00289458|101460026|FG001|Overall Study|Withdrawal by Subject|2|||
33587711|NCT03928418|102038639|FG002|Overall Study|Lost to Follow-up|5|||
33587712|NCT03928418|102038637|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
33587713|NCT03928418|102038638|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
33587714|NCT03928418|102038639|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
33587715|NCT00809835|102038640|FG000|Overall Study|Lost to Follow-up|7|||
33587716|NCT00809835|102038641|FG001|Overall Study|Lost to Follow-up|6|||
33587717|NCT00809835|102038642|FG002|Overall Study|Lost to Follow-up|10|||
33587718|NCT00809835|102038643|FG003|Overall Study|Lost to Follow-up|2|||
33587719|NCT00809835|102038640|FG000|Overall Study|Withdrawal by Subject|1|||
33587720|NCT00809835|102038641|FG001|Overall Study|Withdrawal by Subject|1|||
33587721|NCT00809835|102038642|FG002|Overall Study|Withdrawal by Subject|1|||
33587722|NCT00809835|102038643|FG003|Overall Study|Withdrawal by Subject|0|||
33587723|NCT00553436|102038644|FG000|Overall Study|Conversion to another procedure|1|||
33587724|NCT00372619|102038645|FG000|Overall Study|Ineligible|0|||
33587725|NCT00372619|102038646|FG001|Overall Study|Ineligible|0|||
33587726|NCT00372619|102038647|FG002|Overall Study|Ineligible|0|||
33587727|NCT00372619|102038648|FG003|Overall Study|Ineligible|0|||
33587728|NCT00372619|102038649|FG004|Overall Study|Ineligible|0|||
33587729|NCT00372619|102038650|FG005|Overall Study|Ineligible|2|||
33587730|NCT00372619|102038651|FG006|Overall Study|Ineligible|0|||
33587731|NCT00372619|102038645|FG000|Overall Study|Inevaluable|0|||
33587732|NCT00372619|102038646|FG001|Overall Study|Inevaluable|0|||
33587733|NCT00372619|102038647|FG002|Overall Study|Inevaluable|0|||
33587734|NCT00372619|102038648|FG003|Overall Study|Inevaluable|0|||
33587735|NCT00372619|102038649|FG004|Overall Study|Inevaluable|0|||
33587736|NCT00372619|102038650|FG005|Overall Study|Inevaluable|1|||
33587737|NCT00372619|102038651|FG006|Overall Study|Inevaluable|0|||
33587738|NCT00617084|102038654|FG000|Overall Study|Withdrawal by Subject|5|||
33587739|NCT00617084|102038655|FG001|Overall Study|Withdrawal by Subject|7|||
33587740|NCT00617084|102038654|FG000|Overall Study|Missed 12 Months visit|16|||
33587741|NCT00617084|102038655|FG001|Overall Study|Missed 12 Months visit|19|||
33587742|NCT02241733|102038656|FG000|Overall Study|Lost to Follow-up|9|||
33587743|NCT02241733|102038657|FG001|Overall Study|Lost to Follow-up|4|||
33587744|NCT02241733|102038656|FG000|Overall Study|Physician Decision|6|||
33587745|NCT02241733|102038657|FG001|Overall Study|Physician Decision|2|||
33587746|NCT02241733|102038656|FG000|Overall Study|Withdrawal by Subject|0|||
33587747|NCT02241733|102038657|FG001|Overall Study|Withdrawal by Subject|2|||
33587748|NCT02241733|102038656|FG000|Overall Study|Death|0|||
33587749|NCT02241733|102038657|FG001|Overall Study|Death|2|||
33587750|NCT02817776|102038658|FG000|Overall Study|Excluded|33|||
33587751|NCT02817776|102038658|FG000|Overall Study|Lost to Follow-up|20|||
33587752|NCT02817776|102038658|FG000|Overall Study|Withdrawal by Subject|33|||
33587753|NCT02817776|102038658|FG000|Overall Study|Death|2|||
33587754|NCT04952597|102041657|FG000|Overall Study|Death|12|||
33587755|NCT04952597|102041658|FG001|Overall Study|Death|13|||
33587756|NCT04952597|102041659|FG002|Overall Study|Death|14|||
33587757|NCT04952597|102041657|FG000|Overall Study|Withdrawal by Subject|1|||
33587758|NCT04952597|102041658|FG001|Overall Study|Withdrawal by Subject|0|||
33587759|NCT04952597|102041659|FG002|Overall Study|Withdrawal by Subject|3|||
33587760|NCT04952597|102041657|FG000|Overall Study|Lost to Follow-up|0|||
33587761|NCT04952597|102041658|FG001|Overall Study|Lost to Follow-up|1|||
33587762|NCT04952597|102041659|FG002|Overall Study|Lost to Follow-up|1|||
33587763|NCT00810277|102041660|FG000|Overall Study|Adverse Event|1|||
33587764|NCT00368745|102041661|FG000|Double-blind Treatment Period|Adverse Event|6|||
33587765|NCT00368745|102041662|FG001|Double-blind Treatment Period|Adverse Event|6|||
33587766|NCT00368745|102041661|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
33647681|NCT02547363|102262800|FG001|12-month Follow-up|Lost to Follow-up|1|||
33647682|NCT02547363|102262799|FG000|12-month Follow-up|Lack of Efficacy|1|||
33428515|NCT00289458|101460027|FG002|Overall Study|Withdrawal by Subject|4|||
33428516|NCT02049359|101460030|FG000|Overall Study|Lost to Follow-up|26|||
33428517|NCT02049359|101460031|FG001|Overall Study|Lost to Follow-up|19|||
33428518|NCT04345471|101460032|FG000|Overall Study|Adverse Event|8|||
33587767|NCT00368745|102041662|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
33587768|NCT00368745|102041661|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
33587769|NCT00368745|102041662|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
33587770|NCT00368745|102041661|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
33587771|NCT00368745|102041662|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
33587772|NCT00368745|102041661|FG000|Double-blind Treatment Period|Other|7|||
33587773|NCT00368745|102041662|FG001|Double-blind Treatment Period|Other|6|||
33587774|NCT01961297|102041663|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
33587775|NCT01961297|102041664|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
33587776|NCT01262638|102041665|FG000|Overall Study|Adverse Event|3|||
33428519|NCT04345471|101460033|FG001|Overall Study|Adverse Event|5|||
33428520|NCT04345471|101460034|FG002|Overall Study|Adverse Event|6|||
33428521|NCT04345471|101460032|FG000|Overall Study|Lack of Efficacy|1|||
33428522|NCT04345471|101460033|FG001|Overall Study|Lack of Efficacy|1|||
33428523|NCT04345471|101460034|FG002|Overall Study|Lack of Efficacy|0|||
33428524|NCT04345471|101460032|FG000|Overall Study|Protocol Violation|0|||
33428525|NCT04345471|101460033|FG001|Overall Study|Protocol Violation|1|||
33428526|NCT04345471|101460034|FG002|Overall Study|Protocol Violation|2|||
33428527|NCT04345471|101460032|FG000|Overall Study|Withdrawal by Subject|10|||
33428528|NCT04345471|101460033|FG001|Overall Study|Withdrawal by Subject|5|||
33428529|NCT04345471|101460034|FG002|Overall Study|Withdrawal by Subject|10|||
33428530|NCT00626925|101460037|FG000|Overall Study|Lost to Follow-up|1|||
33428531|NCT00626925|101460038|FG001|Overall Study|Lost to Follow-up|2|||
33428532|NCT00626925|101460037|FG000|Overall Study|relapse|1|||
33428533|NCT00626925|101460038|FG001|Overall Study|relapse|0|||
33428534|NCT00626925|101460037|FG000|Overall Study|Adverse effect|6|||
33428535|NCT00626925|101460038|FG001|Overall Study|Adverse effect|2|||
33428536|NCT00626925|101460037|FG000|Overall Study|Lack of Efficacy|1|||
33428537|NCT00626925|101460038|FG001|Overall Study|Lack of Efficacy|4|||
33428538|NCT00626925|101460037|FG000|Overall Study|Time constraints|3|||
33428539|NCT00626925|101460038|FG001|Overall Study|Time constraints|1|||
33428540|NCT00673790|101460039|FG000|Overall Study|Adverse Event|23|||
33428541|NCT00673790|101460040|FG001|Overall Study|Adverse Event|14|||
33428542|NCT00673790|101460041|FG002|Overall Study|Adverse Event|2|||
33428543|NCT00673790|101460039|FG000|Overall Study|Lack of Efficacy|2|||
33428544|NCT00673790|101460040|FG001|Overall Study|Lack of Efficacy|2|||
33428545|NCT00673790|101460041|FG002|Overall Study|Lack of Efficacy|2|||
33428546|NCT00673790|101460039|FG000|Overall Study|Protocol Violation|6|||
33428547|NCT00673790|101460040|FG001|Overall Study|Protocol Violation|9|||
33428548|NCT00673790|101460041|FG002|Overall Study|Protocol Violation|1|||
33428549|NCT00673790|101460039|FG000|Overall Study|Withdrawal by Subject|7|||
33428550|NCT00673790|101460040|FG001|Overall Study|Withdrawal by Subject|4|||
33428551|NCT00673790|101460041|FG002|Overall Study|Withdrawal by Subject|1|||
33428552|NCT00673790|101460039|FG000|Overall Study|Lost to Follow-up|6|||
33428553|NCT00673790|101460040|FG001|Overall Study|Lost to Follow-up|6|||
33428554|NCT00673790|101460041|FG002|Overall Study|Lost to Follow-up|5|||
33428555|NCT00673790|101460039|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
33428556|NCT00673790|101460040|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
33428557|NCT00673790|101460041|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
33428558|NCT00673790|101460039|FG000|Overall Study|Poor compliance|1|||
33428559|NCT00673790|101460040|FG001|Overall Study|Poor compliance|0|||
33428560|NCT00673790|101460041|FG002|Overall Study|Poor compliance|0|||
33428561|NCT00673790|101460039|FG000|Overall Study|Participated in two Nebivolol studies|0|||
33428562|NCT00673790|101460040|FG001|Overall Study|Participated in two Nebivolol studies|0|||
33428563|NCT00673790|101460041|FG002|Overall Study|Participated in two Nebivolol studies|1|||
33428564|NCT00673790|101460039|FG000|Overall Study|Unconfirmed pregnancy|0|||
33428565|NCT00673790|101460040|FG001|Overall Study|Unconfirmed pregnancy|1|||
33428566|NCT00673790|101460041|FG002|Overall Study|Unconfirmed pregnancy|0|||
33428567|NCT00673790|101460039|FG000|Overall Study|Randomization criteria not met|0|||
33428568|NCT00673790|101460040|FG001|Overall Study|Randomization criteria not met|1|||
33428569|NCT00673790|101460041|FG002|Overall Study|Randomization criteria not met|0|||
33428570|NCT01564758|101460042|FG000|Overall Study|Death|8|||
33428571|NCT01564758|101460042|FG000|Overall Study|Adverse Event|3|||
33428572|NCT01564758|101460042|FG000|Overall Study|Other|3|||
33428573|NCT02843074|101460043|FG000|Overall Study|Withdrawal by Subject|5|||
33428574|NCT02843074|101460043|FG000|Overall Study|Progressive disease|1|||
33428575|NCT02843074|101460043|FG000|Overall Study|Physician Decision|1|||
33428576|NCT02843074|101460043|FG000|Overall Study|Lost to Follow-up|1|||
33428577|NCT02843074|101460043|FG000|Overall Study|Death|9|||
33428578|NCT01186978|101460052|FG000|Overall Study|Withdrawal by Subject|1|||
33428579|NCT01736553|101460053|FG000|Overall Study|Death|12|||
33428580|NCT01736553|101460054|FG001|Overall Study|Death|0|||
33428581|NCT01736553|101460053|FG000|Overall Study|Withdrawal by Subject|5|||
33428582|NCT01736553|101460054|FG001|Overall Study|Withdrawal by Subject|2|||
33428583|NCT01736553|101460053|FG000|Overall Study|Lost to Follow-up|2|||
33428584|NCT01736553|101460054|FG001|Overall Study|Lost to Follow-up|2|||
33428585|NCT00576199|101460056|FG000|Overall Study|Adverse Event|12|||
33428586|NCT00576199|101460056|FG000|Overall Study|Insufficient Therapeutic Response|14|||
33428587|NCT00576199|101460056|FG000|Overall Study|Refused Treatment|2|||
33428588|NCT00576199|101460056|FG000|Overall Study|Reason Unspecified|2|||
33428589|NCT02268045|101460057|FG000|Overall Study|Death|4|||
33428590|NCT02268045|101460058|FG001|Overall Study|Death|4|||
33428591|NCT02268045|101460057|FG000|Overall Study|Disease Progression|2|||
33428592|NCT02268045|101460058|FG001|Overall Study|Disease Progression|1|||
33428593|NCT02268045|101460057|FG000|Overall Study|Adverse Event|7|||
33428594|NCT02268045|101460058|FG001|Overall Study|Adverse Event|7|||
33428595|NCT02268045|101460057|FG000|Overall Study|Withdrawal by Subject|2|||
33428596|NCT02268045|101460058|FG001|Overall Study|Withdrawal by Subject|6|||
33428597|NCT02268045|101460057|FG000|Overall Study|Physician Decision|0|||
33428598|NCT02268045|101460058|FG001|Overall Study|Physician Decision|1|||
33428599|NCT02268045|101460057|FG000|Overall Study|Protocol Violation|1|||
33428600|NCT02268045|101460058|FG001|Overall Study|Protocol Violation|1|||
33428601|NCT03387059|101460059|FG000|Overall Study|Study termination|5|||
33428602|NCT03387059|101460060|FG001|Overall Study|Study termination|4|||
33428603|NCT01759537|101460062|FG000|Overall Study|Death|1|||
33428604|NCT01759537|101460063|FG001|Overall Study|Death|1|||
33428605|NCT01759537|101460062|FG000|Overall Study|Pregnancy|1|||
33428606|NCT01759537|101460063|FG001|Overall Study|Pregnancy|1|||
33428607|NCT01759537|101460062|FG000|Overall Study|Lost to Follow-up|9|||
33428608|NCT01759537|101460063|FG001|Overall Study|Lost to Follow-up|9|||
33428609|NCT01759537|101460062|FG000|Overall Study|Accident involving jaw fracture|1|||
33428610|NCT01759537|101460063|FG001|Overall Study|Accident involving jaw fracture|1|||
33428611|NCT01759537|101460062|FG000|Overall Study|Subcrestal implant too coronal|1|||
33428612|NCT01759537|101460063|FG001|Overall Study|Subcrestal implant too coronal|1|||
33428613|NCT01388647|101460064|FG000|Overall Study|Adverse Event|1|||
33428614|NCT01388647|101460065|FG001|Overall Study|Adverse Event|2|||
33428615|NCT02400905|101460068|FG000|Overall Study|Death|24|||
33428616|NCT02400905|101460068|FG000|Overall Study|Lost to Follow-up|18|||
33428617|NCT02400905|101460068|FG000|Overall Study|Withdrawal by Subject|16|||
33428618|NCT02400905|101460068|FG000|Overall Study|Physician Decision|4|||
33428619|NCT02400905|101460068|FG000|Overall Study|Other|1|||
33428620|NCT02472977|101460069|FG000|Overall Study|Disease progression|4|||
33428621|NCT02472977|101460070|FG001|Overall Study|Disease progression|25|||
33428622|NCT02472977|101460071|FG002|Overall Study|Disease progression|6|||
33428623|NCT02472977|101460069|FG000|Overall Study|Withdrawal by Subject|0|||
33428624|NCT02472977|101460070|FG001|Overall Study|Withdrawal by Subject|1|||
33428625|NCT02472977|101460071|FG002|Overall Study|Withdrawal by Subject|0|||
33428626|NCT02472977|101460069|FG000|Overall Study|Study drug toxicity|2|||
33428627|NCT02472977|101460070|FG001|Overall Study|Study drug toxicity|0|||
33428628|NCT02472977|101460071|FG002|Overall Study|Study drug toxicity|2|||
33428629|NCT02472977|101460069|FG000|Overall Study|Subject request to discontinue treatment|0|||
33428630|NCT02472977|101460070|FG001|Overall Study|Subject request to discontinue treatment|1|||
33428631|NCT02472977|101460071|FG002|Overall Study|Subject request to discontinue treatment|0|||
33428632|NCT02415959|101460072|FG000|Overall Study|Adverse Event|0|||
33428633|NCT02415959|101460073|FG001|Overall Study|Adverse Event|1|||
33428634|NCT02415959|101460074|FG002|Overall Study|Adverse Event|0|||
33428635|NCT02415959|101460075|FG003|Overall Study|Adverse Event|0|||
33428636|NCT02415959|101460076|FG004|Overall Study|Adverse Event|0|||
33428637|NCT02415959|101460072|FG000|Overall Study|Protocol Violation|0|||
33428638|NCT02415959|101460073|FG001|Overall Study|Protocol Violation|0|||
33428639|NCT02415959|101460074|FG002|Overall Study|Protocol Violation|0|||
33428640|NCT02415959|101460075|FG003|Overall Study|Protocol Violation|1|||
33428641|NCT02415959|101460076|FG004|Overall Study|Protocol Violation|0|||
33428642|NCT00905489|101460077|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
33428643|NCT00905489|101460077|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
33428644|NCT00905489|101460077|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
33428645|NCT00697112|101460078|FG000|Overall Study|Adverse Event|8|||
33428646|NCT00697112|101460078|FG000|Overall Study|Lost to Follow-up|1|||
33428647|NCT00697112|101460078|FG000|Overall Study|Did not meet inclusion criteria|1|||
33428648|NCT02742181|101460087|FG000|Overall Study|Physician Decision|1|||
33428649|NCT02742181|101460088|FG001|Overall Study|Physician Decision|0|||
33428650|NCT01789281|101460092|FG000|Overall Study|Disease progression|15|||
33428651|NCT01789281|101460093|FG001|Overall Study|Disease progression|4|||
33428652|NCT01789281|101460092|FG000|Overall Study|Adverse Event|5|||
33428653|NCT01789281|101460093|FG001|Overall Study|Adverse Event|5|||
33428654|NCT01789281|101460092|FG000|Overall Study|Withdrawal by Subject|1|||
33428655|NCT01789281|101460093|FG001|Overall Study|Withdrawal by Subject|0|||
33428656|NCT01789281|101460092|FG000|Overall Study|Lost to Follow-up|1|||
33428657|NCT01789281|101460093|FG001|Overall Study|Lost to Follow-up|0|||
33428658|NCT01789281|101460092|FG000|Overall Study|Administrative problems|0|||
33428659|NCT01789281|101460093|FG001|Overall Study|Administrative problems|1|||
33428660|NCT02109133|101460094|FG000|Overall Study|Lost to Follow-up|1|||
33428661|NCT02109133|101460095|FG001|Overall Study|Lost to Follow-up|0|||
33428662|NCT02614703|101460098|FG000|Overall Study|Withdrawal by Subject|7|||
33428663|NCT02614703|101460099|FG001|Overall Study|Withdrawal by Subject|1|||
33428664|NCT00947856|101460100|FG000|Treatment Period|Progressive Disease|33|||
33428665|NCT00947856|101460101|FG001|Treatment Period|Progressive Disease|12|||
33428666|NCT00947856|101460100|FG000|Treatment Period|Adverse Event|15|||
33428667|NCT00947856|101460101|FG001|Treatment Period|Adverse Event|9|||
33428668|NCT00947856|101460100|FG000|Treatment Period|Physician Decision|14|||
33428669|NCT00947856|101460101|FG001|Treatment Period|Physician Decision|6|||
33428670|NCT00947856|101460100|FG000|Treatment Period|Study Stopped by Sponsor|4|||
33428671|NCT00947856|101460101|FG001|Treatment Period|Study Stopped by Sponsor|4|||
33428672|NCT00947856|101460100|FG000|Treatment Period|Withdrawal by Subject|12|||
33428673|NCT00947856|101460101|FG001|Treatment Period|Withdrawal by Subject|1|||
33428674|NCT00947856|101460100|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
33428675|NCT00947856|101460101|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
33428676|NCT00947856|101460100|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
33428677|NCT00947856|101460101|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
33428678|NCT00947856|101460100|FG000|Follow-up Period|Lost to Follow-up|7|||
33428679|NCT00947856|101460101|FG001|Follow-up Period|Lost to Follow-up|0|||
33428680|NCT00947856|101460100|FG000|Follow-up Period|Patient unavailable for site visits|1|||
33428681|NCT00947856|101460101|FG001|Follow-up Period|Patient unavailable for site visits|0|||
33428682|NCT00947856|101460100|FG000|Follow-up Period|Withdrawal by Subject|1|||
33428683|NCT00947856|101460101|FG001|Follow-up Period|Withdrawal by Subject|0|||
33428684|NCT02826603|101460102|FG000|Overall Study|Adverse Event|17|||
33428685|NCT02826603|101460103|FG001|Overall Study|Adverse Event|9|||
33428686|NCT02826603|101460102|FG000|Overall Study|Lack of Efficacy|4|||
33428687|NCT02826603|101460103|FG001|Overall Study|Lack of Efficacy|9|||
33428688|NCT02826603|101460102|FG000|Overall Study|Lost to Follow-up|13|||
33428689|NCT02826603|101460103|FG001|Overall Study|Lost to Follow-up|12|||
33428690|NCT02826603|101460102|FG000|Overall Study|Noncompliance with treatment|0|||
33428691|NCT02826603|101460103|FG001|Overall Study|Noncompliance with treatment|2|||
33428692|NCT02826603|101460102|FG000|Overall Study|Physician Decision|1|||
33428693|NCT02826603|101460103|FG001|Overall Study|Physician Decision|7|||
33428694|NCT02826603|101460102|FG000|Overall Study|Pregnancy|1|||
33428695|NCT02826603|101460103|FG001|Overall Study|Pregnancy|2|||
33428696|NCT02826603|101460102|FG000|Overall Study|Protocol Violation|3|||
33428697|NCT02826603|101460103|FG001|Overall Study|Protocol Violation|3|||
33428698|NCT02826603|101460102|FG000|Overall Study|Withdrawal by Subject|20|||
33428699|NCT02826603|101460103|FG001|Overall Study|Withdrawal by Subject|19|||
33428700|NCT02826603|101460102|FG000|Overall Study|Death|2|||
33428701|NCT02826603|101460103|FG001|Overall Study|Death|0|||
33428702|NCT02826603|101460102|FG000|Overall Study|New therapy for study indication|0|||
33428703|NCT02826603|101460103|FG001|Overall Study|New therapy for study indication|1|||
33428704|NCT00669955|101460105|FG000|Overall Study|Adverse Event|3|||
33428705|NCT00669955|101460106|FG001|Overall Study|Adverse Event|5|||
33428706|NCT00669955|101460105|FG000|Overall Study|Death|0|||
33428707|NCT00669955|101460106|FG001|Overall Study|Death|1|||
33428708|NCT00669955|101460105|FG000|Overall Study|Withdrawal by Subject|2|||
33428709|NCT00669955|101460106|FG001|Overall Study|Withdrawal by Subject|3|||
33428710|NCT00669955|101460105|FG000|Overall Study|Lost to Follow-up|5|||
33428711|NCT00669955|101460106|FG001|Overall Study|Lost to Follow-up|7|||
33428712|NCT00669955|101460105|FG000|Overall Study|Protocol Violation|2|||
33428713|NCT00669955|101460106|FG001|Overall Study|Protocol Violation|7|||
33587777|NCT01262638|102041666|FG001|Overall Study|Adverse Event|4|||
33587778|NCT01262638|102041667|FG002|Overall Study|Adverse Event|3|||
33587779|NCT01262638|102041668|FG003|Overall Study|Adverse Event|4|||
33587780|NCT01262638|102041665|FG000|Overall Study|Protocol Violation|1|||
33587781|NCT01262638|102041666|FG001|Overall Study|Protocol Violation|0|||
33587782|NCT01262638|102041667|FG002|Overall Study|Protocol Violation|0|||
33587783|NCT01262638|102041668|FG003|Overall Study|Protocol Violation|1|||
33382353|NCT01061736|101283546|FG004|Overall Study|Other than specified above|1|||
33382354|NCT01061736|101283547|FG005|Overall Study|Other than specified above|0|||
33382355|NCT01061736|101283548|FG006|Overall Study|Other than specified above|0|||
33382356|NCT01061736|101283549|FG007|Overall Study|Other than specified above|18|||
33382357|NCT01061736|101283550|FG008|Overall Study|Other than specified above|15|||
33382358|NCT01061736|101283551|FG009|Overall Study|Other than specified above|21|||
33382359|NCT00485589|101283552|FG000|Overall Study|Death|2|||
33382360|NCT00485589|101283553|FG001|Overall Study|Death|2|||
33382361|NCT00485589|101283554|FG002|Overall Study|Death|0|||
33382362|NCT00485589|101283552|FG000|Overall Study|Failure to return|6|||
33382363|NCT00485589|101283553|FG001|Overall Study|Failure to return|5|||
33382364|NCT00485589|101283554|FG002|Overall Study|Failure to return|1|||
33382365|NCT00485589|101283552|FG000|Overall Study|Protocol Violation|1|||
33382366|NCT00485589|101283553|FG001|Overall Study|Protocol Violation|0|||
33382367|NCT00485589|101283554|FG002|Overall Study|Protocol Violation|0|||
33382368|NCT00485589|101283552|FG000|Overall Study|Violation of selection criteria at entry|0|||
33382369|NCT00485589|101283553|FG001|Overall Study|Violation of selection criteria at entry|3|||
33382370|NCT00485589|101283554|FG002|Overall Study|Violation of selection criteria at entry|1|||
33382371|NCT00485589|101283552|FG000|Overall Study|Administrative/Other|1|||
33382372|NCT00485589|101283553|FG001|Overall Study|Administrative/Other|2|||
33382373|NCT00485589|101283554|FG002|Overall Study|Administrative/Other|1|||
33382374|NCT00485589|101283552|FG000|Overall Study|Insufficient therapeutic response|10|||
33382375|NCT00485589|101283553|FG001|Overall Study|Insufficient therapeutic response|3|||
33382376|NCT00485589|101283554|FG002|Overall Study|Insufficient therapeutic response|1|||
33428714|NCT00669955|101460105|FG000|Overall Study|Investigator Sponsor Judgement|0|||
33587784|NCT01262638|102041665|FG000|Overall Study|Withdrawal by Subject|2|||
33587785|NCT01262638|102041666|FG001|Overall Study|Withdrawal by Subject|1|||
33587786|NCT01262638|102041667|FG002|Overall Study|Withdrawal by Subject|0|||
33587787|NCT01262638|102041668|FG003|Overall Study|Withdrawal by Subject|1|||
33382377|NCT00485589|101283552|FG000|Overall Study|Refused treatment/did not cooperate|1|||
33428715|NCT00669955|101460106|FG001|Overall Study|Investigator Sponsor Judgement|1|||
33428716|NCT00669955|101460105|FG000|Overall Study|not compliant with study drug/visit|2|||
33428717|NCT00669955|101460106|FG001|Overall Study|not compliant with study drug/visit|3|||
33382378|NCT00485589|101283553|FG001|Overall Study|Refused treatment/did not cooperate|0|||
33382379|NCT00485589|101283554|FG002|Overall Study|Refused treatment/did not cooperate|2|||
33382380|NCT00485589|101283552|FG000|Overall Study|Withdrawal by Subject|3|||
33382381|NCT00485589|101283553|FG001|Overall Study|Withdrawal by Subject|2|||
33382382|NCT00485589|101283554|FG002|Overall Study|Withdrawal by Subject|2|||
33382383|NCT00485589|101283552|FG000|Overall Study|Adverse Event|3|||
33382384|NCT00485589|101283553|FG001|Overall Study|Adverse Event|3|||
33382385|NCT00485589|101283554|FG002|Overall Study|Adverse Event|10|||
33382386|NCT01283997|101283555|FG000|Overall Study|Physician Decision|8|||
33382387|NCT01283997|101283556|FG001|Overall Study|Physician Decision|10|||
33382388|NCT01283997|101283555|FG000|Overall Study|Withdrawal by Subject|3|||
33382389|NCT01283997|101283556|FG001|Overall Study|Withdrawal by Subject|2|||
33647683|NCT02547363|102262800|FG001|12-month Follow-up|Lack of Efficacy|1|||
33647684|NCT02547363|102262799|FG000|12-month Follow-up|Other|1|||
33647685|NCT02547363|102262800|FG001|12-month Follow-up|Other|0|||
33647686|NCT01112306|102262801|FG000|Overall Study|Death|175|||
33647687|NCT01112306|102262801|FG000|Overall Study|Lost to Follow-up|9|||
33647688|NCT01112306|102262801|FG000|Overall Study|Withdrawal by Subject|31|||
33647689|NCT01112306|102262801|FG000|Overall Study|Other|70|||
33647690|NCT01451437|102262802|FG000|Overall Study|Adverse Event|0|||
33647691|NCT01451437|102262803|FG001|Overall Study|Adverse Event|0|||
33647692|NCT01451437|102262804|FG002|Overall Study|Adverse Event|0|||
33647693|NCT01451437|102262805|FG003|Overall Study|Adverse Event|0|||
33647694|NCT01451437|102262806|FG004|Overall Study|Adverse Event|0|||
33647695|NCT01451437|102262807|FG005|Overall Study|Adverse Event|1|||
33647696|NCT01451437|102262808|FG006|Overall Study|Adverse Event|1|||
33647697|NCT01451437|102262809|FG007|Overall Study|Adverse Event|2|||
33647698|NCT01451437|102262810|FG008|Overall Study|Adverse Event|1|||
33149485|NCT00191646|100460753|FG001|Overall Study|Withdrawal by Subject|39|||
33149486|NCT00191646|100460752|FG000|Overall Study|Protocol Violation|5|||
33149487|NCT00191646|100460753|FG001|Overall Study|Protocol Violation|7|||
33149488|NCT00191646|100460752|FG000|Overall Study|Death|6|||
33382390|NCT01283997|101283555|FG000|Overall Study|Physically unable to continue|0|||
33382391|NCT01283997|101283556|FG001|Overall Study|Physically unable to continue|1|||
33382392|NCT01283997|101283555|FG000|Overall Study|Progressive disease|1|||
33382393|NCT01283997|101283556|FG001|Overall Study|Progressive disease|0|||
33382394|NCT01283997|101283555|FG000|Overall Study|Other|4|||
33382395|NCT01283997|101283556|FG001|Overall Study|Other|4|||
33382396|NCT00892957|101283557|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
33382397|NCT00892957|101283558|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
33382398|NCT00892957|101283557|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
33382399|NCT00892957|101283558|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
33428718|NCT02100956|101460107|FG000|At Least One Week Between Injections|Adverse Event|0|||
33149489|NCT00191646|100460753|FG001|Overall Study|Death|8|||
33149490|NCT00191646|100460752|FG000|Overall Study|Other|33|||
33149491|NCT00191646|100460753|FG001|Overall Study|Other|34|||
33149492|NCT00191646|100460752|FG000|Overall Study|Missing Data|18|||
33149493|NCT00191646|100460753|FG001|Overall Study|Missing Data|11|||
33149494|NCT02927262|100460757|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
33149495|NCT02927262|100460758|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
33149496|NCT02927262|100460757|FG000|Treatment Period (Up to 744 Days)|Death|1|||
33149497|NCT02927262|100460758|FG001|Treatment Period (Up to 744 Days)|Death|0|||
33149498|NCT02927262|100460757|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
33149499|NCT02927262|100460758|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
33149500|NCT02927262|100460757|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
33149501|NCT02927262|100460758|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
33149502|NCT02927262|100460757|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
33149503|NCT02927262|100460758|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
33149504|NCT02927262|100460757|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
33382400|NCT04019795|101283565|FG000|Overall Study|Withdrawal by Subject|1|||
33382401|NCT04019795|101283566|FG001|Overall Study|Withdrawal by Subject|2|||
33428719|NCT02100956|101460108|FG001|At Least One Week Between Injections|Adverse Event|1|||
33428720|NCT02965820|101460124|FG000|Period 2, Second 30 Days|Adverse Event|1|||
33428721|NCT02965820|101460125|FG001|Period 2, Second 30 Days|Adverse Event|1|||
33149505|NCT02927262|100460758|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
33382402|NCT04019795|101283567|FG002|Overall Study|Withdrawal by Subject|2|||
33382403|NCT04019795|101283568|FG003|Overall Study|Withdrawal by Subject|1|||
33587788|NCT01262638|102041665|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
33382404|NCT04019795|101283565|FG000|Overall Study|Lost to Follow-up|0|||
33647699|NCT01451437|102262802|FG000|Overall Study|Physician Decision|1|||
33647700|NCT01451437|102262803|FG001|Overall Study|Physician Decision|1|||
33647701|NCT01451437|102262804|FG002|Overall Study|Physician Decision|2|||
33647702|NCT01451437|102262805|FG003|Overall Study|Physician Decision|0|||
33248569|NCT01090024|100810216|FG011|Period 3|Withdrawal by Subject|0|||
33248570|NCT01090024|100810217|FG012|Period 3|Withdrawal by Subject|0|||
33248571|NCT01090024|100810218|FG013|Period 3|Withdrawal by Subject|0|||
33248572|NCT01090024|100810219|FG014|Period 3|Withdrawal by Subject|0|||
33248573|NCT01090024|100810220|FG015|Period 3|Withdrawal by Subject|1|||
33248574|NCT01090024|100810221|FG016|Period 3|Withdrawal by Subject|0|||
33248575|NCT01090024|100810222|FG017|Period 3|Withdrawal by Subject|0|||
33248576|NCT01090024|100810205|FG000|Period 3|Protocol Violation|0|||
33248577|NCT01090024|100810206|FG001|Period 3|Protocol Violation|0|||
33248578|NCT01090024|100810207|FG002|Period 3|Protocol Violation|0|||
33248579|NCT01090024|100810208|FG003|Period 3|Protocol Violation|0|||
33248580|NCT01090024|100810209|FG004|Period 3|Protocol Violation|0|||
33248581|NCT01090024|100810210|FG005|Period 3|Protocol Violation|0|||
33248582|NCT01090024|100810211|FG006|Period 3|Protocol Violation|0|||
33248583|NCT01090024|100810212|FG007|Period 3|Protocol Violation|0|||
33248584|NCT01090024|100810213|FG008|Period 3|Protocol Violation|1|||
33248585|NCT01090024|100810214|FG009|Period 3|Protocol Violation|0|||
33248586|NCT01090024|100810215|FG010|Period 3|Protocol Violation|0|||
33248587|NCT01090024|100810216|FG011|Period 3|Protocol Violation|0|||
33248588|NCT01090024|100810217|FG012|Period 3|Protocol Violation|0|||
33248589|NCT01090024|100810218|FG013|Period 3|Protocol Violation|0|||
33248590|NCT01090024|100810219|FG014|Period 3|Protocol Violation|0|||
33248591|NCT01090024|100810220|FG015|Period 3|Protocol Violation|0|||
33248592|NCT01090024|100810221|FG016|Period 3|Protocol Violation|0|||
33248593|NCT01090024|100810222|FG017|Period 3|Protocol Violation|0|||
33248594|NCT01090024|100810205|FG000|Period 3|Adverse Event|0|||
33248595|NCT01090024|100810206|FG001|Period 3|Adverse Event|0|||
33248596|NCT01090024|100810207|FG002|Period 3|Adverse Event|0|||
33248597|NCT01090024|100810208|FG003|Period 3|Adverse Event|0|||
33248598|NCT01090024|100810209|FG004|Period 3|Adverse Event|0|||
33248599|NCT01090024|100810210|FG005|Period 3|Adverse Event|1|||
33248600|NCT01090024|100810211|FG006|Period 3|Adverse Event|0|||
33248601|NCT01090024|100810212|FG007|Period 3|Adverse Event|0|||
33248602|NCT01090024|100810213|FG008|Period 3|Adverse Event|0|||
33587789|NCT01262638|102041666|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
33587790|NCT01262638|102041667|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
33587791|NCT01262638|102041668|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
33587792|NCT01262638|102041665|FG000|Overall Study|Lost to Follow-up|1|||
33587793|NCT01262638|102041666|FG001|Overall Study|Lost to Follow-up|1|||
33587794|NCT01262638|102041667|FG002|Overall Study|Lost to Follow-up|1|||
33587795|NCT01262638|102041668|FG003|Overall Study|Lost to Follow-up|1|||
33587796|NCT01262638|102041665|FG000|Overall Study|Participant Went Out of Town|0|||
33587797|NCT01262638|102041666|FG001|Overall Study|Participant Went Out of Town|0|||
33587798|NCT01262638|102041667|FG002|Overall Study|Participant Went Out of Town|1|||
33587799|NCT01262638|102041668|FG003|Overall Study|Participant Went Out of Town|0|||
33587800|NCT01814046|102041671|FG000|Drug Administration|Death due to complications of RSV|1|||
33587801|NCT01814046|102041672|FG001|Drug Administration|Death due to complications of RSV|0|||
33587802|NCT01814046|102041673|FG002|Drug Administration|Death due to complications of RSV|0|||
33587803|NCT03206970|102041674|FG000|Overall Study|Death|21|||
33587804|NCT03206970|102041674|FG000|Overall Study|Withdrawal by Subject|13|||
33587805|NCT03206970|102041674|FG000|Overall Study|Lost to Follow-up|3|||
33587806|NCT03206970|102041674|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
33587807|NCT00759876|102041675|FG000|Overall Study|Sponsor terminated study early|36|||
33587808|NCT01932372|102041676|FG000|Overall Study|Not meeting eligibility criteria|33|||
33587809|NCT01932372|102041677|FG001|Overall Study|Not meeting eligibility criteria|179|||
33587810|NCT04382586|102041678|FG000|Overall Study|Death|3|||
33428722|NCT00415532|101460126|FG000|Treatment Period|Adverse Event|2|||
33587811|NCT04382586|102041679|FG001|Overall Study|Death|4|||
33587812|NCT04382586|102041678|FG000|Overall Study|Lost to Follow-up|11|||
33587813|NCT04382586|102041679|FG001|Overall Study|Lost to Follow-up|8|||
33587814|NCT04382586|102041678|FG000|Overall Study|Withdrawal by Subject|3|||
33587815|NCT04382586|102041679|FG001|Overall Study|Withdrawal by Subject|1|||
33587816|NCT04382586|102041678|FG000|Overall Study|Physician Decision|0|||
33587817|NCT04382586|102041679|FG001|Overall Study|Physician Decision|3|||
33587818|NCT01463696|102041680|FG000|Overall Study|Adverse Event|0|||
33248603|NCT01090024|100810214|FG009|Period 3|Adverse Event|0|||
33248604|NCT01090024|100810215|FG010|Period 3|Adverse Event|0|||
33248605|NCT01090024|100810216|FG011|Period 3|Adverse Event|0|||
33248606|NCT01090024|100810217|FG012|Period 3|Adverse Event|0|||
33248607|NCT01090024|100810218|FG013|Period 3|Adverse Event|0|||
33248608|NCT01090024|100810219|FG014|Period 3|Adverse Event|0|||
33248609|NCT01090024|100810220|FG015|Period 3|Adverse Event|0|||
33248610|NCT01090024|100810221|FG016|Period 3|Adverse Event|0|||
33248611|NCT01090024|100810222|FG017|Period 3|Adverse Event|0|||
33248612|NCT01352507|100810223|FG000|Treatment Period 1|Adverse Event|3|||
33248613|NCT01352507|100810224|FG001|Treatment Period 1|Adverse Event|0|||
33248614|NCT01352507|100810223|FG000|Treatment Period 1|Lost to Follow-up|3|||
33248615|NCT01352507|100810224|FG001|Treatment Period 1|Lost to Follow-up|4|||
33248616|NCT01352507|100810223|FG000|Treatment Period 1|Withdrawal by Subject|7|||
33428723|NCT00415532|101460127|FG001|Treatment Period|Adverse Event|3|||
33428724|NCT00415532|101460126|FG000|Treatment Period|Death|2|||
33382405|NCT04019795|101283566|FG001|Overall Study|Lost to Follow-up|1|||
33382406|NCT04019795|101283567|FG002|Overall Study|Lost to Follow-up|1|||
33382407|NCT04019795|101283568|FG003|Overall Study|Lost to Follow-up|2|||
33382408|NCT04019795|101283565|FG000|Overall Study|Treatment non-compliance|3|||
33382409|NCT04019795|101283566|FG001|Overall Study|Treatment non-compliance|1|||
33382410|NCT04019795|101283567|FG002|Overall Study|Treatment non-compliance|2|||
33382411|NCT04019795|101283568|FG003|Overall Study|Treatment non-compliance|0|||
33382412|NCT04019795|101283565|FG000|Overall Study|Physician Decision|0|||
33382413|NCT04019795|101283566|FG001|Overall Study|Physician Decision|0|||
33382414|NCT04019795|101283567|FG002|Overall Study|Physician Decision|1|||
33382415|NCT04019795|101283568|FG003|Overall Study|Physician Decision|0|||
33382416|NCT04019795|101283565|FG000|Overall Study|Adverse Event|1|||
33382417|NCT04019795|101283566|FG001|Overall Study|Adverse Event|0|||
33382418|NCT04019795|101283567|FG002|Overall Study|Adverse Event|0|||
33382419|NCT04019795|101283568|FG003|Overall Study|Adverse Event|0|||
33382420|NCT02395653|101283574|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
33382421|NCT02395653|101283574|FG000|Overall Study|Consent Withdrawn at Screening|1|||
33382422|NCT02395653|101283574|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
33382423|NCT02395653|101283574|FG000|Overall Study|Investigator Decision at Screening|1|||
33382424|NCT02395653|101283574|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
33382425|NCT02395653|101283574|FG000|Overall Study|Withdrawal by Subject|1|||
33382426|NCT02395653|101283574|FG000|Overall Study|Lost to Follow-up|1|||
33382427|NCT01207388|101283575|FG000|Overall Study|Death|67|||
33382428|NCT01207388|101283575|FG000|Overall Study|Withdrawal by Subject|1|||
33382429|NCT02527148|101283584|FG000|Overall Study|Did not receive study intervention|1|||
33382430|NCT02527148|101283585|FG001|Overall Study|Did not receive study intervention|0|||
33382431|NCT02586077|101283588|FG000|Overall Study|Withdrawal by Subject|1|||
33382432|NCT02586077|101283588|FG000|Overall Study|Physician Decision|4|||
33382433|NCT02586077|101283588|FG000|Overall Study|Lost to Follow-up|3|||
33382434|NCT00792701|101283589|FG000|Overall Study|Adverse Event|0|||
33382435|NCT00792701|101283590|FG001|Overall Study|Adverse Event|22|||
33382436|NCT00792701|101283589|FG000|Overall Study|Ineligible|1|||
33382437|NCT00792701|101283590|FG001|Overall Study|Ineligible|3|||
33382438|NCT00792701|101283589|FG000|Overall Study|Withdrawal by Subject|1|||
33382439|NCT00792701|101283590|FG001|Overall Study|Withdrawal by Subject|19|||
33382440|NCT00792701|101283589|FG000|Overall Study|Not protocol specified|17|||
33382441|NCT00792701|101283590|FG001|Overall Study|Not protocol specified|0|||
33382442|NCT01369849|101283594|FG000|Overall Study|Ineligible prior to treatment|0|||
33382443|NCT01369849|101283595|FG001|Overall Study|Ineligible prior to treatment|0|||
33382444|NCT01369849|101283596|FG002|Overall Study|Ineligible prior to treatment|1|||
33382445|NCT01369849|101283594|FG000|Overall Study|Ineligible after receiving treatment|0|||
33382446|NCT01369849|101283595|FG001|Overall Study|Ineligible after receiving treatment|1|||
33382447|NCT01369849|101283596|FG002|Overall Study|Ineligible after receiving treatment|0|||
33382448|NCT00305604|101283597|FG000|Overall Study|Adverse Event|6|||
33382449|NCT00305604|101283598|FG001|Overall Study|Adverse Event|3|||
33382450|NCT00305604|101283597|FG000|Overall Study|Lack of Efficacy|11|||
33382451|NCT00305604|101283598|FG001|Overall Study|Lack of Efficacy|18|||
33382452|NCT00305604|101283597|FG000|Overall Study|Lost to Follow-up|0|||
33382453|NCT00305604|101283598|FG001|Overall Study|Lost to Follow-up|4|||
33382454|NCT00305604|101283597|FG000|Overall Study|Protocol Violation|2|||
33382455|NCT00305604|101283598|FG001|Overall Study|Protocol Violation|1|||
33382456|NCT00305604|101283597|FG000|Overall Study|Withdrawal by Subject|12|||
33382457|NCT00305604|101283598|FG001|Overall Study|Withdrawal by Subject|21|||
33382458|NCT00305604|101283597|FG000|Overall Study|Patient moved|1|||
33382459|NCT00305604|101283598|FG001|Overall Study|Patient moved|0|||
33382460|NCT02727660|101283612|FG000|Overall Study|Lack of Efficacy|40|||
33382461|NCT02727660|101283613|FG001|Overall Study|Lack of Efficacy|40|||
33382462|NCT02727660|101283614|FG002|Overall Study|Lack of Efficacy|70|||
33382463|NCT02727660|101283612|FG000|Overall Study|Adverse Event|28|||
33382464|NCT02727660|101283613|FG001|Overall Study|Adverse Event|21|||
33382465|NCT02727660|101283614|FG002|Overall Study|Adverse Event|32|||
33382466|NCT02727660|101283612|FG000|Overall Study|Withdrawal by Subject|26|||
33382467|NCT02727660|101283613|FG001|Overall Study|Withdrawal by Subject|25|||
33382468|NCT02727660|101283614|FG002|Overall Study|Withdrawal by Subject|30|||
33382469|NCT02727660|101283612|FG000|Overall Study|Physician Decision|3|||
33382470|NCT02727660|101283613|FG001|Overall Study|Physician Decision|8|||
33428725|NCT00415532|101460127|FG001|Treatment Period|Death|1|||
33428726|NCT00415532|101460126|FG000|Treatment Period|Lost to Follow-up|1|||
33382471|NCT02727660|101283614|FG002|Overall Study|Physician Decision|14|||
33382472|NCT02727660|101283612|FG000|Overall Study|Lost to Follow-up|5|||
33382473|NCT02727660|101283613|FG001|Overall Study|Lost to Follow-up|9|||
33382474|NCT02727660|101283614|FG002|Overall Study|Lost to Follow-up|8|||
33382475|NCT02727660|101283612|FG000|Overall Study|Protocol Violation|7|||
33382476|NCT02727660|101283613|FG001|Overall Study|Protocol Violation|5|||
33382477|NCT02727660|101283614|FG002|Overall Study|Protocol Violation|5|||
33382478|NCT02727660|101283612|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
33428727|NCT00415532|101460127|FG001|Treatment Period|Lost to Follow-up|1|||
33428728|NCT00415532|101460126|FG000|Treatment Period|Protocol Violation|1|||
33428729|NCT00415532|101460127|FG001|Treatment Period|Protocol Violation|0|||
33428730|NCT00415532|101460126|FG000|Treatment Period|Withdrawal by Subject|6|||
33428731|NCT00415532|101460127|FG001|Treatment Period|Withdrawal by Subject|6|||
33428732|NCT00415532|101460126|FG000|Treatment Period|Other|2|||
33428733|NCT00415532|101460127|FG001|Treatment Period|Other|2|||
33428734|NCT00415532|101460126|FG000|Treatment Period|Ineligibility determined|1|||
33428735|NCT00415532|101460127|FG001|Treatment Period|Ineligibility determined|1|||
33428736|NCT00415532|101460126|FG000|Treatment Period|Noncompliance|1|||
33428737|NCT00415532|101460127|FG001|Treatment Period|Noncompliance|1|||
33248617|NCT01352507|100810224|FG001|Treatment Period 1|Withdrawal by Subject|5|||
33248618|NCT01352507|100810223|FG000|Treatment Period 1|Physician Decision|1|||
33248619|NCT01352507|100810224|FG001|Treatment Period 1|Physician Decision|0|||
33248620|NCT01352507|100810223|FG000|Washout Period|Withdrawal by Subject|0|||
33248621|NCT01352507|100810224|FG001|Washout Period|Withdrawal by Subject|1|||
33248622|NCT01352507|100810223|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
33248623|NCT01352507|100810224|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
33248624|NCT01352507|100810223|FG000|Treatment Period 2|Withdrawal by Subject|4|||
33382479|NCT02727660|101283613|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
33428738|NCT00415532|101460126|FG000|Treatment Period|Requirement for alternative therapy|1|||
33428739|NCT00415532|101460127|FG001|Treatment Period|Requirement for alternative therapy|0|||
33428740|NCT00415532|101460126|FG000|Safety Follow Up Period|Adverse Event|1|||
33428741|NCT00415532|101460127|FG001|Safety Follow Up Period|Adverse Event|3|||
33428742|NCT00415532|101460126|FG000|Safety Follow Up Period|Death|3|||
33428743|NCT00415532|101460127|FG001|Safety Follow Up Period|Death|0|||
33428744|NCT00415532|101460126|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
33428745|NCT00415532|101460127|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
33428746|NCT00415532|101460126|FG000|Safety Follow Up Period|Other|1|||
33428747|NCT00415532|101460127|FG001|Safety Follow Up Period|Other|4|||
33428748|NCT00415532|101460126|FG000|Safety Follow Up Period|Ineligibility determined|1|||
33428749|NCT00415532|101460127|FG001|Safety Follow Up Period|Ineligibility determined|1|||
33382480|NCT02727660|101283614|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
33382481|NCT02727660|101283612|FG000|Overall Study|Administrative Reasons|2|||
33382482|NCT02727660|101283613|FG001|Overall Study|Administrative Reasons|3|||
33382483|NCT02727660|101283614|FG002|Overall Study|Administrative Reasons|4|||
33382484|NCT01975246|101283621|FG000|Overall Study|Adverse Event|2|||
33382485|NCT01975246|101283622|FG001|Overall Study|Adverse Event|1|||
33382486|NCT01975246|101283621|FG000|Overall Study|Lack of Efficacy|1|||
33382487|NCT01975246|101283622|FG001|Overall Study|Lack of Efficacy|0|||
33382488|NCT01975246|101283621|FG000|Overall Study|Protocol Violation|1|||
33382489|NCT01975246|101283622|FG001|Overall Study|Protocol Violation|0|||
33382490|NCT01975246|101283621|FG000|Overall Study|Other than stated|0|||
33382491|NCT01975246|101283622|FG001|Overall Study|Other than stated|1|||
33382492|NCT00719953|101283623|FG000|Overall Study|Adverse Event|4|||
33382493|NCT03627494|101283629|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
33382494|NCT03627494|101283630|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
33382495|NCT03627494|101283631|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
33382496|NCT03627494|101283632|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
33382497|NCT03627494|101283633|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
33382498|NCT03627494|101283634|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
33382499|NCT03627494|101283635|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
33382500|NCT03627494|101283636|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
33382501|NCT03627494|101283637|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
33382502|NCT03627494|101283638|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
33382503|NCT03627494|101283639|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
33428750|NCT00415532|101460126|FG000|Safety Follow Up Period|Noncompliance|1|||
33428751|NCT00415532|101460127|FG001|Safety Follow Up Period|Noncompliance|0|||
33428752|NCT00415532|101460126|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
33428753|NCT00415532|101460127|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
33248625|NCT01352507|100810224|FG001|Treatment Period 2|Withdrawal by Subject|3|||
33248626|NCT01352507|100810223|FG000|Treatment Period 2|Lack of Efficacy|1|||
33248627|NCT01352507|100810224|FG001|Treatment Period 2|Lack of Efficacy|0|||
33248628|NCT03107611|100810232|FG000|Overall Study|Adverse Event|1|||
33248629|NCT03107611|100810233|FG001|Overall Study|Adverse Event|0|||
33248630|NCT03107611|100810234|FG002|Overall Study|Adverse Event|2|||
33248631|NCT03107611|100810232|FG000|Overall Study|Lost to Follow-up|3|||
33248632|NCT03107611|100810233|FG001|Overall Study|Lost to Follow-up|3|||
33382504|NCT03627494|101283640|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
33382505|NCT03627494|101283629|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
33382506|NCT03627494|101283630|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
33382507|NCT03627494|101283631|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
33382508|NCT03627494|101283632|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
33428754|NCT00423800|101460128|FG000|Overall Study|Protocol Violation|0|||
33428755|NCT00423800|101460129|FG001|Overall Study|Protocol Violation|1|||
33382509|NCT03627494|101283633|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
33647703|NCT01451437|102262806|FG004|Overall Study|Physician Decision|0|||
33248633|NCT03107611|100810234|FG002|Overall Study|Lost to Follow-up|3|||
33248634|NCT03107611|100810232|FG000|Overall Study|Protocol Violation|0|||
33248635|NCT03107611|100810233|FG001|Overall Study|Protocol Violation|0|||
33248636|NCT03107611|100810234|FG002|Overall Study|Protocol Violation|1|||
33248637|NCT03107611|100810232|FG000|Overall Study|Withdrawal by Subject|1|||
33248638|NCT03107611|100810233|FG001|Overall Study|Withdrawal by Subject|0|||
33248639|NCT03107611|100810234|FG002|Overall Study|Withdrawal by Subject|1|||
33248640|NCT03107611|100810232|FG000|Overall Study|Worsening signs/symptoms|2|||
33248641|NCT03107611|100810233|FG001|Overall Study|Worsening signs/symptoms|1|||
33248642|NCT03107611|100810234|FG002|Overall Study|Worsening signs/symptoms|2|||
33248643|NCT05567952|100810235|FG000|Overall Study|Lost to Follow-up|3|||
33248644|NCT05567952|100810236|FG001|Overall Study|Lost to Follow-up|2|||
33248645|NCT05567952|100810235|FG000|Overall Study|Withdrawal by Subject|6|||
33248646|NCT05567952|100810236|FG001|Overall Study|Withdrawal by Subject|3|||
33248647|NCT05567952|100810235|FG000|Overall Study|Other|3|||
33248648|NCT05567952|100810236|FG001|Overall Study|Other|1|||
33587819|NCT01463696|102041681|FG001|Overall Study|Adverse Event|1|||
33587820|NCT01463696|102041682|FG002|Overall Study|Adverse Event|0|||
33587821|NCT01463696|102041683|FG003|Overall Study|Adverse Event|2|||
33587822|NCT01463696|102041684|FG004|Overall Study|Adverse Event|0|||
33587823|NCT01463696|102041685|FG005|Overall Study|Adverse Event|1|||
33587824|NCT01463696|102041686|FG006|Overall Study|Adverse Event|3|||
33587825|NCT01463696|102041687|FG007|Overall Study|Adverse Event|2|||
33647704|NCT01451437|102262807|FG005|Overall Study|Physician Decision|0|||
33647705|NCT01451437|102262808|FG006|Overall Study|Physician Decision|0|||
33647706|NCT01451437|102262809|FG007|Overall Study|Physician Decision|0|||
33647707|NCT01451437|102262810|FG008|Overall Study|Physician Decision|0|||
33647708|NCT01451437|102262802|FG000|Overall Study|Disease Progression|0|||
33248649|NCT00605033|100810237|FG000|Overall Study|Adverse Event|2|||
33248650|NCT00605033|100810238|FG001|Overall Study|Adverse Event|2|||
33248651|NCT00605033|100810237|FG000|Overall Study|Lost to Follow-up|1|||
33248652|NCT00605033|100810238|FG001|Overall Study|Lost to Follow-up|1|||
33248653|NCT00605033|100810237|FG000|Overall Study|Withdrawal by Subject|3|||
33248654|NCT00605033|100810238|FG001|Overall Study|Withdrawal by Subject|4|||
33248655|NCT00605033|100810237|FG000|Overall Study|Protocol Violation|1|||
33248656|NCT00605033|100810238|FG001|Overall Study|Protocol Violation|1|||
33248657|NCT03235349|100810239|FG000|Overall Study|Adverse Event|1|||
33248658|NCT03235349|100810239|FG000|Overall Study|Other|1|||
33248659|NCT00946114|100810245|FG000|Overall Study|Death|5|||
33248660|NCT00946114|100810246|FG001|Overall Study|Death|2|||
33248661|NCT00946114|100810245|FG000|Overall Study|Other|1|||
33248662|NCT00946114|100810246|FG001|Overall Study|Other|0|||
33248663|NCT00946114|100810245|FG000|Overall Study|Withdrawal by Subject|2|||
33248664|NCT00946114|100810246|FG001|Overall Study|Withdrawal by Subject|0|||
33248665|NCT00149630|100810253|FG000|Overall Study|Incarceration|2|||
33248666|NCT00149630|100810254|FG001|Overall Study|Incarceration|0|||
33647709|NCT01451437|102262803|FG001|Overall Study|Disease Progression|0|||
33647710|NCT01451437|102262804|FG002|Overall Study|Disease Progression|1|||
33647711|NCT01451437|102262805|FG003|Overall Study|Disease Progression|1|||
33647712|NCT01451437|102262806|FG004|Overall Study|Disease Progression|3|||
33647713|NCT01451437|102262807|FG005|Overall Study|Disease Progression|2|||
33647714|NCT01451437|102262808|FG006|Overall Study|Disease Progression|3|||
33647715|NCT01451437|102262809|FG007|Overall Study|Disease Progression|1|||
33647716|NCT01451437|102262810|FG008|Overall Study|Disease Progression|3|||
33647717|NCT01451437|102262802|FG000|Overall Study|Protocol Violation|0|||
33647718|NCT01451437|102262803|FG001|Overall Study|Protocol Violation|0|||
33647719|NCT01451437|102262804|FG002|Overall Study|Protocol Violation|0|||
33647720|NCT01451437|102262805|FG003|Overall Study|Protocol Violation|0|||
33647721|NCT01451437|102262806|FG004|Overall Study|Protocol Violation|0|||
33647722|NCT01451437|102262807|FG005|Overall Study|Protocol Violation|0|||
33248667|NCT00149630|100810253|FG000|Overall Study|Treatment Programs|4|||
33248668|NCT00149630|100810254|FG001|Overall Study|Treatment Programs|5|||
33248669|NCT00149630|100810253|FG000|Overall Study|Adverse Event|2|||
33248670|NCT00149630|100810254|FG001|Overall Study|Adverse Event|0|||
33647723|NCT01451437|102262808|FG006|Overall Study|Protocol Violation|1|||
33647724|NCT01451437|102262809|FG007|Overall Study|Protocol Violation|0|||
33647725|NCT01451437|102262810|FG008|Overall Study|Protocol Violation|0|||
33248671|NCT01360840|100810258|FG000|Overall Study|Ongoing at data cut-off|10|||
33248672|NCT01360840|100810259|FG001|Overall Study|Ongoing at data cut-off|10|||
33248673|NCT01360840|100810260|FG002|Overall Study|Ongoing at data cut-off|9|||
33248674|NCT00470626|100810261|FG000|Overall Study|Lost to Follow-up|10|||
33248675|NCT00470626|100810261|FG000|Overall Study|Withdrawal by Subject|7|||
33248676|NCT03467724|100810262|FG000|Overall Study|Lost to Follow-up|5|||
33647726|NCT01451437|102262802|FG000|Overall Study|Withdrawal by Subject|0|||
33382510|NCT03627494|101283634|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
33647727|NCT01451437|102262803|FG001|Overall Study|Withdrawal by Subject|0|||
33587826|NCT01463696|102041680|FG000|Overall Study|Lost to Follow-up|0|||
33248677|NCT03467724|100810262|FG000|Overall Study|Withdrawal by Subject|1|||
33587827|NCT01463696|102041681|FG001|Overall Study|Lost to Follow-up|0|||
33382511|NCT03627494|101283635|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
33382512|NCT03627494|101283636|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
33382513|NCT03627494|101283637|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
33382514|NCT03627494|101283638|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
33382515|NCT03627494|101283639|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
33382516|NCT03627494|101283640|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
33382517|NCT03627494|101283629|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
33382518|NCT03627494|101283630|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
33382519|NCT03627494|101283631|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
33382520|NCT03627494|101283632|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
33382521|NCT03627494|101283633|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
33382522|NCT03627494|101283634|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
33382523|NCT03627494|101283635|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
33382524|NCT03627494|101283636|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
33382525|NCT03627494|101283637|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
33382526|NCT03627494|101283638|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
33382527|NCT03627494|101283639|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
33382528|NCT03627494|101283640|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
33382529|NCT03210220|101283648|FG000|Overall Study|Physician Decision|1|||
33382530|NCT03210220|101283649|FG001|Overall Study|Physician Decision|0|||
33382531|NCT00168064|101283650|FG000|Overall Study|Adverse Event|26|||
33382532|NCT00168064|101283651|FG001|Overall Study|Adverse Event|22|||
33382533|NCT00168064|101283650|FG000|Overall Study|Withdrawal by Subject|3|||
33382534|NCT00168064|101283651|FG001|Overall Study|Withdrawal by Subject|4|||
33382535|NCT00168064|101283650|FG000|Overall Study|Lack of Efficacy|4|||
33382536|NCT00168064|101283651|FG001|Overall Study|Lack of Efficacy|4|||
33382537|NCT00168064|101283650|FG000|Overall Study|Lost to Follow-up|4|||
33382538|NCT00168064|101283651|FG001|Overall Study|Lost to Follow-up|3|||
33382539|NCT00168064|101283650|FG000|Overall Study|Non-compliance|2|||
33382540|NCT00168064|101283651|FG001|Overall Study|Non-compliance|3|||
33382541|NCT00168064|101283650|FG000|Overall Study|Concurrent Illness|4|||
33382542|NCT00168064|101283651|FG001|Overall Study|Concurrent Illness|3|||
33382543|NCT00168064|101283650|FG000|Overall Study|Subject's Best interest|2|||
33382544|NCT00168064|101283651|FG001|Overall Study|Subject's Best interest|2|||
33382545|NCT00168064|101283650|FG000|Overall Study|Various|4|||
33382546|NCT00168064|101283651|FG001|Overall Study|Various|3|||
33382547|NCT00949910|101287544|FG000|Overall Study|Progressive Disease|3750|||
33382548|NCT00949910|101287544|FG000|Overall Study|Symptomatic Deterioration|1088|||
33382549|NCT00949910|101287544|FG000|Overall Study|Lost to Follow-up|100|||
33382550|NCT00949910|101287544|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
33382551|NCT00949910|101287544|FG000|Overall Study|Participant Refusal|390|||
33382552|NCT00949910|101287544|FG000|Overall Study|Death Due to Malignant Disease|456|||
33382553|NCT00949910|101287544|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
33382554|NCT00949910|101287544|FG000|Overall Study|Death Due to Adverse Event|115|||
33382555|NCT00949910|101287544|FG000|Overall Study|Death Due to Toxicity|3|||
33382556|NCT00949910|101287544|FG000|Overall Study|Death from Unknown Cause|5|||
33382557|NCT00949910|101287544|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
33382558|NCT00949910|101287544|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
33382559|NCT00949910|101287544|FG000|Overall Study|Switched to Commercial Treatment|4|||
33382560|NCT00949910|101287544|FG000|Overall Study|Violation of Eligibility|23|||
33382561|NCT00949910|101287544|FG000|Overall Study|Logistical Reasons|13|||
33382562|NCT00949910|101287544|FG000|Overall Study|Non-Compliance|10|||
33382563|NCT00949910|101287544|FG000|Overall Study|Prolonged Dosing Interruption|4|||
33382564|NCT00949910|101287544|FG000|Overall Study|Adverse Event|83|||
33382565|NCT00949910|101287544|FG000|Overall Study|Serious Adverse Event|6|||
33382566|NCT00949910|101287544|FG000|Overall Study|Physician/Participant Decision|7|||
33382567|NCT00949910|101287544|FG000|Overall Study|Other|4|||
33382568|NCT00949910|101287544|FG000|Overall Study|No Data|9|||
33382569|NCT01641991|101287551|FG000|Overall Study|Physician Decision|0|||
33382570|NCT01641991|101287552|FG001|Overall Study|Physician Decision|1|||
33382571|NCT01641991|101287553|FG002|Overall Study|Physician Decision|7|||
33428756|NCT00306384|101460131|FG000|Overall Study|Adverse Event|103|||
33428757|NCT00306384|101460132|FG001|Overall Study|Adverse Event|87|||
33382572|NCT01641991|101287554|FG003|Overall Study|Physician Decision|5|||
33382573|NCT01641991|101287551|FG000|Overall Study|Withdrawal by Subject|4|||
33382574|NCT01641991|101287552|FG001|Overall Study|Withdrawal by Subject|2|||
33382575|NCT01641991|101287553|FG002|Overall Study|Withdrawal by Subject|1|||
33382576|NCT01641991|101287554|FG003|Overall Study|Withdrawal by Subject|5|||
33382577|NCT01641991|101287551|FG000|Overall Study|Adverse Event|2|||
33382578|NCT01641991|101287552|FG001|Overall Study|Adverse Event|1|||
33382579|NCT01641991|101287553|FG002|Overall Study|Adverse Event|2|||
33382580|NCT01641991|101287554|FG003|Overall Study|Adverse Event|1|||
33382581|NCT01641991|101287551|FG000|Overall Study|Lost to Follow-up|0|||
33382582|NCT01641991|101287552|FG001|Overall Study|Lost to Follow-up|2|||
33382583|NCT01641991|101287553|FG002|Overall Study|Lost to Follow-up|3|||
33382584|NCT01641991|101287554|FG003|Overall Study|Lost to Follow-up|1|||
33382585|NCT01641991|101287551|FG000|Overall Study|Protocol Violation|1|||
33382586|NCT01641991|101287552|FG001|Overall Study|Protocol Violation|1|||
33382587|NCT01641991|101287553|FG002|Overall Study|Protocol Violation|3|||
33382588|NCT01641991|101287554|FG003|Overall Study|Protocol Violation|0|||
33382589|NCT01641991|101287551|FG000|Overall Study|Pregnancy|0|||
33382590|NCT01641991|101287552|FG001|Overall Study|Pregnancy|0|||
33428758|NCT00306384|101460133|FG002|Overall Study|Adverse Event|40|||
33428759|NCT00306384|101460131|FG000|Overall Study|Major protocol deviation|43|||
33428760|NCT00306384|101460132|FG001|Overall Study|Major protocol deviation|51|||
33382591|NCT01641991|101287553|FG002|Overall Study|Pregnancy|1|||
33587828|NCT01463696|102041682|FG002|Overall Study|Lost to Follow-up|1|||
33587829|NCT01463696|102041683|FG003|Overall Study|Lost to Follow-up|0|||
33587830|NCT01463696|102041684|FG004|Overall Study|Lost to Follow-up|0|||
33587831|NCT01463696|102041685|FG005|Overall Study|Lost to Follow-up|0|||
33587832|NCT01463696|102041686|FG006|Overall Study|Lost to Follow-up|0|||
33587833|NCT01463696|102041687|FG007|Overall Study|Lost to Follow-up|0|||
33587834|NCT01463696|102041680|FG000|Overall Study|Progressive Disease|0|||
33587835|NCT01463696|102041681|FG001|Overall Study|Progressive Disease|1|||
33587836|NCT01463696|102041682|FG002|Overall Study|Progressive Disease|0|||
33587837|NCT01463696|102041683|FG003|Overall Study|Progressive Disease|1|||
33587838|NCT01463696|102041684|FG004|Overall Study|Progressive Disease|0|||
33587839|NCT01463696|102041685|FG005|Overall Study|Progressive Disease|1|||
33587840|NCT01463696|102041686|FG006|Overall Study|Progressive Disease|4|||
33587841|NCT01463696|102041687|FG007|Overall Study|Progressive Disease|2|||
33587842|NCT01463696|102041680|FG000|Overall Study|Withdrawal by Subject|0|||
33587843|NCT01463696|102041681|FG001|Overall Study|Withdrawal by Subject|0|||
33587844|NCT01463696|102041682|FG002|Overall Study|Withdrawal by Subject|0|||
33587845|NCT01463696|102041683|FG003|Overall Study|Withdrawal by Subject|1|||
33587846|NCT01463696|102041684|FG004|Overall Study|Withdrawal by Subject|1|||
33587847|NCT01463696|102041685|FG005|Overall Study|Withdrawal by Subject|1|||
33587848|NCT01463696|102041686|FG006|Overall Study|Withdrawal by Subject|2|||
33587849|NCT01463696|102041687|FG007|Overall Study|Withdrawal by Subject|0|||
33587850|NCT01463696|102041680|FG000|Overall Study|Not Treated|0|||
33382592|NCT01641991|101287554|FG003|Overall Study|Pregnancy|0|||
33382593|NCT01641991|101287551|FG000|Overall Study|no longer eligible|2|||
33382594|NCT01641991|101287552|FG001|Overall Study|no longer eligible|1|||
33382595|NCT01641991|101287553|FG002|Overall Study|no longer eligible|0|||
33382596|NCT01641991|101287554|FG003|Overall Study|no longer eligible|4|||
33382597|NCT03219567|101287560|FG000|Overall Study|Withdrawal by Subject|0|||
33382598|NCT03219567|101287561|FG001|Overall Study|Withdrawal by Subject|1|||
33382599|NCT03297216|101287562|FG000|Overall Study|Death|0|||
33382600|NCT03297216|101287563|FG001|Overall Study|Death|1|||
33382601|NCT03297216|101287562|FG000|Overall Study|Miscarriage|0|||
33382602|NCT03297216|101287563|FG001|Overall Study|Miscarriage|2|||
33382603|NCT03297216|101287562|FG000|Overall Study|Lost to Follow-up|3|||
33382604|NCT03297216|101287563|FG001|Overall Study|Lost to Follow-up|2|||
33382605|NCT02034552|101287566|FG000|Overall Study|Never treated|3|||
33382606|NCT02034552|101287567|FG001|Overall Study|Never treated|2|||
33382607|NCT02034552|101287568|FG002|Overall Study|Never treated|0|||
33382608|NCT02034552|101287566|FG000|Overall Study|Radiological progression|3|||
33382609|NCT02034552|101287567|FG001|Overall Study|Radiological progression|5|||
33382610|NCT02034552|101287568|FG002|Overall Study|Radiological progression|4|||
33382611|NCT02034552|101287566|FG000|Overall Study|AE not assoc. with disease progression|1|||
33382612|NCT02034552|101287567|FG001|Overall Study|AE not assoc. with disease progression|4|||
33382613|NCT02034552|101287568|FG002|Overall Study|AE not assoc. with disease progression|2|||
33382614|NCT02034552|101287566|FG000|Overall Study|AE associated with disease progression|0|||
33382615|NCT02034552|101287567|FG001|Overall Study|AE associated with disease progression|1|||
33382616|NCT02034552|101287568|FG002|Overall Study|AE associated with disease progression|0|||
33382617|NCT02034552|101287566|FG000|Overall Study|Withdrawal by Subject|2|||
33382618|NCT02034552|101287567|FG001|Overall Study|Withdrawal by Subject|1|||
33382619|NCT02034552|101287568|FG002|Overall Study|Withdrawal by Subject|1|||
33382620|NCT02034552|101287566|FG000|Overall Study|Non-compliance with study drug|0|||
33382621|NCT02034552|101287567|FG001|Overall Study|Non-compliance with study drug|0|||
33382622|NCT02034552|101287568|FG002|Overall Study|Non-compliance with study drug|1|||
33382623|NCT02034552|101287566|FG000|Overall Study|Clinical progression|5|||
33382624|NCT02034552|101287567|FG001|Overall Study|Clinical progression|7|||
33382625|NCT02034552|101287568|FG002|Overall Study|Clinical progression|9|||
33382626|NCT00965146|101287570|FG000|Overall Study|Death|7|||
33382627|NCT00965146|101287570|FG000|Overall Study|Lost to Follow-up|22|||
33428761|NCT00306384|101460133|FG002|Overall Study|Major protocol deviation|18|||
33587851|NCT01463696|102041681|FG001|Overall Study|Not Treated|0|||
33587852|NCT01463696|102041682|FG002|Overall Study|Not Treated|0|||
33382628|NCT00965146|101287570|FG000|Overall Study|Withdrawal by Subject|17|||
33382629|NCT00965146|101287570|FG000|Overall Study|Unable to return|1|||
33382630|NCT00965146|101287570|FG000|Overall Study|Unwilling to return|11|||
33382631|NCT00965146|101287570|FG000|Overall Study|Intercurrent illness|1|||
33382632|NCT00965146|101287570|FG000|Overall Study|Revision / Removal of Study Implant|6|||
33428762|NCT00306384|101460131|FG000|Overall Study|Lost to Follow-up|57|||
33587853|NCT01463696|102041683|FG003|Overall Study|Not Treated|0|||
33149506|NCT02927262|100460757|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
33248678|NCT03467724|100810262|FG000|Overall Study|Protocol Violation|1|||
33248679|NCT03467724|100810262|FG000|Overall Study|Adverse Event|1|||
33248680|NCT02030028|100810263|FG000|Overall Study|Withdrawal by Subject|4|||
33248681|NCT02030028|100810263|FG000|Overall Study|lack of transportation|1|||
33248682|NCT00587288|100810264|FG000|Overall Study|Adverse Event|0|||
33248683|NCT00587288|100810265|FG001|Overall Study|Adverse Event|1|||
33248684|NCT00587288|100810264|FG000|Overall Study|Lack of Efficacy|2|||
33248685|NCT00587288|100810265|FG001|Overall Study|Lack of Efficacy|8|||
33248686|NCT00587288|100810264|FG000|Overall Study|Protocol Violation|1|||
33248687|NCT00587288|100810265|FG001|Overall Study|Protocol Violation|0|||
33248688|NCT02357784|100810270|FG000|Overall Study|Withdrawal by Subject|1|||
33248689|NCT02930343|100810271|FG000|Overall Study|Lost to Follow-up|9|||
33248690|NCT02930343|100810272|FG001|Overall Study|Lost to Follow-up|7|||
33248691|NCT00927823|100810276|FG000|Continuous Dosing Period|Death|0|||
33248692|NCT00927823|100810277|FG001|Continuous Dosing Period|Death|0|||
33248693|NCT00927823|100810278|FG002|Continuous Dosing Period|Death|6|||
33248694|NCT00927823|100810279|FG003|Continuous Dosing Period|Death|0|||
33248695|NCT00927823|100810276|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
33248696|NCT00927823|100810277|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
33248697|NCT00927823|100810278|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
33248698|NCT00927823|100810279|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
33248699|NCT00927823|100810276|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
33248700|NCT00927823|100810277|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
33248701|NCT00927823|100810278|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
33248702|NCT00927823|100810279|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
33248703|NCT00927823|100810276|FG000|Continuous Dosing Period|Other|1|||
33248704|NCT00927823|100810277|FG001|Continuous Dosing Period|Other|2|||
33248705|NCT00927823|100810278|FG002|Continuous Dosing Period|Other|9|||
33248706|NCT00927823|100810279|FG003|Continuous Dosing Period|Other|3|||
33248707|NCT02246621|100810280|FG000|Overall Study|Withdrawal by Subject|28|||
33248708|NCT02246621|100810281|FG001|Overall Study|Withdrawal by Subject|16|||
33248709|NCT02246621|100810280|FG000|Overall Study|Lost to Follow-up|1|||
33248710|NCT02246621|100810281|FG001|Overall Study|Lost to Follow-up|0|||
33248711|NCT02246621|100810280|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
33248712|NCT02246621|100810281|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
33248713|NCT04148937|100810282|FG000|Overall Study|Withdrawal by Subject|0|||
33248714|NCT04148937|100810283|FG001|Overall Study|Withdrawal by Subject|0|||
33248715|NCT04148937|100810284|FG002|Overall Study|Withdrawal by Subject|0|||
33248716|NCT04148937|100810285|FG003|Overall Study|Withdrawal by Subject|1|||
33248717|NCT04148937|100810286|FG004|Overall Study|Withdrawal by Subject|0|||
33248718|NCT04148937|100810287|FG005|Overall Study|Withdrawal by Subject|1|||
33248719|NCT04148937|100810288|FG006|Overall Study|Withdrawal by Subject|1|||
33248720|NCT04148937|100810289|FG007|Overall Study|Withdrawal by Subject|0|||
33248721|NCT04148937|100810282|FG000|Overall Study|Lost to Follow-up|0|||
33248722|NCT04148937|100810283|FG001|Overall Study|Lost to Follow-up|0|||
33248723|NCT04148937|100810284|FG002|Overall Study|Lost to Follow-up|1|||
33382633|NCT00965146|101287570|FG000|Overall Study|Overall Study Termination|145|||
33647728|NCT01451437|102262804|FG002|Overall Study|Withdrawal by Subject|0|||
33647729|NCT01451437|102262805|FG003|Overall Study|Withdrawal by Subject|0|||
33647730|NCT01451437|102262806|FG004|Overall Study|Withdrawal by Subject|1|||
33647731|NCT01451437|102262807|FG005|Overall Study|Withdrawal by Subject|0|||
33647732|NCT01451437|102262808|FG006|Overall Study|Withdrawal by Subject|1|||
33647733|NCT01451437|102262809|FG007|Overall Study|Withdrawal by Subject|0|||
33647734|NCT01451437|102262810|FG008|Overall Study|Withdrawal by Subject|0|||
33647735|NCT03642132|102262811|FG000|Chemotherapy Period|Adverse Event|1|||
33647736|NCT03642132|102262812|FG001|Chemotherapy Period|Adverse Event|1|||
33248724|NCT04148937|100810285|FG003|Overall Study|Lost to Follow-up|0|||
33248725|NCT04148937|100810286|FG004|Overall Study|Lost to Follow-up|0|||
33248726|NCT04148937|100810287|FG005|Overall Study|Lost to Follow-up|2|||
33382634|NCT04126031|101287571|FG000|Part A|Withdrawal by Subject|0|||
33587854|NCT01463696|102041684|FG004|Overall Study|Not Treated|0|||
33587855|NCT01463696|102041685|FG005|Overall Study|Not Treated|0|||
33587856|NCT01463696|102041686|FG006|Overall Study|Not Treated|1|||
33587857|NCT01463696|102041687|FG007|Overall Study|Not Treated|0|||
33587858|NCT02675751|102041688|FG000|Overall Study|Lost to Follow-up|16|||
33587859|NCT01691105|102041689|FG000|1 Month Follow-up|Lost to Follow-up|41|||
33587860|NCT01691105|102041690|FG001|1 Month Follow-up|Lost to Follow-up|38|||
33647737|NCT03642132|102262813|FG002|Chemotherapy Period|Adverse Event|0|||
33248727|NCT04148937|100810288|FG006|Overall Study|Lost to Follow-up|0|||
33248728|NCT04148937|100810289|FG007|Overall Study|Lost to Follow-up|0|||
33248729|NCT02784704|100810290|FG000|Overall Study|Adverse Event|4|||
33248730|NCT02784704|100810291|FG001|Overall Study|Adverse Event|2|||
33248731|NCT02784704|100810290|FG000|Overall Study|Lost to Follow-up|6|||
33248732|NCT02784704|100810291|FG001|Overall Study|Lost to Follow-up|4|||
33248733|NCT02784704|100810290|FG000|Overall Study|Withdrawal by Subject|1|||
33587861|NCT01691105|102041689|FG000|1 Month Follow-up|Death|2|||
33587862|NCT01691105|102041690|FG001|1 Month Follow-up|Death|3|||
33428763|NCT00306384|101460132|FG001|Overall Study|Lost to Follow-up|41|||
33428764|NCT00306384|101460133|FG002|Overall Study|Lost to Follow-up|35|||
33428765|NCT00306384|101460131|FG000|Overall Study|Voluntary withdrawal|199|||
33428766|NCT00306384|101460132|FG001|Overall Study|Voluntary withdrawal|187|||
33428767|NCT00306384|101460133|FG002|Overall Study|Voluntary withdrawal|91|||
33428768|NCT00306384|101460131|FG000|Overall Study|Study termination|1|||
33428769|NCT00306384|101460132|FG001|Overall Study|Study termination|0|||
33428770|NCT00306384|101460133|FG002|Overall Study|Study termination|1|||
33428771|NCT00306384|101460131|FG000|Overall Study|Pregnancy|3|||
33428772|NCT00306384|101460132|FG001|Overall Study|Pregnancy|1|||
33428773|NCT00306384|101460133|FG002|Overall Study|Pregnancy|1|||
33428774|NCT00306384|101460131|FG000|Overall Study|Lack of Efficacy|26|||
33428775|NCT00306384|101460132|FG001|Overall Study|Lack of Efficacy|40|||
33428776|NCT00306384|101460133|FG002|Overall Study|Lack of Efficacy|38|||
33428777|NCT00306384|101460131|FG000|Overall Study|Investigator discretion|28|||
33428778|NCT00306384|101460132|FG001|Overall Study|Investigator discretion|31|||
33428779|NCT00306384|101460133|FG002|Overall Study|Investigator discretion|21|||
33428780|NCT00306384|101460131|FG000|Overall Study|Other|80|||
33428781|NCT00306384|101460132|FG001|Overall Study|Other|70|||
33428782|NCT00306384|101460133|FG002|Overall Study|Other|32|||
33428783|NCT00306384|101460131|FG000|Overall Study|Site closure|2|||
33428784|NCT00306384|101460132|FG001|Overall Study|Site closure|0|||
33428785|NCT00306384|101460133|FG002|Overall Study|Site closure|0|||
33428786|NCT04378010|101460134|FG000|Overall Study|Adverse Event|8|||
33428787|NCT04378010|101460135|FG001|Overall Study|Adverse Event|14|||
33428788|NCT04378010|101460136|FG002|Overall Study|Adverse Event|4|||
33428789|NCT04378010|101460134|FG000|Overall Study|Withdrawal by Subject|0|||
33428790|NCT04378010|101460135|FG001|Overall Study|Withdrawal by Subject|2|||
33428791|NCT04378010|101460136|FG002|Overall Study|Withdrawal by Subject|1|||
33382635|NCT04126031|101287572|FG001|Part A|Withdrawal by Subject|0|||
33382636|NCT04126031|101287573|FG002|Part A|Withdrawal by Subject|1|||
33382637|NCT04126031|101287574|FG003|Part A|Withdrawal by Subject|0|||
33382638|NCT04126031|101287575|FG004|Part A|Withdrawal by Subject|0|||
33382639|NCT04126031|101287576|FG005|Part A|Withdrawal by Subject|0|||
33382640|NCT04126031|101287571|FG000|Part A|Other|1|||
33382641|NCT04126031|101287572|FG001|Part A|Other|0|||
33382642|NCT04126031|101287573|FG002|Part A|Other|0|||
33382643|NCT04126031|101287574|FG003|Part A|Other|0|||
33382644|NCT04126031|101287575|FG004|Part A|Other|0|||
33382645|NCT04126031|101287576|FG005|Part A|Other|0|||
33382646|NCT04126031|101287571|FG000|Part B|Adverse Event|0|||
33382647|NCT04126031|101287572|FG001|Part B|Adverse Event|0|||
33382648|NCT04126031|101287573|FG002|Part B|Adverse Event|0|||
33382649|NCT04126031|101287574|FG003|Part B|Adverse Event|0|||
33382650|NCT04126031|101287575|FG004|Part B|Adverse Event|0|||
33382651|NCT04126031|101287576|FG005|Part B|Adverse Event|2|||
33382652|NCT04126031|101287571|FG000|Part B|Pre-existing hypertransaminasemia|0|||
33382653|NCT04126031|101287572|FG001|Part B|Pre-existing hypertransaminasemia|0|||
33382654|NCT04126031|101287573|FG002|Part B|Pre-existing hypertransaminasemia|0|||
33382655|NCT04126031|101287574|FG003|Part B|Pre-existing hypertransaminasemia|0|||
33382656|NCT04126031|101287575|FG004|Part B|Pre-existing hypertransaminasemia|1|||
33382657|NCT04126031|101287576|FG005|Part B|Pre-existing hypertransaminasemia|0|||
33382658|NCT00141037|101287577|FG000|Overall Study|Physician Decision|1|||
33382659|NCT00141037|101287578|FG001|Overall Study|Physician Decision|2|||
33382660|NCT00141037|101287577|FG000|Overall Study|Lost to Follow-up|3|||
33382661|NCT00141037|101287578|FG001|Overall Study|Lost to Follow-up|1|||
33382662|NCT00141037|101287577|FG000|Overall Study|Protocol Violation|0|||
33382663|NCT00141037|101287578|FG001|Overall Study|Protocol Violation|2|||
33382664|NCT00141037|101287577|FG000|Overall Study|Withdrawal by Subject|2|||
33382665|NCT00141037|101287578|FG001|Overall Study|Withdrawal by Subject|1|||
33382666|NCT00141037|101287577|FG000|Overall Study|Other|0|||
33382667|NCT00141037|101287578|FG001|Overall Study|Other|1|||
33382668|NCT00141037|101287577|FG000|Overall Study|Moved from area|1|||
33382669|NCT00141037|101287578|FG001|Overall Study|Moved from area|7|||
33382670|NCT00141037|101287577|FG000|Overall Study|Graft Failure|3|||
33382671|NCT00141037|101287578|FG001|Overall Study|Graft Failure|4|||
33382672|NCT05109702|101287579|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
33382673|NCT05109702|101287580|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
33382674|NCT05109702|101287581|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
33428792|NCT04378010|101460134|FG000|Overall Study|Protocol Violation|2|||
33382675|NCT05109702|101287579|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
33382676|NCT05109702|101287580|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
33382677|NCT05109702|101287581|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
33382678|NCT05109702|101287579|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
33382679|NCT05109702|101287580|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
33382680|NCT05109702|101287581|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
33382681|NCT05109702|101287579|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
33382682|NCT05109702|101287580|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
33428793|NCT04378010|101460135|FG001|Overall Study|Protocol Violation|1|||
33382683|NCT05109702|101287581|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
33382684|NCT05109702|101287579|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
33382685|NCT05109702|101287580|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
33382686|NCT05109702|101287581|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
33382687|NCT01203787|101287582|FG000|Overall Study|Death|12|||
33382688|NCT01203787|101287583|FG001|Overall Study|Death|10|||
33382689|NCT01203787|101287582|FG000|Overall Study|Withdrawal by Subject|6|||
33382690|NCT01203787|101287583|FG001|Overall Study|Withdrawal by Subject|2|||
33382691|NCT01203787|101287582|FG000|Overall Study|Lost to Follow-up|2|||
33382692|NCT01203787|101287583|FG001|Overall Study|Lost to Follow-up|0|||
33382693|NCT01203787|101287582|FG000|Overall Study|Adverse Event|11|||
33382694|NCT01203787|101287583|FG001|Overall Study|Adverse Event|15|||
33382695|NCT01769469|101287584|FG000|Overall Study|Consent Withdrawn|5|||
33382696|NCT01769469|101287584|FG000|Overall Study|Moved Out Of Area|3|||
33382697|NCT01769469|101287584|FG000|Overall Study|Lost to Follow-up|17|||
33382698|NCT01769469|101287584|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
33382699|NCT01769469|101287584|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
33382700|NCT03625141|101287585|FG000|Overall Study|Adverse Event|0|||
33382701|NCT03625141|101287586|FG001|Overall Study|Adverse Event|2|||
33382702|NCT03625141|101287585|FG000|Overall Study|Study Terminated By Sponsor|1|||
33382703|NCT03625141|101287586|FG001|Overall Study|Study Terminated By Sponsor|13|||
33382704|NCT03625141|101287585|FG000|Overall Study|Withdrawal by Subject|3|||
33428794|NCT04378010|101460136|FG002|Overall Study|Protocol Violation|4|||
33428795|NCT04378010|101460134|FG000|Overall Study|Study terminated by Sponsor|22|||
33428796|NCT04378010|101460135|FG001|Overall Study|Study terminated by Sponsor|16|||
33428797|NCT04378010|101460136|FG002|Overall Study|Study terminated by Sponsor|22|||
33428798|NCT04378010|101460134|FG000|Overall Study|Subject inability to complete study visit|0|||
33428799|NCT04378010|101460135|FG001|Overall Study|Subject inability to complete study visit|0|||
33428800|NCT04378010|101460136|FG002|Overall Study|Subject inability to complete study visit|1|||
33428801|NCT04378010|101460134|FG000|Overall Study|Subject never dosed|0|||
33428802|NCT04378010|101460135|FG001|Overall Study|Subject never dosed|1|||
33428803|NCT04378010|101460136|FG002|Overall Study|Subject never dosed|0|||
33428804|NCT01199601|101460139|FG000|Overall Study|Lost to Follow-up|47|||
33428805|NCT01199601|101460140|FG001|Overall Study|Lost to Follow-up|66|||
33428806|NCT01199601|101460139|FG000|Overall Study|Withdrawal by Subject|15|||
33428807|NCT01199601|101460140|FG001|Overall Study|Withdrawal by Subject|3|||
33428808|NCT01199601|101460139|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
33428809|NCT01199601|101460140|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
33428810|NCT01162499|101460141|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
33428811|NCT01162499|101460142|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
33428812|NCT01772368|101460149|FG000|Overall Study|Adverse Event|1|||
33428813|NCT01772368|101460149|FG000|Overall Study|Withdrawal by Subject|3|||
33428814|NCT01772368|101460149|FG000|Overall Study|Protocol Violation|2|||
33428815|NCT01772368|101460149|FG000|Overall Study|Other|1|||
33428816|NCT01798485|101460150|FG000|Overall Study|Adverse Event|32|||
33428817|NCT01798485|101460151|FG001|Overall Study|Adverse Event|40|||
33428818|NCT01798485|101460150|FG000|Overall Study|Withdrawal by Subject|27|||
33428819|NCT01798485|101460151|FG001|Overall Study|Withdrawal by Subject|31|||
33428820|NCT01798485|101460150|FG000|Overall Study|Lost to Follow-up|0|||
33428821|NCT01798485|101460151|FG001|Overall Study|Lost to Follow-up|3|||
33428822|NCT01798485|101460150|FG000|Overall Study|Physician Decision|14|||
33428823|NCT01798485|101460151|FG001|Overall Study|Physician Decision|10|||
33428824|NCT01798485|101460150|FG000|Overall Study|Objective Disease Progression|152|||
33428825|NCT01798485|101460151|FG001|Overall Study|Objective Disease Progression|106|||
33428826|NCT01798485|101460150|FG000|Overall Study|Death|25|||
33428827|NCT01798485|101460151|FG001|Overall Study|Death|22|||
33428828|NCT01798485|101460150|FG000|Overall Study|Sponsor Decision|61|||
33428829|NCT01798485|101460151|FG001|Overall Study|Sponsor Decision|54|||
33428830|NCT01798485|101460150|FG000|Overall Study|Clinical Progression|35|||
33428831|NCT01798485|101460151|FG001|Overall Study|Clinical Progression|24|||
33428832|NCT02611752|101460152|FG000|Overall Study|Adverse Event|0|||
33428833|NCT02611752|101460153|FG001|Overall Study|Adverse Event|1|||
33428834|NCT01007916|101460154|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
33428835|NCT01007916|101460155|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
33428836|NCT01007916|101460154|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
33647738|NCT03642132|102262811|FG000|Chemotherapy Period|Physician's decision|4|||
33647739|NCT03642132|102262812|FG001|Chemotherapy Period|Physician's decision|1|||
33647740|NCT03642132|102262813|FG002|Chemotherapy Period|Physician's decision|0|||
33647741|NCT03642132|102262811|FG000|Chemotherapy Period|Progressive disease|0|||
33647742|NCT03642132|102262812|FG001|Chemotherapy Period|Progressive disease|0|||
33647743|NCT03642132|102262813|FG002|Chemotherapy Period|Progressive disease|1|||
33382705|NCT03625141|101287586|FG001|Overall Study|Withdrawal by Subject|0|||
33382706|NCT03625141|101287585|FG000|Overall Study|Withdrawal Of Consent|0|||
33382707|NCT03625141|101287586|FG001|Overall Study|Withdrawal Of Consent|1|||
33382708|NCT03625141|101287585|FG000|Overall Study|Death|11|||
33382709|NCT03625141|101287586|FG001|Overall Study|Death|47|||
33382710|NCT03625141|101287585|FG000|Overall Study|Progressive Disease|0|||
33428837|NCT01007916|101460155|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
33428838|NCT00772577|101460160|FG000|Overall Study|Adverse Event|6|||
33428839|NCT00772577|101460161|FG001|Overall Study|Adverse Event|3|||
33428840|NCT00772577|101460160|FG000|Overall Study|Abnormal laboratory values|0|||
33428841|NCT00772577|101460161|FG001|Overall Study|Abnormal laboratory values|1|||
33428842|NCT00772577|101460160|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33428843|NCT00772577|101460161|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
33428844|NCT00772577|101460160|FG000|Overall Study|Patient withdrew consent|8|||
33428845|NCT00772577|101460161|FG001|Overall Study|Patient withdrew consent|5|||
33428846|NCT00772577|101460160|FG000|Overall Study|Lost to Follow-up|4|||
33428847|NCT00772577|101460161|FG001|Overall Study|Lost to Follow-up|3|||
33428848|NCT00772577|101460160|FG000|Overall Study|Administrative problems|2|||
33428849|NCT00772577|101460161|FG001|Overall Study|Administrative problems|1|||
33428850|NCT00772577|101460160|FG000|Overall Study|Protocol Deviation|3|||
33428851|NCT00772577|101460161|FG001|Overall Study|Protocol Deviation|2|||
33428852|NCT03035227|101460166|FG000|Overall Study|study stopped due to PI leaving institut|1|||
33428853|NCT03035227|101460167|FG001|Overall Study|study stopped due to PI leaving institut|1|||
33428854|NCT00827827|101460170|FG000|Overall Study|Lost to Follow-up|3|||
33428855|NCT00827827|101460171|FG001|Overall Study|Lost to Follow-up|0|||
33428856|NCT00827827|101460170|FG000|Overall Study|Fall at home- hospitalization|1|||
33428857|NCT00827827|101460171|FG001|Overall Study|Fall at home- hospitalization|0|||
33428858|NCT00827827|101460170|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
33428859|NCT00827827|101460171|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
33428860|NCT00827827|101460170|FG000|Overall Study|Gout|1|||
33428861|NCT00827827|101460171|FG001|Overall Study|Gout|0|||
33428862|NCT00827827|101460170|FG000|Overall Study|Transportation issues|1|||
33428863|NCT00827827|101460171|FG001|Overall Study|Transportation issues|0|||
33428864|NCT00827827|101460170|FG000|Overall Study|Burned with water at home|1|||
33428865|NCT00827827|101460171|FG001|Overall Study|Burned with water at home|0|||
33428866|NCT02961920|101460172|FG000|Overall Study|did not achive stydy protocol schedule|1|||
33428867|NCT02961920|101460173|FG001|Overall Study|did not achive stydy protocol schedule|1|||
33428868|NCT01427920|101460174|FG000|Overall Study|Adverse Event|1|||
33428869|NCT01427920|101460175|FG001|Overall Study|Adverse Event|2|||
33428870|NCT01427920|101460174|FG000|Overall Study|Lack of Efficacy|1|||
33428871|NCT01427920|101460175|FG001|Overall Study|Lack of Efficacy|0|||
33428872|NCT01427920|101460174|FG000|Overall Study|Protocol Violation|1|||
33428873|NCT01427920|101460175|FG001|Overall Study|Protocol Violation|3|||
33428874|NCT01427920|101460174|FG000|Overall Study|Withdrawal Criteria|4|||
33428875|NCT01427920|101460175|FG001|Overall Study|Withdrawal Criteria|4|||
33428876|NCT01427920|101460174|FG000|Overall Study|Unclassified|2|||
33428877|NCT01427920|101460175|FG001|Overall Study|Unclassified|8|||
33428878|NCT00441584|101460176|FG000|Overall Study|Lack of Efficacy|79|||
33428879|NCT00441584|101460176|FG000|Overall Study|Withdrawal by Subject|8|||
33428880|NCT00441584|101460176|FG000|Overall Study|Adverse Event|6|||
33428881|NCT00441584|101460176|FG000|Overall Study|Protocol Violation|5|||
33428882|NCT00441584|101460176|FG000|Overall Study|Lost to Follow-up|4|||
33428883|NCT00441584|101460176|FG000|Overall Study|Failure to meet eligibility criteria|3|||
33428884|NCT03770000|101460177|FG000|Overall Study|Premature discontinuation due to PD|0|||
33428885|NCT03770000|101460178|FG001|Overall Study|Premature discontinuation due to PD|0|||
33428886|NCT03770000|101460179|FG002|Overall Study|Premature discontinuation due to PD|1|||
33428887|NCT03770000|101460180|FG003|Overall Study|Premature discontinuation due to PD|3|||
33428888|NCT03770000|101460181|FG004|Overall Study|Premature discontinuation due to PD|2|||
33428889|NCT03740698|101463260|FG000|Overall Study|Physician Decision|0|||
33428890|NCT03740698|101463261|FG001|Overall Study|Physician Decision|1|||
33428891|NCT03740698|101463262|FG002|Overall Study|Physician Decision|1|||
33428892|NCT02482805|101463264|FG000|Overall Study|Lost to Follow-up|4|||
33428893|NCT02482805|101463265|FG001|Overall Study|Lost to Follow-up|4|||
33428894|NCT02482805|101463266|FG002|Overall Study|Lost to Follow-up|0|||
33428895|NCT00832078|101463267|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
33428896|NCT00832078|101463268|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
33428897|NCT00832078|101463267|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
33428898|NCT00832078|101463268|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
33428899|NCT02666430|101463269|FG000|Period 1|Lost to Follow-up|1|||
33428900|NCT02666430|101463270|FG001|Period 1|Lost to Follow-up|0|||
33647744|NCT03642132|102262811|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
33647745|NCT03642132|102262812|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
33428901|NCT02666430|101463269|FG000|Period 1|Adverse Event|0|||
33428902|NCT02666430|101463270|FG001|Period 1|Adverse Event|1|||
33428903|NCT02666430|101463269|FG000|Period 2|Withdrawal by Subject|1|||
33428904|NCT02666430|101463270|FG001|Period 2|Withdrawal by Subject|4|||
33428905|NCT02666430|101463269|FG000|Period 3|Lost to Follow-up|1|||
33428906|NCT02666430|101463270|FG001|Period 3|Lost to Follow-up|0|||
33428907|NCT00419926|101463273|FG000|Overall Study|Withdrawal by Subject|7|||
33428908|NCT00419926|101463274|FG001|Overall Study|Withdrawal by Subject|3|||
33428909|NCT00419926|101463273|FG000|Overall Study|Administrative Problem|4|||
33428910|NCT00419926|101463274|FG001|Overall Study|Administrative Problem|4|||
33428911|NCT00419926|101463273|FG000|Overall Study|Lost to Follow-up|1|||
33428912|NCT00419926|101463274|FG001|Overall Study|Lost to Follow-up|2|||
33428913|NCT00419926|101463273|FG000|Overall Study|Death|2|||
33428914|NCT00419926|101463274|FG001|Overall Study|Death|1|||
33428915|NCT03131999|101463285|FG000|Overall Study|Withdrawal by Subject|0|||
33428916|NCT03131999|101463286|FG001|Overall Study|Withdrawal by Subject|1|||
33382711|NCT03625141|101287586|FG001|Overall Study|Progressive Disease|2|||
33382712|NCT00166517|101287590|FG000|Overall Study|Lost to Follow-up|1|||
33382713|NCT00166517|101287591|FG001|Overall Study|Lost to Follow-up|0|||
33382714|NCT00166517|101287590|FG000|Overall Study|Protocol Violation|4|||
33382715|NCT00166517|101287591|FG001|Overall Study|Protocol Violation|1|||
33382716|NCT00166517|101287590|FG000|Overall Study|Withdrawal by Subject|0|||
33382717|NCT00166517|101287591|FG001|Overall Study|Withdrawal by Subject|1|||
33382718|NCT00788697|101287592|FG000|Overall Study|No study drug administered|12|||
33382719|NCT00788697|101287592|FG000|Overall Study|Training Patients|74|||
33382720|NCT00788697|101287592|FG000|Overall Study|no truth standard procedure available|5|||
33382721|NCT00788697|101287592|FG000|Overall Study|Technically inadequate truth standard|1|||
33382722|NCT00788697|101287592|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
33382723|NCT05563714|101287597|FG000|Overall Study|Death|2|||
33382724|NCT05563714|101287598|FG001|Overall Study|Death|2|||
33382725|NCT05563714|101287599|FG002|Overall Study|Death|0|||
33382726|NCT05563714|101287600|FG003|Overall Study|Death|0|||
33382727|NCT05563714|101287597|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
33382728|NCT05563714|101287598|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
33382729|NCT05563714|101287599|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
33382730|NCT05563714|101287600|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
33382731|NCT05563714|101287597|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
33382732|NCT05563714|101287598|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
33382733|NCT05563714|101287599|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
33382734|NCT05563714|101287600|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
33382735|NCT05563714|101287597|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
33382736|NCT05563714|101287598|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
33382737|NCT05563714|101287599|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
33382738|NCT05563714|101287600|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
33382739|NCT05563714|101287597|FG000|Overall Study|Lost to Follow-up|22|||
33382740|NCT05563714|101287598|FG001|Overall Study|Lost to Follow-up|19|||
33382741|NCT05563714|101287599|FG002|Overall Study|Lost to Follow-up|0|||
33382742|NCT05563714|101287600|FG003|Overall Study|Lost to Follow-up|0|||
33382743|NCT02472795|101287605|FG000|Overall Study|Adverse Event|0|||
33587863|NCT01691105|102041689|FG000|6 Month Follow-up|Lost to Follow-up|39|||
33587864|NCT01691105|102041690|FG001|6 Month Follow-up|Lost to Follow-up|58|||
33587865|NCT01691105|102041689|FG000|6 Month Follow-up|Death|13|||
33587866|NCT01691105|102041690|FG001|6 Month Follow-up|Death|13|||
33587867|NCT01691105|102041689|FG000|12 Month Follow-up|Lost to Follow-up|50|||
33587868|NCT01691105|102041690|FG001|12 Month Follow-up|Lost to Follow-up|71|||
33587869|NCT01691105|102041689|FG000|12 Month Follow-up|Death|22|||
33587870|NCT01691105|102041690|FG001|12 Month Follow-up|Death|30|||
33587871|NCT01691105|102041689|FG000|12 Month Biochemical Verification|Death|22|||
33587872|NCT01691105|102041690|FG001|12 Month Biochemical Verification|Death|30|||
33587873|NCT01691105|102041689|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
33587874|NCT01691105|102041690|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
33647746|NCT03642132|102262813|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
33647747|NCT03642132|102262811|FG000|Chemotherapy Period|Other|1|||
33647748|NCT03642132|102262812|FG001|Chemotherapy Period|Other|0|||
33647749|NCT03642132|102262813|FG002|Chemotherapy Period|Other|2|||
33248734|NCT02784704|100810291|FG001|Overall Study|Withdrawal by Subject|3|||
33248735|NCT02784704|100810290|FG000|Overall Study|Subject Non Compliance|2|||
33248736|NCT02784704|100810291|FG001|Overall Study|Subject Non Compliance|0|||
33248737|NCT02155829|100810292|FG000|Overall Study|Adverse Event|1|||
33248738|NCT02155829|100810293|FG001|Overall Study|Adverse Event|0|||
33248739|NCT02155829|100810292|FG000|Overall Study|Withdrawal by Subject|3|||
33382744|NCT02472795|101287606|FG001|Overall Study|Adverse Event|1|||
33382745|NCT02472795|101287607|FG002|Overall Study|Adverse Event|0|||
33428917|NCT02480010|101463287|FG000|Overall Study|Adverse Event|3|||
33428918|NCT02480010|101463288|FG001|Overall Study|Adverse Event|1|||
33428919|NCT02480010|101463287|FG000|Overall Study|Death|1|||
33248740|NCT02155829|100810293|FG001|Overall Study|Withdrawal by Subject|3|||
33248741|NCT02155829|100810292|FG000|Overall Study|Protocol Violation|2|||
33587875|NCT01691105|102041689|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
33587876|NCT01691105|102041690|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
33587877|NCT03333252|102041694|FG000|Overall Study|Adverse Event|10|||
33248742|NCT02155829|100810293|FG001|Overall Study|Protocol Violation|0|||
33248743|NCT00094809|100810298|FG000|Overall Study|Protocol deviation|2|||
33248744|NCT00094809|100810299|FG001|Overall Study|Protocol deviation|2|||
33428920|NCT02480010|101463288|FG001|Overall Study|Death|0|||
33428921|NCT02480010|101463287|FG000|Overall Study|Insufficient therapeutic response|31|||
33428922|NCT02480010|101463288|FG001|Overall Study|Insufficient therapeutic response|29|||
33428923|NCT02480010|101463287|FG000|Overall Study|Refused Treatment|0|||
33428924|NCT02480010|101463288|FG001|Overall Study|Refused Treatment|3|||
33428925|NCT00788957|101463289|FG000|Part 1|Death|8|||
33428926|NCT00788957|101463290|FG001|Part 1|Death|0|||
33428927|NCT00788957|101463291|FG002|Part 1|Death|0|||
33428928|NCT00788957|101463292|FG003|Part 1|Death|0|||
33428929|NCT00788957|101463293|FG004|Part 1|Death|0|||
33428930|NCT00788957|101463294|FG005|Part 1|Death|0|||
33428931|NCT00788957|101463289|FG000|Part 1|Lost to Follow-up|1|||
33428932|NCT00788957|101463290|FG001|Part 1|Lost to Follow-up|0|||
33428933|NCT00788957|101463291|FG002|Part 1|Lost to Follow-up|0|||
33428934|NCT00788957|101463292|FG003|Part 1|Lost to Follow-up|0|||
33428935|NCT00788957|101463293|FG004|Part 1|Lost to Follow-up|0|||
33428936|NCT00788957|101463294|FG005|Part 1|Lost to Follow-up|0|||
33428937|NCT00788957|101463289|FG000|Part 2|Withdrawal by Subject|0|||
33647750|NCT03642132|102262811|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
33647751|NCT03642132|102262812|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
33248745|NCT00094809|100810298|FG000|Overall Study|Noncompliance|1|||
33248746|NCT00094809|100810299|FG001|Overall Study|Noncompliance|0|||
33248747|NCT00094809|100810298|FG000|Overall Study|Adverse Event|3|||
33248748|NCT00094809|100810299|FG001|Overall Study|Adverse Event|1|||
33248749|NCT00094809|100810298|FG000|Overall Study|Withdrawal by Subject|8|||
33248750|NCT00094809|100810299|FG001|Overall Study|Withdrawal by Subject|9|||
33248751|NCT00094809|100810298|FG000|Overall Study|Disease progression|3|||
33248752|NCT00094809|100810299|FG001|Overall Study|Disease progression|3|||
33248753|NCT00094809|100810298|FG000|Overall Study|Physician Decision|3|||
33248754|NCT00094809|100810299|FG001|Overall Study|Physician Decision|5|||
33248755|NCT00094809|100810298|FG000|Overall Study|Lost to Follow-up|6|||
33248756|NCT00094809|100810299|FG001|Overall Study|Lost to Follow-up|6|||
33248757|NCT00094809|100810298|FG000|Overall Study|Death|19|||
33248758|NCT00094809|100810299|FG001|Overall Study|Death|25|||
33382746|NCT02472795|101287608|FG003|Overall Study|Adverse Event|0|||
33382747|NCT02472795|101287609|FG004|Overall Study|Adverse Event|2|||
33382748|NCT02472795|101287605|FG000|Overall Study|Withdrawal by Subject|0|||
33382749|NCT02472795|101287606|FG001|Overall Study|Withdrawal by Subject|0|||
33382750|NCT02472795|101287607|FG002|Overall Study|Withdrawal by Subject|0|||
33382751|NCT02472795|101287608|FG003|Overall Study|Withdrawal by Subject|0|||
33382752|NCT02472795|101287609|FG004|Overall Study|Withdrawal by Subject|1|||
33382753|NCT01419015|101287610|FG000|Overall Study|Death|2|||
33382754|NCT01928082|101287614|FG000|Overall Study|Study terminated.|1|||
33382755|NCT00373490|101287615|FG000|Overall Study|Adverse Event|0|||
33382756|NCT00373490|101287616|FG001|Overall Study|Adverse Event|1|||
33382757|NCT00373490|101287615|FG000|Overall Study|Lack of Efficacy|9|||
33382758|NCT00373490|101287616|FG001|Overall Study|Lack of Efficacy|4|||
33382759|NCT00373490|101287615|FG000|Overall Study|Withdrawal by Subject|0|||
33382760|NCT00373490|101287616|FG001|Overall Study|Withdrawal by Subject|1|||
33382761|NCT01989754|101287618|FG000|Overall Study|Withdrawal by Subject|10|||
33382762|NCT01989754|101287619|FG001|Overall Study|Withdrawal by Subject|14|||
33382763|NCT01989754|101287618|FG000|Overall Study|Lost to Follow-up|28|||
33382764|NCT01989754|101287619|FG001|Overall Study|Lost to Follow-up|20|||
33382765|NCT01989754|101287618|FG000|Overall Study|Closed Site|1|||
33382766|NCT01989754|101287619|FG001|Overall Study|Closed Site|1|||
33382767|NCT00476996|101287620|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
33382768|NCT00476996|101287621|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
33382769|NCT00476996|101287622|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
33382770|NCT00476996|101287623|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
33382771|NCT00476996|101287620|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
33382772|NCT00476996|101287621|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
33382773|NCT00476996|101287622|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
33382774|NCT00476996|101287623|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
33382775|NCT00476996|101287620|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
33382776|NCT00476996|101287621|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
33428938|NCT00788957|101463290|FG001|Part 2|Withdrawal by Subject|9|||
33428939|NCT00788957|101463291|FG002|Part 2|Withdrawal by Subject|5|||
33428940|NCT00788957|101463292|FG003|Part 2|Withdrawal by Subject|3|||
33428941|NCT00788957|101463293|FG004|Part 2|Withdrawal by Subject|0|||
33428942|NCT00788957|101463294|FG005|Part 2|Withdrawal by Subject|0|||
33428943|NCT00788957|101463289|FG000|Part 2|Death|0|||
33428944|NCT00788957|101463290|FG001|Part 2|Death|32|||
33248759|NCT00094809|100810298|FG000|Overall Study|Protocol-specified criteria|1|||
33248760|NCT00094809|100810299|FG001|Overall Study|Protocol-specified criteria|1|||
33248761|NCT00094809|100810298|FG000|Overall Study|Other|2|||
33248762|NCT00094809|100810299|FG001|Overall Study|Other|4|||
33428945|NCT00788957|101463291|FG002|Part 2|Death|35|||
33428946|NCT00788957|101463292|FG003|Part 2|Death|37|||
33428947|NCT00788957|101463293|FG004|Part 2|Death|0|||
33428948|NCT00788957|101463294|FG005|Part 2|Death|0|||
33428949|NCT00788957|101463289|FG000|Part 2|Lost to Follow-up|0|||
33428950|NCT00788957|101463290|FG001|Part 2|Lost to Follow-up|0|||
33428951|NCT00788957|101463291|FG002|Part 2|Lost to Follow-up|3|||
33428952|NCT00788957|101463292|FG003|Part 2|Lost to Follow-up|0|||
33428953|NCT00788957|101463293|FG004|Part 2|Lost to Follow-up|0|||
33428954|NCT00788957|101463294|FG005|Part 2|Lost to Follow-up|0|||
33428955|NCT00788957|101463289|FG000|Part 2|On-study at time of data cut-off|0|||
33428956|NCT00788957|101463290|FG001|Part 2|On-study at time of data cut-off|1|||
33428957|NCT00788957|101463291|FG002|Part 2|On-study at time of data cut-off|1|||
33428958|NCT00788957|101463292|FG003|Part 2|On-study at time of data cut-off|1|||
33428959|NCT00788957|101463293|FG004|Part 2|On-study at time of data cut-off|0|||
33428960|NCT00788957|101463294|FG005|Part 2|On-study at time of data cut-off|0|||
33428961|NCT00788957|101463289|FG000|Part 3|Withdrawal by Subject|0|||
33428962|NCT00788957|101463290|FG001|Part 3|Withdrawal by Subject|0|||
33428963|NCT00788957|101463291|FG002|Part 3|Withdrawal by Subject|0|||
33428964|NCT00788957|101463292|FG003|Part 3|Withdrawal by Subject|0|||
33428965|NCT00788957|101463293|FG004|Part 3|Withdrawal by Subject|0|||
33428966|NCT00788957|101463294|FG005|Part 3|Withdrawal by Subject|2|||
33428967|NCT00788957|101463289|FG000|Part 3|Death|0|||
33428968|NCT00788957|101463290|FG001|Part 3|Death|0|||
33428969|NCT00788957|101463291|FG002|Part 3|Death|0|||
33428970|NCT00788957|101463292|FG003|Part 3|Death|0|||
33428971|NCT00788957|101463293|FG004|Part 3|Death|8|||
33428972|NCT00788957|101463294|FG005|Part 3|Death|8|||
33428973|NCT00788957|101463289|FG000|Part 3|On-study at time of data cut-off|0|||
33428974|NCT00788957|101463290|FG001|Part 3|On-study at time of data cut-off|0|||
33428975|NCT00788957|101463291|FG002|Part 3|On-study at time of data cut-off|0|||
33428976|NCT00788957|101463292|FG003|Part 3|On-study at time of data cut-off|0|||
33428977|NCT00788957|101463293|FG004|Part 3|On-study at time of data cut-off|1|||
33428978|NCT00788957|101463294|FG005|Part 3|On-study at time of data cut-off|0|||
33428979|NCT01133392|101463295|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
33428980|NCT01133392|101463296|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
33428981|NCT01133392|101463295|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
33428982|NCT01133392|101463296|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
33428983|NCT01664052|101463297|FG000|Phase 1|No device placement|6|||
33428984|NCT01664052|101463298|FG001|Phase 1|No device placement|0|||
33428985|NCT01664052|101463297|FG000|Phase 1|No HSG 1 hr post placement|1|||
33428986|NCT01664052|101463298|FG001|Phase 1|No HSG 1 hr post placement|0|||
33428987|NCT01664052|101463297|FG000|Phase 2|No device placement|0|||
33428988|NCT01664052|101463298|FG001|Phase 2|No device placement|4|||
33428989|NCT01688037|101463299|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
33428990|NCT01688037|101463300|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
33428991|NCT01688037|101463301|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
33428992|NCT01688037|101463299|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
33428993|NCT01688037|101463300|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
33428994|NCT01688037|101463301|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
33428995|NCT01688037|101463299|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
33428996|NCT01688037|101463300|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
33428997|NCT01688037|101463301|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
33428998|NCT01688037|101463299|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
33428999|NCT01688037|101463300|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
33429000|NCT01688037|101463301|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
33429001|NCT01688037|101463299|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
33429002|NCT01688037|101463300|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
33429003|NCT01688037|101463301|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
33429004|NCT01688037|101463299|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
33429005|NCT01688037|101463300|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
33429006|NCT01688037|101463301|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
33429007|NCT01688037|101463299|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
33429008|NCT01688037|101463300|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
33429009|NCT01688037|101463301|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
33429010|NCT01688037|101463299|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
33429011|NCT01688037|101463300|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
33429012|NCT01688037|101463301|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
33429013|NCT01688037|101463299|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
33429014|NCT01688037|101463300|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
33429015|NCT01688037|101463301|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
33429016|NCT01688037|101463299|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
33429017|NCT01688037|101463300|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
33429018|NCT01688037|101463301|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
33429019|NCT00130520|101463302|FG000|Overall Study|Adverse Event|11|||
33382777|NCT00476996|101287622|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
33382778|NCT00476996|101287623|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
33382779|NCT00476996|101287620|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
33382780|NCT00476996|101287621|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
33647752|NCT03642132|102262813|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
33248763|NCT00094809|100810298|FG000|Overall Study|Informed consent signed after treatment|1|||
33248764|NCT00094809|100810299|FG001|Overall Study|Informed consent signed after treatment|0|||
33248765|NCT00094809|100810298|FG000|Overall Study|Study drug not received|2|||
33248766|NCT00094809|100810299|FG001|Overall Study|Study drug not received|8|||
33248767|NCT00094809|100810298|FG000|Overall Study|Other|1|||
33248768|NCT00094809|100810299|FG001|Overall Study|Other|1|||
33248769|NCT03121950|100810300|FG000|Overall Study|Withdrawal by Subject|11|||
33248770|NCT03121950|100810301|FG001|Overall Study|Withdrawal by Subject|2|||
33248771|NCT01076335|100810302|FG000|Overall Study|Withdrawal by Subject|3|||
33248772|NCT01076335|100810302|FG000|Overall Study|Withdrawal without treatment|1|||
33248773|NCT03034915|100810303|FG000|Overall Study|Adverse Event|29|||
33248774|NCT03034915|100810304|FG001|Overall Study|Adverse Event|32|||
33248775|NCT03034915|100810305|FG002|Overall Study|Adverse Event|22|||
33248776|NCT03034915|100810303|FG000|Overall Study|Lost to Follow-up|5|||
33248777|NCT03034915|100810304|FG001|Overall Study|Lost to Follow-up|13|||
33248778|NCT03034915|100810305|FG002|Overall Study|Lost to Follow-up|3|||
33248779|NCT03034915|100810303|FG000|Overall Study|Withdrawal by Subject|29|||
33248780|NCT03034915|100810304|FG001|Overall Study|Withdrawal by Subject|46|||
33248781|NCT03034915|100810305|FG002|Overall Study|Withdrawal by Subject|41|||
33248782|NCT03034915|100810303|FG000|Overall Study|Protocol Deviation|2|||
33248783|NCT03034915|100810304|FG001|Overall Study|Protocol Deviation|14|||
33248784|NCT03034915|100810305|FG002|Overall Study|Protocol Deviation|7|||
33248785|NCT03034915|100810303|FG000|Overall Study|Lack of Efficacy|8|||
33248786|NCT03034915|100810304|FG001|Overall Study|Lack of Efficacy|16|||
33248787|NCT03034915|100810305|FG002|Overall Study|Lack of Efficacy|18|||
33248788|NCT03034915|100810303|FG000|Overall Study|Site closed|2|||
33248789|NCT03034915|100810304|FG001|Overall Study|Site closed|2|||
33248790|NCT03034915|100810305|FG002|Overall Study|Site closed|4|||
33248791|NCT03034915|100810303|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
33248792|NCT03034915|100810304|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
33248793|NCT03034915|100810305|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
33248794|NCT03034915|100810303|FG000|Overall Study|Physician Decision|1|||
33382781|NCT00476996|101287622|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
33382782|NCT00476996|101287623|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
33149507|NCT02927262|100460758|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
33149508|NCT02927262|100460757|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
33149509|NCT02927262|100460758|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
33149510|NCT02927262|100460757|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
33149511|NCT02927262|100460758|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
33149512|NCT02927262|100460757|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
33149513|NCT02927262|100460758|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
33149514|NCT02927262|100460757|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
33149515|NCT02927262|100460758|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
33149516|NCT02927262|100460757|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
33149517|NCT02927262|100460758|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
33149518|NCT02927262|100460757|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
33149519|NCT02927262|100460758|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
33149520|NCT02927262|100460757|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
33149521|NCT02927262|100460758|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
33149522|NCT02927262|100460757|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
33149523|NCT02927262|100460758|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
33149524|NCT02927262|100460757|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
33149525|NCT02927262|100460758|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
33149526|NCT03384693|100460759|FG000|Overall Study|Adverse Event|3|||
33149527|NCT03553836|100460771|FG000|Overall Study|Ongoing in Study|460|||
33149528|NCT03553836|100460772|FG001|Overall Study|Ongoing in Study|459|||
33149529|NCT03553836|100460771|FG000|Overall Study|Withdrawal by Subject|9|||
33149530|NCT03553836|100460772|FG001|Overall Study|Withdrawal by Subject|10|||
33149531|NCT03553836|100460771|FG000|Overall Study|Lost to Follow-up|1|||
33149532|NCT03553836|100460772|FG001|Overall Study|Lost to Follow-up|3|||
33149533|NCT03553836|100460771|FG000|Overall Study|Death|17|||
33248795|NCT03034915|100810304|FG001|Overall Study|Physician Decision|5|||
33248796|NCT03034915|100810305|FG002|Overall Study|Physician Decision|2|||
33248797|NCT04335591|100810312|FG000|Overall Study|Adverse Event|5|||
33248798|NCT04335591|100810313|FG001|Overall Study|Adverse Event|2|||
33248799|NCT04335591|100810314|FG002|Overall Study|Adverse Event|3|||
33429020|NCT00130520|101463302|FG000|Overall Study|Death|1|||
33429021|NCT00130520|101463302|FG000|Overall Study|Physician Decision|1|||
33429022|NCT00130520|101463302|FG000|Overall Study|Withdrawal by Subject|1|||
33429023|NCT00130520|101463302|FG000|Overall Study|Disease Progression|23|||
33429024|NCT00130520|101463302|FG000|Overall Study|Protocol non-compliance|1|||
33429025|NCT00130520|101463302|FG000|Overall Study|Did not meet re-treatment criteria|1|||
33429026|NCT01618305|101463303|FG000|Overall Study|Death|0|||
33429027|NCT01618305|101463304|FG001|Overall Study|Death|1|||
33429028|NCT01618305|101463303|FG000|Overall Study|Lost to Follow-up|11|||
33429029|NCT01618305|101463304|FG001|Overall Study|Lost to Follow-up|7|||
33429030|NCT01618305|101463303|FG000|Overall Study|Protocol Violation|1|||
33429031|NCT01618305|101463304|FG001|Overall Study|Protocol Violation|0|||
33429032|NCT01618305|101463303|FG000|Overall Study|Withdrawal by Subject|3|||
33429033|NCT01618305|101463304|FG001|Overall Study|Withdrawal by Subject|2|||
33429034|NCT01847313|101463309|FG000|Overall Study|Death|0|||
33429035|NCT01847313|101463310|FG001|Overall Study|Death|1|||
33429036|NCT01847313|101463309|FG000|Overall Study|Withdrawal by Subject|0|||
33429037|NCT01847313|101463310|FG001|Overall Study|Withdrawal by Subject|1|||
33429038|NCT02207621|101463311|FG000|Overall Study|Adverse Event|71|||
33429039|NCT02207621|101463312|FG001|Overall Study|Adverse Event|15|||
33429040|NCT02207621|101463313|FG002|Overall Study|Adverse Event|132|||
33429041|NCT02207621|101463311|FG000|Overall Study|Withdrawal by Subject|9|||
33429042|NCT02207621|101463312|FG001|Overall Study|Withdrawal by Subject|9|||
33429043|NCT02207621|101463313|FG002|Overall Study|Withdrawal by Subject|13|||
33429044|NCT02207621|101463311|FG000|Overall Study|Non-Compliant|3|||
33429045|NCT02207621|101463312|FG001|Overall Study|Non-Compliant|3|||
33429046|NCT02207621|101463313|FG002|Overall Study|Non-Compliant|1|||
33429047|NCT02207621|101463311|FG000|Overall Study|Lost to Follow-up|1|||
33429048|NCT02207621|101463312|FG001|Overall Study|Lost to Follow-up|0|||
33429049|NCT02207621|101463313|FG002|Overall Study|Lost to Follow-up|3|||
33429050|NCT02207621|101463311|FG000|Overall Study|Lack of Efficacy|10|||
33429051|NCT02207621|101463312|FG001|Overall Study|Lack of Efficacy|2|||
33429052|NCT02207621|101463313|FG002|Overall Study|Lack of Efficacy|4|||
33429053|NCT02207621|101463311|FG000|Overall Study|Disallowed Concurrent Medication|2|||
33429054|NCT02207621|101463312|FG001|Overall Study|Disallowed Concurrent Medication|5|||
33429055|NCT02207621|101463313|FG002|Overall Study|Disallowed Concurrent Medication|2|||
33429056|NCT02207621|101463311|FG000|Overall Study|Physician Decision|1|||
33429057|NCT02207621|101463312|FG001|Overall Study|Physician Decision|2|||
33429058|NCT02207621|101463313|FG002|Overall Study|Physician Decision|2|||
33429059|NCT02207621|101463311|FG000|Overall Study|Protocol Violation|4|||
33429060|NCT02207621|101463312|FG001|Overall Study|Protocol Violation|10|||
33429061|NCT02207621|101463313|FG002|Overall Study|Protocol Violation|6|||
33429062|NCT02207621|101463311|FG000|Overall Study|Death|2|||
33429063|NCT02207621|101463312|FG001|Overall Study|Death|0|||
33429064|NCT02207621|101463313|FG002|Overall Study|Death|0|||
33429065|NCT02207621|101463311|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
33429066|NCT02207621|101463312|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
33429067|NCT02207621|101463313|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
33429068|NCT02260492|101463319|FG000|Overall Study|Adverse Event|6|||
33429069|NCT02260492|101463320|FG001|Overall Study|Adverse Event|1|||
33429070|NCT02260492|101463321|FG002|Overall Study|Adverse Event|2|||
33429071|NCT02260492|101463319|FG000|Overall Study|Death|0|||
33429072|NCT02260492|101463320|FG001|Overall Study|Death|1|||
33429073|NCT02260492|101463321|FG002|Overall Study|Death|0|||
33429074|NCT02260492|101463319|FG000|Overall Study|Lost to Follow-up|12|||
33429075|NCT02260492|101463320|FG001|Overall Study|Lost to Follow-up|9|||
33429076|NCT02260492|101463321|FG002|Overall Study|Lost to Follow-up|0|||
33429077|NCT02260492|101463319|FG000|Overall Study|Physician Decision|2|||
33429078|NCT02260492|101463320|FG001|Overall Study|Physician Decision|0|||
33429079|NCT02260492|101463321|FG002|Overall Study|Physician Decision|1|||
33429080|NCT02260492|101463319|FG000|Overall Study|Withdrawal by Subject|3|||
33429081|NCT02260492|101463320|FG001|Overall Study|Withdrawal by Subject|2|||
33248800|NCT04335591|100810315|FG003|Overall Study|Adverse Event|2|||
33248801|NCT04335591|100810312|FG000|Overall Study|Protocol Violation|1|||
33429082|NCT02260492|101463321|FG002|Overall Study|Withdrawal by Subject|2|||
33429083|NCT00903383|101463322|FG000|Overall Study|Adverse Event|1|||
33429084|NCT00903383|101463323|FG001|Overall Study|Adverse Event|2|||
33429085|NCT00903383|101463324|FG002|Overall Study|Adverse Event|3|||
33429086|NCT00903383|101463325|FG003|Overall Study|Adverse Event|1|||
33429087|NCT00903383|101463322|FG000|Overall Study|Physician Decision|1|||
33429088|NCT00903383|101463323|FG001|Overall Study|Physician Decision|2|||
33429089|NCT00903383|101463324|FG002|Overall Study|Physician Decision|0|||
33429090|NCT00903383|101463325|FG003|Overall Study|Physician Decision|0|||
33429091|NCT00903383|101463322|FG000|Overall Study|Lost to Follow-up|0|||
33429092|NCT00903383|101463323|FG001|Overall Study|Lost to Follow-up|0|||
33429093|NCT00903383|101463324|FG002|Overall Study|Lost to Follow-up|0|||
33429094|NCT00903383|101463325|FG003|Overall Study|Lost to Follow-up|1|||
33429095|NCT00903383|101463322|FG000|Overall Study|Decision of Sponsor|1|||
33429096|NCT00903383|101463323|FG001|Overall Study|Decision of Sponsor|0|||
33429097|NCT00903383|101463324|FG002|Overall Study|Decision of Sponsor|0|||
33429098|NCT00903383|101463325|FG003|Overall Study|Decision of Sponsor|0|||
33429099|NCT00903383|101463322|FG000|Overall Study|Withdrawal by Subject|4|||
33429100|NCT00903383|101463323|FG001|Overall Study|Withdrawal by Subject|1|||
33429101|NCT00903383|101463324|FG002|Overall Study|Withdrawal by Subject|0|||
33429102|NCT00903383|101463325|FG003|Overall Study|Withdrawal by Subject|2|||
33429103|NCT00903383|101463322|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
33429104|NCT00903383|101463323|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
33429105|NCT00903383|101463324|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
33587878|NCT03333252|102041695|FG001|Overall Study|Adverse Event|6|||
33587879|NCT03333252|102041696|FG002|Overall Study|Adverse Event|5|||
33248802|NCT04335591|100810313|FG001|Overall Study|Protocol Violation|0|||
33382783|NCT00476996|101287620|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
33382784|NCT00476996|101287621|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
33382785|NCT00476996|101287622|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
33382786|NCT00476996|101287623|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
33382787|NCT00476996|101287620|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
33382788|NCT00476996|101287621|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
33382789|NCT00476996|101287622|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
33382790|NCT00476996|101287623|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
33382791|NCT00476996|101287620|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
33382792|NCT00476996|101287621|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
33382793|NCT00476996|101287622|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
33382794|NCT00476996|101287623|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
33382795|NCT00476996|101287620|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
33382796|NCT00476996|101287621|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
33382797|NCT00476996|101287622|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
33382798|NCT00476996|101287623|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
33382799|NCT00476996|101287620|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
33382800|NCT00476996|101287621|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
33382801|NCT00476996|101287622|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
33382802|NCT00476996|101287623|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
33382803|NCT00476996|101287620|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
33382804|NCT00476996|101287621|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
33382805|NCT00476996|101287622|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
33382806|NCT00476996|101287623|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
33382807|NCT00476996|101287620|FG000|OLE Phase (From Week 48)|Death|0|||
33382808|NCT00476996|101287621|FG001|OLE Phase (From Week 48)|Death|0|||
33382809|NCT00476996|101287622|FG002|OLE Phase (From Week 48)|Death|0|||
33382810|NCT00476996|101287623|FG003|OLE Phase (From Week 48)|Death|7|||
33382811|NCT00476996|101287620|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
33382812|NCT00476996|101287621|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
33382813|NCT00476996|101287622|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
33382814|NCT00476996|101287623|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
33382815|NCT00476996|101287620|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
33382816|NCT00476996|101287621|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
33382817|NCT00476996|101287622|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
33382818|NCT00476996|101287623|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
33382819|NCT00476996|101287620|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
33382820|NCT00476996|101287621|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
33382821|NCT00476996|101287622|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
33382822|NCT00476996|101287623|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
33382823|NCT00476996|101287620|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
33382824|NCT00476996|101287621|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
33382825|NCT00476996|101287622|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
33382826|NCT00476996|101287623|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
33382827|NCT00992186|101287624|FG000|Overall Study|Withdrawal by Subject|2|||
33382828|NCT00992186|101287624|FG000|Overall Study|Protocol Violation|1|||
33382829|NCT00992186|101287624|FG000|Overall Study|Physician Decision|1|||
33382830|NCT00992186|101287624|FG000|Overall Study|Adverse Event|9|||
33382831|NCT00992186|101287624|FG000|Overall Study|Progressive Disease|30|||
33382832|NCT00992186|101287624|FG000|Overall Study|Refusal To Receive Study Agent|3|||
33382833|NCT00970268|101287625|FG000|Overall Study|Withdrawal by Subject|12|||
33382834|NCT00970268|101287626|FG001|Overall Study|Withdrawal by Subject|19|||
33382835|NCT00970268|101287625|FG000|Overall Study|Adverse Event|15|||
33382836|NCT00970268|101287626|FG001|Overall Study|Adverse Event|12|||
33382837|NCT00970268|101287625|FG000|Overall Study|Lack of Efficacy|3|||
33382838|NCT00970268|101287626|FG001|Overall Study|Lack of Efficacy|6|||
33382839|NCT00970268|101287625|FG000|Overall Study|Protocol Violation|4|||
33382840|NCT00970268|101287626|FG001|Overall Study|Protocol Violation|7|||
33382841|NCT00970268|101287625|FG000|Overall Study|Other Reason|3|||
33382842|NCT00970268|101287626|FG001|Overall Study|Other Reason|1|||
33382843|NCT00970268|101287625|FG000|Overall Study|COPD Exacerbation|4|||
33587880|NCT03333252|102041697|FG003|Overall Study|Adverse Event|2|||
33429106|NCT00903383|101463325|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
33429107|NCT00903383|101463322|FG000|Overall Study|Patient Decision|0|||
33429108|NCT00903383|101463323|FG001|Overall Study|Patient Decision|0|||
33429109|NCT00903383|101463324|FG002|Overall Study|Patient Decision|0|||
33429110|NCT00903383|101463325|FG003|Overall Study|Patient Decision|1|||
33429111|NCT03433001|101463326|FG000|Overall Study|Lack of Efficacy|109|||
33429112|NCT03433001|101463326|FG000|Overall Study|Adverse Event|69|||
33429113|NCT03433001|101463326|FG000|Overall Study|Withdrawal by Subject|10|||
33429114|NCT03433001|101463326|FG000|Overall Study|Death|12|||
33429115|NCT03433001|101463326|FG000|Overall Study|Lost to Follow-up|4|||
33429116|NCT03433001|101463326|FG000|Overall Study|Other|25|||
33429117|NCT03896490|101463327|FG000|Overall Study|Withdrawal by Subject|1|||
33429118|NCT03896490|101463328|FG001|Overall Study|Withdrawal by Subject|1|||
33429119|NCT01868009|101463331|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
33429120|NCT01868009|101463332|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
33382844|NCT00970268|101287626|FG001|Overall Study|COPD Exacerbation|2|||
33382845|NCT00970268|101287625|FG000|Overall Study|Lost to Follow-up|1|||
33429121|NCT01868009|101463331|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
33429122|NCT01868009|101463332|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
33429123|NCT01868009|101463331|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
33429124|NCT01868009|101463332|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
33429125|NCT01814761|101463333|FG000|Overall Study|Other Reasons|1|||
33429126|NCT01814761|101463334|FG001|Overall Study|Other Reasons|10|||
33429127|NCT01814761|101463333|FG000|Overall Study|Ocular Adverse Event|6|||
33429128|NCT01814761|101463334|FG001|Overall Study|Ocular Adverse Event|15|||
33429129|NCT01814761|101463333|FG000|Overall Study|Lost to Follow-up|1|||
33429130|NCT01814761|101463334|FG001|Overall Study|Lost to Follow-up|5|||
33429131|NCT02168270|101463335|FG000|Overall Study|Lack of Efficacy|4|||
33429132|NCT02789111|101463343|FG000|Overall Study|Withdrawal by Subject|1|||
33429133|NCT02789111|101463344|FG001|Overall Study|Withdrawal by Subject|4|||
33429134|NCT01507896|101463345|FG000|Overall Study|Withdrawal by Subject|1|||
33429135|NCT01507896|101463345|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
33429136|NCT01254045|101463349|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
33429137|NCT01254045|101463350|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
33429138|NCT01254045|101463351|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
33429139|NCT01254045|101463352|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
33429140|NCT01254045|101463353|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
33429141|NCT01254045|101463354|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
33429142|NCT02570165|101463355|FG000|Overall Study|Adverse Event|1|||
33429143|NCT02570165|101463356|FG001|Overall Study|Adverse Event|0|||
33429144|NCT02570165|101463357|FG002|Overall Study|Adverse Event|2|||
33429145|NCT02570165|101463358|FG003|Overall Study|Adverse Event|0|||
33587881|NCT03333252|102041694|FG000|Overall Study|Death|1|||
33587882|NCT03333252|102041695|FG001|Overall Study|Death|3|||
33248803|NCT04335591|100810314|FG002|Overall Study|Protocol Violation|0|||
33248804|NCT04335591|100810315|FG003|Overall Study|Protocol Violation|0|||
33382846|NCT00970268|101287626|FG001|Overall Study|Lost to Follow-up|2|||
33382847|NCT00970268|101287625|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
33382848|NCT00970268|101287626|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
33382849|NCT02227849|101287630|FG000|Overall Study|Adverse Event|4|||
33382850|NCT02227849|101287630|FG000|Overall Study|Physician Decision|1|||
33382851|NCT02227849|101287630|FG000|Overall Study|Withdrawal by Subject|3|||
33382852|NCT01357980|101287631|FG000|Overall Study|Lack of Efficacy|0|||
33382853|NCT01357980|101287632|FG001|Overall Study|Lack of Efficacy|1|||
33382854|NCT01357980|101287633|FG002|Overall Study|Lack of Efficacy|0|||
33382855|NCT01357980|101287634|FG003|Overall Study|Lack of Efficacy|0|||
33382856|NCT01357980|101287631|FG000|Overall Study|Consent withdrawn|0|||
33382857|NCT01357980|101287632|FG001|Overall Study|Consent withdrawn|0|||
33382858|NCT01357980|101287633|FG002|Overall Study|Consent withdrawn|1|||
33382859|NCT01357980|101287634|FG003|Overall Study|Consent withdrawn|0|||
33382860|NCT01419080|101287635|FG000|Overall Study|Withdrawal by Subject|75|||
33382861|NCT01419080|101287635|FG000|Overall Study|Death|30|||
33248805|NCT04335591|100810312|FG000|Overall Study|Withdrawal by Subject|8|||
33248806|NCT04335591|100810313|FG001|Overall Study|Withdrawal by Subject|4|||
33248807|NCT04335591|100810314|FG002|Overall Study|Withdrawal by Subject|4|||
33382862|NCT01419080|101287635|FG000|Overall Study|Lost to Follow-up|23|||
33382863|NCT01419080|101287635|FG000|Overall Study|Too Ill|3|||
33429146|NCT02570165|101463359|FG004|Overall Study|Adverse Event|0|||
33429147|NCT02570165|101463360|FG005|Overall Study|Adverse Event|0|||
33429148|NCT02570165|101463361|FG006|Overall Study|Adverse Event|0|||
33429149|NCT02570165|101463355|FG000|Overall Study|Lack of Efficacy|0|||
33429150|NCT02570165|101463356|FG001|Overall Study|Lack of Efficacy|1|||
33429151|NCT02570165|101463357|FG002|Overall Study|Lack of Efficacy|0|||
33429152|NCT02570165|101463358|FG003|Overall Study|Lack of Efficacy|0|||
33429153|NCT02570165|101463359|FG004|Overall Study|Lack of Efficacy|4|||
33647753|NCT03642132|102262811|FG000|Maintenance Period|Adverse Event|1|||
33382864|NCT00424294|101287636|FG000|Overall Study|Adverse Event|4|||
33587883|NCT03333252|102041696|FG002|Overall Study|Death|0|||
33429154|NCT02570165|101463360|FG005|Overall Study|Lack of Efficacy|0|||
33429155|NCT02570165|101463361|FG006|Overall Study|Lack of Efficacy|0|||
33429156|NCT02570165|101463355|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
33429157|NCT02570165|101463356|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
33429158|NCT02570165|101463357|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
33429159|NCT02570165|101463358|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
33429160|NCT02570165|101463359|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
33429161|NCT02570165|101463360|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
33429162|NCT02570165|101463361|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
33429163|NCT02570165|101463355|FG000|Overall Study|Lost to Follow-up|0|||
33429164|NCT02570165|101463356|FG001|Overall Study|Lost to Follow-up|0|||
33429165|NCT02570165|101463357|FG002|Overall Study|Lost to Follow-up|1|||
33429166|NCT02570165|101463358|FG003|Overall Study|Lost to Follow-up|1|||
33429167|NCT02570165|101463359|FG004|Overall Study|Lost to Follow-up|0|||
33429168|NCT02570165|101463360|FG005|Overall Study|Lost to Follow-up|0|||
33429169|NCT02570165|101463361|FG006|Overall Study|Lost to Follow-up|0|||
33429170|NCT02570165|101463355|FG000|Overall Study|Physician Decision|0|||
33429171|NCT02570165|101463356|FG001|Overall Study|Physician Decision|1|||
33429172|NCT02570165|101463357|FG002|Overall Study|Physician Decision|0|||
33429173|NCT02570165|101463358|FG003|Overall Study|Physician Decision|0|||
33429174|NCT02570165|101463359|FG004|Overall Study|Physician Decision|0|||
33429175|NCT02570165|101463360|FG005|Overall Study|Physician Decision|0|||
33429176|NCT02570165|101463361|FG006|Overall Study|Physician Decision|0|||
33429177|NCT02570165|101463355|FG000|Overall Study|Withdrawal by Subject|0|||
33647754|NCT03642132|102262812|FG001|Maintenance Period|Adverse Event|2|||
33647755|NCT03642132|102262813|FG002|Maintenance Period|Adverse Event|0|||
33429178|NCT02570165|101463356|FG001|Overall Study|Withdrawal by Subject|0|||
33429179|NCT02570165|101463357|FG002|Overall Study|Withdrawal by Subject|0|||
33429180|NCT02570165|101463358|FG003|Overall Study|Withdrawal by Subject|2|||
33429181|NCT02570165|101463359|FG004|Overall Study|Withdrawal by Subject|1|||
33429182|NCT02570165|101463360|FG005|Overall Study|Withdrawal by Subject|0|||
33429183|NCT02570165|101463361|FG006|Overall Study|Withdrawal by Subject|0|||
33429184|NCT02570165|101463355|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
33429185|NCT02570165|101463356|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
33429186|NCT02570165|101463357|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
33647756|NCT03642132|102262811|FG000|Maintenance Period|Non-compliance with study drug|0|||
33382865|NCT00424294|101287637|FG001|Overall Study|Adverse Event|10|||
33382866|NCT00424294|101287636|FG000|Overall Study|Lack of Efficacy|2|||
33382867|NCT00424294|101287637|FG001|Overall Study|Lack of Efficacy|1|||
33382868|NCT00424294|101287636|FG000|Overall Study|Withdrawal by Subject|1|||
33382869|NCT00424294|101287637|FG001|Overall Study|Withdrawal by Subject|2|||
33382870|NCT00424294|101287636|FG000|Overall Study|Other|0|||
33382871|NCT00424294|101287637|FG001|Overall Study|Other|2|||
33382872|NCT00424294|101287636|FG000|Overall Study|Randomized but not Treated|1|||
33382873|NCT00424294|101287637|FG001|Overall Study|Randomized but not Treated|0|||
33382874|NCT02807844|101287638|FG000|Overall Study|Physician Decision|0|||
33382875|NCT02807844|101287639|FG001|Overall Study|Physician Decision|0|||
33382876|NCT02807844|101287640|FG002|Overall Study|Physician Decision|0|||
33382877|NCT02807844|101287641|FG003|Overall Study|Physician Decision|0|||
33382878|NCT02807844|101287642|FG004|Overall Study|Physician Decision|0|||
33382879|NCT02807844|101287643|FG005|Overall Study|Physician Decision|0|||
33382880|NCT02807844|101287644|FG006|Overall Study|Physician Decision|3|||
33382881|NCT02807844|101287645|FG007|Overall Study|Physician Decision|0|||
33382882|NCT02807844|101287646|FG008|Overall Study|Physician Decision|1|||
33382883|NCT02807844|101287647|FG009|Overall Study|Physician Decision|2|||
33382884|NCT02807844|101287638|FG000|Overall Study|Death|0|||
33382885|NCT02807844|101287639|FG001|Overall Study|Death|0|||
33382886|NCT02807844|101287640|FG002|Overall Study|Death|2|||
33382887|NCT02807844|101287641|FG003|Overall Study|Death|4|||
33382888|NCT02807844|101287642|FG004|Overall Study|Death|1|||
33382889|NCT02807844|101287643|FG005|Overall Study|Death|2|||
33382890|NCT02807844|101287644|FG006|Overall Study|Death|1|||
33429187|NCT02570165|101463358|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
33429188|NCT02570165|101463359|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
33429189|NCT02570165|101463360|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
33429190|NCT02570165|101463361|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
33429191|NCT02570165|101463355|FG000|Overall Study|Withdrawal Request by GSK|0|||
33647757|NCT03642132|102262812|FG001|Maintenance Period|Non-compliance with study drug|0|||
33429192|NCT02570165|101463356|FG001|Overall Study|Withdrawal Request by GSK|0|||
33429193|NCT02570165|101463357|FG002|Overall Study|Withdrawal Request by GSK|2|||
33429194|NCT02570165|101463358|FG003|Overall Study|Withdrawal Request by GSK|0|||
33429195|NCT02570165|101463359|FG004|Overall Study|Withdrawal Request by GSK|0|||
33382891|NCT02807844|101287645|FG007|Overall Study|Death|2|||
33382892|NCT02807844|101287646|FG008|Overall Study|Death|0|||
33382893|NCT02807844|101287647|FG009|Overall Study|Death|1|||
33382894|NCT02807844|101287638|FG000|Overall Study|Withdrawal by Subject|0|||
33382895|NCT02807844|101287639|FG001|Overall Study|Withdrawal by Subject|0|||
33429196|NCT02570165|101463360|FG005|Overall Study|Withdrawal Request by GSK|0|||
33429197|NCT02570165|101463361|FG006|Overall Study|Withdrawal Request by GSK|0|||
33429198|NCT04079842|101463367|FG000|Overall Study|Request of subject|2|||
33429199|NCT04079842|101463367|FG000|Overall Study|Unable to draw Arterial samples|1|||
33429200|NCT04228302|101463371|FG000|Overall Study|Adverse Event|0|||
33429201|NCT04228302|101463372|FG001|Overall Study|Adverse Event|0|||
33429202|NCT04228302|101463373|FG002|Overall Study|Adverse Event|0|||
33429203|NCT04228302|101463374|FG003|Overall Study|Adverse Event|0|||
33429204|NCT04228302|101463375|FG004|Overall Study|Adverse Event|1|||
33429205|NCT04228302|101463376|FG005|Overall Study|Adverse Event|0|||
33429206|NCT01706198|101463378|FG000|Overall Study|Adverse Event|12|||
33429207|NCT01706198|101463379|FG001|Overall Study|Adverse Event|15|||
33429208|NCT01706198|101463378|FG000|Overall Study|Protocol Violation|7|||
33429209|NCT01706198|101463379|FG001|Overall Study|Protocol Violation|5|||
33429210|NCT01706198|101463378|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
33429211|NCT01706198|101463379|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
33429212|NCT01706198|101463378|FG000|Overall Study|Lost to Follow-up|97|||
33429213|NCT01706198|101463379|FG001|Overall Study|Lost to Follow-up|93|||
33429214|NCT01706198|101463378|FG000|Overall Study|Physician Decision|23|||
33429215|NCT01706198|101463379|FG001|Overall Study|Physician Decision|37|||
33429216|NCT01706198|101463378|FG000|Overall Study|Withdrawal by Subject|23|||
33429217|NCT01706198|101463379|FG001|Overall Study|Withdrawal by Subject|31|||
33429218|NCT00881959|101463380|FG000|Overall Study|Lost to Follow-up|2|||
33429219|NCT00881959|101463381|FG001|Overall Study|Lost to Follow-up|4|||
33382896|NCT02807844|101287640|FG002|Overall Study|Withdrawal by Subject|2|||
33382897|NCT02807844|101287641|FG003|Overall Study|Withdrawal by Subject|1|||
33382898|NCT02807844|101287642|FG004|Overall Study|Withdrawal by Subject|1|||
33382899|NCT02807844|101287643|FG005|Overall Study|Withdrawal by Subject|0|||
33382900|NCT02807844|101287644|FG006|Overall Study|Withdrawal by Subject|1|||
33382901|NCT02807844|101287645|FG007|Overall Study|Withdrawal by Subject|0|||
33382902|NCT02807844|101287646|FG008|Overall Study|Withdrawal by Subject|0|||
33382903|NCT02807844|101287647|FG009|Overall Study|Withdrawal by Subject|0|||
33382904|NCT02807844|101287638|FG000|Overall Study|Progressive disease|5|||
33382905|NCT02807844|101287639|FG001|Overall Study|Progressive disease|12|||
33382906|NCT02807844|101287640|FG002|Overall Study|Progressive disease|8|||
33382907|NCT02807844|101287641|FG003|Overall Study|Progressive disease|8|||
33429220|NCT00891774|101463382|FG000|Overall Study|Lost to Follow-up|5|||
33429221|NCT00891774|101463382|FG000|Overall Study|Illness (Self/Mother)|3|||
33429222|NCT00891774|101463382|FG000|Overall Study|Withdrawal by Subject|2|||
33429223|NCT00891774|101463382|FG000|Overall Study|Protocol Violation|4|||
33429224|NCT01227668|101463385|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
33429225|NCT01227668|101463386|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
33429226|NCT01227668|101463385|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
33429227|NCT01227668|101463386|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
33149534|NCT03553836|100460772|FG001|Overall Study|Death|17|||
33149535|NCT03583073|100460773|FG000|Overall Study|Lost to Follow-up|8|||
33149536|NCT03583073|100460774|FG001|Overall Study|Lost to Follow-up|12|||
33149537|NCT05136690|100460776|FG000|Period 1|Withdrawal by Subject|0|||
33149538|NCT05136690|100460777|FG001|Period 1|Withdrawal by Subject|1|||
33149539|NCT05136690|100460776|FG000|Period 2|Lost to Follow-up|0|||
33429228|NCT01227668|101463385|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
33429229|NCT01227668|101463386|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
33429230|NCT01227668|101463385|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
33429231|NCT01227668|101463386|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
33429232|NCT01227668|101463385|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
33429233|NCT01227668|101463386|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
33429234|NCT01227668|101463385|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
33429235|NCT01227668|101463386|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
33429236|NCT01227668|101463385|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
33647758|NCT03642132|102262813|FG002|Maintenance Period|Non-compliance with study drug|1|||
33647759|NCT03642132|102262811|FG000|Maintenance Period|Physician's decision|2|||
33647760|NCT03642132|102262812|FG001|Maintenance Period|Physician's decision|2|||
33429237|NCT01227668|101463386|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
33149540|NCT05136690|100460777|FG001|Period 2|Lost to Follow-up|3|||
33382908|NCT02807844|101287642|FG004|Overall Study|Progressive disease|3|||
33647761|NCT03642132|102262813|FG002|Maintenance Period|Physician's decision|2|||
33382909|NCT02807844|101287643|FG005|Overall Study|Progressive disease|8|||
33429238|NCT01227668|101463385|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
33429239|NCT01227668|101463386|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
33429240|NCT01227668|101463385|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
33429241|NCT01227668|101463386|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
33647762|NCT03642132|102262811|FG000|Maintenance Period|Progressive disease|9|||
33149541|NCT05136690|100460776|FG000|Period 2|Withdrawal by Subject|0|||
33382910|NCT02807844|101287644|FG006|Overall Study|Progressive disease|14|||
33382911|NCT02807844|101287645|FG007|Overall Study|Progressive disease|17|||
33429242|NCT01227668|101463385|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
33429243|NCT01227668|101463386|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
33429244|NCT01227668|101463385|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
33429245|NCT01227668|101463386|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
33429246|NCT01227668|101463385|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
33429247|NCT01227668|101463386|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
33429248|NCT01809314|101463389|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
33429249|NCT01809314|101463389|FG000|Overall Study|Adverse Event|6|||
33429250|NCT01809314|101463389|FG000|Overall Study|Insufficient Therapeutic Response|14|||
33429251|NCT01809314|101463389|FG000|Overall Study|Lost to Follow-up|724|||
33429252|NCT04014959|101463390|FG000|Baseline MRI and Assessments|Physician Decision|2|||
33429253|NCT04014959|101463390|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
33429254|NCT04014959|101463390|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
33429255|NCT00410410|101463397|FG000|Induction Period (IP)|Death|1|||
33429256|NCT00410410|101463398|FG001|Induction Period (IP)|Death|0|||
33429257|NCT00410410|101463399|FG002|Induction Period (IP)|Death|0|||
33429258|NCT00410410|101463400|FG003|Induction Period (IP)|Death|0|||
33429259|NCT00410410|101463401|FG004|Induction Period (IP)|Death|0|||
33429260|NCT00410410|101463402|FG005|Induction Period (IP)|Death|0|||
33429261|NCT00410410|101463403|FG006|Induction Period (IP)|Death|0|||
33429262|NCT00410410|101463404|FG007|Induction Period (IP)|Death|0|||
33429263|NCT00410410|101463405|FG008|Induction Period (IP)|Death|0|||
33429264|NCT00410410|101463397|FG000|Induction Period (IP)|Adverse Event|3|||
33429265|NCT00410410|101463398|FG001|Induction Period (IP)|Adverse Event|4|||
33429266|NCT00410410|101463399|FG002|Induction Period (IP)|Adverse Event|2|||
33429267|NCT00410410|101463400|FG003|Induction Period (IP)|Adverse Event|4|||
33429268|NCT00410410|101463401|FG004|Induction Period (IP)|Adverse Event|1|||
33149542|NCT05136690|100460777|FG001|Period 2|Withdrawal by Subject|1|||
33149543|NCT01986907|100460778|FG000|Overall Study|Adverse Event|11|||
33382912|NCT02807844|101287646|FG008|Overall Study|Progressive disease|19|||
33382913|NCT02807844|101287647|FG009|Overall Study|Progressive disease|15|||
33382914|NCT02807844|101287638|FG000|Overall Study|Adverse Event|1|||
33382915|NCT02807844|101287639|FG001|Overall Study|Adverse Event|0|||
33382916|NCT02807844|101287640|FG002|Overall Study|Adverse Event|0|||
33382917|NCT02807844|101287641|FG003|Overall Study|Adverse Event|0|||
33382918|NCT02807844|101287642|FG004|Overall Study|Adverse Event|1|||
33382919|NCT02807844|101287643|FG005|Overall Study|Adverse Event|1|||
33382920|NCT02807844|101287644|FG006|Overall Study|Adverse Event|1|||
33382921|NCT02807844|101287645|FG007|Overall Study|Adverse Event|1|||
33382922|NCT02807844|101287646|FG008|Overall Study|Adverse Event|1|||
33382923|NCT02807844|101287647|FG009|Overall Study|Adverse Event|2|||
33382924|NCT02849626|101287648|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
33382925|NCT02849626|101287649|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
33382926|NCT02849626|101287650|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
33382927|NCT02849626|101287651|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
33382928|NCT02849626|101287648|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
33382929|NCT02849626|101287649|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
33382930|NCT02849626|101287650|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
33382931|NCT02849626|101287651|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
33382932|NCT02849626|101287648|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
33382933|NCT02849626|101287649|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
33382934|NCT02849626|101287650|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
33382935|NCT02849626|101287651|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
33382936|NCT02849626|101287648|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
33382937|NCT02849626|101287649|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
33382938|NCT02849626|101287650|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
33382939|NCT02849626|101287651|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
33382940|NCT02849626|101287648|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
33382941|NCT02849626|101287649|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
33382942|NCT02849626|101287650|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
33382943|NCT02849626|101287651|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
33382944|NCT02849626|101287648|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
33382945|NCT02849626|101287649|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
33647763|NCT03642132|102262812|FG001|Maintenance Period|Progressive disease|3|||
33382946|NCT02849626|101287650|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
33382947|NCT02849626|101287651|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
33382948|NCT02849626|101287648|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
33382949|NCT02849626|101287649|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
33429269|NCT00410410|101463402|FG005|Induction Period (IP)|Adverse Event|0|||
33429270|NCT00410410|101463403|FG006|Induction Period (IP)|Adverse Event|0|||
33429271|NCT00410410|101463404|FG007|Induction Period (IP)|Adverse Event|0|||
33429272|NCT00410410|101463405|FG008|Induction Period (IP)|Adverse Event|0|||
33429273|NCT00410410|101463397|FG000|Induction Period (IP)|Lack of Efficacy|26|||
33587884|NCT03333252|102041697|FG003|Overall Study|Death|0|||
33429274|NCT00410410|101463398|FG001|Induction Period (IP)|Lack of Efficacy|24|||
33429275|NCT00410410|101463399|FG002|Induction Period (IP)|Lack of Efficacy|8|||
33429276|NCT00410410|101463400|FG003|Induction Period (IP)|Lack of Efficacy|8|||
33429277|NCT00410410|101463401|FG004|Induction Period (IP)|Lack of Efficacy|7|||
33429278|NCT00410410|101463402|FG005|Induction Period (IP)|Lack of Efficacy|7|||
33429279|NCT00410410|101463403|FG006|Induction Period (IP)|Lack of Efficacy|0|||
33429280|NCT00410410|101463404|FG007|Induction Period (IP)|Lack of Efficacy|0|||
33429281|NCT00410410|101463405|FG008|Induction Period (IP)|Lack of Efficacy|0|||
33429282|NCT00410410|101463397|FG000|Induction Period (IP)|Lost to Follow-up|2|||
33429283|NCT00410410|101463398|FG001|Induction Period (IP)|Lost to Follow-up|2|||
33429284|NCT00410410|101463399|FG002|Induction Period (IP)|Lost to Follow-up|2|||
33429285|NCT00410410|101463400|FG003|Induction Period (IP)|Lost to Follow-up|3|||
33429286|NCT00410410|101463401|FG004|Induction Period (IP)|Lost to Follow-up|0|||
33647764|NCT03642132|102262813|FG002|Maintenance Period|Progressive disease|6|||
33647765|NCT03642132|102262811|FG000|Maintenance Period|Other|0|||
33647766|NCT03642132|102262812|FG001|Maintenance Period|Other|0|||
33647767|NCT03642132|102262813|FG002|Maintenance Period|Other|3|||
33647768|NCT03642132|102262811|FG000|Maintenance Period|Withdrawal by Subject|1|||
33647769|NCT03642132|102262812|FG001|Maintenance Period|Withdrawal by Subject|1|||
33647770|NCT03642132|102262813|FG002|Maintenance Period|Withdrawal by Subject|2|||
33647771|NCT03642132|102262811|FG000|Follow-up Period|Other|0|||
33647772|NCT03642132|102262812|FG001|Follow-up Period|Other|0|||
33647773|NCT03642132|102262813|FG002|Follow-up Period|Other|1|||
33429287|NCT00410410|101463402|FG005|Induction Period (IP)|Lost to Follow-up|1|||
33429288|NCT00410410|101463403|FG006|Induction Period (IP)|Lost to Follow-up|0|||
33429289|NCT00410410|101463404|FG007|Induction Period (IP)|Lost to Follow-up|0|||
33429290|NCT00410410|101463405|FG008|Induction Period (IP)|Lost to Follow-up|0|||
33429291|NCT00410410|101463397|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
33429292|NCT00410410|101463398|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
33429293|NCT00410410|101463399|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
33429294|NCT00410410|101463400|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
33429295|NCT00410410|101463401|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
33429296|NCT00410410|101463402|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
33429297|NCT00410410|101463403|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
33429298|NCT00410410|101463404|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
33429299|NCT00410410|101463405|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
33429300|NCT00410410|101463397|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33429301|NCT00410410|101463398|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33429302|NCT00410410|101463399|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
33429303|NCT00410410|101463400|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33429304|NCT00410410|101463401|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33429305|NCT00410410|101463402|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33429306|NCT00410410|101463403|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33429307|NCT00410410|101463404|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33429308|NCT00410410|101463405|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
33429309|NCT00410410|101463397|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
33429310|NCT00410410|101463398|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
33429311|NCT00410410|101463399|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
33429312|NCT00410410|101463400|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
33429313|NCT00410410|101463401|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
33429314|NCT00410410|101463402|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
33429315|NCT00410410|101463403|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
33429316|NCT00410410|101463404|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
33429317|NCT00410410|101463405|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
33429318|NCT00410410|101463397|FG000|Induction Period (IP)|Other|0|||
33429319|NCT00410410|101463398|FG001|Induction Period (IP)|Other|0|||
33429320|NCT00410410|101463399|FG002|Induction Period (IP)|Other|1|||
33429321|NCT00410410|101463400|FG003|Induction Period (IP)|Other|0|||
33429322|NCT00410410|101463401|FG004|Induction Period (IP)|Other|0|||
33429323|NCT00410410|101463402|FG005|Induction Period (IP)|Other|0|||
33429324|NCT00410410|101463403|FG006|Induction Period (IP)|Other|0|||
33429325|NCT00410410|101463404|FG007|Induction Period (IP)|Other|0|||
33647774|NCT03642132|102262811|FG000|Follow-up Period|Withdrawal by Subject|1|||
33647775|NCT03642132|102262812|FG001|Follow-up Period|Withdrawal by Subject|2|||
33429326|NCT00410410|101463405|FG008|Induction Period (IP)|Other|0|||
33429327|NCT00410410|101463397|FG000|Maintenance Period (MP)|Death|0|||
33429328|NCT00410410|101463398|FG001|Maintenance Period (MP)|Death|0|||
33429329|NCT00410410|101463399|FG002|Maintenance Period (MP)|Death|0|||
33429330|NCT00410410|101463400|FG003|Maintenance Period (MP)|Death|0|||
33647776|NCT03642132|102262813|FG002|Follow-up Period|Withdrawal by Subject|0|||
33429331|NCT00410410|101463401|FG004|Maintenance Period (MP)|Death|0|||
33429332|NCT00410410|101463402|FG005|Maintenance Period (MP)|Death|0|||
33647777|NCT03642132|102262811|FG000|Follow-up Period|Study terminated by sponsor|1|||
33382950|NCT02849626|101287650|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
33382951|NCT02849626|101287651|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
33382952|NCT02849626|101287648|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
33382953|NCT02849626|101287649|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
33382954|NCT02849626|101287650|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
33382955|NCT02849626|101287651|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
33382956|NCT02849626|101287648|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
33382957|NCT02849626|101287649|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
33382958|NCT02849626|101287650|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
33382959|NCT02849626|101287651|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
33382960|NCT02849626|101287648|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
33382961|NCT02849626|101287649|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
33382962|NCT02849626|101287650|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
33382963|NCT02849626|101287651|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
33382964|NCT02849626|101287648|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
33382965|NCT02849626|101287649|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
33382966|NCT02849626|101287650|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
33382967|NCT02849626|101287651|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
33382968|NCT01601470|101287654|FG000|Period 2 - LCZ696|Physician Decision|1|||
33382969|NCT04199793|101287661|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
33382970|NCT04199793|101287662|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
33382971|NCT04199793|101287661|FG000|Overall Study|Withdrawal by Subject|1|||
33382972|NCT04199793|101287662|FG001|Overall Study|Withdrawal by Subject|1|||
33382973|NCT00764946|101287663|FG000|Overall Study|Lack of Efficacy|1|||
33382974|NCT00764946|101287664|FG001|Overall Study|Lack of Efficacy|0|||
33382975|NCT00764946|101287665|FG002|Overall Study|Lack of Efficacy|0|||
33382976|NCT00764946|101287663|FG000|Overall Study|Lost to Follow-up|3|||
33382977|NCT00764946|101287664|FG001|Overall Study|Lost to Follow-up|4|||
33382978|NCT00764946|101287665|FG002|Overall Study|Lost to Follow-up|0|||
33382979|NCT00764946|101287663|FG000|Overall Study|Physician Decision|2|||
33382980|NCT00764946|101287664|FG001|Overall Study|Physician Decision|4|||
33382981|NCT00764946|101287665|FG002|Overall Study|Physician Decision|0|||
33382982|NCT00764946|101287663|FG000|Overall Study|Adverse Event|3|||
33382983|NCT00764946|101287664|FG001|Overall Study|Adverse Event|2|||
33382984|NCT00764946|101287665|FG002|Overall Study|Adverse Event|1|||
33382985|NCT00764946|101287663|FG000|Overall Study|Withdrawal by Subject|3|||
33382986|NCT00764946|101287664|FG001|Overall Study|Withdrawal by Subject|6|||
33382987|NCT00764946|101287665|FG002|Overall Study|Withdrawal by Subject|2|||
33382988|NCT00764946|101287663|FG000|Overall Study|Never Treated|1|||
33382989|NCT00764946|101287664|FG001|Overall Study|Never Treated|1|||
33382990|NCT00764946|101287665|FG002|Overall Study|Never Treated|1|||
33382991|NCT04209530|101287666|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
33382992|NCT04209530|101287667|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
33382993|NCT04209530|101287666|FG000|Overall Study|Withdrawal by Subject|0|||
33382994|NCT04209530|101287667|FG001|Overall Study|Withdrawal by Subject|1|||
33382995|NCT01337167|101287668|FG000|Infant Series|Adverse Event|1|||
33382996|NCT01337167|101287669|FG001|Infant Series|Adverse Event|1|||
33382997|NCT01337167|101287668|FG000|Infant Series|Death|1|||
33382998|NCT01337167|101287669|FG001|Infant Series|Death|1|||
33382999|NCT01337167|101287668|FG000|Infant Series|Lost to Follow-up|13|||
33383000|NCT01337167|101287669|FG001|Infant Series|Lost to Follow-up|7|||
33383001|NCT01337167|101287668|FG000|Infant Series|Non-compliance with study drug|2|||
33383002|NCT01337167|101287669|FG001|Infant Series|Non-compliance with study drug|1|||
33383003|NCT01337167|101287668|FG000|Infant Series|Physician Decision|3|||
33383004|NCT01337167|101287669|FG001|Infant Series|Physician Decision|1|||
33383005|NCT01337167|101287668|FG000|Infant Series|Protocol Violation|22|||
33383006|NCT01337167|101287669|FG001|Infant Series|Protocol Violation|9|||
33383007|NCT01337167|101287668|FG000|Infant Series|Withdrawal by Subject|15|||
33383008|NCT01337167|101287669|FG001|Infant Series|Withdrawal by Subject|4|||
33383009|NCT01337167|101287668|FG000|Infant Series|Randomized but not vaccinated|5|||
33383010|NCT01337167|101287669|FG001|Infant Series|Randomized but not vaccinated|3|||
33383011|NCT01337167|101287668|FG000|Interim Period|Lost to Follow-up|51|||
33383012|NCT01337167|101287669|FG001|Interim Period|Lost to Follow-up|23|||
33587885|NCT03333252|102041694|FG000|Overall Study|Lack of Efficacy|8|||
33383013|NCT01337167|101287668|FG000|Interim Period|Non-compliance with study drug|1|||
33383014|NCT01337167|101287669|FG001|Interim Period|Non-compliance with study drug|0|||
33383015|NCT01337167|101287668|FG000|Interim Period|Physician Decision|6|||
33383016|NCT01337167|101287669|FG001|Interim Period|Physician Decision|3|||
33383017|NCT01337167|101287668|FG000|Interim Period|Protocol Violation|5|||
33383018|NCT01337167|101287669|FG001|Interim Period|Protocol Violation|3|||
33383019|NCT01337167|101287668|FG000|Interim Period|Withdrawal by Subject|18|||
33383020|NCT01337167|101287669|FG001|Interim Period|Withdrawal by Subject|10|||
33383021|NCT01337167|101287668|FG000|Interim Period|Other protocol criterion not met|0|||
33429333|NCT00410410|101463403|FG006|Maintenance Period (MP)|Death|1|||
33429334|NCT00410410|101463404|FG007|Maintenance Period (MP)|Death|0|||
33429335|NCT00410410|101463405|FG008|Maintenance Period (MP)|Death|0|||
33429336|NCT00410410|101463397|FG000|Maintenance Period (MP)|Adverse Event|0|||
33429337|NCT00410410|101463398|FG001|Maintenance Period (MP)|Adverse Event|0|||
33429338|NCT00410410|101463399|FG002|Maintenance Period (MP)|Adverse Event|0|||
33429339|NCT00410410|101463400|FG003|Maintenance Period (MP)|Adverse Event|0|||
33429340|NCT00410410|101463401|FG004|Maintenance Period (MP)|Adverse Event|0|||
33429341|NCT00410410|101463402|FG005|Maintenance Period (MP)|Adverse Event|0|||
33429342|NCT00410410|101463403|FG006|Maintenance Period (MP)|Adverse Event|1|||
33429343|NCT00410410|101463404|FG007|Maintenance Period (MP)|Adverse Event|3|||
33429344|NCT00410410|101463405|FG008|Maintenance Period (MP)|Adverse Event|0|||
33429345|NCT00410410|101463397|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
33429346|NCT00410410|101463398|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
33429347|NCT00410410|101463399|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
33429348|NCT00410410|101463400|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
33429349|NCT00410410|101463401|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
33429350|NCT00410410|101463402|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
33429351|NCT00410410|101463403|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
33429352|NCT00410410|101463404|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
33429353|NCT00410410|101463405|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
33383022|NCT01337167|101287669|FG001|Interim Period|Other protocol criterion not met|1|||
33383023|NCT01337167|101287668|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
33383024|NCT01337167|101287669|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
33383025|NCT01337167|101287668|FG000|Toddler Vaccinations|Protocol Violation|0|||
33383026|NCT01337167|101287669|FG001|Toddler Vaccinations|Protocol Violation|1|||
33383027|NCT01337167|101287668|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
33383028|NCT01337167|101287669|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
33383029|NCT00290589|101287670|FG000|Overall Study|Lost to Follow-up|2|||
33383030|NCT00290589|101287671|FG001|Overall Study|Lost to Follow-up|2|||
33383031|NCT03457103|101287672|FG000|Overall Study|illness/hospitalization|4|||
33383032|NCT03457103|101287673|FG001|Overall Study|illness/hospitalization|2|||
33383033|NCT03457103|101287672|FG000|Overall Study|Lost to Follow-up|2|||
33383034|NCT03457103|101287673|FG001|Overall Study|Lost to Follow-up|1|||
33383035|NCT03457103|101287672|FG000|Overall Study|Withdrawal by Subject|1|||
33383036|NCT03457103|101287673|FG001|Overall Study|Withdrawal by Subject|2|||
33383037|NCT03457103|101287672|FG000|Overall Study|financial/ insurance issues|1|||
33383038|NCT03457103|101287673|FG001|Overall Study|financial/ insurance issues|1|||
33383039|NCT00400712|101287674|FG000|Overall Study|Death|1|||
33383040|NCT00400712|101287675|FG001|Overall Study|Death|0|||
33383041|NCT00400712|101287674|FG000|Overall Study|Withdrawal by Subject|11|||
33383042|NCT00400712|101287675|FG001|Overall Study|Withdrawal by Subject|12|||
33383043|NCT00400712|101287674|FG000|Overall Study|Physician Decision|5|||
33383044|NCT00400712|101287675|FG001|Overall Study|Physician Decision|4|||
33383045|NCT03172481|101287679|FG000|Double-blind|Withdrawal by Subject|1|||
33383046|NCT03172481|101287680|FG001|Double-blind|Withdrawal by Subject|0|||
33383047|NCT02690207|101287682|FG000|Overall Study|Lost to Follow-up|48|||
33383048|NCT02690207|101287682|FG000|Overall Study|Withdrawal by Subject|46|||
33383049|NCT02690207|101287682|FG000|Overall Study|Protocol Violation|2|||
33383050|NCT02690207|101287682|FG000|Overall Study|Serious adverse event|110|||
33383051|NCT02690207|101287682|FG000|Overall Study|Non-serious Adverse Event|18|||
33383052|NCT02690207|101287682|FG000|Overall Study|Migrated/moved from study area|5|||
33383053|NCT02690207|101287682|FG000|Overall Study|Suspected HZ Episode|1|||
33383054|NCT02690207|101287682|FG000|Overall Study|Other reasons for withdrawal|23|||
33383055|NCT00781963|101287683|FG000|Overall Study|Death|3|||
33383056|NCT00781963|101287684|FG001|Overall Study|Death|0|||
33383057|NCT00781963|101287683|FG000|Overall Study|Lost to Follow-up|2|||
33429354|NCT00410410|101463397|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
33429355|NCT00410410|101463398|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
33429356|NCT00410410|101463399|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
33429357|NCT00410410|101463400|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
33429358|NCT00410410|101463401|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
33429359|NCT00410410|101463402|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
33429360|NCT00410410|101463403|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
33429361|NCT00410410|101463404|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
33429362|NCT00410410|101463405|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
33429363|NCT00410410|101463397|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
33383058|NCT00781963|101287684|FG001|Overall Study|Lost to Follow-up|1|||
33383059|NCT00781963|101287683|FG000|Overall Study|Withdrawal by Subject|3|||
33383060|NCT00781963|101287684|FG001|Overall Study|Withdrawal by Subject|1|||
33383061|NCT00781963|101287683|FG000|Overall Study|Refused follow-up|9|||
33383062|NCT00781963|101287684|FG001|Overall Study|Refused follow-up|0|||
33429364|NCT00410410|101463398|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
33647778|NCT03642132|102262812|FG001|Follow-up Period|Study terminated by sponsor|0|||
33429365|NCT00410410|101463399|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
33383063|NCT00085917|101287685|FG000|Overall Study|Adverse Event|4|||
33429366|NCT00410410|101463400|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
33429367|NCT00410410|101463401|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
33429368|NCT00410410|101463402|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
33429369|NCT00410410|101463403|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
33429370|NCT00410410|101463404|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
33429371|NCT00410410|101463405|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
33429372|NCT00410410|101463397|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
33429373|NCT00410410|101463398|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
33429374|NCT00410410|101463399|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
33429375|NCT00410410|101463400|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
33429376|NCT00410410|101463401|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
33429377|NCT00410410|101463402|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
33429378|NCT00410410|101463403|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
33429379|NCT00410410|101463404|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
33429380|NCT00410410|101463405|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
33429381|NCT00410410|101463397|FG000|Open-Label Period (OL)|Death|0|||
33429382|NCT00410410|101463398|FG001|Open-Label Period (OL)|Death|0|||
33429383|NCT00410410|101463399|FG002|Open-Label Period (OL)|Death|0|||
33429384|NCT00410410|101463400|FG003|Open-Label Period (OL)|Death|0|||
33429385|NCT00410410|101463401|FG004|Open-Label Period (OL)|Death|0|||
33429386|NCT00410410|101463402|FG005|Open-Label Period (OL)|Death|0|||
33429387|NCT00410410|101463403|FG006|Open-Label Period (OL)|Death|0|||
33429388|NCT00410410|101463404|FG007|Open-Label Period (OL)|Death|0|||
33429389|NCT00410410|101463405|FG008|Open-Label Period (OL)|Death|1|||
33429390|NCT00410410|101463397|FG000|Open-Label Period (OL)|Adverse Event|0|||
33429391|NCT00410410|101463398|FG001|Open-Label Period (OL)|Adverse Event|0|||
33429392|NCT00410410|101463399|FG002|Open-Label Period (OL)|Adverse Event|0|||
33429393|NCT00410410|101463400|FG003|Open-Label Period (OL)|Adverse Event|0|||
33429394|NCT00410410|101463401|FG004|Open-Label Period (OL)|Adverse Event|0|||
33429395|NCT00410410|101463402|FG005|Open-Label Period (OL)|Adverse Event|0|||
33429396|NCT00410410|101463403|FG006|Open-Label Period (OL)|Adverse Event|0|||
33429397|NCT00410410|101463404|FG007|Open-Label Period (OL)|Adverse Event|0|||
33429398|NCT00410410|101463405|FG008|Open-Label Period (OL)|Adverse Event|10|||
33429399|NCT00410410|101463397|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
33429400|NCT00410410|101463398|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
33429401|NCT00410410|101463399|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
33429402|NCT00410410|101463400|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
33429403|NCT00410410|101463401|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
33429404|NCT00410410|101463402|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
33429405|NCT00410410|101463403|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
33429406|NCT00410410|101463404|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
33429407|NCT00410410|101463405|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
33429408|NCT00410410|101463397|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
33429409|NCT00410410|101463398|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
33429410|NCT00410410|101463399|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
33429411|NCT00410410|101463400|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
33587886|NCT03333252|102041695|FG001|Overall Study|Lack of Efficacy|4|||
33149544|NCT01986907|100460778|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
33149545|NCT01986907|100460778|FG000|Overall Study|Protocol Violation|4|||
33149546|NCT01986907|100460778|FG000|Overall Study|Withdrawal by Subject|76|||
33383064|NCT00085917|101287686|FG001|Overall Study|Adverse Event|3|||
33383065|NCT02591238|101287691|FG000|Overall Study|Pregnancy|1|||
33383066|NCT02591238|101287692|FG001|Overall Study|Pregnancy|0|||
33383067|NCT02591238|101287693|FG002|Overall Study|Pregnancy|0|||
33383068|NCT02591238|101287694|FG003|Overall Study|Pregnancy|0|||
33383069|NCT02591238|101287691|FG000|Overall Study|Withdrawal by Subject|0|||
33383070|NCT02591238|101287692|FG001|Overall Study|Withdrawal by Subject|0|||
33383071|NCT02591238|101287693|FG002|Overall Study|Withdrawal by Subject|0|||
33383072|NCT02591238|101287694|FG003|Overall Study|Withdrawal by Subject|1|||
33383073|NCT02591238|101287691|FG000|Overall Study|influenza|0|||
33383074|NCT02591238|101287692|FG001|Overall Study|influenza|0|||
33383075|NCT02591238|101287693|FG002|Overall Study|influenza|0|||
33383076|NCT02591238|101287694|FG003|Overall Study|influenza|1|||
33383077|NCT02591238|101287691|FG000|Overall Study|personal circumstances|0|||
33149547|NCT01986907|100460778|FG000|Overall Study|Lost to Follow-up|38|||
33383078|NCT02591238|101287692|FG001|Overall Study|personal circumstances|0|||
33429412|NCT00410410|101463401|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
33429413|NCT00410410|101463402|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
33429414|NCT00410410|101463403|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
33429415|NCT00410410|101463404|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
33429416|NCT00410410|101463405|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
33429417|NCT00410410|101463397|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
33383079|NCT02591238|101287693|FG002|Overall Study|personal circumstances|0|||
33383080|NCT02591238|101287694|FG003|Overall Study|personal circumstances|1|||
33429418|NCT00410410|101463398|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
33429419|NCT00410410|101463399|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
33429420|NCT00410410|101463400|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
33429421|NCT00410410|101463401|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
33429422|NCT00410410|101463402|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
33429423|NCT00410410|101463403|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
33429424|NCT00410410|101463404|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
33429425|NCT00410410|101463405|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
33429426|NCT00410410|101463397|FG000|Open-Label Period (OL)|Pregnancy|0|||
33429427|NCT00410410|101463398|FG001|Open-Label Period (OL)|Pregnancy|0|||
33429428|NCT00410410|101463399|FG002|Open-Label Period (OL)|Pregnancy|0|||
33429429|NCT00410410|101463400|FG003|Open-Label Period (OL)|Pregnancy|0|||
33429430|NCT00410410|101463401|FG004|Open-Label Period (OL)|Pregnancy|0|||
33429431|NCT00410410|101463402|FG005|Open-Label Period (OL)|Pregnancy|0|||
33429432|NCT00410410|101463403|FG006|Open-Label Period (OL)|Pregnancy|0|||
33429433|NCT00410410|101463404|FG007|Open-Label Period (OL)|Pregnancy|0|||
33429434|NCT00410410|101463405|FG008|Open-Label Period (OL)|Pregnancy|1|||
33429435|NCT00410410|101463397|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33429436|NCT00410410|101463398|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33429437|NCT00410410|101463399|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33429438|NCT00410410|101463400|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33429439|NCT00410410|101463401|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33429440|NCT00410410|101463402|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33429441|NCT00410410|101463403|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33429442|NCT00410410|101463404|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
33429443|NCT00410410|101463405|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
33587887|NCT03333252|102041696|FG002|Overall Study|Lack of Efficacy|0|||
33587888|NCT03333252|102041697|FG003|Overall Study|Lack of Efficacy|7|||
33587889|NCT03333252|102041694|FG000|Overall Study|Lost to Follow-up|0|||
33587890|NCT03333252|102041695|FG001|Overall Study|Lost to Follow-up|5|||
33587891|NCT03333252|102041696|FG002|Overall Study|Lost to Follow-up|9|||
33587892|NCT03333252|102041697|FG003|Overall Study|Lost to Follow-up|3|||
33587893|NCT03333252|102041694|FG000|Overall Study|Withdrawal by Subject|14|||
33587894|NCT03333252|102041695|FG001|Overall Study|Withdrawal by Subject|24|||
33587895|NCT03333252|102041696|FG002|Overall Study|Withdrawal by Subject|11|||
33587896|NCT03333252|102041697|FG003|Overall Study|Withdrawal by Subject|17|||
33383081|NCT02591238|101287691|FG000|Overall Study|personal circumstances|0|||
33383082|NCT02591238|101287692|FG001|Overall Study|personal circumstances|1|||
33383083|NCT02591238|101287693|FG002|Overall Study|personal circumstances|0|||
33383084|NCT02591238|101287694|FG003|Overall Study|personal circumstances|0|||
33383085|NCT00605722|101287695|FG000|Overall Study|Adverse Event|6|||
33383086|NCT00605722|101287695|FG000|Overall Study|Insufficient therapeutic response|44|||
33383087|NCT00605722|101287695|FG000|Overall Study|Failure to return|1|||
33383088|NCT03084718|101287696|FG000|Overall Study|Withdrawal by Subject|4|||
33383089|NCT03084718|101287697|FG001|Overall Study|Withdrawal by Subject|3|||
33383090|NCT03084718|101287698|FG002|Overall Study|Withdrawal by Subject|4|||
33383091|NCT03084718|101287699|FG003|Overall Study|Withdrawal by Subject|0|||
33383092|NCT03084718|101287700|FG004|Overall Study|Withdrawal by Subject|0|||
33383093|NCT03084718|101287696|FG000|Overall Study|Physician Decision|1|||
33383094|NCT03084718|101287697|FG001|Overall Study|Physician Decision|0|||
33429444|NCT00410410|101463397|FG000|Open-Label Period (OL)|Other|0|||
33429445|NCT00410410|101463398|FG001|Open-Label Period (OL)|Other|0|||
33429446|NCT00410410|101463399|FG002|Open-Label Period (OL)|Other|0|||
33429447|NCT00410410|101463400|FG003|Open-Label Period (OL)|Other|0|||
33429448|NCT00410410|101463401|FG004|Open-Label Period (OL)|Other|0|||
33429449|NCT00410410|101463402|FG005|Open-Label Period (OL)|Other|0|||
33429450|NCT00410410|101463403|FG006|Open-Label Period (OL)|Other|0|||
33429451|NCT00410410|101463404|FG007|Open-Label Period (OL)|Other|0|||
33429452|NCT00410410|101463405|FG008|Open-Label Period (OL)|Other|7|||
33429453|NCT01347710|101463406|FG000|Overall Study|Withdrawal by Subject|2|||
33429454|NCT01347710|101463406|FG000|Overall Study|Adverse Event|4|||
33429455|NCT01347710|101463406|FG000|Overall Study|Angio or SPECT not completed|18|||
33429456|NCT01347710|101463406|FG000|Overall Study|issue with vitals prior to dosing|1|||
33429457|NCT01347710|101463406|FG000|Overall Study|Lost to Follow-up|1|||
33429458|NCT01347710|101463406|FG000|Overall Study|Physician Decision|2|||
33429459|NCT01347710|101463406|FG000|Overall Study|Other|3|||
33429460|NCT00146770|101463408|FG000|Overall Study|Adverse Event|2|||
33429461|NCT00146770|101463409|FG001|Overall Study|Adverse Event|0|||
33383095|NCT03084718|101287698|FG002|Overall Study|Physician Decision|0|||
33383096|NCT03084718|101287699|FG003|Overall Study|Physician Decision|0|||
33383097|NCT03084718|101287700|FG004|Overall Study|Physician Decision|0|||
33429462|NCT00146770|101463408|FG000|Overall Study|Pregnancy|1|||
33429463|NCT00146770|101463409|FG001|Overall Study|Pregnancy|0|||
33429464|NCT00146770|101463408|FG000|Overall Study|Withdrawal by Subject|2|||
33587897|NCT05145322|102041698|FG000|Overall Study|Lost to Follow-up|4|||
33587898|NCT05145322|102041699|FG001|Overall Study|Lost to Follow-up|5|||
33587899|NCT03300024|102041700|FG000|Overall Study|Physician Decision|4|||
33429465|NCT00146770|101463409|FG001|Overall Study|Withdrawal by Subject|0|||
33429466|NCT01211769|101463410|FG000|Overall Study|Lost to Follow-up|7|||
33429467|NCT01211769|101463411|FG001|Overall Study|Lost to Follow-up|9|||
33429468|NCT01211769|101463412|FG002|Overall Study|Lost to Follow-up|5|||
33429469|NCT01211769|101463413|FG003|Overall Study|Lost to Follow-up|9|||
33429470|NCT01211769|101463410|FG000|Overall Study|Physician Decision|2|||
33429471|NCT01211769|101463411|FG001|Overall Study|Physician Decision|0|||
33429472|NCT01211769|101463412|FG002|Overall Study|Physician Decision|2|||
33429473|NCT01211769|101463413|FG003|Overall Study|Physician Decision|1|||
33429474|NCT01211769|101463410|FG000|Overall Study|Adverse Event|0|||
33383098|NCT03084718|101287696|FG000|Overall Study|Adverse Event|3|||
33383099|NCT03084718|101287697|FG001|Overall Study|Adverse Event|5|||
33429475|NCT01211769|101463411|FG001|Overall Study|Adverse Event|1|||
33429476|NCT01211769|101463412|FG002|Overall Study|Adverse Event|1|||
33429477|NCT01211769|101463413|FG003|Overall Study|Adverse Event|1|||
33429478|NCT00634179|101463416|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
33429479|NCT01452529|101463417|FG000|Run-in Period|Adverse Event|96|||
33429480|NCT01452529|101463418|FG001|Run-in Period|Adverse Event|0|||
33429481|NCT01452529|101463419|FG002|Run-in Period|Adverse Event|0|||
33429482|NCT01452529|101463417|FG000|Run-in Period|Withdrawal by Subject|49|||
33429483|NCT01452529|101463418|FG001|Run-in Period|Withdrawal by Subject|0|||
33429484|NCT01452529|101463419|FG002|Run-in Period|Withdrawal by Subject|0|||
33429485|NCT01452529|101463417|FG000|Run-in Period|Lost to Follow-up|19|||
33429486|NCT01452529|101463418|FG001|Run-in Period|Lost to Follow-up|0|||
33429487|NCT01452529|101463419|FG002|Run-in Period|Lost to Follow-up|0|||
33429488|NCT01452529|101463417|FG000|Run-in Period|Lack of Efficacy|46|||
33149548|NCT01986907|100460778|FG000|Overall Study|Death|9|||
33149549|NCT01554397|100460779|FG000|Overall Study|Withdrawal by Subject|1|||
33149550|NCT01554397|100460780|FG001|Overall Study|Withdrawal by Subject|0|||
33149551|NCT01554397|100460779|FG000|Overall Study|Ineligible|7|||
33429489|NCT01452529|101463418|FG001|Run-in Period|Lack of Efficacy|0|||
33429490|NCT01452529|101463419|FG002|Run-in Period|Lack of Efficacy|0|||
33429491|NCT01452529|101463417|FG000|Run-in Period|Confirmed or suspected diversion|23|||
33429492|NCT01452529|101463418|FG001|Run-in Period|Confirmed or suspected diversion|0|||
33429493|NCT01452529|101463419|FG002|Run-in Period|Confirmed or suspected diversion|0|||
33429494|NCT01452529|101463417|FG000|Run-in Period|Administrative|21|||
33429495|NCT01452529|101463418|FG001|Run-in Period|Administrative|0|||
33429496|NCT01452529|101463419|FG002|Run-in Period|Administrative|0|||
33429497|NCT01452529|101463417|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
33429498|NCT01452529|101463418|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
33429499|NCT01452529|101463419|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
33429500|NCT01452529|101463417|FG000|Double-blind (DB) Period|Adverse Event|0|||
33429501|NCT01452529|101463418|FG001|Double-blind (DB) Period|Adverse Event|18|||
33429502|NCT01452529|101463419|FG002|Double-blind (DB) Period|Adverse Event|11|||
33429503|NCT01452529|101463417|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
33429504|NCT01452529|101463418|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
33429505|NCT01452529|101463419|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
33429506|NCT01452529|101463417|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
33587900|NCT03300024|102041701|FG001|Overall Study|Physician Decision|6|||
33587901|NCT05479097|102041705|FG000|Overall Study|Withdrawal by Subject|2|||
33587902|NCT01202188|102041706|FG000|Overall Study|Protocol deviation|14|||
33383100|NCT03084718|101287698|FG002|Overall Study|Adverse Event|5|||
33383101|NCT03084718|101287699|FG003|Overall Study|Adverse Event|8|||
33383102|NCT03084718|101287700|FG004|Overall Study|Adverse Event|2|||
33383103|NCT03084718|101287696|FG000|Overall Study|Lack of Efficacy|2|||
33383104|NCT03084718|101287697|FG001|Overall Study|Lack of Efficacy|0|||
33383105|NCT03084718|101287698|FG002|Overall Study|Lack of Efficacy|1|||
33383106|NCT03084718|101287699|FG003|Overall Study|Lack of Efficacy|4|||
33383107|NCT03084718|101287700|FG004|Overall Study|Lack of Efficacy|0|||
33383108|NCT03084718|101287696|FG000|Overall Study|Lost to Follow-up|0|||
33383109|NCT03084718|101287697|FG001|Overall Study|Lost to Follow-up|1|||
33383110|NCT03084718|101287698|FG002|Overall Study|Lost to Follow-up|0|||
33383111|NCT03084718|101287699|FG003|Overall Study|Lost to Follow-up|0|||
33383112|NCT03084718|101287700|FG004|Overall Study|Lost to Follow-up|2|||
33429507|NCT01452529|101463418|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
33429508|NCT01452529|101463419|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
33429509|NCT01452529|101463417|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
33149552|NCT01554397|100460780|FG001|Overall Study|Ineligible|0|||
33383113|NCT03084718|101287696|FG000|Overall Study|Protocol Violation|0|||
33383114|NCT03084718|101287697|FG001|Overall Study|Protocol Violation|0|||
33429510|NCT01452529|101463418|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
33429511|NCT01452529|101463419|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
33429512|NCT01452529|101463417|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
33429513|NCT01452529|101463418|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
33587903|NCT01202188|102041707|FG001|Overall Study|Protocol deviation|8|||
33383115|NCT03084718|101287698|FG002|Overall Study|Protocol Violation|1|||
33383116|NCT03084718|101287699|FG003|Overall Study|Protocol Violation|0|||
33429514|NCT01452529|101463419|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
33429515|NCT01452529|101463417|FG000|Double-blind (DB) Period|Administrative|0|||
33429516|NCT01452529|101463418|FG001|Double-blind (DB) Period|Administrative|11|||
33429517|NCT01452529|101463419|FG002|Double-blind (DB) Period|Administrative|7|||
33248808|NCT04335591|100810315|FG003|Overall Study|Withdrawal by Subject|5|||
33248809|NCT04335591|100810312|FG000|Overall Study|Subject planning pregnancy|0|||
33248810|NCT04335591|100810313|FG001|Overall Study|Subject planning pregnancy|1|||
33248811|NCT04335591|100810314|FG002|Overall Study|Subject planning pregnancy|0|||
33248812|NCT04335591|100810315|FG003|Overall Study|Subject planning pregnancy|0|||
33248813|NCT04335591|100810312|FG000|Overall Study|Ukrainian Russian war conflict|4|||
33248814|NCT04335591|100810313|FG001|Overall Study|Ukrainian Russian war conflict|5|||
33248815|NCT04335591|100810314|FG002|Overall Study|Ukrainian Russian war conflict|2|||
33248816|NCT04335591|100810315|FG003|Overall Study|Ukrainian Russian war conflict|0|||
33248817|NCT01368406|100810316|FG000|Overall Study|Lost to Follow-up|8|||
33248818|NCT01368406|100810317|FG001|Overall Study|Lost to Follow-up|4|||
33248819|NCT01368406|100810316|FG000|Overall Study|Withdrawal by Subject|8|||
33248820|NCT01368406|100810317|FG001|Overall Study|Withdrawal by Subject|4|||
33248821|NCT01368406|100810316|FG000|Overall Study|relapse of the disease|3|||
33248822|NCT01368406|100810317|FG001|Overall Study|relapse of the disease|2|||
33248823|NCT01368406|100810316|FG000|Overall Study|started working|2|||
33248824|NCT01368406|100810317|FG001|Overall Study|started working|3|||
33248825|NCT01837641|100810319|FG000|Overall Study|Sponsor decision|1|||
33248826|NCT01837641|100810320|FG001|Overall Study|Sponsor decision|0|||
33248827|NCT01837641|100810321|FG002|Overall Study|Sponsor decision|0|||
33248828|NCT01837641|100810322|FG003|Overall Study|Sponsor decision|0|||
33248829|NCT01837641|100810323|FG004|Overall Study|Sponsor decision|0|||
33248830|NCT01837641|100810324|FG005|Overall Study|Sponsor decision|1|||
33248831|NCT01837641|100810325|FG006|Overall Study|Sponsor decision|0|||
33248832|NCT01837641|100810326|FG007|Overall Study|Sponsor decision|0|||
33248833|NCT01837641|100810319|FG000|Overall Study|Adverse Event|0|||
33248834|NCT01837641|100810320|FG001|Overall Study|Adverse Event|0|||
33248835|NCT01837641|100810321|FG002|Overall Study|Adverse Event|0|||
33248836|NCT01837641|100810322|FG003|Overall Study|Adverse Event|0|||
33248837|NCT01837641|100810323|FG004|Overall Study|Adverse Event|0|||
33248838|NCT01837641|100810324|FG005|Overall Study|Adverse Event|1|||
33248839|NCT01837641|100810325|FG006|Overall Study|Adverse Event|0|||
33248840|NCT01837641|100810326|FG007|Overall Study|Adverse Event|0|||
33248841|NCT01837641|100810319|FG000|Overall Study|Withdrawal by Subject|0|||
33248842|NCT01837641|100810320|FG001|Overall Study|Withdrawal by Subject|0|||
33248843|NCT01837641|100810321|FG002|Overall Study|Withdrawal by Subject|0|||
33248844|NCT01837641|100810322|FG003|Overall Study|Withdrawal by Subject|0|||
33248845|NCT01837641|100810323|FG004|Overall Study|Withdrawal by Subject|1|||
33248846|NCT01837641|100810324|FG005|Overall Study|Withdrawal by Subject|0|||
33248847|NCT01837641|100810325|FG006|Overall Study|Withdrawal by Subject|1|||
33248848|NCT01837641|100810326|FG007|Overall Study|Withdrawal by Subject|0|||
33248849|NCT00290732|100810327|FG000|Overall Study|Inability to instill drug intraductally.|0|||
33248850|NCT00290732|100810328|FG001|Overall Study|Inability to instill drug intraductally.|1|||
33248851|NCT00290732|100810329|FG002|Overall Study|Inability to instill drug intraductally.|1|||
33248852|NCT00290732|100810330|FG003|Overall Study|Inability to instill drug intraductally.|0|||
33248853|NCT00290732|100810331|FG004|Overall Study|Inability to instill drug intraductally.|0|||
33248854|NCT00831792|100810339|FG000|Overall Study|Not Eligible|3|||
33248855|NCT00831792|100810339|FG000|Overall Study|Adverse Event|1|||
33248856|NCT00831792|100810339|FG000|Overall Study|Death|1|||
33248857|NCT00831792|100810339|FG000|Overall Study|Lack of Efficacy|1|||
33248858|NCT00613301|100810340|FG000|Overall Study|Adverse Event|49|||
33248859|NCT00613301|100810340|FG000|Overall Study|Lost to Follow-up|88|||
33248860|NCT00613301|100810340|FG000|Overall Study|Withdrawal by Subject|5|||
33383117|NCT03084718|101287700|FG004|Overall Study|Protocol Violation|0|||
33383118|NCT03084718|101287696|FG000|Overall Study|Death|0|||
33383119|NCT03084718|101287697|FG001|Overall Study|Death|1|||
33383120|NCT03084718|101287698|FG002|Overall Study|Death|0|||
33383121|NCT03084718|101287699|FG003|Overall Study|Death|0|||
33383122|NCT03084718|101287700|FG004|Overall Study|Death|0|||
33248861|NCT00613301|100810340|FG000|Overall Study|Death|6|||
33383123|NCT03084718|101287696|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
33248862|NCT00613301|100810340|FG000|Overall Study|Lack of Efficacy|13|||
33248863|NCT00613301|100810340|FG000|Overall Study|Physician Decision|2|||
33248864|NCT00613301|100810340|FG000|Overall Study|No data was collected|53|||
33248865|NCT00613301|100810340|FG000|Overall Study|Irregularly enrolled patients|12|||
33248866|NCT00586339|100810343|FG000|Overall Study|Withdrawal by Subject|1|||
33383124|NCT03084718|101287697|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
33429518|NCT01073020|101463420|FG000|Overall Study|Withdrawal by Subject|6|||
33248867|NCT00586339|100810344|FG001|Overall Study|Withdrawal by Subject|3|||
33248868|NCT00586339|100810345|FG002|Overall Study|Withdrawal by Subject|1|||
33248869|NCT00586339|100810343|FG000|Overall Study|Migrated/moved from study area|3|||
33248870|NCT00586339|100810344|FG001|Overall Study|Migrated/moved from study area|2|||
33429519|NCT01073020|101463421|FG001|Overall Study|Withdrawal by Subject|4|||
33429520|NCT01073020|101463422|FG002|Overall Study|Withdrawal by Subject|1|||
33429521|NCT01073020|101463423|FG003|Overall Study|Withdrawal by Subject|2|||
33429522|NCT01073020|101463420|FG000|Overall Study|Physician Decision|1|||
33429523|NCT01073020|101463421|FG001|Overall Study|Physician Decision|0|||
33429524|NCT01073020|101463422|FG002|Overall Study|Physician Decision|2|||
33429525|NCT01073020|101463423|FG003|Overall Study|Physician Decision|0|||
33429526|NCT01073020|101463420|FG000|Overall Study|Death|0|||
33429527|NCT01073020|101463421|FG001|Overall Study|Death|1|||
33429528|NCT01073020|101463422|FG002|Overall Study|Death|0|||
33429529|NCT01073020|101463423|FG003|Overall Study|Death|0|||
33429530|NCT00319449|101463424|FG000|Overall Study|Subject did not wish to continue|1|||
33429531|NCT00319449|101463425|FG001|Overall Study|Subject did not wish to continue|0|||
33429532|NCT00319449|101463424|FG000|Overall Study|Noncompliance with the protocol|1|||
33429533|NCT00319449|101463425|FG001|Overall Study|Noncompliance with the protocol|0|||
33429534|NCT02739984|101463435|FG000|Overall Study|Sponsor Decision|1|||
33429535|NCT02739984|101463436|FG001|Overall Study|Sponsor Decision|0|||
33429536|NCT02739984|101463435|FG000|Overall Study|Withdrawal by Subject|1|||
33429537|NCT02739984|101463436|FG001|Overall Study|Withdrawal by Subject|1|||
33149553|NCT04764162|100460781|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
33248871|NCT00586339|100810345|FG002|Overall Study|Migrated/moved from study area|4|||
33248872|NCT00586339|100810343|FG000|Overall Study|Lost to Follow-up|3|||
33383125|NCT03084718|101287698|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
33383126|NCT03084718|101287699|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
33383127|NCT03084718|101287700|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
33383128|NCT00118911|101287703|FG000|Overall Study|Withdrawal by Subject|2|||
33383129|NCT00118911|101287704|FG001|Overall Study|Withdrawal by Subject|5|||
33383130|NCT03479216|101287713|FG000|Overall Study|Withdrawal by Subject|3|||
33383131|NCT03479216|101287714|FG001|Overall Study|Withdrawal by Subject|2|||
33383132|NCT03479216|101287713|FG000|Overall Study|Physician Decision|2|||
33383133|NCT03479216|101287714|FG001|Overall Study|Physician Decision|3|||
33383134|NCT01103778|101287715|FG000|Overall Study|Lost to Follow-up|1|||
33383135|NCT01103778|101287715|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
33383136|NCT01103778|101287715|FG000|Overall Study|Screen failure|1|||
33383137|NCT00225147|101287716|FG000|Open-label Phase|Lost to Follow-up|0|||
33383138|NCT00225147|101287717|FG001|Open-label Phase|Lost to Follow-up|0|||
33383139|NCT00225147|101287718|FG002|Open-label Phase|Lost to Follow-up|0|||
33383140|NCT00225147|101287719|FG003|Open-label Phase|Lost to Follow-up|4|||
33383141|NCT00225147|101287716|FG000|Open-label Phase|Withdrawal by Subject|0|||
33383142|NCT00225147|101287717|FG001|Open-label Phase|Withdrawal by Subject|0|||
33383143|NCT00225147|101287718|FG002|Open-label Phase|Withdrawal by Subject|0|||
33383144|NCT00225147|101287719|FG003|Open-label Phase|Withdrawal by Subject|6|||
33383145|NCT02483078|101287723|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
33383146|NCT02483078|101287724|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
33383147|NCT02483078|101287723|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
33383148|NCT02483078|101287724|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
33383149|NCT02483078|101287723|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
33383150|NCT02483078|101287724|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
33383151|NCT02483078|101287723|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
33383152|NCT02483078|101287724|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
33383153|NCT02483078|101287723|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
33383154|NCT02483078|101287724|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
33383155|NCT02483078|101287723|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
33383156|NCT02483078|101287724|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
33383157|NCT02394795|101287725|FG000|Overall Study|Adverse Event|92|||
33383158|NCT02394795|101287726|FG001|Overall Study|Adverse Event|70|||
33383159|NCT02394795|101287725|FG000|Overall Study|Lost to Follow-up|0|||
33383160|NCT02394795|101287726|FG001|Overall Study|Lost to Follow-up|1|||
33383161|NCT02394795|101287725|FG000|Overall Study|Withdrawal by Subject|17|||
33383162|NCT02394795|101287726|FG001|Overall Study|Withdrawal by Subject|26|||
33429538|NCT02739984|101463435|FG000|Overall Study|Death|0|||
33429539|NCT02739984|101463436|FG001|Overall Study|Death|1|||
33429540|NCT02739984|101463435|FG000|Overall Study|Lost to Follow-up|3|||
33429541|NCT02739984|101463436|FG001|Overall Study|Lost to Follow-up|0|||
33248873|NCT00586339|100810344|FG001|Overall Study|Lost to Follow-up|2|||
33383163|NCT02394795|101287725|FG000|Overall Study|Lack of Efficacy|181|||
33383164|NCT02394795|101287726|FG001|Overall Study|Lack of Efficacy|211|||
33383165|NCT02394795|101287725|FG000|Overall Study|Death|4|||
33383166|NCT02394795|101287726|FG001|Overall Study|Death|5|||
33383167|NCT02394795|101287725|FG000|Overall Study|Physician Decision|109|||
33383168|NCT02394795|101287726|FG001|Overall Study|Physician Decision|93|||
33429542|NCT02585258|101463440|FG000|Overall Study|Adverse Event|28|||
33429543|NCT02585258|101463441|FG001|Overall Study|Adverse Event|29|||
33429544|NCT02585258|101463440|FG000|Overall Study|Death|3|||
33429545|NCT02585258|101463441|FG001|Overall Study|Death|2|||
33149554|NCT04764162|100460782|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
33149555|NCT01822678|100460787|FG000|Overall Study|Withdrawal by Subject|5|||
33149556|NCT01822678|100460788|FG001|Overall Study|Withdrawal by Subject|4|||
33149557|NCT01822678|100460789|FG002|Overall Study|Withdrawal by Subject|4|||
33429546|NCT02585258|101463440|FG000|Overall Study|Lack of Efficacy|7|||
33429547|NCT02585258|101463441|FG001|Overall Study|Lack of Efficacy|9|||
33429548|NCT02585258|101463440|FG000|Overall Study|includes covid-related access problems|42|||
33429549|NCT02585258|101463441|FG001|Overall Study|includes covid-related access problems|46|||
33429550|NCT02585258|101463440|FG000|Overall Study|Lost to Follow-up|5|||
33429551|NCT02585258|101463441|FG001|Overall Study|Lost to Follow-up|2|||
33429552|NCT00673361|101463446|FG000|Overall Study|Screen Failure|2|||
33429553|NCT01626885|101463447|FG000|Overall Study|Adverse Event|8|||
33429554|NCT01626885|101463447|FG000|Overall Study|Withdrawal by Subject|4|||
33429555|NCT02041494|101463448|FG000|Overall Study|Death|1|||
33429556|NCT02041494|101463449|FG001|Overall Study|Death|3|||
33429557|NCT02041494|101463448|FG000|Overall Study|Lost to Follow-up|2|||
33429558|NCT02041494|101463449|FG001|Overall Study|Lost to Follow-up|6|||
33429559|NCT02041494|101463448|FG000|Overall Study|study terminated|16|||
33429560|NCT02041494|101463449|FG001|Overall Study|study terminated|11|||
33429561|NCT03355742|101463450|FG000|Overall Study|Lost to Follow-up|4|||
33429562|NCT03355742|101463450|FG000|Overall Study|Withdrawal by Subject|29|||
33429563|NCT03355742|101463450|FG000|Overall Study|Physician Decision|6|||
33429564|NCT03355742|101463450|FG000|Overall Study|Death|55|||
33429565|NCT03355742|101463450|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
33429566|NCT01313728|101463451|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
33429567|NCT01497938|101463452|FG000|Overall Study|Adverse Event|0|||
33429568|NCT01497938|101463453|FG001|Overall Study|Adverse Event|1|||
33149558|NCT01822678|100460787|FG000|Overall Study|Adverse Event|4|||
33149559|NCT01822678|100460788|FG001|Overall Study|Adverse Event|3|||
33149560|NCT01822678|100460789|FG002|Overall Study|Adverse Event|1|||
33383169|NCT01742078|101287727|FG000|Overall Study|Withdrawal by Subject|0|||
33383170|NCT01742078|101287728|FG001|Overall Study|Withdrawal by Subject|0|||
33383171|NCT01742078|101287729|FG002|Overall Study|Withdrawal by Subject|0|||
33383172|NCT01742078|101287730|FG003|Overall Study|Withdrawal by Subject|1|||
33383173|NCT01742078|101287731|FG004|Overall Study|Withdrawal by Subject|0|||
33383174|NCT01742078|101287732|FG005|Overall Study|Withdrawal by Subject|0|||
33383175|NCT01742078|101287733|FG006|Overall Study|Withdrawal by Subject|0|||
33383176|NCT01742078|101287734|FG007|Overall Study|Withdrawal by Subject|0|||
33383177|NCT01742078|101287735|FG008|Overall Study|Withdrawal by Subject|0|||
33383178|NCT03505749|101287737|FG000|Overall Study|Lost to Follow-up|7|||
33383179|NCT03505749|101287738|FG001|Overall Study|Lost to Follow-up|11|||
33383180|NCT03505749|101287737|FG000|Overall Study|Withdrawal by Subject|6|||
33383181|NCT03505749|101287738|FG001|Overall Study|Withdrawal by Subject|0|||
33383182|NCT03505749|101287737|FG000|Overall Study|Discharged from treatment|3|||
33383183|NCT03505749|101287738|FG001|Overall Study|Discharged from treatment|6|||
33383184|NCT01392378|101287739|FG000|Infant Series|Adverse Event|0|||
33383185|NCT01392378|101287740|FG001|Infant Series|Adverse Event|0|||
33383186|NCT01392378|101287741|FG002|Infant Series|Adverse Event|0|||
33383187|NCT01392378|101287742|FG003|Infant Series|Adverse Event|1|||
33383188|NCT01392378|101287743|FG004|Infant Series|Adverse Event|0|||
33383189|NCT01392378|101287739|FG000|Infant Series|Lost to Follow-up|0|||
33383190|NCT01392378|101287740|FG001|Infant Series|Lost to Follow-up|0|||
33383191|NCT01392378|101287741|FG002|Infant Series|Lost to Follow-up|0|||
33383192|NCT01392378|101287742|FG003|Infant Series|Lost to Follow-up|1|||
33383193|NCT01392378|101287743|FG004|Infant Series|Lost to Follow-up|0|||
33383194|NCT01392378|101287739|FG000|Infant Series|Protocol Violation|0|||
33383195|NCT01392378|101287740|FG001|Infant Series|Protocol Violation|1|||
33383196|NCT01392378|101287741|FG002|Infant Series|Protocol Violation|0|||
33383197|NCT01392378|101287742|FG003|Infant Series|Protocol Violation|0|||
33383198|NCT01392378|101287743|FG004|Infant Series|Protocol Violation|0|||
33383199|NCT01392378|101287739|FG000|Infant Series|Withdrawal by Parent|4|||
33383200|NCT01392378|101287740|FG001|Infant Series|Withdrawal by Parent|1|||
33383201|NCT01392378|101287741|FG002|Infant Series|Withdrawal by Parent|0|||
33429569|NCT01497938|101463452|FG000|Overall Study|Physician Decision|0|||
33429570|NCT01497938|101463453|FG001|Overall Study|Physician Decision|1|||
33429571|NCT01497938|101463452|FG000|Overall Study|Withdrawal by Subject|4|||
33383202|NCT01392378|101287742|FG003|Infant Series|Withdrawal by Parent|0|||
33383203|NCT01392378|101287743|FG004|Infant Series|Withdrawal by Parent|0|||
33429572|NCT01497938|101463453|FG001|Overall Study|Withdrawal by Subject|0|||
33429573|NCT01497938|101463452|FG000|Overall Study|Device Violation|1|||
33429574|NCT01497938|101463453|FG001|Overall Study|Device Violation|0|||
33429575|NCT00472446|101463454|FG000|Overall Study|Protocol Violation|0|||
33383204|NCT01392378|101287739|FG000|After Infant Series|Lost to Follow-up|0|||
33383205|NCT01392378|101287740|FG001|After Infant Series|Lost to Follow-up|0|||
33383206|NCT01392378|101287741|FG002|After Infant Series|Lost to Follow-up|1|||
33383207|NCT01392378|101287742|FG003|After Infant Series|Lost to Follow-up|0|||
33383208|NCT01392378|101287743|FG004|After Infant Series|Lost to Follow-up|0|||
33429576|NCT00472446|101463455|FG001|Overall Study|Protocol Violation|0|||
33429577|NCT00472446|101463456|FG002|Overall Study|Protocol Violation|0|||
33429578|NCT00472446|101463457|FG003|Overall Study|Protocol Violation|1|||
33429579|NCT00472446|101463454|FG000|Overall Study|Reintervention|0|||
33429580|NCT00472446|101463455|FG001|Overall Study|Reintervention|0|||
33429581|NCT00472446|101463456|FG002|Overall Study|Reintervention|1|||
33429582|NCT00472446|101463457|FG003|Overall Study|Reintervention|1|||
33429583|NCT00472446|101463454|FG000|Overall Study|Questionnaires not returned|5|||
33429584|NCT00472446|101463455|FG001|Overall Study|Questionnaires not returned|6|||
33429585|NCT00472446|101463456|FG002|Overall Study|Questionnaires not returned|6|||
33429586|NCT00472446|101463457|FG003|Overall Study|Questionnaires not returned|4|||
33429587|NCT00275028|101463458|FG000|Overall Study|Withdrew consent before treatment began|1|||
33429588|NCT00275028|101463458|FG000|Overall Study|Withdrawal by Subject|5|||
33429589|NCT00275028|101463458|FG000|Overall Study|Adverse Event|9|||
33429590|NCT00275028|101463458|FG000|Overall Study|Progressive Disease|30|||
33429591|NCT00275028|101463458|FG000|Overall Study|Physician Decision|2|||
33429592|NCT00623623|101463459|FG000|Overall Study|Previous enrolment into this study|1|||
33429593|NCT00623623|101463460|FG001|Overall Study|Previous enrolment into this study|1|||
33429594|NCT00947427|101463464|FG000|Overall Study|Withdrawal by Subject|1|||
33429595|NCT00947427|101463465|FG001|Overall Study|Withdrawal by Subject|3|||
33429596|NCT00947427|101463464|FG000|Overall Study|Protocol Violation|0|||
33429597|NCT00947427|101463465|FG001|Overall Study|Protocol Violation|1|||
33429598|NCT02649231|101463466|FG000|Overall Study|Adverse Event|0|||
33429599|NCT02649231|101463467|FG001|Overall Study|Adverse Event|0|||
33429600|NCT02649231|101463468|FG002|Overall Study|Adverse Event|0|||
33429601|NCT02649231|101463469|FG003|Overall Study|Adverse Event|1|||
33429602|NCT02649231|101463466|FG000|Overall Study|Lost to Follow-up|2|||
33429603|NCT02649231|101463467|FG001|Overall Study|Lost to Follow-up|1|||
33429604|NCT02649231|101463468|FG002|Overall Study|Lost to Follow-up|1|||
33429605|NCT02649231|101463469|FG003|Overall Study|Lost to Follow-up|0|||
33429606|NCT02649231|101463466|FG000|Overall Study|Withdrawal by Subject|0|||
33429607|NCT02649231|101463467|FG001|Overall Study|Withdrawal by Subject|1|||
33429608|NCT02649231|101463468|FG002|Overall Study|Withdrawal by Subject|0|||
33429609|NCT02649231|101463469|FG003|Overall Study|Withdrawal by Subject|1|||
33429610|NCT02649231|101463466|FG000|Overall Study|Protocol Violation|2|||
33429611|NCT02649231|101463467|FG001|Overall Study|Protocol Violation|1|||
33429612|NCT02649231|101463468|FG002|Overall Study|Protocol Violation|1|||
33429613|NCT02649231|101463469|FG003|Overall Study|Protocol Violation|0|||
33429614|NCT00681863|101463470|FG000|Overall Study|Adverse Event|1|||
33429615|NCT00681863|101463470|FG000|Overall Study|Lost to Follow-up|2|||
33587904|NCT01202188|102041708|FG002|Overall Study|Protocol deviation|12|||
33149561|NCT01822678|100460787|FG000|Overall Study|Lack of Efficacy|3|||
33149562|NCT01822678|100460788|FG001|Overall Study|Lack of Efficacy|6|||
33149563|NCT01822678|100460789|FG002|Overall Study|Lack of Efficacy|5|||
33149564|NCT01822678|100460787|FG000|Overall Study|Lost to Follow-up|0|||
33149565|NCT01822678|100460788|FG001|Overall Study|Lost to Follow-up|2|||
33149566|NCT01822678|100460789|FG002|Overall Study|Lost to Follow-up|1|||
33149567|NCT03183778|100460790|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
33149568|NCT01229397|100460791|FG000|Overall Study|Withdrawal by Subject|3|||
33149569|NCT01229397|100460792|FG001|Overall Study|Withdrawal by Subject|3|||
33149570|NCT01229397|100460791|FG000|Overall Study|Lost to Follow-up|7|||
33149571|NCT01229397|100460792|FG001|Overall Study|Lost to Follow-up|6|||
33149572|NCT01229397|100460791|FG000|Overall Study|Migrated/moved from study area|1|||
33149573|NCT01229397|100460792|FG001|Overall Study|Migrated/moved from study area|0|||
33149574|NCT01070043|100460793|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
33149575|NCT01070043|100460794|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
33149576|NCT01070043|100460795|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
33149577|NCT01070043|100460793|FG000|Double-Blind Treatment|Adverse Event|0|||
33149578|NCT01070043|100460794|FG001|Double-Blind Treatment|Adverse Event|0|||
33149579|NCT01070043|100460795|FG002|Double-Blind Treatment|Adverse Event|2|||
33587905|NCT01202188|102041709|FG003|Overall Study|Protocol deviation|10|||
33587906|NCT01202188|102041710|FG004|Overall Study|Protocol deviation|11|||
33149580|NCT05007717|100460799|FG000|Overall Study|Death|3|||
33149581|NCT05007717|100460800|FG001|Overall Study|Death|2|||
33149582|NCT03805646|100460803|FG000|Overall Study|Death|40|||
33149583|NCT03805646|100460804|FG001|Overall Study|Death|49|||
33149584|NCT03805646|100460803|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
33149585|NCT03805646|100460804|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
33429616|NCT00681863|101463470|FG000|Overall Study|Lack of Efficacy|2|||
33429617|NCT00681863|101463470|FG000|Overall Study|Other|18|||
33429618|NCT00814320|101463471|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
33429619|NCT00814320|101463472|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
33429620|NCT00814320|101463471|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
33429621|NCT00814320|101463472|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
33429622|NCT00814320|101463471|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
33587907|NCT01202188|102041706|FG000|Overall Study|Subject withdrew consent|12|||
33587908|NCT01202188|102041707|FG001|Overall Study|Subject withdrew consent|13|||
33429623|NCT00814320|101463472|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
33429624|NCT00814320|101463471|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
33429625|NCT00814320|101463472|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
33429626|NCT00814320|101463471|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
33429627|NCT00814320|101463472|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
33429628|NCT00814320|101463471|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
33429629|NCT00814320|101463472|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
33429630|NCT00814320|101463471|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
33429631|NCT00814320|101463472|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
33429632|NCT00814320|101463471|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
33429633|NCT00814320|101463472|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
33429634|NCT00814320|101463471|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
33429635|NCT00814320|101463472|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
33429636|NCT00814320|101463471|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
33429637|NCT00814320|101463472|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
33429638|NCT01752920|101463477|FG000|Overall Study|Adverse Event|1|||
33429639|NCT01752920|101463478|FG001|Overall Study|Adverse Event|0|||
33429640|NCT01752920|101463479|FG002|Overall Study|Adverse Event|5|||
33429641|NCT01752920|101463480|FG003|Overall Study|Adverse Event|10|||
33429642|NCT01752920|101463477|FG000|Overall Study|Clinical Disease Progression|6|||
33429643|NCT01752920|101463478|FG001|Overall Study|Clinical Disease Progression|4|||
33429644|NCT01752920|101463479|FG002|Overall Study|Clinical Disease Progression|1|||
33429645|NCT01752920|101463480|FG003|Overall Study|Clinical Disease Progression|13|||
33429646|NCT01752920|101463477|FG000|Overall Study|Physician Decision|1|||
33429647|NCT01752920|101463478|FG001|Overall Study|Physician Decision|0|||
33429648|NCT01752920|101463479|FG002|Overall Study|Physician Decision|0|||
33429649|NCT01752920|101463480|FG003|Overall Study|Physician Decision|3|||
33429650|NCT01752920|101463477|FG000|Overall Study|Radiographic Disease Progression|20|||
33429651|NCT01752920|101463478|FG001|Overall Study|Radiographic Disease Progression|7|||
33429652|NCT01752920|101463479|FG002|Overall Study|Radiographic Disease Progression|12|||
33429653|NCT01752920|101463480|FG003|Overall Study|Radiographic Disease Progression|29|||
33429654|NCT01752920|101463477|FG000|Overall Study|Study Terminated by Sponsor|0|||
33429655|NCT01752920|101463478|FG001|Overall Study|Study Terminated by Sponsor|0|||
33429656|NCT01752920|101463479|FG002|Overall Study|Study Terminated by Sponsor|0|||
33429657|NCT01752920|101463480|FG003|Overall Study|Study Terminated by Sponsor|1|||
33429658|NCT01752920|101463477|FG000|Overall Study|Withdrawal by Subject|0|||
33429659|NCT01752920|101463478|FG001|Overall Study|Withdrawal by Subject|1|||
33429660|NCT01752920|101463479|FG002|Overall Study|Withdrawal by Subject|0|||
33429661|NCT01752920|101463480|FG003|Overall Study|Withdrawal by Subject|1|||
33429662|NCT01752920|101463477|FG000|Overall Study|Lack of clinical benefit|1|||
33429663|NCT01752920|101463478|FG001|Overall Study|Lack of clinical benefit|1|||
33429664|NCT01752920|101463479|FG002|Overall Study|Lack of clinical benefit|1|||
33429665|NCT01752920|101463480|FG003|Overall Study|Lack of clinical benefit|1|||
33429666|NCT01214330|101463485|FG000|Overall Study|Withdrawal by Subject|2|||
33429667|NCT01214330|101463485|FG000|Overall Study|Withdrawal by Subject|2|||
33429668|NCT01612000|101463487|FG000|Overall Study|Lost to Follow-up|6|||
33429669|NCT01612000|101463488|FG001|Overall Study|Lost to Follow-up|4|||
33429670|NCT01612000|101463489|FG002|Overall Study|Lost to Follow-up|4|||
33429671|NCT01612000|101463490|FG003|Overall Study|Lost to Follow-up|8|||
33429672|NCT01612000|101463487|FG000|Overall Study|Physician Decision|0|||
33429673|NCT01612000|101463488|FG001|Overall Study|Physician Decision|0|||
33429674|NCT01612000|101463489|FG002|Overall Study|Physician Decision|1|||
33429675|NCT01612000|101463490|FG003|Overall Study|Physician Decision|0|||
33429676|NCT01612000|101463487|FG000|Overall Study|Withdrawal by Subject|3|||
33429677|NCT01612000|101463488|FG001|Overall Study|Withdrawal by Subject|1|||
33429678|NCT01612000|101463489|FG002|Overall Study|Withdrawal by Subject|2|||
33429679|NCT01612000|101463490|FG003|Overall Study|Withdrawal by Subject|2|||
33429680|NCT02891200|101463495|FG000|Overall Study|Lost to Follow-up|31|||
33429681|NCT02891200|101463496|FG001|Overall Study|Lost to Follow-up|36|||
33647779|NCT03642132|102262813|FG002|Follow-up Period|Study terminated by sponsor|1|||
33149586|NCT01721070|100460805|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
33149587|NCT01602380|100460809|FG000|Overall Study|Death|147|||
33248874|NCT00586339|100810345|FG002|Overall Study|Lost to Follow-up|1|||
33248875|NCT01167426|100810346|FG000|Overall Study|Lost to Follow-up|6|||
33429682|NCT02891200|101463495|FG000|Overall Study|Death|10|||
33429683|NCT02891200|101463496|FG001|Overall Study|Death|9|||
33248876|NCT01167426|100810346|FG000|Overall Study|Protocol Violation|1|||
33429684|NCT02891200|101463495|FG000|Overall Study|Withdrawal by Subject|1|||
33248877|NCT01167426|100810346|FG000|Overall Study|Withdrawal by Subject|2|||
33429685|NCT02891200|101463496|FG001|Overall Study|Withdrawal by Subject|4|||
33429686|NCT00566709|101463497|FG000|Overall Study|Protocol Violation|5|||
33429687|NCT00566709|101463498|FG001|Overall Study|Protocol Violation|0|||
33429688|NCT01754259|101463499|FG000|Overall Study|Withdrawal by Subject|2|||
33429689|NCT01754259|101463500|FG001|Overall Study|Withdrawal by Subject|4|||
33429690|NCT01754259|101463499|FG000|Overall Study|Adverse Event|3|||
33429691|NCT01754259|101463500|FG001|Overall Study|Adverse Event|1|||
33429692|NCT01754259|101463499|FG000|Overall Study|Lost to Follow-up|0|||
33429693|NCT01754259|101463500|FG001|Overall Study|Lost to Follow-up|1|||
33429694|NCT01565083|101463501|FG000|Overall Study|Withdrawal by Subject|6|||
33429695|NCT01565083|101463502|FG001|Overall Study|Withdrawal by Subject|4|||
33429696|NCT01565083|101463501|FG000|Overall Study|Lost to Follow-up|2|||
33429697|NCT01565083|101463502|FG001|Overall Study|Lost to Follow-up|7|||
33429698|NCT01565083|101463501|FG000|Overall Study|Death|22|||
33429699|NCT01565083|101463502|FG001|Overall Study|Death|23|||
33429700|NCT01565083|101463501|FG000|Overall Study|Other|3|||
33429701|NCT01565083|101463502|FG001|Overall Study|Other|5|||
33429702|NCT01466686|101463503|FG000|Overall Study|Withdrawal by Subject|1|||
33429703|NCT02330081|101463507|FG000|Overall Study|Adverse Event|1|||
33429704|NCT02330081|101463507|FG000|Overall Study|Donation did not meet criteria|1|||
33429705|NCT02330081|101463507|FG000|Overall Study|Protocol Violation|6|||
33429706|NCT02497391|101463508|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
33429707|NCT02497391|101463509|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
33429708|NCT02497391|101463510|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
33429709|NCT02497391|101463511|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
33429710|NCT02497391|101463512|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
33429711|NCT02497391|101463513|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
33429712|NCT02497391|101463508|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
33429713|NCT02497391|101463509|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
33429714|NCT02497391|101463510|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
33429715|NCT02497391|101463511|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
33429716|NCT02497391|101463512|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
33429717|NCT02497391|101463513|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
33429718|NCT02497391|101463508|FG000|Period 3 (14 Days)|Adverse Event|0|||
33429719|NCT02497391|101463509|FG001|Period 3 (14 Days)|Adverse Event|1|||
33429720|NCT02497391|101463510|FG002|Period 3 (14 Days)|Adverse Event|0|||
33429721|NCT02497391|101463511|FG003|Period 3 (14 Days)|Adverse Event|0|||
33429722|NCT02497391|101463512|FG004|Period 3 (14 Days)|Adverse Event|0|||
33429723|NCT02497391|101463513|FG005|Period 3 (14 Days)|Adverse Event|0|||
33429724|NCT02497391|101463508|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
33429725|NCT02497391|101463509|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
33429726|NCT02497391|101463510|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
33429727|NCT02497391|101463511|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
33647780|NCT03642132|102262811|FG000|Follow-up Period|Lack of Efficacy|1|||
33647781|NCT03642132|102262812|FG001|Follow-up Period|Lack of Efficacy|0|||
33647782|NCT03642132|102262813|FG002|Follow-up Period|Lack of Efficacy|0|||
33647783|NCT03642132|102262811|FG000|Follow-up Period|Death|1|||
33647784|NCT03642132|102262812|FG001|Follow-up Period|Death|0|||
33647785|NCT03642132|102262813|FG002|Follow-up Period|Death|2|||
33429728|NCT02497391|101463512|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
33429729|NCT02497391|101463513|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
33429730|NCT02497391|101463508|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
33429731|NCT02497391|101463509|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
33429732|NCT02497391|101463510|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
33429733|NCT02497391|101463511|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
33429734|NCT02497391|101463512|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
33429735|NCT02497391|101463513|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
33429736|NCT01405820|101463518|FG000|Randomized Treatment Period|Adverse Event|3|||
33429737|NCT01405820|101463519|FG001|Randomized Treatment Period|Adverse Event|3|||
33429738|NCT01405820|101463520|FG002|Randomized Treatment Period|Adverse Event|3|||
33429739|NCT01405820|101463521|FG003|Randomized Treatment Period|Adverse Event|0|||
33429740|NCT01405820|101463522|FG004|Randomized Treatment Period|Adverse Event|2|||
33429741|NCT01405820|101463523|FG005|Randomized Treatment Period|Adverse Event|1|||
33429742|NCT01405820|101463518|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
33429743|NCT01405820|101463519|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
33429744|NCT01405820|101463520|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
33429745|NCT01405820|101463521|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
33429746|NCT01405820|101463522|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
33647786|NCT03642132|102262811|FG000|Follow-up Period|Adverse Event|1|||
33647787|NCT03642132|102262812|FG001|Follow-up Period|Adverse Event|0|||
33429747|NCT01405820|101463523|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
33429748|NCT01405820|101463518|FG000|Randomized Treatment Period|Other|2|||
33429749|NCT01405820|101463519|FG001|Randomized Treatment Period|Other|2|||
33429750|NCT01405820|101463520|FG002|Randomized Treatment Period|Other|1|||
33647788|NCT03642132|102262813|FG002|Follow-up Period|Adverse Event|0|||
33429751|NCT01405820|101463521|FG003|Randomized Treatment Period|Other|1|||
33429752|NCT01405820|101463522|FG004|Randomized Treatment Period|Other|0|||
33429753|NCT01405820|101463523|FG005|Randomized Treatment Period|Other|0|||
33429754|NCT01405820|101463518|FG000|Randomized Treatment Period|Physician Decision|0|||
33429755|NCT01405820|101463519|FG001|Randomized Treatment Period|Physician Decision|2|||
33429756|NCT01405820|101463520|FG002|Randomized Treatment Period|Physician Decision|1|||
33647789|NCT00832624|102262815|FG000|Overall Study|Study Terminated|10|||
33647790|NCT02194985|102262816|FG000|Overall Study|Adverse Event|1|||
33429757|NCT01405820|101463521|FG003|Randomized Treatment Period|Physician Decision|0|||
33429758|NCT01405820|101463522|FG004|Randomized Treatment Period|Physician Decision|0|||
33429759|NCT01405820|101463523|FG005|Randomized Treatment Period|Physician Decision|0|||
33429760|NCT01405820|101463518|FG000|Randomized Treatment Period|Rescue|0|||
33429761|NCT01405820|101463519|FG001|Randomized Treatment Period|Rescue|1|||
33429762|NCT01405820|101463520|FG002|Randomized Treatment Period|Rescue|13|||
33429763|NCT01405820|101463521|FG003|Randomized Treatment Period|Rescue|10|||
33429764|NCT01405820|101463522|FG004|Randomized Treatment Period|Rescue|8|||
33587909|NCT01202188|102041708|FG002|Overall Study|Subject withdrew consent|22|||
33587910|NCT01202188|102041709|FG003|Overall Study|Subject withdrew consent|11|||
33587911|NCT01202188|102041710|FG004|Overall Study|Subject withdrew consent|13|||
33587912|NCT01202188|102041706|FG000|Overall Study|Adverse Event|5|||
33587913|NCT01202188|102041707|FG001|Overall Study|Adverse Event|23|||
33248878|NCT01167426|100810346|FG000|Overall Study|Sponsor Decision|1|||
33383209|NCT01392378|101287739|FG000|After Infant Series|Withdrawal by Parent|0|||
33383210|NCT01392378|101287740|FG001|After Infant Series|Withdrawal by Parent|1|||
33383211|NCT01392378|101287741|FG002|After Infant Series|Withdrawal by Parent|1|||
33383212|NCT01392378|101287742|FG003|After Infant Series|Withdrawal by Parent|0|||
33383213|NCT01392378|101287743|FG004|After Infant Series|Withdrawal by Parent|1|||
33383214|NCT01392378|101287739|FG000|Toddler Dose|Lost to Follow-up|0|||
33383215|NCT01392378|101287740|FG001|Toddler Dose|Lost to Follow-up|0|||
33383216|NCT01392378|101287741|FG002|Toddler Dose|Lost to Follow-up|0|||
33383217|NCT01392378|101287742|FG003|Toddler Dose|Lost to Follow-up|1|||
33383218|NCT01392378|101287743|FG004|Toddler Dose|Lost to Follow-up|0|||
33383219|NCT01392378|101287739|FG000|Toddler Dose|Withdrawal by Parent|0|||
33383220|NCT01392378|101287740|FG001|Toddler Dose|Withdrawal by Parent|1|||
33383221|NCT01392378|101287741|FG002|Toddler Dose|Withdrawal by Parent|0|||
33383222|NCT01392378|101287742|FG003|Toddler Dose|Withdrawal by Parent|1|||
33383223|NCT01392378|101287743|FG004|Toddler Dose|Withdrawal by Parent|1|||
33383224|NCT02553317|101287744|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
33383225|NCT02553317|101287745|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
33383226|NCT02553317|101287744|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
33383227|NCT02553317|101287745|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
33383228|NCT02553317|101287744|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
33383229|NCT02553317|101287745|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
33383230|NCT02553317|101287744|FG000|Overall Treatment Period + Follow-up|Death|1|||
33383231|NCT02553317|101287745|FG001|Overall Treatment Period + Follow-up|Death|3|||
33383232|NCT02553317|101287744|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
33383233|NCT02553317|101287745|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
33383234|NCT02553317|101287744|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
33383235|NCT02553317|101287745|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
33383236|NCT02553317|101287744|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
33383237|NCT02553317|101287745|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
33383238|NCT02553317|101287744|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
33383239|NCT02553317|101287745|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
33383240|NCT02553317|101287744|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
33383241|NCT02553317|101287745|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
33383242|NCT02553317|101287744|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
33383243|NCT02553317|101287745|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
33383244|NCT02581982|101287748|FG000|Overall Study|Lack of Efficacy|12|||
33383245|NCT02581982|101287748|FG000|Overall Study|Adverse Event|3|||
33383246|NCT02581982|101287748|FG000|Overall Study|Physician Decision|1|||
33587914|NCT01202188|102041708|FG002|Overall Study|Adverse Event|13|||
33587915|NCT01202188|102041709|FG003|Overall Study|Adverse Event|10|||
33587916|NCT01202188|102041710|FG004|Overall Study|Adverse Event|10|||
33383247|NCT00889681|101287749|FG000|Overall Study|Not meeting qualification Criteria|2|||
33383248|NCT00889681|101287749|FG000|Overall Study|Insurance disapproval|1|||
33383249|NCT04325906|101287750|FG000|Overall Study|Withdrawal by Subject|2|||
33383250|NCT04325906|101287751|FG001|Overall Study|Withdrawal by Subject|0|||
33383251|NCT05567393|101287752|FG000|Overall Study|Voluntary Withdrawal|0|||
33429765|NCT01405820|101463523|FG005|Randomized Treatment Period|Rescue|8|||
33429766|NCT01405820|101463518|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
33429767|NCT01405820|101463519|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
33429768|NCT01405820|101463520|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
33429769|NCT01405820|101463521|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
33429770|NCT01405820|101463522|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
33429771|NCT01405820|101463523|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
33429772|NCT01405820|101463518|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
33587917|NCT01202188|102041706|FG000|Overall Study|Administrative problems|3|||
33587918|NCT01202188|102041707|FG001|Overall Study|Administrative problems|2|||
33587919|NCT01202188|102041708|FG002|Overall Study|Administrative problems|1|||
33429773|NCT01405820|101463519|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
33429774|NCT01405820|101463520|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
33429775|NCT01405820|101463521|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
33429776|NCT01405820|101463522|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
33429777|NCT01405820|101463523|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
33429778|NCT01405820|101463518|FG000|Randomized Treatment Period|Death|0|||
33429779|NCT01405820|101463519|FG001|Randomized Treatment Period|Death|0|||
33429780|NCT01405820|101463520|FG002|Randomized Treatment Period|Death|0|||
33429781|NCT01405820|101463521|FG003|Randomized Treatment Period|Death|1|||
33429782|NCT01405820|101463522|FG004|Randomized Treatment Period|Death|0|||
33429783|NCT01405820|101463523|FG005|Randomized Treatment Period|Death|0|||
33429784|NCT01405820|101463518|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
33429785|NCT01405820|101463519|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
33429786|NCT01405820|101463520|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
33429787|NCT01405820|101463521|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
33429788|NCT01405820|101463522|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
33429789|NCT01405820|101463523|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
33429790|NCT01405820|101463518|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
33429791|NCT01405820|101463519|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
33429792|NCT01405820|101463520|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
33429793|NCT01405820|101463521|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
33429794|NCT01405820|101463522|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
33429795|NCT01405820|101463523|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
33429796|NCT01405820|101463518|FG000|Open-Label Treatment Period|Other|1|||
33429797|NCT01405820|101463519|FG001|Open-Label Treatment Period|Other|1|||
33429798|NCT01405820|101463520|FG002|Open-Label Treatment Period|Other|1|||
33429799|NCT01405820|101463521|FG003|Open-Label Treatment Period|Other|1|||
33429800|NCT01405820|101463522|FG004|Open-Label Treatment Period|Other|1|||
33429801|NCT01405820|101463523|FG005|Open-Label Treatment Period|Other|1|||
33429802|NCT01405820|101463518|FG000|Open-Label Treatment Period|Physician Decision|0|||
33429803|NCT01405820|101463519|FG001|Open-Label Treatment Period|Physician Decision|0|||
33429804|NCT01405820|101463520|FG002|Open-Label Treatment Period|Physician Decision|1|||
33429805|NCT01405820|101463521|FG003|Open-Label Treatment Period|Physician Decision|2|||
33429806|NCT01405820|101463522|FG004|Open-Label Treatment Period|Physician Decision|1|||
33429807|NCT01405820|101463523|FG005|Open-Label Treatment Period|Physician Decision|0|||
33429808|NCT01405820|101463518|FG000|Open-Label Treatment Period|Adverse Event|0|||
33429809|NCT01405820|101463519|FG001|Open-Label Treatment Period|Adverse Event|0|||
33429810|NCT01405820|101463520|FG002|Open-Label Treatment Period|Adverse Event|0|||
33429811|NCT01405820|101463521|FG003|Open-Label Treatment Period|Adverse Event|1|||
33429812|NCT01405820|101463522|FG004|Open-Label Treatment Period|Adverse Event|0|||
33429813|NCT01405820|101463523|FG005|Open-Label Treatment Period|Adverse Event|0|||
33429814|NCT00252187|101463524|FG000|Overall Study|Adverse Event|3|||
33429815|NCT00252187|101463525|FG001|Overall Study|Adverse Event|1|||
33429816|NCT00252187|101463524|FG000|Overall Study|Withdrawal by Subject|1|||
33383252|NCT05567393|101287753|FG001|Overall Study|Voluntary Withdrawal|0|||
33383253|NCT05567393|101287754|FG002|Overall Study|Voluntary Withdrawal|0|||
33383254|NCT05567393|101287755|FG003|Overall Study|Voluntary Withdrawal|0|||
33383255|NCT05567393|101287756|FG004|Overall Study|Voluntary Withdrawal|0|||
33383256|NCT05567393|101287757|FG005|Overall Study|Voluntary Withdrawal|0|||
33383257|NCT05567393|101287758|FG006|Overall Study|Voluntary Withdrawal|0|||
33383258|NCT05567393|101287759|FG007|Overall Study|Voluntary Withdrawal|0|||
33383259|NCT05567393|101287760|FG008|Overall Study|Voluntary Withdrawal|0|||
33383260|NCT05567393|101287761|FG009|Overall Study|Voluntary Withdrawal|0|||
33383261|NCT05567393|101287762|FG010|Overall Study|Voluntary Withdrawal|0|||
33383262|NCT05567393|101287763|FG011|Overall Study|Voluntary Withdrawal|0|||
33383263|NCT05567393|101287764|FG012|Overall Study|Voluntary Withdrawal|0|||
33429817|NCT00252187|101463525|FG001|Overall Study|Withdrawal by Subject|0|||
33429818|NCT00112489|101463529|FG000|Overall Study|Refused further treatment|8|||
33429819|NCT00112489|101463529|FG000|Overall Study|Adverse Event|12|||
33429820|NCT00112489|101463529|FG000|Overall Study|Death|2|||
33429821|NCT00112489|101463529|FG000|Overall Study|Other, Not Specified|9|||
33429822|NCT00112489|101463529|FG000|Overall Study|Patient never treated|2|||
33429823|NCT00112489|101463529|FG000|Overall Study|Ineligible|7|||
33429824|NCT02753400|101463530|FG000|Overall Study|Adverse Event|3|||
33429825|NCT02753400|101463531|FG001|Overall Study|Adverse Event|0|||
33429826|NCT02753400|101463530|FG000|Overall Study|Withdrawal by Subject|2|||
33429827|NCT02753400|101463531|FG001|Overall Study|Withdrawal by Subject|1|||
33429828|NCT01759381|101463536|FG000|Overall Study|Death|1|||
33383264|NCT05567393|101287765|FG013|Overall Study|Voluntary Withdrawal|1|||
33383265|NCT05567393|101287766|FG014|Overall Study|Voluntary Withdrawal|0|||
33429829|NCT01759381|101463537|FG001|Overall Study|Death|0|||
33429830|NCT00685919|101463538|FG000|Overall Study|Withdrawal by Subject|0|||
33429831|NCT00685919|101463539|FG001|Overall Study|Withdrawal by Subject|0|||
33429832|NCT00685919|101463540|FG002|Overall Study|Withdrawal by Subject|1|||
33429833|NCT00685919|101463541|FG003|Overall Study|Withdrawal by Subject|0|||
33429834|NCT00685919|101463538|FG000|Overall Study|Physician Decision|1|||
33429835|NCT00685919|101463539|FG001|Overall Study|Physician Decision|0|||
33429836|NCT00685919|101463540|FG002|Overall Study|Physician Decision|0|||
33429837|NCT00685919|101463541|FG003|Overall Study|Physician Decision|0|||
33429838|NCT03507439|101463542|FG000|Overall Study|Other|2|||
33429839|NCT03507439|101463543|FG001|Overall Study|Other|1|||
33429840|NCT03507439|101463542|FG000|Overall Study|Withdrawal by Subject|1|||
33429841|NCT03507439|101463543|FG001|Overall Study|Withdrawal by Subject|0|||
33429842|NCT03507439|101463542|FG000|Overall Study|Death|1|||
33429843|NCT03507439|101463543|FG001|Overall Study|Death|1|||
33429844|NCT03141177|101463546|FG000|Overall Study|Death|62|||
33429845|NCT03141177|101463547|FG001|Overall Study|Death|13|||
33429846|NCT03141177|101463548|FG002|Overall Study|Death|84|||
33429847|NCT03141177|101463546|FG000|Overall Study|Participant withdrew consent|9|||
33429848|NCT03141177|101463547|FG001|Overall Study|Participant withdrew consent|2|||
33429849|NCT03141177|101463548|FG002|Overall Study|Participant withdrew consent|13|||
33429850|NCT03141177|101463546|FG000|Overall Study|Not reported|1|||
33429851|NCT03141177|101463547|FG001|Overall Study|Not reported|0|||
33429852|NCT03141177|101463548|FG002|Overall Study|Not reported|1|||
33429853|NCT03141177|101463546|FG000|Overall Study|Lost to Follow-up|2|||
33429854|NCT03141177|101463547|FG001|Overall Study|Lost to Follow-up|1|||
33429855|NCT03141177|101463548|FG002|Overall Study|Lost to Follow-up|1|||
33429856|NCT03141177|101463546|FG000|Overall Study|Other reasons|4|||
33429857|NCT03141177|101463547|FG001|Overall Study|Other reasons|0|||
33429858|NCT03141177|101463548|FG002|Overall Study|Other reasons|11|||
33429859|NCT03141177|101463546|FG000|Overall Study|Participants did not start treatment period|3|||
33429860|NCT03141177|101463547|FG001|Overall Study|Participants did not start treatment period|0|||
33429861|NCT03141177|101463548|FG002|Overall Study|Participants did not start treatment period|8|||
33429862|NCT03731182|101463549|FG000|Overall Study|Lost to Follow-up|2|||
33429863|NCT03731182|101463550|FG001|Overall Study|Lost to Follow-up|0|||
33429864|NCT03731182|101463549|FG000|Overall Study|Physician Decision|1|||
33248879|NCT03999554|100810353|FG000|Overall Study|Lost to Follow-up|4|||
33248880|NCT03999554|100810354|FG001|Overall Study|Lost to Follow-up|5|||
33429865|NCT03731182|101463550|FG001|Overall Study|Physician Decision|0|||
33429866|NCT03731182|101463549|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
33429867|NCT03731182|101463550|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
33429868|NCT03922477|101463551|FG000|Overall Study|Death|9|||
33429869|NCT03922477|101463551|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
33429870|NCT03922477|101463551|FG000|Overall Study|Physician Decision|1|||
33429871|NCT03922477|101463551|FG000|Overall Study|Withdrawal by Subject|2|||
33429872|NCT00321711|101463553|FG000|Part A|Adverse Event|3|||
33429873|NCT00321711|101463554|FG001|Part A|Adverse Event|3|||
33429874|NCT00321711|101463555|FG002|Part A|Adverse Event|2|||
33429875|NCT00321711|101463556|FG003|Part A|Adverse Event|0|||
33429876|NCT00321711|101463557|FG004|Part A|Adverse Event|0|||
33429877|NCT00321711|101463553|FG000|Part A|Withdrawal by Subject|1|||
33429878|NCT00321711|101463554|FG001|Part A|Withdrawal by Subject|1|||
33429879|NCT00321711|101463555|FG002|Part A|Withdrawal by Subject|1|||
33429880|NCT00321711|101463556|FG003|Part A|Withdrawal by Subject|0|||
33429881|NCT00321711|101463557|FG004|Part A|Withdrawal by Subject|0|||
33429882|NCT00321711|101463553|FG000|Part A|Disease progression|0|||
33429883|NCT00321711|101463554|FG001|Part A|Disease progression|1|||
33429884|NCT00321711|101463555|FG002|Part A|Disease progression|0|||
33429885|NCT00321711|101463556|FG003|Part A|Disease progression|0|||
33429886|NCT00321711|101463557|FG004|Part A|Disease progression|0|||
33429887|NCT00321711|101463553|FG000|Part A|Requirement for alternative therapy|0|||
33429888|NCT00321711|101463554|FG001|Part A|Requirement for alternative therapy|2|||
33429889|NCT00321711|101463555|FG002|Part A|Requirement for alternative therapy|1|||
33429890|NCT00321711|101463556|FG003|Part A|Requirement for alternative therapy|0|||
33429891|NCT00321711|101463557|FG004|Part A|Requirement for alternative therapy|0|||
33429892|NCT00321711|101463553|FG000|Part A|Physician Decision|0|||
33429893|NCT00321711|101463554|FG001|Part A|Physician Decision|1|||
33429894|NCT00321711|101463555|FG002|Part A|Physician Decision|3|||
33429895|NCT00321711|101463556|FG003|Part A|Physician Decision|0|||
33429896|NCT00321711|101463557|FG004|Part A|Physician Decision|0|||
33429897|NCT00321711|101463553|FG000|Part A|Other|1|||
33429898|NCT00321711|101463554|FG001|Part A|Other|2|||
33429899|NCT00321711|101463555|FG002|Part A|Other|3|||
33429900|NCT00321711|101463556|FG003|Part A|Other|0|||
33429901|NCT00321711|101463557|FG004|Part A|Other|0|||
33429902|NCT00321711|101463553|FG000|Part A|Protocol deviation|0|||
33429903|NCT00321711|101463554|FG001|Part A|Protocol deviation|0|||
33429904|NCT00321711|101463555|FG002|Part A|Protocol deviation|1|||
33429905|NCT00321711|101463556|FG003|Part A|Protocol deviation|0|||
33429906|NCT00321711|101463557|FG004|Part A|Protocol deviation|0|||
33429907|NCT00321711|101463553|FG000|Part B|Noncompliance|0|||
33429908|NCT00321711|101463554|FG001|Part B|Noncompliance|0|||
33429909|NCT00321711|101463555|FG002|Part B|Noncompliance|0|||
33429910|NCT00321711|101463556|FG003|Part B|Noncompliance|0|||
33429911|NCT00321711|101463557|FG004|Part B|Noncompliance|1|||
33429912|NCT00321711|101463553|FG000|Part B|Adverse Event|0|||
33429913|NCT00321711|101463554|FG001|Part B|Adverse Event|0|||
33429914|NCT00321711|101463555|FG002|Part B|Adverse Event|0|||
33429915|NCT00321711|101463556|FG003|Part B|Adverse Event|2|||
33429916|NCT00321711|101463557|FG004|Part B|Adverse Event|1|||
33429917|NCT00321711|101463553|FG000|Part B|Disease progression|0|||
33429918|NCT00321711|101463554|FG001|Part B|Disease progression|0|||
33429919|NCT00321711|101463555|FG002|Part B|Disease progression|0|||
33429920|NCT00321711|101463556|FG003|Part B|Disease progression|1|||
33429921|NCT00321711|101463557|FG004|Part B|Disease progression|0|||
33429922|NCT00321711|101463553|FG000|Part B|Physician Decision|0|||
33429923|NCT00321711|101463554|FG001|Part B|Physician Decision|0|||
33429924|NCT00321711|101463555|FG002|Part B|Physician Decision|0|||
33429925|NCT00321711|101463556|FG003|Part B|Physician Decision|1|||
33429926|NCT00321711|101463557|FG004|Part B|Physician Decision|2|||
33429927|NCT00321711|101463553|FG000|Part B|Death|0|||
33429928|NCT00321711|101463554|FG001|Part B|Death|0|||
33429929|NCT00321711|101463555|FG002|Part B|Death|0|||
33429930|NCT00321711|101463556|FG003|Part B|Death|2|||
33429931|NCT00321711|101463557|FG004|Part B|Death|1|||
33429932|NCT01567306|101463558|FG000|Overall Study|Protocol Violation|2|||
33429933|NCT01567306|101463559|FG001|Overall Study|Protocol Violation|2|||
33429934|NCT01567306|101463560|FG002|Overall Study|Protocol Violation|0|||
33429935|NCT01567306|101463561|FG003|Overall Study|Protocol Violation|3|||
33429936|NCT01567306|101463562|FG004|Overall Study|Protocol Violation|1|||
33429937|NCT01567306|101463563|FG005|Overall Study|Protocol Violation|1|||
33429938|NCT01567306|101463558|FG000|Overall Study|Change site living|1|||
33429939|NCT01567306|101463559|FG001|Overall Study|Change site living|0|||
33429940|NCT01567306|101463560|FG002|Overall Study|Change site living|0|||
33429941|NCT01567306|101463561|FG003|Overall Study|Change site living|0|||
33429942|NCT01567306|101463562|FG004|Overall Study|Change site living|0|||
33429943|NCT01567306|101463563|FG005|Overall Study|Change site living|0|||
33429944|NCT01567306|101463558|FG000|Overall Study|Adverse Event|0|||
33429945|NCT01567306|101463559|FG001|Overall Study|Adverse Event|0|||
33429946|NCT01567306|101463560|FG002|Overall Study|Adverse Event|0|||
33647791|NCT02194985|102262816|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
33647792|NCT02194985|102262816|FG000|Overall Study|Physician Decision|4|||
33647793|NCT02194985|102262816|FG000|Overall Study|Lost to Follow-up|1|||
33647794|NCT02194985|102262816|FG000|Overall Study|Withdrawal by Subject|2|||
33647795|NCT01700387|102262818|FG000|Overall Study|Withdrawal by Subject|1|||
33647796|NCT01700387|102262819|FG001|Overall Study|Withdrawal by Subject|2|||
33647797|NCT01700387|102262818|FG000|Overall Study|Adverse Event|1|||
33647798|NCT01700387|102262819|FG001|Overall Study|Adverse Event|1|||
33647799|NCT01700387|102262818|FG000|Overall Study|Lost to Follow-up|2|||
33647800|NCT01700387|102262819|FG001|Overall Study|Lost to Follow-up|1|||
33647801|NCT03801031|102262822|FG000|Overall Study|Lost to Follow-up|1|||
33647802|NCT03801031|102262823|FG001|Overall Study|Lost to Follow-up|0|||
33647803|NCT03801031|102262822|FG000|Overall Study|Unable to comply|1|||
33647804|NCT03801031|102262823|FG001|Overall Study|Unable to comply|0|||
33647805|NCT03801031|102262822|FG000|Overall Study|Withdrawal by Subject|0|||
33647806|NCT03801031|102262823|FG001|Overall Study|Withdrawal by Subject|1|||
33383266|NCT05567393|101287767|FG015|Overall Study|Voluntary Withdrawal|0|||
33383267|NCT05567393|101287768|FG016|Overall Study|Voluntary Withdrawal|0|||
33383268|NCT05567393|101287769|FG017|Overall Study|Voluntary Withdrawal|0|||
33383269|NCT02871401|101287770|FG000|Overall Study|Adverse Event|1|||
33383270|NCT02871401|101287771|FG001|Overall Study|Adverse Event|0|||
33383271|NCT00618995|101287774|FG000|Period 1|Adverse Event|0|||
33383272|NCT00618995|101287775|FG001|Period 1|Adverse Event|0|||
33383273|NCT00618995|101287776|FG002|Period 1|Adverse Event|1|||
33383274|NCT00618995|101287777|FG003|Period 1|Adverse Event|0|||
33429947|NCT01567306|101463561|FG003|Overall Study|Adverse Event|2|||
33429948|NCT01567306|101463562|FG004|Overall Study|Adverse Event|4|||
33429949|NCT01567306|101463563|FG005|Overall Study|Adverse Event|1|||
33248881|NCT03999554|100810355|FG002|Overall Study|Lost to Follow-up|4|||
33383275|NCT00618995|101287774|FG000|Period 1|Protocol Violation|0|||
33383276|NCT00618995|101287775|FG001|Period 1|Protocol Violation|1|||
33383277|NCT00618995|101287776|FG002|Period 1|Protocol Violation|1|||
33383278|NCT00618995|101287777|FG003|Period 1|Protocol Violation|0|||
33383279|NCT00618995|101287774|FG000|Period 2|Protocol Violation|0|||
33429950|NCT01567306|101463558|FG000|Overall Study|Lost to Follow-up|0|||
33429951|NCT01567306|101463559|FG001|Overall Study|Lost to Follow-up|0|||
33429952|NCT01567306|101463560|FG002|Overall Study|Lost to Follow-up|0|||
33429953|NCT01567306|101463561|FG003|Overall Study|Lost to Follow-up|0|||
33429954|NCT01567306|101463562|FG004|Overall Study|Lost to Follow-up|2|||
33429955|NCT01567306|101463563|FG005|Overall Study|Lost to Follow-up|0|||
33429956|NCT01567306|101463558|FG000|Overall Study|Withdrawal by Subject|0|||
33647807|NCT01788215|102262824|FG000|Overall Study|Withdrawal by Subject|0|||
33149588|NCT01602380|100460810|FG001|Overall Study|Death|145|||
33429957|NCT01567306|101463559|FG001|Overall Study|Withdrawal by Subject|0|||
33429958|NCT01567306|101463560|FG002|Overall Study|Withdrawal by Subject|0|||
33429959|NCT01567306|101463561|FG003|Overall Study|Withdrawal by Subject|0|||
33429960|NCT01567306|101463562|FG004|Overall Study|Withdrawal by Subject|0|||
33429961|NCT01567306|101463563|FG005|Overall Study|Withdrawal by Subject|1|||
33383280|NCT00618995|101287775|FG001|Period 2|Protocol Violation|0|||
33383281|NCT00618995|101287776|FG002|Period 2|Protocol Violation|1|||
33383282|NCT00618995|101287777|FG003|Period 2|Protocol Violation|0|||
33383283|NCT00618995|101287774|FG000|Period 4|Adverse Event|1|||
33383284|NCT00618995|101287775|FG001|Period 4|Adverse Event|0|||
33383285|NCT00618995|101287776|FG002|Period 4|Adverse Event|0|||
33383286|NCT00618995|101287777|FG003|Period 4|Adverse Event|0|||
33647808|NCT01788215|102262825|FG001|Overall Study|Withdrawal by Subject|1|||
33647809|NCT01788215|102262824|FG000|Overall Study|Lost to Follow-up|2|||
33647810|NCT01788215|102262825|FG001|Overall Study|Lost to Follow-up|0|||
33647811|NCT02925338|102262826|FG000|Overall Study|Death|0|||
33647812|NCT02925338|102262827|FG001|Overall Study|Death|2|||
33647813|NCT02925338|102262828|FG002|Overall Study|Death|1|||
33647814|NCT02925338|102262829|FG003|Overall Study|Death|0|||
33647815|NCT02925338|102262830|FG004|Overall Study|Death|0|||
33149589|NCT01602380|100460809|FG000|Overall Study|Withdrawal by Subject|39|||
33149590|NCT01602380|100460810|FG001|Overall Study|Withdrawal by Subject|41|||
33149591|NCT01602380|100460809|FG000|Overall Study|Lost to Follow-up|15|||
33149592|NCT01602380|100460810|FG001|Overall Study|Lost to Follow-up|12|||
33149593|NCT01602380|100460809|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33149594|NCT01602380|100460810|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
33149595|NCT01602380|100460809|FG000|Overall Study|Other|2|||
33149596|NCT01602380|100460810|FG001|Overall Study|Other|0|||
33149597|NCT03104374|100460823|FG000|Overall Study|Adverse Event|7|||
33149598|NCT03104374|100460824|FG001|Overall Study|Adverse Event|6|||
33149599|NCT03104374|100460825|FG002|Overall Study|Adverse Event|12|||
33149600|NCT03104374|100460826|FG003|Overall Study|Adverse Event|15|||
33149601|NCT03104374|100460823|FG000|Overall Study|Withdrawal by Subject|18|||
33149602|NCT03104374|100460824|FG001|Overall Study|Withdrawal by Subject|10|||
33149603|NCT03104374|100460825|FG002|Overall Study|Withdrawal by Subject|10|||
33149604|NCT03104374|100460826|FG003|Overall Study|Withdrawal by Subject|17|||
33149605|NCT03104374|100460823|FG000|Overall Study|Lost to Follow-up|4|||
33149606|NCT03104374|100460824|FG001|Overall Study|Lost to Follow-up|4|||
33149607|NCT03104374|100460825|FG002|Overall Study|Lost to Follow-up|6|||
33149608|NCT03104374|100460826|FG003|Overall Study|Lost to Follow-up|8|||
33149609|NCT03104374|100460823|FG000|Overall Study|Lack of Efficacy|6|||
33149610|NCT03104374|100460824|FG001|Overall Study|Lack of Efficacy|7|||
33149611|NCT03104374|100460825|FG002|Overall Study|Lack of Efficacy|12|||
33149612|NCT03104374|100460826|FG003|Overall Study|Lack of Efficacy|6|||
33149613|NCT03104374|100460823|FG000|Overall Study|Other|2|||
33149614|NCT03104374|100460824|FG001|Overall Study|Other|2|||
33149615|NCT03104374|100460825|FG002|Overall Study|Other|4|||
33149616|NCT03104374|100460826|FG003|Overall Study|Other|7|||
33149617|NCT02063880|100460828|FG000|Overall Study|Death|21|||
33149618|NCT02063880|100460829|FG001|Overall Study|Death|18|||
33149619|NCT02063880|100460828|FG000|Overall Study|Lost to Follow-up|7|||
33149620|NCT02063880|100460829|FG001|Overall Study|Lost to Follow-up|7|||
33149621|NCT02063880|100460828|FG000|Overall Study|Ineligible|0|||
33149622|NCT02063880|100460829|FG001|Overall Study|Ineligible|2|||
33149623|NCT03875118|100460830|FG000|Overall Study|Withdrawal by Subject|4|||
33149624|NCT03875118|100460831|FG001|Overall Study|Withdrawal by Subject|4|||
33149625|NCT01163266|100460842|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
33149626|NCT01163266|100460843|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
33149627|NCT01163266|100460844|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
33149628|NCT01163266|100460842|FG000|Overall Study|Lack of Efficacy|1|||
33149629|NCT01163266|100460843|FG001|Overall Study|Lack of Efficacy|3|||
33647816|NCT02925338|102262826|FG000|Overall Study|Lost to Follow-up|30|||
33647817|NCT02925338|102262827|FG001|Overall Study|Lost to Follow-up|10|||
33647818|NCT02925338|102262828|FG002|Overall Study|Lost to Follow-up|1|||
33647819|NCT02925338|102262829|FG003|Overall Study|Lost to Follow-up|16|||
33647820|NCT02925338|102262830|FG004|Overall Study|Lost to Follow-up|3|||
33647821|NCT02925338|102262826|FG000|Overall Study|Withdrawal by Subject|3|||
33647822|NCT02925338|102262827|FG001|Overall Study|Withdrawal by Subject|0|||
33647823|NCT02925338|102262828|FG002|Overall Study|Withdrawal by Subject|3|||
33149630|NCT01163266|100460844|FG002|Overall Study|Lack of Efficacy|1|||
33149631|NCT01163266|100460842|FG000|Overall Study|Noncompliance with Study Drug|0|||
33149632|NCT01163266|100460843|FG001|Overall Study|Noncompliance with Study Drug|2|||
33149633|NCT01163266|100460844|FG002|Overall Study|Noncompliance with Study Drug|0|||
33383287|NCT03199638|101287785|FG000|Overall Study|inability to drink glutamine during regularly|0|||
33149634|NCT01163266|100460842|FG000|Overall Study|Protocol Deviations|2|||
33383288|NCT03199638|101287786|FG001|Overall Study|inability to drink glutamine during regularly|2|||
33383289|NCT00387348|101287791|FG000|Overall Study|Death|1|||
33383290|NCT00387348|101287792|FG001|Overall Study|Death|1|||
33149635|NCT01163266|100460843|FG001|Overall Study|Protocol Deviations|2|||
33149636|NCT01163266|100460844|FG002|Overall Study|Protocol Deviations|5|||
33149637|NCT01163266|100460842|FG000|Overall Study|Withdrawal of Consent|5|||
33149638|NCT01163266|100460843|FG001|Overall Study|Withdrawal of Consent|7|||
33248882|NCT03999554|100810356|FG003|Overall Study|Lost to Follow-up|5|||
33647824|NCT02925338|102262829|FG003|Overall Study|Withdrawal by Subject|2|||
33647825|NCT02925338|102262830|FG004|Overall Study|Withdrawal by Subject|2|||
33647826|NCT02925338|102262826|FG000|Overall Study|Missing|38|||
33647827|NCT02925338|102262827|FG001|Overall Study|Missing|27|||
33647828|NCT02925338|102262828|FG002|Overall Study|Missing|0|||
33647829|NCT02925338|102262829|FG003|Overall Study|Missing|3|||
33647830|NCT02925338|102262830|FG004|Overall Study|Missing|2|||
33647831|NCT02925338|102262826|FG000|Overall Study|Participant's Decision|11|||
33647832|NCT02925338|102262827|FG001|Overall Study|Participant's Decision|7|||
33647833|NCT02925338|102262828|FG002|Overall Study|Participant's Decision|3|||
33647834|NCT02925338|102262829|FG003|Overall Study|Participant's Decision|8|||
33647835|NCT02925338|102262830|FG004|Overall Study|Participant's Decision|1|||
33647836|NCT02925338|102262826|FG000|Overall Study|Treatment Discontinuation|144|||
33647837|NCT02925338|102262827|FG001|Overall Study|Treatment Discontinuation|65|||
33647838|NCT02925338|102262828|FG002|Overall Study|Treatment Discontinuation|56|||
33647839|NCT02925338|102262829|FG003|Overall Study|Treatment Discontinuation|131|||
33647840|NCT02925338|102262830|FG004|Overall Study|Treatment Discontinuation|22|||
33647841|NCT00744042|102262834|FG000|Overall Study|Withdrawal by Subject|1|||
33647842|NCT02891070|102262837|FG000|Overall Study|Adverse Event|1|||
33647843|NCT02891070|102262838|FG001|Overall Study|Adverse Event|0|||
33647844|NCT02891070|102262837|FG000|Overall Study|Physician Decision|0|||
33647845|NCT02891070|102262838|FG001|Overall Study|Physician Decision|1|||
33647846|NCT02891070|102262837|FG000|Overall Study|Lost to Follow-up|4|||
33647847|NCT02891070|102262838|FG001|Overall Study|Lost to Follow-up|4|||
33647848|NCT02891070|102262837|FG000|Overall Study|Other|1|||
33647849|NCT02891070|102262838|FG001|Overall Study|Other|0|||
33647850|NCT02891070|102262837|FG000|Overall Study|Protocol Violation|0|||
33647851|NCT02891070|102262838|FG001|Overall Study|Protocol Violation|1|||
33647852|NCT02891070|102262837|FG000|Overall Study|Withdrawal by Subject|1|||
33647853|NCT02891070|102262838|FG001|Overall Study|Withdrawal by Subject|2|||
33647854|NCT02891070|102262837|FG000|Overall Study|Death|3|||
33647855|NCT02891070|102262838|FG001|Overall Study|Death|0|||
33647856|NCT01155011|102262844|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
33647857|NCT01155011|102262845|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
33647858|NCT01155011|102262844|FG000|Baseline to 6 Months|investigator decision, moved|4|||
33647859|NCT01155011|102262845|FG001|Baseline to 6 Months|investigator decision, moved|5|||
33647860|NCT01155011|102262844|FG000|Baseline to 6 Months|Death|0|||
33647861|NCT01155011|102262845|FG001|Baseline to 6 Months|Death|1|||
33647862|NCT01155011|102262844|FG000|6 to 12 Months|Withdrawal by Subject|8|||
33647863|NCT01155011|102262845|FG001|6 to 12 Months|Withdrawal by Subject|5|||
33647864|NCT01155011|102262844|FG000|6 to 12 Months|Death|1|||
33647865|NCT01155011|102262845|FG001|6 to 12 Months|Death|5|||
33647866|NCT05194579|102262846|FG000|Overall Study|Lost to Follow-up|2|||
33647867|NCT05194579|102262847|FG001|Overall Study|Lost to Follow-up|3|||
33647868|NCT05194579|102262846|FG000|Overall Study|Withdrawal by Subject|3|||
33647869|NCT05194579|102262847|FG001|Overall Study|Withdrawal by Subject|4|||
33647870|NCT05194579|102262846|FG000|Overall Study|Refused further study procedures|0|||
33647871|NCT05194579|102262847|FG001|Overall Study|Refused further study procedures|1|||
33647872|NCT05194579|102262846|FG000|Overall Study|Protocol deviation|1|||
33149639|NCT01163266|100460844|FG002|Overall Study|Withdrawal of Consent|3|||
33149640|NCT01163266|100460842|FG000|Overall Study|Lost to Follow-up|7|||
33149641|NCT01163266|100460843|FG001|Overall Study|Lost to Follow-up|7|||
33149642|NCT01163266|100460844|FG002|Overall Study|Lost to Follow-up|10|||
33149643|NCT01163266|100460842|FG000|Overall Study|Other|1|||
33149644|NCT01163266|100460843|FG001|Overall Study|Other|1|||
33149645|NCT01163266|100460844|FG002|Overall Study|Other|2|||
33149646|NCT05182125|100463440|FG000|Overall Study|Withdrawal by Subject|0|||
33149647|NCT05182125|100463441|FG001|Overall Study|Withdrawal by Subject|0|||
33149648|NCT05182125|100463442|FG002|Overall Study|Withdrawal by Subject|0|||
33149649|NCT05182125|100463443|FG003|Overall Study|Withdrawal by Subject|0|||
33149650|NCT05182125|100463444|FG004|Overall Study|Withdrawal by Subject|2|||
33149651|NCT05182125|100463445|FG005|Overall Study|Withdrawal by Subject|0|||
33149652|NCT05182125|100463440|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
33149653|NCT05182125|100463441|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
33149654|NCT05182125|100463442|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
33149655|NCT05182125|100463443|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
33149656|NCT05182125|100463444|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
33647873|NCT05194579|102262847|FG001|Overall Study|Protocol deviation|0|||
33647874|NCT03079102|102262848|FG000|Overall Study|Physician Decision|0|||
33647875|NCT03079102|102262849|FG001|Overall Study|Physician Decision|1|||
33647876|NCT04657666|102262855|FG000|Period 1|Withdrawal of participant consent|2|||
33647877|NCT04657666|102262856|FG001|Period 1|Withdrawal of participant consent|1|||
33647878|NCT04657666|102262855|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
33647879|NCT04657666|102262856|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
33647880|NCT04657666|102262855|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
33647881|NCT04657666|102262856|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
33647882|NCT04657666|102262855|FG000|Period 2|Other|2|||
33647883|NCT04657666|102262856|FG001|Period 2|Other|0|||
33149657|NCT05182125|100463445|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
33647884|NCT04657666|102262855|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
33647885|NCT04657666|102262856|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
33647886|NCT01788358|102262859|FG000|Overall Study|Other|11|||
33647887|NCT01788358|102262859|FG000|Overall Study|Logistical difficulties|1|||
33647888|NCT01788358|102262859|FG000|Overall Study|Lost to Follow-up|5|||
33429962|NCT02035137|101463564|FG000|Overall Study|Physician Decision|0|||
33429963|NCT02035137|101463565|FG001|Overall Study|Physician Decision|0|||
33429964|NCT02035137|101463566|FG002|Overall Study|Physician Decision|1|||
33429965|NCT02035137|101463564|FG000|Overall Study|Withdrawal by Subject|0|||
33429966|NCT02035137|101463565|FG001|Overall Study|Withdrawal by Subject|1|||
33429967|NCT02035137|101463566|FG002|Overall Study|Withdrawal by Subject|2|||
33429968|NCT02035137|101463564|FG000|Overall Study|Ineligible|0|||
33429969|NCT02035137|101463565|FG001|Overall Study|Ineligible|1|||
33429970|NCT02035137|101463566|FG002|Overall Study|Ineligible|2|||
33429971|NCT02035137|101463564|FG000|Overall Study|Disease progression prior to treatment start|2|||
33429972|NCT02035137|101463565|FG001|Overall Study|Disease progression prior to treatment start|0|||
33429973|NCT02035137|101463566|FG002|Overall Study|Disease progression prior to treatment start|0|||
33429974|NCT00745251|101463569|FG000|Overall Study|Adverse Event|1|||
33429975|NCT00745251|101463570|FG001|Overall Study|Adverse Event|2|||
33429976|NCT00745251|101463569|FG000|Overall Study|Withdrawal by Subject|1|||
33429977|NCT00745251|101463570|FG001|Overall Study|Withdrawal by Subject|1|||
33429978|NCT02711956|101463571|FG000|Overall Study|Adverse Event|0|||
33429979|NCT02711956|101463572|FG001|Overall Study|Adverse Event|0|||
33429980|NCT02711956|101463573|FG002|Overall Study|Adverse Event|0|||
33429981|NCT02711956|101463574|FG003|Overall Study|Adverse Event|1|||
33429982|NCT02711956|101463575|FG004|Overall Study|Adverse Event|2|||
33429983|NCT02711956|101463576|FG005|Overall Study|Adverse Event|0|||
33429984|NCT02711956|101463577|FG006|Overall Study|Adverse Event|0|||
33429985|NCT02711956|101463578|FG007|Overall Study|Adverse Event|1|||
33429986|NCT02711956|101463579|FG008|Overall Study|Adverse Event|1|||
33429987|NCT02711956|101463580|FG009|Overall Study|Adverse Event|1|||
33429988|NCT02711956|101463581|FG010|Overall Study|Adverse Event|1|||
33429989|NCT02711956|101463582|FG011|Overall Study|Adverse Event|0|||
33429990|NCT02711956|101463583|FG012|Overall Study|Adverse Event|0|||
33429991|NCT02711956|101463584|FG013|Overall Study|Adverse Event|0|||
33429992|NCT02711956|101463585|FG014|Overall Study|Adverse Event|2|||
33587920|NCT01202188|102041709|FG003|Overall Study|Administrative problems|1|||
33587921|NCT01202188|102041710|FG004|Overall Study|Administrative problems|2|||
33587922|NCT01202188|102041706|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33587923|NCT01202188|102041707|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
33587924|NCT01202188|102041708|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
33587925|NCT01202188|102041709|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
33587926|NCT01202188|102041710|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
33587927|NCT01202188|102041706|FG000|Overall Study|Lost to Follow-up|1|||
33587928|NCT01202188|102041707|FG001|Overall Study|Lost to Follow-up|1|||
33587929|NCT01202188|102041708|FG002|Overall Study|Lost to Follow-up|0|||
33587930|NCT01202188|102041709|FG003|Overall Study|Lost to Follow-up|4|||
33587931|NCT01202188|102041710|FG004|Overall Study|Lost to Follow-up|1|||
33587932|NCT01202188|102041706|FG000|Overall Study|Death|1|||
33587933|NCT01202188|102041707|FG001|Overall Study|Death|1|||
33587934|NCT01202188|102041708|FG002|Overall Study|Death|1|||
33587935|NCT01202188|102041709|FG003|Overall Study|Death|1|||
33587936|NCT01202188|102041710|FG004|Overall Study|Death|0|||
33587937|NCT01202188|102041706|FG000|Overall Study|Abnormal test procedure result (s)|0|||
33587938|NCT01202188|102041707|FG001|Overall Study|Abnormal test procedure result (s)|0|||
33587939|NCT01202188|102041708|FG002|Overall Study|Abnormal test procedure result (s)|2|||
33647889|NCT01788358|102262859|FG000|Overall Study|Protocol Violation|3|||
33647890|NCT01788358|102262859|FG000|Overall Study|Withdrawal by Subject|26|||
33647891|NCT01788358|102262859|FG000|Overall Study|Lack of Efficacy|1|||
33647892|NCT01788358|102262859|FG000|Overall Study|Adverse Event|51|||
33647893|NCT02878798|102262860|FG000|Overall Study|Withdrawal by Subject|5|||
33248883|NCT03999554|100810357|FG004|Overall Study|Lost to Follow-up|8|||
33248884|NCT03999554|100810353|FG000|Overall Study|Protocol Violation|0|||
33429993|NCT02711956|101463571|FG000|Overall Study|Physician Decision|0|||
33429994|NCT02711956|101463572|FG001|Overall Study|Physician Decision|0|||
33429995|NCT02711956|101463573|FG002|Overall Study|Physician Decision|0|||
33429996|NCT02711956|101463574|FG003|Overall Study|Physician Decision|2|||
33647894|NCT02878798|102262861|FG001|Overall Study|Withdrawal by Subject|4|||
33248885|NCT03999554|100810354|FG001|Overall Study|Protocol Violation|0|||
33429997|NCT02711956|101463575|FG004|Overall Study|Physician Decision|0|||
33429998|NCT02711956|101463576|FG005|Overall Study|Physician Decision|0|||
33429999|NCT02711956|101463577|FG006|Overall Study|Physician Decision|0|||
33430000|NCT02711956|101463578|FG007|Overall Study|Physician Decision|0|||
33430001|NCT02711956|101463579|FG008|Overall Study|Physician Decision|0|||
33430002|NCT02711956|101463580|FG009|Overall Study|Physician Decision|0|||
33587940|NCT01202188|102041709|FG003|Overall Study|Abnormal test procedure result (s)|0|||
33587941|NCT01202188|102041710|FG004|Overall Study|Abnormal test procedure result (s)|0|||
33587942|NCT04003207|102041711|FG000|Overall Study|Protocol Violation|1|||
33430003|NCT02711956|101463581|FG010|Overall Study|Physician Decision|0|||
33430004|NCT02711956|101463582|FG011|Overall Study|Physician Decision|0|||
33430005|NCT02711956|101463583|FG012|Overall Study|Physician Decision|0|||
33430006|NCT02711956|101463584|FG013|Overall Study|Physician Decision|0|||
33430007|NCT02711956|101463585|FG014|Overall Study|Physician Decision|0|||
33430008|NCT02711956|101463571|FG000|Overall Study|Withdrawal by Subject|0|||
33430009|NCT02711956|101463572|FG001|Overall Study|Withdrawal by Subject|0|||
33430010|NCT02711956|101463573|FG002|Overall Study|Withdrawal by Subject|0|||
33430011|NCT02711956|101463574|FG003|Overall Study|Withdrawal by Subject|0|||
33430012|NCT02711956|101463575|FG004|Overall Study|Withdrawal by Subject|0|||
33430013|NCT02711956|101463576|FG005|Overall Study|Withdrawal by Subject|0|||
33430014|NCT02711956|101463577|FG006|Overall Study|Withdrawal by Subject|1|||
33430015|NCT02711956|101463578|FG007|Overall Study|Withdrawal by Subject|0|||
33430016|NCT02711956|101463579|FG008|Overall Study|Withdrawal by Subject|0|||
33430017|NCT02711956|101463580|FG009|Overall Study|Withdrawal by Subject|0|||
33430018|NCT02711956|101463581|FG010|Overall Study|Withdrawal by Subject|0|||
33430019|NCT02711956|101463582|FG011|Overall Study|Withdrawal by Subject|1|||
33430020|NCT02711956|101463583|FG012|Overall Study|Withdrawal by Subject|6|||
33430021|NCT02711956|101463584|FG013|Overall Study|Withdrawal by Subject|0|||
33430022|NCT02711956|101463585|FG014|Overall Study|Withdrawal by Subject|1|||
33430023|NCT02711956|101463571|FG000|Overall Study|Clinical progression|1|||
33430024|NCT02711956|101463572|FG001|Overall Study|Clinical progression|0|||
33430025|NCT02711956|101463573|FG002|Overall Study|Clinical progression|0|||
33430026|NCT02711956|101463574|FG003|Overall Study|Clinical progression|0|||
33430027|NCT02711956|101463575|FG004|Overall Study|Clinical progression|0|||
33430028|NCT02711956|101463576|FG005|Overall Study|Clinical progression|0|||
33430029|NCT02711956|101463577|FG006|Overall Study|Clinical progression|1|||
33430030|NCT02711956|101463578|FG007|Overall Study|Clinical progression|0|||
33430031|NCT02711956|101463579|FG008|Overall Study|Clinical progression|1|||
33430032|NCT02711956|101463580|FG009|Overall Study|Clinical progression|0|||
33430033|NCT02711956|101463581|FG010|Overall Study|Clinical progression|0|||
33430034|NCT02711956|101463582|FG011|Overall Study|Clinical progression|2|||
33430035|NCT02711956|101463583|FG012|Overall Study|Clinical progression|4|||
33430036|NCT02711956|101463584|FG013|Overall Study|Clinical progression|1|||
33430037|NCT02711956|101463585|FG014|Overall Study|Clinical progression|1|||
33430038|NCT02711956|101463571|FG000|Overall Study|Radiographic progression|1|||
33430039|NCT02711956|101463572|FG001|Overall Study|Radiographic progression|1|||
33430040|NCT02711956|101463573|FG002|Overall Study|Radiographic progression|2|||
33430041|NCT02711956|101463574|FG003|Overall Study|Radiographic progression|0|||
33430042|NCT02711956|101463575|FG004|Overall Study|Radiographic progression|1|||
33430043|NCT02711956|101463576|FG005|Overall Study|Radiographic progression|0|||
33430044|NCT02711956|101463577|FG006|Overall Study|Radiographic progression|0|||
33430045|NCT02711956|101463578|FG007|Overall Study|Radiographic progression|0|||
33430046|NCT02711956|101463579|FG008|Overall Study|Radiographic progression|2|||
33430047|NCT02711956|101463580|FG009|Overall Study|Radiographic progression|1|||
33430048|NCT02711956|101463581|FG010|Overall Study|Radiographic progression|0|||
33430049|NCT02711956|101463582|FG011|Overall Study|Radiographic progression|5|||
33430050|NCT02711956|101463583|FG012|Overall Study|Radiographic progression|3|||
33430051|NCT02711956|101463584|FG013|Overall Study|Radiographic progression|0|||
33430052|NCT02711956|101463585|FG014|Overall Study|Radiographic progression|1|||
33430053|NCT02711956|101463571|FG000|Overall Study|PSA progression with clinical progression|0|||
33430054|NCT02711956|101463572|FG001|Overall Study|PSA progression with clinical progression|0|||
33430055|NCT02711956|101463573|FG002|Overall Study|PSA progression with clinical progression|0|||
33430056|NCT02711956|101463574|FG003|Overall Study|PSA progression with clinical progression|0|||
33430057|NCT02711956|101463575|FG004|Overall Study|PSA progression with clinical progression|1|||
33430058|NCT02711956|101463576|FG005|Overall Study|PSA progression with clinical progression|0|||
33430059|NCT02711956|101463577|FG006|Overall Study|PSA progression with clinical progression|0|||
33430060|NCT02711956|101463578|FG007|Overall Study|PSA progression with clinical progression|0|||
33430061|NCT02711956|101463579|FG008|Overall Study|PSA progression with clinical progression|0|||
33430062|NCT02711956|101463580|FG009|Overall Study|PSA progression with clinical progression|0|||
33430063|NCT02711956|101463581|FG010|Overall Study|PSA progression with clinical progression|0|||
33430064|NCT02711956|101463582|FG011|Overall Study|PSA progression with clinical progression|0|||
33430065|NCT02711956|101463583|FG012|Overall Study|PSA progression with clinical progression|1|||
33430066|NCT02711956|101463584|FG013|Overall Study|PSA progression with clinical progression|1|||
33430067|NCT02711956|101463585|FG014|Overall Study|PSA progression with clinical progression|0|||
33430068|NCT02711956|101463571|FG000|Overall Study|PSA progression with radiographic progression|0|||
33430069|NCT02711956|101463572|FG001|Overall Study|PSA progression with radiographic progression|1|||
33430070|NCT02711956|101463573|FG002|Overall Study|PSA progression with radiographic progression|0|||
33430071|NCT02711956|101463574|FG003|Overall Study|PSA progression with radiographic progression|0|||
33430072|NCT02711956|101463575|FG004|Overall Study|PSA progression with radiographic progression|0|||
33430073|NCT02711956|101463576|FG005|Overall Study|PSA progression with radiographic progression|2|||
33430074|NCT02711956|101463577|FG006|Overall Study|PSA progression with radiographic progression|2|||
33430075|NCT02711956|101463578|FG007|Overall Study|PSA progression with radiographic progression|1|||
33430076|NCT02711956|101463579|FG008|Overall Study|PSA progression with radiographic progression|0|||
33430077|NCT02711956|101463580|FG009|Overall Study|PSA progression with radiographic progression|1|||
33430078|NCT02711956|101463581|FG010|Overall Study|PSA progression with radiographic progression|0|||
33430079|NCT02711956|101463582|FG011|Overall Study|PSA progression with radiographic progression|1|||
33430080|NCT02711956|101463583|FG012|Overall Study|PSA progression with radiographic progression|2|||
33430081|NCT02711956|101463584|FG013|Overall Study|PSA progression with radiographic progression|3|||
33430082|NCT02711956|101463585|FG014|Overall Study|PSA progression with radiographic progression|3|||
33430083|NCT01488578|101463589|FG000|Overall Study|Protocol Violation|1836|||
33430084|NCT00395083|101463593|FG000|Overall Study|Withdrawal by Subject|6|||
33430085|NCT00395083|101463594|FG001|Overall Study|Withdrawal by Subject|5|||
33430086|NCT00395083|101463593|FG000|Overall Study|Developed another disease|4|||
33430087|NCT00395083|101463594|FG001|Overall Study|Developed another disease|3|||
33430088|NCT02087046|101463595|FG000|Overall Study|Adverse Event|4|||
33430089|NCT02087046|101463595|FG000|Overall Study|Death|1|||
33430090|NCT02087046|101463595|FG000|Overall Study|Lost to Follow-up|3|||
33430091|NCT02087046|101463595|FG000|Overall Study|Withdrawal by Subject|2|||
33430092|NCT02087046|101463595|FG000|Overall Study|Physician Decision|1|||
33430093|NCT03008460|101463597|FG000|Overall Study|Protocol deviation|0|||
33430094|NCT03008460|101463598|FG001|Overall Study|Protocol deviation|2|||
33430095|NCT03008460|101463597|FG000|Overall Study|Study drug not dispensed|0|||
33430096|NCT03008460|101463598|FG001|Overall Study|Study drug not dispensed|1|||
33430097|NCT03008460|101463597|FG000|Overall Study|Adverse Event|0|||
33430098|NCT03008460|101463598|FG001|Overall Study|Adverse Event|1|||
33430099|NCT03008460|101463597|FG000|Overall Study|Withdrawal by Subject|5|||
33430100|NCT03008460|101463598|FG001|Overall Study|Withdrawal by Subject|6|||
33430101|NCT03008460|101463597|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
33430102|NCT03008460|101463598|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
33430103|NCT03008460|101463597|FG000|Overall Study|End of study visit outside permitted time window|0|||
33430104|NCT03008460|101463598|FG001|Overall Study|End of study visit outside permitted time window|1|||
33430105|NCT03008460|101463597|FG000|Overall Study|Lost to Follow-up|1|||
33430106|NCT03008460|101463598|FG001|Overall Study|Lost to Follow-up|3|||
33430107|NCT01703741|101463605|FG000|Overall Study|Withdrawal by Subject|6|||
33430108|NCT01703741|101463605|FG000|Overall Study|Adverse Event|2|||
33430109|NCT01703741|101463605|FG000|Overall Study|Physician Decision|2|||
33430110|NCT01703741|101463605|FG000|Overall Study|Protocol Violation|1|||
33430111|NCT01703741|101463605|FG000|Overall Study|Lost to Follow-up|3|||
33430112|NCT01703741|101463605|FG000|Overall Study|Subject did not want to continue|2|||
33430113|NCT01703741|101463605|FG000|Overall Study|Subject cannot comply with study visits|1|||
33430114|NCT01703741|101463605|FG000|Overall Study|Subject started testosterone injections|1|||
33430115|NCT00310856|101463608|FG000|Overall Study|Withdrawal by Subject|2|||
33430116|NCT00310856|101463609|FG001|Overall Study|Withdrawal by Subject|2|||
33430117|NCT00310856|101463610|FG002|Overall Study|Withdrawal by Subject|2|||
33430118|NCT00310856|101463608|FG000|Overall Study|Lost to Follow-up|1|||
33430119|NCT00310856|101463609|FG001|Overall Study|Lost to Follow-up|2|||
33430120|NCT00310856|101463610|FG002|Overall Study|Lost to Follow-up|6|||
33430121|NCT00310856|101463608|FG000|Overall Study|Inappropriate enrollment|1|||
33430122|NCT00310856|101463609|FG001|Overall Study|Inappropriate enrollment|1|||
33430123|NCT00310856|101463610|FG002|Overall Study|Inappropriate enrollment|0|||
33430124|NCT00310856|101463608|FG000|Overall Study|Unable to classify|1|||
33430125|NCT00310856|101463609|FG001|Overall Study|Unable to classify|0|||
33430126|NCT00310856|101463610|FG002|Overall Study|Unable to classify|0|||
33430127|NCT03273387|101463611|FG000|Overall Study|Death|2|||
33430128|NCT03273387|101463612|FG001|Overall Study|Death|2|||
33430129|NCT03273387|101463611|FG000|Overall Study|Withdrawal by Subject|1|||
33430130|NCT03273387|101463612|FG001|Overall Study|Withdrawal by Subject|1|||
33430131|NCT02737306|101463613|FG000|Overall Study|Adverse Event|3|||
33430132|NCT02737306|101463614|FG001|Overall Study|Adverse Event|0|||
33430133|NCT02737306|101463613|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
33430134|NCT02737306|101463614|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
33430135|NCT00712010|101463618|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
33430136|NCT03687125|101463619|FG000|Overall Study|Progressive Disease|2|||
33430137|NCT03687125|101463620|FG001|Overall Study|Progressive Disease|1|||
33430138|NCT03687125|101463619|FG000|Overall Study|Protocol Violation|1|||
33430139|NCT03687125|101463620|FG001|Overall Study|Protocol Violation|0|||
33430140|NCT02295774|101463624|FG000|Overall Study|Physician Decision|1|||
33430141|NCT02295774|101463624|FG000|Overall Study|Withdrawal by Subject|2|||
33430142|NCT05216978|101467262|FG000|Overall Study|Withdrawal by Subject|3|||
33430143|NCT05216978|101467262|FG000|Overall Study|Lost to Follow-up|5|||
33430144|NCT01620983|101467263|FG000|Overall Study|Lost to Follow-up|8|||
33430145|NCT01620983|101467264|FG001|Overall Study|Lost to Follow-up|4|||
33430146|NCT01620983|101467265|FG002|Overall Study|Lost to Follow-up|9|||
33430147|NCT01620983|101467263|FG000|Overall Study|Withdrawal by Subject|6|||
33430148|NCT01620983|101467264|FG001|Overall Study|Withdrawal by Subject|8|||
33587943|NCT03941873|102041712|FG000|Overall Study|Death|0|||
33430149|NCT01620983|101467265|FG002|Overall Study|Withdrawal by Subject|1|||
33430150|NCT01620983|101467263|FG000|Overall Study|Death|2|||
33430151|NCT01620983|101467264|FG001|Overall Study|Death|0|||
33430152|NCT01620983|101467265|FG002|Overall Study|Death|0|||
33430153|NCT01620983|101467263|FG000|Overall Study|Physician Decision|3|||
33430154|NCT01620983|101467264|FG001|Overall Study|Physician Decision|10|||
33430155|NCT01620983|101467265|FG002|Overall Study|Physician Decision|5|||
33430156|NCT04896385|101467270|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
33430157|NCT04896385|101467271|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
33430158|NCT04896385|101467272|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
33430159|NCT04896385|101467273|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
33430160|NCT04896385|101467270|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
33430161|NCT04896385|101467271|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
33430162|NCT04896385|101467272|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
33430163|NCT04896385|101467273|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
33430164|NCT04896385|101467270|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
33430165|NCT04896385|101467271|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
33430166|NCT04896385|101467272|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
33430167|NCT04896385|101467273|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
33430168|NCT04896385|101467270|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
33430169|NCT04896385|101467271|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
33430170|NCT04896385|101467272|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
33430171|NCT04896385|101467273|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
33430172|NCT04896385|101467270|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
33430173|NCT04896385|101467271|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
33430174|NCT04896385|101467272|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
33430175|NCT04896385|101467273|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
33430176|NCT04896385|101467270|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
33430177|NCT04896385|101467271|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
33430178|NCT04896385|101467272|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
33430179|NCT04896385|101467273|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
33430180|NCT01725113|101467274|FG000|Overall Study|Kidney Transplant|1|||
33430181|NCT01725113|101467275|FG001|Overall Study|Kidney Transplant|1|||
33430182|NCT01725113|101467274|FG000|Overall Study|Withdrawal by Subject|0|||
33430183|NCT01725113|101467275|FG001|Overall Study|Withdrawal by Subject|1|||
33430184|NCT03551730|101467276|FG000|Overall Study|Adverse Event|1|||
33430185|NCT03551730|101467277|FG001|Overall Study|Adverse Event|0|||
33430186|NCT03551730|101467278|FG002|Overall Study|Adverse Event|0|||
33430187|NCT03551730|101467279|FG003|Overall Study|Adverse Event|0|||
33430188|NCT00278512|101467282|FG000|Overall Study|Death|1|||
33430189|NCT00278512|101467283|FG001|Overall Study|Death|0|||
33430190|NCT01953783|101467284|FG000|Overall Study|Progressive disease|2|||
33430191|NCT02492958|101467285|FG000|Overall Study|Withdrawal by Subject|0|||
33430192|NCT02492958|101467286|FG001|Overall Study|Withdrawal by Subject|0|||
33430193|NCT02492958|101467287|FG002|Overall Study|Withdrawal by Subject|1|||
33430194|NCT02492958|101467288|FG003|Overall Study|Withdrawal by Subject|0|||
33430195|NCT02492958|101467285|FG000|Overall Study|Adverse Event|1|||
33430196|NCT02492958|101467286|FG001|Overall Study|Adverse Event|0|||
33430197|NCT02492958|101467287|FG002|Overall Study|Adverse Event|1|||
33430198|NCT02492958|101467288|FG003|Overall Study|Adverse Event|0|||
33430199|NCT01717456|101467292|FG000|End of Treatment|Physician Decision|0|||
33430200|NCT01717456|101467293|FG001|End of Treatment|Physician Decision|1|||
33430201|NCT01717456|101467292|FG000|End of Treatment|Lost to Follow-up|0|||
33430202|NCT01717456|101467293|FG001|End of Treatment|Lost to Follow-up|1|||
33430203|NCT01717456|101467292|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
33430204|NCT01717456|101467293|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
33430205|NCT02114931|101467294|FG000|Overall Study|Withdrawal by Subject|15|||
33430206|NCT02114931|101467295|FG001|Overall Study|Withdrawal by Subject|18|||
33430207|NCT02114931|101467294|FG000|Overall Study|Adverse Event|4|||
33430208|NCT02114931|101467295|FG001|Overall Study|Adverse Event|6|||
33430209|NCT02114931|101467294|FG000|Overall Study|Lost to Follow-up|3|||
33430210|NCT02114931|101467295|FG001|Overall Study|Lost to Follow-up|3|||
33430211|NCT02114931|101467294|FG000|Overall Study|Physician Decision|1|||
33430212|NCT02114931|101467295|FG001|Overall Study|Physician Decision|2|||
33430213|NCT02114931|101467294|FG000|Overall Study|Other|2|||
33430214|NCT02114931|101467295|FG001|Overall Study|Other|1|||
33430215|NCT04104646|101467296|FG000|Overall Study|Withdrawal by Subject|1|||
33430216|NCT04104646|101467297|FG001|Overall Study|Withdrawal by Subject|1|||
33430217|NCT04104646|101467296|FG000|Overall Study|Lost to Follow-up|1|||
33430218|NCT04104646|101467297|FG001|Overall Study|Lost to Follow-up|0|||
33430219|NCT04104646|101467296|FG000|Overall Study|Physician Decision|2|||
33430220|NCT04104646|101467297|FG001|Overall Study|Physician Decision|0|||
33430221|NCT01873859|101467298|FG000|Overall Study|Withdrawal by Subject|0|||
33430222|NCT01873859|101467299|FG001|Overall Study|Withdrawal by Subject|4|||
33248886|NCT03999554|100810355|FG002|Overall Study|Protocol Violation|5|||
33248887|NCT03999554|100810356|FG003|Overall Study|Protocol Violation|0|||
33248888|NCT03999554|100810357|FG004|Overall Study|Protocol Violation|0|||
33248889|NCT03999554|100810353|FG000|Overall Study|Pregnancy|0|||
33248890|NCT03999554|100810354|FG001|Overall Study|Pregnancy|0|||
33248891|NCT03999554|100810355|FG002|Overall Study|Pregnancy|1|||
33248892|NCT03999554|100810356|FG003|Overall Study|Pregnancy|0|||
33248893|NCT03999554|100810357|FG004|Overall Study|Pregnancy|0|||
33248894|NCT03999554|100810353|FG000|Overall Study|Withdrawal by Subject|2|||
33248895|NCT03999554|100810354|FG001|Overall Study|Withdrawal by Subject|2|||
33248896|NCT03999554|100810355|FG002|Overall Study|Withdrawal by Subject|2|||
33248897|NCT03999554|100810356|FG003|Overall Study|Withdrawal by Subject|1|||
33248898|NCT03999554|100810357|FG004|Overall Study|Withdrawal by Subject|1|||
33248899|NCT03999554|100810353|FG000|Overall Study|failure to comply with protocol requirements|0|||
33248900|NCT03999554|100810354|FG001|Overall Study|failure to comply with protocol requirements|0|||
33248901|NCT03999554|100810355|FG002|Overall Study|failure to comply with protocol requirements|0|||
33248902|NCT03999554|100810356|FG003|Overall Study|failure to comply with protocol requirements|1|||
33248903|NCT03999554|100810357|FG004|Overall Study|failure to comply with protocol requirements|0|||
33248904|NCT04880733|100810358|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
33248905|NCT04880733|100810359|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
33248906|NCT04880733|100810360|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
33248907|NCT04880733|100810358|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
33248908|NCT04880733|100810359|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
33248909|NCT04880733|100810360|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
33248910|NCT04880733|100810358|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
33248911|NCT04880733|100810359|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
33248912|NCT04880733|100810360|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
33248913|NCT04880733|100810358|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
33248914|NCT04880733|100810359|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
33248915|NCT04880733|100810360|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
33248916|NCT04880733|100810358|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
33248917|NCT04880733|100810359|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
33248918|NCT04880733|100810360|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
33248919|NCT04381494|100810361|FG000|Overall Study|Early termination of trial|19|||
33248920|NCT04381494|100810361|FG000|Overall Study|Investigator's discretion|1|||
33248921|NCT04381494|100810361|FG000|Overall Study|Withdrawal by Subject|9|||
33248922|NCT04381494|100810361|FG000|Overall Study|NSCLC disease progression|4|||
33248923|NCT04381494|100810361|FG000|Overall Study|Device-Related Adverse Event|2|||
33248924|NCT02163915|100810371|FG000|Overall Study|Withdrawal by Subject|2|||
33248925|NCT02163915|100810372|FG001|Overall Study|Withdrawal by Subject|0|||
33248926|NCT02163915|100810373|FG002|Overall Study|Withdrawal by Subject|2|||
33248927|NCT02163915|100810374|FG003|Overall Study|Withdrawal by Subject|2|||
33248928|NCT02163915|100810375|FG004|Overall Study|Withdrawal by Subject|2|||
33248929|NCT02163915|100810371|FG000|Overall Study|Study termination|1|||
33248930|NCT02163915|100810372|FG001|Overall Study|Study termination|0|||
33248931|NCT02163915|100810373|FG002|Overall Study|Study termination|0|||
33248932|NCT02163915|100810374|FG003|Overall Study|Study termination|0|||
33248933|NCT02163915|100810375|FG004|Overall Study|Study termination|2|||
33248934|NCT02163915|100810371|FG000|Overall Study|Physician Decision|0|||
33248935|NCT02163915|100810372|FG001|Overall Study|Physician Decision|0|||
33248936|NCT02163915|100810373|FG002|Overall Study|Physician Decision|0|||
33248937|NCT02163915|100810374|FG003|Overall Study|Physician Decision|1|||
33248938|NCT02163915|100810375|FG004|Overall Study|Physician Decision|0|||
33248939|NCT00130637|100810376|FG000|Overall Study|Adverse Event|2|||
33248940|NCT00130637|100810376|FG000|Overall Study|Withdrawal by Subject|1|||
33248941|NCT00906282|100810378|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
33248942|NCT00906282|100810378|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
33248943|NCT00906282|100810378|FG000|Preoperative Chemotherapy|Progressive disease|6|||
33587944|NCT03941873|102041713|FG001|Overall Study|Death|12|||
33647895|NCT02878798|102262860|FG000|Overall Study|Lost to Follow-up|2|||
33149658|NCT05182125|100463440|FG000|Overall Study|Death|0|||
33587945|NCT03941873|102041714|FG002|Overall Study|Death|2|||
33149659|NCT05182125|100463441|FG001|Overall Study|Death|0|||
33149660|NCT05182125|100463442|FG002|Overall Study|Death|0|||
33149661|NCT05182125|100463443|FG003|Overall Study|Death|0|||
33149662|NCT05182125|100463444|FG004|Overall Study|Death|1|||
33149663|NCT05182125|100463445|FG005|Overall Study|Death|0|||
33149664|NCT05182125|100463440|FG000|Overall Study|Health Contact Follow-up|5|||
33149665|NCT05182125|100463441|FG001|Overall Study|Health Contact Follow-up|5|||
33149666|NCT05182125|100463442|FG002|Overall Study|Health Contact Follow-up|2|||
33149667|NCT05182125|100463443|FG003|Overall Study|Health Contact Follow-up|9|||
33149668|NCT05182125|100463444|FG004|Overall Study|Health Contact Follow-up|7|||
33149669|NCT05182125|100463445|FG005|Overall Study|Health Contact Follow-up|2|||
33149670|NCT05298306|100463446|FG000|Overall Study|Physician Decision|0|||
33430223|NCT00671879|101467300|FG000|Overall Study|Withdrawal by Subject|0|||
33430224|NCT00671879|101467301|FG001|Overall Study|Withdrawal by Subject|4|||
33430225|NCT00671879|101467302|FG002|Overall Study|Withdrawal by Subject|6|||
33430226|NCT00384033|101467303|FG000|Overall Study|Adverse Event|10|||
33430227|NCT00384033|101467304|FG001|Overall Study|Adverse Event|8|||
33430228|NCT00384033|101467305|FG002|Overall Study|Adverse Event|11|||
33430229|NCT00384033|101467306|FG003|Overall Study|Adverse Event|20|||
33430230|NCT00384033|101467303|FG000|Overall Study|Failed to return|1|||
33430231|NCT00384033|101467304|FG001|Overall Study|Failed to return|3|||
33430232|NCT00384033|101467305|FG002|Overall Study|Failed to return|2|||
33430233|NCT00384033|101467306|FG003|Overall Study|Failed to return|2|||
33430234|NCT00384033|101467303|FG000|Overall Study|Physician Decision|1|||
33430235|NCT00384033|101467304|FG001|Overall Study|Physician Decision|0|||
33430236|NCT00384033|101467305|FG002|Overall Study|Physician Decision|0|||
33430237|NCT00384033|101467306|FG003|Overall Study|Physician Decision|0|||
33430238|NCT00384033|101467303|FG000|Overall Study|Lost to Follow-up|6|||
33430239|NCT00384033|101467304|FG001|Overall Study|Lost to Follow-up|12|||
33430240|NCT00384033|101467305|FG002|Overall Study|Lost to Follow-up|7|||
33430241|NCT00384033|101467306|FG003|Overall Study|Lost to Follow-up|7|||
33430242|NCT00384033|101467303|FG000|Overall Study|Other|2|||
33430243|NCT00384033|101467304|FG001|Overall Study|Other|0|||
33647896|NCT02878798|102262861|FG001|Overall Study|Lost to Follow-up|2|||
33647897|NCT02878798|102262860|FG000|Overall Study|Protocol Violation|0|||
33647898|NCT02878798|102262861|FG001|Overall Study|Protocol Violation|1|||
33383291|NCT00387348|101287793|FG002|Overall Study|Death|0|||
33383292|NCT00387348|101287791|FG000|Overall Study|Physician Decision|1|||
33383293|NCT00387348|101287792|FG001|Overall Study|Physician Decision|0|||
33383294|NCT00387348|101287793|FG002|Overall Study|Physician Decision|1|||
33383295|NCT00387348|101287791|FG000|Overall Study|Withdrawal by Subject|0|||
33383296|NCT00387348|101287792|FG001|Overall Study|Withdrawal by Subject|2|||
33383297|NCT00387348|101287793|FG002|Overall Study|Withdrawal by Subject|2|||
33383298|NCT00387348|101287791|FG000|Overall Study|Adverse Event|1|||
33383299|NCT00387348|101287792|FG001|Overall Study|Adverse Event|0|||
33383300|NCT00387348|101287793|FG002|Overall Study|Adverse Event|1|||
33383301|NCT00842361|101287796|FG000|Overall Study|Protocol Violation|1|||
33383302|NCT00842361|101287797|FG001|Overall Study|Protocol Violation|0|||
33383303|NCT00842361|101287796|FG000|Overall Study|Unclassified|0|||
33383304|NCT00842361|101287797|FG001|Overall Study|Unclassified|2|||
33383305|NCT01925612|101287798|FG000|Overall Study|Progressive Disease|1|||
33383306|NCT01925612|101287799|FG001|Overall Study|Progressive Disease|1|||
33383307|NCT01925612|101287800|FG002|Overall Study|Progressive Disease|1|||
33383308|NCT01925612|101287801|FG003|Overall Study|Progressive Disease|0|||
33383309|NCT01925612|101287802|FG004|Overall Study|Progressive Disease|0|||
33383310|NCT01925612|101287798|FG000|Overall Study|Adverse Event|3|||
33383311|NCT01925612|101287799|FG001|Overall Study|Adverse Event|3|||
33383312|NCT01925612|101287800|FG002|Overall Study|Adverse Event|0|||
33383313|NCT01925612|101287801|FG003|Overall Study|Adverse Event|1|||
33383314|NCT01925612|101287802|FG004|Overall Study|Adverse Event|2|||
33383315|NCT00628758|101287803|FG000|Overall Study|Adverse Event|2|||
33383316|NCT00628758|101287804|FG001|Overall Study|Adverse Event|3|||
33383317|NCT00628758|101287803|FG000|Overall Study|Withdrawal by Subject|6|||
33383318|NCT00628758|101287804|FG001|Overall Study|Withdrawal by Subject|3|||
33383319|NCT00628758|101287803|FG000|Overall Study|Death|1|||
33383320|NCT00628758|101287804|FG001|Overall Study|Death|0|||
33383321|NCT00628758|101287803|FG000|Overall Study|Protocol Violation|5|||
33383322|NCT00628758|101287804|FG001|Overall Study|Protocol Violation|1|||
33383323|NCT00628758|101287803|FG000|Overall Study|Lost to Follow-up|25|||
33383324|NCT00628758|101287804|FG001|Overall Study|Lost to Follow-up|31|||
33383325|NCT00628758|101287803|FG000|Overall Study|Pregnancy|2|||
33383326|NCT00628758|101287804|FG001|Overall Study|Pregnancy|2|||
33383327|NCT00628758|101287803|FG000|Overall Study|Investigator Moved|3|||
33383328|NCT00628758|101287804|FG001|Overall Study|Investigator Moved|0|||
33383329|NCT00628758|101287803|FG000|Overall Study|Treatment Failure|0|||
33383330|NCT00628758|101287804|FG001|Overall Study|Treatment Failure|2|||
33430244|NCT00384033|101467305|FG002|Overall Study|Other|0|||
33383331|NCT01957709|101287807|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
33383332|NCT04031404|101287810|FG000|Baseline|Lost to Follow-up|0|||
33430245|NCT00384033|101467306|FG003|Overall Study|Other|0|||
33430246|NCT00384033|101467303|FG000|Overall Study|Protocol Violation|5|||
33647899|NCT02471612|102262864|FG000|Overall Study|Lost to Follow-up|2|||
33647900|NCT01868542|102262865|FG000|Overall Study|Protocol Violation|0|||
33383333|NCT04031404|101287811|FG001|Baseline|Lost to Follow-up|1|||
33383334|NCT04031404|101287810|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
33383335|NCT04031404|101287811|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
33383336|NCT04031404|101287810|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
33430247|NCT00384033|101467304|FG001|Overall Study|Protocol Violation|0|||
33430248|NCT00384033|101467305|FG002|Overall Study|Protocol Violation|5|||
33383337|NCT04031404|101287811|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
33383338|NCT04031404|101287810|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
33430249|NCT00384033|101467306|FG003|Overall Study|Protocol Violation|6|||
33647901|NCT01868542|102262866|FG001|Overall Study|Protocol Violation|1|||
33647902|NCT01868542|102262865|FG000|Overall Study|Unclassified|0|||
33647903|NCT01868542|102262866|FG001|Overall Study|Unclassified|1|||
33647904|NCT02102204|102262868|FG000|Overall Study|Withdrawal by Subject|137|||
33383339|NCT04031404|101287811|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
33383340|NCT04031404|101287810|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
33383341|NCT04031404|101287811|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
33383342|NCT01019252|101287812|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
33383343|NCT01019252|101287813|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
33430250|NCT00384033|101467303|FG000|Overall Study|Withdrawal by Subject|6|||
33430251|NCT00384033|101467304|FG001|Overall Study|Withdrawal by Subject|2|||
33430252|NCT00384033|101467305|FG002|Overall Study|Withdrawal by Subject|5|||
33430253|NCT00384033|101467306|FG003|Overall Study|Withdrawal by Subject|2|||
33430254|NCT00384033|101467303|FG000|Overall Study|Lack of Efficacy|7|||
33430255|NCT00384033|101467304|FG001|Overall Study|Lack of Efficacy|3|||
33430256|NCT00384033|101467305|FG002|Overall Study|Lack of Efficacy|3|||
33430257|NCT00384033|101467306|FG003|Overall Study|Lack of Efficacy|1|||
33430258|NCT00384033|101467303|FG000|Overall Study|Randomized but not treated|3|||
33430259|NCT00384033|101467304|FG001|Overall Study|Randomized but not treated|7|||
33430260|NCT00384033|101467305|FG002|Overall Study|Randomized but not treated|10|||
33430261|NCT00384033|101467306|FG003|Overall Study|Randomized but not treated|2|||
33430262|NCT02669264|101467307|FG000|Overall Study|Death|5|||
33430263|NCT02669264|101467308|FG001|Overall Study|Death|5|||
33430264|NCT02669264|101467309|FG002|Overall Study|Death|3|||
33430265|NCT02669264|101467310|FG003|Overall Study|Death|3|||
33430266|NCT02669264|101467311|FG004|Overall Study|Death|3|||
33430267|NCT02669264|101467312|FG005|Overall Study|Death|6|||
33430268|NCT02669264|101467313|FG006|Overall Study|Death|3|||
33430269|NCT02669264|101467307|FG000|Overall Study|Withdrawal by Subject|0|||
33430270|NCT02669264|101467308|FG001|Overall Study|Withdrawal by Subject|1|||
33430271|NCT02669264|101467309|FG002|Overall Study|Withdrawal by Subject|0|||
33430272|NCT02669264|101467310|FG003|Overall Study|Withdrawal by Subject|0|||
33430273|NCT02669264|101467311|FG004|Overall Study|Withdrawal by Subject|1|||
33430274|NCT02669264|101467312|FG005|Overall Study|Withdrawal by Subject|0|||
33430275|NCT02669264|101467313|FG006|Overall Study|Withdrawal by Subject|0|||
33430276|NCT02669264|101467307|FG000|Overall Study|Lost to Follow-up|0|||
33430277|NCT02669264|101467308|FG001|Overall Study|Lost to Follow-up|0|||
33430278|NCT02669264|101467309|FG002|Overall Study|Lost to Follow-up|0|||
33430279|NCT02669264|101467310|FG003|Overall Study|Lost to Follow-up|0|||
33430280|NCT02669264|101467311|FG004|Overall Study|Lost to Follow-up|1|||
33430281|NCT02669264|101467312|FG005|Overall Study|Lost to Follow-up|0|||
33430282|NCT02669264|101467313|FG006|Overall Study|Lost to Follow-up|0|||
33430283|NCT02669264|101467307|FG000|Overall Study|Miscellaneous|0|||
33430284|NCT02669264|101467308|FG001|Overall Study|Miscellaneous|0|||
33430285|NCT02669264|101467309|FG002|Overall Study|Miscellaneous|0|||
33430286|NCT02669264|101467310|FG003|Overall Study|Miscellaneous|0|||
33430287|NCT02669264|101467311|FG004|Overall Study|Miscellaneous|0|||
33430288|NCT02669264|101467312|FG005|Overall Study|Miscellaneous|0|||
33430289|NCT02669264|101467313|FG006|Overall Study|Miscellaneous|2|||
33430290|NCT00368537|101467314|FG000|Randomization|No study drug dosed|13|||
33430291|NCT00368537|101467315|FG001|Randomization|No study drug dosed|6|||
33430292|NCT00368537|101467314|FG000|Baseline Participants|Lost to Follow-up|16|||
33430293|NCT00368537|101467315|FG001|Baseline Participants|Lost to Follow-up|17|||
33430294|NCT00368537|101467314|FG000|Baseline Participants|Withdrawal by Subject|6|||
33430295|NCT00368537|101467315|FG001|Baseline Participants|Withdrawal by Subject|4|||
33430296|NCT00368537|101467314|FG000|Baseline Participants|Death|1|||
33430297|NCT00368537|101467315|FG001|Baseline Participants|Death|2|||
33383344|NCT01019252|101287812|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
33383345|NCT01019252|101287813|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
33383346|NCT01019252|101287812|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
33383347|NCT01019252|101287813|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
33383348|NCT01019252|101287812|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
33430298|NCT00368537|101467314|FG000|Baseline Participants|No susceptibility|1|||
33647905|NCT02102204|102262868|FG000|Overall Study|Death|92|||
33647906|NCT02102204|102262868|FG000|Overall Study|Lost to Follow-up|65|||
33647907|NCT02102204|102262868|FG000|Overall Study|Sponsor Decision|5|||
33430299|NCT00368537|101467315|FG001|Baseline Participants|No susceptibility|0|||
33430300|NCT00368537|101467314|FG000|Baseline Participants|Patient uncompliant|0|||
33430301|NCT00368537|101467315|FG001|Baseline Participants|Patient uncompliant|1|||
33430302|NCT02668783|101467316|FG000|Overall Study|Pregnancy|0|||
33430303|NCT02668783|101467317|FG001|Overall Study|Pregnancy|1|||
33430304|NCT02668783|101467316|FG000|Overall Study|Protocol Violation|2|||
33430305|NCT02668783|101467317|FG001|Overall Study|Protocol Violation|1|||
33430306|NCT02668783|101467316|FG000|Overall Study|Study terminated by sponsor|9|||
33430307|NCT02668783|101467317|FG001|Overall Study|Study terminated by sponsor|10|||
33430308|NCT02668783|101467316|FG000|Overall Study|Subject moved|1|||
33430309|NCT02668783|101467317|FG001|Overall Study|Subject moved|0|||
33647908|NCT02102204|102262868|FG000|Overall Study|Ongoing|5|||
33430310|NCT02668783|101467316|FG000|Overall Study|Withdrawal by Subject|1|||
33430311|NCT02668783|101467317|FG001|Overall Study|Withdrawal by Subject|0|||
33430312|NCT00192296|101467327|FG000|Overall Study|Withdrawal by Subject|0|||
33430313|NCT00192296|101467328|FG001|Overall Study|Withdrawal by Subject|1|||
33430314|NCT00192296|101467329|FG002|Overall Study|Withdrawal by Subject|0|||
33430315|NCT00192296|101467330|FG003|Overall Study|Withdrawal by Subject|0|||
33430316|NCT01738581|101467333|FG000|Overall Study|Lost to Follow-up|1|||
33430317|NCT01738581|101467334|FG001|Overall Study|Lost to Follow-up|0|||
33430318|NCT00614055|101467335|FG000|Overall Study|Adverse Event|1|||
33430319|NCT00614055|101467336|FG001|Overall Study|Adverse Event|0|||
33430320|NCT00614055|101467337|FG002|Overall Study|Adverse Event|0|||
33430321|NCT00614055|101467335|FG000|Overall Study|Protocol Violation|2|||
33430322|NCT00614055|101467336|FG001|Overall Study|Protocol Violation|2|||
33430323|NCT00614055|101467337|FG002|Overall Study|Protocol Violation|1|||
33430324|NCT00614055|101467335|FG000|Overall Study|Lack of Efficacy|0|||
33430325|NCT00614055|101467336|FG001|Overall Study|Lack of Efficacy|0|||
33430326|NCT00614055|101467337|FG002|Overall Study|Lack of Efficacy|2|||
33430327|NCT00614055|101467335|FG000|Overall Study|Unclassified|1|||
33430328|NCT00614055|101467336|FG001|Overall Study|Unclassified|4|||
33430329|NCT00614055|101467337|FG002|Overall Study|Unclassified|2|||
33430330|NCT02853929|101467338|FG000|Overall Study|Lost to Follow-up|3|||
33430331|NCT02853929|101467339|FG001|Overall Study|Lost to Follow-up|0|||
33430332|NCT02853929|101467338|FG000|Overall Study|Withdrawal by Subject|1|||
33430333|NCT02853929|101467339|FG001|Overall Study|Withdrawal by Subject|0|||
33430334|NCT02853929|101467338|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
33430335|NCT02853929|101467339|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
33430336|NCT01808209|101467342|FG000|Overall Study|Lost to Follow-up|0|||
33430337|NCT01808209|101467343|FG001|Overall Study|Lost to Follow-up|1|||
33430338|NCT02115256|101467345|FG000|Overall Study|Withdrawal by Subject|0|||
33430339|NCT02115256|101467346|FG001|Overall Study|Withdrawal by Subject|1|||
33430340|NCT01793610|101467347|FG000|Overall Study|Withdrawal by Subject|1|||
33430341|NCT01793610|101467348|FG001|Overall Study|Withdrawal by Subject|0|||
33430342|NCT01793610|101467349|FG002|Overall Study|Withdrawal by Subject|1|||
33430343|NCT01618266|101467352|FG000|Overall Study|Lost to Follow-up|9|||
33430344|NCT01618266|101467352|FG000|Overall Study|Treatment satisfaction|10|||
33430345|NCT01618266|101467352|FG000|Overall Study|Other reasons|11|||
33430346|NCT01618266|101467352|FG000|Overall Study|Lack of Efficacy|23|||
33430347|NCT01618266|101467352|FG000|Overall Study|Protocol Violation|43|||
33383349|NCT01019252|101287813|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
33383350|NCT01359046|101287814|FG000|Overall Study|Did not receive allocated intervention|6|||
33383351|NCT01359046|101287815|FG001|Overall Study|Did not receive allocated intervention|6|||
33383352|NCT01359046|101287814|FG000|Overall Study|Physician Decision|1|||
33383353|NCT01359046|101287815|FG001|Overall Study|Physician Decision|11|||
33383354|NCT02031432|101287829|FG000|Overall Study|Protocol Violation|1|||
33383355|NCT02031432|101287829|FG000|Overall Study|Lack of Efficacy|5|||
33383356|NCT02031432|101287829|FG000|Overall Study|Cancer Progression|2|||
33383357|NCT02031432|101287829|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
33383358|NCT02031432|101287829|FG000|Overall Study|Adverse Event|8|||
33383359|NCT02031432|101287829|FG000|Overall Study|Withdrawal by Subject|5|||
33383360|NCT02031432|101287829|FG000|Overall Study|Lost to Follow-up|1|||
33383361|NCT02031432|101287829|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
33383362|NCT02031432|101287829|FG000|Overall Study|Death|10|||
33383363|NCT03819218|101287830|FG000|Overall Study|Protocol Violation|1|||
33383364|NCT00830960|101287831|FG000|Overall Study|Death|5|||
33383365|NCT00830960|101287832|FG001|Overall Study|Death|4|||
33383366|NCT00830960|101287833|FG002|Overall Study|Death|3|||
33383367|NCT00830960|101287834|FG003|Overall Study|Death|2|||
33383368|NCT00830960|101287835|FG004|Overall Study|Death|6|||
33430348|NCT00988169|101467356|FG000|Overall Study|Withdrawal by Subject|1|||
33430349|NCT00753714|101467359|FG000|Overall Study|Lack of Efficacy|21|||
33430350|NCT00753714|101467360|FG001|Overall Study|Lack of Efficacy|34|||
33430351|NCT00753714|101467359|FG000|Overall Study|Adverse Event|26|||
33430352|NCT00753714|101467360|FG001|Overall Study|Adverse Event|18|||
33430353|NCT00753714|101467359|FG000|Overall Study|Protocol Violation|1|||
33430354|NCT00753714|101467360|FG001|Overall Study|Protocol Violation|0|||
33383369|NCT00830960|101287836|FG005|Overall Study|Death|1|||
33383370|NCT00830960|101287831|FG000|Overall Study|Lost to Follow-up|1|||
33383371|NCT00830960|101287832|FG001|Overall Study|Lost to Follow-up|1|||
33383372|NCT00830960|101287833|FG002|Overall Study|Lost to Follow-up|1|||
33383373|NCT00830960|101287834|FG003|Overall Study|Lost to Follow-up|0|||
33383374|NCT00830960|101287835|FG004|Overall Study|Lost to Follow-up|0|||
33383375|NCT00830960|101287836|FG005|Overall Study|Lost to Follow-up|1|||
33430355|NCT00753714|101467359|FG000|Overall Study|Lost to Follow-up|0|||
33430356|NCT00753714|101467360|FG001|Overall Study|Lost to Follow-up|1|||
33430357|NCT00753714|101467359|FG000|Overall Study|Withdrawal by Subject|2|||
33430358|NCT00753714|101467360|FG001|Overall Study|Withdrawal by Subject|1|||
33430359|NCT00753714|101467359|FG000|Overall Study|Death|3|||
33430360|NCT00753714|101467360|FG001|Overall Study|Death|3|||
33430361|NCT00753714|101467359|FG000|Overall Study|Other|7|||
33647909|NCT01915303|102262872|FG000|Core Phase|Adverse Event|7|||
33647910|NCT01915303|102262872|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
33647911|NCT01915303|102262872|FG000|Core Phase|Death|2|||
33647912|NCT01915303|102262872|FG000|Core Phase|Protocol Violation|2|||
33647913|NCT01915303|102262872|FG000|Core Phase|Abnormal lab value|1|||
33647914|NCT01915303|102262872|FG000|Core Phase|Withdrawal by Subject|1|||
33647915|NCT01915303|102262872|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
33647916|NCT01915303|102262872|FG000|Extension Phase|Withdrawal by Subject|4|||
33647917|NCT01915303|102262872|FG000|Extension Phase|Adverse Event|3|||
33647918|NCT01915303|102262872|FG000|Extension Phase|Death|1|||
33647919|NCT01915303|102262872|FG000|Extension Phase|Protocol Violation|1|||
33647920|NCT00773838|102262873|FG000|Overall Study|Adverse Event|29|||
33647921|NCT00773838|102262873|FG000|Overall Study|Lost to Follow-up|1|||
33647922|NCT00773838|102262873|FG000|Overall Study|Physician Decision|8|||
33647923|NCT00773838|102262873|FG000|Overall Study|Progressive Disease|82|||
33647924|NCT00773838|102262873|FG000|Overall Study|Protocol Violation|2|||
33647925|NCT00773838|102262873|FG000|Overall Study|Withdrawal by Subject|21|||
33647926|NCT04881942|102262874|FG000|Overall Study|Adverse Event|0|||
33647927|NCT04881942|102262875|FG001|Overall Study|Adverse Event|0|||
33647928|NCT04881942|102262876|FG002|Overall Study|Adverse Event|0|||
33647929|NCT04881942|102262877|FG003|Overall Study|Adverse Event|0|||
33647930|NCT04881942|102262878|FG004|Overall Study|Adverse Event|1|||
33647931|NCT04881942|102262874|FG000|Overall Study|Alternates|0|||
33647932|NCT04881942|102262875|FG001|Overall Study|Alternates|0|||
33647933|NCT04881942|102262876|FG002|Overall Study|Alternates|0|||
33647934|NCT04881942|102262877|FG003|Overall Study|Alternates|0|||
33647935|NCT04881942|102262878|FG004|Overall Study|Alternates|2|||
33647936|NCT03887702|102262879|FG000|Overall Study|Study terminated|0|||
33647937|NCT03887702|102262880|FG001|Overall Study|Study terminated|0|||
33647938|NCT03887702|102262881|FG002|Overall Study|Study terminated|2|||
33647939|NCT03887702|102262882|FG003|Overall Study|Study terminated|2|||
33647940|NCT00606905|102262883|FG000|Overall Study|No Pregnancy|9|||
33647941|NCT00606905|102262884|FG001|Overall Study|No Pregnancy|6|||
33647942|NCT00606905|102262883|FG000|Overall Study|Non-Index Pregnancy|1|||
33647943|NCT00606905|102262884|FG001|Overall Study|Non-Index Pregnancy|4|||
33647944|NCT00606905|102262883|FG000|Overall Study|Withdrew|5|||
33647945|NCT00606905|102262884|FG001|Overall Study|Withdrew|5|||
33647946|NCT00233454|102262885|FG000|Overall Study|Death|6|||
33647947|NCT00701662|102262889|FG000|Overall Study|Lack of Efficacy|1|||
33647948|NCT03830892|102262890|FG000|Overall Study|Physician Decision|2|||
33647949|NCT03830892|102262891|FG001|Overall Study|Physician Decision|3|||
33647950|NCT03830892|102262890|FG000|Overall Study|Study terminated due to COVID|4|||
33647951|NCT03830892|102262891|FG001|Overall Study|Study terminated due to COVID|0|||
33647952|NCT03830892|102262890|FG000|Overall Study|Protocol Violation|0|||
33647953|NCT03830892|102262891|FG001|Overall Study|Protocol Violation|1|||
33647954|NCT03830892|102262890|FG000|Overall Study|Withdrawal by Subject|0|||
33647955|NCT03830892|102262891|FG001|Overall Study|Withdrawal by Subject|2|||
33248944|NCT00906282|100810378|FG000|Preoperative Chemotherapy|Toxicity|1|||
33248945|NCT04555044|100810383|FG000|Overall Study|Adverse Event|0|||
33248946|NCT04555044|100810384|FG001|Overall Study|Adverse Event|1|||
33248947|NCT05460663|100810386|FG000|Overall Study|Withdrawal by Subject|2|||
33248948|NCT05460663|100810387|FG001|Overall Study|Withdrawal by Subject|5|||
33248949|NCT00299702|100810388|FG000|Overall Study|Death|1|||
33248950|NCT00299702|100810389|FG001|Overall Study|Death|0|||
33248951|NCT00299702|100810388|FG000|Overall Study|Adverse Event|0|||
33248952|NCT00299702|100810389|FG001|Overall Study|Adverse Event|4|||
33248953|NCT00299702|100810388|FG000|Overall Study|Lost to Follow-up|18|||
33248954|NCT00299702|100810389|FG001|Overall Study|Lost to Follow-up|10|||
33248955|NCT00299702|100810388|FG000|Overall Study|Withdrawal by Subject|25|||
33248956|NCT00299702|100810389|FG001|Overall Study|Withdrawal by Subject|23|||
33248957|NCT00299702|100810388|FG000|Overall Study|Pregnancy|0|||
33248958|NCT00299702|100810389|FG001|Overall Study|Pregnancy|1|||
33248959|NCT00299702|100810388|FG000|Overall Study|Insufficient Response|4|||
33647956|NCT02466659|102262892|FG000|Overall Study|Lost to Follow-up|5|||
33647957|NCT02466659|102262893|FG001|Overall Study|Lost to Follow-up|2|||
33248960|NCT00299702|100810389|FG001|Overall Study|Insufficient Response|3|||
33248961|NCT00299702|100810388|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
33647958|NCT01478048|102262894|FG000|Overall Study|Disease Progression|52|||
33647959|NCT01478048|102262895|FG001|Overall Study|Disease Progression|35|||
33647960|NCT01478048|102262894|FG000|Overall Study|study drug toxicity|11|||
33647961|NCT01478048|102262895|FG001|Overall Study|study drug toxicity|14|||
33647962|NCT01478048|102262894|FG000|Overall Study|Adverse Event|2|||
33647963|NCT01478048|102262895|FG001|Overall Study|Adverse Event|11|||
33647964|NCT01478048|102262894|FG000|Overall Study|subject request to discontinue treatment|3|||
33248962|NCT00299702|100810389|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
33248963|NCT03255018|100810390|FG000|Overall Study|Death on study|0|||
33248964|NCT03255018|100810391|FG001|Overall Study|Death on study|5|||
33647965|NCT01478048|102262895|FG001|Overall Study|subject request to discontinue treatment|5|||
33647966|NCT01478048|102262894|FG000|Overall Study|Withdrawal by Subject|2|||
33647967|NCT01478048|102262895|FG001|Overall Study|Withdrawal by Subject|5|||
33430362|NCT00753714|101467360|FG001|Overall Study|Other|5|||
33430363|NCT01405950|101467361|FG000|Overall Study|Withdrawal by Subject|1|||
33430364|NCT01405950|101467362|FG001|Overall Study|Withdrawal by Subject|0|||
33430365|NCT01405950|101467363|FG002|Overall Study|Withdrawal by Subject|0|||
33430366|NCT01405950|101467364|FG003|Overall Study|Withdrawal by Subject|0|||
33430367|NCT02087059|101467369|FG000|Overall Study|Disease Progression|1|||
33430368|NCT02087059|101467369|FG000|Overall Study|Adverse Event|5|||
33430369|NCT02087059|101467369|FG000|Overall Study|Lost to Follow-up|1|||
33430370|NCT03349333|101467371|FG000|Overall Study|Progression of Disease|36|||
33430371|NCT03349333|101467371|FG000|Overall Study|Adverse Event|11|||
33430372|NCT03349333|101467371|FG000|Overall Study|Other|6|||
33430373|NCT03349333|101467371|FG000|Overall Study|Withdrawal by Subject|5|||
33430374|NCT03349333|101467371|FG000|Overall Study|Conditions interfere with participation|2|||
33430375|NCT03349333|101467371|FG000|Overall Study|Physician Decision|2|||
33430376|NCT03349333|101467371|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
33430377|NCT03349333|101467371|FG000|Overall Study|Patients in treatment less than 24 month|8|||
33430378|NCT02419313|101467372|FG000|First Intervention|Lost to Follow-up|2|||
33430379|NCT02419313|101467373|FG001|First Intervention|Lost to Follow-up|0|||
33430380|NCT02419313|101467372|FG000|Second Intervention|Lost to Follow-up|1|||
33430381|NCT02419313|101467373|FG001|Second Intervention|Lost to Follow-up|0|||
33430382|NCT01393990|101467374|FG000|Overall Study|Adverse Event|0|||
33430383|NCT01393990|101467375|FG001|Overall Study|Adverse Event|0|||
33430384|NCT01393990|101467376|FG002|Overall Study|Adverse Event|0|||
33430385|NCT01393990|101467377|FG003|Overall Study|Adverse Event|0|||
33430386|NCT01393990|101467378|FG004|Overall Study|Adverse Event|0|||
33430387|NCT01393990|101467379|FG005|Overall Study|Adverse Event|0|||
33430388|NCT01393990|101467380|FG006|Overall Study|Adverse Event|0|||
33430389|NCT01393990|101467381|FG007|Overall Study|Adverse Event|0|||
33430390|NCT01393990|101467382|FG008|Overall Study|Adverse Event|0|||
33430391|NCT01393990|101467383|FG009|Overall Study|Adverse Event|0|||
33430392|NCT01393990|101467384|FG010|Overall Study|Adverse Event|0|||
33430393|NCT01393990|101467385|FG011|Overall Study|Adverse Event|0|||
33430394|NCT01393990|101467386|FG012|Overall Study|Adverse Event|0|||
33430395|NCT01393990|101467387|FG013|Overall Study|Adverse Event|0|||
33430396|NCT01393990|101467388|FG014|Overall Study|Adverse Event|1|||
33430397|NCT01393990|101467389|FG015|Overall Study|Adverse Event|1|||
33430398|NCT01393990|101467390|FG016|Overall Study|Adverse Event|0|||
33430399|NCT01393990|101467391|FG017|Overall Study|Adverse Event|0|||
33430400|NCT01393990|101467374|FG000|Overall Study|Progressive Disease|1|||
33430401|NCT01393990|101467375|FG001|Overall Study|Progressive Disease|0|||
33430402|NCT01393990|101467376|FG002|Overall Study|Progressive Disease|0|||
33430403|NCT01393990|101467377|FG003|Overall Study|Progressive Disease|1|||
33430404|NCT01393990|101467378|FG004|Overall Study|Progressive Disease|1|||
33430405|NCT01393990|101467379|FG005|Overall Study|Progressive Disease|1|||
33430406|NCT01393990|101467380|FG006|Overall Study|Progressive Disease|1|||
33430407|NCT01393990|101467381|FG007|Overall Study|Progressive Disease|1|||
33430408|NCT01393990|101467382|FG008|Overall Study|Progressive Disease|3|||
33430409|NCT01393990|101467383|FG009|Overall Study|Progressive Disease|1|||
33430410|NCT01393990|101467384|FG010|Overall Study|Progressive Disease|0|||
33430411|NCT01393990|101467385|FG011|Overall Study|Progressive Disease|0|||
33430412|NCT01393990|101467386|FG012|Overall Study|Progressive Disease|0|||
33430413|NCT01393990|101467387|FG013|Overall Study|Progressive Disease|1|||
33430414|NCT01393990|101467388|FG014|Overall Study|Progressive Disease|6|||
33430415|NCT01393990|101467389|FG015|Overall Study|Progressive Disease|1|||
33430416|NCT01393990|101467390|FG016|Overall Study|Progressive Disease|0|||
33430417|NCT01393990|101467391|FG017|Overall Study|Progressive Disease|0|||
33430418|NCT01393990|101467374|FG000|Overall Study|Death|0|||
33430419|NCT01393990|101467375|FG001|Overall Study|Death|0|||
33430420|NCT01393990|101467376|FG002|Overall Study|Death|0|||
33430421|NCT01393990|101467377|FG003|Overall Study|Death|0|||
33430422|NCT01393990|101467378|FG004|Overall Study|Death|1|||
33430423|NCT01393990|101467379|FG005|Overall Study|Death|0|||
33430424|NCT01393990|101467380|FG006|Overall Study|Death|0|||
33430425|NCT01393990|101467381|FG007|Overall Study|Death|0|||
33430426|NCT01393990|101467382|FG008|Overall Study|Death|0|||
33430427|NCT01393990|101467383|FG009|Overall Study|Death|0|||
33430428|NCT01393990|101467384|FG010|Overall Study|Death|0|||
33430429|NCT01393990|101467385|FG011|Overall Study|Death|0|||
33430430|NCT01393990|101467386|FG012|Overall Study|Death|0|||
33430431|NCT01393990|101467387|FG013|Overall Study|Death|1|||
33430432|NCT01393990|101467388|FG014|Overall Study|Death|1|||
33430433|NCT01393990|101467389|FG015|Overall Study|Death|0|||
33430434|NCT01393990|101467390|FG016|Overall Study|Death|0|||
33430435|NCT01393990|101467391|FG017|Overall Study|Death|0|||
33430436|NCT01393990|101467374|FG000|Overall Study|Withdrawal by Subject|0|||
33430437|NCT01393990|101467375|FG001|Overall Study|Withdrawal by Subject|0|||
33430438|NCT01393990|101467376|FG002|Overall Study|Withdrawal by Subject|0|||
33430439|NCT01393990|101467377|FG003|Overall Study|Withdrawal by Subject|0|||
33430440|NCT01393990|101467378|FG004|Overall Study|Withdrawal by Subject|0|||
33430441|NCT01393990|101467379|FG005|Overall Study|Withdrawal by Subject|0|||
33430442|NCT01393990|101467380|FG006|Overall Study|Withdrawal by Subject|0|||
33430443|NCT01393990|101467381|FG007|Overall Study|Withdrawal by Subject|0|||
33430444|NCT01393990|101467382|FG008|Overall Study|Withdrawal by Subject|0|||
33430445|NCT01393990|101467383|FG009|Overall Study|Withdrawal by Subject|0|||
33430446|NCT01393990|101467384|FG010|Overall Study|Withdrawal by Subject|0|||
33430447|NCT01393990|101467385|FG011|Overall Study|Withdrawal by Subject|0|||
33430448|NCT01393990|101467386|FG012|Overall Study|Withdrawal by Subject|0|||
33430449|NCT01393990|101467387|FG013|Overall Study|Withdrawal by Subject|0|||
33430450|NCT01393990|101467388|FG014|Overall Study|Withdrawal by Subject|1|||
33430451|NCT01393990|101467389|FG015|Overall Study|Withdrawal by Subject|1|||
33430452|NCT01393990|101467390|FG016|Overall Study|Withdrawal by Subject|0|||
33430453|NCT01393990|101467391|FG017|Overall Study|Withdrawal by Subject|0|||
33430454|NCT03072459|101467396|FG000|Overall Study|Device revised/removed|1|||
33430455|NCT03072459|101467396|FG000|Overall Study|Subject not able to return|1|||
33430456|NCT00906347|101467397|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
33430457|NCT00906347|101467398|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
33248965|NCT03255018|100810390|FG000|Overall Study|Withdrawal by Subject|0|||
33248966|NCT03255018|100810391|FG001|Overall Study|Withdrawal by Subject|2|||
33248967|NCT00957229|100810392|FG000|Study Start|Adverse Event|0|||
33248968|NCT00957229|100810393|FG001|Study Start|Adverse Event|3|||
33248969|NCT00957229|100810392|FG000|Study Start|Disease Progression|1|||
33248970|NCT00957229|100810393|FG001|Study Start|Disease Progression|0|||
33248971|NCT00957229|100810392|FG000|Reallocated to or Continued Vismodegib|Death|1|||
33248972|NCT00957229|100810393|FG001|Reallocated to or Continued Vismodegib|Death|1|||
33248973|NCT00957229|100810392|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
33248974|NCT00957229|100810393|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
33248975|NCT01467700|100810394|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
33248976|NCT01467700|100810395|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
33248977|NCT01467700|100810396|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
33248978|NCT01467700|100810397|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
33248979|NCT01467700|100810394|FG000|Overall Study|Major Protocol Deviation|3|||
33248980|NCT01467700|100810395|FG001|Overall Study|Major Protocol Deviation|3|||
33248981|NCT01467700|100810396|FG002|Overall Study|Major Protocol Deviation|2|||
33248982|NCT01467700|100810397|FG003|Overall Study|Major Protocol Deviation|3|||
33248983|NCT01467700|100810394|FG000|Overall Study|Lost to Follow-up|6|||
33248984|NCT01467700|100810395|FG001|Overall Study|Lost to Follow-up|5|||
33248985|NCT01467700|100810396|FG002|Overall Study|Lost to Follow-up|2|||
33248986|NCT01467700|100810397|FG003|Overall Study|Lost to Follow-up|3|||
33248987|NCT01467700|100810394|FG000|Overall Study|Voluntary Withdrawal|5|||
33248988|NCT01467700|100810395|FG001|Overall Study|Voluntary Withdrawal|7|||
33248989|NCT01467700|100810396|FG002|Overall Study|Voluntary Withdrawal|6|||
33248990|NCT01467700|100810397|FG003|Overall Study|Voluntary Withdrawal|2|||
33248991|NCT01467700|100810394|FG000|Overall Study|Study Termination|6|||
33248992|NCT01467700|100810395|FG001|Overall Study|Study Termination|5|||
33248993|NCT01467700|100810396|FG002|Overall Study|Study Termination|10|||
33248994|NCT01467700|100810397|FG003|Overall Study|Study Termination|7|||
33383376|NCT00830960|101287831|FG000|Overall Study|Withdrawal by Subject|19|||
33383377|NCT00830960|101287832|FG001|Overall Study|Withdrawal by Subject|19|||
33383378|NCT00830960|101287833|FG002|Overall Study|Withdrawal by Subject|18|||
33383379|NCT00830960|101287834|FG003|Overall Study|Withdrawal by Subject|23|||
33383380|NCT00830960|101287835|FG004|Overall Study|Withdrawal by Subject|16|||
33383381|NCT00830960|101287836|FG005|Overall Study|Withdrawal by Subject|21|||
33383382|NCT00830960|101287831|FG000|Overall Study|Sponsor Decision|1|||
33383383|NCT00830960|101287832|FG001|Overall Study|Sponsor Decision|2|||
33383384|NCT00830960|101287833|FG002|Overall Study|Sponsor Decision|3|||
33383385|NCT00830960|101287834|FG003|Overall Study|Sponsor Decision|4|||
33383386|NCT00830960|101287835|FG004|Overall Study|Sponsor Decision|5|||
33383387|NCT00830960|101287836|FG005|Overall Study|Sponsor Decision|7|||
33383388|NCT00830960|101287831|FG000|Overall Study|No study drug received|7|||
33383389|NCT00830960|101287832|FG001|Overall Study|No study drug received|2|||
33383390|NCT00830960|101287833|FG002|Overall Study|No study drug received|4|||
33383391|NCT00830960|101287834|FG003|Overall Study|No study drug received|3|||
33383392|NCT00830960|101287835|FG004|Overall Study|No study drug received|5|||
33383393|NCT00830960|101287836|FG005|Overall Study|No study drug received|7|||
33383394|NCT04685499|101287837|FG000|Overall Study|Study Terminated Early|1|||
33383395|NCT00871377|101287841|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
33383396|NCT00871377|101287842|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
33383397|NCT00871377|101287843|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
33383398|NCT00871377|101287844|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
33383399|NCT00871377|101287845|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
33383400|NCT00871377|101287846|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
33383401|NCT00871377|101287841|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
33383402|NCT00871377|101287842|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
33383403|NCT00871377|101287843|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
33383404|NCT00871377|101287844|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
33430458|NCT00906347|101467397|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
33430459|NCT00906347|101467398|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
33430460|NCT00906347|101467397|FG000|Received Study Drug|Refused study drug|1|||
33430461|NCT00906347|101467398|FG001|Received Study Drug|Refused study drug|0|||
33430462|NCT00906347|101467397|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
33430463|NCT00906347|101467398|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
33430464|NCT02322879|101467403|FG000|First Intervention|Physician Decision|1|||
33430465|NCT02322879|101467404|FG001|First Intervention|Physician Decision|0|||
33430466|NCT02473510|101467406|FG000|Overall Study|Lost to Follow-up|1|||
33430467|NCT02473510|101467407|FG001|Overall Study|Lost to Follow-up|2|||
33430468|NCT00606684|101467422|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
33430469|NCT00606684|101467423|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
33430470|NCT00606684|101467424|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
33430471|NCT00606684|101467425|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
33430472|NCT00606684|101467426|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
33430473|NCT00606684|101467427|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
33430474|NCT00606684|101467428|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
33430475|NCT00606684|101467422|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
33430476|NCT00606684|101467423|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
33430477|NCT00606684|101467424|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
33430478|NCT00606684|101467425|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
33430479|NCT00606684|101467426|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
33430480|NCT00606684|101467427|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
33430481|NCT00606684|101467428|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
33430482|NCT00606684|101467422|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
33430483|NCT00606684|101467423|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
33430484|NCT00606684|101467424|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
33430485|NCT00606684|101467425|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
33430486|NCT00606684|101467426|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
33430487|NCT00606684|101467427|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
33430488|NCT00606684|101467428|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
33430489|NCT00606684|101467422|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
33430490|NCT00606684|101467423|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
33430491|NCT00606684|101467424|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
33430492|NCT00606684|101467425|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
33430493|NCT00606684|101467426|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
33430494|NCT00606684|101467427|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
33430495|NCT00606684|101467428|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
33430496|NCT00606684|101467422|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
33430497|NCT00606684|101467423|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
33430498|NCT00606684|101467424|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
33430499|NCT00606684|101467425|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
33430500|NCT00606684|101467426|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
33430501|NCT00606684|101467427|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
33430502|NCT00606684|101467428|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
33430503|NCT00606684|101467422|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
33430504|NCT00606684|101467423|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
33430505|NCT00606684|101467424|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
33430506|NCT00606684|101467425|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
33430507|NCT00606684|101467426|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
33430508|NCT00606684|101467427|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
33430509|NCT00606684|101467428|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
33430510|NCT00606684|101467422|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
33430511|NCT00606684|101467423|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
33430512|NCT00606684|101467424|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
33430513|NCT00606684|101467425|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
33430514|NCT00606684|101467426|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
33430515|NCT00606684|101467427|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
33430516|NCT00606684|101467428|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
33430517|NCT00606684|101467422|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33430518|NCT00606684|101467423|FG001|Double-Blind Treatment Period|Adverse Event|3|||
33430519|NCT00606684|101467424|FG002|Double-Blind Treatment Period|Adverse Event|2|||
33430520|NCT00606684|101467425|FG003|Double-Blind Treatment Period|Adverse Event|4|||
33430521|NCT00606684|101467426|FG004|Double-Blind Treatment Period|Adverse Event|2|||
33647968|NCT01478048|102262894|FG000|Overall Study|non-specified|6|||
33647969|NCT01478048|102262895|FG001|Overall Study|non-specified|4|||
33430522|NCT00606684|101467427|FG005|Double-Blind Treatment Period|Adverse Event|0|||
33430523|NCT00606684|101467428|FG006|Double-Blind Treatment Period|Adverse Event|1|||
33430524|NCT00606684|101467422|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
33430525|NCT00606684|101467423|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
33430526|NCT00606684|101467424|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
33430527|NCT00606684|101467425|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
33430528|NCT00606684|101467426|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
33430529|NCT00606684|101467427|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
33430530|NCT00606684|101467428|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
33430531|NCT00606684|101467422|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
33430532|NCT00606684|101467423|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
33430533|NCT00606684|101467424|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
33430534|NCT00606684|101467425|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
33430535|NCT00606684|101467426|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
33430536|NCT00606684|101467427|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
33430537|NCT00606684|101467428|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
33430538|NCT00606684|101467422|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
33430539|NCT00606684|101467423|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
33430540|NCT00606684|101467424|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
33430541|NCT00606684|101467425|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
33430542|NCT00606684|101467426|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
33430543|NCT00606684|101467427|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
33430544|NCT00606684|101467428|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
33430545|NCT00606684|101467422|FG000|Double-Blind Treatment Period|Physician Decision|0|||
33430546|NCT00606684|101467423|FG001|Double-Blind Treatment Period|Physician Decision|5|||
33430547|NCT00606684|101467424|FG002|Double-Blind Treatment Period|Physician Decision|1|||
33430548|NCT00606684|101467425|FG003|Double-Blind Treatment Period|Physician Decision|0|||
33430549|NCT00606684|101467426|FG004|Double-Blind Treatment Period|Physician Decision|3|||
33430550|NCT00606684|101467427|FG005|Double-Blind Treatment Period|Physician Decision|1|||
33430551|NCT00606684|101467428|FG006|Double-Blind Treatment Period|Physician Decision|2|||
33430552|NCT00606684|101467422|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33430553|NCT00606684|101467423|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33430554|NCT00606684|101467424|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33430555|NCT00606684|101467425|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
33430556|NCT00606684|101467426|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33430557|NCT00606684|101467427|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
33430558|NCT00606684|101467428|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33430559|NCT03487796|101467429|FG000|Overall Study|Lost to Follow-up|18|||
33430560|NCT03487796|101467430|FG001|Overall Study|Lost to Follow-up|6|||
33430561|NCT02008721|101467431|FG000|Overall Study|Withdrawal by Subject|5|||
33430562|NCT02008721|101467432|FG001|Overall Study|Withdrawal by Subject|1|||
33430563|NCT02008721|101467431|FG000|Overall Study|Death|4|||
33430564|NCT02008721|101467432|FG001|Overall Study|Death|2|||
33430565|NCT02008721|101467431|FG000|Overall Study|Adverse Event|3|||
33430566|NCT02008721|101467432|FG001|Overall Study|Adverse Event|5|||
33430567|NCT02008721|101467431|FG000|Overall Study|Protocol Violation|3|||
33430568|NCT02008721|101467432|FG001|Overall Study|Protocol Violation|2|||
33430569|NCT03118739|101467434|FG000|Overall Study|Physician Decision|0|||
33430570|NCT03118739|101467435|FG001|Overall Study|Physician Decision|1|||
33430571|NCT03118739|101467434|FG000|Overall Study|Withdrawal by Subject|5|||
33430572|NCT03118739|101467435|FG001|Overall Study|Withdrawal by Subject|3|||
33647970|NCT01478048|102262894|FG000|Overall Study|poor/non-compliance|0|||
33647971|NCT01478048|102262895|FG001|Overall Study|poor/non-compliance|1|||
33647972|NCT01478048|102262894|FG000|Overall Study|no longer meets study criteria|1|||
33647973|NCT01478048|102262895|FG001|Overall Study|no longer meets study criteria|0|||
33647974|NCT01589653|102262898|FG000|Overall Study|Protocol Violation|3|||
33647975|NCT01589653|102262899|FG001|Overall Study|Protocol Violation|1|||
33647976|NCT01589653|102262898|FG000|Overall Study|Withdrawal criteria|4|||
33647977|NCT01589653|102262899|FG001|Overall Study|Withdrawal criteria|7|||
33647978|NCT01589653|102262898|FG000|Overall Study|Unclassified|0|||
33430573|NCT03118739|101467434|FG000|Overall Study|Lost to Follow-up|2|||
33430574|NCT03118739|101467435|FG001|Overall Study|Lost to Follow-up|0|||
33430575|NCT01415921|101467436|FG000|Overall Study|Adverse Event|0|||
33430576|NCT01415921|101467437|FG001|Overall Study|Adverse Event|1|||
33430577|NCT01415921|101467436|FG000|Overall Study|Physician Decision|1|||
33430578|NCT01415921|101467437|FG001|Overall Study|Physician Decision|1|||
33430579|NCT01415921|101467436|FG000|Overall Study|Withdrawal by Subject|0|||
33430580|NCT01415921|101467437|FG001|Overall Study|Withdrawal by Subject|1|||
33430581|NCT01415921|101467436|FG000|Overall Study|Other|2|||
33430582|NCT01415921|101467437|FG001|Overall Study|Other|0|||
33647979|NCT01589653|102262899|FG001|Overall Study|Unclassified|3|||
33647980|NCT02500056|102262900|FG000|Overall Study|Lost to Follow-up|3|||
33647981|NCT02500056|102262901|FG001|Overall Study|Lost to Follow-up|7|||
33248995|NCT01467700|100810394|FG000|Overall Study|Pregnancy|0|||
33248996|NCT01467700|100810395|FG001|Overall Study|Pregnancy|1|||
33248997|NCT01467700|100810396|FG002|Overall Study|Pregnancy|1|||
33248998|NCT01467700|100810397|FG003|Overall Study|Pregnancy|0|||
33383405|NCT00871377|101287845|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
33383406|NCT00871377|101287846|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
33383407|NCT00871377|101287841|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
33383408|NCT00871377|101287842|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
33383409|NCT00871377|101287843|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
33383410|NCT00871377|101287844|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
33383411|NCT00871377|101287845|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
33383412|NCT00871377|101287846|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
33383413|NCT00871377|101287841|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
33383414|NCT00871377|101287842|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
33383415|NCT00871377|101287843|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
33383416|NCT00871377|101287844|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
33383417|NCT00871377|101287845|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
33383418|NCT00871377|101287846|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
33383419|NCT00871377|101287841|FG000|Third Intervention (10 Weeks)|Death|0|||
33383420|NCT00871377|101287842|FG001|Third Intervention (10 Weeks)|Death|0|||
33383421|NCT00871377|101287843|FG002|Third Intervention (10 Weeks)|Death|0|||
33383422|NCT00871377|101287844|FG003|Third Intervention (10 Weeks)|Death|1|||
33383423|NCT00871377|101287845|FG004|Third Intervention (10 Weeks)|Death|0|||
33383424|NCT00871377|101287846|FG005|Third Intervention (10 Weeks)|Death|0|||
33383425|NCT01686958|101287847|FG000|Overall Study|Withdrawal by Subject|1|||
33383426|NCT01617655|101287848|FG000|Overall Study|Adverse Event|2|||
33383427|NCT01617655|101287849|FG001|Overall Study|Adverse Event|3|||
33383428|NCT01617655|101287848|FG000|Overall Study|Poor compliance to protocol|1|||
33383429|NCT01617655|101287849|FG001|Overall Study|Poor compliance to protocol|4|||
33383430|NCT01617655|101287848|FG000|Overall Study|Participants moved|0|||
33383431|NCT01617655|101287849|FG001|Overall Study|Participants moved|4|||
33383432|NCT01617655|101287848|FG000|Overall Study|Consent withdrawn by participant|1|||
33383433|NCT01617655|101287849|FG001|Overall Study|Consent withdrawn by participant|1|||
33383434|NCT01617655|101287848|FG000|Overall Study|Last visit outside protocol visit window|1|||
33383435|NCT01617655|101287849|FG001|Overall Study|Last visit outside protocol visit window|10|||
33587946|NCT03941873|102041715|FG003|Overall Study|Death|53|||
33587947|NCT03941873|102041712|FG000|Overall Study|Withdrawal by Subject|1|||
33587948|NCT03941873|102041713|FG001|Overall Study|Withdrawal by Subject|1|||
33587949|NCT03941873|102041714|FG002|Overall Study|Withdrawal by Subject|0|||
33587950|NCT03941873|102041715|FG003|Overall Study|Withdrawal by Subject|5|||
33587951|NCT03941873|102041712|FG000|Overall Study|Lost to Follow-up|1|||
33587952|NCT03941873|102041713|FG001|Overall Study|Lost to Follow-up|2|||
33587953|NCT03941873|102041714|FG002|Overall Study|Lost to Follow-up|0|||
33587954|NCT03941873|102041715|FG003|Overall Study|Lost to Follow-up|0|||
33587955|NCT03941873|102041712|FG000|Overall Study|Sponsor Decision|0|||
33587956|NCT03941873|102041713|FG001|Overall Study|Sponsor Decision|6|||
33587957|NCT03941873|102041714|FG002|Overall Study|Sponsor Decision|0|||
33587958|NCT03941873|102041715|FG003|Overall Study|Sponsor Decision|15|||
33587959|NCT00964002|102041716|FG000|Overall Study|Protocol Violation|8|||
33587960|NCT02499900|102041717|FG000|Core Study Period|Other|1|||
33587961|NCT02499900|102041718|FG001|Core Study Period|Other|4|||
33587962|NCT02499900|102041717|FG000|Core Study Period|Lost to Follow-up|1|||
33587963|NCT02499900|102041718|FG001|Core Study Period|Lost to Follow-up|2|||
33647982|NCT02500056|102262900|FG000|Overall Study|Recurrence|1|||
33647983|NCT02500056|102262901|FG001|Overall Study|Recurrence|0|||
33647984|NCT02500056|102262900|FG000|Overall Study|Death|3|||
33647985|NCT02500056|102262901|FG001|Overall Study|Death|1|||
33647986|NCT01754402|102262902|FG000|Overall Study|Death|0|||
33647987|NCT01754402|102262903|FG001|Overall Study|Death|0|||
33647988|NCT01754402|102262904|FG002|Overall Study|Death|1|||
33647989|NCT01754402|102262902|FG000|Overall Study|Adverse Event|2|||
33383436|NCT01617655|101287848|FG000|Overall Study|Site closure|3|||
33383437|NCT01617655|101287849|FG001|Overall Study|Site closure|5|||
33383438|NCT01617655|101287848|FG000|Overall Study|Other than specified above|1|||
33149671|NCT05298306|100463447|FG001|Overall Study|Physician Decision|0|||
33248999|NCT01467700|100810394|FG000|Overall Study|Lack of Efficacy|2|||
33383439|NCT01617655|101287849|FG001|Overall Study|Other than specified above|2|||
33249000|NCT01467700|100810395|FG001|Overall Study|Lack of Efficacy|0|||
33383440|NCT01602549|101287850|FG000|Overall Study|Protocol Violation|0|||
33383441|NCT01602549|101287851|FG001|Overall Study|Protocol Violation|1|||
33383442|NCT01602549|101287850|FG000|Overall Study|Withdrawal by Subject|1|||
33383443|NCT01602549|101287851|FG001|Overall Study|Withdrawal by Subject|0|||
33587964|NCT02499900|102041717|FG000|Core Study Period|Per sponsor request|0|||
33587965|NCT02499900|102041718|FG001|Core Study Period|Per sponsor request|1|||
33587966|NCT02499900|102041717|FG000|Core Study Period|Pregnancy|1|||
33587967|NCT02499900|102041718|FG001|Core Study Period|Pregnancy|0|||
33587968|NCT02499900|102041717|FG000|Core Study Period|Protocol Violation|3|||
33647990|NCT01754402|102262903|FG001|Overall Study|Adverse Event|2|||
33249001|NCT01467700|100810396|FG002|Overall Study|Lack of Efficacy|2|||
33249002|NCT01467700|100810397|FG003|Overall Study|Lack of Efficacy|1|||
33249003|NCT01467700|100810394|FG000|Overall Study|Reason not Specified|1|||
33249004|NCT01467700|100810395|FG001|Overall Study|Reason not Specified|3|||
33249005|NCT01467700|100810396|FG002|Overall Study|Reason not Specified|2|||
33249006|NCT01467700|100810397|FG003|Overall Study|Reason not Specified|8|||
33249007|NCT02503202|100810399|FG000|Base Study: Up to Month 6|Death|1|||
33249008|NCT02503202|100810400|FG001|Base Study: Up to Month 6|Death|1|||
33249009|NCT02503202|100810401|FG002|Base Study: Up to Month 6|Death|0|||
33249010|NCT02503202|100810402|FG003|Base Study: Up to Month 6|Death|0|||
33249011|NCT02503202|100810403|FG004|Base Study: Up to Month 6|Death|0|||
33383444|NCT00776555|101287852|FG000|Overall Study|Study terminated|3|||
33587969|NCT02499900|102041718|FG001|Core Study Period|Protocol Violation|0|||
33587970|NCT02499900|102041717|FG000|Core Study Period|Withdrawal by Subject|11|||
33587971|NCT02499900|102041718|FG001|Core Study Period|Withdrawal by Subject|10|||
33587972|NCT02499900|102041717|FG000|Core Study Period|Adverse Event|18|||
33587973|NCT02499900|102041718|FG001|Core Study Period|Adverse Event|14|||
33587974|NCT02499900|102041717|FG000|Core Study Period|Death|0|||
33587975|NCT02499900|102041718|FG001|Core Study Period|Death|1|||
33587976|NCT02499900|102041717|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
33587977|NCT02499900|102041718|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
33587978|NCT02499900|102041717|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
33587979|NCT02499900|102041718|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
33587980|NCT02499900|102041717|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
33587981|NCT02499900|102041718|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
33587982|NCT02499900|102041717|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
33587983|NCT02499900|102041718|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
33587984|NCT02499900|102041717|FG000|Extension Study Period|Adverse Event|2|||
33587985|NCT02499900|102041718|FG001|Extension Study Period|Adverse Event|4|||
33587986|NCT02499900|102041717|FG000|Extension Study Period|Withdrawal by Subject|5|||
33587987|NCT02499900|102041718|FG001|Extension Study Period|Withdrawal by Subject|2|||
33587988|NCT02499900|102041717|FG000|Extension Study Period|Physician Decision|2|||
33587989|NCT02499900|102041718|FG001|Extension Study Period|Physician Decision|5|||
33587990|NCT02499900|102041717|FG000|Extension Study Period|Pregnancy|1|||
33587991|NCT02499900|102041718|FG001|Extension Study Period|Pregnancy|2|||
33587992|NCT02499900|102041717|FG000|Extension Study Period|Lost to Follow-up|2|||
33587993|NCT02499900|102041718|FG001|Extension Study Period|Lost to Follow-up|5|||
33587994|NCT02499900|102041717|FG000|Extension Study Period|Other|0|||
33587995|NCT02499900|102041718|FG001|Extension Study Period|Other|2|||
33587996|NCT01071252|102041719|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
33587997|NCT01071252|102041720|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
33587998|NCT01071252|102041721|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
33587999|NCT01071252|102041722|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
33588000|NCT01071252|102041723|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
33588001|NCT01071252|102041719|FG000|Overall Study|Withdrawal by Subject|8|||
33588002|NCT01071252|102041720|FG001|Overall Study|Withdrawal by Subject|2|||
33588003|NCT01071252|102041721|FG002|Overall Study|Withdrawal by Subject|1|||
33588004|NCT01071252|102041722|FG003|Overall Study|Withdrawal by Subject|2|||
33588005|NCT01071252|102041723|FG004|Overall Study|Withdrawal by Subject|3|||
33588006|NCT01071252|102041719|FG000|Overall Study|administrative problems|1|||
33588007|NCT01071252|102041720|FG001|Overall Study|administrative problems|1|||
33588008|NCT01071252|102041721|FG002|Overall Study|administrative problems|0|||
33588009|NCT01071252|102041722|FG003|Overall Study|administrative problems|2|||
33647991|NCT01754402|102262904|FG002|Overall Study|Adverse Event|1|||
33647992|NCT01754402|102262902|FG000|Overall Study|Withdrawal by Subject|0|||
33647993|NCT01754402|102262903|FG001|Overall Study|Withdrawal by Subject|0|||
33647994|NCT01754402|102262904|FG002|Overall Study|Withdrawal by Subject|1|||
33647995|NCT01754402|102262902|FG000|Overall Study|Lack of Efficacy|0|||
33383445|NCT00776555|101287853|FG001|Overall Study|Study terminated|0|||
33383446|NCT02713789|101287855|FG000|Overall Study|Lost to Follow-up|0|||
33383447|NCT02713789|101287856|FG001|Overall Study|Lost to Follow-up|1|||
33249012|NCT02503202|100810399|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
33249013|NCT02503202|100810400|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
33249014|NCT02503202|100810401|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
33383448|NCT02713789|101287857|FG002|Overall Study|Lost to Follow-up|1|||
33383449|NCT00108953|101287861|FG000|Follow-up|Death|18|||
33383450|NCT00108953|101287862|FG001|Follow-up|Death|26|||
33383451|NCT00108953|101287861|FG000|Follow-up|Lost to Follow-up|1|||
33383452|NCT00108953|101287862|FG001|Follow-up|Lost to Follow-up|1|||
33588010|NCT01071252|102041723|FG004|Overall Study|administrative problems|1|||
33588011|NCT01071252|102041719|FG000|Overall Study|Lost to Follow-up|1|||
33588012|NCT01071252|102041720|FG001|Overall Study|Lost to Follow-up|0|||
33588013|NCT01071252|102041721|FG002|Overall Study|Lost to Follow-up|1|||
33588014|NCT01071252|102041722|FG003|Overall Study|Lost to Follow-up|2|||
33588015|NCT01071252|102041723|FG004|Overall Study|Lost to Follow-up|0|||
33647996|NCT01754402|102262903|FG001|Overall Study|Lack of Efficacy|0|||
33647997|NCT01754402|102262904|FG002|Overall Study|Lack of Efficacy|1|||
33430583|NCT00322556|101467438|FG000|Overall Study|Adverse Event|1|||
33430584|NCT00322556|101467438|FG000|Overall Study|Withdrawal by Subject|1|||
33430585|NCT00322556|101467438|FG000|Overall Study|Lost to Follow-up|3|||
33430586|NCT00322556|101467438|FG000|Overall Study|Other Reason|7|||
33430587|NCT01886300|101467439|FG000|Overall Study|Trial terminated by sponsor|16|||
33430588|NCT01830920|101467440|FG000|Overall Study|Adverse Event|1|||
33430589|NCT01830920|101467441|FG001|Overall Study|Adverse Event|0|||
33430590|NCT01830920|101467442|FG002|Overall Study|Adverse Event|1|||
33430591|NCT01830920|101467443|FG003|Overall Study|Adverse Event|0|||
33430592|NCT01830920|101467444|FG004|Overall Study|Adverse Event|0|||
33430593|NCT01830920|101467440|FG000|Overall Study|Withdrawal by Subject|2|||
33430594|NCT01830920|101467441|FG001|Overall Study|Withdrawal by Subject|2|||
33430595|NCT01830920|101467442|FG002|Overall Study|Withdrawal by Subject|1|||
33430596|NCT01830920|101467443|FG003|Overall Study|Withdrawal by Subject|7|||
33430597|NCT01830920|101467444|FG004|Overall Study|Withdrawal by Subject|1|||
33430598|NCT01830920|101467440|FG000|Overall Study|Death|3|||
33430599|NCT01830920|101467441|FG001|Overall Study|Death|3|||
33430600|NCT01830920|101467442|FG002|Overall Study|Death|5|||
33430601|NCT01830920|101467443|FG003|Overall Study|Death|4|||
33430602|NCT01830920|101467444|FG004|Overall Study|Death|4|||
33430603|NCT01830920|101467440|FG000|Overall Study|Other|15|||
33430604|NCT01830920|101467441|FG001|Overall Study|Other|1|||
33430605|NCT01830920|101467442|FG002|Overall Study|Other|1|||
33430606|NCT01830920|101467443|FG003|Overall Study|Other|5|||
33430607|NCT01830920|101467444|FG004|Overall Study|Other|3|||
33430608|NCT00290745|101467445|FG000|Overall Study|Withdrawal by Subject|4|||
33430609|NCT00290745|101467445|FG000|Overall Study|Physician Decision|2|||
33430610|NCT00290745|101467445|FG000|Overall Study|Surgery after 3 months for progression|3|||
33430611|NCT00290745|101467445|FG000|Overall Study|Baseline MRI not available|3|||
33430612|NCT00798889|101467446|FG000|Overall Study|Adverse Event|53|||
33430613|NCT00798889|101467446|FG000|Overall Study|Protocol Violation|2|||
33430614|NCT00798889|101467446|FG000|Overall Study|Withdrawal by Subject|31|||
33430615|NCT00798889|101467446|FG000|Overall Study|Lost to Follow-up|1|||
33430616|NCT00798889|101467446|FG000|Overall Study|Lack of Efficacy|213|||
33430617|NCT00798889|101467446|FG000|Overall Study|Decision of Sponsor|11|||
33430618|NCT00798889|101467446|FG000|Overall Study|Enrolled, Not treated|3|||
33430619|NCT02764489|101467449|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
33430620|NCT02764489|101467450|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
33430621|NCT02764489|101467449|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
33430622|NCT02764489|101467450|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
33430623|NCT02764489|101467449|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
33430624|NCT02764489|101467450|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
33430625|NCT02764489|101467449|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
33430626|NCT02764489|101467450|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
33430627|NCT02038634|101467459|FG000|Overall Study|Lost to Follow-up|0|||
33430628|NCT02038634|101467460|FG001|Overall Study|Lost to Follow-up|1|||
33430629|NCT03828461|101467461|FG000|Overall Study|Lost to Follow-up|1|||
33430630|NCT03828461|101467461|FG000|Overall Study|Withdrawal by Subject|3|||
33430631|NCT00859469|101467465|FG000|Overall Study|Adverse Event|2|||
33430632|NCT00859469|101467465|FG000|Overall Study|Lack of Efficacy|9|||
33430633|NCT00859469|101467465|FG000|Overall Study|Withdrawal by Subject|1|||
33430634|NCT00859469|101467465|FG000|Overall Study|Death|16|||
33430635|NCT01842958|101467466|FG000|Overall Study|Lost to Follow-up|1|||
33430636|NCT01842958|101467467|FG001|Overall Study|Lost to Follow-up|1|||
33430637|NCT02742090|101467469|FG000|Overall Study|Adverse Event|10|||
33430638|NCT02742090|101467469|FG000|Overall Study|Death|3|||
33647998|NCT01243242|102262909|FG000|Overall Study|Adverse Event|1|||
33149672|NCT05298306|100463448|FG002|Overall Study|Physician Decision|0|||
33149673|NCT05298306|100463449|FG003|Overall Study|Physician Decision|1|||
33149674|NCT05298306|100463450|FG004|Overall Study|Physician Decision|0|||
33430639|NCT02742090|101467469|FG000|Overall Study|Disease Progression|25|||
33430640|NCT02742090|101467469|FG000|Overall Study|Investigator's Decision|1|||
33430641|NCT02742090|101467469|FG000|Overall Study|Lost to Follow-up|1|||
33430642|NCT02742090|101467469|FG000|Overall Study|Non-compliance with Study|1|||
33149675|NCT05298306|100463451|FG005|Overall Study|Physician Decision|0|||
33149676|NCT05147428|100463454|FG000|Overall Study|Removed prior to mailing|289|||
33430643|NCT02742090|101467469|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
33430644|NCT02742090|101467469|FG000|Overall Study|Withdrawal by Subject|4|||
33430645|NCT02742090|101467469|FG000|Overall Study|Reason Not Specified|1|||
33430646|NCT04633837|101467470|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
33647999|NCT01243242|102262910|FG001|Overall Study|Adverse Event|1|||
33430647|NCT04633837|101467471|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
33430648|NCT01855126|101467478|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
33430649|NCT01855126|101467479|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
33430650|NCT01855126|101467478|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
33648000|NCT01243242|102262909|FG000|Overall Study|Withdrawal by Subject|1|||
33249015|NCT02503202|100810402|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
33249016|NCT02503202|100810403|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
33249017|NCT02503202|100810399|FG000|Base Study: Up to Month 6|Physician Decision|0|||
33249018|NCT02503202|100810400|FG001|Base Study: Up to Month 6|Physician Decision|0|||
33249019|NCT02503202|100810401|FG002|Base Study: Up to Month 6|Physician Decision|0|||
33249020|NCT02503202|100810402|FG003|Base Study: Up to Month 6|Physician Decision|0|||
33249021|NCT02503202|100810403|FG004|Base Study: Up to Month 6|Physician Decision|1|||
33249022|NCT02503202|100810399|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
33249023|NCT02503202|100810400|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
33249024|NCT02503202|100810401|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
33249025|NCT02503202|100810402|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
33249026|NCT02503202|100810403|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
33249027|NCT02503202|100810399|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
33249028|NCT02503202|100810400|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
33249029|NCT02503202|100810401|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
33249030|NCT02503202|100810402|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
33249031|NCT02503202|100810403|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
33249032|NCT02503202|100810399|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
33249033|NCT02503202|100810400|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
33249034|NCT02503202|100810401|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
33249035|NCT02503202|100810402|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
33249036|NCT02503202|100810403|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
33249037|NCT02503202|100810399|FG000|Extension: Month 6 to 24|Death|1|||
33249038|NCT02503202|100810400|FG001|Extension: Month 6 to 24|Death|0|||
33249039|NCT02503202|100810401|FG002|Extension: Month 6 to 24|Death|0|||
33249040|NCT02503202|100810402|FG003|Extension: Month 6 to 24|Death|0|||
33249041|NCT02503202|100810403|FG004|Extension: Month 6 to 24|Death|0|||
33249042|NCT02503202|100810399|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
33249043|NCT02503202|100810400|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
33249044|NCT02503202|100810401|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
33249045|NCT02503202|100810402|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
33249046|NCT02503202|100810403|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
33249047|NCT02503202|100810399|FG000|Extension: Month 6 to 24|Physician Decision|1|||
33249048|NCT02503202|100810400|FG001|Extension: Month 6 to 24|Physician Decision|0|||
33249049|NCT02503202|100810401|FG002|Extension: Month 6 to 24|Physician Decision|1|||
33249050|NCT02503202|100810402|FG003|Extension: Month 6 to 24|Physician Decision|3|||
33249051|NCT02503202|100810403|FG004|Extension: Month 6 to 24|Physician Decision|0|||
33249052|NCT02503202|100810399|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
33430651|NCT01855126|101467479|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
33430652|NCT00891293|101467484|FG000|Overall Study|Adverse Event|2|||
33430653|NCT00891293|101467484|FG000|Overall Study|Protocol Violation|2|||
33430654|NCT00891293|101467484|FG000|Overall Study|Laboratory abnormality|4|||
33430655|NCT00891293|101467484|FG000|Overall Study|Lost to Follow-up|7|||
33430656|NCT00891293|101467484|FG000|Overall Study|Subject withdrew consent|7|||
33588016|NCT01071252|102041719|FG000|Overall Study|Adverse Event|1|||
33588017|NCT01071252|102041720|FG001|Overall Study|Adverse Event|1|||
33588018|NCT01071252|102041721|FG002|Overall Study|Adverse Event|0|||
33588019|NCT01071252|102041722|FG003|Overall Study|Adverse Event|1|||
33588020|NCT01071252|102041723|FG004|Overall Study|Adverse Event|0|||
33588021|NCT01071252|102041719|FG000|Overall Study|Death|0|||
33588022|NCT01071252|102041720|FG001|Overall Study|Death|0|||
33588023|NCT01071252|102041721|FG002|Overall Study|Death|0|||
33588024|NCT01071252|102041722|FG003|Overall Study|Death|0|||
33588025|NCT01071252|102041723|FG004|Overall Study|Death|1|||
33588026|NCT01974206|102041724|FG000|Overall Study|Did Not Take Study Drug|0|||
33588027|NCT01974206|102041725|FG001|Overall Study|Did Not Take Study Drug|1|||
33588028|NCT01974206|102041724|FG000|Overall Study|Physician Decision|1|||
33588029|NCT01974206|102041725|FG001|Overall Study|Physician Decision|0|||
33588030|NCT01974206|102041724|FG000|Overall Study|Withdrawal by Subject|3|||
33588031|NCT01974206|102041725|FG001|Overall Study|Withdrawal by Subject|0|||
33588032|NCT01974206|102041724|FG000|Overall Study|Lost to Follow-up|1|||
33588033|NCT01974206|102041725|FG001|Overall Study|Lost to Follow-up|0|||
33588034|NCT01974206|102041724|FG000|Overall Study|Death|1|||
33588035|NCT01974206|102041725|FG001|Overall Study|Death|0|||
33588036|NCT01132651|102041726|FG000|Overall Study|Lost to Follow-up|1|||
33249053|NCT02503202|100810400|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
33588037|NCT01132651|102041727|FG001|Overall Study|Lost to Follow-up|1|||
33588038|NCT04551898|102041728|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
33249054|NCT02503202|100810401|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
33249055|NCT02503202|100810402|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
33588039|NCT04551898|102041729|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
33588040|NCT04551898|102041730|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
33588041|NCT04551898|102041731|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
33430657|NCT00891293|101467484|FG000|Overall Study|Sponsor termination|62|||
33430658|NCT01214603|101467485|FG000|Overall Study|Adverse Event|0|||
33430659|NCT01214603|101467486|FG001|Overall Study|Adverse Event|0|||
33430660|NCT01214603|101467487|FG002|Overall Study|Adverse Event|1|||
33430661|NCT01214603|101467485|FG000|Overall Study|Death|1|||
33430662|NCT01214603|101467486|FG001|Overall Study|Death|0|||
33430663|NCT01214603|101467487|FG002|Overall Study|Death|0|||
33430664|NCT01214603|101467485|FG000|Overall Study|Progressive Disease|4|||
33430665|NCT01214603|101467486|FG001|Overall Study|Progressive Disease|1|||
33430666|NCT01214603|101467487|FG002|Overall Study|Progressive Disease|3|||
33430667|NCT00447603|101467488|FG000|Screening|Withdrawal by Subject|1|||
33430668|NCT00447603|101467489|FG001|Screening|Withdrawal by Subject|0|||
33430669|NCT00447603|101467490|FG002|Screening|Withdrawal by Subject|0|||
33430670|NCT00447603|101467488|FG000|Screening|Protocol Violation|1|||
33430671|NCT00447603|101467489|FG001|Screening|Protocol Violation|0|||
33430672|NCT00447603|101467490|FG002|Screening|Protocol Violation|0|||
33430673|NCT00447603|101467488|FG000|Screening|Screen Failure|4|||
33430674|NCT00447603|101467489|FG001|Screening|Screen Failure|0|||
33430675|NCT00447603|101467490|FG002|Screening|Screen Failure|0|||
33430676|NCT00447603|101467488|FG000|Screening|Study Terminated by Sponsor|15|||
33430677|NCT00447603|101467489|FG001|Screening|Study Terminated by Sponsor|0|||
33249056|NCT02503202|100810403|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
33383453|NCT00108953|101287861|FG000|Follow-up|Study terminated by sponsor|10|||
33383454|NCT00108953|101287862|FG001|Follow-up|Study terminated by sponsor|6|||
33383455|NCT01170702|101287863|FG000|Overall Study|Exclusion criteria met after consent|1|||
33383456|NCT01170702|101287864|FG001|Overall Study|Exclusion criteria met after consent|2|||
33383457|NCT01170702|101287865|FG002|Overall Study|Exclusion criteria met after consent|0|||
33383458|NCT01170702|101287866|FG003|Overall Study|Exclusion criteria met after consent|2|||
33383459|NCT01646398|101287867|FG000|Overall Study|Withdrawal by Subject|1|||
33383460|NCT01646398|101287868|FG001|Overall Study|Withdrawal by Subject|0|||
33383461|NCT02017899|101287870|FG000|Overall Study|Withdrawal by Subject|0|||
33383462|NCT02017899|101287871|FG001|Overall Study|Withdrawal by Subject|0|||
33383463|NCT02017899|101287872|FG002|Overall Study|Withdrawal by Subject|0|||
33383464|NCT02017899|101287873|FG003|Overall Study|Withdrawal by Subject|1|||
33383465|NCT02017899|101287874|FG004|Overall Study|Withdrawal by Subject|1|||
33383466|NCT02017899|101287875|FG005|Overall Study|Withdrawal by Subject|0|||
33383467|NCT03371732|101287876|FG000|Overall Study|Withdrawal by Subject|9|||
33383468|NCT03371732|101287877|FG001|Overall Study|Withdrawal by Subject|3|||
33383469|NCT03371732|101287876|FG000|Overall Study|Refusal to continue|3|||
33383470|NCT03371732|101287877|FG001|Overall Study|Refusal to continue|4|||
33383471|NCT00187889|101287884|FG000|Overall Study|Withdrawal by Subject|6|||
33383472|NCT00187889|101287885|FG001|Overall Study|Withdrawal by Subject|4|||
33383473|NCT02282982|101291364|FG000|Overall Study|Lost to Follow-up|15|||
33383474|NCT02282982|101291364|FG000|Overall Study|Withdrew consent|2|||
33383475|NCT02282982|101291364|FG000|Overall Study|Death|4|||
33383476|NCT02282982|101291364|FG000|Overall Study|Lack of product|156|||
33383477|NCT02282982|101291364|FG000|Overall Study|Palivizumab is ended|11|||
33383478|NCT02282982|101291364|FG000|Overall Study|Other, not specified|18|||
33383479|NCT00109772|101291366|FG000|Double-blind Treatment|Adverse Event|14|||
33383480|NCT00109772|101291367|FG001|Double-blind Treatment|Adverse Event|5|||
33383481|NCT00109772|101291366|FG000|Double-blind Treatment|Lack of Efficacy|1|||
33383482|NCT00109772|101291367|FG001|Double-blind Treatment|Lack of Efficacy|0|||
33383483|NCT00109772|101291366|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
33383484|NCT00109772|101291367|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
33383485|NCT00109772|101291366|FG000|Double-blind Treatment|Lost to Follow-up|2|||
33383486|NCT00109772|101291367|FG001|Double-blind Treatment|Lost to Follow-up|3|||
33383487|NCT00109772|101291366|FG000|Double-blind Treatment|Protocol Violation|0|||
33383488|NCT00109772|101291367|FG001|Double-blind Treatment|Protocol Violation|1|||
33383489|NCT00109772|101291366|FG000|Double-blind Treatment|Other|0|||
33383490|NCT00109772|101291367|FG001|Double-blind Treatment|Other|4|||
33383491|NCT00109772|101291366|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
33430678|NCT00447603|101467490|FG002|Screening|Study Terminated by Sponsor|0|||
33648001|NCT01243242|102262910|FG001|Overall Study|Withdrawal by Subject|1|||
33383492|NCT00109772|101291367|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
33383493|NCT00109772|101291366|FG000|Open-label Extension|Adverse Event|10|||
33383494|NCT00109772|101291367|FG001|Open-label Extension|Adverse Event|19|||
33383495|NCT00109772|101291366|FG000|Open-label Extension|Lack of Efficacy|19|||
33383496|NCT00109772|101291367|FG001|Open-label Extension|Lack of Efficacy|11|||
33383497|NCT00109772|101291366|FG000|Open-label Extension|Withdrawal by Subject|9|||
33383498|NCT00109772|101291367|FG001|Open-label Extension|Withdrawal by Subject|6|||
33383499|NCT00109772|101291366|FG000|Open-label Extension|Lost to Follow-up|1|||
33430679|NCT00447603|101467488|FG000|Filter Period|Adverse Event|0|||
33430680|NCT00447603|101467489|FG001|Filter Period|Adverse Event|0|||
33430681|NCT00447603|101467490|FG002|Filter Period|Adverse Event|1|||
33249057|NCT01119950|100810409|FG000|Overall Study|Adverse Event|25|||
33430682|NCT00447603|101467488|FG000|Filter Period|Screen Failure|0|||
33430683|NCT00447603|101467489|FG001|Filter Period|Screen Failure|3|||
33430684|NCT00447603|101467490|FG002|Filter Period|Screen Failure|4|||
33430685|NCT00447603|101467488|FG000|Filter Period|Study terminated by Sponsor|0|||
33430686|NCT00447603|101467489|FG001|Filter Period|Study terminated by Sponsor|1|||
33430687|NCT00447603|101467490|FG002|Filter Period|Study terminated by Sponsor|10|||
33430688|NCT01141283|101467491|FG000|Overall Study|Adverse Event|56|||
33430689|NCT01141283|101467491|FG000|Overall Study|Lost to Follow-up|4|||
33430690|NCT01141283|101467491|FG000|Overall Study|Withdrawal by Subject|14|||
33430691|NCT01141283|101467491|FG000|Overall Study|Administrative|4|||
33588042|NCT04551898|102041728|FG000|Overall Study|Withdrawal by Subject|5|||
33588043|NCT04551898|102041729|FG001|Overall Study|Withdrawal by Subject|1|||
33588044|NCT04551898|102041730|FG002|Overall Study|Withdrawal by Subject|2|||
33588045|NCT04551898|102041731|FG003|Overall Study|Withdrawal by Subject|2|||
33588046|NCT04551898|102041728|FG000|Overall Study|Lost to Follow-up|2|||
33588047|NCT04551898|102041729|FG001|Overall Study|Lost to Follow-up|1|||
33588048|NCT04551898|102041730|FG002|Overall Study|Lost to Follow-up|2|||
33588049|NCT04551898|102041731|FG003|Overall Study|Lost to Follow-up|2|||
33588050|NCT04551898|102041728|FG000|Overall Study|Death|1|||
33588051|NCT04551898|102041729|FG001|Overall Study|Death|0|||
33588052|NCT04551898|102041730|FG002|Overall Study|Death|0|||
33588053|NCT04551898|102041731|FG003|Overall Study|Death|0|||
33588054|NCT04551898|102041728|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
33588055|NCT04551898|102041729|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
33588056|NCT04551898|102041730|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
33588057|NCT04551898|102041731|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
33588058|NCT03931382|102041732|FG000|Overall Study|Equipment malfunction|2|||
33588059|NCT03931382|102041733|FG001|Overall Study|Equipment malfunction|0|||
33588060|NCT03931382|102041734|FG002|Overall Study|Equipment malfunction|2|||
33588061|NCT03931382|102041732|FG000|Overall Study|Withdrawal by Subject|0|||
33588062|NCT03931382|102041733|FG001|Overall Study|Withdrawal by Subject|1|||
33588063|NCT03931382|102041734|FG002|Overall Study|Withdrawal by Subject|0|||
33588064|NCT03985943|102041735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
33588065|NCT03985943|102041736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
33648002|NCT01243242|102262909|FG000|Overall Study|Physician Decision|0|||
33648003|NCT01243242|102262910|FG001|Overall Study|Physician Decision|1|||
33648004|NCT01243242|102262909|FG000|Overall Study|sponsor decision|0|||
33249058|NCT01119950|100810409|FG000|Overall Study|Withdrawal by Subject|9|||
33383500|NCT00109772|101291367|FG001|Open-label Extension|Lost to Follow-up|0|||
33383501|NCT00109772|101291366|FG000|Open-label Extension|Death|0|||
33383502|NCT00109772|101291367|FG001|Open-label Extension|Death|1|||
33383503|NCT00109772|101291366|FG000|Open-label Extension|Protocol Violation|2|||
33383504|NCT00109772|101291367|FG001|Open-label Extension|Protocol Violation|2|||
33383505|NCT00109772|101291366|FG000|Open-label Extension|Other|4|||
33383506|NCT00109772|101291367|FG001|Open-label Extension|Other|10|||
33383507|NCT00014911|101291368|FG000|Overall Study|Adverse Event|1|||
33383508|NCT00014911|101291368|FG000|Overall Study|Lost to Follow-up|1|||
33383509|NCT00014911|101291368|FG000|Overall Study|Withdrawal by Subject|6|||
33383510|NCT00014911|101291368|FG000|Overall Study|Unknown Reasons|2|||
33383511|NCT00014911|101291368|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
33383512|NCT01576406|101291379|FG000|Overall Study|Lost to Follow-up|1|||
33383513|NCT01576406|101291380|FG001|Overall Study|Lost to Follow-up|2|||
33383514|NCT01576406|101291381|FG002|Overall Study|Lost to Follow-up|0|||
33383515|NCT01576406|101291382|FG003|Overall Study|Lost to Follow-up|0|||
33383516|NCT01576406|101291383|FG004|Overall Study|Lost to Follow-up|0|||
33383517|NCT01576406|101291384|FG005|Overall Study|Lost to Follow-up|0|||
33383518|NCT01576406|101291379|FG000|Overall Study|Death|3|||
33383519|NCT01576406|101291380|FG001|Overall Study|Death|4|||
33383520|NCT01576406|101291381|FG002|Overall Study|Death|8|||
33383521|NCT01576406|101291382|FG003|Overall Study|Death|5|||
33383522|NCT01576406|101291383|FG004|Overall Study|Death|7|||
33383523|NCT01576406|101291384|FG005|Overall Study|Death|9|||
33383524|NCT01576406|101291379|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
33383525|NCT01576406|101291380|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
33383526|NCT01576406|101291381|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
33383527|NCT01576406|101291382|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
33430692|NCT01141283|101467491|FG000|Overall Study|Lack of Efficacy|10|||
33648005|NCT01243242|102262910|FG001|Overall Study|sponsor decision|1|||
33648006|NCT01243242|102262909|FG000|Overall Study|non compliance|1|||
33383528|NCT01576406|101291383|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
33383529|NCT01576406|101291384|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
33383530|NCT01576406|101291379|FG000|Overall Study|Withdrawal the consent|2|||
33383531|NCT01576406|101291380|FG001|Overall Study|Withdrawal the consent|2|||
33430693|NCT01464827|101467492|FG000|Overall Study|Adverse Event|0|||
33430694|NCT01464827|101467493|FG001|Overall Study|Adverse Event|0|||
33430695|NCT01464827|101467494|FG002|Overall Study|Adverse Event|0|||
33588066|NCT03985943|102041737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
33648007|NCT01243242|102262910|FG001|Overall Study|non compliance|0|||
33149677|NCT05147428|100463455|FG001|Overall Study|Removed prior to mailing|306|||
33149678|NCT05147428|100463456|FG002|Overall Study|Removed prior to mailing|270|||
33149679|NCT05147428|100463454|FG000|Overall Study|Died or disenrolled during blackout period|239|||
33149680|NCT05147428|100463455|FG001|Overall Study|Died or disenrolled during blackout period|278|||
33149681|NCT05147428|100463456|FG002|Overall Study|Died or disenrolled during blackout period|273|||
33383532|NCT01576406|101291381|FG002|Overall Study|Withdrawal the consent|5|||
33383533|NCT01576406|101291382|FG003|Overall Study|Withdrawal the consent|1|||
33383534|NCT01576406|101291383|FG004|Overall Study|Withdrawal the consent|1|||
33383535|NCT01576406|101291384|FG005|Overall Study|Withdrawal the consent|3|||
33383536|NCT01576406|101291379|FG000|Overall Study|Other|0|||
33383537|NCT01576406|101291380|FG001|Overall Study|Other|0|||
33383538|NCT01576406|101291381|FG002|Overall Study|Other|2|||
33383539|NCT01576406|101291382|FG003|Overall Study|Other|2|||
33383540|NCT01576406|101291383|FG004|Overall Study|Other|0|||
33383541|NCT01576406|101291384|FG005|Overall Study|Other|0|||
33383542|NCT01116687|101291387|FG000|Overall Study|Withdrawal by Subject|4|||
33383543|NCT02999100|101291388|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
33383544|NCT02999100|101291389|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
33383545|NCT02999100|101291390|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
33383546|NCT02999100|101291391|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
33383547|NCT02999100|101291392|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
33383548|NCT02999100|101291393|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
33383549|NCT02999100|101291388|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
33383550|NCT02999100|101291389|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
33383551|NCT02999100|101291390|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
33383552|NCT02999100|101291391|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
33383553|NCT02999100|101291392|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
33648008|NCT04681352|102262911|FG000|Overall Study|Lost to Follow-up|2|||
33648009|NCT04681352|102262911|FG000|Overall Study|Withdrawal by Subject|22|||
33648010|NCT01105065|102262912|FG000|Overall Study|Adverse Event|5|||
33648011|NCT01105065|102262912|FG000|Overall Study|Technical Problems|1|||
33648012|NCT01149148|102262915|FG000|Overall Study|Lost to Follow-up|1|||
33648013|NCT01149148|102262916|FG001|Overall Study|Lost to Follow-up|2|||
33648014|NCT01149148|102262915|FG000|Overall Study|Death|1|||
33648015|NCT01149148|102262916|FG001|Overall Study|Death|0|||
33648016|NCT01087736|102262917|FG000|Overall Study|Lost to Follow-up|1|||
33648017|NCT01087736|102262918|FG001|Overall Study|Lost to Follow-up|0|||
33648018|NCT01087736|102262917|FG000|Overall Study|Death|0|||
33648019|NCT01087736|102262918|FG001|Overall Study|Death|1|||
33648020|NCT01087736|102262917|FG000|Overall Study|Withdrawal by Subject|0|||
33648021|NCT01087736|102262918|FG001|Overall Study|Withdrawal by Subject|1|||
33149682|NCT03730012|100463457|FG000|Overall Study|Adverse Event|0|||
33149683|NCT03730012|100463458|FG001|Overall Study|Adverse Event|1|||
33383554|NCT02999100|101291393|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
33383555|NCT02999100|101291388|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
33383556|NCT02999100|101291389|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
33383557|NCT02999100|101291390|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
33383558|NCT02999100|101291391|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
33383559|NCT02999100|101291392|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
33383560|NCT02999100|101291393|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
33383561|NCT01575899|101291398|FG000|Overall Study|Lost to Follow-up|3|||
33383562|NCT01575899|101291399|FG001|Overall Study|Lost to Follow-up|4|||
33383563|NCT01575899|101291400|FG002|Overall Study|Lost to Follow-up|2|||
33383564|NCT01575899|101291398|FG000|Overall Study|Protocol Violation|2|||
33383565|NCT01575899|101291399|FG001|Overall Study|Protocol Violation|1|||
33383566|NCT01575899|101291400|FG002|Overall Study|Protocol Violation|0|||
33383567|NCT02224638|101291401|FG000|Overall Study|Adverse Event|1|||
33383568|NCT02224638|101291402|FG001|Overall Study|Adverse Event|1|||
33383569|NCT01879319|101291406|FG000|Overall Study|Withdrawal by Subject|1|||
33383570|NCT01879319|101291407|FG001|Overall Study|Withdrawal by Subject|0|||
33383571|NCT01879319|101291406|FG000|Overall Study|Lost to Follow-up|1|||
33383572|NCT01879319|101291407|FG001|Overall Study|Lost to Follow-up|5|||
33383573|NCT02384395|101291408|FG000|Overall Study|Physician Decision|4|||
33383574|NCT02384395|101291408|FG000|Overall Study|Withdrawal by Subject|3|||
33383575|NCT02384395|101291408|FG000|Overall Study|Lost to Follow-up|3|||
33383576|NCT02924688|101291411|FG000|Overall Study|Adverse Event|9|||
33383577|NCT02924688|101291412|FG001|Overall Study|Adverse Event|3|||
33383578|NCT02924688|101291413|FG002|Overall Study|Adverse Event|2|||
33383579|NCT02924688|101291414|FG003|Overall Study|Adverse Event|2|||
33383580|NCT02924688|101291415|FG004|Overall Study|Adverse Event|3|||
33383581|NCT02924688|101291416|FG005|Overall Study|Adverse Event|2|||
33383582|NCT02924688|101291411|FG000|Overall Study|Lack of Efficacy|2|||
33648022|NCT00881868|102262919|FG000|Overall Study|Adverse Event|0|||
33648023|NCT00881868|102262920|FG001|Overall Study|Adverse Event|1|||
33648024|NCT00881868|102262919|FG000|Overall Study|Lost to Follow-up|2|||
33648025|NCT00881868|102262920|FG001|Overall Study|Lost to Follow-up|1|||
33648026|NCT00881868|102262919|FG000|Overall Study|Physician Decision|4|||
33648027|NCT00881868|102262920|FG001|Overall Study|Physician Decision|0|||
33648028|NCT00881868|102262919|FG000|Overall Study|Protocol Violation|2|||
33648029|NCT00881868|102262920|FG001|Overall Study|Protocol Violation|0|||
33249059|NCT01119950|100810409|FG000|Overall Study|Protocol Violation|5|||
33249060|NCT01119950|100810409|FG000|Overall Study|Lost to Follow-up|4|||
33249061|NCT01119950|100810409|FG000|Overall Study|Administrative|2|||
33249062|NCT01119950|100810409|FG000|Overall Study|Abnormal lab value|1|||
33249063|NCT01119950|100810409|FG000|Overall Study|Death|1|||
33249064|NCT04173572|100810411|FG000|Overall Study|Withdrawal by Subject|1|||
33249065|NCT04173572|100810412|FG001|Overall Study|Withdrawal by Subject|5|||
33249066|NCT04173572|100810411|FG000|Overall Study|Lost to Follow-up|3|||
33249067|NCT04173572|100810412|FG001|Overall Study|Lost to Follow-up|1|||
33249068|NCT03386929|100810413|FG000|Overall Study|Death|0|||
33249069|NCT03386929|100810414|FG001|Overall Study|Death|0|||
33249070|NCT03386929|100810415|FG002|Overall Study|Death|1|||
33249071|NCT03386929|100810413|FG000|Overall Study|Withdrawal by Subject|0|||
33249072|NCT03386929|100810414|FG001|Overall Study|Withdrawal by Subject|1|||
33249073|NCT03386929|100810415|FG002|Overall Study|Withdrawal by Subject|0|||
33249074|NCT03386929|100810413|FG000|Overall Study|Physician Decision|0|||
33249075|NCT03386929|100810414|FG001|Overall Study|Physician Decision|0|||
33249076|NCT03386929|100810415|FG002|Overall Study|Physician Decision|1|||
33249077|NCT03386929|100810413|FG000|Overall Study|Progression|4|||
33249078|NCT03386929|100810414|FG001|Overall Study|Progression|4|||
33249079|NCT03386929|100810415|FG002|Overall Study|Progression|0|||
33249080|NCT03386929|100810413|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
33249081|NCT03386929|100810414|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
33249082|NCT03386929|100810415|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
33249083|NCT03386929|100810413|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
33249084|NCT03386929|100810414|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
33249085|NCT03386929|100810415|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
33249086|NCT02577523|100810416|FG000|Overall Study|Adverse Event|1|||
33249087|NCT02577523|100810417|FG001|Overall Study|Adverse Event|1|||
33249088|NCT02577523|100810416|FG000|Overall Study|Lack of Efficacy|1|||
33249089|NCT02577523|100810417|FG001|Overall Study|Lack of Efficacy|1|||
33249090|NCT02577523|100810416|FG000|Overall Study|Withdrawal by Subject|1|||
33249091|NCT02577523|100810417|FG001|Overall Study|Withdrawal by Subject|0|||
33249092|NCT00109967|100810418|FG000|Overall Study|Cancel Prior to Treatment|2|||
33249093|NCT00109967|100810419|FG001|Overall Study|Cancel Prior to Treatment|0|||
33249094|NCT00109967|100810418|FG000|Overall Study|Adverse Event|12|||
33249095|NCT00109967|100810419|FG001|Overall Study|Adverse Event|1|||
33249096|NCT00109967|100810418|FG000|Overall Study|Withdrawal by Subject|5|||
33249097|NCT00109967|100810419|FG001|Overall Study|Withdrawal by Subject|0|||
33249098|NCT00109967|100810418|FG000|Overall Study|Physician Decision|1|||
33249099|NCT00109967|100810419|FG001|Overall Study|Physician Decision|3|||
33249100|NCT00109967|100810418|FG000|Overall Study|Death|0|||
33249101|NCT00109967|100810419|FG001|Overall Study|Death|2|||
33249102|NCT00920686|100810422|FG000|Overall Study|Lost to Follow-up|2|||
33249103|NCT00920686|100810423|FG001|Overall Study|Lost to Follow-up|3|||
33249104|NCT00920686|100810424|FG002|Overall Study|Lost to Follow-up|1|||
33249105|NCT00920686|100810422|FG000|Overall Study|Study drug dosing criteria not met|17|||
33249106|NCT00920686|100810423|FG001|Overall Study|Study drug dosing criteria not met|19|||
33383583|NCT02924688|101291412|FG001|Overall Study|Lack of Efficacy|3|||
33383584|NCT02924688|101291413|FG002|Overall Study|Lack of Efficacy|4|||
33383585|NCT02924688|101291414|FG003|Overall Study|Lack of Efficacy|2|||
33383586|NCT02924688|101291415|FG004|Overall Study|Lack of Efficacy|1|||
33383587|NCT02924688|101291416|FG005|Overall Study|Lack of Efficacy|1|||
33383588|NCT02924688|101291411|FG000|Overall Study|Protocol Violation|3|||
33383589|NCT02924688|101291412|FG001|Overall Study|Protocol Violation|7|||
33383590|NCT02924688|101291413|FG002|Overall Study|Protocol Violation|5|||
33383591|NCT02924688|101291414|FG003|Overall Study|Protocol Violation|6|||
33383592|NCT02924688|101291415|FG004|Overall Study|Protocol Violation|2|||
33383593|NCT02924688|101291416|FG005|Overall Study|Protocol Violation|2|||
33383594|NCT02924688|101291411|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
33383595|NCT02924688|101291412|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
33383596|NCT02924688|101291413|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
33383597|NCT02924688|101291414|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
33383598|NCT02924688|101291415|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
33383599|NCT02924688|101291416|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
33648030|NCT01715857|102262921|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
33249107|NCT00920686|100810424|FG002|Overall Study|Study drug dosing criteria not met|12|||
33249108|NCT03603717|100810425|FG000|Overall Study|Lost to Follow-up|20|||
33383600|NCT02924688|101291411|FG000|Overall Study|Lost to Follow-up|2|||
33249109|NCT03603717|100810426|FG001|Overall Study|Lost to Follow-up|20|||
33249110|NCT03603717|100810425|FG000|Overall Study|Withdrawal by Subject|16|||
33383601|NCT02924688|101291412|FG001|Overall Study|Lost to Follow-up|4|||
33249111|NCT03603717|100810426|FG001|Overall Study|Withdrawal by Subject|10|||
33249112|NCT03396835|100810427|FG000|Overall Study|Withdrawn prior to completion|1|||
33249113|NCT03396835|100810427|FG000|Overall Study|Did not meet criteria for data analysis|1|||
33249114|NCT01178762|100810429|FG000|Overall Study|Lost to Follow-up|15|||
33249115|NCT02317016|100810430|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
33249116|NCT02317016|100810430|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
33249117|NCT02317016|100810430|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
33249118|NCT02317016|100810430|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
33249119|NCT02317016|100810430|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
33249120|NCT02317016|100810430|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
33249121|NCT02317016|100810430|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
33249122|NCT02390557|100810431|FG000|Wave 2|Survey non-respondent|72|||
33249123|NCT02390557|100810432|FG001|Wave 2|Survey non-respondent|41|||
33249124|NCT02390557|100810433|FG002|Wave 2|Survey non-respondent|23|||
33249125|NCT02333630|100810434|FG000|Overall Study|Lost to Follow-up|5|||
33249126|NCT02333630|100810435|FG001|Overall Study|Lost to Follow-up|2|||
33249127|NCT03357341|100810438|FG000|Overall Study|Withdrawal by Subject|3|||
33249128|NCT03357341|100810439|FG001|Overall Study|Withdrawal by Subject|6|||
33249129|NCT03357341|100810438|FG000|Overall Study|Lost to Follow-up|4|||
33249130|NCT03357341|100810439|FG001|Overall Study|Lost to Follow-up|5|||
33249131|NCT03357341|100810438|FG000|Overall Study|Death|0|||
33249132|NCT03357341|100810439|FG001|Overall Study|Death|1|||
33249133|NCT01362491|100810442|FG000|Overall Study|Ineligible|1|||
33249134|NCT01362491|100810443|FG001|Overall Study|Ineligible|0|||
33249135|NCT01362491|100810444|FG002|Overall Study|Ineligible|0|||
33249136|NCT03635112|100810446|FG000|Overall Study|Adverse Event|5|||
33249137|NCT03635112|100810447|FG001|Overall Study|Adverse Event|9|||
33249138|NCT03635112|100810448|FG002|Overall Study|Adverse Event|14|||
33249139|NCT03635112|100810446|FG000|Overall Study|Lost to Follow-up|1|||
33249140|NCT03635112|100810447|FG001|Overall Study|Lost to Follow-up|0|||
33249141|NCT03635112|100810448|FG002|Overall Study|Lost to Follow-up|1|||
33249142|NCT03635112|100810446|FG000|Overall Study|Physician Decision|5|||
33249143|NCT03635112|100810447|FG001|Overall Study|Physician Decision|7|||
33249144|NCT03635112|100810448|FG002|Overall Study|Physician Decision|5|||
33249145|NCT03635112|100810446|FG000|Overall Study|Protocol Violation|0|||
33249146|NCT03635112|100810447|FG001|Overall Study|Protocol Violation|0|||
33588067|NCT03985943|102041738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
33588068|NCT03985943|102041739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
33588069|NCT03985943|102041740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
33588070|NCT03985943|102041735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
33588071|NCT03985943|102041736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
33588072|NCT03985943|102041737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
33588073|NCT03985943|102041738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
33588074|NCT03985943|102041739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
33588075|NCT03985943|102041740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
33588076|NCT03985943|102041735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
33588077|NCT03985943|102041736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
33588078|NCT03985943|102041737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
33588079|NCT03985943|102041738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
33588080|NCT03985943|102041739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
33588081|NCT03985943|102041740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
33588082|NCT03985943|102041735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
33588083|NCT03985943|102041736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
33588084|NCT03985943|102041737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
33588085|NCT03985943|102041738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
33588086|NCT03985943|102041739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
33588087|NCT03985943|102041740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
33588088|NCT03985943|102041735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
33588089|NCT03985943|102041736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
33588090|NCT03985943|102041737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
33588091|NCT03985943|102041738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
33588092|NCT03985943|102041739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
33249147|NCT03635112|100810448|FG002|Overall Study|Protocol Violation|1|||
33249148|NCT03635112|100810446|FG000|Overall Study|Study Terminated by Sponsor|11|||
33249149|NCT03635112|100810447|FG001|Overall Study|Study Terminated by Sponsor|17|||
33249150|NCT03635112|100810448|FG002|Overall Study|Study Terminated by Sponsor|21|||
33249151|NCT03635112|100810446|FG000|Overall Study|Withdrawal by Subject|4|||
33249152|NCT03635112|100810447|FG001|Overall Study|Withdrawal by Subject|9|||
33249153|NCT03635112|100810448|FG002|Overall Study|Withdrawal by Subject|7|||
33249154|NCT03635112|100810446|FG000|Overall Study|Miscellaneous|0|||
33383602|NCT02924688|101291413|FG002|Overall Study|Lost to Follow-up|2|||
33383603|NCT02924688|101291414|FG003|Overall Study|Lost to Follow-up|4|||
33249155|NCT03635112|100810447|FG001|Overall Study|Miscellaneous|0|||
33249156|NCT03635112|100810448|FG002|Overall Study|Miscellaneous|1|||
33249157|NCT01306331|100810449|FG000|Overall Study|Adverse Event|28|||
33249158|NCT01306331|100810450|FG001|Overall Study|Adverse Event|25|||
33249159|NCT01306331|100810449|FG000|Overall Study|Lost to Follow-up|321|||
33249160|NCT01306331|100810450|FG001|Overall Study|Lost to Follow-up|323|||
33249161|NCT01306331|100810449|FG000|Overall Study|Physician Decision|26|||
33249162|NCT01306331|100810450|FG001|Overall Study|Physician Decision|22|||
33249163|NCT01306331|100810449|FG000|Overall Study|Pregnancy|136|||
33249164|NCT01306331|100810450|FG001|Overall Study|Pregnancy|151|||
33249165|NCT01306331|100810449|FG000|Overall Study|Protocol Violation|154|||
33249166|NCT01306331|100810450|FG001|Overall Study|Protocol Violation|124|||
33249167|NCT01306331|100810449|FG000|Overall Study|Withdrawal by Subject|163|||
33249168|NCT01306331|100810450|FG001|Overall Study|Withdrawal by Subject|152|||
33249169|NCT01306331|100810449|FG000|Overall Study|Not sexually active|29|||
33249170|NCT01306331|100810450|FG001|Overall Study|Not sexually active|28|||
33249171|NCT01306331|100810449|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
33249172|NCT01306331|100810450|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
33249173|NCT01306331|100810449|FG000|Overall Study|Other|34|||
33249174|NCT01306331|100810450|FG001|Overall Study|Other|32|||
33249175|NCT00015457|100810451|FG000|First Intervention|Adverse Event|0|||
33249176|NCT00015457|100810452|FG001|First Intervention|Adverse Event|2|||
33249177|NCT00015457|100810451|FG000|First Intervention|Lack of Efficacy|0|||
33249178|NCT00015457|100810452|FG001|First Intervention|Lack of Efficacy|1|||
33249179|NCT00015457|100810451|FG000|Second Intervention|Withdrawal by Subject|1|||
33249180|NCT00015457|100810452|FG001|Second Intervention|Withdrawal by Subject|0|||
33249181|NCT00383188|100810455|FG000|Overall Study|Adverse Event|4|||
33249182|NCT00383188|100810456|FG001|Overall Study|Adverse Event|7|||
33249183|NCT00383188|100810457|FG002|Overall Study|Adverse Event|9|||
33249184|NCT00383188|100810458|FG003|Overall Study|Adverse Event|8|||
33249185|NCT00383188|100810459|FG004|Overall Study|Adverse Event|8|||
33430696|NCT01464827|101467495|FG003|Overall Study|Adverse Event|0|||
33430697|NCT01464827|101467496|FG004|Overall Study|Adverse Event|0|||
33430698|NCT01464827|101467497|FG005|Overall Study|Adverse Event|0|||
33430699|NCT01464827|101467498|FG006|Overall Study|Adverse Event|0|||
33588093|NCT03985943|102041740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
33588094|NCT03985943|102041735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
33588095|NCT03985943|102041736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
33588096|NCT03985943|102041737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
33588097|NCT03985943|102041738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
33588098|NCT03985943|102041739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
33588099|NCT03985943|102041740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
33588100|NCT03985943|102041735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
33588101|NCT03985943|102041736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
33588102|NCT03985943|102041737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
33588103|NCT03985943|102041738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
33588104|NCT03985943|102041739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
33588105|NCT03985943|102041740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
33588106|NCT03985943|102041735|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
33588107|NCT03985943|102041736|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
33588108|NCT03985943|102041737|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
33588109|NCT03985943|102041738|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
33588110|NCT03985943|102041739|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
33588111|NCT03985943|102041740|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
33588112|NCT03985943|102041735|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
33588113|NCT03985943|102041736|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
33588114|NCT03985943|102041737|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
33588115|NCT03985943|102041738|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
33588116|NCT03985943|102041739|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
33588117|NCT03985943|102041740|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
33648031|NCT00095940|102262925|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
33249186|NCT00383188|100810455|FG000|Overall Study|Lack of Efficacy|9|||
33249187|NCT00383188|100810456|FG001|Overall Study|Lack of Efficacy|3|||
33249188|NCT00383188|100810457|FG002|Overall Study|Lack of Efficacy|3|||
33249189|NCT00383188|100810458|FG003|Overall Study|Lack of Efficacy|2|||
33249190|NCT00383188|100810459|FG004|Overall Study|Lack of Efficacy|6|||
33249191|NCT00383188|100810455|FG000|Overall Study|Other|3|||
33249192|NCT00383188|100810456|FG001|Overall Study|Other|1|||
33249193|NCT00383188|100810457|FG002|Overall Study|Other|0|||
33430700|NCT01464827|101467499|FG007|Overall Study|Adverse Event|0|||
33430701|NCT01464827|101467500|FG008|Overall Study|Adverse Event|0|||
33430702|NCT01464827|101467501|FG009|Overall Study|Adverse Event|0|||
33430703|NCT01464827|101467502|FG010|Overall Study|Adverse Event|0|||
33430704|NCT01464827|101467503|FG011|Overall Study|Adverse Event|0|||
33430705|NCT01464827|101467504|FG012|Overall Study|Adverse Event|1|||
33430706|NCT01464827|101467505|FG013|Overall Study|Adverse Event|0|||
33430707|NCT01464827|101467492|FG000|Overall Study|Withdrawal by Subject|1|||
33430708|NCT01464827|101467493|FG001|Overall Study|Withdrawal by Subject|0|||
33430709|NCT01464827|101467494|FG002|Overall Study|Withdrawal by Subject|0|||
33430710|NCT01464827|101467495|FG003|Overall Study|Withdrawal by Subject|0|||
33430711|NCT01464827|101467496|FG004|Overall Study|Withdrawal by Subject|1|||
33430712|NCT01464827|101467497|FG005|Overall Study|Withdrawal by Subject|0|||
33430713|NCT01464827|101467498|FG006|Overall Study|Withdrawal by Subject|0|||
33430714|NCT01464827|101467499|FG007|Overall Study|Withdrawal by Subject|1|||
33430715|NCT01464827|101467500|FG008|Overall Study|Withdrawal by Subject|0|||
33430716|NCT01464827|101467501|FG009|Overall Study|Withdrawal by Subject|0|||
33430717|NCT01464827|101467502|FG010|Overall Study|Withdrawal by Subject|0|||
33430718|NCT01464827|101467503|FG011|Overall Study|Withdrawal by Subject|0|||
33430719|NCT01464827|101467504|FG012|Overall Study|Withdrawal by Subject|0|||
33430720|NCT01464827|101467505|FG013|Overall Study|Withdrawal by Subject|0|||
33430721|NCT01464827|101467492|FG000|Overall Study|Lost to Follow-up|0|||
33430722|NCT01464827|101467493|FG001|Overall Study|Lost to Follow-up|2|||
33430723|NCT01464827|101467494|FG002|Overall Study|Lost to Follow-up|0|||
33430724|NCT01464827|101467495|FG003|Overall Study|Lost to Follow-up|2|||
33430725|NCT01464827|101467496|FG004|Overall Study|Lost to Follow-up|3|||
33430726|NCT01464827|101467497|FG005|Overall Study|Lost to Follow-up|1|||
33430727|NCT01464827|101467498|FG006|Overall Study|Lost to Follow-up|2|||
33430728|NCT01464827|101467499|FG007|Overall Study|Lost to Follow-up|2|||
33430729|NCT01464827|101467500|FG008|Overall Study|Lost to Follow-up|0|||
33430730|NCT01464827|101467501|FG009|Overall Study|Lost to Follow-up|0|||
33430731|NCT01464827|101467502|FG010|Overall Study|Lost to Follow-up|0|||
33430732|NCT01464827|101467503|FG011|Overall Study|Lost to Follow-up|1|||
33430733|NCT01464827|101467504|FG012|Overall Study|Lost to Follow-up|0|||
33430734|NCT01464827|101467505|FG013|Overall Study|Lost to Follow-up|1|||
33430735|NCT01464827|101467492|FG000|Overall Study|Other|2|||
33430736|NCT01464827|101467493|FG001|Overall Study|Other|3|||
33430737|NCT01464827|101467494|FG002|Overall Study|Other|0|||
33430738|NCT01464827|101467495|FG003|Overall Study|Other|2|||
33430739|NCT01464827|101467496|FG004|Overall Study|Other|3|||
33430740|NCT01464827|101467497|FG005|Overall Study|Other|0|||
33430741|NCT01464827|101467498|FG006|Overall Study|Other|1|||
33430742|NCT01464827|101467499|FG007|Overall Study|Other|0|||
33430743|NCT01464827|101467500|FG008|Overall Study|Other|3|||
33430744|NCT01464827|101467501|FG009|Overall Study|Other|1|||
33430745|NCT01464827|101467502|FG010|Overall Study|Other|2|||
33430746|NCT01464827|101467503|FG011|Overall Study|Other|0|||
33430747|NCT01464827|101467504|FG012|Overall Study|Other|1|||
33430748|NCT01464827|101467505|FG013|Overall Study|Other|0|||
33430749|NCT01464827|101467492|FG000|Overall Study|Not Treated|0|||
33430750|NCT01464827|101467493|FG001|Overall Study|Not Treated|2|||
33430751|NCT01464827|101467494|FG002|Overall Study|Not Treated|0|||
33430752|NCT01464827|101467495|FG003|Overall Study|Not Treated|0|||
33430753|NCT01464827|101467496|FG004|Overall Study|Not Treated|1|||
33430754|NCT01464827|101467497|FG005|Overall Study|Not Treated|0|||
33430755|NCT01464827|101467498|FG006|Overall Study|Not Treated|1|||
33430756|NCT01464827|101467499|FG007|Overall Study|Not Treated|0|||
33430757|NCT01464827|101467500|FG008|Overall Study|Not Treated|0|||
33430758|NCT01464827|101467501|FG009|Overall Study|Not Treated|2|||
33430759|NCT01464827|101467502|FG010|Overall Study|Not Treated|0|||
33430760|NCT01464827|101467503|FG011|Overall Study|Not Treated|1|||
33430761|NCT01464827|101467504|FG012|Overall Study|Not Treated|0|||
33648032|NCT00095940|102262926|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
33648033|NCT00095940|102262927|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
33430762|NCT01464827|101467505|FG013|Overall Study|Not Treated|2|||
33430763|NCT04634409|101467506|FG000|Overall Study|Death|0|||
33430764|NCT04634409|101467507|FG001|Overall Study|Death|0|||
33430765|NCT04634409|101467508|FG002|Overall Study|Death|0|||
33430766|NCT04634409|101467509|FG003|Overall Study|Death|0|||
33430767|NCT04634409|101467510|FG004|Overall Study|Death|0|||
33430768|NCT04634409|101467511|FG005|Overall Study|Death|0|||
33430769|NCT04634409|101467512|FG006|Overall Study|Death|0|||
33430770|NCT04634409|101467513|FG007|Overall Study|Death|0|||
33430771|NCT04634409|101467514|FG008|Overall Study|Death|0|||
33430772|NCT04634409|101467515|FG009|Overall Study|Death|0|||
33430773|NCT04634409|101467516|FG010|Overall Study|Death|1|||
33430774|NCT04634409|101467517|FG011|Overall Study|Death|0|||
33648034|NCT00095940|102262928|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
33430775|NCT04634409|101467518|FG012|Overall Study|Death|1|||
33430776|NCT04634409|101467519|FG013|Overall Study|Death|0|||
33430777|NCT04634409|101467520|FG014|Overall Study|Death|0|||
33430778|NCT04634409|101467521|FG015|Overall Study|Death|0|||
33430779|NCT04634409|101467522|FG016|Overall Study|Death|0|||
33430780|NCT04634409|101467523|FG017|Overall Study|Death|0|||
33430781|NCT04634409|101467524|FG018|Overall Study|Death|0|||
33430782|NCT04634409|101467525|FG019|Overall Study|Death|0|||
33430783|NCT04634409|101467526|FG020|Overall Study|Death|0|||
33430784|NCT04634409|101467527|FG021|Overall Study|Death|0|||
33430785|NCT04634409|101467528|FG022|Overall Study|Death|0|||
33430786|NCT04634409|101467529|FG023|Overall Study|Death|0|||
33430787|NCT04634409|101467530|FG024|Overall Study|Death|0|||
33430788|NCT04634409|101467531|FG025|Overall Study|Death|0|||
33430789|NCT04634409|101467532|FG026|Overall Study|Death|0|||
33430790|NCT04634409|101467506|FG000|Overall Study|Adverse Event|0|||
33430791|NCT04634409|101467507|FG001|Overall Study|Adverse Event|0|||
33430792|NCT04634409|101467508|FG002|Overall Study|Adverse Event|1|||
33430793|NCT04634409|101467509|FG003|Overall Study|Adverse Event|0|||
33430794|NCT04634409|101467510|FG004|Overall Study|Adverse Event|0|||
33430795|NCT04634409|101467511|FG005|Overall Study|Adverse Event|1|||
33430796|NCT04634409|101467512|FG006|Overall Study|Adverse Event|0|||
33430797|NCT04634409|101467513|FG007|Overall Study|Adverse Event|0|||
33430798|NCT04634409|101467514|FG008|Overall Study|Adverse Event|0|||
33430799|NCT04634409|101467515|FG009|Overall Study|Adverse Event|0|||
33430800|NCT04634409|101467516|FG010|Overall Study|Adverse Event|0|||
33430801|NCT04634409|101467517|FG011|Overall Study|Adverse Event|0|||
33430802|NCT04634409|101467518|FG012|Overall Study|Adverse Event|0|||
33430803|NCT04634409|101467519|FG013|Overall Study|Adverse Event|0|||
33430804|NCT04634409|101467520|FG014|Overall Study|Adverse Event|0|||
33430805|NCT04634409|101467521|FG015|Overall Study|Adverse Event|0|||
33430806|NCT04634409|101467522|FG016|Overall Study|Adverse Event|0|||
33430807|NCT04634409|101467523|FG017|Overall Study|Adverse Event|0|||
33430808|NCT04634409|101467524|FG018|Overall Study|Adverse Event|0|||
33430809|NCT04634409|101467525|FG019|Overall Study|Adverse Event|0|||
33430810|NCT04634409|101467526|FG020|Overall Study|Adverse Event|0|||
33430811|NCT04634409|101467527|FG021|Overall Study|Adverse Event|0|||
33430812|NCT04634409|101467528|FG022|Overall Study|Adverse Event|0|||
33430813|NCT04634409|101467529|FG023|Overall Study|Adverse Event|0|||
33430814|NCT04634409|101467530|FG024|Overall Study|Adverse Event|0|||
33430815|NCT04634409|101467531|FG025|Overall Study|Adverse Event|0|||
33430816|NCT04634409|101467532|FG026|Overall Study|Adverse Event|0|||
33430817|NCT04634409|101467506|FG000|Overall Study|Lost to Follow-up|3|||
33430818|NCT04634409|101467507|FG001|Overall Study|Lost to Follow-up|1|||
33430819|NCT04634409|101467508|FG002|Overall Study|Lost to Follow-up|1|||
33430820|NCT04634409|101467509|FG003|Overall Study|Lost to Follow-up|3|||
33430821|NCT04634409|101467510|FG004|Overall Study|Lost to Follow-up|1|||
33430822|NCT04634409|101467511|FG005|Overall Study|Lost to Follow-up|1|||
33430823|NCT04634409|101467512|FG006|Overall Study|Lost to Follow-up|1|||
33430824|NCT04634409|101467513|FG007|Overall Study|Lost to Follow-up|3|||
33430825|NCT04634409|101467514|FG008|Overall Study|Lost to Follow-up|3|||
33430826|NCT04634409|101467515|FG009|Overall Study|Lost to Follow-up|11|||
33430827|NCT04634409|101467516|FG010|Overall Study|Lost to Follow-up|8|||
33430828|NCT04634409|101467517|FG011|Overall Study|Lost to Follow-up|15|||
33430829|NCT04634409|101467518|FG012|Overall Study|Lost to Follow-up|3|||
33430830|NCT04634409|101467519|FG013|Overall Study|Lost to Follow-up|2|||
33430831|NCT04634409|101467520|FG014|Overall Study|Lost to Follow-up|7|||
33430832|NCT04634409|101467521|FG015|Overall Study|Lost to Follow-up|0|||
33430833|NCT04634409|101467522|FG016|Overall Study|Lost to Follow-up|0|||
33430834|NCT04634409|101467523|FG017|Overall Study|Lost to Follow-up|0|||
33430835|NCT04634409|101467524|FG018|Overall Study|Lost to Follow-up|0|||
33430836|NCT04634409|101467525|FG019|Overall Study|Lost to Follow-up|0|||
33430837|NCT04634409|101467526|FG020|Overall Study|Lost to Follow-up|0|||
33430838|NCT04634409|101467527|FG021|Overall Study|Lost to Follow-up|0|||
33430839|NCT04634409|101467528|FG022|Overall Study|Lost to Follow-up|0|||
33430840|NCT04634409|101467529|FG023|Overall Study|Lost to Follow-up|0|||
33430841|NCT04634409|101467530|FG024|Overall Study|Lost to Follow-up|0|||
33430842|NCT04634409|101467531|FG025|Overall Study|Lost to Follow-up|0|||
33588118|NCT03985943|102041735|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
33588119|NCT03985943|102041736|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
33588120|NCT03985943|102041737|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
33588121|NCT03985943|102041738|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
33588122|NCT03985943|102041739|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
33588123|NCT03985943|102041740|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
33588124|NCT03985943|102041735|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
33588125|NCT03985943|102041736|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
33648035|NCT00095940|102262929|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
33430843|NCT04634409|101467532|FG026|Overall Study|Lost to Follow-up|0|||
33430844|NCT04634409|101467506|FG000|Overall Study|Withdrawal by Subject|3|||
33430845|NCT04634409|101467507|FG001|Overall Study|Withdrawal by Subject|1|||
33430846|NCT04634409|101467508|FG002|Overall Study|Withdrawal by Subject|6|||
33430847|NCT04634409|101467509|FG003|Overall Study|Withdrawal by Subject|4|||
33430848|NCT04634409|101467510|FG004|Overall Study|Withdrawal by Subject|2|||
33430849|NCT04634409|101467511|FG005|Overall Study|Withdrawal by Subject|0|||
33430850|NCT04634409|101467512|FG006|Overall Study|Withdrawal by Subject|0|||
33430851|NCT04634409|101467513|FG007|Overall Study|Withdrawal by Subject|2|||
33430852|NCT04634409|101467514|FG008|Overall Study|Withdrawal by Subject|3|||
33588126|NCT03985943|102041737|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
33249194|NCT00383188|100810458|FG003|Overall Study|Other|2|||
33249195|NCT00383188|100810459|FG004|Overall Study|Other|6|||
33249196|NCT00383188|100810455|FG000|Overall Study|No longer willing to participate|1|||
33249197|NCT00383188|100810456|FG001|Overall Study|No longer willing to participate|0|||
33249198|NCT00383188|100810457|FG002|Overall Study|No longer willing to participate|1|||
33249199|NCT00383188|100810458|FG003|Overall Study|No longer willing to participate|0|||
33249200|NCT00383188|100810459|FG004|Overall Study|No longer willing to participate|2|||
33249201|NCT00383188|100810455|FG000|Overall Study|Lost to Follow-up|0|||
33249202|NCT00383188|100810456|FG001|Overall Study|Lost to Follow-up|0|||
33249203|NCT00383188|100810457|FG002|Overall Study|Lost to Follow-up|0|||
33249204|NCT00383188|100810458|FG003|Overall Study|Lost to Follow-up|0|||
33249205|NCT00383188|100810459|FG004|Overall Study|Lost to Follow-up|1|||
33249206|NCT03055767|100810464|FG000|Open-Label Period|Lost to Follow-up|0|||
33249207|NCT03055767|100810465|FG001|Open-Label Period|Lost to Follow-up|0|||
33249208|NCT03055767|100810466|FG002|Open-Label Period|Lost to Follow-up|2|||
33249209|NCT03055767|100810467|FG003|Open-Label Period|Lost to Follow-up|0|||
33249210|NCT03055767|100810464|FG000|Open-Label Period|Withdrawal by Subject|0|||
33249211|NCT03055767|100810465|FG001|Open-Label Period|Withdrawal by Subject|0|||
33249212|NCT03055767|100810466|FG002|Open-Label Period|Withdrawal by Subject|0|||
33249213|NCT03055767|100810467|FG003|Open-Label Period|Withdrawal by Subject|1|||
33249214|NCT02857283|100810468|FG000|First Exposure|Withdrawal by Subject|1|||
33249215|NCT02857283|100810469|FG001|First Exposure|Withdrawal by Subject|0|||
33249216|NCT01451814|100810470|FG000|Overall Study|Withdrawal by Subject|1|||
33249217|NCT01451814|100810471|FG001|Overall Study|Withdrawal by Subject|1|||
33249218|NCT01451814|100810470|FG000|Overall Study|Lost to Follow-up|5|||
33249219|NCT01451814|100810471|FG001|Overall Study|Lost to Follow-up|4|||
33286450|NCT00092521|100943970|FG002|Extension Study (Group 4)|Protocol Violation|0|||
33286451|NCT00092521|100943971|FG003|Extension Study (Group 4)|Protocol Violation|2|||
33286452|NCT00092521|100943968|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
33286453|NCT00092521|100943969|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
33286454|NCT00092521|100943970|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
33286455|NCT00092521|100943971|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
33286456|NCT00092521|100943968|FG000|Extension Study (Group 4)|Moved|0|||
33286457|NCT00092521|100943969|FG001|Extension Study (Group 4)|Moved|0|||
33286458|NCT00092521|100943970|FG002|Extension Study (Group 4)|Moved|0|||
33286459|NCT00092521|100943971|FG003|Extension Study (Group 4)|Moved|16|||
33286460|NCT00092521|100943968|FG000|Extension Study (Group 4)|Site Terminated|0|||
33383604|NCT02924688|101291415|FG004|Overall Study|Lost to Follow-up|2|||
33383605|NCT02924688|101291416|FG005|Overall Study|Lost to Follow-up|4|||
33383606|NCT02924688|101291411|FG000|Overall Study|Physician Decision|2|||
33383607|NCT02924688|101291412|FG001|Overall Study|Physician Decision|1|||
33383608|NCT02924688|101291413|FG002|Overall Study|Physician Decision|0|||
33383609|NCT02924688|101291414|FG003|Overall Study|Physician Decision|1|||
33383610|NCT02924688|101291415|FG004|Overall Study|Physician Decision|1|||
33383611|NCT02924688|101291416|FG005|Overall Study|Physician Decision|1|||
33383612|NCT02924688|101291411|FG000|Overall Study|Withdrawal by Subject|14|||
33383613|NCT02924688|101291412|FG001|Overall Study|Withdrawal by Subject|13|||
33383614|NCT02924688|101291413|FG002|Overall Study|Withdrawal by Subject|9|||
33383615|NCT02924688|101291414|FG003|Overall Study|Withdrawal by Subject|12|||
33383616|NCT02924688|101291415|FG004|Overall Study|Withdrawal by Subject|13|||
33383617|NCT02924688|101291416|FG005|Overall Study|Withdrawal by Subject|14|||
33383618|NCT00505752|101291421|FG000|Overall Study|Adverse Event|1|||
33383619|NCT00505752|101291422|FG001|Overall Study|Adverse Event|0|||
33383620|NCT00505752|101291423|FG002|Overall Study|Adverse Event|1|||
33383621|NCT00505752|101291424|FG003|Overall Study|Adverse Event|0|||
33383622|NCT00505752|101291421|FG000|Overall Study|Lost to Follow-up|1|||
33383623|NCT00505752|101291422|FG001|Overall Study|Lost to Follow-up|0|||
33383624|NCT00505752|101291423|FG002|Overall Study|Lost to Follow-up|0|||
33383625|NCT00505752|101291424|FG003|Overall Study|Lost to Follow-up|0|||
33383626|NCT00505752|101291421|FG000|Overall Study|Lack of ovarian response|1|||
33383627|NCT00505752|101291422|FG001|Overall Study|Lack of ovarian response|3|||
33383628|NCT00505752|101291423|FG002|Overall Study|Lack of ovarian response|0|||
33383629|NCT00505752|101291424|FG003|Overall Study|Lack of ovarian response|0|||
33383630|NCT00505752|101291421|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
33383631|NCT00505752|101291422|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
33588127|NCT03985943|102041738|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
33588128|NCT03985943|102041739|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
33286461|NCT00092521|100943969|FG001|Extension Study (Group 4)|Site Terminated|0|||
33383632|NCT00505752|101291423|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
33383633|NCT00505752|101291424|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
33286462|NCT00092521|100943970|FG002|Extension Study (Group 4)|Site Terminated|0|||
33286463|NCT00092521|100943971|FG003|Extension Study (Group 4)|Site Terminated|4|||
33383634|NCT00505752|101291421|FG000|Overall Study|No oocytes retrieved|0|||
33430853|NCT04634409|101467515|FG009|Overall Study|Withdrawal by Subject|2|||
33430854|NCT04634409|101467516|FG010|Overall Study|Withdrawal by Subject|3|||
33430855|NCT04634409|101467517|FG011|Overall Study|Withdrawal by Subject|2|||
33430856|NCT04634409|101467518|FG012|Overall Study|Withdrawal by Subject|2|||
33430857|NCT04634409|101467519|FG013|Overall Study|Withdrawal by Subject|1|||
33430858|NCT04634409|101467520|FG014|Overall Study|Withdrawal by Subject|5|||
33430859|NCT04634409|101467521|FG015|Overall Study|Withdrawal by Subject|0|||
33430860|NCT04634409|101467522|FG016|Overall Study|Withdrawal by Subject|0|||
33430861|NCT04634409|101467523|FG017|Overall Study|Withdrawal by Subject|1|||
33430862|NCT04634409|101467524|FG018|Overall Study|Withdrawal by Subject|0|||
33430863|NCT04634409|101467525|FG019|Overall Study|Withdrawal by Subject|0|||
33430864|NCT04634409|101467526|FG020|Overall Study|Withdrawal by Subject|0|||
33430865|NCT04634409|101467527|FG021|Overall Study|Withdrawal by Subject|0|||
33430866|NCT04634409|101467528|FG022|Overall Study|Withdrawal by Subject|0|||
33430867|NCT04634409|101467529|FG023|Overall Study|Withdrawal by Subject|1|||
33430868|NCT04634409|101467530|FG024|Overall Study|Withdrawal by Subject|0|||
33430869|NCT04634409|101467531|FG025|Overall Study|Withdrawal by Subject|0|||
33430870|NCT04634409|101467532|FG026|Overall Study|Withdrawal by Subject|0|||
33430871|NCT04634409|101467506|FG000|Overall Study|Other - As reported by Investigator|1|||
33430872|NCT04634409|101467507|FG001|Overall Study|Other - As reported by Investigator|0|||
33430873|NCT04634409|101467508|FG002|Overall Study|Other - As reported by Investigator|0|||
33430874|NCT04634409|101467509|FG003|Overall Study|Other - As reported by Investigator|0|||
33430875|NCT04634409|101467510|FG004|Overall Study|Other - As reported by Investigator|0|||
33430876|NCT04634409|101467511|FG005|Overall Study|Other - As reported by Investigator|0|||
33430877|NCT04634409|101467512|FG006|Overall Study|Other - As reported by Investigator|0|||
33430878|NCT04634409|101467513|FG007|Overall Study|Other - As reported by Investigator|6|||
33430879|NCT04634409|101467514|FG008|Overall Study|Other - As reported by Investigator|4|||
33430880|NCT04634409|101467515|FG009|Overall Study|Other - As reported by Investigator|0|||
33430881|NCT04634409|101467516|FG010|Overall Study|Other - As reported by Investigator|1|||
33430882|NCT04634409|101467517|FG011|Overall Study|Other - As reported by Investigator|2|||
33430883|NCT04634409|101467518|FG012|Overall Study|Other - As reported by Investigator|2|||
33430884|NCT04634409|101467519|FG013|Overall Study|Other - As reported by Investigator|1|||
33430885|NCT04634409|101467520|FG014|Overall Study|Other - As reported by Investigator|0|||
33430886|NCT04634409|101467521|FG015|Overall Study|Other - As reported by Investigator|0|||
33430887|NCT04634409|101467522|FG016|Overall Study|Other - As reported by Investigator|0|||
33430888|NCT04634409|101467523|FG017|Overall Study|Other - As reported by Investigator|0|||
33430889|NCT04634409|101467524|FG018|Overall Study|Other - As reported by Investigator|0|||
33430890|NCT04634409|101467525|FG019|Overall Study|Other - As reported by Investigator|0|||
33430891|NCT04634409|101467526|FG020|Overall Study|Other - As reported by Investigator|0|||
33430892|NCT04634409|101467527|FG021|Overall Study|Other - As reported by Investigator|0|||
33430893|NCT04634409|101467528|FG022|Overall Study|Other - As reported by Investigator|0|||
33430894|NCT04634409|101467529|FG023|Overall Study|Other - As reported by Investigator|0|||
33430895|NCT04634409|101467530|FG024|Overall Study|Other - As reported by Investigator|0|||
33430896|NCT04634409|101467531|FG025|Overall Study|Other - As reported by Investigator|0|||
33430897|NCT04634409|101467532|FG026|Overall Study|Other - As reported by Investigator|0|||
33430898|NCT02231710|101467533|FG000|Overall Study|Physician Decision|1|||
33430899|NCT04049552|101467534|FG000|Overall Study|Lost to Follow-up|1|||
33588129|NCT03985943|102041740|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
33588130|NCT03985943|102041735|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33588131|NCT03985943|102041736|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33588132|NCT03985943|102041737|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
33588133|NCT03985943|102041738|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
33588134|NCT03985943|102041739|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
33588135|NCT03985943|102041740|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
33383635|NCT00505752|101291422|FG001|Overall Study|No oocytes retrieved|2|||
33383636|NCT00505752|101291423|FG002|Overall Study|No oocytes retrieved|0|||
33383637|NCT00505752|101291424|FG003|Overall Study|No oocytes retrieved|1|||
33383638|NCT00505752|101291421|FG000|Overall Study|No Fertilization|1|||
33383639|NCT00505752|101291422|FG001|Overall Study|No Fertilization|1|||
33383640|NCT00505752|101291423|FG002|Overall Study|No Fertilization|2|||
33383641|NCT00505752|101291424|FG003|Overall Study|No Fertilization|1|||
33383642|NCT00505752|101291421|FG000|Overall Study|All embryos/blastocysts discarded|0|||
33383643|NCT00505752|101291422|FG001|Overall Study|All embryos/blastocysts discarded|0|||
33383644|NCT00505752|101291423|FG002|Overall Study|All embryos/blastocysts discarded|1|||
33383645|NCT00505752|101291424|FG003|Overall Study|All embryos/blastocysts discarded|1|||
33383646|NCT00505752|101291421|FG000|Overall Study|Other|1|||
33383647|NCT00505752|101291422|FG001|Overall Study|Other|2|||
33383648|NCT00505752|101291423|FG002|Overall Study|Other|1|||
33383649|NCT00505752|101291424|FG003|Overall Study|Other|2|||
33383650|NCT02273037|101291428|FG000|Overall Study|Lost to Follow-up|1|||
33383651|NCT02273037|101291429|FG001|Overall Study|Lost to Follow-up|0|||
33383652|NCT02273037|101291428|FG000|Overall Study|Delivered before monitoring initiated|1|||
33383653|NCT02273037|101291429|FG001|Overall Study|Delivered before monitoring initiated|3|||
33430900|NCT02140164|101467535|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
33430901|NCT02180061|101467542|FG000|Overall Study|Adverse Event|4|||
33430902|NCT02180061|101467543|FG001|Overall Study|Adverse Event|2|||
33430903|NCT02180061|101467542|FG000|Overall Study|Clinical Progression|5|||
33430904|NCT02180061|101467543|FG001|Overall Study|Clinical Progression|1|||
33430905|NCT02180061|101467542|FG000|Overall Study|Progressive Disease|15|||
33430906|NCT02180061|101467543|FG001|Overall Study|Progressive Disease|5|||
33430907|NCT02180061|101467542|FG000|Overall Study|Physician Decision|1|||
33430908|NCT02180061|101467543|FG001|Overall Study|Physician Decision|0|||
33430909|NCT00106028|101467546|FG000|Overall Study|Adverse Event|3|||
33430910|NCT00106028|101467547|FG001|Overall Study|Adverse Event|2|||
33430911|NCT00106028|101467546|FG000|Overall Study|Protocol Violation|1|||
33430912|NCT00106028|101467547|FG001|Overall Study|Protocol Violation|1|||
33430913|NCT00106028|101467546|FG000|Overall Study|Withdrawal by Subject|2|||
33588136|NCT03985943|102041735|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
33249220|NCT03518112|100814398|FG000|Overall Study|Withdrawal by Subject|1|||
33249221|NCT02299635|100814399|FG000|Overall Study|Adverse Event|2|||
33249222|NCT02299635|100814399|FG000|Overall Study|Death|1|||
33249223|NCT02299635|100814399|FG000|Overall Study|Global deterioration of health status|1|||
33249224|NCT02299635|100814399|FG000|Overall Study|Objective progression or relapse|10|||
33249225|NCT02299635|100814399|FG000|Overall Study|Withdrawal by Subject|2|||
33249226|NCT02299635|100814399|FG000|Overall Study|Other|3|||
33249227|NCT03621761|100814409|FG000|Overall Study|Lost to Follow-up|1|||
33249228|NCT03621761|100814410|FG001|Overall Study|Lost to Follow-up|1|||
33249229|NCT03621761|100814411|FG002|Overall Study|Lost to Follow-up|2|||
33249230|NCT03621761|100814409|FG000|Overall Study|Withdrawal by Subject|2|||
33249231|NCT03621761|100814410|FG001|Overall Study|Withdrawal by Subject|1|||
33249232|NCT03621761|100814411|FG002|Overall Study|Withdrawal by Subject|1|||
33249233|NCT03621761|100814409|FG000|Overall Study|Became Ineligible|0|||
33249234|NCT03621761|100814410|FG001|Overall Study|Became Ineligible|2|||
33249235|NCT03621761|100814411|FG002|Overall Study|Became Ineligible|0|||
33249236|NCT02982213|100814416|FG000|Overall Study|Did not complete follow up questionnaire|5|||
33383654|NCT02273037|101291428|FG000|Overall Study|Breech delivery|2|||
33588137|NCT03985943|102041736|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
33588138|NCT03985943|102041737|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
33588139|NCT03985943|102041738|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
33588140|NCT03985943|102041739|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
33588141|NCT03985943|102041740|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
33588142|NCT03985943|102041735|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
33588143|NCT03985943|102041736|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
33588144|NCT03985943|102041737|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
33588145|NCT03985943|102041738|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
33588146|NCT03985943|102041739|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
33588147|NCT03985943|102041740|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
33588148|NCT03985943|102041735|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
33588149|NCT03985943|102041736|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
33588150|NCT03985943|102041737|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
33588151|NCT03985943|102041738|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
33588152|NCT03985943|102041739|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
33588153|NCT03985943|102041740|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
33588154|NCT01108731|102041741|FG000|Overall Study|Withdrawal by Subject|1|||
33588155|NCT01108731|102041742|FG001|Overall Study|Withdrawal by Subject|1|||
33588156|NCT01108731|102041741|FG000|Overall Study|Adverse Event|3|||
33249237|NCT02982213|100814417|FG001|Overall Study|Did not complete follow up questionnaire|1|||
33249238|NCT00001575|100814418|FG000|Overall Study|Screening failures-Ph I portion|22|||
33249239|NCT00001575|100814418|FG000|Overall Study|Withdrawn/deaths|23|||
33383655|NCT02273037|101291429|FG001|Overall Study|Breech delivery|3|||
33383656|NCT02273037|101291428|FG000|Overall Study|Multiple delivery|2|||
33383657|NCT02273037|101291429|FG001|Overall Study|Multiple delivery|2|||
33383658|NCT02273037|101291428|FG000|Overall Study|Other complication|2|||
33383659|NCT02273037|101291429|FG001|Overall Study|Other complication|0|||
33383660|NCT03595384|101291430|FG000|Overall Study|Other time commitments|8|||
33383661|NCT03595384|101291430|FG000|Overall Study|Changes to session time|7|||
33383662|NCT03595384|101291430|FG000|Overall Study|Relocation out of country|1|||
33588157|NCT01108731|102041742|FG001|Overall Study|Adverse Event|3|||
33588158|NCT05507567|102041743|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
33249240|NCT01648140|100814419|FG000|Overall Study|Physician Decision|1|||
33249241|NCT01648140|100814420|FG001|Overall Study|Physician Decision|0|||
33383663|NCT00615914|101291431|FG000|Overall Study|Adverse Event|274|||
33588159|NCT05507567|102041744|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
33249242|NCT01648140|100814421|FG002|Overall Study|Physician Decision|0|||
33249243|NCT01648140|100814422|FG003|Overall Study|Physician Decision|0|||
33383664|NCT00615914|101291431|FG000|Overall Study|Death|20|||
33249244|NCT01648140|100814419|FG000|Overall Study|Lack of Efficacy|4|||
33430914|NCT00106028|101467547|FG001|Overall Study|Withdrawal by Subject|8|||
33430915|NCT00106028|101467546|FG000|Overall Study|Lost to Follow-up|0|||
33430916|NCT00106028|101467547|FG001|Overall Study|Lost to Follow-up|1|||
33430917|NCT00969332|101467548|FG000|Overall Study|Physician Decision|8|||
33430918|NCT00969332|101467548|FG000|Overall Study|Withdrawal by Subject|3|||
33430919|NCT01896297|101467560|FG000|Overall Study|Died in post treatment phase|1|||
33430920|NCT03271528|101467561|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
33430921|NCT03271528|101467562|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
33430922|NCT03271528|101467561|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
33430923|NCT03271528|101467562|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
33430924|NCT03271528|101467561|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
33430925|NCT03271528|101467562|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
33430926|NCT03271528|101467561|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
33430927|NCT03271528|101467562|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
33430928|NCT03271528|101467561|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
33430929|NCT03271528|101467562|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
33430930|NCT03271528|101467561|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
33430931|NCT03271528|101467562|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
33430932|NCT03271528|101467561|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
33430933|NCT03271528|101467562|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
33430934|NCT04820842|101467563|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
33430935|NCT04820842|101467564|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
33430936|NCT04820842|101467565|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
33430937|NCT04820842|101467566|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
33430938|NCT04820842|101467567|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
33430939|NCT04820842|101467568|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
33430940|NCT04820842|101467569|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
33430941|NCT04820842|101467563|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
33430942|NCT04820842|101467564|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
33430943|NCT04820842|101467565|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
33430944|NCT04820842|101467566|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
33430945|NCT04820842|101467567|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
33430946|NCT04820842|101467568|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
33430947|NCT04820842|101467569|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
33430948|NCT04820842|101467563|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
33430949|NCT04820842|101467564|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
33430950|NCT04820842|101467565|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
33149684|NCT03730012|100463457|FG000|Overall Study|Lack of Efficacy|1|||
33383665|NCT00615914|101291431|FG000|Overall Study|Lack of Efficacy|59|||
33383666|NCT00615914|101291431|FG000|Overall Study|Lost to Follow-up|187|||
33383667|NCT00615914|101291431|FG000|Overall Study|Withdrawal by Subject|16|||
33383668|NCT00615914|101291431|FG000|Overall Study|Physician Decision|4|||
33383669|NCT00615914|101291431|FG000|Overall Study|No data was collected.|65|||
33383670|NCT00615914|101291431|FG000|Overall Study|No treatment|2|||
33383671|NCT00615914|101291431|FG000|Overall Study|Irregularly enrolled patients|10|||
33383672|NCT02759861|101291434|FG000|Overall Study|Death|1|||
33383673|NCT00603733|101291435|FG000|Active Phase ITT|Adverse Event|8|||
33383674|NCT00603733|101291436|FG001|Active Phase ITT|Adverse Event|7|||
33383675|NCT00603733|101291435|FG000|Active Phase ITT|Withdrawal by Subject|0|||
33383676|NCT00603733|101291436|FG001|Active Phase ITT|Withdrawal by Subject|3|||
33383677|NCT00603733|101291435|FG000|Active Phase ITT|Lost to Follow-up|0|||
33383678|NCT00603733|101291436|FG001|Active Phase ITT|Lost to Follow-up|1|||
33383679|NCT00603733|101291435|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
33383680|NCT00603733|101291436|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
33383681|NCT00603733|101291435|FG000|Active Phase ITT|Lack of Efficacy|1|||
33383682|NCT00603733|101291436|FG001|Active Phase ITT|Lack of Efficacy|2|||
33383683|NCT00603733|101291435|FG000|Active Phase ITT|Subject moved, site closed|1|||
33383684|NCT00603733|101291436|FG001|Active Phase ITT|Subject moved, site closed|1|||
33383685|NCT00603733|101291435|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
33383686|NCT00603733|101291436|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
33383687|NCT00603733|101291435|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
33383688|NCT00603733|101291436|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
33383689|NCT00603733|101291435|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
33383690|NCT00603733|101291436|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
33430951|NCT04820842|101467566|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
33430952|NCT04820842|101467567|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
33430953|NCT04820842|101467568|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
33430954|NCT04820842|101467569|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
33430955|NCT04820842|101467563|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
33430956|NCT04820842|101467564|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
33430957|NCT04820842|101467565|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
33430958|NCT04820842|101467566|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
33648036|NCT00095940|102262930|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
33648037|NCT00095940|102262931|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
33648038|NCT00095940|102262932|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
33648039|NCT00095940|102262933|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
33648040|NCT00095940|102262925|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
33648041|NCT00095940|102262926|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
33648042|NCT00095940|102262927|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
33648043|NCT00095940|102262928|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
33648044|NCT00095940|102262929|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
33648045|NCT00095940|102262930|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
33648046|NCT00095940|102262931|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
33648047|NCT00095940|102262932|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
33648048|NCT00095940|102262933|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
33648049|NCT00095940|102262925|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
33648050|NCT00095940|102262926|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
33430959|NCT04820842|101467567|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
33430960|NCT04820842|101467568|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
33430961|NCT04820842|101467569|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
33430962|NCT01890707|101467570|FG000|Overall Study|Lost to Follow-up|1|||
33430963|NCT01890707|101467571|FG001|Overall Study|Lost to Follow-up|1|||
33430964|NCT01748890|101467574|FG000|Overall Study|Insufficient recruitment for analysis|4|||
33430965|NCT00613574|101467575|FG000|Overall Study|Adverse Event|3|||
33430966|NCT00613574|101467575|FG000|Overall Study|Lost to Follow-up|2|||
33430967|NCT00613574|101467575|FG000|Overall Study|Other|1|||
33430968|NCT02004847|101467576|FG000|Overall Study|Protocol Violation|1|||
33430969|NCT02004847|101467577|FG001|Overall Study|Protocol Violation|1|||
33430970|NCT00545233|101467581|FG000|Overall Study|Adverse Event|10|||
33430971|NCT00545233|101467582|FG001|Overall Study|Adverse Event|5|||
33430972|NCT00545233|101467581|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
33648051|NCT00095940|102262927|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
33648052|NCT00095940|102262928|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
33648053|NCT00095940|102262929|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
33149685|NCT03730012|100463458|FG001|Overall Study|Lack of Efficacy|5|||
33149686|NCT03730012|100463457|FG000|Overall Study|Withdrawal by Subject|0|||
33149687|NCT03730012|100463458|FG001|Overall Study|Withdrawal by Subject|1|||
33430973|NCT00545233|101467582|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
33149688|NCT03730012|100463457|FG000|Overall Study|Miscellaneous|2|||
33149689|NCT03730012|100463458|FG001|Overall Study|Miscellaneous|1|||
33149690|NCT02484690|100463459|FG000|Overall Study|Adverse Event|1|||
33149691|NCT02484690|100463460|FG001|Overall Study|Adverse Event|3|||
33648054|NCT00095940|102262930|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
33149692|NCT02484690|100463461|FG002|Overall Study|Adverse Event|0|||
33149693|NCT02484690|100463462|FG003|Overall Study|Adverse Event|0|||
33149694|NCT02484690|100463463|FG004|Overall Study|Adverse Event|5|||
33149695|NCT02484690|100463459|FG000|Overall Study|Death|0|||
33149696|NCT02484690|100463460|FG001|Overall Study|Death|0|||
33149697|NCT02484690|100463461|FG002|Overall Study|Death|0|||
33149698|NCT02484690|100463462|FG003|Overall Study|Death|0|||
33149699|NCT02484690|100463463|FG004|Overall Study|Death|1|||
33149700|NCT02484690|100463459|FG000|Overall Study|Withdrawal by Subject|1|||
33149701|NCT02484690|100463460|FG001|Overall Study|Withdrawal by Subject|3|||
33149702|NCT02484690|100463461|FG002|Overall Study|Withdrawal by Subject|1|||
33149703|NCT02484690|100463462|FG003|Overall Study|Withdrawal by Subject|2|||
33149704|NCT02484690|100463463|FG004|Overall Study|Withdrawal by Subject|0|||
33149705|NCT02484690|100463459|FG000|Overall Study|Physician Decision|2|||
33149706|NCT02484690|100463460|FG001|Overall Study|Physician Decision|0|||
33149707|NCT02484690|100463461|FG002|Overall Study|Physician Decision|1|||
33149708|NCT02484690|100463462|FG003|Overall Study|Physician Decision|0|||
33149709|NCT02484690|100463463|FG004|Overall Study|Physician Decision|0|||
33149710|NCT02484690|100463459|FG000|Overall Study|Lost to Follow-up|0|||
33430974|NCT00545233|101467581|FG000|Overall Study|Protocol Violation|2|||
33430975|NCT00545233|101467582|FG001|Overall Study|Protocol Violation|0|||
33430976|NCT00545233|101467581|FG000|Overall Study|Refused Treatment|9|||
33430977|NCT00545233|101467582|FG001|Overall Study|Refused Treatment|7|||
33430978|NCT00545233|101467581|FG000|Overall Study|Failure to Return|4|||
33430979|NCT00545233|101467582|FG001|Overall Study|Failure to Return|6|||
33430980|NCT00545233|101467581|FG000|Overall Study|Insufficient response|14|||
33430981|NCT00545233|101467582|FG001|Overall Study|Insufficient response|15|||
33430982|NCT00545233|101467581|FG000|Overall Study|Physician Decision|2|||
33430983|NCT00545233|101467582|FG001|Overall Study|Physician Decision|1|||
33430984|NCT03465891|101467589|FG000|Overall Study|Withdrawal by Subject|0|||
33430985|NCT03465891|101467590|FG001|Overall Study|Withdrawal by Subject|1|||
33430986|NCT03465891|101467589|FG000|Overall Study|Disease progression|1|||
33430987|NCT03465891|101467590|FG001|Overall Study|Disease progression|0|||
33430988|NCT03276975|101467591|FG000|Overall Study|Withdrawal by Subject|1|||
33430989|NCT03276975|101467592|FG001|Overall Study|Withdrawal by Subject|0|||
33430990|NCT02919475|101467593|FG000|Overall Study|Adverse Event|3|||
33430991|NCT02919475|101467594|FG001|Overall Study|Adverse Event|3|||
33430992|NCT02919475|101467595|FG002|Overall Study|Adverse Event|3|||
33430993|NCT02919475|101467596|FG003|Overall Study|Adverse Event|9|||
33430994|NCT02919475|101467597|FG004|Overall Study|Adverse Event|2|||
33430995|NCT02919475|101467593|FG000|Overall Study|Death|0|||
33430996|NCT02919475|101467594|FG001|Overall Study|Death|1|||
33430997|NCT02919475|101467595|FG002|Overall Study|Death|0|||
33430998|NCT02919475|101467596|FG003|Overall Study|Death|0|||
33430999|NCT02919475|101467597|FG004|Overall Study|Death|0|||
33431000|NCT02919475|101467593|FG000|Overall Study|Lost to Follow-up|0|||
33431001|NCT02919475|101467594|FG001|Overall Study|Lost to Follow-up|0|||
33431002|NCT02919475|101467595|FG002|Overall Study|Lost to Follow-up|0|||
33431003|NCT02919475|101467596|FG003|Overall Study|Lost to Follow-up|1|||
33431004|NCT02919475|101467597|FG004|Overall Study|Lost to Follow-up|0|||
33431005|NCT02919475|101467593|FG000|Overall Study|Withdrawal by Subject|2|||
33431006|NCT02919475|101467594|FG001|Overall Study|Withdrawal by Subject|3|||
33431007|NCT02919475|101467595|FG002|Overall Study|Withdrawal by Subject|1|||
33431008|NCT02919475|101467596|FG003|Overall Study|Withdrawal by Subject|2|||
33431009|NCT02919475|101467597|FG004|Overall Study|Withdrawal by Subject|2|||
33431010|NCT02919475|101467593|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
33431011|NCT02919475|101467594|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
33431012|NCT02919475|101467595|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
33431013|NCT02919475|101467596|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
33431014|NCT02919475|101467597|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33431015|NCT05431153|101467598|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33431016|NCT05431153|101467599|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33431017|NCT05431153|101467600|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33431018|NCT05431153|101467601|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33431019|NCT05431153|101467602|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
33431020|NCT05431153|101467603|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33431021|NCT01625377|101467604|FG000|Overall Study|Death|1|||
33431022|NCT01625377|101467605|FG001|Overall Study|Death|1|||
33431023|NCT01625377|101467604|FG000|Overall Study|Administrative Problem|1|||
33431024|NCT01625377|101467605|FG001|Overall Study|Administrative Problem|1|||
33431025|NCT01625377|101467604|FG000|Overall Study|Protocol Violation|0|||
33431026|NCT01625377|101467605|FG001|Overall Study|Protocol Violation|3|||
33431027|NCT01625377|101467604|FG000|Overall Study|Adverse Event|3|||
33431028|NCT01625377|101467605|FG001|Overall Study|Adverse Event|16|||
33431029|NCT01625377|101467604|FG000|Overall Study|Graft loss|1|||
33431030|NCT01625377|101467605|FG001|Overall Study|Graft loss|0|||
33431031|NCT01625377|101467604|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33431032|NCT01625377|101467605|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33431033|NCT01625377|101467604|FG000|Overall Study|Abnormal laboratory values|1|||
33431034|NCT01625377|101467605|FG001|Overall Study|Abnormal laboratory values|0|||
33431035|NCT03443869|101467606|FG000|Overall Study|Death|3|||
33431036|NCT03443869|101467607|FG001|Overall Study|Death|3|||
33431037|NCT03443869|101467606|FG000|Overall Study|Withdrawal by Subject|34|||
33431038|NCT03443869|101467607|FG001|Overall Study|Withdrawal by Subject|22|||
33431039|NCT03443869|101467606|FG000|Overall Study|Lost to Follow-up|1|||
33431040|NCT03443869|101467607|FG001|Overall Study|Lost to Follow-up|2|||
33431041|NCT03443869|101467606|FG000|Overall Study|Physician Decision|3|||
33431042|NCT03443869|101467607|FG001|Overall Study|Physician Decision|3|||
33431043|NCT03443869|101467606|FG000|Overall Study|Other|4|||
33431044|NCT03443869|101467607|FG001|Overall Study|Other|4|||
33431045|NCT02668302|101467613|FG000|Overall Study|Withdrawal by Subject|1|||
33431046|NCT02668302|101467614|FG001|Overall Study|Withdrawal by Subject|0|||
33431047|NCT00467584|101467615|FG000|Overall Study|Withdrawal by Subject|4|||
33431048|NCT00467584|101467616|FG001|Overall Study|Withdrawal by Subject|5|||
33431049|NCT00467584|101467617|FG002|Overall Study|Withdrawal by Subject|1|||
33431050|NCT01960816|101467618|FG000|Overall Study|Lost to Follow-up|1|||
33588160|NCT05507567|102041745|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
33431051|NCT03538756|101467619|FG000|Long-Term Follow-up|Adverse Event|0|||
33431052|NCT03538756|101467620|FG001|Long-Term Follow-up|Adverse Event|0|||
33431053|NCT03538756|101467621|FG002|Long-Term Follow-up|Adverse Event|6|||
33431054|NCT03538756|101467619|FG000|Long-Term Follow-up|Death|0|||
33431055|NCT03538756|101467620|FG001|Long-Term Follow-up|Death|0|||
33431056|NCT03538756|101467621|FG002|Long-Term Follow-up|Death|1|||
33431057|NCT03538756|101467619|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
33431058|NCT03538756|101467620|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
33431059|NCT03538756|101467621|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
33431060|NCT03538756|101467619|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
33431061|NCT03538756|101467620|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
33431062|NCT03538756|101467621|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
33431063|NCT03538756|101467619|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
33431064|NCT03538756|101467620|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
33431065|NCT03538756|101467621|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
33431066|NCT01309919|101467624|FG000|Overall Study|Did not receive a postpartum IUD|17|||
33431067|NCT01309919|101467625|FG001|Overall Study|Did not receive a postpartum IUD|48|||
33431068|NCT02153736|101467626|FG000|Overall Study|Lost to Follow-up|1|||
33431069|NCT02153736|101467627|FG001|Overall Study|Lost to Follow-up|0|||
33431070|NCT02153736|101467626|FG000|Overall Study|Medical status change made ineligible|1|||
33431071|NCT02153736|101467627|FG001|Overall Study|Medical status change made ineligible|0|||
33431072|NCT02153736|101467626|FG000|Overall Study|Death|0|||
33431073|NCT02153736|101467627|FG001|Overall Study|Death|1|||
33431074|NCT02153736|101467626|FG000|Overall Study|Withdrawal by Subject|0|||
33431075|NCT02153736|101467627|FG001|Overall Study|Withdrawal by Subject|1|||
33431076|NCT01280981|101467628|FG000|Overall Study|Withdrawal by Subject|11|||
33431077|NCT01280981|101467628|FG000|Overall Study|Protocol Violation|2|||
33431078|NCT01280981|101467628|FG000|Overall Study|Lack of Efficacy|13|||
33431079|NCT01280981|101467628|FG000|Overall Study|Lost to Follow-up|3|||
33431080|NCT01280981|101467628|FG000|Overall Study|Adverse Event|6|||
33431081|NCT01280981|101467628|FG000|Overall Study|Irregular or discontinued menses|3|||
33431082|NCT01280981|101467628|FG000|Overall Study|Failed to return|45|||
33431083|NCT01280981|101467628|FG000|Overall Study|Non-compliance with protocol|3|||
33431084|NCT01280981|101467628|FG000|Overall Study|Withdrawal of consent|3|||
33431085|NCT01280981|101467628|FG000|Overall Study|Elective surgery|2|||
33431086|NCT01280981|101467628|FG000|Overall Study|Study site closure|1|||
33431087|NCT01346410|101467630|FG000|Overall Study|Death|1|||
33431088|NCT02688608|101467631|FG000|Overall Study|Lost to Follow-up|1|||
33431089|NCT02780700|101467632|FG000|Overall Study|Progressive disease|1|||
33431090|NCT01595009|101467633|FG000|Core|Patients completed per protocol|85|||
33431091|NCT01595009|101467634|FG001|Core|Patients completed per protocol|44|||
33431092|NCT01595009|101467635|FG002|Core|Patients completed per protocol|0|||
33431093|NCT01595009|101467636|FG003|Core|Patients completed per protocol|0|||
33431094|NCT01595009|101467633|FG000|Core|Adverse Event|19|||
33431095|NCT01595009|101467634|FG001|Core|Adverse Event|23|||
33431096|NCT01595009|101467635|FG002|Core|Adverse Event|0|||
33431097|NCT01595009|101467636|FG003|Core|Adverse Event|0|||
33431098|NCT01595009|101467633|FG000|Core|Disease progression|14|||
33431099|NCT01595009|101467634|FG001|Core|Disease progression|26|||
33431100|NCT01595009|101467635|FG002|Core|Disease progression|0|||
33431101|NCT01595009|101467636|FG003|Core|Disease progression|0|||
33431102|NCT01595009|101467633|FG000|Core|Withdrawal by Subject|4|||
33431103|NCT01595009|101467634|FG001|Core|Withdrawal by Subject|17|||
33431104|NCT01595009|101467635|FG002|Core|Withdrawal by Subject|0|||
33431105|NCT01595009|101467636|FG003|Core|Withdrawal by Subject|0|||
33431106|NCT01595009|101467633|FG000|Core|Death|3|||
33431107|NCT01595009|101467634|FG001|Core|Death|6|||
33431108|NCT01595009|101467635|FG002|Core|Death|0|||
33431109|NCT01595009|101467636|FG003|Core|Death|0|||
33431110|NCT01595009|101467633|FG000|Core|Lost to Follow-up|1|||
33431111|NCT01595009|101467634|FG001|Core|Lost to Follow-up|2|||
33431112|NCT01595009|101467635|FG002|Core|Lost to Follow-up|0|||
33431113|NCT01595009|101467636|FG003|Core|Lost to Follow-up|0|||
33431114|NCT01595009|101467633|FG000|Core|Protocol deviation|0|||
33431115|NCT01595009|101467634|FG001|Core|Protocol deviation|1|||
33431116|NCT01595009|101467635|FG002|Core|Protocol deviation|0|||
33431117|NCT01595009|101467636|FG003|Core|Protocol deviation|0|||
33431118|NCT01595009|101467633|FG000|Core|Administrative problems|0|||
33431119|NCT01595009|101467634|FG001|Core|Administrative problems|1|||
33431120|NCT01595009|101467635|FG002|Core|Administrative problems|0|||
33431121|NCT01595009|101467636|FG003|Core|Administrative problems|0|||
33431122|NCT01595009|101467633|FG000|Extension|Administrative problems|0|||
33149711|NCT02484690|100463460|FG001|Overall Study|Lost to Follow-up|0|||
33431123|NCT01595009|101467634|FG001|Extension|Administrative problems|0|||
33431124|NCT01595009|101467635|FG002|Extension|Administrative problems|0|||
33431125|NCT01595009|101467636|FG003|Extension|Administrative problems|1|||
33431126|NCT01595009|101467633|FG000|Extension|Patients completed per protocol|0|||
33431127|NCT01595009|101467634|FG001|Extension|Patients completed per protocol|0|||
33431128|NCT01595009|101467635|FG002|Extension|Patients completed per protocol|0|||
33431129|NCT01595009|101467636|FG003|Extension|Patients completed per protocol|2|||
33648055|NCT00095940|102262931|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
33648056|NCT00095940|102262932|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
33648057|NCT00095940|102262933|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
33648058|NCT00336856|102262934|FG000|Overall Study|Withdrawal by Subject|3|||
33648059|NCT00336856|102262934|FG000|Overall Study|Found ineligible at time of analysis|1|||
33648060|NCT00006409|102262935|FG000|Baseline|Protocol Violation|48|||
33648061|NCT00006409|102262936|FG001|Baseline|Protocol Violation|70|||
33648062|NCT00006409|102262937|FG002|Baseline|Protocol Violation|0|||
33249245|NCT01648140|100814420|FG001|Overall Study|Lack of Efficacy|7|||
33249246|NCT01648140|100814421|FG002|Overall Study|Lack of Efficacy|1|||
33249247|NCT01648140|100814422|FG003|Overall Study|Lack of Efficacy|0|||
33249248|NCT01648140|100814419|FG000|Overall Study|Adverse Event|3|||
33249249|NCT01648140|100814420|FG001|Overall Study|Adverse Event|1|||
33249250|NCT01648140|100814421|FG002|Overall Study|Adverse Event|2|||
33249251|NCT01648140|100814422|FG003|Overall Study|Adverse Event|0|||
33249252|NCT01648140|100814419|FG000|Overall Study|Withdrawal by Subject|2|||
33249253|NCT01648140|100814420|FG001|Overall Study|Withdrawal by Subject|3|||
33249254|NCT01648140|100814421|FG002|Overall Study|Withdrawal by Subject|3|||
33249255|NCT01648140|100814422|FG003|Overall Study|Withdrawal by Subject|2|||
33249256|NCT01648140|100814419|FG000|Overall Study|Lost to Follow-up|2|||
33249257|NCT01648140|100814420|FG001|Overall Study|Lost to Follow-up|1|||
33249258|NCT01648140|100814421|FG002|Overall Study|Lost to Follow-up|2|||
33249259|NCT01648140|100814422|FG003|Overall Study|Lost to Follow-up|0|||
33249260|NCT00930813|100814439|FG000|Overall Study|Death|4|||
33249261|NCT00930813|100814440|FG001|Overall Study|Death|5|||
33249262|NCT00930813|100814439|FG000|Overall Study|Withdrawal by Subject|2|||
33249263|NCT00930813|100814440|FG001|Overall Study|Withdrawal by Subject|5|||
33249264|NCT00930813|100814439|FG000|Overall Study|Lost to Follow-up|2|||
33249265|NCT00930813|100814440|FG001|Overall Study|Lost to Follow-up|4|||
33249266|NCT03264456|100814441|FG000|Overall Study|Withdrawal by Subject|3|||
33249267|NCT03264456|100814441|FG000|Overall Study|Lost to Follow-up|1|||
33249268|NCT02232178|100814442|FG000|Overall Study|Lost to Follow-up|0|||
33249269|NCT02232178|100814443|FG001|Overall Study|Lost to Follow-up|1|||
33249270|NCT02232178|100814444|FG002|Overall Study|Lost to Follow-up|0|||
33249271|NCT02232178|100814442|FG000|Overall Study|ineligibility|0|||
33249272|NCT02232178|100814443|FG001|Overall Study|ineligibility|0|||
33249273|NCT02232178|100814444|FG002|Overall Study|ineligibility|1|||
33249274|NCT02232178|100814442|FG000|Overall Study|surgical complication|1|||
33249275|NCT02232178|100814443|FG001|Overall Study|surgical complication|0|||
33249276|NCT02232178|100814444|FG002|Overall Study|surgical complication|0|||
33249277|NCT00269399|100814445|FG000|Overall Study|Lack of Efficacy|27|||
33249278|NCT00269399|100814446|FG001|Overall Study|Lack of Efficacy|10|||
33249279|NCT00269399|100814445|FG000|Overall Study|Adverse Event|10|||
33249280|NCT00269399|100814446|FG001|Overall Study|Adverse Event|4|||
33249281|NCT00269399|100814445|FG000|Overall Study|Withdrawal by Subject|2|||
33249282|NCT00269399|100814446|FG001|Overall Study|Withdrawal by Subject|5|||
33249283|NCT00269399|100814445|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
33249284|NCT00269399|100814446|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
33249285|NCT00269399|100814445|FG000|Overall Study|Other|0|||
33249286|NCT00269399|100814446|FG001|Overall Study|Other|4|||
33249287|NCT00269399|100814445|FG000|Overall Study|Development of exclusion criteria|0|||
33249288|NCT00269399|100814446|FG001|Overall Study|Development of exclusion criteria|1|||
33249289|NCT00494442|100814447|FG000|Overall Study|Death|1|||
33249290|NCT00494442|100814448|FG001|Overall Study|Death|1|||
33249291|NCT00494442|100814447|FG000|Overall Study|Lack of Efficacy|16|||
33249292|NCT00494442|100814448|FG001|Overall Study|Lack of Efficacy|10|||
33648063|NCT00006409|102262938|FG003|Baseline|Protocol Violation|0|||
33648064|NCT00006409|102262939|FG004|Baseline|Protocol Violation|0|||
33648065|NCT00006409|102262940|FG005|Baseline|Protocol Violation|0|||
33648066|NCT00006409|102262935|FG000|Post-2 Year Intervention|Protocol Violation|0|||
33149712|NCT02484690|100463461|FG002|Overall Study|Lost to Follow-up|1|||
33249293|NCT00494442|100814447|FG000|Overall Study|Adverse Event|0|||
33249294|NCT00494442|100814448|FG001|Overall Study|Adverse Event|2|||
33249295|NCT00494442|100814447|FG000|Overall Study|Physician Decision|0|||
33249296|NCT00494442|100814448|FG001|Overall Study|Physician Decision|1|||
33249297|NCT00494442|100814447|FG000|Overall Study|Non-compliance|0|||
33588161|NCT05507567|102041743|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
33249298|NCT00494442|100814448|FG001|Overall Study|Non-compliance|1|||
33249299|NCT00494442|100814447|FG000|Overall Study|Intercurrent illness|0|||
33249300|NCT00494442|100814448|FG001|Overall Study|Intercurrent illness|1|||
33249301|NCT02987543|100814449|FG000|Overall Study|Ongoing study at data cut off|49|||
33249302|NCT02987543|100814450|FG001|Overall Study|Ongoing study at data cut off|21|||
33249303|NCT02987543|100814451|FG002|Overall Study|Ongoing study at data cut off|19|||
33249304|NCT02987543|100814452|FG003|Overall Study|Ongoing study at data cut off|12|||
33648067|NCT00006409|102262936|FG001|Post-2 Year Intervention|Protocol Violation|0|||
33249305|NCT02987543|100814449|FG000|Overall Study|Death|88|||
33249306|NCT02987543|100814450|FG001|Overall Study|Death|54|||
33249307|NCT02987543|100814451|FG002|Overall Study|Death|67|||
33431130|NCT01595009|101467633|FG000|Extension|Disease progression|0|||
33431131|NCT01595009|101467634|FG001|Extension|Disease progression|0|||
33431132|NCT01595009|101467635|FG002|Extension|Disease progression|4|||
33431133|NCT01595009|101467636|FG003|Extension|Disease progression|7|||
33431134|NCT01595009|101467633|FG000|Extension|Adverse Event|0|||
33431135|NCT01595009|101467634|FG001|Extension|Adverse Event|0|||
33431136|NCT01595009|101467635|FG002|Extension|Adverse Event|0|||
33431137|NCT01595009|101467636|FG003|Extension|Adverse Event|1|||
33431138|NCT04947579|101470883|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
33431139|NCT04947579|101470884|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
33431140|NCT04947579|101470885|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
33431141|NCT04947579|101470886|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
33431142|NCT04947579|101470887|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
33431143|NCT04947579|101470888|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
33431144|NCT04947579|101470883|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
33431145|NCT04947579|101470884|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
33431146|NCT04947579|101470885|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
33431147|NCT04947579|101470886|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
33431148|NCT04947579|101470887|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
33431149|NCT04947579|101470888|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
33431150|NCT04947579|101470883|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
33431151|NCT04947579|101470884|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
33431152|NCT04947579|101470885|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
33431153|NCT04947579|101470886|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
33431154|NCT04947579|101470887|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
33431155|NCT04947579|101470888|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
33431156|NCT04947579|101470883|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
33431157|NCT04947579|101470884|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
33431158|NCT04947579|101470885|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
33431159|NCT04947579|101470886|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
33431160|NCT04947579|101470887|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
33431161|NCT04947579|101470888|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
33431162|NCT04947579|101470883|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
33431163|NCT04947579|101470884|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
33431164|NCT04947579|101470885|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
33431165|NCT04947579|101470886|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
33431166|NCT04947579|101470887|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
33431167|NCT04947579|101470888|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
33431168|NCT04947579|101470883|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
33431169|NCT04947579|101470884|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
33431170|NCT04947579|101470885|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
33431171|NCT04947579|101470886|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
33431172|NCT04947579|101470887|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
33431173|NCT04947579|101470888|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
33431174|NCT04947579|101470883|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
33431175|NCT04947579|101470884|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
33431176|NCT04947579|101470885|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
33431177|NCT04947579|101470886|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
33431178|NCT04947579|101470887|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
33431179|NCT04947579|101470888|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
33431180|NCT04947579|101470883|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
33431181|NCT04947579|101470884|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
33431182|NCT04947579|101470885|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
33431183|NCT04947579|101470886|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
33431184|NCT04947579|101470887|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
33431185|NCT04947579|101470888|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
33431186|NCT04947579|101470883|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
33431187|NCT04947579|101470884|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
33431188|NCT04947579|101470885|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
33431189|NCT04947579|101470886|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
33431190|NCT04947579|101470887|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
33431191|NCT04947579|101470888|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
33431192|NCT04947579|101470883|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
33431193|NCT04947579|101470884|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
33431194|NCT04947579|101470885|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
33149713|NCT02484690|100463462|FG003|Overall Study|Lost to Follow-up|0|||
33431195|NCT04947579|101470886|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
33431196|NCT04947579|101470887|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
33431197|NCT04947579|101470888|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
33431198|NCT04947579|101470883|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
33431199|NCT04947579|101470884|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
33431200|NCT04947579|101470885|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
33431201|NCT04947579|101470886|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
33431202|NCT04947579|101470887|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
33431203|NCT04947579|101470888|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
33431204|NCT00467818|101470889|FG000|Overall Study|Adverse Event|1|||
33431205|NCT00467818|101470890|FG001|Overall Study|Adverse Event|0|||
33431206|NCT00467818|101470889|FG000|Overall Study|Lost to Follow-up|2|||
33431207|NCT00467818|101470890|FG001|Overall Study|Lost to Follow-up|2|||
33431208|NCT00928252|101470893|FG000|Overall Study|Physician Decision|3|||
33431209|NCT02043366|101470894|FG000|Overall Study|Lost to Follow-up|2|||
33431210|NCT02043366|101470895|FG001|Overall Study|Lost to Follow-up|2|||
33431211|NCT02043366|101470896|FG002|Overall Study|Lost to Follow-up|2|||
33431212|NCT02043366|101470897|FG003|Overall Study|Lost to Follow-up|2|||
33431213|NCT02043366|101470898|FG004|Overall Study|Lost to Follow-up|2|||
33431214|NCT02043366|101470899|FG005|Overall Study|Lost to Follow-up|2|||
33431215|NCT00720122|101470902|FG000|Overall Study|Lost to Follow-up|1|||
33431216|NCT00720122|101470902|FG000|Overall Study|Physician Decision|1|||
33431217|NCT00720122|101470902|FG000|Overall Study|Withdrawal by Subject|7|||
33431218|NCT02637076|101470910|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
33431219|NCT02637076|101470911|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
33431220|NCT02637076|101470910|FG000|Overall Study|Withdrawal by Subject|0|||
33431221|NCT02637076|101470911|FG001|Overall Study|Withdrawal by Subject|4|||
33431222|NCT00993616|101470913|FG000|Overall Study|No tumor at entry|1|||
33431223|NCT00993616|101470913|FG000|Overall Study|Never treated|1|||
33431224|NCT00672620|101470914|FG000|Overall Study|Adverse Event|7|||
33431225|NCT00672620|101470915|FG001|Overall Study|Adverse Event|7|||
33648068|NCT00006409|102262937|FG002|Post-2 Year Intervention|Protocol Violation|251|||
33648069|NCT00006409|102262938|FG003|Post-2 Year Intervention|Protocol Violation|168|||
33648070|NCT00006409|102262939|FG004|Post-2 Year Intervention|Protocol Violation|0|||
33648071|NCT00006409|102262940|FG005|Post-2 Year Intervention|Protocol Violation|0|||
33648072|NCT00006409|102262935|FG000|Post-3 Year Intervention|Protocol Violation|0|||
33648073|NCT00006409|102262936|FG001|Post-3 Year Intervention|Protocol Violation|0|||
33149714|NCT02484690|100463463|FG004|Overall Study|Lost to Follow-up|0|||
33431226|NCT00672620|101470916|FG002|Overall Study|Adverse Event|12|||
33431227|NCT00672620|101470917|FG003|Overall Study|Adverse Event|17|||
33431228|NCT00672620|101470914|FG000|Overall Study|Lack of Efficacy|1|||
33431229|NCT00672620|101470915|FG001|Overall Study|Lack of Efficacy|2|||
33431230|NCT00672620|101470916|FG002|Overall Study|Lack of Efficacy|2|||
33431231|NCT00672620|101470917|FG003|Overall Study|Lack of Efficacy|0|||
33431232|NCT00672620|101470914|FG000|Overall Study|Noncompliance with Study Drug|3|||
33431233|NCT00672620|101470915|FG001|Overall Study|Noncompliance with Study Drug|4|||
33431234|NCT00672620|101470916|FG002|Overall Study|Noncompliance with Study Drug|0|||
33431235|NCT00672620|101470917|FG003|Overall Study|Noncompliance with Study Drug|2|||
33431236|NCT00672620|101470914|FG000|Overall Study|Protocol Deviations|5|||
33431237|NCT00672620|101470915|FG001|Overall Study|Protocol Deviations|7|||
33431238|NCT00672620|101470916|FG002|Overall Study|Protocol Deviations|2|||
33431239|NCT00672620|101470917|FG003|Overall Study|Protocol Deviations|5|||
33431240|NCT00672620|101470914|FG000|Overall Study|Withdrawal of Consent|6|||
33431241|NCT00672620|101470915|FG001|Overall Study|Withdrawal of Consent|12|||
33431242|NCT00672620|101470916|FG002|Overall Study|Withdrawal of Consent|5|||
33431243|NCT00672620|101470917|FG003|Overall Study|Withdrawal of Consent|6|||
33431244|NCT00672620|101470914|FG000|Overall Study|Lost to Follow-up|8|||
33431245|NCT00672620|101470915|FG001|Overall Study|Lost to Follow-up|19|||
33431246|NCT00672620|101470916|FG002|Overall Study|Lost to Follow-up|8|||
33149715|NCT03274687|100463464|FG000|Overall Study|Protocol Violation|1|||
33149716|NCT03274687|100463465|FG001|Overall Study|Protocol Violation|1|||
33431247|NCT00672620|101470917|FG003|Overall Study|Lost to Follow-up|11|||
33431248|NCT00672620|101470914|FG000|Overall Study|Reason not Specified|3|||
33431249|NCT00672620|101470915|FG001|Overall Study|Reason not Specified|3|||
33431250|NCT00672620|101470916|FG002|Overall Study|Reason not Specified|2|||
33431251|NCT00672620|101470917|FG003|Overall Study|Reason not Specified|1|||
33431252|NCT00385541|101470918|FG000|Overall Study|severe pain, clinician requested unblind|0|||
33431253|NCT00385541|101470919|FG001|Overall Study|severe pain, clinician requested unblind|1|||
33431254|NCT03522948|101470920|FG000|Overall Study|Lost to Follow-up|1|||
33431255|NCT01958281|101470922|FG000|Overall Study|Lack of Efficacy|5|||
33431256|NCT01958281|101470923|FG001|Overall Study|Lack of Efficacy|2|||
33431257|NCT01958281|101470924|FG002|Overall Study|Lack of Efficacy|0|||
33431258|NCT01958281|101470922|FG000|Overall Study|Adverse Event|0|||
33431259|NCT01958281|101470923|FG001|Overall Study|Adverse Event|2|||
33249308|NCT02987543|100814452|FG003|Overall Study|Death|28|||
33249309|NCT02987543|100814449|FG000|Overall Study|Lost to Follow-up|3|||
33249310|NCT02987543|100814450|FG001|Overall Study|Lost to Follow-up|0|||
33249311|NCT02987543|100814451|FG002|Overall Study|Lost to Follow-up|1|||
33249312|NCT02987543|100814452|FG003|Overall Study|Lost to Follow-up|0|||
33249313|NCT02987543|100814449|FG000|Overall Study|Screen failure|0|||
33149717|NCT02891161|100463466|FG000|Study Treatment|Disease Progression|2|||
33588162|NCT05507567|102041744|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
33249314|NCT02987543|100814450|FG001|Overall Study|Screen failure|0|||
33249315|NCT02987543|100814451|FG002|Overall Study|Screen failure|0|||
33249316|NCT02987543|100814452|FG003|Overall Study|Screen failure|1|||
33249317|NCT02987543|100814449|FG000|Overall Study|Withdrawal by Subject|21|||
33249318|NCT02987543|100814450|FG001|Overall Study|Withdrawal by Subject|7|||
33249319|NCT02987543|100814451|FG002|Overall Study|Withdrawal by Subject|7|||
33249320|NCT02987543|100814452|FG003|Overall Study|Withdrawal by Subject|6|||
33249321|NCT02987543|100814449|FG000|Overall Study|Study terminated by sponsor|1|||
33249322|NCT02987543|100814450|FG001|Overall Study|Study terminated by sponsor|0|||
33249323|NCT02987543|100814451|FG002|Overall Study|Study terminated by sponsor|0|||
33249324|NCT02987543|100814452|FG003|Overall Study|Study terminated by sponsor|0|||
33249325|NCT02987543|100814449|FG000|Overall Study|Investigator decision|0|||
33249326|NCT02987543|100814450|FG001|Overall Study|Investigator decision|1|||
33249327|NCT02987543|100814451|FG002|Overall Study|Investigator decision|0|||
33249328|NCT02987543|100814452|FG003|Overall Study|Investigator decision|0|||
33249329|NCT02987543|100814449|FG000|Overall Study|Disease progression|0|||
33249330|NCT02987543|100814450|FG001|Overall Study|Disease progression|0|||
33249331|NCT02987543|100814451|FG002|Overall Study|Disease progression|0|||
33249332|NCT02987543|100814452|FG003|Overall Study|Disease progression|1|||
33249333|NCT00741988|100814456|FG000|Overall Study|Adverse Event|2|||
33249334|NCT00741988|100814457|FG001|Overall Study|Adverse Event|4|||
33249335|NCT00741988|100814456|FG000|Overall Study|Lack of Efficacy|2|||
33249336|NCT00741988|100814457|FG001|Overall Study|Lack of Efficacy|0|||
33588163|NCT05507567|102041745|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
33588164|NCT05507567|102041743|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
33588165|NCT05507567|102041744|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
33588166|NCT05507567|102041745|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
33588167|NCT05507567|102041743|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
33588168|NCT05507567|102041744|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
33588169|NCT05507567|102041745|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
33588170|NCT01639339|102041748|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
33588171|NCT01639339|102041749|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
33588172|NCT01639339|102041748|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
33588173|NCT01639339|102041749|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
33588174|NCT01639339|102041748|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
33149718|NCT02891161|100463467|FG001|Study Treatment|Disease Progression|4|||
33149719|NCT02891161|100463466|FG000|Study Treatment|AE/Side Effects/Complications|1|||
33149720|NCT02891161|100463467|FG001|Study Treatment|AE/Side Effects/Complications|5|||
33149721|NCT02891161|100463466|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
33149722|NCT02891161|100463467|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
33149723|NCT02891161|100463466|FG000|Follow up|Death|4|||
33149724|NCT02891161|100463467|FG001|Follow up|Death|8|||
33149725|NCT02891161|100463466|FG000|Follow up|Refused to Follow up|0|||
33149726|NCT02891161|100463467|FG001|Follow up|Refused to Follow up|2|||
33149727|NCT02891161|100463466|FG000|Follow up|Symptomatic deterioration|0|||
33149728|NCT02891161|100463467|FG001|Follow up|Symptomatic deterioration|1|||
33149729|NCT02891161|100463466|FG000|Follow up|Study terminated|0|||
33149730|NCT02891161|100463467|FG001|Follow up|Study terminated|6|||
33149731|NCT04078178|100463468|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
33149732|NCT04078178|100463469|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
33149733|NCT04078178|100463468|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
33249337|NCT01570751|100814458|FG000|Period A (16 Weeks)|Protocol Violation|1|||
33383691|NCT00603733|101291435|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
33431260|NCT01958281|101470924|FG002|Overall Study|Adverse Event|0|||
33149734|NCT04078178|100463469|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
33249338|NCT01570751|100814459|FG001|Period A (16 Weeks)|Protocol Violation|1|||
33249339|NCT01570751|100814458|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
33249340|NCT01570751|100814459|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
33249341|NCT01570751|100814458|FG000|Period A (16 Weeks)|Unclassified|2|||
33249342|NCT01570751|100814459|FG001|Period A (16 Weeks)|Unclassified|3|||
33249343|NCT01570751|100814458|FG000|Period B (16 Weeks)|Adverse Event|1|||
33249344|NCT01570751|100814459|FG001|Period B (16 Weeks)|Adverse Event|0|||
33249345|NCT01570751|100814458|FG000|Period B (16 Weeks)|Protocol Violation|0|||
33249346|NCT01570751|100814459|FG001|Period B (16 Weeks)|Protocol Violation|1|||
33249347|NCT00768651|100814460|FG000|Overall Study|Withdrawal by Subject|1|||
33383692|NCT00603733|101291436|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
33648074|NCT00006409|102262937|FG002|Post-3 Year Intervention|Protocol Violation|0|||
33648075|NCT00006409|102262938|FG003|Post-3 Year Intervention|Protocol Violation|0|||
33648076|NCT00006409|102262939|FG004|Post-3 Year Intervention|Protocol Violation|62|||
33648077|NCT00006409|102262940|FG005|Post-3 Year Intervention|Protocol Violation|62|||
33648078|NCT01643772|102262941|FG000|Overall Study|Protocol Violation|0|||
33648079|NCT01643772|102262942|FG001|Overall Study|Protocol Violation|0|||
33648080|NCT01643772|102262943|FG002|Overall Study|Protocol Violation|0|||
33648081|NCT01643772|102262944|FG003|Overall Study|Protocol Violation|1|||
33648082|NCT01643772|102262941|FG000|Overall Study|Adverse Event|0|||
33648083|NCT01643772|102262942|FG001|Overall Study|Adverse Event|0|||
33648084|NCT01643772|102262943|FG002|Overall Study|Adverse Event|0|||
33648085|NCT01643772|102262944|FG003|Overall Study|Adverse Event|1|||
33648086|NCT00638183|102262945|FG000|Overall Study|Adverse Event|23|||
33648087|NCT00638183|102262945|FG000|Overall Study|Lack of Efficacy|14|||
33648088|NCT00638183|102262945|FG000|Overall Study|Physician Decision|9|||
33648089|NCT00638183|102262945|FG000|Overall Study|Lost to Follow-up|46|||
33648090|NCT00638183|102262945|FG000|Overall Study|Other reason not defined above|27|||
33648091|NCT00344487|102262951|FG000|Overall Study|immunologic failure|1|||
33648092|NCT00531427|102262952|FG000|Overall Study|Withdrawal by Subject|7|||
33648093|NCT00531427|102262953|FG001|Overall Study|Withdrawal by Subject|13|||
33648094|NCT00531427|102262952|FG000|Overall Study|Adverse Event|44|||
33648095|NCT00531427|102262953|FG001|Overall Study|Adverse Event|30|||
33648096|NCT00531427|102262952|FG000|Overall Study|Lost to Follow-up|4|||
33648097|NCT00531427|102262953|FG001|Overall Study|Lost to Follow-up|3|||
33648098|NCT00531427|102262952|FG000|Overall Study|Lack of Efficacy|14|||
33648099|NCT00531427|102262953|FG001|Overall Study|Lack of Efficacy|39|||
33648100|NCT00531427|102262952|FG000|Overall Study|Administrative|4|||
33648101|NCT00531427|102262953|FG001|Overall Study|Administrative|9|||
33648102|NCT03113136|102262954|FG000|Overall Study|Lost to Follow-up|22|||
33648103|NCT03113136|102262955|FG001|Overall Study|Lost to Follow-up|47|||
33648104|NCT03113136|102262956|FG002|Overall Study|Lost to Follow-up|54|||
33648105|NCT03113136|102262954|FG000|Overall Study|Withdrawal by Subject|4|||
33648106|NCT03113136|102262955|FG001|Overall Study|Withdrawal by Subject|13|||
33648107|NCT03113136|102262956|FG002|Overall Study|Withdrawal by Subject|14|||
33648108|NCT03113136|102262954|FG000|Overall Study|Ineligible|0|||
33648109|NCT03113136|102262955|FG001|Overall Study|Ineligible|2|||
33648110|NCT03113136|102262956|FG002|Overall Study|Ineligible|1|||
33648111|NCT03113136|102262954|FG000|Overall Study|Study Team Decision|1|||
33648112|NCT03113136|102262955|FG001|Overall Study|Study Team Decision|4|||
33648113|NCT03113136|102262956|FG002|Overall Study|Study Team Decision|0|||
33648114|NCT00499616|102262957|FG000|Overall Study|Death|1|||
33648115|NCT00499616|102262958|FG001|Overall Study|Death|5|||
33648116|NCT00499616|102262959|FG002|Overall Study|Death|3|||
33648117|NCT00499616|102262960|FG003|Overall Study|Death|1|||
33648118|NCT00499616|102262957|FG000|Overall Study|Lack of Efficacy|5|||
33648119|NCT00499616|102262958|FG001|Overall Study|Lack of Efficacy|0|||
33648120|NCT00499616|102262959|FG002|Overall Study|Lack of Efficacy|19|||
33648121|NCT00499616|102262960|FG003|Overall Study|Lack of Efficacy|0|||
33648122|NCT00499616|102262957|FG000|Overall Study|Lost to Follow-up|0|||
33648123|NCT00499616|102262958|FG001|Overall Study|Lost to Follow-up|0|||
33648124|NCT00499616|102262959|FG002|Overall Study|Lost to Follow-up|1|||
33648125|NCT00499616|102262960|FG003|Overall Study|Lost to Follow-up|0|||
33648126|NCT00499616|102262957|FG000|Overall Study|Physician Decision|6|||
33648127|NCT00499616|102262958|FG001|Overall Study|Physician Decision|16|||
33648128|NCT00499616|102262959|FG002|Overall Study|Physician Decision|9|||
33648129|NCT00499616|102262960|FG003|Overall Study|Physician Decision|0|||
33648130|NCT00499616|102262957|FG000|Overall Study|Withdrawal by Subject|1|||
33648131|NCT00499616|102262958|FG001|Overall Study|Withdrawal by Subject|0|||
33149735|NCT04078178|100463468|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
33149736|NCT04078178|100463469|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
33149737|NCT04078178|100463468|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
33149738|NCT04078178|100463469|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
33648132|NCT00499616|102262959|FG002|Overall Study|Withdrawal by Subject|1|||
33648133|NCT00499616|102262960|FG003|Overall Study|Withdrawal by Subject|0|||
33648134|NCT00499616|102262957|FG000|Overall Study|Ineligible|1|||
33648135|NCT00499616|102262958|FG001|Overall Study|Ineligible|2|||
33648136|NCT00499616|102262959|FG002|Overall Study|Ineligible|0|||
33648137|NCT00499616|102262960|FG003|Overall Study|Ineligible|15|||
33648138|NCT00499616|102262957|FG000|Overall Study|Not evaluable|0|||
33648139|NCT00499616|102262958|FG001|Overall Study|Not evaluable|0|||
33648140|NCT00499616|102262959|FG002|Overall Study|Not evaluable|0|||
33648141|NCT00499616|102262960|FG003|Overall Study|Not evaluable|41|||
33648142|NCT00499616|102262957|FG000|Overall Study|Patient/Parent Refusal|1|||
33648143|NCT00499616|102262958|FG001|Overall Study|Patient/Parent Refusal|5|||
33648144|NCT00499616|102262959|FG002|Overall Study|Patient/Parent Refusal|3|||
33648145|NCT00499616|102262960|FG003|Overall Study|Patient/Parent Refusal|0|||
33648146|NCT00874939|102262963|FG000|Overall Study|Study terminated|4|||
33648147|NCT00003590|102262964|FG000|Overall Study|Ineligible Patient|1|||
33648148|NCT00003590|102262964|FG000|Overall Study|Adverse Event|7|||
33648149|NCT00003590|102262964|FG000|Overall Study|Withdrawal by Subject|1|||
33648150|NCT00003590|102262964|FG000|Overall Study|Lack of Efficacy|11|||
33648151|NCT00003590|102262964|FG000|Overall Study|Death|1|||
33648152|NCT00003590|102262964|FG000|Overall Study|Physician Decision|1|||
33648153|NCT00271505|102262965|FG000|Overall Study|Screen Failure|3|||
33149739|NCT04078178|100463468|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
33383693|NCT00603733|101291435|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
33383694|NCT00603733|101291436|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
33383695|NCT00603733|101291435|FG000|Maintenance Phase ITT|Adverse Event|3|||
33431261|NCT01958281|101470922|FG000|Overall Study|Withdrew Consent|1|||
33431262|NCT01958281|101470923|FG001|Overall Study|Withdrew Consent|0|||
33431263|NCT01958281|101470924|FG002|Overall Study|Withdrew Consent|0|||
33431264|NCT00264810|101470932|FG000|Baseline|Withdrawal by Subject|10|||
33431265|NCT00264810|101470933|FG001|Baseline|Withdrawal by Subject|10|||
33431266|NCT00264810|101470932|FG000|Baseline|Physician Decision|7|||
33431267|NCT00264810|101470933|FG001|Baseline|Physician Decision|8|||
33431268|NCT00264810|101470932|FG000|Baseline|Subject Compliance Failure|3|||
33431269|NCT00264810|101470933|FG001|Baseline|Subject Compliance Failure|3|||
33431270|NCT00264810|101470932|FG000|Baseline|Insufficient Seizure Frequency|2|||
33431271|NCT00264810|101470933|FG001|Baseline|Insufficient Seizure Frequency|2|||
33431272|NCT00264810|101470932|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
33431273|NCT00264810|101470933|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
33648154|NCT00271505|102262965|FG000|Overall Study|Adverse Event|1|||
33383696|NCT00603733|101291436|FG001|Maintenance Phase ITT|Adverse Event|6|||
33383697|NCT00603733|101291435|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
33383698|NCT00603733|101291436|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
33383699|NCT00603733|101291435|FG000|Maintenance Phase ITT|Protocol Violation|1|||
33383700|NCT00603733|101291436|FG001|Maintenance Phase ITT|Protocol Violation|1|||
33383701|NCT00603733|101291435|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
33383702|NCT00603733|101291436|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
33383703|NCT00603733|101291435|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
33383704|NCT00603733|101291436|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
33383705|NCT00603733|101291435|FG000|Maintenance Phase ITT|Physician Decision|0|||
33383706|NCT00603733|101291436|FG001|Maintenance Phase ITT|Physician Decision|1|||
33383707|NCT00603733|101291435|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
33383708|NCT00603733|101291436|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
33383709|NCT02528253|101291439|FG000|Overall Study|Adverse Event|3|||
33383710|NCT02528253|101291440|FG001|Overall Study|Adverse Event|4|||
33383711|NCT02528253|101291441|FG002|Overall Study|Adverse Event|4|||
33383712|NCT02528253|101291442|FG003|Overall Study|Adverse Event|8|||
33383713|NCT02528253|101291443|FG004|Overall Study|Adverse Event|18|||
33383714|NCT02528253|101291439|FG000|Overall Study|Death|2|||
33383715|NCT02528253|101291440|FG001|Overall Study|Death|2|||
33383716|NCT02528253|101291441|FG002|Overall Study|Death|1|||
33383717|NCT02528253|101291442|FG003|Overall Study|Death|0|||
33383718|NCT02528253|101291443|FG004|Overall Study|Death|1|||
33383719|NCT02528253|101291439|FG000|Overall Study|Insufficient clinical response|7|||
33383720|NCT02528253|101291440|FG001|Overall Study|Insufficient clinical response|10|||
33383721|NCT02528253|101291441|FG002|Overall Study|Insufficient clinical response|13|||
33383722|NCT02528253|101291442|FG003|Overall Study|Insufficient clinical response|12|||
33383723|NCT02528253|101291443|FG004|Overall Study|Insufficient clinical response|16|||
33383724|NCT02528253|101291439|FG000|Overall Study|Lost to Follow-up|16|||
33383725|NCT02528253|101291440|FG001|Overall Study|Lost to Follow-up|9|||
33383726|NCT02528253|101291441|FG002|Overall Study|Lost to Follow-up|31|||
33383727|NCT02528253|101291442|FG003|Overall Study|Lost to Follow-up|16|||
33383728|NCT02528253|101291443|FG004|Overall Study|Lost to Follow-up|34|||
33383729|NCT02528253|101291439|FG000|Overall Study|Other|21|||
33383730|NCT02528253|101291440|FG001|Overall Study|Other|22|||
33383731|NCT02528253|101291441|FG002|Overall Study|Other|58|||
33383732|NCT02528253|101291442|FG003|Overall Study|Other|52|||
33383733|NCT02528253|101291443|FG004|Overall Study|Other|76|||
33383734|NCT02528253|101291439|FG000|Overall Study|Withdrawal by Subject|25|||
33383735|NCT02528253|101291440|FG001|Overall Study|Withdrawal by Subject|20|||
33383736|NCT02528253|101291441|FG002|Overall Study|Withdrawal by Subject|29|||
33383737|NCT02528253|101291442|FG003|Overall Study|Withdrawal by Subject|48|||
33383738|NCT02528253|101291443|FG004|Overall Study|Withdrawal by Subject|73|||
33383739|NCT02528253|101291439|FG000|Overall Study|Protocol Violation|1|||
33383740|NCT02528253|101291440|FG001|Overall Study|Protocol Violation|2|||
33383741|NCT02528253|101291441|FG002|Overall Study|Protocol Violation|4|||
33431274|NCT00264810|101470932|FG000|Baseline|Other|0|||
33383742|NCT02528253|101291442|FG003|Overall Study|Protocol Violation|0|||
33383743|NCT02528253|101291443|FG004|Overall Study|Protocol Violation|4|||
33383744|NCT02528253|101291439|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
33431275|NCT00264810|101470933|FG001|Baseline|Other|1|||
33431276|NCT00264810|101470932|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
33431277|NCT00264810|101470933|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
33648155|NCT00271505|102262965|FG000|Overall Study|Death|1|||
33648156|NCT01349049|102262966|FG000|Overall Study|Disease progression|3|||
33431278|NCT00264810|101470932|FG000|Stimulation Optimization Period|Death|0|||
33431279|NCT00264810|101470933|FG001|Stimulation Optimization Period|Death|1|||
33431280|NCT00264810|101470932|FG000|Blinded Evaluation Period|Explant due to infection|1|||
33431281|NCT00264810|101470933|FG001|Blinded Evaluation Period|Explant due to infection|1|||
33431282|NCT00264810|101470932|FG000|Open Label Evaluation Period|Explant due to infection|1|||
33431283|NCT00264810|101470933|FG001|Open Label Evaluation Period|Explant due to infection|1|||
33431284|NCT00264810|101470932|FG000|Open Label Evaluation Period|Death|3|||
33431285|NCT00264810|101470933|FG001|Open Label Evaluation Period|Death|2|||
33431286|NCT00264810|101470932|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
33431287|NCT00264810|101470933|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
33431288|NCT01165996|101470934|FG000|Overall Study|Death|1|||
33431289|NCT01165996|101470934|FG000|Overall Study|Physician Decision|1|||
33431290|NCT03650400|101470938|FG000|Overall Study|Study terminated by sponsor|0|||
33431291|NCT03650400|101470939|FG001|Overall Study|Study terminated by sponsor|5|||
33431292|NCT01894984|101470940|FG000|Overall Study|Other|314|||
33431293|NCT01894984|101470941|FG001|Overall Study|Other|175|||
33431294|NCT04467697|101470942|FG000|Overall Study|Adverse Event|2|||
33431295|NCT04467697|101470942|FG000|Overall Study|Lost to Follow-up|6|||
33431296|NCT04467697|101470942|FG000|Overall Study|Withdrawal by Subject|9|||
33431297|NCT04467697|101470942|FG000|Overall Study|Protocol Violation|3|||
33431298|NCT04081337|101470943|FG000|Overall Study|Adverse Event|0|||
33431299|NCT04081337|101470944|FG001|Overall Study|Adverse Event|1|||
33431300|NCT04081337|101470943|FG000|Overall Study|Withdrawal by Subject|2|||
33431301|NCT04081337|101470944|FG001|Overall Study|Withdrawal by Subject|0|||
33431302|NCT04081337|101470943|FG000|Overall Study|Physician Decision|1|||
33431303|NCT04081337|101470944|FG001|Overall Study|Physician Decision|2|||
33431304|NCT04081337|101470943|FG000|Overall Study|Lost to Follow-up|1|||
33431305|NCT04081337|101470944|FG001|Overall Study|Lost to Follow-up|0|||
33431306|NCT04527471|101470951|FG000|Overall Study|Adverse Event|1|||
33431307|NCT04527471|101470952|FG001|Overall Study|Adverse Event|0|||
33149740|NCT04078178|100463469|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
33149741|NCT03282565|100463470|FG000|Overall Study|COVID-19 Research Shutdown|0|||
33149742|NCT03282565|100463471|FG001|Overall Study|COVID-19 Research Shutdown|2|||
33149743|NCT03282565|100463472|FG002|Overall Study|COVID-19 Research Shutdown|2|||
33149744|NCT02213926|100463473|FG000|Overall Study|Death|59|||
33149745|NCT02213926|100463473|FG000|Overall Study|Withdrawal by Subject|10|||
33149746|NCT02213926|100463473|FG000|Overall Study|study terminated by sponsor|51|||
33149747|NCT02213926|100463473|FG000|Overall Study|Lost to Follow-up|3|||
33149748|NCT02213926|100463473|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
33149749|NCT03956056|100463481|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
33149750|NCT03956056|100463481|FG000|Overall Study|Lack of Efficacy|1|||
33149751|NCT02545075|100463482|FG000|Randomization|Lost to Follow-up|0|||
33149752|NCT02545075|100463483|FG001|Randomization|Lost to Follow-up|1|||
33149753|NCT02545075|100463482|FG000|Randomization|Withdrawal by Subject|0|||
33149754|NCT02545075|100463483|FG001|Randomization|Withdrawal by Subject|6|||
33149755|NCT02545075|100463482|FG000|Treatment|Disease progression|71|||
33149756|NCT02545075|100463483|FG001|Treatment|Disease progression|32|||
33149757|NCT02545075|100463482|FG000|Treatment|Participant dicontinued study treatment|7|||
33149758|NCT02545075|100463483|FG001|Treatment|Participant dicontinued study treatment|9|||
33149759|NCT02545075|100463482|FG000|Treatment|Withdrawal by Subject|1|||
33149760|NCT02545075|100463483|FG001|Treatment|Withdrawal by Subject|0|||
33149761|NCT02545075|100463482|FG000|Treatment|Adverse event not related to study drug|1|||
33431308|NCT04527471|101470951|FG000|Overall Study|Lost to Follow-up|1|||
33431309|NCT04527471|101470952|FG001|Overall Study|Lost to Follow-up|0|||
33431310|NCT00717756|101470953|FG000|Overall Study|Withdrawal by Subject|1|||
33431311|NCT03692676|101470954|FG000|Overall Study|exclude patients with prior use|4424|||
33431312|NCT03692676|101470955|FG001|Overall Study|exclude patients with prior use|24726|||
33431313|NCT03692676|101470956|FG002|Overall Study|exclude patients with prior use|0|||
33431314|NCT03692676|101470957|FG003|Overall Study|exclude patients with prior use|0|||
33149762|NCT02545075|100463483|FG001|Treatment|Adverse event not related to study drug|0|||
33149763|NCT02545075|100463482|FG000|Treatment|Death|1|||
33149764|NCT02545075|100463483|FG001|Treatment|Death|0|||
33149765|NCT02545075|100463482|FG000|Treatment|Participant drug toxicity|1|||
33149766|NCT02545075|100463483|FG001|Treatment|Participant drug toxicity|0|||
33431315|NCT03692676|101470954|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
33431316|NCT03692676|101470955|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
33431317|NCT03692676|101470956|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
33431318|NCT03692676|101470957|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
33431319|NCT03692676|101470954|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
33431320|NCT03692676|101470955|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
33149767|NCT02545075|100463482|FG000|Treatment|Completed treatment|40|||
33149768|NCT02545075|100463483|FG001|Treatment|Completed treatment|12|||
33149769|NCT00573248|100463484|FG000|Overall Study|scheduling conflicts|15|||
33149770|NCT00573248|100463485|FG001|Overall Study|scheduling conflicts|11|||
33249348|NCT00828672|100814461|FG000|Study Treatment|Lost to Follow-up|1|||
33249349|NCT00828672|100814462|FG001|Study Treatment|Lost to Follow-up|0|||
33249350|NCT00828672|100814461|FG000|Study Treatment|Adverse Event|0|||
33249351|NCT00828672|100814462|FG001|Study Treatment|Adverse Event|1|||
33249352|NCT00828672|100814461|FG000|Study Treatment|Complete response, no surgery|1|||
33249353|NCT00828672|100814462|FG001|Study Treatment|Complete response, no surgery|1|||
33249354|NCT00828672|100814461|FG000|Post-surgery (<30 Days)|No central review materials|0|||
33249355|NCT00828672|100814462|FG001|Post-surgery (<30 Days)|No central review materials|1|||
33249356|NCT02770248|100814463|FG000|Overall Study|Adverse Event|0|||
33249357|NCT02770248|100814464|FG001|Overall Study|Adverse Event|1|||
33249358|NCT02770248|100814463|FG000|Overall Study|Randomized in error, prior to treatment|0|||
33249359|NCT02770248|100814464|FG001|Overall Study|Randomized in error, prior to treatment|1|||
33249360|NCT01616654|100814466|FG000|Overall Study|Lack of Efficacy|1|||
33249361|NCT01616654|100814467|FG001|Overall Study|Lack of Efficacy|0|||
33249362|NCT01616654|100814468|FG002|Overall Study|Lack of Efficacy|0|||
33249363|NCT01616654|100814469|FG003|Overall Study|Lack of Efficacy|0|||
33249364|NCT01616654|100814470|FG004|Overall Study|Lack of Efficacy|1|||
33249365|NCT01616654|100814466|FG000|Overall Study|Adverse Event|0|||
33249366|NCT01616654|100814467|FG001|Overall Study|Adverse Event|1|||
33249367|NCT01616654|100814468|FG002|Overall Study|Adverse Event|2|||
33249368|NCT01616654|100814469|FG003|Overall Study|Adverse Event|1|||
33249369|NCT01616654|100814470|FG004|Overall Study|Adverse Event|0|||
33249370|NCT01616654|100814466|FG000|Overall Study|Withdrawal by Subject|2|||
33249371|NCT01616654|100814467|FG001|Overall Study|Withdrawal by Subject|2|||
33249372|NCT01616654|100814468|FG002|Overall Study|Withdrawal by Subject|3|||
33249373|NCT01616654|100814469|FG003|Overall Study|Withdrawal by Subject|1|||
33249374|NCT01616654|100814470|FG004|Overall Study|Withdrawal by Subject|5|||
33249375|NCT01616654|100814466|FG000|Overall Study|Protocol Violation|0|||
33249376|NCT01616654|100814467|FG001|Overall Study|Protocol Violation|5|||
33249377|NCT01616654|100814468|FG002|Overall Study|Protocol Violation|2|||
33249378|NCT01616654|100814469|FG003|Overall Study|Protocol Violation|4|||
33249379|NCT01616654|100814470|FG004|Overall Study|Protocol Violation|4|||
33249380|NCT01616654|100814466|FG000|Overall Study|Lost to Follow-up|1|||
33249381|NCT01616654|100814467|FG001|Overall Study|Lost to Follow-up|0|||
33249382|NCT01616654|100814468|FG002|Overall Study|Lost to Follow-up|3|||
33249383|NCT01616654|100814469|FG003|Overall Study|Lost to Follow-up|2|||
33249384|NCT01616654|100814470|FG004|Overall Study|Lost to Follow-up|1|||
33249385|NCT01616654|100814466|FG000|Overall Study|Pregnancy|1|||
33249386|NCT01616654|100814467|FG001|Overall Study|Pregnancy|0|||
33249387|NCT01616654|100814468|FG002|Overall Study|Pregnancy|0|||
33249388|NCT01616654|100814469|FG003|Overall Study|Pregnancy|0|||
33249389|NCT01616654|100814470|FG004|Overall Study|Pregnancy|1|||
33249390|NCT02385669|100814477|FG000|Overall Study|Adverse Event|2|||
33249391|NCT04588480|100814480|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
33249392|NCT04588480|100814481|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
33249393|NCT04588480|100814482|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
33249394|NCT04588480|100814480|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
33249395|NCT04588480|100814481|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
33249396|NCT04588480|100814482|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
33249397|NCT00324038|100814483|FG000|Overall Study|Adverse Event|38|||
33249398|NCT00324038|100814484|FG001|Overall Study|Adverse Event|23|||
33249399|NCT00324038|100814483|FG000|Overall Study|Lack of Efficacy|5|||
33249400|NCT00324038|100814484|FG001|Overall Study|Lack of Efficacy|13|||
33249401|NCT00324038|100814483|FG000|Overall Study|Lost to Follow-up|0|||
33249402|NCT00324038|100814484|FG001|Overall Study|Lost to Follow-up|2|||
33249403|NCT00324038|100814483|FG000|Overall Study|Other|6|||
33249404|NCT00324038|100814484|FG001|Overall Study|Other|13|||
33249405|NCT01651949|100814485|FG000|Overall Study|Unknown status|4|||
33249406|NCT01651949|100814486|FG001|Overall Study|Unknown status|4|||
33249407|NCT01651949|100814487|FG002|Overall Study|Unknown status|0|||
33249408|NCT01651949|100814485|FG000|Overall Study|Lost to Follow-up|30|||
33249409|NCT01651949|100814486|FG001|Overall Study|Lost to Follow-up|56|||
33249410|NCT01651949|100814487|FG002|Overall Study|Lost to Follow-up|20|||
33249411|NCT01651949|100814485|FG000|Overall Study|Protocol Violation|0|||
33431321|NCT03692676|101470956|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
33249412|NCT01651949|100814486|FG001|Overall Study|Protocol Violation|2|||
33249413|NCT01651949|100814487|FG002|Overall Study|Protocol Violation|1|||
33249414|NCT01651949|100814485|FG000|Overall Study|Physician Decision|0|||
33431322|NCT03692676|101470957|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
33249415|NCT01651949|100814486|FG001|Overall Study|Physician Decision|2|||
33249416|NCT01651949|100814487|FG002|Overall Study|Physician Decision|0|||
33249417|NCT01651949|100814485|FG000|Overall Study|Adverse Event|0|||
33249418|NCT01651949|100814486|FG001|Overall Study|Adverse Event|2|||
33249419|NCT01651949|100814487|FG002|Overall Study|Adverse Event|1|||
33249420|NCT01651949|100814485|FG000|Overall Study|Screen failure|2|||
33249421|NCT01651949|100814486|FG001|Overall Study|Screen failure|2|||
33249422|NCT01651949|100814487|FG002|Overall Study|Screen failure|0|||
33249423|NCT01651949|100814485|FG000|Overall Study|Withdrawal by Subject|17|||
33431323|NCT03692676|101470954|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
33431324|NCT03692676|101470955|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
33431325|NCT03692676|101470956|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
33431326|NCT03692676|101470957|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
33431327|NCT03692676|101470954|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
33431328|NCT03692676|101470955|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
33431329|NCT03692676|101470956|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
33431330|NCT03692676|101470957|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
33431331|NCT03692676|101470954|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
33431332|NCT03692676|101470955|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
33431333|NCT03692676|101470956|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
33431334|NCT03692676|101470957|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
33431335|NCT03692676|101470954|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
33431336|NCT03692676|101470955|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
33431337|NCT03692676|101470956|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
33431338|NCT03692676|101470957|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
33431339|NCT03692676|101470954|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
33431340|NCT03692676|101470955|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
33431341|NCT03692676|101470956|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
33431342|NCT03692676|101470957|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
33431343|NCT03692676|101470954|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
33431344|NCT03692676|101470955|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
33431345|NCT03692676|101470956|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
33431346|NCT03692676|101470957|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
33431347|NCT03692676|101470954|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
33431348|NCT03692676|101470955|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
33431349|NCT03692676|101470956|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
33431350|NCT03692676|101470957|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
33431351|NCT03692676|101470954|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
33431352|NCT03692676|101470955|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
33431353|NCT03692676|101470956|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
33431354|NCT03692676|101470957|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
33431355|NCT03692676|101470954|FG000|Overall Study|Other|0|||
33431356|NCT03692676|101470955|FG001|Overall Study|Other|805|||
33431357|NCT03692676|101470956|FG002|Overall Study|Other|758|||
33648157|NCT01349049|102262967|FG001|Overall Study|Disease progression|5|||
33383745|NCT02528253|101291440|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
33383746|NCT02528253|101291441|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
33383747|NCT02528253|101291442|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
33383748|NCT02528253|101291443|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
33383749|NCT03271307|101291445|FG000|Overall Study|Lost to Follow-up|0|||
33383750|NCT03271307|101291446|FG001|Overall Study|Lost to Follow-up|0|||
33383751|NCT03271307|101291447|FG002|Overall Study|Lost to Follow-up|0|||
33383752|NCT03271307|101291448|FG003|Overall Study|Lost to Follow-up|28|||
33383753|NCT03271307|101291449|FG004|Overall Study|Lost to Follow-up|91|||
33383754|NCT01957787|101291452|FG000|Overall Study|Death|18|||
33383755|NCT01957787|101291452|FG000|Overall Study|Lost to Follow-up|3|||
33383756|NCT01957787|101291452|FG000|Overall Study|Withdrawal by Subject|3|||
33383757|NCT01957787|101291452|FG000|Overall Study|Entered Hospice or Similar Program|2|||
33383758|NCT01957787|101291452|FG000|Overall Study|Index Tumor(s) Resected|2|||
33383759|NCT01957787|101291452|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
33383760|NCT01957787|101291452|FG000|Overall Study|Local therapy, not cryoablation|6|||
33383761|NCT02029638|101291454|FG000|Overall Study|Death|0|||
33383762|NCT02029638|101291455|FG001|Overall Study|Death|0|||
33383763|NCT02029638|101291456|FG002|Overall Study|Death|1|||
33383764|NCT02029638|101291454|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
33383765|NCT02029638|101291455|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
33383766|NCT02029638|101291456|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
33383767|NCT03404518|101291457|FG000|Overall Study|Lost to Follow-up|28|||
33383768|NCT03404518|101291458|FG001|Overall Study|Lost to Follow-up|30|||
33383769|NCT03404518|101291457|FG000|Overall Study|Protocol Violation|13|||
33383770|NCT03404518|101291458|FG001|Overall Study|Protocol Violation|6|||
33383771|NCT00871572|101291459|FG000|Overall Study|Adverse Event|0|||
33431358|NCT03692676|101470957|FG003|Overall Study|Other|277|||
33431359|NCT03692676|101470954|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
33431360|NCT03692676|101470955|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
33431361|NCT03692676|101470956|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
33431362|NCT03692676|101470957|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
33431363|NCT00331630|101470976|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
33431364|NCT00331630|101470976|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
33431365|NCT00331630|101470976|FG000|Follow up for 5 Years|Death|5|||
33431366|NCT00331630|101470976|FG000|Follow up for 5 Years|Data collection was stopped|24|||
33431367|NCT00608205|101470977|FG000|Overall Study|Adverse Event|3|||
33431368|NCT00608205|101470978|FG001|Overall Study|Adverse Event|2|||
33431369|NCT00608205|101470977|FG000|Overall Study|Patient non-compliant|0|||
33431370|NCT00608205|101470978|FG001|Overall Study|Patient non-compliant|1|||
33431371|NCT02232074|101470979|FG000|Overall Study|Withdrawal by Subject|5|||
33431372|NCT02232074|101470980|FG001|Overall Study|Withdrawal by Subject|3|||
33431373|NCT02232074|101470979|FG000|Overall Study|No legal concerns at baseline|36|||
33431374|NCT02232074|101470980|FG001|Overall Study|No legal concerns at baseline|41|||
33431375|NCT02232074|101470979|FG000|Overall Study|deemed ineligible|0|||
33431376|NCT02232074|101470980|FG001|Overall Study|deemed ineligible|1|||
33431377|NCT01766778|101470987|FG000|Overall Study|Adverse Event|4|||
33431378|NCT01766778|101470988|FG001|Overall Study|Adverse Event|4|||
33431379|NCT01766778|101470987|FG000|Overall Study|Withdrawal by Subject|1|||
33431380|NCT01766778|101470988|FG001|Overall Study|Withdrawal by Subject|0|||
33431381|NCT02866175|101470990|FG000|Overall Study|Adverse Event|56|||
33431382|NCT02866175|101470991|FG001|Overall Study|Adverse Event|54|||
33431383|NCT02866175|101470990|FG000|Overall Study|Withdrawal by Subject|31|||
33431384|NCT02866175|101470991|FG001|Overall Study|Withdrawal by Subject|52|||
33431385|NCT02866175|101470990|FG000|Overall Study|Death|30|||
33431386|NCT02866175|101470991|FG001|Overall Study|Death|23|||
33431387|NCT02866175|101470990|FG000|Overall Study|Other|7|||
33431388|NCT02866175|101470991|FG001|Overall Study|Other|14|||
33431389|NCT02866175|101470990|FG000|Overall Study|Progressive disease|1|||
33431390|NCT02866175|101470991|FG001|Overall Study|Progressive disease|1|||
33431391|NCT02866175|101470990|FG000|Overall Study|Lost to Follow-up|2|||
33431392|NCT02866175|101470991|FG001|Overall Study|Lost to Follow-up|0|||
33431393|NCT02866175|101470990|FG000|Overall Study|Lack of Efficacy|0|||
33431394|NCT02866175|101470991|FG001|Overall Study|Lack of Efficacy|1|||
33431395|NCT02866175|101470990|FG000|Overall Study|Physician Decision|3|||
33431396|NCT02866175|101470991|FG001|Overall Study|Physician Decision|15|||
33431397|NCT02866175|101470990|FG000|Overall Study|Did not receive treatment|5|||
33431398|NCT02866175|101470991|FG001|Overall Study|Did not receive treatment|15|||
33431399|NCT02576990|101470999|FG000|Overall Study|Death|29|||
33431400|NCT02576990|101471000|FG001|Overall Study|Death|18|||
33431401|NCT02576990|101470999|FG000|Overall Study|Physician Decision|1|||
33431402|NCT02576990|101471000|FG001|Overall Study|Physician Decision|0|||
33431403|NCT02576990|101470999|FG000|Overall Study|Screen failure|2|||
33431404|NCT02576990|101471000|FG001|Overall Study|Screen failure|0|||
33431405|NCT02576990|101470999|FG000|Overall Study|Sponsor's decision|24|||
33431406|NCT02576990|101471000|FG001|Overall Study|Sponsor's decision|4|||
33431407|NCT02576990|101470999|FG000|Overall Study|Withdrawal by Subject|0|||
33431408|NCT02576990|101471000|FG001|Overall Study|Withdrawal by Subject|2|||
33431409|NCT03907280|101471001|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
33431410|NCT03907280|101471002|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
33431411|NCT03907280|101471003|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
33431412|NCT01835145|101471006|FG000|Overall Study|Ineligible prior to treatment|1|||
33431413|NCT01835145|101471007|FG001|Overall Study|Ineligible prior to treatment|0|||
33431414|NCT03384745|101471009|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
33431415|NCT03384745|101471010|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
33431416|NCT03384745|101471011|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
33431417|NCT03384745|101471012|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
33431418|NCT03384745|101471013|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
33431419|NCT03384745|101471014|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
33431420|NCT03384745|101471009|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
33431421|NCT03384745|101471010|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
33431422|NCT03384745|101471011|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
33431423|NCT03384745|101471012|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
33431424|NCT03384745|101471013|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
33431425|NCT03384745|101471014|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
33431426|NCT03384745|101471009|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
33431427|NCT03384745|101471010|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
33431428|NCT03384745|101471011|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
33431429|NCT03384745|101471012|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
33431430|NCT03384745|101471013|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
33431431|NCT03384745|101471014|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
33431432|NCT03384745|101471009|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
33431433|NCT03384745|101471010|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
33431434|NCT03384745|101471011|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
33431435|NCT03384745|101471012|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
33431436|NCT03384745|101471013|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
33431437|NCT03384745|101471014|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
33431438|NCT03384745|101471009|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
33431439|NCT03384745|101471010|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
33431440|NCT03384745|101471011|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
33431441|NCT03384745|101471012|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
33431442|NCT03384745|101471013|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
33431443|NCT03384745|101471014|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
33431444|NCT03384745|101471009|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
33431445|NCT03384745|101471010|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
33431446|NCT03384745|101471011|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
33431447|NCT03384745|101471012|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
33431448|NCT03384745|101471013|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
33431449|NCT03384745|101471014|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
33431450|NCT03384745|101471009|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
33431451|NCT03384745|101471010|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
33431452|NCT03384745|101471011|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
33431453|NCT03384745|101471012|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
33431454|NCT03384745|101471013|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
33431455|NCT03384745|101471014|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
33431456|NCT03384745|101471009|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
33431457|NCT03384745|101471010|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
33431458|NCT03384745|101471011|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
33431459|NCT03384745|101471012|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
33431460|NCT03384745|101471013|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
33431461|NCT03384745|101471014|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
33431462|NCT03384745|101471009|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
33431463|NCT03384745|101471010|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
33431464|NCT03384745|101471011|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
33431465|NCT03384745|101471012|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
33431466|NCT03384745|101471013|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
33431467|NCT03384745|101471014|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
33431468|NCT03384745|101471009|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
33431469|NCT03384745|101471010|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
33431470|NCT03384745|101471011|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
33431471|NCT03384745|101471012|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
33431472|NCT03384745|101471013|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
33431473|NCT03384745|101471014|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
33431474|NCT03384745|101471009|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
33431475|NCT03384745|101471010|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
33431476|NCT03384745|101471011|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
33431477|NCT03384745|101471012|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
33431478|NCT03384745|101471013|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
33431479|NCT03384745|101471014|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
33431480|NCT02732561|101471015|FG000|Overall Study|Lost to Follow-up|1|||
33431481|NCT02732561|101471016|FG001|Overall Study|Lost to Follow-up|1|||
33431482|NCT02732561|101471015|FG000|Overall Study|Withdrawal by Subject|1|||
33431483|NCT02732561|101471016|FG001|Overall Study|Withdrawal by Subject|0|||
33431484|NCT01829477|101471017|FG000|Overall Study|Study Terminated by Sponsor|15|||
33431485|NCT01829477|101471018|FG001|Overall Study|Study Terminated by Sponsor|15|||
33431486|NCT01829477|101471017|FG000|Overall Study|Withdrawal by Subject|1|||
33431487|NCT01829477|101471018|FG001|Overall Study|Withdrawal by Subject|0|||
33431488|NCT02688400|101471019|FG000|Overall Study|Protocol Violation|2|||
33431489|NCT02688400|101471020|FG001|Overall Study|Protocol Violation|5|||
33431490|NCT02688400|101471019|FG000|Overall Study|Lack of Efficacy|7|||
33431491|NCT02688400|101471020|FG001|Overall Study|Lack of Efficacy|7|||
33249424|NCT01651949|100814486|FG001|Overall Study|Withdrawal by Subject|18|||
33249425|NCT01651949|100814487|FG002|Overall Study|Withdrawal by Subject|9|||
33249426|NCT00606580|100814488|FG000|Overall Study|Lost to Follow-up|1|||
33431492|NCT02688400|101471019|FG000|Overall Study|Adverse Event|21|||
33431493|NCT02688400|101471020|FG001|Overall Study|Adverse Event|12|||
33431494|NCT02688400|101471019|FG000|Overall Study|Withdrawal by Subject|15|||
33431495|NCT02688400|101471020|FG001|Overall Study|Withdrawal by Subject|13|||
33431496|NCT02688400|101471019|FG000|Overall Study|No study medication intake|1|||
33431497|NCT02688400|101471020|FG001|Overall Study|No study medication intake|4|||
33431498|NCT02688400|101471019|FG000|Overall Study|Lost to Follow-up|0|||
33431499|NCT02688400|101471020|FG001|Overall Study|Lost to Follow-up|3|||
33431500|NCT02795104|101471021|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
33431501|NCT02795104|101471022|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
33431502|NCT02795104|101471023|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
33431503|NCT02795104|101471021|FG000|Overall Study|Withdrawal by Subject|0|||
33431504|NCT02795104|101471022|FG001|Overall Study|Withdrawal by Subject|2|||
33431505|NCT02795104|101471023|FG002|Overall Study|Withdrawal by Subject|0|||
33431506|NCT02795104|101471021|FG000|Overall Study|Lost to Follow-up|0|||
33431507|NCT02795104|101471022|FG001|Overall Study|Lost to Follow-up|0|||
33431508|NCT02795104|101471023|FG002|Overall Study|Lost to Follow-up|1|||
33431509|NCT01506323|101471024|FG000|Overall Study|Lost to Follow-up|5|||
33431510|NCT01506323|101471025|FG001|Overall Study|Lost to Follow-up|4|||
33431511|NCT01506323|101471024|FG000|Overall Study|Withdrawal by Subject|4|||
33431512|NCT01506323|101471025|FG001|Overall Study|Withdrawal by Subject|4|||
33431513|NCT01506323|101471024|FG000|Overall Study|Lack of Efficacy|1|||
33431514|NCT01506323|101471025|FG001|Overall Study|Lack of Efficacy|3|||
33431515|NCT01506323|101471024|FG000|Overall Study|Moved out of area|5|||
33431516|NCT01506323|101471025|FG001|Overall Study|Moved out of area|2|||
33431517|NCT01506323|101471024|FG000|Overall Study|Schedule or Transportation conflict|8|||
33431518|NCT01506323|101471025|FG001|Overall Study|Schedule or Transportation conflict|0|||
33431519|NCT01506323|101471024|FG000|Overall Study|Started another treatment|1|||
33431520|NCT01506323|101471025|FG001|Overall Study|Started another treatment|0|||
33431521|NCT01628120|101471026|FG000|Overall Study|Withdrawal by Subject|7|||
33431522|NCT01628120|101471026|FG000|Overall Study|Adverse Event|12|||
33431523|NCT01628120|101471026|FG000|Overall Study|Lost to Follow-up|1|||
33431524|NCT01628120|101471026|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
33431525|NCT01628120|101471026|FG000|Overall Study|Non-compliant with Study Procedures|1|||
33431526|NCT01628120|101471026|FG000|Overall Study|Not Treated|3|||
33431527|NCT01628120|101471026|FG000|Overall Study|Sponsor Decision|5|||
33431528|NCT01628120|101471026|FG000|Overall Study|Switched Dialysis Method|2|||
33431529|NCT01628120|101471026|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
33431530|NCT01628120|101471026|FG000|Overall Study|Moved or Relocated|5|||
33431531|NCT01628120|101471026|FG000|Overall Study|Kidney Transplant|2|||
33431532|NCT01628120|101471026|FG000|Overall Study|Use of Standard of Care|1|||
33431533|NCT00909727|101471028|FG000|Overall Study|Adverse Event|1|||
33431534|NCT00909727|101471029|FG001|Overall Study|Adverse Event|0|||
33431535|NCT00909727|101471028|FG000|Overall Study|Wrong Genotype|1|||
33431536|NCT00909727|101471029|FG001|Overall Study|Wrong Genotype|0|||
33431537|NCT00909727|101471028|FG000|Overall Study|Withdrawal of Consent|1|||
33431538|NCT00909727|101471029|FG001|Overall Study|Withdrawal of Consent|0|||
33431539|NCT00909727|101471028|FG000|Overall Study|Prohibited Medication|1|||
33431540|NCT00909727|101471029|FG001|Overall Study|Prohibited Medication|0|||
33431541|NCT01090765|101471033|FG000|Overall Study|Patient withdrew consent|0|||
33431542|NCT01090765|101471034|FG001|Overall Study|Patient withdrew consent|0|||
33431543|NCT01090765|101471035|FG002|Overall Study|Patient withdrew consent|0|||
33431544|NCT01090765|101471036|FG003|Overall Study|Patient withdrew consent|0|||
33431545|NCT01090765|101471037|FG004|Overall Study|Patient withdrew consent|1|||
33431546|NCT01090765|101471038|FG005|Overall Study|Patient withdrew consent|1|||
33431547|NCT01090765|101471033|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
33431548|NCT01090765|101471034|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
33431549|NCT01090765|101471035|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
33431550|NCT01090765|101471036|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
33431551|NCT01090765|101471037|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
33431552|NCT01090765|101471038|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
33431553|NCT01090765|101471033|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
33431554|NCT01090765|101471034|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
33431555|NCT01090765|101471035|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
33431556|NCT01090765|101471036|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
33431557|NCT01090765|101471037|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
33431558|NCT01090765|101471038|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
33431559|NCT01077713|101471041|FG000|Overall Study|Withdrawal by Subject|1|||
33431560|NCT01077713|101471042|FG001|Overall Study|Withdrawal by Subject|2|||
33431561|NCT01077713|101471041|FG000|Overall Study|Progressive Disease (PD)|0|||
33431562|NCT01077713|101471042|FG001|Overall Study|Progressive Disease (PD)|1|||
33431563|NCT01077713|101471041|FG000|Overall Study|Death|28|||
33431564|NCT01077713|101471042|FG001|Overall Study|Death|29|||
33431565|NCT01077713|101471041|FG000|Overall Study|Lost to Follow-up|1|||
33431566|NCT01077713|101471042|FG001|Overall Study|Lost to Follow-up|1|||
33431567|NCT01077713|101471041|FG000|Overall Study|Adverse Event|2|||
33431568|NCT01077713|101471042|FG001|Overall Study|Adverse Event|1|||
33431569|NCT01077713|101471041|FG000|Overall Study|Other|4|||
33431570|NCT01077713|101471042|FG001|Overall Study|Other|2|||
33431571|NCT01001169|101471043|FG000|Overall Study|Withdrawal by Subject|2|||
33431572|NCT01001169|101471044|FG001|Overall Study|Withdrawal by Subject|1|||
33431573|NCT02015793|101471045|FG000|Overall Study|Adverse Event|3|||
33431574|NCT02015793|101471046|FG001|Overall Study|Adverse Event|3|||
33431575|NCT02015793|101471045|FG000|Overall Study|Withdrawal by Subject|1|||
33431576|NCT02015793|101471046|FG001|Overall Study|Withdrawal by Subject|1|||
33431577|NCT03342898|101471049|FG000|Overall Study|Adverse Event|3|||
33431578|NCT03342898|101471050|FG001|Overall Study|Adverse Event|1|||
33431579|NCT03342898|101471051|FG002|Overall Study|Adverse Event|0|||
33431580|NCT03342898|101471049|FG000|Overall Study|Lost to Follow-up|44|||
33431581|NCT03342898|101471050|FG001|Overall Study|Lost to Follow-up|40|||
33431582|NCT03342898|101471051|FG002|Overall Study|Lost to Follow-up|42|||
33431583|NCT03342898|101471049|FG000|Overall Study|Withdrawal of Consent|5|||
33431584|NCT03342898|101471050|FG001|Overall Study|Withdrawal of Consent|9|||
33431585|NCT03342898|101471051|FG002|Overall Study|Withdrawal of Consent|11|||
33431586|NCT03342898|101471049|FG000|Overall Study|Death|0|||
33431587|NCT03342898|101471050|FG001|Overall Study|Death|1|||
33431588|NCT03342898|101471051|FG002|Overall Study|Death|1|||
33431589|NCT03342898|101471049|FG000|Overall Study|Reason not Specified|2|||
33431590|NCT03342898|101471050|FG001|Overall Study|Reason not Specified|2|||
33431591|NCT03342898|101471051|FG002|Overall Study|Reason not Specified|0|||
33431592|NCT02637557|101471052|FG000|Overall Study|Adverse Event|3|||
33431593|NCT02637557|101471053|FG001|Overall Study|Adverse Event|1|||
33431594|NCT02637557|101471054|FG002|Overall Study|Adverse Event|3|||
33431595|NCT02637557|101471055|FG003|Overall Study|Adverse Event|3|||
33431596|NCT02637557|101471052|FG000|Overall Study|Lost to Follow-up|1|||
33383772|NCT00871572|101291460|FG001|Overall Study|Adverse Event|2|||
33383773|NCT00871572|101291461|FG002|Overall Study|Adverse Event|0|||
33383774|NCT00871572|101291462|FG003|Overall Study|Adverse Event|3|||
33383775|NCT00871572|101291459|FG000|Overall Study|Investigator Decision|0|||
33383776|NCT00871572|101291460|FG001|Overall Study|Investigator Decision|1|||
33383777|NCT00871572|101291461|FG002|Overall Study|Investigator Decision|0|||
33383778|NCT00871572|101291462|FG003|Overall Study|Investigator Decision|1|||
33383779|NCT00871572|101291459|FG000|Overall Study|Lost to Follow-up|0|||
33383780|NCT00871572|101291460|FG001|Overall Study|Lost to Follow-up|1|||
33383781|NCT00871572|101291461|FG002|Overall Study|Lost to Follow-up|0|||
33383782|NCT00871572|101291462|FG003|Overall Study|Lost to Follow-up|1|||
33383783|NCT00871572|101291459|FG000|Overall Study|Protocol Violation|0|||
33383784|NCT00871572|101291460|FG001|Overall Study|Protocol Violation|0|||
33383785|NCT00871572|101291461|FG002|Overall Study|Protocol Violation|1|||
33383786|NCT00871572|101291462|FG003|Overall Study|Protocol Violation|1|||
33383787|NCT00871572|101291459|FG000|Overall Study|Sponsor Decision|1|||
33383788|NCT00871572|101291460|FG001|Overall Study|Sponsor Decision|0|||
33383789|NCT00871572|101291461|FG002|Overall Study|Sponsor Decision|0|||
33383790|NCT00871572|101291462|FG003|Overall Study|Sponsor Decision|0|||
33383791|NCT00871572|101291459|FG000|Overall Study|Withdrawal by Subject|1|||
33383792|NCT00871572|101291460|FG001|Overall Study|Withdrawal by Subject|2|||
33383793|NCT00871572|101291461|FG002|Overall Study|Withdrawal by Subject|3|||
33383794|NCT00871572|101291462|FG003|Overall Study|Withdrawal by Subject|1|||
33383795|NCT01153841|101291463|FG000|Overall Study|Adverse Event|1|||
33383796|NCT01153841|101291464|FG001|Overall Study|Adverse Event|0|||
33383797|NCT01153841|101291463|FG000|Overall Study|Withdrawal by Subject|1|||
33383798|NCT01153841|101291464|FG001|Overall Study|Withdrawal by Subject|0|||
33383799|NCT01153841|101291463|FG000|Overall Study|Protocol Violation|2|||
33383800|NCT01153841|101291464|FG001|Overall Study|Protocol Violation|0|||
33383801|NCT01153841|101291463|FG000|Overall Study|Lost to Follow-up|2|||
33383802|NCT01153841|101291464|FG001|Overall Study|Lost to Follow-up|0|||
33383803|NCT03517449|101291466|FG000|Overall Study|Death|184|||
33383804|NCT03517449|101291467|FG001|Overall Study|Death|236|||
33383805|NCT03517449|101291466|FG000|Overall Study|Lost to Follow-up|0|||
33383806|NCT03517449|101291467|FG001|Overall Study|Lost to Follow-up|2|||
33383807|NCT03517449|101291466|FG000|Overall Study|Withdrawal by Subject|7|||
33383808|NCT03517449|101291467|FG001|Overall Study|Withdrawal by Subject|26|||
33383809|NCT03517449|101291466|FG000|Overall Study|Participants Ongoing|220|||
33383810|NCT03517449|101291467|FG001|Overall Study|Participants Ongoing|152|||
33431597|NCT02637557|101471053|FG001|Overall Study|Lost to Follow-up|1|||
33431598|NCT02637557|101471054|FG002|Overall Study|Lost to Follow-up|0|||
33431599|NCT02637557|101471055|FG003|Overall Study|Lost to Follow-up|1|||
33431600|NCT02637557|101471052|FG000|Overall Study|Physician Decision|1|||
33431601|NCT02637557|101471053|FG001|Overall Study|Physician Decision|0|||
33431602|NCT02637557|101471054|FG002|Overall Study|Physician Decision|0|||
33383811|NCT02378883|101291468|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
33383812|NCT02378883|101291468|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
33383813|NCT02378883|101291468|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
33383814|NCT02378883|101291468|FG000|30 Day Follow-Up|Physician Decision|2|||
33383815|NCT02378883|101291468|FG000|30 Day Follow-Up|Missed Visit|2|||
33383816|NCT02378883|101291468|FG000|30 Day Follow-Up|Death|1|||
33431603|NCT02637557|101471055|FG003|Overall Study|Physician Decision|0|||
33431604|NCT02637557|101471052|FG000|Overall Study|Protocol Violation|2|||
33431605|NCT02637557|101471053|FG001|Overall Study|Protocol Violation|0|||
33431606|NCT02637557|101471054|FG002|Overall Study|Protocol Violation|2|||
33431607|NCT02637557|101471055|FG003|Overall Study|Protocol Violation|1|||
33431608|NCT02637557|101471052|FG000|Overall Study|Withdrawal by Subject|1|||
33431609|NCT02637557|101471053|FG001|Overall Study|Withdrawal by Subject|3|||
33431610|NCT02637557|101471054|FG002|Overall Study|Withdrawal by Subject|4|||
33431611|NCT02637557|101471055|FG003|Overall Study|Withdrawal by Subject|2|||
33431612|NCT02752776|101471057|FG000|Overall Study|Adverse Event|15|||
33431613|NCT02752776|101471058|FG001|Overall Study|Adverse Event|23|||
33431614|NCT02752776|101471059|FG002|Overall Study|Adverse Event|11|||
33431615|NCT02752776|101471057|FG000|Overall Study|Lack of Efficacy|2|||
33431616|NCT02752776|101471058|FG001|Overall Study|Lack of Efficacy|6|||
33431617|NCT02752776|101471059|FG002|Overall Study|Lack of Efficacy|14|||
33431618|NCT02752776|101471057|FG000|Overall Study|Lost to Follow-up|11|||
33431619|NCT02752776|101471058|FG001|Overall Study|Lost to Follow-up|12|||
33431620|NCT02752776|101471059|FG002|Overall Study|Lost to Follow-up|4|||
33431621|NCT02752776|101471057|FG000|Overall Study|Non-compliance with study treatment|0|||
33431622|NCT02752776|101471058|FG001|Overall Study|Non-compliance with study treatment|0|||
33431623|NCT02752776|101471059|FG002|Overall Study|Non-compliance with study treatment|1|||
33431624|NCT02752776|101471057|FG000|Overall Study|Physician Decision|2|||
33431625|NCT02752776|101471058|FG001|Overall Study|Physician Decision|6|||
33431626|NCT02752776|101471059|FG002|Overall Study|Physician Decision|2|||
33431627|NCT02752776|101471057|FG000|Overall Study|Pregnancy|1|||
33431628|NCT02752776|101471058|FG001|Overall Study|Pregnancy|6|||
33431629|NCT02752776|101471059|FG002|Overall Study|Pregnancy|3|||
33431630|NCT02752776|101471057|FG000|Overall Study|Protocol Violation|10|||
33431631|NCT02752776|101471058|FG001|Overall Study|Protocol Violation|13|||
33431632|NCT02752776|101471059|FG002|Overall Study|Protocol Violation|6|||
33431633|NCT02752776|101471057|FG000|Overall Study|Subject/guardian decision|8|||
33431634|NCT02752776|101471058|FG001|Overall Study|Subject/guardian decision|6|||
33431635|NCT02752776|101471059|FG002|Overall Study|Subject/guardian decision|4|||
33431636|NCT02752776|101471057|FG000|Overall Study|Death|0|||
33431637|NCT02752776|101471058|FG001|Overall Study|Death|0|||
33431638|NCT02752776|101471059|FG002|Overall Study|Death|1|||
33431639|NCT02752776|101471057|FG000|Overall Study|Withdrawal by Subject|3|||
33431640|NCT02752776|101471058|FG001|Overall Study|Withdrawal by Subject|4|||
33431641|NCT02752776|101471059|FG002|Overall Study|Withdrawal by Subject|2|||
33431642|NCT00329602|101471060|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
33431643|NCT00329602|101471061|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
33431644|NCT00329602|101471062|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
33431645|NCT00329602|101471060|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
33431646|NCT00329602|101471061|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
33431647|NCT00329602|101471062|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
33431648|NCT00329602|101471060|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
33431649|NCT00329602|101471061|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
33431650|NCT00329602|101471062|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
33431651|NCT00329602|101471060|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
33431652|NCT00329602|101471061|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
33431653|NCT00329602|101471062|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
33431654|NCT00329602|101471060|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
33431655|NCT00329602|101471061|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
33431656|NCT00329602|101471062|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
33431657|NCT00329602|101471060|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
33431658|NCT00329602|101471061|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
33431659|NCT00329602|101471062|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
33431660|NCT01901055|101471063|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
33431661|NCT01901055|101471064|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
33431662|NCT01901055|101471063|FG000|Randomization But Not Titrated|Physician Decision|0|||
33431663|NCT01901055|101471064|FG001|Randomization But Not Titrated|Physician Decision|1|||
33431664|NCT01901055|101471063|FG000|Started Protocol to Week 6|Physician Decision|2|||
33431665|NCT01901055|101471064|FG001|Started Protocol to Week 6|Physician Decision|1|||
33431666|NCT01901055|101471063|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
33588175|NCT01639339|102041749|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
33588176|NCT01639339|102041748|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
33588177|NCT01639339|102041749|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
33588178|NCT01639339|102041748|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
33149771|NCT01697358|100463488|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
33149772|NCT01697358|100463489|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
33431667|NCT01901055|101471064|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
33431668|NCT01901055|101471063|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
33431669|NCT01901055|101471064|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
33431670|NCT01901055|101471063|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
33431671|NCT01901055|101471064|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
33431672|NCT01901055|101471063|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
33431673|NCT01901055|101471064|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
33431674|NCT01901055|101471063|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
33431675|NCT01901055|101471064|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
33431676|NCT01901055|101471063|FG000|Week 24|Withdrawal by Subject|13|||
33431677|NCT01901055|101471064|FG001|Week 24|Withdrawal by Subject|19|||
33431678|NCT01901055|101471063|FG000|Week 24|Physician Decision|1|||
33431679|NCT01901055|101471064|FG001|Week 24|Physician Decision|0|||
33431680|NCT01901055|101471063|FG000|Week 36|Withdrawal by Subject|0|||
33431681|NCT01901055|101471064|FG001|Week 36|Withdrawal by Subject|5|||
33431682|NCT03377556|101471067|FG000|Overall Study|Adverse Event|5|||
33431683|NCT03377556|101471067|FG000|Overall Study|Refusal unrelated to adverse events|1|||
33431684|NCT03377556|101471067|FG000|Overall Study|Progression/relapse|38|||
33431685|NCT03377556|101471067|FG000|Overall Study|Death|3|||
33431686|NCT02292238|101471079|FG000|Overall Study|Protocol Violation|1|||
33431687|NCT02292238|101471080|FG001|Overall Study|Protocol Violation|2|||
33431688|NCT02292238|101471079|FG000|Overall Study|Withdrawal by Subject|2|||
33431689|NCT02292238|101471080|FG001|Overall Study|Withdrawal by Subject|1|||
33431690|NCT02292238|101471079|FG000|Overall Study|Lost to Follow-up|1|||
33431691|NCT02292238|101471080|FG001|Overall Study|Lost to Follow-up|0|||
33431692|NCT02292238|101471079|FG000|Overall Study|Physician Decision|0|||
33431693|NCT02292238|101471080|FG001|Overall Study|Physician Decision|1|||
33431694|NCT03572933|101471081|FG000|Overall Study|Adverse Event|4|||
33431695|NCT03572933|101471082|FG001|Overall Study|Adverse Event|1|||
33431696|NCT03572933|101471081|FG000|Overall Study|Withdrawal by Subject|0|||
33431697|NCT03572933|101471082|FG001|Overall Study|Withdrawal by Subject|1|||
33588179|NCT01639339|102041749|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
33588180|NCT01639339|102041748|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
33588181|NCT01639339|102041749|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
33588182|NCT01639339|102041748|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
33588183|NCT01639339|102041749|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
33588184|NCT01639339|102041748|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
33588185|NCT01639339|102041749|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
33588186|NCT01639339|102041748|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
33588187|NCT01639339|102041749|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
33149773|NCT01697358|100463488|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
33149774|NCT01697358|100463489|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
33383817|NCT02378883|101291468|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
33383818|NCT02378883|101291468|FG000|12 Months Follow-Up|Death|2|||
33383819|NCT03032510|101291470|FG000|Overall Study|Adverse Event|5|||
33383820|NCT03032510|101291471|FG001|Overall Study|Adverse Event|2|||
33383821|NCT03032510|101291470|FG000|Overall Study|Lost to Follow-up|8|||
33383822|NCT03032510|101291471|FG001|Overall Study|Lost to Follow-up|7|||
33383823|NCT03032510|101291470|FG000|Overall Study|Withdrawal by Subject|8|||
33383824|NCT03032510|101291471|FG001|Overall Study|Withdrawal by Subject|7|||
33383825|NCT03032510|101291470|FG000|Overall Study|Subject noncompliance|4|||
33383826|NCT03032510|101291471|FG001|Overall Study|Subject noncompliance|2|||
33383827|NCT03032510|101291470|FG000|Overall Study|Physician Decision|2|||
33383828|NCT03032510|101291471|FG001|Overall Study|Physician Decision|0|||
33383829|NCT02151682|101291473|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
33383830|NCT02151682|101291474|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
33383831|NCT02151682|101291475|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
33383832|NCT02151682|101291476|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
33383833|NCT02151682|101291477|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
33383834|NCT02151682|101291478|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
33383835|NCT02151682|101291473|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
33383836|NCT02151682|101291474|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
33383837|NCT02151682|101291475|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
33383838|NCT02151682|101291476|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
33383839|NCT02151682|101291477|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
33383840|NCT02151682|101291478|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
33383841|NCT02151682|101291473|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
33431698|NCT03850509|101471084|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
33431699|NCT03850509|101471085|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
33431700|NCT01992107|101471086|FG000|Overall Study|Administrative reasons|2|||
33431701|NCT01992107|101471087|FG001|Overall Study|Administrative reasons|0|||
33431702|NCT01992107|101471088|FG002|Overall Study|Administrative reasons|0|||
33249427|NCT00606580|100814489|FG001|Overall Study|Lost to Follow-up|1|||
33431703|NCT01992107|101471086|FG000|Overall Study|Adverse Event|0|||
33431704|NCT01992107|101471087|FG001|Overall Study|Adverse Event|1|||
33431705|NCT01992107|101471088|FG002|Overall Study|Adverse Event|0|||
33431706|NCT01992107|101471086|FG000|Overall Study|Lost to Follow-up|46|||
33431707|NCT01992107|101471087|FG001|Overall Study|Lost to Follow-up|22|||
33431708|NCT01992107|101471088|FG002|Overall Study|Lost to Follow-up|26|||
33431709|NCT01992107|101471086|FG000|Overall Study|noncompliance and were unavailable|7|||
33431710|NCT01992107|101471087|FG001|Overall Study|noncompliance and were unavailable|3|||
33431711|NCT01992107|101471088|FG002|Overall Study|noncompliance and were unavailable|2|||
33431712|NCT01992107|101471086|FG000|Overall Study|Withdrawal by Subject|13|||
33431713|NCT01992107|101471087|FG001|Overall Study|Withdrawal by Subject|7|||
33431714|NCT01992107|101471088|FG002|Overall Study|Withdrawal by Subject|8|||
33431715|NCT01165684|101471089|FG000|Overall Study|Adverse Event|1|||
33431716|NCT01165684|101471090|FG001|Overall Study|Adverse Event|1|||
33431717|NCT01165684|101471089|FG000|Overall Study|Lack of Efficacy|2|||
33648158|NCT01349049|102262968|FG002|Overall Study|Disease progression|3|||
33648159|NCT01349049|102262969|FG003|Overall Study|Disease progression|2|||
33648160|NCT01349049|102262970|FG004|Overall Study|Disease progression|2|||
33648161|NCT01349049|102262971|FG005|Overall Study|Disease progression|2|||
33648162|NCT01349049|102262972|FG006|Overall Study|Disease progression|3|||
33648163|NCT01349049|102262973|FG007|Overall Study|Disease progression|2|||
33648164|NCT01349049|102262974|FG008|Overall Study|Disease progression|33|||
33648165|NCT01349049|102262966|FG000|Overall Study|Adverse Event|0|||
33648166|NCT01349049|102262967|FG001|Overall Study|Adverse Event|1|||
33648167|NCT01349049|102262968|FG002|Overall Study|Adverse Event|0|||
33648168|NCT01349049|102262969|FG003|Overall Study|Adverse Event|0|||
33648169|NCT01349049|102262970|FG004|Overall Study|Adverse Event|0|||
33648170|NCT01349049|102262971|FG005|Overall Study|Adverse Event|3|||
33648171|NCT01349049|102262972|FG006|Overall Study|Adverse Event|1|||
33648172|NCT01349049|102262973|FG007|Overall Study|Adverse Event|0|||
33648173|NCT01349049|102262974|FG008|Overall Study|Adverse Event|4|||
33648174|NCT01349049|102262966|FG000|Overall Study|Physician Decision|0|||
33648175|NCT01349049|102262967|FG001|Overall Study|Physician Decision|1|||
33648176|NCT01349049|102262968|FG002|Overall Study|Physician Decision|0|||
33648177|NCT01349049|102262969|FG003|Overall Study|Physician Decision|0|||
33648178|NCT01349049|102262970|FG004|Overall Study|Physician Decision|0|||
33648179|NCT01349049|102262971|FG005|Overall Study|Physician Decision|0|||
33648180|NCT01349049|102262972|FG006|Overall Study|Physician Decision|0|||
33648181|NCT01349049|102262973|FG007|Overall Study|Physician Decision|0|||
33648182|NCT01349049|102262974|FG008|Overall Study|Physician Decision|2|||
33648183|NCT01349049|102262966|FG000|Overall Study|Protocol Violation|0|||
33648184|NCT01349049|102262967|FG001|Overall Study|Protocol Violation|0|||
33648185|NCT01349049|102262968|FG002|Overall Study|Protocol Violation|0|||
33648186|NCT01349049|102262969|FG003|Overall Study|Protocol Violation|0|||
33648187|NCT01349049|102262970|FG004|Overall Study|Protocol Violation|0|||
33648188|NCT01349049|102262971|FG005|Overall Study|Protocol Violation|0|||
33431718|NCT01165684|101471090|FG001|Overall Study|Lack of Efficacy|1|||
33431719|NCT01165684|101471089|FG000|Overall Study|Protocol Violation|7|||
33431720|NCT01165684|101471090|FG001|Overall Study|Protocol Violation|15|||
33431721|NCT01165684|101471089|FG000|Overall Study|Withdrawal Criteria|2|||
33431722|NCT01165684|101471090|FG001|Overall Study|Withdrawal Criteria|13|||
33431723|NCT01165684|101471089|FG000|Overall Study|Unclassified|16|||
33431724|NCT01165684|101471090|FG001|Overall Study|Unclassified|22|||
33431725|NCT01132118|101471091|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
33431726|NCT01132118|101471092|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
33431727|NCT01132118|101471091|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
33431728|NCT01132118|101471092|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
33431729|NCT01132118|101471091|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
33431730|NCT01132118|101471092|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
33431731|NCT00295854|101471095|FG000|Overall Study|Adverse Event|7|||
33648189|NCT01349049|102262972|FG006|Overall Study|Protocol Violation|0|||
33431732|NCT00295854|101471096|FG001|Overall Study|Adverse Event|7|||
33431733|NCT00295854|101471097|FG002|Overall Study|Adverse Event|6|||
33431734|NCT00295854|101471095|FG000|Overall Study|Protocol Violation|1|||
33431735|NCT00295854|101471096|FG001|Overall Study|Protocol Violation|1|||
33431736|NCT00295854|101471097|FG002|Overall Study|Protocol Violation|1|||
33431737|NCT00295854|101471095|FG000|Overall Study|Lost to Follow-up|2|||
33588188|NCT01639339|102041748|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
33648190|NCT01349049|102262973|FG007|Overall Study|Protocol Violation|0|||
33648191|NCT01349049|102262974|FG008|Overall Study|Protocol Violation|1|||
33648192|NCT01349049|102262966|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
33648193|NCT01349049|102262967|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
33431738|NCT00295854|101471096|FG001|Overall Study|Lost to Follow-up|0|||
33588189|NCT01639339|102041749|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
33648194|NCT01349049|102262968|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
33648195|NCT01349049|102262969|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
33648196|NCT01349049|102262970|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
33648197|NCT01349049|102262971|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
33249428|NCT00606580|100814490|FG002|Overall Study|Lost to Follow-up|4|||
33249429|NCT00606580|100814488|FG000|Overall Study|Clinical failures|1|||
33249430|NCT00606580|100814489|FG001|Overall Study|Clinical failures|0|||
33249431|NCT00606580|100814490|FG002|Overall Study|Clinical failures|12|||
33249432|NCT00606580|100814488|FG000|Overall Study|Withdrawal by investigator|0|||
33249433|NCT00606580|100814489|FG001|Overall Study|Withdrawal by investigator|1|||
33249434|NCT00606580|100814490|FG002|Overall Study|Withdrawal by investigator|6|||
33249435|NCT00606580|100814488|FG000|Overall Study|Withdrawal by Subject|0|||
33249436|NCT00606580|100814489|FG001|Overall Study|Withdrawal by Subject|1|||
33249437|NCT00606580|100814490|FG002|Overall Study|Withdrawal by Subject|0|||
33249438|NCT01137292|100814491|FG000|Overall Study|Death|30|||
33249439|NCT01137292|100814491|FG000|Overall Study|Adverse Event|3|||
33249440|NCT01137292|100814491|FG000|Overall Study|Lack of Efficacy|13|||
33249441|NCT01137292|100814491|FG000|Overall Study|Lost to Follow-up|1|||
33249442|NCT01137292|100814491|FG000|Overall Study|Other|7|||
33249443|NCT00344019|100814492|FG000|Overall Study|did not meet final inclusion criteria|0|||
33249444|NCT00344019|100814493|FG001|Overall Study|did not meet final inclusion criteria|0|||
33249445|NCT00344019|100814494|FG002|Overall Study|did not meet final inclusion criteria|74|||
33249446|NCT01833832|100814495|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
33249447|NCT00686517|100814496|FG000|Treatment|Serious Adverse Event|1|||
33249448|NCT00686517|100814497|FG001|Treatment|Serious Adverse Event|2|||
33249449|NCT00686517|100814498|FG002|Treatment|Serious Adverse Event|1|||
33249450|NCT00686517|100814496|FG000|Treatment|Adverse Event|2|||
33249451|NCT00686517|100814497|FG001|Treatment|Adverse Event|0|||
33249452|NCT00686517|100814498|FG002|Treatment|Adverse Event|0|||
33249453|NCT00686517|100814496|FG000|Treatment|Poor Protocol Compliance|1|||
33249454|NCT00686517|100814497|FG001|Treatment|Poor Protocol Compliance|0|||
33249455|NCT00686517|100814498|FG002|Treatment|Poor Protocol Compliance|0|||
33249456|NCT00686517|100814496|FG000|Treatment|Protocol Violation|2|||
33249457|NCT00686517|100814497|FG001|Treatment|Protocol Violation|1|||
33249458|NCT00686517|100814498|FG002|Treatment|Protocol Violation|0|||
33249459|NCT00320489|100814500|FG000|Overall Study|Adverse Event|26|||
33249460|NCT00320489|100814501|FG001|Overall Study|Adverse Event|25|||
33249461|NCT00320489|100814500|FG000|Overall Study|Clinical Relapse|26|||
33249462|NCT00320489|100814501|FG001|Overall Study|Clinical Relapse|20|||
33249463|NCT00320489|100814500|FG000|Overall Study|Death|0|||
33249464|NCT00320489|100814501|FG001|Overall Study|Death|2|||
33249465|NCT00320489|100814500|FG000|Overall Study|Entry Criteria Exclusion|2|||
33249466|NCT00320489|100814501|FG001|Overall Study|Entry Criteria Exclusion|4|||
33249467|NCT00320489|100814500|FG000|Overall Study|Lack of Efficacy|16|||
33249468|NCT00320489|100814501|FG001|Overall Study|Lack of Efficacy|7|||
33249469|NCT00320489|100814500|FG000|Overall Study|Lost to Follow-up|21|||
33249470|NCT00320489|100814501|FG001|Overall Study|Lost to Follow-up|22|||
33249471|NCT00320489|100814500|FG000|Overall Study|Physician Decision|8|||
33249472|NCT00320489|100814501|FG001|Overall Study|Physician Decision|8|||
33249473|NCT00320489|100814500|FG000|Overall Study|Protocol Violation|4|||
33249474|NCT00320489|100814501|FG001|Overall Study|Protocol Violation|4|||
33249475|NCT00320489|100814500|FG000|Overall Study|Sponsor Decision|3|||
33249476|NCT00320489|100814501|FG001|Overall Study|Sponsor Decision|3|||
33249477|NCT00320489|100814500|FG000|Overall Study|Withdrawal by Subject|39|||
33249478|NCT00320489|100814501|FG001|Overall Study|Withdrawal by Subject|41|||
33588190|NCT00425698|102041750|FG000|Overall Study|Adverse Event|3|||
33648198|NCT01349049|102262972|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
33648199|NCT01349049|102262973|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
33648200|NCT01349049|102262974|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
33648201|NCT01349049|102262966|FG000|Overall Study|Other|0|||
33149775|NCT01697358|100463488|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
33149776|NCT01697358|100463489|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
33149777|NCT01697358|100463488|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
33149778|NCT01697358|100463489|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
33149779|NCT01697358|100463488|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
33149780|NCT01697358|100463489|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
33149781|NCT01697358|100463488|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
33149782|NCT01697358|100463489|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
33149783|NCT01697358|100463488|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
33149784|NCT01697358|100463489|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
33149785|NCT01697358|100463488|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
33149786|NCT01697358|100463489|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
33149787|NCT01697358|100463488|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
33149788|NCT01697358|100463489|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
33149789|NCT01697358|100463488|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
33149790|NCT01697358|100463489|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
33249479|NCT02046616|100814502|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
33249480|NCT02046616|100814502|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
33648202|NCT01349049|102262967|FG001|Overall Study|Other|0|||
33431739|NCT00295854|101471097|FG002|Overall Study|Lost to Follow-up|1|||
33431740|NCT00295854|101471095|FG000|Overall Study|Withdrawal by Subject|3|||
33431741|NCT00295854|101471096|FG001|Overall Study|Withdrawal by Subject|7|||
33431742|NCT00295854|101471097|FG002|Overall Study|Withdrawal by Subject|4|||
33431743|NCT00295854|101471095|FG000|Overall Study|did not continue to meet criteria|1|||
33431744|NCT00295854|101471096|FG001|Overall Study|did not continue to meet criteria|1|||
33431745|NCT00295854|101471097|FG002|Overall Study|did not continue to meet criteria|2|||
33431746|NCT00295854|101471095|FG000|Overall Study|required a prohibited medication|1|||
33431747|NCT00295854|101471096|FG001|Overall Study|required a prohibited medication|0|||
33431748|NCT00295854|101471097|FG002|Overall Study|required a prohibited medication|0|||
33431749|NCT00295854|101471095|FG000|Overall Study|Other|3|||
33431750|NCT00295854|101471096|FG001|Overall Study|Other|5|||
33431751|NCT00295854|101471097|FG002|Overall Study|Other|1|||
33431752|NCT03982433|101471100|FG000|Overall Study|Lost to Follow-up|1|||
33431753|NCT02346201|101471101|FG000|Overall Study|Adverse Event|3|||
33431754|NCT02346201|101471102|FG001|Overall Study|Adverse Event|2|||
33431755|NCT02346201|101471101|FG000|Overall Study|Lost to Follow-up|1|||
33431756|NCT02346201|101471102|FG001|Overall Study|Lost to Follow-up|0|||
33431757|NCT02346201|101471101|FG000|Overall Study|Withdrawal by Subject|6|||
33431758|NCT02346201|101471102|FG001|Overall Study|Withdrawal by Subject|3|||
33431759|NCT02346201|101471101|FG000|Overall Study|Unavailable for future follow-up|0|||
33431760|NCT02346201|101471102|FG001|Overall Study|Unavailable for future follow-up|1|||
33431761|NCT02346201|101471101|FG000|Overall Study|Physician Decision|0|||
33431762|NCT02346201|101471102|FG001|Overall Study|Physician Decision|1|||
33431763|NCT02346201|101471101|FG000|Overall Study|Missed final visit|0|||
33431764|NCT02346201|101471102|FG001|Overall Study|Missed final visit|2|||
33431765|NCT02097121|101471103|FG000|Overall Study|Other, not specified|4|||
33431766|NCT02097121|101471104|FG001|Overall Study|Other, not specified|2|||
33431767|NCT02097121|101471105|FG002|Overall Study|Other, not specified|3|||
33431768|NCT02097121|101471103|FG000|Overall Study|Lack of Efficacy|2|||
33431769|NCT02097121|101471104|FG001|Overall Study|Lack of Efficacy|1|||
33431770|NCT02097121|101471105|FG002|Overall Study|Lack of Efficacy|3|||
33431771|NCT02097121|101471103|FG000|Overall Study|Withdrawal by Subject|0|||
33431772|NCT02097121|101471104|FG001|Overall Study|Withdrawal by Subject|1|||
33431773|NCT02097121|101471105|FG002|Overall Study|Withdrawal by Subject|2|||
33431774|NCT02097121|101471103|FG000|Overall Study|Adverse Event|0|||
33431775|NCT02097121|101471104|FG001|Overall Study|Adverse Event|1|||
33431776|NCT02097121|101471105|FG002|Overall Study|Adverse Event|0|||
33431777|NCT02097121|101471103|FG000|Overall Study|Lost to Follow-up|1|||
33431778|NCT02097121|101471104|FG001|Overall Study|Lost to Follow-up|1|||
33431779|NCT02097121|101471105|FG002|Overall Study|Lost to Follow-up|2|||
33431780|NCT03495869|101471108|FG000|Overall Study|Lost to Follow-up|4|||
33431781|NCT03495869|101471109|FG001|Overall Study|Lost to Follow-up|17|||
33431782|NCT03495869|101471110|FG002|Overall Study|Lost to Follow-up|8|||
33431783|NCT03495869|101471111|FG003|Overall Study|Lost to Follow-up|14|||
33431784|NCT03495869|101471108|FG000|Overall Study|Withdrawal by Subject|0|||
33431785|NCT03495869|101471109|FG001|Overall Study|Withdrawal by Subject|3|||
33431786|NCT03495869|101471110|FG002|Overall Study|Withdrawal by Subject|0|||
33431787|NCT03495869|101471111|FG003|Overall Study|Withdrawal by Subject|3|||
33431788|NCT03495869|101471108|FG000|Overall Study|Dropped from study|0|||
33431789|NCT03495869|101471109|FG001|Overall Study|Dropped from study|7|||
33431790|NCT03495869|101471110|FG002|Overall Study|Dropped from study|2|||
33431791|NCT03495869|101471111|FG003|Overall Study|Dropped from study|4|||
33431792|NCT00929708|101471112|FG000|Overall Study|Protocol Violation|2|||
33431793|NCT00929708|101471113|FG001|Overall Study|Protocol Violation|1|||
33431794|NCT00929708|101471114|FG002|Overall Study|Protocol Violation|1|||
33431795|NCT00929708|101471115|FG003|Overall Study|Protocol Violation|1|||
33431796|NCT00929708|101471116|FG004|Overall Study|Protocol Violation|1|||
33431797|NCT00929708|101471112|FG000|Overall Study|Withdrawal by Subject|2|||
33588191|NCT00425698|102041751|FG001|Overall Study|Adverse Event|1|||
33588192|NCT00425698|102041750|FG000|Overall Study|Withdrawal by Subject|0|||
33431798|NCT00929708|101471113|FG001|Overall Study|Withdrawal by Subject|0|||
33431799|NCT00929708|101471114|FG002|Overall Study|Withdrawal by Subject|0|||
33431800|NCT00929708|101471115|FG003|Overall Study|Withdrawal by Subject|2|||
33431801|NCT00929708|101471116|FG004|Overall Study|Withdrawal by Subject|1|||
33431802|NCT00929708|101471112|FG000|Overall Study|Adverse Event|0|||
33431803|NCT00929708|101471113|FG001|Overall Study|Adverse Event|0|||
33431804|NCT00929708|101471114|FG002|Overall Study|Adverse Event|0|||
33431805|NCT00929708|101471115|FG003|Overall Study|Adverse Event|0|||
33431806|NCT00929708|101471116|FG004|Overall Study|Adverse Event|3|||
33149791|NCT01865084|100463494|FG000|Double Blind Period (DB)|Adverse Event|2|||
33431807|NCT00929708|101471112|FG000|Overall Study|Physician Decision|0|||
33431808|NCT00929708|101471113|FG001|Overall Study|Physician Decision|2|||
33431809|NCT00929708|101471114|FG002|Overall Study|Physician Decision|2|||
33431810|NCT00929708|101471115|FG003|Overall Study|Physician Decision|2|||
33431811|NCT00929708|101471116|FG004|Overall Study|Physician Decision|1|||
33431812|NCT00929708|101471112|FG000|Overall Study|Lost to Follow-up|0|||
33431813|NCT00929708|101471113|FG001|Overall Study|Lost to Follow-up|0|||
33431814|NCT00929708|101471114|FG002|Overall Study|Lost to Follow-up|0|||
33648203|NCT01349049|102262968|FG002|Overall Study|Other|0|||
33383842|NCT02151682|101291474|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
33383843|NCT02151682|101291475|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
33383844|NCT02151682|101291476|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
33383845|NCT02151682|101291477|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
33383846|NCT02151682|101291478|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
33383847|NCT02151682|101291473|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
33383848|NCT02151682|101291474|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
33383849|NCT02151682|101291475|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
33383850|NCT02151682|101291476|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
33383851|NCT02151682|101291477|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
33383852|NCT02151682|101291478|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
33383853|NCT02151682|101291473|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
33383854|NCT02151682|101291474|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
33383855|NCT02151682|101291475|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
33383856|NCT02151682|101291476|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
33383857|NCT02151682|101291477|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
33383858|NCT02151682|101291478|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
33383859|NCT02151682|101291473|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
33383860|NCT02151682|101291474|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
33383861|NCT02151682|101291475|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
33383862|NCT02151682|101291476|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
33383863|NCT02151682|101291477|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
33383864|NCT02151682|101291478|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
33383865|NCT02151682|101291473|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
33383866|NCT02151682|101291474|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
33383867|NCT02151682|101291475|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
33383868|NCT02151682|101291476|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
33383869|NCT02151682|101291477|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
33383870|NCT02151682|101291478|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
33383871|NCT02151682|101291473|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
33383872|NCT02151682|101291474|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
33383873|NCT02151682|101291475|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
33383874|NCT02151682|101291476|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
33383875|NCT02151682|101291477|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
33383876|NCT02151682|101291478|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
33383877|NCT02151682|101291473|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
33383878|NCT02151682|101291474|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
33383879|NCT02151682|101291475|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
33383880|NCT02151682|101291476|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
33383881|NCT02151682|101291477|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
33383882|NCT02151682|101291478|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
33383883|NCT02151682|101291473|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
33383884|NCT02151682|101291474|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
33383885|NCT02151682|101291475|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
33383886|NCT02151682|101291476|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
33383887|NCT02151682|101291477|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
33383888|NCT02151682|101291478|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
33383889|NCT02151682|101291473|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
33383890|NCT02151682|101291474|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
33383891|NCT02151682|101291475|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
33383892|NCT02151682|101291476|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
33383893|NCT02151682|101291477|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
33383894|NCT02151682|101291478|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
33383895|NCT02151682|101291473|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
33383896|NCT02151682|101291474|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
33383897|NCT02151682|101291475|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
33383898|NCT02151682|101291476|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
33383899|NCT02151682|101291477|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
33383900|NCT02151682|101291478|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
33383901|NCT02151682|101291473|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
33383902|NCT02151682|101291474|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
33431815|NCT00929708|101471115|FG003|Overall Study|Lost to Follow-up|1|||
33249481|NCT02046616|100814502|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
33249482|NCT02046616|100814502|FG000|24-Week Treatment Period|Physician Decision|3|||
33431816|NCT00929708|101471116|FG004|Overall Study|Lost to Follow-up|0|||
33431817|NCT01937364|101471121|FG000|Overall Study|Adverse Event|2|||
33431818|NCT01937364|101471122|FG001|Overall Study|Adverse Event|1|||
33431819|NCT00524459|101471123|FG000|Overall Study|Withdrawal by Subject|1|||
33431820|NCT00524459|101471123|FG000|Overall Study|Other|1|||
33431821|NCT04120194|101471130|FG000|Overall Study|Lost to Follow-up|11|||
33431822|NCT04120194|101471131|FG001|Overall Study|Lost to Follow-up|8|||
33431823|NCT04120194|101471130|FG000|Overall Study|Adverse Event|4|||
33431824|NCT04120194|101471131|FG001|Overall Study|Adverse Event|5|||
33431825|NCT04120194|101471130|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
33431826|NCT04120194|101471131|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
33431827|NCT04120194|101471130|FG000|Overall Study|Miscellaneous|4|||
33431828|NCT04120194|101471131|FG001|Overall Study|Miscellaneous|5|||
33431829|NCT00294723|101471132|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
33431830|NCT00294723|101471133|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
33431831|NCT00294723|101471134|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
33431832|NCT00294723|101471132|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
33431833|NCT00294723|101471133|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
33431834|NCT00294723|101471134|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
33431835|NCT00294723|101471132|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
33431836|NCT00294723|101471133|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
33431837|NCT00294723|101471134|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
33431838|NCT00294723|101471132|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
33431839|NCT00294723|101471133|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
33431840|NCT00294723|101471134|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
33431841|NCT00294723|101471132|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
33431842|NCT00294723|101471133|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
33431843|NCT00294723|101471134|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
33431844|NCT00294723|101471132|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
33431845|NCT00294723|101471133|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
33249483|NCT02046616|100814502|FG000|24-Week Treatment Period|Other|1|||
33383903|NCT02151682|101291475|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
33383904|NCT02151682|101291476|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
33383905|NCT02151682|101291477|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
33383906|NCT02151682|101291478|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
33383907|NCT02151682|101291473|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
33383908|NCT02151682|101291474|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
33383909|NCT02151682|101291475|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
33383910|NCT02151682|101291476|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
33383911|NCT02151682|101291477|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
33383912|NCT02151682|101291478|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
33383913|NCT02151682|101291473|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
33383914|NCT02151682|101291474|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
33383915|NCT02151682|101291475|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
33383916|NCT02151682|101291476|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
33383917|NCT02151682|101291477|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
33383918|NCT02151682|101291478|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
33383919|NCT02151682|101291473|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
33383920|NCT02151682|101291474|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
33383921|NCT02151682|101291475|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
33383922|NCT02151682|101291476|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
33383923|NCT02151682|101291477|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
33383924|NCT02151682|101291478|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
33383925|NCT02151682|101291473|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
33383926|NCT02151682|101291474|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
33383927|NCT02151682|101291475|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
33383928|NCT02151682|101291476|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
33383929|NCT02151682|101291477|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
33383930|NCT02151682|101291478|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
33383931|NCT02151682|101291473|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
33383932|NCT02151682|101291474|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
33383933|NCT02151682|101291475|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
33431846|NCT00294723|101471134|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
33588193|NCT00425698|102041751|FG001|Overall Study|Withdrawal by Subject|1|||
33249484|NCT02046616|100814502|FG000|8-Week FU Period|Lost to Follow-up|1|||
33431847|NCT00294723|101471132|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
33249485|NCT01803646|100814503|FG000|Overall Study|Protocol Violation|1|||
33249486|NCT01803646|100814504|FG001|Overall Study|Protocol Violation|0|||
33431848|NCT00294723|101471133|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
33431849|NCT00294723|101471134|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
33431850|NCT00294723|101471132|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
33431851|NCT00294723|101471133|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
33431852|NCT00294723|101471134|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
33431853|NCT00294723|101471132|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
33431854|NCT00294723|101471133|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
33431855|NCT00294723|101471134|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
33431856|NCT00294723|101471132|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
33431857|NCT00294723|101471133|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
33431858|NCT00294723|101471134|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
33431859|NCT00294723|101471132|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
33431860|NCT00294723|101471133|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
33431861|NCT00294723|101471134|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
33431862|NCT00294723|101471132|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
33431863|NCT00294723|101471133|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
33431864|NCT00294723|101471134|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
33431865|NCT01333033|101471135|FG000|Overall Study|Ineligible|0|||
33431866|NCT01333033|101471136|FG001|Overall Study|Ineligible|0|||
33431867|NCT01333033|101471137|FG002|Overall Study|Ineligible|0|||
33431868|NCT01333033|101471138|FG003|Overall Study|Ineligible|0|||
33431869|NCT01333033|101471139|FG004|Overall Study|Ineligible|6|||
33431870|NCT01333033|101471140|FG005|Overall Study|Ineligible|8|||
33431871|NCT01333033|101471135|FG000|Overall Study|Withdrawal by Subject|0|||
33431872|NCT01333033|101471136|FG001|Overall Study|Withdrawal by Subject|0|||
33431873|NCT01333033|101471137|FG002|Overall Study|Withdrawal by Subject|0|||
33431874|NCT01333033|101471138|FG003|Overall Study|Withdrawal by Subject|0|||
33431875|NCT01333033|101471139|FG004|Overall Study|Withdrawal by Subject|4|||
33431876|NCT01333033|101471140|FG005|Overall Study|Withdrawal by Subject|2|||
33431877|NCT01333033|101471135|FG000|Overall Study|PET inevaluable|0|||
33431878|NCT01333033|101471136|FG001|Overall Study|PET inevaluable|0|||
33431879|NCT01333033|101471137|FG002|Overall Study|PET inevaluable|0|||
33431880|NCT01333033|101471138|FG003|Overall Study|PET inevaluable|0|||
33431881|NCT01333033|101471139|FG004|Overall Study|PET inevaluable|2|||
33431882|NCT01333033|101471140|FG005|Overall Study|PET inevaluable|4|||
33431883|NCT01333033|101471135|FG000|Overall Study|Adverse Event|0|||
33431884|NCT01333033|101471136|FG001|Overall Study|Adverse Event|0|||
33431885|NCT01333033|101471137|FG002|Overall Study|Adverse Event|0|||
33431886|NCT01333033|101471138|FG003|Overall Study|Adverse Event|0|||
33431887|NCT01333033|101471139|FG004|Overall Study|Adverse Event|2|||
33431888|NCT01333033|101471140|FG005|Overall Study|Adverse Event|1|||
33431889|NCT01333033|101471135|FG000|Overall Study|Progression|0|||
33431890|NCT01333033|101471136|FG001|Overall Study|Progression|0|||
33431891|NCT01333033|101471137|FG002|Overall Study|Progression|0|||
33431892|NCT01333033|101471138|FG003|Overall Study|Progression|0|||
33431893|NCT01333033|101471139|FG004|Overall Study|Progression|0|||
33431894|NCT01333033|101471140|FG005|Overall Study|Progression|1|||
33431895|NCT01333033|101471135|FG000|Overall Study|MD Decision|0|||
33431896|NCT01333033|101471136|FG001|Overall Study|MD Decision|0|||
33431897|NCT01333033|101471137|FG002|Overall Study|MD Decision|0|||
33431898|NCT01333033|101471138|FG003|Overall Study|MD Decision|0|||
33431899|NCT01333033|101471139|FG004|Overall Study|MD Decision|0|||
33431900|NCT01333033|101471140|FG005|Overall Study|MD Decision|2|||
33431901|NCT02410252|101471141|FG000|Overall Study|Withdrawal by Subject|4|||
33431902|NCT02410252|101471141|FG000|Overall Study|Physician Decision|2|||
33431903|NCT00759148|101471142|FG000|Overall Study|Adverse Event|1|||
33431904|NCT00759148|101471143|FG001|Overall Study|Adverse Event|6|||
33431905|NCT00759148|101471142|FG000|Overall Study|Withdrawal by Subject|3|||
33431906|NCT00759148|101471143|FG001|Overall Study|Withdrawal by Subject|7|||
33431907|NCT00759148|101471142|FG000|Overall Study|Lost to Follow-up|3|||
33431908|NCT00759148|101471143|FG001|Overall Study|Lost to Follow-up|9|||
33431909|NCT00759148|101471142|FG000|Overall Study|Treatment Failure|6|||
33149792|NCT01865084|100463495|FG001|Double Blind Period (DB)|Adverse Event|2|||
33431910|NCT00759148|101471143|FG001|Overall Study|Treatment Failure|10|||
33431911|NCT00759148|101471142|FG000|Overall Study|Reason not given|1|||
33431912|NCT00759148|101471143|FG001|Overall Study|Reason not given|0|||
33431913|NCT00696709|101471149|FG000|Overall Study|Withdrawal by Subject|1|||
33431914|NCT00696709|101471150|FG001|Overall Study|Withdrawal by Subject|2|||
33431915|NCT00696709|101471151|FG002|Overall Study|Withdrawal by Subject|1|||
33431916|NCT00696709|101471152|FG003|Overall Study|Withdrawal by Subject|4|||
33431917|NCT00696709|101471153|FG004|Overall Study|Withdrawal by Subject|3|||
33431918|NCT00696709|101471149|FG000|Overall Study|Protocol Violation|1|||
33431919|NCT00696709|101471150|FG001|Overall Study|Protocol Violation|0|||
33431920|NCT00696709|101471151|FG002|Overall Study|Protocol Violation|0|||
33431921|NCT00696709|101471152|FG003|Overall Study|Protocol Violation|0|||
33431922|NCT00696709|101471153|FG004|Overall Study|Protocol Violation|0|||
33431923|NCT00696709|101471149|FG000|Overall Study|Lost to Follow-up|1|||
33431924|NCT00696709|101471150|FG001|Overall Study|Lost to Follow-up|1|||
33431925|NCT00696709|101471151|FG002|Overall Study|Lost to Follow-up|0|||
33431926|NCT00696709|101471152|FG003|Overall Study|Lost to Follow-up|0|||
33431927|NCT00696709|101471153|FG004|Overall Study|Lost to Follow-up|0|||
33431928|NCT00696709|101471149|FG000|Overall Study|Adverse Event|0|||
33431929|NCT00696709|101471150|FG001|Overall Study|Adverse Event|0|||
33431930|NCT00696709|101471151|FG002|Overall Study|Adverse Event|0|||
33431931|NCT00696709|101471152|FG003|Overall Study|Adverse Event|1|||
33431932|NCT00696709|101471153|FG004|Overall Study|Adverse Event|0|||
33431933|NCT00585351|101471158|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
33431934|NCT00585351|101471159|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
33431935|NCT00585351|101471160|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
33431936|NCT00585351|101471161|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
33431937|NCT00585351|101471162|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
33431938|NCT00585351|101471163|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
33249487|NCT01803646|100814503|FG000|Overall Study|Adverse Event|1|||
33383934|NCT02151682|101291476|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
33383935|NCT02151682|101291477|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
33383936|NCT02151682|101291478|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
33383937|NCT00903370|101291479|FG000|Overall Study|Death|13|||
33383938|NCT00903370|101291480|FG001|Overall Study|Death|10|||
33383939|NCT00903370|101291479|FG000|Overall Study|Withdrawal by Subject|9|||
33383940|NCT00903370|101291480|FG001|Overall Study|Withdrawal by Subject|6|||
33383941|NCT00903370|101291479|FG000|Overall Study|Lost to Follow-up|6|||
33383942|NCT00903370|101291480|FG001|Overall Study|Lost to Follow-up|8|||
33383943|NCT00676208|101291482|FG000|Overall Study|Lost to Follow-up|0|||
33383944|NCT00676208|101291483|FG001|Overall Study|Lost to Follow-up|2|||
33383945|NCT00676208|101291482|FG000|Overall Study|Incomplete data|2|||
33383946|NCT00676208|101291483|FG001|Overall Study|Incomplete data|4|||
33383947|NCT01747811|101291494|FG000|Overall Study|Lack of Efficacy|2|||
33383948|NCT01747811|101291495|FG001|Overall Study|Lack of Efficacy|4|||
33383949|NCT00369967|101291500|FG000|Overall Study|Lost to Follow-up|23|||
33383950|NCT00369967|101291501|FG001|Overall Study|Lost to Follow-up|12|||
33383951|NCT00966693|101291510|FG000|Overall Study|Adverse Event|0|||
33383952|NCT00966693|101291511|FG001|Overall Study|Adverse Event|0|||
33383953|NCT00966693|101291512|FG002|Overall Study|Adverse Event|1|||
33383954|NCT00966693|101291513|FG003|Overall Study|Adverse Event|2|||
33383955|NCT00966693|101291510|FG000|Overall Study|Death|0|||
33383956|NCT00966693|101291511|FG001|Overall Study|Death|0|||
33383957|NCT00966693|101291512|FG002|Overall Study|Death|1|||
33383958|NCT00966693|101291513|FG003|Overall Study|Death|0|||
33383959|NCT00966693|101291510|FG000|Overall Study|Withdrawal by Subject|1|||
33383960|NCT00966693|101291511|FG001|Overall Study|Withdrawal by Subject|0|||
33383961|NCT00966693|101291512|FG002|Overall Study|Withdrawal by Subject|0|||
33383962|NCT00966693|101291513|FG003|Overall Study|Withdrawal by Subject|5|||
33383963|NCT00966693|101291510|FG000|Overall Study|Disease Progression|0|||
33383964|NCT00966693|101291511|FG001|Overall Study|Disease Progression|0|||
33383965|NCT00966693|101291512|FG002|Overall Study|Disease Progression|1|||
33383966|NCT00966693|101291513|FG003|Overall Study|Disease Progression|16|||
33383967|NCT02939599|101291514|FG000|Overall Study|Adverse Event|1|||
33383968|NCT02939599|101291515|FG001|Overall Study|Adverse Event|0|||
33383969|NCT02939599|101291514|FG000|Overall Study|Study Terminated By Sponsor|2|||
33383970|NCT02939599|101291515|FG001|Overall Study|Study Terminated By Sponsor|2|||
33383971|NCT02198651|101291516|FG000|Lead-in Period|Withdrew consent|13|||
33383972|NCT02198651|101291517|FG001|Lead-in Period|Withdrew consent|0|||
33383973|NCT02198651|101291518|FG002|Lead-in Period|Withdrew consent|0|||
33383974|NCT02198651|101291519|FG003|Lead-in Period|Withdrew consent|0|||
33383975|NCT02198651|101291520|FG004|Lead-in Period|Withdrew consent|0|||
33383976|NCT02198651|101291516|FG000|Lead-in Period|Adverse Event|2|||
33383977|NCT02198651|101291517|FG001|Lead-in Period|Adverse Event|0|||
33383978|NCT02198651|101291518|FG002|Lead-in Period|Adverse Event|0|||
33383979|NCT02198651|101291519|FG003|Lead-in Period|Adverse Event|0|||
33383980|NCT02198651|101291520|FG004|Lead-in Period|Adverse Event|0|||
33383981|NCT02198651|101291516|FG000|Lead-in Period|Other, not specified|22|||
33383982|NCT02198651|101291517|FG001|Lead-in Period|Other, not specified|0|||
33383983|NCT02198651|101291518|FG002|Lead-in Period|Other, not specified|0|||
33383984|NCT02198651|101291519|FG003|Lead-in Period|Other, not specified|0|||
33383985|NCT02198651|101291520|FG004|Lead-in Period|Other, not specified|0|||
33383986|NCT02198651|101291516|FG000|Double-blind Period|Withdrew consent|0|||
33383987|NCT02198651|101291517|FG001|Double-blind Period|Withdrew consent|4|||
33383988|NCT02198651|101291518|FG002|Double-blind Period|Withdrew consent|0|||
33383989|NCT02198651|101291519|FG003|Double-blind Period|Withdrew consent|0|||
33383990|NCT02198651|101291520|FG004|Double-blind Period|Withdrew consent|0|||
33383991|NCT02198651|101291516|FG000|Double-blind Period|Adverse Event|0|||
33383992|NCT02198651|101291517|FG001|Double-blind Period|Adverse Event|1|||
33383993|NCT02198651|101291518|FG002|Double-blind Period|Adverse Event|0|||
33431939|NCT00585351|101471164|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
33383994|NCT02198651|101291519|FG003|Double-blind Period|Adverse Event|0|||
33431940|NCT00585351|101471165|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
33431941|NCT00585351|101471158|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
33431942|NCT00585351|101471159|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
33431943|NCT00585351|101471160|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
33431944|NCT00585351|101471161|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
33431945|NCT00585351|101471162|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
33431946|NCT00585351|101471163|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
33431947|NCT00585351|101471164|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
33431948|NCT00585351|101471165|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
33431949|NCT00585351|101471158|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
33431950|NCT00585351|101471159|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
33431951|NCT00585351|101471160|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
33431952|NCT00585351|101471161|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
33431953|NCT00585351|101471162|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
33431954|NCT00585351|101471163|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
33431955|NCT00585351|101471164|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
33431956|NCT00585351|101471165|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
33431957|NCT00585351|101471158|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
33431958|NCT00585351|101471159|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
33431959|NCT00585351|101471160|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
33431960|NCT00585351|101471161|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
33431961|NCT00585351|101471162|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
33431962|NCT00585351|101471163|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
33431963|NCT00585351|101471164|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
33431964|NCT00585351|101471165|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
33431965|NCT00585351|101471158|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
33431966|NCT00585351|101471159|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
33431967|NCT00585351|101471160|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
33431968|NCT00585351|101471161|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
33431969|NCT00585351|101471162|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
33431970|NCT00585351|101471163|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
33431971|NCT00585351|101471164|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
33431972|NCT00585351|101471165|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
33431973|NCT00585351|101471158|FG000|Enrollment Period (Intervention)|Death|0|||
33648204|NCT01349049|102262969|FG003|Overall Study|Other|0|||
33648205|NCT01349049|102262970|FG004|Overall Study|Other|0|||
33383995|NCT02198651|101291520|FG004|Double-blind Period|Adverse Event|0|||
33383996|NCT02198651|101291516|FG000|Double-blind Period|Other, not specified|0|||
33383997|NCT02198651|101291517|FG001|Double-blind Period|Other, not specified|4|||
33383998|NCT02198651|101291518|FG002|Double-blind Period|Other, not specified|1|||
33383999|NCT02198651|101291519|FG003|Double-blind Period|Other, not specified|0|||
33384000|NCT02198651|101291520|FG004|Double-blind Period|Other, not specified|0|||
33384001|NCT02198651|101291516|FG000|Open-label Rescue Period|Withdrew consent|0|||
33384002|NCT02198651|101291517|FG001|Open-label Rescue Period|Withdrew consent|0|||
33384003|NCT02198651|101291518|FG002|Open-label Rescue Period|Withdrew consent|0|||
33384004|NCT02198651|101291519|FG003|Open-label Rescue Period|Withdrew consent|2|||
33384005|NCT02198651|101291520|FG004|Open-label Rescue Period|Withdrew consent|0|||
33384006|NCT02198651|101291516|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
33384007|NCT02198651|101291517|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
33384008|NCT02198651|101291518|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
33384009|NCT02198651|101291519|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
33384010|NCT02198651|101291520|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
33384011|NCT00340834|101291523|FG000|Core Phase of Study|Adverse Event|26|||
33384012|NCT00340834|101291524|FG001|Core Phase of Study|Adverse Event|9|||
33384013|NCT00340834|101291525|FG002|Core Phase of Study|Adverse Event|9|||
33384014|NCT00340834|101291526|FG003|Core Phase of Study|Adverse Event|0|||
33384015|NCT00340834|101291527|FG004|Core Phase of Study|Adverse Event|0|||
33384016|NCT00340834|101291523|FG000|Core Phase of Study|Withdrawal by Subject|11|||
33384017|NCT00340834|101291524|FG001|Core Phase of Study|Withdrawal by Subject|9|||
33384018|NCT00340834|101291525|FG002|Core Phase of Study|Withdrawal by Subject|16|||
33384019|NCT00340834|101291526|FG003|Core Phase of Study|Withdrawal by Subject|0|||
33384020|NCT00340834|101291527|FG004|Core Phase of Study|Withdrawal by Subject|0|||
33384021|NCT00340834|101291523|FG000|Core Phase of Study|Administrative Problems|6|||
33384022|NCT00340834|101291524|FG001|Core Phase of Study|Administrative Problems|2|||
33384023|NCT00340834|101291525|FG002|Core Phase of Study|Administrative Problems|7|||
33431974|NCT00585351|101471159|FG001|Enrollment Period (Intervention)|Death|0|||
33431975|NCT00585351|101471160|FG002|Enrollment Period (Intervention)|Death|0|||
33149793|NCT01865084|100463496|FG002|Double Blind Period (DB)|Adverse Event|1|||
33149794|NCT01865084|100463494|FG000|Double Blind Period (DB)|Protocol Violation|0|||
33149795|NCT01865084|100463495|FG001|Double Blind Period (DB)|Protocol Violation|0|||
33149796|NCT01865084|100463496|FG002|Double Blind Period (DB)|Protocol Violation|1|||
33149797|NCT01865084|100463494|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
33149798|NCT01865084|100463495|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
33149799|NCT01865084|100463496|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
33149800|NCT01865084|100463494|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
33149801|NCT01865084|100463495|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
33149802|NCT01865084|100463496|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
33149803|NCT01865084|100463494|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
33149804|NCT01865084|100463495|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
33149805|NCT01865084|100463496|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
33149806|NCT01865084|100463494|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
33149807|NCT01865084|100463495|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
33149808|NCT01865084|100463496|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
33149809|NCT01865084|100463494|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
33149810|NCT01865084|100463495|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
33149811|NCT01865084|100463496|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
33149812|NCT01865084|100463494|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
33149813|NCT01865084|100463495|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
33149814|NCT01865084|100463496|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
33149815|NCT01865084|100463494|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
33149816|NCT01865084|100463495|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
33149817|NCT01865084|100463496|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
33149818|NCT00697073|100463497|FG000|Overall Study|Withdrawal by Subject|2|||
33149819|NCT00697073|100463497|FG000|Overall Study|Pregnancy|1|||
33149820|NCT00697073|100463497|FG000|Overall Study|non compliance and other|6|||
33149821|NCT00642473|100463498|FG000|Overall Study|Withdrawal by Subject|0|||
33149822|NCT00642473|100463499|FG001|Overall Study|Withdrawal by Subject|5|||
33149823|NCT00642473|100463498|FG000|Overall Study|Progression or death|2|||
33149824|NCT00642473|100463499|FG001|Overall Study|Progression or death|4|||
33149825|NCT00642473|100463498|FG000|Overall Study|Other|2|||
33149826|NCT00642473|100463499|FG001|Overall Study|Other|2|||
33149827|NCT04493333|100463504|FG000|Overall Study|Withdrawal by Subject|1|||
33149828|NCT04493333|100463505|FG001|Overall Study|Withdrawal by Subject|1|||
33149829|NCT04493333|100463504|FG000|Overall Study|Ineligible|0|||
33149830|NCT04493333|100463505|FG001|Overall Study|Ineligible|1|||
33149831|NCT04493333|100463504|FG000|Overall Study|Noncompliance|2|||
33149832|NCT04493333|100463505|FG001|Overall Study|Noncompliance|1|||
33149833|NCT00054717|100463506|FG000|Overall Study|Randomized but not treated|2|||
33149834|NCT00054717|100463507|FG001|Overall Study|Randomized but not treated|8|||
33149835|NCT00054717|100463506|FG000|Overall Study|Adverse Event|70|||
33149836|NCT00054717|100463507|FG001|Overall Study|Adverse Event|22|||
33149837|NCT00054717|100463506|FG000|Overall Study|Protocol Violation|18|||
33149838|NCT00054717|100463507|FG001|Overall Study|Protocol Violation|19|||
33149839|NCT00054717|100463506|FG000|Overall Study|Lost to Follow-up|23|||
33149840|NCT00054717|100463507|FG001|Overall Study|Lost to Follow-up|13|||
33149841|NCT00054717|100463506|FG000|Overall Study|Withdrawal by Subject|32|||
33149842|NCT00054717|100463507|FG001|Overall Study|Withdrawal by Subject|20|||
33149843|NCT00054717|100463506|FG000|Overall Study|Other reason not defined above|117|||
33149844|NCT00054717|100463507|FG001|Overall Study|Other reason not defined above|217|||
33149845|NCT00764491|100463510|FG000|Overall Study|Lost to Follow-up|35|||
33149846|NCT00764491|100463511|FG001|Overall Study|Lost to Follow-up|17|||
33149847|NCT02057393|100463512|FG000|Overall Study|Withdrawal by Subject|1|||
33149848|NCT02057393|100463512|FG000|Overall Study|Patient did not meet criteria|1|||
33149849|NCT03063203|100463513|FG000|Overall Study|Chose alternative therapy|3|||
33149850|NCT03063203|100463513|FG000|Overall Study|Death|2|||
33149851|NCT03063203|100463513|FG000|Overall Study|Disease progression|4|||
33588194|NCT00606034|102041753|FG000|Overall Study|incarceration|1|||
33149852|NCT03063203|100463513|FG000|Overall Study|Physician Decision|5|||
33149853|NCT03538431|100463514|FG000|Overall Study|Physician Decision|0|||
33149854|NCT03538431|100463515|FG001|Overall Study|Physician Decision|1|||
33149855|NCT03538431|100463514|FG000|Overall Study|Withdrawal by Subject|1|||
33149856|NCT03538431|100463515|FG001|Overall Study|Withdrawal by Subject|0|||
33149857|NCT00884377|100463516|FG000|Overall Study|Withdrawal by Subject|1|||
33588195|NCT02851797|102041754|FG000|Overall Study|Withdrawal by Subject|4|||
33149858|NCT00884377|100463517|FG001|Overall Study|Withdrawal by Subject|0|||
33149859|NCT00884377|100463516|FG000|Overall Study|Could not confirm diagnosis|1|||
33149860|NCT00884377|100463517|FG001|Overall Study|Could not confirm diagnosis|0|||
33149861|NCT00884377|100463516|FG000|Overall Study|Physician Decision|0|||
33149862|NCT00884377|100463517|FG001|Overall Study|Physician Decision|1|||
33149863|NCT04533880|100463530|FG000|Overall Study|Lost to Follow-up|0|||
33149864|NCT04533880|100463531|FG001|Overall Study|Lost to Follow-up|1|||
33249488|NCT01803646|100814504|FG001|Overall Study|Adverse Event|1|||
33249489|NCT01803646|100814503|FG000|Overall Study|Withdrawal by Subject|9|||
33249490|NCT01803646|100814504|FG001|Overall Study|Withdrawal by Subject|6|||
33249491|NCT01803646|100814503|FG000|Overall Study|Randomization error|1|||
33249492|NCT01803646|100814504|FG001|Overall Study|Randomization error|2|||
33249493|NCT01803646|100814503|FG000|Overall Study|Lost to Follow-up|5|||
33249494|NCT01803646|100814504|FG001|Overall Study|Lost to Follow-up|1|||
33249495|NCT02274493|100814505|FG000|Overall Study|Withdrawal by Subject|1|||
33249496|NCT00139737|100814508|FG000|Overall Study|Withdrawal by Subject|190|||
33249497|NCT00139737|100814508|FG000|Overall Study|Adverse Event|58|||
33249498|NCT00139737|100814508|FG000|Overall Study|Lack of Efficacy|40|||
33249499|NCT00139737|100814508|FG000|Overall Study|Lost to Follow-up|8|||
33249500|NCT00139737|100814508|FG000|Overall Study|Death|3|||
33249501|NCT00139737|100814508|FG000|Overall Study|Laboratory Abnormality|2|||
33249502|NCT00139737|100814508|FG000|Overall Study|Protocol Violation|18|||
33249503|NCT00139737|100814508|FG000|Overall Study|Withdrew During Screening Phase|8|||
33249504|NCT00139737|100814508|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
33249505|NCT00139737|100814508|FG000|Overall Study|Screened, Not Treated|13|||
33249506|NCT01072357|100814510|FG000|Overall Study|Lost to Follow-up|0|||
33249507|NCT01072357|100814511|FG001|Overall Study|Lost to Follow-up|1|||
33249508|NCT01212757|100814512|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
33249509|NCT01212757|100814513|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
33249510|NCT01212757|100814514|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
33249511|NCT01212757|100814515|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33249512|NCT01212757|100814516|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33648206|NCT01349049|102262971|FG005|Overall Study|Other|1|||
33648207|NCT01349049|102262972|FG006|Overall Study|Other|0|||
33648208|NCT01349049|102262973|FG007|Overall Study|Other|0|||
33648209|NCT01349049|102262974|FG008|Overall Study|Other|4|||
33249513|NCT01212757|100814517|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33249514|NCT01212757|100814518|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33588196|NCT02851797|102041755|FG001|Overall Study|Withdrawal by Subject|2|||
33588197|NCT02851797|102041754|FG000|Overall Study|Adverse Event|3|||
33588198|NCT02851797|102041755|FG001|Overall Study|Adverse Event|0|||
33588199|NCT03332017|102041759|FG000|Overall Study|Lost to Follow-up|1|||
33588200|NCT03332017|102041760|FG001|Overall Study|Lost to Follow-up|2|||
33588201|NCT03332017|102041759|FG000|Overall Study|Death|17|||
33588202|NCT03332017|102041760|FG001|Overall Study|Death|16|||
33588203|NCT03332017|102041759|FG000|Overall Study|Withdrawal by Subject|6|||
33588204|NCT03332017|102041760|FG001|Overall Study|Withdrawal by Subject|14|||
33588205|NCT03332017|102041759|FG000|Overall Study|Other|1|||
33588206|NCT03332017|102041760|FG001|Overall Study|Other|3|||
33588207|NCT03332017|102041759|FG000|Overall Study|Remained in Study (Ongoing)|47|||
33588208|NCT03332017|102041760|FG001|Overall Study|Remained in Study (Ongoing)|110|||
33588209|NCT00395486|102041764|FG000|Overall Study|Adverse Event|1|||
33588210|NCT00395486|102041765|FG001|Overall Study|Adverse Event|2|||
33588211|NCT00395486|102041764|FG000|Overall Study|Withdrawal by Subject|5|||
33588212|NCT00395486|102041765|FG001|Overall Study|Withdrawal by Subject|2|||
33588213|NCT00395486|102041764|FG000|Overall Study|Lost to Follow-up|0|||
33588214|NCT00395486|102041765|FG001|Overall Study|Lost to Follow-up|1|||
33588215|NCT03315793|102041766|FG000|Overall Study|Adverse Event|4|||
33588216|NCT03315793|102041767|FG001|Overall Study|Adverse Event|2|||
33588217|NCT03315793|102041766|FG000|Overall Study|Protocol Deviation|1|||
33588218|NCT03315793|102041767|FG001|Overall Study|Protocol Deviation|0|||
33588219|NCT03315793|102041766|FG000|Overall Study|Difficult for regular visit|0|||
33588220|NCT03315793|102041767|FG001|Overall Study|Difficult for regular visit|1|||
33588221|NCT00249808|102041768|FG000|Overall Study|Other|27|||
33588222|NCT00249808|102041768|FG000|Overall Study|Protocol Violation|3|||
33588223|NCT00249808|102041768|FG000|Overall Study|Lost to Follow-up|8|||
33588224|NCT00249808|102041768|FG000|Overall Study|Adverse Event|81|||
33588225|NCT00249808|102041768|FG000|Overall Study|Lack of Efficacy|52|||
33588226|NCT00249808|102041768|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
33588227|NCT00616018|102041772|FG000|Overall Study|Protocol Violation|3|||
33588228|NCT02920528|102041773|FG000|Overall Study|Incomplete Data|1|||
33648210|NCT01349049|102262966|FG000|Overall Study|Death|0|||
33249515|NCT01212757|100814519|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33588229|NCT02920528|102041774|FG001|Overall Study|Incomplete Data|1|||
33588230|NCT02920528|102041775|FG002|Overall Study|Incomplete Data|1|||
33588231|NCT02920528|102041773|FG000|Overall Study|Adverse Event|0|||
33588232|NCT02920528|102041774|FG001|Overall Study|Adverse Event|0|||
33588233|NCT02920528|102041775|FG002|Overall Study|Adverse Event|3|||
33588234|NCT02920528|102041773|FG000|Overall Study|Did not meet inclusion criteria|2|||
33588235|NCT02920528|102041774|FG001|Overall Study|Did not meet inclusion criteria|0|||
33249516|NCT01212757|100814520|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
33249517|NCT01212757|100814512|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
33249518|NCT01212757|100814513|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
33648211|NCT01349049|102262967|FG001|Overall Study|Death|0|||
33648212|NCT01349049|102262968|FG002|Overall Study|Death|0|||
33431976|NCT00585351|101471161|FG003|Enrollment Period (Intervention)|Death|0|||
33431977|NCT00585351|101471162|FG004|Enrollment Period (Intervention)|Death|1|||
33431978|NCT00585351|101471163|FG005|Enrollment Period (Intervention)|Death|0|||
33431979|NCT00585351|101471164|FG006|Enrollment Period (Intervention)|Death|1|||
33431980|NCT00585351|101471165|FG007|Enrollment Period (Intervention)|Death|0|||
33431981|NCT00585351|101471158|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
33431982|NCT00585351|101471159|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
33431983|NCT00585351|101471160|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
33431984|NCT00585351|101471161|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
33431985|NCT00585351|101471162|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
33431986|NCT00585351|101471163|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
33431987|NCT00585351|101471164|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
33431988|NCT00585351|101471165|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
33431989|NCT03267264|101471166|FG000|Overall Study|Withdrawal by Subject|1|||
33431990|NCT03267264|101471167|FG001|Overall Study|Withdrawal by Subject|0|||
33431991|NCT03267264|101471168|FG002|Overall Study|Withdrawal by Subject|2|||
33431992|NCT03267264|101471169|FG003|Overall Study|Withdrawal by Subject|4|||
33431993|NCT00278200|101471170|FG000|Overall Study|Death|1|||
33431994|NCT00278200|101471171|FG001|Overall Study|Death|3|||
33431995|NCT00278200|101471170|FG000|Overall Study|Physician Decision|0|||
33431996|NCT00278200|101471171|FG001|Overall Study|Physician Decision|1|||
33431997|NCT00679783|101471176|FG000|Overall Study|Adverse Event|0|||
33431998|NCT00679783|101471177|FG001|Overall Study|Adverse Event|0|||
33431999|NCT00679783|101471178|FG002|Overall Study|Adverse Event|0|||
33432000|NCT00679783|101471179|FG003|Overall Study|Adverse Event|3|||
33432001|NCT00679783|101471180|FG004|Overall Study|Adverse Event|0|||
33432002|NCT00679783|101471181|FG005|Overall Study|Adverse Event|0|||
33432003|NCT00679783|101471182|FG006|Overall Study|Adverse Event|1|||
33432004|NCT00679783|101471176|FG000|Overall Study|Lack of Efficacy|0|||
33432005|NCT00679783|101471177|FG001|Overall Study|Lack of Efficacy|1|||
33432006|NCT00679783|101471178|FG002|Overall Study|Lack of Efficacy|0|||
33588236|NCT02920528|102041775|FG002|Overall Study|Did not meet inclusion criteria|1|||
33149865|NCT04533880|100463532|FG002|Overall Study|Lost to Follow-up|1|||
33384024|NCT00340834|101291526|FG003|Core Phase of Study|Administrative Problems|0|||
33384025|NCT00340834|101291527|FG004|Core Phase of Study|Administrative Problems|0|||
33384026|NCT00340834|101291523|FG000|Core Phase of Study|Lack of Efficacy|3|||
33384027|NCT00340834|101291524|FG001|Core Phase of Study|Lack of Efficacy|3|||
33384028|NCT00340834|101291525|FG002|Core Phase of Study|Lack of Efficacy|7|||
33384029|NCT00340834|101291526|FG003|Core Phase of Study|Lack of Efficacy|0|||
33384030|NCT00340834|101291527|FG004|Core Phase of Study|Lack of Efficacy|0|||
33384031|NCT00340834|101291523|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
33384032|NCT00340834|101291524|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
33384033|NCT00340834|101291525|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
33384034|NCT00340834|101291526|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
33384035|NCT00340834|101291527|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
33384036|NCT00340834|101291523|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
33384037|NCT00340834|101291524|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
33384038|NCT00340834|101291525|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
33384039|NCT00340834|101291526|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
33384040|NCT00340834|101291527|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
33384041|NCT00340834|101291523|FG000|Core Phase of Study|Lost to Follow-up|1|||
33384042|NCT00340834|101291524|FG001|Core Phase of Study|Lost to Follow-up|1|||
33384043|NCT00340834|101291525|FG002|Core Phase of Study|Lost to Follow-up|4|||
33384044|NCT00340834|101291526|FG003|Core Phase of Study|Lost to Follow-up|0|||
33384045|NCT00340834|101291527|FG004|Core Phase of Study|Lost to Follow-up|0|||
33384046|NCT00340834|101291523|FG000|Core Phase of Study|Death|2|||
33384047|NCT00340834|101291524|FG001|Core Phase of Study|Death|0|||
33384048|NCT00340834|101291525|FG002|Core Phase of Study|Death|0|||
33384049|NCT00340834|101291526|FG003|Core Phase of Study|Death|0|||
33384050|NCT00340834|101291527|FG004|Core Phase of Study|Death|0|||
33384051|NCT00340834|101291523|FG000|Core Phase of Study|Protocol Violation|0|||
33384052|NCT00340834|101291524|FG001|Core Phase of Study|Protocol Violation|0|||
33384053|NCT00340834|101291525|FG002|Core Phase of Study|Protocol Violation|2|||
33384054|NCT00340834|101291526|FG003|Core Phase of Study|Protocol Violation|0|||
33384055|NCT00340834|101291527|FG004|Core Phase of Study|Protocol Violation|0|||
33384056|NCT00340834|101291523|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
33384057|NCT00340834|101291524|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
33432007|NCT00679783|101471179|FG003|Overall Study|Lack of Efficacy|2|||
33432008|NCT00679783|101471180|FG004|Overall Study|Lack of Efficacy|0|||
33432009|NCT00679783|101471181|FG005|Overall Study|Lack of Efficacy|0|||
33432010|NCT00679783|101471182|FG006|Overall Study|Lack of Efficacy|0|||
33432011|NCT00679783|101471176|FG000|Overall Study|Withdrawal by Subject|0|||
33432012|NCT00679783|101471177|FG001|Overall Study|Withdrawal by Subject|0|||
33432013|NCT00679783|101471178|FG002|Overall Study|Withdrawal by Subject|1|||
33588237|NCT00748618|102041776|FG000|Overall Study|Adverse Event|1|||
33588238|NCT00748618|102041777|FG001|Overall Study|Adverse Event|0|||
33588239|NCT04551963|102041779|FG000|Overall Study|Physician Decision|1|||
33588240|NCT04551963|102041780|FG001|Overall Study|Physician Decision|1|||
33588241|NCT04551963|102041779|FG000|Overall Study|Death|1|||
33588242|NCT04551963|102041780|FG001|Overall Study|Death|0|||
33588243|NCT04472650|102041781|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
33588244|NCT04472650|102041782|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
33588245|NCT03077438|102041783|FG000|Overall Study|Protocol Violation|3|||
33588246|NCT03077438|102041784|FG001|Overall Study|Protocol Violation|5|||
33588247|NCT03077438|102041783|FG000|Overall Study|Withdrawal by Subject|3|||
33588248|NCT03077438|102041784|FG001|Overall Study|Withdrawal by Subject|6|||
33588249|NCT03077438|102041783|FG000|Overall Study|Lost to Follow-up|6|||
33588250|NCT03077438|102041784|FG001|Overall Study|Lost to Follow-up|3|||
33588251|NCT02701283|102041785|FG000|Overall Study|Death|25|||
33588252|NCT02701283|102041786|FG001|Overall Study|Death|29|||
33149866|NCT03923738|100463533|FG000|Period 1|Adverse Event|1|||
33149867|NCT03923738|100463533|FG000|Period 1|Withdrawal by Subject|1|||
33149868|NCT01143207|100463534|FG000|Overall Study|Lost to Follow-up|2|||
33149869|NCT06238362|100463535|FG000|Overall Study|Insufficient total sleep time|1|||
33149870|NCT06238362|100463536|FG001|Overall Study|Insufficient total sleep time|0|||
33149871|NCT06238362|100463535|FG000|Overall Study|Inadequate signal quality|1|||
33149872|NCT06238362|100463536|FG001|Overall Study|Inadequate signal quality|0|||
33149873|NCT00853073|100463537|FG000|Overall Study|Withdrawal by Subject|3|||
33149874|NCT00853073|100463538|FG001|Overall Study|Withdrawal by Subject|2|||
33149875|NCT04340193|100463539|FG000|Overall Study|Other reason|0|||
33149876|NCT04340193|100463540|FG001|Overall Study|Other reason|0|||
33149877|NCT04340193|100463541|FG002|Overall Study|Other reason|1|||
33149878|NCT04340193|100463539|FG000|Overall Study|Disease recurrence|0|||
33149879|NCT04340193|100463540|FG001|Overall Study|Disease recurrence|1|||
33149880|NCT04340193|100463541|FG002|Overall Study|Disease recurrence|0|||
33588253|NCT02701283|102041787|FG002|Overall Study|Death|19|||
33588254|NCT02701283|102041785|FG000|Overall Study|Lost to Follow-up|3|||
33588255|NCT02701283|102041786|FG001|Overall Study|Lost to Follow-up|8|||
33588256|NCT02701283|102041787|FG002|Overall Study|Lost to Follow-up|1|||
33588257|NCT02701283|102041785|FG000|Overall Study|Withdrawal by Subject|12|||
33588258|NCT02701283|102041786|FG001|Overall Study|Withdrawal by Subject|41|||
33648213|NCT01349049|102262969|FG003|Overall Study|Death|0|||
33648214|NCT01349049|102262970|FG004|Overall Study|Death|0|||
33648215|NCT01349049|102262971|FG005|Overall Study|Death|0|||
33648216|NCT01349049|102262972|FG006|Overall Study|Death|0|||
33648217|NCT01349049|102262973|FG007|Overall Study|Death|1|||
33648218|NCT01349049|102262974|FG008|Overall Study|Death|5|||
33648219|NCT01349049|102262966|FG000|Overall Study|Non-compliance|0|||
33648220|NCT01349049|102262967|FG001|Overall Study|Non-compliance|0|||
33648221|NCT01349049|102262968|FG002|Overall Study|Non-compliance|0|||
33648222|NCT01349049|102262969|FG003|Overall Study|Non-compliance|1|||
33648223|NCT01349049|102262970|FG004|Overall Study|Non-compliance|0|||
33648224|NCT01349049|102262971|FG005|Overall Study|Non-compliance|0|||
33648225|NCT01349049|102262972|FG006|Overall Study|Non-compliance|0|||
33149881|NCT04340193|100463539|FG000|Overall Study|Study drug toxicity|1|||
33149882|NCT04340193|100463540|FG001|Overall Study|Study drug toxicity|0|||
33149883|NCT04340193|100463541|FG002|Overall Study|Study drug toxicity|0|||
33384058|NCT00340834|101291525|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
33384059|NCT00340834|101291526|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
33384060|NCT00340834|101291527|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
33384061|NCT00340834|101291523|FG000|Extension Phase of Study|Subject withdrew consent|26|||
33384062|NCT00340834|101291524|FG001|Extension Phase of Study|Subject withdrew consent|31|||
33384063|NCT00340834|101291525|FG002|Extension Phase of Study|Subject withdrew consent|0|||
33384064|NCT00340834|101291526|FG003|Extension Phase of Study|Subject withdrew consent|12|||
33384065|NCT00340834|101291527|FG004|Extension Phase of Study|Subject withdrew consent|15|||
33384066|NCT00340834|101291523|FG000|Extension Phase of Study|Adverse Event|21|||
33384067|NCT00340834|101291524|FG001|Extension Phase of Study|Adverse Event|22|||
33384068|NCT00340834|101291525|FG002|Extension Phase of Study|Adverse Event|0|||
33384069|NCT00340834|101291526|FG003|Extension Phase of Study|Adverse Event|19|||
33384070|NCT00340834|101291527|FG004|Extension Phase of Study|Adverse Event|7|||
33384071|NCT00340834|101291523|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
33384072|NCT00340834|101291524|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
33588259|NCT02701283|102041787|FG002|Overall Study|Withdrawal by Subject|1|||
33588260|NCT02701283|102041785|FG000|Overall Study|Missed 2-year visit|22|||
33588261|NCT02701283|102041786|FG001|Overall Study|Missed 2-year visit|27|||
33588262|NCT02701283|102041787|FG002|Overall Study|Missed 2-year visit|0|||
33588263|NCT02701283|102041785|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
33648226|NCT01349049|102262973|FG007|Overall Study|Non-compliance|0|||
33149884|NCT04340193|100463539|FG000|Overall Study|Disease progression|1|||
33648227|NCT01349049|102262974|FG008|Overall Study|Non-compliance|0|||
33648228|NCT01349049|102262966|FG000|Overall Study|Withdrawal by Subject|0|||
33432014|NCT00679783|101471179|FG003|Overall Study|Withdrawal by Subject|1|||
33432015|NCT00679783|101471180|FG004|Overall Study|Withdrawal by Subject|0|||
33432016|NCT00679783|101471181|FG005|Overall Study|Withdrawal by Subject|0|||
33432017|NCT00679783|101471182|FG006|Overall Study|Withdrawal by Subject|0|||
33432018|NCT00679783|101471176|FG000|Overall Study|Not Captured|0|||
33432019|NCT00679783|101471177|FG001|Overall Study|Not Captured|0|||
33432020|NCT00679783|101471178|FG002|Overall Study|Not Captured|0|||
33432021|NCT00679783|101471179|FG003|Overall Study|Not Captured|5|||
33432022|NCT00679783|101471180|FG004|Overall Study|Not Captured|0|||
33432023|NCT00679783|101471181|FG005|Overall Study|Not Captured|0|||
33432024|NCT00679783|101471182|FG006|Overall Study|Not Captured|0|||
33432025|NCT00679783|101471176|FG000|Overall Study|Ongoing at data cut-off|2|||
33432026|NCT00679783|101471177|FG001|Overall Study|Ongoing at data cut-off|2|||
33432027|NCT00679783|101471178|FG002|Overall Study|Ongoing at data cut-off|0|||
33432028|NCT00679783|101471179|FG003|Overall Study|Ongoing at data cut-off|9|||
33432029|NCT00679783|101471180|FG004|Overall Study|Ongoing at data cut-off|1|||
33432030|NCT00679783|101471181|FG005|Overall Study|Ongoing at data cut-off|0|||
33432031|NCT00679783|101471182|FG006|Overall Study|Ongoing at data cut-off|0|||
33432032|NCT00836927|101471183|FG000|Overall Study|Progressive disease|2|||
33432033|NCT00836927|101471184|FG001|Overall Study|Progressive disease|0|||
33432034|NCT00836927|101471185|FG002|Overall Study|Progressive disease|0|||
33432035|NCT00836927|101471186|FG003|Overall Study|Progressive disease|1|||
33432036|NCT00836927|101471187|FG004|Overall Study|Progressive disease|1|||
33432037|NCT00836927|101471183|FG000|Overall Study|Withdrawal by Subject|1|||
33432038|NCT00836927|101471184|FG001|Overall Study|Withdrawal by Subject|0|||
33432039|NCT00836927|101471185|FG002|Overall Study|Withdrawal by Subject|0|||
33432040|NCT00836927|101471186|FG003|Overall Study|Withdrawal by Subject|0|||
33432041|NCT00836927|101471187|FG004|Overall Study|Withdrawal by Subject|0|||
33432042|NCT00598559|101471188|FG000|Overall Study|Adverse Event|11|||
33432043|NCT00598559|101471189|FG001|Overall Study|Adverse Event|7|||
33432044|NCT00598559|101471190|FG002|Overall Study|Adverse Event|0|||
33432045|NCT00598559|101471188|FG000|Overall Study|Withdrawal by Subject|2|||
33432046|NCT00598559|101471189|FG001|Overall Study|Withdrawal by Subject|2|||
33432047|NCT00598559|101471190|FG002|Overall Study|Withdrawal by Subject|0|||
33432048|NCT00598559|101471188|FG000|Overall Study|Protocol Non-compliance|1|||
33432049|NCT00598559|101471189|FG001|Overall Study|Protocol Non-compliance|0|||
33432050|NCT00598559|101471190|FG002|Overall Study|Protocol Non-compliance|0|||
33432051|NCT00598559|101471188|FG000|Overall Study|Early discharge from hospital|9|||
33432052|NCT00598559|101471189|FG001|Overall Study|Early discharge from hospital|12|||
33432053|NCT00598559|101471190|FG002|Overall Study|Early discharge from hospital|3|||
33432054|NCT00598559|101471188|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
33432055|NCT00598559|101471189|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
33432056|NCT00598559|101471190|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
33432057|NCT02607800|101471191|FG000|Overall Study|Lost to Follow-up|7|||
33432058|NCT02607800|101471192|FG001|Overall Study|Lost to Follow-up|10|||
33432059|NCT02607800|101471191|FG000|Overall Study|Withdrew Consent|2|||
33432060|NCT02607800|101471192|FG001|Overall Study|Withdrew Consent|0|||
33432061|NCT02607800|101471191|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
33432062|NCT02607800|101471192|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
33432063|NCT01006707|101471195|FG000|Study Session 1|Lost to Follow-up|2|||
33432064|NCT01006707|101471196|FG001|Study Session 1|Lost to Follow-up|0|||
33432065|NCT01006707|101471197|FG002|Study Session 1|Lost to Follow-up|0|||
33432066|NCT01006707|101471195|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
33432067|NCT01006707|101471196|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
33432068|NCT01006707|101471197|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
33432069|NCT01767597|101471198|FG000|Overall Study|Incomplete intervention|3|||
33432070|NCT01767597|101471199|FG001|Overall Study|Incomplete intervention|1|||
33432071|NCT01767597|101471198|FG000|Overall Study|Withdrawal by Subject|1|||
33432072|NCT01767597|101471199|FG001|Overall Study|Withdrawal by Subject|0|||
33432073|NCT00582309|101471200|FG000|Overall Study|Protocol Violation|0|||
33648229|NCT01349049|102262967|FG001|Overall Study|Withdrawal by Subject|0|||
33432074|NCT00582309|101471201|FG001|Overall Study|Protocol Violation|0|||
33432075|NCT00582309|101471202|FG002|Overall Study|Protocol Violation|2|||
33432076|NCT01118728|101471203|FG000|Overall Study|Adverse Event|17|||
33432077|NCT01118728|101471203|FG000|Overall Study|Lack of Efficacy|27|||
33432078|NCT01118728|101471203|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
33432079|NCT01118728|101471203|FG000|Overall Study|Withdrawal by Subject|3|||
33432080|NCT01118728|101471203|FG000|Overall Study|Lost to Follow-up|4|||
33432081|NCT01533428|101471204|FG000|Overall Study|Adverse Event|0|||
33432082|NCT01533428|101471205|FG001|Overall Study|Adverse Event|1|||
33432083|NCT01533428|101471204|FG000|Overall Study|Lost to Follow-up|2|||
33432084|NCT01533428|101471205|FG001|Overall Study|Lost to Follow-up|1|||
33432085|NCT01533428|101471204|FG000|Overall Study|Withdrawal by Subject|7|||
33432086|NCT01533428|101471205|FG001|Overall Study|Withdrawal by Subject|6|||
33432087|NCT01048333|101471206|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
33432088|NCT01048333|101471207|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
33432089|NCT01048333|101471208|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
33432090|NCT01048333|101471209|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
33432091|NCT01048333|101471210|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
33432092|NCT01048333|101471211|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
33432093|NCT01787825|101471212|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
33432094|NCT01787825|101471213|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
33432095|NCT01787825|101471212|FG000|Overall Study|Data Not Analyzable|5|||
33432096|NCT01787825|101471213|FG001|Overall Study|Data Not Analyzable|1|||
33432097|NCT00952484|101471214|FG000|Overall Study|Withdrawal by Subject|0|||
33432098|NCT00952484|101471215|FG001|Overall Study|Withdrawal by Subject|1|||
33432099|NCT00952484|101471216|FG002|Overall Study|Withdrawal by Subject|0|||
33432100|NCT00927810|101471219|FG000|Overall Study|Withdrawal by Subject|0|||
33432101|NCT00927810|101471220|FG001|Overall Study|Withdrawal by Subject|3|||
33432102|NCT00927810|101471221|FG002|Overall Study|Withdrawal by Subject|0|||
33432103|NCT00927810|101471222|FG003|Overall Study|Withdrawal by Subject|1|||
33432104|NCT00927810|101471219|FG000|Overall Study|Lost to Follow-up|0|||
33432105|NCT00927810|101471220|FG001|Overall Study|Lost to Follow-up|2|||
33432106|NCT00927810|101471221|FG002|Overall Study|Lost to Follow-up|1|||
33432107|NCT00927810|101471222|FG003|Overall Study|Lost to Follow-up|1|||
33432108|NCT00927810|101471219|FG000|Overall Study|Death|0|||
33432109|NCT00927810|101471220|FG001|Overall Study|Death|2|||
33432110|NCT00927810|101471221|FG002|Overall Study|Death|0|||
33432111|NCT00927810|101471222|FG003|Overall Study|Death|0|||
33432112|NCT00927810|101471219|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33432113|NCT00927810|101471220|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33432114|NCT00927810|101471221|FG002|Overall Study|Abnormal laboratory value(s)|0|||
33432115|NCT00927810|101471222|FG003|Overall Study|Abnormal laboratory value(s)|0|||
33432116|NCT00601484|101471223|FG000|Overall Study|Adverse Event|0|||
33432117|NCT00601484|101471224|FG001|Overall Study|Adverse Event|1|||
33432118|NCT00601484|101471223|FG000|Overall Study|Lost to Follow-up|4|||
33432119|NCT00601484|101471224|FG001|Overall Study|Lost to Follow-up|3|||
33432120|NCT00601484|101471223|FG000|Overall Study|Lack of Efficacy|0|||
33432121|NCT00601484|101471224|FG001|Overall Study|Lack of Efficacy|2|||
33432122|NCT00601484|101471223|FG000|Overall Study|Withdrawal by Subject|1|||
33432123|NCT00601484|101471224|FG001|Overall Study|Withdrawal by Subject|1|||
33432124|NCT00601484|101471223|FG000|Overall Study|Randomized, but not treated|0|||
33432125|NCT00601484|101471224|FG001|Overall Study|Randomized, but not treated|1|||
33432126|NCT05751629|101471225|FG000|Overall Study|Withdrawal by Subject|6|||
33432127|NCT05751629|101471225|FG000|Overall Study|Death|25|||
33432128|NCT05751629|101471225|FG000|Overall Study|Study Site Closed|9|||
33432129|NCT05751629|101471225|FG000|Overall Study|Physician Decision|1|||
33432130|NCT00210626|101471228|FG000|Overall Study|Adverse Event|1|||
33432131|NCT00210626|101471229|FG001|Overall Study|Adverse Event|2|||
33432132|NCT00210626|101471228|FG000|Overall Study|Protocol Violation|1|||
33432133|NCT00210626|101471229|FG001|Overall Study|Protocol Violation|5|||
33432134|NCT00210626|101471228|FG000|Overall Study|Lost to Follow-up|11|||
33432135|NCT00210626|101471229|FG001|Overall Study|Lost to Follow-up|11|||
33432136|NCT00210626|101471228|FG000|Overall Study|Death|1|||
33432137|NCT00210626|101471229|FG001|Overall Study|Death|0|||
33432138|NCT00210626|101471228|FG000|Overall Study|Withdrawal by Subject|29|||
33432139|NCT00210626|101471229|FG001|Overall Study|Withdrawal by Subject|20|||
33432140|NCT00210626|101471228|FG000|Overall Study|Physician Decision|0|||
33432141|NCT00210626|101471229|FG001|Overall Study|Physician Decision|2|||
33432142|NCT00210626|101471228|FG000|Overall Study|Sponser Request|1|||
33432143|NCT00210626|101471229|FG001|Overall Study|Sponser Request|0|||
33432144|NCT00210626|101471228|FG000|Overall Study|Other|4|||
33432145|NCT00210626|101471229|FG001|Overall Study|Other|5|||
33432146|NCT00886483|101471230|FG000|Overall Study|Lost to Follow-up|0|||
33432147|NCT00886483|101471231|FG001|Overall Study|Lost to Follow-up|1|||
33432148|NCT00886483|101471230|FG000|Overall Study|Pursue medications|1|||
33432149|NCT00886483|101471231|FG001|Overall Study|Pursue medications|2|||
33432150|NCT00886483|101471230|FG000|Overall Study|Distance to center, poor grades|1|||
33432151|NCT00886483|101471231|FG001|Overall Study|Distance to center, poor grades|0|||
33432152|NCT02577354|101471232|FG000|Overall Study|Lack of Efficacy|4|||
33432153|NCT02577354|101471233|FG001|Overall Study|Lack of Efficacy|4|||
33432154|NCT02577354|101471232|FG000|Overall Study|Lost to Follow-up|3|||
33432155|NCT02577354|101471233|FG001|Overall Study|Lost to Follow-up|1|||
33432156|NCT02577354|101471232|FG000|Overall Study|Missed Visit|4|||
33432157|NCT02577354|101471233|FG001|Overall Study|Missed Visit|3|||
33432158|NCT02577354|101471232|FG000|Overall Study|Adverse Event|4|||
33432159|NCT02577354|101471233|FG001|Overall Study|Adverse Event|5|||
33432160|NCT03322462|101474197|FG000|Overall Study|Technical difficulties|2|||
33432161|NCT03322462|101474197|FG000|Overall Study|Other|1|||
33432162|NCT01107535|101474200|FG000|Overall Study|Death|5|||
33432163|NCT02545998|101474201|FG000|Overall Study|Lost to Follow-up|12|||
33432164|NCT02545998|101474202|FG001|Overall Study|Lost to Follow-up|3|||
33432165|NCT02545998|101474201|FG000|Overall Study|Withdrawal by Subject|3|||
33432166|NCT02545998|101474202|FG001|Overall Study|Withdrawal by Subject|2|||
33432167|NCT01170364|101474203|FG000|Overall Study|Protocol Violation|4|||
33432168|NCT01170364|101474204|FG001|Overall Study|Protocol Violation|1|||
33432169|NCT00319956|101474205|FG000|Overall Study|Death|20|||
33432170|NCT00319956|101474206|FG001|Overall Study|Death|24|||
33432171|NCT01368276|101474207|FG000|Overall Study|Death|1|||
33432172|NCT01368276|101474208|FG001|Overall Study|Death|10|||
33432173|NCT00752791|101474213|FG000|Overall Study|Adverse Event|7|||
33432174|NCT00752791|101474213|FG000|Overall Study|Withdrawal by Subject|1|||
33432175|NCT00752791|101474213|FG000|Overall Study|Physician Decision|1|||
33432176|NCT00752791|101474213|FG000|Overall Study|Death|1|||
33432177|NCT00752791|101474213|FG000|Overall Study|Renal transplant|3|||
33432178|NCT00752791|101474213|FG000|Overall Study|Switched to hemodialysis|2|||
33432179|NCT00752791|101474213|FG000|Overall Study|Protocol deviation|1|||
33432180|NCT02352337|101474214|FG000|Overall Study|Patients never treated|4|||
33432181|NCT02352337|101474215|FG001|Overall Study|Patients never treated|1|||
33432182|NCT02352337|101474216|FG002|Overall Study|Patients never treated|2|||
33432183|NCT01709383|101474222|FG000|Overall Study|Lost to Follow-up|1|||
33432184|NCT01709383|101474223|FG001|Overall Study|Lost to Follow-up|0|||
33432185|NCT02130466|101474224|FG000|Overall Study|Death|4|||
33432186|NCT02130466|101474225|FG001|Overall Study|Death|1|||
33432187|NCT02130466|101474226|FG002|Overall Study|Death|1|||
33432188|NCT02130466|101474227|FG003|Overall Study|Death|3|||
33588264|NCT02701283|102041786|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
33588265|NCT02701283|102041787|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
33588266|NCT00583752|102041788|FG000|Overall Study|Lost to Follow-up|5|||
33384073|NCT00340834|101291525|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
33384074|NCT00340834|101291526|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
33384075|NCT00340834|101291527|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
33384076|NCT00340834|101291523|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
33384077|NCT00340834|101291524|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
33384078|NCT00340834|101291525|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
33384079|NCT00340834|101291526|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
33384080|NCT00340834|101291527|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
33384081|NCT00340834|101291523|FG000|Extension Phase of Study|Lost to Follow-up|1|||
33384082|NCT00340834|101291524|FG001|Extension Phase of Study|Lost to Follow-up|1|||
33384083|NCT00340834|101291525|FG002|Extension Phase of Study|Lost to Follow-up|0|||
33384084|NCT00340834|101291526|FG003|Extension Phase of Study|Lost to Follow-up|2|||
33384085|NCT00340834|101291527|FG004|Extension Phase of Study|Lost to Follow-up|3|||
33384086|NCT00340834|101291523|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
33384087|NCT00340834|101291524|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
33384088|NCT00340834|101291525|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
33384089|NCT00340834|101291526|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
33384090|NCT00340834|101291527|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
33384091|NCT00340834|101291523|FG000|Extension Phase of Study|Administrative problems|3|||
33384092|NCT00340834|101291524|FG001|Extension Phase of Study|Administrative problems|0|||
33384093|NCT00340834|101291525|FG002|Extension Phase of Study|Administrative problems|0|||
33384094|NCT00340834|101291526|FG003|Extension Phase of Study|Administrative problems|1|||
33384095|NCT00340834|101291527|FG004|Extension Phase of Study|Administrative problems|1|||
33384096|NCT00340834|101291523|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
33384097|NCT00340834|101291524|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
33384098|NCT00340834|101291525|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
33384099|NCT00340834|101291526|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
33384100|NCT00340834|101291527|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
33384101|NCT00340834|101291523|FG000|Extension Phase of Study|Protocol Violation|3|||
33384102|NCT00340834|101291524|FG001|Extension Phase of Study|Protocol Violation|0|||
33384103|NCT00340834|101291525|FG002|Extension Phase of Study|Protocol Violation|0|||
33384104|NCT00340834|101291526|FG003|Extension Phase of Study|Protocol Violation|0|||
33384105|NCT00340834|101291527|FG004|Extension Phase of Study|Protocol Violation|0|||
33384106|NCT00340834|101291523|FG000|Extension Phase of Study|Death|0|||
33384107|NCT00340834|101291524|FG001|Extension Phase of Study|Death|0|||
33384108|NCT00340834|101291525|FG002|Extension Phase of Study|Death|0|||
33384109|NCT00340834|101291526|FG003|Extension Phase of Study|Death|0|||
33384110|NCT00340834|101291527|FG004|Extension Phase of Study|Death|1|||
33384111|NCT01688635|101291530|FG000|Washout 1|Withdrawal by Subject|1|||
33384112|NCT01688635|101291531|FG001|Washout 1|Withdrawal by Subject|0|||
33384113|NCT01688635|101291530|FG000|Washout 1|Adverse Event|0|||
33384114|NCT01688635|101291531|FG001|Washout 1|Adverse Event|1|||
33432189|NCT02130466|101474228|FG004|Overall Study|Death|2|||
33432190|NCT02130466|101474229|FG005|Overall Study|Death|30|||
33432191|NCT02130466|101474230|FG006|Overall Study|Death|45|||
33432192|NCT02130466|101474231|FG007|Overall Study|Death|2|||
33432193|NCT02130466|101474232|FG008|Overall Study|Death|3|||
33432194|NCT02130466|101474233|FG009|Overall Study|Death|4|||
33432195|NCT02130466|101474234|FG010|Overall Study|Death|5|||
33432196|NCT02130466|101474235|FG011|Overall Study|Death|3|||
33432197|NCT02130466|101474236|FG012|Overall Study|Death|11|||
33432198|NCT02130466|101474237|FG013|Overall Study|Death|7|||
33432199|NCT02130466|101474224|FG000|Overall Study|Lost to Follow-up|1|||
33432200|NCT02130466|101474225|FG001|Overall Study|Lost to Follow-up|0|||
33432201|NCT02130466|101474226|FG002|Overall Study|Lost to Follow-up|0|||
33432202|NCT02130466|101474227|FG003|Overall Study|Lost to Follow-up|0|||
33432203|NCT02130466|101474228|FG004|Overall Study|Lost to Follow-up|0|||
33432204|NCT02130466|101474229|FG005|Overall Study|Lost to Follow-up|1|||
33432205|NCT02130466|101474230|FG006|Overall Study|Lost to Follow-up|0|||
33432206|NCT02130466|101474231|FG007|Overall Study|Lost to Follow-up|0|||
33432207|NCT02130466|101474232|FG008|Overall Study|Lost to Follow-up|0|||
33432208|NCT02130466|101474233|FG009|Overall Study|Lost to Follow-up|0|||
33432209|NCT02130466|101474234|FG010|Overall Study|Lost to Follow-up|0|||
33432210|NCT02130466|101474235|FG011|Overall Study|Lost to Follow-up|0|||
33432211|NCT02130466|101474236|FG012|Overall Study|Lost to Follow-up|1|||
33432212|NCT02130466|101474237|FG013|Overall Study|Lost to Follow-up|0|||
33432213|NCT02130466|101474224|FG000|Overall Study|Physician Decision|0|||
33432214|NCT02130466|101474225|FG001|Overall Study|Physician Decision|0|||
33432215|NCT02130466|101474226|FG002|Overall Study|Physician Decision|0|||
33432216|NCT02130466|101474227|FG003|Overall Study|Physician Decision|0|||
33432217|NCT02130466|101474228|FG004|Overall Study|Physician Decision|0|||
33432218|NCT02130466|101474229|FG005|Overall Study|Physician Decision|1|||
33432219|NCT02130466|101474230|FG006|Overall Study|Physician Decision|1|||
33432220|NCT02130466|101474231|FG007|Overall Study|Physician Decision|0|||
33432221|NCT02130466|101474232|FG008|Overall Study|Physician Decision|0|||
33432222|NCT02130466|101474233|FG009|Overall Study|Physician Decision|0|||
33432223|NCT02130466|101474234|FG010|Overall Study|Physician Decision|0|||
33432224|NCT02130466|101474235|FG011|Overall Study|Physician Decision|0|||
33432225|NCT02130466|101474236|FG012|Overall Study|Physician Decision|0|||
33432226|NCT02130466|101474237|FG013|Overall Study|Physician Decision|0|||
33432227|NCT02130466|101474224|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
33432228|NCT02130466|101474225|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
33432229|NCT02130466|101474226|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
33432230|NCT02130466|101474227|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
33432231|NCT02130466|101474228|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
33432232|NCT02130466|101474229|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
33432233|NCT02130466|101474230|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
33432234|NCT02130466|101474231|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
33432235|NCT02130466|101474232|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
33432236|NCT02130466|101474233|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
33432237|NCT02130466|101474234|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
33432238|NCT02130466|101474235|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
33432239|NCT02130466|101474236|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
33432240|NCT02130466|101474237|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
33432241|NCT02130466|101474224|FG000|Overall Study|Withdrawal by Subject|1|||
33432242|NCT02130466|101474225|FG001|Overall Study|Withdrawal by Subject|0|||
33432243|NCT02130466|101474226|FG002|Overall Study|Withdrawal by Subject|0|||
33432244|NCT02130466|101474227|FG003|Overall Study|Withdrawal by Subject|0|||
33432245|NCT02130466|101474228|FG004|Overall Study|Withdrawal by Subject|0|||
33588267|NCT00583752|102041789|FG001|Overall Study|Lost to Follow-up|5|||
33588268|NCT03350035|102041790|FG000|Overall Study|Lack of Efficacy|2|||
33588269|NCT03350035|102041791|FG001|Overall Study|Lack of Efficacy|0|||
33588270|NCT03350035|102041792|FG002|Overall Study|Lack of Efficacy|0|||
33249519|NCT01212757|100814514|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
33432246|NCT02130466|101474229|FG005|Overall Study|Withdrawal by Subject|1|||
33432247|NCT02130466|101474230|FG006|Overall Study|Withdrawal by Subject|0|||
33588271|NCT03350035|102041790|FG000|Overall Study|Subject discharged to hospice|0|||
33588272|NCT03350035|102041791|FG001|Overall Study|Subject discharged to hospice|0|||
33588273|NCT03350035|102041792|FG002|Overall Study|Subject discharged to hospice|1|||
33432248|NCT02130466|101474231|FG007|Overall Study|Withdrawal by Subject|0|||
33432249|NCT02130466|101474232|FG008|Overall Study|Withdrawal by Subject|1|||
33432250|NCT02130466|101474233|FG009|Overall Study|Withdrawal by Subject|0|||
33432251|NCT02130466|101474234|FG010|Overall Study|Withdrawal by Subject|0|||
33588274|NCT01659996|102041793|FG000|Overall Study|Protocol Violation|3|||
33384115|NCT01688635|101291530|FG000|Washout 1|Physician Decision|0|||
33432252|NCT02130466|101474235|FG011|Overall Study|Withdrawal by Subject|0|||
33432253|NCT02130466|101474236|FG012|Overall Study|Withdrawal by Subject|0|||
33588275|NCT01659996|102041794|FG001|Overall Study|Protocol Violation|3|||
33432254|NCT02130466|101474237|FG013|Overall Study|Withdrawal by Subject|0|||
33432255|NCT00582036|101474238|FG000|Overall Study|Withdrawal by Subject|0|||
33432256|NCT00582036|101474239|FG001|Overall Study|Withdrawal by Subject|1|||
33432257|NCT03211156|101474240|FG000|Overall Study|Withdrawal by Subject|0|||
33432258|NCT03211156|101474241|FG001|Overall Study|Withdrawal by Subject|2|||
33588276|NCT01659996|102041795|FG002|Overall Study|Protocol Violation|3|||
33588277|NCT01659996|102041793|FG000|Overall Study|Lost to Follow-up|1|||
33588278|NCT01659996|102041794|FG001|Overall Study|Lost to Follow-up|3|||
33588279|NCT01659996|102041795|FG002|Overall Study|Lost to Follow-up|2|||
33149885|NCT04340193|100463540|FG001|Overall Study|Disease progression|2|||
33149886|NCT04340193|100463541|FG002|Overall Study|Disease progression|3|||
33149887|NCT04340193|100463539|FG000|Overall Study|Administrative reasons by sponsor|0|||
33149888|NCT04340193|100463540|FG001|Overall Study|Administrative reasons by sponsor|1|||
33149889|NCT04340193|100463541|FG002|Overall Study|Administrative reasons by sponsor|0|||
33149890|NCT04340193|100463539|FG000|Overall Study|Adverse Event|1|||
33149891|NCT04340193|100463540|FG001|Overall Study|Adverse Event|1|||
33149892|NCT04340193|100463541|FG002|Overall Study|Adverse Event|0|||
33149893|NCT00096954|100463545|FG000|Overall Study|Adverse Event|3|||
33149894|NCT00096954|100463546|FG001|Overall Study|Adverse Event|1|||
33149895|NCT00096954|100463545|FG000|Overall Study|Withdrawal by Subject|9|||
33149896|NCT00096954|100463546|FG001|Overall Study|Withdrawal by Subject|8|||
33149897|NCT00096954|100463545|FG000|Overall Study|Physician Decision|1|||
33149898|NCT00096954|100463546|FG001|Overall Study|Physician Decision|1|||
33149899|NCT00096954|100463545|FG000|Overall Study|Sponsors Decision|1|||
33149900|NCT00096954|100463546|FG001|Overall Study|Sponsors Decision|1|||
33149901|NCT00096954|100463545|FG000|Overall Study|Pregnancy|1|||
33149902|NCT00096954|100463546|FG001|Overall Study|Pregnancy|1|||
33149903|NCT00096954|100463545|FG000|Overall Study|Initiation of immunotherapy|1|||
33149904|NCT00096954|100463546|FG001|Overall Study|Initiation of immunotherapy|0|||
33149905|NCT00096954|100463545|FG000|Overall Study|Non-compliance|0|||
33149906|NCT00096954|100463546|FG001|Overall Study|Non-compliance|3|||
33149907|NCT00096954|100463545|FG000|Overall Study|Lost to Follow-up|8|||
33149908|NCT00096954|100463546|FG001|Overall Study|Lost to Follow-up|5|||
33149909|NCT02806973|100463556|FG000|Period 1|Withdrawal by Subject|0|||
33149910|NCT02806973|100463557|FG001|Period 1|Withdrawal by Subject|2|||
33149911|NCT02806973|100463558|FG002|Period 1|Withdrawal by Subject|1|||
33149912|NCT02806973|100463559|FG003|Period 1|Withdrawal by Subject|1|||
33149913|NCT02806973|100463556|FG000|Period 1|Adverse Event|0|||
33149914|NCT02806973|100463557|FG001|Period 1|Adverse Event|0|||
33149915|NCT02806973|100463558|FG002|Period 1|Adverse Event|0|||
33149916|NCT02806973|100463559|FG003|Period 1|Adverse Event|1|||
33149917|NCT02806973|100463556|FG000|Period 3|Withdrawal by Subject|0|||
33149918|NCT02806973|100463557|FG001|Period 3|Withdrawal by Subject|0|||
33149919|NCT02806973|100463558|FG002|Period 3|Withdrawal by Subject|0|||
33149920|NCT02806973|100463559|FG003|Period 3|Withdrawal by Subject|3|||
33249520|NCT01212757|100814515|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33384116|NCT01688635|101291531|FG001|Washout 1|Physician Decision|1|||
33384117|NCT01688635|101291530|FG000|Washout 2|Physician Decision|1|||
33384118|NCT01688635|101291531|FG001|Washout 2|Physician Decision|0|||
33384119|NCT01688635|101291530|FG000|Washout 2|Withdrawal by Subject|1|||
33384120|NCT01688635|101291531|FG001|Washout 2|Withdrawal by Subject|0|||
33384121|NCT01688635|101291530|FG000|Washout 2|Sponsor Decision|1|||
33384122|NCT01688635|101291531|FG001|Washout 2|Sponsor Decision|2|||
33384123|NCT01688635|101291530|FG000|Washout 3|Withdrawal by Subject|1|||
33384124|NCT01688635|101291531|FG001|Washout 3|Withdrawal by Subject|0|||
33384125|NCT00004732|101291536|FG000|Overall Study|Withdrawal by Subject|36|||
33384126|NCT00004732|101291537|FG001|Overall Study|Withdrawal by Subject|64|||
33384127|NCT00004732|101291536|FG000|Overall Study|Lost to Follow-up|33|||
33384128|NCT00004732|101291537|FG001|Overall Study|Lost to Follow-up|47|||
33384129|NCT02810951|101291540|FG000|Overall Study|Adverse Event|1|||
33384130|NCT02806947|101291541|FG000|Overall Study|Withdrawal by Subject|5|||
33384131|NCT02806947|101291542|FG001|Overall Study|Withdrawal by Subject|1|||
33384132|NCT01828099|101291548|FG000|Overall Study|Adverse Event|15|||
33384133|NCT01828099|101291549|FG001|Overall Study|Adverse Event|18|||
33384134|NCT01828099|101291548|FG000|Overall Study|Death|9|||
33384135|NCT01828099|101291549|FG001|Overall Study|Death|11|||
33384136|NCT01828099|101291548|FG000|Overall Study|Lost to Follow-up|2|||
33384137|NCT01828099|101291549|FG001|Overall Study|Lost to Follow-up|0|||
33384138|NCT01828099|101291548|FG000|Overall Study|Non-compliance with study treatment|2|||
33384139|NCT01828099|101291549|FG001|Overall Study|Non-compliance with study treatment|0|||
33384140|NCT01828099|101291548|FG000|Overall Study|Physician Decision|7|||
33384141|NCT01828099|101291549|FG001|Overall Study|Physician Decision|11|||
33384142|NCT01828099|101291548|FG000|Overall Study|Progressive disease|51|||
33149921|NCT02806973|100463556|FG000|Period 3|Adverse Event|0|||
33149922|NCT02806973|100463557|FG001|Period 3|Adverse Event|0|||
33149923|NCT02806973|100463558|FG002|Period 3|Adverse Event|1|||
33384143|NCT01828099|101291549|FG001|Overall Study|Progressive disease|94|||
33384144|NCT01828099|101291548|FG000|Overall Study|Protocol Violation|1|||
33384145|NCT01828099|101291549|FG001|Overall Study|Protocol Violation|0|||
33384146|NCT01828099|101291548|FG000|Overall Study|Subject/guardian decision|7|||
33384147|NCT01828099|101291549|FG001|Overall Study|Subject/guardian decision|23|||
33384148|NCT00880763|101291550|FG000|Extension Period (Part 2)|Adverse Event|0|||
33149924|NCT02806973|100463559|FG003|Period 3|Adverse Event|0|||
33149925|NCT00292318|100463560|FG000|Overall Study|Study terminated by officials|2|||
33384149|NCT00880763|101291551|FG001|Extension Period (Part 2)|Adverse Event|0|||
33384150|NCT00880763|101291552|FG002|Extension Period (Part 2)|Adverse Event|1|||
33432259|NCT03211156|101474240|FG000|Overall Study|Lost to Follow-up|1|||
33432260|NCT03211156|101474241|FG001|Overall Study|Lost to Follow-up|1|||
33432261|NCT03211156|101474240|FG000|Overall Study|Adverse Event|1|||
33432262|NCT03211156|101474241|FG001|Overall Study|Adverse Event|0|||
33432263|NCT03402893|101474245|FG000|Overall Study|Withdrawal by Subject|1|||
33432264|NCT00686036|101474249|FG000|Overall Study|Adverse Event|3|||
33432265|NCT00686036|101474250|FG001|Overall Study|Adverse Event|0|||
33432266|NCT00686036|101474249|FG000|Overall Study|Withdrawal by Subject|3|||
33432267|NCT00686036|101474250|FG001|Overall Study|Withdrawal by Subject|1|||
33432268|NCT00686036|101474249|FG000|Overall Study|Study terminated by AstraZeneca|2|||
33432269|NCT00686036|101474250|FG001|Overall Study|Study terminated by AstraZeneca|1|||
33432270|NCT00686036|101474249|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
33432271|NCT00686036|101474250|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
33432272|NCT00686036|101474249|FG000|Overall Study|Other reasons not identified|0|||
33432273|NCT00686036|101474250|FG001|Overall Study|Other reasons not identified|4|||
33432274|NCT02710071|101474251|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
33432275|NCT02710071|101474252|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
33432276|NCT02710071|101474251|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
33432277|NCT02710071|101474252|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
33432278|NCT00458302|101474253|FG000|Overall Study|Adverse Event|4|||
33432279|NCT00458302|101474254|FG001|Overall Study|Adverse Event|14|||
33432280|NCT00458302|101474253|FG000|Overall Study|Pregnancy|2|||
33432281|NCT00458302|101474254|FG001|Overall Study|Pregnancy|1|||
33432282|NCT00458302|101474253|FG000|Overall Study|Protocol Violation|0|||
33432283|NCT00458302|101474254|FG001|Overall Study|Protocol Violation|2|||
33432284|NCT00458302|101474253|FG000|Overall Study|Withdrawal by Subject|6|||
33432285|NCT00458302|101474254|FG001|Overall Study|Withdrawal by Subject|4|||
33432286|NCT00458302|101474253|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
33432287|NCT00458302|101474254|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
33432288|NCT00458302|101474253|FG000|Overall Study|Study Termination By Sponsor|1|||
33432289|NCT00458302|101474254|FG001|Overall Study|Study Termination By Sponsor|0|||
33432290|NCT00458302|101474253|FG000|Overall Study|Lost to Follow-up|2|||
33432291|NCT00458302|101474254|FG001|Overall Study|Lost to Follow-up|0|||
33432292|NCT00458302|101474253|FG000|Overall Study|Other|4|||
33432293|NCT00458302|101474254|FG001|Overall Study|Other|2|||
33432294|NCT03381248|101474255|FG000|0-6 Months|Withdrawal by Subject|4|||
33432295|NCT03381248|101474256|FG001|0-6 Months|Withdrawal by Subject|1|||
33432296|NCT03381248|101474255|FG000|0-6 Months|Lost to Follow-up|3|||
33432297|NCT03381248|101474256|FG001|0-6 Months|Lost to Follow-up|2|||
33432298|NCT03381248|101474255|FG000|0-6 Months|Lack of Efficacy|1|||
33432299|NCT03381248|101474256|FG001|0-6 Months|Lack of Efficacy|0|||
33432300|NCT03381248|101474255|FG000|0-6 Months|Adverse Event|1|||
33432301|NCT03381248|101474256|FG001|0-6 Months|Adverse Event|0|||
33432302|NCT03381248|101474255|FG000|0-6 Months|Protocol Violation|2|||
33432303|NCT03381248|101474256|FG001|0-6 Months|Protocol Violation|1|||
33432304|NCT03381248|101474255|FG000|0-6 Months|Physician Decision|1|||
33432305|NCT03381248|101474256|FG001|0-6 Months|Physician Decision|0|||
33432306|NCT03381248|101474255|FG000|0-6 Months|Planning another procedure|1|||
33432307|NCT03381248|101474256|FG001|0-6 Months|Planning another procedure|2|||
33432308|NCT03381248|101474255|FG000|6-12 Months|Withdrawal by Subject|1|||
33432309|NCT03381248|101474256|FG001|6-12 Months|Withdrawal by Subject|3|||
33432310|NCT03381248|101474255|FG000|6-12 Months|Lost to Follow-up|0|||
33432311|NCT03381248|101474256|FG001|6-12 Months|Lost to Follow-up|2|||
33432312|NCT03381248|101474255|FG000|6-12 Months|Protocol Violation|3|||
33432313|NCT03381248|101474256|FG001|6-12 Months|Protocol Violation|2|||
33432314|NCT03381248|101474255|FG000|6-12 Months|Planning another procedure|6|||
33432315|NCT03381248|101474256|FG001|6-12 Months|Planning another procedure|2|||
33432316|NCT03381248|101474255|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
33432317|NCT03381248|101474256|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
33432318|NCT03381248|101474255|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
33432319|NCT03381248|101474256|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
33432320|NCT03381248|101474255|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
33432321|NCT03381248|101474256|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
33432322|NCT01751412|101474259|FG000|Overall Study|Disease Progression Before Treatment|1|||
33588280|NCT01659996|102041793|FG000|Overall Study|Adverse Event|0|||
33432323|NCT03283709|101474260|FG000|Overall Study|trial terminated|0|||
33432324|NCT03283709|101474261|FG001|Overall Study|trial terminated|1|||
33432325|NCT01656889|101474264|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
33432326|NCT01656889|101474265|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
33432327|NCT01656889|101474264|FG000|Treatment Period, 12 Weeks|Death|0|||
33432328|NCT01656889|101474265|FG001|Treatment Period, 12 Weeks|Death|1|||
33432329|NCT01656889|101474264|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
33432330|NCT01656889|101474265|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
33432331|NCT01656889|101474264|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
33149926|NCT00292318|100463561|FG001|Overall Study|Study terminated by officials|1|||
33432332|NCT01656889|101474265|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
33432333|NCT01656889|101474264|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
33648230|NCT01349049|102262968|FG002|Overall Study|Withdrawal by Subject|0|||
33648231|NCT01349049|102262969|FG003|Overall Study|Withdrawal by Subject|0|||
33648232|NCT01349049|102262970|FG004|Overall Study|Withdrawal by Subject|0|||
33149927|NCT00620464|100463562|FG000|Overall Study|Adverse Event|15|||
33149928|NCT00620464|100463563|FG001|Overall Study|Adverse Event|17|||
33149929|NCT00620464|100463562|FG000|Overall Study|Lost to Follow-up|1|||
33149930|NCT00620464|100463563|FG001|Overall Study|Lost to Follow-up|1|||
33149931|NCT00620464|100463562|FG000|Overall Study|Planning Pregnancy|1|||
33149932|NCT00620464|100463563|FG001|Overall Study|Planning Pregnancy|4|||
33149933|NCT00620464|100463562|FG000|Overall Study|Personal|2|||
33149934|NCT00620464|100463563|FG001|Overall Study|Personal|2|||
33648233|NCT01349049|102262971|FG005|Overall Study|Withdrawal by Subject|0|||
33648234|NCT01349049|102262972|FG006|Overall Study|Withdrawal by Subject|0|||
33149935|NCT00620464|100463562|FG000|Overall Study|Used prohibited medication|1|||
33149936|NCT00620464|100463563|FG001|Overall Study|Used prohibited medication|0|||
33149937|NCT03766685|100463568|FG000|Overall Study|Lost to Follow-up|1|||
33384151|NCT00880763|101291553|FG003|Extension Period (Part 2)|Adverse Event|1|||
33384152|NCT00880763|101291550|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
33384153|NCT00880763|101291551|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
33384154|NCT00880763|101291552|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
33384155|NCT00880763|101291553|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
33384156|NCT00880763|101291550|FG000|Extension Period (Part 2)|Physician Decision|0|||
33384157|NCT00880763|101291551|FG001|Extension Period (Part 2)|Physician Decision|1|||
33384158|NCT00880763|101291552|FG002|Extension Period (Part 2)|Physician Decision|1|||
33384159|NCT00880763|101291553|FG003|Extension Period (Part 2)|Physician Decision|0|||
33432334|NCT01656889|101474265|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
33432335|NCT01656889|101474264|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
33432336|NCT01656889|101474265|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
33432337|NCT01656889|101474264|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
33432338|NCT01656889|101474265|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
33432339|NCT01656889|101474264|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
33432340|NCT01656889|101474265|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
33432341|NCT01656889|101474264|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
33432342|NCT01656889|101474265|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
33432343|NCT01656889|101474264|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
33432344|NCT01656889|101474265|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
33432345|NCT00601354|101474266|FG000|Overall Study|Lost to Follow-up|4|||
33432346|NCT00601354|101474267|FG001|Overall Study|Lost to Follow-up|5|||
33432347|NCT01046253|101474273|FG000|Second Intervention|Adverse Event|0|||
33432348|NCT01046253|101474274|FG001|Second Intervention|Adverse Event|1|||
33432349|NCT01046253|101474273|FG000|Second Intervention|Protocol Violation|0|||
33432350|NCT01046253|101474274|FG001|Second Intervention|Protocol Violation|1|||
33432351|NCT02034799|101474275|FG000|Overall Study|Withdrawal by Subject|0|||
33432352|NCT02034799|101474276|FG001|Overall Study|Withdrawal by Subject|2|||
33432353|NCT02034799|101474275|FG000|Overall Study|Lost to Follow-up|0|||
33432354|NCT02034799|101474276|FG001|Overall Study|Lost to Follow-up|1|||
33432355|NCT02034799|101474275|FG000|Overall Study|Death|2|||
33432356|NCT02034799|101474276|FG001|Overall Study|Death|1|||
33432357|NCT00491504|101474281|FG000|Overall Study|Adverse Event|0|||
33432358|NCT00491504|101474282|FG001|Overall Study|Adverse Event|1|||
33432359|NCT00491504|101474283|FG002|Overall Study|Adverse Event|0|||
33432360|NCT00491504|101474284|FG003|Overall Study|Adverse Event|0|||
33432361|NCT00491504|101474281|FG000|Overall Study|Withdrawal by Subject|0|||
33432362|NCT00491504|101474282|FG001|Overall Study|Withdrawal by Subject|0|||
33432363|NCT00491504|101474283|FG002|Overall Study|Withdrawal by Subject|1|||
33432364|NCT00491504|101474284|FG003|Overall Study|Withdrawal by Subject|2|||
33432365|NCT00491504|101474281|FG000|Overall Study|Protocol Violation|0|||
33432366|NCT00491504|101474282|FG001|Overall Study|Protocol Violation|0|||
33432367|NCT00491504|101474283|FG002|Overall Study|Protocol Violation|3|||
33432368|NCT00491504|101474284|FG003|Overall Study|Protocol Violation|2|||
33432369|NCT01579474|101474285|FG000|Overall Study|Adverse Event|1|||
33432370|NCT01579474|101474286|FG001|Overall Study|Adverse Event|13|||
33432371|NCT01579474|101474287|FG002|Overall Study|Adverse Event|2|||
33432372|NCT01579474|101474288|FG003|Overall Study|Adverse Event|0|||
33149938|NCT03766685|100463569|FG001|Overall Study|Lost to Follow-up|1|||
33149939|NCT03766685|100463570|FG002|Overall Study|Lost to Follow-up|0|||
33384160|NCT00880763|101291550|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
33432373|NCT01579474|101474289|FG004|Overall Study|Adverse Event|0|||
33432374|NCT01579474|101474290|FG005|Overall Study|Adverse Event|1|||
33432375|NCT01579474|101474285|FG000|Overall Study|Lack of Efficacy|1|||
33432376|NCT01579474|101474286|FG001|Overall Study|Lack of Efficacy|0|||
33432377|NCT01579474|101474287|FG002|Overall Study|Lack of Efficacy|0|||
33432378|NCT01579474|101474288|FG003|Overall Study|Lack of Efficacy|0|||
33432379|NCT01579474|101474289|FG004|Overall Study|Lack of Efficacy|1|||
33432380|NCT01579474|101474290|FG005|Overall Study|Lack of Efficacy|0|||
33648235|NCT01349049|102262973|FG007|Overall Study|Withdrawal by Subject|0|||
33432381|NCT01579474|101474285|FG000|Overall Study|Withdrawal by Subject|1|||
33432382|NCT01579474|101474286|FG001|Overall Study|Withdrawal by Subject|0|||
33432383|NCT01579474|101474287|FG002|Overall Study|Withdrawal by Subject|0|||
33432384|NCT01579474|101474288|FG003|Overall Study|Withdrawal by Subject|0|||
33432385|NCT01579474|101474289|FG004|Overall Study|Withdrawal by Subject|0|||
33432386|NCT01579474|101474290|FG005|Overall Study|Withdrawal by Subject|0|||
33432387|NCT00635154|101474316|FG000|Overall Study|Alternative Treatment|8|||
33432388|NCT00635154|101474316|FG000|Overall Study|Other|4|||
33432389|NCT00635154|101474316|FG000|Overall Study|Still on treatment|21|||
33432390|NCT03083483|101474317|FG000|Overall Study|Adverse Event|1|||
33432391|NCT03083483|101474318|FG001|Overall Study|Adverse Event|1|||
33432392|NCT03083483|101474319|FG002|Overall Study|Adverse Event|1|||
33432393|NCT03083483|101474317|FG000|Overall Study|Lost to Follow-up|2|||
33432394|NCT03083483|101474318|FG001|Overall Study|Lost to Follow-up|1|||
33432395|NCT03083483|101474319|FG002|Overall Study|Lost to Follow-up|1|||
33432396|NCT03083483|101474317|FG000|Overall Study|technological issues|1|||
33432397|NCT03083483|101474318|FG001|Overall Study|technological issues|0|||
33432398|NCT03083483|101474319|FG002|Overall Study|technological issues|1|||
33432399|NCT01387282|101474320|FG000|Overall Study|Death|47|||
33432400|NCT01387282|101474321|FG001|Overall Study|Death|16|||
33432401|NCT01387282|101474320|FG000|Overall Study|Other|5|||
33432402|NCT01387282|101474321|FG001|Overall Study|Other|1|||
33432403|NCT01387282|101474320|FG000|Overall Study|Unrelated AE|6|||
33432404|NCT01387282|101474321|FG001|Overall Study|Unrelated AE|4|||
33432405|NCT01387282|101474320|FG000|Overall Study|Withdrawal by patient|33|||
33432406|NCT01387282|101474321|FG001|Overall Study|Withdrawal by patient|23|||
33432407|NCT01387282|101474320|FG000|Overall Study|Study drug-related AE|2|||
33432408|NCT01387282|101474321|FG001|Overall Study|Study drug-related AE|2|||
33432409|NCT01387282|101474320|FG000|Overall Study|Lost to Follow-up|4|||
33432410|NCT01387282|101474321|FG001|Overall Study|Lost to Follow-up|1|||
33432411|NCT04828161|101474325|FG000|Overall Study|Withdrawal by Subject|0|||
33432412|NCT04828161|101474326|FG001|Overall Study|Withdrawal by Subject|3|||
33432413|NCT04828161|101474327|FG002|Overall Study|Withdrawal by Subject|3|||
33432414|NCT04828161|101474328|FG003|Overall Study|Withdrawal by Subject|4|||
33432415|NCT04828161|101474325|FG000|Overall Study|Lost to Follow-up|1|||
33432416|NCT04828161|101474326|FG001|Overall Study|Lost to Follow-up|4|||
33432417|NCT04828161|101474327|FG002|Overall Study|Lost to Follow-up|2|||
33432418|NCT04828161|101474328|FG003|Overall Study|Lost to Follow-up|2|||
33432419|NCT04828161|101474325|FG000|Overall Study|Other|2|||
33432420|NCT04828161|101474326|FG001|Overall Study|Other|0|||
33432421|NCT04828161|101474327|FG002|Overall Study|Other|2|||
33432422|NCT04828161|101474328|FG003|Overall Study|Other|0|||
33432423|NCT04828161|101474325|FG000|Overall Study|Death|0|||
33432424|NCT04828161|101474326|FG001|Overall Study|Death|0|||
33432425|NCT04828161|101474327|FG002|Overall Study|Death|0|||
33432426|NCT04828161|101474328|FG003|Overall Study|Death|2|||
33432427|NCT03565211|101474329|FG000|Overall Study|Withdrawal by Subject|2|||
33432428|NCT03565211|101474329|FG000|Overall Study|Lost to Follow-up|1|||
33432429|NCT03565211|101474329|FG000|Overall Study|Adverse Event|44|||
33432430|NCT03565211|101474329|FG000|Overall Study|Personal issues|1|||
33432431|NCT00434161|101474330|FG000|Overall Study|Adverse Event|5|||
33432432|NCT00434161|101474331|FG001|Overall Study|Adverse Event|1|||
33432433|NCT00434161|101474332|FG002|Overall Study|Adverse Event|4|||
33432434|NCT00434161|101474330|FG000|Overall Study|Lost to Follow-up|0|||
33432435|NCT00434161|101474331|FG001|Overall Study|Lost to Follow-up|1|||
33588281|NCT01659996|102041794|FG001|Overall Study|Adverse Event|0|||
33432436|NCT00434161|101474332|FG002|Overall Study|Lost to Follow-up|0|||
33588282|NCT01659996|102041795|FG002|Overall Study|Adverse Event|1|||
33588283|NCT01659996|102041793|FG000|Overall Study|Withdrawal by Subject|4|||
33588284|NCT01659996|102041794|FG001|Overall Study|Withdrawal by Subject|1|||
33588285|NCT01659996|102041795|FG002|Overall Study|Withdrawal by Subject|5|||
33588286|NCT01092780|102041796|FG000|Washout Period 1|Adverse Event|0|||
33588287|NCT01092780|102041797|FG001|Washout Period 1|Adverse Event|1|||
33588288|NCT01092780|102041798|FG002|Washout Period 1|Adverse Event|0|||
33588289|NCT01092780|102041799|FG003|Washout Period 1|Adverse Event|0|||
33588290|NCT01092780|102041796|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
33588291|NCT01092780|102041797|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
33588292|NCT01092780|102041798|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
33588293|NCT01092780|102041799|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
33588294|NCT01092780|102041796|FG000|Washout Period 2|Adverse Event|0|||
33588295|NCT01092780|102041797|FG001|Washout Period 2|Adverse Event|1|||
33588296|NCT01092780|102041798|FG002|Washout Period 2|Adverse Event|1|||
33432437|NCT00434161|101474330|FG000|Overall Study|Death|1|||
33432438|NCT00434161|101474331|FG001|Overall Study|Death|0|||
33432439|NCT00434161|101474332|FG002|Overall Study|Death|1|||
33432440|NCT00434161|101474330|FG000|Overall Study|Non-Compliance|1|||
33432441|NCT00434161|101474331|FG001|Overall Study|Non-Compliance|1|||
33432442|NCT00434161|101474332|FG002|Overall Study|Non-Compliance|0|||
33432443|NCT00434161|101474330|FG000|Overall Study|Withdrawal by Subject|2|||
33432444|NCT00434161|101474331|FG001|Overall Study|Withdrawal by Subject|0|||
33249521|NCT01212757|100814516|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33249522|NCT01212757|100814517|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33588297|NCT01092780|102041799|FG003|Washout Period 2|Adverse Event|0|||
33588298|NCT03145064|102041800|FG000|Overall Study|Death|24|||
33588299|NCT03145064|102041800|FG000|Overall Study|Lost to Follow-up|3|||
33588300|NCT03145064|102041800|FG000|Overall Study|Withdrawal by Subject|6|||
33588301|NCT03145064|102041800|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
33588302|NCT03145064|102041800|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
33588303|NCT02712983|102041802|FG000|Treatment Phase|Adverse Event|3|||
33588304|NCT02712983|102041803|FG001|Treatment Phase|Adverse Event|1|||
33588305|NCT02712983|102041804|FG002|Treatment Phase|Adverse Event|1|||
33588306|NCT02712983|102041805|FG003|Treatment Phase|Adverse Event|4|||
33588307|NCT02712983|102041806|FG004|Treatment Phase|Adverse Event|3|||
33588308|NCT02712983|102041807|FG005|Treatment Phase|Adverse Event|0|||
33588309|NCT02712983|102041808|FG006|Treatment Phase|Adverse Event|6|||
33588310|NCT02712983|102041809|FG007|Treatment Phase|Adverse Event|6|||
33588311|NCT02712983|102041810|FG008|Treatment Phase|Adverse Event|1|||
33588312|NCT02712983|102041802|FG000|Treatment Phase|Protocol Deviation|0|||
33588313|NCT02712983|102041803|FG001|Treatment Phase|Protocol Deviation|0|||
33588314|NCT02712983|102041804|FG002|Treatment Phase|Protocol Deviation|0|||
33588315|NCT02712983|102041805|FG003|Treatment Phase|Protocol Deviation|2|||
33648236|NCT01349049|102262974|FG008|Overall Study|Withdrawal by Subject|6|||
33648237|NCT02720042|102262976|FG000|Overall Study|Death|3|||
33648238|NCT02720042|102262976|FG000|Overall Study|Lost to Follow-up|4|||
33648239|NCT02720042|102262976|FG000|Overall Study|Withdrawal by Subject|1|||
33648240|NCT02720042|102262976|FG000|Overall Study|Physician Decision|3|||
33648241|NCT02720042|102262976|FG000|Overall Study|Phasix Mesh explanted|1|||
33648242|NCT02720042|102262976|FG000|Overall Study|unable due to non-study-related illness|3|||
33648243|NCT04661579|102262978|FG000|Overall Study|Lost to Follow-up|19|||
33648244|NCT04661579|102262979|FG001|Overall Study|Lost to Follow-up|10|||
33648245|NCT04661579|102262980|FG002|Overall Study|Lost to Follow-up|2|||
33648246|NCT04661579|102262981|FG003|Overall Study|Lost to Follow-up|7|||
33648247|NCT04661579|102262982|FG004|Overall Study|Lost to Follow-up|11|||
33648248|NCT04661579|102262978|FG000|Overall Study|Physician Decision|2|||
33648249|NCT04661579|102262979|FG001|Overall Study|Physician Decision|0|||
33648250|NCT04661579|102262980|FG002|Overall Study|Physician Decision|0|||
33648251|NCT04661579|102262981|FG003|Overall Study|Physician Decision|1|||
33149940|NCT03766685|100463571|FG003|Overall Study|Lost to Follow-up|0|||
33149941|NCT03766685|100463568|FG000|Overall Study|Adverse Event, not fatal|0|||
33149942|NCT03766685|100463569|FG001|Overall Study|Adverse Event, not fatal|1|||
33149943|NCT03766685|100463570|FG002|Overall Study|Adverse Event, not fatal|0|||
33149944|NCT03766685|100463571|FG003|Overall Study|Adverse Event, not fatal|1|||
33149945|NCT03766685|100463568|FG000|Overall Study|Withdrawal by Subject|0|||
33149946|NCT03766685|100463569|FG001|Overall Study|Withdrawal by Subject|2|||
33149947|NCT03766685|100463570|FG002|Overall Study|Withdrawal by Subject|0|||
33149948|NCT03766685|100463571|FG003|Overall Study|Withdrawal by Subject|0|||
33149949|NCT03766685|100463568|FG000|Overall Study|Protocol Violation|0|||
33149950|NCT03766685|100463569|FG001|Overall Study|Protocol Violation|1|||
33149951|NCT03766685|100463570|FG002|Overall Study|Protocol Violation|0|||
33149952|NCT03766685|100463571|FG003|Overall Study|Protocol Violation|0|||
33149953|NCT03766685|100463568|FG000|Overall Study|Non-compliance|0|||
33149954|NCT03766685|100463569|FG001|Overall Study|Non-compliance|2|||
33149955|NCT03766685|100463570|FG002|Overall Study|Non-compliance|0|||
33149956|NCT03766685|100463571|FG003|Overall Study|Non-compliance|0|||
33149957|NCT00410202|100463572|FG000|On-Treatment|Continuing treatment|69|||
33149958|NCT00410202|100463573|FG001|On-Treatment|Continuing treatment|71|||
33149959|NCT00410202|100463574|FG002|On-Treatment|Continuing treatment|66|||
33149960|NCT00410202|100463572|FG000|On-Treatment|Adverse Event|1|||
33149961|NCT00410202|100463573|FG001|On-Treatment|Adverse Event|3|||
33149962|NCT00410202|100463574|FG002|On-Treatment|Adverse Event|2|||
33149963|NCT00410202|100463572|FG000|On-Treatment|Death|1|||
33149964|NCT00410202|100463573|FG001|On-Treatment|Death|0|||
33149965|NCT00410202|100463574|FG002|On-Treatment|Death|0|||
33149966|NCT00410202|100463572|FG000|On-Treatment|Lost to Follow-up|1|||
33149967|NCT00410202|100463573|FG001|On-Treatment|Lost to Follow-up|0|||
33149968|NCT00410202|100463574|FG002|On-Treatment|Lost to Follow-up|1|||
33149969|NCT00410202|100463572|FG000|On-Treatment|Lack of Efficacy|1|||
33149970|NCT00410202|100463573|FG001|On-Treatment|Lack of Efficacy|4|||
33149971|NCT00410202|100463574|FG002|On-Treatment|Lack of Efficacy|0|||
33149972|NCT00410202|100463572|FG000|On-Treatment|Withdrawal by Subject|2|||
33149973|NCT00410202|100463573|FG001|On-Treatment|Withdrawal by Subject|1|||
33149974|NCT00410202|100463574|FG002|On-Treatment|Withdrawal by Subject|1|||
33149975|NCT00410202|100463572|FG000|On-Treatment|Other Reason|0|||
33149976|NCT00410202|100463573|FG001|On-Treatment|Other Reason|0|||
33149977|NCT00410202|100463574|FG002|On-Treatment|Other Reason|1|||
33149978|NCT00410202|100463572|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
33149979|NCT00410202|100463573|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
33432445|NCT00434161|101474332|FG002|Overall Study|Withdrawal by Subject|3|||
33432446|NCT00434161|101474330|FG000|Overall Study|Logistical error study assessments|1|||
33432447|NCT00434161|101474331|FG001|Overall Study|Logistical error study assessments|0|||
33432448|NCT00434161|101474332|FG002|Overall Study|Logistical error study assessments|3|||
33432449|NCT02736227|101474335|FG000|Overall Study|Withdrawal by Subject|0|||
33432450|NCT02736227|101474336|FG001|Overall Study|Withdrawal by Subject|0|||
33432451|NCT02736227|101474337|FG002|Overall Study|Withdrawal by Subject|1|||
33432452|NCT02736227|101474335|FG000|Overall Study|Physician Decision|0|||
33432453|NCT02736227|101474336|FG001|Overall Study|Physician Decision|0|||
33432454|NCT02736227|101474337|FG002|Overall Study|Physician Decision|5|||
33432455|NCT02736227|101474335|FG000|Overall Study|Non Compliant|0|||
33432456|NCT02736227|101474336|FG001|Overall Study|Non Compliant|0|||
33432457|NCT02736227|101474337|FG002|Overall Study|Non Compliant|2|||
33432458|NCT00429923|101474338|FG000|Overall Study|Adverse Event|0|||
33432459|NCT00429923|101474339|FG001|Overall Study|Adverse Event|2|||
33432460|NCT00429923|101474340|FG002|Overall Study|Adverse Event|3|||
33432461|NCT00429923|101474338|FG000|Overall Study|Lack of Efficacy|4|||
33432462|NCT00429923|101474339|FG001|Overall Study|Lack of Efficacy|1|||
33432463|NCT00429923|101474340|FG002|Overall Study|Lack of Efficacy|33|||
33432464|NCT00429923|101474338|FG000|Overall Study|Lost to Follow-up|0|||
33432465|NCT00429923|101474339|FG001|Overall Study|Lost to Follow-up|0|||
33432466|NCT00429923|101474340|FG002|Overall Study|Lost to Follow-up|2|||
33432467|NCT00429923|101474338|FG000|Overall Study|Withdrew Consent|1|||
33432468|NCT00429923|101474339|FG001|Overall Study|Withdrew Consent|0|||
33432469|NCT00429923|101474340|FG002|Overall Study|Withdrew Consent|1|||
33432470|NCT00429923|101474338|FG000|Overall Study|Early Termination|0|||
33432471|NCT00429923|101474339|FG001|Overall Study|Early Termination|1|||
33432472|NCT00429923|101474340|FG002|Overall Study|Early Termination|0|||
33432473|NCT02784106|101474341|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
33432474|NCT02784106|101474342|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
33432475|NCT02784106|101474343|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
33432476|NCT02784106|101474344|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
33432477|NCT02784106|101474341|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
33432478|NCT02784106|101474342|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
33432479|NCT02784106|101474343|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
33432480|NCT02784106|101474344|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
33432481|NCT02784106|101474341|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
33432482|NCT02784106|101474342|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
33432483|NCT02784106|101474343|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
33432484|NCT02784106|101474344|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
33432485|NCT02784106|101474341|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
33432486|NCT02784106|101474342|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
33432487|NCT02784106|101474343|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
33432488|NCT02784106|101474344|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
33432489|NCT02784106|101474341|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
33432490|NCT02784106|101474342|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
33432491|NCT02784106|101474343|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
33432492|NCT02784106|101474344|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
33432493|NCT02784106|101474341|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
33432494|NCT02784106|101474342|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
33432495|NCT02784106|101474343|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
33432496|NCT02784106|101474344|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
33432497|NCT01966042|101474347|FG000|Overall Study|Death|2|||
33432498|NCT00553540|101474348|FG000|Overall Study|discharged after first visit|2|||
33432499|NCT00553540|101474349|FG001|Overall Study|discharged after first visit|5|||
33432500|NCT05266456|101474350|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
33432501|NCT05266456|101474351|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
33432502|NCT05266456|101474352|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
33432503|NCT05266456|101474353|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
33432504|NCT05266456|101474350|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
33432505|NCT05266456|101474351|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
33432506|NCT05266456|101474352|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
33432507|NCT05266456|101474353|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
33432508|NCT05266456|101474350|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
33432509|NCT05266456|101474351|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
33432510|NCT05266456|101474352|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
33432511|NCT05266456|101474353|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
33432512|NCT05266456|101474350|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
33432513|NCT05266456|101474351|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
33432514|NCT05266456|101474352|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
33432515|NCT05266456|101474353|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
33432516|NCT05266456|101474350|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
33432517|NCT05266456|101474351|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
33432518|NCT05266456|101474352|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
33432519|NCT05266456|101474353|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
33432520|NCT01215942|101474354|FG000|Treatment Period|Adverse Event|15|||
33432521|NCT01215942|101474355|FG001|Treatment Period|Adverse Event|26|||
33432522|NCT01215942|101474354|FG000|Treatment Period|Death|2|||
33432523|NCT01215942|101474355|FG001|Treatment Period|Death|4|||
33432524|NCT01215942|101474354|FG000|Treatment Period|Lack of Efficacy|23|||
33432525|NCT01215942|101474355|FG001|Treatment Period|Lack of Efficacy|62|||
33432526|NCT01215942|101474354|FG000|Treatment Period|Lost to Follow-up|3|||
33432527|NCT01215942|101474355|FG001|Treatment Period|Lost to Follow-up|4|||
33432528|NCT01215942|101474354|FG000|Treatment Period|Withdrawal by Subject|17|||
33432529|NCT01215942|101474355|FG001|Treatment Period|Withdrawal by Subject|40|||
33432530|NCT01215942|101474354|FG000|Treatment Period|Physician Decision|5|||
33432531|NCT01215942|101474355|FG001|Treatment Period|Physician Decision|5|||
33432532|NCT01215942|101474354|FG000|Treatment Period|Protocol Violation|0|||
33432533|NCT01215942|101474355|FG001|Treatment Period|Protocol Violation|1|||
33432534|NCT01215942|101474354|FG000|Treatment Period|Sponsor Decision|349|||
33432535|NCT01215942|101474355|FG001|Treatment Period|Sponsor Decision|530|||
33432536|NCT01215942|101474354|FG000|Post-Treatment Follow-Up Period|Death|0|||
33432537|NCT01215942|101474355|FG001|Post-Treatment Follow-Up Period|Death|1|||
33432538|NCT01215942|101474354|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
33432539|NCT01215942|101474355|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
33432540|NCT01215942|101474354|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
33432541|NCT01215942|101474355|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
33432542|NCT01215942|101474354|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
33432543|NCT01215942|101474355|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
33432544|NCT01215942|101474354|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
33432545|NCT01215942|101474355|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
33432546|NCT03175120|101474362|FG000|Overall Study|Adverse Event|2|||
33432547|NCT03175120|101474363|FG001|Overall Study|Adverse Event|2|||
33432548|NCT03175120|101474362|FG000|Overall Study|Protocol Violation|5|||
33432549|NCT03175120|101474363|FG001|Overall Study|Protocol Violation|2|||
33432550|NCT03175120|101474362|FG000|Overall Study|Lost to Follow-up|1|||
33432551|NCT03175120|101474363|FG001|Overall Study|Lost to Follow-up|0|||
33648252|NCT04661579|102262982|FG004|Overall Study|Physician Decision|0|||
33384161|NCT00880763|101291551|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
33432552|NCT03175120|101474362|FG000|Overall Study|Withdrawal by Subject|2|||
33432553|NCT03175120|101474363|FG001|Overall Study|Withdrawal by Subject|5|||
33432554|NCT03175120|101474362|FG000|Overall Study|Other|2|||
33432555|NCT03175120|101474363|FG001|Overall Study|Other|3|||
33432556|NCT00444795|101474364|FG000|Overall Study|Not Treated|1|||
33432557|NCT00444795|101474364|FG000|Overall Study|Treated Prior to the Contract Date|2|||
33432558|NCT00760383|101474365|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
33432559|NCT00760383|101474366|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
33432560|NCT01059071|101474369|FG000|Overall Study|Lack of Efficacy|1|||
33432561|NCT01059071|101474370|FG001|Overall Study|Lack of Efficacy|4|||
33432562|NCT01059071|101474371|FG002|Overall Study|Lack of Efficacy|2|||
33432563|NCT01059071|101474372|FG003|Overall Study|Lack of Efficacy|3|||
33432564|NCT01059071|101474369|FG000|Overall Study|Withdrawal by Subject|1|||
33432565|NCT01059071|101474370|FG001|Overall Study|Withdrawal by Subject|0|||
33432566|NCT01059071|101474371|FG002|Overall Study|Withdrawal by Subject|0|||
33432567|NCT01059071|101474372|FG003|Overall Study|Withdrawal by Subject|2|||
33648253|NCT04661579|102262978|FG000|Overall Study|Withdrawal by Subject|1|||
33648254|NCT04661579|102262979|FG001|Overall Study|Withdrawal by Subject|4|||
33648255|NCT04661579|102262980|FG002|Overall Study|Withdrawal by Subject|0|||
33648256|NCT04661579|102262981|FG003|Overall Study|Withdrawal by Subject|2|||
33384162|NCT00880763|101291552|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
33384163|NCT00880763|101291553|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
33384164|NCT02670928|101291554|FG000|Overall Study|Adverse Event|3|||
33384165|NCT02670928|101291555|FG001|Overall Study|Adverse Event|1|||
33384166|NCT02670928|101291554|FG000|Overall Study|Withdrawal by Subject|4|||
33384167|NCT02670928|101291555|FG001|Overall Study|Withdrawal by Subject|0|||
33384168|NCT02670928|101291554|FG000|Overall Study|Lost to Follow-up|1|||
33384169|NCT02670928|101291555|FG001|Overall Study|Lost to Follow-up|0|||
33384170|NCT02670928|101291554|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
33384171|NCT02670928|101291555|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
33384172|NCT01425749|101291556|FG000|Overall Study|progression of melanoma|0|||
33384173|NCT01425749|101291557|FG001|Overall Study|progression of melanoma|1|||
33384174|NCT00050960|101291558|FG000|Overall Study|Progressive Disease|137|||
33384175|NCT00050960|101291559|FG001|Overall Study|Progressive Disease|93|||
33384176|NCT00050960|101291558|FG000|Overall Study|Stable Disease|19|||
33384177|NCT00050960|101291559|FG001|Overall Study|Stable Disease|48|||
33384178|NCT00050960|101291558|FG000|Overall Study|Partial Response|14|||
33432568|NCT01059071|101474369|FG000|Overall Study|Physician Decision|0|||
33432569|NCT01059071|101474370|FG001|Overall Study|Physician Decision|0|||
33432570|NCT01059071|101474371|FG002|Overall Study|Physician Decision|0|||
33432571|NCT01059071|101474372|FG003|Overall Study|Physician Decision|1|||
33432572|NCT02006706|101474373|FG000|Overall Study|Lost to Follow-up|1|||
33432573|NCT02708277|101474374|FG000|Overall Study|Lost to Follow-up|7|||
33432574|NCT02708277|101474375|FG001|Overall Study|Lost to Follow-up|4|||
33432575|NCT02985151|101474378|FG000|Original Randomization|Withdrawal by Subject|0|||
33432576|NCT02985151|101474379|FG001|Original Randomization|Withdrawal by Subject|1|||
33432577|NCT01336894|101474380|FG000|Follow-up|Study terminated prematurely|2|||
33432578|NCT01336894|101474381|FG001|Follow-up|Study terminated prematurely|7|||
33432579|NCT01133821|101474382|FG000|Overall Study|Lost to Follow-up|8|||
33432580|NCT01133821|101474383|FG001|Overall Study|Lost to Follow-up|11|||
33432581|NCT01133821|101474382|FG000|Overall Study|Withdrawal by Subject|8|||
33432582|NCT01133821|101474383|FG001|Overall Study|Withdrawal by Subject|3|||
33432583|NCT01133821|101474382|FG000|Overall Study|preferred other treatment|1|||
33432584|NCT01133821|101474383|FG001|Overall Study|preferred other treatment|1|||
33432585|NCT01133821|101474382|FG000|Overall Study|Protocol Violation|0|||
33432586|NCT01133821|101474383|FG001|Overall Study|Protocol Violation|1|||
33432587|NCT01133821|101474382|FG000|Overall Study|Refused participation|1|||
33432588|NCT01133821|101474383|FG001|Overall Study|Refused participation|3|||
33432589|NCT00124020|101474384|FG000|Overall Study|Death|67|||
33432590|NCT00124020|101474385|FG001|Overall Study|Death|71|||
33432591|NCT00124020|101474384|FG000|Overall Study|Withdrawal by Subject|13|||
33432592|NCT00124020|101474385|FG001|Overall Study|Withdrawal by Subject|11|||
33432593|NCT00124020|101474384|FG000|Overall Study|Lost to Follow-up|5|||
33432594|NCT00124020|101474385|FG001|Overall Study|Lost to Follow-up|8|||
33432595|NCT00124020|101474384|FG000|Overall Study|Other|1|||
33432596|NCT00124020|101474385|FG001|Overall Study|Other|1|||
33432597|NCT00124020|101474384|FG000|Overall Study|Transfer to another hospital|2|||
33432598|NCT00124020|101474385|FG001|Overall Study|Transfer to another hospital|0|||
33432599|NCT02236130|101474386|FG000|Overall Study|Lost to Follow-up|7|||
33432600|NCT02236130|101474387|FG001|Overall Study|Lost to Follow-up|12|||
33432601|NCT02518685|101474388|FG000|Overall Study|Adverse Event|29|||
33432602|NCT02518685|101474389|FG001|Overall Study|Adverse Event|1|||
33432603|NCT02518685|101474388|FG000|Overall Study|Withdrawal by Subject|10|||
33432604|NCT02518685|101474389|FG001|Overall Study|Withdrawal by Subject|3|||
33432605|NCT02518685|101474388|FG000|Overall Study|relocation, study fatigue|7|||
33432606|NCT02518685|101474389|FG001|Overall Study|relocation, study fatigue|2|||
33432607|NCT02518685|101474388|FG000|Overall Study|Pregnancy|1|||
33432608|NCT02518685|101474389|FG001|Overall Study|Pregnancy|0|||
33432609|NCT02518685|101474388|FG000|Overall Study|Physician Decision|1|||
33432610|NCT02518685|101474389|FG001|Overall Study|Physician Decision|0|||
33432611|NCT02518685|101474388|FG000|Overall Study|Lost to Follow-up|1|||
33432612|NCT02518685|101474389|FG001|Overall Study|Lost to Follow-up|4|||
33432613|NCT01047345|101474390|FG000|Base Study|Adverse Event|3|||
33432614|NCT01047345|101474391|FG001|Base Study|Adverse Event|0|||
33432615|NCT01047345|101474392|FG002|Base Study|Adverse Event|0|||
33432616|NCT01047345|101474390|FG000|Base Study|Lost to Follow-up|4|||
33432617|NCT01047345|101474391|FG001|Base Study|Lost to Follow-up|1|||
33432618|NCT01047345|101474392|FG002|Base Study|Lost to Follow-up|0|||
33432619|NCT01047345|101474390|FG000|Base Study|Protocol Violation|3|||
33432620|NCT01047345|101474391|FG001|Base Study|Protocol Violation|1|||
33432621|NCT01047345|101474392|FG002|Base Study|Protocol Violation|0|||
33432622|NCT01047345|101474390|FG000|Base Study|Withdrawal by Subject|12|||
33432623|NCT01047345|101474391|FG001|Base Study|Withdrawal by Subject|4|||
33432624|NCT01047345|101474392|FG002|Base Study|Withdrawal by Subject|0|||
33432625|NCT01047345|101474390|FG000|Extension|Withdrawal by Subject|0|||
33588316|NCT02712983|102041806|FG004|Treatment Phase|Protocol Deviation|0|||
33588317|NCT02712983|102041807|FG005|Treatment Phase|Protocol Deviation|0|||
33588318|NCT02712983|102041808|FG006|Treatment Phase|Protocol Deviation|1|||
33149980|NCT00410202|100463574|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
33149981|NCT00410202|100463572|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
33432626|NCT01047345|101474391|FG001|Extension|Withdrawal by Subject|0|||
33432627|NCT01047345|101474392|FG002|Extension|Withdrawal by Subject|1|||
33432628|NCT01047345|101474390|FG000|Extension|Lost to Follow-up|0|||
33432629|NCT01047345|101474391|FG001|Extension|Lost to Follow-up|0|||
33432630|NCT01047345|101474392|FG002|Extension|Lost to Follow-up|5|||
33432631|NCT02322047|101474394|FG000|Overall Study|Physician Decision|1|||
33432632|NCT02322047|101474395|FG001|Overall Study|Physician Decision|0|||
33432633|NCT02322047|101474396|FG002|Overall Study|Physician Decision|0|||
33432634|NCT02322047|101474397|FG003|Overall Study|Physician Decision|0|||
33432635|NCT02322047|101474394|FG000|Overall Study|Withdrawal by Subject|1|||
33432636|NCT02322047|101474395|FG001|Overall Study|Withdrawal by Subject|0|||
33432637|NCT02322047|101474396|FG002|Overall Study|Withdrawal by Subject|0|||
33432638|NCT02322047|101474397|FG003|Overall Study|Withdrawal by Subject|1|||
33432639|NCT02322047|101474394|FG000|Overall Study|Adverse Event|0|||
33432640|NCT02322047|101474395|FG001|Overall Study|Adverse Event|1|||
33432641|NCT02322047|101474396|FG002|Overall Study|Adverse Event|0|||
33249523|NCT01212757|100814518|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33249524|NCT01212757|100814519|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33249525|NCT01212757|100814520|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
33249526|NCT01212757|100814512|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
33249527|NCT01212757|100814513|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
33249528|NCT01212757|100814514|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
33249529|NCT01212757|100814515|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33249530|NCT01212757|100814516|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33249531|NCT01212757|100814517|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33249532|NCT01212757|100814518|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33249533|NCT01212757|100814519|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33249534|NCT01212757|100814520|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
33249535|NCT01212757|100814512|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
33249536|NCT01212757|100814513|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33249537|NCT01212757|100814514|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
33249538|NCT01212757|100814515|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33249539|NCT01212757|100814516|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33249540|NCT01212757|100814517|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33249541|NCT01212757|100814518|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33249542|NCT01212757|100814519|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33249543|NCT01212757|100814520|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
33249544|NCT01212757|100814512|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
33249545|NCT01212757|100814513|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
33249546|NCT01212757|100814514|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
33249547|NCT01212757|100814515|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33249548|NCT01212757|100814516|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33249549|NCT01212757|100814517|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33249550|NCT01212757|100814518|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33249551|NCT01212757|100814519|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33249552|NCT01212757|100814520|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
33249553|NCT01212757|100814512|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33249554|NCT01212757|100814513|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
33249555|NCT01212757|100814514|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
33249556|NCT01212757|100814515|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33249557|NCT01212757|100814516|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33249558|NCT01212757|100814517|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33249559|NCT01212757|100814518|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33249560|NCT01212757|100814519|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33249561|NCT01212757|100814520|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
33249562|NCT01212757|100814512|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
33249563|NCT01212757|100814513|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
33249564|NCT01212757|100814514|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33249565|NCT01212757|100814515|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33249566|NCT01212757|100814516|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33249567|NCT01212757|100814517|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33249568|NCT01212757|100814518|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33249569|NCT01212757|100814519|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33249570|NCT01212757|100814520|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
33249571|NCT01212757|100814512|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
33648257|NCT04661579|102262982|FG004|Overall Study|Withdrawal by Subject|0|||
33648258|NCT04661579|102262978|FG000|Overall Study|Death|1|||
33648259|NCT04661579|102262979|FG001|Overall Study|Death|0|||
33648260|NCT04661579|102262980|FG002|Overall Study|Death|0|||
33648261|NCT04661579|102262981|FG003|Overall Study|Death|0|||
33648262|NCT04661579|102262982|FG004|Overall Study|Death|0|||
33249572|NCT01212757|100814513|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
33249573|NCT01212757|100814514|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
33249574|NCT01212757|100814515|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
33249575|NCT01212757|100814516|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
33249576|NCT01212757|100814517|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
33249577|NCT01212757|100814518|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
33648263|NCT04661579|102262978|FG000|Overall Study|Other|1|||
33249578|NCT01212757|100814519|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
33648264|NCT04661579|102262979|FG001|Overall Study|Other|2|||
33249579|NCT01212757|100814520|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
33384179|NCT00050960|101291559|FG001|Overall Study|Partial Response|19|||
33648265|NCT04661579|102262980|FG002|Overall Study|Other|1|||
33432642|NCT02322047|101474397|FG003|Overall Study|Adverse Event|0|||
33432643|NCT02322047|101474394|FG000|Overall Study|Lost to Follow-up|0|||
33432644|NCT02322047|101474395|FG001|Overall Study|Lost to Follow-up|0|||
33432645|NCT02322047|101474396|FG002|Overall Study|Lost to Follow-up|1|||
33432646|NCT02322047|101474397|FG003|Overall Study|Lost to Follow-up|1|||
33432647|NCT00783796|101474398|FG000|Overall Study|Did not receive any stent|4|||
33432648|NCT00783796|101474398|FG000|Overall Study|Received non-XIENCE V stent|1|||
33432649|NCT00783796|101474398|FG000|Overall Study|Received commercial XIENCE V stent|1|||
33432650|NCT01498484|101474399|FG000|Overall Study|Death|6|||
33432651|NCT01498484|101474400|FG001|Overall Study|Death|3|||
33432652|NCT01498484|101474401|FG002|Overall Study|Death|1|||
33648266|NCT04661579|102262981|FG003|Overall Study|Other|1|||
33384180|NCT00050960|101291558|FG000|Overall Study|Complete Response|0|||
33384181|NCT00050960|101291559|FG001|Overall Study|Complete Response|2|||
33384182|NCT00050960|101291558|FG000|Overall Study|Adverse Event|62|||
33384183|NCT00050960|101291559|FG001|Overall Study|Adverse Event|61|||
33384184|NCT00050960|101291558|FG000|Overall Study|Lost to Follow-up|0|||
33384185|NCT00050960|101291559|FG001|Overall Study|Lost to Follow-up|1|||
33384186|NCT00050960|101291558|FG000|Overall Study|Withdrawal by Subject|23|||
33384187|NCT00050960|101291559|FG001|Overall Study|Withdrawal by Subject|18|||
33384188|NCT00050960|101291558|FG000|Overall Study|Administrative|31|||
33384189|NCT00050960|101291559|FG001|Overall Study|Administrative|46|||
33384190|NCT00050960|101291558|FG000|Overall Study|Non-compliance|3|||
33384191|NCT00050960|101291559|FG001|Overall Study|Non-compliance|1|||
33384192|NCT00050960|101291558|FG000|Overall Study|Death|13|||
33384193|NCT00050960|101291559|FG001|Overall Study|Death|15|||
33384194|NCT02016898|101291562|FG000|Overall Study|Death|1|||
33384195|NCT02016898|101291563|FG001|Overall Study|Death|1|||
33384196|NCT02016898|101291562|FG000|Overall Study|Lost to Follow-up|4|||
33384197|NCT02016898|101291563|FG001|Overall Study|Lost to Follow-up|4|||
33384198|NCT01412060|101291569|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
33384199|NCT01412060|101291570|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
33384200|NCT01412060|101291571|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
33384201|NCT01412060|101291569|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
33384202|NCT01412060|101291570|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
33384203|NCT01412060|101291571|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
33384204|NCT01412060|101291569|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
33384205|NCT01412060|101291570|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
33384206|NCT01412060|101291571|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
33384207|NCT01412060|101291569|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
33384208|NCT01412060|101291570|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
33384209|NCT01412060|101291571|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
33384210|NCT01412060|101291569|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
33384211|NCT01412060|101291570|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
33384212|NCT01412060|101291571|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
33384213|NCT01412060|101291569|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
33384214|NCT01412060|101291570|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
33384215|NCT01412060|101291571|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
33384216|NCT01412060|101291569|FG000|Period Between RIP and SP|Adverse Event|4|||
33384217|NCT01412060|101291570|FG001|Period Between RIP and SP|Adverse Event|0|||
33384218|NCT01412060|101291571|FG002|Period Between RIP and SP|Adverse Event|0|||
33384219|NCT01412060|101291569|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
33384220|NCT01412060|101291570|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
33384221|NCT01412060|101291571|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
33384222|NCT01412060|101291569|FG000|Period Between RIP and SP|Protocol Violation|2|||
33384223|NCT01412060|101291570|FG001|Period Between RIP and SP|Protocol Violation|0|||
33384224|NCT01412060|101291571|FG002|Period Between RIP and SP|Protocol Violation|0|||
33384225|NCT01412060|101291569|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
33384226|NCT01412060|101291570|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
33384227|NCT01412060|101291571|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
33384228|NCT01412060|101291569|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
33384229|NCT01412060|101291570|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
33384230|NCT01412060|101291571|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
33384231|NCT01412060|101291569|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
33384232|NCT01412060|101291570|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
33384233|NCT01412060|101291571|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
33384234|NCT01412060|101291569|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
33384235|NCT01412060|101291570|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
33384236|NCT01412060|101291571|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
33384237|NCT01412060|101291569|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
33432653|NCT01498484|101474402|FG003|Overall Study|Death|1|||
33432654|NCT01498484|101474403|FG004|Overall Study|Death|0|||
33432655|NCT01498484|101474404|FG005|Overall Study|Death|0|||
33432656|NCT01498484|101474405|FG006|Overall Study|Death|10|||
33432657|NCT01498484|101474406|FG007|Overall Study|Death|1|||
33432658|NCT01498484|101474407|FG008|Overall Study|Death|0|||
33432659|NCT01498484|101474399|FG000|Overall Study|Physician Decision|3|||
33432660|NCT01498484|101474400|FG001|Overall Study|Physician Decision|2|||
33432661|NCT01498484|101474401|FG002|Overall Study|Physician Decision|1|||
33432662|NCT01498484|101474402|FG003|Overall Study|Physician Decision|1|||
33432663|NCT01498484|101474403|FG004|Overall Study|Physician Decision|0|||
33432664|NCT01498484|101474404|FG005|Overall Study|Physician Decision|0|||
33432665|NCT01498484|101474405|FG006|Overall Study|Physician Decision|8|||
33432666|NCT01498484|101474406|FG007|Overall Study|Physician Decision|13|||
33432667|NCT01498484|101474407|FG008|Overall Study|Physician Decision|1|||
33432668|NCT01498484|101474399|FG000|Overall Study|Adverse Event|0|||
33432669|NCT01498484|101474400|FG001|Overall Study|Adverse Event|0|||
33432670|NCT01498484|101474401|FG002|Overall Study|Adverse Event|0|||
33432671|NCT01498484|101474402|FG003|Overall Study|Adverse Event|0|||
33432672|NCT01498484|101474403|FG004|Overall Study|Adverse Event|0|||
33432673|NCT01498484|101474404|FG005|Overall Study|Adverse Event|1|||
33432674|NCT01498484|101474405|FG006|Overall Study|Adverse Event|0|||
33432675|NCT01498484|101474406|FG007|Overall Study|Adverse Event|0|||
33432676|NCT01498484|101474407|FG008|Overall Study|Adverse Event|0|||
33432677|NCT01498484|101474399|FG000|Overall Study|Withdrawal by Subject|0|||
33432678|NCT01498484|101474400|FG001|Overall Study|Withdrawal by Subject|0|||
33432679|NCT01498484|101474401|FG002|Overall Study|Withdrawal by Subject|0|||
33432680|NCT01498484|101474402|FG003|Overall Study|Withdrawal by Subject|1|||
33432681|NCT01498484|101474403|FG004|Overall Study|Withdrawal by Subject|0|||
33432682|NCT01498484|101474404|FG005|Overall Study|Withdrawal by Subject|0|||
33432683|NCT01498484|101474405|FG006|Overall Study|Withdrawal by Subject|1|||
33432684|NCT01498484|101474406|FG007|Overall Study|Withdrawal by Subject|0|||
33432685|NCT01498484|101474407|FG008|Overall Study|Withdrawal by Subject|0|||
33432686|NCT01498484|101474399|FG000|Overall Study|Other|5|||
33432687|NCT01498484|101474400|FG001|Overall Study|Other|2|||
33432688|NCT01498484|101474401|FG002|Overall Study|Other|0|||
33432689|NCT01498484|101474402|FG003|Overall Study|Other|0|||
33432690|NCT01498484|101474403|FG004|Overall Study|Other|1|||
33432691|NCT01498484|101474404|FG005|Overall Study|Other|0|||
33432692|NCT01498484|101474405|FG006|Overall Study|Other|3|||
33432693|NCT01498484|101474406|FG007|Overall Study|Other|0|||
33432694|NCT01498484|101474407|FG008|Overall Study|Other|1|||
33432695|NCT00745095|101474410|FG000|Overall Study|Declined to participate|1|||
33432696|NCT00745095|101474411|FG001|Overall Study|Declined to participate|0|||
33432697|NCT00745095|101474412|FG002|Overall Study|Declined to participate|0|||
33432698|NCT00745095|101474413|FG003|Overall Study|Declined to participate|0|||
33432699|NCT00745095|101474414|FG004|Overall Study|Declined to participate|92|||
33432700|NCT00745095|101474415|FG005|Overall Study|Declined to participate|95|||
33432701|NCT00745095|101474410|FG000|Overall Study|Ineligible due to GFR criteria|0|||
33432702|NCT00745095|101474411|FG001|Overall Study|Ineligible due to GFR criteria|2|||
33432703|NCT00745095|101474412|FG002|Overall Study|Ineligible due to GFR criteria|3|||
33432704|NCT00745095|101474413|FG003|Overall Study|Ineligible due to GFR criteria|3|||
33432705|NCT00745095|101474414|FG004|Overall Study|Ineligible due to GFR criteria|30|||
33432706|NCT00745095|101474415|FG005|Overall Study|Ineligible due to GFR criteria|28|||
33432707|NCT01341639|101474416|FG000|Infant Series|Protocol Violation|1|||
33432708|NCT01341639|101474417|FG001|Infant Series|Protocol Violation|0|||
33432709|NCT01341639|101474416|FG000|Infant Series|Not Vaccinated|0|||
33432710|NCT01341639|101474417|FG001|Infant Series|Not Vaccinated|1|||
33432711|NCT01341639|101474416|FG000|Infant Series|Adverse Event|0|||
33432712|NCT01341639|101474417|FG001|Infant Series|Adverse Event|5|||
33432713|NCT01341639|101474416|FG000|Infant Series|Withdrawal by Subject|11|||
33432714|NCT01341639|101474417|FG001|Infant Series|Withdrawal by Subject|8|||
33432715|NCT01341639|101474416|FG000|Infant Series|Lost to Follow-up|0|||
33432716|NCT01341639|101474417|FG001|Infant Series|Lost to Follow-up|2|||
33432717|NCT01341639|101474416|FG000|Infant Series|Site 0048 Participants|17|||
33588319|NCT02712983|102041809|FG007|Treatment Phase|Protocol Deviation|0|||
33588320|NCT02712983|102041810|FG008|Treatment Phase|Protocol Deviation|0|||
33588321|NCT02712983|102041802|FG000|Treatment Phase|Technical Problems|0|||
33149982|NCT00410202|100463573|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
33432718|NCT01341639|101474417|FG001|Infant Series|Site 0048 Participants|16|||
33432719|NCT01341639|101474416|FG000|Interim Period|Withdrawal by Subject|6|||
33432720|NCT01341639|101474417|FG001|Interim Period|Withdrawal by Subject|7|||
33432721|NCT01341639|101474416|FG000|Interim Period|Lost to Follow-up|2|||
33432722|NCT01341639|101474417|FG001|Interim Period|Lost to Follow-up|0|||
33432723|NCT01341639|101474416|FG000|Interim Period|Physician Decision|0|||
33432724|NCT01341639|101474417|FG001|Interim Period|Physician Decision|1|||
33432725|NCT01341639|101474416|FG000|Interim Period|Protocol Violation|0|||
33432726|NCT01341639|101474417|FG001|Interim Period|Protocol Violation|1|||
33432727|NCT01341639|101474416|FG000|Post-Treatment|Withdrawal by Subject|0|||
33432728|NCT01341639|101474417|FG001|Post-Treatment|Withdrawal by Subject|1|||
33432729|NCT01341639|101474416|FG000|Post-Treatment|Adverse Event|0|||
33432730|NCT01341639|101474417|FG001|Post-Treatment|Adverse Event|2|||
33588322|NCT02712983|102041803|FG001|Treatment Phase|Technical Problems|0|||
33588323|NCT02712983|102041804|FG002|Treatment Phase|Technical Problems|0|||
33588324|NCT02712983|102041805|FG003|Treatment Phase|Technical Problems|0|||
33588325|NCT02712983|102041806|FG004|Treatment Phase|Technical Problems|0|||
33588326|NCT02712983|102041807|FG005|Treatment Phase|Technical Problems|0|||
33648267|NCT04661579|102262982|FG004|Overall Study|Other|1|||
33648268|NCT04661579|102262978|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
33149983|NCT00410202|100463574|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
33149984|NCT00410202|100463572|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
33149985|NCT00410202|100463573|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
33149986|NCT00410202|100463574|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
33149987|NCT01539642|100463575|FG000|Overall Study|Lack of Efficacy|20|||
33384238|NCT01412060|101291570|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
33432731|NCT05200858|101474418|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
33588327|NCT02712983|102041808|FG006|Treatment Phase|Technical Problems|1|||
33588328|NCT02712983|102041809|FG007|Treatment Phase|Technical Problems|0|||
33588329|NCT02712983|102041810|FG008|Treatment Phase|Technical Problems|0|||
33648269|NCT04661579|102262979|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
33648270|NCT04661579|102262980|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
33648271|NCT04661579|102262981|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
33648272|NCT04661579|102262982|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
33648273|NCT00899353|102265542|FG000|Overall Study|Adverse Event|2|||
33648274|NCT00899353|102265542|FG000|Overall Study|Lost to Follow-up|1|||
33648275|NCT00899353|102265542|FG000|Overall Study|Withdrawal by Subject|2|||
33648276|NCT01284491|102265543|FG000|Overall Study|Study termination|13|||
33648277|NCT01761162|102265546|FG000|Overall Study|Withdrawal by Subject|3|||
33648278|NCT01536392|102265547|FG000|Overall Study|Adverse Event|2|||
33648279|NCT01536392|102265548|FG001|Overall Study|Adverse Event|2|||
33648280|NCT01536392|102265547|FG000|Overall Study|Physician Decision|2|||
33648281|NCT01536392|102265548|FG001|Overall Study|Physician Decision|3|||
33648282|NCT01536392|102265547|FG000|Overall Study|Withdrawal by Subject|3|||
33648283|NCT01536392|102265548|FG001|Overall Study|Withdrawal by Subject|6|||
33648284|NCT01536392|102265547|FG000|Overall Study|Non Compliance|3|||
33648285|NCT01536392|102265548|FG001|Overall Study|Non Compliance|4|||
33648286|NCT01536392|102265547|FG000|Overall Study|Completed therapy early|3|||
33648287|NCT01536392|102265548|FG001|Overall Study|Completed therapy early|0|||
33648288|NCT02576145|102265551|FG000|Overall Study|Adverse Event|1|||
33648289|NCT02576145|102265552|FG001|Overall Study|Adverse Event|0|||
33648290|NCT02576145|102265551|FG000|Overall Study|Withdrawal by Subject|1|||
33648291|NCT02576145|102265552|FG001|Overall Study|Withdrawal by Subject|0|||
33648292|NCT02576145|102265551|FG000|Overall Study|Acute rejection|1|||
33648293|NCT02576145|102265552|FG001|Overall Study|Acute rejection|0|||
33648294|NCT02576145|102265551|FG000|Overall Study|Tetanus Titers Decreased|0|||
33648295|NCT02576145|102265552|FG001|Overall Study|Tetanus Titers Decreased|1|||
33648296|NCT03704636|102265553|FG000|Overall Study|Inadequate Venous Flow|3|||
33648297|NCT01523275|102265557|FG000|Overall Study|Lost to Follow-up|1|||
33648298|NCT01523275|102265558|FG001|Overall Study|Lost to Follow-up|2|||
33648299|NCT01523275|102265557|FG000|Overall Study|Withdrawal by Subject|1|||
33648300|NCT01523275|102265558|FG001|Overall Study|Withdrawal by Subject|0|||
33648301|NCT00145977|102265559|FG000|Overall Study|Lack of Efficacy|0|||
33648302|NCT00145977|102265560|FG001|Overall Study|Lack of Efficacy|4|||
33648303|NCT00145977|102265559|FG000|Overall Study|Lost to Follow-up|1|||
33648304|NCT00145977|102265560|FG001|Overall Study|Lost to Follow-up|0|||
33648305|NCT00145977|102265559|FG000|Overall Study|Withdrawal by Subject|1|||
33149988|NCT01539642|100463576|FG001|Overall Study|Lack of Efficacy|18|||
33149989|NCT01539642|100463575|FG000|Overall Study|Patient ready for early discharge|8|||
33432732|NCT05200858|101474419|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
33588330|NCT02712983|102041802|FG000|Treatment Phase|Physician Decision|0|||
33588331|NCT02712983|102041803|FG001|Treatment Phase|Physician Decision|0|||
33588332|NCT02712983|102041804|FG002|Treatment Phase|Physician Decision|0|||
33588333|NCT02712983|102041805|FG003|Treatment Phase|Physician Decision|0|||
33588334|NCT02712983|102041806|FG004|Treatment Phase|Physician Decision|0|||
33588335|NCT02712983|102041807|FG005|Treatment Phase|Physician Decision|0|||
33588336|NCT02712983|102041808|FG006|Treatment Phase|Physician Decision|0|||
33648306|NCT00145977|102265560|FG001|Overall Study|Withdrawal by Subject|0|||
33648307|NCT03032380|102265563|FG000|Overall Study|Adverse Event|0|||
33648308|NCT03032380|102265564|FG001|Overall Study|Adverse Event|1|||
33648309|NCT03032380|102265563|FG000|Overall Study|Lack of Efficacy|1|||
33249580|NCT01212757|100814512|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
33648310|NCT03032380|102265564|FG001|Overall Study|Lack of Efficacy|0|||
33648311|NCT03032380|102265563|FG000|Overall Study|Withdrawal by Subject|2|||
33648312|NCT03032380|102265564|FG001|Overall Study|Withdrawal by Subject|3|||
33648313|NCT03032380|102265563|FG000|Overall Study|Recovery|0|||
33648314|NCT03032380|102265564|FG001|Overall Study|Recovery|1|||
33648315|NCT03032380|102265563|FG000|Overall Study|Death|39|||
33648316|NCT03032380|102265564|FG001|Overall Study|Death|34|||
33588337|NCT02712983|102041809|FG007|Treatment Phase|Physician Decision|1|||
33588338|NCT02712983|102041810|FG008|Treatment Phase|Physician Decision|1|||
33588339|NCT02712983|102041802|FG000|Treatment Phase|Subject Decision|2|||
33588340|NCT02712983|102041803|FG001|Treatment Phase|Subject Decision|0|||
33588341|NCT02712983|102041804|FG002|Treatment Phase|Subject Decision|0|||
33588342|NCT02712983|102041805|FG003|Treatment Phase|Subject Decision|2|||
33588343|NCT02712983|102041806|FG004|Treatment Phase|Subject Decision|1|||
33588344|NCT02712983|102041807|FG005|Treatment Phase|Subject Decision|0|||
33588345|NCT02712983|102041808|FG006|Treatment Phase|Subject Decision|1|||
33588346|NCT02712983|102041809|FG007|Treatment Phase|Subject Decision|2|||
33588347|NCT02712983|102041810|FG008|Treatment Phase|Subject Decision|0|||
33588348|NCT02712983|102041802|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33588349|NCT02712983|102041803|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
33588350|NCT02712983|102041804|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33588351|NCT02712983|102041805|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33588352|NCT02712983|102041806|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33588353|NCT02712983|102041807|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33588354|NCT02712983|102041808|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
33588355|NCT02712983|102041809|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
33588356|NCT02712983|102041810|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
33588357|NCT02712983|102041802|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33588358|NCT02712983|102041803|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33588359|NCT02712983|102041804|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33588360|NCT02712983|102041805|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
33588361|NCT02712983|102041806|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33588362|NCT02712983|102041807|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33588363|NCT02712983|102041808|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33588364|NCT02712983|102041809|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33588365|NCT02712983|102041810|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
33588366|NCT02712983|102041802|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
33588367|NCT02712983|102041803|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
33588368|NCT02712983|102041804|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
33588369|NCT02712983|102041805|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
33588370|NCT02712983|102041806|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
33588371|NCT02712983|102041807|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
33588372|NCT02712983|102041808|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
33588373|NCT02712983|102041809|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
33588374|NCT02712983|102041810|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
33588375|NCT04091581|102041811|FG000|Overall Study|Lost to Follow-up|0|||
33588376|NCT04091581|102041812|FG001|Overall Study|Lost to Follow-up|1|||
33588377|NCT03763656|102041819|FG000|Overall Study|Physician Decision|1|||
33588378|NCT03763656|102041819|FG000|Overall Study|Protocol Violation|1|||
33588379|NCT03763656|102041819|FG000|Overall Study|Withdrawal by Subject|7|||
33588380|NCT00218634|102041822|FG000|Overall Study|Lost to Follow-up|8|||
33588381|NCT00218634|102041823|FG001|Overall Study|Lost to Follow-up|15|||
33588382|NCT02993822|102041827|FG000|Overall Study|Lack of Efficacy|1|||
33588383|NCT02993822|102041828|FG001|Overall Study|Lack of Efficacy|1|||
33588384|NCT02993822|102041829|FG002|Overall Study|Lack of Efficacy|0|||
33588385|NCT02993822|102041830|FG003|Overall Study|Lack of Efficacy|0|||
33149990|NCT01539642|100463576|FG001|Overall Study|Patient ready for early discharge|7|||
33149991|NCT01539642|100463575|FG000|Overall Study|Adverse Event|6|||
33149992|NCT01539642|100463576|FG001|Overall Study|Adverse Event|4|||
33149993|NCT01539642|100463575|FG000|Overall Study|Withdrawal by Subject|2|||
33149994|NCT01539642|100463576|FG001|Overall Study|Withdrawal by Subject|2|||
33149995|NCT01462227|100463584|FG000|Second Assignment|Lost to Follow-up|1|||
33149996|NCT01462227|100463585|FG001|Second Assignment|Lost to Follow-up|0|||
33149997|NCT01462227|100463586|FG002|Second Assignment|Lost to Follow-up|0|||
33149998|NCT01462227|100463587|FG003|Second Assignment|Lost to Follow-up|0|||
33249581|NCT01212757|100814513|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
33384239|NCT01412060|101291571|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
33384240|NCT01412060|101291569|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
33384241|NCT01412060|101291570|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
33384242|NCT01412060|101291571|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
33588386|NCT02993822|102041827|FG000|Overall Study|Protocol Violation|1|||
33588387|NCT02993822|102041828|FG001|Overall Study|Protocol Violation|0|||
33588388|NCT02993822|102041829|FG002|Overall Study|Protocol Violation|0|||
33588389|NCT02993822|102041830|FG003|Overall Study|Protocol Violation|0|||
33588390|NCT02993822|102041827|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
33648317|NCT03032380|102265563|FG000|Overall Study|Other - Miscellaneous|0|||
33648318|NCT03032380|102265564|FG001|Overall Study|Other - Miscellaneous|1|||
33149999|NCT01462227|100463584|FG000|Second Assignment|Protocol Violation|0|||
33150000|NCT01462227|100463585|FG001|Second Assignment|Protocol Violation|1|||
33249582|NCT01212757|100814514|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
33249583|NCT01212757|100814515|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
33249584|NCT01212757|100814516|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
33249585|NCT01212757|100814517|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
33249586|NCT01212757|100814518|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
33249587|NCT01212757|100814519|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
33384243|NCT01412060|101291569|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
33384244|NCT01412060|101291570|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
33648319|NCT01368562|102265568|FG000|Overall Study|Adverse Event|1|||
33648320|NCT01368562|102265568|FG000|Overall Study|Disease progression|1|||
33648321|NCT01368562|102265568|FG000|Overall Study|Lost to Follow-up|1|||
33648322|NCT01368562|102265568|FG000|Overall Study|Death|6|||
33648323|NCT01368562|102265568|FG000|Overall Study|Unresponsive to treatment|5|||
33648324|NCT01368562|102265568|FG000|Overall Study|Other|3|||
33648325|NCT01368562|102265568|FG000|Overall Study|Other than specified|2|||
33648326|NCT03860818|102265569|FG000|Overall Study|Death|144|||
33648327|NCT03860818|102265570|FG001|Overall Study|Death|195|||
33648328|NCT03860818|102265569|FG000|Overall Study|Graft Loss|32|||
33648329|NCT03860818|102265570|FG001|Overall Study|Graft Loss|45|||
33648330|NCT00422513|102265578|FG000|Overall Study|Lack of Efficacy|4|||
33648331|NCT00422513|102265579|FG001|Overall Study|Lack of Efficacy|5|||
33648332|NCT00422513|102265578|FG000|Overall Study|Protocol Violation|23|||
33648333|NCT00422513|102265579|FG001|Overall Study|Protocol Violation|7|||
33648334|NCT00422513|102265578|FG000|Overall Study|Refused Treatment|4|||
33648335|NCT00422513|102265579|FG001|Overall Study|Refused Treatment|2|||
33648336|NCT00422513|102265578|FG000|Overall Study|Withdrawal by Subject|2|||
33648337|NCT00422513|102265579|FG001|Overall Study|Withdrawal by Subject|1|||
33648338|NCT00422513|102265578|FG000|Overall Study|early termination of the study|67|||
33648339|NCT00422513|102265579|FG001|Overall Study|early termination of the study|80|||
33648340|NCT00422513|102265578|FG000|Overall Study|Adverse Event|4|||
33648341|NCT00422513|102265579|FG001|Overall Study|Adverse Event|4|||
33648342|NCT00422513|102265578|FG000|Overall Study|Death|3|||
33648343|NCT00422513|102265579|FG001|Overall Study|Death|7|||
33648344|NCT03041129|102265582|FG000|Overall Study|Withdrawal by Subject|2|||
33648345|NCT03041129|102265583|FG001|Overall Study|Withdrawal by Subject|0|||
33648346|NCT03041129|102265584|FG002|Overall Study|Withdrawal by Subject|0|||
33648347|NCT03041129|102265585|FG003|Overall Study|Withdrawal by Subject|0|||
33648348|NCT02864862|102265587|FG000|Overall Study|Lost to Follow-up|1|||
33648349|NCT02864862|102265588|FG001|Overall Study|Lost to Follow-up|0|||
33648350|NCT02864862|102265589|FG002|Overall Study|Lost to Follow-up|1|||
33648351|NCT02864862|102265587|FG000|Overall Study|Protocol Violation|0|||
33648352|NCT02864862|102265588|FG001|Overall Study|Protocol Violation|0|||
33648353|NCT02864862|102265589|FG002|Overall Study|Protocol Violation|1|||
33648354|NCT00505076|102265590|FG000|Overall Study|Adverse Event|1|||
33648355|NCT00505076|102265591|FG001|Overall Study|Adverse Event|0|||
33648356|NCT00505076|102265592|FG002|Overall Study|Adverse Event|1|||
33648357|NCT00505076|102265590|FG000|Overall Study|Protocol Violation|2|||
33648358|NCT00505076|102265591|FG001|Overall Study|Protocol Violation|1|||
33648359|NCT00505076|102265592|FG002|Overall Study|Protocol Violation|2|||
33648360|NCT00505076|102265590|FG000|Overall Study|Withdrawal by Subject|0|||
33648361|NCT00505076|102265591|FG001|Overall Study|Withdrawal by Subject|1|||
33648362|NCT00505076|102265592|FG002|Overall Study|Withdrawal by Subject|2|||
33648363|NCT02437110|102265593|FG000|Screening|Lost to Follow-up|3|||
33648364|NCT02437110|102265593|FG000|Screening|Physician Decision|1|||
33648365|NCT02437110|102265593|FG000|ART|Adverse Event|3|||
33648366|NCT02437110|102265593|FG000|ART|Protocol Violation|3|||
33648367|NCT02437110|102265593|FG000|ART|Withdrawal by Subject|4|||
33150001|NCT01462227|100463586|FG002|Second Assignment|Protocol Violation|1|||
33150002|NCT01462227|100463587|FG003|Second Assignment|Protocol Violation|0|||
33150003|NCT01083173|100463592|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
33150004|NCT01083173|100463593|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
33648368|NCT02437110|102265593|FG000|ART|Lost to follow-up prior to start of intervention|1|||
33648369|NCT02437110|102265593|FG000|ART|Physician decision prior to start of intervention|2|||
33648370|NCT02437110|102265593|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
33648371|NCT02437110|102265593|FG000|Post-ART|Lost to Follow-up|3|||
33648372|NCT02437110|102265593|FG000|Post-ART|Protocol Violation|4|||
33648373|NCT02437110|102265593|FG000|Post-ART|Withdrawal by Subject|3|||
33648374|NCT02870933|102265594|FG000|Overall Study|Death|2|||
33648375|NCT02870933|102265595|FG001|Overall Study|Death|1|||
33648376|NCT02870933|102265594|FG000|Overall Study|Withdrawal by Subject|0|||
33648377|NCT02870933|102265595|FG001|Overall Study|Withdrawal by Subject|1|||
33648378|NCT01233232|102265596|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
33648379|NCT01233232|102265597|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
33648380|NCT01233232|102265598|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
33648381|NCT03135119|102265599|FG000|Overall Study|Lost to Follow-up|2|||
33648382|NCT03135119|102265600|FG001|Overall Study|Lost to Follow-up|0|||
33432733|NCT05200858|101474420|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
33432734|NCT05200858|101474421|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
33432735|NCT00387712|101474434|FG000|Overall Study|Physician Decision|6|||
33432736|NCT00387712|101474435|FG001|Overall Study|Physician Decision|4|||
33432737|NCT00387712|101474434|FG000|Overall Study|Lost to Follow-up|17|||
33432738|NCT00387712|101474435|FG001|Overall Study|Lost to Follow-up|20|||
33432739|NCT00387712|101474434|FG000|Overall Study|Withdrawal by Subject|6|||
33432740|NCT00387712|101474435|FG001|Overall Study|Withdrawal by Subject|12|||
33432741|NCT04272775|101474436|FG000|Overall Study|Study Terminated by Sponsor|1|||
33432742|NCT04272775|101474437|FG001|Overall Study|Study Terminated by Sponsor|0|||
33432743|NCT04272775|101474436|FG000|Overall Study|Protocol Violation|0|||
33432744|NCT04272775|101474437|FG001|Overall Study|Protocol Violation|1|||
33432745|NCT04272775|101474436|FG000|Overall Study|Symptomatic Deterioration|1|||
33432746|NCT04272775|101474437|FG001|Overall Study|Symptomatic Deterioration|1|||
33432747|NCT04272775|101474436|FG000|Overall Study|Withdrawal by Subject|1|||
33432748|NCT04272775|101474437|FG001|Overall Study|Withdrawal by Subject|2|||
33432749|NCT04272775|101474436|FG000|Overall Study|Adverse Event|1|||
33432750|NCT04272775|101474437|FG001|Overall Study|Adverse Event|2|||
33432751|NCT04272775|101474436|FG000|Overall Study|Progressive Disease|3|||
33432752|NCT04272775|101474437|FG001|Overall Study|Progressive Disease|1|||
33432753|NCT01399723|101474443|FG000|Overall Study|Lost to Follow-up|0|||
33432754|NCT01399723|101474444|FG001|Overall Study|Lost to Follow-up|1|||
33432755|NCT00982410|101474446|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
33432756|NCT00982410|101474447|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
33432757|NCT00982410|101474446|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
33432758|NCT00982410|101474447|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
33432759|NCT00982410|101474446|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
33432760|NCT00982410|101474447|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
33432761|NCT00982410|101474446|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
33432762|NCT00982410|101474447|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
33432763|NCT00982410|101474446|FG000|6-month Follow-up Assessment|participant no transportation|1|||
33432764|NCT00982410|101474447|FG001|6-month Follow-up Assessment|participant no transportation|0|||
33432765|NCT00982410|101474446|FG000|6-month Follow-up Assessment|incarceration|0|||
33432766|NCT00982410|101474447|FG001|6-month Follow-up Assessment|incarceration|2|||
33432767|NCT00982410|101474446|FG000|6-month Follow-up Assessment|patent surgery|0|||
33432768|NCT00982410|101474447|FG001|6-month Follow-up Assessment|patent surgery|1|||
33432769|NCT00982410|101474446|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
33432770|NCT00982410|101474447|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
33432771|NCT00982410|101474446|FG000|12-month Follow-up Assessment|Death|0|||
33432772|NCT00982410|101474447|FG001|12-month Follow-up Assessment|Death|2|||
33432773|NCT00982410|101474446|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
33432774|NCT00982410|101474447|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
33432775|NCT00982410|101474446|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
33432776|NCT00982410|101474447|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
33432777|NCT00982410|101474446|FG000|12-month Follow-up Assessment|incarceration|2|||
33432778|NCT00982410|101474447|FG001|12-month Follow-up Assessment|incarceration|1|||
33432779|NCT00982410|101474446|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
33432780|NCT00982410|101474447|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
33432781|NCT00555009|101474448|FG000|Overall Study|Withdrawal by Subject|0|||
33432782|NCT00555009|101474449|FG001|Overall Study|Withdrawal by Subject|1|||
33432783|NCT00555009|101474448|FG000|Overall Study|Terminated by Sponsor|2|||
33432784|NCT00555009|101474449|FG001|Overall Study|Terminated by Sponsor|5|||
33432785|NCT03341273|101474450|FG000|Overall Study|Lost to Follow-up|7|||
33432786|NCT03341273|101474451|FG001|Overall Study|Lost to Follow-up|7|||
33432787|NCT03341273|101474450|FG000|Overall Study|Withdrawal by Subject|4|||
33432788|NCT03341273|101474451|FG001|Overall Study|Withdrawal by Subject|2|||
33432789|NCT03341273|101474450|FG000|Overall Study|Physician Decision|1|||
33432790|NCT03341273|101474451|FG001|Overall Study|Physician Decision|0|||
33432791|NCT03341273|101474450|FG000|Overall Study|Protocol Violation|0|||
33432792|NCT03341273|101474451|FG001|Overall Study|Protocol Violation|1|||
33432793|NCT03341273|101474450|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
33432794|NCT03341273|101474451|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
33432795|NCT03341273|101474450|FG000|Overall Study|Became ineligible after enrollment|1|||
33432796|NCT03341273|101474451|FG001|Overall Study|Became ineligible after enrollment|0|||
33432797|NCT03341273|101474450|FG000|Overall Study|Not Eligible at Enrollment|0|||
33432798|NCT03341273|101474451|FG001|Overall Study|Not Eligible at Enrollment|1|||
33432799|NCT03341273|101474450|FG000|Overall Study|Participant incarcerated|1|||
33432800|NCT03341273|101474451|FG001|Overall Study|Participant incarcerated|0|||
33432801|NCT00182091|101474456|FG000|Overall Study|Withdrawal by Subject|1|||
33432802|NCT00182091|101474457|FG001|Overall Study|Withdrawal by Subject|0|||
33432803|NCT00182091|101474458|FG002|Overall Study|Withdrawal by Subject|0|||
33432804|NCT00182091|101474459|FG003|Overall Study|Withdrawal by Subject|0|||
33432805|NCT01621490|101474464|FG000|Overall Study|Subject no longer meets study criteria|0|||
33432806|NCT01621490|101474465|FG001|Overall Study|Subject no longer meets study criteria|0|||
33432807|NCT01621490|101474466|FG002|Overall Study|Subject no longer meets study criteria|0|||
33432808|NCT01621490|101474467|FG003|Overall Study|Subject no longer meets study criteria|0|||
33432809|NCT01621490|101474468|FG004|Overall Study|Subject no longer meets study criteria|1|||
33432810|NCT01621490|101474469|FG005|Overall Study|Subject no longer meets study criteria|0|||
33432811|NCT01621490|101474470|FG006|Overall Study|Subject no longer meets study criteria|0|||
33432812|NCT01621490|101474471|FG007|Overall Study|Subject no longer meets study criteria|0|||
33432813|NCT01621490|101474472|FG008|Overall Study|Subject no longer meets study criteria|0|||
33432814|NCT01621490|101474473|FG009|Overall Study|Subject no longer meets study criteria|0|||
33432815|NCT01621490|101474474|FG010|Overall Study|Subject no longer meets study criteria|0|||
33432816|NCT01621490|101474464|FG000|Overall Study|Maximum clinical benefit|3|||
33432817|NCT01621490|101474465|FG001|Overall Study|Maximum clinical benefit|2|||
33432818|NCT01621490|101474466|FG002|Overall Study|Maximum clinical benefit|0|||
33432819|NCT01621490|101474467|FG003|Overall Study|Maximum clinical benefit|0|||
33432820|NCT01621490|101474468|FG004|Overall Study|Maximum clinical benefit|0|||
33432821|NCT01621490|101474469|FG005|Overall Study|Maximum clinical benefit|0|||
33432822|NCT01621490|101474470|FG006|Overall Study|Maximum clinical benefit|1|||
33432823|NCT01621490|101474471|FG007|Overall Study|Maximum clinical benefit|2|||
33432824|NCT01621490|101474472|FG008|Overall Study|Maximum clinical benefit|2|||
33432825|NCT01621490|101474473|FG009|Overall Study|Maximum clinical benefit|0|||
33432826|NCT01621490|101474474|FG010|Overall Study|Maximum clinical benefit|0|||
33432827|NCT01621490|101474464|FG000|Overall Study|Withdrawal by Subject|1|||
33432828|NCT01621490|101474465|FG001|Overall Study|Withdrawal by Subject|0|||
33432829|NCT01621490|101474466|FG002|Overall Study|Withdrawal by Subject|0|||
33432830|NCT01621490|101474467|FG003|Overall Study|Withdrawal by Subject|0|||
33432831|NCT01621490|101474468|FG004|Overall Study|Withdrawal by Subject|0|||
33432832|NCT01621490|101474469|FG005|Overall Study|Withdrawal by Subject|1|||
33432833|NCT01621490|101474470|FG006|Overall Study|Withdrawal by Subject|0|||
33432834|NCT01621490|101474471|FG007|Overall Study|Withdrawal by Subject|0|||
33432835|NCT01621490|101474472|FG008|Overall Study|Withdrawal by Subject|0|||
33432836|NCT01621490|101474473|FG009|Overall Study|Withdrawal by Subject|0|||
33432837|NCT01621490|101474474|FG010|Overall Study|Withdrawal by Subject|0|||
33432838|NCT01621490|101474464|FG000|Overall Study|Subject request to discontinue study|1|||
33432839|NCT01621490|101474465|FG001|Overall Study|Subject request to discontinue study|3|||
33432840|NCT01621490|101474466|FG002|Overall Study|Subject request to discontinue study|1|||
33432841|NCT01621490|101474467|FG003|Overall Study|Subject request to discontinue study|1|||
33432842|NCT01621490|101474468|FG004|Overall Study|Subject request to discontinue study|0|||
33432843|NCT01621490|101474469|FG005|Overall Study|Subject request to discontinue study|2|||
33432844|NCT01621490|101474470|FG006|Overall Study|Subject request to discontinue study|1|||
33432845|NCT01621490|101474471|FG007|Overall Study|Subject request to discontinue study|0|||
33432846|NCT01621490|101474472|FG008|Overall Study|Subject request to discontinue study|1|||
33432847|NCT01621490|101474473|FG009|Overall Study|Subject request to discontinue study|0|||
33432848|NCT01621490|101474474|FG010|Overall Study|Subject request to discontinue study|0|||
33432849|NCT01621490|101474464|FG000|Overall Study|Adverse event unrelated to study drug|1|||
33432850|NCT01621490|101474465|FG001|Overall Study|Adverse event unrelated to study drug|1|||
33432851|NCT01621490|101474466|FG002|Overall Study|Adverse event unrelated to study drug|0|||
33432852|NCT01621490|101474467|FG003|Overall Study|Adverse event unrelated to study drug|0|||
33432853|NCT01621490|101474468|FG004|Overall Study|Adverse event unrelated to study drug|0|||
33432854|NCT01621490|101474469|FG005|Overall Study|Adverse event unrelated to study drug|0|||
33432855|NCT01621490|101474470|FG006|Overall Study|Adverse event unrelated to study drug|0|||
33432856|NCT01621490|101474471|FG007|Overall Study|Adverse event unrelated to study drug|2|||
33432857|NCT01621490|101474472|FG008|Overall Study|Adverse event unrelated to study drug|0|||
33432858|NCT01621490|101474473|FG009|Overall Study|Adverse event unrelated to study drug|0|||
33432859|NCT01621490|101474474|FG010|Overall Study|Adverse event unrelated to study drug|0|||
33432860|NCT01621490|101474464|FG000|Overall Study|Disease progression|27|||
33432861|NCT01621490|101474465|FG001|Overall Study|Disease progression|28|||
33432862|NCT01621490|101474466|FG002|Overall Study|Disease progression|1|||
33432863|NCT01621490|101474467|FG003|Overall Study|Disease progression|5|||
33249588|NCT01212757|100814520|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
33249589|NCT01212757|100814512|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33432864|NCT01621490|101474468|FG004|Overall Study|Disease progression|3|||
33432865|NCT01621490|101474469|FG005|Overall Study|Disease progression|8|||
33432866|NCT01621490|101474470|FG006|Overall Study|Disease progression|7|||
33432867|NCT01621490|101474471|FG007|Overall Study|Disease progression|1|||
33432868|NCT01621490|101474472|FG008|Overall Study|Disease progression|4|||
33432869|NCT01621490|101474473|FG009|Overall Study|Disease progression|1|||
33432870|NCT01621490|101474474|FG010|Overall Study|Disease progression|1|||
33432871|NCT01621490|101474464|FG000|Overall Study|Study drug toxicity|1|||
33432872|NCT01621490|101474465|FG001|Overall Study|Study drug toxicity|4|||
33432873|NCT01621490|101474466|FG002|Overall Study|Study drug toxicity|5|||
33432874|NCT01621490|101474467|FG003|Overall Study|Study drug toxicity|3|||
33432875|NCT01621490|101474468|FG004|Overall Study|Study drug toxicity|1|||
33432876|NCT01621490|101474469|FG005|Overall Study|Study drug toxicity|10|||
33432877|NCT01621490|101474470|FG006|Overall Study|Study drug toxicity|1|||
33432878|NCT01621490|101474471|FG007|Overall Study|Study drug toxicity|4|||
33432879|NCT01621490|101474472|FG008|Overall Study|Study drug toxicity|1|||
33432880|NCT01621490|101474473|FG009|Overall Study|Study drug toxicity|0|||
33432881|NCT01621490|101474474|FG010|Overall Study|Study drug toxicity|0|||
33432882|NCT01621490|101474464|FG000|Overall Study|Death|0|||
33150005|NCT01083173|100463592|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
33150006|NCT01083173|100463593|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
33150007|NCT01083173|100463592|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
33150008|NCT01083173|100463593|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
33150009|NCT01083173|100463592|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
33150010|NCT01083173|100463593|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
33150011|NCT01083173|100463592|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
33150012|NCT01083173|100463593|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
33150013|NCT01083173|100463592|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
33150014|NCT01083173|100463593|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
33150015|NCT01083173|100463592|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
33150016|NCT01083173|100463593|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
33150017|NCT01083173|100463592|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
33150018|NCT01083173|100463593|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
33150019|NCT01083173|100463592|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
33432883|NCT01621490|101474465|FG001|Overall Study|Death|0|||
33432884|NCT01621490|101474466|FG002|Overall Study|Death|0|||
33432885|NCT01621490|101474467|FG003|Overall Study|Death|0|||
33432886|NCT01621490|101474468|FG004|Overall Study|Death|0|||
33588391|NCT02993822|102041828|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
33588392|NCT02993822|102041829|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
33588393|NCT02993822|102041830|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
33588394|NCT02993822|102041827|FG000|Overall Study|Adverse Event|3|||
33588395|NCT02993822|102041828|FG001|Overall Study|Adverse Event|1|||
33588396|NCT02993822|102041829|FG002|Overall Study|Adverse Event|7|||
33384245|NCT01412060|101291571|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
33384246|NCT01412060|101291569|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
33384247|NCT01412060|101291570|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
33384248|NCT01412060|101291571|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
33384249|NCT01412060|101291569|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
33384250|NCT01412060|101291570|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
33384251|NCT01412060|101291571|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
33384252|NCT01412060|101291569|FG000|Period Between SP and DBP|Protocol Violation|2|||
33384253|NCT01412060|101291570|FG001|Period Between SP and DBP|Protocol Violation|0|||
33384254|NCT01412060|101291571|FG002|Period Between SP and DBP|Protocol Violation|0|||
33384255|NCT01412060|101291569|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
33384256|NCT01412060|101291570|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
33384257|NCT01412060|101291571|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
33384258|NCT01412060|101291569|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
33384259|NCT01412060|101291570|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
33384260|NCT01412060|101291571|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
33384261|NCT01412060|101291569|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
33384262|NCT01412060|101291570|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
33384263|NCT01412060|101291571|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
33384264|NCT01412060|101291569|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
33384265|NCT01412060|101291570|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
33384266|NCT01412060|101291571|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
33384267|NCT01412060|101291569|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
33384268|NCT01412060|101291570|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
33384269|NCT01412060|101291571|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
33588397|NCT02993822|102041830|FG003|Overall Study|Adverse Event|0|||
33588398|NCT02993822|102041827|FG000|Overall Study|Withdrawal by Subject|4|||
33150020|NCT01083173|100463593|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
33286464|NCT00092521|100943968|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
33384270|NCT01412060|101291569|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
33432887|NCT01621490|101474469|FG005|Overall Study|Death|0|||
33432888|NCT01621490|101474470|FG006|Overall Study|Death|0|||
33432889|NCT01621490|101474471|FG007|Overall Study|Death|0|||
33432890|NCT01621490|101474472|FG008|Overall Study|Death|1|||
33432891|NCT01621490|101474473|FG009|Overall Study|Death|0|||
33648383|NCT03135119|102265599|FG000|Overall Study|Physician Decision|1|||
33249590|NCT01212757|100814513|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33249591|NCT01212757|100814514|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
33249592|NCT01212757|100814515|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33249593|NCT01212757|100814516|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33249594|NCT01212757|100814517|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33249595|NCT01212757|100814518|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33249596|NCT01212757|100814519|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33249597|NCT01212757|100814520|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
33249598|NCT01212757|100814512|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
33249599|NCT01212757|100814513|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
33249600|NCT01212757|100814514|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
33249601|NCT01212757|100814515|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
33249602|NCT01212757|100814516|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
33249603|NCT01212757|100814517|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
33249604|NCT01212757|100814518|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
33249605|NCT01212757|100814519|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
33249606|NCT01212757|100814520|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
33249607|NCT01212757|100814512|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33249608|NCT01212757|100814513|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
33249609|NCT01212757|100814514|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33249610|NCT01212757|100814515|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33249611|NCT01212757|100814516|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
33249612|NCT01212757|100814517|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33249613|NCT01212757|100814518|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33249614|NCT01212757|100814519|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33249615|NCT01212757|100814520|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33249616|NCT01212757|100814512|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
33249617|NCT01212757|100814513|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
33249618|NCT01212757|100814514|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
33249619|NCT01212757|100814515|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
33249620|NCT01212757|100814516|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
33249621|NCT01212757|100814517|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
33249622|NCT01212757|100814518|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
33249623|NCT01212757|100814519|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
33384271|NCT01412060|101291570|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
33384272|NCT01412060|101291571|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
33384273|NCT01412060|101291569|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
33384274|NCT01412060|101291570|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
33384275|NCT01412060|101291571|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
33384276|NCT01412060|101291569|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
33384277|NCT01412060|101291570|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
33384278|NCT01412060|101291571|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
33384279|NCT01412060|101291569|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
33384280|NCT01412060|101291570|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
33384281|NCT01412060|101291571|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
33384282|NCT01412060|101291569|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
33384283|NCT01412060|101291570|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
33384284|NCT01412060|101291571|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
33384285|NCT00209170|101291572|FG000|Overall Study|Adverse Event|0|||
33384286|NCT00209170|101291573|FG001|Overall Study|Adverse Event|1|||
33384287|NCT00209170|101291572|FG000|Overall Study|Withdrawal by Subject|2|||
33150021|NCT01083173|100463592|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
33150022|NCT01083173|100463593|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
33150023|NCT01083173|100463592|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
33150024|NCT01083173|100463593|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
33150025|NCT00736879|100463594|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
33150026|NCT00736879|100463595|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
33150027|NCT00736879|100463596|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
33150028|NCT00736879|100463597|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
33150029|NCT00736879|100463594|FG000|Double Blind Treatment Period|Adverse Event|0|||
33150030|NCT00736879|100463595|FG001|Double Blind Treatment Period|Adverse Event|1|||
33150031|NCT00736879|100463596|FG002|Double Blind Treatment Period|Adverse Event|1|||
33384288|NCT00209170|101291573|FG001|Overall Study|Withdrawal by Subject|1|||
33384289|NCT00209170|101291572|FG000|Overall Study|Lack of Efficacy|0|||
33384290|NCT00209170|101291573|FG001|Overall Study|Lack of Efficacy|1|||
33432892|NCT01621490|101474474|FG010|Overall Study|Death|0|||
33432893|NCT01621490|101474464|FG000|Overall Study|Other reasons|7|||
33432894|NCT01621490|101474465|FG001|Overall Study|Other reasons|6|||
33432895|NCT01621490|101474466|FG002|Overall Study|Other reasons|4|||
33432896|NCT01621490|101474467|FG003|Overall Study|Other reasons|1|||
33432897|NCT01621490|101474468|FG004|Overall Study|Other reasons|1|||
33432898|NCT01621490|101474469|FG005|Overall Study|Other reasons|3|||
33648384|NCT03135119|102265600|FG001|Overall Study|Physician Decision|1|||
33648385|NCT03135119|102265599|FG000|Overall Study|COVID-19 Shutdown|2|||
33648386|NCT03135119|102265600|FG001|Overall Study|COVID-19 Shutdown|2|||
33384291|NCT03803202|101291577|FG000|Overall Study|Other|0|||
33384292|NCT03803202|101291578|FG001|Overall Study|Other|1|||
33384293|NCT03803202|101291579|FG002|Overall Study|Other|0|||
33384294|NCT03803202|101291580|FG003|Overall Study|Other|0|||
33384295|NCT03803202|101291581|FG004|Overall Study|Other|0|||
33384296|NCT03803202|101291582|FG005|Overall Study|Other|0|||
33384297|NCT03803202|101291583|FG006|Overall Study|Other|0|||
33384298|NCT03803202|101291584|FG007|Overall Study|Other|0|||
33384299|NCT03803202|101291585|FG008|Overall Study|Other|0|||
33384300|NCT03803202|101291577|FG000|Overall Study|Death|0|||
33384301|NCT03803202|101291578|FG001|Overall Study|Death|0|||
33384302|NCT03803202|101291579|FG002|Overall Study|Death|0|||
33384303|NCT03803202|101291580|FG003|Overall Study|Death|0|||
33384304|NCT03803202|101291581|FG004|Overall Study|Death|0|||
33384305|NCT03803202|101291582|FG005|Overall Study|Death|1|||
33384306|NCT03803202|101291583|FG006|Overall Study|Death|0|||
33384307|NCT03803202|101291584|FG007|Overall Study|Death|0|||
33384308|NCT03803202|101291585|FG008|Overall Study|Death|0|||
33384309|NCT03803202|101291577|FG000|Overall Study|Withdrawal by Subject|0|||
33384310|NCT03803202|101291578|FG001|Overall Study|Withdrawal by Subject|0|||
33384311|NCT03803202|101291579|FG002|Overall Study|Withdrawal by Subject|1|||
33384312|NCT03803202|101291580|FG003|Overall Study|Withdrawal by Subject|0|||
33384313|NCT03803202|101291581|FG004|Overall Study|Withdrawal by Subject|0|||
33384314|NCT03803202|101291582|FG005|Overall Study|Withdrawal by Subject|0|||
33384315|NCT03803202|101291583|FG006|Overall Study|Withdrawal by Subject|0|||
33384316|NCT03803202|101291584|FG007|Overall Study|Withdrawal by Subject|1|||
33384317|NCT03803202|101291585|FG008|Overall Study|Withdrawal by Subject|0|||
33384318|NCT03803202|101291577|FG000|Overall Study|Lost to Follow-up|0|||
33384319|NCT03803202|101291578|FG001|Overall Study|Lost to Follow-up|0|||
33384320|NCT03803202|101291579|FG002|Overall Study|Lost to Follow-up|0|||
33384321|NCT03803202|101291580|FG003|Overall Study|Lost to Follow-up|1|||
33384322|NCT03803202|101291581|FG004|Overall Study|Lost to Follow-up|1|||
33384323|NCT03803202|101291582|FG005|Overall Study|Lost to Follow-up|0|||
33384324|NCT03803202|101291583|FG006|Overall Study|Lost to Follow-up|1|||
33384325|NCT03803202|101291584|FG007|Overall Study|Lost to Follow-up|0|||
33384326|NCT03803202|101291585|FG008|Overall Study|Lost to Follow-up|0|||
33384327|NCT02146833|101291586|FG000|Overall Study|Death|10|||
33384328|NCT02146833|101291586|FG000|Overall Study|No longer consented to study treatment|1|||
33384329|NCT00719862|101291587|FG000|Overall Study|Adverse Event|1|||
33384330|NCT00719862|101291588|FG001|Overall Study|Adverse Event|2|||
33384331|NCT00719862|101291587|FG000|Overall Study|Lack of Efficacy|3|||
33384332|NCT00719862|101291588|FG001|Overall Study|Lack of Efficacy|0|||
33384333|NCT00719862|101291587|FG000|Overall Study|Non-Compliance|1|||
33384334|NCT00719862|101291588|FG001|Overall Study|Non-Compliance|0|||
33384335|NCT00719862|101291587|FG000|Overall Study|Withdrawal by Subject|1|||
33384336|NCT00719862|101291588|FG001|Overall Study|Withdrawal by Subject|0|||
33384337|NCT00719862|101291587|FG000|Overall Study|Lost to Follow-up|0|||
33384338|NCT00719862|101291588|FG001|Overall Study|Lost to Follow-up|1|||
33384339|NCT00719862|101291587|FG000|Overall Study|Other|2|||
33384340|NCT00719862|101291588|FG001|Overall Study|Other|3|||
33384341|NCT01946412|101291592|FG000|Overall Study|Adverse Event|1|||
33384342|NCT01946412|101291592|FG000|Overall Study|Non-Compliance|1|||
33384343|NCT01946412|101291592|FG000|Overall Study|Continued with commercial Kalydeco|2|||
33384344|NCT01946412|101291592|FG000|Overall Study|Difficulty in swallowing|1|||
33384345|NCT02670915|101291593|FG000|Overall Study|Withdrawal by Subject|0|||
33384346|NCT02670915|101291594|FG001|Overall Study|Withdrawal by Subject|1|||
33384347|NCT02670915|101291595|FG002|Overall Study|Withdrawal by Subject|4|||
33384348|NCT02670915|101291593|FG000|Overall Study|Withdrawal by parent/guardian|4|||
33384349|NCT02670915|101291594|FG001|Overall Study|Withdrawal by parent/guardian|4|||
33384350|NCT02670915|101291595|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33384351|NCT02670915|101291593|FG000|Overall Study|Unclassified|0|||
33384352|NCT02670915|101291594|FG001|Overall Study|Unclassified|3|||
33384353|NCT02670915|101291595|FG002|Overall Study|Unclassified|0|||
33384354|NCT00376246|101291600|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
33384355|NCT00376246|101291601|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
33432899|NCT01621490|101474470|FG006|Overall Study|Other reasons|1|||
33432900|NCT01621490|101474471|FG007|Overall Study|Other reasons|1|||
33432901|NCT01621490|101474472|FG008|Overall Study|Other reasons|1|||
33384356|NCT00376246|101291600|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
33384357|NCT00376246|101291601|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
33432902|NCT01621490|101474473|FG009|Overall Study|Other reasons|0|||
33432903|NCT01621490|101474474|FG010|Overall Study|Other reasons|0|||
33432904|NCT02750761|101474475|FG000|Overall Study|Lost to Follow-up|0|||
33432905|NCT02750761|101474476|FG001|Overall Study|Lost to Follow-up|0|||
33432906|NCT02750761|101474477|FG002|Overall Study|Lost to Follow-up|1|||
33432907|NCT02750761|101474478|FG003|Overall Study|Lost to Follow-up|0|||
33432908|NCT02750761|101474479|FG004|Overall Study|Lost to Follow-up|0|||
33432909|NCT02750761|101474480|FG005|Overall Study|Lost to Follow-up|0|||
33432910|NCT01909466|101474481|FG000|Overall Study|Lost to Follow-up|5|||
33432911|NCT01909466|101474482|FG001|Overall Study|Lost to Follow-up|7|||
33432912|NCT01909466|101474481|FG000|Overall Study|Adverse Event|3|||
33432913|NCT01909466|101474482|FG001|Overall Study|Adverse Event|4|||
33432914|NCT01909466|101474481|FG000|Overall Study|Met Withdrawal Criteria|0|||
33432915|NCT01909466|101474482|FG001|Overall Study|Met Withdrawal Criteria|3|||
33432916|NCT01909466|101474481|FG000|Overall Study|Physician Decision|2|||
33432917|NCT01909466|101474482|FG001|Overall Study|Physician Decision|0|||
33432918|NCT01909466|101474481|FG000|Overall Study|Withdrawal by Subject|11|||
33432919|NCT01909466|101474482|FG001|Overall Study|Withdrawal by Subject|9|||
33432920|NCT01909466|101474481|FG000|Overall Study|Lack of Efficacy|1|||
33648387|NCT00724711|102265602|FG000|Overall Study|Adverse Event|7|||
33648388|NCT00724711|102265603|FG001|Overall Study|Adverse Event|3|||
33384358|NCT00376246|101291600|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
33384359|NCT00376246|101291601|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
33384360|NCT01896856|101291602|FG000|Overall Study|Transportation issues / Non-compliance|0|||
33384361|NCT01896856|101291603|FG001|Overall Study|Transportation issues / Non-compliance|0|||
33384362|NCT01896856|101291604|FG002|Overall Study|Transportation issues / Non-compliance|1|||
33384363|NCT01896856|101291605|FG003|Overall Study|Transportation issues / Non-compliance|0|||
33384364|NCT01896856|101291606|FG004|Overall Study|Transportation issues / Non-compliance|0|||
33384365|NCT01896856|101291607|FG005|Overall Study|Transportation issues / Non-compliance|0|||
33384366|NCT01181778|101291612|FG000|Overall Study|Physician Decision|48|||
33384367|NCT02447458|101291613|FG000|Overall Study|Other|0|||
33384368|NCT02447458|101291614|FG001|Overall Study|Other|0|||
33384369|NCT02447458|101291615|FG002|Overall Study|Other|1|||
33384370|NCT02447458|101291616|FG003|Overall Study|Other|0|||
33384371|NCT02447458|101291617|FG004|Overall Study|Other|0|||
33384372|NCT02447458|101291618|FG005|Overall Study|Other|0|||
33384373|NCT01335698|101291619|FG000|Treatment Stage 1|Lack of Efficacy|3|||
33384374|NCT01335698|101291620|FG001|Treatment Stage 1|Lack of Efficacy|1|||
33384375|NCT01335698|101291621|FG002|Treatment Stage 1|Lack of Efficacy|3|||
33384376|NCT01335698|101291622|FG003|Treatment Stage 1|Lack of Efficacy|3|||
33384377|NCT01335698|101291623|FG004|Treatment Stage 1|Lack of Efficacy|1|||
33384378|NCT01335698|101291619|FG000|Treatment Stage 1|Adverse Event|1|||
33384379|NCT01335698|101291620|FG001|Treatment Stage 1|Adverse Event|2|||
33384380|NCT01335698|101291621|FG002|Treatment Stage 1|Adverse Event|2|||
33384381|NCT01335698|101291622|FG003|Treatment Stage 1|Adverse Event|1|||
33384382|NCT01335698|101291623|FG004|Treatment Stage 1|Adverse Event|1|||
33384383|NCT01335698|101291619|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
33384384|NCT01335698|101291620|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
33384385|NCT01335698|101291621|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
33384386|NCT01335698|101291622|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
33384387|NCT01335698|101291623|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
33384388|NCT01335698|101291619|FG000|Treatment Stage 1|Lost to Follow-up|1|||
33384389|NCT01335698|101291620|FG001|Treatment Stage 1|Lost to Follow-up|1|||
33384390|NCT01335698|101291621|FG002|Treatment Stage 1|Lost to Follow-up|0|||
33384391|NCT01335698|101291622|FG003|Treatment Stage 1|Lost to Follow-up|0|||
33384392|NCT01335698|101291623|FG004|Treatment Stage 1|Lost to Follow-up|0|||
33384393|NCT01335698|101291619|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
33384394|NCT01335698|101291620|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
33384395|NCT01335698|101291621|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
33384396|NCT01335698|101291622|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
33384397|NCT01335698|101291623|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
33384398|NCT01335698|101291619|FG000|Treatment Stage 1|No longer meets study criteria|1|||
33384399|NCT01335698|101291620|FG001|Treatment Stage 1|No longer meets study criteria|1|||
33384400|NCT01335698|101291621|FG002|Treatment Stage 1|No longer meets study criteria|0|||
33384401|NCT01335698|101291622|FG003|Treatment Stage 1|No longer meets study criteria|1|||
33384402|NCT01335698|101291623|FG004|Treatment Stage 1|No longer meets study criteria|0|||
33384403|NCT01335698|101291619|FG000|Treatment Stage 1|Other|1|||
33384404|NCT01335698|101291620|FG001|Treatment Stage 1|Other|0|||
33384405|NCT01335698|101291621|FG002|Treatment Stage 1|Other|0|||
33384406|NCT01335698|101291622|FG003|Treatment Stage 1|Other|1|||
33384407|NCT01335698|101291623|FG004|Treatment Stage 1|Other|0|||
33384408|NCT01335698|101291619|FG000|Treatment Stage 2|Lack of Efficacy|2|||
33432921|NCT01909466|101474482|FG001|Overall Study|Lack of Efficacy|0|||
33648389|NCT00724711|102265602|FG000|Overall Study|Pregnancy|0|||
33384409|NCT01335698|101291620|FG001|Treatment Stage 2|Lack of Efficacy|1|||
33432922|NCT03937466|101474485|FG000|Overall Study|not eligbile after the 2-week diary|9|||
33432923|NCT03937466|101474485|FG000|Overall Study|never returned their diary|6|||
33432924|NCT03937466|101474485|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
33432925|NCT03937466|101474485|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
33432926|NCT04583579|101474486|FG000|Overall Study|Lost to Follow-up|4|||
33432927|NCT02497781|101474493|FG000|Overall Study|Withdrawal by Subject|2|||
33432928|NCT02497781|101474494|FG001|Overall Study|Withdrawal by Subject|0|||
33432929|NCT02497781|101474493|FG000|Overall Study|Lack of Efficacy|0|||
33432930|NCT02497781|101474494|FG001|Overall Study|Lack of Efficacy|1|||
33432931|NCT02497781|101474493|FG000|Overall Study|Randomised but not treated|1|||
33432932|NCT02497781|101474494|FG001|Overall Study|Randomised but not treated|1|||
33432933|NCT02497781|101474493|FG000|Overall Study|Lost to Follow-up|1|||
33432934|NCT02497781|101474494|FG001|Overall Study|Lost to Follow-up|1|||
33432935|NCT01185288|101476693|FG000|Overall Study|Adverse Event|7|||
33432936|NCT01185288|101476694|FG001|Overall Study|Adverse Event|6|||
33432937|NCT01185288|101476693|FG000|Overall Study|Withdrawal by Subject|6|||
33432938|NCT01185288|101476694|FG001|Overall Study|Withdrawal by Subject|4|||
33432939|NCT01185288|101476693|FG000|Overall Study|Lost to Follow-up|2|||
33432940|NCT01185288|101476694|FG001|Overall Study|Lost to Follow-up|5|||
33432941|NCT01185288|101476693|FG000|Overall Study|Lack of Efficacy|2|||
33432942|NCT01185288|101476694|FG001|Overall Study|Lack of Efficacy|0|||
33432943|NCT01185288|101476693|FG000|Overall Study|Investigator discretion|1|||
33432944|NCT01185288|101476694|FG001|Overall Study|Investigator discretion|0|||
33432945|NCT01185288|101476693|FG000|Overall Study|Did not meet inclusion criteria|1|||
33432946|NCT01185288|101476694|FG001|Overall Study|Did not meet inclusion criteria|0|||
33432947|NCT01185288|101476693|FG000|Overall Study|Noncompliance|0|||
33432948|NCT01185288|101476694|FG001|Overall Study|Noncompliance|1|||
33432949|NCT01193608|101476695|FG000|Overall Study|Other|0|||
33432950|NCT01193608|101476696|FG001|Overall Study|Other|1|||
33432951|NCT01193608|101476697|FG002|Overall Study|Other|0|||
33432952|NCT01193608|101476698|FG003|Overall Study|Other|0|||
33432953|NCT01193608|101476699|FG004|Overall Study|Other|0|||
33432954|NCT01193608|101476700|FG005|Overall Study|Other|0|||
33432955|NCT01193608|101476695|FG000|Overall Study|Withdrawal by Subject|0|||
33432956|NCT01193608|101476696|FG001|Overall Study|Withdrawal by Subject|1|||
33432957|NCT01193608|101476697|FG002|Overall Study|Withdrawal by Subject|2|||
33432958|NCT01193608|101476698|FG003|Overall Study|Withdrawal by Subject|3|||
33432959|NCT01193608|101476699|FG004|Overall Study|Withdrawal by Subject|3|||
33432960|NCT01193608|101476700|FG005|Overall Study|Withdrawal by Subject|0|||
33432961|NCT01193608|101476695|FG000|Overall Study|Lost to Follow-up|0|||
33432962|NCT01193608|101476696|FG001|Overall Study|Lost to Follow-up|0|||
33432963|NCT01193608|101476697|FG002|Overall Study|Lost to Follow-up|0|||
33432964|NCT01193608|101476698|FG003|Overall Study|Lost to Follow-up|0|||
33432965|NCT01193608|101476699|FG004|Overall Study|Lost to Follow-up|1|||
33432966|NCT01193608|101476700|FG005|Overall Study|Lost to Follow-up|2|||
33588399|NCT02993822|102041828|FG001|Overall Study|Withdrawal by Subject|2|||
33588400|NCT02993822|102041829|FG002|Overall Study|Withdrawal by Subject|2|||
33588401|NCT02993822|102041830|FG003|Overall Study|Withdrawal by Subject|3|||
33588402|NCT02993822|102041827|FG000|Overall Study|Lost to Follow-up|1|||
33588403|NCT02993822|102041828|FG001|Overall Study|Lost to Follow-up|0|||
33588404|NCT02993822|102041829|FG002|Overall Study|Lost to Follow-up|1|||
33588405|NCT02993822|102041830|FG003|Overall Study|Lost to Follow-up|0|||
33588406|NCT02461290|102041837|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
33588407|NCT02461290|102041837|FG000|Overall Study|Lost to Follow-up|3|||
33588408|NCT04776720|102041838|FG000|Overall Study|COVID Related|4|||
33588409|NCT04776720|102041839|FG001|Overall Study|COVID Related|2|||
33588410|NCT04776720|102041838|FG000|Overall Study|Adverse Event|2|||
33588411|NCT04776720|102041839|FG001|Overall Study|Adverse Event|0|||
33588412|NCT04776720|102041838|FG000|Overall Study|Serious Adverse Event|0|||
33588413|NCT04776720|102041839|FG001|Overall Study|Serious Adverse Event|1|||
33588414|NCT04776720|102041838|FG000|Overall Study|Too Busy|3|||
33588415|NCT04776720|102041839|FG001|Overall Study|Too Busy|1|||
33588416|NCT04776720|102041838|FG000|Overall Study|Lost to Follow-up|1|||
33588417|NCT04776720|102041839|FG001|Overall Study|Lost to Follow-up|2|||
33588418|NCT04776720|102041838|FG000|Overall Study|Family|2|||
33588419|NCT04776720|102041839|FG001|Overall Study|Family|2|||
33588420|NCT04776720|102041838|FG000|Overall Study|No remote technology access|0|||
33432967|NCT01193608|101476695|FG000|Overall Study|Adverse Event|0|||
33432968|NCT01193608|101476696|FG001|Overall Study|Adverse Event|0|||
33432969|NCT01193608|101476697|FG002|Overall Study|Adverse Event|0|||
33588421|NCT04776720|102041839|FG001|Overall Study|No remote technology access|1|||
33432970|NCT01193608|101476698|FG003|Overall Study|Adverse Event|0|||
33432971|NCT01193608|101476699|FG004|Overall Study|Adverse Event|1|||
33432972|NCT01193608|101476700|FG005|Overall Study|Adverse Event|0|||
33588422|NCT04776720|102041838|FG000|Overall Study|Withdrawal by Subject|1|||
33588423|NCT04776720|102041839|FG001|Overall Study|Withdrawal by Subject|0|||
33432973|NCT01400113|101476701|FG000|Overall Study|Withdrawal by Subject|1|||
33432974|NCT01400113|101476702|FG001|Overall Study|Withdrawal by Subject|1|||
33432975|NCT01927757|101476703|FG000|Overall Study|Withdrawal by Subject|14|||
33588424|NCT04776720|102041838|FG000|Overall Study|Cannot tolerate intervention|1|||
33648390|NCT00724711|102265603|FG001|Overall Study|Pregnancy|1|||
33432976|NCT01927757|101476703|FG000|Overall Study|Lost to Follow-up|2|||
33432977|NCT01927757|101476703|FG000|Overall Study|Decision by Sponsor|2|||
33432978|NCT01927757|101476703|FG000|Overall Study|Other|1|||
33432979|NCT01927757|101476703|FG000|Overall Study|Ethical Reasons|4|||
33432980|NCT03294538|101476707|FG000|Overall Study|Adverse Event|0|||
33432981|NCT03294538|101476708|FG001|Overall Study|Adverse Event|1|||
33432982|NCT03294538|101476709|FG002|Overall Study|Adverse Event|1|||
33432983|NCT03294538|101476707|FG000|Overall Study|Lost to Follow-up|1|||
33432984|NCT03294538|101476708|FG001|Overall Study|Lost to Follow-up|0|||
33432985|NCT03294538|101476709|FG002|Overall Study|Lost to Follow-up|0|||
33432986|NCT03294538|101476707|FG000|Overall Study|Outside of Visit Window|4|||
33432987|NCT03294538|101476708|FG001|Overall Study|Outside of Visit Window|4|||
33432988|NCT03294538|101476709|FG002|Overall Study|Outside of Visit Window|1|||
33432989|NCT02507375|101476715|FG000|Overall Study|Progressive Disease|4|||
33432990|NCT02507375|101476716|FG001|Overall Study|Progressive Disease|5|||
33432991|NCT02507375|101476715|FG000|Overall Study|Death|0|||
33432992|NCT02507375|101476716|FG001|Overall Study|Death|1|||
33432993|NCT02507375|101476715|FG000|Overall Study|Refused treatment|0|||
33432994|NCT02507375|101476716|FG001|Overall Study|Refused treatment|1|||
33432995|NCT02507375|101476715|FG000|Overall Study|Adverse Event|0|||
33432996|NCT02507375|101476716|FG001|Overall Study|Adverse Event|1|||
33588425|NCT04776720|102041839|FG001|Overall Study|Cannot tolerate intervention|0|||
33588426|NCT04776720|102041838|FG000|Overall Study|Incomplete outcome data|6|||
33588427|NCT04776720|102041839|FG001|Overall Study|Incomplete outcome data|1|||
33588428|NCT03419897|102041840|FG000|Overall Study|Death|180|||
33588429|NCT03419897|102041840|FG000|Overall Study|Lost to Follow-up|1|||
33150032|NCT00736879|100463597|FG003|Double Blind Treatment Period|Adverse Event|0|||
33150033|NCT00736879|100463594|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
33249624|NCT01212757|100814520|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
33249625|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33249626|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33249627|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33249628|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33249629|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33432997|NCT00901628|101476719|FG000|Overall Study|disconnection of catheter|4|||
33432998|NCT00901628|101476720|FG001|Overall Study|disconnection of catheter|8|||
33432999|NCT00901628|101476719|FG000|Overall Study|disconnection of drain|0|||
33433000|NCT00901628|101476720|FG001|Overall Study|disconnection of drain|1|||
33433001|NCT00901628|101476719|FG000|Overall Study|peroneal nerve palsy|0|||
33433002|NCT00901628|101476720|FG001|Overall Study|peroneal nerve palsy|1|||
33433003|NCT00135707|101476723|FG000|Overall Study|Lost to Follow-up|94|||
33433004|NCT00135707|101476724|FG001|Overall Study|Lost to Follow-up|89|||
33433005|NCT00135707|101476723|FG000|Overall Study|Withdrawal by Subject|0|||
33433006|NCT00135707|101476724|FG001|Overall Study|Withdrawal by Subject|1|||
33433007|NCT00135707|101476723|FG000|Overall Study|Institutional review board request|1|||
33433008|NCT00135707|101476724|FG001|Overall Study|Institutional review board request|0|||
33433009|NCT02524379|101476725|FG000|Overall Study|Death|1|||
33433010|NCT00265759|101476726|FG000|Overall Study|Withdrawal by Subject|0|||
33433011|NCT00265759|101476727|FG001|Overall Study|Withdrawal by Subject|1|||
33433012|NCT00265759|101476728|FG002|Overall Study|Withdrawal by Subject|2|||
33433013|NCT00265759|101476729|FG003|Overall Study|Withdrawal by Subject|2|||
33433014|NCT00265759|101476726|FG000|Overall Study|Cancel|0|||
33433015|NCT00265759|101476727|FG001|Overall Study|Cancel|0|||
33433016|NCT00265759|101476728|FG002|Overall Study|Cancel|0|||
33433017|NCT00265759|101476729|FG003|Overall Study|Cancel|3|||
33433018|NCT00265759|101476726|FG000|Overall Study|Ineligible|0|||
33433019|NCT00265759|101476727|FG001|Overall Study|Ineligible|0|||
33433020|NCT00265759|101476728|FG002|Overall Study|Ineligible|0|||
33433021|NCT00265759|101476729|FG003|Overall Study|Ineligible|1|||
33433022|NCT00265759|101476726|FG000|Overall Study|Bilateral disease|0|||
33433023|NCT00265759|101476727|FG001|Overall Study|Bilateral disease|0|||
33433024|NCT00265759|101476728|FG002|Overall Study|Bilateral disease|0|||
33433025|NCT00265759|101476729|FG003|Overall Study|Bilateral disease|2|||
33433026|NCT00265759|101476726|FG000|Overall Study|Discontinued due to intolerability|0|||
33588430|NCT03419897|102041840|FG000|Overall Study|Withdrawal by Subject|6|||
33433027|NCT00265759|101476727|FG001|Overall Study|Discontinued due to intolerability|0|||
33433028|NCT00265759|101476728|FG002|Overall Study|Discontinued due to intolerability|0|||
33433029|NCT00265759|101476729|FG003|Overall Study|Discontinued due to intolerability|1|||
33433030|NCT00796510|101476732|FG000|Overall Study|Death|1|||
33433031|NCT00796510|101476733|FG001|Overall Study|Death|0|||
33433032|NCT00796510|101476732|FG000|Overall Study|Study Terminated|2|||
33249630|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33433033|NCT00796510|101476733|FG001|Overall Study|Study Terminated|0|||
33433034|NCT01797120|101476736|FG000|Overall Study|Disesae progression|37|||
33433035|NCT01797120|101476737|FG001|Overall Study|Disesae progression|49|||
33433036|NCT01797120|101476736|FG000|Overall Study|Adverse Event|13|||
33433037|NCT01797120|101476737|FG001|Overall Study|Adverse Event|5|||
33433038|NCT01797120|101476736|FG000|Overall Study|Withdrawal by Subject|6|||
33433039|NCT01797120|101476737|FG001|Overall Study|Withdrawal by Subject|6|||
33433040|NCT01797120|101476736|FG000|Overall Study|Symptomatic progression|2|||
33588431|NCT03419897|102041840|FG000|Overall Study|Sponsor Decision|61|||
33588432|NCT03419897|102041840|FG000|Overall Study|Physician Decision|1|||
33588433|NCT01709110|102041844|FG000|Overall Study|Adverse Event|56|||
33588434|NCT01709110|102041845|FG001|Overall Study|Adverse Event|48|||
33588435|NCT01709110|102041844|FG000|Overall Study|Death|14|||
33588436|NCT01709110|102041845|FG001|Overall Study|Death|6|||
33588437|NCT01709110|102041844|FG000|Overall Study|Lost to Follow-up|7|||
33588438|NCT01709110|102041845|FG001|Overall Study|Lost to Follow-up|5|||
33588439|NCT01709110|102041844|FG000|Overall Study|Protocol Violation|4|||
33588440|NCT01709110|102041845|FG001|Overall Study|Protocol Violation|6|||
33588441|NCT01709110|102041844|FG000|Overall Study|Withdrawal by Subject|96|||
33588442|NCT01709110|102041845|FG001|Overall Study|Withdrawal by Subject|89|||
33588443|NCT01709110|102041844|FG000|Overall Study|Physician Decision|4|||
33588444|NCT01709110|102041845|FG001|Overall Study|Physician Decision|10|||
33588445|NCT01709110|102041844|FG000|Overall Study|Sponsor Decision|2|||
33588446|NCT01709110|102041845|FG001|Overall Study|Sponsor Decision|2|||
33588447|NCT01709110|102041844|FG000|Overall Study|Lack of Efficacy|1|||
33588448|NCT01709110|102041845|FG001|Overall Study|Lack of Efficacy|1|||
33588449|NCT01709110|102041844|FG000|Overall Study|Caregiver Decision|1|||
33588450|NCT01709110|102041845|FG001|Overall Study|Caregiver Decision|1|||
33588451|NCT02379988|102041848|FG000|Overall Study|Not eligible|1|||
33588452|NCT01986231|102041849|FG000|Overall Study|Adverse Event|1|||
33588453|NCT03037476|102041852|FG000|Overall Study|Lost to Follow-up|63|||
33588454|NCT03037476|102041853|FG001|Overall Study|Lost to Follow-up|46|||
33588455|NCT00564902|102041854|FG000|Overall Study|Withdrawal by Subject|0|||
33588456|NCT00564902|102041855|FG001|Overall Study|Withdrawal by Subject|3|||
33588457|NCT00564902|102041856|FG002|Overall Study|Withdrawal by Subject|4|||
33588458|NCT00564902|102041854|FG000|Overall Study|Death|1|||
33588459|NCT00564902|102041855|FG001|Overall Study|Death|1|||
33588460|NCT00564902|102041856|FG002|Overall Study|Death|0|||
33588461|NCT03983382|102041857|FG000|Overall Study|Death|1|||
33588462|NCT03983382|102041857|FG000|Overall Study|Lost to Follow-up|3|||
33588463|NCT03983382|102041857|FG000|Overall Study|Physician Decision|2|||
33588464|NCT03983382|102041857|FG000|Overall Study|Withdrawal by Subject|10|||
33588465|NCT03983382|102041857|FG000|Overall Study|Change in cancer treatment|2|||
33588466|NCT01606176|102041858|FG000|Overall Study|Adverse Event|2|||
33588467|NCT01606176|102041859|FG001|Overall Study|Adverse Event|3|||
33588468|NCT01606176|102041858|FG000|Overall Study|Disease progression|1|||
33588469|NCT01606176|102041859|FG001|Overall Study|Disease progression|0|||
33588470|NCT01606176|102041858|FG000|Overall Study|Withdrawal by Subject|1|||
33588471|NCT01606176|102041859|FG001|Overall Study|Withdrawal by Subject|0|||
33588472|NCT01164891|102041869|FG000|Overall Study|Disease Progression|5|||
33588473|NCT01164891|102041869|FG000|Overall Study|Adverse Event|1|||
33588474|NCT00526656|102041870|FG000|Overall Study|Death|1|||
33588475|NCT00526656|102041870|FG000|Overall Study|Refused surgery|1|||
33588476|NCT01252186|102041871|FG000|Overall Study|Adverse Event|9|||
33588477|NCT01252186|102041872|FG001|Overall Study|Adverse Event|6|||
33588478|NCT01252186|102041873|FG002|Overall Study|Adverse Event|8|||
33588479|NCT01252186|102041871|FG000|Overall Study|Withdrawal by Subject|2|||
33588480|NCT01252186|102041872|FG001|Overall Study|Withdrawal by Subject|5|||
33588481|NCT01252186|102041873|FG002|Overall Study|Withdrawal by Subject|2|||
33433041|NCT01797120|101476737|FG001|Overall Study|Symptomatic progression|1|||
33433042|NCT01797120|101476736|FG000|Overall Study|Non-compliance|1|||
33433043|NCT01797120|101476737|FG001|Overall Study|Non-compliance|0|||
33433044|NCT01797120|101476736|FG000|Overall Study|Physician Decision|3|||
33433045|NCT01797120|101476737|FG001|Overall Study|Physician Decision|0|||
33433046|NCT01797120|101476736|FG000|Overall Study|still on treatment|2|||
33588482|NCT01252186|102041871|FG000|Overall Study|Physician Decision|0|||
33588483|NCT01252186|102041872|FG001|Overall Study|Physician Decision|0|||
33588484|NCT01252186|102041873|FG002|Overall Study|Physician Decision|1|||
33588485|NCT01252186|102041871|FG000|Overall Study|Non-compliance|0|||
33588486|NCT01252186|102041872|FG001|Overall Study|Non-compliance|3|||
33588487|NCT01252186|102041873|FG002|Overall Study|Non-compliance|4|||
33588488|NCT01252186|102041871|FG000|Overall Study|Protocol Violation|0|||
33588489|NCT01252186|102041872|FG001|Overall Study|Protocol Violation|0|||
33588490|NCT01252186|102041873|FG002|Overall Study|Protocol Violation|1|||
33588491|NCT01252186|102041871|FG000|Overall Study|Pregnancy|2|||
33588492|NCT01252186|102041872|FG001|Overall Study|Pregnancy|2|||
33588493|NCT01252186|102041873|FG002|Overall Study|Pregnancy|0|||
33588494|NCT01252186|102041871|FG000|Overall Study|Sponsor Request|2|||
33588495|NCT01252186|102041872|FG001|Overall Study|Sponsor Request|1|||
33588496|NCT01252186|102041873|FG002|Overall Study|Sponsor Request|0|||
33150034|NCT00736879|100463595|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
33433047|NCT01797120|101476737|FG001|Overall Study|still on treatment|4|||
33588497|NCT01252186|102041871|FG000|Overall Study|Lost to Follow-up|10|||
33433048|NCT01797120|101476736|FG000|Overall Study|never start protocol therapy|2|||
33588498|NCT01252186|102041872|FG001|Overall Study|Lost to Follow-up|10|||
33588499|NCT01252186|102041873|FG002|Overall Study|Lost to Follow-up|11|||
33588500|NCT01252186|102041871|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
33588501|NCT01252186|102041872|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
33588502|NCT01252186|102041873|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
33588503|NCT00623233|102041874|FG000|Overall Study|Adverse Event|10|||
33588504|NCT00623233|102041874|FG000|Overall Study|Physician Decision|10|||
33588505|NCT00623233|102041874|FG000|Overall Study|Lost to Follow-up|1|||
33588506|NCT00623233|102041874|FG000|Overall Study|Withdrawal by Subject|3|||
33588507|NCT01813058|102041875|FG000|Overall Study|Withdrawal by Subject|5|||
33588508|NCT01813058|102041876|FG001|Overall Study|Withdrawal by Subject|4|||
33588509|NCT00705250|102041877|FG000|Overall Study|Withdrawal by Subject|1|||
33588510|NCT00705250|102041877|FG000|Overall Study|Patient died in car accident|1|||
33588511|NCT00967694|102041878|FG000|Overall Study|Withdrawal by Subject|6|||
33588512|NCT03430843|102041879|FG000|Overall Study|Death|233|||
33588513|NCT03430843|102041880|FG001|Overall Study|Death|233|||
33588514|NCT03430843|102041879|FG000|Overall Study|Sponsor Decision|17|||
33588515|NCT03430843|102041880|FG001|Overall Study|Sponsor Decision|6|||
33588516|NCT03430843|102041879|FG000|Overall Study|Withdrawal by Subject|5|||
33588517|NCT03430843|102041880|FG001|Overall Study|Withdrawal by Subject|14|||
33588518|NCT03430843|102041879|FG000|Overall Study|Lost to Follow-up|1|||
33588519|NCT03430843|102041880|FG001|Overall Study|Lost to Follow-up|3|||
33588520|NCT03249909|102041885|FG000|Overall Study|Withdrawal by Subject|3|||
33588521|NCT03249909|102041886|FG001|Overall Study|Withdrawal by Subject|0|||
33588522|NCT03249909|102041887|FG002|Overall Study|Withdrawal by Subject|0|||
33588523|NCT03249909|102041885|FG000|Overall Study|Adverse Event|3|||
33588524|NCT03249909|102041886|FG001|Overall Study|Adverse Event|0|||
33588525|NCT03249909|102041887|FG002|Overall Study|Adverse Event|0|||
33150035|NCT00736879|100463596|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
33150036|NCT00736879|100463597|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
33150037|NCT00736879|100463594|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
33150038|NCT00736879|100463595|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
33150039|NCT00736879|100463596|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
33150040|NCT00736879|100463597|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
33150041|NCT00736879|100463594|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
33150042|NCT00736879|100463595|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
33150043|NCT00736879|100463596|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
33433049|NCT01797120|101476737|FG001|Overall Study|never start protocol therapy|0|||
33433050|NCT00522457|101476738|FG000|Overall Study|Due to disease progression|16|||
33433051|NCT00522457|101476738|FG000|Overall Study|Adverse Event|2|||
33433052|NCT00829413|101476739|FG000|Overall Study|No study drug admimnistered|13|||
33433053|NCT00829413|101476739|FG000|Overall Study|Training Patients|67|||
33433054|NCT00829413|101476739|FG000|Overall Study|No truth standard procedure available|9|||
33433055|NCT00829413|101476739|FG000|Overall Study|Technically inadequate truth standard|2|||
33433056|NCT00829413|101476739|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
33433057|NCT01844583|101476740|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
33433058|NCT01844583|101476741|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
33433059|NCT03347695|101476742|FG000|Overall Study|Death|0|||
33433060|NCT03347695|101476743|FG001|Overall Study|Death|4|||
33433061|NCT03347695|101476742|FG000|Overall Study|Lost to Follow-up|0|||
33433062|NCT03347695|101476743|FG001|Overall Study|Lost to Follow-up|1|||
33433063|NCT02486796|101476750|FG000|Overall Study|Withdrawal by Subject|1|||
33433064|NCT02486796|101476751|FG001|Overall Study|Withdrawal by Subject|1|||
33433065|NCT02486796|101476750|FG000|Overall Study|Physician Decision|1|||
33433066|NCT02486796|101476751|FG001|Overall Study|Physician Decision|0|||
33433067|NCT01626859|101476754|FG000|Overall Study|Adverse Event|1|||
33588526|NCT03249909|102041885|FG000|Overall Study|Lost to Follow-up|0|||
33588527|NCT03249909|102041886|FG001|Overall Study|Lost to Follow-up|1|||
33384410|NCT01335698|101291621|FG002|Treatment Stage 2|Lack of Efficacy|3|||
33384411|NCT01335698|101291622|FG003|Treatment Stage 2|Lack of Efficacy|1|||
33384412|NCT01335698|101291623|FG004|Treatment Stage 2|Lack of Efficacy|0|||
33384413|NCT01335698|101291619|FG000|Treatment Stage 2|Adverse Event|2|||
33384414|NCT01335698|101291620|FG001|Treatment Stage 2|Adverse Event|0|||
33384415|NCT01335698|101291621|FG002|Treatment Stage 2|Adverse Event|0|||
33384416|NCT01335698|101291622|FG003|Treatment Stage 2|Adverse Event|3|||
33384417|NCT01335698|101291623|FG004|Treatment Stage 2|Adverse Event|0|||
33384418|NCT01335698|101291619|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
33433068|NCT01626859|101476755|FG001|Overall Study|Adverse Event|3|||
33588528|NCT03249909|102041887|FG002|Overall Study|Lost to Follow-up|0|||
33588529|NCT05111002|102041888|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
33588530|NCT05111002|102041889|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
33384419|NCT01335698|101291620|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
33433069|NCT01626859|101476756|FG002|Overall Study|Adverse Event|2|||
33588531|NCT05111002|102041888|FG000|Secondary Outcome|Lost to Follow-up|1|||
33588532|NCT05111002|102041889|FG001|Secondary Outcome|Lost to Follow-up|0|||
33433070|NCT01626859|101476754|FG000|Overall Study|Physician Decision|0|||
33433071|NCT01626859|101476755|FG001|Overall Study|Physician Decision|1|||
33433072|NCT01626859|101476756|FG002|Overall Study|Physician Decision|0|||
33588533|NCT01524224|102041890|FG000|Overall Study|Progressive Disease|1|||
33588534|NCT01524224|102041891|FG001|Overall Study|Progressive Disease|0|||
33588535|NCT01524224|102041892|FG002|Overall Study|Progressive Disease|2|||
33588536|NCT01524224|102041893|FG003|Overall Study|Progressive Disease|1|||
33588537|NCT01524224|102041894|FG004|Overall Study|Progressive Disease|2|||
33588538|NCT01524224|102041895|FG005|Overall Study|Progressive Disease|1|||
33588539|NCT01524224|102041896|FG006|Overall Study|Progressive Disease|1|||
33588540|NCT01524224|102041897|FG007|Overall Study|Progressive Disease|5|||
33588541|NCT01524224|102041890|FG000|Overall Study|Withdrawal by Subject|2|||
33588542|NCT01524224|102041891|FG001|Overall Study|Withdrawal by Subject|0|||
33588543|NCT01524224|102041892|FG002|Overall Study|Withdrawal by Subject|0|||
33588544|NCT01524224|102041893|FG003|Overall Study|Withdrawal by Subject|0|||
33588545|NCT01524224|102041894|FG004|Overall Study|Withdrawal by Subject|0|||
33588546|NCT01524224|102041895|FG005|Overall Study|Withdrawal by Subject|0|||
33588547|NCT01524224|102041896|FG006|Overall Study|Withdrawal by Subject|2|||
33588548|NCT01524224|102041897|FG007|Overall Study|Withdrawal by Subject|0|||
33588549|NCT01524224|102041890|FG000|Overall Study|Adverse Event|0|||
33588550|NCT01524224|102041891|FG001|Overall Study|Adverse Event|1|||
33588551|NCT01524224|102041892|FG002|Overall Study|Adverse Event|0|||
33588552|NCT01524224|102041893|FG003|Overall Study|Adverse Event|0|||
33588553|NCT01524224|102041894|FG004|Overall Study|Adverse Event|0|||
33588554|NCT01524224|102041895|FG005|Overall Study|Adverse Event|1|||
33588555|NCT01524224|102041896|FG006|Overall Study|Adverse Event|0|||
33588556|NCT01524224|102041897|FG007|Overall Study|Adverse Event|0|||
33588557|NCT01524224|102041890|FG000|Overall Study|Physician Decision|0|||
33588558|NCT01524224|102041891|FG001|Overall Study|Physician Decision|0|||
33588559|NCT01524224|102041892|FG002|Overall Study|Physician Decision|0|||
33588560|NCT01524224|102041893|FG003|Overall Study|Physician Decision|1|||
33588561|NCT01524224|102041894|FG004|Overall Study|Physician Decision|1|||
33588562|NCT01524224|102041895|FG005|Overall Study|Physician Decision|0|||
33588563|NCT01524224|102041896|FG006|Overall Study|Physician Decision|0|||
33588564|NCT01524224|102041897|FG007|Overall Study|Physician Decision|1|||
33588565|NCT01524224|102041890|FG000|Overall Study|Sponsor Decision|0|||
33588566|NCT01524224|102041891|FG001|Overall Study|Sponsor Decision|0|||
33588567|NCT01524224|102041892|FG002|Overall Study|Sponsor Decision|0|||
33588568|NCT01524224|102041893|FG003|Overall Study|Sponsor Decision|0|||
33588569|NCT01524224|102041894|FG004|Overall Study|Sponsor Decision|1|||
33588570|NCT01524224|102041895|FG005|Overall Study|Sponsor Decision|0|||
33588571|NCT01524224|102041896|FG006|Overall Study|Sponsor Decision|0|||
33588572|NCT01524224|102041897|FG007|Overall Study|Sponsor Decision|0|||
33588573|NCT01562314|102041898|FG000|Overall Study|Adverse Event|10|||
33588574|NCT01562314|102041899|FG001|Overall Study|Adverse Event|5|||
33588575|NCT01562314|102041898|FG000|Overall Study|Met Withdrawal Criteria|3|||
33588576|NCT01562314|102041899|FG001|Overall Study|Met Withdrawal Criteria|2|||
33588577|NCT01562314|102041898|FG000|Overall Study|Withdrawal by Subject|0|||
33588578|NCT01562314|102041899|FG001|Overall Study|Withdrawal by Subject|1|||
33588579|NCT01066104|102041904|FG000|Overall Study|Adverse Event|1|||
33588580|NCT01066104|102041905|FG001|Overall Study|Adverse Event|1|||
33588581|NCT01066104|102041904|FG000|Overall Study|Protocol Violation|1|||
33588582|NCT01066104|102041905|FG001|Overall Study|Protocol Violation|0|||
33588583|NCT00613327|102041917|FG000|Overall Study|Adverse Event|38|||
33588584|NCT00613327|102041917|FG000|Overall Study|Lost to Follow-up|8|||
33588585|NCT00613327|102041917|FG000|Overall Study|Withdrawal by Subject|6|||
33588586|NCT00613327|102041917|FG000|Overall Study|Protocol Violation|2|||
33588587|NCT00613327|102041917|FG000|Overall Study|Other|47|||
33588588|NCT03268954|102041919|FG000|Overall Study|Ongoing|23|||
33588589|NCT03268954|102041920|FG001|Overall Study|Ongoing|31|||
33588590|NCT03268954|102041919|FG000|Overall Study|Adverse Event|53|||
33588591|NCT03268954|102041920|FG001|Overall Study|Adverse Event|62|||
33588592|NCT03268954|102041919|FG000|Overall Study|Withdrawal by Subject|25|||
33588593|NCT03268954|102041920|FG001|Overall Study|Withdrawal by Subject|16|||
33648391|NCT00724711|102265602|FG000|Overall Study|Lack of Efficacy|0|||
33588594|NCT03268954|102041919|FG000|Overall Study|Progressive Disease|61|||
33648392|NCT00724711|102265603|FG001|Overall Study|Lack of Efficacy|1|||
33648393|NCT00724711|102265602|FG000|Overall Study|Physician Decision|0|||
33648394|NCT00724711|102265603|FG001|Overall Study|Physician Decision|3|||
33588595|NCT03268954|102041920|FG001|Overall Study|Progressive Disease|48|||
33588596|NCT03268954|102041919|FG000|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|25|||
33588597|NCT03268954|102041920|FG001|Overall Study|Progression to Acute Myelogenous Leukemia (AML)|30|||
33588598|NCT03268954|102041919|FG000|Overall Study|Reason not Specified|40|||
33588599|NCT03268954|102041920|FG001|Overall Study|Reason not Specified|40|||
33588600|NCT03062280|102041921|FG000|Overall Study|Adverse Event|1|||
33588601|NCT03062280|102041921|FG000|Overall Study|Death|1|||
33648395|NCT00724711|102265602|FG000|Overall Study|Withdrawal by Subject|5|||
33648396|NCT00724711|102265603|FG001|Overall Study|Withdrawal by Subject|4|||
33648397|NCT00724711|102265602|FG000|Overall Study|Lost to Follow-up|4|||
33588602|NCT03062280|102041921|FG000|Overall Study|Fertility Treatment|2|||
33588603|NCT03062280|102041921|FG000|Overall Study|Physician Decision|2|||
33588604|NCT03062280|102041921|FG000|Overall Study|Pregnancy|5|||
33588605|NCT03062280|102041921|FG000|Overall Study|Withdrawal by Subject|11|||
33588606|NCT02684058|102041924|FG000|Treatment Period|Progressive disease|4|||
33588607|NCT02684058|102041925|FG001|Treatment Period|Progressive disease|10|||
33588608|NCT02684058|102041926|FG002|Treatment Period|Progressive disease|19|||
33588609|NCT02684058|102041924|FG000|Treatment Period|Adverse Event|3|||
33588610|NCT02684058|102041925|FG001|Treatment Period|Adverse Event|8|||
33588611|NCT02684058|102041926|FG002|Treatment Period|Adverse Event|1|||
33588612|NCT02684058|102041924|FG000|Treatment Period|Physician Decision|5|||
33588613|NCT02684058|102041925|FG001|Treatment Period|Physician Decision|1|||
33588614|NCT02684058|102041926|FG002|Treatment Period|Physician Decision|2|||
33588615|NCT02684058|102041924|FG000|Treatment Period|New therapy for study indication|1|||
33588616|NCT02684058|102041925|FG001|Treatment Period|New therapy for study indication|0|||
33648398|NCT00724711|102265603|FG001|Overall Study|Lost to Follow-up|5|||
33648399|NCT00724711|102265602|FG000|Overall Study|Protocol Violation|1|||
33648400|NCT00724711|102265603|FG001|Overall Study|Protocol Violation|0|||
33648401|NCT00363545|102265604|FG000|Overall Study|Serious Adverse Event|0|||
33648402|NCT00363545|102265605|FG001|Overall Study|Serious Adverse Event|1|||
33648403|NCT00363545|102265604|FG000|Overall Study|Withdrawal by Subject|12|||
33648404|NCT00363545|102265605|FG001|Overall Study|Withdrawal by Subject|15|||
33384420|NCT01335698|101291621|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
33384421|NCT01335698|101291622|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
33384422|NCT01335698|101291623|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
33384423|NCT01335698|101291619|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
33384424|NCT01335698|101291620|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
33384425|NCT01335698|101291621|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
33384426|NCT01335698|101291622|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
33384427|NCT01335698|101291623|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
33384428|NCT01335698|101291619|FG000|Treatment Stage 2|Lost to Follow-up|1|||
33384429|NCT01335698|101291620|FG001|Treatment Stage 2|Lost to Follow-up|0|||
33384430|NCT01335698|101291621|FG002|Treatment Stage 2|Lost to Follow-up|0|||
33384431|NCT01335698|101291622|FG003|Treatment Stage 2|Lost to Follow-up|0|||
33384432|NCT01335698|101291623|FG004|Treatment Stage 2|Lost to Follow-up|0|||
33384433|NCT01335698|101291619|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
33384434|NCT01335698|101291620|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
33384435|NCT01335698|101291621|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
33384436|NCT01335698|101291622|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
33384437|NCT01335698|101291623|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
33648405|NCT00363545|102265604|FG000|Overall Study|Migrated/moved from study area|3|||
33648406|NCT00363545|102265605|FG001|Overall Study|Migrated/moved from study area|6|||
33648407|NCT00363545|102265604|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
33648408|NCT00363545|102265605|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
33648409|NCT00363545|102265604|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
33648410|NCT00363545|102265605|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
33648411|NCT00363545|102265604|FG000|Overall Study|Others|1|||
33648412|NCT00363545|102265605|FG001|Overall Study|Others|0|||
33648413|NCT03087617|102265606|FG000|Overall Study|Lost to Follow-up|32|||
33648414|NCT03087617|102265607|FG001|Overall Study|Lost to Follow-up|30|||
33648415|NCT03087617|102265608|FG002|Overall Study|Lost to Follow-up|30|||
33648416|NCT03087617|102265609|FG003|Overall Study|Lost to Follow-up|39|||
33648417|NCT03060551|102265613|FG000|Overall Study|Withdrawal by Subject|1|||
33384438|NCT01335698|101291619|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
33384439|NCT01335698|101291620|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
33384440|NCT01335698|101291621|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
33384441|NCT01335698|101291622|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
33384442|NCT01335698|101291623|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
33384443|NCT01335698|101291619|FG000|Treatment Stage 2|Switched to another formulation|1|||
33384444|NCT01335698|101291620|FG001|Treatment Stage 2|Switched to another formulation|1|||
33384445|NCT01335698|101291621|FG002|Treatment Stage 2|Switched to another formulation|0|||
33384446|NCT01335698|101291622|FG003|Treatment Stage 2|Switched to another formulation|0|||
33384447|NCT01335698|101291623|FG004|Treatment Stage 2|Switched to another formulation|0|||
33384448|NCT00877006|101291626|FG000|Treatment Period|Death|2|||
33588617|NCT02684058|102041926|FG002|Treatment Period|New therapy for study indication|0|||
33588618|NCT02684058|102041924|FG000|Treatment Period|Protocol deviation|0|||
33384449|NCT00877006|101291627|FG001|Treatment Period|Death|1|||
33384450|NCT00877006|101291626|FG000|Treatment Period|Adverse Event|10|||
33384451|NCT00877006|101291627|FG001|Treatment Period|Adverse Event|3|||
33588619|NCT02684058|102041925|FG001|Treatment Period|Protocol deviation|1|||
33648418|NCT03060551|102265613|FG000|Overall Study|Adverse Event|1|||
33648419|NCT00200356|102265616|FG000|Overall Study|Lack of Efficacy|3|||
33648420|NCT00200356|102265617|FG001|Overall Study|Lack of Efficacy|3|||
33648421|NCT00200356|102265616|FG000|Overall Study|Protocol Violation|4|||
33648422|NCT00200356|102265617|FG001|Overall Study|Protocol Violation|4|||
33648423|NCT00200356|102265616|FG000|Overall Study|Nontreatment|1|||
33588620|NCT02684058|102041926|FG002|Treatment Period|Protocol deviation|0|||
33648424|NCT00200356|102265617|FG001|Overall Study|Nontreatment|0|||
33648425|NCT03319745|102265621|FG000|Overall Study|Death|1|||
33648426|NCT03319745|102265621|FG000|Overall Study|Toxicity Precluding Surgery|1|||
33648427|NCT04525885|102265622|FG000|Overall Study|Screen Failure|1|||
33648428|NCT04525885|102265623|FG001|Overall Study|Screen Failure|0|||
33648429|NCT04525885|102265624|FG002|Overall Study|Screen Failure|0|||
33648430|NCT04525885|102265622|FG000|Overall Study|Withdrawal by Subject|14|||
33648431|NCT04525885|102265623|FG001|Overall Study|Withdrawal by Subject|6|||
33648432|NCT04525885|102265624|FG002|Overall Study|Withdrawal by Subject|20|||
33648433|NCT04525885|102265622|FG000|Overall Study|Physician Decision|1|||
33648434|NCT04525885|102265623|FG001|Overall Study|Physician Decision|0|||
33648435|NCT04525885|102265624|FG002|Overall Study|Physician Decision|1|||
33648436|NCT00792571|102265625|FG000|Overall Study|Death|1|||
33648437|NCT00792571|102265625|FG000|Overall Study|Adverse Event|4|||
33648438|NCT00792571|102265625|FG000|Overall Study|Withdrawal by Subject|1|||
33648439|NCT00792571|102265625|FG000|Overall Study|Other|4|||
33648440|NCT03720652|102265631|FG000|Overall Study|Withdrawal by Subject|2|||
33648441|NCT03720652|102265632|FG001|Overall Study|Withdrawal by Subject|7|||
33648442|NCT03720652|102265631|FG000|Overall Study|Lost to Follow-up|0|||
33648443|NCT03720652|102265632|FG001|Overall Study|Lost to Follow-up|4|||
33648444|NCT01014910|102265633|FG000|Overall Study|Withdrawal by Subject|0|||
33648445|NCT01014910|102265634|FG001|Overall Study|Withdrawal by Subject|2|||
33150044|NCT00736879|100463597|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
33433073|NCT01626859|101476754|FG000|Overall Study|Withdrawal by Subject|1|||
33433074|NCT01626859|101476755|FG001|Overall Study|Withdrawal by Subject|4|||
33433075|NCT01626859|101476756|FG002|Overall Study|Withdrawal by Subject|2|||
33433076|NCT03305055|101476757|FG000|Overall Study|Withdrawal by Subject|0|||
33433077|NCT03305055|101476758|FG001|Overall Study|Withdrawal by Subject|1|||
33433078|NCT03305055|101476757|FG000|Overall Study|Adverse Event|1|||
33433079|NCT03305055|101476758|FG001|Overall Study|Adverse Event|1|||
33433080|NCT02729896|101476759|FG000|Overall Study|Death|0|||
33433081|NCT02729896|101476760|FG001|Overall Study|Death|2|||
33433082|NCT02729896|101476761|FG002|Overall Study|Death|13|||
33433083|NCT02729896|101476759|FG000|Overall Study|Lost to Follow-up|0|||
33433084|NCT02729896|101476760|FG001|Overall Study|Lost to Follow-up|2|||
33433085|NCT02729896|101476761|FG002|Overall Study|Lost to Follow-up|3|||
33433086|NCT02729896|101476759|FG000|Overall Study|Other|0|||
33433087|NCT02729896|101476760|FG001|Overall Study|Other|2|||
33433088|NCT02729896|101476761|FG002|Overall Study|Other|0|||
33433089|NCT02729896|101476759|FG000|Overall Study|Physician Decision|1|||
33433090|NCT02729896|101476760|FG001|Overall Study|Physician Decision|2|||
33433091|NCT02729896|101476761|FG002|Overall Study|Physician Decision|3|||
33433092|NCT02729896|101476759|FG000|Overall Study|Progressive Disease|0|||
33433093|NCT02729896|101476760|FG001|Overall Study|Progressive Disease|1|||
33433094|NCT02729896|101476761|FG002|Overall Study|Progressive Disease|0|||
33433095|NCT02729896|101476759|FG000|Overall Study|Withdrawal by Subject|1|||
33433096|NCT02729896|101476760|FG001|Overall Study|Withdrawal by Subject|0|||
33433097|NCT02729896|101476761|FG002|Overall Study|Withdrawal by Subject|3|||
33433098|NCT00449072|101476765|FG000|Overall Study|Adverse Event|3|||
33433099|NCT00449072|101476766|FG001|Overall Study|Adverse Event|1|||
33433100|NCT00449072|101476765|FG000|Overall Study|Protocol Violation|14|||
33433101|NCT00449072|101476766|FG001|Overall Study|Protocol Violation|12|||
33433102|NCT00449072|101476765|FG000|Overall Study|Lost to Follow-up|5|||
33433103|NCT00449072|101476766|FG001|Overall Study|Lost to Follow-up|7|||
33433104|NCT00449072|101476765|FG000|Overall Study|Withdrawal by Subject|11|||
33433105|NCT00449072|101476766|FG001|Overall Study|Withdrawal by Subject|8|||
33433106|NCT00449072|101476765|FG000|Overall Study|Lack of Efficacy|1|||
33433107|NCT00449072|101476766|FG001|Overall Study|Lack of Efficacy|1|||
33433108|NCT00449072|101476765|FG000|Overall Study|Physician Decision|1|||
33433109|NCT00449072|101476766|FG001|Overall Study|Physician Decision|0|||
33433110|NCT00449072|101476765|FG000|Overall Study|Not treated|0|||
33648446|NCT01181986|102265637|FG000|Phase 1|Lost to Follow-up|0|||
33648447|NCT01181986|102265638|FG001|Phase 1|Lost to Follow-up|1|||
33433111|NCT00449072|101476766|FG001|Overall Study|Not treated|1|||
33433112|NCT00449072|101476765|FG000|Overall Study|Excluded medication|0|||
33433113|NCT00449072|101476766|FG001|Overall Study|Excluded medication|2|||
33433114|NCT00449072|101476765|FG000|Overall Study|Non-compliance|2|||
33433115|NCT00449072|101476766|FG001|Overall Study|Non-compliance|5|||
33648448|NCT01181986|102265639|FG002|Phase 1|Lost to Follow-up|1|||
33648449|NCT01181986|102265637|FG000|Phase 1|Adverse Event|0|||
33648450|NCT01181986|102265638|FG001|Phase 1|Adverse Event|0|||
33648451|NCT01181986|102265639|FG002|Phase 1|Adverse Event|1|||
33150045|NCT00736879|100463594|FG000|Double Blind Treatment Period|No longer met criteria|0|||
33150046|NCT00736879|100463595|FG001|Double Blind Treatment Period|No longer met criteria|1|||
33433116|NCT00449072|101476765|FG000|Overall Study|Sponsor decision|1|||
33433117|NCT00449072|101476766|FG001|Overall Study|Sponsor decision|3|||
33433118|NCT00449072|101476765|FG000|Overall Study|Relocation|3|||
33433119|NCT00449072|101476766|FG001|Overall Study|Relocation|2|||
33433120|NCT01411995|101476767|FG000|Overall Study|Failed IUD insertion|0|||
33433121|NCT01411995|101476768|FG001|Overall Study|Failed IUD insertion|1|||
33588621|NCT02684058|102041924|FG000|Treatment Period|Subject/guardian decision|4|||
33588622|NCT02684058|102041925|FG001|Treatment Period|Subject/guardian decision|3|||
33588623|NCT02684058|102041926|FG002|Treatment Period|Subject/guardian decision|0|||
33588624|NCT02684058|102041924|FG000|Treatment Period|Death|0|||
33588625|NCT02684058|102041925|FG001|Treatment Period|Death|0|||
33588626|NCT02684058|102041926|FG002|Treatment Period|Death|2|||
33588627|NCT02684058|102041924|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
33588628|NCT02684058|102041925|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
33588629|NCT02684058|102041926|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
33588630|NCT02684058|102041924|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
33588631|NCT02684058|102041925|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
33588632|NCT02684058|102041926|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
33588633|NCT02684058|102041924|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
33588634|NCT02684058|102041925|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
33588635|NCT02684058|102041926|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
33588636|NCT02684058|102041924|FG000|Post-treatment Efficacy Follow-up|Death|0|||
33588637|NCT02684058|102041925|FG001|Post-treatment Efficacy Follow-up|Death|0|||
33588638|NCT02684058|102041926|FG002|Post-treatment Efficacy Follow-up|Death|3|||
33588639|NCT02684058|102041924|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
33588640|NCT02684058|102041925|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
33588641|NCT02684058|102041926|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
33588642|NCT02684058|102041924|FG000|Post-treatment Survival Follow-up|Death|0|||
33588643|NCT02684058|102041925|FG001|Post-treatment Survival Follow-up|Death|0|||
33588644|NCT02684058|102041926|FG002|Post-treatment Survival Follow-up|Death|7|||
33588645|NCT02684058|102041924|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
33588646|NCT02684058|102041925|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
33249631|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33249632|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
33433122|NCT00622908|101476771|FG000|Overall Study|Protocol Violation|1|||
33588647|NCT02684058|102041926|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
33588648|NCT02684058|102041924|FG000|Crossover Treatment Period|Progressive disease|0|||
33588649|NCT02684058|102041925|FG001|Crossover Treatment Period|Progressive disease|1|||
33588650|NCT02684058|102041926|FG002|Crossover Treatment Period|Progressive disease|0|||
33588651|NCT00316225|102041927|FG000|Overall Study|Adverse Event|2|||
33588652|NCT00316225|102041927|FG000|Overall Study|Physician Decision|3|||
33588653|NCT00316225|102041927|FG000|Overall Study|Progressive Disease|15|||
33588654|NCT00316225|102041927|FG000|Overall Study|Withdrawal by Subject|3|||
33588655|NCT00316225|102041927|FG000|Overall Study|Death|2|||
33588656|NCT01096368|102041928|FG000|Overall Study|Death|0|||
33588657|NCT01096368|102041929|FG001|Overall Study|Death|1|||
33588658|NCT01096368|102041930|FG002|Overall Study|Death|0|||
33588659|NCT01096368|102041931|FG003|Overall Study|Death|0|||
33588660|NCT01096368|102041932|FG004|Overall Study|Death|0|||
33588661|NCT01096368|102041928|FG000|Overall Study|Physician Decision|0|||
33588662|NCT01096368|102041929|FG001|Overall Study|Physician Decision|13|||
33588663|NCT01096368|102041930|FG002|Overall Study|Physician Decision|2|||
33588664|NCT01096368|102041931|FG003|Overall Study|Physician Decision|4|||
33588665|NCT01096368|102041932|FG004|Overall Study|Physician Decision|6|||
33588666|NCT01096368|102041928|FG000|Overall Study|Withdrawal by Subject|0|||
33588667|NCT01096368|102041929|FG001|Overall Study|Withdrawal by Subject|52|||
33588668|NCT01096368|102041930|FG002|Overall Study|Withdrawal by Subject|0|||
33588669|NCT01096368|102041931|FG003|Overall Study|Withdrawal by Subject|10|||
33588670|NCT01096368|102041932|FG004|Overall Study|Withdrawal by Subject|14|||
33588671|NCT01096368|102041928|FG000|Overall Study|Ineligible|0|||
33588672|NCT01096368|102041929|FG001|Overall Study|Ineligible|3|||
33588673|NCT01096368|102041930|FG002|Overall Study|Ineligible|2|||
33588674|NCT01096368|102041931|FG003|Overall Study|Ineligible|0|||
33588675|NCT01096368|102041932|FG004|Overall Study|Ineligible|25|||
33588676|NCT01096368|102041928|FG000|Overall Study|Did not start treatment|0|||
33588677|NCT01096368|102041929|FG001|Overall Study|Did not start treatment|4|||
33588678|NCT01096368|102041930|FG002|Overall Study|Did not start treatment|4|||
33588679|NCT01096368|102041931|FG003|Overall Study|Did not start treatment|0|||
33588680|NCT01096368|102041932|FG004|Overall Study|Did not start treatment|0|||
33588681|NCT01096368|102041928|FG000|Overall Study|Progressive disease|0|||
33648452|NCT01181986|102265637|FG000|Phase 1|Protocol Violation|1|||
33648453|NCT01181986|102265638|FG001|Phase 1|Protocol Violation|0|||
33588682|NCT01096368|102041929|FG001|Overall Study|Progressive disease|6|||
33588683|NCT01096368|102041930|FG002|Overall Study|Progressive disease|0|||
33588684|NCT01096368|102041931|FG003|Overall Study|Progressive disease|10|||
33588685|NCT01096368|102041932|FG004|Overall Study|Progressive disease|3|||
33588686|NCT01096368|102041928|FG000|Overall Study|Other|0|||
33588687|NCT01096368|102041929|FG001|Overall Study|Other|0|||
33588688|NCT01096368|102041930|FG002|Overall Study|Other|1|||
33588689|NCT01096368|102041931|FG003|Overall Study|Other|0|||
33588690|NCT01096368|102041932|FG004|Overall Study|Other|0|||
33648454|NCT01181986|102265639|FG002|Phase 1|Protocol Violation|0|||
33588691|NCT01096368|102041928|FG000|Overall Study|Treated with institutional review|0|||
33588692|NCT01096368|102041929|FG001|Overall Study|Treated with institutional review|0|||
33588693|NCT01096368|102041930|FG002|Overall Study|Treated with institutional review|0|||
33588694|NCT01096368|102041931|FG003|Overall Study|Treated with institutional review|0|||
33588695|NCT01096368|102041932|FG004|Overall Study|Treated with institutional review|1|||
33588696|NCT03654404|102045351|FG000|Overall Study|Death|1|||
33588697|NCT03654404|102045351|FG000|Overall Study|Lost to Follow-up|2|||
33588698|NCT03654404|102045351|FG000|Overall Study|Withdrawal by Subject|5|||
33588699|NCT03219034|102045354|FG000|Overall Study|Lost to Follow-up|9|||
33588700|NCT03219034|102045355|FG001|Overall Study|Lost to Follow-up|13|||
33588701|NCT03219034|102045354|FG000|Overall Study|Additional dental work needed|1|||
33588702|NCT03219034|102045355|FG001|Overall Study|Additional dental work needed|0|||
33588703|NCT03219034|102045354|FG000|Overall Study|UPPP Surgery|1|||
33588704|NCT03219034|102045355|FG001|Overall Study|UPPP Surgery|0|||
33588705|NCT03219034|102045354|FG000|Overall Study|Dental sensitivity|0|||
33588706|NCT03219034|102045355|FG001|Overall Study|Dental sensitivity|1|||
33588707|NCT03219034|102045354|FG000|Overall Study|Death in family|0|||
33588708|NCT03219034|102045355|FG001|Overall Study|Death in family|1|||
33588709|NCT03379259|102045358|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
33588710|NCT03379259|102045359|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
33588711|NCT03379259|102045360|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
33588712|NCT03379259|102045361|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
33588713|NCT03379259|102045362|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
33588714|NCT03379259|102045363|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
33588715|NCT03379259|102045358|FG000|Overall Study|Death|0|||
33588716|NCT03379259|102045359|FG001|Overall Study|Death|1|||
33588717|NCT03379259|102045360|FG002|Overall Study|Death|2|||
33588718|NCT03379259|102045361|FG003|Overall Study|Death|1|||
33588719|NCT03379259|102045362|FG004|Overall Study|Death|4|||
33588720|NCT03379259|102045363|FG005|Overall Study|Death|2|||
33588721|NCT03379259|102045358|FG000|Overall Study|Withdrawal by Subject|0|||
33588722|NCT03379259|102045359|FG001|Overall Study|Withdrawal by Subject|0|||
33588723|NCT03379259|102045360|FG002|Overall Study|Withdrawal by Subject|1|||
33588724|NCT03379259|102045361|FG003|Overall Study|Withdrawal by Subject|0|||
33588725|NCT03379259|102045362|FG004|Overall Study|Withdrawal by Subject|2|||
33588726|NCT03379259|102045363|FG005|Overall Study|Withdrawal by Subject|0|||
33588727|NCT03379259|102045358|FG000|Overall Study|Study terminated by sponsor|0|||
33588728|NCT03379259|102045359|FG001|Overall Study|Study terminated by sponsor|0|||
33588729|NCT03379259|102045360|FG002|Overall Study|Study terminated by sponsor|0|||
33588730|NCT03379259|102045361|FG003|Overall Study|Study terminated by sponsor|1|||
33588731|NCT03379259|102045362|FG004|Overall Study|Study terminated by sponsor|1|||
33588732|NCT03379259|102045363|FG005|Overall Study|Study terminated by sponsor|4|||
33588733|NCT03379259|102045358|FG000|Overall Study|Disease progression|0|||
33588734|NCT03379259|102045359|FG001|Overall Study|Disease progression|0|||
33588735|NCT03379259|102045360|FG002|Overall Study|Disease progression|0|||
33588736|NCT03379259|102045361|FG003|Overall Study|Disease progression|1|||
33588737|NCT03379259|102045362|FG004|Overall Study|Disease progression|0|||
33588738|NCT03379259|102045363|FG005|Overall Study|Disease progression|1|||
33588739|NCT03379259|102045358|FG000|Overall Study|Lost to Follow-up|0|||
33150047|NCT00736879|100463596|FG002|Double Blind Treatment Period|No longer met criteria|0|||
33588740|NCT03379259|102045359|FG001|Overall Study|Lost to Follow-up|0|||
33588741|NCT03379259|102045360|FG002|Overall Study|Lost to Follow-up|0|||
33588742|NCT03379259|102045361|FG003|Overall Study|Lost to Follow-up|0|||
33588743|NCT03379259|102045362|FG004|Overall Study|Lost to Follow-up|1|||
33588744|NCT03379259|102045363|FG005|Overall Study|Lost to Follow-up|0|||
33588745|NCT03379259|102045358|FG000|Overall Study|Deteriorating condition|0|||
33588746|NCT03379259|102045359|FG001|Overall Study|Deteriorating condition|0|||
33588747|NCT03379259|102045360|FG002|Overall Study|Deteriorating condition|0|||
33588748|NCT03379259|102045361|FG003|Overall Study|Deteriorating condition|0|||
33588749|NCT03379259|102045362|FG004|Overall Study|Deteriorating condition|1|||
33150048|NCT00736879|100463597|FG003|Double Blind Treatment Period|No longer met criteria|0|||
33150049|NCT00736879|100463594|FG000|Double Blind Treatment Period|non-specified|0|||
33384452|NCT00877006|101291626|FG000|Treatment Period|Withdrawal by Subject|2|||
33384453|NCT00877006|101291627|FG001|Treatment Period|Withdrawal by Subject|3|||
33384454|NCT00877006|101291626|FG000|Treatment Period|Protocol Violation|1|||
33588750|NCT03379259|102045363|FG005|Overall Study|Deteriorating condition|0|||
33150050|NCT00736879|100463595|FG001|Double Blind Treatment Period|non-specified|1|||
33384455|NCT00877006|101291627|FG001|Treatment Period|Protocol Violation|0|||
33588751|NCT03070223|102045372|FG000|Overall Study|Lost to Follow-up|34|||
33588752|NCT03070223|102045373|FG001|Overall Study|Lost to Follow-up|27|||
33588753|NCT03070223|102045372|FG000|Overall Study|Withdrawal by Subject|12|||
33588754|NCT03070223|102045373|FG001|Overall Study|Withdrawal by Subject|22|||
33588755|NCT03070223|102045372|FG000|Overall Study|Protocol Violation|0|||
33588756|NCT03070223|102045373|FG001|Overall Study|Protocol Violation|1|||
33588757|NCT00157196|102045377|FG000|Overall Study|Ongoing at data cut-off|9|||
33588758|NCT00654745|102045379|FG000|Overall Study|Adverse Event|12|||
33588759|NCT00654745|102045379|FG000|Overall Study|Lost to Follow-up|7|||
33588760|NCT00654745|102045379|FG000|Overall Study|Protocol Violation|11|||
33588761|NCT00654745|102045379|FG000|Overall Study|Withdrawal by Subject|10|||
33588762|NCT00654745|102045379|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
33588763|NCT00413894|102045380|FG000|Overall Study|Withdrawal by Subject|10|||
33588764|NCT00413894|102045380|FG000|Overall Study|Administrative Reasons|1|||
33588765|NCT00413894|102045380|FG000|Overall Study|Hb <10 grams/deciliter|12|||
33588766|NCT00413894|102045380|FG000|Overall Study|Adverse Event|28|||
33588767|NCT00413894|102045380|FG000|Overall Study|Protocol Violation|11|||
33588768|NCT00413894|102045380|FG000|Overall Study|Other|18|||
33588769|NCT00104416|102045381|FG000|Double-Blind Phase|Adverse Event|2|||
33588770|NCT00104416|102045382|FG001|Double-Blind Phase|Adverse Event|1|||
33588771|NCT00104416|102045383|FG002|Double-Blind Phase|Adverse Event|0|||
33588772|NCT00104416|102045384|FG003|Double-Blind Phase|Adverse Event|0|||
33588773|NCT00104416|102045385|FG004|Double-Blind Phase|Adverse Event|0|||
33588774|NCT00104416|102045381|FG000|Double-Blind Phase|Lost to Follow-up|0|||
33588775|NCT00104416|102045382|FG001|Double-Blind Phase|Lost to Follow-up|1|||
33588776|NCT00104416|102045383|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33588777|NCT00104416|102045384|FG003|Double-Blind Phase|Lost to Follow-up|0|||
33588778|NCT00104416|102045385|FG004|Double-Blind Phase|Lost to Follow-up|0|||
33588779|NCT00104416|102045381|FG000|Double-Blind Phase|Protocol Violation|0|||
33588780|NCT00104416|102045382|FG001|Double-Blind Phase|Protocol Violation|1|||
33648455|NCT01181986|102265637|FG000|Phase 2|Adverse Event|0|||
33648456|NCT01181986|102265638|FG001|Phase 2|Adverse Event|3|||
33648457|NCT01181986|102265639|FG002|Phase 2|Adverse Event|0|||
33648458|NCT01181986|102265637|FG000|Phase 2|Medical condition|0|||
33648459|NCT01181986|102265638|FG001|Phase 2|Medical condition|1|||
33648460|NCT01181986|102265639|FG002|Phase 2|Medical condition|0|||
33648461|NCT02160041|102265642|FG000|Overall Study|Adverse Event|11|||
33648462|NCT02160041|102265642|FG000|Overall Study|Death|2|||
33648463|NCT02160041|102265642|FG000|Overall Study|disease progression|57|||
33648464|NCT02160041|102265642|FG000|Overall Study|Protocol Violation|1|||
33648465|NCT02160041|102265642|FG000|Overall Study|non-compliance with study|1|||
33648466|NCT02160041|102265642|FG000|Overall Study|Physician Decision|3|||
33648467|NCT02160041|102265642|FG000|Overall Study|Withdrawal by Subject|8|||
33648468|NCT02160041|102265642|FG000|Overall Study|study terminated by by sponsor|1|||
33648469|NCT01386970|102265643|FG000|Overall Study|Withdrawal by Subject|0|||
33648470|NCT01386970|102265644|FG001|Overall Study|Withdrawal by Subject|1|||
33648471|NCT01386970|102265643|FG000|Overall Study|Adverse Event|4|||
33648472|NCT01386970|102265644|FG001|Overall Study|Adverse Event|1|||
33648473|NCT00548184|102265649|FG000|Overall Study|Adverse Event|3|||
33648474|NCT00548184|102265649|FG000|Overall Study|took other drug|1|||
33648475|NCT00548184|102265649|FG000|Overall Study|Found Her2 negative|1|||
33648476|NCT01018810|102265652|FG000|Overall Study|Withdrawal by Subject|0|||
33648477|NCT01018810|102265653|FG001|Overall Study|Withdrawal by Subject|1|||
33648478|NCT01018810|102265654|FG002|Overall Study|Withdrawal by Subject|0|||
33648479|NCT01018810|102265655|FG003|Overall Study|Withdrawal by Subject|0|||
33648480|NCT01018810|102265656|FG004|Overall Study|Withdrawal by Subject|0|||
33648481|NCT01018810|102265652|FG000|Overall Study|Sponsor Decision|2|||
33648482|NCT01018810|102265653|FG001|Overall Study|Sponsor Decision|0|||
33648483|NCT01018810|102265654|FG002|Overall Study|Sponsor Decision|1|||
33648484|NCT01018810|102265655|FG003|Overall Study|Sponsor Decision|1|||
33648485|NCT01018810|102265656|FG004|Overall Study|Sponsor Decision|1|||
33648486|NCT01012219|102265657|FG000|Period 1|Withdrawal by Subject|1|||
33648487|NCT01012219|102265657|FG000|Period 2|Withdrawal by Subject|1|||
33648488|NCT00475306|102265658|FG000|Overall Study|Protocol Violation|1|||
33648489|NCT00475306|102265659|FG001|Overall Study|Protocol Violation|1|||
33648490|NCT00475306|102265660|FG002|Overall Study|Protocol Violation|0|||
33648491|NCT00475306|102265661|FG003|Overall Study|Protocol Violation|1|||
33648492|NCT00439738|102265662|FG000|Overall Study|Withdrawal by Subject|16|||
33648493|NCT00439738|102265663|FG001|Overall Study|Withdrawal by Subject|13|||
33648494|NCT00439738|102265662|FG000|Overall Study|Adverse Event|6|||
33648495|NCT00439738|102265663|FG001|Overall Study|Adverse Event|4|||
33648496|NCT00439738|102265662|FG000|Overall Study|Lost to Follow-up|5|||
33648497|NCT00439738|102265663|FG001|Overall Study|Lost to Follow-up|6|||
33648498|NCT00439738|102265662|FG000|Overall Study|Protocol Violation|6|||
33648499|NCT00439738|102265663|FG001|Overall Study|Protocol Violation|3|||
33648500|NCT00439738|102265662|FG000|Overall Study|Lack of Efficacy|2|||
33648501|NCT00439738|102265663|FG001|Overall Study|Lack of Efficacy|2|||
33648502|NCT00439738|102265662|FG000|Overall Study|Abnormal Lab Values|1|||
33648503|NCT00439738|102265663|FG001|Overall Study|Abnormal Lab Values|0|||
33588781|NCT00104416|102045383|FG002|Double-Blind Phase|Protocol Violation|0|||
33588782|NCT00104416|102045384|FG003|Double-Blind Phase|Protocol Violation|0|||
33588783|NCT00104416|102045385|FG004|Double-Blind Phase|Protocol Violation|0|||
33588784|NCT00104416|102045381|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
33588785|NCT00104416|102045382|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
33648504|NCT00689117|102265664|FG000|Overall Study|Adverse Event|6|||
33648505|NCT00689117|102265665|FG001|Overall Study|Adverse Event|0|||
33648506|NCT00689117|102265666|FG002|Overall Study|Adverse Event|5|||
33648507|NCT00689117|102265667|FG003|Overall Study|Adverse Event|0|||
33588786|NCT00104416|102045383|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
33588787|NCT00104416|102045384|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
33588788|NCT00104416|102045385|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
33588789|NCT00104416|102045381|FG000|Double-Blind Phase|Pregnancy|1|||
33588790|NCT00104416|102045382|FG001|Double-Blind Phase|Pregnancy|0|||
33588791|NCT00104416|102045383|FG002|Double-Blind Phase|Pregnancy|0|||
33588792|NCT00104416|102045384|FG003|Double-Blind Phase|Pregnancy|0|||
33588793|NCT00104416|102045385|FG004|Double-Blind Phase|Pregnancy|0|||
33588794|NCT00104416|102045381|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
33588795|NCT00104416|102045382|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
33588796|NCT00104416|102045383|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
33588797|NCT00104416|102045384|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
33588798|NCT00104416|102045385|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
33588799|NCT00104416|102045381|FG000|Continuation Phase|Adverse Event|0|||
33588800|NCT00104416|102045382|FG001|Continuation Phase|Adverse Event|0|||
33588801|NCT00104416|102045383|FG002|Continuation Phase|Adverse Event|2|||
33588802|NCT00104416|102045384|FG003|Continuation Phase|Adverse Event|0|||
33588803|NCT00104416|102045385|FG004|Continuation Phase|Adverse Event|2|||
33588804|NCT00104416|102045381|FG000|Continuation Phase|Lost to Follow-up|0|||
33588805|NCT00104416|102045382|FG001|Continuation Phase|Lost to Follow-up|0|||
33588806|NCT00104416|102045383|FG002|Continuation Phase|Lost to Follow-up|1|||
33588807|NCT00104416|102045384|FG003|Continuation Phase|Lost to Follow-up|0|||
33588808|NCT00104416|102045385|FG004|Continuation Phase|Lost to Follow-up|1|||
33588809|NCT00104416|102045381|FG000|Continuation Phase|Withdrawal by Subject|0|||
33588810|NCT00104416|102045382|FG001|Continuation Phase|Withdrawal by Subject|0|||
33588811|NCT00104416|102045383|FG002|Continuation Phase|Withdrawal by Subject|2|||
33588812|NCT00104416|102045384|FG003|Continuation Phase|Withdrawal by Subject|1|||
33588813|NCT00104416|102045385|FG004|Continuation Phase|Withdrawal by Subject|1|||
33588814|NCT00104416|102045381|FG000|Continuation Phase|Pregnancy|0|||
33588815|NCT00104416|102045382|FG001|Continuation Phase|Pregnancy|0|||
33588816|NCT00104416|102045383|FG002|Continuation Phase|Pregnancy|1|||
33588817|NCT00104416|102045384|FG003|Continuation Phase|Pregnancy|1|||
33588818|NCT00104416|102045385|FG004|Continuation Phase|Pregnancy|0|||
33588819|NCT00104416|102045381|FG000|Continuation Phase|Non-compliance|0|||
33588820|NCT00104416|102045382|FG001|Continuation Phase|Non-compliance|0|||
33588821|NCT00104416|102045383|FG002|Continuation Phase|Non-compliance|0|||
33588822|NCT00104416|102045384|FG003|Continuation Phase|Non-compliance|0|||
33588823|NCT00104416|102045385|FG004|Continuation Phase|Non-compliance|1|||
33588824|NCT03493451|102045387|FG000|Overall Study|Death|11|||
33588825|NCT03493451|102045388|FG001|Overall Study|Death|26|||
33588826|NCT03493451|102045389|FG002|Overall Study|Death|3|||
33588827|NCT03493451|102045387|FG000|Overall Study|Lost to Follow-up|1|||
33588828|NCT03493451|102045388|FG001|Overall Study|Lost to Follow-up|4|||
33588829|NCT03493451|102045389|FG002|Overall Study|Lost to Follow-up|1|||
33588830|NCT03493451|102045387|FG000|Overall Study|Withdrawal by Subject|1|||
33588831|NCT03493451|102045388|FG001|Overall Study|Withdrawal by Subject|1|||
33588832|NCT03493451|102045389|FG002|Overall Study|Withdrawal by Subject|2|||
33588833|NCT03493451|102045387|FG000|Overall Study|Progressive Disease|1|||
33588834|NCT03493451|102045388|FG001|Overall Study|Progressive Disease|0|||
33588835|NCT03493451|102045389|FG002|Overall Study|Progressive Disease|0|||
33588836|NCT03493451|102045387|FG000|Overall Study|Transferred to long term extension study|8|||
33588837|NCT03493451|102045388|FG001|Overall Study|Transferred to long term extension study|13|||
33588838|NCT03493451|102045389|FG002|Overall Study|Transferred to long term extension study|5|||
33588839|NCT00113399|102045390|FG000|Overall Study|Death|1|||
33588840|NCT00113399|102045391|FG001|Overall Study|Death|1|||
33588841|NCT00113399|102045390|FG000|Overall Study|Withdrawal by Subject|1|||
33588842|NCT00113399|102045391|FG001|Overall Study|Withdrawal by Subject|2|||
33588843|NCT00113399|102045390|FG000|Overall Study|Complete Response|0|||
33588844|NCT00113399|102045391|FG001|Overall Study|Complete Response|1|||
33588845|NCT00113399|102045390|FG000|Overall Study|Other|0|||
33588846|NCT00113399|102045391|FG001|Overall Study|Other|1|||
33588847|NCT01436656|102045403|FG000|Dose Escalation|Death|1|||
33588848|NCT01436656|102045404|FG001|Dose Escalation|Death|3|||
33588849|NCT01436656|102045405|FG002|Dose Escalation|Death|1|||
33588850|NCT01436656|102045406|FG003|Dose Escalation|Death|0|||
33588851|NCT01436656|102045407|FG004|Dose Escalation|Death|2|||
33588852|NCT01436656|102045408|FG005|Dose Escalation|Death|1|||
33588853|NCT01436656|102045409|FG006|Dose Escalation|Death|1|||
33588854|NCT01436656|102045410|FG007|Dose Escalation|Death|1|||
33588855|NCT01436656|102045411|FG008|Dose Escalation|Death|1|||
33588856|NCT01436656|102045412|FG009|Dose Escalation|Death|0|||
33588857|NCT01436656|102045413|FG010|Dose Escalation|Death|0|||
33588858|NCT01436656|102045414|FG011|Dose Escalation|Death|0|||
33588859|NCT01436656|102045415|FG012|Dose Escalation|Death|0|||
33588860|NCT01436656|102045416|FG013|Dose Escalation|Death|0|||
33588861|NCT01436656|102045417|FG014|Dose Escalation|Death|0|||
33588862|NCT01436656|102045418|FG015|Dose Escalation|Death|0|||
33588863|NCT01436656|102045419|FG016|Dose Escalation|Death|0|||
33588864|NCT01436656|102045420|FG017|Dose Escalation|Death|0|||
33588865|NCT01436656|102045403|FG000|Dose Escalation|Protocol Violation|0|||
33588866|NCT01436656|102045404|FG001|Dose Escalation|Protocol Violation|0|||
33588867|NCT01436656|102045405|FG002|Dose Escalation|Protocol Violation|0|||
33588868|NCT01436656|102045406|FG003|Dose Escalation|Protocol Violation|0|||
33588869|NCT01436656|102045407|FG004|Dose Escalation|Protocol Violation|0|||
33588870|NCT01436656|102045408|FG005|Dose Escalation|Protocol Violation|1|||
33588871|NCT01436656|102045409|FG006|Dose Escalation|Protocol Violation|0|||
33588872|NCT01436656|102045410|FG007|Dose Escalation|Protocol Violation|0|||
33588873|NCT01436656|102045411|FG008|Dose Escalation|Protocol Violation|0|||
33588874|NCT01436656|102045412|FG009|Dose Escalation|Protocol Violation|0|||
33588875|NCT01436656|102045413|FG010|Dose Escalation|Protocol Violation|0|||
33588876|NCT01436656|102045414|FG011|Dose Escalation|Protocol Violation|0|||
33588877|NCT01436656|102045415|FG012|Dose Escalation|Protocol Violation|0|||
33588878|NCT01436656|102045416|FG013|Dose Escalation|Protocol Violation|0|||
33588879|NCT01436656|102045417|FG014|Dose Escalation|Protocol Violation|0|||
33588880|NCT01436656|102045418|FG015|Dose Escalation|Protocol Violation|0|||
33588881|NCT01436656|102045419|FG016|Dose Escalation|Protocol Violation|0|||
33588882|NCT01436656|102045420|FG017|Dose Escalation|Protocol Violation|0|||
33588883|NCT01436656|102045403|FG000|Dose Escalation|Withdrawal by Subject|0|||
33588884|NCT01436656|102045404|FG001|Dose Escalation|Withdrawal by Subject|0|||
33588885|NCT01436656|102045405|FG002|Dose Escalation|Withdrawal by Subject|0|||
33588886|NCT01436656|102045406|FG003|Dose Escalation|Withdrawal by Subject|0|||
33588887|NCT01436656|102045407|FG004|Dose Escalation|Withdrawal by Subject|1|||
33588888|NCT01436656|102045408|FG005|Dose Escalation|Withdrawal by Subject|0|||
33588889|NCT01436656|102045409|FG006|Dose Escalation|Withdrawal by Subject|0|||
33588890|NCT01436656|102045410|FG007|Dose Escalation|Withdrawal by Subject|2|||
33588891|NCT01436656|102045411|FG008|Dose Escalation|Withdrawal by Subject|0|||
33588892|NCT01436656|102045412|FG009|Dose Escalation|Withdrawal by Subject|1|||
33588893|NCT01436656|102045413|FG010|Dose Escalation|Withdrawal by Subject|1|||
33588894|NCT01436656|102045414|FG011|Dose Escalation|Withdrawal by Subject|0|||
33588895|NCT01436656|102045415|FG012|Dose Escalation|Withdrawal by Subject|0|||
33588896|NCT01436656|102045416|FG013|Dose Escalation|Withdrawal by Subject|0|||
33588897|NCT01436656|102045417|FG014|Dose Escalation|Withdrawal by Subject|0|||
33588898|NCT01436656|102045418|FG015|Dose Escalation|Withdrawal by Subject|0|||
33588899|NCT01436656|102045419|FG016|Dose Escalation|Withdrawal by Subject|0|||
33588900|NCT01436656|102045420|FG017|Dose Escalation|Withdrawal by Subject|0|||
33588901|NCT01436656|102045403|FG000|Dose Escalation|Administrative problems|0|||
33588902|NCT01436656|102045404|FG001|Dose Escalation|Administrative problems|1|||
33588903|NCT01436656|102045405|FG002|Dose Escalation|Administrative problems|0|||
33588904|NCT01436656|102045406|FG003|Dose Escalation|Administrative problems|0|||
33588905|NCT01436656|102045407|FG004|Dose Escalation|Administrative problems|0|||
33588906|NCT01436656|102045408|FG005|Dose Escalation|Administrative problems|0|||
33588907|NCT01436656|102045409|FG006|Dose Escalation|Administrative problems|0|||
33588908|NCT01436656|102045410|FG007|Dose Escalation|Administrative problems|0|||
33588909|NCT01436656|102045411|FG008|Dose Escalation|Administrative problems|0|||
33588910|NCT01436656|102045412|FG009|Dose Escalation|Administrative problems|0|||
33588911|NCT01436656|102045413|FG010|Dose Escalation|Administrative problems|0|||
33588912|NCT01436656|102045414|FG011|Dose Escalation|Administrative problems|0|||
33588913|NCT01436656|102045415|FG012|Dose Escalation|Administrative problems|0|||
33588914|NCT01436656|102045416|FG013|Dose Escalation|Administrative problems|0|||
33588915|NCT01436656|102045417|FG014|Dose Escalation|Administrative problems|0|||
33588916|NCT01436656|102045418|FG015|Dose Escalation|Administrative problems|0|||
33588917|NCT01436656|102045419|FG016|Dose Escalation|Administrative problems|0|||
33588918|NCT01436656|102045420|FG017|Dose Escalation|Administrative problems|0|||
33588919|NCT01436656|102045403|FG000|Dose Escalation|Lost to Follow-up|1|||
33588920|NCT01436656|102045404|FG001|Dose Escalation|Lost to Follow-up|0|||
33588921|NCT01436656|102045405|FG002|Dose Escalation|Lost to Follow-up|0|||
33588922|NCT01436656|102045406|FG003|Dose Escalation|Lost to Follow-up|0|||
33588923|NCT01436656|102045407|FG004|Dose Escalation|Lost to Follow-up|1|||
33588924|NCT01436656|102045408|FG005|Dose Escalation|Lost to Follow-up|0|||
33588925|NCT01436656|102045409|FG006|Dose Escalation|Lost to Follow-up|0|||
33588926|NCT01436656|102045410|FG007|Dose Escalation|Lost to Follow-up|0|||
33588927|NCT01436656|102045411|FG008|Dose Escalation|Lost to Follow-up|0|||
33588928|NCT01436656|102045412|FG009|Dose Escalation|Lost to Follow-up|0|||
33150051|NCT00736879|100463596|FG002|Double Blind Treatment Period|non-specified|0|||
33648508|NCT00689117|102265664|FG000|Overall Study|Lost to Follow-up|26|||
33150052|NCT00736879|100463597|FG003|Double Blind Treatment Period|non-specified|0|||
33150053|NCT00736879|100463594|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
33150054|NCT00736879|100463595|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
33588929|NCT01436656|102045413|FG010|Dose Escalation|Lost to Follow-up|0|||
33588930|NCT01436656|102045414|FG011|Dose Escalation|Lost to Follow-up|0|||
33588931|NCT01436656|102045415|FG012|Dose Escalation|Lost to Follow-up|0|||
33588932|NCT01436656|102045416|FG013|Dose Escalation|Lost to Follow-up|0|||
33588933|NCT01436656|102045417|FG014|Dose Escalation|Lost to Follow-up|0|||
33588934|NCT01436656|102045418|FG015|Dose Escalation|Lost to Follow-up|0|||
33588935|NCT01436656|102045419|FG016|Dose Escalation|Lost to Follow-up|0|||
33588936|NCT01436656|102045420|FG017|Dose Escalation|Lost to Follow-up|0|||
33588937|NCT01436656|102045403|FG000|Dose Escalation|New anti-cancer therapy|1|||
33588938|NCT01436656|102045404|FG001|Dose Escalation|New anti-cancer therapy|0|||
33588939|NCT01436656|102045405|FG002|Dose Escalation|New anti-cancer therapy|0|||
33588940|NCT01436656|102045406|FG003|Dose Escalation|New anti-cancer therapy|0|||
33588941|NCT01436656|102045407|FG004|Dose Escalation|New anti-cancer therapy|0|||
33588942|NCT01436656|102045408|FG005|Dose Escalation|New anti-cancer therapy|0|||
33588943|NCT01436656|102045409|FG006|Dose Escalation|New anti-cancer therapy|0|||
33588944|NCT01436656|102045410|FG007|Dose Escalation|New anti-cancer therapy|0|||
33588945|NCT01436656|102045411|FG008|Dose Escalation|New anti-cancer therapy|1|||
33588946|NCT01436656|102045412|FG009|Dose Escalation|New anti-cancer therapy|1|||
33588947|NCT01436656|102045413|FG010|Dose Escalation|New anti-cancer therapy|0|||
33588948|NCT01436656|102045414|FG011|Dose Escalation|New anti-cancer therapy|0|||
33588949|NCT01436656|102045415|FG012|Dose Escalation|New anti-cancer therapy|0|||
33588950|NCT01436656|102045416|FG013|Dose Escalation|New anti-cancer therapy|0|||
33588951|NCT01436656|102045417|FG014|Dose Escalation|New anti-cancer therapy|0|||
33588952|NCT01436656|102045418|FG015|Dose Escalation|New anti-cancer therapy|0|||
33588953|NCT01436656|102045419|FG016|Dose Escalation|New anti-cancer therapy|0|||
33588954|NCT01436656|102045420|FG017|Dose Escalation|New anti-cancer therapy|0|||
33588955|NCT01436656|102045403|FG000|Dose Expansion|Adverse Event|0|||
33588956|NCT01436656|102045404|FG001|Dose Expansion|Adverse Event|0|||
33588957|NCT01436656|102045405|FG002|Dose Expansion|Adverse Event|0|||
33588958|NCT01436656|102045406|FG003|Dose Expansion|Adverse Event|0|||
33588959|NCT01436656|102045407|FG004|Dose Expansion|Adverse Event|0|||
33588960|NCT01436656|102045408|FG005|Dose Expansion|Adverse Event|0|||
33588961|NCT01436656|102045409|FG006|Dose Expansion|Adverse Event|0|||
33588962|NCT01436656|102045410|FG007|Dose Expansion|Adverse Event|0|||
33588963|NCT01436656|102045411|FG008|Dose Expansion|Adverse Event|0|||
33588964|NCT01436656|102045412|FG009|Dose Expansion|Adverse Event|0|||
33588965|NCT01436656|102045413|FG010|Dose Expansion|Adverse Event|0|||
33588966|NCT01436656|102045414|FG011|Dose Expansion|Adverse Event|1|||
33588967|NCT01436656|102045415|FG012|Dose Expansion|Adverse Event|0|||
33588968|NCT01436656|102045416|FG013|Dose Expansion|Adverse Event|0|||
33588969|NCT01436656|102045417|FG014|Dose Expansion|Adverse Event|0|||
33588970|NCT01436656|102045418|FG015|Dose Expansion|Adverse Event|0|||
33588971|NCT01436656|102045419|FG016|Dose Expansion|Adverse Event|0|||
33588972|NCT01436656|102045420|FG017|Dose Expansion|Adverse Event|0|||
33588973|NCT01436656|102045403|FG000|Dose Expansion|Withdrawal by Subject|0|||
33588974|NCT01436656|102045404|FG001|Dose Expansion|Withdrawal by Subject|0|||
33588975|NCT01436656|102045405|FG002|Dose Expansion|Withdrawal by Subject|0|||
33588976|NCT01436656|102045406|FG003|Dose Expansion|Withdrawal by Subject|0|||
33588977|NCT01436656|102045407|FG004|Dose Expansion|Withdrawal by Subject|0|||
33588978|NCT01436656|102045408|FG005|Dose Expansion|Withdrawal by Subject|0|||
33588979|NCT01436656|102045409|FG006|Dose Expansion|Withdrawal by Subject|0|||
33588980|NCT01436656|102045410|FG007|Dose Expansion|Withdrawal by Subject|0|||
33588981|NCT01436656|102045411|FG008|Dose Expansion|Withdrawal by Subject|0|||
33588982|NCT01436656|102045412|FG009|Dose Expansion|Withdrawal by Subject|0|||
33588983|NCT01436656|102045413|FG010|Dose Expansion|Withdrawal by Subject|0|||
33588984|NCT01436656|102045414|FG011|Dose Expansion|Withdrawal by Subject|1|||
33588985|NCT01436656|102045415|FG012|Dose Expansion|Withdrawal by Subject|3|||
33588986|NCT01436656|102045416|FG013|Dose Expansion|Withdrawal by Subject|1|||
33588987|NCT01436656|102045417|FG014|Dose Expansion|Withdrawal by Subject|2|||
33588988|NCT01436656|102045418|FG015|Dose Expansion|Withdrawal by Subject|0|||
33648509|NCT00689117|102265665|FG001|Overall Study|Lost to Follow-up|19|||
33648510|NCT00689117|102265666|FG002|Overall Study|Lost to Follow-up|17|||
33648511|NCT00689117|102265667|FG003|Overall Study|Lost to Follow-up|11|||
33648512|NCT00689117|102265664|FG000|Overall Study|Lack of Efficacy|1|||
33648513|NCT00689117|102265665|FG001|Overall Study|Lack of Efficacy|2|||
33648514|NCT00689117|102265666|FG002|Overall Study|Lack of Efficacy|2|||
33648515|NCT00689117|102265667|FG003|Overall Study|Lack of Efficacy|2|||
33648516|NCT00689117|102265664|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
33648517|NCT00689117|102265665|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
33648518|NCT00689117|102265666|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
33648519|NCT00689117|102265667|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
33588989|NCT01436656|102045419|FG016|Dose Expansion|Withdrawal by Subject|1|||
33588990|NCT01436656|102045420|FG017|Dose Expansion|Withdrawal by Subject|1|||
33588991|NCT01436656|102045403|FG000|Dose Expansion|Death|0|||
33648520|NCT00689117|102265664|FG000|Overall Study|Withdrawal by Subject|19|||
33249633|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
33249634|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
33588992|NCT01436656|102045404|FG001|Dose Expansion|Death|0|||
33648521|NCT00689117|102265665|FG001|Overall Study|Withdrawal by Subject|18|||
33249635|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
33249636|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
33588993|NCT01436656|102045405|FG002|Dose Expansion|Death|0|||
33588994|NCT01436656|102045406|FG003|Dose Expansion|Death|0|||
33588995|NCT01436656|102045407|FG004|Dose Expansion|Death|0|||
33588996|NCT01436656|102045408|FG005|Dose Expansion|Death|0|||
33648522|NCT00689117|102265666|FG002|Overall Study|Withdrawal by Subject|26|||
33648523|NCT00689117|102265667|FG003|Overall Study|Withdrawal by Subject|13|||
33648524|NCT00689117|102265664|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
33648525|NCT00689117|102265665|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
33648526|NCT00689117|102265666|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
33648527|NCT00689117|102265667|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
33648528|NCT00689117|102265664|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
33648529|NCT00689117|102265665|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
33433123|NCT00622908|101476772|FG001|Overall Study|Protocol Violation|0|||
33588997|NCT01436656|102045409|FG006|Dose Expansion|Death|0|||
33588998|NCT01436656|102045410|FG007|Dose Expansion|Death|0|||
33588999|NCT01436656|102045411|FG008|Dose Expansion|Death|0|||
33589000|NCT01436656|102045412|FG009|Dose Expansion|Death|0|||
33589001|NCT01436656|102045413|FG010|Dose Expansion|Death|0|||
33589002|NCT01436656|102045414|FG011|Dose Expansion|Death|0|||
33589003|NCT01436656|102045415|FG012|Dose Expansion|Death|1|||
33589004|NCT01436656|102045416|FG013|Dose Expansion|Death|0|||
33589005|NCT01436656|102045417|FG014|Dose Expansion|Death|3|||
33589006|NCT01436656|102045418|FG015|Dose Expansion|Death|0|||
33589007|NCT01436656|102045419|FG016|Dose Expansion|Death|3|||
33589008|NCT01436656|102045420|FG017|Dose Expansion|Death|3|||
33589009|NCT01436656|102045403|FG000|Dose Expansion|Lost to Follow-up|0|||
33589010|NCT01436656|102045404|FG001|Dose Expansion|Lost to Follow-up|0|||
33589011|NCT01436656|102045405|FG002|Dose Expansion|Lost to Follow-up|0|||
33589012|NCT01436656|102045406|FG003|Dose Expansion|Lost to Follow-up|0|||
33589013|NCT01436656|102045407|FG004|Dose Expansion|Lost to Follow-up|0|||
33589014|NCT01436656|102045408|FG005|Dose Expansion|Lost to Follow-up|0|||
33589015|NCT01436656|102045409|FG006|Dose Expansion|Lost to Follow-up|0|||
33589016|NCT01436656|102045410|FG007|Dose Expansion|Lost to Follow-up|0|||
33589017|NCT01436656|102045411|FG008|Dose Expansion|Lost to Follow-up|0|||
33589018|NCT01436656|102045412|FG009|Dose Expansion|Lost to Follow-up|0|||
33589019|NCT01436656|102045413|FG010|Dose Expansion|Lost to Follow-up|0|||
33589020|NCT01436656|102045414|FG011|Dose Expansion|Lost to Follow-up|0|||
33589021|NCT01436656|102045415|FG012|Dose Expansion|Lost to Follow-up|0|||
33589022|NCT01436656|102045416|FG013|Dose Expansion|Lost to Follow-up|0|||
33589023|NCT01436656|102045417|FG014|Dose Expansion|Lost to Follow-up|0|||
33589024|NCT01436656|102045418|FG015|Dose Expansion|Lost to Follow-up|0|||
33589025|NCT01436656|102045419|FG016|Dose Expansion|Lost to Follow-up|0|||
33589026|NCT01436656|102045420|FG017|Dose Expansion|Lost to Follow-up|3|||
33589027|NCT01436656|102045403|FG000|Dose Expansion|Disease progression|0|||
33589028|NCT01436656|102045404|FG001|Dose Expansion|Disease progression|0|||
33589029|NCT01436656|102045405|FG002|Dose Expansion|Disease progression|0|||
33589030|NCT01436656|102045406|FG003|Dose Expansion|Disease progression|0|||
33589031|NCT01436656|102045407|FG004|Dose Expansion|Disease progression|0|||
33589032|NCT01436656|102045408|FG005|Dose Expansion|Disease progression|0|||
33589033|NCT01436656|102045409|FG006|Dose Expansion|Disease progression|0|||
33589034|NCT01436656|102045410|FG007|Dose Expansion|Disease progression|0|||
33589035|NCT01436656|102045411|FG008|Dose Expansion|Disease progression|0|||
33433124|NCT00622908|101476771|FG000|Overall Study|Adverse Event|0|||
33433125|NCT00622908|101476772|FG001|Overall Study|Adverse Event|1|||
33433126|NCT00622908|101476771|FG000|Overall Study|Lack of Efficacy|1|||
33433127|NCT00622908|101476772|FG001|Overall Study|Lack of Efficacy|7|||
33433128|NCT00622908|101476771|FG000|Overall Study|Lost to Follow-up|1|||
33433129|NCT00622908|101476772|FG001|Overall Study|Lost to Follow-up|0|||
33433130|NCT00622908|101476771|FG000|Overall Study|Refusal|0|||
33433131|NCT00622908|101476772|FG001|Overall Study|Refusal|1|||
33433132|NCT00622908|101476771|FG000|Overall Study|Termination by study sponser|0|||
33433133|NCT00622908|101476772|FG001|Overall Study|Termination by study sponser|1|||
33433134|NCT05188521|101476774|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
33433135|NCT05188521|101476775|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
33589036|NCT01436656|102045412|FG009|Dose Expansion|Disease progression|0|||
33648530|NCT00689117|102265666|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33648531|NCT00689117|102265667|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
33433136|NCT01339910|101476776|FG000|Overall Study|Withdrawal by Subject|1|||
33589037|NCT01436656|102045413|FG010|Dose Expansion|Disease progression|0|||
33589038|NCT01436656|102045414|FG011|Dose Expansion|Disease progression|3|||
33648532|NCT00689117|102265664|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
33648533|NCT00689117|102265665|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
33648534|NCT00689117|102265666|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
33433137|NCT01339910|101476777|FG001|Overall Study|Withdrawal by Subject|0|||
33433138|NCT01339910|101476776|FG000|Overall Study|Physician Decision|1|||
33589039|NCT01436656|102045415|FG012|Dose Expansion|Disease progression|1|||
33589040|NCT01436656|102045416|FG013|Dose Expansion|Disease progression|0|||
33589041|NCT01436656|102045417|FG014|Dose Expansion|Disease progression|1|||
33589042|NCT01436656|102045418|FG015|Dose Expansion|Disease progression|0|||
33589043|NCT01436656|102045419|FG016|Dose Expansion|Disease progression|0|||
33589044|NCT01436656|102045420|FG017|Dose Expansion|Disease progression|1|||
33589045|NCT01436656|102045403|FG000|Dose Expansion|New cancer therapy|0|||
33589046|NCT01436656|102045404|FG001|Dose Expansion|New cancer therapy|0|||
33589047|NCT01436656|102045405|FG002|Dose Expansion|New cancer therapy|0|||
33589048|NCT01436656|102045406|FG003|Dose Expansion|New cancer therapy|0|||
33589049|NCT01436656|102045407|FG004|Dose Expansion|New cancer therapy|0|||
33589050|NCT01436656|102045408|FG005|Dose Expansion|New cancer therapy|0|||
33589051|NCT01436656|102045409|FG006|Dose Expansion|New cancer therapy|0|||
33589052|NCT01436656|102045410|FG007|Dose Expansion|New cancer therapy|0|||
33589053|NCT01436656|102045411|FG008|Dose Expansion|New cancer therapy|0|||
33589054|NCT01436656|102045412|FG009|Dose Expansion|New cancer therapy|0|||
33589055|NCT01436656|102045413|FG010|Dose Expansion|New cancer therapy|0|||
33589056|NCT01436656|102045414|FG011|Dose Expansion|New cancer therapy|1|||
33589057|NCT01436656|102045415|FG012|Dose Expansion|New cancer therapy|1|||
33589058|NCT01436656|102045416|FG013|Dose Expansion|New cancer therapy|0|||
33150055|NCT00736879|100463596|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
33589059|NCT01436656|102045417|FG014|Dose Expansion|New cancer therapy|2|||
33589060|NCT01436656|102045418|FG015|Dose Expansion|New cancer therapy|0|||
33150056|NCT00736879|100463597|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
33150057|NCT00736879|100463594|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
33384456|NCT00877006|101291626|FG000|Treatment Period|Lost to Follow-up|0|||
33384457|NCT00877006|101291627|FG001|Treatment Period|Lost to Follow-up|1|||
33384458|NCT00877006|101291626|FG000|Treatment Period|Disease Progression|1|||
33384459|NCT00877006|101291627|FG001|Treatment Period|Disease Progression|2|||
33384460|NCT00877006|101291626|FG000|Treatment Period|Started New Treatment Regimen|2|||
33384461|NCT00877006|101291627|FG001|Treatment Period|Started New Treatment Regimen|5|||
33384462|NCT00877006|101291626|FG000|Treatment Period|Other|4|||
33384463|NCT00877006|101291627|FG001|Treatment Period|Other|4|||
33384464|NCT00877006|101291626|FG000|Treatment Period|Randomized but Not Treated|3|||
33384465|NCT00877006|101291627|FG001|Treatment Period|Randomized but Not Treated|8|||
33384466|NCT00877006|101291626|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
33384467|NCT00877006|101291627|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
33384468|NCT00877006|101291626|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
33384469|NCT00877006|101291627|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
33384470|NCT00877006|101291626|FG000|Long-Term Follow-up Period|Death|26|||
33433139|NCT01339910|101476777|FG001|Overall Study|Physician Decision|0|||
33433140|NCT01339910|101476776|FG000|Overall Study|Disease relapse|1|||
33433141|NCT01339910|101476777|FG001|Overall Study|Disease relapse|4|||
33433142|NCT02158936|101476778|FG000|Overall Study|Study closed/ terminated|57|||
33433143|NCT02158936|101476779|FG001|Overall Study|Study closed/ terminated|77|||
33433144|NCT02158936|101476778|FG000|Overall Study|Azacitidine tx discontinued|53|||
33433145|NCT02158936|101476779|FG001|Overall Study|Azacitidine tx discontinued|46|||
33433146|NCT02158936|101476778|FG000|Overall Study|Adverse Event|39|||
33433147|NCT02158936|101476779|FG001|Overall Study|Adverse Event|24|||
33433148|NCT02158936|101476778|FG000|Overall Study|Withdrawal by Subject|15|||
33433149|NCT02158936|101476779|FG001|Overall Study|Withdrawal by Subject|16|||
33433150|NCT02158936|101476778|FG000|Overall Study|Physician Decision|15|||
33433151|NCT02158936|101476779|FG001|Overall Study|Physician Decision|13|||
33433152|NCT02158936|101476778|FG000|Overall Study|Lost to Follow-up|0|||
33433153|NCT02158936|101476779|FG001|Overall Study|Lost to Follow-up|1|||
33433154|NCT01974895|101476781|FG000|Overall Study|Protocol Violation|1|||
33433155|NCT01974895|101476782|FG001|Overall Study|Protocol Violation|0|||
33433156|NCT01974895|101476781|FG000|Overall Study|Lost to Follow-up|4|||
33433157|NCT01974895|101476782|FG001|Overall Study|Lost to Follow-up|6|||
33433158|NCT01974895|101476781|FG000|Overall Study|Withdrawal by Subject|0|||
33433159|NCT01974895|101476782|FG001|Overall Study|Withdrawal by Subject|1|||
33433160|NCT01974895|101476781|FG000|Overall Study|Other (Missed Visit)|1|||
33433161|NCT01974895|101476782|FG001|Overall Study|Other (Missed Visit)|0|||
33433162|NCT01974895|101476781|FG000|Overall Study|Other (Reason unknown)|9|||
33433163|NCT01974895|101476782|FG001|Overall Study|Other (Reason unknown)|8|||
33433164|NCT00661505|101476785|FG000|Overall Study|Adverse Event|3|||
33433165|NCT00661505|101476785|FG000|Overall Study|Protocol Violation|14|||
33433166|NCT00661505|101476785|FG000|Overall Study|Withdrawal by Subject|8|||
33433167|NCT00661505|101476785|FG000|Overall Study|Lost to Follow-up|3|||
33433168|NCT00661505|101476785|FG000|Overall Study|Other|2|||
33433169|NCT03529955|101476788|FG000|Overall Study|Adverse Event|1|||
33433170|NCT03529955|101476788|FG000|Overall Study|Lack of Efficacy|1|||
33433171|NCT00475020|101476789|FG000|Overall Study|Physician Decision|3|||
33433172|NCT00475020|101476789|FG000|Overall Study|Insurance Denial|1|||
33589061|NCT01436656|102045419|FG016|Dose Expansion|New cancer therapy|0|||
33589062|NCT01436656|102045420|FG017|Dose Expansion|New cancer therapy|0|||
33384471|NCT00877006|101291627|FG001|Long-Term Follow-up Period|Death|18|||
33384472|NCT00877006|101291626|FG000|Long-Term Follow-up Period|Other|7|||
33433173|NCT00475020|101476789|FG000|Overall Study|Donor not able to donate the last minute|1|||
33589063|NCT00443872|102045425|FG000|Overall Study|Protocol Violation|7|||
33589064|NCT00443872|102045425|FG000|Overall Study|Lost to Follow-up|2|||
33589065|NCT00443872|102045425|FG000|Overall Study|Adverse Event|8|||
33384473|NCT00877006|101291627|FG001|Long-Term Follow-up Period|Other|9|||
33589066|NCT04669262|102045428|FG000|Overall Study|Withdrawal by Subject|0|||
33589067|NCT04669262|102045429|FG001|Overall Study|Withdrawal by Subject|0|||
33589068|NCT04669262|102045430|FG002|Overall Study|Withdrawal by Subject|0|||
33589069|NCT04669262|102045431|FG003|Overall Study|Withdrawal by Subject|1|||
33589070|NCT04669262|102045428|FG000|Overall Study|Randomized but Not Treated|0|||
33589071|NCT04669262|102045429|FG001|Overall Study|Randomized but Not Treated|1|||
33589072|NCT04669262|102045430|FG002|Overall Study|Randomized but Not Treated|0|||
33589073|NCT04669262|102045431|FG003|Overall Study|Randomized but Not Treated|0|||
33589074|NCT02550288|102045432|FG000|Overall Study|Adverse Event|0|||
33589075|NCT02550288|102045433|FG001|Overall Study|Adverse Event|1|||
33589076|NCT02550288|102045434|FG002|Overall Study|Adverse Event|0|||
33589077|NCT02550288|102045435|FG003|Overall Study|Adverse Event|0|||
33589078|NCT02550288|102045436|FG004|Overall Study|Adverse Event|0|||
33589079|NCT02550288|102045432|FG000|Overall Study|Physician Decision|0|||
33589080|NCT02550288|102045433|FG001|Overall Study|Physician Decision|0|||
33589081|NCT02550288|102045434|FG002|Overall Study|Physician Decision|0|||
33589082|NCT02550288|102045435|FG003|Overall Study|Physician Decision|1|||
33589083|NCT02550288|102045436|FG004|Overall Study|Physician Decision|0|||
33589084|NCT02550288|102045432|FG000|Overall Study|Protocol Violation|2|||
33589085|NCT02550288|102045433|FG001|Overall Study|Protocol Violation|2|||
33589086|NCT02550288|102045434|FG002|Overall Study|Protocol Violation|1|||
33589087|NCT02550288|102045435|FG003|Overall Study|Protocol Violation|0|||
33589088|NCT02550288|102045436|FG004|Overall Study|Protocol Violation|3|||
33589089|NCT02550288|102045432|FG000|Overall Study|Participant moved|0|||
33589090|NCT02550288|102045433|FG001|Overall Study|Participant moved|0|||
33589091|NCT02550288|102045434|FG002|Overall Study|Participant moved|0|||
33589092|NCT02550288|102045435|FG003|Overall Study|Participant moved|1|||
33589093|NCT02550288|102045436|FG004|Overall Study|Participant moved|0|||
33589094|NCT02550288|102045432|FG000|Overall Study|Withdrawal by Subject|0|||
33589095|NCT02550288|102045433|FG001|Overall Study|Withdrawal by Subject|0|||
33589096|NCT02550288|102045434|FG002|Overall Study|Withdrawal by Subject|0|||
33589097|NCT02550288|102045435|FG003|Overall Study|Withdrawal by Subject|1|||
33589098|NCT02550288|102045436|FG004|Overall Study|Withdrawal by Subject|0|||
33589099|NCT02301546|102045437|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
33589100|NCT02301546|102045438|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
33589101|NCT02301546|102045437|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
33589102|NCT02301546|102045438|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
33589103|NCT02301546|102045437|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
33589104|NCT02301546|102045438|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
33589105|NCT02301546|102045437|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
33589106|NCT02301546|102045438|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
33589107|NCT02301546|102045437|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
33589108|NCT02301546|102045438|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
33589109|NCT02301546|102045437|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
33589110|NCT02301546|102045438|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
33589111|NCT02301546|102045437|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
33589112|NCT02301546|102045438|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
33589113|NCT00487942|102045439|FG000|Overall Study|Adverse Event|1|||
33589114|NCT00487942|102045440|FG001|Overall Study|Adverse Event|1|||
33589115|NCT00487942|102045441|FG002|Overall Study|Adverse Event|1|||
33589116|NCT00487942|102045442|FG003|Overall Study|Adverse Event|1|||
33589117|NCT00487942|102045439|FG000|Overall Study|Lost to Follow-up|1|||
33589118|NCT00487942|102045440|FG001|Overall Study|Lost to Follow-up|0|||
33589119|NCT00487942|102045441|FG002|Overall Study|Lost to Follow-up|0|||
33589120|NCT00487942|102045442|FG003|Overall Study|Lost to Follow-up|1|||
33589121|NCT00487942|102045439|FG000|Overall Study|Protocol Violation|1|||
33589122|NCT00487942|102045440|FG001|Overall Study|Protocol Violation|1|||
33589123|NCT00487942|102045441|FG002|Overall Study|Protocol Violation|0|||
33589124|NCT00487942|102045442|FG003|Overall Study|Protocol Violation|0|||
33648535|NCT00689117|102265667|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
33150058|NCT00736879|100463595|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
33150059|NCT00736879|100463596|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
33150060|NCT00736879|100463597|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
33150061|NCT03148275|100463602|FG000|Overall Study|Death|6|||
33589125|NCT00487942|102045439|FG000|Overall Study|Withdrawal by Subject|0|||
33589126|NCT00487942|102045440|FG001|Overall Study|Withdrawal by Subject|1|||
33589127|NCT00487942|102045441|FG002|Overall Study|Withdrawal by Subject|2|||
33589128|NCT00487942|102045442|FG003|Overall Study|Withdrawal by Subject|0|||
33589129|NCT02910401|102045446|FG000|Overall Study|Study closure Study closure|0|||
33589130|NCT02910401|102045447|FG001|Overall Study|Study closure Study closure|0|||
33589131|NCT02910401|102045448|FG002|Overall Study|Study closure Study closure|2|||
33589132|NCT02910401|102045446|FG000|Overall Study|Physician Decision|1|||
33589133|NCT02910401|102045447|FG001|Overall Study|Physician Decision|0|||
33150062|NCT03148275|100463602|FG000|Overall Study|Adverse Event|3|||
33150063|NCT03148275|100463602|FG000|Overall Study|Liver transplant|2|||
33589134|NCT02910401|102045448|FG002|Overall Study|Physician Decision|0|||
33589135|NCT00344318|102045449|FG000|Overall Study|Adverse Event|0|||
33589136|NCT00344318|102045450|FG001|Overall Study|Adverse Event|3|||
33589137|NCT00344318|102045451|FG002|Overall Study|Adverse Event|0|||
33589138|NCT00344318|102045452|FG003|Overall Study|Adverse Event|1|||
33589139|NCT00344318|102045449|FG000|Overall Study|Withdrawal by Subject|2|||
33589140|NCT00344318|102045450|FG001|Overall Study|Withdrawal by Subject|2|||
33589141|NCT00344318|102045451|FG002|Overall Study|Withdrawal by Subject|0|||
33589142|NCT00344318|102045452|FG003|Overall Study|Withdrawal by Subject|2|||
33589143|NCT00344318|102045449|FG000|Overall Study|Lost to Follow-up|2|||
33589144|NCT00344318|102045450|FG001|Overall Study|Lost to Follow-up|0|||
33589145|NCT00344318|102045451|FG002|Overall Study|Lost to Follow-up|1|||
33589146|NCT00344318|102045452|FG003|Overall Study|Lost to Follow-up|0|||
33589147|NCT02719691|102045458|FG000|Overall Study|Physician Decision|0|||
33589148|NCT02719691|102045459|FG001|Overall Study|Physician Decision|0|||
33589149|NCT02719691|102045460|FG002|Overall Study|Physician Decision|1|||
33589150|NCT02719691|102045461|FG003|Overall Study|Physician Decision|0|||
33589151|NCT02719691|102045462|FG004|Overall Study|Physician Decision|0|||
33589152|NCT02719691|102045463|FG005|Overall Study|Physician Decision|0|||
33589153|NCT02719691|102045464|FG006|Overall Study|Physician Decision|0|||
33589154|NCT02719691|102045458|FG000|Overall Study|Withdrawal by Subject|0|||
33589155|NCT02719691|102045459|FG001|Overall Study|Withdrawal by Subject|0|||
33589156|NCT02719691|102045460|FG002|Overall Study|Withdrawal by Subject|0|||
33589157|NCT02719691|102045461|FG003|Overall Study|Withdrawal by Subject|0|||
33589158|NCT02719691|102045462|FG004|Overall Study|Withdrawal by Subject|0|||
33589159|NCT02719691|102045463|FG005|Overall Study|Withdrawal by Subject|1|||
33589160|NCT02719691|102045464|FG006|Overall Study|Withdrawal by Subject|0|||
33589161|NCT03635424|102045466|FG000|Overall Study|Adverse Event|1|||
33589162|NCT03635424|102045466|FG000|Overall Study|Death|1|||
33589163|NCT03635424|102045466|FG000|Overall Study|Device not implanted|1|||
33589164|NCT01597908|102045478|FG000|Randomized Phase|Death|217|||
33589165|NCT01597908|102045479|FG001|Randomized Phase|Death|238|||
33589166|NCT01597908|102045480|FG002|Randomized Phase|Death|0|||
33589167|NCT01597908|102045478|FG000|Randomized Phase|Sponsor Decision|93|||
33589168|NCT01597908|102045479|FG001|Randomized Phase|Sponsor Decision|39|||
33589169|NCT01597908|102045480|FG002|Randomized Phase|Sponsor Decision|0|||
33589170|NCT01597908|102045478|FG000|Randomized Phase|Lost to Follow-up|9|||
33589171|NCT01597908|102045479|FG001|Randomized Phase|Lost to Follow-up|16|||
33589172|NCT01597908|102045480|FG002|Randomized Phase|Lost to Follow-up|0|||
33589173|NCT01597908|102045478|FG000|Randomized Phase|Physician Decision|6|||
33589174|NCT01597908|102045479|FG001|Randomized Phase|Physician Decision|3|||
33589175|NCT01597908|102045480|FG002|Randomized Phase|Physician Decision|0|||
33589176|NCT01597908|102045478|FG000|Randomized Phase|Withdrawal by Subject|26|||
33589177|NCT01597908|102045479|FG001|Randomized Phase|Withdrawal by Subject|22|||
33589178|NCT01597908|102045480|FG002|Randomized Phase|Withdrawal by Subject|0|||
33589179|NCT01597908|102045478|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
33589180|NCT01597908|102045479|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
33589181|NCT01597908|102045480|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
33589182|NCT01597908|102045478|FG000|Crossover Phase|Death|0|||
33589183|NCT01597908|102045479|FG001|Crossover Phase|Death|0|||
33589184|NCT01597908|102045480|FG002|Crossover Phase|Death|11|||
33589185|NCT01597908|102045478|FG000|Crossover Phase|Withdrawal by Subject|0|||
33589186|NCT01597908|102045479|FG001|Crossover Phase|Withdrawal by Subject|0|||
33589187|NCT01597908|102045480|FG002|Crossover Phase|Withdrawal by Subject|3|||
33589188|NCT01597908|102045478|FG000|Crossover Phase|Sponsor Decision|0|||
33589189|NCT01597908|102045479|FG001|Crossover Phase|Sponsor Decision|0|||
33589190|NCT01597908|102045480|FG002|Crossover Phase|Sponsor Decision|20|||
33589191|NCT04731298|102045481|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
33589192|NCT04731298|102045482|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
33589193|NCT03655054|102045483|FG000|Overall Study|Lost to Follow-up|1|||
33589194|NCT01357161|102045484|FG000|Part 1 (Open Label Run-in)|Death|5|||
33589195|NCT01357161|102045485|FG001|Part 1 (Open Label Run-in)|Death|0|||
33589196|NCT01357161|102045486|FG002|Part 1 (Open Label Run-in)|Death|0|||
33589197|NCT01357161|102045484|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
33589198|NCT01357161|102045485|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
33589199|NCT01357161|102045486|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
33150064|NCT03148275|100463602|FG000|Overall Study|Patient decision|5|||
33589200|NCT01357161|102045484|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
33589201|NCT01357161|102045485|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
33589202|NCT01357161|102045486|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
33589203|NCT01357161|102045484|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
33589204|NCT01357161|102045485|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
33589205|NCT01357161|102045486|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
33589206|NCT01357161|102045484|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
33589207|NCT01357161|102045485|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
33589208|NCT01357161|102045486|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
33648536|NCT00689117|102265664|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
33589209|NCT01357161|102045484|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
33589210|NCT01357161|102045485|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
33589211|NCT01357161|102045486|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
33589212|NCT01357161|102045484|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
33589213|NCT01357161|102045485|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
33589214|NCT01357161|102045486|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
33589215|NCT01357161|102045484|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
33589216|NCT01357161|102045485|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
33589217|NCT01357161|102045486|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
33589218|NCT01357161|102045484|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
33589219|NCT01357161|102045485|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
33589220|NCT01357161|102045486|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
33589221|NCT01357161|102045484|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
33589222|NCT01357161|102045485|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
33589223|NCT01357161|102045486|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
33589224|NCT01357161|102045484|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
33589225|NCT01357161|102045485|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
33589226|NCT01357161|102045486|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
33589227|NCT00578877|102045487|FG000|Overall Study|Lost to Follow-up|8|||
33589228|NCT00578877|102045488|FG001|Overall Study|Lost to Follow-up|10|||
33589229|NCT00578877|102045487|FG000|Overall Study|early discontinue|61|||
33589230|NCT00578877|102045488|FG001|Overall Study|early discontinue|101|||
33589231|NCT00578877|102045487|FG000|Overall Study|did not provide follow-up data|12|||
33589232|NCT00578877|102045488|FG001|Overall Study|did not provide follow-up data|17|||
33589233|NCT00842153|102045489|FG000|Overall Study|Adverse Event|0|||
33589234|NCT00842153|102045490|FG001|Overall Study|Adverse Event|1|||
33589235|NCT00842153|102045489|FG000|Overall Study|Lost to Follow-up|1|||
33589236|NCT00842153|102045490|FG001|Overall Study|Lost to Follow-up|2|||
33589237|NCT00313313|102045491|FG000|Overall Study|Lack of Efficacy|14|||
33589238|NCT00313313|102045492|FG001|Overall Study|Lack of Efficacy|9|||
33589239|NCT00313313|102045493|FG002|Overall Study|Lack of Efficacy|20|||
33589240|NCT00313313|102045491|FG000|Overall Study|Withdrawal of consent by subject|18|||
33589241|NCT00313313|102045492|FG001|Overall Study|Withdrawal of consent by subject|17|||
33589242|NCT00313313|102045493|FG002|Overall Study|Withdrawal of consent by subject|31|||
33589243|NCT00313313|102045491|FG000|Overall Study|Lost to Follow-up|10|||
33589244|NCT00313313|102045492|FG001|Overall Study|Lost to Follow-up|7|||
33589245|NCT00313313|102045493|FG002|Overall Study|Lost to Follow-up|9|||
33589246|NCT00313313|102045491|FG000|Overall Study|Adverse Event|15|||
33589247|NCT00313313|102045492|FG001|Overall Study|Adverse Event|16|||
33589248|NCT00313313|102045493|FG002|Overall Study|Adverse Event|12|||
33589249|NCT00313313|102045491|FG000|Overall Study|Physician Decision|2|||
33589250|NCT00313313|102045492|FG001|Overall Study|Physician Decision|6|||
33589251|NCT00313313|102045493|FG002|Overall Study|Physician Decision|4|||
33589252|NCT00313313|102045491|FG000|Overall Study|Poor/Noncompliance|3|||
33589253|NCT00313313|102045492|FG001|Overall Study|Poor/Noncompliance|6|||
33589254|NCT00313313|102045493|FG002|Overall Study|Poor/Noncompliance|2|||
33589255|NCT00313313|102045491|FG000|Overall Study|Pregnancy|1|||
33589256|NCT00313313|102045492|FG001|Overall Study|Pregnancy|2|||
33589257|NCT00313313|102045493|FG002|Overall Study|Pregnancy|0|||
33589258|NCT00313313|102045491|FG000|Overall Study|Death|0|||
33589259|NCT00313313|102045492|FG001|Overall Study|Death|0|||
33589260|NCT00313313|102045493|FG002|Overall Study|Death|2|||
33589261|NCT00313313|102045491|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
33589262|NCT00313313|102045492|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
33589263|NCT00313313|102045493|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
33589264|NCT04123093|102045497|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
33589265|NCT04123093|102045498|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
33589266|NCT04123093|102045497|FG000|Phase 2|Physician Decision|0|||
33589267|NCT04123093|102045498|FG001|Phase 2|Physician Decision|1|||
33589268|NCT04123093|102045497|FG000|Phase 2|Withdrawal by Subject|0|||
33589269|NCT04123093|102045498|FG001|Phase 2|Withdrawal by Subject|1|||
33589270|NCT01296711|102045503|FG000|Overall Study|Adverse Event|3|||
33589271|NCT01296711|102045504|FG001|Overall Study|Adverse Event|1|||
33589272|NCT01296711|102045505|FG002|Overall Study|Adverse Event|4|||
33589273|NCT01296711|102045506|FG003|Overall Study|Adverse Event|3|||
33433174|NCT02563522|101476791|FG000|Overall Study|Adverse Event|2|||
33589274|NCT01296711|102045507|FG004|Overall Study|Adverse Event|1|||
33589275|NCT01296711|102045508|FG005|Overall Study|Adverse Event|6|||
33589276|NCT01296711|102045509|FG006|Overall Study|Adverse Event|11|||
33589277|NCT01296711|102045510|FG007|Overall Study|Adverse Event|3|||
33589278|NCT01296711|102045503|FG000|Overall Study|Lack of Efficacy|1|||
33589279|NCT01296711|102045504|FG001|Overall Study|Lack of Efficacy|4|||
33589280|NCT01296711|102045505|FG002|Overall Study|Lack of Efficacy|1|||
33589281|NCT01296711|102045506|FG003|Overall Study|Lack of Efficacy|1|||
33589282|NCT01296711|102045507|FG004|Overall Study|Lack of Efficacy|1|||
33589283|NCT01296711|102045508|FG005|Overall Study|Lack of Efficacy|0|||
33589284|NCT01296711|102045509|FG006|Overall Study|Lack of Efficacy|2|||
33589285|NCT01296711|102045510|FG007|Overall Study|Lack of Efficacy|3|||
33589286|NCT01296711|102045503|FG000|Overall Study|Lost to Follow-up|0|||
33589287|NCT01296711|102045504|FG001|Overall Study|Lost to Follow-up|0|||
33589288|NCT01296711|102045505|FG002|Overall Study|Lost to Follow-up|1|||
33589289|NCT01296711|102045506|FG003|Overall Study|Lost to Follow-up|1|||
33589290|NCT01296711|102045507|FG004|Overall Study|Lost to Follow-up|2|||
33589291|NCT01296711|102045508|FG005|Overall Study|Lost to Follow-up|0|||
33589292|NCT01296711|102045509|FG006|Overall Study|Lost to Follow-up|4|||
33589293|NCT01296711|102045510|FG007|Overall Study|Lost to Follow-up|2|||
33589294|NCT01296711|102045503|FG000|Overall Study|Protocol Violation|0|||
33589295|NCT01296711|102045504|FG001|Overall Study|Protocol Violation|0|||
33589296|NCT01296711|102045505|FG002|Overall Study|Protocol Violation|0|||
33589297|NCT01296711|102045506|FG003|Overall Study|Protocol Violation|1|||
33589298|NCT01296711|102045507|FG004|Overall Study|Protocol Violation|1|||
33589299|NCT01296711|102045508|FG005|Overall Study|Protocol Violation|0|||
33589300|NCT01296711|102045509|FG006|Overall Study|Protocol Violation|0|||
33589301|NCT01296711|102045510|FG007|Overall Study|Protocol Violation|0|||
33589302|NCT01296711|102045503|FG000|Overall Study|Withdrawal by Subject|4|||
33589303|NCT01296711|102045504|FG001|Overall Study|Withdrawal by Subject|2|||
33589304|NCT01296711|102045505|FG002|Overall Study|Withdrawal by Subject|2|||
33648537|NCT00689117|102265665|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
33648538|NCT00689117|102265666|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
33648539|NCT00689117|102265667|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
33648540|NCT00689117|102265664|FG000|Overall Study|Use of Prohibitive Medication|2|||
33648541|NCT00689117|102265665|FG001|Overall Study|Use of Prohibitive Medication|1|||
33648542|NCT00689117|102265666|FG002|Overall Study|Use of Prohibitive Medication|3|||
33648543|NCT00689117|102265667|FG003|Overall Study|Use of Prohibitive Medication|0|||
33648544|NCT00689117|102265664|FG000|Overall Study|Pregnancy|0|||
33648545|NCT00689117|102265665|FG001|Overall Study|Pregnancy|2|||
33648546|NCT00689117|102265666|FG002|Overall Study|Pregnancy|0|||
33648547|NCT00689117|102265667|FG003|Overall Study|Pregnancy|2|||
33648548|NCT00689117|102265664|FG000|Overall Study|Incarceration|2|||
33648549|NCT00689117|102265665|FG001|Overall Study|Incarceration|0|||
33648550|NCT00689117|102265666|FG002|Overall Study|Incarceration|0|||
33648551|NCT00689117|102265667|FG003|Overall Study|Incarceration|0|||
33648552|NCT00689117|102265664|FG000|Overall Study|Fear of Birth Defects|0|||
33648553|NCT00689117|102265665|FG001|Overall Study|Fear of Birth Defects|0|||
33648554|NCT00689117|102265666|FG002|Overall Study|Fear of Birth Defects|1|||
33648555|NCT00689117|102265667|FG003|Overall Study|Fear of Birth Defects|0|||
33648556|NCT00689117|102265664|FG000|Overall Study|Transportation|1|||
33648557|NCT00689117|102265665|FG001|Overall Study|Transportation|0|||
33648558|NCT00689117|102265666|FG002|Overall Study|Transportation|0|||
33648559|NCT00689117|102265667|FG003|Overall Study|Transportation|0|||
33648560|NCT00689117|102265664|FG000|Overall Study|Patient Withdrew from Study|0|||
33648561|NCT00689117|102265665|FG001|Overall Study|Patient Withdrew from Study|0|||
33648562|NCT00689117|102265666|FG002|Overall Study|Patient Withdrew from Study|0|||
33648563|NCT00689117|102265667|FG003|Overall Study|Patient Withdrew from Study|1|||
33648564|NCT00689117|102265664|FG000|Overall Study|Personal Reason|0|||
33648565|NCT00689117|102265665|FG001|Overall Study|Personal Reason|1|||
33648566|NCT00689117|102265666|FG002|Overall Study|Personal Reason|0|||
33648567|NCT00689117|102265667|FG003|Overall Study|Personal Reason|0|||
33648568|NCT00689117|102265664|FG000|Overall Study|Dispensing Error|0|||
33648569|NCT00689117|102265665|FG001|Overall Study|Dispensing Error|1|||
33648570|NCT00689117|102265666|FG002|Overall Study|Dispensing Error|0|||
33648571|NCT00689117|102265667|FG003|Overall Study|Dispensing Error|0|||
33589305|NCT01296711|102045506|FG003|Overall Study|Withdrawal by Subject|1|||
33589306|NCT01296711|102045507|FG004|Overall Study|Withdrawal by Subject|1|||
33589307|NCT01296711|102045508|FG005|Overall Study|Withdrawal by Subject|1|||
33589308|NCT01296711|102045509|FG006|Overall Study|Withdrawal by Subject|2|||
33589309|NCT01296711|102045510|FG007|Overall Study|Withdrawal by Subject|1|||
33589310|NCT01296711|102045503|FG000|Overall Study|Study termination|8|||
33589311|NCT01296711|102045504|FG001|Overall Study|Study termination|1|||
33589312|NCT01296711|102045505|FG002|Overall Study|Study termination|5|||
33589313|NCT01296711|102045506|FG003|Overall Study|Study termination|4|||
33589314|NCT01296711|102045507|FG004|Overall Study|Study termination|4|||
33648572|NCT01454778|102265668|FG000|Overall Study|Lost to Follow-up|2|||
33648573|NCT01454778|102265668|FG000|Overall Study|Death|1|||
33648574|NCT03232333|102265676|FG000|Overall Study|Infection or Osteomyelitis|9|||
33648575|NCT03232333|102265676|FG000|Overall Study|Lost to Follow-up|4|||
33648576|NCT03232333|102265676|FG000|Overall Study|Withdrawal by Subject|2|||
33150065|NCT03148275|100463602|FG000|Overall Study|transition to commercial drug|1|||
33589315|NCT01296711|102045508|FG005|Overall Study|Study termination|4|||
33589316|NCT01296711|102045509|FG006|Overall Study|Study termination|8|||
33648577|NCT02894502|102265677|FG000|Baseline|Withdrawal by Subject|24|||
33648578|NCT02894502|102265678|FG001|Baseline|Withdrawal by Subject|31|||
33648579|NCT02894502|102265679|FG002|Baseline|Withdrawal by Subject|36|||
33648580|NCT02894502|102265677|FG000|Baseline|Death|3|||
33589317|NCT01296711|102045510|FG007|Overall Study|Study termination|10|||
33589318|NCT01296711|102045503|FG000|Overall Study|Continued elevated liver enzymes|0|||
33589319|NCT01296711|102045504|FG001|Overall Study|Continued elevated liver enzymes|0|||
33589320|NCT01296711|102045505|FG002|Overall Study|Continued elevated liver enzymes|0|||
33589321|NCT01296711|102045506|FG003|Overall Study|Continued elevated liver enzymes|1|||
33589322|NCT01296711|102045507|FG004|Overall Study|Continued elevated liver enzymes|0|||
33589323|NCT01296711|102045508|FG005|Overall Study|Continued elevated liver enzymes|0|||
33589324|NCT01296711|102045509|FG006|Overall Study|Continued elevated liver enzymes|0|||
33589325|NCT01296711|102045510|FG007|Overall Study|Continued elevated liver enzymes|0|||
33589326|NCT01296711|102045503|FG000|Overall Study|Methotrexate discontinued|0|||
33589327|NCT01296711|102045504|FG001|Overall Study|Methotrexate discontinued|0|||
33589328|NCT01296711|102045505|FG002|Overall Study|Methotrexate discontinued|0|||
33589329|NCT01296711|102045506|FG003|Overall Study|Methotrexate discontinued|1|||
33589330|NCT01296711|102045507|FG004|Overall Study|Methotrexate discontinued|0|||
33589331|NCT01296711|102045508|FG005|Overall Study|Methotrexate discontinued|0|||
33589332|NCT01296711|102045509|FG006|Overall Study|Methotrexate discontinued|0|||
33433175|NCT02563522|101476792|FG001|Overall Study|Adverse Event|3|||
33433176|NCT02563522|101476791|FG000|Overall Study|Lost to Follow-up|1|||
33433177|NCT02563522|101476792|FG001|Overall Study|Lost to Follow-up|0|||
33433178|NCT02563522|101476791|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
33433179|NCT02563522|101476792|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
33433180|NCT02456909|101476802|FG000|Overall Study|Did not receive allocated intervention|24|||
33433181|NCT02456909|101476803|FG001|Overall Study|Did not receive allocated intervention|26|||
33433182|NCT02456909|101476802|FG000|Overall Study|Did not complete the primary outcome|0|||
33433183|NCT02456909|101476803|FG001|Overall Study|Did not complete the primary outcome|1|||
33433184|NCT01326026|101476804|FG000|Overall Study|Adverse Event|4|||
33433185|NCT01326026|101476805|FG001|Overall Study|Adverse Event|3|||
33433186|NCT01326026|101476804|FG000|Overall Study|Withdrawal Criteria|5|||
33433187|NCT01326026|101476805|FG001|Overall Study|Withdrawal Criteria|7|||
33433188|NCT01326026|101476804|FG000|Overall Study|Other|3|||
33433189|NCT01326026|101476805|FG001|Overall Study|Other|3|||
33433190|NCT02354586|101476806|FG000|Overall Study|Death|230|||
33433191|NCT02354586|101476806|FG000|Overall Study|Withdrawal by Subject|59|||
33433192|NCT02354586|101476806|FG000|Overall Study|Lost to Follow-up|11|||
33433193|NCT02354586|101476806|FG000|Overall Study|Sponsor decision|51|||
33433194|NCT02354586|101476806|FG000|Overall Study|Site closure|2|||
33433195|NCT02354586|101476806|FG000|Overall Study|Intercurrent illness|1|||
33433196|NCT02354586|101476806|FG000|Overall Study|Protocol Violation|3|||
33433197|NCT02354586|101476806|FG000|Overall Study|Physician Decision|13|||
33433198|NCT02354586|101476806|FG000|Overall Study|Lack of Efficacy|86|||
33433199|NCT02354586|101476806|FG000|Overall Study|Adverse Event|7|||
33433200|NCT01673009|101476807|FG000|Overall Study|Physician Decision|5|||
33433201|NCT01673009|101476807|FG000|Overall Study|Withdrawal by Subject|8|||
33433202|NCT03504852|101476810|FG000|Overall Study|Withdrawal of informed consent|2|||
33433203|NCT03504852|101476811|FG001|Overall Study|Withdrawal of informed consent|1|||
33433204|NCT03504852|101476812|FG002|Overall Study|Withdrawal of informed consent|0|||
33433205|NCT03504852|101476810|FG000|Overall Study|Withdrawal by Subject|5|||
33433206|NCT03504852|101476811|FG001|Overall Study|Withdrawal by Subject|5|||
33433207|NCT03504852|101476812|FG002|Overall Study|Withdrawal by Subject|1|||
33433208|NCT03504852|101476810|FG000|Overall Study|Lost to Follow-up|4|||
33433209|NCT03504852|101476811|FG001|Overall Study|Lost to Follow-up|1|||
33433210|NCT03504852|101476812|FG002|Overall Study|Lost to Follow-up|0|||
33433211|NCT03504852|101476810|FG000|Overall Study|New therapy for study indication|1|||
33433212|NCT03504852|101476811|FG001|Overall Study|New therapy for study indication|0|||
33433213|NCT03504852|101476812|FG002|Overall Study|New therapy for study indication|0|||
33433214|NCT03504852|101476810|FG000|Overall Study|Lack of Efficacy|1|||
33433215|NCT03504852|101476811|FG001|Overall Study|Lack of Efficacy|2|||
33433216|NCT03504852|101476812|FG002|Overall Study|Lack of Efficacy|0|||
33433217|NCT03504852|101476810|FG000|Overall Study|Death|0|||
33433218|NCT03504852|101476811|FG001|Overall Study|Death|1|||
33433219|NCT03504852|101476812|FG002|Overall Study|Death|0|||
33433220|NCT03504852|101476810|FG000|Overall Study|Adverse Event|4|||
33433221|NCT03504852|101476811|FG001|Overall Study|Adverse Event|8|||
33433222|NCT03504852|101476812|FG002|Overall Study|Adverse Event|2|||
33589333|NCT01296711|102045510|FG007|Overall Study|Methotrexate discontinued|0|||
33589334|NCT01296711|102045503|FG000|Overall Study|Investigator discretion|0|||
33589335|NCT01296711|102045504|FG001|Overall Study|Investigator discretion|0|||
33589336|NCT01296711|102045505|FG002|Overall Study|Investigator discretion|0|||
33433223|NCT03519256|101476813|FG000|Overall Study|Disease recurrence|4|||
33433224|NCT03519256|101476814|FG001|Overall Study|Disease recurrence|4|||
33433225|NCT03519256|101476815|FG002|Overall Study|Disease recurrence|5|||
33433226|NCT03519256|101476816|FG003|Overall Study|Disease recurrence|2|||
33433227|NCT03519256|101476813|FG000|Overall Study|Study drug toxicity|0|||
33433228|NCT03519256|101476814|FG001|Overall Study|Study drug toxicity|2|||
33433229|NCT03519256|101476815|FG002|Overall Study|Study drug toxicity|5|||
33433230|NCT03519256|101476816|FG003|Overall Study|Study drug toxicity|2|||
33589337|NCT01296711|102045506|FG003|Overall Study|Investigator discretion|0|||
33589338|NCT01296711|102045507|FG004|Overall Study|Investigator discretion|0|||
33589339|NCT01296711|102045508|FG005|Overall Study|Investigator discretion|0|||
33589340|NCT01296711|102045509|FG006|Overall Study|Investigator discretion|1|||
33589341|NCT01296711|102045510|FG007|Overall Study|Investigator discretion|0|||
33589342|NCT01296711|102045503|FG000|Overall Study|Other|0|||
33589343|NCT01296711|102045504|FG001|Overall Study|Other|0|||
33589344|NCT01296711|102045505|FG002|Overall Study|Other|0|||
33589345|NCT01296711|102045506|FG003|Overall Study|Other|0|||
33589346|NCT01296711|102045507|FG004|Overall Study|Other|0|||
33589347|NCT01296711|102045508|FG005|Overall Study|Other|0|||
33589348|NCT01296711|102045509|FG006|Overall Study|Other|1|||
33589349|NCT01296711|102045510|FG007|Overall Study|Other|0|||
33589350|NCT01296711|102045503|FG000|Overall Study|Required restricted steroid injections|0|||
33589351|NCT01296711|102045504|FG001|Overall Study|Required restricted steroid injections|0|||
33589352|NCT01296711|102045505|FG002|Overall Study|Required restricted steroid injections|0|||
33589353|NCT01296711|102045506|FG003|Overall Study|Required restricted steroid injections|0|||
33589354|NCT01296711|102045507|FG004|Overall Study|Required restricted steroid injections|0|||
33589355|NCT01296711|102045508|FG005|Overall Study|Required restricted steroid injections|0|||
33589356|NCT01296711|102045509|FG006|Overall Study|Required restricted steroid injections|1|||
33589357|NCT01296711|102045510|FG007|Overall Study|Required restricted steroid injections|0|||
33589358|NCT01296711|102045503|FG000|Overall Study|Ongoing missed appointments|0|||
33589359|NCT01296711|102045504|FG001|Overall Study|Ongoing missed appointments|0|||
33589360|NCT01296711|102045505|FG002|Overall Study|Ongoing missed appointments|0|||
33589361|NCT01296711|102045506|FG003|Overall Study|Ongoing missed appointments|0|||
33589362|NCT01296711|102045507|FG004|Overall Study|Ongoing missed appointments|0|||
33589363|NCT01296711|102045508|FG005|Overall Study|Ongoing missed appointments|0|||
33589364|NCT01296711|102045509|FG006|Overall Study|Ongoing missed appointments|1|||
33589365|NCT01296711|102045510|FG007|Overall Study|Ongoing missed appointments|0|||
33589366|NCT01296711|102045503|FG000|Overall Study|Failure to comply with visits|0|||
33589367|NCT01296711|102045504|FG001|Overall Study|Failure to comply with visits|0|||
33589368|NCT01296711|102045505|FG002|Overall Study|Failure to comply with visits|0|||
33589369|NCT01296711|102045506|FG003|Overall Study|Failure to comply with visits|0|||
33589370|NCT01296711|102045507|FG004|Overall Study|Failure to comply with visits|0|||
33589371|NCT01296711|102045508|FG005|Overall Study|Failure to comply with visits|0|||
33589372|NCT01296711|102045509|FG006|Overall Study|Failure to comply with visits|0|||
33589373|NCT01296711|102045510|FG007|Overall Study|Failure to comply with visits|1|||
33589374|NCT01296711|102045503|FG000|Overall Study|Patient decision due to transport|0|||
33589375|NCT01296711|102045504|FG001|Overall Study|Patient decision due to transport|0|||
33589376|NCT01296711|102045505|FG002|Overall Study|Patient decision due to transport|0|||
33589377|NCT01296711|102045506|FG003|Overall Study|Patient decision due to transport|0|||
33589378|NCT01296711|102045507|FG004|Overall Study|Patient decision due to transport|0|||
33589379|NCT01296711|102045508|FG005|Overall Study|Patient decision due to transport|0|||
33589380|NCT01296711|102045509|FG006|Overall Study|Patient decision due to transport|0|||
33589381|NCT01296711|102045510|FG007|Overall Study|Patient decision due to transport|1|||
33589382|NCT02265536|102045513|FG000|Overall Study|Adverse Event|1|||
33589383|NCT02265536|102045514|FG001|Overall Study|Adverse Event|0|||
33589384|NCT02265536|102045515|FG002|Overall Study|Adverse Event|0|||
33589385|NCT02265536|102045516|FG003|Overall Study|Adverse Event|0|||
33589386|NCT02265536|102045517|FG004|Overall Study|Adverse Event|1|||
33589387|NCT02265536|102045518|FG005|Overall Study|Adverse Event|0|||
33589388|NCT02265536|102045513|FG000|Overall Study|Physician Decision|0|||
33589389|NCT02265536|102045514|FG001|Overall Study|Physician Decision|0|||
33589390|NCT02265536|102045515|FG002|Overall Study|Physician Decision|0|||
33589391|NCT02265536|102045516|FG003|Overall Study|Physician Decision|0|||
33589392|NCT02265536|102045517|FG004|Overall Study|Physician Decision|2|||
33589393|NCT02265536|102045518|FG005|Overall Study|Physician Decision|0|||
33589394|NCT02265536|102045513|FG000|Overall Study|Withdrawal by Subject|0|||
33589395|NCT02265536|102045514|FG001|Overall Study|Withdrawal by Subject|3|||
33589396|NCT02265536|102045515|FG002|Overall Study|Withdrawal by Subject|0|||
33589397|NCT02265536|102045516|FG003|Overall Study|Withdrawal by Subject|0|||
33589398|NCT02265536|102045517|FG004|Overall Study|Withdrawal by Subject|0|||
33648581|NCT02894502|102265678|FG001|Baseline|Death|1|||
33648582|NCT02894502|102265679|FG002|Baseline|Death|9|||
33648583|NCT02894502|102265677|FG000|First Follow up|Withdrawal by Subject|32|||
33648584|NCT02894502|102265678|FG001|First Follow up|Withdrawal by Subject|29|||
33648585|NCT02894502|102265679|FG002|First Follow up|Withdrawal by Subject|37|||
33648586|NCT02894502|102265677|FG000|First Follow up|Death|2|||
33648587|NCT02894502|102265678|FG001|First Follow up|Death|2|||
33648588|NCT02894502|102265679|FG002|First Follow up|Death|3|||
33648589|NCT02894502|102265677|FG000|Second Follow up|Withdrawal by Subject|13|||
33648590|NCT02894502|102265678|FG001|Second Follow up|Withdrawal by Subject|15|||
33648591|NCT02894502|102265679|FG002|Second Follow up|Withdrawal by Subject|13|||
33150066|NCT03148275|100463602|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
33384474|NCT02514772|101291628|FG000|Overall Study|Adverse Event|1|||
33589399|NCT02265536|102045518|FG005|Overall Study|Withdrawal by Subject|0|||
33589400|NCT00716482|102045521|FG000|Overall Study|Lost to Follow-up|6|||
33589401|NCT00716482|102045521|FG000|Overall Study|Inadequate acquisition or analysis|50|||
33249637|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
33249638|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
33589402|NCT00716482|102045521|FG000|Overall Study|no pathology obtained|10|||
33249639|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
33249640|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
33249641|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
33249642|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
33249643|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
33249644|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
33249645|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
33249646|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
33249647|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
33249648|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
33249649|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
33249650|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
33249651|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
33249652|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33249653|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
33249654|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
33249655|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33249656|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33249657|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33249658|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
33249659|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
33249660|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
33249661|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33249662|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33249663|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
33249664|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33249665|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33249666|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33249667|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33249668|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33249669|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
33249670|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
33249671|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
33249672|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
33249673|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
33249674|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
33249675|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
33249676|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
33249677|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
33249678|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
33249679|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
33249680|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
33249681|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
33384475|NCT02514772|101291629|FG001|Overall Study|Adverse Event|0|||
33384476|NCT02514772|101291628|FG000|Overall Study|Death|0|||
33384477|NCT02514772|101291629|FG001|Overall Study|Death|1|||
33384478|NCT02514772|101291628|FG000|Overall Study|Withdrawal by Subject|2|||
33384479|NCT02514772|101291629|FG001|Overall Study|Withdrawal by Subject|1|||
33384480|NCT01179347|101291638|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
33384481|NCT01179347|101291639|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
33384482|NCT01179347|101291638|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
33384483|NCT01179347|101291639|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
33384484|NCT01179347|101291638|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
33384485|NCT01179347|101291639|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
33384486|NCT01179347|101291638|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
33384487|NCT01179347|101291639|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
33384488|NCT01179347|101291638|FG000|Double-blind Period (12 Weeks)|Other|2|||
33384489|NCT01179347|101291639|FG001|Double-blind Period (12 Weeks)|Other|4|||
33249682|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
33249683|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
33249684|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
33249685|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
33384490|NCT01179347|101291638|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
33384491|NCT01179347|101291639|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
33589403|NCT00716482|102045521|FG000|Overall Study|technical/machine error|28|||
33589404|NCT00716482|102045521|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
33589405|NCT04730635|102045522|FG000|Overall Study|Lost to Follow-up|1|||
33589406|NCT04730635|102045523|FG001|Overall Study|Lost to Follow-up|0|||
33589407|NCT04730635|102045522|FG000|Overall Study|Withdrawal by Subject|0|||
33589408|NCT04730635|102045523|FG001|Overall Study|Withdrawal by Subject|1|||
33589409|NCT01200407|102045527|FG000|Overall Study|Lost to Follow-up|56|||
33589410|NCT01200407|102045527|FG000|Overall Study|Adverse Event|3|||
33589411|NCT01200407|102045527|FG000|Overall Study|Withdrawal by Subject|4|||
33589412|NCT01200407|102045527|FG000|Overall Study|Other|19|||
33589413|NCT01566149|102045528|FG000|Overall Study|Adverse Event|0|||
33589414|NCT01566149|102045529|FG001|Overall Study|Adverse Event|1|||
33589415|NCT01566149|102045528|FG000|Overall Study|Non-compliance with study medication|2|||
33589416|NCT01566149|102045529|FG001|Overall Study|Non-compliance with study medication|0|||
33589417|NCT01566149|102045528|FG000|Overall Study|Protocol Violation|0|||
33589418|NCT01566149|102045529|FG001|Overall Study|Protocol Violation|1|||
33589419|NCT01566149|102045528|FG000|Overall Study|Withdrawal by Subject|1|||
33589420|NCT01566149|102045529|FG001|Overall Study|Withdrawal by Subject|0|||
33589421|NCT00313144|102045530|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
33589422|NCT00313144|102045530|FG000|Overall Study|Death|7|||
33589423|NCT00313144|102045530|FG000|Overall Study|Lost to Follow-up|5|||
33589424|NCT00313144|102045530|FG000|Overall Study|Withdrawal by Subject|4|||
33589425|NCT00313144|102045530|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
33589426|NCT00313144|102045530|FG000|Overall Study|Physician Decision|4|||
33589427|NCT00313144|102045530|FG000|Overall Study|Adverse event - transient|5|||
33589428|NCT00313144|102045530|FG000|Overall Study|Liver transplant|1|||
33589429|NCT00313144|102045530|FG000|Overall Study|Insurance (homecare provider) change|1|||
33589430|NCT00313144|102045530|FG000|Overall Study|Change to different product|1|||
33589431|NCT00313144|102045530|FG000|Overall Study|Due to termination of the study|66|||
33589432|NCT01331837|102045531|FG000|Overall Study|Death|30|||
33589433|NCT01331837|102045532|FG001|Overall Study|Death|34|||
33589434|NCT01331837|102045531|FG000|Overall Study|Lost to Follow-up|3|||
33589435|NCT01331837|102045532|FG001|Overall Study|Lost to Follow-up|1|||
33589436|NCT01331837|102045531|FG000|Overall Study|Info not recorded|10|||
33589437|NCT01331837|102045532|FG001|Overall Study|Info not recorded|16|||
33589438|NCT01331837|102045531|FG000|Overall Study|Withdrawal by Subject|13|||
33589439|NCT01331837|102045532|FG001|Overall Study|Withdrawal by Subject|16|||
33589440|NCT01355679|102045533|FG000|Overall Study|benign tumor types found at biopsy|2|||
33589441|NCT02095873|102045536|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
33589442|NCT02095873|102045537|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
33589443|NCT02095873|102045536|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
33589444|NCT02095873|102045537|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
33589445|NCT02095873|102045536|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
33589446|NCT02095873|102045537|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
33589447|NCT00271856|102045538|FG000|Overall Study|Withdrawal by Subject|1|||
33589448|NCT00271856|102045539|FG001|Overall Study|Withdrawal by Subject|7|||
33589449|NCT00271856|102045538|FG000|Overall Study|Lost to Follow-up|10|||
33589450|NCT00271856|102045539|FG001|Overall Study|Lost to Follow-up|11|||
33589451|NCT04621240|102045544|FG000|Overall Study|Withdrawal by Subject|36|||
33589452|NCT02582814|102045545|FG000|Overall Study|Study-specific withdrawal criteria|1|||
33589453|NCT02582814|102045546|FG001|Overall Study|Study-specific withdrawal criteria|0|||
33589454|NCT02582814|102045545|FG000|Overall Study|Withdrawal by Subject|4|||
33589455|NCT02582814|102045546|FG001|Overall Study|Withdrawal by Subject|3|||
33589456|NCT02582814|102045545|FG000|Overall Study|Adverse Event|4|||
33589457|NCT02582814|102045546|FG001|Overall Study|Adverse Event|4|||
33589458|NCT00566982|102045550|FG000|Overall Study|Adverse Event|6|||
33589459|NCT00566982|102045551|FG001|Overall Study|Adverse Event|48|||
33589460|NCT00566982|102045550|FG000|Overall Study|Withdrawal by Subject|1|||
33589461|NCT00566982|102045551|FG001|Overall Study|Withdrawal by Subject|14|||
33589462|NCT00566982|102045550|FG000|Overall Study|Protocol Violation|1|||
33589463|NCT00566982|102045551|FG001|Overall Study|Protocol Violation|4|||
33589464|NCT00566982|102045550|FG000|Overall Study|Lost to Follow-up|0|||
33589465|NCT00566982|102045551|FG001|Overall Study|Lost to Follow-up|1|||
33589466|NCT00566982|102045550|FG000|Overall Study|Other-family problems & doctor's request|0|||
33648592|NCT02894502|102265677|FG000|Second Follow up|Death|2|||
33648593|NCT02894502|102265678|FG001|Second Follow up|Death|3|||
33589467|NCT00566982|102045551|FG001|Overall Study|Other-family problems & doctor's request|2|||
33648594|NCT02894502|102265679|FG002|Second Follow up|Death|1|||
33433231|NCT03519256|101476813|FG000|Overall Study|Adverse event unrelated to study drug|0|||
33433232|NCT03519256|101476814|FG001|Overall Study|Adverse event unrelated to study drug|1|||
33589468|NCT03201965|102045553|FG000|Overall Study|Death|5|||
33589469|NCT03201965|102045554|FG001|Overall Study|Death|27|||
33589470|NCT03201965|102045555|FG002|Overall Study|Death|27|||
33589471|NCT03201965|102045553|FG000|Overall Study|Lost to Follow-up|0|||
33589472|NCT03201965|102045554|FG001|Overall Study|Lost to Follow-up|1|||
33589473|NCT03201965|102045555|FG002|Overall Study|Lost to Follow-up|0|||
33648595|NCT02894502|102265677|FG000|Third Follow up|Withdrawal by Subject|5|||
33648596|NCT02894502|102265678|FG001|Third Follow up|Withdrawal by Subject|6|||
33648597|NCT02894502|102265679|FG002|Third Follow up|Withdrawal by Subject|3|||
33648598|NCT02894502|102265677|FG000|Third Follow up|Death|1|||
33648599|NCT02894502|102265678|FG001|Third Follow up|Death|1|||
33648600|NCT02894502|102265679|FG002|Third Follow up|Death|0|||
33648601|NCT02365480|102265680|FG000|Overall Study|Withdrawal by Subject|2|||
33648602|NCT02365480|102265681|FG001|Overall Study|Withdrawal by Subject|0|||
33648603|NCT01136785|102265683|FG000|Overall Study|Protocol Violation|2|||
33648604|NCT01136785|102265684|FG001|Overall Study|Protocol Violation|1|||
33648605|NCT02082340|102265685|FG000|Overall Study|Lost to Follow-up|1|||
33648606|NCT02082340|102265686|FG001|Overall Study|Lost to Follow-up|1|||
33648607|NCT01325337|102265687|FG000|Overall Study|Adverse Event|0|||
33648608|NCT01325337|102265688|FG001|Overall Study|Adverse Event|2|||
33648609|NCT01325337|102265689|FG002|Overall Study|Adverse Event|2|||
33648610|NCT01325337|102265690|FG003|Overall Study|Adverse Event|1|||
33648611|NCT01325337|102265691|FG004|Overall Study|Adverse Event|2|||
33648612|NCT01325337|102265687|FG000|Overall Study|Lost to Follow-up|2|||
33648613|NCT01325337|102265688|FG001|Overall Study|Lost to Follow-up|2|||
33648614|NCT01325337|102265689|FG002|Overall Study|Lost to Follow-up|2|||
33648615|NCT01325337|102265690|FG003|Overall Study|Lost to Follow-up|1|||
33648616|NCT01325337|102265691|FG004|Overall Study|Lost to Follow-up|2|||
33648617|NCT01325337|102265687|FG000|Overall Study|Personal Reasons|2|||
33648618|NCT01325337|102265688|FG001|Overall Study|Personal Reasons|5|||
33648619|NCT01325337|102265689|FG002|Overall Study|Personal Reasons|4|||
33648620|NCT01325337|102265690|FG003|Overall Study|Personal Reasons|8|||
33648621|NCT01325337|102265691|FG004|Overall Study|Personal Reasons|3|||
33648622|NCT01325337|102265687|FG000|Overall Study|Withdrawal by Subject|1|||
33249686|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
33589474|NCT03201965|102045553|FG000|Overall Study|Withdrawal by Subject|3|||
33589475|NCT03201965|102045554|FG001|Overall Study|Withdrawal by Subject|13|||
33589476|NCT03201965|102045555|FG002|Overall Study|Withdrawal by Subject|4|||
33589477|NCT03201965|102045553|FG000|Overall Study|Ongoing|20|||
33589478|NCT03201965|102045554|FG001|Overall Study|Ongoing|152|||
33589479|NCT03201965|102045555|FG002|Overall Study|Ongoing|164|||
33589480|NCT00177294|102045556|FG000|Overall Study|Withdrawal by Subject|7|||
33589481|NCT00177294|102045557|FG001|Overall Study|Withdrawal by Subject|5|||
33589482|NCT02789345|102045558|FG000|Overall Study|Adverse Event|0|||
33589483|NCT02789345|102045559|FG001|Overall Study|Adverse Event|0|||
33589484|NCT02789345|102045560|FG002|Overall Study|Adverse Event|1|||
33589485|NCT02789345|102045558|FG000|Overall Study|Death|0|||
33589486|NCT02789345|102045559|FG001|Overall Study|Death|0|||
33589487|NCT02789345|102045560|FG002|Overall Study|Death|1|||
33589488|NCT02789345|102045558|FG000|Overall Study|Physician Decision|2|||
33589489|NCT02789345|102045559|FG001|Overall Study|Physician Decision|0|||
33589490|NCT02789345|102045560|FG002|Overall Study|Physician Decision|1|||
33589491|NCT02789345|102045558|FG000|Overall Study|Progressive Disease|1|||
33589492|NCT02789345|102045559|FG001|Overall Study|Progressive Disease|3|||
33589493|NCT02789345|102045560|FG002|Overall Study|Progressive Disease|14|||
33589494|NCT02487654|102045561|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
33589495|NCT02487654|102045562|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
33589496|NCT02487654|102045561|FG000|Overall Study|Withdrawal by Subject|3|||
33589497|NCT02487654|102045562|FG001|Overall Study|Withdrawal by Subject|7|||
33589498|NCT04308239|102045563|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
33589499|NCT04308239|102045564|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
33589500|NCT04308239|102045563|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
33589501|NCT04308239|102045564|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
33589502|NCT04308239|102045563|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
33589503|NCT04308239|102045564|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
33589504|NCT04308239|102045563|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
33589505|NCT04308239|102045564|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
33589506|NCT01453205|102045569|FG000|Overall Study|Lost to Follow-up|3|||
33589507|NCT01453205|102045570|FG001|Overall Study|Lost to Follow-up|0|||
33589508|NCT01453205|102045571|FG002|Overall Study|Lost to Follow-up|1|||
33589509|NCT01453205|102045569|FG000|Overall Study|Withdrawal by Subject|8|||
33648623|NCT01325337|102265688|FG001|Overall Study|Withdrawal by Subject|0|||
33648624|NCT01325337|102265689|FG002|Overall Study|Withdrawal by Subject|1|||
33648625|NCT01325337|102265690|FG003|Overall Study|Withdrawal by Subject|0|||
33648626|NCT01325337|102265691|FG004|Overall Study|Withdrawal by Subject|1|||
33249687|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
33249688|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33589510|NCT01453205|102045570|FG001|Overall Study|Withdrawal by Subject|3|||
33589511|NCT01453205|102045571|FG002|Overall Study|Withdrawal by Subject|0|||
33648627|NCT01699867|102265697|FG000|Overall Study|Screening Failure|3|||
33648628|NCT00483756|102265698|FG000|Overall Study|Death|2|||
33648629|NCT00483756|102265699|FG001|Overall Study|Death|0|||
33589512|NCT01453205|102045569|FG000|Overall Study|Death|24|||
33589513|NCT01453205|102045570|FG001|Overall Study|Death|22|||
33589514|NCT01453205|102045571|FG002|Overall Study|Death|18|||
33589515|NCT01453205|102045569|FG000|Overall Study|Other|45|||
33589516|NCT01453205|102045570|FG001|Overall Study|Other|27|||
33589517|NCT01453205|102045571|FG002|Overall Study|Other|35|||
33589518|NCT04295681|102045574|FG000|Overall Study|Eligibility error|1|||
33589519|NCT04295681|102045575|FG001|Overall Study|Eligibility error|3|||
33589520|NCT00338286|102045580|FG000|Overall Study|Withdrawal by Subject|50|||
33589521|NCT00338286|102045581|FG001|Overall Study|Withdrawal by Subject|54|||
33589522|NCT00338286|102045580|FG000|Overall Study|Lost to Follow-up|80|||
33589523|NCT00338286|102045581|FG001|Overall Study|Lost to Follow-up|66|||
33589524|NCT00338286|102045580|FG000|Overall Study|Other|103|||
33589525|NCT00338286|102045581|FG001|Overall Study|Other|93|||
33589526|NCT04238481|102045582|FG000|Overall Study|Miscellaneous|0|||
33589527|NCT04238481|102045583|FG001|Overall Study|Miscellaneous|1|||
33589528|NCT04238481|102045584|FG002|Overall Study|Miscellaneous|0|||
33589529|NCT04238481|102045585|FG003|Overall Study|Miscellaneous|0|||
33589530|NCT02839720|102045586|FG000|Overall Study|Adverse Event|2|||
33589531|NCT02839720|102045586|FG000|Overall Study|Non-compliance|2|||
33589532|NCT02839720|102045586|FG000|Overall Study|Intercurrent Illness|1|||
33589533|NCT02839720|102045586|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
33589534|NCT00522418|102045587|FG000|Overall Study|Local IRB Consent Violation|5|||
33589535|NCT00522418|102045588|FG001|Overall Study|Local IRB Consent Violation|5|||
33589536|NCT00522418|102045587|FG000|Overall Study|Early Study Termination|46|||
33589537|NCT00522418|102045588|FG001|Overall Study|Early Study Termination|47|||
33589538|NCT00522418|102045587|FG000|Overall Study|Noncompliance|2|||
33589539|NCT00522418|102045588|FG001|Overall Study|Noncompliance|2|||
33589540|NCT00522418|102045587|FG000|Overall Study|Reason Not Specified|3|||
33589541|NCT00522418|102045588|FG001|Overall Study|Reason Not Specified|1|||
33589542|NCT00522418|102045587|FG000|Overall Study|Consent Withdraw|1|||
33589543|NCT00522418|102045588|FG001|Overall Study|Consent Withdraw|2|||
33589544|NCT00522418|102045587|FG000|Overall Study|Lack of Efficacy|0|||
33589545|NCT00522418|102045588|FG001|Overall Study|Lack of Efficacy|1|||
33589546|NCT00957944|102045589|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
33589547|NCT00957944|102045590|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
33589548|NCT02003638|102045591|FG000|Overall Study|Withdrawal by Subject|1|||
33589549|NCT02003638|102045592|FG001|Overall Study|Withdrawal by Subject|0|||
33589550|NCT03276026|102045593|FG000|Overall Study|Protocol Violation|1|||
33589551|NCT03276026|102045594|FG001|Overall Study|Protocol Violation|0|||
33589552|NCT03136497|102045595|FG000|Overall Study|Screen Failure|1|||
33589553|NCT03136497|102045596|FG001|Overall Study|Screen Failure|0|||
33589554|NCT03136497|102045597|FG002|Overall Study|Screen Failure|0|||
33589555|NCT01126437|102045598|FG000|Overall Study|Not treated|11|||
33589556|NCT01126437|102045599|FG001|Overall Study|Not treated|18|||
33589557|NCT01126437|102045600|FG002|Overall Study|Not treated|19|||
33589558|NCT01126437|102045598|FG000|Overall Study|Sites with data irregularities/fraud|6|||
33589559|NCT01126437|102045599|FG001|Overall Study|Sites with data irregularities/fraud|6|||
33589560|NCT01126437|102045600|FG002|Overall Study|Sites with data irregularities/fraud|7|||
33589561|NCT01126437|102045598|FG000|Overall Study|Adverse Event|602|||
33589562|NCT01126437|102045599|FG001|Overall Study|Adverse Event|606|||
33589563|NCT01126437|102045600|FG002|Overall Study|Adverse Event|635|||
33589564|NCT01126437|102045598|FG000|Overall Study|Lack of Efficacy|65|||
33589565|NCT01126437|102045599|FG001|Overall Study|Lack of Efficacy|60|||
33589566|NCT01126437|102045600|FG002|Overall Study|Lack of Efficacy|59|||
33589567|NCT01126437|102045598|FG000|Overall Study|Protocol Violation|64|||
33589568|NCT01126437|102045599|FG001|Overall Study|Protocol Violation|66|||
33589569|NCT01126437|102045600|FG002|Overall Study|Protocol Violation|41|||
33589570|NCT01126437|102045598|FG000|Overall Study|Lost to Follow-up|52|||
33589571|NCT01126437|102045599|FG001|Overall Study|Lost to Follow-up|63|||
33384492|NCT01179347|101291638|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
33589572|NCT01126437|102045600|FG002|Overall Study|Lost to Follow-up|55|||
33384493|NCT01179347|101291639|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
33589573|NCT01126437|102045598|FG000|Overall Study|Withdrawal by Subject|331|||
33589574|NCT01126437|102045599|FG001|Overall Study|Withdrawal by Subject|335|||
33589575|NCT01126437|102045600|FG002|Overall Study|Withdrawal by Subject|319|||
33589576|NCT01126437|102045598|FG000|Overall Study|Other reason not specified|210|||
33589577|NCT01126437|102045599|FG001|Overall Study|Other reason not specified|176|||
33384494|NCT01179347|101291638|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
33589578|NCT01126437|102045600|FG002|Overall Study|Other reason not specified|178|||
33589579|NCT02321319|102045603|FG000|Overall Study|Product discontinued|5|||
33384495|NCT01179347|101291639|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
33589580|NCT00855933|102045604|FG000|Overall Study|Withdrawal by Subject|0|||
33589581|NCT00855933|102045605|FG001|Overall Study|Withdrawal by Subject|1|||
33589582|NCT01529515|102045606|FG000|TRANSITION PHASE|Adverse Event|16|||
33589583|NCT01529515|102045607|FG001|TRANSITION PHASE|Adverse Event|0|||
33589584|NCT01529515|102045608|FG002|TRANSITION PHASE|Adverse Event|0|||
33589585|NCT01529515|102045609|FG003|TRANSITION PHASE|Adverse Event|0|||
33589586|NCT01529515|102045606|FG000|TRANSITION PHASE|Death|1|||
33589587|NCT01529515|102045607|FG001|TRANSITION PHASE|Death|0|||
33589588|NCT01529515|102045608|FG002|TRANSITION PHASE|Death|0|||
33589589|NCT01529515|102045609|FG003|TRANSITION PHASE|Death|0|||
33589590|NCT01529515|102045606|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
33589591|NCT01529515|102045607|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
33589592|NCT01529515|102045608|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
33589593|NCT01529515|102045609|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
33589594|NCT01529515|102045606|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
33589595|NCT01529515|102045607|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
33589596|NCT01529515|102045608|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
33589597|NCT01529515|102045609|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
33589598|NCT01529515|102045606|FG000|TRANSITION PHASE|Protocol Violation|4|||
33589599|NCT01529515|102045607|FG001|TRANSITION PHASE|Protocol Violation|0|||
33589600|NCT01529515|102045608|FG002|TRANSITION PHASE|Protocol Violation|0|||
33589601|NCT01529515|102045609|FG003|TRANSITION PHASE|Protocol Violation|0|||
33589602|NCT01529515|102045606|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
33589603|NCT01529515|102045607|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
33589604|NCT01529515|102045608|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
33589605|NCT01529515|102045609|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
33589606|NCT01529515|102045606|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
33589607|NCT01529515|102045607|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
33589608|NCT01529515|102045608|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
33589609|NCT01529515|102045609|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
33589610|NCT01529515|102045606|FG000|TRANSITION PHASE|Other|9|||
33589611|NCT01529515|102045607|FG001|TRANSITION PHASE|Other|0|||
33589612|NCT01529515|102045608|FG002|TRANSITION PHASE|Other|0|||
33589613|NCT01529515|102045609|FG003|TRANSITION PHASE|Other|0|||
33589614|NCT01529515|102045606|FG000|MAINTENANCE PHASE|Adverse Event|0|||
33589615|NCT01529515|102045607|FG001|MAINTENANCE PHASE|Adverse Event|10|||
33589616|NCT01529515|102045608|FG002|MAINTENANCE PHASE|Adverse Event|0|||
33589617|NCT01529515|102045609|FG003|MAINTENANCE PHASE|Adverse Event|0|||
33589618|NCT01529515|102045606|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
33589619|NCT01529515|102045607|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
33589620|NCT01529515|102045608|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
33589621|NCT01529515|102045609|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
33589622|NCT01529515|102045606|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
33589623|NCT01529515|102045607|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
33589624|NCT01529515|102045608|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
33589625|NCT01529515|102045609|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
33589626|NCT01529515|102045606|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
33589627|NCT01529515|102045607|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
33589628|NCT01529515|102045608|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
33589629|NCT01529515|102045609|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
33589630|NCT01529515|102045606|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
33589631|NCT01529515|102045607|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
33589632|NCT01529515|102045608|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
33589633|NCT01529515|102045609|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
33589634|NCT01529515|102045606|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
33589635|NCT01529515|102045607|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
33589636|NCT01529515|102045608|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
33589637|NCT01529515|102045609|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
33589638|NCT01529515|102045606|FG000|MAINTENANCE PHASE|Other|0|||
33589639|NCT01529515|102045607|FG001|MAINTENANCE PHASE|Other|10|||
33249689|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33249690|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
33589640|NCT01529515|102045608|FG002|MAINTENANCE PHASE|Other|0|||
33249691|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33589641|NCT01529515|102045609|FG003|MAINTENANCE PHASE|Other|0|||
33589642|NCT01529515|102045606|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
33589643|NCT01529515|102045607|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
33589644|NCT01529515|102045608|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
33589645|NCT01529515|102045609|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
33249692|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33433233|NCT03519256|101476815|FG002|Overall Study|Adverse event unrelated to study drug|1|||
33589646|NCT01529515|102045606|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
33589647|NCT01529515|102045607|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
33589648|NCT01529515|102045608|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
33589649|NCT01529515|102045609|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
33433234|NCT03519256|101476816|FG003|Overall Study|Adverse event unrelated to study drug|0|||
33589650|NCT01529515|102045606|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
33589651|NCT01529515|102045607|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
33589652|NCT01529515|102045608|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
33589653|NCT01529515|102045609|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
33589654|NCT01529515|102045606|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
33589655|NCT01529515|102045607|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
33249693|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33249694|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33249695|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33249696|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
33249697|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33249698|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
33249699|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
33249700|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33249701|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33249702|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33249703|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
33249704|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
33249705|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
33249706|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33249707|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33249708|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33249709|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33249710|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33249711|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33249712|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33249713|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
33249714|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
33249715|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33249716|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
33249717|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33249718|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33249719|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33249720|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33249721|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33249722|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33249723|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
33249724|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
33249725|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
33249726|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
33249727|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
33249728|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
33249729|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
33249730|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
33249731|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
33249732|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
33249733|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
33249734|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
33249735|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
33249736|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
33249737|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
33249738|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
33249739|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
33249740|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
33249741|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
33249742|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
33249743|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
33249744|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
33249745|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
33249746|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
33249747|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
33249748|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
33249749|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
33249750|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
33249751|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
33249752|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
33249753|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
33589656|NCT01529515|102045608|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
33589657|NCT01529515|102045609|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
33249754|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
33249755|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
33249756|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
33249757|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
33249758|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
33589658|NCT01529515|102045606|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
33589659|NCT01529515|102045607|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
33589660|NCT01529515|102045608|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
33589661|NCT01529515|102045609|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
33589662|NCT01529515|102045606|FG000|DOUBLE BLIND PHASE|Other|0|||
33589663|NCT01529515|102045607|FG001|DOUBLE BLIND PHASE|Other|0|||
33589664|NCT01529515|102045608|FG002|DOUBLE BLIND PHASE|Other|9|||
33589665|NCT01529515|102045609|FG003|DOUBLE BLIND PHASE|Other|2|||
33589666|NCT00327015|102045610|FG000|Overall Study|Lack of Efficacy|18|||
33589667|NCT00327015|102045611|FG001|Overall Study|Lack of Efficacy|18|||
33589668|NCT00327015|102045612|FG002|Overall Study|Lack of Efficacy|35|||
33589669|NCT00327015|102045613|FG003|Overall Study|Lack of Efficacy|29|||
33589670|NCT00327015|102045610|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
33589671|NCT00327015|102045611|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
33589672|NCT00327015|102045612|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
33589673|NCT00327015|102045613|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
33589674|NCT00327015|102045610|FG000|Overall Study|Lost to Follow-up|22|||
33589675|NCT00327015|102045611|FG001|Overall Study|Lost to Follow-up|23|||
33589676|NCT00327015|102045612|FG002|Overall Study|Lost to Follow-up|29|||
33589677|NCT00327015|102045613|FG003|Overall Study|Lost to Follow-up|22|||
33589678|NCT00327015|102045610|FG000|Overall Study|Adverse Event|14|||
33589679|NCT00327015|102045611|FG001|Overall Study|Adverse Event|10|||
33589680|NCT00327015|102045612|FG002|Overall Study|Adverse Event|14|||
33589681|NCT00327015|102045613|FG003|Overall Study|Adverse Event|14|||
33589682|NCT00327015|102045610|FG000|Overall Study|Subject no longer meets study criteria|4|||
33589683|NCT00327015|102045611|FG001|Overall Study|Subject no longer meets study criteria|2|||
33589684|NCT00327015|102045612|FG002|Overall Study|Subject no longer meets study criteria|8|||
33589685|NCT00327015|102045613|FG003|Overall Study|Subject no longer meets study criteria|7|||
33589686|NCT00327015|102045610|FG000|Overall Study|Poor/Noncompliance|11|||
33589687|NCT00327015|102045611|FG001|Overall Study|Poor/Noncompliance|8|||
33589688|NCT00327015|102045612|FG002|Overall Study|Poor/Noncompliance|4|||
33589689|NCT00327015|102045613|FG003|Overall Study|Poor/Noncompliance|5|||
33589690|NCT00327015|102045610|FG000|Overall Study|Physician Decision|0|||
33589691|NCT00327015|102045611|FG001|Overall Study|Physician Decision|1|||
33589692|NCT00327015|102045612|FG002|Overall Study|Physician Decision|3|||
33589693|NCT00327015|102045613|FG003|Overall Study|Physician Decision|2|||
33589694|NCT00327015|102045610|FG000|Overall Study|Death|1|||
33589695|NCT00327015|102045611|FG001|Overall Study|Death|2|||
33589696|NCT00327015|102045612|FG002|Overall Study|Death|2|||
33589697|NCT00327015|102045613|FG003|Overall Study|Death|3|||
33589698|NCT00327015|102045610|FG000|Overall Study|Pregnancy|0|||
33589699|NCT00327015|102045611|FG001|Overall Study|Pregnancy|2|||
33589700|NCT00327015|102045612|FG002|Overall Study|Pregnancy|1|||
33589701|NCT00327015|102045613|FG003|Overall Study|Pregnancy|1|||
33589702|NCT00327015|102045610|FG000|Overall Study|Administrative Reason by Sponsor|1|||
33589703|NCT00327015|102045611|FG001|Overall Study|Administrative Reason by Sponsor|2|||
33589704|NCT00327015|102045612|FG002|Overall Study|Administrative Reason by Sponsor|2|||
33589705|NCT00327015|102045613|FG003|Overall Study|Administrative Reason by Sponsor|1|||
33589706|NCT00580034|102045614|FG000|Overall Study|Toxicity|10|||
33589707|NCT00580034|102045615|FG001|Overall Study|Toxicity|0|||
33589708|NCT00322452|102045616|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33589709|NCT00322452|102045617|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33589710|NCT00322452|102045616|FG000|Overall Study|Lost to Follow-up|5|||
33589711|NCT00322452|102045617|FG001|Overall Study|Lost to Follow-up|2|||
33589712|NCT00322452|102045616|FG000|Overall Study|Withdrawal by Subject|19|||
33589713|NCT00322452|102045617|FG001|Overall Study|Withdrawal by Subject|46|||
33589714|NCT00322452|102045616|FG000|Overall Study|Death|223|||
33589715|NCT00322452|102045617|FG001|Overall Study|Death|227|||
33589716|NCT04026009|102045618|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33589717|NCT04026009|102045619|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33589718|NCT04026009|102045620|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
33589719|NCT04026009|102045621|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
33589720|NCT04026009|102045622|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
33589721|NCT04026009|102045618|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
33433235|NCT03519256|101476813|FG000|Overall Study|Participant request to discontinue study treatment|0|||
33589722|NCT04026009|102045619|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
33589723|NCT04026009|102045620|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
33589724|NCT04026009|102045621|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
33648630|NCT00483756|102265700|FG002|Overall Study|Death|1|||
33433236|NCT03519256|101476814|FG001|Overall Study|Participant request to discontinue study treatment|0|||
33589725|NCT04026009|102045622|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
33589726|NCT02374814|102045623|FG000|Overall Study|Lost to Follow-up|1|||
33589727|NCT02374814|102045624|FG001|Overall Study|Lost to Follow-up|1|||
33589728|NCT02374814|102045625|FG002|Overall Study|Lost to Follow-up|0|||
33589729|NCT02374814|102045626|FG003|Overall Study|Lost to Follow-up|1|||
33589730|NCT02374814|102045627|FG004|Overall Study|Lost to Follow-up|0|||
33589731|NCT02374814|102045628|FG005|Overall Study|Lost to Follow-up|0|||
33589732|NCT02374814|102045623|FG000|Overall Study|Withdrawal by Subject|0|||
33589733|NCT02374814|102045624|FG001|Overall Study|Withdrawal by Subject|0|||
33589734|NCT02374814|102045625|FG002|Overall Study|Withdrawal by Subject|1|||
33589735|NCT02374814|102045626|FG003|Overall Study|Withdrawal by Subject|1|||
33589736|NCT02374814|102045627|FG004|Overall Study|Withdrawal by Subject|0|||
33589737|NCT02374814|102045628|FG005|Overall Study|Withdrawal by Subject|0|||
33589738|NCT03006458|102045629|FG000|First Intervention|Unsatisfied Vision|0|||
33589739|NCT03006458|102045630|FG001|First Intervention|Unsatisfied Vision|3|||
33589740|NCT00624585|102050326|FG000|Overall Study|Death|3|||
33589741|NCT00624585|102050326|FG000|Overall Study|Disease Progression|6|||
33589742|NCT00624585|102050326|FG000|Overall Study|Adverse Event|3|||
33589743|NCT04537208|102050331|FG000|Overall Study|Adverse Event|0|||
33589744|NCT04537208|102050332|FG001|Overall Study|Adverse Event|0|||
33589745|NCT04537208|102050333|FG002|Overall Study|Adverse Event|0|||
33589746|NCT04537208|102050334|FG003|Overall Study|Adverse Event|0|||
33589747|NCT04537208|102050335|FG004|Overall Study|Adverse Event|0|||
33589748|NCT04537208|102050336|FG005|Overall Study|Adverse Event|0|||
33589749|NCT04537208|102050337|FG006|Overall Study|Adverse Event|0|||
33589750|NCT04537208|102050338|FG007|Overall Study|Adverse Event|0|||
33589751|NCT04537208|102050339|FG008|Overall Study|Adverse Event|1|||
33589752|NCT04537208|102050340|FG009|Overall Study|Adverse Event|0|||
33589753|NCT04537208|102050341|FG010|Overall Study|Adverse Event|0|||
33589754|NCT04537208|102050331|FG000|Overall Study|Protocol deviation|0|||
33589755|NCT04537208|102050332|FG001|Overall Study|Protocol deviation|0|||
33589756|NCT04537208|102050333|FG002|Overall Study|Protocol deviation|2|||
33589757|NCT04537208|102050334|FG003|Overall Study|Protocol deviation|0|||
33589758|NCT04537208|102050335|FG004|Overall Study|Protocol deviation|0|||
33589759|NCT04537208|102050336|FG005|Overall Study|Protocol deviation|2|||
33589760|NCT04537208|102050337|FG006|Overall Study|Protocol deviation|4|||
33589761|NCT04537208|102050338|FG007|Overall Study|Protocol deviation|0|||
33589762|NCT04537208|102050339|FG008|Overall Study|Protocol deviation|1|||
33589763|NCT04537208|102050340|FG009|Overall Study|Protocol deviation|0|||
33589764|NCT04537208|102050341|FG010|Overall Study|Protocol deviation|2|||
33589765|NCT04537208|102050331|FG000|Overall Study|Withdrawal by Subject|4|||
33589766|NCT04537208|102050332|FG001|Overall Study|Withdrawal by Subject|2|||
33589767|NCT04537208|102050333|FG002|Overall Study|Withdrawal by Subject|1|||
33589768|NCT04537208|102050334|FG003|Overall Study|Withdrawal by Subject|3|||
33589769|NCT04537208|102050335|FG004|Overall Study|Withdrawal by Subject|5|||
33589770|NCT04537208|102050336|FG005|Overall Study|Withdrawal by Subject|1|||
33589771|NCT04537208|102050337|FG006|Overall Study|Withdrawal by Subject|6|||
33589772|NCT04537208|102050338|FG007|Overall Study|Withdrawal by Subject|1|||
33589773|NCT04537208|102050339|FG008|Overall Study|Withdrawal by Subject|7|||
33589774|NCT04537208|102050340|FG009|Overall Study|Withdrawal by Subject|2|||
33589775|NCT04537208|102050341|FG010|Overall Study|Withdrawal by Subject|4|||
33589776|NCT04537208|102050331|FG000|Overall Study|Lost to Follow-up|4|||
33589777|NCT04537208|102050332|FG001|Overall Study|Lost to Follow-up|1|||
33589778|NCT04537208|102050333|FG002|Overall Study|Lost to Follow-up|3|||
33589779|NCT04537208|102050334|FG003|Overall Study|Lost to Follow-up|4|||
33589780|NCT04537208|102050335|FG004|Overall Study|Lost to Follow-up|3|||
33589781|NCT04537208|102050336|FG005|Overall Study|Lost to Follow-up|2|||
33589782|NCT04537208|102050337|FG006|Overall Study|Lost to Follow-up|3|||
33648631|NCT00483756|102265698|FG000|Overall Study|Adverse Event|19|||
33648632|NCT00483756|102265699|FG001|Overall Study|Adverse Event|38|||
33648633|NCT00483756|102265700|FG002|Overall Study|Adverse Event|40|||
33648634|NCT00483756|102265698|FG000|Overall Study|Lack of Efficacy|1|||
33648635|NCT00483756|102265699|FG001|Overall Study|Lack of Efficacy|0|||
33648636|NCT00483756|102265700|FG002|Overall Study|Lack of Efficacy|0|||
33648637|NCT00483756|102265698|FG000|Overall Study|Lost to Follow-up|3|||
33648638|NCT00483756|102265699|FG001|Overall Study|Lost to Follow-up|1|||
33648639|NCT00483756|102265700|FG002|Overall Study|Lost to Follow-up|0|||
33648640|NCT00483756|102265698|FG000|Overall Study|Withdrawal by Subject|5|||
33648641|NCT00483756|102265699|FG001|Overall Study|Withdrawal by Subject|3|||
33648642|NCT00483756|102265700|FG002|Overall Study|Withdrawal by Subject|4|||
33648643|NCT00483756|102265698|FG000|Overall Study|Other|2|||
33648644|NCT00483756|102265699|FG001|Overall Study|Other|4|||
33648645|NCT00483756|102265700|FG002|Overall Study|Other|3|||
33589783|NCT04537208|102050338|FG007|Overall Study|Lost to Follow-up|2|||
33648646|NCT00483756|102265698|FG000|Overall Study|Randomized, Not Treated|1|||
33648647|NCT00483756|102265699|FG001|Overall Study|Randomized, Not Treated|4|||
33648648|NCT00483756|102265700|FG002|Overall Study|Randomized, Not Treated|4|||
33589784|NCT04537208|102050339|FG008|Overall Study|Lost to Follow-up|7|||
33589785|NCT04537208|102050340|FG009|Overall Study|Lost to Follow-up|2|||
33589786|NCT04537208|102050341|FG010|Overall Study|Lost to Follow-up|2|||
33589787|NCT04115748|102050342|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
33589788|NCT04115748|102050343|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
33589789|NCT04115748|102050344|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
33589790|NCT04115748|102050345|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
33648649|NCT00796523|102265701|FG000|Overall Study|Lost to Follow-up|9|||
33648650|NCT00796523|102265702|FG001|Overall Study|Lost to Follow-up|7|||
33648651|NCT03207763|102265703|FG000|Overall Study|Lost to Follow-up|1|||
33648652|NCT03207763|102265704|FG001|Overall Study|Lost to Follow-up|0|||
33648653|NCT04493892|102265705|FG000|Overall Study|Withdrawal by Subject|15|||
33648654|NCT01332799|102265708|FG000|Overall Study|Insufficient funding|10|||
33648655|NCT01332799|102265709|FG001|Overall Study|Insufficient funding|10|||
33648656|NCT01767142|102265710|FG000|Overall Study|Lost to Follow-up|3|||
33648657|NCT01168219|102265711|FG000|Overall Study|off study before starting treatment|2|||
33648658|NCT01168219|102265711|FG000|Overall Study|withdrew before transplant|1|||
33648659|NCT01168219|102265711|FG000|Overall Study|ineligible due to CML|2|||
33648660|NCT01642615|102265712|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
33648661|NCT01642615|102265713|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
33589791|NCT04115748|102050346|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
33589792|NCT04115748|102050347|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
33589793|NCT04115748|102050348|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
33589794|NCT04115748|102050349|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
33589795|NCT04115748|102050350|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
33589796|NCT04115748|102050351|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
33589797|NCT04115748|102050342|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33589798|NCT04115748|102050343|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33589799|NCT04115748|102050344|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33589800|NCT04115748|102050345|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
33589801|NCT04115748|102050346|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33589802|NCT04115748|102050347|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33589803|NCT04115748|102050348|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33589804|NCT04115748|102050349|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33589805|NCT04115748|102050350|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33589806|NCT04115748|102050351|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
33589807|NCT04115748|102050342|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
33589808|NCT04115748|102050343|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
33589809|NCT04115748|102050344|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
33589810|NCT04115748|102050345|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
33589811|NCT04115748|102050346|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
33589812|NCT04115748|102050347|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
33589813|NCT04115748|102050348|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
33589814|NCT04115748|102050349|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
33589815|NCT04115748|102050350|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
33589816|NCT04115748|102050351|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
33589817|NCT04115748|102050342|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33589818|NCT04115748|102050343|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33589819|NCT04115748|102050344|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33589820|NCT04115748|102050345|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33589821|NCT04115748|102050346|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33589822|NCT04115748|102050347|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33589823|NCT04115748|102050348|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33589824|NCT04115748|102050349|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33589825|NCT04115748|102050350|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
33589826|NCT04115748|102050351|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
33589827|NCT01468233|102050354|FG000|Treatment Period 1|Adverse Event|5|||
33589828|NCT01468233|102050355|FG001|Treatment Period 1|Adverse Event|3|||
33589829|NCT01468233|102050356|FG002|Treatment Period 1|Adverse Event|0|||
33589830|NCT01468233|102050357|FG003|Treatment Period 1|Adverse Event|0|||
33589831|NCT01468233|102050358|FG004|Treatment Period 1|Adverse Event|0|||
33589832|NCT01468233|102050359|FG005|Treatment Period 1|Adverse Event|0|||
33589833|NCT01468233|102050354|FG000|Treatment Period 1|Withdrawal by Subject|3|||
33589834|NCT01468233|102050355|FG001|Treatment Period 1|Withdrawal by Subject|4|||
33589835|NCT01468233|102050356|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33589836|NCT01468233|102050357|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33589837|NCT01468233|102050358|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33589838|NCT01468233|102050359|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33589839|NCT01468233|102050354|FG000|Treatment Period 1|Lost to Follow-up|3|||
33648662|NCT01642615|102265714|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
33648663|NCT01642615|102265712|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
33648664|NCT01642615|102265713|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
33249759|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
33249760|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33589840|NCT01468233|102050355|FG001|Treatment Period 1|Lost to Follow-up|0|||
33589841|NCT01468233|102050356|FG002|Treatment Period 1|Lost to Follow-up|0|||
33589842|NCT01468233|102050357|FG003|Treatment Period 1|Lost to Follow-up|0|||
33589843|NCT01468233|102050358|FG004|Treatment Period 1|Lost to Follow-up|0|||
33589844|NCT01468233|102050359|FG005|Treatment Period 1|Lost to Follow-up|0|||
33589845|NCT01468233|102050354|FG000|Treatment Period 1|Other|1|||
33589846|NCT01468233|102050355|FG001|Treatment Period 1|Other|1|||
33589847|NCT01468233|102050356|FG002|Treatment Period 1|Other|0|||
33589848|NCT01468233|102050357|FG003|Treatment Period 1|Other|0|||
33589849|NCT01468233|102050358|FG004|Treatment Period 1|Other|0|||
33589850|NCT01468233|102050359|FG005|Treatment Period 1|Other|0|||
33589851|NCT01468233|102050354|FG000|Treatment Period 2|Adverse Event|0|||
33589852|NCT01468233|102050355|FG001|Treatment Period 2|Adverse Event|0|||
33589853|NCT01468233|102050356|FG002|Treatment Period 2|Adverse Event|3|||
33589854|NCT01468233|102050357|FG003|Treatment Period 2|Adverse Event|0|||
33589855|NCT01468233|102050358|FG004|Treatment Period 2|Adverse Event|2|||
33589856|NCT01468233|102050359|FG005|Treatment Period 2|Adverse Event|1|||
33589857|NCT01468233|102050354|FG000|Treatment Period 2|Lack of Efficacy|0|||
33589858|NCT01468233|102050355|FG001|Treatment Period 2|Lack of Efficacy|0|||
33589859|NCT01468233|102050356|FG002|Treatment Period 2|Lack of Efficacy|9|||
33589860|NCT01468233|102050357|FG003|Treatment Period 2|Lack of Efficacy|2|||
33589861|NCT01468233|102050358|FG004|Treatment Period 2|Lack of Efficacy|0|||
33589862|NCT01468233|102050359|FG005|Treatment Period 2|Lack of Efficacy|1|||
33589863|NCT01468233|102050354|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33589864|NCT01468233|102050355|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33589865|NCT01468233|102050356|FG002|Treatment Period 2|Withdrawal by Subject|9|||
33589866|NCT01468233|102050357|FG003|Treatment Period 2|Withdrawal by Subject|1|||
33589867|NCT01468233|102050358|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33589868|NCT01468233|102050359|FG005|Treatment Period 2|Withdrawal by Subject|1|||
33589869|NCT01468233|102050354|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
33589870|NCT01468233|102050355|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
33589871|NCT01468233|102050356|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
33589872|NCT01468233|102050357|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
33589873|NCT01468233|102050358|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
33589874|NCT01468233|102050359|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
33589875|NCT01468233|102050354|FG000|Treatment Period 2|Lost to Follow-up|0|||
33589876|NCT01468233|102050355|FG001|Treatment Period 2|Lost to Follow-up|0|||
33589877|NCT01468233|102050356|FG002|Treatment Period 2|Lost to Follow-up|3|||
33589878|NCT01468233|102050357|FG003|Treatment Period 2|Lost to Follow-up|0|||
33589879|NCT01468233|102050358|FG004|Treatment Period 2|Lost to Follow-up|2|||
33589880|NCT01468233|102050359|FG005|Treatment Period 2|Lost to Follow-up|0|||
33589881|NCT01468233|102050354|FG000|Treatment Period 2|Other|0|||
33589882|NCT01468233|102050355|FG001|Treatment Period 2|Other|0|||
33589883|NCT01468233|102050356|FG002|Treatment Period 2|Other|3|||
33589884|NCT01468233|102050357|FG003|Treatment Period 2|Other|0|||
33589885|NCT01468233|102050358|FG004|Treatment Period 2|Other|1|||
33589886|NCT01468233|102050359|FG005|Treatment Period 2|Other|0|||
33589887|NCT04550832|102050361|FG000|Overall Study|Adverse Event|0|||
33589888|NCT04550832|102050362|FG001|Overall Study|Adverse Event|0|||
33589889|NCT04550832|102050363|FG002|Overall Study|Adverse Event|2|||
33589890|NCT04550832|102050364|FG003|Overall Study|Adverse Event|0|||
33589891|NCT04550832|102050365|FG004|Overall Study|Adverse Event|1|||
33589892|NCT00211757|102050367|FG000|Overall Study|Withdrawal by Subject|1|||
33589893|NCT00211757|102050368|FG001|Overall Study|Withdrawal by Subject|1|||
33589894|NCT00211757|102050367|FG000|Overall Study|Lack of Efficacy|0|||
33589895|NCT00211757|102050368|FG001|Overall Study|Lack of Efficacy|1|||
33589896|NCT03632993|102050369|FG000|Overall Study|Withdrawal by Subject|1|||
33589897|NCT03632993|102050370|FG001|Overall Study|Withdrawal by Subject|0|||
33589898|NCT03632993|102050371|FG002|Overall Study|Withdrawal by Subject|0|||
33589899|NCT03632993|102050372|FG003|Overall Study|Withdrawal by Subject|0|||
33589900|NCT03632993|102050373|FG004|Overall Study|Withdrawal by Subject|0|||
33589901|NCT03632993|102050374|FG005|Overall Study|Withdrawal by Subject|0|||
33589902|NCT03632993|102050375|FG006|Overall Study|Withdrawal by Subject|0|||
33589903|NCT03632993|102050376|FG007|Overall Study|Withdrawal by Subject|0|||
33589904|NCT03632993|102050377|FG008|Overall Study|Withdrawal by Subject|0|||
33589905|NCT03632993|102050378|FG009|Overall Study|Withdrawal by Subject|1|||
33589906|NCT03632993|102050369|FG000|Overall Study|Protocol Non-compliance|0|||
33589907|NCT03632993|102050370|FG001|Overall Study|Protocol Non-compliance|1|||
33589908|NCT03632993|102050371|FG002|Overall Study|Protocol Non-compliance|0|||
33433237|NCT03519256|101476815|FG002|Overall Study|Participant request to discontinue study treatment|0|||
33589909|NCT03632993|102050372|FG003|Overall Study|Protocol Non-compliance|0|||
33589910|NCT03632993|102050373|FG004|Overall Study|Protocol Non-compliance|0|||
33589911|NCT03632993|102050374|FG005|Overall Study|Protocol Non-compliance|0|||
33433238|NCT03519256|101476816|FG003|Overall Study|Participant request to discontinue study treatment|2|||
33589912|NCT03632993|102050375|FG006|Overall Study|Protocol Non-compliance|0|||
33589913|NCT03632993|102050376|FG007|Overall Study|Protocol Non-compliance|0|||
33589914|NCT03632993|102050377|FG008|Overall Study|Protocol Non-compliance|0|||
33589915|NCT03632993|102050378|FG009|Overall Study|Protocol Non-compliance|0|||
33589916|NCT03632993|102050369|FG000|Overall Study|Lost to Follow-up|0|||
33589917|NCT03632993|102050370|FG001|Overall Study|Lost to Follow-up|0|||
33589918|NCT03632993|102050371|FG002|Overall Study|Lost to Follow-up|0|||
33589919|NCT03632993|102050372|FG003|Overall Study|Lost to Follow-up|0|||
33589920|NCT03632993|102050373|FG004|Overall Study|Lost to Follow-up|0|||
33589921|NCT03632993|102050374|FG005|Overall Study|Lost to Follow-up|1|||
33589922|NCT03632993|102050375|FG006|Overall Study|Lost to Follow-up|0|||
33589923|NCT03632993|102050376|FG007|Overall Study|Lost to Follow-up|1|||
33589924|NCT03632993|102050377|FG008|Overall Study|Lost to Follow-up|0|||
33589925|NCT03632993|102050378|FG009|Overall Study|Lost to Follow-up|0|||
33589926|NCT03632993|102050369|FG000|Overall Study|Adverse Event|0|||
33589927|NCT03632993|102050370|FG001|Overall Study|Adverse Event|0|||
33589928|NCT03632993|102050371|FG002|Overall Study|Adverse Event|0|||
33589929|NCT03632993|102050372|FG003|Overall Study|Adverse Event|0|||
33589930|NCT03632993|102050373|FG004|Overall Study|Adverse Event|0|||
33589931|NCT03632993|102050374|FG005|Overall Study|Adverse Event|1|||
33589932|NCT03632993|102050375|FG006|Overall Study|Adverse Event|0|||
33589933|NCT03632993|102050376|FG007|Overall Study|Adverse Event|1|||
33589934|NCT03632993|102050377|FG008|Overall Study|Adverse Event|0|||
33589935|NCT03632993|102050378|FG009|Overall Study|Adverse Event|0|||
33589936|NCT02566785|102050379|FG000|Overall Study|Lost to Follow-up|0|||
33589937|NCT02566785|102050380|FG001|Overall Study|Lost to Follow-up|2|||
33589938|NCT02566785|102050379|FG000|Overall Study|Worsening condition|1|||
33589939|NCT02566785|102050380|FG001|Overall Study|Worsening condition|1|||
33589940|NCT02957747|102050381|FG000|Overall Study|Withdrawal by Subject|0|||
33589941|NCT02957747|102050382|FG001|Overall Study|Withdrawal by Subject|3|||
33589942|NCT02957747|102050381|FG000|Overall Study|Lost to Follow-up|10|||
33589943|NCT02957747|102050382|FG001|Overall Study|Lost to Follow-up|5|||
33589944|NCT04790279|102050383|FG000|Overall Study|Did not meet medication start criteria|27|||
33589945|NCT04790279|102050384|FG001|Overall Study|Did not meet medication start criteria|15|||
33589946|NCT04790279|102050383|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
33589947|NCT04790279|102050384|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
33589948|NCT04790279|102050383|FG000|Overall Study|Protocol Violation|8|||
33589949|NCT04790279|102050384|FG001|Overall Study|Protocol Violation|3|||
33589950|NCT04790279|102050383|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
33589951|NCT04790279|102050384|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
33589952|NCT03640325|102050392|FG000|Overall Study|Withdrawal by Subject|4|||
33589953|NCT03640325|102050393|FG001|Overall Study|Withdrawal by Subject|1|||
33589954|NCT03640325|102050394|FG002|Overall Study|Withdrawal by Subject|0|||
33589955|NCT03640325|102050392|FG000|Overall Study|Lost to Follow-up|4|||
33589956|NCT03640325|102050393|FG001|Overall Study|Lost to Follow-up|5|||
33589957|NCT03640325|102050394|FG002|Overall Study|Lost to Follow-up|21|||
33589958|NCT03640325|102050392|FG000|Overall Study|Death|5|||
33589959|NCT03640325|102050393|FG001|Overall Study|Death|5|||
33589960|NCT03640325|102050394|FG002|Overall Study|Death|0|||
33589961|NCT00675441|102050395|FG000|Overall Study|Withdrawal by Subject|2|||
33589962|NCT00675441|102050395|FG000|Overall Study|Death|1|||
33589963|NCT04644237|102050396|FG000|Overall Study|Death|3|||
33589964|NCT04644237|102050397|FG001|Overall Study|Death|2|||
33589965|NCT04644237|102050396|FG000|Overall Study|Adverse Event|15|||
33589966|NCT04644237|102050397|FG001|Overall Study|Adverse Event|12|||
33589967|NCT04644237|102050396|FG000|Overall Study|Progressive Disease|47|||
33589968|NCT04644237|102050397|FG001|Overall Study|Progressive Disease|19|||
33589969|NCT04644237|102050396|FG000|Overall Study|Clinical Progression|4|||
33589970|NCT04644237|102050397|FG001|Overall Study|Clinical Progression|1|||
33589971|NCT04644237|102050396|FG000|Overall Study|Withdrawal by Subject|1|||
33589972|NCT04644237|102050397|FG001|Overall Study|Withdrawal by Subject|2|||
33589973|NCT04644237|102050396|FG000|Overall Study|Physician Decision|3|||
33589974|NCT04644237|102050397|FG001|Overall Study|Physician Decision|0|||
33589975|NCT04644237|102050396|FG000|Overall Study|Other|1|||
33589976|NCT04644237|102050397|FG001|Overall Study|Other|0|||
33589977|NCT04644237|102050396|FG000|Overall Study|Randomized but not Treated|1|||
33589978|NCT04644237|102050397|FG001|Overall Study|Randomized but not Treated|0|||
33589979|NCT00433966|102050398|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
33589980|NCT00433966|102050399|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
33589981|NCT00433966|102050400|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
33589982|NCT00433966|102050401|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
33589983|NCT00433966|102050398|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
33589984|NCT00433966|102050399|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
33589985|NCT00433966|102050400|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
33589986|NCT00433966|102050401|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
33589987|NCT00433966|102050398|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
33589988|NCT00433966|102050399|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
33589989|NCT00433966|102050400|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
33589990|NCT00433966|102050401|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
33589991|NCT00433966|102050398|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
33589992|NCT00433966|102050399|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
33589993|NCT00433966|102050400|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
33589994|NCT00433966|102050401|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
33589995|NCT00433966|102050398|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
33589996|NCT00433966|102050399|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
33589997|NCT00433966|102050400|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
33589998|NCT00433966|102050401|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
33589999|NCT05425732|102050402|FG000|Overall Study|Death|4|||
33590000|NCT05425732|102050403|FG001|Overall Study|Death|2|||
33590001|NCT05425732|102050404|FG002|Overall Study|Death|0|||
33590002|NCT05425732|102050405|FG003|Overall Study|Death|0|||
33590003|NCT05425732|102050402|FG000|Overall Study|Lost to Follow-up|10|||
33590004|NCT05425732|102050403|FG001|Overall Study|Lost to Follow-up|15|||
33590005|NCT05425732|102050404|FG002|Overall Study|Lost to Follow-up|5|||
33590006|NCT05425732|102050405|FG003|Overall Study|Lost to Follow-up|3|||
33590007|NCT05425732|102050402|FG000|Overall Study|Physician Decision|0|||
33590008|NCT05425732|102050403|FG001|Overall Study|Physician Decision|2|||
33590009|NCT05425732|102050404|FG002|Overall Study|Physician Decision|0|||
33590010|NCT05425732|102050405|FG003|Overall Study|Physician Decision|0|||
33590011|NCT05425732|102050402|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
33590012|NCT05425732|102050403|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
33590013|NCT05425732|102050404|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33590014|NCT05425732|102050405|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33590015|NCT05425732|102050402|FG000|Overall Study|Withdrawal by Subject|4|||
33590016|NCT05425732|102050403|FG001|Overall Study|Withdrawal by Subject|8|||
33590017|NCT05425732|102050404|FG002|Overall Study|Withdrawal by Subject|1|||
33590018|NCT05425732|102050405|FG003|Overall Study|Withdrawal by Subject|1|||
33590019|NCT05425732|102050402|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
33590020|NCT05425732|102050403|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
33590021|NCT05425732|102050404|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
33590022|NCT05425732|102050405|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
33590023|NCT00066222|102050421|FG000|Overall Study|No protocol treatment received|1|||
33590024|NCT02141399|102050424|FG000|Overall Study|Adverse Event|158|||
33590025|NCT02141399|102050424|FG000|Overall Study|Lack of Efficacy|62|||
33590026|NCT02141399|102050424|FG000|Overall Study|Lost to Follow-up|151|||
33590027|NCT02141399|102050424|FG000|Overall Study|Non-compliance with study drug|18|||
33590028|NCT02141399|102050424|FG000|Overall Study|Other|45|||
33590029|NCT02141399|102050424|FG000|Overall Study|Physician Decision|17|||
33590030|NCT02141399|102050424|FG000|Overall Study|Pregnancy|3|||
33590031|NCT02141399|102050424|FG000|Overall Study|Protocol Violation|38|||
33590032|NCT02141399|102050424|FG000|Overall Study|Withdrawal by Subject|238|||
33590033|NCT02141399|102050424|FG000|Overall Study|Failure to meet eligibility criteria|14|||
33590034|NCT02218697|102050434|FG000|Overall Study|Adverse Event|0|||
33590035|NCT02218697|102050435|FG001|Overall Study|Adverse Event|2|||
33590036|NCT02218697|102050434|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
33590037|NCT02218697|102050435|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
33590038|NCT02218697|102050434|FG000|Overall Study|Withdrawal by Subject|2|||
33590039|NCT02218697|102050435|FG001|Overall Study|Withdrawal by Subject|3|||
33590040|NCT02543281|102050444|FG000|Overall Study|Lost to Follow-up|0|||
33590041|NCT02543281|102050445|FG001|Overall Study|Lost to Follow-up|0|||
33590042|NCT02543281|102050446|FG002|Overall Study|Lost to Follow-up|1|||
33590043|NCT04065074|102050452|FG000|Overall Study|Adverse Event|1|||
33590044|NCT04065074|102050452|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
33590045|NCT03362502|102050457|FG000|Overall Study|Death|0|||
33590046|NCT03362502|102050458|FG001|Overall Study|Death|0|||
33590047|NCT03362502|102050459|FG002|Overall Study|Death|1|||
33590048|NCT02589665|102050460|FG000|Induction Period|Did not receive drug|0|||
33590049|NCT02589665|102050461|FG001|Induction Period|Did not receive drug|0|||
33590050|NCT02589665|102050462|FG002|Induction Period|Did not receive drug|0|||
33590051|NCT02589665|102050463|FG003|Induction Period|Did not receive drug|1|||
33590052|NCT02589665|102050464|FG004|Induction Period|Did not receive drug|0|||
33590053|NCT02589665|102050465|FG005|Induction Period|Did not receive drug|0|||
33590054|NCT02589665|102050466|FG006|Induction Period|Did not receive drug|0|||
33590055|NCT02589665|102050467|FG007|Induction Period|Did not receive drug|0|||
33590056|NCT02589665|102050468|FG008|Induction Period|Did not receive drug|0|||
33590057|NCT02589665|102050469|FG009|Induction Period|Did not receive drug|0|||
33590058|NCT02589665|102050460|FG000|Induction Period|Adverse Event|3|||
33590059|NCT02589665|102050461|FG001|Induction Period|Adverse Event|0|||
33590060|NCT02589665|102050462|FG002|Induction Period|Adverse Event|2|||
33590061|NCT02589665|102050463|FG003|Induction Period|Adverse Event|2|||
33590062|NCT02589665|102050464|FG004|Induction Period|Adverse Event|0|||
33590063|NCT02589665|102050465|FG005|Induction Period|Adverse Event|0|||
33590064|NCT02589665|102050466|FG006|Induction Period|Adverse Event|0|||
33590065|NCT02589665|102050467|FG007|Induction Period|Adverse Event|0|||
33590066|NCT02589665|102050468|FG008|Induction Period|Adverse Event|0|||
33590067|NCT02589665|102050469|FG009|Induction Period|Adverse Event|0|||
33590068|NCT02589665|102050460|FG000|Induction Period|Withdrawal by Subject|0|||
33590069|NCT02589665|102050461|FG001|Induction Period|Withdrawal by Subject|1|||
33590070|NCT02589665|102050462|FG002|Induction Period|Withdrawal by Subject|0|||
33590071|NCT02589665|102050463|FG003|Induction Period|Withdrawal by Subject|1|||
33590072|NCT02589665|102050464|FG004|Induction Period|Withdrawal by Subject|0|||
33590073|NCT02589665|102050465|FG005|Induction Period|Withdrawal by Subject|0|||
33590074|NCT02589665|102050466|FG006|Induction Period|Withdrawal by Subject|0|||
33590075|NCT02589665|102050467|FG007|Induction Period|Withdrawal by Subject|0|||
33590076|NCT02589665|102050468|FG008|Induction Period|Withdrawal by Subject|0|||
33590077|NCT02589665|102050469|FG009|Induction Period|Withdrawal by Subject|0|||
33590078|NCT02589665|102050460|FG000|Induction Period|Protocol Violation|0|||
33590079|NCT02589665|102050461|FG001|Induction Period|Protocol Violation|1|||
33590080|NCT02589665|102050462|FG002|Induction Period|Protocol Violation|0|||
33590081|NCT02589665|102050463|FG003|Induction Period|Protocol Violation|0|||
33590082|NCT02589665|102050464|FG004|Induction Period|Protocol Violation|0|||
33590083|NCT02589665|102050465|FG005|Induction Period|Protocol Violation|0|||
33590084|NCT02589665|102050466|FG006|Induction Period|Protocol Violation|0|||
33590085|NCT02589665|102050467|FG007|Induction Period|Protocol Violation|0|||
33590086|NCT02589665|102050468|FG008|Induction Period|Protocol Violation|0|||
33590087|NCT02589665|102050469|FG009|Induction Period|Protocol Violation|0|||
33590088|NCT02589665|102050460|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590089|NCT02589665|102050461|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590090|NCT02589665|102050462|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590091|NCT02589665|102050463|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590092|NCT02589665|102050464|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
33590093|NCT02589665|102050465|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
33590094|NCT02589665|102050466|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
33590095|NCT02589665|102050467|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590096|NCT02589665|102050468|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590097|NCT02589665|102050469|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590098|NCT02589665|102050460|FG000|Maintenance Period|Withdrawal by Subject|0|||
33590099|NCT02589665|102050461|FG001|Maintenance Period|Withdrawal by Subject|0|||
33590100|NCT02589665|102050462|FG002|Maintenance Period|Withdrawal by Subject|0|||
33590101|NCT02589665|102050463|FG003|Maintenance Period|Withdrawal by Subject|0|||
33590102|NCT02589665|102050464|FG004|Maintenance Period|Withdrawal by Subject|4|||
33590103|NCT02589665|102050465|FG005|Maintenance Period|Withdrawal by Subject|2|||
33590104|NCT02589665|102050466|FG006|Maintenance Period|Withdrawal by Subject|4|||
33590105|NCT02589665|102050467|FG007|Maintenance Period|Withdrawal by Subject|0|||
33590106|NCT02589665|102050468|FG008|Maintenance Period|Withdrawal by Subject|0|||
33590107|NCT02589665|102050469|FG009|Maintenance Period|Withdrawal by Subject|0|||
33590108|NCT02589665|102050460|FG000|Maintenance Period|Lack of Efficacy|0|||
33590109|NCT02589665|102050461|FG001|Maintenance Period|Lack of Efficacy|0|||
33590110|NCT02589665|102050462|FG002|Maintenance Period|Lack of Efficacy|0|||
33590111|NCT02589665|102050463|FG003|Maintenance Period|Lack of Efficacy|0|||
33590112|NCT02589665|102050464|FG004|Maintenance Period|Lack of Efficacy|2|||
33590113|NCT02589665|102050465|FG005|Maintenance Period|Lack of Efficacy|1|||
33590114|NCT02589665|102050466|FG006|Maintenance Period|Lack of Efficacy|0|||
33590115|NCT02589665|102050467|FG007|Maintenance Period|Lack of Efficacy|0|||
33590116|NCT02589665|102050468|FG008|Maintenance Period|Lack of Efficacy|0|||
33590117|NCT02589665|102050469|FG009|Maintenance Period|Lack of Efficacy|0|||
33590118|NCT02589665|102050460|FG000|Maintenance Period|Adverse Event|0|||
33590119|NCT02589665|102050461|FG001|Maintenance Period|Adverse Event|0|||
33648665|NCT01642615|102265714|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
33648666|NCT01642615|102265712|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
33648667|NCT01642615|102265713|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
33648668|NCT01642615|102265714|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
33648669|NCT01642615|102265712|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
33648670|NCT01642615|102265713|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
33648671|NCT01642615|102265714|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
33648672|NCT01642615|102265712|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
33648673|NCT01642615|102265713|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
33648674|NCT01642615|102265714|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
33590120|NCT02589665|102050462|FG002|Maintenance Period|Adverse Event|0|||
33590121|NCT02589665|102050463|FG003|Maintenance Period|Adverse Event|0|||
33590122|NCT02589665|102050464|FG004|Maintenance Period|Adverse Event|0|||
33590123|NCT02589665|102050465|FG005|Maintenance Period|Adverse Event|0|||
33590124|NCT02589665|102050466|FG006|Maintenance Period|Adverse Event|2|||
33590125|NCT02589665|102050467|FG007|Maintenance Period|Adverse Event|0|||
33590126|NCT02589665|102050468|FG008|Maintenance Period|Adverse Event|0|||
33590127|NCT02589665|102050469|FG009|Maintenance Period|Adverse Event|0|||
33590128|NCT02589665|102050460|FG000|Maintenance Period|Lost to Follow-up|0|||
33590129|NCT02589665|102050461|FG001|Maintenance Period|Lost to Follow-up|0|||
33590130|NCT02589665|102050462|FG002|Maintenance Period|Lost to Follow-up|0|||
33590131|NCT02589665|102050463|FG003|Maintenance Period|Lost to Follow-up|0|||
33590132|NCT02589665|102050464|FG004|Maintenance Period|Lost to Follow-up|0|||
33590133|NCT02589665|102050465|FG005|Maintenance Period|Lost to Follow-up|1|||
33590134|NCT02589665|102050466|FG006|Maintenance Period|Lost to Follow-up|0|||
33590135|NCT02589665|102050467|FG007|Maintenance Period|Lost to Follow-up|0|||
33590136|NCT02589665|102050468|FG008|Maintenance Period|Lost to Follow-up|0|||
33590137|NCT02589665|102050469|FG009|Maintenance Period|Lost to Follow-up|0|||
33590138|NCT02589665|102050460|FG000|Maintenance Period|Physician Decision|0|||
33590139|NCT02589665|102050461|FG001|Maintenance Period|Physician Decision|0|||
33590140|NCT02589665|102050462|FG002|Maintenance Period|Physician Decision|0|||
33590141|NCT02589665|102050463|FG003|Maintenance Period|Physician Decision|0|||
33590142|NCT02589665|102050464|FG004|Maintenance Period|Physician Decision|0|||
33590143|NCT02589665|102050465|FG005|Maintenance Period|Physician Decision|1|||
33590144|NCT02589665|102050466|FG006|Maintenance Period|Physician Decision|0|||
33590145|NCT02589665|102050467|FG007|Maintenance Period|Physician Decision|0|||
33590146|NCT02589665|102050468|FG008|Maintenance Period|Physician Decision|0|||
33590147|NCT02589665|102050469|FG009|Maintenance Period|Physician Decision|0|||
33590148|NCT02589665|102050460|FG000|Maintenance Period|Reason Not Collected|0|||
33590149|NCT02589665|102050461|FG001|Maintenance Period|Reason Not Collected|0|||
33590150|NCT02589665|102050462|FG002|Maintenance Period|Reason Not Collected|0|||
33590151|NCT02589665|102050463|FG003|Maintenance Period|Reason Not Collected|0|||
33590152|NCT02589665|102050464|FG004|Maintenance Period|Reason Not Collected|0|||
33590153|NCT02589665|102050465|FG005|Maintenance Period|Reason Not Collected|1|||
33590154|NCT02589665|102050466|FG006|Maintenance Period|Reason Not Collected|1|||
33590155|NCT02589665|102050467|FG007|Maintenance Period|Reason Not Collected|0|||
33590156|NCT02589665|102050468|FG008|Maintenance Period|Reason Not Collected|0|||
33590157|NCT02589665|102050469|FG009|Maintenance Period|Reason Not Collected|0|||
33590158|NCT02589665|102050460|FG000|Induction Extension Period|Adverse Event|0|||
33590159|NCT02589665|102050461|FG001|Induction Extension Period|Adverse Event|0|||
33590160|NCT02589665|102050462|FG002|Induction Extension Period|Adverse Event|0|||
33590161|NCT02589665|102050463|FG003|Induction Extension Period|Adverse Event|0|||
33590162|NCT02589665|102050464|FG004|Induction Extension Period|Adverse Event|0|||
33590163|NCT02589665|102050465|FG005|Induction Extension Period|Adverse Event|0|||
33590164|NCT02589665|102050466|FG006|Induction Extension Period|Adverse Event|0|||
33590165|NCT02589665|102050467|FG007|Induction Extension Period|Adverse Event|0|||
33590166|NCT02589665|102050468|FG008|Induction Extension Period|Adverse Event|4|||
33590167|NCT02589665|102050469|FG009|Induction Extension Period|Adverse Event|0|||
33590168|NCT02589665|102050460|FG000|Induction Extension Period|Lack of Efficacy|0|||
33590169|NCT02589665|102050461|FG001|Induction Extension Period|Lack of Efficacy|0|||
33590170|NCT02589665|102050462|FG002|Induction Extension Period|Lack of Efficacy|0|||
33590171|NCT02589665|102050463|FG003|Induction Extension Period|Lack of Efficacy|0|||
33590172|NCT02589665|102050464|FG004|Induction Extension Period|Lack of Efficacy|0|||
33590173|NCT02589665|102050465|FG005|Induction Extension Period|Lack of Efficacy|0|||
33590174|NCT02589665|102050466|FG006|Induction Extension Period|Lack of Efficacy|0|||
33590175|NCT02589665|102050467|FG007|Induction Extension Period|Lack of Efficacy|0|||
33590176|NCT02589665|102050468|FG008|Induction Extension Period|Lack of Efficacy|3|||
33590177|NCT02589665|102050469|FG009|Induction Extension Period|Lack of Efficacy|0|||
33590178|NCT02589665|102050460|FG000|Induction Extension Period|Withdrawal by Subject|0|||
33590179|NCT02589665|102050461|FG001|Induction Extension Period|Withdrawal by Subject|0|||
33590180|NCT02589665|102050462|FG002|Induction Extension Period|Withdrawal by Subject|0|||
33590181|NCT02589665|102050463|FG003|Induction Extension Period|Withdrawal by Subject|0|||
33590182|NCT02589665|102050464|FG004|Induction Extension Period|Withdrawal by Subject|0|||
33590183|NCT02589665|102050465|FG005|Induction Extension Period|Withdrawal by Subject|0|||
33590184|NCT02589665|102050466|FG006|Induction Extension Period|Withdrawal by Subject|0|||
33590185|NCT02589665|102050467|FG007|Induction Extension Period|Withdrawal by Subject|2|||
33590186|NCT02589665|102050468|FG008|Induction Extension Period|Withdrawal by Subject|3|||
33590187|NCT02589665|102050469|FG009|Induction Extension Period|Withdrawal by Subject|0|||
33590188|NCT02589665|102050460|FG000|Induction Extension Period|Physician Decision|0|||
33590189|NCT02589665|102050461|FG001|Induction Extension Period|Physician Decision|0|||
33590190|NCT02589665|102050462|FG002|Induction Extension Period|Physician Decision|0|||
33590191|NCT02589665|102050463|FG003|Induction Extension Period|Physician Decision|0|||
33590192|NCT02589665|102050464|FG004|Induction Extension Period|Physician Decision|0|||
33590193|NCT02589665|102050465|FG005|Induction Extension Period|Physician Decision|0|||
33590194|NCT02589665|102050466|FG006|Induction Extension Period|Physician Decision|0|||
33590195|NCT02589665|102050467|FG007|Induction Extension Period|Physician Decision|0|||
33590196|NCT02589665|102050468|FG008|Induction Extension Period|Physician Decision|1|||
33590197|NCT02589665|102050469|FG009|Induction Extension Period|Physician Decision|0|||
33590198|NCT02589665|102050460|FG000|Induction Extension Period|Reason Not Collected|0|||
33590199|NCT02589665|102050461|FG001|Induction Extension Period|Reason Not Collected|0|||
33590200|NCT02589665|102050462|FG002|Induction Extension Period|Reason Not Collected|0|||
33590201|NCT02589665|102050463|FG003|Induction Extension Period|Reason Not Collected|0|||
33590202|NCT02589665|102050464|FG004|Induction Extension Period|Reason Not Collected|0|||
33590203|NCT02589665|102050465|FG005|Induction Extension Period|Reason Not Collected|0|||
33590204|NCT02589665|102050466|FG006|Induction Extension Period|Reason Not Collected|0|||
33648675|NCT01642615|102265712|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
33590205|NCT02589665|102050467|FG007|Induction Extension Period|Reason Not Collected|0|||
33590206|NCT02589665|102050468|FG008|Induction Extension Period|Reason Not Collected|1|||
33590207|NCT02589665|102050469|FG009|Induction Extension Period|Reason Not Collected|0|||
33590208|NCT02589665|102050460|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590209|NCT02589665|102050461|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590210|NCT02589665|102050462|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590211|NCT02589665|102050463|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590212|NCT02589665|102050464|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590213|NCT02589665|102050465|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590214|NCT02589665|102050466|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590215|NCT02589665|102050467|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590216|NCT02589665|102050468|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
33590217|NCT02589665|102050469|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
33590218|NCT02589665|102050460|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
33590219|NCT02589665|102050461|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
33590220|NCT02589665|102050462|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
33590221|NCT02589665|102050463|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
33590222|NCT02589665|102050464|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
33590223|NCT02589665|102050465|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
33590224|NCT02589665|102050466|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
33590225|NCT02589665|102050467|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
33590226|NCT02589665|102050468|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
33590227|NCT02589665|102050469|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
33590228|NCT02589665|102050460|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
33590229|NCT02589665|102050461|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
33590230|NCT02589665|102050462|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
33590231|NCT02589665|102050463|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
33590232|NCT02589665|102050464|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
33590233|NCT02589665|102050465|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
33590234|NCT02589665|102050466|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
33590235|NCT02589665|102050467|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
33590236|NCT02589665|102050468|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
33590237|NCT02589665|102050469|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
33590238|NCT02589665|102050460|FG000|Maintenance Extension Period|Adverse Event|0|||
33590239|NCT02589665|102050461|FG001|Maintenance Extension Period|Adverse Event|0|||
33590240|NCT02589665|102050462|FG002|Maintenance Extension Period|Adverse Event|0|||
33590241|NCT02589665|102050463|FG003|Maintenance Extension Period|Adverse Event|0|||
33590242|NCT02589665|102050464|FG004|Maintenance Extension Period|Adverse Event|0|||
33590243|NCT02589665|102050465|FG005|Maintenance Extension Period|Adverse Event|0|||
33590244|NCT02589665|102050466|FG006|Maintenance Extension Period|Adverse Event|0|||
33648676|NCT01642615|102265713|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
33648677|NCT01642615|102265714|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
33648678|NCT01642615|102265712|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
33648679|NCT01642615|102265713|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
33648680|NCT01642615|102265714|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
33648681|NCT01642615|102265712|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
33648682|NCT01642615|102265713|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
33648683|NCT01642615|102265714|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
33648684|NCT01642615|102265712|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
33648685|NCT01642615|102265713|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
33648686|NCT01642615|102265714|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
33433239|NCT03519256|101476813|FG000|Overall Study|Other reasons|0|||
33590245|NCT02589665|102050467|FG007|Maintenance Extension Period|Adverse Event|0|||
33590246|NCT02589665|102050468|FG008|Maintenance Extension Period|Adverse Event|0|||
33590247|NCT02589665|102050469|FG009|Maintenance Extension Period|Adverse Event|2|||
33590248|NCT02589665|102050460|FG000|Maintenance Extension Period|Non-responder|0|||
33590249|NCT02589665|102050461|FG001|Maintenance Extension Period|Non-responder|0|||
33590250|NCT02589665|102050462|FG002|Maintenance Extension Period|Non-responder|0|||
33590251|NCT02589665|102050463|FG003|Maintenance Extension Period|Non-responder|0|||
33648687|NCT02156271|102265727|FG000|Overall Study|Physician Decision|4|||
33150067|NCT00674973|100463607|FG000|Overall Study|Insufficient Therapeutic Response|77|||
33150068|NCT00674973|100463608|FG001|Overall Study|Insufficient Therapeutic Response|72|||
33249761|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
33249762|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
33249763|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33249764|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33249765|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33249766|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
33249767|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
33249768|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
33249769|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
33249770|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
33249771|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
33249772|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
33249773|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
33249774|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
33249775|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
33249776|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
33249777|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
33249778|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33384496|NCT01179347|101291638|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
33384497|NCT01179347|101291639|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
33384498|NCT01179347|101291638|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
33384499|NCT01179347|101291639|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
33648688|NCT02156271|102265728|FG001|Overall Study|Physician Decision|3|||
33648689|NCT01978938|102265729|FG000|Overall Study|Lost to Follow-up|12|||
33648690|NCT01978938|102265730|FG001|Overall Study|Lost to Follow-up|6|||
33648691|NCT01978938|102265729|FG000|Overall Study|Withdrawal by Subject|8|||
33648692|NCT01978938|102265730|FG001|Overall Study|Withdrawal by Subject|4|||
33648693|NCT01978938|102265729|FG000|Overall Study|Adverse Event, non-fatal|2|||
33648694|NCT01978938|102265730|FG001|Overall Study|Adverse Event, non-fatal|1|||
33648695|NCT01978938|102265729|FG000|Overall Study|Participant noncompliance|1|||
33648696|NCT01978938|102265730|FG001|Overall Study|Participant noncompliance|1|||
33648697|NCT01978938|102265729|FG000|Overall Study|Did not meet inclusion criteria|0|||
33648698|NCT01978938|102265730|FG001|Overall Study|Did not meet inclusion criteria|1|||
33648699|NCT01978938|102265729|FG000|Overall Study|Previously scheduled procedure|0|||
33648700|NCT01978938|102265730|FG001|Overall Study|Previously scheduled procedure|1|||
33249779|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33249780|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33249781|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33384500|NCT01179347|101291638|FG000|Open-label Period (12 Weeks)|Other|7|||
33384501|NCT01179347|101291639|FG001|Open-label Period (12 Weeks)|Other|4|||
33384502|NCT04154943|101291640|FG000|Overall Study|Study Ongoing|68|||
33384503|NCT04154943|101291640|FG000|Overall Study|Lost to Follow-up|1|||
33384504|NCT04154943|101291640|FG000|Overall Study|Decision by the Investigator|1|||
33384505|NCT04154943|101291640|FG000|Overall Study|Death|5|||
33384506|NCT04154943|101291640|FG000|Overall Study|Withdrawal by Subject|4|||
33384507|NCT01235728|101291641|FG000|Overall Study|Protocol Violation|0|||
33384508|NCT01235728|101291642|FG001|Overall Study|Protocol Violation|0|||
33384509|NCT01235728|101291643|FG002|Overall Study|Protocol Violation|0|||
33384510|NCT01235728|101291644|FG003|Overall Study|Protocol Violation|1|||
33384511|NCT01235728|101291645|FG004|Overall Study|Protocol Violation|0|||
33384512|NCT01235728|101291646|FG005|Overall Study|Protocol Violation|0|||
33384513|NCT01235728|101291647|FG006|Overall Study|Protocol Violation|0|||
33384514|NCT01235728|101291648|FG007|Overall Study|Protocol Violation|0|||
33384515|NCT01827319|101291650|FG000|Overall Study|Lost to Follow-up|3|||
33590252|NCT02589665|102050464|FG004|Maintenance Extension Period|Non-responder|0|||
33590253|NCT02589665|102050465|FG005|Maintenance Extension Period|Non-responder|0|||
33590254|NCT02589665|102050466|FG006|Maintenance Extension Period|Non-responder|0|||
33590255|NCT02589665|102050467|FG007|Maintenance Extension Period|Non-responder|0|||
33590256|NCT02589665|102050468|FG008|Maintenance Extension Period|Non-responder|0|||
33590257|NCT02589665|102050469|FG009|Maintenance Extension Period|Non-responder|1|||
33590258|NCT04470908|102050470|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
33590259|NCT03255967|102050476|FG000|Overall Study|Adverse Event|26|||
33590260|NCT03255967|102050477|FG001|Overall Study|Adverse Event|30|||
33590261|NCT03255967|102050476|FG000|Overall Study|Withdrawal by Subject|6|||
33590262|NCT03255967|102050477|FG001|Overall Study|Withdrawal by Subject|6|||
33648701|NCT01049009|102265731|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
33648702|NCT01049009|102265732|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
33249782|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33249783|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33249784|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33384516|NCT04295356|101295800|FG000|Overall Study|Physician Decision|1|||
33384517|NCT04295356|101295801|FG001|Overall Study|Physician Decision|0|||
33384518|NCT04295356|101295800|FG000|Overall Study|Lost to Follow-up|0|||
33590263|NCT03255967|102050476|FG000|Overall Study|Schedule conflict|6|||
33590264|NCT03255967|102050477|FG001|Overall Study|Schedule conflict|4|||
33590265|NCT03255967|102050476|FG000|Overall Study|POA did not sign consent form|2|||
33590266|NCT03255967|102050477|FG001|Overall Study|POA did not sign consent form|0|||
33590267|NCT02256384|102050482|FG000|Overall Study|Withdrawal by Subject|12|||
33590268|NCT02256384|102050482|FG000|Overall Study|Equipment not capturing data|2|||
33590269|NCT00227344|102050485|FG000|Overall Study|study terminated early|12|||
33590270|NCT00227344|102050486|FG001|Overall Study|study terminated early|5|||
33590271|NCT00391430|102050491|FG000|Overall Study|Withdrawal by Subject|3|||
33590272|NCT00391430|102050492|FG001|Overall Study|Withdrawal by Subject|0|||
33590273|NCT00391430|102050493|FG002|Overall Study|Withdrawal by Subject|12|||
33590274|NCT00765037|102050495|FG000|Overall Study|Lost to Follow-up|5|||
33590275|NCT00765037|102050495|FG000|Overall Study|Adverse Event|1|||
33590276|NCT00118846|102050501|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
33590277|NCT00118846|102050502|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
33590278|NCT00118846|102050501|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
33590279|NCT00118846|102050502|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
33590280|NCT00118846|102050501|FG000|Overall Study|Physician Decision|1|||
33590281|NCT00118846|102050502|FG001|Overall Study|Physician Decision|0|||
33590282|NCT00118846|102050501|FG000|Overall Study|Medical condition|2|||
33590283|NCT00118846|102050502|FG001|Overall Study|Medical condition|2|||
33590284|NCT00118846|102050501|FG000|Overall Study|Lost to Follow-up|0|||
33590285|NCT00118846|102050502|FG001|Overall Study|Lost to Follow-up|2|||
33590286|NCT00118846|102050501|FG000|Overall Study|Personal reason|4|||
33590287|NCT00118846|102050502|FG001|Overall Study|Personal reason|5|||
33590288|NCT01811485|102050506|FG000|Overall Study|Adverse Event|1|||
33590289|NCT01811485|102050507|FG001|Overall Study|Adverse Event|3|||
33590290|NCT01811485|102050508|FG002|Overall Study|Adverse Event|2|||
33590291|NCT01811485|102050506|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33590292|NCT01811485|102050507|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33590293|NCT01811485|102050508|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
33590294|NCT01811485|102050506|FG000|Overall Study|Administrative problems|1|||
33590295|NCT01811485|102050507|FG001|Overall Study|Administrative problems|0|||
33590296|NCT01811485|102050508|FG002|Overall Study|Administrative problems|0|||
33590297|NCT01811485|102050506|FG000|Overall Study|Protocol Deviation|0|||
33590298|NCT01811485|102050507|FG001|Overall Study|Protocol Deviation|1|||
33590299|NCT01811485|102050508|FG002|Overall Study|Protocol Deviation|0|||
33590300|NCT03172325|102050514|FG000|Overall Study|Adverse Event|2|||
33590301|NCT03172325|102050515|FG001|Overall Study|Adverse Event|3|||
33590302|NCT03172325|102050514|FG000|Overall Study|Positive PPD|1|||
33590303|NCT03172325|102050515|FG001|Overall Study|Positive PPD|0|||
33590304|NCT03172325|102050514|FG000|Overall Study|Poor Compliance|1|||
33590305|NCT03172325|102050515|FG001|Overall Study|Poor Compliance|1|||
33590306|NCT00152477|102050521|FG000|Chemotherapy Period|Adverse Event|9|||
33590307|NCT00152477|102050522|FG001|Chemotherapy Period|Adverse Event|4|||
33590308|NCT00152477|102050523|FG002|Chemotherapy Period|Adverse Event|5|||
33590309|NCT00152477|102050521|FG000|Chemotherapy Period|Death|1|||
33590310|NCT00152477|102050522|FG001|Chemotherapy Period|Death|3|||
33590311|NCT00152477|102050523|FG002|Chemotherapy Period|Death|3|||
33590312|NCT00152477|102050521|FG000|Chemotherapy Period|Lack of Efficacy|4|||
33590313|NCT00152477|102050522|FG001|Chemotherapy Period|Lack of Efficacy|5|||
33590314|NCT00152477|102050523|FG002|Chemotherapy Period|Lack of Efficacy|6|||
33590315|NCT00152477|102050521|FG000|Chemotherapy Period|Lost to Follow-up|1|||
33590316|NCT00152477|102050522|FG001|Chemotherapy Period|Lost to Follow-up|0|||
33590317|NCT00152477|102050523|FG002|Chemotherapy Period|Lost to Follow-up|1|||
33590318|NCT00152477|102050521|FG000|Chemotherapy Period|Protocol Violation|1|||
33590319|NCT00152477|102050522|FG001|Chemotherapy Period|Protocol Violation|1|||
33590320|NCT00152477|102050523|FG002|Chemotherapy Period|Protocol Violation|0|||
33590321|NCT00152477|102050521|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
33590322|NCT00152477|102050522|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
33590323|NCT00152477|102050523|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
33384519|NCT04295356|101295801|FG001|Overall Study|Lost to Follow-up|3|||
33384520|NCT04295356|101295800|FG000|Overall Study|Protocol Violation|0|||
33590324|NCT00152477|102050521|FG000|Chemotherapy Period|Progression of Disease|6|||
33590325|NCT00152477|102050522|FG001|Chemotherapy Period|Progression of Disease|8|||
33590326|NCT00152477|102050523|FG002|Chemotherapy Period|Progression of Disease|4|||
33590327|NCT00152477|102050521|FG000|Chemotherapy Period|Investigator decision|0|||
33590328|NCT00152477|102050522|FG001|Chemotherapy Period|Investigator decision|0|||
33590329|NCT00152477|102050523|FG002|Chemotherapy Period|Investigator decision|1|||
33590330|NCT00152477|102050521|FG000|Chemotherapy Period|Patient condition worsened|1|||
33590331|NCT00152477|102050522|FG001|Chemotherapy Period|Patient condition worsened|0|||
33590332|NCT00152477|102050523|FG002|Chemotherapy Period|Patient condition worsened|0|||
33590333|NCT00152477|102050521|FG000|Monotherapy Period|Adverse Event|1|||
33590334|NCT00152477|102050522|FG001|Monotherapy Period|Adverse Event|0|||
33590335|NCT00152477|102050523|FG002|Monotherapy Period|Adverse Event|5|||
33590336|NCT00152477|102050521|FG000|Monotherapy Period|Death|2|||
33590337|NCT00152477|102050522|FG001|Monotherapy Period|Death|0|||
33590338|NCT00152477|102050523|FG002|Monotherapy Period|Death|1|||
33648703|NCT01049009|102265731|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
33648704|NCT01049009|102265732|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
33590339|NCT00152477|102050521|FG000|Monotherapy Period|Lack of Efficacy|7|||
33590340|NCT00152477|102050522|FG001|Monotherapy Period|Lack of Efficacy|16|||
33590341|NCT00152477|102050523|FG002|Monotherapy Period|Lack of Efficacy|10|||
33590342|NCT00152477|102050521|FG000|Monotherapy Period|Protocol Violation|0|||
33590343|NCT00152477|102050522|FG001|Monotherapy Period|Protocol Violation|1|||
33590344|NCT00152477|102050523|FG002|Monotherapy Period|Protocol Violation|0|||
33590345|NCT00152477|102050521|FG000|Monotherapy Period|Withdrawal by Subject|0|||
33590346|NCT00152477|102050522|FG001|Monotherapy Period|Withdrawal by Subject|0|||
33590347|NCT00152477|102050523|FG002|Monotherapy Period|Withdrawal by Subject|4|||
33590348|NCT00152477|102050521|FG000|Monotherapy Period|Progression of Disease|5|||
33590349|NCT00152477|102050522|FG001|Monotherapy Period|Progression of Disease|11|||
33590350|NCT00152477|102050523|FG002|Monotherapy Period|Progression of Disease|12|||
33590351|NCT00152477|102050521|FG000|Monotherapy Period|Patient decision|0|||
33590352|NCT00152477|102050522|FG001|Monotherapy Period|Patient decision|1|||
33590353|NCT00152477|102050523|FG002|Monotherapy Period|Patient decision|1|||
33590354|NCT00152477|102050521|FG000|Monotherapy Period|Study personel decision|0|||
33590355|NCT00152477|102050522|FG001|Monotherapy Period|Study personel decision|0|||
33590356|NCT00152477|102050523|FG002|Monotherapy Period|Study personel decision|1|||
33590357|NCT01271712|102050527|FG000|Double Blind Treatment|Death|2|||
33590358|NCT01271712|102050528|FG001|Double Blind Treatment|Death|0|||
33590359|NCT01271712|102050527|FG000|Double Blind Treatment|Lack of Efficacy|1|||
33590360|NCT01271712|102050528|FG001|Double Blind Treatment|Lack of Efficacy|0|||
33590361|NCT01271712|102050527|FG000|Double Blind Treatment|Adverse Event|9|||
33590362|NCT01271712|102050528|FG001|Double Blind Treatment|Adverse Event|4|||
33590363|NCT01271712|102050527|FG000|Double Blind Treatment|Progressive disease|23|||
33590364|NCT01271712|102050528|FG001|Double Blind Treatment|Progressive disease|3|||
33590365|NCT01271712|102050527|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
33590366|NCT01271712|102050528|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
33590367|NCT01271712|102050527|FG000|Double Blind Treatment|Non compliance with study drug|2|||
33590368|NCT01271712|102050528|FG001|Double Blind Treatment|Non compliance with study drug|0|||
33590369|NCT01271712|102050527|FG000|Double Blind Treatment|receive no study drug|1|||
33590370|NCT01271712|102050528|FG001|Double Blind Treatment|receive no study drug|0|||
33590371|NCT01271712|102050527|FG000|Open Label Treatment|Death|6|||
33590372|NCT01271712|102050528|FG001|Open Label Treatment|Death|5|||
33590373|NCT01271712|102050527|FG000|Open Label Treatment|Withdrawal by Subject|6|||
33590374|NCT01271712|102050528|FG001|Open Label Treatment|Withdrawal by Subject|11|||
33590375|NCT01271712|102050527|FG000|Open Label Treatment|Physician Decision|2|||
33590376|NCT01271712|102050528|FG001|Open Label Treatment|Physician Decision|0|||
33590377|NCT01271712|102050527|FG000|Open Label Treatment|Adverse Event|14|||
33590378|NCT01271712|102050528|FG001|Open Label Treatment|Adverse Event|8|||
33590379|NCT01271712|102050527|FG000|Open Label Treatment|Progressive disease|59|||
33590380|NCT01271712|102050528|FG001|Open Label Treatment|Progressive disease|32|||
33590381|NCT01271712|102050527|FG000|Open Label Treatment|transferred to rollover study|1|||
33590382|NCT01271712|102050528|FG001|Open Label Treatment|transferred to rollover study|0|||
33590383|NCT01271712|102050527|FG000|Open Label Treatment|Non-compliance with study drug|1|||
33590384|NCT01271712|102050528|FG001|Open Label Treatment|Non-compliance with study drug|0|||
33590385|NCT01271712|102050527|FG000|Open Label Treatment|Protocol Violation|0|||
33590386|NCT01271712|102050528|FG001|Open Label Treatment|Protocol Violation|1|||
33590387|NCT01271712|102050527|FG000|Open Label Treatment|Switching to other therapy|2|||
33590388|NCT01271712|102050528|FG001|Open Label Treatment|Switching to other therapy|1|||
33590389|NCT01271712|102050527|FG000|Safety Follow-up|Death|11|||
33590390|NCT01271712|102050528|FG001|Safety Follow-up|Death|7|||
33590391|NCT01271712|102050527|FG000|Safety Follow-up|Withdrawal by Subject|4|||
33590392|NCT01271712|102050528|FG001|Safety Follow-up|Withdrawal by Subject|2|||
33590393|NCT01271712|102050527|FG000|Safety Follow-up|Protocol Violation|1|||
33590394|NCT01271712|102050528|FG001|Safety Follow-up|Protocol Violation|1|||
33590395|NCT01271712|102050527|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
33590396|NCT01271712|102050528|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
33590397|NCT01271712|102050527|FG000|Safety Follow-up|No follow-up|1|||
33648705|NCT01049009|102265731|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
33648706|NCT01049009|102265732|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
33648707|NCT01049009|102265731|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
33648708|NCT01049009|102265732|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
33384521|NCT04295356|101295801|FG001|Overall Study|Protocol Violation|1|||
33590398|NCT01271712|102050528|FG001|Safety Follow-up|No follow-up|1|||
33590399|NCT01271712|102050527|FG000|Safety Follow-up|Progressive disease|1|||
33590400|NCT01271712|102050528|FG001|Safety Follow-up|Progressive disease|0|||
33590401|NCT01271712|102050527|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
33590402|NCT01271712|102050528|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
33590403|NCT00721578|102050538|FG000|Overall Study|Death|1|||
33590404|NCT00721578|102050539|FG001|Overall Study|Death|1|||
33590405|NCT00721578|102050538|FG000|Overall Study|Withdrawal by Subject|1|||
33590406|NCT00721578|102050539|FG001|Overall Study|Withdrawal by Subject|1|||
33590407|NCT01779856|102050540|FG000|Overall Study|Withdrawal by Subject|15|||
33590408|NCT01779856|102050540|FG000|Overall Study|Death|3|||
33590409|NCT01779856|102050540|FG000|Overall Study|Physician Decision|1|||
33590410|NCT01779856|102050540|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
33590411|NCT01779856|102050540|FG000|Overall Study|Delays in scheduling implant|1|||
33590412|NCT01779856|102050540|FG000|Overall Study|Subject ineligible for Implant|2|||
33590413|NCT04068519|102050542|FG000|Dose Verification|Death|15|||
33590414|NCT04068519|102050542|FG000|Dose Verification|Withdrawal by Subject|1|||
33590415|NCT04068519|102050542|FG000|Pharmacokinetic Sub-study|Death|35|||
33590416|NCT04068519|102050542|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
33590417|NCT04068519|102050542|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
33590418|NCT04068519|102050542|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
33590419|NCT04068519|102050542|FG000|Indication Expansion|Death|152|||
33590420|NCT04068519|102050542|FG000|Indication Expansion|Withdrawal by Subject|10|||
33590421|NCT04068519|102050542|FG000|Indication Expansion|Lost to Follow-up|7|||
33590422|NCT01576146|102050547|FG000|Extension Period 1|Adverse Event|2|||
33590423|NCT01576146|102050547|FG000|Extension Period 1|Death|2|||
33590424|NCT01576146|102050547|FG000|Extension Period 1|Physician Decision|2|||
33590425|NCT01576146|102050547|FG000|Extension Period 1|Withdrawal by Subject|1|||
33590426|NCT01576146|102050547|FG000|Extension Period 1|Lost to Follow-up|1|||
33590427|NCT01576146|102050547|FG000|Extension Period 1|Parathyroidectomy|1|||
33590428|NCT01576146|102050547|FG000|Extension Period 1|Renal Transplant|1|||
33590429|NCT01576146|102050547|FG000|Extension Period 2|Sponsor Decision|13|||
33590430|NCT01576146|102050547|FG000|Extension Period 2|Death|1|||
33590431|NCT01576146|102050547|FG000|Extension Period 2|Adverse Event|1|||
33590432|NCT01576146|102050547|FG000|Extension Period 2|Renal Transplant|1|||
33590433|NCT01576146|102050547|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
33590434|NCT00022763|102050548|FG000|Overall Study|Adverse Event|1|||
33590435|NCT00022763|102050549|FG001|Overall Study|Adverse Event|2|||
33590436|NCT00022763|102050548|FG000|Overall Study|Injection Site Reactions|0|||
33590437|NCT00022763|102050549|FG001|Overall Study|Injection Site Reactions|2|||
33590438|NCT00022763|102050548|FG000|Overall Study|Death|0|||
33590439|NCT00022763|102050549|FG001|Overall Study|Death|1|||
33590440|NCT00022763|102050548|FG000|Overall Study|Lost to Follow-up|0|||
33590441|NCT00022763|102050549|FG001|Overall Study|Lost to Follow-up|3|||
33590442|NCT00022763|102050548|FG000|Overall Study|Withdrawal by Subject|4|||
33590443|NCT00022763|102050549|FG001|Overall Study|Withdrawal by Subject|7|||
33590444|NCT00022763|102050548|FG000|Overall Study|Insufficient Therapy|1|||
33590445|NCT00022763|102050549|FG001|Overall Study|Insufficient Therapy|0|||
33590446|NCT00022763|102050548|FG000|Overall Study|Admin|3|||
33590447|NCT00022763|102050549|FG001|Overall Study|Admin|2|||
33590448|NCT00306293|102050552|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
33590449|NCT00306293|102050553|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
33590450|NCT00306293|102050552|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
33590451|NCT00306293|102050553|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
33590452|NCT00306293|102050552|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
33590453|NCT00306293|102050553|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
33590454|NCT00306293|102050552|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
33590455|NCT00306293|102050553|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
33590456|NCT00306293|102050552|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
33590457|NCT00306293|102050553|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
33590458|NCT00306293|102050552|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
33590459|NCT00306293|102050553|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
33590460|NCT00306293|102050552|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
33648709|NCT02756806|102265733|FG000|Overall Study|Study terminated early|5|||
33648710|NCT01124864|102265734|FG000|Overall Study|Follow up phase competed as per protocol|18|||
33648711|NCT01124864|102265735|FG001|Overall Study|Follow up phase competed as per protocol|22|||
33648712|NCT01124864|102265736|FG002|Overall Study|Follow up phase competed as per protocol|24|||
33648713|NCT01124864|102265737|FG003|Overall Study|Follow up phase competed as per protocol|18|||
33648714|NCT01124864|102265738|FG004|Overall Study|Follow up phase competed as per protocol|26|||
33433240|NCT03519256|101476814|FG001|Overall Study|Other reasons|0|||
33590461|NCT00306293|102050553|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
33648715|NCT01124864|102265739|FG005|Overall Study|Follow up phase competed as per protocol|2|||
33648716|NCT01124864|102265734|FG000|Overall Study|Death|6|||
33648717|NCT01124864|102265735|FG001|Overall Study|Death|9|||
33648718|NCT01124864|102265736|FG002|Overall Study|Death|6|||
33648719|NCT01124864|102265737|FG003|Overall Study|Death|2|||
33648720|NCT01124864|102265738|FG004|Overall Study|Death|1|||
33590462|NCT00306293|102050552|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
33590463|NCT00306293|102050553|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
33590464|NCT01944098|102050554|FG000|Overall Study|Physician Decision|1|||
33590465|NCT01944098|102050555|FG001|Overall Study|Physician Decision|0|||
33648721|NCT01124864|102265739|FG005|Overall Study|Death|0|||
33648722|NCT01124864|102265734|FG000|Overall Study|Withdrawal by Subject|2|||
33648723|NCT01124864|102265735|FG001|Overall Study|Withdrawal by Subject|3|||
33648724|NCT01124864|102265736|FG002|Overall Study|Withdrawal by Subject|4|||
33648725|NCT01124864|102265737|FG003|Overall Study|Withdrawal by Subject|0|||
33648726|NCT01124864|102265738|FG004|Overall Study|Withdrawal by Subject|2|||
33590466|NCT00245050|102050556|FG000|Overall Study|Adverse Event|3|||
33590467|NCT00245050|102050557|FG001|Overall Study|Adverse Event|2|||
33590468|NCT01106651|102050558|FG000|Overall Study|Adverse Event|17|||
33590469|NCT01106651|102050559|FG001|Overall Study|Adverse Event|9|||
33590470|NCT01106651|102050560|FG002|Overall Study|Adverse Event|23|||
33590471|NCT01106651|102050558|FG000|Overall Study|Lost to Follow-up|8|||
33590472|NCT01106651|102050559|FG001|Overall Study|Lost to Follow-up|2|||
33590473|NCT01106651|102050560|FG002|Overall Study|Lost to Follow-up|6|||
33590474|NCT01106651|102050558|FG000|Overall Study|Physician Decision|4|||
33590475|NCT01106651|102050559|FG001|Overall Study|Physician Decision|3|||
33590476|NCT01106651|102050560|FG002|Overall Study|Physician Decision|1|||
33590477|NCT01106651|102050558|FG000|Overall Study|Protocol Violation|1|||
33590478|NCT01106651|102050559|FG001|Overall Study|Protocol Violation|2|||
33590479|NCT01106651|102050560|FG002|Overall Study|Protocol Violation|1|||
33590480|NCT01106651|102050558|FG000|Overall Study|Withdrawal by Subject|14|||
33590481|NCT01106651|102050559|FG001|Overall Study|Withdrawal by Subject|7|||
33590482|NCT01106651|102050560|FG002|Overall Study|Withdrawal by Subject|4|||
33590483|NCT01106651|102050558|FG000|Overall Study|Noncompliance with study drug|1|||
33590484|NCT01106651|102050559|FG001|Overall Study|Noncompliance with study drug|0|||
33590485|NCT01106651|102050560|FG002|Overall Study|Noncompliance with study drug|2|||
33590486|NCT01106651|102050558|FG000|Overall Study|Other|34|||
33590487|NCT01106651|102050559|FG001|Overall Study|Other|31|||
33590488|NCT01106651|102050560|FG002|Overall Study|Other|21|||
33590489|NCT01106651|102050558|FG000|Overall Study|Death|0|||
33590490|NCT01106651|102050559|FG001|Overall Study|Death|3|||
33590491|NCT01106651|102050560|FG002|Overall Study|Death|0|||
33590492|NCT00939029|102050561|FG000|Overall Study|Withdrawal by Subject|3|||
33590493|NCT00939029|102050562|FG001|Overall Study|Withdrawal by Subject|7|||
33590494|NCT00939029|102050561|FG000|Overall Study|Lost to Follow-up|3|||
33590495|NCT00939029|102050562|FG001|Overall Study|Lost to Follow-up|4|||
33590496|NCT00939029|102050561|FG000|Overall Study|Adverse Event|0|||
33590497|NCT00939029|102050562|FG001|Overall Study|Adverse Event|1|||
33590498|NCT02524275|102050563|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
33590499|NCT01450696|102050567|FG000|Overall Study|Never Treated|1|||
33590500|NCT01450696|102050568|FG001|Overall Study|Never Treated|1|||
33590501|NCT01450696|102050567|FG000|Overall Study|Death|77|||
33590502|NCT01450696|102050568|FG001|Overall Study|Death|84|||
33590503|NCT01450696|102050567|FG000|Overall Study|Lost to Follow-up|3|||
33648727|NCT01124864|102265739|FG005|Overall Study|Withdrawal by Subject|1|||
33648728|NCT01124864|102265734|FG000|Overall Study|Lost to Follow-up|1|||
33648729|NCT01124864|102265735|FG001|Overall Study|Lost to Follow-up|1|||
33648730|NCT01124864|102265736|FG002|Overall Study|Lost to Follow-up|0|||
33648731|NCT01124864|102265737|FG003|Overall Study|Lost to Follow-up|1|||
33648732|NCT01124864|102265738|FG004|Overall Study|Lost to Follow-up|0|||
33648733|NCT01124864|102265739|FG005|Overall Study|Lost to Follow-up|0|||
33648734|NCT01124864|102265734|FG000|Overall Study|Protocol Violation|1|||
33648735|NCT01124864|102265735|FG001|Overall Study|Protocol Violation|0|||
33648736|NCT01124864|102265736|FG002|Overall Study|Protocol Violation|0|||
33648737|NCT01124864|102265737|FG003|Overall Study|Protocol Violation|0|||
33648738|NCT01124864|102265738|FG004|Overall Study|Protocol Violation|1|||
33648739|NCT01124864|102265739|FG005|Overall Study|Protocol Violation|0|||
33648740|NCT00777153|102265741|FG000|Overall Study|Lost to Follow-up|1|||
33648741|NCT00777153|102265742|FG001|Overall Study|Lost to Follow-up|1|||
33648742|NCT00777153|102265743|FG002|Overall Study|Lost to Follow-up|0|||
33150069|NCT00674973|100463607|FG000|Overall Study|Refused Treatment|1|||
33150070|NCT00674973|100463608|FG001|Overall Study|Refused Treatment|5|||
33150071|NCT00674973|100463607|FG000|Overall Study|Failure to Return|1|||
33150072|NCT00674973|100463608|FG001|Overall Study|Failure to Return|0|||
33150073|NCT00674973|100463607|FG000|Overall Study|Adverse Event|2|||
33648743|NCT00777153|102265741|FG000|Overall Study|Death|85|||
33648744|NCT00777153|102265742|FG001|Overall Study|Death|73|||
33648745|NCT00777153|102265743|FG002|Overall Study|Death|33|||
33648746|NCT00777153|102265741|FG000|Overall Study|Withdrawal by Subject|3|||
33150074|NCT00674973|100463608|FG001|Overall Study|Adverse Event|9|||
33150075|NCT00674973|100463607|FG000|Overall Study|Death|19|||
33590504|NCT01450696|102050568|FG001|Overall Study|Lost to Follow-up|3|||
33590505|NCT01450696|102050567|FG000|Overall Study|Non-Compliance|1|||
33590506|NCT01450696|102050568|FG001|Overall Study|Non-Compliance|0|||
33590507|NCT01450696|102050567|FG000|Overall Study|Withdrawal by Subject|13|||
33590508|NCT01450696|102050568|FG001|Overall Study|Withdrawal by Subject|2|||
33590509|NCT01450696|102050567|FG000|Overall Study|Study Terminated by Sponsor|53|||
33590510|NCT01450696|102050568|FG001|Overall Study|Study Terminated by Sponsor|58|||
33590511|NCT02516098|102050569|FG000|Period 1|Protocol Violation|1|||
33648747|NCT00777153|102265742|FG001|Overall Study|Withdrawal by Subject|4|||
33648748|NCT00777153|102265743|FG002|Overall Study|Withdrawal by Subject|3|||
33648749|NCT00777153|102265741|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
33648750|NCT00777153|102265742|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
33648751|NCT00777153|102265743|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
33648752|NCT03085914|102265744|FG000|Overall Study|Death|6|||
33648753|NCT03085914|102265745|FG001|Overall Study|Death|6|||
33648754|NCT03085914|102265746|FG002|Overall Study|Death|4|||
33648755|NCT03085914|102265747|FG003|Overall Study|Death|1|||
33648756|NCT03085914|102265748|FG004|Overall Study|Death|5|||
33648757|NCT03085914|102265749|FG005|Overall Study|Death|2|||
33648758|NCT03085914|102265750|FG006|Overall Study|Death|2|||
33648759|NCT03085914|102265744|FG000|Overall Study|Withdrawal by Subject|1|||
33648760|NCT03085914|102265745|FG001|Overall Study|Withdrawal by Subject|1|||
33648761|NCT03085914|102265746|FG002|Overall Study|Withdrawal by Subject|2|||
33433241|NCT03519256|101476815|FG002|Overall Study|Other reasons|2|||
33590512|NCT02516098|102050570|FG001|Period 1|Protocol Violation|0|||
33590513|NCT02516098|102050569|FG000|Washout After Period 1|Adverse Event|0|||
33590514|NCT02516098|102050570|FG001|Washout After Period 1|Adverse Event|1|||
33590515|NCT02516098|102050569|FG000|Period 2|Withdrawal by Subject|0|||
33590516|NCT02516098|102050570|FG001|Period 2|Withdrawal by Subject|1|||
33590517|NCT04187144|102050571|FG000|Overall Study|Lost to Follow-up|12|||
33590518|NCT04187144|102050572|FG001|Overall Study|Lost to Follow-up|11|||
33590519|NCT04187144|102050571|FG000|Overall Study|Withdrawal by Subject|20|||
33590520|NCT04187144|102050572|FG001|Overall Study|Withdrawal by Subject|18|||
33590521|NCT04187144|102050571|FG000|Overall Study|Adverse Event|19|||
33590522|NCT04187144|102050572|FG001|Overall Study|Adverse Event|4|||
33590523|NCT04187144|102050571|FG000|Overall Study|Physician Decision|5|||
33590524|NCT04187144|102050572|FG001|Overall Study|Physician Decision|3|||
33590525|NCT04187144|102050571|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
33590526|NCT04187144|102050572|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
33590527|NCT04187144|102050571|FG000|Overall Study|Protocol Deviation|1|||
33590528|NCT04187144|102050572|FG001|Overall Study|Protocol Deviation|4|||
33590529|NCT00734604|102050573|FG000|Overall Study|Adverse Event|0|||
33590530|NCT00734604|102050574|FG001|Overall Study|Adverse Event|2|||
33590531|NCT00734604|102050575|FG002|Overall Study|Adverse Event|0|||
33590532|NCT00734604|102050576|FG003|Overall Study|Adverse Event|2|||
33590533|NCT00734604|102050577|FG004|Overall Study|Adverse Event|1|||
33590534|NCT00734604|102050578|FG005|Overall Study|Adverse Event|1|||
33590535|NCT00734604|102050573|FG000|Overall Study|Serious Adverse Event|1|||
33590536|NCT00734604|102050574|FG001|Overall Study|Serious Adverse Event|0|||
33590537|NCT00734604|102050575|FG002|Overall Study|Serious Adverse Event|1|||
33590538|NCT00734604|102050576|FG003|Overall Study|Serious Adverse Event|2|||
33590539|NCT00734604|102050577|FG004|Overall Study|Serious Adverse Event|0|||
33590540|NCT00734604|102050578|FG005|Overall Study|Serious Adverse Event|1|||
33590541|NCT00734604|102050573|FG000|Overall Study|Lost to Follow-up|1|||
33590542|NCT00734604|102050574|FG001|Overall Study|Lost to Follow-up|2|||
33590543|NCT00734604|102050575|FG002|Overall Study|Lost to Follow-up|2|||
33590544|NCT00734604|102050576|FG003|Overall Study|Lost to Follow-up|4|||
33590545|NCT00734604|102050577|FG004|Overall Study|Lost to Follow-up|2|||
33590546|NCT00734604|102050578|FG005|Overall Study|Lost to Follow-up|3|||
33590547|NCT00734604|102050573|FG000|Overall Study|Physician Decision|0|||
33590548|NCT00734604|102050574|FG001|Overall Study|Physician Decision|1|||
33590549|NCT00734604|102050575|FG002|Overall Study|Physician Decision|1|||
33590550|NCT00734604|102050576|FG003|Overall Study|Physician Decision|0|||
33590551|NCT00734604|102050577|FG004|Overall Study|Physician Decision|0|||
33590552|NCT00734604|102050578|FG005|Overall Study|Physician Decision|0|||
33590553|NCT00734604|102050573|FG000|Overall Study|Protocol Violation|0|||
33590554|NCT00734604|102050574|FG001|Overall Study|Protocol Violation|2|||
33648762|NCT03085914|102265747|FG003|Overall Study|Withdrawal by Subject|2|||
33648763|NCT03085914|102265748|FG004|Overall Study|Withdrawal by Subject|2|||
33648764|NCT03085914|102265749|FG005|Overall Study|Withdrawal by Subject|0|||
33648765|NCT03085914|102265750|FG006|Overall Study|Withdrawal by Subject|1|||
33648766|NCT03085914|102265744|FG000|Overall Study|Lost to Follow-up|0|||
33150076|NCT00674973|100463608|FG001|Overall Study|Death|15|||
33433242|NCT03519256|101476816|FG003|Overall Study|Other reasons|0|||
33648767|NCT03085914|102265745|FG001|Overall Study|Lost to Follow-up|0|||
33150077|NCT00674973|100463607|FG000|Overall Study|Protocol Violation|0|||
33433243|NCT03519256|101476813|FG000|Overall Study|Disease progression|6|||
33433244|NCT03519256|101476814|FG001|Overall Study|Disease progression|3|||
33590555|NCT00734604|102050575|FG002|Overall Study|Protocol Violation|0|||
33590556|NCT00734604|102050576|FG003|Overall Study|Protocol Violation|0|||
33590557|NCT00734604|102050577|FG004|Overall Study|Protocol Violation|1|||
33590558|NCT00734604|102050578|FG005|Overall Study|Protocol Violation|0|||
33590559|NCT00734604|102050573|FG000|Overall Study|Sponsor Decision|1|||
33590560|NCT00734604|102050574|FG001|Overall Study|Sponsor Decision|2|||
33590561|NCT00734604|102050575|FG002|Overall Study|Sponsor Decision|1|||
33590562|NCT00734604|102050576|FG003|Overall Study|Sponsor Decision|0|||
33648768|NCT03085914|102265746|FG002|Overall Study|Lost to Follow-up|1|||
33648769|NCT03085914|102265747|FG003|Overall Study|Lost to Follow-up|0|||
33590563|NCT00734604|102050577|FG004|Overall Study|Sponsor Decision|2|||
33590564|NCT00734604|102050578|FG005|Overall Study|Sponsor Decision|0|||
33590565|NCT00734604|102050573|FG000|Overall Study|Withdrawal by Subject|0|||
33590566|NCT00734604|102050574|FG001|Overall Study|Withdrawal by Subject|2|||
33590567|NCT00734604|102050575|FG002|Overall Study|Withdrawal by Subject|0|||
33590568|NCT00734604|102050576|FG003|Overall Study|Withdrawal by Subject|1|||
33590569|NCT00734604|102050577|FG004|Overall Study|Withdrawal by Subject|2|||
33590570|NCT00734604|102050578|FG005|Overall Study|Withdrawal by Subject|1|||
33590571|NCT00734604|102050573|FG000|Overall Study|Lack of Efficacy|0|||
33590572|NCT00734604|102050574|FG001|Overall Study|Lack of Efficacy|1|||
33590573|NCT00734604|102050575|FG002|Overall Study|Lack of Efficacy|1|||
33590574|NCT00734604|102050576|FG003|Overall Study|Lack of Efficacy|0|||
33590575|NCT00734604|102050577|FG004|Overall Study|Lack of Efficacy|0|||
33590576|NCT00734604|102050578|FG005|Overall Study|Lack of Efficacy|0|||
33590577|NCT03213938|102050579|FG000|Overall Study|Lost to Follow-up|4|||
33590578|NCT03213938|102050580|FG001|Overall Study|Lost to Follow-up|3|||
33590579|NCT03213938|102050579|FG000|Overall Study|Lack of Efficacy|1|||
33590580|NCT03213938|102050580|FG001|Overall Study|Lack of Efficacy|0|||
33590581|NCT03213938|102050579|FG000|Overall Study|Decline to participate|5|||
33590582|NCT03213938|102050580|FG001|Overall Study|Decline to participate|4|||
33590583|NCT03213938|102050579|FG000|Overall Study|Without reason|4|||
33590584|NCT03213938|102050580|FG001|Overall Study|Without reason|5|||
33590585|NCT00079391|102050581|FG000|Overall Study|Withdrawal by Subject|1|||
33590586|NCT05286658|102050585|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
33590587|NCT05286658|102050585|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
33590588|NCT00984165|102050588|FG000|Overall Study|Death on study|2|||
33590589|NCT00984165|102050589|FG001|Overall Study|Death on study|0|||
33590590|NCT00984165|102050590|FG002|Overall Study|Death on study|0|||
33590591|NCT00984165|102050591|FG003|Overall Study|Death on study|0|||
33590592|NCT00984165|102050588|FG000|Overall Study|Disease progression on study|5|||
33590593|NCT00984165|102050589|FG001|Overall Study|Disease progression on study|1|||
33590594|NCT00984165|102050590|FG002|Overall Study|Disease progression on study|0|||
33590595|NCT00984165|102050591|FG003|Overall Study|Disease progression on study|0|||
33590596|NCT00984165|102050588|FG000|Overall Study|Death of recipient|0|||
33590597|NCT00984165|102050589|FG001|Overall Study|Death of recipient|0|||
33590598|NCT00984165|102050590|FG002|Overall Study|Death of recipient|0|||
33590599|NCT00984165|102050591|FG003|Overall Study|Death of recipient|1|||
33590600|NCT00984165|102050588|FG000|Overall Study|New protocol|0|||
33590601|NCT00984165|102050589|FG001|Overall Study|New protocol|0|||
33590602|NCT00984165|102050590|FG002|Overall Study|New protocol|0|||
33590603|NCT00984165|102050591|FG003|Overall Study|New protocol|1|||
33590604|NCT00984165|102050588|FG000|Overall Study|P+/donor pair removed from protocol|0|||
33590605|NCT00984165|102050589|FG001|Overall Study|P+/donor pair removed from protocol|0|||
33590606|NCT00984165|102050590|FG002|Overall Study|P+/donor pair removed from protocol|0|||
33590607|NCT00984165|102050591|FG003|Overall Study|P+/donor pair removed from protocol|1|||
33590608|NCT00984165|102050588|FG000|Overall Study|removed with a pair recipient|0|||
33590609|NCT00984165|102050589|FG001|Overall Study|removed with a pair recipient|0|||
33590610|NCT00984165|102050590|FG002|Overall Study|removed with a pair recipient|0|||
33590611|NCT00984165|102050591|FG003|Overall Study|removed with a pair recipient|1|||
33590612|NCT01208961|102050597|FG000|High-Fat Period III|Protocol Violation|1|||
33590613|NCT01208961|102050598|FG001|High-Fat Period III|Protocol Violation|0|||
33590614|NCT02305849|102050600|FG000|Overall Study|Adverse Event|10|||
33590615|NCT02305849|102050601|FG001|Overall Study|Adverse Event|12|||
33590616|NCT02305849|102050602|FG002|Overall Study|Adverse Event|7|||
33590617|NCT02305849|102050603|FG003|Overall Study|Adverse Event|3|||
33590618|NCT02305849|102050600|FG000|Overall Study|Lack of Efficacy|10|||
33590619|NCT02305849|102050601|FG001|Overall Study|Lack of Efficacy|6|||
33590620|NCT02305849|102050602|FG002|Overall Study|Lack of Efficacy|3|||
33590621|NCT02305849|102050603|FG003|Overall Study|Lack of Efficacy|9|||
33590622|NCT02305849|102050600|FG000|Overall Study|Withdrawal by Subject|2|||
33590623|NCT02305849|102050601|FG001|Overall Study|Withdrawal by Subject|2|||
33590624|NCT02305849|102050602|FG002|Overall Study|Withdrawal by Subject|1|||
33590625|NCT02305849|102050603|FG003|Overall Study|Withdrawal by Subject|4|||
33590626|NCT02305849|102050600|FG000|Overall Study|Lost to Follow-up|0|||
33590627|NCT02305849|102050601|FG001|Overall Study|Lost to Follow-up|2|||
33590628|NCT02305849|102050602|FG002|Overall Study|Lost to Follow-up|0|||
33590629|NCT02305849|102050603|FG003|Overall Study|Lost to Follow-up|0|||
33590630|NCT02305849|102050600|FG000|Overall Study|Protocol Violation|3|||
33590631|NCT02305849|102050601|FG001|Overall Study|Protocol Violation|2|||
33590632|NCT02305849|102050602|FG002|Overall Study|Protocol Violation|1|||
33590633|NCT02305849|102050603|FG003|Overall Study|Protocol Violation|1|||
33590634|NCT02305849|102050600|FG000|Overall Study|Lab data met discontinuation criteria|0|||
33590635|NCT02305849|102050601|FG001|Overall Study|Lab data met discontinuation criteria|1|||
33590636|NCT02305849|102050602|FG002|Overall Study|Lab data met discontinuation criteria|2|||
33590637|NCT02305849|102050603|FG003|Overall Study|Lab data met discontinuation criteria|1|||
33590638|NCT02305849|102050600|FG000|Overall Study|Miscellaneous|1|||
33590639|NCT02305849|102050601|FG001|Overall Study|Miscellaneous|2|||
33590640|NCT02305849|102050602|FG002|Overall Study|Miscellaneous|4|||
33590641|NCT02305849|102050603|FG003|Overall Study|Miscellaneous|1|||
33590642|NCT02305849|102050600|FG000|Overall Study|Not fulfill eligibility criteria|1|||
33590643|NCT02305849|102050601|FG001|Overall Study|Not fulfill eligibility criteria|1|||
33590644|NCT02305849|102050602|FG002|Overall Study|Not fulfill eligibility criteria|0|||
33590645|NCT02305849|102050603|FG003|Overall Study|Not fulfill eligibility criteria|0|||
33590646|NCT05791565|102050605|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
33590647|NCT05791565|102050606|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
33590648|NCT03006848|102050617|FG000|Overall Study|Adverse Event|1|||
33590649|NCT03006848|102050617|FG000|Overall Study|Physician Decision|1|||
33590650|NCT03006848|102050617|FG000|Overall Study|Lack of Efficacy|16|||
33590651|NCT01681069|102050618|FG000|Overall Study|Withdrawal by Subject|4|||
33590652|NCT01681069|102050619|FG001|Overall Study|Withdrawal by Subject|5|||
33590653|NCT01681069|102050618|FG000|Overall Study|Protocol Violation|1|||
33590654|NCT01681069|102050619|FG001|Overall Study|Protocol Violation|1|||
33590655|NCT01681069|102050618|FG000|Overall Study|Adverse Event|0|||
33590656|NCT01681069|102050619|FG001|Overall Study|Adverse Event|1|||
33590657|NCT03327220|102050620|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
33590658|NCT03327220|102050621|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
33590659|NCT03327220|102050620|FG000|Overall Study|Investigator Decision|2|||
33590660|NCT03327220|102050621|FG001|Overall Study|Investigator Decision|0|||
33590661|NCT03327220|102050620|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
33590662|NCT03327220|102050621|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
33590663|NCT03327220|102050620|FG000|Overall Study|Fungal infection|1|||
33590664|NCT03327220|102050621|FG001|Overall Study|Fungal infection|0|||
33590665|NCT03327220|102050620|FG000|Overall Study|Discharged to Rehabilitation|0|||
33590666|NCT03327220|102050621|FG001|Overall Study|Discharged to Rehabilitation|1|||
33590667|NCT03327220|102050620|FG000|Overall Study|Missing|1|||
33590668|NCT03327220|102050621|FG001|Overall Study|Missing|0|||
33590669|NCT01127607|102050622|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
33590670|NCT01127607|102050623|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
33590671|NCT01127607|102050622|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
33590672|NCT01127607|102050623|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
33590673|NCT00075725|102050624|FG000|Overall Study|Adverse Event|6|||
33590674|NCT00075725|102050625|FG001|Overall Study|Adverse Event|6|||
33590675|NCT00075725|102050626|FG002|Overall Study|Adverse Event|20|||
33590676|NCT00075725|102050627|FG003|Overall Study|Adverse Event|8|||
33590677|NCT00075725|102050628|FG004|Overall Study|Adverse Event|4|||
33590678|NCT00075725|102050629|FG005|Overall Study|Adverse Event|38|||
33590679|NCT00075725|102050630|FG006|Overall Study|Adverse Event|3|||
33590680|NCT00075725|102050631|FG007|Overall Study|Adverse Event|51|||
33590681|NCT00075725|102050632|FG008|Overall Study|Adverse Event|15|||
33590682|NCT00075725|102050633|FG009|Overall Study|Adverse Event|4|||
33590683|NCT00075725|102050634|FG010|Overall Study|Adverse Event|2|||
33590684|NCT00075725|102050635|FG011|Overall Study|Adverse Event|2|||
33590685|NCT00075725|102050624|FG000|Overall Study|Death|3|||
33590686|NCT00075725|102050625|FG001|Overall Study|Death|5|||
33590687|NCT00075725|102050626|FG002|Overall Study|Death|10|||
33590688|NCT00075725|102050627|FG003|Overall Study|Death|2|||
33590689|NCT00075725|102050628|FG004|Overall Study|Death|3|||
33590690|NCT00075725|102050629|FG005|Overall Study|Death|25|||
33590691|NCT00075725|102050630|FG006|Overall Study|Death|4|||
33590692|NCT00075725|102050631|FG007|Overall Study|Death|22|||
33590693|NCT00075725|102050632|FG008|Overall Study|Death|14|||
33590694|NCT00075725|102050633|FG009|Overall Study|Death|4|||
33590695|NCT00075725|102050634|FG010|Overall Study|Death|3|||
33590696|NCT00075725|102050635|FG011|Overall Study|Death|0|||
33590697|NCT00075725|102050624|FG000|Overall Study|Lost to Follow-up|1|||
33590698|NCT00075725|102050625|FG001|Overall Study|Lost to Follow-up|1|||
33590699|NCT00075725|102050626|FG002|Overall Study|Lost to Follow-up|4|||
33590700|NCT00075725|102050627|FG003|Overall Study|Lost to Follow-up|1|||
33590701|NCT00075725|102050628|FG004|Overall Study|Lost to Follow-up|0|||
33590702|NCT00075725|102050629|FG005|Overall Study|Lost to Follow-up|13|||
33590703|NCT00075725|102050630|FG006|Overall Study|Lost to Follow-up|2|||
33590704|NCT00075725|102050631|FG007|Overall Study|Lost to Follow-up|4|||
33590705|NCT00075725|102050632|FG008|Overall Study|Lost to Follow-up|1|||
33150078|NCT00674973|100463608|FG001|Overall Study|Protocol Violation|1|||
33590706|NCT00075725|102050633|FG009|Overall Study|Lost to Follow-up|0|||
33590707|NCT00075725|102050634|FG010|Overall Study|Lost to Follow-up|0|||
33433245|NCT03519256|101476815|FG002|Overall Study|Disease progression|2|||
33590708|NCT00075725|102050635|FG011|Overall Study|Lost to Follow-up|0|||
33590709|NCT00075725|102050624|FG000|Overall Study|Physician Decision|2|||
33590710|NCT00075725|102050625|FG001|Overall Study|Physician Decision|6|||
33590711|NCT00075725|102050626|FG002|Overall Study|Physician Decision|5|||
33590712|NCT00075725|102050627|FG003|Overall Study|Physician Decision|8|||
33590713|NCT00075725|102050628|FG004|Overall Study|Physician Decision|4|||
33590714|NCT00075725|102050629|FG005|Overall Study|Physician Decision|19|||
33590715|NCT00075725|102050630|FG006|Overall Study|Physician Decision|3|||
33590716|NCT00075725|102050631|FG007|Overall Study|Physician Decision|17|||
33590717|NCT00075725|102050632|FG008|Overall Study|Physician Decision|5|||
33590718|NCT00075725|102050633|FG009|Overall Study|Physician Decision|0|||
33590719|NCT00075725|102050634|FG010|Overall Study|Physician Decision|1|||
33590720|NCT00075725|102050635|FG011|Overall Study|Physician Decision|0|||
33590721|NCT00075725|102050624|FG000|Overall Study|Pregnancy|0|||
33590722|NCT00075725|102050625|FG001|Overall Study|Pregnancy|0|||
33590723|NCT00075725|102050626|FG002|Overall Study|Pregnancy|0|||
33590724|NCT00075725|102050627|FG003|Overall Study|Pregnancy|0|||
33590725|NCT00075725|102050628|FG004|Overall Study|Pregnancy|0|||
33590726|NCT00075725|102050629|FG005|Overall Study|Pregnancy|1|||
33590727|NCT00075725|102050630|FG006|Overall Study|Pregnancy|0|||
33590728|NCT00075725|102050631|FG007|Overall Study|Pregnancy|1|||
33590729|NCT00075725|102050632|FG008|Overall Study|Pregnancy|0|||
33590730|NCT00075725|102050633|FG009|Overall Study|Pregnancy|0|||
33590731|NCT00075725|102050634|FG010|Overall Study|Pregnancy|0|||
33590732|NCT00075725|102050635|FG011|Overall Study|Pregnancy|0|||
33590733|NCT00075725|102050624|FG000|Overall Study|Protocol Violation|1|||
33590734|NCT00075725|102050625|FG001|Overall Study|Protocol Violation|1|||
33590735|NCT00075725|102050626|FG002|Overall Study|Protocol Violation|0|||
33590736|NCT00075725|102050627|FG003|Overall Study|Protocol Violation|3|||
33590737|NCT00075725|102050628|FG004|Overall Study|Protocol Violation|3|||
33590738|NCT00075725|102050629|FG005|Overall Study|Protocol Violation|2|||
33590739|NCT00075725|102050630|FG006|Overall Study|Protocol Violation|1|||
33590740|NCT00075725|102050631|FG007|Overall Study|Protocol Violation|2|||
33590741|NCT00075725|102050632|FG008|Overall Study|Protocol Violation|3|||
33590742|NCT00075725|102050633|FG009|Overall Study|Protocol Violation|0|||
33590743|NCT00075725|102050634|FG010|Overall Study|Protocol Violation|0|||
33590744|NCT00075725|102050635|FG011|Overall Study|Protocol Violation|1|||
33590745|NCT00075725|102050624|FG000|Overall Study|Withdrawal by Subject|12|||
33590746|NCT00075725|102050625|FG001|Overall Study|Withdrawal by Subject|3|||
33590747|NCT00075725|102050626|FG002|Overall Study|Withdrawal by Subject|6|||
33590748|NCT00075725|102050627|FG003|Overall Study|Withdrawal by Subject|10|||
33590749|NCT00075725|102050628|FG004|Overall Study|Withdrawal by Subject|6|||
33590750|NCT00075725|102050629|FG005|Overall Study|Withdrawal by Subject|27|||
33590751|NCT00075725|102050630|FG006|Overall Study|Withdrawal by Subject|7|||
33590752|NCT00075725|102050631|FG007|Overall Study|Withdrawal by Subject|31|||
33590753|NCT00075725|102050632|FG008|Overall Study|Withdrawal by Subject|10|||
33590754|NCT00075725|102050633|FG009|Overall Study|Withdrawal by Subject|2|||
33590755|NCT00075725|102050634|FG010|Overall Study|Withdrawal by Subject|0|||
33590756|NCT00075725|102050635|FG011|Overall Study|Withdrawal by Subject|0|||
33384522|NCT01998880|101295802|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
33384523|NCT01998880|101295803|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
33384524|NCT01998880|101295802|FG000|Overall Study|Disease Progression|1|||
33384525|NCT01998880|101295803|FG001|Overall Study|Disease Progression|8|||
33384526|NCT01998880|101295802|FG000|Overall Study|Withdrew Consent|2|||
33384527|NCT01998880|101295803|FG001|Overall Study|Withdrew Consent|1|||
33384528|NCT01998880|101295802|FG000|Overall Study|Death|3|||
33384529|NCT01998880|101295803|FG001|Overall Study|Death|6|||
33590757|NCT00075725|102050624|FG000|Overall Study|Disease Progression, all other reasons|17|||
33590758|NCT00075725|102050625|FG001|Overall Study|Disease Progression, all other reasons|5|||
33590759|NCT00075725|102050626|FG002|Overall Study|Disease Progression, all other reasons|33|||
33590760|NCT00075725|102050627|FG003|Overall Study|Disease Progression, all other reasons|6|||
33590761|NCT00075725|102050628|FG004|Overall Study|Disease Progression, all other reasons|21|||
33590762|NCT00075725|102050629|FG005|Overall Study|Disease Progression, all other reasons|59|||
33590763|NCT00075725|102050630|FG006|Overall Study|Disease Progression, all other reasons|20|||
33590764|NCT00075725|102050631|FG007|Overall Study|Disease Progression, all other reasons|46|||
33590765|NCT00075725|102050632|FG008|Overall Study|Disease Progression, all other reasons|21|||
33590766|NCT00075725|102050633|FG009|Overall Study|Disease Progression, all other reasons|4|||
33590767|NCT00075725|102050634|FG010|Overall Study|Disease Progression, all other reasons|0|||
33590768|NCT00075725|102050635|FG011|Overall Study|Disease Progression, all other reasons|5|||
33590769|NCT00075725|102050624|FG000|Overall Study|Patient off treatment|0|||
33150079|NCT00287079|100463609|FG000|Overall Study|Qualifying relapse|12|||
33384530|NCT01998880|101295802|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33590770|NCT00075725|102050625|FG001|Overall Study|Patient off treatment|0|||
33590771|NCT00075725|102050626|FG002|Overall Study|Patient off treatment|1|||
33590772|NCT00075725|102050627|FG003|Overall Study|Patient off treatment|2|||
33150080|NCT00287079|100463610|FG001|Overall Study|Qualifying relapse|1|||
33150081|NCT00287079|100463609|FG000|Overall Study|Non-qualifying relapse|1|||
33384531|NCT01998880|101295803|FG001|Overall Study|Insufficient Therapeutic Response|5|||
33384532|NCT01998880|101295802|FG000|Overall Study|Administrative/Other|1|||
33590773|NCT00075725|102050628|FG004|Overall Study|Patient off treatment|1|||
33590774|NCT00075725|102050629|FG005|Overall Study|Patient off treatment|0|||
33590775|NCT00075725|102050630|FG006|Overall Study|Patient off treatment|0|||
33590776|NCT00075725|102050631|FG007|Overall Study|Patient off treatment|2|||
33590777|NCT00075725|102050632|FG008|Overall Study|Patient off treatment|1|||
33590778|NCT00075725|102050633|FG009|Overall Study|Patient off treatment|0|||
33590779|NCT00075725|102050634|FG010|Overall Study|Patient off treatment|0|||
33590780|NCT00075725|102050635|FG011|Overall Study|Patient off treatment|0|||
33590781|NCT00075725|102050624|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
33590782|NCT00075725|102050625|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
33590783|NCT00075725|102050626|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
33590784|NCT00075725|102050627|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
33590785|NCT00075725|102050628|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
33590786|NCT00075725|102050629|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
33590787|NCT00075725|102050630|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
33590788|NCT00075725|102050631|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
33590789|NCT00075725|102050632|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
33590790|NCT00075725|102050633|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
33590791|NCT00075725|102050634|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
33590792|NCT00075725|102050635|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
33590793|NCT00075725|102050624|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
33590794|NCT00075725|102050625|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
33590795|NCT00075725|102050626|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
33590796|NCT00075725|102050627|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
33590797|NCT00075725|102050628|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
33590798|NCT00075725|102050629|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
33590799|NCT00075725|102050630|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
33590800|NCT00075725|102050631|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
33590801|NCT00075725|102050632|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
33590802|NCT00075725|102050633|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
33590803|NCT00075725|102050634|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
33590804|NCT00075725|102050635|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
33590805|NCT00075725|102050624|FG000|Overall Study|Pt non compliant with therapy|2|||
33590806|NCT00075725|102050625|FG001|Overall Study|Pt non compliant with therapy|1|||
33590807|NCT00075725|102050626|FG002|Overall Study|Pt non compliant with therapy|1|||
33590808|NCT00075725|102050627|FG003|Overall Study|Pt non compliant with therapy|0|||
33590809|NCT00075725|102050628|FG004|Overall Study|Pt non compliant with therapy|2|||
33590810|NCT00075725|102050629|FG005|Overall Study|Pt non compliant with therapy|14|||
33590811|NCT00075725|102050630|FG006|Overall Study|Pt non compliant with therapy|2|||
33590812|NCT00075725|102050631|FG007|Overall Study|Pt non compliant with therapy|5|||
33590813|NCT00075725|102050632|FG008|Overall Study|Pt non compliant with therapy|3|||
33590814|NCT00075725|102050633|FG009|Overall Study|Pt non compliant with therapy|0|||
33590815|NCT00075725|102050634|FG010|Overall Study|Pt non compliant with therapy|0|||
33590816|NCT00075725|102050635|FG011|Overall Study|Pt non compliant with therapy|0|||
33590817|NCT00075725|102050624|FG000|Overall Study|Pt age out of range for treatment|0|||
33590818|NCT00075725|102050625|FG001|Overall Study|Pt age out of range for treatment|1|||
33590819|NCT00075725|102050626|FG002|Overall Study|Pt age out of range for treatment|0|||
33590820|NCT00075725|102050627|FG003|Overall Study|Pt age out of range for treatment|0|||
33590821|NCT00075725|102050628|FG004|Overall Study|Pt age out of range for treatment|0|||
33590822|NCT00075725|102050629|FG005|Overall Study|Pt age out of range for treatment|1|||
33590823|NCT00075725|102050630|FG006|Overall Study|Pt age out of range for treatment|0|||
33590824|NCT00075725|102050631|FG007|Overall Study|Pt age out of range for treatment|1|||
33590825|NCT00075725|102050632|FG008|Overall Study|Pt age out of range for treatment|0|||
33590826|NCT00075725|102050633|FG009|Overall Study|Pt age out of range for treatment|0|||
33590827|NCT00075725|102050634|FG010|Overall Study|Pt age out of range for treatment|0|||
33590828|NCT00075725|102050635|FG011|Overall Study|Pt age out of range for treatment|0|||
33590829|NCT00075725|102050624|FG000|Overall Study|Insurance issues|0|||
33590830|NCT00075725|102050625|FG001|Overall Study|Insurance issues|1|||
33590831|NCT00075725|102050626|FG002|Overall Study|Insurance issues|0|||
33590832|NCT00075725|102050627|FG003|Overall Study|Insurance issues|1|||
33590833|NCT00075725|102050628|FG004|Overall Study|Insurance issues|1|||
33590834|NCT00075725|102050629|FG005|Overall Study|Insurance issues|1|||
33590835|NCT00075725|102050630|FG006|Overall Study|Insurance issues|0|||
33590836|NCT00075725|102050631|FG007|Overall Study|Insurance issues|1|||
33648770|NCT03085914|102265748|FG004|Overall Study|Lost to Follow-up|0|||
33648771|NCT03085914|102265749|FG005|Overall Study|Lost to Follow-up|1|||
33648772|NCT03085914|102265750|FG006|Overall Study|Lost to Follow-up|1|||
33150082|NCT00287079|100463610|FG001|Overall Study|Non-qualifying relapse|0|||
33433246|NCT03519256|101476816|FG003|Overall Study|Disease progression|1|||
33590837|NCT00075725|102050632|FG008|Overall Study|Insurance issues|0|||
33590838|NCT00075725|102050633|FG009|Overall Study|Insurance issues|0|||
33590839|NCT00075725|102050634|FG010|Overall Study|Insurance issues|0|||
33590840|NCT00075725|102050635|FG011|Overall Study|Insurance issues|0|||
33590841|NCT00075725|102050624|FG000|Overall Study|MRD positive after extended ind|0|||
33590842|NCT00075725|102050625|FG001|Overall Study|MRD positive after extended ind|1|||
33590843|NCT00075725|102050626|FG002|Overall Study|MRD positive after extended ind|1|||
33590844|NCT00075725|102050627|FG003|Overall Study|MRD positive after extended ind|0|||
33648773|NCT03085914|102265744|FG000|Overall Study|Reason was not specified,|2|||
33433247|NCT03519256|101476813|FG000|Overall Study|Lost to Follow-up|0|||
33433248|NCT03519256|101476814|FG001|Overall Study|Lost to Follow-up|1|||
33433249|NCT03519256|101476815|FG002|Overall Study|Lost to Follow-up|0|||
33433250|NCT03519256|101476816|FG003|Overall Study|Lost to Follow-up|0|||
33433251|NCT01821625|101476817|FG000|Overall Study|Withdrawal by Subject|2|||
33433252|NCT01821625|101476817|FG000|Overall Study|Lack of Efficacy|2|||
33433253|NCT01821625|101476817|FG000|Overall Study|Adverse Event|1|||
33433254|NCT01821625|101476817|FG000|Overall Study|Medical contraindication|1|||
33433255|NCT04543136|101476818|FG000|Overall Study|Withdrawal by Subject|0|||
33433256|NCT04543136|101476819|FG001|Overall Study|Withdrawal by Subject|1|||
33433257|NCT04543136|101476820|FG002|Overall Study|Withdrawal by Subject|0|||
33433258|NCT04543136|101476821|FG003|Overall Study|Withdrawal by Subject|1|||
33433259|NCT04543136|101476822|FG004|Overall Study|Withdrawal by Subject|0|||
33433260|NCT04543136|101476823|FG005|Overall Study|Withdrawal by Subject|0|||
33433261|NCT00698685|101476826|FG000|Overall Study|Sister withdrew as donor|1|||
33433262|NCT00698685|101476826|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
33433263|NCT00922779|101476827|FG000|Overall Study|Adverse Event|67|||
33433264|NCT00922779|101476827|FG000|Overall Study|Pregnancy|7|||
33433265|NCT00922779|101476827|FG000|Overall Study|Withdrawal by Subject|308|||
33433266|NCT00922779|101476827|FG000|Overall Study|Lost to Follow-up|44|||
33433267|NCT00922779|101476827|FG000|Overall Study|Other|27|||
33433268|NCT00922779|101476827|FG000|Overall Study|Missing|1874|||
33433269|NCT02192905|101476828|FG000|Overall Study|Lost to Follow-up|1|||
33433270|NCT02224456|101476832|FG000|Overall Study|Lack of Efficacy|1|||
33433271|NCT02224456|101476832|FG000|Overall Study|Lost to Follow-up|15|||
33433272|NCT02224456|101476832|FG000|Overall Study|Withdrawal by Subject|9|||
33433273|NCT02224456|101476832|FG000|Overall Study|Physician Decision|3|||
33433274|NCT02224456|101476832|FG000|Overall Study|Death|2|||
33433275|NCT02224456|101476832|FG000|Overall Study|Pregnancy|4|||
33433276|NCT02224456|101476832|FG000|Overall Study|Protocol Violation|1|||
33433277|NCT02224456|101476832|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
33433278|NCT01691859|101476833|FG000|Overall Study|Adverse Event|19|||
33433279|NCT01691859|101476833|FG000|Overall Study|Lack of Efficacy|11|||
33433280|NCT01691859|101476833|FG000|Overall Study|Protocol Violation|4|||
33433281|NCT01691859|101476833|FG000|Overall Study|Product commercially available|221|||
33433282|NCT01691859|101476833|FG000|Overall Study|Study closed/terminated|50|||
33433283|NCT01691859|101476833|FG000|Overall Study|Lost to Follow-up|5|||
33433284|NCT01691859|101476833|FG000|Overall Study|Physician Decision|6|||
33433285|NCT01691859|101476833|FG000|Overall Study|Withdrawal by Subject|31|||
33433286|NCT01364870|101476834|FG000|Overall Study|Withdrawal by Subject|13|||
33590845|NCT00075725|102050628|FG004|Overall Study|MRD positive after extended ind|1|||
33590846|NCT00075725|102050629|FG005|Overall Study|MRD positive after extended ind|2|||
33590847|NCT00075725|102050630|FG006|Overall Study|MRD positive after extended ind|0|||
33590848|NCT00075725|102050631|FG007|Overall Study|MRD positive after extended ind|1|||
33590849|NCT00075725|102050632|FG008|Overall Study|MRD positive after extended ind|0|||
33590850|NCT00075725|102050633|FG009|Overall Study|MRD positive after extended ind|0|||
33590851|NCT00075725|102050634|FG010|Overall Study|MRD positive after extended ind|0|||
33648774|NCT03085914|102265745|FG001|Overall Study|Reason was not specified,|2|||
33648775|NCT03085914|102265746|FG002|Overall Study|Reason was not specified,|2|||
33648776|NCT03085914|102265747|FG003|Overall Study|Reason was not specified,|3|||
33648777|NCT03085914|102265748|FG004|Overall Study|Reason was not specified,|3|||
33648778|NCT03085914|102265749|FG005|Overall Study|Reason was not specified,|3|||
33648779|NCT03085914|102265750|FG006|Overall Study|Reason was not specified,|6|||
33648780|NCT03085914|102265744|FG000|Overall Study|Progressive Disease|0|||
33648781|NCT03085914|102265745|FG001|Overall Study|Progressive Disease|0|||
33648782|NCT03085914|102265746|FG002|Overall Study|Progressive Disease|2|||
33648783|NCT03085914|102265747|FG003|Overall Study|Progressive Disease|2|||
33648784|NCT03085914|102265748|FG004|Overall Study|Progressive Disease|1|||
33648785|NCT03085914|102265749|FG005|Overall Study|Progressive Disease|1|||
33648786|NCT03085914|102265750|FG006|Overall Study|Progressive Disease|1|||
33648787|NCT03085914|102265744|FG000|Overall Study|Study Terminated by the Sponsor|0|||
33648788|NCT03085914|102265745|FG001|Overall Study|Study Terminated by the Sponsor|0|||
33648789|NCT03085914|102265746|FG002|Overall Study|Study Terminated by the Sponsor|0|||
33648790|NCT03085914|102265747|FG003|Overall Study|Study Terminated by the Sponsor|1|||
33433287|NCT01364870|101476835|FG001|Overall Study|Withdrawal by Subject|24|||
33433288|NCT01364870|101476836|FG002|Overall Study|Withdrawal by Subject|10|||
33433289|NCT01364870|101476834|FG000|Overall Study|Adverse Event|8|||
33648791|NCT03085914|102265748|FG004|Overall Study|Study Terminated by the Sponsor|2|||
33433290|NCT01364870|101476835|FG001|Overall Study|Adverse Event|6|||
33433291|NCT01364870|101476836|FG002|Overall Study|Adverse Event|4|||
33433292|NCT01364870|101476834|FG000|Overall Study|Protocol Violation|1|||
33433293|NCT01364870|101476835|FG001|Overall Study|Protocol Violation|0|||
33590852|NCT00075725|102050635|FG011|Overall Study|MRD positive after extended ind|0|||
33590853|NCT00075725|102050624|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
33648792|NCT03085914|102265749|FG005|Overall Study|Study Terminated by the Sponsor|1|||
33648793|NCT03085914|102265750|FG006|Overall Study|Study Terminated by the Sponsor|0|||
33433294|NCT01364870|101476836|FG002|Overall Study|Protocol Violation|0|||
33433295|NCT01508936|101476837|FG000|Overall Study|Adverse Event|11|||
33433296|NCT01508936|101476838|FG001|Overall Study|Adverse Event|32|||
33433297|NCT01508936|101476837|FG000|Overall Study|Lack of Efficacy|0|||
33433298|NCT01508936|101476838|FG001|Overall Study|Lack of Efficacy|1|||
33433299|NCT01508936|101476837|FG000|Overall Study|Withdrawal by Subject|4|||
33433300|NCT01508936|101476838|FG001|Overall Study|Withdrawal by Subject|18|||
33433301|NCT01508936|101476837|FG000|Overall Study|Protocol Violation|2|||
33590854|NCT00075725|102050625|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
33648794|NCT03255083|102265751|FG000|Overall Study|Clinical progression|1|||
33648795|NCT03255083|102265752|FG001|Overall Study|Clinical progression|0|||
33648796|NCT03255083|102265753|FG002|Overall Study|Clinical progression|0|||
33648797|NCT03255083|102265754|FG003|Overall Study|Clinical progression|0|||
33648798|NCT03255083|102265751|FG000|Overall Study|Adverse Event|0|||
33648799|NCT03255083|102265752|FG001|Overall Study|Adverse Event|1|||
33648800|NCT03255083|102265753|FG002|Overall Study|Adverse Event|0|||
33648801|NCT03255083|102265754|FG003|Overall Study|Adverse Event|0|||
33648802|NCT03255083|102265751|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
33648803|NCT03255083|102265752|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
33648804|NCT03255083|102265753|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
33648805|NCT03255083|102265754|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
33648806|NCT03255083|102265751|FG000|Overall Study|Withdrawal by Subject|1|||
33249785|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
33590855|NCT00075725|102050626|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
33590856|NCT00075725|102050627|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
33249786|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
33433302|NCT01508936|101476838|FG001|Overall Study|Protocol Violation|3|||
33590857|NCT00075725|102050628|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
33590858|NCT00075725|102050629|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
33590859|NCT00075725|102050630|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
33590860|NCT00075725|102050631|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
33590861|NCT00075725|102050632|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
33590862|NCT00075725|102050633|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
33590863|NCT00075725|102050634|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
33590864|NCT00075725|102050635|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
33590865|NCT00075725|102050624|FG000|Overall Study|Inevaluable|1|||
33590866|NCT00075725|102050625|FG001|Overall Study|Inevaluable|1|||
33590867|NCT00075725|102050626|FG002|Overall Study|Inevaluable|4|||
33590868|NCT00075725|102050627|FG003|Overall Study|Inevaluable|2|||
33433303|NCT01508936|101476837|FG000|Overall Study|Lost to Follow-up|2|||
33590869|NCT00075725|102050628|FG004|Overall Study|Inevaluable|2|||
33590870|NCT00075725|102050629|FG005|Overall Study|Inevaluable|9|||
33590871|NCT00075725|102050630|FG006|Overall Study|Inevaluable|1|||
33590872|NCT00075725|102050631|FG007|Overall Study|Inevaluable|11|||
33590873|NCT00075725|102050632|FG008|Overall Study|Inevaluable|2|||
33590874|NCT00075725|102050633|FG009|Overall Study|Inevaluable|0|||
33590875|NCT00075725|102050634|FG010|Overall Study|Inevaluable|1|||
33590876|NCT00075725|102050635|FG011|Overall Study|Inevaluable|0|||
33590877|NCT00075725|102050624|FG000|Overall Study|Other|4|||
33590878|NCT00075725|102050625|FG001|Overall Study|Other|2|||
33590879|NCT00075725|102050626|FG002|Overall Study|Other|1|||
33590880|NCT00075725|102050627|FG003|Overall Study|Other|1|||
33590881|NCT00075725|102050628|FG004|Overall Study|Other|1|||
33590882|NCT00075725|102050629|FG005|Overall Study|Other|4|||
33590883|NCT00075725|102050630|FG006|Overall Study|Other|2|||
33590884|NCT00075725|102050631|FG007|Overall Study|Other|9|||
33648807|NCT03255083|102265752|FG001|Overall Study|Withdrawal by Subject|1|||
33249787|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33249788|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
33249789|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
33249790|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33433304|NCT01508936|101476838|FG001|Overall Study|Lost to Follow-up|9|||
33433305|NCT01508936|101476837|FG000|Overall Study|Other|0|||
33590885|NCT00075725|102050632|FG008|Overall Study|Other|2|||
33590886|NCT00075725|102050633|FG009|Overall Study|Other|1|||
33590887|NCT00075725|102050634|FG010|Overall Study|Other|0|||
33590888|NCT00075725|102050635|FG011|Overall Study|Other|3|||
33590889|NCT00075725|102050624|FG000|Overall Study|Pt trying to find a BM donor|0|||
33648808|NCT03255083|102265753|FG002|Overall Study|Withdrawal by Subject|1|||
33249791|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33433306|NCT01508936|101476838|FG001|Overall Study|Other|5|||
33590890|NCT00075725|102050625|FG001|Overall Study|Pt trying to find a BM donor|1|||
33590891|NCT00075725|102050626|FG002|Overall Study|Pt trying to find a BM donor|0|||
33590892|NCT00075725|102050627|FG003|Overall Study|Pt trying to find a BM donor|0|||
33590893|NCT00075725|102050628|FG004|Overall Study|Pt trying to find a BM donor|0|||
33648809|NCT03255083|102265754|FG003|Overall Study|Withdrawal by Subject|0|||
33648810|NCT00003472|102265756|FG000|Overall Study|Not evaluable|3|||
33433307|NCT01508936|101476837|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
33433308|NCT01508936|101476838|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
33433309|NCT00506753|101476840|FG000|Overall Study|Lost to Follow-up|21|||
33433310|NCT00506753|101476841|FG001|Overall Study|Lost to Follow-up|15|||
33433311|NCT03583333|101476843|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
33433312|NCT03583333|101476844|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
33433313|NCT03583333|101476843|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
33433314|NCT03583333|101476844|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
33433315|NCT03583333|101476843|FG000|Overall Study|Withdrawal by Subject|9|||
33433316|NCT03583333|101476844|FG001|Overall Study|Withdrawal by Subject|5|||
33433317|NCT03583333|101476843|FG000|Overall Study|Physician Decision|3|||
33433318|NCT03583333|101476844|FG001|Overall Study|Physician Decision|2|||
33433319|NCT03583333|101476843|FG000|Overall Study|Death|12|||
33433320|NCT03583333|101476844|FG001|Overall Study|Death|7|||
33433321|NCT02568384|101476845|FG000|Overall Study|Mobile devices incompatible with App|2|||
33433322|NCT02385526|101476846|FG000|Overall Study|Withdrawal by Subject|0|||
33433323|NCT02385526|101476847|FG001|Overall Study|Withdrawal by Subject|2|||
33433324|NCT02385526|101476848|FG002|Overall Study|Withdrawal by Subject|0|||
33433325|NCT02385526|101476846|FG000|Overall Study|Lost to Follow-up|0|||
33433326|NCT02385526|101476847|FG001|Overall Study|Lost to Follow-up|1|||
33433327|NCT02385526|101476848|FG002|Overall Study|Lost to Follow-up|0|||
33433328|NCT02385526|101476846|FG000|Overall Study|Physician Decision|1|||
33433329|NCT02385526|101476847|FG001|Overall Study|Physician Decision|0|||
33433330|NCT02385526|101476848|FG002|Overall Study|Physician Decision|0|||
33433331|NCT02385526|101476846|FG000|Overall Study|Protocol Violation|1|||
33433332|NCT02385526|101476847|FG001|Overall Study|Protocol Violation|0|||
33433333|NCT02385526|101476848|FG002|Overall Study|Protocol Violation|0|||
33433334|NCT02022007|101476850|FG000|Overall Study|Withdrawal by Subject|1|||
33433335|NCT02022007|101476851|FG001|Overall Study|Withdrawal by Subject|1|||
33433336|NCT02022007|101476852|FG002|Overall Study|Withdrawal by Subject|1|||
33433337|NCT02022007|101476850|FG000|Overall Study|Noncompliant|0|||
33433338|NCT02022007|101476851|FG001|Overall Study|Noncompliant|0|||
33433339|NCT02022007|101476852|FG002|Overall Study|Noncompliant|1|||
33433340|NCT03093454|101476856|FG000|Overall Study|Withdrawal by Subject|1|||
33433341|NCT03093454|101476857|FG001|Overall Study|Withdrawal by Subject|1|||
33433342|NCT03093454|101476856|FG000|Overall Study|Scheduling conflict|3|||
33433343|NCT03093454|101476857|FG001|Overall Study|Scheduling conflict|1|||
33433344|NCT03093454|101476856|FG000|Overall Study|Physician Decision|2|||
33433345|NCT03093454|101476857|FG001|Overall Study|Physician Decision|1|||
33433346|NCT03734237|101476858|FG000|Overall Study|Lost to Follow-up|1|||
33433347|NCT03734237|101476859|FG001|Overall Study|Lost to Follow-up|3|||
33433348|NCT03734237|101476860|FG002|Overall Study|Lost to Follow-up|0|||
33433349|NCT03734237|101476858|FG000|Overall Study|Withdrawal by Subject|7|||
33433350|NCT03734237|101476859|FG001|Overall Study|Withdrawal by Subject|9|||
33433351|NCT03734237|101476860|FG002|Overall Study|Withdrawal by Subject|10|||
33433352|NCT00729859|101476863|FG000|Overall Study|Adverse Event|0|||
33433353|NCT00729859|101476864|FG001|Overall Study|Adverse Event|1|||
33433354|NCT00729859|101476865|FG002|Overall Study|Adverse Event|0|||
33433355|NCT00729859|101476863|FG000|Overall Study|Withdrawal by Subject|0|||
33433356|NCT00729859|101476864|FG001|Overall Study|Withdrawal by Subject|1|||
33433357|NCT00729859|101476865|FG002|Overall Study|Withdrawal by Subject|0|||
33433358|NCT01054599|101476867|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
33433359|NCT01054599|101476868|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
33433360|NCT01054599|101476867|FG000|Overall Study|Protocol Violation|1|||
33433361|NCT01054599|101476868|FG001|Overall Study|Protocol Violation|0|||
33433362|NCT01054599|101476867|FG000|Overall Study|Spells/seizure-like episodes|1|||
33433363|NCT01054599|101476868|FG001|Overall Study|Spells/seizure-like episodes|1|||
33433364|NCT01054599|101476867|FG000|Overall Study|Timing/scheduling difficulties|1|||
33590894|NCT00075725|102050629|FG005|Overall Study|Pt trying to find a BM donor|0|||
33590895|NCT00075725|102050630|FG006|Overall Study|Pt trying to find a BM donor|0|||
33590896|NCT00075725|102050631|FG007|Overall Study|Pt trying to find a BM donor|0|||
33590897|NCT00075725|102050632|FG008|Overall Study|Pt trying to find a BM donor|0|||
33433365|NCT01054599|101476868|FG001|Overall Study|Timing/scheduling difficulties|1|||
33433366|NCT01054599|101476867|FG000|Overall Study|Visual impairment, WTAR <80|0|||
33433367|NCT01054599|101476868|FG001|Overall Study|Visual impairment, WTAR <80|1|||
33433368|NCT01054599|101476867|FG000|Overall Study|Lost to Follow-up|0|||
33433369|NCT01054599|101476868|FG001|Overall Study|Lost to Follow-up|2|||
33433370|NCT01054599|101476867|FG000|Overall Study|Adverse Event|0|||
33433371|NCT01054599|101476868|FG001|Overall Study|Adverse Event|1|||
33590898|NCT00075725|102050633|FG009|Overall Study|Pt trying to find a BM donor|0|||
33590899|NCT00075725|102050634|FG010|Overall Study|Pt trying to find a BM donor|0|||
33433372|NCT01054599|101476867|FG000|Overall Study|Withdrawal by Subject|0|||
33433373|NCT01054599|101476868|FG001|Overall Study|Withdrawal by Subject|1|||
33590900|NCT00075725|102050635|FG011|Overall Study|Pt trying to find a BM donor|0|||
33590901|NCT00075725|102050624|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
33433374|NCT01058421|101476878|FG000|1 Month Outcomes|Death|10|||
33433375|NCT01058421|101476879|FG001|1 Month Outcomes|Death|6|||
33433376|NCT01058421|101476878|FG000|1 Month Outcomes|Lost to Follow-up|8|||
33433377|NCT01058421|101476879|FG001|1 Month Outcomes|Lost to Follow-up|7|||
33433378|NCT01058421|101476878|FG000|1 Month Outcomes|Remained in Hospital|5|||
33433379|NCT01058421|101476879|FG001|1 Month Outcomes|Remained in Hospital|12|||
33433380|NCT01058421|101476878|FG000|1 Month Outcomes|Remained in Other Facility|16|||
33433381|NCT01058421|101476879|FG001|1 Month Outcomes|Remained in Other Facility|17|||
33433382|NCT01058421|101476878|FG000|3 Month Outcomes|Death|3|||
33433383|NCT01058421|101476879|FG001|3 Month Outcomes|Death|5|||
33433384|NCT01058421|101476878|FG000|3 Month Outcomes|Lost to Follow-up|12|||
33433385|NCT01058421|101476879|FG001|3 Month Outcomes|Lost to Follow-up|11|||
33433386|NCT01058421|101476878|FG000|3 Month Outcomes|Remained in Hospital|0|||
33433387|NCT01058421|101476879|FG001|3 Month Outcomes|Remained in Hospital|2|||
33433388|NCT01058421|101476878|FG000|3 Month Outcomes|Remained in Other Facility|5|||
33433389|NCT01058421|101476879|FG001|3 Month Outcomes|Remained in Other Facility|8|||
33433390|NCT01058421|101476878|FG000|6 Month Outcomes|Death|2|||
33433391|NCT01058421|101476879|FG001|6 Month Outcomes|Death|2|||
33433392|NCT01058421|101476878|FG000|6 Month Outcomes|Lost to Follow-up|16|||
33433393|NCT01058421|101476879|FG001|6 Month Outcomes|Lost to Follow-up|21|||
33433394|NCT01058421|101476878|FG000|6 Month Outcomes|Remained in Other Facility|1|||
33433395|NCT01058421|101476879|FG001|6 Month Outcomes|Remained in Other Facility|3|||
33433396|NCT00424489|101476882|FG000|Overall Study|Death|3|||
33433397|NCT03775681|101476884|FG000|Overall Study|Physician Decision|3|||
33433398|NCT00708422|101476892|FG000|Overall Study|Adverse Event|3|||
33433399|NCT00708422|101476893|FG001|Overall Study|Adverse Event|1|||
33433400|NCT00708422|101476892|FG000|Overall Study|Withdrawal by Subject|1|||
33433401|NCT00708422|101476893|FG001|Overall Study|Withdrawal by Subject|0|||
33433402|NCT01691248|101476894|FG000|Overall Study|Protocol Violation|43|||
33433403|NCT01691248|101476895|FG001|Overall Study|Protocol Violation|27|||
33433404|NCT01691248|101476894|FG000|Overall Study|Adverse Event|24|||
33433405|NCT01691248|101476895|FG001|Overall Study|Adverse Event|22|||
33433406|NCT01691248|101476894|FG000|Overall Study|Withdrawal by Subject|20|||
33433407|NCT01691248|101476895|FG001|Overall Study|Withdrawal by Subject|18|||
33433408|NCT01691248|101476894|FG000|Overall Study|Confirmed CDAD|14|||
33433409|NCT01691248|101476895|FG001|Overall Study|Confirmed CDAD|31|||
33433410|NCT01691248|101476894|FG000|Overall Study|Lost to Follow-up|2|||
33433411|NCT01691248|101476895|FG001|Overall Study|Lost to Follow-up|5|||
33433412|NCT01691248|101476894|FG000|Overall Study|Reason not provided|4|||
33433413|NCT01691248|101476895|FG001|Overall Study|Reason not provided|4|||
33433414|NCT01691248|101476894|FG000|Overall Study|Not Treated|4|||
33433415|NCT01691248|101476895|FG001|Overall Study|Not Treated|7|||
33433416|NCT01937390|101476896|FG000|Overall Study|Death|2|||
33433417|NCT01937390|101476896|FG000|Overall Study|Lost to Follow-up|7|||
33433418|NCT01937390|101476896|FG000|Overall Study|Withdrawal by Subject|5|||
33433419|NCT01937390|101476896|FG000|Overall Study|Fail to return|21|||
33433420|NCT01606306|101476897|FG000|Overall Study|Lack of Efficacy|2|||
33433421|NCT01606306|101476898|FG001|Overall Study|Lack of Efficacy|1|||
33433422|NCT01606306|101476899|FG002|Overall Study|Lack of Efficacy|4|||
33433423|NCT01606306|101476900|FG003|Overall Study|Lack of Efficacy|4|||
33433424|NCT01606306|101476901|FG004|Overall Study|Lack of Efficacy|1|||
33433425|NCT01606306|101476902|FG005|Overall Study|Lack of Efficacy|2|||
33433426|NCT01606306|101476897|FG000|Overall Study|Adverse Event|1|||
33433427|NCT01606306|101476898|FG001|Overall Study|Adverse Event|0|||
33433428|NCT01606306|101476899|FG002|Overall Study|Adverse Event|1|||
33433429|NCT01606306|101476900|FG003|Overall Study|Adverse Event|1|||
33590902|NCT00075725|102050625|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
33590903|NCT00075725|102050626|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
33590904|NCT00075725|102050627|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
33648811|NCT01457352|102265757|FG000|Period 1|Adverse Event|2|||
33433430|NCT01606306|101476901|FG004|Overall Study|Adverse Event|2|||
33433431|NCT01606306|101476902|FG005|Overall Study|Adverse Event|0|||
33433432|NCT01606306|101476897|FG000|Overall Study|Lost to Follow-up|7|||
33433433|NCT01606306|101476898|FG001|Overall Study|Lost to Follow-up|4|||
33433434|NCT01606306|101476899|FG002|Overall Study|Lost to Follow-up|5|||
33433435|NCT01606306|101476900|FG003|Overall Study|Lost to Follow-up|4|||
33433436|NCT01606306|101476901|FG004|Overall Study|Lost to Follow-up|3|||
33433437|NCT01606306|101476902|FG005|Overall Study|Lost to Follow-up|5|||
33433438|NCT01606306|101476897|FG000|Overall Study|Withdrawal by Subject|4|||
33433439|NCT01606306|101476898|FG001|Overall Study|Withdrawal by Subject|3|||
33433440|NCT01606306|101476899|FG002|Overall Study|Withdrawal by Subject|4|||
33433441|NCT01606306|101476900|FG003|Overall Study|Withdrawal by Subject|4|||
33433442|NCT01606306|101476901|FG004|Overall Study|Withdrawal by Subject|5|||
33433443|NCT01606306|101476902|FG005|Overall Study|Withdrawal by Subject|4|||
33433444|NCT01606306|101476897|FG000|Overall Study|Physician Decision|1|||
33433445|NCT01606306|101476898|FG001|Overall Study|Physician Decision|2|||
33433446|NCT01606306|101476899|FG002|Overall Study|Physician Decision|0|||
33433447|NCT01606306|101476900|FG003|Overall Study|Physician Decision|0|||
33433448|NCT01606306|101476901|FG004|Overall Study|Physician Decision|0|||
33648812|NCT01457352|102265758|FG001|Period 1|Adverse Event|0|||
33648813|NCT01457352|102265757|FG000|Period 1|Withdrawal by Subject|2|||
33648814|NCT01457352|102265758|FG001|Period 1|Withdrawal by Subject|0|||
33648815|NCT01457352|102265757|FG000|Period 1|Physician Decision|2|||
33648816|NCT01457352|102265758|FG001|Period 1|Physician Decision|0|||
33249792|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33249793|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
33384533|NCT01998880|101295803|FG001|Overall Study|Administrative/Other|1|||
33384534|NCT01998880|101295802|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
33384535|NCT01998880|101295803|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
33384536|NCT01998880|101295802|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
33384537|NCT01998880|101295803|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
33384538|NCT01998880|101295802|FG000|Overall Study|Did Not Receive Treatment|3|||
33384539|NCT01998880|101295803|FG001|Overall Study|Did Not Receive Treatment|2|||
33384540|NCT03332303|101295804|FG000|Overall Study|Participant did not dose|1|||
33384541|NCT03332303|101295805|FG001|Overall Study|Participant did not dose|2|||
33384542|NCT03332303|101295806|FG002|Overall Study|Participant did not dose|0|||
33384543|NCT03332303|101295804|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
33384544|NCT03332303|101295805|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
33384545|NCT03332303|101295806|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
33384546|NCT03332303|101295804|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
33590905|NCT00075725|102050628|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
33590906|NCT00075725|102050629|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
33590907|NCT00075725|102050630|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
33590908|NCT00075725|102050631|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
33590909|NCT00075725|102050632|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
33590910|NCT00075725|102050633|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
33590911|NCT00075725|102050634|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
33590912|NCT00075725|102050635|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
33590913|NCT00075725|102050624|FG000|Overall Study|Unsuccessful institutional transfer|0|||
33590914|NCT00075725|102050625|FG001|Overall Study|Unsuccessful institutional transfer|0|||
33590915|NCT00075725|102050626|FG002|Overall Study|Unsuccessful institutional transfer|2|||
33590916|NCT00075725|102050627|FG003|Overall Study|Unsuccessful institutional transfer|0|||
33590917|NCT00075725|102050628|FG004|Overall Study|Unsuccessful institutional transfer|0|||
33590918|NCT00075725|102050629|FG005|Overall Study|Unsuccessful institutional transfer|0|||
33590919|NCT00075725|102050630|FG006|Overall Study|Unsuccessful institutional transfer|0|||
33590920|NCT00075725|102050631|FG007|Overall Study|Unsuccessful institutional transfer|0|||
33590921|NCT00075725|102050632|FG008|Overall Study|Unsuccessful institutional transfer|0|||
33590922|NCT00075725|102050633|FG009|Overall Study|Unsuccessful institutional transfer|1|||
33590923|NCT00075725|102050634|FG010|Overall Study|Unsuccessful institutional transfer|0|||
33590924|NCT00075725|102050635|FG011|Overall Study|Unsuccessful institutional transfer|0|||
33590925|NCT00075725|102050624|FG000|Overall Study|specimen(s) not submitted|0|||
33590926|NCT00075725|102050625|FG001|Overall Study|specimen(s) not submitted|0|||
33590927|NCT00075725|102050626|FG002|Overall Study|specimen(s) not submitted|2|||
33590928|NCT00075725|102050627|FG003|Overall Study|specimen(s) not submitted|0|||
33590929|NCT00075725|102050628|FG004|Overall Study|specimen(s) not submitted|0|||
33590930|NCT00075725|102050629|FG005|Overall Study|specimen(s) not submitted|0|||
33590931|NCT00075725|102050630|FG006|Overall Study|specimen(s) not submitted|0|||
33590932|NCT00075725|102050631|FG007|Overall Study|specimen(s) not submitted|0|||
33590933|NCT00075725|102050632|FG008|Overall Study|specimen(s) not submitted|0|||
33590934|NCT00075725|102050633|FG009|Overall Study|specimen(s) not submitted|0|||
33590935|NCT00075725|102050634|FG010|Overall Study|specimen(s) not submitted|0|||
33590936|NCT00075725|102050635|FG011|Overall Study|specimen(s) not submitted|0|||
33590937|NCT00075725|102050624|FG000|Overall Study|Pt went to transplant|0|||
33590938|NCT00075725|102050625|FG001|Overall Study|Pt went to transplant|0|||
33590939|NCT00075725|102050626|FG002|Overall Study|Pt went to transplant|0|||
33590940|NCT00075725|102050627|FG003|Overall Study|Pt went to transplant|1|||
33590941|NCT00075725|102050628|FG004|Overall Study|Pt went to transplant|0|||
33590942|NCT00075725|102050629|FG005|Overall Study|Pt went to transplant|1|||
33590943|NCT00075725|102050630|FG006|Overall Study|Pt went to transplant|0|||
33590944|NCT00075725|102050631|FG007|Overall Study|Pt went to transplant|0|||
33590945|NCT00075725|102050632|FG008|Overall Study|Pt went to transplant|0|||
33590946|NCT00075725|102050633|FG009|Overall Study|Pt went to transplant|0|||
33590947|NCT00075725|102050634|FG010|Overall Study|Pt went to transplant|0|||
33433449|NCT01606306|101476902|FG005|Overall Study|Physician Decision|0|||
33590948|NCT00075725|102050635|FG011|Overall Study|Pt went to transplant|0|||
33590949|NCT00075725|102050624|FG000|Overall Study|Pt received additional steroids|0|||
33590950|NCT00075725|102050625|FG001|Overall Study|Pt received additional steroids|0|||
33590951|NCT00075725|102050626|FG002|Overall Study|Pt received additional steroids|0|||
33590952|NCT00075725|102050627|FG003|Overall Study|Pt received additional steroids|1|||
33150083|NCT00287079|100463609|FG000|Overall Study|Adverse Event|5|||
33433450|NCT03341507|101476903|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
33433451|NCT01075763|101476908|FG000|Overall Study|Lost to Follow-up|2|||
33433452|NCT01075763|101476909|FG001|Overall Study|Lost to Follow-up|1|||
33433453|NCT01075763|101476908|FG000|Overall Study|Lack of Efficacy|0|||
33433454|NCT01075763|101476909|FG001|Overall Study|Lack of Efficacy|1|||
33433455|NCT01075763|101476908|FG000|Overall Study|Withdrawal by Subject|2|||
33433456|NCT01075763|101476909|FG001|Overall Study|Withdrawal by Subject|2|||
33433457|NCT00462982|101476910|FG000|Overall Study|Adverse Event|1|||
33433458|NCT00462982|101476910|FG000|Overall Study|Patient Not Treated|2|||
33433459|NCT01485536|101476911|FG000|Overall Study|Withdrawal by Subject|3|||
33433460|NCT01485536|101476911|FG000|Overall Study|Adverse Event|1|||
33433461|NCT00743197|101476912|FG000|Overall Study|Study terminated due to departure of PI.|1|||
33433462|NCT00743197|101476913|FG001|Overall Study|Study terminated due to departure of PI.|2|||
33433463|NCT00860028|101476914|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
33433464|NCT00860028|101476915|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
33433465|NCT01104662|101476916|FG000|Overall Study|Adverse Event|2|||
33433466|NCT01104662|101476917|FG001|Overall Study|Adverse Event|2|||
33433467|NCT01104662|101476918|FG002|Overall Study|Adverse Event|0|||
33433468|NCT01104662|101476919|FG003|Overall Study|Adverse Event|1|||
33433469|NCT01104662|101476920|FG004|Overall Study|Adverse Event|1|||
33433470|NCT01104662|101476921|FG005|Overall Study|Adverse Event|1|||
33433471|NCT01104662|101476922|FG006|Overall Study|Adverse Event|0|||
33433472|NCT01104662|101476923|FG007|Overall Study|Adverse Event|0|||
33433473|NCT01104662|101476916|FG000|Overall Study|Clinical Failure|1|||
33433474|NCT01104662|101476917|FG001|Overall Study|Clinical Failure|0|||
33433475|NCT01104662|101476918|FG002|Overall Study|Clinical Failure|0|||
33433476|NCT01104662|101476919|FG003|Overall Study|Clinical Failure|0|||
33433477|NCT01104662|101476920|FG004|Overall Study|Clinical Failure|0|||
33648817|NCT01457352|102265757|FG000|Period 1|MS related disease progression|1|||
33648818|NCT01457352|102265758|FG001|Period 1|MS related disease progression|0|||
33648819|NCT01457352|102265757|FG000|Period 1|Withdrawn|1|||
33648820|NCT01457352|102265758|FG001|Period 1|Withdrawn|0|||
33648821|NCT01457352|102265757|FG000|Period 1|withdrew per sponsor|1|||
33249794|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
33433478|NCT01104662|101476921|FG005|Overall Study|Clinical Failure|1|||
33433479|NCT01104662|101476922|FG006|Overall Study|Clinical Failure|0|||
33433480|NCT01104662|101476923|FG007|Overall Study|Clinical Failure|0|||
33433481|NCT01104662|101476916|FG000|Overall Study|Participant left investigator's care|1|||
33433482|NCT01104662|101476917|FG001|Overall Study|Participant left investigator's care|1|||
33433483|NCT01104662|101476918|FG002|Overall Study|Participant left investigator's care|0|||
33433484|NCT01104662|101476919|FG003|Overall Study|Participant left investigator's care|0|||
33433485|NCT01104662|101476920|FG004|Overall Study|Participant left investigator's care|0|||
33433486|NCT01104662|101476921|FG005|Overall Study|Participant left investigator's care|0|||
33433487|NCT01104662|101476922|FG006|Overall Study|Participant left investigator's care|0|||
33433488|NCT01104662|101476923|FG007|Overall Study|Participant left investigator's care|0|||
33433489|NCT01104662|101476916|FG000|Overall Study|Reason not specified|3|||
33433490|NCT01104662|101476917|FG001|Overall Study|Reason not specified|3|||
33433491|NCT01104662|101476918|FG002|Overall Study|Reason not specified|0|||
33433492|NCT01104662|101476919|FG003|Overall Study|Reason not specified|0|||
33433493|NCT01104662|101476920|FG004|Overall Study|Reason not specified|0|||
33433494|NCT01104662|101476921|FG005|Overall Study|Reason not specified|1|||
33433495|NCT01104662|101476922|FG006|Overall Study|Reason not specified|0|||
33433496|NCT01104662|101476923|FG007|Overall Study|Reason not specified|0|||
33433497|NCT01104662|101476916|FG000|Overall Study|Randomized but not treated|3|||
33433498|NCT01104662|101476917|FG001|Overall Study|Randomized but not treated|4|||
33433499|NCT01104662|101476918|FG002|Overall Study|Randomized but not treated|1|||
33433500|NCT01104662|101476919|FG003|Overall Study|Randomized but not treated|0|||
33433501|NCT01104662|101476920|FG004|Overall Study|Randomized but not treated|0|||
33433502|NCT01104662|101476921|FG005|Overall Study|Randomized but not treated|1|||
33433503|NCT01104662|101476922|FG006|Overall Study|Randomized but not treated|0|||
33433504|NCT01104662|101476923|FG007|Overall Study|Randomized but not treated|0|||
33433505|NCT00704418|101476924|FG000|Overall Study|Withdrawal by Subject|2|||
33433506|NCT00704418|101476925|FG001|Overall Study|Withdrawal by Subject|0|||
33433507|NCT00704418|101476924|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
33433508|NCT00704418|101476925|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
33433509|NCT00996736|101476926|FG000|Overall Study|Death|1|||
33433510|NCT00996736|101476927|FG001|Overall Study|Death|1|||
33648822|NCT01457352|102265758|FG001|Period 1|withdrew per sponsor|0|||
33648823|NCT01457352|102265757|FG000|Period 1|Protocol Violation|4|||
33249795|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
33433511|NCT00996736|101476926|FG000|Overall Study|Lost to Follow-up|15|||
33433512|NCT00996736|101476927|FG001|Overall Study|Lost to Follow-up|14|||
33433513|NCT00996736|101476926|FG000|Overall Study|Visit not within 3-month window|5|||
33433514|NCT00996736|101476927|FG001|Overall Study|Visit not within 3-month window|3|||
33648824|NCT01457352|102265758|FG001|Period 1|Protocol Violation|0|||
33433515|NCT00319111|101476928|FG000|Overall Study|Adverse Event|20|||
33433516|NCT00319111|101476928|FG000|Overall Study|Withdrawal of consent|11|||
33433517|NCT00319111|101476928|FG000|Overall Study|Death|9|||
33433518|NCT00319111|101476928|FG000|Overall Study|Lack of clinical improvement|4|||
33433519|NCT00319111|101476928|FG000|Overall Study|Administrative|2|||
33433520|NCT00319111|101476928|FG000|Overall Study|Treatment failure|1|||
33433521|NCT01475474|101476931|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
33433522|NCT01475474|101476931|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
33433523|NCT01829464|101476932|FG000|Overall Study|Adverse Event|1|||
33590953|NCT00075725|102050628|FG004|Overall Study|Pt received additional steroids|0|||
33590954|NCT00075725|102050629|FG005|Overall Study|Pt received additional steroids|0|||
33590955|NCT00075725|102050630|FG006|Overall Study|Pt received additional steroids|0|||
33590956|NCT00075725|102050631|FG007|Overall Study|Pt received additional steroids|0|||
33590957|NCT00075725|102050632|FG008|Overall Study|Pt received additional steroids|0|||
33590958|NCT00075725|102050633|FG009|Overall Study|Pt received additional steroids|0|||
33590959|NCT00075725|102050634|FG010|Overall Study|Pt received additional steroids|0|||
33590960|NCT00075725|102050635|FG011|Overall Study|Pt received additional steroids|0|||
33590961|NCT00075725|102050624|FG000|Overall Study|Pt relocated|0|||
33590962|NCT00075725|102050625|FG001|Overall Study|Pt relocated|0|||
33590963|NCT00075725|102050626|FG002|Overall Study|Pt relocated|0|||
33590964|NCT00075725|102050627|FG003|Overall Study|Pt relocated|2|||
33590965|NCT00075725|102050628|FG004|Overall Study|Pt relocated|0|||
33590966|NCT00075725|102050629|FG005|Overall Study|Pt relocated|1|||
33590967|NCT00075725|102050630|FG006|Overall Study|Pt relocated|1|||
33590968|NCT00075725|102050631|FG007|Overall Study|Pt relocated|2|||
33590969|NCT00075725|102050632|FG008|Overall Study|Pt relocated|1|||
33590970|NCT00075725|102050633|FG009|Overall Study|Pt relocated|0|||
33590971|NCT00075725|102050634|FG010|Overall Study|Pt relocated|0|||
33590972|NCT00075725|102050635|FG011|Overall Study|Pt relocated|0|||
33590973|NCT00075725|102050624|FG000|Overall Study|Institution Terminated|0|||
33590974|NCT00075725|102050625|FG001|Overall Study|Institution Terminated|0|||
33590975|NCT00075725|102050626|FG002|Overall Study|Institution Terminated|0|||
33590976|NCT00075725|102050627|FG003|Overall Study|Institution Terminated|0|||
33590977|NCT00075725|102050628|FG004|Overall Study|Institution Terminated|1|||
33590978|NCT00075725|102050629|FG005|Overall Study|Institution Terminated|0|||
33590979|NCT00075725|102050630|FG006|Overall Study|Institution Terminated|0|||
33590980|NCT00075725|102050631|FG007|Overall Study|Institution Terminated|3|||
33590981|NCT00075725|102050632|FG008|Overall Study|Institution Terminated|0|||
33590982|NCT00075725|102050633|FG009|Overall Study|Institution Terminated|0|||
33590983|NCT00075725|102050634|FG010|Overall Study|Institution Terminated|0|||
33590984|NCT00075725|102050635|FG011|Overall Study|Institution Terminated|0|||
33590985|NCT00075725|102050624|FG000|Overall Study|Study Closure|1|||
33590986|NCT00075725|102050625|FG001|Overall Study|Study Closure|0|||
33590987|NCT00075725|102050626|FG002|Overall Study|Study Closure|0|||
33590988|NCT00075725|102050627|FG003|Overall Study|Study Closure|0|||
33590989|NCT00075725|102050628|FG004|Overall Study|Study Closure|1|||
33590990|NCT00075725|102050629|FG005|Overall Study|Study Closure|3|||
33590991|NCT00075725|102050630|FG006|Overall Study|Study Closure|0|||
33590992|NCT00075725|102050631|FG007|Overall Study|Study Closure|1|||
33590993|NCT00075725|102050632|FG008|Overall Study|Study Closure|0|||
33590994|NCT00075725|102050633|FG009|Overall Study|Study Closure|0|||
33648825|NCT01457352|102265757|FG000|Period 1|Did not meet eligibility criteria|3|||
33648826|NCT01457352|102265758|FG001|Period 1|Did not meet eligibility criteria|0|||
33648827|NCT01457352|102265757|FG000|Period 2|Withdrawal by Subject|23|||
33648828|NCT01457352|102265758|FG001|Period 2|Withdrawal by Subject|0|||
33648829|NCT01457352|102265757|FG000|Period 2|Adverse Event|22|||
33648830|NCT01457352|102265758|FG001|Period 2|Adverse Event|0|||
33648831|NCT01457352|102265757|FG000|Period 2|no analysis|10|||
33648832|NCT01457352|102265758|FG001|Period 2|no analysis|0|||
33648833|NCT01457352|102265757|FG000|Period 2|Lack of Efficacy|8|||
33648834|NCT01457352|102265758|FG001|Period 2|Lack of Efficacy|0|||
33150084|NCT00287079|100463610|FG001|Overall Study|Adverse Event|0|||
33150085|NCT00287079|100463609|FG000|Overall Study|Protocol Violation|1|||
33590995|NCT00075725|102050634|FG010|Overall Study|Study Closure|0|||
33590996|NCT00075725|102050635|FG011|Overall Study|Study Closure|0|||
33590997|NCT00075725|102050624|FG000|Overall Study|Other complications|0|||
33590998|NCT00075725|102050625|FG001|Overall Study|Other complications|0|||
33590999|NCT00075725|102050626|FG002|Overall Study|Other complications|0|||
33648835|NCT01457352|102265757|FG000|Period 2|Protocol Violation|4|||
33384547|NCT03332303|101295805|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
33384548|NCT03332303|101295806|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
33384549|NCT03332303|101295804|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
33591000|NCT00075725|102050627|FG003|Overall Study|Other complications|0|||
33591001|NCT00075725|102050628|FG004|Overall Study|Other complications|0|||
33591002|NCT00075725|102050629|FG005|Overall Study|Other complications|1|||
33591003|NCT00075725|102050630|FG006|Overall Study|Other complications|0|||
33591004|NCT00075725|102050631|FG007|Overall Study|Other complications|0|||
33648836|NCT01457352|102265758|FG001|Period 2|Protocol Violation|0|||
33648837|NCT01457352|102265757|FG000|Period 2|Sponsor's withdrawal|7|||
33648838|NCT01457352|102265758|FG001|Period 2|Sponsor's withdrawal|0|||
33648839|NCT01457352|102265757|FG000|Period 2|Lost to Follow-up|1|||
33648840|NCT01457352|102265758|FG001|Period 2|Lost to Follow-up|0|||
33648841|NCT01457352|102265757|FG000|Period 2|dose change|1|||
33648842|NCT01457352|102265758|FG001|Period 2|dose change|0|||
33648843|NCT01457352|102265757|FG000|Period 2|Physician Decision|1|||
33648844|NCT01457352|102265758|FG001|Period 2|Physician Decision|0|||
33648845|NCT01457352|102265757|FG000|Period 2|Did not meet eligibility criteria|3|||
33648846|NCT01457352|102265758|FG001|Period 2|Did not meet eligibility criteria|0|||
33648847|NCT01457352|102265757|FG000|Period 3|Adverse Event|1|||
33648848|NCT01457352|102265758|FG001|Period 3|Adverse Event|1|||
33648849|NCT01457352|102265757|FG000|Period 3|Withdrawal by Subject|0|||
33648850|NCT01457352|102265758|FG001|Period 3|Withdrawal by Subject|2|||
33591005|NCT00075725|102050632|FG008|Overall Study|Other complications|0|||
33591006|NCT00075725|102050633|FG009|Overall Study|Other complications|0|||
33591007|NCT00075725|102050634|FG010|Overall Study|Other complications|0|||
33591008|NCT00075725|102050635|FG011|Overall Study|Other complications|0|||
33591009|NCT00075725|102050624|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
33591010|NCT00075725|102050625|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
33591011|NCT00075725|102050626|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
33591012|NCT00075725|102050627|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
33591013|NCT00075725|102050628|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
33591014|NCT00075725|102050629|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
33591015|NCT00075725|102050630|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
33591016|NCT00075725|102050631|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
33591017|NCT00075725|102050632|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
33591018|NCT00075725|102050633|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
33591019|NCT00075725|102050634|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
33591020|NCT00075725|102050635|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
33591021|NCT00075725|102050624|FG000|Overall Study|Pt incarcerated|0|||
33591022|NCT00075725|102050625|FG001|Overall Study|Pt incarcerated|0|||
33591023|NCT00075725|102050626|FG002|Overall Study|Pt incarcerated|0|||
33591024|NCT00075725|102050627|FG003|Overall Study|Pt incarcerated|0|||
33591025|NCT00075725|102050628|FG004|Overall Study|Pt incarcerated|0|||
33591026|NCT00075725|102050629|FG005|Overall Study|Pt incarcerated|0|||
33591027|NCT00075725|102050630|FG006|Overall Study|Pt incarcerated|0|||
33591028|NCT00075725|102050631|FG007|Overall Study|Pt incarcerated|1|||
33591029|NCT00075725|102050632|FG008|Overall Study|Pt incarcerated|0|||
33591030|NCT00075725|102050633|FG009|Overall Study|Pt incarcerated|0|||
33591031|NCT00075725|102050634|FG010|Overall Study|Pt incarcerated|0|||
33591032|NCT00075725|102050635|FG011|Overall Study|Pt incarcerated|0|||
33591033|NCT03575065|102050644|FG000|Overall Study|Death|31|||
33591034|NCT03575065|102050645|FG001|Overall Study|Death|12|||
33591035|NCT03575065|102050644|FG000|Overall Study|Sponsor's Decision|28|||
33591036|NCT03575065|102050645|FG001|Overall Study|Sponsor's Decision|13|||
33591037|NCT03575065|102050644|FG000|Overall Study|Withdrawal by Subject|2|||
33591038|NCT03575065|102050645|FG001|Overall Study|Withdrawal by Subject|1|||
33591039|NCT03575065|102050644|FG000|Overall Study|Lost to Follow-up|1|||
33591040|NCT03575065|102050645|FG001|Overall Study|Lost to Follow-up|0|||
33591041|NCT00557310|102050646|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
33591042|NCT00557310|102050646|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
33591043|NCT00557310|102050646|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
33591044|NCT00557310|102050646|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
33591045|NCT00557310|102050646|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
33591046|NCT00557310|102050646|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
33591047|NCT03299881|102050647|FG000|Overall Study|Study Termination|17|||
33591048|NCT03299881|102050648|FG001|Overall Study|Study Termination|13|||
33591049|NCT04173260|102053907|FG000|Overall Study|Early termination|4|||
33591050|NCT00853242|102053908|FG000|Overall Study|Adverse Event|0|||
33648851|NCT01457352|102265757|FG000|Period 3|incorrect treatment|0|||
33648852|NCT01457352|102265758|FG001|Period 3|incorrect treatment|1|||
33648853|NCT01457352|102265757|FG000|Period 3|Sponsor's withdrawal|0|||
33591051|NCT00853242|102053909|FG001|Overall Study|Adverse Event|1|||
33591052|NCT00853242|102053910|FG002|Overall Study|Adverse Event|1|||
33591053|NCT00853242|102053911|FG003|Overall Study|Adverse Event|0|||
33648854|NCT01457352|102265758|FG001|Period 3|Sponsor's withdrawal|1|||
33648855|NCT01755026|102265764|FG000|Overall Study|Adverse Event|1|||
33648856|NCT01755026|102265765|FG001|Overall Study|Adverse Event|0|||
33591054|NCT00853242|102053912|FG004|Overall Study|Adverse Event|3|||
33591055|NCT00853242|102053913|FG005|Overall Study|Adverse Event|1|||
33591056|NCT00853242|102053914|FG006|Overall Study|Adverse Event|1|||
33591057|NCT00853242|102053908|FG000|Overall Study|Noncompliant|0|||
33591058|NCT00853242|102053909|FG001|Overall Study|Noncompliant|0|||
33591059|NCT00853242|102053910|FG002|Overall Study|Noncompliant|0|||
33591060|NCT00853242|102053911|FG003|Overall Study|Noncompliant|0|||
33433524|NCT01829464|101476933|FG001|Overall Study|Adverse Event|0|||
33433525|NCT01829464|101476934|FG002|Overall Study|Adverse Event|0|||
33433526|NCT01829464|101476932|FG000|Overall Study|Lost to Follow-up|0|||
33433527|NCT01829464|101476933|FG001|Overall Study|Lost to Follow-up|0|||
33433528|NCT01829464|101476934|FG002|Overall Study|Lost to Follow-up|1|||
33433529|NCT01829464|101476932|FG000|Overall Study|Withdrawal by Subject|2|||
33433530|NCT01829464|101476933|FG001|Overall Study|Withdrawal by Subject|0|||
33433531|NCT01829464|101476934|FG002|Overall Study|Withdrawal by Subject|0|||
33433532|NCT01829464|101476932|FG000|Overall Study|Study terminated by sponsor|25|||
33591061|NCT00853242|102053912|FG004|Overall Study|Noncompliant|1|||
33591062|NCT00853242|102053913|FG005|Overall Study|Noncompliant|0|||
33591063|NCT00853242|102053914|FG006|Overall Study|Noncompliant|0|||
33591064|NCT00853242|102053908|FG000|Overall Study|Withdrawal by Subject|1|||
33591065|NCT00853242|102053909|FG001|Overall Study|Withdrawal by Subject|2|||
33249796|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
33591066|NCT00853242|102053910|FG002|Overall Study|Withdrawal by Subject|0|||
33591067|NCT00853242|102053911|FG003|Overall Study|Withdrawal by Subject|4|||
33648857|NCT01755026|102265764|FG000|Overall Study|Withdrawal by Subject|1|||
33433533|NCT01829464|101476933|FG001|Overall Study|Study terminated by sponsor|28|||
33433534|NCT01829464|101476934|FG002|Overall Study|Study terminated by sponsor|25|||
33433535|NCT01829464|101476932|FG000|Overall Study|Lack of Efficacy|0|||
33591068|NCT00853242|102053912|FG004|Overall Study|Withdrawal by Subject|0|||
33591069|NCT00853242|102053913|FG005|Overall Study|Withdrawal by Subject|0|||
33648858|NCT01755026|102265765|FG001|Overall Study|Withdrawal by Subject|1|||
33648859|NCT01256294|102265766|FG000|Overall Study|Adverse Event|1|||
33648860|NCT01256294|102265767|FG001|Overall Study|Adverse Event|0|||
33648861|NCT01256294|102265766|FG000|Overall Study|Withdrawal by Subject|1|||
33648862|NCT01256294|102265767|FG001|Overall Study|Withdrawal by Subject|1|||
33648863|NCT01256294|102265766|FG000|Overall Study|Protocol deviation|2|||
33648864|NCT01256294|102265767|FG001|Overall Study|Protocol deviation|1|||
33648865|NCT03180619|102265768|FG000|Overall Study|Withdrew Consent|5|||
33648866|NCT03180619|102265769|FG001|Overall Study|Withdrew Consent|0|||
33648867|NCT03180619|102265770|FG002|Overall Study|Withdrew Consent|2|||
33648868|NCT03180619|102265768|FG000|Overall Study|Death|2|||
33648869|NCT03180619|102265769|FG001|Overall Study|Death|1|||
33648870|NCT03180619|102265770|FG002|Overall Study|Death|2|||
33648871|NCT03180619|102265768|FG000|Overall Study|Adverse Event|2|||
33648872|NCT03180619|102265769|FG001|Overall Study|Adverse Event|0|||
33648873|NCT03180619|102265770|FG002|Overall Study|Adverse Event|1|||
33648874|NCT03180619|102265768|FG000|Overall Study|Investigator's discretion|2|||
33648875|NCT03180619|102265769|FG001|Overall Study|Investigator's discretion|0|||
33648876|NCT03180619|102265770|FG002|Overall Study|Investigator's discretion|1|||
33648877|NCT00783198|102265777|FG000|Overall Study|Adverse Event|15|||
33648878|NCT00783198|102265778|FG001|Overall Study|Adverse Event|19|||
33648879|NCT00783198|102265779|FG002|Overall Study|Adverse Event|3|||
33648880|NCT00783198|102265777|FG000|Overall Study|Lost to Follow-up|11|||
33648881|NCT00783198|102265778|FG001|Overall Study|Lost to Follow-up|1|||
33648882|NCT00783198|102265779|FG002|Overall Study|Lost to Follow-up|7|||
33648883|NCT00783198|102265777|FG000|Overall Study|Withdrawal by Subject|22|||
33648884|NCT00783198|102265778|FG001|Overall Study|Withdrawal by Subject|14|||
33648885|NCT00783198|102265779|FG002|Overall Study|Withdrawal by Subject|20|||
33648886|NCT00783198|102265777|FG000|Overall Study|Noncompliance with protocol|7|||
33648887|NCT00783198|102265778|FG001|Overall Study|Noncompliance with protocol|7|||
33648888|NCT00783198|102265779|FG002|Overall Study|Noncompliance with protocol|10|||
33648889|NCT00783198|102265777|FG000|Overall Study|Did not meet protocol eligibility|0|||
33648890|NCT00783198|102265778|FG001|Overall Study|Did not meet protocol eligibility|1|||
33648891|NCT00783198|102265779|FG002|Overall Study|Did not meet protocol eligibility|0|||
33648892|NCT00783198|102265777|FG000|Overall Study|Administrative|2|||
33648893|NCT00783198|102265778|FG001|Overall Study|Administrative|1|||
33648894|NCT00783198|102265779|FG002|Overall Study|Administrative|2|||
33648895|NCT02184572|102265783|FG000|Overall Study|Lost to Follow-up|29|||
33648896|NCT02184572|102265784|FG001|Overall Study|Lost to Follow-up|21|||
33648897|NCT02184572|102265783|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
33648898|NCT02184572|102265784|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
33648899|NCT02184572|102265783|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
33648900|NCT02184572|102265784|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
33648901|NCT02184572|102265783|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
33648902|NCT02184572|102265784|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
33648903|NCT02184572|102265783|FG000|Overall Study|Traveling Outside The Country|1|||
33648904|NCT02184572|102265784|FG001|Overall Study|Traveling Outside The Country|0|||
33648905|NCT02184572|102265783|FG000|Overall Study|Withdrawal by Subject|14|||
33648906|NCT02184572|102265784|FG001|Overall Study|Withdrawal by Subject|9|||
33648907|NCT00905645|102265786|FG000|Overall Study|Death (not device related)|10|||
33648908|NCT00905645|102265787|FG001|Overall Study|Death (not device related)|4|||
33648909|NCT00905645|102265788|FG002|Overall Study|Death (not device related)|15|||
33648910|NCT00905645|102265789|FG003|Overall Study|Death (not device related)|8|||
33433536|NCT01829464|101476933|FG001|Overall Study|Lack of Efficacy|1|||
33648911|NCT00905645|102265786|FG000|Overall Study|Explantation of study device(s)|78|||
33648912|NCT00905645|102265787|FG001|Overall Study|Explantation of study device(s)|47|||
33648913|NCT00905645|102265788|FG002|Overall Study|Explantation of study device(s)|28|||
33648914|NCT00905645|102265789|FG003|Overall Study|Explantation of study device(s)|21|||
33648915|NCT00905645|102265786|FG000|Overall Study|Subject Request|41|||
33648916|NCT00905645|102265787|FG001|Overall Study|Subject Request|17|||
33648917|NCT00905645|102265788|FG002|Overall Study|Subject Request|13|||
33648918|NCT00905645|102265789|FG003|Overall Study|Subject Request|11|||
33648919|NCT00905645|102265786|FG000|Overall Study|Lost to Follow-up|299|||
33648920|NCT00905645|102265787|FG001|Overall Study|Lost to Follow-up|103|||
33648921|NCT00905645|102265788|FG002|Overall Study|Lost to Follow-up|51|||
33648922|NCT00905645|102265789|FG003|Overall Study|Lost to Follow-up|12|||
33648923|NCT02600819|102265790|FG000|GEN Phase|Adverse Event|2|||
33648924|NCT02600819|102265791|FG001|GEN Phase|Adverse Event|0|||
33648925|NCT02600819|102265790|FG000|GEN Phase|Death|2|||
33648926|NCT02600819|102265791|FG001|GEN Phase|Death|0|||
33648927|NCT02600819|102265790|FG000|GEN Phase|Investigator's Discretion|4|||
33648928|NCT02600819|102265791|FG001|GEN Phase|Investigator's Discretion|0|||
33648929|NCT02600819|102265790|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
33648930|NCT02600819|102265791|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
33648931|NCT02600819|102265790|FG000|GEN Phase|Withdrew Consent|5|||
33648932|NCT02600819|102265791|FG001|GEN Phase|Withdrew Consent|0|||
33648933|NCT02600819|102265790|FG000|GEN Phase|Lost to Follow-up|2|||
33150086|NCT00287079|100463610|FG001|Overall Study|Protocol Violation|0|||
33150087|NCT00287079|100463609|FG000|Overall Study|Other|3|||
33150088|NCT00287079|100463610|FG001|Overall Study|Other|0|||
33150089|NCT02808650|100463614|FG000|Overall Study|Death|0|||
33150090|NCT02808650|100463615|FG001|Overall Study|Death|0|||
33150091|NCT02808650|100463616|FG002|Overall Study|Death|0|||
33150092|NCT02808650|100463617|FG003|Overall Study|Death|0|||
33150093|NCT02808650|100463618|FG004|Overall Study|Death|1|||
33150094|NCT02808650|100463614|FG000|Overall Study|Lack of Efficacy|5|||
33150095|NCT02808650|100463615|FG001|Overall Study|Lack of Efficacy|5|||
33150096|NCT02808650|100463616|FG002|Overall Study|Lack of Efficacy|6|||
33150097|NCT02808650|100463617|FG003|Overall Study|Lack of Efficacy|5|||
33150098|NCT02808650|100463618|FG004|Overall Study|Lack of Efficacy|4|||
33150099|NCT02808650|100463614|FG000|Overall Study|Physician Decision|1|||
33648934|NCT02600819|102265791|FG001|GEN Phase|Lost to Follow-up|0|||
33648935|NCT02366091|102265792|FG000|Overall Study|Withdrawal by Subject|3|||
33648936|NCT02366091|102265793|FG001|Overall Study|Withdrawal by Subject|7|||
33648937|NCT02366091|102265794|FG002|Overall Study|Withdrawal by Subject|3|||
33648938|NCT02366091|102265795|FG003|Overall Study|Withdrawal by Subject|1|||
33648939|NCT02717832|102265796|FG000|Overall Study|Inability to place IV|3|||
33648940|NCT01250496|102265797|FG000|Overall Study|Study terminated|124|||
33150100|NCT02808650|100463615|FG001|Overall Study|Physician Decision|1|||
33150101|NCT02808650|100463616|FG002|Overall Study|Physician Decision|0|||
33150102|NCT02808650|100463617|FG003|Overall Study|Physician Decision|0|||
33648941|NCT01250496|102265798|FG001|Overall Study|Study terminated|124|||
33648942|NCT00926029|102265799|FG000|Overall Study|Lost to Follow-up|2|||
33648943|NCT00926029|102265800|FG001|Overall Study|Lost to Follow-up|1|||
33648944|NCT00926029|102265801|FG002|Overall Study|Lost to Follow-up|1|||
33648945|NCT02282293|102265802|FG000|Overall Study|Lost to Follow-up|2|||
33648946|NCT02282293|102265803|FG001|Overall Study|Lost to Follow-up|2|||
33648947|NCT02282293|102265802|FG000|Overall Study|Unable to comply with study procedures|1|||
33648948|NCT02282293|102265803|FG001|Overall Study|Unable to comply with study procedures|0|||
33648949|NCT02282293|102265802|FG000|Overall Study|Moved out of study area|0|||
33648950|NCT02282293|102265803|FG001|Overall Study|Moved out of study area|1|||
33150103|NCT02808650|100463618|FG004|Overall Study|Physician Decision|0|||
33150104|NCT02808650|100463614|FG000|Overall Study|Withdrawal by Subject|0|||
33150105|NCT02808650|100463615|FG001|Overall Study|Withdrawal by Subject|0|||
33150106|NCT02808650|100463616|FG002|Overall Study|Withdrawal by Subject|0|||
33150107|NCT02808650|100463617|FG003|Overall Study|Withdrawal by Subject|1|||
33150108|NCT02808650|100463618|FG004|Overall Study|Withdrawal by Subject|1|||
33150109|NCT02544074|100463619|FG000|Overall Study|Withdrawal by Subject|0|||
33150110|NCT02544074|100463620|FG001|Overall Study|Withdrawal by Subject|1|||
33150111|NCT02544074|100463621|FG002|Overall Study|Withdrawal by Subject|0|||
33150112|NCT02544074|100463622|FG003|Overall Study|Withdrawal by Subject|0|||
33150113|NCT02544074|100463623|FG004|Overall Study|Withdrawal by Subject|0|||
33150114|NCT02544074|100463624|FG005|Overall Study|Withdrawal by Subject|0|||
33150115|NCT02544074|100463625|FG006|Overall Study|Withdrawal by Subject|0|||
33150116|NCT02544074|100463626|FG007|Overall Study|Withdrawal by Subject|0|||
33150117|NCT02544074|100463627|FG008|Overall Study|Withdrawal by Subject|0|||
33150118|NCT02544074|100463628|FG009|Overall Study|Withdrawal by Subject|0|||
33150119|NCT02544074|100463629|FG010|Overall Study|Withdrawal by Subject|0|||
33150120|NCT02544074|100463630|FG011|Overall Study|Withdrawal by Subject|0|||
33150121|NCT02544074|100463631|FG012|Overall Study|Withdrawal by Subject|0|||
33150122|NCT02544074|100463632|FG013|Overall Study|Withdrawal by Subject|0|||
33150123|NCT02544074|100463633|FG014|Overall Study|Withdrawal by Subject|0|||
33150124|NCT02544074|100463634|FG015|Overall Study|Withdrawal by Subject|0|||
33150125|NCT02544074|100463635|FG016|Overall Study|Withdrawal by Subject|0|||
33150126|NCT02544074|100463636|FG017|Overall Study|Withdrawal by Subject|0|||
33433537|NCT01829464|101476934|FG002|Overall Study|Lack of Efficacy|0|||
33433538|NCT01003886|101476935|FG000|Overall Study|Lack of Efficacy|5|||
33433539|NCT01003886|101476935|FG000|Overall Study|Lost to Follow-up|169|||
33433540|NCT01003886|101476935|FG000|Overall Study|Withdrawal by Subject|39|||
33433541|NCT01003886|101476935|FG000|Overall Study|Other|14|||
33433542|NCT01003886|101476935|FG000|Overall Study|Adverse Event|3|||
33433543|NCT03036579|101476936|FG000|2 Years|Lost to Follow-up|1|||
33433544|NCT03036579|101476937|FG001|2 Years|Lost to Follow-up|0|||
33433545|NCT03036579|101476936|FG000|3 Years|Lost to Follow-up|0|||
33433546|NCT03036579|101476937|FG001|3 Years|Lost to Follow-up|1|||
33433547|NCT00268346|101476938|FG000|Overall Study|Adverse Event|0|||
33433548|NCT00268346|101476939|FG001|Overall Study|Adverse Event|1|||
33433549|NCT00268346|101476938|FG000|Overall Study|Death|0|||
33433550|NCT00268346|101476939|FG001|Overall Study|Death|1|||
33591070|NCT00853242|102053914|FG006|Overall Study|Withdrawal by Subject|2|||
33591071|NCT00853242|102053908|FG000|Overall Study|Other|2|||
33591072|NCT00853242|102053909|FG001|Overall Study|Other|0|||
33591073|NCT00853242|102053910|FG002|Overall Study|Other|2|||
33591074|NCT00853242|102053911|FG003|Overall Study|Other|0|||
33591075|NCT00853242|102053912|FG004|Overall Study|Other|0|||
33591076|NCT00853242|102053913|FG005|Overall Study|Other|1|||
33591077|NCT00853242|102053914|FG006|Overall Study|Other|2|||
33591078|NCT00951080|102053917|FG000|Overall Study|Adverse Event|3|||
33591079|NCT00951080|102053918|FG001|Overall Study|Adverse Event|3|||
33591080|NCT00951080|102053917|FG000|Overall Study|Lost to Follow-up|0|||
33591081|NCT00951080|102053918|FG001|Overall Study|Lost to Follow-up|1|||
33591082|NCT00951080|102053917|FG000|Overall Study|Physician Decision|4|||
33591083|NCT00951080|102053918|FG001|Overall Study|Physician Decision|1|||
33591084|NCT00951080|102053917|FG000|Overall Study|Other|19|||
33591085|NCT00951080|102053918|FG001|Overall Study|Other|22|||
33591086|NCT00185380|102053928|FG000|Overall Study|Adverse Event|41|||
33591087|NCT00185380|102053929|FG001|Overall Study|Adverse Event|43|||
33591088|NCT00185380|102053930|FG002|Overall Study|Adverse Event|48|||
33591089|NCT00185380|102053928|FG000|Overall Study|Lost to Follow-up|0|||
33591090|NCT00185380|102053929|FG001|Overall Study|Lost to Follow-up|4|||
33591091|NCT00185380|102053930|FG002|Overall Study|Lost to Follow-up|3|||
33591092|NCT00185380|102053928|FG000|Overall Study|Pregnancy|1|||
33591093|NCT00185380|102053929|FG001|Overall Study|Pregnancy|4|||
33591094|NCT00185380|102053930|FG002|Overall Study|Pregnancy|0|||
33591095|NCT00185380|102053928|FG000|Overall Study|Protocol Violation|2|||
33591096|NCT00185380|102053929|FG001|Overall Study|Protocol Violation|2|||
33591097|NCT00185380|102053930|FG002|Overall Study|Protocol Violation|1|||
33591098|NCT00185380|102053928|FG000|Overall Study|Withdrawal by Subject|1|||
33150127|NCT02544074|100463637|FG018|Overall Study|Withdrawal by Subject|0|||
33433551|NCT00268346|101476938|FG000|Overall Study|Withdrawal by Subject|0|||
33433552|NCT00268346|101476939|FG001|Overall Study|Withdrawal by Subject|1|||
33433553|NCT00658320|101476942|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
33433554|NCT00658320|101476943|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
33433555|NCT00658320|101476942|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
33591099|NCT00185380|102053929|FG001|Overall Study|Withdrawal by Subject|2|||
33591100|NCT00185380|102053930|FG002|Overall Study|Withdrawal by Subject|0|||
33591101|NCT00185380|102053928|FG000|Overall Study|Failed insertion|1|||
33591102|NCT00185380|102053929|FG001|Overall Study|Failed insertion|1|||
33591103|NCT00185380|102053930|FG002|Overall Study|Failed insertion|2|||
33591104|NCT00185380|102053928|FG000|Overall Study|Planned pregnancy|9|||
33591105|NCT00185380|102053929|FG001|Overall Study|Planned pregnancy|12|||
33591106|NCT00185380|102053930|FG002|Overall Study|Planned pregnancy|12|||
33591107|NCT00185380|102053928|FG000|Overall Study|No need for contraception|3|||
33591108|NCT00185380|102053929|FG001|Overall Study|No need for contraception|3|||
33591109|NCT00185380|102053930|FG002|Overall Study|No need for contraception|3|||
33150128|NCT02544074|100463638|FG019|Overall Study|Withdrawal by Subject|0|||
33150129|NCT02544074|100463639|FG020|Overall Study|Withdrawal by Subject|0|||
33150130|NCT02544074|100463619|FG000|Overall Study|Tablet error|0|||
33591110|NCT00185380|102053928|FG000|Overall Study|Could not attend visits|2|||
33433556|NCT00658320|101476943|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
33433557|NCT00658320|101476942|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
33433558|NCT00658320|101476943|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
33433559|NCT00658320|101476942|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
33433560|NCT00658320|101476943|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
33433561|NCT01325207|101480818|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
33433562|NCT01325207|101480819|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
33433563|NCT01325207|101480820|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
33591111|NCT00185380|102053929|FG001|Overall Study|Could not attend visits|0|||
33591112|NCT00185380|102053930|FG002|Overall Study|Could not attend visits|4|||
33591113|NCT00185380|102053928|FG000|Overall Study|personal reason|6|||
33591114|NCT00185380|102053929|FG001|Overall Study|personal reason|1|||
33591115|NCT00185380|102053930|FG002|Overall Study|personal reason|1|||
33591116|NCT01205061|102053931|FG000|Overall Study|Adverse Event|4|||
33591117|NCT01205061|102053931|FG000|Overall Study|Withdrawal by Subject|11|||
33591118|NCT01205061|102053931|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
33591119|NCT01205061|102053931|FG000|Overall Study|Lost to Follow-up|9|||
33591120|NCT01205061|102053931|FG000|Overall Study|Other|1|||
33591121|NCT05243745|102053933|FG000|Overall Study|Withdrawal by Subject|0|||
33591122|NCT05243745|102053934|FG001|Overall Study|Withdrawal by Subject|0|||
33591123|NCT05243745|102053935|FG002|Overall Study|Withdrawal by Subject|0|||
33591124|NCT05243745|102053936|FG003|Overall Study|Withdrawal by Subject|1|||
33591125|NCT05243745|102053933|FG000|Overall Study|Unable to Attend Visit 6|0|||
33591126|NCT05243745|102053934|FG001|Overall Study|Unable to Attend Visit 6|0|||
33591127|NCT05243745|102053935|FG002|Overall Study|Unable to Attend Visit 6|1|||
33591128|NCT05243745|102053936|FG003|Overall Study|Unable to Attend Visit 6|0|||
33591129|NCT00473668|102053937|FG000|Overall Study|Withdrawal by Subject|0|||
33591130|NCT00473668|102053938|FG001|Overall Study|Withdrawal by Subject|2|||
33591131|NCT00473668|102053939|FG002|Overall Study|Withdrawal by Subject|0|||
33591132|NCT00473668|102053937|FG000|Overall Study|Migrated/moved from study area|3|||
33591133|NCT00473668|102053938|FG001|Overall Study|Migrated/moved from study area|2|||
33591134|NCT00473668|102053939|FG002|Overall Study|Migrated/moved from study area|0|||
33591135|NCT00473668|102053937|FG000|Overall Study|Lost to Follow-up|0|||
33591136|NCT00473668|102053938|FG001|Overall Study|Lost to Follow-up|4|||
33591137|NCT00473668|102053939|FG002|Overall Study|Lost to Follow-up|6|||
33591138|NCT00473668|102053937|FG000|Overall Study|Other|2|||
33591139|NCT00473668|102053938|FG001|Overall Study|Other|3|||
33591140|NCT00473668|102053939|FG002|Overall Study|Other|4|||
33591141|NCT00812006|102053940|FG000|Overall Study|Lost to Follow-up|0|||
33591142|NCT00812006|102053941|FG001|Overall Study|Lost to Follow-up|0|||
33591143|NCT00812006|102053942|FG002|Overall Study|Lost to Follow-up|2|||
33591144|NCT00812006|102053940|FG000|Overall Study|Physician Decision|0|||
33591145|NCT00812006|102053941|FG001|Overall Study|Physician Decision|0|||
33591146|NCT00812006|102053942|FG002|Overall Study|Physician Decision|1|||
33591147|NCT00812006|102053940|FG000|Overall Study|Withdrawal by Subject|2|||
33591148|NCT00812006|102053941|FG001|Overall Study|Withdrawal by Subject|1|||
33591149|NCT00812006|102053942|FG002|Overall Study|Withdrawal by Subject|1|||
33591150|NCT00812006|102053940|FG000|Overall Study|Lack of Qualifying Event|4|||
33591151|NCT00812006|102053941|FG001|Overall Study|Lack of Qualifying Event|2|||
33433564|NCT01325207|101480821|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
33433565|NCT01325207|101480822|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
33433566|NCT01325207|101480823|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
33433567|NCT01325207|101480818|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
33433568|NCT01325207|101480819|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
33591152|NCT00812006|102053942|FG002|Overall Study|Lack of Qualifying Event|2|||
33591153|NCT01893411|102053943|FG000|Overall Study|Protocol Violation|1|||
33384550|NCT03332303|101295805|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
33384551|NCT03332303|101295806|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
33384552|NCT03332303|101295804|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
33384553|NCT03332303|101295805|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
33384554|NCT03332303|101295806|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
33384555|NCT03332303|101295804|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
33384556|NCT03332303|101295805|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
33591154|NCT01893411|102053944|FG001|Overall Study|Protocol Violation|0|||
33591155|NCT01893411|102053945|FG002|Overall Study|Protocol Violation|0|||
33591156|NCT01893411|102053943|FG000|Overall Study|Physician Decision|1|||
33591157|NCT01893411|102053944|FG001|Overall Study|Physician Decision|1|||
33591158|NCT01893411|102053945|FG002|Overall Study|Physician Decision|2|||
33591159|NCT01893411|102053943|FG000|Overall Study|Lack of Efficacy|2|||
33591160|NCT01893411|102053944|FG001|Overall Study|Lack of Efficacy|1|||
33591161|NCT01893411|102053945|FG002|Overall Study|Lack of Efficacy|0|||
33591162|NCT01893411|102053943|FG000|Overall Study|Other|3|||
33591163|NCT01893411|102053944|FG001|Overall Study|Other|1|||
33591164|NCT01893411|102053945|FG002|Overall Study|Other|3|||
33591165|NCT01893411|102053943|FG000|Overall Study|Adverse Event|1|||
33591166|NCT01893411|102053944|FG001|Overall Study|Adverse Event|0|||
33591167|NCT01893411|102053945|FG002|Overall Study|Adverse Event|0|||
33591168|NCT01893411|102053943|FG000|Overall Study|Withdrawal by Subject|7|||
33591169|NCT01893411|102053944|FG001|Overall Study|Withdrawal by Subject|4|||
33591170|NCT01893411|102053945|FG002|Overall Study|Withdrawal by Subject|3|||
33591171|NCT01893411|102053943|FG000|Overall Study|Lost to Follow-up|2|||
33384557|NCT03332303|101295806|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
33384558|NCT03332303|101295804|FG000|Overall Study|Participant had a significant protocol deviation|0|||
33384559|NCT03332303|101295805|FG001|Overall Study|Participant had a significant protocol deviation|1|||
33384560|NCT03332303|101295806|FG002|Overall Study|Participant had a significant protocol deviation|0|||
33384561|NCT01453998|101295807|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
33384562|NCT01453998|101295808|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
33384563|NCT01453998|101295809|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
33384564|NCT04681729|101295810|FG000|Overall Study|Lack of Efficacy|2|||
33384565|NCT04681729|101295811|FG001|Overall Study|Lack of Efficacy|2|||
33384566|NCT04681729|101295810|FG000|Overall Study|Withdrawal by Subject|8|||
33384567|NCT04681729|101295811|FG001|Overall Study|Withdrawal by Subject|9|||
33384568|NCT00753688|101295812|FG000|Overall Study|Death|102|||
33384569|NCT00753688|101295813|FG001|Overall Study|Death|203|||
33384570|NCT00753688|101295812|FG000|Overall Study|Missing|4|||
33384571|NCT00753688|101295813|FG001|Overall Study|Missing|9|||
33384572|NCT00753688|101295812|FG000|Overall Study|Participant Withdrew Consent|2|||
33384573|NCT00753688|101295813|FG001|Overall Study|Participant Withdrew Consent|2|||
33384574|NCT00753688|101295812|FG000|Overall Study|Ongoing - in Follow-up|15|||
33384575|NCT00753688|101295813|FG001|Overall Study|Ongoing - in Follow-up|31|||
33384576|NCT00753688|101295812|FG000|Overall Study|Adverse Event|0|||
33384577|NCT00753688|101295813|FG001|Overall Study|Adverse Event|1|||
33384578|NCT00879437|101295814|FG000|Overall Study|Protocol Violation|0|||
33384579|NCT00879437|101295815|FG001|Overall Study|Protocol Violation|1|||
33384580|NCT00879437|101295814|FG000|Overall Study|Death|1|||
33384581|NCT00879437|101295815|FG001|Overall Study|Death|0|||
33384582|NCT01225172|101295816|FG000|Overall Study|Subject decision to stop|1|||
33384583|NCT01225172|101295817|FG001|Overall Study|Subject decision to stop|0|||
33384584|NCT01225172|101295816|FG000|Overall Study|Subject request to discontinue treatment|3|||
33384585|NCT01225172|101295817|FG001|Overall Study|Subject request to discontinue treatment|1|||
33591172|NCT01893411|102053944|FG001|Overall Study|Lost to Follow-up|0|||
33150131|NCT02544074|100463620|FG001|Overall Study|Tablet error|0|||
33384586|NCT01225172|101295816|FG000|Overall Study|Subject no longer meets study criteria|1|||
33384587|NCT01225172|101295817|FG001|Overall Study|Subject no longer meets study criteria|0|||
33591173|NCT01893411|102053945|FG002|Overall Study|Lost to Follow-up|1|||
33591174|NCT00676520|102053946|FG000|Overall Study|Withdrawal by Subject|163|||
33150132|NCT02544074|100463621|FG002|Overall Study|Tablet error|0|||
33591175|NCT00676520|102053946|FG000|Overall Study|Lost to Follow-up|162|||
33591176|NCT00676520|102053946|FG000|Overall Study|Death|159|||
33591177|NCT00676520|102053946|FG000|Overall Study|Physician Decision|20|||
33150133|NCT02544074|100463622|FG003|Overall Study|Tablet error|0|||
33591178|NCT00676520|102053946|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
33591179|NCT00676520|102053946|FG000|Overall Study|Other Reason|18|||
33591180|NCT03305081|102053947|FG000|Overall Study|Lost to Follow-up|10|||
33591181|NCT03305081|102053948|FG001|Overall Study|Lost to Follow-up|15|||
33591182|NCT02998203|102053951|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
33591183|NCT02998203|102053952|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
33591184|NCT02998203|102053951|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
33591185|NCT02998203|102053952|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
33591186|NCT03831191|102053953|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
33591187|NCT03831191|102053954|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
33591188|NCT03831191|102053955|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
33591189|NCT03831191|102053956|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
33591190|NCT03831191|102053957|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
33591191|NCT03831191|102053958|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
33591192|NCT03831191|102053959|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
33433569|NCT01325207|101480820|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
33433570|NCT01325207|101480821|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
33433571|NCT01325207|101480822|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
33433572|NCT01325207|101480823|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
33433573|NCT01325207|101480818|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
33433574|NCT01325207|101480819|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
33433575|NCT01325207|101480820|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
33433576|NCT01325207|101480821|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
33433577|NCT01325207|101480822|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
33433578|NCT01325207|101480823|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
33433579|NCT01325207|101480818|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
33433580|NCT01325207|101480819|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
33433581|NCT01325207|101480820|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
33433582|NCT01325207|101480821|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
33433583|NCT01325207|101480822|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
33433584|NCT01325207|101480823|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
33433585|NCT01325207|101480818|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
33433586|NCT01325207|101480819|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
33433587|NCT01325207|101480820|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
33433588|NCT01325207|101480821|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
33433589|NCT01325207|101480822|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
33433590|NCT01325207|101480823|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
33433591|NCT01325207|101480818|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
33433592|NCT01325207|101480819|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
33433593|NCT01325207|101480820|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
33433594|NCT01325207|101480821|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
33591193|NCT03831191|102053960|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
33591194|NCT03831191|102053961|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
33591195|NCT03831191|102053962|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
33591196|NCT03831191|102053963|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
33591197|NCT03831191|102053964|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
33591198|NCT03831191|102053965|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
33591199|NCT03831191|102053966|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
33433595|NCT01325207|101480822|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
33433596|NCT01325207|101480823|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
33433597|NCT01325207|101480818|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
33433598|NCT01325207|101480819|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
33433599|NCT01325207|101480820|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
33433600|NCT01325207|101480821|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
33433601|NCT01325207|101480822|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
33433602|NCT01325207|101480823|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
33433603|NCT02918162|101480824|FG000|Overall Study|Withdrawal by Subject|1|||
33433604|NCT02918162|101480824|FG000|Overall Study|Omental Disease|1|||
33433605|NCT02339909|101480827|FG000|Overall Study|Became ineligible after randomisation|89|||
33433606|NCT02339909|101480828|FG001|Overall Study|Became ineligible after randomisation|63|||
33433607|NCT02339909|101480829|FG002|Overall Study|Became ineligible after randomisation|71|||
33433608|NCT02324465|101480830|FG000|Overall Study|device failure|0|||
33433609|NCT02324465|101480831|FG001|Overall Study|device failure|1|||
33433610|NCT02785913|101480832|FG000|Overall Study|Adverse Event|5|||
33150134|NCT02544074|100463623|FG004|Overall Study|Tablet error|0|||
33384588|NCT01225172|101295816|FG000|Overall Study|Withdrawal by Subject|1|||
33384589|NCT01225172|101295817|FG001|Overall Study|Withdrawal by Subject|0|||
33433611|NCT02785913|101480832|FG000|Overall Study|Death|2|||
33433612|NCT02785913|101480832|FG000|Overall Study|Progression|18|||
33433613|NCT02785913|101480832|FG000|Overall Study|Not protocol specified|1|||
33433614|NCT02806232|101480837|FG000|Overall Study|Lost to Follow-up|1|||
33433615|NCT02806232|101480838|FG001|Overall Study|Lost to Follow-up|2|||
33433616|NCT02806232|101480839|FG002|Overall Study|Lost to Follow-up|1|||
33433617|NCT02806232|101480840|FG003|Overall Study|Lost to Follow-up|0|||
33591200|NCT03831191|102053967|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
33591201|NCT03831191|102053953|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
33591202|NCT03831191|102053954|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
33591203|NCT03831191|102053955|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33591204|NCT03831191|102053956|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33591205|NCT03831191|102053957|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33591206|NCT03831191|102053958|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33591207|NCT03831191|102053959|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33591208|NCT03831191|102053960|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33591209|NCT03831191|102053961|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33591210|NCT03831191|102053962|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33591211|NCT03831191|102053963|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33591212|NCT03831191|102053964|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33591213|NCT03831191|102053965|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33591214|NCT03831191|102053966|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33591215|NCT03831191|102053967|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33591216|NCT03831191|102053953|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
33591217|NCT03831191|102053954|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
33591218|NCT03831191|102053955|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
33591219|NCT03831191|102053956|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
33591220|NCT03831191|102053957|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
33591221|NCT03831191|102053958|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
33591222|NCT03831191|102053959|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
33384590|NCT01677507|101295818|FG000|Initial Assignment|Adverse Event|0|||
33384591|NCT01677507|101295819|FG001|Initial Assignment|Adverse Event|1|||
33384592|NCT01677507|101295818|FG000|Initial Assignment|Protocol Violation|0|||
33384593|NCT01677507|101295819|FG001|Initial Assignment|Protocol Violation|1|||
33384594|NCT01677507|101295818|FG000|Second Assigment|Withdrawal by Subject|2|||
33384595|NCT01677507|101295819|FG001|Second Assigment|Withdrawal by Subject|2|||
33384596|NCT01677507|101295818|FG000|Second Assigment|Adverse Event|1|||
33384597|NCT01677507|101295819|FG001|Second Assigment|Adverse Event|3|||
33384598|NCT01677624|101295823|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
33384599|NCT01459068|101295826|FG000|Overall Study|Withdrawal by Subject|8|||
33384600|NCT01459068|101295827|FG001|Overall Study|Withdrawal by Subject|18|||
33433618|NCT02806232|101480841|FG004|Overall Study|Lost to Follow-up|0|||
33433619|NCT02806232|101480842|FG005|Overall Study|Lost to Follow-up|1|||
33433620|NCT02806232|101480843|FG006|Overall Study|Lost to Follow-up|0|||
33433621|NCT02806232|101480844|FG007|Overall Study|Lost to Follow-up|0|||
33433622|NCT02806232|101480845|FG008|Overall Study|Lost to Follow-up|0|||
33591223|NCT03831191|102053960|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
33591224|NCT03831191|102053961|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
33591225|NCT03831191|102053962|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
33591226|NCT03831191|102053963|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
33591227|NCT03831191|102053964|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
33591228|NCT03831191|102053965|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
33150135|NCT02544074|100463624|FG005|Overall Study|Tablet error|1|||
33591229|NCT03831191|102053966|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
33433623|NCT02806232|101480837|FG000|Overall Study|Withdrawal by Subject|0|||
33433624|NCT02806232|101480838|FG001|Overall Study|Withdrawal by Subject|2|||
33433625|NCT02806232|101480839|FG002|Overall Study|Withdrawal by Subject|0|||
33591230|NCT03831191|102053967|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
33591231|NCT03831191|102053953|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
33591232|NCT03831191|102053954|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
33591233|NCT03831191|102053955|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
33591234|NCT03831191|102053956|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
33591235|NCT03831191|102053957|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
33591236|NCT03831191|102053958|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
33591237|NCT03831191|102053959|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
33591238|NCT03831191|102053960|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
33384601|NCT01459068|101295826|FG000|Overall Study|Lost to Follow-up|31|||
33591239|NCT03831191|102053961|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
33591240|NCT03831191|102053962|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
33591241|NCT03831191|102053963|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
33591242|NCT03831191|102053964|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
33591243|NCT03831191|102053965|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
33591244|NCT03831191|102053966|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
33591245|NCT03831191|102053967|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
33591246|NCT03831191|102053953|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
33591247|NCT03831191|102053954|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
33384602|NCT01459068|101295827|FG001|Overall Study|Lost to Follow-up|15|||
33384603|NCT01459068|101295826|FG000|Overall Study|Death|0|||
33384604|NCT01459068|101295827|FG001|Overall Study|Death|1|||
33384605|NCT02177175|101295828|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
33384606|NCT02177175|101295829|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
33384607|NCT02137837|101295830|FG000|Overall Study|Adverse Event|0|||
33384608|NCT02137837|101295831|FG001|Overall Study|Adverse Event|2|||
33384609|NCT02137837|101295832|FG002|Overall Study|Adverse Event|1|||
33384610|NCT02137837|101295830|FG000|Overall Study|Refusal unrelated to adverse event|2|||
33384611|NCT02137837|101295831|FG001|Overall Study|Refusal unrelated to adverse event|2|||
33433626|NCT02806232|101480840|FG003|Overall Study|Withdrawal by Subject|0|||
33591248|NCT03831191|102053955|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
33591249|NCT03831191|102053956|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
33591250|NCT03831191|102053957|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33384612|NCT02137837|101295832|FG002|Overall Study|Refusal unrelated to adverse event|1|||
33433627|NCT02806232|101480841|FG004|Overall Study|Withdrawal by Subject|2|||
33433628|NCT02806232|101480842|FG005|Overall Study|Withdrawal by Subject|1|||
33433629|NCT02806232|101480843|FG006|Overall Study|Withdrawal by Subject|0|||
33433630|NCT02806232|101480844|FG007|Overall Study|Withdrawal by Subject|0|||
33433631|NCT02806232|101480845|FG008|Overall Study|Withdrawal by Subject|0|||
33384613|NCT02137837|101295830|FG000|Overall Study|Progression/relapse|9|||
33384614|NCT02137837|101295831|FG001|Overall Study|Progression/relapse|7|||
33384615|NCT02137837|101295832|FG002|Overall Study|Progression/relapse|7|||
33384616|NCT02137837|101295830|FG000|Overall Study|Not protocol specified|2|||
33384617|NCT02137837|101295831|FG001|Overall Study|Not protocol specified|1|||
33384618|NCT02137837|101295832|FG002|Overall Study|Not protocol specified|3|||
33384619|NCT03750240|101295833|FG000|Overall Study|Technical Difficulties|2|||
33384620|NCT04449276|101295834|FG000|Overall Study|Adverse Event|1|||
33591251|NCT03831191|102053958|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33591252|NCT03831191|102053959|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33591253|NCT03831191|102053960|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33591254|NCT03831191|102053961|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33591255|NCT03831191|102053962|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33591256|NCT03831191|102053963|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33591257|NCT03831191|102053964|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33591258|NCT03831191|102053965|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33591259|NCT03831191|102053966|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33591260|NCT03831191|102053967|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33591261|NCT03831191|102053953|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
33591262|NCT03831191|102053954|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
33591263|NCT03831191|102053955|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
33591264|NCT03831191|102053956|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
33591265|NCT03831191|102053957|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33591266|NCT03831191|102053958|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33591267|NCT03831191|102053959|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33591268|NCT03831191|102053960|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33591269|NCT03831191|102053961|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33591270|NCT03831191|102053962|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33591271|NCT03831191|102053963|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33591272|NCT03831191|102053964|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33591273|NCT03831191|102053965|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33591274|NCT03831191|102053966|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33591275|NCT03831191|102053967|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
33591276|NCT03831191|102053953|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
33591277|NCT03831191|102053954|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
33591278|NCT03831191|102053955|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
33591279|NCT03831191|102053956|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
33591280|NCT03831191|102053957|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
33591281|NCT03831191|102053958|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
33591282|NCT03831191|102053959|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
33591283|NCT03831191|102053960|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
33591284|NCT03831191|102053961|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
33591285|NCT03831191|102053962|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
33591286|NCT03831191|102053963|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
33591287|NCT03831191|102053964|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
33591288|NCT03831191|102053965|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
33591289|NCT03831191|102053966|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
33591290|NCT03831191|102053967|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
33591291|NCT03831191|102053953|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
33591292|NCT03831191|102053954|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
33591293|NCT03831191|102053955|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
33591294|NCT03831191|102053956|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
33591295|NCT03831191|102053957|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
33591296|NCT03831191|102053958|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
33591297|NCT03831191|102053959|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
33384621|NCT04449276|101295835|FG001|Overall Study|Adverse Event|2|||
33384622|NCT04449276|101295836|FG002|Overall Study|Adverse Event|0|||
33384623|NCT04449276|101295837|FG003|Overall Study|Adverse Event|0|||
33433632|NCT01884025|101480846|FG000|Overall Study|Lost to Follow-up|3|||
33433633|NCT01884025|101480847|FG001|Overall Study|Lost to Follow-up|4|||
33433634|NCT00249821|101480848|FG000|Overall Study|Technical problem|0|||
33591298|NCT03831191|102053960|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
33591299|NCT03831191|102053961|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
33591300|NCT03831191|102053962|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
33384624|NCT04449276|101295838|FG004|Overall Study|Adverse Event|2|||
33591301|NCT03831191|102053963|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
33591302|NCT03831191|102053964|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
33591303|NCT03831191|102053965|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
33591304|NCT03831191|102053966|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
33591305|NCT03831191|102053967|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
33591306|NCT03831191|102053953|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33591307|NCT03831191|102053954|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33591308|NCT03831191|102053955|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33591309|NCT03831191|102053956|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33591310|NCT03831191|102053957|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33591311|NCT03831191|102053958|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33591312|NCT03831191|102053959|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33591313|NCT03831191|102053960|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33591314|NCT03831191|102053961|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33591315|NCT03831191|102053962|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33591316|NCT03831191|102053963|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33591317|NCT03831191|102053964|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33591318|NCT03831191|102053965|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33591319|NCT03831191|102053966|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33591320|NCT03831191|102053967|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
33591321|NCT03831191|102053953|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33591322|NCT03831191|102053954|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33591323|NCT03831191|102053955|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33591324|NCT03831191|102053956|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33591325|NCT03831191|102053957|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33591326|NCT03831191|102053958|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33591327|NCT03831191|102053959|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33591328|NCT03831191|102053960|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33591329|NCT03831191|102053961|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33591330|NCT03831191|102053962|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33591331|NCT03831191|102053963|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33591332|NCT03831191|102053964|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33591333|NCT03831191|102053965|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33591334|NCT03831191|102053966|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33591335|NCT03831191|102053967|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
33591336|NCT03070171|102053970|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
33591337|NCT03070171|102053971|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
33591338|NCT03070171|102053970|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
33591339|NCT03070171|102053971|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
33591340|NCT01110330|102053972|FG000|Overall Study|Adverse Event|0|||
33591341|NCT01110330|102053973|FG001|Overall Study|Adverse Event|4|||
33591342|NCT01110330|102053974|FG002|Overall Study|Adverse Event|3|||
33591343|NCT01110330|102053972|FG000|Overall Study|Lack of Efficacy|3|||
33591344|NCT01110330|102053973|FG001|Overall Study|Lack of Efficacy|1|||
33591345|NCT01110330|102053974|FG002|Overall Study|Lack of Efficacy|1|||
33591346|NCT01110330|102053972|FG000|Overall Study|Lost to Follow-up|9|||
33591347|NCT01110330|102053973|FG001|Overall Study|Lost to Follow-up|10|||
33591348|NCT01110330|102053974|FG002|Overall Study|Lost to Follow-up|15|||
33591349|NCT01110330|102053972|FG000|Overall Study|Physician Decision|0|||
33591350|NCT01110330|102053973|FG001|Overall Study|Physician Decision|1|||
33591351|NCT01110330|102053974|FG002|Overall Study|Physician Decision|0|||
33591352|NCT01110330|102053972|FG000|Overall Study|Protocol Violation|2|||
33591353|NCT01110330|102053973|FG001|Overall Study|Protocol Violation|0|||
33591354|NCT01110330|102053974|FG002|Overall Study|Protocol Violation|4|||
33591355|NCT01110330|102053972|FG000|Overall Study|Withdrawal by Subject|0|||
33591356|NCT01110330|102053973|FG001|Overall Study|Withdrawal by Subject|6|||
33591357|NCT01110330|102053974|FG002|Overall Study|Withdrawal by Subject|2|||
33591358|NCT01110330|102053972|FG000|Overall Study|Other|1|||
33591359|NCT01110330|102053973|FG001|Overall Study|Other|1|||
33591360|NCT01110330|102053974|FG002|Overall Study|Other|1|||
33591361|NCT00962741|102053982|FG000|Overall Study|Failed to return|3|||
33591362|NCT00962741|102053982|FG000|Overall Study|Lost to Follow-up|2|||
33591363|NCT00962741|102053982|FG000|Overall Study|Withdrawal by Subject|1|||
33591364|NCT00962741|102053982|FG000|Overall Study|Lack of Efficacy|1|||
33591365|NCT00962741|102053982|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
33591366|NCT00281099|102053983|FG000|Overall Study|Death|46|||
33591367|NCT00281099|102053984|FG001|Overall Study|Death|57|||
33591368|NCT00281099|102053983|FG000|Overall Study|Lost to Follow-up|10|||
33591369|NCT00281099|102053984|FG001|Overall Study|Lost to Follow-up|19|||
33591370|NCT00281099|102053983|FG000|Overall Study|Withdrawal by Subject|65|||
33591371|NCT00281099|102053984|FG001|Overall Study|Withdrawal by Subject|70|||
33433635|NCT00249821|101480849|FG001|Overall Study|Technical problem|1|||
33433636|NCT02396381|101480850|FG000|Overall Study|Adverse Event|3|||
33433637|NCT02396381|101480851|FG001|Overall Study|Adverse Event|2|||
33433638|NCT02396381|101480850|FG000|Overall Study|Withdrawal by Subject|33|||
33433639|NCT02396381|101480851|FG001|Overall Study|Withdrawal by Subject|24|||
33433640|NCT02396381|101480850|FG000|Overall Study|Lost to Follow-up|49|||
33433641|NCT02396381|101480851|FG001|Overall Study|Lost to Follow-up|31|||
33433642|NCT02396381|101480850|FG000|Overall Study|Protocol Violation|1|||
33433643|NCT02396381|101480851|FG001|Overall Study|Protocol Violation|0|||
33433644|NCT02396381|101480850|FG000|Overall Study|Site terminated by sponsor|7|||
33433645|NCT02396381|101480851|FG001|Overall Study|Site terminated by sponsor|8|||
33433646|NCT02396381|101480850|FG000|Overall Study|Physician Decision|5|||
33433647|NCT02396381|101480851|FG001|Overall Study|Physician Decision|5|||
33591372|NCT00281099|102053983|FG000|Overall Study|Physician Decision|79|||
33591373|NCT00281099|102053984|FG001|Overall Study|Physician Decision|72|||
33591374|NCT00281099|102053983|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
33591375|NCT00281099|102053984|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
33591376|NCT01694121|102053987|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
33591377|NCT01694121|102053988|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
33591378|NCT01406938|102053989|FG000|Induction Period|Subject/guardian decision|6|||
33591379|NCT01406938|102053990|FG001|Induction Period|Subject/guardian decision|8|||
33591380|NCT01406938|102053991|FG002|Induction Period|Subject/guardian decision|0|||
33591381|NCT01406938|102053992|FG003|Induction Period|Subject/guardian decision|0|||
33591382|NCT01406938|102053993|FG004|Induction Period|Subject/guardian decision|0|||
33591383|NCT01406938|102053994|FG005|Induction Period|Subject/guardian decision|0|||
33591384|NCT01406938|102053989|FG000|Induction Period|Protocol deviation|1|||
33591385|NCT01406938|102053990|FG001|Induction Period|Protocol deviation|0|||
33591386|NCT01406938|102053991|FG002|Induction Period|Protocol deviation|0|||
33591387|NCT01406938|102053992|FG003|Induction Period|Protocol deviation|0|||
33591388|NCT01406938|102053993|FG004|Induction Period|Protocol deviation|0|||
33591389|NCT01406938|102053994|FG005|Induction Period|Protocol deviation|0|||
33591390|NCT01406938|102053989|FG000|Induction Period|Adverse Event|8|||
33591391|NCT01406938|102053990|FG001|Induction Period|Adverse Event|9|||
33591392|NCT01406938|102053991|FG002|Induction Period|Adverse Event|0|||
33591393|NCT01406938|102053992|FG003|Induction Period|Adverse Event|0|||
33591394|NCT01406938|102053993|FG004|Induction Period|Adverse Event|0|||
33591395|NCT01406938|102053994|FG005|Induction Period|Adverse Event|0|||
33591396|NCT01406938|102053989|FG000|Induction Period|Lack of Efficacy|1|||
33591397|NCT01406938|102053990|FG001|Induction Period|Lack of Efficacy|0|||
33591398|NCT01406938|102053991|FG002|Induction Period|Lack of Efficacy|0|||
33591399|NCT01406938|102053992|FG003|Induction Period|Lack of Efficacy|0|||
33591400|NCT01406938|102053993|FG004|Induction Period|Lack of Efficacy|0|||
33591401|NCT01406938|102053994|FG005|Induction Period|Lack of Efficacy|0|||
33591402|NCT01406938|102053989|FG000|Induction Period|Lost to Follow-up|2|||
33591403|NCT01406938|102053990|FG001|Induction Period|Lost to Follow-up|3|||
33591404|NCT01406938|102053991|FG002|Induction Period|Lost to Follow-up|0|||
33591405|NCT01406938|102053992|FG003|Induction Period|Lost to Follow-up|0|||
33591406|NCT01406938|102053993|FG004|Induction Period|Lost to Follow-up|0|||
33591407|NCT01406938|102053994|FG005|Induction Period|Lost to Follow-up|0|||
33591408|NCT01406938|102053989|FG000|Maintenance Period|Adverse Event|0|||
33591409|NCT01406938|102053990|FG001|Maintenance Period|Adverse Event|0|||
33591410|NCT01406938|102053991|FG002|Maintenance Period|Adverse Event|2|||
33591411|NCT01406938|102053992|FG003|Maintenance Period|Adverse Event|8|||
33591412|NCT01406938|102053993|FG004|Maintenance Period|Adverse Event|4|||
33591413|NCT01406938|102053994|FG005|Maintenance Period|Adverse Event|2|||
33591414|NCT01406938|102053989|FG000|Maintenance Period|Death|0|||
33591415|NCT01406938|102053990|FG001|Maintenance Period|Death|0|||
33591416|NCT01406938|102053991|FG002|Maintenance Period|Death|0|||
33591417|NCT01406938|102053992|FG003|Maintenance Period|Death|0|||
33591418|NCT01406938|102053993|FG004|Maintenance Period|Death|1|||
33591419|NCT01406938|102053994|FG005|Maintenance Period|Death|0|||
33591420|NCT01406938|102053989|FG000|Maintenance Period|Subject/guardian decision|0|||
33591421|NCT01406938|102053990|FG001|Maintenance Period|Subject/guardian decision|0|||
33591422|NCT01406938|102053991|FG002|Maintenance Period|Subject/guardian decision|11|||
33591423|NCT01406938|102053992|FG003|Maintenance Period|Subject/guardian decision|7|||
33591424|NCT01406938|102053993|FG004|Maintenance Period|Subject/guardian decision|10|||
33591425|NCT01406938|102053994|FG005|Maintenance Period|Subject/guardian decision|7|||
33591426|NCT01406938|102053989|FG000|Maintenance Period|Protocol Violation|0|||
33591427|NCT01406938|102053990|FG001|Maintenance Period|Protocol Violation|0|||
33591428|NCT01406938|102053991|FG002|Maintenance Period|Protocol Violation|2|||
33591429|NCT01406938|102053992|FG003|Maintenance Period|Protocol Violation|2|||
33591430|NCT01406938|102053993|FG004|Maintenance Period|Protocol Violation|2|||
33591431|NCT01406938|102053994|FG005|Maintenance Period|Protocol Violation|2|||
33433648|NCT02396381|101480850|FG000|Overall Study|Pregnancy|2|||
33591432|NCT01406938|102053989|FG000|Maintenance Period|Pregnancy|0|||
33591433|NCT01406938|102053990|FG001|Maintenance Period|Pregnancy|0|||
33384625|NCT04449276|101295839|FG005|Overall Study|Adverse Event|0|||
33384626|NCT04449276|101295840|FG006|Overall Study|Adverse Event|0|||
33384627|NCT04449276|101295841|FG007|Overall Study|Adverse Event|1|||
33384628|NCT04449276|101295834|FG000|Overall Study|Withdrawal by Subject|2|||
33384629|NCT04449276|101295835|FG001|Overall Study|Withdrawal by Subject|0|||
33384630|NCT04449276|101295836|FG002|Overall Study|Withdrawal by Subject|0|||
33384631|NCT04449276|101295837|FG003|Overall Study|Withdrawal by Subject|1|||
33384632|NCT04449276|101295838|FG004|Overall Study|Withdrawal by Subject|0|||
33384633|NCT04449276|101295839|FG005|Overall Study|Withdrawal by Subject|0|||
33150136|NCT02544074|100463625|FG006|Overall Study|Tablet error|0|||
33150137|NCT02544074|100463626|FG007|Overall Study|Tablet error|0|||
33150138|NCT02544074|100463627|FG008|Overall Study|Tablet error|0|||
33384634|NCT04449276|101295840|FG006|Overall Study|Withdrawal by Subject|0|||
33591434|NCT01406938|102053991|FG002|Maintenance Period|Pregnancy|0|||
33591435|NCT01406938|102053992|FG003|Maintenance Period|Pregnancy|0|||
33591436|NCT01406938|102053993|FG004|Maintenance Period|Pregnancy|1|||
33591437|NCT01406938|102053994|FG005|Maintenance Period|Pregnancy|0|||
33591438|NCT01406938|102053989|FG000|Maintenance Period|Lost to Follow-up|0|||
33591439|NCT01406938|102053990|FG001|Maintenance Period|Lost to Follow-up|0|||
33591440|NCT01406938|102053991|FG002|Maintenance Period|Lost to Follow-up|0|||
33591441|NCT01406938|102053992|FG003|Maintenance Period|Lost to Follow-up|0|||
33591442|NCT01406938|102053993|FG004|Maintenance Period|Lost to Follow-up|4|||
33591443|NCT01406938|102053994|FG005|Maintenance Period|Lost to Follow-up|0|||
33591444|NCT01406938|102053989|FG000|Maintenance Period|Lack of Efficacy|0|||
33591445|NCT01406938|102053990|FG001|Maintenance Period|Lack of Efficacy|0|||
33591446|NCT01406938|102053991|FG002|Maintenance Period|Lack of Efficacy|2|||
33591447|NCT01406938|102053992|FG003|Maintenance Period|Lack of Efficacy|1|||
33591448|NCT01406938|102053993|FG004|Maintenance Period|Lack of Efficacy|3|||
33591449|NCT01406938|102053994|FG005|Maintenance Period|Lack of Efficacy|5|||
33591450|NCT01406938|102053989|FG000|Follow up|Lack of Efficacy|3|||
33591451|NCT01406938|102053990|FG001|Follow up|Lack of Efficacy|2|||
33150139|NCT02544074|100463628|FG009|Overall Study|Tablet error|1|||
33591452|NCT01406938|102053991|FG002|Follow up|Lack of Efficacy|1|||
33591453|NCT01406938|102053992|FG003|Follow up|Lack of Efficacy|0|||
33591454|NCT01406938|102053993|FG004|Follow up|Lack of Efficacy|0|||
33433649|NCT02396381|101480851|FG001|Overall Study|Pregnancy|0|||
33433650|NCT02396381|101480850|FG000|Overall Study|Non-compliance with study procedures|1|||
33433651|NCT02396381|101480851|FG001|Overall Study|Non-compliance with study procedures|0|||
33591455|NCT01406938|102053994|FG005|Follow up|Lack of Efficacy|0|||
33591456|NCT01406938|102053989|FG000|Follow up|Patient/guardian decision|4|||
33591457|NCT01406938|102053990|FG001|Follow up|Patient/guardian decision|2|||
33591458|NCT01406938|102053991|FG002|Follow up|Patient/guardian decision|4|||
33591459|NCT01406938|102053992|FG003|Follow up|Patient/guardian decision|2|||
33591460|NCT01406938|102053993|FG004|Follow up|Patient/guardian decision|4|||
33591461|NCT01406938|102053994|FG005|Follow up|Patient/guardian decision|1|||
33591462|NCT01406938|102053989|FG000|Follow up|Protocol Violation|0|||
33591463|NCT01406938|102053990|FG001|Follow up|Protocol Violation|0|||
33591464|NCT01406938|102053991|FG002|Follow up|Protocol Violation|1|||
33591465|NCT01406938|102053992|FG003|Follow up|Protocol Violation|0|||
33591466|NCT01406938|102053993|FG004|Follow up|Protocol Violation|0|||
33591467|NCT01406938|102053994|FG005|Follow up|Protocol Violation|0|||
33591468|NCT01406938|102053989|FG000|Follow up|Physician Decision|0|||
33591469|NCT01406938|102053990|FG001|Follow up|Physician Decision|0|||
33591470|NCT01406938|102053991|FG002|Follow up|Physician Decision|2|||
33591471|NCT01406938|102053992|FG003|Follow up|Physician Decision|0|||
33591472|NCT01406938|102053993|FG004|Follow up|Physician Decision|3|||
33591473|NCT01406938|102053994|FG005|Follow up|Physician Decision|1|||
33591474|NCT01406938|102053989|FG000|Follow up|Lost to Follow-up|1|||
33591475|NCT01406938|102053990|FG001|Follow up|Lost to Follow-up|1|||
33591476|NCT01406938|102053991|FG002|Follow up|Lost to Follow-up|0|||
33591477|NCT01406938|102053992|FG003|Follow up|Lost to Follow-up|1|||
33591478|NCT01406938|102053993|FG004|Follow up|Lost to Follow-up|2|||
33591479|NCT01406938|102053994|FG005|Follow up|Lost to Follow-up|1|||
33591480|NCT05151445|102053995|FG000|Overall Study|Withdrawal by Subject|3|||
33591481|NCT00054327|102053997|FG000|Overall Study|Engraftment failure|1|||
33591482|NCT00054327|102053998|FG001|Overall Study|Engraftment failure|0|||
33591483|NCT00054327|102053999|FG002|Overall Study|Engraftment failure|0|||
33591484|NCT00054327|102054000|FG003|Overall Study|Engraftment failure|0|||
33591485|NCT00054327|102054001|FG004|Overall Study|Engraftment failure|0|||
33591486|NCT00054327|102054002|FG005|Overall Study|Engraftment failure|0|||
33591487|NCT01667224|102054003|FG000|Overall Study|Withdrawal by Subject|3|||
33591488|NCT01667224|102054004|FG001|Overall Study|Withdrawal by Subject|1|||
33591489|NCT01667224|102054003|FG000|Overall Study|Protocol Violation|1|||
33591490|NCT01667224|102054004|FG001|Overall Study|Protocol Violation|1|||
33591491|NCT00666588|102054005|FG000|Overall Study|ineligible|2|||
33591492|NCT00666588|102054006|FG001|Overall Study|ineligible|0|||
33591493|NCT00666588|102054007|FG002|Overall Study|ineligible|0|||
33591494|NCT00666588|102054008|FG003|Overall Study|ineligible|2|||
33591495|NCT00666588|102054005|FG000|Overall Study|inevaluable|2|||
33591496|NCT00666588|102054006|FG001|Overall Study|inevaluable|0|||
33591497|NCT00666588|102054007|FG002|Overall Study|inevaluable|0|||
33591498|NCT00666588|102054008|FG003|Overall Study|inevaluable|0|||
33591499|NCT01257568|102054011|FG000|Overall Study|Lost to Follow-up|2|||
33591500|NCT01257568|102054011|FG000|Overall Study|Withdrawal by Subject|6|||
33591501|NCT01257568|102054011|FG000|Overall Study|Terminated|1|||
33591502|NCT01257568|102054011|FG000|Overall Study|Component Revision|24|||
33591503|NCT01054560|102054012|FG000|Overall Study|Death|10|||
33591504|NCT01054560|102054013|FG001|Overall Study|Death|21|||
33591505|NCT01054560|102054012|FG000|Overall Study|Lost to Follow-up|2|||
33591506|NCT01054560|102054013|FG001|Overall Study|Lost to Follow-up|5|||
33591507|NCT01054560|102054012|FG000|Overall Study|Withdrawal by Subject|0|||
33591508|NCT01054560|102054013|FG001|Overall Study|Withdrawal by Subject|2|||
33591509|NCT01054560|102054012|FG000|Overall Study|Physician Decision|1|||
33591510|NCT01054560|102054013|FG001|Overall Study|Physician Decision|0|||
33591511|NCT01005316|102054016|FG000|Overall Study|Adverse Event|0|||
33591512|NCT01005316|102054017|FG001|Overall Study|Adverse Event|0|||
33591513|NCT01005316|102054018|FG002|Overall Study|Adverse Event|0|||
33591514|NCT01005316|102054019|FG003|Overall Study|Adverse Event|1|||
33591515|NCT01005316|102054016|FG000|Overall Study|Death|20|||
33591516|NCT01005316|102054017|FG001|Overall Study|Death|5|||
33591517|NCT01005316|102054018|FG002|Overall Study|Death|1|||
33591518|NCT01005316|102054019|FG003|Overall Study|Death|15|||
33591519|NCT01005316|102054016|FG000|Overall Study|Study Termination|5|||
33591520|NCT01005316|102054017|FG001|Overall Study|Study Termination|63|||
33150140|NCT02544074|100463629|FG010|Overall Study|Tablet error|0|||
33150141|NCT02544074|100463630|FG011|Overall Study|Tablet error|0|||
33150142|NCT02544074|100463631|FG012|Overall Study|Tablet error|0|||
33150143|NCT02544074|100463632|FG013|Overall Study|Tablet error|0|||
33150144|NCT02544074|100463633|FG014|Overall Study|Tablet error|0|||
33150145|NCT02544074|100463634|FG015|Overall Study|Tablet error|0|||
33150146|NCT02544074|100463635|FG016|Overall Study|Tablet error|0|||
33150147|NCT02544074|100463636|FG017|Overall Study|Tablet error|0|||
33150148|NCT02544074|100463637|FG018|Overall Study|Tablet error|0|||
33150149|NCT02544074|100463638|FG019|Overall Study|Tablet error|0|||
33150150|NCT02544074|100463639|FG020|Overall Study|Tablet error|0|||
33150151|NCT02294773|100463640|FG000|Overall Study|Withdrawal by Subject|0|||
33150152|NCT02294773|100463641|FG001|Overall Study|Withdrawal by Subject|2|||
33150153|NCT01439568|100463642|FG000|Overall Study|Lost to Follow-up|1|||
33150154|NCT01439568|100463643|FG001|Overall Study|Lost to Follow-up|0|||
33150155|NCT01439568|100463642|FG000|Overall Study|Withdrawal by Subject|2|||
33591521|NCT01005316|102054018|FG002|Overall Study|Study Termination|9|||
33591522|NCT01005316|102054019|FG003|Overall Study|Study Termination|85|||
33591523|NCT01005316|102054016|FG000|Overall Study|Lost to Follow-up|1|||
33591524|NCT01005316|102054017|FG001|Overall Study|Lost to Follow-up|3|||
33591525|NCT01005316|102054018|FG002|Overall Study|Lost to Follow-up|0|||
33591526|NCT01005316|102054019|FG003|Overall Study|Lost to Follow-up|2|||
33591527|NCT01005316|102054016|FG000|Overall Study|Physician Decision|6|||
33591528|NCT01005316|102054017|FG001|Overall Study|Physician Decision|0|||
33591529|NCT01005316|102054018|FG002|Overall Study|Physician Decision|0|||
33591530|NCT01005316|102054019|FG003|Overall Study|Physician Decision|0|||
33591531|NCT01005316|102054016|FG000|Overall Study|Sponsor Decision|6|||
33591532|NCT01005316|102054017|FG001|Overall Study|Sponsor Decision|3|||
33591533|NCT01005316|102054018|FG002|Overall Study|Sponsor Decision|0|||
33591534|NCT01005316|102054019|FG003|Overall Study|Sponsor Decision|0|||
33591535|NCT01005316|102054016|FG000|Overall Study|Withdrawal by Subject|1|||
33591536|NCT01005316|102054017|FG001|Overall Study|Withdrawal by Subject|1|||
33591537|NCT01005316|102054018|FG002|Overall Study|Withdrawal by Subject|0|||
33591538|NCT01005316|102054019|FG003|Overall Study|Withdrawal by Subject|2|||
33591539|NCT01005316|102054016|FG000|Overall Study|Consented to Another Study|2|||
33150156|NCT01439568|100463643|FG001|Overall Study|Withdrawal by Subject|2|||
33150157|NCT04072575|100463644|FG000|Overall Study|Physician Decision|1|||
33150158|NCT04072575|100463644|FG000|Overall Study|Adverse Event|7|||
33150159|NCT04072575|100463644|FG000|Overall Study|Withdrawal by Subject|14|||
33150160|NCT04072575|100463644|FG000|Overall Study|Other|2|||
33150161|NCT04850313|100463647|FG000|Overall Study|Withdrawal by Subject|0|||
33150162|NCT04850313|100463648|FG001|Overall Study|Withdrawal by Subject|1|||
33150163|NCT03488927|100463655|FG000|Overall Study|Withdrawal by Subject|44|||
33433652|NCT02396381|101480850|FG000|Overall Study|Moved out of town/state|1|||
33150164|NCT03488927|100463656|FG001|Overall Study|Withdrawal by Subject|118|||
33150165|NCT03488927|100463657|FG002|Overall Study|Withdrawal by Subject|217|||
33150166|NCT01347307|100463658|FG000|Overall Study|Death|0|||
33150167|NCT01347307|100463659|FG001|Overall Study|Death|4|||
33150168|NCT01347307|100463658|FG000|Overall Study|Physician Decision|0|||
33433653|NCT02396381|101480851|FG001|Overall Study|Moved out of town/state|3|||
33591540|NCT01005316|102054017|FG001|Overall Study|Consented to Another Study|0|||
33591541|NCT01005316|102054018|FG002|Overall Study|Consented to Another Study|0|||
33591542|NCT01005316|102054019|FG003|Overall Study|Consented to Another Study|0|||
33591543|NCT01005316|102054016|FG000|Overall Study|Delisted|8|||
33591544|NCT01005316|102054017|FG001|Overall Study|Delisted|0|||
33591545|NCT01005316|102054018|FG002|Overall Study|Delisted|0|||
33591546|NCT01005316|102054019|FG003|Overall Study|Delisted|0|||
33591547|NCT01005316|102054016|FG000|Overall Study|Transferred Care|1|||
33591548|NCT01005316|102054017|FG001|Overall Study|Transferred Care|0|||
33591549|NCT01005316|102054018|FG002|Overall Study|Transferred Care|1|||
33591550|NCT01005316|102054019|FG003|Overall Study|Transferred Care|3|||
33591551|NCT01005316|102054016|FG000|Overall Study|Retransplanted|0|||
33591552|NCT01005316|102054017|FG001|Overall Study|Retransplanted|1|||
33591553|NCT01005316|102054018|FG002|Overall Study|Retransplanted|0|||
33591554|NCT01005316|102054019|FG003|Overall Study|Retransplanted|0|||
33591555|NCT00336284|102054020|FG000|Overall Study|Death|52|||
33591556|NCT00336284|102054021|FG001|Overall Study|Death|26|||
33591557|NCT00336284|102054020|FG000|Overall Study|Lost to Follow-up|82|||
33591558|NCT00336284|102054021|FG001|Overall Study|Lost to Follow-up|61|||
33591559|NCT00336284|102054020|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
33591560|NCT00336284|102054021|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
33591561|NCT01942161|102054022|FG000|Overall Study|Adverse Event|1|||
33591562|NCT01942161|102054023|FG001|Overall Study|Adverse Event|2|||
33591563|NCT01942161|102054024|FG002|Overall Study|Adverse Event|5|||
33591564|NCT01942161|102054022|FG000|Overall Study|Physician Decision|3|||
33591565|NCT01942161|102054023|FG001|Overall Study|Physician Decision|1|||
33591566|NCT01942161|102054024|FG002|Overall Study|Physician Decision|0|||
33591567|NCT01942161|102054022|FG000|Overall Study|Protocol Violation|1|||
33591568|NCT01942161|102054023|FG001|Overall Study|Protocol Violation|0|||
33591569|NCT01942161|102054024|FG002|Overall Study|Protocol Violation|0|||
33591570|NCT01942161|102054022|FG000|Overall Study|Withdrawal by Subject|3|||
33591571|NCT01942161|102054023|FG001|Overall Study|Withdrawal by Subject|3|||
33591572|NCT01942161|102054024|FG002|Overall Study|Withdrawal by Subject|1|||
33591573|NCT01519791|102054029|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
33591574|NCT01519791|102054030|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
33591575|NCT01519791|102054029|FG000|Overall Study|Protocol Violation|6|||
33591576|NCT01519791|102054030|FG001|Overall Study|Protocol Violation|19|||
33591577|NCT01519791|102054029|FG000|Overall Study|Other Reason|87|||
33591578|NCT01519791|102054030|FG001|Overall Study|Other Reason|222|||
33591579|NCT01519791|102054029|FG000|Overall Study|subjects randomized in error|2|||
33591580|NCT01519791|102054030|FG001|Overall Study|subjects randomized in error|0|||
33591581|NCT01519791|102054029|FG000|Overall Study|Lack of Efficacy|16|||
33591582|NCT01519791|102054030|FG001|Overall Study|Lack of Efficacy|20|||
33591583|NCT01519791|102054029|FG000|Overall Study|SAE, non-fatal|6|||
33591584|NCT01519791|102054030|FG001|Overall Study|SAE, non-fatal|22|||
33591585|NCT01519791|102054029|FG000|Overall Study|AE, serious fatal|0|||
33591586|NCT01519791|102054030|FG001|Overall Study|AE, serious fatal|1|||
33591587|NCT01519791|102054029|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
33591588|NCT01519791|102054030|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
33591589|NCT01519791|102054029|FG000|Overall Study|AE, non-serious non-fatal|12|||
33591590|NCT01519791|102054030|FG001|Overall Study|AE, non-serious non-fatal|31|||
33591591|NCT01519791|102054029|FG000|Overall Study|Withdrawal by Subject|15|||
33591592|NCT01519791|102054030|FG001|Overall Study|Withdrawal by Subject|37|||
33591593|NCT01519791|102054029|FG000|Overall Study|Lost to Follow-up|6|||
33591594|NCT01519791|102054030|FG001|Overall Study|Lost to Follow-up|14|||
33591595|NCT02039219|102054031|FG000|Treatment|Withdrawal by Subject|1|||
33591596|NCT02039219|102054032|FG001|Treatment|Withdrawal by Subject|0|||
33591597|NCT02039219|102054031|FG000|Treatment|Adverse Event|0|||
33591598|NCT02039219|102054032|FG001|Treatment|Adverse Event|1|||
33591599|NCT02039219|102054031|FG000|Treatment|Physician Decision|1|||
33591600|NCT02039219|102054032|FG001|Treatment|Physician Decision|0|||
33591601|NCT02039219|102054031|FG000|Treatment|Lost to Follow-up|0|||
33591602|NCT02039219|102054032|FG001|Treatment|Lost to Follow-up|1|||
33591603|NCT02039219|102054031|FG000|Treatment|Protocol Violation|1|||
33591604|NCT02039219|102054032|FG001|Treatment|Protocol Violation|0|||
33591605|NCT02039219|102054031|FG000|Treatment|Death|1|||
33591606|NCT02039219|102054032|FG001|Treatment|Death|0|||
33591607|NCT02039219|102054031|FG000|Follow up|Adverse Event|0|||
33591608|NCT02039219|102054032|FG001|Follow up|Adverse Event|1|||
33591609|NCT00223808|102054034|FG000|Overall Study|<5 hrs therapy before discharge|3|||
33591610|NCT00223808|102054035|FG001|Overall Study|<5 hrs therapy before discharge|5|||
33591611|NCT00223808|102054036|FG002|Overall Study|<5 hrs therapy before discharge|5|||
33591612|NCT00283803|102054038|FG000|Overall Study|Physician Decision|9|||
33591613|NCT00283803|102054038|FG000|Overall Study|Withdrawal by Subject|4|||
33591614|NCT01089413|102054039|FG000|Overall Study|Lost to Follow-up|1|||
33591615|NCT01089413|102054039|FG000|Overall Study|Progressive Disease|93|||
33591616|NCT01089413|102054039|FG000|Overall Study|Participant Withdrew Consent|1|||
33591617|NCT01089413|102054039|FG000|Overall Study|Unacceptable Toxicity|12|||
33591618|NCT01089413|102054039|FG000|Overall Study|Death|10|||
33591619|NCT01089413|102054039|FG000|Overall Study|Metastasectomy|13|||
33591620|NCT01089413|102054039|FG000|Overall Study|Other|71|||
33384635|NCT04449276|101295841|FG007|Overall Study|Withdrawal by Subject|0|||
33384636|NCT04449276|101295834|FG000|Overall Study|Other|0|||
33384637|NCT04449276|101295835|FG001|Overall Study|Other|2|||
33384638|NCT04449276|101295836|FG002|Overall Study|Other|3|||
33384639|NCT04449276|101295837|FG003|Overall Study|Other|2|||
33384640|NCT04449276|101295838|FG004|Overall Study|Other|0|||
33384641|NCT04449276|101295839|FG005|Overall Study|Other|0|||
33150169|NCT01347307|100463659|FG001|Overall Study|Physician Decision|1|||
33150170|NCT04545554|100463660|FG000|Overall Study|Withdrawal by Subject|0|||
33150171|NCT04545554|100463661|FG001|Overall Study|Withdrawal by Subject|0|||
33150172|NCT04545554|100463662|FG002|Overall Study|Withdrawal by Subject|0|||
33384642|NCT04449276|101295840|FG006|Overall Study|Other|0|||
33384643|NCT04449276|101295841|FG007|Overall Study|Other|1|||
33384644|NCT02228564|101295842|FG000|Overall Study|Withdrawal by Subject|10|||
33384645|NCT02228564|101295842|FG000|Overall Study|Death|11|||
33384646|NCT02228564|101295842|FG000|Overall Study|Physician Decision|5|||
33384647|NCT02228564|101295842|FG000|Overall Study|Lost to Follow-up|17|||
33384648|NCT02228564|101295842|FG000|Overall Study|Other|6|||
33384649|NCT04507776|101295844|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
33384650|NCT02685995|101295849|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
33384651|NCT02685995|101295850|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
33384652|NCT03628599|101295852|FG000|Overall Study|Adverse Event|0|||
33433654|NCT02396381|101480850|FG000|Overall Study|Could not complete visit|1|||
33433655|NCT02396381|101480851|FG001|Overall Study|Could not complete visit|0|||
33150173|NCT04545554|100463663|FG003|Overall Study|Withdrawal by Subject|1|||
33384653|NCT03628599|101295853|FG001|Overall Study|Adverse Event|1|||
33384654|NCT01297309|101295854|FG000|Overall Study|Eligibility failure|2|||
33384655|NCT01297309|101295854|FG000|Overall Study|Screen failure|2|||
33384656|NCT01297309|101295854|FG000|Overall Study|Withdrawal by Subject|5|||
33384657|NCT01297309|101295854|FG000|Overall Study|Adverse Event|1|||
33433656|NCT02396381|101480850|FG000|Overall Study|Possible conflict of interest|1|||
33433657|NCT02396381|101480851|FG001|Overall Study|Possible conflict of interest|0|||
33384658|NCT01297309|101295854|FG000|Overall Study|Investigator Decision|2|||
33384659|NCT01297309|101295854|FG000|Overall Study|Death|1|||
33384660|NCT01297309|101295854|FG000|Overall Study|Participant not entering extensionperiod|1|||
33384661|NCT01797445|101295855|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
33384662|NCT01797445|101295856|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
33384663|NCT01797445|101295855|FG000|Double-Blind Phase|Adverse Event|3|||
33384664|NCT01797445|101295856|FG001|Double-Blind Phase|Adverse Event|0|||
33384665|NCT01797445|101295855|FG000|Double-Blind Phase|Death|5|||
33384666|NCT01797445|101295856|FG001|Double-Blind Phase|Death|4|||
33384667|NCT01797445|101295855|FG000|Double-Blind Phase|Pregnancy|0|||
33384668|NCT01797445|101295856|FG001|Double-Blind Phase|Pregnancy|1|||
33384669|NCT01797445|101295855|FG000|Double-Blind Phase|Lack of Efficacy|1|||
33384670|NCT01797445|101295856|FG001|Double-Blind Phase|Lack of Efficacy|2|||
33384671|NCT01797445|101295855|FG000|Double-Blind Phase|Investigator's Discretion|15|||
33384672|NCT01797445|101295856|FG001|Double-Blind Phase|Investigator's Discretion|17|||
33384673|NCT01797445|101295855|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
33384674|NCT01797445|101295856|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
33384675|NCT01797445|101295855|FG000|Double-Blind Phase|Protocol Violation|0|||
33384676|NCT01797445|101295856|FG001|Double-Blind Phase|Protocol Violation|1|||
33384677|NCT01797445|101295855|FG000|Double-Blind Phase|Withdrew Consent|20|||
33384678|NCT01797445|101295856|FG001|Double-Blind Phase|Withdrew Consent|35|||
33384679|NCT01797445|101295855|FG000|Double-Blind Phase|Lost to Follow-up|34|||
33384680|NCT01797445|101295856|FG001|Double-Blind Phase|Lost to Follow-up|26|||
33384681|NCT01797445|101295855|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
33384682|NCT01797445|101295856|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
33384683|NCT01624506|101295857|FG000|Overall Study|Lost to Follow-up|29|||
33384684|NCT01624506|101295858|FG001|Overall Study|Lost to Follow-up|15|||
33384685|NCT01624506|101295857|FG000|Overall Study|Withdrawal by Subject|9|||
33384686|NCT01624506|101295858|FG001|Overall Study|Withdrawal by Subject|2|||
33384687|NCT01624506|101295857|FG000|Overall Study|Death|1|||
33384688|NCT01624506|101295858|FG001|Overall Study|Death|0|||
33384689|NCT01624506|101295857|FG000|Overall Study|LINX explants|23|||
33384690|NCT01624506|101295858|FG001|Overall Study|LINX explants|0|||
33384691|NCT01624506|101295857|FG000|Overall Study|Adverse Event|3|||
33384692|NCT01624506|101295858|FG001|Overall Study|Adverse Event|0|||
33384693|NCT00851253|101295859|FG000|Overall Study|Disease Progression|1|||
33384694|NCT00851253|101295860|FG001|Overall Study|Disease Progression|0|||
33384695|NCT02758613|101295861|FG000|Treatment|Physician and Sponsor Decision|1|||
33384696|NCT02758613|101295862|FG001|Treatment|Physician and Sponsor Decision|0|||
33384697|NCT02758613|101295863|FG002|Treatment|Physician and Sponsor Decision|0|||
33384698|NCT02758613|101295864|FG003|Treatment|Physician and Sponsor Decision|0|||
33384699|NCT02758613|101295861|FG000|Treatment|Withdrawal by Subject|1|||
33384700|NCT02758613|101295862|FG001|Treatment|Withdrawal by Subject|0|||
33384701|NCT02758613|101295863|FG002|Treatment|Withdrawal by Subject|1|||
33384702|NCT02758613|101295864|FG003|Treatment|Withdrawal by Subject|0|||
33384703|NCT02678312|101295865|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
33384704|NCT02678312|101295866|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
33384705|NCT02678312|101295867|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
33384706|NCT02678312|101295868|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
33384707|NCT02678312|101295869|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
33384708|NCT02678312|101295865|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
33384709|NCT02678312|101295866|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
33384710|NCT02678312|101295867|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
33384711|NCT02678312|101295868|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
33384712|NCT02678312|101295869|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
33384713|NCT02678312|101295865|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
33384714|NCT02678312|101295866|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
33384715|NCT02678312|101295867|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
33384716|NCT02678312|101295868|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
33384717|NCT02678312|101295869|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
33384718|NCT02678312|101295865|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
33384719|NCT02678312|101295866|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
33384720|NCT02678312|101295867|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
33384721|NCT02678312|101295868|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
33433658|NCT02396381|101480850|FG000|Overall Study|Randomization/Screening Error|3|||
33433659|NCT02396381|101480851|FG001|Overall Study|Randomization/Screening Error|1|||
33384722|NCT02678312|101295869|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
33384723|NCT02678312|101295865|FG000|Part 2 Double Blind Epoch|Death|0|||
33384724|NCT02678312|101295866|FG001|Part 2 Double Blind Epoch|Death|0|||
33384725|NCT02678312|101295867|FG002|Part 2 Double Blind Epoch|Death|0|||
33384726|NCT02678312|101295868|FG003|Part 2 Double Blind Epoch|Death|8|||
33384727|NCT02678312|101295869|FG004|Part 2 Double Blind Epoch|Death|12|||
33591621|NCT01801436|102054040|FG000|Overall Study|Withdrawal by Subject|3|||
33591622|NCT01801436|102054040|FG000|Overall Study|Adverse Event|2|||
33591623|NCT01801436|102054040|FG000|Overall Study|Progressive disease|4|||
33591624|NCT03403361|102054041|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
33591625|NCT00098748|102054042|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
33591626|NCT00098748|102054043|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
33591627|NCT00098748|102054044|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
33591628|NCT00098748|102054042|FG000|Received Study Treatment|Death|2|||
33591629|NCT00098748|102054043|FG001|Received Study Treatment|Death|1|||
33591630|NCT00098748|102054044|FG002|Received Study Treatment|Death|2|||
33591631|NCT00098748|102054042|FG000|Received Study Treatment|Adverse Event|1|||
33591632|NCT00098748|102054043|FG001|Received Study Treatment|Adverse Event|2|||
33591633|NCT00098748|102054044|FG002|Received Study Treatment|Adverse Event|5|||
33591634|NCT00098748|102054042|FG000|Received Study Treatment|Lack of Efficacy|40|||
33591635|NCT00098748|102054043|FG001|Received Study Treatment|Lack of Efficacy|27|||
33591636|NCT00098748|102054044|FG002|Received Study Treatment|Lack of Efficacy|27|||
33591637|NCT00098748|102054042|FG000|Received Study Treatment|Other|2|||
33591638|NCT00098748|102054043|FG001|Received Study Treatment|Other|2|||
33591639|NCT00098748|102054044|FG002|Received Study Treatment|Other|6|||
33591640|NCT00098748|102054042|FG000|Received Study Treatment|Subject defaulted|3|||
33591641|NCT00098748|102054043|FG001|Received Study Treatment|Subject defaulted|4|||
33591642|NCT00098748|102054044|FG002|Received Study Treatment|Subject defaulted|4|||
33591643|NCT00098748|102054042|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
33591644|NCT00098748|102054043|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
33591645|NCT00098748|102054044|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
33591646|NCT00098748|102054042|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
33591647|NCT00098748|102054043|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
33591648|NCT00098748|102054044|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
33591649|NCT00098748|102054042|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
33591650|NCT00098748|102054043|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
33591651|NCT00098748|102054044|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
33591652|NCT00098748|102054042|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
33591653|NCT00098748|102054043|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
33591654|NCT00098748|102054044|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
33591655|NCT00098748|102054042|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
33591656|NCT00098748|102054043|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
33591657|NCT00098748|102054044|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
33591658|NCT00441142|102054045|FG000|Overall Study|Adverse Event|2|||
33591659|NCT00441142|102054046|FG001|Overall Study|Adverse Event|3|||
33591660|NCT00441142|102054047|FG002|Overall Study|Adverse Event|3|||
33591661|NCT00441142|102054048|FG003|Overall Study|Adverse Event|22|||
33591662|NCT00441142|102054045|FG000|Overall Study|Lack of Efficacy|3|||
33591663|NCT00441142|102054046|FG001|Overall Study|Lack of Efficacy|3|||
33591664|NCT00441142|102054047|FG002|Overall Study|Lack of Efficacy|17|||
33591665|NCT00441142|102054048|FG003|Overall Study|Lack of Efficacy|32|||
33591666|NCT00441142|102054045|FG000|Overall Study|Withdrawal by Subject|0|||
33591667|NCT00441142|102054046|FG001|Overall Study|Withdrawal by Subject|0|||
33591668|NCT00441142|102054047|FG002|Overall Study|Withdrawal by Subject|2|||
33591669|NCT00441142|102054048|FG003|Overall Study|Withdrawal by Subject|10|||
33591670|NCT00441142|102054045|FG000|Overall Study|Patient still receiving active study tx|1|||
33591671|NCT00441142|102054046|FG001|Overall Study|Patient still receiving active study tx|0|||
33591672|NCT00441142|102054047|FG002|Overall Study|Patient still receiving active study tx|0|||
33591673|NCT00441142|102054048|FG003|Overall Study|Patient still receiving active study tx|2|||
33591674|NCT00441142|102054045|FG000|Overall Study|Physician Decision|0|||
33591675|NCT00441142|102054046|FG001|Overall Study|Physician Decision|1|||
33591676|NCT00441142|102054047|FG002|Overall Study|Physician Decision|0|||
33591677|NCT00441142|102054048|FG003|Overall Study|Physician Decision|1|||
33591678|NCT00441142|102054045|FG000|Overall Study|Death|0|||
33591679|NCT00441142|102054046|FG001|Overall Study|Death|0|||
33591680|NCT00441142|102054047|FG002|Overall Study|Death|0|||
33591681|NCT00441142|102054048|FG003|Overall Study|Death|1|||
33591682|NCT04848220|102054059|FG000|Overall Study|Unable to proceed to study procedure|0|||
33591683|NCT04848220|102054060|FG001|Overall Study|Unable to proceed to study procedure|1|||
33591684|NCT04848220|102054061|FG002|Overall Study|Unable to proceed to study procedure|0|||
33591685|NCT04848220|102054059|FG000|Overall Study|Fractional flow not significant|0|||
33591686|NCT04848220|102054060|FG001|Overall Study|Fractional flow not significant|1|||
33591687|NCT04848220|102054061|FG002|Overall Study|Fractional flow not significant|0|||
33591688|NCT02141633|102054064|FG000|Overall Study|Physician Decision|1|||
33591689|NCT02141633|102054065|FG001|Overall Study|Physician Decision|0|||
33591690|NCT00960011|102054068|FG000|Overall Study|Death|5|||
33591691|NCT00960011|102054069|FG001|Overall Study|Death|0|||
33591692|NCT00960011|102054068|FG000|Overall Study|Lost to Follow-up|6|||
33591693|NCT00960011|102054069|FG001|Overall Study|Lost to Follow-up|2|||
33433660|NCT00586521|101480854|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
33433661|NCT00721409|101480855|FG000|Overall Study|Global deterioration of health status|2|||
33433662|NCT00721409|101480856|FG001|Overall Study|Global deterioration of health status|6|||
33433663|NCT00721409|101480857|FG002|Overall Study|Global deterioration of health status|3|||
33433664|NCT00721409|101480855|FG000|Overall Study|Death|0|||
33433665|NCT00721409|101480856|FG001|Overall Study|Death|1|||
33433666|NCT00721409|101480857|FG002|Overall Study|Death|0|||
33433667|NCT00721409|101480855|FG000|Overall Study|Randomized not Treated|0|||
33433668|NCT00721409|101480856|FG001|Overall Study|Randomized not Treated|1|||
33591694|NCT00978380|102054070|FG000|Overall Study|Protocol Violation|2|||
33433669|NCT00721409|101480857|FG002|Overall Study|Randomized not Treated|4|||
33433670|NCT00721409|101480855|FG000|Overall Study|Reason not specified|1|||
33591695|NCT00978380|102054070|FG000|Overall Study|Withdrawal criteria|9|||
33591696|NCT00978380|102054070|FG000|Overall Study|Unclassified|8|||
33591697|NCT04049266|102054071|FG000|Overall Study|Adverse Event|16|||
33591698|NCT04049266|102054072|FG001|Overall Study|Adverse Event|9|||
33591699|NCT04049266|102054071|FG000|Overall Study|Non-compliance with study drug|0|||
33591700|NCT04049266|102054072|FG001|Overall Study|Non-compliance with study drug|3|||
33591701|NCT04049266|102054071|FG000|Overall Study|Withdrawal by Subject|6|||
33591702|NCT04049266|102054072|FG001|Overall Study|Withdrawal by Subject|10|||
33591703|NCT04049266|102054071|FG000|Overall Study|Lost to Follow-up|2|||
33591704|NCT04049266|102054072|FG001|Overall Study|Lost to Follow-up|2|||
33591705|NCT04049266|102054071|FG000|Overall Study|Progressive disease|11|||
33591706|NCT04049266|102054072|FG001|Overall Study|Progressive disease|2|||
33591707|NCT04049266|102054071|FG000|Overall Study|Physician Decision|1|||
33591708|NCT04049266|102054072|FG001|Overall Study|Physician Decision|0|||
33591709|NCT04049266|102054071|FG000|Overall Study|Patient moved out of state|1|||
33591710|NCT04049266|102054072|FG001|Overall Study|Patient moved out of state|0|||
33591711|NCT02954406|102054073|FG000|Overall Study|Adverse Event|0|||
33591712|NCT02954406|102054074|FG001|Overall Study|Adverse Event|1|||
33433671|NCT00721409|101480856|FG001|Overall Study|Reason not specified|0|||
33433672|NCT00721409|101480857|FG002|Overall Study|Reason not specified|2|||
33591713|NCT02954406|102054075|FG002|Overall Study|Adverse Event|0|||
33591714|NCT02954406|102054076|FG003|Overall Study|Adverse Event|0|||
33591715|NCT02954406|102054077|FG004|Overall Study|Adverse Event|1|||
33591716|NCT02954406|102054078|FG005|Overall Study|Adverse Event|0|||
33591717|NCT02954406|102054079|FG006|Overall Study|Adverse Event|0|||
33150174|NCT04545554|100463664|FG004|Overall Study|Withdrawal by Subject|0|||
33433673|NCT00721409|101480855|FG000|Overall Study|Adverse Event|0|||
33150175|NCT04545554|100463665|FG005|Overall Study|Withdrawal by Subject|0|||
33433674|NCT00721409|101480856|FG001|Overall Study|Adverse Event|13|||
33433675|NCT00721409|101480857|FG002|Overall Study|Adverse Event|2|||
33433676|NCT00721409|101480855|FG000|Overall Study|Lost to Follow-up|0|||
33433677|NCT00721409|101480856|FG001|Overall Study|Lost to Follow-up|0|||
33433678|NCT00721409|101480857|FG002|Overall Study|Lost to Follow-up|1|||
33433679|NCT00721409|101480855|FG000|Overall Study|Withdrawal by Subject|1|||
33433680|NCT00721409|101480856|FG001|Overall Study|Withdrawal by Subject|6|||
33433681|NCT00721409|101480857|FG002|Overall Study|Withdrawal by Subject|5|||
33433682|NCT00721409|101480855|FG000|Overall Study|Objective progression or relapse|8|||
33433683|NCT00721409|101480856|FG001|Overall Study|Objective progression or relapse|55|||
33433684|NCT00721409|101480857|FG002|Overall Study|Objective progression or relapse|62|||
33433685|NCT00125359|101480858|FG000|Overall Study|Death|4|||
33433686|NCT00125359|101480858|FG000|Overall Study|Adverse Event|5|||
33433687|NCT00125359|101480858|FG000|Overall Study|Physician Decision|14|||
33433688|NCT03361423|101480868|FG000|Overall Study|Withdrawal by Subject|4|||
33433689|NCT03361423|101480869|FG001|Overall Study|Withdrawal by Subject|3|||
33433690|NCT03361423|101480868|FG000|Overall Study|Did not treat|19|||
33433691|NCT03361423|101480869|FG001|Overall Study|Did not treat|18|||
33433692|NCT03361423|101480868|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
33433693|NCT03361423|101480869|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
33433694|NCT03361423|101480868|FG000|Overall Study|Missing data|4|||
33433695|NCT03361423|101480869|FG001|Overall Study|Missing data|1|||
33433696|NCT00198029|101480870|FG000|Overall Study|Withdrawal by Subject|4|||
33433697|NCT02315898|101480871|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
33433698|NCT02315898|101480872|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
33433699|NCT02315898|101480873|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
33433700|NCT02315898|101480874|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
33433701|NCT04480463|101480875|FG000|Overall Study|Death|0|||
33433702|NCT04480463|101480876|FG001|Overall Study|Death|1|||
33433703|NCT04480463|101480875|FG000|Overall Study|Adverse Event|6|||
33433704|NCT04480463|101480876|FG001|Overall Study|Adverse Event|8|||
33433705|NCT04480463|101480875|FG000|Overall Study|Lost to Follow-up|3|||
33433706|NCT04480463|101480876|FG001|Overall Study|Lost to Follow-up|2|||
33433707|NCT04480463|101480875|FG000|Overall Study|Physician Decision|2|||
33433708|NCT04480463|101480876|FG001|Overall Study|Physician Decision|5|||
33433709|NCT04480463|101480875|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
33433710|NCT04480463|101480876|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
33433711|NCT04480463|101480875|FG000|Overall Study|Protocol Violation|2|||
33433712|NCT04480463|101480876|FG001|Overall Study|Protocol Violation|1|||
33433713|NCT04480463|101480875|FG000|Overall Study|Withdrawal by Subject|6|||
33433714|NCT04480463|101480876|FG001|Overall Study|Withdrawal by Subject|7|||
33433715|NCT04480463|101480875|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
33433716|NCT04480463|101480876|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
33433717|NCT04480463|101480875|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
33433718|NCT04480463|101480876|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
33433719|NCT04480463|101480875|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
33433720|NCT04480463|101480876|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
33433721|NCT04480463|101480875|FG000|Overall Study|Other|6|||
33433722|NCT04480463|101480876|FG001|Overall Study|Other|4|||
33433723|NCT02579096|101480877|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
33433724|NCT02579096|101480878|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
33433725|NCT02579096|101480877|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
33433726|NCT02579096|101480878|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
33433727|NCT02579096|101480877|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
33433728|NCT02579096|101480878|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
33433729|NCT02579096|101480877|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
33433730|NCT02579096|101480878|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
33433731|NCT02579096|101480877|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
33433732|NCT02579096|101480878|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
33433733|NCT02579096|101480877|FG000|Phase 2, Weeks 25 - 48|Death|2|||
33433734|NCT02579096|101480878|FG001|Phase 2, Weeks 25 - 48|Death|4|||
33433735|NCT02579096|101480877|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
33433736|NCT02579096|101480878|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
33591718|NCT02954406|102054080|FG007|Overall Study|Adverse Event|0|||
33591719|NCT02954406|102054081|FG008|Overall Study|Adverse Event|1|||
33591720|NCT02954406|102054082|FG009|Overall Study|Adverse Event|1|||
33433737|NCT02579096|101480877|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
33433738|NCT02579096|101480878|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
33433739|NCT02579096|101480877|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
33591721|NCT02954406|102054083|FG010|Overall Study|Adverse Event|0|||
33433740|NCT02579096|101480878|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
33433741|NCT02579096|101480877|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
33433742|NCT02579096|101480878|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
33433743|NCT02579096|101480877|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
33433744|NCT02579096|101480878|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
33433745|NCT02579096|101480877|FG000|Phase 3, Weeks 49 - 72|Death|3|||
33433746|NCT02579096|101480878|FG001|Phase 3, Weeks 49 - 72|Death|2|||
33433747|NCT02579096|101480877|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
33433748|NCT02579096|101480878|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
33433749|NCT02579096|101480877|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
33433750|NCT02579096|101480878|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
33433751|NCT02579096|101480877|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
33433752|NCT02579096|101480878|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
33150176|NCT01241240|100463666|FG000|Overall Study|Adverse Event|5|||
33150177|NCT01241240|100463667|FG001|Overall Study|Adverse Event|4|||
33384728|NCT02678312|101295865|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
33433753|NCT02579096|101480877|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
33433754|NCT02579096|101480878|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
33150178|NCT01241240|100463666|FG000|Overall Study|Lost to Follow-up|2|||
33433755|NCT02579096|101480877|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
33150179|NCT01241240|100463667|FG001|Overall Study|Lost to Follow-up|4|||
33150180|NCT01241240|100463666|FG000|Overall Study|Personal Reasons|1|||
33150181|NCT01241240|100463667|FG001|Overall Study|Personal Reasons|1|||
33150182|NCT01646073|100463668|FG000|Period A (12 Weeks)|Adverse Event|0|||
33150183|NCT01646073|100463669|FG001|Period A (12 Weeks)|Adverse Event|2|||
33591722|NCT02954406|102054073|FG000|Overall Study|Progressive Disease|3|||
33591723|NCT02954406|102054074|FG001|Overall Study|Progressive Disease|4|||
33591724|NCT02954406|102054075|FG002|Overall Study|Progressive Disease|3|||
33591725|NCT02954406|102054076|FG003|Overall Study|Progressive Disease|4|||
33591726|NCT02954406|102054077|FG004|Overall Study|Progressive Disease|3|||
33591727|NCT02954406|102054078|FG005|Overall Study|Progressive Disease|3|||
33591728|NCT02954406|102054079|FG006|Overall Study|Progressive Disease|2|||
33591729|NCT02954406|102054080|FG007|Overall Study|Progressive Disease|2|||
33591730|NCT02954406|102054081|FG008|Overall Study|Progressive Disease|1|||
33591731|NCT02954406|102054082|FG009|Overall Study|Progressive Disease|1|||
33591732|NCT02954406|102054083|FG010|Overall Study|Progressive Disease|0|||
33591733|NCT02954406|102054073|FG000|Overall Study|Symptomatic Deterioration|0|||
33591734|NCT02954406|102054074|FG001|Overall Study|Symptomatic Deterioration|1|||
33591735|NCT02954406|102054075|FG002|Overall Study|Symptomatic Deterioration|0|||
33591736|NCT02954406|102054076|FG003|Overall Study|Symptomatic Deterioration|0|||
33591737|NCT02954406|102054077|FG004|Overall Study|Symptomatic Deterioration|0|||
33591738|NCT02954406|102054078|FG005|Overall Study|Symptomatic Deterioration|0|||
33591739|NCT02954406|102054079|FG006|Overall Study|Symptomatic Deterioration|0|||
33591740|NCT02954406|102054080|FG007|Overall Study|Symptomatic Deterioration|0|||
33591741|NCT02954406|102054081|FG008|Overall Study|Symptomatic Deterioration|0|||
33591742|NCT02954406|102054082|FG009|Overall Study|Symptomatic Deterioration|0|||
33591743|NCT02954406|102054083|FG010|Overall Study|Symptomatic Deterioration|0|||
33591744|NCT02954406|102054073|FG000|Overall Study|Death|0|||
33591745|NCT02954406|102054074|FG001|Overall Study|Death|0|||
33591746|NCT02954406|102054075|FG002|Overall Study|Death|0|||
33591747|NCT02954406|102054076|FG003|Overall Study|Death|0|||
33591748|NCT02954406|102054077|FG004|Overall Study|Death|1|||
33591749|NCT02954406|102054078|FG005|Overall Study|Death|0|||
33591750|NCT02954406|102054079|FG006|Overall Study|Death|0|||
33591751|NCT02954406|102054080|FG007|Overall Study|Death|0|||
33591752|NCT02954406|102054081|FG008|Overall Study|Death|1|||
33591753|NCT02954406|102054082|FG009|Overall Study|Death|1|||
33591754|NCT02954406|102054083|FG010|Overall Study|Death|0|||
33591755|NCT02954406|102054073|FG000|Overall Study|Reason Not Specified|0|||
33591756|NCT02954406|102054074|FG001|Overall Study|Reason Not Specified|0|||
33591757|NCT02954406|102054075|FG002|Overall Study|Reason Not Specified|3|||
33591758|NCT02954406|102054076|FG003|Overall Study|Reason Not Specified|2|||
33591759|NCT02954406|102054077|FG004|Overall Study|Reason Not Specified|2|||
33591760|NCT02954406|102054078|FG005|Overall Study|Reason Not Specified|0|||
33591761|NCT02954406|102054079|FG006|Overall Study|Reason Not Specified|1|||
33591762|NCT02954406|102054080|FG007|Overall Study|Reason Not Specified|0|||
33591763|NCT02954406|102054081|FG008|Overall Study|Reason Not Specified|1|||
33591764|NCT02954406|102054082|FG009|Overall Study|Reason Not Specified|0|||
33591765|NCT02954406|102054083|FG010|Overall Study|Reason Not Specified|0|||
33591766|NCT03350256|102054084|FG000|Overall Study|Inclusion/exclusion violation|4|||
33150184|NCT01646073|100463668|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
33591767|NCT03350256|102054084|FG000|Overall Study|Recommended for other therapies|2|||
33591768|NCT03350256|102054084|FG000|Overall Study|Protocol Violation|3|||
33591769|NCT03350256|102054084|FG000|Overall Study|Non compliance|2|||
33591770|NCT03350256|102054084|FG000|Overall Study|Denial by insurance|1|||
33591771|NCT03350256|102054084|FG000|Overall Study|Adverse Event|2|||
33591772|NCT03350256|102054084|FG000|Overall Study|Trial failure|12|||
33433756|NCT02579096|101480878|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
33433757|NCT02579096|101480877|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
33433758|NCT02579096|101480878|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
33384729|NCT02678312|101295866|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
33384730|NCT02678312|101295867|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
33433759|NCT01946165|101480880|FG000|Overall Study|Physician Decision|2|||
33433760|NCT01946165|101480881|FG001|Overall Study|Physician Decision|0|||
33433761|NCT01946165|101480880|FG000|Overall Study|Withdrawal by Subject|0|||
33433762|NCT01946165|101480881|FG001|Overall Study|Withdrawal by Subject|2|||
33433763|NCT01922349|101480882|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
33433764|NCT01922349|101480883|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
33433765|NCT01922349|101480884|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
33433766|NCT01922349|101480885|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
33433767|NCT00368966|101480886|FG000|Infant Series|Withdrawal by Subject|11|||
33433768|NCT00368966|101480887|FG001|Infant Series|Withdrawal by Subject|6|||
33433769|NCT00368966|101480886|FG000|Infant Series|Protocol Violation|2|||
33384731|NCT02678312|101295868|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
33384732|NCT02678312|101295869|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
33384733|NCT02678312|101295865|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
33384734|NCT02678312|101295866|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
33384735|NCT02678312|101295867|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
33384736|NCT02678312|101295868|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
33384737|NCT02678312|101295869|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
33384738|NCT02678312|101295865|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
33384739|NCT02678312|101295866|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
33384740|NCT02678312|101295867|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
33384741|NCT02678312|101295868|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
33384742|NCT02678312|101295869|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
33384743|NCT01250756|101295872|FG000|Infant Series|Withdrawal by Subject|4|||
33384744|NCT01250756|101295873|FG001|Infant Series|Withdrawal by Subject|5|||
33384745|NCT01250756|101295872|FG000|Infant Series|Randomized, Not Vaccinated|2|||
33384746|NCT01250756|101295873|FG001|Infant Series|Randomized, Not Vaccinated|2|||
33384747|NCT01250756|101295872|FG000|Infant Series|Other|22|||
33384748|NCT01250756|101295873|FG001|Infant Series|Other|0|||
33384749|NCT01250756|101295872|FG000|After Infant Series|Adverse Event|5|||
33384750|NCT01250756|101295873|FG001|After Infant Series|Adverse Event|2|||
33384751|NCT01250756|101295872|FG000|After Infant Series|Withdrawal by Subject|4|||
33384752|NCT01250756|101295873|FG001|After Infant Series|Withdrawal by Subject|1|||
33384753|NCT01250756|101295872|FG000|After Infant Series|Other|2|||
33384754|NCT01250756|101295873|FG001|After Infant Series|Other|1|||
33384755|NCT01250756|101295872|FG000|Toddler Dose|Adverse Event|0|||
33384756|NCT01250756|101295873|FG001|Toddler Dose|Adverse Event|1|||
33384757|NCT01250756|101295872|FG000|After Toddler Dose|Adverse Event|0|||
33384758|NCT01250756|101295873|FG001|After Toddler Dose|Adverse Event|1|||
33384759|NCT03097614|101295874|FG000|Overall Study|Adverse Event|3|||
33384760|NCT00345540|101295876|FG000|Overall Study|Withdrawal by Subject|1|||
33384761|NCT02022033|101295877|FG000|Overall Study|Physician Decision|1|||
33384762|NCT00425113|101295880|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
33384763|NCT00425113|101295881|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
33384764|NCT00425113|101295880|FG000|Overall Study|diagnosis of abdominal TB|0|||
33384765|NCT00425113|101295881|FG001|Overall Study|diagnosis of abdominal TB|1|||
33384766|NCT00425113|101295880|FG000|Overall Study|missing study drug more than 14 days|0|||
33384767|NCT00425113|101295881|FG001|Overall Study|missing study drug more than 14 days|1|||
33384768|NCT00425113|101295880|FG000|Overall Study|Withdrawal by Subject|1|||
33384769|NCT00425113|101295881|FG001|Overall Study|Withdrawal by Subject|0|||
33384770|NCT04397796|101295882|FG000|Overall Study|Death|3|||
33384771|NCT04397796|101295883|FG001|Overall Study|Death|1|||
33384772|NCT03057951|101295885|FG000|Overall Study|Adverse Event|553|||
33384773|NCT03057951|101295886|FG001|Overall Study|Adverse Event|575|||
33384774|NCT03057951|101295885|FG000|Overall Study|Protocol Violation|30|||
33384775|NCT03057951|101295886|FG001|Overall Study|Protocol Violation|24|||
33433770|NCT00368966|101480887|FG001|Infant Series|Protocol Violation|1|||
33433771|NCT00368966|101480886|FG000|Infant Series|Lost to Follow-up|2|||
33384776|NCT03057951|101295885|FG000|Overall Study|Lost to Follow-up|6|||
33384777|NCT03057951|101295886|FG001|Overall Study|Lost to Follow-up|16|||
33150185|NCT01646073|100463669|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
33384778|NCT03057951|101295885|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
33433772|NCT00368966|101480887|FG001|Infant Series|Lost to Follow-up|0|||
33384779|NCT03057951|101295886|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
33384780|NCT03057951|101295885|FG000|Overall Study|Study drug stopped, reason missing|6|||
33384781|NCT03057951|101295886|FG001|Overall Study|Study drug stopped, reason missing|1|||
33433773|NCT00368966|101480886|FG000|Infant Series|Randomization error|0|||
33591773|NCT03350256|102054084|FG000|Overall Study|Did not proceed to permanent implant|3|||
33591774|NCT03350256|102054084|FG000|Overall Study|Withdrawal by Subject|3|||
33591775|NCT03350256|102054084|FG000|Overall Study|Subject moving out of state|1|||
33591776|NCT03350256|102054084|FG000|Overall Study|Lost to Follow-up|1|||
33591777|NCT03350256|102054084|FG000|Overall Study|Lack of Efficacy|2|||
33591778|NCT00730041|102054085|FG000|Overall Study|Lost to Follow-up|0|||
33591779|NCT00730041|102054086|FG001|Overall Study|Lost to Follow-up|2|||
33591780|NCT00244933|102054087|FG000|Overall Study|Not response evaluable|2|||
33591781|NCT02403817|102054088|FG000|Overall Study|Withdrawal by Subject|5|||
33591782|NCT02403817|102054089|FG001|Overall Study|Withdrawal by Subject|0|||
33591783|NCT01457014|102054090|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
33591784|NCT01457014|102054091|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
33591785|NCT01457014|102054092|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
33591786|NCT01457014|102054093|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
33591787|NCT01457014|102054090|FG000|First Night|Withdrawal by Subject|3|||
33591788|NCT01457014|102054091|FG001|First Night|Withdrawal by Subject|0|||
33591789|NCT01457014|102054092|FG002|First Night|Withdrawal by Subject|0|||
33591790|NCT01457014|102054093|FG003|First Night|Withdrawal by Subject|0|||
33591791|NCT01471028|102054100|FG000|VTI-208|Adverse Event|39|||
33150186|NCT01646073|100463668|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
33150187|NCT01646073|100463669|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
33150188|NCT01646073|100463668|FG000|Period A (12 Weeks)|Protocol Violation|0|||
33591792|NCT01471028|102054101|FG001|VTI-208|Adverse Event|41|||
33591793|NCT01471028|102054100|FG000|VTI-208|Withdrawal by Subject|0|||
33591794|NCT01471028|102054101|FG001|VTI-208|Withdrawal by Subject|2|||
33591795|NCT01471028|102054100|FG000|VTI-208|Lost to Follow-up|1|||
33591796|NCT01471028|102054101|FG001|VTI-208|Lost to Follow-up|1|||
33591797|NCT01471028|102054100|FG000|VTI-208E|Death|7|||
33591798|NCT01471028|102054101|FG001|VTI-208E|Death|10|||
33591799|NCT01471028|102054100|FG000|VTI-208E|Withdrawal by Subject|1|||
33591800|NCT01471028|102054101|FG001|VTI-208E|Withdrawal by Subject|0|||
33591801|NCT01471028|102054100|FG000|VTI-208E|Lost to Follow-up|0|||
33591802|NCT01471028|102054101|FG001|VTI-208E|Lost to Follow-up|2|||
33591803|NCT04659174|102054104|FG000|Overall Study|Sponsor decision to discontinue study|0|||
33591804|NCT04659174|102054105|FG001|Overall Study|Sponsor decision to discontinue study|2|||
33591805|NCT04659174|102054104|FG000|Overall Study|Lost to Follow-up|9|||
33591806|NCT04659174|102054105|FG001|Overall Study|Lost to Follow-up|11|||
33591807|NCT04659174|102054104|FG000|Overall Study|Adverse Event|8|||
33591808|NCT04659174|102054105|FG001|Overall Study|Adverse Event|5|||
33591809|NCT04659174|102054104|FG000|Overall Study|Withdrawal by Subject|17|||
33591810|NCT04659174|102054105|FG001|Overall Study|Withdrawal by Subject|33|||
33591811|NCT04659174|102054104|FG000|Overall Study|Progressive disease|0|||
33591812|NCT04659174|102054105|FG001|Overall Study|Progressive disease|2|||
33591813|NCT04659174|102054104|FG000|Overall Study|Other reasons|0|||
33591814|NCT04659174|102054105|FG001|Overall Study|Other reasons|2|||
33591815|NCT04659174|102054104|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
33591816|NCT04659174|102054105|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
33591817|NCT04659174|102054104|FG000|Overall Study|Alcohol or illegal drug use|0|||
33591818|NCT04659174|102054105|FG001|Overall Study|Alcohol or illegal drug use|3|||
33591819|NCT04659174|102054104|FG000|Overall Study|Violation of entry criteria|1|||
33591820|NCT04659174|102054105|FG001|Overall Study|Violation of entry criteria|0|||
33591821|NCT04659174|102054104|FG000|Overall Study|Death|0|||
33591822|NCT04659174|102054105|FG001|Overall Study|Death|1|||
33591823|NCT01795495|102054106|FG000|Overall Study|Protocol Violation|1|||
33591824|NCT01795495|102054107|FG001|Overall Study|Protocol Violation|0|||
33591825|NCT01795495|102054108|FG002|Overall Study|Protocol Violation|1|||
33591826|NCT01795495|102054106|FG000|Overall Study|Physician Decision|0|||
33591827|NCT01795495|102054107|FG001|Overall Study|Physician Decision|0|||
33591828|NCT01795495|102054108|FG002|Overall Study|Physician Decision|1|||
33591829|NCT01549886|102054111|FG000|Overall Study|Sponsor's decision|2|||
33591830|NCT01549886|102054112|FG001|Overall Study|Sponsor's decision|3|||
33591831|NCT00733291|102054114|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
33591832|NCT00733291|102054115|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
33591833|NCT00733291|102054116|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
33591834|NCT00733291|102054117|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
33591835|NCT01352221|102054118|FG000|Double-blind Phase|Adverse Event|6|||
33591836|NCT01352221|102054119|FG001|Double-blind Phase|Adverse Event|4|||
33591837|NCT01352221|102054120|FG002|Double-blind Phase|Adverse Event|0|||
33591838|NCT01352221|102054121|FG003|Double-blind Phase|Adverse Event|0|||
33591839|NCT01352221|102054118|FG000|Double-blind Phase|Withdrawal by Subject|3|||
33591840|NCT01352221|102054119|FG001|Double-blind Phase|Withdrawal by Subject|5|||
33591841|NCT01352221|102054120|FG002|Double-blind Phase|Withdrawal by Subject|0|||
33591842|NCT01352221|102054121|FG003|Double-blind Phase|Withdrawal by Subject|0|||
33591843|NCT01352221|102054118|FG000|Double-blind Phase|Lost to Follow-up|0|||
33591844|NCT01352221|102054119|FG001|Double-blind Phase|Lost to Follow-up|1|||
33591845|NCT01352221|102054120|FG002|Double-blind Phase|Lost to Follow-up|0|||
33591846|NCT01352221|102054121|FG003|Double-blind Phase|Lost to Follow-up|0|||
33591847|NCT01352221|102054118|FG000|Double-blind Phase|Protocol Violation|0|||
33591848|NCT01352221|102054119|FG001|Double-blind Phase|Protocol Violation|1|||
33591849|NCT01352221|102054120|FG002|Double-blind Phase|Protocol Violation|0|||
33591850|NCT01352221|102054121|FG003|Double-blind Phase|Protocol Violation|0|||
33591851|NCT01352221|102054118|FG000|Open-label Phase|Physician Decision|0|||
33591852|NCT01352221|102054119|FG001|Open-label Phase|Physician Decision|0|||
33591853|NCT01352221|102054120|FG002|Open-label Phase|Physician Decision|2|||
33433774|NCT00368966|101480887|FG001|Infant Series|Randomization error|1|||
33433775|NCT00368966|101480886|FG000|Infant Series|Failed to meet eligibility criteria|0|||
33433776|NCT00368966|101480887|FG001|Infant Series|Failed to meet eligibility criteria|1|||
33433777|NCT00368966|101480886|FG000|Infant Series|Adverse Event|0|||
33591854|NCT01352221|102054121|FG003|Open-label Phase|Physician Decision|1|||
33591855|NCT01352221|102054118|FG000|Open-label Phase|Pregnancy|0|||
33591856|NCT01352221|102054119|FG001|Open-label Phase|Pregnancy|0|||
33591857|NCT01352221|102054120|FG002|Open-label Phase|Pregnancy|1|||
33591858|NCT01352221|102054121|FG003|Open-label Phase|Pregnancy|0|||
33591859|NCT01352221|102054118|FG000|Open-label Phase|Adverse Event|0|||
33591860|NCT01352221|102054119|FG001|Open-label Phase|Adverse Event|0|||
33591861|NCT01352221|102054120|FG002|Open-label Phase|Adverse Event|8|||
33591862|NCT01352221|102054121|FG003|Open-label Phase|Adverse Event|4|||
33591863|NCT01352221|102054118|FG000|Open-label Phase|Withdrawal by Subject|0|||
33591864|NCT01352221|102054119|FG001|Open-label Phase|Withdrawal by Subject|0|||
33591865|NCT01352221|102054120|FG002|Open-label Phase|Withdrawal by Subject|1|||
33591866|NCT01352221|102054121|FG003|Open-label Phase|Withdrawal by Subject|6|||
33591867|NCT01352221|102054118|FG000|Open-label Phase|Worsening of IBD|0|||
33591868|NCT01352221|102054119|FG001|Open-label Phase|Worsening of IBD|0|||
33591869|NCT01352221|102054120|FG002|Open-label Phase|Worsening of IBD|1|||
33591870|NCT01352221|102054121|FG003|Open-label Phase|Worsening of IBD|0|||
33591871|NCT01751906|102054130|FG000|Overall Study|Lost to Follow-up|151|||
33591872|NCT01751906|102054131|FG001|Overall Study|Lost to Follow-up|68|||
33591873|NCT01751906|102054130|FG000|Overall Study|Withdrawal by Subject|22|||
33591874|NCT01751906|102054131|FG001|Overall Study|Withdrawal by Subject|18|||
33591875|NCT01751906|102054130|FG000|Overall Study|Physician Decision|5|||
33591876|NCT01751906|102054131|FG001|Overall Study|Physician Decision|2|||
33591877|NCT01751906|102054130|FG000|Overall Study|Death|84|||
33591878|NCT01751906|102054131|FG001|Overall Study|Death|43|||
33591879|NCT01751906|102054130|FG000|Overall Study|Denied on premises for follow-up by law|1|||
33591880|NCT01751906|102054131|FG001|Overall Study|Denied on premises for follow-up by law|0|||
33591881|NCT02447250|102054134|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
33591882|NCT02447250|102054134|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
33591883|NCT02447250|102054134|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
33591884|NCT00920387|102054135|FG000|Stage 1|Adverse Event|1|||
33591885|NCT00920387|102054136|FG001|Stage 1|Adverse Event|0|||
33591886|NCT00920387|102054137|FG002|Stage 1|Adverse Event|0|||
33591887|NCT05312632|102054138|FG000|Overall Study|Adverse Event|12|||
33591888|NCT05312632|102054138|FG000|Overall Study|Withdrawal by Subject|10|||
33591889|NCT05312632|102054138|FG000|Overall Study|Lack of Efficacy|4|||
33591890|NCT05312632|102054138|FG000|Overall Study|Non-compliance with study procedures|9|||
33591891|NCT05312632|102054138|FG000|Overall Study|Other|4|||
33591892|NCT02220855|102054139|FG000|Overall Study|Adverse Event|8|||
33591893|NCT02220855|102054139|FG000|Overall Study|Disease Progression|5|||
33591894|NCT02220855|102054139|FG000|Overall Study|Withdrawal by Subject|1|||
33591895|NCT00948857|102054141|FG000|Overall Study|Lost to Follow-up|1|||
33591896|NCT00948857|102054142|FG001|Overall Study|Lost to Follow-up|0|||
33591897|NCT00176488|102054143|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
33591898|NCT03319953|102054144|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
33591899|NCT03319953|102054145|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
33591900|NCT03319953|102054146|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
33591901|NCT03319953|102054147|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
33591902|NCT03319953|102054144|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
33591903|NCT03319953|102054145|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
33591904|NCT03319953|102054146|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
33591905|NCT03319953|102054147|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
33591906|NCT00349921|102054163|FG000|First Spinal Injection|Physician Decision|1|||
33591907|NCT00349921|102054164|FG001|First Spinal Injection|Physician Decision|0|||
33591908|NCT00349921|102054165|FG002|First Spinal Injection|Physician Decision|0|||
33591909|NCT00349921|102054166|FG003|First Spinal Injection|Physician Decision|0|||
33591910|NCT00349921|102054163|FG000|First Spinal Injection|Adverse Event|0|||
33591911|NCT00349921|102054164|FG001|First Spinal Injection|Adverse Event|0|||
33591912|NCT00349921|102054165|FG002|First Spinal Injection|Adverse Event|1|||
33591913|NCT00349921|102054166|FG003|First Spinal Injection|Adverse Event|0|||
33591914|NCT01892436|102054167|FG000|Overall Study|Withdrawal by Subject|8|||
33591915|NCT01892436|102054168|FG001|Overall Study|Withdrawal by Subject|15|||
33591916|NCT01892436|102054169|FG002|Overall Study|Withdrawal by Subject|4|||
33591917|NCT01892436|102054170|FG003|Overall Study|Withdrawal by Subject|4|||
33591918|NCT01892436|102054167|FG000|Overall Study|Death|1|||
33591919|NCT01892436|102054168|FG001|Overall Study|Death|1|||
33591920|NCT01892436|102054169|FG002|Overall Study|Death|0|||
33591921|NCT01892436|102054170|FG003|Overall Study|Death|0|||
33591922|NCT01892436|102054167|FG000|Overall Study|Physician Decision|2|||
33591923|NCT01892436|102054168|FG001|Overall Study|Physician Decision|1|||
33433778|NCT00368966|101480887|FG001|Infant Series|Adverse Event|1|||
33433779|NCT00368966|101480886|FG000|Infant Series|Failed to return|1|||
33591924|NCT01892436|102054169|FG002|Overall Study|Physician Decision|0|||
33591925|NCT01892436|102054170|FG003|Overall Study|Physician Decision|1|||
33591926|NCT01892436|102054167|FG000|Overall Study|Pregnancy|0|||
33591927|NCT01892436|102054168|FG001|Overall Study|Pregnancy|2|||
33591928|NCT01892436|102054169|FG002|Overall Study|Pregnancy|1|||
33591929|NCT01892436|102054170|FG003|Overall Study|Pregnancy|0|||
33591930|NCT01892436|102054167|FG000|Overall Study|Technical problems|2|||
33591931|NCT01892436|102054168|FG001|Overall Study|Technical problems|1|||
33591932|NCT01892436|102054169|FG002|Overall Study|Technical problems|1|||
33591933|NCT01892436|102054170|FG003|Overall Study|Technical problems|1|||
33591934|NCT01892436|102054167|FG000|Overall Study|Lack of Efficacy|1|||
33591935|NCT01892436|102054168|FG001|Overall Study|Lack of Efficacy|2|||
33591936|NCT01892436|102054169|FG002|Overall Study|Lack of Efficacy|2|||
33591937|NCT01892436|102054170|FG003|Overall Study|Lack of Efficacy|2|||
33591938|NCT01892436|102054167|FG000|Overall Study|Lost to Follow-up|1|||
33591939|NCT01892436|102054168|FG001|Overall Study|Lost to Follow-up|1|||
33591940|NCT01892436|102054169|FG002|Overall Study|Lost to Follow-up|1|||
33591941|NCT01892436|102054170|FG003|Overall Study|Lost to Follow-up|3|||
33591942|NCT01892436|102054167|FG000|Overall Study|non-compliance with treatment|1|||
33591943|NCT01892436|102054168|FG001|Overall Study|non-compliance with treatment|0|||
33591944|NCT01892436|102054169|FG002|Overall Study|non-compliance with treatment|0|||
33591945|NCT01892436|102054170|FG003|Overall Study|non-compliance with treatment|0|||
33591946|NCT01892436|102054167|FG000|Overall Study|Adverse Event|7|||
33591947|NCT01892436|102054168|FG001|Overall Study|Adverse Event|6|||
33591948|NCT01892436|102054169|FG002|Overall Study|Adverse Event|2|||
33591949|NCT01892436|102054170|FG003|Overall Study|Adverse Event|3|||
33591950|NCT01560637|102054176|FG000|Overall Study|Adverse Event|63|||
33591951|NCT01560637|102054176|FG000|Overall Study|Death|69|||
33591952|NCT01560637|102054176|FG000|Overall Study|Lost to Follow-up|8|||
33591953|NCT01560637|102054176|FG000|Overall Study|Protocol Violation|8|||
33591954|NCT01560637|102054176|FG000|Overall Study|Withdrawal by Subject|24|||
33591955|NCT01560637|102054176|FG000|Overall Study|Progressive Disease|20|||
33591956|NCT01560637|102054176|FG000|Overall Study|Other Reason Not Specified|6|||
33591957|NCT01439971|102054181|FG000|Overall Study|Required number in cohort dosed|0|||
33591958|NCT01439971|102054182|FG001|Overall Study|Required number in cohort dosed|1|||
33591959|NCT01439971|102054183|FG002|Overall Study|Required number in cohort dosed|2|||
33591960|NCT01439971|102054184|FG003|Overall Study|Required number in cohort dosed|0|||
33591961|NCT01439971|102054185|FG004|Overall Study|Required number in cohort dosed|1|||
33591962|NCT03116828|102054188|FG000|Overall Study|Adverse Event|1|||
33591963|NCT03116828|102054189|FG001|Overall Study|Adverse Event|10|||
33591964|NCT03116828|102054188|FG000|Overall Study|Withdrawal by Subject|4|||
33591965|NCT03116828|102054189|FG001|Overall Study|Withdrawal by Subject|8|||
33591966|NCT03116828|102054188|FG000|Overall Study|OTHER|3|||
33591967|NCT03116828|102054189|FG001|Overall Study|OTHER|3|||
33591968|NCT00790647|102054190|FG000|Overall Study|Adverse Event|1|||
33591969|NCT01579565|102054195|FG000|Randomized|Adverse Event|1|||
33591970|NCT01579565|102054196|FG001|Randomized|Adverse Event|3|||
33591971|NCT01579565|102054195|FG000|Randomized|Withdrawal by Subject|3|||
33591972|NCT01579565|102054196|FG001|Randomized|Withdrawal by Subject|0|||
33591973|NCT01579565|102054195|FG000|Randomized|inadequate preoperative pupil dilation|0|||
33433780|NCT00368966|101480887|FG001|Infant Series|Failed to return|0|||
33591974|NCT01579565|102054196|FG001|Randomized|inadequate preoperative pupil dilation|1|||
33591975|NCT01579565|102054195|FG000|Randomized|prohibited preoperative eating|1|||
33591976|NCT01579565|102054196|FG001|Randomized|prohibited preoperative eating|0|||
33591977|NCT01579565|102054195|FG000|Randomized|prohibited preoperative medication|0|||
33591978|NCT01579565|102054196|FG001|Randomized|prohibited preoperative medication|1|||
33433781|NCT00368966|101480886|FG000|After Infant|Failed to return|3|||
33433782|NCT00368966|101480887|FG001|After Infant|Failed to return|1|||
33433783|NCT00368966|101480886|FG000|After Infant|Adverse Event|1|||
33433784|NCT00368966|101480887|FG001|After Infant|Adverse Event|2|||
33433785|NCT00368966|101480886|FG000|After Infant|Withdrawal by Subject|1|||
33433786|NCT00368966|101480887|FG001|After Infant|Withdrawal by Subject|1|||
33433787|NCT00368966|101480886|FG000|After Infant|Death|1|||
33433788|NCT00368966|101480887|FG001|After Infant|Death|0|||
33433789|NCT00368966|101480886|FG000|After Infant|Lost to Follow-up|0|||
33591979|NCT01579565|102054195|FG000|Treated|Physician Decision|0|||
33591980|NCT01579565|102054196|FG001|Treated|Physician Decision|1|||
33591981|NCT01579565|102054195|FG000|Treated|Lost to Follow-up|2|||
33591982|NCT01579565|102054196|FG001|Treated|Lost to Follow-up|1|||
33591983|NCT01579565|102054195|FG000|Treated|declined to return for final visit|0|||
33591984|NCT01579565|102054196|FG001|Treated|declined to return for final visit|1|||
33591985|NCT01229254|102054197|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
33591986|NCT01229254|102054198|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
33591987|NCT01229254|102054199|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
33591988|NCT01229254|102054197|FG000|Overall Study|Adverse Event|4|||
33591989|NCT01229254|102054198|FG001|Overall Study|Adverse Event|5|||
33591990|NCT01229254|102054199|FG002|Overall Study|Adverse Event|3|||
33591991|NCT01229254|102054197|FG000|Overall Study|Lost to Follow-up|3|||
33591992|NCT01229254|102054198|FG001|Overall Study|Lost to Follow-up|0|||
33591993|NCT01229254|102054199|FG002|Overall Study|Lost to Follow-up|1|||
33591994|NCT01229254|102054197|FG000|Overall Study|Physician Decision|0|||
33591995|NCT01229254|102054198|FG001|Overall Study|Physician Decision|3|||
33591996|NCT01229254|102054199|FG002|Overall Study|Physician Decision|0|||
33591997|NCT01229254|102054197|FG000|Overall Study|Protocol Violation|4|||
33591998|NCT01229254|102054198|FG001|Overall Study|Protocol Violation|6|||
33591999|NCT01229254|102054199|FG002|Overall Study|Protocol Violation|5|||
33592000|NCT01229254|102054197|FG000|Overall Study|Withdrawal by Subject|1|||
33592001|NCT01229254|102054198|FG001|Overall Study|Withdrawal by Subject|0|||
33592002|NCT01229254|102054199|FG002|Overall Study|Withdrawal by Subject|1|||
33592003|NCT01229254|102054197|FG000|Overall Study|Non-compliance with Study Drug|0|||
33592004|NCT01229254|102054198|FG001|Overall Study|Non-compliance with Study Drug|1|||
33592005|NCT01229254|102054199|FG002|Overall Study|Non-compliance with Study Drug|1|||
33592006|NCT01271010|102054200|FG000|Overall Study|Reason not specified|11|||
33592007|NCT01271010|102054200|FG000|Overall Study|Start of new CLL therapy|1|||
33433790|NCT00368966|101480887|FG001|After Infant|Lost to Follow-up|1|||
33433791|NCT00368966|101480886|FG000|Toddler Dose|Withdrawal by Subject|1|||
33433792|NCT00368966|101480887|FG001|Toddler Dose|Withdrawal by Subject|1|||
33592008|NCT01271010|102054200|FG000|Overall Study|Protocol Violation|1|||
33592009|NCT01271010|102054200|FG000|Overall Study|Death|2|||
33592010|NCT01271010|102054200|FG000|Overall Study|Progression and relapse of disease|1|||
33433793|NCT00368966|101480886|FG000|Toddler Dose|Lost to Follow-up|0|||
33433794|NCT00368966|101480887|FG001|Toddler Dose|Lost to Follow-up|2|||
33433795|NCT02623829|101480888|FG000|Overall Study|Lost to Follow-up|1|||
33433796|NCT02623829|101480889|FG001|Overall Study|Lost to Follow-up|1|||
33433797|NCT01654380|101480892|FG000|Part B, Period 1|Physician Decision|0|||
33433798|NCT01654380|101480893|FG001|Part B, Period 1|Physician Decision|0|||
33433799|NCT01654380|101480894|FG002|Part B, Period 1|Physician Decision|1|||
33433800|NCT01654380|101480895|FG003|Part B, Period 1|Physician Decision|0|||
33592011|NCT01271010|102054200|FG000|Overall Study|Withdrawal by Subject|18|||
33592012|NCT01271010|102054200|FG000|Overall Study|Disease progression|27|||
33592013|NCT02545517|102054201|FG000|Overall Study|Death|2|||
33592014|NCT02545517|102054202|FG001|Overall Study|Death|2|||
33592015|NCT02545517|102054203|FG002|Overall Study|Death|1|||
33592016|NCT02545517|102054201|FG000|Overall Study|Lost to Follow-up|14|||
33592017|NCT02545517|102054202|FG001|Overall Study|Lost to Follow-up|13|||
33592018|NCT02545517|102054203|FG002|Overall Study|Lost to Follow-up|17|||
33592019|NCT02545517|102054201|FG000|Overall Study|Protocol Violation|0|||
33592020|NCT02545517|102054202|FG001|Overall Study|Protocol Violation|1|||
33592021|NCT02545517|102054203|FG002|Overall Study|Protocol Violation|1|||
33592022|NCT02545517|102054201|FG000|Overall Study|Withdrawal by Subject|5|||
33592023|NCT02545517|102054202|FG001|Overall Study|Withdrawal by Subject|8|||
33592024|NCT02545517|102054203|FG002|Overall Study|Withdrawal by Subject|9|||
33592025|NCT02545517|102054201|FG000|Overall Study|Administrative reason|5|||
33384782|NCT03057951|101295885|FG000|Overall Study|Medical advice|6|||
33592026|NCT02545517|102054202|FG001|Overall Study|Administrative reason|6|||
33592027|NCT02545517|102054203|FG002|Overall Study|Administrative reason|10|||
33592028|NCT02545517|102054201|FG000|Overall Study|Other|2|||
33384783|NCT03057951|101295886|FG001|Overall Study|Medical advice|2|||
33384784|NCT03057951|101295885|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
33384785|NCT03057951|101295886|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
33384786|NCT03057951|101295885|FG000|Overall Study|Investigator decision|2|||
33384787|NCT03057951|101295886|FG001|Overall Study|Investigator decision|0|||
33384788|NCT03057951|101295885|FG000|Overall Study|Patient decision|5|||
33384789|NCT03057951|101295886|FG001|Overall Study|Patient decision|2|||
33384790|NCT03057951|101295885|FG000|Overall Study|Not attending study visits|3|||
33384791|NCT03057951|101295886|FG001|Overall Study|Not attending study visits|0|||
33384792|NCT03057951|101295885|FG000|Overall Study|Patient moved away|3|||
33384793|NCT03057951|101295886|FG001|Overall Study|Patient moved away|4|||
33384794|NCT03057951|101295885|FG000|Overall Study|Other reason than stated above|23|||
33384795|NCT03057951|101295886|FG001|Overall Study|Other reason than stated above|29|||
33384796|NCT03057951|101295885|FG000|Overall Study|Not treated|2|||
33384797|NCT03057951|101295886|FG001|Overall Study|Not treated|1|||
33384798|NCT02899377|101295887|FG000|Overall Study|Adverse Event|1|||
33384799|NCT02899377|101295888|FG001|Overall Study|Adverse Event|0|||
33384800|NCT01245764|101295891|FG000|Study Phase A|Other|3|||
33384801|NCT01245764|101295892|FG001|Study Phase A|Other|2|||
33384802|NCT01245764|101295893|FG002|Study Phase A|Other|3|||
33384803|NCT01245764|101295894|FG003|Study Phase A|Other|1|||
33384804|NCT01245764|101295891|FG000|Study Phase A|Protocol Violation|6|||
33384805|NCT01245764|101295892|FG001|Study Phase A|Protocol Violation|3|||
33384806|NCT01245764|101295893|FG002|Study Phase A|Protocol Violation|2|||
33384807|NCT01245764|101295894|FG003|Study Phase A|Protocol Violation|2|||
33384808|NCT01245764|101295891|FG000|Study Phase A|Lost to Follow-up|0|||
33384809|NCT01245764|101295892|FG001|Study Phase A|Lost to Follow-up|0|||
33384810|NCT01245764|101295893|FG002|Study Phase A|Lost to Follow-up|5|||
33384811|NCT01245764|101295894|FG003|Study Phase A|Lost to Follow-up|0|||
33384812|NCT01838590|101295895|FG000|Overall Study|Lack of Efficacy|12|||
33384813|NCT01838590|101295896|FG001|Overall Study|Lack of Efficacy|4|||
33384814|NCT01838590|101295895|FG000|Overall Study|Lost to Follow-up|0|||
33384815|NCT01838590|101295896|FG001|Overall Study|Lost to Follow-up|1|||
33384816|NCT03805971|101295898|FG000|Overall Study|Withdrawal by Subject|1|||
33384817|NCT03805971|101295898|FG000|Overall Study|Protocol Violation|2|||
33384818|NCT00617591|101295899|FG000|Overall Study|Withdrew consent during Induction|4|||
33384819|NCT00617591|101295899|FG000|Overall Study|Withdrew consent during Maintenance|6|||
33384820|NCT02700919|101295900|FG000|Overall Study|Physician Decision|1|||
33384821|NCT02700919|101295901|FG001|Overall Study|Physician Decision|0|||
33384822|NCT02700919|101295902|FG002|Overall Study|Physician Decision|0|||
33384823|NCT02700919|101295900|FG000|Overall Study|Protocol Violation|1|||
33384824|NCT02700919|101295901|FG001|Overall Study|Protocol Violation|0|||
33433801|NCT01941095|101480896|FG000|Overall Study|Insufficient therapeutic response|13|||
33384825|NCT02700919|101295902|FG002|Overall Study|Protocol Violation|0|||
33384826|NCT02700919|101295900|FG000|Overall Study|Adverse Event|1|||
33384827|NCT02700919|101295901|FG001|Overall Study|Adverse Event|3|||
33384828|NCT02700919|101295902|FG002|Overall Study|Adverse Event|1|||
33384829|NCT02700919|101295900|FG000|Overall Study|Withdrawal by Subject|5|||
33433802|NCT01941095|101480896|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
33433803|NCT01941095|101480896|FG000|Overall Study|Adverse Event|11|||
33592029|NCT02545517|102054202|FG001|Overall Study|Other|4|||
33592030|NCT02545517|102054203|FG002|Overall Study|Other|3|||
33592031|NCT04085458|102054204|FG000|Overall Study|Other|1|||
33433804|NCT01941095|101480896|FG000|Overall Study|Physician Decision|3|||
33433805|NCT01941095|101480896|FG000|Overall Study|Withdrawal by Subject|17|||
33433806|NCT01941095|101480896|FG000|Overall Study|Lost to Follow-up|10|||
33433807|NCT00203307|101480897|FG000|First Intervention|Adverse Event|2|||
33433808|NCT00203307|101480898|FG001|First Intervention|Adverse Event|0|||
33433809|NCT04534283|101480899|FG000|Overall Study|Physician Decision|2|||
33433810|NCT04534283|101480899|FG000|Overall Study|Withdrawal by Subject|1|||
33433811|NCT04534283|101480899|FG000|Overall Study|Disease Progression|12|||
33433812|NCT04534283|101480899|FG000|Overall Study|Adverse Event|1|||
33433813|NCT00619385|101480900|FG000|Overall Study|Adverse Event|0|||
33433814|NCT00619385|101480901|FG001|Overall Study|Adverse Event|0|||
33433815|NCT00619385|101480902|FG002|Overall Study|Adverse Event|3|||
33433816|NCT00619385|101480900|FG000|Overall Study|Other|1|||
33433817|NCT00619385|101480901|FG001|Overall Study|Other|2|||
33433818|NCT00619385|101480902|FG002|Overall Study|Other|1|||
33433819|NCT02199509|101480910|FG000|Overall Study|Suicidal Ideation|0|||
33433820|NCT02199509|101480911|FG001|Overall Study|Suicidal Ideation|1|||
33433821|NCT02199509|101480910|FG000|Overall Study|Misunderstood titration schedule|1|||
33150189|NCT01646073|100463669|FG001|Period A (12 Weeks)|Protocol Violation|1|||
33150190|NCT01646073|100463668|FG000|Period A (12 Weeks)|Other|0|||
33150191|NCT01646073|100463669|FG001|Period A (12 Weeks)|Other|1|||
33150192|NCT01646073|100463668|FG000|Period B (12 Weeks)|Adverse Event|0|||
33384830|NCT02700919|101295901|FG001|Overall Study|Withdrawal by Subject|8|||
33384831|NCT02700919|101295902|FG002|Overall Study|Withdrawal by Subject|2|||
33384832|NCT02700919|101295900|FG000|Overall Study|Lost to Follow-up|2|||
33384833|NCT02700919|101295901|FG001|Overall Study|Lost to Follow-up|0|||
33150193|NCT01646073|100463669|FG001|Period B (12 Weeks)|Adverse Event|7|||
33384834|NCT02700919|101295902|FG002|Overall Study|Lost to Follow-up|0|||
33384835|NCT02700919|101295900|FG000|Overall Study|Other|2|||
33384836|NCT02700919|101295901|FG001|Overall Study|Other|1|||
33384837|NCT02700919|101295902|FG002|Overall Study|Other|1|||
33384838|NCT00089999|101295903|FG000|Overall Study|Adverse Event|4|||
33384839|NCT00089999|101295904|FG001|Overall Study|Adverse Event|7|||
33384840|NCT00089999|101295903|FG000|Overall Study|Withdrawal by Subject|0|||
33384841|NCT00089999|101295904|FG001|Overall Study|Withdrawal by Subject|4|||
33384842|NCT00089999|101295903|FG000|Overall Study|Lost to Follow-up|2|||
33384843|NCT00089999|101295904|FG001|Overall Study|Lost to Follow-up|1|||
33384844|NCT00089999|101295903|FG000|Overall Study|Radiological Progression of Cancer|52|||
33384845|NCT00089999|101295904|FG001|Overall Study|Radiological Progression of Cancer|44|||
33384846|NCT00089999|101295903|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
33384847|NCT00089999|101295904|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
33384848|NCT00089999|101295903|FG000|Overall Study|Death|3|||
33384849|NCT00089999|101295904|FG001|Overall Study|Death|3|||
33384850|NCT00089999|101295903|FG000|Overall Study|Poor General Condition|1|||
33384851|NCT00089999|101295904|FG001|Overall Study|Poor General Condition|0|||
33384852|NCT00089999|101295903|FG000|Overall Study|Clinical Progression|1|||
33592032|NCT04085458|102054204|FG000|Overall Study|Withdrawal by Subject|2|||
33592033|NCT04085458|102054204|FG000|Overall Study|Adverse Event|2|||
33592034|NCT00882583|102054205|FG000|Overall Study|Physician Decision|1|||
33592035|NCT00882583|102054206|FG001|Overall Study|Physician Decision|0|||
33592036|NCT00882583|102054205|FG000|Overall Study|Adverse Event|0|||
33592037|NCT00882583|102054206|FG001|Overall Study|Adverse Event|1|||
33592038|NCT00737568|102054210|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
33592039|NCT00737568|102054211|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
33150194|NCT01646073|100463668|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
33150195|NCT01646073|100463669|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
33150196|NCT01646073|100463668|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
33384853|NCT00089999|101295904|FG001|Overall Study|Clinical Progression|2|||
33384854|NCT00089999|101295903|FG000|Overall Study|Physician Decision|2|||
33384855|NCT00089999|101295904|FG001|Overall Study|Physician Decision|2|||
33384856|NCT00089999|101295903|FG000|Overall Study|Patient Underwent Surgery|2|||
33384857|NCT00089999|101295904|FG001|Overall Study|Patient Underwent Surgery|0|||
33384858|NCT00089999|101295903|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
33384859|NCT00089999|101295904|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
33384860|NCT01595438|101295905|FG000|Overall Study|Lost to Follow-up|20|||
33384861|NCT01595438|101295906|FG001|Overall Study|Lost to Follow-up|20|||
33384862|NCT01595438|101295905|FG000|Overall Study|Withdrawal by Subject|12|||
33384863|NCT01595438|101295906|FG001|Overall Study|Withdrawal by Subject|12|||
33384864|NCT01595438|101295905|FG000|Overall Study|Other Eligibility criteria|11|||
33384865|NCT01595438|101295906|FG001|Overall Study|Other Eligibility criteria|9|||
33384866|NCT01532570|101295910|FG000|Overall Study|Lack of Efficacy|1|||
33384867|NCT01532570|101295911|FG001|Overall Study|Lack of Efficacy|0|||
33384868|NCT01532570|101295912|FG002|Overall Study|Lack of Efficacy|0|||
33384869|NCT01532570|101295913|FG003|Overall Study|Lack of Efficacy|0|||
33384870|NCT01532570|101295910|FG000|Overall Study|Withdrawal by Subject|0|||
33384871|NCT01532570|101295911|FG001|Overall Study|Withdrawal by Subject|1|||
33384872|NCT01532570|101295912|FG002|Overall Study|Withdrawal by Subject|0|||
33384873|NCT01532570|101295913|FG003|Overall Study|Withdrawal by Subject|0|||
33384874|NCT01280266|101295916|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
33384875|NCT01280266|101295917|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
33433822|NCT02199509|101480911|FG001|Overall Study|Misunderstood titration schedule|0|||
33384876|NCT01280266|101295916|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
33384877|NCT01280266|101295917|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
33592040|NCT00737568|102054210|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
33592041|NCT00737568|102054211|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
33592042|NCT00737568|102054210|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
33592043|NCT00737568|102054211|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
33592044|NCT00737568|102054210|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
33592045|NCT00737568|102054211|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
33592046|NCT00737568|102054210|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
33592047|NCT00737568|102054211|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
33592048|NCT00737568|102054210|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
33592049|NCT00737568|102054211|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
33592050|NCT00737568|102054210|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
33592051|NCT00737568|102054211|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
33592052|NCT00737568|102054210|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
33592053|NCT00737568|102054211|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
33592054|NCT00737568|102054210|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
33592055|NCT00737568|102054211|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
33592056|NCT01734395|102054212|FG000|Overall Study|Other|65|||
33592057|NCT01734395|102054212|FG000|Overall Study|Lost to Follow-up|287|||
33592058|NCT01734395|102054212|FG000|Overall Study|Lack of Efficacy|5|||
33592059|NCT01734395|102054212|FG000|Overall Study|Adverse Event|40|||
33592060|NCT01734395|102054212|FG000|Overall Study|Withdrawal by Subject|10|||
33592061|NCT01734395|102054212|FG000|Overall Study|Missing the reasons for not completed|3|||
33592062|NCT00350870|102054213|FG000|Overall Study|Withdrawal by Subject|21|||
33592063|NCT00350870|102054214|FG001|Overall Study|Withdrawal by Subject|17|||
33433823|NCT02093689|101480912|FG000|Overall Study|Physician Decision|4|||
33433824|NCT02093689|101480913|FG001|Overall Study|Physician Decision|0|||
33433825|NCT02093689|101480914|FG002|Overall Study|Physician Decision|0|||
33433826|NCT04588259|101480919|FG000|Run-in Period|Run-in failure|0|||
33433827|NCT04588259|101480920|FG001|Run-in Period|Run-in failure|23|||
33433828|NCT04588259|101480919|FG000|Run-in Period|Withdrawn before randomisation|0|||
33592064|NCT00350870|102054215|FG002|Overall Study|Withdrawal by Subject|15|||
33592065|NCT00350870|102054216|FG003|Overall Study|Withdrawal by Subject|14|||
33592066|NCT00350870|102054213|FG000|Overall Study|Physician Decision|1|||
33592067|NCT00350870|102054214|FG001|Overall Study|Physician Decision|0|||
33592068|NCT00350870|102054215|FG002|Overall Study|Physician Decision|1|||
33592069|NCT00350870|102054216|FG003|Overall Study|Physician Decision|1|||
33592070|NCT00459875|102054217|FG000|Overall Study|Ineligible participant|1|||
33592071|NCT00459875|102054217|FG000|Overall Study|Adverse Event|2|||
33592072|NCT01369641|102054218|FG000|Overall Study|Withdrawal by Subject|1|||
33592073|NCT03650803|102054219|FG000|Overall Study|Lost to Follow-up|6|||
33592074|NCT01468207|102054220|FG000|Treatment Period 1|Adverse Event|1|||
33592075|NCT01468207|102054221|FG001|Treatment Period 1|Adverse Event|0|||
33150197|NCT01646073|100463669|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
33592076|NCT01468207|102054222|FG002|Treatment Period 1|Adverse Event|0|||
33433829|NCT04588259|101480920|FG001|Run-in Period|Withdrawn before randomisation|8|||
33592077|NCT01468207|102054223|FG003|Treatment Period 1|Adverse Event|0|||
33592078|NCT01468207|102054224|FG004|Treatment Period 1|Adverse Event|0|||
33592079|NCT01468207|102054225|FG005|Treatment Period 1|Adverse Event|0|||
33592080|NCT01468207|102054220|FG000|Treatment Period 1|Protocol Violation|1|||
33592081|NCT01468207|102054221|FG001|Treatment Period 1|Protocol Violation|1|||
33592082|NCT01468207|102054222|FG002|Treatment Period 1|Protocol Violation|0|||
33592083|NCT01468207|102054223|FG003|Treatment Period 1|Protocol Violation|0|||
33592084|NCT01468207|102054224|FG004|Treatment Period 1|Protocol Violation|0|||
33592085|NCT01468207|102054225|FG005|Treatment Period 1|Protocol Violation|0|||
33592086|NCT01468207|102054220|FG000|Treatment Period 1|Withdrawal by Subject|5|||
33592087|NCT01468207|102054221|FG001|Treatment Period 1|Withdrawal by Subject|4|||
33592088|NCT01468207|102054222|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33592089|NCT01468207|102054223|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33592090|NCT01468207|102054224|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33592091|NCT01468207|102054225|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33592092|NCT01468207|102054220|FG000|Treatment Period 1|Lost to Follow-up|2|||
33592093|NCT01468207|102054221|FG001|Treatment Period 1|Lost to Follow-up|1|||
33592094|NCT01468207|102054222|FG002|Treatment Period 1|Lost to Follow-up|0|||
33592095|NCT01468207|102054223|FG003|Treatment Period 1|Lost to Follow-up|0|||
33592096|NCT01468207|102054224|FG004|Treatment Period 1|Lost to Follow-up|0|||
33592097|NCT01468207|102054225|FG005|Treatment Period 1|Lost to Follow-up|0|||
33592098|NCT01468207|102054220|FG000|Treatment Period 1|Other|0|||
33592099|NCT01468207|102054221|FG001|Treatment Period 1|Other|2|||
33592100|NCT01468207|102054222|FG002|Treatment Period 1|Other|0|||
33592101|NCT01468207|102054223|FG003|Treatment Period 1|Other|0|||
33592102|NCT01468207|102054224|FG004|Treatment Period 1|Other|0|||
33592103|NCT01468207|102054225|FG005|Treatment Period 1|Other|0|||
33592104|NCT01468207|102054220|FG000|Treatment Period 2|Adverse Event|0|||
33592105|NCT01468207|102054221|FG001|Treatment Period 2|Adverse Event|0|||
33592106|NCT01468207|102054222|FG002|Treatment Period 2|Adverse Event|6|||
33592107|NCT01468207|102054223|FG003|Treatment Period 2|Adverse Event|1|||
33592108|NCT01468207|102054224|FG004|Treatment Period 2|Adverse Event|2|||
33592109|NCT01468207|102054225|FG005|Treatment Period 2|Adverse Event|1|||
33592110|NCT01468207|102054220|FG000|Treatment Period 2|Lack of Efficacy|0|||
33592111|NCT01468207|102054221|FG001|Treatment Period 2|Lack of Efficacy|0|||
33592112|NCT01468207|102054222|FG002|Treatment Period 2|Lack of Efficacy|1|||
33592113|NCT01468207|102054223|FG003|Treatment Period 2|Lack of Efficacy|1|||
33592114|NCT01468207|102054224|FG004|Treatment Period 2|Lack of Efficacy|0|||
33592115|NCT01468207|102054225|FG005|Treatment Period 2|Lack of Efficacy|2|||
33592116|NCT01468207|102054220|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33592117|NCT01468207|102054221|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33592118|NCT01468207|102054222|FG002|Treatment Period 2|Withdrawal by Subject|5|||
33592119|NCT01468207|102054223|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33592120|NCT01468207|102054224|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33592121|NCT01468207|102054225|FG005|Treatment Period 2|Withdrawal by Subject|2|||
33592122|NCT01468207|102054220|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
33592123|NCT01468207|102054221|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
33592124|NCT01468207|102054222|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
33592125|NCT01468207|102054223|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
33592126|NCT01468207|102054224|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
33592127|NCT01468207|102054225|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
33592128|NCT01468207|102054220|FG000|Treatment Period 2|Lost to Follow-up|0|||
33592129|NCT01468207|102054221|FG001|Treatment Period 2|Lost to Follow-up|0|||
33592130|NCT01468207|102054222|FG002|Treatment Period 2|Lost to Follow-up|5|||
33592131|NCT01468207|102054223|FG003|Treatment Period 2|Lost to Follow-up|1|||
33592132|NCT01468207|102054224|FG004|Treatment Period 2|Lost to Follow-up|0|||
33592133|NCT01468207|102054225|FG005|Treatment Period 2|Lost to Follow-up|0|||
33592134|NCT01468207|102054220|FG000|Treatment Period 2|Other|0|||
33592135|NCT01468207|102054221|FG001|Treatment Period 2|Other|0|||
33592136|NCT01468207|102054222|FG002|Treatment Period 2|Other|5|||
33592137|NCT01468207|102054223|FG003|Treatment Period 2|Other|1|||
33592138|NCT01468207|102054224|FG004|Treatment Period 2|Other|1|||
33592139|NCT01468207|102054225|FG005|Treatment Period 2|Other|2|||
33592140|NCT05260073|102054232|FG000|Overall Study|Physician Decision|1|||
33384878|NCT01293006|101295918|FG000|Period 2|Lost to Follow-up|1|||
33592141|NCT05260073|102054232|FG000|Overall Study|Withdrawal by Subject|6|||
33592142|NCT05260073|102054232|FG000|Overall Study|Lost to Follow-up|14|||
33592143|NCT00633074|102057505|FG000|Overall Study|Adverse Event|1|||
33384879|NCT01293006|101295919|FG001|Period 2|Lost to Follow-up|0|||
33384880|NCT01293006|101295920|FG002|Period 2|Lost to Follow-up|0|||
33384881|NCT01293006|101295921|FG003|Period 2|Lost to Follow-up|0|||
33384882|NCT02156804|101295923|FG000|Overall Study|Withdrawal by Subject|1|||
33384883|NCT00249795|101295924|FG000|Overall Study|Not treated|16|||
33384884|NCT00249795|101295925|FG001|Overall Study|Not treated|14|||
33384885|NCT00249795|101295924|FG000|Overall Study|Symptomatic hypotension|127|||
33384886|NCT00249795|101295925|FG001|Overall Study|Symptomatic hypotension|64|||
33592144|NCT00633074|102057506|FG001|Overall Study|Adverse Event|0|||
33592145|NCT00585221|102057507|FG000|Overall Study|Protocol Violation|8|||
33592146|NCT02247011|102057509|FG000|Overall Study|Poor quality of radiological results|125|||
33592147|NCT00064259|102057510|FG000|Overall Study|Adverse Event|1|||
33592148|NCT00064259|102057511|FG001|Overall Study|Adverse Event|0|||
33592149|NCT00064259|102057512|FG002|Overall Study|Adverse Event|0|||
33592150|NCT00064259|102057513|FG003|Overall Study|Adverse Event|1|||
33592151|NCT05935878|102057514|FG000|Overall Study|Death|1|||
33592152|NCT05935878|102057515|FG001|Overall Study|Death|2|||
33592153|NCT05935878|102057514|FG000|Overall Study|Withdrawal by Subject|5|||
33592154|NCT05935878|102057515|FG001|Overall Study|Withdrawal by Subject|5|||
33592155|NCT05935878|102057514|FG000|Overall Study|Revision of implant|1|||
33592156|NCT05935878|102057515|FG001|Overall Study|Revision of implant|1|||
33592157|NCT05935878|102057514|FG000|Overall Study|Mobile bearing dislocation|0|||
33592158|NCT05935878|102057515|FG001|Overall Study|Mobile bearing dislocation|1|||
33592159|NCT00791479|102057521|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
33592160|NCT00791479|102057522|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
33592161|NCT00791479|102057523|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
33592162|NCT00791479|102057524|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
33592163|NCT00791479|102057525|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
33592164|NCT00791479|102057526|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
33592165|NCT00791479|102057521|FG000|Overall Study|Adverse Event|0|||
33592166|NCT00791479|102057522|FG001|Overall Study|Adverse Event|1|||
33592167|NCT00791479|102057523|FG002|Overall Study|Adverse Event|0|||
33592168|NCT00791479|102057524|FG003|Overall Study|Adverse Event|2|||
33592169|NCT00791479|102057525|FG004|Overall Study|Adverse Event|0|||
33592170|NCT00791479|102057526|FG005|Overall Study|Adverse Event|1|||
33592171|NCT00791479|102057521|FG000|Overall Study|Lost to Follow-up|0|||
33592172|NCT00791479|102057522|FG001|Overall Study|Lost to Follow-up|1|||
33592173|NCT00791479|102057523|FG002|Overall Study|Lost to Follow-up|0|||
33592174|NCT00791479|102057524|FG003|Overall Study|Lost to Follow-up|0|||
33592175|NCT00791479|102057525|FG004|Overall Study|Lost to Follow-up|0|||
33592176|NCT00791479|102057526|FG005|Overall Study|Lost to Follow-up|1|||
33592177|NCT00791479|102057521|FG000|Overall Study|Protocol Violation|2|||
33592178|NCT00791479|102057522|FG001|Overall Study|Protocol Violation|1|||
33592179|NCT00791479|102057523|FG002|Overall Study|Protocol Violation|0|||
33592180|NCT00791479|102057524|FG003|Overall Study|Protocol Violation|1|||
33592181|NCT00791479|102057525|FG004|Overall Study|Protocol Violation|0|||
33592182|NCT00791479|102057526|FG005|Overall Study|Protocol Violation|0|||
33592183|NCT00791479|102057521|FG000|Overall Study|Withdrawal by Subject|0|||
33592184|NCT00791479|102057522|FG001|Overall Study|Withdrawal by Subject|0|||
33592185|NCT00791479|102057523|FG002|Overall Study|Withdrawal by Subject|0|||
33592186|NCT00791479|102057524|FG003|Overall Study|Withdrawal by Subject|1|||
33592187|NCT00791479|102057525|FG004|Overall Study|Withdrawal by Subject|0|||
33592188|NCT00791479|102057526|FG005|Overall Study|Withdrawal by Subject|1|||
33592189|NCT00365105|102057527|FG000|Overall Study|Protocol Violation|5|||
33592190|NCT00365105|102057528|FG001|Overall Study|Protocol Violation|8|||
33592191|NCT01631747|102057529|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
33592192|NCT01631747|102057530|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
33592193|NCT01631747|102057529|FG000|Live Birth|Pregnancy Termination|1|||
33592194|NCT01631747|102057530|FG001|Live Birth|Pregnancy Termination|0|||
33592195|NCT01631747|102057529|FG000|Live Birth|MIscarriage|2|||
33592196|NCT01631747|102057530|FG001|Live Birth|MIscarriage|0|||
33249797|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
33384887|NCT00249795|101295924|FG000|Overall Study|Other Serious Adverse Event|84|||
33384888|NCT00249795|101295925|FG001|Overall Study|Other Serious Adverse Event|93|||
33592197|NCT01631747|102057529|FG000|Live Birth|Stillbirth|1|||
33592198|NCT01631747|102057530|FG001|Live Birth|Stillbirth|1|||
33384889|NCT00249795|101295924|FG000|Overall Study|Qualifying condition not present|26|||
33384890|NCT00249795|101295925|FG001|Overall Study|Qualifying condition not present|29|||
33592199|NCT01631747|102057529|FG000|One Year Infant Outcomes|Patient Refused|13|||
33592200|NCT01631747|102057530|FG001|One Year Infant Outcomes|Patient Refused|9|||
33592201|NCT01703208|102057531|FG000|Overall Study|Death|61|||
33592202|NCT01703208|102057532|FG001|Overall Study|Death|48|||
33592203|NCT01703208|102057531|FG000|Overall Study|Lack of Efficacy|1|||
33592204|NCT01703208|102057532|FG001|Overall Study|Lack of Efficacy|2|||
33592205|NCT01703208|102057531|FG000|Overall Study|Lost to Follow-up|68|||
33592206|NCT01703208|102057532|FG001|Overall Study|Lost to Follow-up|62|||
33592207|NCT01703208|102057531|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33592208|NCT01703208|102057532|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33592209|NCT01703208|102057531|FG000|Overall Study|Excluded Medication|1|||
33433830|NCT04588259|101480919|FG000|Treatment Period|Withdrawal by Subject|6|||
33592210|NCT01703208|102057532|FG001|Overall Study|Excluded Medication|2|||
33592211|NCT01703208|102057531|FG000|Overall Study|Site Discontinued Study Participation|23|||
33592212|NCT01703208|102057532|FG001|Overall Study|Site Discontinued Study Participation|27|||
33592213|NCT01703208|102057531|FG000|Overall Study|Physician Decision|11|||
33592214|NCT01703208|102057532|FG001|Overall Study|Physician Decision|13|||
33592215|NCT01703208|102057531|FG000|Overall Study|Progressive disease|2|||
33592216|NCT01703208|102057532|FG001|Overall Study|Progressive disease|2|||
33592217|NCT01703208|102057531|FG000|Overall Study|Protocol Violation|1|||
33592218|NCT01703208|102057532|FG001|Overall Study|Protocol Violation|1|||
33592219|NCT01703208|102057531|FG000|Overall Study|Study Terminated by Sponsor|1710|||
33592220|NCT01703208|102057532|FG001|Overall Study|Study Terminated by Sponsor|1716|||
33592221|NCT01703208|102057531|FG000|Overall Study|Withdrawal by Subject|205|||
33592222|NCT01703208|102057532|FG001|Overall Study|Withdrawal by Subject|209|||
33592223|NCT01703208|102057531|FG000|Overall Study|Adverse Event|14|||
33592224|NCT01703208|102057532|FG001|Overall Study|Adverse Event|19|||
33592225|NCT01703208|102057531|FG000|Overall Study|Technical Problems|0|||
33592226|NCT01703208|102057532|FG001|Overall Study|Technical Problems|1|||
33592227|NCT01703208|102057531|FG000|Overall Study|Protocol Deviation|2|||
33592228|NCT01703208|102057532|FG001|Overall Study|Protocol Deviation|0|||
33592229|NCT01302834|102057533|FG000|Overall Study|Protocol Violation|17|||
33592230|NCT01302834|102057534|FG001|Overall Study|Protocol Violation|23|||
33592231|NCT01302834|102057533|FG000|Overall Study|HIV positive|1|||
33592232|NCT01302834|102057534|FG001|Overall Study|HIV positive|3|||
33592233|NCT03199053|102057537|FG000|ST Period|Withdrawal by Subject|2|||
33592234|NCT03199053|102057538|FG001|ST Period|Withdrawal by Subject|4|||
33592235|NCT03199053|102057539|FG002|ST Period|Withdrawal by Subject|6|||
33592236|NCT03199053|102057537|FG000|ST Period|Withdrawal by parent/guardian|1|||
33592237|NCT03199053|102057538|FG001|ST Period|Withdrawal by parent/guardian|1|||
33592238|NCT03199053|102057539|FG002|ST Period|Withdrawal by parent/guardian|1|||
33592239|NCT03199053|102057537|FG000|ST Period|Lost to Follow-up|2|||
33592240|NCT03199053|102057538|FG001|ST Period|Lost to Follow-up|0|||
33592241|NCT03199053|102057539|FG002|ST Period|Lost to Follow-up|1|||
33592242|NCT03199053|102057537|FG000|LT Period|Withdrawal by Subject|1|||
33592243|NCT03199053|102057538|FG001|LT Period|Withdrawal by Subject|3|||
33592244|NCT03199053|102057539|FG002|LT Period|Withdrawal by Subject|3|||
33592245|NCT03199053|102057537|FG000|LT Period|Withdrawal by parent/guardian|0|||
33592246|NCT03199053|102057538|FG001|LT Period|Withdrawal by parent/guardian|0|||
33592247|NCT03199053|102057539|FG002|LT Period|Withdrawal by parent/guardian|1|||
33592248|NCT03199053|102057537|FG000|LT Period|Lost to Follow-up|0|||
33592249|NCT03199053|102057538|FG001|LT Period|Lost to Follow-up|1|||
33592250|NCT03199053|102057539|FG002|LT Period|Lost to Follow-up|1|||
33592251|NCT03199053|102057537|FG000|LT Period|Miscellaneous|0|||
33592252|NCT03199053|102057538|FG001|LT Period|Miscellaneous|0|||
33592253|NCT03199053|102057539|FG002|LT Period|Miscellaneous|2|||
33592254|NCT03199053|102057537|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
33592255|NCT03199053|102057538|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
33592256|NCT03199053|102057539|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
33592257|NCT03199053|102057537|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
33592258|NCT03199053|102057538|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
33592259|NCT03199053|102057539|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
33592260|NCT03199053|102057537|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
33592261|NCT03199053|102057538|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
33592262|NCT03199053|102057539|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
33592263|NCT03199053|102057537|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
33592264|NCT03199053|102057538|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
33592265|NCT03199053|102057539|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
33592266|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Death|1|||
33592267|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Death|1|||
33592268|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Death|0|||
33592269|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Death|0|||
33592270|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Death|1|||
33592271|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Death|0|||
33592272|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Death|0|||
33592273|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Death|0|||
33592274|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Death|0|||
33592275|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Death|0|||
33592276|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
33592277|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
33592278|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
33592279|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
33592280|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
33592281|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
33592282|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
33592283|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
33433831|NCT04588259|101480920|FG001|Treatment Period|Withdrawal by Subject|6|||
33433832|NCT02220907|101480921|FG000|Overall Study|Adverse Event|7|||
33433833|NCT02220907|101480921|FG000|Overall Study|Physician Decision|1|||
33433834|NCT02220907|101480921|FG000|Overall Study|Withdrawal by Subject|2|||
33433835|NCT02220907|101480921|FG000|Overall Study|Conflict with the stopping criteria|1|||
33433836|NCT00108732|101480922|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
33433837|NCT00108732|101480922|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
33433838|NCT00108732|101480922|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
33433839|NCT00108732|101480922|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
33433840|NCT00108732|101480922|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
33433841|NCT00108732|101480922|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
33433842|NCT00108732|101480922|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
33433843|NCT00865709|101480923|FG000|Treatment|Adverse Event|9|||
33433844|NCT00865709|101480924|FG001|Treatment|Adverse Event|6|||
33433845|NCT00865709|101480923|FG000|Treatment|Withdrawal by Subject|10|||
33433846|NCT00865709|101480924|FG001|Treatment|Withdrawal by Subject|7|||
33433847|NCT00865709|101480923|FG000|Treatment|Physician Decision|3|||
33592284|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
33592285|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
33433848|NCT00865709|101480924|FG001|Treatment|Physician Decision|2|||
33433849|NCT00865709|101480923|FG000|Treatment|Surgery|8|||
33433850|NCT00865709|101480924|FG001|Treatment|Surgery|3|||
33433851|NCT04582266|101480928|FG000|Overall Study|Lost to Follow-up|7|||
33592286|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33592287|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33592288|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33433852|NCT04582266|101480929|FG001|Overall Study|Lost to Follow-up|5|||
33433853|NCT04582266|101480928|FG000|Overall Study|Withdrawal by Subject|1|||
33433854|NCT04582266|101480929|FG001|Overall Study|Withdrawal by Subject|0|||
33433855|NCT04582266|101480928|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
33433856|NCT04582266|101480929|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
33433857|NCT01432171|101480930|FG000|Overall Study|Death|1|||
33433858|NCT01432171|101480931|FG001|Overall Study|Death|2|||
33433859|NCT01432171|101480930|FG000|Overall Study|Lost to Follow-up|6|||
33433860|NCT01432171|101480931|FG001|Overall Study|Lost to Follow-up|5|||
33433861|NCT01432171|101480930|FG000|Overall Study|Withdrawal by Subject|3|||
33433862|NCT01432171|101480931|FG001|Overall Study|Withdrawal by Subject|1|||
33433863|NCT01432171|101480930|FG000|Overall Study|Noncompliance|2|||
33433864|NCT01432171|101480931|FG001|Overall Study|Noncompliance|3|||
33433865|NCT01432171|101480930|FG000|Overall Study|Insurance denial trial coverage|1|||
33433866|NCT01432171|101480931|FG001|Overall Study|Insurance denial trial coverage|0|||
33433867|NCT01432171|101480930|FG000|Overall Study|Patient moved to palliative care|1|||
33433868|NCT01432171|101480931|FG001|Overall Study|Patient moved to palliative care|0|||
33433869|NCT03992196|101480932|FG000|Enrollment|lost to follow-up prior dosing|1|||
33433870|NCT03992196|101480933|FG001|Enrollment|lost to follow-up prior dosing|0|||
33433871|NCT03992196|101480934|FG002|Enrollment|lost to follow-up prior dosing|0|||
33433872|NCT03992196|101480932|FG000|Treatment|Protocol Violation|0|||
33433873|NCT03992196|101480933|FG001|Treatment|Protocol Violation|0|||
33433874|NCT03992196|101480934|FG002|Treatment|Protocol Violation|1|||
33433875|NCT03992196|101480932|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
33433876|NCT03992196|101480933|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
33433877|NCT03992196|101480934|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
33433878|NCT03992196|101480932|FG000|Treatment|Withdrawal due to non-compliance|0|||
33433879|NCT03992196|101480933|FG001|Treatment|Withdrawal due to non-compliance|0|||
33433880|NCT03992196|101480934|FG002|Treatment|Withdrawal due to non-compliance|1|||
33433881|NCT03992196|101480932|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
33433882|NCT03992196|101480933|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
33433883|NCT03992196|101480934|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
33433884|NCT03992196|101480932|FG000|Treatment|Withdrawal by parent/guardian|0|||
33433885|NCT03992196|101480933|FG001|Treatment|Withdrawal by parent/guardian|0|||
33433886|NCT03992196|101480934|FG002|Treatment|Withdrawal by parent/guardian|2|||
33433887|NCT01977092|101480935|FG000|Overall Study|Death|3|||
33433888|NCT01977092|101480936|FG001|Overall Study|Death|4|||
33433889|NCT01977092|101480935|FG000|Overall Study|Lost to Follow-up|23|||
33433890|NCT01977092|101480936|FG001|Overall Study|Lost to Follow-up|14|||
33433891|NCT01977092|101480935|FG000|Overall Study|Withdrawal by Subject|2|||
33433892|NCT01977092|101480936|FG001|Overall Study|Withdrawal by Subject|1|||
33433893|NCT01977092|101480935|FG000|Overall Study|In prison|3|||
33433894|NCT01977092|101480936|FG001|Overall Study|In prison|11|||
33433895|NCT01631864|101480939|FG000|Overall Study|Withdrawal by Subject|0|||
33433896|NCT01631864|101480940|FG001|Overall Study|Withdrawal by Subject|1|||
33433897|NCT01631864|101480939|FG000|Overall Study|Adverse Event|2|||
33433898|NCT01631864|101480940|FG001|Overall Study|Adverse Event|3|||
33433899|NCT00635778|101480941|FG000|Overall Study|Adverse Event|1|||
33433900|NCT00635778|101480942|FG001|Overall Study|Adverse Event|0|||
33433901|NCT00635778|101480943|FG002|Overall Study|Adverse Event|0|||
33433902|NCT00635778|101480944|FG003|Overall Study|Adverse Event|3|||
33433903|NCT00635778|101480945|FG004|Overall Study|Adverse Event|3|||
33433904|NCT00635778|101480946|FG005|Overall Study|Adverse Event|6|||
33433905|NCT00635778|101480947|FG006|Overall Study|Adverse Event|1|||
33433906|NCT00635778|101480941|FG000|Overall Study|Withdrawal by Subject|0|||
33433907|NCT00635778|101480942|FG001|Overall Study|Withdrawal by Subject|0|||
33433908|NCT00635778|101480943|FG002|Overall Study|Withdrawal by Subject|0|||
33433909|NCT00635778|101480944|FG003|Overall Study|Withdrawal by Subject|1|||
33433910|NCT00635778|101480945|FG004|Overall Study|Withdrawal by Subject|0|||
33433911|NCT00635778|101480946|FG005|Overall Study|Withdrawal by Subject|1|||
33433912|NCT00635778|101480947|FG006|Overall Study|Withdrawal by Subject|1|||
33433913|NCT00635778|101480941|FG000|Overall Study|Progressive disease|0|||
33433914|NCT00635778|101480942|FG001|Overall Study|Progressive disease|3|||
33433915|NCT00635778|101480943|FG002|Overall Study|Progressive disease|3|||
33433916|NCT00635778|101480944|FG003|Overall Study|Progressive disease|4|||
33433917|NCT00635778|101480945|FG004|Overall Study|Progressive disease|5|||
33433918|NCT00635778|101480946|FG005|Overall Study|Progressive disease|14|||
33433919|NCT00635778|101480947|FG006|Overall Study|Progressive disease|4|||
33433920|NCT00282256|101480948|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
33433921|NCT00282256|101480948|FG000|Extension Treatment Period|Adverse Event|2|||
33433922|NCT04094870|101480949|FG000|Overall Study|Lost to Follow-up|1|||
33433923|NCT04094870|101480950|FG001|Overall Study|Lost to Follow-up|1|||
33433924|NCT01929109|101480951|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
33433925|NCT01929109|101480952|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
33433926|NCT01929109|101480953|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
33433927|NCT01929109|101480954|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
33433928|NCT01929109|101480955|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
33433929|NCT03387098|101480958|FG000|Overall Study|progressive disease|1|||
33433930|NCT03387098|101480958|FG000|Overall Study|Withdrawal by Subject|2|||
33433931|NCT03387098|101480958|FG000|Overall Study|study terminated by sponsor|1|||
33433932|NCT00113490|101480959|FG000|Overall Study|Withdrawal by Subject|1|||
33433933|NCT00113490|101480960|FG001|Overall Study|Withdrawal by Subject|3|||
33433934|NCT00113490|101480959|FG000|Overall Study|Lost to Follow-up|1|||
33433935|NCT00113490|101480960|FG001|Overall Study|Lost to Follow-up|0|||
33433936|NCT01799590|101480963|FG000|Overall Study|Adverse Event|13|||
33433937|NCT01799590|101480964|FG001|Overall Study|Adverse Event|7|||
33433938|NCT01799590|101480965|FG002|Overall Study|Adverse Event|5|||
33433939|NCT01799590|101480963|FG000|Overall Study|Pregnancy|2|||
33433940|NCT01799590|101480964|FG001|Overall Study|Pregnancy|0|||
33433941|NCT01799590|101480965|FG002|Overall Study|Pregnancy|0|||
33433942|NCT01799590|101480963|FG000|Overall Study|Lack of Efficacy|3|||
33433943|NCT01799590|101480964|FG001|Overall Study|Lack of Efficacy|1|||
33433944|NCT01799590|101480965|FG002|Overall Study|Lack of Efficacy|3|||
33433945|NCT01799590|101480963|FG000|Overall Study|Participants convenience|4|||
33433946|NCT01799590|101480964|FG001|Overall Study|Participants convenience|4|||
33433947|NCT01799590|101480965|FG002|Overall Study|Participants convenience|2|||
33433948|NCT01799590|101480963|FG000|Overall Study|Aggravation of complications|0|||
33433949|NCT01799590|101480964|FG001|Overall Study|Aggravation of complications|1|||
33433950|NCT01799590|101480965|FG002|Overall Study|Aggravation of complications|1|||
33433951|NCT01799590|101480963|FG000|Overall Study|Using drugs with restricted days of use|0|||
33433952|NCT01799590|101480964|FG001|Overall Study|Using drugs with restricted days of use|3|||
33433953|NCT01799590|101480965|FG002|Overall Study|Using drugs with restricted days of use|2|||
33433954|NCT01799590|101480963|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
33433955|NCT01799590|101480964|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
33384891|NCT00249795|101295924|FG000|Overall Study|Withdrawal by Subject|678|||
33384892|NCT00249795|101295925|FG001|Overall Study|Withdrawal by Subject|742|||
33384893|NCT00249795|101295924|FG000|Overall Study|Thromboembolic / outcome event|39|||
33384894|NCT00249795|101295925|FG001|Overall Study|Thromboembolic / outcome event|45|||
33384895|NCT00249795|101295924|FG000|Overall Study|Oral anticoagulant required|2|||
33384896|NCT00249795|101295925|FG001|Overall Study|Oral anticoagulant required|0|||
33384897|NCT00249795|101295924|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
33384898|NCT00249795|101295925|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
33384899|NCT00249795|101295924|FG000|Overall Study|Non-compliance|71|||
33384900|NCT00249795|101295925|FG001|Overall Study|Non-compliance|69|||
33384901|NCT00249795|101295924|FG000|Overall Study|Study drug intolerance|3|||
33384902|NCT00249795|101295925|FG001|Overall Study|Study drug intolerance|3|||
33384903|NCT00249795|101295924|FG000|Overall Study|Other adverse events (non-serious)|188|||
33384904|NCT00249795|101295925|FG001|Overall Study|Other adverse events (non-serious)|159|||
33384905|NCT00249795|101295924|FG000|Overall Study|Physician withdrew consent|71|||
33384906|NCT00249795|101295925|FG001|Overall Study|Physician withdrew consent|63|||
33384907|NCT00249795|101295924|FG000|Overall Study|Surgery / procedure|4|||
33384908|NCT00249795|101295925|FG001|Overall Study|Surgery / procedure|5|||
33384909|NCT00249795|101295924|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
33384910|NCT00249795|101295925|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
33384911|NCT00249795|101295924|FG000|Overall Study|Lightheadedness / dizziness|15|||
33384912|NCT00249795|101295925|FG001|Overall Study|Lightheadedness / dizziness|11|||
33384913|NCT00249795|101295924|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
33384914|NCT00249795|101295925|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
33384915|NCT00249795|101295924|FG000|Overall Study|Other contraindicated medication|1|||
33384916|NCT00249795|101295925|FG001|Overall Study|Other contraindicated medication|1|||
33384917|NCT00249795|101295924|FG000|Overall Study|Event related to cardiac condition|17|||
33384918|NCT00249795|101295925|FG001|Overall Study|Event related to cardiac condition|16|||
33384919|NCT00249795|101295924|FG000|Overall Study|Patient not wish to continue after May08|4|||
33592289|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33592290|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
33592291|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33592292|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33592293|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33592294|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33592295|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
33592296|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
33592297|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33592298|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33592299|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33592300|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33592301|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33592302|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33592303|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33592304|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33592305|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
33592306|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
33592307|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
33592308|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
33592309|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
33592310|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
33592311|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
33592312|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
33592313|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
33592314|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
33592315|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
33592316|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
33592317|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33433956|NCT01799590|101480965|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
33433957|NCT01799590|101480963|FG000|Overall Study|Other|3|||
33433958|NCT01799590|101480964|FG001|Overall Study|Other|0|||
33433959|NCT01799590|101480965|FG002|Overall Study|Other|1|||
33433960|NCT00433381|101480966|FG000|Overall Study|Ineligible / no protocol treatment|3|||
33433961|NCT00433381|101480967|FG001|Overall Study|Ineligible / no protocol treatment|3|||
33433962|NCT05487456|101480968|FG000|Overall Study|Withdrawal by Subject|0|||
33433963|NCT05487456|101480969|FG001|Overall Study|Withdrawal by Subject|0|||
33433964|NCT05487456|101480970|FG002|Overall Study|Withdrawal by Subject|1|||
33433965|NCT05487456|101480971|FG003|Overall Study|Withdrawal by Subject|0|||
33592318|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33592319|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
33592320|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33592321|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33592322|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33592323|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33592324|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33592325|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
33592326|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
33592327|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
33592328|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
33592329|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
33592330|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
33592331|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
33592332|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
33592333|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
33433966|NCT00368277|101480972|FG000|Overall Study|Adverse Event|33|||
33433967|NCT00368277|101480973|FG001|Overall Study|Adverse Event|49|||
33592334|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
33592335|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
33592336|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
33592337|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
33592338|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
33592339|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33592340|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
33592341|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33592342|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33592343|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33592344|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33592345|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33150198|NCT00426231|100463670|FG000|Overall Study|Withdrawal by Subject|9|||
33150199|NCT00426231|100463671|FG001|Overall Study|Withdrawal by Subject|12|||
33150200|NCT01068652|100463672|FG000|Overall Study|Adverse Event|4|||
33150201|NCT01068652|100463673|FG001|Overall Study|Adverse Event|0|||
33150202|NCT01068652|100463672|FG000|Overall Study|Lack of Efficacy|0|||
33150203|NCT01068652|100463673|FG001|Overall Study|Lack of Efficacy|2|||
33150204|NCT01068652|100463672|FG000|Overall Study|Lost to Follow-up|2|||
33150205|NCT01068652|100463673|FG001|Overall Study|Lost to Follow-up|1|||
33150206|NCT01068652|100463672|FG000|Overall Study|Protocol Violation|3|||
33150207|NCT01068652|100463673|FG001|Overall Study|Protocol Violation|6|||
33150208|NCT01068652|100463672|FG000|Overall Study|Withdrawal criteria|1|||
33150209|NCT01068652|100463673|FG001|Overall Study|Withdrawal criteria|2|||
33150210|NCT01068652|100463672|FG000|Overall Study|Patient was not eligible|1|||
33150211|NCT01068652|100463673|FG001|Overall Study|Patient was not eligible|0|||
33150212|NCT01068652|100463672|FG000|Overall Study|Unclassified|7|||
33150213|NCT01068652|100463673|FG001|Overall Study|Unclassified|4|||
33150214|NCT00857415|100463674|FG000|Overall Study|Image acquisition failure|2|||
33150215|NCT00857415|100463675|FG001|Overall Study|Image acquisition failure|0|||
33249798|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
33150216|NCT00857415|100463674|FG000|Overall Study|Invalid image or not imaged|3|||
33150217|NCT00857415|100463675|FG001|Overall Study|Invalid image or not imaged|0|||
33150218|NCT00857415|100463674|FG000|Overall Study|Subject still living at end of study|110|||
33150219|NCT00857415|100463675|FG001|Overall Study|Subject still living at end of study|0|||
33150220|NCT00857415|100463674|FG000|Overall Study|Deceased with no autopsy|2|||
33150221|NCT00857415|100463675|FG001|Overall Study|Deceased with no autopsy|0|||
33150222|NCT00518973|100463680|FG000|Overall Study|Withdrawal by Subject|3|||
33150223|NCT00518973|100463681|FG001|Overall Study|Withdrawal by Subject|2|||
33150224|NCT00386607|100463682|FG000|Core|Adverse Event|40|||
33150225|NCT00386607|100463683|FG001|Core|Adverse Event|0|||
33150226|NCT00386607|100463682|FG000|Core|Abnormal laboratory value(s)|3|||
33433968|NCT00368277|101480972|FG000|Overall Study|Death|2|||
33433969|NCT00368277|101480973|FG001|Overall Study|Death|1|||
33150227|NCT00386607|100463683|FG001|Core|Abnormal laboratory value(s)|0|||
33150228|NCT00386607|100463682|FG000|Core|Unsatisfactory therapeutic effect|23|||
33150229|NCT00386607|100463683|FG001|Core|Unsatisfactory therapeutic effect|0|||
33384920|NCT00249795|101295925|FG001|Overall Study|Patient not wish to continue after May08|6|||
33384921|NCT00249795|101295924|FG000|Overall Study|Site not agree to continue after May08|1|||
33384922|NCT00249795|101295925|FG001|Overall Study|Site not agree to continue after May08|1|||
33592346|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
33592347|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
33592348|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
33592349|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
33592350|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
33592351|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
33592352|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
33592353|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
33592354|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
33592355|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
33592356|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
33592357|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
33592358|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33592359|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
33592360|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
33592361|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33592362|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33592363|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33592364|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33592365|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33592366|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592367|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592368|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
33592369|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592370|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
33592371|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592372|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592373|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592374|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592375|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592376|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
33592377|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
33592378|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
33592379|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
33592380|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
33592381|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
33592382|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
33592383|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
33592384|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
33150230|NCT00386607|100463682|FG000|Core|Condition no longer requires study drug|4|||
33592385|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
33592386|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592387|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33384923|NCT00249795|101295924|FG000|Overall Study|Lost to Follow-up|0|||
33384924|NCT00249795|101295925|FG001|Overall Study|Lost to Follow-up|2|||
33592388|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592389|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
33592390|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
33592391|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592392|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592393|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592394|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592395|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592396|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
33592397|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33592398|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
33592399|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
33592400|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
33592401|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33592402|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33592403|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33592404|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33592405|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33592406|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
33592407|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592408|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592409|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592410|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
33592411|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592412|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592413|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592414|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592415|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
33592416|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592417|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592418|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592419|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592420|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
33592421|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33384925|NCT00249795|101295924|FG000|Overall Study|Missing|0|||
33150231|NCT00386607|100463683|FG001|Core|Condition no longer requires study drug|0|||
33150232|NCT00386607|100463682|FG000|Core|Patient withdrew consent|15|||
33150233|NCT00386607|100463683|FG001|Core|Patient withdrew consent|0|||
33150234|NCT00386607|100463682|FG000|Core|Lost to Follow-up|23|||
33150235|NCT00386607|100463683|FG001|Core|Lost to Follow-up|0|||
33150236|NCT00386607|100463682|FG000|Core|Administrative problems|1|||
33433970|NCT00368277|101480972|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
33433971|NCT00368277|101480973|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
33433972|NCT00368277|101480972|FG000|Overall Study|Protocol deviation|7|||
33433973|NCT00368277|101480973|FG001|Overall Study|Protocol deviation|0|||
33433974|NCT00368277|101480972|FG000|Overall Study|Patient withdrew consent|32|||
33150237|NCT00386607|100463683|FG001|Core|Administrative problems|0|||
33150238|NCT00386607|100463682|FG000|Core|Protocol Deviation|6|||
33150239|NCT00386607|100463683|FG001|Core|Protocol Deviation|0|||
33150240|NCT00386607|100463682|FG000|Extension|Adverse Event|0|||
33150241|NCT00386607|100463683|FG001|Extension|Adverse Event|6|||
33150242|NCT00386607|100463682|FG000|Extension|Abnormal laboratory value(s)|0|||
33150243|NCT00386607|100463683|FG001|Extension|Abnormal laboratory value(s)|1|||
33150244|NCT00386607|100463682|FG000|Extension|Administrative problems|0|||
33150245|NCT00386607|100463683|FG001|Extension|Administrative problems|1|||
33433975|NCT00368277|101480973|FG001|Overall Study|Patient withdrew consent|28|||
33433976|NCT00368277|101480972|FG000|Overall Study|Lost to Follow-up|8|||
33150246|NCT00386607|100463682|FG000|Extension|Lost to Follow-up|0|||
33150247|NCT00386607|100463683|FG001|Extension|Lost to Follow-up|3|||
33150248|NCT00386607|100463682|FG000|Extension|Patient withdrew consent|0|||
33150249|NCT00386607|100463683|FG001|Extension|Patient withdrew consent|5|||
33150250|NCT00386607|100463682|FG000|Extension|Unsatisfactory therapeutic effect|0|||
33150251|NCT00386607|100463683|FG001|Extension|Unsatisfactory therapeutic effect|1|||
33150252|NCT01676727|100463686|FG000|Overall Study|Death|18|||
33150253|NCT01676727|100463686|FG000|Overall Study|Withdrawal by Subject|6|||
33433977|NCT00368277|101480973|FG001|Overall Study|Lost to Follow-up|6|||
33150254|NCT01676727|100463686|FG000|Overall Study|Screening failure|5|||
33150255|NCT01676727|100463686|FG000|Overall Study|Not willing to attend 1-year visit|2|||
33433978|NCT00275002|101480974|FG000|Overall Study|Death|1|||
33150256|NCT01676727|100463686|FG000|Overall Study|Valve explanted|1|||
33150257|NCT03139279|100463687|FG000|Overall Study|Physician Decision|2|||
33150258|NCT03139279|100463688|FG001|Overall Study|Physician Decision|0|||
33433979|NCT00275002|101480975|FG001|Overall Study|Death|0|||
33384926|NCT00249795|101295925|FG001|Overall Study|Missing|1|||
33433980|NCT00275002|101480974|FG000|Overall Study|Disease progression|21|||
33592422|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592423|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592424|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592425|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592426|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33592427|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
33592428|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33592429|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33592430|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
33592431|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33592432|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33592433|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33592434|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33592435|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
33592436|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
33592437|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33592438|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33592439|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33592440|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
33592441|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33592442|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33592443|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33592444|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33592445|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
33592446|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
33592447|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
33592448|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
33592449|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
33592450|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
33592451|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
33592452|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
33592453|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
33592454|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
33592455|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
33592456|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Other|5|||
33592457|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Other|1|||
33592458|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Other|0|||
33592459|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Other|3|||
33592460|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Other|0|||
33592461|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Other|0|||
33592462|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Other|0|||
33384927|NCT01924299|101295937|FG000|Period 2|Withdrawal by Subject|1|||
33384928|NCT01924299|101295938|FG001|Period 2|Withdrawal by Subject|0|||
33384929|NCT01924299|101295937|FG000|Period 2|Adverse Event|0|||
33384930|NCT01924299|101295938|FG001|Period 2|Adverse Event|1|||
33384931|NCT02148211|101295939|FG000|Overall Study|Lost to Follow-up|352|||
33384932|NCT01410799|101295940|FG000|Overall Study|PI decision|13|||
33384933|NCT01270958|101295941|FG000|Overall Study|Lost to Follow-up|2|||
33384934|NCT01270958|101295941|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
33384935|NCT03657810|101295942|FG000|Overall Study|Adverse Event|0|||
33384936|NCT03657810|101295943|FG001|Overall Study|Adverse Event|1|||
33384937|NCT03657810|101295944|FG002|Overall Study|Adverse Event|0|||
33384938|NCT03657810|101295942|FG000|Overall Study|Lack of Efficacy|4|||
33384939|NCT03657810|101295943|FG001|Overall Study|Lack of Efficacy|1|||
33384940|NCT03657810|101295944|FG002|Overall Study|Lack of Efficacy|3|||
33384941|NCT03657810|101295942|FG000|Overall Study|Protocol Violation|1|||
33384942|NCT03657810|101295943|FG001|Overall Study|Protocol Violation|0|||
33384943|NCT03657810|101295944|FG002|Overall Study|Protocol Violation|0|||
33384944|NCT03657810|101295942|FG000|Overall Study|Lost to Follow-up|0|||
33384945|NCT03657810|101295943|FG001|Overall Study|Lost to Follow-up|1|||
33384946|NCT03657810|101295944|FG002|Overall Study|Lost to Follow-up|0|||
33433981|NCT00275002|101480975|FG001|Overall Study|Disease progression|15|||
33384947|NCT03657810|101295942|FG000|Overall Study|Not provided|0|||
33150259|NCT03139279|100463687|FG000|Overall Study|Protocol Violation|5|||
33384948|NCT03657810|101295943|FG001|Overall Study|Not provided|1|||
33433982|NCT00275002|101480974|FG000|Overall Study|Adverse Event|0|||
33433983|NCT00275002|101480975|FG001|Overall Study|Adverse Event|1|||
33433984|NCT00662129|101480976|FG000|Overall Study|Protocol Violation|1|||
33433985|NCT00662129|101480976|FG000|Overall Study|Cancel prior to beginning treatment|1|||
33433986|NCT00662129|101480976|FG000|Overall Study|Ineligible|1|||
33433987|NCT04471935|101480977|FG000|Overall Study|Withdrawal by Subject|1|||
33433988|NCT04471935|101480977|FG000|Overall Study|Deemed ineligible to participate|1|||
33433989|NCT00299156|101480978|FG000|Period 2 (Randomized)|Screen Failure|0|||
33433990|NCT00299156|101480979|FG001|Period 2 (Randomized)|Screen Failure|1|||
33433991|NCT00299156|101480980|FG002|Period 2 (Randomized)|Screen Failure|0|||
33433992|NCT02750306|101480981|FG000|Overall Study|Withdrawal by Subject|5|||
33433993|NCT02750306|101480982|FG001|Overall Study|Withdrawal by Subject|2|||
33433994|NCT02750306|101480981|FG000|Overall Study|Protocol Violation|1|||
33433995|NCT02750306|101480982|FG001|Overall Study|Protocol Violation|0|||
33433996|NCT04161144|101480987|FG000|Overall Study|Withdrawal by Subject|0|||
33433997|NCT04161144|101480988|FG001|Overall Study|Withdrawal by Subject|1|||
33433998|NCT04161144|101480987|FG000|Overall Study|Protocol Violation|1|||
33433999|NCT04161144|101480988|FG001|Overall Study|Protocol Violation|0|||
33434000|NCT02224391|101480989|FG000|Overall Study|Lost to Follow-up|26|||
33434001|NCT02224391|101480990|FG001|Overall Study|Lost to Follow-up|19|||
33434002|NCT02224391|101480989|FG000|Overall Study|Withdrawal by Subject|6|||
33434003|NCT02224391|101480990|FG001|Overall Study|Withdrawal by Subject|5|||
33434004|NCT02848599|101480991|FG000|Overall Study|Protocol Violation|7|||
33434005|NCT02848599|101480992|FG001|Overall Study|Protocol Violation|9|||
33434006|NCT02162758|101480997|FG000|Overall Study|Study termination|0|||
33434007|NCT02162758|101480998|FG001|Overall Study|Study termination|1|||
33249799|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
33249800|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
33384949|NCT03657810|101295944|FG002|Overall Study|Not provided|0|||
33384950|NCT00728936|101295945|FG000|Overall Study|Withdrawal by Subject|0|||
33384951|NCT00728936|101295946|FG001|Overall Study|Withdrawal by Subject|0|||
33384952|NCT00728936|101295947|FG002|Overall Study|Withdrawal by Subject|0|||
33384953|NCT00728936|101295948|FG003|Overall Study|Withdrawal by Subject|0|||
33384954|NCT00728936|101295949|FG004|Overall Study|Withdrawal by Subject|0|||
33384955|NCT00728936|101295950|FG005|Overall Study|Withdrawal by Subject|1|||
33384956|NCT00728936|101295951|FG006|Overall Study|Withdrawal by Subject|0|||
33384957|NCT03024255|101295953|FG000|Overall Study|Adverse Event|1|||
33384958|NCT03024255|101295954|FG001|Overall Study|Adverse Event|4|||
33384959|NCT03024255|101295955|FG002|Overall Study|Adverse Event|8|||
33384960|NCT03024255|101295956|FG003|Overall Study|Adverse Event|0|||
33384961|NCT03024255|101295953|FG000|Overall Study|Withdrawal by Subject|3|||
33384962|NCT03024255|101295954|FG001|Overall Study|Withdrawal by Subject|1|||
33384963|NCT03024255|101295955|FG002|Overall Study|Withdrawal by Subject|0|||
33384964|NCT03024255|101295956|FG003|Overall Study|Withdrawal by Subject|3|||
33384965|NCT03024255|101295953|FG000|Overall Study|Protocol Violation|0|||
33384966|NCT03024255|101295954|FG001|Overall Study|Protocol Violation|0|||
33384967|NCT03024255|101295955|FG002|Overall Study|Protocol Violation|2|||
33384968|NCT03024255|101295956|FG003|Overall Study|Protocol Violation|0|||
33384969|NCT03024255|101295953|FG000|Overall Study|Lost to Follow-up|1|||
33384970|NCT03024255|101295954|FG001|Overall Study|Lost to Follow-up|2|||
33384971|NCT03024255|101295955|FG002|Overall Study|Lost to Follow-up|1|||
33384972|NCT03024255|101295956|FG003|Overall Study|Lost to Follow-up|1|||
33384973|NCT03024255|101295953|FG000|Overall Study|Lack of Efficacy|1|||
33384974|NCT03024255|101295954|FG001|Overall Study|Lack of Efficacy|0|||
33384975|NCT03024255|101295955|FG002|Overall Study|Lack of Efficacy|0|||
33384976|NCT03024255|101295956|FG003|Overall Study|Lack of Efficacy|0|||
33384977|NCT03024255|101295953|FG000|Overall Study|Protocol Noncompliance|1|||
33384978|NCT03024255|101295954|FG001|Overall Study|Protocol Noncompliance|1|||
33384979|NCT03024255|101295955|FG002|Overall Study|Protocol Noncompliance|0|||
33384980|NCT03024255|101295956|FG003|Overall Study|Protocol Noncompliance|1|||
33384981|NCT03814005|101295957|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
33384982|NCT03814005|101295958|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
33384983|NCT03814005|101295959|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
33384984|NCT03814005|101295957|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
33384985|NCT03814005|101295958|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
33434008|NCT00720798|101480999|FG000|Overall Study|Adverse Event|304|||
33434009|NCT00720798|101480999|FG000|Overall Study|Death|39|||
33434010|NCT00720798|101480999|FG000|Overall Study|Insufficient Therapeutic Response|129|||
33434011|NCT00720798|101480999|FG000|Overall Study|Protocol Violation|4|||
33434012|NCT00720798|101480999|FG000|Overall Study|Refused Treatment|151|||
33434013|NCT00720798|101480999|FG000|Overall Study|Failure to Return|46|||
33249801|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
33434014|NCT00720798|101480999|FG000|Overall Study|Reason not Specified|83|||
33434015|NCT00625807|101481002|FG000|Overall Study|schedule conflict|2|||
33434016|NCT00625807|101481003|FG001|Overall Study|schedule conflict|8|||
33434017|NCT04000009|101481004|FG000|Overall Study|Adverse Event|13|||
33434018|NCT04000009|101481004|FG000|Overall Study|Lack of Efficacy|7|||
33592463|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Other|0|||
33592464|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Other|0|||
33592465|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Other|0|||
33592466|NCT03352557|102057540|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
33592467|NCT03352557|102057541|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
33592468|NCT03352557|102057542|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
33592469|NCT03352557|102057543|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
33592470|NCT03352557|102057544|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
33592471|NCT03352557|102057545|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
33592472|NCT03352557|102057546|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
33592473|NCT03352557|102057547|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
33592474|NCT03352557|102057548|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
33592475|NCT03352557|102057549|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
33592476|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|Death|0|||
33592477|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|Death|0|||
33592478|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|Death|0|||
33592479|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|Death|0|||
33592480|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|Death|0|||
33592481|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|Death|1|||
33592482|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|Death|0|||
33592483|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|Death|1|||
33592484|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|Death|1|||
33592485|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|Death|1|||
33592486|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33592487|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33592488|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33592489|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33592490|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33592491|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
33592492|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33592493|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33592494|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33434019|NCT04000009|101481004|FG000|Overall Study|Lost to Follow-up|8|||
33434020|NCT04000009|101481004|FG000|Overall Study|Noncompliance with study drug|4|||
33434021|NCT04000009|101481004|FG000|Overall Study|Physician Decision|1|||
33592495|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
33592496|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33592497|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33592498|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33592499|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33592500|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33592501|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33592502|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33592503|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33592504|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
33592505|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
33592506|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
33592507|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
33592508|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
33592509|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
33592510|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
33592511|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
33592512|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
33592513|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
33592514|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
33592515|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
33592516|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33592517|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33592518|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33592519|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33592520|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33592521|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
33592522|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
33592523|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
33592524|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
33592525|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
33592526|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33592527|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33592528|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33592529|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33592530|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33592531|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
33592532|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33592533|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
33592534|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
33592535|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
33592536|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
33592537|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
33592538|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
33592539|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
33592540|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
33592541|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
33592542|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
33592543|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
33592544|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
33592545|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
33592546|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592547|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592548|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592549|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592550|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592551|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592552|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592553|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
33592554|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
33384986|NCT03814005|101295959|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
33384987|NCT03814005|101295957|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
33384988|NCT03814005|101295958|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
33384989|NCT03814005|101295959|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
33384990|NCT03814005|101295957|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
33384991|NCT03814005|101295958|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
33592555|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
33592556|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33592557|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33592558|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33384992|NCT03814005|101295959|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
33434022|NCT04000009|101481004|FG000|Overall Study|Use of prohibited medication|3|||
33434023|NCT04000009|101481004|FG000|Overall Study|Pregnancy|1|||
33434024|NCT04000009|101481004|FG000|Overall Study|Withdrawal by Subject|22|||
33434025|NCT04000009|101481004|FG000|Overall Study|Study terminated by sponsor|98|||
33434026|NCT04000009|101481004|FG000|Overall Study|Not further specified|8|||
33434027|NCT00358826|101481005|FG000|Core Study|Adverse Event|1|||
33434028|NCT00358826|101481006|FG001|Core Study|Adverse Event|3|||
33434029|NCT00358826|101481007|FG002|Core Study|Adverse Event|1|||
33434030|NCT00358826|101481008|FG003|Core Study|Adverse Event|1|||
33434031|NCT00358826|101481009|FG004|Core Study|Adverse Event|0|||
33434032|NCT00358826|101481010|FG005|Core Study|Adverse Event|0|||
33434033|NCT00358826|101481011|FG006|Core Study|Adverse Event|0|||
33434034|NCT00358826|101481012|FG007|Core Study|Adverse Event|0|||
33592559|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33592560|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33592561|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33592562|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33592563|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
33592564|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33384993|NCT03814005|101295957|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
33384994|NCT03814005|101295958|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
33384995|NCT03814005|101295959|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
33384996|NCT03814005|101295957|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
33384997|NCT03814005|101295958|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
33384998|NCT03814005|101295959|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
33384999|NCT01142193|101295960|FG000|Overall Study|Adverse Event|12|||
33385000|NCT01142193|101295961|FG001|Overall Study|Adverse Event|4|||
33385001|NCT01142193|101295960|FG000|Overall Study|Lack of Efficacy|2|||
33385002|NCT01142193|101295961|FG001|Overall Study|Lack of Efficacy|1|||
33385003|NCT01142193|101295960|FG000|Overall Study|Physician Decision|1|||
33385004|NCT01142193|101295961|FG001|Overall Study|Physician Decision|1|||
33385005|NCT01142193|101295960|FG000|Overall Study|Withdrawal by Subject|4|||
33385006|NCT01142193|101295961|FG001|Overall Study|Withdrawal by Subject|3|||
33385007|NCT01142193|101295960|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
33385008|NCT01142193|101295961|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
33385009|NCT01142193|101295960|FG000|Overall Study|Other|1|||
33385010|NCT01142193|101295961|FG001|Overall Study|Other|2|||
33385011|NCT00696436|101295962|FG000|Overall Study|Adverse Event|7|||
33385012|NCT00696436|101295963|FG001|Overall Study|Adverse Event|9|||
33385013|NCT00696436|101295964|FG002|Overall Study|Adverse Event|8|||
33385014|NCT00696436|101295965|FG003|Overall Study|Adverse Event|6|||
33385015|NCT00696436|101295966|FG004|Overall Study|Adverse Event|4|||
33385016|NCT00696436|101295962|FG000|Overall Study|Protocol Violation|3|||
33385017|NCT00696436|101295963|FG001|Overall Study|Protocol Violation|2|||
33385018|NCT00696436|101295964|FG002|Overall Study|Protocol Violation|2|||
33385019|NCT00696436|101295965|FG003|Overall Study|Protocol Violation|0|||
33385020|NCT00696436|101295966|FG004|Overall Study|Protocol Violation|1|||
33385021|NCT00696436|101295962|FG000|Overall Study|Lost to Follow-up|1|||
33385022|NCT00696436|101295963|FG001|Overall Study|Lost to Follow-up|6|||
33385023|NCT00696436|101295964|FG002|Overall Study|Lost to Follow-up|2|||
33385024|NCT00696436|101295965|FG003|Overall Study|Lost to Follow-up|4|||
33434035|NCT00358826|101481005|FG000|Core Study|Withdrawal by Subject|2|||
33434036|NCT00358826|101481006|FG001|Core Study|Withdrawal by Subject|2|||
33434037|NCT00358826|101481007|FG002|Core Study|Withdrawal by Subject|0|||
33434038|NCT00358826|101481008|FG003|Core Study|Withdrawal by Subject|0|||
33434039|NCT00358826|101481009|FG004|Core Study|Withdrawal by Subject|0|||
33434040|NCT00358826|101481010|FG005|Core Study|Withdrawal by Subject|0|||
33434041|NCT00358826|101481011|FG006|Core Study|Withdrawal by Subject|0|||
33385025|NCT00696436|101295966|FG004|Overall Study|Lost to Follow-up|3|||
33385026|NCT00696436|101295962|FG000|Overall Study|Withdrawal by Subject|4|||
33385027|NCT00696436|101295963|FG001|Overall Study|Withdrawal by Subject|11|||
33434042|NCT00358826|101481012|FG007|Core Study|Withdrawal by Subject|0|||
33150260|NCT03139279|100463688|FG001|Overall Study|Protocol Violation|4|||
33385028|NCT00696436|101295964|FG002|Overall Study|Withdrawal by Subject|5|||
33434043|NCT00358826|101481005|FG000|Core Study|Lost to Follow-up|0|||
33385029|NCT00696436|101295965|FG003|Overall Study|Withdrawal by Subject|7|||
33385030|NCT00696436|101295966|FG004|Overall Study|Withdrawal by Subject|1|||
33385031|NCT00696436|101295962|FG000|Overall Study|Lack of Efficacy|3|||
33385032|NCT00696436|101295963|FG001|Overall Study|Lack of Efficacy|1|||
33385033|NCT00696436|101295964|FG002|Overall Study|Lack of Efficacy|5|||
33385034|NCT00696436|101295965|FG003|Overall Study|Lack of Efficacy|2|||
33385035|NCT00696436|101295966|FG004|Overall Study|Lack of Efficacy|4|||
33385036|NCT00696436|101295962|FG000|Overall Study|Participant Unavailability|2|||
33385037|NCT00696436|101295963|FG001|Overall Study|Participant Unavailability|0|||
33385038|NCT00696436|101295964|FG002|Overall Study|Participant Unavailability|2|||
33385039|NCT00696436|101295965|FG003|Overall Study|Participant Unavailability|1|||
33385040|NCT00696436|101295966|FG004|Overall Study|Participant Unavailability|0|||
33385041|NCT00696436|101295962|FG000|Overall Study|Administrative Error|2|||
33385042|NCT00696436|101295963|FG001|Overall Study|Administrative Error|0|||
33385043|NCT00696436|101295964|FG002|Overall Study|Administrative Error|2|||
33385044|NCT00696436|101295965|FG003|Overall Study|Administrative Error|0|||
33385045|NCT00696436|101295966|FG004|Overall Study|Administrative Error|0|||
33385046|NCT00696436|101295962|FG000|Overall Study|Participant Non-compliance|0|||
33385047|NCT00696436|101295963|FG001|Overall Study|Participant Non-compliance|0|||
33385048|NCT00696436|101295964|FG002|Overall Study|Participant Non-compliance|1|||
33385049|NCT00696436|101295965|FG003|Overall Study|Participant Non-compliance|2|||
33434044|NCT00358826|101481006|FG001|Core Study|Lost to Follow-up|0|||
33434045|NCT00358826|101481007|FG002|Core Study|Lost to Follow-up|0|||
33434046|NCT00358826|101481008|FG003|Core Study|Lost to Follow-up|1|||
33434047|NCT00358826|101481009|FG004|Core Study|Lost to Follow-up|0|||
33434048|NCT00358826|101481010|FG005|Core Study|Lost to Follow-up|0|||
33434049|NCT00358826|101481011|FG006|Core Study|Lost to Follow-up|0|||
33434050|NCT00358826|101481012|FG007|Core Study|Lost to Follow-up|0|||
33434051|NCT00358826|101481005|FG000|Core Study|Physician Decision|0|||
33434052|NCT00358826|101481006|FG001|Core Study|Physician Decision|0|||
33434053|NCT00358826|101481007|FG002|Core Study|Physician Decision|1|||
33434054|NCT00358826|101481008|FG003|Core Study|Physician Decision|0|||
33434055|NCT00358826|101481009|FG004|Core Study|Physician Decision|0|||
33434056|NCT00358826|101481010|FG005|Core Study|Physician Decision|0|||
33434057|NCT00358826|101481011|FG006|Core Study|Physician Decision|0|||
33434058|NCT00358826|101481012|FG007|Core Study|Physician Decision|0|||
33434059|NCT00358826|101481005|FG000|MDCT Substudy|Adverse Event|0|||
33434060|NCT00358826|101481006|FG001|MDCT Substudy|Adverse Event|0|||
33434061|NCT00358826|101481007|FG002|MDCT Substudy|Adverse Event|0|||
33434062|NCT00358826|101481008|FG003|MDCT Substudy|Adverse Event|0|||
33434063|NCT00358826|101481009|FG004|MDCT Substudy|Adverse Event|1|||
33434064|NCT00358826|101481010|FG005|MDCT Substudy|Adverse Event|0|||
33434065|NCT00358826|101481011|FG006|MDCT Substudy|Adverse Event|0|||
33434066|NCT00358826|101481012|FG007|MDCT Substudy|Adverse Event|0|||
33434067|NCT00358826|101481005|FG000|MDCT Substudy|Lost to Follow-up|0|||
33434068|NCT00358826|101481006|FG001|MDCT Substudy|Lost to Follow-up|0|||
33434069|NCT00358826|101481007|FG002|MDCT Substudy|Lost to Follow-up|0|||
33434070|NCT00358826|101481008|FG003|MDCT Substudy|Lost to Follow-up|0|||
33434071|NCT00358826|101481009|FG004|MDCT Substudy|Lost to Follow-up|0|||
33434072|NCT00358826|101481010|FG005|MDCT Substudy|Lost to Follow-up|1|||
33434073|NCT00358826|101481011|FG006|MDCT Substudy|Lost to Follow-up|0|||
33434074|NCT00358826|101481012|FG007|MDCT Substudy|Lost to Follow-up|0|||
33434075|NCT00358826|101481005|FG000|MDCT Substudy|Withdrawal by Subject|0|||
33434076|NCT00358826|101481006|FG001|MDCT Substudy|Withdrawal by Subject|0|||
33150261|NCT03139279|100463687|FG000|Overall Study|Withdrawal by Subject|0|||
33385050|NCT00696436|101295966|FG004|Overall Study|Participant Non-compliance|0|||
33385051|NCT00696436|101295962|FG000|Overall Study|Administrative Decision|1|||
33385052|NCT00696436|101295963|FG001|Overall Study|Administrative Decision|0|||
33385053|NCT00696436|101295964|FG002|Overall Study|Administrative Decision|0|||
33385054|NCT00696436|101295965|FG003|Overall Study|Administrative Decision|0|||
33385055|NCT00696436|101295966|FG004|Overall Study|Administrative Decision|0|||
33434077|NCT00358826|101481007|FG002|MDCT Substudy|Withdrawal by Subject|0|||
33434078|NCT00358826|101481008|FG003|MDCT Substudy|Withdrawal by Subject|0|||
33434079|NCT00358826|101481009|FG004|MDCT Substudy|Withdrawal by Subject|0|||
33434080|NCT00358826|101481010|FG005|MDCT Substudy|Withdrawal by Subject|1|||
33434081|NCT00358826|101481011|FG006|MDCT Substudy|Withdrawal by Subject|0|||
33434082|NCT00358826|101481012|FG007|MDCT Substudy|Withdrawal by Subject|0|||
33434083|NCT02768298|101481013|FG000|Overall Study|Adverse Event|1|||
33434084|NCT02768298|101481014|FG001|Overall Study|Adverse Event|4|||
33434085|NCT02768298|101481013|FG000|Overall Study|Death|2|||
33434086|NCT02768298|101481014|FG001|Overall Study|Death|1|||
33434087|NCT02768298|101481013|FG000|Overall Study|Non-compliance with study treatment|0|||
33434088|NCT02768298|101481014|FG001|Overall Study|Non-compliance with study treatment|1|||
33434089|NCT02768298|101481013|FG000|Overall Study|Subject/guardian decision|1|||
33434090|NCT02768298|101481014|FG001|Overall Study|Subject/guardian decision|0|||
33150262|NCT03139279|100463688|FG001|Overall Study|Withdrawal by Subject|2|||
33150263|NCT01986140|100463691|FG000|Overall Study|Withdrawal by Subject|31|||
33150264|NCT01986140|100463692|FG001|Overall Study|Withdrawal by Subject|25|||
33150265|NCT01986140|100463691|FG000|Overall Study|alternative treatment|1|||
33150266|NCT01986140|100463692|FG001|Overall Study|alternative treatment|1|||
33150267|NCT01986140|100463691|FG000|Overall Study|found not eligible|3|||
33150268|NCT01986140|100463692|FG001|Overall Study|found not eligible|0|||
33150269|NCT01986140|100463691|FG000|Overall Study|Adverse Event|0|||
33150270|NCT01986140|100463692|FG001|Overall Study|Adverse Event|1|||
33150271|NCT01986140|100463691|FG000|Overall Study|progression disease|0|||
33249802|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
33150272|NCT01986140|100463692|FG001|Overall Study|progression disease|1|||
33385056|NCT00696436|101295962|FG000|Overall Study|Missing|0|||
33592565|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
33592566|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33592567|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33592568|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33592569|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33592570|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33592571|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33592572|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33592573|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
33592574|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33592575|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
33592576|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592577|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592578|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592579|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592580|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592581|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592582|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592583|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
33592584|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
33592585|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
33592586|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33592587|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33592588|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33592589|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33592590|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33592591|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
33592592|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33592593|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33592594|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
33592595|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
33592596|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33592597|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33592598|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33592599|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33592600|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33592601|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33592602|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33592603|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33592604|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
33592605|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
33385057|NCT00696436|101295963|FG001|Overall Study|Missing|1|||
33385058|NCT00696436|101295964|FG002|Overall Study|Missing|1|||
33385059|NCT00696436|101295965|FG003|Overall Study|Missing|0|||
33385060|NCT00696436|101295966|FG004|Overall Study|Missing|0|||
33385061|NCT01814826|101295967|FG000|Overall Study|Other|3|||
33385062|NCT01814826|101295968|FG001|Overall Study|Other|5|||
33385063|NCT01814826|101295969|FG002|Overall Study|Other|0|||
33385064|NCT01814826|101295967|FG000|Overall Study|Death|29|||
33385065|NCT01814826|101295968|FG001|Overall Study|Death|24|||
33385066|NCT01814826|101295969|FG002|Overall Study|Death|3|||
33434091|NCT02768298|101481013|FG000|Overall Study|Withdrawal of informed consent|0|||
33434092|NCT02768298|101481014|FG001|Overall Study|Withdrawal of informed consent|1|||
33434093|NCT01296932|101481015|FG000|Overall Study|Dose limiting toxicity|0|||
33434094|NCT01296932|101481016|FG001|Overall Study|Dose limiting toxicity|0|||
33434095|NCT01296932|101481017|FG002|Overall Study|Dose limiting toxicity|0|||
33434096|NCT01296932|101481018|FG003|Overall Study|Dose limiting toxicity|0|||
33434097|NCT01296932|101481019|FG004|Overall Study|Dose limiting toxicity|0|||
33434098|NCT01296932|101481020|FG005|Overall Study|Dose limiting toxicity|0|||
33434099|NCT01296932|101481021|FG006|Overall Study|Dose limiting toxicity|1|||
33434100|NCT01296932|101481022|FG007|Overall Study|Dose limiting toxicity|0|||
33434101|NCT01296932|101481023|FG008|Overall Study|Dose limiting toxicity|1|||
33434102|NCT01296932|101481015|FG000|Overall Study|Progressive disease|2|||
33434103|NCT01296932|101481016|FG001|Overall Study|Progressive disease|0|||
33434104|NCT01296932|101481017|FG002|Overall Study|Progressive disease|1|||
33150273|NCT00910988|100463693|FG000|Overall Study|Lost to Follow-up|2|||
33150274|NCT00910988|100463694|FG001|Overall Study|Lost to Follow-up|4|||
33150275|NCT00910988|100463695|FG002|Overall Study|Lost to Follow-up|3|||
33249803|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
33249804|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
33249805|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
33385067|NCT00924729|101295970|FG000|Overall Study|insufficient volume for analysis|1|||
33385068|NCT00924729|101295971|FG001|Overall Study|insufficient volume for analysis|0|||
33385069|NCT00924729|101295970|FG000|Overall Study|Protocol Violation|1|||
33385070|NCT00924729|101295971|FG001|Overall Study|Protocol Violation|0|||
33385071|NCT00709124|101295972|FG000|Overall Study|Death|3|||
33385072|NCT00709124|101295973|FG001|Overall Study|Death|1|||
33385073|NCT00709124|101295972|FG000|Overall Study|encephalopathy; can't do assessment|1|||
33385074|NCT00709124|101295973|FG001|Overall Study|encephalopathy; can't do assessment|0|||
33385075|NCT02674685|101295974|FG000|Overall Study|Withdrawal by Subject|4|||
33385076|NCT02983799|101295976|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
33385077|NCT02983799|101295977|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
33385078|NCT02983799|101295978|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
33385079|NCT02983799|101295979|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
33385080|NCT02983799|101295980|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
33385081|NCT02983799|101295976|FG000|Overall Study|Death|20|||
33385082|NCT02983799|101295977|FG001|Overall Study|Death|5|||
33385083|NCT02983799|101295978|FG002|Overall Study|Death|23|||
33385084|NCT02983799|101295979|FG003|Overall Study|Death|47|||
33385085|NCT02983799|101295980|FG004|Overall Study|Death|7|||
33385086|NCT02983799|101295976|FG000|Overall Study|Withdrawal by Subject|1|||
33385087|NCT02983799|101295977|FG001|Overall Study|Withdrawal by Subject|0|||
33385088|NCT02983799|101295978|FG002|Overall Study|Withdrawal by Subject|3|||
33385089|NCT02983799|101295979|FG003|Overall Study|Withdrawal by Subject|4|||
33385090|NCT02983799|101295980|FG004|Overall Study|Withdrawal by Subject|1|||
33385091|NCT02983799|101295976|FG000|Overall Study|Protocol Violation|0|||
33385092|NCT02983799|101295977|FG001|Overall Study|Protocol Violation|1|||
33385093|NCT02983799|101295978|FG002|Overall Study|Protocol Violation|0|||
33385094|NCT02983799|101295979|FG003|Overall Study|Protocol Violation|0|||
33385095|NCT02983799|101295980|FG004|Overall Study|Protocol Violation|1|||
33385096|NCT02983799|101295976|FG000|Overall Study|Lost to Follow-up|1|||
33385097|NCT02983799|101295977|FG001|Overall Study|Lost to Follow-up|0|||
33385098|NCT02983799|101295978|FG002|Overall Study|Lost to Follow-up|1|||
33385099|NCT02983799|101295979|FG003|Overall Study|Lost to Follow-up|0|||
33385100|NCT02983799|101295980|FG004|Overall Study|Lost to Follow-up|0|||
33385101|NCT01517412|101295981|FG000|Overall Study|Adverse Event|10|||
33385102|NCT01517412|101295982|FG001|Overall Study|Adverse Event|11|||
33385103|NCT01517412|101295981|FG000|Overall Study|Lack of Efficacy|10|||
33385104|NCT01517412|101295982|FG001|Overall Study|Lack of Efficacy|5|||
33385105|NCT01517412|101295981|FG000|Overall Study|Poor compliance to protocol|8|||
33385106|NCT01517412|101295982|FG001|Overall Study|Poor compliance to protocol|3|||
33385107|NCT01517412|101295981|FG000|Overall Study|Other than specified above|8|||
33385108|NCT01517412|101295982|FG001|Overall Study|Other than specified above|5|||
33385109|NCT02248857|101295986|FG000|3 Month|Withdrawal by Subject|9|||
33385110|NCT02248857|101295987|FG001|3 Month|Withdrawal by Subject|3|||
33385111|NCT02248857|101295988|FG002|3 Month|Withdrawal by Subject|4|||
33385112|NCT02248857|101295986|FG000|3 Month|Unable to reach for 3 month|35|||
33385113|NCT02248857|101295987|FG001|3 Month|Unable to reach for 3 month|29|||
33385114|NCT02248857|101295988|FG002|3 Month|Unable to reach for 3 month|26|||
33385115|NCT02248857|101295986|FG000|3 Month|Partially completed, unable to finish|2|||
33434105|NCT01296932|101481018|FG003|Overall Study|Progressive disease|1|||
33150276|NCT00910988|100463696|FG003|Overall Study|Lost to Follow-up|0|||
33385116|NCT02248857|101295987|FG001|3 Month|Partially completed, unable to finish|2|||
33385117|NCT02248857|101295988|FG002|3 Month|Partially completed, unable to finish|1|||
33385118|NCT02248857|101295986|FG000|6 Month|Lost to Follow-up|27|||
33434106|NCT01296932|101481019|FG004|Overall Study|Progressive disease|2|||
33434107|NCT01296932|101481020|FG005|Overall Study|Progressive disease|3|||
33434108|NCT01296932|101481021|FG006|Overall Study|Progressive disease|1|||
33150277|NCT02713204|100463697|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
33150278|NCT02713204|100463698|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
33385119|NCT02248857|101295987|FG001|6 Month|Lost to Follow-up|26|||
33385120|NCT02248857|101295988|FG002|6 Month|Lost to Follow-up|15|||
33385121|NCT02248857|101295986|FG000|6 Month|Partially completed, unable to finish|0|||
33385122|NCT02248857|101295987|FG001|6 Month|Partially completed, unable to finish|1|||
33385123|NCT02248857|101295988|FG002|6 Month|Partially completed, unable to finish|0|||
33385124|NCT02248857|101295986|FG000|6 Month|Withdrawal by Subject|0|||
33592606|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33592607|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33592608|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33592609|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33592610|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33592611|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33592612|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33592613|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
33592614|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
33592615|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
33592616|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33592617|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33592618|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33592619|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33592620|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33592621|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33592622|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33592623|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
33592624|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
33592625|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
33592626|NCT03352557|102057540|FG000|LTE Period: Week 80 to Week 173|Other|0|||
33592627|NCT03352557|102057541|FG001|LTE Period: Week 80 to Week 173|Other|0|||
33592628|NCT03352557|102057542|FG002|LTE Period: Week 80 to Week 173|Other|0|||
33592629|NCT03352557|102057543|FG003|LTE Period: Week 80 to Week 173|Other|0|||
33592630|NCT03352557|102057544|FG004|LTE Period: Week 80 to Week 173|Other|0|||
33592631|NCT03352557|102057545|FG005|LTE Period: Week 80 to Week 173|Other|0|||
33592632|NCT03352557|102057546|FG006|LTE Period: Week 80 to Week 173|Other|0|||
33385125|NCT02248857|101295987|FG001|6 Month|Withdrawal by Subject|2|||
33385126|NCT02248857|101295988|FG002|6 Month|Withdrawal by Subject|2|||
33592633|NCT03352557|102057547|FG007|LTE Period: Week 80 to Week 173|Other|1|||
33592634|NCT03352557|102057548|FG008|LTE Period: Week 80 to Week 173|Other|0|||
33592635|NCT03352557|102057549|FG009|LTE Period: Week 80 to Week 173|Other|0|||
33592636|NCT02585830|102057550|FG000|Overall Study|Withdrawal by Subject|3|||
33592637|NCT01190475|102057551|FG000|Overall Study|Withdrawal by Subject|0|||
33592638|NCT01190475|102057552|FG001|Overall Study|Withdrawal by Subject|0|||
33592639|NCT01190475|102057553|FG002|Overall Study|Withdrawal by Subject|1|||
33592640|NCT01126268|102057554|FG000|Overall Study|Adverse Event|1|||
33592641|NCT03505788|102057557|FG000|Overall Study|Lost to Follow-up|2|||
33592642|NCT03505788|102057558|FG001|Overall Study|Lost to Follow-up|1|||
33592643|NCT03505788|102057557|FG000|Overall Study|Withdrawal by Subject|1|||
33592644|NCT03505788|102057558|FG001|Overall Study|Withdrawal by Subject|3|||
33592645|NCT03505788|102057557|FG000|Overall Study|Physician Decision|0|||
33592646|NCT03505788|102057558|FG001|Overall Study|Physician Decision|1|||
33592647|NCT00096174|102057563|FG000|Overall Study|Lack of Efficacy|9|||
33592648|NCT00096174|102057563|FG000|Overall Study|Adverse Event|15|||
33434109|NCT01296932|101481022|FG007|Overall Study|Progressive disease|0|||
33592649|NCT00096174|102057563|FG000|Overall Study|Death|6|||
33592650|NCT00096174|102057563|FG000|Overall Study|Withdrawal by Subject|15|||
33385127|NCT02248857|101295986|FG000|6 Month|Death|1|||
33385128|NCT02248857|101295987|FG001|6 Month|Death|0|||
33592651|NCT00096174|102057563|FG000|Overall Study|Not started protocol therapy|3|||
33592652|NCT00096174|102057563|FG000|Overall Study|Ineligible|6|||
33385129|NCT02248857|101295988|FG002|6 Month|Death|0|||
33385130|NCT01185704|101295989|FG000|Overall Study|Randomized but not treated|3|||
33385131|NCT01185704|101295990|FG001|Overall Study|Randomized but not treated|3|||
33385132|NCT01185704|101295989|FG000|Overall Study|Lack of ovarian response|5|||
33385133|NCT01185704|101295990|FG001|Overall Study|Lack of ovarian response|1|||
33385134|NCT01185704|101295989|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
33385135|NCT01185704|101295990|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
33385136|NCT01185704|101295989|FG000|Overall Study|Ectopic pregnancy|0|||
33434110|NCT01296932|101481023|FG008|Overall Study|Progressive disease|0|||
33434111|NCT01296932|101481015|FG000|Overall Study|Withdrawal by Subject|0|||
33592653|NCT00096174|102057563|FG000|Overall Study|other reason|8|||
33592654|NCT02379221|102057564|FG000|Overall Study|Lost to Follow-up|1|||
33592655|NCT00695955|102057576|FG000|Cohort 1|Adverse Event|26|||
33592656|NCT00695955|102057576|FG000|Cohort 1|Protocol Violation|2|||
33592657|NCT00695955|102057576|FG000|Cohort 1|Lost to Follow-up|30|||
33592658|NCT00695955|102057576|FG000|Cohort 1|Withdrawal by Subject|25|||
33434112|NCT01296932|101481016|FG001|Overall Study|Withdrawal by Subject|0|||
33592659|NCT00695955|102057576|FG000|Cohort 1|Lack of Efficacy|3|||
33592660|NCT00695955|102057576|FG000|Cohort 1|Other|16|||
33592661|NCT00695955|102057576|FG000|Cohort 2|Adverse Event|24|||
33434113|NCT01296932|101481017|FG002|Overall Study|Withdrawal by Subject|1|||
33434114|NCT01296932|101481018|FG003|Overall Study|Withdrawal by Subject|1|||
33434115|NCT01296932|101481019|FG004|Overall Study|Withdrawal by Subject|0|||
33434116|NCT01296932|101481020|FG005|Overall Study|Withdrawal by Subject|0|||
33434117|NCT01296932|101481021|FG006|Overall Study|Withdrawal by Subject|3|||
33434118|NCT01296932|101481022|FG007|Overall Study|Withdrawal by Subject|0|||
33434119|NCT01296932|101481023|FG008|Overall Study|Withdrawal by Subject|0|||
33434120|NCT01296932|101481015|FG000|Overall Study|Adverse Event|1|||
33434121|NCT01296932|101481016|FG001|Overall Study|Adverse Event|1|||
33434122|NCT01296932|101481017|FG002|Overall Study|Adverse Event|1|||
33434123|NCT01296932|101481018|FG003|Overall Study|Adverse Event|2|||
33434124|NCT01296932|101481019|FG004|Overall Study|Adverse Event|1|||
33434125|NCT01296932|101481020|FG005|Overall Study|Adverse Event|0|||
33434126|NCT01296932|101481021|FG006|Overall Study|Adverse Event|0|||
33434127|NCT01296932|101481022|FG007|Overall Study|Adverse Event|0|||
33434128|NCT01296932|101481023|FG008|Overall Study|Adverse Event|1|||
33434129|NCT01296932|101481015|FG000|Overall Study|Investigator decision|0|||
33434130|NCT01296932|101481016|FG001|Overall Study|Investigator decision|1|||
33434131|NCT01296932|101481017|FG002|Overall Study|Investigator decision|0|||
33434132|NCT01296932|101481018|FG003|Overall Study|Investigator decision|1|||
33434133|NCT01296932|101481019|FG004|Overall Study|Investigator decision|0|||
33434134|NCT01296932|101481020|FG005|Overall Study|Investigator decision|0|||
33434135|NCT01296932|101481021|FG006|Overall Study|Investigator decision|1|||
33434136|NCT01296932|101481022|FG007|Overall Study|Investigator decision|0|||
33434137|NCT01296932|101481023|FG008|Overall Study|Investigator decision|1|||
33434138|NCT01296932|101481015|FG000|Overall Study|No clinical benefit anymore|0|||
33434139|NCT01296932|101481016|FG001|Overall Study|No clinical benefit anymore|1|||
33434140|NCT01296932|101481017|FG002|Overall Study|No clinical benefit anymore|0|||
33434141|NCT01296932|101481018|FG003|Overall Study|No clinical benefit anymore|0|||
33434142|NCT01296932|101481019|FG004|Overall Study|No clinical benefit anymore|0|||
33434143|NCT01296932|101481020|FG005|Overall Study|No clinical benefit anymore|0|||
33434144|NCT01296932|101481021|FG006|Overall Study|No clinical benefit anymore|0|||
33434145|NCT01296932|101481022|FG007|Overall Study|No clinical benefit anymore|0|||
33434146|NCT01296932|101481023|FG008|Overall Study|No clinical benefit anymore|0|||
33434147|NCT01296932|101481015|FG000|Overall Study|Physician Decision|0|||
33434148|NCT01296932|101481016|FG001|Overall Study|Physician Decision|0|||
33434149|NCT01296932|101481017|FG002|Overall Study|Physician Decision|1|||
33434150|NCT01296932|101481018|FG003|Overall Study|Physician Decision|0|||
33434151|NCT01296932|101481019|FG004|Overall Study|Physician Decision|0|||
33434152|NCT01296932|101481020|FG005|Overall Study|Physician Decision|0|||
33434153|NCT01296932|101481021|FG006|Overall Study|Physician Decision|0|||
33434154|NCT01296932|101481022|FG007|Overall Study|Physician Decision|0|||
33434155|NCT01296932|101481023|FG008|Overall Study|Physician Decision|0|||
33434156|NCT01296932|101481015|FG000|Overall Study|IV problems, administration not possible|0|||
33434157|NCT01296932|101481016|FG001|Overall Study|IV problems, administration not possible|0|||
33434158|NCT01296932|101481017|FG002|Overall Study|IV problems, administration not possible|1|||
33434159|NCT01296932|101481018|FG003|Overall Study|IV problems, administration not possible|0|||
33434160|NCT01296932|101481019|FG004|Overall Study|IV problems, administration not possible|0|||
33434161|NCT01296932|101481020|FG005|Overall Study|IV problems, administration not possible|0|||
33434162|NCT01296932|101481021|FG006|Overall Study|IV problems, administration not possible|0|||
33434163|NCT01296932|101481022|FG007|Overall Study|IV problems, administration not possible|0|||
33434164|NCT01296932|101481023|FG008|Overall Study|IV problems, administration not possible|0|||
33434165|NCT01296932|101481015|FG000|Overall Study|per protocol|0|||
33434166|NCT01296932|101481016|FG001|Overall Study|per protocol|0|||
33434167|NCT01296932|101481017|FG002|Overall Study|per protocol|1|||
33434168|NCT01296932|101481018|FG003|Overall Study|per protocol|1|||
33434169|NCT01296932|101481019|FG004|Overall Study|per protocol|0|||
33434170|NCT01296932|101481020|FG005|Overall Study|per protocol|0|||
33434171|NCT01296932|101481021|FG006|Overall Study|per protocol|0|||
33434172|NCT01296932|101481022|FG007|Overall Study|per protocol|0|||
33434173|NCT01296932|101481023|FG008|Overall Study|per protocol|0|||
33434174|NCT01296932|101481015|FG000|Overall Study|Low benefit and too many side effects|0|||
33434175|NCT01296932|101481016|FG001|Overall Study|Low benefit and too many side effects|0|||
33434176|NCT01296932|101481017|FG002|Overall Study|Low benefit and too many side effects|0|||
33434177|NCT01296932|101481018|FG003|Overall Study|Low benefit and too many side effects|0|||
33434178|NCT01296932|101481019|FG004|Overall Study|Low benefit and too many side effects|0|||
33434179|NCT01296932|101481020|FG005|Overall Study|Low benefit and too many side effects|0|||
33434180|NCT01296932|101481021|FG006|Overall Study|Low benefit and too many side effects|0|||
33434181|NCT01296932|101481022|FG007|Overall Study|Low benefit and too many side effects|1|||
33434182|NCT01296932|101481023|FG008|Overall Study|Low benefit and too many side effects|0|||
33434183|NCT01296932|101481015|FG000|Overall Study|No adequate treatment response|0|||
33592662|NCT00695955|102057576|FG000|Cohort 2|Protocol Violation|5|||
33434184|NCT01296932|101481016|FG001|Overall Study|No adequate treatment response|0|||
33434185|NCT01296932|101481017|FG002|Overall Study|No adequate treatment response|0|||
33385137|NCT01185704|101295990|FG001|Overall Study|Ectopic pregnancy|1|||
33434186|NCT01296932|101481018|FG003|Overall Study|No adequate treatment response|0|||
33434187|NCT01296932|101481019|FG004|Overall Study|No adequate treatment response|0|||
33434188|NCT01296932|101481020|FG005|Overall Study|No adequate treatment response|0|||
33434189|NCT01296932|101481021|FG006|Overall Study|No adequate treatment response|0|||
33434190|NCT01296932|101481022|FG007|Overall Study|No adequate treatment response|1|||
33434191|NCT01296932|101481023|FG008|Overall Study|No adequate treatment response|0|||
33434192|NCT01296932|101481015|FG000|Overall Study|Dosage already reduced, AE still present|0|||
33434193|NCT01296932|101481016|FG001|Overall Study|Dosage already reduced, AE still present|0|||
33434194|NCT01296932|101481017|FG002|Overall Study|Dosage already reduced, AE still present|0|||
33434195|NCT01296932|101481018|FG003|Overall Study|Dosage already reduced, AE still present|0|||
33434196|NCT01296932|101481019|FG004|Overall Study|Dosage already reduced, AE still present|0|||
33434197|NCT01296932|101481020|FG005|Overall Study|Dosage already reduced, AE still present|0|||
33434198|NCT01296932|101481021|FG006|Overall Study|Dosage already reduced, AE still present|0|||
33434199|NCT01296932|101481022|FG007|Overall Study|Dosage already reduced, AE still present|0|||
33434200|NCT01296932|101481023|FG008|Overall Study|Dosage already reduced, AE still present|1|||
33434201|NCT01478620|101481027|FG000|Overall Study|Lost to Follow-up|6|||
33434202|NCT02201251|101481028|FG000|Overall Study|Adverse Event|1|||
33434203|NCT02201251|101481029|FG001|Overall Study|Adverse Event|1|||
33434204|NCT02201251|101481028|FG000|Overall Study|Protocol Violation|1|||
33434205|NCT02201251|101481029|FG001|Overall Study|Protocol Violation|0|||
33434206|NCT02201251|101481028|FG000|Overall Study|Noncompliance with Study Drug|0|||
33434207|NCT02201251|101481029|FG001|Overall Study|Noncompliance with Study Drug|1|||
33434208|NCT02201251|101481028|FG000|Overall Study|Withdrawal by Subject|2|||
33434209|NCT02201251|101481029|FG001|Overall Study|Withdrawal by Subject|1|||
33434210|NCT00738673|101481037|FG000|Overall Study|Adverse Event|1|||
33434211|NCT00738673|101481038|FG001|Overall Study|Adverse Event|0|||
33434212|NCT00738673|101481037|FG000|Overall Study|Lack of Efficacy|19|||
33434213|NCT00738673|101481038|FG001|Overall Study|Lack of Efficacy|8|||
33434214|NCT00738673|101481037|FG000|Overall Study|Protocol Violation|1|||
33434215|NCT00738673|101481038|FG001|Overall Study|Protocol Violation|2|||
33434216|NCT00738673|101481037|FG000|Overall Study|Withdrawal by Subject|3|||
33434217|NCT00738673|101481038|FG001|Overall Study|Withdrawal by Subject|1|||
33434218|NCT01338636|101481039|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
33434219|NCT02040766|101481040|FG000|Overall Study|Adverse Event|1|||
33434220|NCT02040766|101481041|FG001|Overall Study|Adverse Event|1|||
33592663|NCT00695955|102057576|FG000|Cohort 2|Lost to Follow-up|38|||
33592664|NCT00695955|102057576|FG000|Cohort 2|Withdrawal by Subject|28|||
33592665|NCT00695955|102057576|FG000|Cohort 2|Lack of Efficacy|4|||
33592666|NCT00695955|102057576|FG000|Cohort 2|Other|5|||
33592667|NCT00347438|102057577|FG000|Overall Study|Withdrawal by Subject|1|||
33592668|NCT00347438|102057577|FG000|Overall Study|Physician Decision|1|||
33592669|NCT02324205|102057586|FG000|Overall Study|Withdrawal by Subject|37|||
33592670|NCT01895543|102057587|FG000|Overall Study|Withdrawal by Subject|43|||
33592671|NCT01895543|102057587|FG000|Overall Study|Lost to Follow-up|25|||
33592672|NCT01895543|102057587|FG000|Overall Study|Adverse Event|28|||
33592673|NCT01895543|102057587|FG000|Overall Study|Subject's substantial non-compliance|6|||
33592674|NCT01895543|102057587|FG000|Overall Study|Protocol Violation|1|||
33592675|NCT01895543|102057587|FG000|Overall Study|Physician Decision|2|||
33592676|NCT01895543|102057587|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
33592677|NCT01166373|102057588|FG000|Overall Study|Lost to Follow-up|3|||
33592678|NCT01166373|102057589|FG001|Overall Study|Lost to Follow-up|2|||
33592679|NCT01166373|102057590|FG002|Overall Study|Lost to Follow-up|2|||
33592680|NCT01166373|102057591|FG003|Overall Study|Lost to Follow-up|2|||
33592681|NCT01166373|102057588|FG000|Overall Study|Withdrawal by Subject|1|||
33592682|NCT01166373|102057589|FG001|Overall Study|Withdrawal by Subject|2|||
33592683|NCT01166373|102057590|FG002|Overall Study|Withdrawal by Subject|2|||
33592684|NCT01166373|102057591|FG003|Overall Study|Withdrawal by Subject|3|||
33592685|NCT01166373|102057588|FG000|Overall Study|Physician Decision|1|||
33592686|NCT01166373|102057589|FG001|Overall Study|Physician Decision|0|||
33592687|NCT01166373|102057590|FG002|Overall Study|Physician Decision|0|||
33592688|NCT01166373|102057591|FG003|Overall Study|Physician Decision|0|||
33592689|NCT03905265|102057592|FG000|Overall Study|Withdrawal by Subject|1|||
33592690|NCT03905265|102057593|FG001|Overall Study|Withdrawal by Subject|1|||
33592691|NCT03905265|102057594|FG002|Overall Study|Withdrawal by Subject|0|||
33592692|NCT03905265|102057595|FG003|Overall Study|Withdrawal by Subject|0|||
33592693|NCT02750345|102057596|FG000|Intervention 1|Adverse Event|0|||
33592694|NCT02750345|102057597|FG001|Intervention 1|Adverse Event|0|||
33592695|NCT02750345|102057598|FG002|Intervention 1|Adverse Event|0|||
33592696|NCT02750345|102057599|FG003|Intervention 1|Adverse Event|0|||
33592697|NCT02750345|102057600|FG004|Intervention 1|Adverse Event|1|||
33434221|NCT02040766|101481042|FG002|Overall Study|Adverse Event|1|||
33434222|NCT02040766|101481043|FG003|Overall Study|Adverse Event|0|||
33434223|NCT02040766|101481044|FG004|Overall Study|Adverse Event|2|||
33592698|NCT02750345|102057601|FG005|Intervention 1|Adverse Event|0|||
33592699|NCT00541866|102057602|FG000|Overall Study|Adverse Event|3|||
33592700|NCT00541866|102057603|FG001|Overall Study|Adverse Event|0|||
33592701|NCT00541866|102057604|FG002|Overall Study|Adverse Event|0|||
33592702|NCT00541866|102057605|FG003|Overall Study|Adverse Event|0|||
33434224|NCT02040766|101481040|FG000|Overall Study|Withdrawal by Subject|4|||
33434225|NCT02040766|101481041|FG001|Overall Study|Withdrawal by Subject|3|||
33434226|NCT02040766|101481042|FG002|Overall Study|Withdrawal by Subject|2|||
33592703|NCT00541866|102057606|FG004|Overall Study|Adverse Event|0|||
33434227|NCT02040766|101481043|FG003|Overall Study|Withdrawal by Subject|3|||
33434228|NCT02040766|101481044|FG004|Overall Study|Withdrawal by Subject|2|||
33434229|NCT02040766|101481040|FG000|Overall Study|Non-compliance|0|||
33434230|NCT02040766|101481041|FG001|Overall Study|Non-compliance|1|||
33434231|NCT02040766|101481042|FG002|Overall Study|Non-compliance|0|||
33434232|NCT02040766|101481043|FG003|Overall Study|Non-compliance|0|||
33434233|NCT02040766|101481044|FG004|Overall Study|Non-compliance|0|||
33434234|NCT02040766|101481040|FG000|Overall Study|Protocol Violation|2|||
33434235|NCT02040766|101481041|FG001|Overall Study|Protocol Violation|1|||
33434236|NCT02040766|101481042|FG002|Overall Study|Protocol Violation|2|||
33434237|NCT02040766|101481043|FG003|Overall Study|Protocol Violation|3|||
33434238|NCT02040766|101481044|FG004|Overall Study|Protocol Violation|0|||
33434239|NCT02040766|101481040|FG000|Overall Study|Lost to Follow-up|4|||
33434240|NCT02040766|101481041|FG001|Overall Study|Lost to Follow-up|1|||
33434241|NCT02040766|101481042|FG002|Overall Study|Lost to Follow-up|3|||
33434242|NCT02040766|101481043|FG003|Overall Study|Lost to Follow-up|1|||
33434243|NCT02040766|101481044|FG004|Overall Study|Lost to Follow-up|4|||
33434244|NCT02040766|101481040|FG000|Overall Study|Not reported|1|||
33434245|NCT02040766|101481041|FG001|Overall Study|Not reported|0|||
33434246|NCT02040766|101481042|FG002|Overall Study|Not reported|0|||
33434247|NCT02040766|101481043|FG003|Overall Study|Not reported|0|||
33434248|NCT02040766|101481044|FG004|Overall Study|Not reported|0|||
33434249|NCT02040766|101481040|FG000|Overall Study|Lack of Efficacy|6|||
33434250|NCT02040766|101481041|FG001|Overall Study|Lack of Efficacy|3|||
33434251|NCT02040766|101481042|FG002|Overall Study|Lack of Efficacy|4|||
33434252|NCT02040766|101481043|FG003|Overall Study|Lack of Efficacy|6|||
33434253|NCT02040766|101481044|FG004|Overall Study|Lack of Efficacy|5|||
33434254|NCT00878995|101481047|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
33434255|NCT00878995|101481048|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
33434256|NCT00266409|101481049|FG000|Overall Study|Lack of Efficacy|2|||
33434257|NCT00266409|101481050|FG001|Overall Study|Lack of Efficacy|6|||
33434258|NCT00266409|101481051|FG002|Overall Study|Lack of Efficacy|1|||
33434259|NCT00266409|101481052|FG003|Overall Study|Lack of Efficacy|2|||
33434260|NCT00266409|101481049|FG000|Overall Study|Adverse Event|7|||
33434261|NCT00266409|101481050|FG001|Overall Study|Adverse Event|2|||
33434262|NCT00266409|101481051|FG002|Overall Study|Adverse Event|1|||
33434263|NCT00266409|101481052|FG003|Overall Study|Adverse Event|1|||
33434264|NCT00266409|101481049|FG000|Overall Study|Lost to Follow-up|18|||
33434265|NCT00266409|101481050|FG001|Overall Study|Lost to Follow-up|21|||
33434266|NCT00266409|101481051|FG002|Overall Study|Lost to Follow-up|6|||
33434267|NCT00266409|101481052|FG003|Overall Study|Lost to Follow-up|8|||
33434268|NCT00266409|101481049|FG000|Overall Study|Withdrawal by Subject|6|||
33434269|NCT00266409|101481050|FG001|Overall Study|Withdrawal by Subject|10|||
33434270|NCT00266409|101481051|FG002|Overall Study|Withdrawal by Subject|3|||
33434271|NCT00266409|101481052|FG003|Overall Study|Withdrawal by Subject|9|||
33434272|NCT00266409|101481049|FG000|Overall Study|Protocol Violation|5|||
33249806|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
33249807|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
33249808|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
33249809|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
33249810|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
33249811|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
33249812|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
33249813|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
33249814|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33249815|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
33434273|NCT00266409|101481050|FG001|Overall Study|Protocol Violation|3|||
33249816|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33434274|NCT00266409|101481051|FG002|Overall Study|Protocol Violation|4|||
33434275|NCT00266409|101481052|FG003|Overall Study|Protocol Violation|2|||
33434276|NCT00266409|101481049|FG000|Overall Study|Other|7|||
33434277|NCT00266409|101481050|FG001|Overall Study|Other|4|||
33434278|NCT00266409|101481051|FG002|Overall Study|Other|2|||
33434279|NCT00266409|101481052|FG003|Overall Study|Other|0|||
33592704|NCT00541866|102057602|FG000|Overall Study|Death|1|||
33434280|NCT01893138|101481055|FG000|Double-Blind Period|Withdrawal by Subject|1|||
33434281|NCT01893138|101481056|FG001|Double-Blind Period|Withdrawal by Subject|1|||
33434282|NCT01893138|101481055|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
33592705|NCT00541866|102057603|FG001|Overall Study|Death|0|||
33385138|NCT01194869|101295998|FG000|Overall Study|Disease Progression|2|||
33385139|NCT01194869|101295998|FG000|Overall Study|Toxicity|2|||
33385140|NCT01779648|101296001|FG000|Overall Study|Protocol Violation|1|||
33385141|NCT01779648|101296002|FG001|Overall Study|Protocol Violation|0|||
33385142|NCT03549117|101296003|FG000|Overall Study|Withdrawal by Subject|1|||
33385143|NCT03549117|101296004|FG001|Overall Study|Withdrawal by Subject|0|||
33385144|NCT00525785|101296011|FG000|Overall Study|Withdrawal by Subject|1|||
33385145|NCT00525785|101296011|FG000|Overall Study|Lack of Efficacy|1|||
33385146|NCT00525785|101296011|FG000|Overall Study|Physician Decision|1|||
33385147|NCT02501902|101296012|FG000|Overall Study|Subject Refused Further Follow-up|0|||
33385148|NCT02501902|101296013|FG001|Overall Study|Subject Refused Further Follow-up|0|||
33385149|NCT02501902|101296014|FG002|Overall Study|Subject Refused Further Follow-up|0|||
33385150|NCT02501902|101296015|FG003|Overall Study|Subject Refused Further Follow-up|0|||
33385151|NCT02501902|101296016|FG004|Overall Study|Subject Refused Further Follow-up|0|||
33385152|NCT02501902|101296017|FG005|Overall Study|Subject Refused Further Follow-up|0|||
33385153|NCT02501902|101296018|FG006|Overall Study|Subject Refused Further Follow-up|0|||
33385154|NCT02501902|101296019|FG007|Overall Study|Subject Refused Further Follow-up|1|||
33385155|NCT02501902|101296012|FG000|Overall Study|Study Terminated by Sponsor|0|||
33385156|NCT02501902|101296013|FG001|Overall Study|Study Terminated by Sponsor|3|||
33385157|NCT02501902|101296014|FG002|Overall Study|Study Terminated by Sponsor|0|||
33385158|NCT02501902|101296015|FG003|Overall Study|Study Terminated by Sponsor|1|||
33434283|NCT01893138|101481056|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
33434284|NCT01893138|101481055|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
33434285|NCT01893138|101481056|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
33434286|NCT01893138|101481055|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
33434287|NCT01893138|101481056|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
33592706|NCT00541866|102057604|FG002|Overall Study|Death|0|||
33592707|NCT00541866|102057605|FG003|Overall Study|Death|0|||
33592708|NCT00541866|102057606|FG004|Overall Study|Death|0|||
33592709|NCT00541866|102057602|FG000|Overall Study|Lack of Efficacy|19|||
33592710|NCT00541866|102057603|FG001|Overall Study|Lack of Efficacy|15|||
33592711|NCT00541866|102057604|FG002|Overall Study|Lack of Efficacy|10|||
33592712|NCT00541866|102057605|FG003|Overall Study|Lack of Efficacy|12|||
33592713|NCT00541866|102057606|FG004|Overall Study|Lack of Efficacy|14|||
33592714|NCT00541866|102057602|FG000|Overall Study|Not Reported or Other|11|||
33592715|NCT00541866|102057603|FG001|Overall Study|Not Reported or Other|3|||
33592716|NCT00541866|102057604|FG002|Overall Study|Not Reported or Other|3|||
33592717|NCT00541866|102057605|FG003|Overall Study|Not Reported or Other|3|||
33592718|NCT00541866|102057606|FG004|Overall Study|Not Reported or Other|1|||
33592719|NCT00541866|102057602|FG000|Overall Study|Physician Decision|0|||
33592720|NCT00541866|102057603|FG001|Overall Study|Physician Decision|0|||
33592721|NCT00541866|102057604|FG002|Overall Study|Physician Decision|2|||
33592722|NCT00541866|102057605|FG003|Overall Study|Physician Decision|1|||
33592723|NCT00541866|102057606|FG004|Overall Study|Physician Decision|0|||
33592724|NCT02080481|102057607|FG000|Overall Study|Never received a block.|1|||
33592725|NCT02080481|102057608|FG001|Overall Study|Never received a block.|0|||
33592726|NCT01945216|102057609|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
33592727|NCT01945216|102057609|FG000|Overall Study|Protocol Violation|42|||
33592728|NCT01945216|102057609|FG000|Overall Study|CRF not assured by investigators|5|||
33592729|NCT01007435|102057610|FG000|Overall Study|Adverse Event|16|||
33592730|NCT01007435|102057611|FG001|Overall Study|Adverse Event|25|||
33592731|NCT01007435|102057612|FG002|Overall Study|Adverse Event|47|||
33592732|NCT01007435|102057613|FG003|Overall Study|Adverse Event|31|||
33592733|NCT01007435|102057610|FG000|Overall Study|Death|2|||
33592734|NCT01007435|102057611|FG001|Overall Study|Death|4|||
33592735|NCT01007435|102057612|FG002|Overall Study|Death|2|||
33592736|NCT01007435|102057613|FG003|Overall Study|Death|1|||
33592737|NCT01007435|102057610|FG000|Overall Study|Insufficient Therapeutic Response|21|||
33592738|NCT01007435|102057611|FG001|Overall Study|Insufficient Therapeutic Response|7|||
33592739|NCT01007435|102057612|FG002|Overall Study|Insufficient Therapeutic Response|2|||
33592740|NCT01007435|102057613|FG003|Overall Study|Insufficient Therapeutic Response|9|||
33592741|NCT01007435|102057610|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
33385159|NCT02501902|101296016|FG004|Overall Study|Study Terminated by Sponsor|1|||
33385160|NCT02501902|101296017|FG005|Overall Study|Study Terminated by Sponsor|0|||
33385161|NCT02501902|101296018|FG006|Overall Study|Study Terminated by Sponsor|2|||
33385162|NCT02501902|101296019|FG007|Overall Study|Study Terminated by Sponsor|4|||
33434288|NCT01893138|101481055|FG000|Open Label - Unblinded Period|Adverse Event|1|||
33592742|NCT01007435|102057611|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
33592743|NCT01007435|102057612|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
33592744|NCT01007435|102057613|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
33592745|NCT01007435|102057610|FG000|Overall Study|Other Protocol Violation|2|||
33592746|NCT01007435|102057611|FG001|Overall Study|Other Protocol Violation|0|||
33592747|NCT01007435|102057612|FG002|Overall Study|Other Protocol Violation|1|||
33249817|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33249818|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33385163|NCT02501902|101296012|FG000|Overall Study|Death|3|||
33385164|NCT02501902|101296013|FG001|Overall Study|Death|4|||
33385165|NCT02501902|101296014|FG002|Overall Study|Death|4|||
33385166|NCT02501902|101296015|FG003|Overall Study|Death|10|||
33434289|NCT01893138|101481056|FG001|Open Label - Unblinded Period|Adverse Event|0|||
33434290|NCT02660242|101481057|FG000|Glucose Tabs|Lost to Follow-up|1|||
33434291|NCT02660242|101481057|FG000|Glucagon Injection|Lost to Follow-up|1|||
33434292|NCT00782509|101481059|FG000|Overall Study|Adverse Event|20|||
33434293|NCT00782509|101481060|FG001|Overall Study|Adverse Event|10|||
33434294|NCT00782509|101481061|FG002|Overall Study|Adverse Event|20|||
33434295|NCT00782509|101481059|FG000|Overall Study|Lost to Follow-up|1|||
33385167|NCT02501902|101296016|FG004|Overall Study|Death|10|||
33385168|NCT02501902|101296017|FG005|Overall Study|Death|11|||
33385169|NCT02501902|101296018|FG006|Overall Study|Death|7|||
33434296|NCT00782509|101481060|FG001|Overall Study|Lost to Follow-up|2|||
33592748|NCT01007435|102057613|FG003|Overall Study|Other Protocol Violation|0|||
33592749|NCT01007435|102057610|FG000|Overall Study|Refused Treatment|13|||
33592750|NCT01007435|102057611|FG001|Overall Study|Refused Treatment|13|||
33592751|NCT01007435|102057612|FG002|Overall Study|Refused Treatment|5|||
33592752|NCT01007435|102057613|FG003|Overall Study|Refused Treatment|8|||
33592753|NCT01007435|102057610|FG000|Overall Study|Failure to Return|5|||
33592754|NCT01007435|102057611|FG001|Overall Study|Failure to Return|4|||
33592755|NCT01007435|102057612|FG002|Overall Study|Failure to Return|3|||
33592756|NCT01007435|102057613|FG003|Overall Study|Failure to Return|6|||
33592757|NCT01007435|102057610|FG000|Overall Study|Reason not Specified|1|||
33592758|NCT01007435|102057611|FG001|Overall Study|Reason not Specified|1|||
33592759|NCT01007435|102057612|FG002|Overall Study|Reason not Specified|2|||
33592760|NCT01007435|102057613|FG003|Overall Study|Reason not Specified|1|||
33592761|NCT00096226|102057614|FG000|Overall Study|Ineligible|2|||
33592762|NCT00096226|102057614|FG000|Overall Study|Protocol treatment not started|1|||
33592763|NCT01972308|102057617|FG000|Overall Study|Withdrawal by Subject|0|||
33592764|NCT01972308|102057618|FG001|Overall Study|Withdrawal by Subject|1|||
33592765|NCT01972308|102057617|FG000|Overall Study|Lost to Follow-up|4|||
33592766|NCT01972308|102057618|FG001|Overall Study|Lost to Follow-up|6|||
33592767|NCT01972308|102057617|FG000|Overall Study|Death|4|||
33592768|NCT01972308|102057618|FG001|Overall Study|Death|1|||
33592769|NCT00519376|102057619|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592770|NCT00519376|102057620|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592771|NCT00519376|102057621|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592772|NCT00519376|102057622|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592773|NCT00519376|102057623|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592774|NCT00519376|102057624|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592775|NCT00519376|102057625|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592776|NCT00519376|102057626|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592777|NCT00519376|102057627|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592778|NCT00519376|102057628|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592779|NCT00519376|102057629|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592780|NCT00519376|102057630|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592781|NCT00519376|102057631|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
33592782|NCT00519376|102057632|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592783|NCT00519376|102057633|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592784|NCT00519376|102057634|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
33592785|NCT00519376|102057619|FG000|Treatment Period 4|Lost to Follow-up|0|||
33592786|NCT00519376|102057620|FG001|Treatment Period 4|Lost to Follow-up|0|||
33592787|NCT00519376|102057621|FG002|Treatment Period 4|Lost to Follow-up|1|||
33592788|NCT00519376|102057622|FG003|Treatment Period 4|Lost to Follow-up|0|||
33592789|NCT00519376|102057623|FG004|Treatment Period 4|Lost to Follow-up|0|||
33592790|NCT00519376|102057624|FG005|Treatment Period 4|Lost to Follow-up|0|||
33592791|NCT00519376|102057625|FG006|Treatment Period 4|Lost to Follow-up|0|||
33592792|NCT00519376|102057626|FG007|Treatment Period 4|Lost to Follow-up|0|||
33592793|NCT00519376|102057627|FG008|Treatment Period 4|Lost to Follow-up|0|||
33592794|NCT00519376|102057628|FG009|Treatment Period 4|Lost to Follow-up|0|||
33592795|NCT00519376|102057629|FG010|Treatment Period 4|Lost to Follow-up|0|||
33592796|NCT00519376|102057630|FG011|Treatment Period 4|Lost to Follow-up|0|||
33592797|NCT00519376|102057631|FG012|Treatment Period 4|Lost to Follow-up|0|||
33592798|NCT00519376|102057632|FG013|Treatment Period 4|Lost to Follow-up|0|||
33592799|NCT00519376|102057633|FG014|Treatment Period 4|Lost to Follow-up|0|||
33592800|NCT00519376|102057634|FG015|Treatment Period 4|Lost to Follow-up|0|||
33385170|NCT02501902|101296019|FG007|Overall Study|Death|15|||
33434297|NCT00782509|101481061|FG002|Overall Study|Lost to Follow-up|3|||
33434298|NCT00782509|101481059|FG000|Overall Study|Withdrawal by Subject|3|||
33434299|NCT00782509|101481060|FG001|Overall Study|Withdrawal by Subject|5|||
33249819|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33249820|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33249821|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33249822|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
33385171|NCT00865189|101296020|FG000|Overall Study|Other|1|||
33385172|NCT00865189|101296021|FG001|Overall Study|Other|2|||
33385173|NCT00865189|101296020|FG000|Overall Study|Death|4|||
33385174|NCT00865189|101296021|FG001|Overall Study|Death|11|||
33385175|NCT00865189|101296020|FG000|Overall Study|Lost to Follow-up|6|||
33385176|NCT00865189|101296021|FG001|Overall Study|Lost to Follow-up|6|||
33385177|NCT00865189|101296020|FG000|Overall Study|Withdrawal by Subject|1|||
33385178|NCT00865189|101296021|FG001|Overall Study|Withdrawal by Subject|0|||
33385179|NCT03559192|101296024|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
33385180|NCT03559192|101296025|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
33385181|NCT03559192|101296026|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
33385182|NCT03559192|101296024|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
33385183|NCT03559192|101296025|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
33385184|NCT03559192|101296026|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
33385185|NCT03559192|101296024|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
33385186|NCT03559192|101296025|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
33385187|NCT03559192|101296026|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
33385188|NCT03559192|101296024|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
33385189|NCT03559192|101296025|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
33385190|NCT03559192|101296026|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
33385191|NCT03559192|101296024|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
33385192|NCT03559192|101296025|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
33385193|NCT03559192|101296026|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
33385194|NCT03559192|101296024|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
33385195|NCT03559192|101296025|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
33385196|NCT03559192|101296026|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
33385197|NCT03559192|101296024|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
33385198|NCT03559192|101296025|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
33385199|NCT03559192|101296026|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
33385200|NCT03559192|101296024|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
33385201|NCT03559192|101296025|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
33385202|NCT03559192|101296026|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
33385203|NCT03559192|101296024|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
33385204|NCT03559192|101296025|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
33385205|NCT03559192|101296026|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
33385206|NCT01998399|101296030|FG000|Overall Study|Lost to Follow-up|1|||
33385207|NCT01998399|101296031|FG001|Overall Study|Lost to Follow-up|3|||
33385208|NCT01998399|101296030|FG000|Overall Study|Death|4|||
33385209|NCT01998399|101296031|FG001|Overall Study|Death|2|||
33385210|NCT01998399|101296030|FG000|Overall Study|Study stopped before dosing completed|3|||
33592801|NCT05289271|102057637|FG000|Overall Study|Mistakenly allocated, untreated|1|||
33592802|NCT05289271|102057638|FG001|Overall Study|Mistakenly allocated, untreated|0|||
33592803|NCT02442310|102057639|FG000|Overall Study|Adverse Event|2|||
33592804|NCT02442310|102057639|FG000|Overall Study|Withdrawal by Subject|1|||
33592805|NCT05593913|102057640|FG000|Overall Study|Insufficient image quality|39|||
33592806|NCT01923363|102057643|FG000|Overall Study|Protocol Violation|1|||
33592807|NCT01939002|102057645|FG000|Overall Study|Adverse Event|13|||
33592808|NCT01939002|102057646|FG001|Overall Study|Adverse Event|13|||
33592809|NCT01939002|102057645|FG000|Overall Study|Withdrawal by Subject|5|||
33592810|NCT01939002|102057646|FG001|Overall Study|Withdrawal by Subject|3|||
33592811|NCT01939002|102057645|FG000|Overall Study|Other|1|||
33592812|NCT01939002|102057646|FG001|Overall Study|Other|2|||
33592813|NCT00503581|102057647|FG000|Overall Study|Study closed|3|||
33592814|NCT00503581|102057648|FG001|Overall Study|Study closed|4|||
33592815|NCT00503581|102057649|FG002|Overall Study|Study closed|2|||
33592816|NCT00252694|102057650|FG000|Overall Study|Withdrawal by Subject|83|||
33434300|NCT00782509|101481061|FG002|Overall Study|Withdrawal by Subject|8|||
33434301|NCT00782509|101481059|FG000|Overall Study|Non compliance with protocol|2|||
33434302|NCT00782509|101481060|FG001|Overall Study|Non compliance with protocol|0|||
33434303|NCT00782509|101481061|FG002|Overall Study|Non compliance with protocol|0|||
33434304|NCT00782509|101481059|FG000|Overall Study|Other reasons not stated above|5|||
33434305|NCT00782509|101481060|FG001|Overall Study|Other reasons not stated above|2|||
33434306|NCT00782509|101481061|FG002|Overall Study|Other reasons not stated above|3|||
33434307|NCT00782509|101481059|FG000|Overall Study|Lack of Efficacy|10|||
33434308|NCT00782509|101481060|FG001|Overall Study|Lack of Efficacy|5|||
33434309|NCT00782509|101481061|FG002|Overall Study|Lack of Efficacy|2|||
33434310|NCT02178709|101481062|FG000|Overall Study|Adverse Event|5|||
33434311|NCT02178709|101481062|FG000|Overall Study|Death|2|||
33434312|NCT02178709|101481062|FG000|Overall Study|Withdrawal by Subject|2|||
33434313|NCT02178709|101481062|FG000|Overall Study|Physician Decision|2|||
33434314|NCT02178709|101481062|FG000|Overall Study|Disease Progression|5|||
33434315|NCT01620177|101481063|FG000|Overall Study|Failure at Screening Visit|43|||
33434316|NCT01620177|101481063|FG000|Overall Study|Withdrawal by Subject|26|||
33434317|NCT01620177|101481063|FG000|Overall Study|Lost to Follow-up|7|||
33434318|NCT01620177|101481063|FG000|Overall Study|Physician Decision|2|||
33434319|NCT01620177|101481063|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
33434320|NCT01521559|101481064|FG000|Overall Study|Adverse Event|0|||
33249823|NCT01212757|100814512|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
33249824|NCT01212757|100814513|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
33249825|NCT01212757|100814514|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
33434321|NCT01521559|101481065|FG001|Overall Study|Adverse Event|4|||
33434322|NCT01521559|101481064|FG000|Overall Study|Death|1|||
33434323|NCT01521559|101481065|FG001|Overall Study|Death|0|||
33434324|NCT01521559|101481064|FG000|Overall Study|Withdrawal by Subject|9|||
33434325|NCT01521559|101481065|FG001|Overall Study|Withdrawal by Subject|11|||
33434326|NCT01521559|101481064|FG000|Overall Study|Lost to Follow-up|3|||
33434327|NCT01521559|101481065|FG001|Overall Study|Lost to Follow-up|1|||
33434328|NCT01521559|101481064|FG000|Overall Study|Protocol Violation|1|||
33434329|NCT01521559|101481065|FG001|Overall Study|Protocol Violation|0|||
33434330|NCT01521559|101481064|FG000|Overall Study|Other|1|||
33434331|NCT01521559|101481065|FG001|Overall Study|Other|2|||
33434332|NCT01254409|101481066|FG000|Overall Study|Adverse Event|0|||
33434333|NCT01254409|101481067|FG001|Overall Study|Adverse Event|1|||
33434334|NCT01254409|101481068|FG002|Overall Study|Adverse Event|0|||
33434335|NCT01254409|101481069|FG003|Overall Study|Adverse Event|0|||
33592817|NCT00252694|102057651|FG001|Overall Study|Withdrawal by Subject|91|||
33592818|NCT00252694|102057650|FG000|Overall Study|Death|36|||
33592819|NCT00252694|102057651|FG001|Overall Study|Death|34|||
33592820|NCT00252694|102057650|FG000|Overall Study|Mostly Lost to Follow Up|8|||
33592821|NCT00252694|102057651|FG001|Overall Study|Mostly Lost to Follow Up|13|||
33592822|NCT00252694|102057650|FG000|Overall Study|Patient Moving|17|||
33592823|NCT00252694|102057651|FG001|Overall Study|Patient Moving|16|||
33592824|NCT04027049|102057652|FG000|Overall Study|Withdrawn by family|1|||
33592825|NCT04027049|102057653|FG001|Overall Study|Withdrawn by family|0|||
33592826|NCT04027049|102057652|FG000|Overall Study|Participant safety|1|||
33592827|NCT04027049|102057653|FG001|Overall Study|Participant safety|0|||
33592828|NCT00396136|102057654|FG000|Overall Study|Death|43|||
33592829|NCT00396136|102057654|FG000|Overall Study|Withdrawal by Subject|59|||
33592830|NCT00396136|102057654|FG000|Overall Study|Lost to Follow-up|15|||
33592831|NCT00396136|102057654|FG000|Overall Study|Study device explanted|8|||
33592832|NCT00712725|102057655|FG000|Overall Study|Adverse Event|1|||
33592833|NCT00712725|102057656|FG001|Overall Study|Adverse Event|0|||
33592834|NCT00712725|102057657|FG002|Overall Study|Adverse Event|0|||
33592835|NCT00712725|102057658|FG003|Overall Study|Adverse Event|1|||
33592836|NCT00712725|102057659|FG004|Overall Study|Adverse Event|0|||
33592837|NCT00712725|102057660|FG005|Overall Study|Adverse Event|0|||
33592838|NCT00712725|102057661|FG006|Overall Study|Adverse Event|0|||
33592839|NCT00712725|102057662|FG007|Overall Study|Adverse Event|0|||
33592840|NCT00712725|102057655|FG000|Overall Study|Lost to Follow-up|3|||
33592841|NCT00712725|102057656|FG001|Overall Study|Lost to Follow-up|2|||
33592842|NCT00712725|102057657|FG002|Overall Study|Lost to Follow-up|1|||
33592843|NCT00712725|102057658|FG003|Overall Study|Lost to Follow-up|1|||
33434336|NCT02204371|101481073|FG000|Overall Study|Adverse Event|1|||
33434337|NCT02275364|101481077|FG000|Period 1|Withdrawal by Subject|1|||
33434338|NCT02275364|101481078|FG001|Period 1|Withdrawal by Subject|0|||
33434339|NCT02275364|101481077|FG000|Period 1|Other reason|1|||
33434340|NCT02275364|101481078|FG001|Period 1|Other reason|0|||
33434341|NCT02359890|101481079|FG000|Overall Study|Not meeting eligibility|4|||
33150279|NCT02713204|100463699|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
33150280|NCT02713204|100463700|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
33150281|NCT02713204|100463701|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
33385211|NCT01998399|101296031|FG001|Overall Study|Study stopped before dosing completed|3|||
33385212|NCT01998399|101296030|FG000|Overall Study|Withdrawal by Subject|0|||
33385213|NCT01998399|101296031|FG001|Overall Study|Withdrawal by Subject|1|||
33385214|NCT01332019|101296032|FG000|Overall Study|Was Not Dosed|1|||
33385215|NCT01332019|101296033|FG001|Overall Study|Was Not Dosed|0|||
33385216|NCT01332019|101296032|FG000|Overall Study|Other|16|||
33385217|NCT01332019|101296033|FG001|Overall Study|Other|18|||
33385218|NCT01332019|101296032|FG000|Overall Study|Death|2|||
33385219|NCT01332019|101296033|FG001|Overall Study|Death|1|||
33385220|NCT01332019|101296032|FG000|Overall Study|Physician Decision|4|||
33385221|NCT01332019|101296033|FG001|Overall Study|Physician Decision|3|||
33385222|NCT01332019|101296032|FG000|Overall Study|Withdrawal by Subject|73|||
33385223|NCT01332019|101296033|FG001|Overall Study|Withdrawal by Subject|71|||
33385224|NCT01332019|101296032|FG000|Overall Study|Lost to Follow-up|4|||
33385225|NCT01332019|101296033|FG001|Overall Study|Lost to Follow-up|7|||
33385226|NCT01332019|101296032|FG000|Overall Study|Adverse Event|13|||
33385227|NCT01332019|101296033|FG001|Overall Study|Adverse Event|22|||
33385228|NCT02062398|101296034|FG000|Overall Study|Implant removal|1|||
33385229|NCT04179786|101296035|FG000|Overall Study|Withdrawal by Subject|8|||
33385230|NCT03434418|101296036|FG000|Overall Study|Disease Progression|11|||
33385231|NCT03434418|101296036|FG000|Overall Study|Adverse Event|2|||
33385232|NCT03434418|101296036|FG000|Overall Study|Physician Decision|1|||
33385233|NCT03434418|101296036|FG000|Overall Study|Decline in Performance Status (PS)|1|||
33385234|NCT00179517|101296037|FG000|Overall Study|Withdrawal by Subject|2|||
33385235|NCT00179517|101296038|FG001|Overall Study|Withdrawal by Subject|1|||
33385236|NCT02980692|101296039|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
33385237|NCT02980692|101296040|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
33385238|NCT02980692|101296041|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
33385239|NCT02980692|101296042|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
33385240|NCT02980692|101296043|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
33385241|NCT02980692|101296039|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
33385242|NCT02980692|101296040|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
33385243|NCT02980692|101296041|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
33385244|NCT02980692|101296042|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
33385245|NCT02980692|101296043|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
33385246|NCT02980692|101296039|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
33385247|NCT02980692|101296040|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
33150282|NCT02713204|100463702|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
33385248|NCT02980692|101296041|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
33385249|NCT02980692|101296042|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
33385250|NCT02980692|101296043|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
33385251|NCT02980692|101296039|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
33434342|NCT02359890|101481079|FG000|Overall Study|Never treated with study catheter|6|||
33434343|NCT03222141|101481080|FG000|Overall Study|Death|15|||
33434344|NCT03222141|101481080|FG000|Overall Study|Lost to Follow-up|3|||
33434345|NCT01290263|101481086|FG000|Overall Study|Adverse Event|0|||
33434346|NCT01290263|101481087|FG001|Overall Study|Adverse Event|0|||
33434347|NCT01290263|101481088|FG002|Overall Study|Adverse Event|0|||
33434348|NCT01290263|101481089|FG003|Overall Study|Adverse Event|1|||
33434349|NCT01290263|101481090|FG004|Overall Study|Adverse Event|1|||
33434350|NCT01290263|101481086|FG000|Overall Study|Lack of Efficacy|8|||
33434351|NCT01290263|101481087|FG001|Overall Study|Lack of Efficacy|2|||
33434352|NCT01290263|101481088|FG002|Overall Study|Lack of Efficacy|7|||
33434353|NCT01290263|101481089|FG003|Overall Study|Lack of Efficacy|24|||
33434354|NCT01290263|101481090|FG004|Overall Study|Lack of Efficacy|33|||
33434355|NCT01290263|101481086|FG000|Overall Study|Withdrawal by Subject|3|||
33434356|NCT01290263|101481087|FG001|Overall Study|Withdrawal by Subject|1|||
33434357|NCT01290263|101481088|FG002|Overall Study|Withdrawal by Subject|0|||
33434358|NCT01290263|101481089|FG003|Overall Study|Withdrawal by Subject|1|||
33434359|NCT01290263|101481090|FG004|Overall Study|Withdrawal by Subject|2|||
33434360|NCT01290263|101481086|FG000|Overall Study|Participant Non-Compliance|0|||
33434361|NCT01290263|101481087|FG001|Overall Study|Participant Non-Compliance|0|||
33434362|NCT01290263|101481088|FG002|Overall Study|Participant Non-Compliance|0|||
33434363|NCT01290263|101481089|FG003|Overall Study|Participant Non-Compliance|1|||
33434364|NCT01290263|101481090|FG004|Overall Study|Participant Non-Compliance|1|||
33434365|NCT00992407|101481092|FG000|Overall Study|Protocol Violation|2|||
33434366|NCT00992407|101481093|FG001|Overall Study|Protocol Violation|1|||
33434367|NCT00992407|101481092|FG000|Overall Study|Lost to Follow-up|3|||
33434368|NCT00992407|101481093|FG001|Overall Study|Lost to Follow-up|3|||
33434369|NCT00992407|101481092|FG000|Overall Study|Adverse Event|3|||
33434370|NCT00992407|101481093|FG001|Overall Study|Adverse Event|2|||
33434371|NCT00992407|101481092|FG000|Overall Study|protocol Violation & Adverse events|2|||
33434372|NCT00992407|101481093|FG001|Overall Study|protocol Violation & Adverse events|4|||
33434373|NCT00992407|101481092|FG000|Overall Study|Other|2|||
33434374|NCT00992407|101481093|FG001|Overall Study|Other|0|||
33434375|NCT00992407|101481092|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
33434376|NCT00992407|101481093|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
33434377|NCT00992407|101481092|FG000|Overall Study|Study medication not administered|17|||
33434378|NCT00992407|101481093|FG001|Overall Study|Study medication not administered|13|||
33434379|NCT01066052|101481094|FG000|Overall Study|Enrolled But Not Treated|3|||
33434380|NCT01066052|101481095|FG001|Overall Study|Enrolled But Not Treated|0|||
33434381|NCT01569152|101481100|FG000|Phase IIa, Period 1|Early Escape|5|||
33434382|NCT01569152|101481101|FG001|Phase IIa, Period 1|Early Escape|22|||
33434383|NCT01569152|101481102|FG002|Phase IIa, Period 1|Early Escape|0|||
33434384|NCT01569152|101481100|FG000|Phase IIa, Period 1|Adverse Event|4|||
33434385|NCT01569152|101481101|FG001|Phase IIa, Period 1|Adverse Event|0|||
33434386|NCT01569152|101481102|FG002|Phase IIa, Period 1|Adverse Event|0|||
33434387|NCT01569152|101481100|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
33434388|NCT01569152|101481101|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
33434389|NCT01569152|101481102|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
33434390|NCT01569152|101481100|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
33434391|NCT01569152|101481101|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
33434392|NCT01569152|101481102|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
33434393|NCT01569152|101481100|FG000|Phase IIa, Period 1|Protocol Violation|0|||
33434394|NCT01569152|101481101|FG001|Phase IIa, Period 1|Protocol Violation|1|||
33434395|NCT01569152|101481102|FG002|Phase IIa, Period 1|Protocol Violation|0|||
33434396|NCT01569152|101481100|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
33434397|NCT01569152|101481101|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
33434398|NCT01569152|101481102|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
33434399|NCT01569152|101481100|FG000|Safety Extension, Period 3|Adverse Event|0|||
33434400|NCT01569152|101481101|FG001|Safety Extension, Period 3|Adverse Event|0|||
33434401|NCT01569152|101481102|FG002|Safety Extension, Period 3|Adverse Event|4|||
33434402|NCT01569152|101481100|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
33434403|NCT01569152|101481101|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
33434404|NCT01569152|101481102|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
33434405|NCT01569152|101481100|FG000|Safety Extension, Period 3|Physician Decision|0|||
33434406|NCT01569152|101481101|FG001|Safety Extension, Period 3|Physician Decision|0|||
33434407|NCT01569152|101481102|FG002|Safety Extension, Period 3|Physician Decision|2|||
33434408|NCT01569152|101481100|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
33434409|NCT01569152|101481101|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
33434410|NCT01569152|101481102|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
33434411|NCT02277769|101481103|FG000|Overall Study|Protocol Violation|3|||
33434412|NCT02277769|101481104|FG001|Overall Study|Protocol Violation|3|||
33434413|NCT02277769|101481105|FG002|Overall Study|Protocol Violation|5|||
33434414|NCT02277769|101481103|FG000|Overall Study|Lack of Efficacy|17|||
33434415|NCT02277769|101481104|FG001|Overall Study|Lack of Efficacy|0|||
33434416|NCT02277769|101481105|FG002|Overall Study|Lack of Efficacy|4|||
33434417|NCT02277769|101481103|FG000|Overall Study|Adverse Event|14|||
33385252|NCT02980692|101296040|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
33385253|NCT02980692|101296041|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
33385254|NCT02980692|101296042|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
33385255|NCT02980692|101296043|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
33385256|NCT02980692|101296039|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
33385257|NCT02980692|101296040|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
33385258|NCT02980692|101296041|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
33434418|NCT02277769|101481104|FG001|Overall Study|Adverse Event|2|||
33434419|NCT02277769|101481105|FG002|Overall Study|Adverse Event|4|||
33434420|NCT02277769|101481103|FG000|Overall Study|Other than specified above|12|||
33434421|NCT02277769|101481104|FG001|Overall Study|Other than specified above|8|||
33249826|NCT01212757|100814515|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
33249827|NCT01212757|100814516|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
33249828|NCT01212757|100814517|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
33249829|NCT01212757|100814518|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
33249830|NCT01212757|100814519|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
33150283|NCT02713204|100463703|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
33150284|NCT02713204|100463704|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
33150285|NCT02713204|100463697|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33150286|NCT02713204|100463698|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33249831|NCT01212757|100814520|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
33249832|NCT00367055|100814521|FG000|Overall Study|Adverse Event|6|||
33249833|NCT00367055|100814522|FG001|Overall Study|Adverse Event|3|||
33249834|NCT00367055|100814521|FG000|Overall Study|Patient's Willing|3|||
33249835|NCT00367055|100814522|FG001|Overall Study|Patient's Willing|2|||
33249836|NCT00367055|100814521|FG000|Overall Study|Lack of Efficacy|1|||
33249837|NCT00367055|100814522|FG001|Overall Study|Lack of Efficacy|2|||
33249838|NCT00367055|100814521|FG000|Overall Study|Lost to Follow-up|1|||
33249839|NCT00367055|100814522|FG001|Overall Study|Lost to Follow-up|1|||
33434422|NCT02277769|101481105|FG002|Overall Study|Other than specified above|5|||
33434423|NCT02343120|101481113|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
33434424|NCT02343120|101481114|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
33434425|NCT02343120|101481115|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
33592844|NCT00712725|102057659|FG004|Overall Study|Lost to Follow-up|2|||
33592845|NCT00712725|102057660|FG005|Overall Study|Lost to Follow-up|2|||
33592846|NCT00712725|102057661|FG006|Overall Study|Lost to Follow-up|3|||
33592847|NCT00712725|102057662|FG007|Overall Study|Lost to Follow-up|1|||
33592848|NCT00712725|102057655|FG000|Overall Study|Physician Decision|2|||
33592849|NCT00712725|102057656|FG001|Overall Study|Physician Decision|0|||
33592850|NCT00712725|102057657|FG002|Overall Study|Physician Decision|0|||
33592851|NCT00712725|102057658|FG003|Overall Study|Physician Decision|0|||
33592852|NCT00712725|102057659|FG004|Overall Study|Physician Decision|1|||
33592853|NCT00712725|102057660|FG005|Overall Study|Physician Decision|0|||
33592854|NCT00712725|102057661|FG006|Overall Study|Physician Decision|2|||
33592855|NCT00712725|102057662|FG007|Overall Study|Physician Decision|0|||
33592856|NCT00712725|102057655|FG000|Overall Study|Pregnancy|0|||
33592857|NCT00712725|102057656|FG001|Overall Study|Pregnancy|1|||
33592858|NCT00712725|102057657|FG002|Overall Study|Pregnancy|0|||
33592859|NCT00712725|102057658|FG003|Overall Study|Pregnancy|0|||
33592860|NCT00712725|102057659|FG004|Overall Study|Pregnancy|1|||
33592861|NCT00712725|102057660|FG005|Overall Study|Pregnancy|0|||
33592862|NCT00712725|102057661|FG006|Overall Study|Pregnancy|2|||
33592863|NCT00712725|102057662|FG007|Overall Study|Pregnancy|0|||
33592864|NCT00712725|102057655|FG000|Overall Study|Protocol Violation|2|||
33592865|NCT00712725|102057656|FG001|Overall Study|Protocol Violation|0|||
33592866|NCT00712725|102057657|FG002|Overall Study|Protocol Violation|1|||
33592867|NCT00712725|102057658|FG003|Overall Study|Protocol Violation|3|||
33592868|NCT00712725|102057659|FG004|Overall Study|Protocol Violation|2|||
33592869|NCT00712725|102057660|FG005|Overall Study|Protocol Violation|0|||
33592870|NCT00712725|102057661|FG006|Overall Study|Protocol Violation|1|||
33592871|NCT00712725|102057662|FG007|Overall Study|Protocol Violation|1|||
33592872|NCT00712725|102057655|FG000|Overall Study|Withdrawal by Subject|2|||
33592873|NCT00712725|102057656|FG001|Overall Study|Withdrawal by Subject|1|||
33592874|NCT00712725|102057657|FG002|Overall Study|Withdrawal by Subject|1|||
33592875|NCT00712725|102057658|FG003|Overall Study|Withdrawal by Subject|2|||
33385259|NCT02980692|101296042|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
33385260|NCT02980692|101296043|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
33385261|NCT02980692|101296039|FG000|Double Blind Placebo Controlled Period|Other|1|||
33385262|NCT02980692|101296040|FG001|Double Blind Placebo Controlled Period|Other|0|||
33385263|NCT02980692|101296041|FG002|Double Blind Placebo Controlled Period|Other|0|||
33385264|NCT02980692|101296042|FG003|Double Blind Placebo Controlled Period|Other|0|||
33385265|NCT02980692|101296043|FG004|Double Blind Placebo Controlled Period|Other|1|||
33385266|NCT02980692|101296039|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
33385267|NCT02980692|101296040|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
33385268|NCT02980692|101296041|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
33385269|NCT02980692|101296042|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
33150287|NCT02713204|100463699|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
33150288|NCT02713204|100463700|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33150289|NCT02713204|100463701|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33150290|NCT02713204|100463702|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33592876|NCT00712725|102057659|FG004|Overall Study|Withdrawal by Subject|1|||
33592877|NCT00712725|102057660|FG005|Overall Study|Withdrawal by Subject|1|||
33592878|NCT00712725|102057661|FG006|Overall Study|Withdrawal by Subject|1|||
33592879|NCT00712725|102057662|FG007|Overall Study|Withdrawal by Subject|2|||
33592880|NCT00712725|102057655|FG000|Overall Study|Lack of Qualifying Event|16|||
33592881|NCT00712725|102057656|FG001|Overall Study|Lack of Qualifying Event|2|||
33592882|NCT00712725|102057657|FG002|Overall Study|Lack of Qualifying Event|6|||
33592883|NCT00712725|102057658|FG003|Overall Study|Lack of Qualifying Event|8|||
33592884|NCT00712725|102057659|FG004|Overall Study|Lack of Qualifying Event|11|||
33592885|NCT00712725|102057660|FG005|Overall Study|Lack of Qualifying Event|13|||
33592886|NCT00712725|102057661|FG006|Overall Study|Lack of Qualifying Event|11|||
33592887|NCT00712725|102057662|FG007|Overall Study|Lack of Qualifying Event|6|||
33592888|NCT00712725|102057655|FG000|Overall Study|Protocol Specified Criteria|3|||
33592889|NCT00712725|102057656|FG001|Overall Study|Protocol Specified Criteria|0|||
33592890|NCT00712725|102057657|FG002|Overall Study|Protocol Specified Criteria|1|||
33592891|NCT00712725|102057658|FG003|Overall Study|Protocol Specified Criteria|2|||
33592892|NCT00712725|102057659|FG004|Overall Study|Protocol Specified Criteria|1|||
33592893|NCT00712725|102057660|FG005|Overall Study|Protocol Specified Criteria|0|||
33592894|NCT00712725|102057661|FG006|Overall Study|Protocol Specified Criteria|2|||
33150291|NCT02713204|100463703|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33150292|NCT02713204|100463704|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
33150293|NCT02713204|100463697|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33150294|NCT02713204|100463698|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
33150295|NCT02713204|100463699|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33150296|NCT02713204|100463700|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33150297|NCT02713204|100463701|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33150298|NCT02713204|100463702|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33150299|NCT02713204|100463703|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33150300|NCT02713204|100463704|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
33150301|NCT02713204|100463697|FG000|From Week 12 up to Week 36|Adverse Event|1|||
33150302|NCT02713204|100463698|FG001|From Week 12 up to Week 36|Adverse Event|0|||
33150303|NCT02713204|100463699|FG002|From Week 12 up to Week 36|Adverse Event|0|||
33150304|NCT02713204|100463700|FG003|From Week 12 up to Week 36|Adverse Event|1|||
33385270|NCT02980692|101296043|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
33385271|NCT02980692|101296039|FG000|Double-blind Follow-up Period|Adverse Event|0|||
33385272|NCT02980692|101296040|FG001|Double-blind Follow-up Period|Adverse Event|0|||
33592895|NCT00712725|102057662|FG007|Overall Study|Protocol Specified Criteria|1|||
33592896|NCT00090233|102057663|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
33150305|NCT02713204|100463701|FG004|From Week 12 up to Week 36|Adverse Event|1|||
33150306|NCT02713204|100463702|FG005|From Week 12 up to Week 36|Adverse Event|0|||
33385273|NCT02980692|101296041|FG002|Double-blind Follow-up Period|Adverse Event|0|||
33385274|NCT02980692|101296042|FG003|Double-blind Follow-up Period|Adverse Event|1|||
33385275|NCT02980692|101296043|FG004|Double-blind Follow-up Period|Adverse Event|1|||
33385276|NCT02980692|101296039|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
33385277|NCT02980692|101296040|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
33385278|NCT02980692|101296041|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
33385279|NCT02980692|101296042|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
33385280|NCT02980692|101296043|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
33385281|NCT02980692|101296039|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
33385282|NCT02980692|101296040|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
33385283|NCT02980692|101296041|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
33385284|NCT02980692|101296042|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
33385285|NCT02980692|101296043|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
33385286|NCT02980692|101296039|FG000|Double-blind Follow-up Period|Pregnancy|0|||
33385287|NCT02980692|101296040|FG001|Double-blind Follow-up Period|Pregnancy|0|||
33385288|NCT02980692|101296041|FG002|Double-blind Follow-up Period|Pregnancy|1|||
33385289|NCT02980692|101296042|FG003|Double-blind Follow-up Period|Pregnancy|1|||
33385290|NCT02980692|101296043|FG004|Double-blind Follow-up Period|Pregnancy|0|||
33385291|NCT02980692|101296039|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
33385292|NCT02980692|101296040|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
33385293|NCT02980692|101296041|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
33385294|NCT02980692|101296042|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
33385295|NCT02980692|101296043|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
33385296|NCT02980692|101296039|FG000|Double-blind Follow-up Period|Other|0|||
33385297|NCT02980692|101296040|FG001|Double-blind Follow-up Period|Other|0|||
33385298|NCT02980692|101296041|FG002|Double-blind Follow-up Period|Other|1|||
33385299|NCT02980692|101296042|FG003|Double-blind Follow-up Period|Other|1|||
33385300|NCT02980692|101296043|FG004|Double-blind Follow-up Period|Other|3|||
33385301|NCT03148756|101296048|FG000|Overall Study|Study Terminated|0|||
33385302|NCT03148756|101296049|FG001|Overall Study|Study Terminated|1|||
33385303|NCT04114539|101296050|FG000|Overall Study|Adverse Event|14|||
33385304|NCT04114539|101296050|FG000|Overall Study|Lost to Follow-up|2|||
33385305|NCT04114539|101296050|FG000|Overall Study|Non-compliance with Protocol|2|||
33385306|NCT04114539|101296050|FG000|Overall Study|Non-compliance with Study Drug|1|||
33385307|NCT04114539|101296050|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
33385308|NCT04114539|101296050|FG000|Overall Study|Withdrew consent|10|||
33385309|NCT04114539|101296050|FG000|Overall Study|Others not specified|5|||
33385310|NCT04114539|101296050|FG000|Overall Study|Investigator Decision|2|||
33385311|NCT01255306|101296055|FG000|Overall Study|Physician Decision|1|||
33385312|NCT01255306|101296056|FG001|Overall Study|Physician Decision|1|||
33385313|NCT01342952|101296059|FG000|Overall Study|Adverse Event|0|||
33150307|NCT02713204|100463703|FG006|From Week 12 up to Week 36|Adverse Event|2|||
33249840|NCT00367055|100814521|FG000|Overall Study|Protocol Violation|0|||
33249841|NCT00367055|100814522|FG001|Overall Study|Protocol Violation|1|||
33249842|NCT00367055|100814521|FG000|Overall Study|Stopping Criterion Met|0|||
33385314|NCT01342952|101296060|FG001|Overall Study|Adverse Event|5|||
33385315|NCT01342952|101296061|FG002|Overall Study|Adverse Event|1|||
33249843|NCT00367055|100814522|FG001|Overall Study|Stopping Criterion Met|1|||
33249844|NCT00367055|100814521|FG000|Overall Study|Participant Living too Far from Hospital|0|||
33249845|NCT00367055|100814522|FG001|Overall Study|Participant Living too Far from Hospital|1|||
33249846|NCT01020838|100814523|FG000|Overall Study|Death|90|||
33249847|NCT01020838|100814523|FG000|Overall Study|Adverse Event|1|||
33249848|NCT01020838|100814523|FG000|Overall Study|Withdrawal by Subject|9|||
33249849|NCT01020838|100814523|FG000|Overall Study|Lost to Follow-up|6|||
33249850|NCT01020838|100814523|FG000|Overall Study|Most common: Study ended by sponsor|77|||
33249851|NCT02517307|100814525|FG000|Overall Study|Withdrawal by Subject|1|||
33249852|NCT02517307|100814526|FG001|Overall Study|Withdrawal by Subject|0|||
33249853|NCT02517307|100814527|FG002|Overall Study|Withdrawal by Subject|1|||
33249854|NCT02517307|100814528|FG003|Overall Study|Withdrawal by Subject|0|||
33249855|NCT02517307|100814525|FG000|Overall Study|Protocol Violation|0|||
33249856|NCT02517307|100814526|FG001|Overall Study|Protocol Violation|0|||
33249857|NCT02517307|100814527|FG002|Overall Study|Protocol Violation|1|||
33249858|NCT02517307|100814528|FG003|Overall Study|Protocol Violation|1|||
33249859|NCT03612804|100814529|FG000|Overall Study|Death|0|||
33249860|NCT03612804|100814530|FG001|Overall Study|Death|7|||
33249861|NCT03612804|100814531|FG002|Overall Study|Death|0|||
33249862|NCT03612804|100814532|FG003|Overall Study|Death|8|||
33249863|NCT03612804|100814529|FG000|Overall Study|Medication copay coverage issues|0|||
33249864|NCT03612804|100814530|FG001|Overall Study|Medication copay coverage issues|0|||
33249865|NCT03612804|100814531|FG002|Overall Study|Medication copay coverage issues|0|||
33249866|NCT03612804|100814532|FG003|Overall Study|Medication copay coverage issues|17|||
33249867|NCT03612804|100814529|FG000|Overall Study|Not current smoker at time of screening|0|||
33249868|NCT03612804|100814530|FG001|Overall Study|Not current smoker at time of screening|1|||
33249869|NCT03612804|100814531|FG002|Overall Study|Not current smoker at time of screening|0|||
33249870|NCT03612804|100814532|FG003|Overall Study|Not current smoker at time of screening|3|||
33249871|NCT03612804|100814529|FG000|Overall Study|Non-veteran status|0|||
33249872|NCT03612804|100814530|FG001|Overall Study|Non-veteran status|1|||
33249873|NCT03612804|100814531|FG002|Overall Study|Non-veteran status|0|||
33249874|NCT03612804|100814532|FG003|Overall Study|Non-veteran status|0|||
33249875|NCT03612804|100814529|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
33249876|NCT03612804|100814530|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
33249877|NCT03612804|100814531|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
33249878|NCT03612804|100814532|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
33249879|NCT03612804|100814529|FG000|Overall Study|Provider retired from VA|0|||
33249880|NCT03612804|100814530|FG001|Overall Study|Provider retired from VA|0|||
33249881|NCT03612804|100814531|FG002|Overall Study|Provider retired from VA|2|||
33249882|NCT03612804|100814532|FG003|Overall Study|Provider retired from VA|0|||
33249883|NCT03612804|100814529|FG000|Overall Study|Withdrawal by Subject|0|||
33249884|NCT03612804|100814530|FG001|Overall Study|Withdrawal by Subject|0|||
33249885|NCT03612804|100814531|FG002|Overall Study|Withdrawal by Subject|7|||
33249886|NCT03612804|100814532|FG003|Overall Study|Withdrawal by Subject|0|||
33249887|NCT03612804|100814529|FG000|Overall Study|Provider involved with study activities|1|||
33249888|NCT03612804|100814530|FG001|Overall Study|Provider involved with study activities|0|||
33249889|NCT03612804|100814531|FG002|Overall Study|Provider involved with study activities|0|||
33249890|NCT03612804|100814532|FG003|Overall Study|Provider involved with study activities|0|||
33249891|NCT00430300|100814533|FG000|Overall Study|Adverse Event|0|||
33249892|NCT00430300|100814534|FG001|Overall Study|Adverse Event|2|||
33249893|NCT00430300|100814535|FG002|Overall Study|Adverse Event|1|||
33249894|NCT00430300|100814536|FG003|Overall Study|Adverse Event|1|||
33385316|NCT01342952|101296062|FG003|Overall Study|Adverse Event|0|||
33385317|NCT01342952|101296059|FG000|Overall Study|Lost to Follow-up|0|||
33385318|NCT01342952|101296060|FG001|Overall Study|Lost to Follow-up|2|||
33385319|NCT01342952|101296061|FG002|Overall Study|Lost to Follow-up|0|||
33592897|NCT00090233|102057664|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
33592898|NCT00090233|102057663|FG000|Overall Study|Adverse Event|214|||
33150308|NCT02713204|100463704|FG007|From Week 12 up to Week 36|Adverse Event|1|||
33150309|NCT02713204|100463697|FG000|From Week 12 up to Week 36|Death|0|||
33150310|NCT02713204|100463698|FG001|From Week 12 up to Week 36|Death|0|||
33150311|NCT02713204|100463699|FG002|From Week 12 up to Week 36|Death|0|||
33150312|NCT02713204|100463700|FG003|From Week 12 up to Week 36|Death|1|||
33150313|NCT02713204|100463701|FG004|From Week 12 up to Week 36|Death|0|||
33150314|NCT02713204|100463702|FG005|From Week 12 up to Week 36|Death|1|||
33150315|NCT02713204|100463703|FG006|From Week 12 up to Week 36|Death|0|||
33150316|NCT02713204|100463704|FG007|From Week 12 up to Week 36|Death|3|||
33150317|NCT02713204|100463697|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
33150318|NCT02713204|100463698|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
33150319|NCT02713204|100463699|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
33150320|NCT02713204|100463700|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
33150321|NCT02713204|100463701|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
33150322|NCT02713204|100463702|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
33150323|NCT02713204|100463703|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
33150324|NCT02713204|100463704|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
33385320|NCT01342952|101296062|FG003|Overall Study|Lost to Follow-up|0|||
33385321|NCT01342952|101296059|FG000|Overall Study|Withdrawal by Subject|1|||
33385322|NCT01342952|101296060|FG001|Overall Study|Withdrawal by Subject|1|||
33385323|NCT01342952|101296061|FG002|Overall Study|Withdrawal by Subject|0|||
33385324|NCT01342952|101296062|FG003|Overall Study|Withdrawal by Subject|0|||
33385325|NCT01342952|101296059|FG000|Overall Study|Physician Decision|3|||
33385326|NCT01342952|101296060|FG001|Overall Study|Physician Decision|3|||
33385327|NCT01342952|101296061|FG002|Overall Study|Physician Decision|1|||
33592899|NCT00090233|102057664|FG001|Overall Study|Adverse Event|198|||
33385328|NCT01342952|101296062|FG003|Overall Study|Physician Decision|0|||
33592900|NCT00090233|102057663|FG000|Overall Study|Lost to Follow-up|68|||
33592901|NCT00090233|102057664|FG001|Overall Study|Lost to Follow-up|95|||
33592902|NCT00090233|102057663|FG000|Overall Study|Protocol Violation|960|||
33592903|NCT00090233|102057664|FG001|Overall Study|Protocol Violation|1022|||
33592904|NCT00090233|102057663|FG000|Overall Study|Withdrawal by Subject|182|||
33592905|NCT00090233|102057664|FG001|Overall Study|Withdrawal by Subject|211|||
33592906|NCT00090233|102057663|FG000|Overall Study|Moved|203|||
33592907|NCT00090233|102057664|FG001|Overall Study|Moved|189|||
33592908|NCT00090233|102057663|FG000|Overall Study|Other|1211|||
33592909|NCT00090233|102057664|FG001|Overall Study|Other|1160|||
33592910|NCT00090233|102057663|FG000|Overall Study|Data not available at data cut-off point|1552|||
33592911|NCT00090233|102057664|FG001|Overall Study|Data not available at data cut-off point|1563|||
33592912|NCT01265563|102057672|FG000|Overall Study|Withdrawal by Subject|0|||
33592913|NCT01265563|102057673|FG001|Overall Study|Withdrawal by Subject|1|||
33592914|NCT01265563|102057674|FG002|Overall Study|Withdrawal by Subject|1|||
33592915|NCT01265563|102057675|FG003|Overall Study|Withdrawal by Subject|0|||
33592916|NCT01265563|102057676|FG004|Overall Study|Withdrawal by Subject|2|||
33592917|NCT02513485|102057679|FG000|Overall Study|Adverse Event|1|||
33592918|NCT02513485|102057680|FG001|Overall Study|Adverse Event|0|||
33592919|NCT01451931|102057681|FG000|Overall Study|Lost to Follow-up|17|||
33592920|NCT01451931|102057682|FG001|Overall Study|Lost to Follow-up|36|||
33592921|NCT01451931|102057683|FG002|Overall Study|Lost to Follow-up|21|||
33592922|NCT01451931|102057681|FG000|Overall Study|Withdrawal by Subject|16|||
33592923|NCT01451931|102057682|FG001|Overall Study|Withdrawal by Subject|22|||
33592924|NCT01451931|102057683|FG002|Overall Study|Withdrawal by Subject|22|||
33592925|NCT02752958|102057684|FG000|Overall Study|Adverse Event|3|||
33592926|NCT02752958|102057684|FG000|Overall Study|Lost to Follow-up|1|||
33592927|NCT02752958|102057684|FG000|Overall Study|Protocol Violation|1|||
33592928|NCT02752958|102057684|FG000|Overall Study|Withdrawal by Subject|2|||
33592929|NCT02752958|102057684|FG000|Overall Study|Other (Reason not specified)|2|||
33592930|NCT01289353|102057685|FG000|Overall Study|Lost to Follow-up|2|||
33592931|NCT01610557|102057686|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
33592932|NCT01610557|102057687|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
33592933|NCT01610557|102057688|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
33592934|NCT01610557|102057689|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
33592935|NCT01610557|102057690|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
33592936|NCT01610557|102057686|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
33592937|NCT01610557|102057687|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
33592938|NCT01610557|102057688|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
33592939|NCT01610557|102057689|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
33592940|NCT01610557|102057690|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
33592941|NCT02019108|102057691|FG000|Overall Study|Lost to Follow-up|5|||
33592942|NCT02019108|102057692|FG001|Overall Study|Lost to Follow-up|7|||
33592943|NCT01610713|102057693|FG000|Overall Study|Adverse Event|3|||
33592944|NCT01610713|102057694|FG001|Overall Study|Adverse Event|0|||
33592945|NCT01610713|102057693|FG000|Overall Study|Lack of Efficacy|1|||
33592946|NCT01610713|102057694|FG001|Overall Study|Lack of Efficacy|0|||
33592947|NCT01610713|102057693|FG000|Overall Study|low mood and poor motivation|1|||
33592948|NCT01610713|102057694|FG001|Overall Study|low mood and poor motivation|0|||
33592949|NCT01610713|102057693|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
33592950|NCT01610713|102057694|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
33592951|NCT01610713|102057693|FG000|Overall Study|Lost to Follow-up|0|||
33592952|NCT01610713|102057694|FG001|Overall Study|Lost to Follow-up|1|||
33592953|NCT03298984|102057695|FG000|Overall Study|Physician Decision|1|||
33592954|NCT03298984|102057696|FG001|Overall Study|Physician Decision|0|||
33592955|NCT03298984|102057697|FG002|Overall Study|Physician Decision|0|||
33592956|NCT03298984|102057698|FG003|Overall Study|Physician Decision|6|||
33592957|NCT03298984|102057695|FG000|Overall Study|Lack of Efficacy|0|||
33592958|NCT03298984|102057696|FG001|Overall Study|Lack of Efficacy|1|||
33592959|NCT03298984|102057697|FG002|Overall Study|Lack of Efficacy|1|||
33592960|NCT03298984|102057698|FG003|Overall Study|Lack of Efficacy|4|||
33592961|NCT03298984|102057695|FG000|Overall Study|Relapsed disease (following remission)|0|||
33592962|NCT03298984|102057696|FG001|Overall Study|Relapsed disease (following remission)|0|||
33592963|NCT03298984|102057697|FG002|Overall Study|Relapsed disease (following remission)|1|||
33592964|NCT03298984|102057698|FG003|Overall Study|Relapsed disease (following remission)|1|||
33592965|NCT03298984|102057695|FG000|Overall Study|Adverse Event|0|||
33592966|NCT03298984|102057696|FG001|Overall Study|Adverse Event|0|||
33592967|NCT03298984|102057697|FG002|Overall Study|Adverse Event|0|||
33592968|NCT03298984|102057698|FG003|Overall Study|Adverse Event|1|||
33592969|NCT03298984|102057695|FG000|Overall Study|Death|0|||
33592970|NCT03298984|102057696|FG001|Overall Study|Death|0|||
33592971|NCT03298984|102057697|FG002|Overall Study|Death|0|||
33592972|NCT03298984|102057698|FG003|Overall Study|Death|2|||
33592973|NCT03298984|102057695|FG000|Overall Study|Insurance Company Decision|0|||
33592974|NCT03298984|102057696|FG001|Overall Study|Insurance Company Decision|0|||
33592975|NCT03298984|102057697|FG002|Overall Study|Insurance Company Decision|0|||
33385329|NCT01188538|101296063|FG000|Overall Study|Lost to Follow-up|0|||
33385330|NCT01188538|101296064|FG001|Overall Study|Lost to Follow-up|1|||
33385331|NCT02142504|101296065|FG000|Overall Study|Protocol Violation|2|||
33385332|NCT02142504|101296066|FG001|Overall Study|Protocol Violation|1|||
33385333|NCT02142504|101296067|FG002|Overall Study|Protocol Violation|2|||
33592976|NCT03298984|102057698|FG003|Overall Study|Insurance Company Decision|1|||
33592977|NCT00608023|102057699|FG000|Overall Study|Withdrawal by Subject|8|||
33592978|NCT00608023|102057700|FG001|Overall Study|Withdrawal by Subject|10|||
33592979|NCT00608023|102057701|FG002|Overall Study|Withdrawal by Subject|7|||
33592980|NCT00608023|102057699|FG000|Overall Study|Adverse Event|1|||
33592981|NCT00608023|102057700|FG001|Overall Study|Adverse Event|4|||
33592982|NCT00608023|102057701|FG002|Overall Study|Adverse Event|5|||
33592983|NCT00608023|102057699|FG000|Overall Study|Lost to Follow-up|2|||
33592984|NCT00608023|102057700|FG001|Overall Study|Lost to Follow-up|2|||
33592985|NCT00608023|102057701|FG002|Overall Study|Lost to Follow-up|1|||
33592986|NCT00608023|102057699|FG000|Overall Study|Protocol Violation|1|||
33592987|NCT00608023|102057700|FG001|Overall Study|Protocol Violation|3|||
33592988|NCT00608023|102057701|FG002|Overall Study|Protocol Violation|1|||
33592989|NCT00608023|102057699|FG000|Overall Study|Unknown reason|0|||
33592990|NCT00608023|102057700|FG001|Overall Study|Unknown reason|3|||
33592991|NCT00608023|102057701|FG002|Overall Study|Unknown reason|0|||
33592992|NCT00385944|102057702|FG000|1st Maintenance Dose Period|Physician Decision|1|||
33592993|NCT00385944|102057703|FG001|1st Maintenance Dose Period|Physician Decision|0|||
33592994|NCT00385944|102057704|FG002|1st Maintenance Dose Period|Physician Decision|0|||
33592995|NCT00385944|102057702|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
33592996|NCT00385944|102057703|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
33592997|NCT00385944|102057704|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
33592998|NCT00385944|102057702|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
33592999|NCT00385944|102057703|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
33593000|NCT00385944|102057704|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
33593001|NCT00385944|102057702|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
33593002|NCT00385944|102057703|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
33593003|NCT00385944|102057704|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
33593004|NCT02649218|102057705|FG000|Overall Study|Adverse Event|8|||
33593005|NCT02649218|102057705|FG000|Overall Study|Lack of Efficacy|8|||
33593006|NCT02649218|102057705|FG000|Overall Study|Pregnancy|3|||
33593007|NCT02649218|102057705|FG000|Overall Study|Protocol Violation|3|||
33593008|NCT02649218|102057705|FG000|Overall Study|Physician Decision|1|||
33593009|NCT02649218|102057705|FG000|Overall Study|Withdrawal by Subject|2|||
33593010|NCT03596047|102057706|FG000|Overall Study|Withdrawal by Subject|7|||
33593011|NCT03596047|102057707|FG001|Overall Study|Withdrawal by Subject|4|||
33593012|NCT03596047|102057706|FG000|Overall Study|Lost to Follow-up|0|||
33593013|NCT03596047|102057707|FG001|Overall Study|Lost to Follow-up|2|||
33593014|NCT02901054|102057708|FG000|Overall Study|Physician Decision|1|||
33593015|NCT02901054|102057708|FG000|Overall Study|Withdrawal by Subject|3|||
33593016|NCT03195660|102057717|FG000|Overall Study|The study was terminated|2|||
33593017|NCT03222973|102057719|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
33593018|NCT03222973|102057720|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
33593019|NCT03222973|102057721|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
33593020|NCT03222973|102057722|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
33593021|NCT03222973|102057719|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
33593022|NCT03222973|102057720|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
33593023|NCT03222973|102057721|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
33593024|NCT03222973|102057722|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
33593025|NCT03222973|102057719|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
33593026|NCT03222973|102057720|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
33593027|NCT03222973|102057721|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
33593028|NCT03222973|102057722|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
33593029|NCT03222973|102057719|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
33593030|NCT03222973|102057720|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
33593031|NCT03222973|102057721|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
33593032|NCT03222973|102057722|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
33593033|NCT03222973|102057719|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
33593034|NCT03222973|102057720|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
33593035|NCT03222973|102057721|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
33593036|NCT03222973|102057722|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
33593037|NCT03222973|102057719|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
33593038|NCT03222973|102057720|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
33593039|NCT03222973|102057721|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
33593040|NCT03222973|102057722|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
33593041|NCT03222973|102057719|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
33593042|NCT03222973|102057720|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
33593043|NCT03222973|102057721|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
33593044|NCT03222973|102057722|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
33593045|NCT03222973|102057719|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
33593046|NCT03222973|102057720|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
33593047|NCT03222973|102057721|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
33593048|NCT03222973|102057722|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
33593049|NCT03222973|102057719|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
33593050|NCT03222973|102057720|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
33593051|NCT03222973|102057721|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
33593052|NCT03222973|102057722|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
33593053|NCT03222973|102057719|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
33385334|NCT02142504|101296065|FG000|Overall Study|Adverse Event|2|||
33593054|NCT03222973|102057720|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
33593055|NCT03222973|102057721|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
33249895|NCT00430300|100814533|FG000|Overall Study|Withdrawal by Subject|1|||
33249896|NCT00430300|100814534|FG001|Overall Study|Withdrawal by Subject|0|||
33249897|NCT00430300|100814535|FG002|Overall Study|Withdrawal by Subject|5|||
33249898|NCT00430300|100814536|FG003|Overall Study|Withdrawal by Subject|0|||
33249899|NCT00430300|100814533|FG000|Overall Study|Laboratory abnormality|1|||
33249900|NCT00430300|100814534|FG001|Overall Study|Laboratory abnormality|0|||
33249901|NCT00430300|100814535|FG002|Overall Study|Laboratory abnormality|0|||
33249902|NCT00430300|100814536|FG003|Overall Study|Laboratory abnormality|0|||
33249903|NCT00430300|100814533|FG000|Overall Study|Other|0|||
33593056|NCT03222973|102057722|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
33593057|NCT03222973|102057719|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
33593058|NCT03222973|102057720|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
33593059|NCT03222973|102057721|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
33593060|NCT03222973|102057722|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
33593061|NCT03222973|102057719|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
33593062|NCT03222973|102057720|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
33593063|NCT03222973|102057721|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
33593064|NCT03222973|102057722|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
33593065|NCT01257230|102057725|FG000|Overall Study|Not Treated|0|||
33593066|NCT01257230|102057726|FG001|Overall Study|Not Treated|0|||
33593067|NCT01257230|102057727|FG002|Overall Study|Not Treated|1|||
33593068|NCT01257230|102057725|FG000|Overall Study|Adverse Event|2|||
33593069|NCT01257230|102057726|FG001|Overall Study|Adverse Event|0|||
33593070|NCT01257230|102057727|FG002|Overall Study|Adverse Event|0|||
33593071|NCT01257230|102057725|FG000|Overall Study|Lack of Efficacy|0|||
33593072|NCT01257230|102057726|FG001|Overall Study|Lack of Efficacy|1|||
33593073|NCT01257230|102057727|FG002|Overall Study|Lack of Efficacy|0|||
33385335|NCT02142504|101296066|FG001|Overall Study|Adverse Event|3|||
33385336|NCT02142504|101296067|FG002|Overall Study|Adverse Event|4|||
33385337|NCT02142504|101296065|FG000|Overall Study|Lost to Follow-up|12|||
33385338|NCT02142504|101296066|FG001|Overall Study|Lost to Follow-up|19|||
33385339|NCT02142504|101296067|FG002|Overall Study|Lost to Follow-up|17|||
33385340|NCT02142504|101296065|FG000|Overall Study|Withdrawal by Subject|7|||
33385341|NCT02142504|101296066|FG001|Overall Study|Withdrawal by Subject|9|||
33385342|NCT02142504|101296067|FG002|Overall Study|Withdrawal by Subject|11|||
33385343|NCT02142504|101296065|FG000|Overall Study|Pregnancy|4|||
33385344|NCT02142504|101296066|FG001|Overall Study|Pregnancy|4|||
33385345|NCT02142504|101296067|FG002|Overall Study|Pregnancy|2|||
33385346|NCT02142504|101296065|FG000|Overall Study|Physician Decision|0|||
33385347|NCT02142504|101296066|FG001|Overall Study|Physician Decision|1|||
33385348|NCT02142504|101296067|FG002|Overall Study|Physician Decision|3|||
33385349|NCT02142504|101296065|FG000|Overall Study|Reason Not Specified|4|||
33385350|NCT02142504|101296066|FG001|Overall Study|Reason Not Specified|5|||
33385351|NCT02142504|101296067|FG002|Overall Study|Reason Not Specified|4|||
33385352|NCT01149343|101296068|FG000|Overall Study|Withdrawal by Subject|1|||
33385353|NCT01149343|101296069|FG001|Overall Study|Withdrawal by Subject|1|||
33385354|NCT01149343|101296070|FG002|Overall Study|Withdrawal by Subject|1|||
33385355|NCT01149343|101296071|FG003|Overall Study|Withdrawal by Subject|5|||
33385356|NCT01149343|101296068|FG000|Overall Study|Death|10|||
33385357|NCT01149343|101296069|FG001|Overall Study|Death|13|||
33385358|NCT01149343|101296070|FG002|Overall Study|Death|18|||
33385359|NCT01149343|101296071|FG003|Overall Study|Death|18|||
33385360|NCT01149343|101296068|FG000|Overall Study|Lost to Follow-up|1|||
33385361|NCT01149343|101296069|FG001|Overall Study|Lost to Follow-up|0|||
33385362|NCT01149343|101296070|FG002|Overall Study|Lost to Follow-up|0|||
33385363|NCT01149343|101296071|FG003|Overall Study|Lost to Follow-up|1|||
33385364|NCT01149343|101296068|FG000|Overall Study|Other|8|||
33385365|NCT01149343|101296069|FG001|Overall Study|Other|10|||
33385366|NCT01149343|101296070|FG002|Overall Study|Other|2|||
33385367|NCT01149343|101296071|FG003|Overall Study|Other|14|||
33385368|NCT01149343|101296068|FG000|Overall Study|Sponsor study termination|0|||
33385369|NCT01149343|101296069|FG001|Overall Study|Sponsor study termination|0|||
33385370|NCT01149343|101296070|FG002|Overall Study|Sponsor study termination|0|||
33385371|NCT01149343|101296071|FG003|Overall Study|Sponsor study termination|2|||
33385372|NCT01149343|101296068|FG000|Overall Study|Recurrence / Progressive disease|0|||
33434426|NCT02343120|101481116|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
33593074|NCT01257230|102057725|FG000|Overall Study|Protocol Violation|3|||
33249904|NCT00430300|100814534|FG001|Overall Study|Other|0|||
33249905|NCT00430300|100814535|FG002|Overall Study|Other|0|||
33385373|NCT01149343|101296069|FG001|Overall Study|Recurrence / Progressive disease|0|||
33593075|NCT01257230|102057726|FG001|Overall Study|Protocol Violation|0|||
33593076|NCT01257230|102057727|FG002|Overall Study|Protocol Violation|1|||
33593077|NCT01257230|102057725|FG000|Overall Study|Withdrawal by Subject|0|||
33593078|NCT01257230|102057726|FG001|Overall Study|Withdrawal by Subject|4|||
33385374|NCT01149343|101296070|FG002|Overall Study|Recurrence / Progressive disease|1|||
33385375|NCT01149343|101296071|FG003|Overall Study|Recurrence / Progressive disease|0|||
33385376|NCT04294095|101296076|FG000|Overall Study|Adverse Event|1|||
33385377|NCT04294095|101296077|FG001|Overall Study|Adverse Event|0|||
33434427|NCT02343120|101481117|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
33434428|NCT02343120|101481113|FG000|Part 1: Dose Escalation|Death|1|||
33434429|NCT02343120|101481114|FG001|Part 1: Dose Escalation|Death|2|||
33434430|NCT02343120|101481115|FG002|Part 1: Dose Escalation|Death|2|||
33434431|NCT02343120|101481116|FG003|Part 1: Dose Escalation|Death|2|||
33434432|NCT02343120|101481117|FG004|Part 1: Dose Escalation|Death|1|||
33150325|NCT02713204|100463697|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
33150326|NCT02713204|100463698|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
33150327|NCT02713204|100463699|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
33385378|NCT05441540|101296078|FG000|Overall Study|Withdrawal by Subject|2|||
33385379|NCT00990249|101296082|FG000|Overall Study|Disease Progression|8|||
33385380|NCT00990249|101296082|FG000|Overall Study|Non-Compliance|1|||
33385381|NCT00990249|101296082|FG000|Overall Study|Death|2|||
33385382|NCT00990249|101296082|FG000|Overall Study|Not treated|2|||
33434433|NCT02343120|101481113|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
33434434|NCT02343120|101481114|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
33434435|NCT02343120|101481115|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
33385383|NCT03587584|101296083|FG000|Overall Study|SOC deviations|4|||
33385384|NCT03587584|101296084|FG001|Overall Study|SOC deviations|6|||
33385385|NCT03587584|101296083|FG000|Overall Study|Incomplete data|0|||
33385386|NCT03587584|101296084|FG001|Overall Study|Incomplete data|3|||
33385387|NCT00092677|101296085|FG000|Overall Study|Lost to Follow-up|0|||
33385388|NCT00092677|101296086|FG001|Overall Study|Lost to Follow-up|2|||
33385389|NCT00092677|101296085|FG000|Overall Study|Adminstrative|5|||
33385390|NCT00092677|101296086|FG001|Overall Study|Adminstrative|9|||
33385391|NCT02064205|101296090|FG000|Overall Study|Withdrawal by Subject|1|||
33385392|NCT05552859|101296091|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
33385393|NCT05552859|101296092|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
33593079|NCT01257230|102057727|FG002|Overall Study|Withdrawal by Subject|1|||
33593080|NCT01257230|102057725|FG000|Overall Study|Other reason not defined above|1|||
33593081|NCT01257230|102057726|FG001|Overall Study|Other reason not defined above|5|||
33593082|NCT01257230|102057727|FG002|Overall Study|Other reason not defined above|3|||
33593083|NCT00433160|102057728|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
33593084|NCT00433160|102057729|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
33593085|NCT00433160|102057728|FG000|52-Week Double-Blind (DB) Period|Death|0|||
33593086|NCT00433160|102057729|FG001|52-Week Double-Blind (DB) Period|Death|0|||
33593087|NCT00433160|102057728|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
33593088|NCT00433160|102057729|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
33593089|NCT00433160|102057728|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
33593090|NCT00433160|102057729|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
33593091|NCT00433160|102057728|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
33593092|NCT00433160|102057729|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
33593093|NCT00433160|102057728|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
33593094|NCT00433160|102057729|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
33593095|NCT00433160|102057728|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
33593096|NCT00433160|102057729|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
33593097|NCT00433160|102057728|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
33593098|NCT00433160|102057729|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
33593099|NCT00433160|102057728|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
33593100|NCT00433160|102057729|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
33593101|NCT00433160|102057728|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
33593102|NCT00433160|102057729|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
33593103|NCT00433160|102057728|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
33593104|NCT00433160|102057729|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
33593105|NCT00433160|102057728|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
33593106|NCT00433160|102057729|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
33150328|NCT02713204|100463700|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
33150329|NCT02713204|100463701|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
33150330|NCT02713204|100463702|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
33150331|NCT02713204|100463703|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
33150332|NCT02713204|100463704|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
33150333|NCT01927341|100463705|FG000|Phase 1b|Lost to Follow-up|1|||
33249906|NCT00430300|100814536|FG003|Overall Study|Other|1|||
33150334|NCT01927341|100463706|FG001|Phase 1b|Lost to Follow-up|0|||
33249907|NCT00880906|100814537|FG000|Overall Study|Lost to Follow-up|0|||
33249908|NCT00880906|100814538|FG001|Overall Study|Lost to Follow-up|1|||
33249909|NCT00880906|100814537|FG000|Overall Study|Did not meet criteria following patholog|12|||
33249910|NCT00880906|100814538|FG001|Overall Study|Did not meet criteria following patholog|6|||
33434436|NCT02343120|101481116|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
33434437|NCT02343120|101481117|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
33434438|NCT02343120|101481113|FG000|Part 2: Expansion|Sponsor decision|0|||
33434439|NCT02343120|101481114|FG001|Part 2: Expansion|Sponsor decision|0|||
33434440|NCT02343120|101481115|FG002|Part 2: Expansion|Sponsor decision|0|||
33434441|NCT02343120|101481116|FG003|Part 2: Expansion|Sponsor decision|165|||
33434442|NCT02343120|101481117|FG004|Part 2: Expansion|Sponsor decision|67|||
33434443|NCT02343120|101481113|FG000|Part 2: Expansion|Death|0|||
33434444|NCT02343120|101481114|FG001|Part 2: Expansion|Death|0|||
33434445|NCT02343120|101481115|FG002|Part 2: Expansion|Death|0|||
33434446|NCT02343120|101481116|FG003|Part 2: Expansion|Death|74|||
33434447|NCT02343120|101481117|FG004|Part 2: Expansion|Death|17|||
33434448|NCT02343120|101481113|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
33434449|NCT02343120|101481114|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
33434450|NCT02343120|101481115|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
33434451|NCT02343120|101481116|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
33434452|NCT02343120|101481117|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
33434453|NCT02343120|101481113|FG000|Part 2: Expansion|Lost to Follow-up|0|||
33434454|NCT02343120|101481114|FG001|Part 2: Expansion|Lost to Follow-up|0|||
33434455|NCT02343120|101481115|FG002|Part 2: Expansion|Lost to Follow-up|0|||
33434456|NCT02343120|101481116|FG003|Part 2: Expansion|Lost to Follow-up|5|||
33434457|NCT02343120|101481117|FG004|Part 2: Expansion|Lost to Follow-up|2|||
33434458|NCT02343120|101481113|FG000|Part 2: Expansion|Other|0|||
33434459|NCT02343120|101481114|FG001|Part 2: Expansion|Other|0|||
33434460|NCT02343120|101481115|FG002|Part 2: Expansion|Other|0|||
33434461|NCT02343120|101481116|FG003|Part 2: Expansion|Other|1|||
33434462|NCT02343120|101481117|FG004|Part 2: Expansion|Other|5|||
33434463|NCT02343120|101481113|FG000|Part 2: Expansion|Adverse Event|0|||
33434464|NCT02343120|101481114|FG001|Part 2: Expansion|Adverse Event|0|||
33434465|NCT02343120|101481115|FG002|Part 2: Expansion|Adverse Event|0|||
33434466|NCT02343120|101481116|FG003|Part 2: Expansion|Adverse Event|1|||
33434467|NCT02343120|101481117|FG004|Part 2: Expansion|Adverse Event|1|||
33434468|NCT01531205|101481118|FG000|Overall Study|Did not proceed to surgery|1|||
33434469|NCT02928848|101481119|FG000|Arm 2|Withdrawal by Subject|1|||
33434470|NCT02928848|101481120|FG001|Arm 2|Withdrawal by Subject|0|||
33434471|NCT02623959|101481122|FG000|Overall Study|Progression|0|||
33434472|NCT02623959|101481123|FG001|Overall Study|Progression|1|||
33434473|NCT01298570|101481124|FG000|Overall Study|Disease progression, relapse during acti|64|||
33434474|NCT01298570|101481125|FG001|Overall Study|Disease progression, relapse during acti|40|||
33434475|NCT01298570|101481124|FG000|Overall Study|Adverse Event|20|||
33434476|NCT01298570|101481125|FG001|Overall Study|Adverse Event|2|||
33434477|NCT01298570|101481124|FG000|Overall Study|Withdrawal by Subject|21|||
33593107|NCT00433160|102057728|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
33150335|NCT01927341|100463707|FG002|Phase 1b|Lost to Follow-up|0|||
33150336|NCT01927341|100463708|FG003|Phase 1b|Lost to Follow-up|0|||
33150337|NCT01927341|100463709|FG004|Phase 1b|Lost to Follow-up|0|||
33150338|NCT01927341|100463705|FG000|Phase 1b|Death|2|||
33150339|NCT01927341|100463706|FG001|Phase 1b|Death|0|||
33150340|NCT01927341|100463707|FG002|Phase 1b|Death|0|||
33150341|NCT01927341|100463708|FG003|Phase 1b|Death|0|||
33434478|NCT01298570|101481125|FG001|Overall Study|Withdrawal by Subject|6|||
33434479|NCT01298570|101481124|FG000|Overall Study|Treatment delay > 4 weeks|4|||
33434480|NCT01298570|101481125|FG001|Overall Study|Treatment delay > 4 weeks|5|||
33434481|NCT01298570|101481124|FG000|Overall Study|Physician Decision|4|||
33434482|NCT01298570|101481125|FG001|Overall Study|Physician Decision|2|||
33434483|NCT01298570|101481124|FG000|Overall Study|Other complicating disease|2|||
33434484|NCT01298570|101481125|FG001|Overall Study|Other complicating disease|1|||
33434485|NCT01298570|101481124|FG000|Overall Study|Surgery|2|||
33434486|NCT01298570|101481125|FG001|Overall Study|Surgery|1|||
33434487|NCT01298570|101481124|FG000|Overall Study|Symptomatic progression/deterioration|3|||
33434488|NCT01298570|101481125|FG001|Overall Study|Symptomatic progression/deterioration|2|||
33434489|NCT01298570|101481124|FG000|Overall Study|Death|0|||
33593108|NCT00433160|102057729|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
33593109|NCT00433160|102057728|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
33593110|NCT00433160|102057729|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
33593111|NCT00433160|102057728|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
33385394|NCT00196196|101296097|FG000|Overall Study|Withdrawal by Subject|2|||
33385395|NCT00196196|101296097|FG000|Overall Study|Did not have required condition (hydroce|5|||
33385396|NCT03943446|101296098|FG000|Overall Study|Lost to Follow-up|0|||
33385397|NCT03943446|101296099|FG001|Overall Study|Lost to Follow-up|0|||
33385398|NCT03943446|101296100|FG002|Overall Study|Lost to Follow-up|1|||
33385399|NCT03943446|101296098|FG000|Overall Study|Withdrawal by Subject|1|||
33385400|NCT03943446|101296099|FG001|Overall Study|Withdrawal by Subject|1|||
33385401|NCT03943446|101296100|FG002|Overall Study|Withdrawal by Subject|2|||
33385402|NCT03943446|101296098|FG000|Overall Study|Study Terminated by Sponsor|1|||
33434490|NCT01298570|101481125|FG001|Overall Study|Death|1|||
33434491|NCT01298570|101481124|FG000|Overall Study|Ineligibility|0|||
33434492|NCT01298570|101481125|FG001|Overall Study|Ineligibility|1|||
33434493|NCT02801877|101481131|FG000|Overall Study|Lost to Follow-up|1|||
33434494|NCT02801877|101481132|FG001|Overall Study|Lost to Follow-up|1|||
33434495|NCT02801877|101481133|FG002|Overall Study|Lost to Follow-up|2|||
33150342|NCT01927341|100463709|FG004|Phase 1b|Death|0|||
33385403|NCT03943446|101296099|FG001|Overall Study|Study Terminated by Sponsor|2|||
33434496|NCT02801877|101481134|FG003|Overall Study|Lost to Follow-up|0|||
33434497|NCT02801877|101481131|FG000|Overall Study|Never Started Treatment|2|||
33385404|NCT03943446|101296100|FG002|Overall Study|Study Terminated by Sponsor|1|||
33385405|NCT03943446|101296098|FG000|Overall Study|Reason not Specified|5|||
33385406|NCT03943446|101296099|FG001|Overall Study|Reason not Specified|1|||
33385407|NCT03943446|101296100|FG002|Overall Study|Reason not Specified|3|||
33385408|NCT03407170|101296101|FG000|Overall Study|Adverse Event|1|||
33385409|NCT03097029|101296103|FG000|Overall Study|Withdrawal by Subject|1|||
33385410|NCT00065442|101296104|FG000|Overall Study|Lost to Follow-up|1|||
33385411|NCT00065442|101296105|FG001|Overall Study|Lost to Follow-up|1|||
33385412|NCT00065442|101296104|FG000|Overall Study|Death|121|||
33385413|NCT00065442|101296105|FG001|Overall Study|Death|210|||
33385414|NCT00065442|101296104|FG000|Overall Study|Withdrawal by Subject|3|||
33385415|NCT00065442|101296105|FG001|Overall Study|Withdrawal by Subject|9|||
33385416|NCT00888615|101296106|FG000|Overall Study|No treatment|2|||
33385417|NCT01504971|101296107|FG000|Overall Study|Physician Decision|13|||
33385418|NCT02966353|101299081|FG000|Overall Study|Withdrawal by Subject|7|||
33385419|NCT02966353|101299081|FG000|Overall Study|Adverse Event|4|||
33385420|NCT02966353|101299081|FG000|Overall Study|Death|4|||
33385421|NCT02966353|101299081|FG000|Overall Study|Physician Decision|3|||
33385422|NCT02966353|101299081|FG000|Overall Study|Progressive disease|2|||
33434498|NCT02801877|101481132|FG001|Overall Study|Never Started Treatment|0|||
33434499|NCT02801877|101481133|FG002|Overall Study|Never Started Treatment|4|||
33434500|NCT02801877|101481134|FG003|Overall Study|Never Started Treatment|0|||
33434501|NCT03335371|101481140|FG000|Overall Study|Lost to Follow-up|0|||
33434502|NCT03335371|101481141|FG001|Overall Study|Lost to Follow-up|0|||
33434503|NCT03335371|101481142|FG002|Overall Study|Lost to Follow-up|0|||
33434504|NCT03335371|101481143|FG003|Overall Study|Lost to Follow-up|0|||
33434505|NCT03335371|101481144|FG004|Overall Study|Lost to Follow-up|1|||
33434506|NCT03335371|101481140|FG000|Overall Study|Withdrawal by Subject|0|||
33434507|NCT03335371|101481141|FG001|Overall Study|Withdrawal by Subject|0|||
33434508|NCT03335371|101481142|FG002|Overall Study|Withdrawal by Subject|0|||
33434509|NCT03335371|101481143|FG003|Overall Study|Withdrawal by Subject|0|||
33434510|NCT03335371|101481144|FG004|Overall Study|Withdrawal by Subject|1|||
33434511|NCT03335371|101481140|FG000|Overall Study|Randomization Error|0|||
33434512|NCT03335371|101481141|FG001|Overall Study|Randomization Error|0|||
33434513|NCT03335371|101481142|FG002|Overall Study|Randomization Error|1|||
33434514|NCT03335371|101481143|FG003|Overall Study|Randomization Error|0|||
33434515|NCT03335371|101481144|FG004|Overall Study|Randomization Error|0|||
33434516|NCT00602030|101481145|FG000|Lead-in Phase|Disease Progression|2|||
33434517|NCT00602030|101481146|FG001|Lead-in Phase|Disease Progression|3|||
33434518|NCT00602030|101481147|FG002|Lead-in Phase|Disease Progression|0|||
33434519|NCT00602030|101481148|FG003|Lead-in Phase|Disease Progression|0|||
33434520|NCT00602030|101481149|FG004|Lead-in Phase|Disease Progression|0|||
33434521|NCT00602030|101481145|FG000|Lead-in Phase|Adverse Event|0|||
33434522|NCT00602030|101481146|FG001|Lead-in Phase|Adverse Event|2|||
33434523|NCT00602030|101481147|FG002|Lead-in Phase|Adverse Event|0|||
33434524|NCT00602030|101481148|FG003|Lead-in Phase|Adverse Event|0|||
33434525|NCT00602030|101481149|FG004|Lead-in Phase|Adverse Event|0|||
33434526|NCT00602030|101481145|FG000|Double-blind Phase|Disease progression|0|||
33434527|NCT00602030|101481146|FG001|Double-blind Phase|Disease progression|0|||
33434528|NCT00602030|101481147|FG002|Double-blind Phase|Disease progression|33|||
33434529|NCT00602030|101481148|FG003|Double-blind Phase|Disease progression|30|||
33434530|NCT00602030|101481149|FG004|Double-blind Phase|Disease progression|0|||
33434531|NCT00602030|101481145|FG000|Double-blind Phase|Adverse Event|0|||
33434532|NCT00602030|101481146|FG001|Double-blind Phase|Adverse Event|0|||
33434533|NCT00602030|101481147|FG002|Double-blind Phase|Adverse Event|9|||
33434534|NCT00602030|101481148|FG003|Double-blind Phase|Adverse Event|18|||
33434535|NCT00602030|101481149|FG004|Double-blind Phase|Adverse Event|0|||
33434536|NCT00602030|101481145|FG000|Double-blind Phase|Consent withdrawal|0|||
33593112|NCT00433160|102057729|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
33150343|NCT01927341|100463705|FG000|Phase 1b|Follow-up completed|7|||
33150344|NCT01927341|100463706|FG001|Phase 1b|Follow-up completed|0|||
33150345|NCT01927341|100463707|FG002|Phase 1b|Follow-up completed|0|||
33150346|NCT01927341|100463708|FG003|Phase 1b|Follow-up completed|0|||
33150347|NCT01927341|100463709|FG004|Phase 1b|Follow-up completed|0|||
33150348|NCT01927341|100463705|FG000|Phase 2|Lost to Follow-up|0|||
33150349|NCT01927341|100463706|FG001|Phase 2|Lost to Follow-up|1|||
33150350|NCT01927341|100463707|FG002|Phase 2|Lost to Follow-up|0|||
33150351|NCT01927341|100463708|FG003|Phase 2|Lost to Follow-up|0|||
33150352|NCT01927341|100463709|FG004|Phase 2|Lost to Follow-up|0|||
33150353|NCT01927341|100463705|FG000|Phase 2|Participant withdrew consent|0|||
33150354|NCT01927341|100463706|FG001|Phase 2|Participant withdrew consent|2|||
33150355|NCT01927341|100463707|FG002|Phase 2|Participant withdrew consent|1|||
33593113|NCT00433160|102057728|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
33593114|NCT00433160|102057729|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
33593115|NCT00072293|102057730|FG000|Overall Study|Lost to Follow-up|1|||
33593116|NCT00072293|102057731|FG001|Overall Study|Lost to Follow-up|1|||
33593117|NCT00072293|102057730|FG000|Overall Study|Withdrawal by Subject|0|||
33593118|NCT00072293|102057731|FG001|Overall Study|Withdrawal by Subject|1|||
33593119|NCT00873041|102057732|FG000|Core Study|Adverse Event|2|||
33593120|NCT00873041|102057733|FG001|Core Study|Adverse Event|3|||
33593121|NCT00873041|102057734|FG002|Core Study|Adverse Event|1|||
33593122|NCT00873041|102057732|FG000|Core Study|Withdrawal by Subject|1|||
33593123|NCT00873041|102057733|FG001|Core Study|Withdrawal by Subject|2|||
33593124|NCT00873041|102057734|FG002|Core Study|Withdrawal by Subject|2|||
33593125|NCT00873041|102057732|FG000|Core Study|Lost to Follow-up|3|||
33593126|NCT00873041|102057733|FG001|Core Study|Lost to Follow-up|1|||
33593127|NCT00873041|102057734|FG002|Core Study|Lost to Follow-up|0|||
33593128|NCT00873041|102057732|FG000|Core Study|Abnormal laboratory value|0|||
33593129|NCT00873041|102057733|FG001|Core Study|Abnormal laboratory value|0|||
33593130|NCT00873041|102057734|FG002|Core Study|Abnormal laboratory value|1|||
33593131|NCT00873041|102057732|FG000|Core Study|Protocol deviation|1|||
33593132|NCT00873041|102057733|FG001|Core Study|Protocol deviation|0|||
33593133|NCT00873041|102057734|FG002|Core Study|Protocol deviation|1|||
33593134|NCT00873041|102057732|FG000|Extension Study|Adverse Event|1|||
33593135|NCT00873041|102057733|FG001|Extension Study|Adverse Event|0|||
33593136|NCT00873041|102057734|FG002|Extension Study|Adverse Event|1|||
33593137|NCT00873041|102057732|FG000|Extension Study|Administrative reasons|0|||
33593138|NCT00873041|102057733|FG001|Extension Study|Administrative reasons|0|||
33593139|NCT00873041|102057734|FG002|Extension Study|Administrative reasons|1|||
33593140|NCT00290771|102057735|FG000|Overall Study|Disease progression|95|||
33593141|NCT00290771|102057736|FG001|Overall Study|Disease progression|73|||
33593142|NCT00290771|102057735|FG000|Overall Study|Death|11|||
33593143|NCT00290771|102057736|FG001|Overall Study|Death|10|||
33593144|NCT00290771|102057735|FG000|Overall Study|Adverse Event|12|||
33150356|NCT01927341|100463708|FG003|Phase 2|Participant withdrew consent|2|||
33150357|NCT01927341|100463709|FG004|Phase 2|Participant withdrew consent|3|||
33150358|NCT01927341|100463705|FG000|Phase 2|Death|0|||
33150359|NCT01927341|100463706|FG001|Phase 2|Death|4|||
33150360|NCT01927341|100463707|FG002|Phase 2|Death|0|||
33150361|NCT01927341|100463708|FG003|Phase 2|Death|3|||
33434537|NCT00602030|101481146|FG001|Double-blind Phase|Consent withdrawal|0|||
33434538|NCT00602030|101481147|FG002|Double-blind Phase|Consent withdrawal|4|||
33434539|NCT00602030|101481148|FG003|Double-blind Phase|Consent withdrawal|3|||
33434540|NCT00602030|101481149|FG004|Double-blind Phase|Consent withdrawal|0|||
33434541|NCT00602030|101481145|FG000|Double-blind Phase|Death|0|||
33434542|NCT00602030|101481146|FG001|Double-blind Phase|Death|0|||
33593145|NCT00290771|102057736|FG001|Overall Study|Adverse Event|6|||
33593146|NCT00290771|102057735|FG000|Overall Study|Withdrawal by Subject|5|||
33593147|NCT00290771|102057736|FG001|Overall Study|Withdrawal by Subject|6|||
33593148|NCT00290771|102057735|FG000|Overall Study|Administrative problems|2|||
33593149|NCT00290771|102057736|FG001|Overall Study|Administrative problems|1|||
33150362|NCT01927341|100463709|FG004|Phase 2|Death|2|||
33434543|NCT00602030|101481147|FG002|Double-blind Phase|Death|3|||
33593150|NCT00290771|102057735|FG000|Overall Study|Protocol Violation|2|||
33434544|NCT00602030|101481148|FG003|Double-blind Phase|Death|3|||
33434545|NCT00602030|101481149|FG004|Double-blind Phase|Death|0|||
33434546|NCT00602030|101481145|FG000|Double-blind Phase|Administrative decision|0|||
33434547|NCT00602030|101481146|FG001|Double-blind Phase|Administrative decision|0|||
33434548|NCT00602030|101481147|FG002|Double-blind Phase|Administrative decision|0|||
33434549|NCT00602030|101481148|FG003|Double-blind Phase|Administrative decision|2|||
33434550|NCT00602030|101481149|FG004|Double-blind Phase|Administrative decision|0|||
33434551|NCT00602030|101481145|FG000|Double-blind Phase|Ineligibility|0|||
33434552|NCT00602030|101481146|FG001|Double-blind Phase|Ineligibility|0|||
33434553|NCT00602030|101481147|FG002|Double-blind Phase|Ineligibility|0|||
33434554|NCT00602030|101481148|FG003|Double-blind Phase|Ineligibility|1|||
33434555|NCT00602030|101481149|FG004|Double-blind Phase|Ineligibility|0|||
33434556|NCT00602030|101481145|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
33434557|NCT00602030|101481146|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
33434558|NCT00602030|101481147|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
33434559|NCT00602030|101481148|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
33434560|NCT00602030|101481149|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
33434561|NCT00602030|101481145|FG000|Double-blind Phase|Reason not specified|0|||
33434562|NCT00602030|101481146|FG001|Double-blind Phase|Reason not specified|0|||
33434563|NCT00602030|101481147|FG002|Double-blind Phase|Reason not specified|4|||
33434564|NCT00602030|101481148|FG003|Double-blind Phase|Reason not specified|2|||
33434565|NCT00602030|101481149|FG004|Double-blind Phase|Reason not specified|0|||
33434566|NCT00602030|101481145|FG000|Crossover Phase|Disease Progression|0|||
33434567|NCT00602030|101481146|FG001|Crossover Phase|Disease Progression|0|||
33434568|NCT00602030|101481147|FG002|Crossover Phase|Disease Progression|0|||
33434569|NCT00602030|101481148|FG003|Crossover Phase|Disease Progression|0|||
33434570|NCT00602030|101481149|FG004|Crossover Phase|Disease Progression|11|||
33434571|NCT00602030|101481145|FG000|Crossover Phase|Adverse Event|0|||
33434572|NCT00602030|101481146|FG001|Crossover Phase|Adverse Event|0|||
33434573|NCT00602030|101481147|FG002|Crossover Phase|Adverse Event|0|||
33434574|NCT00602030|101481148|FG003|Crossover Phase|Adverse Event|0|||
33434575|NCT00602030|101481149|FG004|Crossover Phase|Adverse Event|3|||
33434576|NCT00602030|101481145|FG000|Crossover Phase|Consent withdrawal|0|||
33434577|NCT00602030|101481146|FG001|Crossover Phase|Consent withdrawal|0|||
33434578|NCT00602030|101481147|FG002|Crossover Phase|Consent withdrawal|0|||
33434579|NCT00602030|101481148|FG003|Crossover Phase|Consent withdrawal|0|||
33434580|NCT00602030|101481149|FG004|Crossover Phase|Consent withdrawal|2|||
33434581|NCT00531206|101481150|FG000|Overall Study|Adverse Event related|5|||
33434582|NCT00531206|101481150|FG000|Overall Study|Lack of Efficacy|2|||
33434583|NCT00531206|101481150|FG000|Overall Study|Lost to Follow-up|5|||
33434584|NCT00531206|101481150|FG000|Overall Study|including non-related adverse events|8|||
33434585|NCT01816477|101481153|FG000|Overall Study|Withdrawal by Subject|13|||
33434586|NCT01816477|101481154|FG001|Overall Study|Withdrawal by Subject|1|||
33434587|NCT01816477|101481153|FG000|Overall Study|Unable to tolerate catheter placement|3|||
33434588|NCT01816477|101481154|FG001|Overall Study|Unable to tolerate catheter placement|0|||
33434589|NCT02799602|101481159|FG000|Overall Study|Protocol Violation|1|||
33434590|NCT02799602|101481160|FG001|Overall Study|Protocol Violation|0|||
33434591|NCT02799602|101481159|FG000|Overall Study|Physician Decision|5|||
33434592|NCT02799602|101481160|FG001|Overall Study|Physician Decision|6|||
33434593|NCT02799602|101481159|FG000|Overall Study|Lost to Follow-up|4|||
33434594|NCT02799602|101481160|FG001|Overall Study|Lost to Follow-up|2|||
33434595|NCT02799602|101481159|FG000|Overall Study|Additional primary malignancy|11|||
33434596|NCT02799602|101481160|FG001|Overall Study|Additional primary malignancy|6|||
33434597|NCT02799602|101481159|FG000|Overall Study|Non-compliance with study drug|14|||
33434598|NCT02799602|101481160|FG001|Overall Study|Non-compliance with study drug|12|||
33434599|NCT02799602|101481159|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
33434600|NCT02799602|101481160|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
33434601|NCT02799602|101481159|FG000|Overall Study|Withdrawal by Subject|26|||
33434602|NCT02799602|101481160|FG001|Overall Study|Withdrawal by Subject|40|||
33434603|NCT02799602|101481159|FG000|Overall Study|Progressive disease - clinical progression|131|||
33434604|NCT02799602|101481160|FG001|Overall Study|Progressive disease - clinical progression|276|||
33434605|NCT02799602|101481159|FG000|Overall Study|Progressive disease - radiological progression|90|||
33434606|NCT02799602|101481160|FG001|Overall Study|Progressive disease - radiological progression|133|||
33434607|NCT02799602|101481159|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
33434608|NCT02799602|101481160|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
33434609|NCT02799602|101481159|FG000|Overall Study|Death|9|||
33434610|NCT02799602|101481160|FG001|Overall Study|Death|5|||
33434611|NCT02799602|101481159|FG000|Overall Study|Other|287|||
33434612|NCT02799602|101481160|FG001|Overall Study|Other|118|||
33434613|NCT02799602|101481159|FG000|Overall Study|Study drug never administered|0|||
33434614|NCT02799602|101481160|FG001|Overall Study|Study drug never administered|3|||
33434615|NCT00536575|101481162|FG000|Overall Study|Withdrawal by Subject|1|||
33434616|NCT00536575|101481162|FG000|Overall Study|Death|1|||
33434617|NCT03870997|101481167|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
33434618|NCT03870997|101481168|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
33434619|NCT03870997|101481169|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
33434620|NCT03870997|101481170|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
33434621|NCT03870997|101481171|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
33434622|NCT03870997|101481172|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
33434623|NCT02672553|101481176|FG000|Overall Study|Death|3|||
33434624|NCT02672553|101481177|FG001|Overall Study|Death|5|||
33434625|NCT02672553|101481176|FG000|Overall Study|Valve Explant|1|||
33434626|NCT02672553|101481177|FG001|Overall Study|Valve Explant|0|||
33434627|NCT02672553|101481176|FG000|Overall Study|Conversion to Commercial Valve|3|||
33434628|NCT02672553|101481177|FG001|Overall Study|Conversion to Commercial Valve|0|||
33434629|NCT02672553|101481176|FG000|Overall Study|Withdrawal by Subject|3|||
33434630|NCT02672553|101481177|FG001|Overall Study|Withdrawal by Subject|3|||
33434631|NCT02672553|101481176|FG000|Overall Study|Intraoperative screen failure|2|||
33434632|NCT02672553|101481177|FG001|Overall Study|Intraoperative screen failure|0|||
33434633|NCT03532009|101481181|FG000|Overall Study|Other|1|||
33434634|NCT03532009|101481182|FG001|Overall Study|Other|1|||
33434635|NCT03532009|101481181|FG000|Overall Study|Death|1|||
33434636|NCT03532009|101481182|FG001|Overall Study|Death|1|||
33434637|NCT03532009|101481181|FG000|Overall Study|Withdrawal by Patient|0|||
33434638|NCT03532009|101481182|FG001|Overall Study|Withdrawal by Patient|2|||
33434639|NCT00376220|101484427|FG000|Overall Study|Lost to Follow-up|7|||
33434640|NCT00376220|101484428|FG001|Overall Study|Lost to Follow-up|10|||
33434641|NCT00376220|101484427|FG000|Overall Study|Withdrawal by Subject|3|||
33434642|NCT00376220|101484428|FG001|Overall Study|Withdrawal by Subject|2|||
33434643|NCT00989261|101484435|FG000|Overall Study|Still in follow up|12|||
33434644|NCT00989261|101484436|FG001|Overall Study|Still in follow up|21|||
33434645|NCT00989261|101484435|FG000|Overall Study|Withdrawal by Subject|0|||
33434646|NCT00989261|101484436|FG001|Overall Study|Withdrawal by Subject|1|||
33434647|NCT00989261|101484435|FG000|Overall Study|Lost to Follow-up|3|||
33434648|NCT00989261|101484436|FG001|Overall Study|Lost to Follow-up|0|||
33434649|NCT03464136|101484437|FG000|Overall Study|Lost to Follow-up|5|||
33434650|NCT03464136|101484438|FG001|Overall Study|Lost to Follow-up|8|||
33434651|NCT03464136|101484437|FG000|Overall Study|Withdrawal by Subject|16|||
33434652|NCT03464136|101484438|FG001|Overall Study|Withdrawal by Subject|13|||
33434653|NCT03464136|101484437|FG000|Overall Study|Death|1|||
33434654|NCT03464136|101484438|FG001|Overall Study|Death|0|||
33434655|NCT03464136|101484437|FG000|Overall Study|Other|8|||
33434656|NCT03464136|101484438|FG001|Overall Study|Other|4|||
33434657|NCT02247479|101484439|FG000|Overall Study|Adverse Event|8|||
33593151|NCT00290771|102057736|FG001|Overall Study|Protocol Violation|0|||
33593152|NCT00290771|102057735|FG000|Overall Study|Lost to Follow-up|0|||
33593153|NCT00290771|102057736|FG001|Overall Study|Lost to Follow-up|1|||
33593154|NCT00470093|102057738|FG000|Overall Study|Adverse Event|2|||
33593155|NCT01443364|102057741|FG000|Overall Study|Lack of Efficacy|14|||
33593156|NCT01443364|102057741|FG000|Overall Study|Lost to Follow-up|3|||
33593157|NCT01443364|102057741|FG000|Overall Study|Withdrawal by Subject|5|||
33593158|NCT01443364|102057741|FG000|Overall Study|Other Reason|4|||
33593159|NCT01443364|102057741|FG000|Overall Study|SAE, non-fatal|6|||
33593160|NCT01443364|102057741|FG000|Overall Study|AE, non-serious non-fatal|8|||
33593161|NCT01443364|102057741|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33593162|NCT00132691|102057742|FG000|Overall Study|Lost to Follow-up|5|||
33593163|NCT00132691|102057743|FG001|Overall Study|Lost to Follow-up|8|||
33593164|NCT00132691|102057742|FG000|Overall Study|Missed 2-year visit|4|||
33593165|NCT00132691|102057743|FG001|Overall Study|Missed 2-year visit|4|||
33593166|NCT00132691|102057742|FG000|Overall Study|Death|2|||
33434658|NCT02247479|101484440|FG001|Overall Study|Adverse Event|9|||
33434659|NCT02247479|101484441|FG002|Overall Study|Adverse Event|8|||
33434660|NCT02247479|101484439|FG000|Overall Study|Death|5|||
33434661|NCT02247479|101484440|FG001|Overall Study|Death|4|||
33434662|NCT02247479|101484441|FG002|Overall Study|Death|6|||
33593167|NCT00132691|102057743|FG001|Overall Study|Death|0|||
33593168|NCT02185014|102057744|FG000|Overall Study|Adverse Event|18|||
33593169|NCT02185014|102057744|FG000|Overall Study|Withdrew Consent|8|||
33434663|NCT02247479|101484439|FG000|Overall Study|Lost to Follow-up|3|||
33434664|NCT02247479|101484440|FG001|Overall Study|Lost to Follow-up|3|||
33434665|NCT02247479|101484441|FG002|Overall Study|Lost to Follow-up|1|||
33434666|NCT02247479|101484439|FG000|Overall Study|Non-compliance|0|||
33434667|NCT02247479|101484440|FG001|Overall Study|Non-compliance|0|||
33593170|NCT02185014|102057744|FG000|Overall Study|Lost to Follow-up|4|||
33150363|NCT01927341|100463705|FG000|Phase 2|New cancer therapy|0|||
33593171|NCT02185014|102057744|FG000|Overall Study|Lack of Efficacy|14|||
33593172|NCT02185014|102057744|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
33593173|NCT02185014|102057744|FG000|Overall Study|Subject Noncompliance|1|||
33593174|NCT02185014|102057744|FG000|Overall Study|Other|4|||
33593175|NCT00294645|102057745|FG000|Overall Study|Death|10|||
33593176|NCT00294645|102057746|FG001|Overall Study|Death|18|||
33593177|NCT00294645|102057745|FG000|Overall Study|Lost to Follow-up|1|||
33593178|NCT00294645|102057746|FG001|Overall Study|Lost to Follow-up|10|||
33593179|NCT00294645|102057745|FG000|Overall Study|Withdrawal by Subject|18|||
33150364|NCT01927341|100463706|FG001|Phase 2|New cancer therapy|1|||
33593180|NCT00294645|102057746|FG001|Overall Study|Withdrawal by Subject|34|||
33434668|NCT02247479|101484441|FG002|Overall Study|Non-compliance|1|||
33434669|NCT02247479|101484439|FG000|Overall Study|Withdrawal by Subject|25|||
33434670|NCT02247479|101484440|FG001|Overall Study|Withdrawal by Subject|29|||
33434671|NCT02247479|101484441|FG002|Overall Study|Withdrawal by Subject|24|||
33434672|NCT02247479|101484439|FG000|Overall Study|Study Terminated by Sponsor|98|||
33434673|NCT02247479|101484440|FG001|Overall Study|Study Terminated by Sponsor|88|||
33434674|NCT02247479|101484441|FG002|Overall Study|Study Terminated by Sponsor|94|||
33434675|NCT02247479|101484439|FG000|Overall Study|Physician Decision|1|||
33434676|NCT02247479|101484440|FG001|Overall Study|Physician Decision|0|||
33434677|NCT02247479|101484441|FG002|Overall Study|Physician Decision|2|||
33434678|NCT02247479|101484439|FG000|Overall Study|Unspecified Reason|2|||
33434679|NCT02247479|101484440|FG001|Overall Study|Unspecified Reason|5|||
33434680|NCT02247479|101484441|FG002|Overall Study|Unspecified Reason|2|||
33434681|NCT01361126|101484450|FG000|Overall Study|Sponsor decision|0|||
33434682|NCT01361126|101484451|FG001|Overall Study|Sponsor decision|2|||
33434683|NCT02536378|101484452|FG000|Overall Study|Physician Decision|0|||
33434684|NCT02536378|101484453|FG001|Overall Study|Physician Decision|2|||
33434685|NCT02536378|101484452|FG000|Overall Study|Withdrawal by Subject|0|||
33434686|NCT02536378|101484453|FG001|Overall Study|Withdrawal by Subject|1|||
33434687|NCT02536378|101484452|FG000|Overall Study|Death|1|||
33434688|NCT02536378|101484453|FG001|Overall Study|Death|2|||
33434689|NCT02536378|101484452|FG000|Overall Study|Patient refused further follow up|6|||
33434690|NCT02536378|101484453|FG001|Overall Study|Patient refused further follow up|2|||
33434691|NCT00812253|101484455|FG000|Overall Study|Withdrawal by Subject|3|||
33434692|NCT00812253|101484456|FG001|Overall Study|Withdrawal by Subject|2|||
33434693|NCT00812253|101484455|FG000|Overall Study|Protocol Violation|1|||
33434694|NCT00812253|101484456|FG001|Overall Study|Protocol Violation|1|||
33434695|NCT00812253|101484455|FG000|Overall Study|Lost to Follow-up|2|||
33434696|NCT00812253|101484456|FG001|Overall Study|Lost to Follow-up|0|||
33434697|NCT03997448|101484458|FG000|Study Treatment|Disease Progression|1|||
33434698|NCT03997448|101484458|FG000|Study Treatment|Symptomatic Deterioration|1|||
33434699|NCT03997448|101484458|FG000|Follow up|Death|2|||
33434700|NCT03997448|101484458|FG000|Follow up|study terminated|1|||
33434701|NCT00617461|101484461|FG000|First Treatment Intervention Period|Adverse Event|2|||
33434702|NCT00617461|101484462|FG001|First Treatment Intervention Period|Adverse Event|0|||
33434703|NCT00617461|101484461|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
33434704|NCT00617461|101484462|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
33434705|NCT00617461|101484461|FG000|First Treatment Intervention Period|Protocol Violation|2|||
33434706|NCT00617461|101484462|FG001|First Treatment Intervention Period|Protocol Violation|1|||
33434707|NCT00617461|101484461|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
33434708|NCT00617461|101484462|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
33434709|NCT00617461|101484461|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
33434710|NCT00617461|101484462|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
33434711|NCT00617461|101484461|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
33434712|NCT00617461|101484462|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
33434713|NCT00617461|101484461|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
33434714|NCT00617461|101484462|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
33434715|NCT00617461|101484461|FG000|Second Treatment Intervention Period|Adverse Event|0|||
33434716|NCT00617461|101484462|FG001|Second Treatment Intervention Period|Adverse Event|1|||
33434717|NCT00617461|101484461|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
33434718|NCT00617461|101484462|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
33434719|NCT00617461|101484461|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
33434720|NCT00617461|101484462|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
33434721|NCT00617461|101484461|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
33434722|NCT00617461|101484462|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
33434723|NCT00810368|101484465|FG000|Overall Study|Lost to Follow-up|4|||
33434724|NCT00810368|101484466|FG001|Overall Study|Lost to Follow-up|2|||
33434725|NCT00810368|101484465|FG000|Overall Study|Lack of Efficacy|2|||
33434726|NCT00810368|101484466|FG001|Overall Study|Lack of Efficacy|0|||
33434727|NCT04604184|101484467|FG000|Overall Study|Adverse Event|5|||
33434728|NCT04604184|101484468|FG001|Overall Study|Adverse Event|5|||
33434729|NCT04604184|101484467|FG000|Overall Study|Death|2|||
33434730|NCT04604184|101484468|FG001|Overall Study|Death|1|||
33593181|NCT00294645|102057745|FG000|Overall Study|Physician Decision|15|||
33593182|NCT00294645|102057746|FG001|Overall Study|Physician Decision|20|||
33593183|NCT00294645|102057745|FG000|Overall Study|Other|4|||
33593184|NCT00294645|102057746|FG001|Overall Study|Other|10|||
33593185|NCT03466099|102057750|FG000|Overall Study|Adverse Event|1|||
33434731|NCT04604184|101484467|FG000|Overall Study|Withdrawal by Subject|1|||
33434732|NCT04604184|101484468|FG001|Overall Study|Withdrawal by Subject|3|||
33434733|NCT04604184|101484467|FG000|Overall Study|Not treated|2|||
33434734|NCT04604184|101484468|FG001|Overall Study|Not treated|2|||
33434735|NCT04604184|101484467|FG000|Overall Study|Due to sponsor decision|9|||
33434736|NCT04604184|101484468|FG001|Overall Study|Due to sponsor decision|7|||
33593186|NCT03466099|102057751|FG001|Overall Study|Adverse Event|1|||
33434737|NCT04604184|101484467|FG000|Overall Study|Physician Decision|0|||
33434738|NCT04604184|101484468|FG001|Overall Study|Physician Decision|1|||
33434739|NCT04604184|101484467|FG000|Overall Study|Transfer to healthcare|1|||
33434740|NCT04604184|101484468|FG001|Overall Study|Transfer to healthcare|0|||
33434741|NCT01030965|101484469|FG000|Overall Study|Lack of Efficacy|3|||
33434742|NCT01030965|101484470|FG001|Overall Study|Lack of Efficacy|2|||
33434743|NCT01030965|101484471|FG002|Overall Study|Lack of Efficacy|0|||
33434744|NCT01030965|101484472|FG003|Overall Study|Lack of Efficacy|3|||
33434745|NCT01030965|101484469|FG000|Overall Study|Protocol Violation|1|||
33434746|NCT01030965|101484470|FG001|Overall Study|Protocol Violation|1|||
33434747|NCT01030965|101484471|FG002|Overall Study|Protocol Violation|1|||
33434748|NCT01030965|101484472|FG003|Overall Study|Protocol Violation|1|||
33434749|NCT01030965|101484469|FG000|Overall Study|Adverse Event|0|||
33434750|NCT01030965|101484470|FG001|Overall Study|Adverse Event|1|||
33434751|NCT01030965|101484471|FG002|Overall Study|Adverse Event|2|||
33434752|NCT01030965|101484472|FG003|Overall Study|Adverse Event|1|||
33434753|NCT01030965|101484469|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
33434754|NCT01030965|101484470|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
33434755|NCT01030965|101484471|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
33434756|NCT01030965|101484472|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
33434757|NCT01030965|101484469|FG000|Overall Study|Withdrawal by Subject|0|||
33434758|NCT01030965|101484470|FG001|Overall Study|Withdrawal by Subject|1|||
33593187|NCT03466099|102057752|FG002|Overall Study|Adverse Event|1|||
33593188|NCT03466099|102057750|FG000|Overall Study|Withdrawal by Subject|2|||
33593189|NCT03466099|102057751|FG001|Overall Study|Withdrawal by Subject|3|||
33593190|NCT03466099|102057752|FG002|Overall Study|Withdrawal by Subject|1|||
33593191|NCT03466099|102057750|FG000|Overall Study|Use of rescue medication|8|||
33593192|NCT03466099|102057751|FG001|Overall Study|Use of rescue medication|9|||
33593193|NCT03466099|102057752|FG002|Overall Study|Use of rescue medication|13|||
33593194|NCT03466099|102057750|FG000|Overall Study|Rescued without meeting criteria|4|||
33593195|NCT03466099|102057751|FG001|Overall Study|Rescued without meeting criteria|1|||
33593196|NCT03466099|102057752|FG002|Overall Study|Rescued without meeting criteria|1|||
33593197|NCT03466099|102057750|FG000|Overall Study|Subject compliance|2|||
33593198|NCT03466099|102057751|FG001|Overall Study|Subject compliance|0|||
33593199|NCT03466099|102057752|FG002|Overall Study|Subject compliance|0|||
33593200|NCT03466099|102057750|FG000|Overall Study|Worsening disease|0|||
33593201|NCT03466099|102057751|FG001|Overall Study|Worsening disease|0|||
33593202|NCT03466099|102057752|FG002|Overall Study|Worsening disease|1|||
33593203|NCT00724854|102057753|FG000|Overall Study|Lack of Efficacy|187|||
33593204|NCT00724854|102057754|FG001|Overall Study|Lack of Efficacy|13|||
33593205|NCT00724854|102057753|FG000|Overall Study|Lost to Follow-up|87|||
33593206|NCT00724854|102057754|FG001|Overall Study|Lost to Follow-up|10|||
33593207|NCT00724854|102057753|FG000|Overall Study|Adverse Event|62|||
33593208|NCT00724854|102057754|FG001|Overall Study|Adverse Event|4|||
33593209|NCT00724854|102057753|FG000|Overall Study|Other|42|||
33593210|NCT00724854|102057754|FG001|Overall Study|Other|3|||
33593211|NCT00724854|102057753|FG000|Overall Study|Death|11|||
33593212|NCT00724854|102057754|FG001|Overall Study|Death|0|||
33593213|NCT00724854|102057753|FG000|Overall Study|Change of treatment|7|||
33593214|NCT00724854|102057754|FG001|Overall Study|Change of treatment|0|||
33593215|NCT00724854|102057753|FG000|Overall Study|Withdrawal by Subject|5|||
33593216|NCT00724854|102057754|FG001|Overall Study|Withdrawal by Subject|0|||
33593217|NCT00724854|102057753|FG000|Overall Study|Adverse event + lack of efficacy|2|||
33593218|NCT00724854|102057754|FG001|Overall Study|Adverse event + lack of efficacy|1|||
33593219|NCT05426031|102057755|FG000|Overall Study|Circulatory Arrest|3|||
33593220|NCT05426031|102057756|FG001|Overall Study|Circulatory Arrest|2|||
33593221|NCT02013206|102057757|FG000|Overall Study|Progressive disease (PD)|14|||
33593222|NCT02013206|102057758|FG001|Overall Study|Progressive disease (PD)|17|||
33593223|NCT02013206|102057757|FG000|Overall Study|Symptomatic deterioration|3|||
33593224|NCT02013206|102057758|FG001|Overall Study|Symptomatic deterioration|1|||
33593225|NCT02013206|102057757|FG000|Overall Study|Adverse Event|1|||
33593226|NCT02013206|102057758|FG001|Overall Study|Adverse Event|0|||
33593227|NCT02013206|102057757|FG000|Overall Study|Patient refusal|2|||
33593228|NCT02013206|102057758|FG001|Overall Study|Patient refusal|0|||
33593229|NCT02013206|102057757|FG000|Overall Study|Patient non-compliance|1|||
33593230|NCT02013206|102057758|FG001|Overall Study|Patient non-compliance|0|||
33593231|NCT02013206|102057757|FG000|Overall Study|Death|1|||
33593232|NCT02013206|102057758|FG001|Overall Study|Death|2|||
33593233|NCT02013206|102057757|FG000|Overall Study|Other reasons off treatment|5|||
33593234|NCT02013206|102057758|FG001|Overall Study|Other reasons off treatment|2|||
33593235|NCT01535599|102057759|FG000|Overall Study|Adverse Event|6|||
33593236|NCT01535599|102057760|FG001|Overall Study|Adverse Event|15|||
33593237|NCT01535599|102057759|FG000|Overall Study|Lost to Follow-up|3|||
33593238|NCT01535599|102057760|FG001|Overall Study|Lost to Follow-up|4|||
33593239|NCT01535599|102057759|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
33434759|NCT01030965|101484471|FG002|Overall Study|Withdrawal by Subject|0|||
33434760|NCT01030965|101484472|FG003|Overall Study|Withdrawal by Subject|2|||
33434761|NCT00806156|101484473|FG000|Overall Study|Death|35|||
33434762|NCT00806156|101484474|FG001|Overall Study|Death|95|||
33593240|NCT01535599|102057760|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
33593241|NCT01535599|102057759|FG000|Overall Study|Treatment Failure|33|||
33593242|NCT01535599|102057760|FG001|Overall Study|Treatment Failure|66|||
33385423|NCT02966353|101299081|FG000|Overall Study|Protocol deviation|2|||
33385424|NCT04702984|101299082|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
33385425|NCT00367432|101299083|FG000|First Period (16 Weeks)|Adverse Event|6|||
33385426|NCT00367432|101299084|FG001|First Period (16 Weeks)|Adverse Event|0|||
33385427|NCT00367432|101299083|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
33385428|NCT00367432|101299084|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
33385429|NCT00367432|101299083|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
33385430|NCT00367432|101299084|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
33385431|NCT00367432|101299083|FG000|First Period (16 Weeks)|Other Reason|2|||
33385432|NCT00367432|101299084|FG001|First Period (16 Weeks)|Other Reason|0|||
33385433|NCT00367432|101299083|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
33385434|NCT00367432|101299084|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
33385435|NCT00367432|101299083|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
33385436|NCT00367432|101299084|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
33385437|NCT00367432|101299083|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
33385438|NCT00367432|101299084|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
33385439|NCT00367432|101299083|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
33385440|NCT00367432|101299084|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
33593243|NCT01535599|102057759|FG000|Overall Study|BL Culture + for Group A Strep|0|||
33593244|NCT01535599|102057760|FG001|Overall Study|BL Culture + for Group A Strep|1|||
33385441|NCT00367432|101299083|FG000|Second Period (up to 54 Months)|Other Reason|6|||
33385442|NCT00367432|101299084|FG001|Second Period (up to 54 Months)|Other Reason|2|||
33385443|NCT00510484|101299085|FG000|Wash-out Period|Adverse Event|0|||
33385444|NCT00510484|101299086|FG001|Wash-out Period|Adverse Event|1|||
33385445|NCT01610206|101299087|FG000|Overall Study|Adverse Event|10|||
33385446|NCT01610206|101299088|FG001|Overall Study|Adverse Event|30|||
33385447|NCT00646113|101299089|FG000|Overall Study|Lost to Follow-up|5|||
33385448|NCT00646113|101299089|FG000|Overall Study|Adverse Event|3|||
33385449|NCT03485222|101299090|FG000|Overall Study|Death|0|||
33385450|NCT03485222|101299091|FG001|Overall Study|Death|1|||
33385451|NCT03485222|101299090|FG000|Overall Study|Lost to Follow-up|2|||
33385452|NCT03485222|101299091|FG001|Overall Study|Lost to Follow-up|1|||
33385453|NCT00637377|101299093|FG000|Overall Study|Adverse Event|2|||
33385454|NCT00637377|101299094|FG001|Overall Study|Adverse Event|6|||
33385455|NCT00637377|101299095|FG002|Overall Study|Adverse Event|8|||
33385456|NCT00637377|101299096|FG003|Overall Study|Adverse Event|9|||
33385457|NCT00637377|101299093|FG000|Overall Study|Death|1|||
33385458|NCT00637377|101299094|FG001|Overall Study|Death|3|||
33385459|NCT00637377|101299095|FG002|Overall Study|Death|2|||
33385460|NCT00637377|101299096|FG003|Overall Study|Death|1|||
33385461|NCT00637377|101299093|FG000|Overall Study|Lack of Efficacy|0|||
33385462|NCT00637377|101299094|FG001|Overall Study|Lack of Efficacy|0|||
33385463|NCT00637377|101299095|FG002|Overall Study|Lack of Efficacy|1|||
33385464|NCT00637377|101299096|FG003|Overall Study|Lack of Efficacy|1|||
33385465|NCT00637377|101299093|FG000|Overall Study|Lost to Follow-up|4|||
33593245|NCT01535599|102057759|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
33593246|NCT01535599|102057760|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
33593247|NCT01535599|102057759|FG000|Overall Study|Randomized in Error|2|||
33593248|NCT01535599|102057760|FG001|Overall Study|Randomized in Error|4|||
33593249|NCT01535599|102057759|FG000|Overall Study|Did not use product|1|||
33593250|NCT01535599|102057760|FG001|Overall Study|Did not use product|0|||
33593251|NCT01535599|102057759|FG000|Overall Study|Other|1|||
33593252|NCT01535599|102057760|FG001|Overall Study|Other|0|||
33593253|NCT01535599|102057759|FG000|Overall Study|Stopped medication|0|||
33593254|NCT01535599|102057760|FG001|Overall Study|Stopped medication|1|||
33593255|NCT01535599|102057759|FG000|Overall Study|Noncompliance|0|||
33593256|NCT01535599|102057760|FG001|Overall Study|Noncompliance|1|||
33593257|NCT01239381|102057766|FG000|Overall Study|Protocol Violation|1|||
33385466|NCT00637377|101299094|FG001|Overall Study|Lost to Follow-up|1|||
33385467|NCT00637377|101299095|FG002|Overall Study|Lost to Follow-up|2|||
33385468|NCT00637377|101299096|FG003|Overall Study|Lost to Follow-up|2|||
33385469|NCT00637377|101299093|FG000|Overall Study|Protocol Violation|2|||
33593258|NCT01239381|102057766|FG000|Overall Study|Withdrawal by Subject|1|||
33385470|NCT00637377|101299094|FG001|Overall Study|Protocol Violation|1|||
33385471|NCT00637377|101299095|FG002|Overall Study|Protocol Violation|1|||
33593259|NCT00688324|102057768|FG000|Overall Study|Withdrawal by Subject|2|||
33593260|NCT00688324|102057768|FG000|Overall Study|Physician Decision|5|||
33593261|NCT00688324|102057768|FG000|Overall Study|Lost to Follow-up|1|||
33593262|NCT01035463|102057769|FG000|Overall Study|Adverse Event|0|||
33385472|NCT00637377|101299096|FG003|Overall Study|Protocol Violation|0|||
33385473|NCT00637377|101299093|FG000|Overall Study|Withdrawal by Subject|11|||
33385474|NCT00637377|101299094|FG001|Overall Study|Withdrawal by Subject|15|||
33385475|NCT00637377|101299095|FG002|Overall Study|Withdrawal by Subject|13|||
33593263|NCT01035463|102057770|FG001|Overall Study|Adverse Event|0|||
33434763|NCT00806156|101484473|FG000|Overall Study|Did not meet eligibility criteria|1|||
33434764|NCT00806156|101484474|FG001|Overall Study|Did not meet eligibility criteria|0|||
33434765|NCT00806156|101484473|FG000|Overall Study|Study terminated by Sponsor|2|||
33434766|NCT00806156|101484474|FG001|Overall Study|Study terminated by Sponsor|40|||
33434767|NCT00806156|101484473|FG000|Overall Study|Consent withdrawn by subject|1|||
33434768|NCT00806156|101484474|FG001|Overall Study|Consent withdrawn by subject|3|||
33434769|NCT00806156|101484473|FG000|Overall Study|Lost to Follow-up|0|||
33150365|NCT01927341|100463707|FG002|Phase 2|New cancer therapy|0|||
33150366|NCT01927341|100463708|FG003|Phase 2|New cancer therapy|4|||
33150367|NCT01927341|100463709|FG004|Phase 2|New cancer therapy|1|||
33150368|NCT01927341|100463705|FG000|Phase 2|Disease progression|0|||
33150369|NCT01927341|100463706|FG001|Phase 2|Disease progression|1|||
33150370|NCT01927341|100463707|FG002|Phase 2|Disease progression|1|||
33150371|NCT01927341|100463708|FG003|Phase 2|Disease progression|1|||
33150372|NCT01927341|100463709|FG004|Phase 2|Disease progression|0|||
33150373|NCT01927341|100463705|FG000|Phase 2|Follow-up completed|0|||
33385476|NCT00637377|101299096|FG003|Overall Study|Withdrawal by Subject|11|||
33385477|NCT00637377|101299093|FG000|Overall Study|Other (no further information available)|7|||
33385478|NCT00637377|101299094|FG001|Overall Study|Other (no further information available)|6|||
33385479|NCT00637377|101299095|FG002|Overall Study|Other (no further information available)|10|||
33385480|NCT00637377|101299096|FG003|Overall Study|Other (no further information available)|5|||
33385481|NCT01705587|101299099|FG000|Overall Study|Withdrawal by Subject|0|||
33385482|NCT01705587|101299100|FG001|Overall Study|Withdrawal by Subject|1|||
33385483|NCT02917629|101299101|FG000|Overall Study|Withdrawal by Subject|0|||
33385484|NCT02917629|101299102|FG001|Overall Study|Withdrawal by Subject|1|||
33385485|NCT04581863|101299107|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
33385486|NCT04581863|101299108|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
33385487|NCT00260429|101299109|FG000|Overall Study|failure to follow appointments|1|||
33385488|NCT00260429|101299110|FG001|Overall Study|failure to follow appointments|0|||
33385489|NCT00260429|101299109|FG000|Overall Study|scheduled hand surgery|1|||
33385490|NCT00260429|101299110|FG001|Overall Study|scheduled hand surgery|0|||
33385491|NCT02141217|101299111|FG000|Overall Study|Adverse Event|1|||
33385492|NCT02141217|101299112|FG001|Overall Study|Adverse Event|2|||
33385493|NCT02141217|101299111|FG000|Overall Study|Protocol Violation|1|||
33385494|NCT02141217|101299112|FG001|Overall Study|Protocol Violation|4|||
33385495|NCT02141217|101299111|FG000|Overall Study|Withdrawal by Subject|6|||
33385496|NCT02141217|101299112|FG001|Overall Study|Withdrawal by Subject|0|||
33385497|NCT02141217|101299111|FG000|Overall Study|Lost to Follow-up|1|||
33385498|NCT02141217|101299112|FG001|Overall Study|Lost to Follow-up|1|||
33385499|NCT02141217|101299111|FG000|Overall Study|Physician Decision|1|||
33385500|NCT02141217|101299112|FG001|Overall Study|Physician Decision|0|||
33385501|NCT02141217|101299111|FG000|Overall Study|Surgical Intervention|1|||
33385502|NCT02141217|101299112|FG001|Overall Study|Surgical Intervention|1|||
33385503|NCT02150213|101299113|FG000|Overall Study|Lost to Follow-up|1|||
33385504|NCT02150213|101299113|FG000|Overall Study|Withdrawal by Subject|1|||
33385505|NCT01803711|101299120|FG000|Overall Study|Adverse Event|1|||
33385506|NCT01803711|101299121|FG001|Overall Study|Adverse Event|1|||
33385507|NCT01357889|101299124|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
33385508|NCT01357889|101299125|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
33385509|NCT01357889|101299124|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
33385510|NCT01357889|101299125|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
33385511|NCT01357889|101299124|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
33385512|NCT01357889|101299125|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
33385513|NCT01357889|101299124|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
33385514|NCT01357889|101299125|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
33385515|NCT01357889|101299124|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
33385516|NCT01357889|101299125|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
33385517|NCT01357889|101299124|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
33385518|NCT01357889|101299125|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
33385519|NCT01357889|101299124|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
33385520|NCT01357889|101299125|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
33385521|NCT01357889|101299124|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
33385522|NCT01357889|101299125|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
33385523|NCT01357889|101299124|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
33385524|NCT01357889|101299125|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
33434770|NCT00806156|101484474|FG001|Overall Study|Lost to Follow-up|1|||
33434771|NCT03144687|101484482|FG000|Overall Study|Death|0|||
33434772|NCT03144687|101484483|FG001|Overall Study|Death|2|||
33150374|NCT01927341|100463706|FG001|Phase 2|Follow-up completed|6|||
33150375|NCT01927341|100463707|FG002|Phase 2|Follow-up completed|3|||
33434773|NCT03144687|101484482|FG000|Overall Study|Lost to Follow-up|0|||
33150376|NCT01927341|100463708|FG003|Phase 2|Follow-up completed|5|||
33434774|NCT03144687|101484483|FG001|Overall Study|Lost to Follow-up|1|||
33434775|NCT03144687|101484482|FG000|Overall Study|Physician Decision|0|||
33434776|NCT03144687|101484483|FG001|Overall Study|Physician Decision|1|||
33434777|NCT03144687|101484482|FG000|Overall Study|Withdrawal by Subject|1|||
33434778|NCT03144687|101484483|FG001|Overall Study|Withdrawal by Subject|3|||
33434779|NCT03144687|101484482|FG000|Overall Study|Not Reported|2|||
33434780|NCT03144687|101484483|FG001|Overall Study|Not Reported|0|||
33434781|NCT01769378|101484490|FG000|Overall Study|Adverse Event|10|||
33434782|NCT01769378|101484491|FG001|Overall Study|Adverse Event|0|||
33434783|NCT01769378|101484490|FG000|Overall Study|Entry criteria not met|1|||
33434784|NCT01769378|101484491|FG001|Overall Study|Entry criteria not met|0|||
33434785|NCT01769378|101484490|FG000|Overall Study|Protocol Violation|1|||
33593264|NCT01035463|102057771|FG002|Overall Study|Adverse Event|4|||
33593265|NCT01035463|102057772|FG003|Overall Study|Adverse Event|1|||
33593266|NCT01035463|102057773|FG004|Overall Study|Adverse Event|5|||
33593267|NCT01035463|102057774|FG005|Overall Study|Adverse Event|7|||
33593268|NCT01035463|102057769|FG000|Overall Study|Withdrawal by Subject|0|||
33593269|NCT01035463|102057770|FG001|Overall Study|Withdrawal by Subject|2|||
33593270|NCT01035463|102057771|FG002|Overall Study|Withdrawal by Subject|1|||
33593271|NCT01035463|102057772|FG003|Overall Study|Withdrawal by Subject|0|||
33593272|NCT01035463|102057773|FG004|Overall Study|Withdrawal by Subject|1|||
33593273|NCT01035463|102057774|FG005|Overall Study|Withdrawal by Subject|4|||
33593274|NCT01035463|102057769|FG000|Overall Study|Disease progression|0|||
33593275|NCT01035463|102057770|FG001|Overall Study|Disease progression|0|||
33593276|NCT01035463|102057771|FG002|Overall Study|Disease progression|0|||
33593277|NCT01035463|102057772|FG003|Overall Study|Disease progression|0|||
33593278|NCT01035463|102057773|FG004|Overall Study|Disease progression|0|||
33150377|NCT01927341|100463709|FG004|Phase 2|Follow-up completed|2|||
33150378|NCT02237911|100463711|FG000|Overall Study|Withdrawal by Subject|4|||
33385525|NCT01357889|101299124|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
33385526|NCT01357889|101299125|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
33385527|NCT01357889|101299124|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
33385528|NCT01357889|101299125|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
33385529|NCT01357889|101299124|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
33385530|NCT01357889|101299125|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
33385531|NCT01357889|101299124|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
33385532|NCT01357889|101299125|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
33385533|NCT01082367|101299128|FG000|Double-blind Period|Administrative problems|0|||
33385534|NCT01082367|101299129|FG001|Double-blind Period|Administrative problems|1|||
33593279|NCT01035463|102057774|FG005|Overall Study|Disease progression|3|||
33593280|NCT01035463|102057769|FG000|Overall Study|Other Malignancy|0|||
33593281|NCT01035463|102057770|FG001|Overall Study|Other Malignancy|0|||
33593282|NCT01035463|102057771|FG002|Overall Study|Other Malignancy|0|||
33593283|NCT01035463|102057772|FG003|Overall Study|Other Malignancy|0|||
33593284|NCT01035463|102057773|FG004|Overall Study|Other Malignancy|0|||
33593285|NCT01035463|102057774|FG005|Overall Study|Other Malignancy|2|||
33593286|NCT01035463|102057769|FG000|Overall Study|Other|0|||
33593287|NCT01035463|102057770|FG001|Overall Study|Other|0|||
33593288|NCT01035463|102057771|FG002|Overall Study|Other|0|||
33593289|NCT01035463|102057772|FG003|Overall Study|Other|1|||
33593290|NCT01035463|102057773|FG004|Overall Study|Other|0|||
33593291|NCT01035463|102057774|FG005|Overall Study|Other|2|||
33593292|NCT00328562|102057781|FG000|Overall Study|Disease progression|1|||
33593293|NCT03194568|102057784|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
33593294|NCT02120300|102057785|FG000|Overall Study|Enrolled but Never Treated|2|||
33593295|NCT02120300|102057786|FG001|Overall Study|Enrolled but Never Treated|0|||
33385535|NCT01082367|101299128|FG000|Double-blind Period|Lack of Efficacy|5|||
33385536|NCT01082367|101299129|FG001|Double-blind Period|Lack of Efficacy|11|||
33385537|NCT01082367|101299128|FG000|Double-blind Period|Adverse Event|0|||
33385538|NCT01082367|101299129|FG001|Double-blind Period|Adverse Event|1|||
33385539|NCT01082367|101299128|FG000|Follow-up (F-U) Period|Administrative problems|1|||
33385540|NCT01082367|101299129|FG001|Follow-up (F-U) Period|Administrative problems|0|||
33385541|NCT01082367|101299128|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
33593296|NCT02120300|102057787|FG002|Overall Study|Enrolled but Never Treated|0|||
33593297|NCT02120300|102057788|FG003|Overall Study|Enrolled but Never Treated|0|||
33593298|NCT02120300|102057785|FG000|Overall Study|Lack of Efficacy|0|||
33593299|NCT02120300|102057786|FG001|Overall Study|Lack of Efficacy|0|||
33385542|NCT01082367|101299129|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
33434786|NCT01769378|101484491|FG001|Overall Study|Protocol Violation|1|||
33434787|NCT01769378|101484490|FG000|Overall Study|Withdrawal by Subject|10|||
33150379|NCT02237911|100463712|FG001|Overall Study|Withdrawal by Subject|7|||
33434788|NCT01769378|101484491|FG001|Overall Study|Withdrawal by Subject|3|||
33434789|NCT01769378|101484490|FG000|Overall Study|Sponsor Decision|1|||
33593300|NCT02120300|102057787|FG002|Overall Study|Lack of Efficacy|0|||
33434790|NCT01769378|101484491|FG001|Overall Study|Sponsor Decision|0|||
33434791|NCT01769378|101484490|FG000|Overall Study|Lost to Follow-up|2|||
33434792|NCT01769378|101484491|FG001|Overall Study|Lost to Follow-up|0|||
33434793|NCT02994056|101484492|FG000|Overall Study|Death|8|||
33434794|NCT02994056|101484492|FG000|Overall Study|Withdrew Consent|1|||
33434795|NCT00819247|101484493|FG000|Overall Study|Adverse Event|0|||
33434796|NCT00819247|101484494|FG001|Overall Study|Adverse Event|5|||
33434797|NCT00819247|101484495|FG002|Overall Study|Adverse Event|3|||
33434798|NCT00819247|101484493|FG000|Overall Study|Insufficient testosterone response|5|||
33434799|NCT00819247|101484494|FG001|Overall Study|Insufficient testosterone response|8|||
33434800|NCT00819247|101484495|FG002|Overall Study|Insufficient testosterone response|10|||
33434801|NCT00819247|101484493|FG000|Overall Study|Withdrawal by Subject|1|||
33434802|NCT00819247|101484494|FG001|Overall Study|Withdrawal by Subject|0|||
33434803|NCT00819247|101484495|FG002|Overall Study|Withdrawal by Subject|0|||
33434804|NCT00819247|101484493|FG000|Overall Study|Protocol Violation|1|||
33434805|NCT00819247|101484494|FG001|Overall Study|Protocol Violation|0|||
33434806|NCT00819247|101484495|FG002|Overall Study|Protocol Violation|1|||
33434807|NCT00819247|101484493|FG000|Overall Study|Mistakenly withdrawn|0|||
33150380|NCT02237911|100463713|FG002|Overall Study|Withdrawal by Subject|2|||
33434808|NCT00819247|101484494|FG001|Overall Study|Mistakenly withdrawn|1|||
33434809|NCT00819247|101484495|FG002|Overall Study|Mistakenly withdrawn|0|||
33150381|NCT02237911|100463711|FG000|Overall Study|Lost to Follow-up|3|||
33150382|NCT02237911|100463712|FG001|Overall Study|Lost to Follow-up|1|||
33434810|NCT00819247|101484493|FG000|Overall Study|Bad prostate-specific antigen response|3|||
33593301|NCT02120300|102057788|FG003|Overall Study|Lack of Efficacy|1|||
33593302|NCT02120300|102057785|FG000|Overall Study|Lost to Follow-up|1|||
33593303|NCT02120300|102057786|FG001|Overall Study|Lost to Follow-up|0|||
33593304|NCT02120300|102057787|FG002|Overall Study|Lost to Follow-up|0|||
33593305|NCT02120300|102057788|FG003|Overall Study|Lost to Follow-up|0|||
33593306|NCT00503776|102057789|FG000|Overall Study|Withdrawal by Subject|1|||
33593307|NCT00503776|102057790|FG001|Overall Study|Withdrawal by Subject|0|||
33593308|NCT00503776|102057791|FG002|Overall Study|Withdrawal by Subject|1|||
33593309|NCT00503776|102057792|FG003|Overall Study|Withdrawal by Subject|1|||
33593310|NCT00503776|102057789|FG000|Overall Study|Physician Decision|0|||
33593311|NCT00503776|102057790|FG001|Overall Study|Physician Decision|0|||
33593312|NCT00503776|102057791|FG002|Overall Study|Physician Decision|1|||
33593313|NCT00503776|102057792|FG003|Overall Study|Physician Decision|1|||
33593314|NCT01340625|102057799|FG000|First Intervention|Adverse Event|1|||
33593315|NCT01340625|102057800|FG001|First Intervention|Adverse Event|0|||
33593316|NCT01340625|102057799|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
33593317|NCT01340625|102057800|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
33593318|NCT03359785|102057801|FG000|Overall Study|Protocol Violation|0|||
33593319|NCT03359785|102057802|FG001|Overall Study|Protocol Violation|1|||
33593320|NCT03359785|102057803|FG002|Overall Study|Protocol Violation|0|||
33593321|NCT03359785|102057804|FG003|Overall Study|Protocol Violation|0|||
33593322|NCT03359785|102057801|FG000|Overall Study|Early study termination due to study pause|0|||
33593323|NCT03359785|102057802|FG001|Overall Study|Early study termination due to study pause|0|||
33593324|NCT03359785|102057803|FG002|Overall Study|Early study termination due to study pause|2|||
33593325|NCT03359785|102057804|FG003|Overall Study|Early study termination due to study pause|0|||
33593326|NCT03359785|102057801|FG000|Overall Study|Withdrawal by Subject|2|||
33593327|NCT03359785|102057802|FG001|Overall Study|Withdrawal by Subject|2|||
33593328|NCT03359785|102057803|FG002|Overall Study|Withdrawal by Subject|0|||
33593329|NCT03359785|102057804|FG003|Overall Study|Withdrawal by Subject|0|||
33593330|NCT01044745|102057806|FG000|Overall Study|Ineiligible|2|||
33593331|NCT00875485|102057807|FG000|Challenge Dose Epoch|Pregnancy|1|||
33593332|NCT00875485|102057808|FG001|Challenge Dose Epoch|Pregnancy|0|||
33593333|NCT01380535|102057809|FG000|Overall Study|Adverse Event|3|||
33593334|NCT01380535|102057810|FG001|Overall Study|Adverse Event|3|||
33593335|NCT01380535|102057809|FG000|Overall Study|Death|3|||
33593336|NCT01380535|102057810|FG001|Overall Study|Death|0|||
33593337|NCT01380535|102057809|FG000|Overall Study|Study site closed|0|||
33593338|NCT01380535|102057810|FG001|Overall Study|Study site closed|5|||
33593339|NCT01380535|102057809|FG000|Overall Study|Withdrawal by Subject|1|||
33593340|NCT01380535|102057810|FG001|Overall Study|Withdrawal by Subject|2|||
33593341|NCT01380535|102057809|FG000|Overall Study|Protocol Violation|0|||
33593342|NCT01380535|102057810|FG001|Overall Study|Protocol Violation|2|||
33593343|NCT01380535|102057809|FG000|Overall Study|Lack of Efficacy|0|||
33593344|NCT01380535|102057810|FG001|Overall Study|Lack of Efficacy|3|||
33593345|NCT02438384|102057815|FG000|Overall Study|Lost to Follow-up|8|||
33593346|NCT02438384|102057816|FG001|Overall Study|Lost to Follow-up|6|||
33593347|NCT02438384|102057817|FG002|Overall Study|Lost to Follow-up|4|||
33593348|NCT01988662|102060467|FG000|Overall Study|Subject/guardian decision|1|||
33593349|NCT01988662|102060468|FG001|Overall Study|Subject/guardian decision|1|||
33593350|NCT01988662|102060467|FG000|Overall Study|Adverse Event|3|||
33593351|NCT01988662|102060468|FG001|Overall Study|Adverse Event|1|||
33593352|NCT04225676|102060469|FG000|Overall Study|Physician Decision|1|||
33593353|NCT04225676|102060469|FG000|Overall Study|Lack of Efficacy|1|||
33593354|NCT04225676|102060469|FG000|Overall Study|Study terminated by sponsor|3|||
33593355|NCT02199314|102060470|FG000|Overall Study|Withdrawal by Subject|6|||
33593356|NCT02199314|102060470|FG000|Overall Study|Physician Decision|10|||
33593357|NCT01482169|102060474|FG000|Overall Study|Physician Decision|2|||
33593358|NCT01421303|102060479|FG000|Overall Study|Lost to Follow-up|13|||
33150383|NCT02237911|100463713|FG002|Overall Study|Lost to Follow-up|1|||
33150384|NCT03190369|100463714|FG000|Overall Study|Poor compliance to protocol|0|||
33150385|NCT03190369|100463715|FG001|Overall Study|Poor compliance to protocol|1|||
33150386|NCT03190369|100463714|FG000|Overall Study|Withdraw before treatment|1|||
33150387|NCT03190369|100463715|FG001|Overall Study|Withdraw before treatment|5|||
33150388|NCT03190369|100463714|FG000|Overall Study|Randomized but not treated|0|||
33150389|NCT03190369|100463715|FG001|Overall Study|Randomized but not treated|2|||
33249911|NCT02351180|100814539|FG000|Overall Study|Withdrawal by Subject|1|||
33434811|NCT00819247|101484494|FG001|Overall Study|Bad prostate-specific antigen response|2|||
33434812|NCT00819247|101484495|FG002|Overall Study|Bad prostate-specific antigen response|0|||
33434813|NCT00819247|101484493|FG000|Overall Study|Other|1|||
33593359|NCT01421303|102060479|FG000|Overall Study|Non compliance with study procedure|1|||
33593360|NCT01421303|102060479|FG000|Overall Study|Other|7|||
33593361|NCT01421303|102060479|FG000|Overall Study|Withdrawal by Subject|1|||
33593362|NCT01814878|102060485|FG000|Overall Study|Adverse Event|16|||
33593363|NCT01814878|102060486|FG001|Overall Study|Adverse Event|5|||
33593364|NCT01814878|102060485|FG000|Overall Study|Withdrawal by Subject|20|||
33593365|NCT01814878|102060486|FG001|Overall Study|Withdrawal by Subject|16|||
33593366|NCT01814878|102060485|FG000|Overall Study|Protocol Violation|5|||
33593367|NCT01814878|102060486|FG001|Overall Study|Protocol Violation|5|||
33593368|NCT01814878|102060485|FG000|Overall Study|Physician Decision|3|||
33593369|NCT01814878|102060486|FG001|Overall Study|Physician Decision|1|||
33593370|NCT01814878|102060485|FG000|Overall Study|Screening failure (drop-out)|0|||
33593371|NCT01814878|102060486|FG001|Overall Study|Screening failure (drop-out)|3|||
33593372|NCT01814878|102060485|FG000|Overall Study|Other|2|||
33593373|NCT01814878|102060486|FG001|Overall Study|Other|0|||
33593374|NCT04096820|102060488|FG000|Overall Study|Did not return for intervention|2|||
33593375|NCT04096820|102060488|FG000|Overall Study|Death|1|||
33593376|NCT02449889|102060491|FG000|Overall Study|Adverse Event|1|||
33593377|NCT02449889|102060492|FG001|Overall Study|Adverse Event|2|||
33593378|NCT02449889|102060493|FG002|Overall Study|Adverse Event|0|||
33593379|NCT02449889|102060491|FG000|Overall Study|Protocol Violation|0|||
33593380|NCT02449889|102060492|FG001|Overall Study|Protocol Violation|4|||
33434814|NCT00819247|101484494|FG001|Overall Study|Other|0|||
33434815|NCT00819247|101484495|FG002|Overall Study|Other|0|||
33434816|NCT02427607|101484496|FG000|Overall Study|Withdrawal by Subject|1|||
33434817|NCT03977584|101484497|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
33434818|NCT03977584|101484498|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
33434819|NCT03977584|101484499|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
33434820|NCT00970281|101484502|FG000|Overall Study|Lack of Efficacy|1|||
33434821|NCT00970281|101484503|FG001|Overall Study|Lack of Efficacy|14|||
33434822|NCT00970281|101484502|FG000|Overall Study|Withdrawal by Subject|0|||
33434823|NCT00970281|101484503|FG001|Overall Study|Withdrawal by Subject|1|||
33434824|NCT00970281|101484502|FG000|Overall Study|Physician Decision|1|||
33434825|NCT00970281|101484503|FG001|Overall Study|Physician Decision|1|||
33434826|NCT04471207|101484504|FG000|Overall Study|Lost to Follow-up|4|||
33434827|NCT04471207|101484505|FG001|Overall Study|Lost to Follow-up|1|||
33434828|NCT04471207|101484504|FG000|Overall Study|Medication Contraindication|0|||
33434829|NCT04471207|101484505|FG001|Overall Study|Medication Contraindication|1|||
33434830|NCT04471207|101484504|FG000|Overall Study|Loss of Interest|2|||
33434831|NCT04471207|101484505|FG001|Overall Study|Loss of Interest|1|||
33434832|NCT04471207|101484504|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
33434833|NCT04471207|101484505|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
33434834|NCT04471207|101484504|FG000|Overall Study|Scheduling Conflicts|3|||
33434835|NCT04471207|101484505|FG001|Overall Study|Scheduling Conflicts|1|||
33434836|NCT04471207|101484504|FG000|Overall Study|Physician Decision|1|||
33434837|NCT04471207|101484505|FG001|Overall Study|Physician Decision|0|||
33434838|NCT04471207|101484504|FG000|Overall Study|Unwilling to Use System|0|||
33434839|NCT04471207|101484505|FG001|Overall Study|Unwilling to Use System|1|||
33434840|NCT01759290|101484508|FG000|Overall Study|Subjects withdrawn consent|5|||
33434841|NCT01759290|101484508|FG000|Overall Study|Physician Decision|2|||
33593381|NCT02449889|102060493|FG002|Overall Study|Protocol Violation|1|||
33593382|NCT02509052|102060496|FG000|Overall Study|Non compliance|0|||
33593383|NCT02509052|102060497|FG001|Overall Study|Non compliance|0|||
33593384|NCT02509052|102060498|FG002|Overall Study|Non compliance|1|||
33434842|NCT01759290|101484508|FG000|Overall Study|Death|17|||
33593385|NCT00920218|102060501|FG000|Overall Study|Serious Adverse Event|2|||
33434843|NCT01759290|101484508|FG000|Overall Study|Lost to Follow-up|53|||
33434844|NCT01759290|101484508|FG000|Overall Study|Unknown reason|4|||
33593386|NCT00920218|102060502|FG001|Overall Study|Serious Adverse Event|0|||
33593387|NCT00920218|102060503|FG002|Overall Study|Serious Adverse Event|2|||
33593388|NCT00920218|102060504|FG003|Overall Study|Serious Adverse Event|1|||
33593389|NCT00920218|102060501|FG000|Overall Study|Withdrawal by Subject|0|||
33593390|NCT00920218|102060502|FG001|Overall Study|Withdrawal by Subject|3|||
33593391|NCT00920218|102060503|FG002|Overall Study|Withdrawal by Subject|2|||
33593392|NCT00920218|102060504|FG003|Overall Study|Withdrawal by Subject|0|||
33593393|NCT00920218|102060501|FG000|Overall Study|Migrated/moved from study area|0|||
33593394|NCT00920218|102060502|FG001|Overall Study|Migrated/moved from study area|0|||
33593395|NCT00920218|102060503|FG002|Overall Study|Migrated/moved from study area|1|||
33593396|NCT00920218|102060504|FG003|Overall Study|Migrated/moved from study area|0|||
33593397|NCT00920218|102060501|FG000|Overall Study|Lost to Follow-up|0|||
33593398|NCT00920218|102060502|FG001|Overall Study|Lost to Follow-up|1|||
33593399|NCT00920218|102060503|FG002|Overall Study|Lost to Follow-up|0|||
33593400|NCT00920218|102060504|FG003|Overall Study|Lost to Follow-up|3|||
33593401|NCT00920218|102060501|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
33593402|NCT00920218|102060502|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
33593403|NCT00920218|102060503|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
33593404|NCT00920218|102060504|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
33593405|NCT00920218|102060501|FG000|Overall Study|Other|0|||
33593406|NCT00920218|102060502|FG001|Overall Study|Other|0|||
33593407|NCT00920218|102060503|FG002|Overall Study|Other|1|||
33593408|NCT00920218|102060504|FG003|Overall Study|Other|0|||
33593409|NCT00322023|102060505|FG000|Overall Study|various|0|||
33593410|NCT00322023|102060506|FG001|Overall Study|various|2|||
33593411|NCT00322023|102060507|FG002|Overall Study|various|6|||
33593412|NCT00090142|102060508|FG000|Treatment Period I|Lost to Follow-up|1|||
33593413|NCT00090142|102060509|FG001|Treatment Period I|Lost to Follow-up|2|||
33593414|NCT00090142|102060508|FG000|Treatment Period I|Protocol Violation|2|||
33593415|NCT00090142|102060509|FG001|Treatment Period I|Protocol Violation|0|||
33593416|NCT00090142|102060508|FG000|Treatment Period I|Withdrawal by Subject|2|||
33593417|NCT00090142|102060509|FG001|Treatment Period I|Withdrawal by Subject|0|||
33593418|NCT00090142|102060508|FG000|Treatment Period I|Other|0|||
33593419|NCT00090142|102060509|FG001|Treatment Period I|Other|1|||
33150390|NCT01672736|100463716|FG000|Overall Study|Available drug expired on 31 May 16|3|||
33434845|NCT00454636|101484510|FG000|Overall Study|Adverse Event|10|||
33434846|NCT00454636|101484511|FG001|Overall Study|Adverse Event|6|||
33434847|NCT00454636|101484512|FG002|Overall Study|Adverse Event|9|||
33434848|NCT00454636|101484513|FG003|Overall Study|Adverse Event|15|||
33434849|NCT00454636|101484510|FG000|Overall Study|Disease Progression|11|||
33434850|NCT00454636|101484511|FG001|Overall Study|Disease Progression|12|||
33434851|NCT00454636|101484512|FG002|Overall Study|Disease Progression|4|||
33434852|NCT00454636|101484513|FG003|Overall Study|Disease Progression|11|||
33434853|NCT00454636|101484510|FG000|Overall Study|Protocol Violation|3|||
33434854|NCT00454636|101484511|FG001|Overall Study|Protocol Violation|2|||
33434855|NCT00454636|101484512|FG002|Overall Study|Protocol Violation|3|||
33434856|NCT00454636|101484513|FG003|Overall Study|Protocol Violation|3|||
33434857|NCT00454636|101484510|FG000|Overall Study|Death|6|||
33434858|NCT00454636|101484511|FG001|Overall Study|Death|1|||
33434859|NCT00454636|101484512|FG002|Overall Study|Death|1|||
33434860|NCT00454636|101484513|FG003|Overall Study|Death|1|||
33434861|NCT00454636|101484510|FG000|Overall Study|Patient refusal|1|||
33434862|NCT00454636|101484511|FG001|Overall Study|Patient refusal|1|||
33434863|NCT00454636|101484512|FG002|Overall Study|Patient refusal|3|||
33434864|NCT00454636|101484513|FG003|Overall Study|Patient refusal|2|||
33434865|NCT00454636|101484510|FG000|Overall Study|Lost to Follow-up|0|||
33434866|NCT00454636|101484511|FG001|Overall Study|Lost to Follow-up|1|||
33434867|NCT00454636|101484512|FG002|Overall Study|Lost to Follow-up|0|||
33593420|NCT00090142|102060508|FG000|Treatment Period II|Other|1|||
33593421|NCT00090142|102060509|FG001|Treatment Period II|Other|0|||
33434868|NCT00454636|101484513|FG003|Overall Study|Lost to Follow-up|0|||
33434869|NCT00922974|101484514|FG000|Phase II Component|Protocol Violation|2|||
33434870|NCT00922974|101484515|FG001|Phase II Component|Protocol Violation|0|||
33593422|NCT00368836|102060510|FG000|Phase II|Screen Failure|1|||
33593423|NCT00368836|102060510|FG000|Phase II|Withdrawal by Subject|1|||
33593424|NCT00368836|102060510|FG000|Phase II|unable to collect blood and/or breath|17|||
33249912|NCT02351180|100814540|FG001|Overall Study|Withdrawal by Subject|0|||
33434871|NCT00922974|101484514|FG000|Phase II Component|Not evaluable for treatment review|5|||
33593425|NCT00368836|102060510|FG000|Phase II|Protocol Violation|2|||
33593426|NCT01960998|102060511|FG000|Overall Study|Lost to Follow-up|3|||
33593427|NCT01960998|102060512|FG001|Overall Study|Lost to Follow-up|7|||
33593428|NCT01960998|102060511|FG000|Overall Study|Death|0|||
33593429|NCT01960998|102060512|FG001|Overall Study|Death|1|||
33593430|NCT01960998|102060511|FG000|Overall Study|Withdrawal by Subject|8|||
33593431|NCT01960998|102060512|FG001|Overall Study|Withdrawal by Subject|2|||
33593432|NCT01960998|102060511|FG000|Overall Study|lost computer access|0|||
33593433|NCT01960998|102060512|FG001|Overall Study|lost computer access|1|||
33593434|NCT02152371|102060513|FG000|Overall Study|Adverse Event|6|||
33593435|NCT02152371|102060514|FG001|Overall Study|Adverse Event|2|||
33593436|NCT02152371|102060513|FG000|Overall Study|Withdrawal by Subject|3|||
33593437|NCT02152371|102060514|FG001|Overall Study|Withdrawal by Subject|7|||
33593438|NCT02152371|102060513|FG000|Overall Study|Protocol Violation|2|||
33593439|NCT02152371|102060514|FG001|Overall Study|Protocol Violation|3|||
33593440|NCT02152371|102060513|FG000|Overall Study|Lost to Follow-up|1|||
33593441|NCT02152371|102060514|FG001|Overall Study|Lost to Follow-up|0|||
33593442|NCT02152371|102060513|FG000|Overall Study|Lack of Efficacy|0|||
33593443|NCT02152371|102060514|FG001|Overall Study|Lack of Efficacy|1|||
33593444|NCT02152371|102060513|FG000|Overall Study|Physician Decision|0|||
33593445|NCT02152371|102060514|FG001|Overall Study|Physician Decision|2|||
33593446|NCT02152371|102060513|FG000|Overall Study|Reason Not Given|0|||
33593447|NCT02152371|102060514|FG001|Overall Study|Reason Not Given|1|||
33593448|NCT02290691|102060515|FG000|Overall Study|Noncompliance|0|||
33593449|NCT02290691|102060516|FG001|Overall Study|Noncompliance|1|||
33593450|NCT02290691|102060515|FG000|Overall Study|Withdrawal by Subject|1|||
33593451|NCT02290691|102060516|FG001|Overall Study|Withdrawal by Subject|1|||
33593452|NCT02290691|102060515|FG000|Overall Study|Lost to Follow-up|7|||
33593453|NCT02290691|102060516|FG001|Overall Study|Lost to Follow-up|7|||
33593454|NCT01885208|102060519|FG000|Overall Study|Unclassified|32|||
33593455|NCT01885208|102060520|FG001|Overall Study|Unclassified|38|||
33593456|NCT00778258|102060523|FG000|Overall Study|Adverse Event|1|||
33593457|NCT00778258|102060524|FG001|Overall Study|Adverse Event|0|||
33593458|NCT00778258|102060525|FG002|Overall Study|Adverse Event|0|||
33593459|NCT00778258|102060526|FG003|Overall Study|Adverse Event|0|||
33593460|NCT00778258|102060527|FG004|Overall Study|Adverse Event|0|||
33593461|NCT00778258|102060528|FG005|Overall Study|Adverse Event|1|||
33593462|NCT00778258|102060529|FG006|Overall Study|Adverse Event|0|||
33593463|NCT00778258|102060530|FG007|Overall Study|Adverse Event|0|||
33593464|NCT00778258|102060531|FG008|Overall Study|Adverse Event|0|||
33593465|NCT00778258|102060523|FG000|Overall Study|Lost to Follow-up|0|||
33593466|NCT00778258|102060524|FG001|Overall Study|Lost to Follow-up|0|||
33593467|NCT00778258|102060525|FG002|Overall Study|Lost to Follow-up|2|||
33593468|NCT00778258|102060526|FG003|Overall Study|Lost to Follow-up|0|||
33593469|NCT00778258|102060527|FG004|Overall Study|Lost to Follow-up|0|||
33593470|NCT00778258|102060528|FG005|Overall Study|Lost to Follow-up|3|||
33593471|NCT00778258|102060529|FG006|Overall Study|Lost to Follow-up|2|||
33593472|NCT00778258|102060530|FG007|Overall Study|Lost to Follow-up|2|||
33593473|NCT00778258|102060531|FG008|Overall Study|Lost to Follow-up|0|||
33593474|NCT00778258|102060523|FG000|Overall Study|Withdrawal by Subject|6|||
33593475|NCT00778258|102060524|FG001|Overall Study|Withdrawal by Subject|2|||
33593476|NCT00778258|102060525|FG002|Overall Study|Withdrawal by Subject|8|||
33593477|NCT00778258|102060526|FG003|Overall Study|Withdrawal by Subject|2|||
33593478|NCT00778258|102060527|FG004|Overall Study|Withdrawal by Subject|0|||
33593479|NCT00778258|102060528|FG005|Overall Study|Withdrawal by Subject|6|||
33593480|NCT00778258|102060529|FG006|Overall Study|Withdrawal by Subject|12|||
33593481|NCT00778258|102060530|FG007|Overall Study|Withdrawal by Subject|12|||
33593482|NCT00778258|102060531|FG008|Overall Study|Withdrawal by Subject|4|||
33593483|NCT00778258|102060523|FG000|Overall Study|New Contraindication|0|||
33593484|NCT00778258|102060524|FG001|Overall Study|New Contraindication|0|||
33593485|NCT00778258|102060525|FG002|Overall Study|New Contraindication|0|||
33593486|NCT00778258|102060526|FG003|Overall Study|New Contraindication|0|||
33593487|NCT00778258|102060527|FG004|Overall Study|New Contraindication|0|||
33593488|NCT00778258|102060528|FG005|Overall Study|New Contraindication|0|||
33593489|NCT00778258|102060529|FG006|Overall Study|New Contraindication|0|||
33593490|NCT00778258|102060530|FG007|Overall Study|New Contraindication|1|||
33593491|NCT00778258|102060531|FG008|Overall Study|New Contraindication|0|||
33593492|NCT00778258|102060523|FG000|Overall Study|Non-compliance|0|||
33593493|NCT00778258|102060524|FG001|Overall Study|Non-compliance|0|||
33593494|NCT00778258|102060525|FG002|Overall Study|Non-compliance|0|||
33593495|NCT00778258|102060526|FG003|Overall Study|Non-compliance|1|||
33593496|NCT00778258|102060527|FG004|Overall Study|Non-compliance|0|||
33593497|NCT00778258|102060528|FG005|Overall Study|Non-compliance|0|||
33593498|NCT00778258|102060529|FG006|Overall Study|Non-compliance|0|||
33593499|NCT00778258|102060530|FG007|Overall Study|Non-compliance|0|||
33593500|NCT00778258|102060531|FG008|Overall Study|Non-compliance|0|||
33593501|NCT00778258|102060523|FG000|Overall Study|Other|0|||
33593502|NCT00778258|102060524|FG001|Overall Study|Other|0|||
33593503|NCT00778258|102060525|FG002|Overall Study|Other|0|||
33593504|NCT00778258|102060526|FG003|Overall Study|Other|0|||
33593505|NCT00778258|102060527|FG004|Overall Study|Other|0|||
33593506|NCT00778258|102060528|FG005|Overall Study|Other|0|||
33593507|NCT00778258|102060529|FG006|Overall Study|Other|1|||
33593508|NCT00778258|102060530|FG007|Overall Study|Other|0|||
33593509|NCT00778258|102060531|FG008|Overall Study|Other|0|||
33593510|NCT02557100|102060532|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
33593511|NCT02557100|102060533|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
33593512|NCT02557100|102060534|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
33593513|NCT02557100|102060532|FG000|Single Blind Treatment Period|Death|0|||
33593514|NCT02557100|102060533|FG001|Single Blind Treatment Period|Death|1|||
33593515|NCT02557100|102060534|FG002|Single Blind Treatment Period|Death|0|||
33593516|NCT02557100|102060532|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
33593517|NCT02557100|102060533|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
33593518|NCT02557100|102060534|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
33593519|NCT02557100|102060532|FG000|Single Blind Treatment Period|Adverse Event|0|||
33434872|NCT00922974|101484515|FG001|Phase II Component|Not evaluable for treatment review|0|||
33150391|NCT05736224|100463719|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
33150392|NCT01886716|100463721|FG000|Week 1|Lost to Follow-up|0|||
33434873|NCT00922974|101484514|FG000|Phase III Component|Protocol Violation|8|||
33434874|NCT00922974|101484515|FG001|Phase III Component|Protocol Violation|6|||
33434875|NCT00365352|101484516|FG000|Overall Study|Adverse Event|6|||
33434876|NCT00365352|101484517|FG001|Overall Study|Adverse Event|7|||
33434877|NCT00365352|101484518|FG002|Overall Study|Adverse Event|8|||
33434878|NCT00365352|101484516|FG000|Overall Study|Participant Withdrew Consent|8|||
33434879|NCT00365352|101484517|FG001|Overall Study|Participant Withdrew Consent|3|||
33434880|NCT00365352|101484518|FG002|Overall Study|Participant Withdrew Consent|4|||
33434881|NCT00365352|101484516|FG000|Overall Study|Lack of Efficacy|3|||
33434882|NCT00365352|101484517|FG001|Overall Study|Lack of Efficacy|0|||
33434883|NCT00365352|101484518|FG002|Overall Study|Lack of Efficacy|0|||
33434884|NCT00365352|101484516|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
33434885|NCT00365352|101484517|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
33434886|NCT00365352|101484518|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
33434887|NCT00365352|101484516|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
33434888|NCT00365352|101484517|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
33434889|NCT00365352|101484518|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
33434890|NCT00365352|101484516|FG000|Overall Study|Lost to Follow-up|1|||
33434891|NCT00365352|101484517|FG001|Overall Study|Lost to Follow-up|1|||
33434892|NCT00365352|101484518|FG002|Overall Study|Lost to Follow-up|0|||
33434893|NCT00365352|101484516|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
33434894|NCT00365352|101484517|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
33434895|NCT00365352|101484518|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
33434896|NCT02070744|101484519|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
33434897|NCT02070744|101484520|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
33434898|NCT02070744|101484521|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
33434899|NCT02070744|101484522|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
33434900|NCT02070744|101484523|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
33434901|NCT02070744|101484519|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
33434902|NCT02070744|101484520|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
33434903|NCT02070744|101484521|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
33434904|NCT02070744|101484522|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
33434905|NCT02070744|101484523|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
33434906|NCT02070744|101484519|FG000|OLE Phase (48 Weeks)|Other|0|||
33434907|NCT02070744|101484520|FG001|OLE Phase (48 Weeks)|Other|0|||
33434908|NCT02070744|101484521|FG002|OLE Phase (48 Weeks)|Other|0|||
33434909|NCT02070744|101484522|FG003|OLE Phase (48 Weeks)|Other|0|||
33434910|NCT02070744|101484523|FG004|OLE Phase (48 Weeks)|Other|1|||
33434911|NCT02978326|101484524|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
33150393|NCT01886716|100463722|FG001|Week 1|Lost to Follow-up|0|||
33150394|NCT01886716|100463723|FG002|Week 1|Lost to Follow-up|2|||
33434912|NCT02978326|101484525|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
33434913|NCT02978326|101484526|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
33434914|NCT02978326|101484524|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
33385543|NCT01082367|101299128|FG000|Follow-up (F-U) Period|Adverse Event|0|||
33385544|NCT01082367|101299129|FG001|Follow-up (F-U) Period|Adverse Event|1|||
33385545|NCT00973622|101299135|FG000|Overall Study|did not attend MRI|14|||
33385546|NCT00973622|101299136|FG001|Overall Study|did not attend MRI|3|||
33385547|NCT00973622|101299135|FG000|Overall Study|did not pass MRI screen|6|||
33385548|NCT00973622|101299136|FG001|Overall Study|did not pass MRI screen|0|||
33385549|NCT00973622|101299135|FG000|Overall Study|did not complete rTMS sessions|11|||
33385550|NCT00973622|101299136|FG001|Overall Study|did not complete rTMS sessions|2|||
33434915|NCT02978326|101484525|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
33593520|NCT02557100|102060533|FG001|Single Blind Treatment Period|Adverse Event|1|||
33593521|NCT02557100|102060534|FG002|Single Blind Treatment Period|Adverse Event|0|||
33593522|NCT02557100|102060532|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
33593523|NCT02557100|102060533|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
33593524|NCT02557100|102060534|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
33593525|NCT02557100|102060532|FG000|Cumulative Abatacept Period|Other Reasons|0|||
33593526|NCT02557100|102060533|FG001|Cumulative Abatacept Period|Other Reasons|0|||
33593527|NCT02557100|102060534|FG002|Cumulative Abatacept Period|Other Reasons|1|||
33593528|NCT02557100|102060532|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
33593529|NCT02557100|102060533|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
33593530|NCT02557100|102060534|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
33593531|NCT02557100|102060532|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
33593532|NCT02557100|102060533|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
33593533|NCT02557100|102060534|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
33593534|NCT02570152|102060535|FG000|Overall Study|Protocol Violation|2|||
33593535|NCT02570152|102060535|FG000|Overall Study|Migrated/moved from study area|13|||
33434916|NCT02978326|101484526|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
33434917|NCT02978326|101484524|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
33434918|NCT02978326|101484525|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
33434919|NCT02978326|101484526|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
33434920|NCT02978326|101484524|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
33434921|NCT02978326|101484525|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
33434922|NCT02978326|101484526|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
33434923|NCT03481309|101484527|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
33434924|NCT03481309|101484528|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
33434925|NCT03481309|101484529|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
33434926|NCT03481309|101484530|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
33434927|NCT03481309|101484531|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
33434928|NCT03481309|101484532|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
33434929|NCT00502775|101484534|FG000|Overall Study|Adverse Event|1|||
33434930|NCT00502775|101484535|FG001|Overall Study|Adverse Event|2|||
33434931|NCT00502775|101484536|FG002|Overall Study|Adverse Event|1|||
33434932|NCT00502775|101484534|FG000|Overall Study|Protocol Violation|1|||
33434933|NCT00502775|101484535|FG001|Overall Study|Protocol Violation|5|||
33434934|NCT00502775|101484536|FG002|Overall Study|Protocol Violation|2|||
33434935|NCT00502775|101484534|FG000|Overall Study|Withdrawal by Subject|1|||
33434936|NCT00502775|101484535|FG001|Overall Study|Withdrawal by Subject|1|||
33593536|NCT01920568|102060536|FG000|Overall Study|Adverse Event|27|||
33593537|NCT01920568|102060537|FG001|Overall Study|Adverse Event|8|||
33593538|NCT01920568|102060536|FG000|Overall Study|Protocol Violation|5|||
33593539|NCT01920568|102060537|FG001|Overall Study|Protocol Violation|3|||
33593540|NCT01920568|102060536|FG000|Overall Study|Lost to Follow-up|2|||
33593541|NCT01920568|102060537|FG001|Overall Study|Lost to Follow-up|2|||
33593542|NCT01920568|102060536|FG000|Overall Study|Physician Decision|13|||
33593543|NCT01920568|102060537|FG001|Overall Study|Physician Decision|4|||
33593544|NCT01920568|102060536|FG000|Overall Study|Withdrawal by Subject|79|||
33593545|NCT01920568|102060537|FG001|Overall Study|Withdrawal by Subject|55|||
33593546|NCT01920568|102060536|FG000|Overall Study|Death due to disease progression|25|||
33593547|NCT01920568|102060537|FG001|Overall Study|Death due to disease progression|12|||
33593548|NCT02778555|102060538|FG000|Overall Study|Withdrawal by Subject|55|||
33593549|NCT02778555|102060539|FG001|Overall Study|Withdrawal by Subject|32|||
33593550|NCT02778555|102060540|FG002|Overall Study|Withdrawal by Subject|107|||
33593551|NCT00404755|102060541|FG000|Phase I (Bupropion)|Adverse Event|3|||
33593552|NCT00404755|102060541|FG000|Phase I (Bupropion)|Other|1|||
33593553|NCT00404755|102060541|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
33593554|NCT00759356|102060544|FG000|Overall Study|Adverse Event|0|||
33593555|NCT00759356|102060545|FG001|Overall Study|Adverse Event|1|||
33593556|NCT00759356|102060544|FG000|Overall Study|Withdrawal by Subject|0|||
33593557|NCT00759356|102060545|FG001|Overall Study|Withdrawal by Subject|2|||
33593558|NCT00759356|102060544|FG000|Overall Study|Subject was unable to return|1|||
33593559|NCT00759356|102060545|FG001|Overall Study|Subject was unable to return|0|||
33593560|NCT01145352|102060549|FG000|Overall Study|Found to have been registered twice|6|||
33593561|NCT01145352|102060549|FG000|Overall Study|Treated before marketing approval|4|||
33593562|NCT01145352|102060549|FG000|Overall Study|Syringe formulation was used|1|||
33593563|NCT02692040|102060550|FG000|Overall Study|Protocol Violation|0|||
33593564|NCT02692040|102060551|FG001|Overall Study|Protocol Violation|0|||
33593565|NCT02692040|102060552|FG002|Overall Study|Protocol Violation|0|||
33593566|NCT02692040|102060553|FG003|Overall Study|Protocol Violation|0|||
33593567|NCT02692040|102060554|FG004|Overall Study|Protocol Violation|0|||
33593568|NCT02692040|102060555|FG005|Overall Study|Protocol Violation|0|||
33593569|NCT02692040|102060556|FG006|Overall Study|Protocol Violation|0|||
33593570|NCT02692040|102060557|FG007|Overall Study|Protocol Violation|0|||
33593571|NCT02692040|102060558|FG008|Overall Study|Protocol Violation|0|||
33593572|NCT02692040|102060559|FG009|Overall Study|Protocol Violation|0|||
33593573|NCT02692040|102060560|FG010|Overall Study|Protocol Violation|0|||
33593574|NCT02692040|102060561|FG011|Overall Study|Protocol Violation|0|||
33593575|NCT02692040|102060562|FG012|Overall Study|Protocol Violation|1|||
33593576|NCT02692040|102060563|FG013|Overall Study|Protocol Violation|0|||
33434937|NCT00502775|101484536|FG002|Overall Study|Withdrawal by Subject|2|||
33434938|NCT00502775|101484534|FG000|Overall Study|Sponsor Terminated Study|1|||
33593577|NCT02692040|102060564|FG014|Overall Study|Protocol Violation|0|||
33593578|NCT02692040|102060565|FG015|Overall Study|Protocol Violation|0|||
33593579|NCT02692040|102060566|FG016|Overall Study|Protocol Violation|0|||
33593580|NCT02692040|102060550|FG000|Overall Study|Adverse Event|0|||
33150395|NCT01886716|100463724|FG003|Week 1|Lost to Follow-up|2|||
33434939|NCT00502775|101484535|FG001|Overall Study|Sponsor Terminated Study|0|||
33593581|NCT02692040|102060551|FG001|Overall Study|Adverse Event|0|||
33434940|NCT00502775|101484536|FG002|Overall Study|Sponsor Terminated Study|1|||
33434941|NCT00502775|101484534|FG000|Overall Study|Non-compliance with eDiary|4|||
33434942|NCT00502775|101484535|FG001|Overall Study|Non-compliance with eDiary|1|||
33434943|NCT00502775|101484536|FG002|Overall Study|Non-compliance with eDiary|1|||
33434944|NCT00502775|101484534|FG000|Overall Study|Subject unable to swallow capsule|1|||
33434945|NCT00502775|101484535|FG001|Overall Study|Subject unable to swallow capsule|0|||
33434946|NCT00502775|101484536|FG002|Overall Study|Subject unable to swallow capsule|1|||
33434947|NCT00502775|101484534|FG000|Overall Study|Logpad compliance <80%|1|||
33434948|NCT00502775|101484535|FG001|Overall Study|Logpad compliance <80%|0|||
33434949|NCT00502775|101484536|FG002|Overall Study|Logpad compliance <80%|0|||
33434950|NCT00502775|101484534|FG000|Overall Study|Randomized in error|0|||
33434951|NCT00502775|101484535|FG001|Overall Study|Randomized in error|1|||
33434952|NCT00502775|101484536|FG002|Overall Study|Randomized in error|1|||
33434953|NCT00502775|101484534|FG000|Overall Study|Non-compliance|0|||
33434954|NCT00502775|101484535|FG001|Overall Study|Non-compliance|2|||
33434955|NCT00502775|101484536|FG002|Overall Study|Non-compliance|2|||
33434956|NCT00502775|101484534|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
33434957|NCT00502775|101484535|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
33434958|NCT00502775|101484536|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
33434959|NCT00502775|101484534|FG000|Overall Study|Declining pollen counts|0|||
33434960|NCT00502775|101484535|FG001|Overall Study|Declining pollen counts|1|||
33593582|NCT02692040|102060552|FG002|Overall Study|Adverse Event|0|||
33593583|NCT02692040|102060553|FG003|Overall Study|Adverse Event|0|||
33593584|NCT02692040|102060554|FG004|Overall Study|Adverse Event|0|||
33593585|NCT02692040|102060555|FG005|Overall Study|Adverse Event|0|||
33593586|NCT02692040|102060556|FG006|Overall Study|Adverse Event|0|||
33593587|NCT02692040|102060557|FG007|Overall Study|Adverse Event|0|||
33593588|NCT02692040|102060558|FG008|Overall Study|Adverse Event|0|||
33593589|NCT02692040|102060559|FG009|Overall Study|Adverse Event|0|||
33593590|NCT02692040|102060560|FG010|Overall Study|Adverse Event|0|||
33593591|NCT02692040|102060561|FG011|Overall Study|Adverse Event|0|||
33593592|NCT02692040|102060562|FG012|Overall Study|Adverse Event|0|||
33593593|NCT02692040|102060563|FG013|Overall Study|Adverse Event|3|||
33593594|NCT02692040|102060564|FG014|Overall Study|Adverse Event|1|||
33593595|NCT02692040|102060565|FG015|Overall Study|Adverse Event|1|||
33593596|NCT02692040|102060566|FG016|Overall Study|Adverse Event|0|||
33593597|NCT03645421|102060567|FG000|Overall Study|Adverse Event|0|||
33593598|NCT03645421|102060568|FG001|Overall Study|Adverse Event|0|||
33593599|NCT03645421|102060569|FG002|Overall Study|Adverse Event|4|||
33593600|NCT03645421|102060570|FG003|Overall Study|Adverse Event|1|||
33593601|NCT03645421|102060567|FG000|Overall Study|Withdrawal by patient|0|||
33593602|NCT03645421|102060568|FG001|Overall Study|Withdrawal by patient|0|||
33593603|NCT03645421|102060569|FG002|Overall Study|Withdrawal by patient|0|||
33593604|NCT03645421|102060570|FG003|Overall Study|Withdrawal by patient|3|||
33593605|NCT03645421|102060567|FG000|Overall Study|Study specific withdrawal criteria|0|||
33593606|NCT03645421|102060568|FG001|Overall Study|Study specific withdrawal criteria|0|||
33593607|NCT03645421|102060569|FG002|Overall Study|Study specific withdrawal criteria|1|||
33593608|NCT03645421|102060570|FG003|Overall Study|Study specific withdrawal criteria|0|||
33593609|NCT04941807|102060571|FG000|Overall Study|Lost to Follow-up|1|||
33593610|NCT04941807|102060572|FG001|Overall Study|Lost to Follow-up|1|||
33593611|NCT00543803|102060581|FG000|Overall Study|Adverse Event|14|||
33593612|NCT00543803|102060581|FG000|Overall Study|Lack of Efficacy|22|||
33593613|NCT00543803|102060581|FG000|Overall Study|Lost to Follow-up|20|||
33593614|NCT00543803|102060581|FG000|Overall Study|Other|86|||
33593615|NCT03730961|102060582|FG000|Overall Study|Adverse Event|0|||
33593616|NCT03730961|102060583|FG001|Overall Study|Adverse Event|1|||
33593617|NCT01713283|102060584|FG000|Overall Study|Lack of Efficacy|10|||
33593618|NCT01713283|102060585|FG001|Overall Study|Lack of Efficacy|2|||
33593619|NCT01713283|102060584|FG000|Overall Study|Lost to Follow-up|1|||
33593620|NCT01713283|102060585|FG001|Overall Study|Lost to Follow-up|1|||
33593621|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Adverse Event|76|||
33593622|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Adverse Event|0|||
33593623|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Adverse Event|0|||
33593624|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Death|3|||
33593625|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Death|0|||
33593626|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Death|0|||
33593627|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
33593628|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
33593629|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
33434961|NCT00502775|101484536|FG002|Overall Study|Declining pollen counts|1|||
33434962|NCT00502775|101484534|FG000|Overall Study|Subject in jail|0|||
33434963|NCT00502775|101484535|FG001|Overall Study|Subject in jail|1|||
33593630|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Physician Decision|9|||
33434964|NCT00502775|101484536|FG002|Overall Study|Subject in jail|0|||
33593631|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Physician Decision|0|||
33593632|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Physician Decision|0|||
33593633|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
33434965|NCT00502775|101484534|FG000|Overall Study|Subject took disallowed drug|0|||
33434966|NCT00502775|101484535|FG001|Overall Study|Subject took disallowed drug|0|||
33434967|NCT00502775|101484536|FG002|Overall Study|Subject took disallowed drug|1|||
33385551|NCT03841526|101299137|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
33434968|NCT00669864|101484538|FG000|Overall Study|Lost to Follow-up|2|||
33434969|NCT00669864|101484538|FG000|Overall Study|Protocol Violation|2|||
33434970|NCT00669864|101484538|FG000|Overall Study|Withdrawal by Subject|3|||
33434971|NCT00669864|101484538|FG000|Overall Study|Other|2|||
33434972|NCT01766921|101484539|FG000|Overall Study|Administrative Reason|5|||
33434973|NCT01766921|101484540|FG001|Overall Study|Administrative Reason|5|||
33434974|NCT01766921|101484539|FG000|Overall Study|Death|1|||
33434975|NCT01766921|101484540|FG001|Overall Study|Death|1|||
33434976|NCT01766921|101484539|FG000|Overall Study|Lost to Follow-up|1|||
33434977|NCT01766921|101484540|FG001|Overall Study|Lost to Follow-up|3|||
33434978|NCT01766921|101484539|FG000|Overall Study|Unclassified|2|||
33593634|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
33593635|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
33593636|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Disease progression|45|||
33593637|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Disease progression|0|||
33249913|NCT01145885|100814541|FG000|Overall Study|Progressive Disease|7|||
33385552|NCT03841526|101299138|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
33593638|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Disease progression|0|||
33593639|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
33593640|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
33593641|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
33593642|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
33593643|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
33593644|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
33593645|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
33593646|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
33593647|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
33593648|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
33593649|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
33593650|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
33593651|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
33593652|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
33593653|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
33593654|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
33593655|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
33385553|NCT03841526|101299139|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
33385554|NCT03841526|101299140|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
33385555|NCT03841526|101299141|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
33385556|NCT03841526|101299142|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
33385557|NCT03841526|101299137|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
33385558|NCT03841526|101299138|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
33385559|NCT03841526|101299139|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
33385560|NCT03841526|101299140|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
33385561|NCT03841526|101299141|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
33385562|NCT03841526|101299142|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
33385563|NCT03841526|101299137|FG000|Outpatient Phase Treatment|Physician Decision|0|||
33385564|NCT03841526|101299138|FG001|Outpatient Phase Treatment|Physician Decision|1|||
33385565|NCT03841526|101299139|FG002|Outpatient Phase Treatment|Physician Decision|0|||
33385566|NCT03841526|101299140|FG003|Outpatient Phase Treatment|Physician Decision|0|||
33385567|NCT03841526|101299141|FG004|Outpatient Phase Treatment|Physician Decision|0|||
33385568|NCT03841526|101299142|FG005|Outpatient Phase Treatment|Physician Decision|0|||
33385569|NCT03841526|101299137|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
33434979|NCT01766921|101484540|FG001|Overall Study|Unclassified|2|||
33150396|NCT01886716|100463721|FG000|Week 2|Lost to Follow-up|3|||
33150397|NCT01886716|100463722|FG001|Week 2|Lost to Follow-up|2|||
33150398|NCT01886716|100463723|FG002|Week 2|Lost to Follow-up|1|||
33249914|NCT02236559|100814542|FG000|Overall Study|Met Exclusion|3|||
33249915|NCT02236559|100814543|FG001|Overall Study|Met Exclusion|6|||
33434980|NCT01766921|101484539|FG000|Overall Study|Protocol Violation|1|||
33150399|NCT01886716|100463724|FG003|Week 2|Lost to Follow-up|3|||
33150400|NCT01886716|100463721|FG000|Week 3|Lost to Follow-up|1|||
33150401|NCT01886716|100463722|FG001|Week 3|Lost to Follow-up|1|||
33150402|NCT01886716|100463723|FG002|Week 3|Lost to Follow-up|0|||
33150403|NCT01886716|100463724|FG003|Week 3|Lost to Follow-up|1|||
33150404|NCT00945555|100463728|FG000|Overall Study|Referred to another hospital|5|||
33150405|NCT00945555|100463728|FG000|Overall Study|Worsening condition, intensive care unit|1|||
33150406|NCT00945555|100463728|FG000|Overall Study|Withdrawal by Subject|2|||
33150407|NCT00945555|100463728|FG000|Overall Study|Participant continued treatment at home|1|||
33434981|NCT01766921|101484540|FG001|Overall Study|Protocol Violation|1|||
33434982|NCT01766921|101484539|FG000|Overall Study|Withdrawal by Subject|14|||
33434983|NCT01766921|101484540|FG001|Overall Study|Withdrawal by Subject|5|||
33434984|NCT01659567|101484541|FG000|Overall Study|Lack of Efficacy|22|||
33593656|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
33593657|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
33593658|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
33593659|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
33593660|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
33593661|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
33593662|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
33593663|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
33593664|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
33593665|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
33593666|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Promotor request|1|||
33593667|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Promotor request|0|||
33593668|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Promotor request|0|||
33385570|NCT03841526|101299138|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
33385571|NCT03841526|101299139|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
33385572|NCT03841526|101299140|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
33385573|NCT03841526|101299141|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
33385574|NCT03841526|101299142|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
33385575|NCT03094611|101299143|FG000|Overall Study|Lack of Efficacy|1|||
33593669|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
33150408|NCT00945555|100463728|FG000|Overall Study|Death|18|||
33385576|NCT03094611|101299143|FG000|Overall Study|Stem Cell Transplant|1|||
33150409|NCT00945555|100463728|FG000|Overall Study|Other|1|||
33150410|NCT04251273|100463729|FG000|Overall Study|Lost to Follow-up|331|||
33434985|NCT01659567|101484541|FG000|Overall Study|Switched to Pegferon|6|||
33434986|NCT01659567|101484541|FG000|Overall Study|Adverse Event|12|||
33150411|NCT04251273|100463730|FG001|Overall Study|Lost to Follow-up|290|||
33150412|NCT01484054|100466797|FG000|Period 1|Withdrawal by Subject|0|||
33385577|NCT04992546|101299145|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
33385578|NCT04992546|101299145|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
33385579|NCT04992546|101299145|FG000|Open-Label Treatment Period|Adverse Event|3|||
33385580|NCT04992546|101299145|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
33385581|NCT03447821|101299146|FG000|Overall Study|Withdrawal by Subject|1|||
33249916|NCT02236559|100814542|FG000|Overall Study|Did not Meet Inclusion|3|||
33385582|NCT03447821|101299147|FG001|Overall Study|Withdrawal by Subject|1|||
33434987|NCT01659567|101484541|FG000|Overall Study|Good result at early stage of treatment|5|||
33434988|NCT01659567|101484541|FG000|Overall Study|Withdrawal by Subject|64|||
33434989|NCT01659567|101484541|FG000|Overall Study|Progression of the main disease|1|||
33434990|NCT01659567|101484541|FG000|Overall Study|Other|13|||
33434991|NCT00408902|101484542|FG000|Overall Study|Lack of Efficacy|7|||
33434992|NCT00408902|101484542|FG000|Overall Study|Adverse Event|3|||
33434993|NCT01153984|101484543|FG000|Overall Study|Withdrawal by Subject|1|||
33434994|NCT01153984|101484543|FG000|Overall Study|Adverse Event|1|||
33434995|NCT04956666|101484550|FG000|Overall Study|Adverse Event|18|||
33434996|NCT04956666|101484550|FG000|Overall Study|Physician Decision|5|||
33434997|NCT00634907|101484552|FG000|Overall Study|Withdrawal by Subject|3|||
33434998|NCT00634907|101484553|FG001|Overall Study|Withdrawal by Subject|0|||
33434999|NCT00634907|101484552|FG000|Overall Study|Physician Decision|3|||
33435000|NCT00634907|101484553|FG001|Overall Study|Physician Decision|9|||
33435001|NCT00634907|101484552|FG000|Overall Study|Withdrawal by Subject|11|||
33593670|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
33435002|NCT00634907|101484553|FG001|Overall Study|Withdrawal by Subject|8|||
33435003|NCT01984242|101484559|FG000|Overall Study|Death|52|||
33435004|NCT01984242|101484560|FG001|Overall Study|Death|50|||
33435005|NCT01984242|101484561|FG002|Overall Study|Death|52|||
33435006|NCT01984242|101484559|FG000|Overall Study|Withdrawal by Subject|5|||
33435007|NCT01984242|101484560|FG001|Overall Study|Withdrawal by Subject|3|||
33435008|NCT01984242|101484561|FG002|Overall Study|Withdrawal by Subject|10|||
33435009|NCT01984242|101484559|FG000|Overall Study|Physician Decision|0|||
33435010|NCT01984242|101484560|FG001|Overall Study|Physician Decision|0|||
33435011|NCT01984242|101484561|FG002|Overall Study|Physician Decision|1|||
33435012|NCT01984242|101484559|FG000|Overall Study|Lost to Follow-up|4|||
33435013|NCT01984242|101484560|FG001|Overall Study|Lost to Follow-up|0|||
33435014|NCT01984242|101484561|FG002|Overall Study|Lost to Follow-up|3|||
33435015|NCT01984242|101484559|FG000|Overall Study|Sponsor Decision|1|||
33435016|NCT01984242|101484560|FG001|Overall Study|Sponsor Decision|0|||
33435017|NCT01984242|101484561|FG002|Overall Study|Sponsor Decision|0|||
33435018|NCT01984242|101484559|FG000|Overall Study|Non-Compliance|1|||
33435019|NCT01984242|101484560|FG001|Overall Study|Non-Compliance|0|||
33435020|NCT01984242|101484561|FG002|Overall Study|Non-Compliance|0|||
33435021|NCT01984242|101484559|FG000|Overall Study|Study terminated by Sponsor|38|||
33435022|NCT01984242|101484560|FG001|Overall Study|Study terminated by Sponsor|50|||
33435023|NCT01984242|101484561|FG002|Overall Study|Study terminated by Sponsor|34|||
33435024|NCT01984242|101484559|FG000|Overall Study|Disease Progression|0|||
33435025|NCT01984242|101484560|FG001|Overall Study|Disease Progression|0|||
33435026|NCT01984242|101484561|FG002|Overall Study|Disease Progression|1|||
33435027|NCT03594123|101484579|FG000|Overall Study|Lost to Follow-up|0|||
33435028|NCT03594123|101484580|FG001|Overall Study|Lost to Follow-up|1|||
33435029|NCT03594123|101484579|FG000|Overall Study|Adverse Event|8|||
33435030|NCT03594123|101484580|FG001|Overall Study|Adverse Event|5|||
33435031|NCT03594123|101484579|FG000|Overall Study|Site Terminated by Sponsor|4|||
33435032|NCT03594123|101484580|FG001|Overall Study|Site Terminated by Sponsor|1|||
33435033|NCT03594123|101484579|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
33435034|NCT03594123|101484580|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
33435035|NCT03594123|101484579|FG000|Overall Study|Lack of Efficacy|1|||
33593671|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
33593672|NCT01461928|102060586|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
33593673|NCT01461928|102060587|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
33593674|NCT01461928|102060588|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
33593675|NCT01461928|102060586|FG000|Maintenance I (24 Months)|Death|3|||
33593676|NCT01461928|102060587|FG001|Maintenance I (24 Months)|Death|0|||
33593677|NCT01461928|102060588|FG002|Maintenance I (24 Months)|Death|0|||
33593678|NCT01461928|102060586|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
33593679|NCT01461928|102060587|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
33593680|NCT01461928|102060588|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
33593681|NCT01461928|102060586|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
33593682|NCT01461928|102060587|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
33593683|NCT01461928|102060588|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
33593684|NCT01461928|102060586|FG000|Maintenance I (24 Months)|Diseases progression|91|||
33593685|NCT01461928|102060587|FG001|Maintenance I (24 Months)|Diseases progression|0|||
33593686|NCT01461928|102060588|FG002|Maintenance I (24 Months)|Diseases progression|0|||
33593687|NCT01461928|102060586|FG000|Maintenance I (24 Months)|Adverse Event|70|||
33593688|NCT01461928|102060587|FG001|Maintenance I (24 Months)|Adverse Event|0|||
33593689|NCT01461928|102060588|FG002|Maintenance I (24 Months)|Adverse Event|0|||
33593690|NCT01461928|102060586|FG000|Maintenance I (24 Months)|Physician Decision|9|||
33435036|NCT03594123|101484580|FG001|Overall Study|Lack of Efficacy|0|||
33435037|NCT03594123|101484579|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
33435038|NCT03594123|101484580|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
33435039|NCT05034731|101484581|FG000|Overall Study|Screen fail|1|||
33435040|NCT05034731|101484582|FG001|Overall Study|Screen fail|1|||
33435041|NCT01029353|101484583|FG000|Overall Study|Lost to Follow-up|4|||
33150413|NCT01484054|100466798|FG001|Period 1|Withdrawal by Subject|1|||
33150414|NCT00598702|100466799|FG000|Overall Study|Other|0|||
33150415|NCT00598702|100466800|FG001|Overall Study|Other|2|||
33150416|NCT00598702|100466801|FG002|Overall Study|Other|0|||
33150417|NCT00598702|100466802|FG003|Overall Study|Other|0|||
33150418|NCT00598702|100466803|FG004|Overall Study|Other|0|||
33150419|NCT00598702|100466804|FG005|Overall Study|Other|1|||
33150420|NCT00598702|100466805|FG006|Overall Study|Other|0|||
33150421|NCT00598702|100466806|FG007|Overall Study|Other|0|||
33150422|NCT00598702|100466799|FG000|Overall Study|Early discharge from hospital|0|||
33150423|NCT00598702|100466800|FG001|Overall Study|Early discharge from hospital|0|||
33150424|NCT00598702|100466801|FG002|Overall Study|Early discharge from hospital|2|||
33150425|NCT00598702|100466802|FG003|Overall Study|Early discharge from hospital|5|||
33150426|NCT00598702|100466803|FG004|Overall Study|Early discharge from hospital|0|||
33150427|NCT00598702|100466804|FG005|Overall Study|Early discharge from hospital|10|||
33150428|NCT00598702|100466805|FG006|Overall Study|Early discharge from hospital|1|||
33150429|NCT00598702|100466806|FG007|Overall Study|Early discharge from hospital|0|||
33150430|NCT00598702|100466799|FG000|Overall Study|Adverse Event|0|||
33150431|NCT00598702|100466800|FG001|Overall Study|Adverse Event|0|||
33150432|NCT00598702|100466801|FG002|Overall Study|Adverse Event|0|||
33150433|NCT00598702|100466802|FG003|Overall Study|Adverse Event|1|||
33150434|NCT00598702|100466803|FG004|Overall Study|Adverse Event|0|||
33150435|NCT00598702|100466804|FG005|Overall Study|Adverse Event|0|||
33150436|NCT00598702|100466805|FG006|Overall Study|Adverse Event|0|||
33150437|NCT00598702|100466806|FG007|Overall Study|Adverse Event|0|||
33150438|NCT00598702|100466799|FG000|Overall Study|Withdrawal by Subject|0|||
33150439|NCT00598702|100466800|FG001|Overall Study|Withdrawal by Subject|0|||
33150440|NCT00598702|100466801|FG002|Overall Study|Withdrawal by Subject|0|||
33150441|NCT00598702|100466802|FG003|Overall Study|Withdrawal by Subject|1|||
33150442|NCT00598702|100466803|FG004|Overall Study|Withdrawal by Subject|1|||
33150443|NCT00598702|100466804|FG005|Overall Study|Withdrawal by Subject|0|||
33150444|NCT00598702|100466805|FG006|Overall Study|Withdrawal by Subject|0|||
33150445|NCT00598702|100466806|FG007|Overall Study|Withdrawal by Subject|0|||
33435042|NCT01029353|101484584|FG001|Overall Study|Lost to Follow-up|5|||
33150446|NCT00598702|100466799|FG000|Overall Study|Physician Decision|0|||
33150447|NCT00598702|100466800|FG001|Overall Study|Physician Decision|0|||
33385583|NCT03447821|101299148|FG002|Overall Study|Withdrawal by Subject|0|||
33385584|NCT03447821|101299146|FG000|Overall Study|Lost to Follow-up|0|||
33385585|NCT03447821|101299147|FG001|Overall Study|Lost to Follow-up|0|||
33385586|NCT03447821|101299148|FG002|Overall Study|Lost to Follow-up|1|||
33385587|NCT00724815|101299149|FG000|Overall Study|Randomized, not treated|31|||
33385588|NCT00724815|101299150|FG001|Overall Study|Randomized, not treated|30|||
33385589|NCT00724815|101299149|FG000|Overall Study|Adverse Event|5|||
33385590|NCT00724815|101299150|FG001|Overall Study|Adverse Event|3|||
33385591|NCT00724815|101299149|FG000|Overall Study|Lost to Follow-up|4|||
33385592|NCT00724815|101299150|FG001|Overall Study|Lost to Follow-up|1|||
33435043|NCT01029353|101484585|FG002|Overall Study|Lost to Follow-up|5|||
33435044|NCT01029353|101484586|FG003|Overall Study|Lost to Follow-up|4|||
33435045|NCT01029353|101484583|FG000|Overall Study|Consent Withdrawn|2|||
33435046|NCT01029353|101484584|FG001|Overall Study|Consent Withdrawn|0|||
33435047|NCT01029353|101484585|FG002|Overall Study|Consent Withdrawn|0|||
33435048|NCT01029353|101484586|FG003|Overall Study|Consent Withdrawn|0|||
33435049|NCT01029353|101484583|FG000|Overall Study|Primary Outcome Indeterminate|1|||
33435050|NCT01029353|101484584|FG001|Overall Study|Primary Outcome Indeterminate|3|||
33435051|NCT01029353|101484585|FG002|Overall Study|Primary Outcome Indeterminate|2|||
33435052|NCT01029353|101484586|FG003|Overall Study|Primary Outcome Indeterminate|0|||
33435053|NCT00678392|101484587|FG000|Overall Study|Adverse Event|0|||
33435054|NCT00678392|101484588|FG001|Overall Study|Adverse Event|6|||
33435055|NCT00678392|101484587|FG000|Overall Study|Death|280|||
33435056|NCT00678392|101484588|FG001|Overall Study|Death|269|||
33435057|NCT00678392|101484587|FG000|Overall Study|Lost to Follow-up|15|||
33435058|NCT00678392|101484588|FG001|Overall Study|Lost to Follow-up|13|||
33435059|NCT00678392|101484587|FG000|Overall Study|Objective Progression or Relapse|3|||
33435060|NCT00678392|101484588|FG001|Overall Study|Objective Progression or Relapse|8|||
33435061|NCT00678392|101484587|FG000|Overall Study|Sponsor's Decision|1|||
33435062|NCT00678392|101484588|FG001|Overall Study|Sponsor's Decision|2|||
33435063|NCT00678392|101484587|FG000|Overall Study|Withdrawal by Subject|4|||
33435064|NCT00678392|101484588|FG001|Overall Study|Withdrawal by Subject|4|||
33435065|NCT00678392|101484587|FG000|Overall Study|Randomized But Not Treated|2|||
33435066|NCT00678392|101484588|FG001|Overall Study|Randomized But Not Treated|7|||
33435067|NCT00678392|101484587|FG000|Overall Study|Other|56|||
33435068|NCT00678392|101484588|FG001|Overall Study|Other|53|||
33435069|NCT02336737|101484589|FG000|Overall Study|Withdrawal by Subject|5|||
33435070|NCT02336737|101484589|FG000|Overall Study|Physician Decision|8|||
33435071|NCT02974114|101484592|FG000|Overall Study|Other (Not specified)|0|||
33435072|NCT02974114|101484593|FG001|Overall Study|Other (Not specified)|1|||
33435073|NCT02974114|101484594|FG002|Overall Study|Other (Not specified)|2|||
33435074|NCT02518113|101484595|FG000|Overall Study|Adverse Event|1|||
33435075|NCT02518113|101484596|FG001|Overall Study|Adverse Event|0|||
33435076|NCT02518113|101484597|FG002|Overall Study|Adverse Event|1|||
33435077|NCT02518113|101484598|FG003|Overall Study|Adverse Event|0|||
33435078|NCT02518113|101484595|FG000|Overall Study|Death|1|||
33435079|NCT02518113|101484596|FG001|Overall Study|Death|2|||
33435080|NCT02518113|101484597|FG002|Overall Study|Death|0|||
33435081|NCT02518113|101484598|FG003|Overall Study|Death|0|||
33435082|NCT02518113|101484595|FG000|Overall Study|Physician Decision|0|||
33435083|NCT02518113|101484596|FG001|Overall Study|Physician Decision|1|||
33435084|NCT02518113|101484597|FG002|Overall Study|Physician Decision|0|||
33593691|NCT01461928|102060587|FG001|Maintenance I (24 Months)|Physician Decision|0|||
33435085|NCT02518113|101484598|FG003|Overall Study|Physician Decision|0|||
33435086|NCT02518113|101484595|FG000|Overall Study|Progressive Disease|1|||
33435087|NCT02518113|101484596|FG001|Overall Study|Progressive Disease|2|||
33435088|NCT02518113|101484597|FG002|Overall Study|Progressive Disease|3|||
33435089|NCT02518113|101484598|FG003|Overall Study|Progressive Disease|0|||
33435090|NCT00944697|101484599|FG000|Overall Study|Withdrawal by Subject|1|||
33435091|NCT00944697|101484600|FG001|Overall Study|Withdrawal by Subject|1|||
33435092|NCT00944697|101484599|FG000|Overall Study|Adverse Event|0|||
33435093|NCT00944697|101484600|FG001|Overall Study|Adverse Event|3|||
33435094|NCT00944697|101484599|FG000|Overall Study|Administrative|1|||
33435095|NCT00944697|101484600|FG001|Overall Study|Administrative|1|||
33435096|NCT02448771|101484603|FG000|Overall Study|Disease Progression|30|||
33435097|NCT02448771|101484603|FG000|Overall Study|Unacceptable Toxicity|1|||
33435098|NCT02448771|101484603|FG000|Overall Study|Physician Decision|3|||
33435099|NCT02448771|101484603|FG000|Overall Study|Started new therapy|2|||
33435100|NCT01890915|101484604|FG000|Overall Study|Adverse Event|1|||
33435101|NCT01890915|101484605|FG001|Overall Study|Adverse Event|0|||
33435102|NCT01890915|101484604|FG000|Overall Study|Protocol Violation|2|||
33435103|NCT01890915|101484605|FG001|Overall Study|Protocol Violation|0|||
33435104|NCT01890915|101484604|FG000|Overall Study|Equipment Malfunction|0|||
33435105|NCT01890915|101484605|FG001|Overall Study|Equipment Malfunction|1|||
33435106|NCT02540356|101484606|FG000|Overall Study|Terminated due to disease progression|1|||
33435107|NCT02540356|101484607|FG001|Overall Study|Terminated due to disease progression|0|||
33435108|NCT02114697|101484614|FG000|Overall Study|Study terminated|5|||
33435109|NCT02114697|101484615|FG001|Overall Study|Study terminated|4|||
33435110|NCT01144663|101484618|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
33435111|NCT01144663|101484619|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
33435112|NCT01144663|101484620|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
33435113|NCT01144663|101484621|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
33435114|NCT01144663|101484618|FG000|Primary Vaccination Phase|Adverse Event|1|||
33435115|NCT01144663|101484619|FG001|Primary Vaccination Phase|Adverse Event|0|||
33435116|NCT01144663|101484620|FG002|Primary Vaccination Phase|Adverse Event|0|||
33435117|NCT01144663|101484621|FG003|Primary Vaccination Phase|Adverse Event|1|||
33435118|NCT01144663|101484618|FG000|Primary Vaccination Phase|Protocol Violation|2|||
33435119|NCT01144663|101484619|FG001|Primary Vaccination Phase|Protocol Violation|0|||
33435120|NCT01144663|101484620|FG002|Primary Vaccination Phase|Protocol Violation|1|||
33435121|NCT01144663|101484621|FG003|Primary Vaccination Phase|Protocol Violation|0|||
33435122|NCT01144663|101484618|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
33435123|NCT01144663|101484619|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
33435124|NCT01144663|101484620|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
33435125|NCT01144663|101484621|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
33435126|NCT01144663|101484618|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
33435127|NCT01144663|101484619|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
33435128|NCT01144663|101484620|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
33150448|NCT00598702|100466801|FG002|Overall Study|Physician Decision|0|||
33150449|NCT00598702|100466802|FG003|Overall Study|Physician Decision|0|||
33150450|NCT00598702|100466803|FG004|Overall Study|Physician Decision|1|||
33150451|NCT00598702|100466804|FG005|Overall Study|Physician Decision|0|||
33150452|NCT00598702|100466805|FG006|Overall Study|Physician Decision|0|||
33150453|NCT00598702|100466806|FG007|Overall Study|Physician Decision|0|||
33150454|NCT00598702|100466799|FG000|Overall Study|Dose limiting toxicity|0|||
33150455|NCT00598702|100466800|FG001|Overall Study|Dose limiting toxicity|0|||
33150456|NCT00598702|100466801|FG002|Overall Study|Dose limiting toxicity|0|||
33150457|NCT00598702|100466802|FG003|Overall Study|Dose limiting toxicity|1|||
33150458|NCT00598702|100466803|FG004|Overall Study|Dose limiting toxicity|1|||
33150459|NCT00598702|100466804|FG005|Overall Study|Dose limiting toxicity|1|||
33150460|NCT00598702|100466805|FG006|Overall Study|Dose limiting toxicity|0|||
33150461|NCT00598702|100466806|FG007|Overall Study|Dose limiting toxicity|0|||
33150462|NCT04916769|100466807|FG000|Period 1|Physician Decision|0|||
33150463|NCT04916769|100466808|FG001|Period 1|Physician Decision|0|||
33150464|NCT04916769|100466809|FG002|Period 1|Physician Decision|0|||
33150465|NCT04916769|100466810|FG003|Period 1|Physician Decision|0|||
33150466|NCT04916769|100466811|FG004|Period 1|Physician Decision|0|||
33150467|NCT04916769|100466812|FG005|Period 1|Physician Decision|1|||
33150468|NCT04916769|100466807|FG000|Period 2|Physician Decision|0|||
33150469|NCT04916769|100466808|FG001|Period 2|Physician Decision|1|||
33150470|NCT04916769|100466809|FG002|Period 2|Physician Decision|0|||
33150471|NCT04916769|100466810|FG003|Period 2|Physician Decision|0|||
33150472|NCT04916769|100466811|FG004|Period 2|Physician Decision|0|||
33150473|NCT04916769|100466812|FG005|Period 2|Physician Decision|0|||
33435129|NCT01144663|101484621|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
33435130|NCT01144663|101484618|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
33435131|NCT01144663|101484619|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
33435132|NCT01144663|101484620|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
33435133|NCT01144663|101484621|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
33435134|NCT01144663|101484618|FG000|Primary Vaccination Phase|Other|0|||
33435135|NCT01144663|101484619|FG001|Primary Vaccination Phase|Other|1|||
33150474|NCT00423670|100466813|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
33150475|NCT00423670|100466814|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
33150476|NCT00423670|100466815|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
33150477|NCT00423670|100466816|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
33150478|NCT00423670|100466817|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
33150479|NCT00423670|100466818|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
33150480|NCT00423670|100466819|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
33150481|NCT00423670|100466820|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
33435136|NCT01144663|101484620|FG002|Primary Vaccination Phase|Other|0|||
33435137|NCT01144663|101484621|FG003|Primary Vaccination Phase|Other|2|||
33435138|NCT01144663|101484618|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
33435139|NCT01144663|101484619|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
33435140|NCT01144663|101484620|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
33435141|NCT01144663|101484621|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
33435142|NCT01144663|101484618|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
33435143|NCT01144663|101484619|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
33435144|NCT01144663|101484620|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
33435145|NCT01144663|101484621|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
33435146|NCT01144663|101484618|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
33435147|NCT01144663|101484619|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
33435148|NCT01144663|101484620|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
33435149|NCT01144663|101484621|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
33435150|NCT01144663|101484618|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
33435151|NCT01144663|101484619|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
33435152|NCT01144663|101484620|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
33435153|NCT01144663|101484621|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
33435154|NCT01144663|101484618|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
33435155|NCT01144663|101484619|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
33435156|NCT01144663|101484620|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
33435157|NCT01144663|101484621|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
33435158|NCT01144663|101484618|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
33435159|NCT01144663|101484619|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
33435160|NCT01144663|101484620|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
33435161|NCT01144663|101484621|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
33435162|NCT01004172|101484622|FG000|Overall Study|Progressive Disease in CNS Only|16|||
33435163|NCT01004172|101484622|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
33435164|NCT01004172|101484622|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
33435165|NCT01004172|101484622|FG000|Overall Study|Adverse Event|1|||
33435166|NCT01004172|101484622|FG000|Overall Study|Physician Decision|1|||
33435167|NCT01004172|101484622|FG000|Overall Study|Symptomatic Deterioration|2|||
33435168|NCT01996033|101484623|FG000|Overall Study|Death|1|||
33435169|NCT01996033|101484623|FG000|Overall Study|Physician Decision|1|||
33435170|NCT01996033|101484623|FG000|Overall Study|Withdrawal by Subject|4|||
33435171|NCT01996033|101484623|FG000|Overall Study|Lost to Follow-up|3|||
33435172|NCT01789320|101484624|FG000|Overall Study|Re-enrolled into study|1|||
33435173|NCT01789320|101484624|FG000|Overall Study|Lost to Follow-up|1|||
33435174|NCT00510510|101484638|FG000|Overall Study|Adverse Event|4|||
33435175|NCT00510510|101484639|FG001|Overall Study|Adverse Event|3|||
33435176|NCT00510510|101484640|FG002|Overall Study|Adverse Event|6|||
33435177|NCT00510510|101484638|FG000|Overall Study|Lack of Efficacy|0|||
33150482|NCT00423670|100466813|FG000|Treatment Period|Adverse Event|8|||
33150483|NCT00423670|100466814|FG001|Treatment Period|Adverse Event|12|||
33150484|NCT00423670|100466815|FG002|Treatment Period|Adverse Event|15|||
33150485|NCT00423670|100466816|FG003|Treatment Period|Adverse Event|20|||
33150486|NCT00423670|100466817|FG004|Treatment Period|Adverse Event|9|||
33150487|NCT00423670|100466818|FG005|Treatment Period|Adverse Event|4|||
33150488|NCT00423670|100466819|FG006|Treatment Period|Adverse Event|7|||
33150489|NCT00423670|100466820|FG007|Treatment Period|Adverse Event|2|||
33435178|NCT00510510|101484639|FG001|Overall Study|Lack of Efficacy|1|||
33435179|NCT00510510|101484640|FG002|Overall Study|Lack of Efficacy|1|||
33435180|NCT00510510|101484638|FG000|Overall Study|Subjects no longer requires study drug|0|||
33150490|NCT00423670|100466813|FG000|Treatment Period|Protocol-defined clinical event|0|||
33150491|NCT00423670|100466814|FG001|Treatment Period|Protocol-defined clinical event|7|||
33150492|NCT00423670|100466815|FG002|Treatment Period|Protocol-defined clinical event|4|||
33150493|NCT00423670|100466816|FG003|Treatment Period|Protocol-defined clinical event|12|||
33150494|NCT00423670|100466817|FG004|Treatment Period|Protocol-defined clinical event|5|||
33150495|NCT00423670|100466818|FG005|Treatment Period|Protocol-defined clinical event|4|||
33150496|NCT00423670|100466819|FG006|Treatment Period|Protocol-defined clinical event|16|||
33150497|NCT00423670|100466820|FG007|Treatment Period|Protocol-defined clinical event|15|||
33435181|NCT00510510|101484639|FG001|Overall Study|Subjects no longer requires study drug|0|||
33435182|NCT00510510|101484640|FG002|Overall Study|Subjects no longer requires study drug|2|||
33435183|NCT00510510|101484638|FG000|Overall Study|Withdrawal by Subject|1|||
33150498|NCT00423670|100466813|FG000|Treatment Period|Lost to Follow-up|2|||
33150499|NCT00423670|100466814|FG001|Treatment Period|Lost to Follow-up|1|||
33150500|NCT00423670|100466815|FG002|Treatment Period|Lost to Follow-up|3|||
33150501|NCT00423670|100466816|FG003|Treatment Period|Lost to Follow-up|1|||
33150502|NCT00423670|100466817|FG004|Treatment Period|Lost to Follow-up|6|||
33150503|NCT00423670|100466818|FG005|Treatment Period|Lost to Follow-up|0|||
33150504|NCT00423670|100466819|FG006|Treatment Period|Lost to Follow-up|3|||
33150505|NCT00423670|100466820|FG007|Treatment Period|Lost to Follow-up|1|||
33150506|NCT00423670|100466813|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
33150507|NCT00423670|100466814|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
33150508|NCT00423670|100466815|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
33150509|NCT00423670|100466816|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
33150510|NCT00423670|100466817|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
33150511|NCT00423670|100466818|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
33150512|NCT00423670|100466819|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
33593692|NCT01461928|102060588|FG002|Maintenance I (24 Months)|Physician Decision|0|||
33593693|NCT01461928|102060586|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
33150513|NCT00423670|100466820|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
33385593|NCT00724815|101299149|FG000|Overall Study|Other Various|3|||
33385594|NCT00724815|101299150|FG001|Overall Study|Other Various|5|||
33385595|NCT01601704|101299151|FG000|Overall Study|Randomized but not dispensed study med|1|||
33385596|NCT01601704|101299152|FG001|Overall Study|Randomized but not dispensed study med|4|||
33385597|NCT03371251|101299153|FG000|Overall Study|Withdrawal by Subject|1|||
33385598|NCT03371251|101299154|FG001|Overall Study|Withdrawal by Subject|0|||
33385599|NCT03371251|101299155|FG002|Overall Study|Withdrawal by Subject|1|||
33385600|NCT03371251|101299156|FG003|Overall Study|Withdrawal by Subject|0|||
33435184|NCT00510510|101484639|FG001|Overall Study|Withdrawal by Subject|2|||
33593694|NCT01461928|102060587|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
33593695|NCT01461928|102060588|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
33593696|NCT01461928|102060586|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
33593697|NCT01461928|102060587|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
33593698|NCT01461928|102060588|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
33593699|NCT01461928|102060586|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
33593700|NCT01461928|102060587|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
33593701|NCT01461928|102060588|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
33593702|NCT01461928|102060586|FG000|Maintenance I (24 Months)|Not compliant|1|||
33593703|NCT01461928|102060587|FG001|Maintenance I (24 Months)|Not compliant|0|||
33593704|NCT01461928|102060588|FG002|Maintenance I (24 Months)|Not compliant|0|||
33593705|NCT01461928|102060586|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
33593706|NCT01461928|102060587|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
33593707|NCT01461928|102060588|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
33593708|NCT01461928|102060586|FG000|Maintenance II (15 Months)|Adverse Event|0|||
33593709|NCT01461928|102060587|FG001|Maintenance II (15 Months)|Adverse Event|2|||
33593710|NCT01461928|102060588|FG002|Maintenance II (15 Months)|Adverse Event|0|||
33593711|NCT01461928|102060586|FG000|Maintenance II (15 Months)|Death|0|||
33593712|NCT01461928|102060587|FG001|Maintenance II (15 Months)|Death|10|||
33593713|NCT01461928|102060588|FG002|Maintenance II (15 Months)|Death|8|||
33150514|NCT00423670|100466813|FG000|Treatment Period|Investigator decision|0|||
33385601|NCT03371251|101299157|FG004|Overall Study|Withdrawal by Subject|2|||
33435185|NCT00510510|101484640|FG002|Overall Study|Withdrawal by Subject|3|||
33435186|NCT00510510|101484638|FG000|Overall Study|Lost to Follow-up|0|||
33435187|NCT00510510|101484639|FG001|Overall Study|Lost to Follow-up|0|||
33435188|NCT00510510|101484640|FG002|Overall Study|Lost to Follow-up|1|||
33435189|NCT00510510|101484638|FG000|Overall Study|Protocol Violation|0|||
33435190|NCT00510510|101484639|FG001|Overall Study|Protocol Violation|3|||
33435191|NCT00510510|101484640|FG002|Overall Study|Protocol Violation|4|||
33435192|NCT00561730|101484641|FG000|Overall Study|Adverse Event|2|||
33435193|NCT00561730|101484641|FG000|Overall Study|Handling of the drug|1|||
33435194|NCT00561730|101484641|FG000|Overall Study|Lost to Follow-up|5|||
33435195|NCT00561730|101484641|FG000|Overall Study|Not specified reasons|1|||
33435196|NCT02841709|101484642|FG000|5th Intervention|Adverse Event|2|||
33435197|NCT02841709|101484643|FG001|5th Intervention|Adverse Event|0|||
33435198|NCT02841709|101484644|FG002|5th Intervention|Adverse Event|0|||
33435199|NCT02841709|101484645|FG003|5th Intervention|Adverse Event|0|||
33435200|NCT02841709|101484646|FG004|5th Intervention|Adverse Event|2|||
33435201|NCT02001558|101484647|FG000|Overall Study|Lost to Follow-up|8|||
33435202|NCT02001558|101484648|FG001|Overall Study|Lost to Follow-up|14|||
33435203|NCT02153398|101484649|FG000|Overall Study|Withdrawal by Subject|1|||
33435204|NCT02153398|101484650|FG001|Overall Study|Withdrawal by Subject|0|||
33435205|NCT02153398|101484651|FG002|Overall Study|Withdrawal by Subject|0|||
33435206|NCT02153398|101484652|FG003|Overall Study|Withdrawal by Subject|0|||
33435207|NCT02153398|101484653|FG004|Overall Study|Withdrawal by Subject|0|||
33435208|NCT02153398|101484649|FG000|Overall Study|Adverse Event|0|||
33435209|NCT02153398|101484650|FG001|Overall Study|Adverse Event|0|||
33435210|NCT02153398|101484651|FG002|Overall Study|Adverse Event|1|||
33435211|NCT02153398|101484652|FG003|Overall Study|Adverse Event|1|||
33435212|NCT02153398|101484653|FG004|Overall Study|Adverse Event|0|||
33435213|NCT02192099|101484654|FG000|Overall Study|Adverse Event|1|||
33435214|NCT02192099|101484654|FG000|Overall Study|Lost to Follow-up|2|||
33435215|NCT02192099|101484654|FG000|Overall Study|Physician Decision|1|||
33435216|NCT02192099|101484654|FG000|Overall Study|Pregnancy|1|||
33435217|NCT02192099|101484654|FG000|Overall Study|Protocol Violation|8|||
33435218|NCT02192099|101484654|FG000|Overall Study|Study Terminated by Sponsor|32|||
33435219|NCT02192099|101484654|FG000|Overall Study|Withdrawal by Subject|11|||
33435220|NCT02192099|101484654|FG000|Overall Study|Miscellaneous Reasons|5|||
33435221|NCT02374918|101484655|FG000|Overall Study|Protocol Violation|2|||
33435222|NCT02374918|101484656|FG001|Overall Study|Protocol Violation|0|||
33435223|NCT02374918|101484657|FG002|Overall Study|Protocol Violation|2|||
33435224|NCT02374918|101484658|FG003|Overall Study|Protocol Violation|1|||
33435225|NCT02374918|101484655|FG000|Overall Study|Withdrawal by Subject|1|||
33435226|NCT02374918|101484656|FG001|Overall Study|Withdrawal by Subject|1|||
33435227|NCT02374918|101484657|FG002|Overall Study|Withdrawal by Subject|1|||
33435228|NCT02374918|101484658|FG003|Overall Study|Withdrawal by Subject|0|||
33435229|NCT02374918|101484655|FG000|Overall Study|Lack of Efficacy|0|||
33435230|NCT02374918|101484656|FG001|Overall Study|Lack of Efficacy|0|||
33435231|NCT02374918|101484657|FG002|Overall Study|Lack of Efficacy|1|||
33435232|NCT02374918|101484658|FG003|Overall Study|Lack of Efficacy|1|||
33435233|NCT00084084|101484659|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
33435234|NCT00084084|101484659|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
33435235|NCT01644890|101484662|FG000|Overall Study|Adverse Event|7|||
33435236|NCT01644890|101484663|FG001|Overall Study|Adverse Event|20|||
33435237|NCT01644890|101484662|FG000|Overall Study|Death|1|||
33435238|NCT01644890|101484663|FG001|Overall Study|Death|3|||
33435239|NCT01644890|101484662|FG000|Overall Study|Physician Decision|3|||
33435240|NCT01644890|101484663|FG001|Overall Study|Physician Decision|9|||
33435241|NCT01644890|101484662|FG000|Overall Study|Protocol Violation|6|||
33435242|NCT01644890|101484663|FG001|Overall Study|Protocol Violation|7|||
33435243|NCT01644890|101484662|FG000|Overall Study|Withdrawal by Subject|19|||
33435244|NCT01644890|101484663|FG001|Overall Study|Withdrawal by Subject|27|||
33435245|NCT01644890|101484662|FG000|Overall Study|Progression Disease|160|||
33435246|NCT01644890|101484663|FG001|Overall Study|Progression Disease|131|||
33435247|NCT01644890|101484662|FG000|Overall Study|Clinical Progression|6|||
33435248|NCT01644890|101484663|FG001|Overall Study|Clinical Progression|6|||
33435249|NCT01644890|101484662|FG000|Overall Study|> 28 days since last dose of study drug|6|||
33435250|NCT01644890|101484663|FG001|Overall Study|> 28 days since last dose of study drug|3|||
33435251|NCT01644890|101484662|FG000|Overall Study|Other|8|||
33435252|NCT01644890|101484663|FG001|Overall Study|Other|9|||
33435253|NCT01915732|101484665|FG000|Overall Study|Withdrawal by Subject|18|||
33435254|NCT01915732|101484666|FG001|Overall Study|Withdrawal by Subject|18|||
33435255|NCT01915732|101484665|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
33435256|NCT01915732|101484666|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
33435257|NCT01915732|101484665|FG000|Overall Study|Adverse Event|12|||
33435258|NCT01915732|101484666|FG001|Overall Study|Adverse Event|4|||
33435259|NCT01915732|101484665|FG000|Overall Study|Protocol Violation|5|||
33435260|NCT01915732|101484666|FG001|Overall Study|Protocol Violation|5|||
33435261|NCT01915732|101484665|FG000|Overall Study|Lack of Efficacy|6|||
33435262|NCT01915732|101484666|FG001|Overall Study|Lack of Efficacy|11|||
33435263|NCT01915732|101484665|FG000|Overall Study|Lost to Follow-up|22|||
33435264|NCT01915732|101484666|FG001|Overall Study|Lost to Follow-up|26|||
33435265|NCT01915732|101484665|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
33435266|NCT01915732|101484666|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
33435267|NCT01915732|101484665|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
33435268|NCT01915732|101484666|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
33385602|NCT03371251|101299158|FG005|Overall Study|Withdrawal by Subject|2|||
33385603|NCT03371251|101299153|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
33385604|NCT03371251|101299154|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
33385605|NCT03371251|101299155|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
33385606|NCT03371251|101299156|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
33385607|NCT03371251|101299157|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
33435269|NCT01915732|101484665|FG000|Overall Study|Drug Release Error|1|||
33435270|NCT01915732|101484666|FG001|Overall Study|Drug Release Error|0|||
33593714|NCT01461928|102060586|FG000|Maintenance II (15 Months)|Physician Decision|0|||
33593715|NCT01461928|102060587|FG001|Maintenance II (15 Months)|Physician Decision|0|||
33593716|NCT01461928|102060588|FG002|Maintenance II (15 Months)|Physician Decision|4|||
33593717|NCT01461928|102060586|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
33593718|NCT01461928|102060587|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
33593719|NCT01461928|102060588|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
33593720|NCT01461928|102060586|FG000|Maintenance II (15 Months)|Moved to another town|0|||
33593721|NCT01461928|102060587|FG001|Maintenance II (15 Months)|Moved to another town|1|||
33593722|NCT01461928|102060588|FG002|Maintenance II (15 Months)|Moved to another town|0|||
33593723|NCT01461928|102060586|FG000|Maintenance II (15 Months)|Disease progression|0|||
33593724|NCT01461928|102060587|FG001|Maintenance II (15 Months)|Disease progression|0|||
33435271|NCT01915732|101484665|FG000|Overall Study|Recovered|1|||
33435272|NCT01915732|101484666|FG001|Overall Study|Recovered|0|||
33435273|NCT01915732|101484665|FG000|Overall Study|Pregnancy|1|||
33593725|NCT01461928|102060588|FG002|Maintenance II (15 Months)|Disease progression|3|||
33593726|NCT01461928|102060586|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
33593727|NCT01461928|102060587|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
33435274|NCT01915732|101484666|FG001|Overall Study|Pregnancy|0|||
33435275|NCT01915732|101484665|FG000|Overall Study|Poor Perceived Efficacy|1|||
33435276|NCT01915732|101484666|FG001|Overall Study|Poor Perceived Efficacy|0|||
33435277|NCT01915732|101484665|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
33435278|NCT01915732|101484666|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
33435279|NCT01915732|101484665|FG000|Overall Study|Got Well|0|||
33435280|NCT01915732|101484666|FG001|Overall Study|Got Well|1|||
33435281|NCT01915732|101484665|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
33435282|NCT01915732|101484666|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
33435283|NCT01915732|101484665|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
33435284|NCT01915732|101484666|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
33435285|NCT01915732|101484665|FG000|Overall Study|Job Transfer|0|||
33435286|NCT01915732|101484666|FG001|Overall Study|Job Transfer|1|||
33435287|NCT01915732|101484665|FG000|Overall Study|Improper Facial Procedure|0|||
33435288|NCT01915732|101484666|FG001|Overall Study|Improper Facial Procedure|1|||
33435289|NCT01915732|101484665|FG000|Overall Study|Poor Conscious Effect|0|||
33435290|NCT01915732|101484666|FG001|Overall Study|Poor Conscious Effect|1|||
33435291|NCT00287118|101484669|FG000|Overall Study|Adverse Event|30|||
33435292|NCT00287118|101484669|FG000|Overall Study|Death|1|||
33435293|NCT00287118|101484669|FG000|Overall Study|Lack of Efficacy|11|||
33435294|NCT00287118|101484669|FG000|Overall Study|Lost to Follow-up|1|||
33593728|NCT01461928|102060588|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
33593729|NCT01461928|102060586|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
33593730|NCT01461928|102060587|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
33593731|NCT01461928|102060588|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
33593732|NCT01461928|102060586|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
33593733|NCT01461928|102060587|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
33593734|NCT01461928|102060588|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
33593735|NCT01461928|102060586|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
33593736|NCT01461928|102060587|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
33593737|NCT01461928|102060588|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
33593738|NCT01461928|102060586|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
33593739|NCT01461928|102060587|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
33593740|NCT01461928|102060588|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
33593741|NCT01328535|102060589|FG000|Overall Study|Ineligible|1|||
33593742|NCT01170065|102060590|FG000|Overall Study|Adverse Event|17|||
33593743|NCT01170065|102060591|FG001|Overall Study|Adverse Event|50|||
33249917|NCT02236559|100814543|FG001|Overall Study|Did not Meet Inclusion|3|||
33435295|NCT00287118|101484669|FG000|Overall Study|Protocol Violation|2|||
33435296|NCT00287118|101484669|FG000|Overall Study|Other|7|||
33435297|NCT02514174|101484672|FG000|Overall Study|Patient refused to continue medication|1|||
33435298|NCT02514174|101484672|FG000|Overall Study|Adverse Event|2|||
33435299|NCT02514174|101484672|FG000|Overall Study|Study closed by sponsor|9|||
33435300|NCT02514174|101484672|FG000|Overall Study|Progressive disease|11|||
33435301|NCT02514174|101484672|FG000|Overall Study|Treatment change|1|||
33435302|NCT02514174|101484672|FG000|Overall Study|Treated off study with Afatinib.|1|||
33435303|NCT00948675|101484673|FG000|Overall Study|Lost to Follow-up|1|||
33435304|NCT00948675|101484674|FG001|Overall Study|Lost to Follow-up|0|||
33435305|NCT01241461|101484675|FG000|Overall Study|Progressive Disease|3|||
33435306|NCT01241461|101484676|FG001|Overall Study|Progressive Disease|6|||
33435307|NCT02207231|101484680|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
33435308|NCT02207231|101484681|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
33435309|NCT02207231|101484682|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
33435310|NCT02207231|101484683|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
33435311|NCT02207231|101484680|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
33435312|NCT02207231|101484681|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
33435313|NCT02207231|101484682|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
33435314|NCT02207231|101484683|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
33593744|NCT01170065|102060592|FG002|Overall Study|Adverse Event|10|||
33593745|NCT01170065|102060590|FG000|Overall Study|Lost to Follow-up|1|||
33593746|NCT01170065|102060591|FG001|Overall Study|Lost to Follow-up|4|||
33249918|NCT02236559|100814542|FG000|Overall Study|Subject Did Not Consent|4|||
33593747|NCT01170065|102060592|FG002|Overall Study|Lost to Follow-up|1|||
33593748|NCT01170065|102060590|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
33593749|NCT01170065|102060591|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
33249919|NCT02236559|100814543|FG001|Overall Study|Subject Did Not Consent|2|||
33435315|NCT02207231|101484680|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
33435316|NCT02207231|101484681|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
33435317|NCT02207231|101484682|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
33435318|NCT02207231|101484683|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
33435319|NCT02207231|101484680|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
33435320|NCT02207231|101484681|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
33435321|NCT02207231|101484682|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
33435322|NCT02207231|101484683|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
33435323|NCT02207231|101484680|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
33593750|NCT01170065|102060592|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
33593751|NCT01170065|102060590|FG000|Overall Study|Reason other than specified|3|||
33593752|NCT01170065|102060591|FG001|Overall Study|Reason other than specified|8|||
33593753|NCT01170065|102060592|FG002|Overall Study|Reason other than specified|3|||
33593754|NCT01170065|102060590|FG000|Overall Study|Ongoing after planned observation time|5|||
33593755|NCT01170065|102060591|FG001|Overall Study|Ongoing after planned observation time|26|||
33593756|NCT01170065|102060592|FG002|Overall Study|Ongoing after planned observation time|10|||
33593757|NCT02046226|102060595|FG000|Overall Study|Lost to Follow-up|7|||
33593758|NCT02867813|102060597|FG000|Overall Study|Withdrawal by Subject|57|||
33593759|NCT02867813|102060598|FG001|Overall Study|Withdrawal by Subject|56|||
33593760|NCT02867813|102060597|FG000|Overall Study|Decision by Sponsor|7|||
33593761|NCT02867813|102060598|FG001|Overall Study|Decision by Sponsor|7|||
33593762|NCT02867813|102060597|FG000|Overall Study|Lost to Follow-up|91|||
33593763|NCT02867813|102060598|FG001|Overall Study|Lost to Follow-up|78|||
33593764|NCT02867813|102060597|FG000|Overall Study|Missing|2|||
33593765|NCT02867813|102060598|FG001|Overall Study|Missing|1|||
33593766|NCT02867813|102060597|FG000|Overall Study|Death|294|||
33593767|NCT02867813|102060598|FG001|Overall Study|Death|268|||
33593768|NCT01082874|102060607|FG000|Overall Study|Lost to Follow-up|10|||
33593769|NCT01082874|102060608|FG001|Overall Study|Lost to Follow-up|10|||
33593770|NCT01082874|102060609|FG002|Overall Study|Lost to Follow-up|6|||
33593771|NCT01082874|102060610|FG003|Overall Study|Lost to Follow-up|10|||
33593772|NCT01082874|102060607|FG000|Overall Study|Withdrawal by Subject|1|||
33593773|NCT01082874|102060608|FG001|Overall Study|Withdrawal by Subject|2|||
33593774|NCT01082874|102060609|FG002|Overall Study|Withdrawal by Subject|5|||
33593775|NCT01082874|102060610|FG003|Overall Study|Withdrawal by Subject|3|||
33593776|NCT02725593|102060614|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
33593777|NCT02725593|102060615|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
33593778|NCT02725593|102060614|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
33593779|NCT02725593|102060615|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
33593780|NCT02725593|102060614|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
33593781|NCT02725593|102060615|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
33593782|NCT02725593|102060614|FG000|Long Term Extension|Withdrawal by Subject|1|||
33593783|NCT02725593|102060615|FG001|Long Term Extension|Withdrawal by Subject|3|||
33593784|NCT00737711|102060616|FG000|Overall Study|Adverse Event|2|||
33593785|NCT00737711|102060616|FG000|Overall Study|Death|8|||
33593786|NCT00737711|102060616|FG000|Overall Study|Failure to return|4|||
33593787|NCT00737711|102060616|FG000|Overall Study|Protocol Violation|1|||
33593788|NCT00737711|102060616|FG000|Overall Study|Withdrawal by Subject|5|||
33593789|NCT00737711|102060616|FG000|Overall Study|Blood transfusion|6|||
33593790|NCT00737711|102060616|FG000|Overall Study|Other|5|||
33593791|NCT01330628|102060617|FG000|Overall Study|Death|2|||
33593792|NCT01330628|102060618|FG001|Overall Study|Death|3|||
33593793|NCT01330628|102060617|FG000|Overall Study|Lost to Follow-up|5|||
33593794|NCT01330628|102060618|FG001|Overall Study|Lost to Follow-up|6|||
33593795|NCT01330628|102060617|FG000|Overall Study|Adverse Event|44|||
33593796|NCT01330628|102060618|FG001|Overall Study|Adverse Event|25|||
33593797|NCT01330628|102060617|FG000|Overall Study|Withdrawn|18|||
33593798|NCT01330628|102060618|FG001|Overall Study|Withdrawn|6|||
33593799|NCT01330628|102060617|FG000|Overall Study|Didn't receive study treatment|1|||
33593800|NCT01330628|102060618|FG001|Overall Study|Didn't receive study treatment|0|||
33593801|NCT00394251|102060629|FG000|Overall Study|Adverse Event|7|||
33593802|NCT00394251|102060630|FG001|Overall Study|Adverse Event|5|||
33593803|NCT00394251|102060629|FG000|Overall Study|Unacceptable Toxicity|20|||
33593804|NCT00394251|102060630|FG001|Overall Study|Unacceptable Toxicity|18|||
33593805|NCT00394251|102060629|FG000|Overall Study|Physician Decision|1|||
33593806|NCT00394251|102060630|FG001|Overall Study|Physician Decision|1|||
33593807|NCT00394251|102060629|FG000|Overall Study|Protocol Violation|0|||
33593808|NCT00394251|102060630|FG001|Overall Study|Protocol Violation|1|||
33593809|NCT00394251|102060629|FG000|Overall Study|Withdrawal by Subject|7|||
33593810|NCT00394251|102060630|FG001|Overall Study|Withdrawal by Subject|11|||
33385608|NCT03371251|101299158|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
33385609|NCT03371251|101299153|FG000|Overall Study|Adverse Event|0|||
33385610|NCT03371251|101299154|FG001|Overall Study|Adverse Event|0|||
33385611|NCT03371251|101299155|FG002|Overall Study|Adverse Event|0|||
33385612|NCT03371251|101299156|FG003|Overall Study|Adverse Event|0|||
33385613|NCT03371251|101299157|FG004|Overall Study|Adverse Event|1|||
33385614|NCT03371251|101299158|FG005|Overall Study|Adverse Event|0|||
33593811|NCT00394251|102060629|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
33593812|NCT00394251|102060630|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
33593813|NCT01646645|102060635|FG000|Overall Study|No Treated|1|||
33593814|NCT01646645|102060635|FG000|Overall Study|Inevaluable Donor|29|||
33593815|NCT01774253|102060638|FG000|Overall Study|Lack of Efficacy|4|||
33593816|NCT01774253|102060638|FG000|Overall Study|Physician Decision|2|||
33150515|NCT00423670|100466814|FG001|Treatment Period|Investigator decision|0|||
33150516|NCT00423670|100466815|FG002|Treatment Period|Investigator decision|0|||
33150517|NCT00423670|100466816|FG003|Treatment Period|Investigator decision|0|||
33150518|NCT00423670|100466817|FG004|Treatment Period|Investigator decision|0|||
33385615|NCT03371251|101299153|FG000|Overall Study|Decision by Sponsor|0|||
33385616|NCT03371251|101299154|FG001|Overall Study|Decision by Sponsor|0|||
33385617|NCT03371251|101299155|FG002|Overall Study|Decision by Sponsor|0|||
33385618|NCT03371251|101299156|FG003|Overall Study|Decision by Sponsor|0|||
33385619|NCT03371251|101299157|FG004|Overall Study|Decision by Sponsor|2|||
33385620|NCT03371251|101299158|FG005|Overall Study|Decision by Sponsor|0|||
33385621|NCT00807014|101299164|FG000|Overall Study|Participant Considered Disease Cured|13|||
33385622|NCT00807014|101299165|FG001|Overall Study|Participant Considered Disease Cured|2|||
33385623|NCT00807014|101299164|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
33385624|NCT00807014|101299165|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
33385625|NCT00807014|101299164|FG000|Overall Study|Protocol Violation|2|||
33385626|NCT00807014|101299165|FG001|Overall Study|Protocol Violation|8|||
33385627|NCT00807014|101299164|FG000|Overall Study|Adverse Event|0|||
33385628|NCT00807014|101299165|FG001|Overall Study|Adverse Event|2|||
33385629|NCT00807014|101299164|FG000|Overall Study|Lost to Follow-up|9|||
33385630|NCT00807014|101299165|FG001|Overall Study|Lost to Follow-up|7|||
33385631|NCT00807014|101299164|FG000|Overall Study|Recovery|1|||
33385632|NCT00807014|101299165|FG001|Overall Study|Recovery|0|||
33385633|NCT00807014|101299164|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
33385634|NCT00807014|101299165|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
33385635|NCT01263093|101299166|FG000|Washout|Physician Decision|1|||
33385636|NCT01263093|101299167|FG001|Washout|Physician Decision|0|||
33385637|NCT01263093|101299166|FG000|Period 2|Adverse Event|1|||
33385638|NCT01263093|101299167|FG001|Period 2|Adverse Event|0|||
33385639|NCT00994162|101299168|FG000|Overall Study|Withdrawal by Subject|1|||
33385640|NCT00994162|101299168|FG000|Overall Study|Lost to Follow-up|2|||
33385641|NCT00994162|101299168|FG000|Overall Study|Product Complaint|1|||
33593817|NCT01774253|102060638|FG000|Overall Study|Withdrawal by Subject|2|||
33435324|NCT02207231|101484681|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
33593818|NCT01774253|102060638|FG000|Overall Study|Death|1|||
33593819|NCT01685801|102060641|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
33593820|NCT01685801|102060642|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
33593821|NCT01685801|102060643|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
33593822|NCT01685801|102060644|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
33593823|NCT01685801|102060641|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
33593824|NCT01685801|102060642|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
33593825|NCT01685801|102060643|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
33593826|NCT01685801|102060644|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
33593827|NCT03746600|102060645|FG000|Overall Study|Withdrawal by Subject|3|||
33593828|NCT03746600|102060646|FG001|Overall Study|Withdrawal by Subject|3|||
33593829|NCT03746600|102060645|FG000|Overall Study|dismissed from study|1|||
33593830|NCT03746600|102060646|FG001|Overall Study|dismissed from study|0|||
33593831|NCT03746600|102060645|FG000|Overall Study|Lost to Follow-up|1|||
33593832|NCT03746600|102060646|FG001|Overall Study|Lost to Follow-up|0|||
33593833|NCT02974855|102060649|FG000|Overall Study|Adverse Event|0|||
33593834|NCT02974855|102060650|FG001|Overall Study|Adverse Event|1|||
33593835|NCT02974855|102060651|FG002|Overall Study|Adverse Event|0|||
33593836|NCT02974855|102060652|FG003|Overall Study|Adverse Event|1|||
33593837|NCT00405964|102060653|FG000|Overall Study|Treatment Failure|17|||
33593838|NCT00405964|102060654|FG001|Overall Study|Treatment Failure|45|||
33593839|NCT00405964|102060653|FG000|Overall Study|Adverse Event|7|||
33593840|NCT00405964|102060654|FG001|Overall Study|Adverse Event|16|||
33593841|NCT00405964|102060653|FG000|Overall Study|Lost to Follow-up|5|||
33593842|NCT00405964|102060654|FG001|Overall Study|Lost to Follow-up|5|||
33593843|NCT00405964|102060653|FG000|Overall Study|Withdrawal by Subject|19|||
33593844|NCT00405964|102060654|FG001|Overall Study|Withdrawal by Subject|23|||
33593845|NCT00405964|102060653|FG000|Overall Study|Protocol Violation|11|||
33593846|NCT00405964|102060654|FG001|Overall Study|Protocol Violation|6|||
33593847|NCT03727646|102060655|FG000|Overall Study|Adverse Event|1|||
33593848|NCT03727646|102060656|FG001|Overall Study|Adverse Event|0|||
33593849|NCT01534260|102060660|FG000|Overall Study|Adverse Event|1|||
33593850|NCT01534260|102060661|FG001|Overall Study|Adverse Event|8|||
33593851|NCT01534260|102060660|FG000|Overall Study|Death|2|||
33593852|NCT01534260|102060661|FG001|Overall Study|Death|0|||
33593853|NCT01534260|102060660|FG000|Overall Study|Lack of Efficacy|1|||
33593854|NCT01534260|102060661|FG001|Overall Study|Lack of Efficacy|1|||
33593855|NCT01534260|102060660|FG000|Overall Study|Withdrawal by Subject|1|||
33593856|NCT01534260|102060661|FG001|Overall Study|Withdrawal by Subject|3|||
33593857|NCT01534260|102060660|FG000|Overall Study|Disease Progression|8|||
33593858|NCT01534260|102060661|FG001|Overall Study|Disease Progression|6|||
33593859|NCT01534260|102060660|FG000|Overall Study|Physician Decision|3|||
33593860|NCT01534260|102060661|FG001|Overall Study|Physician Decision|1|||
33593861|NCT01534260|102060660|FG000|Overall Study|No treatment, per protocol|0|||
33593862|NCT01534260|102060661|FG001|Overall Study|No treatment, per protocol|1|||
33593863|NCT04606199|102060662|FG000|Overall Study|Withdrawal by Subject|2|||
33593864|NCT03576066|102060663|FG000|Overall Study|Noncompliance with study drug|0|||
33593865|NCT03576066|102060664|FG001|Overall Study|Noncompliance with study drug|1|||
33593866|NCT00515294|102060665|FG000|Overall Study|Lost to Follow-up|3|||
33593867|NCT00515294|102060666|FG001|Overall Study|Lost to Follow-up|2|||
33593868|NCT00515294|102060667|FG002|Overall Study|Lost to Follow-up|3|||
33593869|NCT00515294|102060668|FG003|Overall Study|Lost to Follow-up|1|||
33593870|NCT00515294|102060665|FG000|Overall Study|Driver simulator problems|1|||
33593871|NCT00515294|102060666|FG001|Overall Study|Driver simulator problems|1|||
33593872|NCT00515294|102060667|FG002|Overall Study|Driver simulator problems|1|||
33593873|NCT00515294|102060668|FG003|Overall Study|Driver simulator problems|3|||
33593874|NCT00515294|102060665|FG000|Overall Study|Caffeine amount inaccurate|5|||
33593875|NCT00515294|102060666|FG001|Overall Study|Caffeine amount inaccurate|0|||
33593876|NCT00515294|102060667|FG002|Overall Study|Caffeine amount inaccurate|7|||
33593877|NCT00515294|102060668|FG003|Overall Study|Caffeine amount inaccurate|0|||
33593878|NCT05032690|102060669|FG000|Period 1|Adverse Event|0|||
33593879|NCT05032690|102060670|FG001|Period 1|Adverse Event|1|||
33593880|NCT05032690|102060671|FG002|Period 1|Adverse Event|0|||
33593881|NCT05032690|102060672|FG003|Period 1|Adverse Event|0|||
33593882|NCT05032690|102060669|FG000|Period 1|Withdrawal by Subject|1|||
33593883|NCT05032690|102060670|FG001|Period 1|Withdrawal by Subject|0|||
33593884|NCT05032690|102060671|FG002|Period 1|Withdrawal by Subject|0|||
33593885|NCT05032690|102060672|FG003|Period 1|Withdrawal by Subject|0|||
33593886|NCT05032690|102060669|FG000|Period 1|No longer meets eligibility criteria|0|||
33593887|NCT05032690|102060670|FG001|Period 1|No longer meets eligibility criteria|1|||
33593888|NCT05032690|102060671|FG002|Period 1|No longer meets eligibility criteria|0|||
33593889|NCT05032690|102060672|FG003|Period 1|No longer meets eligibility criteria|0|||
33593890|NCT05032690|102060669|FG000|Period 2|Adverse Event|1|||
33593891|NCT05032690|102060670|FG001|Period 2|Adverse Event|0|||
33593892|NCT05032690|102060671|FG002|Period 2|Adverse Event|0|||
33150519|NCT00423670|100466818|FG005|Treatment Period|Investigator decision|0|||
33150520|NCT00423670|100466819|FG006|Treatment Period|Investigator decision|0|||
33150521|NCT00423670|100466820|FG007|Treatment Period|Investigator decision|1|||
33150522|NCT00423670|100466813|FG000|Treatment Period|Non-compliance with protocol|3|||
33150523|NCT00423670|100466814|FG001|Treatment Period|Non-compliance with protocol|1|||
33249920|NCT02236559|100814542|FG000|Overall Study|Physician Decision|1|||
33385642|NCT00994162|101299168|FG000|Overall Study|Poor Compliance|5|||
33385643|NCT00994162|101299168|FG000|Overall Study|Lack of Response|3|||
33385644|NCT00994162|101299168|FG000|Overall Study|Discharged from Hospital|4|||
33593893|NCT05032690|102060672|FG003|Period 2|Adverse Event|0|||
33150524|NCT00423670|100466815|FG002|Treatment Period|Non-compliance with protocol|1|||
33150525|NCT00423670|100466816|FG003|Treatment Period|Non-compliance with protocol|3|||
33150526|NCT00423670|100466817|FG004|Treatment Period|Non-compliance with protocol|2|||
33150527|NCT00423670|100466818|FG005|Treatment Period|Non-compliance with protocol|0|||
33150528|NCT00423670|100466819|FG006|Treatment Period|Non-compliance with protocol|2|||
33150529|NCT00423670|100466820|FG007|Treatment Period|Non-compliance with protocol|2|||
33150530|NCT00423670|100466813|FG000|Follow-up Period|Lost to Follow-up|0|||
33150531|NCT00423670|100466814|FG001|Follow-up Period|Lost to Follow-up|12|||
33150532|NCT00423670|100466815|FG002|Follow-up Period|Lost to Follow-up|8|||
33150533|NCT00423670|100466816|FG003|Follow-up Period|Lost to Follow-up|3|||
33150534|NCT00423670|100466817|FG004|Follow-up Period|Lost to Follow-up|1|||
33150535|NCT00423670|100466818|FG005|Follow-up Period|Lost to Follow-up|0|||
33150536|NCT00423670|100466819|FG006|Follow-up Period|Lost to Follow-up|5|||
33150537|NCT00423670|100466820|FG007|Follow-up Period|Lost to Follow-up|0|||
33150538|NCT00423670|100466813|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
33150539|NCT00423670|100466814|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
33150540|NCT00423670|100466815|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
33150541|NCT00423670|100466816|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
33150542|NCT00423670|100466817|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
33150543|NCT00423670|100466818|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
33593894|NCT05032690|102060669|FG000|Period 2|Withdrawal by Subject|0|||
33593895|NCT05032690|102060670|FG001|Period 2|Withdrawal by Subject|1|||
33593896|NCT05032690|102060671|FG002|Period 2|Withdrawal by Subject|0|||
33593897|NCT05032690|102060672|FG003|Period 2|Withdrawal by Subject|0|||
33593898|NCT05032690|102060669|FG000|Period 2|No longer meets eligibility criteria|0|||
33593899|NCT05032690|102060670|FG001|Period 2|No longer meets eligibility criteria|1|||
33593900|NCT05032690|102060671|FG002|Period 2|No longer meets eligibility criteria|0|||
33593901|NCT05032690|102060672|FG003|Period 2|No longer meets eligibility criteria|0|||
33593902|NCT05032690|102060669|FG000|Period 3|Adverse Event|0|||
33593903|NCT05032690|102060670|FG001|Period 3|Adverse Event|1|||
33593904|NCT05032690|102060671|FG002|Period 3|Adverse Event|0|||
33593905|NCT05032690|102060672|FG003|Period 3|Adverse Event|0|||
33593906|NCT00837265|102060673|FG000|Pilot Phase|Withdrawal by Subject|0|||
33593907|NCT00837265|102060674|FG001|Pilot Phase|Withdrawal by Subject|2|||
33593908|NCT00837265|102060675|FG002|Pilot Phase|Withdrawal by Subject|3|||
33593909|NCT00837265|102060676|FG003|Pilot Phase|Withdrawal by Subject|2|||
33593910|NCT00837265|102060677|FG004|Pilot Phase|Withdrawal by Subject|0|||
33593911|NCT00837265|102060678|FG005|Pilot Phase|Withdrawal by Subject|0|||
33593912|NCT00837265|102060679|FG006|Pilot Phase|Withdrawal by Subject|0|||
33593913|NCT00837265|102060673|FG000|Pilot Phase|Decision of the investigator|2|||
33593914|NCT00837265|102060674|FG001|Pilot Phase|Decision of the investigator|1|||
33593915|NCT00837265|102060675|FG002|Pilot Phase|Decision of the investigator|0|||
33385645|NCT00994162|101299168|FG000|Overall Study|Death|2|||
33593916|NCT00837265|102060676|FG003|Pilot Phase|Decision of the investigator|0|||
33593917|NCT00837265|102060677|FG004|Pilot Phase|Decision of the investigator|0|||
33593918|NCT00837265|102060678|FG005|Pilot Phase|Decision of the investigator|0|||
33593919|NCT00837265|102060679|FG006|Pilot Phase|Decision of the investigator|0|||
33593920|NCT00837265|102060673|FG000|Pilot Phase|Adverse Event|1|||
33593921|NCT00837265|102060674|FG001|Pilot Phase|Adverse Event|0|||
33385646|NCT00994162|101299168|FG000|Overall Study|Care Transferred to Another Physician|2|||
33385647|NCT00994162|101299168|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
33385648|NCT00994162|101299168|FG000|Overall Study|Physician Decision|2|||
33385649|NCT00994162|101299168|FG000|Overall Study|Surrounding Wound Erythematous|1|||
33385650|NCT00994162|101299168|FG000|Overall Study|Machine Losing Vaccum|1|||
33385651|NCT00994162|101299168|FG000|Overall Study|Patient Lived Too Far Away|1|||
33385652|NCT00994162|101299168|FG000|Overall Study|Above Knee Amputation|1|||
33385653|NCT00994162|101299168|FG000|Overall Study|Reason Not Reported By Site|1|||
33385654|NCT02174861|101299169|FG000|Overall Study|Decision by sponsor|8|||
33385655|NCT02174861|101299169|FG000|Overall Study|Withdrawal by Subject|124|||
33385656|NCT02174861|101299169|FG000|Overall Study|Lost to Follow-up|26|||
33385657|NCT00415519|101299172|FG000|Overall Study|Adverse Event|1|||
33385658|NCT00415519|101299173|FG001|Overall Study|Adverse Event|0|||
33385659|NCT00415519|101299172|FG000|Overall Study|Withdrawal by Subject|2|||
33385660|NCT00415519|101299173|FG001|Overall Study|Withdrawal by Subject|0|||
33385661|NCT00415519|101299172|FG000|Overall Study|Patient's convenience|1|||
33385662|NCT00415519|101299173|FG001|Overall Study|Patient's convenience|0|||
33385663|NCT00436982|101299184|FG000|Overall Study|Withdrawal by Subject|3|||
33385664|NCT00436982|101299185|FG001|Overall Study|Withdrawal by Subject|1|||
33385665|NCT00436982|101299184|FG000|Overall Study|Did not receive allocated intervention|0|||
33385666|NCT00436982|101299185|FG001|Overall Study|Did not receive allocated intervention|1|||
33435325|NCT02207231|101484682|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
33435326|NCT02207231|101484683|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
33435327|NCT02207231|101484680|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
33435328|NCT02207231|101484681|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
33435329|NCT02207231|101484682|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
33435330|NCT02207231|101484683|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
33435331|NCT02207231|101484680|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
33435332|NCT02207231|101484681|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
33435333|NCT02207231|101484682|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
33435334|NCT02207231|101484683|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
33435335|NCT02207231|101484680|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
33435336|NCT02207231|101484681|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
33435337|NCT02207231|101484682|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
33435338|NCT02207231|101484683|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
33435339|NCT02207231|101484680|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
33435340|NCT02207231|101484681|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
33435341|NCT02207231|101484682|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
33435342|NCT02207231|101484683|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
33435343|NCT02207231|101484680|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
33435344|NCT02207231|101484681|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
33435345|NCT02207231|101484682|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
33435346|NCT02207231|101484683|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
33435347|NCT02207231|101484680|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
33435348|NCT02207231|101484681|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
33435349|NCT02207231|101484682|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
33435350|NCT02207231|101484683|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
33435351|NCT02207231|101484680|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
33435352|NCT02207231|101484681|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
33435353|NCT02207231|101484682|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
33435354|NCT02207231|101484683|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
33435355|NCT02207231|101484680|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
33435356|NCT02207231|101484681|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
33435357|NCT02207231|101484682|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
33435358|NCT02207231|101484683|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
33435359|NCT02207231|101484680|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
33435360|NCT02207231|101484681|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
33435361|NCT02207231|101484682|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
33435362|NCT02207231|101484683|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
33435363|NCT02207231|101484680|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
33435364|NCT02207231|101484681|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
33435365|NCT02207231|101484682|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
33435366|NCT02207231|101484683|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
33435367|NCT02207231|101484680|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
33435368|NCT02207231|101484681|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
33435369|NCT02207231|101484682|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
33435370|NCT02207231|101484683|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
33435371|NCT02207231|101484680|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
33435372|NCT02207231|101484681|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
33435373|NCT02207231|101484682|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
33435374|NCT02207231|101484683|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
33435375|NCT02207231|101484680|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
33435376|NCT02207231|101484681|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
33435377|NCT02207231|101484682|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
33435378|NCT02207231|101484683|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
33435379|NCT02207231|101484680|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
33435380|NCT02207231|101484681|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
33435381|NCT02207231|101484682|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
33435382|NCT02207231|101484683|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
33435383|NCT02207231|101484680|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
33435384|NCT02207231|101484681|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
33593922|NCT00837265|102060675|FG002|Pilot Phase|Adverse Event|0|||
33593923|NCT00837265|102060676|FG003|Pilot Phase|Adverse Event|0|||
33435385|NCT02207231|101484682|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
33435386|NCT02207231|101484683|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
33435387|NCT02207231|101484680|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
33435388|NCT02207231|101484681|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
33593924|NCT00837265|102060677|FG004|Pilot Phase|Adverse Event|0|||
33150544|NCT00423670|100466819|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
33150545|NCT00423670|100466820|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
33150546|NCT00423670|100466813|FG000|Follow-up Period|Non-compliance with protocol|2|||
33150547|NCT00423670|100466814|FG001|Follow-up Period|Non-compliance with protocol|0|||
33435389|NCT02207231|101484682|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
33435390|NCT02207231|101484683|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
33435391|NCT02154529|101484684|FG000|Overall Study|Death|1|||
33435392|NCT02154529|101484685|FG001|Overall Study|Death|1|||
33435393|NCT02154529|101484686|FG002|Overall Study|Death|5|||
33435394|NCT02154529|101484687|FG003|Overall Study|Death|1|||
33435395|NCT02154529|101484684|FG000|Overall Study|Termination of study by sponsor|2|||
33435396|NCT02154529|101484685|FG001|Overall Study|Termination of study by sponsor|2|||
33435397|NCT02154529|101484686|FG002|Overall Study|Termination of study by sponsor|3|||
33435398|NCT02154529|101484687|FG003|Overall Study|Termination of study by sponsor|1|||
33435399|NCT02154529|101484684|FG000|Overall Study|Lost to Follow-up|1|||
33435400|NCT02154529|101484685|FG001|Overall Study|Lost to Follow-up|0|||
33435401|NCT02154529|101484686|FG002|Overall Study|Lost to Follow-up|0|||
33435402|NCT02154529|101484687|FG003|Overall Study|Lost to Follow-up|0|||
33435403|NCT00680121|101484688|FG000|Overall Study|Lost to Follow-up|27|||
33435404|NCT00680121|101484689|FG001|Overall Study|Lost to Follow-up|23|||
33435405|NCT03730103|101484695|FG000|Overall Study|Did not meet inclusion criteria|0|||
33435406|NCT03730103|101484696|FG001|Overall Study|Did not meet inclusion criteria|5|||
33435407|NCT01265784|101488116|FG000|Overall Study|Lost to Follow-up|5|||
33435408|NCT01265784|101488117|FG001|Overall Study|Lost to Follow-up|3|||
33435409|NCT01265784|101488118|FG002|Overall Study|Lost to Follow-up|2|||
33435410|NCT01265784|101488116|FG000|Overall Study|Withdrawal by Subject|0|||
33435411|NCT01265784|101488117|FG001|Overall Study|Withdrawal by Subject|5|||
33435412|NCT01265784|101488118|FG002|Overall Study|Withdrawal by Subject|0|||
33435413|NCT01265784|101488116|FG000|Overall Study|Physician Decision|1|||
33435414|NCT01265784|101488117|FG001|Overall Study|Physician Decision|0|||
33435415|NCT01265784|101488118|FG002|Overall Study|Physician Decision|1|||
33435416|NCT01265784|101488116|FG000|Overall Study|Adverse Event|1|||
33435417|NCT01265784|101488117|FG001|Overall Study|Adverse Event|0|||
33435418|NCT01265784|101488118|FG002|Overall Study|Adverse Event|0|||
33435419|NCT01265784|101488116|FG000|Overall Study|Death|3|||
33435420|NCT01265784|101488117|FG001|Overall Study|Death|0|||
33435421|NCT01265784|101488118|FG002|Overall Study|Death|0|||
33435422|NCT01265784|101488116|FG000|Overall Study|Protocol Violation|2|||
33435423|NCT01265784|101488117|FG001|Overall Study|Protocol Violation|0|||
33435424|NCT01265784|101488118|FG002|Overall Study|Protocol Violation|0|||
33435425|NCT01265784|101488116|FG000|Overall Study|Incorrectly Randomized|0|||
33435426|NCT01265784|101488117|FG001|Overall Study|Incorrectly Randomized|0|||
33435427|NCT01265784|101488118|FG002|Overall Study|Incorrectly Randomized|1|||
33435428|NCT04799158|101488119|FG000|Run-In Period|Adverse Event|6|||
33435429|NCT04799158|101488120|FG001|Run-In Period|Adverse Event|0|||
33435430|NCT04799158|101488121|FG002|Run-In Period|Adverse Event|0|||
33435431|NCT04799158|101488122|FG003|Run-In Period|Adverse Event|0|||
33435432|NCT04799158|101488123|FG004|Run-In Period|Adverse Event|0|||
33435433|NCT04799158|101488119|FG000|Run-In Period|Lost to Follow-up|4|||
33435434|NCT04799158|101488120|FG001|Run-In Period|Lost to Follow-up|0|||
33435435|NCT04799158|101488121|FG002|Run-In Period|Lost to Follow-up|0|||
33435436|NCT04799158|101488122|FG003|Run-In Period|Lost to Follow-up|0|||
33249921|NCT02236559|100814543|FG001|Overall Study|Physician Decision|1|||
33385667|NCT00436982|101299184|FG000|Overall Study|no RSA data|1|||
33385668|NCT00436982|101299185|FG001|Overall Study|no RSA data|2|||
33385669|NCT02513771|101299191|FG000|Overall Study|Lost to Follow-up|1|||
33385670|NCT02513771|101299192|FG001|Overall Study|Lost to Follow-up|1|||
33385671|NCT02513771|101299191|FG000|Overall Study|Not being able to get to clinic|1|||
33385672|NCT02513771|101299192|FG001|Overall Study|Not being able to get to clinic|0|||
33385673|NCT00830115|101299193|FG000|Overall Study|Adverse Event|2|||
33385674|NCT00830115|101299193|FG000|Overall Study|Improvement/recovery|1|||
33385675|NCT01938001|101299195|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
33385676|NCT01938001|101299196|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
33385677|NCT01938001|101299195|FG000|Pre-Treatment|Death|1|||
33385678|NCT01938001|101299196|FG001|Pre-Treatment|Death|0|||
33385679|NCT01938001|101299195|FG000|Treatment|Death|2|||
33385680|NCT01938001|101299196|FG001|Treatment|Death|0|||
33385681|NCT01938001|101299195|FG000|Treatment|Adverse Event|14|||
33385682|NCT01938001|101299196|FG001|Treatment|Adverse Event|8|||
33385683|NCT01938001|101299195|FG000|Treatment|Progressive Disease|21|||
33385684|NCT01938001|101299196|FG001|Treatment|Progressive Disease|54|||
33385685|NCT01938001|101299195|FG000|Treatment|Withdrawal by Subject|13|||
33385686|NCT01938001|101299196|FG001|Treatment|Withdrawal by Subject|7|||
33385687|NCT01938001|101299195|FG000|Treatment|Other reasons|2|||
33385688|NCT01938001|101299196|FG001|Treatment|Other reasons|1|||
33435437|NCT04799158|101488123|FG004|Run-In Period|Lost to Follow-up|0|||
33435438|NCT04799158|101488119|FG000|Run-In Period|Significant Protocol Deviation|1|||
33435439|NCT04799158|101488120|FG001|Run-In Period|Significant Protocol Deviation|0|||
33435440|NCT04799158|101488121|FG002|Run-In Period|Significant Protocol Deviation|0|||
33593925|NCT00837265|102060678|FG005|Pilot Phase|Adverse Event|0|||
33593926|NCT00837265|102060679|FG006|Pilot Phase|Adverse Event|0|||
33593927|NCT00837265|102060673|FG000|Pilot Phase|Disease progression|0|||
33593928|NCT00837265|102060674|FG001|Pilot Phase|Disease progression|0|||
33593929|NCT00837265|102060675|FG002|Pilot Phase|Disease progression|0|||
33593930|NCT00837265|102060676|FG003|Pilot Phase|Disease progression|1|||
33593931|NCT00837265|102060677|FG004|Pilot Phase|Disease progression|0|||
33593932|NCT00837265|102060678|FG005|Pilot Phase|Disease progression|0|||
33593933|NCT00837265|102060679|FG006|Pilot Phase|Disease progression|0|||
33385689|NCT00801892|101299204|FG000|Main Study Period|Withdrawal by Subject|0|||
33385690|NCT00801892|101299205|FG001|Main Study Period|Withdrawal by Subject|1|||
33385691|NCT00801892|101299204|FG000|Sham Crossover Period|Lost to Follow-up|0|||
33435441|NCT04799158|101488122|FG003|Run-In Period|Significant Protocol Deviation|0|||
33435442|NCT04799158|101488123|FG004|Run-In Period|Significant Protocol Deviation|0|||
33593934|NCT00837265|102060673|FG000|Pilot Phase|Participant left the city|0|||
33593935|NCT00837265|102060674|FG001|Pilot Phase|Participant left the city|0|||
33593936|NCT00837265|102060675|FG002|Pilot Phase|Participant left the city|0|||
33593937|NCT00837265|102060676|FG003|Pilot Phase|Participant left the city|1|||
33593938|NCT00837265|102060677|FG004|Pilot Phase|Participant left the city|0|||
33593939|NCT00837265|102060678|FG005|Pilot Phase|Participant left the city|0|||
33593940|NCT00837265|102060679|FG006|Pilot Phase|Participant left the city|0|||
33593941|NCT00837265|102060673|FG000|Main Phase|Withdrawal by Subject|0|||
33593942|NCT00837265|102060674|FG001|Main Phase|Withdrawal by Subject|0|||
33593943|NCT00837265|102060675|FG002|Main Phase|Withdrawal by Subject|0|||
33593944|NCT00837265|102060676|FG003|Main Phase|Withdrawal by Subject|0|||
33593945|NCT00837265|102060677|FG004|Main Phase|Withdrawal by Subject|4|||
33593946|NCT00837265|102060678|FG005|Main Phase|Withdrawal by Subject|2|||
33593947|NCT00837265|102060679|FG006|Main Phase|Withdrawal by Subject|1|||
33593948|NCT00837265|102060673|FG000|Main Phase|Decision of the investigator|0|||
33593949|NCT00837265|102060674|FG001|Main Phase|Decision of the investigator|0|||
33593950|NCT00837265|102060675|FG002|Main Phase|Decision of the investigator|0|||
33593951|NCT00837265|102060676|FG003|Main Phase|Decision of the investigator|0|||
33593952|NCT00837265|102060677|FG004|Main Phase|Decision of the investigator|0|||
33593953|NCT00837265|102060678|FG005|Main Phase|Decision of the investigator|2|||
33593954|NCT00837265|102060679|FG006|Main Phase|Decision of the investigator|1|||
33593955|NCT00837265|102060673|FG000|Main Phase|Adverse Event|0|||
33593956|NCT00837265|102060674|FG001|Main Phase|Adverse Event|0|||
33593957|NCT00837265|102060675|FG002|Main Phase|Adverse Event|0|||
33593958|NCT00837265|102060676|FG003|Main Phase|Adverse Event|0|||
33593959|NCT00837265|102060677|FG004|Main Phase|Adverse Event|0|||
33593960|NCT00837265|102060678|FG005|Main Phase|Adverse Event|1|||
33593961|NCT00837265|102060679|FG006|Main Phase|Adverse Event|0|||
33593962|NCT00837265|102060673|FG000|Main Phase|Death|0|||
33593963|NCT00837265|102060674|FG001|Main Phase|Death|0|||
33593964|NCT00837265|102060675|FG002|Main Phase|Death|0|||
33593965|NCT00837265|102060676|FG003|Main Phase|Death|0|||
33593966|NCT00837265|102060677|FG004|Main Phase|Death|2|||
33593967|NCT00837265|102060678|FG005|Main Phase|Death|0|||
33593968|NCT00837265|102060679|FG006|Main Phase|Death|1|||
33593969|NCT00837265|102060673|FG000|Main Phase|Lost to Follow-up|0|||
33593970|NCT00837265|102060674|FG001|Main Phase|Lost to Follow-up|0|||
33593971|NCT00837265|102060675|FG002|Main Phase|Lost to Follow-up|0|||
33593972|NCT00837265|102060676|FG003|Main Phase|Lost to Follow-up|0|||
33593973|NCT00837265|102060677|FG004|Main Phase|Lost to Follow-up|1|||
33593974|NCT00837265|102060678|FG005|Main Phase|Lost to Follow-up|0|||
33593975|NCT00837265|102060679|FG006|Main Phase|Lost to Follow-up|0|||
33593976|NCT00837265|102060673|FG000|Main Phase|Principal investigator resignation|0|||
33593977|NCT00837265|102060674|FG001|Main Phase|Principal investigator resignation|0|||
33593978|NCT00837265|102060675|FG002|Main Phase|Principal investigator resignation|0|||
33593979|NCT00837265|102060676|FG003|Main Phase|Principal investigator resignation|0|||
33593980|NCT00837265|102060677|FG004|Main Phase|Principal investigator resignation|2|||
33593981|NCT00837265|102060678|FG005|Main Phase|Principal investigator resignation|0|||
33593982|NCT00837265|102060679|FG006|Main Phase|Principal investigator resignation|0|||
33150548|NCT00423670|100466815|FG002|Follow-up Period|Non-compliance with protocol|1|||
33150549|NCT00423670|100466816|FG003|Follow-up Period|Non-compliance with protocol|1|||
33150550|NCT00423670|100466817|FG004|Follow-up Period|Non-compliance with protocol|0|||
33150551|NCT00423670|100466818|FG005|Follow-up Period|Non-compliance with protocol|0|||
33150552|NCT00423670|100466819|FG006|Follow-up Period|Non-compliance with protocol|3|||
33150553|NCT00423670|100466820|FG007|Follow-up Period|Non-compliance with protocol|2|||
33150554|NCT03114488|100466821|FG000|Time Period 2|Withdrawal by Subject|1|||
33150555|NCT03114488|100466822|FG001|Time Period 2|Withdrawal by Subject|3|||
33150556|NCT04963231|100466823|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
33150557|NCT04963231|100466824|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
33150558|NCT04963231|100466825|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
33150559|NCT04963231|100466823|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
33150560|NCT04963231|100466824|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
33150561|NCT04963231|100466825|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
33150562|NCT04963231|100466823|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
33150563|NCT04963231|100466824|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
33150564|NCT04963231|100466825|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
33150565|NCT04963231|100466823|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
33150566|NCT04963231|100466824|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
33150567|NCT04963231|100466825|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
33150568|NCT04963231|100466823|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
33150569|NCT04963231|100466824|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
33150570|NCT04963231|100466825|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
33150571|NCT04963231|100466823|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
33150572|NCT04963231|100466824|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
33150573|NCT04963231|100466825|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
33150574|NCT04963231|100466823|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
33150575|NCT04963231|100466824|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
33150576|NCT04963231|100466825|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
33150577|NCT01107418|100466826|FG000|Overall Study|Disease Progression|45|||
33150578|NCT01107418|100466826|FG000|Overall Study|Adverse Event|3|||
33150579|NCT01107418|100466826|FG000|Overall Study|Withdrawal by Subject|1|||
33150580|NCT01107418|100466826|FG000|Overall Study|Study Closing|1|||
33150581|NCT01107418|100466826|FG000|Overall Study|Started Other Therapy|1|||
33150582|NCT01107418|100466826|FG000|Overall Study|Entered Extension Study|1|||
33150583|NCT02943460|100466827|FG000|Blinded Study Phase|Adverse Event|3|||
33150584|NCT02943460|100466828|FG001|Blinded Study Phase|Adverse Event|0|||
33435443|NCT04799158|101488119|FG000|Run-In Period|Withdrawal by Subject|11|||
33435444|NCT04799158|101488120|FG001|Run-In Period|Withdrawal by Subject|0|||
33435445|NCT04799158|101488121|FG002|Run-In Period|Withdrawal by Subject|0|||
33435446|NCT04799158|101488122|FG003|Run-In Period|Withdrawal by Subject|0|||
33435447|NCT04799158|101488123|FG004|Run-In Period|Withdrawal by Subject|0|||
33435448|NCT04799158|101488119|FG000|Run-In Period|Miscellaneous|3|||
33435449|NCT04799158|101488120|FG001|Run-In Period|Miscellaneous|0|||
33435450|NCT04799158|101488121|FG002|Run-In Period|Miscellaneous|0|||
33435451|NCT04799158|101488122|FG003|Run-In Period|Miscellaneous|0|||
33435452|NCT04799158|101488123|FG004|Run-In Period|Miscellaneous|0|||
33435453|NCT04799158|101488119|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
33435454|NCT04799158|101488120|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
33435455|NCT04799158|101488121|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
33435456|NCT04799158|101488122|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
33435457|NCT04799158|101488123|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
33435458|NCT04799158|101488119|FG000|On-Demand Treatment Period|Adverse Event|0|||
33435459|NCT04799158|101488120|FG001|On-Demand Treatment Period|Adverse Event|1|||
33435460|NCT04799158|101488121|FG002|On-Demand Treatment Period|Adverse Event|0|||
33435461|NCT04799158|101488122|FG003|On-Demand Treatment Period|Adverse Event|0|||
33435462|NCT04799158|101488123|FG004|On-Demand Treatment Period|Adverse Event|1|||
33435463|NCT04799158|101488119|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
33435464|NCT04799158|101488120|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
33435465|NCT04799158|101488121|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
33435466|NCT04799158|101488122|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
33435467|NCT04799158|101488123|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
33435468|NCT04799158|101488119|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
33435469|NCT04799158|101488120|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
33435470|NCT04799158|101488121|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
33435471|NCT04799158|101488122|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
33435472|NCT04799158|101488123|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
33435473|NCT04799158|101488119|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
33435474|NCT04799158|101488120|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
33435475|NCT04799158|101488121|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
33435476|NCT04799158|101488122|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
33435477|NCT04799158|101488123|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
33435478|NCT04799158|101488119|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
33435479|NCT04799158|101488120|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
33593983|NCT00837265|102060673|FG000|Main Phase|Participant's personal reason|0|||
33593984|NCT00837265|102060674|FG001|Main Phase|Participant's personal reason|0|||
33593985|NCT00837265|102060675|FG002|Main Phase|Participant's personal reason|0|||
33593986|NCT00837265|102060676|FG003|Main Phase|Participant's personal reason|0|||
33593987|NCT00837265|102060677|FG004|Main Phase|Participant's personal reason|1|||
33593988|NCT00837265|102060678|FG005|Main Phase|Participant's personal reason|0|||
33593989|NCT00837265|102060679|FG006|Main Phase|Participant's personal reason|0|||
33593990|NCT00907803|102060680|FG000|Overall Study|Withdrawal of consent - long commute|1|||
33593991|NCT00907803|102060681|FG001|Overall Study|Withdrawal of consent - long commute|0|||
33593992|NCT00907803|102060682|FG002|Overall Study|Withdrawal of consent - long commute|0|||
33593993|NCT00907803|102060680|FG000|Overall Study|Adverse Event|2|||
33593994|NCT00907803|102060681|FG001|Overall Study|Adverse Event|0|||
33593995|NCT00907803|102060682|FG002|Overall Study|Adverse Event|0|||
33593996|NCT00907803|102060680|FG000|Overall Study|Withdrawal by Subject|0|||
33593997|NCT00907803|102060681|FG001|Overall Study|Withdrawal by Subject|1|||
33593998|NCT00907803|102060682|FG002|Overall Study|Withdrawal by Subject|0|||
33593999|NCT00907803|102060680|FG000|Overall Study|Lost to Follow-up|0|||
33594000|NCT00907803|102060681|FG001|Overall Study|Lost to Follow-up|1|||
33594001|NCT00907803|102060682|FG002|Overall Study|Lost to Follow-up|0|||
33594002|NCT00907803|102060680|FG000|Overall Study|Protocol Violation|0|||
33594003|NCT00907803|102060681|FG001|Overall Study|Protocol Violation|1|||
33594004|NCT00907803|102060682|FG002|Overall Study|Protocol Violation|0|||
33594005|NCT03224507|102060685|FG000|Overall Study|Death|3|||
33594006|NCT03224507|102060686|FG001|Overall Study|Death|0|||
33594007|NCT03224507|102060685|FG000|Overall Study|Lack of Efficacy|6|||
33594008|NCT03224507|102060686|FG001|Overall Study|Lack of Efficacy|0|||
33249922|NCT02236559|100814542|FG000|Overall Study|Withdrawal by Subject|1|||
33594009|NCT03224507|102060685|FG000|Overall Study|Withdrawal by Subject|6|||
33594010|NCT03224507|102060686|FG001|Overall Study|Withdrawal by Subject|0|||
33594011|NCT01349322|102060687|FG000|Overall Study|Protocol Violation|45|||
33594012|NCT01349322|102060688|FG001|Overall Study|Protocol Violation|47|||
33385692|NCT00801892|101299205|FG001|Sham Crossover Period|Lost to Follow-up|2|||
33385693|NCT00571688|101299206|FG000|Overall Study|Lost to Follow-up|3|||
33385694|NCT00571688|101299207|FG001|Overall Study|Lost to Follow-up|6|||
33385695|NCT00571688|101299206|FG000|Overall Study|subject did not tolerate Consta|1|||
33435480|NCT04799158|101488121|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
33435481|NCT04799158|101488122|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
33435482|NCT04799158|101488123|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
33435483|NCT04799158|101488119|FG000|On-Demand Treatment Period|Miscellaneous|0|||
33435484|NCT04799158|101488120|FG001|On-Demand Treatment Period|Miscellaneous|0|||
33435485|NCT04799158|101488121|FG002|On-Demand Treatment Period|Miscellaneous|0|||
33435486|NCT04799158|101488122|FG003|On-Demand Treatment Period|Miscellaneous|0|||
33435487|NCT04799158|101488123|FG004|On-Demand Treatment Period|Miscellaneous|1|||
33435488|NCT01644500|101488124|FG000|Overall Study|Adverse Event|6|||
33435489|NCT01644500|101488125|FG001|Overall Study|Adverse Event|1|||
33435490|NCT01644500|101488126|FG002|Overall Study|Adverse Event|2|||
33435491|NCT01644500|101488124|FG000|Overall Study|Death|0|||
33435492|NCT01644500|101488125|FG001|Overall Study|Death|1|||
33435493|NCT01644500|101488126|FG002|Overall Study|Death|0|||
33435494|NCT01644500|101488124|FG000|Overall Study|Lost to Follow-up|3|||
33435495|NCT01644500|101488125|FG001|Overall Study|Lost to Follow-up|8|||
33435496|NCT01644500|101488126|FG002|Overall Study|Lost to Follow-up|0|||
33435497|NCT01644500|101488124|FG000|Overall Study|Protocol Violation|1|||
33435498|NCT01644500|101488125|FG001|Overall Study|Protocol Violation|1|||
33435499|NCT01644500|101488126|FG002|Overall Study|Protocol Violation|0|||
33435500|NCT01644500|101488124|FG000|Overall Study|Withdrawal by Subject|11|||
33435501|NCT01644500|101488125|FG001|Overall Study|Withdrawal by Subject|12|||
33435502|NCT01644500|101488126|FG002|Overall Study|Withdrawal by Subject|12|||
33435503|NCT01644500|101488124|FG000|Overall Study|Physician Decision|1|||
33435504|NCT01644500|101488125|FG001|Overall Study|Physician Decision|1|||
33435505|NCT01644500|101488126|FG002|Overall Study|Physician Decision|1|||
33435506|NCT02576509|101488129|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
33435507|NCT02576509|101488130|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
33435508|NCT02576509|101488129|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
33435509|NCT02576509|101488130|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
33385696|NCT00571688|101299207|FG001|Overall Study|subject did not tolerate Consta|0|||
33385697|NCT00571688|101299206|FG000|Overall Study|subject moved out of the area|1|||
33385698|NCT00571688|101299207|FG001|Overall Study|subject moved out of the area|0|||
33385699|NCT01467661|101299208|FG000|Overall Study|Adverse Event|16|||
33385700|NCT01467661|101299208|FG000|Overall Study|Withdrawal by Subject|1|||
33385701|NCT01467661|101299208|FG000|Overall Study|Lack of Efficacy|3|||
33435510|NCT02576509|101488129|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
33435511|NCT02576509|101488130|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
33435512|NCT02576509|101488129|FG000|Treatment Period|Disease progression|245|||
33435513|NCT02576509|101488130|FG001|Treatment Period|Disease progression|240|||
33435514|NCT02576509|101488129|FG000|Treatment Period|Study drug toxicity|32|||
33435515|NCT02576509|101488130|FG001|Treatment Period|Study drug toxicity|41|||
33435516|NCT02576509|101488129|FG000|Treatment Period|Death|1|||
33435517|NCT02576509|101488130|FG001|Treatment Period|Death|1|||
33435518|NCT02576509|101488129|FG000|Treatment Period|Adverse event unrelated to study drug|37|||
33435519|NCT02576509|101488130|FG001|Treatment Period|Adverse event unrelated to study drug|40|||
33435520|NCT02576509|101488129|FG000|Treatment Period|Participant request to stop treatment|8|||
33435521|NCT02576509|101488130|FG001|Treatment Period|Participant request to stop treatment|17|||
33435522|NCT02576509|101488129|FG000|Treatment Period|Participant withdrew consent|2|||
33435523|NCT02576509|101488130|FG001|Treatment Period|Participant withdrew consent|7|||
33435524|NCT02576509|101488129|FG000|Treatment Period|Lost to Follow-up|0|||
33435525|NCT02576509|101488130|FG001|Treatment Period|Lost to Follow-up|1|||
33435526|NCT02576509|101488129|FG000|Treatment Period|Maximum clinical benefit|1|||
33435527|NCT02576509|101488130|FG001|Treatment Period|Maximum clinical benefit|0|||
33435528|NCT02576509|101488129|FG000|Treatment Period|Poor/non-compliance|0|||
33435529|NCT02576509|101488130|FG001|Treatment Period|Poor/non-compliance|1|||
33435530|NCT02576509|101488129|FG000|Treatment Period|Participant no longer meets criteria|1|||
33435531|NCT02576509|101488130|FG001|Treatment Period|Participant no longer meets criteria|0|||
33435532|NCT02576509|101488129|FG000|Treatment Period|Other reason|2|||
33435533|NCT02576509|101488130|FG001|Treatment Period|Other reason|7|||
33435534|NCT02576509|101488129|FG000|Follow-up Period|Death|41|||
33435535|NCT02576509|101488130|FG001|Follow-up Period|Death|35|||
33435536|NCT02576509|101488129|FG000|Follow-up Period|Participant withdrew consent|7|||
33435537|NCT02576509|101488130|FG001|Follow-up Period|Participant withdrew consent|14|||
33435538|NCT02576509|101488129|FG000|Follow-up Period|Lost to Follow-up|0|||
33435539|NCT02576509|101488130|FG001|Follow-up Period|Lost to Follow-up|1|||
33435540|NCT02576509|101488129|FG000|Follow-up Period|Other reason|1|||
33594013|NCT02310230|102060691|FG000|Overall Study|Physician Decision|1|||
33594014|NCT02310230|102060692|FG001|Overall Study|Physician Decision|3|||
33594015|NCT02310230|102060691|FG000|Overall Study|monitor baseline taken after induction|2|||
33594016|NCT02310230|102060692|FG001|Overall Study|monitor baseline taken after induction|7|||
33594017|NCT02310230|102060691|FG000|Overall Study|Poor signal quality|5|||
33594018|NCT02310230|102060692|FG001|Overall Study|Poor signal quality|8|||
33594019|NCT02310230|102060691|FG000|Overall Study|Case cancelled|1|||
33594020|NCT02310230|102060692|FG001|Overall Study|Case cancelled|0|||
33594021|NCT00420004|102060695|FG000|Overall Study|Adverse Event|4|||
33594022|NCT00420004|102060696|FG001|Overall Study|Adverse Event|1|||
33594023|NCT00420004|102060697|FG002|Overall Study|Adverse Event|1|||
33594024|NCT00420004|102060695|FG000|Overall Study|Lack of Efficacy|5|||
33594025|NCT00420004|102060696|FG001|Overall Study|Lack of Efficacy|4|||
33594026|NCT00420004|102060697|FG002|Overall Study|Lack of Efficacy|1|||
33594027|NCT00420004|102060695|FG000|Overall Study|Lost to Follow-up|31|||
33594028|NCT00420004|102060696|FG001|Overall Study|Lost to Follow-up|12|||
33594029|NCT00420004|102060697|FG002|Overall Study|Lost to Follow-up|10|||
33594030|NCT00420004|102060695|FG000|Overall Study|Entry Criteria Not Met|0|||
33594031|NCT00420004|102060696|FG001|Overall Study|Entry Criteria Not Met|1|||
33594032|NCT00420004|102060697|FG002|Overall Study|Entry Criteria Not Met|0|||
33594033|NCT00420004|102060695|FG000|Overall Study|Physician Decision|14|||
33594034|NCT00420004|102060696|FG001|Overall Study|Physician Decision|4|||
33594035|NCT00420004|102060697|FG002|Overall Study|Physician Decision|2|||
33594036|NCT00420004|102060695|FG000|Overall Study|Protocol Violation|5|||
33594037|NCT00420004|102060696|FG001|Overall Study|Protocol Violation|4|||
33594038|NCT00420004|102060697|FG002|Overall Study|Protocol Violation|3|||
33594039|NCT00420004|102060695|FG000|Overall Study|Withdrawal by Subject|67|||
33594040|NCT00420004|102060696|FG001|Overall Study|Withdrawal by Subject|42|||
33385702|NCT01467661|101299208|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
33385703|NCT01451398|101299209|FG000|Overall Study|Adverse Event|7|||
33385704|NCT01451398|101299210|FG001|Overall Study|Adverse Event|9|||
33385705|NCT01451398|101299209|FG000|Overall Study|Protocol Violation|1|||
33385706|NCT01451398|101299210|FG001|Overall Study|Protocol Violation|2|||
33385707|NCT01451398|101299209|FG000|Overall Study|Physician Decision|1|||
33385708|NCT01451398|101299210|FG001|Overall Study|Physician Decision|1|||
33385709|NCT01451398|101299209|FG000|Overall Study|Withdrawal by Subject|10|||
33385710|NCT01451398|101299210|FG001|Overall Study|Withdrawal by Subject|14|||
33385711|NCT01451398|101299209|FG000|Overall Study|Lost to Follow-up|6|||
33385712|NCT01451398|101299210|FG001|Overall Study|Lost to Follow-up|4|||
33385713|NCT01451398|101299209|FG000|Overall Study|Non-compliance with study drug|1|||
33385714|NCT01451398|101299210|FG001|Overall Study|Non-compliance with study drug|3|||
33385715|NCT01451398|101299209|FG000|Overall Study|Non-compliance with protocol|1|||
33435541|NCT02576509|101488130|FG001|Follow-up Period|Other reason|2|||
33435542|NCT00777829|101488131|FG000|Overall Study|Withdrawal by Subject|0|||
33435543|NCT00777829|101488132|FG001|Overall Study|Withdrawal by Subject|2|||
33435544|NCT00472290|101488133|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
33594041|NCT00420004|102060697|FG002|Overall Study|Withdrawal by Subject|14|||
33594042|NCT00420004|102060695|FG000|Overall Study|Sponsor Decision|3|||
33594043|NCT00420004|102060696|FG001|Overall Study|Sponsor Decision|3|||
33594044|NCT00420004|102060697|FG002|Overall Study|Sponsor Decision|1|||
33594045|NCT04098367|102060700|FG000|Overall Study|Adverse Event|0|||
33594046|NCT04098367|102060701|FG001|Overall Study|Adverse Event|0|||
33435545|NCT00472290|101488133|FG000|Overall Study|Protocol Specified Criteria|7|||
33435546|NCT00472290|101488133|FG000|Overall Study|Administrative Decision|37|||
33435547|NCT00472290|101488133|FG000|Overall Study|Death|3|||
33435548|NCT00472290|101488133|FG000|Overall Study|Lost to Follow-up|1|||
33435549|NCT00472290|101488133|FG000|Overall Study|Lack of Efficacy|1|||
33435550|NCT00472290|101488133|FG000|Overall Study|Disease Progression|4|||
33435551|NCT00472290|101488133|FG000|Overall Study|Withdrawal by Subject|5|||
33435552|NCT00472290|101488133|FG000|Overall Study|Adverse Event|6|||
33435553|NCT00472290|101488133|FG000|Overall Study|Requirement for alternative therapy|7|||
33435554|NCT00337571|101488134|FG000|Overall Study|Lack of Efficacy|3|||
33435555|NCT00337571|101488135|FG001|Overall Study|Lack of Efficacy|0|||
33435556|NCT00337571|101488136|FG002|Overall Study|Lack of Efficacy|0|||
33435557|NCT00337571|101488137|FG003|Overall Study|Lack of Efficacy|0|||
33435558|NCT00337571|101488134|FG000|Overall Study|Adverse Event|4|||
33435559|NCT00337571|101488135|FG001|Overall Study|Adverse Event|5|||
33435560|NCT00337571|101488136|FG002|Overall Study|Adverse Event|8|||
33435561|NCT00337571|101488137|FG003|Overall Study|Adverse Event|4|||
33435562|NCT00337571|101488134|FG000|Overall Study|Withdrawal by Subject|2|||
33435563|NCT00337571|101488135|FG001|Overall Study|Withdrawal by Subject|2|||
33435564|NCT00337571|101488136|FG002|Overall Study|Withdrawal by Subject|1|||
33435565|NCT00337571|101488137|FG003|Overall Study|Withdrawal by Subject|0|||
33435566|NCT00337571|101488134|FG000|Overall Study|Lost to Follow-up|3|||
33435567|NCT00337571|101488135|FG001|Overall Study|Lost to Follow-up|1|||
33435568|NCT00337571|101488136|FG002|Overall Study|Lost to Follow-up|0|||
33435569|NCT00337571|101488137|FG003|Overall Study|Lost to Follow-up|1|||
33435570|NCT00337571|101488134|FG000|Overall Study|Poor/noncompliance|1|||
33435571|NCT00337571|101488135|FG001|Overall Study|Poor/noncompliance|1|||
33435572|NCT00337571|101488136|FG002|Overall Study|Poor/noncompliance|1|||
33435573|NCT00337571|101488137|FG003|Overall Study|Poor/noncompliance|1|||
33435574|NCT00337571|101488134|FG000|Overall Study|No longer met study criteria|1|||
33435575|NCT00337571|101488135|FG001|Overall Study|No longer met study criteria|0|||
33435576|NCT00337571|101488136|FG002|Overall Study|No longer met study criteria|0|||
33435577|NCT00337571|101488137|FG003|Overall Study|No longer met study criteria|0|||
33435578|NCT00337571|101488134|FG000|Overall Study|High Potassium level|0|||
33435579|NCT00337571|101488135|FG001|Overall Study|High Potassium level|0|||
33435580|NCT00337571|101488136|FG002|Overall Study|High Potassium level|0|||
33435581|NCT00337571|101488137|FG003|Overall Study|High Potassium level|1|||
33435582|NCT00958243|101488138|FG000|Overall Study|Withdrawal by Subject|0|||
33435583|NCT00958243|101488139|FG001|Overall Study|Withdrawal by Subject|1|||
33594047|NCT04098367|102060702|FG002|Overall Study|Adverse Event|1|||
33594048|NCT04098367|102060700|FG000|Overall Study|Lost to Follow-up|1|||
33594049|NCT04098367|102060701|FG001|Overall Study|Lost to Follow-up|5|||
33594050|NCT04098367|102060702|FG002|Overall Study|Lost to Follow-up|2|||
33594051|NCT04098367|102060700|FG000|Overall Study|Withdrawal by Subject|0|||
33594052|NCT04098367|102060701|FG001|Overall Study|Withdrawal by Subject|0|||
33594053|NCT04098367|102060702|FG002|Overall Study|Withdrawal by Subject|1|||
33594054|NCT04098367|102060700|FG000|Overall Study|Sick . Could not attend visit|1|||
33594055|NCT04098367|102060701|FG001|Overall Study|Sick . Could not attend visit|0|||
33594056|NCT04098367|102060702|FG002|Overall Study|Sick . Could not attend visit|0|||
33594057|NCT00129701|102060703|FG000|Overall Study|Withdrawal by Subject|33|||
33594058|NCT02826421|102060704|FG000|Overall Study|Adverse Event|1|||
33594059|NCT02826421|102060705|FG001|Overall Study|Adverse Event|0|||
33594060|NCT02826421|102060706|FG002|Overall Study|Adverse Event|0|||
33594061|NCT02826421|102060707|FG003|Overall Study|Adverse Event|1|||
33594062|NCT02826421|102060704|FG000|Overall Study|Withdrawal by Subject|1|||
33435584|NCT00958243|101488140|FG002|Overall Study|Withdrawal by Subject|3|||
33435585|NCT00958243|101488141|FG003|Overall Study|Withdrawal by Subject|1|||
33435586|NCT00958243|101488142|FG004|Overall Study|Withdrawal by Subject|1|||
33435587|NCT00958243|101488143|FG005|Overall Study|Withdrawal by Subject|5|||
33435588|NCT00958243|101488138|FG000|Overall Study|Lost to Follow-up|2|||
33594063|NCT02826421|102060705|FG001|Overall Study|Withdrawal by Subject|3|||
33594064|NCT02826421|102060706|FG002|Overall Study|Withdrawal by Subject|1|||
33594065|NCT02826421|102060707|FG003|Overall Study|Withdrawal by Subject|1|||
33594066|NCT02826421|102060704|FG000|Overall Study|Reason not given|1|||
33594067|NCT02826421|102060705|FG001|Overall Study|Reason not given|0|||
33594068|NCT02826421|102060706|FG002|Overall Study|Reason not given|1|||
33594069|NCT02826421|102060707|FG003|Overall Study|Reason not given|0|||
33150585|NCT02943460|100466829|FG002|Blinded Study Phase|Adverse Event|0|||
33150586|NCT02943460|100466827|FG000|Blinded Study Phase|Withdrew Consent|0|||
33435589|NCT00958243|101488139|FG001|Overall Study|Lost to Follow-up|5|||
33435590|NCT00958243|101488140|FG002|Overall Study|Lost to Follow-up|11|||
33435591|NCT00958243|101488141|FG003|Overall Study|Lost to Follow-up|2|||
33435592|NCT00958243|101488142|FG004|Overall Study|Lost to Follow-up|8|||
33435593|NCT00958243|101488143|FG005|Overall Study|Lost to Follow-up|5|||
33594070|NCT02182440|102060712|FG000|Overall Study|Adverse Event|0|||
33594071|NCT02182440|102060713|FG001|Overall Study|Adverse Event|1|||
33594072|NCT02182440|102060714|FG002|Overall Study|Adverse Event|0|||
33594073|NCT02182440|102060715|FG003|Overall Study|Adverse Event|0|||
33150587|NCT02943460|100466828|FG001|Blinded Study Phase|Withdrew Consent|1|||
33150588|NCT02943460|100466829|FG002|Blinded Study Phase|Withdrew Consent|0|||
33150589|NCT02943460|100466827|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
33150590|NCT02943460|100466828|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
33150591|NCT02943460|100466829|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
33150592|NCT02943460|100466827|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
33150593|NCT02943460|100466828|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
33150594|NCT02943460|100466829|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
33150595|NCT02943460|100466827|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
33150596|NCT02943460|100466828|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
33150597|NCT02943460|100466829|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
33150598|NCT02719327|100466830|FG000|Overall Study|Withdrawal by Subject|11|||
33150599|NCT02719327|100466831|FG001|Overall Study|Withdrawal by Subject|8|||
33435594|NCT01238848|101488144|FG000|Overall Study|Physician Decision|13|||
33435595|NCT01238848|101488145|FG001|Overall Study|Physician Decision|5|||
33435596|NCT00193609|101488146|FG000|Overall Study|Lack of Efficacy|2|||
33435597|NCT00193609|101488146|FG000|Overall Study|Adverse Event|2|||
33435598|NCT03295721|101488147|FG000|Overall Study|Adverse Event|1|||
33435599|NCT03295721|101488148|FG001|Overall Study|Adverse Event|0|||
33435600|NCT03295721|101488149|FG002|Overall Study|Adverse Event|0|||
33435601|NCT03295721|101488147|FG000|Overall Study|Lost to Follow-up|1|||
33435602|NCT03295721|101488148|FG001|Overall Study|Lost to Follow-up|1|||
33435603|NCT03295721|101488149|FG002|Overall Study|Lost to Follow-up|1|||
33435604|NCT03295721|101488147|FG000|Overall Study|Withdrawal by Subject|1|||
33435605|NCT03295721|101488148|FG001|Overall Study|Withdrawal by Subject|0|||
33435606|NCT03295721|101488149|FG002|Overall Study|Withdrawal by Subject|1|||
33435607|NCT03295721|101488147|FG000|Overall Study|Death|0|||
33435608|NCT03295721|101488148|FG001|Overall Study|Death|0|||
33435609|NCT03295721|101488149|FG002|Overall Study|Death|1|||
33435610|NCT02927847|101488155|FG000|Overall Study|Lost to Follow-up|1|||
33435611|NCT02927847|101488156|FG001|Overall Study|Lost to Follow-up|0|||
33435612|NCT02927847|101488155|FG000|Overall Study|Withdrawal by Subject|4|||
33435613|NCT02927847|101488156|FG001|Overall Study|Withdrawal by Subject|2|||
33435614|NCT02927847|101488155|FG000|Overall Study|PI withdrawn due to missed visits|1|||
33594074|NCT02182440|102060712|FG000|Overall Study|Death|31|||
33594075|NCT02182440|102060713|FG001|Overall Study|Death|8|||
33594076|NCT02182440|102060714|FG002|Overall Study|Death|5|||
33594077|NCT02182440|102060715|FG003|Overall Study|Death|16|||
33594078|NCT02182440|102060712|FG000|Overall Study|Protocol Violation|0|||
33594079|NCT02182440|102060713|FG001|Overall Study|Protocol Violation|1|||
33594080|NCT02182440|102060714|FG002|Overall Study|Protocol Violation|0|||
33594081|NCT02182440|102060715|FG003|Overall Study|Protocol Violation|0|||
33594082|NCT02182440|102060712|FG000|Overall Study|Physician Decision|1|||
33594083|NCT02182440|102060713|FG001|Overall Study|Physician Decision|0|||
33594084|NCT02182440|102060714|FG002|Overall Study|Physician Decision|0|||
33594085|NCT02182440|102060715|FG003|Overall Study|Physician Decision|0|||
33594086|NCT02182440|102060712|FG000|Overall Study|Withdrawal by Subject|1|||
33594087|NCT02182440|102060713|FG001|Overall Study|Withdrawal by Subject|1|||
33594088|NCT02182440|102060714|FG002|Overall Study|Withdrawal by Subject|3|||
33594089|NCT02182440|102060715|FG003|Overall Study|Withdrawal by Subject|4|||
33594090|NCT02182440|102060712|FG000|Overall Study|different, e.g adm other hospital|12|||
33594091|NCT02182440|102060713|FG001|Overall Study|different, e.g adm other hospital|3|||
33594092|NCT02182440|102060714|FG002|Overall Study|different, e.g adm other hospital|3|||
33594093|NCT02182440|102060715|FG003|Overall Study|different, e.g adm other hospital|10|||
33594094|NCT02214225|102060716|FG000|Overall Study|Lost to Follow-up|46|||
33594095|NCT02214225|102060717|FG001|Overall Study|Lost to Follow-up|18|||
33594096|NCT02214225|102060718|FG002|Overall Study|Lost to Follow-up|18|||
33594097|NCT02214225|102060716|FG000|Overall Study|Withdrawal by Subject|2|||
33594098|NCT02214225|102060717|FG001|Overall Study|Withdrawal by Subject|0|||
33594099|NCT02214225|102060718|FG002|Overall Study|Withdrawal by Subject|2|||
33594100|NCT02214225|102060716|FG000|Overall Study|Death|5|||
33594101|NCT02214225|102060717|FG001|Overall Study|Death|0|||
33594102|NCT02214225|102060718|FG002|Overall Study|Death|1|||
33594103|NCT02214225|102060716|FG000|Overall Study|randomized in error, not vaccinated|2|||
33594104|NCT02214225|102060717|FG001|Overall Study|randomized in error, not vaccinated|1|||
33594105|NCT02214225|102060718|FG002|Overall Study|randomized in error, not vaccinated|1|||
33594106|NCT01118520|102060719|FG000|Overall Study|AAA repair|9|||
33594107|NCT01118520|102060720|FG001|Overall Study|AAA repair|7|||
33594108|NCT01118520|102060721|FG002|Overall Study|AAA repair|9|||
33594109|NCT01118520|102060719|FG000|Overall Study|Adverse Event|3|||
33594110|NCT01118520|102060720|FG001|Overall Study|Adverse Event|3|||
33594111|NCT01118520|102060721|FG002|Overall Study|Adverse Event|3|||
33594112|NCT01118520|102060719|FG000|Overall Study|Withdrawal by Subject|8|||
33150600|NCT04073368|100466832|FG000|Overall Study|Adverse Event|2|||
33150601|NCT04073368|100466833|FG001|Overall Study|Adverse Event|0|||
33249923|NCT02236559|100814543|FG001|Overall Study|Withdrawal by Subject|0|||
33249924|NCT00387465|100814544|FG000|Overall Study|Withdrawal by Subject|0|||
33249925|NCT00387465|100814545|FG001|Overall Study|Withdrawal by Subject|1|||
33385716|NCT01451398|101299210|FG001|Overall Study|Non-compliance with protocol|1|||
33385717|NCT01451398|101299209|FG000|Overall Study|Moved out of country|0|||
33385718|NCT01451398|101299210|FG001|Overall Study|Moved out of country|1|||
33385719|NCT01451398|101299209|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
33385720|NCT01451398|101299210|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
33385721|NCT01451398|101299209|FG000|Overall Study|Lack of Efficacy|0|||
33594113|NCT01118520|102060720|FG001|Overall Study|Withdrawal by Subject|13|||
33594114|NCT01118520|102060721|FG002|Overall Study|Withdrawal by Subject|8|||
33594115|NCT04376684|102060722|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
33594116|NCT04376684|102060723|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
33594117|NCT04376684|102060724|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
33594118|NCT04376684|102060725|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
33594119|NCT04376684|102060722|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
33594120|NCT04376684|102060723|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
33594121|NCT04376684|102060724|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
33594122|NCT04376684|102060725|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
33594123|NCT04376684|102060722|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
33594124|NCT04376684|102060723|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
33594125|NCT04376684|102060724|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
33594126|NCT04376684|102060725|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
33594127|NCT04376684|102060722|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
33594128|NCT04376684|102060723|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
33594129|NCT04376684|102060724|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
33594130|NCT04376684|102060725|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
33594131|NCT04376684|102060722|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
33594132|NCT04376684|102060723|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
33594133|NCT04376684|102060724|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
33594134|NCT04376684|102060725|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
33594135|NCT04376684|102060722|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
33594136|NCT04376684|102060723|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
33594137|NCT04376684|102060724|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
33594138|NCT04376684|102060725|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
33594139|NCT04376684|102060722|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
33594140|NCT04376684|102060723|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
33594141|NCT04376684|102060724|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
33594142|NCT04376684|102060725|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
33594143|NCT00496483|102060726|FG000|Overall Study|Not dosed|9|||
33594144|NCT00496483|102060726|FG000|Overall Study|Adverse Event|2|||
33594145|NCT00496483|102060726|FG000|Overall Study|Lack of Efficacy|1|||
33594146|NCT01818258|102060729|FG000|Overall Study|Death|3|||
33385722|NCT01451398|101299210|FG001|Overall Study|Lack of Efficacy|1|||
33385723|NCT00268463|101299211|FG000|Overall Study|study terminated due to low accrual|10|||
33385724|NCT00268463|101299212|FG001|Overall Study|study terminated due to low accrual|12|||
33385725|NCT03039738|101299214|FG000|Overall Study|Incomplete data sets|54|||
33385726|NCT03039738|101299215|FG001|Overall Study|Incomplete data sets|0|||
33385727|NCT04377672|101299216|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
33594147|NCT01818258|102060730|FG001|Overall Study|Death|0|||
33594148|NCT01818258|102060729|FG000|Overall Study|Withdrawal by Subject|0|||
33594149|NCT01818258|102060730|FG001|Overall Study|Withdrawal by Subject|1|||
33594150|NCT01818258|102060729|FG000|Overall Study|Lost to Follow-up|0|||
33150602|NCT04073368|100466834|FG002|Overall Study|Adverse Event|1|||
33150603|NCT04073368|100466835|FG003|Overall Study|Adverse Event|1|||
33594151|NCT01818258|102060730|FG001|Overall Study|Lost to Follow-up|1|||
33594152|NCT01818258|102060729|FG000|Overall Study|Unable to Travel to Clinic|0|||
33594153|NCT01818258|102060730|FG001|Overall Study|Unable to Travel to Clinic|1|||
33594154|NCT00782171|102060732|FG000|Overall Study|Lost to Follow-up|2|||
33594155|NCT00782171|102060733|FG001|Overall Study|Lost to Follow-up|2|||
33150604|NCT04073368|100466832|FG000|Overall Study|Withdrawal by Subject|2|||
33150605|NCT04073368|100466833|FG001|Overall Study|Withdrawal by Subject|2|||
33150606|NCT04073368|100466834|FG002|Overall Study|Withdrawal by Subject|1|||
33150607|NCT04073368|100466835|FG003|Overall Study|Withdrawal by Subject|1|||
33150608|NCT04073368|100466832|FG000|Overall Study|Lost to Follow-up|1|||
33150609|NCT04073368|100466833|FG001|Overall Study|Lost to Follow-up|1|||
33594156|NCT00782171|102060732|FG000|Overall Study|Withdrawal by Subject|2|||
33594157|NCT00782171|102060733|FG001|Overall Study|Withdrawal by Subject|1|||
33594158|NCT00782171|102060732|FG000|Overall Study|complications|3|||
33594159|NCT00782171|102060733|FG001|Overall Study|complications|1|||
33594160|NCT00782171|102060732|FG000|Overall Study|others|7|||
33594161|NCT00782171|102060733|FG001|Overall Study|others|9|||
33594162|NCT00782171|102060732|FG000|Overall Study|not eligible|8|||
33594163|NCT00782171|102060733|FG001|Overall Study|not eligible|6|||
33594164|NCT03425006|102060734|FG000|Overall Study|Withdrawal by Subject|1|||
33594165|NCT03425006|102060734|FG000|Overall Study|Physician Decision|1|||
33594166|NCT03425006|102060734|FG000|Overall Study|Death|1|||
33594167|NCT00813865|102060738|FG000|Overall Study|Failure to Respond|3|||
33594168|NCT00813865|102060738|FG000|Overall Study|Lost to Follow-up|3|||
33594169|NCT00813865|102060738|FG000|Overall Study|Withdrawal by Subject|1|||
33594170|NCT05659719|102060741|FG000|Overall Study|At sponsor's request|0|||
33594171|NCT05659719|102060742|FG001|Overall Study|At sponsor's request|0|||
33594172|NCT05659719|102060743|FG002|Overall Study|At sponsor's request|0|||
33594173|NCT05659719|102060744|FG003|Overall Study|At sponsor's request|95|||
33594174|NCT05659719|102060741|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
33594175|NCT05659719|102060742|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
33594176|NCT05659719|102060743|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
33594177|NCT05659719|102060744|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
33594178|NCT05659719|102060741|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
33594179|NCT05659719|102060742|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
33594180|NCT05659719|102060743|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
33594181|NCT05659719|102060744|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
33150610|NCT04073368|100466834|FG002|Overall Study|Lost to Follow-up|1|||
33150611|NCT04073368|100466835|FG003|Overall Study|Lost to Follow-up|0|||
33150612|NCT04073368|100466832|FG000|Overall Study|Protocol Violation|0|||
33594182|NCT05659719|102060741|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
33385728|NCT02667457|101299217|FG000|Overall Study|Withdrawal by Subject|1|||
33385729|NCT02667457|101299218|FG001|Overall Study|Withdrawal by Subject|0|||
33385730|NCT02667457|101299217|FG000|Overall Study|Other Reason|0|||
33385731|NCT02667457|101299218|FG001|Overall Study|Other Reason|2|||
33385732|NCT00562640|101299219|FG000|Overall Study|Death|0|||
33385733|NCT00562640|101299220|FG001|Overall Study|Death|1|||
33385734|NCT00562640|101299221|FG002|Overall Study|Death|1|||
33150613|NCT04073368|100466833|FG001|Overall Study|Protocol Violation|1|||
33150614|NCT04073368|100466834|FG002|Overall Study|Protocol Violation|0|||
33150615|NCT04073368|100466835|FG003|Overall Study|Protocol Violation|0|||
33150616|NCT04073368|100466832|FG000|Overall Study|Subject noncompliance|7|||
33150617|NCT04073368|100466833|FG001|Overall Study|Subject noncompliance|4|||
33150618|NCT04073368|100466834|FG002|Overall Study|Subject noncompliance|0|||
33150619|NCT04073368|100466835|FG003|Overall Study|Subject noncompliance|0|||
33150620|NCT02595970|100466836|FG000|Overall Study|Withdrawal by Subject|2|||
33150621|NCT02595970|100466836|FG000|Overall Study|Physician Decision|2|||
33150622|NCT02595970|100466836|FG000|Overall Study|Protocol Violation|4|||
33150623|NCT02595970|100466836|FG000|Overall Study|Adverse Event|5|||
33150624|NCT02595970|100466836|FG000|Overall Study|Lack of Efficacy|7|||
33150625|NCT00589290|100466838|FG000|Overall Study|Withdrawal by Subject|1|||
33150626|NCT00751621|100466841|FG000|Overall Study|Adverse Event|1|||
33150627|NCT00751621|100466841|FG000|Overall Study|Withdrawal by Subject|1|||
33150628|NCT00751621|100466841|FG000|Overall Study|Subject moved to another country|1|||
33150629|NCT00751621|100466841|FG000|Overall Study|Poor adherence to asthma treatment|1|||
33150630|NCT00771316|100466847|FG000|Overall Study|Adverse Event|0|||
33150631|NCT00771316|100466848|FG001|Overall Study|Adverse Event|1|||
33150632|NCT00771316|100466847|FG000|Overall Study|Patient withdrew consent|1|||
33150633|NCT00771316|100466848|FG001|Overall Study|Patient withdrew consent|0|||
33150634|NCT00771316|100466847|FG000|Overall Study|Discontinued due to early termination|1|||
33150635|NCT00771316|100466848|FG001|Overall Study|Discontinued due to early termination|0|||
33150636|NCT01484132|100466853|FG000|Overall Study|Lost to Follow-up|8|||
33150637|NCT01484132|100466853|FG000|Overall Study|Difficulty with time commitment|2|||
33150638|NCT01484132|100466853|FG000|Overall Study|Ineligible|1|||
33150639|NCT01484132|100466853|FG000|Overall Study|No pre-treatment urine sample collected|1|||
33150640|NCT01484132|100466853|FG000|Overall Study|No post-treatment urine sample collected|10|||
33150641|NCT05274165|100466855|FG000|Overall Study|Withdrawal by Subject|3|||
33150642|NCT05274165|100466856|FG001|Overall Study|Withdrawal by Subject|3|||
33150643|NCT01011738|100466858|FG000|Overall Study|Death|12|||
33150644|NCT01011738|100466859|FG001|Overall Study|Death|3|||
33150645|NCT01011738|100466860|FG002|Overall Study|Death|0|||
33150646|NCT01011738|100466858|FG000|Overall Study|Unknown reasons|312|||
33150647|NCT01011738|100466859|FG001|Overall Study|Unknown reasons|291|||
33150648|NCT01011738|100466860|FG002|Overall Study|Unknown reasons|17|||
33150649|NCT00445978|100466861|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
33150650|NCT00445978|100466861|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
33150651|NCT00445978|100466861|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
33150652|NCT00445978|100466861|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
33150653|NCT00445978|100466861|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
33150654|NCT00445978|100466861|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
33150655|NCT00445978|100466861|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
33150656|NCT00445978|100466861|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
33150657|NCT00445978|100466861|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
33150658|NCT01555983|100466862|FG000|Overall Study|Withdrawal by Subject|1|||
33150659|NCT01555983|100466863|FG001|Overall Study|Withdrawal by Subject|0|||
33150660|NCT01555983|100466864|FG002|Overall Study|Withdrawal by Subject|0|||
33150661|NCT01555983|100466865|FG003|Overall Study|Withdrawal by Subject|0|||
33594183|NCT05659719|102060742|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
33594184|NCT05659719|102060743|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
33594185|NCT05659719|102060744|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
33594186|NCT05659719|102060741|FG000|Overall Study|Lost to Follow-up|0|||
33594187|NCT05659719|102060742|FG001|Overall Study|Lost to Follow-up|0|||
33594188|NCT05659719|102060743|FG002|Overall Study|Lost to Follow-up|0|||
33594189|NCT05659719|102060744|FG003|Overall Study|Lost to Follow-up|2|||
33150662|NCT01555983|100466866|FG004|Overall Study|Withdrawal by Subject|1|||
33150663|NCT01555983|100466867|FG005|Overall Study|Withdrawal by Subject|1|||
33150664|NCT01282203|100466868|FG000|Overall Study|Adverse Event|1|||
33150665|NCT04041375|100466869|FG000|Intervention Phase|Withdrawal by Subject|2|||
33435615|NCT02927847|101488156|FG001|Overall Study|PI withdrawn due to missed visits|1|||
33594190|NCT05659719|102060741|FG000|Overall Study|Moved to another observational study|0|||
33249926|NCT00387465|100814546|FG002|Overall Study|Withdrawal by Subject|0|||
33385735|NCT00562640|101299222|FG003|Overall Study|Death|0|||
33150666|NCT04041375|100466870|FG001|Intervention Phase|Withdrawal by Subject|2|||
33150667|NCT04041375|100466869|FG000|Follow-up Phase|Death|2|||
33150668|NCT04041375|100466870|FG001|Follow-up Phase|Death|0|||
33385736|NCT01231607|101299223|FG000|Overall Study|Adverse Event|0|||
33385737|NCT01231607|101299224|FG001|Overall Study|Adverse Event|8|||
33385738|NCT01231607|101299225|FG002|Overall Study|Adverse Event|4|||
33385739|NCT01231607|101299226|FG003|Overall Study|Adverse Event|4|||
33385740|NCT01231607|101299227|FG004|Overall Study|Adverse Event|5|||
33385741|NCT01231607|101299223|FG000|Overall Study|Lost to Follow-up|13|||
33385742|NCT01231607|101299224|FG001|Overall Study|Lost to Follow-up|11|||
33385743|NCT01231607|101299225|FG002|Overall Study|Lost to Follow-up|10|||
33385744|NCT01231607|101299226|FG003|Overall Study|Lost to Follow-up|10|||
33385745|NCT01231607|101299227|FG004|Overall Study|Lost to Follow-up|4|||
33385746|NCT01231607|101299223|FG000|Overall Study|Physician Decision|4|||
33385747|NCT01231607|101299224|FG001|Overall Study|Physician Decision|4|||
33385748|NCT01231607|101299225|FG002|Overall Study|Physician Decision|3|||
33385749|NCT01231607|101299226|FG003|Overall Study|Physician Decision|5|||
33385750|NCT01231607|101299227|FG004|Overall Study|Physician Decision|4|||
33385751|NCT01231607|101299223|FG000|Overall Study|Protocol Violation|3|||
33385752|NCT01231607|101299224|FG001|Overall Study|Protocol Violation|2|||
33385753|NCT01231607|101299225|FG002|Overall Study|Protocol Violation|0|||
33385754|NCT01231607|101299226|FG003|Overall Study|Protocol Violation|2|||
33385755|NCT01231607|101299227|FG004|Overall Study|Protocol Violation|2|||
33385756|NCT01231607|101299223|FG000|Overall Study|Withdrawal by Subject|9|||
33385757|NCT01231607|101299224|FG001|Overall Study|Withdrawal by Subject|9|||
33385758|NCT01231607|101299225|FG002|Overall Study|Withdrawal by Subject|14|||
33385759|NCT01231607|101299226|FG003|Overall Study|Withdrawal by Subject|17|||
33385760|NCT01231607|101299227|FG004|Overall Study|Withdrawal by Subject|9|||
33385761|NCT01563107|101299229|FG000|Overall Study|Physician Decision|0|||
33385762|NCT01563107|101299230|FG001|Overall Study|Physician Decision|1|||
33385763|NCT01563107|101299231|FG002|Overall Study|Physician Decision|1|||
33385764|NCT01563107|101299232|FG003|Overall Study|Physician Decision|3|||
33385765|NCT01563107|101299229|FG000|Overall Study|Withdrawal by Subject|1|||
33385766|NCT01563107|101299230|FG001|Overall Study|Withdrawal by Subject|2|||
33385767|NCT01563107|101299231|FG002|Overall Study|Withdrawal by Subject|1|||
33385768|NCT01563107|101299232|FG003|Overall Study|Withdrawal by Subject|2|||
33385769|NCT01135017|101299234|FG000|Overall Study|Adverse Event|3|||
33385770|NCT01135017|101299235|FG001|Overall Study|Adverse Event|8|||
33385771|NCT01135017|101299234|FG000|Overall Study|Other than above|3|||
33385772|NCT01135017|101299235|FG001|Overall Study|Other than above|4|||
33385773|NCT03310580|101299237|FG000|Overall Study|Adverse Event|0|||
33435616|NCT00958256|101488159|FG000|Overall Study|Adverse Event|3|||
33435617|NCT01867242|101488163|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
33594191|NCT05659719|102060742|FG001|Overall Study|Moved to another observational study|0|||
33594192|NCT05659719|102060743|FG002|Overall Study|Moved to another observational study|0|||
33594193|NCT05659719|102060744|FG003|Overall Study|Moved to another observational study|1|||
33594194|NCT05659719|102060741|FG000|Overall Study|The child was enrolled in an interventional study|0|||
33594195|NCT05659719|102060742|FG001|Overall Study|The child was enrolled in an interventional study|0|||
33594196|NCT05659719|102060743|FG002|Overall Study|The child was enrolled in an interventional study|0|||
33594197|NCT05659719|102060744|FG003|Overall Study|The child was enrolled in an interventional study|55|||
33594198|NCT05659719|102060741|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
33594199|NCT05659719|102060742|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
33594200|NCT05659719|102060743|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
33594201|NCT05659719|102060744|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
33594202|NCT05659719|102060741|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
33594203|NCT05659719|102060742|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
33594204|NCT05659719|102060743|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
33150669|NCT04041375|100466869|FG000|Follow-up Phase|Lost to Follow-up|2|||
33150670|NCT04041375|100466870|FG001|Follow-up Phase|Lost to Follow-up|1|||
33385774|NCT03310580|101299238|FG001|Overall Study|Adverse Event|1|||
33435618|NCT01867242|101488164|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
33150671|NCT04041375|100466869|FG000|Follow-up Phase|Too ill|3|||
33385775|NCT03310580|101299239|FG002|Overall Study|Adverse Event|0|||
33385776|NCT05159362|101299240|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
33385777|NCT05159362|101299241|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
33385778|NCT05159362|101299242|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
33385779|NCT01929707|101299243|FG000|Intervention Period 1|Lost to Follow-up|0|||
33385780|NCT01929707|101299244|FG001|Intervention Period 1|Lost to Follow-up|0|||
33435619|NCT01867242|101488165|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
33150672|NCT04041375|100466870|FG001|Follow-up Phase|Too ill|0|||
33150673|NCT03894046|100466872|FG000|Overall Study|Protocol Violation|1|||
33594205|NCT05659719|102060744|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
33150674|NCT03894046|100466873|FG001|Overall Study|Protocol Violation|0|||
33150675|NCT03894046|100466874|FG002|Overall Study|Protocol Violation|0|||
33150676|NCT03894046|100466872|FG000|Overall Study|Adverse Event|0|||
33150677|NCT03894046|100466873|FG001|Overall Study|Adverse Event|1|||
33150678|NCT03894046|100466874|FG002|Overall Study|Adverse Event|0|||
33150679|NCT03894046|100466872|FG000|Overall Study|Withdrawal by Subject|2|||
33150680|NCT03894046|100466873|FG001|Overall Study|Withdrawal by Subject|3|||
33150681|NCT03894046|100466874|FG002|Overall Study|Withdrawal by Subject|1|||
33150682|NCT03894046|100466872|FG000|Overall Study|Death|15|||
33150683|NCT03894046|100466873|FG001|Overall Study|Death|21|||
33150684|NCT03894046|100466874|FG002|Overall Study|Death|4|||
33150685|NCT03894046|100466872|FG000|Overall Study|No growth of ABC|2|||
33150686|NCT03894046|100466873|FG001|Overall Study|No growth of ABC|1|||
33150687|NCT03894046|100466874|FG002|Overall Study|No growth of ABC|0|||
33150688|NCT03894046|100466872|FG000|Overall Study|Physician Decision|1|||
33150689|NCT03894046|100466873|FG001|Overall Study|Physician Decision|1|||
33150690|NCT03894046|100466874|FG002|Overall Study|Physician Decision|1|||
33150691|NCT03894046|100466872|FG000|Overall Study|Prohibited concomitant medication|1|||
33150692|NCT03894046|100466873|FG001|Overall Study|Prohibited concomitant medication|0|||
33150693|NCT03894046|100466874|FG002|Overall Study|Prohibited concomitant medication|0|||
33150694|NCT03894046|100466872|FG000|Overall Study|Transferred to other arm/group|1|||
33150695|NCT03894046|100466873|FG001|Overall Study|Transferred to other arm/group|1|||
33150696|NCT03894046|100466874|FG002|Overall Study|Transferred to other arm/group|0|||
33150697|NCT02556203|100466880|FG000|Overall Study|Withdrawal by Subject|21|||
33150698|NCT02556203|100466881|FG001|Overall Study|Withdrawal by Subject|21|||
33150699|NCT02556203|100466880|FG000|Overall Study|Lost to Follow-up|5|||
33150700|NCT02556203|100466881|FG001|Overall Study|Lost to Follow-up|5|||
33150701|NCT02556203|100466880|FG000|Overall Study|Adverse Event|1|||
33150702|NCT02556203|100466881|FG001|Overall Study|Adverse Event|0|||
33150703|NCT01869725|100466882|FG000|Overall Study|ineligible after registration|1|||
33150704|NCT01869725|100466882|FG000|Overall Study|Death|1|||
33150705|NCT01869725|100466882|FG000|Overall Study|Lost to Follow-up|2|||
33150706|NCT01675427|100466886|FG000|Overall Study|Withdrawal by Subject|7|||
33150707|NCT01675427|100466886|FG000|Overall Study|Participant Refused Sample Collection|18|||
33150708|NCT01675427|100466886|FG000|Overall Study|Sample not Collected by Mistake|2|||
33385781|NCT01929707|101299245|FG002|Intervention Period 1|Lost to Follow-up|0|||
33385782|NCT01929707|101299246|FG003|Intervention Period 1|Lost to Follow-up|1|||
33385783|NCT01929707|101299247|FG004|Intervention Period 1|Lost to Follow-up|0|||
33385784|NCT01929707|101299248|FG005|Intervention Period 1|Lost to Follow-up|0|||
33385785|NCT01929707|101299249|FG006|Intervention Period 1|Lost to Follow-up|0|||
33385786|NCT01929707|101299250|FG007|Intervention Period 1|Lost to Follow-up|0|||
33385787|NCT01929707|101299243|FG000|Intervention Period 1|Withdrawal by Subject|0|||
33385788|NCT01929707|101299244|FG001|Intervention Period 1|Withdrawal by Subject|0|||
33385789|NCT01929707|101299245|FG002|Intervention Period 1|Withdrawal by Subject|0|||
33385790|NCT01929707|101299246|FG003|Intervention Period 1|Withdrawal by Subject|2|||
33385791|NCT01929707|101299247|FG004|Intervention Period 1|Withdrawal by Subject|0|||
33150709|NCT01675427|100466886|FG000|Overall Study|Lost to Follow-up|5|||
33150710|NCT01675427|100466886|FG000|Overall Study|Other|2|||
33150711|NCT04950166|100466892|FG000|Overall Study|Withdrawal by Subject|1|||
33150712|NCT02869438|100466893|FG000|Overall Study|Lost to Follow-up|1|||
33150713|NCT02869438|100466894|FG001|Overall Study|Lost to Follow-up|0|||
33385792|NCT01929707|101299248|FG005|Intervention Period 1|Withdrawal by Subject|0|||
33385793|NCT01929707|101299249|FG006|Intervention Period 1|Withdrawal by Subject|0|||
33594206|NCT01425359|102060745|FG000|Overall Study|Randomized but Not Treated|2|||
33150714|NCT02869438|100466893|FG000|Overall Study|Adverse Event|1|||
33150715|NCT02869438|100466894|FG001|Overall Study|Adverse Event|0|||
33150716|NCT02869438|100466893|FG000|Overall Study|Withdrawal by Subject|1|||
33150717|NCT02869438|100466894|FG001|Overall Study|Withdrawal by Subject|2|||
33150718|NCT01067976|100466901|FG000|Overall Study|Study drug never administered|20|||
33385794|NCT01929707|101299250|FG007|Intervention Period 1|Withdrawal by Subject|0|||
33385795|NCT01929707|101299243|FG000|Intervention Period 2|Withdrawal by Subject|0|||
33594207|NCT01425359|102060746|FG001|Overall Study|Randomized but Not Treated|3|||
33150719|NCT01067976|100466901|FG000|Overall Study|Study prematurely discontinued|2|||
33150720|NCT00122278|100466906|FG000|Overall Study|Lost to Follow-up|2|||
33249927|NCT01235949|100814550|FG000|Primary Phase|Migrated/moved from study area|1|||
33249928|NCT01235949|100814551|FG001|Primary Phase|Migrated/moved from study area|1|||
33249929|NCT01235949|100814552|FG002|Primary Phase|Migrated/moved from study area|0|||
33249930|NCT01235949|100814553|FG003|Primary Phase|Migrated/moved from study area|0|||
33435620|NCT03038113|101488166|FG000|Overall Study|Withdrawal by Subject|0|||
33435621|NCT03038113|101488167|FG001|Overall Study|Withdrawal by Subject|0|||
33435622|NCT03038113|101488168|FG002|Overall Study|Withdrawal by Subject|1|||
33435623|NCT03038113|101488169|FG003|Overall Study|Withdrawal by Subject|0|||
33435624|NCT03038113|101488170|FG004|Overall Study|Withdrawal by Subject|0|||
33435625|NCT03038113|101488171|FG005|Overall Study|Withdrawal by Subject|0|||
33435626|NCT03038113|101488172|FG006|Overall Study|Withdrawal by Subject|0|||
33435627|NCT03038113|101488173|FG007|Overall Study|Withdrawal by Subject|0|||
33435628|NCT03038113|101488174|FG008|Overall Study|Withdrawal by Subject|0|||
33435629|NCT03038113|101488175|FG009|Overall Study|Withdrawal by Subject|0|||
33435630|NCT03038113|101488176|FG010|Overall Study|Withdrawal by Subject|0|||
33435631|NCT03038113|101488177|FG011|Overall Study|Withdrawal by Subject|0|||
33435632|NCT03038113|101488178|FG012|Overall Study|Withdrawal by Subject|0|||
33435633|NCT03038113|101488179|FG013|Overall Study|Withdrawal by Subject|1|||
33435634|NCT03038113|101488166|FG000|Overall Study|Lost to Follow-up|0|||
33435635|NCT03038113|101488167|FG001|Overall Study|Lost to Follow-up|0|||
33435636|NCT03038113|101488168|FG002|Overall Study|Lost to Follow-up|0|||
33435637|NCT03038113|101488169|FG003|Overall Study|Lost to Follow-up|0|||
33435638|NCT03038113|101488170|FG004|Overall Study|Lost to Follow-up|0|||
33435639|NCT03038113|101488171|FG005|Overall Study|Lost to Follow-up|0|||
33150721|NCT00122278|100466907|FG001|Overall Study|Lost to Follow-up|0|||
33150722|NCT05036369|100466908|FG000|Overall Study|Run In non compliance|1|||
33150723|NCT05036369|100466909|FG001|Overall Study|Run In non compliance|2|||
33150724|NCT05036369|100466908|FG000|Overall Study|Change in eligibility criteria|0|||
33150725|NCT05036369|100466909|FG001|Overall Study|Change in eligibility criteria|1|||
33150726|NCT00986479|100466911|FG000|Period 1|Improved mood|1|||
33150727|NCT00986479|100466912|FG001|Period 1|Improved mood|0|||
33150728|NCT00986479|100466911|FG000|Period 1|Administrative reasons|1|||
33150729|NCT00986479|100466912|FG001|Period 1|Administrative reasons|0|||
33150730|NCT01199731|100466913|FG000|Overall Study|Adverse Event|0|||
33150731|NCT01199731|100466914|FG001|Overall Study|Adverse Event|1|||
33249931|NCT01235949|100814554|FG004|Primary Phase|Migrated/moved from study area|1|||
33249932|NCT01235949|100814555|FG005|Primary Phase|Migrated/moved from study area|2|||
33249933|NCT01235949|100814556|FG006|Primary Phase|Migrated/moved from study area|0|||
33249934|NCT01235949|100814557|FG007|Primary Phase|Migrated/moved from study area|0|||
33249935|NCT01235949|100814558|FG008|Primary Phase|Migrated/moved from study area|0|||
33435640|NCT03038113|101488172|FG006|Overall Study|Lost to Follow-up|1|||
33435641|NCT03038113|101488173|FG007|Overall Study|Lost to Follow-up|0|||
33150732|NCT01199731|100466915|FG002|Overall Study|Adverse Event|0|||
33435642|NCT03038113|101488174|FG008|Overall Study|Lost to Follow-up|0|||
33435643|NCT03038113|101488175|FG009|Overall Study|Lost to Follow-up|0|||
33150733|NCT01199731|100466913|FG000|Overall Study|Study closed/terminated|7|||
33150734|NCT01199731|100466914|FG001|Overall Study|Study closed/terminated|9|||
33249936|NCT01235949|100814559|FG009|Primary Phase|Migrated/moved from study area|0|||
33249937|NCT01235949|100814560|FG010|Primary Phase|Migrated/moved from study area|0|||
33435644|NCT03038113|101488176|FG010|Overall Study|Lost to Follow-up|0|||
33435645|NCT03038113|101488177|FG011|Overall Study|Lost to Follow-up|0|||
33150735|NCT01199731|100466915|FG002|Overall Study|Study closed/terminated|7|||
33150736|NCT01199731|100466913|FG000|Overall Study|Lost to Follow-up|0|||
33150737|NCT01199731|100466914|FG001|Overall Study|Lost to Follow-up|0|||
33150738|NCT01199731|100466915|FG002|Overall Study|Lost to Follow-up|2|||
33150739|NCT01199731|100466913|FG000|Overall Study|Physician Decision|0|||
33150740|NCT01199731|100466914|FG001|Overall Study|Physician Decision|1|||
33150741|NCT01199731|100466915|FG002|Overall Study|Physician Decision|1|||
33150742|NCT01199731|100466913|FG000|Overall Study|Withdrawal by Subject|2|||
33150743|NCT01199731|100466914|FG001|Overall Study|Withdrawal by Subject|0|||
33150744|NCT01199731|100466915|FG002|Overall Study|Withdrawal by Subject|0|||
33594208|NCT01425359|102060745|FG000|Overall Study|Adverse Event|9|||
33594209|NCT01425359|102060746|FG001|Overall Study|Adverse Event|8|||
33594210|NCT01425359|102060745|FG000|Overall Study|Revascularization|0|||
33594211|NCT01425359|102060746|FG001|Overall Study|Revascularization|1|||
33594212|NCT01425359|102060745|FG000|Overall Study|Death|0|||
33594213|NCT01425359|102060746|FG001|Overall Study|Death|1|||
33594214|NCT01425359|102060745|FG000|Overall Study|Unsatisfactory Response|1|||
33594215|NCT01425359|102060746|FG001|Overall Study|Unsatisfactory Response|0|||
33594216|NCT01425359|102060745|FG000|Overall Study|Protocol Violation|1|||
33594217|NCT01425359|102060746|FG001|Overall Study|Protocol Violation|2|||
33594218|NCT01425359|102060745|FG000|Overall Study|Subject Withdrew Consent|1|||
33594219|NCT01425359|102060746|FG001|Overall Study|Subject Withdrew Consent|2|||
33594220|NCT01425359|102060745|FG000|Overall Study|Investigator's Discretion|2|||
33594221|NCT01425359|102060746|FG001|Overall Study|Investigator's Discretion|0|||
33594222|NCT01425359|102060745|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
33594223|NCT01425359|102060746|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
33594224|NCT00559845|102060749|FG000|Overall Study|Withdrew Consent|1|||
33594225|NCT00559845|102060749|FG000|Overall Study|Disease Progression|1|||
33150745|NCT02611037|100466916|FG000|Overall Study|Withdrawal prior to treatment|2|||
33150746|NCT02611037|100466917|FG001|Overall Study|Withdrawal prior to treatment|0|||
33150747|NCT04521777|100466918|FG000|Overall Study|Death|2|||
33150748|NCT04521777|100466918|FG000|Overall Study|Withdrawal by Subject|2|||
33594226|NCT00559845|102060749|FG000|Overall Study|Adverse Event|3|||
33594227|NCT00559845|102060749|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
33150749|NCT01570868|100466921|FG000|Overall Study|Adverse Event|8|||
33150750|NCT01570868|100466922|FG001|Overall Study|Adverse Event|1|||
33150751|NCT01570868|100466921|FG000|Overall Study|FDA Recommendation|23|||
33594228|NCT00559845|102060749|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
33594229|NCT00790868|102060752|FG000|Overall Study|Withdrawal by Subject|4|||
33594230|NCT00790868|102060753|FG001|Overall Study|Withdrawal by Subject|5|||
33385796|NCT01929707|101299244|FG001|Intervention Period 2|Withdrawal by Subject|0|||
33435646|NCT03038113|101488178|FG012|Overall Study|Lost to Follow-up|0|||
33435647|NCT03038113|101488179|FG013|Overall Study|Lost to Follow-up|0|||
33435648|NCT00718159|101488180|FG000|Overall Study|Progressive Disease|3|||
33435649|NCT00718159|101488181|FG001|Overall Study|Progressive Disease|3|||
33435650|NCT00718159|101488182|FG002|Overall Study|Progressive Disease|2|||
33435651|NCT00718159|101488183|FG003|Overall Study|Progressive Disease|0|||
33594231|NCT00790868|102060752|FG000|Overall Study|Lost to Follow-up|2|||
33594232|NCT00790868|102060753|FG001|Overall Study|Lost to Follow-up|12|||
33594233|NCT03215758|102060761|FG000|Overall Study|Technical Problems|1|||
33594234|NCT03215758|102060762|FG001|Overall Study|Technical Problems|0|||
33594235|NCT03215758|102060761|FG000|Overall Study|Protocol deviation|0|||
33594236|NCT03215758|102060762|FG001|Overall Study|Protocol deviation|1|||
33594237|NCT03215758|102060761|FG000|Overall Study|Physician Decision|0|||
33594238|NCT03215758|102060762|FG001|Overall Study|Physician Decision|1|||
33594239|NCT03215758|102060761|FG000|Overall Study|Death|0|||
33594240|NCT03215758|102060762|FG001|Overall Study|Death|1|||
33385797|NCT01929707|101299245|FG002|Intervention Period 2|Withdrawal by Subject|0|||
33385798|NCT01929707|101299246|FG003|Intervention Period 2|Withdrawal by Subject|0|||
33385799|NCT01929707|101299247|FG004|Intervention Period 2|Withdrawal by Subject|0|||
33385800|NCT01929707|101299248|FG005|Intervention Period 2|Withdrawal by Subject|2|||
33385801|NCT01929707|101299249|FG006|Intervention Period 2|Withdrawal by Subject|0|||
33385802|NCT01929707|101299250|FG007|Intervention Period 2|Withdrawal by Subject|0|||
33385803|NCT04095442|101299251|FG000|Overall Study|Lost to Follow-up|0|||
33385804|NCT04095442|101299252|FG001|Overall Study|Lost to Follow-up|1|||
33385805|NCT04095442|101299251|FG000|Overall Study|Screen failure|1|||
33385806|NCT04095442|101299252|FG001|Overall Study|Screen failure|0|||
33435652|NCT00718159|101488184|FG004|Overall Study|Progressive Disease|6|||
33594241|NCT03215758|102060761|FG000|Overall Study|Adverse Event|1|||
33385807|NCT03205982|101299253|FG000|Overall Study|Lost to Follow-up|20|||
33385808|NCT03205982|101299254|FG001|Overall Study|Lost to Follow-up|19|||
33594242|NCT03215758|102060762|FG001|Overall Study|Adverse Event|2|||
33594243|NCT03215758|102060761|FG000|Overall Study|Subject/Guardian Decision|3|||
33150752|NCT01570868|100466922|FG001|Overall Study|FDA Recommendation|3|||
33150753|NCT01570868|100466921|FG000|Overall Study|Physician Decision|10|||
33435653|NCT00718159|101488185|FG005|Overall Study|Progressive Disease|0|||
33435654|NCT00718159|101488186|FG006|Overall Study|Progressive Disease|0|||
33435655|NCT00718159|101488180|FG000|Overall Study|Death due to Adverse Event|0|||
33435656|NCT00718159|101488181|FG001|Overall Study|Death due to Adverse Event|0|||
33435657|NCT00718159|101488182|FG002|Overall Study|Death due to Adverse Event|0|||
33435658|NCT00718159|101488183|FG003|Overall Study|Death due to Adverse Event|2|||
33435659|NCT00718159|101488184|FG004|Overall Study|Death due to Adverse Event|2|||
33435660|NCT00718159|101488185|FG005|Overall Study|Death due to Adverse Event|0|||
33435661|NCT00718159|101488186|FG006|Overall Study|Death due to Adverse Event|0|||
33435662|NCT00718159|101488180|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
33435663|NCT00718159|101488181|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
33435664|NCT00718159|101488182|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
33435665|NCT00718159|101488183|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
33435666|NCT00718159|101488184|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
33435667|NCT00718159|101488185|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
33435668|NCT00718159|101488186|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
33435669|NCT00718159|101488180|FG000|Overall Study|Investigator Decision|0|||
33435670|NCT00718159|101488181|FG001|Overall Study|Investigator Decision|0|||
33435671|NCT00718159|101488182|FG002|Overall Study|Investigator Decision|0|||
33435672|NCT00718159|101488183|FG003|Overall Study|Investigator Decision|0|||
33435673|NCT00718159|101488184|FG004|Overall Study|Investigator Decision|0|||
33435674|NCT00718159|101488185|FG005|Overall Study|Investigator Decision|1|||
33435675|NCT00718159|101488186|FG006|Overall Study|Investigator Decision|1|||
33435676|NCT04591626|101488187|FG000|Overall Study|Adverse Event|4|||
33435677|NCT04591626|101488188|FG001|Overall Study|Adverse Event|0|||
33435678|NCT04591626|101488187|FG000|Overall Study|Withdrawal by Subject|5|||
33435679|NCT04591626|101488188|FG001|Overall Study|Withdrawal by Subject|3|||
33435680|NCT04591626|101488187|FG000|Overall Study|Physician Decision|0|||
33435681|NCT04591626|101488188|FG001|Overall Study|Physician Decision|1|||
33435682|NCT04591626|101488187|FG000|Overall Study|Death|0|||
33435683|NCT04591626|101488188|FG001|Overall Study|Death|1|||
33435684|NCT04591626|101488187|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33150754|NCT01570868|100466922|FG001|Overall Study|Physician Decision|4|||
33150755|NCT01570868|100466921|FG000|Overall Study|Lost to Follow-up|1|||
33150756|NCT01570868|100466922|FG001|Overall Study|Lost to Follow-up|0|||
33249938|NCT01235949|100814561|FG011|Primary Phase|Migrated/moved from study area|0|||
33435685|NCT04591626|101488188|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33435686|NCT04700449|101488190|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
33435687|NCT04700449|101488191|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
33594244|NCT03215758|102060762|FG001|Overall Study|Subject/Guardian Decision|3|||
33150757|NCT01570868|100466921|FG000|Overall Study|Withdrawal by Subject|1|||
33150758|NCT01570868|100466922|FG001|Overall Study|Withdrawal by Subject|0|||
33150759|NCT00950911|100466925|FG000|Overall Study|Adverse Event|0|||
33150760|NCT00950911|100466926|FG001|Overall Study|Adverse Event|2|||
33150761|NCT00950911|100466925|FG000|Overall Study|Death|4|||
33150762|NCT00950911|100466926|FG001|Overall Study|Death|6|||
33249939|NCT01235949|100814562|FG012|Primary Phase|Migrated/moved from study area|0|||
33150763|NCT00950911|100466925|FG000|Overall Study|Disease progression|2|||
33150764|NCT00950911|100466926|FG001|Overall Study|Disease progression|2|||
33150765|NCT00950911|100466925|FG000|Overall Study|Consent withdrawn|1|||
33150766|NCT00950911|100466926|FG001|Overall Study|Consent withdrawn|3|||
33435688|NCT04700449|101488192|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
33435689|NCT04700449|101488193|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
33435690|NCT04700449|101488190|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
33435691|NCT04700449|101488191|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
33435692|NCT04700449|101488192|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
33435693|NCT04700449|101488193|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
33435694|NCT04700449|101488190|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
33435695|NCT04700449|101488191|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
33435696|NCT04700449|101488192|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
33435697|NCT04700449|101488193|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
33435698|NCT04700449|101488190|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
33150767|NCT00950911|100466925|FG000|Overall Study|Administrative decision|3|||
33150768|NCT00950911|100466926|FG001|Overall Study|Administrative decision|1|||
33150769|NCT00950911|100466925|FG000|Overall Study|Ineligibility determined|1|||
33385809|NCT03205982|101299253|FG000|Overall Study|Withdrawal by Subject|4|||
33385810|NCT03205982|101299254|FG001|Overall Study|Withdrawal by Subject|3|||
33385811|NCT03205982|101299253|FG000|Overall Study|Withdrawal by PI|0|||
33385812|NCT03205982|101299254|FG001|Overall Study|Withdrawal by PI|1|||
33385813|NCT00435994|101299255|FG000|Overall Study|Lost to Follow-up|7|||
33385814|NCT00435994|101299256|FG001|Overall Study|Lost to Follow-up|0|||
33385815|NCT00435994|101299257|FG002|Overall Study|Lost to Follow-up|0|||
33385816|NCT02759562|101299258|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
33385817|NCT02759562|101299259|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
33385818|NCT02759562|101299258|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
33385819|NCT02759562|101299259|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
33385820|NCT00438464|101299269|FG000|Overall Study|Terminated Early|14|||
33385821|NCT00438464|101299270|FG001|Overall Study|Terminated Early|5|||
33385822|NCT00438464|101299269|FG000|Overall Study|Incomplete data submission|0|||
33385823|NCT00438464|101299270|FG001|Overall Study|Incomplete data submission|2|||
33385824|NCT01167153|101299271|FG000|Overall Study|Non-effective therapy|1|||
33385825|NCT01167153|101299272|FG001|Overall Study|Non-effective therapy|4|||
33385826|NCT01167153|101299271|FG000|Overall Study|AE including clinical laboratory AE|2|||
33385827|NCT01167153|101299272|FG001|Overall Study|AE including clinical laboratory AE|8|||
33385828|NCT01167153|101299271|FG000|Overall Study|Hypotension|1|||
33385829|NCT01167153|101299272|FG001|Overall Study|Hypotension|0|||
33385830|NCT01167153|101299271|FG000|Overall Study|Lost to Follow-up|7|||
33385831|NCT01167153|101299272|FG001|Overall Study|Lost to Follow-up|9|||
33385832|NCT01167153|101299271|FG000|Overall Study|Non-compliance to concomitant medication|0|||
33385833|NCT01167153|101299272|FG001|Overall Study|Non-compliance to concomitant medication|2|||
33385834|NCT01167153|101299271|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
33385835|NCT01167153|101299272|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
33385836|NCT01167153|101299271|FG000|Overall Study|Withdrawal consent|1|||
33385837|NCT01167153|101299272|FG001|Overall Study|Withdrawal consent|1|||
33385838|NCT01167153|101299271|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
33385839|NCT01167153|101299272|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
33385840|NCT01001234|101299273|FG000|Overall Study|Withdrawal by Subject|2|||
33385841|NCT01001234|101299274|FG001|Overall Study|Withdrawal by Subject|0|||
33385842|NCT01001234|101299275|FG002|Overall Study|Withdrawal by Subject|3|||
33385843|NCT01001234|101299276|FG003|Overall Study|Withdrawal by Subject|0|||
33385844|NCT01001234|101299277|FG004|Overall Study|Withdrawal by Subject|0|||
33385845|NCT01001234|101299273|FG000|Overall Study|Protocol Violation|34|||
33385846|NCT01001234|101299274|FG001|Overall Study|Protocol Violation|3|||
33385847|NCT01001234|101299275|FG002|Overall Study|Protocol Violation|19|||
33385848|NCT01001234|101299276|FG003|Overall Study|Protocol Violation|18|||
33385849|NCT01001234|101299277|FG004|Overall Study|Protocol Violation|0|||
33385850|NCT01001234|101299273|FG000|Overall Study|Lost to Follow-up|0|||
33385851|NCT01001234|101299274|FG001|Overall Study|Lost to Follow-up|0|||
33385852|NCT01001234|101299275|FG002|Overall Study|Lost to Follow-up|1|||
33385853|NCT01001234|101299276|FG003|Overall Study|Lost to Follow-up|2|||
33385854|NCT01001234|101299277|FG004|Overall Study|Lost to Follow-up|0|||
33385855|NCT01001234|101299273|FG000|Overall Study|Physician Decision|1|||
33385856|NCT01001234|101299274|FG001|Overall Study|Physician Decision|0|||
33385857|NCT01001234|101299275|FG002|Overall Study|Physician Decision|0|||
33385858|NCT01001234|101299276|FG003|Overall Study|Physician Decision|0|||
33385859|NCT01001234|101299277|FG004|Overall Study|Physician Decision|0|||
33385860|NCT01001234|101299273|FG000|Overall Study|Not Treated: Adverse Event|1|||
33385861|NCT01001234|101299274|FG001|Overall Study|Not Treated: Adverse Event|0|||
33385862|NCT01001234|101299275|FG002|Overall Study|Not Treated: Adverse Event|0|||
33385863|NCT01001234|101299276|FG003|Overall Study|Not Treated: Adverse Event|0|||
33385864|NCT01001234|101299277|FG004|Overall Study|Not Treated: Adverse Event|0|||
33385865|NCT01001234|101299273|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
33385866|NCT01001234|101299274|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
33385867|NCT01001234|101299275|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
33435699|NCT04700449|101488191|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
33150770|NCT00950911|100466926|FG001|Overall Study|Ineligibility determined|0|||
33249940|NCT01235949|100814563|FG013|Primary Phase|Migrated/moved from study area|0|||
33249941|NCT01235949|100814564|FG014|Primary Phase|Migrated/moved from study area|0|||
33435700|NCT04700449|101488192|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
33435701|NCT04700449|101488193|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
33435702|NCT04700449|101488190|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
33435703|NCT04700449|101488191|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
33435704|NCT04700449|101488192|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
33435705|NCT04700449|101488193|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
33435706|NCT04700449|101488190|FG000|Stage 1: Double-Blind Period|Other|0|||
33435707|NCT04700449|101488191|FG001|Stage 1: Double-Blind Period|Other|0|||
33435708|NCT04700449|101488192|FG002|Stage 1: Double-Blind Period|Other|1|||
33435709|NCT04700449|101488193|FG003|Stage 1: Double-Blind Period|Other|0|||
33435710|NCT04700449|101488190|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
33435711|NCT04700449|101488191|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
33435712|NCT04700449|101488192|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
33435713|NCT04700449|101488193|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
33435714|NCT04700449|101488190|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
33385868|NCT01001234|101299276|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
33385869|NCT01001234|101299277|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
33385870|NCT01001234|101299273|FG000|Overall Study|Not Treated: Protocol Violation|3|||
33385871|NCT01001234|101299274|FG001|Overall Study|Not Treated: Protocol Violation|0|||
33385872|NCT01001234|101299275|FG002|Overall Study|Not Treated: Protocol Violation|0|||
33385873|NCT01001234|101299276|FG003|Overall Study|Not Treated: Protocol Violation|0|||
33249942|NCT01235949|100814565|FG015|Primary Phase|Migrated/moved from study area|0|||
33385874|NCT01001234|101299277|FG004|Overall Study|Not Treated: Protocol Violation|0|||
33150771|NCT00950911|100466925|FG000|Overall Study|Noncompliance|1|||
33150772|NCT00950911|100466926|FG001|Overall Study|Noncompliance|0|||
33150773|NCT00950911|100466925|FG000|Overall Study|Poor performance status|0|||
33385875|NCT01001234|101299273|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
33385876|NCT01001234|101299274|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
33385877|NCT01001234|101299275|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
33150774|NCT00950911|100466926|FG001|Overall Study|Poor performance status|1|||
33150775|NCT03555435|100466927|FG000|Overall Study|Lost to Follow-up|17|||
33150776|NCT03555435|100466928|FG001|Overall Study|Lost to Follow-up|19|||
33150777|NCT03555435|100466929|FG002|Overall Study|Lost to Follow-up|8|||
33150778|NCT02764697|100466930|FG000|Overall Study|Lack of Efficacy|3|||
33150779|NCT04761822|100466935|FG000|Overall Study|Adverse Event|3|||
33150780|NCT04761822|100466936|FG001|Overall Study|Adverse Event|1|||
33150781|NCT04761822|100466937|FG002|Overall Study|Adverse Event|1|||
33150782|NCT04761822|100466938|FG003|Overall Study|Adverse Event|3|||
33150783|NCT04761822|100466935|FG000|Overall Study|Lost to Follow-up|1|||
33150784|NCT04761822|100466936|FG001|Overall Study|Lost to Follow-up|0|||
33150785|NCT04761822|100466937|FG002|Overall Study|Lost to Follow-up|2|||
33150786|NCT04761822|100466938|FG003|Overall Study|Lost to Follow-up|3|||
33150787|NCT04761822|100466935|FG000|Overall Study|Physician Decision|0|||
33150788|NCT04761822|100466936|FG001|Overall Study|Physician Decision|1|||
33150789|NCT04761822|100466937|FG002|Overall Study|Physician Decision|0|||
33150790|NCT04761822|100466938|FG003|Overall Study|Physician Decision|0|||
33150791|NCT04761822|100466935|FG000|Overall Study|Withdrawal by Subject|3|||
33249943|NCT01235949|100814566|FG016|Primary Phase|Migrated/moved from study area|0|||
33435715|NCT04700449|101488191|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
33435716|NCT04700449|101488192|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
33435717|NCT04700449|101488193|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
33435718|NCT04700449|101488190|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
33150792|NCT04761822|100466936|FG001|Overall Study|Withdrawal by Subject|8|||
33435719|NCT04700449|101488191|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
33435720|NCT04700449|101488192|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
33435721|NCT04700449|101488193|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
33435722|NCT04700449|101488190|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
33435723|NCT04700449|101488191|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
33435724|NCT04700449|101488192|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
33435725|NCT04700449|101488193|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
33435726|NCT04700449|101488190|FG000|Stage 2 Sub-study 1|Other|1|||
33435727|NCT04700449|101488191|FG001|Stage 2 Sub-study 1|Other|2|||
33435728|NCT04700449|101488192|FG002|Stage 2 Sub-study 1|Other|0|||
33435729|NCT04700449|101488193|FG003|Stage 2 Sub-study 1|Other|0|||
33435730|NCT04700449|101488190|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
33435731|NCT04700449|101488191|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
33435732|NCT04700449|101488192|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
33435733|NCT04700449|101488193|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
33435734|NCT04700449|101488190|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
33435735|NCT04700449|101488191|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
33435736|NCT04700449|101488192|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
33435737|NCT04700449|101488193|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
33435738|NCT04700449|101488190|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
33435739|NCT04700449|101488191|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
33435740|NCT04700449|101488192|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
33435741|NCT04700449|101488193|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
33435742|NCT04700449|101488190|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
33435743|NCT04700449|101488191|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
33435744|NCT04700449|101488192|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
33435745|NCT04700449|101488193|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
33435746|NCT04700449|101488190|FG000|Stage 2 Sub-study 2|Other|0|||
33435747|NCT04700449|101488191|FG001|Stage 2 Sub-study 2|Other|0|||
33435748|NCT04700449|101488192|FG002|Stage 2 Sub-study 2|Other|0|||
33435749|NCT04700449|101488193|FG003|Stage 2 Sub-study 2|Other|5|||
33435750|NCT01031537|101488196|FG000|Overall Study|medical reasons not related to study|3|||
33435751|NCT01031537|101488196|FG000|Overall Study|Lack of Efficacy|1|||
33435752|NCT01031537|101488196|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
33435753|NCT01031537|101488196|FG000|Overall Study|moved, met exclusion criteria|10|||
33435754|NCT01031537|101488196|FG000|Overall Study|Withdrawal by Subject|5|||
33435755|NCT01031537|101488196|FG000|Overall Study|PI removal, no longer met eligibility|12|||
33435756|NCT02309099|101488201|FG000|Overall Study|Adverse Event|2|||
33435757|NCT02309099|101488202|FG001|Overall Study|Adverse Event|0|||
33435758|NCT02132247|101488204|FG000|Overall Study|Protocol Violation|1|||
33435759|NCT02132247|101488205|FG001|Overall Study|Protocol Violation|0|||
33435760|NCT01267266|101488206|FG000|Enrollment Phase|Withdrawal by Subject|2|||
33435761|NCT01267266|101488207|FG001|Enrollment Phase|Withdrawal by Subject|0|||
33435762|NCT01267266|101488206|FG000|Lead-in Phase|Lack of Efficacy|20|||
33435763|NCT01267266|101488207|FG001|Lead-in Phase|Lack of Efficacy|0|||
33435764|NCT01267266|101488206|FG000|Lead-in Phase|Adverse Event|2|||
33435765|NCT01267266|101488207|FG001|Lead-in Phase|Adverse Event|0|||
33435766|NCT01267266|101488206|FG000|Lead-in Phase|Withdrawal by Subject|1|||
33435767|NCT01267266|101488207|FG001|Lead-in Phase|Withdrawal by Subject|0|||
33435768|NCT01575054|101488210|FG000|Overall Study|Other Reasons|5|||
33435769|NCT01575054|101488211|FG001|Overall Study|Other Reasons|3|||
33435770|NCT01575054|101488210|FG000|Overall Study|Protocol Violation|2|||
33435771|NCT01575054|101488211|FG001|Overall Study|Protocol Violation|1|||
33435772|NCT01575054|101488210|FG000|Overall Study|Personal Reasons|10|||
33435773|NCT01575054|101488211|FG001|Overall Study|Personal Reasons|11|||
33435774|NCT01575054|101488210|FG000|Overall Study|Lost to Follow-up|3|||
33150793|NCT04761822|100466937|FG002|Overall Study|Withdrawal by Subject|1|||
33435775|NCT01575054|101488211|FG001|Overall Study|Lost to Follow-up|3|||
33435776|NCT01575054|101488210|FG000|Overall Study|Adverse Event|9|||
33435777|NCT01575054|101488211|FG001|Overall Study|Adverse Event|8|||
33435778|NCT01802879|101488219|FG000|Overall Study|Administrative problems|2|||
33435779|NCT01802879|101488219|FG000|Overall Study|Disease progression|6|||
33435780|NCT01226797|101488227|FG000|Overall Study|Adverse Event|1|||
33435781|NCT01226797|101488228|FG001|Overall Study|Adverse Event|0|||
33435782|NCT01226797|101488227|FG000|Overall Study|No longer willing to participate|1|||
33435783|NCT01226797|101488228|FG001|Overall Study|No longer willing to participate|0|||
33435784|NCT01226797|101488227|FG000|Overall Study|Protocol Violation|0|||
33150794|NCT04761822|100466938|FG003|Overall Study|Withdrawal by Subject|11|||
33150795|NCT04761822|100466935|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
33385878|NCT01001234|101299276|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
33385879|NCT01001234|101299277|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
33385880|NCT01001234|101299273|FG000|Overall Study|Not Treated: Pregnancy|3|||
33385881|NCT01001234|101299274|FG001|Overall Study|Not Treated: Pregnancy|0|||
33385882|NCT01001234|101299275|FG002|Overall Study|Not Treated: Pregnancy|0|||
33385883|NCT01001234|101299276|FG003|Overall Study|Not Treated: Pregnancy|0|||
33385884|NCT01001234|101299277|FG004|Overall Study|Not Treated: Pregnancy|0|||
33385885|NCT01001234|101299273|FG000|Overall Study|Not Treated: Physician Decision|37|||
33385886|NCT01001234|101299274|FG001|Overall Study|Not Treated: Physician Decision|4|||
33385887|NCT01001234|101299275|FG002|Overall Study|Not Treated: Physician Decision|0|||
33385888|NCT01001234|101299276|FG003|Overall Study|Not Treated: Physician Decision|0|||
33385889|NCT01001234|101299277|FG004|Overall Study|Not Treated: Physician Decision|0|||
33385890|NCT01001234|101299273|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
33385891|NCT01001234|101299274|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
33385892|NCT01001234|101299275|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
33385893|NCT01001234|101299276|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
33385894|NCT01001234|101299277|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
33385895|NCT02633046|101299282|FG000|Overall Study|Adverse Event|8|||
33385896|NCT02633046|101299282|FG000|Overall Study|Physician Decision|7|||
33385897|NCT02633046|101299282|FG000|Overall Study|Withdrawal by Subject|8|||
33385898|NCT02633046|101299282|FG000|Overall Study|Increased proteinuria|2|||
33385899|NCT02633046|101299282|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
33385900|NCT02633046|101299282|FG000|Overall Study|Mutual decision patient and physician|1|||
33150796|NCT04761822|100466936|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
33150797|NCT04761822|100466937|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
33150798|NCT04761822|100466938|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
33150799|NCT04761822|100466935|FG000|Overall Study|Participant requested unblinding|0|||
33150800|NCT04761822|100466936|FG001|Overall Study|Participant requested unblinding|0|||
33150801|NCT04761822|100466937|FG002|Overall Study|Participant requested unblinding|0|||
33385901|NCT01438307|101299283|FG000|Overall Study|Death|1|||
33385902|NCT01438307|101299284|FG001|Overall Study|Death|1|||
33385903|NCT00091026|101299288|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
33385904|NCT00091026|101299289|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
33385905|NCT00091026|101299288|FG000|Overall Study|Patient withdrew and never received trea|0|||
33385906|NCT00091026|101299289|FG001|Overall Study|Patient withdrew and never received trea|2|||
33385907|NCT00091026|101299288|FG000|Overall Study|Unknown-never received treatment|0|||
33385908|NCT00091026|101299289|FG001|Overall Study|Unknown-never received treatment|1|||
33385909|NCT00563368|101299292|FG000|Overall Study|Lost to Follow-up|14|||
33385910|NCT00563368|101299293|FG001|Overall Study|Lost to Follow-up|14|||
33385911|NCT00563368|101299294|FG002|Overall Study|Lost to Follow-up|12|||
33385912|NCT00563368|101299295|FG003|Overall Study|Lost to Follow-up|6|||
33385913|NCT00563368|101299296|FG004|Overall Study|Lost to Follow-up|9|||
33385914|NCT00563368|101299297|FG005|Overall Study|Lost to Follow-up|8|||
33385915|NCT00563368|101299298|FG006|Overall Study|Lost to Follow-up|9|||
33385916|NCT00563368|101299292|FG000|Overall Study|Adverse Event|3|||
33385917|NCT00563368|101299293|FG001|Overall Study|Adverse Event|4|||
33385918|NCT00563368|101299294|FG002|Overall Study|Adverse Event|5|||
33385919|NCT00563368|101299295|FG003|Overall Study|Adverse Event|9|||
33385920|NCT00563368|101299296|FG004|Overall Study|Adverse Event|6|||
33385921|NCT00563368|101299297|FG005|Overall Study|Adverse Event|10|||
33385922|NCT00563368|101299298|FG006|Overall Study|Adverse Event|17|||
33385923|NCT00563368|101299292|FG000|Overall Study|Withdrawal by Subject|11|||
33385924|NCT00563368|101299293|FG001|Overall Study|Withdrawal by Subject|6|||
33385925|NCT00563368|101299294|FG002|Overall Study|Withdrawal by Subject|5|||
33385926|NCT00563368|101299295|FG003|Overall Study|Withdrawal by Subject|7|||
33385927|NCT00563368|101299296|FG004|Overall Study|Withdrawal by Subject|8|||
33385928|NCT00563368|101299297|FG005|Overall Study|Withdrawal by Subject|5|||
33385929|NCT00563368|101299298|FG006|Overall Study|Withdrawal by Subject|4|||
33385930|NCT00563368|101299292|FG000|Overall Study|protocol non-compliance|1|||
33385931|NCT00563368|101299293|FG001|Overall Study|protocol non-compliance|1|||
33385932|NCT00563368|101299294|FG002|Overall Study|protocol non-compliance|2|||
33385933|NCT00563368|101299295|FG003|Overall Study|protocol non-compliance|1|||
33385934|NCT00563368|101299296|FG004|Overall Study|protocol non-compliance|0|||
33385935|NCT00563368|101299297|FG005|Overall Study|protocol non-compliance|1|||
33385936|NCT00563368|101299298|FG006|Overall Study|protocol non-compliance|3|||
33385937|NCT00563368|101299292|FG000|Overall Study|Pregnancy|1|||
33385938|NCT00563368|101299293|FG001|Overall Study|Pregnancy|0|||
33385939|NCT00563368|101299294|FG002|Overall Study|Pregnancy|1|||
33150802|NCT04761822|100466938|FG003|Overall Study|Participant requested unblinding|1|||
33385940|NCT00563368|101299295|FG003|Overall Study|Pregnancy|2|||
33385941|NCT00563368|101299296|FG004|Overall Study|Pregnancy|1|||
33150803|NCT02423772|100466940|FG000|Overall Study|Lost to Follow-up|3|||
33150804|NCT02423772|100466941|FG001|Overall Study|Lost to Follow-up|3|||
33150805|NCT02423772|100466940|FG000|Overall Study|Did not begin intervention|2|||
33385942|NCT00563368|101299297|FG005|Overall Study|Pregnancy|2|||
33385943|NCT00563368|101299298|FG006|Overall Study|Pregnancy|0|||
33385944|NCT00563368|101299292|FG000|Overall Study|requirement for restricted medication|0|||
33385945|NCT00563368|101299293|FG001|Overall Study|requirement for restricted medication|0|||
33385946|NCT00563368|101299294|FG002|Overall Study|requirement for restricted medication|2|||
33385947|NCT00563368|101299295|FG003|Overall Study|requirement for restricted medication|0|||
33385948|NCT00563368|101299296|FG004|Overall Study|requirement for restricted medication|0|||
33385949|NCT00563368|101299297|FG005|Overall Study|requirement for restricted medication|0|||
33385950|NCT00563368|101299298|FG006|Overall Study|requirement for restricted medication|0|||
33385951|NCT00563368|101299292|FG000|Overall Study|Other|5|||
33385952|NCT00563368|101299293|FG001|Overall Study|Other|5|||
33385953|NCT00563368|101299294|FG002|Overall Study|Other|3|||
33150806|NCT02423772|100466941|FG001|Overall Study|Did not begin intervention|5|||
33385954|NCT00563368|101299295|FG003|Overall Study|Other|4|||
33385955|NCT00563368|101299296|FG004|Overall Study|Other|4|||
33435785|NCT01226797|101488228|FG001|Overall Study|Protocol Violation|1|||
33435786|NCT01424722|101488229|FG000|Overall Study|Sponsor terminated investigation|2258|||
33435787|NCT01957488|101488234|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
33435788|NCT01957488|101488235|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
33435789|NCT01957488|101488236|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
33435790|NCT01957488|101488237|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
33435791|NCT01957488|101488238|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
33435792|NCT01957488|101488239|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
33435793|NCT01957488|101488234|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
33435794|NCT01957488|101488235|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
33150807|NCT01008150|100466942|FG000|Overall Study|did not receive study drug|1|||
33150808|NCT01008150|100466943|FG001|Overall Study|did not receive study drug|1|||
33150809|NCT01008150|100466944|FG002|Overall Study|did not receive study drug|1|||
33150810|NCT01008150|100466945|FG003|Overall Study|did not receive study drug|0|||
33150811|NCT00567593|100466946|FG000|Overall Study|Adverse Event|1|||
33150812|NCT00567593|100466946|FG000|Overall Study|Physician Decision|1|||
33150813|NCT01907100|100466947|FG000|Overall Study|PD based on modified RECIST criteria|31|||
33150814|NCT01907100|100466948|FG001|Overall Study|PD based on modified RECIST criteria|32|||
33150815|NCT01907100|100466949|FG002|Overall Study|PD based on modified RECIST criteria|95|||
33150816|NCT01907100|100466950|FG003|Overall Study|PD based on modified RECIST criteria|92|||
33150817|NCT01907100|100466947|FG000|Overall Study|Withdrawal by Subject|2|||
33150818|NCT01907100|100466948|FG001|Overall Study|Withdrawal by Subject|5|||
33150819|NCT01907100|100466949|FG002|Overall Study|Withdrawal by Subject|10|||
33150820|NCT01907100|100466950|FG003|Overall Study|Withdrawal by Subject|13|||
33150821|NCT01907100|100466947|FG000|Overall Study|Protocol Violation|0|||
33150822|NCT01907100|100466948|FG001|Overall Study|Protocol Violation|0|||
33150823|NCT01907100|100466949|FG002|Overall Study|Protocol Violation|1|||
33150824|NCT01907100|100466950|FG003|Overall Study|Protocol Violation|1|||
33150825|NCT01907100|100466947|FG000|Overall Study|Lost to Follow-up|0|||
33150826|NCT01907100|100466948|FG001|Overall Study|Lost to Follow-up|0|||
33150827|NCT01907100|100466949|FG002|Overall Study|Lost to Follow-up|0|||
33150828|NCT01907100|100466950|FG003|Overall Study|Lost to Follow-up|1|||
33150829|NCT01907100|100466947|FG000|Overall Study|Not treated|2|||
33150830|NCT01907100|100466948|FG001|Overall Study|Not treated|0|||
33150831|NCT01907100|100466949|FG002|Overall Study|Not treated|1|||
33150832|NCT01907100|100466950|FG003|Overall Study|Not treated|2|||
33150833|NCT01907100|100466947|FG000|Overall Study|Other than reasons specified|1|||
33150834|NCT01907100|100466948|FG001|Overall Study|Other than reasons specified|0|||
33150835|NCT01907100|100466949|FG002|Overall Study|Other than reasons specified|10|||
33249944|NCT01235949|100814567|FG017|Primary Phase|Migrated/moved from study area|0|||
33249945|NCT01235949|100814550|FG000|Primary Phase|Adverse Event|0|||
33249946|NCT01235949|100814551|FG001|Primary Phase|Adverse Event|0|||
33249947|NCT01235949|100814552|FG002|Primary Phase|Adverse Event|0|||
33249948|NCT01235949|100814553|FG003|Primary Phase|Adverse Event|1|||
33249949|NCT01235949|100814554|FG004|Primary Phase|Adverse Event|0|||
33249950|NCT01235949|100814555|FG005|Primary Phase|Adverse Event|0|||
33249951|NCT01235949|100814556|FG006|Primary Phase|Adverse Event|0|||
33249952|NCT01235949|100814557|FG007|Primary Phase|Adverse Event|0|||
33249953|NCT01235949|100814558|FG008|Primary Phase|Adverse Event|0|||
33249954|NCT01235949|100814559|FG009|Primary Phase|Adverse Event|0|||
33249955|NCT01235949|100814560|FG010|Primary Phase|Adverse Event|0|||
33249956|NCT01235949|100814561|FG011|Primary Phase|Adverse Event|0|||
33249957|NCT01235949|100814562|FG012|Primary Phase|Adverse Event|0|||
33249958|NCT01235949|100814563|FG013|Primary Phase|Adverse Event|0|||
33249959|NCT01235949|100814564|FG014|Primary Phase|Adverse Event|0|||
33249960|NCT01235949|100814565|FG015|Primary Phase|Adverse Event|0|||
33249961|NCT01235949|100814566|FG016|Primary Phase|Adverse Event|0|||
33249962|NCT01235949|100814567|FG017|Primary Phase|Adverse Event|0|||
33249963|NCT01235949|100814550|FG000|Primary Phase|Withdrawal by Subject|3|||
33249964|NCT01235949|100814551|FG001|Primary Phase|Withdrawal by Subject|2|||
33249965|NCT01235949|100814552|FG002|Primary Phase|Withdrawal by Subject|2|||
33385956|NCT00563368|101299297|FG005|Overall Study|Other|4|||
33385957|NCT00563368|101299298|FG006|Overall Study|Other|0|||
33249966|NCT01235949|100814553|FG003|Primary Phase|Withdrawal by Subject|0|||
33249967|NCT01235949|100814554|FG004|Primary Phase|Withdrawal by Subject|0|||
33249968|NCT01235949|100814555|FG005|Primary Phase|Withdrawal by Subject|3|||
33249969|NCT01235949|100814556|FG006|Primary Phase|Withdrawal by Subject|0|||
33150836|NCT01907100|100466950|FG003|Overall Study|Other than reasons specified|6|||
33150837|NCT01907100|100466947|FG000|Overall Study|Adverse event (AE)|6|||
33150838|NCT01907100|100466948|FG001|Overall Study|Adverse event (AE)|3|||
33249970|NCT01235949|100814557|FG007|Primary Phase|Withdrawal by Subject|0|||
33150839|NCT01907100|100466949|FG002|Overall Study|Adverse event (AE)|22|||
33150840|NCT01907100|100466950|FG003|Overall Study|Adverse event (AE)|23|||
33150841|NCT01907100|100466947|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
33150842|NCT01907100|100466948|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
33150843|NCT01907100|100466949|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
33150844|NCT01907100|100466950|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
33150845|NCT04449861|100466952|FG000|Overall Study|Withdrawal by Subject|4|||
33150846|NCT04449861|100466952|FG000|Overall Study|Lost to Follow-up|5|||
33150847|NCT04449861|100466952|FG000|Overall Study|Death|112|||
33150848|NCT01442038|100466953|FG000|Overall Study|Death|35|||
33150849|NCT01442038|100466954|FG001|Overall Study|Death|29|||
33150850|NCT01442038|100466953|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
33150851|NCT01442038|100466954|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
33150852|NCT01442038|100466953|FG000|Overall Study|Participant Withdrew Consent|137|||
33150853|NCT01442038|100466954|FG001|Overall Study|Participant Withdrew Consent|102|||
33150854|NCT01442038|100466953|FG000|Overall Study|Lost to Follow-up|37|||
33150855|NCT01442038|100466954|FG001|Overall Study|Lost to Follow-up|51|||
33150856|NCT01442038|100466953|FG000|Overall Study|Adverse Event|26|||
33150857|NCT01442038|100466954|FG001|Overall Study|Adverse Event|15|||
33150858|NCT01442038|100466953|FG000|Overall Study|Protocol Deviation|9|||
33150859|NCT01442038|100466954|FG001|Overall Study|Protocol Deviation|20|||
33150860|NCT01442038|100466953|FG000|Overall Study|Investigator's Discretion|13|||
33150861|NCT01442038|100466954|FG001|Overall Study|Investigator's Discretion|16|||
33150862|NCT01442038|100466953|FG000|Overall Study|Study Terminated By Sponsor|2|||
33150863|NCT01442038|100466954|FG001|Overall Study|Study Terminated By Sponsor|3|||
33150864|NCT04996797|100466955|FG000|Overall Study|Adverse Event|0|||
33150865|NCT04996797|100466956|FG001|Overall Study|Adverse Event|2|||
33150866|NCT04996797|100466957|FG002|Overall Study|Adverse Event|0|||
33150867|NCT04996797|100466958|FG003|Overall Study|Adverse Event|1|||
33150868|NCT04996797|100466955|FG000|Overall Study|Lack of Efficacy|0|||
33150869|NCT04996797|100466956|FG001|Overall Study|Lack of Efficacy|2|||
33150870|NCT04996797|100466957|FG002|Overall Study|Lack of Efficacy|0|||
33150871|NCT04996797|100466958|FG003|Overall Study|Lack of Efficacy|0|||
33150872|NCT04996797|100466955|FG000|Overall Study|Prohibited Medication|0|||
33150873|NCT04996797|100466956|FG001|Overall Study|Prohibited Medication|1|||
33150874|NCT04996797|100466957|FG002|Overall Study|Prohibited Medication|0|||
33150875|NCT04996797|100466958|FG003|Overall Study|Prohibited Medication|0|||
33249971|NCT01235949|100814558|FG008|Primary Phase|Withdrawal by Subject|0|||
33150876|NCT04996797|100466955|FG000|Overall Study|Ongoing|68|||
33150877|NCT04996797|100466956|FG001|Overall Study|Ongoing|60|||
33150878|NCT04996797|100466957|FG002|Overall Study|Ongoing|22|||
33150879|NCT04996797|100466958|FG003|Overall Study|Ongoing|20|||
33150880|NCT04996797|100466955|FG000|Overall Study|Withdrawal by Subject|0|||
33150881|NCT04996797|100466956|FG001|Overall Study|Withdrawal by Subject|2|||
33150882|NCT04996797|100466957|FG002|Overall Study|Withdrawal by Subject|0|||
33150883|NCT04996797|100466958|FG003|Overall Study|Withdrawal by Subject|0|||
33150884|NCT01052844|100466959|FG000|Overall Study|Adverse Event|0|||
33435795|NCT01957488|101488236|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
33435796|NCT01957488|101488237|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
33435797|NCT01957488|101488238|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
33435798|NCT01957488|101488239|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
33435799|NCT01957488|101488234|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
33435800|NCT01957488|101488235|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
33435801|NCT01957488|101488236|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
33435802|NCT01957488|101488237|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
33435803|NCT01957488|101488238|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
33435804|NCT01957488|101488239|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
33435805|NCT01957488|101488234|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
33435806|NCT01957488|101488235|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
33435807|NCT01957488|101488236|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
33435808|NCT01957488|101488237|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
33435809|NCT01957488|101488238|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
33435810|NCT01957488|101488239|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
33435811|NCT01957488|101488234|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
33435812|NCT01957488|101488235|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
33435813|NCT01957488|101488236|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
33435814|NCT01957488|101488237|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
33435815|NCT01957488|101488238|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
33435816|NCT01957488|101488239|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
33435817|NCT01957488|101488234|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
33435818|NCT01957488|101488235|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
33435819|NCT01957488|101488236|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
33435820|NCT01957488|101488237|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
33435821|NCT01957488|101488238|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
33435822|NCT01957488|101488239|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
33435823|NCT01957488|101488234|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
33435824|NCT01957488|101488235|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
33435825|NCT01957488|101488236|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
33435826|NCT01957488|101488237|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
33435827|NCT01957488|101488238|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
33435828|NCT01957488|101488239|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
33435829|NCT01957488|101488234|FG000|Test Period 2 (2 Weeks)|Other|1|||
33150885|NCT01052844|100466960|FG001|Overall Study|Adverse Event|1|||
33435830|NCT01957488|101488235|FG001|Test Period 2 (2 Weeks)|Other|0|||
33435831|NCT01957488|101488236|FG002|Test Period 2 (2 Weeks)|Other|0|||
33435832|NCT01957488|101488237|FG003|Test Period 2 (2 Weeks)|Other|0|||
33150886|NCT00760214|100466961|FG000|Overall Study|Adverse Event|8|||
33150887|NCT00760214|100466962|FG001|Overall Study|Adverse Event|9|||
33435833|NCT01957488|101488238|FG004|Test Period 2 (2 Weeks)|Other|0|||
33435834|NCT01957488|101488239|FG005|Test Period 2 (2 Weeks)|Other|0|||
33435835|NCT01957488|101488234|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
33435836|NCT01957488|101488235|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
33435837|NCT01957488|101488236|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
33435838|NCT01957488|101488237|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
33435839|NCT01957488|101488238|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
33435840|NCT01957488|101488239|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
33435841|NCT01957488|101488234|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
33435842|NCT01957488|101488235|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
33435843|NCT01957488|101488236|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
33435844|NCT01957488|101488237|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
33435845|NCT01957488|101488238|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
33435846|NCT01957488|101488239|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
33435847|NCT01957488|101488234|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
33435848|NCT01957488|101488235|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
33435849|NCT01957488|101488236|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
33435850|NCT01957488|101488237|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
33435851|NCT01957488|101488238|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
33435852|NCT01957488|101488239|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
33150888|NCT00760214|100466963|FG002|Overall Study|Adverse Event|12|||
33150889|NCT00760214|100466961|FG000|Overall Study|Protocol Violation|3|||
33249972|NCT01235949|100814559|FG009|Primary Phase|Withdrawal by Subject|0|||
33435853|NCT01957488|101488234|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
33435854|NCT01957488|101488235|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
33150890|NCT00760214|100466962|FG001|Overall Study|Protocol Violation|0|||
33435855|NCT01957488|101488236|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
33435856|NCT01957488|101488237|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
33435857|NCT01957488|101488238|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
33435858|NCT01957488|101488239|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
33435859|NCT01957488|101488234|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
33435860|NCT01957488|101488235|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
33435861|NCT01957488|101488236|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
33435862|NCT01957488|101488237|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
33435863|NCT01957488|101488238|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
33435864|NCT01957488|101488239|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
33435865|NCT01379781|101488243|FG000|Overall Study|Lost to Follow-up|11|||
33435866|NCT01379781|101488244|FG001|Overall Study|Lost to Follow-up|8|||
33435867|NCT00661999|101488245|FG000|Overall Study|Adverse Event|11|||
33435868|NCT00661999|101488246|FG001|Overall Study|Adverse Event|5|||
33435869|NCT00661999|101488247|FG002|Overall Study|Adverse Event|8|||
33435870|NCT00661999|101488245|FG000|Overall Study|Death|8|||
33435871|NCT00661999|101488246|FG001|Overall Study|Death|6|||
33435872|NCT00661999|101488247|FG002|Overall Study|Death|3|||
33435873|NCT00661999|101488245|FG000|Overall Study|Other Reasons|5|||
33435874|NCT00661999|101488246|FG001|Overall Study|Other Reasons|12|||
33435875|NCT00661999|101488247|FG002|Overall Study|Other Reasons|23|||
33435876|NCT00661999|101488245|FG000|Overall Study|Withdrawal by Subject|30|||
33150891|NCT00760214|100466963|FG002|Overall Study|Protocol Violation|3|||
33150892|NCT00760214|100466961|FG000|Overall Study|Lost to Follow-up|0|||
33249973|NCT01235949|100814560|FG010|Primary Phase|Withdrawal by Subject|0|||
33435877|NCT00661999|101488246|FG001|Overall Study|Withdrawal by Subject|23|||
33435878|NCT00661999|101488247|FG002|Overall Study|Withdrawal by Subject|14|||
33435879|NCT00661999|101488245|FG000|Overall Study|Alternative Treatment|1|||
33435880|NCT00661999|101488246|FG001|Overall Study|Alternative Treatment|0|||
33435881|NCT00661999|101488247|FG002|Overall Study|Alternative Treatment|0|||
33435882|NCT00661999|101488245|FG000|Overall Study|Other Medical Problems|4|||
33435883|NCT00661999|101488246|FG001|Overall Study|Other Medical Problems|4|||
33435884|NCT00661999|101488247|FG002|Overall Study|Other Medical Problems|9|||
33435885|NCT02658084|101488251|FG000|Overall Study|Withdrawal by Subject|1|||
33150893|NCT00760214|100466962|FG001|Overall Study|Lost to Follow-up|0|||
33435886|NCT02658084|101488252|FG001|Overall Study|Withdrawal by Subject|0|||
33435887|NCT02658084|101488251|FG000|Overall Study|Study Termination|1|||
33435888|NCT02658084|101488252|FG001|Overall Study|Study Termination|0|||
33435889|NCT02974153|101488253|FG000|Overall Study|Adverse Event|6|||
33435890|NCT02974153|101488254|FG001|Overall Study|Adverse Event|0|||
33435891|NCT02974153|101488255|FG002|Overall Study|Adverse Event|1|||
33435892|NCT02974153|101488253|FG000|Overall Study|Lack of Efficacy|6|||
33435893|NCT02974153|101488254|FG001|Overall Study|Lack of Efficacy|5|||
33435894|NCT02974153|101488255|FG002|Overall Study|Lack of Efficacy|10|||
33435895|NCT02974153|101488253|FG000|Overall Study|Lost to Follow-up|9|||
33435896|NCT02974153|101488254|FG001|Overall Study|Lost to Follow-up|10|||
33435897|NCT02974153|101488255|FG002|Overall Study|Lost to Follow-up|17|||
33435898|NCT02974153|101488253|FG000|Overall Study|Physician Decision|0|||
33435899|NCT02974153|101488254|FG001|Overall Study|Physician Decision|2|||
33435900|NCT02974153|101488255|FG002|Overall Study|Physician Decision|1|||
33435901|NCT02974153|101488253|FG000|Overall Study|Withdrawal by Subject|9|||
33435902|NCT02974153|101488254|FG001|Overall Study|Withdrawal by Subject|16|||
33435903|NCT02974153|101488255|FG002|Overall Study|Withdrawal by Subject|11|||
33435904|NCT02974153|101488253|FG000|Overall Study|Study Burden|8|||
33435905|NCT02974153|101488254|FG001|Overall Study|Study Burden|7|||
33435906|NCT02974153|101488255|FG002|Overall Study|Study Burden|3|||
33435907|NCT02974153|101488253|FG000|Overall Study|Other|14|||
33435908|NCT02974153|101488254|FG001|Overall Study|Other|8|||
33435909|NCT02974153|101488255|FG002|Overall Study|Other|7|||
33435910|NCT03066999|101488256|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
33435911|NCT03066999|101488257|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
33435912|NCT03882047|101488258|FG000|Overall Study|Adverse Event|0|||
33435913|NCT03882047|101488259|FG001|Overall Study|Adverse Event|2|||
33435914|NCT03882047|101488260|FG002|Overall Study|Adverse Event|2|||
33435915|NCT03882047|101488258|FG000|Overall Study|Treatment Failure|3|||
33435916|NCT03882047|101488259|FG001|Overall Study|Treatment Failure|3|||
33435917|NCT03882047|101488260|FG002|Overall Study|Treatment Failure|12|||
33435918|NCT03882047|101488258|FG000|Overall Study|Lost to Follow-up|0|||
33435919|NCT03882047|101488259|FG001|Overall Study|Lost to Follow-up|1|||
33435920|NCT03882047|101488260|FG002|Overall Study|Lost to Follow-up|0|||
33435921|NCT03882047|101488258|FG000|Overall Study|Did Not Wish to Continue|1|||
33435922|NCT03882047|101488259|FG001|Overall Study|Did Not Wish to Continue|4|||
33435923|NCT03882047|101488260|FG002|Overall Study|Did Not Wish to Continue|1|||
33435924|NCT03882047|101488258|FG000|Overall Study|Noncompliance With Protocol|2|||
33435925|NCT03882047|101488259|FG001|Overall Study|Noncompliance With Protocol|0|||
33435926|NCT03882047|101488260|FG002|Overall Study|Noncompliance With Protocol|0|||
33435927|NCT03882047|101488258|FG000|Overall Study|Did Not Meet Eligibility|0|||
33435928|NCT03882047|101488259|FG001|Overall Study|Did Not Meet Eligibility|0|||
33435929|NCT03882047|101488260|FG002|Overall Study|Did Not Meet Eligibility|1|||
33435930|NCT01000337|101488261|FG000|Overall Study|Lost to Follow-up|4|||
33435931|NCT01000337|101488262|FG001|Overall Study|Lost to Follow-up|3|||
33435932|NCT01513148|101488263|FG000|Overall Study|Protocol Violation|2|||
33435933|NCT01513148|101488264|FG001|Overall Study|Protocol Violation|2|||
33435934|NCT00322491|101488265|FG000|Overall Study|Adverse Event|1|||
33435935|NCT00322491|101488266|FG001|Overall Study|Adverse Event|0|||
33249974|NCT01235949|100814561|FG011|Primary Phase|Withdrawal by Subject|0|||
33435936|NCT00322491|101488265|FG000|Overall Study|Death|1|||
33435937|NCT00322491|101488266|FG001|Overall Study|Death|2|||
33435938|NCT02532764|101488269|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
33435939|NCT02532764|101488270|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
33435940|NCT02532764|101488271|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
33435941|NCT02532764|101488272|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
33435942|NCT02532764|101488273|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
33435943|NCT02532764|101488274|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
33435944|NCT02532764|101488275|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
33435945|NCT02532764|101488276|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
33435946|NCT02532764|101488277|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
33435947|NCT02532764|101488278|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
33435948|NCT02564263|101488279|FG000|Overall Study|Adverse Event|31|||
33435949|NCT02564263|101488280|FG001|Overall Study|Adverse Event|29|||
33435950|NCT02564263|101488279|FG000|Overall Study|Death|270|||
33435951|NCT02564263|101488280|FG001|Overall Study|Death|262|||
33435952|NCT02564263|101488279|FG000|Overall Study|Withdrawal by Subject|4|||
33435953|NCT02564263|101488280|FG001|Overall Study|Withdrawal by Subject|19|||
33435954|NCT02564263|101488279|FG000|Overall Study|Sponsor's decision|9|||
33435955|NCT02564263|101488280|FG001|Overall Study|Sponsor's decision|4|||
33435956|NCT02016300|101488281|FG000|Overall Study|Lost to Follow-up|0|||
33435957|NCT02016300|101488282|FG001|Overall Study|Lost to Follow-up|3|||
33435958|NCT01367275|101488283|FG000|Overall Study|Ineligible|1|||
33435959|NCT01367275|101488283|FG000|Overall Study|Disease Progression|2|||
33435960|NCT04849988|101488284|FG000|Overall Study|Lack of Efficacy|3|||
33435961|NCT04849988|101488285|FG001|Overall Study|Lack of Efficacy|4|||
33435962|NCT04849988|101488286|FG002|Overall Study|Lack of Efficacy|1|||
33435963|NCT04849988|101488287|FG003|Overall Study|Lack of Efficacy|4|||
33435964|NCT04849988|101488284|FG000|Overall Study|Other reasons|1|||
33435965|NCT04849988|101488285|FG001|Overall Study|Other reasons|2|||
33435966|NCT04849988|101488286|FG002|Overall Study|Other reasons|2|||
33435967|NCT04849988|101488287|FG003|Overall Study|Other reasons|1|||
33435968|NCT01180244|101488288|FG000|Overall Study|Lack of Efficacy|0|||
33435969|NCT01180244|101488289|FG001|Overall Study|Lack of Efficacy|7|||
33435970|NCT01180244|101488288|FG000|Overall Study|Physician Decision|3|||
33435971|NCT01180244|101488289|FG001|Overall Study|Physician Decision|0|||
33435972|NCT01180244|101488288|FG000|Overall Study|Adverse Event|1|||
33435973|NCT01180244|101488289|FG001|Overall Study|Adverse Event|0|||
33435974|NCT01180244|101488288|FG000|Overall Study|Withdrawal by Subject|0|||
33435975|NCT01180244|101488289|FG001|Overall Study|Withdrawal by Subject|1|||
33435976|NCT01180244|101488288|FG000|Overall Study|Protocol Violation|1|||
33435977|NCT01180244|101488289|FG001|Overall Study|Protocol Violation|0|||
33435978|NCT01180244|101488288|FG000|Overall Study|Lost to Follow-up|1|||
33435979|NCT01180244|101488289|FG001|Overall Study|Lost to Follow-up|0|||
33435980|NCT03444038|101488296|FG000|Overall Study|Adverse Event|12|||
33435981|NCT03444038|101488296|FG000|Overall Study|Withdrawal by Subject|7|||
33435982|NCT03444038|101488296|FG000|Overall Study|Lost to Follow-up|1|||
33385958|NCT01162304|101299299|FG000|Overall Study|Beck scale to high|11|||
33385959|NCT02126670|101299300|FG000|Overall Study|Withdrawal by Subject|1|||
33385960|NCT02126670|101299301|FG001|Overall Study|Withdrawal by Subject|0|||
33385961|NCT02126670|101299302|FG002|Overall Study|Withdrawal by Subject|0|||
33385962|NCT02126670|101299303|FG003|Overall Study|Withdrawal by Subject|1|||
33385963|NCT01148693|101299304|FG000|Overall Study|Attempts for cannulation were failed|13|||
33385964|NCT01148693|101299305|FG001|Overall Study|Attempts for cannulation were failed|10|||
33385965|NCT02661464|101299306|FG000|Overall Study|Lost to Follow-up|28|||
33385966|NCT02661464|101299307|FG001|Overall Study|Lost to Follow-up|0|||
33385967|NCT02661464|101299308|FG002|Overall Study|Lost to Follow-up|0|||
33385968|NCT02661464|101299309|FG003|Overall Study|Lost to Follow-up|0|||
33435983|NCT03444038|101488296|FG000|Overall Study|Physician Decision|2|||
33435984|NCT03444038|101488296|FG000|Overall Study|Lack of Efficacy|7|||
33435985|NCT00623103|101488297|FG000|Overall Study|Adverse Event|70|||
33435986|NCT00623103|101488298|FG001|Overall Study|Adverse Event|60|||
33385969|NCT02661464|101299306|FG000|Overall Study|Withdrawal by Subject|3|||
33435987|NCT00623103|101488297|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33435988|NCT00623103|101488298|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
33435989|NCT00623103|101488297|FG000|Overall Study|Withdrawal by Subject|18|||
33435990|NCT00623103|101488298|FG001|Overall Study|Withdrawal by Subject|24|||
33435991|NCT00623103|101488297|FG000|Overall Study|Lost to Follow-up|4|||
33435992|NCT00623103|101488298|FG001|Overall Study|Lost to Follow-up|1|||
33435993|NCT00623103|101488297|FG000|Overall Study|Administrative problems|2|||
33435994|NCT00623103|101488298|FG001|Overall Study|Administrative problems|4|||
33435995|NCT00623103|101488297|FG000|Overall Study|Death|11|||
33435996|NCT00623103|101488298|FG001|Overall Study|Death|11|||
33435997|NCT00623103|101488297|FG000|Overall Study|Protocol deviation|2|||
33435998|NCT00623103|101488298|FG001|Overall Study|Protocol deviation|1|||
33435999|NCT00797108|101488301|FG000|Overall Study|Adverse Event|1|||
33436000|NCT00797108|101488302|FG001|Overall Study|Adverse Event|0|||
33436001|NCT00797108|101488303|FG002|Overall Study|Adverse Event|3|||
33436002|NCT00797108|101488301|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
33436003|NCT00797108|101488302|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
33436004|NCT00797108|101488303|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
33436005|NCT00797108|101488301|FG000|Overall Study|Global Deterioration of Health Status|0|||
33385970|NCT02661464|101299307|FG001|Overall Study|Withdrawal by Subject|1|||
33385971|NCT02661464|101299308|FG002|Overall Study|Withdrawal by Subject|0|||
33436006|NCT00797108|101488302|FG001|Overall Study|Global Deterioration of Health Status|1|||
33436007|NCT00797108|101488303|FG002|Overall Study|Global Deterioration of Health Status|0|||
33385972|NCT02661464|101299309|FG003|Overall Study|Withdrawal by Subject|0|||
33385973|NCT02661464|101299306|FG000|Overall Study|Participants terminated prematurely|288|||
33385974|NCT02661464|101299307|FG001|Overall Study|Participants terminated prematurely|52|||
33385975|NCT02661464|101299308|FG002|Overall Study|Participants terminated prematurely|1|||
33385976|NCT02661464|101299309|FG003|Overall Study|Participants terminated prematurely|1|||
33385977|NCT02661464|101299306|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
33385978|NCT02661464|101299307|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
33385979|NCT02661464|101299308|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
33385980|NCT02661464|101299309|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
33385981|NCT00045630|101299310|FG000|Overall Study|Adverse Event|1|||
33385982|NCT00045630|101299310|FG000|Overall Study|Refusal unrelated to adverse event|1|||
33385983|NCT00045630|101299310|FG000|Overall Study|Progression/relapse|1|||
33385984|NCT00045630|101299310|FG000|Overall Study|Death|1|||
33385985|NCT00045630|101299310|FG000|Overall Study|Ineligible|2|||
33385986|NCT02023112|101299311|FG000|Overall Study|Withdrawal by Subject|2|||
33385987|NCT02023112|101299312|FG001|Overall Study|Withdrawal by Subject|1|||
33385988|NCT03488238|101299320|FG000|Overall Study|Equipment malfunction|1|||
33385989|NCT03488238|101299320|FG000|Overall Study|Adverse Event|1|||
33385990|NCT00422903|101299321|FG000|Overall Study|Disease Progression|3|||
33385991|NCT00422903|101299322|FG001|Overall Study|Disease Progression|1|||
33385992|NCT00422903|101299321|FG000|Overall Study|Adverse Event|0|||
33385993|NCT00422903|101299322|FG001|Overall Study|Adverse Event|2|||
33385994|NCT00422903|101299321|FG000|Overall Study|Informed Consent Withdrawn|1|||
33436008|NCT00797108|101488301|FG000|Overall Study|Lack of Efficacy|1|||
33436009|NCT00797108|101488302|FG001|Overall Study|Lack of Efficacy|0|||
33436010|NCT00797108|101488303|FG002|Overall Study|Lack of Efficacy|1|||
33436011|NCT00797108|101488301|FG000|Overall Study|Other|0|||
33436012|NCT00797108|101488302|FG001|Overall Study|Other|0|||
33436013|NCT00797108|101488303|FG002|Overall Study|Other|2|||
33436014|NCT00797108|101488301|FG000|Overall Study|Randomized but not Treated|2|||
33436015|NCT00797108|101488302|FG001|Overall Study|Randomized but not Treated|0|||
33436016|NCT00797108|101488303|FG002|Overall Study|Randomized but not Treated|0|||
33436017|NCT02398188|101488304|FG000|Overall Study|Adverse Event|2|||
33436018|NCT02398188|101488305|FG001|Overall Study|Adverse Event|3|||
33436019|NCT02398188|101488304|FG000|Overall Study|Lost to Follow-up|5|||
33436020|NCT02398188|101488305|FG001|Overall Study|Lost to Follow-up|0|||
33436021|NCT02398188|101488304|FG000|Overall Study|Non-compliance|4|||
33436022|NCT02398188|101488305|FG001|Overall Study|Non-compliance|4|||
33436023|NCT02398188|101488304|FG000|Overall Study|Protocol Violation|6|||
33436024|NCT02398188|101488305|FG001|Overall Study|Protocol Violation|10|||
33436025|NCT02398188|101488304|FG000|Overall Study|Sponsor Decision|2|||
33436026|NCT02398188|101488305|FG001|Overall Study|Sponsor Decision|1|||
33436027|NCT02398188|101488304|FG000|Overall Study|Pregnancy|1|||
33436028|NCT02398188|101488305|FG001|Overall Study|Pregnancy|0|||
33436029|NCT02398188|101488304|FG000|Overall Study|Withdrawal by Subject|7|||
33385995|NCT00422903|101299322|FG001|Overall Study|Informed Consent Withdrawn|2|||
33385996|NCT03326869|101299323|FG000|Overall Study|Study data has been lost to natural disa|1|||
33385997|NCT03326869|101299324|FG001|Overall Study|Study data has been lost to natural disa|1|||
33385998|NCT00810810|101299330|FG000|Overall Study|Withdrawal by Subject|0|||
33385999|NCT00810810|101299331|FG001|Overall Study|Withdrawal by Subject|8|||
33386000|NCT00810810|101299332|FG002|Overall Study|Withdrawal by Subject|10|||
33386001|NCT00810810|101299333|FG003|Overall Study|Withdrawal by Subject|8|||
33386002|NCT00810810|101299330|FG000|Overall Study|Physician Decision|0|||
33436030|NCT02398188|101488305|FG001|Overall Study|Withdrawal by Subject|16|||
33436031|NCT01202747|101488309|FG000|Overall Study|Withdrawal by Subject|1|||
33436032|NCT04128007|101488314|FG000|Overall Study|Withdrawal by Subject|9|||
33150894|NCT00760214|100466963|FG002|Overall Study|Lost to Follow-up|1|||
33150895|NCT00760214|100466961|FG000|Overall Study|Withdrawal by Subject|12|||
33150896|NCT00760214|100466962|FG001|Overall Study|Withdrawal by Subject|14|||
33150897|NCT00760214|100466963|FG002|Overall Study|Withdrawal by Subject|13|||
33150898|NCT00760214|100466961|FG000|Overall Study|Lack of Efficacy|3|||
33150899|NCT00760214|100466962|FG001|Overall Study|Lack of Efficacy|2|||
33150900|NCT00760214|100466963|FG002|Overall Study|Lack of Efficacy|4|||
33150901|NCT00760214|100466961|FG000|Overall Study|Pregnancy|0|||
33150902|NCT00760214|100466962|FG001|Overall Study|Pregnancy|0|||
33150903|NCT00760214|100466963|FG002|Overall Study|Pregnancy|1|||
33150904|NCT00760214|100466961|FG000|Overall Study|Physician Decision|1|||
33150905|NCT00760214|100466962|FG001|Overall Study|Physician Decision|1|||
33150906|NCT00760214|100466963|FG002|Overall Study|Physician Decision|1|||
33436033|NCT04128007|101488315|FG001|Overall Study|Withdrawal by Subject|6|||
33150907|NCT00760214|100466961|FG000|Overall Study|Other|3|||
33150908|NCT00760214|100466962|FG001|Overall Study|Other|4|||
33150909|NCT00760214|100466963|FG002|Overall Study|Other|6|||
33150910|NCT00116428|100466964|FG000|Overall Study|Withdrawal by Subject|2|||
33436034|NCT04128007|101488314|FG000|Overall Study|Protocol Violation|1|||
33436035|NCT04128007|101488315|FG001|Overall Study|Protocol Violation|0|||
33249975|NCT01235949|100814562|FG012|Primary Phase|Withdrawal by Subject|0|||
33249976|NCT01235949|100814563|FG013|Primary Phase|Withdrawal by Subject|0|||
33150911|NCT00116428|100466965|FG001|Overall Study|Withdrawal by Subject|5|||
33249977|NCT01235949|100814564|FG014|Primary Phase|Withdrawal by Subject|0|||
33386003|NCT00810810|101299331|FG001|Overall Study|Physician Decision|3|||
33436036|NCT04128007|101488314|FG000|Overall Study|Lost to Follow-up|8|||
33436037|NCT04128007|101488315|FG001|Overall Study|Lost to Follow-up|7|||
33436038|NCT04128007|101488314|FG000|Overall Study|Adverse Event|5|||
33436039|NCT04128007|101488315|FG001|Overall Study|Adverse Event|2|||
33436040|NCT04128007|101488314|FG000|Overall Study|Not reported|0|||
33436041|NCT04128007|101488315|FG001|Overall Study|Not reported|2|||
33436042|NCT00560235|101488316|FG000|Phase 1|Discontinued|8|||
33436043|NCT00560235|101488317|FG001|Phase 1|Discontinued|0|||
33436044|NCT00560235|101488318|FG002|Phase 1|Discontinued|0|||
33436045|NCT00560235|101488316|FG000|Phase 1B|Discontinued|0|||
33436046|NCT00560235|101488317|FG001|Phase 1B|Discontinued|19|||
33436047|NCT00560235|101488318|FG002|Phase 1B|Discontinued|0|||
33436048|NCT00560235|101488316|FG000|Phase 2|Discontinued|0|||
33436049|NCT00560235|101488317|FG001|Phase 2|Discontinued|0|||
33436050|NCT00560235|101488318|FG002|Phase 2|Discontinued|96|||
33436051|NCT00560235|101488316|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
33436052|NCT00560235|101488317|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
33386004|NCT00810810|101299332|FG002|Overall Study|Physician Decision|1|||
33386005|NCT00810810|101299333|FG003|Overall Study|Physician Decision|5|||
33386006|NCT02427100|101299341|FG000|Overall Study|Lost to Follow-up|0|||
33386007|NCT02427100|101299342|FG001|Overall Study|Lost to Follow-up|2|||
33386008|NCT01040845|101299343|FG000|Overall Study|Withdrawal by Subject|1|||
33386009|NCT01040845|101299344|FG001|Overall Study|Withdrawal by Subject|1|||
33436053|NCT00560235|101488318|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
33436054|NCT01694485|101488319|FG000|Overall Study|Withdrawal by Subject|20|||
33436055|NCT01694485|101488320|FG001|Overall Study|Withdrawal by Subject|6|||
33436056|NCT01694485|101488321|FG002|Overall Study|Withdrawal by Subject|7|||
33436057|NCT01694485|101488322|FG003|Overall Study|Withdrawal by Subject|25|||
33436058|NCT01694485|101488323|FG004|Overall Study|Withdrawal by Subject|18|||
33436059|NCT01694485|101488319|FG000|Overall Study|Sponsor Decision|3|||
33436060|NCT01694485|101488320|FG001|Overall Study|Sponsor Decision|0|||
33436061|NCT01694485|101488321|FG002|Overall Study|Sponsor Decision|0|||
33436062|NCT01694485|101488322|FG003|Overall Study|Sponsor Decision|2|||
33436063|NCT01694485|101488323|FG004|Overall Study|Sponsor Decision|0|||
33436064|NCT01694485|101488319|FG000|Overall Study|Lost to Follow-up|9|||
33436065|NCT01694485|101488320|FG001|Overall Study|Lost to Follow-up|1|||
33386010|NCT01040845|101299343|FG000|Overall Study|Physician Decision|1|||
33386011|NCT01040845|101299344|FG001|Overall Study|Physician Decision|0|||
33386012|NCT03287869|101299345|FG000|Overall Study|Adverse Event|14|||
33386013|NCT03287869|101299346|FG001|Overall Study|Adverse Event|12|||
33386014|NCT03287869|101299345|FG000|Overall Study|Lack of Efficacy|1|||
33386015|NCT03287869|101299346|FG001|Overall Study|Lack of Efficacy|0|||
33386016|NCT03287869|101299345|FG000|Overall Study|Lost to Follow-up|13|||
33386017|NCT03287869|101299346|FG001|Overall Study|Lost to Follow-up|19|||
33386018|NCT03287869|101299345|FG000|Overall Study|Non-Compliance With Study Drug|5|||
33436066|NCT01694485|101488321|FG002|Overall Study|Lost to Follow-up|6|||
33150912|NCT00116428|100466964|FG000|Overall Study|Did not meet inclusion criteria|1|||
33150913|NCT00116428|100466965|FG001|Overall Study|Did not meet inclusion criteria|0|||
33150914|NCT02939079|100466966|FG000|Overall Study|Adverse Event|2|||
33150915|NCT02939079|100466967|FG001|Overall Study|Adverse Event|1|||
33150916|NCT02939079|100466966|FG000|Overall Study|Lost to Follow-up|0|||
33150917|NCT02939079|100466967|FG001|Overall Study|Lost to Follow-up|2|||
33150918|NCT02939079|100466966|FG000|Overall Study|Protocol Violation|1|||
33150919|NCT02939079|100466967|FG001|Overall Study|Protocol Violation|0|||
33150920|NCT02939079|100466966|FG000|Overall Study|Withdrawal by Subject|0|||
33150921|NCT02939079|100466967|FG001|Overall Study|Withdrawal by Subject|1|||
33150922|NCT02939079|100466966|FG000|Overall Study|relapse during the study|1|||
33150923|NCT02939079|100466967|FG001|Overall Study|relapse during the study|1|||
33150924|NCT02476422|100466968|FG000|Overall Study|Subject/guardian decision|0|||
33150925|NCT02476422|100466969|FG001|Overall Study|Subject/guardian decision|1|||
33150926|NCT01104701|100466972|FG000|Overall Study|Withdrawal by Subject|0|||
33150927|NCT01104701|100466973|FG001|Overall Study|Withdrawal by Subject|1|||
33150928|NCT01104701|100466974|FG002|Overall Study|Withdrawal by Subject|2|||
33150929|NCT01104701|100466975|FG003|Overall Study|Withdrawal by Subject|1|||
33150930|NCT01104701|100466972|FG000|Overall Study|Adverse Event|0|||
33150931|NCT01104701|100466973|FG001|Overall Study|Adverse Event|0|||
33150932|NCT01104701|100466974|FG002|Overall Study|Adverse Event|0|||
33150933|NCT01104701|100466975|FG003|Overall Study|Adverse Event|1|||
33150934|NCT01104701|100466972|FG000|Overall Study|Physician Decision|0|||
33150935|NCT01104701|100466973|FG001|Overall Study|Physician Decision|2|||
33436067|NCT01694485|101488322|FG003|Overall Study|Lost to Follow-up|10|||
33436068|NCT01694485|101488323|FG004|Overall Study|Lost to Follow-up|7|||
33436069|NCT01694485|101488319|FG000|Overall Study|Death|1|||
33436070|NCT01694485|101488320|FG001|Overall Study|Death|0|||
33436071|NCT01694485|101488321|FG002|Overall Study|Death|0|||
33436072|NCT01694485|101488322|FG003|Overall Study|Death|1|||
33436073|NCT01694485|101488323|FG004|Overall Study|Death|0|||
33436074|NCT02041702|101488324|FG000|Overall Study|Lost to Follow-up|1|||
33436075|NCT02041702|101488325|FG001|Overall Study|Lost to Follow-up|6|||
33436076|NCT02041702|101488324|FG000|Overall Study|Death|4|||
33436077|NCT02041702|101488325|FG001|Overall Study|Death|0|||
33436078|NCT02041702|101488324|FG000|Overall Study|Withdrawal by Subject|4|||
33436079|NCT02041702|101488325|FG001|Overall Study|Withdrawal by Subject|3|||
33436080|NCT02041702|101488324|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
33436081|NCT02041702|101488325|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
33436082|NCT02041702|101488324|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
33436083|NCT02041702|101488325|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
33436084|NCT01469546|101488326|FG000|Received 5 mg Dose|Adverse Event|13|||
33436085|NCT01469546|101488326|FG000|Received 5 mg Dose|Death|2|||
33436086|NCT01469546|101488326|FG000|Received 5 mg Dose|Protocol Violation|2|||
33436087|NCT01469546|101488326|FG000|Received 5 mg Dose|Progressive Disease|3|||
33436088|NCT01469546|101488326|FG000|Received 5 mg Dose|Physician Decision|3|||
33436089|NCT01513551|101488329|FG000|Overall Study|Death|0|||
33436090|NCT01513551|101488330|FG001|Overall Study|Death|1|||
33436091|NCT01513551|101488331|FG002|Overall Study|Death|0|||
33436092|NCT01513551|101488329|FG000|Overall Study|Lost to Follow-up|3|||
33436093|NCT01513551|101488330|FG001|Overall Study|Lost to Follow-up|5|||
33436094|NCT01513551|101488331|FG002|Overall Study|Lost to Follow-up|2|||
33436095|NCT01513551|101488329|FG000|Overall Study|Withdrawal by Subject|1|||
33436096|NCT01513551|101488330|FG001|Overall Study|Withdrawal by Subject|0|||
33436097|NCT01513551|101488331|FG002|Overall Study|Withdrawal by Subject|2|||
33436098|NCT01513551|101488329|FG000|Overall Study|Randomized but not vaccinated|0|||
33436099|NCT01513551|101488330|FG001|Overall Study|Randomized but not vaccinated|0|||
33436100|NCT01513551|101488331|FG002|Overall Study|Randomized but not vaccinated|1|||
33436101|NCT03702621|101488336|FG000|Overall Study|Physician Decision|6|||
33436102|NCT03702621|101488337|FG001|Overall Study|Physician Decision|6|||
33436103|NCT01179919|101488338|FG000|Overall Study|Protocol Violation|1|||
33436104|NCT01179919|101488338|FG000|Overall Study|Adverse Event|1|||
33436105|NCT05346055|101488339|FG000|Overall Study|Withdrawal by Subject|1|||
33436106|NCT05346055|101488339|FG000|Overall Study|Protocol Violation|1|||
33436107|NCT05346055|101488339|FG000|Overall Study|Therapist decision|1|||
33436108|NCT00818623|101488341|FG000|Overall Study|Adverse Event|1|||
33436109|NCT00818623|101488342|FG001|Overall Study|Adverse Event|0|||
33436110|NCT00818623|101488343|FG002|Overall Study|Adverse Event|1|||
33436111|NCT00818623|101488344|FG003|Overall Study|Adverse Event|0|||
33436112|NCT00818623|101488345|FG004|Overall Study|Adverse Event|0|||
33436113|NCT00818623|101488346|FG005|Overall Study|Adverse Event|1|||
33436114|NCT00818623|101488347|FG006|Overall Study|Adverse Event|0|||
33436115|NCT00818623|101488348|FG007|Overall Study|Adverse Event|0|||
33436116|NCT00818623|101488341|FG000|Overall Study|Bad prostate specific antigen response|0|||
33436117|NCT00818623|101488342|FG001|Overall Study|Bad prostate specific antigen response|3|||
33436118|NCT00818623|101488343|FG002|Overall Study|Bad prostate specific antigen response|2|||
33436119|NCT00818623|101488344|FG003|Overall Study|Bad prostate specific antigen response|5|||
33436120|NCT00818623|101488345|FG004|Overall Study|Bad prostate specific antigen response|0|||
33436121|NCT00818623|101488346|FG005|Overall Study|Bad prostate specific antigen response|1|||
33436122|NCT00818623|101488347|FG006|Overall Study|Bad prostate specific antigen response|0|||
33436123|NCT00818623|101488348|FG007|Overall Study|Bad prostate specific antigen response|0|||
33436124|NCT00818623|101488341|FG000|Overall Study|Withdrawal by Subject|0|||
33436125|NCT00818623|101488342|FG001|Overall Study|Withdrawal by Subject|1|||
33436126|NCT00818623|101488343|FG002|Overall Study|Withdrawal by Subject|1|||
33436127|NCT00818623|101488344|FG003|Overall Study|Withdrawal by Subject|0|||
33436128|NCT00818623|101488345|FG004|Overall Study|Withdrawal by Subject|0|||
33436129|NCT00818623|101488346|FG005|Overall Study|Withdrawal by Subject|1|||
33436130|NCT00818623|101488347|FG006|Overall Study|Withdrawal by Subject|1|||
33436131|NCT00818623|101488348|FG007|Overall Study|Withdrawal by Subject|1|||
33436132|NCT00818623|101488341|FG000|Overall Study|Protocol Violation|1|||
33436133|NCT00818623|101488342|FG001|Overall Study|Protocol Violation|0|||
33436134|NCT00818623|101488343|FG002|Overall Study|Protocol Violation|0|||
33436135|NCT00818623|101488344|FG003|Overall Study|Protocol Violation|0|||
33436136|NCT00818623|101488345|FG004|Overall Study|Protocol Violation|1|||
33436137|NCT00818623|101488346|FG005|Overall Study|Protocol Violation|0|||
33436138|NCT00818623|101488347|FG006|Overall Study|Protocol Violation|1|||
33436139|NCT00818623|101488348|FG007|Overall Study|Protocol Violation|0|||
33436140|NCT00818623|101488341|FG000|Overall Study|Need of additional treatment|0|||
33436141|NCT00818623|101488342|FG001|Overall Study|Need of additional treatment|0|||
33436142|NCT00818623|101488343|FG002|Overall Study|Need of additional treatment|0|||
33436143|NCT00818623|101488344|FG003|Overall Study|Need of additional treatment|0|||
33436144|NCT00818623|101488345|FG004|Overall Study|Need of additional treatment|1|||
33436145|NCT00818623|101488346|FG005|Overall Study|Need of additional treatment|0|||
33436146|NCT00818623|101488347|FG006|Overall Study|Need of additional treatment|0|||
33436147|NCT00818623|101488348|FG007|Overall Study|Need of additional treatment|0|||
33436148|NCT00818623|101488341|FG000|Overall Study|Lack of trial drug at site|0|||
33436149|NCT00818623|101488342|FG001|Overall Study|Lack of trial drug at site|0|||
33436150|NCT00818623|101488343|FG002|Overall Study|Lack of trial drug at site|0|||
33436151|NCT00818623|101488344|FG003|Overall Study|Lack of trial drug at site|0|||
33436152|NCT00818623|101488345|FG004|Overall Study|Lack of trial drug at site|2|||
33436153|NCT00818623|101488346|FG005|Overall Study|Lack of trial drug at site|0|||
33436154|NCT00818623|101488347|FG006|Overall Study|Lack of trial drug at site|1|||
33436155|NCT00818623|101488348|FG007|Overall Study|Lack of trial drug at site|0|||
33436156|NCT00818623|101488341|FG000|Overall Study|Disease progression|0|||
33436157|NCT00818623|101488342|FG001|Overall Study|Disease progression|0|||
33436158|NCT00818623|101488343|FG002|Overall Study|Disease progression|0|||
33436159|NCT00818623|101488344|FG003|Overall Study|Disease progression|0|||
33436160|NCT00818623|101488345|FG004|Overall Study|Disease progression|0|||
33436161|NCT00818623|101488346|FG005|Overall Study|Disease progression|0|||
33436162|NCT00818623|101488347|FG006|Overall Study|Disease progression|1|||
33436163|NCT00818623|101488348|FG007|Overall Study|Disease progression|0|||
33436164|NCT01734772|101488351|FG000|Overall Study|Adverse Event|1|||
33436165|NCT01734772|101488352|FG001|Overall Study|Adverse Event|2|||
33436166|NCT01734772|101488351|FG000|Overall Study|Withdrawal by Subject|0|||
33436167|NCT01734772|101488352|FG001|Overall Study|Withdrawal by Subject|1|||
33436168|NCT04117607|101488353|FG000|Overall Study|Early Termination|0|||
33436169|NCT04117607|101488354|FG001|Overall Study|Early Termination|1|||
33436170|NCT04117607|101488355|FG002|Overall Study|Early Termination|0|||
33436171|NCT04117607|101488356|FG003|Overall Study|Early Termination|0|||
33436172|NCT04117607|101488357|FG004|Overall Study|Early Termination|0|||
33436173|NCT04117607|101488358|FG005|Overall Study|Early Termination|0|||
33436174|NCT04117607|101488359|FG006|Overall Study|Early Termination|1|||
33436175|NCT04117607|101488360|FG007|Overall Study|Early Termination|0|||
33436176|NCT04117607|101488361|FG008|Overall Study|Early Termination|0|||
33436177|NCT04117607|101488362|FG009|Overall Study|Early Termination|0|||
33436178|NCT04117607|101488363|FG010|Overall Study|Early Termination|0|||
33436179|NCT04117607|101488364|FG011|Overall Study|Early Termination|0|||
33436180|NCT04117607|101488365|FG012|Overall Study|Early Termination|0|||
33436181|NCT04117607|101488366|FG013|Overall Study|Early Termination|0|||
33436182|NCT04025879|101488367|FG000|Randomization|Participant withdrew consent|0|||
33436183|NCT04025879|101488368|FG001|Randomization|Participant withdrew consent|1|||
33436184|NCT04025879|101488367|FG000|Randomization|Participant no longer met study criteria|1|||
33436185|NCT04025879|101488368|FG001|Randomization|Participant no longer met study criteria|1|||
33436186|NCT04025879|101488367|FG000|Treatment|Ongoing treatment|10|||
33436187|NCT04025879|101488368|FG001|Treatment|Ongoing treatment|8|||
33436188|NCT04025879|101488367|FG000|Treatment|Disease progression/recurrence|36|||
33436189|NCT04025879|101488368|FG001|Treatment|Disease progression/recurrence|72|||
33436190|NCT04025879|101488367|FG000|Treatment|Study drug toxicity|36|||
33436191|NCT04025879|101488368|FG001|Treatment|Study drug toxicity|13|||
33436192|NCT04025879|101488367|FG000|Treatment|Death|2|||
33436193|NCT04025879|101488368|FG001|Treatment|Death|0|||
33436194|NCT04025879|101488367|FG000|Treatment|Adverse event unrelated to study drug|21|||
33150936|NCT01104701|100466974|FG002|Overall Study|Physician Decision|0|||
33150937|NCT01104701|100466975|FG003|Overall Study|Physician Decision|0|||
33150938|NCT04223232|100466976|FG000|Overall Study|Withdrawal by Subject|1|||
33150939|NCT02106910|100466978|FG000|Overall Study|Lost to Follow-up|1|||
33436195|NCT04025879|101488368|FG001|Treatment|Adverse event unrelated to study drug|14|||
33436196|NCT04025879|101488367|FG000|Treatment|Participant request to discontinue study treatment|16|||
33436197|NCT04025879|101488368|FG001|Treatment|Participant request to discontinue study treatment|8|||
33150940|NCT02106910|100466979|FG001|Overall Study|Lost to Follow-up|1|||
33436198|NCT04025879|101488367|FG000|Treatment|Participant withdrew consent|1|||
33436199|NCT04025879|101488368|FG001|Treatment|Participant withdrew consent|3|||
33150941|NCT00467610|100466981|FG000|Overall Study|Withdrawal by Subject|1|||
33150942|NCT00369122|100466982|FG000|Overall Study|Ineligible|10|||
33436200|NCT04025879|101488367|FG000|Treatment|Participant no longer meets study criteria|3|||
33436201|NCT04025879|101488368|FG001|Treatment|Participant no longer meets study criteria|2|||
33436202|NCT04025879|101488367|FG000|Treatment|Lost to Follow-up|1|||
33386019|NCT03287869|101299346|FG001|Overall Study|Non-Compliance With Study Drug|9|||
33386020|NCT03287869|101299345|FG000|Overall Study|Progressive Disease|1|||
33386021|NCT03287869|101299346|FG001|Overall Study|Progressive Disease|0|||
33386022|NCT03287869|101299345|FG000|Overall Study|Protocol Deviation|2|||
33386023|NCT03287869|101299346|FG001|Overall Study|Protocol Deviation|1|||
33386024|NCT03287869|101299345|FG000|Overall Study|Withdrawal by Subject|36|||
33436203|NCT04025879|101488368|FG001|Treatment|Lost to Follow-up|0|||
33386025|NCT03287869|101299346|FG001|Overall Study|Withdrawal by Subject|43|||
33386026|NCT03287869|101299345|FG000|Overall Study|Early Closure of the Site|0|||
33436204|NCT04025879|101488367|FG000|Treatment|Other reasons|15|||
33436205|NCT04025879|101488368|FG001|Treatment|Other reasons|17|||
33436206|NCT04025879|101488367|FG000|Treatment|Administrative reason by sponsor|0|||
33436207|NCT04025879|101488368|FG001|Treatment|Administrative reason by sponsor|1|||
33436208|NCT04025879|101488367|FG000|Treatment|Not reported|2|||
33436209|NCT04025879|101488368|FG001|Treatment|Not reported|0|||
33436210|NCT00436007|101488372|FG000|Overall Study|Withdrawal by Subject|5|||
33436211|NCT00436007|101488373|FG001|Overall Study|Withdrawal by Subject|3|||
33436212|NCT00436007|101488374|FG002|Overall Study|Withdrawal by Subject|4|||
33436213|NCT00436007|101488372|FG000|Overall Study|Lost to Follow-up|14|||
33436214|NCT00436007|101488373|FG001|Overall Study|Lost to Follow-up|10|||
33436215|NCT00436007|101488374|FG002|Overall Study|Lost to Follow-up|13|||
33436216|NCT00436007|101488372|FG000|Overall Study|Physician Decision|0|||
33436217|NCT00436007|101488373|FG001|Overall Study|Physician Decision|0|||
33386027|NCT03287869|101299346|FG001|Overall Study|Early Closure of the Site|1|||
33386028|NCT03287869|101299345|FG000|Overall Study|Physician Decision|5|||
33436218|NCT00436007|101488374|FG002|Overall Study|Physician Decision|2|||
33436219|NCT00436007|101488372|FG000|Overall Study|Death|0|||
33436220|NCT00436007|101488373|FG001|Overall Study|Death|1|||
33436221|NCT00436007|101488374|FG002|Overall Study|Death|3|||
33436222|NCT00436007|101488372|FG000|Overall Study|Other|0|||
33436223|NCT00436007|101488373|FG001|Overall Study|Other|0|||
33436224|NCT00436007|101488374|FG002|Overall Study|Other|1|||
33436225|NCT02674334|101488375|FG000|Overall Study|Lost to Follow-up|5|||
33436226|NCT02674334|101488376|FG001|Overall Study|Lost to Follow-up|3|||
33436227|NCT02674334|101488375|FG000|Overall Study|participant difficulty breathing|1|||
33436228|NCT02674334|101488376|FG001|Overall Study|participant difficulty breathing|0|||
33436229|NCT02674334|101488375|FG000|Overall Study|NIRS not recording|1|||
33436230|NCT02674334|101488376|FG001|Overall Study|NIRS not recording|0|||
33436231|NCT02483975|101488377|FG000|Overall Study|Adverse Event|0|||
33436232|NCT02483975|101488378|FG001|Overall Study|Adverse Event|1|||
33436233|NCT02483975|101488377|FG000|Overall Study|Lost to Follow-up|0|||
33436234|NCT02483975|101488378|FG001|Overall Study|Lost to Follow-up|1|||
33436235|NCT02483975|101488377|FG000|Overall Study|Physician Decision|2|||
33436236|NCT02483975|101488378|FG001|Overall Study|Physician Decision|0|||
33436237|NCT00684671|101488379|FG000|Overall Study|Adverse Event|1|||
33436238|NCT00684671|101488380|FG001|Overall Study|Adverse Event|0|||
33436239|NCT00684671|101488381|FG002|Overall Study|Adverse Event|0|||
33436240|NCT00684671|101488379|FG000|Overall Study|Lost to Follow-up|1|||
33436241|NCT00684671|101488380|FG001|Overall Study|Lost to Follow-up|0|||
33436242|NCT00684671|101488381|FG002|Overall Study|Lost to Follow-up|0|||
33436243|NCT00684671|101488379|FG000|Overall Study|Alcoholic dependance|1|||
33436244|NCT00684671|101488380|FG001|Overall Study|Alcoholic dependance|0|||
33436245|NCT00684671|101488381|FG002|Overall Study|Alcoholic dependance|0|||
33436246|NCT00356200|101488382|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
33436247|NCT00356200|101488383|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
33436248|NCT00356200|101488382|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
33436249|NCT00356200|101488383|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
33436250|NCT01166568|101488384|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
33436251|NCT01166568|101488385|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
33436252|NCT01166568|101488386|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
33436253|NCT01166568|101488384|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
33436254|NCT01166568|101488385|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
33436255|NCT01166568|101488386|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
33436256|NCT01166568|101488384|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
33436257|NCT01166568|101488385|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
33436258|NCT01166568|101488386|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
33436259|NCT03738332|101488389|FG000|Overall Study|Withdrawal by Subject|1|||
33436260|NCT01611090|101488392|FG000|Randomized Period|Lost to Follow-up|8|||
33436261|NCT01611090|101488393|FG001|Randomized Period|Lost to Follow-up|3|||
33436262|NCT01611090|101488394|FG002|Randomized Period|Lost to Follow-up|0|||
33436263|NCT01611090|101488392|FG000|Randomized Period|Withdrawal by Subject|22|||
33436264|NCT01611090|101488393|FG001|Randomized Period|Withdrawal by Subject|26|||
33436265|NCT01611090|101488394|FG002|Randomized Period|Withdrawal by Subject|0|||
33436266|NCT01611090|101488392|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
33436267|NCT01611090|101488393|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
33436268|NCT01611090|101488394|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
33436269|NCT01611090|101488392|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
33436270|NCT01611090|101488393|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
33436271|NCT01611090|101488394|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
33436272|NCT00663871|101488399|FG000|Overall Study|Lost to Follow-up|5|||
33436273|NCT00663871|101488400|FG001|Overall Study|Lost to Follow-up|5|||
33436274|NCT00663871|101488399|FG000|Overall Study|Withdrawal by Subject|5|||
33436275|NCT00663871|101488400|FG001|Overall Study|Withdrawal by Subject|2|||
33436276|NCT03717064|101488401|FG000|Period 2|Adverse Event|1|||
33436277|NCT03213210|101488402|FG000|Overall Study|Lost to Follow-up|2|||
33436278|NCT03213210|101488402|FG000|Overall Study|Study termination|3|||
33436279|NCT02187042|101488403|FG000|Overall Study|Death|1|||
33436280|NCT02187042|101488404|FG001|Overall Study|Death|1|||
33436281|NCT02187042|101488403|FG000|Overall Study|Toxicity|6|||
33436282|NCT02187042|101488404|FG001|Overall Study|Toxicity|5|||
33436283|NCT02187042|101488403|FG000|Overall Study|Participant choice|1|||
33436284|NCT02187042|101488404|FG001|Overall Study|Participant choice|0|||
33436285|NCT02187042|101488403|FG000|Overall Study|Doctor choice|1|||
33436286|NCT02187042|101488404|FG001|Overall Study|Doctor choice|0|||
33436287|NCT02187042|101488403|FG000|Overall Study|Progressive disease|4|||
33436288|NCT02187042|101488404|FG001|Overall Study|Progressive disease|8|||
33436289|NCT04015232|101488408|FG000|Overall Study|Withdrawal by Subject|7|||
33436290|NCT04015232|101488409|FG001|Overall Study|Withdrawal by Subject|4|||
33436291|NCT04015232|101488408|FG000|Overall Study|Protocol Violation|1|||
33386029|NCT03287869|101299346|FG001|Overall Study|Physician Decision|5|||
33386030|NCT03287869|101299345|FG000|Overall Study|Reason not Specified|6|||
33386031|NCT03287869|101299346|FG001|Overall Study|Reason not Specified|3|||
33386032|NCT01522443|101299347|FG000|Overall Study|No longer receiving clinical benefit|36|||
33386033|NCT01522443|101299348|FG001|Overall Study|No longer receiving clinical benefit|28|||
33386034|NCT01522443|101299347|FG000|Overall Study|Adverse Event|10|||
33386035|NCT01522443|101299348|FG001|Overall Study|Adverse Event|15|||
33386036|NCT01522443|101299347|FG000|Overall Study|Withdrawal by Subject|5|||
33386037|NCT01522443|101299348|FG001|Overall Study|Withdrawal by Subject|8|||
33386038|NCT01522443|101299347|FG000|Overall Study|No study treatment given|1|||
33386039|NCT01522443|101299348|FG001|Overall Study|No study treatment given|1|||
33386040|NCT01522443|101299347|FG000|Overall Study|Other|1|||
33386041|NCT01522443|101299348|FG001|Overall Study|Other|3|||
33386042|NCT01878097|101299349|FG000|Baseline|Surveys not fully completed|2497|||
33386043|NCT01878097|101299350|FG001|Baseline|Surveys not fully completed|1800|||
33386044|NCT01878097|101299349|FG000|Implementation Year 1|Surveys not fully completed|3202|||
33386045|NCT01878097|101299350|FG001|Implementation Year 1|Surveys not fully completed|2549|||
33386046|NCT01878097|101299349|FG000|Implementation Year 2|Surveys not fully completed|3281|||
33386047|NCT01878097|101299350|FG001|Implementation Year 2|Surveys not fully completed|2841|||
33386048|NCT01878097|101299349|FG000|Implementation Year 3|Surveys not fully completed|3494|||
33386049|NCT01878097|101299350|FG001|Implementation Year 3|Surveys not fully completed|2980|||
33386050|NCT01878097|101299349|FG000|Implementation Year 4|Surveys not fully completed|3604|||
33386051|NCT01878097|101299350|FG001|Implementation Year 4|Surveys not fully completed|3007|||
33386052|NCT01170221|101299353|FG000|Overall Study|Lost to Follow-up|22|||
33386053|NCT01170221|101299354|FG001|Overall Study|Lost to Follow-up|21|||
33386054|NCT01170221|101299353|FG000|Overall Study|Withdrawal by Subject|9|||
33386055|NCT01170221|101299354|FG001|Overall Study|Withdrawal by Subject|7|||
33386056|NCT01170221|101299353|FG000|Overall Study|Subject completed only screening and LFU|1|||
33386057|NCT01170221|101299354|FG001|Overall Study|Subject completed only screening and LFU|0|||
33386058|NCT01170221|101299353|FG000|Overall Study|Randomized but not treated|1|||
33150943|NCT00369122|100466982|FG000|Overall Study|No protocol treatment|1|||
33150944|NCT01231347|100466987|FG000|Overall Study|Full Consent withdrawn|19|||
33150945|NCT01231347|100466988|FG001|Overall Study|Full Consent withdrawn|19|||
33150946|NCT01231347|100466989|FG002|Overall Study|Full Consent withdrawn|11|||
33150947|NCT01231347|100466987|FG000|Overall Study|Lost to Follow-up|4|||
33150948|NCT01231347|100466988|FG001|Overall Study|Lost to Follow-up|2|||
33150949|NCT01231347|100466989|FG002|Overall Study|Lost to Follow-up|2|||
33436292|NCT04015232|101488409|FG001|Overall Study|Protocol Violation|0|||
33436293|NCT04015232|101488408|FG000|Overall Study|Medical Grounds|3|||
33150950|NCT01231347|100466987|FG000|Overall Study|Death|202|||
33150951|NCT01231347|100466988|FG001|Overall Study|Death|210|||
33150952|NCT01231347|100466989|FG002|Overall Study|Death|101|||
33150953|NCT01231347|100466987|FG000|Overall Study|other event|7|||
33150954|NCT01231347|100466988|FG001|Overall Study|other event|9|||
33150955|NCT01231347|100466989|FG002|Overall Study|other event|3|||
33150956|NCT01933217|100466990|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
33150957|NCT01933217|100466991|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
33150958|NCT01933217|100466990|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
33150959|NCT01933217|100466991|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
33150960|NCT02612129|100466994|FG000|Single Dose Treatment Period|Screening Failure|1|||
33150961|NCT02612129|100466995|FG001|Single Dose Treatment Period|Screening Failure|0|||
33150962|NCT02612129|100466996|FG002|Single Dose Treatment Period|Screening Failure|0|||
33150963|NCT02612129|100466994|FG000|Continuous Treatment Period|Early Escape|0|||
33150964|NCT02612129|100466995|FG001|Continuous Treatment Period|Early Escape|2|||
33249978|NCT01235949|100814565|FG015|Primary Phase|Withdrawal by Subject|0|||
33249979|NCT01235949|100814566|FG016|Primary Phase|Withdrawal by Subject|0|||
33249980|NCT01235949|100814567|FG017|Primary Phase|Withdrawal by Subject|0|||
33249981|NCT01235949|100814550|FG000|Primary Phase|Lost to Follow-up|0|||
33249982|NCT01235949|100814551|FG001|Primary Phase|Lost to Follow-up|0|||
33249983|NCT01235949|100814552|FG002|Primary Phase|Lost to Follow-up|1|||
33249984|NCT01235949|100814553|FG003|Primary Phase|Lost to Follow-up|1|||
33249985|NCT01235949|100814554|FG004|Primary Phase|Lost to Follow-up|0|||
33249986|NCT01235949|100814555|FG005|Primary Phase|Lost to Follow-up|2|||
33249987|NCT01235949|100814556|FG006|Primary Phase|Lost to Follow-up|0|||
33249988|NCT01235949|100814557|FG007|Primary Phase|Lost to Follow-up|0|||
33249989|NCT01235949|100814558|FG008|Primary Phase|Lost to Follow-up|0|||
33249990|NCT01235949|100814559|FG009|Primary Phase|Lost to Follow-up|0|||
33249991|NCT01235949|100814560|FG010|Primary Phase|Lost to Follow-up|0|||
33249992|NCT01235949|100814561|FG011|Primary Phase|Lost to Follow-up|0|||
33249993|NCT01235949|100814562|FG012|Primary Phase|Lost to Follow-up|0|||
33249994|NCT01235949|100814563|FG013|Primary Phase|Lost to Follow-up|0|||
33249995|NCT01235949|100814564|FG014|Primary Phase|Lost to Follow-up|0|||
33249996|NCT01235949|100814565|FG015|Primary Phase|Lost to Follow-up|0|||
33249997|NCT01235949|100814566|FG016|Primary Phase|Lost to Follow-up|0|||
33249998|NCT01235949|100814567|FG017|Primary Phase|Lost to Follow-up|0|||
33249999|NCT01235949|100814550|FG000|Booster Phase|Migrated/moved from study area|0|||
33250000|NCT01235949|100814551|FG001|Booster Phase|Migrated/moved from study area|0|||
33250001|NCT01235949|100814552|FG002|Booster Phase|Migrated/moved from study area|0|||
33250002|NCT01235949|100814553|FG003|Booster Phase|Migrated/moved from study area|0|||
33250003|NCT01235949|100814554|FG004|Booster Phase|Migrated/moved from study area|0|||
33150965|NCT02612129|100466996|FG002|Continuous Treatment Period|Early Escape|0|||
33150966|NCT02612129|100466994|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
33250004|NCT01235949|100814555|FG005|Booster Phase|Migrated/moved from study area|0|||
33250005|NCT01235949|100814556|FG006|Booster Phase|Migrated/moved from study area|0|||
33250006|NCT01235949|100814557|FG007|Booster Phase|Migrated/moved from study area|0|||
33250007|NCT01235949|100814558|FG008|Booster Phase|Migrated/moved from study area|0|||
33250008|NCT01235949|100814559|FG009|Booster Phase|Migrated/moved from study area|0|||
33250009|NCT01235949|100814560|FG010|Booster Phase|Migrated/moved from study area|0|||
33250010|NCT01235949|100814561|FG011|Booster Phase|Migrated/moved from study area|1|||
33150967|NCT02612129|100466995|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
33250011|NCT01235949|100814562|FG012|Booster Phase|Migrated/moved from study area|1|||
33250012|NCT01235949|100814563|FG013|Booster Phase|Migrated/moved from study area|0|||
33436294|NCT04015232|101488409|FG001|Overall Study|Medical Grounds|3|||
33150968|NCT02612129|100466996|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
33150969|NCT02612129|100466994|FG000|Continuous Treatment Period|Safety Reasons|0|||
33150970|NCT02612129|100466995|FG001|Continuous Treatment Period|Safety Reasons|3|||
33150971|NCT02612129|100466996|FG002|Continuous Treatment Period|Safety Reasons|0|||
33150972|NCT02612129|100466994|FG000|Continuous Treatment Period|Death|0|||
33150973|NCT02612129|100466995|FG001|Continuous Treatment Period|Death|1|||
33150974|NCT02612129|100466996|FG002|Continuous Treatment Period|Death|0|||
33150975|NCT02612129|100466994|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
33150976|NCT02612129|100466995|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
33150977|NCT02612129|100466996|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
33150978|NCT02810340|100467001|FG000|Overall Study|Withdrawal by Subject|1|||
33250013|NCT01235949|100814564|FG014|Booster Phase|Migrated/moved from study area|0|||
33250014|NCT01235949|100814565|FG015|Booster Phase|Migrated/moved from study area|0|||
33250015|NCT01235949|100814566|FG016|Booster Phase|Migrated/moved from study area|0|||
33250016|NCT01235949|100814567|FG017|Booster Phase|Migrated/moved from study area|1|||
33250017|NCT01235949|100814550|FG000|Booster Phase|Adverse Event|0|||
33250018|NCT01235949|100814551|FG001|Booster Phase|Adverse Event|0|||
33250019|NCT01235949|100814552|FG002|Booster Phase|Adverse Event|0|||
33250020|NCT01235949|100814553|FG003|Booster Phase|Adverse Event|0|||
33250021|NCT01235949|100814554|FG004|Booster Phase|Adverse Event|0|||
33250022|NCT01235949|100814555|FG005|Booster Phase|Adverse Event|0|||
33250023|NCT01235949|100814556|FG006|Booster Phase|Adverse Event|0|||
33250024|NCT01235949|100814557|FG007|Booster Phase|Adverse Event|0|||
33250025|NCT01235949|100814558|FG008|Booster Phase|Adverse Event|0|||
33250026|NCT01235949|100814559|FG009|Booster Phase|Adverse Event|0|||
33250027|NCT01235949|100814560|FG010|Booster Phase|Adverse Event|0|||
33250028|NCT01235949|100814561|FG011|Booster Phase|Adverse Event|0|||
33250029|NCT01235949|100814562|FG012|Booster Phase|Adverse Event|0|||
33250030|NCT01235949|100814563|FG013|Booster Phase|Adverse Event|0|||
33250031|NCT01235949|100814564|FG014|Booster Phase|Adverse Event|0|||
33250032|NCT01235949|100814565|FG015|Booster Phase|Adverse Event|1|||
33250033|NCT01235949|100814566|FG016|Booster Phase|Adverse Event|0|||
33250034|NCT01235949|100814567|FG017|Booster Phase|Adverse Event|0|||
33250035|NCT01235949|100814550|FG000|Booster Phase|Withdrawal by Subject|0|||
33250036|NCT01235949|100814551|FG001|Booster Phase|Withdrawal by Subject|0|||
33250037|NCT01235949|100814552|FG002|Booster Phase|Withdrawal by Subject|0|||
33250038|NCT01235949|100814553|FG003|Booster Phase|Withdrawal by Subject|0|||
33250039|NCT01235949|100814554|FG004|Booster Phase|Withdrawal by Subject|0|||
33250040|NCT01235949|100814555|FG005|Booster Phase|Withdrawal by Subject|0|||
33250041|NCT01235949|100814556|FG006|Booster Phase|Withdrawal by Subject|0|||
33250042|NCT01235949|100814557|FG007|Booster Phase|Withdrawal by Subject|1|||
33250043|NCT01235949|100814558|FG008|Booster Phase|Withdrawal by Subject|1|||
33386059|NCT01170221|101299354|FG001|Overall Study|Randomized but not treated|0|||
33250044|NCT01235949|100814559|FG009|Booster Phase|Withdrawal by Subject|0|||
33250045|NCT01235949|100814560|FG010|Booster Phase|Withdrawal by Subject|1|||
33250046|NCT01235949|100814561|FG011|Booster Phase|Withdrawal by Subject|1|||
33250047|NCT01235949|100814562|FG012|Booster Phase|Withdrawal by Subject|2|||
33250048|NCT01235949|100814563|FG013|Booster Phase|Withdrawal by Subject|0|||
33250049|NCT01235949|100814564|FG014|Booster Phase|Withdrawal by Subject|2|||
33250050|NCT01235949|100814565|FG015|Booster Phase|Withdrawal by Subject|0|||
33250051|NCT01235949|100814566|FG016|Booster Phase|Withdrawal by Subject|0|||
33386060|NCT03235726|101299358|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33250052|NCT01235949|100814567|FG017|Booster Phase|Withdrawal by Subject|0|||
33250053|NCT01235949|100814550|FG000|Booster Phase|Lost to Follow-up|0|||
33250054|NCT01235949|100814551|FG001|Booster Phase|Lost to Follow-up|0|||
33250055|NCT01235949|100814552|FG002|Booster Phase|Lost to Follow-up|0|||
33150979|NCT02810340|100467002|FG001|Overall Study|Withdrawal by Subject|0|||
33436295|NCT03209570|101488412|FG000|Overall Study|Death|1|||
33436296|NCT03209570|101488413|FG001|Overall Study|Death|0|||
33436297|NCT03209570|101488412|FG000|Overall Study|Incomplete Data|8|||
33436298|NCT03209570|101488413|FG001|Overall Study|Incomplete Data|10|||
33436299|NCT03209570|101488412|FG000|Overall Study|Protocol Violation|1|||
33436300|NCT03209570|101488413|FG001|Overall Study|Protocol Violation|0|||
33150980|NCT02810340|100467003|FG002|Overall Study|Withdrawal by Subject|0|||
33150981|NCT02810340|100467001|FG000|Overall Study|Incarceration|0|||
33150982|NCT02810340|100467002|FG001|Overall Study|Incarceration|1|||
33150983|NCT02810340|100467003|FG002|Overall Study|Incarceration|0|||
33436301|NCT03209570|101488412|FG000|Overall Study|Withdrawal by Subject|0|||
33150984|NCT02810340|100467001|FG000|Overall Study|Lost to Follow-up|0|||
33150985|NCT02810340|100467002|FG001|Overall Study|Lost to Follow-up|0|||
33150986|NCT02810340|100467003|FG002|Overall Study|Lost to Follow-up|1|||
33150987|NCT01323946|100467006|FG000|Overall Study|Lost to Follow-up|0|||
33150988|NCT01323946|100467007|FG001|Overall Study|Lost to Follow-up|1|||
33150989|NCT01323946|100467008|FG002|Overall Study|Lost to Follow-up|0|||
33436302|NCT03209570|101488413|FG001|Overall Study|Withdrawal by Subject|3|||
33436303|NCT00824265|101488414|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
33436304|NCT00824265|101488415|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
33436305|NCT00824265|101488414|FG000|Treatment Phase|Protocol Violation|1|||
33436306|NCT00824265|101488415|FG001|Treatment Phase|Protocol Violation|0|||
33436307|NCT00824265|101488414|FG000|Treatment Phase|Lost to Follow-up|1|||
33436308|NCT00824265|101488415|FG001|Treatment Phase|Lost to Follow-up|1|||
33436309|NCT00824265|101488414|FG000|Treatment Phase|Physician Decision|6|||
33436310|NCT00824265|101488415|FG001|Treatment Phase|Physician Decision|12|||
33436311|NCT00824265|101488414|FG000|Treatment Phase|Withdrawal by Subject|6|||
33436312|NCT00824265|101488415|FG001|Treatment Phase|Withdrawal by Subject|15|||
33436313|NCT00824265|101488414|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
33436314|NCT00824265|101488415|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
33436315|NCT00824265|101488414|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
33436316|NCT00824265|101488415|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
33436317|NCT00444145|101488418|FG000|Overall Study|Withdrawal by Subject|2|||
33436318|NCT00444145|101488418|FG000|Overall Study|Lost to Follow-up|1|||
33436319|NCT00444145|101488418|FG000|Overall Study|non-compliant|11|||
33436320|NCT00444145|101488418|FG000|Overall Study|Screen Failures|5|||
33436321|NCT00337077|101492394|FG000|Overall Study|Progressive disease|25|||
33436322|NCT00337077|101492395|FG001|Overall Study|Progressive disease|37|||
33436323|NCT00337077|101492396|FG002|Overall Study|Progressive disease|19|||
33436324|NCT00337077|101492394|FG000|Overall Study|Adverse Event|7|||
33436325|NCT00337077|101492395|FG001|Overall Study|Adverse Event|7|||
33436326|NCT00337077|101492396|FG002|Overall Study|Adverse Event|1|||
33436327|NCT00337077|101492394|FG000|Overall Study|Death|0|||
33436328|NCT00337077|101492395|FG001|Overall Study|Death|1|||
33436329|NCT00337077|101492396|FG002|Overall Study|Death|0|||
33436330|NCT00337077|101492394|FG000|Overall Study|Withdrawal by Subject|7|||
33436331|NCT00337077|101492395|FG001|Overall Study|Withdrawal by Subject|2|||
33436332|NCT00337077|101492396|FG002|Overall Study|Withdrawal by Subject|2|||
33436333|NCT00337077|101492394|FG000|Overall Study|Alternative therapy|1|||
33436334|NCT00337077|101492395|FG001|Overall Study|Alternative therapy|0|||
33436335|NCT00337077|101492396|FG002|Overall Study|Alternative therapy|0|||
33436336|NCT00337077|101492394|FG000|Overall Study|Physician Decision|1|||
33436337|NCT00337077|101492395|FG001|Overall Study|Physician Decision|4|||
33436338|NCT00337077|101492396|FG002|Overall Study|Physician Decision|2|||
33436339|NCT00337077|101492394|FG000|Overall Study|Never started treatment|1|||
33150990|NCT01323946|100467006|FG000|Overall Study|Parents refused the last blood draw|1|||
33150991|NCT01323946|100467007|FG001|Overall Study|Parents refused the last blood draw|0|||
33386061|NCT03235726|101299359|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33386062|NCT03235726|101299360|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33386063|NCT03235726|101299361|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33386064|NCT03235726|101299362|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
33386065|NCT03235726|101299363|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33386066|NCT03235726|101299364|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33386067|NCT03235726|101299365|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33386068|NCT03235726|101299366|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33386069|NCT03235726|101299367|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
33386070|NCT03235726|101299358|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33386071|NCT03235726|101299359|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33386072|NCT03235726|101299360|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33386073|NCT03235726|101299361|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33386074|NCT03235726|101299362|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
33386075|NCT03235726|101299363|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33150992|NCT01323946|100467008|FG002|Overall Study|Parents refused the last blood draw|0|||
33150993|NCT01323946|100467006|FG000|Overall Study|Withdrawal by Subject|2|||
33150994|NCT01323946|100467007|FG001|Overall Study|Withdrawal by Subject|2|||
33150995|NCT01323946|100467008|FG002|Overall Study|Withdrawal by Subject|0|||
33150996|NCT02963831|100467009|FG000|Overall Study|Progressive Disease|3|||
33150997|NCT02963831|100467010|FG001|Overall Study|Progressive Disease|3|||
33150998|NCT02963831|100467011|FG002|Overall Study|Progressive Disease|16|||
33150999|NCT02963831|100467012|FG003|Overall Study|Progressive Disease|27|||
33151000|NCT02963831|100467009|FG000|Overall Study|Withdrawal by Subject|1|||
33151001|NCT02963831|100467010|FG001|Overall Study|Withdrawal by Subject|0|||
33151002|NCT02963831|100467011|FG002|Overall Study|Withdrawal by Subject|2|||
33151003|NCT02963831|100467012|FG003|Overall Study|Withdrawal by Subject|4|||
33151004|NCT02963831|100467009|FG000|Overall Study|Adverse Event|0|||
33151005|NCT02963831|100467010|FG001|Overall Study|Adverse Event|1|||
33151006|NCT02963831|100467011|FG002|Overall Study|Adverse Event|1|||
33151007|NCT02963831|100467012|FG003|Overall Study|Adverse Event|2|||
33151008|NCT02963831|100467009|FG000|Overall Study|Death|0|||
33151009|NCT02963831|100467010|FG001|Overall Study|Death|0|||
33151010|NCT02963831|100467011|FG002|Overall Study|Death|0|||
33151011|NCT02963831|100467012|FG003|Overall Study|Death|2|||
33151012|NCT04439175|100467013|FG000|Overall Study|Never started treatment|4|||
33151013|NCT04439175|100467013|FG000|Overall Study|Ineligible|5|||
33151014|NCT04439175|100467013|FG000|Overall Study|Adverse Event|6|||
33151015|NCT04439175|100467013|FG000|Overall Study|Death|4|||
33151016|NCT04439175|100467013|FG000|Overall Study|Disease progression|44|||
33151017|NCT04439175|100467013|FG000|Overall Study|Withdrawal by Subject|4|||
33151018|NCT04439175|100467013|FG000|Overall Study|Alternative Therapy|1|||
33151019|NCT04439175|100467013|FG000|Overall Study|Other|2|||
33151020|NCT01822496|100467014|FG000|Overall Study|Protocol Violation|2|||
33151021|NCT01822496|100467015|FG001|Overall Study|Protocol Violation|2|||
33151022|NCT01822496|100467016|FG002|Overall Study|Protocol Violation|0|||
33151023|NCT01822496|100467017|FG003|Overall Study|Protocol Violation|1|||
33151024|NCT01822496|100467014|FG000|Overall Study|Withdrawal by Subject|0|||
33151025|NCT01822496|100467015|FG001|Overall Study|Withdrawal by Subject|0|||
33250056|NCT01235949|100814553|FG003|Booster Phase|Lost to Follow-up|0|||
33151026|NCT01822496|100467016|FG002|Overall Study|Withdrawal by Subject|0|||
33151027|NCT01822496|100467017|FG003|Overall Study|Withdrawal by Subject|3|||
33151028|NCT05268055|100467018|FG000|Overall Study|Lost to Follow-up|68|||
33151029|NCT05268055|100467019|FG001|Overall Study|Lost to Follow-up|68|||
33151030|NCT05268055|100467018|FG000|Overall Study|Withdrawal by Subject|12|||
33151031|NCT05268055|100467019|FG001|Overall Study|Withdrawal by Subject|8|||
33151032|NCT01243671|100467020|FG000|Overall Study|Adverse Event|3|||
33151033|NCT01243671|100467020|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
33151034|NCT01243671|100467020|FG000|Overall Study|Other|1|||
33151035|NCT04399837|100467022|FG000|Overall Study|Other than listed|0|||
33151036|NCT04399837|100467023|FG001|Overall Study|Other than listed|2|||
33151037|NCT04399837|100467024|FG002|Overall Study|Other than listed|2|||
33151038|NCT04399837|100467025|FG003|Overall Study|Other than listed|3|||
33151039|NCT04399837|100467022|FG000|Overall Study|Withdrawal by Subject|1|||
33151040|NCT04399837|100467023|FG001|Overall Study|Withdrawal by Subject|2|||
33151041|NCT04399837|100467024|FG002|Overall Study|Withdrawal by Subject|1|||
33151042|NCT04399837|100467025|FG003|Overall Study|Withdrawal by Subject|1|||
33151043|NCT04795622|100467026|FG000|Overall Study|Adverse Event|1|||
33151044|NCT04795622|100467027|FG001|Overall Study|Adverse Event|0|||
33151045|NCT04795622|100467026|FG000|Overall Study|Withdrawal by Subject|3|||
33151046|NCT04795622|100467027|FG001|Overall Study|Withdrawal by Subject|3|||
33151047|NCT04795622|100467026|FG000|Overall Study|Protocol Violation|0|||
33151048|NCT04795622|100467027|FG001|Overall Study|Protocol Violation|2|||
33151049|NCT04795622|100467026|FG000|Overall Study|Lost to Follow-up|2|||
33151050|NCT04795622|100467027|FG001|Overall Study|Lost to Follow-up|3|||
33151051|NCT04795622|100467026|FG000|Overall Study|Other|7|||
33151052|NCT04795622|100467027|FG001|Overall Study|Other|8|||
33151053|NCT01147172|100467029|FG000|Overall Study|Withdrawal by Subject|2|||
33151054|NCT01147172|100467029|FG000|Overall Study|Lost to Follow-up|2|||
33151055|NCT00943124|100467032|FG000|Period 1|Withdrawal by Subject|1|||
33151056|NCT00943124|100467033|FG001|Period 1|Withdrawal by Subject|1|||
33151057|NCT00943124|100467032|FG000|Period 1|Did Not Follow Study Procedures|1|||
33151058|NCT00943124|100467033|FG001|Period 1|Did Not Follow Study Procedures|0|||
33151059|NCT00943124|100467032|FG000|Period 1|Personal Reasons|0|||
33151060|NCT00943124|100467033|FG001|Period 1|Personal Reasons|1|||
33151061|NCT01225887|100467034|FG000|Overall Study|Ineligible:required test not done|2|||
33151062|NCT01225887|100467034|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
33436340|NCT00337077|101492395|FG001|Overall Study|Never started treatment|1|||
33151063|NCT01225887|100467034|FG000|Overall Study|Ineligible:inadequate pathology|2|||
33151064|NCT01086423|100467035|FG000|Overall Study|Protocol Violation|0|||
33151065|NCT01086423|100467036|FG001|Overall Study|Protocol Violation|0|||
33151066|NCT01086423|100467037|FG002|Overall Study|Protocol Violation|1|||
33151067|NCT01086423|100467035|FG000|Overall Study|Migrated/moved from study area|2|||
33151068|NCT01086423|100467036|FG001|Overall Study|Migrated/moved from study area|0|||
33151069|NCT01086423|100467037|FG002|Overall Study|Migrated/moved from study area|4|||
33151070|NCT01086423|100467035|FG000|Overall Study|Adverse event, fatal|1|||
33151071|NCT01086423|100467036|FG001|Overall Study|Adverse event, fatal|1|||
33151072|NCT01086423|100467037|FG002|Overall Study|Adverse event, fatal|0|||
33151073|NCT01086423|100467035|FG000|Overall Study|Adverse event, non-fatal|2|||
33151074|NCT01086423|100467036|FG001|Overall Study|Adverse event, non-fatal|1|||
33151075|NCT01086423|100467037|FG002|Overall Study|Adverse event, non-fatal|0|||
33436341|NCT00337077|101492396|FG002|Overall Study|Never started treatment|0|||
33436342|NCT00337077|101492394|FG000|Overall Study|Ineligible|1|||
33436343|NCT00337077|101492395|FG001|Overall Study|Ineligible|1|||
33436344|NCT00337077|101492396|FG002|Overall Study|Ineligible|1|||
33436345|NCT00576901|101492409|FG000|Overall Study|Withdrawal by Subject|1|||
33436346|NCT00576901|101492409|FG000|Overall Study|Disease course|1|||
33436347|NCT00576901|101492409|FG000|Overall Study|Protocol Violation|1|||
33436348|NCT00950872|101492410|FG000|Overall Study|Withdrawal by Subject|1|||
33436349|NCT00950872|101492410|FG000|Overall Study|Did not have surgery|2|||
33436350|NCT03309956|101492413|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
33436351|NCT03823300|101492414|FG000|Overall Study|Withdrawal by Subject|16|||
33436352|NCT03823300|101492415|FG001|Overall Study|Withdrawal by Subject|22|||
33436353|NCT03823300|101492414|FG000|Overall Study|Death|10|||
33436354|NCT03823300|101492415|FG001|Overall Study|Death|14|||
33436355|NCT03823300|101492414|FG000|Overall Study|Adverse Event|3|||
33436356|NCT03823300|101492415|FG001|Overall Study|Adverse Event|5|||
33151076|NCT01086423|100467035|FG000|Overall Study|Withdrawal by Subject|5|||
33151077|NCT01086423|100467036|FG001|Overall Study|Withdrawal by Subject|1|||
33151078|NCT01086423|100467037|FG002|Overall Study|Withdrawal by Subject|3|||
33151079|NCT01086423|100467035|FG000|Overall Study|Lost to Follow-up|0|||
33151080|NCT01086423|100467036|FG001|Overall Study|Lost to Follow-up|0|||
33151081|NCT01086423|100467037|FG002|Overall Study|Lost to Follow-up|1|||
33151082|NCT01104155|100467038|FG000|Overall Study|Adverse Event|15|||
33151083|NCT01104155|100467039|FG001|Overall Study|Adverse Event|8|||
33151084|NCT01104155|100467038|FG000|Overall Study|Participant choice|6|||
33151085|NCT01104155|100467039|FG001|Overall Study|Participant choice|5|||
33151086|NCT01104155|100467038|FG000|Overall Study|Withdrawal of consent|1|||
33151087|NCT01104155|100467039|FG001|Overall Study|Withdrawal of consent|1|||
33151088|NCT01104155|100467038|FG000|Overall Study|Other|3|||
33151089|NCT01104155|100467039|FG001|Overall Study|Other|4|||
33151090|NCT00932737|100467042|FG000|Overall Study|Not treated in second episode|1|||
33151091|NCT00932737|100467043|FG001|Overall Study|Not treated in second episode|0|||
33151092|NCT00932737|100467042|FG000|Overall Study|Adverse Event|0|||
33151093|NCT00932737|100467043|FG001|Overall Study|Adverse Event|1|||
33151094|NCT03799211|100467044|FG000|Overall Study|Lost to Follow-up|2|||
33151095|NCT03799211|100467045|FG001|Overall Study|Lost to Follow-up|13|||
33151096|NCT03799211|100467044|FG000|Overall Study|Withdrawal by Subject|2|||
33151097|NCT03799211|100467045|FG001|Overall Study|Withdrawal by Subject|0|||
33151098|NCT03004443|100467052|FG000|Overall Study|Pregnancy|0|||
33151099|NCT03004443|100467053|FG001|Overall Study|Pregnancy|1|||
33151100|NCT03875235|100467054|FG000|Overall Study|Ongoing study treatment|63|||
33151101|NCT03875235|100467055|FG001|Overall Study|Ongoing study treatment|20|||
33151102|NCT03875235|100467054|FG000|Overall Study|Off treatment|77|||
33151103|NCT03875235|100467055|FG001|Overall Study|Off treatment|91|||
33151104|NCT03875235|100467054|FG000|Overall Study|Withdrawal by Subject|3|||
33151105|NCT03875235|100467055|FG001|Overall Study|Withdrawal by Subject|10|||
33151106|NCT03875235|100467054|FG000|Overall Study|Death|198|||
33151107|NCT03875235|100467055|FG001|Overall Study|Death|223|||
33151108|NCT01631812|100467058|FG000|Overall Study|Adverse Event|25|||
33151109|NCT01631812|100467058|FG000|Overall Study|Lack of Efficacy|5|||
33151110|NCT01631812|100467058|FG000|Overall Study|Withdrawal by Subject|4|||
33151111|NCT01631812|100467058|FG000|Overall Study|Physician Decision|3|||
33151112|NCT02520661|100467059|FG000|Overall Study|Lost to Follow-up|7|||
33151113|NCT02520661|100467060|FG001|Overall Study|Lost to Follow-up|3|||
33151114|NCT02520661|100467059|FG000|Overall Study|Admitted from ED|49|||
33151115|NCT02520661|100467060|FG001|Overall Study|Admitted from ED|48|||
33151116|NCT02520661|100467059|FG000|Overall Study|ED greater than 24 hours|29|||
33151117|NCT02520661|100467060|FG001|Overall Study|ED greater than 24 hours|38|||
33151118|NCT02520661|100467059|FG000|Overall Study|other ineligibility|14|||
33151119|NCT02520661|100467060|FG001|Overall Study|other ineligibility|22|||
33151120|NCT02520661|100467059|FG000|Overall Study|Withdrawal by Subject|7|||
33151121|NCT02520661|100467060|FG001|Overall Study|Withdrawal by Subject|16|||
33151122|NCT00591344|100470113|FG000|Overall Study|Transportation issues|1|||
33386076|NCT03235726|101299364|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33386077|NCT03235726|101299365|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33386078|NCT03235726|101299366|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33386079|NCT03235726|101299367|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
33386080|NCT01455415|101299368|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
33386081|NCT01455415|101299369|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
33386082|NCT01455415|101299368|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
33386083|NCT01455415|101299369|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
33386084|NCT01455415|101299368|FG000|Period 1|Drug Error not Associated to AE|0|||
33386085|NCT01455415|101299369|FG001|Period 1|Drug Error not Associated to AE|1|||
33386086|NCT01455415|101299368|FG000|Period 1|AE Not Related to Study Drug|2|||
33386087|NCT01455415|101299369|FG001|Period 1|AE Not Related to Study Drug|6|||
33386088|NCT01455415|101299368|FG000|Period 1|Withdrawal by Subject|4|||
33386089|NCT01455415|101299369|FG001|Period 1|Withdrawal by Subject|5|||
33386090|NCT01455415|101299368|FG000|Period 1|Unspecified Reason|1|||
33386091|NCT01455415|101299369|FG001|Period 1|Unspecified Reason|1|||
33386092|NCT01455415|101299368|FG000|Period 1|Protocol Violation|0|||
33386093|NCT01455415|101299369|FG001|Period 1|Protocol Violation|2|||
33386094|NCT01455415|101299368|FG000|Washout|AE Related to Study Drug|2|||
33386095|NCT01455415|101299369|FG001|Washout|AE Related to Study Drug|0|||
33386096|NCT01455415|101299368|FG000|Washout|Lost to Follow-up|1|||
33386097|NCT01455415|101299369|FG001|Washout|Lost to Follow-up|0|||
33436357|NCT03823300|101492414|FG000|Overall Study|Physician Decision|1|||
33151123|NCT00591344|100470114|FG001|Overall Study|Transportation issues|0|||
33151124|NCT00591344|100470113|FG000|Overall Study|Moved out of state|1|||
33151125|NCT00591344|100470114|FG001|Overall Study|Moved out of state|0|||
33151126|NCT00591344|100470113|FG000|Overall Study|Medical complications|1|||
33151127|NCT00591344|100470114|FG001|Overall Study|Medical complications|3|||
33151128|NCT00591344|100470113|FG000|Overall Study|Underwent DBS|2|||
33151129|NCT00591344|100470114|FG001|Overall Study|Underwent DBS|2|||
33151130|NCT00591344|100470113|FG000|Overall Study|Death|0|||
33151131|NCT00591344|100470114|FG001|Overall Study|Death|1|||
33436358|NCT03823300|101492415|FG001|Overall Study|Physician Decision|7|||
33436359|NCT03823300|101492414|FG000|Overall Study|Lost to Follow-up|1|||
33436360|NCT03823300|101492415|FG001|Overall Study|Lost to Follow-up|3|||
33436361|NCT03823300|101492414|FG000|Overall Study|Protocol Violation|1|||
33436362|NCT03823300|101492415|FG001|Overall Study|Protocol Violation|1|||
33436363|NCT03823300|101492414|FG000|Overall Study|Lack of Efficacy|1|||
33436364|NCT03823300|101492415|FG001|Overall Study|Lack of Efficacy|1|||
33436365|NCT03823300|101492414|FG000|Overall Study|Not Eligible|0|||
33436366|NCT03823300|101492415|FG001|Overall Study|Not Eligible|1|||
33436367|NCT03823300|101492414|FG000|Overall Study|Other|1|||
33436368|NCT03823300|101492415|FG001|Overall Study|Other|0|||
33436369|NCT00977106|101492416|FG000|Overall Study|Adverse Event|5|||
33436370|NCT00977106|101492417|FG001|Overall Study|Adverse Event|6|||
33436371|NCT00977106|101492416|FG000|Overall Study|Withdrawal by Subject|2|||
33436372|NCT00977106|101492417|FG001|Overall Study|Withdrawal by Subject|2|||
33436373|NCT00977106|101492416|FG000|Overall Study|Lack of Efficacy|2|||
33436374|NCT00977106|101492417|FG001|Overall Study|Lack of Efficacy|2|||
33436375|NCT00977106|101492416|FG000|Overall Study|Protocol Violation|0|||
33436376|NCT00977106|101492417|FG001|Overall Study|Protocol Violation|1|||
33436377|NCT00977106|101492416|FG000|Overall Study|Other|1|||
33436378|NCT00977106|101492417|FG001|Overall Study|Other|0|||
33436379|NCT02761980|101492418|FG000|Overall Study|Adverse Event|4|||
33436380|NCT02761980|101492419|FG001|Overall Study|Adverse Event|6|||
33436381|NCT02761980|101492420|FG002|Overall Study|Adverse Event|5|||
33436382|NCT02761980|101492421|FG003|Overall Study|Adverse Event|6|||
33436383|NCT02761980|101492418|FG000|Overall Study|Withdrawal by Subject|0|||
33436384|NCT02761980|101492419|FG001|Overall Study|Withdrawal by Subject|1|||
33436385|NCT02761980|101492420|FG002|Overall Study|Withdrawal by Subject|0|||
33436386|NCT02761980|101492421|FG003|Overall Study|Withdrawal by Subject|0|||
33436387|NCT02761980|101492418|FG000|Overall Study|Other|0|||
33436388|NCT02761980|101492419|FG001|Overall Study|Other|0|||
33436389|NCT02761980|101492420|FG002|Overall Study|Other|1|||
33436390|NCT02761980|101492421|FG003|Overall Study|Other|0|||
33436391|NCT00497796|101492426|FG000|Overall Study|Adverse event (not related)|9|||
33436392|NCT00497796|101492427|FG001|Overall Study|Adverse event (not related)|9|||
33436393|NCT00497796|101492426|FG000|Overall Study|Adverse event (related)|5|||
33436394|NCT00497796|101492427|FG001|Overall Study|Adverse event (related)|4|||
33436395|NCT00497796|101492426|FG000|Overall Study|CMV infection or disease treatment|30|||
33436396|NCT00497796|101492427|FG001|Overall Study|CMV infection or disease treatment|4|||
33436397|NCT00497796|101492426|FG000|Overall Study|Consent withdrawn|10|||
33436398|NCT00497796|101492427|FG001|Overall Study|Consent withdrawn|3|||
33436399|NCT00497796|101492426|FG000|Overall Study|Investigator/sponsor discretion|31|||
33436400|NCT00497796|101492427|FG001|Overall Study|Investigator/sponsor discretion|34|||
33436401|NCT00497796|101492426|FG000|Overall Study|Lost to Follow-up|0|||
33436402|NCT00497796|101492427|FG001|Overall Study|Lost to Follow-up|1|||
33386098|NCT01455415|101299368|FG000|Washout|Drug Error not Associated to AE|2|||
33386099|NCT01455415|101299369|FG001|Washout|Drug Error not Associated to AE|1|||
33386100|NCT01455415|101299368|FG000|Washout|AE Not Related to Study Drug|2|||
33386101|NCT01455415|101299369|FG001|Washout|AE Not Related to Study Drug|3|||
33386102|NCT01455415|101299368|FG000|Washout|Unspecified Reason|1|||
33386103|NCT01455415|101299369|FG001|Washout|Unspecified Reason|2|||
33386104|NCT01455415|101299368|FG000|Washout|Protocol Violation|0|||
33386105|NCT01455415|101299369|FG001|Washout|Protocol Violation|1|||
33386106|NCT01455415|101299368|FG000|Period 2|AE Related to Study Drug|1|||
33436403|NCT00497796|101492426|FG000|Overall Study|Not applicable (randomized not treated)|0|||
33436404|NCT00497796|101492427|FG001|Overall Study|Not applicable (randomized not treated)|4|||
33436405|NCT01725451|101492428|FG000|Period 1|Withdrawal by Subject|1|||
33436406|NCT01725451|101492429|FG001|Period 1|Withdrawal by Subject|0|||
33436407|NCT01725451|101492430|FG002|Period 1|Withdrawal by Subject|0|||
33436408|NCT01725451|101492431|FG003|Period 1|Withdrawal by Subject|0|||
33436409|NCT01725451|101492428|FG000|Washout From Period 3|Protocol Violation|0|||
33436410|NCT01725451|101492429|FG001|Washout From Period 3|Protocol Violation|0|||
33436411|NCT01725451|101492430|FG002|Washout From Period 3|Protocol Violation|1|||
33436412|NCT01725451|101492431|FG003|Washout From Period 3|Protocol Violation|0|||
33436413|NCT01725451|101492428|FG000|Washout From Period 3|Adverse Event|0|||
33436414|NCT01725451|101492429|FG001|Washout From Period 3|Adverse Event|1|||
33436415|NCT01725451|101492430|FG002|Washout From Period 3|Adverse Event|0|||
33436416|NCT01725451|101492431|FG003|Washout From Period 3|Adverse Event|0|||
33386107|NCT01455415|101299369|FG001|Period 2|AE Related to Study Drug|2|||
33151132|NCT00591344|100470113|FG000|Overall Study|Lost to Follow-up|0|||
33151133|NCT00591344|100470114|FG001|Overall Study|Lost to Follow-up|1|||
33151134|NCT00591344|100470113|FG000|Overall Study|Did not want to come off medication|0|||
33151135|NCT00591344|100470114|FG001|Overall Study|Did not want to come off medication|1|||
33151136|NCT00900601|100470116|FG000|Overall Study|Physician Decision|1|||
33151137|NCT00537238|100470119|FG000|Overall Study|Death|1|||
33151138|NCT00537238|100470120|FG001|Overall Study|Death|2|||
33151139|NCT00537238|100470119|FG000|Overall Study|Adverse Event|31|||
33151140|NCT00537238|100470120|FG001|Overall Study|Adverse Event|22|||
33151141|NCT00537238|100470119|FG000|Overall Study|Lack of Efficacy|20|||
33151142|NCT00537238|100470120|FG001|Overall Study|Lack of Efficacy|21|||
33151143|NCT00537238|100470119|FG000|Overall Study|Lost to Follow-up|12|||
33151144|NCT00537238|100470120|FG001|Overall Study|Lost to Follow-up|8|||
33151145|NCT00537238|100470119|FG000|Overall Study|Withdrawal by Subject|51|||
33151146|NCT00537238|100470120|FG001|Overall Study|Withdrawal by Subject|47|||
33151147|NCT00537238|100470119|FG000|Overall Study|Protocol Violation|15|||
33151148|NCT00537238|100470120|FG001|Overall Study|Protocol Violation|19|||
33151149|NCT00537238|100470119|FG000|Overall Study|Does not meet entrance criteria|0|||
33151150|NCT00537238|100470120|FG001|Overall Study|Does not meet entrance criteria|2|||
33151151|NCT00537238|100470119|FG000|Overall Study|Other|44|||
33151152|NCT00537238|100470120|FG001|Overall Study|Other|52|||
33151153|NCT04526509|100470121|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
33151154|NCT04526509|100470122|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
33151155|NCT04526509|100470123|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
33151156|NCT04526509|100470124|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
33151157|NCT04526509|100470125|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
33151158|NCT04526509|100470126|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
33151159|NCT04526509|100470127|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
33151160|NCT04526509|100470121|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
33151161|NCT04526509|100470122|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
33151162|NCT04526509|100470123|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
33151163|NCT04526509|100470124|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
33151164|NCT04526509|100470125|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
33151165|NCT04526509|100470126|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
33151166|NCT04526509|100470127|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
33151167|NCT04526509|100470121|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
33151168|NCT04526509|100470122|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
33151169|NCT04526509|100470123|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
33386108|NCT01455415|101299368|FG000|Period 2|Lost to Follow-up|2|||
33386109|NCT01455415|101299369|FG001|Period 2|Lost to Follow-up|1|||
33386110|NCT01455415|101299368|FG000|Period 2|AE Not Related to Study Drug|2|||
33386111|NCT01455415|101299369|FG001|Period 2|AE Not Related to Study Drug|1|||
33386112|NCT01455415|101299368|FG000|Period 2|Lack of Efficacy|2|||
33386113|NCT01455415|101299369|FG001|Period 2|Lack of Efficacy|0|||
33386114|NCT01455415|101299368|FG000|Period 2|Withdrawal by Subject|2|||
33386115|NCT01455415|101299369|FG001|Period 2|Withdrawal by Subject|3|||
33386116|NCT01455415|101299368|FG000|Period 2|Unspecified Reason|2|||
33386117|NCT01455415|101299369|FG001|Period 2|Unspecified Reason|3|||
33386118|NCT01455415|101299368|FG000|Period 2|Protocol Violation|2|||
33386119|NCT01455415|101299369|FG001|Period 2|Protocol Violation|0|||
33386120|NCT01455415|101299368|FG000|Follow-up|AE Related to Study Drug|0|||
33386121|NCT01455415|101299369|FG001|Follow-up|AE Related to Study Drug|1|||
33386122|NCT01455415|101299368|FG000|Follow-up|Lack of Efficacy|0|||
33386123|NCT01455415|101299369|FG001|Follow-up|Lack of Efficacy|1|||
33250057|NCT01235949|100814554|FG004|Booster Phase|Lost to Follow-up|0|||
33386124|NCT01455415|101299368|FG000|Follow-up|Withdrawal by Subject|2|||
33386125|NCT01455415|101299369|FG001|Follow-up|Withdrawal by Subject|0|||
33386126|NCT01455415|101299368|FG000|Follow-up|Unspecified Reason|1|||
33386127|NCT01455415|101299369|FG001|Follow-up|Unspecified Reason|0|||
33386128|NCT00132314|101299379|FG000|Overall Study|Lost to Follow-up|70|||
33386129|NCT00132314|101299380|FG001|Overall Study|Lost to Follow-up|62|||
33386130|NCT00132314|101299379|FG000|Overall Study|Lacked SSN|1|||
33386131|NCT00132314|101299380|FG001|Overall Study|Lacked SSN|3|||
33386132|NCT00132314|101299379|FG000|Overall Study|Refused intervention at baseline|2|||
33386133|NCT00132314|101299380|FG001|Overall Study|Refused intervention at baseline|7|||
33386134|NCT00861380|101299383|FG000|Overall Study|Withdrawal Information not recorded|8427|||
33386135|NCT00861380|101299384|FG001|Overall Study|Withdrawal Information not recorded|9112|||
33386136|NCT00861380|101299385|FG002|Overall Study|Withdrawal Information not recorded|8872|||
33386137|NCT00861380|101299386|FG003|Overall Study|Withdrawal Information not recorded|3689|||
33386138|NCT00861380|101299387|FG004|Overall Study|Withdrawal Information not recorded|1812|||
33386139|NCT00861380|101299388|FG005|Overall Study|Withdrawal Information not recorded|6249|||
33386140|NCT00861380|101299389|FG006|Overall Study|Withdrawal Information not recorded|3020|||
33386141|NCT01213264|101299390|FG000|Overall Study|Adverse Event|1|||
33386142|NCT01213264|101299391|FG001|Overall Study|Adverse Event|0|||
33151170|NCT04526509|100470124|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
33151171|NCT04526509|100470125|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
33151172|NCT04526509|100470126|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
33151173|NCT04526509|100470127|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
33151174|NCT04526509|100470121|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
33151175|NCT04526509|100470122|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
33151176|NCT04526509|100470123|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
33151177|NCT04526509|100470124|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
33151178|NCT04526509|100470125|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
33151179|NCT04526509|100470126|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
33151180|NCT04526509|100470127|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
33151181|NCT04526509|100470121|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
33151182|NCT04526509|100470122|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
33151183|NCT04526509|100470123|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
33151184|NCT04526509|100470124|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
33151185|NCT04526509|100470125|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
33151186|NCT04526509|100470126|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
33151187|NCT04526509|100470127|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
33151188|NCT04526509|100470121|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
33151189|NCT04526509|100470122|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
33151190|NCT04526509|100470123|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
33151191|NCT04526509|100470124|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
33151192|NCT04526509|100470125|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
33151193|NCT04526509|100470126|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
33151194|NCT04526509|100470127|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
33151195|NCT04526509|100470121|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
33151196|NCT04526509|100470122|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
33151197|NCT04526509|100470123|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
33151198|NCT04526509|100470124|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
33151199|NCT04526509|100470125|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
33151200|NCT04526509|100470126|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
33151201|NCT04526509|100470127|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
33151202|NCT04526509|100470121|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
33151203|NCT04526509|100470122|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
33151204|NCT04526509|100470123|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
33151205|NCT04526509|100470124|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
33250058|NCT01235949|100814555|FG005|Booster Phase|Lost to Follow-up|0|||
33151206|NCT04526509|100470125|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
33151207|NCT04526509|100470126|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
33151208|NCT04526509|100470127|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
33151209|NCT04526509|100470121|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
33151210|NCT04526509|100470122|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
33151211|NCT04526509|100470123|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
33151212|NCT04526509|100470124|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
33151213|NCT04526509|100470125|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
33151214|NCT04526509|100470126|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
33151215|NCT04526509|100470127|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
33151216|NCT04526509|100470121|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
33151217|NCT04526509|100470122|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
33151218|NCT04526509|100470123|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
33151219|NCT04526509|100470124|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
33151220|NCT04526509|100470125|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
33250059|NCT01235949|100814556|FG006|Booster Phase|Lost to Follow-up|0|||
33250060|NCT01235949|100814557|FG007|Booster Phase|Lost to Follow-up|0|||
33250061|NCT01235949|100814558|FG008|Booster Phase|Lost to Follow-up|1|||
33250062|NCT01235949|100814559|FG009|Booster Phase|Lost to Follow-up|1|||
33386143|NCT01213264|101299392|FG002|Overall Study|Adverse Event|0|||
33250063|NCT01235949|100814560|FG010|Booster Phase|Lost to Follow-up|1|||
33151221|NCT04526509|100470126|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
33151222|NCT04526509|100470127|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
33151223|NCT04526509|100470121|FG000|Enrolled|Study Terminated by Sponsor|0|||
33151224|NCT04526509|100470122|FG001|Enrolled|Study Terminated by Sponsor|0|||
33151225|NCT04526509|100470123|FG002|Enrolled|Study Terminated by Sponsor|0|||
33151226|NCT04526509|100470124|FG003|Enrolled|Study Terminated by Sponsor|0|||
33151227|NCT04526509|100470125|FG004|Enrolled|Study Terminated by Sponsor|0|||
33151228|NCT04526509|100470126|FG005|Enrolled|Study Terminated by Sponsor|0|||
33151229|NCT04526509|100470127|FG006|Enrolled|Study Terminated by Sponsor|1|||
33151230|NCT04526509|100470121|FG000|Enrolled|Death prior to lymphodepletion|0|||
33151231|NCT04526509|100470122|FG001|Enrolled|Death prior to lymphodepletion|0|||
33151232|NCT04526509|100470123|FG002|Enrolled|Death prior to lymphodepletion|0|||
33151233|NCT04526509|100470124|FG003|Enrolled|Death prior to lymphodepletion|1|||
33151234|NCT04526509|100470125|FG004|Enrolled|Death prior to lymphodepletion|0|||
33151235|NCT04526509|100470126|FG005|Enrolled|Death prior to lymphodepletion|0|||
33151236|NCT04526509|100470127|FG006|Enrolled|Death prior to lymphodepletion|0|||
33151237|NCT04526509|100470121|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
33151238|NCT04526509|100470122|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
33151239|NCT04526509|100470123|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
33151240|NCT04526509|100470124|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
33151241|NCT04526509|100470125|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
33151242|NCT04526509|100470126|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
33151243|NCT04526509|100470127|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
33151244|NCT04526509|100470121|FG000|Enrolled|Physician Decision|0|||
33151245|NCT04526509|100470122|FG001|Enrolled|Physician Decision|1|||
33151246|NCT04526509|100470123|FG002|Enrolled|Physician Decision|0|||
33151247|NCT04526509|100470124|FG003|Enrolled|Physician Decision|0|||
33151248|NCT04526509|100470125|FG004|Enrolled|Physician Decision|0|||
33151249|NCT04526509|100470126|FG005|Enrolled|Physician Decision|0|||
33151250|NCT04526509|100470127|FG006|Enrolled|Physician Decision|0|||
33151251|NCT02963935|100470130|FG000|Overall Study|Adverse Event|12|||
33151252|NCT02963935|100470131|FG001|Overall Study|Adverse Event|6|||
33151253|NCT02963935|100470130|FG000|Overall Study|Protocol Violation|2|||
33151254|NCT02963935|100470131|FG001|Overall Study|Protocol Violation|1|||
33151255|NCT02963935|100470130|FG000|Overall Study|Lack of Efficacy|0|||
33151256|NCT02963935|100470131|FG001|Overall Study|Lack of Efficacy|2|||
33151257|NCT02963935|100470130|FG000|Overall Study|Lost to Follow-up|1|||
33151258|NCT02963935|100470131|FG001|Overall Study|Lost to Follow-up|6|||
33151259|NCT02963935|100470130|FG000|Overall Study|Unclassified|13|||
33151260|NCT02963935|100470131|FG001|Overall Study|Unclassified|22|||
33151261|NCT02160782|100470136|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
33151262|NCT02160782|100470137|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
33151263|NCT02160782|100470138|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
33151264|NCT02160782|100470139|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
33151265|NCT02160782|100470140|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
33151266|NCT02160782|100470136|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
33151267|NCT02160782|100470137|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
33151268|NCT02160782|100470138|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
33151269|NCT02160782|100470139|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
33151270|NCT02160782|100470140|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
33151271|NCT02160782|100470136|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
33151272|NCT02160782|100470137|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
33151273|NCT02160782|100470138|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
33151274|NCT02160782|100470139|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
33151275|NCT02160782|100470140|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
33151276|NCT02160782|100470136|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
33151277|NCT02160782|100470137|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
33151278|NCT02160782|100470138|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
33151279|NCT02160782|100470139|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
33151280|NCT02160782|100470140|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
33151281|NCT02160782|100470136|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
33151282|NCT02160782|100470137|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
33151283|NCT02160782|100470138|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
33151284|NCT02160782|100470139|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
33151285|NCT02160782|100470140|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
33151286|NCT02160782|100470136|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
33151287|NCT02160782|100470137|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
33436417|NCT01725451|101492428|FG000|Period 4|Adverse Event|0|||
33436418|NCT01725451|101492429|FG001|Period 4|Adverse Event|0|||
33436419|NCT01725451|101492430|FG002|Period 4|Adverse Event|1|||
33436420|NCT01725451|101492431|FG003|Period 4|Adverse Event|0|||
33436421|NCT00418184|101492441|FG000|Double-blind Phase|Withdrawal by Subject|22|||
33436422|NCT00418184|101492442|FG001|Double-blind Phase|Withdrawal by Subject|9|||
33436423|NCT00418184|101492441|FG000|Double-blind Phase|Adverse Event|2|||
33436424|NCT00418184|101492442|FG001|Double-blind Phase|Adverse Event|1|||
33436425|NCT00418184|101492441|FG000|Double-blind Phase|Poor compliance|3|||
33151288|NCT02160782|100470138|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
33151289|NCT02160782|100470139|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
33151290|NCT02160782|100470140|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
33386144|NCT01213264|101299390|FG000|Overall Study|Lost to Follow-up|1|||
33386145|NCT01213264|101299391|FG001|Overall Study|Lost to Follow-up|2|||
33436426|NCT00418184|101492442|FG001|Double-blind Phase|Poor compliance|1|||
33151291|NCT02160782|100470136|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
33151292|NCT02160782|100470137|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
33151293|NCT02160782|100470138|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
33151294|NCT02160782|100470139|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
33151295|NCT02160782|100470140|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
33151296|NCT01859143|100470142|FG000|Overall Study|Lost to Follow-up|2|||
33151297|NCT01859143|100470143|FG001|Overall Study|Lost to Follow-up|0|||
33151298|NCT03347188|100470145|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
33151299|NCT03347188|100470146|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
33151300|NCT03347188|100470145|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
33151301|NCT03347188|100470146|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
33151302|NCT03347188|100470145|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
33151303|NCT03347188|100470146|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
33151304|NCT03347188|100470145|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
33151305|NCT03347188|100470146|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
33151306|NCT03347188|100470145|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
33151307|NCT03347188|100470146|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
33151308|NCT03347188|100470145|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
33151309|NCT03347188|100470146|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
33151310|NCT03347188|100470145|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
33151311|NCT03347188|100470146|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
33151312|NCT03347188|100470145|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
33151313|NCT03347188|100470146|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
33436427|NCT02907203|101492443|FG000|Overall Study|Death|1|||
33436428|NCT02907203|101492443|FG000|Overall Study|Lost to Follow-up|3|||
33436429|NCT02907203|101492443|FG000|Overall Study|Withdrawal by Subject|3|||
33436430|NCT02907203|101492443|FG000|Overall Study|Surgical bypass|1|||
33436431|NCT02534493|101492444|FG000|Overall Study|Lost to Follow-up|1|||
33436432|NCT02534493|101492444|FG000|Overall Study|Withdrawal by Subject|1|||
33436433|NCT02428699|101492445|FG000|Washout Period 1|Screen Failure|1|||
33436434|NCT02428699|101492446|FG001|Washout Period 1|Screen Failure|2|||
33436435|NCT01025037|101492447|FG000|Overall Study|Adverse Event|3|||
33436436|NCT01025037|101492447|FG000|Overall Study|Lost to Follow-up|7|||
33436437|NCT01025037|101492447|FG000|Overall Study|Withdrawal by Subject|1|||
33436438|NCT02888171|101492456|FG000|Overall Study|Lost to Follow-up|2|||
33436439|NCT02888171|101492457|FG001|Overall Study|Lost to Follow-up|1|||
33436440|NCT02888171|101492456|FG000|Overall Study|Withdrawal by Subject|3|||
33436441|NCT02888171|101492457|FG001|Overall Study|Withdrawal by Subject|2|||
33436442|NCT02888171|101492456|FG000|Overall Study|Adverse Event|0|||
33436443|NCT02888171|101492457|FG001|Overall Study|Adverse Event|1|||
33436444|NCT00449150|101492458|FG000|Overall Study|Adverse Event|11|||
33151314|NCT04209348|100470147|FG000|Overall Study|Lost to Follow-up|1|||
33151315|NCT04209348|100470148|FG001|Overall Study|Lost to Follow-up|0|||
33151316|NCT02787551|100470150|FG000|Core Period: 26 Weeks|Adverse Event|10|||
33151317|NCT02787551|100470151|FG001|Core Period: 26 Weeks|Adverse Event|0|||
33386146|NCT01213264|101299392|FG002|Overall Study|Lost to Follow-up|6|||
33386147|NCT00884221|101299393|FG000|Overall Study|Withdrawal by Subject|0|||
33386148|NCT00884221|101299394|FG001|Overall Study|Withdrawal by Subject|3|||
33386149|NCT00884221|101299393|FG000|Overall Study|Adverse Event|6|||
33386150|NCT00884221|101299394|FG001|Overall Study|Adverse Event|3|||
33386151|NCT00884221|101299393|FG000|Overall Study|Protocol Violation|16|||
33386152|NCT00884221|101299394|FG001|Overall Study|Protocol Violation|13|||
33436445|NCT00449150|101492459|FG001|Overall Study|Adverse Event|18|||
33436446|NCT00449150|101492460|FG002|Overall Study|Adverse Event|9|||
33436447|NCT00449150|101492458|FG000|Overall Study|Lack of Efficacy|1|||
33436448|NCT00449150|101492459|FG001|Overall Study|Lack of Efficacy|2|||
33436449|NCT00449150|101492460|FG002|Overall Study|Lack of Efficacy|2|||
33436450|NCT00449150|101492458|FG000|Overall Study|Other|16|||
33436451|NCT00449150|101492459|FG001|Overall Study|Other|13|||
33436452|NCT00449150|101492460|FG002|Overall Study|Other|14|||
33436453|NCT00449150|101492458|FG000|Overall Study|Withdrawal by Subject|17|||
33151318|NCT02787551|100470150|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
33151319|NCT02787551|100470151|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
33151320|NCT02787551|100470150|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
33151321|NCT02787551|100470151|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
33250064|NCT01235949|100814561|FG011|Booster Phase|Lost to Follow-up|1|||
33436454|NCT00449150|101492459|FG001|Overall Study|Withdrawal by Subject|18|||
33436455|NCT00449150|101492460|FG002|Overall Study|Withdrawal by Subject|21|||
33436456|NCT00449150|101492458|FG000|Overall Study|Protocol Violation|1|||
33151322|NCT02787551|100470150|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
33151323|NCT02787551|100470151|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
33250065|NCT01235949|100814562|FG012|Booster Phase|Lost to Follow-up|0|||
33250066|NCT01235949|100814563|FG013|Booster Phase|Lost to Follow-up|0|||
33250067|NCT01235949|100814564|FG014|Booster Phase|Lost to Follow-up|0|||
33250068|NCT01235949|100814565|FG015|Booster Phase|Lost to Follow-up|0|||
33250069|NCT01235949|100814566|FG016|Booster Phase|Lost to Follow-up|0|||
33250070|NCT01235949|100814567|FG017|Booster Phase|Lost to Follow-up|1|||
33386153|NCT00884221|101299393|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
33436457|NCT00449150|101492459|FG001|Overall Study|Protocol Violation|2|||
33436458|NCT00449150|101492460|FG002|Overall Study|Protocol Violation|1|||
33151324|NCT02787551|100470150|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
33386154|NCT00884221|101299394|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
33386155|NCT00510068|101302419|FG000|Double-blind Period|Disease progression|98|||
33386156|NCT00510068|101302420|FG001|Double-blind Period|Disease progression|169|||
33151325|NCT02787551|100470151|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
33151326|NCT02787551|100470150|FG000|Core Period: 26 Weeks|Other than specified|3|||
33151327|NCT02787551|100470151|FG001|Core Period: 26 Weeks|Other than specified|1|||
33151328|NCT02787551|100470150|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
33151329|NCT02787551|100470151|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
33151330|NCT02787551|100470150|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
33151331|NCT02787551|100470151|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
33151332|NCT02787551|100470150|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
33151333|NCT02787551|100470151|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
33151334|NCT00761579|100470152|FG000|Overall Study|Adverse Event|10|||
33151335|NCT00761579|100470152|FG000|Overall Study|Death|2|||
33151336|NCT00761579|100470152|FG000|Overall Study|Lack of Efficacy|21|||
33151337|NCT00761579|100470152|FG000|Overall Study|Lost to Follow-up|16|||
33151338|NCT00761579|100470152|FG000|Overall Study|Pregnancy|1|||
33151339|NCT00761579|100470152|FG000|Overall Study|Withdrawal by Subject|34|||
33151340|NCT00761579|100470152|FG000|Overall Study|Lack of compliance|2|||
33151341|NCT00761579|100470152|FG000|Overall Study|Protocol deviation|1|||
33151342|NCT00761579|100470152|FG000|Overall Study|Drug overdose|1|||
33151343|NCT00761579|100470152|FG000|Overall Study|Aggravation of depression|1|||
33151344|NCT00761579|100470152|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
33151345|NCT00761579|100470152|FG000|Overall Study|Lost survey form|1|||
33151346|NCT00761579|100470152|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
33151347|NCT02322021|100470153|FG000|Core Phase|Adverse Event|1|||
33151348|NCT02322021|100470154|FG001|Core Phase|Adverse Event|3|||
33151349|NCT02322021|100470155|FG002|Core Phase|Adverse Event|4|||
33151350|NCT02322021|100470156|FG003|Core Phase|Adverse Event|2|||
33151351|NCT02322021|100470157|FG004|Core Phase|Adverse Event|0|||
33151352|NCT02322021|100470153|FG000|Core Phase|Participant Choice|4|||
33151353|NCT02322021|100470154|FG001|Core Phase|Participant Choice|5|||
33151354|NCT02322021|100470155|FG002|Core Phase|Participant Choice|4|||
33151355|NCT02322021|100470156|FG003|Core Phase|Participant Choice|2|||
33151356|NCT02322021|100470157|FG004|Core Phase|Participant Choice|0|||
33151357|NCT02322021|100470153|FG000|Core Phase|Lost to Follow-up|0|||
33151358|NCT02322021|100470154|FG001|Core Phase|Lost to Follow-up|0|||
33151359|NCT02322021|100470155|FG002|Core Phase|Lost to Follow-up|0|||
33151360|NCT02322021|100470156|FG003|Core Phase|Lost to Follow-up|1|||
33151361|NCT02322021|100470157|FG004|Core Phase|Lost to Follow-up|0|||
33151362|NCT02322021|100470153|FG000|Core Phase|Other|0|||
33151363|NCT02322021|100470154|FG001|Core Phase|Other|0|||
33151364|NCT02322021|100470155|FG002|Core Phase|Other|1|||
33151365|NCT02322021|100470156|FG003|Core Phase|Other|0|||
33151366|NCT02322021|100470157|FG004|Core Phase|Other|0|||
33151367|NCT02322021|100470153|FG000|Extension Phase|Adverse Event|0|||
33151368|NCT02322021|100470154|FG001|Extension Phase|Adverse Event|0|||
33151369|NCT02322021|100470155|FG002|Extension Phase|Adverse Event|0|||
33151370|NCT02322021|100470156|FG003|Extension Phase|Adverse Event|0|||
33151371|NCT02322021|100470157|FG004|Extension Phase|Adverse Event|3|||
33151372|NCT02322021|100470153|FG000|Extension Phase|Participant Choice|0|||
33151373|NCT02322021|100470154|FG001|Extension Phase|Participant Choice|0|||
33151374|NCT02322021|100470155|FG002|Extension Phase|Participant Choice|0|||
33151375|NCT02322021|100470156|FG003|Extension Phase|Participant Choice|0|||
33151376|NCT02322021|100470157|FG004|Extension Phase|Participant Choice|6|||
33151377|NCT02322021|100470153|FG000|Extension Phase|Other|0|||
33151378|NCT02322021|100470154|FG001|Extension Phase|Other|0|||
33151379|NCT02322021|100470155|FG002|Extension Phase|Other|0|||
33151380|NCT02322021|100470156|FG003|Extension Phase|Other|0|||
33151381|NCT02322021|100470157|FG004|Extension Phase|Other|3|||
33151382|NCT02322021|100470153|FG000|Extension Phase|Lost to Follow-up|0|||
33151383|NCT02322021|100470154|FG001|Extension Phase|Lost to Follow-up|0|||
33151384|NCT02322021|100470155|FG002|Extension Phase|Lost to Follow-up|0|||
33151385|NCT02322021|100470156|FG003|Extension Phase|Lost to Follow-up|0|||
33151386|NCT02322021|100470157|FG004|Extension Phase|Lost to Follow-up|1|||
33386157|NCT00510068|101302419|FG000|Double-blind Period|Final primary analysis|52|||
33386158|NCT00510068|101302420|FG001|Double-blind Period|Final primary analysis|18|||
33386159|NCT00510068|101302419|FG000|Double-blind Period|Adverse Event|37|||
33386160|NCT00510068|101302420|FG001|Double-blind Period|Adverse Event|7|||
33386161|NCT00510068|101302419|FG000|Double-blind Period|Withdrawal by Subject|8|||
33151387|NCT02322021|100470153|FG000|Extension Phase|Study terminated by sponsor|0|||
33151388|NCT02322021|100470154|FG001|Extension Phase|Study terminated by sponsor|0|||
33151389|NCT02322021|100470155|FG002|Extension Phase|Study terminated by sponsor|0|||
33151390|NCT02322021|100470156|FG003|Extension Phase|Study terminated by sponsor|0|||
33151391|NCT02322021|100470157|FG004|Extension Phase|Study terminated by sponsor|28|||
33151392|NCT05314478|100470158|FG000|Overall Study|Physician Decision|1|||
33151393|NCT01702571|100470159|FG000|Overall Study|Death|1067|||
33151394|NCT01702571|100470160|FG001|Overall Study|Death|76|||
33151395|NCT01702571|100470159|FG000|Overall Study|Lost to Follow-up|144|||
33151396|NCT01702571|100470160|FG001|Overall Study|Lost to Follow-up|10|||
33151397|NCT01702571|100470159|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
33436459|NCT03125200|101492463|FG000|Overall Study|Study Termination|0|||
33436460|NCT03125200|101492464|FG001|Overall Study|Study Termination|0|||
33436461|NCT03125200|101492465|FG002|Overall Study|Study Termination|0|||
33436462|NCT03125200|101492466|FG003|Overall Study|Study Termination|1|||
33436463|NCT03125200|101492467|FG004|Overall Study|Study Termination|1|||
33436464|NCT03125200|101492468|FG005|Overall Study|Study Termination|2|||
33436465|NCT03125200|101492469|FG006|Overall Study|Study Termination|1|||
33436466|NCT03125200|101492463|FG000|Overall Study|Clinical Progression|0|||
33436467|NCT03125200|101492464|FG001|Overall Study|Clinical Progression|0|||
33436468|NCT03125200|101492465|FG002|Overall Study|Clinical Progression|0|||
33436469|NCT03125200|101492466|FG003|Overall Study|Clinical Progression|1|||
33436470|NCT03125200|101492467|FG004|Overall Study|Clinical Progression|0|||
33436471|NCT03125200|101492468|FG005|Overall Study|Clinical Progression|1|||
33436472|NCT03125200|101492469|FG006|Overall Study|Clinical Progression|0|||
33436473|NCT03125200|101492463|FG000|Overall Study|Progressive Disease|2|||
33436474|NCT03125200|101492464|FG001|Overall Study|Progressive Disease|1|||
33436475|NCT03125200|101492465|FG002|Overall Study|Progressive Disease|2|||
33436476|NCT03125200|101492466|FG003|Overall Study|Progressive Disease|1|||
33151398|NCT01702571|100470160|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
33436477|NCT03125200|101492467|FG004|Overall Study|Progressive Disease|2|||
33436478|NCT03125200|101492468|FG005|Overall Study|Progressive Disease|0|||
33436479|NCT03125200|101492469|FG006|Overall Study|Progressive Disease|1|||
33436480|NCT03125200|101492463|FG000|Overall Study|Lack of Efficacy|0|||
33436481|NCT03125200|101492464|FG001|Overall Study|Lack of Efficacy|0|||
33436482|NCT03125200|101492465|FG002|Overall Study|Lack of Efficacy|0|||
33151399|NCT01702571|100470159|FG000|Overall Study|Investigator Decision|5|||
33151400|NCT01702571|100470160|FG001|Overall Study|Investigator Decision|0|||
33151401|NCT01702571|100470159|FG000|Overall Study|Not Classifiable|1|||
33151402|NCT01702571|100470160|FG001|Overall Study|Not Classifiable|0|||
33151403|NCT01702571|100470159|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
33151404|NCT01702571|100470160|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
33151405|NCT01702571|100470159|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
33151406|NCT01702571|100470160|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
33151407|NCT01702571|100470159|FG000|Overall Study|Progressive Disease|3|||
33151408|NCT01702571|100470160|FG001|Overall Study|Progressive Disease|0|||
33151409|NCT01702571|100470159|FG000|Overall Study|Protocol Violation|2|||
33151410|NCT01702571|100470160|FG001|Overall Study|Protocol Violation|0|||
33151411|NCT01702571|100470159|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
33151412|NCT01702571|100470160|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
33151413|NCT01702571|100470159|FG000|Overall Study|Termination By Sponsor|4|||
33151414|NCT01702571|100470160|FG001|Overall Study|Termination By Sponsor|0|||
33151415|NCT01702571|100470159|FG000|Overall Study|Withdrawal by Subject|177|||
33151416|NCT01702571|100470160|FG001|Overall Study|Withdrawal by Subject|29|||
33151417|NCT03360747|100470161|FG000|Overall Study|Voluntary Withdrawal|1|||
33151418|NCT00976677|100470162|FG000|Overall Study|Adverse Event|1|||
33151419|NCT00976677|100470163|FG001|Overall Study|Adverse Event|0|||
33151420|NCT00976677|100470162|FG000|Overall Study|Withdrawal by Subject|0|||
33151421|NCT00976677|100470163|FG001|Overall Study|Withdrawal by Subject|2|||
33151422|NCT00976677|100470162|FG000|Overall Study|Disease progression|1|||
33151423|NCT00976677|100470163|FG001|Overall Study|Disease progression|1|||
33151424|NCT00976677|100470162|FG000|Overall Study|Trial unblinded|2|||
33151425|NCT00976677|100470163|FG001|Overall Study|Trial unblinded|2|||
33151426|NCT00976677|100470162|FG000|Overall Study|Unknown/Missing|1|||
33151427|NCT00976677|100470163|FG001|Overall Study|Unknown/Missing|0|||
33151428|NCT02497612|100470164|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
33151429|NCT02497612|100470165|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
33151430|NCT02497612|100470166|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
33151431|NCT02497612|100470167|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
33151432|NCT02497612|100470164|FG000|Overall Study|Participant's request|2|||
33151433|NCT02497612|100470165|FG001|Overall Study|Participant's request|3|||
33151434|NCT02497612|100470166|FG002|Overall Study|Participant's request|4|||
33151435|NCT02497612|100470167|FG003|Overall Study|Participant's request|1|||
33436483|NCT03125200|101492466|FG003|Overall Study|Lack of Efficacy|1|||
33436484|NCT03125200|101492467|FG004|Overall Study|Lack of Efficacy|0|||
33151436|NCT02497612|100470164|FG000|Overall Study|Investigator's judgement|1|||
33151437|NCT02497612|100470165|FG001|Overall Study|Investigator's judgement|0|||
33151438|NCT02497612|100470166|FG002|Overall Study|Investigator's judgement|0|||
33151439|NCT02497612|100470167|FG003|Overall Study|Investigator's judgement|2|||
33151440|NCT02497612|100470164|FG000|Overall Study|Adverse Event|3|||
33151441|NCT02497612|100470165|FG001|Overall Study|Adverse Event|1|||
33151442|NCT02497612|100470166|FG002|Overall Study|Adverse Event|4|||
33151443|NCT02497612|100470167|FG003|Overall Study|Adverse Event|1|||
33151444|NCT02497612|100470164|FG000|Overall Study|Lost to Follow-up|1|||
33151445|NCT02497612|100470165|FG001|Overall Study|Lost to Follow-up|1|||
33151446|NCT02497612|100470166|FG002|Overall Study|Lost to Follow-up|0|||
33151447|NCT02497612|100470167|FG003|Overall Study|Lost to Follow-up|1|||
33151448|NCT02497612|100470164|FG000|Overall Study|Other unspecified|1|||
33250071|NCT03254394|100814568|FG000|Overall Study|Withdrawal by Subject|0|||
33436485|NCT03125200|101492468|FG005|Overall Study|Lack of Efficacy|0|||
33151449|NCT02497612|100470165|FG001|Overall Study|Other unspecified|1|||
33151450|NCT02497612|100470166|FG002|Overall Study|Other unspecified|2|||
33151451|NCT02497612|100470167|FG003|Overall Study|Other unspecified|0|||
33151452|NCT02497612|100470164|FG000|Overall Study|Not eligible|1|||
33151453|NCT02497612|100470165|FG001|Overall Study|Not eligible|0|||
33151454|NCT02497612|100470166|FG002|Overall Study|Not eligible|0|||
33151455|NCT02497612|100470167|FG003|Overall Study|Not eligible|1|||
33151456|NCT02024529|100470170|FG000|Overall Study|Withdrawal by Subject|11|||
33151457|NCT02024529|100470171|FG001|Overall Study|Withdrawal by Subject|21|||
33151458|NCT02024529|100470170|FG000|Overall Study|Lost to Follow-up|2|||
33151459|NCT02024529|100470171|FG001|Overall Study|Lost to Follow-up|4|||
33151460|NCT02758171|100470172|FG000|Wash-out|Withdrawal by Subject|1|||
33151461|NCT02758171|100470173|FG001|Wash-out|Withdrawal by Subject|0|||
33151462|NCT02758171|100470172|FG000|Wash-out|Other reason|1|||
33151463|NCT02758171|100470173|FG001|Wash-out|Other reason|0|||
33151464|NCT01130103|100470174|FG000|Randomized Treatment|Adverse Event|1|||
33151465|NCT01130103|100470175|FG001|Randomized Treatment|Adverse Event|1|||
33151466|NCT01130103|100470174|FG000|Randomized Treatment|Lost to Follow-up|1|||
33151467|NCT01130103|100470175|FG001|Randomized Treatment|Lost to Follow-up|0|||
33151468|NCT01130103|100470174|FG000|Randomized Treatment|Protocol Violation|3|||
33151469|NCT01130103|100470175|FG001|Randomized Treatment|Protocol Violation|2|||
33151470|NCT01130103|100470174|FG000|Randomized Treatment|Withdrawal by Subject|1|||
33151471|NCT01130103|100470175|FG001|Randomized Treatment|Withdrawal by Subject|2|||
33151472|NCT01130103|100470174|FG000|Maintenance Treatment|Lack of Efficacy|0|||
33151473|NCT01130103|100470175|FG001|Maintenance Treatment|Lack of Efficacy|1|||
33151474|NCT01130103|100470174|FG000|Maintenance Treatment|Lost to Follow-up|1|||
33151475|NCT01130103|100470175|FG001|Maintenance Treatment|Lost to Follow-up|1|||
33151476|NCT01130103|100470174|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
33151477|NCT01130103|100470175|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
33151478|NCT02642029|100470176|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
33151479|NCT02642029|100470177|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
33151480|NCT02642029|100470178|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
33151481|NCT02642029|100470179|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
33151482|NCT02642029|100470180|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
33151483|NCT02642029|100470181|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
33151484|NCT02642029|100470176|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
33151485|NCT02642029|100470177|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
33151486|NCT02642029|100470178|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
33151487|NCT02642029|100470179|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
33151488|NCT02642029|100470180|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
33151489|NCT02642029|100470181|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
33151490|NCT02642029|100470176|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
33151491|NCT02642029|100470177|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
33386162|NCT00510068|101302420|FG001|Double-blind Period|Withdrawal by Subject|6|||
33386163|NCT00510068|101302419|FG000|Double-blind Period|Death|4|||
33386164|NCT00510068|101302420|FG001|Double-blind Period|Death|3|||
33386165|NCT00510068|101302419|FG000|Double-blind Period|Abnormal test result (s)|1|||
33386166|NCT00510068|101302420|FG001|Double-blind Period|Abnormal test result (s)|0|||
33386167|NCT00510068|101302419|FG000|Double-blind Period|Lost to Follow-up|1|||
33386168|NCT00510068|101302420|FG001|Double-blind Period|Lost to Follow-up|0|||
33386169|NCT00510068|101302419|FG000|Double-blind Period|Protocol Violation|6|||
33386170|NCT00510068|101302420|FG001|Double-blind Period|Protocol Violation|0|||
33386171|NCT00510068|101302419|FG000|Open-label Period|Disease Progression|124|||
33386172|NCT00510068|101302420|FG001|Open-label Period|Disease Progression|0|||
33386173|NCT00510068|101302419|FG000|Open-label Period|Adverse Event|46|||
33386174|NCT00510068|101302420|FG001|Open-label Period|Adverse Event|0|||
33386175|NCT00510068|101302419|FG000|Open-label Period|Withdrawal by Subject|21|||
33386176|NCT00510068|101302420|FG001|Open-label Period|Withdrawal by Subject|0|||
33386177|NCT00510068|101302419|FG000|Open-label Period|Administrative problems|17|||
33386178|NCT00510068|101302420|FG001|Open-label Period|Administrative problems|0|||
33151492|NCT02642029|100470178|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
33386179|NCT00510068|101302419|FG000|Open-label Period|Death|7|||
33250072|NCT03254394|100814569|FG001|Overall Study|Withdrawal by Subject|2|||
33386180|NCT00510068|101302420|FG001|Open-label Period|Death|0|||
33386181|NCT00510068|101302419|FG000|Open-label Period|New cancer therapy|7|||
33386182|NCT00510068|101302420|FG001|Open-label Period|New cancer therapy|0|||
33250073|NCT01806714|100814570|FG000|Overall Study|No functioning phone number|200|||
33250074|NCT01806714|100814571|FG001|Overall Study|No functioning phone number|170|||
33250075|NCT01689519|100814572|FG000|Intent to Treat|Death|157|||
33250076|NCT01689519|100814573|FG001|Intent to Treat|Death|167|||
33386183|NCT00510068|101302419|FG000|Open-label Period|Protocol Violation|2|||
33386184|NCT00510068|101302420|FG001|Open-label Period|Protocol Violation|0|||
33386185|NCT00510068|101302419|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
33386186|NCT00510068|101302420|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
33386187|NCT03820726|101302427|FG000|Overall Study|Other than listed|23|||
33386188|NCT03820726|101302427|FG000|Overall Study|Withdrawal by Subject|37|||
33386189|NCT03820726|101302427|FG000|Overall Study|Lost to Follow-up|3|||
33386190|NCT03820726|101302427|FG000|Overall Study|Protocol deviation|1|||
33386191|NCT03820726|101302427|FG000|Overall Study|Adverse Event|146|||
33386192|NCT03820726|101302427|FG000|Overall Study|Not treated|1|||
33386193|NCT01293084|101302428|FG000|Overall Study|Physician Decision|3|||
33386194|NCT01293084|101302428|FG000|Overall Study|Withdrawal by Subject|2|||
33386195|NCT03673956|101302429|FG000|Overall Study|Lost to Follow-up|1|||
33386196|NCT03673956|101302430|FG001|Overall Study|Lost to Follow-up|0|||
33386197|NCT03673956|101302431|FG002|Overall Study|Lost to Follow-up|0|||
33386198|NCT03673956|101302432|FG003|Overall Study|Lost to Follow-up|0|||
33386199|NCT03673956|101302429|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
33386200|NCT03673956|101302430|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
33250077|NCT01689519|100814572|FG000|Intent to Treat|Lost to Follow-up|4|||
33250078|NCT01689519|100814573|FG001|Intent to Treat|Lost to Follow-up|8|||
33386201|NCT03673956|101302431|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
33386202|NCT03673956|101302432|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
33386203|NCT01711541|101302433|FG000|Overall Study|Cancel prior to treatment|0|||
33151493|NCT02642029|100470179|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
33151494|NCT02642029|100470180|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
33151495|NCT02642029|100470181|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
33151496|NCT02642029|100470176|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
33151497|NCT02642029|100470177|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
33151498|NCT02642029|100470178|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
33151499|NCT02642029|100470179|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
33151500|NCT02642029|100470180|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
33151501|NCT02642029|100470181|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
33151502|NCT02642029|100470176|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
33151503|NCT02642029|100470177|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
33151504|NCT02642029|100470178|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
33151505|NCT02642029|100470179|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
33151506|NCT02642029|100470180|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
33151507|NCT02642029|100470181|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
33151508|NCT02642029|100470176|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
33151509|NCT02642029|100470177|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
33151510|NCT02642029|100470178|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
33151511|NCT02642029|100470179|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
33151512|NCT02642029|100470180|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
33151513|NCT02642029|100470181|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
33151514|NCT02611960|100470182|FG000|Overall Study|Adverse Event|7|||
33151515|NCT02611960|100470183|FG001|Overall Study|Adverse Event|8|||
33151516|NCT02611960|100470182|FG000|Overall Study|Death|98|||
33151517|NCT02611960|100470183|FG001|Overall Study|Death|92|||
33151518|NCT02611960|100470182|FG000|Overall Study|Withdrawal by Subject|1|||
33151519|NCT02611960|100470183|FG001|Overall Study|Withdrawal by Subject|5|||
33151520|NCT02611960|100470182|FG000|Overall Study|Sponsor Decision|11|||
33151521|NCT02611960|100470183|FG001|Overall Study|Sponsor Decision|11|||
33151522|NCT03452228|100470185|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
33151523|NCT03452228|100470186|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
33151524|NCT03452228|100470187|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
33250079|NCT01689519|100814572|FG000|Intent to Treat|Other|2|||
33151525|NCT03452228|100470185|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
33151526|NCT03452228|100470186|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
33250080|NCT01689519|100814573|FG001|Intent to Treat|Other|4|||
33436486|NCT03125200|101492469|FG006|Overall Study|Lack of Efficacy|0|||
33151527|NCT03452228|100470187|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
33151528|NCT03452228|100470185|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
33151529|NCT03452228|100470186|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
33250081|NCT01689519|100814572|FG000|Intent to Treat|Physician Decision|4|||
33386204|NCT01711541|101302434|FG001|Overall Study|Cancel prior to treatment|0|||
33386205|NCT01711541|101302435|FG002|Overall Study|Cancel prior to treatment|0|||
33386206|NCT01711541|101302436|FG003|Overall Study|Cancel prior to treatment|1|||
33386207|NCT01711541|101302437|FG004|Overall Study|Cancel prior to treatment|0|||
33386208|NCT01711541|101302433|FG000|Overall Study|Ineligible|0|||
33386209|NCT01711541|101302434|FG001|Overall Study|Ineligible|1|||
33386210|NCT01711541|101302435|FG002|Overall Study|Ineligible|0|||
33386211|NCT01711541|101302436|FG003|Overall Study|Ineligible|0|||
33386212|NCT01711541|101302437|FG004|Overall Study|Ineligible|0|||
33386213|NCT02290340|101302438|FG000|Overall Study|Lost to Follow-up|0|||
33386214|NCT02290340|101302439|FG001|Overall Study|Lost to Follow-up|0|||
33386215|NCT02290340|101302440|FG002|Overall Study|Lost to Follow-up|0|||
33386216|NCT02290340|101302441|FG003|Overall Study|Lost to Follow-up|1|||
33436487|NCT03125200|101492463|FG000|Overall Study|Toxicity|0|||
33436488|NCT03125200|101492464|FG001|Overall Study|Toxicity|0|||
33436489|NCT03125200|101492465|FG002|Overall Study|Toxicity|0|||
33436490|NCT03125200|101492466|FG003|Overall Study|Toxicity|1|||
33436491|NCT03125200|101492467|FG004|Overall Study|Toxicity|0|||
33436492|NCT03125200|101492468|FG005|Overall Study|Toxicity|0|||
33436493|NCT03125200|101492469|FG006|Overall Study|Toxicity|0|||
33436494|NCT03125200|101492463|FG000|Overall Study|Consent Withdrawn by Subject|0|||
33436495|NCT03125200|101492464|FG001|Overall Study|Consent Withdrawn by Subject|1|||
33436496|NCT03125200|101492465|FG002|Overall Study|Consent Withdrawn by Subject|0|||
33436497|NCT03125200|101492466|FG003|Overall Study|Consent Withdrawn by Subject|0|||
33436498|NCT03125200|101492467|FG004|Overall Study|Consent Withdrawn by Subject|1|||
33436499|NCT03125200|101492468|FG005|Overall Study|Consent Withdrawn by Subject|0|||
33436500|NCT03125200|101492469|FG006|Overall Study|Consent Withdrawn by Subject|1|||
33250082|NCT01689519|100814573|FG001|Intent to Treat|Physician Decision|1|||
33386217|NCT02290340|101302438|FG000|Overall Study|Withdrawal by Subject|1|||
33436501|NCT02946385|101492472|FG000|Overall Study|Lost to Follow-up|0|||
33436502|NCT02946385|101492473|FG001|Overall Study|Lost to Follow-up|0|||
33386218|NCT02290340|101302439|FG001|Overall Study|Withdrawal by Subject|0|||
33386219|NCT02290340|101302440|FG002|Overall Study|Withdrawal by Subject|0|||
33386220|NCT02290340|101302441|FG003|Overall Study|Withdrawal by Subject|0|||
33386221|NCT02290340|101302438|FG000|Overall Study|Other|1|||
33151530|NCT03452228|100470187|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
33151531|NCT03452228|100470185|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
33151532|NCT03452228|100470186|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
33151533|NCT03452228|100470187|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
33151534|NCT02203071|100470188|FG000|Overall Study|Lost to Follow-up|3|||
33151535|NCT02203071|100470189|FG001|Overall Study|Lost to Follow-up|1|||
33151536|NCT03438383|100470194|FG000|Overall Study|Protocol Violation|9|||
33151537|NCT03438383|100470195|FG001|Overall Study|Protocol Violation|3|||
33151538|NCT02770170|100470198|FG000|Overall Study|Withdrawal by Subject|0|||
33151539|NCT02770170|100470199|FG001|Overall Study|Withdrawal by Subject|0|||
33151540|NCT02770170|100470200|FG002|Overall Study|Withdrawal by Subject|0|||
33151541|NCT02770170|100470201|FG003|Overall Study|Withdrawal by Subject|2|||
33151542|NCT02770170|100470198|FG000|Overall Study|due to pregnancy|1|||
33151543|NCT02770170|100470199|FG001|Overall Study|due to pregnancy|0|||
33151544|NCT02770170|100470200|FG002|Overall Study|due to pregnancy|0|||
33151545|NCT02770170|100470201|FG003|Overall Study|due to pregnancy|0|||
33151546|NCT02770170|100470198|FG000|Overall Study|Lack of Efficacy|2|||
33151547|NCT02770170|100470199|FG001|Overall Study|Lack of Efficacy|0|||
33151548|NCT02770170|100470200|FG002|Overall Study|Lack of Efficacy|0|||
33151549|NCT02770170|100470201|FG003|Overall Study|Lack of Efficacy|1|||
33151550|NCT02770170|100470198|FG000|Overall Study|Adverse Event|4|||
33151551|NCT02770170|100470199|FG001|Overall Study|Adverse Event|3|||
33151552|NCT02770170|100470200|FG002|Overall Study|Adverse Event|5|||
33151553|NCT02770170|100470201|FG003|Overall Study|Adverse Event|3|||
33151554|NCT02770170|100470198|FG000|Overall Study|due to disease worsening|0|||
33151555|NCT02770170|100470199|FG001|Overall Study|due to disease worsening|0|||
33151556|NCT02770170|100470200|FG002|Overall Study|due to disease worsening|0|||
33151557|NCT02770170|100470201|FG003|Overall Study|due to disease worsening|1|||
33151558|NCT03698331|100470204|FG000|Overall Study|Adverse Event|2|||
33151559|NCT03698331|100470205|FG001|Overall Study|Adverse Event|3|||
33151560|NCT03698331|100470204|FG000|Overall Study|Withdrawal by Subject|1|||
33151561|NCT03698331|100470205|FG001|Overall Study|Withdrawal by Subject|1|||
33436503|NCT02946385|101492474|FG002|Overall Study|Lost to Follow-up|3|||
33151562|NCT03698331|100470204|FG000|Overall Study|Lost to Follow-up|0|||
33151563|NCT03698331|100470205|FG001|Overall Study|Lost to Follow-up|2|||
33151564|NCT03698331|100470204|FG000|Overall Study|Non-compliance with study drug|1|||
33151565|NCT03698331|100470205|FG001|Overall Study|Non-compliance with study drug|0|||
33151566|NCT01090973|100470207|FG000|Overall Study|Disease progression|1|||
33151567|NCT02239224|100470212|FG000|Overall Study|Administrative|0|||
33151568|NCT02239224|100470213|FG001|Overall Study|Administrative|0|||
33151569|NCT02239224|100470214|FG002|Overall Study|Administrative|3|||
33151570|NCT02239224|100470215|FG003|Overall Study|Administrative|1|||
33151571|NCT01230710|100470216|FG000|Overall Study|Disease Progression|41|||
33151572|NCT01230710|100470216|FG000|Overall Study|Lost to Follow-up|3|||
33151573|NCT01230710|100470216|FG000|Overall Study|Death|4|||
33151574|NCT01230710|100470216|FG000|Overall Study|Withdrawal of Consent|1|||
33250083|NCT01689519|100814572|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
33250084|NCT01689519|100814573|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
33250085|NCT01689519|100814572|FG000|Intent to Treat|Withdrawal by Subject|21|||
33151575|NCT00694707|100470227|FG000|Overall Study|Did Not Receive Treatment|0|||
33151576|NCT00694707|100470228|FG001|Overall Study|Did Not Receive Treatment|0|||
33386222|NCT02290340|101302439|FG001|Overall Study|Other|0|||
33386223|NCT02290340|101302440|FG002|Overall Study|Other|0|||
33386224|NCT02290340|101302441|FG003|Overall Study|Other|1|||
33386225|NCT03276572|101302442|FG000|Overall Study|In follow-up|0|||
33386226|NCT03276572|101302443|FG001|Overall Study|In follow-up|0|||
33386227|NCT03276572|101302444|FG002|Overall Study|In follow-up|0|||
33386228|NCT03276572|101302445|FG003|Overall Study|In follow-up|0|||
33386229|NCT03276572|101302446|FG004|Overall Study|In follow-up|0|||
33386230|NCT03276572|101302447|FG005|Overall Study|In follow-up|1|||
33151577|NCT00694707|100470229|FG002|Overall Study|Did Not Receive Treatment|1|||
33151578|NCT00694707|100470230|FG003|Overall Study|Did Not Receive Treatment|1|||
33151579|NCT00694707|100470231|FG004|Overall Study|Did Not Receive Treatment|1|||
33151580|NCT00694707|100470227|FG000|Overall Study|Adverse Event|22|||
33386231|NCT03276572|101302448|FG006|Overall Study|In follow-up|1|||
33151581|NCT00694707|100470228|FG001|Overall Study|Adverse Event|14|||
33151582|NCT00694707|100470229|FG002|Overall Study|Adverse Event|8|||
33151583|NCT00694707|100470230|FG003|Overall Study|Adverse Event|12|||
33151584|NCT00694707|100470231|FG004|Overall Study|Adverse Event|13|||
33151585|NCT00694707|100470227|FG000|Overall Study|Insufficient Therapeutic Response|33|||
33151586|NCT00694707|100470228|FG001|Overall Study|Insufficient Therapeutic Response|18|||
33151587|NCT00694707|100470229|FG002|Overall Study|Insufficient Therapeutic Response|17|||
33151588|NCT00694707|100470230|FG003|Overall Study|Insufficient Therapeutic Response|15|||
33151589|NCT00694707|100470231|FG004|Overall Study|Insufficient Therapeutic Response|10|||
33151590|NCT00694707|100470227|FG000|Overall Study|Protocol Violation|1|||
33151591|NCT00694707|100470228|FG001|Overall Study|Protocol Violation|2|||
33151592|NCT00694707|100470229|FG002|Overall Study|Protocol Violation|1|||
33151593|NCT00694707|100470230|FG003|Overall Study|Protocol Violation|3|||
33151594|NCT00694707|100470231|FG004|Overall Study|Protocol Violation|1|||
33151595|NCT00694707|100470227|FG000|Overall Study|Withdrawal of Consent|14|||
33151596|NCT00694707|100470228|FG001|Overall Study|Withdrawal of Consent|18|||
33151597|NCT00694707|100470229|FG002|Overall Study|Withdrawal of Consent|22|||
33151598|NCT00694707|100470230|FG003|Overall Study|Withdrawal of Consent|16|||
33151599|NCT00694707|100470231|FG004|Overall Study|Withdrawal of Consent|15|||
33151600|NCT00694707|100470227|FG000|Overall Study|Lost to Follow-up|0|||
33151601|NCT00694707|100470228|FG001|Overall Study|Lost to Follow-up|1|||
33151602|NCT00694707|100470229|FG002|Overall Study|Lost to Follow-up|2|||
33151603|NCT00694707|100470230|FG003|Overall Study|Lost to Follow-up|0|||
33151604|NCT00694707|100470231|FG004|Overall Study|Lost to Follow-up|0|||
33151605|NCT00694707|100470227|FG000|Overall Study|Jeopardizing Parole Status|1|||
33151606|NCT00694707|100470228|FG001|Overall Study|Jeopardizing Parole Status|0|||
33151607|NCT00694707|100470229|FG002|Overall Study|Jeopardizing Parole Status|0|||
33151608|NCT00694707|100470230|FG003|Overall Study|Jeopardizing Parole Status|0|||
33151609|NCT00694707|100470231|FG004|Overall Study|Jeopardizing Parole Status|0|||
33151610|NCT00694707|100470227|FG000|Overall Study|Death in the Family|1|||
33151611|NCT00694707|100470228|FG001|Overall Study|Death in the Family|0|||
33151612|NCT00694707|100470229|FG002|Overall Study|Death in the Family|0|||
33151613|NCT00694707|100470230|FG003|Overall Study|Death in the Family|0|||
33151614|NCT00694707|100470231|FG004|Overall Study|Death in the Family|0|||
33151615|NCT00694707|100470227|FG000|Overall Study|Arrest by Police|0|||
33151616|NCT00694707|100470228|FG001|Overall Study|Arrest by Police|1|||
33151617|NCT00694707|100470229|FG002|Overall Study|Arrest by Police|0|||
33151618|NCT00694707|100470230|FG003|Overall Study|Arrest by Police|0|||
33151619|NCT00694707|100470231|FG004|Overall Study|Arrest by Police|0|||
33151620|NCT00694707|100470227|FG000|Overall Study|Administrative Reasons|0|||
33151621|NCT00694707|100470228|FG001|Overall Study|Administrative Reasons|1|||
33151622|NCT00694707|100470229|FG002|Overall Study|Administrative Reasons|0|||
33151623|NCT00694707|100470230|FG003|Overall Study|Administrative Reasons|2|||
33151624|NCT00694707|100470231|FG004|Overall Study|Administrative Reasons|0|||
33151625|NCT00694707|100470227|FG000|Overall Study|Notification of Past Head Injury|0|||
33151626|NCT00694707|100470228|FG001|Overall Study|Notification of Past Head Injury|0|||
33151627|NCT00694707|100470229|FG002|Overall Study|Notification of Past Head Injury|0|||
33151628|NCT00694707|100470230|FG003|Overall Study|Notification of Past Head Injury|1|||
33151629|NCT00694707|100470231|FG004|Overall Study|Notification of Past Head Injury|0|||
33151630|NCT00828854|100470232|FG000|Overall Study|Disease Progression|17|||
33151631|NCT00828854|100470232|FG000|Overall Study|Adverse Event|9|||
33151632|NCT00828854|100470232|FG000|Overall Study|Reason not Specified|1|||
33151633|NCT04738734|100470243|FG000|Overall Study|Withdrawal by Subject|2|||
33151634|NCT04738734|100470244|FG001|Overall Study|Withdrawal by Subject|4|||
33151635|NCT04738734|100470243|FG000|Overall Study|Lost to Follow-up|5|||
33386232|NCT03276572|101302442|FG000|Overall Study|Lost to Follow-up|0|||
33151636|NCT04738734|100470244|FG001|Overall Study|Lost to Follow-up|2|||
33151637|NCT04738734|100470243|FG000|Overall Study|Physician Decision|0|||
33151638|NCT04738734|100470244|FG001|Overall Study|Physician Decision|1|||
33151639|NCT04738734|100470243|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
33151640|NCT04738734|100470244|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
33151641|NCT00464269|100470246|FG000|Overall Study|Lack of Efficacy|1|||
33151642|NCT00464269|100470247|FG001|Overall Study|Lack of Efficacy|0|||
33151643|NCT00464269|100470248|FG002|Overall Study|Lack of Efficacy|0|||
33151644|NCT00464269|100470249|FG003|Overall Study|Lack of Efficacy|0|||
33151645|NCT00464269|100470246|FG000|Overall Study|Lost to Follow-up|0|||
33151646|NCT00464269|100470247|FG001|Overall Study|Lost to Follow-up|4|||
33151647|NCT00464269|100470248|FG002|Overall Study|Lost to Follow-up|0|||
33151648|NCT00464269|100470249|FG003|Overall Study|Lost to Follow-up|1|||
33151649|NCT00464269|100470246|FG000|Overall Study|Withdrawal by Subject|0|||
33151650|NCT00464269|100470247|FG001|Overall Study|Withdrawal by Subject|2|||
33151651|NCT00464269|100470248|FG002|Overall Study|Withdrawal by Subject|1|||
33151652|NCT00464269|100470249|FG003|Overall Study|Withdrawal by Subject|1|||
33151653|NCT00464269|100470246|FG000|Overall Study|Other reason|3|||
33151654|NCT00464269|100470247|FG001|Overall Study|Other reason|3|||
33151655|NCT00464269|100470248|FG002|Overall Study|Other reason|1|||
33151656|NCT00464269|100470249|FG003|Overall Study|Other reason|1|||
33151657|NCT00464269|100470246|FG000|Overall Study|AE, serious fatal|0|||
33151658|NCT00464269|100470247|FG001|Overall Study|AE, serious fatal|0|||
33151659|NCT00464269|100470248|FG002|Overall Study|AE, serious fatal|1|||
33151660|NCT00464269|100470249|FG003|Overall Study|AE, serious fatal|1|||
33151661|NCT00464269|100470246|FG000|Overall Study|SAE, non-fatal|0|||
33151662|NCT00464269|100470247|FG001|Overall Study|SAE, non-fatal|0|||
33386233|NCT03276572|101302443|FG001|Overall Study|Lost to Follow-up|0|||
33151663|NCT00464269|100470248|FG002|Overall Study|SAE, non-fatal|0|||
33151664|NCT00464269|100470249|FG003|Overall Study|SAE, non-fatal|1|||
33151665|NCT00464269|100470246|FG000|Overall Study|AE, non-serious non-fatal|2|||
33386234|NCT03276572|101302444|FG002|Overall Study|Lost to Follow-up|0|||
33151666|NCT00464269|100470247|FG001|Overall Study|AE, non-serious non-fatal|8|||
33151667|NCT00464269|100470248|FG002|Overall Study|AE, non-serious non-fatal|3|||
33151668|NCT00464269|100470249|FG003|Overall Study|AE, non-serious non-fatal|4|||
33151669|NCT00464269|100470246|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
33151670|NCT00464269|100470247|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
33151671|NCT00464269|100470248|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
33151672|NCT00464269|100470249|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
33151673|NCT03439657|100470257|FG000|Overall Study|Adverse Event|2|||
33151674|NCT03439657|100470258|FG001|Overall Study|Adverse Event|3|||
33151675|NCT03439657|100470257|FG000|Overall Study|Lost to Follow-up|1|||
33151676|NCT03439657|100470258|FG001|Overall Study|Lost to Follow-up|0|||
33151677|NCT03439657|100470257|FG000|Overall Study|Protocol Violation|1|||
33151678|NCT03439657|100470258|FG001|Overall Study|Protocol Violation|1|||
33151679|NCT03439657|100470257|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
33151680|NCT03439657|100470258|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
33151681|NCT03589469|100470259|FG000|Overall Study|Withdrawal by Subject|8|||
33151682|NCT03589469|100470259|FG000|Overall Study|Physician Decision|20|||
33151683|NCT03589469|100470259|FG000|Overall Study|Death|97|||
33151684|NCT03589469|100470259|FG000|Overall Study|Lost to Follow-up|8|||
33151685|NCT03589469|100470259|FG000|Overall Study|Miscellaneous|1|||
33151686|NCT02027376|100470265|FG000|Overall Study|Death|1|||
33151687|NCT02027376|100470266|FG001|Overall Study|Death|0|||
33151688|NCT02027376|100470267|FG002|Overall Study|Death|0|||
33151689|NCT04060862|100470268|FG000|Overall Study|Symptomatic Deterioration|1|||
33151690|NCT04060862|100470268|FG000|Overall Study|Un-specified|6|||
33151691|NCT04060862|100470268|FG000|Overall Study|Progressive disease|12|||
33151692|NCT04060862|100470268|FG000|Overall Study|Physician Decision|1|||
33151693|NCT01385371|100470269|FG000|Overall Study|Adverse Event|54|||
33151694|NCT01385371|100470270|FG001|Overall Study|Adverse Event|19|||
33151695|NCT01385371|100470269|FG000|Overall Study|Lost to Follow-up|16|||
33151696|NCT01385371|100470270|FG001|Overall Study|Lost to Follow-up|16|||
33151697|NCT01385371|100470269|FG000|Overall Study|Withdrawal by Subject|52|||
33151698|NCT01385371|100470270|FG001|Overall Study|Withdrawal by Subject|39|||
33151699|NCT01385371|100470269|FG000|Overall Study|Protocol Violation|25|||
33151700|NCT01385371|100470270|FG001|Overall Study|Protocol Violation|21|||
33151701|NCT01385371|100470269|FG000|Overall Study|Administrative|2|||
33151702|NCT01385371|100470270|FG001|Overall Study|Administrative|2|||
33151703|NCT04447417|100470273|FG000|Overall Study|Withdrawal by Subject|1|||
33151704|NCT04447417|100470274|FG001|Overall Study|Withdrawal by Subject|0|||
33151705|NCT04447417|100470273|FG000|Overall Study|Failure to meet inclusion criteria|1|||
33151706|NCT04447417|100470274|FG001|Overall Study|Failure to meet inclusion criteria|0|||
33151707|NCT04447417|100470273|FG000|Overall Study|Lost to Follow-up|1|||
33151708|NCT04447417|100470274|FG001|Overall Study|Lost to Follow-up|0|||
33151709|NCT00071396|100470275|FG000|Overall Study|Withdrawal by Subject|1|||
33151710|NCT00071396|100470275|FG000|Overall Study|Physician Decision|2|||
33151711|NCT00700570|100470290|FG000|Overall Study|Adverse Event|2|||
33151712|NCT00700570|100470291|FG001|Overall Study|Adverse Event|6|||
33151713|NCT00700570|100470290|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
33151714|NCT00700570|100470291|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
33151715|NCT00700570|100470290|FG000|Overall Study|Disease Progression|8|||
33151716|NCT00700570|100470291|FG001|Overall Study|Disease Progression|11|||
33151717|NCT00700570|100470290|FG000|Overall Study|Withdrawal by Subject|1|||
33151718|NCT00700570|100470291|FG001|Overall Study|Withdrawal by Subject|6|||
33151719|NCT01925274|100470298|FG000|Overall Study|Death|1|||
33151720|NCT01925274|100470299|FG001|Overall Study|Death|0|||
33436504|NCT02946385|101492475|FG003|Overall Study|Lost to Follow-up|0|||
33151721|NCT01925274|100470300|FG002|Overall Study|Death|0|||
33151722|NCT01925274|100470298|FG000|Overall Study|Lost to Follow-up|0|||
33436505|NCT02946385|101492476|FG004|Overall Study|Lost to Follow-up|2|||
33151723|NCT01925274|100470299|FG001|Overall Study|Lost to Follow-up|1|||
33151724|NCT01925274|100470300|FG002|Overall Study|Lost to Follow-up|0|||
33151725|NCT01925274|100470298|FG000|Overall Study|Withdrawal by Subject|1|||
33151726|NCT01925274|100470299|FG001|Overall Study|Withdrawal by Subject|2|||
33151727|NCT01925274|100470300|FG002|Overall Study|Withdrawal by Subject|0|||
33151728|NCT01925274|100470298|FG000|Overall Study|Study terminated by sponsor|4|||
33151729|NCT01925274|100470299|FG001|Overall Study|Study terminated by sponsor|0|||
33151730|NCT01925274|100470300|FG002|Overall Study|Study terminated by sponsor|0|||
33151731|NCT01925274|100470298|FG000|Overall Study|Protocol amendment|1|||
33151732|NCT01925274|100470299|FG001|Overall Study|Protocol amendment|3|||
33436506|NCT02946385|101492477|FG005|Overall Study|Lost to Follow-up|1|||
33436507|NCT03679741|101492479|FG000|Period 1|No longer meet eligibility criteria|1|||
33436508|NCT03679741|101492480|FG001|Period 1|No longer meet eligibility criteria|0|||
33436509|NCT03679741|101492479|FG000|Period 1|Lost to Follow-up|0|||
33436510|NCT03679741|101492480|FG001|Period 1|Lost to Follow-up|1|||
33436511|NCT03679741|101492479|FG000|Period 1|Adverse Event|1|||
33436512|NCT03679741|101492480|FG001|Period 1|Adverse Event|1|||
33436513|NCT03679741|101492479|FG000|Period 1|Withdrawal by Subject|0|||
33436514|NCT03679741|101492480|FG001|Period 1|Withdrawal by Subject|1|||
33436515|NCT03679741|101492479|FG000|Period 2|Adverse Event|2|||
33436516|NCT03679741|101492480|FG001|Period 2|Adverse Event|1|||
33436517|NCT03679741|101492479|FG000|Period 2|Withdrawal by Subject|1|||
33436518|NCT03679741|101492480|FG001|Period 2|Withdrawal by Subject|1|||
33436519|NCT00543309|101492483|FG000|Overall Study|Physician Decision|0|||
33436520|NCT00543309|101492484|FG001|Overall Study|Physician Decision|1|||
33436521|NCT00543309|101492485|FG002|Overall Study|Physician Decision|0|||
33436522|NCT03561883|101492488|FG000|Overall Study|Adverse Event|10|||
33436523|NCT03561883|101492489|FG001|Overall Study|Adverse Event|13|||
33436524|NCT03561883|101492488|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33436525|NCT03561883|101492489|FG001|Overall Study|Non-Compliance With Study Drug|2|||
33436526|NCT03561883|101492488|FG000|Overall Study|Protocol Violation|2|||
33436527|NCT03561883|101492489|FG001|Overall Study|Protocol Violation|3|||
33436528|NCT03561883|101492488|FG000|Overall Study|Withdrawal by Subject|14|||
33436529|NCT03561883|101492489|FG001|Overall Study|Withdrawal by Subject|6|||
33436530|NCT03561883|101492488|FG000|Overall Study|Lost to Follow-up|2|||
33436531|NCT03561883|101492489|FG001|Overall Study|Lost to Follow-up|6|||
33436532|NCT03561883|101492488|FG000|Overall Study|Study Terminated by Sponsor|12|||
33436533|NCT03561883|101492489|FG001|Overall Study|Study Terminated by Sponsor|11|||
33436534|NCT03561883|101492488|FG000|Overall Study|Physician Decision|1|||
33436535|NCT03561883|101492489|FG001|Overall Study|Physician Decision|0|||
33436536|NCT03561883|101492488|FG000|Overall Study|Randomized by Mistake|1|||
33436537|NCT03561883|101492489|FG001|Overall Study|Randomized by Mistake|0|||
33436538|NCT03561883|101492488|FG000|Overall Study|Other, Not Specified|3|||
33436539|NCT03561883|101492489|FG001|Overall Study|Other, Not Specified|2|||
33436540|NCT02270736|101492500|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
33436541|NCT02270736|101492501|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
33436542|NCT02270736|101492502|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
33436543|NCT02270736|101492503|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
33436544|NCT02270736|101492504|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
33436545|NCT02270736|101492500|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
33436546|NCT02270736|101492501|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
33436547|NCT02270736|101492502|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
33436548|NCT02270736|101492503|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
33436549|NCT02270736|101492504|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
33436550|NCT02270736|101492500|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
33436551|NCT02270736|101492501|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
33436552|NCT02270736|101492502|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
33436553|NCT02270736|101492503|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
33436554|NCT02270736|101492504|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
33436555|NCT02270736|101492500|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
33436556|NCT02270736|101492501|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
33436557|NCT02270736|101492502|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
33436558|NCT02270736|101492503|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
33436559|NCT02270736|101492504|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
33436560|NCT02270736|101492500|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
33436561|NCT02270736|101492501|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
33436562|NCT02270736|101492502|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
33151733|NCT01925274|100470300|FG002|Overall Study|Protocol amendment|6|||
33436563|NCT02270736|101492503|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
33151734|NCT00437320|100470303|FG000|Overall Study|Participant request|2|||
33151735|NCT00437320|100470304|FG001|Overall Study|Participant request|1|||
33151736|NCT00437320|100470305|FG002|Overall Study|Participant request|4|||
33151737|NCT02517866|100470310|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
33436564|NCT02270736|101492504|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
33436565|NCT02270736|101492500|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
33436566|NCT02270736|101492501|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
33436567|NCT02270736|101492502|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
33436568|NCT02270736|101492503|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
33151738|NCT02517866|100470311|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
33151739|NCT02517866|100470312|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
33151740|NCT02517866|100470310|FG000|Overall Study|Significant Protocol Deviation|4|||
33151741|NCT02517866|100470311|FG001|Overall Study|Significant Protocol Deviation|1|||
33436569|NCT02270736|101492504|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
33436570|NCT02270736|101492500|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
33151742|NCT02517866|100470312|FG002|Overall Study|Significant Protocol Deviation|0|||
33151743|NCT02517866|100470310|FG000|Overall Study|Lost to Follow-up|1|||
33151744|NCT02517866|100470311|FG001|Overall Study|Lost to Follow-up|0|||
33151745|NCT02517866|100470312|FG002|Overall Study|Lost to Follow-up|0|||
33436571|NCT02270736|101492501|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
33436572|NCT02270736|101492502|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
33436573|NCT02270736|101492503|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
33151746|NCT02517866|100470310|FG000|Overall Study|Voluntary Withdrawal|2|||
33436574|NCT02270736|101492504|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
33436575|NCT02270736|101492500|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
33436576|NCT02270736|101492501|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
33436577|NCT02270736|101492502|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
33436578|NCT02270736|101492503|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
33436579|NCT02270736|101492504|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
33436580|NCT02270736|101492500|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
33436581|NCT02270736|101492501|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
33436582|NCT02270736|101492502|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
33436583|NCT02270736|101492503|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
33436584|NCT02270736|101492504|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
33436585|NCT00577460|101492505|FG000|Overall Study|Adverse Event|11|||
33436586|NCT00577460|101492506|FG001|Overall Study|Adverse Event|7|||
33436587|NCT00577460|101492507|FG002|Overall Study|Adverse Event|14|||
33436588|NCT00577460|101492505|FG000|Overall Study|Protocol Violation|0|||
33436589|NCT00577460|101492506|FG001|Overall Study|Protocol Violation|1|||
33436590|NCT00577460|101492507|FG002|Overall Study|Protocol Violation|1|||
33436591|NCT00577460|101492505|FG000|Overall Study|Lost to Follow-up|0|||
33436592|NCT00577460|101492506|FG001|Overall Study|Lost to Follow-up|3|||
33436593|NCT00577460|101492507|FG002|Overall Study|Lost to Follow-up|4|||
33436594|NCT00577460|101492505|FG000|Overall Study|Withdrawal by Subject|5|||
33436595|NCT00577460|101492506|FG001|Overall Study|Withdrawal by Subject|5|||
33436596|NCT00577460|101492507|FG002|Overall Study|Withdrawal by Subject|6|||
33436597|NCT00577460|101492505|FG000|Overall Study|Other|0|||
33151747|NCT02517866|100470311|FG001|Overall Study|Voluntary Withdrawal|2|||
33436598|NCT00577460|101492506|FG001|Overall Study|Other|3|||
33436599|NCT00577460|101492507|FG002|Overall Study|Other|2|||
33436600|NCT01755858|101492508|FG000|Overall Study|Adverse Event|1|||
33436601|NCT01755858|101492509|FG001|Overall Study|Adverse Event|1|||
33436602|NCT01574248|101492510|FG000|Overall Study|Withdrawal by Subject|2|||
33436603|NCT01574248|101492511|FG001|Overall Study|Withdrawal by Subject|0|||
33436604|NCT01574248|101492510|FG000|Overall Study|Missing primary endpoint data|1|||
33436605|NCT01574248|101492511|FG001|Overall Study|Missing primary endpoint data|0|||
33436606|NCT02655237|101492512|FG000|Overall Study|Adverse Event|10|||
33436607|NCT02655237|101492513|FG001|Overall Study|Adverse Event|7|||
33436608|NCT02655237|101492512|FG000|Overall Study|Protocol Deviation|2|||
33436609|NCT02655237|101492513|FG001|Overall Study|Protocol Deviation|0|||
33436610|NCT02655237|101492512|FG000|Overall Study|Withdrawal by Participant|1|||
33436611|NCT02655237|101492513|FG001|Overall Study|Withdrawal by Participant|2|||
33436612|NCT02655237|101492512|FG000|Overall Study|Lack of Efficacy|0|||
33436613|NCT02655237|101492513|FG001|Overall Study|Lack of Efficacy|1|||
33436614|NCT02655237|101492512|FG000|Overall Study|Recovery Leading to Surgery|2|||
33436615|NCT02655237|101492513|FG001|Overall Study|Recovery Leading to Surgery|1|||
33436616|NCT02655237|101492512|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
33151748|NCT02517866|100470312|FG002|Overall Study|Voluntary Withdrawal|0|||
33436617|NCT02655237|101492513|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
33436618|NCT02655237|101492512|FG000|Overall Study|Randomized but Not Treated|1|||
33436619|NCT02655237|101492513|FG001|Overall Study|Randomized but Not Treated|0|||
33436620|NCT02863575|101492514|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
33151749|NCT02517866|100470310|FG000|Overall Study|Investigator Decision|2|||
33151750|NCT02517866|100470311|FG001|Overall Study|Investigator Decision|1|||
33151751|NCT02517866|100470312|FG002|Overall Study|Investigator Decision|0|||
33151752|NCT02517866|100470310|FG000|Overall Study|Reason not specified|2|||
33151753|NCT02517866|100470311|FG001|Overall Study|Reason not specified|0|||
33151754|NCT02517866|100470312|FG002|Overall Study|Reason not specified|0|||
33151755|NCT01397201|100470313|FG000|Overall Study|Not treated|0|||
33151756|NCT01397201|100470314|FG001|Overall Study|Not treated|0|||
33151757|NCT01397201|100470315|FG002|Overall Study|Not treated|1|||
33151758|NCT01397201|100470316|FG003|Overall Study|Not treated|0|||
33151759|NCT01397201|100470317|FG004|Overall Study|Not treated|0|||
33151760|NCT01397201|100470313|FG000|Overall Study|Not yet defined|3|||
33151761|NCT01397201|100470314|FG001|Overall Study|Not yet defined|6|||
33386235|NCT03276572|101302445|FG003|Overall Study|Lost to Follow-up|0|||
33386236|NCT03276572|101302446|FG004|Overall Study|Lost to Follow-up|0|||
33386237|NCT03276572|101302447|FG005|Overall Study|Lost to Follow-up|0|||
33386238|NCT03276572|101302448|FG006|Overall Study|Lost to Follow-up|1|||
33386239|NCT02023268|101302449|FG000|Overall Study|Lack of Efficacy|0|||
33386240|NCT02023268|101302450|FG001|Overall Study|Lack of Efficacy|1|||
33386241|NCT02023268|101302449|FG000|Overall Study|Adverse Event|0|||
33386242|NCT02023268|101302450|FG001|Overall Study|Adverse Event|2|||
33386243|NCT02023268|101302449|FG000|Overall Study|Withdrawal by Subject|0|||
33386244|NCT02023268|101302450|FG001|Overall Study|Withdrawal by Subject|1|||
33386245|NCT00391807|101302453|FG000|Overall Study|Did not receive study medication|23|||
33386246|NCT00391807|101302453|FG000|Overall Study|Adverse Event|177|||
33386247|NCT00391807|101302453|FG000|Overall Study|Pregnancy|25|||
33386248|NCT00391807|101302453|FG000|Overall Study|Lost to Follow-up|227|||
33386249|NCT00391807|101302453|FG000|Overall Study|Withdrawal by Subject|147|||
33386250|NCT00391807|101302453|FG000|Overall Study|Protocol Violation|20|||
33386251|NCT00391807|101302453|FG000|Overall Study|Various|96|||
33386252|NCT01192204|101302454|FG000|Overall Study|could not keep recall appointments|1|||
33386253|NCT01192204|101302455|FG001|Overall Study|could not keep recall appointments|0|||
33386254|NCT03911869|101302461|FG000|Safety Lead-in Phase|Death|7|||
33386255|NCT03911869|101302462|FG001|Safety Lead-in Phase|Death|0|||
33386256|NCT03911869|101302463|FG002|Safety Lead-in Phase|Death|0|||
33386257|NCT03911869|101302461|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
33386258|NCT03911869|101302462|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
33386259|NCT03911869|101302463|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
33386260|NCT03911869|101302461|FG000|Safety Lead-in Phase|Other|1|||
33386261|NCT03911869|101302462|FG001|Safety Lead-in Phase|Other|0|||
33386262|NCT03911869|101302463|FG002|Safety Lead-in Phase|Other|0|||
33386263|NCT03911869|101302461|FG000|Phase 2|Death|0|||
33386264|NCT03911869|101302462|FG001|Phase 2|Death|3|||
33386265|NCT03911869|101302463|FG002|Phase 2|Death|0|||
33386266|NCT01002742|101302464|FG000|Overall Study|Determined to be ineligible|0|||
33386267|NCT01002742|101302465|FG001|Overall Study|Determined to be ineligible|1|||
33386268|NCT01281189|101302467|FG000|Overall Study|Adverse Event|7|||
33386269|NCT01281189|101302468|FG001|Overall Study|Adverse Event|9|||
33386270|NCT01281189|101302467|FG000|Overall Study|Lost to Follow-up|6|||
33386271|NCT01281189|101302468|FG001|Overall Study|Lost to Follow-up|4|||
33386272|NCT01281189|101302467|FG000|Overall Study|Withdrawal by Subject|21|||
33386273|NCT01281189|101302468|FG001|Overall Study|Withdrawal by Subject|24|||
33386274|NCT01281189|101302467|FG000|Overall Study|Physician Decision|2|||
33386275|NCT01281189|101302468|FG001|Overall Study|Physician Decision|3|||
33386276|NCT01281189|101302467|FG000|Overall Study|Death|103|||
33386277|NCT01281189|101302468|FG001|Overall Study|Death|91|||
33436621|NCT02863575|101492515|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
33151762|NCT01397201|100470315|FG002|Overall Study|Not yet defined|5|||
33151763|NCT01397201|100470316|FG003|Overall Study|Not yet defined|5|||
33151764|NCT01397201|100470317|FG004|Overall Study|Not yet defined|4|||
33250086|NCT01689519|100814573|FG001|Intent to Treat|Withdrawal by Subject|20|||
33386278|NCT01281189|101302467|FG000|Overall Study|Other|8|||
33386279|NCT01281189|101302468|FG001|Overall Study|Other|12|||
33436622|NCT02863575|101492516|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
33436623|NCT02863575|101492514|FG000|Overall Study|Withdrawal by Subject|0|||
33436624|NCT02863575|101492515|FG001|Overall Study|Withdrawal by Subject|1|||
33436625|NCT02863575|101492516|FG002|Overall Study|Withdrawal by Subject|1|||
33436626|NCT02863575|101492514|FG000|Overall Study|Adverse Event|0|||
33436627|NCT02863575|101492515|FG001|Overall Study|Adverse Event|1|||
33436628|NCT02863575|101492516|FG002|Overall Study|Adverse Event|0|||
33436629|NCT00950807|101492517|FG000|Treatment Period 1|Lack of Efficacy|1|||
33436630|NCT00950807|101492518|FG001|Treatment Period 1|Lack of Efficacy|0|||
33436631|NCT00950807|101492519|FG002|Treatment Period 1|Lack of Efficacy|0|||
33436632|NCT00950807|101492520|FG003|Treatment Period 1|Lack of Efficacy|0|||
33436633|NCT00950807|101492521|FG004|Treatment Period 1|Lack of Efficacy|0|||
33436634|NCT00950807|101492522|FG005|Treatment Period 1|Lack of Efficacy|1|||
33436635|NCT00950807|101492523|FG006|Treatment Period 1|Lack of Efficacy|0|||
33436636|NCT00950807|101492524|FG007|Treatment Period 1|Lack of Efficacy|0|||
33436637|NCT00950807|101492525|FG008|Treatment Period 1|Lack of Efficacy|0|||
33436638|NCT00950807|101492526|FG009|Treatment Period 1|Lack of Efficacy|0|||
33436639|NCT00950807|101492517|FG000|Treatment Period 1|Protocol Violation|1|||
33151765|NCT01397201|100470313|FG000|Overall Study|Adverse Event|2|||
33151766|NCT01397201|100470314|FG001|Overall Study|Adverse Event|0|||
33151767|NCT01397201|100470315|FG002|Overall Study|Adverse Event|0|||
33151768|NCT01397201|100470316|FG003|Overall Study|Adverse Event|0|||
33151769|NCT01397201|100470317|FG004|Overall Study|Adverse Event|0|||
33151770|NCT00810693|100470318|FG000|Treatment Period|Adverse Event|8|||
33436640|NCT00950807|101492518|FG001|Treatment Period 1|Protocol Violation|0|||
33151771|NCT00810693|100470319|FG001|Treatment Period|Adverse Event|1|||
33151772|NCT00810693|100470320|FG002|Treatment Period|Adverse Event|7|||
33151773|NCT00810693|100470318|FG000|Treatment Period|Death|0|||
33151774|NCT00810693|100470319|FG001|Treatment Period|Death|1|||
33151775|NCT00810693|100470320|FG002|Treatment Period|Death|2|||
33151776|NCT00810693|100470318|FG000|Treatment Period|Lack of Efficacy|0|||
33151777|NCT00810693|100470319|FG001|Treatment Period|Lack of Efficacy|0|||
33151778|NCT00810693|100470320|FG002|Treatment Period|Lack of Efficacy|1|||
33151779|NCT00810693|100470318|FG000|Treatment Period|Lost to Follow-up|1|||
33151780|NCT00810693|100470319|FG001|Treatment Period|Lost to Follow-up|0|||
33151781|NCT00810693|100470320|FG002|Treatment Period|Lost to Follow-up|0|||
33151782|NCT00810693|100470318|FG000|Treatment Period|Non-compliance|1|||
33151783|NCT00810693|100470319|FG001|Treatment Period|Non-compliance|0|||
33151784|NCT00810693|100470320|FG002|Treatment Period|Non-compliance|0|||
33151785|NCT00810693|100470318|FG000|Treatment Period|Protocol Violation|1|||
33151786|NCT00810693|100470319|FG001|Treatment Period|Protocol Violation|2|||
33151787|NCT00810693|100470320|FG002|Treatment Period|Protocol Violation|2|||
33151788|NCT00810693|100470318|FG000|Treatment Period|Withdrawal by Subject|6|||
33151789|NCT00810693|100470319|FG001|Treatment Period|Withdrawal by Subject|2|||
33151790|NCT00810693|100470320|FG002|Treatment Period|Withdrawal by Subject|3|||
33151791|NCT00810693|100470318|FG000|Treatment Period|Not treated|0|||
33151792|NCT00810693|100470319|FG001|Treatment Period|Not treated|1|||
33151793|NCT00810693|100470320|FG002|Treatment Period|Not treated|1|||
33151794|NCT00810693|100470318|FG000|Follow-up Period (FUP)|Adverse Event|3|||
33151795|NCT00810693|100470319|FG001|Follow-up Period (FUP)|Adverse Event|1|||
33151796|NCT00810693|100470320|FG002|Follow-up Period (FUP)|Adverse Event|1|||
33151797|NCT00810693|100470318|FG000|Follow-up Period (FUP)|Death|2|||
33151798|NCT00810693|100470319|FG001|Follow-up Period (FUP)|Death|0|||
33151799|NCT00810693|100470320|FG002|Follow-up Period (FUP)|Death|1|||
33151800|NCT00810693|100470318|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
33151801|NCT00810693|100470319|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
33151802|NCT00810693|100470320|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
33151803|NCT00810693|100470318|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
33151804|NCT00810693|100470319|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
33151805|NCT00810693|100470320|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
33151806|NCT00810693|100470318|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
33151807|NCT00810693|100470319|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
33151808|NCT00810693|100470320|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
33151809|NCT03161093|100470321|FG000|Overall Study|Protocol Violation|11|||
33436641|NCT00950807|101492519|FG002|Treatment Period 1|Protocol Violation|0|||
33436642|NCT00950807|101492520|FG003|Treatment Period 1|Protocol Violation|0|||
33151810|NCT03161093|100470322|FG001|Overall Study|Protocol Violation|14|||
33436643|NCT00950807|101492521|FG004|Treatment Period 1|Protocol Violation|0|||
33436644|NCT00950807|101492522|FG005|Treatment Period 1|Protocol Violation|0|||
33436645|NCT00950807|101492523|FG006|Treatment Period 1|Protocol Violation|0|||
33436646|NCT00950807|101492524|FG007|Treatment Period 1|Protocol Violation|0|||
33151811|NCT03161093|100470323|FG002|Overall Study|Protocol Violation|6|||
33151812|NCT03161093|100470324|FG003|Overall Study|Protocol Violation|13|||
33151813|NCT03161093|100470325|FG004|Overall Study|Protocol Violation|1|||
33151814|NCT03161093|100470326|FG005|Overall Study|Protocol Violation|0|||
33151815|NCT03161093|100470321|FG000|Overall Study|Adverse Event|5|||
33151816|NCT03161093|100470322|FG001|Overall Study|Adverse Event|21|||
33151817|NCT03161093|100470323|FG002|Overall Study|Adverse Event|16|||
33151818|NCT03161093|100470324|FG003|Overall Study|Adverse Event|35|||
33151819|NCT03161093|100470325|FG004|Overall Study|Adverse Event|2|||
33151820|NCT03161093|100470326|FG005|Overall Study|Adverse Event|1|||
33151821|NCT03161093|100470321|FG000|Overall Study|Lack of Efficacy|9|||
33151822|NCT03161093|100470322|FG001|Overall Study|Lack of Efficacy|13|||
33151823|NCT03161093|100470323|FG002|Overall Study|Lack of Efficacy|9|||
33151824|NCT03161093|100470324|FG003|Overall Study|Lack of Efficacy|24|||
33151825|NCT03161093|100470325|FG004|Overall Study|Lack of Efficacy|4|||
33151826|NCT03161093|100470326|FG005|Overall Study|Lack of Efficacy|1|||
33151827|NCT03161093|100470321|FG000|Overall Study|Physician Decision|0|||
33151828|NCT03161093|100470322|FG001|Overall Study|Physician Decision|1|||
33151829|NCT03161093|100470323|FG002|Overall Study|Physician Decision|0|||
33151830|NCT03161093|100470324|FG003|Overall Study|Physician Decision|2|||
33151831|NCT03161093|100470325|FG004|Overall Study|Physician Decision|17|||
33151832|NCT03161093|100470326|FG005|Overall Study|Physician Decision|15|||
33151833|NCT03161093|100470321|FG000|Overall Study|Withdrawal by Subject|24|||
33151834|NCT03161093|100470322|FG001|Overall Study|Withdrawal by Subject|73|||
33151835|NCT03161093|100470323|FG002|Overall Study|Withdrawal by Subject|44|||
33151836|NCT03161093|100470324|FG003|Overall Study|Withdrawal by Subject|97|||
33151837|NCT03161093|100470325|FG004|Overall Study|Withdrawal by Subject|11|||
33151838|NCT03161093|100470326|FG005|Overall Study|Withdrawal by Subject|10|||
33151839|NCT03161093|100470321|FG000|Overall Study|Lost to Follow-up|3|||
33151840|NCT03161093|100470322|FG001|Overall Study|Lost to Follow-up|12|||
33151841|NCT03161093|100470323|FG002|Overall Study|Lost to Follow-up|4|||
33151842|NCT03161093|100470324|FG003|Overall Study|Lost to Follow-up|7|||
33151843|NCT03161093|100470325|FG004|Overall Study|Lost to Follow-up|8|||
33151844|NCT03161093|100470326|FG005|Overall Study|Lost to Follow-up|13|||
33151845|NCT03161093|100470321|FG000|Overall Study|Death|3|||
33151846|NCT03161093|100470322|FG001|Overall Study|Death|9|||
33151847|NCT03161093|100470323|FG002|Overall Study|Death|7|||
33151848|NCT03161093|100470324|FG003|Overall Study|Death|9|||
33151849|NCT03161093|100470325|FG004|Overall Study|Death|0|||
33151850|NCT03161093|100470326|FG005|Overall Study|Death|0|||
33151851|NCT03161093|100470321|FG000|Overall Study|Unknown - Not reported|0|||
33151852|NCT03161093|100470322|FG001|Overall Study|Unknown - Not reported|1|||
33151853|NCT03161093|100470323|FG002|Overall Study|Unknown - Not reported|0|||
33151854|NCT03161093|100470324|FG003|Overall Study|Unknown - Not reported|0|||
33151855|NCT03161093|100470325|FG004|Overall Study|Unknown - Not reported|0|||
33151856|NCT03161093|100470326|FG005|Overall Study|Unknown - Not reported|1|||
33151857|NCT00237185|100470329|FG000|Core|Adverse Event|3|||
33151858|NCT00237185|100470330|FG001|Core|Adverse Event|4|||
33151859|NCT00237185|100470329|FG000|Core|Abnormal laboratory value|0|||
33151860|NCT00237185|100470330|FG001|Core|Abnormal laboratory value|4|||
33151861|NCT00237185|100470329|FG000|Core|Abnormal test procedure results|1|||
33151862|NCT00237185|100470330|FG001|Core|Abnormal test procedure results|0|||
33151863|NCT00237185|100470329|FG000|Core|Lack of Efficacy|30|||
33151864|NCT00237185|100470330|FG001|Core|Lack of Efficacy|23|||
33151865|NCT00237185|100470329|FG000|Core|Protocol Violation|1|||
33151866|NCT00237185|100470330|FG001|Core|Protocol Violation|1|||
33151867|NCT00237185|100470329|FG000|Core|Withdrawal by Subject|4|||
33151868|NCT00237185|100470330|FG001|Core|Withdrawal by Subject|4|||
33151869|NCT00237185|100470329|FG000|Core|Administrative problems|0|||
33151870|NCT00237185|100470330|FG001|Core|Administrative problems|1|||
33151871|NCT00237185|100470329|FG000|Core|Death|4|||
33151872|NCT00237185|100470330|FG001|Core|Death|0|||
33151873|NCT00237185|100470329|FG000|Core|Determined ineligible post randomization|1|||
33151874|NCT00237185|100470330|FG001|Core|Determined ineligible post randomization|0|||
33151875|NCT00237185|100470329|FG000|Extension|Adverse Event|1|||
33151876|NCT00237185|100470330|FG001|Extension|Adverse Event|0|||
33151877|NCT00237185|100470329|FG000|Extension|Abnormal laboratory value|0|||
33151878|NCT00237185|100470330|FG001|Extension|Abnormal laboratory value|1|||
33151879|NCT00237185|100470329|FG000|Extension|Lack of Efficacy|9|||
33151880|NCT00237185|100470330|FG001|Extension|Lack of Efficacy|14|||
33151881|NCT00237185|100470329|FG000|Extension|Condition no longer required study drug|0|||
33250087|NCT01689519|100814572|FG000|Safety Population|Death|158|||
33250088|NCT01689519|100814573|FG001|Safety Population|Death|165|||
33151882|NCT00237185|100470330|FG001|Extension|Condition no longer required study drug|1|||
33250089|NCT01689519|100814572|FG000|Safety Population|Lost to Follow-up|4|||
33151883|NCT00237185|100470329|FG000|Extension|Withdrawal by Subject|3|||
33151884|NCT00237185|100470330|FG001|Extension|Withdrawal by Subject|2|||
33151885|NCT00237185|100470329|FG000|Extension|Lost to Follow-up|1|||
33151886|NCT00237185|100470330|FG001|Extension|Lost to Follow-up|0|||
33151887|NCT00237185|100470329|FG000|Extension|Administrative problems|1|||
33151888|NCT00237185|100470330|FG001|Extension|Administrative problems|0|||
33250090|NCT01689519|100814573|FG001|Safety Population|Lost to Follow-up|8|||
33151889|NCT00237185|100470329|FG000|Extension|Death|1|||
33151890|NCT00237185|100470330|FG001|Extension|Death|1|||
33151891|NCT01193842|100470333|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
33151892|NCT01193842|100470334|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
33151893|NCT01193842|100470335|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
33151894|NCT01193842|100470336|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
33151895|NCT01193842|100470337|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
33151896|NCT01193842|100470333|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
33151897|NCT01193842|100470334|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
33151898|NCT01193842|100470335|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
33151899|NCT01193842|100470336|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
33151900|NCT01193842|100470337|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
33151901|NCT01193842|100470333|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
33151902|NCT01193842|100470334|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
33151903|NCT01193842|100470335|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
33151904|NCT01193842|100470336|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
33151905|NCT01193842|100470337|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
33151906|NCT01193842|100470333|FG000|Phase II: Randomized Groups|Death|0|||
33151907|NCT01193842|100470334|FG001|Phase II: Randomized Groups|Death|0|||
33151908|NCT01193842|100470335|FG002|Phase II: Randomized Groups|Death|0|||
33151909|NCT01193842|100470336|FG003|Phase II: Randomized Groups|Death|1|||
33151910|NCT01193842|100470337|FG004|Phase II: Randomized Groups|Death|1|||
33151911|NCT01193842|100470333|FG000|Phase II: Randomized Groups|Adverse Event|0|||
33151912|NCT01193842|100470334|FG001|Phase II: Randomized Groups|Adverse Event|0|||
33151913|NCT01193842|100470335|FG002|Phase II: Randomized Groups|Adverse Event|0|||
33151914|NCT01193842|100470336|FG003|Phase II: Randomized Groups|Adverse Event|5|||
33151915|NCT01193842|100470337|FG004|Phase II: Randomized Groups|Adverse Event|3|||
33151916|NCT01193842|100470333|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
33151917|NCT01193842|100470334|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
33151918|NCT01193842|100470335|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
33151919|NCT01193842|100470336|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
33151920|NCT01193842|100470337|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
33151921|NCT01193842|100470333|FG000|Phase II: Randomized Groups|Ineligible|0|||
33151922|NCT01193842|100470334|FG001|Phase II: Randomized Groups|Ineligible|0|||
33151923|NCT01193842|100470335|FG002|Phase II: Randomized Groups|Ineligible|0|||
33151924|NCT01193842|100470336|FG003|Phase II: Randomized Groups|Ineligible|0|||
33151925|NCT01193842|100470337|FG004|Phase II: Randomized Groups|Ineligible|1|||
33151926|NCT01193842|100470333|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
33151927|NCT01193842|100470334|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
33151928|NCT01193842|100470335|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
33151929|NCT01193842|100470336|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
33151930|NCT01193842|100470337|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
33151931|NCT03113916|100470338|FG000|Overall Study|Withdrawal by Subject|9|||
33151932|NCT03113916|100470339|FG001|Overall Study|Withdrawal by Subject|7|||
33151933|NCT03113916|100470338|FG000|Overall Study|Pregnancy|1|||
33151934|NCT03113916|100470339|FG001|Overall Study|Pregnancy|3|||
33151935|NCT03113916|100470338|FG000|Overall Study|Lost to Follow-up|1|||
33151936|NCT03113916|100470339|FG001|Overall Study|Lost to Follow-up|2|||
33151937|NCT04068610|100470340|FG000|Overall Study|Death|4|||
33151938|NCT04068610|100470341|FG001|Overall Study|Death|8|||
33151939|NCT04068610|100470342|FG002|Overall Study|Death|13|||
33151940|NCT04068610|100470340|FG000|Overall Study|Lost to Follow-up|0|||
33151941|NCT04068610|100470341|FG001|Overall Study|Lost to Follow-up|2|||
33151942|NCT04068610|100470342|FG002|Overall Study|Lost to Follow-up|0|||
33151943|NCT04068610|100470340|FG000|Overall Study|Withdrawal by Subject|0|||
33151944|NCT04068610|100470341|FG001|Overall Study|Withdrawal by Subject|4|||
33151945|NCT04068610|100470342|FG002|Overall Study|Withdrawal by Subject|2|||
33151946|NCT04068610|100470340|FG000|Overall Study|Other|3|||
33151947|NCT04068610|100470341|FG001|Overall Study|Other|12|||
33151948|NCT04068610|100470342|FG002|Overall Study|Other|11|||
33151949|NCT01251744|100470343|FG000|Overall Study|Lost to Follow-up|1|||
33151950|NCT01251744|100470344|FG001|Overall Study|Lost to Follow-up|0|||
33151951|NCT02169284|100470345|FG000|Overall Study|Physician Decision|0|||
33151952|NCT02169284|100470346|FG001|Overall Study|Physician Decision|1|||
33151953|NCT00147251|100470347|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
33151954|NCT00147251|100470348|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
33151955|NCT00915356|100470349|FG000|Overall Study|Withdrawal by Subject|1|||
33151956|NCT00915356|100470350|FG001|Overall Study|Withdrawal by Subject|0|||
33151957|NCT00915356|100470351|FG002|Overall Study|Withdrawal by Subject|0|||
33151958|NCT00915356|100470352|FG003|Overall Study|Withdrawal by Subject|0|||
33151959|NCT00915356|100470353|FG004|Overall Study|Withdrawal by Subject|0|||
33151960|NCT01977937|100470354|FG000|Overall Study|Withdrawal by Subject|2|||
33151961|NCT01977937|100470355|FG001|Overall Study|Withdrawal by Subject|1|||
33151962|NCT01977937|100470354|FG000|Overall Study|Adverse Event|1|||
33250091|NCT01689519|100814572|FG000|Safety Population|Other|2|||
33151963|NCT01977937|100470355|FG001|Overall Study|Adverse Event|0|||
33151964|NCT01977937|100470354|FG000|Overall Study|Physician Decision|0|||
33151965|NCT01977937|100470355|FG001|Overall Study|Physician Decision|1|||
33151966|NCT00586066|100470356|FG000|Overall Study|Lost to Follow-up|6|||
33151967|NCT00586066|100470357|FG001|Overall Study|Lost to Follow-up|3|||
33151968|NCT00586066|100470356|FG000|Overall Study|Lack of Efficacy|5|||
33151969|NCT00586066|100470357|FG001|Overall Study|Lack of Efficacy|3|||
33151970|NCT00586066|100470356|FG000|Overall Study|Adverse Event|2|||
33151971|NCT00586066|100470357|FG001|Overall Study|Adverse Event|2|||
33151972|NCT00586066|100470356|FG000|Overall Study|Physician Decision|1|||
33151973|NCT00586066|100470357|FG001|Overall Study|Physician Decision|0|||
33151974|NCT00586066|100470356|FG000|Overall Study|Withdrawal of consent|4|||
33151975|NCT00586066|100470357|FG001|Overall Study|Withdrawal of consent|2|||
33151976|NCT05430022|100470358|FG000|Overall Study|Withdrawal by Subject|4|||
33151977|NCT05430022|100470359|FG001|Overall Study|Withdrawal by Subject|4|||
33151978|NCT04137224|100470362|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
33151979|NCT04137224|100470363|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
33151980|NCT04137224|100470362|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
33151981|NCT04137224|100470363|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
33151982|NCT04137224|100470362|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
33151983|NCT04137224|100470363|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
33151984|NCT02046733|100470364|FG000|Overall Study|never initiated 'treatment visits'|6|||
33151985|NCT02046733|100470365|FG001|Overall Study|never initiated 'treatment visits'|0|||
33151986|NCT04502979|100470366|FG000|Overall Study|Lost to Follow-up|1|||
33151987|NCT04502979|100470367|FG001|Overall Study|Lost to Follow-up|3|||
33151988|NCT04502979|100470366|FG000|Overall Study|Withdrawal by Subject|2|||
33151989|NCT04502979|100470367|FG001|Overall Study|Withdrawal by Subject|1|||
33151990|NCT01795638|100470368|FG000|Overall Study|Death|0|||
33151991|NCT01795638|100470369|FG001|Overall Study|Death|3|||
33151992|NCT01795638|100470368|FG000|Overall Study|transferred to quaternary hospital|2|||
33151993|NCT01795638|100470369|FG001|Overall Study|transferred to quaternary hospital|3|||
33151994|NCT01795638|100470368|FG000|Overall Study|Protocol Violation|3|||
33151995|NCT01795638|100470369|FG001|Overall Study|Protocol Violation|0|||
33151996|NCT01795638|100470368|FG000|Overall Study|discharged from hospital|7|||
33151997|NCT01795638|100470369|FG001|Overall Study|discharged from hospital|5|||
33151998|NCT01795638|100470368|FG000|Overall Study|Withdrawal by Subject|1|||
33151999|NCT01795638|100470369|FG001|Overall Study|Withdrawal by Subject|0|||
33152000|NCT00559754|100470370|FG000|Overall Study|Disease progression|1|||
33152001|NCT00559754|100470370|FG000|Overall Study|Adverse Event|5|||
33152002|NCT00559754|100470370|FG000|Overall Study|Protocol Violation|1|||
33152003|NCT00559754|100470370|FG000|Overall Study|Investigator criteria|2|||
33152004|NCT00559754|100470370|FG000|Overall Study|Withdrawal by Subject|2|||
33152005|NCT00678080|100470371|FG000|Overall Study|Physician Decision|2|||
33152006|NCT00678080|100470372|FG001|Overall Study|Physician Decision|0|||
33152007|NCT00678080|100470371|FG000|Overall Study|Lost to Follow-up|1|||
33152008|NCT00678080|100470372|FG001|Overall Study|Lost to Follow-up|0|||
33152009|NCT00678080|100470371|FG000|Overall Study|Withdrawal by Subject|0|||
33152010|NCT00678080|100470372|FG001|Overall Study|Withdrawal by Subject|1|||
33152011|NCT02428608|100470373|FG000|Overall Study|Pregnancy|2|||
33152012|NCT02428608|100470373|FG000|Overall Study|Lost to Follow-up|37|||
33152013|NCT02428608|100470373|FG000|Overall Study|Withdrawal by Subject|2|||
33152014|NCT02428608|100470373|FG000|Overall Study|scheduling conflicts|15|||
33152015|NCT02428608|100470373|FG000|Overall Study|moved away|10|||
33152016|NCT02428608|100470373|FG000|Overall Study|Death|1|||
33152017|NCT02428608|100470373|FG000|Overall Study|various|16|||
33152018|NCT00470847|100470374|FG000|Overall Study|Pt still receiving treatment|1|||
33152019|NCT02360111|100470375|FG000|Overall Study|Death|2|||
33152020|NCT03971071|100470382|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
33152021|NCT03971071|100470383|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
33152022|NCT03971071|100470384|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
33152023|NCT03971071|100470385|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
33152024|NCT03971071|100470386|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
33152025|NCT03971071|100470382|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
33152026|NCT03971071|100470383|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
33152027|NCT03971071|100470384|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
33152028|NCT03971071|100470385|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
33152029|NCT03971071|100470386|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
33152030|NCT03971071|100470382|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
33152031|NCT03971071|100470383|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
33152032|NCT03971071|100470384|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
33152033|NCT03971071|100470385|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
33152034|NCT03971071|100470386|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
33152035|NCT03971071|100470382|FG000|Open-label Treatment Period|Sponsor decision|0|||
33152036|NCT03971071|100470383|FG001|Open-label Treatment Period|Sponsor decision|0|||
33152037|NCT03971071|100470384|FG002|Open-label Treatment Period|Sponsor decision|0|||
33152038|NCT03971071|100470385|FG003|Open-label Treatment Period|Sponsor decision|0|||
33152039|NCT03971071|100470386|FG004|Open-label Treatment Period|Sponsor decision|1|||
33250092|NCT01689519|100814573|FG001|Safety Population|Other|4|||
33250093|NCT01689519|100814572|FG000|Safety Population|Physician Decision|4|||
33250094|NCT01689519|100814573|FG001|Safety Population|Physician Decision|1|||
33250095|NCT01689519|100814572|FG000|Safety Population|Study Terminated By Sponsor|60|||
33250096|NCT01689519|100814573|FG001|Safety Population|Study Terminated By Sponsor|47|||
33250097|NCT01689519|100814572|FG000|Safety Population|Withdrawal by Subject|20|||
33250098|NCT01689519|100814573|FG001|Safety Population|Withdrawal by Subject|20|||
33250099|NCT05298111|100814574|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
33250100|NCT05298111|100814575|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
33250101|NCT02943993|100814576|FG000|Overall Study|Withdrawal by Subject|52|||
33250102|NCT02943993|100814576|FG000|Overall Study|Transfer to another institution|6|||
33250103|NCT02943993|100814576|FG000|Overall Study|Lost to Follow-up|135|||
33250104|NCT02943993|100814576|FG000|Overall Study|Death|98|||
33250105|NCT02943993|100814576|FG000|Overall Study|Other reason for premature termination|32|||
33250106|NCT02943993|100814576|FG000|Overall Study|Missing reason for termination|7|||
33250107|NCT03743246|100814579|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
33250108|NCT03743246|100814580|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
33250109|NCT03743246|100814581|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
33250110|NCT03743246|100814582|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
33250111|NCT03743246|100814579|FG000|Pre-Treatment Period|Death|0|||
33250112|NCT03743246|100814580|FG001|Pre-Treatment Period|Death|1|||
33250113|NCT03743246|100814581|FG002|Pre-Treatment Period|Death|0|||
33250114|NCT03743246|100814582|FG003|Pre-Treatment Period|Death|1|||
33250115|NCT03743246|100814579|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
33250116|NCT03743246|100814580|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
33250117|NCT03743246|100814581|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
33250118|NCT03743246|100814582|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
33250119|NCT03743246|100814579|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
33250120|NCT03743246|100814580|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
33250121|NCT03743246|100814581|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
33250122|NCT03743246|100814582|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
33250123|NCT03743246|100814579|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
33152040|NCT03971071|100470382|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
33152041|NCT03971071|100470383|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
33152042|NCT03971071|100470384|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
33152043|NCT03971071|100470385|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
33152044|NCT03971071|100470386|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
33152045|NCT03971071|100470382|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
33152046|NCT03971071|100470383|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
33152047|NCT03971071|100470384|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
33152048|NCT03971071|100470385|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
33152049|NCT03971071|100470386|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
33152050|NCT02367131|100470388|FG000|Overall Study|Adverse Event|64|||
33152051|NCT02367131|100470388|FG000|Overall Study|No visit since the first visit|3|||
33152052|NCT02367131|100470388|FG000|Overall Study|Request by patient|53|||
33152053|NCT02367131|100470388|FG000|Overall Study|Improvement/remission|2|||
33152054|NCT02367131|100470388|FG000|Overall Study|No change/progressive disease|78|||
33152055|NCT02367131|100470388|FG000|Overall Study|Other than stated above|20|||
33152056|NCT02367131|100470388|FG000|Overall Study|Not treated|2|||
33152057|NCT01368432|100470390|FG000|Overall Study|Lost to Follow-up|0|||
33152058|NCT01368432|100470391|FG001|Overall Study|Lost to Follow-up|1|||
33152059|NCT01810432|100470392|FG000|Washout|Protocol Violation|0|||
33152060|NCT01810432|100470393|FG001|Washout|Protocol Violation|1|||
33152061|NCT01810432|100470392|FG000|Washout|Adverse Event|1|||
33152062|NCT01810432|100470393|FG001|Washout|Adverse Event|0|||
33152063|NCT01810432|100470392|FG000|Period 2|Withdrawal by Subject|2|||
33250124|NCT03743246|100814580|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
33250125|NCT03743246|100814581|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
33250126|NCT03743246|100814582|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
33250127|NCT03743246|100814579|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
33250128|NCT03743246|100814580|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
33250129|NCT03743246|100814581|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
33250130|NCT03743246|100814582|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
33152064|NCT01810432|100470393|FG001|Period 2|Withdrawal by Subject|1|||
33250131|NCT03743246|100814579|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
33250132|NCT03743246|100814580|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
33250133|NCT03743246|100814581|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
33250134|NCT03743246|100814582|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
33152065|NCT01810432|100470392|FG000|Period 2|Physician Decision|1|||
33152066|NCT01810432|100470393|FG001|Period 2|Physician Decision|0|||
33152067|NCT01810432|100470392|FG000|Period 2|Lost to Follow-up|1|||
33152068|NCT01810432|100470393|FG001|Period 2|Lost to Follow-up|1|||
33152069|NCT00702689|100470394|FG000|Overall Study|Withdrawal by Subject|4|||
33152070|NCT00702689|100470394|FG000|Overall Study|Recurrent malignancy|1|||
33152071|NCT00702689|100470394|FG000|Overall Study|Adverse Event|1|||
33152072|NCT00629772|100470395|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
33152073|NCT00629772|100470396|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
33152074|NCT00629772|100470395|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
33152075|NCT00629772|100470396|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
33152076|NCT01134315|100470397|FG000|Overall Study|Adverse Event|1|||
33152077|NCT01134315|100470398|FG001|Overall Study|Adverse Event|2|||
33152078|NCT01134315|100470397|FG000|Overall Study|Other Reason|8|||
33152079|NCT01134315|100470398|FG001|Overall Study|Other Reason|17|||
33152080|NCT00569270|100470399|FG000|Period: First Intervention|Protocol Violation|0|||
33152081|NCT00569270|100470400|FG001|Period: First Intervention|Protocol Violation|1|||
33152082|NCT02966873|100470403|FG000|Overall Study|Lost to Follow-up|16|||
33152083|NCT02966873|100470404|FG001|Overall Study|Lost to Follow-up|15|||
33152084|NCT04228783|100470405|FG000|Overall Study|Adverse Event|1|||
33152085|NCT04228783|100470406|FG001|Overall Study|Adverse Event|0|||
33152086|NCT04228783|100470407|FG002|Overall Study|Adverse Event|2|||
33152087|NCT04228783|100470408|FG003|Overall Study|Adverse Event|0|||
33152088|NCT04228783|100470409|FG004|Overall Study|Adverse Event|0|||
33152089|NCT04228783|100470410|FG005|Overall Study|Adverse Event|1|||
33152090|NCT04228783|100470405|FG000|Overall Study|Death|0|||
33152091|NCT04228783|100470406|FG001|Overall Study|Death|0|||
33152092|NCT04228783|100470407|FG002|Overall Study|Death|0|||
33250135|NCT03743246|100814579|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
33250136|NCT03743246|100814580|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
33250137|NCT03743246|100814581|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
33250138|NCT03743246|100814582|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
33250139|NCT03743246|100814579|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
33250140|NCT03743246|100814580|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
33152093|NCT04228783|100470408|FG003|Overall Study|Death|0|||
33152094|NCT04228783|100470409|FG004|Overall Study|Death|1|||
33152095|NCT04228783|100470410|FG005|Overall Study|Death|0|||
33152096|NCT04228783|100470405|FG000|Overall Study|Lost to Follow-up|36|||
33152097|NCT04228783|100470406|FG001|Overall Study|Lost to Follow-up|36|||
33152098|NCT04228783|100470407|FG002|Overall Study|Lost to Follow-up|28|||
33152099|NCT04228783|100470408|FG003|Overall Study|Lost to Follow-up|6|||
33152100|NCT04228783|100470409|FG004|Overall Study|Lost to Follow-up|14|||
33152101|NCT04228783|100470410|FG005|Overall Study|Lost to Follow-up|3|||
33152102|NCT04228783|100470405|FG000|Overall Study|Physician Decision|1|||
33152103|NCT04228783|100470406|FG001|Overall Study|Physician Decision|2|||
33250141|NCT03743246|100814581|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
33250142|NCT03743246|100814582|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
33250143|NCT03478696|100814583|FG000|Overall Study|Adverse Event|1|||
33250144|NCT03478696|100814584|FG001|Overall Study|Adverse Event|5|||
33250145|NCT03478696|100814583|FG000|Overall Study|Lost to Follow-up|1|||
33250146|NCT03478696|100814584|FG001|Overall Study|Lost to Follow-up|0|||
33250147|NCT03478696|100814583|FG000|Overall Study|Physician Decision|6|||
33250148|NCT03478696|100814584|FG001|Overall Study|Physician Decision|3|||
33250149|NCT03478696|100814583|FG000|Overall Study|Withdrawal by Subject|9|||
33250150|NCT03478696|100814584|FG001|Overall Study|Withdrawal by Subject|4|||
33152104|NCT04228783|100470407|FG002|Overall Study|Physician Decision|0|||
33152105|NCT04228783|100470408|FG003|Overall Study|Physician Decision|0|||
33152106|NCT04228783|100470409|FG004|Overall Study|Physician Decision|0|||
33152107|NCT04228783|100470410|FG005|Overall Study|Physician Decision|0|||
33250151|NCT00117988|100814587|FG000|Overall Study|Death|3|||
33250152|NCT00117988|100814587|FG000|Overall Study|Adverse Event|1|||
33250153|NCT03265210|100814588|FG000|Overall Study|Withdrawal by Subject|7|||
33250154|NCT03265210|100814589|FG001|Overall Study|Withdrawal by Subject|9|||
33250155|NCT03265210|100814588|FG000|Overall Study|Lost to Follow-up|2|||
33436647|NCT00950807|101492525|FG008|Treatment Period 1|Protocol Violation|0|||
33250156|NCT03265210|100814589|FG001|Overall Study|Lost to Follow-up|0|||
33250157|NCT03265210|100814588|FG000|Overall Study|Physician Decision|2|||
33250158|NCT03265210|100814589|FG001|Overall Study|Physician Decision|0|||
33152108|NCT04228783|100470405|FG000|Overall Study|Protocol Violation|0|||
33250159|NCT03265210|100814588|FG000|Overall Study|Adverse Event|1|||
33250160|NCT03265210|100814589|FG001|Overall Study|Adverse Event|0|||
33250161|NCT01959412|100814590|FG000|Overall Study|Protocol deviation|1|||
33250162|NCT01959412|100814591|FG001|Overall Study|Protocol deviation|1|||
33250163|NCT01959412|100814592|FG002|Overall Study|Protocol deviation|0|||
33250164|NCT01959412|100814593|FG003|Overall Study|Protocol deviation|1|||
33250165|NCT01959412|100814594|FG004|Overall Study|Protocol deviation|3|||
33250166|NCT01959412|100814595|FG005|Overall Study|Protocol deviation|0|||
33250167|NCT01959412|100814590|FG000|Overall Study|Adverse Event|0|||
33250168|NCT01959412|100814591|FG001|Overall Study|Adverse Event|0|||
33250169|NCT01959412|100814592|FG002|Overall Study|Adverse Event|0|||
33250170|NCT01959412|100814593|FG003|Overall Study|Adverse Event|1|||
33250171|NCT01959412|100814594|FG004|Overall Study|Adverse Event|0|||
33250172|NCT01959412|100814595|FG005|Overall Study|Adverse Event|0|||
33250173|NCT00646451|100814596|FG000|Overall Study|Adverse Event|3|||
33250174|NCT00646451|100814597|FG001|Overall Study|Adverse Event|0|||
33250175|NCT00646451|100814596|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
33250176|NCT00646451|100814597|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
33250177|NCT02993471|100814598|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
33250178|NCT02993471|100814598|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
33250179|NCT00591838|100814601|FG000|Overall Study|Withdrawal by Subject|0|||
33250180|NCT00591838|100814602|FG001|Overall Study|Withdrawal by Subject|0|||
33250181|NCT00591838|100814603|FG002|Overall Study|Withdrawal by Subject|0|||
33250182|NCT00591838|100814604|FG003|Overall Study|Withdrawal by Subject|1|||
33250183|NCT00591838|100814605|FG004|Overall Study|Withdrawal by Subject|0|||
33250184|NCT03140176|100814606|FG000|Overall Study|Reason missing|23|||
33250185|NCT03140176|100814606|FG000|Overall Study|Death|33|||
33250186|NCT03140176|100814606|FG000|Overall Study|Disease progression|1|||
33250187|NCT03140176|100814606|FG000|Overall Study|Physician Decision|1|||
33250188|NCT03140176|100814606|FG000|Overall Study|Withdrawal by Subject|1|||
33250189|NCT03140176|100814606|FG000|Overall Study|Lost to Follow-up|15|||
33250190|NCT05019729|100814607|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
33250191|NCT05019729|100814608|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
33152109|NCT04228783|100470406|FG001|Overall Study|Protocol Violation|0|||
33152110|NCT04228783|100470407|FG002|Overall Study|Protocol Violation|0|||
33152111|NCT04228783|100470408|FG003|Overall Study|Protocol Violation|1|||
33152112|NCT04228783|100470409|FG004|Overall Study|Protocol Violation|0|||
33152113|NCT04228783|100470410|FG005|Overall Study|Protocol Violation|0|||
33152114|NCT04228783|100470405|FG000|Overall Study|Withdrawal by Subject|6|||
33250192|NCT05019729|100814609|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
33250193|NCT05019729|100814610|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
33386280|NCT00282867|101302469|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
33386281|NCT00282867|101302470|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
33386282|NCT00282867|101302471|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
33386283|NCT01732107|101302472|FG000|Overall Study|Adverse Event|2|||
33386284|NCT01732107|101302472|FG000|Overall Study|Disease Progression|8|||
33386285|NCT01732107|101302472|FG000|Overall Study|Physician Decision|1|||
33386286|NCT01732107|101302472|FG000|Overall Study|Withdrawal by Subject|2|||
33386287|NCT01306032|101302473|FG000|First Intervention|Adverse Event|1|||
33386288|NCT01306032|101302474|FG001|First Intervention|Adverse Event|0|||
33386289|NCT01306032|101302475|FG002|First Intervention|Adverse Event|1|||
33386290|NCT01306032|101302476|FG003|First Intervention|Adverse Event|0|||
33386291|NCT01306032|101302477|FG004|First Intervention|Adverse Event|0|||
33386292|NCT01306032|101302478|FG005|First Intervention|Adverse Event|1|||
33386293|NCT01306032|101302473|FG000|First Intervention|Withdrawal by Subject|0|||
33386294|NCT01306032|101302474|FG001|First Intervention|Withdrawal by Subject|2|||
33386295|NCT01306032|101302475|FG002|First Intervention|Withdrawal by Subject|0|||
33386296|NCT01306032|101302476|FG003|First Intervention|Withdrawal by Subject|1|||
33386297|NCT01306032|101302477|FG004|First Intervention|Withdrawal by Subject|0|||
33386298|NCT01306032|101302478|FG005|First Intervention|Withdrawal by Subject|0|||
33386299|NCT01306032|101302473|FG000|First Intervention|Death|0|||
33386300|NCT01306032|101302474|FG001|First Intervention|Death|0|||
33386301|NCT01306032|101302475|FG002|First Intervention|Death|1|||
33386302|NCT01306032|101302476|FG003|First Intervention|Death|0|||
33386303|NCT01306032|101302477|FG004|First Intervention|Death|0|||
33386304|NCT01306032|101302478|FG005|First Intervention|Death|0|||
33250194|NCT05019729|100814611|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
33250195|NCT05019729|100814612|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
33250196|NCT00891618|100814613|FG000|Overall Study|Withdrawal by Subject|1|||
33250197|NCT01585038|100814615|FG000|Overall Study|Adverse Event|2|||
33250198|NCT01585038|100814616|FG001|Overall Study|Adverse Event|2|||
33250199|NCT00530842|100814617|FG000|Overall Study|Adverse Event|10|||
33250200|NCT00530842|100814618|FG001|Overall Study|Adverse Event|6|||
33386305|NCT01306032|101302473|FG000|First Intervention|Ineligible|0|||
33250201|NCT00530842|100814617|FG000|Overall Study|Lack of Efficacy|2|||
33250202|NCT00530842|100814618|FG001|Overall Study|Lack of Efficacy|1|||
33250203|NCT00530842|100814617|FG000|Overall Study|Lost to Follow-up|0|||
33250204|NCT00530842|100814618|FG001|Overall Study|Lost to Follow-up|4|||
33250205|NCT00530842|100814617|FG000|Overall Study|Protocol Violation|3|||
33250206|NCT00530842|100814618|FG001|Overall Study|Protocol Violation|2|||
33250207|NCT00530842|100814617|FG000|Overall Study|Withdrawal by Subject|4|||
33250208|NCT00530842|100814618|FG001|Overall Study|Withdrawal by Subject|5|||
33386306|NCT01306032|101302474|FG001|First Intervention|Ineligible|0|||
33386307|NCT01306032|101302475|FG002|First Intervention|Ineligible|0|||
33386308|NCT01306032|101302476|FG003|First Intervention|Ineligible|0|||
33386309|NCT01306032|101302477|FG004|First Intervention|Ineligible|0|||
33386310|NCT01306032|101302478|FG005|First Intervention|Ineligible|1|||
33386311|NCT01306032|101302473|FG000|First Intervention|Progressive disease|0|||
33386312|NCT01306032|101302474|FG001|First Intervention|Progressive disease|0|||
33386313|NCT01306032|101302475|FG002|First Intervention|Progressive disease|0|||
33386314|NCT01306032|101302476|FG003|First Intervention|Progressive disease|0|||
33250209|NCT00530842|100814617|FG000|Overall Study|Individual different reasons|4|||
33250210|NCT00530842|100814618|FG001|Overall Study|Individual different reasons|3|||
33436648|NCT00950807|101492526|FG009|Treatment Period 1|Protocol Violation|0|||
33250211|NCT00530842|100814617|FG000|Period 1|Adverse Event|7|||
33436649|NCT00950807|101492517|FG000|Treatment Period 1|Lost to Follow-up|0|||
33436650|NCT00950807|101492518|FG001|Treatment Period 1|Lost to Follow-up|0|||
33436651|NCT00950807|101492519|FG002|Treatment Period 1|Lost to Follow-up|1|||
33436652|NCT00950807|101492520|FG003|Treatment Period 1|Lost to Follow-up|0|||
33250212|NCT00530842|100814618|FG001|Period 1|Adverse Event|3|||
33250213|NCT00530842|100814617|FG000|Period 1|Lack of Efficacy|1|||
33250214|NCT00530842|100814618|FG001|Period 1|Lack of Efficacy|1|||
33250215|NCT00530842|100814617|FG000|Period 1|Protocol Violation|2|||
33250216|NCT00530842|100814618|FG001|Period 1|Protocol Violation|1|||
33250217|NCT00530842|100814617|FG000|Period 1|Withdrawal by Subject|2|||
33250218|NCT00530842|100814618|FG001|Period 1|Withdrawal by Subject|3|||
33250219|NCT00530842|100814617|FG000|Period 1|Individual different reasons|2|||
33250220|NCT00530842|100814618|FG001|Period 1|Individual different reasons|3|||
33250221|NCT00530842|100814617|FG000|Period 2|Adverse Event|3|||
33250222|NCT00530842|100814618|FG001|Period 2|Adverse Event|3|||
33250223|NCT00530842|100814617|FG000|Period 2|Lack of Efficacy|1|||
33250224|NCT00530842|100814618|FG001|Period 2|Lack of Efficacy|0|||
33250225|NCT00530842|100814617|FG000|Period 2|Lost to Follow-up|0|||
33250226|NCT00530842|100814618|FG001|Period 2|Lost to Follow-up|4|||
33250227|NCT00530842|100814617|FG000|Period 2|Protocol Violation|1|||
33250228|NCT00530842|100814618|FG001|Period 2|Protocol Violation|0|||
33250229|NCT00530842|100814617|FG000|Period 2|Withdrawal by Subject|1|||
33250230|NCT00530842|100814618|FG001|Period 2|Withdrawal by Subject|2|||
33250231|NCT00530842|100814617|FG000|Period 2|Individual different reasons|2|||
33250232|NCT00530842|100814618|FG001|Period 2|Individual different reasons|0|||
33250233|NCT04107805|100814619|FG000|Overall Study|Adverse Event|0|||
33436653|NCT00950807|101492521|FG004|Treatment Period 1|Lost to Follow-up|0|||
33436654|NCT00950807|101492522|FG005|Treatment Period 1|Lost to Follow-up|0|||
33250234|NCT04107805|100814620|FG001|Overall Study|Adverse Event|0|||
33250235|NCT04107805|100814621|FG002|Overall Study|Adverse Event|0|||
33250236|NCT04107805|100814622|FG003|Overall Study|Adverse Event|1|||
33250237|NCT04107805|100814623|FG004|Overall Study|Adverse Event|0|||
33250238|NCT04107805|100814624|FG005|Overall Study|Adverse Event|1|||
33250239|NCT04107805|100814625|FG006|Overall Study|Adverse Event|0|||
33250240|NCT04107805|100814626|FG007|Overall Study|Adverse Event|0|||
33436655|NCT00950807|101492523|FG006|Treatment Period 1|Lost to Follow-up|0|||
33436656|NCT00950807|101492524|FG007|Treatment Period 1|Lost to Follow-up|0|||
33152115|NCT04228783|100470406|FG001|Overall Study|Withdrawal by Subject|10|||
33152116|NCT04228783|100470407|FG002|Overall Study|Withdrawal by Subject|19|||
33152117|NCT04228783|100470408|FG003|Overall Study|Withdrawal by Subject|1|||
33152118|NCT04228783|100470409|FG004|Overall Study|Withdrawal by Subject|2|||
33152119|NCT04228783|100470410|FG005|Overall Study|Withdrawal by Subject|0|||
33152120|NCT04228783|100470405|FG000|Overall Study|Other|4|||
33152121|NCT04228783|100470406|FG001|Overall Study|Other|3|||
33152122|NCT04228783|100470407|FG002|Overall Study|Other|2|||
33152123|NCT04228783|100470408|FG003|Overall Study|Other|1|||
33152124|NCT04228783|100470409|FG004|Overall Study|Other|0|||
33152125|NCT04228783|100470410|FG005|Overall Study|Other|0|||
33152126|NCT02030938|100470412|FG000|Overall Study|Lost to Follow-up|4|||
33152127|NCT02030938|100470412|FG000|Overall Study|Withdrawal by Subject|1|||
33152128|NCT01756053|100472805|FG000|Period 1 (10 Days)|Protocol Violation|1|||
33152129|NCT01756053|100472806|FG001|Period 1 (10 Days)|Protocol Violation|1|||
33152130|NCT01756053|100472805|FG000|Period 2 (10 Days)|Protocol Violation|0|||
33152131|NCT01756053|100472806|FG001|Period 2 (10 Days)|Protocol Violation|2|||
33152132|NCT04128371|100472809|FG000|Overall Study|Lack of Efficacy|1|||
33152133|NCT02979197|100472813|FG000|Overall Study|Adverse Event|4|||
33152134|NCT02979197|100472814|FG001|Overall Study|Adverse Event|2|||
33152135|NCT02979197|100472815|FG002|Overall Study|Adverse Event|0|||
33152136|NCT02979197|100472813|FG000|Overall Study|Protocol Violation|0|||
33152137|NCT02979197|100472814|FG001|Overall Study|Protocol Violation|1|||
33250241|NCT04107805|100814627|FG008|Overall Study|Adverse Event|1|||
33152138|NCT02979197|100472815|FG002|Overall Study|Protocol Violation|0|||
33152139|NCT02979197|100472813|FG000|Overall Study|Subject unable to commit to study dates|0|||
33152140|NCT02979197|100472814|FG001|Overall Study|Subject unable to commit to study dates|1|||
33250242|NCT00678795|100814628|FG000|Overall Study|Adverse Event|7|||
33250243|NCT00678795|100814629|FG001|Overall Study|Adverse Event|3|||
33250244|NCT00678795|100814628|FG000|Overall Study|Withdrawal by Subject|3|||
33250245|NCT00678795|100814629|FG001|Overall Study|Withdrawal by Subject|0|||
33250246|NCT00678795|100814628|FG000|Overall Study|Protocol Violation|0|||
33250247|NCT00678795|100814629|FG001|Overall Study|Protocol Violation|1|||
33250248|NCT00678795|100814628|FG000|Overall Study|Lost to Follow-up|0|||
33250249|NCT00678795|100814629|FG001|Overall Study|Lost to Follow-up|1|||
33250250|NCT00678795|100814628|FG000|Overall Study|Lack of Efficacy|1|||
33250251|NCT00678795|100814629|FG001|Overall Study|Lack of Efficacy|1|||
33250252|NCT02595398|100814630|FG000|Overall Study|Non-compliance|1|||
33250253|NCT02595398|100814631|FG001|Overall Study|Non-compliance|0|||
33250254|NCT02595398|100814630|FG000|Overall Study|Withdrawal by Subject|2|||
33250255|NCT02595398|100814631|FG001|Overall Study|Withdrawal by Subject|1|||
33250256|NCT02595398|100814630|FG000|Overall Study|Lost to Follow-up|1|||
33250257|NCT02595398|100814631|FG001|Overall Study|Lost to Follow-up|0|||
33250258|NCT00619645|100814632|FG000|Overall Study|Adverse Event|1|||
33250259|NCT01729819|100814633|FG000|Overall Study|Adverse Event|2|||
33250260|NCT01729819|100814634|FG001|Overall Study|Adverse Event|4|||
33250261|NCT01729819|100814633|FG000|Overall Study|Lack of Efficacy|1|||
33250262|NCT01729819|100814634|FG001|Overall Study|Lack of Efficacy|0|||
33386315|NCT01306032|101302477|FG004|First Intervention|Progressive disease|2|||
33386316|NCT01306032|101302478|FG005|First Intervention|Progressive disease|0|||
33386317|NCT01306032|101302473|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
33386318|NCT01306032|101302474|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
33386319|NCT01306032|101302475|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
33386320|NCT01306032|101302476|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
33386321|NCT01306032|101302477|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
33386322|NCT01306032|101302478|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
33386323|NCT01306032|101302473|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
33386324|NCT01306032|101302474|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
33386325|NCT01306032|101302475|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
33386326|NCT01306032|101302476|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
33386327|NCT01306032|101302477|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
33386328|NCT01306032|101302478|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
33386329|NCT01296698|101302479|FG000|Overall Study|Adverse Event|1|||
33386330|NCT01296698|101302480|FG001|Overall Study|Adverse Event|0|||
33386331|NCT01296698|101302479|FG000|Overall Study|Death|1|||
33386332|NCT01296698|101302480|FG001|Overall Study|Death|0|||
33386333|NCT01296698|101302479|FG000|Overall Study|Lost to Follow-up|19|||
33386334|NCT01296698|101302480|FG001|Overall Study|Lost to Follow-up|1|||
33386335|NCT01296698|101302479|FG000|Overall Study|Withdrawal by Subject|12|||
33250263|NCT01729819|100814633|FG000|Overall Study|Lost to Follow-up|2|||
33250264|NCT01729819|100814634|FG001|Overall Study|Lost to Follow-up|0|||
33250265|NCT01729819|100814633|FG000|Overall Study|Other reason|1|||
33386336|NCT01296698|101302480|FG001|Overall Study|Withdrawal by Subject|0|||
33250266|NCT01729819|100814634|FG001|Overall Study|Other reason|0|||
33250267|NCT01729819|100814633|FG000|Overall Study|Protocol Violation|0|||
33152141|NCT02979197|100472815|FG002|Overall Study|Subject unable to commit to study dates|0|||
33152142|NCT03845543|100472816|FG000|Overall Study|Death|25|||
33152143|NCT03845543|100472816|FG000|Overall Study|Withdrawal by Subject|2|||
33152144|NCT03845543|100472816|FG000|Overall Study|Lost to Follow-up|12|||
33152145|NCT03845543|100472816|FG000|Overall Study|Adverse Event|17|||
33152146|NCT03911154|100472817|FG000|Overall Study|Withdrawal by Subject|1|||
33152147|NCT03181893|100472818|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33152148|NCT03181893|100472819|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
33152149|NCT03181893|100472820|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33152150|NCT03181893|100472821|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33152151|NCT03181893|100472822|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33152152|NCT03181893|100472823|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33152153|NCT03181893|100472824|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33152154|NCT03181893|100472825|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33152155|NCT03181893|100472826|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33152156|NCT03181893|100472827|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33152157|NCT03181893|100472828|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
33436657|NCT00950807|101492525|FG008|Treatment Period 1|Lost to Follow-up|0|||
33436658|NCT00950807|101492526|FG009|Treatment Period 1|Lost to Follow-up|0|||
33436659|NCT00950807|101492517|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33436660|NCT00950807|101492518|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33436661|NCT00950807|101492519|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33436662|NCT00950807|101492520|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33436663|NCT00950807|101492521|FG004|Treatment Period 1|Withdrawal by Subject|1|||
33436664|NCT00950807|101492522|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33436665|NCT00950807|101492523|FG006|Treatment Period 1|Withdrawal by Subject|0|||
33436666|NCT00950807|101492524|FG007|Treatment Period 1|Withdrawal by Subject|0|||
33152158|NCT03181893|100472818|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
33152159|NCT03181893|100472819|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
33152160|NCT03181893|100472820|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33152161|NCT03181893|100472821|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33152162|NCT03181893|100472822|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33152163|NCT03181893|100472823|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33152164|NCT03181893|100472824|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33152165|NCT03181893|100472825|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33152166|NCT03181893|100472826|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33152167|NCT03181893|100472827|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33152168|NCT03181893|100472828|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
33152169|NCT03181893|100472818|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33152170|NCT03181893|100472819|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33152171|NCT03181893|100472820|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33152172|NCT03181893|100472821|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33152173|NCT03181893|100472822|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33152174|NCT03181893|100472823|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33152175|NCT03181893|100472824|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33152176|NCT03181893|100472825|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
33152177|NCT03181893|100472826|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
33250268|NCT01729819|100814634|FG001|Overall Study|Protocol Violation|1|||
33250269|NCT01729819|100814633|FG000|Overall Study|Withdrawal by Subject|0|||
33250270|NCT01729819|100814634|FG001|Overall Study|Withdrawal by Subject|2|||
33436667|NCT00950807|101492525|FG008|Treatment Period 1|Withdrawal by Subject|1|||
33152178|NCT03181893|100472827|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33152179|NCT03181893|100472828|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
33436668|NCT00950807|101492526|FG009|Treatment Period 1|Withdrawal by Subject|0|||
33436669|NCT00950807|101492517|FG000|Treatment Period 1|Adverse Event|0|||
33436670|NCT00950807|101492518|FG001|Treatment Period 1|Adverse Event|0|||
33436671|NCT00950807|101492519|FG002|Treatment Period 1|Adverse Event|0|||
33436672|NCT00950807|101492520|FG003|Treatment Period 1|Adverse Event|0|||
33436673|NCT00950807|101492521|FG004|Treatment Period 1|Adverse Event|0|||
33436674|NCT00950807|101492522|FG005|Treatment Period 1|Adverse Event|1|||
33250271|NCT02711826|100814635|FG000|Overall Study|Physician Decision|0|||
33250272|NCT02711826|100814636|FG001|Overall Study|Physician Decision|0|||
33250273|NCT02711826|100814637|FG002|Overall Study|Physician Decision|0|||
33250274|NCT02711826|100814638|FG003|Overall Study|Physician Decision|1|||
33250275|NCT02711826|100814639|FG004|Overall Study|Physician Decision|0|||
33250276|NCT02711826|100814635|FG000|Overall Study|Withdrawal by Subject|0|||
33250277|NCT02711826|100814636|FG001|Overall Study|Withdrawal by Subject|1|||
33250278|NCT02711826|100814637|FG002|Overall Study|Withdrawal by Subject|0|||
33250279|NCT02711826|100814638|FG003|Overall Study|Withdrawal by Subject|4|||
33250280|NCT02711826|100814639|FG004|Overall Study|Withdrawal by Subject|0|||
33250281|NCT02711826|100814635|FG000|Overall Study|Failure to manufacture cellular product|0|||
33250282|NCT02711826|100814636|FG001|Overall Study|Failure to manufacture cellular product|0|||
33250283|NCT02711826|100814637|FG002|Overall Study|Failure to manufacture cellular product|5|||
33250284|NCT02711826|100814638|FG003|Overall Study|Failure to manufacture cellular product|0|||
33250285|NCT02711826|100814639|FG004|Overall Study|Failure to manufacture cellular product|0|||
33250286|NCT02711826|100814635|FG000|Overall Study|Infusion canceled for active infection|0|||
33250287|NCT02711826|100814636|FG001|Overall Study|Infusion canceled for active infection|1|||
33386337|NCT01296698|101302479|FG000|Overall Study|Difficulty Contacting Subject|2|||
33386338|NCT01296698|101302480|FG001|Overall Study|Difficulty Contacting Subject|0|||
33386339|NCT01296698|101302479|FG000|Overall Study|Study Terminated by Sponsor|209|||
33386340|NCT01296698|101302480|FG001|Overall Study|Study Terminated by Sponsor|12|||
33386341|NCT03351478|101302481|FG000|Overall Study|At the subject's own request|11|||
33386342|NCT03351478|101302482|FG001|Overall Study|At the subject's own request|12|||
33386343|NCT03351478|101302483|FG002|Overall Study|At the subject's own request|5|||
33386344|NCT03351478|101302481|FG000|Overall Study|Adverse Event|1|||
33386345|NCT03351478|101302482|FG001|Overall Study|Adverse Event|2|||
33386346|NCT03351478|101302483|FG002|Overall Study|Adverse Event|1|||
33386347|NCT03351478|101302481|FG000|Overall Study|Poor compliance to protocol|1|||
33386348|NCT03351478|101302482|FG001|Overall Study|Poor compliance to protocol|0|||
33386349|NCT03351478|101302483|FG002|Overall Study|Poor compliance to protocol|0|||
33386350|NCT03351478|101302481|FG000|Overall Study|Reason not Specified|1|||
33386351|NCT03351478|101302482|FG001|Overall Study|Reason not Specified|3|||
33386352|NCT03351478|101302483|FG002|Overall Study|Reason not Specified|0|||
33386353|NCT03351478|101302481|FG000|Overall Study|Lost to Follow-up|0|||
33386354|NCT03351478|101302482|FG001|Overall Study|Lost to Follow-up|0|||
33386355|NCT03351478|101302483|FG002|Overall Study|Lost to Follow-up|1|||
33386356|NCT03363919|101302493|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
33386357|NCT03363919|101302494|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
33386358|NCT03363919|101302493|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
33386359|NCT03363919|101302494|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
33386360|NCT02091921|101302501|FG000|Overall Study|Adverse Event|3|||
33386361|NCT02773368|101302504|FG000|Overall Study|Lost to Follow-up|4|||
33386362|NCT02773368|101302505|FG001|Overall Study|Lost to Follow-up|1|||
33386363|NCT02773368|101302504|FG000|Overall Study|Withdrawal by Subject|5|||
33386364|NCT02773368|101302505|FG001|Overall Study|Withdrawal by Subject|1|||
33386365|NCT02773368|101302504|FG000|Overall Study|Unclassified|1|||
33386366|NCT02773368|101302505|FG001|Overall Study|Unclassified|1|||
33386367|NCT02773368|101302504|FG000|Overall Study|Missing|0|||
33386368|NCT02773368|101302505|FG001|Overall Study|Missing|1|||
33386369|NCT00291499|101302506|FG000|Overall Study|Adverse Event|3|||
33386370|NCT00291499|101302507|FG001|Overall Study|Adverse Event|8|||
33386371|NCT00291499|101302506|FG000|Overall Study|Change to other therapy|2|||
33386372|NCT00291499|101302507|FG001|Overall Study|Change to other therapy|1|||
33386373|NCT00291499|101302506|FG000|Overall Study|Intercurrent illness|1|||
33386374|NCT00291499|101302507|FG001|Overall Study|Intercurrent illness|0|||
33386375|NCT00291499|101302506|FG000|Overall Study|Protocol Violation|2|||
33386376|NCT00291499|101302507|FG001|Overall Study|Protocol Violation|2|||
33386377|NCT00291499|101302506|FG000|Overall Study|Other reasons|1|||
33386378|NCT00291499|101302507|FG001|Overall Study|Other reasons|4|||
33386379|NCT01376245|101302509|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
33386380|NCT01376245|101302510|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
33386381|NCT01376245|101302511|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
33436675|NCT00950807|101492523|FG006|Treatment Period 1|Adverse Event|0|||
33250288|NCT02711826|100814637|FG002|Overall Study|Infusion canceled for active infection|0|||
33250289|NCT02711826|100814638|FG003|Overall Study|Infusion canceled for active infection|0|||
33250290|NCT02711826|100814639|FG004|Overall Study|Infusion canceled for active infection|0|||
33152180|NCT03181893|100472818|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33152181|NCT03181893|100472819|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33152182|NCT03181893|100472820|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33152183|NCT03181893|100472821|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33152184|NCT03181893|100472822|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33250291|NCT02711826|100814635|FG000|Overall Study|Screen failures|0|||
33250292|NCT02711826|100814636|FG001|Overall Study|Screen failures|0|||
33250293|NCT02711826|100814637|FG002|Overall Study|Screen failures|0|||
33250294|NCT02711826|100814638|FG003|Overall Study|Screen failures|4|||
33386382|NCT01376245|101302512|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
33386383|NCT01376245|101302513|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
33386384|NCT01376245|101302509|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
33386385|NCT01376245|101302510|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
33386386|NCT01376245|101302511|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
33386387|NCT01376245|101302512|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
33386388|NCT01376245|101302513|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
33152185|NCT03181893|100472823|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33152186|NCT03181893|100472824|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33152187|NCT03181893|100472825|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33152188|NCT03181893|100472826|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33152189|NCT03181893|100472827|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
33152190|NCT03181893|100472828|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
33152191|NCT03181893|100472818|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33152192|NCT03181893|100472819|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33152193|NCT03181893|100472820|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33152194|NCT03181893|100472821|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33152195|NCT03181893|100472822|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33152196|NCT03181893|100472823|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33152197|NCT03181893|100472824|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33152198|NCT03181893|100472825|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33152199|NCT03181893|100472826|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33152200|NCT03181893|100472827|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
33152201|NCT03181893|100472828|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
33152202|NCT01609231|100472836|FG000|Overall Study|Adverse Event|1|||
33152203|NCT01609231|100472837|FG001|Overall Study|Adverse Event|3|||
33152204|NCT01609231|100472836|FG000|Overall Study|Physician Decision|1|||
33152205|NCT01609231|100472837|FG001|Overall Study|Physician Decision|0|||
33152206|NCT01609231|100472836|FG000|Overall Study|Withdrawal by Subject|1|||
33152207|NCT01609231|100472837|FG001|Overall Study|Withdrawal by Subject|0|||
33152208|NCT01528215|100472838|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
33436676|NCT00950807|101492524|FG007|Treatment Period 1|Adverse Event|0|||
33436677|NCT00950807|101492525|FG008|Treatment Period 1|Adverse Event|0|||
33436678|NCT00950807|101492526|FG009|Treatment Period 1|Adverse Event|0|||
33436679|NCT00950807|101492517|FG000|Washout Period 1|Lack of Efficacy|0|||
33436680|NCT00950807|101492518|FG001|Washout Period 1|Lack of Efficacy|0|||
33436681|NCT00950807|101492519|FG002|Washout Period 1|Lack of Efficacy|0|||
33436682|NCT00950807|101492520|FG003|Washout Period 1|Lack of Efficacy|0|||
33436683|NCT00950807|101492521|FG004|Washout Period 1|Lack of Efficacy|0|||
33436684|NCT00950807|101492522|FG005|Washout Period 1|Lack of Efficacy|0|||
33436685|NCT00950807|101492523|FG006|Washout Period 1|Lack of Efficacy|1|||
33436686|NCT00950807|101492524|FG007|Washout Period 1|Lack of Efficacy|0|||
33436687|NCT00950807|101492525|FG008|Washout Period 1|Lack of Efficacy|0|||
33436688|NCT00950807|101492526|FG009|Washout Period 1|Lack of Efficacy|0|||
33436689|NCT00950807|101492517|FG000|Washout Period 1|Withdrawal by Subject|0|||
33436690|NCT00950807|101492518|FG001|Washout Period 1|Withdrawal by Subject|0|||
33436691|NCT00950807|101492519|FG002|Washout Period 1|Withdrawal by Subject|0|||
33436692|NCT00950807|101492520|FG003|Washout Period 1|Withdrawal by Subject|0|||
33436693|NCT00950807|101492521|FG004|Washout Period 1|Withdrawal by Subject|0|||
33436694|NCT00950807|101492522|FG005|Washout Period 1|Withdrawal by Subject|0|||
33436695|NCT00950807|101492523|FG006|Washout Period 1|Withdrawal by Subject|0|||
33436696|NCT00950807|101492524|FG007|Washout Period 1|Withdrawal by Subject|0|||
33436697|NCT00950807|101492525|FG008|Washout Period 1|Withdrawal by Subject|1|||
33436698|NCT00950807|101492526|FG009|Washout Period 1|Withdrawal by Subject|0|||
33436699|NCT00950807|101492517|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
33436700|NCT00950807|101492518|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
33436701|NCT00950807|101492519|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
33436702|NCT00950807|101492520|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
33436703|NCT00950807|101492521|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
33436704|NCT00950807|101492522|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
33436705|NCT00950807|101492523|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
33436706|NCT00950807|101492524|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
33436707|NCT00950807|101492525|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
33436708|NCT00950807|101492526|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
33436709|NCT00950807|101492517|FG000|Washout Period 1|Adverse Event|2|||
33436710|NCT00950807|101492518|FG001|Washout Period 1|Adverse Event|0|||
33436711|NCT00950807|101492519|FG002|Washout Period 1|Adverse Event|0|||
33436712|NCT00950807|101492520|FG003|Washout Period 1|Adverse Event|1|||
33436713|NCT00950807|101492521|FG004|Washout Period 1|Adverse Event|1|||
33436714|NCT00950807|101492522|FG005|Washout Period 1|Adverse Event|0|||
33436715|NCT00950807|101492523|FG006|Washout Period 1|Adverse Event|0|||
33436716|NCT00950807|101492524|FG007|Washout Period 1|Adverse Event|0|||
33436717|NCT00950807|101492525|FG008|Washout Period 1|Adverse Event|0|||
33152209|NCT01528215|100472839|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
33250295|NCT02711826|100814639|FG004|Overall Study|Screen failures|0|||
33436718|NCT00950807|101492526|FG009|Washout Period 1|Adverse Event|0|||
33436719|NCT00950807|101492517|FG000|Treatment Period 2|Lack of Efficacy|1|||
33436720|NCT00950807|101492518|FG001|Treatment Period 2|Lack of Efficacy|0|||
33436721|NCT00950807|101492519|FG002|Treatment Period 2|Lack of Efficacy|0|||
33436722|NCT00950807|101492520|FG003|Treatment Period 2|Lack of Efficacy|0|||
33436723|NCT00950807|101492521|FG004|Treatment Period 2|Lack of Efficacy|0|||
33152210|NCT01528215|100472838|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
33152211|NCT01528215|100472839|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
33152212|NCT01528215|100472838|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
33436724|NCT00950807|101492522|FG005|Treatment Period 2|Lack of Efficacy|0|||
33436725|NCT00950807|101492523|FG006|Treatment Period 2|Lack of Efficacy|0|||
33436726|NCT00950807|101492524|FG007|Treatment Period 2|Lack of Efficacy|0|||
33436727|NCT00950807|101492525|FG008|Treatment Period 2|Lack of Efficacy|0|||
33436728|NCT00950807|101492526|FG009|Treatment Period 2|Lack of Efficacy|0|||
33436729|NCT00950807|101492517|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33436730|NCT00950807|101492518|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33436731|NCT00950807|101492519|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33436732|NCT00950807|101492520|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33436733|NCT00950807|101492521|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33436734|NCT00950807|101492522|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33436735|NCT00950807|101492523|FG006|Treatment Period 2|Withdrawal by Subject|1|||
33436736|NCT00950807|101492524|FG007|Treatment Period 2|Withdrawal by Subject|2|||
33436737|NCT00950807|101492525|FG008|Treatment Period 2|Withdrawal by Subject|0|||
33436738|NCT00950807|101492526|FG009|Treatment Period 2|Withdrawal by Subject|0|||
33436739|NCT00950807|101492517|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
33436740|NCT00950807|101492518|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33152213|NCT01528215|100472839|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
33152214|NCT01528215|100472838|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
33152215|NCT01528215|100472839|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
33152216|NCT02047227|100472842|FG000|Overall Study|Adverse Event|2|||
33152217|NCT02047227|100472843|FG001|Overall Study|Adverse Event|4|||
33152218|NCT02047227|100472842|FG000|Overall Study|Lost to Follow-up|0|||
33152219|NCT02047227|100472843|FG001|Overall Study|Lost to Follow-up|3|||
33152220|NCT02047227|100472842|FG000|Overall Study|Protocol Violation|1|||
33152221|NCT02047227|100472843|FG001|Overall Study|Protocol Violation|0|||
33152222|NCT02047227|100472842|FG000|Overall Study|Spontaneous pregnancy|1|||
33152223|NCT02047227|100472843|FG001|Overall Study|Spontaneous pregnancy|0|||
33152224|NCT02047227|100472842|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
33152225|NCT02047227|100472843|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
33152226|NCT02047227|100472842|FG000|Overall Study|No oocytes retrieved|21|||
33152227|NCT02047227|100472843|FG001|Overall Study|No oocytes retrieved|20|||
33152228|NCT02047227|100472842|FG000|Overall Study|No fertilization|61|||
33152229|NCT02047227|100472843|FG001|Overall Study|No fertilization|51|||
33152230|NCT02047227|100472842|FG000|Overall Study|Intention to freeze all embryos|1|||
33152231|NCT02047227|100472843|FG001|Overall Study|Intention to freeze all embryos|0|||
33152232|NCT02047227|100472842|FG000|Overall Study|All embryos discarded|12|||
33152233|NCT02047227|100472843|FG001|Overall Study|All embryos discarded|11|||
33152234|NCT02047227|100472842|FG000|Overall Study|Other|10|||
33152235|NCT02047227|100472843|FG001|Overall Study|Other|9|||
33152236|NCT01614600|100472847|FG000|Overall Study|Unacceptable fit|1|||
33152237|NCT01614600|100472847|FG000|Overall Study|Discomfort|1|||
33152238|NCT01614600|100472847|FG000|Overall Study|Unable to remove lens at the end of day|1|||
33152239|NCT01614600|100472847|FG000|Overall Study|Protocol deviation|1|||
33152240|NCT01303861|100472848|FG000|Overall Study|Lost to Follow-up|34|||
33152241|NCT01303861|100472849|FG001|Overall Study|Lost to Follow-up|14|||
33152242|NCT01303861|100472850|FG002|Overall Study|Lost to Follow-up|27|||
33152243|NCT01303861|100472851|FG003|Overall Study|Lost to Follow-up|31|||
33152244|NCT01303861|100472848|FG000|Overall Study|Lack of Efficacy|3|||
33152245|NCT01303861|100472849|FG001|Overall Study|Lack of Efficacy|2|||
33152246|NCT01303861|100472850|FG002|Overall Study|Lack of Efficacy|1|||
33152247|NCT01303861|100472851|FG003|Overall Study|Lack of Efficacy|0|||
33152248|NCT01303861|100472848|FG000|Overall Study|Withdrawal by Subject|16|||
33152249|NCT01303861|100472849|FG001|Overall Study|Withdrawal by Subject|8|||
33152250|NCT01303861|100472850|FG002|Overall Study|Withdrawal by Subject|8|||
33152251|NCT01303861|100472851|FG003|Overall Study|Withdrawal by Subject|23|||
33152252|NCT01303861|100472848|FG000|Overall Study|Adverse Event|4|||
33152253|NCT01303861|100472849|FG001|Overall Study|Adverse Event|1|||
33152254|NCT01303861|100472850|FG002|Overall Study|Adverse Event|0|||
33152255|NCT01303861|100472851|FG003|Overall Study|Adverse Event|5|||
33152256|NCT01303861|100472848|FG000|Overall Study|Pregnancy|1|||
33152257|NCT01303861|100472849|FG001|Overall Study|Pregnancy|0|||
33152258|NCT01303861|100472850|FG002|Overall Study|Pregnancy|0|||
33152259|NCT01303861|100472851|FG003|Overall Study|Pregnancy|0|||
33152260|NCT03343067|100472852|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
33152261|NCT03343067|100472853|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
33152262|NCT03343067|100472854|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
33152263|NCT01187433|100472855|FG000|Overall Study|Protocol Violation|6|||
33152264|NCT01187433|100472856|FG001|Overall Study|Protocol Violation|2|||
33152265|NCT01187433|100472855|FG000|Overall Study|Withdrawal by Subject|5|||
33152266|NCT01187433|100472856|FG001|Overall Study|Withdrawal by Subject|2|||
33152267|NCT00902668|100472860|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
33152268|NCT00057954|100472865|FG000|Overall Study|Death|1|||
33152269|NCT00057954|100472865|FG000|Overall Study|Disease progression|1|||
33250296|NCT00377455|100814650|FG000|Overall Study|Withdrawal by Subject|1|||
33250297|NCT03525119|100814651|FG000|Overall Study|Adverse Event|0|||
33152270|NCT02395666|100472868|FG000|Overall Study|Physician Decision|3|||
33152271|NCT02395666|100472869|FG001|Overall Study|Physician Decision|0|||
33152272|NCT02395666|100472868|FG000|Overall Study|Lost to Follow-up|1|||
33152273|NCT02395666|100472869|FG001|Overall Study|Lost to Follow-up|0|||
33152274|NCT02395666|100472868|FG000|Overall Study|Withdrawal by Subject|2|||
33250298|NCT03525119|100814652|FG001|Overall Study|Adverse Event|1|||
33250299|NCT03525119|100814653|FG002|Overall Study|Adverse Event|0|||
33250300|NCT03525119|100814651|FG000|Overall Study|Lost to Follow-up|32|||
33152275|NCT02395666|100472869|FG001|Overall Study|Withdrawal by Subject|1|||
33152276|NCT03553927|100472870|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
33250301|NCT03525119|100814652|FG001|Overall Study|Lost to Follow-up|33|||
33250302|NCT03525119|100814653|FG002|Overall Study|Lost to Follow-up|37|||
33250303|NCT03525119|100814651|FG000|Overall Study|Withdrawal by Subject|5|||
33250304|NCT03525119|100814652|FG001|Overall Study|Withdrawal by Subject|4|||
33250305|NCT03525119|100814653|FG002|Overall Study|Withdrawal by Subject|2|||
33250306|NCT03525119|100814651|FG000|Overall Study|Reason not Specified|2|||
33250307|NCT03525119|100814652|FG001|Overall Study|Reason not Specified|1|||
33250308|NCT03525119|100814653|FG002|Overall Study|Reason not Specified|2|||
33250309|NCT03525119|100814651|FG000|Overall Study|Randomized but not Vaccinated|1|||
33250310|NCT03525119|100814652|FG001|Overall Study|Randomized but not Vaccinated|0|||
33250311|NCT03525119|100814653|FG002|Overall Study|Randomized but not Vaccinated|2|||
33250312|NCT00837616|100814654|FG000|Overall Study|Withdrawal by Subject|0|||
33250313|NCT00837616|100814655|FG001|Overall Study|Withdrawal by Subject|1|||
33250314|NCT01196988|100814656|FG000|Overall Study|Adverse Event|1|||
33250315|NCT01196988|100814657|FG001|Overall Study|Adverse Event|2|||
33250316|NCT01196988|100814658|FG002|Overall Study|Adverse Event|0|||
33250317|NCT01196988|100814659|FG003|Overall Study|Adverse Event|0|||
33250318|NCT01196988|100814656|FG000|Overall Study|Withdrawal by Subject|5|||
33250319|NCT01196988|100814657|FG001|Overall Study|Withdrawal by Subject|1|||
33250320|NCT01196988|100814658|FG002|Overall Study|Withdrawal by Subject|4|||
33250321|NCT01196988|100814659|FG003|Overall Study|Withdrawal by Subject|0|||
33250322|NCT01196988|100814656|FG000|Overall Study|Lost to Follow-up|16|||
33250323|NCT01196988|100814657|FG001|Overall Study|Lost to Follow-up|29|||
33250324|NCT01196988|100814658|FG002|Overall Study|Lost to Follow-up|21|||
33250325|NCT01196988|100814659|FG003|Overall Study|Lost to Follow-up|1|||
33250326|NCT01196988|100814656|FG000|Overall Study|Other|2|||
33250327|NCT01196988|100814657|FG001|Overall Study|Other|0|||
33250328|NCT01196988|100814658|FG002|Overall Study|Other|0|||
33250329|NCT01196988|100814659|FG003|Overall Study|Other|0|||
33250330|NCT01801930|100814660|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
33250331|NCT01801930|100814661|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
33250332|NCT01801930|100814662|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
33250333|NCT01801930|100814663|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
33250334|NCT01801930|100814660|FG000|Overall Study|DLT occurs|0|||
33250335|NCT01801930|100814661|FG001|Overall Study|DLT occurs|1|||
33250336|NCT01801930|100814662|FG002|Overall Study|DLT occurs|0|||
33250337|NCT01801930|100814663|FG003|Overall Study|DLT occurs|0|||
33250338|NCT04364269|100814664|FG000|Overall Study|Adverse Event|1|||
33250339|NCT04364269|100814665|FG001|Overall Study|Adverse Event|0|||
33250340|NCT04364269|100814666|FG002|Overall Study|Adverse Event|0|||
33250341|NCT04364269|100814664|FG000|Overall Study|Withdrawal by Subject|0|||
33250342|NCT04364269|100814665|FG001|Overall Study|Withdrawal by Subject|1|||
33250343|NCT04364269|100814666|FG002|Overall Study|Withdrawal by Subject|0|||
33250344|NCT01080131|100814673|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
33250345|NCT01080131|100814674|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
33250346|NCT01080131|100814673|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
33250347|NCT01080131|100814674|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
33250348|NCT01080131|100814673|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
33250349|NCT01080131|100814674|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
33152277|NCT03553927|100472871|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
33250350|NCT01080131|100814673|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
33250351|NCT01080131|100814674|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
33250352|NCT01080131|100814673|FG000|Core Study (0- 12 Weeks)|Death|1|||
33250353|NCT01080131|100814674|FG001|Core Study (0- 12 Weeks)|Death|0|||
33250354|NCT01080131|100814673|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
33250355|NCT01080131|100814674|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
33250356|NCT01080131|100814673|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
33250357|NCT01080131|100814674|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
33250358|NCT01080131|100814673|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
33250359|NCT01080131|100814674|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
33250360|NCT01080131|100814673|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
33436741|NCT00950807|101492519|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33250361|NCT01080131|100814674|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
33250362|NCT01080131|100814673|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
33250363|NCT01080131|100814674|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
33250364|NCT01080131|100814673|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
33250365|NCT01080131|100814674|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
33250366|NCT01080131|100814673|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
33250367|NCT01080131|100814674|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
33250368|NCT01080131|100814673|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
33250369|NCT01080131|100814674|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
33250370|NCT00395018|100814675|FG000|On-Treatment|Death|4|||
33250371|NCT00395018|100814675|FG000|On-Treatment|Other Reason|2|||
33250372|NCT00395018|100814675|FG000|On-Treatment|Poor/non-compliance|2|||
33250373|NCT00395018|100814675|FG000|On-Treatment|Subject no longer meets study criteria|2|||
33250374|NCT00395018|100814675|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
33250375|NCT00395018|100814675|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
33250376|NCT00395018|100814675|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
33250377|NCT01185522|100814677|FG000|Overall Study|Lack of Efficacy|28|||
33250378|NCT01185522|100814677|FG000|Overall Study|Lost to Follow-up|19|||
33436742|NCT00950807|101492520|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33436743|NCT00950807|101492521|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33152278|NCT03553927|100472870|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
33152279|NCT03553927|100472871|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
33152280|NCT01147640|100472874|FG000|Overall Study|Adverse Event|2|||
33152281|NCT01147640|100472875|FG001|Overall Study|Adverse Event|0|||
33250379|NCT01185522|100814677|FG000|Overall Study|Withdrawal by Subject|10|||
33250380|NCT01185522|100814677|FG000|Overall Study|Poor tolerance|39|||
33250381|NCT01185522|100814677|FG000|Overall Study|Other reasons|12|||
33250382|NCT03987451|100814678|FG000|Overall Study|Lost to Follow-up|1|||
33250383|NCT03987451|100814679|FG001|Overall Study|Lost to Follow-up|0|||
33250384|NCT03987451|100814678|FG000|Overall Study|Withdrawal by Subject|1|||
33250385|NCT03987451|100814679|FG001|Overall Study|Withdrawal by Subject|1|||
33250386|NCT03545984|100814680|FG000|Overall Study|CSF cases not present during rotation|11|||
33250387|NCT03545984|100814681|FG001|Overall Study|CSF cases not present during rotation|9|||
33250388|NCT00408928|100814682|FG000|Overall Study|Withdrawal by Subject|1|||
33250389|NCT00408928|100814682|FG000|Overall Study|Death|1|||
33250390|NCT00408928|100814682|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
33250391|NCT01253226|100814683|FG000|Overall Study|Adverse Event|0|||
33250392|NCT01253226|100814684|FG001|Overall Study|Adverse Event|0|||
33250393|NCT01253226|100814685|FG002|Overall Study|Adverse Event|1|||
33250394|NCT01253226|100814686|FG003|Overall Study|Adverse Event|0|||
33250395|NCT01253226|100814687|FG004|Overall Study|Adverse Event|0|||
33250396|NCT01253226|100814683|FG000|Overall Study|Death|0|||
33250397|NCT01253226|100814684|FG001|Overall Study|Death|1|||
33250398|NCT01253226|100814685|FG002|Overall Study|Death|0|||
33250399|NCT01253226|100814686|FG003|Overall Study|Death|0|||
33250400|NCT01253226|100814687|FG004|Overall Study|Death|0|||
33250401|NCT01253226|100814683|FG000|Overall Study|Physician Decision|0|||
33250402|NCT01253226|100814684|FG001|Overall Study|Physician Decision|0|||
33250403|NCT01253226|100814685|FG002|Overall Study|Physician Decision|0|||
33250404|NCT01253226|100814686|FG003|Overall Study|Physician Decision|0|||
33250405|NCT01253226|100814687|FG004|Overall Study|Physician Decision|2|||
33250406|NCT01253226|100814683|FG000|Overall Study|Withdrawal by Subject|0|||
33250407|NCT01253226|100814684|FG001|Overall Study|Withdrawal by Subject|0|||
33250408|NCT01253226|100814685|FG002|Overall Study|Withdrawal by Subject|0|||
33250409|NCT01253226|100814686|FG003|Overall Study|Withdrawal by Subject|1|||
33250410|NCT01253226|100814687|FG004|Overall Study|Withdrawal by Subject|0|||
33436744|NCT00950807|101492522|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33436745|NCT00950807|101492523|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33436746|NCT00950807|101492524|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33436747|NCT00950807|101492525|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33250411|NCT02954848|100814688|FG000|Overall Study|Randomized but Not Treated|0|||
33250412|NCT02954848|100814689|FG001|Overall Study|Randomized but Not Treated|1|||
33250413|NCT02954848|100814688|FG000|Overall Study|Adverse Event|2|||
33250414|NCT02954848|100814689|FG001|Overall Study|Adverse Event|3|||
33250415|NCT02954848|100814688|FG000|Overall Study|Withdrawal by Participant|0|||
33250416|NCT02954848|100814689|FG001|Overall Study|Withdrawal by Participant|1|||
33250417|NCT01460342|100814690|FG000|Overall Study|Adverse Event|5|||
33250418|NCT01460342|100814691|FG001|Overall Study|Adverse Event|4|||
33250419|NCT01460342|100814690|FG000|Overall Study|Lost to Follow-up|1|||
33250420|NCT01460342|100814691|FG001|Overall Study|Lost to Follow-up|2|||
33250421|NCT01460342|100814690|FG000|Overall Study|Protocol Violation|0|||
33250422|NCT01460342|100814691|FG001|Overall Study|Protocol Violation|1|||
33152282|NCT01147640|100472874|FG000|Overall Study|Physician Decision|1|||
33250423|NCT01460342|100814690|FG000|Overall Study|Withdrawal by Subject|3|||
33152283|NCT01147640|100472875|FG001|Overall Study|Physician Decision|0|||
33152284|NCT01147640|100472874|FG000|Overall Study|Withdrawal by Subject|1|||
33152285|NCT01147640|100472875|FG001|Overall Study|Withdrawal by Subject|0|||
33152286|NCT01147640|100472874|FG000|Overall Study|Lost to Follow-up|0|||
33152287|NCT01147640|100472875|FG001|Overall Study|Lost to Follow-up|1|||
33152288|NCT01147640|100472874|FG000|Overall Study|Didn't meet eligibility criteria|1|||
33152289|NCT01147640|100472875|FG001|Overall Study|Didn't meet eligibility criteria|0|||
33152290|NCT00591266|100472878|FG000|Overall Study|Adverse Event|2|||
33152291|NCT00591266|100472879|FG001|Overall Study|Adverse Event|2|||
33152292|NCT00591266|100472880|FG002|Overall Study|Adverse Event|3|||
33152293|NCT00591266|100472878|FG000|Overall Study|Lost to Follow-up|0|||
33152294|NCT00591266|100472879|FG001|Overall Study|Lost to Follow-up|1|||
33152295|NCT00591266|100472880|FG002|Overall Study|Lost to Follow-up|0|||
33152296|NCT00591266|100472878|FG000|Overall Study|Protocol Violation|0|||
33152297|NCT00591266|100472879|FG001|Overall Study|Protocol Violation|0|||
33152298|NCT00591266|100472880|FG002|Overall Study|Protocol Violation|1|||
33152299|NCT00591266|100472878|FG000|Overall Study|Withdrawal by Subject|6|||
33152300|NCT00591266|100472879|FG001|Overall Study|Withdrawal by Subject|2|||
33152301|NCT00591266|100472880|FG002|Overall Study|Withdrawal by Subject|5|||
33152302|NCT00591266|100472878|FG000|Overall Study|Lack of Efficacy|0|||
33152303|NCT00591266|100472879|FG001|Overall Study|Lack of Efficacy|2|||
33152304|NCT00591266|100472880|FG002|Overall Study|Lack of Efficacy|0|||
33152305|NCT00591266|100472878|FG000|Overall Study|Other|1|||
33152306|NCT00591266|100472879|FG001|Overall Study|Other|4|||
33152307|NCT00591266|100472880|FG002|Overall Study|Other|5|||
33152308|NCT02633501|100472881|FG000|Overall Study|Adverse Event|0|||
33152309|NCT02633501|100472882|FG001|Overall Study|Adverse Event|0|||
33152310|NCT02633501|100472883|FG002|Overall Study|Adverse Event|1|||
33152311|NCT02633501|100472884|FG003|Overall Study|Adverse Event|0|||
33152312|NCT02633501|100472885|FG004|Overall Study|Adverse Event|1|||
33152313|NCT02633501|100472886|FG005|Overall Study|Adverse Event|1|||
33152314|NCT02633501|100472881|FG000|Overall Study|Withdrawal by Subject|2|||
33152315|NCT02633501|100472882|FG001|Overall Study|Withdrawal by Subject|1|||
33152316|NCT02633501|100472883|FG002|Overall Study|Withdrawal by Subject|2|||
33152317|NCT02633501|100472884|FG003|Overall Study|Withdrawal by Subject|2|||
33152318|NCT02633501|100472885|FG004|Overall Study|Withdrawal by Subject|1|||
33152319|NCT02633501|100472886|FG005|Overall Study|Withdrawal by Subject|3|||
33152320|NCT02633501|100472881|FG000|Overall Study|Various other reasons|0|||
33152321|NCT02633501|100472882|FG001|Overall Study|Various other reasons|2|||
33152322|NCT02633501|100472883|FG002|Overall Study|Various other reasons|4|||
33152323|NCT02633501|100472884|FG003|Overall Study|Various other reasons|1|||
33152324|NCT02633501|100472885|FG004|Overall Study|Various other reasons|7|||
33152325|NCT02633501|100472886|FG005|Overall Study|Various other reasons|11|||
33152326|NCT02633501|100472881|FG000|Overall Study|Lost to Follow-up|0|||
33152327|NCT02633501|100472882|FG001|Overall Study|Lost to Follow-up|0|||
33152328|NCT02633501|100472883|FG002|Overall Study|Lost to Follow-up|0|||
33152329|NCT02633501|100472884|FG003|Overall Study|Lost to Follow-up|1|||
33152330|NCT02633501|100472885|FG004|Overall Study|Lost to Follow-up|2|||
33152331|NCT02633501|100472886|FG005|Overall Study|Lost to Follow-up|0|||
33152332|NCT03793556|100472887|FG000|Overall Study|Withdrawal by Subject|12|||
33152333|NCT03793556|100472888|FG001|Overall Study|Withdrawal by Subject|1|||
33152334|NCT03793556|100472887|FG000|Overall Study|Lost to Follow-up|1|||
33152335|NCT03793556|100472888|FG001|Overall Study|Lost to Follow-up|1|||
33152336|NCT01710046|100472889|FG000|Overall Study|Lost to Follow-up|1|||
33152337|NCT01710046|100472890|FG001|Overall Study|Lost to Follow-up|0|||
33152338|NCT01033851|100472891|FG000|Overall Study|Withdrawal by Subject|3|||
33152339|NCT01033851|100472892|FG001|Overall Study|Withdrawal by Subject|7|||
33152340|NCT01927627|100472893|FG000|Overall Study|Adverse Event|3|||
33152341|NCT01927627|100472893|FG000|Overall Study|Lack of Efficacy|1|||
33152342|NCT01927627|100472893|FG000|Overall Study|Financial Concerns|1|||
33152343|NCT00215683|100472894|FG000|Overall Study|Adverse Event|15|||
33152344|NCT00215683|100472895|FG001|Overall Study|Adverse Event|16|||
33152345|NCT00215683|100472896|FG002|Overall Study|Adverse Event|15|||
33152346|NCT00215683|100472894|FG000|Overall Study|Lack of Efficacy|5|||
33152347|NCT00215683|100472895|FG001|Overall Study|Lack of Efficacy|1|||
33152348|NCT00215683|100472896|FG002|Overall Study|Lack of Efficacy|2|||
33152349|NCT00215683|100472894|FG000|Overall Study|Lost to Follow-up|0|||
33152350|NCT00215683|100472895|FG001|Overall Study|Lost to Follow-up|2|||
33152351|NCT00215683|100472896|FG002|Overall Study|Lost to Follow-up|1|||
33152352|NCT00215683|100472894|FG000|Overall Study|Withdrawal by Subject|9|||
33152353|NCT00215683|100472895|FG001|Overall Study|Withdrawal by Subject|4|||
33152354|NCT00215683|100472896|FG002|Overall Study|Withdrawal by Subject|13|||
33152355|NCT00215683|100472894|FG000|Overall Study|Physician Decision|0|||
33152356|NCT00215683|100472895|FG001|Overall Study|Physician Decision|0|||
33152357|NCT00215683|100472896|FG002|Overall Study|Physician Decision|1|||
33152358|NCT00215683|100472894|FG000|Overall Study|Difficult to attend visits|0|||
33152359|NCT00215683|100472895|FG001|Overall Study|Difficult to attend visits|1|||
33152360|NCT00215683|100472896|FG002|Overall Study|Difficult to attend visits|0|||
33152361|NCT00215683|100472894|FG000|Overall Study|No study drug available|0|||
33152362|NCT00215683|100472895|FG001|Overall Study|No study drug available|1|||
33152363|NCT00215683|100472896|FG002|Overall Study|No study drug available|0|||
33152364|NCT00215683|100472894|FG000|Overall Study|Intermittent therapy required|0|||
33152365|NCT00215683|100472895|FG001|Overall Study|Intermittent therapy required|1|||
33152366|NCT00215683|100472896|FG002|Overall Study|Intermittent therapy required|0|||
33152367|NCT01134731|100472897|FG000|Overall Study|Adverse Event|3|||
33152368|NCT01134731|100472898|FG001|Overall Study|Adverse Event|2|||
33152369|NCT01134731|100472899|FG002|Overall Study|Adverse Event|1|||
33152370|NCT01134731|100472897|FG000|Overall Study|Physician Decision|2|||
33152371|NCT01134731|100472898|FG001|Overall Study|Physician Decision|2|||
33152372|NCT01134731|100472899|FG002|Overall Study|Physician Decision|2|||
33152373|NCT01134731|100472897|FG000|Overall Study|Lack of Efficacy|0|||
33152374|NCT01134731|100472898|FG001|Overall Study|Lack of Efficacy|0|||
33152375|NCT01134731|100472899|FG002|Overall Study|Lack of Efficacy|1|||
33152376|NCT01134731|100472897|FG000|Overall Study|Withdrawal by Subject|3|||
33152377|NCT01134731|100472898|FG001|Overall Study|Withdrawal by Subject|3|||
33152378|NCT01134731|100472899|FG002|Overall Study|Withdrawal by Subject|1|||
33152379|NCT01134731|100472897|FG000|Overall Study|Lost to Follow-up|5|||
33152380|NCT01134731|100472898|FG001|Overall Study|Lost to Follow-up|4|||
33152381|NCT01134731|100472899|FG002|Overall Study|Lost to Follow-up|3|||
33152382|NCT04093414|100472900|FG000|3 Month Follow up|Physician Decision|0|||
33152383|NCT04093414|100472901|FG001|3 Month Follow up|Physician Decision|1|||
33152384|NCT04093414|100472900|FG000|6month Follow up|Physician Decision|1|||
33152385|NCT04093414|100472901|FG001|6month Follow up|Physician Decision|3|||
33152386|NCT01024231|100472902|FG000|Overall Study|Other Reasons|1|||
33436748|NCT00950807|101492526|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33436749|NCT00950807|101492517|FG000|Treatment Period 2|Adverse Event|0|||
33436750|NCT00950807|101492518|FG001|Treatment Period 2|Adverse Event|1|||
33436751|NCT00950807|101492519|FG002|Treatment Period 2|Adverse Event|0|||
33436752|NCT00950807|101492520|FG003|Treatment Period 2|Adverse Event|1|||
33436753|NCT00950807|101492521|FG004|Treatment Period 2|Adverse Event|0|||
33436754|NCT00950807|101492522|FG005|Treatment Period 2|Adverse Event|1|||
33250424|NCT01460342|100814691|FG001|Overall Study|Withdrawal by Subject|4|||
33250425|NCT01460342|100814690|FG000|Overall Study|Physician Decision|1|||
33250426|NCT01460342|100814691|FG001|Overall Study|Physician Decision|3|||
33152387|NCT01024231|100472903|FG001|Overall Study|Other Reasons|2|||
33152388|NCT01024231|100472904|FG002|Overall Study|Other Reasons|0|||
33152389|NCT01024231|100472905|FG003|Overall Study|Other Reasons|0|||
33386389|NCT01376245|101302509|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
33386390|NCT01376245|101302510|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
33152390|NCT01024231|100472906|FG004|Overall Study|Other Reasons|2|||
33386391|NCT01376245|101302511|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
33386392|NCT01376245|101302512|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
33386393|NCT01376245|101302513|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
33386394|NCT01376245|101302509|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
33386395|NCT01376245|101302510|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
33386396|NCT01376245|101302511|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
33386397|NCT01376245|101302512|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
33386398|NCT01376245|101302513|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
33386399|NCT01376245|101302509|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
33386400|NCT01376245|101302510|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
33386401|NCT01376245|101302511|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
33386402|NCT01376245|101302512|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
33386403|NCT01376245|101302513|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
33386404|NCT01376245|101302509|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
33386405|NCT01376245|101302510|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
33386406|NCT01376245|101302511|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
33386407|NCT01376245|101302512|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
33386408|NCT01376245|101302513|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
33386409|NCT01376245|101302509|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
33436755|NCT00950807|101492523|FG006|Treatment Period 2|Adverse Event|0|||
33436756|NCT00950807|101492524|FG007|Treatment Period 2|Adverse Event|1|||
33436757|NCT00950807|101492525|FG008|Treatment Period 2|Adverse Event|0|||
33436758|NCT00950807|101492526|FG009|Treatment Period 2|Adverse Event|0|||
33436759|NCT00950807|101492517|FG000|Washout Period 2|Lack of Efficacy|1|||
33436760|NCT00950807|101492518|FG001|Washout Period 2|Lack of Efficacy|0|||
33436761|NCT00950807|101492519|FG002|Washout Period 2|Lack of Efficacy|0|||
33436762|NCT00950807|101492520|FG003|Washout Period 2|Lack of Efficacy|0|||
33436763|NCT00950807|101492521|FG004|Washout Period 2|Lack of Efficacy|0|||
33436764|NCT00950807|101492522|FG005|Washout Period 2|Lack of Efficacy|0|||
33436765|NCT00950807|101492523|FG006|Washout Period 2|Lack of Efficacy|0|||
33436766|NCT00950807|101492524|FG007|Washout Period 2|Lack of Efficacy|0|||
33436767|NCT00950807|101492525|FG008|Washout Period 2|Lack of Efficacy|0|||
33436768|NCT00950807|101492526|FG009|Washout Period 2|Lack of Efficacy|0|||
33436769|NCT00950807|101492517|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
33436770|NCT00950807|101492518|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
33436771|NCT00950807|101492519|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
33436772|NCT00950807|101492520|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
33436773|NCT00950807|101492521|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
33436774|NCT00950807|101492522|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
33436775|NCT00950807|101492523|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
33436776|NCT00950807|101492524|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
33436777|NCT00950807|101492525|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
33436778|NCT00950807|101492526|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
33436779|NCT00950807|101492517|FG000|Washout Period 2|Adverse Event|3|||
33436780|NCT00950807|101492518|FG001|Washout Period 2|Adverse Event|0|||
33436781|NCT00950807|101492519|FG002|Washout Period 2|Adverse Event|0|||
33436782|NCT00950807|101492520|FG003|Washout Period 2|Adverse Event|1|||
33436783|NCT00950807|101492521|FG004|Washout Period 2|Adverse Event|0|||
33436784|NCT00950807|101492522|FG005|Washout Period 2|Adverse Event|0|||
33436785|NCT00950807|101492523|FG006|Washout Period 2|Adverse Event|0|||
33436786|NCT00950807|101492524|FG007|Washout Period 2|Adverse Event|0|||
33436787|NCT00950807|101492525|FG008|Washout Period 2|Adverse Event|0|||
33436788|NCT00950807|101492526|FG009|Washout Period 2|Adverse Event|0|||
33436789|NCT00950807|101492517|FG000|Treatment Period 3|Withdrawal by Subject|0|||
33436790|NCT00950807|101492518|FG001|Treatment Period 3|Withdrawal by Subject|0|||
33436791|NCT00950807|101492519|FG002|Treatment Period 3|Withdrawal by Subject|0|||
33436792|NCT00950807|101492520|FG003|Treatment Period 3|Withdrawal by Subject|0|||
33436793|NCT00950807|101492521|FG004|Treatment Period 3|Withdrawal by Subject|0|||
33436794|NCT00950807|101492522|FG005|Treatment Period 3|Withdrawal by Subject|0|||
33436795|NCT00950807|101492523|FG006|Treatment Period 3|Withdrawal by Subject|0|||
33436796|NCT00950807|101492524|FG007|Treatment Period 3|Withdrawal by Subject|0|||
33436797|NCT00950807|101492525|FG008|Treatment Period 3|Withdrawal by Subject|0|||
33436798|NCT00950807|101492526|FG009|Treatment Period 3|Withdrawal by Subject|1|||
33436799|NCT00950807|101492517|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
33436800|NCT00950807|101492518|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33436801|NCT00950807|101492519|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33436802|NCT00950807|101492520|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33436803|NCT00950807|101492521|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33436804|NCT00950807|101492522|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33436805|NCT00950807|101492523|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33436806|NCT00950807|101492524|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
33436807|NCT00950807|101492525|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33152391|NCT01024231|100472907|FG005|Overall Study|Other Reasons|0|||
33436808|NCT00950807|101492526|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33386410|NCT01376245|101302510|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
33386411|NCT01376245|101302511|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
33386412|NCT01376245|101302512|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
33386413|NCT01376245|101302513|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
33152392|NCT01024231|100472908|FG006|Overall Study|Other Reasons|1|||
33152393|NCT01024231|100472902|FG000|Overall Study|Maximum Clinical Benefit|1|||
33152394|NCT01024231|100472903|FG001|Overall Study|Maximum Clinical Benefit|2|||
33152395|NCT01024231|100472904|FG002|Overall Study|Maximum Clinical Benefit|0|||
33152396|NCT01024231|100472905|FG003|Overall Study|Maximum Clinical Benefit|1|||
33152397|NCT01024231|100472906|FG004|Overall Study|Maximum Clinical Benefit|1|||
33152398|NCT01024231|100472907|FG005|Overall Study|Maximum Clinical Benefit|0|||
33152399|NCT01024231|100472908|FG006|Overall Study|Maximum Clinical Benefit|0|||
33152400|NCT01024231|100472902|FG000|Overall Study|Disease Progression|3|||
33152401|NCT01024231|100472903|FG001|Overall Study|Disease Progression|1|||
33152402|NCT01024231|100472904|FG002|Overall Study|Disease Progression|3|||
33152403|NCT01024231|100472905|FG003|Overall Study|Disease Progression|0|||
33152404|NCT01024231|100472906|FG004|Overall Study|Disease Progression|4|||
33152405|NCT01024231|100472907|FG005|Overall Study|Disease Progression|11|||
33152406|NCT01024231|100472908|FG006|Overall Study|Disease Progression|6|||
33152407|NCT01024231|100472902|FG000|Overall Study|AE unrelated to Study Drug|0|||
33152408|NCT01024231|100472903|FG001|Overall Study|AE unrelated to Study Drug|1|||
33386414|NCT01376245|101302509|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
33152409|NCT01024231|100472904|FG002|Overall Study|AE unrelated to Study Drug|0|||
33386415|NCT01376245|101302510|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
33152410|NCT01024231|100472905|FG003|Overall Study|AE unrelated to Study Drug|0|||
33152411|NCT01024231|100472906|FG004|Overall Study|AE unrelated to Study Drug|0|||
33152412|NCT01024231|100472907|FG005|Overall Study|AE unrelated to Study Drug|0|||
33152413|NCT01024231|100472908|FG006|Overall Study|AE unrelated to Study Drug|0|||
33152414|NCT01024231|100472902|FG000|Overall Study|No longer meets criteria|0|||
33152415|NCT01024231|100472903|FG001|Overall Study|No longer meets criteria|0|||
33152416|NCT01024231|100472904|FG002|Overall Study|No longer meets criteria|0|||
33386416|NCT01376245|101302511|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
33436809|NCT00950807|101492517|FG000|Treatment Period 3|Adverse Event|0|||
33152417|NCT01024231|100472905|FG003|Overall Study|No longer meets criteria|0|||
33152418|NCT01024231|100472906|FG004|Overall Study|No longer meets criteria|1|||
33152419|NCT01024231|100472907|FG005|Overall Study|No longer meets criteria|0|||
33152420|NCT01024231|100472908|FG006|Overall Study|No longer meets criteria|1|||
33152421|NCT01024231|100472902|FG000|Overall Study|Study Drug Toxicity|1|||
33152422|NCT01024231|100472903|FG001|Overall Study|Study Drug Toxicity|6|||
33152423|NCT01024231|100472904|FG002|Overall Study|Study Drug Toxicity|6|||
33250427|NCT01460342|100814690|FG000|Overall Study|Lack of Efficacy|1|||
33250428|NCT01460342|100814691|FG001|Overall Study|Lack of Efficacy|0|||
33250429|NCT00337818|100814692|FG000|Overall Study|Lost to Follow-up|289|||
33250430|NCT00337818|100814693|FG001|Overall Study|Lost to Follow-up|91|||
33250431|NCT00337818|100814694|FG002|Overall Study|Lost to Follow-up|107|||
33250432|NCT01751724|100814695|FG000|Overall Study|extubated bef.start assigned treatment|1|||
33250433|NCT01751724|100814696|FG001|Overall Study|extubated bef.start assigned treatment|0|||
33250434|NCT01751724|100814695|FG000|Overall Study|withdrawn by parent|0|||
33250435|NCT01751724|100814696|FG001|Overall Study|withdrawn by parent|2|||
33250436|NCT00768664|100814699|FG000|Overall Study|Death|57|||
33250437|NCT00768664|100814699|FG000|Overall Study|Lost to Follow-up|2|||
33250438|NCT00768664|100814699|FG000|Overall Study|Other|9|||
33250439|NCT00768664|100814699|FG000|Overall Study|Participant refused|1|||
33250440|NCT01329328|100814700|FG000|Overall Study|Withdrawal by Subject|2|||
33250441|NCT01329328|100814701|FG001|Overall Study|Withdrawal by Subject|4|||
33250442|NCT01329328|100814702|FG002|Overall Study|Withdrawal by Subject|3|||
33250443|NCT00197236|100814703|FG000|Overall Study|Adverse Event|1|||
33250444|NCT00197236|100814704|FG001|Overall Study|Adverse Event|0|||
33250445|NCT00197236|100814705|FG002|Overall Study|Adverse Event|1|||
33250446|NCT00197236|100814703|FG000|Overall Study|Lost to Follow-up|5|||
33250447|NCT00197236|100814704|FG001|Overall Study|Lost to Follow-up|14|||
33386417|NCT01376245|101302512|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
33386418|NCT01376245|101302513|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
33386419|NCT01376245|101302509|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
33386420|NCT01376245|101302510|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
33386421|NCT01376245|101302511|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
33386422|NCT01376245|101302512|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
33386423|NCT01376245|101302513|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
33386424|NCT01376245|101302509|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33436810|NCT00950807|101492518|FG001|Treatment Period 3|Adverse Event|0|||
33436811|NCT00950807|101492519|FG002|Treatment Period 3|Adverse Event|0|||
33436812|NCT00950807|101492520|FG003|Treatment Period 3|Adverse Event|0|||
33152424|NCT01024231|100472905|FG003|Overall Study|Study Drug Toxicity|4|||
33152425|NCT01024231|100472906|FG004|Overall Study|Study Drug Toxicity|2|||
33152426|NCT01024231|100472907|FG005|Overall Study|Study Drug Toxicity|0|||
33152427|NCT01024231|100472908|FG006|Overall Study|Study Drug Toxicity|7|||
33250448|NCT00197236|100814705|FG002|Overall Study|Lost to Follow-up|6|||
33250449|NCT00197236|100814703|FG000|Overall Study|Protocol Violation|0|||
33250450|NCT00197236|100814704|FG001|Overall Study|Protocol Violation|0|||
33250451|NCT00197236|100814705|FG002|Overall Study|Protocol Violation|1|||
33250452|NCT00197236|100814703|FG000|Overall Study|Withdrawal by Subject|7|||
33436813|NCT00950807|101492521|FG004|Treatment Period 3|Adverse Event|0|||
33250453|NCT00197236|100814704|FG001|Overall Study|Withdrawal by Subject|3|||
33250454|NCT00197236|100814705|FG002|Overall Study|Withdrawal by Subject|11|||
33250455|NCT00197236|100814703|FG000|Overall Study|Study drug/medication expiration|1|||
33250456|NCT00197236|100814704|FG001|Overall Study|Study drug/medication expiration|0|||
33250457|NCT00197236|100814705|FG002|Overall Study|Study drug/medication expiration|3|||
33250458|NCT00197236|100814703|FG000|Overall Study|Returned out of specified time window|0|||
33250459|NCT00197236|100814704|FG001|Overall Study|Returned out of specified time window|0|||
33436814|NCT00950807|101492522|FG005|Treatment Period 3|Adverse Event|0|||
33386425|NCT01376245|101302510|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
33386426|NCT01376245|101302511|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
33386427|NCT01376245|101302512|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
33386428|NCT01376245|101302513|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
33386429|NCT01376245|101302509|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
33386430|NCT01376245|101302510|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
33386431|NCT01376245|101302511|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
33386432|NCT01376245|101302512|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
33386433|NCT01376245|101302513|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
33436815|NCT00950807|101492523|FG006|Treatment Period 3|Adverse Event|1|||
33152428|NCT01024231|100472902|FG000|Overall Study|Death|6|||
33152429|NCT01024231|100472903|FG001|Overall Study|Death|2|||
33152430|NCT01024231|100472904|FG002|Overall Study|Death|1|||
33152431|NCT01024231|100472905|FG003|Overall Study|Death|0|||
33152432|NCT01024231|100472906|FG004|Overall Study|Death|4|||
33152433|NCT01024231|100472907|FG005|Overall Study|Death|3|||
33152434|NCT01024231|100472908|FG006|Overall Study|Death|5|||
33250460|NCT00197236|100814705|FG002|Overall Study|Returned out of specified time window|1|||
33250461|NCT02537522|100814706|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
33250462|NCT02537522|100814707|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
33250463|NCT02537522|100814708|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
33250464|NCT02537522|100814709|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
33250465|NCT02537522|100814706|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
33250466|NCT02537522|100814707|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
33250467|NCT02537522|100814708|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
33250468|NCT02537522|100814709|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
33386434|NCT01376245|101302509|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
33386435|NCT01376245|101302510|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
33386436|NCT01376245|101302511|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
33386437|NCT01376245|101302512|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
33386438|NCT01376245|101302513|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
33386439|NCT00443846|101302519|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
33386440|NCT00443846|101302520|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
33386441|NCT00443846|101302519|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
33386442|NCT00443846|101302520|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
33386443|NCT00443846|101302519|FG000|Overall Study|Adverse Event|0|||
33386444|NCT00443846|101302520|FG001|Overall Study|Adverse Event|1|||
33386445|NCT00443846|101302519|FG000|Overall Study|Personal reason|8|||
33386446|NCT00443846|101302520|FG001|Overall Study|Personal reason|3|||
33386447|NCT00443846|101302519|FG000|Overall Study|Lost to Follow-up|1|||
33386448|NCT00443846|101302520|FG001|Overall Study|Lost to Follow-up|2|||
33386449|NCT03549429|101302521|FG000|Overall Study|Protocol Violation|5|||
33386450|NCT03549429|101302522|FG001|Overall Study|Protocol Violation|3|||
33250469|NCT02537522|100814706|FG000|Phase I - Contralateral|incorrect randomization|0|||
33386451|NCT01599806|101302523|FG000|Overall Study|Lost to Follow-up|20|||
33250470|NCT02537522|100814707|FG001|Phase I - Contralateral|incorrect randomization|1|||
33250471|NCT02537522|100814708|FG002|Phase I - Contralateral|incorrect randomization|0|||
33386452|NCT01599806|101302524|FG001|Overall Study|Lost to Follow-up|20|||
33152435|NCT01024231|100472902|FG000|Overall Study|Lost to Follow-up|0|||
33250472|NCT02537522|100814709|FG003|Phase I - Contralateral|incorrect randomization|0|||
33250473|NCT02537522|100814706|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
33250474|NCT02537522|100814707|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
33152436|NCT01024231|100472903|FG001|Overall Study|Lost to Follow-up|0|||
33386453|NCT01599806|101302523|FG000|Overall Study|Withdrawal by Subject|12|||
33386454|NCT01599806|101302524|FG001|Overall Study|Withdrawal by Subject|12|||
33386455|NCT01599806|101302523|FG000|Overall Study|Other Eligibility criteria|11|||
33386456|NCT01599806|101302524|FG001|Overall Study|Other Eligibility criteria|9|||
33386457|NCT03228394|101302525|FG000|Overall Study|Lost to Follow-up|0|||
33386458|NCT03228394|101302526|FG001|Overall Study|Lost to Follow-up|0|||
33386459|NCT03228394|101302527|FG002|Overall Study|Lost to Follow-up|1|||
33386460|NCT03228394|101302528|FG003|Overall Study|Lost to Follow-up|1|||
33386461|NCT03228394|101302529|FG004|Overall Study|Lost to Follow-up|0|||
33386462|NCT03228394|101302530|FG005|Overall Study|Lost to Follow-up|0|||
33386463|NCT03228394|101302531|FG006|Overall Study|Lost to Follow-up|2|||
33386464|NCT03228394|101302532|FG007|Overall Study|Lost to Follow-up|0|||
33386465|NCT03228394|101302525|FG000|Overall Study|Withdrawal by Subject|0|||
33386466|NCT03228394|101302526|FG001|Overall Study|Withdrawal by Subject|0|||
33386467|NCT03228394|101302527|FG002|Overall Study|Withdrawal by Subject|1|||
33386468|NCT03228394|101302528|FG003|Overall Study|Withdrawal by Subject|0|||
33386469|NCT03228394|101302529|FG004|Overall Study|Withdrawal by Subject|0|||
33386470|NCT03228394|101302530|FG005|Overall Study|Withdrawal by Subject|0|||
33386471|NCT03228394|101302531|FG006|Overall Study|Withdrawal by Subject|1|||
33386472|NCT03228394|101302532|FG007|Overall Study|Withdrawal by Subject|3|||
33386473|NCT03228394|101302525|FG000|Overall Study|Protocol Violation|0|||
33386474|NCT03228394|101302526|FG001|Overall Study|Protocol Violation|0|||
33386475|NCT03228394|101302527|FG002|Overall Study|Protocol Violation|0|||
33386476|NCT03228394|101302528|FG003|Overall Study|Protocol Violation|1|||
33386477|NCT03228394|101302529|FG004|Overall Study|Protocol Violation|0|||
33386478|NCT03228394|101302530|FG005|Overall Study|Protocol Violation|0|||
33386479|NCT03228394|101302531|FG006|Overall Study|Protocol Violation|0|||
33386480|NCT03228394|101302532|FG007|Overall Study|Protocol Violation|0|||
33386481|NCT03228394|101302525|FG000|Overall Study|Physician Decision|0|||
33386482|NCT03228394|101302526|FG001|Overall Study|Physician Decision|0|||
33386483|NCT03228394|101302527|FG002|Overall Study|Physician Decision|0|||
33152437|NCT01024231|100472904|FG002|Overall Study|Lost to Follow-up|0|||
33152438|NCT01024231|100472905|FG003|Overall Study|Lost to Follow-up|0|||
33152439|NCT01024231|100472906|FG004|Overall Study|Lost to Follow-up|0|||
33152440|NCT01024231|100472907|FG005|Overall Study|Lost to Follow-up|0|||
33152441|NCT01024231|100472908|FG006|Overall Study|Lost to Follow-up|1|||
33152442|NCT01024231|100472902|FG000|Overall Study|Withdrew Consent|0|||
33386484|NCT03228394|101302528|FG003|Overall Study|Physician Decision|0|||
33386485|NCT03228394|101302529|FG004|Overall Study|Physician Decision|0|||
33386486|NCT03228394|101302530|FG005|Overall Study|Physician Decision|0|||
33386487|NCT03228394|101302531|FG006|Overall Study|Physician Decision|1|||
33386488|NCT03228394|101302532|FG007|Overall Study|Physician Decision|0|||
33386489|NCT03228394|101302525|FG000|Overall Study|Noncompliance|0|||
33386490|NCT03228394|101302526|FG001|Overall Study|Noncompliance|0|||
33386491|NCT03228394|101302527|FG002|Overall Study|Noncompliance|0|||
33386492|NCT03228394|101302528|FG003|Overall Study|Noncompliance|0|||
33386493|NCT03228394|101302529|FG004|Overall Study|Noncompliance|0|||
33386494|NCT03228394|101302530|FG005|Overall Study|Noncompliance|0|||
33386495|NCT03228394|101302531|FG006|Overall Study|Noncompliance|1|||
33386496|NCT03228394|101302532|FG007|Overall Study|Noncompliance|0|||
33386497|NCT02460978|101302540|FG000|Overall Study|Adverse Event|17|||
33386498|NCT02460978|101302541|FG001|Overall Study|Adverse Event|11|||
33386499|NCT02460978|101302542|FG002|Overall Study|Adverse Event|11|||
33386500|NCT02460978|101302540|FG000|Overall Study|Withdrawal by Subject|5|||
33386501|NCT02460978|101302541|FG001|Overall Study|Withdrawal by Subject|5|||
33386502|NCT02460978|101302542|FG002|Overall Study|Withdrawal by Subject|14|||
33386503|NCT02460978|101302540|FG000|Overall Study|Lost to Follow-up|2|||
33386504|NCT02460978|101302541|FG001|Overall Study|Lost to Follow-up|3|||
33386505|NCT02460978|101302542|FG002|Overall Study|Lost to Follow-up|1|||
33386506|NCT02460978|101302540|FG000|Overall Study|Protocol Violation|1|||
33386507|NCT02460978|101302541|FG001|Overall Study|Protocol Violation|1|||
33386508|NCT02460978|101302542|FG002|Overall Study|Protocol Violation|1|||
33386509|NCT02460978|101302540|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
33386510|NCT02460978|101302541|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
33386511|NCT02460978|101302542|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
33152443|NCT01024231|100472903|FG001|Overall Study|Withdrew Consent|1|||
33152444|NCT01024231|100472904|FG002|Overall Study|Withdrew Consent|0|||
33386512|NCT02460978|101302540|FG000|Overall Study|Pregnancy|0|||
33386513|NCT02460978|101302541|FG001|Overall Study|Pregnancy|0|||
33386514|NCT02460978|101302542|FG002|Overall Study|Pregnancy|2|||
33386515|NCT00033371|101302543|FG000|Overall Study|Adverse Event|1|||
33386516|NCT00033371|101302544|FG001|Overall Study|Adverse Event|5|||
33386517|NCT00033371|101302543|FG000|Overall Study|Lost to Follow-up|2|||
33386518|NCT00033371|101302544|FG001|Overall Study|Lost to Follow-up|1|||
33386519|NCT00033371|101302543|FG000|Overall Study|Withdrawal by Subject|3|||
33386520|NCT00033371|101302544|FG001|Overall Study|Withdrawal by Subject|3|||
33386521|NCT00033371|101302543|FG000|Overall Study|Disease Progression|0|||
33386522|NCT00033371|101302544|FG001|Overall Study|Disease Progression|1|||
33386523|NCT00981747|101302547|FG000|Losartan|Withdrawal by Subject|1|||
33386524|NCT00981747|101302547|FG000|Losartan|Death|1|||
33152445|NCT01024231|100472905|FG003|Overall Study|Withdrew Consent|0|||
33152446|NCT01024231|100472906|FG004|Overall Study|Withdrew Consent|0|||
33152447|NCT01024231|100472907|FG005|Overall Study|Withdrew Consent|0|||
33152448|NCT01024231|100472908|FG006|Overall Study|Withdrew Consent|0|||
33152449|NCT01024231|100472902|FG000|Overall Study|Continuing on Treatment|0|||
33152450|NCT01024231|100472903|FG001|Overall Study|Continuing on Treatment|0|||
33152451|NCT01024231|100472904|FG002|Overall Study|Continuing on Treatment|0|||
33152452|NCT01024231|100472905|FG003|Overall Study|Continuing on Treatment|0|||
33152453|NCT01024231|100472906|FG004|Overall Study|Continuing on Treatment|3|||
33152454|NCT01024231|100472907|FG005|Overall Study|Continuing on Treatment|2|||
33152455|NCT01024231|100472908|FG006|Overall Study|Continuing on Treatment|0|||
33152456|NCT01400815|100472909|FG000|Overall Study|Adverse Event|3|||
33152457|NCT01400815|100472910|FG001|Overall Study|Adverse Event|0|||
33152458|NCT01400815|100472909|FG000|Overall Study|Death|0|||
33152459|NCT01400815|100472910|FG001|Overall Study|Death|1|||
33152460|NCT01400815|100472909|FG000|Overall Study|Lost to Follow-up|18|||
33152461|NCT01400815|100472910|FG001|Overall Study|Lost to Follow-up|11|||
33152462|NCT01400815|100472909|FG000|Overall Study|Protocol Violation|0|||
33152463|NCT01400815|100472910|FG001|Overall Study|Protocol Violation|1|||
33152464|NCT01400815|100472909|FG000|Overall Study|Physician Decision|1|||
33152465|NCT01400815|100472910|FG001|Overall Study|Physician Decision|0|||
33152466|NCT01400815|100472909|FG000|Overall Study|Withdrawal by Subject|15|||
33152467|NCT01400815|100472910|FG001|Overall Study|Withdrawal by Subject|8|||
33152468|NCT01400815|100472909|FG000|Overall Study|Subject in jail|1|||
33152469|NCT01400815|100472910|FG001|Overall Study|Subject in jail|0|||
33152470|NCT03633617|100472914|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
33152471|NCT03633617|100472915|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
33152472|NCT03633617|100472916|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33152473|NCT03633617|100472917|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33152474|NCT03633617|100472918|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33152475|NCT03633617|100472919|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33152476|NCT03633617|100472920|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33152477|NCT03633617|100472921|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33152478|NCT03633617|100472922|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33152479|NCT03633617|100472923|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33152480|NCT03633617|100472924|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
33152481|NCT03633617|100472914|FG000|Part A|Unconfirmed early termination visit|1|||
33152482|NCT03633617|100472915|FG001|Part A|Unconfirmed early termination visit|0|||
33152483|NCT03633617|100472916|FG002|Part A|Unconfirmed early termination visit|0|||
33152484|NCT03633617|100472917|FG003|Part A|Unconfirmed early termination visit|0|||
33152485|NCT03633617|100472918|FG004|Part A|Unconfirmed early termination visit|0|||
33152486|NCT03633617|100472919|FG005|Part A|Unconfirmed early termination visit|0|||
33152487|NCT03633617|100472920|FG006|Part A|Unconfirmed early termination visit|0|||
33152488|NCT03633617|100472921|FG007|Part A|Unconfirmed early termination visit|0|||
33152489|NCT03633617|100472922|FG008|Part A|Unconfirmed early termination visit|0|||
33152490|NCT03633617|100472923|FG009|Part A|Unconfirmed early termination visit|0|||
33152491|NCT03633617|100472924|FG010|Part A|Unconfirmed early termination visit|0|||
33152492|NCT03633617|100472914|FG000|Part A|Adverse Event|0|||
33152493|NCT03633617|100472915|FG001|Part A|Adverse Event|1|||
33152494|NCT03633617|100472916|FG002|Part A|Adverse Event|0|||
33152495|NCT03633617|100472917|FG003|Part A|Adverse Event|0|||
33152496|NCT03633617|100472918|FG004|Part A|Adverse Event|0|||
33152497|NCT03633617|100472919|FG005|Part A|Adverse Event|0|||
33152498|NCT03633617|100472920|FG006|Part A|Adverse Event|0|||
33152499|NCT03633617|100472921|FG007|Part A|Adverse Event|0|||
33152500|NCT03633617|100472922|FG008|Part A|Adverse Event|0|||
33152501|NCT03633617|100472923|FG009|Part A|Adverse Event|0|||
33152502|NCT03633617|100472924|FG010|Part A|Adverse Event|0|||
33152503|NCT03633617|100472914|FG000|Part A|Pregnancy|1|||
33152504|NCT03633617|100472915|FG001|Part A|Pregnancy|0|||
33152505|NCT03633617|100472916|FG002|Part A|Pregnancy|0|||
33152506|NCT03633617|100472917|FG003|Part A|Pregnancy|0|||
33152507|NCT03633617|100472918|FG004|Part A|Pregnancy|0|||
33152508|NCT03633617|100472919|FG005|Part A|Pregnancy|0|||
33152509|NCT03633617|100472920|FG006|Part A|Pregnancy|0|||
33152510|NCT03633617|100472921|FG007|Part A|Pregnancy|0|||
33152511|NCT03633617|100472922|FG008|Part A|Pregnancy|0|||
33152512|NCT03633617|100472923|FG009|Part A|Pregnancy|0|||
33152513|NCT03633617|100472924|FG010|Part A|Pregnancy|0|||
33152514|NCT03633617|100472914|FG000|Part A|Withdrawal by Subject|0|||
33152515|NCT03633617|100472915|FG001|Part A|Withdrawal by Subject|1|||
33152516|NCT03633617|100472916|FG002|Part A|Withdrawal by Subject|0|||
33152517|NCT03633617|100472917|FG003|Part A|Withdrawal by Subject|0|||
33152518|NCT03633617|100472918|FG004|Part A|Withdrawal by Subject|0|||
33152519|NCT03633617|100472919|FG005|Part A|Withdrawal by Subject|0|||
33386525|NCT00981747|101302547|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
33152520|NCT03633617|100472920|FG006|Part A|Withdrawal by Subject|0|||
33152521|NCT03633617|100472921|FG007|Part A|Withdrawal by Subject|0|||
33152522|NCT03633617|100472922|FG008|Part A|Withdrawal by Subject|0|||
33152523|NCT03633617|100472923|FG009|Part A|Withdrawal by Subject|0|||
33152524|NCT03633617|100472924|FG010|Part A|Withdrawal by Subject|0|||
33152525|NCT03633617|100472914|FG000|Part B|Adverse Event|0|||
33152526|NCT03633617|100472915|FG001|Part B|Adverse Event|0|||
33152527|NCT03633617|100472916|FG002|Part B|Adverse Event|2|||
33152528|NCT03633617|100472917|FG003|Part B|Adverse Event|2|||
33152529|NCT03633617|100472918|FG004|Part B|Adverse Event|1|||
33152530|NCT03633617|100472919|FG005|Part B|Adverse Event|0|||
33152531|NCT03633617|100472920|FG006|Part B|Adverse Event|0|||
33152532|NCT03633617|100472921|FG007|Part B|Adverse Event|0|||
33152533|NCT03633617|100472922|FG008|Part B|Adverse Event|0|||
33152534|NCT03633617|100472923|FG009|Part B|Adverse Event|0|||
33152535|NCT03633617|100472924|FG010|Part B|Adverse Event|0|||
33152536|NCT03633617|100472914|FG000|Part B|Withdrawal by Subject|0|||
33152537|NCT03633617|100472915|FG001|Part B|Withdrawal by Subject|0|||
33152538|NCT03633617|100472916|FG002|Part B|Withdrawal by Subject|1|||
33152539|NCT03633617|100472917|FG003|Part B|Withdrawal by Subject|0|||
33152540|NCT03633617|100472918|FG004|Part B|Withdrawal by Subject|2|||
33152541|NCT03633617|100472919|FG005|Part B|Withdrawal by Subject|0|||
33152542|NCT03633617|100472920|FG006|Part B|Withdrawal by Subject|0|||
33152543|NCT03633617|100472921|FG007|Part B|Withdrawal by Subject|0|||
33152544|NCT03633617|100472922|FG008|Part B|Withdrawal by Subject|0|||
33152545|NCT03633617|100472923|FG009|Part B|Withdrawal by Subject|0|||
33152546|NCT03633617|100472924|FG010|Part B|Withdrawal by Subject|0|||
33152547|NCT03633617|100472914|FG000|Part B|Lost to Follow-up|0|||
33152548|NCT03633617|100472915|FG001|Part B|Lost to Follow-up|0|||
33152549|NCT03633617|100472916|FG002|Part B|Lost to Follow-up|0|||
33152550|NCT03633617|100472917|FG003|Part B|Lost to Follow-up|0|||
33152551|NCT03633617|100472918|FG004|Part B|Lost to Follow-up|1|||
33152552|NCT03633617|100472919|FG005|Part B|Lost to Follow-up|0|||
33152553|NCT03633617|100472920|FG006|Part B|Lost to Follow-up|0|||
33152554|NCT03633617|100472921|FG007|Part B|Lost to Follow-up|0|||
33152555|NCT03633617|100472922|FG008|Part B|Lost to Follow-up|0|||
33152556|NCT03633617|100472923|FG009|Part B|Lost to Follow-up|0|||
33152557|NCT03633617|100472924|FG010|Part B|Lost to Follow-up|0|||
33152558|NCT03633617|100472914|FG000|Part B|Physician Decision|0|||
33152559|NCT03633617|100472915|FG001|Part B|Physician Decision|0|||
33152560|NCT03633617|100472916|FG002|Part B|Physician Decision|0|||
33152561|NCT03633617|100472917|FG003|Part B|Physician Decision|0|||
33152562|NCT03633617|100472918|FG004|Part B|Physician Decision|1|||
33152563|NCT03633617|100472919|FG005|Part B|Physician Decision|0|||
33152564|NCT03633617|100472920|FG006|Part B|Physician Decision|0|||
33152565|NCT03633617|100472921|FG007|Part B|Physician Decision|0|||
33152566|NCT03633617|100472922|FG008|Part B|Physician Decision|0|||
33152567|NCT03633617|100472923|FG009|Part B|Physician Decision|0|||
33152568|NCT03633617|100472924|FG010|Part B|Physician Decision|0|||
33152569|NCT03633617|100472914|FG000|Part B|COVID-19 Restrictions|0|||
33152570|NCT03633617|100472915|FG001|Part B|COVID-19 Restrictions|0|||
33152571|NCT03633617|100472916|FG002|Part B|COVID-19 Restrictions|1|||
33152572|NCT03633617|100472917|FG003|Part B|COVID-19 Restrictions|0|||
33152573|NCT03633617|100472918|FG004|Part B|COVID-19 Restrictions|0|||
33152574|NCT03633617|100472919|FG005|Part B|COVID-19 Restrictions|0|||
33152575|NCT03633617|100472920|FG006|Part B|COVID-19 Restrictions|0|||
33152576|NCT03633617|100472921|FG007|Part B|COVID-19 Restrictions|0|||
33152577|NCT03633617|100472922|FG008|Part B|COVID-19 Restrictions|0|||
33152578|NCT03633617|100472923|FG009|Part B|COVID-19 Restrictions|0|||
33152579|NCT03633617|100472924|FG010|Part B|COVID-19 Restrictions|0|||
33152580|NCT03633617|100472914|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33152581|NCT03633617|100472915|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33152582|NCT03633617|100472916|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
33152583|NCT03633617|100472917|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33152584|NCT03633617|100472918|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33152585|NCT03633617|100472919|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33152586|NCT03633617|100472920|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33152587|NCT03633617|100472921|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33386526|NCT03034057|101302550|FG000|Overall Study|Withdrawal by Subject|10|||
33152588|NCT03633617|100472922|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33152589|NCT03633617|100472923|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33152590|NCT03633617|100472924|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
33152591|NCT03633617|100472914|FG000|Part C (& Follow-up)|Adverse Event|0|||
33152592|NCT03633617|100472915|FG001|Part C (& Follow-up)|Adverse Event|0|||
33152593|NCT03633617|100472916|FG002|Part C (& Follow-up)|Adverse Event|0|||
33152594|NCT03633617|100472917|FG003|Part C (& Follow-up)|Adverse Event|0|||
33152595|NCT03633617|100472918|FG004|Part C (& Follow-up)|Adverse Event|0|||
33436816|NCT00950807|101492524|FG007|Treatment Period 3|Adverse Event|0|||
33386527|NCT03034057|101302550|FG000|Overall Study|Protocol Violation|1|||
33386528|NCT03034057|101302550|FG000|Overall Study|Not defined|2|||
33386529|NCT03034057|101302550|FG000|Overall Study|Lost to Follow-up|19|||
33386530|NCT03034057|101302550|FG000|Overall Study|Adverse Event|22|||
33386531|NCT03034057|101302550|FG000|Overall Study|Medication error without associated AE|1|||
33386532|NCT01548417|101302551|FG000|Overall Study|Withdrawal by Subject|0|||
33386533|NCT01548417|101302552|FG001|Overall Study|Withdrawal by Subject|2|||
33386534|NCT01444898|101302555|FG000|Overall Study|Withdrawal by Subject|1|||
33386535|NCT01665768|101302556|FG000|Overall Study|Adverse Event|3|||
33386536|NCT01665768|101302556|FG000|Overall Study|Lack of Efficacy|19|||
33386537|NCT01665768|101302556|FG000|Overall Study|Withdrawal by Subject|1|||
33436817|NCT00950807|101492525|FG008|Treatment Period 3|Adverse Event|0|||
33436818|NCT00950807|101492526|FG009|Treatment Period 3|Adverse Event|0|||
33436819|NCT03552757|101492543|FG000|Overall Study|Withdrawal by Subject|10|||
33436820|NCT03552757|101492544|FG001|Overall Study|Withdrawal by Subject|5|||
33386538|NCT01253187|101302557|FG000|Period 2|Withdrawal by Subject|0|||
33386539|NCT01253187|101302558|FG001|Period 2|Withdrawal by Subject|0|||
33436821|NCT03552757|101492545|FG002|Overall Study|Withdrawal by Subject|12|||
33436822|NCT03552757|101492543|FG000|Overall Study|Lost to Follow-up|2|||
33436823|NCT03552757|101492544|FG001|Overall Study|Lost to Follow-up|7|||
33436824|NCT03552757|101492545|FG002|Overall Study|Lost to Follow-up|7|||
33436825|NCT03552757|101492543|FG000|Overall Study|Death|1|||
33152596|NCT03633617|100472919|FG005|Part C (& Follow-up)|Adverse Event|1|||
33250475|NCT02537522|100814708|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
33250476|NCT02537522|100814709|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
33250477|NCT02537522|100814706|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
33250478|NCT02537522|100814707|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
33250479|NCT02537522|100814708|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
33250480|NCT02537522|100814709|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
33250481|NCT03184558|100817765|FG000|Overall Study|Withdrawal by Subject|2|||
33250482|NCT03184558|100817765|FG000|Overall Study|Death|16|||
33250483|NCT03184558|100817765|FG000|Overall Study|Lost to Follow-up|2|||
33250484|NCT03184558|100817765|FG000|Overall Study|Other|9|||
33250485|NCT02072226|100817768|FG000|Overall Study|Lost to Follow-up|11|||
33250486|NCT02072226|100817769|FG001|Overall Study|Lost to Follow-up|7|||
33250487|NCT02072226|100817768|FG000|Overall Study|Patient Non-compliance|2|||
33250488|NCT02072226|100817769|FG001|Overall Study|Patient Non-compliance|3|||
33250489|NCT02072226|100817768|FG000|Overall Study|Death|1|||
33152597|NCT03633617|100472920|FG006|Part C (& Follow-up)|Adverse Event|0|||
33152598|NCT03633617|100472921|FG007|Part C (& Follow-up)|Adverse Event|1|||
33250490|NCT02072226|100817769|FG001|Overall Study|Death|0|||
33250491|NCT02072226|100817768|FG000|Overall Study|Patient Withdrawal of Consent|1|||
33250492|NCT02072226|100817769|FG001|Overall Study|Patient Withdrawal of Consent|0|||
33250493|NCT00961636|100817770|FG000|Overall Study|Adverse Event|35|||
33250494|NCT00961636|100817771|FG001|Overall Study|Adverse Event|54|||
33250495|NCT00961636|100817772|FG002|Overall Study|Adverse Event|13|||
33250496|NCT00961636|100817770|FG000|Overall Study|Flushing Symptoms|29|||
33436826|NCT03552757|101492544|FG001|Overall Study|Death|1|||
33152599|NCT03633617|100472922|FG008|Part C (& Follow-up)|Adverse Event|0|||
33152600|NCT03633617|100472923|FG009|Part C (& Follow-up)|Adverse Event|0|||
33152601|NCT03633617|100472924|FG010|Part C (& Follow-up)|Adverse Event|0|||
33152602|NCT03633617|100472914|FG000|Part C (& Follow-up)|Pregnancy|0|||
33152603|NCT03633617|100472915|FG001|Part C (& Follow-up)|Pregnancy|0|||
33152604|NCT03633617|100472916|FG002|Part C (& Follow-up)|Pregnancy|0|||
33152605|NCT03633617|100472917|FG003|Part C (& Follow-up)|Pregnancy|0|||
33152606|NCT03633617|100472918|FG004|Part C (& Follow-up)|Pregnancy|0|||
33152607|NCT03633617|100472919|FG005|Part C (& Follow-up)|Pregnancy|0|||
33152608|NCT03633617|100472920|FG006|Part C (& Follow-up)|Pregnancy|0|||
33152609|NCT03633617|100472921|FG007|Part C (& Follow-up)|Pregnancy|0|||
33250497|NCT00961636|100817771|FG001|Overall Study|Flushing Symptoms|46|||
33250498|NCT00961636|100817772|FG002|Overall Study|Flushing Symptoms|3|||
33250499|NCT00961636|100817770|FG000|Overall Study|Lost to Follow-up|2|||
33436827|NCT03552757|101492545|FG002|Overall Study|Death|1|||
33436828|NCT03500484|101492546|FG000|Overall Study|Adverse Event|2|||
33152610|NCT03633617|100472922|FG008|Part C (& Follow-up)|Pregnancy|0|||
33250500|NCT00961636|100817771|FG001|Overall Study|Lost to Follow-up|3|||
33250501|NCT00961636|100817772|FG002|Overall Study|Lost to Follow-up|1|||
33250502|NCT00961636|100817770|FG000|Overall Study|Physician Decision|3|||
33250503|NCT00961636|100817771|FG001|Overall Study|Physician Decision|1|||
33250504|NCT00961636|100817772|FG002|Overall Study|Physician Decision|1|||
33250505|NCT00961636|100817770|FG000|Overall Study|Protocol Violation|9|||
33386540|NCT01253187|101302559|FG002|Period 2|Withdrawal by Subject|0|||
33386541|NCT01253187|101302560|FG003|Period 2|Withdrawal by Subject|0|||
33386542|NCT01253187|101302561|FG004|Period 2|Withdrawal by Subject|1|||
33386543|NCT01253187|101302562|FG005|Period 2|Withdrawal by Subject|0|||
33436829|NCT03500484|101492547|FG001|Overall Study|Adverse Event|0|||
33436830|NCT03500484|101492546|FG000|Overall Study|Physician Decision|1|||
33152611|NCT03633617|100472923|FG009|Part C (& Follow-up)|Pregnancy|1|||
33152612|NCT03633617|100472924|FG010|Part C (& Follow-up)|Pregnancy|0|||
33152613|NCT03633617|100472914|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
33152614|NCT03633617|100472915|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
33152615|NCT03633617|100472916|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
33152616|NCT03633617|100472917|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
33152617|NCT03633617|100472918|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
33152618|NCT03633617|100472919|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
33152619|NCT03633617|100472920|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
33152620|NCT03633617|100472921|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
33152621|NCT03633617|100472922|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
33152622|NCT03633617|100472923|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
33152623|NCT03633617|100472924|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
33152624|NCT03633617|100472914|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
33152625|NCT03633617|100472915|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
33152626|NCT03633617|100472916|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
33152627|NCT03633617|100472917|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
33152628|NCT03633617|100472918|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
33152629|NCT03633617|100472919|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
33152630|NCT03633617|100472920|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
33152631|NCT03633617|100472921|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
33152632|NCT03633617|100472922|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
33152633|NCT03633617|100472923|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
33152634|NCT03633617|100472924|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
33152635|NCT03633617|100472914|FG000|Part C (& Follow-up)|Physician Decision|0|||
33152636|NCT03633617|100472915|FG001|Part C (& Follow-up)|Physician Decision|0|||
33152637|NCT03633617|100472916|FG002|Part C (& Follow-up)|Physician Decision|0|||
33152638|NCT03633617|100472917|FG003|Part C (& Follow-up)|Physician Decision|0|||
33152639|NCT03633617|100472918|FG004|Part C (& Follow-up)|Physician Decision|0|||
33152640|NCT03633617|100472919|FG005|Part C (& Follow-up)|Physician Decision|0|||
33152641|NCT03633617|100472920|FG006|Part C (& Follow-up)|Physician Decision|0|||
33152642|NCT03633617|100472921|FG007|Part C (& Follow-up)|Physician Decision|1|||
33152643|NCT03633617|100472922|FG008|Part C (& Follow-up)|Physician Decision|0|||
33152644|NCT03633617|100472923|FG009|Part C (& Follow-up)|Physician Decision|0|||
33152645|NCT03633617|100472924|FG010|Part C (& Follow-up)|Physician Decision|1|||
33152646|NCT03633617|100472914|FG000|Part C (& Follow-up)|COVID-19 related|0|||
33152647|NCT03633617|100472915|FG001|Part C (& Follow-up)|COVID-19 related|0|||
33152648|NCT03633617|100472916|FG002|Part C (& Follow-up)|COVID-19 related|0|||
33152649|NCT03633617|100472917|FG003|Part C (& Follow-up)|COVID-19 related|0|||
33152650|NCT03633617|100472918|FG004|Part C (& Follow-up)|COVID-19 related|0|||
33386544|NCT01253187|101302557|FG000|Period 3|Pregnancy|1|||
33386545|NCT01253187|101302558|FG001|Period 3|Pregnancy|0|||
33152651|NCT03633617|100472919|FG005|Part C (& Follow-up)|COVID-19 related|1|||
33152652|NCT03633617|100472920|FG006|Part C (& Follow-up)|COVID-19 related|0|||
33152653|NCT03633617|100472921|FG007|Part C (& Follow-up)|COVID-19 related|0|||
33152654|NCT03633617|100472922|FG008|Part C (& Follow-up)|COVID-19 related|0|||
33386546|NCT01253187|101302559|FG002|Period 3|Pregnancy|0|||
33152655|NCT03633617|100472923|FG009|Part C (& Follow-up)|COVID-19 related|0|||
33386547|NCT01253187|101302560|FG003|Period 3|Pregnancy|0|||
33152656|NCT03633617|100472924|FG010|Part C (& Follow-up)|COVID-19 related|0|||
33152657|NCT03633617|100472914|FG000|Part C (& Follow-up)|Protocol Violation|0|||
33152658|NCT03633617|100472915|FG001|Part C (& Follow-up)|Protocol Violation|0|||
33386548|NCT01253187|101302561|FG004|Period 3|Pregnancy|0|||
33152659|NCT03633617|100472916|FG002|Part C (& Follow-up)|Protocol Violation|0|||
33152660|NCT03633617|100472917|FG003|Part C (& Follow-up)|Protocol Violation|0|||
33152661|NCT03633617|100472918|FG004|Part C (& Follow-up)|Protocol Violation|0|||
33152662|NCT03633617|100472919|FG005|Part C (& Follow-up)|Protocol Violation|0|||
33152663|NCT03633617|100472920|FG006|Part C (& Follow-up)|Protocol Violation|0|||
33152664|NCT03633617|100472921|FG007|Part C (& Follow-up)|Protocol Violation|0|||
33152665|NCT03633617|100472922|FG008|Part C (& Follow-up)|Protocol Violation|0|||
33250506|NCT00961636|100817771|FG001|Overall Study|Protocol Violation|5|||
33250507|NCT00961636|100817772|FG002|Overall Study|Protocol Violation|1|||
33250508|NCT00961636|100817770|FG000|Overall Study|Withdrawal by Subject|29|||
33250509|NCT00961636|100817771|FG001|Overall Study|Withdrawal by Subject|22|||
33250510|NCT00961636|100817772|FG002|Overall Study|Withdrawal by Subject|13|||
33250511|NCT00487578|100817775|FG000|Overall Study|Adverse Event|1|||
33250512|NCT00487578|100817776|FG001|Overall Study|Adverse Event|2|||
33152666|NCT03633617|100472923|FG009|Part C (& Follow-up)|Protocol Violation|3|||
33152667|NCT03633617|100472924|FG010|Part C (& Follow-up)|Protocol Violation|1|||
33152668|NCT03633617|100472914|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
33152669|NCT03633617|100472915|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
33152670|NCT03633617|100472916|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
33152671|NCT03633617|100472917|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
33152672|NCT03633617|100472918|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
33152673|NCT03633617|100472919|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
33152674|NCT03633617|100472920|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
33152675|NCT03633617|100472921|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
33152676|NCT03633617|100472922|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
33152677|NCT03633617|100472923|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
33152678|NCT03633617|100472924|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
33152679|NCT02395016|100472929|FG000|Overall Study|Adverse Event|4|||
33152680|NCT02395016|100472930|FG001|Overall Study|Adverse Event|3|||
33152681|NCT02395016|100472929|FG000|Overall Study|Withdrawal by Subject|9|||
33152682|NCT02395016|100472930|FG001|Overall Study|Withdrawal by Subject|6|||
33152683|NCT02395016|100472929|FG000|Overall Study|Protocol Violation|2|||
33152684|NCT02395016|100472930|FG001|Overall Study|Protocol Violation|3|||
33152685|NCT01904058|100472933|FG000|Overall Study|Adverse Event|2|||
33152686|NCT01904058|100472934|FG001|Overall Study|Adverse Event|0|||
33152687|NCT01904058|100472935|FG002|Overall Study|Adverse Event|0|||
33152688|NCT01904058|100472936|FG003|Overall Study|Adverse Event|0|||
33152689|NCT01904058|100472933|FG000|Overall Study|Withdrawal by Subject|1|||
33152690|NCT01904058|100472934|FG001|Overall Study|Withdrawal by Subject|0|||
33152691|NCT01904058|100472935|FG002|Overall Study|Withdrawal by Subject|1|||
33152692|NCT01904058|100472936|FG003|Overall Study|Withdrawal by Subject|0|||
33152693|NCT01904058|100472933|FG000|Overall Study|Pregnancy|0|||
33152694|NCT01904058|100472934|FG001|Overall Study|Pregnancy|0|||
33152695|NCT01904058|100472935|FG002|Overall Study|Pregnancy|0|||
33152696|NCT01904058|100472936|FG003|Overall Study|Pregnancy|1|||
33152697|NCT04416633|100472939|FG000|Overall Study|Death|1|||
33152698|NCT04416633|100472939|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
33152699|NCT04416633|100472939|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
33152700|NCT04416633|100472939|FG000|Overall Study|Adverse Event|6|||
33152701|NCT04416633|100472939|FG000|Overall Study|Withdrawal by Subject|6|||
33152702|NCT00736957|100472940|FG000|Overall Study|Adverse Event|43|||
33152703|NCT00736957|100472940|FG000|Overall Study|Withdrawal by Subject|49|||
33250513|NCT00487578|100817775|FG000|Overall Study|Lack of Efficacy|0|||
33250514|NCT00487578|100817776|FG001|Overall Study|Lack of Efficacy|1|||
33250515|NCT00487578|100817775|FG000|Overall Study|Lost to Follow-up|0|||
33250516|NCT00487578|100817776|FG001|Overall Study|Lost to Follow-up|1|||
33250517|NCT00208767|100817777|FG000|Overall Study|Adverse Event|9|||
33152704|NCT00736957|100472940|FG000|Overall Study|violation of eligibility criteria|2|||
33152705|NCT00736957|100472940|FG000|Overall Study|did not attend hospital appointments|1|||
33152706|NCT00736957|100472940|FG000|Overall Study|not eligible for Treatment Period I|22|||
33152707|NCT00736957|100472940|FG000|Overall Study|Physician Decision|5|||
33152708|NCT03516812|100472942|FG000|Overall Study|Adverse Event|4|||
33250518|NCT00208767|100817778|FG001|Overall Study|Adverse Event|1|||
33250519|NCT00208767|100817777|FG000|Overall Study|Withdrawal by Subject|14|||
33250520|NCT00208767|100817778|FG001|Overall Study|Withdrawal by Subject|3|||
33250521|NCT00208767|100817777|FG000|Overall Study|Death|1|||
33250522|NCT00208767|100817778|FG001|Overall Study|Death|0|||
33250523|NCT00208767|100817777|FG000|Overall Study|Lost to Follow-up|3|||
33250524|NCT00208767|100817778|FG001|Overall Study|Lost to Follow-up|3|||
33250525|NCT00972504|100817780|FG000|Overall Study|Adverse Event|2|||
33250526|NCT00972504|100817780|FG000|Overall Study|Investigator discretion|1|||
33250527|NCT02674750|100817784|FG000|Overall Study|Death|4|||
33250528|NCT02674750|100817785|FG001|Overall Study|Death|5|||
33250529|NCT02674750|100817786|FG002|Overall Study|Death|8|||
33250530|NCT02674750|100817784|FG000|Overall Study|Lost to Follow-up|0|||
33250531|NCT02674750|100817785|FG001|Overall Study|Lost to Follow-up|8|||
33250532|NCT02674750|100817786|FG002|Overall Study|Lost to Follow-up|0|||
33250533|NCT02674750|100817784|FG000|Overall Study|Lack of Efficacy|1|||
33250534|NCT02674750|100817785|FG001|Overall Study|Lack of Efficacy|17|||
33250535|NCT02674750|100817786|FG002|Overall Study|Lack of Efficacy|3|||
33250536|NCT02674750|100817784|FG000|Overall Study|Withdrawal by Subject|0|||
33250537|NCT02674750|100817785|FG001|Overall Study|Withdrawal by Subject|7|||
33250538|NCT02674750|100817786|FG002|Overall Study|Withdrawal by Subject|1|||
33250539|NCT02674750|100817784|FG000|Overall Study|Other|0|||
33250540|NCT02674750|100817785|FG001|Overall Study|Other|8|||
33250541|NCT02674750|100817786|FG002|Overall Study|Other|0|||
33250542|NCT01123083|100817787|FG000|Overall Study|Investigator recommendation|1|||
33250543|NCT01123083|100817788|FG001|Overall Study|Investigator recommendation|1|||
33436831|NCT03500484|101492547|FG001|Overall Study|Physician Decision|0|||
33250544|NCT01123083|100817787|FG000|Overall Study|Administrative reasons|0|||
33250545|NCT01123083|100817788|FG001|Overall Study|Administrative reasons|4|||
33250546|NCT01123083|100817787|FG000|Overall Study|Lost to Follow-up|2|||
33250547|NCT01123083|100817788|FG001|Overall Study|Lost to Follow-up|6|||
33250548|NCT01123083|100817787|FG000|Overall Study|Adverse Event|1|||
33250549|NCT01123083|100817788|FG001|Overall Study|Adverse Event|0|||
33250550|NCT01123083|100817787|FG000|Overall Study|Withdrew for another reason not covered|0|||
33250551|NCT01123083|100817788|FG001|Overall Study|Withdrew for another reason not covered|1|||
33250552|NCT01123083|100817787|FG000|Overall Study|Participant/legal representative request|7|||
33250553|NCT01123083|100817788|FG001|Overall Study|Participant/legal representative request|3|||
33250554|NCT00919763|100817793|FG000|Overall Study|Adverse Event|7|||
33250555|NCT00919763|100817794|FG001|Overall Study|Adverse Event|1|||
33250556|NCT00919763|100817793|FG000|Overall Study|Lost to Follow-up|1|||
33386549|NCT01253187|101302562|FG005|Period 3|Pregnancy|0|||
33386550|NCT01253187|101302557|FG000|Period 3|difficulty with blood sampling|0|||
33436832|NCT03500484|101492546|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
33436833|NCT03500484|101492547|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
33436834|NCT00421174|101492548|FG000|Overall Study|Withdrawal by Subject|0|||
33436835|NCT00421174|101492549|FG001|Overall Study|Withdrawal by Subject|1|||
33436836|NCT00421174|101492548|FG000|Overall Study|Ineligible due to infection|2|||
33436837|NCT00421174|101492549|FG001|Overall Study|Ineligible due to infection|0|||
33436838|NCT00175019|101492550|FG000|Overall Study|Adverse Event|54|||
33250557|NCT00919763|100817794|FG001|Overall Study|Lost to Follow-up|0|||
33250558|NCT00919763|100817793|FG000|Overall Study|Protocol Violation|1|||
33250559|NCT00919763|100817794|FG001|Overall Study|Protocol Violation|1|||
33250560|NCT00919763|100817793|FG000|Overall Study|Withdrawal by Subject|3|||
33250561|NCT00919763|100817794|FG001|Overall Study|Withdrawal by Subject|1|||
33250562|NCT00919763|100817793|FG000|Overall Study|Non-compliance|0|||
33250563|NCT00919763|100817794|FG001|Overall Study|Non-compliance|1|||
33386551|NCT01253187|101302558|FG001|Period 3|difficulty with blood sampling|1|||
33386552|NCT01253187|101302559|FG002|Period 3|difficulty with blood sampling|0|||
33386553|NCT01253187|101302560|FG003|Period 3|difficulty with blood sampling|0|||
33386554|NCT01253187|101302561|FG004|Period 3|difficulty with blood sampling|0|||
33386555|NCT01253187|101302562|FG005|Period 3|difficulty with blood sampling|0|||
33386556|NCT01253187|101302557|FG000|Period 3|non-compliance|0|||
33386557|NCT01253187|101302558|FG001|Period 3|non-compliance|0|||
33386558|NCT01253187|101302559|FG002|Period 3|non-compliance|0|||
33386559|NCT01253187|101302560|FG003|Period 3|non-compliance|0|||
33386560|NCT01253187|101302561|FG004|Period 3|non-compliance|1|||
33386561|NCT01253187|101302562|FG005|Period 3|non-compliance|0|||
33436839|NCT00175019|101492551|FG001|Overall Study|Adverse Event|22|||
33250564|NCT04860258|100817798|FG000|Overall Study|Withdrawal by Subject|0|||
33250565|NCT04860258|100817799|FG001|Overall Study|Withdrawal by Subject|0|||
33386562|NCT00351819|101302565|FG000|Overall Study|Lost to Follow-up|4|||
33386563|NCT00351819|101302566|FG001|Overall Study|Lost to Follow-up|4|||
33386564|NCT00351819|101302565|FG000|Overall Study|Withdrawal by Subject|0|||
33386565|NCT00351819|101302566|FG001|Overall Study|Withdrawal by Subject|4|||
33386566|NCT00351819|101302565|FG000|Overall Study|Elevated PSA|1|||
33386567|NCT00351819|101302566|FG001|Overall Study|Elevated PSA|1|||
33250566|NCT04860258|100817800|FG002|Overall Study|Withdrawal by Subject|4|||
33250567|NCT04860258|100817801|FG003|Overall Study|Withdrawal by Subject|1|||
33386568|NCT00351819|101302565|FG000|Overall Study|Traumatic ankle fracture|1|||
33436840|NCT00175019|101492552|FG002|Overall Study|Adverse Event|2|||
33436841|NCT00175019|101492550|FG000|Overall Study|Protocol Violation|6|||
33436842|NCT00175019|101492551|FG001|Overall Study|Protocol Violation|3|||
33436843|NCT00175019|101492552|FG002|Overall Study|Protocol Violation|3|||
33436844|NCT00175019|101492550|FG000|Overall Study|Lost to Follow-up|42|||
33436845|NCT00175019|101492551|FG001|Overall Study|Lost to Follow-up|39|||
33436846|NCT00175019|101492552|FG002|Overall Study|Lost to Follow-up|9|||
33436847|NCT00175019|101492550|FG000|Overall Study|Did not continue under Amendment 4|1|||
33436848|NCT00175019|101492551|FG001|Overall Study|Did not continue under Amendment 4|1|||
33436849|NCT00175019|101492552|FG002|Overall Study|Did not continue under Amendment 4|2|||
33436850|NCT00175019|101492550|FG000|Overall Study|Personal Reason(s)|39|||
33436851|NCT00175019|101492551|FG001|Overall Study|Personal Reason(s)|31|||
33436852|NCT00175019|101492552|FG002|Overall Study|Personal Reason(s)|8|||
33436853|NCT00175019|101492550|FG000|Overall Study|Therapeutic Failure|10|||
33436854|NCT00175019|101492551|FG001|Overall Study|Therapeutic Failure|38|||
33436855|NCT00175019|101492552|FG002|Overall Study|Therapeutic Failure|22|||
33436856|NCT00175019|101492550|FG000|Overall Study|Gout Flare|2|||
33436857|NCT00175019|101492551|FG001|Overall Study|Gout Flare|3|||
33436858|NCT00175019|101492552|FG002|Overall Study|Gout Flare|0|||
33436859|NCT00175019|101492550|FG000|Overall Study|Reason Not Specified|40|||
33436860|NCT00175019|101492551|FG001|Overall Study|Reason Not Specified|34|||
33436861|NCT00175019|101492552|FG002|Overall Study|Reason Not Specified|11|||
33436862|NCT03655106|101492553|FG000|Overall Study|Withdrawal by Subject|3|||
33436863|NCT03655106|101492554|FG001|Overall Study|Withdrawal by Subject|2|||
33436864|NCT03655106|101492553|FG000|Overall Study|Lost to Follow-up|2|||
33436865|NCT03655106|101492554|FG001|Overall Study|Lost to Follow-up|1|||
33436866|NCT03655106|101492553|FG000|Overall Study|Duplicate Enrollment|1|||
33436867|NCT03655106|101492554|FG001|Overall Study|Duplicate Enrollment|1|||
33436868|NCT03655106|101492553|FG000|Overall Study|Protocol Violation|3|||
33386569|NCT00351819|101302566|FG001|Overall Study|Traumatic ankle fracture|0|||
33386570|NCT00351819|101302565|FG000|Overall Study|Unprofessional behavior|1|||
33386571|NCT00351819|101302566|FG001|Overall Study|Unprofessional behavior|0|||
33386572|NCT00351819|101302565|FG000|Overall Study|Non-compliance|0|||
33386573|NCT00351819|101302566|FG001|Overall Study|Non-compliance|1|||
33386574|NCT00351819|101302565|FG000|Overall Study|Incarcerated|0|||
33386575|NCT00351819|101302566|FG001|Overall Study|Incarcerated|1|||
33386576|NCT00351819|101302565|FG000|Overall Study|Enrolled in another trial|0|||
33386577|NCT00351819|101302566|FG001|Overall Study|Enrolled in another trial|1|||
33386578|NCT01125293|101302567|FG000|Overall Study|Disease Progression|1|||
33386579|NCT01125293|101302568|FG001|Overall Study|Disease Progression|3|||
33386580|NCT01125293|101302569|FG002|Overall Study|Disease Progression|4|||
33386581|NCT01125293|101302570|FG003|Overall Study|Disease Progression|3|||
33386582|NCT01125293|101302571|FG004|Overall Study|Disease Progression|5|||
33386583|NCT01125293|101302572|FG005|Overall Study|Disease Progression|12|||
33436869|NCT03655106|101492554|FG001|Overall Study|Protocol Violation|0|||
33436870|NCT00576381|101492555|FG000|Overall Study|Reoperation|3|||
33436871|NCT00576381|101492555|FG000|Overall Study|Adverse Event|4|||
33436872|NCT01315249|101492556|FG000|Overall Study|Adverse Event|22|||
33436873|NCT01315249|101492557|FG001|Overall Study|Adverse Event|26|||
33436874|NCT01315249|101492556|FG000|Overall Study|Withdrawal by Subject|11|||
33436875|NCT01315249|101492557|FG001|Overall Study|Withdrawal by Subject|10|||
33436876|NCT01315249|101492556|FG000|Overall Study|Protocol Violation|8|||
33436877|NCT01315249|101492557|FG001|Overall Study|Protocol Violation|5|||
33436878|NCT01315249|101492556|FG000|Overall Study|Abnormal test results|1|||
33436879|NCT01315249|101492557|FG001|Overall Study|Abnormal test results|2|||
33436880|NCT01315249|101492556|FG000|Overall Study|Administrative problems|1|||
33386584|NCT01125293|101302567|FG000|Overall Study|Adverse Event|1|||
33386585|NCT01125293|101302568|FG001|Overall Study|Adverse Event|0|||
33386586|NCT01125293|101302569|FG002|Overall Study|Adverse Event|0|||
33386587|NCT01125293|101302570|FG003|Overall Study|Adverse Event|0|||
33436881|NCT01315249|101492557|FG001|Overall Study|Administrative problems|0|||
33436882|NCT01315249|101492556|FG000|Overall Study|inability to use device|1|||
33436883|NCT01315249|101492557|FG001|Overall Study|inability to use device|0|||
33436884|NCT01315249|101492556|FG000|Overall Study|Lack of Efficacy|0|||
33436885|NCT01315249|101492557|FG001|Overall Study|Lack of Efficacy|1|||
33436886|NCT01315249|101492556|FG000|Overall Study|Lost to Follow-up|0|||
33436887|NCT01315249|101492557|FG001|Overall Study|Lost to Follow-up|2|||
33436888|NCT01315249|101492556|FG000|Overall Study|Death|0|||
33436889|NCT01315249|101492557|FG001|Overall Study|Death|1|||
33436890|NCT01089647|101492558|FG000|Overall Study|Lost to Follow-up|2|||
33436891|NCT01089647|101492559|FG001|Overall Study|Lost to Follow-up|2|||
33436892|NCT01089647|101492558|FG000|Overall Study|Withdrawal by Subject|2|||
33436893|NCT01089647|101492559|FG001|Overall Study|Withdrawal by Subject|1|||
33436894|NCT01089647|101492558|FG000|Overall Study|Adverse Event|0|||
33436895|NCT01089647|101492559|FG001|Overall Study|Adverse Event|1|||
33436896|NCT02603952|101492569|FG000|Overall Study|Withdrawal by Subject|1|||
33386588|NCT01125293|101302571|FG004|Overall Study|Adverse Event|2|||
33436897|NCT02603952|101492570|FG001|Overall Study|Withdrawal by Subject|0|||
33436898|NCT02603952|101492571|FG002|Overall Study|Withdrawal by Subject|0|||
33250568|NCT04860258|100817802|FG004|Overall Study|Withdrawal by Subject|4|||
33250569|NCT04860258|100817803|FG005|Overall Study|Withdrawal by Subject|1|||
33250570|NCT04860258|100817804|FG006|Overall Study|Withdrawal by Subject|0|||
33250571|NCT02486588|100817805|FG000|Overall Study|Randomized in error- ineligible|738|||
33250572|NCT02486588|100817806|FG001|Overall Study|Randomized in error- ineligible|750|||
33250573|NCT02486588|100817807|FG002|Overall Study|Randomized in error- ineligible|755|||
33250574|NCT02486588|100817808|FG003|Overall Study|Randomized in error- ineligible|738|||
33250575|NCT02486588|100817809|FG004|Overall Study|Randomized in error- ineligible|746|||
33250576|NCT02486588|100817810|FG005|Overall Study|Randomized in error- ineligible|746|||
33250577|NCT02299336|100817815|FG000|Overall Study|Withdrawal by Subject|11|||
33250578|NCT02299336|100817815|FG000|Overall Study|Adverse Event|1|||
33250579|NCT02299336|100817815|FG000|Overall Study|Death|1|||
33250580|NCT02299336|100817815|FG000|Overall Study|Lost to Follow-up|1|||
33250581|NCT04072822|100817820|FG000|Treatment|Adverse Event|9|||
33250582|NCT04072822|100817821|FG001|Treatment|Adverse Event|5|||
33250583|NCT04072822|100817820|FG000|Treatment|Met Stopping Criteria|13|||
33250584|NCT04072822|100817821|FG001|Treatment|Met Stopping Criteria|24|||
33250585|NCT04072822|100817820|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
33250586|NCT04072822|100817821|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
33250587|NCT04072822|100817820|FG000|Treatment|Withdrawal by Subject|0|||
33250588|NCT04072822|100817821|FG001|Treatment|Withdrawal by Subject|2|||
33250589|NCT04072822|100817820|FG000|Treatment|Death|0|||
33250590|NCT04072822|100817821|FG001|Treatment|Death|2|||
33250591|NCT04072822|100817820|FG000|Treatment|Lost to Follow-up|11|||
33250592|NCT04072822|100817821|FG001|Treatment|Lost to Follow-up|3|||
33250593|NCT04072822|100817820|FG000|Treatment|Physician Decision|1|||
33250594|NCT04072822|100817821|FG001|Treatment|Physician Decision|0|||
33250595|NCT04072822|100817820|FG000|Treatment|Other|7|||
33250596|NCT04072822|100817821|FG001|Treatment|Other|9|||
33250597|NCT04072822|100817820|FG000|Follow-up|Withdrawal by Subject|1|||
33250598|NCT04072822|100817821|FG001|Follow-up|Withdrawal by Subject|0|||
33250599|NCT04072822|100817820|FG000|Follow-up|Lost to Follow-up|5|||
33250600|NCT04072822|100817821|FG001|Follow-up|Lost to Follow-up|4|||
33250601|NCT00762463|100817822|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
33250602|NCT00762463|100817823|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
33250603|NCT00762463|100817824|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
33250604|NCT00762463|100817825|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
33250605|NCT00762463|100817822|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
33250606|NCT00762463|100817823|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
33250607|NCT00762463|100817824|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
33250608|NCT00762463|100817825|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
33250609|NCT00762463|100817822|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
33250610|NCT00762463|100817823|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
33250611|NCT00762463|100817824|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
33250612|NCT00762463|100817825|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
33152709|NCT03516812|100472942|FG000|Overall Study|Lack of Efficacy|2|||
33152710|NCT04697056|100472944|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
33152711|NCT04697056|100472945|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
33152712|NCT01642407|100472946|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
33152713|NCT01642407|100472946|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
33152714|NCT01642407|100472946|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
33152715|NCT01066000|100472949|FG000|Overall Study|Protocol Violation|4|||
33152716|NCT01066000|100472949|FG000|Overall Study|Death|3|||
33152717|NCT01066000|100472949|FG000|Overall Study|Withdrawal by Subject|1|||
33152718|NCT01066000|100472949|FG000|Overall Study|Adverse Event|1|||
33152719|NCT02955797|100472952|FG000|Overall Study|Protocol Violation|1|||
33152720|NCT02955797|100472953|FG001|Overall Study|Protocol Violation|0|||
33152721|NCT02955797|100472954|FG002|Overall Study|Protocol Violation|0|||
33152722|NCT02955797|100472955|FG003|Overall Study|Protocol Violation|1|||
33152723|NCT02955797|100472952|FG000|Overall Study|Withdrawal by Subject|2|||
33152724|NCT02955797|100472953|FG001|Overall Study|Withdrawal by Subject|2|||
33152725|NCT02955797|100472954|FG002|Overall Study|Withdrawal by Subject|0|||
33152726|NCT02955797|100472955|FG003|Overall Study|Withdrawal by Subject|1|||
33152727|NCT02955797|100472952|FG000|Overall Study|Lost to Follow-up|0|||
33152728|NCT02955797|100472953|FG001|Overall Study|Lost to Follow-up|1|||
33152729|NCT02955797|100472954|FG002|Overall Study|Lost to Follow-up|0|||
33152730|NCT02955797|100472955|FG003|Overall Study|Lost to Follow-up|0|||
33152731|NCT04043728|100472956|FG000|Overall Study|Lost to Follow-up|1|||
33152732|NCT04043728|100472957|FG001|Overall Study|Lost to Follow-up|2|||
33152733|NCT04043728|100472958|FG002|Overall Study|Lost to Follow-up|0|||
33152734|NCT05490771|100472959|FG000|Overall Study|Disease progression|18|||
33152735|NCT05490771|100472959|FG000|Overall Study|Adverse Event|3|||
33152736|NCT05490771|100472959|FG000|Overall Study|Other complicating disease|1|||
33152737|NCT05490771|100472959|FG000|Overall Study|Withdrawal by Subject|3|||
33436899|NCT02603952|101492572|FG003|Overall Study|Withdrawal by Subject|0|||
33436900|NCT02603952|101492569|FG000|Overall Study|Received oseltamivir by error|0|||
33436901|NCT02603952|101492570|FG001|Overall Study|Received oseltamivir by error|0|||
33436902|NCT02603952|101492571|FG002|Overall Study|Received oseltamivir by error|0|||
33250613|NCT00762463|100817822|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
33250614|NCT00762463|100817823|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
33250615|NCT00762463|100817824|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
33250616|NCT00762463|100817825|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
33250617|NCT00762463|100817822|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
33250618|NCT00762463|100817823|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
33250619|NCT00762463|100817824|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
33250620|NCT00762463|100817825|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
33250621|NCT00762463|100817822|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
33250622|NCT00762463|100817823|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
33250623|NCT00762463|100817824|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
33250624|NCT00762463|100817825|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
33250625|NCT00762463|100817822|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
33250626|NCT00762463|100817823|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
33250627|NCT00762463|100817824|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
33386589|NCT01125293|101302572|FG005|Overall Study|Adverse Event|8|||
33386590|NCT01125293|101302567|FG000|Overall Study|Symptomatic Deterioration|1|||
33386591|NCT01125293|101302568|FG001|Overall Study|Symptomatic Deterioration|0|||
33386592|NCT01125293|101302569|FG002|Overall Study|Symptomatic Deterioration|0|||
33386593|NCT01125293|101302570|FG003|Overall Study|Symptomatic Deterioration|0|||
33386594|NCT01125293|101302571|FG004|Overall Study|Symptomatic Deterioration|0|||
33386595|NCT01125293|101302572|FG005|Overall Study|Symptomatic Deterioration|0|||
33152738|NCT05490771|100472959|FG000|Overall Study|Physician Decision|1|||
33152739|NCT05490771|100472959|FG000|Overall Study|Still on treatment|2|||
33152740|NCT05490771|100472959|FG000|Overall Study|Never start protocol therapy|5|||
33152741|NCT05490771|100472959|FG000|Overall Study|Ineligible|2|||
33152742|NCT03078907|100472960|FG000|Overall Study|Adverse Event|2|||
33152743|NCT03078907|100472961|FG001|Overall Study|Adverse Event|0|||
33386596|NCT01125293|101302567|FG000|Overall Study|Death|0|||
33386597|NCT01125293|101302568|FG001|Overall Study|Death|0|||
33386598|NCT01125293|101302569|FG002|Overall Study|Death|0|||
33386599|NCT01125293|101302570|FG003|Overall Study|Death|0|||
33386600|NCT01125293|101302571|FG004|Overall Study|Death|1|||
33386601|NCT01125293|101302572|FG005|Overall Study|Death|0|||
33386602|NCT01125293|101302567|FG000|Overall Study|Withdrawal by Subject|0|||
33386603|NCT01125293|101302568|FG001|Overall Study|Withdrawal by Subject|0|||
33386604|NCT01125293|101302569|FG002|Overall Study|Withdrawal by Subject|0|||
33386605|NCT01125293|101302570|FG003|Overall Study|Withdrawal by Subject|0|||
33386606|NCT01125293|101302571|FG004|Overall Study|Withdrawal by Subject|2|||
33386607|NCT01125293|101302572|FG005|Overall Study|Withdrawal by Subject|1|||
33386608|NCT01125293|101302567|FG000|Overall Study|Physician Decision|0|||
33386609|NCT01125293|101302568|FG001|Overall Study|Physician Decision|0|||
33386610|NCT01125293|101302569|FG002|Overall Study|Physician Decision|0|||
33436903|NCT02603952|101492572|FG003|Overall Study|Received oseltamivir by error|1|||
33436904|NCT01506947|101492573|FG000|Overall Study|Lost to Follow-up|7|||
33152744|NCT03078907|100472960|FG000|Overall Study|Other|1|||
33250628|NCT00762463|100817825|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
33250629|NCT00762463|100817822|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
33250630|NCT00762463|100817823|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
33250631|NCT00762463|100817824|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
33250632|NCT00762463|100817825|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
33250633|NCT01697319|100817827|FG000|Primary Phase|Withdrawal by Subject|1|||
33250634|NCT01697319|100817827|FG000|Extension Phase|Terminated by Sponsor|15|||
33250635|NCT02482233|100817828|FG000|Overall Study|Lost to Follow-up|1|||
33250636|NCT02482233|100817829|FG001|Overall Study|Lost to Follow-up|1|||
33250637|NCT03418324|100817830|FG000|Overall Study|Death|0|||
33250638|NCT03418324|100817831|FG001|Overall Study|Death|1|||
33250639|NCT03418324|100817830|FG000|Overall Study|Physician Decision|1|||
33250640|NCT03418324|100817831|FG001|Overall Study|Physician Decision|1|||
33250641|NCT01693614|100817834|FG000|Overall Study|Adverse Event|7|||
33250642|NCT01693614|100817835|FG001|Overall Study|Adverse Event|11|||
33250643|NCT01693614|100817836|FG002|Overall Study|Adverse Event|5|||
33250644|NCT01693614|100817834|FG000|Overall Study|Disease progression|11|||
33250645|NCT01693614|100817835|FG001|Overall Study|Disease progression|8|||
33250646|NCT01693614|100817836|FG002|Overall Study|Disease progression|7|||
33250647|NCT01693614|100817834|FG000|Overall Study|Protocol Violation|5|||
33250648|NCT01693614|100817835|FG001|Overall Study|Protocol Violation|2|||
33250649|NCT01693614|100817836|FG002|Overall Study|Protocol Violation|1|||
33250650|NCT01693614|100817834|FG000|Overall Study|Death|1|||
33250651|NCT01693614|100817835|FG001|Overall Study|Death|0|||
33250652|NCT01693614|100817836|FG002|Overall Study|Death|0|||
33250653|NCT01693614|100817834|FG000|Overall Study|Physician Decision|1|||
33250654|NCT01693614|100817835|FG001|Overall Study|Physician Decision|1|||
33250655|NCT01693614|100817836|FG002|Overall Study|Physician Decision|4|||
33250656|NCT01693614|100817834|FG000|Overall Study|Withdrawal by subject/guardian|0|||
33250657|NCT01693614|100817835|FG001|Overall Study|Withdrawal by subject/guardian|0|||
33250658|NCT01693614|100817836|FG002|Overall Study|Withdrawal by subject/guardian|2|||
33250659|NCT01693614|100817834|FG000|Overall Study|Withdrawal by Subject|1|||
33250660|NCT01693614|100817835|FG001|Overall Study|Withdrawal by Subject|0|||
33250661|NCT01693614|100817836|FG002|Overall Study|Withdrawal by Subject|5|||
33250662|NCT01981850|100817837|FG000|Main Phase Stage 1|Death|2|||
33250663|NCT01981850|100817838|FG001|Main Phase Stage 1|Death|0|||
33250664|NCT01981850|100817839|FG002|Main Phase Stage 1|Death|0|||
33386611|NCT01125293|101302570|FG003|Overall Study|Physician Decision|0|||
33386612|NCT01125293|101302571|FG004|Overall Study|Physician Decision|0|||
33386613|NCT01125293|101302572|FG005|Overall Study|Physician Decision|2|||
33386614|NCT00425100|101302574|FG000|Overall Study|Adverse Event|36|||
33386615|NCT00425100|101302574|FG000|Overall Study|Lack of Efficacy|4|||
33386616|NCT00425100|101302574|FG000|Overall Study|Lost to Follow-up|2|||
33386617|NCT00425100|101302574|FG000|Overall Study|Protocol Violation|4|||
33386618|NCT00425100|101302574|FG000|Overall Study|Withdrawal by Subject|7|||
33386619|NCT03365947|101302575|FG000|Overall Study|Lost to Follow-up|0|||
33386620|NCT03365947|101302576|FG001|Overall Study|Lost to Follow-up|0|||
33386621|NCT03365947|101302577|FG002|Overall Study|Lost to Follow-up|0|||
33386622|NCT03365947|101302578|FG003|Overall Study|Lost to Follow-up|0|||
33250665|NCT01981850|100817840|FG003|Main Phase Stage 1|Death|0|||
33386623|NCT03365947|101302579|FG004|Overall Study|Lost to Follow-up|0|||
33250666|NCT01981850|100817841|FG004|Main Phase Stage 1|Death|0|||
33250667|NCT01981850|100817842|FG005|Main Phase Stage 1|Death|0|||
33250668|NCT01981850|100817843|FG006|Main Phase Stage 1|Death|0|||
33250669|NCT01981850|100817844|FG007|Main Phase Stage 1|Death|0|||
33250670|NCT01981850|100817845|FG008|Main Phase Stage 1|Death|0|||
33386624|NCT03365947|101302580|FG005|Overall Study|Lost to Follow-up|1|||
33436905|NCT01506947|101492573|FG000|Overall Study|Adverse Event|5|||
33250671|NCT01981850|100817846|FG009|Main Phase Stage 1|Death|0|||
33250672|NCT01981850|100817837|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
33250673|NCT01981850|100817838|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33386625|NCT03365947|101302581|FG006|Overall Study|Lost to Follow-up|0|||
33250674|NCT01981850|100817839|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33250675|NCT01981850|100817840|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33250676|NCT01981850|100817841|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33250677|NCT01981850|100817842|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33250678|NCT01981850|100817843|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33436906|NCT01506947|101492573|FG000|Overall Study|Death|1|||
33436907|NCT01506947|101492573|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
33436908|NCT03331042|101492574|FG000|Overall Study|Protocol Violation|1|||
33436909|NCT03331042|101492575|FG001|Overall Study|Protocol Violation|0|||
33436910|NCT03331042|101492576|FG002|Overall Study|Protocol Violation|0|||
33436911|NCT03331042|101492577|FG003|Overall Study|Protocol Violation|0|||
33436912|NCT03331042|101492574|FG000|Overall Study|Physician Decision|0|||
33436913|NCT03331042|101492575|FG001|Overall Study|Physician Decision|0|||
33436914|NCT03331042|101492576|FG002|Overall Study|Physician Decision|1|||
33436915|NCT03331042|101492577|FG003|Overall Study|Physician Decision|0|||
33436916|NCT03331042|101492574|FG000|Overall Study|Lost to Follow-up|0|||
33436917|NCT03331042|101492575|FG001|Overall Study|Lost to Follow-up|0|||
33436918|NCT03331042|101492576|FG002|Overall Study|Lost to Follow-up|0|||
33436919|NCT03331042|101492577|FG003|Overall Study|Lost to Follow-up|1|||
33436920|NCT01400425|101492578|FG000|Overall Study|Withdrawal by Subject|10|||
33436921|NCT02305758|101492579|FG000|Overall Study|Death|27|||
33436922|NCT02305758|101492580|FG001|Overall Study|Death|27|||
33436923|NCT02305758|101492579|FG000|Overall Study|Withdrew consent|9|||
33436924|NCT02305758|101492580|FG001|Overall Study|Withdrew consent|2|||
33436925|NCT02305758|101492579|FG000|Overall Study|Lost to Follow-up|6|||
33436926|NCT02305758|101492580|FG001|Overall Study|Lost to Follow-up|1|||
33436927|NCT02305758|101492579|FG000|Overall Study|Study Terminated by Sponsor|21|||
33436928|NCT02305758|101492580|FG001|Overall Study|Study Terminated by Sponsor|34|||
33436929|NCT02305758|101492579|FG000|Overall Study|Other, not specified|2|||
33436930|NCT02305758|101492580|FG001|Overall Study|Other, not specified|1|||
33436931|NCT01479439|101492581|FG000|Overall Study|Adverse Event|1|||
33436932|NCT01479439|101492582|FG001|Overall Study|Adverse Event|0|||
33436933|NCT01479439|101492583|FG002|Overall Study|Adverse Event|0|||
33436934|NCT01479439|101492581|FG000|Overall Study|Lost to Follow-up|0|||
33436935|NCT01479439|101492582|FG001|Overall Study|Lost to Follow-up|1|||
33436936|NCT01479439|101492583|FG002|Overall Study|Lost to Follow-up|0|||
33250679|NCT01981850|100817844|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33250680|NCT01981850|100817845|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33436937|NCT01479439|101492581|FG000|Overall Study|Protocol Violation|0|||
33436938|NCT01479439|101492582|FG001|Overall Study|Protocol Violation|0|||
33436939|NCT01479439|101492583|FG002|Overall Study|Protocol Violation|2|||
33436940|NCT03311646|101492584|FG000|Overall Study|Physician Decision|1|||
33436941|NCT03311646|101492584|FG000|Overall Study|Withdrawal by Subject|5|||
33436942|NCT03311646|101492584|FG000|Overall Study|Lost to Follow-up|5|||
33250681|NCT01981850|100817846|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
33250682|NCT01981850|100817837|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
33250683|NCT01981850|100817838|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
33250684|NCT01981850|100817839|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
33250685|NCT01981850|100817840|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
33436943|NCT03311646|101492584|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
33436944|NCT01179048|101492586|FG000|Overall Study|Withdrawn - does not allow contact|4|||
33436945|NCT01179048|101492587|FG001|Overall Study|Withdrawn - does not allow contact|8|||
33436946|NCT01179048|101492586|FG000|Overall Study|Lost to Follow-up|8|||
33436947|NCT01179048|101492587|FG001|Overall Study|Lost to Follow-up|9|||
33436948|NCT01179048|101492586|FG000|Overall Study|Alive|127|||
33436949|NCT01179048|101492587|FG001|Overall Study|Alive|142|||
33436950|NCT01658943|101492588|FG000|Overall Study|Adverse Event|6|||
33436951|NCT01658943|101492589|FG001|Overall Study|Adverse Event|13|||
33436952|NCT01658943|101492588|FG000|Overall Study|Withdrawal by Subject|9|||
33436953|NCT01658943|101492589|FG001|Overall Study|Withdrawal by Subject|2|||
33436954|NCT01658943|101492588|FG000|Overall Study|Progression/Relapse|39|||
33436955|NCT01658943|101492589|FG001|Overall Study|Progression/Relapse|40|||
33436956|NCT01658943|101492588|FG000|Overall Study|Death|4|||
33436957|NCT01658943|101492589|FG001|Overall Study|Death|2|||
33436958|NCT01658943|101492588|FG000|Overall Study|not protocol specified|4|||
33250686|NCT01981850|100817841|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
33250687|NCT01981850|100817842|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
33436959|NCT01658943|101492589|FG001|Overall Study|not protocol specified|1|||
33436960|NCT01658943|101492588|FG000|Overall Study|Not eligible|7|||
33436961|NCT01658943|101492589|FG001|Overall Study|Not eligible|9|||
33436962|NCT01658943|101492588|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
33436963|NCT01658943|101492589|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
33436964|NCT00723554|101492590|FG000|Overall Study|Adverse Event|12|||
33436965|NCT00723554|101492590|FG000|Overall Study|Investigator's judgement|5|||
33436966|NCT00723554|101492590|FG000|Overall Study|Inhaled medication other than iloprost|4|||
33436967|NCT00723554|101492590|FG000|Overall Study|Withdrawal of consent|3|||
33436968|NCT00723554|101492590|FG000|Overall Study|Other|3|||
33436969|NCT00723554|101492590|FG000|Overall Study|Lost to Follow-up|1|||
33436970|NCT00723554|101492590|FG000|Overall Study|Non-compliance|1|||
33436971|NCT00520741|101492597|FG000|Overall Study|Adverse Event|16|||
33436972|NCT00520741|101492598|FG001|Overall Study|Adverse Event|56|||
33436973|NCT00520741|101492597|FG000|Overall Study|Lack of Efficacy|11|||
33436974|NCT00520741|101492598|FG001|Overall Study|Lack of Efficacy|30|||
33436975|NCT00520741|101492597|FG000|Overall Study|Withdrawal by Subject|0|||
33436976|NCT00520741|101492598|FG001|Overall Study|Withdrawal by Subject|11|||
33436977|NCT00520741|101492597|FG000|Overall Study|Protocol Violation|2|||
33436978|NCT00520741|101492598|FG001|Overall Study|Protocol Violation|15|||
33436979|NCT00520741|101492597|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
33436980|NCT00520741|101492598|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
33436981|NCT00520741|101492597|FG000|Overall Study|Lost to Follow-up|4|||
33436982|NCT00520741|101492598|FG001|Overall Study|Lost to Follow-up|4|||
33436983|NCT00520741|101492597|FG000|Overall Study|Other reasons for premature termination|0|||
33436984|NCT00520741|101492598|FG001|Overall Study|Other reasons for premature termination|6|||
33436985|NCT04099888|101492604|FG000|Overall Study|Study terminated by sponsor|9|||
33436986|NCT04099888|101492605|FG001|Overall Study|Study terminated by sponsor|11|||
33436987|NCT04099888|101492604|FG000|Overall Study|Lost to Follow-up|1|||
33436988|NCT04099888|101492605|FG001|Overall Study|Lost to Follow-up|1|||
33436989|NCT04099888|101492604|FG000|Overall Study|Withdrawal by Subject|5|||
33436990|NCT04099888|101492605|FG001|Overall Study|Withdrawal by Subject|6|||
33436991|NCT04099888|101492604|FG000|Overall Study|Death|5|||
33436992|NCT04099888|101492605|FG001|Overall Study|Death|2|||
33436993|NCT04099888|101492604|FG000|Overall Study|Other|1|||
33436994|NCT04099888|101492605|FG001|Overall Study|Other|0|||
33436995|NCT00920140|101492606|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
33250688|NCT01981850|100817843|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
33250689|NCT01981850|100817844|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
33436996|NCT00920140|101492607|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
33436997|NCT00920140|101492608|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
33436998|NCT00920140|101492609|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
33436999|NCT00920140|101492610|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
33250690|NCT01981850|100817845|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
33437000|NCT00920140|101492606|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
33437001|NCT00920140|101492607|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
33437002|NCT00920140|101492608|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
33437003|NCT00920140|101492609|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
33250691|NCT01981850|100817846|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
33152745|NCT03078907|100472961|FG001|Overall Study|Other|0|||
33152746|NCT03078907|100472960|FG000|Overall Study|Protocol Violation|0|||
33152747|NCT03078907|100472961|FG001|Overall Study|Protocol Violation|1|||
33152748|NCT01863953|100472962|FG000|Overall Study|Adverse Event|0|||
33152749|NCT01863953|100472963|FG001|Overall Study|Adverse Event|0|||
33152750|NCT01863953|100472964|FG002|Overall Study|Adverse Event|1|||
33152751|NCT02507973|100472965|FG000|Overall Study|Adverse Event|1|||
33152752|NCT00737438|100472966|FG000|Overall Study|Withdrawal by Subject|2|||
33152753|NCT00737438|100472966|FG000|Overall Study|Patient ineligible|1|||
33152754|NCT02213042|100472967|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
33152755|NCT02213042|100472968|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
33152756|NCT02213042|100472969|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
33152757|NCT02213042|100472967|FG000|Overall Study|Adverse Event|2|||
33152758|NCT02213042|100472968|FG001|Overall Study|Adverse Event|1|||
33152759|NCT02213042|100472969|FG002|Overall Study|Adverse Event|0|||
33386626|NCT03365947|101302582|FG007|Overall Study|Lost to Follow-up|0|||
33152760|NCT02213042|100472967|FG000|Overall Study|Withdrawal by Subject|0|||
33386627|NCT03365947|101302583|FG008|Overall Study|Lost to Follow-up|0|||
33152761|NCT02213042|100472968|FG001|Overall Study|Withdrawal by Subject|1|||
33152762|NCT02213042|100472969|FG002|Overall Study|Withdrawal by Subject|1|||
33152763|NCT02213042|100472967|FG000|Overall Study|Protocol Violation|1|||
33152764|NCT02213042|100472968|FG001|Overall Study|Protocol Violation|0|||
33152765|NCT02213042|100472969|FG002|Overall Study|Protocol Violation|0|||
33152766|NCT02213042|100472967|FG000|Overall Study|Investigator discretion|0|||
33152767|NCT02213042|100472968|FG001|Overall Study|Investigator discretion|0|||
33152768|NCT02213042|100472969|FG002|Overall Study|Investigator discretion|1|||
33152769|NCT03265665|100472970|FG000|24-week Data Collection|Withdrawal by Subject|2|||
33152770|NCT03265665|100472971|FG001|24-week Data Collection|Withdrawal by Subject|2|||
33152771|NCT03265665|100472970|FG000|24-week Data Collection|Lost to Follow-up|4|||
33152772|NCT03265665|100472971|FG001|24-week Data Collection|Lost to Follow-up|5|||
33152773|NCT03265665|100472970|FG000|36-week Data Collection|Lost to Follow-up|6|||
33152774|NCT03265665|100472971|FG001|36-week Data Collection|Lost to Follow-up|8|||
33152775|NCT02791594|100472972|FG000|Overall Study|Physician Decision|2|||
33152776|NCT04810481|100472973|FG000|Overall Study|Disqualified data sets|10|||
33152777|NCT04810481|100472974|FG001|Overall Study|Disqualified data sets|28|||
33152778|NCT01193660|100472977|FG000|Overall Study|Withdrawal by Subject|2|||
33152779|NCT01193660|100472978|FG001|Overall Study|Withdrawal by Subject|3|||
33152780|NCT01193660|100472979|FG002|Overall Study|Withdrawal by Subject|1|||
33152781|NCT01193660|100472977|FG000|Overall Study|Death|1|||
33152782|NCT01193660|100472978|FG001|Overall Study|Death|0|||
33152783|NCT01193660|100472979|FG002|Overall Study|Death|0|||
33152784|NCT01193660|100472977|FG000|Overall Study|Physician Decision|1|||
33152785|NCT01193660|100472978|FG001|Overall Study|Physician Decision|0|||
33152786|NCT01193660|100472979|FG002|Overall Study|Physician Decision|1|||
33152787|NCT02853344|100472980|FG000|Overall Study|Lost to Follow-up|1|||
33152788|NCT02853344|100472981|FG001|Overall Study|Lost to Follow-up|1|||
33152789|NCT02853344|100472980|FG000|Overall Study|Withdrawal by Subject|2|||
33152790|NCT02853344|100472981|FG001|Overall Study|Withdrawal by Subject|4|||
33152791|NCT02853344|100472980|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
33152792|NCT02853344|100472981|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
33152793|NCT02853344|100472980|FG000|Overall Study|Death|70|||
33152794|NCT02853344|100472981|FG001|Overall Study|Death|112|||
33152795|NCT01069627|100472982|FG000|Overall Study|Disease progression|7|||
33152796|NCT01069627|100472982|FG000|Overall Study|Adverse Event|12|||
33152797|NCT01069627|100472982|FG000|Overall Study|Protocol Violation|1|||
33152798|NCT02130024|100472989|FG000|Overall Study|Adverse Event|10|||
33152799|NCT02130024|100472990|FG001|Overall Study|Adverse Event|11|||
33152800|NCT02130024|100472989|FG000|Overall Study|Death|2|||
33152801|NCT02130024|100472990|FG001|Overall Study|Death|2|||
33152802|NCT02130024|100472989|FG000|Overall Study|Lost to Follow-up|1|||
33152803|NCT02130024|100472990|FG001|Overall Study|Lost to Follow-up|1|||
33152804|NCT02130024|100472989|FG000|Overall Study|Physician Decision|1|||
33152805|NCT02130024|100472990|FG001|Overall Study|Physician Decision|3|||
33152806|NCT02130024|100472989|FG000|Overall Study|Protocol Deviation|4|||
33152807|NCT02130024|100472990|FG001|Overall Study|Protocol Deviation|0|||
33152808|NCT02130024|100472989|FG000|Overall Study|Site Administration Problems|1|||
33152809|NCT02130024|100472990|FG001|Overall Study|Site Administration Problems|0|||
33152810|NCT02130024|100472989|FG000|Overall Study|Subject Withdrew Consent|6|||
33152811|NCT02130024|100472990|FG001|Overall Study|Subject Withdrew Consent|14|||
33152812|NCT04635059|100472991|FG000|Overall Study|Study terminated early.|4|||
33152813|NCT01200524|100472999|FG000|Overall Study|Withdrawal by Subject|1|||
33152814|NCT01200524|100473000|FG001|Overall Study|Withdrawal by Subject|1|||
33152815|NCT01200524|100473001|FG002|Overall Study|Withdrawal by Subject|3|||
33152816|NCT01200524|100472999|FG000|Overall Study|Adverse Event|1|||
33152817|NCT01200524|100473000|FG001|Overall Study|Adverse Event|0|||
33152818|NCT01200524|100473001|FG002|Overall Study|Adverse Event|0|||
33152819|NCT01200524|100472999|FG000|Overall Study|Non availability of study nurse|0|||
33152820|NCT01200524|100473000|FG001|Overall Study|Non availability of study nurse|0|||
33152821|NCT01200524|100473001|FG002|Overall Study|Non availability of study nurse|1|||
33152822|NCT04171765|100473006|FG000|Overall Study|Adverse Event|2|||
33437004|NCT00920140|101492610|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
33437005|NCT00920140|101492606|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
33437006|NCT00920140|101492607|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
33152823|NCT04171765|100473007|FG001|Overall Study|Adverse Event|0|||
33152824|NCT04171765|100473008|FG002|Overall Study|Adverse Event|1|||
33152825|NCT04171765|100473009|FG003|Overall Study|Adverse Event|0|||
33152826|NCT04171765|100473006|FG000|Overall Study|Lost to Follow-up|0|||
33152827|NCT04171765|100473007|FG001|Overall Study|Lost to Follow-up|2|||
33152828|NCT04171765|100473008|FG002|Overall Study|Lost to Follow-up|2|||
33152829|NCT04171765|100473009|FG003|Overall Study|Lost to Follow-up|2|||
33152830|NCT04171765|100473006|FG000|Overall Study|Week 58 visit missed|0|||
33152831|NCT04171765|100473007|FG001|Overall Study|Week 58 visit missed|0|||
33152832|NCT04171765|100473008|FG002|Overall Study|Week 58 visit missed|1|||
33152833|NCT04171765|100473009|FG003|Overall Study|Week 58 visit missed|0|||
33152834|NCT04171765|100473006|FG000|Overall Study|Study terminated by sponsor|2|||
33250692|NCT01981850|100817837|FG000|Main Phase Stage 1|Various reasons|0|||
33250693|NCT01981850|100817838|FG001|Main Phase Stage 1|Various reasons|0|||
33250694|NCT01981850|100817839|FG002|Main Phase Stage 1|Various reasons|2|||
33437007|NCT00920140|101492608|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
33250695|NCT01981850|100817840|FG003|Main Phase Stage 1|Various reasons|0|||
33250696|NCT01981850|100817841|FG004|Main Phase Stage 1|Various reasons|0|||
33250697|NCT01981850|100817842|FG005|Main Phase Stage 1|Various reasons|0|||
33250698|NCT01981850|100817843|FG006|Main Phase Stage 1|Various reasons|0|||
33250699|NCT01981850|100817844|FG007|Main Phase Stage 1|Various reasons|0|||
33250700|NCT01981850|100817845|FG008|Main Phase Stage 1|Various reasons|0|||
33250701|NCT01981850|100817846|FG009|Main Phase Stage 1|Various reasons|0|||
33250702|NCT01981850|100817837|FG000|Main Phase Stage 2|Adverse Event|0|||
33250703|NCT01981850|100817838|FG001|Main Phase Stage 2|Adverse Event|0|||
33250704|NCT01981850|100817839|FG002|Main Phase Stage 2|Adverse Event|0|||
33250705|NCT01981850|100817840|FG003|Main Phase Stage 2|Adverse Event|0|||
33386628|NCT03365947|101302584|FG009|Overall Study|Lost to Follow-up|0|||
33386629|NCT03365947|101302585|FG010|Overall Study|Lost to Follow-up|0|||
33386630|NCT03365947|101302586|FG011|Overall Study|Lost to Follow-up|0|||
33386631|NCT03365947|101302587|FG012|Overall Study|Lost to Follow-up|0|||
33437008|NCT00920140|101492609|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
33437009|NCT00920140|101492610|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
33437010|NCT00920140|101492606|FG000|Phase 2|Adverse Event|0|||
33437011|NCT00920140|101492607|FG001|Phase 2|Adverse Event|0|||
33437012|NCT00920140|101492608|FG002|Phase 2|Adverse Event|14|||
33437013|NCT00920140|101492609|FG003|Phase 2|Adverse Event|2|||
33437014|NCT00920140|101492610|FG004|Phase 2|Adverse Event|3|||
33437015|NCT00920140|101492606|FG000|Phase 2|Lack of Efficacy|0|||
33437016|NCT00920140|101492607|FG001|Phase 2|Lack of Efficacy|0|||
33386632|NCT03365947|101302588|FG013|Overall Study|Lost to Follow-up|0|||
33386633|NCT03365947|101302589|FG014|Overall Study|Lost to Follow-up|0|||
33386634|NCT03365947|101302590|FG015|Overall Study|Lost to Follow-up|0|||
33386635|NCT03365947|101302591|FG016|Overall Study|Lost to Follow-up|0|||
33386636|NCT03365947|101302592|FG017|Overall Study|Lost to Follow-up|0|||
33386637|NCT03365947|101302593|FG018|Overall Study|Lost to Follow-up|0|||
33386638|NCT01494987|101302594|FG000|Overall Study|Adverse Event|6|||
33386639|NCT01494987|101302595|FG001|Overall Study|Adverse Event|5|||
33437017|NCT00920140|101492608|FG002|Phase 2|Lack of Efficacy|29|||
33437018|NCT00920140|101492609|FG003|Phase 2|Lack of Efficacy|14|||
33437019|NCT00920140|101492610|FG004|Phase 2|Lack of Efficacy|5|||
33386640|NCT01494987|101302594|FG000|Overall Study|Hyperglycemia|6|||
33386641|NCT01494987|101302595|FG001|Overall Study|Hyperglycemia|4|||
33250706|NCT01981850|100817841|FG004|Main Phase Stage 2|Adverse Event|6|||
33250707|NCT01981850|100817842|FG005|Main Phase Stage 2|Adverse Event|5|||
33437020|NCT00920140|101492606|FG000|Phase 2|Lost to Follow-up|0|||
33437021|NCT00920140|101492607|FG001|Phase 2|Lost to Follow-up|0|||
33437022|NCT00920140|101492608|FG002|Phase 2|Lost to Follow-up|0|||
33152835|NCT04171765|100473007|FG001|Overall Study|Study terminated by sponsor|0|||
33152836|NCT04171765|100473008|FG002|Overall Study|Study terminated by sponsor|0|||
33152837|NCT04171765|100473009|FG003|Overall Study|Study terminated by sponsor|0|||
33152838|NCT04171765|100473006|FG000|Overall Study|Withdrawal by Subject|1|||
33152839|NCT04171765|100473007|FG001|Overall Study|Withdrawal by Subject|0|||
33152840|NCT04171765|100473008|FG002|Overall Study|Withdrawal by Subject|0|||
33152841|NCT04171765|100473009|FG003|Overall Study|Withdrawal by Subject|3|||
33152842|NCT01346969|100473010|FG000|Overall Study|Withdrawal by Subject|0|||
33152843|NCT01346969|100473011|FG001|Overall Study|Withdrawal by Subject|0|||
33152844|NCT01346969|100473012|FG002|Overall Study|Withdrawal by Subject|1|||
33152845|NCT01346969|100473013|FG003|Overall Study|Withdrawal by Subject|0|||
33152846|NCT01346969|100473010|FG000|Overall Study|Lost to Follow-up|1|||
33152847|NCT01346969|100473011|FG001|Overall Study|Lost to Follow-up|0|||
33152848|NCT01346969|100473012|FG002|Overall Study|Lost to Follow-up|2|||
33152849|NCT01346969|100473013|FG003|Overall Study|Lost to Follow-up|0|||
33152850|NCT01346969|100473010|FG000|Overall Study|Physician Decision|0|||
33250708|NCT01981850|100817843|FG006|Main Phase Stage 2|Adverse Event|7|||
33250709|NCT01981850|100817844|FG007|Main Phase Stage 2|Adverse Event|0|||
33386642|NCT01494987|101302594|FG000|Overall Study|Investigator's Discretion|1|||
33386643|NCT01494987|101302595|FG001|Overall Study|Investigator's Discretion|2|||
33386644|NCT01494987|101302594|FG000|Overall Study|Lost to Follow-up|1|||
33386645|NCT01494987|101302595|FG001|Overall Study|Lost to Follow-up|1|||
33386646|NCT01494987|101302594|FG000|Overall Study|Protocol Violation|3|||
33386647|NCT01494987|101302595|FG001|Overall Study|Protocol Violation|3|||
33386648|NCT01494987|101302594|FG000|Overall Study|Subject Non-Compliance|9|||
33386649|NCT01494987|101302595|FG001|Overall Study|Subject Non-Compliance|10|||
33386650|NCT01494987|101302594|FG000|Overall Study|Subject Withdrew Consent|2|||
33386651|NCT01494987|101302595|FG001|Overall Study|Subject Withdrew Consent|3|||
33386652|NCT02067533|101302598|FG000|Overall Study|Lost to Follow-up|4|||
33386653|NCT02067533|101302599|FG001|Overall Study|Lost to Follow-up|2|||
33386654|NCT02267278|101302602|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
33152851|NCT01346969|100473011|FG001|Overall Study|Physician Decision|0|||
33152852|NCT01346969|100473012|FG002|Overall Study|Physician Decision|0|||
33152853|NCT01346969|100473013|FG003|Overall Study|Physician Decision|1|||
33152854|NCT01346969|100473010|FG000|Overall Study|Randomized but not treated|1|||
33250710|NCT01981850|100817845|FG008|Main Phase Stage 2|Adverse Event|0|||
33152855|NCT01346969|100473011|FG001|Overall Study|Randomized but not treated|0|||
33152856|NCT01346969|100473012|FG002|Overall Study|Randomized but not treated|0|||
33152857|NCT01346969|100473013|FG003|Overall Study|Randomized but not treated|0|||
33152858|NCT01736124|100473016|FG000|Post-intervention Assessment|Death|2|||
33437023|NCT00920140|101492609|FG003|Phase 2|Lost to Follow-up|1|||
33437024|NCT00920140|101492610|FG004|Phase 2|Lost to Follow-up|0|||
33437025|NCT00920140|101492606|FG000|Phase 2|Physician Decision|0|||
33437026|NCT00920140|101492607|FG001|Phase 2|Physician Decision|0|||
33437027|NCT00920140|101492608|FG002|Phase 2|Physician Decision|3|||
33437028|NCT00920140|101492609|FG003|Phase 2|Physician Decision|3|||
33437029|NCT00920140|101492610|FG004|Phase 2|Physician Decision|2|||
33437030|NCT00920140|101492606|FG000|Phase 2|Withdrawal by Subject|0|||
33437031|NCT00920140|101492607|FG001|Phase 2|Withdrawal by Subject|0|||
33437032|NCT00920140|101492608|FG002|Phase 2|Withdrawal by Subject|4|||
33437033|NCT00920140|101492609|FG003|Phase 2|Withdrawal by Subject|2|||
33437034|NCT00920140|101492610|FG004|Phase 2|Withdrawal by Subject|1|||
33437035|NCT00117949|101492611|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
33437036|NCT00117949|101492612|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
33437037|NCT00117949|101492613|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
33152859|NCT01736124|100473017|FG001|Post-intervention Assessment|Death|2|||
33152860|NCT01736124|100473016|FG000|Post-intervention Assessment|lost computer access|1|||
33152861|NCT01736124|100473017|FG001|Post-intervention Assessment|lost computer access|1|||
33152862|NCT01736124|100473016|FG000|Post-intervention Assessment|Moved away|3|||
33437038|NCT00117949|101492614|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
33437039|NCT00117949|101492611|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
33152863|NCT01736124|100473017|FG001|Post-intervention Assessment|Moved away|1|||
33152864|NCT01736124|100473016|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
33152865|NCT01736124|100473017|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
33250711|NCT01981850|100817846|FG009|Main Phase Stage 2|Adverse Event|0|||
33250712|NCT01981850|100817837|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
33250713|NCT01981850|100817838|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
33250714|NCT01981850|100817839|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
33250715|NCT01981850|100817840|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
33250716|NCT01981850|100817841|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
33250717|NCT01981850|100817842|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
33250718|NCT01981850|100817843|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
33250719|NCT01981850|100817844|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
33152866|NCT01736124|100473016|FG000|Post-intervention Assessment|Illness|3|||
33152867|NCT01736124|100473017|FG001|Post-intervention Assessment|Illness|2|||
33152868|NCT01736124|100473016|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
33250720|NCT01981850|100817845|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
33250721|NCT01981850|100817846|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
33437040|NCT00117949|101492612|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
33437041|NCT00117949|101492613|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
33437042|NCT00117949|101492614|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
33437043|NCT00117949|101492611|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
33437044|NCT00117949|101492612|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
33152869|NCT01736124|100473017|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
33152870|NCT01736124|100473016|FG000|Post-intervention Assessment|Temporarily away|3|||
33152871|NCT01736124|100473017|FG001|Post-intervention Assessment|Temporarily away|1|||
33250722|NCT01981850|100817837|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
33437045|NCT00117949|101492613|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
33437046|NCT00117949|101492614|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
33437047|NCT00117949|101492611|FG000|Overall Study|PSA increase >=10ng/mL|0|||
33437048|NCT00117949|101492612|FG001|Overall Study|PSA increase >=10ng/mL|1|||
33437049|NCT00117949|101492613|FG002|Overall Study|PSA increase >=10ng/mL|1|||
33437050|NCT00117949|101492614|FG003|Overall Study|PSA increase >=10ng/mL|0|||
33437051|NCT00117949|101492611|FG000|Overall Study|PSA reduction <=50%|0|||
33437052|NCT00117949|101492612|FG001|Overall Study|PSA reduction <=50%|2|||
33437053|NCT00117949|101492613|FG002|Overall Study|PSA reduction <=50%|2|||
33437054|NCT00117949|101492614|FG003|Overall Study|PSA reduction <=50%|4|||
33437055|NCT00117949|101492611|FG000|Overall Study|Hepatic abnormalities|0|||
33437056|NCT00117949|101492612|FG001|Overall Study|Hepatic abnormalities|1|||
33437057|NCT00117949|101492613|FG002|Overall Study|Hepatic abnormalities|0|||
33437058|NCT00117949|101492614|FG003|Overall Study|Hepatic abnormalities|1|||
33437059|NCT00243932|101492617|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
33437060|NCT00243932|101492618|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
33437061|NCT00243932|101492619|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
33437062|NCT01249664|101492620|FG000|Overall Study|Withdrawal by Subject|5|||
33437063|NCT01249664|101492621|FG001|Overall Study|Withdrawal by Subject|0|||
33437064|NCT01249664|101492620|FG000|Overall Study|Adverse Event|1|||
33437065|NCT01249664|101492621|FG001|Overall Study|Adverse Event|0|||
33437066|NCT02402166|101492622|FG000|Overall Study|Adverse Event|2|||
33437067|NCT02402166|101492622|FG000|Overall Study|Withdrawal by Subject|2|||
33437068|NCT02402166|101492622|FG000|Overall Study|Lost to Follow-up|1|||
33437069|NCT01335477|101492624|FG000|Overall Study|Adverse Event|30|||
33152872|NCT01736124|100473016|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
33437070|NCT01335477|101492625|FG001|Overall Study|Adverse Event|42|||
33437071|NCT01335477|101492624|FG000|Overall Study|Non compliant with protocol|0|||
33437072|NCT01335477|101492625|FG001|Overall Study|Non compliant with protocol|2|||
33437073|NCT01335477|101492624|FG000|Overall Study|Lost to Follow-up|1|||
33437074|NCT01335477|101492625|FG001|Overall Study|Lost to Follow-up|2|||
33250723|NCT01981850|100817838|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
33437075|NCT01335477|101492624|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
33437076|NCT01335477|101492625|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
33437077|NCT01335477|101492624|FG000|Overall Study|Not treated|1|||
33437078|NCT01335477|101492625|FG001|Overall Study|Not treated|2|||
33152873|NCT01736124|100473017|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
33152874|NCT01736124|100473016|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
33152875|NCT01736124|100473017|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
33152876|NCT01736124|100473016|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
33152877|NCT01736124|100473017|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
33152878|NCT01736124|100473016|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
33152879|NCT01736124|100473017|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
33152880|NCT01736124|100473016|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
33152881|NCT01736124|100473017|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
33152882|NCT01736124|100473016|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
33152883|NCT01736124|100473017|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
33152884|NCT01736124|100473016|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
33152885|NCT01736124|100473017|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
33152886|NCT01736124|100473016|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
33152887|NCT01736124|100473017|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
33152888|NCT01736124|100473016|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
33152889|NCT01736124|100473017|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
33152890|NCT02337738|100473018|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
33152891|NCT02337738|100473019|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
33152892|NCT02337738|100473020|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
33152893|NCT02337738|100473018|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
33152894|NCT02337738|100473019|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
33152895|NCT02337738|100473020|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
33152896|NCT02337738|100473018|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
33152897|NCT02337738|100473019|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
33152898|NCT02337738|100473020|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
33152899|NCT02337738|100473018|FG000|Overall Study|Voluntary Withdrawal|10|||
33152900|NCT02337738|100473019|FG001|Overall Study|Voluntary Withdrawal|5|||
33152901|NCT02337738|100473020|FG002|Overall Study|Voluntary Withdrawal|2|||
33250724|NCT01981850|100817839|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
33437079|NCT01335477|101492624|FG000|Overall Study|Reason other than those stated above|2|||
33437080|NCT01335477|101492625|FG001|Overall Study|Reason other than those stated above|2|||
33437081|NCT02896361|101492626|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
33437082|NCT02896361|101492627|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
33437083|NCT02896361|101492628|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
33437084|NCT02896361|101492626|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
33437085|NCT02896361|101492627|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
33437086|NCT02896361|101492628|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
33437087|NCT03544138|101492631|FG000|Overall Study|Lost to Follow-up|29|||
33437088|NCT01060670|101492632|FG000|Run In|screen failure|0|||
33437089|NCT01060670|101492633|FG001|Run In|screen failure|238|||
33437090|NCT01345019|101492634|FG000|Blinded Treatment Phase|Death|147|||
33437091|NCT01345019|101492635|FG001|Blinded Treatment Phase|Death|137|||
33437092|NCT01345019|101492634|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
33250725|NCT01981850|100817840|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
33386655|NCT02267278|101302602|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
33386656|NCT02267278|101302602|FG000|Overall Study|Developed new cancer diagnoses|2|||
33386657|NCT02267278|101302602|FG000|Overall Study|prescribed prohibited medication|1|||
33386658|NCT04968353|101302604|FG000|Overall Study|Non-compliance|1|||
33386659|NCT04968353|101302605|FG001|Overall Study|Non-compliance|0|||
33386660|NCT04968353|101302606|FG002|Overall Study|Non-compliance|2|||
33386661|NCT04968353|101302607|FG003|Overall Study|Non-compliance|0|||
33386662|NCT02088541|101302608|FG000|Overall Study|Adverse Event|3|||
33386663|NCT02088541|101302609|FG001|Overall Study|Adverse Event|0|||
33437093|NCT01345019|101492635|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
33386664|NCT02088541|101302610|FG002|Overall Study|Adverse Event|3|||
33437094|NCT01345019|101492634|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
33250726|NCT01981850|100817841|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
33386665|NCT02088541|101302611|FG003|Overall Study|Adverse Event|3|||
33386666|NCT02088541|101302612|FG004|Overall Study|Adverse Event|0|||
33437095|NCT01345019|101492635|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
33250727|NCT01981850|100817842|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
33250728|NCT01981850|100817843|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
33250729|NCT01981850|100817844|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
33437096|NCT01345019|101492634|FG000|Blinded Treatment Phase|Disease Progression|12|||
33437097|NCT01345019|101492635|FG001|Blinded Treatment Phase|Disease Progression|10|||
33437098|NCT01345019|101492634|FG000|Blinded Treatment Phase|Adverse Event|6|||
33437099|NCT01345019|101492635|FG001|Blinded Treatment Phase|Adverse Event|13|||
33437100|NCT01345019|101492634|FG000|Blinded Treatment Phase|Administrative Decision|10|||
33437101|NCT01345019|101492635|FG001|Blinded Treatment Phase|Administrative Decision|8|||
33437102|NCT01345019|101492634|FG000|Blinded Treatment Phase|Noncompliance|5|||
33437103|NCT01345019|101492635|FG001|Blinded Treatment Phase|Noncompliance|3|||
33437104|NCT01345019|101492634|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
33437105|NCT01345019|101492635|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
33437106|NCT01345019|101492634|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
33437107|NCT01345019|101492635|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
33437108|NCT01345019|101492634|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
33437109|NCT01345019|101492635|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
33437110|NCT01345019|101492634|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
33437111|NCT01345019|101492635|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
33437112|NCT01345019|101492634|FG000|Open Label Treatment Phase|Death|49|||
33437113|NCT01345019|101492635|FG001|Open Label Treatment Phase|Death|48|||
33437114|NCT01345019|101492634|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
33437115|NCT01345019|101492635|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
33437116|NCT01345019|101492634|FG000|Open Label Treatment Phase|Adverse Event|30|||
33437117|NCT01345019|101492635|FG001|Open Label Treatment Phase|Adverse Event|51|||
33437118|NCT01345019|101492634|FG000|Open Label Treatment Phase|Administrative Decision|30|||
33437119|NCT01345019|101492635|FG001|Open Label Treatment Phase|Administrative Decision|15|||
33437120|NCT01345019|101492634|FG000|Open Label Treatment Phase|Disease Progression|17|||
33437121|NCT01345019|101492635|FG001|Open Label Treatment Phase|Disease Progression|18|||
33437122|NCT01345019|101492634|FG000|Open Label Treatment Phase|Noncompliance|5|||
33437123|NCT01345019|101492635|FG001|Open Label Treatment Phase|Noncompliance|4|||
33437124|NCT01345019|101492634|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
33437125|NCT01345019|101492635|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
33437126|NCT01345019|101492634|FG000|Open Label Treatment Phase|Pregnancy|1|||
33437127|NCT01345019|101492635|FG001|Open Label Treatment Phase|Pregnancy|0|||
33437128|NCT01345019|101492634|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
33437129|NCT01345019|101492635|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
33437130|NCT01345019|101492634|FG000|Open Label Treatment Phase|Protocol Violation|0|||
33437131|NCT01345019|101492635|FG001|Open Label Treatment Phase|Protocol Violation|1|||
33437132|NCT01411332|101492639|FG000|Enrollment|Protocol Violation|0|||
33437133|NCT01411332|101492640|FG001|Enrollment|Protocol Violation|1|||
33437134|NCT01411332|101492639|FG000|Enrollment|Withdrawal by Subject|0|||
33437135|NCT01411332|101492640|FG001|Enrollment|Withdrawal by Subject|1|||
33437136|NCT01411332|101492639|FG000|Treatment|Lost to Follow-up|1|||
33437137|NCT01411332|101492640|FG001|Treatment|Lost to Follow-up|0|||
33437138|NCT01706926|101492641|FG000|Overall Study|Lost to Follow-up|0|||
33437139|NCT01706926|101492642|FG001|Overall Study|Lost to Follow-up|0|||
33437140|NCT01706926|101492643|FG002|Overall Study|Lost to Follow-up|1|||
33437141|NCT01706926|101492644|FG003|Overall Study|Lost to Follow-up|0|||
33437142|NCT01706926|101492641|FG000|Overall Study|Withdrawal by Subject|2|||
33437143|NCT01706926|101492642|FG001|Overall Study|Withdrawal by Subject|0|||
33437144|NCT01706926|101492643|FG002|Overall Study|Withdrawal by Subject|1|||
33437145|NCT01706926|101492644|FG003|Overall Study|Withdrawal by Subject|2|||
33437146|NCT01706926|101492641|FG000|Overall Study|Other|4|||
33437147|NCT01706926|101492642|FG001|Overall Study|Other|4|||
33250730|NCT01981850|100817845|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
33250731|NCT01981850|100817846|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
33386667|NCT02088541|101302608|FG000|Overall Study|Death|51|||
33386668|NCT02088541|101302609|FG001|Overall Study|Death|21|||
33386669|NCT02088541|101302610|FG002|Overall Study|Death|85|||
33386670|NCT02088541|101302611|FG003|Overall Study|Death|28|||
33386671|NCT02088541|101302612|FG004|Overall Study|Death|38|||
33386672|NCT02088541|101302608|FG000|Overall Study|Lost to Follow-up|2|||
33386673|NCT02088541|101302609|FG001|Overall Study|Lost to Follow-up|0|||
33386674|NCT02088541|101302610|FG002|Overall Study|Lost to Follow-up|1|||
33386675|NCT02088541|101302611|FG003|Overall Study|Lost to Follow-up|0|||
33386676|NCT02088541|101302612|FG004|Overall Study|Lost to Follow-up|0|||
33386677|NCT02088541|101302608|FG000|Overall Study|Physician Decision|2|||
33386678|NCT02088541|101302609|FG001|Overall Study|Physician Decision|1|||
33386679|NCT02088541|101302610|FG002|Overall Study|Physician Decision|2|||
33386680|NCT02088541|101302611|FG003|Overall Study|Physician Decision|0|||
33437148|NCT01706926|101492643|FG002|Overall Study|Other|4|||
33437149|NCT01706926|101492644|FG003|Overall Study|Other|3|||
33437150|NCT00442936|101492646|FG000|Overall Study|Protocol Violation|1|||
33437151|NCT00442936|101492647|FG001|Overall Study|Protocol Violation|0|||
33437152|NCT00442936|101492648|FG002|Overall Study|Protocol Violation|1|||
33437153|NCT00442936|101492649|FG003|Overall Study|Protocol Violation|1|||
33437154|NCT00048568|101492652|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
33437155|NCT00048568|101492653|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
33437156|NCT00048568|101492654|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
33437157|NCT00048568|101492652|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
33437158|NCT00048568|101492653|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
33437159|NCT00048568|101492654|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
33437160|NCT00048568|101492652|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
33437161|NCT00048568|101492653|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
33250732|NCT01981850|100817837|FG000|Main Phase Stage 2|Various reasons|0|||
33250733|NCT01981850|100817838|FG001|Main Phase Stage 2|Various reasons|0|||
33250734|NCT01981850|100817839|FG002|Main Phase Stage 2|Various reasons|0|||
33250735|NCT01981850|100817840|FG003|Main Phase Stage 2|Various reasons|0|||
33250736|NCT01981850|100817841|FG004|Main Phase Stage 2|Various reasons|2|||
33250737|NCT01981850|100817842|FG005|Main Phase Stage 2|Various reasons|0|||
33250738|NCT01981850|100817843|FG006|Main Phase Stage 2|Various reasons|1|||
33250739|NCT01981850|100817844|FG007|Main Phase Stage 2|Various reasons|0|||
33250740|NCT01981850|100817845|FG008|Main Phase Stage 2|Various reasons|0|||
33250741|NCT01981850|100817846|FG009|Main Phase Stage 2|Various reasons|0|||
33250742|NCT01981850|100817837|FG000|Main Phase Stage 2|Progressive Disease|0|||
33250743|NCT01981850|100817838|FG001|Main Phase Stage 2|Progressive Disease|0|||
33250744|NCT01981850|100817839|FG002|Main Phase Stage 2|Progressive Disease|0|||
33250745|NCT01981850|100817840|FG003|Main Phase Stage 2|Progressive Disease|0|||
33250746|NCT01981850|100817841|FG004|Main Phase Stage 2|Progressive Disease|0|||
33386681|NCT02088541|101302612|FG004|Overall Study|Physician Decision|2|||
33386682|NCT02088541|101302608|FG000|Overall Study|Disease progression|7|||
33386683|NCT02088541|101302609|FG001|Overall Study|Disease progression|1|||
33386684|NCT02088541|101302610|FG002|Overall Study|Disease progression|2|||
33386685|NCT02088541|101302611|FG003|Overall Study|Disease progression|3|||
33386686|NCT02088541|101302612|FG004|Overall Study|Disease progression|1|||
33386687|NCT02088541|101302608|FG000|Overall Study|Study terminated by sponsor|1|||
33386688|NCT02088541|101302609|FG001|Overall Study|Study terminated by sponsor|1|||
33386689|NCT02088541|101302610|FG002|Overall Study|Study terminated by sponsor|12|||
33386690|NCT02088541|101302611|FG003|Overall Study|Study terminated by sponsor|2|||
33386691|NCT02088541|101302612|FG004|Overall Study|Study terminated by sponsor|6|||
33386692|NCT02088541|101302608|FG000|Overall Study|Withdrawal by Subject|3|||
33386693|NCT02088541|101302609|FG001|Overall Study|Withdrawal by Subject|2|||
33386694|NCT02088541|101302610|FG002|Overall Study|Withdrawal by Subject|9|||
33386695|NCT02088541|101302611|FG003|Overall Study|Withdrawal by Subject|7|||
33386696|NCT02088541|101302612|FG004|Overall Study|Withdrawal by Subject|10|||
33386697|NCT02088541|101302608|FG000|Overall Study|Other|2|||
33386698|NCT02088541|101302609|FG001|Overall Study|Other|1|||
33386699|NCT02088541|101302610|FG002|Overall Study|Other|3|||
33386700|NCT02088541|101302611|FG003|Overall Study|Other|1|||
33386701|NCT02088541|101302612|FG004|Overall Study|Other|1|||
33386702|NCT03175562|101302613|FG000|Overall Study|Adverse Event|1|||
33386703|NCT03175562|101302613|FG000|Overall Study|Lost to Follow-up|3|||
33386704|NCT03175562|101302613|FG000|Overall Study|Withdrawal by Subject|7|||
33386705|NCT03175562|101302613|FG000|Overall Study|Other (Not Specified)|5|||
33386706|NCT04839393|101302619|FG000|Overall Study|Adverse Event|0|||
33386707|NCT04839393|101302620|FG001|Overall Study|Adverse Event|0|||
33386708|NCT04839393|101302621|FG002|Overall Study|Adverse Event|2|||
33386709|NCT04839393|101302619|FG000|Overall Study|Withdrawal by participant|0|||
33386710|NCT04839393|101302620|FG001|Overall Study|Withdrawal by participant|0|||
33386711|NCT04839393|101302621|FG002|Overall Study|Withdrawal by participant|1|||
33386712|NCT01090102|101302626|FG000|First 12 Weeks|Withdrawal by Subject|1|||
33386713|NCT01090102|101302627|FG001|First 12 Weeks|Withdrawal by Subject|1|||
33437162|NCT00048568|101492654|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
33437163|NCT00048568|101492652|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
33437164|NCT00048568|101492653|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
33437165|NCT00048568|101492654|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
33437166|NCT00048568|101492652|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
33250747|NCT01981850|100817842|FG005|Main Phase Stage 2|Progressive Disease|6|||
33250748|NCT01981850|100817843|FG006|Main Phase Stage 2|Progressive Disease|6|||
33386714|NCT01090102|101302626|FG000|First 12 Weeks|Adverse Event|2|||
33386715|NCT01090102|101302627|FG001|First 12 Weeks|Adverse Event|0|||
33386716|NCT01090102|101302626|FG000|First 12 Weeks|Death|1|||
33386717|NCT01090102|101302627|FG001|First 12 Weeks|Death|1|||
33437167|NCT00048568|101492653|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
33386718|NCT01090102|101302626|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
33386719|NCT01090102|101302627|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
33386720|NCT01061567|101302628|FG000|Overall Study|Adverse Event|32|||
33250749|NCT01981850|100817844|FG007|Main Phase Stage 2|Progressive Disease|0|||
33250750|NCT01981850|100817845|FG008|Main Phase Stage 2|Progressive Disease|0|||
33250751|NCT01981850|100817846|FG009|Main Phase Stage 2|Progressive Disease|0|||
33250752|NCT01981850|100817837|FG000|Open Label Extension (OLE)|Adverse Event|0|||
33250753|NCT01981850|100817838|FG001|Open Label Extension (OLE)|Adverse Event|0|||
33250754|NCT01981850|100817839|FG002|Open Label Extension (OLE)|Adverse Event|0|||
33386721|NCT01061567|101302628|FG000|Overall Study|Death|2|||
33386722|NCT01061567|101302628|FG000|Overall Study|Lack of Efficacy|3|||
33250755|NCT01981850|100817840|FG003|Open Label Extension (OLE)|Adverse Event|0|||
33250756|NCT01981850|100817841|FG004|Open Label Extension (OLE)|Adverse Event|0|||
33250757|NCT01981850|100817842|FG005|Open Label Extension (OLE)|Adverse Event|0|||
33250758|NCT01981850|100817843|FG006|Open Label Extension (OLE)|Adverse Event|0|||
33250759|NCT01981850|100817844|FG007|Open Label Extension (OLE)|Adverse Event|2|||
33250760|NCT01981850|100817845|FG008|Open Label Extension (OLE)|Adverse Event|1|||
33250761|NCT01981850|100817846|FG009|Open Label Extension (OLE)|Adverse Event|8|||
33250762|NCT01981850|100817837|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
33250763|NCT01981850|100817838|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
33250764|NCT01981850|100817839|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
33250765|NCT01981850|100817840|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
33250766|NCT01981850|100817841|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
33250767|NCT01981850|100817842|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
33250768|NCT01981850|100817843|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
33250769|NCT01981850|100817844|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
33250770|NCT01981850|100817845|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
33250771|NCT01981850|100817846|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
33250772|NCT01981850|100817837|FG000|Open Label Extension (OLE)|Various reasons|0|||
33250773|NCT01981850|100817838|FG001|Open Label Extension (OLE)|Various reasons|0|||
33250774|NCT01981850|100817839|FG002|Open Label Extension (OLE)|Various reasons|0|||
33250775|NCT01981850|100817840|FG003|Open Label Extension (OLE)|Various reasons|0|||
33250776|NCT01981850|100817841|FG004|Open Label Extension (OLE)|Various reasons|0|||
33250777|NCT01981850|100817842|FG005|Open Label Extension (OLE)|Various reasons|0|||
33250778|NCT01981850|100817843|FG006|Open Label Extension (OLE)|Various reasons|0|||
33250779|NCT01981850|100817844|FG007|Open Label Extension (OLE)|Various reasons|3|||
33250780|NCT01981850|100817845|FG008|Open Label Extension (OLE)|Various reasons|1|||
33152902|NCT02337738|100473018|FG000|Overall Study|Lack of Efficacy|2|||
33152903|NCT02337738|100473019|FG001|Overall Study|Lack of Efficacy|4|||
33152904|NCT02337738|100473020|FG002|Overall Study|Lack of Efficacy|0|||
33152905|NCT02337738|100473018|FG000|Overall Study|Investigator's Judgment|1|||
33152906|NCT02337738|100473019|FG001|Overall Study|Investigator's Judgment|1|||
33152907|NCT02337738|100473020|FG002|Overall Study|Investigator's Judgment|3|||
33152908|NCT00532155|100473021|FG000|Overall Study|Adverse Event|66|||
33152909|NCT00532155|100473022|FG001|Overall Study|Adverse Event|123|||
33152910|NCT00532155|100473021|FG000|Overall Study|Lack of Efficacy|332|||
33152911|NCT00532155|100473022|FG001|Overall Study|Lack of Efficacy|255|||
33152912|NCT00532155|100473021|FG000|Overall Study|Protocol Violation|1|||
33152913|NCT00532155|100473022|FG001|Overall Study|Protocol Violation|3|||
33152914|NCT00532155|100473021|FG000|Overall Study|Lost to Follow-up|2|||
33152915|NCT00532155|100473022|FG001|Overall Study|Lost to Follow-up|0|||
33152916|NCT00532155|100473021|FG000|Overall Study|Physician Decision|16|||
33152917|NCT00532155|100473022|FG001|Overall Study|Physician Decision|15|||
33152918|NCT00532155|100473021|FG000|Overall Study|Withdrawal by Subject|23|||
33152919|NCT00532155|100473022|FG001|Overall Study|Withdrawal by Subject|44|||
33152920|NCT00532155|100473021|FG000|Overall Study|Consent withdrawn|5|||
33152921|NCT00532155|100473022|FG001|Overall Study|Consent withdrawn|7|||
33152922|NCT00532155|100473021|FG000|Overall Study|Moved|1|||
33152923|NCT00532155|100473022|FG001|Overall Study|Moved|0|||
33152924|NCT00532155|100473021|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
33386723|NCT01061567|101302628|FG000|Overall Study|Lost to Follow-up|24|||
33386724|NCT01061567|101302628|FG000|Overall Study|Protocol Violation|1|||
33152925|NCT00532155|100473022|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
33152926|NCT00532155|100473021|FG000|Overall Study|Occurence of a second cancer|0|||
33152927|NCT00532155|100473022|FG001|Overall Study|Occurence of a second cancer|1|||
33250781|NCT01981850|100817846|FG009|Open Label Extension (OLE)|Various reasons|3|||
33250782|NCT01981850|100817837|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
33250783|NCT01981850|100817838|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
33386725|NCT01061567|101302628|FG000|Overall Study|Withdrawal by Subject|11|||
33152928|NCT00532155|100473021|FG000|Overall Study|Occurence of a secondary cancer|0|||
33152929|NCT00532155|100473022|FG001|Overall Study|Occurence of a secondary cancer|1|||
33152930|NCT00532155|100473021|FG000|Overall Study|Promotor ended study|1|||
33152931|NCT00532155|100473022|FG001|Overall Study|Promotor ended study|0|||
33152932|NCT00532155|100473021|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
33250784|NCT01981850|100817839|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
33250785|NCT01981850|100817840|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
33250786|NCT01981850|100817841|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
33250787|NCT01981850|100817842|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
33152933|NCT00532155|100473022|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
33152934|NCT00532155|100473021|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
33152935|NCT00532155|100473022|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
33152936|NCT00532155|100473021|FG000|Overall Study|Study stopped|1|||
33250788|NCT01981850|100817843|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
33250789|NCT01981850|100817844|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
33250790|NCT01981850|100817845|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
33250791|NCT01981850|100817846|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
33386726|NCT01061567|101302628|FG000|Overall Study|Other reason than stated above|3|||
33386727|NCT00762268|101302630|FG000|Overall Study|Withdrawal by Subject|3|||
33386728|NCT00762268|101302631|FG001|Overall Study|Withdrawal by Subject|3|||
33386729|NCT01851863|101302632|FG000|Overall Study|Did not receive study medication|2|||
33386730|NCT01851863|101302633|FG001|Overall Study|Did not receive study medication|5|||
33386731|NCT01851863|101302634|FG002|Overall Study|Did not receive study medication|3|||
33386732|NCT01851863|101302635|FG003|Overall Study|Did not receive study medication|0|||
33386733|NCT01851863|101302632|FG000|Overall Study|Lost to Follow-up|3|||
33386734|NCT01851863|101302633|FG001|Overall Study|Lost to Follow-up|4|||
33386735|NCT01851863|101302634|FG002|Overall Study|Lost to Follow-up|2|||
33386736|NCT01851863|101302635|FG003|Overall Study|Lost to Follow-up|3|||
33386737|NCT03168555|101302636|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
33386738|NCT03168555|101302636|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
33437168|NCT00048568|101492654|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
33437169|NCT00048568|101492652|FG000|Double-Blind Period Days 170 to 365|Death|1|||
33437170|NCT00048568|101492653|FG001|Double-Blind Period Days 170 to 365|Death|1|||
33437171|NCT00048568|101492654|FG002|Double-Blind Period Days 170 to 365|Death|0|||
33437172|NCT00048568|101492652|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
33437173|NCT00048568|101492653|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
33437174|NCT00048568|101492654|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
33437175|NCT00048568|101492652|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
33437176|NCT00048568|101492653|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
33437177|NCT00048568|101492654|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
33437178|NCT00048568|101492652|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
33386739|NCT03168555|101302636|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
33437179|NCT00048568|101492653|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
33437180|NCT00048568|101492654|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
33437181|NCT00048568|101492652|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
33437182|NCT00048568|101492653|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
33437183|NCT00048568|101492654|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
33437184|NCT00048568|101492652|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
33437185|NCT00048568|101492653|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
33437186|NCT00048568|101492654|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
33437187|NCT00048568|101492652|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
33437188|NCT00048568|101492653|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
33437189|NCT00048568|101492654|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
33437190|NCT00048568|101492652|FG000|Open-Label Period|Death|0|||
33437191|NCT00048568|101492653|FG001|Open-Label Period|Death|0|||
33437192|NCT00048568|101492654|FG002|Open-Label Period|Death|13|||
33437193|NCT00048568|101492652|FG000|Open-Label Period|Adverse Event|0|||
33437194|NCT00048568|101492653|FG001|Open-Label Period|Adverse Event|0|||
33437195|NCT00048568|101492654|FG002|Open-Label Period|Adverse Event|49|||
33437196|NCT00048568|101492652|FG000|Open-Label Period|Lack of Efficacy|0|||
33386740|NCT03168555|101302636|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
33386741|NCT00355134|101302637|FG000|Core Phase|Withdrawal by Subject|35|||
33386742|NCT00355134|101302638|FG001|Core Phase|Withdrawal by Subject|24|||
33386743|NCT00355134|101302639|FG002|Core Phase|Withdrawal by Subject|35|||
33437197|NCT00048568|101492653|FG001|Open-Label Period|Lack of Efficacy|0|||
33437198|NCT00048568|101492654|FG002|Open-Label Period|Lack of Efficacy|32|||
33152937|NCT00532155|100473022|FG001|Overall Study|Study stopped|0|||
33152938|NCT00532155|100473021|FG000|Overall Study|Study terminated by sponsor|1|||
33152939|NCT00532155|100473022|FG001|Overall Study|Study terminated by sponsor|0|||
33152940|NCT00532155|100473021|FG000|Overall Study|Study termination stop further treatment|4|||
33250792|NCT01981850|100817837|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33437199|NCT00048568|101492652|FG000|Open-Label Period|Withdrawal by Subject|0|||
33437200|NCT00048568|101492653|FG001|Open-Label Period|Withdrawal by Subject|0|||
33437201|NCT00048568|101492654|FG002|Open-Label Period|Withdrawal by Subject|26|||
33437202|NCT00048568|101492652|FG000|Open-Label Period|Pregnancy|0|||
33437203|NCT00048568|101492653|FG001|Open-Label Period|Pregnancy|0|||
33437204|NCT00048568|101492654|FG002|Open-Label Period|Pregnancy|5|||
33437205|NCT00048568|101492652|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
33437206|NCT00048568|101492653|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
33437207|NCT00048568|101492654|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
33437208|NCT00048568|101492652|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
33437209|NCT00048568|101492653|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
33386744|NCT00355134|101302640|FG003|Core Phase|Withdrawal by Subject|0|||
33386745|NCT00355134|101302641|FG004|Core Phase|Withdrawal by Subject|0|||
33386746|NCT00355134|101302637|FG000|Core Phase|Adverse Event|28|||
33386747|NCT00355134|101302638|FG001|Core Phase|Adverse Event|22|||
33386748|NCT00355134|101302639|FG002|Core Phase|Adverse Event|16|||
33386749|NCT00355134|101302640|FG003|Core Phase|Adverse Event|0|||
33386750|NCT00355134|101302641|FG004|Core Phase|Adverse Event|0|||
33386751|NCT00355134|101302637|FG000|Core Phase|Lost to Follow-up|17|||
33386752|NCT00355134|101302638|FG001|Core Phase|Lost to Follow-up|13|||
33386753|NCT00355134|101302639|FG002|Core Phase|Lost to Follow-up|21|||
33386754|NCT00355134|101302640|FG003|Core Phase|Lost to Follow-up|0|||
33386755|NCT00355134|101302641|FG004|Core Phase|Lost to Follow-up|0|||
33386756|NCT00355134|101302637|FG000|Core Phase|Abnormal laboratory value(s)|19|||
33386757|NCT00355134|101302638|FG001|Core Phase|Abnormal laboratory value(s)|14|||
33386758|NCT00355134|101302639|FG002|Core Phase|Abnormal laboratory value(s)|2|||
33386759|NCT00355134|101302640|FG003|Core Phase|Abnormal laboratory value(s)|0|||
33386760|NCT00355134|101302641|FG004|Core Phase|Abnormal laboratory value(s)|0|||
33386761|NCT00355134|101302637|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
33386762|NCT00355134|101302638|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
33386763|NCT00355134|101302639|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
33386764|NCT00355134|101302640|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
33386765|NCT00355134|101302641|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
33386766|NCT00355134|101302637|FG000|Core Phase|Administrative problems|5|||
33386767|NCT00355134|101302638|FG001|Core Phase|Administrative problems|3|||
33386768|NCT00355134|101302639|FG002|Core Phase|Administrative problems|5|||
33386769|NCT00355134|101302640|FG003|Core Phase|Administrative problems|0|||
33386770|NCT00355134|101302641|FG004|Core Phase|Administrative problems|0|||
33386771|NCT00355134|101302637|FG000|Core Phase|Protocol Violation|3|||
33386772|NCT00355134|101302638|FG001|Core Phase|Protocol Violation|2|||
33386773|NCT00355134|101302639|FG002|Core Phase|Protocol Violation|2|||
33386774|NCT00355134|101302640|FG003|Core Phase|Protocol Violation|0|||
33386775|NCT00355134|101302641|FG004|Core Phase|Protocol Violation|0|||
33386776|NCT00355134|101302637|FG000|Core Phase|Abnormal test procedure result(s)|1|||
33386777|NCT00355134|101302638|FG001|Core Phase|Abnormal test procedure result(s)|2|||
33386778|NCT00355134|101302639|FG002|Core Phase|Abnormal test procedure result(s)|1|||
33386779|NCT00355134|101302640|FG003|Core Phase|Abnormal test procedure result(s)|0|||
33386780|NCT00355134|101302641|FG004|Core Phase|Abnormal test procedure result(s)|0|||
33386781|NCT00355134|101302637|FG000|Core Phase|Condition no longer requires study drug|1|||
33386782|NCT00355134|101302638|FG001|Core Phase|Condition no longer requires study drug|0|||
33386783|NCT00355134|101302639|FG002|Core Phase|Condition no longer requires study drug|1|||
33386784|NCT00355134|101302640|FG003|Core Phase|Condition no longer requires study drug|0|||
33386785|NCT00355134|101302641|FG004|Core Phase|Condition no longer requires study drug|0|||
33386786|NCT00355134|101302637|FG000|Extension Phase|Withdrawal by Subject|7|||
33386787|NCT00355134|101302638|FG001|Extension Phase|Withdrawal by Subject|11|||
33386788|NCT00355134|101302639|FG002|Extension Phase|Withdrawal by Subject|0|||
33386789|NCT00355134|101302640|FG003|Extension Phase|Withdrawal by Subject|7|||
33386790|NCT00355134|101302641|FG004|Extension Phase|Withdrawal by Subject|5|||
33386791|NCT00355134|101302637|FG000|Extension Phase|Adverse Event|13|||
33386792|NCT00355134|101302638|FG001|Extension Phase|Adverse Event|9|||
33386793|NCT00355134|101302639|FG002|Extension Phase|Adverse Event|0|||
33386794|NCT00355134|101302640|FG003|Extension Phase|Adverse Event|3|||
33386795|NCT00355134|101302641|FG004|Extension Phase|Adverse Event|5|||
33386796|NCT00355134|101302637|FG000|Extension Phase|Lost to Follow-up|2|||
33386797|NCT00355134|101302638|FG001|Extension Phase|Lost to Follow-up|6|||
33386798|NCT00355134|101302639|FG002|Extension Phase|Lost to Follow-up|0|||
33386799|NCT00355134|101302640|FG003|Extension Phase|Lost to Follow-up|2|||
33437210|NCT00048568|101492654|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
33437211|NCT00048568|101492652|FG000|Open-Label Period|Unknown Reasons|0|||
33437212|NCT00048568|101492653|FG001|Open-Label Period|Unknown Reasons|0|||
33437213|NCT00048568|101492654|FG002|Open-Label Period|Unknown Reasons|25|||
33437214|NCT00048568|101492652|FG000|Open-Label Period|Lost to Follow-up|0|||
33437215|NCT00048568|101492653|FG001|Open-Label Period|Lost to Follow-up|0|||
33437216|NCT00048568|101492654|FG002|Open-Label Period|Lost to Follow-up|7|||
33437217|NCT02143102|101492658|FG000|Overall Study|Lost to Follow-up|11|||
33437218|NCT02143102|101492659|FG001|Overall Study|Lost to Follow-up|0|||
33437219|NCT05150964|101492660|FG000|Overall Study|Lost to Follow-up|2|||
33437220|NCT00788125|101492661|FG000|Overall Study|Death|6|||
33437221|NCT04529109|101492662|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
33437222|NCT04529109|101492663|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
33437223|NCT00094302|101492664|FG000|Overall Study|Lost to Follow-up|43|||
33437224|NCT00094302|101492665|FG001|Overall Study|Lost to Follow-up|41|||
33437225|NCT00094302|101492664|FG000|Overall Study|Physician Decision|5|||
33437226|NCT00094302|101492665|FG001|Overall Study|Physician Decision|8|||
33437227|NCT00094302|101492664|FG000|Overall Study|Withdrawal by Subject|103|||
33437228|NCT00094302|101492665|FG001|Overall Study|Withdrawal by Subject|111|||
33437229|NCT00094302|101492664|FG000|Overall Study|Death|266|||
33437230|NCT00094302|101492665|FG001|Overall Study|Death|246|||
33437231|NCT03247556|101492666|FG000|Overall Study|Adverse Event|1|||
33437232|NCT03247556|101492667|FG001|Overall Study|Adverse Event|4|||
33437233|NCT03247556|101492668|FG002|Overall Study|Adverse Event|5|||
33437234|NCT03247556|101492666|FG000|Overall Study|Lost to Follow-up|5|||
33437235|NCT03247556|101492667|FG001|Overall Study|Lost to Follow-up|5|||
33437236|NCT03247556|101492668|FG002|Overall Study|Lost to Follow-up|4|||
33437237|NCT03247556|101492666|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
33437238|NCT03247556|101492667|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
33437239|NCT03247556|101492668|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
33437240|NCT03247556|101492666|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
33437241|NCT03247556|101492667|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
33437242|NCT03247556|101492668|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
33437243|NCT03247556|101492666|FG000|Overall Study|Protocol Violation|2|||
33437244|NCT03247556|101492667|FG001|Overall Study|Protocol Violation|0|||
33437245|NCT03247556|101492668|FG002|Overall Study|Protocol Violation|1|||
33437246|NCT03247556|101492666|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
33437247|NCT03247556|101492667|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
33437248|NCT03247556|101492668|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
33437249|NCT00796822|101492669|FG000|Overall Study|Lost to Follow-up|2|||
33437250|NCT00796822|101492670|FG001|Overall Study|Lost to Follow-up|0|||
33437251|NCT00796822|101492669|FG000|Overall Study|Adverse Event|1|||
33437252|NCT00796822|101492670|FG001|Overall Study|Adverse Event|0|||
33437253|NCT01225146|101492673|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
33437254|NCT01225146|101492674|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
33437255|NCT00870870|101492675|FG000|Overall Study|Withdrawal by Subject|0|||
33437256|NCT00870870|101492676|FG001|Overall Study|Withdrawal by Subject|1|||
33437257|NCT00870870|101492677|FG002|Overall Study|Withdrawal by Subject|1|||
33152941|NCT00532155|100473022|FG001|Overall Study|Study termination stop further treatment|0|||
33437258|NCT00870870|101492678|FG003|Overall Study|Withdrawal by Subject|3|||
33250793|NCT01981850|100817838|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33437259|NCT00870870|101492675|FG000|Overall Study|Adverse Event|0|||
33437260|NCT00870870|101492676|FG001|Overall Study|Adverse Event|0|||
33437261|NCT00870870|101492677|FG002|Overall Study|Adverse Event|2|||
33437262|NCT00870870|101492678|FG003|Overall Study|Adverse Event|2|||
33437263|NCT00727571|101492681|FG000|Overall Study|Ineligibility determined|1|||
33437264|NCT00727571|101492682|FG001|Overall Study|Ineligibility determined|1|||
33437265|NCT00727571|101492683|FG002|Overall Study|Ineligibility determined|1|||
33437266|NCT00727571|101492684|FG003|Overall Study|Ineligibility determined|0|||
33437267|NCT00727571|101492681|FG000|Overall Study|Death|0|||
33437268|NCT00727571|101492682|FG001|Overall Study|Death|19|||
33437269|NCT00727571|101492683|FG002|Overall Study|Death|5|||
33437270|NCT00727571|101492684|FG003|Overall Study|Death|1|||
33437271|NCT00727571|101492681|FG000|Overall Study|Physician Decision|0|||
33437272|NCT00727571|101492682|FG001|Overall Study|Physician Decision|5|||
33437273|NCT00727571|101492683|FG002|Overall Study|Physician Decision|0|||
33437274|NCT00727571|101492684|FG003|Overall Study|Physician Decision|0|||
33437275|NCT00727571|101492681|FG000|Overall Study|Withdrawal by Subject|0|||
33437276|NCT00727571|101492682|FG001|Overall Study|Withdrawal by Subject|10|||
33437277|NCT00727571|101492683|FG002|Overall Study|Withdrawal by Subject|11|||
33152942|NCT00532155|100473021|FG000|Overall Study|Did not receive study medication|2|||
33152943|NCT00532155|100473022|FG001|Overall Study|Did not receive study medication|6|||
33152944|NCT01626495|100473024|FG000|Overall Study|Adverse Event|3|||
33152945|NCT01626495|100473024|FG000|Overall Study|Disease progression|27|||
33386800|NCT00355134|101302641|FG004|Extension Phase|Lost to Follow-up|4|||
33386801|NCT00355134|101302637|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
33386802|NCT00355134|101302638|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
33386803|NCT00355134|101302639|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
33386804|NCT00355134|101302640|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
33386805|NCT00355134|101302641|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
33386806|NCT00355134|101302637|FG000|Extension Phase|Administrative problems|2|||
33386807|NCT00355134|101302638|FG001|Extension Phase|Administrative problems|4|||
33386808|NCT00355134|101302639|FG002|Extension Phase|Administrative problems|0|||
33386809|NCT00355134|101302640|FG003|Extension Phase|Administrative problems|1|||
33386810|NCT00355134|101302641|FG004|Extension Phase|Administrative problems|1|||
33386811|NCT00355134|101302637|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
33386812|NCT00355134|101302638|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
33152946|NCT01626495|100473024|FG000|Overall Study|Withdrawal by Subject|1|||
33152947|NCT01626495|100473024|FG000|Overall Study|Administrative problem|1|||
33152948|NCT01626495|100473024|FG000|Overall Study|Death|2|||
33152949|NCT01626495|100473024|FG000|Overall Study|Physician Decision|1|||
33152950|NCT01626495|100473024|FG000|Overall Study|New cancer therapy|16|||
33152951|NCT01626495|100473024|FG000|Overall Study|Manufacturing failure|1|||
33152952|NCT00735254|100473025|FG000|Overall Study|Protocol Violation|1|||
33152953|NCT00735254|100473026|FG001|Overall Study|Protocol Violation|1|||
33152954|NCT00735254|100473027|FG002|Overall Study|Protocol Violation|1|||
33152955|NCT00735254|100473028|FG003|Overall Study|Protocol Violation|0|||
33152956|NCT03906461|100473030|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
33152957|NCT03906461|100473030|FG000|Completed 12-month Follow-up|Missed Visit|6|||
33152958|NCT03468985|100473033|FG000|Overall Study|Adverse Event|0|||
33152959|NCT03468985|100473034|FG001|Overall Study|Adverse Event|2|||
33152960|NCT03468985|100473035|FG002|Overall Study|Adverse Event|0|||
33152961|NCT03468985|100473036|FG003|Overall Study|Adverse Event|0|||
33152962|NCT03468985|100473033|FG000|Overall Study|Withdrawal by Subject|0|||
33152963|NCT03468985|100473034|FG001|Overall Study|Withdrawal by Subject|0|||
33152964|NCT03468985|100473035|FG002|Overall Study|Withdrawal by Subject|0|||
33152965|NCT03468985|100473036|FG003|Overall Study|Withdrawal by Subject|1|||
33152966|NCT01123850|100473038|FG000|Overall Study|Slow enrollment|45|||
33386813|NCT00355134|101302639|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
33437278|NCT00727571|101492684|FG003|Overall Study|Withdrawal by Subject|0|||
33386814|NCT00355134|101302640|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
33437279|NCT00727571|101492681|FG000|Overall Study|Subject Non Compliance|0|||
33437280|NCT00727571|101492682|FG001|Overall Study|Subject Non Compliance|6|||
33152967|NCT00338104|100473040|FG000|Overall Study|Protocol Violation|2|||
33152968|NCT00338104|100473041|FG001|Overall Study|Protocol Violation|1|||
33437281|NCT00727571|101492683|FG002|Overall Study|Subject Non Compliance|0|||
33152969|NCT00338104|100473042|FG002|Overall Study|Protocol Violation|3|||
33152970|NCT02477839|100473043|FG000|Overall Study|Adverse Event|0|||
33152971|NCT02477839|100473044|FG001|Overall Study|Adverse Event|1|||
33152972|NCT02477839|100473043|FG000|Overall Study|Protocol Violation|0|||
33152973|NCT02477839|100473044|FG001|Overall Study|Protocol Violation|2|||
33152974|NCT02477839|100473043|FG000|Overall Study|Withdrawal by Subject|3|||
33152975|NCT02477839|100473044|FG001|Overall Study|Withdrawal by Subject|3|||
33152976|NCT02477839|100473043|FG000|Overall Study|Participant had PGS during V6|0|||
33152977|NCT02477839|100473044|FG001|Overall Study|Participant had PGS during V6|1|||
33152978|NCT02477839|100473043|FG000|Overall Study|Parents decided to stop medication|0|||
33152979|NCT02477839|100473044|FG001|Overall Study|Parents decided to stop medication|1|||
33152980|NCT02477839|100473043|FG000|Overall Study|Lack of tolerability|0|||
33152981|NCT02477839|100473044|FG001|Overall Study|Lack of tolerability|1|||
33152982|NCT02477839|100473043|FG000|Overall Study|Exclusion criterion|0|||
33152983|NCT02477839|100473044|FG001|Overall Study|Exclusion criterion|1|||
33152984|NCT03595774|100473045|FG000|Overall Study|Adverse Event|1|||
33152985|NCT03595774|100473046|FG001|Overall Study|Adverse Event|0|||
33152986|NCT03595774|100473047|FG002|Overall Study|Adverse Event|1|||
33152987|NCT03595774|100473048|FG003|Overall Study|Adverse Event|0|||
33152988|NCT03595774|100473045|FG000|Overall Study|screen failure|0|||
33152989|NCT03595774|100473046|FG001|Overall Study|screen failure|1|||
33386815|NCT00355134|101302641|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
33386816|NCT00355134|101302637|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
33386817|NCT00355134|101302638|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
33386818|NCT00355134|101302639|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
33386819|NCT00355134|101302640|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
33386820|NCT00355134|101302641|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
33386821|NCT00355134|101302637|FG000|Extension Phase|Protocol Violation|0|||
33386822|NCT00355134|101302638|FG001|Extension Phase|Protocol Violation|0|||
33152990|NCT03595774|100473047|FG002|Overall Study|screen failure|0|||
33152991|NCT03595774|100473048|FG003|Overall Study|screen failure|1|||
33152992|NCT04439279|100473051|FG000|Overall Study|Adverse Event|7|||
33152993|NCT04439279|100473051|FG000|Overall Study|Death|4|||
33152994|NCT04439279|100473051|FG000|Overall Study|Disease progression|17|||
33152995|NCT04439279|100473051|FG000|Overall Study|Complicating disease|3|||
33152996|NCT04439279|100473051|FG000|Overall Study|Withdrawal by Subject|2|||
33152997|NCT04439279|100473051|FG000|Overall Study|Ineligible|1|||
33152998|NCT04439279|100473051|FG000|Overall Study|Treatment still ongoing|1|||
33152999|NCT03387683|100473052|FG000|Overall Study|In receipt of disallowed medication|1|||
33153000|NCT03387683|100473053|FG001|Overall Study|In receipt of disallowed medication|0|||
33153001|NCT03387683|100473052|FG000|Overall Study|Did not receive treatment|1|||
33153002|NCT03387683|100473053|FG001|Overall Study|Did not receive treatment|0|||
33153003|NCT03331250|100473054|FG000|Overall Study|Withdrawal by Subject|1|||
33153004|NCT02001181|100473058|FG000|Overall Study|Adverse Event|0|||
33153005|NCT02001181|100473059|FG001|Overall Study|Adverse Event|2|||
33153006|NCT02001181|100473058|FG000|Overall Study|Lost to Follow-up|1|||
33153007|NCT02001181|100473059|FG001|Overall Study|Lost to Follow-up|0|||
33386823|NCT00355134|101302639|FG002|Extension Phase|Protocol Violation|0|||
33386824|NCT00355134|101302640|FG003|Extension Phase|Protocol Violation|1|||
33386825|NCT00355134|101302641|FG004|Extension Phase|Protocol Violation|0|||
33153008|NCT02001181|100473058|FG000|Overall Study|Withdrawal by Subject|0|||
33153009|NCT02001181|100473059|FG001|Overall Study|Withdrawal by Subject|1|||
33250794|NCT01981850|100817839|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33386826|NCT00656084|101302642|FG000|Overall Study|Adverse Event|4|||
33386827|NCT00656084|101302642|FG000|Overall Study|Withdrawal by Subject|1|||
33153010|NCT01824342|100475422|FG000|Overall Study|Withdrawal by Subject|0|||
33153011|NCT01824342|100475423|FG001|Overall Study|Withdrawal by Subject|3|||
33153012|NCT01824342|100475422|FG000|Overall Study|Adverse Event|1|||
33153013|NCT01824342|100475423|FG001|Overall Study|Adverse Event|1|||
33153014|NCT01824342|100475422|FG000|Overall Study|Disease Progression|1|||
33153015|NCT01824342|100475423|FG001|Overall Study|Disease Progression|1|||
33153016|NCT01824342|100475422|FG000|Overall Study|Physician Decision|5|||
33250795|NCT01981850|100817840|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33250796|NCT01981850|100817841|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33250797|NCT01981850|100817842|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33250798|NCT01981850|100817843|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33250799|NCT01981850|100817844|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33250800|NCT01981850|100817845|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
33250801|NCT01981850|100817846|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
33250802|NCT01981850|100817837|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
33250803|NCT01981850|100817838|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
33250804|NCT01981850|100817839|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
33250805|NCT01981850|100817840|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
33250806|NCT01981850|100817841|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
33250807|NCT01981850|100817842|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
33250808|NCT01981850|100817843|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
33250809|NCT01981850|100817844|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
33250810|NCT01981850|100817845|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
33250811|NCT01981850|100817846|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
33250812|NCT02148133|100817850|FG000|Overall Study|Investigator discretion|1|||
33250813|NCT02148133|100817850|FG000|Overall Study|Lack of Efficacy|1|||
33250814|NCT02148133|100817850|FG000|Overall Study|Protocol deviation|1|||
33386828|NCT00656084|101302642|FG000|Overall Study|Patient Request|1|||
33386829|NCT00656084|101302642|FG000|Overall Study|Investigator Request|1|||
33250815|NCT02148133|100817850|FG000|Overall Study|Protocol-defined stopping criteria|2|||
33437282|NCT00727571|101492684|FG003|Overall Study|Subject Non Compliance|4|||
33250816|NCT00906035|100817851|FG000|Overall Study|Withdrawal by Subject|2|||
33250817|NCT00906035|100817852|FG001|Overall Study|Withdrawal by Subject|3|||
33250818|NCT00906035|100817853|FG002|Overall Study|Withdrawal by Subject|0|||
33250819|NCT02914522|100817866|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
33250820|NCT02914522|100817867|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
33250821|NCT02914522|100817868|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
33250822|NCT02914522|100817869|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
33250823|NCT02914522|100817870|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
33250824|NCT02914522|100817871|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
33250825|NCT02914522|100817872|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
33250826|NCT02914522|100817873|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
33250827|NCT02914522|100817874|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
33250828|NCT02914522|100817875|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
33250829|NCT02914522|100817876|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
33250830|NCT02914522|100817866|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
33250831|NCT02914522|100817867|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
33250832|NCT02914522|100817868|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
33250833|NCT02914522|100817869|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
33250834|NCT02914522|100817870|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
33250835|NCT02914522|100817871|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
33250836|NCT02914522|100817872|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
33250837|NCT02914522|100817873|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
33250838|NCT02914522|100817874|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
33250839|NCT02914522|100817875|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
33250840|NCT02914522|100817876|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
33250841|NCT02914522|100817866|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
33250842|NCT02914522|100817867|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
33250843|NCT02914522|100817868|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
33250844|NCT02914522|100817869|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
33250845|NCT02914522|100817870|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
33250846|NCT02914522|100817871|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
33250847|NCT02914522|100817872|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
33250848|NCT02914522|100817873|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
33250849|NCT02914522|100817874|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
33250850|NCT02914522|100817875|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
33250851|NCT02914522|100817876|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
33250852|NCT02914522|100817866|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33250853|NCT02914522|100817867|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
33250854|NCT02914522|100817868|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
33250855|NCT02914522|100817869|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
33250856|NCT02914522|100817870|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33386830|NCT00431496|101302643|FG000|Overall Study|Adverse Event|3|||
33386831|NCT00431496|101302643|FG000|Overall Study|Lost to Follow-up|1|||
33386832|NCT00431496|101302643|FG000|Overall Study|Withdrawal by Subject|2|||
33386833|NCT00431496|101302643|FG000|Overall Study|Protocol-specified criteria|5|||
33386834|NCT00379236|101302655|FG000|Double-blind|Adverse Event|11|||
33386835|NCT00379236|101302656|FG001|Double-blind|Adverse Event|6|||
33386836|NCT00379236|101302657|FG002|Double-blind|Adverse Event|0|||
33386837|NCT00379236|101302655|FG000|Double-blind|Protocol Violation|3|||
33386838|NCT00379236|101302656|FG001|Double-blind|Protocol Violation|3|||
33386839|NCT00379236|101302657|FG002|Double-blind|Protocol Violation|0|||
33386840|NCT00379236|101302655|FG000|Double-blind|Withdrawal by Subject|12|||
33386841|NCT00379236|101302656|FG001|Double-blind|Withdrawal by Subject|13|||
33386842|NCT00379236|101302657|FG002|Double-blind|Withdrawal by Subject|0|||
33386843|NCT00379236|101302655|FG000|Double-blind|Lost to Follow-up|4|||
33386844|NCT00379236|101302656|FG001|Double-blind|Lost to Follow-up|3|||
33386845|NCT00379236|101302657|FG002|Double-blind|Lost to Follow-up|0|||
33386846|NCT00379236|101302655|FG000|Double-blind|Use of exclusionary medication|1|||
33386847|NCT00379236|101302656|FG001|Double-blind|Use of exclusionary medication|2|||
33437283|NCT00727571|101492681|FG000|Overall Study|Dismissed from nursing home|0|||
33250857|NCT02914522|100817871|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33250858|NCT02914522|100817872|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33250859|NCT02914522|100817873|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33250860|NCT02914522|100817874|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33250861|NCT02914522|100817875|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33250862|NCT02914522|100817876|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
33250863|NCT02914522|100817866|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33250864|NCT02914522|100817867|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33250865|NCT02914522|100817868|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33250866|NCT02914522|100817869|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33250867|NCT02914522|100817870|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
33250868|NCT02914522|100817871|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33250869|NCT02914522|100817872|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33250870|NCT02914522|100817873|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33250871|NCT02914522|100817874|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33250872|NCT02914522|100817875|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33250873|NCT02914522|100817876|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
33250874|NCT02914522|100817866|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
33250875|NCT02914522|100817867|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33250876|NCT02914522|100817868|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33250877|NCT02914522|100817869|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33250878|NCT02914522|100817870|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33250879|NCT02914522|100817871|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33250880|NCT02914522|100817872|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33250881|NCT02914522|100817873|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33250882|NCT02914522|100817874|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33250883|NCT02914522|100817875|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33250884|NCT02914522|100817876|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
33250885|NCT02914522|100817866|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
33250886|NCT02914522|100817867|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
33250887|NCT02914522|100817868|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
33250888|NCT02914522|100817869|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
33250889|NCT02914522|100817870|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
33250890|NCT02914522|100817871|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
33250891|NCT02914522|100817872|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
33250892|NCT02914522|100817873|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
33250893|NCT02914522|100817874|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
33250894|NCT02914522|100817875|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
33250895|NCT02914522|100817876|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
33250896|NCT02914522|100817866|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33386848|NCT00379236|101302657|FG002|Double-blind|Use of exclusionary medication|0|||
33386849|NCT00379236|101302655|FG000|Double-blind|Other|3|||
33153017|NCT01824342|100475423|FG001|Overall Study|Physician Decision|0|||
33153018|NCT01824342|100475422|FG000|Overall Study|Death|2|||
33153019|NCT01824342|100475423|FG001|Overall Study|Death|0|||
33153020|NCT00471146|100475424|FG000|Overall Study|Adverse Event|32|||
33153021|NCT00471146|100475425|FG001|Overall Study|Adverse Event|33|||
33153022|NCT00471146|100475424|FG000|Overall Study|Withdrawal by Subject|14|||
33250897|NCT02914522|100817867|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
33250898|NCT02914522|100817868|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33250899|NCT02914522|100817869|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33250900|NCT02914522|100817870|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
33250901|NCT02914522|100817871|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
33250902|NCT02914522|100817872|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33250903|NCT02914522|100817873|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33250904|NCT02914522|100817874|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33250905|NCT02914522|100817875|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33250906|NCT02914522|100817876|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
33250907|NCT02914522|100817866|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
33250908|NCT02914522|100817867|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
33250909|NCT02914522|100817868|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
33250910|NCT02914522|100817869|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
33250911|NCT02914522|100817870|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
33250912|NCT02914522|100817871|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
33250913|NCT02914522|100817872|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
33250914|NCT02914522|100817873|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
33250915|NCT02914522|100817874|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
33250916|NCT02914522|100817875|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
33250917|NCT02914522|100817876|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
33250918|NCT02914522|100817866|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
33250919|NCT02914522|100817867|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
33250920|NCT02914522|100817868|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
33250921|NCT02914522|100817869|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
33250922|NCT02914522|100817870|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
33250923|NCT02914522|100817871|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
33250924|NCT02914522|100817872|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
33250925|NCT02914522|100817873|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
33250926|NCT02914522|100817874|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
33250927|NCT02914522|100817875|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
33250928|NCT02914522|100817876|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
33250929|NCT02914522|100817866|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
33250930|NCT02914522|100817867|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
33250931|NCT02914522|100817868|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
33250932|NCT02914522|100817869|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
33250933|NCT02914522|100817870|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
33250934|NCT02914522|100817871|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
33250935|NCT02914522|100817872|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
33250936|NCT02914522|100817873|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
33250937|NCT02914522|100817874|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
33250938|NCT02914522|100817875|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
33250939|NCT02914522|100817876|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
33250940|NCT02914522|100817866|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
33250941|NCT02914522|100817867|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
33250942|NCT02914522|100817868|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
33250943|NCT02914522|100817869|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
33250944|NCT02914522|100817870|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
33250945|NCT02914522|100817871|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
33250946|NCT02914522|100817872|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
33250947|NCT02914522|100817873|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
33250948|NCT02914522|100817874|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
33250949|NCT02914522|100817875|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
33250950|NCT02914522|100817876|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
33250951|NCT02914522|100817866|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
33250952|NCT02914522|100817867|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
33250953|NCT02914522|100817868|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
33437284|NCT00727571|101492682|FG001|Overall Study|Dismissed from nursing home|9|||
33437285|NCT00727571|101492683|FG002|Overall Study|Dismissed from nursing home|5|||
33437286|NCT00727571|101492684|FG003|Overall Study|Dismissed from nursing home|0|||
33437287|NCT00727571|101492681|FG000|Overall Study|Hospitalization|0|||
33250954|NCT02914522|100817869|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
33250955|NCT02914522|100817870|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
33250956|NCT02914522|100817871|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
33250957|NCT02914522|100817872|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
33437288|NCT00727571|101492682|FG001|Overall Study|Hospitalization|1|||
33437289|NCT00727571|101492683|FG002|Overall Study|Hospitalization|0|||
33437290|NCT00727571|101492684|FG003|Overall Study|Hospitalization|1|||
33437291|NCT00727571|101492681|FG000|Overall Study|AE not leading to hospitalization|0|||
33437292|NCT00727571|101492682|FG001|Overall Study|AE not leading to hospitalization|0|||
33437293|NCT00727571|101492683|FG002|Overall Study|AE not leading to hospitalization|2|||
33437294|NCT00727571|101492684|FG003|Overall Study|AE not leading to hospitalization|0|||
33437295|NCT00727571|101492681|FG000|Overall Study|Other|0|||
33153023|NCT00471146|100475425|FG001|Overall Study|Withdrawal by Subject|11|||
33153024|NCT00471146|100475424|FG000|Overall Study|Death|11|||
33153025|NCT00471146|100475425|FG001|Overall Study|Death|12|||
33153026|NCT00471146|100475424|FG000|Overall Study|Lost to Follow-up|4|||
33153027|NCT00471146|100475425|FG001|Overall Study|Lost to Follow-up|2|||
33153028|NCT00471146|100475424|FG000|Overall Study|Protocol Violation|2|||
33153029|NCT00471146|100475425|FG001|Overall Study|Protocol Violation|2|||
33250958|NCT02914522|100817873|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
33250959|NCT02914522|100817874|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
33250960|NCT02914522|100817875|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
33250961|NCT02914522|100817876|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
33250962|NCT02914522|100817866|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33250963|NCT02914522|100817867|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33250964|NCT02914522|100817868|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33250965|NCT02914522|100817869|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33250966|NCT02914522|100817870|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33250967|NCT02914522|100817871|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33250968|NCT02914522|100817872|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33250969|NCT02914522|100817873|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
33250970|NCT02914522|100817874|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
33250971|NCT02914522|100817875|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33250972|NCT02914522|100817876|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
33250973|NCT02914522|100817866|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33250974|NCT02914522|100817867|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33386850|NCT00379236|101302656|FG001|Double-blind|Other|7|||
33386851|NCT00379236|101302657|FG002|Double-blind|Other|0|||
33386852|NCT00379236|101302655|FG000|Double-blind|Data could not be retrieved|2|||
33386853|NCT00379236|101302656|FG001|Double-blind|Data could not be retrieved|2|||
33386854|NCT00379236|101302657|FG002|Double-blind|Data could not be retrieved|0|||
33386855|NCT00379236|101302655|FG000|Open-label Extension|Adverse Event|0|||
33386856|NCT00379236|101302656|FG001|Open-label Extension|Adverse Event|0|||
33386857|NCT00379236|101302657|FG002|Open-label Extension|Adverse Event|13|||
33386858|NCT00379236|101302655|FG000|Open-label Extension|Protocol Violation|0|||
33386859|NCT00379236|101302656|FG001|Open-label Extension|Protocol Violation|0|||
33386860|NCT00379236|101302657|FG002|Open-label Extension|Protocol Violation|7|||
33386861|NCT00379236|101302655|FG000|Open-label Extension|Withdrawal by Subject|0|||
33386862|NCT00379236|101302656|FG001|Open-label Extension|Withdrawal by Subject|0|||
33386863|NCT00379236|101302657|FG002|Open-label Extension|Withdrawal by Subject|13|||
33386864|NCT00379236|101302655|FG000|Open-label Extension|Lost to Follow-up|0|||
33386865|NCT00379236|101302656|FG001|Open-label Extension|Lost to Follow-up|0|||
33386866|NCT00379236|101302657|FG002|Open-label Extension|Lost to Follow-up|12|||
33386867|NCT00379236|101302655|FG000|Open-label Extension|Use of exclusionary medication|0|||
33386868|NCT00379236|101302656|FG001|Open-label Extension|Use of exclusionary medication|0|||
33386869|NCT00379236|101302657|FG002|Open-label Extension|Use of exclusionary medication|3|||
33386870|NCT00379236|101302655|FG000|Open-label Extension|Other|0|||
33386871|NCT00379236|101302656|FG001|Open-label Extension|Other|0|||
33386872|NCT00379236|101302657|FG002|Open-label Extension|Other|7|||
33386873|NCT02057068|101302658|FG000|Overall Study|Withdrawal by Subject|2|||
33386874|NCT02057068|101302659|FG001|Overall Study|Withdrawal by Subject|2|||
33386875|NCT02057068|101302658|FG000|Overall Study|Caregiver (CG) Health|0|||
33386876|NCT02057068|101302659|FG001|Overall Study|Caregiver (CG) Health|2|||
33386877|NCT02057068|101302658|FG000|Overall Study|Carepartner (CP) Health|4|||
33386878|NCT02057068|101302659|FG001|Overall Study|Carepartner (CP) Health|2|||
33386879|NCT02057068|101302658|FG000|Overall Study|Lost to Follow-up|2|||
33386880|NCT02057068|101302659|FG001|Overall Study|Lost to Follow-up|2|||
33386881|NCT00416312|101302662|FG000|Overall Study|tumors not visible on imaging|2|||
33386882|NCT04018612|101302664|FG000|Overall Study|Withdrawal by Subject|1|||
33386883|NCT04018612|101302665|FG001|Overall Study|Withdrawal by Subject|0|||
33386884|NCT04018612|101302666|FG002|Overall Study|Withdrawal by Subject|1|||
33386885|NCT00927758|101302667|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
33386886|NCT00927758|101302668|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
33386887|NCT00927758|101302669|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
33153030|NCT00471146|100475424|FG000|Overall Study|Objective progression or relapse|84|||
33250975|NCT02914522|100817868|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33250976|NCT02914522|100817869|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33250977|NCT02914522|100817870|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33250978|NCT02914522|100817871|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33250979|NCT02914522|100817872|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33250980|NCT02914522|100817873|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33250981|NCT02914522|100817874|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
33250982|NCT02914522|100817875|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
33250983|NCT02914522|100817876|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
33250984|NCT02914522|100817866|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33250985|NCT02914522|100817867|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33250986|NCT02914522|100817868|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33250987|NCT02914522|100817869|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33250988|NCT02914522|100817870|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33250989|NCT02914522|100817871|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33250990|NCT02914522|100817872|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33250991|NCT02914522|100817873|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33250992|NCT02914522|100817874|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33250993|NCT02914522|100817875|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
33250994|NCT02914522|100817876|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
33250995|NCT01591616|100817883|FG000|Overall Study|Withdrawal by Subject|1|||
33250996|NCT00038103|100817884|FG000|Overall Study|Adverse Event|5|||
33250997|NCT00038103|100817885|FG001|Overall Study|Adverse Event|6|||
33250998|NCT00038103|100817884|FG000|Overall Study|Lack of Efficacy|48|||
33250999|NCT00038103|100817885|FG001|Overall Study|Lack of Efficacy|41|||
33251000|NCT00038103|100817884|FG000|Overall Study|Withdrawal by Subject|0|||
33251001|NCT00038103|100817885|FG001|Overall Study|Withdrawal by Subject|3|||
33251002|NCT00038103|100817884|FG000|Overall Study|Lost to Follow-up|0|||
33251003|NCT00038103|100817885|FG001|Overall Study|Lost to Follow-up|3|||
33251004|NCT00038103|100817884|FG000|Overall Study|Protocol Violation|0|||
33251005|NCT00038103|100817885|FG001|Overall Study|Protocol Violation|2|||
33251006|NCT00038103|100817884|FG000|Overall Study|Sponsor Decision|0|||
33251007|NCT00038103|100817885|FG001|Overall Study|Sponsor Decision|1|||
33251008|NCT00038103|100817884|FG000|Overall Study|Randomized/never treated|2|||
33251009|NCT00038103|100817885|FG001|Overall Study|Randomized/never treated|0|||
33251010|NCT02613364|100817888|FG000|Overall Study|Other|19|||
33386888|NCT00927758|101302670|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
33386889|NCT00927758|101302671|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
33386890|NCT00927758|101302672|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
33386891|NCT00927758|101302667|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
33386892|NCT00927758|101302668|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
33386893|NCT00927758|101302669|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
33386894|NCT00927758|101302670|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
33386895|NCT00927758|101302671|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
33386896|NCT00927758|101302672|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
33386897|NCT05742841|101302673|FG000|Overall Study|Withdrawal by Subject|1|||
33386898|NCT05742841|101302673|FG000|Overall Study|Lost to Follow-up|1|||
33386899|NCT02197897|101302674|FG000|Overall Study|not eligible|1|||
33386900|NCT03725293|101302675|FG000|Overall Study|Physician Decision|9|||
33386901|NCT03725293|101302676|FG001|Overall Study|Physician Decision|6|||
33386902|NCT03725293|101302675|FG000|Overall Study|alternative vascular access needs|1|||
33386903|NCT03725293|101302676|FG001|Overall Study|alternative vascular access needs|2|||
33386904|NCT03725293|101302675|FG000|Overall Study|venous anatomy screen failures|2|||
33386905|NCT03725293|101302676|FG001|Overall Study|venous anatomy screen failures|1|||
33386906|NCT00802867|101302677|FG000|Overall Study|Lost to Follow-up|6|||
33386907|NCT00802867|101302677|FG000|Overall Study|Protocol Violation|6|||
33386908|NCT00802867|101302677|FG000|Overall Study|Withdrawal by Subject|1|||
33386909|NCT02650895|101302678|FG000|Overall Study|Withdrawal by Subject|0|||
33386910|NCT02650895|101302679|FG001|Overall Study|Withdrawal by Subject|1|||
33386911|NCT02650895|101302680|FG002|Overall Study|Withdrawal by Subject|0|||
33386912|NCT02650895|101302681|FG003|Overall Study|Withdrawal by Subject|0|||
33386913|NCT02650895|101302682|FG004|Overall Study|Withdrawal by Subject|0|||
33386914|NCT02650895|101302683|FG005|Overall Study|Withdrawal by Subject|0|||
33386915|NCT00469209|101302684|FG000|Overall Study|Adverse Event|1|||
33386916|NCT00469209|101302685|FG001|Overall Study|Adverse Event|0|||
33386917|NCT00469209|101302686|FG002|Overall Study|Adverse Event|1|||
33251011|NCT02613364|100817889|FG001|Overall Study|Other|29|||
33251012|NCT02613364|100817890|FG002|Overall Study|Other|17|||
33386918|NCT01742091|101302687|FG000|Overall Study|Adverse Event|0|||
33251013|NCT02613364|100817888|FG000|Overall Study|Too time consuming|21|||
33251014|NCT02613364|100817889|FG001|Overall Study|Too time consuming|26|||
33251015|NCT02613364|100817890|FG002|Overall Study|Too time consuming|26|||
33251016|NCT02613364|100817888|FG000|Overall Study|Withdrawal by Subject|13|||
33251017|NCT02613364|100817889|FG001|Overall Study|Withdrawal by Subject|18|||
33251018|NCT02613364|100817890|FG002|Overall Study|Withdrawal by Subject|17|||
33251019|NCT02613364|100817888|FG000|Overall Study|Medical|12|||
33251020|NCT02613364|100817889|FG001|Overall Study|Medical|13|||
33251021|NCT02613364|100817890|FG002|Overall Study|Medical|9|||
33251022|NCT02613364|100817888|FG000|Overall Study|Disliked Study Procedure|1|||
33251023|NCT02613364|100817889|FG001|Overall Study|Disliked Study Procedure|1|||
33251024|NCT02613364|100817890|FG002|Overall Study|Disliked Study Procedure|4|||
33251025|NCT02613364|100817888|FG000|Overall Study|Disliked Intervention|0|||
33251026|NCT02613364|100817889|FG001|Overall Study|Disliked Intervention|3|||
33251027|NCT02613364|100817890|FG002|Overall Study|Disliked Intervention|3|||
33251028|NCT02459899|100817898|FG000|Overall Study|Adverse Event|1|||
33251029|NCT02459899|100817899|FG001|Overall Study|Adverse Event|1|||
33251030|NCT02459899|100817900|FG002|Overall Study|Adverse Event|0|||
33251031|NCT02459899|100817901|FG003|Overall Study|Adverse Event|0|||
33251032|NCT02459899|100817898|FG000|Overall Study|Lost to Follow-up|1|||
33251033|NCT02459899|100817899|FG001|Overall Study|Lost to Follow-up|2|||
33251034|NCT02459899|100817900|FG002|Overall Study|Lost to Follow-up|0|||
33251035|NCT02459899|100817901|FG003|Overall Study|Lost to Follow-up|1|||
33251036|NCT02459899|100817898|FG000|Overall Study|Non-compliance with the treatment|0|||
33251037|NCT02459899|100817899|FG001|Overall Study|Non-compliance with the treatment|0|||
33251038|NCT02459899|100817900|FG002|Overall Study|Non-compliance with the treatment|0|||
33251039|NCT02459899|100817901|FG003|Overall Study|Non-compliance with the treatment|1|||
33251040|NCT02459899|100817898|FG000|Overall Study|Withdrawal by Subject|1|||
33251041|NCT02459899|100817899|FG001|Overall Study|Withdrawal by Subject|3|||
33251042|NCT02459899|100817900|FG002|Overall Study|Withdrawal by Subject|0|||
33153031|NCT00471146|100475425|FG001|Overall Study|Objective progression or relapse|87|||
33153032|NCT00471146|100475424|FG000|Overall Study|Global deterioration of health status|12|||
33251043|NCT02459899|100817901|FG003|Overall Study|Withdrawal by Subject|0|||
33251044|NCT00771849|100817902|FG000|Overall Study|Lost to Follow-up|1|||
33251045|NCT00771849|100817903|FG001|Overall Study|Lost to Follow-up|2|||
33251046|NCT00771849|100817902|FG000|Overall Study|Withdrawal by Subject|1|||
33251047|NCT00771849|100817903|FG001|Overall Study|Withdrawal by Subject|1|||
33251048|NCT00771849|100817902|FG000|Overall Study|Not vaccinated|0|||
33251049|NCT00771849|100817903|FG001|Overall Study|Not vaccinated|1|||
33251050|NCT00559949|100817904|FG000|Overall Study|Progressive Disease during cycle 1|1|||
33437296|NCT00727571|101492682|FG001|Overall Study|Other|4|||
33437297|NCT00727571|101492683|FG002|Overall Study|Other|6|||
33437298|NCT00727571|101492684|FG003|Overall Study|Other|0|||
33437299|NCT00688064|101492685|FG000|Overall Study|Protocol Violation|0|||
33153033|NCT00471146|100475425|FG001|Overall Study|Global deterioration of health status|14|||
33153034|NCT00471146|100475424|FG000|Overall Study|Randomized but not treated|9|||
33153035|NCT00471146|100475425|FG001|Overall Study|Randomized but not treated|8|||
33153036|NCT00471146|100475424|FG000|Overall Study|Other|4|||
33153037|NCT00471146|100475425|FG001|Overall Study|Other|5|||
33153038|NCT04357782|100475426|FG000|Overall Study|Discharged from hospital|1|||
33153039|NCT04357782|100475427|FG001|Overall Study|Discharged from hospital|0|||
33153040|NCT04357782|100475426|FG000|Overall Study|Death|0|||
33153041|NCT04357782|100475427|FG001|Overall Study|Death|2|||
33153042|NCT01309165|100475428|FG000|Overall Study|Lost to Follow-up|4|||
33153043|NCT01309165|100475429|FG001|Overall Study|Lost to Follow-up|3|||
33153044|NCT01309165|100475428|FG000|Overall Study|Return to work|1|||
33251051|NCT00559949|100817904|FG000|Overall Study|Adverse Event|1|||
33153045|NCT01309165|100475429|FG001|Overall Study|Return to work|2|||
33153046|NCT01309165|100475428|FG000|Overall Study|Left country|0|||
33153047|NCT01309165|100475429|FG001|Overall Study|Left country|1|||
33251052|NCT00559949|100817904|FG000|Overall Study|Withdrawal by Subject|4|||
33251053|NCT00559949|100817904|FG000|Overall Study|No disease evaluation per protocol|1|||
33251054|NCT03537651|100817905|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
33251055|NCT03537651|100817905|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
33251056|NCT03537651|100817905|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
33251057|NCT03537651|100817905|FG000|Part A (Up to 96 Weeks)|Other|1|||
33251058|NCT03537651|100817905|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
33251059|NCT03537651|100817905|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
33251060|NCT03537651|100817905|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
33251061|NCT03537651|100817905|FG000|Part B (Up to 192 Weeks)|Other|1|||
33153048|NCT01309165|100475428|FG000|Overall Study|No transportation|0|||
33153049|NCT01309165|100475429|FG001|Overall Study|No transportation|1|||
33153050|NCT01309165|100475428|FG000|Overall Study|Admitted to hospital for second stroke|1|||
33251062|NCT02685033|100817906|FG000|Overall Study|Withdrawal of Consent|0|||
33251063|NCT02685033|100817907|FG001|Overall Study|Withdrawal of Consent|1|||
33251064|NCT02685033|100817906|FG000|Overall Study|Lost to Follow-up|2|||
33251065|NCT02685033|100817907|FG001|Overall Study|Lost to Follow-up|1|||
33251066|NCT02685033|100817906|FG000|Overall Study|Adverse Event|1|||
33251067|NCT02685033|100817907|FG001|Overall Study|Adverse Event|0|||
33251068|NCT01490580|100817908|FG000|Overall Study|Parents withdrew consent|0|||
33251069|NCT01490580|100817909|FG001|Overall Study|Parents withdrew consent|2|||
33251070|NCT00256243|100817910|FG000|Overall Study|Lost to Follow-up|2|||
33251071|NCT00256243|100817910|FG000|Overall Study|Death|7|||
33251072|NCT00256243|100817910|FG000|Overall Study|Not treated|1|||
33251073|NCT00762606|100817912|FG000|Overall Study|Lost to Follow-up|18|||
33251074|NCT00762606|100817913|FG001|Overall Study|Lost to Follow-up|13|||
33251075|NCT03395353|100817919|FG000|Overall Study|Adverse Event|20|||
33251076|NCT03395353|100817919|FG000|Overall Study|Protocol Violation|1|||
33251077|NCT03395353|100817919|FG000|Overall Study|Lack of Efficacy|3|||
33251078|NCT03395353|100817919|FG000|Overall Study|Withdrawal by Subject|24|||
33251079|NCT03395353|100817919|FG000|Overall Study|Discontinued visit|1|||
33251080|NCT03395353|100817919|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
33251081|NCT03395353|100817919|FG000|Overall Study|Physician Decision|4|||
33251082|NCT03395353|100817919|FG000|Overall Study|Early termination of overall study|33|||
33251083|NCT02975934|100817920|FG000|Treatment Phase|Ongoing at data-analysis|33|||
33251084|NCT02975934|100817921|FG001|Treatment Phase|Ongoing at data-analysis|5|||
33251085|NCT02975934|100817920|FG000|Treatment Phase|Discontinued prior to study drug|0|||
33251086|NCT02975934|100817921|FG001|Treatment Phase|Discontinued prior to study drug|5|||
33251087|NCT02975934|100817920|FG000|Cross-Over Phase|Ongoing at data-analysis|0|||
33251088|NCT02975934|100817921|FG001|Cross-Over Phase|Ongoing at data-analysis|7|||
33251089|NCT05193318|100817924|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
33437300|NCT00688064|101492686|FG001|Overall Study|Protocol Violation|1|||
33437301|NCT00688064|101492685|FG000|Overall Study|Adverse Event|2|||
33153051|NCT01309165|100475429|FG001|Overall Study|Admitted to hospital for second stroke|0|||
33153052|NCT01461980|100475431|FG000|Overall Study|Other|9|||
33153053|NCT01461980|100475432|FG001|Overall Study|Other|8|||
33153054|NCT01461980|100475433|FG002|Overall Study|Other|6|||
33153055|NCT01461980|100475431|FG000|Overall Study|Medication error|7|||
33153056|NCT01461980|100475432|FG001|Overall Study|Medication error|5|||
33153057|NCT01461980|100475433|FG002|Overall Study|Medication error|6|||
33153058|NCT01461980|100475431|FG000|Overall Study|Adverse Event|12|||
33153059|NCT01461980|100475432|FG001|Overall Study|Adverse Event|5|||
33153060|NCT01461980|100475433|FG002|Overall Study|Adverse Event|6|||
33153061|NCT01461980|100475431|FG000|Overall Study|Protocol Violation|12|||
33153062|NCT01461980|100475432|FG001|Overall Study|Protocol Violation|19|||
33153063|NCT01461980|100475433|FG002|Overall Study|Protocol Violation|16|||
33153064|NCT01461980|100475431|FG000|Overall Study|No longer meets eligibility criteria|18|||
33153065|NCT01461980|100475432|FG001|Overall Study|No longer meets eligibility criteria|9|||
33153066|NCT01461980|100475433|FG002|Overall Study|No longer meets eligibility criteria|19|||
33153067|NCT01461980|100475431|FG000|Overall Study|Lost to Follow-up|52|||
33153068|NCT01461980|100475432|FG001|Overall Study|Lost to Follow-up|53|||
33153069|NCT01461980|100475433|FG002|Overall Study|Lost to Follow-up|51|||
33153070|NCT01461980|100475431|FG000|Overall Study|No longer willing to participate|52|||
33153071|NCT01461980|100475432|FG001|Overall Study|No longer willing to participate|38|||
33251090|NCT05193318|100817924|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
33251091|NCT00544440|100817925|FG000|Overall Study|Other|1|||
33251092|NCT00544440|100817925|FG000|Overall Study|Adverse Event|1|||
33251093|NCT00544440|100817925|FG000|Overall Study|Withdrawal by Subject|2|||
33251094|NCT00544440|100817925|FG000|Overall Study|Subject Non-compliance|1|||
33251095|NCT00544440|100817925|FG000|Overall Study|Progressive Disease|47|||
33251096|NCT00544440|100817925|FG000|Overall Study|Other|5|||
33251097|NCT01289119|100817928|FG000|Overall Study|Adverse Event|2|||
33251098|NCT01289119|100817929|FG001|Overall Study|Adverse Event|1|||
33251099|NCT01289119|100817930|FG002|Overall Study|Adverse Event|0|||
33251100|NCT01289119|100817931|FG003|Overall Study|Adverse Event|2|||
33251101|NCT01289119|100817932|FG004|Overall Study|Adverse Event|1|||
33251102|NCT01289119|100817933|FG005|Overall Study|Adverse Event|0|||
33251103|NCT01289119|100817928|FG000|Overall Study|Major Protocol Deviation|2|||
33251104|NCT01289119|100817929|FG001|Overall Study|Major Protocol Deviation|1|||
33251105|NCT01289119|100817930|FG002|Overall Study|Major Protocol Deviation|3|||
33251106|NCT01289119|100817931|FG003|Overall Study|Major Protocol Deviation|0|||
33251107|NCT01289119|100817932|FG004|Overall Study|Major Protocol Deviation|2|||
33251108|NCT01289119|100817933|FG005|Overall Study|Major Protocol Deviation|1|||
33251109|NCT01289119|100817928|FG000|Overall Study|Lost to Follow-up|0|||
33251110|NCT01289119|100817929|FG001|Overall Study|Lost to Follow-up|3|||
33251111|NCT01289119|100817930|FG002|Overall Study|Lost to Follow-up|0|||
33251112|NCT01289119|100817931|FG003|Overall Study|Lost to Follow-up|0|||
33251113|NCT01289119|100817932|FG004|Overall Study|Lost to Follow-up|0|||
33251114|NCT01289119|100817933|FG005|Overall Study|Lost to Follow-up|1|||
33251115|NCT01289119|100817928|FG000|Overall Study|Withdrawal by Subject|4|||
33251116|NCT01289119|100817929|FG001|Overall Study|Withdrawal by Subject|2|||
33251117|NCT01289119|100817930|FG002|Overall Study|Withdrawal by Subject|4|||
33251118|NCT01289119|100817931|FG003|Overall Study|Withdrawal by Subject|3|||
33251119|NCT01289119|100817932|FG004|Overall Study|Withdrawal by Subject|1|||
33251120|NCT01289119|100817933|FG005|Overall Study|Withdrawal by Subject|1|||
33251121|NCT01289119|100817928|FG000|Overall Study|Pregnancy|0|||
33386919|NCT01742091|101302688|FG001|Overall Study|Adverse Event|0|||
33251122|NCT01289119|100817929|FG001|Overall Study|Pregnancy|1|||
33251123|NCT01289119|100817930|FG002|Overall Study|Pregnancy|0|||
33251124|NCT01289119|100817931|FG003|Overall Study|Pregnancy|0|||
33386920|NCT01742091|101302689|FG002|Overall Study|Adverse Event|0|||
33251125|NCT01289119|100817932|FG004|Overall Study|Pregnancy|0|||
33251126|NCT01289119|100817933|FG005|Overall Study|Pregnancy|0|||
33251127|NCT01289119|100817928|FG000|Overall Study|Lack of Efficacy|0|||
33251128|NCT01289119|100817929|FG001|Overall Study|Lack of Efficacy|1|||
33251129|NCT01289119|100817930|FG002|Overall Study|Lack of Efficacy|1|||
33251130|NCT01289119|100817931|FG003|Overall Study|Lack of Efficacy|1|||
33251131|NCT01289119|100817932|FG004|Overall Study|Lack of Efficacy|1|||
33437302|NCT00688064|101492686|FG001|Overall Study|Adverse Event|4|||
33251132|NCT01289119|100817933|FG005|Overall Study|Lack of Efficacy|1|||
33251133|NCT01289119|100817928|FG000|Overall Study|Other|1|||
33251134|NCT01289119|100817929|FG001|Overall Study|Other|0|||
33251135|NCT01289119|100817930|FG002|Overall Study|Other|1|||
33251136|NCT01289119|100817931|FG003|Overall Study|Other|0|||
33251137|NCT01289119|100817932|FG004|Overall Study|Other|0|||
33251138|NCT01289119|100817933|FG005|Overall Study|Other|0|||
33251139|NCT01149681|100817934|FG000|Overall Study|Withdrawal by Subject|7|||
33251140|NCT01149681|100817934|FG000|Overall Study|Progressive disease|1|||
33251141|NCT01149681|100817934|FG000|Overall Study|Physician Decision|2|||
33251142|NCT01149681|100817934|FG000|Overall Study|adverse events nonrelated study drug|2|||
33251143|NCT05136443|100817937|FG000|Overall Study|Lost to Follow-up|2|||
33251144|NCT05136443|100817937|FG000|Overall Study|Adverse Event|2|||
33251145|NCT00424762|100817940|FG000|Overall Study|Withdrawal by Subject|18|||
33251146|NCT00424762|100817941|FG001|Overall Study|Withdrawal by Subject|19|||
33251147|NCT00424762|100817940|FG000|Overall Study|Lost to Follow-up|2|||
33251148|NCT00424762|100817941|FG001|Overall Study|Lost to Follow-up|3|||
33251149|NCT02955069|100817942|FG000|Overall Study|Adverse Event|7|||
33251150|NCT02955069|100817943|FG001|Overall Study|Adverse Event|2|||
33251151|NCT02955069|100817942|FG000|Overall Study|Death|7|||
33251152|NCT02955069|100817943|FG001|Overall Study|Death|3|||
33251153|NCT02955069|100817942|FG000|Overall Study|Physician Decision|10|||
33251154|NCT02955069|100817943|FG001|Overall Study|Physician Decision|2|||
33251155|NCT02955069|100817942|FG000|Overall Study|Progressive disease|64|||
33251156|NCT02955069|100817943|FG001|Overall Study|Progressive disease|13|||
33251157|NCT02955069|100817942|FG000|Overall Study|Study terminated by sponsor|4|||
33251158|NCT02955069|100817943|FG001|Overall Study|Study terminated by sponsor|0|||
33251159|NCT02955069|100817942|FG000|Overall Study|Subject/Guardian decision|3|||
33251160|NCT02955069|100817943|FG001|Overall Study|Subject/Guardian decision|1|||
33251161|NCT01419717|100817946|FG000|Overall Study|Protocol-specified Criteria|62|||
33251162|NCT01419717|100817946|FG000|Overall Study|Adverse Event|19|||
33251163|NCT01419717|100817946|FG000|Overall Study|Death|17|||
33251164|NCT01419717|100817946|FG000|Overall Study|Withdrawal by Subject|10|||
33251165|NCT01419717|100817946|FG000|Overall Study|Disease Progression|9|||
33251166|NCT01419717|100817946|FG000|Overall Study|Other|4|||
33251167|NCT01419717|100817946|FG000|Overall Study|Lost to Follow-up|2|||
33251168|NCT01419717|100817946|FG000|Overall Study|Administrative Decision|1|||
33251169|NCT01419717|100817946|FG000|Overall Study|Noncompliance|1|||
33251170|NCT02962674|100817952|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
33251171|NCT00798096|100817958|FG000|Overall Study|Ongoing|2|||
33251172|NCT01835899|100817960|FG000|Overall Study|Adverse Event|0|||
33251173|NCT01835899|100817961|FG001|Overall Study|Adverse Event|0|||
33251174|NCT01835899|100817962|FG002|Overall Study|Adverse Event|1|||
33251175|NCT01835899|100817960|FG000|Overall Study|Other than stated above|0|||
33251176|NCT01835899|100817961|FG001|Overall Study|Other than stated above|1|||
33251177|NCT01835899|100817962|FG002|Overall Study|Other than stated above|0|||
33251178|NCT00954707|100817963|FG000|Overall Study|Death|34|||
33251179|NCT00954707|100817963|FG000|Overall Study|Withdrawal by Subject|100|||
33251180|NCT00954707|100817963|FG000|Overall Study|Lost to Follow-up|33|||
33251181|NCT00546871|100817964|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
33251182|NCT00546871|100817965|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
33251183|NCT00546871|100817964|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
33251184|NCT00546871|100817965|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
33251185|NCT00546871|100817964|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
33251186|NCT00546871|100817965|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
33251187|NCT00546871|100817964|FG000|Study Extension Period|Protocol Violation|1|||
33251188|NCT00546871|100817965|FG001|Study Extension Period|Protocol Violation|0|||
33251189|NCT00546871|100817964|FG000|Study Extension Period|Withdrawal by Subject|0|||
33251190|NCT00546871|100817965|FG001|Study Extension Period|Withdrawal by Subject|1|||
33251191|NCT00853827|100817972|FG000|Single Blind Period (1 Week)|Other|4|||
33251192|NCT00853827|100817973|FG001|Single Blind Period (1 Week)|Other|0|||
33251193|NCT00853827|100817972|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
33251194|NCT00853827|100817973|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
33251195|NCT00853827|100817972|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
33251196|NCT00853827|100817973|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
33251197|NCT00853827|100817972|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
33251198|NCT00853827|100817973|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
33251199|NCT00853827|100817972|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
33251200|NCT00853827|100817973|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
33251201|NCT00853827|100817972|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
33251202|NCT00853827|100817973|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
33251203|NCT00853827|100817972|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
33251204|NCT00853827|100817973|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
33251205|NCT00853827|100817972|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
33251206|NCT00853827|100817973|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
33437303|NCT00688064|101492685|FG000|Overall Study|Withdrawal by Subject|7|||
33437304|NCT00688064|101492686|FG001|Overall Study|Withdrawal by Subject|7|||
33437305|NCT00688064|101492685|FG000|Overall Study|Lost to Follow-up|10|||
33437306|NCT00688064|101492686|FG001|Overall Study|Lost to Follow-up|10|||
33386921|NCT01742091|101302690|FG003|Overall Study|Adverse Event|0|||
33437307|NCT00688064|101492685|FG000|Overall Study|Lack of Efficacy|0|||
33437308|NCT00688064|101492686|FG001|Overall Study|Lack of Efficacy|1|||
33437309|NCT00688064|101492685|FG000|Overall Study|Pregnancy|1|||
33386922|NCT01742091|101302691|FG004|Overall Study|Adverse Event|1|||
33437310|NCT00688064|101492686|FG001|Overall Study|Pregnancy|0|||
33251207|NCT00853827|100817972|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
33251208|NCT00853827|100817973|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
33251209|NCT00853827|100817972|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
33251210|NCT00853827|100817973|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
33251211|NCT00853827|100817972|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
33251212|NCT00853827|100817973|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
33251213|NCT00853827|100817972|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
33251214|NCT00853827|100817973|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
33251215|NCT00853827|100817972|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
33251216|NCT00853827|100817973|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
33251217|NCT00853827|100817972|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
33251218|NCT00853827|100817973|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
33251219|NCT00853827|100817972|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
33251220|NCT00853827|100817973|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
33251221|NCT00853827|100817972|FG000|Double Blind Period (103 Weeks)|Death|1|||
33251222|NCT00853827|100817973|FG001|Double Blind Period (103 Weeks)|Death|6|||
33251223|NCT03179787|100817974|FG000|Overall Study|Lost to Follow-up|15|||
33251224|NCT03179787|100817974|FG000|Overall Study|Case report failures|2|||
33251225|NCT03179787|100817974|FG000|Overall Study|Treatment not administered|1|||
33251226|NCT04889664|100817978|FG000|Screen|Lost to Follow-up|1|||
33251227|NCT04889664|100817978|FG000|Screen|Failed to meet screening criteria|1|||
33251228|NCT04889664|100817978|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
33251229|NCT03181958|100817979|FG000|Overall Study|Lost to Follow-up|17|||
33251230|NCT03181958|100817980|FG001|Overall Study|Lost to Follow-up|21|||
33251231|NCT03181958|100817981|FG002|Overall Study|Lost to Follow-up|15|||
33251232|NCT01233050|100817982|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
33251233|NCT01233050|100817983|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
33251234|NCT01048788|100817984|FG000|Overall Study|Adverse Event|5|||
33251235|NCT01048788|100817985|FG001|Overall Study|Adverse Event|1|||
33251236|NCT01048788|100817986|FG002|Overall Study|Adverse Event|1|||
33251237|NCT01048788|100817984|FG000|Overall Study|Lack of Efficacy|0|||
33251238|NCT01048788|100817985|FG001|Overall Study|Lack of Efficacy|0|||
33437311|NCT00688064|101492685|FG000|Overall Study|Any other reasons|1|||
33437312|NCT00688064|101492686|FG001|Overall Study|Any other reasons|3|||
33437313|NCT00048048|101492691|FG000|Core Treatment|Withdrawal by Subject|0|||
33437314|NCT00048048|101492692|FG001|Core Treatment|Withdrawal by Subject|0|||
33437315|NCT00048048|101492693|FG002|Core Treatment|Withdrawal by Subject|1|||
33437316|NCT00048048|101492694|FG003|Core Treatment|Withdrawal by Subject|0|||
33251239|NCT01048788|100817986|FG002|Overall Study|Lack of Efficacy|1|||
33251240|NCT01048788|100817984|FG000|Overall Study|Withdrawal by Subject|0|||
33251241|NCT01048788|100817985|FG001|Overall Study|Withdrawal by Subject|1|||
33251242|NCT01048788|100817986|FG002|Overall Study|Withdrawal by Subject|0|||
33251243|NCT01152190|100817989|FG000|Overall Study|Adverse Event|2|||
33251244|NCT01152190|100817990|FG001|Overall Study|Adverse Event|4|||
33251245|NCT01152190|100817989|FG000|Overall Study|Death|1|||
33251246|NCT01152190|100817990|FG001|Overall Study|Death|0|||
33251247|NCT01152190|100817989|FG000|Overall Study|Protocol Violation|1|||
33251248|NCT01152190|100817990|FG001|Overall Study|Protocol Violation|1|||
33251249|NCT01152190|100817989|FG000|Overall Study|Withdrawal by Subject|1|||
33251250|NCT01152190|100817990|FG001|Overall Study|Withdrawal by Subject|3|||
33251251|NCT00957658|100817991|FG000|Overall Study|Death|1|||
33251252|NCT00957658|100817991|FG000|Overall Study|Lost to Follow-up|4|||
33437317|NCT00048048|101492695|FG004|Core Treatment|Withdrawal by Subject|0|||
33251253|NCT00957658|100817991|FG000|Overall Study|Withdrawal by Subject|12|||
33153072|NCT01461980|100475433|FG002|Overall Study|No longer willing to participate|54|||
33153073|NCT01461980|100475431|FG000|Overall Study|Randomized but not vaccinated|4|||
33153074|NCT01461980|100475432|FG001|Overall Study|Randomized but not vaccinated|8|||
33153075|NCT01461980|100475433|FG002|Overall Study|Randomized but not vaccinated|7|||
33153076|NCT01051466|100475434|FG000|Overall Study|Adverse Event|1|||
33153077|NCT01051466|100475435|FG001|Overall Study|Adverse Event|0|||
33153078|NCT01051466|100475434|FG000|Overall Study|Lost to Follow-up|1|||
33153079|NCT01051466|100475435|FG001|Overall Study|Lost to Follow-up|1|||
33153080|NCT01051466|100475434|FG000|Overall Study|Withdrawal by Subject|5|||
33153081|NCT01051466|100475435|FG001|Overall Study|Withdrawal by Subject|1|||
33153082|NCT01051466|100475434|FG000|Overall Study|Entry Criteria Not Met|0|||
33153083|NCT01051466|100475435|FG001|Overall Study|Entry Criteria Not Met|3|||
33153084|NCT01051466|100475434|FG000|Overall Study|Physician Decision|1|||
33153085|NCT01051466|100475435|FG001|Overall Study|Physician Decision|0|||
33153086|NCT03875768|100475436|FG000|Overall Study|Lost to Follow-up|16|||
33153087|NCT03875768|100475437|FG001|Overall Study|Lost to Follow-up|13|||
33153088|NCT03875768|100475436|FG000|Overall Study|Withdrawal by Subject|10|||
33153089|NCT03875768|100475437|FG001|Overall Study|Withdrawal by Subject|21|||
33153090|NCT03875768|100475436|FG000|Overall Study|Did not complete assessment|21|||
33153091|NCT03875768|100475437|FG001|Overall Study|Did not complete assessment|12|||
33153092|NCT03875768|100475436|FG000|Overall Study|Became ineligible|1|||
33153093|NCT03875768|100475437|FG001|Overall Study|Became ineligible|0|||
33153094|NCT04676412|100475438|FG000|Overall Study|Death|17|||
33153095|NCT04676412|100475439|FG001|Overall Study|Death|23|||
33153096|NCT04676412|100475438|FG000|Overall Study|Withdrawal by Subject|0|||
33153097|NCT04676412|100475439|FG001|Overall Study|Withdrawal by Subject|2|||
33153098|NCT04676412|100475438|FG000|Overall Study|Participants ongoing|32|||
33153099|NCT04676412|100475439|FG001|Overall Study|Participants ongoing|33|||
33153100|NCT01262573|100475440|FG000|Overall Study|Withdrawal by Subject|0|||
33153101|NCT01262573|100475441|FG001|Overall Study|Withdrawal by Subject|1|||
33153102|NCT00611533|100475446|FG000|First Intervention (6 Weeks)|Never started study|0|||
33153103|NCT00611533|100475447|FG001|First Intervention (6 Weeks)|Never started study|1|||
33153104|NCT00611533|100475446|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
33153105|NCT00611533|100475447|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
33153106|NCT00611533|100475446|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
33153107|NCT00611533|100475447|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
33153108|NCT01386008|100475450|FG000|Overall Study|exited w/o incident /study discontinued|17|||
33153109|NCT01386008|100475450|FG000|Overall Study|Adverse Event|3|||
33153110|NCT00331422|100475455|FG000|Overall Study|Did not receive entire study regimen|5|||
33153111|NCT01898208|100475456|FG000|Overall Study|Positive blood culture|17|||
33153112|NCT01898208|100475457|FG001|Overall Study|Positive blood culture|23|||
33153113|NCT01898208|100475458|FG002|Overall Study|Positive blood culture|15|||
33153114|NCT01898208|100475456|FG000|Overall Study|Death/comfort care within 24 hours|10|||
33153115|NCT01898208|100475457|FG001|Overall Study|Death/comfort care within 24 hours|9|||
33153116|NCT01898208|100475458|FG002|Overall Study|Death/comfort care within 24 hours|8|||
33153117|NCT01898208|100475456|FG000|Overall Study|Negative Gram Stain|6|||
33153118|NCT01898208|100475457|FG001|Overall Study|Negative Gram Stain|9|||
33153119|NCT01898208|100475458|FG002|Overall Study|Negative Gram Stain|6|||
33153120|NCT01898208|100475456|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
33153121|NCT01898208|100475457|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
33153122|NCT01898208|100475458|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
33153123|NCT01898208|100475456|FG000|Overall Study|System/Technical Error|1|||
33153124|NCT01898208|100475457|FG001|Overall Study|System/Technical Error|2|||
33153125|NCT01898208|100475458|FG002|Overall Study|System/Technical Error|3|||
33153126|NCT01898208|100475456|FG000|Overall Study|Lost to Follow-up|3|||
33153127|NCT01898208|100475457|FG001|Overall Study|Lost to Follow-up|1|||
33153128|NCT01898208|100475458|FG002|Overall Study|Lost to Follow-up|1|||
33153129|NCT00973674|100475459|FG000|Overall Study|Protocol Violation|2|||
33153130|NCT00973674|100475460|FG001|Overall Study|Protocol Violation|0|||
33153131|NCT03672643|100475462|FG000|Overall Study|Adverse Event|3|||
33153132|NCT03672643|100475462|FG000|Overall Study|Death|2|||
33153133|NCT03672643|100475462|FG000|Overall Study|Withdrawal by Subject|1|||
33153134|NCT03672643|100475462|FG000|Overall Study|Progressive disease|11|||
33153135|NCT03672643|100475462|FG000|Overall Study|Global deterioration of health status|1|||
33153136|NCT03672643|100475462|FG000|Overall Study|Refused further treatment|7|||
33153137|NCT03672643|100475462|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
33153138|NCT03021304|100475467|FG000|Overall Study|Lack of Efficacy|1|||
33153139|NCT02448810|100475468|FG000|Overall Study|Adverse Event|0|||
33153140|NCT02448810|100475469|FG001|Overall Study|Adverse Event|0|||
33153141|NCT02448810|100475470|FG002|Overall Study|Adverse Event|1|||
33153142|NCT02448810|100475471|FG003|Overall Study|Adverse Event|0|||
33153143|NCT02448810|100475472|FG004|Overall Study|Adverse Event|0|||
33153144|NCT02448810|100475473|FG005|Overall Study|Adverse Event|0|||
33153145|NCT02448810|100475474|FG006|Overall Study|Adverse Event|0|||
33153146|NCT02448810|100475475|FG007|Overall Study|Adverse Event|0|||
33153147|NCT02448810|100475468|FG000|Overall Study|Withdrawal by Subject|0|||
33153148|NCT02448810|100475469|FG001|Overall Study|Withdrawal by Subject|0|||
33153149|NCT02448810|100475470|FG002|Overall Study|Withdrawal by Subject|1|||
33153150|NCT02448810|100475471|FG003|Overall Study|Withdrawal by Subject|0|||
33153151|NCT02448810|100475472|FG004|Overall Study|Withdrawal by Subject|3|||
33153152|NCT02448810|100475473|FG005|Overall Study|Withdrawal by Subject|5|||
33153153|NCT02448810|100475474|FG006|Overall Study|Withdrawal by Subject|0|||
33153154|NCT02448810|100475475|FG007|Overall Study|Withdrawal by Subject|2|||
33153155|NCT02448810|100475468|FG000|Overall Study|Other (study terminated by sponsor)|0|||
33153156|NCT02448810|100475469|FG001|Overall Study|Other (study terminated by sponsor)|0|||
33153157|NCT02448810|100475470|FG002|Overall Study|Other (study terminated by sponsor)|0|||
33153158|NCT02448810|100475471|FG003|Overall Study|Other (study terminated by sponsor)|0|||
33153159|NCT02448810|100475472|FG004|Overall Study|Other (study terminated by sponsor)|4|||
33153160|NCT02448810|100475473|FG005|Overall Study|Other (study terminated by sponsor)|2|||
33153161|NCT02448810|100475474|FG006|Overall Study|Other (study terminated by sponsor)|2|||
33153162|NCT02448810|100475475|FG007|Overall Study|Other (study terminated by sponsor)|1|||
33153163|NCT02448810|100475468|FG000|Overall Study|Death|1|||
33153164|NCT02448810|100475469|FG001|Overall Study|Death|0|||
33153165|NCT02448810|100475470|FG002|Overall Study|Death|1|||
33153166|NCT02448810|100475471|FG003|Overall Study|Death|0|||
33153167|NCT02448810|100475472|FG004|Overall Study|Death|1|||
33153168|NCT02448810|100475473|FG005|Overall Study|Death|0|||
33153169|NCT02448810|100475474|FG006|Overall Study|Death|0|||
33153170|NCT02448810|100475475|FG007|Overall Study|Death|0|||
33386923|NCT01742091|101302692|FG005|Overall Study|Adverse Event|0|||
33386924|NCT01742091|101302687|FG000|Overall Study|Physician Decision|0|||
33386925|NCT01742091|101302688|FG001|Overall Study|Physician Decision|0|||
33386926|NCT01742091|101302689|FG002|Overall Study|Physician Decision|0|||
33153171|NCT02448810|100475468|FG000|Overall Study|Other (Progressive disease)|2|||
33153172|NCT02448810|100475469|FG001|Overall Study|Other (Progressive disease)|2|||
33153173|NCT02448810|100475470|FG002|Overall Study|Other (Progressive disease)|0|||
33153174|NCT02448810|100475471|FG003|Overall Study|Other (Progressive disease)|3|||
33386927|NCT01742091|101302690|FG003|Overall Study|Physician Decision|0|||
33386928|NCT01742091|101302691|FG004|Overall Study|Physician Decision|0|||
33386929|NCT01742091|101302692|FG005|Overall Study|Physician Decision|1|||
33386930|NCT01742091|101302687|FG000|Overall Study|Withdrawal by Subject|0|||
33386931|NCT01742091|101302688|FG001|Overall Study|Withdrawal by Subject|0|||
33153175|NCT02448810|100475472|FG004|Overall Study|Other (Progressive disease)|23|||
33386932|NCT01742091|101302689|FG002|Overall Study|Withdrawal by Subject|0|||
33386933|NCT01742091|101302690|FG003|Overall Study|Withdrawal by Subject|1|||
33386934|NCT01742091|101302691|FG004|Overall Study|Withdrawal by Subject|0|||
33386935|NCT01742091|101302692|FG005|Overall Study|Withdrawal by Subject|0|||
33437318|NCT00048048|101492696|FG005|Core Treatment|Withdrawal by Subject|0|||
33153176|NCT02448810|100475473|FG005|Overall Study|Other (Progressive disease)|9|||
33153177|NCT02448810|100475474|FG006|Overall Study|Other (Progressive disease)|14|||
33153178|NCT02448810|100475475|FG007|Overall Study|Other (Progressive disease)|5|||
33153179|NCT02448810|100475468|FG000|Overall Study|Lost to Follow-up|0|||
33153180|NCT02448810|100475469|FG001|Overall Study|Lost to Follow-up|1|||
33251254|NCT00957658|100817991|FG000|Overall Study|Revision|1|||
33437319|NCT00048048|101492697|FG006|Core Treatment|Withdrawal by Subject|0|||
33437320|NCT00048048|101492698|FG007|Core Treatment|Withdrawal by Subject|0|||
33437321|NCT00048048|101492699|FG008|Core Treatment|Withdrawal by Subject|0|||
33437322|NCT00048048|101492700|FG009|Core Treatment|Withdrawal by Subject|0|||
33437323|NCT00048048|101492701|FG010|Core Treatment|Withdrawal by Subject|0|||
33437324|NCT00048048|101492702|FG011|Core Treatment|Withdrawal by Subject|0|||
33437325|NCT00048048|101492691|FG000|Core Treatment|Adverse Event|0|||
33153181|NCT02448810|100475470|FG002|Overall Study|Lost to Follow-up|0|||
33437326|NCT00048048|101492692|FG001|Core Treatment|Adverse Event|0|||
33153182|NCT02448810|100475471|FG003|Overall Study|Lost to Follow-up|0|||
33153183|NCT02448810|100475472|FG004|Overall Study|Lost to Follow-up|0|||
33153184|NCT02448810|100475473|FG005|Overall Study|Lost to Follow-up|0|||
33153185|NCT02448810|100475474|FG006|Overall Study|Lost to Follow-up|0|||
33153186|NCT02448810|100475475|FG007|Overall Study|Lost to Follow-up|0|||
33153187|NCT02448810|100475468|FG000|Overall Study|Other (unspecified)|0|||
33153188|NCT02448810|100475469|FG001|Overall Study|Other (unspecified)|0|||
33153189|NCT02448810|100475470|FG002|Overall Study|Other (unspecified)|0|||
33153190|NCT02448810|100475471|FG003|Overall Study|Other (unspecified)|0|||
33153191|NCT02448810|100475472|FG004|Overall Study|Other (unspecified)|0|||
33153192|NCT02448810|100475473|FG005|Overall Study|Other (unspecified)|0|||
33153193|NCT02448810|100475474|FG006|Overall Study|Other (unspecified)|2|||
33153194|NCT02448810|100475475|FG007|Overall Study|Other (unspecified)|0|||
33153195|NCT01466179|100475479|FG000|Overall Study|Ongoing in core study|2|||
33153196|NCT01466179|100475479|FG000|Overall Study|Physician Decision|46|||
33153197|NCT01466179|100475479|FG000|Overall Study|Progressive disease|43|||
33153198|NCT01466179|100475479|FG000|Overall Study|Adverse Event|32|||
33153199|NCT01466179|100475479|FG000|Overall Study|Disease relapse|23|||
33153200|NCT01466179|100475479|FG000|Overall Study|Lack of Efficacy|14|||
33153201|NCT01466179|100475479|FG000|Overall Study|Death|7|||
33153202|NCT01466179|100475479|FG000|Overall Study|Withdrawal by Subject|7|||
33153203|NCT01466179|100475479|FG000|Overall Study|Protocol Violation|2|||
33153204|NCT01466179|100475479|FG000|Overall Study|Other|3|||
33153205|NCT00723398|100475480|FG000|Overall Study|Withdrawal by Subject|2|||
33153206|NCT00723398|100475481|FG001|Overall Study|Withdrawal by Subject|6|||
33153207|NCT00723398|100475482|FG002|Overall Study|Withdrawal by Subject|4|||
33153208|NCT00723398|100475483|FG003|Overall Study|Withdrawal by Subject|4|||
33437327|NCT00048048|101492693|FG002|Core Treatment|Adverse Event|0|||
33437328|NCT00048048|101492694|FG003|Core Treatment|Adverse Event|0|||
33437329|NCT00048048|101492695|FG004|Core Treatment|Adverse Event|0|||
33437330|NCT00048048|101492696|FG005|Core Treatment|Adverse Event|0|||
33153209|NCT00723398|100475484|FG004|Overall Study|Withdrawal by Subject|4|||
33153210|NCT00723398|100475480|FG000|Overall Study|Protocol Violation|2|||
33153211|NCT00723398|100475481|FG001|Overall Study|Protocol Violation|1|||
33153212|NCT00723398|100475482|FG002|Overall Study|Protocol Violation|5|||
33153213|NCT00723398|100475483|FG003|Overall Study|Protocol Violation|0|||
33153214|NCT00723398|100475484|FG004|Overall Study|Protocol Violation|0|||
33153215|NCT00723398|100475480|FG000|Overall Study|Physician Decision|2|||
33153216|NCT00723398|100475481|FG001|Overall Study|Physician Decision|2|||
33437331|NCT00048048|101492697|FG006|Core Treatment|Adverse Event|0|||
33437332|NCT00048048|101492698|FG007|Core Treatment|Adverse Event|1|||
33437333|NCT00048048|101492699|FG008|Core Treatment|Adverse Event|0|||
33437334|NCT00048048|101492700|FG009|Core Treatment|Adverse Event|0|||
33153217|NCT00723398|100475482|FG002|Overall Study|Physician Decision|5|||
33153218|NCT00723398|100475483|FG003|Overall Study|Physician Decision|0|||
33153219|NCT00723398|100475484|FG004|Overall Study|Physician Decision|1|||
33153220|NCT00723398|100475480|FG000|Overall Study|Adverse Event|0|||
33153221|NCT00723398|100475481|FG001|Overall Study|Adverse Event|5|||
33153222|NCT00723398|100475482|FG002|Overall Study|Adverse Event|3|||
33153223|NCT00723398|100475483|FG003|Overall Study|Adverse Event|1|||
33153224|NCT00723398|100475484|FG004|Overall Study|Adverse Event|4|||
33153225|NCT00723398|100475480|FG000|Overall Study|Lost to Follow-up|0|||
33153226|NCT00723398|100475481|FG001|Overall Study|Lost to Follow-up|1|||
33153227|NCT00723398|100475482|FG002|Overall Study|Lost to Follow-up|0|||
33153228|NCT00723398|100475483|FG003|Overall Study|Lost to Follow-up|0|||
33153229|NCT00723398|100475484|FG004|Overall Study|Lost to Follow-up|0|||
33153230|NCT02298023|100475485|FG000|Overall Study|Withdrawal by Subject|1|||
33153231|NCT02298023|100475486|FG001|Overall Study|Withdrawal by Subject|0|||
33153232|NCT02298023|100475487|FG002|Overall Study|Withdrawal by Subject|0|||
33153233|NCT02913612|100475488|FG000|Overall Study|Lost to Follow-up|6|||
33153234|NCT02913612|100475489|FG001|Overall Study|Lost to Follow-up|5|||
33437335|NCT00048048|101492701|FG010|Core Treatment|Adverse Event|0|||
33153235|NCT02913612|100475490|FG002|Overall Study|Lost to Follow-up|2|||
33153236|NCT02913612|100475491|FG003|Overall Study|Lost to Follow-up|0|||
33153237|NCT02913612|100475488|FG000|Overall Study|Physician Decision|1|||
33153238|NCT02913612|100475489|FG001|Overall Study|Physician Decision|4|||
33153239|NCT02913612|100475490|FG002|Overall Study|Physician Decision|1|||
33437336|NCT00048048|101492702|FG011|Core Treatment|Adverse Event|0|||
33153240|NCT02913612|100475491|FG003|Overall Study|Physician Decision|0|||
33153241|NCT02913612|100475488|FG000|Overall Study|Withdrawal by Subject|2|||
33153242|NCT02913612|100475489|FG001|Overall Study|Withdrawal by Subject|4|||
33153243|NCT02913612|100475490|FG002|Overall Study|Withdrawal by Subject|0|||
33153244|NCT02913612|100475491|FG003|Overall Study|Withdrawal by Subject|0|||
33153245|NCT02913612|100475488|FG000|Overall Study|Hemangioma resolved|1|||
33153246|NCT02913612|100475489|FG001|Overall Study|Hemangioma resolved|0|||
33153247|NCT02913612|100475490|FG002|Overall Study|Hemangioma resolved|0|||
33153248|NCT02913612|100475491|FG003|Overall Study|Hemangioma resolved|0|||
33153249|NCT02913612|100475488|FG000|Overall Study|Local IRB decision|1|||
33153250|NCT02913612|100475489|FG001|Overall Study|Local IRB decision|0|||
33153251|NCT02913612|100475490|FG002|Overall Study|Local IRB decision|0|||
33153252|NCT02913612|100475491|FG003|Overall Study|Local IRB decision|0|||
33153253|NCT02913612|100475488|FG000|Overall Study|Study drug non-compliance|1|||
33153254|NCT02913612|100475489|FG001|Overall Study|Study drug non-compliance|1|||
33153255|NCT02913612|100475490|FG002|Overall Study|Study drug non-compliance|0|||
33153256|NCT02913612|100475491|FG003|Overall Study|Study drug non-compliance|0|||
33153257|NCT02913612|100475488|FG000|Overall Study|Insurance issues|0|||
33153258|NCT02913612|100475489|FG001|Overall Study|Insurance issues|1|||
33153259|NCT02913612|100475490|FG002|Overall Study|Insurance issues|0|||
33153260|NCT02913612|100475491|FG003|Overall Study|Insurance issues|0|||
33153261|NCT02913612|100475488|FG000|Overall Study|Needed to treat second hemangioma|0|||
33153262|NCT02913612|100475489|FG001|Overall Study|Needed to treat second hemangioma|1|||
33153263|NCT02913612|100475490|FG002|Overall Study|Needed to treat second hemangioma|0|||
33153264|NCT02913612|100475491|FG003|Overall Study|Needed to treat second hemangioma|0|||
33153265|NCT02913612|100475488|FG000|Overall Study|Study completion criteria not met|0|||
33153266|NCT02913612|100475489|FG001|Overall Study|Study completion criteria not met|1|||
33153267|NCT02913612|100475490|FG002|Overall Study|Study completion criteria not met|0|||
33153268|NCT02913612|100475491|FG003|Overall Study|Study completion criteria not met|0|||
33153269|NCT02913612|100475488|FG000|Overall Study|Ineligible|0|||
33153270|NCT02913612|100475489|FG001|Overall Study|Ineligible|1|||
33153271|NCT02913612|100475490|FG002|Overall Study|Ineligible|0|||
33153272|NCT02913612|100475491|FG003|Overall Study|Ineligible|0|||
33153273|NCT01180647|100475492|FG000|Overall Study|Lost to Follow-up|5|||
33153274|NCT01180647|100475493|FG001|Overall Study|Lost to Follow-up|6|||
33153275|NCT00467857|100475494|FG000|Overall Study|Adverse Event|1|||
33153276|NCT00467857|100475495|FG001|Overall Study|Adverse Event|0|||
33153277|NCT00467857|100475494|FG000|Overall Study|Withdrew consent|2|||
33153278|NCT00467857|100475495|FG001|Overall Study|Withdrew consent|0|||
33153279|NCT00467857|100475494|FG000|Overall Study|Death|0|||
33153280|NCT00467857|100475495|FG001|Overall Study|Death|1|||
33153281|NCT00467857|100475494|FG000|Overall Study|Discharged from court service|0|||
33153282|NCT00467857|100475495|FG001|Overall Study|Discharged from court service|1|||
33153283|NCT00467857|100475494|FG000|Overall Study|Emergency care required|0|||
33153284|NCT00467857|100475495|FG001|Overall Study|Emergency care required|1|||
33153285|NCT00467857|100475494|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
33153286|NCT00467857|100475495|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
33153287|NCT00467857|100475494|FG000|Overall Study|Discontinuation reason missing|0|||
33153288|NCT00467857|100475495|FG001|Overall Study|Discontinuation reason missing|3|||
33153289|NCT05021081|100475496|FG000|Phase 2|Subject enrolled in error|1|||
33153290|NCT05021081|100475497|FG001|Phase 2|Subject enrolled in error|1|||
33153291|NCT05021081|100475498|FG002|Phase 2|Subject enrolled in error|0|||
33153292|NCT01281137|100475499|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
33153293|NCT01281137|100475500|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
33153294|NCT01281137|100475499|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
33153295|NCT01281137|100475500|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
33153296|NCT01281137|100475499|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
33153297|NCT01281137|100475500|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
33153298|NCT01281137|100475499|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
33153299|NCT01281137|100475500|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
33153300|NCT01281137|100475499|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
33251255|NCT00957658|100817991|FG000|Overall Study|Incomplete 2 yr data|28|||
33251256|NCT00957658|100817991|FG000|Overall Study|Site termination|10|||
33251257|NCT00957658|100817991|FG000|Overall Study|unwilling/unable to return|2|||
33251258|NCT00957658|100817991|FG000|Overall Study|surgery cancelled|2|||
33251259|NCT00957658|100817991|FG000|Overall Study|Protocol Violation|5|||
33251260|NCT00486330|100817992|FG000|Overall Study|Adverse Event|2|||
33251261|NCT01988233|100817998|FG000|Overall Study|Lost to Follow-up|64|||
33251262|NCT01988233|100817999|FG001|Overall Study|Lost to Follow-up|51|||
33251263|NCT00817635|100818000|FG000|Overall Study|Adverse Event|1|||
33251264|NCT00817635|100818001|FG001|Overall Study|Adverse Event|0|||
33251265|NCT00817635|100818002|FG002|Overall Study|Adverse Event|0|||
33251266|NCT00817635|100818003|FG003|Overall Study|Adverse Event|1|||
33251267|NCT00817635|100818004|FG004|Overall Study|Adverse Event|1|||
33251268|NCT00817635|100818000|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
33251269|NCT00817635|100818001|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
33251270|NCT00817635|100818002|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
33251271|NCT00817635|100818003|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
33251272|NCT00817635|100818004|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
33251273|NCT00817635|100818000|FG000|Overall Study|Withdrawal by Subject|2|||
33251274|NCT00817635|100818001|FG001|Overall Study|Withdrawal by Subject|1|||
33251275|NCT00817635|100818002|FG002|Overall Study|Withdrawal by Subject|0|||
33251276|NCT00817635|100818003|FG003|Overall Study|Withdrawal by Subject|1|||
33251277|NCT00817635|100818004|FG004|Overall Study|Withdrawal by Subject|2|||
33251278|NCT00817635|100818000|FG000|Overall Study|Lost to Follow-up|0|||
33153301|NCT01281137|100475500|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
33153302|NCT04889222|100475501|FG000|Overall Study|Did not meet eligibility criteria|8|||
33153303|NCT04889222|100475501|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
33153304|NCT04889222|100475501|FG000|Overall Study|Did not proceed due to time constraints|5|||
33437337|NCT00048048|101492691|FG000|Extension Year 1|Early withdrawals|0|||
33437338|NCT00048048|101492692|FG001|Extension Year 1|Early withdrawals|0|||
33437339|NCT00048048|101492693|FG002|Extension Year 1|Early withdrawals|0|||
33437340|NCT00048048|101492694|FG003|Extension Year 1|Early withdrawals|0|||
33437341|NCT00048048|101492695|FG004|Extension Year 1|Early withdrawals|0|||
33437342|NCT00048048|101492696|FG005|Extension Year 1|Early withdrawals|0|||
33437343|NCT00048048|101492697|FG006|Extension Year 1|Early withdrawals|0|||
33437344|NCT00048048|101492698|FG007|Extension Year 1|Early withdrawals|0|||
33437345|NCT00048048|101492699|FG008|Extension Year 1|Early withdrawals|0|||
33437346|NCT00048048|101492700|FG009|Extension Year 1|Early withdrawals|2|||
33437347|NCT00048048|101492701|FG010|Extension Year 1|Early withdrawals|2|||
33437348|NCT00048048|101492702|FG011|Extension Year 1|Early withdrawals|4|||
33153305|NCT02600351|100475502|FG000|Overall Study|Lack of Efficacy|3|||
33153306|NCT02600351|100475503|FG001|Overall Study|Lack of Efficacy|0|||
33153307|NCT02600351|100475504|FG002|Overall Study|Lack of Efficacy|5|||
33153308|NCT02600351|100475505|FG003|Overall Study|Lack of Efficacy|2|||
33153309|NCT02600351|100475502|FG000|Overall Study|Lost to Follow-up|1|||
33153310|NCT02600351|100475503|FG001|Overall Study|Lost to Follow-up|0|||
33153311|NCT02600351|100475504|FG002|Overall Study|Lost to Follow-up|0|||
33153312|NCT02600351|100475505|FG003|Overall Study|Lost to Follow-up|0|||
33153313|NCT02600351|100475502|FG000|Overall Study|Randomized but Not Treated|1|||
33153314|NCT02600351|100475503|FG001|Overall Study|Randomized but Not Treated|0|||
33153315|NCT02600351|100475504|FG002|Overall Study|Randomized but Not Treated|1|||
33251279|NCT00817635|100818001|FG001|Overall Study|Lost to Follow-up|1|||
33251280|NCT00817635|100818002|FG002|Overall Study|Lost to Follow-up|0|||
33251281|NCT00817635|100818003|FG003|Overall Study|Lost to Follow-up|1|||
33251282|NCT00817635|100818004|FG004|Overall Study|Lost to Follow-up|0|||
33437349|NCT00048048|101492691|FG000|Extension Year 2|Early withdrawals|0|||
33251283|NCT00817635|100818000|FG000|Overall Study|Administrative Problems|0|||
33153316|NCT02600351|100475505|FG003|Overall Study|Randomized but Not Treated|3|||
33153317|NCT05394350|100475506|FG000|Overall Study|Death|2|||
33251284|NCT00817635|100818001|FG001|Overall Study|Administrative Problems|0|||
33251285|NCT00817635|100818002|FG002|Overall Study|Administrative Problems|0|||
33251286|NCT00817635|100818003|FG003|Overall Study|Administrative Problems|0|||
33251287|NCT00817635|100818004|FG004|Overall Study|Administrative Problems|1|||
33251288|NCT00817635|100818000|FG000|Overall Study|Protocol Violation|5|||
33251289|NCT00817635|100818001|FG001|Overall Study|Protocol Violation|1|||
33251290|NCT00817635|100818002|FG002|Overall Study|Protocol Violation|3|||
33251291|NCT00817635|100818003|FG003|Overall Study|Protocol Violation|2|||
33251292|NCT00817635|100818004|FG004|Overall Study|Protocol Violation|3|||
33251293|NCT00739102|100818005|FG000|Overall Study|Death|5|||
33251294|NCT00739102|100818005|FG000|Overall Study|Withdrawal by Subject|10|||
33251295|NCT01908634|100818006|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
33251296|NCT01908634|100818006|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
33251297|NCT01194258|100818009|FG000|Titration Period|Withdrawal by Subject|6|||
33251298|NCT01194258|100818010|FG001|Titration Period|Withdrawal by Subject|0|||
33251299|NCT01194258|100818011|FG002|Titration Period|Withdrawal by Subject|0|||
33251300|NCT01194258|100818012|FG003|Titration Period|Withdrawal by Subject|0|||
33251301|NCT01194258|100818013|FG004|Titration Period|Withdrawal by Subject|0|||
33251302|NCT01194258|100818009|FG000|Titration Period|Lost to Follow-up|2|||
33251303|NCT01194258|100818010|FG001|Titration Period|Lost to Follow-up|0|||
33251304|NCT01194258|100818011|FG002|Titration Period|Lost to Follow-up|0|||
33251305|NCT01194258|100818012|FG003|Titration Period|Lost to Follow-up|0|||
33251306|NCT01194258|100818013|FG004|Titration Period|Lost to Follow-up|0|||
33251307|NCT01194258|100818009|FG000|Titration Period|Titration failure|3|||
33251308|NCT01194258|100818010|FG001|Titration Period|Titration failure|0|||
33251309|NCT01194258|100818011|FG002|Titration Period|Titration failure|0|||
33251310|NCT01194258|100818012|FG003|Titration Period|Titration failure|0|||
33251311|NCT01194258|100818013|FG004|Titration Period|Titration failure|0|||
33251312|NCT01194258|100818009|FG000|Period 1 (12 Weeks)|Death|0|||
33251313|NCT01194258|100818010|FG001|Period 1 (12 Weeks)|Death|0|||
33251314|NCT01194258|100818011|FG002|Period 1 (12 Weeks)|Death|0|||
33251315|NCT01194258|100818012|FG003|Period 1 (12 Weeks)|Death|0|||
33251316|NCT01194258|100818013|FG004|Period 1 (12 Weeks)|Death|1|||
33251317|NCT01194258|100818009|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
33251318|NCT01194258|100818010|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
33251319|NCT01194258|100818011|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
33251320|NCT01194258|100818012|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
33251321|NCT01194258|100818013|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
33251322|NCT01194258|100818009|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
33251323|NCT01194258|100818010|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
33251324|NCT01194258|100818011|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
33251325|NCT01194258|100818012|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
33251326|NCT01194258|100818013|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
33251327|NCT01194258|100818009|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33251328|NCT01194258|100818010|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33251329|NCT01194258|100818011|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33251330|NCT01194258|100818012|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33251331|NCT01194258|100818013|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33251332|NCT01956669|100818014|FG000|Overall Study|Disease Progression|12|||
33251333|NCT01956669|100818015|FG001|Overall Study|Disease Progression|7|||
33251334|NCT01956669|100818016|FG002|Overall Study|Disease Progression|7|||
33251335|NCT01956669|100818017|FG003|Overall Study|Disease Progression|8|||
33251336|NCT01956669|100818018|FG004|Overall Study|Disease Progression|4|||
33251337|NCT01956669|100818019|FG005|Overall Study|Disease Progression|3|||
33251338|NCT01956669|100818020|FG006|Overall Study|Disease Progression|5|||
33251339|NCT01956669|100818014|FG000|Overall Study|Adverse Event|0|||
33251340|NCT01956669|100818015|FG001|Overall Study|Adverse Event|2|||
33251341|NCT01956669|100818016|FG002|Overall Study|Adverse Event|2|||
33251342|NCT01956669|100818017|FG003|Overall Study|Adverse Event|1|||
33251343|NCT01956669|100818018|FG004|Overall Study|Adverse Event|0|||
33251344|NCT01956669|100818019|FG005|Overall Study|Adverse Event|0|||
33251345|NCT01956669|100818020|FG006|Overall Study|Adverse Event|0|||
33251346|NCT01956669|100818014|FG000|Overall Study|Physician Decision|0|||
33251347|NCT01956669|100818015|FG001|Overall Study|Physician Decision|2|||
33251348|NCT01956669|100818016|FG002|Overall Study|Physician Decision|0|||
33251349|NCT01956669|100818017|FG003|Overall Study|Physician Decision|0|||
33437350|NCT00048048|101492692|FG001|Extension Year 2|Early withdrawals|0|||
33437351|NCT00048048|101492693|FG002|Extension Year 2|Early withdrawals|0|||
33251350|NCT01956669|100818018|FG004|Overall Study|Physician Decision|0|||
33251351|NCT01956669|100818019|FG005|Overall Study|Physician Decision|1|||
33251352|NCT01956669|100818020|FG006|Overall Study|Physician Decision|0|||
33251353|NCT01956669|100818014|FG000|Overall Study|Withdrawal by Subject|0|||
33251354|NCT01956669|100818015|FG001|Overall Study|Withdrawal by Subject|0|||
33251355|NCT01956669|100818016|FG002|Overall Study|Withdrawal by Subject|1|||
33251356|NCT01956669|100818017|FG003|Overall Study|Withdrawal by Subject|1|||
33251357|NCT01956669|100818018|FG004|Overall Study|Withdrawal by Subject|0|||
33251358|NCT01956669|100818019|FG005|Overall Study|Withdrawal by Subject|0|||
33251359|NCT01956669|100818020|FG006|Overall Study|Withdrawal by Subject|1|||
33251360|NCT00357396|100818021|FG000|Overall Study|Adverse Event|1|||
33437352|NCT00048048|101492694|FG003|Extension Year 2|Early withdrawals|0|||
33437353|NCT00048048|101492695|FG004|Extension Year 2|Early withdrawals|0|||
33437354|NCT00048048|101492696|FG005|Extension Year 2|Early withdrawals|0|||
33437355|NCT00048048|101492697|FG006|Extension Year 2|Early withdrawals|0|||
33437356|NCT00048048|101492698|FG007|Extension Year 2|Early withdrawals|0|||
33437357|NCT00048048|101492699|FG008|Extension Year 2|Early withdrawals|0|||
33437358|NCT00048048|101492700|FG009|Extension Year 2|Early withdrawals|0|||
33437359|NCT00048048|101492701|FG010|Extension Year 2|Early withdrawals|4|||
33437360|NCT00048048|101492702|FG011|Extension Year 2|Early withdrawals|2|||
33437361|NCT03482882|101492713|FG000|Overall Study|Adverse Event|3|||
33251361|NCT00357396|100818022|FG001|Overall Study|Adverse Event|0|||
33251362|NCT00940992|100818023|FG000|Overall Study|Adverse Event|2|||
33437362|NCT03482882|101492713|FG000|Overall Study|Lost to Follow-up|1|||
33437363|NCT03482882|101492713|FG000|Overall Study|Protocol Violation|2|||
33437364|NCT03482882|101492713|FG000|Overall Study|Not further specified|1|||
33437365|NCT01860976|101492715|FG000|Blinded Treatment|Adverse Event|1|||
33251363|NCT00940992|100818024|FG001|Overall Study|Adverse Event|0|||
33251364|NCT00940992|100818025|FG002|Overall Study|Adverse Event|1|||
33251365|NCT00940992|100818023|FG000|Overall Study|subject request|2|||
33251366|NCT00940992|100818024|FG001|Overall Study|subject request|1|||
33251367|NCT00940992|100818025|FG002|Overall Study|subject request|0|||
33251368|NCT00940992|100818023|FG000|Overall Study|Lost to Follow-up|0|||
33251369|NCT00940992|100818024|FG001|Overall Study|Lost to Follow-up|1|||
33251370|NCT00940992|100818025|FG002|Overall Study|Lost to Follow-up|1|||
33251371|NCT02174562|100818026|FG000|Overall Study|Withdrawal by Subject|7|||
33251372|NCT02174562|100818027|FG001|Overall Study|Withdrawal by Subject|2|||
33251373|NCT02174562|100818026|FG000|Overall Study|Death|2|||
33251374|NCT02174562|100818027|FG001|Overall Study|Death|0|||
33251375|NCT02174562|100818026|FG000|Overall Study|Lost to Follow-up|0|||
33251376|NCT02174562|100818027|FG001|Overall Study|Lost to Follow-up|3|||
33386936|NCT01742091|101302687|FG000|Overall Study|Lost to Follow-up|0|||
33386937|NCT01742091|101302688|FG001|Overall Study|Lost to Follow-up|0|||
33386938|NCT01742091|101302689|FG002|Overall Study|Lost to Follow-up|0|||
33437366|NCT01860976|101492716|FG001|Blinded Treatment|Adverse Event|3|||
33153318|NCT05394350|100475507|FG001|Overall Study|Death|2|||
33251377|NCT01876511|100818047|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
33251378|NCT01876511|100818048|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
33153319|NCT05394350|100475508|FG002|Overall Study|Death|4|||
33153320|NCT05394350|100475509|FG003|Overall Study|Death|0|||
33153321|NCT05394350|100475510|FG004|Overall Study|Death|1|||
33153322|NCT05394350|100475511|FG005|Overall Study|Death|0|||
33153323|NCT05394350|100475506|FG000|Overall Study|Study terminated by sponsor|1|||
33153324|NCT05394350|100475507|FG001|Overall Study|Study terminated by sponsor|1|||
33153325|NCT05394350|100475508|FG002|Overall Study|Study terminated by sponsor|7|||
33153326|NCT05394350|100475509|FG003|Overall Study|Study terminated by sponsor|3|||
33153327|NCT05394350|100475510|FG004|Overall Study|Study terminated by sponsor|2|||
33153328|NCT05394350|100475511|FG005|Overall Study|Study terminated by sponsor|4|||
33153329|NCT05061966|100475512|FG000|Overall Study|Lost to Follow-up|13|||
33153330|NCT05061966|100475513|FG001|Overall Study|Lost to Follow-up|13|||
33153331|NCT02282358|100475514|FG000|Overall Study|Nonevaluable|1|||
33153332|NCT01719783|100475517|FG000|Dose 2|Physician Decision|1|||
33153333|NCT01719783|100475518|FG001|Dose 2|Physician Decision|0|||
33153334|NCT03800173|100475524|FG000|Overall Study|Lost to Follow-up|0|||
33153335|NCT03800173|100475525|FG001|Overall Study|Lost to Follow-up|0|||
33153336|NCT03800173|100475526|FG002|Overall Study|Lost to Follow-up|0|||
33153337|NCT03800173|100475527|FG003|Overall Study|Lost to Follow-up|0|||
33153338|NCT03800173|100475528|FG004|Overall Study|Lost to Follow-up|1|||
33153339|NCT03228420|100475529|FG000|Overall Study|Lost to Follow-up|5|||
33153340|NCT03228420|100475530|FG001|Overall Study|Lost to Follow-up|3|||
33153341|NCT03228420|100475529|FG000|Overall Study|Withdrawal by Subject|10|||
33153342|NCT03228420|100475530|FG001|Overall Study|Withdrawal by Subject|0|||
33153343|NCT03228420|100475529|FG000|Overall Study|Adverse Event|5|||
33153344|NCT03228420|100475530|FG001|Overall Study|Adverse Event|2|||
33153345|NCT00107783|100475532|FG000|Overall Study|Adverse Event|0|||
33153346|NCT00107783|100475533|FG001|Overall Study|Adverse Event|2|||
33153347|NCT00107783|100475532|FG000|Overall Study|Death|0|||
33153348|NCT00107783|100475533|FG001|Overall Study|Death|1|||
33153349|NCT00107783|100475532|FG000|Overall Study|Withdrawal by Subject|2|||
33153350|NCT00107783|100475533|FG001|Overall Study|Withdrawal by Subject|0|||
33153351|NCT00107783|100475532|FG000|Overall Study|Second hip replacement|1|||
33153352|NCT00107783|100475533|FG001|Overall Study|Second hip replacement|1|||
33153353|NCT00722800|100475538|FG000|Overall Study|Withdrawal by Subject|1|||
33153354|NCT00722800|100475539|FG001|Overall Study|Withdrawal by Subject|0|||
33153355|NCT00722800|100475538|FG000|Overall Study|Physician Decision|1|||
33153356|NCT00722800|100475539|FG001|Overall Study|Physician Decision|0|||
33153357|NCT00285818|100475540|FG000|Overall Study|Withdrawal by Subject|3|||
33153358|NCT00285818|100475541|FG001|Overall Study|Withdrawal by Subject|2|||
33153359|NCT00285818|100475540|FG000|Overall Study|Lost to Follow-up|1|||
33153360|NCT00285818|100475541|FG001|Overall Study|Lost to Follow-up|0|||
33153361|NCT02024555|100475542|FG000|Overall Study|Lost to Follow-up|1|||
33153362|NCT02024555|100475543|FG001|Overall Study|Lost to Follow-up|1|||
33153363|NCT02024555|100475542|FG000|Overall Study|Withdrawal by Subject|5|||
33153364|NCT02024555|100475543|FG001|Overall Study|Withdrawal by Subject|1|||
33153365|NCT02020577|100475544|FG000|Overall Study|Progressive disease|3|||
33153366|NCT02020577|100475545|FG001|Overall Study|Progressive disease|38|||
33153367|NCT02020577|100475544|FG000|Overall Study|Other AE or clinical progression|0|||
33153368|NCT02020577|100475545|FG001|Overall Study|Other AE or clinical progression|15|||
33153369|NCT02020577|100475544|FG000|Overall Study|Withdrawal by Subject|0|||
33153370|NCT02020577|100475545|FG001|Overall Study|Withdrawal by Subject|1|||
33251379|NCT01876511|100818049|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
33386939|NCT01742091|101302690|FG003|Overall Study|Lost to Follow-up|0|||
33153371|NCT02020577|100475544|FG000|Overall Study|Other than stated above|0|||
33153372|NCT02020577|100475545|FG001|Overall Study|Other than stated above|1|||
33153373|NCT02437513|100475546|FG000|Overall Study|Withdrawal by Subject|2|||
33153374|NCT01013350|100475551|FG000|Overall Study|Lost to Follow-up|15|||
33153375|NCT01013350|100475552|FG001|Overall Study|Lost to Follow-up|95|||
33153376|NCT01013350|100475551|FG000|Overall Study|Adverse Event|0|||
33153377|NCT01013350|100475552|FG001|Overall Study|Adverse Event|1|||
33153378|NCT01013350|100475551|FG000|Overall Study|Physician Decision|4|||
33153379|NCT01013350|100475552|FG001|Overall Study|Physician Decision|20|||
33153380|NCT01013350|100475551|FG000|Overall Study|Withdrawal by Subject|15|||
33153381|NCT01013350|100475552|FG001|Overall Study|Withdrawal by Subject|38|||
33153382|NCT01013350|100475551|FG000|Overall Study|Death|3|||
33153383|NCT01013350|100475552|FG001|Overall Study|Death|5|||
33251380|NCT01876511|100818047|FG000|Overall Study|Death (unrelated)|3|||
33251381|NCT01876511|100818048|FG001|Overall Study|Death (unrelated)|0|||
33251382|NCT01876511|100818049|FG002|Overall Study|Death (unrelated)|2|||
33251383|NCT01876511|100818047|FG000|Overall Study|Drug-related Toxicity|5|||
33251384|NCT01876511|100818048|FG001|Overall Study|Drug-related Toxicity|1|||
33251385|NCT01876511|100818049|FG002|Overall Study|Drug-related Toxicity|6|||
33251386|NCT01876511|100818047|FG000|Overall Study|Patient Decision|3|||
33251387|NCT01876511|100818048|FG001|Overall Study|Patient Decision|0|||
33251388|NCT01876511|100818049|FG002|Overall Study|Patient Decision|6|||
33251389|NCT01876511|100818047|FG000|Overall Study|Physician Decision|1|||
33251390|NCT01876511|100818048|FG001|Overall Study|Physician Decision|0|||
33251391|NCT01876511|100818049|FG002|Overall Study|Physician Decision|1|||
33251392|NCT04176458|100818050|FG000|Overall Study|Covid 19|4|||
33251393|NCT00305695|100820588|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
33251394|NCT00305695|100820589|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
33251395|NCT00305695|100820588|FG000|Overall Study|Did not have baseline scan|1|||
33251396|NCT00305695|100820589|FG001|Overall Study|Did not have baseline scan|1|||
33251397|NCT04580303|100820590|FG000|Overall Study|Adverse Event|0|||
33386940|NCT01742091|101302691|FG004|Overall Study|Lost to Follow-up|0|||
33386941|NCT01742091|101302692|FG005|Overall Study|Lost to Follow-up|1|||
33251398|NCT04580303|100820591|FG001|Overall Study|Adverse Event|1|||
33251399|NCT04580303|100820592|FG002|Overall Study|Adverse Event|0|||
33251400|NCT04580303|100820593|FG003|Overall Study|Adverse Event|0|||
33251401|NCT04580303|100820590|FG000|Overall Study|Withdrawal by Subject|0|||
33251402|NCT04580303|100820591|FG001|Overall Study|Withdrawal by Subject|0|||
33251403|NCT04580303|100820592|FG002|Overall Study|Withdrawal by Subject|1|||
33251404|NCT04580303|100820593|FG003|Overall Study|Withdrawal by Subject|0|||
33251405|NCT02041104|100820596|FG000|Overall Study|Lost to Follow-up|1|||
33251406|NCT02041104|100820597|FG001|Overall Study|Lost to Follow-up|4|||
33251407|NCT02041104|100820596|FG000|Overall Study|discomfort during OGTT|0|||
33251408|NCT02041104|100820597|FG001|Overall Study|discomfort during OGTT|3|||
33251409|NCT01254019|100820598|FG000|Overall Study|Adverse Event|0|||
33251410|NCT01254019|100820599|FG001|Overall Study|Adverse Event|2|||
33251411|NCT01254019|100820598|FG000|Overall Study|Protocol Violation|1|||
33386942|NCT00389441|101302693|FG000|Overall Study|Adverse Event|7|||
33386943|NCT00389441|101302693|FG000|Overall Study|Death|4|||
33386944|NCT00389441|101302693|FG000|Overall Study|Lost to Follow-up|2|||
33386945|NCT00389441|101302693|FG000|Overall Study|Withdrawal by Subject|4|||
33251412|NCT01254019|100820599|FG001|Overall Study|Protocol Violation|0|||
33251413|NCT01254019|100820598|FG000|Overall Study|Withdrawal by Subject|0|||
33251414|NCT01254019|100820599|FG001|Overall Study|Withdrawal by Subject|2|||
33251415|NCT01977612|100820600|FG000|Overall Study|Lost to Follow-up|1|||
33386946|NCT00389441|101302693|FG000|Overall Study|Physician Decision|1|||
33386947|NCT00389441|101302693|FG000|Overall Study|Protocol Violation|1|||
33386948|NCT00389441|101302693|FG000|Overall Study|Global deterioration of health status|4|||
33386949|NCT00389441|101302693|FG000|Overall Study|Objective progression or relapse|26|||
33153384|NCT01013350|100475551|FG000|Overall Study|Participant entered interventional study|0|||
33153385|NCT01013350|100475552|FG001|Overall Study|Participant entered interventional study|8|||
33251416|NCT01977612|100820601|FG001|Overall Study|Lost to Follow-up|1|||
33251417|NCT02918071|100820602|FG000|Overall Study|Withdrawal by Subject|2|||
33386950|NCT00389441|101302693|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
33386951|NCT00389441|101302693|FG000|Overall Study|Clinical progression|1|||
33386952|NCT00701103|101302694|FG000|Overall Study|Adverse Event|0|||
33386953|NCT00701103|101302695|FG001|Overall Study|Adverse Event|0|||
33386954|NCT00701103|101302696|FG002|Overall Study|Adverse Event|1|||
33386955|NCT00701103|101302697|FG003|Overall Study|Adverse Event|1|||
33251418|NCT02918071|100820602|FG000|Overall Study|Lost to Follow-up|1|||
33386956|NCT00701103|101302698|FG004|Overall Study|Adverse Event|0|||
33153386|NCT01013350|100475551|FG000|Overall Study|Other|1|||
33153387|NCT01013350|100475552|FG001|Overall Study|Other|25|||
33153388|NCT03403374|100475553|FG000|Overall Study|Lost to Follow-up|1|||
33153389|NCT01558739|100475554|FG000|Overall Study|Adverse Event|7|||
33153390|NCT01558739|100475554|FG000|Overall Study|Withdrawal by Subject|2|||
33153391|NCT01558739|100475554|FG000|Overall Study|Death|3|||
33153392|NCT01558739|100475554|FG000|Overall Study|Disease Progression|4|||
33153393|NCT01558739|100475554|FG000|Overall Study|Protocol Violation|1|||
33153394|NCT05055128|100475555|FG000|Overall Study|Adverse Event|0|||
33153395|NCT05055128|100475556|FG001|Overall Study|Adverse Event|0|||
33153396|NCT05055128|100475557|FG002|Overall Study|Adverse Event|0|||
33153397|NCT05055128|100475558|FG003|Overall Study|Adverse Event|1|||
33153398|NCT05055128|100475559|FG004|Overall Study|Adverse Event|1|||
33153399|NCT05055128|100475555|FG000|Overall Study|Protocol Violation|0|||
33153400|NCT05055128|100475556|FG001|Overall Study|Protocol Violation|0|||
33153401|NCT05055128|100475557|FG002|Overall Study|Protocol Violation|0|||
33153402|NCT05055128|100475558|FG003|Overall Study|Protocol Violation|1|||
33153403|NCT05055128|100475559|FG004|Overall Study|Protocol Violation|0|||
33153404|NCT05055128|100475555|FG000|Overall Study|Withdrawal by Subject|5|||
33153405|NCT05055128|100475556|FG001|Overall Study|Withdrawal by Subject|2|||
33153406|NCT05055128|100475557|FG002|Overall Study|Withdrawal by Subject|2|||
33153407|NCT05055128|100475558|FG003|Overall Study|Withdrawal by Subject|4|||
33153408|NCT05055128|100475559|FG004|Overall Study|Withdrawal by Subject|2|||
33251419|NCT00364286|100820607|FG000|Overall Study|Withdrawal by Subject|1|||
33251420|NCT00364286|100820607|FG000|Overall Study|Adverse Event|2|||
33153409|NCT05055128|100475555|FG000|Overall Study|Randomized By Mistake|0|||
33153410|NCT05055128|100475556|FG001|Overall Study|Randomized By Mistake|1|||
33153411|NCT05055128|100475557|FG002|Overall Study|Randomized By Mistake|0|||
33153412|NCT05055128|100475558|FG003|Overall Study|Randomized By Mistake|0|||
33251421|NCT03008915|100820614|FG000|Treatment 1|Withdrawal by Subject|0|||
33251422|NCT03008915|100820615|FG001|Treatment 1|Withdrawal by Subject|1|||
33251423|NCT02131324|100820616|FG000|Overall Study|Withdrawal by Subject|1|||
33251424|NCT02131324|100820617|FG001|Overall Study|Withdrawal by Subject|2|||
33251425|NCT02131324|100820616|FG000|Overall Study|Lost to Follow-up|1|||
33251426|NCT02131324|100820617|FG001|Overall Study|Lost to Follow-up|1|||
33251427|NCT05257798|100820622|FG000|Follow-up Phase|Lost to Follow-up|1|||
33251428|NCT05257798|100820623|FG001|Follow-up Phase|Lost to Follow-up|0|||
33251429|NCT05046132|100820624|FG000|Overall Study|Adverse Event|4|||
33251430|NCT05046132|100820625|FG001|Overall Study|Adverse Event|0|||
33251431|NCT05046132|100820626|FG002|Overall Study|Adverse Event|0|||
33251432|NCT05046132|100820624|FG000|Overall Study|Withdrawal by Subject|3|||
33251433|NCT05046132|100820625|FG001|Overall Study|Withdrawal by Subject|0|||
33251434|NCT05046132|100820626|FG002|Overall Study|Withdrawal by Subject|0|||
33251435|NCT05046132|100820624|FG000|Overall Study|Positive Covid19 Result.|0|||
33251436|NCT05046132|100820625|FG001|Overall Study|Positive Covid19 Result.|1|||
33251437|NCT05046132|100820626|FG002|Overall Study|Positive Covid19 Result.|0|||
33251438|NCT01393119|100820627|FG000|Overall Study|Adverse Event|1|||
33251439|NCT01393119|100820628|FG001|Overall Study|Adverse Event|1|||
33251440|NCT01393119|100820629|FG002|Overall Study|Adverse Event|0|||
33251441|NCT01393119|100820630|FG003|Overall Study|Adverse Event|1|||
33251442|NCT01393119|100820627|FG000|Overall Study|Withdrawal by Subject|0|||
33251443|NCT01393119|100820628|FG001|Overall Study|Withdrawal by Subject|1|||
33251444|NCT01393119|100820629|FG002|Overall Study|Withdrawal by Subject|1|||
33251445|NCT01393119|100820630|FG003|Overall Study|Withdrawal by Subject|0|||
33251446|NCT01393119|100820627|FG000|Overall Study|Lack of Efficacy|1|||
33251447|NCT01393119|100820628|FG001|Overall Study|Lack of Efficacy|0|||
33251448|NCT01393119|100820629|FG002|Overall Study|Lack of Efficacy|2|||
33251449|NCT01393119|100820630|FG003|Overall Study|Lack of Efficacy|1|||
33251450|NCT01393119|100820627|FG000|Overall Study|Protocol Violation|0|||
33251451|NCT01393119|100820628|FG001|Overall Study|Protocol Violation|0|||
33251452|NCT01393119|100820629|FG002|Overall Study|Protocol Violation|1|||
33251453|NCT01393119|100820630|FG003|Overall Study|Protocol Violation|0|||
33251454|NCT01393119|100820627|FG000|Overall Study|Death|0|||
33251455|NCT01393119|100820628|FG001|Overall Study|Death|0|||
33251456|NCT01393119|100820629|FG002|Overall Study|Death|0|||
33251457|NCT01393119|100820630|FG003|Overall Study|Death|1|||
33251458|NCT01393119|100820627|FG000|Overall Study|Randomized but Not treated|1|||
33251459|NCT01393119|100820628|FG001|Overall Study|Randomized but Not treated|0|||
33251460|NCT01393119|100820629|FG002|Overall Study|Randomized but Not treated|1|||
33251461|NCT01393119|100820630|FG003|Overall Study|Randomized but Not treated|1|||
33251462|NCT01393119|100820627|FG000|Overall Study|Sponsor Termination of Study|11|||
33251463|NCT01393119|100820628|FG001|Overall Study|Sponsor Termination of Study|12|||
33251464|NCT01393119|100820629|FG002|Overall Study|Sponsor Termination of Study|9|||
33251465|NCT01393119|100820630|FG003|Overall Study|Sponsor Termination of Study|12|||
33251466|NCT01802632|100820631|FG000|Overall Study|Death|28|||
33251467|NCT01802632|100820632|FG001|Overall Study|Death|1|||
33251468|NCT01802632|100820633|FG002|Overall Study|Death|38|||
33251469|NCT01802632|100820634|FG003|Overall Study|Death|0|||
33251470|NCT01802632|100820635|FG004|Overall Study|Death|2|||
33251471|NCT01802632|100820636|FG005|Overall Study|Death|0|||
33251472|NCT01802632|100820631|FG000|Overall Study|Withdrawal by Subject|4|||
33251473|NCT01802632|100820632|FG001|Overall Study|Withdrawal by Subject|2|||
33251474|NCT01802632|100820633|FG002|Overall Study|Withdrawal by Subject|7|||
33251475|NCT01802632|100820634|FG003|Overall Study|Withdrawal by Subject|3|||
33251476|NCT01802632|100820635|FG004|Overall Study|Withdrawal by Subject|0|||
33251477|NCT01802632|100820636|FG005|Overall Study|Withdrawal by Subject|1|||
33251478|NCT01802632|100820631|FG000|Overall Study|Objective Disease Progression|1|||
33251479|NCT01802632|100820632|FG001|Overall Study|Objective Disease Progression|12|||
33251480|NCT01802632|100820633|FG002|Overall Study|Objective Disease Progression|104|||
33251481|NCT01802632|100820634|FG003|Overall Study|Objective Disease Progression|6|||
33251482|NCT01802632|100820635|FG004|Overall Study|Objective Disease Progression|4|||
33386957|NCT00701103|101302699|FG005|Overall Study|Adverse Event|1|||
33386958|NCT00701103|101302700|FG006|Overall Study|Adverse Event|1|||
33386959|NCT00701103|101302701|FG007|Overall Study|Adverse Event|0|||
33251483|NCT01802632|100820636|FG005|Overall Study|Objective Disease Progression|4|||
33251484|NCT01802632|100820631|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
33251485|NCT01802632|100820632|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
33251486|NCT01802632|100820633|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
33251487|NCT01802632|100820634|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
33251488|NCT01802632|100820635|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
33251489|NCT01802632|100820636|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
33251490|NCT01802632|100820631|FG000|Overall Study|Other (not specified)|0|||
33251491|NCT01802632|100820632|FG001|Overall Study|Other (not specified)|0|||
33386960|NCT00701103|101302702|FG008|Overall Study|Adverse Event|0|||
33386961|NCT00701103|101302703|FG009|Overall Study|Adverse Event|2|||
33386962|NCT00701103|101302704|FG010|Overall Study|Adverse Event|0|||
33386963|NCT00701103|101302694|FG000|Overall Study|Progressive Disease|5|||
33251492|NCT01802632|100820633|FG002|Overall Study|Other (not specified)|7|||
33251493|NCT01802632|100820634|FG003|Overall Study|Other (not specified)|1|||
33251494|NCT01802632|100820635|FG004|Overall Study|Other (not specified)|0|||
33251495|NCT01802632|100820636|FG005|Overall Study|Other (not specified)|1|||
33251496|NCT02194933|100820638|FG000|Overall Study|Lost to Follow-up|1|||
33251497|NCT02194933|100820639|FG001|Overall Study|Lost to Follow-up|2|||
33251498|NCT02194933|100820638|FG000|Overall Study|Participant met withdrawal criteria|1|||
33251499|NCT02194933|100820639|FG001|Overall Study|Participant met withdrawal criteria|3|||
33251500|NCT02194933|100820638|FG000|Overall Study|Withdrawal by Subject|0|||
33251501|NCT02194933|100820639|FG001|Overall Study|Withdrawal by Subject|2|||
33251502|NCT02194933|100820638|FG000|Overall Study|Lack of Efficacy|1|||
33251503|NCT02194933|100820639|FG001|Overall Study|Lack of Efficacy|2|||
33251504|NCT01405924|100820640|FG000|Overall Study|Protocol Violation|8|||
33251505|NCT01405924|100820640|FG000|Overall Study|Missing/Incomplete Data|2|||
33251506|NCT00319436|100820643|FG000|Overall Study|Withdrawal by Subject|6|||
33251507|NCT00319436|100820644|FG001|Overall Study|Withdrawal by Subject|7|||
33251508|NCT01510912|100820645|FG000|Overall Study|Adverse Event|99|||
33251509|NCT01510912|100820645|FG000|Overall Study|Lack of Efficacy|12|||
33251510|NCT01510912|100820645|FG000|Overall Study|Non-compliance with trial drug|23|||
33251511|NCT01510912|100820645|FG000|Overall Study|Withdrawal by Subject|49|||
33251512|NCT01510912|100820645|FG000|Overall Study|Physician Decision|1|||
33251513|NCT01510912|100820645|FG000|Overall Study|Protocol Violation|27|||
33251514|NCT01510912|100820645|FG000|Overall Study|Lost to Follow-up|26|||
33251515|NCT01510912|100820645|FG000|Overall Study|Other, including joint replacement|5|||
33251516|NCT00573833|100820646|FG000|Overall Study|Not Treated|2|||
33251517|NCT00612586|100820655|FG000|Overall Study|Adverse Event|6|||
33251518|NCT00612586|100820656|FG001|Overall Study|Adverse Event|2|||
33251519|NCT00612586|100820655|FG000|Overall Study|Death|1|||
33251520|NCT00612586|100820656|FG001|Overall Study|Death|0|||
33251521|NCT00612586|100820655|FG000|Overall Study|Entry Criteria Not Met|0|||
33251522|NCT00612586|100820656|FG001|Overall Study|Entry Criteria Not Met|2|||
33251523|NCT00612586|100820655|FG000|Overall Study|Withdrawal by Subject|7|||
33251524|NCT00612586|100820656|FG001|Overall Study|Withdrawal by Subject|9|||
33251525|NCT00612586|100820655|FG000|Overall Study|Physician Decision|1|||
33251526|NCT00612586|100820656|FG001|Overall Study|Physician Decision|2|||
33251527|NCT00612586|100820655|FG000|Overall Study|Sponsor Decision|1|||
33251528|NCT00612586|100820656|FG001|Overall Study|Sponsor Decision|1|||
33251529|NCT00612586|100820655|FG000|Overall Study|Progressive Disease|26|||
33251530|NCT00612586|100820656|FG001|Overall Study|Progressive Disease|24|||
33251531|NCT00612586|100820655|FG000|Overall Study|Randomized and Not Treated|1|||
33251532|NCT00612586|100820656|FG001|Overall Study|Randomized and Not Treated|1|||
33251533|NCT01546155|100820657|FG000|Overall Study|could not tolerate long scan duration|3|||
33251534|NCT01897233|100820658|FG000|Part B (24 Weeks)|Adverse Event|1|||
33251535|NCT01897233|100820658|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
33251536|NCT01897233|100820658|FG000|Part B (24 Weeks)|Physician Decision|1|||
33251537|NCT00309452|100820659|FG000|Overall Study|Withdrawal by Subject|3|||
33251538|NCT00309452|100820660|FG001|Overall Study|Withdrawal by Subject|0|||
33251539|NCT00831415|100820661|FG000|Overall Study|Adverse Event|14|||
33251540|NCT00831415|100820661|FG000|Overall Study|Failed to return|3|||
33251541|NCT00831415|100820661|FG000|Overall Study|Physician Decision|6|||
33251542|NCT00831415|100820661|FG000|Overall Study|Lost to Follow-up|9|||
33251543|NCT00831415|100820661|FG000|Overall Study|Protocol Violation|3|||
33251544|NCT00831415|100820661|FG000|Overall Study|Withdrawal by Subject|35|||
33251545|NCT00831415|100820661|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
33251546|NCT00831415|100820661|FG000|Overall Study|Death|1|||
33251547|NCT00794118|100820662|FG000|Overall Study|Lost to Follow-up|16|||
33251548|NCT00794118|100820662|FG000|Overall Study|Withdrawal by Subject|9|||
33386964|NCT00701103|101302695|FG001|Overall Study|Progressive Disease|2|||
33386965|NCT00701103|101302696|FG002|Overall Study|Progressive Disease|6|||
33251549|NCT00794118|100820662|FG000|Overall Study|Changed hospital center|2|||
33251550|NCT01251354|100820666|FG000|Overall Study|Adverse Event|1|||
33251551|NCT01251354|100820666|FG000|Overall Study|Investigator's Decision|1|||
33251552|NCT01251354|100820666|FG000|Overall Study|Disease Progression|4|||
33251553|NCT01792830|100820669|FG000|Overall Study|Withdrawal by Subject|22|||
33251554|NCT01792830|100820670|FG001|Overall Study|Withdrawal by Subject|0|||
33251555|NCT01792830|100820671|FG002|Overall Study|Withdrawal by Subject|0|||
33251556|NCT01792830|100820672|FG003|Overall Study|Withdrawal by Subject|2|||
33251557|NCT01792830|100820673|FG004|Overall Study|Withdrawal by Subject|1|||
33251558|NCT01792830|100820674|FG005|Overall Study|Withdrawal by Subject|1|||
33386966|NCT00701103|101302697|FG003|Overall Study|Progressive Disease|5|||
33386967|NCT00701103|101302698|FG004|Overall Study|Progressive Disease|6|||
33386968|NCT00701103|101302699|FG005|Overall Study|Progressive Disease|5|||
33251559|NCT01792830|100820675|FG006|Overall Study|Withdrawal by Subject|1|||
33251560|NCT01792830|100820676|FG007|Overall Study|Withdrawal by Subject|1|||
33251561|NCT01792830|100820677|FG008|Overall Study|Withdrawal by Subject|7|||
33251562|NCT01792830|100820678|FG009|Overall Study|Withdrawal by Subject|0|||
33251563|NCT01792830|100820679|FG010|Overall Study|Withdrawal by Subject|2|||
33251564|NCT01792830|100820669|FG000|Overall Study|Death|3|||
33437367|NCT01860976|101492715|FG000|Blinded Treatment|Lack of Efficacy|5|||
33153413|NCT05055128|100475559|FG004|Overall Study|Randomized By Mistake|0|||
33153414|NCT05055128|100475555|FG000|Overall Study|Other|1|||
33153415|NCT05055128|100475556|FG001|Overall Study|Other|0|||
33386969|NCT00701103|101302700|FG006|Overall Study|Progressive Disease|7|||
33437368|NCT01860976|101492716|FG001|Blinded Treatment|Lack of Efficacy|12|||
33437369|NCT01860976|101492715|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
33153416|NCT05055128|100475557|FG002|Overall Study|Other|0|||
33386970|NCT00701103|101302701|FG007|Overall Study|Progressive Disease|7|||
33153417|NCT05055128|100475558|FG003|Overall Study|Other|0|||
33153418|NCT05055128|100475559|FG004|Overall Study|Other|0|||
33153419|NCT01691898|100475560|FG000|Overall Study|Death|34|||
33153420|NCT01691898|100475561|FG001|Overall Study|Death|32|||
33153421|NCT01691898|100475562|FG002|Overall Study|Death|6|||
33153422|NCT01691898|100475563|FG003|Overall Study|Death|3|||
33153423|NCT01691898|100475564|FG004|Overall Study|Death|8|||
33153424|NCT01691898|100475565|FG005|Overall Study|Death|31|||
33153425|NCT01691898|100475560|FG000|Overall Study|Adverse Event|0|||
33153426|NCT01691898|100475561|FG001|Overall Study|Adverse Event|1|||
33153427|NCT01691898|100475562|FG002|Overall Study|Adverse Event|0|||
33153428|NCT01691898|100475563|FG003|Overall Study|Adverse Event|1|||
33153429|NCT01691898|100475564|FG004|Overall Study|Adverse Event|1|||
33153430|NCT01691898|100475565|FG005|Overall Study|Adverse Event|0|||
33153431|NCT01691898|100475560|FG000|Overall Study|Progression of Disease|1|||
33153432|NCT01691898|100475561|FG001|Overall Study|Progression of Disease|2|||
33153433|NCT01691898|100475562|FG002|Overall Study|Progression of Disease|1|||
33153434|NCT01691898|100475563|FG003|Overall Study|Progression of Disease|0|||
33153435|NCT01691898|100475564|FG004|Overall Study|Progression of Disease|0|||
33153436|NCT01691898|100475565|FG005|Overall Study|Progression of Disease|1|||
33153437|NCT01691898|100475560|FG000|Overall Study|Lost to Follow-up|3|||
33153438|NCT01691898|100475561|FG001|Overall Study|Lost to Follow-up|1|||
33153439|NCT01691898|100475562|FG002|Overall Study|Lost to Follow-up|0|||
33153440|NCT01691898|100475563|FG003|Overall Study|Lost to Follow-up|0|||
33153441|NCT01691898|100475564|FG004|Overall Study|Lost to Follow-up|1|||
33153442|NCT01691898|100475565|FG005|Overall Study|Lost to Follow-up|0|||
33153443|NCT01691898|100475560|FG000|Overall Study|Withdrawal by Subject|9|||
33153444|NCT01691898|100475561|FG001|Overall Study|Withdrawal by Subject|8|||
33153445|NCT01691898|100475562|FG002|Overall Study|Withdrawal by Subject|2|||
33153446|NCT01691898|100475563|FG003|Overall Study|Withdrawal by Subject|1|||
33153447|NCT01691898|100475564|FG004|Overall Study|Withdrawal by Subject|3|||
33153448|NCT01691898|100475565|FG005|Overall Study|Withdrawal by Subject|3|||
33153449|NCT01691898|100475560|FG000|Overall Study|Non-Compliance|0|||
33153450|NCT01691898|100475561|FG001|Overall Study|Non-Compliance|0|||
33153451|NCT01691898|100475562|FG002|Overall Study|Non-Compliance|0|||
33153452|NCT01691898|100475563|FG003|Overall Study|Non-Compliance|0|||
33153453|NCT01691898|100475564|FG004|Overall Study|Non-Compliance|1|||
33153454|NCT01691898|100475565|FG005|Overall Study|Non-Compliance|0|||
33153455|NCT01297920|100475566|FG000|Overall Study|Adverse Event|42|||
33153456|NCT01297920|100475567|FG001|Overall Study|Adverse Event|10|||
33153457|NCT01297920|100475568|FG002|Overall Study|Adverse Event|38|||
33153458|NCT01297920|100475566|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
33386971|NCT00701103|101302702|FG008|Overall Study|Progressive Disease|8|||
33386972|NCT00701103|101302703|FG009|Overall Study|Progressive Disease|8|||
33386973|NCT00701103|101302704|FG010|Overall Study|Progressive Disease|11|||
33386974|NCT00701103|101302694|FG000|Overall Study|Withdrawal by Subject|0|||
33386975|NCT00701103|101302695|FG001|Overall Study|Withdrawal by Subject|1|||
33386976|NCT00701103|101302696|FG002|Overall Study|Withdrawal by Subject|1|||
33386977|NCT00701103|101302697|FG003|Overall Study|Withdrawal by Subject|0|||
33386978|NCT00701103|101302698|FG004|Overall Study|Withdrawal by Subject|0|||
33386979|NCT00701103|101302699|FG005|Overall Study|Withdrawal by Subject|0|||
33386980|NCT00701103|101302700|FG006|Overall Study|Withdrawal by Subject|0|||
33386981|NCT00701103|101302701|FG007|Overall Study|Withdrawal by Subject|0|||
33386982|NCT00701103|101302702|FG008|Overall Study|Withdrawal by Subject|0|||
33437370|NCT01860976|101492716|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
33437371|NCT01860976|101492715|FG000|Blinded Treatment|Withdrawal by Subject|3|||
33437372|NCT01860976|101492716|FG001|Blinded Treatment|Withdrawal by Subject|5|||
33437373|NCT01860976|101492715|FG000|Blinded Treatment|Subject no longer met criteria|1|||
33437374|NCT01860976|101492716|FG001|Blinded Treatment|Subject no longer met criteria|0|||
33437375|NCT01860976|101492715|FG000|Blinded Treatment|Entered Open-Label in error|0|||
33437376|NCT01860976|101492716|FG001|Blinded Treatment|Entered Open-Label in error|1|||
33437377|NCT01860976|101492715|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
33153459|NCT01297920|100475567|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
33153460|NCT01297920|100475568|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
33153461|NCT01297920|100475566|FG000|Overall Study|Noncompliance|1|||
33153462|NCT01297920|100475567|FG001|Overall Study|Noncompliance|0|||
33153463|NCT01297920|100475568|FG002|Overall Study|Noncompliance|0|||
33153464|NCT01297920|100475566|FG000|Overall Study|Protocol Violation|1|||
33153465|NCT01297920|100475567|FG001|Overall Study|Protocol Violation|3|||
33386983|NCT00701103|101302703|FG009|Overall Study|Withdrawal by Subject|0|||
33386984|NCT00701103|101302704|FG010|Overall Study|Withdrawal by Subject|0|||
33437378|NCT01860976|101492716|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
33153466|NCT01297920|100475568|FG002|Overall Study|Protocol Violation|0|||
33153467|NCT01297920|100475566|FG000|Overall Study|Inadequate Control of IOP|7|||
33153468|NCT01297920|100475567|FG001|Overall Study|Inadequate Control of IOP|9|||
33153469|NCT01297920|100475568|FG002|Overall Study|Inadequate Control of IOP|17|||
33153470|NCT01297920|100475566|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
33437379|NCT01860976|101492715|FG000|Open-Label|Adverse Event|2|||
33437380|NCT01860976|101492716|FG001|Open-Label|Adverse Event|4|||
33437381|NCT01860976|101492715|FG000|Open-Label|Lack of Efficacy|16|||
33437382|NCT01860976|101492716|FG001|Open-Label|Lack of Efficacy|8|||
33437383|NCT01860976|101492715|FG000|Open-Label|Lost to Follow-up|1|||
33437384|NCT01860976|101492716|FG001|Open-Label|Lost to Follow-up|2|||
33437385|NCT01860976|101492715|FG000|Open-Label|Subject request discontinue treatment|4|||
33437386|NCT01860976|101492716|FG001|Open-Label|Subject request discontinue treatment|3|||
33437387|NCT01860976|101492715|FG000|Open-Label|Withdrawal by Subject|4|||
33437388|NCT01860976|101492716|FG001|Open-Label|Withdrawal by Subject|1|||
33437389|NCT01860976|101492715|FG000|Open-Label|Other Reasons|1|||
33437390|NCT01860976|101492716|FG001|Open-Label|Other Reasons|1|||
33437391|NCT01860976|101492715|FG000|Long Term Extension|Adverse Event|4|||
33437392|NCT01860976|101492716|FG001|Long Term Extension|Adverse Event|0|||
33437393|NCT01860976|101492715|FG000|Long Term Extension|Lack of Efficacy|2|||
33437394|NCT01860976|101492716|FG001|Long Term Extension|Lack of Efficacy|0|||
33437395|NCT01860976|101492715|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
33437396|NCT01860976|101492716|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
33437397|NCT01860976|101492715|FG000|Long Term Extension|Lost to Follow-up|2|||
33437398|NCT01860976|101492716|FG001|Long Term Extension|Lost to Follow-up|0|||
33437399|NCT01860976|101492715|FG000|Long Term Extension|subject withdrew consent|7|||
33437400|NCT01860976|101492716|FG001|Long Term Extension|subject withdrew consent|0|||
33437401|NCT01941030|101492717|FG000|Overall Study|Death|3|||
33437402|NCT01941030|101492718|FG001|Overall Study|Death|2|||
33153471|NCT01297920|100475567|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
33153472|NCT01297920|100475568|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
33153473|NCT01845818|100475569|FG000|Overall Study|Withdrawal by Subject|0|||
33153474|NCT01845818|100475570|FG001|Overall Study|Withdrawal by Subject|1|||
33153475|NCT01845818|100475569|FG000|Overall Study|Lost to Follow-up|7|||
33153476|NCT01845818|100475570|FG001|Overall Study|Lost to Follow-up|5|||
33437403|NCT01941030|101492717|FG000|Overall Study|Lost to Follow-up|6|||
33437404|NCT01941030|101492718|FG001|Overall Study|Lost to Follow-up|5|||
33437405|NCT01941030|101492717|FG000|Overall Study|Withdrawal by Subject|4|||
33437406|NCT01941030|101492718|FG001|Overall Study|Withdrawal by Subject|6|||
33437407|NCT00525590|101492719|FG000|Overall Study|Adverse Event|3|||
33437408|NCT00525590|101492719|FG000|Overall Study|Physician Decision|3|||
33437409|NCT00525590|101492719|FG000|Overall Study|Withdrawal by Subject|16|||
33437410|NCT00525590|101492719|FG000|Overall Study|Lost to Follow-up|1|||
33437411|NCT00525590|101492719|FG000|Overall Study|Death|9|||
33437412|NCT00525590|101492719|FG000|Overall Study|Other|13|||
33437413|NCT00623779|101492720|FG000|Overall Study|Adverse Event|1|||
33437414|NCT00623779|101492721|FG001|Overall Study|Adverse Event|3|||
33437415|NCT00623779|101492722|FG002|Overall Study|Adverse Event|0|||
33437416|NCT00623779|101492720|FG000|Overall Study|Criteria from CSR|2|||
33437417|NCT00623779|101492721|FG001|Overall Study|Criteria from CSR|0|||
33437418|NCT00623779|101492722|FG002|Overall Study|Criteria from CSR|1|||
33437419|NCT02906709|101492723|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
33437420|NCT02906709|101492724|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
33437421|NCT02906709|101492723|FG000|Phase A (Week 0 to Week 16)|Death|0|||
33437422|NCT02906709|101492724|FG001|Phase A (Week 0 to Week 16)|Death|1|||
33437423|NCT02906709|101492723|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
33153477|NCT01845818|100475569|FG000|Overall Study|Administrative Reasons|3|||
33153478|NCT01845818|100475570|FG001|Overall Study|Administrative Reasons|1|||
33153479|NCT01845818|100475569|FG000|Overall Study|Serious Adverse Event|1|||
33153480|NCT01845818|100475570|FG001|Overall Study|Serious Adverse Event|1|||
33153481|NCT01845818|100475569|FG000|Overall Study|Other|25|||
33153482|NCT01845818|100475570|FG001|Overall Study|Other|8|||
33153483|NCT01845818|100475569|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
33153484|NCT01845818|100475570|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
33153485|NCT01845818|100475569|FG000|Overall Study|No Follow-Up Data Available|4|||
33251565|NCT01792830|100820670|FG001|Overall Study|Death|0|||
33386985|NCT00701103|101302694|FG000|Overall Study|Other|0|||
33437424|NCT02906709|101492724|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
33437425|NCT02906709|101492723|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
33437426|NCT02906709|101492724|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
33437427|NCT04041570|101492725|FG000|Overall Study|Moved from Area|0|||
33153486|NCT01845818|100475570|FG001|Overall Study|No Follow-Up Data Available|1|||
33437428|NCT04041570|101492726|FG001|Overall Study|Moved from Area|2|||
33437429|NCT03019965|101492729|FG000|Overall Study|Withdrawal by Subject|1|||
33437430|NCT03019965|101492730|FG001|Overall Study|Withdrawal by Subject|0|||
33437431|NCT03019965|101492729|FG000|Overall Study|Protocol Violation|1|||
33437432|NCT03019965|101492730|FG001|Overall Study|Protocol Violation|3|||
33437433|NCT03019965|101492729|FG000|Overall Study|viral or fungal infection|3|||
33437434|NCT03019965|101492730|FG001|Overall Study|viral or fungal infection|4|||
33153487|NCT00580970|100475571|FG000|Pre-treatment|Non-compliance|1|||
33437435|NCT03019965|101492729|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
33437436|NCT03019965|101492730|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
33437437|NCT03019965|101492729|FG000|Overall Study|Physician Decision|1|||
33437438|NCT03019965|101492730|FG001|Overall Study|Physician Decision|1|||
33437439|NCT02116803|101492731|FG000|Overall Study|Adverse Event|2|||
33437440|NCT02116803|101492732|FG001|Overall Study|Adverse Event|1|||
33437441|NCT02116803|101492731|FG000|Overall Study|Physician Decision|1|||
33437442|NCT02116803|101492732|FG001|Overall Study|Physician Decision|0|||
33437443|NCT02116803|101492731|FG000|Overall Study|Progressive disease|4|||
33437444|NCT02116803|101492732|FG001|Overall Study|Progressive disease|0|||
33437445|NCT02116803|101492731|FG000|Overall Study|Study terminated by sponsor|2|||
33437446|NCT02116803|101492732|FG001|Overall Study|Study terminated by sponsor|1|||
33437447|NCT02116803|101492731|FG000|Overall Study|Death|1|||
33437448|NCT02116803|101492732|FG001|Overall Study|Death|0|||
33437449|NCT01939197|101492739|FG000|Overall Study|Withdrawal by Subject|1|||
33437450|NCT01939197|101492740|FG001|Overall Study|Withdrawal by Subject|0|||
33437451|NCT01939197|101492741|FG002|Overall Study|Withdrawal by Subject|0|||
33437452|NCT01939197|101492742|FG003|Overall Study|Withdrawal by Subject|0|||
33437453|NCT01939197|101492743|FG004|Overall Study|Withdrawal by Subject|1|||
33153488|NCT00580970|100475571|FG000|Treatment (Lovastatin)|Non-compliance|6|||
33153489|NCT00580970|100475571|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
33153490|NCT00580970|100475571|FG000|Treatment (Lovastatin)|Physician Decision|4|||
33153491|NCT00580970|100475571|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
33153492|NCT00580970|100475571|FG000|Treatment (Lovastatin)|Death|1|||
33153493|NCT02155881|100475572|FG000|Overall Study|Withdrawal by Subject|0|||
33153494|NCT02155881|100475573|FG001|Overall Study|Withdrawal by Subject|2|||
33153495|NCT02155881|100475572|FG000|Overall Study|Inappropriately randomized|2|||
33153496|NCT02155881|100475573|FG001|Overall Study|Inappropriately randomized|2|||
33153497|NCT02149875|100475574|FG000|Overall Study|Lost to Follow-up|3|||
33153498|NCT02149875|100475575|FG001|Overall Study|Lost to Follow-up|4|||
33153499|NCT02149875|100475576|FG002|Overall Study|Lost to Follow-up|5|||
33153500|NCT02149875|100475574|FG000|Overall Study|Withdrawal by Subject|3|||
33386986|NCT00701103|101302695|FG001|Overall Study|Other|0|||
33386987|NCT00701103|101302696|FG002|Overall Study|Other|0|||
33386988|NCT00701103|101302697|FG003|Overall Study|Other|0|||
33386989|NCT00701103|101302698|FG004|Overall Study|Other|0|||
33386990|NCT00701103|101302699|FG005|Overall Study|Other|0|||
33386991|NCT00701103|101302700|FG006|Overall Study|Other|0|||
33386992|NCT00701103|101302701|FG007|Overall Study|Other|0|||
33437454|NCT01939197|101492744|FG005|Overall Study|Withdrawal by Subject|0|||
33437455|NCT01939197|101492745|FG006|Overall Study|Withdrawal by Subject|0|||
33437456|NCT01939197|101492739|FG000|Overall Study|Lost to Follow-up|0|||
33437457|NCT01939197|101492740|FG001|Overall Study|Lost to Follow-up|1|||
33437458|NCT01939197|101492741|FG002|Overall Study|Lost to Follow-up|0|||
33437459|NCT01939197|101492742|FG003|Overall Study|Lost to Follow-up|1|||
33437460|NCT01939197|101492743|FG004|Overall Study|Lost to Follow-up|3|||
33437461|NCT01939197|101492744|FG005|Overall Study|Lost to Follow-up|1|||
33437462|NCT01939197|101492745|FG006|Overall Study|Lost to Follow-up|2|||
33437463|NCT00395226|101492746|FG000|Overall Study|Adverse Event|4|||
33437464|NCT00395226|101492747|FG001|Overall Study|Adverse Event|3|||
33437465|NCT00395226|101492746|FG000|Overall Study|Withdrawal by Subject|0|||
33386993|NCT00701103|101302702|FG008|Overall Study|Other|1|||
33386994|NCT00701103|101302703|FG009|Overall Study|Other|1|||
33153501|NCT02149875|100475575|FG001|Overall Study|Withdrawal by Subject|2|||
33153502|NCT02149875|100475576|FG002|Overall Study|Withdrawal by Subject|2|||
33386995|NCT00701103|101302704|FG010|Overall Study|Other|0|||
33386996|NCT03395223|101302705|FG000|Overall Study|Lost to Follow-up|3|||
33153503|NCT02149875|100475574|FG000|Overall Study|Physician Decision|1|||
33153504|NCT02149875|100475575|FG001|Overall Study|Physician Decision|2|||
33386997|NCT03395223|101302705|FG000|Overall Study|Other|1|||
33386998|NCT01484561|101302706|FG000|Overall Study|Lack of Efficacy|3|||
33386999|NCT01484561|101302707|FG001|Overall Study|Lack of Efficacy|1|||
33437466|NCT00395226|101492747|FG001|Overall Study|Withdrawal by Subject|1|||
33437467|NCT00395226|101492746|FG000|Overall Study|Lost to Follow-up|0|||
33437468|NCT00395226|101492747|FG001|Overall Study|Lost to Follow-up|1|||
33437469|NCT01505530|101492751|FG000|Overall Study|Progressive Disease|19|||
33437470|NCT01505530|101492752|FG001|Overall Study|Progressive Disease|17|||
33437471|NCT01505530|101492753|FG002|Overall Study|Progressive Disease|18|||
33437472|NCT01505530|101492751|FG000|Overall Study|Adverse Event|1|||
33437473|NCT01505530|101492752|FG001|Overall Study|Adverse Event|1|||
33437474|NCT01505530|101492753|FG002|Overall Study|Adverse Event|0|||
33153505|NCT02149875|100475576|FG002|Overall Study|Physician Decision|2|||
33153506|NCT01669928|100475577|FG000|First Intervention|Withdrawal by Subject|3|||
33153507|NCT01669928|100475578|FG001|First Intervention|Withdrawal by Subject|5|||
33153508|NCT03841448|100475579|FG000|Double-blind Treatment (DBT) Period|Death|1|||
33153509|NCT03841448|100475580|FG001|Double-blind Treatment (DBT) Period|Death|1|||
33153510|NCT03841448|100475581|FG002|Double-blind Treatment (DBT) Period|Death|0|||
33153511|NCT03841448|100475582|FG003|Double-blind Treatment (DBT) Period|Death|0|||
33153512|NCT03841448|100475579|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
33153513|NCT03841448|100475580|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
33153514|NCT03841448|100475581|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
33153515|NCT03841448|100475582|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
33153516|NCT03841448|100475579|FG000|Open-Label Extension (OLE) Period|Death|0|||
33153517|NCT03841448|100475580|FG001|Open-Label Extension (OLE) Period|Death|0|||
33153518|NCT03841448|100475581|FG002|Open-Label Extension (OLE) Period|Death|0|||
33153519|NCT03841448|100475582|FG003|Open-Label Extension (OLE) Period|Death|1|||
33153520|NCT03841448|100475579|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
33153521|NCT03841448|100475580|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
33153522|NCT03841448|100475581|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
33153523|NCT03841448|100475582|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
33153524|NCT03841448|100475579|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
33153525|NCT03841448|100475580|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
33153526|NCT03841448|100475581|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
33387000|NCT01484561|101302706|FG000|Overall Study|Lost to Follow-up|1|||
33153527|NCT03841448|100475582|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
33153528|NCT03841448|100475579|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
33251566|NCT01792830|100820671|FG002|Overall Study|Death|0|||
33251567|NCT01792830|100820672|FG003|Overall Study|Death|1|||
33251568|NCT01792830|100820673|FG004|Overall Study|Death|0|||
33437475|NCT01505530|101492751|FG000|Overall Study|Withdrawal by Subject|7|||
33153529|NCT03841448|100475580|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
33153530|NCT03841448|100475581|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
33153531|NCT03841448|100475582|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
33153532|NCT02635776|100475583|FG000|Overall Study|Physician Decision|1|||
33153533|NCT02635776|100475584|FG001|Overall Study|Physician Decision|0|||
33153534|NCT02635776|100475583|FG000|Overall Study|Adverse Event|51|||
33153535|NCT02635776|100475584|FG001|Overall Study|Adverse Event|3|||
33153536|NCT02635776|100475583|FG000|Overall Study|Withdrawal by Subject|41|||
33153537|NCT02635776|100475584|FG001|Overall Study|Withdrawal by Subject|7|||
33153538|NCT02635776|100475583|FG000|Overall Study|Lost to Follow-up|4|||
33153539|NCT02635776|100475584|FG001|Overall Study|Lost to Follow-up|0|||
33153540|NCT02635776|100475583|FG000|Overall Study|Other reasons|5|||
33153541|NCT02635776|100475584|FG001|Overall Study|Other reasons|1|||
33153542|NCT03540030|100475585|FG000|Overall Study|Withdrawal by Subject|2|||
33153543|NCT03540030|100475586|FG001|Overall Study|Withdrawal by Subject|1|||
33153544|NCT03540030|100475585|FG000|Overall Study|screen fail|7|||
33387001|NCT01484561|101302707|FG001|Overall Study|Lost to Follow-up|0|||
33153545|NCT03540030|100475586|FG001|Overall Study|screen fail|1|||
33153546|NCT03540030|100475585|FG000|Overall Study|never had surgery after signing consent|9|||
33251569|NCT01792830|100820674|FG005|Overall Study|Death|0|||
33251570|NCT01792830|100820675|FG006|Overall Study|Death|1|||
33153547|NCT03540030|100475586|FG001|Overall Study|never had surgery after signing consent|1|||
33153548|NCT01460368|100475587|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
33153549|NCT01460368|100475588|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
33153550|NCT01460368|100475589|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
33153551|NCT01460368|100475590|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
33153552|NCT01460368|100475591|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
33153553|NCT01460368|100475592|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
33153554|NCT01460368|100475593|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
33153555|NCT01460368|100475587|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
33251571|NCT01792830|100820676|FG007|Overall Study|Death|0|||
33251572|NCT01792830|100820677|FG008|Overall Study|Death|1|||
33251573|NCT01792830|100820678|FG009|Overall Study|Death|0|||
33251574|NCT01792830|100820679|FG010|Overall Study|Death|1|||
33153556|NCT01460368|100475588|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
33251575|NCT01792830|100820669|FG000|Overall Study|Adverse Event|0|||
33153557|NCT01460368|100475589|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
33153558|NCT01460368|100475590|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
33153559|NCT01460368|100475591|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
33153560|NCT01460368|100475592|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
33153561|NCT01460368|100475593|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
33153562|NCT01460368|100475587|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
33153563|NCT01460368|100475588|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
33153564|NCT01460368|100475589|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
33153565|NCT01460368|100475590|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
33153566|NCT01460368|100475591|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
33153567|NCT01460368|100475592|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
33153568|NCT01460368|100475593|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
33153569|NCT01460368|100475587|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
33251576|NCT01792830|100820670|FG001|Overall Study|Adverse Event|0|||
33251577|NCT01792830|100820671|FG002|Overall Study|Adverse Event|0|||
33251578|NCT01792830|100820672|FG003|Overall Study|Adverse Event|0|||
33251579|NCT01792830|100820673|FG004|Overall Study|Adverse Event|0|||
33251580|NCT01792830|100820674|FG005|Overall Study|Adverse Event|0|||
33251581|NCT01792830|100820675|FG006|Overall Study|Adverse Event|0|||
33251582|NCT01792830|100820676|FG007|Overall Study|Adverse Event|0|||
33251583|NCT01792830|100820677|FG008|Overall Study|Adverse Event|1|||
33251584|NCT01792830|100820678|FG009|Overall Study|Adverse Event|0|||
33251585|NCT01792830|100820679|FG010|Overall Study|Adverse Event|0|||
33153570|NCT01460368|100475588|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
33153571|NCT01460368|100475589|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
33153572|NCT01460368|100475590|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
33153573|NCT01460368|100475591|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
33153574|NCT01460368|100475592|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
33153575|NCT01460368|100475593|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
33153576|NCT01460368|100475587|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
33153577|NCT01460368|100475588|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
33153578|NCT01460368|100475589|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
33153579|NCT01460368|100475590|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
33153580|NCT01460368|100475591|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
33251586|NCT02614560|100820680|FG000|Overall Study|Death|6|||
33251587|NCT02614560|100820681|FG001|Overall Study|Death|2|||
33251588|NCT02698241|100820682|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
33251589|NCT02698241|100820682|FG000|Overall Study|Screening not met|7|||
33251590|NCT02698241|100820682|FG000|Overall Study|Withdrawal by Subject|7|||
33251591|NCT02698241|100820682|FG000|Overall Study|Physician Decision|2|||
33251592|NCT02698241|100820682|FG000|Overall Study|Subject underwent system modification|2|||
33251593|NCT02698241|100820682|FG000|Overall Study|Lost to Follow-up|3|||
33251594|NCT02698241|100820682|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
33251595|NCT02698241|100820682|FG000|Overall Study|geographic and licensing issue|1|||
33251596|NCT02698241|100820682|FG000|Overall Study|Death|2|||
33251597|NCT03125382|100820683|FG000|Randomization|screening failure|1|||
33153581|NCT01460368|100475592|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
33153582|NCT01460368|100475593|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
33153583|NCT00543543|100475594|FG000|Base Study|Adverse Event|1|||
33153584|NCT00543543|100475595|FG001|Base Study|Adverse Event|11|||
33153585|NCT00543543|100475596|FG002|Base Study|Adverse Event|0|||
33153586|NCT00543543|100475597|FG003|Base Study|Adverse Event|5|||
33153587|NCT00543543|100475594|FG000|Base Study|Lost to Follow-up|12|||
33153588|NCT00543543|100475595|FG001|Base Study|Lost to Follow-up|749|||
33153589|NCT00543543|100475596|FG002|Base Study|Lost to Follow-up|9|||
33251598|NCT03125382|100820684|FG001|Randomization|screening failure|4|||
33251599|NCT03125382|100820685|FG002|Randomization|screening failure|2|||
33251600|NCT03125382|100820686|FG003|Randomization|screening failure|0|||
33153590|NCT00543543|100475597|FG003|Base Study|Lost to Follow-up|701|||
33153591|NCT00543543|100475594|FG000|Base Study|Physician Decision|0|||
33153592|NCT00543543|100475595|FG001|Base Study|Physician Decision|4|||
33251601|NCT03125382|100820683|FG000|Follow-up|Death|1|||
33251602|NCT03125382|100820684|FG001|Follow-up|Death|2|||
33153593|NCT00543543|100475596|FG002|Base Study|Physician Decision|0|||
33153594|NCT00543543|100475597|FG003|Base Study|Physician Decision|7|||
33153595|NCT00543543|100475594|FG000|Base Study|Protocol Violation|0|||
33153596|NCT00543543|100475595|FG001|Base Study|Protocol Violation|6|||
33153597|NCT00543543|100475596|FG002|Base Study|Protocol Violation|0|||
33437476|NCT01505530|101492752|FG001|Overall Study|Withdrawal by Subject|8|||
33437477|NCT01505530|101492753|FG002|Overall Study|Withdrawal by Subject|6|||
33437478|NCT01505530|101492751|FG000|Overall Study|Physician Decision|6|||
33437479|NCT01505530|101492752|FG001|Overall Study|Physician Decision|2|||
33437480|NCT01505530|101492753|FG002|Overall Study|Physician Decision|5|||
33437481|NCT01505530|101492751|FG000|Overall Study|Sponsor Decision|1|||
33437482|NCT01505530|101492752|FG001|Overall Study|Sponsor Decision|8|||
33437483|NCT01505530|101492753|FG002|Overall Study|Sponsor Decision|7|||
33437484|NCT01505530|101492751|FG000|Overall Study|Death|7|||
33437485|NCT01505530|101492752|FG001|Overall Study|Death|6|||
33437486|NCT01505530|101492753|FG002|Overall Study|Death|5|||
33437487|NCT01505530|101492751|FG000|Overall Study|entry criteria not met|0|||
33437488|NCT01505530|101492752|FG001|Overall Study|entry criteria not met|1|||
33437489|NCT01505530|101492753|FG002|Overall Study|entry criteria not met|0|||
33437490|NCT00626548|101495964|FG000|Overall Study|Adverse Event|164|||
33437491|NCT00626548|101495965|FG001|Overall Study|Adverse Event|44|||
33437492|NCT00626548|101495964|FG000|Overall Study|Withdrawal by Subject|42|||
33437493|NCT00626548|101495965|FG001|Overall Study|Withdrawal by Subject|46|||
33437494|NCT00626548|101495964|FG000|Overall Study|Protocol Violation|4|||
33437495|NCT00626548|101495965|FG001|Overall Study|Protocol Violation|11|||
33437496|NCT00626548|101495964|FG000|Overall Study|Lost to Follow-up|2|||
33437497|NCT00626548|101495965|FG001|Overall Study|Lost to Follow-up|2|||
33437498|NCT00626548|101495964|FG000|Overall Study|Other termination reason|493|||
33437499|NCT00626548|101495965|FG001|Overall Study|Other termination reason|613|||
33437500|NCT02242201|101495976|FG000|Overall Study|preoperative identified neuropathy|2|||
33437501|NCT02242201|101495977|FG001|Overall Study|preoperative identified neuropathy|0|||
33437502|NCT02242201|101495978|FG002|Overall Study|preoperative identified neuropathy|0|||
33437503|NCT02242201|101495976|FG000|Overall Study|planned post-op anticoagulation|1|||
33437504|NCT02242201|101495977|FG001|Overall Study|planned post-op anticoagulation|0|||
33437505|NCT02242201|101495978|FG002|Overall Study|planned post-op anticoagulation|0|||
33437506|NCT02242201|101495976|FG000|Overall Study|changed surgical procedure|1|||
33437507|NCT02242201|101495977|FG001|Overall Study|changed surgical procedure|0|||
33153598|NCT00543543|100475597|FG003|Base Study|Protocol Violation|6|||
33437508|NCT02242201|101495978|FG002|Overall Study|changed surgical procedure|0|||
33437509|NCT02242201|101495976|FG000|Overall Study|postponed surgery|0|||
33437510|NCT02242201|101495977|FG001|Overall Study|postponed surgery|0|||
33437511|NCT02242201|101495978|FG002|Overall Study|postponed surgery|1|||
33387002|NCT01484561|101302706|FG000|Overall Study|Withdrawal by Subject|3|||
33387003|NCT01484561|101302707|FG001|Overall Study|Withdrawal by Subject|0|||
33387004|NCT01484561|101302706|FG000|Overall Study|Other|1|||
33387005|NCT01484561|101302707|FG001|Overall Study|Other|1|||
33387006|NCT01484561|101302706|FG000|Overall Study|Adverse Event|1|||
33387007|NCT01484561|101302707|FG001|Overall Study|Adverse Event|4|||
33387008|NCT03379376|101302708|FG000|Overall Study|Lost to Follow-up|2|||
33153599|NCT00543543|100475594|FG000|Base Study|Withdrawal by Subject|7|||
33153600|NCT00543543|100475595|FG001|Base Study|Withdrawal by Subject|482|||
33153601|NCT00543543|100475596|FG002|Base Study|Withdrawal by Subject|5|||
33153602|NCT00543543|100475597|FG003|Base Study|Withdrawal by Subject|503|||
33153603|NCT00543543|100475594|FG000|Extension Study|Adverse Event|0|||
33153604|NCT00543543|100475595|FG001|Extension Study|Adverse Event|0|||
33153605|NCT00543543|100475596|FG002|Extension Study|Adverse Event|0|||
33153606|NCT00543543|100475597|FG003|Extension Study|Adverse Event|5|||
33153607|NCT00543543|100475594|FG000|Extension Study|Lost to Follow-up|0|||
33153608|NCT00543543|100475595|FG001|Extension Study|Lost to Follow-up|0|||
33153609|NCT00543543|100475596|FG002|Extension Study|Lost to Follow-up|0|||
33153610|NCT00543543|100475597|FG003|Extension Study|Lost to Follow-up|77|||
33153611|NCT00543543|100475594|FG000|Extension Study|Physician Decision|0|||
33153612|NCT00543543|100475595|FG001|Extension Study|Physician Decision|0|||
33153613|NCT00543543|100475596|FG002|Extension Study|Physician Decision|0|||
33153614|NCT00543543|100475597|FG003|Extension Study|Physician Decision|7|||
33153615|NCT00543543|100475594|FG000|Extension Study|Pregnancy|0|||
33153616|NCT00543543|100475595|FG001|Extension Study|Pregnancy|0|||
33153617|NCT00543543|100475596|FG002|Extension Study|Pregnancy|0|||
33153618|NCT00543543|100475597|FG003|Extension Study|Pregnancy|6|||
33153619|NCT00543543|100475594|FG000|Extension Study|Protocol Violation|0|||
33153620|NCT00543543|100475595|FG001|Extension Study|Protocol Violation|0|||
33153621|NCT00543543|100475596|FG002|Extension Study|Protocol Violation|0|||
33153622|NCT00543543|100475597|FG003|Extension Study|Protocol Violation|11|||
33153623|NCT00543543|100475594|FG000|Extension Study|Withdrawal by Subject|0|||
33153624|NCT00543543|100475595|FG001|Extension Study|Withdrawal by Subject|0|||
33153625|NCT00543543|100475596|FG002|Extension Study|Withdrawal by Subject|0|||
33153626|NCT00543543|100475597|FG003|Extension Study|Withdrawal by Subject|120|||
33153627|NCT02919696|100475598|FG000|Overall Study|Adverse Event|1|||
33153628|NCT02919696|100475599|FG001|Overall Study|Adverse Event|2|||
33153629|NCT02919696|100475598|FG000|Overall Study|Withdrawal by Subject|2|||
33153630|NCT02919696|100475599|FG001|Overall Study|Withdrawal by Subject|1|||
33153631|NCT02919696|100475598|FG000|Overall Study|Sponsor Decision|1|||
33153632|NCT02919696|100475599|FG001|Overall Study|Sponsor Decision|1|||
33153633|NCT02919696|100475598|FG000|Overall Study|Never Treated|0|||
33153634|NCT02919696|100475599|FG001|Overall Study|Never Treated|1|||
33153635|NCT03954132|100475600|FG000|Overall Study|Adverse Event|2|||
33153636|NCT03954132|100475601|FG001|Overall Study|Adverse Event|0|||
33153637|NCT03954132|100475600|FG000|Overall Study|Patient's wish|5|||
33153638|NCT03954132|100475601|FG001|Overall Study|Patient's wish|0|||
33153639|NCT03954132|100475600|FG000|Overall Study|Lost to Follow-up|10|||
33387009|NCT03379376|101302708|FG000|Overall Study|Did not wish to complete follow up|1|||
33387010|NCT03379376|101302708|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
33153640|NCT03954132|100475601|FG001|Overall Study|Lost to Follow-up|0|||
33251603|NCT03125382|100820685|FG002|Follow-up|Death|1|||
33153641|NCT03954132|100475600|FG000|Overall Study|Screening failure|0|||
33153642|NCT03954132|100475601|FG001|Overall Study|Screening failure|1|||
33153643|NCT03954132|100475600|FG000|Overall Study|No registration after Visit 1|5|||
33153644|NCT03954132|100475601|FG001|Overall Study|No registration after Visit 1|2|||
33153645|NCT03954132|100475600|FG000|Overall Study|Other reason than listed|2|||
33153646|NCT03954132|100475601|FG001|Overall Study|Other reason than listed|2|||
33153647|NCT03954132|100475600|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
33153648|NCT03954132|100475601|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
33153649|NCT03954132|100475600|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
33153650|NCT03954132|100475601|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
33153651|NCT02435147|100475604|FG000|Overall Study|non-evaluable DXA scan|11|||
33153652|NCT00447005|100475606|FG000|Overall Study|Adverse Event|1|||
33153653|NCT00447005|100475606|FG000|Overall Study|Lack of Efficacy|11|||
33153654|NCT01050543|100475609|FG000|Overall Study|Withdrawal by Subject|0|||
33153655|NCT01050543|100475610|FG001|Overall Study|Withdrawal by Subject|2|||
33153656|NCT01050543|100475609|FG000|Overall Study|Protocol Violation|0|||
33153657|NCT01050543|100475610|FG001|Overall Study|Protocol Violation|1|||
33153658|NCT01050543|100475609|FG000|Overall Study|Administrative|4|||
33153659|NCT01050543|100475610|FG001|Overall Study|Administrative|1|||
33153660|NCT01031706|100475613|FG000|Overall Study|Adverse Event|1|||
33153661|NCT01031706|100475614|FG001|Overall Study|Adverse Event|0|||
33153662|NCT01031706|100475613|FG000|Overall Study|Withdrawal by Subject|1|||
33153663|NCT01031706|100475614|FG001|Overall Study|Withdrawal by Subject|1|||
33437512|NCT02242201|101495976|FG000|Overall Study|preoperative opioid consumption|0|||
33437513|NCT02242201|101495977|FG001|Overall Study|preoperative opioid consumption|1|||
33153664|NCT00958789|100475615|FG000|Overall Study|Death|5|||
33153665|NCT00958789|100475615|FG000|Overall Study|Lost to Follow-up|14|||
33153666|NCT00958789|100475615|FG000|Overall Study|Withdrawal by Subject|17|||
33153667|NCT00958789|100475615|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
33153668|NCT00958789|100475615|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
33153669|NCT00958789|100475615|FG000|Overall Study|Subject terminated|2|||
33153670|NCT00958789|100475615|FG000|Overall Study|Revision|7|||
33153671|NCT02900976|100475618|FG000|Overall Study|Adverse Event|0|||
33153672|NCT02900976|100475619|FG001|Overall Study|Adverse Event|1|||
33153673|NCT02900976|100475618|FG000|Overall Study|Physician Decision|0|||
33153674|NCT02900976|100475619|FG001|Overall Study|Physician Decision|2|||
33153675|NCT02900976|100475618|FG000|Overall Study|Progressive disease|0|||
33153676|NCT02900976|100475619|FG001|Overall Study|Progressive disease|6|||
33153677|NCT02081183|100475620|FG000|Overall Study|Lost to Follow-up|0|||
33153678|NCT02081183|100475621|FG001|Overall Study|Lost to Follow-up|1|||
33153679|NCT02081183|100475620|FG000|Overall Study|Protocol Violation|1|||
33153680|NCT02081183|100475621|FG001|Overall Study|Protocol Violation|0|||
33153681|NCT02081183|100475620|FG000|Overall Study|Other|3|||
33153682|NCT02081183|100475621|FG001|Overall Study|Other|3|||
33153683|NCT01938573|100475622|FG000|Overall Study|Lack of Efficacy|1|||
33153684|NCT01938573|100475623|FG001|Overall Study|Lack of Efficacy|0|||
33153685|NCT01938573|100475622|FG000|Overall Study|Operation at other hospital|1|||
33153686|NCT01938573|100475623|FG001|Overall Study|Operation at other hospital|0|||
33153687|NCT02572388|100475624|FG000|Overall Study|Withdrawal by Subject|1|||
33153688|NCT02572388|100475625|FG001|Overall Study|Withdrawal by Subject|1|||
33153689|NCT02572388|100475626|FG002|Overall Study|Withdrawal by Subject|2|||
33153690|NCT02572388|100475627|FG003|Overall Study|Withdrawal by Subject|2|||
33153691|NCT00753766|100475628|FG000|Overall Study|Physician Decision|1|||
33153692|NCT00753766|100475629|FG001|Overall Study|Physician Decision|0|||
33153693|NCT01683019|100475630|FG000|Overall Study|Withdrawal by Subject|2|||
33153694|NCT01683019|100475631|FG001|Overall Study|Withdrawal by Subject|1|||
33153695|NCT01683019|100475632|FG002|Overall Study|Withdrawal by Subject|4|||
33153696|NCT00423514|100475640|FG000|Overall Study|Ineligible|1|||
33153697|NCT00423514|100475641|FG001|Overall Study|Ineligible|0|||
33153698|NCT00131508|100475642|FG000|Overall Study|Disease progression|0|||
33153699|NCT00131508|100475643|FG001|Overall Study|Disease progression|2|||
33153700|NCT00131508|100475642|FG000|Overall Study|Non-Compliance|2|||
33153701|NCT00131508|100475643|FG001|Overall Study|Non-Compliance|4|||
33153702|NCT00131508|100475642|FG000|Overall Study|Withdrawal by Subject|1|||
33153703|NCT00131508|100475643|FG001|Overall Study|Withdrawal by Subject|2|||
33153704|NCT01565642|100475644|FG000|Overall Study|Withdrawal by Subject|2|||
33153705|NCT01565642|100475645|FG001|Overall Study|Withdrawal by Subject|1|||
33153706|NCT00299182|100475646|FG000|Overall Study|Withdrawal by Subject|0|||
33153707|NCT00299182|100475647|FG001|Overall Study|Withdrawal by Subject|0|||
33153708|NCT00299182|100475648|FG002|Overall Study|Withdrawal by Subject|1|||
33153709|NCT00299182|100475649|FG003|Overall Study|Withdrawal by Subject|0|||
33153710|NCT00299182|100475650|FG004|Overall Study|Withdrawal by Subject|1|||
33153711|NCT00299182|100475651|FG005|Overall Study|Withdrawal by Subject|2|||
33153712|NCT00299182|100475652|FG006|Overall Study|Withdrawal by Subject|0|||
33153713|NCT00299182|100475646|FG000|Overall Study|Chemotherapy Changed|0|||
33153714|NCT00299182|100475647|FG001|Overall Study|Chemotherapy Changed|0|||
33153715|NCT00299182|100475648|FG002|Overall Study|Chemotherapy Changed|1|||
33153716|NCT00299182|100475649|FG003|Overall Study|Chemotherapy Changed|0|||
33153717|NCT00299182|100475650|FG004|Overall Study|Chemotherapy Changed|1|||
33153718|NCT00299182|100475651|FG005|Overall Study|Chemotherapy Changed|0|||
33153719|NCT00299182|100475652|FG006|Overall Study|Chemotherapy Changed|1|||
33153720|NCT00299182|100475646|FG000|Overall Study|Adverse Event|0|||
33153721|NCT00299182|100475647|FG001|Overall Study|Adverse Event|0|||
33153722|NCT00299182|100475648|FG002|Overall Study|Adverse Event|0|||
33153723|NCT00299182|100475649|FG003|Overall Study|Adverse Event|0|||
33153724|NCT00299182|100475650|FG004|Overall Study|Adverse Event|0|||
33153725|NCT00299182|100475651|FG005|Overall Study|Adverse Event|1|||
33387011|NCT03379376|101302708|FG000|Overall Study|Death|1|||
33387012|NCT00796003|101302709|FG000|Overall Study|Disease Progression|2|||
33387013|NCT00796003|101302710|FG001|Overall Study|Disease Progression|13|||
33387014|NCT00796003|101302709|FG000|Overall Study|Adverse Event|1|||
33387015|NCT00796003|101302710|FG001|Overall Study|Adverse Event|7|||
33387016|NCT00796003|101302709|FG000|Overall Study|Specified organ function not met|0|||
33153726|NCT00299182|100475652|FG006|Overall Study|Adverse Event|0|||
33153727|NCT00299182|100475646|FG000|Overall Study|Not Eligible|0|||
33153728|NCT00299182|100475647|FG001|Overall Study|Not Eligible|0|||
33153729|NCT00299182|100475648|FG002|Overall Study|Not Eligible|0|||
33153730|NCT00299182|100475649|FG003|Overall Study|Not Eligible|0|||
33153731|NCT00299182|100475650|FG004|Overall Study|Not Eligible|1|||
33153732|NCT00299182|100475651|FG005|Overall Study|Not Eligible|0|||
33153733|NCT00299182|100475652|FG006|Overall Study|Not Eligible|0|||
33153734|NCT04308304|100475653|FG000|Overall Study|Withdrawal by Subject|4|||
33153735|NCT04308304|100475654|FG001|Overall Study|Withdrawal by Subject|0|||
33153736|NCT04308304|100475653|FG000|Overall Study|Protocol Violation|1|||
33153737|NCT04308304|100475654|FG001|Overall Study|Protocol Violation|0|||
33153738|NCT02805972|100475655|FG000|Washout Period|Lost to Follow-up|3|||
33153739|NCT02805972|100475656|FG001|Washout Period|Lost to Follow-up|0|||
33153740|NCT00195273|100475657|FG000|Overall Study|Adverse Event|9|||
33437514|NCT02242201|101495978|FG002|Overall Study|preoperative opioid consumption|0|||
33437515|NCT00925769|101495986|FG000|Overall Study|Major toxicity|1|||
33437516|NCT00925769|101495987|FG001|Overall Study|Major toxicity|0|||
33437517|NCT00925769|101495988|FG002|Overall Study|Major toxicity|1|||
33437518|NCT00925769|101495989|FG003|Overall Study|Major toxicity|1|||
33437519|NCT00925769|101495990|FG004|Overall Study|Major toxicity|0|||
33437520|NCT00925769|101495991|FG005|Overall Study|Major toxicity|0|||
33437521|NCT00925769|101495986|FG000|Overall Study|Disease progression|4|||
33437522|NCT00925769|101495987|FG001|Overall Study|Disease progression|5|||
33437523|NCT00925769|101495988|FG002|Overall Study|Disease progression|3|||
33437524|NCT00925769|101495989|FG003|Overall Study|Disease progression|4|||
33437525|NCT00925769|101495990|FG004|Overall Study|Disease progression|2|||
33437526|NCT00925769|101495991|FG005|Overall Study|Disease progression|3|||
33437527|NCT00925769|101495986|FG000|Overall Study|Death|0|||
33437528|NCT00925769|101495987|FG001|Overall Study|Death|0|||
33437529|NCT00925769|101495988|FG002|Overall Study|Death|1|||
33437530|NCT00925769|101495989|FG003|Overall Study|Death|0|||
33437531|NCT00925769|101495990|FG004|Overall Study|Death|0|||
33437532|NCT00925769|101495991|FG005|Overall Study|Death|0|||
33437533|NCT00925769|101495986|FG000|Overall Study|Physician Decision|1|||
33437534|NCT00925769|101495987|FG001|Overall Study|Physician Decision|0|||
33437535|NCT00925769|101495988|FG002|Overall Study|Physician Decision|0|||
33437536|NCT00925769|101495989|FG003|Overall Study|Physician Decision|0|||
33437537|NCT00925769|101495990|FG004|Overall Study|Physician Decision|0|||
33437538|NCT00925769|101495991|FG005|Overall Study|Physician Decision|0|||
33437539|NCT00925769|101495986|FG000|Overall Study|Missing documentation|0|||
33437540|NCT00925769|101495987|FG001|Overall Study|Missing documentation|1|||
33437541|NCT00925769|101495988|FG002|Overall Study|Missing documentation|0|||
33153741|NCT00195273|100475658|FG001|Overall Study|Adverse Event|9|||
33153742|NCT00195273|100475657|FG000|Overall Study|Protocol deviation|0|||
33153743|NCT00195273|100475658|FG001|Overall Study|Protocol deviation|1|||
33153744|NCT00195273|100475657|FG000|Overall Study|Lack of Efficacy|3|||
33153745|NCT00195273|100475658|FG001|Overall Study|Lack of Efficacy|1|||
33153746|NCT00195273|100475657|FG000|Overall Study|Procedural complications|9|||
33153747|NCT00195273|100475658|FG001|Overall Study|Procedural complications|3|||
33153748|NCT00910273|100475661|FG000|Overall Study|Lack of Efficacy|6|||
33153749|NCT00910273|100475662|FG001|Overall Study|Lack of Efficacy|9|||
33153750|NCT00910273|100475661|FG000|Overall Study|Adverse Event|1|||
33153751|NCT00910273|100475662|FG001|Overall Study|Adverse Event|1|||
33153752|NCT00910273|100475661|FG000|Overall Study|Withdrawal by Subject|1|||
33153753|NCT00910273|100475662|FG001|Overall Study|Withdrawal by Subject|0|||
33251604|NCT03125382|100820686|FG003|Follow-up|Death|2|||
33251605|NCT03125382|100820683|FG000|Follow-up|Lost to Follow-up|1|||
33251606|NCT03125382|100820684|FG001|Follow-up|Lost to Follow-up|4|||
33153754|NCT00910273|100475661|FG000|Overall Study|Discontinuation of study by sponsor|8|||
33153755|NCT00910273|100475662|FG001|Overall Study|Discontinuation of study by sponsor|2|||
33153756|NCT00910273|100475661|FG000|Overall Study|Protocol Violation|1|||
33153757|NCT00910273|100475662|FG001|Overall Study|Protocol Violation|0|||
33153758|NCT00910273|100475661|FG000|Overall Study|Lost to Follow-up|1|||
33153759|NCT00910273|100475662|FG001|Overall Study|Lost to Follow-up|1|||
33251607|NCT03125382|100820685|FG002|Follow-up|Lost to Follow-up|3|||
33251608|NCT03125382|100820686|FG003|Follow-up|Lost to Follow-up|1|||
33251609|NCT00217672|100820694|FG000|Allocation|Ineligible|2|||
33387017|NCT00796003|101302710|FG001|Overall Study|Specified organ function not met|1|||
33387018|NCT00796003|101302709|FG000|Overall Study|Physician Decision|0|||
33387019|NCT00796003|101302710|FG001|Overall Study|Physician Decision|4|||
33387020|NCT00796003|101302709|FG000|Overall Study|Withdrawal by Subject|0|||
33387021|NCT00796003|101302710|FG001|Overall Study|Withdrawal by Subject|1|||
33387022|NCT00796003|101302709|FG000|Overall Study|Other|0|||
33387023|NCT00796003|101302710|FG001|Overall Study|Other|1|||
33387024|NCT00796003|101302709|FG000|Overall Study|Participants Not treated|0|||
33387025|NCT00796003|101302710|FG001|Overall Study|Participants Not treated|2|||
33387026|NCT01015820|101302719|FG000|Overall Study|Suboptimal measurements|1|||
33153760|NCT02478372|100475665|FG000|Overall Study|Protocol Violation|12|||
33251610|NCT00217672|100820695|FG001|Allocation|Ineligible|0|||
33251611|NCT00217672|100820694|FG000|Treatment|disease progression|33|||
33153761|NCT02478372|100475666|FG001|Overall Study|Protocol Violation|8|||
33153762|NCT02478372|100475665|FG000|Overall Study|Lost to Follow-up|1|||
33153763|NCT02478372|100475666|FG001|Overall Study|Lost to Follow-up|4|||
33153764|NCT02478372|100475665|FG000|Overall Study|Death|0|||
33153765|NCT02478372|100475666|FG001|Overall Study|Death|2|||
33153766|NCT00617851|100475667|FG000|Overall Study|Death|0|||
33153767|NCT00617851|100475668|FG001|Overall Study|Death|0|||
33153768|NCT00617851|100475669|FG002|Overall Study|Death|0|||
33153769|NCT00617851|100475670|FG003|Overall Study|Death|1|||
33153770|NCT00617851|100475667|FG000|Overall Study|Withdrawal by Subject|14|||
33153771|NCT00617851|100475668|FG001|Overall Study|Withdrawal by Subject|7|||
33153772|NCT00617851|100475669|FG002|Overall Study|Withdrawal by Subject|12|||
33153773|NCT00617851|100475670|FG003|Overall Study|Withdrawal by Subject|4|||
33153774|NCT00617851|100475667|FG000|Overall Study|Lost to Follow-up|27|||
33153775|NCT00617851|100475668|FG001|Overall Study|Lost to Follow-up|29|||
33153776|NCT00617851|100475669|FG002|Overall Study|Lost to Follow-up|31|||
33153777|NCT00617851|100475670|FG003|Overall Study|Lost to Follow-up|19|||
33153778|NCT00617851|100475667|FG000|Overall Study|Inappropriate Enrollment|5|||
33153779|NCT00617851|100475668|FG001|Overall Study|Inappropriate Enrollment|4|||
33153780|NCT00617851|100475669|FG002|Overall Study|Inappropriate Enrollment|1|||
33153781|NCT00617851|100475670|FG003|Overall Study|Inappropriate Enrollment|1|||
33153782|NCT00617851|100475667|FG000|Overall Study|Unable to classify|1|||
33153783|NCT00617851|100475668|FG001|Overall Study|Unable to classify|0|||
33153784|NCT00617851|100475669|FG002|Overall Study|Unable to classify|1|||
33153785|NCT00617851|100475670|FG003|Overall Study|Unable to classify|0|||
33153786|NCT03945266|100479306|FG000|Overall Study|Withdrawal by Subject|1|||
33153787|NCT03945266|100479307|FG001|Overall Study|Withdrawal by Subject|0|||
33153788|NCT03945266|100479306|FG000|Overall Study|Miscarriage|0|||
33153789|NCT03945266|100479307|FG001|Overall Study|Miscarriage|2|||
33153790|NCT03945266|100479306|FG000|Overall Study|Lost to Follow-up|1|||
33153791|NCT03945266|100479307|FG001|Overall Study|Lost to Follow-up|0|||
33153792|NCT02413372|100479317|FG000|Treatment|Lost to Follow-up|0|||
33153793|NCT02413372|100479318|FG001|Treatment|Lost to Follow-up|2|||
33153794|NCT02413372|100479319|FG002|Treatment|Lost to Follow-up|1|||
33153795|NCT02413372|100479317|FG000|Treatment|Withdrawal by Subject|1|||
33153796|NCT02413372|100479318|FG001|Treatment|Withdrawal by Subject|0|||
33153797|NCT02413372|100479319|FG002|Treatment|Withdrawal by Subject|0|||
33153798|NCT02413372|100479317|FG000|Follow-up|Lost to Follow-up|1|||
33153799|NCT02413372|100479318|FG001|Follow-up|Lost to Follow-up|1|||
33153800|NCT02413372|100479319|FG002|Follow-up|Lost to Follow-up|0|||
33153801|NCT02413372|100479317|FG000|Follow-up|Subject Withdrew Consent|1|||
33153802|NCT02413372|100479318|FG001|Follow-up|Subject Withdrew Consent|0|||
33153803|NCT02413372|100479319|FG002|Follow-up|Subject Withdrew Consent|1|||
33153804|NCT02413372|100479317|FG000|Follow-up|Subject unable to return for visit|0|||
33153805|NCT02413372|100479318|FG001|Follow-up|Subject unable to return for visit|0|||
33153806|NCT02413372|100479319|FG002|Follow-up|Subject unable to return for visit|1|||
33153807|NCT03257371|100479320|FG000|Overall Study|Lost to Follow-up|1|||
33153808|NCT01578330|100479325|FG000|Overall Study|Adverse Event|2|||
33153809|NCT01578330|100479325|FG000|Overall Study|Protocol Violation|5|||
33153810|NCT01528033|100479326|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
33153811|NCT01528033|100479327|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
33153812|NCT01528033|100479326|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
33153813|NCT01528033|100479327|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
33387027|NCT01015820|101302720|FG001|Overall Study|Suboptimal measurements|0|||
33387028|NCT00719537|101302721|FG000|Overall Study|Withdrawal by Subject|1|||
33387029|NCT00719537|101302722|FG001|Overall Study|Withdrawal by Subject|0|||
33153814|NCT01528033|100479326|FG000|Primary Endpoint Assessment ITT|Death|2|||
33153815|NCT01528033|100479327|FG001|Primary Endpoint Assessment ITT|Death|2|||
33153816|NCT01528033|100479326|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
33153817|NCT01528033|100479327|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
33153818|NCT01528033|100479326|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
33153819|NCT01528033|100479327|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
33153820|NCT01528033|100479326|FG000|Follow Up|No data available|46|||
33153821|NCT01528033|100479327|FG001|Follow Up|No data available|44|||
33153822|NCT03001882|100479328|FG000|Overall Study|Death|1|||
33153823|NCT03001882|100479329|FG001|Overall Study|Death|0|||
33153824|NCT03001882|100479330|FG002|Overall Study|Death|0|||
33153825|NCT03001882|100479331|FG003|Overall Study|Death|3|||
33153826|NCT03001882|100479328|FG000|Overall Study|Participant withdrew consent|0|||
33153827|NCT03001882|100479329|FG001|Overall Study|Participant withdrew consent|1|||
33153828|NCT03001882|100479330|FG002|Overall Study|Participant withdrew consent|0|||
33153829|NCT03001882|100479331|FG003|Overall Study|Participant withdrew consent|5|||
33153830|NCT03001882|100479328|FG000|Overall Study|Other reasons|1|||
33153831|NCT03001882|100479329|FG001|Overall Study|Other reasons|2|||
33387030|NCT00719537|101302721|FG000|Overall Study|Lost to Follow-up|0|||
33387031|NCT00719537|101302722|FG001|Overall Study|Lost to Follow-up|1|||
33153832|NCT03001882|100479330|FG002|Overall Study|Other reasons|0|||
33153833|NCT03001882|100479331|FG003|Overall Study|Other reasons|5|||
33153834|NCT03001882|100479328|FG000|Overall Study|Administrative reason by sponsor|0|||
33153835|NCT03001882|100479329|FG001|Overall Study|Administrative reason by sponsor|0|||
33153836|NCT03001882|100479330|FG002|Overall Study|Administrative reason by sponsor|0|||
33153837|NCT03001882|100479331|FG003|Overall Study|Administrative reason by sponsor|1|||
33153838|NCT03001882|100479328|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
33153839|NCT03001882|100479329|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
33153840|NCT03001882|100479330|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
33153841|NCT03001882|100479331|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
33153842|NCT03001882|100479328|FG000|Overall Study|Not reported|0|||
33153843|NCT03001882|100479329|FG001|Overall Study|Not reported|0|||
33153844|NCT03001882|100479330|FG002|Overall Study|Not reported|0|||
33153845|NCT03001882|100479331|FG003|Overall Study|Not reported|6|||
33153846|NCT03001882|100479328|FG000|Overall Study|Maximum clinical benefit|2|||
33153847|NCT03001882|100479329|FG001|Overall Study|Maximum clinical benefit|3|||
33153848|NCT03001882|100479330|FG002|Overall Study|Maximum clinical benefit|0|||
33153849|NCT03001882|100479331|FG003|Overall Study|Maximum clinical benefit|10|||
33153850|NCT03001882|100479328|FG000|Overall Study|AE unrelated to study drug|3|||
33153851|NCT03001882|100479329|FG001|Overall Study|AE unrelated to study drug|3|||
33153852|NCT03001882|100479330|FG002|Overall Study|AE unrelated to study drug|0|||
33153853|NCT03001882|100479331|FG003|Overall Study|AE unrelated to study drug|11|||
33153854|NCT03001882|100479328|FG000|Overall Study|Study Drug Toxicity|8|||
33153855|NCT03001882|100479329|FG001|Overall Study|Study Drug Toxicity|5|||
33153856|NCT03001882|100479330|FG002|Overall Study|Study Drug Toxicity|0|||
33153857|NCT03001882|100479331|FG003|Overall Study|Study Drug Toxicity|37|||
33153858|NCT03001882|100479328|FG000|Overall Study|Disease progression|16|||
33153859|NCT03001882|100479329|FG001|Overall Study|Disease progression|14|||
33153860|NCT03001882|100479330|FG002|Overall Study|Disease progression|1|||
33153861|NCT03001882|100479331|FG003|Overall Study|Disease progression|90|||
33153862|NCT02003365|100479335|FG000|Overall Study|Lost to Follow-up|0|||
33153863|NCT02003365|100479336|FG001|Overall Study|Lost to Follow-up|0|||
33153864|NCT02003365|100479337|FG002|Overall Study|Lost to Follow-up|1|||
33153865|NCT00484094|100479340|FG000|Overall Study|Discontinued|39|||
33153866|NCT00484094|100479340|FG000|Overall Study|Other|3|||
33153867|NCT02586064|100479343|FG000|Overall Study|Other Obligations|6|||
33153868|NCT02586064|100479344|FG001|Overall Study|Other Obligations|6|||
33153869|NCT02586064|100479343|FG000|Overall Study|Other|3|||
33153870|NCT02586064|100479344|FG001|Overall Study|Other|7|||
33153871|NCT02586064|100479343|FG000|Overall Study|Never Started|3|||
33153872|NCT02586064|100479344|FG001|Overall Study|Never Started|3|||
33153873|NCT02586064|100479343|FG000|Overall Study|Lost Interest|1|||
33153874|NCT02586064|100479344|FG001|Overall Study|Lost Interest|4|||
33153875|NCT02586064|100479343|FG000|Overall Study|Miscellaneous Life Issues|0|||
33153876|NCT02586064|100479344|FG001|Overall Study|Miscellaneous Life Issues|5|||
33153877|NCT02586064|100479343|FG000|Overall Study|Infrequent Attendance|2|||
33153878|NCT02586064|100479344|FG001|Overall Study|Infrequent Attendance|1|||
33153879|NCT02586064|100479343|FG000|Overall Study|Timed Out|2|||
33153880|NCT02586064|100479344|FG001|Overall Study|Timed Out|0|||
33153881|NCT02586064|100479343|FG000|Overall Study|AUD relapse|0|||
33153882|NCT02586064|100479344|FG001|Overall Study|AUD relapse|2|||
33153883|NCT02586064|100479343|FG000|Overall Study|Legal Issue|1|||
33153884|NCT02586064|100479344|FG001|Overall Study|Legal Issue|0|||
33153885|NCT03911713|100479348|FG000|Overall Study|Lost to Follow-up|0|||
33153886|NCT03911713|100479349|FG001|Overall Study|Lost to Follow-up|2|||
33153887|NCT03911713|100479350|FG002|Overall Study|Lost to Follow-up|0|||
33153888|NCT03911713|100479351|FG003|Overall Study|Lost to Follow-up|0|||
33153889|NCT03911713|100479352|FG004|Overall Study|Lost to Follow-up|0|||
33153890|NCT03911713|100479348|FG000|Overall Study|Other|0|||
33153891|NCT03911713|100479349|FG001|Overall Study|Other|0|||
33153892|NCT03911713|100479350|FG002|Overall Study|Other|0|||
33153893|NCT03911713|100479351|FG003|Overall Study|Other|1|||
33153894|NCT03911713|100479352|FG004|Overall Study|Other|0|||
33153895|NCT03911713|100479348|FG000|Overall Study|Randomized, Never Dosed|1|||
33153896|NCT03911713|100479349|FG001|Overall Study|Randomized, Never Dosed|0|||
33153897|NCT03911713|100479350|FG002|Overall Study|Randomized, Never Dosed|0|||
33153898|NCT03911713|100479351|FG003|Overall Study|Randomized, Never Dosed|1|||
33153899|NCT03911713|100479352|FG004|Overall Study|Randomized, Never Dosed|0|||
33153900|NCT00100178|100479355|FG000|Overall Study|Lost to Follow-up|0|||
33153901|NCT00100178|100479356|FG001|Overall Study|Lost to Follow-up|6|||
33153902|NCT00100178|100479357|FG002|Overall Study|Lost to Follow-up|5|||
33153903|NCT00100178|100479355|FG000|Overall Study|Adverse Event|2|||
33153904|NCT00100178|100479356|FG001|Overall Study|Adverse Event|2|||
33153905|NCT00100178|100479357|FG002|Overall Study|Adverse Event|1|||
33153906|NCT00100178|100479355|FG000|Overall Study|Withdrawal by Subject|1|||
33153907|NCT00100178|100479356|FG001|Overall Study|Withdrawal by Subject|1|||
33437542|NCT00925769|101495989|FG003|Overall Study|Missing documentation|0|||
33153908|NCT00100178|100479357|FG002|Overall Study|Withdrawal by Subject|1|||
33153909|NCT00100178|100479355|FG000|Overall Study|Physician Decision|6|||
33153910|NCT00100178|100479356|FG001|Overall Study|Physician Decision|1|||
33153911|NCT00100178|100479357|FG002|Overall Study|Physician Decision|3|||
33153912|NCT00891462|100479358|FG000|Overall Study|Withdrawal by Subject|9|||
33153913|NCT00891462|100479359|FG001|Overall Study|Withdrawal by Subject|6|||
33153914|NCT00891462|100479360|FG002|Overall Study|Withdrawal by Subject|7|||
33153915|NCT00891462|100479358|FG000|Overall Study|Adverse Event|7|||
33153916|NCT00891462|100479359|FG001|Overall Study|Adverse Event|8|||
33153917|NCT00891462|100479360|FG002|Overall Study|Adverse Event|7|||
33153918|NCT00891462|100479358|FG000|Overall Study|Lack of Efficacy|10|||
33153919|NCT00891462|100479359|FG001|Overall Study|Lack of Efficacy|5|||
33153920|NCT00891462|100479360|FG002|Overall Study|Lack of Efficacy|1|||
33153921|NCT00891462|100479358|FG000|Overall Study|COPD exacerbation|7|||
33153922|NCT00891462|100479359|FG001|Overall Study|COPD exacerbation|4|||
33153923|NCT00891462|100479360|FG002|Overall Study|COPD exacerbation|1|||
33153924|NCT00891462|100479358|FG000|Overall Study|Other Reason|2|||
33153925|NCT00891462|100479359|FG001|Overall Study|Other Reason|5|||
33153926|NCT00891462|100479360|FG002|Overall Study|Other Reason|3|||
33153927|NCT00891462|100479358|FG000|Overall Study|Protocol Violation|2|||
33153928|NCT00891462|100479359|FG001|Overall Study|Protocol Violation|1|||
33153929|NCT00891462|100479360|FG002|Overall Study|Protocol Violation|3|||
33387032|NCT01373918|101302723|FG000|Overall Study|Physician Decision|0|||
33387033|NCT01373918|101302724|FG001|Overall Study|Physician Decision|1|||
33153930|NCT00891462|100479358|FG000|Overall Study|Inclusion/exclusion criteria|0|||
33153931|NCT00891462|100479359|FG001|Overall Study|Inclusion/exclusion criteria|2|||
33153932|NCT00891462|100479360|FG002|Overall Study|Inclusion/exclusion criteria|2|||
33153933|NCT00891462|100479358|FG000|Overall Study|Lost to Follow-up|0|||
33153934|NCT00891462|100479359|FG001|Overall Study|Lost to Follow-up|2|||
33153935|NCT00891462|100479360|FG002|Overall Study|Lost to Follow-up|0|||
33437543|NCT00925769|101495990|FG004|Overall Study|Missing documentation|0|||
33437544|NCT00925769|101495991|FG005|Overall Study|Missing documentation|0|||
33437545|NCT00925769|101495986|FG000|Overall Study|End of study visit not done|0|||
33437546|NCT00925769|101495987|FG001|Overall Study|End of study visit not done|0|||
33437547|NCT00925769|101495988|FG002|Overall Study|End of study visit not done|1|||
33437548|NCT00925769|101495989|FG003|Overall Study|End of study visit not done|0|||
33437549|NCT00925769|101495990|FG004|Overall Study|End of study visit not done|0|||
33437550|NCT00925769|101495991|FG005|Overall Study|End of study visit not done|0|||
33437551|NCT00925769|101495986|FG000|Overall Study|Participant is unable to swallow drug|0|||
33437552|NCT00925769|101495987|FG001|Overall Study|Participant is unable to swallow drug|0|||
33437553|NCT00925769|101495988|FG002|Overall Study|Participant is unable to swallow drug|0|||
33437554|NCT00925769|101495989|FG003|Overall Study|Participant is unable to swallow drug|1|||
33437555|NCT00925769|101495990|FG004|Overall Study|Participant is unable to swallow drug|0|||
33437556|NCT00925769|101495991|FG005|Overall Study|Participant is unable to swallow drug|0|||
33437557|NCT00925769|101495986|FG000|Overall Study|Adverse Event|0|||
33437558|NCT00925769|101495987|FG001|Overall Study|Adverse Event|0|||
33437559|NCT00925769|101495988|FG002|Overall Study|Adverse Event|0|||
33437560|NCT00925769|101495989|FG003|Overall Study|Adverse Event|0|||
33437561|NCT00925769|101495990|FG004|Overall Study|Adverse Event|1|||
33437562|NCT00925769|101495991|FG005|Overall Study|Adverse Event|0|||
33437563|NCT02003183|101495997|FG000|Overall Study|Lost to Follow-up|0|||
33153936|NCT02349542|100479367|FG000|Overall Study|Withdrawal by Subject|5|||
33153937|NCT00257608|100479368|FG000|Chemotherapy Phase|Adverse Event|138|||
33153938|NCT00257608|100479369|FG001|Chemotherapy Phase|Adverse Event|0|||
33153939|NCT00257608|100479370|FG002|Chemotherapy Phase|Adverse Event|0|||
33251612|NCT00217672|100820695|FG001|Treatment|disease progression|4|||
33437564|NCT02003183|101495998|FG001|Overall Study|Lost to Follow-up|2|||
33437565|NCT00881621|101495999|FG000|Overall Study|Physician Decision|34|||
33437566|NCT00302952|101496000|FG000|Overall Study|Physician Decision|1|||
33437567|NCT00302952|101496001|FG001|Overall Study|Physician Decision|1|||
33437568|NCT00302952|101496000|FG000|Overall Study|Withdrawal by Subject|2|||
33437569|NCT00302952|101496001|FG001|Overall Study|Withdrawal by Subject|3|||
33437570|NCT00302952|101496000|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
33437571|NCT00302952|101496001|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
33153940|NCT00257608|100479368|FG000|Chemotherapy Phase|Disease progression|139|||
33251613|NCT00217672|100820694|FG000|Treatment|Adverse Event|18|||
33437572|NCT01936948|101496002|FG000|Overall Study|no 30-day follow-up data|0|||
33437573|NCT01936948|101496003|FG001|Overall Study|no 30-day follow-up data|3|||
33437574|NCT01936948|101496004|FG002|Overall Study|no 30-day follow-up data|3|||
33153941|NCT00257608|100479369|FG001|Chemotherapy Phase|Disease progression|0|||
33153942|NCT00257608|100479370|FG002|Chemotherapy Phase|Disease progression|0|||
33153943|NCT00257608|100479368|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
33153944|NCT00257608|100479369|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
33153945|NCT00257608|100479370|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
33153946|NCT00257608|100479368|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
33153947|NCT00257608|100479369|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
33153948|NCT00257608|100479370|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
33153949|NCT00257608|100479368|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
33153950|NCT00257608|100479369|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
33153951|NCT00257608|100479370|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
33153952|NCT00257608|100479368|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
33153953|NCT00257608|100479369|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
33153954|NCT00257608|100479370|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
33153955|NCT00257608|100479368|FG000|Chemotherapy Phase|Physician Decision|28|||
33153956|NCT00257608|100479369|FG001|Chemotherapy Phase|Physician Decision|0|||
33153957|NCT00257608|100479370|FG002|Chemotherapy Phase|Physician Decision|0|||
33153958|NCT00257608|100479368|FG000|Post Chemotherapy Phase|Adverse Event|0|||
33153959|NCT00257608|100479369|FG001|Post Chemotherapy Phase|Adverse Event|34|||
33153960|NCT00257608|100479370|FG002|Post Chemotherapy Phase|Adverse Event|38|||
33153961|NCT00257608|100479368|FG000|Post Chemotherapy Phase|Disease progression|0|||
33153962|NCT00257608|100479369|FG001|Post Chemotherapy Phase|Disease progression|204|||
33153963|NCT00257608|100479370|FG002|Post Chemotherapy Phase|Disease progression|168|||
33153964|NCT00257608|100479368|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
33153965|NCT00257608|100479369|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
33153966|NCT00257608|100479370|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
33251614|NCT00217672|100820695|FG001|Treatment|Adverse Event|2|||
33251615|NCT00217672|100820694|FG000|Treatment|reqd treatment not permitted by protocol|6|||
33251616|NCT00217672|100820695|FG001|Treatment|reqd treatment not permitted by protocol|0|||
33251617|NCT00217672|100820694|FG000|Treatment|Physician Decision|6|||
33251618|NCT00217672|100820695|FG001|Treatment|Physician Decision|0|||
33251619|NCT00217672|100820694|FG000|Treatment|insurance issues|1|||
33437575|NCT01936948|101496005|FG003|Overall Study|no 30-day follow-up data|3|||
33437576|NCT04149964|101496006|FG000|Overall Study|Lost to Follow-up|19|||
33437577|NCT04149964|101496007|FG001|Overall Study|Lost to Follow-up|18|||
33437578|NCT00662025|101496010|FG000|Overall Study|Objective progression or relapse|51|||
33437579|NCT00662025|101496010|FG000|Overall Study|Adverse Event|7|||
33437580|NCT00662025|101496010|FG000|Overall Study|Withdrawal by Subject|1|||
33437581|NCT00662025|101496010|FG000|Overall Study|Results of other clinical study|2|||
33437582|NCT00662025|101496010|FG000|Overall Study|Target lesion cannot be evaluated|1|||
33437583|NCT00662025|101496010|FG000|Overall Study|Domestic circumstances|1|||
33251620|NCT00217672|100820695|FG001|Treatment|insurance issues|1|||
33251621|NCT00217672|100820694|FG000|Treatment|Death|2|||
33251622|NCT00217672|100820695|FG001|Treatment|Death|0|||
33251623|NCT00217672|100820694|FG000|Treatment|secondary malignancy|1|||
33251624|NCT00217672|100820695|FG001|Treatment|secondary malignancy|0|||
33251625|NCT00217672|100820694|FG000|Follow-up|Withdrawal by Subject|4|||
33251626|NCT00217672|100820695|FG001|Follow-up|Withdrawal by Subject|0|||
33251627|NCT00217672|100820694|FG000|Follow-up|Lost to Follow-up|1|||
33251628|NCT00217672|100820695|FG001|Follow-up|Lost to Follow-up|0|||
33251629|NCT04012853|100820698|FG000|Overall Study|Withdrawal by Subject|1|||
33437584|NCT00440557|101496013|FG000|Overall Study|Withdrawal by Subject|10|||
33437585|NCT00440557|101496014|FG001|Overall Study|Withdrawal by Subject|5|||
33437586|NCT00440557|101496015|FG002|Overall Study|Withdrawal by Subject|11|||
33153967|NCT00257608|100479368|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
33153968|NCT00257608|100479369|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
33153969|NCT00257608|100479370|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
33153970|NCT00257608|100479368|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
33153971|NCT00257608|100479369|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
33153972|NCT00257608|100479370|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
33153973|NCT00257608|100479368|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
33153974|NCT00257608|100479369|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
33153975|NCT00257608|100479370|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
33153976|NCT00257608|100479368|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
33437587|NCT00440557|101496013|FG000|Overall Study|Lost to Follow-up|1|||
33437588|NCT00440557|101496014|FG001|Overall Study|Lost to Follow-up|2|||
33437589|NCT00440557|101496015|FG002|Overall Study|Lost to Follow-up|6|||
33437590|NCT00440557|101496013|FG000|Overall Study|Adverse Event|3|||
33437591|NCT00440557|101496014|FG001|Overall Study|Adverse Event|3|||
33153977|NCT00257608|100479369|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
33153978|NCT00257608|100479370|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
33251630|NCT04012853|100820699|FG001|Overall Study|Withdrawal by Subject|1|||
33251631|NCT04012853|100820698|FG000|Overall Study|Protocol Violation|1|||
33437592|NCT00440557|101496015|FG002|Overall Study|Adverse Event|5|||
33437593|NCT00440557|101496013|FG000|Overall Study|Death|2|||
33437594|NCT00440557|101496014|FG001|Overall Study|Death|6|||
33251632|NCT04012853|100820699|FG001|Overall Study|Protocol Violation|0|||
33251633|NCT04012853|100820698|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
33251634|NCT04012853|100820699|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
33251635|NCT00909363|100820700|FG000|Overall Study|Withdrawal by Subject|1|||
33251636|NCT00909363|100820701|FG001|Overall Study|Withdrawal by Subject|0|||
33251637|NCT00909363|100820702|FG002|Overall Study|Withdrawal by Subject|0|||
33251638|NCT00909363|100820700|FG000|Overall Study|Lack of Efficacy|1|||
33437595|NCT00440557|101496015|FG002|Overall Study|Death|3|||
33437596|NCT00440557|101496013|FG000|Overall Study|Began Dialysis|4|||
33437597|NCT00440557|101496014|FG001|Overall Study|Began Dialysis|1|||
33437598|NCT00440557|101496015|FG002|Overall Study|Began Dialysis|4|||
33437599|NCT00440557|101496013|FG000|Overall Study|Principal Investigator decision|0|||
33437600|NCT00440557|101496014|FG001|Overall Study|Principal Investigator decision|3|||
33437601|NCT00440557|101496015|FG002|Overall Study|Principal Investigator decision|1|||
33437602|NCT00440557|101496013|FG000|Overall Study|Patient moved|1|||
33437603|NCT00440557|101496014|FG001|Overall Study|Patient moved|2|||
33437604|NCT00440557|101496015|FG002|Overall Study|Patient moved|1|||
33437605|NCT00440557|101496013|FG000|Overall Study|Principal Investigator's office closed|3|||
33437606|NCT00440557|101496014|FG001|Overall Study|Principal Investigator's office closed|6|||
33437607|NCT00440557|101496015|FG002|Overall Study|Principal Investigator's office closed|4|||
33437608|NCT00440557|101496013|FG000|Overall Study|Patient transferred to nursing home|0|||
33437609|NCT00440557|101496014|FG001|Overall Study|Patient transferred to nursing home|1|||
33437610|NCT00440557|101496015|FG002|Overall Study|Patient transferred to nursing home|0|||
33437611|NCT00440557|101496013|FG000|Overall Study|Patient had surgery|1|||
33437612|NCT00440557|101496014|FG001|Overall Study|Patient had surgery|0|||
33437613|NCT00440557|101496015|FG002|Overall Study|Patient had surgery|0|||
33437614|NCT00883090|101496016|FG000|Overall Study|Sponsor's decision|1|||
33437615|NCT00883090|101496016|FG000|Overall Study|Withdrawal by Subject|1|||
33437616|NCT04646109|101496017|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
33437617|NCT04646109|101496018|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
33153979|NCT00257608|100479368|FG000|Post Chemotherapy Phase|Physician Decision|0|||
33251639|NCT00909363|100820701|FG001|Overall Study|Lack of Efficacy|0|||
33437618|NCT01739790|101496021|FG000|Overall Study|Early Trial Termination|2|||
33437619|NCT01739790|101496022|FG001|Overall Study|Early Trial Termination|4|||
33437620|NCT02920996|101496023|FG000|Overall Study|Adverse Event|8|||
33437621|NCT02920996|101496024|FG001|Overall Study|Adverse Event|0|||
33437622|NCT02920996|101496023|FG000|Overall Study|Physician Decision|1|||
33153980|NCT00257608|100479369|FG001|Post Chemotherapy Phase|Physician Decision|8|||
33153981|NCT00257608|100479370|FG002|Post Chemotherapy Phase|Physician Decision|11|||
33153982|NCT00257608|100479368|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
33153983|NCT00257608|100479369|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
33153984|NCT00257608|100479370|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
33153985|NCT00257608|100479368|FG000|Post Chemotherapy Phase|Not treated|0|||
33153986|NCT00257608|100479369|FG001|Post Chemotherapy Phase|Not treated|4|||
33153987|NCT00257608|100479370|FG002|Post Chemotherapy Phase|Not treated|7|||
33153988|NCT01973569|100479375|FG000|Overall Study|Adverse Event|9|||
33153989|NCT01973569|100479376|FG001|Overall Study|Adverse Event|2|||
33153990|NCT01973569|100479377|FG002|Overall Study|Adverse Event|4|||
33153991|NCT01973569|100479375|FG000|Overall Study|Protocol Violation|2|||
33153992|NCT01973569|100479376|FG001|Overall Study|Protocol Violation|1|||
33153993|NCT01973569|100479377|FG002|Overall Study|Protocol Violation|3|||
33153994|NCT01973569|100479375|FG000|Overall Study|Withdrawal by Subject|7|||
33153995|NCT01973569|100479376|FG001|Overall Study|Withdrawal by Subject|5|||
33153996|NCT01973569|100479377|FG002|Overall Study|Withdrawal by Subject|2|||
33153997|NCT01973569|100479375|FG000|Overall Study|Invasive dental treatment|3|||
33153998|NCT01973569|100479376|FG001|Overall Study|Invasive dental treatment|5|||
33153999|NCT01973569|100479377|FG002|Overall Study|Invasive dental treatment|6|||
33154000|NCT01973569|100479375|FG000|Overall Study|Prohibited concomitant d|1|||
33154001|NCT01973569|100479376|FG001|Overall Study|Prohibited concomitant d|5|||
33154002|NCT01973569|100479377|FG002|Overall Study|Prohibited concomitant d|0|||
33154003|NCT01973569|100479375|FG000|Overall Study|Disease progression|0|||
33154004|NCT01973569|100479376|FG001|Overall Study|Disease progression|3|||
33154005|NCT01973569|100479377|FG002|Overall Study|Disease progression|0|||
33154006|NCT01973569|100479375|FG000|Overall Study|Other|1|||
33154007|NCT01973569|100479376|FG001|Overall Study|Other|1|||
33154008|NCT01973569|100479377|FG002|Overall Study|Other|0|||
33251640|NCT00909363|100820702|FG002|Overall Study|Lack of Efficacy|0|||
33251641|NCT02026258|100820705|FG000|Randomized|Did not start treatment|2|||
33251642|NCT02026258|100820706|FG001|Randomized|Did not start treatment|1|||
33251643|NCT02026258|100820705|FG000|Randomized|Change in treatment plan|1|||
33251644|NCT02026258|100820706|FG001|Randomized|Change in treatment plan|0|||
33251645|NCT02026258|100820705|FG000|Randomized|Presence of periodontal disease|1|||
33251646|NCT02026258|100820706|FG001|Randomized|Presence of periodontal disease|1|||
33387034|NCT02096042|101302725|FG000|Overall Study|Disease Progression|1|||
33387035|NCT02096042|101302726|FG001|Overall Study|Disease Progression|0|||
33387036|NCT02096042|101302727|FG002|Overall Study|Disease Progression|0|||
33387037|NCT03000686|101302729|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
33387038|NCT03000686|101302730|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
33387039|NCT03000686|101302731|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
33387040|NCT03000686|101302732|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
33387041|NCT01042938|101302735|FG000|Overall Study|Withdrawal by Subject|1|||
33387042|NCT01042938|101302736|FG001|Overall Study|Withdrawal by Subject|1|||
33387043|NCT01042938|101302735|FG000|Overall Study|Protocol Violation|1|||
33387044|NCT01042938|101302736|FG001|Overall Study|Protocol Violation|1|||
33437623|NCT02920996|101496024|FG001|Overall Study|Physician Decision|0|||
33437624|NCT02920996|101496023|FG000|Overall Study|Death|1|||
33437625|NCT02920996|101496024|FG001|Overall Study|Death|0|||
33437626|NCT02920996|101496023|FG000|Overall Study|Missing|1|||
33154009|NCT01973569|100479375|FG000|Overall Study|Did not receive study drug|6|||
33154010|NCT01973569|100479376|FG001|Overall Study|Did not receive study drug|3|||
33154011|NCT01973569|100479377|FG002|Overall Study|Did not receive study drug|3|||
33154012|NCT00302107|100479378|FG000|Overall Study|Lost to Follow-up|6|||
33154013|NCT00302107|100479379|FG001|Overall Study|Lost to Follow-up|5|||
33154014|NCT00302107|100479378|FG000|Overall Study|Protocol Violation|1|||
33154015|NCT00302107|100479379|FG001|Overall Study|Protocol Violation|0|||
33154016|NCT00302107|100479378|FG000|Overall Study|Relocation|0|||
33154017|NCT00302107|100479379|FG001|Overall Study|Relocation|1|||
33154018|NCT00302107|100479378|FG000|Overall Study|Withdrawal by Subject|0|||
33154019|NCT00302107|100479379|FG001|Overall Study|Withdrawal by Subject|3|||
33154020|NCT00302107|100479378|FG000|Overall Study|Adverse Event|1|||
33154021|NCT00302107|100479379|FG001|Overall Study|Adverse Event|0|||
33154022|NCT00864721|100479383|FG000|Overall Study|Patient request|11|||
33154023|NCT00864721|100479383|FG000|Overall Study|Hospitalized|1|||
33154024|NCT00864721|100479383|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
33154025|NCT00864721|100479383|FG000|Overall Study|Adverse Event|21|||
33154026|NCT00287365|100479384|FG000|Overall Study|sample not acquired|13|||
33154027|NCT01759511|100479385|FG000|Overall Study|Adverse Event|4|||
33154028|NCT01759511|100479385|FG000|Overall Study|Death|2|||
33154029|NCT01759511|100479385|FG000|Overall Study|Lack of Efficacy|2|||
33154030|NCT01759511|100479385|FG000|Overall Study|Physician Decision|1|||
33154031|NCT01759511|100479385|FG000|Overall Study|Progressive Disease|5|||
33154032|NCT01759511|100479385|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
33154033|NCT01759511|100479385|FG000|Overall Study|Study Terminated by Sponsor|13|||
33154034|NCT01759511|100479385|FG000|Overall Study|Withdrawal by Subject|3|||
33154035|NCT01934972|100479386|FG000|Overall Study|Withdrawal by Subject|9|||
33154036|NCT01934972|100479387|FG001|Overall Study|Withdrawal by Subject|6|||
33154037|NCT01254630|100479389|FG000|Overall Study|Adverse Event|36|||
33154038|NCT01254630|100479390|FG001|Overall Study|Adverse Event|15|||
33154039|NCT01254630|100479391|FG002|Overall Study|Adverse Event|40|||
33154040|NCT01254630|100479392|FG003|Overall Study|Adverse Event|8|||
33154041|NCT01254630|100479389|FG000|Overall Study|Death|461|||
33154042|NCT01254630|100479390|FG001|Overall Study|Death|151|||
33154043|NCT01254630|100479391|FG002|Overall Study|Death|478|||
33154044|NCT01254630|100479392|FG003|Overall Study|Death|139|||
33154045|NCT01254630|100479389|FG000|Overall Study|Lost to Follow-up|80|||
33154046|NCT01254630|100479390|FG001|Overall Study|Lost to Follow-up|26|||
33154047|NCT01254630|100479391|FG002|Overall Study|Lost to Follow-up|89|||
33154048|NCT01254630|100479392|FG003|Overall Study|Lost to Follow-up|32|||
33154049|NCT01254630|100479389|FG000|Overall Study|Physician Decision|24|||
33154050|NCT01254630|100479390|FG001|Overall Study|Physician Decision|8|||
33154051|NCT01254630|100479391|FG002|Overall Study|Physician Decision|16|||
33154052|NCT01254630|100479392|FG003|Overall Study|Physician Decision|7|||
33154053|NCT01254630|100479389|FG000|Overall Study|Withdrawal by Subject|201|||
33154054|NCT01254630|100479390|FG001|Overall Study|Withdrawal by Subject|94|||
33154055|NCT01254630|100479391|FG002|Overall Study|Withdrawal by Subject|188|||
33154056|NCT01254630|100479392|FG003|Overall Study|Withdrawal by Subject|89|||
33154057|NCT01254630|100479389|FG000|Overall Study|Study terminated by sponsor|0|||
33154058|NCT01254630|100479390|FG001|Overall Study|Study terminated by sponsor|994|||
33154059|NCT01254630|100479391|FG002|Overall Study|Study terminated by sponsor|0|||
33154060|NCT01254630|100479392|FG003|Overall Study|Study terminated by sponsor|1010|||
33154061|NCT01254630|100479389|FG000|Overall Study|Status not recorded|0|||
33154062|NCT01254630|100479390|FG001|Overall Study|Status not recorded|0|||
33154063|NCT01254630|100479391|FG002|Overall Study|Status not recorded|1|||
33154064|NCT01254630|100479392|FG003|Overall Study|Status not recorded|0|||
33154065|NCT02180165|100479393|FG000|Overall Study|Not Treated|0|||
33154066|NCT02180165|100479394|FG001|Overall Study|Not Treated|0|||
33154067|NCT02180165|100479395|FG002|Overall Study|Not Treated|1|||
33154068|NCT02180165|100479396|FG003|Overall Study|Not Treated|0|||
33154069|NCT02180165|100479393|FG000|Overall Study|Adverse Event|7|||
33154070|NCT02180165|100479394|FG001|Overall Study|Adverse Event|0|||
33154071|NCT02180165|100479395|FG002|Overall Study|Adverse Event|18|||
33154072|NCT02180165|100479396|FG003|Overall Study|Adverse Event|3|||
33154073|NCT02180165|100479393|FG000|Overall Study|Lack of Efficacy|0|||
33387045|NCT01042938|101302735|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
33387046|NCT01042938|101302736|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
33387047|NCT03004976|101302737|FG000|Overall Study|Lost to Follow-up|7|||
33154074|NCT02180165|100479394|FG001|Overall Study|Lack of Efficacy|1|||
33154075|NCT02180165|100479395|FG002|Overall Study|Lack of Efficacy|3|||
33154076|NCT02180165|100479396|FG003|Overall Study|Lack of Efficacy|2|||
33154077|NCT02180165|100479393|FG000|Overall Study|Physician Decision|1|||
33154078|NCT02180165|100479394|FG001|Overall Study|Physician Decision|0|||
33154079|NCT02180165|100479395|FG002|Overall Study|Physician Decision|5|||
33154080|NCT02180165|100479396|FG003|Overall Study|Physician Decision|0|||
33154081|NCT02180165|100479393|FG000|Overall Study|Withdrawal by Subject|3|||
33154082|NCT02180165|100479394|FG001|Overall Study|Withdrawal by Subject|0|||
33154083|NCT02180165|100479395|FG002|Overall Study|Withdrawal by Subject|2|||
33154084|NCT02180165|100479396|FG003|Overall Study|Withdrawal by Subject|1|||
33154085|NCT01419626|100479397|FG000|Overall Study|Protocol Violation|3|||
33154086|NCT01419626|100479398|FG001|Overall Study|Protocol Violation|2|||
33154087|NCT01419626|100479399|FG002|Overall Study|Protocol Violation|2|||
33154088|NCT01419626|100479397|FG000|Overall Study|Withdrawal by Subject|1|||
33154089|NCT01419626|100479398|FG001|Overall Study|Withdrawal by Subject|0|||
33154090|NCT01419626|100479399|FG002|Overall Study|Withdrawal by Subject|0|||
33154091|NCT01419626|100479397|FG000|Overall Study|Lost to Follow-up|0|||
33154092|NCT01419626|100479398|FG001|Overall Study|Lost to Follow-up|1|||
33154093|NCT01419626|100479399|FG002|Overall Study|Lost to Follow-up|1|||
33154094|NCT03344796|100479403|FG000|Overall Study|Lost to Follow-up|0|||
33154095|NCT03344796|100479404|FG001|Overall Study|Lost to Follow-up|0|||
33154096|NCT03344796|100479405|FG002|Overall Study|Lost to Follow-up|0|||
33154097|NCT03344796|100479406|FG003|Overall Study|Lost to Follow-up|0|||
33154098|NCT03344796|100479407|FG004|Overall Study|Lost to Follow-up|0|||
33154099|NCT03344796|100479408|FG005|Overall Study|Lost to Follow-up|2|||
33154100|NCT02764333|100479409|FG000|Overall Study|Ineligible|1|||
33154101|NCT03576495|100479413|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
33154102|NCT03576495|100479414|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
33154103|NCT04087213|100479415|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
33154104|NCT04087213|100479415|FG000|In-Facility Introduction|Adverse Event|1|||
33154105|NCT04087213|100479415|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
33154106|NCT04087213|100479415|FG000|Assisted Evaluable Period|Personal reasons|3|||
33154107|NCT04087213|100479415|FG000|Transition Period B|Renal Transplantation|1|||
33154108|NCT00747812|100479423|FG000|Overall Study|Research Site Staff Relocation|5|||
33154109|NCT00747812|100479424|FG001|Overall Study|Research Site Staff Relocation|3|||
33154110|NCT00002651|100479429|FG000|Induction|Adverse Event|44|||
33154111|NCT00002651|100479430|FG001|Induction|Adverse Event|0|||
33154112|NCT00002651|100479431|FG002|Induction|Adverse Event|0|||
33154113|NCT00002651|100479429|FG000|Induction|Refusal unrelated to adverse event|50|||
33154114|NCT00002651|100479430|FG001|Induction|Refusal unrelated to adverse event|0|||
33154115|NCT00002651|100479431|FG002|Induction|Refusal unrelated to adverse event|0|||
33154116|NCT00002651|100479429|FG000|Induction|Progression/relapse|274|||
33154117|NCT00002651|100479430|FG001|Induction|Progression/relapse|0|||
33154118|NCT00002651|100479431|FG002|Induction|Progression/relapse|0|||
33154119|NCT00002651|100479429|FG000|Induction|Death|62|||
33154120|NCT00002651|100479430|FG001|Induction|Death|0|||
33154121|NCT00002651|100479431|FG002|Induction|Death|0|||
33154122|NCT00002651|100479429|FG000|Induction|Other|823|||
33154123|NCT00002651|100479430|FG001|Induction|Other|0|||
33154124|NCT00002651|100479431|FG002|Induction|Other|0|||
33154125|NCT00002651|100479429|FG000|Induction|not eligible|90|||
33154126|NCT00002651|100479430|FG001|Induction|not eligible|0|||
33154127|NCT00002651|100479431|FG002|Induction|not eligible|0|||
33154128|NCT00002651|100479429|FG000|Consolidation and Randomization|Adverse Event|0|||
33154129|NCT00002651|100479430|FG001|Consolidation and Randomization|Adverse Event|36|||
33154130|NCT00002651|100479431|FG002|Consolidation and Randomization|Adverse Event|14|||
33154131|NCT00002651|100479429|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
33154132|NCT00002651|100479430|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
33154133|NCT00002651|100479431|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
33154134|NCT00002651|100479429|FG000|Consolidation and Randomization|Progression/relapse|0|||
33154135|NCT00002651|100479430|FG001|Consolidation and Randomization|Progression/relapse|295|||
33154136|NCT00002651|100479431|FG002|Consolidation and Randomization|Progression/relapse|298|||
33154137|NCT00002651|100479429|FG000|Consolidation and Randomization|Death|0|||
33154138|NCT00002651|100479430|FG001|Consolidation and Randomization|Death|38|||
33154139|NCT00002651|100479431|FG002|Consolidation and Randomization|Death|48|||
33154140|NCT00002651|100479429|FG000|Consolidation and Randomization|Other|0|||
33154141|NCT00002651|100479430|FG001|Consolidation and Randomization|Other|314|||
33154142|NCT00002651|100479431|FG002|Consolidation and Randomization|Other|313|||
33154143|NCT00002651|100479429|FG000|Consolidation and Randomization|not eligible|0|||
33154144|NCT00002651|100479430|FG001|Consolidation and Randomization|not eligible|102|||
33154145|NCT00002651|100479431|FG002|Consolidation and Randomization|not eligible|112|||
33154146|NCT00913380|100479432|FG000|Clinical Outcomes|Lost to Follow-up|6|||
33154147|NCT00913380|100479433|FG001|Clinical Outcomes|Lost to Follow-up|6|||
33154148|NCT02083081|100479440|FG000|Overall Study|Lost to Follow-up|31|||
33154149|NCT02083081|100479441|FG001|Overall Study|Lost to Follow-up|9|||
33154150|NCT00304239|100479444|FG000|Overall Study|Protocol Deviations/Violations|15|||
33154151|NCT00304239|100479445|FG001|Overall Study|Protocol Deviations/Violations|0|||
33387048|NCT03004976|101302738|FG001|Overall Study|Lost to Follow-up|5|||
33387049|NCT03004976|101302737|FG000|Overall Study|Physician Decision|1|||
33154152|NCT00304239|100479444|FG000|Overall Study|Adverse Event|2|||
33154153|NCT00304239|100479445|FG001|Overall Study|Adverse Event|0|||
33154154|NCT00422097|100479457|FG000|Dose Level 2|Still on treatment|0|||
33154155|NCT00422097|100479458|FG001|Dose Level 2|Still on treatment|1|||
33154156|NCT00422097|100479459|FG002|Dose Level 2|Still on treatment|0|||
33154157|NCT00422097|100479460|FG003|Dose Level 2|Still on treatment|0|||
33387050|NCT03004976|101302738|FG001|Overall Study|Physician Decision|0|||
33154158|NCT00422097|100479461|FG004|Dose Level 2|Still on treatment|0|||
33154159|NCT00422097|100479462|FG005|Dose Level 2|Still on treatment|0|||
33154160|NCT00422097|100479463|FG006|Dose Level 2|Still on treatment|0|||
33154161|NCT00422097|100479464|FG007|Dose Level 2|Still on treatment|0|||
33154162|NCT00669396|100479465|FG000|Overall Study|Lost to Follow-up|10|||
33154163|NCT00669396|100479466|FG001|Overall Study|Lost to Follow-up|12|||
33154164|NCT00810355|100479467|FG000|Overall Study|Lost to Follow-up|13|||
33154165|NCT00810355|100479468|FG001|Overall Study|Lost to Follow-up|17|||
33154166|NCT00810355|100479469|FG002|Overall Study|Lost to Follow-up|11|||
33154167|NCT00810355|100479467|FG000|Overall Study|Withdrawal by Subject|1|||
33154168|NCT00810355|100479468|FG001|Overall Study|Withdrawal by Subject|0|||
33154169|NCT00810355|100479469|FG002|Overall Study|Withdrawal by Subject|0|||
33154170|NCT01146912|100479470|FG000|Overall Study|Already received influenza vaccination|817|||
33154171|NCT01146912|100479471|FG001|Overall Study|Already received influenza vaccination|822|||
33154172|NCT01146912|100479472|FG002|Overall Study|Already received influenza vaccination|13|||
33154173|NCT01146912|100479473|FG003|Overall Study|Already received influenza vaccination|15|||
33154174|NCT01146912|100479474|FG004|Overall Study|Already received influenza vaccination|41|||
33154175|NCT01146912|100479475|FG005|Overall Study|Already received influenza vaccination|61|||
33154176|NCT01146912|100479476|FG006|Overall Study|Already received influenza vaccination|56|||
33154177|NCT01146912|100479477|FG007|Overall Study|Already received influenza vaccination|0|||
33154178|NCT01146912|100479470|FG000|Overall Study|< 14 weeks gestational age|0|||
33154179|NCT01146912|100479471|FG001|Overall Study|< 14 weeks gestational age|0|||
33154180|NCT01146912|100479472|FG002|Overall Study|< 14 weeks gestational age|3|||
33154181|NCT01146912|100479473|FG003|Overall Study|< 14 weeks gestational age|2|||
33154182|NCT01146912|100479474|FG004|Overall Study|< 14 weeks gestational age|0|||
33154183|NCT01146912|100479475|FG005|Overall Study|< 14 weeks gestational age|0|||
33154184|NCT01146912|100479476|FG006|Overall Study|< 14 weeks gestational age|0|||
33154185|NCT01146912|100479477|FG007|Overall Study|< 14 weeks gestational age|0|||
33154186|NCT01146912|100479470|FG000|Overall Study|Duplicate patient|0|||
33154187|NCT01146912|100479471|FG001|Overall Study|Duplicate patient|0|||
33154188|NCT01146912|100479472|FG002|Overall Study|Duplicate patient|1|||
33154189|NCT01146912|100479473|FG003|Overall Study|Duplicate patient|0|||
33154190|NCT01146912|100479474|FG004|Overall Study|Duplicate patient|0|||
33154191|NCT01146912|100479475|FG005|Overall Study|Duplicate patient|0|||
33154192|NCT01146912|100479476|FG006|Overall Study|Duplicate patient|0|||
33154193|NCT01146912|100479477|FG007|Overall Study|Duplicate patient|0|||
33154194|NCT00122109|100479478|FG000|Overall Study|Did not meet criteria|6|||
33154195|NCT00122109|100479479|FG001|Overall Study|Did not meet criteria|7|||
33154196|NCT02436681|100479480|FG000|Overall Study|Lost to Follow-up|10|||
33154197|NCT02436681|100479480|FG000|Overall Study|Withdrawal by Subject|2|||
33154198|NCT02436681|100479480|FG000|Overall Study|Death|2|||
33154199|NCT03570697|100479481|FG000|Overall Study|Lost to Follow-up|0|||
33154200|NCT03570697|100479482|FG001|Overall Study|Lost to Follow-up|1|||
33154201|NCT03570697|100479481|FG000|Overall Study|Death|2|||
33154202|NCT03570697|100479482|FG001|Overall Study|Death|0|||
33154203|NCT03570697|100479481|FG000|Overall Study|Withdrawal by Subject|4|||
33154204|NCT03570697|100479482|FG001|Overall Study|Withdrawal by Subject|2|||
33154205|NCT02589405|100479483|FG000|Overall Study|Adverse Event|3|||
33154206|NCT02589405|100479483|FG000|Overall Study|Withdrawal by Subject|1|||
33387051|NCT03004976|101302737|FG000|Overall Study|Withdrawal by Subject|1|||
33387052|NCT03004976|101302738|FG001|Overall Study|Withdrawal by Subject|0|||
33387053|NCT03004976|101302737|FG000|Overall Study|Death|4|||
33387054|NCT03004976|101302738|FG001|Overall Study|Death|1|||
33387055|NCT01153893|101306196|FG000|Overall Study|Adverse Event|1|||
33387056|NCT01153893|101306197|FG001|Overall Study|Adverse Event|0|||
33387057|NCT04583969|101306200|FG000|Overall Study|Death|31|||
33387058|NCT04583969|101306201|FG001|Overall Study|Death|38|||
33387059|NCT04583969|101306200|FG000|Overall Study|Lost to Follow-up|16|||
33387060|NCT04583969|101306201|FG001|Overall Study|Lost to Follow-up|13|||
33387061|NCT04583969|101306200|FG000|Overall Study|Protocol Violation|1|||
33387062|NCT04583969|101306201|FG001|Overall Study|Protocol Violation|0|||
33154207|NCT02486302|100479485|FG000|Overall Study|Discontinued prematurely|410|||
33154208|NCT02486302|100479485|FG000|Overall Study|Documentation not completed|255|||
33154209|NCT02486302|100479485|FG000|Overall Study|Excluded due to legal reasons|8|||
33154210|NCT02486302|100479485|FG000|Overall Study|Not treated|3|||
33154211|NCT03212690|100479490|FG000|Overall Study|Protocol Violation|1|||
33154212|NCT03198078|100479491|FG000|Overall Study|Adverse Event|0|||
33154213|NCT03198078|100479492|FG001|Overall Study|Adverse Event|1|||
33154214|NCT03198078|100479493|FG002|Overall Study|Adverse Event|2|||
33154215|NCT03198078|100479491|FG000|Overall Study|Lack of Efficacy|0|||
33154216|NCT03198078|100479492|FG001|Overall Study|Lack of Efficacy|0|||
33387063|NCT04583969|101306200|FG000|Overall Study|Withdrawal by Subject|3|||
33387064|NCT04583969|101306201|FG001|Overall Study|Withdrawal by Subject|3|||
33154217|NCT03198078|100479493|FG002|Overall Study|Lack of Efficacy|3|||
33387065|NCT04583969|101306200|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
33154218|NCT03198078|100479491|FG000|Overall Study|Lost to Follow-up|1|||
33154219|NCT03198078|100479492|FG001|Overall Study|Lost to Follow-up|0|||
33154220|NCT03198078|100479493|FG002|Overall Study|Lost to Follow-up|0|||
33154221|NCT03198078|100479491|FG000|Overall Study|Pregnancy|0|||
33387066|NCT04583969|101306201|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
33387067|NCT04583969|101306200|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
33387068|NCT04583969|101306201|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
33387069|NCT04583969|101306200|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
33387070|NCT04583969|101306201|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
33387071|NCT04583969|101306200|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
33387072|NCT04583969|101306201|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
33387073|NCT04583969|101306200|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
33387074|NCT04583969|101306201|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
33387075|NCT01248364|101306204|FG000|Overall Study|Adverse Event|0|||
33387076|NCT01248364|101306205|FG001|Overall Study|Adverse Event|1|||
33387077|NCT01248364|101306206|FG002|Overall Study|Adverse Event|0|||
33387078|NCT01248364|101306207|FG003|Overall Study|Adverse Event|0|||
33387079|NCT00830804|101306208|FG000|Overall Study|Lost to Follow-up|4|||
33387080|NCT00830804|101306208|FG000|Overall Study|Death|1|||
33154222|NCT03198078|100479492|FG001|Overall Study|Pregnancy|1|||
33251647|NCT02026258|100820705|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
33251648|NCT02026258|100820706|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
33251649|NCT02026258|100820705|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
33251650|NCT02026258|100820706|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
33251651|NCT03885596|100820707|FG000|Overall Study|Withdrawal by Subject|2|||
33251652|NCT03885596|100820708|FG001|Overall Study|Withdrawal by Subject|1|||
33251653|NCT03885596|100820709|FG002|Overall Study|Withdrawal by Subject|0|||
33251654|NCT03885596|100820710|FG003|Overall Study|Withdrawal by Subject|0|||
33251655|NCT03061474|100820715|FG000|Overall Study|Adverse Event|2|||
33251656|NCT03061474|100820716|FG001|Overall Study|Adverse Event|0|||
33387081|NCT00830804|101306208|FG000|Overall Study|Unable to get to clinic|7|||
33387082|NCT00830804|101306208|FG000|Overall Study|Consent withdrawn|2|||
33387083|NCT00830804|101306208|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
33387084|NCT00659126|101306209|FG000|Overall Study|Adverse Event|2|||
33387085|NCT00659126|101306210|FG001|Overall Study|Adverse Event|2|||
33387086|NCT00659126|101306209|FG000|Overall Study|Screen failure|1|||
33387087|NCT00659126|101306210|FG001|Overall Study|Screen failure|1|||
33387088|NCT00659126|101306209|FG000|Overall Study|Technical problems with MRI|0|||
33387089|NCT00659126|101306210|FG001|Overall Study|Technical problems with MRI|1|||
33387090|NCT01527110|101306211|FG000|Overall Study|Adverse Event|1|||
33387091|NCT00669032|101306213|FG000|Overall Study|Lost to Follow-up|6|||
33387092|NCT00669032|101306214|FG001|Overall Study|Lost to Follow-up|5|||
33387093|NCT00669032|101306213|FG000|Overall Study|Lack of Efficacy|8|||
33387094|NCT00669032|101306214|FG001|Overall Study|Lack of Efficacy|19|||
33387095|NCT00669032|101306213|FG000|Overall Study|Withdrawal by Subject|12|||
33387096|NCT00669032|101306214|FG001|Overall Study|Withdrawal by Subject|13|||
33387097|NCT00669032|101306213|FG000|Overall Study|Adverse Event|12|||
33387098|NCT00669032|101306214|FG001|Overall Study|Adverse Event|16|||
33387099|NCT00669032|101306213|FG000|Overall Study|Physician Decision|1|||
33387100|NCT00669032|101306214|FG001|Overall Study|Physician Decision|1|||
33387101|NCT00669032|101306213|FG000|Overall Study|No fulfilment of the selection criteria|5|||
33387102|NCT00669032|101306214|FG001|Overall Study|No fulfilment of the selection criteria|5|||
33387103|NCT00996593|101306219|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
33387104|NCT00996593|101306219|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
33387105|NCT00996593|101306219|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
33387106|NCT00996593|101306219|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
33387107|NCT00996593|101306219|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
33387108|NCT00996593|101306219|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
33387109|NCT00996593|101306219|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
33387110|NCT00996593|101306219|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
33387111|NCT00996593|101306219|FG000|Long-Term Follow-Up|Site Closed|1|||
33387112|NCT00023712|101306220|FG000|Overall Study|Not platinum sensitive|1|||
33387113|NCT00023712|101306221|FG001|Overall Study|Not platinum sensitive|0|||
33387114|NCT00023712|101306220|FG000|Overall Study|Never treated|1|||
33387115|NCT00023712|101306221|FG001|Overall Study|Never treated|1|||
33387116|NCT01611298|101306222|FG000|Overall Study|Relapsed|2|||
33387117|NCT00105560|101306223|FG000|Overall Study|Lost to Follow-up|1|||
33387118|NCT00094835|101306230|FG000|Overall Study|Physician Decision|1|||
33387119|NCT00094835|101306231|FG001|Overall Study|Physician Decision|0|||
33387120|NCT00094835|101306232|FG002|Overall Study|Physician Decision|0|||
33387121|NCT00094835|101306233|FG003|Overall Study|Physician Decision|0|||
33387122|NCT00094835|101306234|FG004|Overall Study|Physician Decision|0|||
33387123|NCT00094835|101306235|FG005|Overall Study|Physician Decision|1|||
33387124|NCT00094835|101306236|FG006|Overall Study|Physician Decision|0|||
33387125|NCT00094835|101306230|FG000|Overall Study|Withdrawal by Subject|0|||
33387126|NCT00094835|101306231|FG001|Overall Study|Withdrawal by Subject|0|||
33387127|NCT00094835|101306232|FG002|Overall Study|Withdrawal by Subject|0|||
33387128|NCT00094835|101306233|FG003|Overall Study|Withdrawal by Subject|0|||
33387129|NCT00094835|101306234|FG004|Overall Study|Withdrawal by Subject|0|||
33387130|NCT00094835|101306235|FG005|Overall Study|Withdrawal by Subject|0|||
33387131|NCT00094835|101306236|FG006|Overall Study|Withdrawal by Subject|1|||
33387132|NCT00094835|101306230|FG000|Overall Study|Lost to Follow-up|0|||
33437627|NCT02920996|101496024|FG001|Overall Study|Missing|0|||
33387133|NCT00094835|101306231|FG001|Overall Study|Lost to Follow-up|0|||
33387134|NCT00094835|101306232|FG002|Overall Study|Lost to Follow-up|0|||
33387135|NCT00094835|101306233|FG003|Overall Study|Lost to Follow-up|0|||
33387136|NCT00094835|101306234|FG004|Overall Study|Lost to Follow-up|1|||
33387137|NCT00094835|101306235|FG005|Overall Study|Lost to Follow-up|0|||
33437628|NCT02920996|101496023|FG000|Overall Study|Subject Non-Compliance|1|||
33387138|NCT00094835|101306236|FG006|Overall Study|Lost to Follow-up|0|||
33387139|NCT00094835|101306230|FG000|Overall Study|Death|1|||
33251657|NCT03061474|100820715|FG000|Overall Study|Safety Risk|0|||
33251658|NCT03061474|100820716|FG001|Overall Study|Safety Risk|1|||
33251659|NCT03061474|100820715|FG000|Overall Study|Participant unwilling or unable to participate|0|||
33387140|NCT00094835|101306231|FG001|Overall Study|Death|0|||
33387141|NCT00094835|101306232|FG002|Overall Study|Death|0|||
33437629|NCT02920996|101496024|FG001|Overall Study|Subject Non-Compliance|0|||
33437630|NCT00720096|101496029|FG000|Overall Study|Withdrawal by Subject|0|||
33437631|NCT00720096|101496030|FG001|Overall Study|Withdrawal by Subject|2|||
33437632|NCT00385684|101496037|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
33437633|NCT00385684|101496038|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
33437634|NCT00385684|101496037|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
33437635|NCT00385684|101496038|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
33437636|NCT00385684|101496037|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
33437637|NCT00385684|101496038|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
33437638|NCT01256684|101496041|FG000|Overall Study|Adverse Event|1|||
33437639|NCT01256684|101496042|FG001|Overall Study|Adverse Event|4|||
33437640|NCT01256684|101496043|FG002|Overall Study|Adverse Event|2|||
33437641|NCT01256684|101496041|FG000|Overall Study|Withdrawal by Subject|4|||
33437642|NCT01256684|101496042|FG001|Overall Study|Withdrawal by Subject|0|||
33437643|NCT01256684|101496043|FG002|Overall Study|Withdrawal by Subject|2|||
33437644|NCT01256684|101496041|FG000|Overall Study|Physician Decision|0|||
33437645|NCT01256684|101496042|FG001|Overall Study|Physician Decision|1|||
33437646|NCT01256684|101496043|FG002|Overall Study|Physician Decision|0|||
33437647|NCT01256684|101496041|FG000|Overall Study|Lack of Efficacy|0|||
33437648|NCT01256684|101496042|FG001|Overall Study|Lack of Efficacy|1|||
33437649|NCT01256684|101496043|FG002|Overall Study|Lack of Efficacy|1|||
33437650|NCT01256684|101496041|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
33437651|NCT01256684|101496042|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
33154223|NCT03198078|100479493|FG002|Overall Study|Pregnancy|0|||
33154224|NCT03198078|100479491|FG000|Overall Study|Withdrawal by Subject|1|||
33154225|NCT03198078|100479492|FG001|Overall Study|Withdrawal by Subject|0|||
33154226|NCT03198078|100479493|FG002|Overall Study|Withdrawal by Subject|2|||
33154227|NCT03198078|100479491|FG000|Overall Study|Withdrawal by Caregiver|1|||
33154228|NCT03198078|100479492|FG001|Overall Study|Withdrawal by Caregiver|3|||
33154229|NCT03198078|100479493|FG002|Overall Study|Withdrawal by Caregiver|5|||
33154230|NCT01160211|100479494|FG000|Overall Study|ongoing|90|||
33154231|NCT01160211|100479495|FG001|Overall Study|ongoing|75|||
33154232|NCT01160211|100479496|FG002|Overall Study|ongoing|79|||
33154233|NCT01160211|100479494|FG000|Overall Study|Withdrawal by Subject|3|||
33154234|NCT01160211|100479495|FG001|Overall Study|Withdrawal by Subject|5|||
33154235|NCT01160211|100479496|FG002|Overall Study|Withdrawal by Subject|3|||
33154236|NCT01160211|100479494|FG000|Overall Study|Physician Decision|2|||
33154237|NCT01160211|100479495|FG001|Overall Study|Physician Decision|0|||
33154238|NCT01160211|100479496|FG002|Overall Study|Physician Decision|0|||
33154239|NCT01160211|100479494|FG000|Overall Study|Lost to Follow-up|4|||
33154240|NCT01160211|100479495|FG001|Overall Study|Lost to Follow-up|7|||
33154241|NCT01160211|100479496|FG002|Overall Study|Lost to Follow-up|5|||
33154242|NCT03605212|100479498|FG000|Treatment Period|Adverse Event|1|||
33154243|NCT03605212|100479499|FG001|Treatment Period|Adverse Event|0|||
33154244|NCT03605212|100479500|FG002|Treatment Period|Adverse Event|0|||
33154245|NCT03605212|100479501|FG003|Treatment Period|Adverse Event|0|||
33154246|NCT03605212|100479502|FG004|Treatment Period|Adverse Event|0|||
33154247|NCT03605212|100479498|FG000|Treatment Period|Physician Decision|0|||
33154248|NCT03605212|100479499|FG001|Treatment Period|Physician Decision|0|||
33154249|NCT03605212|100479500|FG002|Treatment Period|Physician Decision|0|||
33154250|NCT03605212|100479501|FG003|Treatment Period|Physician Decision|0|||
33154251|NCT03605212|100479502|FG004|Treatment Period|Physician Decision|1|||
33154252|NCT02935842|100479503|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
33154253|NCT02935842|100479504|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
33154254|NCT02935842|100479505|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
33154255|NCT02935842|100479506|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
33154256|NCT02935842|100479503|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
33251660|NCT03061474|100820716|FG001|Overall Study|Participant unwilling or unable to participate|2|||
33251661|NCT03061474|100820715|FG000|Overall Study|Lost to Follow-up|0|||
33251662|NCT03061474|100820716|FG001|Overall Study|Lost to Follow-up|1|||
33251663|NCT03439124|100820717|FG000|Overall Study|Adverse Event|2|||
33387142|NCT00094835|101306233|FG003|Overall Study|Death|0|||
33387143|NCT00094835|101306234|FG004|Overall Study|Death|1|||
33387144|NCT00094835|101306235|FG005|Overall Study|Death|0|||
33387145|NCT00094835|101306236|FG006|Overall Study|Death|0|||
33387146|NCT00094835|101306230|FG000|Overall Study|Non-compliance|1|||
33387147|NCT00094835|101306231|FG001|Overall Study|Non-compliance|2|||
33387148|NCT00094835|101306232|FG002|Overall Study|Non-compliance|2|||
33387149|NCT00094835|101306233|FG003|Overall Study|Non-compliance|0|||
33387150|NCT00094835|101306234|FG004|Overall Study|Non-compliance|2|||
33387151|NCT00094835|101306235|FG005|Overall Study|Non-compliance|2|||
33387152|NCT00094835|101306236|FG006|Overall Study|Non-compliance|1|||
33437652|NCT01256684|101496043|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
33251664|NCT03439124|100820718|FG001|Overall Study|Adverse Event|0|||
33387153|NCT00094835|101306230|FG000|Overall Study|Other|1|||
33387154|NCT00094835|101306231|FG001|Overall Study|Other|1|||
33251665|NCT03439124|100820717|FG000|Overall Study|Lost to Follow-up|1|||
33251666|NCT03439124|100820718|FG001|Overall Study|Lost to Follow-up|0|||
33251667|NCT03439124|100820717|FG000|Overall Study|Other reasons|1|||
33251668|NCT03439124|100820718|FG001|Overall Study|Other reasons|0|||
33251669|NCT02739035|100820719|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
33251670|NCT02739035|100820720|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
33251671|NCT02739035|100820719|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
33251672|NCT02739035|100820720|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
33251673|NCT02739035|100820719|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
33251674|NCT02739035|100820720|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
33251675|NCT02739035|100820719|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
33251676|NCT02739035|100820720|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
33251677|NCT01241292|100820721|FG000|Overall Study|Administrative Reason by Sponsor|1|||
33251678|NCT01241292|100820722|FG001|Overall Study|Administrative Reason by Sponsor|0|||
33251679|NCT01241292|100820721|FG000|Overall Study|Disease Progression|2|||
33251680|NCT01241292|100820722|FG001|Overall Study|Disease Progression|0|||
33251681|NCT01241292|100820721|FG000|Overall Study|Study Drug Toxicity|0|||
33251682|NCT01241292|100820722|FG001|Overall Study|Study Drug Toxicity|1|||
33251683|NCT01241292|100820721|FG000|Overall Study|Participant Discontinued Treatment|0|||
33251684|NCT01241292|100820722|FG001|Overall Study|Participant Discontinued Treatment|2|||
33251685|NCT01121549|100820723|FG000|Overall Study|Adverse Event|10|||
33251686|NCT01121549|100820723|FG000|Overall Study|Lack of Efficacy|11|||
33251687|NCT01121549|100820723|FG000|Overall Study|Lost to Follow-up|12|||
33387155|NCT00094835|101306232|FG002|Overall Study|Other|1|||
33387156|NCT00094835|101306233|FG003|Overall Study|Other|1|||
33387157|NCT00094835|101306234|FG004|Overall Study|Other|0|||
33387158|NCT00094835|101306235|FG005|Overall Study|Other|0|||
33387159|NCT00094835|101306236|FG006|Overall Study|Other|0|||
33387160|NCT01981109|101306240|FG000|Overall Study|Death|36|||
33387161|NCT01981109|101306240|FG000|Overall Study|Withdrawal by Subject|40|||
33387162|NCT01981109|101306240|FG000|Overall Study|Lost to Follow-up|9|||
33387163|NCT01981109|101306240|FG000|Overall Study|No Discontinuation Documentation|37|||
33387164|NCT01981109|101306240|FG000|Overall Study|Study Termination|100|||
33387165|NCT01981109|101306240|FG000|Overall Study|No data available|2|||
33387166|NCT00718523|101306243|FG000|Overall Study|Withdrawal by Subject|5|||
33387167|NCT00718523|101306244|FG001|Overall Study|Withdrawal by Subject|7|||
33387168|NCT00718523|101306243|FG000|Overall Study|Death|13|||
33387169|NCT00718523|101306244|FG001|Overall Study|Death|17|||
33387170|NCT01302691|101306245|FG000|Overall Study|Adverse Event|2|||
33387171|NCT01302691|101306246|FG001|Overall Study|Adverse Event|0|||
33387172|NCT01302691|101306245|FG000|Overall Study|Death|0|||
33387173|NCT01302691|101306246|FG001|Overall Study|Death|1|||
33387174|NCT01302691|101306245|FG000|Overall Study|Lost to Follow-up|1|||
33387175|NCT01302691|101306246|FG001|Overall Study|Lost to Follow-up|0|||
33387176|NCT01302691|101306245|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
33387177|NCT01302691|101306246|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
33251688|NCT01121549|100820723|FG000|Overall Study|Did not meet entrance criteria|9|||
33251689|NCT01121549|100820723|FG000|Overall Study|Study terminated by sponsor|197|||
33251690|NCT01121549|100820723|FG000|Overall Study|Pregnancy|1|||
33251691|NCT01121549|100820723|FG000|Overall Study|Protocol Violation|33|||
33251692|NCT01121549|100820723|FG000|Overall Study|Withdrawal by Subject|16|||
33251693|NCT01121549|100820723|FG000|Overall Study|Other|58|||
33251694|NCT03068468|100820729|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
33387178|NCT01302691|101306245|FG000|Overall Study|Physician Decision|0|||
33251695|NCT03068468|100820730|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
33251696|NCT03068468|100820731|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
33387179|NCT01302691|101306246|FG001|Overall Study|Physician Decision|1|||
33387180|NCT01302691|101306245|FG000|Overall Study|Protocol Violation|1|||
33251697|NCT03068468|100820732|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
33251698|NCT03068468|100820729|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
33251699|NCT03068468|100820730|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
33251700|NCT03068468|100820731|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
33251701|NCT03068468|100820732|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
33251702|NCT03068468|100820729|FG000|Placebo-Controlled Period|Adverse Event|16|||
33251703|NCT03068468|100820730|FG001|Placebo-Controlled Period|Adverse Event|21|||
33251704|NCT03068468|100820731|FG002|Placebo-Controlled Period|Adverse Event|0|||
33251705|NCT03068468|100820732|FG003|Placebo-Controlled Period|Adverse Event|0|||
33251706|NCT03068468|100820729|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
33251707|NCT03068468|100820730|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
33251708|NCT03068468|100820731|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
33251709|NCT03068468|100820732|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
33251710|NCT03068468|100820729|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
33251711|NCT03068468|100820730|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
33251712|NCT03068468|100820731|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33387181|NCT01302691|101306246|FG001|Overall Study|Protocol Violation|0|||
33387182|NCT00555568|101306251|FG000|Overall Study|Lost to Follow-up|26|||
33387183|NCT00555568|101306252|FG001|Overall Study|Lost to Follow-up|16|||
33387184|NCT00555568|101306253|FG002|Overall Study|Lost to Follow-up|16|||
33387185|NCT00062647|101306254|FG000|Overall Study|Death|2|||
33437653|NCT01617668|101496046|FG000|Overall Study|Adverse Event|7|||
33437654|NCT01617668|101496047|FG001|Overall Study|Adverse Event|0|||
33387186|NCT00062647|101306255|FG001|Overall Study|Death|2|||
33387187|NCT00062647|101306254|FG000|Overall Study|Adverse Event|1|||
33387188|NCT00062647|101306255|FG001|Overall Study|Adverse Event|1|||
33387189|NCT00062647|101306254|FG000|Overall Study|Withdrawal by Subject|2|||
33387190|NCT00062647|101306255|FG001|Overall Study|Withdrawal by Subject|1|||
33387191|NCT00062647|101306254|FG000|Overall Study|Protocol Violation|1|||
33387192|NCT00062647|101306255|FG001|Overall Study|Protocol Violation|0|||
33387193|NCT00062647|101306254|FG000|Overall Study|Lost to Follow-up|1|||
33387194|NCT00062647|101306255|FG001|Overall Study|Lost to Follow-up|2|||
33387195|NCT00062647|101306254|FG000|Overall Study|Failed continuation criteria|4|||
33387196|NCT00062647|101306255|FG001|Overall Study|Failed continuation criteria|2|||
33387197|NCT00062647|101306254|FG000|Overall Study|Other|4|||
33387198|NCT00062647|101306255|FG001|Overall Study|Other|4|||
33387199|NCT00062647|101306254|FG000|Overall Study|Never received study treatment|1|||
33387200|NCT00062647|101306255|FG001|Overall Study|Never received study treatment|1|||
33387201|NCT02186561|101306263|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
33387202|NCT02186561|101306263|FG000|Enrollment|Enrollment Cap Reached|5|||
33387203|NCT02186561|101306263|FG000|Enrollment|Insurance Denial|2|||
33387204|NCT02186561|101306263|FG000|Enrollment|Withdrawal by Subject|2|||
33387205|NCT02186561|101306263|FG000|Enrollment|Investigator Withdrew Consent|1|||
33387206|NCT02186561|101306263|FG000|30-Day Post Index Procedure Visit|Death|1|||
33387207|NCT02186561|101306263|FG000|1- Year Post Index Procedure Visit|Death|1|||
33387208|NCT02186561|101306263|FG000|1- Year Post Index Procedure Visit|Missed|1|||
33387209|NCT01570309|101306264|FG000|Overall Study|Withdrawal by Subject|3|||
33387210|NCT01570309|101306265|FG001|Overall Study|Withdrawal by Subject|3|||
33387211|NCT03934203|101306268|FG000|Overall Study|Adverse Event|0|||
33387212|NCT03934203|101306269|FG001|Overall Study|Adverse Event|0|||
33387213|NCT03934203|101306270|FG002|Overall Study|Adverse Event|1|||
33387214|NCT03934203|101306271|FG003|Overall Study|Adverse Event|0|||
33387215|NCT03934203|101306272|FG004|Overall Study|Adverse Event|1|||
33387216|NCT03934203|101306273|FG005|Overall Study|Adverse Event|0|||
33387217|NCT03934203|101306274|FG006|Overall Study|Adverse Event|2|||
33387218|NCT03934203|101306275|FG007|Overall Study|Adverse Event|0|||
33387219|NCT03934203|101306276|FG008|Overall Study|Adverse Event|0|||
33387220|NCT03934203|101306277|FG009|Overall Study|Adverse Event|0|||
33387221|NCT03934203|101306278|FG010|Overall Study|Adverse Event|0|||
33387222|NCT03934203|101306279|FG011|Overall Study|Adverse Event|0|||
33387223|NCT03934203|101306280|FG012|Overall Study|Adverse Event|0|||
33387224|NCT03934203|101306281|FG013|Overall Study|Adverse Event|1|||
33387225|NCT03934203|101306282|FG014|Overall Study|Adverse Event|0|||
33387226|NCT00050622|101306283|FG000|Overall Study|Adverse Event|1|||
33437655|NCT01617668|101496048|FG002|Overall Study|Adverse Event|12|||
33251713|NCT03068468|100820732|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
33251714|NCT03068468|100820729|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
33387227|NCT04285853|101306284|FG000|Overall Study|Withdrawal by Subject|1|||
33387228|NCT04285853|101306285|FG001|Overall Study|Withdrawal by Subject|0|||
33387229|NCT04285853|101306284|FG000|Overall Study|Lost to Follow-up|9|||
33387230|NCT04285853|101306285|FG001|Overall Study|Lost to Follow-up|5|||
33437656|NCT01617668|101496049|FG003|Overall Study|Adverse Event|5|||
33251715|NCT03068468|100820730|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
33251716|NCT03068468|100820731|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
33251717|NCT03068468|100820732|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
33251718|NCT03068468|100820729|FG000|Placebo-Controlled Period|Death|0|||
33251719|NCT03068468|100820730|FG001|Placebo-Controlled Period|Death|1|||
33251720|NCT03068468|100820731|FG002|Placebo-Controlled Period|Death|0|||
33251721|NCT03068468|100820732|FG003|Placebo-Controlled Period|Death|0|||
33251722|NCT03068468|100820729|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
33251723|NCT03068468|100820730|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
33251724|NCT03068468|100820731|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
33251725|NCT03068468|100820732|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
33251726|NCT03068468|100820729|FG000|Open-Label Extension Period|Adverse Event|0|||
33251727|NCT03068468|100820730|FG001|Open-Label Extension Period|Adverse Event|0|||
33251728|NCT03068468|100820731|FG002|Open-Label Extension Period|Adverse Event|13|||
33251729|NCT03068468|100820732|FG003|Open-Label Extension Period|Adverse Event|17|||
33251730|NCT03068468|100820729|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
33251731|NCT03068468|100820730|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
33251732|NCT03068468|100820731|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
33251733|NCT03068468|100820732|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
33251734|NCT03068468|100820729|FG000|Open-Label Extension Period|Death|0|||
33251735|NCT03068468|100820730|FG001|Open-Label Extension Period|Death|0|||
33251736|NCT03068468|100820731|FG002|Open-Label Extension Period|Death|0|||
33251737|NCT03068468|100820732|FG003|Open-Label Extension Period|Death|1|||
33251738|NCT03068468|100820729|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
33251739|NCT03068468|100820730|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
33251740|NCT03068468|100820731|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
33251741|NCT03068468|100820732|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
33251742|NCT03068468|100820729|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
33251743|NCT03068468|100820730|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
33251744|NCT03068468|100820731|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
33251745|NCT03068468|100820732|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
33251746|NCT03068468|100820729|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
33251747|NCT03068468|100820730|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
33251748|NCT03068468|100820731|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
33251749|NCT03068468|100820732|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
33251750|NCT03068468|100820729|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
33251751|NCT03068468|100820730|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
33251752|NCT03068468|100820731|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
33251753|NCT03068468|100820732|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
33251754|NCT03068468|100820729|FG000|Open-Label Extension Period|Reason not Specified|0|||
33251755|NCT03068468|100820730|FG001|Open-Label Extension Period|Reason not Specified|0|||
33251756|NCT03068468|100820731|FG002|Open-Label Extension Period|Reason not Specified|1|||
33251757|NCT03068468|100820732|FG003|Open-Label Extension Period|Reason not Specified|4|||
33251758|NCT00758602|100820738|FG000|Overall Study|Adverse Event|11|||
33251759|NCT00758602|100820739|FG001|Overall Study|Adverse Event|10|||
33251760|NCT00758602|100820738|FG000|Overall Study|Lost to Follow-up|4|||
33251761|NCT00758602|100820739|FG001|Overall Study|Lost to Follow-up|3|||
33251762|NCT00758602|100820738|FG000|Overall Study|Withdrawal by Subject|1|||
33251763|NCT00758602|100820739|FG001|Overall Study|Withdrawal by Subject|3|||
33387231|NCT01809197|101306291|FG000|Overall Study|Lost to Follow-up|4|||
33387232|NCT01809197|101306292|FG001|Overall Study|Lost to Follow-up|2|||
33387233|NCT01809197|101306291|FG000|Overall Study|Adverse Event|2|||
33387234|NCT01809197|101306292|FG001|Overall Study|Adverse Event|3|||
33387235|NCT01809197|101306291|FG000|Overall Study|Failed slit lamp exam|1|||
33387236|NCT01809197|101306292|FG001|Overall Study|Failed slit lamp exam|0|||
33387237|NCT01809197|101306291|FG000|Overall Study|Non-Compliance|1|||
33387238|NCT01809197|101306292|FG001|Overall Study|Non-Compliance|1|||
33387239|NCT01809197|101306291|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
33387240|NCT01809197|101306292|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
33387241|NCT01809197|101306291|FG000|Overall Study|Withdrawal by Subject|1|||
33387242|NCT01809197|101306292|FG001|Overall Study|Withdrawal by Subject|1|||
33251764|NCT00758602|100820738|FG000|Overall Study|Protocol Violation|0|||
33251765|NCT00758602|100820739|FG001|Overall Study|Protocol Violation|2|||
33251766|NCT00758602|100820738|FG000|Overall Study|Death|0|||
33251767|NCT00758602|100820739|FG001|Overall Study|Death|1|||
33251768|NCT00758602|100820738|FG000|Overall Study|Reason not specified|3|||
33251769|NCT00758602|100820739|FG001|Overall Study|Reason not specified|3|||
33251770|NCT01390402|100820742|FG000|Overall Study|Death|1|||
33251771|NCT01390402|100820742|FG000|Overall Study|Disease Progression|4|||
33387243|NCT01809197|101306291|FG000|Overall Study|Product not available|0|||
33387244|NCT01809197|101306292|FG001|Overall Study|Product not available|1|||
33387245|NCT00418717|101306293|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
33251772|NCT01460290|100820743|FG000|Overall Study|Adverse Event|3|||
33251773|NCT01460290|100820743|FG000|Overall Study|Elevated liver function|1|||
33251774|NCT02057692|100820744|FG000|Overall Study|Adverse Event|1|||
33251775|NCT02057692|100820745|FG001|Overall Study|Adverse Event|0|||
33251776|NCT02057692|100820746|FG002|Overall Study|Adverse Event|0|||
33251777|NCT02057692|100820747|FG003|Overall Study|Adverse Event|0|||
33251778|NCT02057692|100820744|FG000|Overall Study|Lost to Follow-up|0|||
33251779|NCT02057692|100820745|FG001|Overall Study|Lost to Follow-up|0|||
33251780|NCT02057692|100820746|FG002|Overall Study|Lost to Follow-up|0|||
33251781|NCT02057692|100820747|FG003|Overall Study|Lost to Follow-up|1|||
33251782|NCT02524288|100820750|FG000|Overall Study|Adverse Event|115|||
33251783|NCT02524288|100820750|FG000|Overall Study|Lost to Follow-up|216|||
33251784|NCT02524288|100820750|FG000|Overall Study|Non-Compliance With Protocol|32|||
33251785|NCT02524288|100820750|FG000|Overall Study|Non-Compliance With Study Drug|14|||
33251786|NCT02524288|100820750|FG000|Overall Study|Pregnancy Wish|6|||
33251787|NCT02524288|100820750|FG000|Overall Study|Protocol Violation|6|||
33251788|NCT02524288|100820750|FG000|Overall Study|Screen Failure|2|||
33251789|NCT02524288|100820750|FG000|Overall Study|Site Discontinued Study Participation|1|||
33251790|NCT02524288|100820750|FG000|Overall Study|Study Terminated By Sponsor|1417|||
33251791|NCT02524288|100820750|FG000|Overall Study|Subject Moved|32|||
33251792|NCT02524288|100820750|FG000|Overall Study|Withdrawal by Subject|76|||
33251793|NCT02524288|100820750|FG000|Overall Study|Pregnancy|22|||
33251794|NCT02524288|100820750|FG000|Overall Study|Physician Decision|2|||
33251795|NCT01713530|100820755|FG000|Overall Study|Adverse Event|0|||
33251796|NCT01713530|100820756|FG001|Overall Study|Adverse Event|5|||
33251797|NCT01713530|100820755|FG000|Overall Study|Withdrawal criteria|21|||
33251798|NCT01713530|100820756|FG001|Overall Study|Withdrawal criteria|12|||
33251799|NCT01713530|100820755|FG000|Overall Study|Unclassified|4|||
33251800|NCT01713530|100820756|FG001|Overall Study|Unclassified|2|||
33251801|NCT01157182|100820757|FG000|Washout of 28 Days|Adverse Event|2|||
33251802|NCT01157182|100820758|FG001|Washout of 28 Days|Adverse Event|0|||
33251803|NCT02248480|100820759|FG000|Overall Study|Lack of Efficacy|4|||
33251804|NCT02248480|100820760|FG001|Overall Study|Lack of Efficacy|6|||
33251805|NCT02248480|100820759|FG000|Overall Study|Adverse Event|11|||
33251806|NCT02248480|100820760|FG001|Overall Study|Adverse Event|2|||
33251807|NCT02248480|100820759|FG000|Overall Study|Withdrawal by Subject|2|||
33251808|NCT02248480|100820760|FG001|Overall Study|Withdrawal by Subject|4|||
33251809|NCT02248480|100820759|FG000|Overall Study|Entry Criteria Not Met|0|||
33251810|NCT02248480|100820760|FG001|Overall Study|Entry Criteria Not Met|1|||
33251811|NCT02248480|100820759|FG000|Overall Study|Other:Physician Decision|0|||
33251812|NCT02248480|100820760|FG001|Overall Study|Other:Physician Decision|1|||
33251813|NCT01144182|100820761|FG000|Overall Study|Death|5|||
33251814|NCT01144182|100820762|FG001|Overall Study|Death|6|||
33251815|NCT01144182|100820761|FG000|Overall Study|Withdrawal by Subject|3|||
33251816|NCT01144182|100820762|FG001|Overall Study|Withdrawal by Subject|6|||
33251817|NCT01144182|100820761|FG000|Overall Study|Lost to Follow-up|9|||
33251818|NCT01144182|100820762|FG001|Overall Study|Lost to Follow-up|9|||
33251819|NCT02873754|100820763|FG000|Overall Study|Lost to Follow-up|5|||
33251820|NCT02873754|100820763|FG000|Overall Study|Couldn't complete study procedures|1|||
33387246|NCT00418717|101306293|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
33387247|NCT02120352|101306294|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
33251821|NCT03278028|100820764|FG000|Overall Study|Lost to Follow-up|1|||
33251822|NCT03278028|100820765|FG001|Overall Study|Lost to Follow-up|0|||
33251823|NCT03278028|100820764|FG000|Overall Study|Withdrawal by Subject|3|||
33251824|NCT03278028|100820765|FG001|Overall Study|Withdrawal by Subject|1|||
33251825|NCT03278028|100820764|FG000|Overall Study|Pregnancy|0|||
33251826|NCT03278028|100820765|FG001|Overall Study|Pregnancy|1|||
33251827|NCT04678830|100820772|FG000|Overall Study|Lack of Efficacy|2|||
33251828|NCT04678830|100820773|FG001|Overall Study|Lack of Efficacy|0|||
33251829|NCT04678830|100820772|FG000|Overall Study|Withdrawal by Subject|0|||
33251830|NCT04678830|100820773|FG001|Overall Study|Withdrawal by Subject|1|||
33251831|NCT02736799|100820774|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
33251832|NCT02736799|100820775|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
33251833|NCT02736799|100820776|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
33251834|NCT02736799|100820777|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
33251835|NCT01810263|100820781|FG000|Overall Study|Lost to Follow-up|8|||
33251836|NCT01810263|100820782|FG001|Overall Study|Lost to Follow-up|7|||
33251837|NCT01786564|100820785|FG000|Overall Study|Lost to Follow-up|47|||
33251838|NCT01786564|100820785|FG000|Overall Study|Ineligible|17|||
33251839|NCT05179837|100820786|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
33251840|NCT05179837|100820786|FG000|Overall Study|Device malfunctioned|1|||
33251841|NCT05179837|100820786|FG000|Overall Study|Image quality too low|2|||
33251842|NCT01499134|100820787|FG000|Overall Study|Withdrawal by Subject|0|||
33251843|NCT01499134|100820788|FG001|Overall Study|Withdrawal by Subject|1|||
33251844|NCT02106442|100820789|FG000|Overall Study|Case Report Forms Uncollected|7|||
33251845|NCT02106442|100820789|FG000|Overall Study|Protocol Deviation|30|||
33437657|NCT01617668|101496046|FG000|Overall Study|Physician Decision|1|||
33437658|NCT01617668|101496047|FG001|Overall Study|Physician Decision|2|||
33437659|NCT01617668|101496048|FG002|Overall Study|Physician Decision|3|||
33437660|NCT01617668|101496049|FG003|Overall Study|Physician Decision|0|||
33437661|NCT01617668|101496046|FG000|Overall Study|Progressive Disease|4|||
33437662|NCT01617668|101496047|FG001|Overall Study|Progressive Disease|4|||
33437663|NCT01617668|101496048|FG002|Overall Study|Progressive Disease|6|||
33437664|NCT01617668|101496049|FG003|Overall Study|Progressive Disease|9|||
33437665|NCT01617668|101496046|FG000|Overall Study|Subject/guardian decision|1|||
33387248|NCT02120352|101306295|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
33387249|NCT02120352|101306296|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
33387250|NCT02120352|101306297|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
33387251|NCT02120352|101306298|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
33387252|NCT02120352|101306299|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
33387253|NCT02120352|101306300|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
33387254|NCT02120352|101306294|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
33387255|NCT02120352|101306295|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
33387256|NCT02120352|101306296|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
33387257|NCT02120352|101306297|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
33387258|NCT02120352|101306298|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
33387259|NCT02120352|101306299|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
33387260|NCT02120352|101306300|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
33387261|NCT02120352|101306294|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
33387262|NCT02120352|101306295|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
33387263|NCT02120352|101306296|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
33387264|NCT02120352|101306297|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
33387265|NCT02120352|101306298|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
33387266|NCT02120352|101306299|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
33387267|NCT02120352|101306300|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
33387268|NCT02120352|101306294|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
33387269|NCT02120352|101306295|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
33387270|NCT02120352|101306296|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
33387271|NCT02120352|101306297|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
33387272|NCT02120352|101306298|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
33387273|NCT02120352|101306299|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
33387274|NCT02120352|101306300|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
33387275|NCT02120352|101306294|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
33387276|NCT02120352|101306295|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
33387277|NCT02120352|101306296|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
33387278|NCT02120352|101306297|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
33387279|NCT02120352|101306298|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
33387280|NCT02120352|101306299|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
33387281|NCT02120352|101306300|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
33387282|NCT02120352|101306294|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
33437666|NCT01617668|101496047|FG001|Overall Study|Subject/guardian decision|3|||
33437667|NCT01617668|101496048|FG002|Overall Study|Subject/guardian decision|2|||
33387283|NCT02120352|101306295|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
33387284|NCT02120352|101306296|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
33387285|NCT02120352|101306297|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
33387286|NCT02120352|101306298|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
33387287|NCT02120352|101306299|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
33387288|NCT02120352|101306300|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
33387289|NCT02120352|101306294|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
33387290|NCT02120352|101306295|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
33387291|NCT02120352|101306296|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
33387292|NCT02120352|101306297|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
33387293|NCT02120352|101306298|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
33387294|NCT02120352|101306299|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
33387295|NCT02120352|101306300|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
33387296|NCT02120352|101306294|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
33387297|NCT02120352|101306295|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
33387298|NCT02120352|101306296|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
33387299|NCT02120352|101306297|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
33437668|NCT01617668|101496049|FG003|Overall Study|Subject/guardian decision|1|||
33437669|NCT03500692|101496055|FG000|Overall Study|Death|163|||
33437670|NCT03500692|101496055|FG000|Overall Study|Lost to Follow-up|75|||
33437671|NCT03500692|101496055|FG000|Overall Study|Termination Reasons|3|||
33437672|NCT01991470|101496056|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
33437673|NCT01991470|101496056|FG000|Enlite 1 Period|Adverse Event|1|||
33437674|NCT01991470|101496056|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
33437675|NCT01991470|101496056|FG000|Enlite 3 Period|Lost to Follow-up|1|||
33437676|NCT01991470|101496056|FG000|Enlite 3 Period|Physician Decision|2|||
33437677|NCT01991470|101496056|FG000|Enlite 3 Period|Physician Decision|8|||
33437678|NCT01991470|101496056|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
33437679|NCT01440283|101496065|FG000|Overall Study|Death|3|||
33437680|NCT01440283|101496065|FG000|Overall Study|Withdrawal by Subject|4|||
33437681|NCT01440283|101496065|FG000|Overall Study|Physician Decision|3|||
33437682|NCT00262600|101496066|FG000|Overall Study|Lost to Follow-up|17|||
33437683|NCT00262600|101496067|FG001|Overall Study|Lost to Follow-up|31|||
33437684|NCT00262600|101496068|FG002|Overall Study|Lost to Follow-up|41|||
33437685|NCT00262600|101496066|FG000|Overall Study|Withdrawal by Subject|128|||
33437686|NCT00262600|101496067|FG001|Overall Study|Withdrawal by Subject|145|||
33437687|NCT00262600|101496068|FG002|Overall Study|Withdrawal by Subject|139|||
33437688|NCT00262600|101496066|FG000|Overall Study|Not Treated|32|||
33437689|NCT00262600|101496067|FG001|Overall Study|Not Treated|17|||
33437690|NCT00262600|101496068|FG002|Overall Study|Not Treated|24|||
33437691|NCT00262600|101496066|FG000|Overall Study|Other|58|||
33437692|NCT00262600|101496067|FG001|Overall Study|Other|59|||
33437693|NCT00262600|101496068|FG002|Overall Study|Other|62|||
33387300|NCT02120352|101306298|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
33437694|NCT02166697|101496072|FG000|Overall Study|Protocol Violation|347|||
33437695|NCT03194464|101496075|FG000|Overall Study|data not usable|2|||
33437696|NCT01074554|101496080|FG000|Overall Study|Adverse Event|3|||
33437697|NCT01074554|101496081|FG001|Overall Study|Adverse Event|3|||
33437698|NCT01074554|101496080|FG000|Overall Study|Lost to Follow-up|0|||
33437699|NCT01074554|101496081|FG001|Overall Study|Lost to Follow-up|1|||
33437700|NCT00220337|101496084|FG000|Overall Study|Adverse Event|70|||
33437701|NCT00220337|101496084|FG000|Overall Study|Lack of Efficacy|17|||
33437702|NCT00220337|101496084|FG000|Overall Study|Withdrawal by Subject|68|||
33437703|NCT00220337|101496084|FG000|Overall Study|Protocol Violation|2|||
33437704|NCT00220337|101496084|FG000|Overall Study|Lost to Follow-up|5|||
33437705|NCT00220337|101496084|FG000|Overall Study|Other|12|||
33437706|NCT00220337|101496084|FG000|Overall Study|Unsatisfactory compliance|5|||
33437707|NCT01492361|101496085|FG000|Overall Study|Withdrawal by Subject|281|||
33437708|NCT01492361|101496086|FG001|Overall Study|Withdrawal by Subject|297|||
33437709|NCT01492361|101496085|FG000|Overall Study|Physician Decision|12|||
33437710|NCT01492361|101496086|FG001|Overall Study|Physician Decision|12|||
33437711|NCT01492361|101496085|FG000|Overall Study|Lost to Follow-up|6|||
33437712|NCT01492361|101496086|FG001|Overall Study|Lost to Follow-up|13|||
33437713|NCT01492361|101496085|FG000|Overall Study|Other than specified above|106|||
33437714|NCT01492361|101496086|FG001|Overall Study|Other than specified above|138|||
33437715|NCT00918567|101496087|FG000|Overall Study|Lack of Efficacy|3|||
33437716|NCT00918567|101496088|FG001|Overall Study|Lack of Efficacy|1|||
33437717|NCT00918567|101496087|FG000|Overall Study|Withdrawal by Subject|1|||
33437718|NCT00918567|101496088|FG001|Overall Study|Withdrawal by Subject|1|||
33437719|NCT00918567|101496087|FG000|Overall Study|Adverse Event|1|||
33437720|NCT00918567|101496088|FG001|Overall Study|Adverse Event|0|||
33437721|NCT01475838|101496089|FG000|Randomized Phase|Randomized but Not Treated|0|||
33437722|NCT01475838|101496090|FG001|Randomized Phase|Randomized but Not Treated|5|||
33437723|NCT01475838|101496089|FG000|Randomized Phase|Adverse Event|6|||
33437724|NCT01475838|101496090|FG001|Randomized Phase|Adverse Event|1|||
33437725|NCT01475838|101496089|FG000|Randomized Phase|Pregnancy|0|||
33437726|NCT01475838|101496090|FG001|Randomized Phase|Pregnancy|1|||
33437727|NCT01475838|101496089|FG000|Randomized Phase|Investigators Discretion|1|||
33437728|NCT01475838|101496090|FG001|Randomized Phase|Investigators Discretion|2|||
33437729|NCT01475838|101496089|FG000|Randomized Phase|Withdrew Consent|10|||
33437730|NCT01475838|101496090|FG001|Randomized Phase|Withdrew Consent|14|||
33437731|NCT01475838|101496089|FG000|Randomized Phase|Lost to Follow-up|3|||
33437732|NCT01475838|101496090|FG001|Randomized Phase|Lost to Follow-up|4|||
33437733|NCT01475838|101496089|FG000|Randomized Phase|Participant Noncompliance|1|||
33437734|NCT01475838|101496090|FG001|Randomized Phase|Participant Noncompliance|5|||
33437735|NCT01475838|101496089|FG000|Randomized Phase|Protocol Violation|9|||
33437736|NCT01475838|101496090|FG001|Randomized Phase|Protocol Violation|4|||
33437737|NCT01475838|101496089|FG000|Extension Phase|Participant Noncompliance|1|||
33437738|NCT01475838|101496090|FG001|Extension Phase|Participant Noncompliance|0|||
33437739|NCT02079532|101496091|FG000|Overall Study|Adverse Event|7|||
33437740|NCT02079532|101496091|FG000|Overall Study|Additional or changed therapy|2|||
33437741|NCT02079532|101496091|FG000|Overall Study|Lack of Efficacy|9|||
33437742|NCT02079532|101496091|FG000|Overall Study|Protocol Violation|3|||
33437743|NCT02079532|101496091|FG000|Overall Study|Withdrawal by Subject|1|||
33437744|NCT02079532|101496091|FG000|Overall Study|Administrative problems|1|||
33437745|NCT02079532|101496091|FG000|Overall Study|Inclusion into ReFIRST|3|||
33437746|NCT02079532|101496091|FG000|Overall Study|Other|3|||
33437747|NCT02016170|101496095|FG000|Overall Study|Adverse Event|1|||
33437748|NCT02016170|101496096|FG001|Overall Study|Adverse Event|1|||
33437749|NCT02016170|101496097|FG002|Overall Study|Adverse Event|0|||
33437750|NCT02016170|101496095|FG000|Overall Study|Protocol Violation|1|||
33437751|NCT02016170|101496096|FG001|Overall Study|Protocol Violation|0|||
33437752|NCT02016170|101496097|FG002|Overall Study|Protocol Violation|0|||
33437753|NCT03980483|101496098|FG000|Overall Study|Adverse Event|13|||
33437754|NCT03980483|101496099|FG001|Overall Study|Adverse Event|29|||
33437755|NCT03980483|101496100|FG002|Overall Study|Adverse Event|11|||
33437756|NCT03980483|101496101|FG003|Overall Study|Adverse Event|2|||
33437757|NCT03980483|101496102|FG004|Overall Study|Adverse Event|2|||
33437758|NCT03980483|101496103|FG005|Overall Study|Adverse Event|2|||
33437759|NCT03980483|101496098|FG000|Overall Study|Lack of Efficacy|7|||
33437760|NCT03980483|101496099|FG001|Overall Study|Lack of Efficacy|6|||
33251846|NCT01838200|100820790|FG000|Overall Study|Adverse Event|0|||
33437761|NCT03980483|101496100|FG002|Overall Study|Lack of Efficacy|0|||
33437762|NCT03980483|101496101|FG003|Overall Study|Lack of Efficacy|3|||
33437763|NCT03980483|101496102|FG004|Overall Study|Lack of Efficacy|1|||
33437764|NCT03980483|101496103|FG005|Overall Study|Lack of Efficacy|1|||
33437765|NCT03980483|101496098|FG000|Overall Study|Lost to Follow-up|2|||
33437766|NCT03980483|101496099|FG001|Overall Study|Lost to Follow-up|4|||
33437767|NCT03980483|101496100|FG002|Overall Study|Lost to Follow-up|2|||
33437768|NCT03980483|101496101|FG003|Overall Study|Lost to Follow-up|1|||
33437769|NCT03980483|101496102|FG004|Overall Study|Lost to Follow-up|2|||
33437770|NCT03980483|101496103|FG005|Overall Study|Lost to Follow-up|0|||
33437771|NCT03980483|101496098|FG000|Overall Study|Protocol Violation|4|||
33437772|NCT03980483|101496099|FG001|Overall Study|Protocol Violation|2|||
33437773|NCT03980483|101496100|FG002|Overall Study|Protocol Violation|1|||
33251847|NCT01838200|100820791|FG001|Overall Study|Adverse Event|2|||
33154257|NCT02935842|100479504|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
33154258|NCT02935842|100479505|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
33154259|NCT02935842|100479506|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
33154260|NCT02935842|100479503|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
33154261|NCT02935842|100479504|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
33154262|NCT02935842|100479505|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
33154263|NCT02935842|100479506|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
33154264|NCT02935842|100479503|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
33154265|NCT02935842|100479504|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
33154266|NCT02935842|100479505|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
33154267|NCT02935842|100479506|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
33154268|NCT02935842|100479503|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
33154269|NCT02935842|100479504|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
33154270|NCT02935842|100479505|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
33154271|NCT02935842|100479506|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
33154272|NCT00397215|100479509|FG000|Month 0 (Day 0)|Adverse Event|0|||
33154273|NCT00397215|100479510|FG001|Month 0 (Day 0)|Adverse Event|1|||
33154274|NCT00397215|100479511|FG002|Month 0 (Day 0)|Adverse Event|0|||
33154275|NCT00397215|100479512|FG003|Month 0 (Day 0)|Adverse Event|0|||
33154276|NCT00397215|100479509|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
33154277|NCT00397215|100479510|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
33154278|NCT00397215|100479511|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
33154279|NCT00397215|100479512|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
33154280|NCT00397215|100479509|FG000|Month 0 (Day 0)|Other|4|||
33154281|NCT00397215|100479510|FG001|Month 0 (Day 0)|Other|1|||
33154282|NCT00397215|100479511|FG002|Month 0 (Day 0)|Other|3|||
33154283|NCT00397215|100479512|FG003|Month 0 (Day 0)|Other|3|||
33154284|NCT00397215|100479509|FG000|Month 6 (Day 180)|Adverse Event|0|||
33154285|NCT00397215|100479510|FG001|Month 6 (Day 180)|Adverse Event|3|||
33154286|NCT00397215|100479511|FG002|Month 6 (Day 180)|Adverse Event|2|||
33154287|NCT00397215|100479512|FG003|Month 6 (Day 180)|Adverse Event|0|||
33154288|NCT00397215|100479509|FG000|Month 6 (Day 180)|Other|2|||
33154289|NCT00397215|100479510|FG001|Month 6 (Day 180)|Other|0|||
33154290|NCT00397215|100479511|FG002|Month 6 (Day 180)|Other|3|||
33154291|NCT00397215|100479512|FG003|Month 6 (Day 180)|Other|0|||
33154292|NCT01680965|100479517|FG000|Overall Study|Death|0|||
33154293|NCT01680965|100479518|FG001|Overall Study|Death|0|||
33154294|NCT01680965|100479519|FG002|Overall Study|Death|0|||
33154295|NCT01680965|100479520|FG003|Overall Study|Death|6|||
33154296|NCT02121522|100479523|FG000|Overall Study|Adverse Event|1|||
33154297|NCT00516074|100479524|FG000|Overall Study|Adverse Event|0|||
33154298|NCT00516074|100479525|FG001|Overall Study|Adverse Event|1|||
33154299|NCT00516074|100479524|FG000|Overall Study|Subject Decision|4|||
33154300|NCT00516074|100479525|FG001|Overall Study|Subject Decision|2|||
33154301|NCT00516074|100479524|FG000|Overall Study|Loss of Glucose Control|2|||
33154302|NCT00516074|100479525|FG001|Overall Study|Loss of Glucose Control|0|||
33154303|NCT02147184|100479526|FG000|Overall Study|Lost to Follow-up|28|||
33154304|NCT02147184|100479527|FG001|Overall Study|Lost to Follow-up|15|||
33154305|NCT02147184|100479526|FG000|Overall Study|Study Burden|11|||
33154306|NCT02147184|100479527|FG001|Overall Study|Study Burden|7|||
33154307|NCT02147184|100479526|FG000|Overall Study|Pregnancy|6|||
33251848|NCT01838200|100820790|FG000|Overall Study|Progressive disease|3|||
33251849|NCT01838200|100820791|FG001|Overall Study|Progressive disease|0|||
33387301|NCT02120352|101306299|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
33387302|NCT02120352|101306300|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
33387303|NCT02120352|101306294|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
33387304|NCT02120352|101306295|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
33387305|NCT02120352|101306296|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
33387306|NCT02120352|101306297|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
33387307|NCT02120352|101306298|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
33154308|NCT02147184|100479527|FG001|Overall Study|Pregnancy|0|||
33154309|NCT02147184|100479526|FG000|Overall Study|Moved out of state|3|||
33154310|NCT02147184|100479527|FG001|Overall Study|Moved out of state|3|||
33154311|NCT02147184|100479526|FG000|Overall Study|Physician Decision|0|||
33154312|NCT02147184|100479527|FG001|Overall Study|Physician Decision|2|||
33154313|NCT02147184|100479526|FG000|Overall Study|Other|1|||
33154314|NCT02147184|100479527|FG001|Overall Study|Other|0|||
33251850|NCT00517933|100820793|FG000|Period 1|Death|2|||
33154315|NCT04122534|100479528|FG000|Overall Study|Lost to Follow-up|4|||
33251851|NCT00517933|100820794|FG001|Period 1|Death|1|||
33251852|NCT00517933|100820793|FG000|Period 1|Adverse Event|4|||
33251853|NCT00517933|100820794|FG001|Period 1|Adverse Event|4|||
33251854|NCT00517933|100820793|FG000|Period 1|Lost to Follow-up|2|||
33251855|NCT00517933|100820794|FG001|Period 1|Lost to Follow-up|0|||
33251856|NCT00517933|100820793|FG000|Period 1|Underwent lung transplant|0|||
33251857|NCT00517933|100820794|FG001|Period 1|Underwent lung transplant|1|||
33251858|NCT00517933|100820793|FG000|Period 2|Death|2|||
33251859|NCT00517933|100820794|FG001|Period 2|Death|4|||
33251860|NCT00517933|100820793|FG000|Period 2|Adverse Event|2|||
33251861|NCT00517933|100820794|FG001|Period 2|Adverse Event|4|||
33251862|NCT00517933|100820793|FG000|Period 2|Physician Decision|1|||
33251863|NCT00517933|100820794|FG001|Period 2|Physician Decision|0|||
33437774|NCT03980483|101496101|FG003|Overall Study|Protocol Violation|1|||
33437775|NCT03980483|101496102|FG004|Overall Study|Protocol Violation|0|||
33437776|NCT03980483|101496103|FG005|Overall Study|Protocol Violation|0|||
33437777|NCT03980483|101496098|FG000|Overall Study|Physician Decision|14|||
33437778|NCT03980483|101496099|FG001|Overall Study|Physician Decision|10|||
33437779|NCT03980483|101496100|FG002|Overall Study|Physician Decision|7|||
33437780|NCT03980483|101496101|FG003|Overall Study|Physician Decision|4|||
33437781|NCT03980483|101496102|FG004|Overall Study|Physician Decision|4|||
33437782|NCT03980483|101496103|FG005|Overall Study|Physician Decision|2|||
33437783|NCT03980483|101496098|FG000|Overall Study|Withdrawal by Subject|38|||
33437784|NCT03980483|101496099|FG001|Overall Study|Withdrawal by Subject|21|||
33154316|NCT01268150|100479529|FG000|Treatment Phase|Progression of disease|18|||
33154317|NCT01268150|100479529|FG000|Treatment Phase|Adverse Event|3|||
33154318|NCT01268150|100479529|FG000|Treatment Phase|Withdrawal by Subject|3|||
33154319|NCT01268150|100479529|FG000|Treatment Phase|Other|4|||
33154320|NCT01268150|100479529|FG000|Extension Phase|Adverse Event|3|||
33154321|NCT01268150|100479529|FG000|Extension Phase|Disease progression|18|||
33154322|NCT01268150|100479529|FG000|Extension Phase|Other|6|||
33154323|NCT03061097|100479530|FG000|Overall Study|Withdrawal by Subject|0|||
33154324|NCT03061097|100479531|FG001|Overall Study|Withdrawal by Subject|3|||
33154325|NCT04439344|100479532|FG000|Overall Study|Never started threapy|3|||
33154326|NCT04439344|100479532|FG000|Overall Study|Ineligible|3|||
33154327|NCT04439344|100479532|FG000|Overall Study|Adverse Event|13|||
33154328|NCT04439344|100479532|FG000|Overall Study|Death|2|||
33154329|NCT04439344|100479532|FG000|Overall Study|Disease progression|29|||
33154330|NCT04439344|100479532|FG000|Overall Study|Withdrawal by Subject|2|||
33154331|NCT04439344|100479532|FG000|Overall Study|Alternative therapy|1|||
33154332|NCT01229371|100479534|FG000|Overall Study|Withdrawal by Subject|0|||
33154333|NCT01229371|100479535|FG001|Overall Study|Withdrawal by Subject|1|||
33154334|NCT01229371|100479536|FG002|Overall Study|Withdrawal by Subject|0|||
33154335|NCT01229371|100479537|FG003|Overall Study|Withdrawal by Subject|0|||
33154336|NCT01032174|100479538|FG000|Overall Study|Adverse Event|0|||
33154337|NCT01032174|100479539|FG001|Overall Study|Adverse Event|1|||
33154338|NCT02628938|100479547|FG000|Overall Study|Did not attend the follow up recall|2|||
33154339|NCT02628938|100479548|FG001|Overall Study|Did not attend the follow up recall|2|||
33154340|NCT02628938|100479549|FG002|Overall Study|Did not attend the follow up recall|1|||
33154341|NCT02628938|100479547|FG000|Overall Study|Failure to comply with the instructions|3|||
33154342|NCT02628938|100479548|FG001|Overall Study|Failure to comply with the instructions|0|||
33154343|NCT02628938|100479549|FG002|Overall Study|Failure to comply with the instructions|3|||
33154344|NCT03491215|100479554|FG000|Overall Study|Death|6|||
33154345|NCT03491215|100479555|FG001|Overall Study|Death|2|||
33154346|NCT03491215|100479556|FG002|Overall Study|Death|1|||
33154347|NCT03491215|100479557|FG003|Overall Study|Death|0|||
33154348|NCT03491215|100479554|FG000|Overall Study|Physician Decision|1|||
33154349|NCT03491215|100479555|FG001|Overall Study|Physician Decision|0|||
33154350|NCT03491215|100479556|FG002|Overall Study|Physician Decision|0|||
33154351|NCT03491215|100479557|FG003|Overall Study|Physician Decision|0|||
33154352|NCT00590135|100479558|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
33251864|NCT00517933|100820793|FG000|Period 2|Withdrawal by Subject|1|||
33437785|NCT03980483|101496100|FG002|Overall Study|Withdrawal by Subject|15|||
33437786|NCT03980483|101496101|FG003|Overall Study|Withdrawal by Subject|5|||
33437787|NCT03980483|101496102|FG004|Overall Study|Withdrawal by Subject|3|||
33437788|NCT03980483|101496103|FG005|Overall Study|Withdrawal by Subject|4|||
33437789|NCT03980483|101496098|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
33437790|NCT03980483|101496099|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
33437791|NCT03980483|101496100|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
33437792|NCT03980483|101496101|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
33154353|NCT03398200|100479559|FG000|Overall Study|Withdrawal by Subject|0|||
33154354|NCT03398200|100479560|FG001|Overall Study|Withdrawal by Subject|1|||
33154355|NCT02247531|100479561|FG000|Overall Study|Adverse Event|3|||
33154356|NCT02247531|100479562|FG001|Overall Study|Adverse Event|4|||
33154357|NCT02247531|100479563|FG002|Overall Study|Adverse Event|9|||
33154358|NCT02247531|100479561|FG000|Overall Study|Death|8|||
33154359|NCT02247531|100479562|FG001|Overall Study|Death|9|||
33251865|NCT00517933|100820794|FG001|Period 2|Withdrawal by Subject|3|||
33251866|NCT00517933|100820793|FG000|Period 2|Underwent lung transplant|0|||
33251867|NCT00517933|100820794|FG001|Period 2|Underwent lung transplant|2|||
33251868|NCT00811057|100820797|FG000|Overall Study|Protocol Violation|5|||
33251869|NCT00811057|100820798|FG001|Overall Study|Protocol Violation|10|||
33251870|NCT00811057|100820799|FG002|Overall Study|Protocol Violation|10|||
33251871|NCT03394027|100820807|FG000|Overall Study|Ineligible|3|||
33251872|NCT03394027|100820808|FG001|Overall Study|Ineligible|1|||
33251873|NCT03394027|100820809|FG002|Overall Study|Ineligible|3|||
33251874|NCT03394027|100820807|FG000|Overall Study|Participant declined to participate before treatment started|0|||
33251875|NCT03394027|100820808|FG001|Overall Study|Participant declined to participate before treatment started|0|||
33251876|NCT03394027|100820809|FG002|Overall Study|Participant declined to participate before treatment started|1|||
33251877|NCT01596504|100820817|FG000|Overall Study|Participant's Private Reason|0|||
33251878|NCT01596504|100820818|FG001|Overall Study|Participant's Private Reason|1|||
33251879|NCT01596504|100820819|FG002|Overall Study|Participant's Private Reason|0|||
33251880|NCT01596504|100820817|FG000|Overall Study|Adverse Event|1|||
33251881|NCT01596504|100820818|FG001|Overall Study|Adverse Event|2|||
33251882|NCT01596504|100820819|FG002|Overall Study|Adverse Event|1|||
33251883|NCT01596504|100820817|FG000|Overall Study|Withdrawal by Subject|1|||
33251884|NCT01596504|100820818|FG001|Overall Study|Withdrawal by Subject|0|||
33251885|NCT01596504|100820819|FG002|Overall Study|Withdrawal by Subject|0|||
33251886|NCT02371746|100820822|FG000|Overall Study|Consent withdrawn|0|||
33251887|NCT02371746|100820823|FG001|Overall Study|Consent withdrawn|0|||
33251888|NCT02371746|100820824|FG002|Overall Study|Consent withdrawn|0|||
33251889|NCT02371746|100820825|FG003|Overall Study|Consent withdrawn|0|||
33251890|NCT02371746|100820826|FG004|Overall Study|Consent withdrawn|0|||
33251891|NCT02371746|100820827|FG005|Overall Study|Consent withdrawn|0|||
33251892|NCT02371746|100820828|FG006|Overall Study|Consent withdrawn|1|||
33251893|NCT04842604|100820829|FG000|Overall Study|Death|1|||
33251894|NCT04842604|100820830|FG001|Overall Study|Death|0|||
33251895|NCT04842604|100820829|FG000|Overall Study|Other|4|||
33251896|NCT04842604|100820830|FG001|Overall Study|Other|4|||
33251897|NCT04842604|100820829|FG000|Overall Study|Randomized but not treated|1|||
33251898|NCT04842604|100820830|FG001|Overall Study|Randomized but not treated|0|||
33251899|NCT01768676|100820831|FG000|Overall Study|Adverse Event|3|||
33251900|NCT01768676|100820832|FG001|Overall Study|Adverse Event|3|||
33251901|NCT01768676|100820831|FG000|Overall Study|Lost to Follow-up|13|||
33251902|NCT01768676|100820832|FG001|Overall Study|Lost to Follow-up|16|||
33251903|NCT01768676|100820831|FG000|Overall Study|Protocol Violation|1|||
33251904|NCT01768676|100820832|FG001|Overall Study|Protocol Violation|1|||
33251905|NCT01768676|100820831|FG000|Overall Study|Physician Decision|4|||
33154360|NCT02247531|100479563|FG002|Overall Study|Death|5|||
33251906|NCT01768676|100820832|FG001|Overall Study|Physician Decision|1|||
33251907|NCT01768676|100820831|FG000|Overall Study|Withdrawal by Subject|3|||
33251908|NCT01768676|100820832|FG001|Overall Study|Withdrawal by Subject|10|||
33251909|NCT04379713|100820833|FG000|Overall Study|Adverse Event|2|||
33251910|NCT04379713|100820834|FG001|Overall Study|Adverse Event|0|||
33154361|NCT02247531|100479561|FG000|Overall Study|Lost to Follow-up|1|||
33251911|NCT04379713|100820833|FG000|Overall Study|Physician Decision|2|||
33251912|NCT04379713|100820834|FG001|Overall Study|Physician Decision|1|||
33251913|NCT04379713|100820833|FG000|Overall Study|Protocol Violation|11|||
33251914|NCT04379713|100820834|FG001|Overall Study|Protocol Violation|6|||
33251915|NCT04379713|100820833|FG000|Overall Study|No longer met eligibility criteria|14|||
33251916|NCT04379713|100820834|FG001|Overall Study|No longer met eligibility criteria|11|||
33437793|NCT03980483|101496102|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
33251917|NCT04379713|100820833|FG000|Overall Study|Withdrawal by parent/guardian|36|||
33251918|NCT04379713|100820834|FG001|Overall Study|Withdrawal by parent/guardian|15|||
33251919|NCT04379713|100820833|FG000|Overall Study|Lost to Follow-up|31|||
33251920|NCT04379713|100820834|FG001|Overall Study|Lost to Follow-up|21|||
33251921|NCT00770965|100820835|FG000|Safety Set|Withdrawal by Subject|0|||
33154362|NCT02247531|100479562|FG001|Overall Study|Lost to Follow-up|8|||
33251922|NCT00770965|100820836|FG001|Safety Set|Withdrawal by Subject|0|||
33251923|NCT00770965|100820837|FG002|Safety Set|Withdrawal by Subject|0|||
33251924|NCT00770965|100820838|FG003|Safety Set|Withdrawal by Subject|1|||
33251925|NCT00770965|100820835|FG000|Safety Set|Protocol deviation|0|||
33251926|NCT00770965|100820836|FG001|Safety Set|Protocol deviation|0|||
33251927|NCT00770965|100820837|FG002|Safety Set|Protocol deviation|1|||
33251928|NCT00770965|100820838|FG003|Safety Set|Protocol deviation|0|||
33251929|NCT00770965|100820835|FG000|Excluded Set|Administrative problems|14|||
33251930|NCT00770965|100820836|FG001|Excluded Set|Administrative problems|12|||
33251931|NCT00770965|100820837|FG002|Excluded Set|Administrative problems|12|||
33251932|NCT00770965|100820838|FG003|Excluded Set|Administrative problems|10|||
33251933|NCT00770965|100820835|FG000|Excluded Set|Withdrawal by Subject|1|||
33251934|NCT00770965|100820836|FG001|Excluded Set|Withdrawal by Subject|1|||
33251935|NCT00770965|100820837|FG002|Excluded Set|Withdrawal by Subject|2|||
33251936|NCT00770965|100820838|FG003|Excluded Set|Withdrawal by Subject|3|||
33251937|NCT01537133|100820839|FG000|Overall Study|Withdrawal by Subject|2|||
33154363|NCT02247531|100479563|FG002|Overall Study|Lost to Follow-up|3|||
33154364|NCT02247531|100479561|FG000|Overall Study|Non-compliance|2|||
33154365|NCT02247531|100479562|FG001|Overall Study|Non-compliance|2|||
33387308|NCT02120352|101306299|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
33387309|NCT02120352|101306300|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
33387310|NCT02120352|101306294|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
33387311|NCT02120352|101306295|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
33154366|NCT02247531|100479563|FG002|Overall Study|Non-compliance|0|||
33154367|NCT02247531|100479561|FG000|Overall Study|Withdrawal by Subject|26|||
33154368|NCT02247531|100479562|FG001|Overall Study|Withdrawal by Subject|31|||
33154369|NCT02247531|100479563|FG002|Overall Study|Withdrawal by Subject|25|||
33154370|NCT02247531|100479561|FG000|Overall Study|Study Terminated by Sponsor|64|||
33154371|NCT02247531|100479562|FG001|Overall Study|Study Terminated by Sponsor|66|||
33154372|NCT02247531|100479563|FG002|Overall Study|Study Terminated by Sponsor|62|||
33154373|NCT02247531|100479561|FG000|Overall Study|Physician Decision|0|||
33154374|NCT02247531|100479562|FG001|Overall Study|Physician Decision|2|||
33154375|NCT02247531|100479563|FG002|Overall Study|Physician Decision|2|||
33154376|NCT02247531|100479561|FG000|Overall Study|Unspecified Reason|2|||
33154377|NCT02247531|100479562|FG001|Overall Study|Unspecified Reason|3|||
33154378|NCT02247531|100479563|FG002|Overall Study|Unspecified Reason|4|||
33154379|NCT00398411|100479568|FG000|Overall Study|Death|0|||
33154380|NCT00398411|100479569|FG001|Overall Study|Death|1|||
33154381|NCT00721123|100479570|FG000|Overall Study|Adverse Event|96|||
33154382|NCT00721123|100479570|FG000|Overall Study|Death|10|||
33154383|NCT00721123|100479570|FG000|Overall Study|Insufficient Therapeutic Response|21|||
33154384|NCT00721123|100479570|FG000|Overall Study|Protocol Violation|1|||
33154385|NCT00721123|100479570|FG000|Overall Study|Refused Treatment|41|||
33154386|NCT00721123|100479570|FG000|Overall Study|Failure to Return|9|||
33154387|NCT00721123|100479570|FG000|Overall Study|Withdrawal by Subject|5|||
33154388|NCT04879225|100479571|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
33154389|NCT04879225|100479571|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
33154390|NCT03643159|100479572|FG000|Overall Study|Adverse Event|1|||
33154391|NCT03643159|100479572|FG000|Overall Study|Withdrawal by Subject|1|||
33154392|NCT04327674|100479573|FG000|Overall Study|Protocol Violation|19|||
33154393|NCT01092507|100479575|FG000|Overall Study|Withdrawal by Subject|2|||
33154394|NCT01092507|100479576|FG001|Overall Study|Withdrawal by Subject|0|||
33154395|NCT00347360|100479577|FG000|Overall Study|Adverse Event|1|||
33154396|NCT00347360|100479578|FG001|Overall Study|Adverse Event|2|||
33154397|NCT00347360|100479579|FG002|Overall Study|Adverse Event|0|||
33154398|NCT00347360|100479580|FG003|Overall Study|Adverse Event|4|||
33154399|NCT00347360|100479581|FG004|Overall Study|Adverse Event|1|||
33154400|NCT00347360|100479582|FG005|Overall Study|Adverse Event|2|||
33154401|NCT00347360|100479583|FG006|Overall Study|Adverse Event|2|||
33154402|NCT00347360|100479584|FG007|Overall Study|Adverse Event|0|||
33154403|NCT00347360|100479585|FG008|Overall Study|Adverse Event|2|||
33154404|NCT00347360|100479586|FG009|Overall Study|Adverse Event|3|||
33154405|NCT00347360|100479587|FG010|Overall Study|Adverse Event|3|||
33154406|NCT00347360|100479588|FG011|Overall Study|Adverse Event|1|||
33154407|NCT00347360|100479589|FG012|Overall Study|Adverse Event|3|||
33154408|NCT00347360|100479590|FG013|Overall Study|Adverse Event|2|||
33154409|NCT00347360|100479591|FG014|Overall Study|Adverse Event|2|||
33154410|NCT00347360|100479577|FG000|Overall Study|Lost to Follow-up|0|||
33154411|NCT00347360|100479578|FG001|Overall Study|Lost to Follow-up|0|||
33154412|NCT00347360|100479579|FG002|Overall Study|Lost to Follow-up|0|||
33154413|NCT00347360|100479580|FG003|Overall Study|Lost to Follow-up|2|||
33251938|NCT01537133|100820840|FG001|Overall Study|Withdrawal by Subject|0|||
33251939|NCT01537133|100820841|FG002|Overall Study|Withdrawal by Subject|0|||
33251940|NCT01537133|100820842|FG003|Overall Study|Withdrawal by Subject|0|||
33251941|NCT01537133|100820839|FG000|Overall Study|Lost to Follow-up|1|||
33251942|NCT01537133|100820840|FG001|Overall Study|Lost to Follow-up|0|||
33251943|NCT01537133|100820841|FG002|Overall Study|Lost to Follow-up|0|||
33251944|NCT01537133|100820842|FG003|Overall Study|Lost to Follow-up|0|||
33251945|NCT01194154|100820844|FG000|Overall Study|Adverse Event|12|||
33251946|NCT01194154|100820845|FG001|Overall Study|Adverse Event|7|||
33251947|NCT01194154|100820844|FG000|Overall Study|Lost to Follow-up|2|||
33251948|NCT01194154|100820845|FG001|Overall Study|Lost to Follow-up|3|||
33251949|NCT01194154|100820844|FG000|Overall Study|Protocol Violation|0|||
33251950|NCT01194154|100820845|FG001|Overall Study|Protocol Violation|1|||
33251951|NCT01194154|100820844|FG000|Overall Study|Withdrawal by Subject|5|||
33251952|NCT01194154|100820845|FG001|Overall Study|Withdrawal by Subject|6|||
33251953|NCT01194154|100820844|FG000|Overall Study|Blood pressure increase|5|||
33251954|NCT01194154|100820845|FG001|Overall Study|Blood pressure increase|3|||
33251955|NCT01194154|100820844|FG000|Overall Study|Hemoglobin decrease|0|||
33251956|NCT01194154|100820845|FG001|Overall Study|Hemoglobin decrease|1|||
33251957|NCT01194154|100820844|FG000|Overall Study|Hemoglobin increase|12|||
33251958|NCT01194154|100820845|FG001|Overall Study|Hemoglobin increase|3|||
33251959|NCT01194154|100820844|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
33251960|NCT01194154|100820845|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
33251961|NCT01194154|100820844|FG000|Overall Study|Treatment with prohibited medication|4|||
33251962|NCT01194154|100820845|FG001|Overall Study|Treatment with prohibited medication|5|||
33251963|NCT01194154|100820844|FG000|Overall Study|Other|4|||
33251964|NCT01194154|100820845|FG001|Overall Study|Other|0|||
33251965|NCT01194154|100820844|FG000|Overall Study|Did not receive study medication|2|||
33251966|NCT01194154|100820845|FG001|Overall Study|Did not receive study medication|4|||
33251967|NCT01595321|100820854|FG000|Overall Study|Adverse Event|1|||
33251968|NCT01595321|100820855|FG001|Overall Study|Adverse Event|1|||
33251969|NCT01595321|100820856|FG002|Overall Study|Adverse Event|1|||
33251970|NCT01595321|100820854|FG000|Overall Study|Lack of Efficacy|0|||
33251971|NCT01595321|100820855|FG001|Overall Study|Lack of Efficacy|0|||
33154414|NCT00347360|100479581|FG004|Overall Study|Lost to Follow-up|1|||
33251972|NCT01595321|100820856|FG002|Overall Study|Lack of Efficacy|4|||
33251973|NCT00436644|100820859|FG000|Overall Study|Adverse Event|2|||
33251974|NCT00436644|100820859|FG000|Overall Study|Death|1|||
33251975|NCT03058991|100823520|FG000|Overall Study|Lost to Follow-up|17|||
33251976|NCT03058991|100823521|FG001|Overall Study|Lost to Follow-up|12|||
33251977|NCT03058991|100823522|FG002|Overall Study|Lost to Follow-up|12|||
33251978|NCT03058991|100823520|FG000|Overall Study|Withdrawal by Subject|1|||
33251979|NCT03058991|100823521|FG001|Overall Study|Withdrawal by Subject|0|||
33251980|NCT03058991|100823522|FG002|Overall Study|Withdrawal by Subject|0|||
33251981|NCT00547118|100823525|FG000|Overall Study|Did not qualify prior to starting drug|1|||
33251982|NCT00547118|100823526|FG001|Overall Study|Did not qualify prior to starting drug|1|||
33251983|NCT00547118|100823525|FG000|Overall Study|Study suspended|7|||
33251984|NCT00547118|100823526|FG001|Overall Study|Study suspended|8|||
33251985|NCT00814346|100823531|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
33251986|NCT00814346|100823532|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
33251987|NCT00814346|100823531|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
33251988|NCT00814346|100823532|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
33154415|NCT00347360|100479582|FG005|Overall Study|Lost to Follow-up|1|||
33154416|NCT00347360|100479583|FG006|Overall Study|Lost to Follow-up|0|||
33437794|NCT03980483|101496103|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
33437795|NCT03980483|101496098|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
33437796|NCT03980483|101496099|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
33437797|NCT03980483|101496100|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
33437798|NCT03980483|101496101|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
33437799|NCT03980483|101496102|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
33437800|NCT03980483|101496103|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
33437801|NCT03980483|101496098|FG000|Overall Study|Other|0|||
33437802|NCT03980483|101496099|FG001|Overall Study|Other|1|||
33437803|NCT03980483|101496100|FG002|Overall Study|Other|0|||
33437804|NCT03980483|101496101|FG003|Overall Study|Other|0|||
33437805|NCT03980483|101496102|FG004|Overall Study|Other|0|||
33437806|NCT03980483|101496103|FG005|Overall Study|Other|0|||
33437807|NCT01545076|101496109|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
33437808|NCT01545076|101496110|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
33437809|NCT01545076|101496111|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
33437810|NCT01545076|101496112|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
33437811|NCT01545076|101496113|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
33437812|NCT01545076|101496109|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
33437813|NCT01545076|101496110|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
33437814|NCT01545076|101496111|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
33437815|NCT01545076|101496112|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
33437816|NCT01545076|101496113|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
33437817|NCT01545076|101496109|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
33437818|NCT01545076|101496110|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
33437819|NCT01545076|101496111|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
33437820|NCT01545076|101496112|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
33437821|NCT01545076|101496113|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
33437822|NCT01545076|101496109|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
33437823|NCT01545076|101496110|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
33437824|NCT01545076|101496111|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
33437825|NCT01545076|101496112|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
33437826|NCT01545076|101496113|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
33437827|NCT01545076|101496109|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
33437828|NCT01545076|101496110|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
33437829|NCT01545076|101496111|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
33437830|NCT01545076|101496112|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
33437831|NCT01545076|101496113|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
33437832|NCT01545076|101496109|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
33437833|NCT01545076|101496110|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
33437834|NCT01545076|101496111|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
33437835|NCT01545076|101496112|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
33437836|NCT01545076|101496113|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
33437837|NCT01545076|101496109|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
33437838|NCT01545076|101496110|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
33437839|NCT01545076|101496111|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
33437840|NCT01545076|101496112|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
33437841|NCT01545076|101496113|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
33154417|NCT00347360|100479584|FG007|Overall Study|Lost to Follow-up|1|||
33437842|NCT01545076|101496109|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
33437843|NCT01545076|101496110|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
33437844|NCT01545076|101496111|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
33154418|NCT00347360|100479585|FG008|Overall Study|Lost to Follow-up|1|||
33154419|NCT00347360|100479586|FG009|Overall Study|Lost to Follow-up|2|||
33154420|NCT00347360|100479587|FG010|Overall Study|Lost to Follow-up|0|||
33154421|NCT00347360|100479588|FG011|Overall Study|Lost to Follow-up|0|||
33154422|NCT00347360|100479589|FG012|Overall Study|Lost to Follow-up|1|||
33154423|NCT00347360|100479590|FG013|Overall Study|Lost to Follow-up|0|||
33154424|NCT00347360|100479591|FG014|Overall Study|Lost to Follow-up|0|||
33154425|NCT00347360|100479577|FG000|Overall Study|Protocol Violation|2|||
33154426|NCT00347360|100479578|FG001|Overall Study|Protocol Violation|3|||
33154427|NCT00347360|100479579|FG002|Overall Study|Protocol Violation|1|||
33154428|NCT00347360|100479580|FG003|Overall Study|Protocol Violation|2|||
33154429|NCT00347360|100479581|FG004|Overall Study|Protocol Violation|1|||
33437845|NCT01545076|101496112|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
33437846|NCT01545076|101496113|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
33437847|NCT01545076|101496109|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
33437848|NCT01545076|101496110|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
33437849|NCT01545076|101496111|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
33437850|NCT01545076|101496112|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
33437851|NCT01545076|101496113|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
33437852|NCT01439165|101496118|FG000|Overall Study|Protocol Violation|3|||
33437853|NCT01439165|101496119|FG001|Overall Study|Protocol Violation|0|||
33437854|NCT01439165|101496118|FG000|Overall Study|Lost to Follow-up|11|||
33437855|NCT01439165|101496119|FG001|Overall Study|Lost to Follow-up|1|||
33437856|NCT01439165|101496118|FG000|Overall Study|Withdrawal by Subject|7|||
33437857|NCT01439165|101496119|FG001|Overall Study|Withdrawal by Subject|1|||
33437858|NCT02146430|101496120|FG000|Overall Study|Protocol Violation|5|||
33437859|NCT02146430|101496121|FG001|Overall Study|Protocol Violation|4|||
33437860|NCT02146430|101496122|FG002|Overall Study|Protocol Violation|8|||
33437861|NCT02146430|101496123|FG003|Overall Study|Protocol Violation|6|||
33154430|NCT00347360|100479582|FG005|Overall Study|Protocol Violation|2|||
33154431|NCT00347360|100479583|FG006|Overall Study|Protocol Violation|0|||
33154432|NCT00347360|100479584|FG007|Overall Study|Protocol Violation|0|||
33154433|NCT00347360|100479585|FG008|Overall Study|Protocol Violation|1|||
33154434|NCT00347360|100479586|FG009|Overall Study|Protocol Violation|2|||
33154435|NCT00347360|100479587|FG010|Overall Study|Protocol Violation|0|||
33154436|NCT00347360|100479588|FG011|Overall Study|Protocol Violation|0|||
33154437|NCT00347360|100479589|FG012|Overall Study|Protocol Violation|0|||
33154438|NCT00347360|100479590|FG013|Overall Study|Protocol Violation|1|||
33154439|NCT00347360|100479591|FG014|Overall Study|Protocol Violation|0|||
33154440|NCT00347360|100479577|FG000|Overall Study|Withdrawal by Subject|0|||
33154441|NCT00347360|100479578|FG001|Overall Study|Withdrawal by Subject|1|||
33154442|NCT00347360|100479579|FG002|Overall Study|Withdrawal by Subject|2|||
33154443|NCT00347360|100479580|FG003|Overall Study|Withdrawal by Subject|4|||
33154444|NCT00347360|100479581|FG004|Overall Study|Withdrawal by Subject|1|||
33154445|NCT00347360|100479582|FG005|Overall Study|Withdrawal by Subject|2|||
33154446|NCT00347360|100479583|FG006|Overall Study|Withdrawal by Subject|1|||
33154447|NCT00347360|100479584|FG007|Overall Study|Withdrawal by Subject|1|||
33154448|NCT00347360|100479585|FG008|Overall Study|Withdrawal by Subject|1|||
33154449|NCT00347360|100479586|FG009|Overall Study|Withdrawal by Subject|1|||
33154450|NCT00347360|100479587|FG010|Overall Study|Withdrawal by Subject|0|||
33154451|NCT00347360|100479588|FG011|Overall Study|Withdrawal by Subject|3|||
33154452|NCT00347360|100479589|FG012|Overall Study|Withdrawal by Subject|4|||
33154453|NCT00347360|100479590|FG013|Overall Study|Withdrawal by Subject|2|||
33154454|NCT00347360|100479591|FG014|Overall Study|Withdrawal by Subject|1|||
33154455|NCT00347360|100479577|FG000|Overall Study|Lack of Efficacy|1|||
33154456|NCT00347360|100479578|FG001|Overall Study|Lack of Efficacy|1|||
33154457|NCT00347360|100479579|FG002|Overall Study|Lack of Efficacy|3|||
33437862|NCT02146430|101496120|FG000|Overall Study|Lack of Efficacy|13|||
33437863|NCT02146430|101496121|FG001|Overall Study|Lack of Efficacy|11|||
33154458|NCT00347360|100479580|FG003|Overall Study|Lack of Efficacy|1|||
33154459|NCT00347360|100479581|FG004|Overall Study|Lack of Efficacy|0|||
33154460|NCT00347360|100479582|FG005|Overall Study|Lack of Efficacy|1|||
33154461|NCT00347360|100479583|FG006|Overall Study|Lack of Efficacy|0|||
33154462|NCT00347360|100479584|FG007|Overall Study|Lack of Efficacy|1|||
33154463|NCT00347360|100479585|FG008|Overall Study|Lack of Efficacy|1|||
33154464|NCT00347360|100479586|FG009|Overall Study|Lack of Efficacy|0|||
33437864|NCT02146430|101496122|FG002|Overall Study|Lack of Efficacy|8|||
33154465|NCT00347360|100479587|FG010|Overall Study|Lack of Efficacy|0|||
33154466|NCT00347360|100479588|FG011|Overall Study|Lack of Efficacy|0|||
33154467|NCT00347360|100479589|FG012|Overall Study|Lack of Efficacy|0|||
33154468|NCT00347360|100479590|FG013|Overall Study|Lack of Efficacy|0|||
33154469|NCT00347360|100479591|FG014|Overall Study|Lack of Efficacy|0|||
33154470|NCT00347360|100479577|FG000|Overall Study|Reason not listed/blank|1|||
33437865|NCT02146430|101496123|FG003|Overall Study|Lack of Efficacy|5|||
33437866|NCT02146430|101496120|FG000|Overall Study|Adverse Event|20|||
33437867|NCT02146430|101496121|FG001|Overall Study|Adverse Event|40|||
33437868|NCT02146430|101496122|FG002|Overall Study|Adverse Event|32|||
33437869|NCT02146430|101496123|FG003|Overall Study|Adverse Event|49|||
33437870|NCT02146430|101496120|FG000|Overall Study|Reason missing or not reported|2|||
33437871|NCT02146430|101496121|FG001|Overall Study|Reason missing or not reported|3|||
33437872|NCT02146430|101496122|FG002|Overall Study|Reason missing or not reported|4|||
33437873|NCT02146430|101496123|FG003|Overall Study|Reason missing or not reported|5|||
33437874|NCT02146430|101496120|FG000|Overall Study|Withdrawal by Subject|27|||
33437875|NCT02146430|101496121|FG001|Overall Study|Withdrawal by Subject|29|||
33437876|NCT02146430|101496122|FG002|Overall Study|Withdrawal by Subject|30|||
33437877|NCT02146430|101496123|FG003|Overall Study|Withdrawal by Subject|34|||
33437878|NCT02365207|101496127|FG000|Overall Study|Withdrawal by Subject|1|||
33437879|NCT02365207|101496127|FG000|Overall Study|Physician Decision|1|||
33437880|NCT04652453|101496128|FG000|Overall Study|Death|8|||
33437881|NCT04652453|101496129|FG001|Overall Study|Death|2|||
33437882|NCT04652453|101496130|FG002|Overall Study|Death|0|||
33437883|NCT04652453|101496128|FG000|Overall Study|Hospice|5|||
33437884|NCT04652453|101496129|FG001|Overall Study|Hospice|5|||
33437885|NCT04652453|101496130|FG002|Overall Study|Hospice|0|||
33437886|NCT04652453|101496128|FG000|Overall Study|Withdrawal by Subject|2|||
33437887|NCT04652453|101496129|FG001|Overall Study|Withdrawal by Subject|0|||
33437888|NCT04652453|101496130|FG002|Overall Study|Withdrawal by Subject|0|||
33437889|NCT00313703|101496131|FG000|Overall Study|Lost to Follow-up|11|||
33437890|NCT00313703|101496132|FG001|Overall Study|Lost to Follow-up|2|||
33437891|NCT00313703|101496133|FG002|Overall Study|Lost to Follow-up|5|||
33437892|NCT00313703|101496134|FG003|Overall Study|Lost to Follow-up|12|||
33437893|NCT03805438|101496135|FG000|Overall Study|Lack of Efficacy|1|||
33437894|NCT03805438|101496135|FG000|Overall Study|Protocol Violation|1|||
33437895|NCT03527745|101496141|FG000|Overall Study|Lost to Follow-up|3|||
33437896|NCT03527745|101496142|FG001|Overall Study|Lost to Follow-up|6|||
33437897|NCT03527745|101496143|FG002|Overall Study|Lost to Follow-up|7|||
33437898|NCT03527745|101496144|FG003|Overall Study|Lost to Follow-up|9|||
33437899|NCT03527745|101496145|FG004|Overall Study|Lost to Follow-up|0|||
33437900|NCT03527745|101496146|FG005|Overall Study|Lost to Follow-up|2|||
33437901|NCT03527745|101496147|FG006|Overall Study|Lost to Follow-up|3|||
33437902|NCT03527745|101496148|FG007|Overall Study|Lost to Follow-up|2|||
33437903|NCT03527745|101496149|FG008|Overall Study|Lost to Follow-up|3|||
33437904|NCT03527745|101496150|FG009|Overall Study|Lost to Follow-up|2|||
33437905|NCT03527745|101496151|FG010|Overall Study|Lost to Follow-up|1|||
33437906|NCT03527745|101496152|FG011|Overall Study|Lost to Follow-up|1|||
33437907|NCT03527745|101496153|FG012|Overall Study|Lost to Follow-up|0|||
33437908|NCT03527745|101496154|FG013|Overall Study|Lost to Follow-up|0|||
33437909|NCT03527745|101496155|FG014|Overall Study|Lost to Follow-up|0|||
33437910|NCT03527745|101496156|FG015|Overall Study|Lost to Follow-up|0|||
33437911|NCT03527745|101496157|FG016|Overall Study|Lost to Follow-up|1|||
33437912|NCT03527745|101496158|FG017|Overall Study|Lost to Follow-up|0|||
33437913|NCT03527745|101496159|FG018|Overall Study|Lost to Follow-up|0|||
33437914|NCT03527745|101496160|FG019|Overall Study|Lost to Follow-up|1|||
33154471|NCT00347360|100479578|FG001|Overall Study|Reason not listed/blank|0|||
33154472|NCT00347360|100479579|FG002|Overall Study|Reason not listed/blank|0|||
33437915|NCT03527745|101496161|FG020|Overall Study|Lost to Follow-up|1|||
33437916|NCT03527745|101496162|FG021|Overall Study|Lost to Follow-up|5|||
33437917|NCT03527745|101496163|FG022|Overall Study|Lost to Follow-up|6|||
33437918|NCT03527745|101496164|FG023|Overall Study|Lost to Follow-up|8|||
33437919|NCT03527745|101496165|FG024|Overall Study|Lost to Follow-up|1|||
33437920|NCT03527745|101496166|FG025|Overall Study|Lost to Follow-up|3|||
33437921|NCT02849652|101496167|FG000|Overall Study|Lost to Follow-up|104|||
33437922|NCT02849652|101496168|FG001|Overall Study|Lost to Follow-up|35|||
33437923|NCT02849652|101496169|FG002|Overall Study|Lost to Follow-up|116|||
33437924|NCT02849652|101496170|FG003|Overall Study|Lost to Follow-up|22|||
33437925|NCT02849652|101496167|FG000|Overall Study|Withdrawal by Subject|10|||
33154473|NCT00347360|100479580|FG003|Overall Study|Reason not listed/blank|0|||
33437926|NCT02849652|101496168|FG001|Overall Study|Withdrawal by Subject|2|||
33437927|NCT02849652|101496169|FG002|Overall Study|Withdrawal by Subject|8|||
33437928|NCT02849652|101496170|FG003|Overall Study|Withdrawal by Subject|4|||
33437929|NCT03184441|101496184|FG000|Overall Study|Withdrawal by Subject|1|||
33437930|NCT02720510|101496185|FG000|Overall Study|Study Terminated by the sponsor|2|||
33437931|NCT02720510|101496186|FG001|Overall Study|Study Terminated by the sponsor|0|||
33437932|NCT02720510|101496185|FG000|Overall Study|Adverse Event|0|||
33437933|NCT02720510|101496186|FG001|Overall Study|Adverse Event|1|||
33251989|NCT00814346|100823531|FG000|Open Phase (17 Months)|Adverse Event|5|||
33154474|NCT00347360|100479581|FG004|Overall Study|Reason not listed/blank|0|||
33154475|NCT00347360|100479582|FG005|Overall Study|Reason not listed/blank|0|||
33154476|NCT00347360|100479583|FG006|Overall Study|Reason not listed/blank|1|||
33154477|NCT00347360|100479584|FG007|Overall Study|Reason not listed/blank|0|||
33154478|NCT00347360|100479585|FG008|Overall Study|Reason not listed/blank|0|||
33154479|NCT00347360|100479586|FG009|Overall Study|Reason not listed/blank|0|||
33154480|NCT00347360|100479587|FG010|Overall Study|Reason not listed/blank|0|||
33154481|NCT00347360|100479588|FG011|Overall Study|Reason not listed/blank|0|||
33154482|NCT00347360|100479589|FG012|Overall Study|Reason not listed/blank|0|||
33154483|NCT00347360|100479590|FG013|Overall Study|Reason not listed/blank|1|||
33154484|NCT00347360|100479591|FG014|Overall Study|Reason not listed/blank|0|||
33154485|NCT00347360|100479577|FG000|Overall Study|Per sponsors instruction|0|||
33154486|NCT00347360|100479578|FG001|Overall Study|Per sponsors instruction|1|||
33251990|NCT00814346|100823532|FG001|Open Phase (17 Months)|Adverse Event|0|||
33154487|NCT00347360|100479579|FG002|Overall Study|Per sponsors instruction|0|||
33251991|NCT00814346|100823531|FG000|Open Phase (17 Months)|Consent|2|||
33251992|NCT00814346|100823532|FG001|Open Phase (17 Months)|Consent|0|||
33387312|NCT02120352|101306296|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
33154488|NCT00347360|100479580|FG003|Overall Study|Per sponsors instruction|0|||
33154489|NCT00347360|100479581|FG004|Overall Study|Per sponsors instruction|0|||
33154490|NCT00347360|100479582|FG005|Overall Study|Per sponsors instruction|0|||
33251993|NCT00814346|100823531|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
33387313|NCT02120352|101306297|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
33387314|NCT02120352|101306298|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
33387315|NCT02120352|101306299|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
33387316|NCT02120352|101306300|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
33387317|NCT02120352|101306294|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
33387318|NCT02120352|101306295|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
33387319|NCT02120352|101306296|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
33387320|NCT02120352|101306297|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
33387321|NCT02120352|101306298|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
33387322|NCT02120352|101306299|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
33387323|NCT02120352|101306300|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
33387324|NCT02120352|101306294|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
33387325|NCT02120352|101306295|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
33387326|NCT02120352|101306296|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
33387327|NCT02120352|101306297|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
33154491|NCT00347360|100479583|FG006|Overall Study|Per sponsors instruction|0|||
33154492|NCT00347360|100479584|FG007|Overall Study|Per sponsors instruction|0|||
33154493|NCT00347360|100479585|FG008|Overall Study|Per sponsors instruction|0|||
33154494|NCT00347360|100479586|FG009|Overall Study|Per sponsors instruction|0|||
33154495|NCT00347360|100479587|FG010|Overall Study|Per sponsors instruction|0|||
33154496|NCT00347360|100479588|FG011|Overall Study|Per sponsors instruction|0|||
33154497|NCT00347360|100479589|FG012|Overall Study|Per sponsors instruction|0|||
33154498|NCT00347360|100479590|FG013|Overall Study|Per sponsors instruction|0|||
33154499|NCT00347360|100479591|FG014|Overall Study|Per sponsors instruction|0|||
33154500|NCT00347360|100479577|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
33154501|NCT00347360|100479578|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
33154502|NCT00347360|100479579|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
33154503|NCT00347360|100479580|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
33154504|NCT00347360|100479581|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
33154505|NCT00347360|100479582|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
33154506|NCT00347360|100479583|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
33154507|NCT00347360|100479584|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
33154508|NCT00347360|100479585|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
33154509|NCT00347360|100479586|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
33154510|NCT00347360|100479587|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
33154511|NCT00347360|100479588|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
33154512|NCT00347360|100479589|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
33154513|NCT00347360|100479590|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
33154514|NCT00347360|100479591|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
33154515|NCT00347360|100479577|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
33154516|NCT00347360|100479578|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
33154517|NCT00347360|100479579|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
33154518|NCT00347360|100479580|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
33154519|NCT00347360|100479581|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
33154520|NCT00347360|100479582|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
33154521|NCT00347360|100479583|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
33154522|NCT00347360|100479584|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
33154523|NCT00347360|100479585|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
33154524|NCT00347360|100479586|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
33154525|NCT00347360|100479587|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
33154526|NCT00347360|100479588|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
33154527|NCT00347360|100479589|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
33154528|NCT00347360|100479590|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
33154529|NCT00347360|100479591|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
33154530|NCT00347360|100479577|FG000|Overall Study|Abnormal lab values|0|||
33154531|NCT00347360|100479578|FG001|Overall Study|Abnormal lab values|0|||
33154532|NCT00347360|100479579|FG002|Overall Study|Abnormal lab values|0|||
33154533|NCT00347360|100479580|FG003|Overall Study|Abnormal lab values|0|||
33154534|NCT00347360|100479581|FG004|Overall Study|Abnormal lab values|0|||
33154535|NCT00347360|100479582|FG005|Overall Study|Abnormal lab values|0|||
33154536|NCT00347360|100479583|FG006|Overall Study|Abnormal lab values|1|||
33154537|NCT00347360|100479584|FG007|Overall Study|Abnormal lab values|0|||
33154538|NCT00347360|100479585|FG008|Overall Study|Abnormal lab values|0|||
33154539|NCT00347360|100479586|FG009|Overall Study|Abnormal lab values|0|||
33154540|NCT00347360|100479587|FG010|Overall Study|Abnormal lab values|0|||
33154541|NCT00347360|100479588|FG011|Overall Study|Abnormal lab values|0|||
33154542|NCT00347360|100479589|FG012|Overall Study|Abnormal lab values|0|||
33154543|NCT00347360|100479590|FG013|Overall Study|Abnormal lab values|0|||
33154544|NCT00347360|100479591|FG014|Overall Study|Abnormal lab values|0|||
33154545|NCT00347360|100479577|FG000|Overall Study|PI recommended early withdrawal|0|||
33154546|NCT00347360|100479578|FG001|Overall Study|PI recommended early withdrawal|0|||
33251994|NCT00814346|100823532|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
33251995|NCT00814346|100823531|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
33251996|NCT00814346|100823532|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
33251997|NCT03895034|100823533|FG000|Overall Study|Lost to Follow-up|2|||
33437934|NCT02720510|101496185|FG000|Overall Study|Physician Decision|1|||
33437935|NCT02720510|101496186|FG001|Overall Study|Physician Decision|2|||
33154547|NCT00347360|100479579|FG002|Overall Study|PI recommended early withdrawal|0|||
33154548|NCT00347360|100479580|FG003|Overall Study|PI recommended early withdrawal|0|||
33437936|NCT00755326|101496187|FG000|Overall Study|Lost to Follow-up|2|||
33437937|NCT00755326|101496188|FG001|Overall Study|Lost to Follow-up|3|||
33154549|NCT00347360|100479581|FG004|Overall Study|PI recommended early withdrawal|0|||
33154550|NCT00347360|100479582|FG005|Overall Study|PI recommended early withdrawal|0|||
33154551|NCT00347360|100479583|FG006|Overall Study|PI recommended early withdrawal|0|||
33251998|NCT00878722|100823534|FG000|Overall Study|Progressive disease|3|||
33251999|NCT00878722|100823535|FG001|Overall Study|Progressive disease|3|||
33252000|NCT00878722|100823536|FG002|Overall Study|Progressive disease|3|||
33252001|NCT00878722|100823537|FG003|Overall Study|Progressive disease|7|||
33252002|NCT00878722|100823538|FG004|Overall Study|Progressive disease|7|||
33252003|NCT00878722|100823539|FG005|Overall Study|Progressive disease|1|||
33252004|NCT00878722|100823540|FG006|Overall Study|Progressive disease|4|||
33252005|NCT00878722|100823541|FG007|Overall Study|Progressive disease|3|||
33252006|NCT00878722|100823534|FG000|Overall Study|Death|0|||
33252007|NCT00878722|100823535|FG001|Overall Study|Death|0|||
33252008|NCT00878722|100823536|FG002|Overall Study|Death|0|||
33252009|NCT00878722|100823537|FG003|Overall Study|Death|1|||
33252010|NCT00878722|100823538|FG004|Overall Study|Death|0|||
33252011|NCT00878722|100823539|FG005|Overall Study|Death|1|||
33252012|NCT00878722|100823540|FG006|Overall Study|Death|0|||
33252013|NCT00878722|100823541|FG007|Overall Study|Death|2|||
33252014|NCT00878722|100823534|FG000|Overall Study|Adverse Event|0|||
33252015|NCT00878722|100823535|FG001|Overall Study|Adverse Event|0|||
33252016|NCT00878722|100823536|FG002|Overall Study|Adverse Event|0|||
33252017|NCT00878722|100823537|FG003|Overall Study|Adverse Event|0|||
33252018|NCT00878722|100823538|FG004|Overall Study|Adverse Event|0|||
33252019|NCT00878722|100823539|FG005|Overall Study|Adverse Event|0|||
33252020|NCT00878722|100823540|FG006|Overall Study|Adverse Event|2|||
33252021|NCT00878722|100823541|FG007|Overall Study|Adverse Event|0|||
33252022|NCT00878722|100823534|FG000|Overall Study|Withdrawal by Subject|0|||
33252023|NCT00878722|100823535|FG001|Overall Study|Withdrawal by Subject|0|||
33252024|NCT00878722|100823536|FG002|Overall Study|Withdrawal by Subject|0|||
33252025|NCT00878722|100823537|FG003|Overall Study|Withdrawal by Subject|0|||
33252026|NCT00878722|100823538|FG004|Overall Study|Withdrawal by Subject|0|||
33252027|NCT00878722|100823539|FG005|Overall Study|Withdrawal by Subject|0|||
33252028|NCT00878722|100823540|FG006|Overall Study|Withdrawal by Subject|0|||
33252029|NCT00878722|100823541|FG007|Overall Study|Withdrawal by Subject|2|||
33252030|NCT00878722|100823534|FG000|Overall Study|Relapse|0|||
33252031|NCT00878722|100823535|FG001|Overall Study|Relapse|0|||
33252032|NCT00878722|100823536|FG002|Overall Study|Relapse|0|||
33252033|NCT00878722|100823537|FG003|Overall Study|Relapse|1|||
33252034|NCT00878722|100823538|FG004|Overall Study|Relapse|0|||
33252035|NCT00878722|100823539|FG005|Overall Study|Relapse|0|||
33252036|NCT00878722|100823540|FG006|Overall Study|Relapse|0|||
33252037|NCT00878722|100823541|FG007|Overall Study|Relapse|0|||
33252038|NCT00854906|100823545|FG000|Overall Study|One person had no ocular history|1|||
33252039|NCT01930045|100823550|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
33252040|NCT01930045|100823551|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
33252041|NCT01930045|100823552|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
33252042|NCT01930045|100823553|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
33252043|NCT01930045|100823554|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
33252044|NCT01930045|100823555|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
33252045|NCT01930045|100823550|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
33252046|NCT01930045|100823551|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
33252047|NCT01930045|100823552|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
33252048|NCT01930045|100823553|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
33252049|NCT01930045|100823554|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
33252050|NCT01930045|100823555|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
33252051|NCT02263508|100823556|FG000|Overall Study|Withdrawal by Subject|1|||
33252052|NCT02263508|100823557|FG001|Overall Study|Withdrawal by Subject|23|||
33252053|NCT02263508|100823558|FG002|Overall Study|Withdrawal by Subject|17|||
33252054|NCT02263508|100823556|FG000|Overall Study|Sponsor Decision|12|||
33252055|NCT02263508|100823557|FG001|Overall Study|Sponsor Decision|165|||
33252056|NCT02263508|100823558|FG002|Overall Study|Sponsor Decision|182|||
33252057|NCT02263508|100823556|FG000|Overall Study|Lost to Follow-up|2|||
33252058|NCT02263508|100823557|FG001|Overall Study|Lost to Follow-up|7|||
33252059|NCT02263508|100823558|FG002|Overall Study|Lost to Follow-up|7|||
33252060|NCT02263508|100823556|FG000|Overall Study|Death|6|||
33252061|NCT02263508|100823557|FG001|Overall Study|Death|151|||
33252062|NCT02263508|100823558|FG002|Overall Study|Death|140|||
33252063|NCT00868192|100823559|FG000|Overall Study|Ineligible|4|||
33252064|NCT00726999|100823562|FG000|Overall Study|Physician Decision|0|||
33252065|NCT00726999|100823563|FG001|Overall Study|Physician Decision|1|||
33252066|NCT00726999|100823562|FG000|Overall Study|Withdrawal by Subject|2|||
33252067|NCT00726999|100823563|FG001|Overall Study|Withdrawal by Subject|0|||
33252068|NCT00726999|100823562|FG000|Overall Study|Protocol Violation|1|||
33252069|NCT00726999|100823563|FG001|Overall Study|Protocol Violation|0|||
33252070|NCT00843193|100823564|FG000|Overall Study|Adverse Event|2|||
33252071|NCT00843193|100823565|FG001|Overall Study|Adverse Event|4|||
33252072|NCT00843193|100823564|FG000|Overall Study|Lack of Efficacy|1|||
33252073|NCT00843193|100823565|FG001|Overall Study|Lack of Efficacy|1|||
33252074|NCT00843193|100823564|FG000|Overall Study|Protocol Violation|1|||
33252075|NCT00843193|100823565|FG001|Overall Study|Protocol Violation|2|||
33252076|NCT00843193|100823564|FG000|Overall Study|Lost to Follow-up|1|||
33252077|NCT00843193|100823565|FG001|Overall Study|Lost to Follow-up|0|||
33252078|NCT00843193|100823564|FG000|Overall Study|Physician Decision|0|||
33252079|NCT00843193|100823565|FG001|Overall Study|Physician Decision|1|||
33252080|NCT00843193|100823564|FG000|Overall Study|Withdrawal by Subject|3|||
33252081|NCT00843193|100823565|FG001|Overall Study|Withdrawal by Subject|3|||
33252082|NCT05149313|100823572|FG000|Overall Study|Adverse Event|2|||
33252083|NCT05149313|100823573|FG001|Overall Study|Adverse Event|2|||
33252084|NCT05149313|100823572|FG000|Overall Study|Lost to Follow-up|2|||
33252085|NCT05149313|100823573|FG001|Overall Study|Lost to Follow-up|3|||
33252086|NCT05149313|100823572|FG000|Overall Study|Pregnancy|1|||
33252087|NCT05149313|100823573|FG001|Overall Study|Pregnancy|0|||
33252088|NCT05149313|100823572|FG000|Overall Study|Withdrawal by Subject|2|||
33252089|NCT05149313|100823573|FG001|Overall Study|Withdrawal by Subject|5|||
33252090|NCT05149313|100823572|FG000|Overall Study|Physician Decision|1|||
33252091|NCT05149313|100823573|FG001|Overall Study|Physician Decision|0|||
33252092|NCT05149313|100823572|FG000|Overall Study|Other|0|||
33252093|NCT05149313|100823573|FG001|Overall Study|Other|1|||
33252094|NCT02082158|100823574|FG000|Overall Study|Withdrawal by Subject|0|||
33252095|NCT02082158|100823575|FG001|Overall Study|Withdrawal by Subject|0|||
33252096|NCT02082158|100823576|FG002|Overall Study|Withdrawal by Subject|0|||
33252097|NCT02082158|100823577|FG003|Overall Study|Withdrawal by Subject|0|||
33252098|NCT02082158|100823578|FG004|Overall Study|Withdrawal by Subject|1|||
33252099|NCT02082158|100823579|FG005|Overall Study|Withdrawal by Subject|0|||
33252100|NCT02082158|100823574|FG000|Overall Study|Failed Fit-testing|8|||
33252101|NCT02082158|100823575|FG001|Overall Study|Failed Fit-testing|8|||
33252102|NCT02082158|100823576|FG002|Overall Study|Failed Fit-testing|14|||
33252103|NCT02082158|100823577|FG003|Overall Study|Failed Fit-testing|4|||
33252104|NCT02082158|100823578|FG004|Overall Study|Failed Fit-testing|3|||
33252105|NCT02082158|100823579|FG005|Overall Study|Failed Fit-testing|7|||
33252106|NCT03808883|100823583|FG000|Overall Study|Withdrawal by Subject|2|||
33252107|NCT03808883|100823584|FG001|Overall Study|Withdrawal by Subject|0|||
33252108|NCT03808883|100823583|FG000|Overall Study|Did not complete pre test or post test survey|4|||
33252109|NCT03808883|100823584|FG001|Overall Study|Did not complete pre test or post test survey|3|||
33252110|NCT00918957|100823585|FG000|Overall Study|Adverse Event|2|||
33252111|NCT00918957|100823586|FG001|Overall Study|Adverse Event|0|||
33252112|NCT00918957|100823585|FG000|Overall Study|Withdrawal by Subject|1|||
33252113|NCT00918957|100823586|FG001|Overall Study|Withdrawal by Subject|0|||
33252114|NCT01943799|100823589|FG000|Overall Study|Lost to Follow-up|0|||
33252115|NCT01943799|100823590|FG001|Overall Study|Lost to Follow-up|1|||
33387328|NCT02120352|101306298|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
33387329|NCT02120352|101306299|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
33252116|NCT01943799|100823591|FG002|Overall Study|Lost to Follow-up|1|||
33252117|NCT01943799|100823592|FG003|Overall Study|Lost to Follow-up|0|||
33252118|NCT01943799|100823589|FG000|Overall Study|Protocol Violation|1|||
33252119|NCT01943799|100823590|FG001|Overall Study|Protocol Violation|0|||
33252120|NCT01943799|100823591|FG002|Overall Study|Protocol Violation|0|||
33252121|NCT01943799|100823592|FG003|Overall Study|Protocol Violation|0|||
33252122|NCT01943799|100823589|FG000|Overall Study|Withdrawal by Subject|4|||
33252123|NCT01943799|100823590|FG001|Overall Study|Withdrawal by Subject|2|||
33252124|NCT01943799|100823591|FG002|Overall Study|Withdrawal by Subject|1|||
33252125|NCT01943799|100823592|FG003|Overall Study|Withdrawal by Subject|0|||
33252126|NCT00442117|100823593|FG000|Overall Study|Adverse Event|3|||
33252127|NCT00442117|100823594|FG001|Overall Study|Adverse Event|2|||
33252128|NCT00442117|100823593|FG000|Overall Study|Lack of Efficacy|2|||
33252129|NCT00442117|100823594|FG001|Overall Study|Lack of Efficacy|6|||
33252130|NCT00442117|100823593|FG000|Overall Study|Lost to Follow-up|1|||
33252131|NCT00442117|100823594|FG001|Overall Study|Lost to Follow-up|2|||
33252132|NCT00442117|100823593|FG000|Overall Study|Withdrawal by Subject|2|||
33252133|NCT00442117|100823594|FG001|Overall Study|Withdrawal by Subject|2|||
33252134|NCT00442117|100823593|FG000|Overall Study|Major Deviation|25|||
33252135|NCT00442117|100823594|FG001|Overall Study|Major Deviation|20|||
33252136|NCT00442117|100823593|FG000|Overall Study|Non compliance with protocol|3|||
33252137|NCT00442117|100823594|FG001|Overall Study|Non compliance with protocol|5|||
33252138|NCT00442117|100823593|FG000|Overall Study|Met Withdrawal Criteria|2|||
33252139|NCT00442117|100823594|FG001|Overall Study|Met Withdrawal Criteria|1|||
33252140|NCT01831791|100823602|FG000|Overall Study|Withdrawal by Subject|10|||
33252141|NCT03939819|100823603|FG000|Overall Study|Death|2|||
33252142|NCT03939819|100823604|FG001|Overall Study|Death|0|||
33252143|NCT00545077|100823607|FG000|Overall Study|Treatment not received|5|||
33252144|NCT00545077|100823608|FG001|Overall Study|Treatment not received|1|||
33252145|NCT00545077|100823607|FG000|Overall Study|Disease Progression|131|||
33252146|NCT00545077|100823608|FG001|Overall Study|Disease Progression|98|||
33252147|NCT00545077|100823607|FG000|Overall Study|Withdrawal by Subject|3|||
33252148|NCT00545077|100823608|FG001|Overall Study|Withdrawal by Subject|14|||
33252149|NCT00545077|100823607|FG000|Overall Study|Physician Decision|6|||
33252150|NCT00545077|100823608|FG001|Overall Study|Physician Decision|3|||
33252151|NCT00545077|100823607|FG000|Overall Study|Lost to Follow-up|2|||
33252152|NCT00545077|100823608|FG001|Overall Study|Lost to Follow-up|0|||
33252153|NCT00545077|100823607|FG000|Overall Study|Protocol Violation|1|||
33252154|NCT00545077|100823608|FG001|Overall Study|Protocol Violation|0|||
33252155|NCT00545077|100823607|FG000|Overall Study|Adverse Event|0|||
33252156|NCT00545077|100823608|FG001|Overall Study|Adverse Event|31|||
33252157|NCT00545077|100823607|FG000|Overall Study|Death|0|||
33252158|NCT00545077|100823608|FG001|Overall Study|Death|8|||
33252159|NCT04340362|100823618|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
33252160|NCT04347954|100823620|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
33252161|NCT04347954|100823621|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
33252162|NCT04347954|100823622|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
33252163|NCT04347954|100823620|FG000|Overall Study|Lost to Follow-up|0|||
33252164|NCT04347954|100823621|FG001|Overall Study|Lost to Follow-up|1|||
33252165|NCT04347954|100823622|FG002|Overall Study|Lost to Follow-up|0|||
33252166|NCT00158054|100823623|FG000|Overall Study|Refused to continue|3|||
33252167|NCT00158054|100823624|FG001|Overall Study|Refused to continue|0|||
33252168|NCT00158054|100823623|FG000|Overall Study|Unavailable for follow up|7|||
33252169|NCT00158054|100823624|FG001|Overall Study|Unavailable for follow up|3|||
33252170|NCT03646123|100823625|FG000|Overall Study|Patient transferred and not able to get testing completed|0|||
33252171|NCT03646123|100823626|FG001|Overall Study|Patient transferred and not able to get testing completed|1|||
33252172|NCT03646123|100823627|FG002|Overall Study|Patient transferred and not able to get testing completed|0|||
33252173|NCT03646123|100823625|FG000|Overall Study|Participant no longer met inclusion criteria and never received treatment|1|||
33252174|NCT03646123|100823626|FG001|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
33252175|NCT03646123|100823627|FG002|Overall Study|Participant no longer met inclusion criteria and never received treatment|0|||
33252176|NCT03646123|100823625|FG000|Overall Study|Non-compliance to study protocol|1|||
33387330|NCT02120352|101306300|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
33387331|NCT02120352|101306294|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
33387332|NCT02120352|101306295|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
33387333|NCT02120352|101306296|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
33387334|NCT02120352|101306297|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
33387335|NCT02120352|101306298|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
33252177|NCT03646123|100823626|FG001|Overall Study|Non-compliance to study protocol|0|||
33252178|NCT03646123|100823627|FG002|Overall Study|Non-compliance to study protocol|0|||
33252179|NCT03646123|100823625|FG000|Overall Study|Ineligible due to progression during screening|0|||
33252180|NCT03646123|100823626|FG001|Overall Study|Ineligible due to progression during screening|0|||
33252181|NCT03646123|100823627|FG002|Overall Study|Ineligible due to progression during screening|1|||
33252182|NCT03646123|100823625|FG000|Overall Study|Withdrawal by Subject|2|||
33252183|NCT03646123|100823626|FG001|Overall Study|Withdrawal by Subject|1|||
33252184|NCT03646123|100823627|FG002|Overall Study|Withdrawal by Subject|3|||
33252185|NCT03646123|100823625|FG000|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
33252186|NCT03646123|100823626|FG001|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|0|||
33252187|NCT03646123|100823627|FG002|Overall Study|Additional CT scan showed inclusion criteria were not met for Part C|1|||
33252188|NCT03646123|100823625|FG000|Overall Study|Death|2|||
33252189|NCT03646123|100823626|FG001|Overall Study|Death|1|||
33252190|NCT03646123|100823627|FG002|Overall Study|Death|1|||
33252191|NCT03646123|100823625|FG000|Overall Study|Lost to Follow-up|4|||
33252192|NCT03646123|100823626|FG001|Overall Study|Lost to Follow-up|7|||
33252193|NCT03646123|100823627|FG002|Overall Study|Lost to Follow-up|6|||
33252194|NCT03646123|100823625|FG000|Overall Study|Participants in long term follow-up|0|||
33252195|NCT03646123|100823626|FG001|Overall Study|Participants in long term follow-up|48|||
33252196|NCT03646123|100823627|FG002|Overall Study|Participants in long term follow-up|144|||
33252197|NCT01196429|100823630|FG000|Overall Study|Ineligible - inadequate pathology|1|||
33252198|NCT01196429|100823631|FG001|Overall Study|Ineligible - inadequate pathology|0|||
33252199|NCT01196429|100823630|FG000|Overall Study|Ineligible - wrong cell type|1|||
33252200|NCT01196429|100823631|FG001|Overall Study|Ineligible - wrong cell type|0|||
33252201|NCT01196429|100823630|FG000|Overall Study|Refused - Never Treated|1|||
33252202|NCT01196429|100823631|FG001|Overall Study|Refused - Never Treated|0|||
33252203|NCT00845832|100823632|FG000|Treatment Period|Adverse Event|0|||
33252204|NCT00845832|100823633|FG001|Treatment Period|Adverse Event|2|||
33252205|NCT00845832|100823634|FG002|Treatment Period|Adverse Event|0|||
33252206|NCT00845832|100823632|FG000|Treatment Period|Protocol Violation|1|||
33252207|NCT00845832|100823633|FG001|Treatment Period|Protocol Violation|1|||
33252208|NCT00845832|100823634|FG002|Treatment Period|Protocol Violation|0|||
33252209|NCT00845832|100823632|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
33252210|NCT00845832|100823633|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
33252211|NCT00845832|100823634|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
33252212|NCT00845832|100823632|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
33252213|NCT00845832|100823633|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
33252214|NCT00845832|100823634|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
33252215|NCT02888080|100823635|FG000|Overall Study|Subject / Guardian decision|1|||
33252216|NCT02888080|100823636|FG001|Overall Study|Subject / Guardian decision|3|||
33252217|NCT02888080|100823635|FG000|Overall Study|New Therapy for study indication|1|||
33252218|NCT02888080|100823636|FG001|Overall Study|New Therapy for study indication|0|||
33252219|NCT02888080|100823635|FG000|Overall Study|Lack of Efficacy|0|||
33252220|NCT02888080|100823636|FG001|Overall Study|Lack of Efficacy|1|||
33252221|NCT02888080|100823635|FG000|Overall Study|Adverse Event|0|||
33252222|NCT02888080|100823636|FG001|Overall Study|Adverse Event|1|||
33252223|NCT00457691|100823637|FG000|Overall Study|Adverse Event|4|||
33252224|NCT00457691|100823638|FG001|Overall Study|Adverse Event|1|||
33252225|NCT00457691|100823637|FG000|Overall Study|Death|163|||
33252226|NCT00457691|100823638|FG001|Overall Study|Death|148|||
33252227|NCT00457691|100823637|FG000|Overall Study|Protocol Violation|1|||
33252228|NCT00457691|100823638|FG001|Overall Study|Protocol Violation|3|||
33252229|NCT00457691|100823637|FG000|Overall Study|Lost to Follow-up|23|||
33252230|NCT00457691|100823638|FG001|Overall Study|Lost to Follow-up|14|||
33252231|NCT00457691|100823637|FG000|Overall Study|Study terminated by Sponsor|1|||
33252232|NCT00457691|100823638|FG001|Overall Study|Study terminated by Sponsor|1|||
33252233|NCT00457691|100823637|FG000|Overall Study|Subject refused (reason other than AE)|14|||
33252234|NCT00457691|100823638|FG001|Overall Study|Subject refused (reason other than AE)|19|||
33252235|NCT00457691|100823637|FG000|Overall Study|Disease progression, study terminated|180|||
33252236|NCT00457691|100823638|FG001|Overall Study|Disease progression, study terminated|196|||
33252237|NCT00708032|100823639|FG000|Overall Study|Adverse Event|0|||
33252238|NCT00708032|100823640|FG001|Overall Study|Adverse Event|2|||
33252239|NCT00708032|100823639|FG000|Overall Study|Lost to Follow-up|1|||
33252240|NCT00708032|100823640|FG001|Overall Study|Lost to Follow-up|2|||
33252241|NCT00708032|100823639|FG000|Overall Study|Pregnancy|0|||
33252242|NCT00708032|100823640|FG001|Overall Study|Pregnancy|1|||
33252243|NCT00708032|100823639|FG000|Overall Study|Poor vision|0|||
33252244|NCT00708032|100823640|FG001|Overall Study|Poor vision|6|||
33387336|NCT02120352|101306299|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
33252245|NCT00708032|100823639|FG000|Overall Study|Visit out of range at month 12|4|||
33252246|NCT00708032|100823640|FG001|Overall Study|Visit out of range at month 12|1|||
33252247|NCT00708032|100823639|FG000|Overall Study|Did not meet protocol criteria|1|||
33387337|NCT02120352|101306300|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
33252248|NCT00708032|100823640|FG001|Overall Study|Did not meet protocol criteria|2|||
33252249|NCT00708032|100823639|FG000|Overall Study|Protocol Violation|4|||
33252250|NCT00708032|100823640|FG001|Overall Study|Protocol Violation|1|||
33252251|NCT00708032|100823639|FG000|Overall Study|Withdrawal by Subject|0|||
33252252|NCT00708032|100823640|FG001|Overall Study|Withdrawal by Subject|1|||
33252253|NCT02001623|100823641|FG000|Overall Study|Disease Progression|2|||
33252254|NCT02001623|100823642|FG001|Overall Study|Disease Progression|2|||
33252255|NCT02001623|100823643|FG002|Overall Study|Disease Progression|3|||
33252256|NCT02001623|100823644|FG003|Overall Study|Disease Progression|2|||
33252257|NCT02001623|100823645|FG004|Overall Study|Disease Progression|3|||
33252258|NCT02001623|100823646|FG005|Overall Study|Disease Progression|2|||
33252259|NCT02001623|100823647|FG006|Overall Study|Disease Progression|3|||
33252260|NCT02001623|100823648|FG007|Overall Study|Disease Progression|3|||
33252261|NCT02001623|100823649|FG008|Overall Study|Disease Progression|7|||
33252262|NCT02001623|100823650|FG009|Overall Study|Disease Progression|40|||
33252263|NCT02001623|100823651|FG010|Overall Study|Disease Progression|5|||
33252264|NCT02001623|100823652|FG011|Overall Study|Disease Progression|9|||
33252265|NCT02001623|100823653|FG012|Overall Study|Disease Progression|9|||
33252266|NCT02001623|100823654|FG013|Overall Study|Disease Progression|20|||
33252267|NCT02001623|100823655|FG014|Overall Study|Disease Progression|9|||
33252268|NCT02001623|100823641|FG000|Overall Study|Physician Decision|0|||
33252269|NCT02001623|100823642|FG001|Overall Study|Physician Decision|0|||
33252270|NCT02001623|100823643|FG002|Overall Study|Physician Decision|0|||
33252271|NCT02001623|100823644|FG003|Overall Study|Physician Decision|0|||
33252272|NCT02001623|100823645|FG004|Overall Study|Physician Decision|0|||
33252273|NCT02001623|100823646|FG005|Overall Study|Physician Decision|0|||
33252274|NCT02001623|100823647|FG006|Overall Study|Physician Decision|0|||
33252275|NCT02001623|100823648|FG007|Overall Study|Physician Decision|0|||
33252276|NCT02001623|100823649|FG008|Overall Study|Physician Decision|3|||
33252277|NCT02001623|100823650|FG009|Overall Study|Physician Decision|2|||
33252278|NCT02001623|100823651|FG010|Overall Study|Physician Decision|3|||
33252279|NCT02001623|100823652|FG011|Overall Study|Physician Decision|3|||
33252280|NCT02001623|100823653|FG012|Overall Study|Physician Decision|1|||
33252281|NCT02001623|100823654|FG013|Overall Study|Physician Decision|2|||
33252282|NCT02001623|100823655|FG014|Overall Study|Physician Decision|1|||
33252283|NCT02001623|100823641|FG000|Overall Study|Death|0|||
33252284|NCT02001623|100823642|FG001|Overall Study|Death|1|||
33252285|NCT02001623|100823643|FG002|Overall Study|Death|0|||
33252286|NCT02001623|100823644|FG003|Overall Study|Death|0|||
33252287|NCT02001623|100823645|FG004|Overall Study|Death|0|||
33252288|NCT02001623|100823646|FG005|Overall Study|Death|0|||
33252289|NCT02001623|100823647|FG006|Overall Study|Death|0|||
33252290|NCT02001623|100823648|FG007|Overall Study|Death|0|||
33252291|NCT02001623|100823649|FG008|Overall Study|Death|0|||
33252292|NCT02001623|100823650|FG009|Overall Study|Death|0|||
33252293|NCT02001623|100823651|FG010|Overall Study|Death|0|||
33252294|NCT02001623|100823652|FG011|Overall Study|Death|0|||
33252295|NCT02001623|100823653|FG012|Overall Study|Death|0|||
33252296|NCT02001623|100823654|FG013|Overall Study|Death|0|||
33252297|NCT02001623|100823655|FG014|Overall Study|Death|0|||
33252298|NCT02001623|100823641|FG000|Overall Study|Adverse Event|0|||
33252299|NCT02001623|100823642|FG001|Overall Study|Adverse Event|0|||
33252300|NCT02001623|100823643|FG002|Overall Study|Adverse Event|0|||
33252301|NCT02001623|100823644|FG003|Overall Study|Adverse Event|0|||
33252302|NCT02001623|100823645|FG004|Overall Study|Adverse Event|0|||
33252303|NCT02001623|100823646|FG005|Overall Study|Adverse Event|1|||
33252304|NCT02001623|100823647|FG006|Overall Study|Adverse Event|0|||
33252305|NCT02001623|100823648|FG007|Overall Study|Adverse Event|3|||
33252306|NCT02001623|100823649|FG008|Overall Study|Adverse Event|4|||
33252307|NCT02001623|100823650|FG009|Overall Study|Adverse Event|6|||
33252308|NCT02001623|100823651|FG010|Overall Study|Adverse Event|4|||
33252309|NCT02001623|100823652|FG011|Overall Study|Adverse Event|0|||
33252310|NCT02001623|100823653|FG012|Overall Study|Adverse Event|3|||
33252311|NCT02001623|100823654|FG013|Overall Study|Adverse Event|5|||
33252312|NCT02001623|100823655|FG014|Overall Study|Adverse Event|6|||
33252313|NCT02001623|100823641|FG000|Overall Study|Other - Miscellaneous|0|||
33252314|NCT02001623|100823642|FG001|Overall Study|Other - Miscellaneous|0|||
33252315|NCT02001623|100823643|FG002|Overall Study|Other - Miscellaneous|0|||
33252316|NCT02001623|100823644|FG003|Overall Study|Other - Miscellaneous|0|||
33252317|NCT02001623|100823645|FG004|Overall Study|Other - Miscellaneous|0|||
33252318|NCT02001623|100823646|FG005|Overall Study|Other - Miscellaneous|0|||
33252319|NCT02001623|100823647|FG006|Overall Study|Other - Miscellaneous|0|||
33252320|NCT02001623|100823648|FG007|Overall Study|Other - Miscellaneous|0|||
33252321|NCT02001623|100823649|FG008|Overall Study|Other - Miscellaneous|0|||
33252322|NCT02001623|100823650|FG009|Overall Study|Other - Miscellaneous|1|||
33252323|NCT02001623|100823651|FG010|Overall Study|Other - Miscellaneous|0|||
33252324|NCT02001623|100823652|FG011|Overall Study|Other - Miscellaneous|0|||
33387338|NCT02120352|101306294|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
33387339|NCT02120352|101306295|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
33387340|NCT02120352|101306296|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
33387341|NCT02120352|101306297|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
33387342|NCT02120352|101306298|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
33387343|NCT02120352|101306299|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
33387344|NCT02120352|101306300|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
33387345|NCT02120352|101306294|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
33387346|NCT02120352|101306295|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
33387347|NCT02120352|101306296|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
33437938|NCT02626949|101496189|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
33437939|NCT02626949|101496190|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
33437940|NCT02626949|101496189|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
33437941|NCT02626949|101496190|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
33154552|NCT00347360|100479584|FG007|Overall Study|PI recommended early withdrawal|0|||
33154553|NCT00347360|100479585|FG008|Overall Study|PI recommended early withdrawal|0|||
33154554|NCT00347360|100479586|FG009|Overall Study|PI recommended early withdrawal|1|||
33154555|NCT00347360|100479587|FG010|Overall Study|PI recommended early withdrawal|0|||
33154556|NCT00347360|100479588|FG011|Overall Study|PI recommended early withdrawal|0|||
33154557|NCT00347360|100479589|FG012|Overall Study|PI recommended early withdrawal|0|||
33154558|NCT00347360|100479590|FG013|Overall Study|PI recommended early withdrawal|0|||
33154559|NCT00347360|100479591|FG014|Overall Study|PI recommended early withdrawal|0|||
33154560|NCT00347360|100479577|FG000|Overall Study|Did not meet criteria before ABPM|0|||
33154561|NCT00347360|100479578|FG001|Overall Study|Did not meet criteria before ABPM|0|||
33154562|NCT00347360|100479579|FG002|Overall Study|Did not meet criteria before ABPM|0|||
33154563|NCT00347360|100479580|FG003|Overall Study|Did not meet criteria before ABPM|0|||
33154564|NCT00347360|100479581|FG004|Overall Study|Did not meet criteria before ABPM|0|||
33154565|NCT00347360|100479582|FG005|Overall Study|Did not meet criteria before ABPM|0|||
33154566|NCT00347360|100479583|FG006|Overall Study|Did not meet criteria before ABPM|0|||
33154567|NCT00347360|100479584|FG007|Overall Study|Did not meet criteria before ABPM|0|||
33154568|NCT00347360|100479585|FG008|Overall Study|Did not meet criteria before ABPM|0|||
33154569|NCT00347360|100479586|FG009|Overall Study|Did not meet criteria before ABPM|0|||
33154570|NCT00347360|100479587|FG010|Overall Study|Did not meet criteria before ABPM|1|||
33154571|NCT00347360|100479588|FG011|Overall Study|Did not meet criteria before ABPM|0|||
33154572|NCT00347360|100479589|FG012|Overall Study|Did not meet criteria before ABPM|0|||
33154573|NCT00347360|100479590|FG013|Overall Study|Did not meet criteria before ABPM|0|||
33154574|NCT00347360|100479591|FG014|Overall Study|Did not meet criteria before ABPM|0|||
33154575|NCT00347360|100479577|FG000|Overall Study|Randomized in error|0|||
33154576|NCT00347360|100479578|FG001|Overall Study|Randomized in error|0|||
33154577|NCT00347360|100479579|FG002|Overall Study|Randomized in error|0|||
33154578|NCT00347360|100479580|FG003|Overall Study|Randomized in error|0|||
33154579|NCT00347360|100479581|FG004|Overall Study|Randomized in error|0|||
33154580|NCT00347360|100479582|FG005|Overall Study|Randomized in error|0|||
33154581|NCT00347360|100479583|FG006|Overall Study|Randomized in error|0|||
33154582|NCT00347360|100479584|FG007|Overall Study|Randomized in error|0|||
33154583|NCT00347360|100479585|FG008|Overall Study|Randomized in error|0|||
33154584|NCT00347360|100479586|FG009|Overall Study|Randomized in error|0|||
33154585|NCT00347360|100479587|FG010|Overall Study|Randomized in error|0|||
33154586|NCT00347360|100479588|FG011|Overall Study|Randomized in error|1|||
33154587|NCT00347360|100479589|FG012|Overall Study|Randomized in error|0|||
33154588|NCT00347360|100479590|FG013|Overall Study|Randomized in error|0|||
33154589|NCT00347360|100479591|FG014|Overall Study|Randomized in error|0|||
33154590|NCT00347360|100479577|FG000|Overall Study|Failed inclusion criteria #4|0|||
33252325|NCT02001623|100823653|FG012|Overall Study|Other - Miscellaneous|0|||
33252326|NCT02001623|100823654|FG013|Overall Study|Other - Miscellaneous|1|||
33252327|NCT02001623|100823655|FG014|Overall Study|Other - Miscellaneous|0|||
33252328|NCT02001623|100823641|FG000|Overall Study|Withdrawal by Subject|1|||
33252329|NCT02001623|100823642|FG001|Overall Study|Withdrawal by Subject|0|||
33252330|NCT02001623|100823643|FG002|Overall Study|Withdrawal by Subject|0|||
33252331|NCT02001623|100823644|FG003|Overall Study|Withdrawal by Subject|0|||
33252332|NCT02001623|100823645|FG004|Overall Study|Withdrawal by Subject|0|||
33252333|NCT02001623|100823646|FG005|Overall Study|Withdrawal by Subject|0|||
33437942|NCT02626949|101496189|FG000|Enrolled|Lost to Follow-up|7|||
33437943|NCT02626949|101496190|FG001|Enrolled|Lost to Follow-up|6|||
33437944|NCT02626949|101496189|FG000|Enrolled|Withdrawal by Subject|3|||
33437945|NCT02626949|101496190|FG001|Enrolled|Withdrawal by Subject|2|||
33437946|NCT02979353|101496191|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
33437947|NCT02979353|101496192|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
33154591|NCT00347360|100479578|FG001|Overall Study|Failed inclusion criteria #4|0|||
33154592|NCT00347360|100479579|FG002|Overall Study|Failed inclusion criteria #4|0|||
33154593|NCT00347360|100479580|FG003|Overall Study|Failed inclusion criteria #4|0|||
33154594|NCT00347360|100479581|FG004|Overall Study|Failed inclusion criteria #4|0|||
33154595|NCT00347360|100479582|FG005|Overall Study|Failed inclusion criteria #4|0|||
33154596|NCT00347360|100479583|FG006|Overall Study|Failed inclusion criteria #4|0|||
33154597|NCT00347360|100479584|FG007|Overall Study|Failed inclusion criteria #4|0|||
33154598|NCT00347360|100479585|FG008|Overall Study|Failed inclusion criteria #4|0|||
33154599|NCT00347360|100479586|FG009|Overall Study|Failed inclusion criteria #4|0|||
33154600|NCT00347360|100479587|FG010|Overall Study|Failed inclusion criteria #4|0|||
33154601|NCT00347360|100479588|FG011|Overall Study|Failed inclusion criteria #4|1|||
33154602|NCT00347360|100479589|FG012|Overall Study|Failed inclusion criteria #4|0|||
33252334|NCT02001623|100823647|FG006|Overall Study|Withdrawal by Subject|0|||
33252335|NCT02001623|100823648|FG007|Overall Study|Withdrawal by Subject|0|||
33252336|NCT02001623|100823649|FG008|Overall Study|Withdrawal by Subject|1|||
33154603|NCT00347360|100479590|FG013|Overall Study|Failed inclusion criteria #4|0|||
33252337|NCT02001623|100823650|FG009|Overall Study|Withdrawal by Subject|3|||
33154604|NCT00347360|100479591|FG014|Overall Study|Failed inclusion criteria #4|0|||
33252338|NCT02001623|100823651|FG010|Overall Study|Withdrawal by Subject|2|||
33252339|NCT02001623|100823652|FG011|Overall Study|Withdrawal by Subject|2|||
33252340|NCT02001623|100823653|FG012|Overall Study|Withdrawal by Subject|1|||
33387348|NCT02120352|101306297|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
33154605|NCT00347360|100479577|FG000|Overall Study|Prolonged duration between visits|0|||
33154606|NCT00347360|100479578|FG001|Overall Study|Prolonged duration between visits|0|||
33154607|NCT00347360|100479579|FG002|Overall Study|Prolonged duration between visits|0|||
33154608|NCT00347360|100479580|FG003|Overall Study|Prolonged duration between visits|0|||
33154609|NCT00347360|100479581|FG004|Overall Study|Prolonged duration between visits|0|||
33154610|NCT00347360|100479582|FG005|Overall Study|Prolonged duration between visits|0|||
33154611|NCT00347360|100479583|FG006|Overall Study|Prolonged duration between visits|0|||
33154612|NCT00347360|100479584|FG007|Overall Study|Prolonged duration between visits|0|||
33154613|NCT00347360|100479585|FG008|Overall Study|Prolonged duration between visits|0|||
33154614|NCT00347360|100479586|FG009|Overall Study|Prolonged duration between visits|0|||
33154615|NCT00347360|100479587|FG010|Overall Study|Prolonged duration between visits|0|||
33154616|NCT00347360|100479588|FG011|Overall Study|Prolonged duration between visits|0|||
33154617|NCT00347360|100479589|FG012|Overall Study|Prolonged duration between visits|1|||
33154618|NCT00347360|100479590|FG013|Overall Study|Prolonged duration between visits|0|||
33154619|NCT00347360|100479591|FG014|Overall Study|Prolonged duration between visits|0|||
33154620|NCT00347360|100479577|FG000|Overall Study|Subject left town, ran out of study drug|0|||
33154621|NCT00347360|100479578|FG001|Overall Study|Subject left town, ran out of study drug|0|||
33154622|NCT00347360|100479579|FG002|Overall Study|Subject left town, ran out of study drug|0|||
33154623|NCT00347360|100479580|FG003|Overall Study|Subject left town, ran out of study drug|0|||
33154624|NCT00347360|100479581|FG004|Overall Study|Subject left town, ran out of study drug|0|||
33154625|NCT00347360|100479582|FG005|Overall Study|Subject left town, ran out of study drug|0|||
33154626|NCT00347360|100479583|FG006|Overall Study|Subject left town, ran out of study drug|0|||
33154627|NCT00347360|100479584|FG007|Overall Study|Subject left town, ran out of study drug|0|||
33154628|NCT00347360|100479585|FG008|Overall Study|Subject left town, ran out of study drug|0|||
33154629|NCT00347360|100479586|FG009|Overall Study|Subject left town, ran out of study drug|0|||
33154630|NCT00347360|100479587|FG010|Overall Study|Subject left town, ran out of study drug|0|||
33154631|NCT00347360|100479588|FG011|Overall Study|Subject left town, ran out of study drug|0|||
33437948|NCT02979353|101496191|FG000|Overall Study|Withdrawal by Subject|16|||
33437949|NCT02979353|101496192|FG001|Overall Study|Withdrawal by Subject|12|||
33437950|NCT02979353|101496191|FG000|Overall Study|Death|10|||
33437951|NCT02979353|101496192|FG001|Overall Study|Death|11|||
33437952|NCT02979353|101496191|FG000|Overall Study|Transfer to Hospice Care|19|||
33437953|NCT02979353|101496192|FG001|Overall Study|Transfer to Hospice Care|14|||
33437954|NCT02979353|101496191|FG000|Overall Study|Lost to Follow-up|1|||
33437955|NCT02979353|101496192|FG001|Overall Study|Lost to Follow-up|5|||
33437956|NCT00101582|101496193|FG000|Overall Study|Ineligibility determined|0|||
33437957|NCT00101582|101496194|FG001|Overall Study|Ineligibility determined|1|||
33437958|NCT00101582|101496193|FG000|Overall Study|Adverse Event|1|||
33437959|NCT00101582|101496194|FG001|Overall Study|Adverse Event|4|||
33437960|NCT00101582|101496193|FG000|Overall Study|Withdrawal by Subject|6|||
33437961|NCT00101582|101496194|FG001|Overall Study|Withdrawal by Subject|4|||
33437962|NCT00101582|101496193|FG000|Overall Study|Physician Decision|1|||
33437963|NCT00101582|101496194|FG001|Overall Study|Physician Decision|0|||
33437964|NCT00101582|101496193|FG000|Overall Study|Death|3|||
33437965|NCT00101582|101496194|FG001|Overall Study|Death|5|||
33437966|NCT00101582|101496193|FG000|Overall Study|Other|0|||
33437967|NCT00101582|101496194|FG001|Overall Study|Other|1|||
33437968|NCT03103100|101496200|FG000|Overall Study|Adverse Event|1|||
33437969|NCT03103100|101496201|FG001|Overall Study|Adverse Event|0|||
33154632|NCT00347360|100479589|FG012|Overall Study|Subject left town, ran out of study drug|0|||
33154633|NCT00347360|100479590|FG013|Overall Study|Subject left town, ran out of study drug|1|||
33154634|NCT00347360|100479591|FG014|Overall Study|Subject left town, ran out of study drug|0|||
33154635|NCT00347360|100479577|FG000|Overall Study|Subject refuse to sign updated consent|0|||
33154636|NCT00347360|100479578|FG001|Overall Study|Subject refuse to sign updated consent|0|||
33154637|NCT00347360|100479579|FG002|Overall Study|Subject refuse to sign updated consent|0|||
33154638|NCT00347360|100479580|FG003|Overall Study|Subject refuse to sign updated consent|0|||
33154639|NCT00347360|100479581|FG004|Overall Study|Subject refuse to sign updated consent|0|||
33437970|NCT03103100|101496202|FG002|Overall Study|Adverse Event|0|||
33437971|NCT03103100|101496200|FG000|Overall Study|Physician Decision|1|||
33437972|NCT03103100|101496201|FG001|Overall Study|Physician Decision|0|||
33437973|NCT03103100|101496202|FG002|Overall Study|Physician Decision|2|||
33154640|NCT00347360|100479582|FG005|Overall Study|Subject refuse to sign updated consent|0|||
33154641|NCT00347360|100479583|FG006|Overall Study|Subject refuse to sign updated consent|0|||
33154642|NCT00347360|100479584|FG007|Overall Study|Subject refuse to sign updated consent|0|||
33154643|NCT00347360|100479585|FG008|Overall Study|Subject refuse to sign updated consent|0|||
33154644|NCT00347360|100479586|FG009|Overall Study|Subject refuse to sign updated consent|0|||
33154645|NCT00347360|100479587|FG010|Overall Study|Subject refuse to sign updated consent|0|||
33154646|NCT00347360|100479588|FG011|Overall Study|Subject refuse to sign updated consent|0|||
33154647|NCT00347360|100479589|FG012|Overall Study|Subject refuse to sign updated consent|0|||
33154648|NCT00347360|100479590|FG013|Overall Study|Subject refuse to sign updated consent|0|||
33154649|NCT00347360|100479591|FG014|Overall Study|Subject refuse to sign updated consent|1|||
33154650|NCT00347360|100479577|FG000|Overall Study|Visits conflicted with new job|0|||
33154651|NCT00347360|100479578|FG001|Overall Study|Visits conflicted with new job|0|||
33154652|NCT00347360|100479579|FG002|Overall Study|Visits conflicted with new job|0|||
33154653|NCT00347360|100479580|FG003|Overall Study|Visits conflicted with new job|0|||
33154654|NCT00347360|100479581|FG004|Overall Study|Visits conflicted with new job|0|||
33154655|NCT00347360|100479582|FG005|Overall Study|Visits conflicted with new job|0|||
33154656|NCT00347360|100479583|FG006|Overall Study|Visits conflicted with new job|1|||
33154657|NCT00347360|100479584|FG007|Overall Study|Visits conflicted with new job|0|||
33154658|NCT00347360|100479585|FG008|Overall Study|Visits conflicted with new job|0|||
33154659|NCT00347360|100479586|FG009|Overall Study|Visits conflicted with new job|0|||
33154660|NCT00347360|100479587|FG010|Overall Study|Visits conflicted with new job|0|||
33154661|NCT00347360|100479588|FG011|Overall Study|Visits conflicted with new job|0|||
33154662|NCT00347360|100479589|FG012|Overall Study|Visits conflicted with new job|0|||
33154663|NCT00347360|100479590|FG013|Overall Study|Visits conflicted with new job|0|||
33154664|NCT00347360|100479591|FG014|Overall Study|Visits conflicted with new job|0|||
33154665|NCT02405780|100479592|FG000|Period I|Adverse Event|8|||
33252341|NCT02001623|100823654|FG013|Overall Study|Withdrawal by Subject|5|||
33252342|NCT02001623|100823655|FG014|Overall Study|Withdrawal by Subject|2|||
33252343|NCT02001623|100823641|FG000|Overall Study|Lost to Follow-up|0|||
33154666|NCT02405780|100479593|FG001|Period I|Adverse Event|0|||
33154667|NCT02405780|100479594|FG002|Period I|Adverse Event|3|||
33154668|NCT02405780|100479595|FG003|Period I|Adverse Event|7|||
33154669|NCT02405780|100479592|FG000|Period I|Medical reasons|1|||
33154670|NCT02405780|100479593|FG001|Period I|Medical reasons|1|||
33154671|NCT02405780|100479594|FG002|Period I|Medical reasons|0|||
33154672|NCT02405780|100479595|FG003|Period I|Medical reasons|1|||
33154673|NCT02405780|100479592|FG000|Period I|Screening Failure|1|||
33154674|NCT02405780|100479593|FG001|Period I|Screening Failure|0|||
33154675|NCT02405780|100479594|FG002|Period I|Screening Failure|1|||
33154676|NCT02405780|100479595|FG003|Period I|Screening Failure|0|||
33154677|NCT02405780|100479592|FG000|Period I|Withdrawal by Subject|9|||
33154678|NCT02405780|100479593|FG001|Period I|Withdrawal by Subject|1|||
33154679|NCT02405780|100479594|FG002|Period I|Withdrawal by Subject|3|||
33154680|NCT02405780|100479595|FG003|Period I|Withdrawal by Subject|4|||
33154681|NCT02405780|100479592|FG000|Period I|Non-compliance with study procedures|8|||
33154682|NCT02405780|100479593|FG001|Period I|Non-compliance with study procedures|6|||
33154683|NCT02405780|100479594|FG002|Period I|Non-compliance with study procedures|8|||
33154684|NCT02405780|100479595|FG003|Period I|Non-compliance with study procedures|11|||
33154685|NCT02405780|100479592|FG000|Period II|Adverse Event|3|||
33154686|NCT02405780|100479593|FG001|Period II|Adverse Event|5|||
33154687|NCT02405780|100479594|FG002|Period II|Adverse Event|4|||
33154688|NCT02405780|100479595|FG003|Period II|Adverse Event|11|||
33154689|NCT02405780|100479592|FG000|Period II|Medical reason|0|||
33154690|NCT02405780|100479593|FG001|Period II|Medical reason|1|||
33154691|NCT02405780|100479594|FG002|Period II|Medical reason|0|||
33154692|NCT02405780|100479595|FG003|Period II|Medical reason|0|||
33154693|NCT02405780|100479592|FG000|Period II|Pregnancy|0|||
33154694|NCT02405780|100479593|FG001|Period II|Pregnancy|0|||
33154695|NCT02405780|100479594|FG002|Period II|Pregnancy|1|||
33154696|NCT02405780|100479595|FG003|Period II|Pregnancy|0|||
33154697|NCT02405780|100479592|FG000|Period II|Withdrawal by Subject|7|||
33154698|NCT02405780|100479593|FG001|Period II|Withdrawal by Subject|4|||
33154699|NCT02405780|100479594|FG002|Period II|Withdrawal by Subject|0|||
33154700|NCT02405780|100479595|FG003|Period II|Withdrawal by Subject|3|||
33154701|NCT02405780|100479592|FG000|Period II|Non-compliance with study procedures|5|||
33154702|NCT02405780|100479593|FG001|Period II|Non-compliance with study procedures|2|||
33154703|NCT02405780|100479594|FG002|Period II|Non-compliance with study procedures|7|||
33154704|NCT02405780|100479595|FG003|Period II|Non-compliance with study procedures|4|||
33154705|NCT04729621|100479597|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
33154706|NCT04729621|100479598|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
33154707|NCT04729621|100479599|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
33154708|NCT04729621|100479600|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
33154709|NCT04729621|100479601|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
33154710|NCT04729621|100479597|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
33154711|NCT04729621|100479598|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
33154712|NCT04729621|100479599|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
33154713|NCT04729621|100479600|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
33154714|NCT04729621|100479601|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
33154715|NCT04729621|100479597|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
33154716|NCT04729621|100479598|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
33154717|NCT04729621|100479599|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
33154718|NCT04729621|100479600|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
33154719|NCT04729621|100479601|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
33154720|NCT04729621|100479597|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
33154721|NCT04729621|100479598|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
33154722|NCT04729621|100479599|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
33154723|NCT04729621|100479600|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
33154724|NCT04729621|100479601|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
33154725|NCT04729621|100479597|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
33154726|NCT04729621|100479598|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
33154727|NCT04729621|100479599|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
33154728|NCT04729621|100479600|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
33154729|NCT04729621|100479601|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
33154730|NCT04729621|100479597|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
33154731|NCT04729621|100479598|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
33154732|NCT04729621|100479599|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
33154733|NCT04729621|100479600|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
33154734|NCT04729621|100479601|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
33154735|NCT01811225|100479602|FG000|Treatment Period 1|Adverse Event|2|||
33154736|NCT01811225|100479603|FG001|Treatment Period 1|Adverse Event|3|||
33154737|NCT01811225|100479602|FG000|Treatment Period 1|Lost to Follow-up|12|||
33154738|NCT01811225|100479603|FG001|Treatment Period 1|Lost to Follow-up|8|||
33154739|NCT01811225|100479602|FG000|Treatment Period 1|transporation|1|||
33154740|NCT01811225|100479603|FG001|Treatment Period 1|transporation|0|||
33154741|NCT01811225|100479602|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
33387349|NCT02120352|101306298|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
33154742|NCT01811225|100479603|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
33154743|NCT01811225|100479602|FG000|Treatment Period 2|Lost to Follow-up|1|||
33154744|NCT01811225|100479603|FG001|Treatment Period 2|Lost to Follow-up|2|||
33154745|NCT01811225|100479602|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
33154746|NCT01811225|100479603|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
33154747|NCT01914757|100479604|FG000|Overall Study|Severe non-compliance to protocol|3|||
33154748|NCT01914757|100479605|FG001|Overall Study|Severe non-compliance to protocol|1|||
33154749|NCT01914757|100479606|FG002|Overall Study|Severe non-compliance to protocol|2|||
33154750|NCT01914757|100479604|FG000|Overall Study|Lost to Follow-up|5|||
33154751|NCT01914757|100479605|FG001|Overall Study|Lost to Follow-up|8|||
33154752|NCT01914757|100479606|FG002|Overall Study|Lost to Follow-up|6|||
33154753|NCT01914757|100479604|FG000|Overall Study|Withdrawal by Subject|15|||
33154754|NCT01914757|100479605|FG001|Overall Study|Withdrawal by Subject|27|||
33154755|NCT01914757|100479606|FG002|Overall Study|Withdrawal by Subject|19|||
33154756|NCT01914757|100479604|FG000|Overall Study|Death|2|||
33154757|NCT01914757|100479605|FG001|Overall Study|Death|2|||
33154758|NCT01914757|100479606|FG002|Overall Study|Death|1|||
33154759|NCT01914757|100479604|FG000|Overall Study|Adverse Event|4|||
33154760|NCT01914757|100479605|FG001|Overall Study|Adverse Event|3|||
33154761|NCT01914757|100479606|FG002|Overall Study|Adverse Event|4|||
33154762|NCT01914757|100479604|FG000|Overall Study|Study specific withdrawal criteria|0|||
33154763|NCT01914757|100479605|FG001|Overall Study|Study specific withdrawal criteria|1|||
33154764|NCT01914757|100479606|FG002|Overall Study|Study specific withdrawal criteria|0|||
33154765|NCT01914757|100479604|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
33154766|NCT01914757|100479605|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33154767|NCT01914757|100479606|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
33154768|NCT01914757|100479604|FG000|Overall Study|Other reasons|5|||
33154769|NCT01914757|100479605|FG001|Overall Study|Other reasons|9|||
33154770|NCT01914757|100479606|FG002|Overall Study|Other reasons|4|||
33154771|NCT01772160|100479607|FG000|Overall Study|Death|3|||
33154772|NCT01772160|100479607|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
33154773|NCT01772160|100479607|FG000|Overall Study|Consent withdrawal|3|||
33154774|NCT01772160|100479607|FG000|Overall Study|Migrated / moved from the study area|4|||
33154775|NCT01772160|100479607|FG000|Overall Study|Lost to Follow-up|30|||
33154776|NCT01772160|100479607|FG000|Overall Study|Other|5|||
33154777|NCT00451451|100479608|FG000|Overall Study|Adverse Event|11|||
33154778|NCT00451451|100479609|FG001|Overall Study|Adverse Event|21|||
33154779|NCT00451451|100479610|FG002|Overall Study|Adverse Event|26|||
33154780|NCT00451451|100479611|FG003|Overall Study|Adverse Event|10|||
33154781|NCT00451451|100479608|FG000|Overall Study|Lost to Follow-up|11|||
33154782|NCT00451451|100479609|FG001|Overall Study|Lost to Follow-up|9|||
33154783|NCT00451451|100479610|FG002|Overall Study|Lost to Follow-up|8|||
33154784|NCT00451451|100479611|FG003|Overall Study|Lost to Follow-up|11|||
33154785|NCT00451451|100479608|FG000|Overall Study|Consent Withdrawn|14|||
33154786|NCT00451451|100479609|FG001|Overall Study|Consent Withdrawn|9|||
33154787|NCT00451451|100479610|FG002|Overall Study|Consent Withdrawn|17|||
33154788|NCT00451451|100479611|FG003|Overall Study|Consent Withdrawn|17|||
33154789|NCT00451451|100479608|FG000|Overall Study|Investigator Decision|6|||
33154790|NCT00451451|100479609|FG001|Overall Study|Investigator Decision|2|||
33154791|NCT00451451|100479610|FG002|Overall Study|Investigator Decision|1|||
33154792|NCT00451451|100479611|FG003|Overall Study|Investigator Decision|2|||
33154793|NCT00451451|100479608|FG000|Overall Study|Subject Non-Compliance|8|||
33154794|NCT00451451|100479609|FG001|Overall Study|Subject Non-Compliance|4|||
33154795|NCT00451451|100479610|FG002|Overall Study|Subject Non-Compliance|3|||
33154796|NCT00451451|100479611|FG003|Overall Study|Subject Non-Compliance|3|||
33154797|NCT00451451|100479608|FG000|Overall Study|Death|1|||
33154798|NCT00451451|100479609|FG001|Overall Study|Death|0|||
33154799|NCT00451451|100479610|FG002|Overall Study|Death|0|||
33154800|NCT00451451|100479611|FG003|Overall Study|Death|1|||
33154801|NCT00451451|100479608|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
33154802|NCT00451451|100479609|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
33154803|NCT00451451|100479610|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
33154804|NCT00451451|100479611|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
33154805|NCT00839852|100479624|FG000|Overall Study|Adverse Event|10|||
33154806|NCT00839852|100479624|FG000|Overall Study|Insufficient Therapeutic Response|3|||
33154807|NCT00839852|100479624|FG000|Overall Study|Protocol Violation|9|||
33154808|NCT00839852|100479624|FG000|Overall Study|Withdrawal of Consent|16|||
33154809|NCT00839852|100479624|FG000|Overall Study|Lost to Follow-up|7|||
33154810|NCT00839852|100479624|FG000|Overall Study|Lack of Compliance While in Jail|1|||
33154811|NCT00839852|100479624|FG000|Overall Study|Pregnancy|1|||
33154812|NCT03307785|100479627|FG000|Part A: Up to 28.5 Months|Disease progression|2|||
33387350|NCT02120352|101306299|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
33154813|NCT03307785|100479628|FG001|Part A: Up to 28.5 Months|Disease progression|0|||
33154814|NCT03307785|100479629|FG002|Part A: Up to 28.5 Months|Disease progression|0|||
33154815|NCT03307785|100479630|FG003|Part A: Up to 28.5 Months|Disease progression|0|||
33154816|NCT03307785|100479631|FG004|Part A: Up to 28.5 Months|Disease progression|0|||
33154817|NCT03307785|100479632|FG005|Part A: Up to 28.5 Months|Disease progression|0|||
33154818|NCT03307785|100479633|FG006|Part A: Up to 28.5 Months|Disease progression|0|||
33154819|NCT03307785|100479634|FG007|Part A: Up to 28.5 Months|Disease progression|0|||
33154820|NCT03307785|100479635|FG008|Part A: Up to 28.5 Months|Disease progression|0|||
33154821|NCT03307785|100479636|FG009|Part A: Up to 28.5 Months|Disease progression|0|||
33154822|NCT03307785|100479637|FG010|Part A: Up to 28.5 Months|Disease progression|0|||
33154823|NCT03307785|100479627|FG000|Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
33154824|NCT03307785|100479628|FG001|Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
33154825|NCT03307785|100479629|FG002|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33154826|NCT03307785|100479630|FG003|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33154827|NCT03307785|100479631|FG004|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33154828|NCT03307785|100479632|FG005|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33154829|NCT03307785|100479633|FG006|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33154830|NCT03307785|100479634|FG007|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33154831|NCT03307785|100479635|FG008|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33437974|NCT03127137|101496203|FG000|Overall Study|Requested sedation after consent|1|||
33437975|NCT03127137|101496204|FG001|Overall Study|Requested sedation after consent|0|||
33437976|NCT03127137|101496203|FG000|Overall Study|Malfunction in electronic data collection|1|||
33437977|NCT03127137|101496204|FG001|Overall Study|Malfunction in electronic data collection|0|||
33437978|NCT03127137|101496203|FG000|Overall Study|Post procedure testing could not be obtained|0|||
33437979|NCT03127137|101496204|FG001|Overall Study|Post procedure testing could not be obtained|1|||
33437980|NCT01196052|101496205|FG000|Overall Study|Adverse Event|9|||
33437981|NCT01196052|101496205|FG000|Overall Study|Lost to Follow-up|1|||
33437982|NCT01196052|101496205|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
33437983|NCT01196052|101496205|FG000|Overall Study|Reason not Specified|5|||
33437984|NCT01196052|101496205|FG000|Overall Study|Withdrawal by Subject|6|||
33437985|NCT00001849|101496208|FG000|Overall Study|Death|4|||
33437986|NCT00001849|101496208|FG000|Overall Study|Lost to Follow-up|2|||
33437987|NCT00001849|101496208|FG000|Overall Study|Withdrawal by Subject|2|||
33437988|NCT00001849|101496208|FG000|Overall Study|tumor remained occult|6|||
33437989|NCT03312530|101496209|FG000|Overall Study|Death|5|||
33437990|NCT03312530|101496210|FG001|Overall Study|Death|5|||
33437991|NCT03312530|101496211|FG002|Overall Study|Death|4|||
33437992|NCT03312530|101496212|FG003|Overall Study|Death|10|||
33437993|NCT03312530|101496213|FG004|Overall Study|Death|8|||
33437994|NCT03312530|101496209|FG000|Overall Study|Lost to Follow-up|0|||
33437995|NCT03312530|101496210|FG001|Overall Study|Lost to Follow-up|0|||
33437996|NCT03312530|101496211|FG002|Overall Study|Lost to Follow-up|0|||
33437997|NCT03312530|101496212|FG003|Overall Study|Lost to Follow-up|1|||
33437998|NCT03312530|101496213|FG004|Overall Study|Lost to Follow-up|0|||
33437999|NCT03312530|101496209|FG000|Overall Study|Participant in another sponsor study.|0|||
33438000|NCT03312530|101496210|FG001|Overall Study|Participant in another sponsor study.|0|||
33438001|NCT03312530|101496211|FG002|Overall Study|Participant in another sponsor study.|0|||
33438002|NCT03312530|101496212|FG003|Overall Study|Participant in another sponsor study.|1|||
33438003|NCT03312530|101496213|FG004|Overall Study|Participant in another sponsor study.|0|||
33438004|NCT03312530|101496209|FG000|Overall Study|Study terminated by sponsor|1|||
33438005|NCT03312530|101496210|FG001|Overall Study|Study terminated by sponsor|0|||
33438006|NCT03312530|101496211|FG002|Overall Study|Study terminated by sponsor|2|||
33438007|NCT03312530|101496212|FG003|Overall Study|Study terminated by sponsor|3|||
33438008|NCT03312530|101496213|FG004|Overall Study|Study terminated by sponsor|7|||
33438009|NCT03312530|101496209|FG000|Overall Study|Withdrawal by Subject|0|||
33438010|NCT03312530|101496210|FG001|Overall Study|Withdrawal by Subject|1|||
33438011|NCT03312530|101496211|FG002|Overall Study|Withdrawal by Subject|0|||
33438012|NCT03312530|101496212|FG003|Overall Study|Withdrawal by Subject|0|||
33438013|NCT03312530|101496213|FG004|Overall Study|Withdrawal by Subject|0|||
33438014|NCT03312530|101496209|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
33438015|NCT03312530|101496210|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
33438016|NCT03312530|101496211|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
33252344|NCT02001623|100823642|FG001|Overall Study|Lost to Follow-up|0|||
33252345|NCT02001623|100823643|FG002|Overall Study|Lost to Follow-up|0|||
33252346|NCT02001623|100823644|FG003|Overall Study|Lost to Follow-up|0|||
33252347|NCT02001623|100823645|FG004|Overall Study|Lost to Follow-up|0|||
33252348|NCT02001623|100823646|FG005|Overall Study|Lost to Follow-up|0|||
33252349|NCT02001623|100823647|FG006|Overall Study|Lost to Follow-up|0|||
33438017|NCT03312530|101496212|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
33438018|NCT03312530|101496213|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
33438019|NCT00841100|101496214|FG000|Phase 1 (28 Days)|Adverse Event|1|||
33438020|NCT00841100|101496214|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
33438021|NCT01717976|101496215|FG000|Overall Study|Protocol Violation|0|||
33438022|NCT01717976|101496216|FG001|Overall Study|Protocol Violation|1|||
33438023|NCT00352690|101496221|FG000|Overall Study|Determined to be ineligible|2|||
33438024|NCT00352690|101496222|FG001|Overall Study|Determined to be ineligible|0|||
33438025|NCT02228382|101496223|FG000|Overall Study|Death|5|||
33438026|NCT02228382|101496224|FG001|Overall Study|Death|7|||
33438027|NCT02228382|101496225|FG002|Overall Study|Death|5|||
33438028|NCT02228382|101496226|FG003|Overall Study|Death|0|||
33438029|NCT02228382|101496227|FG004|Overall Study|Death|2|||
33438030|NCT02228382|101496223|FG000|Overall Study|Participant refused further follow-up|0|||
33154832|NCT03307785|100479636|FG009|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33154833|NCT03307785|100479637|FG010|Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
33154834|NCT03307785|100479627|FG000|Part A: Up to 28.5 Months|Death|4|||
33154835|NCT03307785|100479628|FG001|Part A: Up to 28.5 Months|Death|4|||
33387351|NCT02120352|101306300|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
33154836|NCT03307785|100479629|FG002|Part A: Up to 28.5 Months|Death|0|||
33154837|NCT03307785|100479630|FG003|Part A: Up to 28.5 Months|Death|0|||
33154838|NCT03307785|100479631|FG004|Part A: Up to 28.5 Months|Death|0|||
33154839|NCT03307785|100479632|FG005|Part A: Up to 28.5 Months|Death|0|||
33387352|NCT02120352|101306294|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
33387353|NCT02120352|101306295|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
33387354|NCT02120352|101306296|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
33387355|NCT02120352|101306297|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
33387356|NCT02120352|101306298|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
33387357|NCT02120352|101306299|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
33387358|NCT02120352|101306300|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
33387359|NCT02120352|101306294|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
33387360|NCT02120352|101306295|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
33387361|NCT02120352|101306296|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
33387362|NCT02120352|101306297|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
33387363|NCT02120352|101306298|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
33387364|NCT02120352|101306299|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
33387365|NCT02120352|101306300|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
33387366|NCT02120352|101306294|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
33387367|NCT02120352|101306295|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
33387368|NCT02120352|101306296|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
33387369|NCT02120352|101306297|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
33387370|NCT02120352|101306298|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
33387371|NCT02120352|101306299|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
33387372|NCT02120352|101306300|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
33387373|NCT02120352|101306294|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
33387374|NCT02120352|101306295|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
33387375|NCT02120352|101306296|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
33387376|NCT02120352|101306297|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
33438031|NCT02228382|101496224|FG001|Overall Study|Participant refused further follow-up|0|||
33438032|NCT02228382|101496225|FG002|Overall Study|Participant refused further follow-up|1|||
33438033|NCT02228382|101496226|FG003|Overall Study|Participant refused further follow-up|0|||
33154840|NCT03307785|100479633|FG006|Part A: Up to 28.5 Months|Death|0|||
33387377|NCT02120352|101306298|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
33387378|NCT02120352|101306299|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
33387379|NCT02120352|101306300|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
33387380|NCT02120352|101306294|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
33387381|NCT02120352|101306295|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
33387382|NCT02120352|101306296|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
33387383|NCT02120352|101306297|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
33387384|NCT02120352|101306298|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
33387385|NCT02120352|101306299|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
33387386|NCT02120352|101306300|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
33387387|NCT02120352|101306294|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
33387388|NCT02120352|101306295|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
33387389|NCT02120352|101306296|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
33387390|NCT02120352|101306297|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
33387391|NCT02120352|101306298|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
33387392|NCT02120352|101306299|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
33387393|NCT02120352|101306300|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
33387394|NCT02120352|101306294|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
33387395|NCT02120352|101306295|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
33387396|NCT02120352|101306296|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
33387397|NCT02120352|101306297|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
33387398|NCT02120352|101306298|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
33387399|NCT02120352|101306299|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
33387400|NCT02120352|101306300|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
33387401|NCT00640146|101306301|FG000|Overall Study|Adverse Event|2|||
33387402|NCT00640146|101306302|FG001|Overall Study|Adverse Event|0|||
33387403|NCT00640146|101306301|FG000|Overall Study|Lost to Follow-up|0|||
33438034|NCT02228382|101496227|FG004|Overall Study|Participant refused further follow-up|0|||
33438035|NCT02228382|101496223|FG000|Overall Study|Study terminated by sponsor|3|||
33438036|NCT02228382|101496224|FG001|Overall Study|Study terminated by sponsor|5|||
33438037|NCT02228382|101496225|FG002|Overall Study|Study terminated by sponsor|7|||
33438038|NCT02228382|101496226|FG003|Overall Study|Study terminated by sponsor|0|||
33438039|NCT02228382|101496227|FG004|Overall Study|Study terminated by sponsor|0|||
33438040|NCT02228382|101496223|FG000|Overall Study|Lost to Follow-up|0|||
33438041|NCT02228382|101496224|FG001|Overall Study|Lost to Follow-up|0|||
33438042|NCT02228382|101496225|FG002|Overall Study|Lost to Follow-up|3|||
33438043|NCT02228382|101496226|FG003|Overall Study|Lost to Follow-up|1|||
33438044|NCT02228382|101496227|FG004|Overall Study|Lost to Follow-up|0|||
33438045|NCT02228382|101496223|FG000|Overall Study|Withdrawal by Subject|0|||
33154841|NCT03307785|100479634|FG007|Part A: Up to 28.5 Months|Death|0|||
33154842|NCT03307785|100479635|FG008|Part A: Up to 28.5 Months|Death|0|||
33154843|NCT03307785|100479636|FG009|Part A: Up to 28.5 Months|Death|0|||
33154844|NCT03307785|100479637|FG010|Part A: Up to 28.5 Months|Death|0|||
33154845|NCT03307785|100479627|FG000|Part A: Up to 28.5 Months|Physician Decision|3|||
33154846|NCT03307785|100479628|FG001|Part A: Up to 28.5 Months|Physician Decision|1|||
33154847|NCT03307785|100479629|FG002|Part A: Up to 28.5 Months|Physician Decision|0|||
33154848|NCT03307785|100479630|FG003|Part A: Up to 28.5 Months|Physician Decision|0|||
33252350|NCT02001623|100823648|FG007|Overall Study|Lost to Follow-up|0|||
33252351|NCT02001623|100823649|FG008|Overall Study|Lost to Follow-up|0|||
33154849|NCT03307785|100479631|FG004|Part A: Up to 28.5 Months|Physician Decision|0|||
33154850|NCT03307785|100479632|FG005|Part A: Up to 28.5 Months|Physician Decision|0|||
33154851|NCT03307785|100479633|FG006|Part A: Up to 28.5 Months|Physician Decision|0|||
33154852|NCT03307785|100479634|FG007|Part A: Up to 28.5 Months|Physician Decision|0|||
33154853|NCT03307785|100479635|FG008|Part A: Up to 28.5 Months|Physician Decision|0|||
33154854|NCT03307785|100479636|FG009|Part A: Up to 28.5 Months|Physician Decision|0|||
33154855|NCT03307785|100479637|FG010|Part A: Up to 28.5 Months|Physician Decision|0|||
33154856|NCT03307785|100479627|FG000|Part B: Up to Approx. 66 Months|Disease progression|0|||
33154857|NCT03307785|100479628|FG001|Part B: Up to Approx. 66 Months|Disease progression|0|||
33154858|NCT03307785|100479629|FG002|Part B: Up to Approx. 66 Months|Disease progression|2|||
33154859|NCT03307785|100479630|FG003|Part B: Up to Approx. 66 Months|Disease progression|0|||
33154860|NCT03307785|100479631|FG004|Part B: Up to Approx. 66 Months|Disease progression|0|||
33154861|NCT03307785|100479632|FG005|Part B: Up to Approx. 66 Months|Disease progression|0|||
33154862|NCT03307785|100479633|FG006|Part B: Up to Approx. 66 Months|Disease progression|0|||
33154863|NCT03307785|100479634|FG007|Part B: Up to Approx. 66 Months|Disease progression|0|||
33154864|NCT03307785|100479635|FG008|Part B: Up to Approx. 66 Months|Disease progression|0|||
33252352|NCT02001623|100823650|FG009|Overall Study|Lost to Follow-up|1|||
33252353|NCT02001623|100823651|FG010|Overall Study|Lost to Follow-up|0|||
33252354|NCT02001623|100823652|FG011|Overall Study|Lost to Follow-up|0|||
33252355|NCT02001623|100823653|FG012|Overall Study|Lost to Follow-up|0|||
33252356|NCT02001623|100823654|FG013|Overall Study|Lost to Follow-up|0|||
33252357|NCT02001623|100823655|FG014|Overall Study|Lost to Follow-up|0|||
33252358|NCT02001623|100823641|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
33252359|NCT02001623|100823642|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
33387404|NCT00640146|101306302|FG001|Overall Study|Lost to Follow-up|1|||
33387405|NCT00640146|101306301|FG000|Overall Study|Lack of Efficacy|0|||
33387406|NCT00640146|101306302|FG001|Overall Study|Lack of Efficacy|1|||
33387407|NCT00640146|101306301|FG000|Overall Study|Withdrawal by Subject|1|||
33387408|NCT00640146|101306302|FG001|Overall Study|Withdrawal by Subject|1|||
33387409|NCT00640146|101306301|FG000|Overall Study|Randomized but not treated|1|||
33387410|NCT00640146|101306302|FG001|Overall Study|Randomized but not treated|3|||
33387411|NCT02709109|101306306|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
33387412|NCT02709109|101306307|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
33387413|NCT02709109|101306308|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
33387414|NCT02709109|101306309|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
33387415|NCT02709109|101306306|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
33387416|NCT02709109|101306307|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
33252360|NCT02001623|100823643|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
33252361|NCT02001623|100823644|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
33252362|NCT02001623|100823645|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
33252363|NCT02001623|100823646|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
33387417|NCT02709109|101306308|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
33438046|NCT02228382|101496224|FG001|Overall Study|Withdrawal by Subject|3|||
33387418|NCT02709109|101306309|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
33387419|NCT02709109|101306306|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
33438047|NCT02228382|101496225|FG002|Overall Study|Withdrawal by Subject|2|||
33154865|NCT03307785|100479636|FG009|Part B: Up to Approx. 66 Months|Disease progression|0|||
33154866|NCT03307785|100479637|FG010|Part B: Up to Approx. 66 Months|Disease progression|0|||
33154867|NCT03307785|100479627|FG000|Part B: Up to Approx. 66 Months|Death|0|||
33154868|NCT03307785|100479628|FG001|Part B: Up to Approx. 66 Months|Death|0|||
33252364|NCT02001623|100823647|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
33387420|NCT02709109|101306307|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
33387421|NCT02709109|101306308|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
33154869|NCT03307785|100479629|FG002|Part B: Up to Approx. 66 Months|Death|7|||
33438048|NCT02228382|101496226|FG003|Overall Study|Withdrawal by Subject|1|||
33438049|NCT02228382|101496227|FG004|Overall Study|Withdrawal by Subject|0|||
33438050|NCT02228382|101496223|FG000|Overall Study|Other|2|||
33438051|NCT02228382|101496224|FG001|Overall Study|Other|3|||
33438052|NCT02228382|101496225|FG002|Overall Study|Other|3|||
33438053|NCT02228382|101496226|FG003|Overall Study|Other|0|||
33438054|NCT02228382|101496227|FG004|Overall Study|Other|0|||
33438055|NCT03361228|101496229|FG000|Overall Study|Other|1|||
33438056|NCT03361228|101496230|FG001|Overall Study|Other|1|||
33438057|NCT03361228|101496229|FG000|Overall Study|Death|3|||
33438058|NCT03361228|101496230|FG001|Overall Study|Death|0|||
33438059|NCT03093324|101496231|FG000|Overall Study|Adverse Event|4|||
33438060|NCT03093324|101496232|FG001|Overall Study|Adverse Event|15|||
33438061|NCT03093324|101496231|FG000|Overall Study|Lost to Follow-up|1|||
33438062|NCT03093324|101496232|FG001|Overall Study|Lost to Follow-up|0|||
33438063|NCT03093324|101496231|FG000|Overall Study|Protocol Deviation|2|||
33438064|NCT03093324|101496232|FG001|Overall Study|Protocol Deviation|2|||
33438065|NCT03093324|101496231|FG000|Overall Study|Withdrawal by Subject|2|||
33438066|NCT03093324|101496232|FG001|Overall Study|Withdrawal by Subject|2|||
33438067|NCT01402908|101496233|FG000|Overall Study|Withdrawal by Subject|30|||
33438068|NCT01402908|101496234|FG001|Overall Study|Withdrawal by Subject|17|||
33438069|NCT01402908|101496233|FG000|Overall Study|Lost to Follow-up|3|||
33387422|NCT02709109|101306309|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
33387423|NCT02709109|101306306|FG000|Washout Period (28 Days)|Other|2|||
33387424|NCT02709109|101306307|FG001|Washout Period (28 Days)|Other|2|||
33387425|NCT02709109|101306308|FG002|Washout Period (28 Days)|Other|3|||
33387426|NCT02709109|101306309|FG003|Washout Period (28 Days)|Other|0|||
33387427|NCT02709109|101306306|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
33387428|NCT02709109|101306307|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
33387429|NCT02709109|101306308|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
33387430|NCT02709109|101306309|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
33387431|NCT02709109|101306306|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
33387432|NCT02709109|101306307|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
33387433|NCT02709109|101306308|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
33387434|NCT02709109|101306309|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
33387435|NCT02709109|101306306|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
33387436|NCT02709109|101306307|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
33387437|NCT02709109|101306308|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
33387438|NCT02709109|101306309|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
33387439|NCT02709109|101306306|FG000|Treatment Period 2 (28 Days)|Other|0|||
33387440|NCT02709109|101306307|FG001|Treatment Period 2 (28 Days)|Other|0|||
33387441|NCT02709109|101306308|FG002|Treatment Period 2 (28 Days)|Other|1|||
33387442|NCT02709109|101306309|FG003|Treatment Period 2 (28 Days)|Other|0|||
33387443|NCT02455388|101306310|FG000|Overall Study|Protocol Violation|1|||
33387444|NCT02455388|101306311|FG001|Overall Study|Protocol Violation|0|||
33387445|NCT02455388|101306312|FG002|Overall Study|Protocol Violation|4|||
33387446|NCT02455388|101306310|FG000|Overall Study|Withdrawal by Subject|0|||
33387447|NCT02455388|101306311|FG001|Overall Study|Withdrawal by Subject|0|||
33387448|NCT02455388|101306312|FG002|Overall Study|Withdrawal by Subject|7|||
33387449|NCT03934541|101306315|FG000|Overall Study|Study Terminated by Sponsor|0|||
33387450|NCT03934541|101306316|FG001|Overall Study|Study Terminated by Sponsor|1|||
33387451|NCT03934541|101306317|FG002|Overall Study|Study Terminated by Sponsor|0|||
33387452|NCT03934541|101306318|FG003|Overall Study|Study Terminated by Sponsor|0|||
33438070|NCT01402908|101496234|FG001|Overall Study|Lost to Follow-up|1|||
33154870|NCT03307785|100479630|FG003|Part B: Up to Approx. 66 Months|Death|0|||
33438071|NCT01402908|101496233|FG000|Overall Study|Physician Decision|1|||
33438072|NCT01402908|101496234|FG001|Overall Study|Physician Decision|0|||
33154871|NCT03307785|100479631|FG004|Part B: Up to Approx. 66 Months|Death|0|||
33154872|NCT03307785|100479632|FG005|Part B: Up to Approx. 66 Months|Death|0|||
33154873|NCT03307785|100479633|FG006|Part B: Up to Approx. 66 Months|Death|0|||
33154874|NCT03307785|100479634|FG007|Part B: Up to Approx. 66 Months|Death|0|||
33154875|NCT03307785|100479635|FG008|Part B: Up to Approx. 66 Months|Death|0|||
33154876|NCT03307785|100479636|FG009|Part B: Up to Approx. 66 Months|Death|0|||
33154877|NCT03307785|100479637|FG010|Part B: Up to Approx. 66 Months|Death|0|||
33154878|NCT03307785|100479627|FG000|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
33154879|NCT03307785|100479628|FG001|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
33252365|NCT02001623|100823648|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
33252366|NCT02001623|100823649|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
33252367|NCT02001623|100823650|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
33252368|NCT02001623|100823651|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
33154880|NCT03307785|100479629|FG002|Part B: Up to Approx. 66 Months|Withdrawal by Subject|2|||
33154881|NCT03307785|100479630|FG003|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
33154882|NCT03307785|100479631|FG004|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
33252369|NCT02001623|100823652|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
33252370|NCT02001623|100823653|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
33252371|NCT02001623|100823654|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
33252372|NCT02001623|100823655|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
33252373|NCT02001623|100823641|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
33252374|NCT02001623|100823642|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
33252375|NCT02001623|100823643|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
33252376|NCT02001623|100823644|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
33252377|NCT02001623|100823645|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
33252378|NCT02001623|100823646|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
33252379|NCT02001623|100823647|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
33252380|NCT02001623|100823648|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
33252381|NCT02001623|100823649|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
33252382|NCT02001623|100823650|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
33252383|NCT02001623|100823651|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
33252384|NCT02001623|100823652|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
33252385|NCT02001623|100823653|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
33252386|NCT02001623|100823654|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
33252387|NCT02001623|100823655|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
33252388|NCT01466881|100823656|FG000|Overall Study|Ineligible|5|||
33252389|NCT01466881|100823656|FG000|Overall Study|Adverse Event|6|||
33252390|NCT01466881|100823656|FG000|Overall Study|Progression/relapse|20|||
33252391|NCT01466881|100823656|FG000|Overall Study|Death|4|||
33252392|NCT01466881|100823656|FG000|Overall Study|Other reason not protocol specified|5|||
33252393|NCT01909778|100823657|FG000|Overall Study|failed screening|1|||
33252394|NCT01597258|100823658|FG000|Overall Study|No Drug Administration|1|||
33252395|NCT03959241|100823659|FG000|Overall Study|Withdrawal by Subject|7|||
33252396|NCT03959241|100823660|FG001|Overall Study|Withdrawal by Subject|8|||
33252397|NCT03959241|100823659|FG000|Overall Study|Lost to Follow-up|1|||
33387453|NCT03483116|101306321|FG000|Overall Study|Adverse Event|0|||
33252398|NCT03959241|100823660|FG001|Overall Study|Lost to Follow-up|0|||
33252399|NCT03959241|100823659|FG000|Overall Study|Move to Hospice Care|1|||
33252400|NCT03959241|100823660|FG001|Overall Study|Move to Hospice Care|0|||
33252401|NCT03959241|100823659|FG000|Overall Study|Screen Failure|1|||
33252402|NCT03959241|100823660|FG001|Overall Study|Screen Failure|0|||
33252403|NCT03959241|100823659|FG000|Overall Study|Disease Relapse|0|||
33438073|NCT01259869|101496252|FG000|Overall Study|Duplicated registration|1|||
33252404|NCT03959241|100823660|FG001|Overall Study|Disease Relapse|1|||
33438074|NCT01469364|101496253|FG000|Overall Study|Adverse Event|1|||
33438075|NCT01469364|101496253|FG000|Overall Study|Withdrawal by Subject|1|||
33438076|NCT01124149|101496256|FG000|Acute Phase|Withdrawal by Subject|22|||
33438077|NCT01124149|101496256|FG000|Acute Phase|Adverse Event|21|||
33438078|NCT01124149|101496256|FG000|Acute Phase|Lack of Efficacy|17|||
33438079|NCT01124149|101496256|FG000|Acute Phase|Protocol Violation|14|||
33438080|NCT01124149|101496256|FG000|Acute Phase|Lost to Follow-up|2|||
33438081|NCT01124149|101496256|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
33438082|NCT01124149|101496256|FG000|Acute Phase|Sponsor request|1|||
33438083|NCT01124149|101496256|FG000|Acute Phase|UC symptoms not ameliorated|1|||
33438084|NCT01124149|101496256|FG000|Acute Phase|Non-compliance|1|||
33252405|NCT03959241|100823659|FG000|Overall Study|Off Study|1|||
33252406|NCT03959241|100823660|FG001|Overall Study|Off Study|0|||
33252407|NCT02049866|100823661|FG000|Overall Study|Withdrawal by Subject|1|||
33252408|NCT02534350|100823663|FG000|Overall Study|Randomized But Not Treated|1|||
33252409|NCT02534350|100823664|FG001|Overall Study|Randomized But Not Treated|0|||
33252410|NCT02534350|100823663|FG000|Overall Study|Protocol Violation|1|||
33252411|NCT02534350|100823664|FG001|Overall Study|Protocol Violation|0|||
33252412|NCT02534350|100823663|FG000|Overall Study|Withdrew Consent|2|||
33252413|NCT02534350|100823664|FG001|Overall Study|Withdrew Consent|0|||
33252414|NCT03185819|100823665|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
33252415|NCT03185819|100823666|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
33252416|NCT03185819|100823667|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
33252417|NCT03185819|100823668|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
33252418|NCT03185819|100823665|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
33252419|NCT03185819|100823666|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
33252420|NCT03185819|100823667|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
33252421|NCT03185819|100823668|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
33252422|NCT03185819|100823665|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
33252423|NCT03185819|100823666|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
33252424|NCT03185819|100823667|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
33387454|NCT03483116|101306322|FG001|Overall Study|Adverse Event|1|||
33387455|NCT03483116|101306323|FG002|Overall Study|Adverse Event|0|||
33387456|NCT03483116|101306324|FG003|Overall Study|Adverse Event|1|||
33387457|NCT03483116|101306321|FG000|Overall Study|Protocol Violation|1|||
33387458|NCT03483116|101306322|FG001|Overall Study|Protocol Violation|0|||
33387459|NCT03483116|101306323|FG002|Overall Study|Protocol Violation|0|||
33387460|NCT03483116|101306324|FG003|Overall Study|Protocol Violation|7|||
33252425|NCT03185819|100823668|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
33252426|NCT03185819|100823665|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
33387461|NCT03483116|101306321|FG000|Overall Study|Lost to Follow-up|9|||
33387462|NCT03483116|101306322|FG001|Overall Study|Lost to Follow-up|4|||
33387463|NCT03483116|101306323|FG002|Overall Study|Lost to Follow-up|9|||
33387464|NCT03483116|101306324|FG003|Overall Study|Lost to Follow-up|5|||
33438085|NCT01124149|101496256|FG000|Acute Phase|Low hemoglobin|1|||
33154883|NCT03307785|100479632|FG005|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
33154884|NCT03307785|100479633|FG006|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
33154885|NCT03307785|100479634|FG007|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
33154886|NCT03307785|100479635|FG008|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
33154887|NCT03307785|100479636|FG009|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
33154888|NCT03307785|100479637|FG010|Part B: Up to Approx. 66 Months|Withdrawal by Subject|0|||
33154889|NCT03307785|100479627|FG000|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
33154890|NCT03307785|100479628|FG001|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
33154891|NCT03307785|100479629|FG002|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|2|||
33154892|NCT03307785|100479630|FG003|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
33154893|NCT03307785|100479631|FG004|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
33154894|NCT03307785|100479632|FG005|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
33154895|NCT03307785|100479633|FG006|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
33387465|NCT03483116|101306321|FG000|Overall Study|Death|1|||
33387466|NCT03483116|101306322|FG001|Overall Study|Death|0|||
33387467|NCT03483116|101306323|FG002|Overall Study|Death|2|||
33387468|NCT03483116|101306324|FG003|Overall Study|Death|1|||
33387469|NCT03483116|101306321|FG000|Overall Study|Withdrawal by Subject|14|||
33387470|NCT03483116|101306322|FG001|Overall Study|Withdrawal by Subject|16|||
33387471|NCT03483116|101306323|FG002|Overall Study|Withdrawal by Subject|14|||
33438086|NCT01124149|101496256|FG000|Acute Phase|Travelling to another country|1|||
33438087|NCT01124149|101496256|FG000|Acute Phase|Sponsor decision|1|||
33438088|NCT01124149|101496256|FG000|Maintenance Phase|Lack of Efficacy|40|||
33438089|NCT01124149|101496256|FG000|Maintenance Phase|Adverse Event|24|||
33438090|NCT01124149|101496256|FG000|Maintenance Phase|Lost to Follow-up|15|||
33438091|NCT01124149|101496256|FG000|Maintenance Phase|Withdrawal by Subject|10|||
33438092|NCT01124149|101496256|FG000|Maintenance Phase|Protocol Violation|5|||
33438093|NCT01124149|101496256|FG000|Maintenance Phase|Coordinator error|1|||
33438094|NCT01124149|101496256|FG000|Maintenance Phase|Non-compliance|1|||
33438095|NCT02388763|101496260|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
33438096|NCT02388763|101496261|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
33438097|NCT02388763|101496260|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
33438098|NCT02388763|101496261|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
33438099|NCT00220701|101496262|FG000|Overall Study|Lost to Follow-up|5|||
33438100|NCT00220701|101496263|FG001|Overall Study|Lost to Follow-up|4|||
33438101|NCT02999178|101496270|FG000|Overall Study|Adverse Event|85|||
33438102|NCT02999178|101496271|FG001|Overall Study|Adverse Event|62|||
33438103|NCT02999178|101496270|FG000|Overall Study|Protocol Violation|1|||
33438104|NCT02999178|101496271|FG001|Overall Study|Protocol Violation|2|||
33438105|NCT02999178|101496270|FG000|Overall Study|Lost to Follow-up|0|||
33438106|NCT02999178|101496271|FG001|Overall Study|Lost to Follow-up|2|||
33438107|NCT02999178|101496270|FG000|Overall Study|Withdrawal by Subject|21|||
33438108|NCT02999178|101496271|FG001|Overall Study|Withdrawal by Subject|21|||
33438109|NCT02999178|101496270|FG000|Overall Study|Other reason not defined above|7|||
33438110|NCT02999178|101496271|FG001|Overall Study|Other reason not defined above|13|||
33438111|NCT00973700|101496272|FG000|Overall Study|Withdrawal by Subject|2|||
33438112|NCT00973700|101496273|FG001|Overall Study|Withdrawal by Subject|2|||
33438113|NCT00973700|101496274|FG002|Overall Study|Withdrawal by Subject|8|||
33438114|NCT00973700|101496275|FG003|Overall Study|Withdrawal by Subject|4|||
33438115|NCT00973700|101496276|FG004|Overall Study|Withdrawal by Subject|4|||
33438116|NCT00973700|101496272|FG000|Overall Study|Lost to Follow-up|5|||
33438117|NCT00973700|101496273|FG001|Overall Study|Lost to Follow-up|0|||
33438118|NCT00973700|101496274|FG002|Overall Study|Lost to Follow-up|1|||
33438119|NCT00973700|101496275|FG003|Overall Study|Lost to Follow-up|8|||
33438120|NCT00973700|101496276|FG004|Overall Study|Lost to Follow-up|5|||
33438121|NCT00973700|101496272|FG000|Overall Study|Inappropriate enrolment|0|||
33438122|NCT00973700|101496273|FG001|Overall Study|Inappropriate enrolment|0|||
33438123|NCT00973700|101496274|FG002|Overall Study|Inappropriate enrolment|0|||
33438124|NCT00973700|101496275|FG003|Overall Study|Inappropriate enrolment|4|||
33438125|NCT00973700|101496276|FG004|Overall Study|Inappropriate enrolment|0|||
33438126|NCT00973700|101496272|FG000|Overall Study|Unable to Classify|0|||
33438127|NCT00973700|101496273|FG001|Overall Study|Unable to Classify|0|||
33387472|NCT03483116|101306324|FG003|Overall Study|Withdrawal by Subject|16|||
33438128|NCT00973700|101496274|FG002|Overall Study|Unable to Classify|1|||
33438129|NCT00973700|101496275|FG003|Overall Study|Unable to Classify|2|||
33438130|NCT00973700|101496276|FG004|Overall Study|Unable to Classify|1|||
33438131|NCT02848326|101496277|FG000|Treatment Period|Adverse Event|5|||
33438132|NCT02848326|101496278|FG001|Treatment Period|Adverse Event|4|||
33438133|NCT02848326|101496279|FG002|Treatment Period|Adverse Event|11|||
33438134|NCT02848326|101496280|FG003|Treatment Period|Adverse Event|6|||
33438135|NCT02848326|101496281|FG004|Treatment Period|Adverse Event|5|||
33387473|NCT03483116|101306321|FG000|Overall Study|Unknown other reason|3|||
33387474|NCT03483116|101306322|FG001|Overall Study|Unknown other reason|2|||
33438136|NCT02848326|101496282|FG005|Treatment Period|Adverse Event|7|||
33154896|NCT03307785|100479634|FG007|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
33154897|NCT03307785|100479635|FG008|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
33154898|NCT03307785|100479636|FG009|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
33154899|NCT03307785|100479637|FG010|Part B: Up to Approx. 66 Months|Ongoing With Treatment in PACT phase|0|||
33154900|NCT03307785|100479627|FG000|Part B: Up to Approx. 66 Months|Physician Decision|0|||
33154901|NCT03307785|100479628|FG001|Part B: Up to Approx. 66 Months|Physician Decision|0|||
33154902|NCT03307785|100479629|FG002|Part B: Up to Approx. 66 Months|Physician Decision|1|||
33154903|NCT03307785|100479630|FG003|Part B: Up to Approx. 66 Months|Physician Decision|0|||
33154904|NCT03307785|100479631|FG004|Part B: Up to Approx. 66 Months|Physician Decision|0|||
33154905|NCT03307785|100479632|FG005|Part B: Up to Approx. 66 Months|Physician Decision|0|||
33154906|NCT03307785|100479633|FG006|Part B: Up to Approx. 66 Months|Physician Decision|0|||
33154907|NCT03307785|100479634|FG007|Part B: Up to Approx. 66 Months|Physician Decision|0|||
33154908|NCT03307785|100479635|FG008|Part B: Up to Approx. 66 Months|Physician Decision|0|||
33154909|NCT03307785|100479636|FG009|Part B: Up to Approx. 66 Months|Physician Decision|0|||
33154910|NCT03307785|100479637|FG010|Part B: Up to Approx. 66 Months|Physician Decision|0|||
33154911|NCT03307785|100479627|FG000|Part C: Up to Approx. 60 Months|Physician Decision|0|||
33154912|NCT03307785|100479628|FG001|Part C: Up to Approx. 60 Months|Physician Decision|0|||
33154913|NCT03307785|100479629|FG002|Part C: Up to Approx. 60 Months|Physician Decision|0|||
33154914|NCT03307785|100479630|FG003|Part C: Up to Approx. 60 Months|Physician Decision|3|||
33154915|NCT03307785|100479631|FG004|Part C: Up to Approx. 60 Months|Physician Decision|1|||
33154916|NCT03307785|100479632|FG005|Part C: Up to Approx. 60 Months|Physician Decision|0|||
33154917|NCT03307785|100479633|FG006|Part C: Up to Approx. 60 Months|Physician Decision|0|||
33154918|NCT03307785|100479634|FG007|Part C: Up to Approx. 60 Months|Physician Decision|0|||
33154919|NCT03307785|100479635|FG008|Part C: Up to Approx. 60 Months|Physician Decision|0|||
33154920|NCT03307785|100479636|FG009|Part C: Up to Approx. 60 Months|Physician Decision|0|||
33154921|NCT03307785|100479637|FG010|Part C: Up to Approx. 60 Months|Physician Decision|0|||
33154922|NCT03307785|100479627|FG000|Part C: Up to Approx. 60 Months|Death|0|||
33154923|NCT03307785|100479628|FG001|Part C: Up to Approx. 60 Months|Death|0|||
33154924|NCT03307785|100479629|FG002|Part C: Up to Approx. 60 Months|Death|0|||
33154925|NCT03307785|100479630|FG003|Part C: Up to Approx. 60 Months|Death|2|||
33154926|NCT03307785|100479631|FG004|Part C: Up to Approx. 60 Months|Death|5|||
33154927|NCT03307785|100479632|FG005|Part C: Up to Approx. 60 Months|Death|0|||
33154928|NCT03307785|100479633|FG006|Part C: Up to Approx. 60 Months|Death|0|||
33154929|NCT03307785|100479634|FG007|Part C: Up to Approx. 60 Months|Death|0|||
33154930|NCT03307785|100479635|FG008|Part C: Up to Approx. 60 Months|Death|0|||
33154931|NCT03307785|100479636|FG009|Part C: Up to Approx. 60 Months|Death|0|||
33154932|NCT03307785|100479637|FG010|Part C: Up to Approx. 60 Months|Death|0|||
33154933|NCT03307785|100479627|FG000|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
33154934|NCT03307785|100479628|FG001|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
33154935|NCT03307785|100479629|FG002|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
33154936|NCT03307785|100479630|FG003|Part C: Up to Approx. 60 Months|Withdrawal by Subject|1|||
33252427|NCT03185819|100823666|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
33252428|NCT03185819|100823667|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
33252429|NCT03185819|100823668|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
33252430|NCT03185819|100823665|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
33252431|NCT03185819|100823666|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
33154937|NCT03307785|100479631|FG004|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
33154938|NCT03307785|100479632|FG005|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
33154939|NCT03307785|100479633|FG006|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
33154940|NCT03307785|100479634|FG007|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
33154941|NCT03307785|100479635|FG008|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
33154942|NCT03307785|100479636|FG009|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
33154943|NCT03307785|100479637|FG010|Part C: Up to Approx. 60 Months|Withdrawal by Subject|0|||
33154944|NCT03307785|100479627|FG000|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
33154945|NCT03307785|100479628|FG001|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
33154946|NCT03307785|100479629|FG002|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
33154947|NCT03307785|100479630|FG003|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
33154948|NCT03307785|100479631|FG004|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|1|||
33154949|NCT03307785|100479632|FG005|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
33154950|NCT03307785|100479633|FG006|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
33154951|NCT03307785|100479634|FG007|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
33154952|NCT03307785|100479635|FG008|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
33154953|NCT03307785|100479636|FG009|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
33154954|NCT03307785|100479637|FG010|Part C: Up to Approx. 60 Months|Went on Another Clinical Trial|0|||
33154955|NCT03307785|100479627|FG000|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
33154956|NCT03307785|100479628|FG001|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
33154957|NCT03307785|100479629|FG002|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
33154958|NCT03307785|100479630|FG003|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
33154959|NCT03307785|100479631|FG004|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
33154960|NCT03307785|100479632|FG005|Part D: Up to Approx. 62.5 Months|Physician Decision|2|||
33154961|NCT03307785|100479633|FG006|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
33154962|NCT03307785|100479634|FG007|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
33154963|NCT03307785|100479635|FG008|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
33154964|NCT03307785|100479636|FG009|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
33154965|NCT03307785|100479637|FG010|Part D: Up to Approx. 62.5 Months|Physician Decision|0|||
33154966|NCT03307785|100479627|FG000|Part D: Up to Approx. 62.5 Months|Death|0|||
33154967|NCT03307785|100479628|FG001|Part D: Up to Approx. 62.5 Months|Death|0|||
33154968|NCT03307785|100479629|FG002|Part D: Up to Approx. 62.5 Months|Death|0|||
33154969|NCT03307785|100479630|FG003|Part D: Up to Approx. 62.5 Months|Death|0|||
33154970|NCT03307785|100479631|FG004|Part D: Up to Approx. 62.5 Months|Death|0|||
33154971|NCT03307785|100479632|FG005|Part D: Up to Approx. 62.5 Months|Death|1|||
33154972|NCT03307785|100479633|FG006|Part D: Up to Approx. 62.5 Months|Death|0|||
33154973|NCT03307785|100479634|FG007|Part D: Up to Approx. 62.5 Months|Death|0|||
33154974|NCT03307785|100479635|FG008|Part D: Up to Approx. 62.5 Months|Death|0|||
33154975|NCT03307785|100479636|FG009|Part D: Up to Approx. 62.5 Months|Death|0|||
33154976|NCT03307785|100479637|FG010|Part D: Up to Approx. 62.5 Months|Death|0|||
33154977|NCT03307785|100479627|FG000|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
33154978|NCT03307785|100479628|FG001|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
33154979|NCT03307785|100479629|FG002|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
33154980|NCT03307785|100479630|FG003|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
33154981|NCT03307785|100479631|FG004|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
33154982|NCT03307785|100479632|FG005|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|1|||
33154983|NCT03307785|100479633|FG006|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
33154984|NCT03307785|100479634|FG007|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
33154985|NCT03307785|100479635|FG008|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
33154986|NCT03307785|100479636|FG009|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
33154987|NCT03307785|100479637|FG010|Part D: Up to Approx. 62.5 Months|Withdrawal by Subject|0|||
33154988|NCT03307785|100479627|FG000|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
33154989|NCT03307785|100479628|FG001|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
33154990|NCT03307785|100479629|FG002|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
33154991|NCT03307785|100479630|FG003|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
33154992|NCT03307785|100479631|FG004|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
33154993|NCT03307785|100479632|FG005|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|1|||
33154994|NCT03307785|100479633|FG006|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
33154995|NCT03307785|100479634|FG007|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
33154996|NCT03307785|100479635|FG008|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
33154997|NCT03307785|100479636|FG009|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
33154998|NCT03307785|100479637|FG010|Part D: Up to Approx. 62.5 Months|Ongoing With Treatment in PACT phase|0|||
33154999|NCT03307785|100479627|FG000|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
33155000|NCT03307785|100479628|FG001|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
33387475|NCT03483116|101306323|FG002|Overall Study|Unknown other reason|1|||
33387476|NCT03483116|101306324|FG003|Overall Study|Unknown other reason|1|||
33387477|NCT03339401|101306325|FG000|Overall Study|Death|2|||
33387478|NCT03339401|101306326|FG001|Overall Study|Death|1|||
33155001|NCT03307785|100479629|FG002|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
33387479|NCT03339401|101306325|FG000|Overall Study|Withdrawal by Subject|2|||
33387480|NCT03339401|101306326|FG001|Overall Study|Withdrawal by Subject|0|||
33387481|NCT03339401|101306325|FG000|Overall Study|Study terminated|4|||
33387482|NCT03339401|101306326|FG001|Overall Study|Study terminated|3|||
33438137|NCT02848326|101496277|FG000|Treatment Period|Withdrawal of Consent|20|||
33438138|NCT02848326|101496278|FG001|Treatment Period|Withdrawal of Consent|6|||
33438139|NCT02848326|101496279|FG002|Treatment Period|Withdrawal of Consent|9|||
33438140|NCT02848326|101496280|FG003|Treatment Period|Withdrawal of Consent|6|||
33438141|NCT02848326|101496281|FG004|Treatment Period|Withdrawal of Consent|9|||
33438142|NCT02848326|101496282|FG005|Treatment Period|Withdrawal of Consent|6|||
33438143|NCT02848326|101496277|FG000|Treatment Period|Lost to Follow-up|5|||
33155002|NCT03307785|100479630|FG003|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
33155003|NCT03307785|100479631|FG004|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
33155004|NCT03307785|100479632|FG005|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|1|||
33155005|NCT03307785|100479633|FG006|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
33155006|NCT03307785|100479634|FG007|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
33155007|NCT03307785|100479635|FG008|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
33155008|NCT03307785|100479636|FG009|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
33155009|NCT03307785|100479637|FG010|Part D: Up to Approx. 62.5 Months|Completed EOT and Began New Study|0|||
33155010|NCT03307785|100479627|FG000|Part E: Up to 4.4 Months|Death|0|||
33155011|NCT03307785|100479628|FG001|Part E: Up to 4.4 Months|Death|0|||
33155012|NCT03307785|100479629|FG002|Part E: Up to 4.4 Months|Death|0|||
33155013|NCT03307785|100479630|FG003|Part E: Up to 4.4 Months|Death|0|||
33155014|NCT03307785|100479631|FG004|Part E: Up to 4.4 Months|Death|0|||
33155015|NCT03307785|100479632|FG005|Part E: Up to 4.4 Months|Death|0|||
33155016|NCT03307785|100479633|FG006|Part E: Up to 4.4 Months|Death|1|||
33155017|NCT03307785|100479634|FG007|Part E: Up to 4.4 Months|Death|0|||
33155018|NCT03307785|100479635|FG008|Part E: Up to 4.4 Months|Death|0|||
33155019|NCT03307785|100479636|FG009|Part E: Up to 4.4 Months|Death|0|||
33155020|NCT03307785|100479637|FG010|Part E: Up to 4.4 Months|Death|0|||
33155021|NCT03307785|100479627|FG000|Part E: Up to 4.4 Months|Physician Decision|0|||
33155022|NCT03307785|100479628|FG001|Part E: Up to 4.4 Months|Physician Decision|0|||
33155023|NCT03307785|100479629|FG002|Part E: Up to 4.4 Months|Physician Decision|0|||
33155024|NCT03307785|100479630|FG003|Part E: Up to 4.4 Months|Physician Decision|0|||
33155025|NCT03307785|100479631|FG004|Part E: Up to 4.4 Months|Physician Decision|0|||
33155026|NCT03307785|100479632|FG005|Part E: Up to 4.4 Months|Physician Decision|0|||
33155027|NCT03307785|100479633|FG006|Part E: Up to 4.4 Months|Physician Decision|1|||
33155028|NCT03307785|100479634|FG007|Part E: Up to 4.4 Months|Physician Decision|0|||
33155029|NCT03307785|100479635|FG008|Part E: Up to 4.4 Months|Physician Decision|0|||
33155030|NCT03307785|100479636|FG009|Part E: Up to 4.4 Months|Physician Decision|0|||
33155031|NCT03307785|100479637|FG010|Part E: Up to 4.4 Months|Physician Decision|0|||
33438144|NCT02848326|101496278|FG001|Treatment Period|Lost to Follow-up|1|||
33438145|NCT02848326|101496279|FG002|Treatment Period|Lost to Follow-up|11|||
33438146|NCT02848326|101496280|FG003|Treatment Period|Lost to Follow-up|7|||
33155032|NCT03307785|100479627|FG000|Part F: Up to 3.5 Months|Physician Decision|0|||
33155033|NCT03307785|100479628|FG001|Part F: Up to 3.5 Months|Physician Decision|0|||
33155034|NCT03307785|100479629|FG002|Part F: Up to 3.5 Months|Physician Decision|0|||
33155035|NCT03307785|100479630|FG003|Part F: Up to 3.5 Months|Physician Decision|0|||
33155036|NCT03307785|100479631|FG004|Part F: Up to 3.5 Months|Physician Decision|0|||
33155037|NCT03307785|100479632|FG005|Part F: Up to 3.5 Months|Physician Decision|0|||
33155038|NCT03307785|100479633|FG006|Part F: Up to 3.5 Months|Physician Decision|0|||
33387483|NCT03339401|101306325|FG000|Overall Study|Investigator Decision|1|||
33387484|NCT03339401|101306326|FG001|Overall Study|Investigator Decision|0|||
33155039|NCT03307785|100479634|FG007|Part F: Up to 3.5 Months|Physician Decision|1|||
33387485|NCT01369225|101306329|FG000|Overall Study|Withdrawal by Subject|1|||
33387486|NCT01369225|101306330|FG001|Overall Study|Withdrawal by Subject|0|||
33387487|NCT01369225|101306331|FG002|Overall Study|Withdrawal by Subject|2|||
33155040|NCT03307785|100479635|FG008|Part F: Up to 3.5 Months|Physician Decision|0|||
33155041|NCT03307785|100479636|FG009|Part F: Up to 3.5 Months|Physician Decision|0|||
33155042|NCT03307785|100479637|FG010|Part F: Up to 3.5 Months|Physician Decision|0|||
33155043|NCT00406718|100479638|FG000|Overall Study|Withdrawal by Subject|2|||
33155044|NCT00406718|100479639|FG001|Overall Study|Withdrawal by Subject|9|||
33438147|NCT02848326|101496281|FG004|Treatment Period|Lost to Follow-up|2|||
33438148|NCT02848326|101496282|FG005|Treatment Period|Lost to Follow-up|3|||
33155045|NCT00406718|100479640|FG002|Overall Study|Withdrawal by Subject|4|||
33155046|NCT00406718|100479638|FG000|Overall Study|Lost to Follow-up|2|||
33155047|NCT00406718|100479639|FG001|Overall Study|Lost to Follow-up|5|||
33155048|NCT00406718|100479640|FG002|Overall Study|Lost to Follow-up|4|||
33155049|NCT01601132|100479642|FG000|Overall Study|Patient withdrew consent|1|||
33155050|NCT01601132|100479642|FG000|Overall Study|Protocol deviation|1|||
33155051|NCT01453725|100479643|FG000|Overall Study|Adverse Event|3|||
33155052|NCT01453725|100479644|FG001|Overall Study|Adverse Event|3|||
33155053|NCT01453725|100479643|FG000|Overall Study|Lost to Follow-up|4|||
33155054|NCT01453725|100479644|FG001|Overall Study|Lost to Follow-up|0|||
33155055|NCT01453725|100479643|FG000|Overall Study|Non-compliance With Protocol|1|||
33155056|NCT01453725|100479644|FG001|Overall Study|Non-compliance With Protocol|2|||
33155057|NCT01453725|100479643|FG000|Overall Study|Protocol Violation|1|||
33155058|NCT01453725|100479644|FG001|Overall Study|Protocol Violation|0|||
33155059|NCT01453725|100479643|FG000|Overall Study|Withdrawal by Subject|2|||
33155060|NCT01453725|100479644|FG001|Overall Study|Withdrawal by Subject|3|||
33155061|NCT01453725|100479643|FG000|Overall Study|Pregnancy Wish|0|||
33155062|NCT01453725|100479644|FG001|Overall Study|Pregnancy Wish|2|||
33155063|NCT01453725|100479643|FG000|Overall Study|Pregnancy|1|||
33155064|NCT01453725|100479644|FG001|Overall Study|Pregnancy|0|||
33387488|NCT01369225|101306332|FG003|Overall Study|Withdrawal by Subject|1|||
33387489|NCT01369225|101306333|FG004|Overall Study|Withdrawal by Subject|0|||
33387490|NCT01369225|101306334|FG005|Overall Study|Withdrawal by Subject|0|||
33387491|NCT01369225|101306329|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
33387492|NCT01369225|101306330|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
33438149|NCT02848326|101496277|FG000|Treatment Period|Pregnancy|0|||
33438150|NCT02848326|101496278|FG001|Treatment Period|Pregnancy|0|||
33438151|NCT02848326|101496279|FG002|Treatment Period|Pregnancy|1|||
33155065|NCT01453725|100479643|FG000|Overall Study|Physician Decision|1|||
33155066|NCT01453725|100479644|FG001|Overall Study|Physician Decision|1|||
33155067|NCT01436396|100479645|FG000|Overall Study|Protocol Violation|7|||
33155068|NCT01436396|100479646|FG001|Overall Study|Protocol Violation|5|||
33155069|NCT01436396|100479645|FG000|Overall Study|Adverse Event|1|||
33155070|NCT01436396|100479646|FG001|Overall Study|Adverse Event|2|||
33438152|NCT02848326|101496280|FG003|Treatment Period|Pregnancy|1|||
33155071|NCT01436396|100479645|FG000|Overall Study|Withdrawal by Subject|19|||
33155072|NCT01436396|100479646|FG001|Overall Study|Withdrawal by Subject|29|||
33155073|NCT01436396|100479645|FG000|Overall Study|Serious adverse event|2|||
33155074|NCT01436396|100479646|FG001|Overall Study|Serious adverse event|3|||
33155075|NCT01436396|100479645|FG000|Overall Study|Lost to Follow-up|3|||
33155076|NCT01436396|100479646|FG001|Overall Study|Lost to Follow-up|3|||
33155077|NCT00333801|100479647|FG000|Overall Study|Moved to another state|5|||
33387493|NCT01369225|101306331|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
33387494|NCT01369225|101306332|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
33387495|NCT01369225|101306333|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
33155078|NCT00333801|100479648|FG001|Overall Study|Moved to another state|3|||
33387496|NCT01369225|101306334|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
33155079|NCT00333801|100479647|FG000|Overall Study|Lost to Follow-up|2|||
33155080|NCT00333801|100479648|FG001|Overall Study|Lost to Follow-up|0|||
33155081|NCT00333801|100479647|FG000|Overall Study|Incarcerated|1|||
33155082|NCT00333801|100479648|FG001|Overall Study|Incarcerated|2|||
33155083|NCT00333801|100479647|FG000|Overall Study|Withdrawal by Subject|0|||
33155084|NCT00333801|100479648|FG001|Overall Study|Withdrawal by Subject|1|||
33155085|NCT00936611|100479649|FG000|Overall Study|Progressive Disease|3|||
33155086|NCT00936611|100479649|FG000|Overall Study|New Systemic Therapy|22|||
33155087|NCT00936611|100479649|FG000|Overall Study|Lost to Follow-up|1|||
33438153|NCT02848326|101496281|FG004|Treatment Period|Pregnancy|0|||
33155088|NCT00936611|100479649|FG000|Overall Study|Withdrawal by Subject|2|||
33155089|NCT00936611|100479649|FG000|Overall Study|Still on Follow-up|1|||
33155090|NCT00936611|100479649|FG000|Overall Study|Still on Active Therapy|7|||
33252432|NCT03185819|100823667|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
33252433|NCT03185819|100823668|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
33252434|NCT03185819|100823665|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
33252435|NCT03185819|100823666|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
33252436|NCT03185819|100823667|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
33252437|NCT03185819|100823668|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
33252438|NCT03185819|100823665|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
33252439|NCT03185819|100823666|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
33252440|NCT03185819|100823667|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
33252441|NCT03185819|100823668|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
33252442|NCT03185819|100823665|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
33252443|NCT03185819|100823666|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
33252444|NCT03185819|100823667|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
33252445|NCT03185819|100823668|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
33252446|NCT03185819|100823665|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
33252447|NCT03185819|100823666|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
33252448|NCT03185819|100823667|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
33252449|NCT03185819|100823668|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
33252450|NCT03185819|100823665|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
33252451|NCT03185819|100823666|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
33252452|NCT03185819|100823667|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
33252453|NCT03185819|100823668|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
33252454|NCT03185819|100823665|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
33252455|NCT03185819|100823666|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
33252456|NCT03185819|100823667|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
33252457|NCT03185819|100823668|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
33252458|NCT03185819|100823665|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
33252459|NCT03185819|100823666|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
33252460|NCT03185819|100823667|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
33252461|NCT03185819|100823668|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
33252462|NCT03185819|100823665|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
33252463|NCT03185819|100823666|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
33252464|NCT03185819|100823667|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
33387497|NCT01369225|101306329|FG000|Overall Study|Other|1|||
33387498|NCT01369225|101306330|FG001|Overall Study|Other|0|||
33387499|NCT01369225|101306331|FG002|Overall Study|Other|0|||
33387500|NCT01369225|101306332|FG003|Overall Study|Other|0|||
33387501|NCT01369225|101306333|FG004|Overall Study|Other|1|||
33387502|NCT01369225|101306334|FG005|Overall Study|Other|0|||
33387503|NCT01369225|101306329|FG000|Overall Study|Adverse Event|0|||
33387504|NCT01369225|101306330|FG001|Overall Study|Adverse Event|0|||
33387505|NCT01369225|101306331|FG002|Overall Study|Adverse Event|0|||
33387506|NCT01369225|101306332|FG003|Overall Study|Adverse Event|1|||
33387507|NCT01369225|101306333|FG004|Overall Study|Adverse Event|1|||
33387508|NCT01369225|101306334|FG005|Overall Study|Adverse Event|0|||
33387509|NCT02910219|101306337|FG000|Overall Study|Withdrawal by Subject|1|||
33155091|NCT00936611|100479649|FG000|Overall Study|Ineligible for Study Drug|3|||
33155092|NCT01254292|100479653|FG000|Comparative Phase|Adverse Event|25|||
33155093|NCT01254292|100479654|FG001|Comparative Phase|Adverse Event|25|||
33155094|NCT01254292|100479653|FG000|Comparative Phase|Lost to Follow-up|3|||
33155095|NCT01254292|100479654|FG001|Comparative Phase|Lost to Follow-up|21|||
33155096|NCT01254292|100479653|FG000|Comparative Phase|Pregnancy|2|||
33155097|NCT01254292|100479654|FG001|Comparative Phase|Pregnancy|6|||
33155098|NCT01254292|100479653|FG000|Comparative Phase|Withdrawal by Subject|20|||
33155099|NCT01254292|100479654|FG001|Comparative Phase|Withdrawal by Subject|21|||
33252465|NCT03185819|100823668|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
33252466|NCT01370694|100823669|FG000|Overall Study|Switched to rituximab|4|||
33252467|NCT01370694|100823669|FG000|Overall Study|Progressive disease|2|||
33252468|NCT00754936|100823671|FG000|Overall Study|Lost to Follow-up|3|||
33252469|NCT00754936|100823671|FG000|Overall Study|Physician Decision|1|||
33252470|NCT00754936|100823671|FG000|Overall Study|Withdrawal by Subject|2|||
33252471|NCT00754936|100823671|FG000|Overall Study|Side Effects|3|||
33252472|NCT00754936|100823671|FG000|Overall Study|Inter-current medical events|3|||
33252473|NCT01069341|100823672|FG000|Overall Study|Lost to Follow-up|1|||
33252474|NCT04033432|100823674|FG000|Overall Study|Progressive Disease|8|||
33252475|NCT04033432|100823674|FG000|Overall Study|Adverse Event|4|||
33252476|NCT04033432|100823674|FG000|Overall Study|Death|1|||
33252477|NCT03920215|100823676|FG000|Overall Study|Lost to Follow-up|1|||
33252478|NCT03920215|100823677|FG001|Overall Study|Lost to Follow-up|2|||
33252479|NCT03920215|100823678|FG002|Overall Study|Lost to Follow-up|0|||
33252480|NCT03920215|100823679|FG003|Overall Study|Lost to Follow-up|0|||
33252481|NCT03920215|100823676|FG000|Overall Study|Death|0|||
33252482|NCT03920215|100823677|FG001|Overall Study|Death|0|||
33252483|NCT03920215|100823678|FG002|Overall Study|Death|0|||
33252484|NCT03920215|100823679|FG003|Overall Study|Death|1|||
33252485|NCT02994654|100823684|FG000|Overall Study|Lost to Follow-up|1|||
33252486|NCT01321606|100823689|FG000|Overall Study|Lost to Follow-up|0|||
33252487|NCT01321606|100823690|FG001|Overall Study|Lost to Follow-up|0|||
33252488|NCT01321606|100823691|FG002|Overall Study|Lost to Follow-up|0|||
33252489|NCT01321606|100823692|FG003|Overall Study|Lost to Follow-up|1|||
33252490|NCT03993392|100823695|FG000|Overall Study|Withdrawal by Subject|3|||
33252491|NCT03993392|100823695|FG000|Overall Study|Lost to Follow-up|2|||
33252492|NCT03993392|100823695|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
33252493|NCT01290224|100823696|FG000|Overall Study|Adverse Event|1|||
33252494|NCT01290224|100823696|FG000|Overall Study|Refused Further Treatment|4|||
33252495|NCT02013830|100823700|FG000|Overall Study|Adverse Event|3|||
33252496|NCT02013830|100823700|FG000|Overall Study|Death|1|||
33252497|NCT02013830|100823700|FG000|Overall Study|Insufficient therapeutic response|25|||
33387510|NCT02910219|101306338|FG001|Overall Study|Withdrawal by Subject|1|||
33387511|NCT00407550|101306339|FG000|Overall Study|Adverse Event|0|||
33387512|NCT00407550|101306340|FG001|Overall Study|Adverse Event|1|||
33387513|NCT00407550|101306339|FG000|Overall Study|Withdrawal by Subject|0|||
33387514|NCT00407550|101306340|FG001|Overall Study|Withdrawal by Subject|2|||
33387515|NCT00407550|101306339|FG000|Overall Study|Death|1|||
33387516|NCT00407550|101306340|FG001|Overall Study|Death|0|||
33387517|NCT00407550|101306339|FG000|Overall Study|Insurance or Other medical condition|2|||
33387518|NCT00407550|101306340|FG001|Overall Study|Insurance or Other medical condition|1|||
33387519|NCT00856986|101306341|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
33387520|NCT00856986|101306342|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
33387521|NCT00856986|101306343|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
33387522|NCT00856986|101306344|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
33387523|NCT00856986|101306345|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
33387524|NCT00856986|101306341|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
33387525|NCT00856986|101306342|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
33387526|NCT00856986|101306343|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
33387527|NCT00856986|101306344|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
33387528|NCT00856986|101306345|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
33387529|NCT00856986|101306341|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
33387530|NCT00856986|101306342|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
33387531|NCT00856986|101306343|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
33387532|NCT00856986|101306344|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
33387533|NCT00856986|101306345|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
33387534|NCT00856986|101306341|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
33387535|NCT00856986|101306342|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
33252498|NCT02013830|100823700|FG000|Overall Study|Refused treatment|1|||
33252499|NCT00688519|100823703|FG000|Overall Study|Adverse Event|2|||
33252500|NCT00688519|100823704|FG001|Overall Study|Adverse Event|3|||
33387536|NCT00856986|101306343|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
33387537|NCT00856986|101306344|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
33438154|NCT02848326|101496282|FG005|Treatment Period|Pregnancy|1|||
33252501|NCT00688519|100823703|FG000|Overall Study|Lost to Follow-up|3|||
33252502|NCT00688519|100823704|FG001|Overall Study|Lost to Follow-up|3|||
33252503|NCT00688519|100823703|FG000|Overall Study|Lack of Efficacy|3|||
33387538|NCT00856986|101306345|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
33387539|NCT00856986|101306341|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
33252504|NCT00688519|100823704|FG001|Overall Study|Lack of Efficacy|1|||
33252505|NCT00688519|100823703|FG000|Overall Study|Withdrawal by Subject|7|||
33252506|NCT00688519|100823704|FG001|Overall Study|Withdrawal by Subject|6|||
33252507|NCT00688519|100823703|FG000|Overall Study|Prohibited medication|1|||
33252508|NCT00688519|100823704|FG001|Overall Study|Prohibited medication|0|||
33252509|NCT00688519|100823703|FG000|Overall Study|Non-compliance|0|||
33252510|NCT00688519|100823704|FG001|Overall Study|Non-compliance|1|||
33252511|NCT00688519|100823703|FG000|Overall Study|Subject moved out of state|1|||
33252512|NCT00688519|100823704|FG001|Overall Study|Subject moved out of state|0|||
33252513|NCT00688519|100823703|FG000|Overall Study|Investigator decision|1|||
33252514|NCT00688519|100823704|FG001|Overall Study|Investigator decision|0|||
33252515|NCT00688519|100823703|FG000|Overall Study|Subject moved out of area|1|||
33252516|NCT00688519|100823704|FG001|Overall Study|Subject moved out of area|0|||
33252517|NCT00688519|100823703|FG000|Overall Study|Pregnancy|0|||
33252518|NCT00688519|100823704|FG001|Overall Study|Pregnancy|1|||
33252519|NCT01391130|100823708|FG000|Overall Study|Withdrawal by Subject|3|||
33252520|NCT01391130|100823709|FG001|Overall Study|Withdrawal by Subject|2|||
33252521|NCT01391130|100823708|FG000|Overall Study|Physician Decision|2|||
33252522|NCT01391130|100823709|FG001|Overall Study|Physician Decision|3|||
33438155|NCT02848326|101496277|FG000|Treatment Period|Protocol Violation|4|||
33438156|NCT02848326|101496278|FG001|Treatment Period|Protocol Violation|3|||
33438157|NCT02848326|101496279|FG002|Treatment Period|Protocol Violation|4|||
33438158|NCT02848326|101496280|FG003|Treatment Period|Protocol Violation|2|||
33252523|NCT01391130|100823708|FG000|Overall Study|Did not Receive Drug|1|||
33252524|NCT01391130|100823709|FG001|Overall Study|Did not Receive Drug|1|||
33252525|NCT04246762|100823717|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
33252526|NCT00157014|100823723|FG000|Overall Study|Death|4|||
33252527|NCT00157014|100823724|FG001|Overall Study|Death|2|||
33252528|NCT00157014|100823725|FG002|Overall Study|Death|1|||
33252529|NCT00157014|100823726|FG003|Overall Study|Death|1|||
33252530|NCT00157014|100823723|FG000|Overall Study|Physician Decision|0|||
33252531|NCT00157014|100823724|FG001|Overall Study|Physician Decision|1|||
33252532|NCT00157014|100823725|FG002|Overall Study|Physician Decision|0|||
33252533|NCT00157014|100823726|FG003|Overall Study|Physician Decision|0|||
33252534|NCT00157014|100823723|FG000|Overall Study|Medications withdrawn on family request|0|||
33252535|NCT00157014|100823724|FG001|Overall Study|Medications withdrawn on family request|1|||
33252536|NCT00157014|100823725|FG002|Overall Study|Medications withdrawn on family request|0|||
33252537|NCT00157014|100823726|FG003|Overall Study|Medications withdrawn on family request|0|||
33252538|NCT00157014|100823723|FG000|Overall Study|Patient withdrawn by investigator|1|||
33252539|NCT00157014|100823724|FG001|Overall Study|Patient withdrawn by investigator|0|||
33252540|NCT00157014|100823725|FG002|Overall Study|Patient withdrawn by investigator|0|||
33252541|NCT00157014|100823726|FG003|Overall Study|Patient withdrawn by investigator|0|||
33252542|NCT00157014|100823723|FG000|Overall Study|Patient unable to return in nursing home|1|||
33252543|NCT00157014|100823724|FG001|Overall Study|Patient unable to return in nursing home|0|||
33438159|NCT02848326|101496281|FG004|Treatment Period|Protocol Violation|3|||
33155100|NCT01254292|100479653|FG000|Comparative Phase|Protocol Violation|1|||
33155101|NCT01254292|100479654|FG001|Comparative Phase|Protocol Violation|2|||
33155102|NCT01254292|100479653|FG000|Comparative Phase|Wish for pregnancy|4|||
33155103|NCT01254292|100479654|FG001|Comparative Phase|Wish for pregnancy|6|||
33155104|NCT01254292|100479653|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
33155105|NCT01254292|100479654|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
33155106|NCT01254292|100479653|FG000|LCS12 Extension Phase|Adverse Event|9|||
33155107|NCT01254292|100479654|FG001|LCS12 Extension Phase|Adverse Event|0|||
33155108|NCT01254292|100479653|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
33155109|NCT01254292|100479654|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
33155110|NCT01254292|100479653|FG000|LCS12 Extension Phase|Other unknown|4|||
33155111|NCT01254292|100479654|FG001|LCS12 Extension Phase|Other unknown|0|||
33155112|NCT01254292|100479653|FG000|LCS12 Extension Phase|Pregnancy|2|||
33155113|NCT01254292|100479654|FG001|LCS12 Extension Phase|Pregnancy|0|||
33155114|NCT01254292|100479653|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
33155115|NCT01254292|100479654|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
33155116|NCT02905149|100479659|FG000|Overall Study|Lost to Follow-up|2|||
33155117|NCT02905149|100479660|FG001|Overall Study|Lost to Follow-up|0|||
33155118|NCT02186873|100482393|FG000|Overall Study|Adverse Event|1|||
33252544|NCT00157014|100823725|FG002|Overall Study|Patient unable to return in nursing home|0|||
33252545|NCT00157014|100823726|FG003|Overall Study|Patient unable to return in nursing home|0|||
33252546|NCT00157014|100823723|FG000|Overall Study|Patient would not receive transplant|0|||
33252547|NCT00157014|100823724|FG001|Overall Study|Patient would not receive transplant|1|||
33252548|NCT00157014|100823725|FG002|Overall Study|Patient would not receive transplant|0|||
33252549|NCT00157014|100823726|FG003|Overall Study|Patient would not receive transplant|0|||
33252550|NCT00157014|100823723|FG000|Overall Study|Withdrawal by Subject|1|||
33252551|NCT00157014|100823724|FG001|Overall Study|Withdrawal by Subject|0|||
33252552|NCT00157014|100823725|FG002|Overall Study|Withdrawal by Subject|0|||
33252553|NCT00157014|100823726|FG003|Overall Study|Withdrawal by Subject|0|||
33252554|NCT02551055|100823727|FG000|Overall Study|Death|2|||
33252555|NCT02551055|100823728|FG001|Overall Study|Death|4|||
33252556|NCT02551055|100823729|FG002|Overall Study|Death|2|||
33252557|NCT02551055|100823730|FG003|Overall Study|Death|2|||
33252558|NCT02551055|100823731|FG004|Overall Study|Death|2|||
33252559|NCT02551055|100823732|FG005|Overall Study|Death|1|||
33438160|NCT02848326|101496282|FG005|Treatment Period|Protocol Violation|3|||
33438161|NCT02848326|101496277|FG000|Treatment Period|Non-compliance with Study Drug|4|||
33438162|NCT02848326|101496278|FG001|Treatment Period|Non-compliance with Study Drug|0|||
33438163|NCT02848326|101496279|FG002|Treatment Period|Non-compliance with Study Drug|0|||
33438164|NCT02848326|101496280|FG003|Treatment Period|Non-compliance with Study Drug|1|||
33438165|NCT02848326|101496281|FG004|Treatment Period|Non-compliance with Study Drug|0|||
33438166|NCT02848326|101496282|FG005|Treatment Period|Non-compliance with Study Drug|0|||
33438167|NCT02848326|101496277|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
33438168|NCT02848326|101496278|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
33438169|NCT02848326|101496279|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
33438170|NCT02848326|101496280|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
33438171|NCT02848326|101496281|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
33438172|NCT02848326|101496282|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
33438173|NCT02848326|101496277|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
33438174|NCT02848326|101496278|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
33438175|NCT02848326|101496279|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
33438176|NCT02848326|101496280|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
33438177|NCT02848326|101496281|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
33438178|NCT02848326|101496282|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
33438179|NCT03708211|101496286|FG000|Overall Study|Progressive Disease|10|||
33438180|NCT03708211|101496287|FG001|Overall Study|Progressive Disease|7|||
33438181|NCT03708211|101496286|FG000|Overall Study|Withdrawal by Subject|0|||
33438182|NCT03708211|101496287|FG001|Overall Study|Withdrawal by Subject|1|||
33438183|NCT03708211|101496286|FG000|Overall Study|Other|2|||
33438184|NCT03708211|101496287|FG001|Overall Study|Other|0|||
33438185|NCT02899338|101496288|FG000|Overall Study|Adverse Event|1|||
33438186|NCT02899338|101496289|FG001|Overall Study|Adverse Event|2|||
33155119|NCT02186873|100482394|FG001|Overall Study|Adverse Event|3|||
33155120|NCT02186873|100482393|FG000|Overall Study|Lack of Efficacy|0|||
33155121|NCT02186873|100482394|FG001|Overall Study|Lack of Efficacy|1|||
33155122|NCT02186873|100482393|FG000|Overall Study|Lost to Follow-up|1|||
33252560|NCT02551055|100823733|FG006|Overall Study|Death|2|||
33252561|NCT02551055|100823734|FG007|Overall Study|Death|0|||
33438187|NCT02899338|101496288|FG000|Overall Study|Withdrawal by Subject|2|||
33155123|NCT02186873|100482394|FG001|Overall Study|Lost to Follow-up|2|||
33155124|NCT02186873|100482393|FG000|Overall Study|Withdrawal by Subject|7|||
33252562|NCT02551055|100823727|FG000|Overall Study|Study Terminated by Sponsor|1|||
33252563|NCT02551055|100823728|FG001|Overall Study|Study Terminated by Sponsor|1|||
33438188|NCT02899338|101496289|FG001|Overall Study|Withdrawal by Subject|0|||
33438189|NCT02227862|101496290|FG000|Overall Study|Protocol Violation|7|||
33438190|NCT02227862|101496291|FG001|Overall Study|Protocol Violation|9|||
33438191|NCT02227862|101496290|FG000|Overall Study|Other|0|||
33438192|NCT02227862|101496291|FG001|Overall Study|Other|2|||
33438193|NCT02227862|101496290|FG000|Overall Study|Adverse Event|4|||
33438194|NCT02227862|101496291|FG001|Overall Study|Adverse Event|3|||
33438195|NCT02227862|101496290|FG000|Overall Study|Withdrawal by Subject|7|||
33438196|NCT02227862|101496291|FG001|Overall Study|Withdrawal by Subject|6|||
33438197|NCT02227862|101496290|FG000|Overall Study|Lost to Follow-up|1|||
33438198|NCT02227862|101496291|FG001|Overall Study|Lost to Follow-up|2|||
33155125|NCT02186873|100482394|FG001|Overall Study|Withdrawal by Subject|2|||
33155126|NCT00808483|100482400|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
33155127|NCT00808483|100482401|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
33155128|NCT00808483|100482400|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
33252564|NCT02551055|100823729|FG002|Overall Study|Study Terminated by Sponsor|0|||
33252565|NCT02551055|100823730|FG003|Overall Study|Study Terminated by Sponsor|2|||
33252566|NCT02551055|100823731|FG004|Overall Study|Study Terminated by Sponsor|2|||
33252567|NCT02551055|100823732|FG005|Overall Study|Study Terminated by Sponsor|0|||
33252568|NCT02551055|100823733|FG006|Overall Study|Study Terminated by Sponsor|0|||
33252569|NCT02551055|100823734|FG007|Overall Study|Study Terminated by Sponsor|0|||
33252570|NCT02551055|100823727|FG000|Overall Study|Withdrawal by Subject|1|||
33252571|NCT02551055|100823728|FG001|Overall Study|Withdrawal by Subject|1|||
33252572|NCT02551055|100823729|FG002|Overall Study|Withdrawal by Subject|0|||
33252573|NCT02551055|100823730|FG003|Overall Study|Withdrawal by Subject|1|||
33252574|NCT02551055|100823731|FG004|Overall Study|Withdrawal by Subject|2|||
33252575|NCT02551055|100823732|FG005|Overall Study|Withdrawal by Subject|0|||
33252576|NCT02551055|100823733|FG006|Overall Study|Withdrawal by Subject|0|||
33252577|NCT02551055|100823734|FG007|Overall Study|Withdrawal by Subject|0|||
33252578|NCT02551055|100823727|FG000|Overall Study|Reason not specified|0|||
33252579|NCT02551055|100823728|FG001|Overall Study|Reason not specified|0|||
33155129|NCT00808483|100482401|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
33155130|NCT00808483|100482400|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
33155131|NCT00808483|100482401|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
33155132|NCT02019277|100482402|FG000|Overall Study|Withdrawal by Subject|3|||
33155133|NCT02019277|100482402|FG000|Overall Study|Death|7|||
33252580|NCT02551055|100823729|FG002|Overall Study|Reason not specified|0|||
33252581|NCT02551055|100823730|FG003|Overall Study|Reason not specified|0|||
33252582|NCT02551055|100823731|FG004|Overall Study|Reason not specified|1|||
33252583|NCT02551055|100823732|FG005|Overall Study|Reason not specified|0|||
33252584|NCT02551055|100823733|FG006|Overall Study|Reason not specified|1|||
33252585|NCT02551055|100823734|FG007|Overall Study|Reason not specified|0|||
33252586|NCT00410124|100823735|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
33252587|NCT00410124|100823736|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
33252588|NCT00410124|100823735|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
33252589|NCT00410124|100823736|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
33252590|NCT00410124|100823735|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
33252591|NCT00410124|100823736|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
33252592|NCT00410124|100823735|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
33252593|NCT00410124|100823736|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
33252594|NCT00410124|100823735|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
33252595|NCT00410124|100823736|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
33387540|NCT00856986|101306342|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
33387541|NCT00856986|101306343|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
33387542|NCT00856986|101306344|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
33387543|NCT00856986|101306345|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
33155134|NCT02019277|100482402|FG000|Overall Study|Did no Cooperate|1|||
33155135|NCT02019277|100482402|FG000|Overall Study|Adverse Event|1|||
33155136|NCT03039192|100482407|FG000|Overall Study|Lost to Follow-up|4|||
33155137|NCT03039192|100482408|FG001|Overall Study|Lost to Follow-up|4|||
33155138|NCT03039192|100482407|FG000|Overall Study|Adverse event, serious fatal|0|||
33155139|NCT03039192|100482408|FG001|Overall Study|Adverse event, serious fatal|1|||
33155140|NCT03039192|100482407|FG000|Overall Study|Adverse event, non-fatal|0|||
33155141|NCT03039192|100482408|FG001|Overall Study|Adverse event, non-fatal|2|||
33252596|NCT00410124|100823735|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
33252597|NCT00410124|100823736|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
33252598|NCT00410124|100823735|FG000|Core Phase Double Blind (15 Months)|Death|7|||
33252599|NCT00410124|100823736|FG001|Core Phase Double Blind (15 Months)|Death|4|||
33252600|NCT00410124|100823735|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
33252601|NCT00410124|100823736|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
33252602|NCT00410124|100823735|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
33252603|NCT00410124|100823736|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
33252604|NCT00410124|100823735|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
33252605|NCT00410124|100823736|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
33252606|NCT00410124|100823735|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
33252607|NCT00410124|100823736|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
33252608|NCT00410124|100823735|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
33252609|NCT00410124|100823736|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
33252610|NCT00410124|100823735|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
33252611|NCT00410124|100823736|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
33252612|NCT00410124|100823735|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
33252613|NCT00410124|100823736|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
33252614|NCT00410124|100823735|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
33252615|NCT00410124|100823736|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
33252616|NCT00410124|100823735|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
33252617|NCT00410124|100823736|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
33252618|NCT01883492|100823737|FG000|Overall Study|Lost to Follow-up|3|||
33252619|NCT01883492|100823738|FG001|Overall Study|Lost to Follow-up|4|||
33252620|NCT01883492|100823737|FG000|Overall Study|Surgery on contra-lateral hip|0|||
33252621|NCT01883492|100823738|FG001|Overall Study|Surgery on contra-lateral hip|1|||
33252622|NCT01883492|100823737|FG000|Overall Study|Poor X-ray quality|7|||
33252623|NCT01883492|100823738|FG001|Overall Study|Poor X-ray quality|4|||
33252624|NCT01883492|100823737|FG000|Overall Study|Withdrawal by Subject|1|||
33252625|NCT01883492|100823738|FG001|Overall Study|Withdrawal by Subject|0|||
33252626|NCT01883492|100823737|FG000|Overall Study|inappropriate implant used|1|||
33252627|NCT01883492|100823738|FG001|Overall Study|inappropriate implant used|1|||
33252628|NCT01883492|100823737|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
33252629|NCT01883492|100823738|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
33252630|NCT00189202|100823740|FG000|Overall Study|Physician Decision|5|||
33252631|NCT03441360|100823743|FG000|Overall Study|Radiological disease progression|5|||
33252632|NCT03441360|100823744|FG001|Overall Study|Radiological disease progression|6|||
33252633|NCT03441360|100823745|FG002|Overall Study|Radiological disease progression|4|||
33252634|NCT03441360|100823743|FG000|Overall Study|Clinical disease progression|2|||
33252635|NCT03441360|100823744|FG001|Overall Study|Clinical disease progression|2|||
33252636|NCT03441360|100823745|FG002|Overall Study|Clinical disease progression|0|||
33252637|NCT03441360|100823743|FG000|Overall Study|Adverse Event|1|||
33252638|NCT03441360|100823744|FG001|Overall Study|Adverse Event|0|||
33252639|NCT03441360|100823745|FG002|Overall Study|Adverse Event|1|||
33155142|NCT03039192|100482407|FG000|Overall Study|Withdrawal by Subject|6|||
33155143|NCT03039192|100482408|FG001|Overall Study|Withdrawal by Subject|9|||
33155144|NCT03039192|100482407|FG000|Overall Study|Discontinued from treatment phase|19|||
33155145|NCT03039192|100482408|FG001|Overall Study|Discontinued from treatment phase|12|||
33155146|NCT03039192|100482407|FG000|Overall Study|Other|3|||
33155147|NCT03039192|100482408|FG001|Overall Study|Other|2|||
33155148|NCT00631696|100482414|FG000|Overall Study|Entered, not randomized to treatment|1|||
33155149|NCT00631696|100482415|FG001|Overall Study|Entered, not randomized to treatment|1|||
33155150|NCT00631696|100482414|FG000|Overall Study|Discontinued after database release date|1|||
33155151|NCT00631696|100482415|FG001|Overall Study|Discontinued after database release date|0|||
33155152|NCT00631696|100482414|FG000|Overall Study|Follow up after database release date|1|||
33155153|NCT00631696|100482415|FG001|Overall Study|Follow up after database release date|0|||
33155154|NCT00631696|100482414|FG000|Overall Study|Lost to Follow-up|7|||
33155155|NCT00631696|100482415|FG001|Overall Study|Lost to Follow-up|10|||
33155156|NCT00631696|100482414|FG000|Overall Study|Withdrawal by Subject|2|||
33155157|NCT00631696|100482415|FG001|Overall Study|Withdrawal by Subject|9|||
33438199|NCT01434693|101496292|FG000|Overall Study|Adverse Event|1|||
33155158|NCT00631696|100482414|FG000|Overall Study|Other|8|||
33155159|NCT00631696|100482415|FG001|Overall Study|Other|8|||
33252640|NCT03710564|100823746|FG000|Overall Study|Study Terminated by Sponsor|104|||
33155160|NCT00631696|100482414|FG000|Overall Study|Protocol Violation|9|||
33252641|NCT03710564|100823747|FG001|Overall Study|Study Terminated by Sponsor|55|||
33252642|NCT03710564|100823746|FG000|Overall Study|Withdrawal by Subject|57|||
33252643|NCT03710564|100823747|FG001|Overall Study|Withdrawal by Subject|25|||
33252644|NCT03710564|100823746|FG000|Overall Study|Death|10|||
33252645|NCT03710564|100823747|FG001|Overall Study|Death|4|||
33252646|NCT03710564|100823746|FG000|Overall Study|Lost to Follow-up|5|||
33387544|NCT00856986|101306341|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
33155161|NCT00631696|100482415|FG001|Overall Study|Protocol Violation|9|||
33155162|NCT00631696|100482414|FG000|Overall Study|Study terminated by sponsor|3|||
33155163|NCT00631696|100482415|FG001|Overall Study|Study terminated by sponsor|3|||
33155164|NCT00631696|100482414|FG000|Overall Study|Adverse Event|5|||
33155165|NCT00631696|100482415|FG001|Overall Study|Adverse Event|0|||
33155166|NCT02639546|100482416|FG000|Overall Study|Death|2|||
33155167|NCT02639546|100482417|FG001|Overall Study|Death|2|||
33155168|NCT02639546|100482418|FG002|Overall Study|Death|1|||
33155169|NCT02639546|100482419|FG003|Overall Study|Death|2|||
33155170|NCT02639546|100482420|FG004|Overall Study|Death|2|||
33252647|NCT03710564|100823747|FG001|Overall Study|Lost to Follow-up|4|||
33252648|NCT03710564|100823746|FG000|Overall Study|Protocol Violation|3|||
33155171|NCT02639546|100482421|FG005|Overall Study|Death|2|||
33155172|NCT02639546|100482422|FG006|Overall Study|Death|0|||
33155173|NCT02639546|100482423|FG007|Overall Study|Death|0|||
33155174|NCT02639546|100482416|FG000|Overall Study|Lost to Follow-up|0|||
33155175|NCT02639546|100482417|FG001|Overall Study|Lost to Follow-up|0|||
33155176|NCT02639546|100482418|FG002|Overall Study|Lost to Follow-up|1|||
33155177|NCT02639546|100482419|FG003|Overall Study|Lost to Follow-up|0|||
33155178|NCT02639546|100482420|FG004|Overall Study|Lost to Follow-up|1|||
33155179|NCT02639546|100482421|FG005|Overall Study|Lost to Follow-up|1|||
33155180|NCT02639546|100482422|FG006|Overall Study|Lost to Follow-up|0|||
33155181|NCT02639546|100482423|FG007|Overall Study|Lost to Follow-up|1|||
33155182|NCT02639546|100482416|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
33155183|NCT02639546|100482417|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
33252649|NCT03710564|100823747|FG001|Overall Study|Protocol Violation|2|||
33155184|NCT02639546|100482418|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
33252650|NCT03710564|100823746|FG000|Overall Study|Adverse Event|3|||
33155185|NCT02639546|100482419|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
33155186|NCT02639546|100482420|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
33155187|NCT02639546|100482421|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
33155188|NCT02639546|100482422|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
33155189|NCT02639546|100482423|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
33155190|NCT02639546|100482416|FG000|Overall Study|Study Terminated By Sponsor|0|||
33155191|NCT02639546|100482417|FG001|Overall Study|Study Terminated By Sponsor|2|||
33155192|NCT02639546|100482418|FG002|Overall Study|Study Terminated By Sponsor|3|||
33155193|NCT02639546|100482419|FG003|Overall Study|Study Terminated By Sponsor|4|||
33155194|NCT02639546|100482420|FG004|Overall Study|Study Terminated By Sponsor|4|||
33155195|NCT02639546|100482421|FG005|Overall Study|Study Terminated By Sponsor|3|||
33155196|NCT02639546|100482422|FG006|Overall Study|Study Terminated By Sponsor|3|||
33155197|NCT02639546|100482423|FG007|Overall Study|Study Terminated By Sponsor|9|||
33155198|NCT02639546|100482416|FG000|Overall Study|Withdrawal by Subject|2|||
33155199|NCT02639546|100482417|FG001|Overall Study|Withdrawal by Subject|2|||
33155200|NCT02639546|100482418|FG002|Overall Study|Withdrawal by Subject|1|||
33155201|NCT02639546|100482419|FG003|Overall Study|Withdrawal by Subject|0|||
33155202|NCT02639546|100482420|FG004|Overall Study|Withdrawal by Subject|0|||
33155203|NCT02639546|100482421|FG005|Overall Study|Withdrawal by Subject|1|||
33155204|NCT02639546|100482422|FG006|Overall Study|Withdrawal by Subject|2|||
33155205|NCT02639546|100482423|FG007|Overall Study|Withdrawal by Subject|1|||
33155206|NCT03855228|100482424|FG000|Overall Study|Adverse Event|2|||
33155207|NCT03855228|100482425|FG001|Overall Study|Adverse Event|4|||
33155208|NCT03855228|100482426|FG002|Overall Study|Adverse Event|4|||
33155209|NCT03855228|100482427|FG003|Overall Study|Adverse Event|8|||
33155210|NCT03855228|100482424|FG000|Overall Study|Treatment Failure|1|||
33155211|NCT03855228|100482425|FG001|Overall Study|Treatment Failure|2|||
33155212|NCT03855228|100482426|FG002|Overall Study|Treatment Failure|1|||
33155213|NCT03855228|100482427|FG003|Overall Study|Treatment Failure|8|||
33155214|NCT03855228|100482424|FG000|Overall Study|Lost to Follow-up|0|||
33155215|NCT03855228|100482425|FG001|Overall Study|Lost to Follow-up|0|||
33155216|NCT03855228|100482426|FG002|Overall Study|Lost to Follow-up|0|||
33155217|NCT03855228|100482427|FG003|Overall Study|Lost to Follow-up|1|||
33438200|NCT01434693|101496293|FG001|Overall Study|Adverse Event|0|||
33155218|NCT03855228|100482424|FG000|Overall Study|Protocol Violation|0|||
33155219|NCT03855228|100482425|FG001|Overall Study|Protocol Violation|1|||
33155220|NCT03855228|100482426|FG002|Overall Study|Protocol Violation|2|||
33155221|NCT03855228|100482427|FG003|Overall Study|Protocol Violation|1|||
33155222|NCT03855228|100482424|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
33155223|NCT03855228|100482425|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
33155224|NCT03855228|100482426|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
33155225|NCT03855228|100482427|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
33155226|NCT01788046|100482444|FG000|Overall Study|Withdrawal by Subject|12|||
33155227|NCT01788046|100482445|FG001|Overall Study|Withdrawal by Subject|12|||
33155228|NCT01788046|100482444|FG000|Overall Study|Lost to Follow-up|12|||
33155229|NCT01788046|100482445|FG001|Overall Study|Lost to Follow-up|19|||
33155230|NCT01788046|100482444|FG000|Overall Study|Death|7|||
33155231|NCT01788046|100482445|FG001|Overall Study|Death|5|||
33155232|NCT01788046|100482444|FG000|Overall Study|Protocol Specified Criteria|25|||
33155233|NCT01788046|100482445|FG001|Overall Study|Protocol Specified Criteria|1|||
33155234|NCT00113087|100482446|FG000|Overall Study|Death or Transplant|14|||
33155235|NCT00113087|100482447|FG001|Overall Study|Death or Transplant|16|||
33155236|NCT00113087|100482446|FG000|Overall Study|Family or MD withdrew subject|10|||
33155237|NCT00113087|100482447|FG001|Overall Study|Family or MD withdrew subject|5|||
33155238|NCT01790932|100482448|FG000|Overall Study|Disease Progression|41|||
33155239|NCT01790932|100482448|FG000|Overall Study|Adverse Event|7|||
33387545|NCT00856986|101306342|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
33387546|NCT00856986|101306343|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
33387547|NCT00856986|101306344|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
33387548|NCT00856986|101306345|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
33387549|NCT00856986|101306341|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
33387550|NCT00856986|101306342|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
33387551|NCT00856986|101306343|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
33387552|NCT00856986|101306344|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
33387553|NCT00856986|101306345|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
33387554|NCT00856986|101306341|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
33387555|NCT00856986|101306342|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
33387556|NCT00856986|101306343|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
33438201|NCT01434693|101496294|FG002|Overall Study|Adverse Event|0|||
33155240|NCT01790932|100482448|FG000|Overall Study|Physician Decision|1|||
33155241|NCT01790932|100482448|FG000|Overall Study|Withdrawal by Subject|1|||
33155242|NCT00413244|100482449|FG000|Overall Study|Withdrawal by Subject|10|||
33155243|NCT00413244|100482450|FG001|Overall Study|Withdrawal by Subject|1|||
33438202|NCT01434693|101496295|FG003|Overall Study|Adverse Event|0|||
33438203|NCT01434693|101496292|FG000|Overall Study|Withdrawal by Subject|1|||
33438204|NCT01434693|101496293|FG001|Overall Study|Withdrawal by Subject|0|||
33438205|NCT01434693|101496294|FG002|Overall Study|Withdrawal by Subject|1|||
33438206|NCT01434693|101496295|FG003|Overall Study|Withdrawal by Subject|1|||
33438207|NCT01434693|101496292|FG000|Overall Study|Lost to Follow-up|1|||
33438208|NCT01434693|101496293|FG001|Overall Study|Lost to Follow-up|0|||
33387557|NCT00856986|101306344|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
33387558|NCT00856986|101306345|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
33387559|NCT00856986|101306341|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
33387560|NCT00856986|101306342|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
33387561|NCT00856986|101306343|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
33387562|NCT00856986|101306344|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
33387563|NCT00856986|101306345|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
33387564|NCT00856986|101306341|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
33387565|NCT00856986|101306342|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
33387566|NCT00856986|101306343|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
33387567|NCT00856986|101306344|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
33387568|NCT00856986|101306345|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
33387569|NCT00856986|101306341|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
33438209|NCT01434693|101496294|FG002|Overall Study|Lost to Follow-up|0|||
33155244|NCT00676338|100482456|FG000|Overall Study|Adverse Event|6|||
33155245|NCT00676338|100482457|FG001|Overall Study|Adverse Event|6|||
33155246|NCT00676338|100482458|FG002|Overall Study|Adverse Event|5|||
33155247|NCT00676338|100482459|FG003|Overall Study|Adverse Event|1|||
33155248|NCT00676338|100482456|FG000|Overall Study|Lost to Follow-up|4|||
33155249|NCT00676338|100482457|FG001|Overall Study|Lost to Follow-up|1|||
33155250|NCT00676338|100482458|FG002|Overall Study|Lost to Follow-up|3|||
33155251|NCT00676338|100482459|FG003|Overall Study|Lost to Follow-up|4|||
33155252|NCT00676338|100482456|FG000|Overall Study|Physician Decision|3|||
33155253|NCT00676338|100482457|FG001|Overall Study|Physician Decision|3|||
33155254|NCT00676338|100482458|FG002|Overall Study|Physician Decision|2|||
33155255|NCT00676338|100482459|FG003|Overall Study|Physician Decision|3|||
33155256|NCT00676338|100482456|FG000|Overall Study|Protocol Violation|5|||
33155257|NCT00676338|100482457|FG001|Overall Study|Protocol Violation|9|||
33155258|NCT00676338|100482458|FG002|Overall Study|Protocol Violation|2|||
33155259|NCT00676338|100482459|FG003|Overall Study|Protocol Violation|5|||
33155260|NCT00676338|100482456|FG000|Overall Study|Withdrawal by Subject|17|||
33155261|NCT00676338|100482457|FG001|Overall Study|Withdrawal by Subject|9|||
33155262|NCT00676338|100482458|FG002|Overall Study|Withdrawal by Subject|12|||
33155263|NCT00676338|100482459|FG003|Overall Study|Withdrawal by Subject|6|||
33155264|NCT00676338|100482456|FG000|Overall Study|Entry Criteria Not Met|0|||
33155265|NCT00676338|100482457|FG001|Overall Study|Entry Criteria Not Met|2|||
33155266|NCT00676338|100482458|FG002|Overall Study|Entry Criteria Not Met|1|||
33155267|NCT00676338|100482459|FG003|Overall Study|Entry Criteria Not Met|1|||
33155268|NCT00676338|100482456|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
33155269|NCT00676338|100482457|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
33155270|NCT00676338|100482458|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
33155271|NCT00676338|100482459|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
33155272|NCT03896165|100482460|FG000|Overall Study|Withdrawal by Subject|2|||
33155273|NCT00423722|100482463|FG000|Overall Study|Death|4|||
33155274|NCT00423722|100482464|FG001|Overall Study|Death|4|||
33155275|NCT00423722|100482463|FG000|Overall Study|Declined to participate|2|||
33155276|NCT00423722|100482464|FG001|Overall Study|Declined to participate|3|||
33155277|NCT00423722|100482463|FG000|Overall Study|Unable to complete questionnaires|4|||
33155278|NCT00423722|100482464|FG001|Overall Study|Unable to complete questionnaires|4|||
33155279|NCT00423722|100482463|FG000|Overall Study|Withdrawal by Subject|4|||
33155280|NCT00423722|100482464|FG001|Overall Study|Withdrawal by Subject|2|||
33155281|NCT00289016|100482465|FG000|Overall Study|Disease Progression|29|||
33155282|NCT00289016|100482465|FG000|Overall Study|Death|2|||
33155283|NCT00289016|100482465|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
33438210|NCT01434693|101496295|FG003|Overall Study|Lost to Follow-up|0|||
33438211|NCT02636907|101496299|FG000|Autoinjector Assessment Period|Adverse Event|2|||
33438212|NCT02636907|101496299|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
33438213|NCT02636907|101496299|FG000|Extension Phase|Adverse Event|2|||
33438214|NCT02636907|101496299|FG000|Extension Phase|Withdrawal by Subject|4|||
33155284|NCT00289016|100482465|FG000|Overall Study|Withdrawal by Subject|2|||
33155285|NCT00289016|100482465|FG000|Overall Study|Adverse Event|1|||
33155286|NCT00289016|100482465|FG000|Overall Study|Other|1|||
33155287|NCT03330288|100482466|FG000|Overall Study|Other reason|1|||
33438215|NCT02636907|101496299|FG000|Extension Phase|Physician Decision|1|||
33155288|NCT03330288|100482467|FG001|Overall Study|Other reason|1|||
33155289|NCT03330288|100482466|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
33155290|NCT03330288|100482467|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
33155291|NCT03330288|100482466|FG000|Overall Study|Adverse Event|1|||
33155292|NCT03330288|100482467|FG001|Overall Study|Adverse Event|0|||
33155293|NCT03330288|100482466|FG000|Overall Study|Withdrawal by Subject|1|||
33155294|NCT03330288|100482467|FG001|Overall Study|Withdrawal by Subject|0|||
33155295|NCT03330288|100482466|FG000|Overall Study|Lost to Follow-up|26|||
33155296|NCT03330288|100482467|FG001|Overall Study|Lost to Follow-up|7|||
33438216|NCT02636907|101496299|FG000|Extension Phase|Lost to Follow-up|2|||
33438217|NCT02636907|101496299|FG000|Extension Phase|Lack of Efficacy|1|||
33438218|NCT01703832|101496300|FG000|Overall Study|Withdrawal by Subject|1|||
33438219|NCT01703832|101496301|FG001|Overall Study|Withdrawal by Subject|0|||
33438220|NCT02246920|101496303|FG000|Overall Study|Adverse Event|3|||
33438221|NCT02246920|101496304|FG001|Overall Study|Adverse Event|1|||
33438222|NCT02246920|101496305|FG002|Overall Study|Adverse Event|1|||
33438223|NCT02246920|101496303|FG000|Overall Study|Lost to Follow-up|2|||
33438224|NCT02246920|101496304|FG001|Overall Study|Lost to Follow-up|1|||
33438225|NCT02246920|101496305|FG002|Overall Study|Lost to Follow-up|0|||
33438226|NCT02246920|101496303|FG000|Overall Study|Protocol Violation|2|||
33438227|NCT02246920|101496304|FG001|Overall Study|Protocol Violation|5|||
33438228|NCT02246920|101496305|FG002|Overall Study|Protocol Violation|1|||
33438229|NCT02246920|101496303|FG000|Overall Study|Withdrawal by Subject|0|||
33438230|NCT02246920|101496304|FG001|Overall Study|Withdrawal by Subject|0|||
33438231|NCT02246920|101496305|FG002|Overall Study|Withdrawal by Subject|1|||
33438232|NCT02073643|101496306|FG000|Overall Study|Lost to Follow-up|24|||
33438233|NCT02173704|101499780|FG000|Overall Study|Adverse Event|1|||
33438234|NCT02173704|101499781|FG001|Overall Study|Adverse Event|0|||
33438235|NCT02173704|101499780|FG000|Overall Study|Lost to Follow-up|1|||
33438236|NCT02173704|101499781|FG001|Overall Study|Lost to Follow-up|0|||
33438237|NCT02173704|101499780|FG000|Overall Study|Other|1|||
33438238|NCT02173704|101499781|FG001|Overall Study|Other|0|||
33252651|NCT03710564|100823747|FG001|Overall Study|Adverse Event|0|||
33438239|NCT02173704|101499780|FG000|Overall Study|Protocol Violation|1|||
33438240|NCT02173704|101499781|FG001|Overall Study|Protocol Violation|0|||
33438241|NCT02173704|101499780|FG000|Overall Study|Withdrawal by Subject|9|||
33438242|NCT02173704|101499781|FG001|Overall Study|Withdrawal by Subject|4|||
33438243|NCT00659607|101499782|FG000|Overall Study|No blood pressure recorded|147|||
33438244|NCT00659607|101499782|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
33438245|NCT00659607|101499782|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
33252652|NCT03710564|100823746|FG000|Overall Study|Physician Decision|2|||
33438246|NCT00659607|101499782|FG000|Overall Study|No recorded efficacy data|15|||
33438247|NCT00659607|101499782|FG000|Overall Study|Inconsistent BP measuring date|2|||
33155297|NCT00961649|100482471|FG000|Overall Study|Adverse Event|4|||
33155298|NCT00961649|100482472|FG001|Overall Study|Adverse Event|0|||
33155299|NCT00961649|100482473|FG002|Overall Study|Adverse Event|0|||
33155300|NCT00961649|100482474|FG003|Overall Study|Adverse Event|2|||
33155301|NCT00961649|100482471|FG000|Overall Study|Inadequate control of IOP|0|||
33155302|NCT00961649|100482472|FG001|Overall Study|Inadequate control of IOP|0|||
33155303|NCT00961649|100482473|FG002|Overall Study|Inadequate control of IOP|0|||
33155304|NCT00961649|100482474|FG003|Overall Study|Inadequate control of IOP|1|||
33155305|NCT00961649|100482471|FG000|Overall Study|Patient has travel plans during holidays|0|||
33155306|NCT00961649|100482472|FG001|Overall Study|Patient has travel plans during holidays|0|||
33155307|NCT00961649|100482473|FG002|Overall Study|Patient has travel plans during holidays|1|||
33155308|NCT00961649|100482474|FG003|Overall Study|Patient has travel plans during holidays|0|||
33155309|NCT00961649|100482471|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
33155310|NCT00961649|100482472|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
33155311|NCT00961649|100482473|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
33155312|NCT00961649|100482474|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
33155313|NCT00961649|100482471|FG000|Overall Study|Study terminated by sponsor|4|||
33155314|NCT00961649|100482472|FG001|Overall Study|Study terminated by sponsor|4|||
33155315|NCT00961649|100482473|FG002|Overall Study|Study terminated by sponsor|4|||
33155316|NCT00961649|100482474|FG003|Overall Study|Study terminated by sponsor|1|||
33155317|NCT03546062|100482475|FG000|Overall Study|Adverse Event|6|||
33155318|NCT03546062|100482476|FG001|Overall Study|Adverse Event|5|||
33155319|NCT03546062|100482477|FG002|Overall Study|Adverse Event|8|||
33155320|NCT00621959|100482478|FG000|Overall Study|Adverse Event|4|||
33155321|NCT00621959|100482479|FG001|Overall Study|Adverse Event|2|||
33155322|NCT00621959|100482478|FG000|Overall Study|Lack of Efficacy|1|||
33155323|NCT00621959|100482479|FG001|Overall Study|Lack of Efficacy|1|||
33155324|NCT00621959|100482478|FG000|Overall Study|Lost to Follow-up|0|||
33155325|NCT00621959|100482479|FG001|Overall Study|Lost to Follow-up|2|||
33155326|NCT00621959|100482478|FG000|Overall Study|Withdrawal by Subject|1|||
33155327|NCT00621959|100482479|FG001|Overall Study|Withdrawal by Subject|1|||
33155328|NCT00621959|100482478|FG000|Overall Study|Other|1|||
33155329|NCT00621959|100482479|FG001|Overall Study|Other|3|||
33155330|NCT02833350|100482480|FG000|Overall Study|Adverse Event|0|||
33438248|NCT00154102|101499783|FG000|Overall Study|investigational study phase ongoing|7|||
33155331|NCT02833350|100482481|FG001|Overall Study|Adverse Event|3|||
33155332|NCT02833350|100482482|FG002|Overall Study|Adverse Event|4|||
33155333|NCT02833350|100482483|FG003|Overall Study|Adverse Event|4|||
33155334|NCT02833350|100482484|FG004|Overall Study|Adverse Event|1|||
33155335|NCT02833350|100482485|FG005|Overall Study|Adverse Event|0|||
33155336|NCT02833350|100482486|FG006|Overall Study|Adverse Event|1|||
33155337|NCT02833350|100482480|FG000|Overall Study|Death|0|||
33155338|NCT02833350|100482481|FG001|Overall Study|Death|0|||
33155339|NCT02833350|100482482|FG002|Overall Study|Death|1|||
33155340|NCT02833350|100482483|FG003|Overall Study|Death|0|||
33155341|NCT02833350|100482484|FG004|Overall Study|Death|0|||
33155342|NCT02833350|100482485|FG005|Overall Study|Death|0|||
33155343|NCT02833350|100482486|FG006|Overall Study|Death|0|||
33155344|NCT02833350|100482480|FG000|Overall Study|Lack of Efficacy|0|||
33438249|NCT00154102|101499784|FG001|Overall Study|investigational study phase ongoing|2|||
33155345|NCT02833350|100482481|FG001|Overall Study|Lack of Efficacy|2|||
33155346|NCT02833350|100482482|FG002|Overall Study|Lack of Efficacy|1|||
33155347|NCT02833350|100482483|FG003|Overall Study|Lack of Efficacy|4|||
33155348|NCT02833350|100482484|FG004|Overall Study|Lack of Efficacy|0|||
33438250|NCT00105196|101499788|FG000|Overall Study|Lack of Efficacy|2|||
33155349|NCT02833350|100482485|FG005|Overall Study|Lack of Efficacy|1|||
33155350|NCT02833350|100482486|FG006|Overall Study|Lack of Efficacy|1|||
33438251|NCT00105196|101499789|FG001|Overall Study|Lack of Efficacy|3|||
33438252|NCT00105196|101499788|FG000|Overall Study|Adverse Event|11|||
33155351|NCT02833350|100482480|FG000|Overall Study|Lost to Follow-up|0|||
33155352|NCT02833350|100482481|FG001|Overall Study|Lost to Follow-up|1|||
33155353|NCT02833350|100482482|FG002|Overall Study|Lost to Follow-up|0|||
33155354|NCT02833350|100482483|FG003|Overall Study|Lost to Follow-up|0|||
33155355|NCT02833350|100482484|FG004|Overall Study|Lost to Follow-up|0|||
33155356|NCT02833350|100482485|FG005|Overall Study|Lost to Follow-up|0|||
33155357|NCT02833350|100482486|FG006|Overall Study|Lost to Follow-up|1|||
33387570|NCT00856986|101306342|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
33387571|NCT00856986|101306343|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
33387572|NCT00856986|101306344|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
33387573|NCT00856986|101306345|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
33438253|NCT00105196|101499789|FG001|Overall Study|Adverse Event|3|||
33438254|NCT00105196|101499788|FG000|Overall Study|Withdrawal by Subject|6|||
33438255|NCT00105196|101499789|FG001|Overall Study|Withdrawal by Subject|6|||
33155358|NCT02833350|100482480|FG000|Overall Study|Withdrawal by Subject|3|||
33155359|NCT02833350|100482481|FG001|Overall Study|Withdrawal by Subject|3|||
33155360|NCT02833350|100482482|FG002|Overall Study|Withdrawal by Subject|2|||
33155361|NCT02833350|100482483|FG003|Overall Study|Withdrawal by Subject|0|||
33155362|NCT02833350|100482484|FG004|Overall Study|Withdrawal by Subject|2|||
33155363|NCT02833350|100482485|FG005|Overall Study|Withdrawal by Subject|0|||
33155364|NCT02833350|100482486|FG006|Overall Study|Withdrawal by Subject|2|||
33155365|NCT01858376|100482487|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
33155366|NCT04032652|100482488|FG000|Overall Study|The study was terminated and the PI has|1|||
33155367|NCT04032652|100482489|FG001|Overall Study|The study was terminated and the PI has|1|||
33155368|NCT02949700|100482491|FG000|Phase I|Withdrawal by Subject|1|||
33155369|NCT02949700|100482492|FG001|Phase I|Withdrawal by Subject|1|||
33155370|NCT02949700|100482493|FG002|Phase I|Withdrawal by Subject|0|||
33155371|NCT02949700|100482494|FG003|Phase I|Withdrawal by Subject|0|||
33155372|NCT02949700|100482491|FG000|Phase I|Protocol Violation|1|||
33252653|NCT03710564|100823747|FG001|Overall Study|Physician Decision|3|||
33252654|NCT00346151|100823752|FG000|Overall Study|Withdrawal by Subject|3|||
33252655|NCT01456936|100823753|FG000|Overall Study|Other reason|41|||
33387574|NCT00856986|101306341|FG000|Main Period, Weeks 0-26|Unclassified|7|||
33155373|NCT02949700|100482492|FG001|Phase I|Protocol Violation|0|||
33155374|NCT02949700|100482493|FG002|Phase I|Protocol Violation|0|||
33252656|NCT01456936|100823754|FG001|Overall Study|Other reason|30|||
33155375|NCT02949700|100482494|FG003|Phase I|Protocol Violation|0|||
33155376|NCT02949700|100482491|FG000|Phase II|Withdrawal by Subject|0|||
33155377|NCT02949700|100482492|FG001|Phase II|Withdrawal by Subject|0|||
33155378|NCT02949700|100482493|FG002|Phase II|Withdrawal by Subject|0|||
33155379|NCT02949700|100482494|FG003|Phase II|Withdrawal by Subject|2|||
33155380|NCT02949700|100482491|FG000|Phase II|Protocol Violation|0|||
33155381|NCT02949700|100482492|FG001|Phase II|Protocol Violation|0|||
33155382|NCT02949700|100482493|FG002|Phase II|Protocol Violation|1|||
33155383|NCT02949700|100482494|FG003|Phase II|Protocol Violation|3|||
33155384|NCT03082261|100482495|FG000|Overall Study|Death|4|||
33155385|NCT03082261|100482495|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
33155386|NCT03082261|100482495|FG000|Overall Study|Insurance denial|1|||
33155387|NCT03082261|100482495|FG000|Overall Study|Peripheral lead added|1|||
33155388|NCT03082261|100482495|FG000|Overall Study|Withdrawal by Subject|40|||
33155389|NCT03082261|100482495|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
33155390|NCT03082261|100482495|FG000|Overall Study|Subject implanted with device other than study device|1|||
33438256|NCT00105196|101499788|FG000|Overall Study|Lost to Follow-up|3|||
33155391|NCT03082261|100482495|FG000|Overall Study|Lost to Follow-up|14|||
33155392|NCT03082261|100482495|FG000|Overall Study|Subject moved to a different state|1|||
33155393|NCT03082261|100482495|FG000|Overall Study|Subject non-compliance|2|||
33155394|NCT03082261|100482495|FG000|Overall Study|Subject participation terminated by investigator|9|||
33155395|NCT03082261|100482495|FG000|Overall Study|Subject participation terminated by sponsor|4|||
33155396|NCT03082261|100482495|FG000|Overall Study|System explant|19|||
33155397|NCT03082261|100482495|FG000|Overall Study|Unable to place lead(s)|2|||
33155398|NCT03082261|100482495|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
33155399|NCT01612858|100482496|FG000|Overall Study|Withdrawal by Subject|5|||
33155400|NCT01612858|100482497|FG001|Overall Study|Withdrawal by Subject|1|||
33155401|NCT00395733|100482499|FG000|Period 2|Withdrawal by Subject|1|||
33155402|NCT00395733|100482500|FG001|Period 2|Withdrawal by Subject|2|||
33155403|NCT00395733|100482499|FG000|Period 2|Protocol Violation|0|||
33155404|NCT00395733|100482500|FG001|Period 2|Protocol Violation|1|||
33155405|NCT00395733|100482499|FG000|Period 2|Adverse Event|0|||
33155406|NCT00395733|100482500|FG001|Period 2|Adverse Event|2|||
33155407|NCT00395733|100482499|FG000|Period 2|Technical problems|1|||
33155408|NCT00395733|100482500|FG001|Period 2|Technical problems|0|||
33155409|NCT00354614|100482501|FG000|Overall Study|Lack of Efficacy|28|||
33155410|NCT03417219|100482502|FG000|Overall Study|Lost to Follow-up|0|||
33155411|NCT03417219|100482503|FG001|Overall Study|Lost to Follow-up|3|||
33155412|NCT01332331|100482504|FG000|Overall Study|Lost to Follow-up|0|||
33155413|NCT01332331|100482505|FG001|Overall Study|Lost to Follow-up|1|||
33252657|NCT01456936|100823755|FG002|Overall Study|Other reason|36|||
33155414|NCT01332331|100482504|FG000|Overall Study|Adverse Event|1|||
33155415|NCT01332331|100482505|FG001|Overall Study|Adverse Event|1|||
33155416|NCT01332331|100482504|FG000|Overall Study|Physician Decision|1|||
33438257|NCT00105196|101499789|FG001|Overall Study|Lost to Follow-up|2|||
33155417|NCT01332331|100482505|FG001|Overall Study|Physician Decision|0|||
33155418|NCT01967173|100482513|FG000|Overall Study|Lost to Follow-up|5|||
33438258|NCT00105196|101499788|FG000|Overall Study|Poor/noncompliance|3|||
33438259|NCT00105196|101499789|FG001|Overall Study|Poor/noncompliance|4|||
33438260|NCT00105196|101499788|FG000|Overall Study|Protocol Violation|5|||
33438261|NCT00105196|101499789|FG001|Overall Study|Protocol Violation|2|||
33438262|NCT00105196|101499788|FG000|Overall Study|pending surgery|0|||
33438263|NCT00105196|101499789|FG001|Overall Study|pending surgery|1|||
33438264|NCT00105196|101499788|FG000|Overall Study|marijuana use|0|||
33438265|NCT00105196|101499789|FG001|Overall Study|marijuana use|1|||
33438266|NCT00105196|101499788|FG000|Overall Study|Subject became unblinded|0|||
33438267|NCT00105196|101499789|FG001|Overall Study|Subject became unblinded|1|||
33438268|NCT01471522|101499792|FG000|Overall Study|Withdrawal by Subject|28|||
33438269|NCT01471522|101499793|FG001|Overall Study|Withdrawal by Subject|22|||
33438270|NCT01471522|101499792|FG000|Overall Study|Lost to Follow-up|36|||
33438271|NCT01471522|101499793|FG001|Overall Study|Lost to Follow-up|26|||
33438272|NCT01648166|101499795|FG000|Overall Study|inadequate toenail samples|53|||
33438273|NCT01648166|101499796|FG001|Overall Study|inadequate toenail samples|100|||
33438274|NCT01139164|101499800|FG000|Overall Study|Withdrawn prior to study start|0|||
33438275|NCT01139164|101499801|FG001|Overall Study|Withdrawn prior to study start|2|||
33438276|NCT01139164|101499802|FG002|Overall Study|Withdrawn prior to study start|0|||
33438277|NCT01790568|101499803|FG000|Overall Study|Progression prior to transplant|0|||
33438278|NCT01790568|101499804|FG001|Overall Study|Progression prior to transplant|1|||
33438279|NCT03227445|101499807|FG000|Period 1 (28 Days)|Adverse Event|1|||
33438280|NCT03227445|101499808|FG001|Period 1 (28 Days)|Adverse Event|2|||
33438281|NCT03227445|101499809|FG002|Period 1 (28 Days)|Adverse Event|0|||
33438282|NCT03227445|101499810|FG003|Period 1 (28 Days)|Adverse Event|1|||
33438283|NCT03227445|101499807|FG000|Period 1 (28 Days)|Protocol Violation|1|||
33438284|NCT03227445|101499808|FG001|Period 1 (28 Days)|Protocol Violation|0|||
33438285|NCT03227445|101499809|FG002|Period 1 (28 Days)|Protocol Violation|0|||
33438286|NCT03227445|101499810|FG003|Period 1 (28 Days)|Protocol Violation|0|||
33438287|NCT03227445|101499807|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
33155419|NCT01967173|100482514|FG001|Overall Study|Lost to Follow-up|3|||
33155420|NCT01967173|100482515|FG002|Overall Study|Lost to Follow-up|2|||
33438288|NCT03227445|101499808|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
33438289|NCT03227445|101499809|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
33438290|NCT03227445|101499810|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
33438291|NCT03227445|101499807|FG000|Period 2 (28 Days)|Adverse Event|1|||
33438292|NCT03227445|101499808|FG001|Period 2 (28 Days)|Adverse Event|0|||
33438293|NCT03227445|101499809|FG002|Period 2 (28 Days)|Adverse Event|2|||
33438294|NCT03227445|101499810|FG003|Period 2 (28 Days)|Adverse Event|1|||
33438295|NCT03227445|101499807|FG000|Period 2 (28 Days)|Protocol Violation|0|||
33438296|NCT03227445|101499808|FG001|Period 2 (28 Days)|Protocol Violation|0|||
33438297|NCT03227445|101499809|FG002|Period 2 (28 Days)|Protocol Violation|0|||
33438298|NCT03227445|101499810|FG003|Period 2 (28 Days)|Protocol Violation|1|||
33438299|NCT03227445|101499807|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
33438300|NCT03227445|101499808|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
33438301|NCT03227445|101499809|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
33438302|NCT03227445|101499810|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
33438303|NCT00760266|101499811|FG000|Overall Study|Adverse Event|13|||
33438304|NCT00760266|101499812|FG001|Overall Study|Adverse Event|7|||
33438305|NCT00760266|101499811|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33438306|NCT00760266|101499812|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33438307|NCT00760266|101499811|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33438308|NCT00760266|101499812|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33438309|NCT00760266|101499811|FG000|Overall Study|Lack of Efficacy|2|||
33155421|NCT01967173|100482516|FG003|Overall Study|Lost to Follow-up|4|||
33438310|NCT00760266|101499812|FG001|Overall Study|Lack of Efficacy|2|||
33438311|NCT00760266|101499811|FG000|Overall Study|Protocol deviation|2|||
33438312|NCT00760266|101499812|FG001|Overall Study|Protocol deviation|4|||
33438313|NCT00760266|101499811|FG000|Overall Study|Patient withdrew consent|3|||
33438314|NCT00760266|101499812|FG001|Overall Study|Patient withdrew consent|3|||
33438315|NCT00760266|101499811|FG000|Overall Study|Lost to Follow-up|2|||
33438316|NCT00760266|101499812|FG001|Overall Study|Lost to Follow-up|1|||
33438317|NCT00760266|101499811|FG000|Overall Study|Administrative Problems|0|||
33438318|NCT00760266|101499812|FG001|Overall Study|Administrative Problems|1|||
33387575|NCT00856986|101306342|FG001|Main Period, Weeks 0-26|Unclassified|6|||
33387576|NCT00856986|101306343|FG002|Main Period, Weeks 0-26|Unclassified|7|||
33387577|NCT00856986|101306344|FG003|Main Period, Weeks 0-26|Unclassified|0|||
33387578|NCT00856986|101306345|FG004|Main Period, Weeks 0-26|Unclassified|0|||
33387579|NCT00856986|101306341|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
33387580|NCT00856986|101306342|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
33387581|NCT00856986|101306343|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
33387582|NCT00856986|101306344|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
33387583|NCT00856986|101306345|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
33387584|NCT00856986|101306341|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
33387585|NCT00856986|101306342|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
33387586|NCT00856986|101306343|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
33387587|NCT00856986|101306344|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
33387588|NCT00856986|101306345|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
33387589|NCT00856986|101306341|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
33387590|NCT00856986|101306342|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
33387591|NCT00856986|101306343|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
33387592|NCT00856986|101306344|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
33387593|NCT00856986|101306345|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
33387594|NCT00856986|101306341|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
33387595|NCT00856986|101306342|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
33387596|NCT00856986|101306343|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
33387597|NCT00856986|101306344|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
33387598|NCT00856986|101306345|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
33387599|NCT00856986|101306341|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
33387600|NCT00856986|101306342|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
33387601|NCT00856986|101306343|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
33387602|NCT00856986|101306344|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
33155422|NCT01967173|100482517|FG004|Overall Study|Lost to Follow-up|8|||
33155423|NCT01967173|100482518|FG005|Overall Study|Lost to Follow-up|12|||
33155424|NCT01967173|100482519|FG006|Overall Study|Lost to Follow-up|6|||
33155425|NCT01967173|100482520|FG007|Overall Study|Lost to Follow-up|8|||
33155426|NCT01967173|100482513|FG000|Overall Study|Physician Decision|2|||
33155427|NCT01967173|100482514|FG001|Overall Study|Physician Decision|0|||
33155428|NCT01967173|100482515|FG002|Overall Study|Physician Decision|2|||
33438319|NCT01893905|101499819|FG000|Overall Study|Withdrawal by Subject|1|||
33438320|NCT01893905|101499820|FG001|Overall Study|Withdrawal by Subject|0|||
33438321|NCT01893905|101499819|FG000|Overall Study|Adverse Event|9|||
33438322|NCT01893905|101499820|FG001|Overall Study|Adverse Event|3|||
33438323|NCT01893905|101499819|FG000|Overall Study|Lack of Efficacy|5|||
33438324|NCT01893905|101499820|FG001|Overall Study|Lack of Efficacy|7|||
33387603|NCT00856986|101306345|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
33438325|NCT01893905|101499819|FG000|Overall Study|Lost to Follow-up|1|||
33438326|NCT01893905|101499820|FG001|Overall Study|Lost to Follow-up|0|||
33438327|NCT01893905|101499819|FG000|Overall Study|Protocol Violation|6|||
33155429|NCT01967173|100482516|FG003|Overall Study|Physician Decision|1|||
33387604|NCT00856986|101306341|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
33387605|NCT00856986|101306342|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
33387606|NCT00856986|101306343|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
33387607|NCT00856986|101306344|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
33387608|NCT00856986|101306345|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
33387609|NCT03170258|101306346|FG000|Overall Study|Physician Decision|4|||
33387610|NCT03170258|101306347|FG001|Overall Study|Physician Decision|0|||
33387611|NCT03170258|101306346|FG000|Overall Study|Equipment issues|1|||
33387612|NCT03170258|101306347|FG001|Overall Study|Equipment issues|0|||
33387613|NCT03170258|101306346|FG000|Overall Study|Medication|1|||
33387614|NCT03170258|101306347|FG001|Overall Study|Medication|0|||
33387615|NCT03170258|101306346|FG000|Overall Study|Sleep issues|1|||
33387616|NCT03170258|101306347|FG001|Overall Study|Sleep issues|0|||
33387617|NCT02905825|101306350|FG000|Overall Study|Protocol Violation|11|||
33438328|NCT01893905|101499820|FG001|Overall Study|Protocol Violation|1|||
33438329|NCT01893905|101499819|FG000|Overall Study|Lack of adherence to treatment|2|||
33155430|NCT01967173|100482517|FG004|Overall Study|Physician Decision|1|||
33155431|NCT01967173|100482518|FG005|Overall Study|Physician Decision|1|||
33438330|NCT01893905|101499820|FG001|Overall Study|Lack of adherence to treatment|0|||
33155432|NCT01967173|100482519|FG006|Overall Study|Physician Decision|1|||
33438331|NCT01893905|101499819|FG000|Overall Study|Other reason|1|||
33438332|NCT01893905|101499820|FG001|Overall Study|Other reason|3|||
33438333|NCT03340727|101499828|FG000|Overall Study|Death|1|||
33438334|NCT03340727|101499829|FG001|Overall Study|Death|0|||
33438335|NCT03340727|101499828|FG000|Overall Study|Lost to Follow-up|31|||
33438336|NCT03340727|101499829|FG001|Overall Study|Lost to Follow-up|35|||
33438337|NCT03340727|101499828|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
33438338|NCT03340727|101499829|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
33155433|NCT01967173|100482520|FG007|Overall Study|Physician Decision|0|||
33155434|NCT01967173|100482513|FG000|Overall Study|Lack of Efficacy|2|||
33155435|NCT01967173|100482514|FG001|Overall Study|Lack of Efficacy|0|||
33155436|NCT01967173|100482515|FG002|Overall Study|Lack of Efficacy|2|||
33155437|NCT01967173|100482516|FG003|Overall Study|Lack of Efficacy|2|||
33155438|NCT01967173|100482517|FG004|Overall Study|Lack of Efficacy|0|||
33155439|NCT01967173|100482518|FG005|Overall Study|Lack of Efficacy|1|||
33252658|NCT01456936|100823756|FG003|Overall Study|Other reason|33|||
33252659|NCT01456936|100823753|FG000|Overall Study|No longer meets eligibility criteria|4|||
33252660|NCT01456936|100823754|FG001|Overall Study|No longer meets eligibility criteria|8|||
33252661|NCT01456936|100823755|FG002|Overall Study|No longer meets eligibility criteria|6|||
33252662|NCT01456936|100823756|FG003|Overall Study|No longer meets eligibility criteria|5|||
33438339|NCT03340727|101499828|FG000|Overall Study|Transferred to another facility|10|||
33438340|NCT03340727|101499829|FG001|Overall Study|Transferred to another facility|7|||
33252663|NCT01456936|100823753|FG000|Overall Study|Protocol Violation|4|||
33252664|NCT01456936|100823754|FG001|Overall Study|Protocol Violation|2|||
33252665|NCT01456936|100823755|FG002|Overall Study|Protocol Violation|5|||
33252666|NCT01456936|100823756|FG003|Overall Study|Protocol Violation|5|||
33252667|NCT01456936|100823753|FG000|Overall Study|Pregnancy|1|||
33252668|NCT01456936|100823754|FG001|Overall Study|Pregnancy|0|||
33252669|NCT01456936|100823755|FG002|Overall Study|Pregnancy|0|||
33252670|NCT01456936|100823756|FG003|Overall Study|Pregnancy|1|||
33387618|NCT02905825|101306350|FG000|Overall Study|Device Malfunction|1|||
33387619|NCT03136484|101306351|FG000|Overall Study|Withdrawal by Subject|19|||
33387620|NCT03136484|101306352|FG001|Overall Study|Withdrawal by Subject|14|||
33387621|NCT03136484|101306351|FG000|Overall Study|Lost to Follow-up|7|||
33387622|NCT03136484|101306352|FG001|Overall Study|Lost to Follow-up|8|||
33387623|NCT03136484|101306351|FG000|Overall Study|Death|1|||
33387624|NCT03136484|101306352|FG001|Overall Study|Death|0|||
33387625|NCT00239356|101306355|FG000|Overall Study|Lack of Efficacy|1|||
33387626|NCT00239356|101306356|FG001|Overall Study|Lack of Efficacy|0|||
33387627|NCT00239356|101306355|FG000|Overall Study|Adverse Event|6|||
33387628|NCT00239356|101306356|FG001|Overall Study|Adverse Event|0|||
33387629|NCT00239356|101306355|FG000|Overall Study|Withdrawal by Subject|15|||
33387630|NCT00239356|101306356|FG001|Overall Study|Withdrawal by Subject|6|||
33387631|NCT00239356|101306355|FG000|Overall Study|Lost to Follow-up|3|||
33438341|NCT03340727|101499828|FG000|Overall Study|Withdrawal by Subject|28|||
33438342|NCT03340727|101499829|FG001|Overall Study|Withdrawal by Subject|17|||
33252671|NCT01456936|100823753|FG000|Overall Study|Insufficient clinical response|4|||
33155440|NCT01967173|100482519|FG006|Overall Study|Lack of Efficacy|0|||
33155441|NCT01967173|100482520|FG007|Overall Study|Lack of Efficacy|2|||
33387632|NCT00239356|101306356|FG001|Overall Study|Lost to Follow-up|0|||
33252672|NCT01456936|100823754|FG001|Overall Study|Insufficient clinical response|4|||
33387633|NCT00239356|101306355|FG000|Overall Study|poor/non-compliance|2|||
33438343|NCT02930005|101499830|FG000|Overall Study|Lost to Follow-up|1|||
33438344|NCT02930005|101499831|FG001|Overall Study|Lost to Follow-up|5|||
33438345|NCT01572948|101499832|FG000|Overall Study|Lost to Follow-up|1|||
33387634|NCT00239356|101306356|FG001|Overall Study|poor/non-compliance|0|||
33387635|NCT00239356|101306355|FG000|Overall Study|Pregnancy|1|||
33252673|NCT01456936|100823755|FG002|Overall Study|Insufficient clinical response|14|||
33252674|NCT01456936|100823756|FG003|Overall Study|Insufficient clinical response|13|||
33252675|NCT01456936|100823753|FG000|Overall Study|No longer willing to participate|195|||
33252676|NCT01456936|100823754|FG001|Overall Study|No longer willing to participate|218|||
33252677|NCT01456936|100823755|FG002|Overall Study|No longer willing to participate|224|||
33252678|NCT01456936|100823756|FG003|Overall Study|No longer willing to participate|248|||
33252679|NCT01456936|100823753|FG000|Overall Study|Lost to Follow-up|135|||
33252680|NCT01456936|100823754|FG001|Overall Study|Lost to Follow-up|126|||
33252681|NCT01456936|100823755|FG002|Overall Study|Lost to Follow-up|144|||
33252682|NCT01456936|100823756|FG003|Overall Study|Lost to Follow-up|127|||
33252683|NCT01456936|100823753|FG000|Overall Study|Medication error|0|||
33252684|NCT01456936|100823754|FG001|Overall Study|Medication error|1|||
33252685|NCT01456936|100823755|FG002|Overall Study|Medication error|0|||
33252686|NCT01456936|100823756|FG003|Overall Study|Medication error|1|||
33252687|NCT01456936|100823753|FG000|Overall Study|Adverse event (study drug)|25|||
33252688|NCT01456936|100823754|FG001|Overall Study|Adverse event (study drug)|21|||
33252689|NCT01456936|100823755|FG002|Overall Study|Adverse event (study drug)|26|||
33252690|NCT01456936|100823756|FG003|Overall Study|Adverse event (study drug)|17|||
33387636|NCT00239356|101306356|FG001|Overall Study|Pregnancy|0|||
33387637|NCT00239356|101306355|FG000|Overall Study|Administrative reason|0|||
33387638|NCT00239356|101306356|FG001|Overall Study|Administrative reason|1|||
33387639|NCT00239356|101306355|FG000|Overall Study|Drug available on market|11|||
33387640|NCT00239356|101306356|FG001|Overall Study|Drug available on market|2|||
33387641|NCT02571972|101306357|FG000|Overall Study|Protocol Violation|2|||
33387642|NCT02571972|101306357|FG000|Overall Study|Withdrawal by Subject|2|||
33387643|NCT00587301|101306358|FG000|Overall Study|Screen Failure|9|||
33387644|NCT00587301|101306358|FG000|Overall Study|Lost to Follow-up|22|||
33387645|NCT00587301|101306358|FG000|Overall Study|Withdrawal by Subject|7|||
33387646|NCT00587301|101306358|FG000|Overall Study|Protocol Violation|7|||
33387647|NCT00961116|101306361|FG000|Washout Period of 7 Days|Adverse Event|1|||
33387648|NCT00961116|101306362|FG001|Washout Period of 7 Days|Adverse Event|1|||
33387649|NCT00961116|101306361|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
33387650|NCT00961116|101306362|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33387651|NCT00961116|101306361|FG000|Washout Period of 7 Days|Protocol Violation|0|||
33387652|NCT00961116|101306362|FG001|Washout Period of 7 Days|Protocol Violation|1|||
33387653|NCT00636441|101306363|FG000|Overall Study|Adverse Event|0|||
33387654|NCT00636441|101306364|FG001|Overall Study|Adverse Event|1|||
33387655|NCT00636441|101306365|FG002|Overall Study|Adverse Event|1|||
33387656|NCT00636441|101306366|FG003|Overall Study|Adverse Event|0|||
33387657|NCT00636441|101306367|FG004|Overall Study|Adverse Event|0|||
33387658|NCT00636441|101306368|FG005|Overall Study|Adverse Event|1|||
33387659|NCT00636441|101306369|FG006|Overall Study|Adverse Event|0|||
33387660|NCT00636441|101306363|FG000|Overall Study|Late, ineligible|0|||
33387661|NCT00636441|101306364|FG001|Overall Study|Late, ineligible|0|||
33387662|NCT00636441|101306365|FG002|Overall Study|Late, ineligible|0|||
33387663|NCT00636441|101306366|FG003|Overall Study|Late, ineligible|0|||
33387664|NCT00636441|101306367|FG004|Overall Study|Late, ineligible|0|||
33387665|NCT00636441|101306368|FG005|Overall Study|Late, ineligible|0|||
33387666|NCT00636441|101306369|FG006|Overall Study|Late, ineligible|1|||
33387667|NCT00636441|101306363|FG000|Overall Study|Screen Failure|0|||
33387668|NCT00636441|101306364|FG001|Overall Study|Screen Failure|0|||
33387669|NCT00636441|101306365|FG002|Overall Study|Screen Failure|0|||
33252691|NCT01456936|100823753|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
33252692|NCT01456936|100823754|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
33387670|NCT00636441|101306366|FG003|Overall Study|Screen Failure|0|||
33387671|NCT00636441|101306367|FG004|Overall Study|Screen Failure|0|||
33387672|NCT00636441|101306368|FG005|Overall Study|Screen Failure|0|||
33387673|NCT00636441|101306369|FG006|Overall Study|Screen Failure|17|||
33387674|NCT00323310|101306370|FG000|Overall Study|Withdrawal by Subject|1|||
33252693|NCT01456936|100823755|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
33252694|NCT01456936|100823756|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
33252695|NCT01456936|100823753|FG000|Overall Study|Death|0|||
33252696|NCT01456936|100823754|FG001|Overall Study|Death|3|||
33252697|NCT01456936|100823755|FG002|Overall Study|Death|1|||
33252698|NCT01456936|100823756|FG003|Overall Study|Death|3|||
33252699|NCT01456936|100823753|FG000|Overall Study|Randomized but not treated|21|||
33252700|NCT01456936|100823754|FG001|Overall Study|Randomized but not treated|28|||
33252701|NCT01456936|100823755|FG002|Overall Study|Randomized but not treated|16|||
33252702|NCT01456936|100823756|FG003|Overall Study|Randomized but not treated|21|||
33252703|NCT00414648|100823758|FG000|Overall Study|Adverse Event|5|||
33252704|NCT00414648|100823759|FG001|Overall Study|Adverse Event|5|||
33252705|NCT00414648|100823758|FG000|Overall Study|Death|0|||
33252706|NCT00414648|100823759|FG001|Overall Study|Death|1|||
33252707|NCT00414648|100823758|FG000|Overall Study|Lack of Efficacy|0|||
33252708|NCT00414648|100823759|FG001|Overall Study|Lack of Efficacy|2|||
33252709|NCT00414648|100823758|FG000|Overall Study|Withdrawal by Subject|0|||
33252710|NCT00414648|100823759|FG001|Overall Study|Withdrawal by Subject|1|||
33252711|NCT02104765|100823762|FG000|Overall Study|Lost to Follow-up|0|||
33252712|NCT02104765|100823763|FG001|Overall Study|Lost to Follow-up|0|||
33252713|NCT02104765|100823764|FG002|Overall Study|Lost to Follow-up|1|||
33252714|NCT02104765|100823765|FG003|Overall Study|Lost to Follow-up|0|||
33252715|NCT02104765|100823766|FG004|Overall Study|Lost to Follow-up|0|||
33252716|NCT02104765|100823767|FG005|Overall Study|Lost to Follow-up|0|||
33252717|NCT02104765|100823768|FG006|Overall Study|Lost to Follow-up|0|||
33252718|NCT02104765|100823762|FG000|Overall Study|Withdrawal by Subject|0|||
33252719|NCT02104765|100823763|FG001|Overall Study|Withdrawal by Subject|0|||
33252720|NCT02104765|100823764|FG002|Overall Study|Withdrawal by Subject|0|||
33252721|NCT02104765|100823765|FG003|Overall Study|Withdrawal by Subject|1|||
33252722|NCT02104765|100823766|FG004|Overall Study|Withdrawal by Subject|1|||
33252723|NCT02104765|100823767|FG005|Overall Study|Withdrawal by Subject|0|||
33252724|NCT02104765|100823768|FG006|Overall Study|Withdrawal by Subject|1|||
33252725|NCT01050569|100823769|FG000|Overall Study|Lost to Follow-up|20|||
33252726|NCT01050569|100823770|FG001|Overall Study|Lost to Follow-up|14|||
33252727|NCT01050569|100823771|FG002|Overall Study|Lost to Follow-up|16|||
33252728|NCT01050569|100823769|FG000|Overall Study|Withdrawal by Subject|9|||
33252729|NCT01050569|100823770|FG001|Overall Study|Withdrawal by Subject|3|||
33252730|NCT01050569|100823771|FG002|Overall Study|Withdrawal by Subject|11|||
33252731|NCT01050569|100823769|FG000|Overall Study|Lack of Efficacy|5|||
33252732|NCT01050569|100823770|FG001|Overall Study|Lack of Efficacy|4|||
33252733|NCT01050569|100823771|FG002|Overall Study|Lack of Efficacy|3|||
33252734|NCT01050569|100823769|FG000|Overall Study|Adverse Event|1|||
33252735|NCT01050569|100823770|FG001|Overall Study|Adverse Event|0|||
33387675|NCT00323310|101306370|FG000|Overall Study|a parent refused blood draw|1|||
33252736|NCT01050569|100823771|FG002|Overall Study|Adverse Event|0|||
33252737|NCT01050569|100823769|FG000|Overall Study|Physician Decision|3|||
33252738|NCT01050569|100823770|FG001|Overall Study|Physician Decision|3|||
33252739|NCT01050569|100823771|FG002|Overall Study|Physician Decision|3|||
33252740|NCT01140048|100823772|FG000|Overall Study|Physician Decision|1|||
33252741|NCT01140048|100823772|FG000|Overall Study|Withdrawal by Subject|13|||
33252742|NCT01140048|100823772|FG000|Overall Study|Lost to Follow-up|31|||
33252743|NCT02698891|100823773|FG000|Overall Study|Withdrawal by Subject|2|||
33252744|NCT02698891|100823773|FG000|Overall Study|deemed ineligible|1|||
33252745|NCT02698891|100823773|FG000|Overall Study|Adverse Event|9|||
33155442|NCT01967173|100482513|FG000|Overall Study|Pregnancy|0|||
33155443|NCT01967173|100482514|FG001|Overall Study|Pregnancy|0|||
33155444|NCT01967173|100482515|FG002|Overall Study|Pregnancy|0|||
33155445|NCT01967173|100482516|FG003|Overall Study|Pregnancy|0|||
33155446|NCT01967173|100482517|FG004|Overall Study|Pregnancy|0|||
33155447|NCT01967173|100482518|FG005|Overall Study|Pregnancy|0|||
33155448|NCT01967173|100482519|FG006|Overall Study|Pregnancy|1|||
33155449|NCT01967173|100482520|FG007|Overall Study|Pregnancy|1|||
33155450|NCT01967173|100482513|FG000|Overall Study|Adverse Event|0|||
33155451|NCT01967173|100482514|FG001|Overall Study|Adverse Event|0|||
33155452|NCT01967173|100482515|FG002|Overall Study|Adverse Event|0|||
33155453|NCT01967173|100482516|FG003|Overall Study|Adverse Event|0|||
33155454|NCT01967173|100482517|FG004|Overall Study|Adverse Event|0|||
33155455|NCT01967173|100482518|FG005|Overall Study|Adverse Event|0|||
33387676|NCT00323310|101306370|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
33387677|NCT03209362|101306379|FG000|Overall Study|Adverse Event|0|||
33387678|NCT03209362|101306380|FG001|Overall Study|Adverse Event|1|||
33387679|NCT03209362|101306379|FG000|Overall Study|Lost to Follow-up|0|||
33387680|NCT03209362|101306380|FG001|Overall Study|Lost to Follow-up|1|||
33387681|NCT03209362|101306379|FG000|Overall Study|Withdrawal by Subject|2|||
33387682|NCT03209362|101306380|FG001|Overall Study|Withdrawal by Subject|0|||
33387683|NCT03209362|101306379|FG000|Overall Study|Other|0|||
33155456|NCT01967173|100482519|FG006|Overall Study|Adverse Event|0|||
33155457|NCT01967173|100482520|FG007|Overall Study|Adverse Event|1|||
33155458|NCT01967173|100482513|FG000|Overall Study|Withdrawal by Subject|15|||
33155459|NCT01967173|100482514|FG001|Overall Study|Withdrawal by Subject|14|||
33155460|NCT01967173|100482515|FG002|Overall Study|Withdrawal by Subject|10|||
33155461|NCT01967173|100482516|FG003|Overall Study|Withdrawal by Subject|7|||
33155462|NCT01967173|100482517|FG004|Overall Study|Withdrawal by Subject|8|||
33387684|NCT03209362|101306380|FG001|Overall Study|Other|1|||
33387685|NCT04605159|101306385|FG000|Overall Study|Adverse Event|6|||
33438346|NCT01572948|101499833|FG001|Overall Study|Lost to Follow-up|0|||
33155463|NCT01967173|100482518|FG005|Overall Study|Withdrawal by Subject|9|||
33155464|NCT01967173|100482519|FG006|Overall Study|Withdrawal by Subject|10|||
33155465|NCT01967173|100482520|FG007|Overall Study|Withdrawal by Subject|12|||
33155466|NCT04402060|100482525|FG000|Overall Study|Death|1|||
33155467|NCT04402060|100482526|FG001|Overall Study|Death|12|||
33155468|NCT04402060|100482527|FG002|Overall Study|Death|7|||
33155469|NCT04402060|100482525|FG000|Overall Study|Adverse Event|0|||
33387686|NCT04605159|101306386|FG001|Overall Study|Adverse Event|3|||
33155470|NCT04402060|100482526|FG001|Overall Study|Adverse Event|0|||
33155471|NCT04402060|100482527|FG002|Overall Study|Adverse Event|1|||
33155472|NCT04402060|100482525|FG000|Overall Study|Withdrawal by Subject|0|||
33155473|NCT04402060|100482526|FG001|Overall Study|Withdrawal by Subject|1|||
33155474|NCT04402060|100482527|FG002|Overall Study|Withdrawal by Subject|2|||
33155475|NCT04402060|100482525|FG000|Overall Study|Sponsor Request|0|||
33155476|NCT04402060|100482526|FG001|Overall Study|Sponsor Request|2|||
33155477|NCT04402060|100482527|FG002|Overall Study|Sponsor Request|0|||
33155478|NCT04402060|100482525|FG000|Overall Study|Physician Decision|0|||
33155479|NCT04402060|100482526|FG001|Overall Study|Physician Decision|0|||
33155480|NCT04402060|100482527|FG002|Overall Study|Physician Decision|1|||
33155481|NCT04402060|100482525|FG000|Overall Study|Other|0|||
33155482|NCT04402060|100482526|FG001|Overall Study|Other|1|||
33155483|NCT04402060|100482527|FG002|Overall Study|Other|0|||
33155484|NCT05246397|100482531|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
33252746|NCT00842257|100827303|FG000|Overall Study|Adverse Event|1|||
33387687|NCT04605159|101306387|FG002|Overall Study|Adverse Event|21|||
33387688|NCT04605159|101306388|FG003|Overall Study|Adverse Event|4|||
33387689|NCT04605159|101306385|FG000|Overall Study|Lost to Follow-up|74|||
33387690|NCT04605159|101306386|FG001|Overall Study|Lost to Follow-up|45|||
33387691|NCT04605159|101306387|FG002|Overall Study|Lost to Follow-up|119|||
33387692|NCT04605159|101306388|FG003|Overall Study|Lost to Follow-up|80|||
33387693|NCT04605159|101306385|FG000|Overall Study|Protocol Violation|4|||
33387694|NCT04605159|101306386|FG001|Overall Study|Protocol Violation|5|||
33387695|NCT04605159|101306387|FG002|Overall Study|Protocol Violation|2|||
33387696|NCT04605159|101306388|FG003|Overall Study|Protocol Violation|0|||
33387697|NCT04605159|101306385|FG000|Overall Study|Withdrawal by Subject|66|||
33387698|NCT04605159|101306386|FG001|Overall Study|Withdrawal by Subject|37|||
33387699|NCT04605159|101306387|FG002|Overall Study|Withdrawal by Subject|68|||
33387700|NCT04605159|101306388|FG003|Overall Study|Withdrawal by Subject|50|||
33387701|NCT04605159|101306385|FG000|Overall Study|Migrated / moved from the study area|32|||
33387702|NCT04605159|101306386|FG001|Overall Study|Migrated / moved from the study area|22|||
33387703|NCT04605159|101306387|FG002|Overall Study|Migrated / moved from the study area|41|||
33387704|NCT04605159|101306388|FG003|Overall Study|Migrated / moved from the study area|21|||
33387705|NCT04605159|101306385|FG000|Overall Study|Other|1|||
33387706|NCT04605159|101306386|FG001|Overall Study|Other|2|||
33387707|NCT04605159|101306387|FG002|Overall Study|Other|7|||
33155485|NCT02231918|100482532|FG000|Overall Study|Withdrawal by Subject|0|||
33155486|NCT02231918|100482533|FG001|Overall Study|Withdrawal by Subject|1|||
33155487|NCT02231918|100482534|FG002|Overall Study|Withdrawal by Subject|0|||
33387708|NCT04605159|101306388|FG003|Overall Study|Other|3|||
33387709|NCT03621189|101306411|FG000|Overall Study|Withdrawal by Subject|0|||
33387710|NCT03621189|101306412|FG001|Overall Study|Withdrawal by Subject|3|||
33387711|NCT03621189|101306411|FG000|Overall Study|Physician Decision|0|||
33387712|NCT03621189|101306412|FG001|Overall Study|Physician Decision|2|||
33387713|NCT01068717|101306415|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
33387714|NCT01068717|101306416|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
33387715|NCT01068717|101306417|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
33387716|NCT01068717|101306418|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
33387717|NCT01807949|101306419|FG000|Overall Study|Adverse Event|1|||
33387718|NCT01807949|101306420|FG001|Overall Study|Adverse Event|2|||
33387719|NCT01807949|101306421|FG002|Overall Study|Adverse Event|2|||
33387720|NCT01807949|101306419|FG000|Overall Study|Withdrawal by Subject|1|||
33387721|NCT01807949|101306420|FG001|Overall Study|Withdrawal by Subject|2|||
33387722|NCT01807949|101306421|FG002|Overall Study|Withdrawal by Subject|2|||
33155488|NCT02231918|100482532|FG000|Overall Study|Adverse Event|0|||
33155489|NCT02231918|100482533|FG001|Overall Study|Adverse Event|0|||
33155490|NCT02231918|100482534|FG002|Overall Study|Adverse Event|1|||
33155491|NCT02215096|100482535|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
33155492|NCT02215096|100482536|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
33155493|NCT02215096|100482537|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
33155494|NCT02215096|100482538|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
33155495|NCT02215096|100482539|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
33155496|NCT02215096|100482535|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
33155497|NCT02215096|100482536|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
33252747|NCT01025843|100827304|FG000|Washout 4|Withdrawal by Subject|0|||
33252748|NCT01025843|100827305|FG001|Washout 4|Withdrawal by Subject|0|||
33252749|NCT01025843|100827306|FG002|Washout 4|Withdrawal by Subject|1|||
33252750|NCT01025843|100827307|FG003|Washout 4|Withdrawal by Subject|1|||
33387723|NCT01807949|101306419|FG000|Overall Study|Non-Compliance|0|||
33387724|NCT01807949|101306420|FG001|Overall Study|Non-Compliance|0|||
33387725|NCT01807949|101306421|FG002|Overall Study|Non-Compliance|1|||
33387726|NCT01807949|101306419|FG000|Overall Study|Undefined|0|||
33387727|NCT01807949|101306420|FG001|Overall Study|Undefined|1|||
33387728|NCT01807949|101306421|FG002|Overall Study|Undefined|2|||
33387729|NCT01807949|101306419|FG000|Overall Study|Randomized But Not Treated|0|||
33387730|NCT01807949|101306420|FG001|Overall Study|Randomized But Not Treated|2|||
33387731|NCT01807949|101306421|FG002|Overall Study|Randomized But Not Treated|2|||
33387732|NCT01392742|101306422|FG000|Overall Study|Premature study termination|42|||
33387733|NCT01392742|101306422|FG000|Overall Study|Failure to return|35|||
33387734|NCT01392742|101306422|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
33387735|NCT01392742|101306422|FG000|Overall Study|Lost to Follow-up|34|||
33387736|NCT01392742|101306422|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
33387737|NCT01392742|101306422|FG000|Overall Study|ITR and Protocol deviation|1|||
33387738|NCT01392742|101306422|FG000|Overall Study|Adverse event/intercurrent illness|17|||
33155498|NCT02215096|100482537|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
33155499|NCT02215096|100482538|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
33155500|NCT02215096|100482539|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
33252751|NCT01025843|100827308|FG004|Washout 4|Withdrawal by Subject|0|||
33252752|NCT01025843|100827309|FG005|Washout 4|Withdrawal by Subject|0|||
33252753|NCT01025843|100827310|FG006|Washout 4|Withdrawal by Subject|0|||
33252754|NCT01025843|100827311|FG007|Washout 4|Withdrawal by Subject|0|||
33252755|NCT01025843|100827312|FG008|Washout 4|Withdrawal by Subject|0|||
33252756|NCT01025843|100827313|FG009|Washout 4|Withdrawal by Subject|0|||
33252757|NCT00732381|100827314|FG000|Overall Study|Adverse Event|1|||
33252758|NCT00732381|100827315|FG001|Overall Study|Adverse Event|0|||
33252759|NCT00732381|100827314|FG000|Overall Study|Treatment Failure|1|||
33252760|NCT00732381|100827315|FG001|Overall Study|Treatment Failure|1|||
33252761|NCT01353963|100827320|FG000|Overall Study|Adverse Event|2|||
33252762|NCT02000817|100827321|FG000|Overall Study|Withdrawal by Subject|2|||
33252763|NCT02000817|100827322|FG001|Overall Study|Withdrawal by Subject|0|||
33252764|NCT02000817|100827323|FG002|Overall Study|Withdrawal by Subject|0|||
33252765|NCT02000817|100827324|FG003|Overall Study|Withdrawal by Subject|0|||
33252766|NCT02000817|100827321|FG000|Overall Study|Adverse Event|0|||
33387739|NCT01392742|101306422|FG000|Overall Study|Protocol Violation|14|||
33387740|NCT01392742|101306422|FG000|Overall Study|Other|3|||
33387741|NCT01392742|101306422|FG000|Overall Study|Missing information|13|||
33387742|NCT01421069|101306423|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
33155501|NCT02215096|100482535|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
33252767|NCT02000817|100827322|FG001|Overall Study|Adverse Event|1|||
33252768|NCT02000817|100827323|FG002|Overall Study|Adverse Event|0|||
33252769|NCT02000817|100827324|FG003|Overall Study|Adverse Event|0|||
33252770|NCT02000817|100827321|FG000|Overall Study|Lost to Follow-up|0|||
33252771|NCT02000817|100827322|FG001|Overall Study|Lost to Follow-up|0|||
33252772|NCT02000817|100827323|FG002|Overall Study|Lost to Follow-up|1|||
33387743|NCT01421069|101306423|FG000|Parent Study|Failed to return|3|||
33155502|NCT02215096|100482536|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
33155503|NCT02215096|100482537|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
33155504|NCT02215096|100482538|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
33155505|NCT02215096|100482539|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
33155506|NCT02215096|100482535|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
33155507|NCT02215096|100482536|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
33155508|NCT02215096|100482537|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
33155509|NCT02215096|100482538|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
33155510|NCT02215096|100482539|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
33155511|NCT03666624|100482547|FG000|Overall Study|participant grieving over recent death of parent|1|||
33155512|NCT03666624|100482548|FG001|Overall Study|participant grieving over recent death of parent|0|||
33155513|NCT02959983|100482549|FG000|Overall Study|Protocol Violation|0|||
33155514|NCT02959983|100482550|FG001|Overall Study|Protocol Violation|1|||
33155515|NCT02959983|100482549|FG000|Overall Study|Lack of Efficacy|0|||
33155516|NCT02959983|100482550|FG001|Overall Study|Lack of Efficacy|1|||
33155517|NCT02959983|100482549|FG000|Overall Study|Lost to Follow-up|12|||
33155518|NCT02959983|100482550|FG001|Overall Study|Lost to Follow-up|9|||
33155519|NCT02959983|100482549|FG000|Overall Study|Other|1|||
33155520|NCT02959983|100482550|FG001|Overall Study|Other|1|||
33155521|NCT02959983|100482549|FG000|Overall Study|Physician Decision|1|||
33155522|NCT02959983|100482550|FG001|Overall Study|Physician Decision|0|||
33387744|NCT01421069|101306423|FG000|Parent Study|Withdrawal by Subject|1|||
33387745|NCT01421069|101306423|FG000|Parent Study|Lost to Follow-up|2|||
33387746|NCT01421069|101306423|FG000|Parent Study|Lack of Efficacy|1|||
33387747|NCT01421069|101306423|FG000|Overall Period for Extension Study|Other|2|||
33387748|NCT01421069|101306423|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
33387749|NCT01421069|101306423|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
33387750|NCT01421069|101306423|FG000|Overall Period for Extension Study|Pregnancy|1|||
33387751|NCT01421069|101306423|FG000|Overall Period for Extension Study|Adverse Event|1|||
33155523|NCT02959983|100482549|FG000|Overall Study|Adverse Event|5|||
33155524|NCT02959983|100482550|FG001|Overall Study|Adverse Event|1|||
33155525|NCT02959983|100482549|FG000|Overall Study|Withdrawal by Subject|7|||
33155526|NCT02959983|100482550|FG001|Overall Study|Withdrawal by Subject|12|||
33155527|NCT00191906|100482551|FG000|Study Period II|Adverse Event|0|||
33155528|NCT00191906|100482552|FG001|Study Period II|Adverse Event|1|||
33155529|NCT00191906|100482553|FG002|Study Period II|Adverse Event|0|||
33155530|NCT00191906|100482554|FG003|Study Period II|Adverse Event|0|||
33155531|NCT00191906|100482551|FG000|Study Period II|Withdrawal by Subject|0|||
33155532|NCT00191906|100482552|FG001|Study Period II|Withdrawal by Subject|3|||
33155533|NCT00191906|100482553|FG002|Study Period II|Withdrawal by Subject|0|||
33155534|NCT00191906|100482554|FG003|Study Period II|Withdrawal by Subject|0|||
33155535|NCT00191906|100482551|FG000|Study Period II|Parent/Caregiver Decision|0|||
33155536|NCT00191906|100482552|FG001|Study Period II|Parent/Caregiver Decision|1|||
33155537|NCT00191906|100482553|FG002|Study Period II|Parent/Caregiver Decision|0|||
33155538|NCT00191906|100482554|FG003|Study Period II|Parent/Caregiver Decision|0|||
33155539|NCT00191906|100482551|FG000|Study Period II|Entry Criteria Exclusion|0|||
33155540|NCT00191906|100482552|FG001|Study Period II|Entry Criteria Exclusion|0|||
33155541|NCT00191906|100482553|FG002|Study Period II|Entry Criteria Exclusion|1|||
33155542|NCT00191906|100482554|FG003|Study Period II|Entry Criteria Exclusion|0|||
33155543|NCT00191906|100482551|FG000|Study Period III|Adverse Event|1|||
33155544|NCT00191906|100482552|FG001|Study Period III|Adverse Event|0|||
33155545|NCT00191906|100482553|FG002|Study Period III|Adverse Event|0|||
33155546|NCT00191906|100482554|FG003|Study Period III|Adverse Event|0|||
33155547|NCT00191906|100482551|FG000|Study Period III|Lost to Follow-up|0|||
33155548|NCT00191906|100482552|FG001|Study Period III|Lost to Follow-up|1|||
33155549|NCT00191906|100482553|FG002|Study Period III|Lost to Follow-up|0|||
33155550|NCT00191906|100482554|FG003|Study Period III|Lost to Follow-up|0|||
33155551|NCT00191906|100482551|FG000|Study Period III|Parent/Caregiver Decision|1|||
33155552|NCT00191906|100482552|FG001|Study Period III|Parent/Caregiver Decision|0|||
33155553|NCT00191906|100482553|FG002|Study Period III|Parent/Caregiver Decision|0|||
33155554|NCT00191906|100482554|FG003|Study Period III|Parent/Caregiver Decision|0|||
33155555|NCT00191906|100482551|FG000|Study Period III|Lack of Efficacy|3|||
33155556|NCT00191906|100482552|FG001|Study Period III|Lack of Efficacy|3|||
33155557|NCT00191906|100482553|FG002|Study Period III|Lack of Efficacy|0|||
33155558|NCT00191906|100482554|FG003|Study Period III|Lack of Efficacy|0|||
33155559|NCT00566111|100482555|FG000|Overall Study|Adverse Event|0|||
33155560|NCT00566111|100482556|FG001|Overall Study|Adverse Event|2|||
33155561|NCT03511664|100482567|FG000|Overall Study|Treatment ongoing|49|||
33155562|NCT03511664|100482568|FG001|Overall Study|Treatment ongoing|5|||
33155563|NCT03511664|100482567|FG000|Overall Study|Entered long-term follow-up|140|||
33155564|NCT03511664|100482568|FG001|Overall Study|Entered long-term follow-up|50|||
33155565|NCT03511664|100482567|FG000|Overall Study|Withdrawal by Subject|29|||
33155566|NCT03511664|100482568|FG001|Overall Study|Withdrawal by Subject|53|||
33155567|NCT03511664|100482567|FG000|Overall Study|Lost to Follow-up|4|||
33155568|NCT03511664|100482568|FG001|Overall Study|Lost to Follow-up|4|||
33155569|NCT03511664|100482567|FG000|Overall Study|Physician Decision|0|||
33155570|NCT03511664|100482568|FG001|Overall Study|Physician Decision|1|||
33155571|NCT02840721|100482572|FG000|Treatment Period|Adverse Event|1|||
33155572|NCT02840721|100482572|FG000|Follow-Up|Lack of Efficacy|1|||
33155573|NCT02840721|100482572|FG000|Follow-Up|Withdrawal by Subject|4|||
33155574|NCT02840721|100482572|FG000|Follow-Up|Withdrawal of Consent|2|||
33155575|NCT01497275|100482573|FG000|Overall Study|Death|1|||
33387752|NCT01421069|101306423|FG000|Overall Period for Extension Study|Protocol Violation|1|||
33387753|NCT01421069|101306423|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
33387754|NCT01421069|101306423|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
33387755|NCT01421069|101306423|FG000|Active Treatment Period|Other|1|||
33387756|NCT01421069|101306423|FG000|Active Treatment Period|No longer willing to participate in study|8|||
33155576|NCT01497275|100482573|FG000|Overall Study|Adverse Event|1|||
33155577|NCT01414608|100482574|FG000|Overall Study|Ineligible|5|||
33155578|NCT01414608|100482575|FG001|Overall Study|Ineligible|2|||
33155579|NCT03626168|100482576|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
33155580|NCT03626168|100482577|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
33155581|NCT03626168|100482576|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
33155582|NCT03626168|100482577|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
33155583|NCT03626168|100482576|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
33155584|NCT03626168|100482577|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
33155585|NCT03270644|100482579|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
33155586|NCT03270644|100482579|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
33155587|NCT04223973|100482589|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
33155588|NCT04223973|100482590|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
33387757|NCT01421069|101306423|FG000|Active Treatment Period|Insufficient clinical response|1|||
33387758|NCT01421069|101306423|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
33155589|NCT04223973|100482589|FG000|Overall Study|Adverse Event|4|||
33155590|NCT04223973|100482590|FG001|Overall Study|Adverse Event|0|||
33155591|NCT04223973|100482589|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
33155592|NCT04223973|100482590|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
33155593|NCT04223973|100482589|FG000|Overall Study|Physician Decision|1|||
33155594|NCT04223973|100482590|FG001|Overall Study|Physician Decision|1|||
33155595|NCT04223973|100482589|FG000|Overall Study|Withdrawal by Subject|0|||
33155596|NCT04223973|100482590|FG001|Overall Study|Withdrawal by Subject|1|||
33155597|NCT04553679|100482591|FG000|Overall Study|Withdrawal by Subject|2|||
33155598|NCT04553679|100482592|FG001|Overall Study|Withdrawal by Subject|0|||
33155599|NCT04553679|100482591|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
33155600|NCT04553679|100482592|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
33155601|NCT01856907|100482593|FG000|Overall Study|Pregnancy|0|||
33155602|NCT01856907|100482594|FG001|Overall Study|Pregnancy|1|||
33155603|NCT01856907|100482595|FG002|Overall Study|Pregnancy|0|||
33155604|NCT01856907|100482593|FG000|Overall Study|Pregnancy|0|||
33155605|NCT01856907|100482594|FG001|Overall Study|Pregnancy|1|||
33155606|NCT01856907|100482595|FG002|Overall Study|Pregnancy|0|||
33155607|NCT01856907|100482593|FG000|Overall Study|Withdrawal by Subject|0|||
33155608|NCT01856907|100482594|FG001|Overall Study|Withdrawal by Subject|1|||
33155609|NCT01856907|100482595|FG002|Overall Study|Withdrawal by Subject|0|||
33155610|NCT00595465|100482596|FG000|Overall Study|Adverse Event|4|||
33155611|NCT00595465|100482597|FG001|Overall Study|Adverse Event|3|||
33155612|NCT00595465|100482598|FG002|Overall Study|Adverse Event|3|||
33155613|NCT00595465|100482596|FG000|Overall Study|Pregnancy|0|||
33155614|NCT00595465|100482597|FG001|Overall Study|Pregnancy|0|||
33155615|NCT00595465|100482598|FG002|Overall Study|Pregnancy|1|||
33155616|NCT00595465|100482596|FG000|Overall Study|Protocol Violation|2|||
33155617|NCT00595465|100482597|FG001|Overall Study|Protocol Violation|1|||
33155618|NCT00595465|100482598|FG002|Overall Study|Protocol Violation|0|||
33155619|NCT00595465|100482596|FG000|Overall Study|Lost to Follow-up|0|||
33155620|NCT00595465|100482597|FG001|Overall Study|Lost to Follow-up|0|||
33155621|NCT00595465|100482598|FG002|Overall Study|Lost to Follow-up|2|||
33155622|NCT00595465|100482596|FG000|Overall Study|administrative reason|0|||
33155623|NCT00595465|100482597|FG001|Overall Study|administrative reason|0|||
33155624|NCT00595465|100482598|FG002|Overall Study|administrative reason|1|||
33155625|NCT03848065|100482599|FG000|Overall Study|Death|0|||
33155626|NCT03848065|100482600|FG001|Overall Study|Death|1|||
33155627|NCT03848065|100482601|FG002|Overall Study|Death|0|||
33155628|NCT03848065|100482599|FG000|Overall Study|Lost to Follow-up|0|||
33155629|NCT03848065|100482600|FG001|Overall Study|Lost to Follow-up|0|||
33155630|NCT03848065|100482601|FG002|Overall Study|Lost to Follow-up|1|||
33155631|NCT03848065|100482599|FG000|Overall Study|Physician Decision|0|||
33155632|NCT03848065|100482600|FG001|Overall Study|Physician Decision|0|||
33155633|NCT03848065|100482601|FG002|Overall Study|Physician Decision|1|||
33155634|NCT01254331|100482603|FG000|Initial Phase|Adverse Event|3|||
33155635|NCT01254331|100482603|FG000|Initial Phase|Withdrawal by Subject|1|||
33155636|NCT01254331|100482603|FG000|Initial Phase|Pregnancy|1|||
33155637|NCT01254331|100482603|FG000|Extension Phase|Lack of Efficacy|1|||
33155638|NCT01254331|100482603|FG000|Extension Phase|Lost to Follow-up|3|||
33155639|NCT00331864|100482604|FG000|Overall Study|Adverse Event|30|||
33155640|NCT00331864|100482605|FG001|Overall Study|Adverse Event|1|||
33155641|NCT00331864|100482604|FG000|Overall Study|Lack of Efficacy|4|||
33155642|NCT00331864|100482605|FG001|Overall Study|Lack of Efficacy|0|||
33387759|NCT01421069|101306423|FG000|Active Treatment Period|Pregnancy|1|||
33252773|NCT02000817|100827324|FG003|Overall Study|Lost to Follow-up|0|||
33387760|NCT01421069|101306423|FG000|Active Treatment Period|Adverse Event|1|||
33387761|NCT01421069|101306423|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
33387762|NCT01421069|101306423|FG000|Active Treatment Period|Enrolled in observational period|29|||
33155643|NCT00331864|100482604|FG000|Overall Study|Protocol Violation|3|||
33155644|NCT00331864|100482605|FG001|Overall Study|Protocol Violation|0|||
33155645|NCT00331864|100482604|FG000|Overall Study|Withdrawal by Subject|10|||
33155646|NCT00331864|100482605|FG001|Overall Study|Withdrawal by Subject|0|||
33155647|NCT00331864|100482604|FG000|Overall Study|Lost to Follow-up|4|||
33155648|NCT00331864|100482605|FG001|Overall Study|Lost to Follow-up|3|||
33155649|NCT00331864|100482604|FG000|Overall Study|Administrative Problems|1|||
33155650|NCT00331864|100482605|FG001|Overall Study|Administrative Problems|0|||
33155651|NCT00331864|100482604|FG000|Overall Study|Death|6|||
33155652|NCT00331864|100482605|FG001|Overall Study|Death|0|||
33155653|NCT00788073|100482611|FG000|STX209 Then Placebo|Adverse Event|1|||
33155654|NCT00788073|100482612|FG001|STX209 Then Placebo|Adverse Event|0|||
33155655|NCT00788073|100482611|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
33155656|NCT00788073|100482612|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
33155657|NCT00788073|100482611|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
33155658|NCT00788073|100482612|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
33155659|NCT00788073|100482611|FG000|STX209 Then Placebo|unable to return due to travel|0|||
33155660|NCT00788073|100482612|FG001|STX209 Then Placebo|unable to return due to travel|1|||
33155661|NCT00788073|100482611|FG000|Placebo Then STX209|Adverse Event|2|||
33155662|NCT00788073|100482612|FG001|Placebo Then STX209|Adverse Event|0|||
33155663|NCT00788073|100482611|FG000|Placebo Then STX209|Protocol Violation|0|||
33155664|NCT00788073|100482612|FG001|Placebo Then STX209|Protocol Violation|1|||
33252774|NCT03257813|100827326|FG000|Overall Study|Protocol Violation|6|||
33155665|NCT02651467|100482613|FG000|Overall Study|Withdrawal by Subject|0|||
33155666|NCT02651467|100482614|FG001|Overall Study|Withdrawal by Subject|0|||
33252775|NCT03257813|100827327|FG001|Overall Study|Protocol Violation|3|||
33252776|NCT02393716|100827328|FG000|Overall Study|Death|29|||
33155667|NCT02651467|100482615|FG002|Overall Study|Withdrawal by Subject|2|||
33155668|NCT02651467|100482613|FG000|Overall Study|Other (Not specified)|1|||
33155669|NCT02651467|100482614|FG001|Overall Study|Other (Not specified)|0|||
33155670|NCT02651467|100482615|FG002|Overall Study|Other (Not specified)|2|||
33155671|NCT01025154|100482616|FG000|Overall Study|Lost to Follow-up|1|||
33155672|NCT01025154|100482616|FG000|Overall Study|Withdrawal by Subject|1|||
33155673|NCT03437512|100482617|FG000|Randomized|Withdrawal by Subject|0|||
33155674|NCT03437512|100482618|FG001|Randomized|Withdrawal by Subject|2|||
33155675|NCT03437512|100482617|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
33438347|NCT01572948|101499832|FG000|Overall Study|unable to contact|0|||
33438348|NCT01572948|101499833|FG001|Overall Study|unable to contact|1|||
33438349|NCT00912288|101499834|FG000|Overall Study|Death|0|||
33438350|NCT00912288|101499835|FG001|Overall Study|Death|1|||
33438351|NCT00912288|101499834|FG000|Overall Study|Adverse Event|1|||
33155676|NCT03437512|100482618|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
33438352|NCT00912288|101499835|FG001|Overall Study|Adverse Event|1|||
33438353|NCT00912288|101499834|FG000|Overall Study|Lost to Follow-up|1|||
33438354|NCT00912288|101499835|FG001|Overall Study|Lost to Follow-up|0|||
33438355|NCT00912288|101499834|FG000|Overall Study|Protocol Violation|1|||
33438356|NCT00912288|101499835|FG001|Overall Study|Protocol Violation|0|||
33438357|NCT00912288|101499834|FG000|Overall Study|Withdrawal by Subject|3|||
33387763|NCT01421069|101306423|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
33387764|NCT01421069|101306423|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
33387765|NCT01421069|101306423|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
33438358|NCT00912288|101499835|FG001|Overall Study|Withdrawal by Subject|3|||
33438359|NCT00912288|101499834|FG000|Overall Study|Study terminated by sponsor|34|||
33438360|NCT00912288|101499835|FG001|Overall Study|Study terminated by sponsor|35|||
33438361|NCT00912288|101499834|FG000|Overall Study|Other|1|||
33438362|NCT00912288|101499835|FG001|Overall Study|Other|0|||
33438363|NCT03883906|101499841|FG000|Overall Study|Withdrawal by Subject|2|||
33387766|NCT01421069|101306423|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
33387767|NCT01421069|101306423|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
33387768|NCT01421069|101306423|FG000|2b. Retreatment Period|Protocol Violation|1|||
33387769|NCT01421069|101306423|FG000|Observational Period|Other|1|||
33387770|NCT01421069|101306423|FG000|Observational Period|No longer willing to participate in study|4|||
33387771|NCT01421069|101306423|FG000|Observational Period|Lost to Follow-up|3|||
33387772|NCT00293241|101306426|FG000|Overall Study|Lost to Follow-up|9|||
33438364|NCT03883906|101499841|FG000|Overall Study|Physician Decision|5|||
33438365|NCT01781637|101499843|FG000|Overall Study|Adverse Event|1|||
33438366|NCT01781637|101499844|FG001|Overall Study|Adverse Event|0|||
33438367|NCT01781637|101499843|FG000|Overall Study|Lack of Efficacy|2|||
33387773|NCT00293241|101306427|FG001|Overall Study|Lost to Follow-up|16|||
33155677|NCT00181155|100482619|FG000|Overall Study|Physician Decision|1|||
33155678|NCT00181155|100482620|FG001|Overall Study|Physician Decision|0|||
33155679|NCT00181155|100482619|FG000|Overall Study|Withdrawal by Subject|1|||
33155680|NCT00181155|100482620|FG001|Overall Study|Withdrawal by Subject|0|||
33155681|NCT01890746|100482621|FG000|Overall Study|Death|39|||
33155682|NCT01890746|100482622|FG001|Overall Study|Death|30|||
33155683|NCT01890746|100482621|FG000|Overall Study|Adverse Event|1|||
33252777|NCT02393716|100827328|FG000|Overall Study|Withdrawal by Subject|8|||
33252778|NCT02393716|100827328|FG000|Overall Study|Device Explanted|8|||
33252779|NCT02393716|100827328|FG000|Overall Study|Missed visit|16|||
33252780|NCT02670525|100827329|FG000|Overall Study|Death|94|||
33252781|NCT02670525|100827330|FG001|Overall Study|Death|14|||
33252782|NCT02670525|100827329|FG000|Overall Study|Lost to Follow-up|4|||
33252783|NCT02670525|100827330|FG001|Overall Study|Lost to Follow-up|1|||
33252784|NCT02670525|100827329|FG000|Overall Study|Subject withdrew consent|1|||
33252785|NCT02670525|100827330|FG001|Overall Study|Subject withdrew consent|0|||
33252786|NCT02670525|100827329|FG000|Overall Study|Unknown, data entry delayed|123|||
33252787|NCT02670525|100827330|FG001|Overall Study|Unknown, data entry delayed|78|||
33252788|NCT00801983|100827331|FG000|Period 1|Lost to Follow-up|2|||
33252789|NCT00801983|100827332|FG001|Period 1|Lost to Follow-up|0|||
33155684|NCT01890746|100482622|FG001|Overall Study|Adverse Event|0|||
33155685|NCT01890746|100482621|FG000|Overall Study|Lost to Follow-up|4|||
33155686|NCT01890746|100482622|FG001|Overall Study|Lost to Follow-up|1|||
33155687|NCT01890746|100482621|FG000|Overall Study|Physician Decision|3|||
33155688|NCT01890746|100482622|FG001|Overall Study|Physician Decision|2|||
33155689|NCT01890746|100482621|FG000|Overall Study|Withdrawal by Subject|5|||
33155690|NCT01890746|100482622|FG001|Overall Study|Withdrawal by Subject|8|||
33155691|NCT04587271|100482623|FG000|Overall Study|Lost to Follow-up|2|||
33155692|NCT04587271|100482624|FG001|Overall Study|Lost to Follow-up|2|||
33155693|NCT04587271|100482625|FG002|Overall Study|Lost to Follow-up|0|||
33155694|NCT04587271|100482626|FG003|Overall Study|Lost to Follow-up|2|||
33155695|NCT04587271|100482627|FG004|Overall Study|Lost to Follow-up|2|||
33155696|NCT04587271|100482628|FG005|Overall Study|Lost to Follow-up|0|||
33155697|NCT04587271|100482623|FG000|Overall Study|Caregiver brought child to visits|0|||
33155698|NCT04587271|100482624|FG001|Overall Study|Caregiver brought child to visits|0|||
33155699|NCT04587271|100482625|FG002|Overall Study|Caregiver brought child to visits|0|||
33155700|NCT04587271|100482626|FG003|Overall Study|Caregiver brought child to visits|1|||
33387774|NCT00293241|101306426|FG000|Overall Study|Physician Decision|23|||
33387775|NCT00293241|101306427|FG001|Overall Study|Physician Decision|17|||
33387776|NCT00293241|101306426|FG000|Overall Study|Withdrawal by Subject|4|||
33387777|NCT00293241|101306427|FG001|Overall Study|Withdrawal by Subject|8|||
33387778|NCT04362813|101306428|FG000|Overall Study|Death|12|||
33387779|NCT04362813|101306429|FG001|Overall Study|Death|16|||
33387780|NCT04362813|101306428|FG000|Overall Study|Withdrawal by Subject|3|||
33387781|NCT04362813|101306429|FG001|Overall Study|Withdrawal by Subject|1|||
33387782|NCT04362813|101306428|FG000|Overall Study|Protocol Violation|0|||
33387783|NCT04362813|101306429|FG001|Overall Study|Protocol Violation|3|||
33387784|NCT04362813|101306428|FG000|Overall Study|Lost to Follow-up|1|||
33387785|NCT04362813|101306429|FG001|Overall Study|Lost to Follow-up|1|||
33387786|NCT04362813|101306428|FG000|Overall Study|Enrolled but did not receive treatment|2|||
33387787|NCT04362813|101306429|FG001|Overall Study|Enrolled but did not receive treatment|4|||
33387788|NCT00912340|101306430|FG000|Overall Study|Adverse Event|2|||
33387789|NCT00912340|101306431|FG001|Overall Study|Adverse Event|4|||
33387790|NCT00912340|101306432|FG002|Overall Study|Adverse Event|0|||
33387791|NCT00912340|101306430|FG000|Overall Study|Protocol revised to remove arm|0|||
33387792|NCT00912340|101306431|FG001|Overall Study|Protocol revised to remove arm|0|||
33387793|NCT00912340|101306432|FG002|Overall Study|Protocol revised to remove arm|4|||
33387794|NCT01906476|101306433|FG000|Overall Study|Lost to Follow-up|17|||
33387795|NCT01906476|101306434|FG001|Overall Study|Lost to Follow-up|16|||
33155701|NCT04587271|100482627|FG004|Overall Study|Caregiver brought child to visits|0|||
33155702|NCT04587271|100482628|FG005|Overall Study|Caregiver brought child to visits|0|||
33387796|NCT00813917|101306437|FG000|Overall Study|Adverse Event|0|||
33387797|NCT00813917|101306438|FG001|Overall Study|Adverse Event|1|||
33387798|NCT00813917|101306437|FG000|Overall Study|Withdrawal by Subject|3|||
33387799|NCT00813917|101306438|FG001|Overall Study|Withdrawal by Subject|4|||
33155703|NCT03608254|100482629|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
33155704|NCT03608254|100482629|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
33155705|NCT01823146|100482630|FG000|Overall Study|Withdrawal by Subject|0|||
33387800|NCT00813917|101306437|FG000|Overall Study|Lost to Follow-up|3|||
33387801|NCT00813917|101306438|FG001|Overall Study|Lost to Follow-up|1|||
33155706|NCT01823146|100482631|FG001|Overall Study|Withdrawal by Subject|1|||
33155707|NCT01823146|100482630|FG000|Overall Study|Lost to Follow-up|2|||
33155708|NCT01823146|100482631|FG001|Overall Study|Lost to Follow-up|1|||
33155709|NCT00333840|100482634|FG000|First-line Treatment Period|Adverse Event|38|||
33155710|NCT00333840|100482635|FG001|First-line Treatment Period|Adverse Event|37|||
33155711|NCT00333840|100482636|FG002|First-line Treatment Period|Adverse Event|0|||
33155712|NCT00333840|100482637|FG003|First-line Treatment Period|Adverse Event|0|||
33155713|NCT00333840|100482634|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
33155714|NCT00333840|100482635|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
33155715|NCT00333840|100482636|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
33155716|NCT00333840|100482637|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
33155717|NCT00333840|100482634|FG000|First-line Treatment Period|Abnormal procedure|2|||
33155718|NCT00333840|100482635|FG001|First-line Treatment Period|Abnormal procedure|0|||
33155719|NCT00333840|100482636|FG002|First-line Treatment Period|Abnormal procedure|0|||
33155720|NCT00333840|100482637|FG003|First-line Treatment Period|Abnormal procedure|0|||
33155721|NCT00333840|100482634|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
33155722|NCT00333840|100482635|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
33155723|NCT00333840|100482636|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
33155724|NCT00333840|100482637|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
33155725|NCT00333840|100482634|FG000|First-line Treatment Period|No longer required study drug|21|||
33155726|NCT00333840|100482635|FG001|First-line Treatment Period|No longer required study drug|8|||
33155727|NCT00333840|100482636|FG002|First-line Treatment Period|No longer required study drug|0|||
33155728|NCT00333840|100482637|FG003|First-line Treatment Period|No longer required study drug|0|||
33155729|NCT00333840|100482634|FG000|First-line Treatment Period|Protocol Violation|17|||
33155730|NCT00333840|100482635|FG001|First-line Treatment Period|Protocol Violation|17|||
33155731|NCT00333840|100482636|FG002|First-line Treatment Period|Protocol Violation|0|||
33155732|NCT00333840|100482637|FG003|First-line Treatment Period|Protocol Violation|0|||
33155733|NCT00333840|100482634|FG000|First-line Treatment Period|Subject withdrew consent|57|||
33155734|NCT00333840|100482635|FG001|First-line Treatment Period|Subject withdrew consent|77|||
33155735|NCT00333840|100482636|FG002|First-line Treatment Period|Subject withdrew consent|0|||
33155736|NCT00333840|100482637|FG003|First-line Treatment Period|Subject withdrew consent|0|||
33155737|NCT00333840|100482634|FG000|First-line Treatment Period|Lost to Follow-up|15|||
33155738|NCT00333840|100482635|FG001|First-line Treatment Period|Lost to Follow-up|6|||
33155739|NCT00333840|100482636|FG002|First-line Treatment Period|Lost to Follow-up|0|||
33155740|NCT00333840|100482637|FG003|First-line Treatment Period|Lost to Follow-up|0|||
33155741|NCT00333840|100482634|FG000|First-line Treatment Period|Administrative problems|12|||
33155742|NCT00333840|100482635|FG001|First-line Treatment Period|Administrative problems|6|||
33155743|NCT00333840|100482636|FG002|First-line Treatment Period|Administrative problems|0|||
33155744|NCT00333840|100482637|FG003|First-line Treatment Period|Administrative problems|0|||
33155745|NCT00333840|100482634|FG000|First-line Treatment Period|Death|19|||
33155746|NCT00333840|100482635|FG001|First-line Treatment Period|Death|2|||
33387802|NCT00732641|101306439|FG000|Overall Study|Relapse or Progressive Disease|65|||
33387803|NCT00732641|101306440|FG001|Overall Study|Relapse or Progressive Disease|101|||
33387804|NCT00732641|101306439|FG000|Overall Study|Serious Adverse Events|12|||
33387805|NCT00732641|101306440|FG001|Overall Study|Serious Adverse Events|3|||
33387806|NCT00732641|101306439|FG000|Overall Study|Physician Decision|6|||
33387807|NCT00732641|101306440|FG001|Overall Study|Physician Decision|0|||
33155747|NCT00333840|100482636|FG002|First-line Treatment Period|Death|0|||
33155748|NCT00333840|100482637|FG003|First-line Treatment Period|Death|0|||
33155749|NCT00333840|100482634|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
33155750|NCT00333840|100482635|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
33155751|NCT00333840|100482636|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
33387808|NCT00732641|101306439|FG000|Overall Study|Withdrawal by Subject|4|||
33387809|NCT00732641|101306440|FG001|Overall Study|Withdrawal by Subject|2|||
33155752|NCT00333840|100482637|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
33155753|NCT00333840|100482634|FG000|Second-line Treatment Period|Adverse Event|0|||
33155754|NCT00333840|100482635|FG001|Second-line Treatment Period|Adverse Event|0|||
33155755|NCT00333840|100482636|FG002|Second-line Treatment Period|Adverse Event|3|||
33438368|NCT01781637|101499844|FG001|Overall Study|Lack of Efficacy|6|||
33438369|NCT01781637|101499843|FG000|Overall Study|Withdrawal by Subject|1|||
33438370|NCT01781637|101499844|FG001|Overall Study|Withdrawal by Subject|0|||
33438371|NCT05894577|101499845|FG000|Overall Study|No receipt of study drug|14|||
33438372|NCT05894577|101499846|FG001|Overall Study|No receipt of study drug|13|||
33438373|NCT05894577|101499845|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
33438374|NCT05894577|101499846|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
33438375|NCT05894577|101499845|FG000|Overall Study|Screen Fail|2|||
33438376|NCT05894577|101499846|FG001|Overall Study|Screen Fail|0|||
33438377|NCT05894577|101499845|FG000|Overall Study|Study drug recall|86|||
33438378|NCT05894577|101499846|FG001|Overall Study|Study drug recall|63|||
33438379|NCT00818883|101499849|FG000|Overall Study|Adverse Event|28|||
33438380|NCT00818883|101499850|FG001|Overall Study|Adverse Event|19|||
33438381|NCT00818883|101499849|FG000|Overall Study|Protocol Violation|2|||
33438382|NCT00818883|101499850|FG001|Overall Study|Protocol Violation|2|||
33438383|NCT00818883|101499849|FG000|Overall Study|Lost to Follow-up|3|||
33438384|NCT00818883|101499850|FG001|Overall Study|Lost to Follow-up|2|||
33438385|NCT00818883|101499849|FG000|Overall Study|Withdrawal by Subject|16|||
33438386|NCT00818883|101499850|FG001|Overall Study|Withdrawal by Subject|14|||
33438387|NCT00818883|101499849|FG000|Overall Study|Lack of Efficacy|0|||
33438388|NCT00818883|101499850|FG001|Overall Study|Lack of Efficacy|2|||
33438389|NCT00818883|101499849|FG000|Overall Study|Other|2|||
33438390|NCT00818883|101499850|FG001|Overall Study|Other|7|||
33438391|NCT00379340|101499860|FG000|Overall Study|Death|0|||
33438392|NCT00379340|101499861|FG001|Overall Study|Death|0|||
33438393|NCT00379340|101499862|FG002|Overall Study|Death|0|||
33438394|NCT00379340|101499863|FG003|Overall Study|Death|2|||
33438395|NCT00379340|101499864|FG004|Overall Study|Death|0|||
33438396|NCT00379340|101499860|FG000|Overall Study|Lack of Efficacy|6|||
33438397|NCT00379340|101499861|FG001|Overall Study|Lack of Efficacy|1|||
33438398|NCT00379340|101499862|FG002|Overall Study|Lack of Efficacy|0|||
33438399|NCT00379340|101499863|FG003|Overall Study|Lack of Efficacy|4|||
33438400|NCT00379340|101499864|FG004|Overall Study|Lack of Efficacy|3|||
33438401|NCT00379340|101499860|FG000|Overall Study|Physician Decision|6|||
33438402|NCT00379340|101499861|FG001|Overall Study|Physician Decision|2|||
33438403|NCT00379340|101499862|FG002|Overall Study|Physician Decision|1|||
33438404|NCT00379340|101499863|FG003|Overall Study|Physician Decision|2|||
33438405|NCT00379340|101499864|FG004|Overall Study|Physician Decision|3|||
33438406|NCT00379340|101499860|FG000|Overall Study|Withdrawal by Subject|0|||
33438407|NCT00379340|101499861|FG001|Overall Study|Withdrawal by Subject|0|||
33438408|NCT00379340|101499862|FG002|Overall Study|Withdrawal by Subject|0|||
33438409|NCT00379340|101499863|FG003|Overall Study|Withdrawal by Subject|1|||
33438410|NCT00379340|101499864|FG004|Overall Study|Withdrawal by Subject|0|||
33438411|NCT00379340|101499860|FG000|Overall Study|Refusal of further protocol therapy|1|||
33438412|NCT00379340|101499861|FG001|Overall Study|Refusal of further protocol therapy|0|||
33438413|NCT00379340|101499862|FG002|Overall Study|Refusal of further protocol therapy|1|||
33438414|NCT00379340|101499863|FG003|Overall Study|Refusal of further protocol therapy|1|||
33438415|NCT00379340|101499864|FG004|Overall Study|Refusal of further protocol therapy|7|||
33438416|NCT00379340|101499860|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
33438417|NCT00379340|101499861|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
33438418|NCT00379340|101499862|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
33438419|NCT00379340|101499863|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
33438420|NCT00379340|101499864|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
33438421|NCT00379340|101499860|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
33438422|NCT00379340|101499861|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
33438423|NCT00379340|101499862|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
33438424|NCT00379340|101499863|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
33438425|NCT00379340|101499864|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
33155756|NCT00333840|100482637|FG003|Second-line Treatment Period|Adverse Event|34|||
33438426|NCT02581345|101499865|FG000|Part 1: up to Week 16|Adverse Event|3|||
33252790|NCT00801983|100827331|FG000|Period 1|Withdrawal by Subject|2|||
33438427|NCT02581345|101499866|FG001|Part 1: up to Week 16|Adverse Event|8|||
33438428|NCT02581345|101499867|FG002|Part 1: up to Week 16|Adverse Event|0|||
33155757|NCT00333840|100482634|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
33155758|NCT00333840|100482635|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
33155759|NCT00333840|100482636|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
33155760|NCT00333840|100482637|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
33155761|NCT00333840|100482634|FG000|Second-line Treatment Period|Abnormal procedure|0|||
33155762|NCT00333840|100482635|FG001|Second-line Treatment Period|Abnormal procedure|0|||
33155763|NCT00333840|100482636|FG002|Second-line Treatment Period|Abnormal procedure|0|||
33155764|NCT00333840|100482637|FG003|Second-line Treatment Period|Abnormal procedure|1|||
33155765|NCT00333840|100482634|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
33155766|NCT00333840|100482635|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
33155767|NCT00333840|100482636|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
33155768|NCT00333840|100482637|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
33155769|NCT00333840|100482634|FG000|Second-line Treatment Period|No longer required study drug|0|||
33155770|NCT00333840|100482635|FG001|Second-line Treatment Period|No longer required study drug|0|||
33155771|NCT00333840|100482636|FG002|Second-line Treatment Period|No longer required study drug|1|||
33155772|NCT00333840|100482637|FG003|Second-line Treatment Period|No longer required study drug|14|||
33155773|NCT00333840|100482634|FG000|Second-line Treatment Period|Protocol Violation|0|||
33155774|NCT00333840|100482635|FG001|Second-line Treatment Period|Protocol Violation|0|||
33155775|NCT00333840|100482636|FG002|Second-line Treatment Period|Protocol Violation|1|||
33155776|NCT00333840|100482637|FG003|Second-line Treatment Period|Protocol Violation|10|||
33155777|NCT00333840|100482634|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
33155778|NCT00333840|100482635|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
33155779|NCT00333840|100482636|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
33155780|NCT00333840|100482637|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
33155781|NCT00333840|100482634|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
33155782|NCT00333840|100482635|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
33155783|NCT00333840|100482636|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
33155784|NCT00333840|100482637|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
33155785|NCT00333840|100482634|FG000|Second-line Treatment Period|Administrative problems|0|||
33155786|NCT00333840|100482635|FG001|Second-line Treatment Period|Administrative problems|0|||
33155787|NCT00333840|100482636|FG002|Second-line Treatment Period|Administrative problems|0|||
33155788|NCT00333840|100482637|FG003|Second-line Treatment Period|Administrative problems|7|||
33155789|NCT00333840|100482634|FG000|Second-line Treatment Period|Death|0|||
33155790|NCT00333840|100482635|FG001|Second-line Treatment Period|Death|0|||
33155791|NCT00333840|100482636|FG002|Second-line Treatment Period|Death|0|||
33155792|NCT00333840|100482637|FG003|Second-line Treatment Period|Death|9|||
33155793|NCT04289623|100482638|FG000|Wave 1 Emails|Email was not delivered|268|||
33155794|NCT04289623|100482639|FG001|Wave 1 Emails|Email was not delivered|257|||
33438429|NCT02581345|101499868|FG003|Part 1: up to Week 16|Adverse Event|0|||
33438430|NCT02581345|101499865|FG000|Part 1: up to Week 16|Physician Decision|2|||
33438431|NCT02581345|101499866|FG001|Part 1: up to Week 16|Physician Decision|4|||
33438432|NCT02581345|101499867|FG002|Part 1: up to Week 16|Physician Decision|0|||
33438433|NCT02581345|101499868|FG003|Part 1: up to Week 16|Physician Decision|0|||
33438434|NCT02581345|101499865|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
33438435|NCT02581345|101499866|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
33438436|NCT02581345|101499867|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
33155795|NCT04289623|100482640|FG002|Wave 1 Emails|Email was not delivered|0|||
33155796|NCT04289623|100482641|FG003|Wave 1 Emails|Email was not delivered|0|||
33155797|NCT04289623|100482642|FG004|Wave 1 Emails|Email was not delivered|0|||
33155798|NCT04289623|100482643|FG005|Wave 1 Emails|Email was not delivered|0|||
33155799|NCT01903031|100482644|FG000|Overall Study|Not Able to Attend Clinic|1|||
33155800|NCT01903031|100482645|FG001|Overall Study|Not Able to Attend Clinic|1|||
33155801|NCT01903031|100482646|FG002|Overall Study|Not Able to Attend Clinic|0|||
33438437|NCT02581345|101499868|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
33438438|NCT02581345|101499865|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
33438439|NCT02581345|101499866|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
33438440|NCT02581345|101499867|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
33438441|NCT02581345|101499868|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
33438442|NCT02581345|101499865|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
33438443|NCT02581345|101499866|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
33438444|NCT02581345|101499867|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
33438445|NCT02581345|101499868|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
33438446|NCT02581345|101499865|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
33438447|NCT02581345|101499866|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
33438448|NCT02581345|101499867|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
33438449|NCT02581345|101499868|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
33438450|NCT02581345|101499865|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
33438451|NCT02581345|101499866|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
33438452|NCT02581345|101499867|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
33438453|NCT02581345|101499868|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
33438454|NCT02581345|101499865|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
33438455|NCT02581345|101499866|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
33438456|NCT02581345|101499867|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
33438457|NCT02581345|101499868|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
33438458|NCT02581345|101499865|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
33438459|NCT02581345|101499866|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
33438460|NCT02581345|101499867|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
33438461|NCT02581345|101499868|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
33438462|NCT02581345|101499865|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
33438463|NCT02581345|101499866|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
33438464|NCT02581345|101499867|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
33438465|NCT02581345|101499868|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
33438466|NCT02581345|101499865|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
33438467|NCT02581345|101499866|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
33438468|NCT02581345|101499867|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
33438469|NCT02581345|101499868|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
33438470|NCT02581345|101499865|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
33438471|NCT02581345|101499866|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
33438472|NCT02581345|101499867|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
33438473|NCT02581345|101499868|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
33438474|NCT00076102|101499869|FG000|Overall Study|Clinical progression|1|||
33438475|NCT00076102|101499869|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
33438476|NCT00076102|101499869|FG000|Overall Study|plexiform neurofibroma surgery|1|||
33438477|NCT00076102|101499869|FG000|Overall Study|refusal of further therapy|2|||
33438478|NCT01735630|101499870|FG000|Overall Study|Adverse Event|8|||
33438479|NCT01735630|101499871|FG001|Overall Study|Adverse Event|7|||
33438480|NCT01735630|101499870|FG000|Overall Study|Lost to Follow-up|1|||
33438481|NCT01735630|101499871|FG001|Overall Study|Lost to Follow-up|0|||
33438482|NCT01735630|101499870|FG000|Overall Study|Physician Decision|0|||
33438483|NCT01735630|101499871|FG001|Overall Study|Physician Decision|1|||
33438484|NCT01735630|101499870|FG000|Overall Study|Sponsor Decision|2|||
33438485|NCT01735630|101499871|FG001|Overall Study|Sponsor Decision|1|||
33438486|NCT01735630|101499870|FG000|Overall Study|Withdrawal by Subject|7|||
33438487|NCT01735630|101499871|FG001|Overall Study|Withdrawal by Subject|9|||
33438488|NCT02684344|101499873|FG000|Overall Study|Withdrawal by Subject|0|||
33438489|NCT02684344|101499874|FG001|Overall Study|Withdrawal by Subject|1|||
33438490|NCT01062256|101499875|FG000|Overall Study|Adverse Event|1|||
33438491|NCT01062256|101499876|FG001|Overall Study|Adverse Event|0|||
33438492|NCT01062256|101499877|FG002|Overall Study|Adverse Event|0|||
33438493|NCT01062256|101499875|FG000|Overall Study|Withdrawal by Subject|1|||
33438494|NCT01062256|101499876|FG001|Overall Study|Withdrawal by Subject|1|||
33438495|NCT01062256|101499877|FG002|Overall Study|Withdrawal by Subject|1|||
33155802|NCT01903031|100482644|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
33438496|NCT01062256|101499875|FG000|Overall Study|Ineligible|1|||
33438497|NCT01062256|101499876|FG001|Overall Study|Ineligible|4|||
33438498|NCT01062256|101499877|FG002|Overall Study|Ineligible|3|||
33438499|NCT01062256|101499875|FG000|Overall Study|Administrative|0|||
33252791|NCT00801983|100827332|FG001|Period 1|Withdrawal by Subject|8|||
33155803|NCT01903031|100482645|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
33155804|NCT01903031|100482646|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
33155805|NCT01903031|100482644|FG000|Overall Study|Adverse Event|0|||
33155806|NCT01903031|100482645|FG001|Overall Study|Adverse Event|1|||
33155807|NCT01903031|100482646|FG002|Overall Study|Adverse Event|0|||
33155808|NCT01903031|100482644|FG000|Overall Study|Withdrawal by Subject|0|||
33155809|NCT01903031|100482645|FG001|Overall Study|Withdrawal by Subject|1|||
33155810|NCT01903031|100482646|FG002|Overall Study|Withdrawal by Subject|1|||
33155811|NCT01903031|100482644|FG000|Overall Study|Protocol Violation|0|||
33155812|NCT01903031|100482645|FG001|Overall Study|Protocol Violation|0|||
33155813|NCT01903031|100482646|FG002|Overall Study|Protocol Violation|2|||
33155814|NCT01903031|100482644|FG000|Overall Study|Lost to Follow-up|0|||
33155815|NCT01903031|100482645|FG001|Overall Study|Lost to Follow-up|0|||
33155816|NCT01903031|100482646|FG002|Overall Study|Lost to Follow-up|1|||
33155817|NCT01903031|100482644|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
33155818|NCT01903031|100482645|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
33155819|NCT01903031|100482646|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
33155820|NCT00241358|100482648|FG000|Overall Study|Determined to be not ineligible|0|||
33155821|NCT00241358|100482649|FG001|Overall Study|Determined to be not ineligible|1|||
33155822|NCT00241358|100482650|FG002|Overall Study|Determined to be not ineligible|1|||
33155823|NCT01361568|100482651|FG000|Overall Study|Adverse Event|0|||
33155824|NCT01361568|100482652|FG001|Overall Study|Adverse Event|0|||
33155825|NCT01361568|100482653|FG002|Overall Study|Adverse Event|0|||
33155826|NCT01361568|100482654|FG003|Overall Study|Adverse Event|0|||
33155827|NCT01361568|100482655|FG004|Overall Study|Adverse Event|1|||
33155828|NCT01361568|100482656|FG005|Overall Study|Adverse Event|0|||
33155829|NCT01361568|100482651|FG000|Overall Study|Physician Decision|0|||
33155830|NCT01361568|100482652|FG001|Overall Study|Physician Decision|0|||
33155831|NCT01361568|100482653|FG002|Overall Study|Physician Decision|0|||
33155832|NCT01361568|100482654|FG003|Overall Study|Physician Decision|0|||
33155833|NCT01361568|100482655|FG004|Overall Study|Physician Decision|0|||
33155834|NCT01361568|100482656|FG005|Overall Study|Physician Decision|1|||
33155835|NCT01361568|100482651|FG000|Overall Study|Withdrawal by Subject|2|||
33155836|NCT01361568|100482652|FG001|Overall Study|Withdrawal by Subject|1|||
33155837|NCT01361568|100482653|FG002|Overall Study|Withdrawal by Subject|0|||
33155838|NCT01361568|100482654|FG003|Overall Study|Withdrawal by Subject|0|||
33155839|NCT01361568|100482655|FG004|Overall Study|Withdrawal by Subject|0|||
33155840|NCT01361568|100482656|FG005|Overall Study|Withdrawal by Subject|1|||
33155841|NCT01495975|100482659|FG000|Overall Study|Lost to Follow-up|1|||
33155842|NCT01495975|100482660|FG001|Overall Study|Lost to Follow-up|0|||
33155843|NCT03643575|100485384|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
33155844|NCT03643575|100485385|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
33155845|NCT03643575|100485386|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
33155846|NCT03643575|100485387|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
33155847|NCT03643575|100485388|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
33155848|NCT03643575|100485389|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
33155849|NCT03643575|100485384|FG000|Washout: 7 Days|Adverse Event|1|||
33155850|NCT03643575|100485385|FG001|Washout: 7 Days|Adverse Event|0|||
33387810|NCT00732641|101306439|FG000|Overall Study|Unable to Complete|1|||
33387811|NCT00732641|101306440|FG001|Overall Study|Unable to Complete|1|||
33387812|NCT00732641|101306439|FG000|Overall Study|Other|18|||
33387813|NCT00732641|101306440|FG001|Overall Study|Other|5|||
33387814|NCT00953225|101306441|FG000|Overall Study|Withdrawal by Subject|2|||
33387815|NCT00953225|101306442|FG001|Overall Study|Withdrawal by Subject|0|||
33387816|NCT03693404|101306443|FG000|Overall Study|Withdrawal by Subject|1|||
33387817|NCT03693404|101306444|FG001|Overall Study|Withdrawal by Subject|0|||
33387818|NCT03693404|101306443|FG000|Overall Study|Lost to Follow-up|0|||
33387819|NCT03693404|101306444|FG001|Overall Study|Lost to Follow-up|5|||
33387820|NCT03693404|101306443|FG000|Overall Study|Excluded from Analysis|0|||
33387821|NCT03693404|101306444|FG001|Overall Study|Excluded from Analysis|1|||
33387822|NCT01072448|101306445|FG000|Overall Study|Adverse Event|9|||
33387823|NCT01072448|101306446|FG001|Overall Study|Adverse Event|10|||
33387824|NCT01072448|101306445|FG000|Overall Study|Subject withdrew consent|4|||
33387825|NCT01072448|101306446|FG001|Overall Study|Subject withdrew consent|9|||
33387826|NCT01072448|101306445|FG000|Overall Study|Protocol deviation|3|||
33387827|NCT01072448|101306446|FG001|Overall Study|Protocol deviation|4|||
33387828|NCT01072448|101306445|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33387829|NCT01072448|101306446|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33387830|NCT01072448|101306445|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33387831|NCT01072448|101306446|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33387832|NCT01072448|101306445|FG000|Overall Study|Lost to Follow-up|1|||
33387833|NCT01072448|101306446|FG001|Overall Study|Lost to Follow-up|1|||
33387834|NCT01072448|101306445|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33155851|NCT03643575|100485386|FG002|Washout: 7 Days|Adverse Event|0|||
33155852|NCT03643575|100485387|FG003|Washout: 7 Days|Adverse Event|0|||
33155853|NCT03643575|100485388|FG004|Washout: 7 Days|Adverse Event|0|||
33155854|NCT03643575|100485389|FG005|Washout: 7 Days|Adverse Event|0|||
33155855|NCT03643575|100485384|FG000|Washout: 7 Days|Non compliance check in|0|||
33155856|NCT03643575|100485385|FG001|Washout: 7 Days|Non compliance check in|1|||
33155857|NCT03643575|100485386|FG002|Washout: 7 Days|Non compliance check in|0|||
33155858|NCT03643575|100485387|FG003|Washout: 7 Days|Non compliance check in|0|||
33155859|NCT03643575|100485388|FG004|Washout: 7 Days|Non compliance check in|0|||
33155860|NCT03643575|100485389|FG005|Washout: 7 Days|Non compliance check in|0|||
33155861|NCT02360995|100485393|FG000|Overall Study|Lost to Follow-up|2|||
33155862|NCT02360995|100485394|FG001|Overall Study|Lost to Follow-up|0|||
33155863|NCT02360995|100485395|FG002|Overall Study|Lost to Follow-up|2|||
33155864|NCT02360995|100485393|FG000|Overall Study|Withdrawal by Subject|0|||
33155865|NCT02360995|100485394|FG001|Overall Study|Withdrawal by Subject|1|||
33155866|NCT02360995|100485395|FG002|Overall Study|Withdrawal by Subject|0|||
33155867|NCT02124161|100485396|FG000|Overall Study|Other unspecified|0|||
33155868|NCT02124161|100485397|FG001|Overall Study|Other unspecified|1|||
33155869|NCT02124161|100485396|FG000|Overall Study|Death|1|||
33155870|NCT02124161|100485397|FG001|Overall Study|Death|0|||
33155871|NCT02124161|100485396|FG000|Overall Study|Protocol Violation|2|||
33155872|NCT02124161|100485397|FG001|Overall Study|Protocol Violation|1|||
33155873|NCT02124161|100485396|FG000|Overall Study|Withdrawal by Subject|1|||
33155874|NCT02124161|100485397|FG001|Overall Study|Withdrawal by Subject|2|||
33155875|NCT02124161|100485396|FG000|Overall Study|Adverse Event|2|||
33155876|NCT02124161|100485397|FG001|Overall Study|Adverse Event|0|||
33155877|NCT02124161|100485396|FG000|Overall Study|Does not meet entrance criteria|2|||
33155878|NCT02124161|100485397|FG001|Overall Study|Does not meet entrance criteria|3|||
33155879|NCT02124161|100485396|FG000|Overall Study|No longer meets eligibility criteria|5|||
33155880|NCT02124161|100485397|FG001|Overall Study|No longer meets eligibility criteria|4|||
33155881|NCT02124161|100485396|FG000|Overall Study|Lost to Follow-up|3|||
33155882|NCT02124161|100485397|FG001|Overall Study|Lost to Follow-up|4|||
33155883|NCT02410551|100485398|FG000|Overall Study|Adverse Event|1|||
33155884|NCT02410551|100485398|FG000|Overall Study|Withdrawal by Subject|1|||
33155885|NCT02410551|100485398|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
33155886|NCT02846545|100485399|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
33155887|NCT02846545|100485400|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
33155888|NCT02846545|100485399|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
33155889|NCT02846545|100485400|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
33155890|NCT02846545|100485399|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
33155891|NCT02846545|100485400|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
33155892|NCT02846545|100485399|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
33155893|NCT02846545|100485400|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
33155894|NCT02846545|100485399|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
33155895|NCT02846545|100485400|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
33155896|NCT04203498|100485401|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
33155897|NCT04203498|100485402|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
33155898|NCT04203498|100485401|FG000|Overall Study|Withdrawal of patient consent|7|||
33155899|NCT04203498|100485402|FG001|Overall Study|Withdrawal of patient consent|2|||
33155900|NCT04203498|100485401|FG000|Overall Study|Adverse Event|4|||
33155901|NCT04203498|100485402|FG001|Overall Study|Adverse Event|1|||
33155902|NCT04203498|100485401|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
33155903|NCT04203498|100485402|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
33155904|NCT04203498|100485401|FG000|Overall Study|Did not receive IMP|2|||
33387835|NCT01072448|101306446|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33387836|NCT01072448|101306445|FG000|Overall Study|Death|0|||
33387837|NCT01072448|101306446|FG001|Overall Study|Death|2|||
33387838|NCT02254551|101306450|FG000|Dose Escalation|Physician Decision|1|||
33387839|NCT02254551|101306450|FG000|Dose Escalation|Dose-limiting toxicity|2|||
33387840|NCT00967226|101306451|FG000|Overall Study|Adverse Event|0|||
33387841|NCT00967226|101306452|FG001|Overall Study|Adverse Event|5|||
33387842|NCT00967226|101306451|FG000|Overall Study|Protocol Violation|2|||
33387843|NCT00967226|101306452|FG001|Overall Study|Protocol Violation|0|||
33387844|NCT00967226|101306451|FG000|Overall Study|Physician Decision|0|||
33387845|NCT00967226|101306452|FG001|Overall Study|Physician Decision|1|||
33387846|NCT03215667|101306454|FG000|Overall Study|Physician Decision|4|||
33387847|NCT01432457|101306461|FG000|Overall Study|Adverse Event|7|||
33252792|NCT00801983|100827331|FG000|Period 2|Withdrawal by Subject|2|||
33252793|NCT00801983|100827332|FG001|Period 2|Withdrawal by Subject|1|||
33252794|NCT02715258|100827341|FG000|Overall Study|Withdrawal by Subject|6|||
33252795|NCT02715258|100827342|FG001|Overall Study|Withdrawal by Subject|1|||
33252796|NCT02715258|100827341|FG000|Overall Study|Lost to Follow-up|7|||
33252797|NCT02715258|100827342|FG001|Overall Study|Lost to Follow-up|1|||
33252798|NCT02715258|100827341|FG000|Overall Study|Terminated by Sponsor|0|||
33252799|NCT02715258|100827342|FG001|Overall Study|Terminated by Sponsor|1|||
33252800|NCT02715258|100827341|FG000|Overall Study|Death|0|||
33252801|NCT02715258|100827342|FG001|Overall Study|Death|1|||
33252802|NCT02715258|100827341|FG000|Overall Study|Subject non-compliant|1|||
33252803|NCT02715258|100827342|FG001|Overall Study|Subject non-compliant|1|||
33252804|NCT02715258|100827341|FG000|Overall Study|GCP violation|2|||
33252805|NCT02715258|100827342|FG001|Overall Study|GCP violation|1|||
33252806|NCT00922207|100827345|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
33252807|NCT00922207|100827346|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
33252808|NCT00922207|100827347|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
33252809|NCT00922207|100827345|FG000|Overall Study|Insufficient Therapeutic Response|0|||
33252810|NCT00922207|100827346|FG001|Overall Study|Insufficient Therapeutic Response|0|||
33252811|NCT00922207|100827347|FG002|Overall Study|Insufficient Therapeutic Response|1|||
33252812|NCT00922207|100827345|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
33252813|NCT00922207|100827346|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
33252814|NCT00922207|100827347|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
33252815|NCT00922207|100827345|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
33252816|NCT00922207|100827346|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
33252817|NCT00922207|100827347|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
33252818|NCT00922207|100827345|FG000|Overall Study|Withdrew Consent|2|||
33252819|NCT00922207|100827346|FG001|Overall Study|Withdrew Consent|5|||
33252820|NCT00922207|100827347|FG002|Overall Study|Withdrew Consent|2|||
33387848|NCT01432457|101306462|FG001|Overall Study|Adverse Event|10|||
33387849|NCT01432457|101306463|FG002|Overall Study|Adverse Event|16|||
33387850|NCT01432457|101306461|FG000|Overall Study|Lack of Efficacy|2|||
33252821|NCT00922207|100827345|FG000|Overall Study|Abnormality of Laboratory Test|0|||
33252822|NCT00922207|100827346|FG001|Overall Study|Abnormality of Laboratory Test|1|||
33252823|NCT00922207|100827347|FG002|Overall Study|Abnormality of Laboratory Test|1|||
33387851|NCT01432457|101306462|FG001|Overall Study|Lack of Efficacy|1|||
33387852|NCT01432457|101306463|FG002|Overall Study|Lack of Efficacy|1|||
33387853|NCT01432457|101306461|FG000|Overall Study|Lost to Follow-up|11|||
33387854|NCT01432457|101306462|FG001|Overall Study|Lost to Follow-up|15|||
33252824|NCT02281318|100827348|FG000|Overall Study|Adverse Event|2|||
33387855|NCT01432457|101306463|FG002|Overall Study|Lost to Follow-up|20|||
33387856|NCT01432457|101306461|FG000|Overall Study|Protocol Violation|3|||
33387857|NCT01432457|101306462|FG001|Overall Study|Protocol Violation|2|||
33387858|NCT01432457|101306463|FG002|Overall Study|Protocol Violation|6|||
33387859|NCT01432457|101306461|FG000|Overall Study|Withdrawal by Subject|6|||
33387860|NCT01432457|101306462|FG001|Overall Study|Withdrawal by Subject|11|||
33387861|NCT01432457|101306463|FG002|Overall Study|Withdrawal by Subject|9|||
33155905|NCT04203498|100485402|FG001|Overall Study|Did not receive IMP|0|||
33155906|NCT05095454|100485403|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
33155907|NCT05095454|100485404|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
33155908|NCT00075218|100485405|FG000|Double-Blind Treatment|Adverse Event|23|||
33155909|NCT00075218|100485406|FG001|Double-Blind Treatment|Adverse Event|4|||
33155910|NCT00075218|100485407|FG002|Double-Blind Treatment|Adverse Event|0|||
33155911|NCT00075218|100485405|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
33155912|NCT00075218|100485406|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
33155913|NCT00075218|100485407|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
33155914|NCT00075218|100485405|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
33155915|NCT00075218|100485406|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
33155916|NCT00075218|100485407|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
33155917|NCT00075218|100485405|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
33155918|NCT00075218|100485406|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
33155919|NCT00075218|100485407|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
33155920|NCT00075218|100485405|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
33155921|NCT00075218|100485406|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
33155922|NCT00075218|100485407|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
33155923|NCT00075218|100485405|FG000|Double-Blind Treatment|No study medication taken|2|||
33155924|NCT00075218|100485406|FG001|Double-Blind Treatment|No study medication taken|0|||
33155925|NCT00075218|100485407|FG002|Double-Blind Treatment|No study medication taken|0|||
33155926|NCT00075218|100485405|FG000|Open-Label Treatment|Lack of Efficacy|0|||
33155927|NCT00075218|100485406|FG001|Open-Label Treatment|Lack of Efficacy|0|||
33155928|NCT00075218|100485407|FG002|Open-Label Treatment|Lack of Efficacy|174|||
33155929|NCT00075218|100485405|FG000|Open-Label Treatment|Adverse Event|0|||
33155930|NCT00075218|100485406|FG001|Open-Label Treatment|Adverse Event|0|||
33155931|NCT00075218|100485407|FG002|Open-Label Treatment|Adverse Event|51|||
33155932|NCT00075218|100485405|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
33155933|NCT00075218|100485406|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
33155934|NCT00075218|100485407|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
33155935|NCT00075218|100485405|FG000|Open-Label Treatment|Decision of Sponsor|0|||
33155936|NCT00075218|100485406|FG001|Open-Label Treatment|Decision of Sponsor|0|||
33155937|NCT00075218|100485407|FG002|Open-Label Treatment|Decision of Sponsor|8|||
33155938|NCT00075218|100485405|FG000|Open-Label Treatment|Protocol Violation|0|||
33155939|NCT00075218|100485406|FG001|Open-Label Treatment|Protocol Violation|0|||
33155940|NCT00075218|100485407|FG002|Open-Label Treatment|Protocol Violation|1|||
33155941|NCT00075218|100485405|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
33155942|NCT00075218|100485406|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
33155943|NCT00075218|100485407|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
33387862|NCT01432457|101306461|FG000|Overall Study|Reasons not defined|2|||
33387863|NCT01432457|101306462|FG001|Overall Study|Reasons not defined|3|||
33438500|NCT01062256|101499876|FG001|Overall Study|Administrative|2|||
33438501|NCT01062256|101499877|FG002|Overall Study|Administrative|0|||
33155944|NCT02777333|100485409|FG000|Overall Study|Withdrawal by Subject|0|||
33155945|NCT02777333|100485410|FG001|Overall Study|Withdrawal by Subject|1|||
33155946|NCT02777333|100485409|FG000|Overall Study|Lost to Follow-up|0|||
33155947|NCT02777333|100485410|FG001|Overall Study|Lost to Follow-up|1|||
33155948|NCT03080454|100485415|FG000|Baseline|Adverse Event|2|||
33155949|NCT03080454|100485415|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
33155950|NCT03080454|100485415|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
33155951|NCT04545385|100485416|FG000|Overall Study|Withdrawal by Subject|2|||
33155952|NCT04545385|100485417|FG001|Overall Study|Withdrawal by Subject|0|||
33252825|NCT02281318|100827349|FG001|Overall Study|Adverse Event|2|||
33252826|NCT02281318|100827348|FG000|Overall Study|Lack of Efficacy|2|||
33252827|NCT02281318|100827349|FG001|Overall Study|Lack of Efficacy|0|||
33252828|NCT02281318|100827348|FG000|Overall Study|Lost to Follow-up|2|||
33252829|NCT02281318|100827349|FG001|Overall Study|Lost to Follow-up|1|||
33252830|NCT02281318|100827348|FG000|Overall Study|Physician Decision|2|||
33252831|NCT02281318|100827349|FG001|Overall Study|Physician Decision|0|||
33252832|NCT02281318|100827348|FG000|Overall Study|Withdrawal by Subject|6|||
33252833|NCT02281318|100827349|FG001|Overall Study|Withdrawal by Subject|2|||
33252834|NCT01585558|100827350|FG000|Overall Study|Withdrawal by Subject|4|||
33252835|NCT01585558|100827351|FG001|Overall Study|Withdrawal by Subject|5|||
33252836|NCT01585558|100827352|FG002|Overall Study|Withdrawal by Subject|8|||
33252837|NCT01585558|100827350|FG000|Overall Study|Lost to Follow-up|2|||
33252838|NCT01585558|100827351|FG001|Overall Study|Lost to Follow-up|0|||
33252839|NCT01585558|100827352|FG002|Overall Study|Lost to Follow-up|3|||
33252840|NCT01585558|100827350|FG000|Overall Study|Adverse Event|3|||
33252841|NCT01585558|100827351|FG001|Overall Study|Adverse Event|4|||
33252842|NCT01585558|100827352|FG002|Overall Study|Adverse Event|1|||
33252843|NCT01585558|100827350|FG000|Overall Study|Protocol Violation|4|||
33252844|NCT01585558|100827351|FG001|Overall Study|Protocol Violation|3|||
33252845|NCT01585558|100827352|FG002|Overall Study|Protocol Violation|2|||
33252846|NCT01585558|100827350|FG000|Overall Study|Lack of Efficacy|0|||
33252847|NCT01585558|100827351|FG001|Overall Study|Lack of Efficacy|0|||
33438502|NCT01210001|101499878|FG000|Overall Study|Not treated|1|||
33155953|NCT04545385|100485416|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
33155954|NCT04545385|100485417|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
33155955|NCT04545385|100485416|FG000|Overall Study|Study termination|10|||
33155956|NCT04545385|100485417|FG001|Overall Study|Study termination|10|||
33252848|NCT01585558|100827352|FG002|Overall Study|Lack of Efficacy|1|||
33252849|NCT00468910|100827353|FG000|Overall Study|Lost to Follow-up|2|||
33252850|NCT00468910|100827354|FG001|Overall Study|Lost to Follow-up|1|||
33252851|NCT00468910|100827353|FG000|Overall Study|Withdrawal by Subject|2|||
33155957|NCT04545385|100485416|FG000|Overall Study|Sponsor decision|2|||
33387864|NCT01432457|101306463|FG002|Overall Study|Reasons not defined|4|||
33387865|NCT01432457|101306461|FG000|Overall Study|Did not take study drug|6|||
33387866|NCT01432457|101306462|FG001|Overall Study|Did not take study drug|6|||
33387867|NCT01432457|101306463|FG002|Overall Study|Did not take study drug|3|||
33387868|NCT03446612|101306464|FG000|Overall Study|Protocol defined stopping criteria|0|||
33387869|NCT03446612|101306465|FG001|Overall Study|Protocol defined stopping criteria|1|||
33387870|NCT00565812|101306471|FG000|Overall Study|Death|2|||
33387871|NCT00565812|101306472|FG001|Overall Study|Death|1|||
33387872|NCT00565812|101306473|FG002|Overall Study|Death|3|||
33387873|NCT00565812|101306471|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
33438503|NCT01210001|101499879|FG001|Overall Study|Not treated|0|||
33438504|NCT01210001|101499880|FG002|Overall Study|Not treated|0|||
33155958|NCT04545385|100485417|FG001|Overall Study|Sponsor decision|2|||
33387874|NCT00565812|101306472|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
33387875|NCT00565812|101306473|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
33387876|NCT00565812|101306471|FG000|Overall Study|Lost to Follow-up|10|||
33438505|NCT01210001|101499878|FG000|Overall Study|Adverse Event|4|||
33438506|NCT01210001|101499879|FG001|Overall Study|Adverse Event|2|||
33252852|NCT00468910|100827354|FG001|Overall Study|Withdrawal by Subject|1|||
33252853|NCT00468910|100827353|FG000|Overall Study|Medical Contraindication|0|||
33252854|NCT00468910|100827354|FG001|Overall Study|Medical Contraindication|1|||
33252855|NCT01070888|100827355|FG000|First Intervention (14 Days)|Adverse Event|0|||
33252856|NCT01070888|100827356|FG001|First Intervention (14 Days)|Adverse Event|1|||
33252857|NCT01070888|100827355|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
33252858|NCT01070888|100827356|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
33155959|NCT04545385|100485416|FG000|Overall Study|Other than specified|1|||
33155960|NCT04545385|100485417|FG001|Overall Study|Other than specified|0|||
33155961|NCT00761631|100485418|FG000|Overall Study|Parent/legal guardian request|8|||
33155962|NCT00761631|100485419|FG001|Overall Study|Parent/legal guardian request|3|||
33155963|NCT00761631|100485420|FG002|Overall Study|Parent/legal guardian request|8|||
33155964|NCT00761631|100485421|FG003|Overall Study|Parent/legal guardian request|0|||
33155965|NCT00761631|100485422|FG004|Overall Study|Parent/legal guardian request|5|||
33155966|NCT00761631|100485423|FG005|Overall Study|Parent/legal guardian request|0|||
33155967|NCT00761631|100485418|FG000|Overall Study|Lost to Follow-up|2|||
33155968|NCT00761631|100485419|FG001|Overall Study|Lost to Follow-up|4|||
33155969|NCT00761631|100485420|FG002|Overall Study|Lost to Follow-up|7|||
33155970|NCT00761631|100485421|FG003|Overall Study|Lost to Follow-up|1|||
33155971|NCT00761631|100485422|FG004|Overall Study|Lost to Follow-up|6|||
33155972|NCT00761631|100485423|FG005|Overall Study|Lost to Follow-up|1|||
33155973|NCT00761631|100485418|FG000|Overall Study|Protocol Violation|2|||
33252859|NCT01070888|100827355|FG000|Washout (14 Days)|Physician Decision|1|||
33252860|NCT01070888|100827356|FG001|Washout (14 Days)|Physician Decision|0|||
33252861|NCT02621424|100827357|FG000|Overall Study|Withdrawal by Subject|1|||
33252862|NCT02621424|100827358|FG001|Overall Study|Withdrawal by Subject|2|||
33252863|NCT00746330|100827359|FG000|Period 1|Abnormal test procedure result|0|||
33252864|NCT00746330|100827360|FG001|Period 1|Abnormal test procedure result|0|||
33252865|NCT00746330|100827361|FG002|Period 1|Abnormal test procedure result|1|||
33438507|NCT01210001|101499880|FG002|Overall Study|Adverse Event|5|||
33438508|NCT01210001|101499878|FG000|Overall Study|Non compliant with protocol|2|||
33438509|NCT01210001|101499879|FG001|Overall Study|Non compliant with protocol|2|||
33438510|NCT01210001|101499880|FG002|Overall Study|Non compliant with protocol|3|||
33438511|NCT01210001|101499878|FG000|Overall Study|Lost to Follow-up|4|||
33438512|NCT01210001|101499879|FG001|Overall Study|Lost to Follow-up|3|||
33438513|NCT01210001|101499880|FG002|Overall Study|Lost to Follow-up|2|||
33438514|NCT01210001|101499878|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
33438515|NCT01210001|101499879|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
33438516|NCT01210001|101499880|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
33438517|NCT01210001|101499878|FG000|Overall Study|Other reason not defined above|2|||
33438518|NCT01210001|101499879|FG001|Overall Study|Other reason not defined above|2|||
33438519|NCT01210001|101499880|FG002|Overall Study|Other reason not defined above|1|||
33438520|NCT01402947|101499881|FG000|First Intervention|Adverse Event|0|||
33438521|NCT01402947|101499882|FG001|First Intervention|Adverse Event|1|||
33438522|NCT00090857|101499883|FG000|Overall Study|Lost to Follow-up|0|||
33438523|NCT00090857|101499884|FG001|Overall Study|Lost to Follow-up|1|||
33438524|NCT00090857|101499883|FG000|Overall Study|Withdrawal by Subject|2|||
33438525|NCT00090857|101499884|FG001|Overall Study|Withdrawal by Subject|0|||
33438526|NCT00090857|101499883|FG000|Overall Study|Adverse Event|2|||
33438527|NCT00090857|101499884|FG001|Overall Study|Adverse Event|2|||
33252866|NCT00746330|100827362|FG003|Period 1|Abnormal test procedure result|0|||
33252867|NCT00246012|100827363|FG000|Overall Study|Adverse Event|0|||
33438528|NCT03661528|101499885|FG000|Overall Study|Death|1|||
33438529|NCT03661528|101499886|FG001|Overall Study|Death|0|||
33438530|NCT03661528|101499885|FG000|Overall Study|Physician Decision|3|||
33438531|NCT03661528|101499886|FG001|Overall Study|Physician Decision|1|||
33438532|NCT03661528|101499885|FG000|Overall Study|Other than Specified|5|||
33438533|NCT03661528|101499886|FG001|Overall Study|Other than Specified|2|||
33438534|NCT03661528|101499885|FG000|Overall Study|Withdrawal by Subject|5|||
33438535|NCT03661528|101499886|FG001|Overall Study|Withdrawal by Subject|3|||
33155974|NCT00761631|100485419|FG001|Overall Study|Protocol Violation|0|||
33252868|NCT00246012|100827364|FG001|Overall Study|Adverse Event|0|||
33252869|NCT00246012|100827365|FG002|Overall Study|Adverse Event|0|||
33252870|NCT00246012|100827366|FG003|Overall Study|Adverse Event|0|||
33252871|NCT00246012|100827367|FG004|Overall Study|Adverse Event|0|||
33252872|NCT00246012|100827368|FG005|Overall Study|Adverse Event|1|||
33252873|NCT00246012|100827369|FG006|Overall Study|Adverse Event|0|||
33252874|NCT00246012|100827370|FG007|Overall Study|Adverse Event|0|||
33252875|NCT00246012|100827371|FG008|Overall Study|Adverse Event|2|||
33252876|NCT00246012|100827363|FG000|Overall Study|Withdrawal by Subject|0|||
33438536|NCT03661528|101499885|FG000|Overall Study|Disease Progression|8|||
33252877|NCT00246012|100827364|FG001|Overall Study|Withdrawal by Subject|0|||
33438537|NCT03661528|101499886|FG001|Overall Study|Disease Progression|13|||
33438538|NCT03661528|101499885|FG000|Overall Study|Adverse Event|61|||
33438539|NCT03661528|101499886|FG001|Overall Study|Adverse Event|55|||
33438540|NCT01424644|101499887|FG000|Overall Study|Adverse Event|2|||
33438541|NCT01424644|101499888|FG001|Overall Study|Adverse Event|0|||
33438542|NCT01424644|101499887|FG000|Overall Study|Withdrawal by Subject|9|||
33155975|NCT00761631|100485420|FG002|Overall Study|Protocol Violation|0|||
33155976|NCT00761631|100485421|FG003|Overall Study|Protocol Violation|1|||
33252878|NCT00246012|100827365|FG002|Overall Study|Withdrawal by Subject|0|||
33252879|NCT00246012|100827366|FG003|Overall Study|Withdrawal by Subject|0|||
33252880|NCT00246012|100827367|FG004|Overall Study|Withdrawal by Subject|0|||
33438543|NCT01424644|101499888|FG001|Overall Study|Withdrawal by Subject|12|||
33155977|NCT00761631|100485422|FG004|Overall Study|Protocol Violation|5|||
33155978|NCT00761631|100485423|FG005|Overall Study|Protocol Violation|1|||
33155979|NCT00761631|100485418|FG000|Overall Study|Randomized, not treated|1|||
33155980|NCT00761631|100485419|FG001|Overall Study|Randomized, not treated|0|||
33155981|NCT00761631|100485420|FG002|Overall Study|Randomized, not treated|0|||
33155982|NCT00761631|100485421|FG003|Overall Study|Randomized, not treated|0|||
33155983|NCT00761631|100485422|FG004|Overall Study|Randomized, not treated|0|||
33155984|NCT00761631|100485423|FG005|Overall Study|Randomized, not treated|0|||
33155985|NCT00761631|100485418|FG000|Overall Study|Failed to return|1|||
33155986|NCT00761631|100485419|FG001|Overall Study|Failed to return|0|||
33155987|NCT00761631|100485420|FG002|Overall Study|Failed to return|1|||
33155988|NCT00761631|100485421|FG003|Overall Study|Failed to return|1|||
33155989|NCT00761631|100485422|FG004|Overall Study|Failed to return|5|||
33155990|NCT00761631|100485423|FG005|Overall Study|Failed to return|2|||
33155991|NCT00761631|100485418|FG000|Overall Study|Physician Decision|1|||
33155992|NCT00761631|100485419|FG001|Overall Study|Physician Decision|0|||
33155993|NCT00761631|100485420|FG002|Overall Study|Physician Decision|0|||
33155994|NCT00761631|100485421|FG003|Overall Study|Physician Decision|0|||
33155995|NCT00761631|100485422|FG004|Overall Study|Physician Decision|0|||
33155996|NCT00761631|100485423|FG005|Overall Study|Physician Decision|0|||
33155997|NCT00761631|100485418|FG000|Overall Study|Other|0|||
33155998|NCT00761631|100485419|FG001|Overall Study|Other|0|||
33155999|NCT00761631|100485420|FG002|Overall Study|Other|0|||
33156000|NCT00761631|100485421|FG003|Overall Study|Other|0|||
33156001|NCT00761631|100485422|FG004|Overall Study|Other|1|||
33156002|NCT00761631|100485423|FG005|Overall Study|Other|1|||
33156003|NCT02423109|100485424|FG000|Lens 1|Adverse Event|1|||
33156004|NCT02423109|100485425|FG001|Lens 1|Adverse Event|0|||
33156005|NCT00579098|100485428|FG000|Overall Study|Lost to Follow-up|2|||
33156006|NCT00579098|100485429|FG001|Overall Study|Lost to Follow-up|0|||
33156007|NCT00579098|100485428|FG000|Overall Study|Adverse Event|2|||
33156008|NCT00579098|100485429|FG001|Overall Study|Adverse Event|3|||
33156009|NCT00579098|100485428|FG000|Overall Study|Withdrawal by Subject|2|||
33156010|NCT00579098|100485429|FG001|Overall Study|Withdrawal by Subject|3|||
33156011|NCT00579098|100485428|FG000|Overall Study|AF returned after ablation|3|||
33156012|NCT00579098|100485429|FG001|Overall Study|AF returned after ablation|2|||
33156013|NCT02083965|100485430|FG000|Treatment Period|Other|1|||
33156014|NCT02083965|100485431|FG001|Treatment Period|Other|0|||
33156015|NCT00697788|100485432|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
33156016|NCT00697788|100485433|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
33156017|NCT00697788|100485434|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
33156018|NCT00697788|100485435|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
33156019|NCT00697788|100485436|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
33156020|NCT00697788|100485437|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
33156021|NCT00697788|100485438|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
33156022|NCT00697788|100485439|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
33156023|NCT00697788|100485432|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
33156024|NCT00697788|100485433|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
33156025|NCT00697788|100485434|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
33156026|NCT00697788|100485435|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
33156027|NCT00697788|100485436|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
33156028|NCT00697788|100485437|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
33156029|NCT00697788|100485438|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
33156030|NCT00697788|100485439|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
33156031|NCT02104752|100485443|FG000|Overall Study|Withdrawal by Subject|1|||
33252881|NCT00246012|100827368|FG005|Overall Study|Withdrawal by Subject|1|||
33156032|NCT02104752|100485444|FG001|Overall Study|Withdrawal by Subject|0|||
33156033|NCT02104752|100485443|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
33156034|NCT02104752|100485444|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
33156035|NCT01649804|100485445|FG000|Overall Study|Administrative/Other|8|||
33156036|NCT01042678|100485447|FG000|Overall Study|Physician Decision|1|||
33156037|NCT01042678|100485448|FG001|Overall Study|Physician Decision|0|||
33156038|NCT01042678|100485449|FG002|Overall Study|Physician Decision|0|||
33156039|NCT01042678|100485450|FG003|Overall Study|Physician Decision|0|||
33156040|NCT01042678|100485451|FG004|Overall Study|Physician Decision|0|||
33252882|NCT00246012|100827369|FG006|Overall Study|Withdrawal by Subject|0|||
33252883|NCT00246012|100827370|FG007|Overall Study|Withdrawal by Subject|0|||
33252884|NCT00246012|100827371|FG008|Overall Study|Withdrawal by Subject|0|||
33252885|NCT00246012|100827363|FG000|Overall Study|Disease progression|3|||
33252886|NCT00246012|100827364|FG001|Overall Study|Disease progression|1|||
33252887|NCT00246012|100827365|FG002|Overall Study|Disease progression|2|||
33387877|NCT00565812|101306472|FG001|Overall Study|Lost to Follow-up|8|||
33387878|NCT00565812|101306473|FG002|Overall Study|Lost to Follow-up|8|||
33156041|NCT01042678|100485452|FG005|Overall Study|Physician Decision|0|||
33156042|NCT02357979|100485453|FG000|Overall Study|Lost to Follow-up|5|||
33156043|NCT02357979|100485454|FG001|Overall Study|Lost to Follow-up|5|||
33156044|NCT03945214|100485455|FG000|Overall Study|Lost to Follow-up|3|||
33156045|NCT03945214|100485456|FG001|Overall Study|Lost to Follow-up|4|||
33156046|NCT03945214|100485457|FG002|Overall Study|Lost to Follow-up|7|||
33156047|NCT03945214|100485458|FG003|Overall Study|Lost to Follow-up|4|||
33156048|NCT01083485|100485459|FG000|Overall Study|Adverse Event|0|||
33156049|NCT01083485|100485460|FG001|Overall Study|Adverse Event|1|||
33156050|NCT01083485|100485459|FG000|Overall Study|Protocol Violation|1|||
33156051|NCT01083485|100485460|FG001|Overall Study|Protocol Violation|0|||
33156052|NCT01083485|100485459|FG000|Overall Study|Withdrawal by Subject|5|||
33156053|NCT01083485|100485460|FG001|Overall Study|Withdrawal by Subject|2|||
33156054|NCT01083485|100485459|FG000|Overall Study|Other|1|||
33156055|NCT01083485|100485460|FG001|Overall Study|Other|0|||
33156056|NCT04154930|100485461|FG000|Overall Study|Withdrawal by Subject|15|||
33156057|NCT04154930|100485462|FG001|Overall Study|Withdrawal by Subject|6|||
33156058|NCT04154930|100485461|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
33156059|NCT04154930|100485462|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
33156060|NCT04154930|100485461|FG000|Overall Study|Lost to Follow-up|14|||
33156061|NCT04154930|100485462|FG001|Overall Study|Lost to Follow-up|6|||
33156062|NCT04154930|100485461|FG000|Overall Study|Other|6|||
33156063|NCT04154930|100485462|FG001|Overall Study|Other|0|||
33156064|NCT00810108|100485463|FG000|Overall Study|Withdrawal by Subject|1|||
33156065|NCT00810108|100485464|FG001|Overall Study|Withdrawal by Subject|0|||
33156066|NCT03917459|100485465|FG000|Overall Study|Adverse Event|1|||
33387879|NCT00565812|101306471|FG000|Overall Study|Withdrawal by Subject|58|||
33387880|NCT00565812|101306472|FG001|Overall Study|Withdrawal by Subject|47|||
33387881|NCT00565812|101306473|FG002|Overall Study|Withdrawal by Subject|48|||
33387882|NCT00565812|101306471|FG000|Overall Study|Work Schedule|5|||
33438544|NCT01424644|101499887|FG000|Overall Study|Lost to Follow-up|16|||
33252888|NCT00246012|100827366|FG003|Overall Study|Disease progression|3|||
33387883|NCT00565812|101306472|FG001|Overall Study|Work Schedule|3|||
33438545|NCT01424644|101499888|FG001|Overall Study|Lost to Follow-up|12|||
33252889|NCT00246012|100827367|FG004|Overall Study|Disease progression|3|||
33252890|NCT00246012|100827368|FG005|Overall Study|Disease progression|25|||
33252891|NCT00246012|100827369|FG006|Overall Study|Disease progression|30|||
33252892|NCT00246012|100827370|FG007|Overall Study|Disease progression|27|||
33252893|NCT00246012|100827371|FG008|Overall Study|Disease progression|26|||
33252894|NCT00246012|100827363|FG000|Overall Study|Other|0|||
33252895|NCT00246012|100827364|FG001|Overall Study|Other|0|||
33252896|NCT00246012|100827365|FG002|Overall Study|Other|0|||
33252897|NCT00246012|100827366|FG003|Overall Study|Other|0|||
33252898|NCT00246012|100827367|FG004|Overall Study|Other|0|||
33252899|NCT00246012|100827368|FG005|Overall Study|Other|0|||
33252900|NCT00246012|100827369|FG006|Overall Study|Other|0|||
33252901|NCT00246012|100827370|FG007|Overall Study|Other|1|||
33252902|NCT00246012|100827371|FG008|Overall Study|Other|0|||
33252903|NCT00246012|100827363|FG000|Overall Study|Randomly assigned but not treated|0|||
33252904|NCT00246012|100827364|FG001|Overall Study|Randomly assigned but not treated|0|||
33252905|NCT00246012|100827365|FG002|Overall Study|Randomly assigned but not treated|0|||
33252906|NCT00246012|100827366|FG003|Overall Study|Randomly assigned but not treated|0|||
33252907|NCT00246012|100827367|FG004|Overall Study|Randomly assigned but not treated|0|||
33252908|NCT00246012|100827368|FG005|Overall Study|Randomly assigned but not treated|1|||
33252909|NCT00246012|100827369|FG006|Overall Study|Randomly assigned but not treated|1|||
33252910|NCT00246012|100827370|FG007|Overall Study|Randomly assigned but not treated|0|||
33252911|NCT00246012|100827371|FG008|Overall Study|Randomly assigned but not treated|0|||
33252912|NCT01212991|100827373|FG000|Double-blind|Lost to Follow-up|8|||
33252913|NCT01212991|100827374|FG001|Double-blind|Lost to Follow-up|4|||
33252914|NCT01212991|100827375|FG002|Double-blind|Lost to Follow-up|0|||
33252915|NCT01212991|100827373|FG000|Double-blind|Death|699|||
33252916|NCT01212991|100827374|FG001|Double-blind|Death|550|||
33252917|NCT01212991|100827375|FG002|Double-blind|Death|0|||
33252918|NCT01212991|100827373|FG000|Double-blind|Withdrawal by Subject|16|||
33252919|NCT01212991|100827374|FG001|Double-blind|Withdrawal by Subject|19|||
33252920|NCT01212991|100827375|FG002|Double-blind|Withdrawal by Subject|0|||
33252921|NCT01212991|100827373|FG000|Double-blind|Other|7|||
33252922|NCT01212991|100827374|FG001|Double-blind|Other|0|||
33252923|NCT01212991|100827375|FG002|Double-blind|Other|0|||
33387884|NCT00565812|101306473|FG002|Overall Study|Work Schedule|1|||
33387885|NCT00565812|101306471|FG000|Overall Study|Protocol Violation|2|||
33387886|NCT00565812|101306472|FG001|Overall Study|Protocol Violation|6|||
33387887|NCT00565812|101306473|FG002|Overall Study|Protocol Violation|4|||
33387888|NCT00565812|101306471|FG000|Overall Study|Adverse Event|41|||
33387889|NCT00565812|101306472|FG001|Overall Study|Adverse Event|54|||
33387890|NCT00565812|101306473|FG002|Overall Study|Adverse Event|40|||
33387891|NCT00565812|101306471|FG000|Overall Study|Jury Duty|1|||
33387892|NCT00565812|101306472|FG001|Overall Study|Jury Duty|0|||
33387893|NCT00565812|101306473|FG002|Overall Study|Jury Duty|0|||
33387894|NCT00565812|101306471|FG000|Overall Study|Relocated Out of Area|5|||
33387895|NCT00565812|101306472|FG001|Overall Study|Relocated Out of Area|8|||
33438546|NCT01424644|101499887|FG000|Overall Study|Protocol Violation|4|||
33438547|NCT01424644|101499888|FG001|Overall Study|Protocol Violation|3|||
33438548|NCT01424644|101499887|FG000|Overall Study|Administrative Reason|1|||
33438549|NCT01424644|101499888|FG001|Overall Study|Administrative Reason|0|||
33438550|NCT01424644|101499887|FG000|Overall Study|Unable to Classify|1|||
33438551|NCT01424644|101499888|FG001|Overall Study|Unable to Classify|0|||
33438552|NCT00677365|101499889|FG000|Overall Study|Adverse Event|2|||
33252924|NCT01212991|100827373|FG000|Double-blind|Sponsor decision|142|||
33252925|NCT01212991|100827374|FG001|Double-blind|Sponsor decision|38|||
33387896|NCT00565812|101306473|FG002|Overall Study|Relocated Out of Area|9|||
33387897|NCT00565812|101306471|FG000|Overall Study|Sponsor Decision|1|||
33252926|NCT01212991|100827375|FG002|Double-blind|Sponsor decision|0|||
33252927|NCT01212991|100827373|FG000|Open-label|Death|0|||
33252928|NCT01212991|100827374|FG001|Open-label|Death|0|||
33387898|NCT00565812|101306472|FG001|Overall Study|Sponsor Decision|5|||
33438553|NCT00677365|101499890|FG001|Overall Study|Adverse Event|1|||
33438554|NCT00677365|101499891|FG002|Overall Study|Adverse Event|1|||
33438555|NCT00677365|101499892|FG003|Overall Study|Adverse Event|2|||
33252929|NCT01212991|100827375|FG002|Open-label|Death|166|||
33252930|NCT01212991|100827373|FG000|Open-label|Lost to Follow-up|0|||
33252931|NCT01212991|100827374|FG001|Open-label|Lost to Follow-up|0|||
33252932|NCT01212991|100827375|FG002|Open-label|Lost to Follow-up|5|||
33387899|NCT00565812|101306473|FG002|Overall Study|Sponsor Decision|1|||
33387900|NCT00565812|101306471|FG000|Overall Study|Domestic Reasons|7|||
33387901|NCT00565812|101306472|FG001|Overall Study|Domestic Reasons|1|||
33252933|NCT01212991|100827373|FG000|Open-label|Withdrawal by Subject|0|||
33252934|NCT01212991|100827374|FG001|Open-label|Withdrawal by Subject|0|||
33252935|NCT01212991|100827375|FG002|Open-label|Withdrawal by Subject|7|||
33252936|NCT01212991|100827373|FG000|Open-label|Sponsor decision|0|||
33252937|NCT01212991|100827374|FG001|Open-label|Sponsor decision|0|||
33252938|NCT01212991|100827375|FG002|Open-label|Sponsor decision|53|||
33252939|NCT01212991|100827373|FG000|Open-label|Other|0|||
33252940|NCT01212991|100827374|FG001|Open-label|Other|0|||
33252941|NCT01212991|100827375|FG002|Open-label|Other|3|||
33252942|NCT05355116|100827376|FG000|Overall Study|Withdrawal by Subject|2|||
33252943|NCT05001945|100827377|FG000|Overall Study|Adverse Event|0|||
33252944|NCT05001945|100827378|FG001|Overall Study|Adverse Event|0|||
33252945|NCT05001945|100827379|FG002|Overall Study|Adverse Event|0|||
33252946|NCT05001945|100827380|FG003|Overall Study|Adverse Event|1|||
33252947|NCT05001945|100827381|FG004|Overall Study|Adverse Event|0|||
33252948|NCT05001945|100827382|FG005|Overall Study|Adverse Event|0|||
33252949|NCT05001945|100827383|FG006|Overall Study|Adverse Event|0|||
33252950|NCT05001945|100827384|FG007|Overall Study|Adverse Event|0|||
33252951|NCT05001945|100827377|FG000|Overall Study|Lost to Follow-up|0|||
33252952|NCT05001945|100827378|FG001|Overall Study|Lost to Follow-up|1|||
33252953|NCT05001945|100827379|FG002|Overall Study|Lost to Follow-up|1|||
33252954|NCT05001945|100827380|FG003|Overall Study|Lost to Follow-up|2|||
33252955|NCT05001945|100827381|FG004|Overall Study|Lost to Follow-up|0|||
33252956|NCT05001945|100827382|FG005|Overall Study|Lost to Follow-up|1|||
33252957|NCT05001945|100827383|FG006|Overall Study|Lost to Follow-up|0|||
33252958|NCT05001945|100827384|FG007|Overall Study|Lost to Follow-up|0|||
33252959|NCT05001945|100827377|FG000|Overall Study|Protocol Violation|1|||
33252960|NCT05001945|100827378|FG001|Overall Study|Protocol Violation|0|||
33252961|NCT05001945|100827379|FG002|Overall Study|Protocol Violation|1|||
33252962|NCT05001945|100827380|FG003|Overall Study|Protocol Violation|1|||
33252963|NCT05001945|100827381|FG004|Overall Study|Protocol Violation|0|||
33252964|NCT05001945|100827382|FG005|Overall Study|Protocol Violation|1|||
33252965|NCT05001945|100827383|FG006|Overall Study|Protocol Violation|0|||
33252966|NCT05001945|100827384|FG007|Overall Study|Protocol Violation|0|||
33252967|NCT05001945|100827377|FG000|Overall Study|Withdrawal by Subject|0|||
33252968|NCT05001945|100827378|FG001|Overall Study|Withdrawal by Subject|0|||
33252969|NCT05001945|100827379|FG002|Overall Study|Withdrawal by Subject|0|||
33252970|NCT05001945|100827380|FG003|Overall Study|Withdrawal by Subject|1|||
33252971|NCT05001945|100827381|FG004|Overall Study|Withdrawal by Subject|1|||
33252972|NCT05001945|100827382|FG005|Overall Study|Withdrawal by Subject|1|||
33252973|NCT05001945|100827383|FG006|Overall Study|Withdrawal by Subject|0|||
33252974|NCT05001945|100827384|FG007|Overall Study|Withdrawal by Subject|1|||
33252975|NCT05001945|100827377|FG000|Overall Study|Not specified by Investigator|0|||
33252976|NCT05001945|100827378|FG001|Overall Study|Not specified by Investigator|3|||
33252977|NCT05001945|100827379|FG002|Overall Study|Not specified by Investigator|0|||
33252978|NCT05001945|100827380|FG003|Overall Study|Not specified by Investigator|0|||
33252979|NCT05001945|100827381|FG004|Overall Study|Not specified by Investigator|1|||
33252980|NCT05001945|100827382|FG005|Overall Study|Not specified by Investigator|0|||
33252981|NCT05001945|100827383|FG006|Overall Study|Not specified by Investigator|0|||
33252982|NCT05001945|100827384|FG007|Overall Study|Not specified by Investigator|0|||
33252983|NCT00855465|100827385|FG000|Treatment Period|Adverse Event|4|||
33252984|NCT00855465|100827386|FG001|Treatment Period|Adverse Event|2|||
33156067|NCT03917459|100485466|FG001|Overall Study|Adverse Event|0|||
33252985|NCT00855465|100827385|FG000|Treatment Period|Death|2|||
33252986|NCT00855465|100827386|FG001|Treatment Period|Death|2|||
33252987|NCT00855465|100827385|FG000|Treatment Period|Lack of Efficacy|2|||
33252988|NCT00855465|100827386|FG001|Treatment Period|Lack of Efficacy|1|||
33252989|NCT00855465|100827385|FG000|Treatment Period|Non-compliance|1|||
33252990|NCT00855465|100827386|FG001|Treatment Period|Non-compliance|0|||
33252991|NCT00855465|100827385|FG000|Treatment Period|Protocol Violation|2|||
33252992|NCT00855465|100827386|FG001|Treatment Period|Protocol Violation|0|||
33252993|NCT00855465|100827385|FG000|Treatment Period|Withdrawal by Subject|2|||
33252994|NCT00855465|100827386|FG001|Treatment Period|Withdrawal by Subject|0|||
33252995|NCT00855465|100827385|FG000|Treatment Period|Not treated|1|||
33252996|NCT00855465|100827386|FG001|Treatment Period|Not treated|0|||
33252997|NCT00855465|100827385|FG000|Follow-up Period (FUP)|Adverse Event|0|||
33252998|NCT00855465|100827386|FG001|Follow-up Period (FUP)|Adverse Event|1|||
33252999|NCT00855465|100827385|FG000|Follow-up Period (FUP)|Death|0|||
33253000|NCT00855465|100827386|FG001|Follow-up Period (FUP)|Death|1|||
33253001|NCT00855465|100827385|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
33253002|NCT00855465|100827386|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
33253003|NCT00855465|100827385|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
33253004|NCT00855465|100827386|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
33253005|NCT00855465|100827385|FG000|Follow-up Period (FUP)|Missing|1|||
33253006|NCT00855465|100827386|FG001|Follow-up Period (FUP)|Missing|0|||
33253007|NCT02950558|100827387|FG000|Overall Study|Lost to Follow-up|2|||
33253008|NCT02950558|100827388|FG001|Overall Study|Lost to Follow-up|0|||
33253009|NCT00420316|100827390|FG000|Overall Study|Withdrawal by Subject|0|||
33156068|NCT03917459|100485465|FG000|Overall Study|Withdrawal by Subject|0|||
33156069|NCT03917459|100485466|FG001|Overall Study|Withdrawal by Subject|1|||
33156070|NCT00074984|100485467|FG000|Overall Study|Death|1|||
33156071|NCT00074984|100485468|FG001|Overall Study|Death|2|||
33156072|NCT00074984|100485467|FG000|Overall Study|Withdrawal by Subject|2|||
33156073|NCT00074984|100485468|FG001|Overall Study|Withdrawal by Subject|3|||
33156074|NCT00074984|100485467|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
33156075|NCT00074984|100485468|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
33156076|NCT01611155|100485478|FG000|Overall Study|Adverse Event|1|||
33156077|NCT01611155|100485479|FG001|Overall Study|Adverse Event|1|||
33156078|NCT01611155|100485478|FG000|Overall Study|Refused further treatment|6|||
33156079|NCT01611155|100485479|FG001|Overall Study|Refused further treatment|4|||
33156080|NCT01611155|100485478|FG000|Overall Study|Disease progression|1|||
33156081|NCT01611155|100485479|FG001|Overall Study|Disease progression|0|||
33156082|NCT01611155|100485478|FG000|Overall Study|Withdrawal by Subject|1|||
33156083|NCT01611155|100485479|FG001|Overall Study|Withdrawal by Subject|0|||
33156084|NCT01611155|100485478|FG000|Overall Study|Alternative treatment|0|||
33156085|NCT01611155|100485479|FG001|Overall Study|Alternative treatment|1|||
33156086|NCT01611155|100485478|FG000|Overall Study|Ineligible patient|0|||
33156087|NCT01611155|100485479|FG001|Overall Study|Ineligible patient|1|||
33156088|NCT01328431|100485482|FG000|Baseline|Protocol Violation|0|||
33156089|NCT01328431|100485483|FG001|Baseline|Protocol Violation|2|||
33156090|NCT01328431|100485482|FG000|1 Month (1M)|Lost to Follow-up|55|||
33156091|NCT01328431|100485483|FG001|1 Month (1M)|Lost to Follow-up|58|||
33156092|NCT01328431|100485482|FG000|3 Month (3M)|Death|2|||
33156093|NCT01328431|100485483|FG001|3 Month (3M)|Death|2|||
33156094|NCT01328431|100485482|FG000|3 Month (3M)|Lost to Follow-up|75|||
33156095|NCT01328431|100485483|FG001|3 Month (3M)|Lost to Follow-up|70|||
33156096|NCT01328431|100485482|FG000|12 Month (12M)|Death|2|||
33156097|NCT01328431|100485483|FG001|12 Month (12M)|Death|6|||
33156098|NCT01328431|100485482|FG000|12 Month (12M)|Lost to Follow-up|82|||
33156099|NCT01328431|100485483|FG001|12 Month (12M)|Lost to Follow-up|91|||
33156100|NCT01980940|100485486|FG000|Overall Study|Protocol Violation|0|||
33156101|NCT01980940|100485487|FG001|Overall Study|Protocol Violation|0|||
33156102|NCT01980940|100485488|FG002|Overall Study|Protocol Violation|0|||
33156103|NCT01980940|100485489|FG003|Overall Study|Protocol Violation|0|||
33156104|NCT01980940|100485490|FG004|Overall Study|Protocol Violation|0|||
33156105|NCT01980940|100485491|FG005|Overall Study|Protocol Violation|2|||
33156106|NCT01980940|100485492|FG006|Overall Study|Protocol Violation|0|||
33156107|NCT01980940|100485493|FG007|Overall Study|Protocol Violation|0|||
33156108|NCT04806503|100485494|FG000|Overall Study|Lost to Follow-up|0|||
33156109|NCT04806503|100485495|FG001|Overall Study|Lost to Follow-up|0|||
33156110|NCT04806503|100485496|FG002|Overall Study|Lost to Follow-up|1|||
33253010|NCT00420316|100827391|FG001|Overall Study|Withdrawal by Subject|1|||
33253011|NCT00420316|100827390|FG000|Overall Study|Lost to Follow-up|12|||
33253012|NCT00420316|100827391|FG001|Overall Study|Lost to Follow-up|8|||
33253013|NCT03299816|100827392|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
33156111|NCT04806503|100485497|FG003|Overall Study|Lost to Follow-up|0|||
33156112|NCT04806503|100485498|FG004|Overall Study|Lost to Follow-up|0|||
33156113|NCT04806503|100485494|FG000|Overall Study|Withdrawal by Subject|1|||
33156114|NCT04806503|100485495|FG001|Overall Study|Withdrawal by Subject|0|||
33156115|NCT04806503|100485496|FG002|Overall Study|Withdrawal by Subject|1|||
33156116|NCT04806503|100485497|FG003|Overall Study|Withdrawal by Subject|1|||
33253014|NCT03299816|100827393|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
33253015|NCT03299816|100827392|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
33253016|NCT03299816|100827393|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
33253017|NCT03299816|100827392|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
33253018|NCT03299816|100827393|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
33253019|NCT05686421|100827394|FG000|Overall Study|Screen failure|22|||
33253020|NCT05686421|100827395|FG001|Overall Study|Screen failure|0|||
33253021|NCT05686421|100827396|FG002|Overall Study|Screen failure|0|||
33253022|NCT05686421|100827397|FG003|Overall Study|Screen failure|0|||
33253023|NCT00509769|100827398|FG000|Overall Study|Progressive disease|77|||
33253024|NCT00509769|100827398|FG000|Overall Study|Adverse Event|4|||
33253025|NCT00509769|100827398|FG000|Overall Study|Patient's decision|1|||
33253026|NCT00509769|100827398|FG000|Overall Study|Physician Decision|8|||
33253027|NCT00509769|100827398|FG000|Overall Study|Use of prohibited therapies during study|1|||
33253028|NCT01134562|100827399|FG000|Overall Study|Adverse Event|0|||
33253029|NCT01134562|100827400|FG001|Overall Study|Adverse Event|1|||
33253030|NCT01134562|100827401|FG002|Overall Study|Adverse Event|0|||
33253031|NCT01134562|100827402|FG003|Overall Study|Adverse Event|0|||
33253032|NCT01134562|100827403|FG004|Overall Study|Adverse Event|0|||
33253033|NCT00597519|100827404|FG000|Overall Study|Death|1|||
33253034|NCT00588666|100827405|FG000|Overall Study|Adverse Event|4|||
33253035|NCT00835380|100827406|FG000|Overall Study|Withdrawal by Subject|2|||
33156117|NCT04806503|100485498|FG004|Overall Study|Withdrawal by Subject|1|||
33156118|NCT04806503|100485494|FG000|Overall Study|Adverse Event|1|||
33156119|NCT04806503|100485495|FG001|Overall Study|Adverse Event|1|||
33156120|NCT04806503|100485496|FG002|Overall Study|Adverse Event|0|||
33156121|NCT04806503|100485497|FG003|Overall Study|Adverse Event|1|||
33156122|NCT04806503|100485498|FG004|Overall Study|Adverse Event|0|||
33156123|NCT03948581|100485499|FG000|Overall Study|Lost to Follow-up|0|||
33156124|NCT03948581|100485500|FG001|Overall Study|Lost to Follow-up|1|||
33156125|NCT00494299|100485501|FG000|Overall Study|Adverse Event|93|||
33156126|NCT00494299|100485502|FG001|Overall Study|Adverse Event|13|||
33156127|NCT00494299|100485501|FG000|Overall Study|Lost to Follow-up|1|||
33156128|NCT00494299|100485502|FG001|Overall Study|Lost to Follow-up|0|||
33156129|NCT00494299|100485501|FG000|Overall Study|Physician Decision|0|||
33156130|NCT00494299|100485502|FG001|Overall Study|Physician Decision|2|||
33156131|NCT00494299|100485501|FG000|Overall Study|Protocol Violation|1|||
33156132|NCT00494299|100485502|FG001|Overall Study|Protocol Violation|2|||
33156133|NCT00494299|100485501|FG000|Overall Study|Withdrawal by Subject|8|||
33156134|NCT00494299|100485502|FG001|Overall Study|Withdrawal by Subject|3|||
33156135|NCT00494299|100485501|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
33156136|NCT00494299|100485502|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
33156137|NCT00494299|100485501|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
33156138|NCT00494299|100485502|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
33156139|NCT00494299|100485501|FG000|Overall Study|Site Closed by Sponsor|6|||
33156140|NCT00494299|100485502|FG001|Overall Study|Site Closed by Sponsor|0|||
33156141|NCT00494299|100485501|FG000|Overall Study|Protocol Driven Decision Point|11|||
33156142|NCT00494299|100485502|FG001|Overall Study|Protocol Driven Decision Point|22|||
33156143|NCT03386474|100485503|FG000|Overall Study|Death|1|||
33156144|NCT03386474|100485504|FG001|Overall Study|Death|0|||
33156145|NCT03386474|100485503|FG000|Overall Study|Adverse Event|0|||
33156146|NCT03386474|100485504|FG001|Overall Study|Adverse Event|1|||
33156147|NCT00799422|100485505|FG000|First Week of Wear|Lost to Follow-up|0|||
33156148|NCT00799422|100485506|FG001|First Week of Wear|Lost to Follow-up|0|||
33156149|NCT00799422|100485507|FG002|First Week of Wear|Lost to Follow-up|1|||
33156150|NCT00799422|100485508|FG003|First Week of Wear|Lost to Follow-up|0|||
33156151|NCT00799422|100485509|FG004|First Week of Wear|Lost to Follow-up|0|||
33156152|NCT00799422|100485510|FG005|First Week of Wear|Lost to Follow-up|0|||
33156153|NCT00799422|100485505|FG000|First Week of Wear|Adverse Event|0|||
33156154|NCT00799422|100485506|FG001|First Week of Wear|Adverse Event|0|||
33156155|NCT00799422|100485507|FG002|First Week of Wear|Adverse Event|0|||
33156156|NCT00799422|100485508|FG003|First Week of Wear|Adverse Event|1|||
33156157|NCT00799422|100485509|FG004|First Week of Wear|Adverse Event|0|||
33156158|NCT00799422|100485510|FG005|First Week of Wear|Adverse Event|0|||
33156159|NCT01500031|100485511|FG000|Overall Study|Death|1|||
33156160|NCT01500031|100485511|FG000|Overall Study|Withdrawal by Subject|4|||
33156161|NCT01484275|100485527|FG000|Overall Study|Study terminated by sponsor|28|||
33253036|NCT02631148|100827407|FG000|Overall Study|8 were ineligible|8|||
33253037|NCT02631148|100827408|FG001|Overall Study|8 were ineligible|0|||
33253038|NCT02631148|100827407|FG000|Overall Study|Withdrawal by Subject|1|||
33253039|NCT02631148|100827408|FG001|Overall Study|Withdrawal by Subject|0|||
33253040|NCT02631148|100827407|FG000|Overall Study|PAH not available to study participant|1|||
33253041|NCT02631148|100827408|FG001|Overall Study|PAH not available to study participant|0|||
33253042|NCT00558363|100827409|FG000|Overall Study|Physician Decision|18|||
33253043|NCT00558363|100827410|FG001|Overall Study|Physician Decision|4|||
33156162|NCT01484275|100485528|FG001|Overall Study|Study terminated by sponsor|32|||
33156163|NCT01484275|100485527|FG000|Overall Study|Other|10|||
33156164|NCT01484275|100485528|FG001|Overall Study|Other|0|||
33156165|NCT01484275|100485527|FG000|Overall Study|Death|3|||
33156166|NCT01484275|100485528|FG001|Overall Study|Death|4|||
33156167|NCT01484275|100485527|FG000|Overall Study|Withdrawal by Subject|1|||
33156168|NCT01484275|100485528|FG001|Overall Study|Withdrawal by Subject|5|||
33156169|NCT01484275|100485527|FG000|Overall Study|Lost to Follow-up|1|||
33156170|NCT01484275|100485528|FG001|Overall Study|Lost to Follow-up|1|||
33156171|NCT00044083|100485533|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
33156172|NCT00044083|100485534|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
33156173|NCT00044083|100485533|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
33156174|NCT00044083|100485534|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
33156175|NCT00044083|100485533|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
33156176|NCT00044083|100485534|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
33156177|NCT00044083|100485533|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
33156178|NCT00044083|100485534|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
33156179|NCT00044083|100485533|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
33156180|NCT00044083|100485534|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
33156181|NCT00044083|100485533|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
33156182|NCT00044083|100485534|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
33156183|NCT00044083|100485533|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
33156184|NCT00044083|100485534|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
33156185|NCT00044083|100485533|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
33156186|NCT00044083|100485534|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
33156187|NCT00044083|100485533|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
33156188|NCT00044083|100485534|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
33156189|NCT00044083|100485533|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
33156190|NCT00044083|100485534|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
33156191|NCT00917501|100485536|FG000|Overall Study|Lost to Follow-up|4|||
33156192|NCT00917501|100485537|FG001|Overall Study|Lost to Follow-up|1|||
33156193|NCT00917501|100485536|FG000|Overall Study|Withdrawal by Subject|3|||
33156194|NCT00917501|100485537|FG001|Overall Study|Withdrawal by Subject|1|||
33156195|NCT00917501|100485536|FG000|Overall Study|Lack of Efficacy|1|||
33156196|NCT00917501|100485537|FG001|Overall Study|Lack of Efficacy|2|||
33156197|NCT00917501|100485536|FG000|Overall Study|trouble swollowing capsules|0|||
33156198|NCT00917501|100485537|FG001|Overall Study|trouble swollowing capsules|1|||
33156199|NCT02202837|100485538|FG000|Overall Study|Enbrel treatment discontinued|36|||
33156200|NCT02202837|100485539|FG001|Overall Study|Enbrel treatment discontinued|4|||
33156201|NCT02202837|100485538|FG000|Overall Study|Other|10|||
33156202|NCT02202837|100485539|FG001|Overall Study|Other|0|||
33156203|NCT02202837|100485538|FG000|Overall Study|Lost to Follow-up|7|||
33156204|NCT02202837|100485539|FG001|Overall Study|Lost to Follow-up|1|||
33156205|NCT00657358|100485540|FG000|Overall Study|Lack of Efficacy|6|||
33156206|NCT02716805|100485541|FG000|Overall Study|Progressive disease|2|||
33156207|NCT02716805|100485542|FG001|Overall Study|Progressive disease|0|||
33156208|NCT02716805|100485543|FG002|Overall Study|Progressive disease|0|||
33156209|NCT02716805|100485544|FG003|Overall Study|Progressive disease|0|||
33156210|NCT02229383|100485549|FG000|Overall Study|Adverse Event|7|||
33156211|NCT02229383|100485550|FG001|Overall Study|Adverse Event|4|||
33156212|NCT02229383|100485549|FG000|Overall Study|Death|0|||
33156213|NCT02229383|100485550|FG001|Overall Study|Death|1|||
33156214|NCT02229383|100485549|FG000|Overall Study|Lost to Follow-up|5|||
33156215|NCT02229383|100485550|FG001|Overall Study|Lost to Follow-up|3|||
33156216|NCT02229383|100485549|FG000|Overall Study|Withdrawal by Subject|4|||
33156217|NCT02229383|100485550|FG001|Overall Study|Withdrawal by Subject|6|||
33156218|NCT02229383|100485549|FG000|Overall Study|Did not receive treatment|1|||
33156219|NCT02229383|100485550|FG001|Overall Study|Did not receive treatment|0|||
33156220|NCT02229383|100485549|FG000|Overall Study|Other|3|||
33156221|NCT02229383|100485550|FG001|Overall Study|Other|8|||
33156222|NCT03650556|100485552|FG000|Overall Study|Death|2|||
33156223|NCT03650556|100485552|FG000|Overall Study|Withdrawal by Subject|20|||
33156224|NCT03650556|100485552|FG000|Overall Study|Physician Decision|2|||
33438556|NCT00677365|101499889|FG000|Overall Study|Withdrawal by Subject|0|||
33438557|NCT00677365|101499890|FG001|Overall Study|Withdrawal by Subject|0|||
33438558|NCT00677365|101499891|FG002|Overall Study|Withdrawal by Subject|1|||
33438559|NCT00677365|101499892|FG003|Overall Study|Withdrawal by Subject|0|||
33438560|NCT00677365|101499889|FG000|Overall Study|Other reason|0|||
33438561|NCT00677365|101499890|FG001|Overall Study|Other reason|0|||
33438562|NCT00677365|101499891|FG002|Overall Study|Other reason|0|||
33156225|NCT03650556|100485552|FG000|Overall Study|Lost to Follow-up|8|||
33156226|NCT03650556|100485552|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
33156227|NCT03650556|100485552|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
33156228|NCT04638660|100485553|FG000|Overall Study|Withdrawal by Subject|2|||
33156229|NCT04638660|100485554|FG001|Overall Study|Withdrawal by Subject|0|||
33156230|NCT04638660|100485553|FG000|Overall Study|Lost to Follow-up|1|||
33156231|NCT04638660|100485554|FG001|Overall Study|Lost to Follow-up|0|||
33438563|NCT00677365|101499892|FG003|Overall Study|Other reason|1|||
33438564|NCT01044732|101499899|FG000|Overall Study|Lost to Follow-up|2|||
33156232|NCT01031381|100485555|FG000|Overall Study|Physician Decision|3|||
33156233|NCT01031381|100485555|FG000|Overall Study|Withdrawal by Subject|6|||
33156234|NCT02128932|100485556|FG000|Overall Study|Withdrawal by Subject|11|||
33156235|NCT02128932|100485557|FG001|Overall Study|Withdrawal by Subject|7|||
33156236|NCT02128932|100485558|FG002|Overall Study|Withdrawal by Subject|8|||
33156237|NCT02128932|100485556|FG000|Overall Study|Death|2|||
33156238|NCT02128932|100485557|FG001|Overall Study|Death|0|||
33156239|NCT02128932|100485558|FG002|Overall Study|Death|2|||
33156240|NCT02128932|100485556|FG000|Overall Study|Lost to Follow-up|2|||
33156241|NCT02128932|100485557|FG001|Overall Study|Lost to Follow-up|1|||
33156242|NCT02128932|100485558|FG002|Overall Study|Lost to Follow-up|1|||
33438565|NCT01044732|101499900|FG001|Overall Study|Lost to Follow-up|1|||
33438566|NCT01044732|101499899|FG000|Overall Study|Physician Decision|5|||
33156243|NCT02128932|100485556|FG000|Overall Study|No reason for withdrawal|12|||
33156244|NCT02128932|100485557|FG001|Overall Study|No reason for withdrawal|11|||
33438567|NCT01044732|101499900|FG001|Overall Study|Physician Decision|3|||
33438568|NCT01044732|101499899|FG000|Overall Study|Protocol Violation|11|||
33156245|NCT02128932|100485558|FG002|Overall Study|No reason for withdrawal|7|||
33156246|NCT00165984|100485561|FG000|Overall Study|Death|15|||
33156247|NCT00785928|100485562|FG000|Treatment Phase|Adverse Event|1|||
33156248|NCT00785928|100485563|FG001|Treatment Phase|Adverse Event|1|||
33156249|NCT00785928|100485564|FG002|Treatment Phase|Adverse Event|2|||
33156250|NCT00785928|100485565|FG003|Treatment Phase|Adverse Event|0|||
33156251|NCT00785928|100485566|FG004|Treatment Phase|Adverse Event|0|||
33156252|NCT00785928|100485567|FG005|Treatment Phase|Adverse Event|0|||
33156253|NCT00785928|100485568|FG006|Treatment Phase|Adverse Event|2|||
33253044|NCT00558363|100827409|FG000|Overall Study|Withdrawal by Subject|11|||
33253045|NCT00558363|100827410|FG001|Overall Study|Withdrawal by Subject|4|||
33253046|NCT00558363|100827409|FG000|Overall Study|Adverse Event|5|||
33438569|NCT01044732|101499900|FG001|Overall Study|Protocol Violation|12|||
33438570|NCT01044732|101499899|FG000|Overall Study|Withdrawal by Subject|0|||
33438571|NCT01044732|101499900|FG001|Overall Study|Withdrawal by Subject|1|||
33438572|NCT01044732|101499899|FG000|Overall Study|Inadequate bowel preparation|11|||
33438573|NCT01044732|101499900|FG001|Overall Study|Inadequate bowel preparation|17|||
33438574|NCT01044732|101499899|FG000|Overall Study|Inability to reach cecum|5|||
33438575|NCT01044732|101499900|FG001|Overall Study|Inability to reach cecum|2|||
33438576|NCT01044732|101499899|FG000|Overall Study|Technical error or malfunction|15|||
33438577|NCT01044732|101499900|FG001|Overall Study|Technical error or malfunction|14|||
33438578|NCT01126736|101499901|FG000|Overall Study|Death|2|||
33438579|NCT01126736|101499902|FG001|Overall Study|Death|2|||
33438580|NCT01126736|101499903|FG002|Overall Study|Death|1|||
33438581|NCT01126736|101499904|FG003|Overall Study|Death|19|||
33156254|NCT00785928|100485562|FG000|Treatment Phase|Inadequate Response|0|||
33253047|NCT00558363|100827410|FG001|Overall Study|Adverse Event|5|||
33253048|NCT00558363|100827409|FG000|Overall Study|Lack of Efficacy|2|||
33253049|NCT00558363|100827410|FG001|Overall Study|Lack of Efficacy|2|||
33253050|NCT00558363|100827409|FG000|Overall Study|Protocol Violation|2|||
33253051|NCT00558363|100827410|FG001|Overall Study|Protocol Violation|1|||
33387902|NCT00565812|101306473|FG002|Overall Study|Domestic Reasons|3|||
33387903|NCT00565812|101306471|FG000|Overall Study|Research Site Closure|6|||
33387904|NCT00565812|101306472|FG001|Overall Study|Research Site Closure|1|||
33387905|NCT00565812|101306473|FG002|Overall Study|Research Site Closure|8|||
33387906|NCT00565812|101306471|FG000|Overall Study|Surgical Intervention|0|||
33387907|NCT00565812|101306472|FG001|Overall Study|Surgical Intervention|1|||
33387908|NCT00565812|101306473|FG002|Overall Study|Surgical Intervention|2|||
33387909|NCT00565812|101306471|FG000|Overall Study|Low Compliance|1|||
33387910|NCT00565812|101306472|FG001|Overall Study|Low Compliance|0|||
33387911|NCT00565812|101306473|FG002|Overall Study|Low Compliance|1|||
33387912|NCT00565812|101306471|FG000|Overall Study|Follow-up Visit Not Completed|2|||
33387913|NCT00565812|101306472|FG001|Overall Study|Follow-up Visit Not Completed|0|||
33387914|NCT00565812|101306473|FG002|Overall Study|Follow-up Visit Not Completed|1|||
33387915|NCT00565812|101306471|FG000|Overall Study|Physician Decision|2|||
33387916|NCT00565812|101306472|FG001|Overall Study|Physician Decision|0|||
33387917|NCT00565812|101306473|FG002|Overall Study|Physician Decision|0|||
33387918|NCT02337686|101306475|FG000|Overall Study|Adverse Event|1|||
33387919|NCT04423757|101306488|FG000|Overall Study|Adverse Event|2|||
33387920|NCT04423757|101306489|FG001|Overall Study|Adverse Event|0|||
33387921|NCT04423757|101306488|FG000|Overall Study|Not treated|1|||
33387922|NCT04423757|101306489|FG001|Overall Study|Not treated|1|||
33387923|NCT00424346|101306490|FG000|Core Study|Adverse Event|5|||
33387924|NCT00424346|101306491|FG001|Core Study|Adverse Event|3|||
33387925|NCT00424346|101306492|FG002|Core Study|Adverse Event|1|||
33387926|NCT00424346|101306493|FG003|Core Study|Adverse Event|1|||
33387927|NCT00424346|101306490|FG000|Core Study|Abnormal Laboratory Values|0|||
33387928|NCT00424346|101306491|FG001|Core Study|Abnormal Laboratory Values|1|||
33387929|NCT00424346|101306492|FG002|Core Study|Abnormal Laboratory Values|0|||
33387930|NCT00424346|101306493|FG003|Core Study|Abnormal Laboratory Values|0|||
33387931|NCT00424346|101306490|FG000|Core Study|Lack of Efficacy|1|||
33438582|NCT01126736|101499905|FG004|Overall Study|Death|19|||
33253052|NCT00558363|100827409|FG000|Overall Study|Lost to Follow-up|0|||
33253053|NCT00558363|100827410|FG001|Overall Study|Lost to Follow-up|1|||
33253054|NCT00558363|100827409|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
33253055|NCT00558363|100827410|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
33253056|NCT00558363|100827409|FG000|Overall Study|Randomized in Error|1|||
33438583|NCT01126736|101499901|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
33438584|NCT01126736|101499902|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
33438585|NCT01126736|101499903|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
33156255|NCT00785928|100485563|FG001|Treatment Phase|Inadequate Response|1|||
33253057|NCT00558363|100827410|FG001|Overall Study|Randomized in Error|2|||
33387932|NCT00424346|101306491|FG001|Core Study|Lack of Efficacy|3|||
33387933|NCT00424346|101306492|FG002|Core Study|Lack of Efficacy|0|||
33387934|NCT00424346|101306493|FG003|Core Study|Lack of Efficacy|4|||
33387935|NCT00424346|101306490|FG000|Core Study|Withdrawal by Subject|1|||
33387936|NCT00424346|101306491|FG001|Core Study|Withdrawal by Subject|0|||
33387937|NCT00424346|101306492|FG002|Core Study|Withdrawal by Subject|0|||
33438586|NCT01126736|101499904|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
33438587|NCT01126736|101499905|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
33438588|NCT01126736|101499901|FG000|Overall Study|Lost to Follow-up|0|||
33438589|NCT01126736|101499902|FG001|Overall Study|Lost to Follow-up|0|||
33438590|NCT01126736|101499903|FG002|Overall Study|Lost to Follow-up|0|||
33438591|NCT01126736|101499904|FG003|Overall Study|Lost to Follow-up|1|||
33438592|NCT01126736|101499905|FG004|Overall Study|Lost to Follow-up|1|||
33438593|NCT01126736|101499901|FG000|Overall Study|Administrative reasons|0|||
33438594|NCT01126736|101499902|FG001|Overall Study|Administrative reasons|0|||
33438595|NCT01126736|101499903|FG002|Overall Study|Administrative reasons|0|||
33438596|NCT01126736|101499904|FG003|Overall Study|Administrative reasons|0|||
33438597|NCT01126736|101499905|FG004|Overall Study|Administrative reasons|1|||
33253058|NCT00558363|100827409|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
33253059|NCT00558363|100827410|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
33438598|NCT01126736|101499901|FG000|Overall Study|Progressive disease|0|||
33438599|NCT01126736|101499902|FG001|Overall Study|Progressive disease|0|||
33438600|NCT01126736|101499903|FG002|Overall Study|Progressive disease|0|||
33438601|NCT01126736|101499904|FG003|Overall Study|Progressive disease|2|||
33438602|NCT01126736|101499905|FG004|Overall Study|Progressive disease|1|||
33438603|NCT01126736|101499901|FG000|Overall Study|Withdrawal by Subject|0|||
33438604|NCT01126736|101499902|FG001|Overall Study|Withdrawal by Subject|0|||
33438605|NCT01126736|101499903|FG002|Overall Study|Withdrawal by Subject|0|||
33438606|NCT01126736|101499904|FG003|Overall Study|Withdrawal by Subject|1|||
33438607|NCT01126736|101499905|FG004|Overall Study|Withdrawal by Subject|1|||
33438608|NCT01126736|101499901|FG000|Overall Study|Other|2|||
33438609|NCT01126736|101499902|FG001|Overall Study|Other|4|||
33438610|NCT01126736|101499903|FG002|Overall Study|Other|4|||
33438611|NCT01126736|101499904|FG003|Overall Study|Other|16|||
33438612|NCT01126736|101499905|FG004|Overall Study|Other|15|||
33438613|NCT03048500|101499906|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
33387938|NCT00424346|101306493|FG003|Core Study|Withdrawal by Subject|2|||
33387939|NCT00424346|101306490|FG000|Core Study|Lost to Follow-up|1|||
33387940|NCT00424346|101306491|FG001|Core Study|Lost to Follow-up|1|||
33387941|NCT00424346|101306492|FG002|Core Study|Lost to Follow-up|0|||
33387942|NCT00424346|101306493|FG003|Core Study|Lost to Follow-up|0|||
33387943|NCT00424346|101306490|FG000|Core Study|Administrative Problems|1|||
33387944|NCT00424346|101306491|FG001|Core Study|Administrative Problems|0|||
33387945|NCT00424346|101306492|FG002|Core Study|Administrative Problems|1|||
33387946|NCT00424346|101306493|FG003|Core Study|Administrative Problems|0|||
33387947|NCT00424346|101306490|FG000|Core Study|Protocol Violation|0|||
33438614|NCT03048500|101499906|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
33438615|NCT03048500|101499906|FG000|Reached 1st Response/Continued Treatment|Death|1|||
33438616|NCT03048500|101499906|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
33438617|NCT03048500|101499906|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
33438618|NCT03048500|101499906|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
33438619|NCT03048500|101499906|FG000|Follow up for 3 Years|Death|12|||
33438620|NCT00728949|101499907|FG000|Overall Study|Adverse Event|8|||
33438621|NCT00728949|101499908|FG001|Overall Study|Adverse Event|0|||
33438622|NCT00728949|101499907|FG000|Overall Study|Withdrawal by Subject|2|||
33438623|NCT00728949|101499908|FG001|Overall Study|Withdrawal by Subject|2|||
33438624|NCT00728949|101499907|FG000|Overall Study|Abnormal Lab Results|0|||
33438625|NCT00728949|101499908|FG001|Overall Study|Abnormal Lab Results|2|||
33438626|NCT00728949|101499907|FG000|Overall Study|On treatment at cutoff date|1|||
33438627|NCT00728949|101499908|FG001|Overall Study|On treatment at cutoff date|0|||
33438628|NCT03401112|101499909|FG000|Overall Study|Adverse Event|1|||
33438629|NCT03401112|101499910|FG001|Overall Study|Adverse Event|2|||
33438630|NCT03401112|101499911|FG002|Overall Study|Adverse Event|3|||
33438631|NCT03401112|101499912|FG003|Overall Study|Adverse Event|2|||
33387948|NCT00424346|101306491|FG001|Core Study|Protocol Violation|0|||
33387949|NCT00424346|101306492|FG002|Core Study|Protocol Violation|2|||
33438632|NCT03401112|101499913|FG004|Overall Study|Adverse Event|0|||
33438633|NCT03401112|101499909|FG000|Overall Study|Lost to Follow-up|1|||
33253060|NCT01692730|100827413|FG000|Overall Study|Lost to Follow-up|225|||
33253061|NCT01692730|100827414|FG001|Overall Study|Lost to Follow-up|227|||
33253062|NCT00753012|100827416|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
33387950|NCT00424346|101306493|FG003|Core Study|Protocol Violation|0|||
33387951|NCT00424346|101306490|FG000|Extension Phase|Adverse Event|0|||
33387952|NCT00424346|101306491|FG001|Extension Phase|Adverse Event|9|||
33438634|NCT03401112|101499910|FG001|Overall Study|Lost to Follow-up|0|||
33438635|NCT03401112|101499911|FG002|Overall Study|Lost to Follow-up|0|||
33438636|NCT03401112|101499912|FG003|Overall Study|Lost to Follow-up|0|||
33438637|NCT03401112|101499913|FG004|Overall Study|Lost to Follow-up|0|||
33438638|NCT03401112|101499909|FG000|Overall Study|Noncompliance|1|||
33438639|NCT03401112|101499910|FG001|Overall Study|Noncompliance|2|||
33387953|NCT00424346|101306492|FG002|Extension Phase|Adverse Event|5|||
33438640|NCT03401112|101499911|FG002|Overall Study|Noncompliance|3|||
33387954|NCT00424346|101306493|FG003|Extension Phase|Adverse Event|4|||
33438641|NCT03401112|101499912|FG003|Overall Study|Noncompliance|0|||
33438642|NCT03401112|101499913|FG004|Overall Study|Noncompliance|0|||
33438643|NCT03401112|101499909|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
33438644|NCT03401112|101499910|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
33438645|NCT03401112|101499911|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
33438646|NCT03401112|101499912|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
33438647|NCT03401112|101499913|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
33438648|NCT03401112|101499909|FG000|Overall Study|Withdrawal by Subject|0|||
33438649|NCT03401112|101499910|FG001|Overall Study|Withdrawal by Subject|3|||
33438650|NCT03401112|101499911|FG002|Overall Study|Withdrawal by Subject|2|||
33438651|NCT03401112|101499912|FG003|Overall Study|Withdrawal by Subject|1|||
33438652|NCT03401112|101499913|FG004|Overall Study|Withdrawal by Subject|0|||
33438653|NCT03401112|101499909|FG000|Overall Study|Physician Decision|0|||
33438654|NCT03401112|101499910|FG001|Overall Study|Physician Decision|0|||
33438655|NCT03401112|101499911|FG002|Overall Study|Physician Decision|0|||
33438656|NCT03401112|101499912|FG003|Overall Study|Physician Decision|2|||
33387955|NCT00424346|101306490|FG000|Extension Phase|Lack of Efficacy|0|||
33387956|NCT00424346|101306491|FG001|Extension Phase|Lack of Efficacy|16|||
33438657|NCT03401112|101499913|FG004|Overall Study|Physician Decision|0|||
33438658|NCT03401112|101499909|FG000|Overall Study|Study was Terminated by Sponsor|0|||
33438659|NCT03401112|101499910|FG001|Overall Study|Study was Terminated by Sponsor|0|||
33438660|NCT03401112|101499911|FG002|Overall Study|Study was Terminated by Sponsor|0|||
33438661|NCT03401112|101499912|FG003|Overall Study|Study was Terminated by Sponsor|1|||
33438662|NCT03401112|101499913|FG004|Overall Study|Study was Terminated by Sponsor|0|||
33438663|NCT03401112|101499909|FG000|Overall Study|Day 1 Assessment not Done|1|||
33438664|NCT03401112|101499910|FG001|Overall Study|Day 1 Assessment not Done|0|||
33438665|NCT03401112|101499911|FG002|Overall Study|Day 1 Assessment not Done|0|||
33438666|NCT03401112|101499912|FG003|Overall Study|Day 1 Assessment not Done|0|||
33387957|NCT00424346|101306492|FG002|Extension Phase|Lack of Efficacy|14|||
33387958|NCT00424346|101306493|FG003|Extension Phase|Lack of Efficacy|11|||
33387959|NCT00424346|101306490|FG000|Extension Phase|Withdrawal by Subject|0|||
33387960|NCT00424346|101306491|FG001|Extension Phase|Withdrawal by Subject|5|||
33387961|NCT00424346|101306492|FG002|Extension Phase|Withdrawal by Subject|3|||
33387962|NCT00424346|101306493|FG003|Extension Phase|Withdrawal by Subject|4|||
33387963|NCT00424346|101306490|FG000|Extension Phase|Lost to Follow-up|0|||
33387964|NCT00424346|101306491|FG001|Extension Phase|Lost to Follow-up|2|||
33387965|NCT00424346|101306492|FG002|Extension Phase|Lost to Follow-up|0|||
33387966|NCT00424346|101306493|FG003|Extension Phase|Lost to Follow-up|0|||
33438667|NCT03401112|101499913|FG004|Overall Study|Day 1 Assessment not Done|0|||
33438668|NCT03401112|101499909|FG000|Overall Study|Not Dosed|0|||
33438669|NCT03401112|101499910|FG001|Overall Study|Not Dosed|0|||
33438670|NCT03401112|101499911|FG002|Overall Study|Not Dosed|1|||
33438671|NCT03401112|101499912|FG003|Overall Study|Not Dosed|0|||
33438672|NCT03401112|101499913|FG004|Overall Study|Not Dosed|0|||
33438673|NCT03401112|101499909|FG000|Overall Study|Missed Clinical Visit|0|||
33438674|NCT03401112|101499910|FG001|Overall Study|Missed Clinical Visit|0|||
33438675|NCT03401112|101499911|FG002|Overall Study|Missed Clinical Visit|1|||
33438676|NCT03401112|101499912|FG003|Overall Study|Missed Clinical Visit|0|||
33438677|NCT03401112|101499913|FG004|Overall Study|Missed Clinical Visit|0|||
33438678|NCT03401112|101499909|FG000|Overall Study|Missed Doses|0|||
33438679|NCT03401112|101499910|FG001|Overall Study|Missed Doses|0|||
33438680|NCT03401112|101499911|FG002|Overall Study|Missed Doses|1|||
33438681|NCT03401112|101499912|FG003|Overall Study|Missed Doses|0|||
33438682|NCT03401112|101499913|FG004|Overall Study|Missed Doses|0|||
33438683|NCT02097290|101499914|FG000|Overall Study|Death|6|||
33438684|NCT02097290|101499914|FG000|Overall Study|Total Withdrawals|3|||
33156256|NCT00785928|100485564|FG002|Treatment Phase|Inadequate Response|0|||
33387967|NCT00424346|101306490|FG000|Extension Phase|Administrative Problems|0|||
33438685|NCT02097290|101499914|FG000|Overall Study|Attempt|8|||
33438686|NCT00463606|101499915|FG000|Overall Study|Adverse Event|21|||
33438687|NCT00463606|101499916|FG001|Overall Study|Adverse Event|18|||
33438688|NCT00463606|101499917|FG002|Overall Study|Adverse Event|11|||
33438689|NCT00463606|101499915|FG000|Overall Study|Withdrawal by Subject|11|||
33438690|NCT00463606|101499916|FG001|Overall Study|Withdrawal by Subject|11|||
33438691|NCT00463606|101499917|FG002|Overall Study|Withdrawal by Subject|5|||
33438692|NCT00463606|101499915|FG000|Overall Study|Lost to Follow-up|2|||
33438693|NCT00463606|101499916|FG001|Overall Study|Lost to Follow-up|2|||
33438694|NCT00463606|101499917|FG002|Overall Study|Lost to Follow-up|3|||
33387968|NCT00424346|101306491|FG001|Extension Phase|Administrative Problems|69|||
33438695|NCT00463606|101499915|FG000|Overall Study|Subject noncompliance|1|||
33438696|NCT00463606|101499916|FG001|Overall Study|Subject noncompliance|1|||
33438697|NCT00463606|101499917|FG002|Overall Study|Subject noncompliance|0|||
33438698|NCT00463606|101499915|FG000|Overall Study|Subject moved out of town|1|||
33438699|NCT00463606|101499916|FG001|Overall Study|Subject moved out of town|0|||
33438700|NCT00463606|101499917|FG002|Overall Study|Subject moved out of town|0|||
33438701|NCT00463606|101499915|FG000|Overall Study|Physician Decision|0|||
33438702|NCT00463606|101499916|FG001|Overall Study|Physician Decision|1|||
33438703|NCT00463606|101499917|FG002|Overall Study|Physician Decision|0|||
33438704|NCT00463606|101499915|FG000|Overall Study|Sponsor request|0|||
33438705|NCT00463606|101499916|FG001|Overall Study|Sponsor request|1|||
33438706|NCT00463606|101499917|FG002|Overall Study|Sponsor request|0|||
33438707|NCT00463606|101499915|FG000|Overall Study|Exclusion criteria violation|2|||
33438708|NCT00463606|101499916|FG001|Overall Study|Exclusion criteria violation|0|||
33438709|NCT00463606|101499917|FG002|Overall Study|Exclusion criteria violation|0|||
33438710|NCT00463606|101499915|FG000|Overall Study|Coordinator error|1|||
33438711|NCT00463606|101499916|FG001|Overall Study|Coordinator error|0|||
33438712|NCT00463606|101499917|FG002|Overall Study|Coordinator error|0|||
33438713|NCT00463606|101499915|FG000|Overall Study|Patient randomized in error|1|||
33438714|NCT00463606|101499916|FG001|Overall Study|Patient randomized in error|0|||
33438715|NCT00463606|101499917|FG002|Overall Study|Patient randomized in error|0|||
33438716|NCT00463606|101499915|FG000|Overall Study|Participation in another ABT-335 trial|1|||
33438717|NCT00463606|101499916|FG001|Overall Study|Participation in another ABT-335 trial|0|||
33438718|NCT00463606|101499917|FG002|Overall Study|Participation in another ABT-335 trial|0|||
33438719|NCT00463606|101499915|FG000|Overall Study|Protocol Violation|0|||
33438720|NCT00463606|101499916|FG001|Overall Study|Protocol Violation|0|||
33438721|NCT00463606|101499917|FG002|Overall Study|Protocol Violation|1|||
33438722|NCT02480764|101499922|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
33438723|NCT02480764|101499923|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
33438724|NCT02480764|101499924|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
33438725|NCT02480764|101499922|FG000|Overall Study|Major Protocol Deviation|1|||
33438726|NCT02480764|101499923|FG001|Overall Study|Major Protocol Deviation|4|||
33438727|NCT02480764|101499924|FG002|Overall Study|Major Protocol Deviation|3|||
33438728|NCT02480764|101499922|FG000|Overall Study|Lost to Follow-up|0|||
33438729|NCT02480764|101499923|FG001|Overall Study|Lost to Follow-up|1|||
33438730|NCT02480764|101499924|FG002|Overall Study|Lost to Follow-up|2|||
33438731|NCT02480764|101499922|FG000|Overall Study|Voluntary Withdrawal|6|||
33438732|NCT02480764|101499923|FG001|Overall Study|Voluntary Withdrawal|5|||
33438733|NCT02480764|101499924|FG002|Overall Study|Voluntary Withdrawal|10|||
33438734|NCT02480764|101499922|FG000|Overall Study|Lack of Efficacy|0|||
33438735|NCT02480764|101499923|FG001|Overall Study|Lack of Efficacy|3|||
33438736|NCT02480764|101499924|FG002|Overall Study|Lack of Efficacy|3|||
33438737|NCT02480764|101499922|FG000|Overall Study|Reason not Specified|0|||
33438738|NCT02480764|101499923|FG001|Overall Study|Reason not Specified|1|||
33438739|NCT02480764|101499924|FG002|Overall Study|Reason not Specified|0|||
33438740|NCT01199861|101499925|FG000|Overall Study|Administrative problems|1|||
33438741|NCT01199861|101499926|FG001|Overall Study|Administrative problems|0|||
33438742|NCT01199861|101499925|FG000|Overall Study|Adverse Event|1|||
33438743|NCT01199861|101499926|FG001|Overall Study|Adverse Event|0|||
33438744|NCT01919190|101499929|FG000|Overall Study|Intra-op findings, etc.|3|||
33438745|NCT01919190|101499930|FG001|Overall Study|Intra-op findings, etc.|0|||
33438746|NCT04638153|101499931|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33438747|NCT04638153|101499932|FG001|Overall Study|Withdrawal by parent/guardian|0|||
33438748|NCT04638153|101499933|FG002|Overall Study|Withdrawal by parent/guardian|1|||
33438749|NCT04638153|101499931|FG000|Overall Study|Study terminated by sponsor|4|||
33438750|NCT04638153|101499932|FG001|Overall Study|Study terminated by sponsor|2|||
33438751|NCT04638153|101499933|FG002|Overall Study|Study terminated by sponsor|14|||
33438752|NCT01720264|101499936|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
33438753|NCT01720264|101499936|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
33438754|NCT01720264|101499936|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
33438755|NCT01626079|101499941|FG000|Overall Study|Death|167|||
33438756|NCT01626079|101499942|FG001|Overall Study|Death|192|||
33438757|NCT01626079|101499943|FG002|Overall Study|Death|39|||
33438758|NCT01626079|101499941|FG000|Overall Study|Withdrawal by Subject|23|||
33438759|NCT01626079|101499942|FG001|Overall Study|Withdrawal by Subject|37|||
33438760|NCT01626079|101499943|FG002|Overall Study|Withdrawal by Subject|5|||
33438761|NCT01626079|101499941|FG000|Overall Study|Lost to Follow-up|7|||
33438762|NCT01626079|101499942|FG001|Overall Study|Lost to Follow-up|4|||
33438763|NCT01626079|101499943|FG002|Overall Study|Lost to Follow-up|2|||
33438764|NCT01626079|101499941|FG000|Overall Study|Missed Visits|1|||
33438765|NCT01626079|101499942|FG001|Overall Study|Missed Visits|4|||
33438766|NCT01626079|101499943|FG002|Overall Study|Missed Visits|6|||
33438767|NCT01494506|101499944|FG000|Overall Study|Lack of Efficacy|77|||
33387969|NCT00424346|101306492|FG002|Extension Phase|Administrative Problems|32|||
33387970|NCT00424346|101306493|FG003|Extension Phase|Administrative Problems|35|||
33387971|NCT00424346|101306490|FG000|Extension Phase|Death|0|||
33387972|NCT00424346|101306491|FG001|Extension Phase|Death|0|||
33387973|NCT00424346|101306492|FG002|Extension Phase|Death|0|||
33387974|NCT00424346|101306493|FG003|Extension Phase|Death|1|||
33387975|NCT00424346|101306490|FG000|Extension Phase|Protocol Violation|0|||
33387976|NCT00424346|101306491|FG001|Extension Phase|Protocol Violation|1|||
33387977|NCT00424346|101306492|FG002|Extension Phase|Protocol Violation|1|||
33387978|NCT00424346|101306493|FG003|Extension Phase|Protocol Violation|0|||
33387979|NCT01146951|101306494|FG000|Overall Study|Adverse Event|4|||
33387980|NCT01146951|101306495|FG001|Overall Study|Adverse Event|1|||
33387981|NCT02988219|101306499|FG000|Overall Study|Lack of Efficacy|1|||
33387982|NCT02988219|101306500|FG001|Overall Study|Lack of Efficacy|1|||
33387983|NCT02988219|101306499|FG000|Overall Study|Withdrawal by Subject|0|||
33387984|NCT02988219|101306500|FG001|Overall Study|Withdrawal by Subject|2|||
33387985|NCT01000025|101309062|FG000|Overall Study|Adverse Event|43|||
33387986|NCT01000025|101309063|FG001|Overall Study|Adverse Event|2|||
33387987|NCT01000025|101309062|FG000|Overall Study|Withdrawal by Subject|13|||
33387988|NCT01000025|101309063|FG001|Overall Study|Withdrawal by Subject|8|||
33387989|NCT01000025|101309062|FG000|Overall Study|Death|23|||
33387990|NCT01000025|101309063|FG001|Overall Study|Death|13|||
33387991|NCT01000025|101309062|FG000|Overall Study|Lack of Efficacy|363|||
33387992|NCT01000025|101309063|FG001|Overall Study|Lack of Efficacy|208|||
33387993|NCT01000025|101309062|FG000|Overall Study|Intercurrent Illness|26|||
33387994|NCT01000025|101309063|FG001|Overall Study|Intercurrent Illness|7|||
33387995|NCT01590212|101309064|FG000|Overall Study|Withdrawal by Subject|2|||
33387996|NCT01590212|101309065|FG001|Overall Study|Withdrawal by Subject|2|||
33387997|NCT01590212|101309066|FG002|Overall Study|Withdrawal by Subject|2|||
33387998|NCT01590212|101309064|FG000|Overall Study|Lost to Follow-up|1|||
33387999|NCT01590212|101309065|FG001|Overall Study|Lost to Follow-up|2|||
33388000|NCT01590212|101309066|FG002|Overall Study|Lost to Follow-up|3|||
33388001|NCT01449955|101309067|FG000|Overall Study|Withdrawal by Subject|1|||
33388002|NCT01449955|101309068|FG001|Overall Study|Withdrawal by Subject|2|||
33388003|NCT01156532|101309069|FG000|Overall Study|Family Reasons|1|||
33388004|NCT01156532|101309069|FG000|Overall Study|Lost to Follow-up|1|||
33388005|NCT01176240|101309070|FG000|Study 306A|Lack of Efficacy|2|||
33388006|NCT01176240|101309071|FG001|Study 306A|Lack of Efficacy|1|||
33388007|NCT01176240|101309070|FG000|Study 306A|Protocol Violation|0|||
33388008|NCT01176240|101309071|FG001|Study 306A|Protocol Violation|1|||
33438768|NCT01494506|101499945|FG001|Overall Study|Lack of Efficacy|83|||
33388009|NCT01176240|101309070|FG000|Study 306A|Withdrawal by Subject|0|||
33438769|NCT01494506|101499946|FG002|Overall Study|Lack of Efficacy|57|||
33438770|NCT01494506|101499944|FG000|Overall Study|Adverse Event|17|||
33388010|NCT01176240|101309071|FG001|Study 306A|Withdrawal by Subject|1|||
33438771|NCT01494506|101499945|FG001|Overall Study|Adverse Event|10|||
33438772|NCT01494506|101499946|FG002|Overall Study|Adverse Event|11|||
33438773|NCT01494506|101499944|FG000|Overall Study|Death|9|||
33156257|NCT00785928|100485565|FG003|Treatment Phase|Inadequate Response|0|||
33253063|NCT00753012|100827417|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
33388011|NCT01176240|101309070|FG000|Study 306A|Stop due to diverse problems|1|||
33388012|NCT01176240|101309071|FG001|Study 306A|Stop due to diverse problems|0|||
33388013|NCT01176240|101309070|FG000|Study 306B|Lack of Efficacy|5|||
33388014|NCT01176240|101309071|FG001|Study 306B|Lack of Efficacy|3|||
33388015|NCT01176240|101309070|FG000|Study 306B|Adverse Event|10|||
33388016|NCT01176240|101309071|FG001|Study 306B|Adverse Event|5|||
33388017|NCT01176240|101309070|FG000|Study 306B|Protocol Violation|2|||
33388018|NCT01176240|101309071|FG001|Study 306B|Protocol Violation|3|||
33388019|NCT01176240|101309070|FG000|Study 306B|Withdrawal by Subject|4|||
33388020|NCT01176240|101309071|FG001|Study 306B|Withdrawal by Subject|1|||
33388021|NCT01176240|101309070|FG000|Study 306B|Physician Decision|2|||
33388022|NCT01176240|101309071|FG001|Study 306B|Physician Decision|1|||
33388023|NCT01176240|101309070|FG000|Study 306B|Supine Hypertension|1|||
33388024|NCT01176240|101309071|FG001|Study 306B|Supine Hypertension|2|||
33156258|NCT00785928|100485566|FG004|Treatment Phase|Inadequate Response|0|||
33156259|NCT00785928|100485567|FG005|Treatment Phase|Inadequate Response|0|||
33156260|NCT00785928|100485568|FG006|Treatment Phase|Inadequate Response|0|||
33156261|NCT00785928|100485562|FG000|Treatment Phase|Lack of Efficacy|0|||
33156262|NCT00785928|100485563|FG001|Treatment Phase|Lack of Efficacy|1|||
33156263|NCT00785928|100485564|FG002|Treatment Phase|Lack of Efficacy|1|||
33388025|NCT01176240|101309070|FG000|Study 306B|Lost to Follow-up|0|||
33388026|NCT01176240|101309071|FG001|Study 306B|Lost to Follow-up|1|||
33388027|NCT01176240|101309070|FG000|Study 306B|withdrew prior to dosing|2|||
33156264|NCT00785928|100485565|FG003|Treatment Phase|Lack of Efficacy|0|||
33156265|NCT00785928|100485566|FG004|Treatment Phase|Lack of Efficacy|0|||
33156266|NCT00785928|100485567|FG005|Treatment Phase|Lack of Efficacy|0|||
33156267|NCT00785928|100485568|FG006|Treatment Phase|Lack of Efficacy|0|||
33156268|NCT00785928|100485562|FG000|Treatment Phase|Physician Decision|0|||
33156269|NCT00785928|100485563|FG001|Treatment Phase|Physician Decision|0|||
33156270|NCT00785928|100485564|FG002|Treatment Phase|Physician Decision|0|||
33156271|NCT00785928|100485565|FG003|Treatment Phase|Physician Decision|0|||
33156272|NCT00785928|100485566|FG004|Treatment Phase|Physician Decision|1|||
33156273|NCT00785928|100485567|FG005|Treatment Phase|Physician Decision|0|||
33156274|NCT00785928|100485568|FG006|Treatment Phase|Physician Decision|0|||
33156275|NCT00785928|100485562|FG000|Treatment Phase|Sponsor Decision|1|||
33156276|NCT00785928|100485563|FG001|Treatment Phase|Sponsor Decision|0|||
33156277|NCT00785928|100485564|FG002|Treatment Phase|Sponsor Decision|0|||
33156278|NCT00785928|100485565|FG003|Treatment Phase|Sponsor Decision|0|||
33156279|NCT00785928|100485566|FG004|Treatment Phase|Sponsor Decision|0|||
33156280|NCT00785928|100485567|FG005|Treatment Phase|Sponsor Decision|0|||
33156281|NCT00785928|100485568|FG006|Treatment Phase|Sponsor Decision|1|||
33156282|NCT00785928|100485562|FG000|Treatment Phase|Withdrawal by Subject|1|||
33156283|NCT00785928|100485563|FG001|Treatment Phase|Withdrawal by Subject|2|||
33156284|NCT00785928|100485564|FG002|Treatment Phase|Withdrawal by Subject|0|||
33156285|NCT00785928|100485565|FG003|Treatment Phase|Withdrawal by Subject|0|||
33156286|NCT00785928|100485566|FG004|Treatment Phase|Withdrawal by Subject|1|||
33156287|NCT00785928|100485567|FG005|Treatment Phase|Withdrawal by Subject|0|||
33156288|NCT00785928|100485568|FG006|Treatment Phase|Withdrawal by Subject|0|||
33156289|NCT02264639|100485570|FG000|Overall Study|Death (after completing single-dose phase)|1|||
33156290|NCT02264639|100485571|FG001|Overall Study|Death (after completing single-dose phase)|0|||
33156291|NCT02264639|100485572|FG002|Overall Study|Death (after completing single-dose phase)|0|||
33156292|NCT02264639|100485573|FG003|Overall Study|Death (after completing single-dose phase)|0|||
33156293|NCT02264639|100485574|FG004|Overall Study|Death (after completing single-dose phase)|0|||
33156294|NCT02264639|100485570|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
33156295|NCT02264639|100485571|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
33156296|NCT02264639|100485572|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
33156297|NCT02264639|100485573|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
33156298|NCT02264639|100485574|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
33156299|NCT02264639|100485570|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
33156300|NCT02264639|100485571|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
33156301|NCT02264639|100485572|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
33156302|NCT02264639|100485573|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
33156303|NCT02264639|100485574|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
33156304|NCT02264639|100485570|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
33156305|NCT02264639|100485571|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
33156306|NCT02264639|100485572|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
33156307|NCT02264639|100485573|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
33156308|NCT02264639|100485574|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
33156309|NCT00932126|100485575|FG000|Overall Study|Adverse Event|0|||
33156310|NCT00932126|100485576|FG001|Overall Study|Adverse Event|0|||
33156311|NCT00932126|100485577|FG002|Overall Study|Adverse Event|0|||
33156312|NCT00932126|100485578|FG003|Overall Study|Adverse Event|0|||
33156313|NCT00932126|100485579|FG004|Overall Study|Adverse Event|0|||
33156314|NCT00932126|100485580|FG005|Overall Study|Adverse Event|0|||
33156315|NCT00932126|100485581|FG006|Overall Study|Adverse Event|1|||
33156316|NCT00932126|100485582|FG007|Overall Study|Adverse Event|2|||
33253064|NCT00753012|100827416|FG000|Overall Study|Adverse Event|2|||
33156317|NCT00932126|100485575|FG000|Overall Study|Protocol Violation|0|||
33156318|NCT00932126|100485576|FG001|Overall Study|Protocol Violation|0|||
33156319|NCT00932126|100485577|FG002|Overall Study|Protocol Violation|0|||
33156320|NCT00932126|100485578|FG003|Overall Study|Protocol Violation|0|||
33156321|NCT00932126|100485579|FG004|Overall Study|Protocol Violation|1|||
33156322|NCT00932126|100485580|FG005|Overall Study|Protocol Violation|0|||
33156323|NCT00932126|100485581|FG006|Overall Study|Protocol Violation|0|||
33156324|NCT00932126|100485582|FG007|Overall Study|Protocol Violation|0|||
33156325|NCT00932126|100485575|FG000|Overall Study|Withdrawal by Subject|0|||
33156326|NCT00932126|100485576|FG001|Overall Study|Withdrawal by Subject|0|||
33156327|NCT00932126|100485577|FG002|Overall Study|Withdrawal by Subject|1|||
33156328|NCT00932126|100485578|FG003|Overall Study|Withdrawal by Subject|0|||
33156329|NCT00932126|100485579|FG004|Overall Study|Withdrawal by Subject|0|||
33156330|NCT00932126|100485580|FG005|Overall Study|Withdrawal by Subject|0|||
33156331|NCT00932126|100485581|FG006|Overall Study|Withdrawal by Subject|0|||
33156332|NCT00932126|100485582|FG007|Overall Study|Withdrawal by Subject|1|||
33156333|NCT00932126|100485575|FG000|Overall Study|Objective progression or relapse|3|||
33156334|NCT00932126|100485576|FG001|Overall Study|Objective progression or relapse|3|||
33156335|NCT00932126|100485577|FG002|Overall Study|Objective progression or relapse|2|||
33156336|NCT00932126|100485578|FG003|Overall Study|Objective progression or relapse|3|||
33156337|NCT00932126|100485579|FG004|Overall Study|Objective progression or relapse|3|||
33156338|NCT00932126|100485580|FG005|Overall Study|Objective progression or relapse|3|||
33156339|NCT00932126|100485581|FG006|Overall Study|Objective progression or relapse|3|||
33156340|NCT00932126|100485582|FG007|Overall Study|Objective progression or relapse|5|||
33253065|NCT00753012|100827417|FG001|Overall Study|Adverse Event|0|||
33253066|NCT00753012|100827416|FG000|Overall Study|Withdrawal by Subject|0|||
33253067|NCT00753012|100827417|FG001|Overall Study|Withdrawal by Subject|1|||
33253068|NCT00753012|100827416|FG000|Overall Study|Lost to Follow-up|4|||
33253069|NCT00753012|100827417|FG001|Overall Study|Lost to Follow-up|0|||
33253070|NCT00753012|100827416|FG000|Overall Study|Confounded endpoint data|1|||
33253071|NCT00753012|100827417|FG001|Overall Study|Confounded endpoint data|0|||
33253072|NCT04222959|100827421|FG000|Overall Study|Lost to Follow-up|76|||
33253073|NCT04222959|100827422|FG001|Overall Study|Lost to Follow-up|28|||
33253074|NCT02613871|100827423|FG000|Overall Study|Death|2|||
33253075|NCT02613871|100827423|FG000|Overall Study|Withdrew Consent|1|||
33388028|NCT01176240|101309071|FG001|Study 306B|withdrew prior to dosing|1|||
33388029|NCT00423592|101309072|FG000|Overall Study|Adverse Event (through Week 12)|2|||
33388030|NCT00423592|101309072|FG000|Overall Study|Adverse Event (post Week 12)|5|||
33388031|NCT01915095|101309073|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
33388032|NCT01915095|101309074|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
33388033|NCT01915095|101309075|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
33388034|NCT01915095|101309076|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
33388035|NCT01915095|101309077|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
33388036|NCT01457924|101309081|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
33388037|NCT01457924|101309082|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
33388038|NCT01457924|101309083|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
33388039|NCT01457924|101309084|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
33388040|NCT01457924|101309085|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
33388041|NCT01457924|101309081|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
33388042|NCT01457924|101309082|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
33388043|NCT01457924|101309083|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
33388044|NCT01457924|101309084|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
33388045|NCT01457924|101309085|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
33388046|NCT01457924|101309081|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
33388047|NCT01457924|101309082|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
33388048|NCT01457924|101309083|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
33388049|NCT01457924|101309084|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
33388050|NCT01457924|101309085|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
33388051|NCT01457924|101309081|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
33388052|NCT01457924|101309082|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
33388053|NCT01457924|101309083|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
33388054|NCT01457924|101309084|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
33388055|NCT01457924|101309085|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
33388056|NCT01457924|101309081|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
33388057|NCT01457924|101309082|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
33388058|NCT01457924|101309083|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
33388059|NCT01457924|101309084|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
33388060|NCT01457924|101309085|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
33438774|NCT01494506|101499945|FG001|Overall Study|Death|5|||
33438775|NCT01494506|101499946|FG002|Overall Study|Death|2|||
33438776|NCT01494506|101499944|FG000|Overall Study|Physician Decision|7|||
33438777|NCT01494506|101499945|FG001|Overall Study|Physician Decision|5|||
33388061|NCT01457924|101309081|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
33388062|NCT01457924|101309082|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
33438778|NCT01494506|101499946|FG002|Overall Study|Physician Decision|4|||
33156341|NCT00932126|100485575|FG000|Overall Study|Other|0|||
33156342|NCT00932126|100485576|FG001|Overall Study|Other|0|||
33156343|NCT00932126|100485577|FG002|Overall Study|Other|0|||
33156344|NCT00932126|100485578|FG003|Overall Study|Other|0|||
33253076|NCT00361283|100827434|FG000|Overall Study|Lost to Follow-up|27|||
33156345|NCT00932126|100485579|FG004|Overall Study|Other|1|||
33156346|NCT00932126|100485580|FG005|Overall Study|Other|0|||
33156347|NCT00932126|100485581|FG006|Overall Study|Other|1|||
33156348|NCT00932126|100485582|FG007|Overall Study|Other|2|||
33156349|NCT05447897|100485584|FG000|Overall Study|Did not participate in survey|2|||
33156350|NCT02699593|100485585|FG000|Period 1|Unsatisfactory Visual Response|0|||
33156351|NCT02699593|100485586|FG001|Period 1|Unsatisfactory Visual Response|1|||
33156352|NCT02699593|100485585|FG000|Period 1|Torn Contact Len|4|||
33156353|NCT02699593|100485586|FG001|Period 1|Torn Contact Len|3|||
33438779|NCT01494506|101499944|FG000|Overall Study|Withdrawal by Subject|17|||
33438780|NCT01494506|101499945|FG001|Overall Study|Withdrawal by Subject|20|||
33438781|NCT01494506|101499946|FG002|Overall Study|Withdrawal by Subject|14|||
33438782|NCT01494506|101499944|FG000|Overall Study|Clinical Deterioration|21|||
33156354|NCT02699593|100485585|FG000|Period 1|Protocol Violation|0|||
33156355|NCT02699593|100485586|FG001|Period 1|Protocol Violation|1|||
33156356|NCT02699593|100485585|FG000|Period 1|Withdrawal by Subject|0|||
33156357|NCT02699593|100485586|FG001|Period 1|Withdrawal by Subject|1|||
33156358|NCT02699593|100485585|FG000|Period 1|Adverse Event|1|||
33156359|NCT02699593|100485586|FG001|Period 1|Adverse Event|1|||
33156360|NCT02699593|100485585|FG000|Period 2|Adverse Event|1|||
33156361|NCT02699593|100485586|FG001|Period 2|Adverse Event|1|||
33156362|NCT02699593|100485585|FG000|Period 2|Lost Contact Lens|0|||
33156363|NCT02699593|100485586|FG001|Period 2|Lost Contact Lens|1|||
33156364|NCT02699593|100485585|FG000|Period 2|Torn Contact Lens|1|||
33388063|NCT01457924|101309083|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
33156365|NCT02699593|100485586|FG001|Period 2|Torn Contact Lens|0|||
33388064|NCT01457924|101309084|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
33388065|NCT01457924|101309085|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
33388066|NCT01457924|101309081|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
33388067|NCT01457924|101309082|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
33388068|NCT01457924|101309083|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
33388069|NCT01457924|101309084|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
33388070|NCT01457924|101309085|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
33388071|NCT01457924|101309081|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
33388072|NCT01457924|101309082|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
33388073|NCT01457924|101309083|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
33388074|NCT01457924|101309084|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
33388075|NCT01457924|101309085|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
33388076|NCT01457924|101309081|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
33388077|NCT01457924|101309082|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
33388078|NCT01457924|101309083|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
33388079|NCT01457924|101309084|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
33388080|NCT01457924|101309085|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
33388081|NCT01457924|101309081|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
33388082|NCT01457924|101309082|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
33388083|NCT01457924|101309083|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
33388084|NCT01457924|101309084|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
33388085|NCT01457924|101309085|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
33388086|NCT01457924|101309081|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
33388087|NCT01457924|101309082|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
33388088|NCT01457924|101309083|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
33388089|NCT01457924|101309084|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
33388090|NCT01457924|101309085|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
33388091|NCT01457924|101309081|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
33388092|NCT01457924|101309082|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
33438783|NCT01494506|101499945|FG001|Overall Study|Clinical Deterioration|17|||
33388093|NCT01457924|101309083|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
33388094|NCT01457924|101309084|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
33438784|NCT01494506|101499946|FG002|Overall Study|Clinical Deterioration|13|||
33156366|NCT00004635|100485593|FG000|Period One|refused|2|||
33156367|NCT00004635|100485594|FG001|Period One|refused|1|||
33156368|NCT00004635|100485593|FG000|Period One|Withdrawal by Subject|1|||
33156369|NCT00004635|100485594|FG001|Period One|Withdrawal by Subject|1|||
33438785|NCT01494506|101499944|FG000|Overall Study|Sponsor Decision|0|||
33156370|NCT00004635|100485593|FG000|Period One|Protocol Violation|1|||
33156371|NCT00004635|100485594|FG001|Period One|Protocol Violation|0|||
33156372|NCT00004635|100485593|FG000|Period One|PSA did not go <5 ng/mL|1|||
33156373|NCT00004635|100485594|FG001|Period One|PSA did not go <5 ng/mL|0|||
33156374|NCT00004635|100485593|FG000|Period One|second malignancy|1|||
33156375|NCT00004635|100485594|FG001|Period One|second malignancy|0|||
33156376|NCT00004635|100485593|FG000|Period One|progressed|0|||
33388095|NCT01457924|101309085|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
33388096|NCT01457924|101309081|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
33388097|NCT01457924|101309082|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
33388098|NCT01457924|101309083|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
33388099|NCT01457924|101309084|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
33388100|NCT01457924|101309085|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
33156377|NCT00004635|100485594|FG001|Period One|progressed|2|||
33156378|NCT00004635|100485593|FG000|Period One|health problem|0|||
33156379|NCT00004635|100485594|FG001|Period One|health problem|1|||
33156380|NCT00004635|100485593|FG000|Period One|discrepancy in data entry|0|||
33156381|NCT00004635|100485594|FG001|Period One|discrepancy in data entry|1|||
33156382|NCT00004635|100485593|FG000|Period Two|progression|2|||
33156383|NCT00004635|100485594|FG001|Period Two|progression|3|||
33156384|NCT00004635|100485593|FG000|Period Two|Adverse Event|1|||
33156385|NCT00004635|100485594|FG001|Period Two|Adverse Event|0|||
33156386|NCT00004635|100485593|FG000|Period Two|refused|0|||
33156387|NCT00004635|100485594|FG001|Period Two|refused|2|||
33156388|NCT00004635|100485593|FG000|Period Two|health problem|1|||
33156389|NCT00004635|100485594|FG001|Period Two|health problem|1|||
33156390|NCT00004635|100485593|FG000|Period Two|travel issues|0|||
33156391|NCT00004635|100485594|FG001|Period Two|travel issues|1|||
33156392|NCT00004635|100485593|FG000|Period Two|secondary malignancy|1|||
33156393|NCT00004635|100485594|FG001|Period Two|secondary malignancy|1|||
33156394|NCT00004635|100485593|FG000|Period Two|Lost to Follow-up|1|||
33156395|NCT00004635|100485594|FG001|Period Two|Lost to Follow-up|0|||
33156396|NCT00004635|100485593|FG000|Period Two|discrepancy in data entry|0|||
33156397|NCT00004635|100485594|FG001|Period Two|discrepancy in data entry|1|||
33156398|NCT00239590|100485601|FG000|Randomized|Lost to Follow-up|0|||
33156399|NCT00239590|100485602|FG001|Randomized|Lost to Follow-up|1|||
33156400|NCT00239590|100485601|FG000|Randomized|Withdrawal by Subject|0|||
33156401|NCT00239590|100485602|FG001|Randomized|Withdrawal by Subject|1|||
33156402|NCT00239590|100485601|FG000|Completed Study Protocol|Adverse Event|1|||
33156403|NCT00239590|100485602|FG001|Completed Study Protocol|Adverse Event|1|||
33156404|NCT00239590|100485601|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
33156405|NCT00239590|100485602|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
33156406|NCT02846324|100485603|FG000|Overall Study|Other|1|||
33156407|NCT02846324|100485604|FG001|Overall Study|Other|0|||
33156408|NCT02846324|100485605|FG002|Overall Study|Other|0|||
33156409|NCT02846324|100485606|FG003|Overall Study|Other|0|||
33156410|NCT02846324|100485603|FG000|Overall Study|Withdrawal by Subject|1|||
33156411|NCT02846324|100485604|FG001|Overall Study|Withdrawal by Subject|0|||
33156412|NCT02846324|100485605|FG002|Overall Study|Withdrawal by Subject|4|||
33156413|NCT02846324|100485606|FG003|Overall Study|Withdrawal by Subject|0|||
33156414|NCT02762578|100485609|FG000|Overall Study|Adverse Event|1|||
33156415|NCT02762578|100485610|FG001|Overall Study|Adverse Event|6|||
33156416|NCT02762578|100485609|FG000|Overall Study|Protocol Violation|4|||
33156417|NCT02762578|100485610|FG001|Overall Study|Protocol Violation|2|||
33388101|NCT00865046|101309086|FG000|Overall Study|Lost to Follow-up|1|||
33388102|NCT00865046|101309087|FG001|Overall Study|Lost to Follow-up|4|||
33388103|NCT00865046|101309088|FG002|Overall Study|Lost to Follow-up|0|||
33388104|NCT00865046|101309086|FG000|Overall Study|Death|0|||
33388105|NCT00865046|101309087|FG001|Overall Study|Death|1|||
33388106|NCT00865046|101309088|FG002|Overall Study|Death|1|||
33388107|NCT00865046|101309086|FG000|Overall Study|Withdrawal by Subject|5|||
33388108|NCT00865046|101309087|FG001|Overall Study|Withdrawal by Subject|0|||
33388109|NCT00865046|101309088|FG002|Overall Study|Withdrawal by Subject|0|||
33388110|NCT02715804|101309089|FG000|Overall Study|Death|222|||
33388111|NCT02715804|101309090|FG001|Overall Study|Death|106|||
33388112|NCT02715804|101309089|FG000|Overall Study|Withdrawal by Subject|5|||
33388113|NCT02715804|101309090|FG001|Overall Study|Withdrawal by Subject|4|||
33388114|NCT02715804|101309089|FG000|Overall Study|Other than specified|2|||
33388115|NCT02715804|101309090|FG001|Overall Study|Other than specified|3|||
33388116|NCT01931150|101309091|FG000|Overall Study|Withdrawal by Subject|1|||
33388117|NCT01931150|101309092|FG001|Overall Study|Withdrawal by Subject|2|||
33388118|NCT02896192|101309093|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
33388119|NCT02896192|101309093|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
33388120|NCT02896192|101309093|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
33253077|NCT02547922|100827440|FG000|Overall Study|Withdrawal by Subject|9|||
33253078|NCT02547922|100827441|FG001|Overall Study|Withdrawal by Subject|6|||
33253079|NCT02547922|100827442|FG002|Overall Study|Withdrawal by Subject|10|||
33388121|NCT00361218|101309095|FG000|Overall Study|Lost to Follow-up|11|||
33388122|NCT00361218|101309095|FG000|Overall Study|Personal Reasons|7|||
33388123|NCT00361218|101309095|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
33388124|NCT00047008|101309099|FG000|Overall Study|Withdrawn consent|2|||
33156418|NCT02762578|100485609|FG000|Overall Study|Withdrawal by Subject|4|||
33156419|NCT02762578|100485610|FG001|Overall Study|Withdrawal by Subject|2|||
33156420|NCT02762578|100485609|FG000|Overall Study|Unclassified|6|||
33156421|NCT02762578|100485610|FG001|Overall Study|Unclassified|0|||
33156422|NCT00875979|100485611|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
33156423|NCT00875979|100485612|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
33156424|NCT00875979|100485611|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
33156425|NCT00875979|100485612|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
33156426|NCT00875979|100485611|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
33156427|NCT00875979|100485612|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
33388125|NCT00047008|101309100|FG001|Overall Study|Withdrawn consent|3|||
33156428|NCT00875979|100485611|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
33156429|NCT00875979|100485612|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
33156430|NCT00875979|100485611|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
33156431|NCT00875979|100485612|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
33156432|NCT00875979|100485611|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
33156433|NCT00875979|100485612|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
33156434|NCT00875979|100485611|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
33156435|NCT00875979|100485612|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
33156436|NCT00875979|100485611|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
33156437|NCT00875979|100485612|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
33156438|NCT00875979|100485611|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
33156439|NCT00875979|100485612|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
33156440|NCT01539083|100485615|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
33156441|NCT01539083|100485616|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
33156442|NCT01539083|100485617|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
33156443|NCT01539083|100485615|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
33156444|NCT01539083|100485616|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
33156445|NCT01539083|100485617|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
33156446|NCT01539083|100485615|FG000|Before Randomization (VCD Induction)|Death|6|||
33156447|NCT01539083|100485616|FG001|Before Randomization (VCD Induction)|Death|0|||
33156448|NCT01539083|100485617|FG002|Before Randomization (VCD Induction)|Death|0|||
33156449|NCT01539083|100485615|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
33156450|NCT01539083|100485616|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
33156451|NCT01539083|100485617|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
33156452|NCT01539083|100485615|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
33156453|NCT01539083|100485616|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
33156454|NCT01539083|100485617|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
33156455|NCT01539083|100485615|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
33156456|NCT01539083|100485616|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
33253080|NCT02547922|100827440|FG000|Overall Study|Adverse Event|3|||
33156457|NCT01539083|100485617|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
33156458|NCT01539083|100485615|FG000|Before Randomization (VCD Induction)|Other|5|||
33156459|NCT01539083|100485616|FG001|Before Randomization (VCD Induction)|Other|0|||
33156460|NCT01539083|100485617|FG002|Before Randomization (VCD Induction)|Other|0|||
33156461|NCT01539083|100485615|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
33156462|NCT01539083|100485616|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
33156463|NCT01539083|100485617|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
33156464|NCT01539083|100485615|FG000|After Randomization (TP and VTP)|Other|0|||
33156465|NCT01539083|100485616|FG001|After Randomization (TP and VTP)|Other|1|||
33156466|NCT01539083|100485617|FG002|After Randomization (TP and VTP)|Other|1|||
33156467|NCT01539083|100485615|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
33156468|NCT01539083|100485616|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
33156469|NCT01539083|100485617|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
33156470|NCT01539083|100485615|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
33156471|NCT01539083|100485616|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
33156472|NCT01539083|100485617|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
33156473|NCT01539083|100485615|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
33156474|NCT01539083|100485616|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
33156475|NCT01539083|100485617|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
33156476|NCT01539083|100485615|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
33156477|NCT01539083|100485616|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
33156478|NCT01539083|100485617|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
33156479|NCT01539083|100485615|FG000|After Randomization (TP and VTP)|Death|0|||
33156480|NCT01539083|100485616|FG001|After Randomization (TP and VTP)|Death|6|||
33156481|NCT01539083|100485617|FG002|After Randomization (TP and VTP)|Death|11|||
33156482|NCT02436304|100485620|FG000|Overall Study|Lost to Follow-up|0|||
33156483|NCT02436304|100485621|FG001|Overall Study|Lost to Follow-up|1|||
33156484|NCT02436304|100485622|FG002|Overall Study|Lost to Follow-up|0|||
33253081|NCT02547922|100827441|FG001|Overall Study|Adverse Event|1|||
33253082|NCT02547922|100827442|FG002|Overall Study|Adverse Event|2|||
33253083|NCT02547922|100827440|FG000|Overall Study|Lost to Follow-up|1|||
33156485|NCT02436304|100485620|FG000|Overall Study|Withdrawal by Subject|0|||
33156486|NCT02436304|100485621|FG001|Overall Study|Withdrawal by Subject|1|||
33156487|NCT02436304|100485622|FG002|Overall Study|Withdrawal by Subject|0|||
33156488|NCT02436304|100485620|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
33156489|NCT02436304|100485621|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
33253084|NCT02547922|100827441|FG001|Overall Study|Lost to Follow-up|0|||
33253085|NCT02547922|100827442|FG002|Overall Study|Lost to Follow-up|0|||
33253086|NCT02547922|100827440|FG000|Overall Study|Lack of Efficacy|5|||
33253087|NCT02547922|100827441|FG001|Overall Study|Lack of Efficacy|7|||
33253088|NCT02547922|100827442|FG002|Overall Study|Lack of Efficacy|4|||
33156490|NCT02436304|100485622|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
33253089|NCT02547922|100827440|FG000|Overall Study|Death|1|||
33253090|NCT02547922|100827441|FG001|Overall Study|Death|0|||
33253091|NCT02547922|100827442|FG002|Overall Study|Death|0|||
33253092|NCT02547922|100827440|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
33253093|NCT02547922|100827441|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
33388126|NCT00047008|101309099|FG000|Overall Study|Ineligible|9|||
33438786|NCT01494506|101499945|FG001|Overall Study|Sponsor Decision|0|||
33156491|NCT02122458|100485623|FG000|Overall Study|Withdrawal by Subject|0|||
33156492|NCT02122458|100485624|FG001|Overall Study|Withdrawal by Subject|0|||
33156493|NCT02122458|100485625|FG002|Overall Study|Withdrawal by Subject|0|||
33156494|NCT02122458|100485626|FG003|Overall Study|Withdrawal by Subject|4|||
33156495|NCT02122458|100485627|FG004|Overall Study|Withdrawal by Subject|4|||
33156496|NCT02122458|100485628|FG005|Overall Study|Withdrawal by Subject|4|||
33156497|NCT02122458|100485629|FG006|Overall Study|Withdrawal by Subject|0|||
33156498|NCT02122458|100485623|FG000|Overall Study|Lost to Follow-up|1|||
33156499|NCT02122458|100485624|FG001|Overall Study|Lost to Follow-up|3|||
33156500|NCT02122458|100485625|FG002|Overall Study|Lost to Follow-up|0|||
33156501|NCT02122458|100485626|FG003|Overall Study|Lost to Follow-up|7|||
33156502|NCT02122458|100485627|FG004|Overall Study|Lost to Follow-up|5|||
33156503|NCT02122458|100485628|FG005|Overall Study|Lost to Follow-up|15|||
33156504|NCT02122458|100485629|FG006|Overall Study|Lost to Follow-up|1|||
33156505|NCT02122458|100485623|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
33156506|NCT02122458|100485624|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
33156507|NCT02122458|100485625|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
33156508|NCT02122458|100485626|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
33156509|NCT02122458|100485627|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
33156510|NCT02122458|100485628|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
33156511|NCT02122458|100485629|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
33156512|NCT02122458|100485623|FG000|Overall Study|Adverse Event|1|||
33156513|NCT02122458|100485624|FG001|Overall Study|Adverse Event|0|||
33156514|NCT02122458|100485625|FG002|Overall Study|Adverse Event|0|||
33156515|NCT02122458|100485626|FG003|Overall Study|Adverse Event|0|||
33156516|NCT02122458|100485627|FG004|Overall Study|Adverse Event|0|||
33156517|NCT02122458|100485628|FG005|Overall Study|Adverse Event|0|||
33156518|NCT02122458|100485629|FG006|Overall Study|Adverse Event|0|||
33156519|NCT02122458|100485623|FG000|Overall Study|Experimental Error|0|||
33156520|NCT02122458|100485624|FG001|Overall Study|Experimental Error|0|||
33156521|NCT02122458|100485625|FG002|Overall Study|Experimental Error|0|||
33156522|NCT02122458|100485626|FG003|Overall Study|Experimental Error|0|||
33156523|NCT02122458|100485627|FG004|Overall Study|Experimental Error|3|||
33156524|NCT02122458|100485628|FG005|Overall Study|Experimental Error|0|||
33156525|NCT02122458|100485629|FG006|Overall Study|Experimental Error|0|||
33156526|NCT02122458|100485623|FG000|Overall Study|Deployed or Moved|0|||
33156527|NCT02122458|100485624|FG001|Overall Study|Deployed or Moved|0|||
33156528|NCT02122458|100485625|FG002|Overall Study|Deployed or Moved|0|||
33156529|NCT02122458|100485626|FG003|Overall Study|Deployed or Moved|0|||
33156530|NCT02122458|100485627|FG004|Overall Study|Deployed or Moved|1|||
33156531|NCT02122458|100485628|FG005|Overall Study|Deployed or Moved|0|||
33156532|NCT02122458|100485629|FG006|Overall Study|Deployed or Moved|0|||
33156533|NCT02122458|100485623|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
33156534|NCT02122458|100485624|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
33156535|NCT02122458|100485625|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
33156536|NCT02122458|100485626|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
33156537|NCT02122458|100485627|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
33156538|NCT02122458|100485628|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
33156539|NCT02122458|100485629|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
33156540|NCT02122458|100485623|FG000|Overall Study|Noncompliance|0|||
33156541|NCT02122458|100485624|FG001|Overall Study|Noncompliance|1|||
33156542|NCT02122458|100485625|FG002|Overall Study|Noncompliance|0|||
33156543|NCT02122458|100485626|FG003|Overall Study|Noncompliance|0|||
33156544|NCT02122458|100485627|FG004|Overall Study|Noncompliance|0|||
33156545|NCT02122458|100485628|FG005|Overall Study|Noncompliance|0|||
33156546|NCT02122458|100485629|FG006|Overall Study|Noncompliance|0|||
33156547|NCT03096483|100485630|FG000|Overall Study|Withdrawal by site|1|||
33156548|NCT01145625|100485631|FG000|Overall Study|Lost to Follow-up|8|||
33156549|NCT01145625|100485632|FG001|Overall Study|Lost to Follow-up|9|||
33156550|NCT01145625|100485631|FG000|Overall Study|Adverse Event|6|||
33156551|NCT01145625|100485632|FG001|Overall Study|Adverse Event|4|||
33156552|NCT01145625|100485631|FG000|Overall Study|Protocol Violation|3|||
33156553|NCT01145625|100485632|FG001|Overall Study|Protocol Violation|1|||
33156554|NCT01145625|100485631|FG000|Overall Study|Withdrawal by Subject|7|||
33156555|NCT01145625|100485632|FG001|Overall Study|Withdrawal by Subject|16|||
33156556|NCT01145625|100485631|FG000|Overall Study|Pregnancy|0|||
33156557|NCT01145625|100485632|FG001|Overall Study|Pregnancy|1|||
33156558|NCT00216476|100485633|FG000|Overall Study|Withdrawal by Subject|59|||
33156559|NCT00216476|100485634|FG001|Overall Study|Withdrawal by Subject|72|||
33156560|NCT00216476|100485635|FG002|Overall Study|Withdrawal by Subject|9|||
33156561|NCT00216476|100485633|FG000|Overall Study|Lost to Follow-up|10|||
33156562|NCT00216476|100485634|FG001|Overall Study|Lost to Follow-up|9|||
33156563|NCT00216476|100485635|FG002|Overall Study|Lost to Follow-up|1|||
33438787|NCT01494506|101499946|FG002|Overall Study|Sponsor Decision|1|||
33438788|NCT01494506|101499944|FG000|Overall Study|Other|0|||
33438789|NCT01494506|101499945|FG001|Overall Study|Other|3|||
33438790|NCT01494506|101499946|FG002|Overall Study|Other|1|||
33438791|NCT00553280|101499947|FG000|Overall Study|Adverse Event|19|||
33438792|NCT00553280|101499947|FG000|Overall Study|Lack of Efficacy|3|||
33438793|NCT00553280|101499947|FG000|Overall Study|Withdrawal by Subject|3|||
33438794|NCT00553280|101499947|FG000|Overall Study|Physician Decision|1|||
33438795|NCT00264797|101499948|FG000|Overall Study|Withdrawal by Subject|11|||
33156564|NCT00216476|100485633|FG000|Overall Study|Adverse Event|6|||
33156565|NCT00216476|100485634|FG001|Overall Study|Adverse Event|10|||
33388127|NCT00047008|101309100|FG001|Overall Study|Ineligible|8|||
33388128|NCT01181141|101309101|FG000|Overall Study|Adverse Event|2|||
33388129|NCT01181141|101309102|FG001|Overall Study|Adverse Event|1|||
33388130|NCT01181141|101309101|FG000|Overall Study|Lack of Efficacy|1|||
33388131|NCT01181141|101309102|FG001|Overall Study|Lack of Efficacy|0|||
33388132|NCT01181141|101309101|FG000|Overall Study|Lost to Follow-up|1|||
33388133|NCT01181141|101309102|FG001|Overall Study|Lost to Follow-up|1|||
33388134|NCT01181141|101309101|FG000|Overall Study|Physician Decision|2|||
33388135|NCT01181141|101309102|FG001|Overall Study|Physician Decision|0|||
33388136|NCT01181141|101309101|FG000|Overall Study|Protocol Violation|3|||
33388137|NCT01181141|101309102|FG001|Overall Study|Protocol Violation|1|||
33388138|NCT01181141|101309101|FG000|Overall Study|Withdrawal by Subject|3|||
33388139|NCT01181141|101309102|FG001|Overall Study|Withdrawal by Subject|1|||
33388140|NCT04186663|101309105|FG000|Overall Study|Lost to Follow-up|1|||
33388141|NCT04186663|101309105|FG000|Overall Study|Unable to complete blood draw|3|||
33388142|NCT00105183|101309110|FG000|Overall Study|Death|19|||
33388143|NCT00105183|101309111|FG001|Overall Study|Death|13|||
33388144|NCT00105183|101309112|FG002|Overall Study|Death|15|||
33388145|NCT00105183|101309110|FG000|Overall Study|Withdrawal by Subject|1|||
33388146|NCT00105183|101309111|FG001|Overall Study|Withdrawal by Subject|1|||
33388147|NCT00105183|101309112|FG002|Overall Study|Withdrawal by Subject|4|||
33388148|NCT00105183|101309110|FG000|Overall Study|Physician Decision|1|||
33388149|NCT00105183|101309111|FG001|Overall Study|Physician Decision|2|||
33388150|NCT00105183|101309112|FG002|Overall Study|Physician Decision|3|||
33388151|NCT00105183|101309110|FG000|Overall Study|Lost to Follow-up|0|||
33438796|NCT00264797|101499949|FG001|Overall Study|Withdrawal by Subject|11|||
33388152|NCT00105183|101309111|FG001|Overall Study|Lost to Follow-up|1|||
33156566|NCT00216476|100485635|FG002|Overall Study|Adverse Event|1|||
33156567|NCT00216476|100485633|FG000|Overall Study|Lack of Efficacy|4|||
33156568|NCT00216476|100485634|FG001|Overall Study|Lack of Efficacy|3|||
33438797|NCT00264797|101499948|FG000|Overall Study|Lost to Follow-up|9|||
33438798|NCT00264797|101499949|FG001|Overall Study|Lost to Follow-up|17|||
33156569|NCT00216476|100485635|FG002|Overall Study|Lack of Efficacy|0|||
33156570|NCT00216476|100485633|FG000|Overall Study|Death|2|||
33156571|NCT00216476|100485634|FG001|Overall Study|Death|0|||
33156572|NCT00216476|100485635|FG002|Overall Study|Death|0|||
33156573|NCT00216476|100485633|FG000|Overall Study|Pregnancy|0|||
33156574|NCT00216476|100485634|FG001|Overall Study|Pregnancy|1|||
33156575|NCT00216476|100485635|FG002|Overall Study|Pregnancy|1|||
33156576|NCT00216476|100485633|FG000|Overall Study|Other|0|||
33253094|NCT02547922|100827442|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
33253095|NCT02547922|100827440|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
33253096|NCT02547922|100827441|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
33253097|NCT02547922|100827442|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
33253098|NCT02547922|100827440|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
33253099|NCT02547922|100827441|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
33253100|NCT02547922|100827442|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
33253101|NCT02547922|100827440|FG000|Overall Study|Physician Decision|2|||
33253102|NCT02547922|100827441|FG001|Overall Study|Physician Decision|1|||
33253103|NCT02547922|100827442|FG002|Overall Study|Physician Decision|2|||
33253104|NCT02547922|100827440|FG000|Overall Study|Patients did not receive IP|1|||
33253105|NCT02547922|100827441|FG001|Overall Study|Patients did not receive IP|1|||
33253106|NCT02547922|100827442|FG002|Overall Study|Patients did not receive IP|0|||
33253107|NCT00790790|100827443|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
33253108|NCT00790790|100827444|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
33253109|NCT00790790|100827445|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
33253110|NCT00790790|100827443|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
33253111|NCT00790790|100827444|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
33253112|NCT00790790|100827445|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
33253113|NCT00790790|100827443|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
33253114|NCT00790790|100827444|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
33253115|NCT00790790|100827445|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
33253116|NCT00790790|100827443|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
33253117|NCT00790790|100827444|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
33253118|NCT00790790|100827445|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
33253119|NCT00790790|100827443|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
33253120|NCT00790790|100827444|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
33253121|NCT00790790|100827445|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
33253122|NCT01199705|100827446|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
33253123|NCT04661150|100827450|FG000|Overall Study|Ongoing in study|19|||
33253124|NCT04661150|100827451|FG001|Overall Study|Ongoing in study|20|||
33253125|NCT04661150|100827450|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
33253126|NCT04661150|100827451|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
33253127|NCT04661150|100827450|FG000|Overall Study|Death|2|||
33253128|NCT04661150|100827451|FG001|Overall Study|Death|0|||
33253129|NCT00419094|100827452|FG000|Overall Study|Adverse Event|3|||
33253130|NCT00419094|100827453|FG001|Overall Study|Adverse Event|7|||
33253131|NCT00419094|100827452|FG000|Overall Study|Lack of Efficacy|1|||
33253132|NCT00419094|100827453|FG001|Overall Study|Lack of Efficacy|0|||
33253133|NCT00419094|100827452|FG000|Overall Study|Lost to Follow-up|0|||
33253134|NCT00419094|100827453|FG001|Overall Study|Lost to Follow-up|2|||
33388153|NCT00105183|101309112|FG002|Overall Study|Lost to Follow-up|1|||
33388154|NCT00105183|101309110|FG000|Overall Study|Other reason|1|||
33388155|NCT00105183|101309111|FG001|Overall Study|Other reason|2|||
33156577|NCT00216476|100485634|FG001|Overall Study|Other|0|||
33253135|NCT00419094|100827452|FG000|Overall Study|Protocol Violation|1|||
33253136|NCT00419094|100827453|FG001|Overall Study|Protocol Violation|14|||
33253137|NCT00419094|100827452|FG000|Overall Study|Withdrawal of consent|1|||
33253138|NCT00419094|100827453|FG001|Overall Study|Withdrawal of consent|5|||
33253139|NCT00419094|100827452|FG000|Overall Study|Other: Error determining exit criteria|1|||
33253140|NCT00419094|100827453|FG001|Overall Study|Other: Error determining exit criteria|0|||
33253141|NCT00419094|100827452|FG000|Overall Study|Other: Patient non-compliant|0|||
33253142|NCT00419094|100827453|FG001|Overall Study|Other: Patient non-compliant|1|||
33156578|NCT00216476|100485635|FG002|Overall Study|Other|1|||
33156579|NCT00216476|100485633|FG000|Overall Study|Refuses Injection|11|||
33156580|NCT00216476|100485634|FG001|Overall Study|Refuses Injection|0|||
33253143|NCT00419094|100827452|FG000|Overall Study|Other: No contact for extended period|0|||
33253144|NCT00419094|100827453|FG001|Overall Study|Other: No contact for extended period|1|||
33253145|NCT00367991|100827456|FG000|Overall Study|Withdrawal by Subject|1|||
33253146|NCT00367991|100827457|FG001|Overall Study|Withdrawal by Subject|1|||
33253147|NCT00367991|100827456|FG000|Overall Study|Adverse Event|1|||
33253148|NCT00367991|100827457|FG001|Overall Study|Adverse Event|1|||
33253149|NCT03512756|100827458|FG000|Part 1|Death|23|||
33253150|NCT03512756|100827459|FG001|Part 1|Death|18|||
33253151|NCT03512756|100827460|FG002|Part 1|Death|0|||
33253152|NCT03512756|100827461|FG003|Part 1|Death|0|||
33253153|NCT03512756|100827458|FG000|Part 1|Lost to Follow-up|0|||
33253154|NCT03512756|100827459|FG001|Part 1|Lost to Follow-up|3|||
33253155|NCT03512756|100827460|FG002|Part 1|Lost to Follow-up|0|||
33253156|NCT03512756|100827461|FG003|Part 1|Lost to Follow-up|0|||
33253157|NCT03512756|100827458|FG000|Part 1|Physician Decision|0|||
33253158|NCT03512756|100827459|FG001|Part 1|Physician Decision|1|||
33253159|NCT03512756|100827460|FG002|Part 1|Physician Decision|0|||
33253160|NCT03512756|100827461|FG003|Part 1|Physician Decision|0|||
33253161|NCT03512756|100827458|FG000|Part 1|Withdrawal by Subject|2|||
33253162|NCT03512756|100827459|FG001|Part 1|Withdrawal by Subject|2|||
33253163|NCT03512756|100827460|FG002|Part 1|Withdrawal by Subject|0|||
33253164|NCT03512756|100827461|FG003|Part 1|Withdrawal by Subject|0|||
33253165|NCT03512756|100827458|FG000|Part 2|Death|0|||
33253166|NCT03512756|100827459|FG001|Part 2|Death|0|||
33253167|NCT03512756|100827460|FG002|Part 2|Death|32|||
33253168|NCT03512756|100827461|FG003|Part 2|Death|21|||
33253169|NCT03512756|100827458|FG000|Part 2|Lost to Follow-up|0|||
33253170|NCT03512756|100827459|FG001|Part 2|Lost to Follow-up|0|||
33253171|NCT03512756|100827460|FG002|Part 2|Lost to Follow-up|1|||
33253172|NCT03512756|100827461|FG003|Part 2|Lost to Follow-up|0|||
33253173|NCT03512756|100827458|FG000|Part 2|Physician Decision|0|||
33253174|NCT03512756|100827459|FG001|Part 2|Physician Decision|0|||
33253175|NCT03512756|100827460|FG002|Part 2|Physician Decision|2|||
33253176|NCT03512756|100827461|FG003|Part 2|Physician Decision|4|||
33253177|NCT03512756|100827458|FG000|Part 2|Study Terminated by Sponsor|0|||
33253178|NCT03512756|100827459|FG001|Part 2|Study Terminated by Sponsor|0|||
33253179|NCT03512756|100827460|FG002|Part 2|Study Terminated by Sponsor|2|||
33253180|NCT03512756|100827461|FG003|Part 2|Study Terminated by Sponsor|6|||
33253181|NCT03512756|100827458|FG000|Part 2|Protocol Violation|0|||
33253182|NCT03512756|100827459|FG001|Part 2|Protocol Violation|0|||
33253183|NCT03512756|100827460|FG002|Part 2|Protocol Violation|1|||
33253184|NCT03512756|100827461|FG003|Part 2|Protocol Violation|0|||
33253185|NCT03512756|100827458|FG000|Part 2|Withdrawal by Subject|0|||
33253186|NCT03512756|100827459|FG001|Part 2|Withdrawal by Subject|0|||
33253187|NCT03512756|100827460|FG002|Part 2|Withdrawal by Subject|3|||
33253188|NCT03512756|100827461|FG003|Part 2|Withdrawal by Subject|9|||
33253189|NCT03192046|100827462|FG000|Overall Study|Withdrawal by Subject|1|||
33253190|NCT03192046|100827463|FG001|Overall Study|Withdrawal by Subject|1|||
33253191|NCT04353037|100827464|FG000|Overall Study|Lost to Follow-up|0|||
33253192|NCT04353037|100827465|FG001|Overall Study|Lost to Follow-up|1|||
33253193|NCT04353037|100827466|FG002|Overall Study|Lost to Follow-up|2|||
33253194|NCT04353037|100827467|FG003|Overall Study|Lost to Follow-up|3|||
33253195|NCT04353037|100827464|FG000|Overall Study|Withdrawal by Subject|0|||
33438799|NCT00264797|101499948|FG000|Overall Study|Moved from area|3|||
33438800|NCT00264797|101499949|FG001|Overall Study|Moved from area|1|||
33156581|NCT00216476|100485635|FG002|Overall Study|Refuses Injection|0|||
33156582|NCT00216476|100485633|FG000|Overall Study|No Further Need for Treatment|3|||
33156583|NCT00216476|100485634|FG001|Overall Study|No Further Need for Treatment|4|||
33156584|NCT00216476|100485635|FG002|Overall Study|No Further Need for Treatment|1|||
33156585|NCT00216476|100485633|FG000|Overall Study|Non-compliance|0|||
33156586|NCT00216476|100485634|FG001|Overall Study|Non-compliance|4|||
33156587|NCT00216476|100485635|FG002|Overall Study|Non-compliance|1|||
33156588|NCT00216476|100485633|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
33156589|NCT00216476|100485634|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
33156590|NCT00216476|100485635|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
33156591|NCT00216476|100485633|FG000|Overall Study|Administrative Reasons|1|||
33156592|NCT00216476|100485634|FG001|Overall Study|Administrative Reasons|1|||
33156593|NCT00216476|100485635|FG002|Overall Study|Administrative Reasons|0|||
33156594|NCT00216476|100485633|FG000|Overall Study|Protocol Deviation|5|||
33156595|NCT00216476|100485634|FG001|Overall Study|Protocol Deviation|1|||
33156596|NCT00216476|100485635|FG002|Overall Study|Protocol Deviation|0|||
33156597|NCT00216476|100485633|FG000|Overall Study|Patient Moved|2|||
33156598|NCT00216476|100485634|FG001|Overall Study|Patient Moved|2|||
33156599|NCT00216476|100485635|FG002|Overall Study|Patient Moved|0|||
33156600|NCT02345226|100485648|FG000|Double-Blind Phase|Adverse Event|5|||
33156601|NCT02345226|100485649|FG001|Double-Blind Phase|Adverse Event|6|||
33156602|NCT02345226|100485648|FG000|Double-Blind Phase|Death|3|||
33156603|NCT02345226|100485649|FG001|Double-Blind Phase|Death|0|||
33156604|NCT02345226|100485648|FG000|Double-Blind Phase|Pregnancy|0|||
33156605|NCT02345226|100485649|FG001|Double-Blind Phase|Pregnancy|1|||
33156606|NCT02345226|100485648|FG000|Double-Blind Phase|Lack of Efficacy|1|||
33253196|NCT04353037|100827465|FG001|Overall Study|Withdrawal by Subject|2|||
33253197|NCT04353037|100827466|FG002|Overall Study|Withdrawal by Subject|3|||
33253198|NCT04353037|100827467|FG003|Overall Study|Withdrawal by Subject|5|||
33253199|NCT04353037|100827464|FG000|Overall Study|Adverse Event|0|||
33253200|NCT04353037|100827465|FG001|Overall Study|Adverse Event|0|||
33253201|NCT04353037|100827466|FG002|Overall Study|Adverse Event|2|||
33253202|NCT04353037|100827467|FG003|Overall Study|Adverse Event|0|||
33253203|NCT04353037|100827464|FG000|Overall Study|Exposure Change|0|||
33253204|NCT04353037|100827465|FG001|Overall Study|Exposure Change|0|||
33253205|NCT04353037|100827466|FG002|Overall Study|Exposure Change|0|||
33253206|NCT04353037|100827467|FG003|Overall Study|Exposure Change|2|||
33253207|NCT04493242|100827468|FG000|Overall Study|Death|10|||
33253208|NCT04493242|100827469|FG001|Overall Study|Death|14|||
33253209|NCT04493242|100827470|FG002|Overall Study|Death|16|||
33253210|NCT04493242|100827468|FG000|Overall Study|Lost to Follow-up|1|||
33253211|NCT04493242|100827469|FG001|Overall Study|Lost to Follow-up|1|||
33253212|NCT04493242|100827470|FG002|Overall Study|Lost to Follow-up|0|||
33253213|NCT04493242|100827468|FG000|Overall Study|Withdrawal by Subject|1|||
33253214|NCT04493242|100827469|FG001|Overall Study|Withdrawal by Subject|0|||
33253215|NCT04493242|100827470|FG002|Overall Study|Withdrawal by Subject|0|||
33253216|NCT04493242|100827468|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
33253217|NCT04493242|100827469|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
33438801|NCT00264797|101499948|FG000|Overall Study|Practical Problems|2|||
33253218|NCT04493242|100827470|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
33253219|NCT04493242|100827468|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
33253220|NCT04493242|100827469|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
33253221|NCT04493242|100827470|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
33253222|NCT02314117|100827475|FG000|Overall Study|Lost to Follow-up|9|||
33253223|NCT02314117|100827476|FG001|Overall Study|Lost to Follow-up|14|||
33253224|NCT02314117|100827475|FG000|Overall Study|Withdrawal by Subject|3|||
33253225|NCT02314117|100827476|FG001|Overall Study|Withdrawal by Subject|2|||
33253226|NCT02507752|100827477|FG000|Overall Study|Adverse Event|1|||
33253227|NCT02507752|100827477|FG000|Overall Study|Protocol Violation|6|||
33253228|NCT02507752|100827477|FG000|Overall Study|Lost to Follow-up|7|||
33253229|NCT02507752|100827477|FG000|Overall Study|Infusion reaction at first infusion|1|||
33253230|NCT02507752|100827477|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
33388156|NCT00105183|101309112|FG002|Overall Study|Other reason|0|||
33388157|NCT00608842|101309113|FG000|Overall Study|Participant's Request|0|||
33388158|NCT00608842|101309114|FG001|Overall Study|Participant's Request|1|||
33388159|NCT00608842|101309115|FG002|Overall Study|Participant's Request|2|||
33388160|NCT00608842|101309116|FG003|Overall Study|Participant's Request|1|||
33388161|NCT00608842|101309113|FG000|Overall Study|Lost to Follow-up|1|||
33388162|NCT00608842|101309114|FG001|Overall Study|Lost to Follow-up|0|||
33388163|NCT00608842|101309115|FG002|Overall Study|Lost to Follow-up|0|||
33438802|NCT00264797|101499949|FG001|Overall Study|Practical Problems|3|||
33253231|NCT02507752|100827477|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
33253232|NCT04567888|100827482|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
33253233|NCT04567888|100827483|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
33253234|NCT04567888|100827482|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
33388164|NCT00608842|101309116|FG003|Overall Study|Lost to Follow-up|0|||
33388165|NCT03597503|101309119|FG000|Overall Study|Withdrawal by Subject|0|||
33438803|NCT00264797|101499948|FG000|Overall Study|Incarceration|4|||
33438804|NCT00264797|101499949|FG001|Overall Study|Incarceration|5|||
33438805|NCT00264797|101499948|FG000|Overall Study|Pressure/advice from Outsiders|1|||
33438806|NCT00264797|101499949|FG001|Overall Study|Pressure/advice from Outsiders|1|||
33438807|NCT00264797|101499948|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
33438808|NCT00264797|101499949|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
33388166|NCT03597503|101309120|FG001|Overall Study|Withdrawal by Subject|2|||
33388167|NCT03597503|101309119|FG000|Overall Study|Lost to Follow-up|1|||
33388168|NCT03597503|101309120|FG001|Overall Study|Lost to Follow-up|2|||
33388169|NCT03597503|101309119|FG000|Overall Study|Protocol Violation|1|||
33388170|NCT03597503|101309120|FG001|Overall Study|Protocol Violation|0|||
33388171|NCT01263444|101309126|FG000|Overall Study|Adverse Event|8|||
33388172|NCT01263444|101309126|FG000|Overall Study|Withdrawal by Subject|1|||
33388173|NCT01263444|101309126|FG000|Overall Study|Protocol Violation|1|||
33388174|NCT02566109|101309127|FG000|Overall Study|Withdrawal by Subject|1|||
33388175|NCT00651313|101309128|FG000|Overall Study|Adverse Event|0|||
33388176|NCT00651313|101309129|FG001|Overall Study|Adverse Event|1|||
33388177|NCT00651313|101309128|FG000|Overall Study|Withdrawal by Subject|3|||
33388178|NCT00651313|101309129|FG001|Overall Study|Withdrawal by Subject|1|||
33388179|NCT00651313|101309128|FG000|Overall Study|Lost to Follow-up|1|||
33388180|NCT00651313|101309129|FG001|Overall Study|Lost to Follow-up|1|||
33388181|NCT00651313|101309128|FG000|Overall Study|Adminstrative Discontinuation|2|||
33388182|NCT00651313|101309129|FG001|Overall Study|Adminstrative Discontinuation|3|||
33388183|NCT01106391|101309130|FG000|Overall Study|Death|12|||
33388184|NCT01106391|101309130|FG000|Overall Study|Withdrawal by Subject|7|||
33388185|NCT01822223|101309133|FG000|Overall Study|Death|0|||
33388186|NCT01822223|101309134|FG001|Overall Study|Death|1|||
33388187|NCT01079195|101309135|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
33388188|NCT01079195|101309135|FG000|Overall Study|No Documentation Available|437|||
33388189|NCT01079195|101309135|FG000|Overall Study|Adverse Event|157|||
33388190|NCT01079195|101309135|FG000|Overall Study|Reason Unknown|39|||
33388191|NCT01079195|101309135|FG000|Overall Study|Withdrawal by Subject|18|||
33388192|NCT01079195|101309135|FG000|Overall Study|Financial Reasons|15|||
33388193|NCT01079195|101309135|FG000|Overall Study|Lack of Effectiveness|12|||
33388194|NCT01079195|101309135|FG000|Overall Study|Physician Decision|4|||
33388195|NCT01079195|101309135|FG000|Overall Study|Improved Status of Participant|4|||
33388196|NCT01079195|101309135|FG000|Overall Study|No Follow-up Documentation Available|4|||
33388197|NCT01079195|101309135|FG000|Overall Study|Non-compliance|2|||
33388198|NCT00606177|101309138|FG000|Overall Study|Adverse Event|9|||
33388199|NCT00606177|101309139|FG001|Overall Study|Adverse Event|5|||
33388200|NCT00606177|101309138|FG000|Overall Study|Lack of Efficacy|3|||
33388201|NCT00606177|101309139|FG001|Overall Study|Lack of Efficacy|7|||
33388202|NCT00606177|101309138|FG000|Overall Study|Physician Decision|1|||
33388203|NCT00606177|101309139|FG001|Overall Study|Physician Decision|0|||
33388204|NCT00606177|101309138|FG000|Overall Study|Protocol Violation|1|||
33388205|NCT00606177|101309139|FG001|Overall Study|Protocol Violation|4|||
33388206|NCT00606177|101309138|FG000|Overall Study|Withdrawal by Subject|5|||
33438809|NCT00264797|101499948|FG000|Overall Study|Other|3|||
33438810|NCT00264797|101499949|FG001|Overall Study|Other|4|||
33438811|NCT02433678|101499952|FG000|Overall Study|Lost to Follow-up|1|||
33388207|NCT00606177|101309139|FG001|Overall Study|Withdrawal by Subject|6|||
33388208|NCT00606177|101309138|FG000|Overall Study|Progression to depressive phase|6|||
33388209|NCT00606177|101309139|FG001|Overall Study|Progression to depressive phase|1|||
33438812|NCT02433678|101499953|FG001|Overall Study|Lost to Follow-up|2|||
33253235|NCT04567888|100827483|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
33253236|NCT04567888|100827482|FG000|Overall Study|Reported Unusual Birth Year|2|||
33253237|NCT04567888|100827483|FG001|Overall Study|Reported Unusual Birth Year|3|||
33253238|NCT04567888|100827482|FG000|Overall Study|Duplicate Responses|0|||
33253239|NCT04567888|100827483|FG001|Overall Study|Duplicate Responses|1|||
33253240|NCT03823911|100827484|FG000|Overall Study|Lost to Follow-up|1|||
33253241|NCT03823911|100827485|FG001|Overall Study|Lost to Follow-up|5|||
33253242|NCT03823911|100827486|FG002|Overall Study|Lost to Follow-up|2|||
33253243|NCT03823911|100827484|FG000|Overall Study|Did not meet eligibility criteria|13|||
33253244|NCT03823911|100827485|FG001|Overall Study|Did not meet eligibility criteria|7|||
33253245|NCT03823911|100827486|FG002|Overall Study|Did not meet eligibility criteria|4|||
33253246|NCT03823911|100827484|FG000|Overall Study|Death|0|||
33253247|NCT03823911|100827485|FG001|Overall Study|Death|1|||
33253248|NCT03823911|100827486|FG002|Overall Study|Death|0|||
33253249|NCT00244855|100827489|FG000|Overall Study|Withdrawal by Subject|0|||
33253250|NCT00244855|100827490|FG001|Overall Study|Withdrawal by Subject|1|||
33253251|NCT05609032|100827491|FG000|Overall Study|Lost to Follow-up|3|||
33253252|NCT05609032|100827492|FG001|Overall Study|Lost to Follow-up|1|||
33253253|NCT05609032|100827491|FG000|Overall Study|Withdrawal by Subject|1|||
33253254|NCT05609032|100827492|FG001|Overall Study|Withdrawal by Subject|0|||
33253255|NCT05790408|100827495|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
33253256|NCT01131494|100827501|FG000|Overall Study|Withdrawal by Subject|2|||
33253257|NCT04439799|100827504|FG000|Overall Study|Lost to Follow-up|6|||
33253258|NCT04439799|100827505|FG001|Overall Study|Lost to Follow-up|6|||
33253259|NCT04439799|100827504|FG000|Overall Study|Withdrawal by Subject|2|||
33253260|NCT04439799|100827505|FG001|Overall Study|Withdrawal by Subject|6|||
33253261|NCT04439799|100827504|FG000|Overall Study|Adverse Event|2|||
33253262|NCT04439799|100827505|FG001|Overall Study|Adverse Event|5|||
33253263|NCT02261467|100827511|FG000|Overall Study|Enrolled in Error|1|||
33253264|NCT02261467|100827512|FG001|Overall Study|Enrolled in Error|0|||
33253265|NCT02261467|100827511|FG000|Overall Study|Protocol Violation|0|||
33253266|NCT02261467|100827512|FG001|Overall Study|Protocol Violation|1|||
33253267|NCT02261467|100827511|FG000|Overall Study|Personal Reasons|17|||
33388210|NCT00606177|101309138|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
33388211|NCT00606177|101309139|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
33388212|NCT00606177|101309138|FG000|Overall Study|Change of residence or other commitments|1|||
33388213|NCT00606177|101309139|FG001|Overall Study|Change of residence or other commitments|1|||
33388214|NCT02679781|101309140|FG000|Overall Study|Lost to Follow-up|1|||
33388215|NCT02679781|101309141|FG001|Overall Study|Lost to Follow-up|2|||
33388216|NCT02679781|101309140|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
33388217|NCT02679781|101309141|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
33388218|NCT00753623|101309142|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
33388219|NCT00753623|101309143|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
33388220|NCT00753623|101309142|FG000|Phase I (14 Days)|Physician Decision|1|||
33388221|NCT00753623|101309143|FG001|Phase I (14 Days)|Physician Decision|2|||
33388222|NCT00753623|101309142|FG000|Phase I (14 Days)|Adverse Event|0|||
33388223|NCT00753623|101309143|FG001|Phase I (14 Days)|Adverse Event|1|||
33388224|NCT00753623|101309142|FG000|Washout (7 Days)|Physician Decision|1|||
33388225|NCT00753623|101309143|FG001|Washout (7 Days)|Physician Decision|0|||
33388226|NCT00753623|101309142|FG000|Phase II (14 Days)|Physician Decision|0|||
33388227|NCT00753623|101309143|FG001|Phase II (14 Days)|Physician Decision|1|||
33388228|NCT02533401|101309147|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
33388229|NCT02533401|101309147|FG000|Overall Study|Death|5|||
33388230|NCT02533401|101309147|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
33388231|NCT02533401|101309147|FG000|Overall Study|Lost to Follow-up|1|||
33388232|NCT02533401|101309147|FG000|Overall Study|Violation of Selection Criteria|1|||
33388233|NCT02420795|101309155|FG000|Overall Study|Withdrawal by Subject|1|||
33388234|NCT02420795|101309156|FG001|Overall Study|Withdrawal by Subject|0|||
33388235|NCT02420795|101309157|FG002|Overall Study|Withdrawal by Subject|0|||
33388236|NCT02420795|101309155|FG000|Overall Study|Adverse Event|1|||
33388237|NCT02420795|101309156|FG001|Overall Study|Adverse Event|0|||
33438813|NCT02170688|101499954|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
33253268|NCT02261467|100827512|FG001|Overall Study|Personal Reasons|22|||
33253269|NCT02261467|100827511|FG000|Overall Study|Lost to Follow-up|2|||
33253270|NCT02261467|100827512|FG001|Overall Study|Lost to Follow-up|13|||
33253271|NCT02261467|100827511|FG000|Overall Study|Adverse Event|1|||
33253272|NCT02261467|100827512|FG001|Overall Study|Adverse Event|1|||
33253273|NCT00102063|100827513|FG000|Overall Study|Lack of Efficacy|5|||
33388238|NCT02420795|101309157|FG002|Overall Study|Adverse Event|0|||
33388239|NCT02420795|101309155|FG000|Overall Study|Progressive disease|2|||
33388240|NCT02420795|101309156|FG001|Overall Study|Progressive disease|2|||
33388241|NCT02420795|101309157|FG002|Overall Study|Progressive disease|4|||
33253274|NCT00102063|100827514|FG001|Overall Study|Lack of Efficacy|1|||
33253275|NCT00102063|100827515|FG002|Overall Study|Lack of Efficacy|1|||
33253276|NCT00102063|100827513|FG000|Overall Study|Adverse Event|7|||
33253277|NCT00102063|100827514|FG001|Overall Study|Adverse Event|4|||
33438814|NCT02170688|101499955|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
33438815|NCT02170688|101499956|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
33438816|NCT02170688|101499957|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
33438817|NCT02170688|101499958|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
33438818|NCT02170688|101499954|FG000|Overall Study|Full dose not received|0|||
33438819|NCT02170688|101499955|FG001|Overall Study|Full dose not received|1|||
33438820|NCT02170688|101499956|FG002|Overall Study|Full dose not received|0|||
33438821|NCT02170688|101499957|FG003|Overall Study|Full dose not received|0|||
33438822|NCT02170688|101499958|FG004|Overall Study|Full dose not received|0|||
33438823|NCT02170688|101499954|FG000|Overall Study|Physician Decision|0|||
33438824|NCT02170688|101499955|FG001|Overall Study|Physician Decision|0|||
33438825|NCT02170688|101499956|FG002|Overall Study|Physician Decision|1|||
33253278|NCT00102063|100827515|FG002|Overall Study|Adverse Event|2|||
33388242|NCT02420795|101309155|FG000|Overall Study|Death|0|||
33388243|NCT02420795|101309156|FG001|Overall Study|Death|0|||
33388244|NCT02420795|101309157|FG002|Overall Study|Death|1|||
33388245|NCT00150345|101309158|FG000|Overall Study|Death|5|||
33388246|NCT00150345|101309159|FG001|Overall Study|Death|2|||
33388247|NCT00150345|101309158|FG000|Overall Study|Adverse Event|8|||
33388248|NCT00150345|101309159|FG001|Overall Study|Adverse Event|6|||
33388249|NCT00150345|101309158|FG000|Overall Study|Lack of Efficacy|5|||
33388250|NCT00150345|101309159|FG001|Overall Study|Lack of Efficacy|4|||
33388251|NCT00150345|101309158|FG000|Overall Study|Withdrawal by Subject|3|||
33388252|NCT00150345|101309159|FG001|Overall Study|Withdrawal by Subject|4|||
33388253|NCT00150345|101309158|FG000|Overall Study|Laboratory abnormality|1|||
33388254|NCT00150345|101309159|FG001|Overall Study|Laboratory abnormality|2|||
33388255|NCT00150345|101309158|FG000|Overall Study|Other|12|||
33388256|NCT00150345|101309159|FG001|Overall Study|Other|14|||
33388257|NCT01947894|101309161|FG000|Overall Study|Other|3|||
33388258|NCT01947894|101309162|FG001|Overall Study|Other|4|||
33388259|NCT01947894|101309163|FG002|Overall Study|Other|3|||
33388260|NCT01947894|101309161|FG000|Overall Study|Withdrawal by Subject|12|||
33388261|NCT01947894|101309162|FG001|Overall Study|Withdrawal by Subject|4|||
33388262|NCT01947894|101309163|FG002|Overall Study|Withdrawal by Subject|1|||
33388263|NCT01947894|101309161|FG000|Overall Study|Death|12|||
33388264|NCT01947894|101309162|FG001|Overall Study|Death|1|||
33388265|NCT01947894|101309163|FG002|Overall Study|Death|0|||
33388266|NCT01947894|101309161|FG000|Overall Study|Physician Decision|2|||
33388267|NCT01947894|101309162|FG001|Overall Study|Physician Decision|0|||
33388268|NCT01947894|101309163|FG002|Overall Study|Physician Decision|0|||
33388269|NCT01947894|101309161|FG000|Overall Study|Adverse Event|5|||
33388270|NCT01947894|101309162|FG001|Overall Study|Adverse Event|1|||
33388271|NCT01947894|101309163|FG002|Overall Study|Adverse Event|0|||
33388272|NCT01947894|101309161|FG000|Overall Study|Switched to other growth hormone brand|53|||
33388273|NCT01947894|101309162|FG001|Overall Study|Switched to other growth hormone brand|8|||
33388274|NCT01947894|101309163|FG002|Overall Study|Switched to other growth hormone brand|23|||
33388275|NCT00524043|101309168|FG000|Overall Study|Lack of Efficacy|15|||
33388276|NCT00524043|101309169|FG001|Overall Study|Lack of Efficacy|13|||
33388277|NCT00524043|101309170|FG002|Overall Study|Lack of Efficacy|14|||
33388278|NCT00524043|101309168|FG000|Overall Study|Withdrawal by Subject|5|||
33388279|NCT00524043|101309169|FG001|Overall Study|Withdrawal by Subject|7|||
33388280|NCT00524043|101309170|FG002|Overall Study|Withdrawal by Subject|7|||
33388281|NCT00524043|101309168|FG000|Overall Study|Adverse Event|5|||
33388282|NCT00524043|101309169|FG001|Overall Study|Adverse Event|2|||
33388283|NCT00524043|101309170|FG002|Overall Study|Adverse Event|7|||
33388284|NCT00524043|101309168|FG000|Overall Study|Lost to Follow-up|3|||
33388285|NCT00524043|101309169|FG001|Overall Study|Lost to Follow-up|5|||
33388286|NCT00524043|101309170|FG002|Overall Study|Lost to Follow-up|3|||
33388287|NCT00524043|101309168|FG000|Overall Study|Various (eg, incarceration)|2|||
33388288|NCT00524043|101309169|FG001|Overall Study|Various (eg, incarceration)|1|||
33388289|NCT00524043|101309170|FG002|Overall Study|Various (eg, incarceration)|0|||
33388290|NCT04209400|101309171|FG000|Overall Study|Withdrawal by Subject|0|||
33388291|NCT04209400|101309172|FG001|Overall Study|Withdrawal by Subject|1|||
33388292|NCT01329341|101309173|FG000|Overall Study|Withdrawal by Subject|44|||
33388293|NCT05263921|101309177|FG000|Overall Study|Other: family emergency.|0|||
33388294|NCT05263921|101309178|FG001|Overall Study|Other: family emergency.|0|||
33388295|NCT05263921|101309179|FG002|Overall Study|Other: family emergency.|1|||
33388296|NCT05263921|101309180|FG003|Overall Study|Other: family emergency.|0|||
33388297|NCT00254163|101309183|FG000|Overall Study|Adverse Event|29|||
33388298|NCT00254163|101309184|FG001|Overall Study|Adverse Event|26|||
33388299|NCT00254163|101309183|FG000|Overall Study|Patient request/withdrew consent|6|||
33388300|NCT00254163|101309184|FG001|Overall Study|Patient request/withdrew consent|4|||
33438826|NCT02170688|101499957|FG003|Overall Study|Physician Decision|0|||
33253279|NCT00102063|100827513|FG000|Overall Study|Withdrawal by Subject|4|||
33388301|NCT00254163|101309183|FG000|Overall Study|Investigator request|1|||
33388302|NCT00254163|101309184|FG001|Overall Study|Investigator request|3|||
33388303|NCT00254163|101309183|FG000|Overall Study|Failed entry|1|||
33438827|NCT02170688|101499958|FG004|Overall Study|Physician Decision|0|||
33438828|NCT03831048|101499959|FG000|Overall Study|Protocol Violation|9|||
33438829|NCT03831048|101499960|FG001|Overall Study|Protocol Violation|3|||
33438830|NCT03831048|101499959|FG000|Overall Study|Death|4|||
33438831|NCT03831048|101499960|FG001|Overall Study|Death|9|||
33388304|NCT00254163|101309184|FG001|Overall Study|Failed entry|3|||
33388305|NCT00254163|101309183|FG000|Overall Study|Progressive disease|0|||
33388306|NCT00254163|101309184|FG001|Overall Study|Progressive disease|1|||
33388307|NCT00254163|101309183|FG000|Overall Study|Death|0|||
33388308|NCT00254163|101309184|FG001|Overall Study|Death|1|||
33388309|NCT00254163|101309183|FG000|Overall Study|Other|8|||
33388310|NCT00254163|101309184|FG001|Overall Study|Other|8|||
33388311|NCT01997281|101309185|FG000|Overall Study|Withdrawal by Subject|1|||
33388312|NCT01997281|101309186|FG001|Overall Study|Withdrawal by Subject|0|||
33388313|NCT02033850|101309187|FG000|Overall Study|Death|1|||
33388314|NCT02033850|101309188|FG001|Overall Study|Death|0|||
33388315|NCT02033850|101309187|FG000|Overall Study|unrelated medical reason|1|||
33388316|NCT02033850|101309188|FG001|Overall Study|unrelated medical reason|1|||
33388317|NCT03363165|101309190|FG000|3-month Follow-up|Death|0|||
33388318|NCT03363165|101309191|FG001|3-month Follow-up|Death|1|||
33388319|NCT03363165|101309190|FG000|6-month Follow-up|Death|0|||
33388320|NCT03363165|101309191|FG001|6-month Follow-up|Death|1|||
33388321|NCT03363165|101309190|FG000|6-month Follow-up|Withdrawal by Subject|1|||
33388322|NCT03363165|101309191|FG001|6-month Follow-up|Withdrawal by Subject|1|||
33388323|NCT03363165|101309190|FG000|12-month Follow-up|Death|1|||
33388324|NCT03363165|101309191|FG001|12-month Follow-up|Death|1|||
33388325|NCT03363165|101309190|FG000|12-month Follow-up|Withdrawal by Subject|1|||
33388326|NCT03363165|101309191|FG001|12-month Follow-up|Withdrawal by Subject|1|||
33388327|NCT01313078|101309192|FG000|Overall Study|Death|1|||
33388328|NCT01313078|101309192|FG000|Overall Study|Discontinued study drug|1|||
33388329|NCT01313078|101309192|FG000|Overall Study|Withdrawal by Subject|1|||
33388330|NCT01175590|101309193|FG000|Overall Study|Lost to Follow-up|1|||
33388331|NCT01175590|101309194|FG001|Overall Study|Lost to Follow-up|0|||
33388332|NCT01175590|101309193|FG000|Overall Study|Withdrawal by Subject|0|||
33388333|NCT01175590|101309194|FG001|Overall Study|Withdrawal by Subject|2|||
33388334|NCT01175590|101309193|FG000|Overall Study|Adverse Event|4|||
33438832|NCT03831048|101499959|FG000|Overall Study|Re-transplant|0|||
33438833|NCT03831048|101499960|FG001|Overall Study|Re-transplant|2|||
33388335|NCT01175590|101309194|FG001|Overall Study|Adverse Event|0|||
33388336|NCT01175590|101309193|FG000|Overall Study|Physician Decision|1|||
33388337|NCT01175590|101309194|FG001|Overall Study|Physician Decision|4|||
33388338|NCT01175590|101309193|FG000|Overall Study|Lack of Efficacy|1|||
33438834|NCT03831048|101499959|FG000|Overall Study|Protocol violation and death|1|||
33438835|NCT03831048|101499960|FG001|Overall Study|Protocol violation and death|1|||
33388339|NCT01175590|101309194|FG001|Overall Study|Lack of Efficacy|1|||
33438836|NCT01666730|101499962|FG000|Overall Study|Adverse Event|16|||
33438837|NCT01666730|101499962|FG000|Overall Study|Death|2|||
33438838|NCT01666730|101499962|FG000|Overall Study|Physician Decision|5|||
33438839|NCT01666730|101499962|FG000|Overall Study|Withdrawal by Subject|9|||
33438840|NCT01666730|101499962|FG000|Overall Study|Disease progression/relapse|18|||
33438841|NCT04276883|101499965|FG000|Overall Study|Withdrawal by Subject|2|||
33388340|NCT01175590|101309193|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
33388341|NCT01175590|101309194|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
33388342|NCT01175590|101309193|FG000|Overall Study|Treated not as randomized|3|||
33388343|NCT01175590|101309194|FG001|Overall Study|Treated not as randomized|2|||
33388344|NCT01175590|101309193|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
33388345|NCT01175590|101309194|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
33388346|NCT01175590|101309193|FG000|Overall Study|Protocol Violation|0|||
33438842|NCT04276883|101499966|FG001|Overall Study|Withdrawal by Subject|3|||
33438843|NCT04276883|101499967|FG002|Overall Study|Withdrawal by Subject|6|||
33438844|NCT04276883|101499965|FG000|Overall Study|Lost to Follow-up|1|||
33438845|NCT04276883|101499966|FG001|Overall Study|Lost to Follow-up|3|||
33438846|NCT04276883|101499967|FG002|Overall Study|Lost to Follow-up|0|||
33438847|NCT04276883|101499965|FG000|Overall Study|Adverse Event|0|||
33156607|NCT02345226|100485649|FG001|Double-Blind Phase|Lack of Efficacy|0|||
33156608|NCT02345226|100485648|FG000|Double-Blind Phase|Investigator's Discretion|4|||
33156609|NCT02345226|100485649|FG001|Double-Blind Phase|Investigator's Discretion|3|||
33156610|NCT02345226|100485648|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
33156611|NCT02345226|100485649|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
33156612|NCT02345226|100485648|FG000|Double-Blind Phase|Withdrew Consent|41|||
33156613|NCT02345226|100485649|FG001|Double-Blind Phase|Withdrew Consent|39|||
33156614|NCT02345226|100485648|FG000|Double-Blind Phase|Lost to Follow-up|12|||
33156615|NCT02345226|100485649|FG001|Double-Blind Phase|Lost to Follow-up|16|||
33156616|NCT02345226|100485648|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
33156617|NCT02345226|100485649|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
33156618|NCT02345226|100485648|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
33156619|NCT02345226|100485649|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
33156620|NCT00142935|100485650|FG000|Overall Study|Other reason|1|||
33156621|NCT00142935|100485651|FG001|Overall Study|Other reason|1|||
33156622|NCT00142935|100485652|FG002|Overall Study|Other reason|1|||
33156623|NCT00142935|100485650|FG000|Overall Study|Lost to Follow-up|2|||
33156624|NCT00142935|100485651|FG001|Overall Study|Lost to Follow-up|5|||
33156625|NCT00142935|100485652|FG002|Overall Study|Lost to Follow-up|5|||
33156626|NCT00142935|100485650|FG000|Overall Study|Death|0|||
33156627|NCT00142935|100485651|FG001|Overall Study|Death|2|||
33156628|NCT00142935|100485652|FG002|Overall Study|Death|1|||
33156629|NCT04195906|100485655|FG000|Part 1|Adverse Event|3|||
33156630|NCT04195906|100485656|FG001|Part 1|Adverse Event|7|||
33156631|NCT04195906|100485655|FG000|Part 1|Withdrawal by Subject|0|||
33156632|NCT04195906|100485656|FG001|Part 1|Withdrawal by Subject|1|||
33156633|NCT04195906|100485655|FG000|Part 2|Adverse Event|1|||
33156634|NCT04195906|100485656|FG001|Part 2|Adverse Event|1|||
33156635|NCT04195906|100485655|FG000|Part 2|Withdrawal by Subject|0|||
33156636|NCT04195906|100485656|FG001|Part 2|Withdrawal by Subject|3|||
33156637|NCT04195906|100485655|FG000|Part 2|Other|1|||
33156638|NCT04195906|100485656|FG001|Part 2|Other|3|||
33156639|NCT02601027|100485667|FG000|Registration to Surgery|Withdrawal by Subject|20|||
33156640|NCT02601027|100485668|FG001|Registration to Surgery|Withdrawal by Subject|10|||
33388347|NCT01175590|101309194|FG001|Overall Study|Protocol Violation|1|||
33388348|NCT02076334|101309195|FG000|Overall Study|Protocol Violation|1|||
33388349|NCT02076334|101309196|FG001|Overall Study|Protocol Violation|0|||
33388350|NCT02076334|101309197|FG002|Overall Study|Protocol Violation|0|||
33388351|NCT02076334|101309198|FG003|Overall Study|Protocol Violation|0|||
33388352|NCT02076334|101309195|FG000|Overall Study|Lost to Follow-up|0|||
33388353|NCT02076334|101309196|FG001|Overall Study|Lost to Follow-up|1|||
33438848|NCT04276883|101499966|FG001|Overall Study|Adverse Event|1|||
33438849|NCT04276883|101499967|FG002|Overall Study|Adverse Event|0|||
33438850|NCT04276883|101499965|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
33156641|NCT01952145|100485676|FG000|Overall Study|Protocol Violation|2|||
33156642|NCT01952145|100485677|FG001|Overall Study|Protocol Violation|1|||
33438851|NCT04276883|101499966|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
33438852|NCT04276883|101499967|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
33156643|NCT01952145|100485676|FG000|Overall Study|Death|0|||
33156644|NCT01952145|100485677|FG001|Overall Study|Death|1|||
33156645|NCT01952145|100485676|FG000|Overall Study|Adverse Event|9|||
33156646|NCT01952145|100485677|FG001|Overall Study|Adverse Event|0|||
33156647|NCT01952145|100485676|FG000|Overall Study|Withdrawal Criteria|16|||
33156648|NCT01952145|100485677|FG001|Overall Study|Withdrawal Criteria|11|||
33388354|NCT02076334|101309197|FG002|Overall Study|Lost to Follow-up|1|||
33388355|NCT02076334|101309198|FG003|Overall Study|Lost to Follow-up|0|||
33156649|NCT01952145|100485676|FG000|Overall Study|Unclassified|1|||
33156650|NCT01952145|100485677|FG001|Overall Study|Unclassified|1|||
33156651|NCT00968864|100485678|FG000|Overall Study|Protocol exception/ not evaluable|1|||
33156652|NCT03277690|100485679|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
33156653|NCT03277690|100485680|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
33156654|NCT03277690|100485679|FG000|Dose Titration and Maintenance|Physician Decision|1|||
33156655|NCT03277690|100485680|FG001|Dose Titration and Maintenance|Physician Decision|0|||
33156656|NCT03277690|100485679|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
33156657|NCT03277690|100485680|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
33156658|NCT03277690|100485679|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
33156659|NCT03277690|100485680|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
33156660|NCT03277690|100485679|FG000|Dose Titration and Maintenance|Adverse Event|15|||
33156661|NCT03277690|100485680|FG001|Dose Titration and Maintenance|Adverse Event|0|||
33156662|NCT03277690|100485679|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
33156663|NCT03277690|100485680|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
33156664|NCT03277690|100485679|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
33156665|NCT03277690|100485680|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
33156666|NCT02609828|100485687|FG000|Overall Study|Adverse Event|8|||
33156667|NCT02609828|100485688|FG001|Overall Study|Adverse Event|1|||
33156668|NCT02609828|100485689|FG002|Overall Study|Adverse Event|0|||
33156669|NCT02609828|100485690|FG003|Overall Study|Adverse Event|6|||
33156670|NCT02609828|100485687|FG000|Overall Study|Death|15|||
33156671|NCT02609828|100485688|FG001|Overall Study|Death|1|||
33156672|NCT02609828|100485689|FG002|Overall Study|Death|1|||
33156673|NCT02609828|100485690|FG003|Overall Study|Death|19|||
33156674|NCT02609828|100485687|FG000|Overall Study|Insufficient clinical response|2|||
33156675|NCT02609828|100485688|FG001|Overall Study|Insufficient clinical response|1|||
33156676|NCT02609828|100485689|FG002|Overall Study|Insufficient clinical response|0|||
33156677|NCT02609828|100485690|FG003|Overall Study|Insufficient clinical response|0|||
33156678|NCT02609828|100485687|FG000|Overall Study|Lost to Follow-up|0|||
33156679|NCT02609828|100485688|FG001|Overall Study|Lost to Follow-up|0|||
33156680|NCT02609828|100485689|FG002|Overall Study|Lost to Follow-up|0|||
33156681|NCT02609828|100485690|FG003|Overall Study|Lost to Follow-up|1|||
33156682|NCT02609828|100485687|FG000|Overall Study|Protocol Violation|2|||
33156683|NCT02609828|100485688|FG001|Overall Study|Protocol Violation|0|||
33156684|NCT02609828|100485689|FG002|Overall Study|Protocol Violation|0|||
33156685|NCT02609828|100485690|FG003|Overall Study|Protocol Violation|1|||
33156686|NCT02609828|100485687|FG000|Overall Study|Withdrawal by Subject|12|||
33156687|NCT02609828|100485688|FG001|Overall Study|Withdrawal by Subject|1|||
33156688|NCT02609828|100485689|FG002|Overall Study|Withdrawal by Subject|0|||
33156689|NCT02609828|100485690|FG003|Overall Study|Withdrawal by Subject|10|||
33156690|NCT02609828|100485687|FG000|Overall Study|Other|3|||
33156691|NCT02609828|100485688|FG001|Overall Study|Other|0|||
33156692|NCT02609828|100485689|FG002|Overall Study|Other|0|||
33156693|NCT02609828|100485690|FG003|Overall Study|Other|6|||
33156694|NCT02609828|100485687|FG000|Overall Study|Randomized but not treated|1|||
33156695|NCT02609828|100485688|FG001|Overall Study|Randomized but not treated|0|||
33156696|NCT02609828|100485689|FG002|Overall Study|Randomized but not treated|0|||
33156697|NCT02609828|100485690|FG003|Overall Study|Randomized but not treated|0|||
33156698|NCT02281773|100485691|FG000|Overall Study|Adverse Event|6|||
33156699|NCT02281773|100485692|FG001|Overall Study|Adverse Event|1|||
33156700|NCT02281773|100485693|FG002|Overall Study|Adverse Event|4|||
33156701|NCT02281773|100485694|FG003|Overall Study|Adverse Event|8|||
33156702|NCT02281773|100485695|FG004|Overall Study|Adverse Event|9|||
33156703|NCT02281773|100485691|FG000|Overall Study|Protocol Violation|1|||
33156704|NCT02281773|100485692|FG001|Overall Study|Protocol Violation|0|||
33156705|NCT02281773|100485693|FG002|Overall Study|Protocol Violation|0|||
33156706|NCT02281773|100485694|FG003|Overall Study|Protocol Violation|2|||
33156707|NCT02281773|100485695|FG004|Overall Study|Protocol Violation|2|||
33156708|NCT02281773|100485691|FG000|Overall Study|Lost to Follow-up|2|||
33156709|NCT02281773|100485692|FG001|Overall Study|Lost to Follow-up|2|||
33156710|NCT02281773|100485693|FG002|Overall Study|Lost to Follow-up|6|||
33156711|NCT02281773|100485694|FG003|Overall Study|Lost to Follow-up|2|||
33156712|NCT02281773|100485695|FG004|Overall Study|Lost to Follow-up|10|||
33388356|NCT02076334|101309195|FG000|Overall Study|muscle soreness|0|||
33156713|NCT02281773|100485691|FG000|Overall Study|Withdrawal by Subject|2|||
33156714|NCT02281773|100485692|FG001|Overall Study|Withdrawal by Subject|8|||
33156715|NCT02281773|100485693|FG002|Overall Study|Withdrawal by Subject|6|||
33156716|NCT02281773|100485694|FG003|Overall Study|Withdrawal by Subject|6|||
33156717|NCT02281773|100485695|FG004|Overall Study|Withdrawal by Subject|8|||
33438853|NCT01045096|101499969|FG000|Overall Study|Withdrawal by Subject|2|||
33438854|NCT01045096|101499970|FG001|Overall Study|Withdrawal by Subject|0|||
33438855|NCT01045096|101499971|FG002|Overall Study|Withdrawal by Subject|0|||
33438856|NCT01045096|101499969|FG000|Overall Study|Other|1|||
33438857|NCT01045096|101499970|FG001|Overall Study|Other|0|||
33438858|NCT01045096|101499971|FG002|Overall Study|Other|0|||
33438859|NCT00683293|101499985|FG000|Overall Study|Withdrawal by Subject|2|||
33438860|NCT00683293|101499986|FG001|Overall Study|Withdrawal by Subject|3|||
33438861|NCT05097326|101499987|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
33438862|NCT05097326|101499988|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
33438863|NCT01391793|101499991|FG000|Overall Study|Ineligible|3|||
33438864|NCT01391793|101499992|FG001|Overall Study|Ineligible|0|||
33156718|NCT02281773|100485691|FG000|Overall Study|Other Reason|0|||
33156719|NCT02281773|100485692|FG001|Overall Study|Other Reason|4|||
33156720|NCT02281773|100485693|FG002|Overall Study|Other Reason|2|||
33156721|NCT02281773|100485694|FG003|Overall Study|Other Reason|3|||
33156722|NCT02281773|100485695|FG004|Overall Study|Other Reason|1|||
33156723|NCT02761733|100489630|FG000|Overall Study|Death|3|||
33156724|NCT02761733|100489631|FG001|Overall Study|Death|5|||
33156725|NCT02761733|100489632|FG002|Overall Study|Death|1|||
33156726|NCT02761733|100489633|FG003|Overall Study|Death|1|||
33156727|NCT02761733|100489630|FG000|Overall Study|Lost to Follow-up|6|||
33156728|NCT02761733|100489631|FG001|Overall Study|Lost to Follow-up|7|||
33156729|NCT02761733|100489632|FG002|Overall Study|Lost to Follow-up|0|||
33156730|NCT02761733|100489633|FG003|Overall Study|Lost to Follow-up|3|||
33156731|NCT02761733|100489630|FG000|Overall Study|Physician Decision|4|||
33156732|NCT02761733|100489631|FG001|Overall Study|Physician Decision|0|||
33156733|NCT02761733|100489632|FG002|Overall Study|Physician Decision|0|||
33156734|NCT02761733|100489633|FG003|Overall Study|Physician Decision|0|||
33156735|NCT02761733|100489630|FG000|Overall Study|Withdrawal by Subject|2|||
33156736|NCT02761733|100489631|FG001|Overall Study|Withdrawal by Subject|0|||
33156737|NCT02761733|100489632|FG002|Overall Study|Withdrawal by Subject|0|||
33156738|NCT02761733|100489633|FG003|Overall Study|Withdrawal by Subject|0|||
33156739|NCT02761733|100489630|FG000|Overall Study|Discharged from Study Site|10|||
33156740|NCT02761733|100489631|FG001|Overall Study|Discharged from Study Site|9|||
33156741|NCT02761733|100489632|FG002|Overall Study|Discharged from Study Site|25|||
33156742|NCT02761733|100489633|FG003|Overall Study|Discharged from Study Site|11|||
33156743|NCT02761733|100489630|FG000|Overall Study|Cognitive Impairment|5|||
33156744|NCT02761733|100489631|FG001|Overall Study|Cognitive Impairment|0|||
33156745|NCT02761733|100489632|FG002|Overall Study|Cognitive Impairment|1|||
33156746|NCT02761733|100489633|FG003|Overall Study|Cognitive Impairment|0|||
33156747|NCT02058693|100489647|FG000|Phase 1|Withdrawal by Subject|3|||
33156748|NCT02058693|100489648|FG001|Phase 1|Withdrawal by Subject|2|||
33156749|NCT02058693|100489647|FG000|Phase 1|Adverse Event|0|||
33156750|NCT02058693|100489648|FG001|Phase 1|Adverse Event|1|||
33156751|NCT02058693|100489647|FG000|Phase 1|Lack of Efficacy|1|||
33156752|NCT02058693|100489648|FG001|Phase 1|Lack of Efficacy|0|||
33156753|NCT02058693|100489647|FG000|Phase 1|Physician Decision|1|||
33156754|NCT02058693|100489648|FG001|Phase 1|Physician Decision|1|||
33388357|NCT02076334|101309196|FG001|Overall Study|muscle soreness|0|||
33388358|NCT02076334|101309197|FG002|Overall Study|muscle soreness|0|||
33388359|NCT02076334|101309198|FG003|Overall Study|muscle soreness|1|||
33388360|NCT02443805|101309200|FG000|Overall Study|Adverse Event|100|||
33388361|NCT02443805|101309201|FG001|Overall Study|Adverse Event|18|||
33388362|NCT02443805|101309200|FG000|Overall Study|Withdrawal by Subject|73|||
33388363|NCT02443805|101309201|FG001|Overall Study|Withdrawal by Subject|74|||
33388364|NCT02443805|101309200|FG000|Overall Study|Lost to Follow-up|19|||
33388365|NCT02443805|101309201|FG001|Overall Study|Lost to Follow-up|14|||
33388366|NCT02443805|101309200|FG000|Overall Study|Pregnancy|6|||
33388367|NCT02443805|101309201|FG001|Overall Study|Pregnancy|5|||
33388368|NCT02443805|101309200|FG000|Overall Study|Protocol Violation|2|||
33438865|NCT01391793|101499991|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
33438866|NCT01391793|101499992|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
33438867|NCT01391793|101499991|FG000|Overall Study|No DMSA|73|||
33438868|NCT01391793|101499992|FG001|Overall Study|No DMSA|57|||
33438869|NCT02684578|101499997|FG000|Overall Study|Withdrawal by Subject|10|||
33156755|NCT02058693|100489647|FG000|Phase 2|Withdrawal by Subject|0|||
33156756|NCT02058693|100489648|FG001|Phase 2|Withdrawal by Subject|2|||
33156757|NCT02476201|100489649|FG000|Overall Study|Unable to program MPP|9|||
33156758|NCT02476201|100489649|FG000|Overall Study|Study echo not performed|5|||
33156759|NCT02476201|100489649|FG000|Overall Study|Adverse Event|4|||
33388369|NCT02443805|101309201|FG001|Overall Study|Protocol Violation|4|||
33388370|NCT02443805|101309200|FG000|Overall Study|Lack of Efficacy|1|||
33156760|NCT02476201|100489649|FG000|Overall Study|Death|2|||
33156761|NCT02476201|100489649|FG000|Overall Study|Lost to Follow-up|2|||
33156762|NCT02476201|100489649|FG000|Overall Study|MPP programmed to OFF|2|||
33156763|NCT02476201|100489649|FG000|Overall Study|Withdrawal by Subject|1|||
33156764|NCT02476201|100489649|FG000|Overall Study|Unsuccessful implant|1|||
33388371|NCT02443805|101309201|FG001|Overall Study|Lack of Efficacy|1|||
33438870|NCT02684578|101499998|FG001|Overall Study|Withdrawal by Subject|7|||
33438871|NCT02684578|101499997|FG000|Overall Study|Lost to Follow-up|0|||
33438872|NCT02684578|101499998|FG001|Overall Study|Lost to Follow-up|3|||
33438873|NCT02684578|101499997|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
33438874|NCT02684578|101499998|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
33388372|NCT02443805|101309200|FG000|Overall Study|Non-compliance with study drug|6|||
33388373|NCT02443805|101309201|FG001|Overall Study|Non-compliance with study drug|4|||
33388374|NCT02443805|101309200|FG000|Overall Study|Withdrawal by parent/guardian|3|||
33388375|NCT02443805|101309201|FG001|Overall Study|Withdrawal by parent/guardian|5|||
33388376|NCT02443805|101309200|FG000|Overall Study|Any other reason not above-mentioned|3|||
33388377|NCT02443805|101309201|FG001|Overall Study|Any other reason not above-mentioned|2|||
33388378|NCT00688545|101309202|FG000|Overall Study|Lost to Follow-up|1|||
33388379|NCT00688545|101309203|FG001|Overall Study|Lost to Follow-up|4|||
33388380|NCT00688545|101309202|FG000|Overall Study|Insurance/cost of drug|0|||
33388381|NCT00688545|101309203|FG001|Overall Study|Insurance/cost of drug|1|||
33388382|NCT00688545|101309202|FG000|Overall Study|Withdrawal by Subject|2|||
33388383|NCT00688545|101309203|FG001|Overall Study|Withdrawal by Subject|3|||
33388384|NCT00688545|101309202|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
33388385|NCT00688545|101309203|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
33388386|NCT02657434|101309206|FG000|Overall Study|Study Terminated By Sponsor|64|||
33388387|NCT02657434|101309207|FG001|Overall Study|Study Terminated By Sponsor|82|||
33388388|NCT02657434|101309206|FG000|Overall Study|Death|189|||
33388389|NCT02657434|101309207|FG001|Overall Study|Death|190|||
33388390|NCT02657434|101309206|FG000|Overall Study|Lost to Follow-up|2|||
33388391|NCT02657434|101309207|FG001|Overall Study|Lost to Follow-up|2|||
33388392|NCT02657434|101309206|FG000|Overall Study|Randomization by Error|2|||
33388393|NCT02657434|101309207|FG001|Overall Study|Randomization by Error|0|||
33388394|NCT02657434|101309206|FG000|Overall Study|Withdrawal by Subject|28|||
33388395|NCT02657434|101309207|FG001|Overall Study|Withdrawal by Subject|17|||
33388396|NCT02657434|101309206|FG000|Overall Study|Protocol Violation|1|||
33388397|NCT02657434|101309207|FG001|Overall Study|Protocol Violation|0|||
33438875|NCT02684578|101499997|FG000|Overall Study|Missing follow-up data|0|||
33388398|NCT02657434|101309206|FG000|Overall Study|Physician Decision|0|||
33388399|NCT02657434|101309207|FG001|Overall Study|Physician Decision|1|||
33388400|NCT02574481|101309208|FG000|Overall Study|Withdrawal by Subject|29|||
33388401|NCT02574481|101309209|FG001|Overall Study|Withdrawal by Subject|15|||
33156765|NCT00370071|100489650|FG000|Overall Study|Withdrawal by Subject|2|||
33156766|NCT02906332|100489651|FG000|Overall Study|Withdrawal by Subject|1|||
33156767|NCT00734474|100489652|FG000|Overall Study|Entry Criteria Not Met|0|||
33156768|NCT00734474|100489653|FG001|Overall Study|Entry Criteria Not Met|0|||
33156769|NCT00734474|100489654|FG002|Overall Study|Entry Criteria Not Met|5|||
33156770|NCT00734474|100489655|FG003|Overall Study|Entry Criteria Not Met|0|||
33156771|NCT00734474|100489656|FG004|Overall Study|Entry Criteria Not Met|3|||
33156772|NCT00734474|100489657|FG005|Overall Study|Entry Criteria Not Met|1|||
33156773|NCT00734474|100489658|FG006|Overall Study|Entry Criteria Not Met|0|||
33156774|NCT00734474|100489659|FG007|Overall Study|Entry Criteria Not Met|1|||
33156775|NCT00734474|100489660|FG008|Overall Study|Entry Criteria Not Met|1|||
33156776|NCT00734474|100489652|FG000|Overall Study|Lost to Follow-up|1|||
33156777|NCT00734474|100489653|FG001|Overall Study|Lost to Follow-up|0|||
33156778|NCT00734474|100489654|FG002|Overall Study|Lost to Follow-up|13|||
33156779|NCT00734474|100489655|FG003|Overall Study|Lost to Follow-up|0|||
33156780|NCT00734474|100489656|FG004|Overall Study|Lost to Follow-up|11|||
33156781|NCT00734474|100489657|FG005|Overall Study|Lost to Follow-up|1|||
33156782|NCT00734474|100489658|FG006|Overall Study|Lost to Follow-up|0|||
33156783|NCT00734474|100489659|FG007|Overall Study|Lost to Follow-up|9|||
33156784|NCT00734474|100489660|FG008|Overall Study|Lost to Follow-up|4|||
33156785|NCT00734474|100489652|FG000|Overall Study|Withdrawal by Subject|2|||
33156786|NCT00734474|100489653|FG001|Overall Study|Withdrawal by Subject|1|||
33156787|NCT00734474|100489654|FG002|Overall Study|Withdrawal by Subject|18|||
33156788|NCT00734474|100489655|FG003|Overall Study|Withdrawal by Subject|0|||
33156789|NCT00734474|100489656|FG004|Overall Study|Withdrawal by Subject|24|||
33156790|NCT00734474|100489657|FG005|Overall Study|Withdrawal by Subject|2|||
33156791|NCT00734474|100489658|FG006|Overall Study|Withdrawal by Subject|0|||
33253280|NCT00102063|100827514|FG001|Overall Study|Withdrawal by Subject|12|||
33253281|NCT00102063|100827515|FG002|Overall Study|Withdrawal by Subject|5|||
33253282|NCT00102063|100827513|FG000|Overall Study|Lost to Follow-up|0|||
33253283|NCT00102063|100827514|FG001|Overall Study|Lost to Follow-up|0|||
33253284|NCT00102063|100827515|FG002|Overall Study|Lost to Follow-up|1|||
33253285|NCT00102063|100827513|FG000|Overall Study|Protocol Violation|0|||
33253286|NCT00102063|100827514|FG001|Overall Study|Protocol Violation|1|||
33388402|NCT02574481|101309210|FG002|Overall Study|Withdrawal by Subject|4|||
33388403|NCT02574481|101309211|FG003|Overall Study|Withdrawal by Subject|1|||
33388404|NCT02574481|101309208|FG000|Overall Study|Adverse Event|5|||
33388405|NCT02574481|101309209|FG001|Overall Study|Adverse Event|1|||
33388406|NCT02574481|101309210|FG002|Overall Study|Adverse Event|1|||
33388407|NCT02574481|101309211|FG003|Overall Study|Adverse Event|0|||
33388408|NCT02574481|101309208|FG000|Overall Study|Visit Missed|15|||
33388409|NCT02574481|101309209|FG001|Overall Study|Visit Missed|7|||
33388410|NCT02574481|101309210|FG002|Overall Study|Visit Missed|5|||
33388411|NCT02574481|101309211|FG003|Overall Study|Visit Missed|0|||
33388412|NCT02574481|101309208|FG000|Overall Study|Other|7|||
33388413|NCT02574481|101309209|FG001|Overall Study|Other|2|||
33388414|NCT02574481|101309210|FG002|Overall Study|Other|0|||
33388415|NCT02574481|101309211|FG003|Overall Study|Other|0|||
33388416|NCT02574481|101309208|FG000|Overall Study|Death|48|||
33388417|NCT02574481|101309209|FG001|Overall Study|Death|26|||
33388418|NCT02574481|101309210|FG002|Overall Study|Death|12|||
33388419|NCT02574481|101309211|FG003|Overall Study|Death|4|||
33388420|NCT02574481|101309208|FG000|Overall Study|Physician Decision|5|||
33156792|NCT00734474|100489659|FG007|Overall Study|Withdrawal by Subject|36|||
33388421|NCT02574481|101309209|FG001|Overall Study|Physician Decision|2|||
33156793|NCT00734474|100489660|FG008|Overall Study|Withdrawal by Subject|21|||
33156794|NCT00734474|100489652|FG000|Overall Study|Physician Decision|0|||
33253287|NCT00102063|100827515|FG002|Overall Study|Protocol Violation|1|||
33253288|NCT01063036|100827516|FG000|Participants Treated With Study Drug|Adverse Event|1|||
33253289|NCT01063036|100827516|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
33388422|NCT02574481|101309210|FG002|Overall Study|Physician Decision|0|||
33156795|NCT00734474|100489653|FG001|Overall Study|Physician Decision|0|||
33156796|NCT00734474|100489654|FG002|Overall Study|Physician Decision|4|||
33156797|NCT00734474|100489655|FG003|Overall Study|Physician Decision|1|||
33156798|NCT00734474|100489656|FG004|Overall Study|Physician Decision|11|||
33156799|NCT00734474|100489657|FG005|Overall Study|Physician Decision|0|||
33156800|NCT00734474|100489658|FG006|Overall Study|Physician Decision|0|||
33156801|NCT00734474|100489659|FG007|Overall Study|Physician Decision|9|||
33156802|NCT00734474|100489660|FG008|Overall Study|Physician Decision|9|||
33156803|NCT00734474|100489652|FG000|Overall Study|Adverse Event|4|||
33156804|NCT00734474|100489653|FG001|Overall Study|Adverse Event|4|||
33156805|NCT00734474|100489654|FG002|Overall Study|Adverse Event|63|||
33156806|NCT00734474|100489655|FG003|Overall Study|Adverse Event|1|||
33156807|NCT00734474|100489656|FG004|Overall Study|Adverse Event|64|||
33156808|NCT00734474|100489657|FG005|Overall Study|Adverse Event|0|||
33156809|NCT00734474|100489658|FG006|Overall Study|Adverse Event|1|||
33156810|NCT00734474|100489659|FG007|Overall Study|Adverse Event|65|||
33156811|NCT00734474|100489660|FG008|Overall Study|Adverse Event|39|||
33156812|NCT00734474|100489652|FG000|Overall Study|Protocol Violation|0|||
33156813|NCT00734474|100489653|FG001|Overall Study|Protocol Violation|0|||
33388423|NCT02574481|101309211|FG003|Overall Study|Physician Decision|0|||
33388424|NCT02574481|101309208|FG000|Overall Study|Lost to Follow-up|5|||
33388425|NCT02574481|101309209|FG001|Overall Study|Lost to Follow-up|1|||
33388426|NCT02574481|101309210|FG002|Overall Study|Lost to Follow-up|3|||
33156814|NCT00734474|100489654|FG002|Overall Study|Protocol Violation|4|||
33156815|NCT00734474|100489655|FG003|Overall Study|Protocol Violation|0|||
33156816|NCT00734474|100489656|FG004|Overall Study|Protocol Violation|3|||
33156817|NCT00734474|100489657|FG005|Overall Study|Protocol Violation|0|||
33253290|NCT01063036|100827516|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
33253291|NCT01063036|100827516|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
33388427|NCT02574481|101309211|FG003|Overall Study|Lost to Follow-up|0|||
33438876|NCT02684578|101499998|FG001|Overall Study|Missing follow-up data|1|||
33156818|NCT00734474|100489658|FG006|Overall Study|Protocol Violation|0|||
33388428|NCT02925312|101309215|FG000|Overall Study|Lost to Follow-up|25|||
33388429|NCT02925312|101309216|FG001|Overall Study|Lost to Follow-up|0|||
33388430|NCT02925312|101309215|FG000|Overall Study|Adverse Event|2|||
33388431|NCT02925312|101309216|FG001|Overall Study|Adverse Event|0|||
33388432|NCT00517413|101309218|FG000|Overall Study|Adverse Event|7|||
33388433|NCT00517413|101309218|FG000|Overall Study|Death|13|||
33388434|NCT00517413|101309218|FG000|Overall Study|Protocol Violation|15|||
33388435|NCT00517413|101309218|FG000|Overall Study|Withdrawal by Subject|2|||
33388436|NCT00517413|101309218|FG000|Overall Study|Failure to return|1|||
33388437|NCT00517413|101309218|FG000|Overall Study|Other-Reasons|23|||
33388438|NCT01468701|101309219|FG000|Overall Study|Not eligible|91|||
33388439|NCT01468701|101309220|FG001|Overall Study|Not eligible|140|||
33388440|NCT01468701|101309221|FG002|Overall Study|Not eligible|29|||
33438877|NCT02796664|101499999|FG000|Overall Study|Withdrawal by Subject|0|||
33438878|NCT02796664|101500000|FG001|Overall Study|Withdrawal by Subject|3|||
33438879|NCT02796664|101499999|FG000|Overall Study|Noncompliance|1|||
33388441|NCT01468701|101309222|FG003|Overall Study|Not eligible|12|||
33388442|NCT01468701|101309223|FG004|Overall Study|Not eligible|22|||
33388443|NCT01468701|101309224|FG005|Overall Study|Not eligible|2|||
33388444|NCT01468701|101309225|FG006|Overall Study|Not eligible|39|||
33388445|NCT01468701|101309226|FG007|Overall Study|Not eligible|1|||
33388446|NCT01468701|101309227|FG008|Overall Study|Not eligible|40|||
33388447|NCT01468701|101309228|FG009|Overall Study|Not eligible|126|||
33388448|NCT01468701|101309229|FG010|Overall Study|Not eligible|39|||
33388449|NCT01468701|101309230|FG011|Overall Study|Not eligible|33|||
33388450|NCT01468701|101309231|FG012|Overall Study|Not eligible|1|||
33388451|NCT01468701|101309232|FG013|Overall Study|Not eligible|19|||
33388452|NCT01468701|101309233|FG014|Overall Study|Not eligible|1|||
33388453|NCT01468701|101309234|FG015|Overall Study|Not eligible|32|||
33388454|NCT01468701|101309235|FG016|Overall Study|Not eligible|0|||
33388455|NCT01468701|101309219|FG000|Overall Study|Lost to Follow-up|306|||
33388456|NCT01468701|101309220|FG001|Overall Study|Lost to Follow-up|0|||
33388457|NCT01468701|101309221|FG002|Overall Study|Lost to Follow-up|0|||
33388458|NCT01468701|101309222|FG003|Overall Study|Lost to Follow-up|0|||
33388459|NCT01468701|101309223|FG004|Overall Study|Lost to Follow-up|0|||
33388460|NCT01468701|101309224|FG005|Overall Study|Lost to Follow-up|0|||
33388461|NCT01468701|101309225|FG006|Overall Study|Lost to Follow-up|0|||
33388462|NCT01468701|101309226|FG007|Overall Study|Lost to Follow-up|0|||
33388463|NCT01468701|101309227|FG008|Overall Study|Lost to Follow-up|215|||
33388464|NCT01468701|101309228|FG009|Overall Study|Lost to Follow-up|309|||
33388465|NCT01468701|101309229|FG010|Overall Study|Lost to Follow-up|224|||
33388466|NCT01468701|101309230|FG011|Overall Study|Lost to Follow-up|212|||
33388467|NCT01468701|101309231|FG012|Overall Study|Lost to Follow-up|11|||
33388468|NCT01468701|101309232|FG013|Overall Study|Lost to Follow-up|164|||
33388469|NCT01468701|101309233|FG014|Overall Study|Lost to Follow-up|17|||
33388470|NCT01468701|101309234|FG015|Overall Study|Lost to Follow-up|127|||
33388471|NCT01468701|101309235|FG016|Overall Study|Lost to Follow-up|1|||
33438880|NCT02796664|101500000|FG001|Overall Study|Noncompliance|1|||
33388472|NCT01468701|101309219|FG000|Overall Study|Withdrawal by Subject|165|||
33388473|NCT01468701|101309220|FG001|Overall Study|Withdrawal by Subject|0|||
33388474|NCT01468701|101309221|FG002|Overall Study|Withdrawal by Subject|0|||
33388475|NCT01468701|101309222|FG003|Overall Study|Withdrawal by Subject|0|||
33388476|NCT01468701|101309223|FG004|Overall Study|Withdrawal by Subject|0|||
33438881|NCT02796664|101499999|FG000|Overall Study|Death|0|||
33438882|NCT02796664|101500000|FG001|Overall Study|Death|1|||
33438883|NCT00770510|101500001|FG000|Overall Study|Lost to Follow-up|2|||
33438884|NCT00770510|101500001|FG000|Overall Study|Pregnancy|1|||
33438885|NCT00770510|101500001|FG000|Overall Study|Withdrawal by Subject|2|||
33438886|NCT01287013|101500006|FG000|Overall Study|Non-evaluable|3|||
33438887|NCT01287013|101500007|FG001|Overall Study|Non-evaluable|5|||
33438888|NCT01287013|101500008|FG002|Overall Study|Non-evaluable|21|||
33438889|NCT00620763|101500009|FG000|Period: First Intervention|Withdrawal by Subject|0|||
33438890|NCT00620763|101500010|FG001|Period: First Intervention|Withdrawal by Subject|2|||
33438891|NCT00620763|101500009|FG000|Period: First Intervention|Protocol Violation|0|||
33438892|NCT00620763|101500010|FG001|Period: First Intervention|Protocol Violation|3|||
33438893|NCT00620763|101500009|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
33438894|NCT00620763|101500010|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
33438895|NCT00365300|101500011|FG000|Open-label Phase|Adverse Event|4|||
33438896|NCT00365300|101500012|FG001|Open-label Phase|Adverse Event|0|||
33438897|NCT00365300|101500011|FG000|Open-label Phase|Failed to Return|1|||
33438898|NCT00365300|101500012|FG001|Open-label Phase|Failed to Return|0|||
33438899|NCT00365300|101500011|FG000|Open-label Phase|Physician Decision|1|||
33438900|NCT00365300|101500012|FG001|Open-label Phase|Physician Decision|0|||
33438901|NCT00365300|101500011|FG000|Open-label Phase|Noncompliance|9|||
33438902|NCT00365300|101500012|FG001|Open-label Phase|Noncompliance|0|||
33438903|NCT00365300|101500011|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
33156819|NCT00734474|100489659|FG007|Overall Study|Protocol Violation|3|||
33156820|NCT00734474|100489660|FG008|Overall Study|Protocol Violation|1|||
33156821|NCT00734474|100489652|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
33156822|NCT00734474|100489653|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
33156823|NCT00734474|100489654|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
33156824|NCT00734474|100489655|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
33156825|NCT00734474|100489656|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
33156826|NCT00734474|100489657|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
33156827|NCT00734474|100489658|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
33156828|NCT00734474|100489659|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
33156829|NCT00734474|100489660|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
33156830|NCT00734474|100489652|FG000|Overall Study|Sponsor Decision|0|||
33156831|NCT00734474|100489653|FG001|Overall Study|Sponsor Decision|0|||
33438904|NCT00365300|101500012|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
33156832|NCT00734474|100489654|FG002|Overall Study|Sponsor Decision|0|||
33156833|NCT00734474|100489655|FG003|Overall Study|Sponsor Decision|0|||
33156834|NCT00734474|100489656|FG004|Overall Study|Sponsor Decision|2|||
33438905|NCT00365300|101500011|FG000|Open-label Phase|Protocol Violation|1|||
33156835|NCT00734474|100489657|FG005|Overall Study|Sponsor Decision|0|||
33438906|NCT00365300|101500012|FG001|Open-label Phase|Protocol Violation|0|||
33438907|NCT00365300|101500011|FG000|Open-label Phase|Lack of Efficacy|1|||
33438908|NCT00365300|101500012|FG001|Open-label Phase|Lack of Efficacy|0|||
33438909|NCT00365300|101500011|FG000|Open-label Phase|Patient skipped open label phase|1|||
33438910|NCT00365300|101500012|FG001|Open-label Phase|Patient skipped open label phase|0|||
33438911|NCT00365300|101500011|FG000|Double-blind Phase|Failed to return|1|||
33438912|NCT00365300|101500012|FG001|Double-blind Phase|Failed to return|0|||
33438913|NCT00365300|101500011|FG000|Double-blind Phase|Noncompliance|1|||
33438914|NCT00365300|101500012|FG001|Double-blind Phase|Noncompliance|1|||
33438915|NCT00365300|101500011|FG000|Double-blind Phase|Withdrawal by Subject|0|||
33438916|NCT00365300|101500012|FG001|Double-blind Phase|Withdrawal by Subject|1|||
33438917|NCT00365300|101500011|FG000|Double-blind Phase|Protocol Violation|3|||
33438918|NCT00365300|101500012|FG001|Double-blind Phase|Protocol Violation|1|||
33438919|NCT00365300|101500011|FG000|Double-blind Phase|Lack of Efficacy|6|||
33438920|NCT00365300|101500012|FG001|Double-blind Phase|Lack of Efficacy|6|||
33156836|NCT00734474|100489658|FG006|Overall Study|Sponsor Decision|0|||
33156837|NCT00734474|100489659|FG007|Overall Study|Sponsor Decision|0|||
33156838|NCT00734474|100489660|FG008|Overall Study|Sponsor Decision|0|||
33156839|NCT00734474|100489652|FG000|Overall Study|Death|0|||
33156840|NCT00734474|100489653|FG001|Overall Study|Death|0|||
33156841|NCT00734474|100489654|FG002|Overall Study|Death|1|||
33156842|NCT00734474|100489655|FG003|Overall Study|Death|0|||
33156843|NCT00734474|100489656|FG004|Overall Study|Death|0|||
33156844|NCT00734474|100489657|FG005|Overall Study|Death|0|||
33156845|NCT00734474|100489658|FG006|Overall Study|Death|0|||
33253292|NCT01063036|100827516|FG000|Participants Treated With Study Drug|Pregnancy|1|||
33253293|NCT01063036|100827516|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
33253294|NCT01063036|100827516|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
33253295|NCT01063036|100827516|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
33253296|NCT03615924|100827519|FG000|Overall Study|Withdrawal by Subject|2|||
33253297|NCT03615924|100827520|FG001|Overall Study|Withdrawal by Subject|5|||
33253298|NCT03615924|100827519|FG000|Overall Study|Death|3|||
33253299|NCT03615924|100827520|FG001|Overall Study|Death|1|||
33253300|NCT03615924|100827519|FG000|Overall Study|Lost to Follow-up|1|||
33438921|NCT03897088|101500014|FG000|Overall Study|Withdrawal by Subject|12|||
33438922|NCT03897088|101500015|FG001|Overall Study|Withdrawal by Subject|12|||
33156846|NCT00734474|100489659|FG007|Overall Study|Death|2|||
33156847|NCT00734474|100489660|FG008|Overall Study|Death|1|||
33156848|NCT00734474|100489652|FG000|Overall Study|Lack of Efficacy|0|||
33438923|NCT03897088|101500014|FG000|Overall Study|Lost to Follow-up|7|||
33156849|NCT00734474|100489653|FG001|Overall Study|Lack of Efficacy|0|||
33156850|NCT00734474|100489654|FG002|Overall Study|Lack of Efficacy|4|||
33253301|NCT03615924|100827520|FG001|Overall Study|Lost to Follow-up|0|||
33438924|NCT03897088|101500015|FG001|Overall Study|Lost to Follow-up|15|||
33156851|NCT00734474|100489655|FG003|Overall Study|Lack of Efficacy|0|||
33156852|NCT00734474|100489656|FG004|Overall Study|Lack of Efficacy|0|||
33438925|NCT03897088|101500014|FG000|Overall Study|Sponsor Decision|1|||
33438926|NCT03897088|101500015|FG001|Overall Study|Sponsor Decision|2|||
33438927|NCT03897088|101500014|FG000|Overall Study|COVID-19|2|||
33438928|NCT03897088|101500015|FG001|Overall Study|COVID-19|0|||
33438929|NCT03897088|101500014|FG000|Overall Study|Other|3|||
33438930|NCT03897088|101500015|FG001|Overall Study|Other|0|||
33438931|NCT03897088|101500014|FG000|Overall Study|Non-compliance with Study Drug|1|||
33253302|NCT03615924|100827519|FG000|Overall Study|Randomized in error|1|||
33438932|NCT03897088|101500015|FG001|Overall Study|Non-compliance with Study Drug|1|||
33438933|NCT03897088|101500014|FG000|Overall Study|Pregnancy|0|||
33438934|NCT03897088|101500015|FG001|Overall Study|Pregnancy|1|||
33156853|NCT00734474|100489657|FG005|Overall Study|Lack of Efficacy|0|||
33156854|NCT00734474|100489658|FG006|Overall Study|Lack of Efficacy|0|||
33156855|NCT00734474|100489659|FG007|Overall Study|Lack of Efficacy|4|||
33156856|NCT00734474|100489660|FG008|Overall Study|Lack of Efficacy|6|||
33156857|NCT01298531|100489661|FG000|Overall Study|Lack of Efficacy|0|||
33156858|NCT01298531|100489662|FG001|Overall Study|Lack of Efficacy|1|||
33156859|NCT01298531|100489661|FG000|Overall Study|Lost to Follow-up|2|||
33156860|NCT01298531|100489662|FG001|Overall Study|Lost to Follow-up|0|||
33156861|NCT01298531|100489661|FG000|Overall Study|Protocol Violation|1|||
33156862|NCT01298531|100489662|FG001|Overall Study|Protocol Violation|1|||
33156863|NCT01298531|100489661|FG000|Overall Study|Adverse Event|4|||
33156864|NCT01298531|100489662|FG001|Overall Study|Adverse Event|3|||
33156865|NCT01298531|100489661|FG000|Overall Study|Does not meet entrance criteria|0|||
33156866|NCT01298531|100489662|FG001|Overall Study|Does not meet entrance criteria|1|||
33156867|NCT01298531|100489661|FG000|Overall Study|Other|2|||
33156868|NCT01298531|100489662|FG001|Overall Study|Other|1|||
33156869|NCT02598960|100489663|FG000|Treatment Period|Disease Progression|4|||
33156870|NCT02598960|100489664|FG001|Treatment Period|Disease Progression|4|||
33156871|NCT02598960|100489665|FG002|Treatment Period|Disease Progression|4|||
33156872|NCT02598960|100489666|FG003|Treatment Period|Disease Progression|6|||
33156873|NCT02598960|100489667|FG004|Treatment Period|Disease Progression|8|||
33156874|NCT02598960|100489668|FG005|Treatment Period|Disease Progression|2|||
33156875|NCT02598960|100489669|FG006|Treatment Period|Disease Progression|2|||
33156876|NCT02598960|100489670|FG007|Treatment Period|Disease Progression|3|||
33156877|NCT02598960|100489671|FG008|Treatment Period|Disease Progression|7|||
33156878|NCT02598960|100489672|FG009|Treatment Period|Disease Progression|9|||
33156879|NCT02598960|100489673|FG010|Treatment Period|Disease Progression|7|||
33156880|NCT02598960|100489674|FG011|Treatment Period|Disease Progression|143|||
33156881|NCT02598960|100489675|FG012|Treatment Period|Disease Progression|23|||
33156882|NCT02598960|100489663|FG000|Treatment Period|Study drug toxicity|0|||
33156883|NCT02598960|100489664|FG001|Treatment Period|Study drug toxicity|0|||
33156884|NCT02598960|100489665|FG002|Treatment Period|Study drug toxicity|0|||
33156885|NCT02598960|100489666|FG003|Treatment Period|Study drug toxicity|0|||
33156886|NCT02598960|100489667|FG004|Treatment Period|Study drug toxicity|0|||
33156887|NCT02598960|100489668|FG005|Treatment Period|Study drug toxicity|0|||
33156888|NCT02598960|100489669|FG006|Treatment Period|Study drug toxicity|0|||
33156889|NCT02598960|100489670|FG007|Treatment Period|Study drug toxicity|0|||
33156890|NCT02598960|100489671|FG008|Treatment Period|Study drug toxicity|0|||
33156891|NCT02598960|100489672|FG009|Treatment Period|Study drug toxicity|1|||
33156892|NCT02598960|100489673|FG010|Treatment Period|Study drug toxicity|0|||
33156893|NCT02598960|100489674|FG011|Treatment Period|Study drug toxicity|3|||
33156894|NCT02598960|100489675|FG012|Treatment Period|Study drug toxicity|0|||
33156895|NCT02598960|100489663|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
33156896|NCT02598960|100489664|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
33156897|NCT02598960|100489665|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
33156898|NCT02598960|100489666|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
33156899|NCT02598960|100489667|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
33156900|NCT02598960|100489668|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
33156901|NCT02598960|100489669|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
33156902|NCT02598960|100489670|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
33156903|NCT02598960|100489671|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
33156904|NCT02598960|100489672|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
33156905|NCT02598960|100489673|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
33156906|NCT02598960|100489674|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
33156907|NCT02598960|100489675|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
33156908|NCT02598960|100489663|FG000|Treatment Period|participant request to discontinue|0|||
33156909|NCT02598960|100489664|FG001|Treatment Period|participant request to discontinue|1|||
33156910|NCT02598960|100489665|FG002|Treatment Period|participant request to discontinue|0|||
33156911|NCT02598960|100489666|FG003|Treatment Period|participant request to discontinue|0|||
33156912|NCT02598960|100489667|FG004|Treatment Period|participant request to discontinue|1|||
33156913|NCT02598960|100489668|FG005|Treatment Period|participant request to discontinue|0|||
33156914|NCT02598960|100489669|FG006|Treatment Period|participant request to discontinue|0|||
33156915|NCT02598960|100489670|FG007|Treatment Period|participant request to discontinue|0|||
33156916|NCT02598960|100489671|FG008|Treatment Period|participant request to discontinue|0|||
33438935|NCT02430870|101500018|FG000|Part 2|Voluntary Withdrawal|0|||
33438936|NCT02430870|101500019|FG001|Part 2|Voluntary Withdrawal|0|||
33438937|NCT02430870|101500020|FG002|Part 2|Voluntary Withdrawal|0|||
33438938|NCT02430870|101500021|FG003|Part 2|Voluntary Withdrawal|0|||
33438939|NCT02430870|101500022|FG004|Part 2|Voluntary Withdrawal|0|||
33438940|NCT02430870|101500023|FG005|Part 2|Voluntary Withdrawal|0|||
33438941|NCT02430870|101500024|FG006|Part 2|Voluntary Withdrawal|1|||
33438942|NCT02430870|101500025|FG007|Part 2|Voluntary Withdrawal|0|||
33438943|NCT02430870|101500018|FG000|Part 2|Other Reason Not Specified|0|||
33438944|NCT02430870|101500019|FG001|Part 2|Other Reason Not Specified|0|||
33438945|NCT02430870|101500020|FG002|Part 2|Other Reason Not Specified|0|||
33438946|NCT02430870|101500021|FG003|Part 2|Other Reason Not Specified|0|||
33438947|NCT02430870|101500022|FG004|Part 2|Other Reason Not Specified|0|||
33438948|NCT02430870|101500023|FG005|Part 2|Other Reason Not Specified|0|||
33438949|NCT02430870|101500024|FG006|Part 2|Other Reason Not Specified|0|||
33438950|NCT02430870|101500025|FG007|Part 2|Other Reason Not Specified|1|||
33438951|NCT03338972|101500026|FG000|Overall Study|Death|1|||
33438952|NCT03338972|101500027|FG001|Overall Study|Death|1|||
33438953|NCT03338972|101500028|FG002|Overall Study|Death|0|||
33438954|NCT03338972|101500029|FG003|Overall Study|Death|0|||
33438955|NCT03338972|101500026|FG000|Overall Study|Withdrawal by Subject|1|||
33438956|NCT03338972|101500027|FG001|Overall Study|Withdrawal by Subject|0|||
33438957|NCT03338972|101500028|FG002|Overall Study|Withdrawal by Subject|0|||
33438958|NCT03338972|101500029|FG003|Overall Study|Withdrawal by Subject|0|||
33438959|NCT00406848|101500034|FG000|Overall Study|Withdrawal by Subject|27|||
33438960|NCT00406848|101500035|FG001|Overall Study|Withdrawal by Subject|22|||
33438961|NCT00406848|101500034|FG000|Overall Study|Adverse Event|38|||
33438962|NCT00406848|101500035|FG001|Overall Study|Adverse Event|7|||
33438963|NCT00406848|101500034|FG000|Overall Study|Lack of Efficacy|9|||
33438964|NCT00406848|101500035|FG001|Overall Study|Lack of Efficacy|14|||
33438965|NCT00406848|101500034|FG000|Overall Study|Protocol Violation|10|||
33438966|NCT00406848|101500035|FG001|Overall Study|Protocol Violation|6|||
33438967|NCT00406848|101500034|FG000|Overall Study|Lost to Follow-up|6|||
33438968|NCT00406848|101500035|FG001|Overall Study|Lost to Follow-up|2|||
33438969|NCT00406848|101500034|FG000|Overall Study|Physician Decision|2|||
33438970|NCT00406848|101500035|FG001|Overall Study|Physician Decision|2|||
33438971|NCT00406848|101500034|FG000|Overall Study|Sponsor Decision|1|||
33438972|NCT00406848|101500035|FG001|Overall Study|Sponsor Decision|1|||
33438973|NCT01451762|101500040|FG000|Overall Study|Lost to Follow-up|3|||
33438974|NCT01451762|101500041|FG001|Overall Study|Lost to Follow-up|6|||
33438975|NCT01451762|101500042|FG002|Overall Study|Lost to Follow-up|6|||
33438976|NCT03830164|101500044|FG000|Overall Study|Adverse Event|0|||
33438977|NCT03830164|101500045|FG001|Overall Study|Adverse Event|2|||
33438978|NCT03830164|101500046|FG002|Overall Study|Adverse Event|0|||
33438979|NCT03830164|101500044|FG000|Overall Study|Lack of Efficacy|1|||
33438980|NCT03830164|101500045|FG001|Overall Study|Lack of Efficacy|5|||
33438981|NCT03830164|101500046|FG002|Overall Study|Lack of Efficacy|0|||
33438982|NCT03830164|101500044|FG000|Overall Study|Lost to Follow-up|0|||
33438983|NCT03830164|101500045|FG001|Overall Study|Lost to Follow-up|1|||
33438984|NCT03830164|101500046|FG002|Overall Study|Lost to Follow-up|0|||
33438985|NCT03830164|101500044|FG000|Overall Study|Withdrawal by Subject|1|||
33438986|NCT03830164|101500045|FG001|Overall Study|Withdrawal by Subject|0|||
33438987|NCT03830164|101500046|FG002|Overall Study|Withdrawal by Subject|0|||
33438988|NCT05593965|101500050|FG000|1st Intervention (1 Day)|Technical error|1|||
33438989|NCT05593965|101500051|FG001|1st Intervention (1 Day)|Technical error|0|||
33438990|NCT02216071|101500052|FG000|Overall Study|Withdrawal by Subject|7|||
33438991|NCT02216071|101500053|FG001|Overall Study|Withdrawal by Subject|2|||
33438992|NCT02216071|101500052|FG000|Overall Study|Lost to Follow-up|3|||
33438993|NCT02216071|101500053|FG001|Overall Study|Lost to Follow-up|3|||
33438994|NCT02216071|101500052|FG000|Overall Study|Protocol Violation|3|||
33438995|NCT02216071|101500053|FG001|Overall Study|Protocol Violation|5|||
33438996|NCT02216071|101500052|FG000|Overall Study|Other|2|||
33438997|NCT02216071|101500053|FG001|Overall Study|Other|2|||
33438998|NCT02017964|101500054|FG000|Overall Study|Patient deemed ineligible|1|||
33438999|NCT01492400|101500055|FG000|Overall Study|Miscellaneous Reasons|2|||
33439000|NCT01492400|101500056|FG001|Overall Study|Miscellaneous Reasons|3|||
33439001|NCT01492400|101500055|FG000|Overall Study|Personal Reasons|0|||
33439002|NCT01492400|101500056|FG001|Overall Study|Personal Reasons|5|||
33439003|NCT01492400|101500055|FG000|Overall Study|Lost to Follow-up|3|||
33439004|NCT01492400|101500056|FG001|Overall Study|Lost to Follow-up|1|||
33156917|NCT02598960|100489672|FG009|Treatment Period|participant request to discontinue|0|||
33439005|NCT01492400|101500055|FG000|Overall Study|Pregnancy|0|||
33439006|NCT01492400|101500056|FG001|Overall Study|Pregnancy|1|||
33439007|NCT01492400|101500055|FG000|Overall Study|Lack of Efficacy|1|||
33439008|NCT01492400|101500056|FG001|Overall Study|Lack of Efficacy|1|||
33439009|NCT01492400|101500055|FG000|Overall Study|Adverse Event|10|||
33439010|NCT01492400|101500056|FG001|Overall Study|Adverse Event|5|||
33439011|NCT02395822|101500057|FG000|Overall Study|Withdrawal by Subject|1|||
33439012|NCT02395822|101500057|FG000|Overall Study|Death|1|||
33439013|NCT02178722|101500061|FG000|Overall Study|Withdrawal by Subject|0|||
33156918|NCT02598960|100489673|FG010|Treatment Period|participant request to discontinue|1|||
33156919|NCT02598960|100489674|FG011|Treatment Period|participant request to discontinue|4|||
33156920|NCT02598960|100489675|FG012|Treatment Period|participant request to discontinue|0|||
33156921|NCT02598960|100489663|FG000|Treatment Period|participant withdrew consent|0|||
33388477|NCT01468701|101309224|FG005|Overall Study|Withdrawal by Subject|0|||
33388478|NCT01468701|101309225|FG006|Overall Study|Withdrawal by Subject|0|||
33439014|NCT02178722|101500062|FG001|Overall Study|Withdrawal by Subject|0|||
33388479|NCT01468701|101309226|FG007|Overall Study|Withdrawal by Subject|0|||
33388480|NCT01468701|101309227|FG008|Overall Study|Withdrawal by Subject|83|||
33388481|NCT01468701|101309228|FG009|Overall Study|Withdrawal by Subject|88|||
33388482|NCT01468701|101309229|FG010|Overall Study|Withdrawal by Subject|100|||
33388483|NCT01468701|101309230|FG011|Overall Study|Withdrawal by Subject|114|||
33388484|NCT01468701|101309231|FG012|Overall Study|Withdrawal by Subject|9|||
33388485|NCT01468701|101309232|FG013|Overall Study|Withdrawal by Subject|47|||
33388486|NCT01468701|101309233|FG014|Overall Study|Withdrawal by Subject|6|||
33388487|NCT01468701|101309234|FG015|Overall Study|Withdrawal by Subject|31|||
33388488|NCT01468701|101309235|FG016|Overall Study|Withdrawal by Subject|0|||
33388489|NCT01468701|101309219|FG000|Overall Study|Other reasons than listed|437|||
33388490|NCT01468701|101309220|FG001|Overall Study|Other reasons than listed|0|||
33388491|NCT01468701|101309221|FG002|Overall Study|Other reasons than listed|0|||
33388492|NCT01468701|101309222|FG003|Overall Study|Other reasons than listed|0|||
33388493|NCT01468701|101309223|FG004|Overall Study|Other reasons than listed|0|||
33388494|NCT01468701|101309224|FG005|Overall Study|Other reasons than listed|0|||
33388495|NCT01468701|101309225|FG006|Overall Study|Other reasons than listed|0|||
33388496|NCT01468701|101309226|FG007|Overall Study|Other reasons than listed|0|||
33156922|NCT02598960|100489664|FG001|Treatment Period|participant withdrew consent|0|||
33156923|NCT02598960|100489665|FG002|Treatment Period|participant withdrew consent|0|||
33388497|NCT01468701|101309227|FG008|Overall Study|Other reasons than listed|318|||
33388498|NCT01468701|101309228|FG009|Overall Study|Other reasons than listed|658|||
33388499|NCT01468701|101309229|FG010|Overall Study|Other reasons than listed|433|||
33388500|NCT01468701|101309230|FG011|Overall Study|Other reasons than listed|504|||
33388501|NCT01468701|101309231|FG012|Overall Study|Other reasons than listed|28|||
33388502|NCT01468701|101309232|FG013|Overall Study|Other reasons than listed|239|||
33388503|NCT01468701|101309233|FG014|Overall Study|Other reasons than listed|39|||
33388504|NCT01468701|101309234|FG015|Overall Study|Other reasons than listed|172|||
33388505|NCT01468701|101309235|FG016|Overall Study|Other reasons than listed|0|||
33388506|NCT01468701|101309219|FG000|Overall Study|No end of study case report form|0|||
33388507|NCT01468701|101309220|FG001|Overall Study|No end of study case report form|0|||
33388508|NCT01468701|101309221|FG002|Overall Study|No end of study case report form|0|||
33388509|NCT01468701|101309222|FG003|Overall Study|No end of study case report form|0|||
33388510|NCT01468701|101309223|FG004|Overall Study|No end of study case report form|0|||
33388511|NCT01468701|101309224|FG005|Overall Study|No end of study case report form|0|||
33388512|NCT01468701|101309225|FG006|Overall Study|No end of study case report form|0|||
33388513|NCT01468701|101309226|FG007|Overall Study|No end of study case report form|0|||
33388514|NCT01468701|101309227|FG008|Overall Study|No end of study case report form|4|||
33388515|NCT01468701|101309228|FG009|Overall Study|No end of study case report form|1|||
33388516|NCT01468701|101309229|FG010|Overall Study|No end of study case report form|2|||
33388517|NCT01468701|101309230|FG011|Overall Study|No end of study case report form|3|||
33388518|NCT01468701|101309231|FG012|Overall Study|No end of study case report form|0|||
33388519|NCT01468701|101309232|FG013|Overall Study|No end of study case report form|1|||
33388520|NCT01468701|101309233|FG014|Overall Study|No end of study case report form|0|||
33156924|NCT02598960|100489666|FG003|Treatment Period|participant withdrew consent|0|||
33156925|NCT02598960|100489667|FG004|Treatment Period|participant withdrew consent|0|||
33388521|NCT01468701|101309234|FG015|Overall Study|No end of study case report form|0|||
33388522|NCT01468701|101309235|FG016|Overall Study|No end of study case report form|0|||
33156926|NCT02598960|100489668|FG005|Treatment Period|participant withdrew consent|0|||
33156927|NCT02598960|100489669|FG006|Treatment Period|participant withdrew consent|0|||
33156928|NCT02598960|100489670|FG007|Treatment Period|participant withdrew consent|0|||
33156929|NCT02598960|100489671|FG008|Treatment Period|participant withdrew consent|0|||
33156930|NCT02598960|100489672|FG009|Treatment Period|participant withdrew consent|0|||
33156931|NCT02598960|100489673|FG010|Treatment Period|participant withdrew consent|0|||
33156932|NCT02598960|100489674|FG011|Treatment Period|participant withdrew consent|3|||
33156933|NCT02598960|100489675|FG012|Treatment Period|participant withdrew consent|0|||
33156934|NCT02598960|100489663|FG000|Treatment Period|No longer meets study criteria|0|||
33156935|NCT02598960|100489664|FG001|Treatment Period|No longer meets study criteria|0|||
33156936|NCT02598960|100489665|FG002|Treatment Period|No longer meets study criteria|0|||
33156937|NCT02598960|100489666|FG003|Treatment Period|No longer meets study criteria|0|||
33156938|NCT02598960|100489667|FG004|Treatment Period|No longer meets study criteria|0|||
33156939|NCT02598960|100489668|FG005|Treatment Period|No longer meets study criteria|0|||
33156940|NCT02598960|100489669|FG006|Treatment Period|No longer meets study criteria|0|||
33156941|NCT02598960|100489670|FG007|Treatment Period|No longer meets study criteria|0|||
33156942|NCT02598960|100489671|FG008|Treatment Period|No longer meets study criteria|0|||
33253303|NCT03615924|100827520|FG001|Overall Study|Randomized in error|0|||
33253304|NCT03615924|100827519|FG000|Overall Study|Study termination by Sponsor|94|||
33253305|NCT03615924|100827520|FG001|Overall Study|Study termination by Sponsor|86|||
33253306|NCT02957539|100827523|FG000|Baseline to Week 16|Lost to Follow-up|8|||
33253307|NCT02957539|100827524|FG001|Baseline to Week 16|Lost to Follow-up|10|||
33253308|NCT02957539|100827525|FG002|Baseline to Week 16|Lost to Follow-up|16|||
33253309|NCT02957539|100827523|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
33439015|NCT02178722|101500063|FG002|Overall Study|Withdrawal by Subject|0|||
33439016|NCT02178722|101500064|FG003|Overall Study|Withdrawal by Subject|2|||
33156943|NCT02598960|100489672|FG009|Treatment Period|No longer meets study criteria|0|||
33253310|NCT02957539|100827524|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
33253311|NCT02957539|100827525|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
33253312|NCT02957539|100827523|FG000|Week 16 to 32|Withdrawal by Subject|3|||
33253313|NCT02957539|100827524|FG001|Week 16 to 32|Withdrawal by Subject|3|||
33253314|NCT02957539|100827525|FG002|Week 16 to 32|Withdrawal by Subject|1|||
33253315|NCT02957539|100827523|FG000|Week 16 to 32|Lost to Follow-up|8|||
33253316|NCT02957539|100827524|FG001|Week 16 to 32|Lost to Follow-up|7|||
33253317|NCT02957539|100827525|FG002|Week 16 to 32|Lost to Follow-up|5|||
33253318|NCT02957539|100827523|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
33253319|NCT02957539|100827524|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
33253320|NCT02957539|100827525|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
33253321|NCT02957539|100827523|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
33253322|NCT02957539|100827524|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
33253323|NCT02957539|100827525|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
33253324|NCT03691428|100827526|FG000|Overall Study|Withdrawal by Subject|6|||
33253325|NCT03691428|100827527|FG001|Overall Study|Withdrawal by Subject|8|||
33253326|NCT04707313|100827532|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
33388523|NCT01468701|101309219|FG000|Overall Study|Not being followed up|0|||
33388524|NCT01468701|101309220|FG001|Overall Study|Not being followed up|4963|||
33388525|NCT01468701|101309221|FG002|Overall Study|Not being followed up|1755|||
33388526|NCT01468701|101309222|FG003|Overall Study|Not being followed up|703|||
33388527|NCT01468701|101309223|FG004|Overall Study|Not being followed up|1714|||
33388528|NCT01468701|101309224|FG005|Overall Study|Not being followed up|126|||
33388529|NCT01468701|101309225|FG006|Overall Study|Not being followed up|1170|||
33388530|NCT01468701|101309226|FG007|Overall Study|Not being followed up|4|||
33388531|NCT01468701|101309227|FG008|Overall Study|Not being followed up|0|||
33388532|NCT01468701|101309228|FG009|Overall Study|Not being followed up|0|||
33388533|NCT01468701|101309229|FG010|Overall Study|Not being followed up|0|||
33388534|NCT01468701|101309230|FG011|Overall Study|Not being followed up|0|||
33388535|NCT01468701|101309231|FG012|Overall Study|Not being followed up|0|||
33388536|NCT01468701|101309232|FG013|Overall Study|Not being followed up|0|||
33388537|NCT01468701|101309233|FG014|Overall Study|Not being followed up|0|||
33388538|NCT01468701|101309234|FG015|Overall Study|Not being followed up|0|||
33388539|NCT01468701|101309235|FG016|Overall Study|Not being followed up|0|||
33388540|NCT01496274|101309236|FG000|Overall Study|Protocol Violation|0|||
33439017|NCT02178722|101500065|FG004|Overall Study|Withdrawal by Subject|33|||
33439018|NCT02178722|101500061|FG000|Overall Study|Death|2|||
33253327|NCT04707313|100827533|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
33439019|NCT02178722|101500062|FG001|Overall Study|Death|13|||
33439020|NCT02178722|101500063|FG002|Overall Study|Death|12|||
33253328|NCT04707313|100827534|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
33253329|NCT04707313|100827535|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
33253330|NCT04707313|100827536|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
33253331|NCT04707313|100827537|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
33253332|NCT04707313|100827538|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
33388541|NCT01496274|101309237|FG001|Overall Study|Protocol Violation|1|||
33388542|NCT01496274|101309236|FG000|Overall Study|Adverse Event|1|||
33388543|NCT01496274|101309237|FG001|Overall Study|Adverse Event|1|||
33388544|NCT01496274|101309236|FG000|Overall Study|Withdrawal by Subject|2|||
33388545|NCT01496274|101309237|FG001|Overall Study|Withdrawal by Subject|0|||
33388546|NCT01496274|101309236|FG000|Overall Study|Lost to Follow-up|0|||
33388547|NCT01496274|101309237|FG001|Overall Study|Lost to Follow-up|3|||
33253333|NCT04707313|100827539|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
33253334|NCT04707313|100827540|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
33253335|NCT04707313|100827541|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
33388548|NCT02580240|101309239|FG000|Overall Study|Physician Decision|2|||
33253336|NCT04707313|100827542|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
33253337|NCT04707313|100827543|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
33439021|NCT02178722|101500064|FG003|Overall Study|Death|12|||
33439022|NCT02178722|101500065|FG004|Overall Study|Death|205|||
33439023|NCT02178722|101500061|FG000|Overall Study|Lost to Follow-up|0|||
33439024|NCT02178722|101500062|FG001|Overall Study|Lost to Follow-up|0|||
33439025|NCT02178722|101500063|FG002|Overall Study|Lost to Follow-up|0|||
33439026|NCT02178722|101500064|FG003|Overall Study|Lost to Follow-up|2|||
33439027|NCT02178722|101500065|FG004|Overall Study|Lost to Follow-up|11|||
33439028|NCT02178722|101500061|FG000|Overall Study|Study terminated by Sponsor|2|||
33439029|NCT02178722|101500062|FG001|Overall Study|Study terminated by Sponsor|7|||
33439030|NCT02178722|101500063|FG002|Overall Study|Study terminated by Sponsor|6|||
33439031|NCT02178722|101500064|FG003|Overall Study|Study terminated by Sponsor|4|||
33439032|NCT02178722|101500065|FG004|Overall Study|Study terminated by Sponsor|128|||
33439033|NCT02178722|101500061|FG000|Overall Study|Physician Decision|0|||
33439034|NCT02178722|101500062|FG001|Overall Study|Physician Decision|0|||
33439035|NCT02178722|101500063|FG002|Overall Study|Physician Decision|0|||
33439036|NCT02178722|101500064|FG003|Overall Study|Physician Decision|0|||
33439037|NCT02178722|101500065|FG004|Overall Study|Physician Decision|3|||
33439038|NCT02178722|101500061|FG000|Overall Study|Other|0|||
33439039|NCT02178722|101500062|FG001|Overall Study|Other|0|||
33156944|NCT02598960|100489673|FG010|Treatment Period|No longer meets study criteria|0|||
33439040|NCT02178722|101500063|FG002|Overall Study|Other|0|||
33439041|NCT02178722|101500064|FG003|Overall Study|Other|0|||
33439042|NCT02178722|101500065|FG004|Overall Study|Other|2|||
33439043|NCT00569374|101500066|FG000|Overall Study|Withdrawal by Subject|4|||
33439044|NCT00813293|101500067|FG000|Overall Study|Intercurrent illness|1|||
33156945|NCT02598960|100489674|FG011|Treatment Period|No longer meets study criteria|1|||
33156946|NCT02598960|100489675|FG012|Treatment Period|No longer meets study criteria|0|||
33156947|NCT02598960|100489663|FG000|Treatment Period|Other Reasons|0|||
33156948|NCT02598960|100489664|FG001|Treatment Period|Other Reasons|0|||
33156949|NCT02598960|100489665|FG002|Treatment Period|Other Reasons|0|||
33156950|NCT02598960|100489666|FG003|Treatment Period|Other Reasons|0|||
33156951|NCT02598960|100489667|FG004|Treatment Period|Other Reasons|0|||
33156952|NCT02598960|100489668|FG005|Treatment Period|Other Reasons|0|||
33156953|NCT02598960|100489669|FG006|Treatment Period|Other Reasons|0|||
33156954|NCT02598960|100489670|FG007|Treatment Period|Other Reasons|0|||
33156955|NCT02598960|100489671|FG008|Treatment Period|Other Reasons|0|||
33156956|NCT02598960|100489672|FG009|Treatment Period|Other Reasons|0|||
33156957|NCT02598960|100489673|FG010|Treatment Period|Other Reasons|0|||
33156958|NCT02598960|100489674|FG011|Treatment Period|Other Reasons|0|||
33156959|NCT02598960|100489675|FG012|Treatment Period|Other Reasons|1|||
33156960|NCT02598960|100489663|FG000|Participants Entering Follow Up Period|Death|1|||
33156961|NCT02598960|100489664|FG001|Participants Entering Follow Up Period|Death|0|||
33156962|NCT02598960|100489665|FG002|Participants Entering Follow Up Period|Death|0|||
33156963|NCT02598960|100489666|FG003|Participants Entering Follow Up Period|Death|0|||
33156964|NCT02598960|100489667|FG004|Participants Entering Follow Up Period|Death|0|||
33156965|NCT02598960|100489668|FG005|Participants Entering Follow Up Period|Death|0|||
33156966|NCT02598960|100489669|FG006|Participants Entering Follow Up Period|Death|0|||
33156967|NCT02598960|100489670|FG007|Participants Entering Follow Up Period|Death|0|||
33156968|NCT02598960|100489671|FG008|Participants Entering Follow Up Period|Death|0|||
33156969|NCT02598960|100489672|FG009|Participants Entering Follow Up Period|Death|1|||
33156970|NCT02598960|100489673|FG010|Participants Entering Follow Up Period|Death|0|||
33156971|NCT02598960|100489674|FG011|Participants Entering Follow Up Period|Death|11|||
33156972|NCT02598960|100489675|FG012|Participants Entering Follow Up Period|Death|2|||
33156973|NCT02598960|100489663|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
33156974|NCT02598960|100489664|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
33156975|NCT02598960|100489665|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
33156976|NCT02598960|100489666|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
33156977|NCT02598960|100489667|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
33156978|NCT02598960|100489668|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
33156979|NCT02598960|100489669|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
33156980|NCT02598960|100489670|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
33156981|NCT02598960|100489671|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
33156982|NCT02598960|100489672|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
33156983|NCT02598960|100489673|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
33156984|NCT02598960|100489674|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
33156985|NCT02598960|100489675|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
33156986|NCT02598960|100489663|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
33156987|NCT02598960|100489664|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
33156988|NCT02598960|100489665|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
33156989|NCT02598960|100489666|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
33156990|NCT02598960|100489667|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
33156991|NCT02598960|100489668|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
33156992|NCT02598960|100489669|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
33156993|NCT02598960|100489670|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
33156994|NCT02598960|100489671|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
33156995|NCT02598960|100489672|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
33156996|NCT02598960|100489673|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
33156997|NCT02598960|100489674|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
33156998|NCT02598960|100489675|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
33156999|NCT02598960|100489663|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33157000|NCT02598960|100489664|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33157001|NCT02598960|100489665|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33157002|NCT02598960|100489666|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33157003|NCT02598960|100489667|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33157004|NCT02598960|100489668|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33157005|NCT02598960|100489669|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33157006|NCT02598960|100489670|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33157007|NCT02598960|100489671|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33157008|NCT02598960|100489672|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33157009|NCT02598960|100489673|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33157010|NCT02598960|100489674|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
33157011|NCT02598960|100489675|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
33157012|NCT02598960|100489663|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
33157013|NCT02598960|100489664|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
33157014|NCT02598960|100489665|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
33157015|NCT02598960|100489666|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
33157016|NCT02598960|100489667|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
33157017|NCT02598960|100489668|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
33157018|NCT02598960|100489669|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
33157019|NCT02598960|100489670|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
33157020|NCT02598960|100489671|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
33157021|NCT02598960|100489672|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
33157022|NCT02598960|100489673|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
33157023|NCT02598960|100489674|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
33157024|NCT02598960|100489675|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
33157025|NCT01206166|100489676|FG000|Overall Study|No evaluable data|2|||
33157026|NCT01206166|100489677|FG001|Overall Study|No evaluable data|3|||
33157027|NCT00747461|100489678|FG000|Overall Study|study terminated by sponsor|5|||
33157028|NCT01868503|100489679|FG000|Overall Study|Withdrawal by Subject|1|||
33157029|NCT01868503|100489679|FG000|Overall Study|Protocol Violation|1|||
33157030|NCT01897714|100489686|FG000|Phase I (Dose Escalation)|Disease progression|3|||
33157031|NCT01897714|100489687|FG001|Phase I (Dose Escalation)|Disease progression|5|||
33157032|NCT01897714|100489688|FG002|Phase I (Dose Escalation)|Disease progression|1|||
33157033|NCT01897714|100489689|FG003|Phase I (Dose Escalation)|Disease progression|3|||
33157034|NCT01897714|100489690|FG004|Phase I (Dose Escalation)|Disease progression|0|||
33157035|NCT01897714|100489691|FG005|Phase I (Dose Escalation)|Disease progression|0|||
33157036|NCT01897714|100489686|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
33157037|NCT01897714|100489687|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
33157038|NCT01897714|100489688|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
33157039|NCT01897714|100489689|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
33157040|NCT01897714|100489690|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
33157041|NCT01897714|100489691|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
33157042|NCT01897714|100489686|FG000|Phase I (Dose Escalation)|Other|0|||
33157043|NCT01897714|100489687|FG001|Phase I (Dose Escalation)|Other|1|||
33157044|NCT01897714|100489688|FG002|Phase I (Dose Escalation)|Other|0|||
33157045|NCT01897714|100489689|FG003|Phase I (Dose Escalation)|Other|0|||
33157046|NCT01897714|100489690|FG004|Phase I (Dose Escalation)|Other|0|||
33157047|NCT01897714|100489691|FG005|Phase I (Dose Escalation)|Other|0|||
33157048|NCT01897714|100489686|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
33157049|NCT01897714|100489687|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
33157050|NCT01897714|100489688|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
33157051|NCT01897714|100489689|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
33157052|NCT01897714|100489690|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
33157053|NCT01897714|100489691|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
33157054|NCT01897714|100489686|FG000|Phase II (MTD)|Lost to Follow-up|0|||
33157055|NCT01897714|100489687|FG001|Phase II (MTD)|Lost to Follow-up|0|||
33157056|NCT01897714|100489688|FG002|Phase II (MTD)|Lost to Follow-up|0|||
33157057|NCT01897714|100489689|FG003|Phase II (MTD)|Lost to Follow-up|0|||
33157058|NCT01897714|100489690|FG004|Phase II (MTD)|Lost to Follow-up|1|||
33157059|NCT01897714|100489691|FG005|Phase II (MTD)|Lost to Follow-up|0|||
33157060|NCT01897714|100489686|FG000|Phase II (MTD)|Death|0|||
33157061|NCT01897714|100489687|FG001|Phase II (MTD)|Death|0|||
33157062|NCT01897714|100489688|FG002|Phase II (MTD)|Death|0|||
33157063|NCT01897714|100489689|FG003|Phase II (MTD)|Death|0|||
33157064|NCT01897714|100489690|FG004|Phase II (MTD)|Death|25|||
33157065|NCT01897714|100489691|FG005|Phase II (MTD)|Death|10|||
33157066|NCT01897714|100489686|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
33157067|NCT01897714|100489687|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
33388549|NCT02580240|101309240|FG001|Overall Study|Physician Decision|0|||
33388550|NCT01587274|101309241|FG000|Overall Study|Lost to Follow-up|4|||
33157068|NCT01897714|100489688|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
33157069|NCT01897714|100489689|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
33388551|NCT01587274|101309242|FG001|Overall Study|Lost to Follow-up|5|||
33157070|NCT01897714|100489690|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
33157071|NCT01897714|100489691|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
33157072|NCT01897714|100489686|FG000|Phase II (MTD)|Other|0|||
33157073|NCT01897714|100489687|FG001|Phase II (MTD)|Other|0|||
33157074|NCT01897714|100489688|FG002|Phase II (MTD)|Other|0|||
33157075|NCT01897714|100489689|FG003|Phase II (MTD)|Other|0|||
33157076|NCT01897714|100489690|FG004|Phase II (MTD)|Other|3|||
33157077|NCT01897714|100489691|FG005|Phase II (MTD)|Other|0|||
33157078|NCT03822182|100489692|FG000|Overall Study|Protocol Violation|0|||
33157079|NCT03822182|100489693|FG001|Overall Study|Protocol Violation|1|||
33157080|NCT03822182|100489694|FG002|Overall Study|Protocol Violation|1|||
33157081|NCT00573937|100489695|FG000|Overall Study|Study Terminated|0|||
33157082|NCT00573937|100489696|FG001|Overall Study|Study Terminated|1|||
33157083|NCT01548287|100489697|FG000|Screening|No reason provided|0|||
33157084|NCT01548287|100489698|FG001|Screening|No reason provided|0|||
33157085|NCT01548287|100489699|FG002|Screening|No reason provided|0|||
33157086|NCT01548287|100489700|FG003|Screening|No reason provided|0|||
33157087|NCT01548287|100489701|FG004|Screening|No reason provided|9|||
33157088|NCT01548287|100489697|FG000|Screening|Did not meet eligibility criteria|0|||
33157089|NCT01548287|100489698|FG001|Screening|Did not meet eligibility criteria|0|||
33157090|NCT01548287|100489699|FG002|Screening|Did not meet eligibility criteria|0|||
33157091|NCT01548287|100489700|FG003|Screening|Did not meet eligibility criteria|0|||
33157092|NCT01548287|100489701|FG004|Screening|Did not meet eligibility criteria|74|||
33157093|NCT01548287|100489697|FG000|Randomized Period|Did not meet inclusion criteria|0|||
33157094|NCT01548287|100489698|FG001|Randomized Period|Did not meet inclusion criteria|0|||
33157095|NCT01548287|100489699|FG002|Randomized Period|Did not meet inclusion criteria|2|||
33157096|NCT01548287|100489700|FG003|Randomized Period|Did not meet inclusion criteria|0|||
33157097|NCT01548287|100489701|FG004|Randomized Period|Did not meet inclusion criteria|0|||
33157098|NCT01548287|100489697|FG000|Randomized Period|Adverse Event|0|||
33388552|NCT01587274|101309243|FG002|Overall Study|Lost to Follow-up|3|||
33388553|NCT03073213|101309244|FG000|Multiple Dose Period|Protocol Violation|0|||
33388554|NCT03073213|101309245|FG001|Multiple Dose Period|Protocol Violation|0|||
33388555|NCT03073213|101309246|FG002|Multiple Dose Period|Protocol Violation|1|||
33388556|NCT00412113|101309247|FG000|Overall Study|Adverse Event|11|||
33388557|NCT00412113|101309248|FG001|Overall Study|Adverse Event|15|||
33388558|NCT00412113|101309247|FG000|Overall Study|did not receive treatment|1|||
33388559|NCT00412113|101309248|FG001|Overall Study|did not receive treatment|0|||
33388560|NCT03970824|101309251|FG000|Overall Study|Withdrawal by Subject|1|||
33388561|NCT03970824|101309252|FG001|Overall Study|Withdrawal by Subject|1|||
33388562|NCT03970824|101309253|FG002|Overall Study|Withdrawal by Subject|3|||
33388563|NCT03970824|101309251|FG000|Overall Study|Lost to Follow-up|0|||
33157099|NCT01548287|100489698|FG001|Randomized Period|Adverse Event|2|||
33157100|NCT01548287|100489699|FG002|Randomized Period|Adverse Event|5|||
33157101|NCT01548287|100489700|FG003|Randomized Period|Adverse Event|0|||
33157102|NCT01548287|100489701|FG004|Randomized Period|Adverse Event|0|||
33253338|NCT04707313|100827544|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
33253339|NCT04707313|100827532|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
33253340|NCT04707313|100827533|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
33253341|NCT04707313|100827534|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
33253342|NCT04707313|100827535|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
33388564|NCT03970824|101309252|FG001|Overall Study|Lost to Follow-up|2|||
33157103|NCT00246753|100489703|FG000|Overall Study|Withdrawal by Subject|2|||
33157104|NCT00246753|100489703|FG000|Overall Study|Physician Decision|2|||
33157105|NCT00246753|100489703|FG000|Overall Study|Adverse Event|2|||
33157106|NCT00246753|100489703|FG000|Overall Study|Unacceptable toxicity|2|||
33388565|NCT03970824|101309253|FG002|Overall Study|Lost to Follow-up|1|||
33388566|NCT03970824|101309251|FG000|Overall Study|Adverse Event|1|||
33157107|NCT01758523|100489704|FG000|Overall Study|Adverse Event|2|||
33157108|NCT01758523|100489705|FG001|Overall Study|Adverse Event|1|||
33388567|NCT03970824|101309252|FG001|Overall Study|Adverse Event|0|||
33253343|NCT04707313|100827536|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
33253344|NCT04707313|100827537|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
33253345|NCT04707313|100827538|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
33439045|NCT00813293|101500068|FG001|Overall Study|Intercurrent illness|0|||
33439046|NCT00813293|101500067|FG000|Overall Study|Adverse Event|0|||
33439047|NCT00813293|101500068|FG001|Overall Study|Adverse Event|1|||
33439048|NCT01273181|101500070|FG000|Phase I, Dose 1|Study termination|1|||
33439049|NCT01273181|101500071|FG001|Phase I, Dose 1|Study termination|0|||
33439050|NCT01273181|101500072|FG002|Phase I, Dose 1|Study termination|0|||
33439051|NCT01273181|101500073|FG003|Phase I, Dose 1|Study termination|0|||
33439052|NCT01273181|101500070|FG000|Phase I, Dose 2|Death during treatment|0|||
33439053|NCT01273181|101500071|FG001|Phase I, Dose 2|Death during treatment|1|||
33439054|NCT01273181|101500072|FG002|Phase I, Dose 2|Death during treatment|0|||
33439055|NCT01273181|101500073|FG003|Phase I, Dose 2|Death during treatment|0|||
33439056|NCT01273181|101500070|FG000|Phase 2, Dose 1|Study termination|0|||
33439057|NCT01273181|101500071|FG001|Phase 2, Dose 1|Study termination|0|||
33439058|NCT01273181|101500072|FG002|Phase 2, Dose 1|Study termination|1|||
33439059|NCT01273181|101500073|FG003|Phase 2, Dose 1|Study termination|0|||
33439060|NCT01273181|101500070|FG000|Phase 2, Dose 2|Death during treatment|0|||
33439061|NCT01273181|101500071|FG001|Phase 2, Dose 2|Death during treatment|0|||
33439062|NCT01273181|101500072|FG002|Phase 2, Dose 2|Death during treatment|0|||
33439063|NCT01273181|101500073|FG003|Phase 2, Dose 2|Death during treatment|1|||
33439064|NCT00762086|101500074|FG000|Overall Study|Adverse Event|2|||
33439065|NCT00762086|101500075|FG001|Overall Study|Adverse Event|0|||
33439066|NCT00762086|101500074|FG000|Overall Study|Lost to Follow-up|0|||
33439067|NCT00762086|101500075|FG001|Overall Study|Lost to Follow-up|2|||
33439068|NCT00762086|101500074|FG000|Overall Study|Non compliance|1|||
33439069|NCT00762086|101500075|FG001|Overall Study|Non compliance|0|||
33388568|NCT03970824|101309253|FG002|Overall Study|Adverse Event|0|||
33388569|NCT00493467|101309254|FG000|Overall Study|Death|1|||
33157109|NCT01758523|100489704|FG000|Overall Study|Lack of Efficacy|4|||
33157110|NCT01758523|100489705|FG001|Overall Study|Lack of Efficacy|2|||
33388570|NCT01437267|101309255|FG000|Overall Study|Withdrawal by Subject|0|||
33388571|NCT01437267|101309256|FG001|Overall Study|Withdrawal by Subject|0|||
33388572|NCT01437267|101309257|FG002|Overall Study|Withdrawal by Subject|0|||
33388573|NCT01437267|101309258|FG003|Overall Study|Withdrawal by Subject|1|||
33388574|NCT01437267|101309259|FG004|Overall Study|Withdrawal by Subject|0|||
33388575|NCT01437267|101309260|FG005|Overall Study|Withdrawal by Subject|0|||
33388576|NCT01437267|101309255|FG000|Overall Study|Protocol Violation|0|||
33388577|NCT01437267|101309256|FG001|Overall Study|Protocol Violation|1|||
33388578|NCT01437267|101309257|FG002|Overall Study|Protocol Violation|0|||
33388579|NCT01437267|101309258|FG003|Overall Study|Protocol Violation|0|||
33388580|NCT01437267|101309259|FG004|Overall Study|Protocol Violation|0|||
33388581|NCT01437267|101309260|FG005|Overall Study|Protocol Violation|0|||
33388582|NCT00981682|101309268|FG000|Overall Study|Adverse Event|48|||
33388583|NCT00981682|101309268|FG000|Overall Study|Withdrawal by Subject|52|||
33388584|NCT00981682|101309268|FG000|Overall Study|Lost to Follow-up|14|||
33388585|NCT00981682|101309268|FG000|Overall Study|Lack of Efficacy|13|||
33388586|NCT00981682|101309268|FG000|Overall Study|Protocol Violation|6|||
33388587|NCT00981682|101309268|FG000|Overall Study|administrative|9|||
33388588|NCT03927911|101309269|FG000|Overall Study|problems with eDiary|0|||
33388589|NCT03927911|101309270|FG001|Overall Study|problems with eDiary|1|||
33388590|NCT03927911|101309271|FG002|Overall Study|problems with eDiary|0|||
33388591|NCT03927911|101309272|FG003|Overall Study|problems with eDiary|1|||
33439070|NCT00762086|101500074|FG000|Overall Study|Withdrawal by Subject|2|||
33439071|NCT00762086|101500075|FG001|Overall Study|Withdrawal by Subject|2|||
33439072|NCT00762086|101500074|FG000|Overall Study|Ineligible to participate in the study|1|||
33439073|NCT00762086|101500075|FG001|Overall Study|Ineligible to participate in the study|0|||
33388592|NCT03927911|101309273|FG004|Overall Study|problems with eDiary|0|||
33388593|NCT03927911|101309274|FG005|Overall Study|problems with eDiary|4|||
33388594|NCT03927911|101309269|FG000|Overall Study|Adverse Event|0|||
33253346|NCT04707313|100827539|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
33253347|NCT04707313|100827540|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
33253348|NCT04707313|100827541|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
33253349|NCT04707313|100827542|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
33253350|NCT04707313|100827543|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
33253351|NCT04707313|100827544|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
33253352|NCT04707313|100827532|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
33253353|NCT04707313|100827533|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
33253354|NCT04707313|100827534|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
33253355|NCT04707313|100827535|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
33253356|NCT04707313|100827536|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
33253357|NCT04707313|100827537|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
33253358|NCT04707313|100827538|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
33253359|NCT04707313|100827539|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
33253360|NCT04707313|100827540|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
33253361|NCT04707313|100827541|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
33253362|NCT04707313|100827542|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
33253363|NCT04707313|100827543|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
33253364|NCT04707313|100827544|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
33253365|NCT04707313|100827532|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
33253366|NCT04707313|100827533|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
33253367|NCT04707313|100827534|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
33388595|NCT03927911|101309270|FG001|Overall Study|Adverse Event|0|||
33388596|NCT03927911|101309271|FG002|Overall Study|Adverse Event|0|||
33253368|NCT04707313|100827535|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
33253369|NCT04707313|100827536|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
33253370|NCT04707313|100827537|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
33253371|NCT04707313|100827538|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
33253372|NCT04707313|100827539|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
33253373|NCT04707313|100827540|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
33253374|NCT04707313|100827541|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
33388597|NCT03927911|101309272|FG003|Overall Study|Adverse Event|0|||
33253375|NCT04707313|100827542|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
33253376|NCT04707313|100827543|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
33253377|NCT04707313|100827544|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
33253378|NCT04707313|100827532|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
33253379|NCT04707313|100827533|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
33253380|NCT04707313|100827534|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
33253381|NCT04707313|100827535|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
33253382|NCT04707313|100827536|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
33253383|NCT04707313|100827537|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
33253384|NCT04707313|100827538|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
33253385|NCT04707313|100827539|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
33253386|NCT04707313|100827540|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
33253387|NCT04707313|100827541|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
33253388|NCT04707313|100827542|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
33253389|NCT04707313|100827543|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
33253390|NCT04707313|100827544|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
33253391|NCT04707313|100827532|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
33253392|NCT04707313|100827533|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
33253393|NCT04707313|100827534|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
33253394|NCT04707313|100827535|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
33253395|NCT04707313|100827536|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
33253396|NCT04707313|100827537|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
33253397|NCT04707313|100827538|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
33253398|NCT04707313|100827539|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
33253399|NCT04707313|100827540|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
33253400|NCT04707313|100827541|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
33253401|NCT04707313|100827542|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
33253402|NCT04707313|100827543|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
33253403|NCT04707313|100827544|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
33253404|NCT04707313|100827532|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
33253405|NCT04707313|100827533|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
33253406|NCT04707313|100827534|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
33253407|NCT04707313|100827535|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
33253408|NCT04707313|100827536|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
33253409|NCT04707313|100827537|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
33253410|NCT04707313|100827538|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
33253411|NCT04707313|100827539|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
33253412|NCT04707313|100827540|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
33253413|NCT04707313|100827541|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
33253414|NCT04707313|100827542|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
33253415|NCT04707313|100827543|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
33253416|NCT04707313|100827544|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
33253417|NCT04707313|100827532|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
33253418|NCT04707313|100827533|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
33253419|NCT04707313|100827534|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
33253420|NCT04707313|100827535|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
33253421|NCT04707313|100827536|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
33253422|NCT04707313|100827537|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
33253423|NCT04707313|100827538|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
33253424|NCT04707313|100827539|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
33253425|NCT04707313|100827540|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
33253426|NCT04707313|100827541|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
33253427|NCT04707313|100827542|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
33253428|NCT04707313|100827543|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
33253429|NCT04707313|100827544|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
33253430|NCT04707313|100827532|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
33253431|NCT04707313|100827533|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
33253432|NCT04707313|100827534|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
33253433|NCT04707313|100827535|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
33253434|NCT04707313|100827536|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
33253435|NCT04707313|100827537|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
33253436|NCT04707313|100827538|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
33253437|NCT04707313|100827539|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
33253438|NCT04707313|100827540|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
33253439|NCT04707313|100827541|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
33253440|NCT04707313|100827542|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
33253441|NCT04707313|100827543|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
33253442|NCT04707313|100827544|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
33388598|NCT03927911|101309273|FG004|Overall Study|Adverse Event|0|||
33388599|NCT03927911|101309274|FG005|Overall Study|Adverse Event|1|||
33388600|NCT03927911|101309269|FG000|Overall Study|not treated -study terminated by sponsor|0|||
33388601|NCT03927911|101309270|FG001|Overall Study|not treated -study terminated by sponsor|1|||
33388602|NCT03927911|101309271|FG002|Overall Study|not treated -study terminated by sponsor|0|||
33388603|NCT03927911|101309272|FG003|Overall Study|not treated -study terminated by sponsor|0|||
33388604|NCT03927911|101309273|FG004|Overall Study|not treated -study terminated by sponsor|0|||
33388605|NCT03927911|101309274|FG005|Overall Study|not treated -study terminated by sponsor|0|||
33388606|NCT03927911|101309269|FG000|Overall Study|Surgery cancelled|0|||
33388607|NCT03927911|101309270|FG001|Overall Study|Surgery cancelled|0|||
33388608|NCT03927911|101309271|FG002|Overall Study|Surgery cancelled|0|||
33388609|NCT03927911|101309272|FG003|Overall Study|Surgery cancelled|1|||
33388610|NCT03927911|101309273|FG004|Overall Study|Surgery cancelled|0|||
33388611|NCT03927911|101309274|FG005|Overall Study|Surgery cancelled|1|||
33388612|NCT03927911|101309269|FG000|Overall Study|Protocol Violation|0|||
33388613|NCT03927911|101309270|FG001|Overall Study|Protocol Violation|0|||
33388614|NCT03927911|101309271|FG002|Overall Study|Protocol Violation|0|||
33388615|NCT03927911|101309272|FG003|Overall Study|Protocol Violation|0|||
33388616|NCT03927911|101309273|FG004|Overall Study|Protocol Violation|0|||
33388617|NCT03927911|101309274|FG005|Overall Study|Protocol Violation|1|||
33388618|NCT00968708|101309275|FG000|Overall Study|Adverse Event|169|||
33388619|NCT00968708|101309276|FG001|Overall Study|Adverse Event|150|||
33388620|NCT00968708|101309275|FG000|Overall Study|Major Protocol Deviation|0|||
33388621|NCT00968708|101309276|FG001|Overall Study|Major Protocol Deviation|1|||
33388622|NCT00968708|101309275|FG000|Overall Study|Lost to Follow-up|19|||
33388623|NCT00968708|101309276|FG001|Overall Study|Lost to Follow-up|11|||
33388624|NCT00968708|101309275|FG000|Overall Study|Voluntary Withdrawal|104|||
33388625|NCT00968708|101309276|FG001|Overall Study|Voluntary Withdrawal|101|||
33388626|NCT00968708|101309275|FG000|Overall Study|Investigator Discretion|0|||
33157111|NCT01758523|100489704|FG000|Overall Study|Lost to Follow-up|3|||
33157112|NCT01758523|100489705|FG001|Overall Study|Lost to Follow-up|4|||
33388627|NCT00968708|101309276|FG001|Overall Study|Investigator Discretion|1|||
33388628|NCT00968708|101309275|FG000|Overall Study|Other|26|||
33388629|NCT00968708|101309276|FG001|Overall Study|Other|34|||
33388630|NCT00615459|101309280|FG000|Period I|Adverse Event|2|||
33388631|NCT00615459|101309281|FG001|Period I|Adverse Event|0|||
33388632|NCT00615459|101309282|FG002|Period I|Adverse Event|1|||
33388633|NCT00615459|101309283|FG003|Period I|Adverse Event|0|||
33388634|NCT00615459|101309280|FG000|Period I|Subject withdrew consent|1|||
33388635|NCT00615459|101309281|FG001|Period I|Subject withdrew consent|0|||
33388636|NCT00615459|101309282|FG002|Period I|Subject withdrew consent|0|||
33388637|NCT00615459|101309283|FG003|Period I|Subject withdrew consent|1|||
33439074|NCT01417078|101500076|FG000|Overall Study|Withdrawal by Subject|1|||
33388638|NCT00615459|101309280|FG000|Period I|Abnormal test procedure results|1|||
33157113|NCT01758523|100489704|FG000|Overall Study|Withdrawal by Subject|12|||
33157114|NCT01758523|100489705|FG001|Overall Study|Withdrawal by Subject|7|||
33157115|NCT00369824|100489710|FG000|Overall Study|Adverse Event|0|||
33157116|NCT00369824|100489711|FG001|Overall Study|Adverse Event|2|||
33157117|NCT00369824|100489712|FG002|Overall Study|Adverse Event|0|||
33157118|NCT00369824|100489713|FG003|Overall Study|Adverse Event|0|||
33157119|NCT00369824|100489714|FG004|Overall Study|Adverse Event|1|||
33157120|NCT00369824|100489715|FG005|Overall Study|Adverse Event|0|||
33157121|NCT00369824|100489710|FG000|Overall Study|Protocol Violation|0|||
33157122|NCT00369824|100489711|FG001|Overall Study|Protocol Violation|1|||
33157123|NCT00369824|100489712|FG002|Overall Study|Protocol Violation|0|||
33157124|NCT00369824|100489713|FG003|Overall Study|Protocol Violation|1|||
33157125|NCT00369824|100489714|FG004|Overall Study|Protocol Violation|1|||
33157126|NCT00369824|100489715|FG005|Overall Study|Protocol Violation|0|||
33157127|NCT00369824|100489710|FG000|Overall Study|Withdrawal by Subject|9|||
33253443|NCT04707313|100827532|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
33253444|NCT04707313|100827533|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
33253445|NCT04707313|100827534|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
33253446|NCT04707313|100827535|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
33253447|NCT04707313|100827536|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
33253448|NCT04707313|100827537|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
33253449|NCT04707313|100827538|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
33253450|NCT04707313|100827539|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
33253451|NCT04707313|100827540|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
33253452|NCT04707313|100827541|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
33253453|NCT04707313|100827542|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
33253454|NCT04707313|100827543|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
33253455|NCT04707313|100827544|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
33253456|NCT04707313|100827532|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
33253457|NCT04707313|100827533|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
33253458|NCT04707313|100827534|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
33253459|NCT04707313|100827535|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
33253460|NCT04707313|100827536|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
33253461|NCT04707313|100827537|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
33253462|NCT04707313|100827538|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
33253463|NCT04707313|100827539|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
33253464|NCT04707313|100827540|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
33253465|NCT04707313|100827541|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
33253466|NCT04707313|100827542|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
33253467|NCT04707313|100827543|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
33253468|NCT04707313|100827544|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
33253469|NCT04707313|100827532|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
33253470|NCT04707313|100827533|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
33253471|NCT04707313|100827534|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
33253472|NCT04707313|100827535|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
33253473|NCT04707313|100827536|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
33157128|NCT00369824|100489711|FG001|Overall Study|Withdrawal by Subject|5|||
33157129|NCT00369824|100489712|FG002|Overall Study|Withdrawal by Subject|5|||
33253474|NCT04707313|100827537|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
33253475|NCT04707313|100827538|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
33253476|NCT04707313|100827539|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
33253477|NCT04707313|100827540|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
33157130|NCT00369824|100489713|FG003|Overall Study|Withdrawal by Subject|4|||
33157131|NCT00369824|100489714|FG004|Overall Study|Withdrawal by Subject|6|||
33157132|NCT00369824|100489715|FG005|Overall Study|Withdrawal by Subject|2|||
33157133|NCT00369824|100489710|FG000|Overall Study|Lost to Follow-up|6|||
33157134|NCT00369824|100489711|FG001|Overall Study|Lost to Follow-up|11|||
33157135|NCT00369824|100489712|FG002|Overall Study|Lost to Follow-up|7|||
33157136|NCT00369824|100489713|FG003|Overall Study|Lost to Follow-up|8|||
33157137|NCT00369824|100489714|FG004|Overall Study|Lost to Follow-up|9|||
33157138|NCT00369824|100489715|FG005|Overall Study|Lost to Follow-up|6|||
33157139|NCT00369824|100489710|FG000|Overall Study|Other|0|||
33157140|NCT00369824|100489711|FG001|Overall Study|Other|0|||
33157141|NCT00369824|100489712|FG002|Overall Study|Other|0|||
33157142|NCT00369824|100489713|FG003|Overall Study|Other|2|||
33157143|NCT00369824|100489714|FG004|Overall Study|Other|1|||
33157144|NCT00369824|100489715|FG005|Overall Study|Other|3|||
33157145|NCT00005044|100489716|FG000|Overall Study|Protocol Violation|37|||
33157146|NCT00005044|100489717|FG001|Overall Study|Protocol Violation|46|||
33157147|NCT00005044|100489716|FG000|Overall Study|Withdrawal by Subject|1|||
33157148|NCT00005044|100489717|FG001|Overall Study|Withdrawal by Subject|5|||
33157149|NCT00005044|100489716|FG000|Overall Study|No protocol treatment|0|||
33157150|NCT00005044|100489717|FG001|Overall Study|No protocol treatment|1|||
33157151|NCT02158975|100489718|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
33157152|NCT02302807|100489719|FG000|Overall Study|Withdrawal by Subject|28|||
33157153|NCT02302807|100489720|FG001|Overall Study|Withdrawal by Subject|11|||
33157154|NCT02302807|100489719|FG000|Overall Study|Lost to Follow-up|4|||
33157155|NCT02302807|100489720|FG001|Overall Study|Lost to Follow-up|6|||
33157156|NCT02302807|100489719|FG000|Overall Study|Death|397|||
33157157|NCT02302807|100489720|FG001|Overall Study|Death|385|||
33157158|NCT02302807|100489719|FG000|Overall Study|Study Terminated By Sponsor|35|||
33157159|NCT02302807|100489720|FG001|Overall Study|Study Terminated By Sponsor|64|||
33157160|NCT02302807|100489719|FG000|Overall Study|Physician Decision|0|||
33157161|NCT02302807|100489720|FG001|Overall Study|Physician Decision|1|||
33157162|NCT01453361|100489721|FG000|Overall Study|Disease Progression|6|||
33157163|NCT01453361|100489721|FG000|Overall Study|Screen-Failures|10|||
33157164|NCT00660673|100489722|FG000|Overall Study|Adverse Event|84|||
33157165|NCT00660673|100489722|FG000|Overall Study|Lack of Efficacy|7|||
33157166|NCT00660673|100489722|FG000|Overall Study|Withdrawal by Subject|22|||
33157167|NCT00660673|100489722|FG000|Overall Study|Administrative|2|||
33157168|NCT00660673|100489722|FG000|Overall Study|Protocol Violation|2|||
33157169|NCT00408629|100489723|FG000|Overall Study|Adverse Event|13|||
33157170|NCT00408629|100489724|FG001|Overall Study|Adverse Event|27|||
33157171|NCT00408629|100489723|FG000|Overall Study|Withdrawal by Subject|8|||
33157172|NCT00408629|100489724|FG001|Overall Study|Withdrawal by Subject|4|||
33157173|NCT00408629|100489723|FG000|Overall Study|Lost to Follow-up|1|||
33157174|NCT00408629|100489724|FG001|Overall Study|Lost to Follow-up|1|||
33157175|NCT00408629|100489723|FG000|Overall Study|Lack of Efficacy|63|||
33157176|NCT00408629|100489724|FG001|Overall Study|Lack of Efficacy|73|||
33157177|NCT00408629|100489723|FG000|Overall Study|Protocol Violation|1|||
33388639|NCT00615459|101309281|FG001|Period I|Abnormal test procedure results|1|||
33157178|NCT00408629|100489724|FG001|Overall Study|Protocol Violation|5|||
33157179|NCT00408629|100489723|FG000|Overall Study|Miscellaneous|11|||
33157180|NCT00408629|100489724|FG001|Overall Study|Miscellaneous|15|||
33157181|NCT02899299|100489727|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
33157182|NCT02899299|100489728|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
33157183|NCT02899299|100489727|FG000|Pre-treatment|Participant withdrew consent|1|||
33157184|NCT02899299|100489728|FG001|Pre-treatment|Participant withdrew consent|11|||
33157185|NCT02899299|100489727|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
33157186|NCT02899299|100489728|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
33157187|NCT02899299|100489727|FG000|Pre-treatment|Not reported|0|||
33157188|NCT02899299|100489728|FG001|Pre-treatment|Not reported|1|||
33157189|NCT02899299|100489727|FG000|Treatment|Disease Progression|182|||
33157190|NCT02899299|100489728|FG001|Treatment|Disease Progression|43|||
33157191|NCT02899299|100489727|FG000|Treatment|Study Drug Toxicity|60|||
33157192|NCT02899299|100489728|FG001|Treatment|Study Drug Toxicity|24|||
33157193|NCT02899299|100489727|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
33157194|NCT02899299|100489728|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
33157195|NCT02899299|100489727|FG000|Treatment|Participant request to discontinue Study treatment|4|||
33157196|NCT02899299|100489728|FG001|Treatment|Participant request to discontinue Study treatment|10|||
33157197|NCT02899299|100489727|FG000|Treatment|Participant withdrew consent|6|||
33157198|NCT02899299|100489728|FG001|Treatment|Participant withdrew consent|3|||
33157199|NCT02899299|100489727|FG000|Treatment|Lost to Follow-up|0|||
33157200|NCT02899299|100489728|FG001|Treatment|Lost to Follow-up|2|||
33157201|NCT02899299|100489727|FG000|Treatment|Maximum Clinical Benefit|11|||
33157202|NCT02899299|100489728|FG001|Treatment|Maximum Clinical Benefit|2|||
33157203|NCT02899299|100489727|FG000|Treatment|Poor/Non-compliance|1|||
33157204|NCT02899299|100489728|FG001|Treatment|Poor/Non-compliance|0|||
33157205|NCT02899299|100489727|FG000|Treatment|Participant no longer meets Study criteria|4|||
33157206|NCT02899299|100489728|FG001|Treatment|Participant no longer meets Study criteria|0|||
33157207|NCT02899299|100489727|FG000|Treatment|Administrative reason by Sponsor|2|||
33157208|NCT02899299|100489728|FG001|Treatment|Administrative reason by Sponsor|0|||
33439075|NCT04453202|101500084|FG000|Overall Study|Adverse Event|0|||
33439076|NCT04453202|101500085|FG001|Overall Study|Adverse Event|0|||
33439077|NCT04453202|101500086|FG002|Overall Study|Adverse Event|0|||
33157209|NCT02899299|100489727|FG000|Treatment|Other reasons|12|||
33157210|NCT02899299|100489728|FG001|Treatment|Other reasons|2|||
33157211|NCT02899299|100489727|FG000|Treatment|Not reported|7|||
33388640|NCT00615459|101309282|FG002|Period I|Abnormal test procedure results|1|||
33388641|NCT00615459|101309283|FG003|Period I|Abnormal test procedure results|0|||
33388642|NCT00615459|101309280|FG000|Period II|Adverse Event|1|||
33388643|NCT00615459|101309281|FG001|Period II|Adverse Event|0|||
33388644|NCT00615459|101309282|FG002|Period II|Adverse Event|0|||
33388645|NCT00615459|101309283|FG003|Period II|Adverse Event|0|||
33388646|NCT00615459|101309280|FG000|Period II|Lost to Follow-up|0|||
33388647|NCT00615459|101309281|FG001|Period II|Lost to Follow-up|0|||
33388648|NCT00615459|101309282|FG002|Period II|Lost to Follow-up|0|||
33388649|NCT00615459|101309283|FG003|Period II|Lost to Follow-up|1|||
33388650|NCT00615459|101309280|FG000|Period III|Adverse Event|0|||
33388651|NCT00615459|101309281|FG001|Period III|Adverse Event|1|||
33388652|NCT00615459|101309282|FG002|Period III|Adverse Event|0|||
33388653|NCT00615459|101309283|FG003|Period III|Adverse Event|0|||
33388654|NCT00615459|101309280|FG000|Period III|Administrative problems|0|||
33388655|NCT00615459|101309281|FG001|Period III|Administrative problems|1|||
33388656|NCT00615459|101309282|FG002|Period III|Administrative problems|1|||
33388657|NCT00615459|101309283|FG003|Period III|Administrative problems|0|||
33388658|NCT00615459|101309280|FG000|Period III|Unsatisfactory therapeutic effect|0|||
33388659|NCT00615459|101309281|FG001|Period III|Unsatisfactory therapeutic effect|1|||
33388660|NCT00615459|101309282|FG002|Period III|Unsatisfactory therapeutic effect|0|||
33388661|NCT00615459|101309283|FG003|Period III|Unsatisfactory therapeutic effect|0|||
33388662|NCT03984812|101309284|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33388663|NCT03984812|101309285|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33388664|NCT03984812|101309286|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
33388665|NCT03984812|101309287|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33388666|NCT03984812|101309288|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33388667|NCT03984812|101309289|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33388668|NCT03984812|101309290|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33388669|NCT03984812|101309291|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33388670|NCT03984812|101309292|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33388671|NCT03984812|101309293|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33388672|NCT03984812|101309294|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
33388673|NCT01855425|101309295|FG000|Overall Study|Physician Decision|20|||
33388674|NCT03947255|101309303|FG000|Overall Study|Study Closure by Sponsor|2|||
33439078|NCT04453202|101500087|FG003|Overall Study|Adverse Event|0|||
33439079|NCT04453202|101500088|FG004|Overall Study|Adverse Event|0|||
33157212|NCT02899299|100489728|FG001|Treatment|Not reported|0|||
33157213|NCT01409434|100489735|FG000|Overall Study|Protocol Violation|4|||
33253478|NCT04707313|100827541|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
33388675|NCT03947255|101309304|FG001|Overall Study|Study Closure by Sponsor|2|||
33388676|NCT03947255|101309303|FG000|Overall Study|Withdrawal by Subject|2|||
33388677|NCT03947255|101309304|FG001|Overall Study|Withdrawal by Subject|2|||
33157214|NCT01426438|100489736|FG000|Overall Study|Lost to Follow-up|1|||
33157215|NCT01426438|100489737|FG001|Overall Study|Lost to Follow-up|3|||
33157216|NCT01426438|100489736|FG000|Overall Study|Off study Treatment|9|||
33157217|NCT01426438|100489737|FG001|Overall Study|Off study Treatment|3|||
33157218|NCT01426438|100489736|FG000|Overall Study|Poor scan quality|3|||
33157219|NCT01426438|100489737|FG001|Overall Study|Poor scan quality|2|||
33157220|NCT01426438|100489736|FG000|Overall Study|Missed Scan|2|||
33439080|NCT04453202|101500089|FG005|Overall Study|Adverse Event|0|||
33439081|NCT04453202|101500090|FG006|Overall Study|Adverse Event|1|||
33439082|NCT04453202|101500091|FG007|Overall Study|Adverse Event|0|||
33439083|NCT04453202|101500092|FG008|Overall Study|Adverse Event|0|||
33439084|NCT04453202|101500093|FG009|Overall Study|Adverse Event|0|||
33439085|NCT04453202|101500094|FG010|Overall Study|Adverse Event|0|||
33439086|NCT04453202|101500084|FG000|Overall Study|Death|0|||
33439087|NCT04453202|101500085|FG001|Overall Study|Death|0|||
33157221|NCT01426438|100489737|FG001|Overall Study|Missed Scan|2|||
33157222|NCT00306189|100489741|FG000|Overall Study|Physician Decision|0|||
33157223|NCT00306189|100489742|FG001|Overall Study|Physician Decision|0|||
33157224|NCT00306189|100489743|FG002|Overall Study|Physician Decision|0|||
33157225|NCT00306189|100489744|FG003|Overall Study|Physician Decision|1|||
33157226|NCT00306189|100489741|FG000|Overall Study|Adverse Event|3|||
33157227|NCT00306189|100489742|FG001|Overall Study|Adverse Event|3|||
33157228|NCT00306189|100489743|FG002|Overall Study|Adverse Event|2|||
33157229|NCT00306189|100489744|FG003|Overall Study|Adverse Event|2|||
33157230|NCT00306189|100489741|FG000|Overall Study|Withdrawal by Subject|4|||
33157231|NCT00306189|100489742|FG001|Overall Study|Withdrawal by Subject|2|||
33157232|NCT00306189|100489743|FG002|Overall Study|Withdrawal by Subject|8|||
33157233|NCT00306189|100489744|FG003|Overall Study|Withdrawal by Subject|1|||
33157234|NCT00306189|100489741|FG000|Overall Study|Ineligibility determined|1|||
33157235|NCT00306189|100489742|FG001|Overall Study|Ineligibility determined|1|||
33157236|NCT00306189|100489743|FG002|Overall Study|Ineligibility determined|1|||
33157237|NCT00306189|100489744|FG003|Overall Study|Ineligibility determined|1|||
33157238|NCT00306189|100489741|FG000|Overall Study|Other|1|||
33157239|NCT00306189|100489742|FG001|Overall Study|Other|0|||
33157240|NCT00306189|100489743|FG002|Overall Study|Other|0|||
33157241|NCT00306189|100489744|FG003|Overall Study|Other|0|||
33157242|NCT01786148|100489745|FG000|Overall Study|Lost to Follow-up|21|||
33157243|NCT01786148|100489746|FG001|Overall Study|Lost to Follow-up|13|||
33157244|NCT01786148|100489745|FG000|Overall Study|Death|0|||
33157245|NCT01786148|100489746|FG001|Overall Study|Death|1|||
33157246|NCT01786148|100489745|FG000|Overall Study|Withdrawal by Subject|0|||
33157247|NCT01786148|100489746|FG001|Overall Study|Withdrawal by Subject|7|||
33157248|NCT01786148|100489745|FG000|Overall Study|Incarceration|1|||
33157249|NCT01786148|100489746|FG001|Overall Study|Incarceration|1|||
33157250|NCT00491764|100489747|FG000|Overall Study|Adverse Event|1|||
33157251|NCT00491764|100489748|FG001|Overall Study|Adverse Event|2|||
33157252|NCT00491764|100489749|FG002|Overall Study|Adverse Event|4|||
33157253|NCT00491764|100489750|FG003|Overall Study|Adverse Event|4|||
33157254|NCT00491764|100489751|FG004|Overall Study|Adverse Event|0|||
33157255|NCT00491764|100489752|FG005|Overall Study|Adverse Event|1|||
33157256|NCT00491764|100489747|FG000|Overall Study|Lost to Follow-up|0|||
33157257|NCT00491764|100489748|FG001|Overall Study|Lost to Follow-up|1|||
33157258|NCT00491764|100489749|FG002|Overall Study|Lost to Follow-up|0|||
33157259|NCT00491764|100489750|FG003|Overall Study|Lost to Follow-up|1|||
33157260|NCT00491764|100489751|FG004|Overall Study|Lost to Follow-up|0|||
33439088|NCT04453202|101500086|FG002|Overall Study|Death|0|||
33439089|NCT04453202|101500087|FG003|Overall Study|Death|0|||
33439090|NCT04453202|101500088|FG004|Overall Study|Death|0|||
33439091|NCT04453202|101500089|FG005|Overall Study|Death|0|||
33157261|NCT00491764|100489752|FG005|Overall Study|Lost to Follow-up|3|||
33157262|NCT00491764|100489747|FG000|Overall Study|Withdrawal by Subject|2|||
33157263|NCT00491764|100489748|FG001|Overall Study|Withdrawal by Subject|3|||
33157264|NCT00491764|100489749|FG002|Overall Study|Withdrawal by Subject|1|||
33253479|NCT04707313|100827542|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
33388678|NCT03947255|101309303|FG000|Overall Study|Lost to Follow-up|2|||
33157265|NCT00491764|100489750|FG003|Overall Study|Withdrawal by Subject|2|||
33157266|NCT00491764|100489751|FG004|Overall Study|Withdrawal by Subject|2|||
33157267|NCT00491764|100489752|FG005|Overall Study|Withdrawal by Subject|4|||
33157268|NCT00491764|100489747|FG000|Overall Study|Non Compliance with the Protocol|1|||
33157269|NCT00491764|100489748|FG001|Overall Study|Non Compliance with the Protocol|0|||
33157270|NCT00491764|100489749|FG002|Overall Study|Non Compliance with the Protocol|0|||
33157271|NCT00491764|100489750|FG003|Overall Study|Non Compliance with the Protocol|0|||
33157272|NCT00491764|100489751|FG004|Overall Study|Non Compliance with the Protocol|0|||
33157273|NCT00491764|100489752|FG005|Overall Study|Non Compliance with the Protocol|0|||
33157274|NCT00491764|100489747|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
33157275|NCT00491764|100489748|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
33388679|NCT03947255|101309304|FG001|Overall Study|Lost to Follow-up|0|||
33388680|NCT03947255|101309303|FG000|Overall Study|Death|0|||
33388681|NCT03947255|101309304|FG001|Overall Study|Death|2|||
33439092|NCT04453202|101500090|FG006|Overall Study|Death|0|||
33388682|NCT02517268|101309305|FG000|Overall Study|Withdrawal by Subject|1|||
33439093|NCT04453202|101500091|FG007|Overall Study|Death|0|||
33439094|NCT04453202|101500092|FG008|Overall Study|Death|0|||
33439095|NCT04453202|101500093|FG009|Overall Study|Death|1|||
33439096|NCT04453202|101500094|FG010|Overall Study|Death|0|||
33439097|NCT04453202|101500084|FG000|Overall Study|Lost to Follow-up|0|||
33439098|NCT04453202|101500085|FG001|Overall Study|Lost to Follow-up|1|||
33439099|NCT04453202|101500086|FG002|Overall Study|Lost to Follow-up|0|||
33439100|NCT04453202|101500087|FG003|Overall Study|Lost to Follow-up|1|||
33439101|NCT04453202|101500088|FG004|Overall Study|Lost to Follow-up|0|||
33439102|NCT04453202|101500089|FG005|Overall Study|Lost to Follow-up|0|||
33439103|NCT04453202|101500090|FG006|Overall Study|Lost to Follow-up|0|||
33439104|NCT04453202|101500091|FG007|Overall Study|Lost to Follow-up|0|||
33439105|NCT04453202|101500092|FG008|Overall Study|Lost to Follow-up|0|||
33439106|NCT04453202|101500093|FG009|Overall Study|Lost to Follow-up|1|||
33439107|NCT04453202|101500094|FG010|Overall Study|Lost to Follow-up|1|||
33439108|NCT04453202|101500084|FG000|Overall Study|Withdrawal by Subject|1|||
33439109|NCT04453202|101500085|FG001|Overall Study|Withdrawal by Subject|2|||
33388683|NCT02517268|101309306|FG001|Overall Study|Withdrawal by Subject|0|||
33388684|NCT02873208|101309311|FG000|Overall Study|Withdrawal by Subject|36|||
33388685|NCT02873208|101309311|FG000|Overall Study|Lost to Follow-up|22|||
33388686|NCT02873208|101309311|FG000|Overall Study|Adverse Event|15|||
33388687|NCT02873208|101309311|FG000|Overall Study|Non-compliance with study drug|12|||
33388688|NCT02873208|101309311|FG000|Overall Study|Protocol Violation|8|||
33388689|NCT02873208|101309311|FG000|Overall Study|Pregnancy|2|||
33388690|NCT02873208|101309311|FG000|Overall Study|Incarceration|1|||
33388691|NCT02873208|101309311|FG000|Overall Study|Lack of Efficacy|1|||
33388692|NCT02873208|101309311|FG000|Overall Study|Physician Decision|1|||
33388693|NCT01400139|101309314|FG000|HYD Core Study|Adverse Event|210|||
33388694|NCT01400139|101309314|FG000|HYD Core Study|Lack of Efficacy|59|||
33388695|NCT01400139|101309314|FG000|HYD Core Study|Withdrawal by Subject|114|||
33388696|NCT01400139|101309314|FG000|HYD Core Study|Lost to Follow-up|39|||
33388697|NCT01400139|101309314|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
33388698|NCT01400139|101309314|FG000|HYD Core Study|Administrative|56|||
33388699|NCT01400139|101309314|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
33388700|NCT01400139|101309314|FG000|HYD Extension Period|Adverse Event|8|||
33439110|NCT04453202|101500086|FG002|Overall Study|Withdrawal by Subject|1|||
33439111|NCT04453202|101500087|FG003|Overall Study|Withdrawal by Subject|2|||
33439112|NCT04453202|101500088|FG004|Overall Study|Withdrawal by Subject|1|||
33439113|NCT04453202|101500089|FG005|Overall Study|Withdrawal by Subject|1|||
33439114|NCT04453202|101500090|FG006|Overall Study|Withdrawal by Subject|0|||
33157276|NCT00491764|100489749|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
33157277|NCT00491764|100489750|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
33157278|NCT00491764|100489751|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
33157279|NCT00491764|100489752|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
33157280|NCT00491764|100489747|FG000|Overall Study|Administrative|1|||
33157281|NCT00491764|100489748|FG001|Overall Study|Administrative|0|||
33157282|NCT00491764|100489749|FG002|Overall Study|Administrative|2|||
33157283|NCT00491764|100489750|FG003|Overall Study|Administrative|1|||
33157284|NCT00491764|100489751|FG004|Overall Study|Administrative|0|||
33157285|NCT00491764|100489752|FG005|Overall Study|Administrative|0|||
33157286|NCT00400764|100489757|FG000|Phase Ib|Adverse Event|1|||
33157287|NCT00400764|100489758|FG001|Phase Ib|Adverse Event|0|||
33157288|NCT00400764|100489759|FG002|Phase Ib|Adverse Event|0|||
33157289|NCT00400764|100489760|FG003|Phase Ib|Adverse Event|0|||
33157290|NCT00400764|100489761|FG004|Phase Ib|Adverse Event|0|||
33439115|NCT04453202|101500091|FG007|Overall Study|Withdrawal by Subject|0|||
33439116|NCT04453202|101500092|FG008|Overall Study|Withdrawal by Subject|0|||
33157291|NCT00400764|100489757|FG000|Phase Ib|Death|1|||
33157292|NCT00400764|100489758|FG001|Phase Ib|Death|0|||
33157293|NCT00400764|100489759|FG002|Phase Ib|Death|0|||
33157294|NCT00400764|100489760|FG003|Phase Ib|Death|0|||
33157295|NCT00400764|100489761|FG004|Phase Ib|Death|0|||
33157296|NCT00400764|100489757|FG000|Phase Ib|Disease Progression|4|||
33157297|NCT00400764|100489758|FG001|Phase Ib|Disease Progression|4|||
33157298|NCT00400764|100489759|FG002|Phase Ib|Disease Progression|0|||
33157299|NCT00400764|100489760|FG003|Phase Ib|Disease Progression|0|||
33157300|NCT00400764|100489761|FG004|Phase Ib|Disease Progression|0|||
33157301|NCT00400764|100489757|FG000|Phase II|Death|0|||
33157302|NCT00400764|100489758|FG001|Phase II|Death|0|||
33157303|NCT00400764|100489759|FG002|Phase II|Death|1|||
33157304|NCT00400764|100489760|FG003|Phase II|Death|2|||
33157305|NCT00400764|100489761|FG004|Phase II|Death|0|||
33157306|NCT00400764|100489757|FG000|Phase II|Lost to Follow-up|0|||
33157307|NCT00400764|100489758|FG001|Phase II|Lost to Follow-up|0|||
33157308|NCT00400764|100489759|FG002|Phase II|Lost to Follow-up|1|||
33157309|NCT00400764|100489760|FG003|Phase II|Lost to Follow-up|0|||
33439117|NCT04453202|101500093|FG009|Overall Study|Withdrawal by Subject|1|||
33157310|NCT00400764|100489761|FG004|Phase II|Lost to Follow-up|0|||
33157311|NCT00400764|100489757|FG000|Phase II|Physician Decision|0|||
33157312|NCT00400764|100489758|FG001|Phase II|Physician Decision|0|||
33157313|NCT00400764|100489759|FG002|Phase II|Physician Decision|1|||
33157314|NCT00400764|100489760|FG003|Phase II|Physician Decision|1|||
33157315|NCT00400764|100489761|FG004|Phase II|Physician Decision|0|||
33157316|NCT00400764|100489757|FG000|Phase II|Sponsor's decision to terminate|0|||
33157317|NCT00400764|100489758|FG001|Phase II|Sponsor's decision to terminate|0|||
33157318|NCT00400764|100489759|FG002|Phase II|Sponsor's decision to terminate|18|||
33157319|NCT00400764|100489760|FG003|Phase II|Sponsor's decision to terminate|22|||
33157320|NCT00400764|100489761|FG004|Phase II|Sponsor's decision to terminate|11|||
33157321|NCT00400764|100489757|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
33157322|NCT00400764|100489758|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
33157323|NCT00400764|100489759|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
33157324|NCT00400764|100489760|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
33157325|NCT00400764|100489761|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
33157326|NCT00400764|100489757|FG000|Phase II|Withdrawal by Subject|0|||
33157327|NCT00400764|100489758|FG001|Phase II|Withdrawal by Subject|0|||
33157328|NCT00400764|100489759|FG002|Phase II|Withdrawal by Subject|1|||
33157329|NCT00400764|100489760|FG003|Phase II|Withdrawal by Subject|1|||
33157330|NCT00400764|100489761|FG004|Phase II|Withdrawal by Subject|0|||
33157331|NCT00091442|100489763|FG000|Overall Study|Progressive Disease|220|||
33157332|NCT00091442|100489764|FG001|Overall Study|Progressive Disease|189|||
33157333|NCT00091442|100489763|FG000|Overall Study|Physician Decision|61|||
33157334|NCT00091442|100489764|FG001|Overall Study|Physician Decision|58|||
33157335|NCT00091442|100489763|FG000|Overall Study|Withdrawal by Subject|38|||
33157336|NCT00091442|100489764|FG001|Overall Study|Withdrawal by Subject|46|||
33157337|NCT00091442|100489763|FG000|Overall Study|Adverse Event|29|||
33157338|NCT00091442|100489764|FG001|Overall Study|Adverse Event|48|||
33157339|NCT00091442|100489763|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
33157340|NCT00091442|100489764|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
33157341|NCT00091442|100489763|FG000|Overall Study|Death|9|||
33157342|NCT00091442|100489764|FG001|Overall Study|Death|7|||
33157343|NCT00091442|100489763|FG000|Overall Study|Lost to Follow-up|1|||
33157344|NCT00091442|100489764|FG001|Overall Study|Lost to Follow-up|3|||
33157345|NCT00091442|100489763|FG000|Overall Study|Other|2|||
33157346|NCT00091442|100489764|FG001|Overall Study|Other|6|||
33157347|NCT02008318|100489772|FG000|Overall Study|Adverse Event|4|||
33439118|NCT04453202|101500094|FG010|Overall Study|Withdrawal by Subject|0|||
33439119|NCT04453202|101500084|FG000|Overall Study|Adverse Event|0|||
33439120|NCT04453202|101500085|FG001|Overall Study|Adverse Event|0|||
33439121|NCT04453202|101500086|FG002|Overall Study|Adverse Event|0|||
33157348|NCT02008318|100489773|FG001|Overall Study|Adverse Event|0|||
33157349|NCT02008318|100489772|FG000|Overall Study|Physician Decision|2|||
33157350|NCT02008318|100489773|FG001|Overall Study|Physician Decision|0|||
33157351|NCT02008318|100489772|FG000|Overall Study|Progressive Disease|2|||
33157352|NCT02008318|100489773|FG001|Overall Study|Progressive Disease|0|||
33157353|NCT02008318|100489772|FG000|Overall Study|Protocol Violation|1|||
33157354|NCT02008318|100489773|FG001|Overall Study|Protocol Violation|1|||
33157355|NCT02008318|100489772|FG000|Overall Study|Withdrawal by Subject|3|||
33157356|NCT02008318|100489773|FG001|Overall Study|Withdrawal by Subject|0|||
33157357|NCT01950169|100489774|FG000|Overall Study|Withdrawal by Subject|2|||
33157358|NCT01950169|100489775|FG001|Overall Study|Withdrawal by Subject|8|||
33157359|NCT01950169|100489776|FG002|Overall Study|Withdrawal by Subject|1|||
33157360|NCT01950169|100489774|FG000|Overall Study|Death|1|||
33157361|NCT01950169|100489775|FG001|Overall Study|Death|0|||
33157362|NCT01950169|100489776|FG002|Overall Study|Death|0|||
33157363|NCT00660699|100489777|FG000|Overall Study|Withdrawal by Subject|2|||
33157364|NCT03780543|100489781|FG000|Overall Study|Adverse Event|1|||
33157365|NCT03780543|100489782|FG001|Overall Study|Adverse Event|0|||
33157366|NCT03780543|100489783|FG002|Overall Study|Adverse Event|2|||
33157367|NCT03780543|100489781|FG000|Overall Study|Lost to Follow-up|2|||
33157368|NCT03780543|100489782|FG001|Overall Study|Lost to Follow-up|0|||
33157369|NCT03780543|100489783|FG002|Overall Study|Lost to Follow-up|1|||
33157370|NCT03780543|100489781|FG000|Overall Study|Study terminated by Sponsor|8|||
33157371|NCT03780543|100489782|FG001|Overall Study|Study terminated by Sponsor|7|||
33157372|NCT03780543|100489783|FG002|Overall Study|Study terminated by Sponsor|13|||
33157373|NCT03780543|100489781|FG000|Overall Study|Withdrawal by Subject|1|||
33157374|NCT03780543|100489782|FG001|Overall Study|Withdrawal by Subject|8|||
33157375|NCT03780543|100489783|FG002|Overall Study|Withdrawal by Subject|1|||
33157376|NCT03780543|100489781|FG000|Overall Study|Noncompliance with study drug|1|||
33157377|NCT03780543|100489782|FG001|Overall Study|Noncompliance with study drug|0|||
33157378|NCT03780543|100489783|FG002|Overall Study|Noncompliance with study drug|0|||
33157379|NCT00404235|100489786|FG000|Overall Study|Withdrawal by Subject|1|||
33157380|NCT00404235|100489787|FG001|Overall Study|Withdrawal by Subject|2|||
33388701|NCT01400139|101309314|FG000|HYD Extension Period|Withdrawal by Subject|5|||
33388702|NCT01400139|101309314|FG000|HYD Extension Period|Administrative|10|||
33388703|NCT02920450|101309315|FG000|Overall Study|Death|1|||
33388704|NCT02920450|101309316|FG001|Overall Study|Death|0|||
33157381|NCT02110238|100489788|FG000|12 Week Pivotal Phase|Adverse Event|3|||
33388705|NCT02920450|101309317|FG002|Overall Study|Death|0|||
33388706|NCT02920450|101309318|FG003|Overall Study|Death|0|||
33157382|NCT02110238|100489789|FG001|12 Week Pivotal Phase|Adverse Event|0|||
33157383|NCT02110238|100489788|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
33157384|NCT02110238|100489789|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
33157385|NCT02110238|100489788|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
33157386|NCT02110238|100489789|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
33157387|NCT02110238|100489788|FG000|12 Week Pivotal Phase|Physician Decision|0|||
33157388|NCT02110238|100489789|FG001|12 Week Pivotal Phase|Physician Decision|2|||
33157389|NCT02110238|100489788|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
33157390|NCT02110238|100489789|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
33157391|NCT02110238|100489788|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
33157392|NCT02110238|100489789|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
33157393|NCT02110238|100489788|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
33157394|NCT02110238|100489789|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
33157395|NCT02110238|100489788|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
33157396|NCT02110238|100489789|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
33157397|NCT02110238|100489788|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
33253480|NCT04707313|100827543|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
33253481|NCT04707313|100827544|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
33157398|NCT02110238|100489789|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
33157399|NCT02110238|100489788|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
33253482|NCT04707313|100827532|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
33253483|NCT04707313|100827533|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
33253484|NCT04707313|100827534|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
33253485|NCT04707313|100827535|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
33157400|NCT02110238|100489789|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
33157401|NCT02110238|100489788|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
33157402|NCT02110238|100489789|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
33157403|NCT04696055|100489790|FG000|Overall Study|Adverse Event|10|||
33157404|NCT04696055|100489791|FG001|Overall Study|Adverse Event|0|||
33157405|NCT04696055|100489790|FG000|Overall Study|Death|2|||
33157406|NCT04696055|100489791|FG001|Overall Study|Death|1|||
33157407|NCT04696055|100489790|FG000|Overall Study|Other|4|||
33157408|NCT04696055|100489791|FG001|Overall Study|Other|0|||
33157409|NCT04696055|100489790|FG000|Overall Study|Physician Decision|1|||
33157410|NCT04696055|100489791|FG001|Overall Study|Physician Decision|0|||
33157411|NCT04696055|100489790|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
33157412|NCT04696055|100489791|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
33157413|NCT04696055|100489790|FG000|Overall Study|Progressive Disease - Radiological Progression|36|||
33157414|NCT04696055|100489791|FG001|Overall Study|Progressive Disease - Radiological Progression|13|||
33157415|NCT04696055|100489790|FG000|Overall Study|Subject Decision|1|||
33157416|NCT04696055|100489791|FG001|Overall Study|Subject Decision|2|||
33157417|NCT04696055|100489790|FG000|Overall Study|Ongoing with study treatment|13|||
33157418|NCT04696055|100489791|FG001|Overall Study|Ongoing with study treatment|10|||
33157419|NCT04057365|100489792|FG000|Overall Study|Withdrawal by Subject|2|||
33157420|NCT04057365|100489793|FG001|Overall Study|Withdrawal by Subject|0|||
33157421|NCT04478266|100489797|FG000|Overall Study|Adverse Event|20|||
33157422|NCT04478266|100489798|FG001|Overall Study|Adverse Event|21|||
33157423|NCT04478266|100489797|FG000|Overall Study|Progressive disease|146|||
33157424|NCT04478266|100489798|FG001|Overall Study|Progressive disease|168|||
33157425|NCT04478266|100489797|FG000|Overall Study|Poor compliance to protocol|1|||
33157426|NCT04478266|100489798|FG001|Overall Study|Poor compliance to protocol|0|||
33157427|NCT04478266|100489797|FG000|Overall Study|Withdrawal by Subject|19|||
33157428|NCT04478266|100489798|FG001|Overall Study|Withdrawal by Subject|16|||
33157429|NCT04478266|100489797|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
33157430|NCT04478266|100489798|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
33157431|NCT04478266|100489797|FG000|Overall Study|Study terminated by sponsor|33|||
33388707|NCT02920450|101309315|FG000|Overall Study|Withdrawal by Subject|1|||
33388708|NCT02920450|101309316|FG001|Overall Study|Withdrawal by Subject|0|||
33388709|NCT02920450|101309317|FG002|Overall Study|Withdrawal by Subject|0|||
33439122|NCT04453202|101500087|FG003|Overall Study|Adverse Event|0|||
33439123|NCT04453202|101500088|FG004|Overall Study|Adverse Event|0|||
33439124|NCT04453202|101500089|FG005|Overall Study|Adverse Event|1|||
33439125|NCT04453202|101500090|FG006|Overall Study|Adverse Event|0|||
33439126|NCT04453202|101500091|FG007|Overall Study|Adverse Event|0|||
33439127|NCT04453202|101500092|FG008|Overall Study|Adverse Event|0|||
33439128|NCT04453202|101500093|FG009|Overall Study|Adverse Event|0|||
33439129|NCT04453202|101500094|FG010|Overall Study|Adverse Event|0|||
33439130|NCT00162123|101500103|FG000|Overall Study|Disease progression|27|||
33388710|NCT02920450|101309318|FG003|Overall Study|Withdrawal by Subject|0|||
33388711|NCT02563925|101309321|FG000|Overall Study|Withdrawal by Subject|2|||
33388712|NCT01688999|101309322|FG000|Overall Study|Withdrawal by Subject|5|||
33388713|NCT01688999|101309323|FG001|Overall Study|Withdrawal by Subject|1|||
33439131|NCT00162123|101500104|FG001|Overall Study|Disease progression|19|||
33157432|NCT04478266|100489798|FG001|Overall Study|Study terminated by sponsor|35|||
33157433|NCT04478266|100489797|FG000|Overall Study|Other: unspecified|5|||
33157434|NCT04478266|100489798|FG001|Overall Study|Other: unspecified|7|||
33157435|NCT04478266|100489797|FG000|Overall Study|Randomized but not treated|1|||
33388714|NCT01688999|101309324|FG002|Overall Study|Withdrawal by Subject|1|||
33388715|NCT01688999|101309322|FG000|Overall Study|Adverse Event|2|||
33157436|NCT04478266|100489798|FG001|Overall Study|Randomized but not treated|1|||
33439132|NCT00162123|101500105|FG002|Overall Study|Disease progression|10|||
33439133|NCT00162123|101500106|FG003|Overall Study|Disease progression|4|||
33439134|NCT00162123|101500107|FG004|Overall Study|Disease progression|8|||
33439135|NCT00162123|101500108|FG005|Overall Study|Disease progression|3|||
33157437|NCT01128842|100489799|FG000|Overall Study|Adverse Event|1|||
33157438|NCT01128842|100489799|FG000|Overall Study|Disease Progression|6|||
33157439|NCT00085709|100489800|FG000|Overall Study|Adverse Event|8|||
33157440|NCT00085709|100489801|FG001|Overall Study|Adverse Event|0|||
33157441|NCT00085709|100489800|FG000|Overall Study|Death|8|||
33157442|NCT00085709|100489801|FG001|Overall Study|Death|2|||
33157443|NCT00085709|100489800|FG000|Overall Study|Refusal unrelated to adverse events|1|||
33157444|NCT00085709|100489801|FG001|Overall Study|Refusal unrelated to adverse events|2|||
33157445|NCT00085709|100489800|FG000|Overall Study|Progression|3|||
33157446|NCT00085709|100489801|FG001|Overall Study|Progression|4|||
33157447|NCT00085709|100489800|FG000|Overall Study|Not protocol specified|12|||
33157448|NCT00085709|100489801|FG001|Overall Study|Not protocol specified|22|||
33157449|NCT00085709|100489800|FG000|Overall Study|Not eligible|19|||
33157450|NCT00085709|100489801|FG001|Overall Study|Not eligible|19|||
33157451|NCT00085709|100489800|FG000|Overall Study|Withdrawal by Subject|2|||
33157452|NCT00085709|100489801|FG001|Overall Study|Withdrawal by Subject|1|||
33157453|NCT01522248|100489802|FG000|Overall Study|Lost to Follow-up|1|||
33157454|NCT01522248|100489803|FG001|Overall Study|Lost to Follow-up|0|||
33157455|NCT02663908|100489805|FG000|Overall Study|Withdrawal by Subject|8|||
33157456|NCT02663908|100489806|FG001|Overall Study|Withdrawal by Subject|5|||
33157457|NCT02663908|100489805|FG000|Overall Study|Lost to Follow-up|1|||
33157458|NCT02663908|100489806|FG001|Overall Study|Lost to Follow-up|5|||
33157459|NCT02663908|100489805|FG000|Overall Study|Adverse Event|13|||
33157460|NCT02663908|100489806|FG001|Overall Study|Adverse Event|11|||
33157461|NCT02663908|100489805|FG000|Overall Study|Protocol Violation|1|||
33157462|NCT02663908|100489806|FG001|Overall Study|Protocol Violation|2|||
33157463|NCT02663908|100489805|FG000|Overall Study|Lack of therapeutic response|2|||
33157464|NCT02663908|100489806|FG001|Overall Study|Lack of therapeutic response|0|||
33157465|NCT02663908|100489805|FG000|Overall Study|COVID-19|1|||
33157466|NCT02663908|100489806|FG001|Overall Study|COVID-19|0|||
33157467|NCT02663908|100489805|FG000|Overall Study|Site closed|1|||
33439136|NCT00162123|101500109|FG006|Overall Study|Disease progression|1|||
33439137|NCT00162123|101500110|FG007|Overall Study|Disease progression|0|||
33439138|NCT00162123|101500103|FG000|Overall Study|Study drug toxicity|6|||
33157468|NCT02663908|100489806|FG001|Overall Study|Site closed|0|||
33157469|NCT02663908|100489805|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
33157470|NCT02663908|100489806|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
33157471|NCT02663908|100489805|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
33157472|NCT02663908|100489806|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
33157473|NCT02663908|100489805|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
33157474|NCT02663908|100489806|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
33439139|NCT00162123|101500104|FG001|Overall Study|Study drug toxicity|1|||
33157475|NCT02663908|100489805|FG000|Overall Study|Death|1|||
33157476|NCT02663908|100489806|FG001|Overall Study|Death|0|||
33157477|NCT02663908|100489805|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
33253486|NCT04707313|100827536|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
33253487|NCT04707313|100827537|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
33253488|NCT04707313|100827538|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
33253489|NCT04707313|100827539|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
33253490|NCT04707313|100827540|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
33253491|NCT04707313|100827541|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
33253492|NCT04707313|100827542|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
33253493|NCT04707313|100827543|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
33253494|NCT04707313|100827544|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
33253495|NCT04707313|100827532|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
33253496|NCT04707313|100827533|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
33253497|NCT04707313|100827534|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
33253498|NCT04707313|100827535|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
33253499|NCT04707313|100827536|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
33253500|NCT04707313|100827537|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
33253501|NCT04707313|100827538|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
33253502|NCT04707313|100827539|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
33253503|NCT04707313|100827540|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
33253504|NCT04707313|100827541|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
33388716|NCT01688999|101309323|FG001|Overall Study|Adverse Event|0|||
33388717|NCT01688999|101309324|FG002|Overall Study|Adverse Event|2|||
33157478|NCT02663908|100489806|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
33157479|NCT02663908|100489805|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
33157480|NCT02663908|100489806|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
33157481|NCT01893203|100489807|FG000|Overall Study|Withdrawal by Subject|1|||
33157482|NCT00866788|100489808|FG000|Overall Study|Adverse Event|0|||
33157483|NCT00866788|100489809|FG001|Overall Study|Adverse Event|2|||
33157484|NCT00866788|100489810|FG002|Overall Study|Adverse Event|0|||
33157485|NCT00866788|100489811|FG003|Overall Study|Adverse Event|1|||
33157486|NCT00866788|100489808|FG000|Overall Study|Lost to Follow-up|1|||
33157487|NCT00866788|100489809|FG001|Overall Study|Lost to Follow-up|1|||
33157488|NCT00866788|100489810|FG002|Overall Study|Lost to Follow-up|0|||
33157489|NCT00866788|100489811|FG003|Overall Study|Lost to Follow-up|2|||
33157490|NCT00866788|100489808|FG000|Overall Study|Withdrawal by Subject|2|||
33157491|NCT00866788|100489809|FG001|Overall Study|Withdrawal by Subject|1|||
33253505|NCT04707313|100827542|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
33253506|NCT04707313|100827543|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
33253507|NCT04707313|100827544|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
33253508|NCT01685606|100827545|FG000|Overall Study|Withdrawal by Subject|1|||
33253509|NCT01901276|100827548|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
33253510|NCT01901276|100827549|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
33253511|NCT00172185|100827550|FG000|Overall Study|Adverse Event|0|||
33253512|NCT00172185|100827551|FG001|Overall Study|Adverse Event|1|||
33253513|NCT00172185|100827552|FG002|Overall Study|Adverse Event|3|||
33253514|NCT00172185|100827553|FG003|Overall Study|Adverse Event|4|||
33253515|NCT00172185|100827550|FG000|Overall Study|Physician Decision|0|||
33253516|NCT00172185|100827551|FG001|Overall Study|Physician Decision|0|||
33253517|NCT00172185|100827552|FG002|Overall Study|Physician Decision|1|||
33253518|NCT00172185|100827553|FG003|Overall Study|Physician Decision|0|||
33253519|NCT00172185|100827550|FG000|Overall Study|SPONSOR Decision|0|||
33253520|NCT00172185|100827551|FG001|Overall Study|SPONSOR Decision|1|||
33253521|NCT00172185|100827552|FG002|Overall Study|SPONSOR Decision|0|||
33253522|NCT00172185|100827553|FG003|Overall Study|SPONSOR Decision|0|||
33253523|NCT00172185|100827550|FG000|Overall Study|Withdrawal by Subject|0|||
33253524|NCT00172185|100827551|FG001|Overall Study|Withdrawal by Subject|0|||
33253525|NCT00172185|100827552|FG002|Overall Study|Withdrawal by Subject|1|||
33253526|NCT00172185|100827553|FG003|Overall Study|Withdrawal by Subject|0|||
33253527|NCT00943735|100827554|FG000|Overall Study|Adverse Event|12|||
33253528|NCT00943735|100827554|FG000|Overall Study|Withdrawal by Subject|8|||
33253529|NCT00943735|100827554|FG000|Overall Study|Death|1|||
33253530|NCT00943735|100827554|FG000|Overall Study|Other|8|||
33253531|NCT00943735|100827554|FG000|Overall Study|Other|3|||
33253532|NCT02031471|100827555|FG000|24 Week Treatment Period|Adverse Event|6|||
33253533|NCT02031471|100827555|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
33253534|NCT02031471|100827555|FG000|24 Week Treatment Period|Protocol Violation|1|||
33253535|NCT02031471|100827555|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
33253536|NCT02031471|100827555|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
33253537|NCT02031471|100827555|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
33253538|NCT02031471|100827555|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
33253539|NCT00970307|100827556|FG000|Overall Study|Serious Adverse Event|1|||
33253540|NCT00970307|100827557|FG001|Overall Study|Serious Adverse Event|0|||
33253541|NCT00970307|100827558|FG002|Overall Study|Serious Adverse Event|0|||
33253542|NCT00970307|100827556|FG000|Overall Study|Withdrawal by Subject|2|||
33253543|NCT00970307|100827557|FG001|Overall Study|Withdrawal by Subject|3|||
33253544|NCT00970307|100827558|FG002|Overall Study|Withdrawal by Subject|2|||
33253545|NCT05274217|100827561|FG000|Overall Study|Study terminated.|11|||
33253546|NCT05274217|100827562|FG001|Overall Study|Study terminated.|0|||
33439140|NCT00162123|101500105|FG002|Overall Study|Study drug toxicity|5|||
33439141|NCT00162123|101500106|FG003|Overall Study|Study drug toxicity|0|||
33253547|NCT04480827|100827565|FG000|Overall Study|Adverse Event|0|||
33253548|NCT04480827|100827566|FG001|Overall Study|Adverse Event|0|||
33253549|NCT04480827|100827567|FG002|Overall Study|Adverse Event|0|||
33253550|NCT04480827|100827568|FG003|Overall Study|Adverse Event|0|||
33253551|NCT04480827|100827569|FG004|Overall Study|Adverse Event|0|||
33253552|NCT04480827|100827570|FG005|Overall Study|Adverse Event|1|||
33253553|NCT04480827|100827571|FG006|Overall Study|Adverse Event|0|||
33253554|NCT02441036|100827576|FG000|Overall Study|No tissue resected|0|||
33253555|NCT02441036|100827577|FG001|Overall Study|No tissue resected|1|||
33253556|NCT02441036|100827578|FG002|Overall Study|No tissue resected|0|||
33253557|NCT02441036|100827579|FG003|Overall Study|No tissue resected|1|||
33253558|NCT02441036|100827580|FG004|Overall Study|No tissue resected|0|||
33253559|NCT01183780|100827582|FG000|Overall Study|Withdrawal by Subject|25|||
33253560|NCT01183780|100827583|FG001|Overall Study|Withdrawal by Subject|14|||
33253561|NCT01183780|100827582|FG000|Overall Study|Lost to Follow-up|6|||
33253562|NCT01183780|100827583|FG001|Overall Study|Lost to Follow-up|11|||
33253563|NCT01039688|100827584|FG000|Overall Study|Adverse Event|38|||
33253564|NCT01039688|100827585|FG001|Overall Study|Adverse Event|39|||
33253565|NCT01039688|100827586|FG002|Overall Study|Adverse Event|24|||
33253566|NCT01039688|100827584|FG000|Overall Study|Lack of Efficacy|20|||
33253567|NCT01039688|100827585|FG001|Overall Study|Lack of Efficacy|11|||
33253568|NCT01039688|100827586|FG002|Overall Study|Lack of Efficacy|26|||
33253569|NCT01039688|100827584|FG000|Overall Study|Lost to Follow-up|11|||
33253570|NCT01039688|100827585|FG001|Overall Study|Lost to Follow-up|9|||
33253571|NCT01039688|100827586|FG002|Overall Study|Lost to Follow-up|5|||
33253572|NCT01039688|100827584|FG000|Overall Study|Other|13|||
33388718|NCT01688999|101309322|FG000|Overall Study|Ineligible/Not treated|1|||
33388719|NCT01688999|101309323|FG001|Overall Study|Ineligible/Not treated|0|||
33388720|NCT01688999|101309324|FG002|Overall Study|Ineligible/Not treated|0|||
33388721|NCT02944513|101309328|FG000|Overall Study|Withdrawal by Subject|4|||
33388722|NCT02944513|101309329|FG001|Overall Study|Withdrawal by Subject|1|||
33388723|NCT02693691|101309332|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
33388724|NCT02693691|101309332|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
33253573|NCT01039688|100827585|FG001|Overall Study|Other|25|||
33253574|NCT01039688|100827586|FG002|Overall Study|Other|12|||
33388725|NCT02693691|101309332|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
33388726|NCT02693691|101309332|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
33388727|NCT02693691|101309332|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
33388728|NCT02693691|101309332|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
33388729|NCT02693691|101309332|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
33388730|NCT02009930|101309336|FG000|Overall Study|withdrawn|5|||
33388731|NCT01989572|101309337|FG000|Overall Study|Lack of Efficacy|35|||
33388732|NCT01989572|101309338|FG001|Overall Study|Lack of Efficacy|48|||
33439142|NCT00162123|101500107|FG004|Overall Study|Study drug toxicity|4|||
33439143|NCT00162123|101500108|FG005|Overall Study|Study drug toxicity|1|||
33253575|NCT01039688|100827584|FG000|Overall Study|Withdrawal by Subject|23|||
33253576|NCT01039688|100827585|FG001|Overall Study|Withdrawal by Subject|27|||
33253577|NCT01039688|100827586|FG002|Overall Study|Withdrawal by Subject|13|||
33253578|NCT01039688|100827584|FG000|Overall Study|Death|2|||
33253579|NCT01039688|100827585|FG001|Overall Study|Death|0|||
33253580|NCT01039688|100827586|FG002|Overall Study|Death|0|||
33253581|NCT00880048|100827587|FG000|Overall Study|Adverse Event|2|||
33157492|NCT00866788|100489810|FG002|Overall Study|Withdrawal by Subject|0|||
33157493|NCT00866788|100489811|FG003|Overall Study|Withdrawal by Subject|1|||
33157494|NCT00866788|100489808|FG000|Overall Study|Pregnancy|0|||
33157495|NCT00866788|100489809|FG001|Overall Study|Pregnancy|1|||
33157496|NCT00866788|100489810|FG002|Overall Study|Pregnancy|0|||
33157497|NCT00866788|100489811|FG003|Overall Study|Pregnancy|0|||
33388733|NCT01989572|101309339|FG002|Overall Study|Lack of Efficacy|48|||
33157498|NCT00866788|100489808|FG000|Overall Study|Disease progression|3|||
33157499|NCT00866788|100489809|FG001|Overall Study|Disease progression|1|||
33388734|NCT01989572|101309340|FG003|Overall Study|Lack of Efficacy|43|||
33388735|NCT01989572|101309341|FG004|Overall Study|Lack of Efficacy|71|||
33388736|NCT01989572|101309342|FG005|Overall Study|Lack of Efficacy|79|||
33388737|NCT01989572|101309337|FG000|Overall Study|Adverse Event|2|||
33388738|NCT01989572|101309338|FG001|Overall Study|Adverse Event|1|||
33439144|NCT00162123|101500109|FG006|Overall Study|Study drug toxicity|1|||
33439145|NCT00162123|101500110|FG007|Overall Study|Study drug toxicity|0|||
33388739|NCT01989572|101309339|FG002|Overall Study|Adverse Event|3|||
33388740|NCT01989572|101309340|FG003|Overall Study|Adverse Event|0|||
33388741|NCT01989572|101309341|FG004|Overall Study|Adverse Event|3|||
33388742|NCT01989572|101309342|FG005|Overall Study|Adverse Event|0|||
33157500|NCT00866788|100489810|FG002|Overall Study|Disease progression|1|||
33157501|NCT00866788|100489811|FG003|Overall Study|Disease progression|0|||
33157502|NCT00866788|100489808|FG000|Overall Study|Physician Decision|0|||
33157503|NCT00866788|100489809|FG001|Overall Study|Physician Decision|0|||
33157504|NCT00866788|100489810|FG002|Overall Study|Physician Decision|1|||
33157505|NCT00866788|100489811|FG003|Overall Study|Physician Decision|1|||
33157506|NCT01020981|100489814|FG000|Overall Study|Did not return mailed survey|74|||
33157507|NCT01020981|100489815|FG001|Overall Study|Did not return mailed survey|58|||
33157508|NCT01020981|100489814|FG000|Overall Study|Survey returned undeliverable|8|||
33157509|NCT01020981|100489815|FG001|Overall Study|Survey returned undeliverable|32|||
33157510|NCT01020981|100489814|FG000|Overall Study|Participant declined to complete survey|2|||
33157511|NCT01020981|100489815|FG001|Overall Study|Participant declined to complete survey|0|||
33157512|NCT01817530|100489816|FG000|Overall Study|Exclusionary Medication Received|0|||
33157513|NCT01817530|100489817|FG001|Overall Study|Exclusionary Medication Received|0|||
33157514|NCT01817530|100489818|FG002|Overall Study|Exclusionary Medication Received|0|||
33157515|NCT01817530|100489819|FG003|Overall Study|Exclusionary Medication Received|0|||
33157516|NCT01817530|100489820|FG004|Overall Study|Exclusionary Medication Received|1|||
33157517|NCT01817530|100489821|FG005|Overall Study|Exclusionary Medication Received|0|||
33157518|NCT01817530|100489822|FG006|Overall Study|Exclusionary Medication Received|0|||
33157519|NCT01817530|100489823|FG007|Overall Study|Exclusionary Medication Received|0|||
33157520|NCT01817530|100489816|FG000|Overall Study|Adverse Event|6|||
33157521|NCT01817530|100489817|FG001|Overall Study|Adverse Event|3|||
33157522|NCT01817530|100489818|FG002|Overall Study|Adverse Event|2|||
33157523|NCT01817530|100489819|FG003|Overall Study|Adverse Event|5|||
33157524|NCT01817530|100489820|FG004|Overall Study|Adverse Event|0|||
33157525|NCT01817530|100489821|FG005|Overall Study|Adverse Event|10|||
33157526|NCT01817530|100489822|FG006|Overall Study|Adverse Event|5|||
33439146|NCT00162123|101500103|FG000|Overall Study|Death|3|||
33157527|NCT01817530|100489823|FG007|Overall Study|Adverse Event|8|||
33157528|NCT01817530|100489816|FG000|Overall Study|Subject Noncompliant|3|||
33157529|NCT01817530|100489817|FG001|Overall Study|Subject Noncompliant|1|||
33157530|NCT01817530|100489818|FG002|Overall Study|Subject Noncompliant|0|||
33157531|NCT01817530|100489819|FG003|Overall Study|Subject Noncompliant|4|||
33157532|NCT01817530|100489820|FG004|Overall Study|Subject Noncompliant|0|||
33157533|NCT01817530|100489821|FG005|Overall Study|Subject Noncompliant|1|||
33157534|NCT01817530|100489822|FG006|Overall Study|Subject Noncompliant|1|||
33157535|NCT01817530|100489823|FG007|Overall Study|Subject Noncompliant|1|||
33157536|NCT01817530|100489816|FG000|Overall Study|Lack of Efficacy|1|||
33157537|NCT01817530|100489817|FG001|Overall Study|Lack of Efficacy|0|||
33157538|NCT01817530|100489818|FG002|Overall Study|Lack of Efficacy|0|||
33157539|NCT01817530|100489819|FG003|Overall Study|Lack of Efficacy|0|||
33157540|NCT01817530|100489820|FG004|Overall Study|Lack of Efficacy|0|||
33157541|NCT01817530|100489821|FG005|Overall Study|Lack of Efficacy|1|||
33157542|NCT01817530|100489822|FG006|Overall Study|Lack of Efficacy|0|||
33157543|NCT01817530|100489823|FG007|Overall Study|Lack of Efficacy|1|||
33157544|NCT01817530|100489816|FG000|Overall Study|Pregnancy|0|||
33157545|NCT01817530|100489817|FG001|Overall Study|Pregnancy|0|||
33157546|NCT01817530|100489818|FG002|Overall Study|Pregnancy|0|||
33157547|NCT01817530|100489819|FG003|Overall Study|Pregnancy|0|||
33157548|NCT01817530|100489820|FG004|Overall Study|Pregnancy|0|||
33157549|NCT01817530|100489821|FG005|Overall Study|Pregnancy|1|||
33157550|NCT01817530|100489822|FG006|Overall Study|Pregnancy|0|||
33439147|NCT00162123|101500104|FG001|Overall Study|Death|3|||
33157551|NCT01817530|100489823|FG007|Overall Study|Pregnancy|0|||
33388743|NCT01989572|101309337|FG000|Overall Study|Death|0|||
33388744|NCT01989572|101309338|FG001|Overall Study|Death|0|||
33388745|NCT01989572|101309339|FG002|Overall Study|Death|0|||
33388746|NCT01989572|101309340|FG003|Overall Study|Death|0|||
33388747|NCT01989572|101309341|FG004|Overall Study|Death|1|||
33388748|NCT01989572|101309342|FG005|Overall Study|Death|0|||
33388749|NCT01989572|101309337|FG000|Overall Study|Withdrawal by Subject|4|||
33388750|NCT01989572|101309338|FG001|Overall Study|Withdrawal by Subject|1|||
33388751|NCT01989572|101309339|FG002|Overall Study|Withdrawal by Subject|5|||
33388752|NCT01989572|101309340|FG003|Overall Study|Withdrawal by Subject|1|||
33157552|NCT01817530|100489816|FG000|Overall Study|Other|0|||
33157553|NCT01817530|100489817|FG001|Overall Study|Other|1|||
33388753|NCT01989572|101309341|FG004|Overall Study|Withdrawal by Subject|12|||
33388754|NCT01989572|101309342|FG005|Overall Study|Withdrawal by Subject|4|||
33157554|NCT01817530|100489818|FG002|Overall Study|Other|0|||
33157555|NCT01817530|100489819|FG003|Overall Study|Other|0|||
33157556|NCT01817530|100489820|FG004|Overall Study|Other|1|||
33157557|NCT01817530|100489821|FG005|Overall Study|Other|0|||
33157558|NCT01817530|100489822|FG006|Overall Study|Other|5|||
33157559|NCT01817530|100489823|FG007|Overall Study|Other|0|||
33157560|NCT01817530|100489816|FG000|Overall Study|Surgery or Invasive Intervention|1|||
33388755|NCT01989572|101309337|FG000|Overall Study|complicating disease|1|||
33388756|NCT01989572|101309338|FG001|Overall Study|complicating disease|1|||
33388757|NCT01989572|101309339|FG002|Overall Study|complicating disease|2|||
33157561|NCT01817530|100489817|FG001|Overall Study|Surgery or Invasive Intervention|0|||
33157562|NCT01817530|100489818|FG002|Overall Study|Surgery or Invasive Intervention|0|||
33157563|NCT01817530|100489819|FG003|Overall Study|Surgery or Invasive Intervention|0|||
33157564|NCT01817530|100489820|FG004|Overall Study|Surgery or Invasive Intervention|1|||
33157565|NCT01817530|100489821|FG005|Overall Study|Surgery or Invasive Intervention|1|||
33157566|NCT01817530|100489822|FG006|Overall Study|Surgery or Invasive Intervention|1|||
33157567|NCT01817530|100489823|FG007|Overall Study|Surgery or Invasive Intervention|0|||
33388758|NCT01989572|101309340|FG003|Overall Study|complicating disease|0|||
33439148|NCT00162123|101500105|FG002|Overall Study|Death|1|||
33439149|NCT00162123|101500106|FG003|Overall Study|Death|1|||
33388759|NCT01989572|101309341|FG004|Overall Study|complicating disease|1|||
33439150|NCT00162123|101500107|FG004|Overall Study|Death|1|||
33439151|NCT00162123|101500108|FG005|Overall Study|Death|1|||
33439152|NCT00162123|101500109|FG006|Overall Study|Death|0|||
33439153|NCT00162123|101500110|FG007|Overall Study|Death|0|||
33439154|NCT00162123|101500103|FG000|Overall Study|Withdrawal by Subject|2|||
33439155|NCT00162123|101500104|FG001|Overall Study|Withdrawal by Subject|0|||
33439156|NCT00162123|101500105|FG002|Overall Study|Withdrawal by Subject|2|||
33439157|NCT00162123|101500106|FG003|Overall Study|Withdrawal by Subject|1|||
33439158|NCT00162123|101500107|FG004|Overall Study|Withdrawal by Subject|1|||
33439159|NCT00162123|101500108|FG005|Overall Study|Withdrawal by Subject|2|||
33439160|NCT00162123|101500109|FG006|Overall Study|Withdrawal by Subject|1|||
33439161|NCT00162123|101500110|FG007|Overall Study|Withdrawal by Subject|0|||
33439162|NCT00162123|101500103|FG000|Overall Study|Deterioration without progression|2|||
33439163|NCT00162123|101500104|FG001|Overall Study|Deterioration without progression|2|||
33439164|NCT00162123|101500105|FG002|Overall Study|Deterioration without progression|3|||
33439165|NCT00162123|101500106|FG003|Overall Study|Deterioration without progression|0|||
33439166|NCT00162123|101500107|FG004|Overall Study|Deterioration without progression|1|||
33439167|NCT00162123|101500108|FG005|Overall Study|Deterioration without progression|0|||
33439168|NCT00162123|101500109|FG006|Overall Study|Deterioration without progression|0|||
33439169|NCT00162123|101500110|FG007|Overall Study|Deterioration without progression|0|||
33439170|NCT00162123|101500103|FG000|Overall Study|Adverse Event|1|||
33439171|NCT00162123|101500104|FG001|Overall Study|Adverse Event|2|||
33439172|NCT00162123|101500105|FG002|Overall Study|Adverse Event|0|||
33439173|NCT00162123|101500106|FG003|Overall Study|Adverse Event|2|||
33439174|NCT00162123|101500107|FG004|Overall Study|Adverse Event|1|||
33439175|NCT00162123|101500108|FG005|Overall Study|Adverse Event|0|||
33157568|NCT01817530|100489816|FG000|Overall Study|Consent Withdrawn by Subject|3|||
33157569|NCT01817530|100489817|FG001|Overall Study|Consent Withdrawn by Subject|4|||
33157570|NCT01817530|100489818|FG002|Overall Study|Consent Withdrawn by Subject|7|||
33157571|NCT01817530|100489819|FG003|Overall Study|Consent Withdrawn by Subject|3|||
33157572|NCT01817530|100489820|FG004|Overall Study|Consent Withdrawn by Subject|5|||
33157573|NCT01817530|100489821|FG005|Overall Study|Consent Withdrawn by Subject|3|||
33157574|NCT01817530|100489822|FG006|Overall Study|Consent Withdrawn by Subject|3|||
33157575|NCT01817530|100489823|FG007|Overall Study|Consent Withdrawn by Subject|10|||
33157576|NCT01817530|100489816|FG000|Overall Study|Lost to Follow-up|1|||
33157577|NCT01817530|100489817|FG001|Overall Study|Lost to Follow-up|4|||
33157578|NCT01817530|100489818|FG002|Overall Study|Lost to Follow-up|2|||
33157579|NCT01817530|100489819|FG003|Overall Study|Lost to Follow-up|1|||
33157580|NCT01817530|100489820|FG004|Overall Study|Lost to Follow-up|3|||
33157581|NCT01817530|100489821|FG005|Overall Study|Lost to Follow-up|2|||
33157582|NCT01817530|100489822|FG006|Overall Study|Lost to Follow-up|8|||
33157583|NCT01817530|100489823|FG007|Overall Study|Lost to Follow-up|4|||
33157584|NCT00809354|100489824|FG000|Overall Study|Adverse Event|32|||
33157585|NCT00809354|100489825|FG001|Overall Study|Adverse Event|45|||
33157586|NCT00809354|100489826|FG002|Overall Study|Adverse Event|37|||
33157587|NCT00809354|100489827|FG003|Overall Study|Adverse Event|53|||
33157588|NCT00809354|100489828|FG004|Overall Study|Adverse Event|26|||
33157589|NCT00809354|100489829|FG005|Overall Study|Adverse Event|33|||
33253582|NCT00880048|100827588|FG001|Overall Study|Adverse Event|3|||
33253583|NCT00880048|100827589|FG002|Overall Study|Adverse Event|5|||
33253584|NCT00880048|100827587|FG000|Overall Study|Lack of Efficacy|1|||
33253585|NCT00880048|100827588|FG001|Overall Study|Lack of Efficacy|2|||
33253586|NCT00880048|100827589|FG002|Overall Study|Lack of Efficacy|2|||
33253587|NCT00880048|100827587|FG000|Overall Study|Protocol Violation|4|||
33253588|NCT00880048|100827588|FG001|Overall Study|Protocol Violation|6|||
33253589|NCT00880048|100827589|FG002|Overall Study|Protocol Violation|5|||
33253590|NCT00880048|100827587|FG000|Overall Study|Lost to Follow-up|6|||
33253591|NCT00880048|100827588|FG001|Overall Study|Lost to Follow-up|6|||
33157590|NCT00809354|100489830|FG006|Overall Study|Adverse Event|44|||
33157591|NCT00809354|100489831|FG007|Overall Study|Adverse Event|40|||
33157592|NCT00809354|100489832|FG008|Overall Study|Adverse Event|46|||
33157593|NCT00809354|100489833|FG009|Overall Study|Adverse Event|26|||
33253592|NCT00880048|100827589|FG002|Overall Study|Lost to Follow-up|5|||
33439176|NCT00162123|101500109|FG006|Overall Study|Adverse Event|0|||
33157594|NCT00809354|100489824|FG000|Overall Study|Lack of Efficacy|23|||
33157595|NCT00809354|100489825|FG001|Overall Study|Lack of Efficacy|23|||
33157596|NCT00809354|100489826|FG002|Overall Study|Lack of Efficacy|22|||
33157597|NCT00809354|100489827|FG003|Overall Study|Lack of Efficacy|15|||
33157598|NCT00809354|100489828|FG004|Overall Study|Lack of Efficacy|40|||
33157599|NCT00809354|100489829|FG005|Overall Study|Lack of Efficacy|19|||
33157600|NCT00809354|100489830|FG006|Overall Study|Lack of Efficacy|21|||
33157601|NCT00809354|100489831|FG007|Overall Study|Lack of Efficacy|15|||
33157602|NCT00809354|100489832|FG008|Overall Study|Lack of Efficacy|18|||
33157603|NCT00809354|100489833|FG009|Overall Study|Lack of Efficacy|38|||
33157604|NCT00809354|100489824|FG000|Overall Study|Lost to Follow-up|10|||
33157605|NCT00809354|100489825|FG001|Overall Study|Lost to Follow-up|11|||
33157606|NCT00809354|100489826|FG002|Overall Study|Lost to Follow-up|8|||
33157607|NCT00809354|100489827|FG003|Overall Study|Lost to Follow-up|13|||
33157608|NCT00809354|100489828|FG004|Overall Study|Lost to Follow-up|6|||
33157609|NCT00809354|100489829|FG005|Overall Study|Lost to Follow-up|2|||
33157610|NCT00809354|100489830|FG006|Overall Study|Lost to Follow-up|0|||
33157611|NCT00809354|100489831|FG007|Overall Study|Lost to Follow-up|5|||
33157612|NCT00809354|100489832|FG008|Overall Study|Lost to Follow-up|4|||
33157613|NCT00809354|100489833|FG009|Overall Study|Lost to Follow-up|0|||
33253593|NCT00880048|100827587|FG000|Overall Study|Physician Decision|1|||
33253594|NCT00880048|100827588|FG001|Overall Study|Physician Decision|1|||
33253595|NCT00880048|100827589|FG002|Overall Study|Physician Decision|7|||
33253596|NCT00880048|100827587|FG000|Overall Study|Withdrawal by Subject|5|||
33253597|NCT00880048|100827588|FG001|Overall Study|Withdrawal by Subject|8|||
33253598|NCT00880048|100827589|FG002|Overall Study|Withdrawal by Subject|5|||
33253599|NCT00880048|100827587|FG000|Overall Study|Study closed/terminated|9|||
33253600|NCT00880048|100827588|FG001|Overall Study|Study closed/terminated|7|||
33253601|NCT00880048|100827589|FG002|Overall Study|Study closed/terminated|6|||
33253602|NCT01692938|100827590|FG000|Overall Study|Protocol Deviation|1|||
33253603|NCT01692938|100827591|FG001|Overall Study|Protocol Deviation|1|||
33253604|NCT01692938|100827590|FG000|Overall Study|Study completed prior to site completion|3|||
33253605|NCT01692938|100827591|FG001|Overall Study|Study completed prior to site completion|3|||
33157614|NCT00809354|100489824|FG000|Overall Study|Protocol Violation|7|||
33253606|NCT03861767|100827593|FG000|Overall Study|Withdrawal by Subject|2|||
33253607|NCT03861767|100827594|FG001|Overall Study|Withdrawal by Subject|1|||
33157615|NCT00809354|100489825|FG001|Overall Study|Protocol Violation|14|||
33157616|NCT00809354|100489826|FG002|Overall Study|Protocol Violation|14|||
33157617|NCT00809354|100489827|FG003|Overall Study|Protocol Violation|12|||
33253608|NCT03861767|100827595|FG002|Overall Study|Withdrawal by Subject|0|||
33253609|NCT03861767|100827596|FG003|Overall Study|Withdrawal by Subject|5|||
33253610|NCT03861767|100827597|FG004|Overall Study|Withdrawal by Subject|2|||
33253611|NCT03861767|100827598|FG005|Overall Study|Withdrawal by Subject|1|||
33157618|NCT00809354|100489828|FG004|Overall Study|Protocol Violation|14|||
33157619|NCT00809354|100489829|FG005|Overall Study|Protocol Violation|6|||
33157620|NCT00809354|100489830|FG006|Overall Study|Protocol Violation|4|||
33157621|NCT00809354|100489831|FG007|Overall Study|Protocol Violation|6|||
33157622|NCT00809354|100489832|FG008|Overall Study|Protocol Violation|9|||
33157623|NCT00809354|100489833|FG009|Overall Study|Protocol Violation|3|||
33157624|NCT00809354|100489824|FG000|Overall Study|Withdrawal by Subject|32|||
33157625|NCT00809354|100489825|FG001|Overall Study|Withdrawal by Subject|27|||
33157626|NCT00809354|100489826|FG002|Overall Study|Withdrawal by Subject|31|||
33157627|NCT00809354|100489827|FG003|Overall Study|Withdrawal by Subject|33|||
33157628|NCT00809354|100489828|FG004|Overall Study|Withdrawal by Subject|34|||
33157629|NCT00809354|100489829|FG005|Overall Study|Withdrawal by Subject|29|||
33157630|NCT00809354|100489830|FG006|Overall Study|Withdrawal by Subject|27|||
33157631|NCT00809354|100489831|FG007|Overall Study|Withdrawal by Subject|19|||
33157632|NCT00809354|100489832|FG008|Overall Study|Withdrawal by Subject|18|||
33157633|NCT00809354|100489833|FG009|Overall Study|Withdrawal by Subject|20|||
33157634|NCT00809354|100489824|FG000|Overall Study|Other|10|||
33157635|NCT00809354|100489825|FG001|Overall Study|Other|2|||
33157636|NCT00809354|100489826|FG002|Overall Study|Other|7|||
33157637|NCT00809354|100489827|FG003|Overall Study|Other|10|||
33157638|NCT00809354|100489828|FG004|Overall Study|Other|5|||
33157639|NCT00809354|100489829|FG005|Overall Study|Other|3|||
33157640|NCT00809354|100489830|FG006|Overall Study|Other|2|||
33157641|NCT00809354|100489831|FG007|Overall Study|Other|3|||
33253612|NCT03861767|100827599|FG006|Overall Study|Withdrawal by Subject|3|||
33253613|NCT03861767|100827600|FG007|Overall Study|Withdrawal by Subject|1|||
33253614|NCT03861767|100827601|FG008|Overall Study|Withdrawal by Subject|0|||
33253615|NCT03861767|100827602|FG009|Overall Study|Withdrawal by Subject|5|||
33253616|NCT00711958|100827610|FG000|Overall Study|Withdrawal by Subject|6|||
33253617|NCT00711958|100827611|FG001|Overall Study|Withdrawal by Subject|8|||
33253618|NCT00711958|100827610|FG000|Overall Study|Lack of Efficacy|3|||
33253619|NCT00711958|100827611|FG001|Overall Study|Lack of Efficacy|1|||
33253620|NCT00711958|100827610|FG000|Overall Study|Clinical deterioration|1|||
33253621|NCT00711958|100827611|FG001|Overall Study|Clinical deterioration|0|||
33253622|NCT00711958|100827610|FG000|Overall Study|Adverse Event|9|||
33253623|NCT00711958|100827611|FG001|Overall Study|Adverse Event|7|||
33157642|NCT00809354|100489832|FG008|Overall Study|Other|4|||
33157643|NCT00809354|100489833|FG009|Overall Study|Other|3|||
33157644|NCT00809354|100489824|FG000|Overall Study|Study terminated by sponsor|138|||
33157645|NCT00809354|100489825|FG001|Overall Study|Study terminated by sponsor|134|||
33157646|NCT00809354|100489826|FG002|Overall Study|Study terminated by sponsor|129|||
33157647|NCT00809354|100489827|FG003|Overall Study|Study terminated by sponsor|120|||
33157648|NCT00809354|100489828|FG004|Overall Study|Study terminated by sponsor|126|||
33157649|NCT00809354|100489829|FG005|Overall Study|Study terminated by sponsor|133|||
33157650|NCT00809354|100489830|FG006|Overall Study|Study terminated by sponsor|124|||
33439177|NCT00162123|101500110|FG007|Overall Study|Adverse Event|0|||
33439178|NCT00162123|101500103|FG000|Overall Study|Not specified (before treatment)|2|||
33439179|NCT00162123|101500104|FG001|Overall Study|Not specified (before treatment)|0|||
33439180|NCT00162123|101500105|FG002|Overall Study|Not specified (before treatment)|0|||
33439181|NCT00162123|101500106|FG003|Overall Study|Not specified (before treatment)|0|||
33439182|NCT00162123|101500107|FG004|Overall Study|Not specified (before treatment)|12|||
33439183|NCT00162123|101500108|FG005|Overall Study|Not specified (before treatment)|1|||
33439184|NCT00162123|101500109|FG006|Overall Study|Not specified (before treatment)|0|||
33439185|NCT00162123|101500110|FG007|Overall Study|Not specified (before treatment)|0|||
33439186|NCT00162123|101500103|FG000|Overall Study|Not specified (after start of treatment)|0|||
33439187|NCT00162123|101500104|FG001|Overall Study|Not specified (after start of treatment)|0|||
33439188|NCT00162123|101500105|FG002|Overall Study|Not specified (after start of treatment)|0|||
33439189|NCT00162123|101500106|FG003|Overall Study|Not specified (after start of treatment)|0|||
33439190|NCT00162123|101500107|FG004|Overall Study|Not specified (after start of treatment)|3|||
33439191|NCT00162123|101500108|FG005|Overall Study|Not specified (after start of treatment)|0|||
33439192|NCT00162123|101500109|FG006|Overall Study|Not specified (after start of treatment)|0|||
33439193|NCT00162123|101500110|FG007|Overall Study|Not specified (after start of treatment)|0|||
33439194|NCT00162123|101500103|FG000|Overall Study|Physician Decision|1|||
33439195|NCT00162123|101500104|FG001|Overall Study|Physician Decision|2|||
33157651|NCT00809354|100489831|FG007|Overall Study|Study terminated by sponsor|148|||
33157652|NCT00809354|100489832|FG008|Overall Study|Study terminated by sponsor|127|||
33157653|NCT00809354|100489833|FG009|Overall Study|Study terminated by sponsor|135|||
33157654|NCT00809354|100489824|FG000|Overall Study|Withdrawn due to pregnancy|0|||
33157655|NCT00809354|100489825|FG001|Overall Study|Withdrawn due to pregnancy|1|||
33157656|NCT00809354|100489826|FG002|Overall Study|Withdrawn due to pregnancy|0|||
33253624|NCT00711958|100827610|FG000|Overall Study|Protocol Violation|1|||
33253625|NCT00711958|100827611|FG001|Overall Study|Protocol Violation|0|||
33253626|NCT00711958|100827610|FG000|Overall Study|Lost to Follow-up|2|||
33439196|NCT00162123|101500105|FG002|Overall Study|Physician Decision|0|||
33439197|NCT00162123|101500106|FG003|Overall Study|Physician Decision|0|||
33439198|NCT00162123|101500107|FG004|Overall Study|Physician Decision|0|||
33439199|NCT00162123|101500108|FG005|Overall Study|Physician Decision|1|||
33439200|NCT00162123|101500109|FG006|Overall Study|Physician Decision|1|||
33439201|NCT00162123|101500110|FG007|Overall Study|Physician Decision|0|||
33439202|NCT00162123|101500103|FG000|Overall Study|Tumor assessment only (not treated)|0|||
33439203|NCT00162123|101500104|FG001|Overall Study|Tumor assessment only (not treated)|0|||
33439204|NCT00162123|101500105|FG002|Overall Study|Tumor assessment only (not treated)|0|||
33439205|NCT00162123|101500106|FG003|Overall Study|Tumor assessment only (not treated)|0|||
33439206|NCT00162123|101500107|FG004|Overall Study|Tumor assessment only (not treated)|0|||
33439207|NCT00162123|101500108|FG005|Overall Study|Tumor assessment only (not treated)|0|||
33439208|NCT00162123|101500109|FG006|Overall Study|Tumor assessment only (not treated)|0|||
33439209|NCT00162123|101500110|FG007|Overall Study|Tumor assessment only (not treated)|1|||
33439210|NCT00162123|101500103|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
33439211|NCT00162123|101500104|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
33439212|NCT00162123|101500105|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
33439213|NCT00162123|101500106|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
33439214|NCT00162123|101500107|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
33439215|NCT00162123|101500108|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
33439216|NCT00162123|101500109|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
33439217|NCT00162123|101500110|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
33439218|NCT01223365|101500111|FG000|Open-label Titration Period|Enrolled but not treated|1|||
33439219|NCT01223365|101500111|FG000|Open-label Titration Period|Adverse Event|23|||
33439220|NCT01223365|101500111|FG000|Open-label Titration Period|Lack of Efficacy|3|||
33439221|NCT01223365|101500111|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
33439222|NCT01223365|101500111|FG000|Open-label Titration Period|Protocol Violation|1|||
33439223|NCT01223365|101500111|FG000|Open-label Titration Period|Lost to Follow-up|2|||
33439224|NCT01223365|101500111|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
33439225|NCT01223365|101500111|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
33439226|NCT01223365|101500111|FG000|Open-label Titration Period|Starting physical therapy|1|||
33439227|NCT01223365|101500111|FG000|Open-label Treatment Period|Adverse Event|39|||
33439228|NCT01223365|101500111|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
33439229|NCT01223365|101500111|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
33439230|NCT01223365|101500111|FG000|Open-label Treatment Period|Protocol Violation|15|||
33439231|NCT01223365|101500111|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
33439232|NCT01223365|101500111|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
33439233|NCT01223365|101500111|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
33439234|NCT01223365|101500111|FG000|Open-label Treatment Period|Moved out of area|2|||
33439235|NCT01223365|101500111|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
33439236|NCT01223365|101500111|FG000|Open-label Treatment Period|"Out of window"|1|||
33439237|NCT01223365|101500111|FG000|Open-label Treatment Period|Starting physical therapy|1|||
33439238|NCT01223365|101500111|FG000|Open-label Treatment Period|Physician Decision|2|||
33439239|NCT02319148|101502739|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
33439240|NCT02319148|101502740|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
33439241|NCT02319148|101502741|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
33439242|NCT02319148|101502742|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
33439243|NCT02319148|101502739|FG000|Second Intervention Period|No longer willing to participate|0|||
33439244|NCT02319148|101502740|FG001|Second Intervention Period|No longer willing to participate|1|||
33439245|NCT02319148|101502741|FG002|Second Intervention Period|No longer willing to participate|0|||
33439246|NCT02319148|101502742|FG003|Second Intervention Period|No longer willing to participate|0|||
33439247|NCT02319148|101502739|FG000|Second Intervention Period|Other|0|||
33439248|NCT02319148|101502740|FG001|Second Intervention Period|Other|0|||
33439249|NCT02319148|101502741|FG002|Second Intervention Period|Other|0|||
33439250|NCT02319148|101502742|FG003|Second Intervention Period|Other|1|||
33439251|NCT02066922|101502745|FG000|Overall Study|Adverse Event|1|||
33439252|NCT01900730|101502755|FG000|Overall Study|Withdrawal by Subject|1|||
33439253|NCT01900730|101502756|FG001|Overall Study|Withdrawal by Subject|0|||
33439254|NCT01900730|101502755|FG000|Overall Study|Screen Failure|1|||
33439255|NCT01900730|101502756|FG001|Overall Study|Screen Failure|0|||
33439256|NCT00376623|101502757|FG000|Overall Study|Progressive disease|35|||
33439257|NCT00376623|101502758|FG001|Overall Study|Progressive disease|22|||
33439258|NCT00376623|101502759|FG002|Overall Study|Progressive disease|17|||
33253627|NCT00711958|100827611|FG001|Overall Study|Lost to Follow-up|2|||
33439259|NCT00376623|101502757|FG000|Overall Study|Lost to Follow-up|0|||
33439260|NCT00376623|101502758|FG001|Overall Study|Lost to Follow-up|1|||
33439261|NCT00376623|101502759|FG002|Overall Study|Lost to Follow-up|0|||
33439262|NCT00376623|101502757|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
33439263|NCT00376623|101502758|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
33439264|NCT00376623|101502759|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
33439265|NCT00376623|101502757|FG000|Overall Study|Not treated with BI 2536|1|||
33439266|NCT00376623|101502758|FG001|Overall Study|Not treated with BI 2536|0|||
33439267|NCT00376623|101502759|FG002|Overall Study|Not treated with BI 2536|0|||
33439268|NCT00376623|101502757|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
33439269|NCT00376623|101502758|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
33439270|NCT00376623|101502759|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
33439271|NCT00376623|101502757|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
33439272|NCT00376623|101502758|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
33157657|NCT00809354|100489827|FG003|Overall Study|Withdrawn due to pregnancy|0|||
33157658|NCT00809354|100489828|FG004|Overall Study|Withdrawn due to pregnancy|0|||
33157659|NCT00809354|100489829|FG005|Overall Study|Withdrawn due to pregnancy|0|||
33157660|NCT00809354|100489830|FG006|Overall Study|Withdrawn due to pregnancy|0|||
33157661|NCT00809354|100489831|FG007|Overall Study|Withdrawn due to pregnancy|0|||
33157662|NCT00809354|100489832|FG008|Overall Study|Withdrawn due to pregnancy|0|||
33157663|NCT00809354|100489833|FG009|Overall Study|Withdrawn due to pregnancy|0|||
33157664|NCT00809354|100489824|FG000|Overall Study|Randomized but not Treated|3|||
33157665|NCT00809354|100489825|FG001|Overall Study|Randomized but not Treated|1|||
33253628|NCT00711958|100827610|FG000|Overall Study|Death|10|||
33253629|NCT00711958|100827611|FG001|Overall Study|Death|5|||
33439273|NCT00376623|101502759|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
33439274|NCT00376623|101502757|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
33439275|NCT00376623|101502758|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
33439276|NCT00376623|101502759|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
33439277|NCT00376623|101502757|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
33439278|NCT00376623|101502758|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
33439279|NCT00376623|101502759|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
33439280|NCT00376623|101502757|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
33439281|NCT00376623|101502758|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
33439282|NCT00376623|101502759|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
33439283|NCT00376623|101502757|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
33439284|NCT00376623|101502758|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
33439285|NCT00376623|101502759|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
33439286|NCT00376623|101502757|FG000|Overall Study|Increase of tumour markers|0|||
33439287|NCT00376623|101502758|FG001|Overall Study|Increase of tumour markers|1|||
33439288|NCT00376623|101502759|FG002|Overall Study|Increase of tumour markers|0|||
33439289|NCT00376623|101502757|FG000|Overall Study|Bone metastasis|1|||
33439290|NCT00376623|101502758|FG001|Overall Study|Bone metastasis|0|||
33439291|NCT00376623|101502759|FG002|Overall Study|Bone metastasis|0|||
33439292|NCT02193880|101502769|FG000|Overall Study|patients did not collect enough HPC|3|||
33439293|NCT00832377|101502775|FG000|Overall Study|Protocol Violation|1|||
33439294|NCT00854100|101502776|FG000|Overall Study|Inability to complete the study visits|0|||
33439295|NCT00854100|101502777|FG001|Overall Study|Inability to complete the study visits|0|||
33439296|NCT00854100|101502778|FG002|Overall Study|Inability to complete the study visits|1|||
33439297|NCT00854100|101502776|FG000|Overall Study|Lost to Follow-up|2|||
33439298|NCT00854100|101502777|FG001|Overall Study|Lost to Follow-up|0|||
33439299|NCT00854100|101502778|FG002|Overall Study|Lost to Follow-up|3|||
33439300|NCT00854100|101502776|FG000|Overall Study|Withdrawal by Subject|3|||
33439301|NCT00854100|101502777|FG001|Overall Study|Withdrawal by Subject|1|||
33439302|NCT00854100|101502778|FG002|Overall Study|Withdrawal by Subject|2|||
33439303|NCT00854100|101502776|FG000|Overall Study|Protocol Violation|2|||
33439304|NCT00854100|101502777|FG001|Overall Study|Protocol Violation|4|||
33439305|NCT00854100|101502778|FG002|Overall Study|Protocol Violation|3|||
33439306|NCT00854100|101502776|FG000|Overall Study|Adverse Event|2|||
33439307|NCT00854100|101502777|FG001|Overall Study|Adverse Event|1|||
33439308|NCT00854100|101502778|FG002|Overall Study|Adverse Event|2|||
33439309|NCT01876706|101502779|FG000|Overall Study|BPH Intervention|9|||
33439310|NCT01876706|101502779|FG000|Overall Study|Lost to Follow-up|7|||
33439311|NCT01876706|101502779|FG000|Overall Study|Withdrawals|6|||
33439312|NCT01876706|101502779|FG000|Overall Study|Death|3|||
33439313|NCT00755196|101502780|FG000|Overall Study|Lost to Follow-up|1|||
33253630|NCT00711958|100827610|FG000|Overall Study|Progression of disease|1|||
33253631|NCT00711958|100827611|FG001|Overall Study|Progression of disease|0|||
33253632|NCT03837028|100827612|FG000|Overall Study|Lost to Follow-up|4|||
33439314|NCT00755196|101502780|FG000|Overall Study|Lack of Efficiency|1|||
33439315|NCT00694551|101502787|FG000|Overall Study|Disease Progression|1|||
33439316|NCT00694551|101502788|FG001|Overall Study|Disease Progression|0|||
33439317|NCT00694551|101502789|FG002|Overall Study|Disease Progression|1|||
33439318|NCT00995553|101502790|FG000|Overall Study|Withdrawal by Subject|2|||
33439319|NCT00995553|101502791|FG001|Overall Study|Withdrawal by Subject|6|||
33439320|NCT00604500|101502792|FG000|Overall Study|Adverse Event|2|||
33439321|NCT00604500|101502792|FG000|Overall Study|Protocol Violation|2|||
33439322|NCT00604500|101502792|FG000|Overall Study|Treatment Failure|1|||
33439323|NCT00604500|101502792|FG000|Overall Study|Withdrawal by Subject|4|||
33439324|NCT00604500|101502792|FG000|Overall Study|Administrative|1|||
33439325|NCT00604500|101502792|FG000|Overall Study|Did not meet protocol eligibility|1|||
33439326|NCT03787680|101502797|FG000|Overall Study|Physician Decision|2|||
33439327|NCT03787680|101502798|FG001|Overall Study|Physician Decision|3|||
33439328|NCT03787680|101502797|FG000|Overall Study|Adverse Event|7|||
33439329|NCT03787680|101502798|FG001|Overall Study|Adverse Event|3|||
33439330|NCT03787680|101502797|FG000|Overall Study|Withdrawal by Subject|2|||
33439331|NCT03787680|101502798|FG001|Overall Study|Withdrawal by Subject|1|||
33439332|NCT03725605|101502799|FG000|Overall Study|Unsuccessful TIL expansion|2|||
33439333|NCT00051025|101502807|FG000|Overall Study|Progressive Disease|1|||
33439334|NCT00051025|101502808|FG001|Overall Study|Progressive Disease|1|||
33439335|NCT00051025|101502807|FG000|Overall Study|Adverse Event|1|||
33439336|NCT00051025|101502808|FG001|Overall Study|Adverse Event|1|||
33439337|NCT00051025|101502807|FG000|Overall Study|Withdrawal by Subject|0|||
33439338|NCT00051025|101502808|FG001|Overall Study|Withdrawal by Subject|1|||
33439339|NCT00051025|101502807|FG000|Overall Study|Death|0|||
33439340|NCT00051025|101502808|FG001|Overall Study|Death|1|||
33439341|NCT00630305|101502809|FG000|Overall Study|Withdrawal by Subject|1|||
33439342|NCT00630305|101502809|FG000|Overall Study|Inability to insert contact lens|1|||
33439343|NCT01203878|101502813|FG000|Overall Study|Withdrawal by Subject|0|||
33439344|NCT01203878|101502814|FG001|Overall Study|Withdrawal by Subject|0|||
33439345|NCT01203878|101502815|FG002|Overall Study|Withdrawal by Subject|1|||
33439346|NCT01203878|101502813|FG000|Overall Study|Adverse Event|0|||
33157666|NCT00809354|100489826|FG002|Overall Study|Randomized but not Treated|6|||
33439347|NCT01203878|101502814|FG001|Overall Study|Adverse Event|0|||
33439348|NCT01203878|101502815|FG002|Overall Study|Adverse Event|2|||
33439349|NCT00679367|101502816|FG000|Overall Study|Adverse Event|7|||
33439350|NCT00679367|101502816|FG000|Overall Study|inability to swallow oral drugs|1|||
33439351|NCT00679367|101502816|FG000|Overall Study|Lack of Efficacy|3|||
33439352|NCT00679367|101502816|FG000|Overall Study|Withdrawal by Subject|1|||
33439353|NCT03450070|101502817|FG000|Overall Study|Withdrawal by Subject|8|||
33439354|NCT00386009|101502819|FG000|Overall Study|Adverse Event|0|||
33439355|NCT00386009|101502820|FG001|Overall Study|Adverse Event|2|||
33439356|NCT00386009|101502819|FG000|Overall Study|Death|1|||
33439357|NCT00386009|101502820|FG001|Overall Study|Death|0|||
33439358|NCT00386009|101502819|FG000|Overall Study|Entry Criteria Not Met|0|||
33439359|NCT00386009|101502820|FG001|Overall Study|Entry Criteria Not Met|2|||
33439360|NCT00386009|101502819|FG000|Overall Study|Lost to Follow-up|1|||
33439361|NCT00386009|101502820|FG001|Overall Study|Lost to Follow-up|1|||
33439362|NCT00386009|101502819|FG000|Overall Study|Protocol Violation|1|||
33439363|NCT00386009|101502820|FG001|Overall Study|Protocol Violation|0|||
33157667|NCT00809354|100489827|FG003|Overall Study|Randomized but not Treated|0|||
33157668|NCT00809354|100489828|FG004|Overall Study|Randomized but not Treated|5|||
33439364|NCT00386009|101502819|FG000|Overall Study|Sponsor Decision|1|||
33439365|NCT00386009|101502820|FG001|Overall Study|Sponsor Decision|1|||
33439366|NCT00386009|101502819|FG000|Overall Study|Withdrawal by Subject|5|||
33439367|NCT00386009|101502820|FG001|Overall Study|Withdrawal by Subject|4|||
33439368|NCT03553823|101502825|FG000|Overall Study|Physician Decision|0|||
33439369|NCT03553823|101502826|FG001|Overall Study|Physician Decision|1|||
33439370|NCT04538170|101502831|FG000|Overall Study|Withdrawal by Subject|104|||
33439371|NCT04538170|101502832|FG001|Overall Study|Withdrawal by Subject|210|||
33439372|NCT00527423|101502833|FG000|Overall Study|Protocol Violation|1|||
33439373|NCT00527423|101502833|FG000|Overall Study|Adverse Event|5|||
33439374|NCT00527423|101502833|FG000|Overall Study|Physician Decision|4|||
33439375|NCT00527423|101502833|FG000|Overall Study|Withdrawal by Subject|10|||
33439376|NCT00527423|101502833|FG000|Overall Study|Lost to Follow-up|4|||
33439377|NCT00527423|101502833|FG000|Overall Study|OTHER|4|||
33253633|NCT03837028|100827613|FG001|Overall Study|Lost to Follow-up|0|||
33253634|NCT03837028|100827614|FG002|Overall Study|Lost to Follow-up|2|||
33253635|NCT03837028|100827615|FG003|Overall Study|Lost to Follow-up|0|||
33253636|NCT03837028|100827612|FG000|Overall Study|Withdrawal by Subject|12|||
33253637|NCT03837028|100827613|FG001|Overall Study|Withdrawal by Subject|11|||
33253638|NCT03837028|100827614|FG002|Overall Study|Withdrawal by Subject|11|||
33253639|NCT03837028|100827615|FG003|Overall Study|Withdrawal by Subject|7|||
33253640|NCT00057837|100827616|FG000|Overall Study|Progression/relapse|12|||
33253641|NCT00057837|100827617|FG001|Overall Study|Progression/relapse|14|||
33253642|NCT00057837|100827616|FG000|Overall Study|Adverse Event|2|||
33253643|NCT00057837|100827617|FG001|Overall Study|Adverse Event|12|||
33253644|NCT00057837|100827616|FG000|Overall Study|Death|5|||
33253645|NCT00057837|100827617|FG001|Overall Study|Death|4|||
33253646|NCT00057837|100827616|FG000|Overall Study|Withdrawal by Subject|5|||
33253647|NCT00057837|100827617|FG001|Overall Study|Withdrawal by Subject|3|||
33253648|NCT00057837|100827616|FG000|Overall Study|Alternative therapy|0|||
33253649|NCT00057837|100827617|FG001|Overall Study|Alternative therapy|1|||
33253650|NCT00057837|100827616|FG000|Overall Study|Other complicating disease|2|||
33253651|NCT00057837|100827617|FG001|Overall Study|Other complicating disease|1|||
33253652|NCT00057837|100827616|FG000|Overall Study|Physician Decision|1|||
33253653|NCT00057837|100827617|FG001|Overall Study|Physician Decision|0|||
33253654|NCT00057837|100827616|FG000|Overall Study|Ineligible|3|||
33253655|NCT00057837|100827617|FG001|Overall Study|Ineligible|3|||
33253656|NCT00057837|100827616|FG000|Overall Study|Never started treatment|1|||
33253657|NCT00057837|100827617|FG001|Overall Study|Never started treatment|1|||
33253658|NCT01490086|100827623|FG000|Overall Study|Consent withdrawn|4|||
33253659|NCT01490086|100827624|FG001|Overall Study|Consent withdrawn|4|||
33253660|NCT01490086|100827625|FG002|Overall Study|Consent withdrawn|3|||
33253661|NCT01490086|100827626|FG003|Overall Study|Consent withdrawn|0|||
33253662|NCT01490086|100827627|FG004|Overall Study|Consent withdrawn|1|||
33253663|NCT01490086|100827623|FG000|Overall Study|Non-compliance|0|||
33253664|NCT01490086|100827624|FG001|Overall Study|Non-compliance|1|||
33253665|NCT01490086|100827625|FG002|Overall Study|Non-compliance|0|||
33253666|NCT01490086|100827626|FG003|Overall Study|Non-compliance|0|||
33253667|NCT01490086|100827627|FG004|Overall Study|Non-compliance|0|||
33253668|NCT01490086|100827623|FG000|Overall Study|Abnormal laboratory findings|1|||
33253669|NCT01490086|100827624|FG001|Overall Study|Abnormal laboratory findings|0|||
33253670|NCT01490086|100827625|FG002|Overall Study|Abnormal laboratory findings|0|||
33253671|NCT01490086|100827626|FG003|Overall Study|Abnormal laboratory findings|0|||
33253672|NCT01490086|100827627|FG004|Overall Study|Abnormal laboratory findings|0|||
33253673|NCT01490086|100827623|FG000|Overall Study|Lost to Follow-up|0|||
33253674|NCT01490086|100827624|FG001|Overall Study|Lost to Follow-up|0|||
33253675|NCT01490086|100827625|FG002|Overall Study|Lost to Follow-up|0|||
33253676|NCT01490086|100827626|FG003|Overall Study|Lost to Follow-up|0|||
33253677|NCT01490086|100827627|FG004|Overall Study|Lost to Follow-up|1|||
33157669|NCT00809354|100489829|FG005|Overall Study|Randomized but not Treated|0|||
33157670|NCT00809354|100489830|FG006|Overall Study|Randomized but not Treated|1|||
33253678|NCT01490086|100827623|FG000|Overall Study|Physician Decision|3|||
33253679|NCT01490086|100827624|FG001|Overall Study|Physician Decision|4|||
33157671|NCT00809354|100489831|FG007|Overall Study|Randomized but not Treated|1|||
33157672|NCT00809354|100489832|FG008|Overall Study|Randomized but not Treated|2|||
33253680|NCT01490086|100827625|FG002|Overall Study|Physician Decision|2|||
33253681|NCT01490086|100827626|FG003|Overall Study|Physician Decision|3|||
33253682|NCT01490086|100827627|FG004|Overall Study|Physician Decision|1|||
33253683|NCT01490086|100827623|FG000|Overall Study|Adverse Event|0|||
33253684|NCT01490086|100827624|FG001|Overall Study|Adverse Event|0|||
33253685|NCT01490086|100827625|FG002|Overall Study|Adverse Event|1|||
33253686|NCT01490086|100827626|FG003|Overall Study|Adverse Event|2|||
33253687|NCT01490086|100827627|FG004|Overall Study|Adverse Event|0|||
33253688|NCT01490086|100827623|FG000|Overall Study|Lack of Efficacy|0|||
33253689|NCT01490086|100827624|FG001|Overall Study|Lack of Efficacy|3|||
33253690|NCT01490086|100827625|FG002|Overall Study|Lack of Efficacy|1|||
33253691|NCT01490086|100827626|FG003|Overall Study|Lack of Efficacy|0|||
33253692|NCT01490086|100827627|FG004|Overall Study|Lack of Efficacy|8|||
33253693|NCT01490086|100827623|FG000|Overall Study|Worsening of symptoms|0|||
33253694|NCT01490086|100827624|FG001|Overall Study|Worsening of symptoms|1|||
33253695|NCT01490086|100827625|FG002|Overall Study|Worsening of symptoms|0|||
33253696|NCT01490086|100827626|FG003|Overall Study|Worsening of symptoms|1|||
33253697|NCT01490086|100827627|FG004|Overall Study|Worsening of symptoms|0|||
33253698|NCT01490086|100827623|FG000|Overall Study|Subject uncontrollable and abusive|0|||
33253699|NCT01490086|100827624|FG001|Overall Study|Subject uncontrollable and abusive|1|||
33253700|NCT01490086|100827625|FG002|Overall Study|Subject uncontrollable and abusive|0|||
33253701|NCT01490086|100827626|FG003|Overall Study|Subject uncontrollable and abusive|0|||
33253702|NCT01490086|100827627|FG004|Overall Study|Subject uncontrollable and abusive|0|||
33253703|NCT01490086|100827623|FG000|Overall Study|Subject left hospital|0|||
33253704|NCT01490086|100827624|FG001|Overall Study|Subject left hospital|1|||
33253705|NCT01490086|100827625|FG002|Overall Study|Subject left hospital|0|||
33253706|NCT01490086|100827626|FG003|Overall Study|Subject left hospital|1|||
33253707|NCT01490086|100827627|FG004|Overall Study|Subject left hospital|0|||
33253708|NCT00988637|100827628|FG000|Overall Study|Lost to Follow-up|2|||
33253709|NCT00988637|100827629|FG001|Overall Study|Lost to Follow-up|1|||
33253710|NCT00988637|100827628|FG000|Overall Study|Withdrawal by Subject|1|||
33253711|NCT00988637|100827629|FG001|Overall Study|Withdrawal by Subject|1|||
33253712|NCT00988637|100827628|FG000|Overall Study|non-compliance with study drug|0|||
33253713|NCT00988637|100827629|FG001|Overall Study|non-compliance with study drug|1|||
33253714|NCT01063517|100827634|FG000|Overall Study|Consent withdrawal|1|||
33253715|NCT01063517|100827635|FG001|Overall Study|Consent withdrawal|0|||
33253716|NCT01063517|100827634|FG000|Overall Study|Study reached data cut-off|19|||
33439378|NCT00527423|101502833|FG000|Overall Study|Death|9|||
33253717|NCT01063517|100827635|FG001|Overall Study|Study reached data cut-off|7|||
33253718|NCT01063517|100827634|FG000|Overall Study|Lost to Follow-up|4|||
33253719|NCT01063517|100827635|FG001|Overall Study|Lost to Follow-up|3|||
33253720|NCT01063517|100827634|FG000|Overall Study|Withdrawal by Subject|1|||
33253721|NCT01063517|100827635|FG001|Overall Study|Withdrawal by Subject|2|||
33253722|NCT01063517|100827634|FG000|Overall Study|Death|33|||
33439379|NCT00995410|101502834|FG000|Overall Study|Adverse Event|51|||
33253723|NCT01063517|100827635|FG001|Overall Study|Death|48|||
33253724|NCT00630786|100830231|FG000|Overall Study|Physician Decision|0|||
33253725|NCT00630786|100830232|FG001|Overall Study|Physician Decision|0|||
33253726|NCT00630786|100830233|FG002|Overall Study|Physician Decision|1|||
33253727|NCT00630786|100830231|FG000|Overall Study|Withdrawal by Subject|0|||
33253728|NCT00630786|100830232|FG001|Overall Study|Withdrawal by Subject|1|||
33253729|NCT00630786|100830233|FG002|Overall Study|Withdrawal by Subject|1|||
33253730|NCT00630786|100830231|FG000|Overall Study|Lost to Follow-up|0|||
33253731|NCT00630786|100830232|FG001|Overall Study|Lost to Follow-up|1|||
33253732|NCT00630786|100830233|FG002|Overall Study|Lost to Follow-up|0|||
33253733|NCT00630786|100830231|FG000|Overall Study|Other|1|||
33253734|NCT00630786|100830232|FG001|Overall Study|Other|0|||
33253735|NCT00630786|100830233|FG002|Overall Study|Other|0|||
33253736|NCT02027558|100830234|FG000|Overall Study|Death|0|||
33253737|NCT02027558|100830235|FG001|Overall Study|Death|1|||
33253738|NCT02027558|100830234|FG000|Overall Study|Withdrawal by Subject|2|||
33253739|NCT02027558|100830235|FG001|Overall Study|Withdrawal by Subject|0|||
33253740|NCT02027558|100830234|FG000|Overall Study|Lost to Follow-up|4|||
33157673|NCT00809354|100489833|FG009|Overall Study|Randomized but not Treated|1|||
33157674|NCT00809354|100489824|FG000|Overall Study|Death|0|||
33157675|NCT00809354|100489825|FG001|Overall Study|Death|0|||
33157676|NCT00809354|100489826|FG002|Overall Study|Death|0|||
33157677|NCT00809354|100489827|FG003|Overall Study|Death|0|||
33157678|NCT00809354|100489828|FG004|Overall Study|Death|0|||
33157679|NCT00809354|100489829|FG005|Overall Study|Death|0|||
33157680|NCT00809354|100489830|FG006|Overall Study|Death|0|||
33157681|NCT00809354|100489831|FG007|Overall Study|Death|1|||
33157682|NCT00809354|100489832|FG008|Overall Study|Death|0|||
33157683|NCT00809354|100489833|FG009|Overall Study|Death|0|||
33157684|NCT03758443|100489834|FG000|Induction Period|Adverse Event|2|||
33157685|NCT03758443|100489835|FG001|Induction Period|Adverse Event|4|||
33157686|NCT03758443|100489836|FG002|Induction Period|Adverse Event|2|||
33157687|NCT03758443|100489837|FG003|Induction Period|Adverse Event|3|||
33157688|NCT03758443|100489834|FG000|Induction Period|Physician Decision|1|||
33157689|NCT03758443|100489835|FG001|Induction Period|Physician Decision|1|||
33157690|NCT03758443|100489836|FG002|Induction Period|Physician Decision|3|||
33157691|NCT03758443|100489837|FG003|Induction Period|Physician Decision|0|||
33157692|NCT03758443|100489834|FG000|Induction Period|Protocol Violation|0|||
33157693|NCT03758443|100489835|FG001|Induction Period|Protocol Violation|0|||
33157694|NCT03758443|100489836|FG002|Induction Period|Protocol Violation|0|||
33157695|NCT03758443|100489837|FG003|Induction Period|Protocol Violation|1|||
33157696|NCT03758443|100489834|FG000|Induction Period|Withdrawal by Subject|3|||
33157697|NCT03758443|100489835|FG001|Induction Period|Withdrawal by Subject|2|||
33157698|NCT03758443|100489836|FG002|Induction Period|Withdrawal by Subject|2|||
33157699|NCT03758443|100489837|FG003|Induction Period|Withdrawal by Subject|4|||
33157700|NCT03758443|100489834|FG000|Extended Induction Period|Adverse Event|1|||
33157701|NCT03758443|100489835|FG001|Extended Induction Period|Adverse Event|1|||
33157702|NCT03758443|100489836|FG002|Extended Induction Period|Adverse Event|0|||
33157703|NCT03758443|100489837|FG003|Extended Induction Period|Adverse Event|1|||
33157704|NCT03758443|100489834|FG000|Extended Induction Period|Lost to Follow-up|1|||
33157705|NCT03758443|100489835|FG001|Extended Induction Period|Lost to Follow-up|0|||
33157706|NCT03758443|100489836|FG002|Extended Induction Period|Lost to Follow-up|0|||
33157707|NCT03758443|100489837|FG003|Extended Induction Period|Lost to Follow-up|0|||
33157708|NCT03758443|100489834|FG000|Extended Induction Period|Physician Decision|2|||
33157709|NCT03758443|100489835|FG001|Extended Induction Period|Physician Decision|1|||
33157710|NCT03758443|100489836|FG002|Extended Induction Period|Physician Decision|2|||
33157711|NCT03758443|100489837|FG003|Extended Induction Period|Physician Decision|2|||
33157712|NCT03758443|100489834|FG000|Extended Induction Period|Protocol Violation|0|||
33157713|NCT03758443|100489835|FG001|Extended Induction Period|Protocol Violation|0|||
33157714|NCT03758443|100489836|FG002|Extended Induction Period|Protocol Violation|0|||
33157715|NCT03758443|100489837|FG003|Extended Induction Period|Protocol Violation|1|||
33157716|NCT03758443|100489834|FG000|Extended Induction Period|Withdrawal by Subject|8|||
33157717|NCT03758443|100489835|FG001|Extended Induction Period|Withdrawal by Subject|1|||
33157718|NCT03758443|100489836|FG002|Extended Induction Period|Withdrawal by Subject|7|||
33157719|NCT03758443|100489837|FG003|Extended Induction Period|Withdrawal by Subject|3|||
33157720|NCT03758443|100489834|FG000|Extended Induction Period|Miscellaneous|1|||
33157721|NCT03758443|100489835|FG001|Extended Induction Period|Miscellaneous|0|||
33157722|NCT03758443|100489836|FG002|Extended Induction Period|Miscellaneous|0|||
33157723|NCT03758443|100489837|FG003|Extended Induction Period|Miscellaneous|0|||
33157724|NCT03758443|100489834|FG000|Maintenance Period|Adverse Event|1|||
33157725|NCT03758443|100489835|FG001|Maintenance Period|Adverse Event|2|||
33157726|NCT03758443|100489836|FG002|Maintenance Period|Adverse Event|0|||
33253741|NCT02027558|100830235|FG001|Overall Study|Lost to Follow-up|1|||
33253742|NCT02027558|100830234|FG000|Overall Study|Refused assessment|3|||
33253743|NCT02027558|100830235|FG001|Overall Study|Refused assessment|0|||
33253744|NCT03804918|100830236|FG000|Overall Study|Participant did not use the app|1|||
33253745|NCT01787760|100830237|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
33253746|NCT01787760|100830238|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
33253747|NCT01787760|100830239|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
33253748|NCT01787760|100830237|FG000|Overall Study|Decompensated on left exotropia|0|||
33253749|NCT01787760|100830238|FG001|Overall Study|Decompensated on left exotropia|0|||
33253750|NCT01787760|100830239|FG002|Overall Study|Decompensated on left exotropia|1|||
33253751|NCT01787760|100830237|FG000|Overall Study|Dryness|0|||
33253752|NCT01787760|100830238|FG001|Overall Study|Dryness|1|||
33253753|NCT01787760|100830239|FG002|Overall Study|Dryness|0|||
33253754|NCT01787760|100830237|FG000|Overall Study|Relocation|1|||
33253755|NCT01787760|100830238|FG001|Overall Study|Relocation|1|||
33253756|NCT01787760|100830239|FG002|Overall Study|Relocation|0|||
33253757|NCT01787760|100830237|FG000|Overall Study|Lens discomfort|3|||
33253758|NCT01787760|100830238|FG001|Overall Study|Lens discomfort|0|||
33253759|NCT01787760|100830239|FG002|Overall Study|Lens discomfort|0|||
33253760|NCT01787760|100830237|FG000|Overall Study|Lens handling difficulty|1|||
33253761|NCT01787760|100830238|FG001|Overall Study|Lens handling difficulty|2|||
33253762|NCT01787760|100830239|FG002|Overall Study|Lens handling difficulty|0|||
33253763|NCT01787760|100830237|FG000|Overall Study|Protocol Violation|6|||
33253764|NCT01787760|100830238|FG001|Overall Study|Protocol Violation|0|||
33253765|NCT01787760|100830239|FG002|Overall Study|Protocol Violation|1|||
33253766|NCT01787760|100830237|FG000|Overall Study|Withdrawal by Subject|5|||
33253767|NCT01787760|100830238|FG001|Overall Study|Withdrawal by Subject|1|||
33253768|NCT01787760|100830239|FG002|Overall Study|Withdrawal by Subject|2|||
33253769|NCT01787760|100830237|FG000|Overall Study|Lost to Follow-up|1|||
33253770|NCT01787760|100830238|FG001|Overall Study|Lost to Follow-up|0|||
33253771|NCT01787760|100830239|FG002|Overall Study|Lost to Follow-up|1|||
33253772|NCT01787760|100830237|FG000|Overall Study|Stroke|1|||
33253773|NCT01787760|100830238|FG001|Overall Study|Stroke|0|||
33253774|NCT01787760|100830239|FG002|Overall Study|Stroke|0|||
33253775|NCT01787760|100830237|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
33253776|NCT01787760|100830238|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
33253777|NCT01787760|100830239|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
33253778|NCT01787760|100830237|FG000|Overall Study|Unsatisfactory physiological response|2|||
33253779|NCT01787760|100830238|FG001|Overall Study|Unsatisfactory physiological response|4|||
33253780|NCT01787760|100830239|FG002|Overall Study|Unsatisfactory physiological response|0|||
33253781|NCT01787760|100830237|FG000|Overall Study|Unsatisfactory visual response|1|||
33253782|NCT01787760|100830238|FG001|Overall Study|Unsatisfactory visual response|1|||
33253783|NCT01787760|100830239|FG002|Overall Study|Unsatisfactory visual response|0|||
33253784|NCT01787760|100830237|FG000|Overall Study|Near vision blur|1|||
33253785|NCT01787760|100830238|FG001|Overall Study|Near vision blur|0|||
33253786|NCT01787760|100830239|FG002|Overall Study|Near vision blur|0|||
33253787|NCT03380390|100830240|FG000|Overall Study|Adverse Event|3|||
33253788|NCT02878330|100830241|FG000|Overall Study|Death|3|||
33253789|NCT02878330|100830242|FG001|Overall Study|Death|2|||
33253790|NCT02878330|100830241|FG000|Overall Study|Lost to Follow-up|11|||
33253791|NCT02878330|100830242|FG001|Overall Study|Lost to Follow-up|26|||
33439380|NCT00995410|101502834|FG000|Overall Study|Withdrawal by Subject|7|||
33439381|NCT00995410|101502834|FG000|Overall Study|Lost to Follow-up|2|||
33439382|NCT00995410|101502834|FG000|Overall Study|Misc|28|||
33439383|NCT01471093|101502836|FG000|Overall Study|Adverse Event|1|||
33439384|NCT01471093|101502837|FG001|Overall Study|Adverse Event|0|||
33439385|NCT01471093|101502838|FG002|Overall Study|Adverse Event|0|||
33439386|NCT01471093|101502839|FG003|Overall Study|Adverse Event|0|||
33439387|NCT00419770|101502842|FG000|Overall Study|Withdrawal by Subject|5|||
33439388|NCT00419770|101502843|FG001|Overall Study|Withdrawal by Subject|1|||
33439389|NCT00822926|101502844|FG000|Second Injection Visit|Lost to Follow-up|1|||
33253792|NCT02878330|100830241|FG000|Overall Study|Withdrawal by Subject|11|||
33439390|NCT00822926|101502845|FG001|Second Injection Visit|Lost to Follow-up|0|||
33253793|NCT02878330|100830242|FG001|Overall Study|Withdrawal by Subject|21|||
33253794|NCT02878330|100830241|FG000|Overall Study|Other|4|||
33253795|NCT02878330|100830242|FG001|Overall Study|Other|7|||
33439391|NCT00822926|101502844|FG000|Second Injection Visit|Withdrawal by Subject|0|||
33439392|NCT00822926|101502845|FG001|Second Injection Visit|Withdrawal by Subject|1|||
33253796|NCT04009577|100830244|FG000|Core Study|Adverse Event|1|||
33253797|NCT04009577|100830245|FG001|Core Study|Adverse Event|0|||
33253798|NCT04009577|100830246|FG002|Core Study|Adverse Event|2|||
33253799|NCT04009577|100830247|FG003|Core Study|Adverse Event|4|||
33253800|NCT04009577|100830244|FG000|Core Study|Withdrawal by Subject|0|||
33253801|NCT04009577|100830245|FG001|Core Study|Withdrawal by Subject|0|||
33253802|NCT04009577|100830246|FG002|Core Study|Withdrawal by Subject|2|||
33253803|NCT04009577|100830247|FG003|Core Study|Withdrawal by Subject|0|||
33253804|NCT04009577|100830244|FG000|Core Study|Other|0|||
33253805|NCT04009577|100830245|FG001|Core Study|Other|0|||
33253806|NCT04009577|100830246|FG002|Core Study|Other|0|||
33439393|NCT00414466|101502846|FG000|Overall Study|Adverse Event|0|||
33439394|NCT00414466|101502847|FG001|Overall Study|Adverse Event|0|||
33439395|NCT00414466|101502848|FG002|Overall Study|Adverse Event|1|||
33439396|NCT00414466|101502849|FG003|Overall Study|Adverse Event|1|||
33439397|NCT00414466|101502846|FG000|Overall Study|Lack of Efficacy|1|||
33439398|NCT00414466|101502847|FG001|Overall Study|Lack of Efficacy|0|||
33439399|NCT00414466|101502848|FG002|Overall Study|Lack of Efficacy|0|||
33439400|NCT00414466|101502849|FG003|Overall Study|Lack of Efficacy|0|||
33439401|NCT00414466|101502846|FG000|Overall Study|Withdrawn by Sponsor|1|||
33439402|NCT00414466|101502847|FG001|Overall Study|Withdrawn by Sponsor|0|||
33439403|NCT00414466|101502848|FG002|Overall Study|Withdrawn by Sponsor|0|||
33439404|NCT00414466|101502849|FG003|Overall Study|Withdrawn by Sponsor|0|||
33439405|NCT04091971|101502850|FG000|Overall Study|Withdrawal by Subject|1|||
33439406|NCT04091971|101502850|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
33439407|NCT04091971|101502850|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
33439408|NCT02353169|101502851|FG000|Overall Study|QTc > 450 msec|1|||
33439409|NCT02353169|101502852|FG001|Overall Study|QTc > 450 msec|1|||
33439410|NCT02353169|101502853|FG002|Overall Study|QTc > 450 msec|1|||
33439411|NCT02353169|101502854|FG003|Overall Study|QTc > 450 msec|1|||
33439412|NCT02353169|101502851|FG000|Overall Study|OR team declined|2|||
33439413|NCT02353169|101502852|FG001|Overall Study|OR team declined|0|||
33439414|NCT02353169|101502853|FG002|Overall Study|OR team declined|0|||
33253807|NCT04009577|100830247|FG003|Core Study|Other|1|||
33253808|NCT04009577|100830244|FG000|Extension Phase|Adverse Event|0|||
33253809|NCT04009577|100830245|FG001|Extension Phase|Adverse Event|0|||
33253810|NCT04009577|100830246|FG002|Extension Phase|Adverse Event|0|||
33439415|NCT02353169|101502854|FG003|Overall Study|OR team declined|0|||
33439416|NCT02353169|101502851|FG000|Overall Study|Inhalational induction|0|||
33157727|NCT03758443|100489837|FG003|Maintenance Period|Adverse Event|0|||
33157728|NCT03758443|100489834|FG000|Maintenance Period|Lost to Follow-up|0|||
33157729|NCT03758443|100489835|FG001|Maintenance Period|Lost to Follow-up|0|||
33157730|NCT03758443|100489836|FG002|Maintenance Period|Lost to Follow-up|0|||
33157731|NCT03758443|100489837|FG003|Maintenance Period|Lost to Follow-up|1|||
33157732|NCT03758443|100489834|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
33157733|NCT03758443|100489835|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
33157734|NCT03758443|100489836|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
33157735|NCT03758443|100489837|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
33157736|NCT03758443|100489834|FG000|Maintenance Period|Protocol Violation|0|||
33157737|NCT03758443|100489835|FG001|Maintenance Period|Protocol Violation|1|||
33157738|NCT03758443|100489836|FG002|Maintenance Period|Protocol Violation|0|||
33157739|NCT03758443|100489837|FG003|Maintenance Period|Protocol Violation|0|||
33157740|NCT03758443|100489834|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
33157741|NCT03758443|100489835|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
33157742|NCT03758443|100489836|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
33157743|NCT03758443|100489837|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
33157744|NCT03758443|100489834|FG000|Maintenance Period|Withdrawal by Subject|1|||
33157745|NCT03758443|100489835|FG001|Maintenance Period|Withdrawal by Subject|0|||
33157746|NCT03758443|100489836|FG002|Maintenance Period|Withdrawal by Subject|1|||
33157747|NCT03758443|100489837|FG003|Maintenance Period|Withdrawal by Subject|1|||
33157748|NCT03758443|100489834|FG000|Maintenance Period|Miscellaneous|0|||
33157749|NCT03758443|100489835|FG001|Maintenance Period|Miscellaneous|0|||
33157750|NCT03758443|100489836|FG002|Maintenance Period|Miscellaneous|1|||
33157751|NCT03758443|100489837|FG003|Maintenance Period|Miscellaneous|0|||
33157752|NCT00369707|100489838|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
33157753|NCT00369707|100489838|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
33157754|NCT00369707|100489838|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
33157755|NCT00369707|100489838|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
33157756|NCT00369707|100489838|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
33157757|NCT00369707|100489838|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
33157758|NCT00369707|100489838|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
33157759|NCT00369707|100489838|FG000|Follow up for 2 Years After Treatment|Death|1|||
33157760|NCT00369707|100489838|FG000|Follow up for 2 Years After Treatment|Other|2|||
33157761|NCT01696071|100489839|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
33157762|NCT01696071|100489840|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
33157763|NCT02339285|100489844|FG000|Overall Study|Withdrawal by Subject|0|||
33157764|NCT02339285|100489845|FG001|Overall Study|Withdrawal by Subject|1|||
33157765|NCT02339285|100489846|FG002|Overall Study|Withdrawal by Subject|1|||
33157766|NCT02339285|100489844|FG000|Overall Study|Lost to Follow-up|1|||
33439417|NCT02353169|101502852|FG001|Overall Study|Inhalational induction|2|||
33439418|NCT02353169|101502853|FG002|Overall Study|Inhalational induction|0|||
33439419|NCT02353169|101502854|FG003|Overall Study|Inhalational induction|0|||
33439420|NCT02353169|101502851|FG000|Overall Study|ECG data error|0|||
33439421|NCT02353169|101502852|FG001|Overall Study|ECG data error|3|||
33439422|NCT02353169|101502853|FG002|Overall Study|ECG data error|2|||
33439423|NCT02353169|101502854|FG003|Overall Study|ECG data error|2|||
33439424|NCT02353169|101502851|FG000|Overall Study|Pre-op medication|0|||
33439425|NCT02353169|101502852|FG001|Overall Study|Pre-op medication|0|||
33439426|NCT02353169|101502853|FG002|Overall Study|Pre-op medication|1|||
33439427|NCT02353169|101502854|FG003|Overall Study|Pre-op medication|0|||
33439428|NCT01087970|101502855|FG000|Overall Study|Protocol Violation|2|||
33439429|NCT00486837|101502857|FG000|Overall Study|Withdrawal by Subject|1|||
33439430|NCT00486837|101502858|FG001|Overall Study|Withdrawal by Subject|0|||
33439431|NCT00486837|101502857|FG000|Overall Study|Adverse Event|1|||
33439432|NCT00486837|101502858|FG001|Overall Study|Adverse Event|1|||
33439433|NCT00486837|101502857|FG000|Overall Study|Protocol Violation|4|||
33157767|NCT02339285|100489845|FG001|Overall Study|Lost to Follow-up|1|||
33439434|NCT00486837|101502858|FG001|Overall Study|Protocol Violation|2|||
33439435|NCT00486837|101502857|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
33439436|NCT00486837|101502858|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
33157768|NCT02339285|100489846|FG002|Overall Study|Lost to Follow-up|1|||
33157769|NCT02339285|100489844|FG000|Overall Study|Protocol Deviation|0|||
33157770|NCT02339285|100489845|FG001|Overall Study|Protocol Deviation|1|||
33157771|NCT02339285|100489846|FG002|Overall Study|Protocol Deviation|0|||
33157772|NCT00066729|100489847|FG000|Overall Study|Lost to Follow-up|1|||
33439437|NCT00625443|101502859|FG000|Overall Study|Adverse Event|1|||
33439438|NCT00625443|101502860|FG001|Overall Study|Adverse Event|4|||
33439439|NCT00625443|101502861|FG002|Overall Study|Adverse Event|0|||
33439440|NCT00625443|101502859|FG000|Overall Study|Non-compliance with protocol|0|||
33439441|NCT00625443|101502860|FG001|Overall Study|Non-compliance with protocol|1|||
33439442|NCT00625443|101502861|FG002|Overall Study|Non-compliance with protocol|0|||
33439443|NCT00625443|101502859|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
33439444|NCT00625443|101502860|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
33157773|NCT00066729|100489847|FG000|Overall Study|Disease progression|1|||
33157774|NCT00137631|100489848|FG000|Overall Study|Lost to Follow-up|37|||
33157775|NCT00137631|100489849|FG001|Overall Study|Lost to Follow-up|41|||
33157776|NCT01739309|100489850|FG000|Overall Study|Adverse Event|1|||
33157777|NCT01739309|100489850|FG000|Overall Study|Withdrawal by Subject|1|||
33157778|NCT01788228|100489853|FG000|Overall Study|Migrated/moved from study area|1|||
33157779|NCT01788228|100489854|FG001|Overall Study|Migrated/moved from study area|0|||
33157780|NCT02564796|100489855|FG000|Overall Study|Physician Decision|2|||
33157781|NCT02564796|100489856|FG001|Overall Study|Physician Decision|2|||
33157782|NCT00199875|100489860|FG000|Overall Study|Withdrawal by Subject|0|||
33157783|NCT00199875|100489861|FG001|Overall Study|Withdrawal by Subject|0|||
33157784|NCT00199875|100489862|FG002|Overall Study|Withdrawal by Subject|0|||
33157785|NCT00199875|100489863|FG003|Overall Study|Withdrawal by Subject|0|||
33157786|NCT00199875|100489864|FG004|Overall Study|Withdrawal by Subject|1|||
33157787|NCT00939640|100489867|FG000|Overall Study|Physician Decision|1|||
33157788|NCT00231842|100489874|FG000|Overall Study|Withdrawal by Subject|3|||
33157789|NCT00231842|100489874|FG000|Overall Study|Did not complete the last 3 cycle|8|||
33157790|NCT02095223|100489875|FG000|Overall Study|Withdrawal by Subject|1|||
33157791|NCT02095223|100489876|FG001|Overall Study|Withdrawal by Subject|0|||
33157792|NCT04295772|100489877|FG000|Overall Study|Protocol Violation|1|||
33157793|NCT04295772|100489878|FG001|Overall Study|Protocol Violation|0|||
33157794|NCT04295772|100489877|FG000|Overall Study|Ongoing for safety monitoring|14|||
33157795|NCT04295772|100489878|FG001|Overall Study|Ongoing for safety monitoring|1|||
33157796|NCT04295772|100489877|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
33157797|NCT04295772|100489878|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
33157798|NCT02191137|100489879|FG000|Treatment|Death|4|||
33157799|NCT02191137|100489879|FG000|Treatment|Withdrawal by Subject|3|||
33253811|NCT04009577|100830247|FG003|Extension Phase|Adverse Event|1|||
33439445|NCT00625443|101502861|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
33439446|NCT00625443|101502859|FG000|Overall Study|Withdrawal by Subject|0|||
33157800|NCT02191137|100489879|FG000|Treatment|Adverse Event|2|||
33157801|NCT02191137|100489879|FG000|Treatment|Other|1|||
33157802|NCT02191137|100489879|FG000|Follow-up|Lost to Follow-up|2|||
33157803|NCT02191137|100489879|FG000|Follow-up|Ongoing/unknown|2|||
33157804|NCT02191137|100489879|FG000|Follow-up|Adverse Event|1|||
33439447|NCT00625443|101502860|FG001|Overall Study|Withdrawal by Subject|1|||
33439448|NCT00625443|101502861|FG002|Overall Study|Withdrawal by Subject|2|||
33253812|NCT04009577|100830244|FG000|Extension Phase|Inadequate therapeutic effect|0|||
33253813|NCT04009577|100830245|FG001|Extension Phase|Inadequate therapeutic effect|0|||
33253814|NCT04009577|100830246|FG002|Extension Phase|Inadequate therapeutic effect|1|||
33253815|NCT04009577|100830247|FG003|Extension Phase|Inadequate therapeutic effect|0|||
33253816|NCT04009577|100830244|FG000|Extension Phase|Withdrawal by Subject|0|||
33253817|NCT04009577|100830245|FG001|Extension Phase|Withdrawal by Subject|0|||
33253818|NCT04009577|100830246|FG002|Extension Phase|Withdrawal by Subject|1|||
33253819|NCT04009577|100830247|FG003|Extension Phase|Withdrawal by Subject|0|||
33253820|NCT04009577|100830244|FG000|Extension Phase|Not Treated|0|||
33253821|NCT04009577|100830245|FG001|Extension Phase|Not Treated|0|||
33253822|NCT04009577|100830246|FG002|Extension Phase|Not Treated|2|||
33253823|NCT04009577|100830247|FG003|Extension Phase|Not Treated|0|||
33253824|NCT03102710|100830248|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
33253825|NCT03102710|100830249|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
33253826|NCT03102710|100830250|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
33253827|NCT03102710|100830248|FG000|Overall Study|Technical issues during final MRI scan|0|||
33253828|NCT03102710|100830249|FG001|Overall Study|Technical issues during final MRI scan|1|||
33253829|NCT03102710|100830250|FG002|Overall Study|Technical issues during final MRI scan|0|||
33253830|NCT03102710|100830248|FG000|Overall Study|Nausea during MRI scan|0|||
33253831|NCT03102710|100830249|FG001|Overall Study|Nausea during MRI scan|1|||
33253832|NCT03102710|100830250|FG002|Overall Study|Nausea during MRI scan|0|||
33253833|NCT03102710|100830248|FG000|Overall Study|Subject unable to attend final session|0|||
33253834|NCT03102710|100830249|FG001|Overall Study|Subject unable to attend final session|1|||
33253835|NCT03102710|100830250|FG002|Overall Study|Subject unable to attend final session|0|||
33253836|NCT03460756|100830253|FG000|Overall Study|Adverse Event|0|||
33253837|NCT03460756|100830254|FG001|Overall Study|Adverse Event|0|||
33253838|NCT03460756|100830255|FG002|Overall Study|Adverse Event|0|||
33253839|NCT03460756|100830256|FG003|Overall Study|Adverse Event|1|||
33253840|NCT03460756|100830253|FG000|Overall Study|Lack of Efficacy|0|||
33253841|NCT03460756|100830254|FG001|Overall Study|Lack of Efficacy|0|||
33253842|NCT03460756|100830255|FG002|Overall Study|Lack of Efficacy|0|||
33439449|NCT00625443|101502859|FG000|Overall Study|Physician Decision|0|||
33439450|NCT00625443|101502860|FG001|Overall Study|Physician Decision|4|||
33439451|NCT00625443|101502861|FG002|Overall Study|Physician Decision|2|||
33439452|NCT00625443|101502859|FG000|Overall Study|Other|0|||
33439453|NCT00625443|101502860|FG001|Overall Study|Other|1|||
33439454|NCT00625443|101502861|FG002|Overall Study|Other|1|||
33439455|NCT01449630|101502862|FG000|Period 1|Physician Decision|1|||
33439456|NCT01449630|101502863|FG001|Period 1|Physician Decision|0|||
33439457|NCT01449630|101502864|FG002|Period 1|Physician Decision|0|||
33439458|NCT01449630|101502865|FG003|Period 1|Physician Decision|1|||
33439459|NCT01449630|101502866|FG004|Period 1|Physician Decision|0|||
33439460|NCT01449630|101502867|FG005|Period 1|Physician Decision|0|||
33439461|NCT01449630|101502868|FG006|Period 1|Physician Decision|0|||
33439462|NCT01449630|101502869|FG007|Period 1|Physician Decision|0|||
33439463|NCT01449630|101502870|FG008|Period 1|Physician Decision|0|||
33439464|NCT01449630|101502862|FG000|Period 1|Sponsor Decision|0|||
33253843|NCT03460756|100830256|FG003|Overall Study|Lack of Efficacy|2|||
33439465|NCT01449630|101502863|FG001|Period 1|Sponsor Decision|0|||
33439466|NCT01449630|101502864|FG002|Period 1|Sponsor Decision|0|||
33439467|NCT01449630|101502865|FG003|Period 1|Sponsor Decision|0|||
33439468|NCT01449630|101502866|FG004|Period 1|Sponsor Decision|0|||
33439469|NCT01449630|101502867|FG005|Period 1|Sponsor Decision|1|||
33439470|NCT01449630|101502868|FG006|Period 1|Sponsor Decision|0|||
33439471|NCT01449630|101502869|FG007|Period 1|Sponsor Decision|0|||
33439472|NCT01449630|101502870|FG008|Period 1|Sponsor Decision|0|||
33439473|NCT01449630|101502862|FG000|Period 2|Sponsor Decision|0|||
33439474|NCT01449630|101502863|FG001|Period 2|Sponsor Decision|0|||
33439475|NCT01449630|101502864|FG002|Period 2|Sponsor Decision|0|||
33439476|NCT01449630|101502865|FG003|Period 2|Sponsor Decision|0|||
33439477|NCT01449630|101502866|FG004|Period 2|Sponsor Decision|0|||
33439478|NCT01449630|101502867|FG005|Period 2|Sponsor Decision|0|||
33439479|NCT01449630|101502868|FG006|Period 2|Sponsor Decision|1|||
33157805|NCT00531934|100489881|FG000|Overall Study|Adverse Event|4|||
33253844|NCT03460756|100830253|FG000|Overall Study|Lost to Follow-up|0|||
33439480|NCT01449630|101502869|FG007|Period 2|Sponsor Decision|0|||
33253845|NCT03460756|100830254|FG001|Overall Study|Lost to Follow-up|1|||
33253846|NCT03460756|100830255|FG002|Overall Study|Lost to Follow-up|2|||
33253847|NCT03460756|100830256|FG003|Overall Study|Lost to Follow-up|1|||
33439481|NCT01449630|101502870|FG008|Period 2|Sponsor Decision|0|||
33439482|NCT00552669|101502871|FG000|Overall Study|Death|3|||
33439483|NCT00552669|101502872|FG001|Overall Study|Death|7|||
33439484|NCT04109222|101502873|FG000|Overall Study|Adverse Event|1|||
33439485|NCT04109222|101502874|FG001|Overall Study|Adverse Event|0|||
33157806|NCT00531934|100489882|FG001|Overall Study|Adverse Event|8|||
33157807|NCT00531934|100489881|FG000|Overall Study|Progression|52|||
33157808|NCT00531934|100489882|FG001|Overall Study|Progression|42|||
33157809|NCT00531934|100489881|FG000|Overall Study|Death|7|||
33157810|NCT00531934|100489882|FG001|Overall Study|Death|10|||
33157811|NCT00531934|100489881|FG000|Overall Study|Withdrawal by Subject|1|||
33157812|NCT00531934|100489882|FG001|Overall Study|Withdrawal by Subject|1|||
33157813|NCT00531934|100489881|FG000|Overall Study|Other|2|||
33157814|NCT00531934|100489882|FG001|Overall Study|Other|2|||
33157815|NCT00508755|100489887|FG000|Overall Study|Withdrawal by Subject|1|||
33157816|NCT00586625|100489892|FG000|Overall Study|Adverse Event|6|||
33157817|NCT00586625|100489893|FG001|Overall Study|Adverse Event|6|||
33157818|NCT00586625|100489892|FG000|Overall Study|Protocol Violation|3|||
33157819|NCT00586625|100489893|FG001|Overall Study|Protocol Violation|0|||
33157820|NCT00586625|100489892|FG000|Overall Study|Withdrawal by Subject|32|||
33157821|NCT00586625|100489893|FG001|Overall Study|Withdrawal by Subject|10|||
33157822|NCT00586625|100489892|FG000|Overall Study|Subject non-compliance|0|||
33157823|NCT00586625|100489893|FG001|Overall Study|Subject non-compliance|1|||
33439486|NCT04109222|101502875|FG002|Overall Study|Adverse Event|0|||
33439487|NCT00064753|101502876|FG000|Overall Study|Death|251|||
33439488|NCT00064753|101502877|FG001|Overall Study|Death|242|||
33439489|NCT00064753|101502876|FG000|Overall Study|Withdrawal by Subject|198|||
33439490|NCT00064753|101502877|FG001|Overall Study|Withdrawal by Subject|171|||
33439491|NCT00064753|101502876|FG000|Overall Study|Lost to Follow-up|225|||
33439492|NCT00064753|101502877|FG001|Overall Study|Lost to Follow-up|235|||
33439493|NCT00429364|101502880|FG000|Overall Study|Withdrawal by Subject|11|||
33439494|NCT00429364|101502881|FG001|Overall Study|Withdrawal by Subject|5|||
33157824|NCT00586625|100489892|FG000|Overall Study|Subject unable to return for visit|2|||
33157825|NCT00586625|100489893|FG001|Overall Study|Subject unable to return for visit|0|||
33157826|NCT03308786|100489898|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
33439495|NCT00429364|101502880|FG000|Overall Study|Physician Decision|4|||
33439496|NCT00429364|101502881|FG001|Overall Study|Physician Decision|2|||
33439497|NCT00429364|101502880|FG000|Overall Study|Lost to Follow-up|7|||
33439498|NCT00429364|101502881|FG001|Overall Study|Lost to Follow-up|6|||
33439499|NCT00429364|101502880|FG000|Overall Study|Death|0|||
33439500|NCT00429364|101502881|FG001|Overall Study|Death|1|||
33439501|NCT00429364|101502880|FG000|Overall Study|Underwent aortic root surgery|10|||
33439502|NCT00429364|101502881|FG001|Overall Study|Underwent aortic root surgery|18|||
33157827|NCT00911547|100489901|FG000|Overall Study|Adverse Event|8|||
33157828|NCT00911547|100489902|FG001|Overall Study|Adverse Event|27|||
33439503|NCT00429364|101502880|FG000|Overall Study|Pregnancy|0|||
33439504|NCT00429364|101502881|FG001|Overall Study|Pregnancy|1|||
33439505|NCT00454909|101502884|FG000|Overall Study|Withdrawal by Subject|1|||
33439506|NCT00454909|101502885|FG001|Overall Study|Withdrawal by Subject|0|||
33439507|NCT00454909|101502886|FG002|Overall Study|Withdrawal by Subject|0|||
33439508|NCT00454909|101502884|FG000|Overall Study|Migrated/moved from study area|0|||
33439509|NCT00454909|101502885|FG001|Overall Study|Migrated/moved from study area|0|||
33439510|NCT00454909|101502886|FG002|Overall Study|Migrated/moved from study area|1|||
33439511|NCT00454909|101502884|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
33439512|NCT00454909|101502885|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
33439513|NCT00454909|101502886|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
33439514|NCT00454909|101502884|FG000|Overall Study|Others|1|||
33439515|NCT00454909|101502885|FG001|Overall Study|Others|0|||
33439516|NCT00454909|101502886|FG002|Overall Study|Others|0|||
33439517|NCT00984295|101502889|FG000|Overall Study|Lost to Follow-up|31|||
33439518|NCT00984295|101502890|FG001|Overall Study|Lost to Follow-up|12|||
33439519|NCT00984295|101502891|FG002|Overall Study|Lost to Follow-up|13|||
33157829|NCT00911547|100489903|FG002|Overall Study|Adverse Event|11|||
33157830|NCT00911547|100489904|FG003|Overall Study|Adverse Event|6|||
33157831|NCT00911547|100489901|FG000|Overall Study|Lost to Follow-up|0|||
33157832|NCT00911547|100489902|FG001|Overall Study|Lost to Follow-up|0|||
33157833|NCT00911547|100489903|FG002|Overall Study|Lost to Follow-up|2|||
33439520|NCT00984295|101502889|FG000|Overall Study|Protocol Violation|2|||
33439521|NCT00984295|101502890|FG001|Overall Study|Protocol Violation|1|||
33439522|NCT00984295|101502891|FG002|Overall Study|Protocol Violation|4|||
33439523|NCT00984295|101502889|FG000|Overall Study|Withdrawal by Subject|18|||
33439524|NCT00984295|101502890|FG001|Overall Study|Withdrawal by Subject|9|||
33439525|NCT00984295|101502891|FG002|Overall Study|Withdrawal by Subject|12|||
33157834|NCT00911547|100489904|FG003|Overall Study|Lost to Follow-up|1|||
33157835|NCT00911547|100489901|FG000|Overall Study|Protocol Violation|0|||
33157836|NCT00911547|100489902|FG001|Overall Study|Protocol Violation|5|||
33157837|NCT00911547|100489903|FG002|Overall Study|Protocol Violation|5|||
33157838|NCT00911547|100489904|FG003|Overall Study|Protocol Violation|1|||
33439526|NCT00984295|101502889|FG000|Overall Study|CAE - discontinued test vaccine|0|||
33439527|NCT00984295|101502890|FG001|Overall Study|CAE - discontinued test vaccine|1|||
33439528|NCT00984295|101502891|FG002|Overall Study|CAE - discontinued test vaccine|3|||
33439529|NCT00984295|101502889|FG000|Overall Study|Missed one or more blood samplings|3|||
33157839|NCT00911547|100489901|FG000|Overall Study|Withdrawal by Subject|3|||
33439530|NCT00984295|101502890|FG001|Overall Study|Missed one or more blood samplings|7|||
33439531|NCT00984295|101502891|FG002|Overall Study|Missed one or more blood samplings|2|||
33439532|NCT00984295|101502889|FG000|Overall Study|Incomplete safety follow-up|11|||
33439533|NCT00984295|101502890|FG001|Overall Study|Incomplete safety follow-up|2|||
33439534|NCT00984295|101502891|FG002|Overall Study|Incomplete safety follow-up|3|||
33439535|NCT03420300|101502895|FG000|Overall Study|Death|2|||
33439536|NCT04088760|101502896|FG000|Overall Study|Physician Decision|1|||
33439537|NCT02458638|101502897|FG000|Overall Study|Death|309|||
33439538|NCT02458638|101502897|FG000|Overall Study|End of Cohort/End of Study|67|||
33439539|NCT02458638|101502897|FG000|Overall Study|Lost to Follow-up|31|||
33439540|NCT02458638|101502897|FG000|Overall Study|Other Reasons|4|||
33439541|NCT02458638|101502897|FG000|Overall Study|Physician Decision|1|||
33439542|NCT02458638|101502897|FG000|Overall Study|Withdrawal by Subject|47|||
33439543|NCT01052116|101502902|FG000|Overall Study|Lost to Follow-up|11|||
33439544|NCT01052116|101502903|FG001|Overall Study|Lost to Follow-up|17|||
33439545|NCT01052116|101502902|FG000|Overall Study|Withdrawal by Subject|3|||
33439546|NCT01052116|101502903|FG001|Overall Study|Withdrawal by Subject|6|||
33439547|NCT01052116|101502902|FG000|Overall Study|Spirometry not performed|0|||
33439548|NCT01052116|101502903|FG001|Overall Study|Spirometry not performed|4|||
33439549|NCT02194998|101502904|FG000|On-HCV Treatment|Did not pick up study medication|0|||
33439550|NCT02194998|101502905|FG001|On-HCV Treatment|Did not pick up study medication|1|||
33439551|NCT02194998|101502906|FG002|On-HCV Treatment|Did not pick up study medication|0|||
33439552|NCT02194998|101502907|FG003|On-HCV Treatment|Did not pick up study medication|0|||
33439553|NCT02194998|101502904|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
33439554|NCT02194998|101502905|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
33439555|NCT02194998|101502906|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
33439556|NCT02194998|101502907|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
33439557|NCT01406795|101502908|FG000|Overall Study|Withdrawal by Subject|1|||
33439558|NCT00565448|101502910|FG000|Overall Study|Adverse Event|1|||
33439559|NCT00565448|101502911|FG001|Overall Study|Adverse Event|2|||
33439560|NCT00565448|101502910|FG000|Overall Study|Disease progression|1|||
33439561|NCT00565448|101502911|FG001|Overall Study|Disease progression|0|||
33439562|NCT00565448|101502910|FG000|Overall Study|Withdrawal by Subject|1|||
33439563|NCT00565448|101502911|FG001|Overall Study|Withdrawal by Subject|0|||
33439564|NCT01001208|101502912|FG000|Overall Study|Adverse Event|10|||
33439565|NCT01001208|101502913|FG001|Overall Study|Adverse Event|5|||
33439566|NCT01001208|101502912|FG000|Overall Study|Lost to Follow-up|5|||
33439567|NCT01001208|101502913|FG001|Overall Study|Lost to Follow-up|9|||
33157840|NCT00911547|100489902|FG001|Overall Study|Withdrawal by Subject|10|||
33157841|NCT00911547|100489903|FG002|Overall Study|Withdrawal by Subject|4|||
33439568|NCT01001208|101502912|FG000|Overall Study|Physician Decision|1|||
33439569|NCT01001208|101502913|FG001|Overall Study|Physician Decision|0|||
33439570|NCT01001208|101502912|FG000|Overall Study|Withdrawal by Subject|4|||
33439571|NCT01001208|101502913|FG001|Overall Study|Withdrawal by Subject|5|||
33439572|NCT01001208|101502912|FG000|Overall Study|Ineligibility Determined|4|||
33439573|NCT01001208|101502913|FG001|Overall Study|Ineligibility Determined|2|||
33439574|NCT01001208|101502912|FG000|Overall Study|Noncompliance|4|||
33439575|NCT01001208|101502913|FG001|Overall Study|Noncompliance|7|||
33439576|NCT01001208|101502912|FG000|Overall Study|Disease Progression|0|||
33439577|NCT01001208|101502913|FG001|Overall Study|Disease Progression|3|||
33439578|NCT01001208|101502912|FG000|Overall Study|Other|0|||
33439579|NCT01001208|101502913|FG001|Overall Study|Other|2|||
33439580|NCT00591630|101502914|FG000|Overall Study|Death|0|||
33439581|NCT00591630|101502915|FG001|Overall Study|Death|0|||
33439582|NCT00591630|101502916|FG002|Overall Study|Death|1|||
33439583|NCT00591630|101502917|FG003|Overall Study|Death|0|||
33439584|NCT02465567|101502924|FG000|Overall Study|Adverse Event|118|||
33439585|NCT02465567|101502925|FG001|Overall Study|Adverse Event|113|||
33439586|NCT02465567|101502926|FG002|Overall Study|Adverse Event|147|||
33439587|NCT02465567|101502927|FG003|Overall Study|Adverse Event|138|||
33439588|NCT02465567|101502924|FG000|Overall Study|Lack of Efficacy|103|||
33439589|NCT02465567|101502925|FG001|Overall Study|Lack of Efficacy|102|||
33157842|NCT00911547|100489904|FG003|Overall Study|Withdrawal by Subject|8|||
33439590|NCT02465567|101502926|FG002|Overall Study|Lack of Efficacy|171|||
33439591|NCT02465567|101502927|FG003|Overall Study|Lack of Efficacy|135|||
33439592|NCT02465567|101502924|FG000|Overall Study|Withdrawal by Subject|104|||
33439593|NCT02465567|101502925|FG001|Overall Study|Withdrawal by Subject|94|||
33439594|NCT02465567|101502926|FG002|Overall Study|Withdrawal by Subject|123|||
33439595|NCT02465567|101502927|FG003|Overall Study|Withdrawal by Subject|130|||
33439596|NCT02465567|101502924|FG000|Overall Study|Physician Decision|23|||
33439597|NCT02465567|101502925|FG001|Overall Study|Physician Decision|33|||
33439598|NCT02465567|101502926|FG002|Overall Study|Physician Decision|38|||
33439599|NCT02465567|101502927|FG003|Overall Study|Physician Decision|28|||
33439600|NCT02465567|101502924|FG000|Overall Study|Major Protocol Deviation|24|||
33439601|NCT02465567|101502925|FG001|Overall Study|Major Protocol Deviation|26|||
33439602|NCT02465567|101502926|FG002|Overall Study|Major Protocol Deviation|22|||
33439603|NCT02465567|101502927|FG003|Overall Study|Major Protocol Deviation|25|||
33439604|NCT02465567|101502924|FG000|Overall Study|Lost to Follow-up|25|||
33439605|NCT02465567|101502925|FG001|Overall Study|Lost to Follow-up|21|||
33439606|NCT02465567|101502926|FG002|Overall Study|Lost to Follow-up|19|||
33439607|NCT02465567|101502927|FG003|Overall Study|Lost to Follow-up|15|||
33439608|NCT02465567|101502924|FG000|Overall Study|Protocol Specified Criteria|20|||
33439609|NCT02465567|101502925|FG001|Overall Study|Protocol Specified Criteria|10|||
33439610|NCT02465567|101502926|FG002|Overall Study|Protocol Specified Criteria|9|||
33439611|NCT02465567|101502927|FG003|Overall Study|Protocol Specified Criteria|12|||
33439612|NCT02465567|101502924|FG000|Overall Study|Administrative Reasons|12|||
33439613|NCT02465567|101502925|FG001|Overall Study|Administrative Reasons|9|||
33439614|NCT02465567|101502926|FG002|Overall Study|Administrative Reasons|11|||
33439615|NCT02465567|101502927|FG003|Overall Study|Administrative Reasons|5|||
33439616|NCT02465567|101502924|FG000|Overall Study|Randomized but not treated|1|||
33388760|NCT01989572|101309342|FG005|Overall Study|complicating disease|0|||
33388761|NCT01989572|101309337|FG000|Overall Study|error|2|||
33388762|NCT01989572|101309338|FG001|Overall Study|error|1|||
33388763|NCT01989572|101309339|FG002|Overall Study|error|1|||
33388764|NCT01989572|101309340|FG003|Overall Study|error|1|||
33388765|NCT01989572|101309341|FG004|Overall Study|error|1|||
33388766|NCT01989572|101309342|FG005|Overall Study|error|1|||
33388767|NCT01989572|101309337|FG000|Overall Study|maximum dose reached|0|||
33388768|NCT01989572|101309338|FG001|Overall Study|maximum dose reached|1|||
33388769|NCT01989572|101309339|FG002|Overall Study|maximum dose reached|0|||
33388770|NCT01989572|101309340|FG003|Overall Study|maximum dose reached|0|||
33388771|NCT01989572|101309341|FG004|Overall Study|maximum dose reached|1|||
33388772|NCT01989572|101309342|FG005|Overall Study|maximum dose reached|0|||
33388773|NCT01989572|101309337|FG000|Overall Study|unknown/not specify|3|||
33388774|NCT01989572|101309338|FG001|Overall Study|unknown/not specify|4|||
33388775|NCT01989572|101309339|FG002|Overall Study|unknown/not specify|1|||
33388776|NCT01989572|101309340|FG003|Overall Study|unknown/not specify|3|||
33388777|NCT01989572|101309341|FG004|Overall Study|unknown/not specify|3|||
33388778|NCT01989572|101309342|FG005|Overall Study|unknown/not specify|5|||
33388779|NCT01989572|101309337|FG000|Overall Study|not start protocol therapy|5|||
33388780|NCT01989572|101309338|FG001|Overall Study|not start protocol therapy|1|||
33388781|NCT01989572|101309339|FG002|Overall Study|not start protocol therapy|2|||
33388782|NCT01989572|101309340|FG003|Overall Study|not start protocol therapy|3|||
33388783|NCT01989572|101309341|FG004|Overall Study|not start protocol therapy|4|||
33388784|NCT01989572|101309342|FG005|Overall Study|not start protocol therapy|18|||
33388785|NCT01989572|101309337|FG000|Overall Study|alternative therapy|3|||
33388786|NCT01989572|101309338|FG001|Overall Study|alternative therapy|0|||
33388787|NCT01989572|101309339|FG002|Overall Study|alternative therapy|0|||
33388788|NCT01989572|101309340|FG003|Overall Study|alternative therapy|0|||
33388789|NCT01989572|101309341|FG004|Overall Study|alternative therapy|1|||
33388790|NCT01989572|101309342|FG005|Overall Study|alternative therapy|3|||
33388791|NCT03862495|101309344|FG000|Overall Study|Lost to Follow-up|37|||
33388792|NCT03862495|101309345|FG001|Overall Study|Lost to Follow-up|35|||
33388793|NCT00499460|101309346|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
33388794|NCT00499460|101309347|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
33388795|NCT00499460|101309346|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
33388796|NCT00499460|101309347|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
33388797|NCT00499460|101309346|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
33388798|NCT00499460|101309347|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
33388799|NCT00114218|101309348|FG000|Overall Study|Wrong Cell Type|2|||
33388800|NCT00114218|101309348|FG000|Overall Study|Wrong Primary|1|||
33388801|NCT00114218|101309348|FG000|Overall Study|Never Treated|1|||
33388802|NCT00712933|101309349|FG000|Overall Study|Adverse Event|69|||
33388803|NCT00712933|101309349|FG000|Overall Study|Lack of Efficacy|6|||
33388804|NCT00712933|101309349|FG000|Overall Study|Lost to Follow-up|22|||
33388805|NCT00712933|101309349|FG000|Overall Study|Non-compliance with study drug|13|||
33388806|NCT00712933|101309349|FG000|Overall Study|Other Pregnancy|37|||
33388807|NCT00712933|101309349|FG000|Overall Study|Sponsor decision|14|||
33388808|NCT00712933|101309349|FG000|Overall Study|Withdrew consent|4|||
33439617|NCT02465567|101502925|FG001|Overall Study|Randomized but not treated|5|||
33439618|NCT02465567|101502926|FG002|Overall Study|Randomized but not treated|4|||
33439619|NCT02465567|101502927|FG003|Overall Study|Randomized but not treated|5|||
33439620|NCT02465567|101502924|FG000|Overall Study|enrolled in >1 studies|18|||
33439621|NCT02465567|101502925|FG001|Overall Study|enrolled in >1 studies|11|||
33439622|NCT02465567|101502926|FG002|Overall Study|enrolled in >1 studies|19|||
33439623|NCT02465567|101502927|FG003|Overall Study|enrolled in >1 studies|15|||
33439624|NCT02465567|101502924|FG000|Overall Study|missing PI Signature|1|||
33439625|NCT02465567|101502925|FG001|Overall Study|missing PI Signature|0|||
33439626|NCT02465567|101502926|FG002|Overall Study|missing PI Signature|0|||
33439627|NCT02465567|101502927|FG003|Overall Study|missing PI Signature|0|||
33439628|NCT03595657|101502928|FG000|Overall Study|Adverse Event|14|||
33439629|NCT03595657|101502928|FG000|Overall Study|Death|1|||
33439630|NCT03595657|101502928|FG000|Overall Study|Lack of Efficacy|40|||
33439631|NCT03595657|101502928|FG000|Overall Study|Withdrawal by Subject|10|||
33439632|NCT03595657|101502928|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
33439633|NCT03595657|101502928|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
33439634|NCT04625114|101502929|FG000|Overall Study|Adverse Event|3|||
33439635|NCT04625114|101502930|FG001|Overall Study|Adverse Event|1|||
33439636|NCT04625114|101502929|FG000|Overall Study|Withdrawal by Subject|2|||
33439637|NCT04625114|101502930|FG001|Overall Study|Withdrawal by Subject|0|||
33439638|NCT02262377|101502932|FG000|Overall Study|Lost to Follow-up|5|||
33439639|NCT02262377|101502933|FG001|Overall Study|Lost to Follow-up|6|||
33439640|NCT02262377|101502932|FG000|Overall Study|Found ineligible after enrollment|3|||
33439641|NCT02262377|101502933|FG001|Overall Study|Found ineligible after enrollment|0|||
33439642|NCT02262377|101502932|FG000|Overall Study|Withdrawal by Subject|4|||
33439643|NCT02262377|101502933|FG001|Overall Study|Withdrawal by Subject|0|||
33439644|NCT02473640|101502934|FG000|Treatment Period 1|Adverse Event|1|||
33439645|NCT01396278|101502937|FG000|Overall Study|Adverse Event|0|||
33439646|NCT01396278|101502938|FG001|Overall Study|Adverse Event|0|||
33439647|NCT01396278|101502939|FG002|Overall Study|Adverse Event|0|||
33439648|NCT01396278|101502940|FG003|Overall Study|Adverse Event|2|||
33439649|NCT01396278|101502941|FG004|Overall Study|Adverse Event|0|||
33439650|NCT01396278|101502937|FG000|Overall Study|Withdraw due to trial termination|2|||
33439651|NCT01396278|101502938|FG001|Overall Study|Withdraw due to trial termination|1|||
33253848|NCT03460756|100830253|FG000|Overall Study|Pregnancy|0|||
33439652|NCT01396278|101502939|FG002|Overall Study|Withdraw due to trial termination|1|||
33439653|NCT01396278|101502940|FG003|Overall Study|Withdraw due to trial termination|0|||
33439654|NCT01396278|101502941|FG004|Overall Study|Withdraw due to trial termination|2|||
33157843|NCT04622306|100489905|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
33157844|NCT04622306|100489906|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
33157845|NCT04622306|100489907|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
33157846|NCT04622306|100489908|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
33157847|NCT04622306|100489909|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
33157848|NCT04622306|100489910|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
33157849|NCT04622306|100489905|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
33157850|NCT04622306|100489906|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
33157851|NCT04622306|100489907|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
33157852|NCT04622306|100489908|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
33157853|NCT04622306|100489909|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
33157854|NCT04622306|100489910|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
33157855|NCT03846804|100489911|FG000|Overall Study|Refused blood draw|1|||
33157856|NCT03846804|100489911|FG000|Overall Study|Protocol Violation|1|||
33157857|NCT01604408|100489912|FG000|Treatment Period 1|Protocol Violation|0|||
33157858|NCT01604408|100489913|FG001|Treatment Period 1|Protocol Violation|1|||
33157859|NCT01604408|100489912|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33157860|NCT01604408|100489913|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33157861|NCT01604408|100489912|FG000|Treatment Period 2|Protocol Violation|1|||
33157862|NCT01604408|100489913|FG001|Treatment Period 2|Protocol Violation|0|||
33157863|NCT01604408|100489912|FG000|Treatment Period 2|Adverse Event|0|||
33157864|NCT01604408|100489913|FG001|Treatment Period 2|Adverse Event|1|||
33157865|NCT01604408|100489912|FG000|Treatment Period 3|Protocol Violation|1|||
33157866|NCT01604408|100489913|FG001|Treatment Period 3|Protocol Violation|1|||
33157867|NCT01604408|100489912|FG000|Treatment Period 3|Adverse Event|0|||
33157868|NCT01604408|100489913|FG001|Treatment Period 3|Adverse Event|3|||
33157869|NCT01604408|100489912|FG000|Treatment Period 3|Withdrawal by Subject|3|||
33157870|NCT01604408|100489913|FG001|Treatment Period 3|Withdrawal by Subject|1|||
33157871|NCT01604408|100489912|FG000|Treatment Period 3|Sponsor Decision|1|||
33157872|NCT01604408|100489913|FG001|Treatment Period 3|Sponsor Decision|0|||
33157873|NCT01604408|100489912|FG000|Treatment Period 4|Death|1|||
33157874|NCT01604408|100489913|FG001|Treatment Period 4|Death|0|||
33157875|NCT01604408|100489912|FG000|Treatment Period 4|Withdrawal by Subject|2|||
33157876|NCT01604408|100489913|FG001|Treatment Period 4|Withdrawal by Subject|1|||
33157877|NCT01604408|100489912|FG000|Treatment Period 4|Adverse Event|0|||
33157878|NCT01604408|100489913|FG001|Treatment Period 4|Adverse Event|1|||
33157879|NCT01604408|100489912|FG000|Treatment Period 5|Adverse Event|4|||
33157880|NCT01604408|100489913|FG001|Treatment Period 5|Adverse Event|0|||
33157881|NCT01604408|100489912|FG000|Treatment Period 6|Lost to Follow-up|0|||
33157882|NCT01604408|100489913|FG001|Treatment Period 6|Lost to Follow-up|1|||
33157883|NCT01604408|100489912|FG000|Treatment Period 6|Adverse Event|2|||
33157884|NCT01604408|100489913|FG001|Treatment Period 6|Adverse Event|0|||
33157885|NCT01604408|100489912|FG000|Treatment Period 6|Sponsor decision|0|||
33157886|NCT01604408|100489913|FG001|Treatment Period 6|Sponsor decision|1|||
33157887|NCT01604408|100489912|FG000|Observation Period|Adverse Event|1|||
33157888|NCT01604408|100489913|FG001|Observation Period|Adverse Event|1|||
33157889|NCT01604408|100489912|FG000|Observation Period|Withdrawal by Subject|0|||
33157890|NCT01604408|100489913|FG001|Observation Period|Withdrawal by Subject|2|||
33157891|NCT01201785|100489916|FG000|Overall Study|Lost to Follow-up|16|||
33157892|NCT01058655|100489919|FG000|Overall Study|Withdrawal by Subject|1|||
33157893|NCT01058655|100489920|FG001|Overall Study|Withdrawal by Subject|0|||
33157894|NCT01058655|100489921|FG002|Overall Study|Withdrawal by Subject|3|||
33157895|NCT01058655|100489922|FG003|Overall Study|Withdrawal by Subject|4|||
33157896|NCT01058655|100489919|FG000|Overall Study|Prolonged Treatment Delay|0|||
33157897|NCT01058655|100489920|FG001|Overall Study|Prolonged Treatment Delay|0|||
33253849|NCT03460756|100830254|FG001|Overall Study|Pregnancy|0|||
33439655|NCT02587962|101502944|FG000|Overall Study|Adverse Event|0|||
33439656|NCT02587962|101502945|FG001|Overall Study|Adverse Event|0|||
33157898|NCT01058655|100489921|FG002|Overall Study|Prolonged Treatment Delay|0|||
33157899|NCT01058655|100489922|FG003|Overall Study|Prolonged Treatment Delay|2|||
33157900|NCT01058655|100489919|FG000|Overall Study|Symptomatic Deterioration|0|||
33157901|NCT01058655|100489920|FG001|Overall Study|Symptomatic Deterioration|0|||
33253850|NCT03460756|100830255|FG002|Overall Study|Pregnancy|0|||
33439657|NCT02587962|101502946|FG002|Overall Study|Adverse Event|1|||
33157902|NCT01058655|100489921|FG002|Overall Study|Symptomatic Deterioration|0|||
33157903|NCT01058655|100489922|FG003|Overall Study|Symptomatic Deterioration|1|||
33157904|NCT01058655|100489919|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
33157905|NCT01058655|100489920|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
33157906|NCT01058655|100489921|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
33157907|NCT01058655|100489922|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
33157908|NCT01058655|100489919|FG000|Overall Study|Death|0|||
33439658|NCT02587962|101502947|FG003|Overall Study|Adverse Event|0|||
33439659|NCT02587962|101502948|FG004|Overall Study|Adverse Event|0|||
33439660|NCT02587962|101502944|FG000|Overall Study|Withdrawal by Subject|0|||
33439661|NCT02587962|101502945|FG001|Overall Study|Withdrawal by Subject|0|||
33439662|NCT02587962|101502946|FG002|Overall Study|Withdrawal by Subject|1|||
33439663|NCT02587962|101502947|FG003|Overall Study|Withdrawal by Subject|1|||
33157909|NCT01058655|100489920|FG001|Overall Study|Death|1|||
33157910|NCT01058655|100489921|FG002|Overall Study|Death|1|||
33157911|NCT01058655|100489922|FG003|Overall Study|Death|0|||
33253851|NCT03460756|100830256|FG003|Overall Study|Pregnancy|1|||
33157912|NCT01058655|100489919|FG000|Overall Study|Disease Progression|1|||
33157913|NCT01058655|100489920|FG001|Overall Study|Disease Progression|2|||
33157914|NCT01058655|100489921|FG002|Overall Study|Disease Progression|4|||
33157915|NCT01058655|100489922|FG003|Overall Study|Disease Progression|24|||
33157916|NCT01058655|100489919|FG000|Overall Study|Other|0|||
33157917|NCT01058655|100489920|FG001|Overall Study|Other|0|||
33157918|NCT01058655|100489921|FG002|Overall Study|Other|0|||
33157919|NCT01058655|100489922|FG003|Overall Study|Other|4|||
33157920|NCT02607930|100489923|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
33157921|NCT02607930|100489924|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
33157922|NCT02607930|100489925|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
33157923|NCT02607930|100489926|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
33157924|NCT02607930|100489923|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
33157925|NCT02607930|100489924|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
33157926|NCT02607930|100489925|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
33157927|NCT02607930|100489926|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
33157928|NCT02607930|100489923|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
33157929|NCT02607930|100489924|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
33157930|NCT02607930|100489925|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
33157931|NCT02607930|100489926|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
33157932|NCT02607930|100489923|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
33157933|NCT02607930|100489924|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
33157934|NCT02607930|100489925|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
33157935|NCT02607930|100489926|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
33157936|NCT02607930|100489923|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
33253852|NCT03460756|100830253|FG000|Overall Study|Protocol Violation|0|||
33253853|NCT03460756|100830254|FG001|Overall Study|Protocol Violation|0|||
33253854|NCT03460756|100830255|FG002|Overall Study|Protocol Violation|0|||
33253855|NCT03460756|100830256|FG003|Overall Study|Protocol Violation|1|||
33253856|NCT03460756|100830253|FG000|Overall Study|Withdrawal by Subject|0|||
33253857|NCT03460756|100830254|FG001|Overall Study|Withdrawal by Subject|4|||
33439664|NCT02587962|101502948|FG004|Overall Study|Withdrawal by Subject|4|||
33439665|NCT02587962|101502944|FG000|Overall Study|Radiological progression|2|||
33439666|NCT02587962|101502945|FG001|Overall Study|Radiological progression|2|||
33439667|NCT02587962|101502946|FG002|Overall Study|Radiological progression|2|||
33439668|NCT02587962|101502947|FG003|Overall Study|Radiological progression|5|||
33157937|NCT02607930|100489924|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
33157938|NCT02607930|100489925|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
33157939|NCT02607930|100489926|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
33157940|NCT02607930|100489923|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
33157941|NCT02607930|100489924|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
33253858|NCT03460756|100830255|FG002|Overall Study|Withdrawal by Subject|7|||
33253859|NCT03460756|100830256|FG003|Overall Study|Withdrawal by Subject|3|||
33439669|NCT02587962|101502948|FG004|Overall Study|Radiological progression|10|||
33439670|NCT02587962|101502944|FG000|Overall Study|Clinical progression|0|||
33439671|NCT02587962|101502945|FG001|Overall Study|Clinical progression|1|||
33439672|NCT02587962|101502946|FG002|Overall Study|Clinical progression|2|||
33439673|NCT02587962|101502947|FG003|Overall Study|Clinical progression|0|||
33439674|NCT02587962|101502948|FG004|Overall Study|Clinical progression|1|||
33439675|NCT01619800|101502953|FG000|Overall Study|study terminated|2|||
33439676|NCT01619800|101502954|FG001|Overall Study|study terminated|0|||
33439677|NCT01387737|101502955|FG000|Overall Study|Adverse Event|20|||
33439678|NCT01387737|101502956|FG001|Overall Study|Adverse Event|30|||
33439679|NCT01387737|101502955|FG000|Overall Study|Lack of Efficacy|1|||
33439680|NCT01387737|101502956|FG001|Overall Study|Lack of Efficacy|0|||
33439681|NCT01387737|101502955|FG000|Overall Study|Physician Decision|3|||
33439682|NCT01387737|101502956|FG001|Overall Study|Physician Decision|10|||
33439683|NCT01387737|101502955|FG000|Overall Study|Withdrawal by Subject|27|||
33439684|NCT01387737|101502956|FG001|Overall Study|Withdrawal by Subject|31|||
33439685|NCT01387737|101502955|FG000|Overall Study|Clearly not eligible for the study|1|||
33439686|NCT01387737|101502956|FG001|Overall Study|Clearly not eligible for the study|3|||
33439687|NCT00095212|101502957|FG000|Overall Study|Withdrawal by Subject|1|||
33439688|NCT00095212|101502958|FG001|Overall Study|Withdrawal by Subject|3|||
33439689|NCT00048581|101502959|FG000|Double-Blind Period|Adverse Event|9|||
33439690|NCT00048581|101502960|FG001|Double-Blind Period|Adverse Event|5|||
33439691|NCT00048581|101502961|FG002|Double-Blind Period|Adverse Event|0|||
33439692|NCT00048581|101502959|FG000|Double-Blind Period|Lack of Efficacy|14|||
33439693|NCT00048581|101502960|FG001|Double-Blind Period|Lack of Efficacy|27|||
33439694|NCT00048581|101502961|FG002|Double-Blind Period|Lack of Efficacy|0|||
33439695|NCT00048581|101502959|FG000|Double-Blind Period|Lost to Follow-up|5|||
33439696|NCT00048581|101502960|FG001|Double-Blind Period|Lost to Follow-up|0|||
33439697|NCT00048581|101502961|FG002|Double-Blind Period|Lost to Follow-up|0|||
33439698|NCT00048581|101502959|FG000|Double-Blind Period|Withdrawal by Subject|5|||
33439699|NCT00048581|101502960|FG001|Double-Blind Period|Withdrawal by Subject|2|||
33439700|NCT00048581|101502961|FG002|Double-Blind Period|Withdrawal by Subject|0|||
33439701|NCT00048581|101502959|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
33439702|NCT00048581|101502960|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
33439703|NCT00048581|101502961|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
33439704|NCT00048581|101502959|FG000|Double-Blind Period|Investigator Decision|1|||
33439705|NCT00048581|101502960|FG001|Double-Blind Period|Investigator Decision|0|||
33439706|NCT00048581|101502961|FG002|Double-Blind Period|Investigator Decision|0|||
33439707|NCT00048581|101502959|FG000|Open-Label Period|Death|0|||
33439708|NCT00048581|101502960|FG001|Open-Label Period|Death|0|||
33439709|NCT00048581|101502961|FG002|Open-Label Period|Death|4|||
33439710|NCT00048581|101502959|FG000|Open-Label Period|Adverse Event|0|||
33439711|NCT00048581|101502960|FG001|Open-Label Period|Adverse Event|0|||
33439712|NCT00048581|101502961|FG002|Open-Label Period|Adverse Event|37|||
33439713|NCT00048581|101502959|FG000|Open-Label Period|Lack of Efficacy|0|||
33439714|NCT00048581|101502960|FG001|Open-Label Period|Lack of Efficacy|0|||
33439715|NCT00048581|101502961|FG002|Open-Label Period|Lack of Efficacy|69|||
33439716|NCT00048581|101502959|FG000|Open-Label Period|Lost to Follow-up|0|||
33439717|NCT00048581|101502960|FG001|Open-Label Period|Lost to Follow-up|0|||
33439718|NCT00048581|101502961|FG002|Open-Label Period|Lost to Follow-up|14|||
33439719|NCT00048581|101502959|FG000|Open-Label Period|Withdrawal by Subject|0|||
33439720|NCT00048581|101502960|FG001|Open-Label Period|Withdrawal by Subject|0|||
33439721|NCT00048581|101502961|FG002|Open-Label Period|Withdrawal by Subject|20|||
33439722|NCT00048581|101502959|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
33439723|NCT00048581|101502960|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
33439724|NCT00048581|101502961|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
33439725|NCT00048581|101502959|FG000|Open-Label Period|Poor/Non-compliance|0|||
33439726|NCT00048581|101502960|FG001|Open-Label Period|Poor/Non-compliance|0|||
33439727|NCT00048581|101502961|FG002|Open-Label Period|Poor/Non-compliance|5|||
33439728|NCT00048581|101502959|FG000|Open-Label Period|Pregnancy|0|||
33439729|NCT00048581|101502960|FG001|Open-Label Period|Pregnancy|0|||
33439730|NCT00048581|101502961|FG002|Open-Label Period|Pregnancy|7|||
33439731|NCT00048581|101502959|FG000|Open-Label Period|Study Site Closure|0|||
33439732|NCT00048581|101502960|FG001|Open-Label Period|Study Site Closure|0|||
33439733|NCT00048581|101502961|FG002|Open-Label Period|Study Site Closure|2|||
33439734|NCT00048581|101502959|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
33439735|NCT00048581|101502960|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
33439736|NCT00048581|101502961|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
33439737|NCT00048581|101502959|FG000|Open-Label Period|Problem With Transportation To Site|0|||
33439738|NCT00048581|101502960|FG001|Open-Label Period|Problem With Transportation To Site|0|||
33439739|NCT00048581|101502961|FG002|Open-Label Period|Problem With Transportation To Site|1|||
33439740|NCT00048581|101502959|FG000|Open-Label Period|Primary Investigator Retired|0|||
33439741|NCT00048581|101502960|FG001|Open-Label Period|Primary Investigator Retired|0|||
33439742|NCT00048581|101502961|FG002|Open-Label Period|Primary Investigator Retired|2|||
33439743|NCT00048581|101502959|FG000|Open-Label Period|Study Ended By Sponsor|0|||
33439744|NCT00048581|101502960|FG001|Open-Label Period|Study Ended By Sponsor|0|||
33439745|NCT00048581|101502961|FG002|Open-Label Period|Study Ended By Sponsor|1|||
33439746|NCT01399736|101502962|FG000|Overall Study|Withdrawal by Subject|4|||
33439747|NCT01399736|101502963|FG001|Overall Study|Withdrawal by Subject|2|||
33439748|NCT01399736|101502962|FG000|Overall Study|Lost to Follow-up|0|||
33439749|NCT01399736|101502963|FG001|Overall Study|Lost to Follow-up|2|||
33439750|NCT01706536|101502965|FG000|Overall Study|Withdrawal by Subject|1|||
33439751|NCT01706536|101502966|FG001|Overall Study|Withdrawal by Subject|0|||
33439752|NCT01706536|101502967|FG002|Overall Study|Withdrawal by Subject|1|||
33439753|NCT01706536|101502968|FG003|Overall Study|Withdrawal by Subject|0|||
33439754|NCT01706536|101502969|FG004|Overall Study|Withdrawal by Subject|0|||
33439755|NCT01706536|101502965|FG000|Overall Study|Adverse Event|2|||
33439756|NCT01706536|101502966|FG001|Overall Study|Adverse Event|3|||
33439757|NCT01706536|101502967|FG002|Overall Study|Adverse Event|4|||
33439758|NCT01706536|101502968|FG003|Overall Study|Adverse Event|3|||
33439759|NCT01706536|101502969|FG004|Overall Study|Adverse Event|2|||
33439760|NCT01706536|101502965|FG000|Overall Study|Lack of Efficacy|1|||
33439761|NCT01706536|101502966|FG001|Overall Study|Lack of Efficacy|0|||
33439762|NCT01706536|101502967|FG002|Overall Study|Lack of Efficacy|0|||
33439763|NCT01706536|101502968|FG003|Overall Study|Lack of Efficacy|1|||
33439764|NCT01706536|101502969|FG004|Overall Study|Lack of Efficacy|0|||
33439765|NCT01706536|101502965|FG000|Overall Study|non compliance|0|||
33439766|NCT01706536|101502966|FG001|Overall Study|non compliance|1|||
33439767|NCT01706536|101502967|FG002|Overall Study|non compliance|0|||
33439768|NCT01706536|101502968|FG003|Overall Study|non compliance|0|||
33439769|NCT01706536|101502969|FG004|Overall Study|non compliance|0|||
33439770|NCT01079988|101502973|FG000|Overall Study|Lost to Follow-up|0|||
33439771|NCT01079988|101502974|FG001|Overall Study|Lost to Follow-up|0|||
33439772|NCT01079988|101502975|FG002|Overall Study|Lost to Follow-up|0|||
33439773|NCT01079988|101502976|FG003|Overall Study|Lost to Follow-up|1|||
33439774|NCT01079988|101502977|FG004|Overall Study|Lost to Follow-up|0|||
33439775|NCT01079988|101502973|FG000|Overall Study|Lack of Efficacy|1|||
33439776|NCT01079988|101502974|FG001|Overall Study|Lack of Efficacy|0|||
33439777|NCT01079988|101502975|FG002|Overall Study|Lack of Efficacy|0|||
33439778|NCT01079988|101502976|FG003|Overall Study|Lack of Efficacy|0|||
33439779|NCT01079988|101502977|FG004|Overall Study|Lack of Efficacy|0|||
33439780|NCT01079988|101502973|FG000|Overall Study|Other|0|||
33439781|NCT01079988|101502974|FG001|Overall Study|Other|0|||
33439782|NCT01079988|101502975|FG002|Overall Study|Other|0|||
33439783|NCT01079988|101502976|FG003|Overall Study|Other|2|||
33439784|NCT01079988|101502977|FG004|Overall Study|Other|1|||
33439785|NCT03365375|101502978|FG000|Overall Study|Withdrawal by Subject|0|||
33439786|NCT03365375|101502979|FG001|Overall Study|Withdrawal by Subject|1|||
33439787|NCT03365375|101502978|FG000|Overall Study|Lost to Follow-up|0|||
33439788|NCT03365375|101502979|FG001|Overall Study|Lost to Follow-up|4|||
33439789|NCT02015390|101502985|FG000|Overall Study|Lost to Follow-up|1|||
33439790|NCT02015390|101502986|FG001|Overall Study|Lost to Follow-up|0|||
33439791|NCT02015390|101502985|FG000|Overall Study|Adverse Event|0|||
33439792|NCT02015390|101502986|FG001|Overall Study|Adverse Event|3|||
33439793|NCT02015390|101502985|FG000|Overall Study|Physician Decision|0|||
33439794|NCT02015390|101502986|FG001|Overall Study|Physician Decision|1|||
33439795|NCT01781286|101502987|FG000|Overall Study|Lost to Follow-up|0|||
33439796|NCT01781286|101502988|FG001|Overall Study|Lost to Follow-up|0|||
33439797|NCT01781286|101502989|FG002|Overall Study|Lost to Follow-up|0|||
33439798|NCT01781286|101502990|FG003|Overall Study|Lost to Follow-up|0|||
33439799|NCT01781286|101502991|FG004|Overall Study|Lost to Follow-up|0|||
33439800|NCT01781286|101502992|FG005|Overall Study|Lost to Follow-up|1|||
33439801|NCT01781286|101502987|FG000|Overall Study|Time Constraints|2|||
33439802|NCT01781286|101502988|FG001|Overall Study|Time Constraints|0|||
33439803|NCT01781286|101502989|FG002|Overall Study|Time Constraints|2|||
33439804|NCT01781286|101502990|FG003|Overall Study|Time Constraints|0|||
33439805|NCT01781286|101502991|FG004|Overall Study|Time Constraints|0|||
33439806|NCT01781286|101502992|FG005|Overall Study|Time Constraints|0|||
33439807|NCT01781286|101502987|FG000|Overall Study|Noncompliance|0|||
33439808|NCT01781286|101502988|FG001|Overall Study|Noncompliance|0|||
33439809|NCT01781286|101502989|FG002|Overall Study|Noncompliance|0|||
33439810|NCT01781286|101502990|FG003|Overall Study|Noncompliance|1|||
33439811|NCT01781286|101502991|FG004|Overall Study|Noncompliance|0|||
33439812|NCT01781286|101502992|FG005|Overall Study|Noncompliance|0|||
33439813|NCT02246478|101502995|FG000|Multiple-dose Phase|Protocol Violation|1|||
33439814|NCT02246478|101502996|FG001|Multiple-dose Phase|Protocol Violation|0|||
33439815|NCT02246478|101502997|FG002|Multiple-dose Phase|Protocol Violation|0|||
33439816|NCT02246478|101502998|FG003|Multiple-dose Phase|Protocol Violation|1|||
33439817|NCT01856309|101503003|FG000|Overall Study|Death|4|||
33439818|NCT01856309|101503004|FG001|Overall Study|Death|6|||
33439819|NCT01856309|101503005|FG002|Overall Study|Death|11|||
33439820|NCT01856309|101503006|FG003|Overall Study|Death|6|||
33439821|NCT01856309|101503003|FG000|Overall Study|Lost to Follow-up|6|||
33439822|NCT01856309|101503004|FG001|Overall Study|Lost to Follow-up|2|||
33439823|NCT01856309|101503005|FG002|Overall Study|Lost to Follow-up|4|||
33439824|NCT01856309|101503006|FG003|Overall Study|Lost to Follow-up|8|||
33439825|NCT01856309|101503003|FG000|Overall Study|Withdrawal by Subject|11|||
33439826|NCT01856309|101503004|FG001|Overall Study|Withdrawal by Subject|13|||
33439827|NCT01856309|101503005|FG002|Overall Study|Withdrawal by Subject|28|||
33439828|NCT01856309|101503006|FG003|Overall Study|Withdrawal by Subject|26|||
33439829|NCT01856309|101503003|FG000|Overall Study|Other|227|||
33439830|NCT01856309|101503004|FG001|Overall Study|Other|225|||
33439831|NCT01856309|101503005|FG002|Overall Study|Other|447|||
33439832|NCT01856309|101503006|FG003|Overall Study|Other|469|||
33439833|NCT01856309|101503003|FG000|Overall Study|Lack of Efficacy|14|||
33439834|NCT01856309|101503004|FG001|Overall Study|Lack of Efficacy|9|||
33439835|NCT01856309|101503005|FG002|Overall Study|Lack of Efficacy|40|||
33439836|NCT01856309|101503006|FG003|Overall Study|Lack of Efficacy|25|||
33439837|NCT01856309|101503003|FG000|Overall Study|Adverse Event|31|||
33439838|NCT01856309|101503004|FG001|Overall Study|Adverse Event|31|||
33439839|NCT01856309|101503005|FG002|Overall Study|Adverse Event|55|||
33439840|NCT01856309|101503006|FG003|Overall Study|Adverse Event|65|||
33439841|NCT01856309|101503003|FG000|Overall Study|Pregnancy|0|||
33439842|NCT01856309|101503004|FG001|Overall Study|Pregnancy|0|||
33439843|NCT01856309|101503005|FG002|Overall Study|Pregnancy|0|||
33439844|NCT01856309|101503006|FG003|Overall Study|Pregnancy|1|||
33439845|NCT01856309|101503003|FG000|Overall Study|Physician Decision|6|||
33439846|NCT01856309|101503004|FG001|Overall Study|Physician Decision|1|||
33439847|NCT01856309|101503005|FG002|Overall Study|Physician Decision|6|||
33439848|NCT01856309|101503006|FG003|Overall Study|Physician Decision|8|||
33439849|NCT01856309|101503003|FG000|Overall Study|Noncompliance With Study Drug|0|||
33439850|NCT01856309|101503004|FG001|Overall Study|Noncompliance With Study Drug|1|||
33439851|NCT01856309|101503005|FG002|Overall Study|Noncompliance With Study Drug|4|||
33439852|NCT01856309|101503006|FG003|Overall Study|Noncompliance With Study Drug|1|||
33439853|NCT01604850|101503007|FG000|Overall Study|Enrolled but never treated|0|||
33439854|NCT01604850|101503008|FG001|Overall Study|Enrolled but never treated|1|||
33439855|NCT01604850|101503007|FG000|Overall Study|Efficacy Failure|50|||
33439856|NCT01604850|101503008|FG001|Overall Study|Efficacy Failure|29|||
33157942|NCT02607930|100489925|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
33157943|NCT02607930|100489926|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
33439857|NCT01604850|101503007|FG000|Overall Study|Lost to Follow-up|1|||
33439858|NCT01604850|101503008|FG001|Overall Study|Lost to Follow-up|0|||
33439859|NCT01604850|101503007|FG000|Overall Study|Subject withdrew consent|1|||
33439860|NCT01604850|101503008|FG001|Overall Study|Subject withdrew consent|0|||
33439861|NCT01458405|101503009|FG000|Phase 1 (up to 12 Months)|Other|0|||
33439862|NCT01458405|101503010|FG001|Phase 1 (up to 12 Months)|Other|1|||
33439863|NCT01458405|101503011|FG002|Phase 1 (up to 12 Months)|Other|0|||
33439864|NCT01458405|101503012|FG003|Phase 1 (up to 12 Months)|Other|0|||
33439865|NCT01458405|101503009|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
33439866|NCT01458405|101503010|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
33439867|NCT01458405|101503011|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
33439868|NCT01458405|101503012|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
33439869|NCT01458405|101503009|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
33439870|NCT01458405|101503010|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
33439871|NCT01458405|101503011|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
33439872|NCT01458405|101503012|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
33439873|NCT01458405|101503009|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
33439874|NCT01458405|101503010|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
33439875|NCT01458405|101503011|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
33439876|NCT01458405|101503012|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
33439877|NCT01422538|101503014|FG000|Overall Study|Lost to Follow-up|0|||
33439878|NCT01422538|101503015|FG001|Overall Study|Lost to Follow-up|1|||
33439879|NCT01422538|101503016|FG002|Overall Study|Lost to Follow-up|1|||
33439880|NCT01422538|101503014|FG000|Overall Study|Missed visit|0|||
33439881|NCT01422538|101503015|FG001|Overall Study|Missed visit|1|||
33439882|NCT01422538|101503016|FG002|Overall Study|Missed visit|1|||
33439883|NCT02460159|101505723|FG000|Overall Study|Adverse Event|4|||
33439884|NCT02460159|101505724|FG001|Overall Study|Adverse Event|1|||
33439885|NCT02460159|101505723|FG000|Overall Study|Withdrawal by Subject|2|||
33439886|NCT02460159|101505724|FG001|Overall Study|Withdrawal by Subject|0|||
33439887|NCT01355081|101505725|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
33439888|NCT01355081|101505726|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
33439889|NCT01355081|101505727|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
33439890|NCT01355081|101505725|FG000|Overall Study|Major Protocol Deviation|0|||
33439891|NCT01355081|101505726|FG001|Overall Study|Major Protocol Deviation|1|||
33253860|NCT02798835|100830257|FG000|Overall Study|Protocol Violation|0|||
33253861|NCT02798835|100830258|FG001|Overall Study|Protocol Violation|0|||
33439892|NCT01355081|101505727|FG002|Overall Study|Major Protocol Deviation|0|||
33439893|NCT01355081|101505725|FG000|Overall Study|Lost to Follow-up|0|||
33439894|NCT01355081|101505726|FG001|Overall Study|Lost to Follow-up|0|||
33439895|NCT01355081|101505727|FG002|Overall Study|Lost to Follow-up|1|||
33439896|NCT01355081|101505725|FG000|Overall Study|Withdrawal of Consent|2|||
33439897|NCT01355081|101505726|FG001|Overall Study|Withdrawal of Consent|3|||
33439898|NCT01355081|101505727|FG002|Overall Study|Withdrawal of Consent|3|||
33439899|NCT01355081|101505725|FG000|Overall Study|Lack of Efficacy|2|||
33439900|NCT01355081|101505726|FG001|Overall Study|Lack of Efficacy|1|||
33439901|NCT01355081|101505727|FG002|Overall Study|Lack of Efficacy|1|||
33439902|NCT01355081|101505725|FG000|Overall Study|Non Compliance with Study Medication|0|||
33157944|NCT02607930|100489923|FG000|Double-Blinded Treatment Phase|Death|2|||
33157945|NCT02607930|100489924|FG001|Double-Blinded Treatment Phase|Death|1|||
33157946|NCT02607930|100489925|FG002|Double-Blinded Treatment Phase|Death|0|||
33157947|NCT02607930|100489926|FG003|Double-Blinded Treatment Phase|Death|0|||
33157948|NCT02607930|100489923|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
33157949|NCT02607930|100489924|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
33157950|NCT02607930|100489925|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
33157951|NCT02607930|100489926|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
33157952|NCT02607930|100489923|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
33157953|NCT02607930|100489924|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
33157954|NCT02607930|100489925|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
33157955|NCT02607930|100489926|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
33157956|NCT02607930|100489923|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
33157957|NCT02607930|100489924|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
33157958|NCT02607930|100489925|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
33157959|NCT02607930|100489926|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
33157960|NCT02607930|100489923|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
33157961|NCT02607930|100489924|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
33157962|NCT02607930|100489925|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
33157963|NCT02607930|100489926|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
33157964|NCT02607930|100489923|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
33157965|NCT02607930|100489924|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
33157966|NCT02607930|100489925|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
33157967|NCT02607930|100489926|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
33439903|NCT01355081|101505726|FG001|Overall Study|Non Compliance with Study Medication|1|||
33157968|NCT02607930|100489923|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
33439904|NCT01355081|101505727|FG002|Overall Study|Non Compliance with Study Medication|0|||
33439905|NCT00324168|101505728|FG000|Overall Study|Lost to Follow-up|19|||
33439906|NCT00324168|101505729|FG001|Overall Study|Lost to Follow-up|18|||
33157969|NCT02607930|100489924|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
33253862|NCT02798835|100830259|FG002|Overall Study|Protocol Violation|3|||
33253863|NCT01924767|100830260|FG000|Overall Study|Adverse Event|1|||
33439907|NCT00324168|101505728|FG000|Overall Study|Death|3|||
33157970|NCT02607930|100489925|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
33157971|NCT02607930|100489926|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
33157972|NCT02607930|100489923|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
33157973|NCT02607930|100489924|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
33157974|NCT02607930|100489925|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
33157975|NCT02607930|100489926|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
33157976|NCT02607930|100489923|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
33157977|NCT02607930|100489924|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
33157978|NCT02607930|100489925|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
33157979|NCT02607930|100489926|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
33157980|NCT02607930|100489923|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
33157981|NCT02607930|100489924|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
33157982|NCT02607930|100489925|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
33157983|NCT02607930|100489926|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
33157984|NCT04674644|100489929|FG000|Overall Study|with missing data|37|||
33253864|NCT01924767|100830261|FG001|Overall Study|Adverse Event|0|||
33157985|NCT01824875|100489930|FG000|Overall Study|Disease progression|22|||
33157986|NCT01824875|100489931|FG001|Overall Study|Disease progression|15|||
33157987|NCT01824875|100489930|FG000|Overall Study|Withdrawal by Subject|5|||
33157988|NCT01824875|100489931|FG001|Overall Study|Withdrawal by Subject|4|||
33157989|NCT01824875|100489930|FG000|Overall Study|Adverse Event|4|||
33157990|NCT01824875|100489931|FG001|Overall Study|Adverse Event|10|||
33157991|NCT01824875|100489930|FG000|Overall Study|Alternative therapy|3|||
33157992|NCT01824875|100489931|FG001|Overall Study|Alternative therapy|0|||
33157993|NCT01824875|100489930|FG000|Overall Study|Complicating disease|1|||
33157994|NCT01824875|100489931|FG001|Overall Study|Complicating disease|0|||
33157995|NCT01824875|100489930|FG000|Overall Study|Physician Decision|0|||
33157996|NCT01824875|100489931|FG001|Overall Study|Physician Decision|1|||
33157997|NCT01824875|100489930|FG000|Overall Study|Non-compliance|1|||
33157998|NCT01824875|100489931|FG001|Overall Study|Non-compliance|1|||
33157999|NCT01824875|100489930|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
33158000|NCT01824875|100489931|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
33158001|NCT01824875|100489930|FG000|Overall Study|Administrative issues|0|||
33158002|NCT01824875|100489931|FG001|Overall Study|Administrative issues|2|||
33158003|NCT01824875|100489930|FG000|Overall Study|Ineligible or never started treatment|9|||
33158004|NCT01824875|100489931|FG001|Overall Study|Ineligible or never started treatment|5|||
33158005|NCT01824875|100489930|FG000|Overall Study|Other|0|||
33158006|NCT01824875|100489931|FG001|Overall Study|Other|2|||
33158007|NCT02171065|100489932|FG000|Overall Study|Withdrawal by Subject|1|||
33158008|NCT02171065|100489933|FG001|Overall Study|Withdrawal by Subject|0|||
33158009|NCT02171065|100489934|FG002|Overall Study|Withdrawal by Subject|0|||
33158010|NCT02171065|100489932|FG000|Overall Study|Lost to Follow-up|0|||
33158011|NCT02171065|100489933|FG001|Overall Study|Lost to Follow-up|0|||
33253865|NCT01924767|100830262|FG002|Overall Study|Adverse Event|1|||
33253866|NCT01924767|100830263|FG003|Overall Study|Adverse Event|0|||
33439908|NCT00324168|101505729|FG001|Overall Study|Death|3|||
33439909|NCT00324168|101505728|FG000|Overall Study|Patient did not visit in f/u window|6|||
33439910|NCT00324168|101505729|FG001|Overall Study|Patient did not visit in f/u window|9|||
33439911|NCT03025880|101505730|FG000|Overall Study|Adverse Event|1|||
33439912|NCT03025880|101505731|FG001|Overall Study|Adverse Event|0|||
33439913|NCT03025880|101505730|FG000|Overall Study|Death|1|||
33439914|NCT03025880|101505731|FG001|Overall Study|Death|1|||
33439915|NCT03025880|101505730|FG000|Overall Study|Withdrawal by Subject|0|||
33439916|NCT03025880|101505731|FG001|Overall Study|Withdrawal by Subject|1|||
33439917|NCT03025880|101505730|FG000|Overall Study|Physician Decision|0|||
33439918|NCT03025880|101505731|FG001|Overall Study|Physician Decision|1|||
33439919|NCT03025880|101505730|FG000|Overall Study|Progressive Disease|12|||
33439920|NCT03025880|101505731|FG001|Overall Study|Progressive Disease|19|||
33439921|NCT00389064|101505732|FG000|Overall Study|Adverse Event|11|||
33439922|NCT00389064|101505733|FG001|Overall Study|Adverse Event|3|||
33439923|NCT00389064|101505732|FG000|Overall Study|Lack of Efficacy|3|||
33439924|NCT00389064|101505733|FG001|Overall Study|Lack of Efficacy|14|||
33439925|NCT00389064|101505732|FG000|Overall Study|Withdrawal by Subject|17|||
33439926|NCT00389064|101505733|FG001|Overall Study|Withdrawal by Subject|27|||
33439927|NCT00389064|101505732|FG000|Overall Study|Physician Decision|2|||
33439928|NCT00389064|101505733|FG001|Overall Study|Physician Decision|2|||
33439929|NCT00389064|101505732|FG000|Overall Study|Lost to Follow-up|1|||
33439930|NCT00389064|101505733|FG001|Overall Study|Lost to Follow-up|2|||
33439931|NCT00389064|101505732|FG000|Overall Study|Protocol Violation|2|||
33439932|NCT00389064|101505733|FG001|Overall Study|Protocol Violation|0|||
33439933|NCT00389064|101505732|FG000|Overall Study|Multiple Reasons|9|||
33439934|NCT00389064|101505733|FG001|Overall Study|Multiple Reasons|11|||
33439935|NCT00214422|101505734|FG000|Overall Study|Physician Decision|2|||
33439936|NCT00214422|101505735|FG001|Overall Study|Physician Decision|0|||
33439937|NCT00214422|101505736|FG002|Overall Study|Physician Decision|0|||
33439938|NCT00214422|101505734|FG000|Overall Study|Developed esophageal ca|1|||
33439939|NCT00214422|101505735|FG001|Overall Study|Developed esophageal ca|0|||
33253867|NCT01924767|100830264|FG004|Overall Study|Adverse Event|0|||
33253868|NCT04594759|100830276|FG000|Overall Study|Lost to Follow-up|3|||
33253869|NCT01849055|100830277|FG000|Overall Study|Withdrawal by Subject|0|||
33253870|NCT01849055|100830278|FG001|Overall Study|Withdrawal by Subject|0|||
33253871|NCT01849055|100830279|FG002|Overall Study|Withdrawal by Subject|1|||
33253872|NCT01849055|100830280|FG003|Overall Study|Withdrawal by Subject|0|||
33253873|NCT01849055|100830281|FG004|Overall Study|Withdrawal by Subject|0|||
33253874|NCT01849055|100830282|FG005|Overall Study|Withdrawal by Subject|0|||
33253875|NCT00959946|100830283|FG000|Overall Study|Adverse Event|0|||
33253876|NCT00959946|100830284|FG001|Overall Study|Adverse Event|0|||
33253877|NCT00959946|100830285|FG002|Overall Study|Adverse Event|2|||
33253878|NCT00959946|100830286|FG003|Overall Study|Adverse Event|1|||
33253879|NCT00959946|100830287|FG004|Overall Study|Adverse Event|0|||
33253880|NCT00959946|100830288|FG005|Overall Study|Adverse Event|1|||
33253881|NCT00959946|100830289|FG006|Overall Study|Adverse Event|0|||
33253882|NCT00959946|100830290|FG007|Overall Study|Adverse Event|0|||
33253883|NCT00959946|100830283|FG000|Overall Study|Death|0|||
33253884|NCT00959946|100830284|FG001|Overall Study|Death|0|||
33253885|NCT00959946|100830285|FG002|Overall Study|Death|0|||
33253886|NCT00959946|100830286|FG003|Overall Study|Death|0|||
33253887|NCT00959946|100830287|FG004|Overall Study|Death|0|||
33253888|NCT00959946|100830288|FG005|Overall Study|Death|1|||
33253889|NCT00959946|100830289|FG006|Overall Study|Death|0|||
33253890|NCT00959946|100830290|FG007|Overall Study|Death|0|||
33253891|NCT00959946|100830283|FG000|Overall Study|Disease Progression|2|||
33253892|NCT00959946|100830284|FG001|Overall Study|Disease Progression|4|||
33253893|NCT00959946|100830285|FG002|Overall Study|Disease Progression|2|||
33253894|NCT00959946|100830286|FG003|Overall Study|Disease Progression|4|||
33253895|NCT00959946|100830287|FG004|Overall Study|Disease Progression|4|||
33253896|NCT00959946|100830288|FG005|Overall Study|Disease Progression|6|||
33253897|NCT00959946|100830289|FG006|Overall Study|Disease Progression|2|||
33253898|NCT00959946|100830290|FG007|Overall Study|Disease Progression|2|||
33253899|NCT00959946|100830283|FG000|Overall Study|Withdrawal by Subject|0|||
33439940|NCT00214422|101505736|FG002|Overall Study|Developed esophageal ca|0|||
33439941|NCT00214422|101505734|FG000|Overall Study|Pt taken off study|1|||
33439942|NCT00214422|101505735|FG001|Overall Study|Pt taken off study|1|||
33439943|NCT00214422|101505736|FG002|Overall Study|Pt taken off study|0|||
33439944|NCT00214422|101505734|FG000|Overall Study|Disease progression on study|1|||
33253900|NCT00959946|100830284|FG001|Overall Study|Withdrawal by Subject|0|||
33253901|NCT00959946|100830285|FG002|Overall Study|Withdrawal by Subject|0|||
33253902|NCT00959946|100830286|FG003|Overall Study|Withdrawal by Subject|0|||
33253903|NCT00959946|100830287|FG004|Overall Study|Withdrawal by Subject|0|||
33158012|NCT02171065|100489934|FG002|Overall Study|Lost to Follow-up|1|||
33158013|NCT01871142|100489936|FG000|Overall Study|Adverse Event|1|||
33158014|NCT00319501|100489942|FG000|Double-blind Period|Withdrawal by Subject|0|||
33158015|NCT00319501|100489943|FG001|Double-blind Period|Withdrawal by Subject|3|||
33253904|NCT00959946|100830288|FG005|Overall Study|Withdrawal by Subject|1|||
33253905|NCT00959946|100830289|FG006|Overall Study|Withdrawal by Subject|0|||
33253906|NCT00959946|100830290|FG007|Overall Study|Withdrawal by Subject|0|||
33253907|NCT03781336|100830291|FG000|Overall Study|Withdrawal by Subject|2|||
33253908|NCT03781336|100830292|FG001|Overall Study|Withdrawal by Subject|2|||
33253909|NCT01538719|100830293|FG000|Overall Study|Lost to Follow-up|2|||
33439945|NCT00214422|101505735|FG001|Overall Study|Disease progression on study|0|||
33253910|NCT01538719|100830294|FG001|Overall Study|Lost to Follow-up|0|||
33253911|NCT01179334|100830297|FG000|Treatment Period|Adverse Event|1|||
33253912|NCT01179334|100830298|FG001|Treatment Period|Adverse Event|0|||
33253913|NCT01179334|100830297|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
33253914|NCT01179334|100830298|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
33253915|NCT01179334|100830297|FG000|Long-term Extension (LTE) Period|Death|3|||
33253916|NCT01179334|100830298|FG001|Long-term Extension (LTE) Period|Death|0|||
33253917|NCT01179334|100830297|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
33253918|NCT01179334|100830298|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
33253919|NCT00628862|100830299|FG000|Overall Study|Adverse Event|6|||
33253920|NCT00628862|100830300|FG001|Overall Study|Adverse Event|8|||
33253921|NCT00628862|100830301|FG002|Overall Study|Adverse Event|10|||
33253922|NCT00628862|100830299|FG000|Overall Study|Withdrawal by Subject|4|||
33253923|NCT00628862|100830300|FG001|Overall Study|Withdrawal by Subject|6|||
33253924|NCT00628862|100830301|FG002|Overall Study|Withdrawal by Subject|11|||
33253925|NCT00628862|100830299|FG000|Overall Study|Lost to Follow-up|0|||
33439946|NCT00214422|101505736|FG002|Overall Study|Disease progression on study|0|||
33253926|NCT00628862|100830300|FG001|Overall Study|Lost to Follow-up|2|||
33253927|NCT00628862|100830301|FG002|Overall Study|Lost to Follow-up|1|||
33253928|NCT00628862|100830299|FG000|Overall Study|Protocol Violation|1|||
33253929|NCT00628862|100830300|FG001|Overall Study|Protocol Violation|0|||
33253930|NCT00628862|100830301|FG002|Overall Study|Protocol Violation|0|||
33253931|NCT00628862|100830299|FG000|Overall Study|COPD Exacerbation|0|||
33253932|NCT00628862|100830300|FG001|Overall Study|COPD Exacerbation|1|||
33253933|NCT00628862|100830301|FG002|Overall Study|COPD Exacerbation|0|||
33439947|NCT00214422|101505734|FG000|Overall Study|Unable to make a radiation treatment|0|||
33439948|NCT00214422|101505735|FG001|Overall Study|Unable to make a radiation treatment|0|||
33439949|NCT00214422|101505736|FG002|Overall Study|Unable to make a radiation treatment|1|||
33439950|NCT00385593|101505737|FG000|Overall Study|Adverse Event|3|||
33439951|NCT00385593|101505738|FG001|Overall Study|Adverse Event|2|||
33439952|NCT00385593|101505737|FG000|Overall Study|Withdrawal by Subject|17|||
33439953|NCT00385593|101505738|FG001|Overall Study|Withdrawal by Subject|7|||
33439954|NCT00385593|101505737|FG000|Overall Study|Lost to Follow-up|12|||
33439955|NCT00385593|101505738|FG001|Overall Study|Lost to Follow-up|8|||
33439956|NCT00385593|101505737|FG000|Overall Study|Protocol Violation|7|||
33439957|NCT00385593|101505738|FG001|Overall Study|Protocol Violation|4|||
33439958|NCT00385593|101505737|FG000|Overall Study|Several reasons|17|||
33439959|NCT00385593|101505738|FG001|Overall Study|Several reasons|15|||
33439960|NCT00385593|101505737|FG000|Overall Study|Incorrect inclusion|2|||
33439961|NCT00385593|101505738|FG001|Overall Study|Incorrect inclusion|0|||
33439962|NCT00385593|101505737|FG000|Overall Study|Incorrect randomization|0|||
33439963|NCT00385593|101505738|FG001|Overall Study|Incorrect randomization|1|||
33439964|NCT03991494|101505739|FG000|Overall Study|Progressive Disease|4|||
33439965|NCT02032888|101505740|FG000|Treatment Period|Poor compliance/noncompliance|1|||
33439966|NCT02032888|101505741|FG001|Treatment Period|Poor compliance/noncompliance|1|||
33439967|NCT02032888|101505742|FG002|Treatment Period|Poor compliance/noncompliance|0|||
33439968|NCT02032888|101505740|FG000|Treatment Period|Other|1|||
33439969|NCT02032888|101505741|FG001|Treatment Period|Other|1|||
33439970|NCT02032888|101505742|FG002|Treatment Period|Other|0|||
33439971|NCT02032888|101505740|FG000|Follow-up Period|Lost to Follow-up|1|||
33439972|NCT02032888|101505741|FG001|Follow-up Period|Lost to Follow-up|1|||
33439973|NCT02032888|101505742|FG002|Follow-up Period|Lost to Follow-up|0|||
33439974|NCT02032888|101505740|FG000|Follow-up Period|Death|1|||
33439975|NCT02032888|101505741|FG001|Follow-up Period|Death|1|||
33439976|NCT02032888|101505742|FG002|Follow-up Period|Death|0|||
33439977|NCT02032888|101505740|FG000|Follow-up Period|Other|1|||
33439978|NCT02032888|101505741|FG001|Follow-up Period|Other|0|||
33439979|NCT02032888|101505742|FG002|Follow-up Period|Other|0|||
33439980|NCT02495857|101505748|FG000|Overall Study|Adverse Event|5|||
33439981|NCT02495857|101505749|FG001|Overall Study|Adverse Event|0|||
33439982|NCT02495857|101505750|FG002|Overall Study|Adverse Event|1|||
33439983|NCT02495857|101505748|FG000|Overall Study|Withdrawal by Subject|9|||
33439984|NCT02495857|101505749|FG001|Overall Study|Withdrawal by Subject|6|||
33439985|NCT02495857|101505750|FG002|Overall Study|Withdrawal by Subject|10|||
33439986|NCT02495857|101505748|FG000|Overall Study|Physician Decision|0|||
33439987|NCT02495857|101505749|FG001|Overall Study|Physician Decision|1|||
33439988|NCT02495857|101505750|FG002|Overall Study|Physician Decision|0|||
33439989|NCT02495857|101505748|FG000|Overall Study|Protocol Violation|1|||
33439990|NCT02495857|101505749|FG001|Overall Study|Protocol Violation|1|||
33253934|NCT02808338|100830302|FG000|Screening|Screen Failure|10|||
33253935|NCT02808338|100830302|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
33253936|NCT02808338|100830302|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
33439991|NCT02495857|101505750|FG002|Overall Study|Protocol Violation|2|||
33439992|NCT02495857|101505748|FG000|Overall Study|Lost to Follow-up|4|||
33439993|NCT02495857|101505749|FG001|Overall Study|Lost to Follow-up|5|||
33439994|NCT02495857|101505750|FG002|Overall Study|Lost to Follow-up|3|||
33253937|NCT01185782|100830306|FG000|Overall Study|Adverse Event|0|||
33253938|NCT01185782|100830307|FG001|Overall Study|Adverse Event|1|||
33253939|NCT01185782|100830306|FG000|Overall Study|Protocol Violation|1|||
33253940|NCT01185782|100830307|FG001|Overall Study|Protocol Violation|0|||
33253941|NCT01185782|100830306|FG000|Overall Study|Poor Response to Treatment|3|||
33253942|NCT01185782|100830307|FG001|Overall Study|Poor Response to Treatment|1|||
33253943|NCT01185782|100830306|FG000|Overall Study|Other|2|||
33253944|NCT01185782|100830307|FG001|Overall Study|Other|5|||
33253945|NCT01185782|100830306|FG000|Overall Study|Randomized but not treated|0|||
33253946|NCT01185782|100830307|FG001|Overall Study|Randomized but not treated|4|||
33253947|NCT04464421|100830311|FG000|Overall Study|Lost to Follow-up|2|||
33253948|NCT04464421|100830312|FG001|Overall Study|Lost to Follow-up|2|||
33253949|NCT02158091|100830314|FG000|Overall Study|DLT|2|||
33253950|NCT02158091|100830315|FG001|Overall Study|DLT|1|||
33253951|NCT02158091|100830316|FG002|Overall Study|DLT|0|||
33253952|NCT01111526|100830327|FG000|Overall Study|GVHD Disease Progression|0|||
33253953|NCT01111526|100830328|FG001|Overall Study|GVHD Disease Progression|1|||
33253954|NCT01111526|100830329|FG002|Overall Study|GVHD Disease Progression|2|||
33253955|NCT00396084|100830330|FG000|Overall Study|Adverse Event|0|||
33253956|NCT00396084|100830331|FG001|Overall Study|Adverse Event|0|||
33253957|NCT00396084|100830332|FG002|Overall Study|Adverse Event|0|||
33253958|NCT00396084|100830333|FG003|Overall Study|Adverse Event|0|||
33253959|NCT00396084|100830334|FG004|Overall Study|Adverse Event|1|||
33253960|NCT00396084|100830335|FG005|Overall Study|Adverse Event|2|||
33253961|NCT00396084|100830330|FG000|Overall Study|Withdrawal by Subject|0|||
33253962|NCT00396084|100830331|FG001|Overall Study|Withdrawal by Subject|0|||
33439995|NCT02495857|101505748|FG000|Overall Study|Other|3|||
33439996|NCT02495857|101505749|FG001|Overall Study|Other|3|||
33439997|NCT02495857|101505750|FG002|Overall Study|Other|2|||
33439998|NCT00304083|101505755|FG000|Overall Study|Withdrawal by Subject|4|||
33439999|NCT00304083|101505756|FG001|Overall Study|Withdrawal by Subject|2|||
33440000|NCT00304083|101505755|FG000|Overall Study|Physician Decision|8|||
33440001|NCT00304083|101505756|FG001|Overall Study|Physician Decision|3|||
33440002|NCT00304083|101505755|FG000|Overall Study|Disease Progression|5|||
33440003|NCT00304083|101505756|FG001|Overall Study|Disease Progression|1|||
33440004|NCT00304083|101505755|FG000|Overall Study|Other|5|||
33440005|NCT00304083|101505756|FG001|Overall Study|Other|2|||
33253963|NCT00396084|100830332|FG002|Overall Study|Withdrawal by Subject|0|||
33440006|NCT00617305|101505757|FG000|Overall Study|Adverse Event|4|||
33440007|NCT00617305|101505758|FG001|Overall Study|Adverse Event|0|||
33253964|NCT00396084|100830333|FG003|Overall Study|Withdrawal by Subject|1|||
33253965|NCT00396084|100830334|FG004|Overall Study|Withdrawal by Subject|0|||
33253966|NCT00396084|100830335|FG005|Overall Study|Withdrawal by Subject|0|||
33253967|NCT02694978|100830336|FG000|Overall Study|Adverse Event|10|||
33253968|NCT02694978|100830337|FG001|Overall Study|Adverse Event|9|||
33253969|NCT02694978|100830336|FG000|Overall Study|Withdrawal by Subject|22|||
33253970|NCT02694978|100830337|FG001|Overall Study|Withdrawal by Subject|19|||
33253971|NCT02694978|100830336|FG000|Overall Study|Lost to Follow-up|14|||
33253972|NCT02694978|100830337|FG001|Overall Study|Lost to Follow-up|17|||
33440008|NCT00617305|101505759|FG002|Overall Study|Adverse Event|0|||
33440009|NCT00617305|101505757|FG000|Overall Study|Death|1|||
33158016|NCT00319501|100489942|FG000|Double-blind Period|Sponsor Request|1|||
33158017|NCT00319501|100489943|FG001|Double-blind Period|Sponsor Request|0|||
33158018|NCT00319501|100489942|FG000|Double-blind Period|Did not receive treatment|42|||
33158019|NCT00319501|100489943|FG001|Double-blind Period|Did not receive treatment|29|||
33158020|NCT00319501|100489942|FG000|Open-label Period|Adverse Event|5|||
33158021|NCT00319501|100489943|FG001|Open-label Period|Adverse Event|0|||
33158022|NCT00319501|100489942|FG000|Open-label Period|Protocol Violation|6|||
33158023|NCT00319501|100489943|FG001|Open-label Period|Protocol Violation|0|||
33158024|NCT00319501|100489942|FG000|Open-label Period|Withdrawal by Subject|38|||
33440010|NCT00617305|101505758|FG001|Overall Study|Death|0|||
33440011|NCT00617305|101505759|FG002|Overall Study|Death|0|||
33440012|NCT00617305|101505757|FG000|Overall Study|Physician Decision|1|||
33440013|NCT00617305|101505758|FG001|Overall Study|Physician Decision|0|||
33440014|NCT00617305|101505759|FG002|Overall Study|Physician Decision|0|||
33440015|NCT00617305|101505757|FG000|Overall Study|Protocol Violation|1|||
33440016|NCT00617305|101505758|FG001|Overall Study|Protocol Violation|0|||
33440017|NCT00617305|101505759|FG002|Overall Study|Protocol Violation|1|||
33440018|NCT00617305|101505757|FG000|Overall Study|Withdrawal by Subject|1|||
33440019|NCT00617305|101505758|FG001|Overall Study|Withdrawal by Subject|0|||
33440020|NCT00617305|101505759|FG002|Overall Study|Withdrawal by Subject|0|||
33440021|NCT04185909|101505765|FG000|Overall Study|Lost to Follow-up|1|||
33440022|NCT00615069|101505777|FG000|Overall Study|Death|10|||
33440023|NCT00615069|101505777|FG000|Overall Study|Physician Decision|2|||
33440024|NCT00615069|101505777|FG000|Overall Study|Withdrawal by Subject|4|||
33440025|NCT03657160|101505778|FG000|Overall Study|Adverse Event|5|||
33440026|NCT03657160|101505779|FG001|Overall Study|Adverse Event|6|||
33440027|NCT03657160|101505778|FG000|Overall Study|Protocol Deviation|3|||
33440028|NCT03657160|101505779|FG001|Overall Study|Protocol Deviation|0|||
33440029|NCT03657160|101505778|FG000|Overall Study|Withdrawal by Subject|18|||
33440030|NCT03657160|101505779|FG001|Overall Study|Withdrawal by Subject|16|||
33440031|NCT03657160|101505778|FG000|Overall Study|Site Termination|1|||
33440032|NCT03657160|101505779|FG001|Overall Study|Site Termination|0|||
33440033|NCT03657160|101505778|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
33440034|NCT03657160|101505779|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
33440035|NCT03657160|101505778|FG000|Overall Study|Death|33|||
33440036|NCT03657160|101505779|FG001|Overall Study|Death|26|||
33440037|NCT03657160|101505778|FG000|Overall Study|Death (COVID-19-Related)|1|||
33440038|NCT03657160|101505779|FG001|Overall Study|Death (COVID-19-Related)|0|||
33440039|NCT03657160|101505778|FG000|Overall Study|Reason Not Specified|5|||
33440040|NCT03657160|101505779|FG001|Overall Study|Reason Not Specified|5|||
33440041|NCT03657160|101505778|FG000|Overall Study|Other (COVID-19-Related)|0|||
33440042|NCT03657160|101505779|FG001|Overall Study|Other (COVID-19-Related)|1|||
33440043|NCT01395030|101505780|FG000|Overall Study|Did not complete FCH PET/CT|7|||
33440044|NCT02272777|101505781|FG000|Overall Study|Adverse Event|0|||
33440045|NCT02272777|101505782|FG001|Overall Study|Adverse Event|1|||
33440046|NCT02272777|101505781|FG000|Overall Study|Withdrawal by Subject|0|||
33440047|NCT02272777|101505782|FG001|Overall Study|Withdrawal by Subject|3|||
33440048|NCT02272777|101505781|FG000|Overall Study|Lost to Follow-up|2|||
33440049|NCT02272777|101505782|FG001|Overall Study|Lost to Follow-up|0|||
33440050|NCT02272777|101505781|FG000|Overall Study|Other|2|||
33440051|NCT02272777|101505782|FG001|Overall Study|Other|0|||
33440052|NCT00320112|101505785|FG000|Overall Study|Lost to Follow-up|3|||
33440053|NCT00320112|101505786|FG001|Overall Study|Lost to Follow-up|4|||
33440054|NCT00320112|101505785|FG000|Overall Study|Withdrawal by Subject|3|||
33440055|NCT00320112|101505786|FG001|Overall Study|Withdrawal by Subject|0|||
33440056|NCT00320112|101505785|FG000|Overall Study|Death|2|||
33440057|NCT00320112|101505786|FG001|Overall Study|Death|1|||
33440058|NCT02109042|101505787|FG000|Overall Study|Sponsor Decision|15|||
33158025|NCT00319501|100489943|FG001|Open-label Period|Withdrawal by Subject|0|||
33158026|NCT00319501|100489942|FG000|Open-label Period|Principal Investigator decision|6|||
33440059|NCT02127281|101505788|FG000|Overall Study|Lost to Follow-up|1|||
33440060|NCT02127281|101505789|FG001|Overall Study|Lost to Follow-up|0|||
33440061|NCT00863746|101505790|FG000|Treatment|Not treated|4|||
33158027|NCT00319501|100489943|FG001|Open-label Period|Principal Investigator decision|0|||
33440062|NCT00863746|101505791|FG001|Treatment|Not treated|2|||
33440063|NCT00863746|101505790|FG000|Treatment|Adverse Event|41|||
33440064|NCT00863746|101505791|FG001|Treatment|Adverse Event|16|||
33440065|NCT00863746|101505790|FG000|Treatment|non-compliant with study medication|4|||
33440066|NCT00863746|101505791|FG001|Treatment|non-compliant with study medication|0|||
33440067|NCT00863746|101505790|FG000|Treatment|Consent withdrawn|15|||
33440068|NCT00863746|101505791|FG001|Treatment|Consent withdrawn|14|||
33440069|NCT00863746|101505790|FG000|Treatment|Lost to Follow-up|1|||
33440070|NCT00863746|101505791|FG001|Treatment|Lost to Follow-up|0|||
33440071|NCT00863746|101505790|FG000|Treatment|Protocol Violation|5|||
33440072|NCT00863746|101505791|FG001|Treatment|Protocol Violation|3|||
33440073|NCT00863746|101505790|FG000|Treatment|Other|1|||
33440074|NCT00863746|101505791|FG001|Treatment|Other|0|||
33440075|NCT00863746|101505790|FG000|Survival Follow up|Death|244|||
33440076|NCT00863746|101505791|FG001|Survival Follow up|Death|271|||
33440077|NCT00863746|101505790|FG000|Survival Follow up|Lost to Follow-up|2|||
33440078|NCT00863746|101505791|FG001|Survival Follow up|Lost to Follow-up|1|||
33440079|NCT00863746|101505790|FG000|Survival Follow up|Consent Withdrawn|7|||
33440080|NCT00863746|101505791|FG001|Survival Follow up|Consent Withdrawn|8|||
33440081|NCT01059903|101505792|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
33440082|NCT01059903|101505793|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
33440083|NCT02674477|101505794|FG000|Overall Study|Protocol Violation|8|||
33440084|NCT02674477|101505795|FG001|Overall Study|Protocol Violation|2|||
33440085|NCT04526210|101505801|FG000|Overall Study|Sponsor decision|7|||
33440086|NCT04526210|101505802|FG001|Overall Study|Sponsor decision|5|||
33440087|NCT04526210|101505801|FG000|Overall Study|Withdrawal by Subject|3|||
33440088|NCT04526210|101505802|FG001|Overall Study|Withdrawal by Subject|2|||
33440089|NCT00735904|101505805|FG000|Overall Study|Adverse Event|3|||
33440090|NCT00735904|101505805|FG000|Overall Study|Death|20|||
33440091|NCT00735904|101505805|FG000|Overall Study|Protocol Violation|1|||
33440092|NCT00735904|101505805|FG000|Overall Study|Withdrawal by Subject|1|||
33440093|NCT00735904|101505805|FG000|Overall Study|Study Terminated by Sponsor|5|||
33440094|NCT00735904|101505805|FG000|Overall Study|Other|8|||
33440095|NCT03546842|101505806|FG000|Overall Study|Protocol Violation|1|||
33440096|NCT03546842|101505806|FG000|Overall Study|Withdrawal by Subject|2|||
33440097|NCT01374919|101505807|FG000|Overall Study|Withdrawal by Subject|2|||
33440098|NCT03480425|101505811|FG000|Overall Study|Force transducer technical failure|1|||
33440099|NCT01239121|101505814|FG000|Overall Study|Withdrawal by Subject|2|||
33440100|NCT01239121|101505815|FG001|Overall Study|Withdrawal by Subject|4|||
33440101|NCT01239121|101505816|FG002|Overall Study|Withdrawal by Subject|0|||
33440102|NCT02087904|101505818|FG000|Overall Study|Did Not Receive Study Drug|0|||
33440103|NCT02087904|101505819|FG001|Overall Study|Did Not Receive Study Drug|0|||
33440104|NCT02087904|101505820|FG002|Overall Study|Did Not Receive Study Drug|2|||
33440105|NCT02087904|101505821|FG003|Overall Study|Did Not Receive Study Drug|1|||
33440106|NCT02087904|101505818|FG000|Overall Study|Adverse Event|8|||
33440107|NCT02087904|101505819|FG001|Overall Study|Adverse Event|4|||
33440108|NCT02087904|101505820|FG002|Overall Study|Adverse Event|4|||
33440109|NCT02087904|101505821|FG003|Overall Study|Adverse Event|12|||
33440110|NCT02087904|101505818|FG000|Overall Study|Lack of Efficacy|3|||
33440111|NCT02087904|101505819|FG001|Overall Study|Lack of Efficacy|6|||
33440112|NCT02087904|101505820|FG002|Overall Study|Lack of Efficacy|3|||
33440113|NCT02087904|101505821|FG003|Overall Study|Lack of Efficacy|2|||
33440114|NCT02087904|101505818|FG000|Overall Study|Other|6|||
33440115|NCT02087904|101505819|FG001|Overall Study|Other|2|||
33440116|NCT02087904|101505820|FG002|Overall Study|Other|4|||
33440117|NCT02087904|101505821|FG003|Overall Study|Other|4|||
33440118|NCT02087904|101505818|FG000|Overall Study|Withdrawal by Subject|8|||
33440119|NCT02087904|101505819|FG001|Overall Study|Withdrawal by Subject|3|||
33440120|NCT02087904|101505820|FG002|Overall Study|Withdrawal by Subject|7|||
33440121|NCT02087904|101505821|FG003|Overall Study|Withdrawal by Subject|4|||
33440122|NCT02087904|101505818|FG000|Overall Study|Lost to Follow-up|0|||
33440123|NCT02087904|101505819|FG001|Overall Study|Lost to Follow-up|4|||
33440124|NCT02087904|101505820|FG002|Overall Study|Lost to Follow-up|2|||
33440125|NCT02087904|101505821|FG003|Overall Study|Lost to Follow-up|2|||
33440126|NCT04753437|101505823|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33440127|NCT04753437|101505824|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
33440128|NCT04753437|101505823|FG000|Overall Study|Liver Function Test Abnormalities|2|||
33440129|NCT04753437|101505824|FG001|Overall Study|Liver Function Test Abnormalities|4|||
33440130|NCT03164772|101505825|FG000|Overall Study|Death|4|||
33440131|NCT03164772|101505826|FG001|Overall Study|Death|2|||
33440132|NCT03164772|101505825|FG000|Overall Study|Adverse Event|1|||
33440133|NCT03164772|101505826|FG001|Overall Study|Adverse Event|4|||
33440134|NCT03164772|101505825|FG000|Overall Study|Progressive Disease|11|||
33440135|NCT03164772|101505826|FG001|Overall Study|Progressive Disease|21|||
33440136|NCT03164772|101505825|FG000|Overall Study|Physician Decision|2|||
33440137|NCT03164772|101505826|FG001|Overall Study|Physician Decision|0|||
33440138|NCT03164772|101505825|FG000|Overall Study|Withdrawal by Subject|0|||
33440139|NCT03164772|101505826|FG001|Overall Study|Withdrawal by Subject|4|||
33440140|NCT02924038|101505827|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
33440141|NCT02924038|101505828|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
33440142|NCT00723528|101505830|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
33440143|NCT00723528|101505831|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
33440144|NCT00723528|101505832|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
33440145|NCT00723528|101505833|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
33440146|NCT00723528|101505834|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
33440147|NCT00723528|101505835|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
33440148|NCT00723528|101505836|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
33440149|NCT00723528|101505830|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
33440150|NCT00723528|101505831|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
33440151|NCT00723528|101505832|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
33440152|NCT00723528|101505833|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
33440153|NCT00723528|101505834|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
33440154|NCT00723528|101505835|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
33440155|NCT00723528|101505836|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
33440156|NCT00723528|101505830|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
33440157|NCT00723528|101505831|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
33440158|NCT00723528|101505832|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
33440159|NCT00723528|101505833|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
33440160|NCT00723528|101505834|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
33440161|NCT00723528|101505835|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
33440162|NCT00723528|101505836|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
33440163|NCT00723528|101505830|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
33440164|NCT00723528|101505831|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
33440165|NCT00723528|101505832|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
33440166|NCT00723528|101505833|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
33440167|NCT00723528|101505834|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
33440168|NCT00723528|101505835|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
33440169|NCT00723528|101505836|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
33440170|NCT00723528|101505830|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
33440171|NCT00723528|101505831|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
33440172|NCT00723528|101505832|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
33440173|NCT00723528|101505833|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
33440174|NCT00723528|101505834|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
33440175|NCT00723528|101505835|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
33440176|NCT00723528|101505836|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
33440177|NCT00723528|101505830|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
33440178|NCT00723528|101505831|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
33440179|NCT00723528|101505832|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
33158028|NCT00319501|100489942|FG000|Open-label Period|Sponsor request|12|||
33440180|NCT00723528|101505833|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
33440181|NCT00723528|101505834|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
33440182|NCT00723528|101505835|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
33440183|NCT00723528|101505836|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
33440184|NCT00723528|101505830|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
33440185|NCT00723528|101505831|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
33440186|NCT00723528|101505832|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
33440187|NCT00723528|101505833|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
33440188|NCT00723528|101505834|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
33440189|NCT00723528|101505835|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
33440190|NCT00723528|101505836|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
33440191|NCT00723528|101505830|FG000|Period 2: After Controlled Period|Other|0|||
33440192|NCT00723528|101505831|FG001|Period 2: After Controlled Period|Other|0|||
33440193|NCT00723528|101505832|FG002|Period 2: After Controlled Period|Other|0|||
33440194|NCT00723528|101505833|FG003|Period 2: After Controlled Period|Other|0|||
33440195|NCT00723528|101505834|FG004|Period 2: After Controlled Period|Other|1|||
33440196|NCT00723528|101505835|FG005|Period 2: After Controlled Period|Other|4|||
33440197|NCT00723528|101505836|FG006|Period 2: After Controlled Period|Other|0|||
33440198|NCT00723528|101505830|FG000|Period 2: After Controlled Period|Adverse Event|0|||
33440199|NCT00723528|101505831|FG001|Period 2: After Controlled Period|Adverse Event|0|||
33440200|NCT00723528|101505832|FG002|Period 2: After Controlled Period|Adverse Event|0|||
33440201|NCT00723528|101505833|FG003|Period 2: After Controlled Period|Adverse Event|0|||
33158029|NCT00319501|100489943|FG001|Open-label Period|Sponsor request|0|||
33158030|NCT00319501|100489942|FG000|Open-label Period|Lost to Follow-up|5|||
33158031|NCT00319501|100489943|FG001|Open-label Period|Lost to Follow-up|0|||
33440202|NCT00723528|101505834|FG004|Period 2: After Controlled Period|Adverse Event|1|||
33440203|NCT00723528|101505835|FG005|Period 2: After Controlled Period|Adverse Event|0|||
33440204|NCT00723528|101505836|FG006|Period 2: After Controlled Period|Adverse Event|1|||
33440205|NCT00723528|101505830|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
33440206|NCT00723528|101505831|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
33440207|NCT00723528|101505832|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
33440208|NCT00723528|101505833|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
33440209|NCT00723528|101505834|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
33440210|NCT00723528|101505835|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
33440211|NCT00723528|101505836|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
33440212|NCT00723528|101505830|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
33440213|NCT00723528|101505831|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
33158032|NCT00319501|100489942|FG000|Open-label Period|Did not receive treatment|33|||
33440214|NCT00723528|101505832|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
33440215|NCT00723528|101505833|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
33440216|NCT00723528|101505834|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
33440217|NCT00723528|101505835|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
33440218|NCT00723528|101505836|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
33440219|NCT04885296|101505837|FG000|Period 1|Covid-19 Related|1|||
33158033|NCT00319501|100489943|FG001|Open-label Period|Did not receive treatment|0|||
33158034|NCT00319501|100489942|FG000|Open-label Period|Other|11|||
33158035|NCT00319501|100489943|FG001|Open-label Period|Other|0|||
33158036|NCT00319501|100489942|FG000|Open-label Extension Period|Adverse Event|2|||
33158037|NCT00319501|100489943|FG001|Open-label Extension Period|Adverse Event|0|||
33158038|NCT00319501|100489942|FG000|Open-label Extension Period|Did not receive treatment|18|||
33158039|NCT00319501|100489943|FG001|Open-label Extension Period|Did not receive treatment|0|||
33158040|NCT00319501|100489942|FG000|Open-label Extension Period|Other|1|||
33158041|NCT00319501|100489943|FG001|Open-label Extension Period|Other|0|||
33158042|NCT00319501|100489942|FG000|Open-label Extension Period|Principal investigator decision|2|||
33158043|NCT00319501|100489943|FG001|Open-label Extension Period|Principal investigator decision|0|||
33158044|NCT00319501|100489942|FG000|Open-label Extension Period|Sponsor request|26|||
33158045|NCT00319501|100489943|FG001|Open-label Extension Period|Sponsor request|0|||
33158046|NCT00319501|100489942|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
33158047|NCT00319501|100489943|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
33158048|NCT00371826|100489944|FG000|Core Phase (12 Months)|Adverse Event|15|||
33158049|NCT00371826|100489945|FG001|Core Phase (12 Months)|Adverse Event|4|||
33158050|NCT00371826|100489946|FG002|Core Phase (12 Months)|Adverse Event|9|||
33158051|NCT00371826|100489944|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
33440220|NCT04885296|101505838|FG001|Period 1|Covid-19 Related|0|||
33440221|NCT04885296|101505837|FG000|Period 1|Adverse Event|0|||
33440222|NCT04885296|101505838|FG001|Period 1|Adverse Event|1|||
33440223|NCT04885296|101505837|FG000|Period 1|Withdrawal by Subject|1|||
33440224|NCT04885296|101505838|FG001|Period 1|Withdrawal by Subject|1|||
33440225|NCT04885296|101505837|FG000|Period 1|Test Article No Longer Available|1|||
33440226|NCT04885296|101505838|FG001|Period 1|Test Article No Longer Available|0|||
33440227|NCT04885296|101505837|FG000|Period 1|Dispensed Study lens in Error|1|||
33440228|NCT04885296|101505838|FG001|Period 1|Dispensed Study lens in Error|0|||
33440229|NCT04885296|101505837|FG000|Period 1|Lost to Follow-up|1|||
33440230|NCT04885296|101505838|FG001|Period 1|Lost to Follow-up|0|||
33440231|NCT04885296|101505837|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
33440232|NCT04885296|101505838|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
33440233|NCT01700621|101505842|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
33158052|NCT00371826|100489945|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
33158053|NCT00371826|100489946|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
33158054|NCT00371826|100489944|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
33158055|NCT00371826|100489945|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
33158056|NCT00371826|100489946|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
33158057|NCT00371826|100489944|FG000|Core Phase (12 Months)|Protocol Violation|1|||
33158058|NCT00371826|100489945|FG001|Core Phase (12 Months)|Protocol Violation|0|||
33158059|NCT00371826|100489946|FG002|Core Phase (12 Months)|Protocol Violation|1|||
33158060|NCT00371826|100489944|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
33158061|NCT00371826|100489945|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
33158062|NCT00371826|100489946|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
33158063|NCT00371826|100489944|FG000|Core Phase (12 Months)|Administrative problems|1|||
33158064|NCT00371826|100489945|FG001|Core Phase (12 Months)|Administrative problems|0|||
33158065|NCT00371826|100489946|FG002|Core Phase (12 Months)|Administrative problems|8|||
33158066|NCT00371826|100489944|FG000|Core Phase (12 Months)|Graft Loss|0|||
33158067|NCT00371826|100489945|FG001|Core Phase (12 Months)|Graft Loss|1|||
33440234|NCT01700621|101505843|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
33440235|NCT01700621|101505842|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
33440236|NCT01700621|101505843|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
33440237|NCT01700621|101505842|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
33440238|NCT01700621|101505843|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
33440239|NCT00259012|101505844|FG000|Overall Study|Adverse Event|0|||
33440240|NCT00259012|101505845|FG001|Overall Study|Adverse Event|1|||
33440241|NCT00259012|101505844|FG000|Overall Study|Withdrawal by Subject|1|||
33440242|NCT00259012|101505845|FG001|Overall Study|Withdrawal by Subject|0|||
33440243|NCT00259012|101505844|FG000|Overall Study|Physician Decision|0|||
33158068|NCT00371826|100489946|FG002|Core Phase (12 Months)|Graft Loss|0|||
33158069|NCT00371826|100489944|FG000|Extension Phase (24 Months)|Adverse Event|4|||
33158070|NCT00371826|100489945|FG001|Extension Phase (24 Months)|Adverse Event|5|||
33158071|NCT00371826|100489946|FG002|Extension Phase (24 Months)|Adverse Event|0|||
33158072|NCT00371826|100489944|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
33158073|NCT00371826|100489945|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
33158074|NCT00371826|100489946|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
33440244|NCT00259012|101505845|FG001|Overall Study|Physician Decision|1|||
33440245|NCT00259012|101505844|FG000|Overall Study|Lost to Follow-up|0|||
33440246|NCT00259012|101505845|FG001|Overall Study|Lost to Follow-up|1|||
33440247|NCT00259012|101505844|FG000|Overall Study|Protocol Violation|1|||
33440248|NCT00259012|101505845|FG001|Overall Study|Protocol Violation|1|||
33440249|NCT00893464|101505846|FG000|Overall Study|Did not complete therapy/experience PD|0|||
33440250|NCT00893464|101505847|FG001|Overall Study|Did not complete therapy/experience PD|0|||
33440251|NCT00893464|101505848|FG002|Overall Study|Did not complete therapy/experience PD|0|||
33440252|NCT00893464|101505849|FG003|Overall Study|Did not complete therapy/experience PD|0|||
33440253|NCT00893464|101505850|FG004|Overall Study|Did not complete therapy/experience PD|0|||
33158075|NCT00371826|100489944|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
33158076|NCT00371826|100489945|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
33158077|NCT00371826|100489946|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
33158078|NCT00371826|100489944|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
33158079|NCT00371826|100489945|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
33158080|NCT00371826|100489946|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
33158081|NCT00371826|100489944|FG000|Extension Phase (24 Months)|Administrative problems|0|||
33158082|NCT00371826|100489945|FG001|Extension Phase (24 Months)|Administrative problems|0|||
33158083|NCT00371826|100489946|FG002|Extension Phase (24 Months)|Administrative problems|2|||
33158084|NCT00892047|100489947|FG000|Overall Study|Adverse Event|2|||
33158085|NCT00892047|100489948|FG001|Overall Study|Adverse Event|2|||
33158086|NCT00892047|100489947|FG000|Overall Study|subject burden|2|||
33158087|NCT00892047|100489948|FG001|Overall Study|subject burden|3|||
33158088|NCT00892047|100489947|FG000|Overall Study|Lack of Efficacy|0|||
33158089|NCT00892047|100489948|FG001|Overall Study|Lack of Efficacy|2|||
33158090|NCT02106975|100489960|FG000|Overall Study|Death|25|||
33158091|NCT02106975|100489961|FG001|Overall Study|Death|39|||
33158092|NCT00066365|100489962|FG000|Overall Study|Adverse Event|1|||
33158093|NCT00066365|100489963|FG001|Overall Study|Adverse Event|0|||
33158094|NCT00066365|100489962|FG000|Overall Study|Lack of Efficacy|15|||
33158095|NCT00066365|100489963|FG001|Overall Study|Lack of Efficacy|12|||
33158096|NCT00066365|100489962|FG000|Overall Study|Physician Decision|1|||
33158097|NCT00066365|100489963|FG001|Overall Study|Physician Decision|0|||
33158098|NCT00066365|100489962|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
33158099|NCT00066365|100489963|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
33158100|NCT00066365|100489962|FG000|Overall Study|Ineligible|4|||
33158101|NCT00066365|100489963|FG001|Overall Study|Ineligible|2|||
33158102|NCT04515394|100489968|FG000|Overall Study|Participant did not receive treatment|1|||
33158103|NCT03208127|100489969|FG000|Overall Study|Death|1|||
33158104|NCT00880542|100489972|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
33440254|NCT00893464|101505851|FG005|Overall Study|Did not complete therapy/experience PD|0|||
33158105|NCT00880542|100489972|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
33158106|NCT00880542|100489972|FG000|REP: Surgical Resection|progressive disease|1|||
33158107|NCT02925117|100489973|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
33158108|NCT02925117|100489974|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
33158109|NCT02925117|100489975|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
33158110|NCT02925117|100489976|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
33158111|NCT02925117|100489977|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33158112|NCT02925117|100489978|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33158113|NCT02925117|100489979|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33158114|NCT02925117|100489980|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33440255|NCT00893464|101505852|FG006|Overall Study|Did not complete therapy/experience PD|2|||
33440256|NCT00893464|101505853|FG007|Overall Study|Did not complete therapy/experience PD|2|||
33440257|NCT01722877|101505854|FG000|Overall Study|Death|1|||
33440258|NCT01722877|101505854|FG000|Overall Study|Lost to Follow-up|1|||
33440259|NCT01244126|101505855|FG000|Overall Study|Protocol Violation|3|||
33440260|NCT01244126|101505856|FG001|Overall Study|Protocol Violation|3|||
33440261|NCT01244126|101505857|FG002|Overall Study|Protocol Violation|9|||
33440262|NCT02193178|101505858|FG000|Overall Study|Lost to Follow-up|1|||
33158115|NCT02925117|100489981|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33158116|NCT02925117|100489982|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33158117|NCT02925117|100489983|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33440263|NCT02193178|101505858|FG000|Overall Study|Dry eyes|1|||
33440264|NCT02008565|101505859|FG000|Overall Study|Protocol Violation|1|||
33158118|NCT02925117|100489984|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
33158119|NCT02925117|100489973|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
33158120|NCT02925117|100489974|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
33158121|NCT02925117|100489975|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
33158122|NCT02925117|100489976|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33158123|NCT02925117|100489977|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33158124|NCT02925117|100489978|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33158125|NCT02925117|100489979|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33158126|NCT02925117|100489980|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33158127|NCT02925117|100489981|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33158128|NCT02925117|100489982|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33158129|NCT02925117|100489983|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33158130|NCT02925117|100489984|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
33158131|NCT02925117|100489973|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
33158132|NCT02925117|100489974|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
33158133|NCT02925117|100489975|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33158134|NCT02925117|100489976|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33158135|NCT02925117|100489977|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33158136|NCT02925117|100489978|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33158137|NCT02925117|100489979|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33158138|NCT02925117|100489980|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33158139|NCT02925117|100489981|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33158140|NCT02925117|100489982|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33158141|NCT02925117|100489983|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33158142|NCT02925117|100489984|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
33158143|NCT02925117|100489973|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
33158144|NCT02925117|100489974|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
33440265|NCT02008565|101505860|FG001|Overall Study|Protocol Violation|1|||
33440266|NCT02008565|101505861|FG002|Overall Study|Protocol Violation|2|||
33158145|NCT02925117|100489975|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
33158146|NCT02925117|100489976|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
33158147|NCT02925117|100489977|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
33158148|NCT02925117|100489978|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
33158149|NCT02925117|100489979|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
33158150|NCT02925117|100489980|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
33440267|NCT02008565|101505862|FG003|Overall Study|Protocol Violation|0|||
33440268|NCT00366899|101505864|FG000|Infant Series|Withdrawal by Subject|4|||
33440269|NCT00366899|101505865|FG001|Infant Series|Withdrawal by Subject|7|||
33440270|NCT00366899|101505864|FG000|Infant Series|Protocol Violation|2|||
33440271|NCT00366899|101505865|FG001|Infant Series|Protocol Violation|1|||
33440272|NCT00366899|101505864|FG000|Infant Series|Failed to return|1|||
33158151|NCT02925117|100489981|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
33158152|NCT02925117|100489982|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
33440273|NCT00366899|101505865|FG001|Infant Series|Failed to return|1|||
33440274|NCT00366899|101505864|FG000|Infant Series|Lost to Follow-up|0|||
33440275|NCT00366899|101505865|FG001|Infant Series|Lost to Follow-up|2|||
33440276|NCT00366899|101505864|FG000|Infant Series|Adverse Event|0|||
33158153|NCT02925117|100489983|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
33158154|NCT02925117|100489984|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
33158155|NCT02925117|100489973|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33440277|NCT00366899|101505865|FG001|Infant Series|Adverse Event|1|||
33440278|NCT00366899|101505864|FG000|Infant Series|Physician Decision|1|||
33158156|NCT02925117|100489974|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33158157|NCT02925117|100489975|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33440279|NCT00366899|101505865|FG001|Infant Series|Physician Decision|0|||
33440280|NCT00366899|101505864|FG000|Infant Series|Randomized but not consented|1|||
33158158|NCT02925117|100489976|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33158159|NCT02925117|100489977|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33158160|NCT02925117|100489978|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
33158161|NCT02925117|100489979|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33158162|NCT02925117|100489980|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33158163|NCT02925117|100489981|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33158164|NCT02925117|100489982|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
33158165|NCT02925117|100489983|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
33440281|NCT00366899|101505865|FG001|Infant Series|Randomized but not consented|0|||
33440282|NCT00366899|101505864|FG000|After Infant Series|Lost to Follow-up|4|||
33440283|NCT00366899|101505865|FG001|After Infant Series|Lost to Follow-up|3|||
33158166|NCT02925117|100489984|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
33158167|NCT02925117|100489973|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
33158168|NCT02925117|100489974|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
33440284|NCT00366899|101505864|FG000|After Infant Series|Withdrawal by Subject|1|||
33440285|NCT00366899|101505865|FG001|After Infant Series|Withdrawal by Subject|4|||
33440286|NCT00366899|101505864|FG000|After Infant Series|Adverse Event|1|||
33440287|NCT00366899|101505865|FG001|After Infant Series|Adverse Event|2|||
33440288|NCT00366899|101505864|FG000|After Infant Series|Protocol Violation|1|||
33440289|NCT00366899|101505865|FG001|After Infant Series|Protocol Violation|0|||
33440290|NCT00366899|101505864|FG000|Toddler Dose|Withdrawal by Subject|1|||
33440291|NCT00366899|101505865|FG001|Toddler Dose|Withdrawal by Subject|1|||
33440292|NCT00366899|101505864|FG000|Toddler Dose|Protocol Violation|1|||
33440293|NCT00366899|101505865|FG001|Toddler Dose|Protocol Violation|0|||
33440294|NCT03049488|101505866|FG000|Overall Study|Lost to Follow-up|1|||
33440295|NCT03049488|101505867|FG001|Overall Study|Lost to Follow-up|1|||
33440296|NCT03049488|101505868|FG002|Overall Study|Lost to Follow-up|0|||
33440297|NCT03049488|101505869|FG003|Overall Study|Lost to Follow-up|0|||
33440298|NCT03049488|101505870|FG004|Overall Study|Lost to Follow-up|0|||
33440299|NCT03049488|101505871|FG005|Overall Study|Lost to Follow-up|0|||
33253973|NCT02694978|100830336|FG000|Overall Study|Death|4|||
33158169|NCT02925117|100489975|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
33158170|NCT02925117|100489976|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
33158171|NCT02925117|100489977|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
33158172|NCT02925117|100489978|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
33158173|NCT02925117|100489979|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
33158174|NCT02925117|100489980|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
33158175|NCT02925117|100489981|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
33158176|NCT02925117|100489982|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
33158177|NCT02925117|100489983|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
33158178|NCT02925117|100489984|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
33158179|NCT02925117|100489973|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
33158180|NCT02925117|100489974|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
33158181|NCT02925117|100489975|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
33158182|NCT02925117|100489976|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
33158183|NCT02925117|100489977|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
33158184|NCT02925117|100489978|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
33158185|NCT02925117|100489979|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
33158186|NCT02925117|100489980|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
33158187|NCT02925117|100489981|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
33158188|NCT02925117|100489982|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
33158189|NCT02925117|100489983|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
33158190|NCT02925117|100489984|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
33158191|NCT02925117|100489973|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
33158192|NCT02925117|100489974|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
33158193|NCT02925117|100489975|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
33158194|NCT02925117|100489976|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
33158195|NCT02925117|100489977|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
33158196|NCT02925117|100489978|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
33158197|NCT02925117|100489979|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
33158198|NCT02925117|100489980|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
33158199|NCT02925117|100489981|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
33158200|NCT02925117|100489982|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
33158201|NCT02925117|100489983|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
33158202|NCT02925117|100489984|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
33158203|NCT03469934|100489985|FG000|Overall Study|Withdrawal by Subject|0|||
33158204|NCT03469934|100489986|FG001|Overall Study|Withdrawal by Subject|1|||
33158205|NCT01313312|100493989|FG000|Overall Study|Adverse Event|5|||
33158206|NCT01313312|100493989|FG000|Overall Study|Withdrawal by Subject|18|||
33158207|NCT01313312|100493989|FG000|Overall Study|Lack of Efficacy|3|||
33158208|NCT01313312|100493989|FG000|Overall Study|Investigator Decision|1|||
33158209|NCT01313312|100493989|FG000|Overall Study|Observational Phase|1|||
33158210|NCT01313312|100493989|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
33158211|NCT01313312|100493989|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
33158212|NCT00518687|100493990|FG000|Overall Study|Adverse Event|201|||
33158213|NCT00518687|100493991|FG001|Overall Study|Adverse Event|177|||
33440300|NCT03049488|101505866|FG000|Overall Study|Moved from Area|1|||
33440301|NCT03049488|101505867|FG001|Overall Study|Moved from Area|0|||
33440302|NCT03049488|101505868|FG002|Overall Study|Moved from Area|0|||
33440303|NCT03049488|101505869|FG003|Overall Study|Moved from Area|1|||
33440304|NCT03049488|101505870|FG004|Overall Study|Moved from Area|1|||
33440305|NCT03049488|101505871|FG005|Overall Study|Moved from Area|0|||
33440306|NCT03049488|101505866|FG000|Overall Study|Physician Decision|0|||
33440307|NCT03049488|101505867|FG001|Overall Study|Physician Decision|1|||
33440308|NCT03049488|101505868|FG002|Overall Study|Physician Decision|0|||
33440309|NCT03049488|101505869|FG003|Overall Study|Physician Decision|0|||
33440310|NCT03049488|101505870|FG004|Overall Study|Physician Decision|0|||
33158214|NCT00518687|100493990|FG000|Overall Study|Lost to Follow-up|144|||
33158215|NCT00518687|100493991|FG001|Overall Study|Lost to Follow-up|155|||
33253974|NCT02694978|100830337|FG001|Overall Study|Death|1|||
33440311|NCT03049488|101505871|FG005|Overall Study|Physician Decision|0|||
33158216|NCT00518687|100493990|FG000|Overall Study|Physician Decision|42|||
33158217|NCT00518687|100493991|FG001|Overall Study|Physician Decision|48|||
33158218|NCT00518687|100493990|FG000|Overall Study|Progressive disease|2|||
33158219|NCT00518687|100493991|FG001|Overall Study|Progressive disease|2|||
33158220|NCT00518687|100493990|FG000|Overall Study|Protocol Violation|8|||
33158221|NCT00518687|100493991|FG001|Overall Study|Protocol Violation|10|||
33158222|NCT00518687|100493990|FG000|Overall Study|Study terminated by sponsor|930|||
33158223|NCT00518687|100493991|FG001|Overall Study|Study terminated by sponsor|918|||
33158224|NCT00518687|100493990|FG000|Overall Study|Withdrawal by Subject|110|||
33158225|NCT00518687|100493991|FG001|Overall Study|Withdrawal by Subject|110|||
33158226|NCT02693119|100493992|FG000|Open-Label Period|Withdrawal by Subject|0|||
33158227|NCT02693119|100493993|FG001|Open-Label Period|Withdrawal by Subject|1|||
33158228|NCT04218695|100493994|FG000|Overall Study|Adverse Event|1|||
33158229|NCT04218695|100493995|FG001|Overall Study|Adverse Event|0|||
33158230|NCT01890473|100493996|FG000|Overall Study|Lost to Follow-up|1|||
33158231|NCT01890473|100493997|FG001|Overall Study|Lost to Follow-up|0|||
33158232|NCT01890473|100493996|FG000|Overall Study|Poor/non-compliance|1|||
33158233|NCT01890473|100493997|FG001|Overall Study|Poor/non-compliance|0|||
33158234|NCT00142298|100493998|FG000|Overall Study|Adverse Event|10|||
33158235|NCT00142298|100493999|FG001|Overall Study|Adverse Event|10|||
33158236|NCT00142298|100494000|FG002|Overall Study|Adverse Event|1|||
33158237|NCT00142298|100494001|FG003|Overall Study|Adverse Event|5|||
33158238|NCT00142298|100494002|FG004|Overall Study|Adverse Event|2|||
33158239|NCT00142298|100494003|FG005|Overall Study|Adverse Event|2|||
33158240|NCT00142298|100494004|FG006|Overall Study|Adverse Event|0|||
33158241|NCT00142298|100494005|FG007|Overall Study|Adverse Event|0|||
33440312|NCT03049488|101505866|FG000|Overall Study|Withdrawal by Subject|0|||
33440313|NCT03049488|101505867|FG001|Overall Study|Withdrawal by Subject|0|||
33158242|NCT00142298|100494006|FG008|Overall Study|Adverse Event|0|||
33158243|NCT00142298|100494007|FG009|Overall Study|Adverse Event|0|||
33158244|NCT00142298|100493998|FG000|Overall Study|Clinical disease progression|1|||
33158245|NCT00142298|100493999|FG001|Overall Study|Clinical disease progression|0|||
33158246|NCT00142298|100494000|FG002|Overall Study|Clinical disease progression|0|||
33158247|NCT00142298|100494001|FG003|Overall Study|Clinical disease progression|0|||
33158248|NCT00142298|100494002|FG004|Overall Study|Clinical disease progression|0|||
33440314|NCT03049488|101505868|FG002|Overall Study|Withdrawal by Subject|0|||
33440315|NCT03049488|101505869|FG003|Overall Study|Withdrawal by Subject|1|||
33440316|NCT03049488|101505870|FG004|Overall Study|Withdrawal by Subject|1|||
33440317|NCT03049488|101505871|FG005|Overall Study|Withdrawal by Subject|0|||
33440318|NCT03639311|101505877|FG000|Maintenance Phase|Lost to Follow-up|1|||
33440319|NCT03639311|101505878|FG001|Maintenance Phase|Lost to Follow-up|0|||
33440320|NCT03639311|101505879|FG002|Maintenance Phase|Lost to Follow-up|0|||
33440321|NCT03639311|101505877|FG000|Maintenance Phase|Adverse Event|1|||
33440322|NCT03639311|101505878|FG001|Maintenance Phase|Adverse Event|0|||
33440323|NCT03639311|101505879|FG002|Maintenance Phase|Adverse Event|0|||
33440324|NCT03639311|101505877|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
33440325|NCT03639311|101505878|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
33440326|NCT03639311|101505879|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
33440327|NCT03639311|101505877|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
33440328|NCT03639311|101505878|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
33440329|NCT03639311|101505879|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
33440330|NCT03639311|101505877|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
33440331|NCT03639311|101505878|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
33440332|NCT03639311|101505879|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
33440333|NCT03639311|101505877|FG000|Maintenance Phase|Lack of Efficacy|1|||
33440334|NCT03639311|101505878|FG001|Maintenance Phase|Lack of Efficacy|0|||
33440335|NCT03639311|101505879|FG002|Maintenance Phase|Lack of Efficacy|0|||
33440336|NCT03329027|101505883|FG000|Overall Study|Lost to Follow-up|1|||
33440337|NCT03329027|101505884|FG001|Overall Study|Lost to Follow-up|0|||
33440338|NCT03329027|101505885|FG002|Overall Study|Lost to Follow-up|1|||
33440339|NCT03329027|101505883|FG000|Overall Study|Protocol Violation|9|||
33440340|NCT03329027|101505884|FG001|Overall Study|Protocol Violation|5|||
33440341|NCT03329027|101505885|FG002|Overall Study|Protocol Violation|7|||
33440342|NCT03693430|101505887|FG000|Overall Study|Lost to Follow-up|3|||
33440343|NCT03693430|101505888|FG001|Overall Study|Lost to Follow-up|14|||
33440344|NCT03693430|101505887|FG000|Overall Study|Death|1|||
33440345|NCT03693430|101505888|FG001|Overall Study|Death|0|||
33440346|NCT03693430|101505887|FG000|Overall Study|Withdrawal by Subject|0|||
33440347|NCT03693430|101505888|FG001|Overall Study|Withdrawal by Subject|4|||
33440348|NCT00150462|101505889|FG000|Overall Study|Disease Progression or Relapse|3|||
33440349|NCT00150462|101505890|FG001|Overall Study|Disease Progression or Relapse|1|||
33440350|NCT00150462|101505891|FG002|Overall Study|Disease Progression or Relapse|2|||
33440351|NCT00150462|101505892|FG003|Overall Study|Disease Progression or Relapse|1|||
33440352|NCT00150462|101505893|FG004|Overall Study|Disease Progression or Relapse|2|||
33440353|NCT00150462|101505894|FG005|Overall Study|Disease Progression or Relapse|2|||
33440354|NCT00150462|101505895|FG006|Overall Study|Disease Progression or Relapse|3|||
33440355|NCT00150462|101505896|FG007|Overall Study|Disease Progression or Relapse|5|||
33440356|NCT00150462|101505897|FG008|Overall Study|Disease Progression or Relapse|5|||
33440357|NCT00150462|101505898|FG009|Overall Study|Disease Progression or Relapse|3|||
33440358|NCT00150462|101505899|FG010|Overall Study|Disease Progression or Relapse|2|||
33440359|NCT00150462|101505889|FG000|Overall Study|Withdrawal by Subject|0|||
33440360|NCT00150462|101505890|FG001|Overall Study|Withdrawal by Subject|1|||
33440361|NCT00150462|101505891|FG002|Overall Study|Withdrawal by Subject|1|||
33440362|NCT00150462|101505892|FG003|Overall Study|Withdrawal by Subject|0|||
33440363|NCT00150462|101505893|FG004|Overall Study|Withdrawal by Subject|1|||
33440364|NCT00150462|101505894|FG005|Overall Study|Withdrawal by Subject|2|||
33440365|NCT00150462|101505895|FG006|Overall Study|Withdrawal by Subject|0|||
33440366|NCT00150462|101505896|FG007|Overall Study|Withdrawal by Subject|1|||
33440367|NCT00150462|101505897|FG008|Overall Study|Withdrawal by Subject|0|||
33440368|NCT00150462|101505898|FG009|Overall Study|Withdrawal by Subject|1|||
33440369|NCT00150462|101505899|FG010|Overall Study|Withdrawal by Subject|0|||
33440370|NCT00150462|101505889|FG000|Overall Study|Death|0|||
33440371|NCT00150462|101505890|FG001|Overall Study|Death|1|||
33440372|NCT00150462|101505891|FG002|Overall Study|Death|0|||
33440373|NCT00150462|101505892|FG003|Overall Study|Death|0|||
33440374|NCT00150462|101505893|FG004|Overall Study|Death|0|||
33440375|NCT00150462|101505894|FG005|Overall Study|Death|0|||
33440376|NCT00150462|101505895|FG006|Overall Study|Death|0|||
33440377|NCT00150462|101505896|FG007|Overall Study|Death|0|||
33440378|NCT00150462|101505897|FG008|Overall Study|Death|1|||
33440379|NCT00150462|101505898|FG009|Overall Study|Death|0|||
33440380|NCT00150462|101505899|FG010|Overall Study|Death|0|||
33440381|NCT00150462|101505889|FG000|Overall Study|Adverse Event|0|||
33440382|NCT00150462|101505890|FG001|Overall Study|Adverse Event|0|||
33440383|NCT00150462|101505891|FG002|Overall Study|Adverse Event|0|||
33440384|NCT00150462|101505892|FG003|Overall Study|Adverse Event|1|||
33440385|NCT00150462|101505893|FG004|Overall Study|Adverse Event|0|||
33440386|NCT00150462|101505894|FG005|Overall Study|Adverse Event|0|||
33440387|NCT00150462|101505895|FG006|Overall Study|Adverse Event|0|||
33440388|NCT00150462|101505896|FG007|Overall Study|Adverse Event|2|||
33440389|NCT00150462|101505897|FG008|Overall Study|Adverse Event|0|||
33440390|NCT00150462|101505898|FG009|Overall Study|Adverse Event|1|||
33440391|NCT00150462|101505899|FG010|Overall Study|Adverse Event|0|||
33440392|NCT00150462|101505889|FG000|Overall Study|Physician Decision|0|||
33440393|NCT00150462|101505890|FG001|Overall Study|Physician Decision|0|||
33158249|NCT00142298|100494003|FG005|Overall Study|Clinical disease progression|0|||
33440394|NCT00150462|101505891|FG002|Overall Study|Physician Decision|1|||
33440395|NCT00150462|101505892|FG003|Overall Study|Physician Decision|1|||
33440396|NCT00150462|101505893|FG004|Overall Study|Physician Decision|0|||
33440397|NCT00150462|101505894|FG005|Overall Study|Physician Decision|0|||
33440398|NCT00150462|101505895|FG006|Overall Study|Physician Decision|0|||
33440399|NCT00150462|101505896|FG007|Overall Study|Physician Decision|0|||
33440400|NCT00150462|101505897|FG008|Overall Study|Physician Decision|0|||
33440401|NCT00150462|101505898|FG009|Overall Study|Physician Decision|0|||
33440402|NCT00150462|101505899|FG010|Overall Study|Physician Decision|0|||
33440403|NCT00150462|101505889|FG000|Overall Study|Other|0|||
33440404|NCT00150462|101505890|FG001|Overall Study|Other|0|||
33440405|NCT00150462|101505891|FG002|Overall Study|Other|0|||
33440406|NCT00150462|101505892|FG003|Overall Study|Other|0|||
33440407|NCT00150462|101505893|FG004|Overall Study|Other|0|||
33440408|NCT00150462|101505894|FG005|Overall Study|Other|0|||
33440409|NCT00150462|101505895|FG006|Overall Study|Other|0|||
33440410|NCT00150462|101505896|FG007|Overall Study|Other|0|||
33440411|NCT00150462|101505897|FG008|Overall Study|Other|0|||
33440412|NCT00150462|101505898|FG009|Overall Study|Other|1|||
33440413|NCT00150462|101505899|FG010|Overall Study|Other|1|||
33440414|NCT02421952|101505900|FG000|Overall Study|Diary Not Returned|93|||
33440415|NCT02421952|101505900|FG000|Overall Study|Failed seriation task|13|||
33440416|NCT02421952|101505900|FG000|Overall Study|Subject uncooperative for baseline test|2|||
33440417|NCT02421952|101505900|FG000|Overall Study|Surgery cancelled|1|||
33440418|NCT02202850|101505903|FG000|Overall Study|Other|2|||
33440419|NCT02202850|101505904|FG001|Overall Study|Other|2|||
33440420|NCT02202850|101505903|FG000|Overall Study|Enbrel treatment discontinued|15|||
33440421|NCT02202850|101505904|FG001|Overall Study|Enbrel treatment discontinued|3|||
33440422|NCT02202850|101505903|FG000|Overall Study|Lost to Follow-up|7|||
33440423|NCT02202850|101505904|FG001|Overall Study|Lost to Follow-up|1|||
33440424|NCT01697696|101505905|FG000|Overall Study|Study terminated by sponsor|0|||
33440425|NCT01697696|101505906|FG001|Overall Study|Study terminated by sponsor|3|||
33440426|NCT01697696|101505905|FG000|Overall Study|Protocol deviation|1|||
33440427|NCT01697696|101505906|FG001|Overall Study|Protocol deviation|0|||
33440428|NCT01697696|101505905|FG000|Overall Study|Physician Decision|1|||
33440429|NCT01697696|101505906|FG001|Overall Study|Physician Decision|0|||
33440430|NCT01697696|101505905|FG000|Overall Study|Death|4|||
33440431|NCT01697696|101505906|FG001|Overall Study|Death|2|||
33440432|NCT01697696|101505905|FG000|Overall Study|Lost to Follow-up|10|||
33440433|NCT01697696|101505906|FG001|Overall Study|Lost to Follow-up|7|||
33440434|NCT01697696|101505905|FG000|Overall Study|Subject/guardian decision|31|||
33440435|NCT01697696|101505906|FG001|Overall Study|Subject/guardian decision|35|||
33440436|NCT03203447|101505909|FG000|Overall Study|Withdrawal by Subject|2|||
33158250|NCT00142298|100494004|FG006|Overall Study|Clinical disease progression|0|||
33158251|NCT00142298|100494005|FG007|Overall Study|Clinical disease progression|0|||
33158252|NCT00142298|100494006|FG008|Overall Study|Clinical disease progression|0|||
33158253|NCT00142298|100494007|FG009|Overall Study|Clinical disease progression|0|||
33158254|NCT00142298|100493998|FG000|Overall Study|Death|1|||
33158255|NCT00142298|100493999|FG001|Overall Study|Death|1|||
33158256|NCT00142298|100494000|FG002|Overall Study|Death|1|||
33158257|NCT00142298|100494001|FG003|Overall Study|Death|0|||
33158258|NCT00142298|100494002|FG004|Overall Study|Death|0|||
33158259|NCT00142298|100494003|FG005|Overall Study|Death|6|||
33158260|NCT00142298|100494004|FG006|Overall Study|Death|0|||
33158261|NCT00142298|100494005|FG007|Overall Study|Death|0|||
33158262|NCT00142298|100494006|FG008|Overall Study|Death|0|||
33158263|NCT00142298|100494007|FG009|Overall Study|Death|0|||
33158264|NCT00142298|100493998|FG000|Overall Study|Lack of Efficacy|44|||
33158265|NCT00142298|100493999|FG001|Overall Study|Lack of Efficacy|62|||
33158266|NCT00142298|100494000|FG002|Overall Study|Lack of Efficacy|9|||
33158267|NCT00142298|100494001|FG003|Overall Study|Lack of Efficacy|12|||
33158268|NCT00142298|100494002|FG004|Overall Study|Lack of Efficacy|1|||
33158269|NCT00142298|100494003|FG005|Overall Study|Lack of Efficacy|0|||
33158270|NCT00142298|100494004|FG006|Overall Study|Lack of Efficacy|0|||
33158271|NCT00142298|100494005|FG007|Overall Study|Lack of Efficacy|1|||
33158272|NCT00142298|100494006|FG008|Overall Study|Lack of Efficacy|0|||
33158273|NCT00142298|100494007|FG009|Overall Study|Lack of Efficacy|0|||
33158274|NCT00142298|100493998|FG000|Overall Study|Non-compliance|15|||
33158275|NCT00142298|100493999|FG001|Overall Study|Non-compliance|13|||
33158276|NCT00142298|100494000|FG002|Overall Study|Non-compliance|0|||
33158277|NCT00142298|100494001|FG003|Overall Study|Non-compliance|6|||
33158278|NCT00142298|100494002|FG004|Overall Study|Non-compliance|1|||
33158279|NCT00142298|100494003|FG005|Overall Study|Non-compliance|0|||
33158280|NCT00142298|100494004|FG006|Overall Study|Non-compliance|0|||
33158281|NCT00142298|100494005|FG007|Overall Study|Non-compliance|3|||
33158282|NCT00142298|100494006|FG008|Overall Study|Non-compliance|3|||
33158283|NCT00142298|100494007|FG009|Overall Study|Non-compliance|0|||
33158284|NCT00142298|100493998|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
33158285|NCT00142298|100493999|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
33158286|NCT00142298|100494000|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
33158287|NCT00142298|100494001|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
33158288|NCT00142298|100494002|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
33158289|NCT00142298|100494003|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
33158290|NCT00142298|100494004|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
33440437|NCT03203447|101505910|FG001|Overall Study|Withdrawal by Subject|1|||
33440438|NCT03203447|101505909|FG000|Overall Study|Lost to Follow-up|1|||
33440439|NCT03203447|101505910|FG001|Overall Study|Lost to Follow-up|10|||
33158291|NCT00142298|100494005|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
33158292|NCT00142298|100494006|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
33158293|NCT00142298|100494007|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
33158294|NCT00142298|100493998|FG000|Overall Study|Pregnancy|4|||
33158295|NCT00142298|100493999|FG001|Overall Study|Pregnancy|4|||
33158296|NCT00142298|100494000|FG002|Overall Study|Pregnancy|2|||
33440440|NCT03203447|101505909|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
33440441|NCT03203447|101505910|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
33440442|NCT00854308|101505911|FG000|Overall Study|Disease progression|42|||
33440443|NCT00854308|101505912|FG001|Overall Study|Disease progression|50|||
33440444|NCT00854308|101505911|FG000|Overall Study|Adverse Event|8|||
33440445|NCT00854308|101505912|FG001|Overall Study|Adverse Event|3|||
33158297|NCT00142298|100494001|FG003|Overall Study|Pregnancy|3|||
33440446|NCT00854308|101505911|FG000|Overall Study|Death|2|||
33440447|NCT00854308|101505912|FG001|Overall Study|Death|5|||
33440448|NCT00854308|101505911|FG000|Overall Study|Physician Decision|6|||
33440449|NCT00854308|101505912|FG001|Overall Study|Physician Decision|6|||
33440450|NCT00854308|101505911|FG000|Overall Study|Withdrawal by Subject|4|||
33440451|NCT00854308|101505912|FG001|Overall Study|Withdrawal by Subject|2|||
33440452|NCT00854308|101505911|FG000|Overall Study|Sponsor's decision to terminate study|0|||
33440453|NCT00854308|101505912|FG001|Overall Study|Sponsor's decision to terminate study|1|||
33440454|NCT02079766|101505913|FG000|Overall Study|Physician Decision|1|||
33440455|NCT02079766|101505914|FG001|Overall Study|Physician Decision|0|||
33440456|NCT02079766|101505913|FG000|Overall Study|Withdrawal by Subject|1|||
33440457|NCT02079766|101505914|FG001|Overall Study|Withdrawal by Subject|0|||
33440458|NCT03733925|101505915|FG000|Overall Study|Lost to Follow-up|1|||
33440459|NCT03733925|101505915|FG000|Overall Study|Withdrawal by Subject|2|||
33440460|NCT03733925|101505915|FG000|Overall Study|Adverse Event|2|||
33440461|NCT03733925|101505915|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33440462|NCT00440297|101505917|FG000|Overall Study|Adverse Event|8|||
33440463|NCT00440297|101505918|FG001|Overall Study|Adverse Event|5|||
33440464|NCT00440297|101505917|FG000|Overall Study|Lost to Follow-up|1|||
33440465|NCT00440297|101505918|FG001|Overall Study|Lost to Follow-up|0|||
33440466|NCT00440297|101505917|FG000|Overall Study|Physician Decision|1|||
33440467|NCT00440297|101505918|FG001|Overall Study|Physician Decision|0|||
33440468|NCT00440297|101505917|FG000|Overall Study|Protocol Violation|11|||
33440469|NCT00440297|101505918|FG001|Overall Study|Protocol Violation|7|||
33440470|NCT00440297|101505917|FG000|Overall Study|Withdrawal by Subject|1|||
33440471|NCT00440297|101505918|FG001|Overall Study|Withdrawal by Subject|6|||
33440472|NCT00440297|101505917|FG000|Overall Study|Randomized by mistake|1|||
33440473|NCT00440297|101505918|FG001|Overall Study|Randomized by mistake|0|||
33440474|NCT00686959|101505919|FG000|Overall Study|Participants censored (no death events)|124|||
33440475|NCT00686959|101505920|FG001|Overall Study|Participants censored (no death events)|117|||
33440476|NCT02719522|101505927|FG000|Overall Study|Implant Failure|4|||
33158298|NCT00142298|100494002|FG004|Overall Study|Pregnancy|0|||
33253975|NCT02694978|100830336|FG000|Overall Study|Other-Decision of Participant|6|||
33253976|NCT02694978|100830337|FG001|Overall Study|Other-Decision of Participant|1|||
33253977|NCT02694978|100830336|FG000|Overall Study|Other-Investigator's decision|1|||
33253978|NCT02694978|100830337|FG001|Overall Study|Other-Investigator's decision|0|||
33440477|NCT02719522|101505927|FG000|Overall Study|Death|2|||
33440478|NCT02719522|101505927|FG000|Overall Study|Lost to Follow-up|5|||
33440479|NCT02781727|101505931|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
33440480|NCT02781727|101505932|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
33440481|NCT02781727|101505931|FG000|Treatment Period|Withdrawal by Subject|1|||
33440482|NCT02781727|101505932|FG001|Treatment Period|Withdrawal by Subject|0|||
33440483|NCT02781727|101505931|FG000|Treatment Period|Lost to Follow-up|0|||
33440484|NCT02781727|101505932|FG001|Treatment Period|Lost to Follow-up|1|||
33440485|NCT02637232|101505933|FG000|Overall Study|Lost to Follow-up|42|||
33440486|NCT02637232|101505933|FG000|Overall Study|Adverse Event|11|||
33440487|NCT02637232|101505933|FG000|Overall Study|patient 's decision|2|||
33440488|NCT02441309|101505934|FG000|Overall Study|Disease progression|2|||
33440489|NCT02441309|101505935|FG001|Overall Study|Disease progression|1|||
33440490|NCT02441309|101505936|FG002|Overall Study|Disease progression|2|||
33440491|NCT02441309|101505934|FG000|Overall Study|Adverse Event|0|||
33440492|NCT02441309|101505935|FG001|Overall Study|Adverse Event|1|||
33440493|NCT02441309|101505936|FG002|Overall Study|Adverse Event|0|||
33440494|NCT02441309|101505934|FG000|Overall Study|Withdrawal by Subject|1|||
33440495|NCT02441309|101505935|FG001|Overall Study|Withdrawal by Subject|0|||
33440496|NCT02441309|101505936|FG002|Overall Study|Withdrawal by Subject|1|||
33440497|NCT03583606|101505937|FG000|Overall Study|Lost to Follow-up|0|||
33440498|NCT03583606|101505938|FG001|Overall Study|Lost to Follow-up|1|||
33440499|NCT03583606|101505939|FG002|Overall Study|Lost to Follow-up|0|||
33440500|NCT03583606|101505937|FG000|Overall Study|Ineligible at baseline|1|||
33440501|NCT03583606|101505938|FG001|Overall Study|Ineligible at baseline|0|||
33440502|NCT03583606|101505939|FG002|Overall Study|Ineligible at baseline|0|||
33440503|NCT01682083|101505940|FG000|Overall Study|Lost to Follow-up|11|||
33440504|NCT01682083|101505941|FG001|Overall Study|Lost to Follow-up|18|||
33440505|NCT01682083|101505940|FG000|Overall Study|Withdrawal by Subject|31|||
33440506|NCT01682083|101505941|FG001|Overall Study|Withdrawal by Subject|40|||
33440507|NCT01682083|101505940|FG000|Overall Study|Death|60|||
33440508|NCT01682083|101505941|FG001|Overall Study|Death|93|||
33440509|NCT01682083|101505940|FG000|Overall Study|Physician Decision|5|||
33253979|NCT02694978|100830336|FG000|Overall Study|Other-Unable to be reached|0|||
33440510|NCT01682083|101505941|FG001|Overall Study|Physician Decision|4|||
33440511|NCT02732210|101505942|FG000|Overall Study|Site Closed|0|||
33440512|NCT02732210|101505943|FG001|Overall Study|Site Closed|11|||
33440513|NCT02732210|101505942|FG000|Overall Study|Study Ended|13|||
33440514|NCT02732210|101505943|FG001|Overall Study|Study Ended|13|||
33440515|NCT02732210|101505942|FG000|Overall Study|Withdrawal by Subject|28|||
33440516|NCT02732210|101505943|FG001|Overall Study|Withdrawal by Subject|87|||
33440517|NCT02732210|101505942|FG000|Overall Study|Lost to Follow-up|5|||
33440518|NCT02732210|101505943|FG001|Overall Study|Lost to Follow-up|57|||
33440519|NCT02732210|101505942|FG000|Overall Study|Death|4|||
33440520|NCT02732210|101505943|FG001|Overall Study|Death|15|||
33440521|NCT02732210|101505942|FG000|Overall Study|Other|35|||
33440522|NCT02732210|101505943|FG001|Overall Study|Other|103|||
33440523|NCT02732210|101505942|FG000|Overall Study|Missing|0|||
33440524|NCT02732210|101505943|FG001|Overall Study|Missing|8|||
33440525|NCT02731157|101505946|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
33440526|NCT03629249|101505947|FG000|Overall Study|Study terminated by sponsor|197|||
33440527|NCT03629249|101505948|FG001|Overall Study|Study terminated by sponsor|197|||
33440528|NCT03629249|101505949|FG002|Overall Study|Study terminated by sponsor|194|||
33440529|NCT03629249|101505947|FG000|Overall Study|Protocol deviation|0|||
33440530|NCT03629249|101505948|FG001|Overall Study|Protocol deviation|2|||
33440531|NCT03629249|101505949|FG002|Overall Study|Protocol deviation|5|||
33440532|NCT03629249|101505947|FG000|Overall Study|Subject decision|1|||
33440533|NCT03629249|101505948|FG001|Overall Study|Subject decision|1|||
33440534|NCT03629249|101505949|FG002|Overall Study|Subject decision|3|||
33440535|NCT03629249|101505947|FG000|Overall Study|Adverse Event|1|||
33440536|NCT03629249|101505948|FG001|Overall Study|Adverse Event|1|||
33440537|NCT03629249|101505949|FG002|Overall Study|Adverse Event|0|||
33440538|NCT03629249|101505947|FG000|Overall Study|Death|1|||
33440539|NCT03629249|101505948|FG001|Overall Study|Death|0|||
33440540|NCT03629249|101505949|FG002|Overall Study|Death|0|||
33440541|NCT03629249|101505947|FG000|Overall Study|Physician Decision|1|||
33440542|NCT03629249|101505948|FG001|Overall Study|Physician Decision|0|||
33440543|NCT03629249|101505949|FG002|Overall Study|Physician Decision|0|||
33440544|NCT00056160|101505950|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
33440545|NCT00056160|101505951|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
33440546|NCT00056160|101505950|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
33440547|NCT00056160|101505951|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
33440548|NCT00056160|101505950|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
33440549|NCT00056160|101505951|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
33440550|NCT00056160|101505950|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
33440551|NCT00056160|101505951|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
33440552|NCT00056160|101505950|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
33440553|NCT00056160|101505951|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
33440554|NCT00056160|101505950|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
33440555|NCT00056160|101505951|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
33440556|NCT00056160|101505950|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
33440557|NCT00056160|101505951|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
33440558|NCT00056160|101505950|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
33440559|NCT00056160|101505951|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
33440560|NCT00056160|101505950|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
33440561|NCT00056160|101505951|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
33440562|NCT00056160|101505950|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
33440563|NCT00056160|101505951|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
33440564|NCT00056160|101505950|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
33440565|NCT00056160|101505951|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
33440566|NCT00056160|101505950|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
33440567|NCT00056160|101505951|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
33440568|NCT00056160|101505950|FG000|Final Follow-up|Transferred into expanded access study.|3|||
33440569|NCT00056160|101505951|FG001|Final Follow-up|Transferred into expanded access study.|0|||
33440570|NCT00056160|101505950|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
33440571|NCT00056160|101505951|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
33440572|NCT00056160|101505950|FG000|Final Follow-up|Adverse Event|1|||
33440573|NCT00056160|101505951|FG001|Final Follow-up|Adverse Event|0|||
33440574|NCT00855738|101505952|FG000|Overall Study|Lost to Follow-up|2|||
33440575|NCT00855738|101505952|FG000|Overall Study|Adverse Event|1|||
33440576|NCT00855738|101505952|FG000|Overall Study|Subject Defaulted|1|||
33440577|NCT00855738|101505952|FG000|Overall Study|Death|1|||
33440578|NCT03100903|101505957|FG000|Overall Study|Withdrawal by Subject|0|||
33440579|NCT03100903|101505958|FG001|Overall Study|Withdrawal by Subject|0|||
33440580|NCT03100903|101505959|FG002|Overall Study|Withdrawal by Subject|1|||
33440581|NCT04510285|101505965|FG000|Overall Study|Death|1|||
33440582|NCT02682602|101505966|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
33440583|NCT02682602|101505967|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
33440584|NCT02682602|101505966|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
33440585|NCT02682602|101505967|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
33440586|NCT03555305|101508977|FG000|Period 1|Physician Decision|0|||
33440587|NCT03555305|101508978|FG001|Period 1|Physician Decision|1|||
33440588|NCT03555305|101508977|FG000|Period 1|Adverse Event|0|||
33440589|NCT03555305|101508978|FG001|Period 1|Adverse Event|1|||
33440590|NCT01389102|101508984|FG000|Overall Study|Adverse Event|1|||
33440591|NCT01389102|101508985|FG001|Overall Study|Adverse Event|3|||
33440592|NCT01389102|101508986|FG002|Overall Study|Adverse Event|2|||
33440593|NCT01389102|101508987|FG003|Overall Study|Adverse Event|2|||
33440594|NCT01389102|101508988|FG004|Overall Study|Adverse Event|2|||
33440595|NCT01389102|101508989|FG005|Overall Study|Adverse Event|2|||
33440596|NCT01389102|101508984|FG000|Overall Study|Hurricane Katrina|4|||
33440597|NCT01389102|101508985|FG001|Overall Study|Hurricane Katrina|2|||
33440598|NCT01389102|101508986|FG002|Overall Study|Hurricane Katrina|3|||
33440599|NCT01389102|101508987|FG003|Overall Study|Hurricane Katrina|0|||
33440600|NCT01389102|101508988|FG004|Overall Study|Hurricane Katrina|3|||
33440601|NCT01389102|101508989|FG005|Overall Study|Hurricane Katrina|1|||
33440602|NCT01389102|101508984|FG000|Overall Study|Lost to Follow-up|4|||
33440603|NCT01389102|101508985|FG001|Overall Study|Lost to Follow-up|1|||
33440604|NCT01389102|101508986|FG002|Overall Study|Lost to Follow-up|1|||
33440605|NCT01389102|101508987|FG003|Overall Study|Lost to Follow-up|2|||
33440606|NCT01389102|101508988|FG004|Overall Study|Lost to Follow-up|4|||
33440607|NCT01389102|101508989|FG005|Overall Study|Lost to Follow-up|1|||
33440608|NCT01389102|101508984|FG000|Overall Study|Protocol Violation|0|||
33440609|NCT01389102|101508985|FG001|Overall Study|Protocol Violation|0|||
33440610|NCT01389102|101508986|FG002|Overall Study|Protocol Violation|3|||
33440611|NCT01389102|101508987|FG003|Overall Study|Protocol Violation|0|||
33440612|NCT01389102|101508988|FG004|Overall Study|Protocol Violation|1|||
33440613|NCT01389102|101508989|FG005|Overall Study|Protocol Violation|1|||
33440614|NCT01389102|101508984|FG000|Overall Study|Withdrawal by Subject|7|||
33440615|NCT01389102|101508985|FG001|Overall Study|Withdrawal by Subject|4|||
33440616|NCT01389102|101508986|FG002|Overall Study|Withdrawal by Subject|9|||
33440617|NCT01389102|101508987|FG003|Overall Study|Withdrawal by Subject|2|||
33440618|NCT01389102|101508988|FG004|Overall Study|Withdrawal by Subject|3|||
33440619|NCT01389102|101508989|FG005|Overall Study|Withdrawal by Subject|3|||
33440620|NCT01389102|101508984|FG000|Overall Study|Subject Traveling Out of Country|0|||
33440621|NCT01389102|101508985|FG001|Overall Study|Subject Traveling Out of Country|0|||
33440622|NCT01389102|101508986|FG002|Overall Study|Subject Traveling Out of Country|0|||
33440623|NCT01389102|101508987|FG003|Overall Study|Subject Traveling Out of Country|1|||
33440624|NCT01389102|101508988|FG004|Overall Study|Subject Traveling Out of Country|0|||
33440625|NCT01389102|101508989|FG005|Overall Study|Subject Traveling Out of Country|0|||
33440626|NCT01389102|101508984|FG000|Overall Study|Subject Moved|2|||
33440627|NCT01389102|101508985|FG001|Overall Study|Subject Moved|0|||
33440628|NCT01389102|101508986|FG002|Overall Study|Subject Moved|1|||
33440629|NCT01389102|101508987|FG003|Overall Study|Subject Moved|0|||
33440630|NCT01389102|101508988|FG004|Overall Study|Subject Moved|0|||
33440631|NCT01389102|101508989|FG005|Overall Study|Subject Moved|0|||
33440632|NCT01389102|101508984|FG000|Overall Study|Unavailable due to husband's illness|0|||
33440633|NCT01389102|101508985|FG001|Overall Study|Unavailable due to husband's illness|1|||
33440634|NCT01389102|101508986|FG002|Overall Study|Unavailable due to husband's illness|0|||
33440635|NCT01389102|101508987|FG003|Overall Study|Unavailable due to husband's illness|0|||
33440636|NCT01389102|101508988|FG004|Overall Study|Unavailable due to husband's illness|0|||
33440637|NCT01389102|101508989|FG005|Overall Study|Unavailable due to husband's illness|0|||
33440638|NCT01389102|101508984|FG000|Overall Study|Investigator Judgement|0|||
33253980|NCT02694978|100830337|FG001|Overall Study|Other-Unable to be reached|1|||
33253981|NCT02694978|100830336|FG000|Overall Study|Other-Protocol noncompliant|2|||
33253982|NCT02694978|100830337|FG001|Overall Study|Other-Protocol noncompliant|1|||
33253983|NCT02694978|100830336|FG000|Overall Study|Other-Personal reasons|3|||
33253984|NCT02694978|100830337|FG001|Overall Study|Other-Personal reasons|3|||
33253985|NCT02694978|100830336|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
33253986|NCT02694978|100830337|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
33253987|NCT01576484|100830338|FG000|Overall Study|Adverse Event|1|||
33253988|NCT01576484|100830339|FG001|Overall Study|Adverse Event|1|||
33253989|NCT01576484|100830338|FG000|Overall Study|Protocol Violation|0|||
33253990|NCT01576484|100830339|FG001|Overall Study|Protocol Violation|2|||
33253991|NCT01576484|100830338|FG000|Overall Study|Sponsor Decision|2|||
33253992|NCT01576484|100830339|FG001|Overall Study|Sponsor Decision|8|||
33253993|NCT01576484|100830338|FG000|Overall Study|Withdrawal by Subject|0|||
33253994|NCT01576484|100830339|FG001|Overall Study|Withdrawal by Subject|3|||
33253995|NCT01576484|100830338|FG000|Overall Study|Other|2|||
33253996|NCT01576484|100830339|FG001|Overall Study|Other|5|||
33253997|NCT00223795|100830345|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
33253998|NCT00223795|100830346|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
33253999|NCT00223795|100830345|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
33254000|NCT00223795|100830346|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
33254001|NCT00834834|100830347|FG000|Overall Study|Withdrawal by Subject|4|||
33254002|NCT00834834|100830348|FG001|Overall Study|Withdrawal by Subject|3|||
33254003|NCT00258895|100830349|FG000|Overall Study|Lost to Follow-up|3|||
33254004|NCT00258895|100830350|FG001|Overall Study|Lost to Follow-up|1|||
33254005|NCT00258895|100830349|FG000|Overall Study|Protocol Violation|6|||
33254006|NCT00258895|100830350|FG001|Overall Study|Protocol Violation|2|||
33254007|NCT00258895|100830349|FG000|Overall Study|Withdrawal by Subject|1|||
33254008|NCT00258895|100830350|FG001|Overall Study|Withdrawal by Subject|0|||
33254009|NCT01281813|100830351|FG000|Overall Study|Adverse Event|0|||
33254010|NCT01281813|100830352|FG001|Overall Study|Adverse Event|0|||
33254011|NCT01281813|100830353|FG002|Overall Study|Adverse Event|10|||
33254012|NCT01281813|100830351|FG000|Overall Study|Lost to Follow-up|0|||
33254013|NCT01281813|100830352|FG001|Overall Study|Lost to Follow-up|0|||
33254014|NCT01281813|100830353|FG002|Overall Study|Lost to Follow-up|31|||
33440639|NCT01389102|101508985|FG001|Overall Study|Investigator Judgement|1|||
33440640|NCT01389102|101508986|FG002|Overall Study|Investigator Judgement|0|||
33440641|NCT01389102|101508987|FG003|Overall Study|Investigator Judgement|0|||
33440642|NCT01389102|101508988|FG004|Overall Study|Investigator Judgement|0|||
33440643|NCT01389102|101508989|FG005|Overall Study|Investigator Judgement|0|||
33440644|NCT04657770|101508990|FG000|Overall Study|Withdrawal by Subject|3|||
33440645|NCT04657770|101508990|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
33440646|NCT00397488|101508991|FG000|Overall Study|Withdrawal by Subject|3|||
33440647|NCT00397488|101508991|FG000|Overall Study|Adverse Event|3|||
33440648|NCT00397488|101508991|FG000|Overall Study|Death|1|||
33440649|NCT03206177|101508993|FG000|Overall Study|Withdrawal by Subject|1|||
33440650|NCT03952143|101508994|FG000|Lead-In Period|Adverse Event|2|||
33440651|NCT03952143|101508995|FG001|Lead-In Period|Adverse Event|0|||
33440652|NCT03952143|101508996|FG002|Lead-In Period|Adverse Event|0|||
33440653|NCT03952143|101508994|FG000|Lead-In Period|Lack of Efficacy|2|||
33440654|NCT03952143|101508995|FG001|Lead-In Period|Lack of Efficacy|0|||
33440655|NCT03952143|101508996|FG002|Lead-In Period|Lack of Efficacy|0|||
33440656|NCT03952143|101508994|FG000|Lead-In Period|Physician Decision|5|||
33440657|NCT03952143|101508995|FG001|Lead-In Period|Physician Decision|0|||
33440658|NCT03952143|101508996|FG002|Lead-In Period|Physician Decision|0|||
33440659|NCT03952143|101508994|FG000|Lead-In Period|Protocol Violation|5|||
33440660|NCT03952143|101508995|FG001|Lead-In Period|Protocol Violation|0|||
33440661|NCT03952143|101508996|FG002|Lead-In Period|Protocol Violation|0|||
33440662|NCT03952143|101508994|FG000|Lead-In Period|Withdrawal by Subject|19|||
33254015|NCT01281813|100830351|FG000|Overall Study|Withdrawal by Subject|0|||
33254016|NCT01281813|100830352|FG001|Overall Study|Withdrawal by Subject|0|||
33254017|NCT01281813|100830353|FG002|Overall Study|Withdrawal by Subject|13|||
33254018|NCT01281813|100830351|FG000|Overall Study|Subject Non-Compliant|0|||
33254019|NCT01281813|100830352|FG001|Overall Study|Subject Non-Compliant|0|||
33254020|NCT01281813|100830353|FG002|Overall Study|Subject Non-Compliant|6|||
33440663|NCT03952143|101508995|FG001|Lead-In Period|Withdrawal by Subject|0|||
33440664|NCT03952143|101508996|FG002|Lead-In Period|Withdrawal by Subject|0|||
33440665|NCT03952143|101508994|FG000|Treatment Period|Adverse Event|0|||
33440666|NCT03952143|101508995|FG001|Treatment Period|Adverse Event|0|||
33440667|NCT03952143|101508996|FG002|Treatment Period|Adverse Event|1|||
33440668|NCT03952143|101508994|FG000|Treatment Period|Lost to Follow-up|0|||
33440669|NCT03952143|101508995|FG001|Treatment Period|Lost to Follow-up|2|||
33440670|NCT03952143|101508996|FG002|Treatment Period|Lost to Follow-up|0|||
33440671|NCT03952143|101508994|FG000|Treatment Period|Physician Decision|0|||
33440672|NCT03952143|101508995|FG001|Treatment Period|Physician Decision|0|||
33440673|NCT03952143|101508996|FG002|Treatment Period|Physician Decision|2|||
33440674|NCT03952143|101508994|FG000|Treatment Period|Protocol Violation|0|||
33440675|NCT03952143|101508995|FG001|Treatment Period|Protocol Violation|0|||
33254021|NCT01281813|100830351|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
33440676|NCT03952143|101508996|FG002|Treatment Period|Protocol Violation|1|||
33440677|NCT03952143|101508994|FG000|Treatment Period|Withdrawal by Subject|0|||
33254022|NCT01281813|100830352|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
33254023|NCT01281813|100830353|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
33254024|NCT01281813|100830351|FG000|Overall Study|Sponsor's Decision|4|||
33254025|NCT01281813|100830352|FG001|Overall Study|Sponsor's Decision|3|||
33254026|NCT01281813|100830353|FG002|Overall Study|Sponsor's Decision|7|||
33254027|NCT01281813|100830351|FG000|Overall Study|Switched to Commercially Available Medication|0|||
33254028|NCT01281813|100830352|FG001|Overall Study|Switched to Commercially Available Medication|0|||
33254029|NCT01281813|100830353|FG002|Overall Study|Switched to Commercially Available Medication|26|||
33254030|NCT01281813|100830351|FG000|Overall Study|Other|0|||
33254031|NCT01281813|100830352|FG001|Overall Study|Other|1|||
33254032|NCT01281813|100830353|FG002|Overall Study|Other|39|||
33254033|NCT00658996|100830357|FG000|First Intervention|Positive slit lamp finding|1|||
33440678|NCT03952143|101508995|FG001|Treatment Period|Withdrawal by Subject|5|||
33440679|NCT03952143|101508996|FG002|Treatment Period|Withdrawal by Subject|26|||
33254034|NCT00658996|100830358|FG001|First Intervention|Positive slit lamp finding|0|||
33254035|NCT00658996|100830357|FG000|First Intervention|Lack of lenses|0|||
33254036|NCT00658996|100830358|FG001|First Intervention|Lack of lenses|1|||
33254037|NCT00658996|100830357|FG000|Crossover Period|Physician Decision|1|||
33254038|NCT00658996|100830358|FG001|Crossover Period|Physician Decision|0|||
33440680|NCT03952143|101508994|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
33440681|NCT03952143|101508995|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
33440682|NCT03952143|101508996|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
33440683|NCT03952143|101508994|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
33440684|NCT03952143|101508995|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
33440685|NCT03952143|101508996|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
33440686|NCT01544127|101508997|FG000|Overall Study|Lost to Follow-up|4|||
33440687|NCT01544127|101508998|FG001|Overall Study|Lost to Follow-up|2|||
33440688|NCT01544127|101508999|FG002|Overall Study|Lost to Follow-up|9|||
33440689|NCT01544127|101508997|FG000|Overall Study|Withdrawal by Subject|2|||
33440690|NCT01544127|101508998|FG001|Overall Study|Withdrawal by Subject|2|||
33440691|NCT01544127|101508999|FG002|Overall Study|Withdrawal by Subject|1|||
33440692|NCT01544127|101508997|FG000|Overall Study|Discharged out of catchment area|1|||
33440693|NCT01544127|101508998|FG001|Overall Study|Discharged out of catchment area|1|||
33440694|NCT01544127|101508999|FG002|Overall Study|Discharged out of catchment area|1|||
33440695|NCT01544127|101508997|FG000|Overall Study|Death|1|||
33440696|NCT01544127|101508998|FG001|Overall Study|Death|0|||
33440697|NCT01544127|101508999|FG002|Overall Study|Death|0|||
33440698|NCT01544127|101508997|FG000|Overall Study|Jail or Prison|1|||
33440699|NCT01544127|101508998|FG001|Overall Study|Jail or Prison|1|||
33440700|NCT01544127|101508999|FG002|Overall Study|Jail or Prison|2|||
33440701|NCT01544127|101508997|FG000|Overall Study|Became Psychotic|1|||
33440702|NCT01544127|101508998|FG001|Overall Study|Became Psychotic|0|||
33440703|NCT01544127|101508999|FG002|Overall Study|Became Psychotic|0|||
33440704|NCT01544127|101508997|FG000|Overall Study|Researcher withdrew|1|||
33440705|NCT01544127|101508998|FG001|Overall Study|Researcher withdrew|0|||
33440706|NCT01544127|101508999|FG002|Overall Study|Researcher withdrew|0|||
33440707|NCT01544127|101508997|FG000|Overall Study|Went active duty|0|||
33440708|NCT01544127|101508998|FG001|Overall Study|Went active duty|0|||
33440709|NCT01544127|101508999|FG002|Overall Study|Went active duty|1|||
33440710|NCT04786184|101509000|FG000|Overall Study|Adverse Event|4|||
33440711|NCT04786184|101509001|FG001|Overall Study|Adverse Event|0|||
33440712|NCT04786184|101509000|FG000|Overall Study|Withdrawal by Subject|3|||
33440713|NCT04786184|101509001|FG001|Overall Study|Withdrawal by Subject|1|||
33440714|NCT04786184|101509000|FG000|Overall Study|Lost to Follow-up|4|||
33440715|NCT04786184|101509001|FG001|Overall Study|Lost to Follow-up|2|||
33440716|NCT03785548|101509002|FG000|Overall Study|age > 80|1|||
33440717|NCT03785548|101509003|FG001|Overall Study|age > 80|0|||
33440718|NCT03785548|101509002|FG000|Overall Study|no Postop queries|1|||
33440719|NCT03785548|101509003|FG001|Overall Study|no Postop queries|0|||
33440720|NCT00874237|101509009|FG000|Overall Study|Physician Decision|0|||
33440721|NCT00874237|101509010|FG001|Overall Study|Physician Decision|1|||
33440722|NCT00874237|101509011|FG002|Overall Study|Physician Decision|0|||
33440723|NCT00874237|101509012|FG003|Overall Study|Physician Decision|0|||
33440724|NCT00874237|101509013|FG004|Overall Study|Physician Decision|0|||
33440725|NCT00874237|101509014|FG005|Overall Study|Physician Decision|0|||
33440726|NCT00874237|101509009|FG000|Overall Study|Withdrawal by Subject|0|||
33440727|NCT00874237|101509010|FG001|Overall Study|Withdrawal by Subject|0|||
33440728|NCT00874237|101509011|FG002|Overall Study|Withdrawal by Subject|1|||
33440729|NCT00874237|101509012|FG003|Overall Study|Withdrawal by Subject|0|||
33440730|NCT00874237|101509013|FG004|Overall Study|Withdrawal by Subject|0|||
33440731|NCT00874237|101509014|FG005|Overall Study|Withdrawal by Subject|0|||
33440732|NCT00819741|101509018|FG000|Overall Study|Adverse Event|5|||
33440733|NCT00819741|101509019|FG001|Overall Study|Adverse Event|2|||
33440734|NCT00819741|101509018|FG000|Overall Study|Lack of Efficacy|0|||
33440735|NCT00819741|101509019|FG001|Overall Study|Lack of Efficacy|2|||
33440736|NCT00819741|101509018|FG000|Overall Study|Lost to Follow-up|3|||
33440737|NCT00819741|101509019|FG001|Overall Study|Lost to Follow-up|1|||
33440738|NCT00819741|101509018|FG000|Overall Study|Protocol Violation|3|||
33440739|NCT00819741|101509019|FG001|Overall Study|Protocol Violation|4|||
33440740|NCT00819741|101509018|FG000|Overall Study|Withdrawal by Subject|2|||
33440741|NCT00819741|101509019|FG001|Overall Study|Withdrawal by Subject|2|||
33440742|NCT00819741|101509018|FG000|Overall Study|Unclassified|6|||
33440743|NCT00819741|101509019|FG001|Overall Study|Unclassified|0|||
33440744|NCT00819741|101509018|FG000|Overall Study|Reasons unknown|3|||
33440745|NCT00819741|101509019|FG001|Overall Study|Reasons unknown|3|||
33440746|NCT00814463|101509021|FG000|Overall Study|Lost to Follow-up|1|||
33440747|NCT01085045|101509022|FG000|Part A|Withdrawal by Subject|4|||
33440748|NCT01085045|101509022|FG000|Part A|Adverse Event|6|||
33440749|NCT01085045|101509022|FG000|Part A|Protocol Violation|1|||
33440750|NCT01085045|101509022|FG000|Part A|Protocol Specified Criteria|7|||
33440751|NCT01085045|101509022|FG000|Part B|Withdrawal by Subject|2|||
33440752|NCT01085045|101509022|FG000|Part B|Protocol Specified Criteria|6|||
33440753|NCT01085045|101509022|FG000|Part B|Lost to Follow-up|1|||
33440754|NCT01085045|101509022|FG000|Part B|Adverse Event|6|||
33440755|NCT02648347|101509024|FG000|Overall Study|Death|174|||
33440756|NCT02648347|101509025|FG001|Overall Study|Death|167|||
33440757|NCT02648347|101509024|FG000|Overall Study|Withdrawal by Subject|16|||
33440758|NCT02648347|101509025|FG001|Overall Study|Withdrawal by Subject|9|||
33440759|NCT02648347|101509024|FG000|Overall Study|Lost to Follow-up|18|||
33440760|NCT02648347|101509025|FG001|Overall Study|Lost to Follow-up|21|||
33440761|NCT02648347|101509024|FG000|Overall Study|Missing|1|||
33440762|NCT02648347|101509025|FG001|Overall Study|Missing|0|||
33440763|NCT03966365|101509026|FG000|Overall Study|Protocol Violation|1|||
33440764|NCT03966365|101509027|FG001|Overall Study|Protocol Violation|0|||
33440765|NCT02932878|101509031|FG000|Overall Study|Due to Lab Results|2|||
33440766|NCT02932878|101509032|FG001|Overall Study|Due to Lab Results|1|||
33440767|NCT03616106|101509033|FG000|Overall Study|Removed by PI|6|||
33440768|NCT03616106|101509034|FG001|Overall Study|Removed by PI|0|||
33440769|NCT03616106|101509033|FG000|Overall Study|Withdrawal by Subject|1|||
33440770|NCT03616106|101509034|FG001|Overall Study|Withdrawal by Subject|1|||
33440771|NCT03616106|101509033|FG000|Overall Study|Lost to Follow-up|7|||
33440772|NCT03616106|101509034|FG001|Overall Study|Lost to Follow-up|0|||
33440773|NCT01390844|101509035|FG000|Treatment Phase|Adverse Event|12|||
33440774|NCT01390844|101509036|FG001|Treatment Phase|Adverse Event|2|||
33440775|NCT01390844|101509037|FG002|Treatment Phase|Adverse Event|3|||
33440776|NCT01390844|101509038|FG003|Treatment Phase|Adverse Event|2|||
33440777|NCT01390844|101509035|FG000|Treatment Phase|Treatment Failure|23|||
33440778|NCT01390844|101509036|FG001|Treatment Phase|Treatment Failure|25|||
33440779|NCT01390844|101509037|FG002|Treatment Phase|Treatment Failure|10|||
33440780|NCT01390844|101509038|FG003|Treatment Phase|Treatment Failure|13|||
33440781|NCT01390844|101509035|FG000|Treatment Phase|Non-Medical Reasons|5|||
33440782|NCT01390844|101509036|FG001|Treatment Phase|Non-Medical Reasons|1|||
33440783|NCT01390844|101509037|FG002|Treatment Phase|Non-Medical Reasons|8|||
33440784|NCT01390844|101509038|FG003|Treatment Phase|Non-Medical Reasons|1|||
33440785|NCT01390844|101509035|FG000|Treatment Phase|Non-GCP Compliant|0|||
33440786|NCT01390844|101509036|FG001|Treatment Phase|Non-GCP Compliant|0|||
33440787|NCT01390844|101509037|FG002|Treatment Phase|Non-GCP Compliant|10|||
33440788|NCT01390844|101509038|FG003|Treatment Phase|Non-GCP Compliant|3|||
33440789|NCT01390844|101509035|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
33440790|NCT01390844|101509036|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
33440791|NCT01390844|101509037|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
33440792|NCT01390844|101509038|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
33440793|NCT00336479|101509039|FG000|Overall Study|Adverse Event|8|||
33440794|NCT00336479|101509040|FG001|Overall Study|Adverse Event|11|||
33440795|NCT00336479|101509041|FG002|Overall Study|Adverse Event|18|||
33440796|NCT00336479|101509042|FG003|Overall Study|Adverse Event|4|||
33440797|NCT00336479|101509039|FG000|Overall Study|Noncompliant|1|||
33440798|NCT00336479|101509040|FG001|Overall Study|Noncompliant|7|||
33440799|NCT00336479|101509041|FG002|Overall Study|Noncompliant|3|||
33440800|NCT00336479|101509042|FG003|Overall Study|Noncompliant|0|||
33440801|NCT00336479|101509039|FG000|Overall Study|Physician Decision|2|||
33440802|NCT00336479|101509040|FG001|Overall Study|Physician Decision|3|||
33440803|NCT00336479|101509041|FG002|Overall Study|Physician Decision|1|||
33440804|NCT00336479|101509042|FG003|Overall Study|Physician Decision|0|||
33440805|NCT00336479|101509039|FG000|Overall Study|Lost to Follow-up|3|||
33440806|NCT00336479|101509040|FG001|Overall Study|Lost to Follow-up|2|||
33440807|NCT00336479|101509041|FG002|Overall Study|Lost to Follow-up|0|||
33440808|NCT00336479|101509042|FG003|Overall Study|Lost to Follow-up|0|||
33440809|NCT00336479|101509039|FG000|Overall Study|Withdrawal by Subject|3|||
33440810|NCT00336479|101509040|FG001|Overall Study|Withdrawal by Subject|2|||
33440811|NCT00336479|101509041|FG002|Overall Study|Withdrawal by Subject|3|||
33440812|NCT00336479|101509042|FG003|Overall Study|Withdrawal by Subject|0|||
33440813|NCT00336479|101509039|FG000|Overall Study|Other|0|||
33440814|NCT00336479|101509040|FG001|Overall Study|Other|0|||
33440815|NCT00336479|101509041|FG002|Overall Study|Other|1|||
33440816|NCT00336479|101509042|FG003|Overall Study|Other|0|||
33440817|NCT00336479|101509039|FG000|Overall Study|Virologic Stopping Rule|20|||
33440818|NCT00336479|101509040|FG001|Overall Study|Virologic Stopping Rule|0|||
33440819|NCT00336479|101509041|FG002|Overall Study|Virologic Stopping Rule|0|||
33440820|NCT00336479|101509042|FG003|Overall Study|Virologic Stopping Rule|0|||
33440821|NCT02726581|101509045|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
33440822|NCT02726581|101509046|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
33440823|NCT02726581|101509047|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
33440824|NCT02726581|101509045|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
33440825|NCT02726581|101509046|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
33440826|NCT02726581|101509047|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
33440827|NCT02726581|101509045|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
33440828|NCT02726581|101509046|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33440829|NCT02726581|101509047|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33440830|NCT02726581|101509045|FG000|Treatment Period|Disease progression|47|||
33440831|NCT02726581|101509046|FG001|Treatment Period|Disease progression|50|||
33440832|NCT02726581|101509047|FG002|Treatment Period|Disease progression|16|||
33440833|NCT02726581|101509045|FG000|Treatment Period|Other reasons|9|||
33440834|NCT02726581|101509046|FG001|Treatment Period|Other reasons|8|||
33440835|NCT02726581|101509047|FG002|Treatment Period|Other reasons|2|||
33440836|NCT02726581|101509045|FG000|Treatment Period|Study drug toxicity|6|||
33440837|NCT02726581|101509046|FG001|Treatment Period|Study drug toxicity|3|||
33440838|NCT02726581|101509047|FG002|Treatment Period|Study drug toxicity|2|||
33440839|NCT02726581|101509045|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
33158299|NCT00142298|100494003|FG005|Overall Study|Pregnancy|0|||
33158300|NCT00142298|100494004|FG006|Overall Study|Pregnancy|0|||
33158301|NCT00142298|100494005|FG007|Overall Study|Pregnancy|0|||
33158302|NCT00142298|100494006|FG008|Overall Study|Pregnancy|1|||
33158303|NCT00142298|100494007|FG009|Overall Study|Pregnancy|0|||
33158304|NCT00142298|100493998|FG000|Overall Study|Virologic breakthrough|19|||
33158305|NCT00142298|100493999|FG001|Overall Study|Virologic breakthrough|23|||
33158306|NCT00142298|100494000|FG002|Overall Study|Virologic breakthrough|9|||
33158307|NCT00142298|100494001|FG003|Overall Study|Virologic breakthrough|7|||
33440840|NCT02726581|101509046|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
33440841|NCT02726581|101509047|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
33440842|NCT02726581|101509045|FG000|Treatment Period|Participant withdrew consent|3|||
33440843|NCT02726581|101509046|FG001|Treatment Period|Participant withdrew consent|1|||
33440844|NCT02726581|101509047|FG002|Treatment Period|Participant withdrew consent|1|||
33158308|NCT00142298|100494002|FG004|Overall Study|Virologic breakthrough|2|||
33158309|NCT00142298|100494003|FG005|Overall Study|Virologic breakthrough|3|||
33158310|NCT00142298|100494004|FG006|Overall Study|Virologic breakthrough|3|||
33254039|NCT00658996|100830357|FG000|Crossover Period|Ineligible|1|||
33440845|NCT02726581|101509045|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
33440846|NCT02726581|101509046|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
33440847|NCT02726581|101509047|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
33440848|NCT02726581|101509045|FG000|Treatment Period|Maximum clinical benefit|0|||
33440849|NCT02726581|101509046|FG001|Treatment Period|Maximum clinical benefit|2|||
33440850|NCT02726581|101509047|FG002|Treatment Period|Maximum clinical benefit|0|||
33440851|NCT02726581|101509045|FG000|Treatment Period|Death|1|||
33440852|NCT02726581|101509046|FG001|Treatment Period|Death|0|||
33440853|NCT02726581|101509047|FG002|Treatment Period|Death|0|||
33440854|NCT02726581|101509045|FG000|Treatment Period|Poor/non-compliance|1|||
33440855|NCT02726581|101509046|FG001|Treatment Period|Poor/non-compliance|0|||
33440856|NCT02726581|101509047|FG002|Treatment Period|Poor/non-compliance|0|||
33440857|NCT02726581|101509045|FG000|Treatment Period|Participant no longer meets study criteria|0|||
33440858|NCT02726581|101509046|FG001|Treatment Period|Participant no longer meets study criteria|1|||
33440859|NCT02726581|101509047|FG002|Treatment Period|Participant no longer meets study criteria|0|||
33440860|NCT02472366|101509048|FG000|Overall Study|Lost to Follow-up|1|||
33440861|NCT02472366|101509049|FG001|Overall Study|Lost to Follow-up|0|||
33440862|NCT02131129|101509052|FG000|Overall Study|Withdrawal by Subject|1|||
33440863|NCT02131129|101509053|FG001|Overall Study|Withdrawal by Subject|0|||
33440864|NCT05067647|101509054|FG000|Overall Study|Lost to Follow-up|1|||
33440865|NCT02457520|101509055|FG000|Active Treatment Phase|Adverse Event|10|||
33440866|NCT02457520|101509055|FG000|Active Treatment Phase|Lost to Follow-up|8|||
33440867|NCT02457520|101509055|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
33440868|NCT02457520|101509055|FG000|Active Treatment Phase|other|4|||
33440869|NCT02457520|101509055|FG000|Active Treatment Phase|Physician Decision|1|||
33440870|NCT02457520|101509055|FG000|Active Treatment Phase|Protocol Violation|1|||
33440871|NCT02457520|101509055|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
33440872|NCT02457520|101509055|FG000|Post-treatment Period|Other: Retreatment Required|7|||
33440873|NCT02457520|101509055|FG000|Post-treatment Period|Lost to Follow-up|23|||
33440874|NCT02457520|101509055|FG000|Post-treatment Period|Other|3|||
33440875|NCT02457520|101509055|FG000|Post-treatment Period|Physician Decision|1|||
33440876|NCT02457520|101509055|FG000|Post-treatment Period|Withdrawal by Subject|14|||
33440877|NCT02612337|101509056|FG000|Overall Study|Lack of Efficacy|1|||
33158311|NCT00142298|100494005|FG007|Overall Study|Virologic breakthrough|0|||
33158312|NCT00142298|100494006|FG008|Overall Study|Virologic breakthrough|0|||
33158313|NCT00142298|100494007|FG009|Overall Study|Virologic breakthrough|0|||
33158314|NCT00142298|100493998|FG000|Overall Study|Other- not specified|0|||
33158315|NCT00142298|100493999|FG001|Overall Study|Other- not specified|3|||
33158316|NCT00142298|100494000|FG002|Overall Study|Other- not specified|0|||
33158317|NCT00142298|100494001|FG003|Overall Study|Other- not specified|1|||
33158318|NCT00142298|100494002|FG004|Overall Study|Other- not specified|0|||
33158319|NCT00142298|100494003|FG005|Overall Study|Other- not specified|0|||
33158320|NCT00142298|100494004|FG006|Overall Study|Other- not specified|0|||
33158321|NCT00142298|100494005|FG007|Overall Study|Other- not specified|0|||
33158322|NCT00142298|100494006|FG008|Overall Study|Other- not specified|0|||
33158323|NCT00142298|100494007|FG009|Overall Study|Other- not specified|0|||
33440878|NCT02612337|101509057|FG001|Overall Study|Lack of Efficacy|0|||
33440879|NCT02612337|101509056|FG000|Overall Study|Withdrawal by Subject|2|||
33440880|NCT02612337|101509057|FG001|Overall Study|Withdrawal by Subject|2|||
33440881|NCT02612337|101509056|FG000|Overall Study|Did not receive study drug|0|||
33440882|NCT02612337|101509057|FG001|Overall Study|Did not receive study drug|1|||
33440883|NCT01370408|101509065|FG000|Overall Study|treatment failure|9|||
33440884|NCT04274686|101509066|FG000|Overall Study|Physician Decision|1|||
33440885|NCT04274686|101509067|FG001|Overall Study|Physician Decision|0|||
33440886|NCT02468778|101509074|FG000|Overall Study|Death|2|||
33440887|NCT02468778|101509075|FG001|Overall Study|Death|1|||
33440888|NCT02468778|101509076|FG002|Overall Study|Death|0|||
33440889|NCT02468778|101509074|FG000|Overall Study|Lost to Follow-up|1|||
33440890|NCT02468778|101509075|FG001|Overall Study|Lost to Follow-up|2|||
33440891|NCT02468778|101509076|FG002|Overall Study|Lost to Follow-up|2|||
33440892|NCT02468778|101509074|FG000|Overall Study|Withdrawal by Subject|0|||
33440893|NCT02468778|101509075|FG001|Overall Study|Withdrawal by Subject|1|||
33440894|NCT02468778|101509076|FG002|Overall Study|Withdrawal by Subject|1|||
33440895|NCT02883452|101509079|FG000|Overall Study|Withdrawal by Subject|1|||
33440896|NCT02883452|101509080|FG001|Overall Study|Withdrawal by Subject|1|||
33440897|NCT02883452|101509081|FG002|Overall Study|Withdrawal by Subject|3|||
33440898|NCT02883452|101509082|FG003|Overall Study|Withdrawal by Subject|0|||
33440899|NCT02883452|101509083|FG004|Overall Study|Withdrawal by Subject|2|||
33440900|NCT02883452|101509084|FG005|Overall Study|Withdrawal by Subject|5|||
33440901|NCT02883452|101509079|FG000|Overall Study|Disease progression|1|||
33440902|NCT02883452|101509080|FG001|Overall Study|Disease progression|0|||
33440903|NCT02883452|101509081|FG002|Overall Study|Disease progression|0|||
33440904|NCT02883452|101509082|FG003|Overall Study|Disease progression|1|||
33440905|NCT02883452|101509083|FG004|Overall Study|Disease progression|4|||
33440906|NCT02883452|101509084|FG005|Overall Study|Disease progression|5|||
33440907|NCT02883452|101509079|FG000|Overall Study|Adverse Event|2|||
33158324|NCT00142298|100493998|FG000|Overall Study|Lost to Follow-up|0|||
33158325|NCT00142298|100493999|FG001|Overall Study|Lost to Follow-up|0|||
33158326|NCT00142298|100494000|FG002|Overall Study|Lost to Follow-up|0|||
33158327|NCT00142298|100494001|FG003|Overall Study|Lost to Follow-up|0|||
33158328|NCT00142298|100494002|FG004|Overall Study|Lost to Follow-up|0|||
33440908|NCT02883452|101509080|FG001|Overall Study|Adverse Event|1|||
33440909|NCT02883452|101509081|FG002|Overall Study|Adverse Event|1|||
33440910|NCT02883452|101509082|FG003|Overall Study|Adverse Event|1|||
33440911|NCT02883452|101509083|FG004|Overall Study|Adverse Event|1|||
33440912|NCT02883452|101509084|FG005|Overall Study|Adverse Event|3|||
33158329|NCT00142298|100494003|FG005|Overall Study|Lost to Follow-up|0|||
33158330|NCT00142298|100494004|FG006|Overall Study|Lost to Follow-up|2|||
33158331|NCT00142298|100494005|FG007|Overall Study|Lost to Follow-up|0|||
33158332|NCT00142298|100494006|FG008|Overall Study|Lost to Follow-up|0|||
33158333|NCT00142298|100494007|FG009|Overall Study|Lost to Follow-up|0|||
33158334|NCT00142298|100493998|FG000|Overall Study|Treatment Failure|0|||
33158335|NCT00142298|100493999|FG001|Overall Study|Treatment Failure|0|||
33158336|NCT00142298|100494000|FG002|Overall Study|Treatment Failure|0|||
33158337|NCT00142298|100494001|FG003|Overall Study|Treatment Failure|0|||
33158338|NCT00142298|100494002|FG004|Overall Study|Treatment Failure|0|||
33158339|NCT00142298|100494003|FG005|Overall Study|Treatment Failure|2|||
33158340|NCT00142298|100494004|FG006|Overall Study|Treatment Failure|2|||
33158341|NCT00142298|100494005|FG007|Overall Study|Treatment Failure|0|||
33158342|NCT00142298|100494006|FG008|Overall Study|Treatment Failure|0|||
33158343|NCT00142298|100494007|FG009|Overall Study|Treatment Failure|0|||
33158344|NCT02404220|100494008|FG000|Overall Study|Adverse Event|0|||
33158345|NCT02404220|100494009|FG001|Overall Study|Adverse Event|0|||
33158346|NCT02404220|100494010|FG002|Overall Study|Adverse Event|1|||
33440913|NCT02883452|101509079|FG000|Overall Study|Physician Decision|0|||
33440914|NCT02883452|101509080|FG001|Overall Study|Physician Decision|0|||
33440915|NCT02883452|101509081|FG002|Overall Study|Physician Decision|0|||
33440916|NCT02883452|101509082|FG003|Overall Study|Physician Decision|0|||
33440917|NCT02883452|101509083|FG004|Overall Study|Physician Decision|4|||
33158347|NCT02404220|100494011|FG003|Overall Study|Adverse Event|0|||
33158348|NCT02404220|100494008|FG000|Overall Study|Death|5|||
33158349|NCT02404220|100494009|FG001|Overall Study|Death|5|||
33158350|NCT02404220|100494010|FG002|Overall Study|Death|3|||
33158351|NCT02404220|100494011|FG003|Overall Study|Death|8|||
33158352|NCT02404220|100494008|FG000|Overall Study|Progressive Disease|0|||
33158353|NCT02404220|100494009|FG001|Overall Study|Progressive Disease|0|||
33158354|NCT02404220|100494010|FG002|Overall Study|Progressive Disease|1|||
33158355|NCT02404220|100494011|FG003|Overall Study|Progressive Disease|1|||
33158356|NCT02404220|100494008|FG000|Overall Study|Study Terminated by Sponsor|0|||
33158357|NCT02404220|100494009|FG001|Overall Study|Study Terminated by Sponsor|0|||
33158358|NCT02404220|100494010|FG002|Overall Study|Study Terminated by Sponsor|2|||
33158359|NCT02404220|100494011|FG003|Overall Study|Study Terminated by Sponsor|1|||
33158360|NCT02404220|100494008|FG000|Overall Study|Withdrawal by Subject|0|||
33158361|NCT02404220|100494009|FG001|Overall Study|Withdrawal by Subject|1|||
33158362|NCT02404220|100494010|FG002|Overall Study|Withdrawal by Subject|0|||
33158363|NCT02404220|100494011|FG003|Overall Study|Withdrawal by Subject|0|||
33158364|NCT02404220|100494008|FG000|Overall Study|Enrolled but Never Treated|0|||
33158365|NCT02404220|100494009|FG001|Overall Study|Enrolled but Never Treated|2|||
33158366|NCT02404220|100494010|FG002|Overall Study|Enrolled but Never Treated|0|||
33158367|NCT02404220|100494011|FG003|Overall Study|Enrolled but Never Treated|0|||
33158368|NCT02038881|100494012|FG000|Overall Study|Withdrawal by Subject|0|||
33158369|NCT02038881|100494013|FG001|Overall Study|Withdrawal by Subject|0|||
33158370|NCT02038881|100494014|FG002|Overall Study|Withdrawal by Subject|1|||
33158371|NCT02038881|100494012|FG000|Overall Study|Lost to Follow-up|2|||
33158372|NCT02038881|100494013|FG001|Overall Study|Lost to Follow-up|0|||
33158373|NCT02038881|100494014|FG002|Overall Study|Lost to Follow-up|0|||
33158374|NCT02038881|100494012|FG000|Overall Study|incarcerated|1|||
33158375|NCT02038881|100494013|FG001|Overall Study|incarcerated|0|||
33440918|NCT02883452|101509084|FG005|Overall Study|Physician Decision|1|||
33440919|NCT02883452|101509079|FG000|Overall Study|Death|1|||
33440920|NCT02883452|101509080|FG001|Overall Study|Death|0|||
33440921|NCT02883452|101509081|FG002|Overall Study|Death|1|||
33440922|NCT02883452|101509082|FG003|Overall Study|Death|0|||
33440923|NCT02883452|101509083|FG004|Overall Study|Death|0|||
33440924|NCT02883452|101509084|FG005|Overall Study|Death|0|||
33440925|NCT02883452|101509079|FG000|Overall Study|Other|0|||
33440926|NCT02883452|101509080|FG001|Overall Study|Other|0|||
33440927|NCT02883452|101509081|FG002|Overall Study|Other|0|||
33440928|NCT02883452|101509082|FG003|Overall Study|Other|0|||
33440929|NCT02883452|101509083|FG004|Overall Study|Other|0|||
33440930|NCT02883452|101509084|FG005|Overall Study|Other|1|||
33440931|NCT04611789|101509086|FG000|Overall Study|Lost to Follow-up|1|||
33440932|NCT04611789|101509087|FG001|Overall Study|Lost to Follow-up|0|||
33440933|NCT04611789|101509088|FG002|Overall Study|Lost to Follow-up|0|||
33440934|NCT02152566|101509089|FG000|Overall Study|Lost to Follow-up|1|||
33440935|NCT02152566|101509089|FG000|Overall Study|Withdrawal by Subject|2|||
33440936|NCT00667862|101509090|FG000|Overall Study|Adverse Event|9|||
33440937|NCT00667862|101509090|FG000|Overall Study|Death|1|||
33440938|NCT00667862|101509090|FG000|Overall Study|Disease Progression|22|||
33440939|NCT00667862|101509090|FG000|Overall Study|Withdrawal by Subject|3|||
33440940|NCT02924883|101509091|FG000|Overall Study|Death|39|||
33440941|NCT02924883|101509092|FG001|Overall Study|Death|20|||
33440942|NCT02924883|101509091|FG000|Overall Study|Lost to Follow-up|1|||
33440943|NCT02924883|101509092|FG001|Overall Study|Lost to Follow-up|0|||
33440944|NCT02924883|101509091|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
33440945|NCT02924883|101509092|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
33440946|NCT02924883|101509091|FG000|Overall Study|Protocol Violation|1|||
33440947|NCT02924883|101509092|FG001|Overall Study|Protocol Violation|0|||
33440948|NCT02924883|101509091|FG000|Overall Study|Withdrawal by Subject|22|||
33440949|NCT02924883|101509092|FG001|Overall Study|Withdrawal by Subject|16|||
33440950|NCT02924883|101509091|FG000|Overall Study|Progressive Disease|1|||
33440951|NCT02924883|101509092|FG001|Overall Study|Progressive Disease|0|||
33440952|NCT02924883|101509091|FG000|Overall Study|Study Terminated by Sponsor|69|||
33440953|NCT02924883|101509092|FG001|Overall Study|Study Terminated by Sponsor|32|||
33440954|NCT03262012|101509095|FG000|Overall Study|Withdrawal by Subject|15|||
33440955|NCT03262012|101509096|FG001|Overall Study|Withdrawal by Subject|13|||
33440956|NCT03262012|101509097|FG002|Overall Study|Withdrawal by Subject|8|||
33440957|NCT03262012|101509098|FG003|Overall Study|Withdrawal by Subject|7|||
33440958|NCT03262012|101509095|FG000|Overall Study|Adverse Event|10|||
33440959|NCT03262012|101509096|FG001|Overall Study|Adverse Event|12|||
33440960|NCT03262012|101509097|FG002|Overall Study|Adverse Event|4|||
33440961|NCT03262012|101509098|FG003|Overall Study|Adverse Event|6|||
33440962|NCT03262012|101509095|FG000|Overall Study|Physician Decision|2|||
33440963|NCT03262012|101509096|FG001|Overall Study|Physician Decision|5|||
33440964|NCT03262012|101509097|FG002|Overall Study|Physician Decision|1|||
33440965|NCT03262012|101509098|FG003|Overall Study|Physician Decision|0|||
33440966|NCT03262012|101509095|FG000|Overall Study|Lack of Efficacy|0|||
33440967|NCT03262012|101509096|FG001|Overall Study|Lack of Efficacy|5|||
33440968|NCT03262012|101509097|FG002|Overall Study|Lack of Efficacy|1|||
33440969|NCT03262012|101509098|FG003|Overall Study|Lack of Efficacy|2|||
33440970|NCT03262012|101509095|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
33440971|NCT03262012|101509096|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
33440972|NCT03262012|101509097|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
33440973|NCT03262012|101509098|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
33440974|NCT02076022|101509101|FG000|Overall Study|Withdrawal by Subject|2|||
33440975|NCT02076022|101509102|FG001|Overall Study|Withdrawal by Subject|0|||
33440976|NCT01263704|101509105|FG000|Overall Study|Progressive disease|18|||
33440977|NCT01263704|101509105|FG000|Overall Study|Adverse Event|3|||
33440978|NCT01263704|101509105|FG000|Overall Study|Death|2|||
33440979|NCT01263704|101509105|FG000|Overall Study|Patient withdrew consent|2|||
33440980|NCT01263704|101509105|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
33440981|NCT01263704|101509105|FG000|Overall Study|Lost to Follow-up|1|||
33440982|NCT01263704|101509105|FG000|Overall Study|Colon metastases|1|||
33440983|NCT01263704|101509105|FG000|Overall Study|Principal Investigator (PI) decision|1|||
33440984|NCT00880568|101509106|FG000|Overall Study|Disease progression|3|||
33440985|NCT00880568|101509107|FG001|Overall Study|Disease progression|3|||
33440986|NCT00880568|101509108|FG002|Overall Study|Disease progression|3|||
33440987|NCT00880568|101509109|FG003|Overall Study|Disease progression|1|||
33440988|NCT00880568|101509110|FG004|Overall Study|Disease progression|3|||
33440989|NCT00880568|101509111|FG005|Overall Study|Disease progression|3|||
33440990|NCT00880568|101509112|FG006|Overall Study|Disease progression|5|||
33440991|NCT00880568|101509113|FG007|Overall Study|Disease progression|0|||
33440992|NCT00880568|101509114|FG008|Overall Study|Disease progression|3|||
33440993|NCT00880568|101509106|FG000|Overall Study|Adverse Event|0|||
33440994|NCT00880568|101509107|FG001|Overall Study|Adverse Event|0|||
33440995|NCT00880568|101509108|FG002|Overall Study|Adverse Event|0|||
33440996|NCT00880568|101509109|FG003|Overall Study|Adverse Event|0|||
33440997|NCT00880568|101509110|FG004|Overall Study|Adverse Event|0|||
33440998|NCT00880568|101509111|FG005|Overall Study|Adverse Event|0|||
33440999|NCT00880568|101509112|FG006|Overall Study|Adverse Event|1|||
33441000|NCT00880568|101509113|FG007|Overall Study|Adverse Event|1|||
33441001|NCT00880568|101509114|FG008|Overall Study|Adverse Event|0|||
33441002|NCT00880568|101509106|FG000|Overall Study|Withdrawal by Subject|0|||
33441003|NCT00880568|101509107|FG001|Overall Study|Withdrawal by Subject|0|||
33441004|NCT00880568|101509108|FG002|Overall Study|Withdrawal by Subject|0|||
33441005|NCT00880568|101509109|FG003|Overall Study|Withdrawal by Subject|0|||
33441006|NCT00880568|101509110|FG004|Overall Study|Withdrawal by Subject|0|||
33441007|NCT00880568|101509111|FG005|Overall Study|Withdrawal by Subject|0|||
33441008|NCT00880568|101509112|FG006|Overall Study|Withdrawal by Subject|0|||
33441009|NCT00880568|101509113|FG007|Overall Study|Withdrawal by Subject|1|||
33441010|NCT00880568|101509114|FG008|Overall Study|Withdrawal by Subject|0|||
33441011|NCT03292653|101509121|FG000|Overall Study|Adverse Event|0|||
33441012|NCT03292653|101509122|FG001|Overall Study|Adverse Event|0|||
33441013|NCT03292653|101509123|FG002|Overall Study|Adverse Event|1|||
33441014|NCT03292653|101509121|FG000|Overall Study|Did not Receive Treatment|1|||
33441015|NCT03292653|101509122|FG001|Overall Study|Did not Receive Treatment|0|||
33441016|NCT03292653|101509123|FG002|Overall Study|Did not Receive Treatment|0|||
33441017|NCT04188106|101509124|FG000|Overall Study|Lost to Follow-up|5|||
33441018|NCT04188106|101509124|FG000|Overall Study|Non-Compliance|1|||
33441019|NCT01010542|101509125|FG000|Overall Study|Adverse Event|0|||
33441020|NCT01010542|101509126|FG001|Overall Study|Adverse Event|1|||
33441021|NCT01010542|101509127|FG002|Overall Study|Adverse Event|0|||
33441022|NCT01010542|101509125|FG000|Overall Study|Lost to Follow-up|0|||
33441023|NCT01010542|101509126|FG001|Overall Study|Lost to Follow-up|1|||
33441024|NCT01010542|101509127|FG002|Overall Study|Lost to Follow-up|0|||
33441025|NCT01010542|101509125|FG000|Overall Study|Withdrawal by Subject|0|||
33441026|NCT01010542|101509126|FG001|Overall Study|Withdrawal by Subject|3|||
33441027|NCT01010542|101509127|FG002|Overall Study|Withdrawal by Subject|2|||
33441028|NCT00050778|101509139|FG000|Overall Study|Adverse Event|13|||
33441029|NCT00050778|101509140|FG001|Overall Study|Adverse Event|3|||
33441030|NCT00050778|101509141|FG002|Overall Study|Adverse Event|2|||
33441031|NCT00050778|101509139|FG000|Overall Study|Death|0|||
33441032|NCT00050778|101509140|FG001|Overall Study|Death|1|||
33441033|NCT00050778|101509141|FG002|Overall Study|Death|1|||
33441034|NCT00050778|101509139|FG000|Overall Study|Lack of Efficacy|16|||
33441035|NCT00050778|101509140|FG001|Overall Study|Lack of Efficacy|2|||
33441036|NCT00050778|101509141|FG002|Overall Study|Lack of Efficacy|2|||
33441037|NCT00050778|101509139|FG000|Overall Study|Lost to Follow-up|0|||
33441038|NCT00050778|101509140|FG001|Overall Study|Lost to Follow-up|2|||
33441039|NCT00050778|101509141|FG002|Overall Study|Lost to Follow-up|4|||
33441040|NCT00050778|101509139|FG000|Overall Study|Physician Decision|3|||
33441041|NCT00050778|101509140|FG001|Overall Study|Physician Decision|0|||
33441042|NCT00050778|101509141|FG002|Overall Study|Physician Decision|2|||
33441043|NCT00050778|101509139|FG000|Overall Study|Protocol Violation|2|||
33441044|NCT00050778|101509140|FG001|Overall Study|Protocol Violation|0|||
33441045|NCT00050778|101509141|FG002|Overall Study|Protocol Violation|1|||
33441046|NCT00050778|101509139|FG000|Overall Study|Withdrawal by Subject|6|||
33441047|NCT00050778|101509140|FG001|Overall Study|Withdrawal by Subject|8|||
33441048|NCT00050778|101509141|FG002|Overall Study|Withdrawal by Subject|4|||
33441049|NCT00050778|101509139|FG000|Overall Study|Randomized but not treated|4|||
33441050|NCT00050778|101509140|FG001|Overall Study|Randomized but not treated|5|||
33441051|NCT00050778|101509141|FG002|Overall Study|Randomized but not treated|2|||
33441052|NCT00050778|101509139|FG000|Overall Study|Familial and personal reasons|1|||
33441053|NCT00050778|101509140|FG001|Overall Study|Familial and personal reasons|0|||
33441054|NCT00050778|101509141|FG002|Overall Study|Familial and personal reasons|0|||
33441055|NCT02865538|101509142|FG000|Overall Study|Withdrawal by Subject|0|||
33441056|NCT02865538|101509143|FG001|Overall Study|Withdrawal by Subject|0|||
33441057|NCT02865538|101509144|FG002|Overall Study|Withdrawal by Subject|1|||
33441058|NCT02865538|101509145|FG003|Overall Study|Withdrawal by Subject|0|||
33441059|NCT02865538|101509146|FG004|Overall Study|Withdrawal by Subject|0|||
33441060|NCT02865538|101509142|FG000|Overall Study|Lost to Follow-up|1|||
33441061|NCT02865538|101509143|FG001|Overall Study|Lost to Follow-up|0|||
33441062|NCT02865538|101509144|FG002|Overall Study|Lost to Follow-up|0|||
33441063|NCT02865538|101509145|FG003|Overall Study|Lost to Follow-up|0|||
33441064|NCT02865538|101509146|FG004|Overall Study|Lost to Follow-up|0|||
33441065|NCT02910037|101509153|FG000|Overall Study|Withdrawal by Subject|4|||
33441066|NCT02910037|101509153|FG000|Overall Study|Lost to Follow-up|6|||
33441067|NCT00436553|101509154|FG000|Overall Study|Adverse Event|4|||
33441068|NCT00436553|101509155|FG001|Overall Study|Adverse Event|3|||
33441069|NCT00436553|101509156|FG002|Overall Study|Adverse Event|4|||
33441070|NCT00436553|101509154|FG000|Overall Study|Death|3|||
33441071|NCT00436553|101509155|FG001|Overall Study|Death|1|||
33441072|NCT00436553|101509156|FG002|Overall Study|Death|3|||
33441073|NCT00436553|101509154|FG000|Overall Study|Lost to Follow-up|0|||
33441074|NCT00436553|101509155|FG001|Overall Study|Lost to Follow-up|2|||
33441075|NCT00436553|101509156|FG002|Overall Study|Lost to Follow-up|0|||
33441076|NCT00436553|101509154|FG000|Overall Study|Protocol Violation|1|||
33441077|NCT00436553|101509155|FG001|Overall Study|Protocol Violation|0|||
33441078|NCT00436553|101509156|FG002|Overall Study|Protocol Violation|0|||
33441079|NCT00436553|101509154|FG000|Overall Study|Withdrawal by Subject|5|||
33441080|NCT00436553|101509155|FG001|Overall Study|Withdrawal by Subject|6|||
33441081|NCT00436553|101509156|FG002|Overall Study|Withdrawal by Subject|3|||
33441082|NCT01318499|101509157|FG000|Overall Study|Adverse Event|16|||
33441083|NCT01318499|101509158|FG001|Overall Study|Adverse Event|11|||
33441084|NCT01318499|101509159|FG002|Overall Study|Adverse Event|6|||
33441085|NCT01318499|101509157|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
33441086|NCT01318499|101509158|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
33441087|NCT01318499|101509159|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
33441088|NCT01318499|101509157|FG000|Overall Study|Noncompliance|2|||
33441089|NCT01318499|101509158|FG001|Overall Study|Noncompliance|3|||
33441090|NCT01318499|101509159|FG002|Overall Study|Noncompliance|0|||
33441091|NCT01318499|101509157|FG000|Overall Study|Treatment Failure|19|||
33441092|NCT01318499|101509158|FG001|Overall Study|Treatment Failure|19|||
33441093|NCT01318499|101509159|FG002|Overall Study|Treatment Failure|101|||
33158376|NCT02038881|100494014|FG002|Overall Study|incarcerated|0|||
33158377|NCT00851630|100494015|FG000|Overall Study|Death|2|||
33158378|NCT00851630|100494016|FG001|Overall Study|Death|1|||
33158379|NCT00851630|100494015|FG000|Overall Study|Clinical failure|0|||
33158380|NCT00851630|100494016|FG001|Overall Study|Clinical failure|1|||
33158381|NCT02248701|100494019|FG000|Overall Study|Withdrawal by Subject|2|||
33158382|NCT02248701|100494020|FG001|Overall Study|Withdrawal by Subject|1|||
33441094|NCT01318499|101509157|FG000|Overall Study|Protocol Violation|2|||
33441095|NCT01318499|101509158|FG001|Overall Study|Protocol Violation|4|||
33441096|NCT01318499|101509159|FG002|Overall Study|Protocol Violation|2|||
33441097|NCT01318499|101509157|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
33441098|NCT01318499|101509158|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
33441099|NCT01318499|101509159|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
33441100|NCT01318499|101509157|FG000|Overall Study|Other|7|||
33441101|NCT01318499|101509158|FG001|Overall Study|Other|10|||
33441102|NCT01318499|101509159|FG002|Overall Study|Other|22|||
33441103|NCT04869787|101509161|FG000|Screening|Physician Decision|1|||
33441104|NCT04869787|101509161|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
33441105|NCT01536405|101509174|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
33441106|NCT01536405|101509175|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
33441107|NCT01536405|101509174|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
33441108|NCT01536405|101509175|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
33441109|NCT01536405|101509174|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
33441110|NCT01536405|101509175|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
33441111|NCT01536405|101509174|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
33441112|NCT01536405|101509175|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
33441113|NCT01536405|101509174|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
33441114|NCT01536405|101509175|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
33441115|NCT01536405|101509174|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
33441116|NCT01536405|101509175|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
33441117|NCT01536405|101509174|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
33441118|NCT01536405|101509175|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
33441119|NCT01536405|101509174|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
33441120|NCT01536405|101509175|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
33441121|NCT01536405|101509174|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
33441122|NCT01536405|101509175|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
33441123|NCT01536405|101509174|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
33441124|NCT01536405|101509175|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
33441125|NCT01536405|101509174|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
33441126|NCT01536405|101509175|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
33441127|NCT01536405|101509174|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
33441128|NCT01536405|101509175|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
33441129|NCT01536405|101509174|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
33441130|NCT01536405|101509175|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
33158383|NCT02248701|100494019|FG000|Overall Study|Physician Decision|0|||
33441131|NCT02100228|101509176|FG000|Overall Study|Other|19|||
33441132|NCT02100228|101509177|FG001|Overall Study|Other|19|||
33441133|NCT02100228|101509176|FG000|Overall Study|Administrative reason|0|||
33441134|NCT02100228|101509177|FG001|Overall Study|Administrative reason|1|||
33441135|NCT02100228|101509176|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
33441136|NCT02100228|101509177|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
33441137|NCT02100228|101509176|FG000|Overall Study|Non-compliance|0|||
33441138|NCT02100228|101509177|FG001|Overall Study|Non-compliance|3|||
33441139|NCT02100228|101509176|FG000|Overall Study|Lost to Follow-up|0|||
33441140|NCT02100228|101509177|FG001|Overall Study|Lost to Follow-up|1|||
33441141|NCT02100228|101509176|FG000|Overall Study|Withdrawal by Subject|27|||
33441142|NCT02100228|101509177|FG001|Overall Study|Withdrawal by Subject|37|||
33441143|NCT02100228|101509176|FG000|Overall Study|Adverse Event|16|||
33441144|NCT02100228|101509177|FG001|Overall Study|Adverse Event|12|||
33441145|NCT02100228|101509176|FG000|Overall Study|Death|1|||
33441146|NCT02100228|101509177|FG001|Overall Study|Death|1|||
33441147|NCT01866319|101509178|FG000|Overall Study|Adverse Event|12|||
33441148|NCT01866319|101509179|FG001|Overall Study|Adverse Event|5|||
33441149|NCT01866319|101509180|FG002|Overall Study|Adverse Event|9|||
33441150|NCT01866319|101509178|FG000|Overall Study|Clinical progression|3|||
33441151|NCT01866319|101509179|FG001|Overall Study|Clinical progression|2|||
33441152|NCT01866319|101509180|FG002|Overall Study|Clinical progression|2|||
33441153|NCT01866319|101509178|FG000|Overall Study|Death|153|||
33441154|NCT01866319|101509179|FG001|Overall Study|Death|154|||
33441155|NCT01866319|101509180|FG002|Overall Study|Death|147|||
33441156|NCT01866319|101509178|FG000|Overall Study|Lost to Follow-up|6|||
33441157|NCT01866319|101509179|FG001|Overall Study|Lost to Follow-up|3|||
33441158|NCT01866319|101509180|FG002|Overall Study|Lost to Follow-up|8|||
33441159|NCT01866319|101509178|FG000|Overall Study|Physician Decision|1|||
33441160|NCT01866319|101509179|FG001|Overall Study|Physician Decision|0|||
33441161|NCT01866319|101509180|FG002|Overall Study|Physician Decision|1|||
33441162|NCT01866319|101509178|FG000|Overall Study|Protocol Violation|0|||
33441163|NCT01866319|101509179|FG001|Overall Study|Protocol Violation|0|||
33441164|NCT01866319|101509180|FG002|Overall Study|Protocol Violation|1|||
33441165|NCT01866319|101509178|FG000|Overall Study|Withdrawal by Subject|32|||
33441166|NCT01866319|101509179|FG001|Overall Study|Withdrawal by Subject|14|||
33441167|NCT01866319|101509180|FG002|Overall Study|Withdrawal by Subject|12|||
33441168|NCT00533273|101509181|FG000|Double-blind|Withdrew consent|0|||
33441169|NCT00533273|101509182|FG001|Double-blind|Withdrew consent|2|||
33441170|NCT00533273|101509181|FG000|Open-label|Withdrawal by Subject|6|||
33441171|NCT00533273|101509182|FG001|Open-label|Withdrawal by Subject|0|||
33441172|NCT05612724|101509185|FG000|Overall Study|Lost to Follow-up|4|||
33441173|NCT00862979|101509187|FG000|Overall Study|Adverse Event|6|||
33441174|NCT00862979|101509188|FG001|Overall Study|Adverse Event|3|||
33441175|NCT00862979|101509187|FG000|Overall Study|Protocol Violation|0|||
33441176|NCT00862979|101509188|FG001|Overall Study|Protocol Violation|1|||
33441177|NCT00862979|101509187|FG000|Overall Study|Patient withdrew consent|2|||
33441178|NCT00862979|101509188|FG001|Overall Study|Patient withdrew consent|1|||
33441179|NCT00862979|101509187|FG000|Overall Study|Administrative problems|0|||
33441180|NCT00862979|101509188|FG001|Overall Study|Administrative problems|1|||
33441181|NCT00862979|101509187|FG000|Overall Study|Death|0|||
33441182|NCT00862979|101509188|FG001|Overall Study|Death|1|||
33441183|NCT01248247|101509189|FG000|Overall Study|Adverse Event|2|||
33441184|NCT01248247|101509190|FG001|Overall Study|Adverse Event|4|||
33441185|NCT01248247|101509191|FG002|Overall Study|Adverse Event|4|||
33441186|NCT01248247|101509192|FG003|Overall Study|Adverse Event|2|||
33441187|NCT01248247|101509189|FG000|Overall Study|Death|0|||
33441188|NCT01248247|101509190|FG001|Overall Study|Death|1|||
33441189|NCT01248247|101509191|FG002|Overall Study|Death|4|||
33441190|NCT01248247|101509192|FG003|Overall Study|Death|7|||
33441191|NCT01248247|101509189|FG000|Overall Study|Lost to Follow-up|0|||
33441192|NCT01248247|101509190|FG001|Overall Study|Lost to Follow-up|1|||
33441193|NCT01248247|101509191|FG002|Overall Study|Lost to Follow-up|1|||
33441194|NCT01248247|101509192|FG003|Overall Study|Lost to Follow-up|0|||
33441195|NCT01248247|101509189|FG000|Overall Study|Alternative treatment|0|||
33441196|NCT01248247|101509190|FG001|Overall Study|Alternative treatment|1|||
33441197|NCT01248247|101509191|FG002|Overall Study|Alternative treatment|0|||
33441198|NCT01248247|101509192|FG003|Overall Study|Alternative treatment|0|||
33441199|NCT01248247|101509189|FG000|Overall Study|Other|2|||
33441200|NCT01248247|101509190|FG001|Overall Study|Other|8|||
33441201|NCT01248247|101509191|FG002|Overall Study|Other|8|||
33441202|NCT01248247|101509192|FG003|Overall Study|Other|5|||
33441203|NCT01248247|101509189|FG000|Overall Study|Progression|18|||
33441204|NCT01248247|101509190|FG001|Overall Study|Progression|27|||
33441205|NCT01248247|101509191|FG002|Overall Study|Progression|56|||
33441206|NCT01248247|101509192|FG003|Overall Study|Progression|44|||
33441207|NCT01248247|101509189|FG000|Overall Study|Refuse further treatment|0|||
33441208|NCT01248247|101509190|FG001|Overall Study|Refuse further treatment|0|||
33441209|NCT01248247|101509191|FG002|Overall Study|Refuse further treatment|1|||
33441210|NCT01248247|101509192|FG003|Overall Study|Refuse further treatment|2|||
33441211|NCT01248247|101509189|FG000|Overall Study|Complicating disease|0|||
33441212|NCT01248247|101509190|FG001|Overall Study|Complicating disease|0|||
33441213|NCT01248247|101509191|FG002|Overall Study|Complicating disease|1|||
33441214|NCT01248247|101509192|FG003|Overall Study|Complicating disease|1|||
33441215|NCT00667095|101509193|FG000|Overall Study|Withdrawal by Subject|0|||
33441216|NCT00667095|101509194|FG001|Overall Study|Withdrawal by Subject|1|||
33441217|NCT03435081|101509195|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
33441218|NCT03435081|101509196|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
33441219|NCT03435081|101509197|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
33441220|NCT03435081|101509195|FG000|Week 0 to Week 16|Adverse Event|2|||
33441221|NCT03435081|101509196|FG001|Week 0 to Week 16|Adverse Event|2|||
33441222|NCT03435081|101509197|FG002|Week 0 to Week 16|Adverse Event|2|||
33441223|NCT03435081|101509195|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
33441224|NCT03435081|101509196|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
33441225|NCT03435081|101509197|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
33441226|NCT03435081|101509195|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
33441227|NCT03435081|101509196|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
33441228|NCT03435081|101509197|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
33441229|NCT03435081|101509195|FG000|Week 0 to Week 16|Pregnancy|1|||
33441230|NCT03435081|101509196|FG001|Week 0 to Week 16|Pregnancy|0|||
33441231|NCT03435081|101509197|FG002|Week 0 to Week 16|Pregnancy|0|||
33441232|NCT03435081|101509195|FG000|Week 0 to Week 16|Non-compliance|1|||
33441233|NCT03435081|101509196|FG001|Week 0 to Week 16|Non-compliance|0|||
33441234|NCT03435081|101509197|FG002|Week 0 to Week 16|Non-compliance|2|||
33441235|NCT03435081|101509195|FG000|Week 0 to Week 16|Inadequate Response|0|||
33158384|NCT02248701|100494020|FG001|Overall Study|Physician Decision|1|||
33158385|NCT02248701|100494019|FG000|Overall Study|Adverse Event|1|||
33158386|NCT02248701|100494020|FG001|Overall Study|Adverse Event|0|||
33158387|NCT02248701|100494019|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
33158388|NCT02248701|100494020|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
33158389|NCT00406354|100494021|FG000|All Randomized Patients|Protocol Violation|0|||
33158390|NCT00406354|100494022|FG001|All Randomized Patients|Protocol Violation|0|||
33158391|NCT00406354|100494023|FG002|All Randomized Patients|Protocol Violation|1|||
33158392|NCT00406354|100494021|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
33158393|NCT00406354|100494022|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
33158394|NCT00406354|100494023|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
33158395|NCT00406354|100494021|FG000|All Randomized and Treated Patients|Adverse Event|6|||
33158396|NCT00406354|100494022|FG001|All Randomized and Treated Patients|Adverse Event|2|||
33158397|NCT00406354|100494023|FG002|All Randomized and Treated Patients|Adverse Event|1|||
33158398|NCT00406354|100494021|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
33158399|NCT00406354|100494022|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
33158400|NCT00406354|100494023|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
33158401|NCT00406354|100494021|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
33158402|NCT00406354|100494022|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
33158403|NCT00406354|100494023|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
33158404|NCT00406354|100494021|FG000|All Randomized and Treated Patients|Physician Decision|0|||
33158405|NCT00406354|100494022|FG001|All Randomized and Treated Patients|Physician Decision|0|||
33158406|NCT00406354|100494023|FG002|All Randomized and Treated Patients|Physician Decision|1|||
33158407|NCT03113071|100494025|FG000|Overall Study|Withdrawal by Subject|1|||
33158408|NCT03113071|100494026|FG001|Overall Study|Withdrawal by Subject|0|||
33158409|NCT01193530|100494027|FG000|Overall Study|Withdrawal by Subject|2|||
33158410|NCT01193530|100494028|FG001|Overall Study|Withdrawal by Subject|2|||
33158411|NCT01193530|100494027|FG000|Overall Study|Began Contraindicated Therapy|1|||
33158412|NCT01193530|100494028|FG001|Overall Study|Began Contraindicated Therapy|0|||
33158413|NCT01193530|100494027|FG000|Overall Study|Lost Light Box|0|||
33158414|NCT01193530|100494028|FG001|Overall Study|Lost Light Box|1|||
33158415|NCT01193530|100494027|FG000|Overall Study|Returned home - out of state|0|||
33158416|NCT01193530|100494028|FG001|Overall Study|Returned home - out of state|1|||
33158417|NCT01193530|100494027|FG000|Overall Study|Non-Compliance|0|||
33158418|NCT01193530|100494028|FG001|Overall Study|Non-Compliance|1|||
33158419|NCT03606512|100494029|FG000|Overall Study|Lost to Follow-up|0|||
33254040|NCT00658996|100830358|FG001|Crossover Period|Ineligible|1|||
33254041|NCT00658996|100830357|FG000|Second Intervention|Developed a stye on upper lid|1|||
33254042|NCT00658996|100830358|FG001|Second Intervention|Developed a stye on upper lid|0|||
33441236|NCT03435081|101509196|FG001|Week 0 to Week 16|Inadequate Response|1|||
33254043|NCT00658996|100830357|FG000|Second Intervention|Positive slit lamp finding|0|||
33254044|NCT00658996|100830358|FG001|Second Intervention|Positive slit lamp finding|1|||
33254045|NCT00486759|100830359|FG000|Treatment|Adverse event/intercurrent illness|86|||
33441237|NCT03435081|101509197|FG002|Week 0 to Week 16|Inadequate Response|0|||
33441238|NCT03435081|101509195|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
33441239|NCT03435081|101509196|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
33254046|NCT00486759|100830360|FG001|Treatment|Adverse event/intercurrent illness|39|||
33254047|NCT00486759|100830359|FG000|Treatment|Insufficient therapeutic response|37|||
33254048|NCT00486759|100830360|FG001|Treatment|Insufficient therapeutic response|39|||
33254049|NCT00486759|100830359|FG000|Treatment|Death|17|||
33254050|NCT00486759|100830360|FG001|Treatment|Death|10|||
33254051|NCT00486759|100830359|FG000|Treatment|Withdrew consent|15|||
33254052|NCT00486759|100830360|FG001|Treatment|Withdrew consent|12|||
33254053|NCT00486759|100830359|FG000|Treatment|Administrative/reason not specified|17|||
33254054|NCT00486759|100830360|FG001|Treatment|Administrative/reason not specified|21|||
33254055|NCT00486759|100830359|FG000|Treatment|Refused treatment|10|||
33254056|NCT00486759|100830360|FG001|Treatment|Refused treatment|7|||
33441240|NCT03435081|101509197|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
33441241|NCT03435081|101509195|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
33441242|NCT03435081|101509196|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
33441243|NCT03435081|101509197|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
33441244|NCT03435081|101509195|FG000|Week 16 to Week 104|Adverse Event|1|||
33441245|NCT03435081|101509196|FG001|Week 16 to Week 104|Adverse Event|0|||
33441246|NCT03435081|101509197|FG002|Week 16 to Week 104|Adverse Event|2|||
33441247|NCT03435081|101509195|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
33441248|NCT03435081|101509196|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
33441249|NCT03435081|101509197|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
33441250|NCT03435081|101509195|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
33441251|NCT03435081|101509196|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
33441252|NCT03435081|101509197|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
33441253|NCT03435081|101509195|FG000|Week 16 to Week 104|Non--Compliance|0|||
33441254|NCT03435081|101509196|FG001|Week 16 to Week 104|Non--Compliance|0|||
33441255|NCT03435081|101509197|FG002|Week 16 to Week 104|Non--Compliance|1|||
33441256|NCT01520909|101509203|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
33441257|NCT01520909|101509204|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
33441258|NCT01520909|101509205|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
33441259|NCT01520909|101509203|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
33441260|NCT01520909|101509204|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
33441261|NCT01520909|101509205|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
33441262|NCT01520909|101509203|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
33441263|NCT01520909|101509204|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
33441264|NCT01520909|101509205|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
33441265|NCT01520909|101509203|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
33441266|NCT01520909|101509204|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
33441267|NCT01520909|101509205|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
33441268|NCT02728102|101509207|FG000|Overall Study|Death|3|||
33441269|NCT02728102|101509208|FG001|Overall Study|Death|0|||
33441270|NCT02728102|101509209|FG002|Overall Study|Death|1|||
33441271|NCT02728102|101509207|FG000|Overall Study|Withdrawal by Subject|0|||
33254057|NCT00486759|100830359|FG000|Treatment|Violation of selection criteria at entry|3|||
33254058|NCT00486759|100830360|FG001|Treatment|Violation of selection criteria at entry|3|||
33441272|NCT02728102|101509208|FG001|Overall Study|Withdrawal by Subject|2|||
33441273|NCT02728102|101509209|FG002|Overall Study|Withdrawal by Subject|3|||
33441274|NCT02728102|101509207|FG000|Overall Study|Physician Decision|1|||
33441275|NCT02728102|101509208|FG001|Overall Study|Physician Decision|1|||
33441276|NCT02728102|101509209|FG002|Overall Study|Physician Decision|0|||
33441277|NCT02728102|101509207|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
33441278|NCT02728102|101509208|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
33441279|NCT02728102|101509209|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
33254059|NCT00486759|100830359|FG000|Treatment|Other protocol violation|1|||
33441280|NCT02728102|101509207|FG000|Overall Study|Covid|0|||
33441281|NCT02728102|101509208|FG001|Overall Study|Covid|0|||
33441282|NCT02728102|101509209|FG002|Overall Study|Covid|1|||
33441283|NCT04213326|101509212|FG000|Overall Study|Consent withdrawn|51|||
33441284|NCT04213326|101509213|FG001|Overall Study|Consent withdrawn|241|||
33441285|NCT04213326|101509212|FG000|Overall Study|Lost to Follow-up|50|||
33441286|NCT04213326|101509213|FG001|Overall Study|Lost to Follow-up|902|||
33158420|NCT03606512|100494030|FG001|Overall Study|Lost to Follow-up|1|||
33158421|NCT03606512|100494029|FG000|Overall Study|'moved from study area|0|||
33158422|NCT03606512|100494030|FG001|Overall Study|'moved from study area|1|||
33158423|NCT00762229|100494031|FG000|Overall Study|Lost to Follow-up|1|||
33158424|NCT00762229|100494032|FG001|Overall Study|Lost to Follow-up|1|||
33158425|NCT00762229|100494031|FG000|Overall Study|did not recveive intervention|0|||
33158426|NCT00762229|100494032|FG001|Overall Study|did not recveive intervention|1|||
33158427|NCT01752985|100494033|FG000|Treatment Period|Subject request to discontinue treatment|1|||
33158428|NCT01752985|100494034|FG001|Treatment Period|Subject request to discontinue treatment|0|||
33158429|NCT01752985|100494035|FG002|Treatment Period|Subject request to discontinue treatment|1|||
33158430|NCT01752985|100494033|FG000|Treatment Period|Subject no longer meets study criteria|0|||
33158431|NCT01752985|100494034|FG001|Treatment Period|Subject no longer meets study criteria|1|||
33158432|NCT01752985|100494035|FG002|Treatment Period|Subject no longer meets study criteria|1|||
33158433|NCT01752985|100494033|FG000|Treatment Period|Adverse Event|2|||
33158434|NCT01752985|100494034|FG001|Treatment Period|Adverse Event|1|||
33158435|NCT01752985|100494035|FG002|Treatment Period|Adverse Event|2|||
33158436|NCT01752985|100494033|FG000|Treatment Period|Withdrawal by Subject|1|||
33158437|NCT01752985|100494034|FG001|Treatment Period|Withdrawal by Subject|1|||
33158438|NCT01752985|100494035|FG002|Treatment Period|Withdrawal by Subject|0|||
33158439|NCT01752985|100494033|FG000|Treatment Period|Lost to Follow-up|0|||
33158440|NCT01752985|100494034|FG001|Treatment Period|Lost to Follow-up|0|||
33158441|NCT01752985|100494035|FG002|Treatment Period|Lost to Follow-up|1|||
33158442|NCT00806351|100494038|FG000|Overall Study|Death|5|||
33158443|NCT00806351|100494039|FG001|Overall Study|Death|4|||
33158444|NCT01030536|100494043|FG000|Overall Study|Withdrawal by Subject|0|||
33158445|NCT01030536|100494044|FG001|Overall Study|Withdrawal by Subject|0|||
33158446|NCT01030536|100494045|FG002|Overall Study|Withdrawal by Subject|1|||
33158447|NCT01030536|100494046|FG003|Overall Study|Withdrawal by Subject|0|||
33158448|NCT01030536|100494047|FG004|Overall Study|Withdrawal by Subject|0|||
33158449|NCT01030536|100494043|FG000|Overall Study|undefined|1|||
33158450|NCT01030536|100494044|FG001|Overall Study|undefined|0|||
33158451|NCT01030536|100494045|FG002|Overall Study|undefined|1|||
33158452|NCT01030536|100494046|FG003|Overall Study|undefined|1|||
33158453|NCT01030536|100494047|FG004|Overall Study|undefined|0|||
33158454|NCT01030536|100494043|FG000|Overall Study|Adverse Event|0|||
33158455|NCT01030536|100494044|FG001|Overall Study|Adverse Event|3|||
33158456|NCT01030536|100494045|FG002|Overall Study|Adverse Event|1|||
33158457|NCT01030536|100494046|FG003|Overall Study|Adverse Event|0|||
33158458|NCT01030536|100494047|FG004|Overall Study|Adverse Event|1|||
33158459|NCT01030536|100494043|FG000|Overall Study|Progressive disease|6|||
33158460|NCT01030536|100494044|FG001|Overall Study|Progressive disease|2|||
33158461|NCT01030536|100494045|FG002|Overall Study|Progressive disease|3|||
33158462|NCT01030536|100494046|FG003|Overall Study|Progressive disease|2|||
33158463|NCT01030536|100494047|FG004|Overall Study|Progressive disease|0|||
33158464|NCT01030536|100494043|FG000|Overall Study|Death|0|||
33158465|NCT01030536|100494044|FG001|Overall Study|Death|1|||
33158466|NCT01030536|100494045|FG002|Overall Study|Death|0|||
33158467|NCT01030536|100494046|FG003|Overall Study|Death|0|||
33158468|NCT01030536|100494047|FG004|Overall Study|Death|0|||
33158469|NCT00691301|100494048|FG000|Overall Study|Adverse Event|10|||
33158470|NCT00691301|100494048|FG000|Overall Study|Death|2|||
33158471|NCT00691301|100494048|FG000|Overall Study|Lack of Efficacy|32|||
33158472|NCT00691301|100494048|FG000|Overall Study|Withdrawal by Subject|4|||
33158473|NCT00691301|100494048|FG000|Overall Study|Concurrent illness|2|||
33158474|NCT00691301|100494048|FG000|Overall Study|other reason|3|||
33158475|NCT00691301|100494048|FG000|Overall Study|Did not initiate study treatment|1|||
33158476|NCT02004522|100494049|FG000|Overall Study|Adverse Event|55|||
33158477|NCT02004522|100494050|FG001|Overall Study|Adverse Event|6|||
33158478|NCT02004522|100494049|FG000|Overall Study|Withdrawal by Subject|13|||
33158479|NCT02004522|100494050|FG001|Overall Study|Withdrawal by Subject|7|||
33158480|NCT02004522|100494049|FG000|Overall Study|Death|12|||
33441287|NCT04213326|101509212|FG000|Overall Study|Protocol Violation|3|||
33158481|NCT02004522|100494050|FG001|Overall Study|Death|3|||
33158482|NCT02004522|100494049|FG000|Overall Study|Physician Decision|3|||
33158483|NCT02004522|100494050|FG001|Overall Study|Physician Decision|4|||
33158484|NCT02004522|100494049|FG000|Overall Study|Protocol Violation|1|||
33158485|NCT02004522|100494050|FG001|Overall Study|Protocol Violation|0|||
33158486|NCT02004522|100494049|FG000|Overall Study|Other is reason listed by PI|4|||
33158487|NCT02004522|100494050|FG001|Overall Study|Other is reason listed by PI|1|||
33158488|NCT02004522|100494049|FG000|Overall Study|Never Dosed|2|||
33441288|NCT04213326|101509213|FG001|Overall Study|Protocol Violation|25|||
33441289|NCT04213326|101509212|FG000|Overall Study|Participant eligibility changed|106|||
33254060|NCT00486759|100830360|FG001|Treatment|Other protocol violation|5|||
33254061|NCT00486759|100830359|FG000|Treatment|Failure to return|1|||
33254062|NCT00486759|100830360|FG001|Treatment|Failure to return|1|||
33441290|NCT04213326|101509213|FG001|Overall Study|Participant eligibility changed|19|||
33441291|NCT04213326|101509212|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
33441292|NCT04213326|101509213|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
33441293|NCT04213326|101509212|FG000|Overall Study|Incomplete study visit|0|||
33441294|NCT04213326|101509213|FG001|Overall Study|Incomplete study visit|367|||
33441295|NCT01691508|101509214|FG000|Overall Study|Adverse Event|3|||
33441296|NCT01691508|101509215|FG001|Overall Study|Adverse Event|3|||
33441297|NCT01691508|101509214|FG000|Overall Study|Withdrawal by Subject|1|||
33158489|NCT02004522|100494050|FG001|Overall Study|Never Dosed|4|||
33158490|NCT02004522|100494049|FG000|Overall Study|Disease Progression|35|||
33158491|NCT02004522|100494050|FG001|Overall Study|Disease Progression|31|||
33158492|NCT02004522|100494049|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
33158493|NCT02004522|100494050|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
33158494|NCT01393301|100494051|FG000|Overall Study|Lost to Follow-up|5|||
33158495|NCT01393301|100494052|FG001|Overall Study|Lost to Follow-up|3|||
33158496|NCT01393301|100494051|FG000|Overall Study|Withdrawal by Subject|2|||
33158497|NCT01393301|100494052|FG001|Overall Study|Withdrawal by Subject|0|||
33158498|NCT01393301|100494051|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
33158499|NCT01393301|100494052|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
33158500|NCT00242216|100494057|FG000|Overall Study|Lost to Follow-up|12|||
33158501|NCT00242216|100494058|FG001|Overall Study|Lost to Follow-up|17|||
33158502|NCT00242216|100494057|FG000|Overall Study|Death|4|||
33158503|NCT00242216|100494058|FG001|Overall Study|Death|2|||
33158504|NCT00242216|100494057|FG000|Overall Study|Lack of Efficacy|1|||
33158505|NCT00242216|100494058|FG001|Overall Study|Lack of Efficacy|2|||
33158506|NCT00242216|100494057|FG000|Overall Study|no medicaiton dispensed|1|||
33158507|NCT00242216|100494058|FG001|Overall Study|no medicaiton dispensed|1|||
33158508|NCT00293215|100494059|FG000|Overall Study|Progressive disease|3|||
33158509|NCT00293215|100494060|FG001|Overall Study|Progressive disease|1|||
33158510|NCT00293215|100494059|FG000|Overall Study|Adverse Event|2|||
33158511|NCT00293215|100494060|FG001|Overall Study|Adverse Event|2|||
33158512|NCT00293033|100494061|FG000|Open-label Titration Period|Adverse Event|10|||
33158513|NCT00293033|100494061|FG000|Open-label Titration Period|Death|3|||
33158514|NCT00293033|100494061|FG000|Open-label Titration Period|Lack of Efficacy|5|||
33158515|NCT00293033|100494061|FG000|Open-label Titration Period|Protocol Violation|2|||
33158516|NCT00293033|100494061|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
33158517|NCT00293033|100494061|FG000|Open-label Titration Period|Noncompliance and other|27|||
33441298|NCT01691508|101509215|FG001|Overall Study|Withdrawal by Subject|0|||
33441299|NCT01027143|101509217|FG000|Overall Study|Lost to Follow-up|9|||
33441300|NCT01027143|101509218|FG001|Overall Study|Lost to Follow-up|4|||
33441301|NCT03687736|101509219|FG000|Overall Study|Lost to Follow-up|7|||
33441302|NCT03687736|101509219|FG000|Overall Study|Withdrawal by Subject|3|||
33441303|NCT01270503|101509227|FG000|Overall Study|Lost to Follow-up|1|||
33441304|NCT04567186|101509228|FG000|Period 1|COVID-19 related|1|||
33158518|NCT00293033|100494061|FG000|Double-blind Treatment Period|Adverse Event|3|||
33158519|NCT00293033|100494061|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
33158520|NCT00293033|100494061|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
33254063|NCT00486759|100830359|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
33158521|NCT00293033|100494061|FG000|Double-blind Treatment Period|Noncompliance|4|||
33158522|NCT00724932|100494062|FG000|Overall Study|Lost to Follow-up|1|||
33254064|NCT00486759|100830360|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
33441305|NCT04567186|101509229|FG001|Period 1|COVID-19 related|0|||
33441306|NCT04567186|101509228|FG000|Period 1|Protocol Violation|0|||
33441307|NCT04567186|101509229|FG001|Period 1|Protocol Violation|1|||
33254065|NCT00486759|100830359|FG000|Safety Follow-up|Death|40|||
33254066|NCT00486759|100830360|FG001|Safety Follow-up|Death|29|||
33254067|NCT00486759|100830359|FG000|Safety Follow-up|Withdrew consent|32|||
33254068|NCT00486759|100830360|FG001|Safety Follow-up|Withdrew consent|23|||
33254069|NCT00486759|100830359|FG000|Safety Follow-up|Failure to return|9|||
33254070|NCT00486759|100830360|FG001|Safety Follow-up|Failure to return|6|||
33254071|NCT00486759|100830359|FG000|Safety Follow-up|Administrative/not specified|8|||
33254072|NCT00486759|100830360|FG001|Safety Follow-up|Administrative/not specified|6|||
33254073|NCT00486759|100830359|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
33254074|NCT00486759|100830360|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
33254075|NCT00486759|100830359|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
33254076|NCT00486759|100830360|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
33254077|NCT00617201|100830361|FG000|Overall Study|Lost to Follow-up|9|||
33254078|NCT00617201|100830362|FG001|Overall Study|Lost to Follow-up|13|||
33254079|NCT04424641|100830363|FG000|Overall Study|Death|1|||
33254080|NCT04424641|100830364|FG001|Overall Study|Death|2|||
33254081|NCT04424641|100830365|FG002|Overall Study|Death|3|||
33254082|NCT04424641|100830366|FG003|Overall Study|Death|0|||
33254083|NCT04424641|100830367|FG004|Overall Study|Death|3|||
33254084|NCT04424641|100830368|FG005|Overall Study|Death|0|||
33254085|NCT04424641|100830369|FG006|Overall Study|Death|1|||
33254086|NCT04424641|100830370|FG007|Overall Study|Death|2|||
33254087|NCT04424641|100830363|FG000|Overall Study|Sponsor decision|0|||
33254088|NCT04424641|100830364|FG001|Overall Study|Sponsor decision|2|||
33254089|NCT04424641|100830365|FG002|Overall Study|Sponsor decision|3|||
33254090|NCT04424641|100830366|FG003|Overall Study|Sponsor decision|7|||
33254091|NCT04424641|100830367|FG004|Overall Study|Sponsor decision|2|||
33254092|NCT04424641|100830368|FG005|Overall Study|Sponsor decision|2|||
33254093|NCT04424641|100830369|FG006|Overall Study|Sponsor decision|3|||
33254094|NCT04424641|100830370|FG007|Overall Study|Sponsor decision|4|||
33254095|NCT04424641|100830363|FG000|Overall Study|Withdrawal by Subject|0|||
33254096|NCT04424641|100830364|FG001|Overall Study|Withdrawal by Subject|0|||
33254097|NCT04424641|100830365|FG002|Overall Study|Withdrawal by Subject|0|||
33254098|NCT04424641|100830366|FG003|Overall Study|Withdrawal by Subject|0|||
33254099|NCT04424641|100830367|FG004|Overall Study|Withdrawal by Subject|1|||
33254100|NCT04424641|100830368|FG005|Overall Study|Withdrawal by Subject|0|||
33254101|NCT04424641|100830369|FG006|Overall Study|Withdrawal by Subject|0|||
33254102|NCT04424641|100830370|FG007|Overall Study|Withdrawal by Subject|0|||
33254103|NCT04424641|100830363|FG000|Overall Study|Other|0|||
33254104|NCT04424641|100830364|FG001|Overall Study|Other|0|||
33254105|NCT04424641|100830365|FG002|Overall Study|Other|1|||
33254106|NCT04424641|100830366|FG003|Overall Study|Other|0|||
33254107|NCT04424641|100830367|FG004|Overall Study|Other|0|||
33254108|NCT04424641|100830368|FG005|Overall Study|Other|0|||
33254109|NCT04424641|100830369|FG006|Overall Study|Other|0|||
33254110|NCT04424641|100830370|FG007|Overall Study|Other|0|||
33254111|NCT00716144|100830373|FG000|Overall Study|Withdrawal by Subject|4|||
33254112|NCT00716144|100830374|FG001|Overall Study|Withdrawal by Subject|2|||
33254113|NCT00716144|100830375|FG002|Overall Study|Withdrawal by Subject|6|||
33254114|NCT00716144|100830376|FG003|Overall Study|Withdrawal by Subject|6|||
33254115|NCT00716144|100830373|FG000|Overall Study|Lost to Follow-up|2|||
33254116|NCT00716144|100830374|FG001|Overall Study|Lost to Follow-up|2|||
33254117|NCT00716144|100830375|FG002|Overall Study|Lost to Follow-up|1|||
33254118|NCT00716144|100830376|FG003|Overall Study|Lost to Follow-up|2|||
33254119|NCT00716144|100830373|FG000|Overall Study|Adverse Event|0|||
33254120|NCT00716144|100830374|FG001|Overall Study|Adverse Event|0|||
33254121|NCT00716144|100830375|FG002|Overall Study|Adverse Event|0|||
33254122|NCT00716144|100830376|FG003|Overall Study|Adverse Event|2|||
33254123|NCT00716144|100830373|FG000|Overall Study|Non-compliance|1|||
33254124|NCT00716144|100830374|FG001|Overall Study|Non-compliance|0|||
33254125|NCT00716144|100830375|FG002|Overall Study|Non-compliance|0|||
33254126|NCT00716144|100830376|FG003|Overall Study|Non-compliance|0|||
33441308|NCT04567186|101509228|FG000|Period 1|Adverse Event|0|||
33441309|NCT04567186|101509229|FG001|Period 1|Adverse Event|2|||
33254127|NCT00716144|100830373|FG000|Overall Study|Protocol Violation|2|||
33254128|NCT00716144|100830374|FG001|Overall Study|Protocol Violation|0|||
33441310|NCT04567186|101509228|FG000|Period 2|COVID-19 Related|0|||
33254129|NCT00716144|100830375|FG002|Overall Study|Protocol Violation|1|||
33254130|NCT00716144|100830376|FG003|Overall Study|Protocol Violation|0|||
33254131|NCT00716144|100830373|FG000|Overall Study|Physician Decision|0|||
33441311|NCT04567186|101509229|FG001|Period 2|COVID-19 Related|1|||
33254132|NCT00716144|100830374|FG001|Overall Study|Physician Decision|1|||
33254133|NCT00716144|100830375|FG002|Overall Study|Physician Decision|2|||
33254134|NCT00716144|100830376|FG003|Overall Study|Physician Decision|2|||
33254135|NCT00716144|100830373|FG000|Overall Study|Intercurrent illness|0|||
33254136|NCT00716144|100830374|FG001|Overall Study|Intercurrent illness|0|||
33254137|NCT00716144|100830375|FG002|Overall Study|Intercurrent illness|1|||
33254138|NCT00716144|100830376|FG003|Overall Study|Intercurrent illness|0|||
33441312|NCT04567186|101509228|FG000|Period 2|Protocol Violation|0|||
33158523|NCT00724932|100494063|FG001|Overall Study|Lost to Follow-up|0|||
33158524|NCT00724932|100494062|FG000|Overall Study|Not treated|4|||
33158525|NCT00724932|100494063|FG001|Overall Study|Not treated|3|||
33158526|NCT00570765|100494064|FG000|DB Phase|Withdrawal by Subject|1|||
33158527|NCT00570765|100494065|FG001|DB Phase|Withdrawal by Subject|0|||
33158528|NCT00570765|100494066|FG002|DB Phase|Withdrawal by Subject|0|||
33158529|NCT00570765|100494067|FG003|DB Phase|Withdrawal by Subject|0|||
33158530|NCT00570765|100494064|FG000|DB Phase|Protocol Violation|0|||
33158531|NCT00570765|100494065|FG001|DB Phase|Protocol Violation|1|||
33158532|NCT00570765|100494066|FG002|DB Phase|Protocol Violation|0|||
33158533|NCT00570765|100494067|FG003|DB Phase|Protocol Violation|0|||
33158534|NCT00570765|100494064|FG000|DB Phase|Adverse Event|3|||
33158535|NCT00570765|100494065|FG001|DB Phase|Adverse Event|6|||
33158536|NCT00570765|100494066|FG002|DB Phase|Adverse Event|0|||
33158537|NCT00570765|100494067|FG003|DB Phase|Adverse Event|0|||
33158538|NCT00570765|100494064|FG000|DB Phase|Did Not Receive Study Drug|0|||
33158539|NCT00570765|100494065|FG001|DB Phase|Did Not Receive Study Drug|0|||
33158540|NCT00570765|100494066|FG002|DB Phase|Did Not Receive Study Drug|1|||
33158541|NCT00570765|100494067|FG003|DB Phase|Did Not Receive Study Drug|0|||
33158542|NCT00570765|100494064|FG000|LTSE Phase|Withdrawal by Subject|0|||
33158543|NCT00570765|100494065|FG001|LTSE Phase|Withdrawal by Subject|0|||
33158544|NCT00570765|100494066|FG002|LTSE Phase|Withdrawal by Subject|0|||
33158545|NCT00570765|100494067|FG003|LTSE Phase|Withdrawal by Subject|1|||
33158546|NCT00570765|100494064|FG000|LTSE Phase|Adverse Event|0|||
33158547|NCT00570765|100494065|FG001|LTSE Phase|Adverse Event|0|||
33158548|NCT00570765|100494066|FG002|LTSE Phase|Adverse Event|0|||
33158549|NCT00570765|100494067|FG003|LTSE Phase|Adverse Event|7|||
33158550|NCT00570765|100494064|FG000|LTSE Phase|Physician Decision|0|||
33158551|NCT00570765|100494065|FG001|LTSE Phase|Physician Decision|0|||
33158552|NCT00570765|100494066|FG002|LTSE Phase|Physician Decision|0|||
33158553|NCT00570765|100494067|FG003|LTSE Phase|Physician Decision|4|||
33158554|NCT04528732|100494068|FG000|Overall Study|Death|1|||
33158555|NCT04528732|100494069|FG001|Overall Study|Death|0|||
33158556|NCT04528732|100494070|FG002|Overall Study|Death|1|||
33158557|NCT04528732|100494068|FG000|Overall Study|Lost to Follow-up|0|||
33158558|NCT04528732|100494069|FG001|Overall Study|Lost to Follow-up|1|||
33158559|NCT04528732|100494070|FG002|Overall Study|Lost to Follow-up|2|||
33158560|NCT00434954|100494071|FG000|Overall Study|Adverse Event|17|||
33158561|NCT00434954|100494072|FG001|Overall Study|Adverse Event|2|||
33158562|NCT00434954|100494071|FG000|Overall Study|Entry criteria not met|14|||
33158563|NCT00434954|100494072|FG001|Overall Study|Entry criteria not met|16|||
33158564|NCT00434954|100494071|FG000|Overall Study|Lost to Follow-up|0|||
33158565|NCT00434954|100494072|FG001|Overall Study|Lost to Follow-up|1|||
33158566|NCT00434954|100494071|FG000|Overall Study|Physician Decision|6|||
33158567|NCT00434954|100494072|FG001|Overall Study|Physician Decision|3|||
33158568|NCT00434954|100494071|FG000|Overall Study|Protocol Violation|36|||
33158569|NCT00434954|100494072|FG001|Overall Study|Protocol Violation|27|||
33158570|NCT00434954|100494071|FG000|Overall Study|Sponsor decision|1|||
33158571|NCT00434954|100494072|FG001|Overall Study|Sponsor decision|0|||
33158572|NCT00434954|100494071|FG000|Overall Study|Subject decision|8|||
33158573|NCT00434954|100494072|FG001|Overall Study|Subject decision|22|||
33158574|NCT00313300|100494075|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
33158575|NCT00313300|100494076|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
33158576|NCT00313300|100494077|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
33158577|NCT00313300|100494078|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
33158578|NCT00313300|100494079|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
33158579|NCT00313300|100494075|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
33158580|NCT00313300|100494076|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
33158581|NCT00313300|100494077|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
33158582|NCT00313300|100494078|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
33158583|NCT00313300|100494079|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
33158584|NCT00313300|100494075|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
33158585|NCT00313300|100494076|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
33158586|NCT00313300|100494077|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
33158587|NCT00313300|100494078|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
33158588|NCT00313300|100494079|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
33158589|NCT00313300|100494075|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
33158590|NCT00313300|100494076|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
33158591|NCT00313300|100494077|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
33158592|NCT00313300|100494078|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
33158593|NCT00313300|100494079|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
33158594|NCT00313300|100494075|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
33158595|NCT00313300|100494076|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
33441313|NCT04567186|101509229|FG001|Period 2|Protocol Violation|1|||
33158596|NCT00313300|100494077|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
33158597|NCT00313300|100494078|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
33158598|NCT00313300|100494079|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
33158599|NCT00313300|100494075|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
33158600|NCT00313300|100494076|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
33158601|NCT00313300|100494077|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
33158602|NCT00313300|100494078|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
33158603|NCT00313300|100494079|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
33158604|NCT00313300|100494075|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
33158605|NCT00313300|100494076|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
33441314|NCT04567186|101509228|FG000|Period 2|Lost to Follow-up|0|||
33158606|NCT00313300|100494077|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
33158607|NCT00313300|100494078|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
33158608|NCT00313300|100494079|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
33158609|NCT00313300|100494075|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
33158610|NCT00313300|100494076|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
33158611|NCT00313300|100494077|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
33158612|NCT00313300|100494078|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
33158613|NCT00313300|100494079|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
33158614|NCT00313300|100494075|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
33158615|NCT00313300|100494076|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
33158616|NCT00313300|100494077|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
33158617|NCT00313300|100494078|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
33158618|NCT00313300|100494079|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
33158619|NCT00313300|100494075|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
33158620|NCT00313300|100494076|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
33158621|NCT00313300|100494077|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
33158622|NCT00313300|100494078|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
33158623|NCT00313300|100494079|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
33158624|NCT00313300|100494075|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
33441315|NCT04567186|101509229|FG001|Period 2|Lost to Follow-up|1|||
33158625|NCT00313300|100494076|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
33158626|NCT00313300|100494077|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
33158627|NCT00313300|100494078|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
33158628|NCT00313300|100494079|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
33441316|NCT04567186|101509228|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
33441317|NCT04567186|101509229|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
33441318|NCT01768858|101509230|FG000|Overall Study|Lost to Follow-up|9|||
33441319|NCT01768858|101509230|FG000|Overall Study|Lack of Efficacy|8|||
33441320|NCT01768858|101509230|FG000|Overall Study|Serious Adverse Event|1|||
33441321|NCT01768858|101509230|FG000|Overall Study|Participant moved to Germany|1|||
33158629|NCT00313300|100494075|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
33158630|NCT00313300|100494076|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
33158631|NCT00313300|100494077|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
33441322|NCT01768858|101509230|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
33441323|NCT01768858|101509230|FG000|Overall Study|Exanthema|1|||
33441324|NCT01768858|101509230|FG000|Overall Study|Withdrawal by Subject|1|||
33441325|NCT00119379|101509233|FG000|Overall Study|Adverse Event|4|||
33158632|NCT00313300|100494078|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
33158633|NCT00313300|100494079|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
33158634|NCT00313300|100494075|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
33158635|NCT00313300|100494076|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
33158636|NCT00313300|100494077|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
33158637|NCT00313300|100494078|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
33158638|NCT00313300|100494079|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
33158639|NCT00313300|100494075|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
33158640|NCT00313300|100494076|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
33158641|NCT00313300|100494077|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
33158642|NCT00313300|100494078|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
33158643|NCT00313300|100494079|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
33158644|NCT00313300|100494075|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
33158645|NCT00313300|100494076|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
33158646|NCT00313300|100494077|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
33158647|NCT00313300|100494078|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
33158648|NCT00313300|100494079|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
33158649|NCT00313300|100494075|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
33158650|NCT00313300|100494076|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
33158651|NCT00313300|100494077|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
33158652|NCT00313300|100494078|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
33158653|NCT00313300|100494079|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
33158654|NCT00313300|100494075|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
33158655|NCT00313300|100494076|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
33158656|NCT00313300|100494077|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
33158657|NCT00313300|100494078|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
33158658|NCT00313300|100494079|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
33158659|NCT00313300|100494075|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
33158660|NCT00313300|100494076|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
33158661|NCT00313300|100494077|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
33158662|NCT00313300|100494078|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
33158663|NCT00313300|100494079|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
33158664|NCT00313300|100494075|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
33441326|NCT00119379|101509234|FG001|Overall Study|Adverse Event|1|||
33441327|NCT00939003|101509235|FG000|Double-blind Treatment Period|Adverse Event|1|||
33441328|NCT00939003|101509236|FG001|Double-blind Treatment Period|Adverse Event|1|||
33441329|NCT00939003|101509235|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
33441330|NCT00939003|101509236|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
33441331|NCT00939003|101509235|FG000|Double-blind Treatment Period|Pregnancy|0|||
33441332|NCT00939003|101509236|FG001|Double-blind Treatment Period|Pregnancy|1|||
33441333|NCT00939003|101509235|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
33441334|NCT00939003|101509236|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
33441335|NCT00939003|101509235|FG000|Open-label Treatment Period|Adverse Event|4|||
33441336|NCT00939003|101509236|FG001|Open-label Treatment Period|Adverse Event|8|||
33441337|NCT00939003|101509235|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
33441338|NCT00939003|101509236|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
33441339|NCT00939003|101509235|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
33441340|NCT00939003|101509236|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
33441341|NCT00939003|101509235|FG000|Open-label Treatment Period|Pregnancy|1|||
33441342|NCT00939003|101509236|FG001|Open-label Treatment Period|Pregnancy|1|||
33441343|NCT00939003|101509235|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
33441344|NCT00939003|101509236|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
33441345|NCT00939003|101509235|FG000|Open-label Treatment Period|Site Closure|3|||
33441346|NCT00939003|101509236|FG001|Open-label Treatment Period|Site Closure|4|||
33441347|NCT02711852|101509237|FG000|Overall Study|Death|5|||
33441348|NCT02711852|101509237|FG000|Overall Study|Lost to Follow-up|1|||
33441349|NCT02711852|101509237|FG000|Overall Study|Completed follow-up|3|||
33441350|NCT02711852|101509237|FG000|Overall Study|Withdrawal by Subject|1|||
33441351|NCT00860405|101509238|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
33158665|NCT00313300|100494076|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
33441352|NCT00860405|101509239|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
33441353|NCT01185821|101509240|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33441354|NCT01185821|101509241|FG001|Overall Study|Abnormal laboratory value(s)|2|||
33441355|NCT01185821|101509242|FG002|Overall Study|Abnormal laboratory value(s)|1|||
33441356|NCT01185821|101509243|FG003|Overall Study|Abnormal laboratory value(s)|0|||
33441357|NCT01185821|101509244|FG004|Overall Study|Abnormal laboratory value(s)|0|||
33441358|NCT01185821|101509240|FG000|Overall Study|Protocol Violation|0|||
33441359|NCT01185821|101509241|FG001|Overall Study|Protocol Violation|0|||
33441360|NCT01185821|101509242|FG002|Overall Study|Protocol Violation|0|||
33441361|NCT01185821|101509243|FG003|Overall Study|Protocol Violation|1|||
33441362|NCT01185821|101509244|FG004|Overall Study|Protocol Violation|1|||
33441363|NCT01185821|101509240|FG000|Overall Study|Abnormal test procedure result|0|||
33441364|NCT01185821|101509241|FG001|Overall Study|Abnormal test procedure result|0|||
33441365|NCT01185821|101509242|FG002|Overall Study|Abnormal test procedure result|0|||
33441366|NCT01185821|101509243|FG003|Overall Study|Abnormal test procedure result|0|||
33441367|NCT01185821|101509244|FG004|Overall Study|Abnormal test procedure result|1|||
33441368|NCT01185821|101509240|FG000|Overall Study|Death|0|||
33441369|NCT01185821|101509241|FG001|Overall Study|Death|1|||
33441370|NCT01185821|101509242|FG002|Overall Study|Death|0|||
33441371|NCT01185821|101509243|FG003|Overall Study|Death|0|||
33441372|NCT01185821|101509244|FG004|Overall Study|Death|0|||
33441373|NCT01185821|101509240|FG000|Overall Study|Condition no longer required study drug|0|||
33441374|NCT01185821|101509241|FG001|Overall Study|Condition no longer required study drug|0|||
33441375|NCT01185821|101509242|FG002|Overall Study|Condition no longer required study drug|0|||
33441376|NCT01185821|101509243|FG003|Overall Study|Condition no longer required study drug|0|||
33441377|NCT01185821|101509244|FG004|Overall Study|Condition no longer required study drug|1|||
33441378|NCT01185821|101509240|FG000|Overall Study|Adverse Event|2|||
33441379|NCT01185821|101509241|FG001|Overall Study|Adverse Event|3|||
33441380|NCT01185821|101509242|FG002|Overall Study|Adverse Event|1|||
33441381|NCT01185821|101509243|FG003|Overall Study|Adverse Event|2|||
33441382|NCT01185821|101509244|FG004|Overall Study|Adverse Event|5|||
33441383|NCT01185821|101509240|FG000|Overall Study|Lack of Efficacy|0|||
33441384|NCT01185821|101509241|FG001|Overall Study|Lack of Efficacy|0|||
33441385|NCT01185821|101509242|FG002|Overall Study|Lack of Efficacy|3|||
33441386|NCT01185821|101509243|FG003|Overall Study|Lack of Efficacy|0|||
33441387|NCT01185821|101509244|FG004|Overall Study|Lack of Efficacy|9|||
33441388|NCT01185821|101509240|FG000|Overall Study|Withdrawal by Subject|3|||
33441389|NCT01185821|101509241|FG001|Overall Study|Withdrawal by Subject|2|||
33254139|NCT00716144|100830373|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
33441390|NCT01185821|101509242|FG002|Overall Study|Withdrawal by Subject|2|||
33441391|NCT01185821|101509243|FG003|Overall Study|Withdrawal by Subject|1|||
33441392|NCT01185821|101509244|FG004|Overall Study|Withdrawal by Subject|3|||
33441393|NCT01185821|101509240|FG000|Overall Study|Lost to Follow-up|1|||
33158666|NCT00313300|100494077|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
33158667|NCT00313300|100494078|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
33158668|NCT00313300|100494079|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
33158669|NCT00313300|100494075|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
33158670|NCT00313300|100494076|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
33158671|NCT00313300|100494077|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
33158672|NCT00313300|100494078|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
33158673|NCT00313300|100494079|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
33158674|NCT00313300|100494075|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
33158675|NCT00313300|100494076|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
33158676|NCT00313300|100494077|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
33158677|NCT00313300|100494078|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
33158678|NCT00313300|100494079|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
33158679|NCT00191269|100494080|FG000|Overall Study|Protocol Violation|0|||
33158680|NCT00191269|100494081|FG001|Overall Study|Protocol Violation|2|||
33158681|NCT00191269|100494080|FG000|Overall Study|Adverse Event|1|||
33158682|NCT00191269|100494081|FG001|Overall Study|Adverse Event|4|||
33158683|NCT00191269|100494080|FG000|Overall Study|Progression of Disease|4|||
33158684|NCT00191269|100494081|FG001|Overall Study|Progression of Disease|42|||
33158685|NCT00191269|100494080|FG000|Overall Study|Lack of Efficacy|1|||
33254140|NCT00716144|100830374|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
33254141|NCT00716144|100830375|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
33254142|NCT00716144|100830376|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
33254143|NCT00716144|100830373|FG000|Overall Study|Adverse event: left foot pain|0|||
33254144|NCT00716144|100830374|FG001|Overall Study|Adverse event: left foot pain|1|||
33254145|NCT00716144|100830375|FG002|Overall Study|Adverse event: left foot pain|0|||
33158686|NCT00191269|100494081|FG001|Overall Study|Lack of Efficacy|5|||
33158687|NCT00191269|100494080|FG000|Overall Study|Withdrawal by Subject|0|||
33158688|NCT00191269|100494081|FG001|Overall Study|Withdrawal by Subject|1|||
33158689|NCT00191269|100494080|FG000|Overall Study|Pathologic Aggrevation|0|||
33158690|NCT00191269|100494081|FG001|Overall Study|Pathologic Aggrevation|1|||
33158691|NCT00191269|100494080|FG000|Overall Study|Physician Decision|0|||
33158692|NCT00191269|100494081|FG001|Overall Study|Physician Decision|3|||
33158693|NCT01602120|100494082|FG000|Overall Study|Adverse Event|3|||
33158694|NCT01602120|100494083|FG001|Overall Study|Adverse Event|6|||
33158695|NCT01602120|100494084|FG002|Overall Study|Adverse Event|0|||
33158696|NCT01602120|100494085|FG003|Overall Study|Adverse Event|2|||
33158697|NCT01602120|100494082|FG000|Overall Study|Death|0|||
33254146|NCT00716144|100830376|FG003|Overall Study|Adverse event: left foot pain|0|||
33254147|NCT00716144|100830373|FG000|Overall Study|Clinical Depression|0|||
33254148|NCT00716144|100830374|FG001|Overall Study|Clinical Depression|1|||
33254149|NCT00716144|100830375|FG002|Overall Study|Clinical Depression|0|||
33254150|NCT00716144|100830376|FG003|Overall Study|Clinical Depression|0|||
33254151|NCT00311363|100830377|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
33254152|NCT00311363|100830378|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
33254153|NCT00311363|100830379|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
33254154|NCT00311363|100830377|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
33254155|NCT00311363|100830378|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
33254156|NCT00311363|100830379|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
33254157|NCT00311363|100830377|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
33254158|NCT00311363|100830378|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
33441394|NCT01185821|101509241|FG001|Overall Study|Lost to Follow-up|1|||
33254159|NCT00311363|100830379|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
33441395|NCT01185821|101509242|FG002|Overall Study|Lost to Follow-up|2|||
33441396|NCT01185821|101509243|FG003|Overall Study|Lost to Follow-up|1|||
33441397|NCT01185821|101509244|FG004|Overall Study|Lost to Follow-up|2|||
33441398|NCT01185821|101509240|FG000|Overall Study|Administrative problems|0|||
33441399|NCT01185821|101509241|FG001|Overall Study|Administrative problems|0|||
33441400|NCT01185821|101509242|FG002|Overall Study|Administrative problems|1|||
33441401|NCT01185821|101509243|FG003|Overall Study|Administrative problems|1|||
33158698|NCT01602120|100494083|FG001|Overall Study|Death|4|||
33158699|NCT01602120|100494084|FG002|Overall Study|Death|0|||
33158700|NCT01602120|100494085|FG003|Overall Study|Death|0|||
33158701|NCT01602120|100494082|FG000|Overall Study|Lost to Follow-up|0|||
33158702|NCT01602120|100494083|FG001|Overall Study|Lost to Follow-up|1|||
33158703|NCT01602120|100494084|FG002|Overall Study|Lost to Follow-up|0|||
33158704|NCT01602120|100494085|FG003|Overall Study|Lost to Follow-up|1|||
33158705|NCT01602120|100494082|FG000|Overall Study|Protocol Violation|1|||
33158706|NCT01602120|100494083|FG001|Overall Study|Protocol Violation|1|||
33158707|NCT01602120|100494084|FG002|Overall Study|Protocol Violation|0|||
33158708|NCT01602120|100494085|FG003|Overall Study|Protocol Violation|0|||
33158709|NCT01602120|100494082|FG000|Overall Study|Non-compliance|0|||
33158710|NCT01602120|100494083|FG001|Overall Study|Non-compliance|3|||
33158711|NCT01602120|100494084|FG002|Overall Study|Non-compliance|0|||
33158712|NCT01602120|100494085|FG003|Overall Study|Non-compliance|1|||
33158713|NCT01602120|100494082|FG000|Overall Study|Withdrawal by Subject|8|||
33158714|NCT01602120|100494083|FG001|Overall Study|Withdrawal by Subject|17|||
33158715|NCT01602120|100494084|FG002|Overall Study|Withdrawal by Subject|0|||
33158716|NCT01602120|100494085|FG003|Overall Study|Withdrawal by Subject|3|||
33158717|NCT01602120|100494082|FG000|Overall Study|Study Terminated by Sponsor|12|||
33158718|NCT01602120|100494083|FG001|Overall Study|Study Terminated by Sponsor|24|||
33158719|NCT01602120|100494084|FG002|Overall Study|Study Terminated by Sponsor|17|||
33158720|NCT01602120|100494085|FG003|Overall Study|Study Terminated by Sponsor|44|||
33158721|NCT01602120|100494082|FG000|Overall Study|Physician Decision|2|||
33158722|NCT01602120|100494083|FG001|Overall Study|Physician Decision|3|||
33158723|NCT01602120|100494084|FG002|Overall Study|Physician Decision|0|||
33158724|NCT01602120|100494085|FG003|Overall Study|Physician Decision|0|||
33158725|NCT01602120|100494082|FG000|Overall Study|Unspecified Reason|3|||
33158726|NCT01602120|100494083|FG001|Overall Study|Unspecified Reason|1|||
33158727|NCT01602120|100494084|FG002|Overall Study|Unspecified Reason|0|||
33158728|NCT01602120|100494085|FG003|Overall Study|Unspecified Reason|2|||
33158729|NCT00696800|100494091|FG000|Overall Study|Adverse Event|16|||
33158730|NCT00696800|100494092|FG001|Overall Study|Adverse Event|3|||
33158731|NCT00696800|100494091|FG000|Overall Study|Insufficient compliance with medication|2|||
33158732|NCT00696800|100494092|FG001|Overall Study|Insufficient compliance with medication|1|||
33158733|NCT00696800|100494091|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
33158734|NCT00696800|100494092|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
33158735|NCT00696800|100494091|FG000|Overall Study|Insufficient ovarian response|4|||
33158736|NCT00696800|100494092|FG001|Overall Study|Insufficient ovarian response|1|||
33158737|NCT00696800|100494091|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
33158738|NCT00696800|100494092|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
33158739|NCT00696800|100494091|FG000|Overall Study|Too high ovarian response|6|||
33158740|NCT00696800|100494092|FG001|Overall Study|Too high ovarian response|1|||
33158741|NCT00696800|100494091|FG000|Overall Study|No/too few/bad quality oocytes|4|||
33158742|NCT00696800|100494092|FG001|Overall Study|No/too few/bad quality oocytes|3|||
33158743|NCT00696800|100494091|FG000|Overall Study|No/abnormal fertilization|11|||
33158744|NCT00696800|100494092|FG001|Overall Study|No/abnormal fertilization|13|||
33158745|NCT00696800|100494091|FG000|Overall Study|No/too few/bad quality embryos|24|||
33158746|NCT00696800|100494092|FG001|Overall Study|No/too few/bad quality embryos|18|||
33158747|NCT00696800|100494091|FG000|Overall Study|Other Reasons|5|||
33158748|NCT00696800|100494092|FG001|Overall Study|Other Reasons|3|||
33158749|NCT00696800|100494091|FG000|Overall Study|Not treated|1|||
33158750|NCT00696800|100494092|FG001|Overall Study|Not treated|2|||
33158751|NCT03685123|100494093|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
33158752|NCT03685123|100494094|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
33158753|NCT03685123|100494095|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
33158754|NCT03685123|100494093|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
33158755|NCT03685123|100494094|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
33158756|NCT03685123|100494095|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
33158757|NCT03685123|100494093|FG000|Weight Loss Phase|Lost to Follow-up|1|||
33254160|NCT00311363|100830377|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
33254161|NCT00311363|100830378|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
33254162|NCT00311363|100830379|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
33388809|NCT00712933|101309349|FG000|Overall Study|Hip replacement surgery|1|||
33158758|NCT03685123|100494094|FG001|Weight Loss Phase|Lost to Follow-up|0|||
33158759|NCT03685123|100494095|FG002|Weight Loss Phase|Lost to Follow-up|0|||
33158760|NCT03685123|100494093|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
33158761|NCT03685123|100494094|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
33158762|NCT03685123|100494095|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
33158763|NCT03685123|100494093|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
33158764|NCT03685123|100494094|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
33158765|NCT03685123|100494095|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
33158766|NCT03685123|100494093|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
33158767|NCT03685123|100494094|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
33158768|NCT03685123|100494095|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
33158769|NCT02059408|100494096|FG000|Overall Study|Did not get tested|0|||
33158770|NCT02059408|100494097|FG001|Overall Study|Did not get tested|330|||
33441402|NCT01185821|101509244|FG004|Overall Study|Administrative problems|2|||
33441403|NCT00488774|101509245|FG000|Overall Study|Withdrawal of consent|2|||
33441404|NCT00488774|101509246|FG001|Overall Study|Withdrawal of consent|2|||
33441405|NCT00488774|101509247|FG002|Overall Study|Withdrawal of consent|2|||
33441406|NCT00488774|101509248|FG003|Overall Study|Withdrawal of consent|0|||
33441407|NCT00488774|101509245|FG000|Overall Study|Other|6|||
33441408|NCT00488774|101509246|FG001|Overall Study|Other|3|||
33441409|NCT00488774|101509247|FG002|Overall Study|Other|2|||
33441410|NCT00488774|101509248|FG003|Overall Study|Other|2|||
33441411|NCT00488774|101509245|FG000|Overall Study|Lost to Follow-up|0|||
33441412|NCT00488774|101509246|FG001|Overall Study|Lost to Follow-up|0|||
33441413|NCT00488774|101509247|FG002|Overall Study|Lost to Follow-up|1|||
33441414|NCT00488774|101509248|FG003|Overall Study|Lost to Follow-up|1|||
33441415|NCT01110005|101509251|FG000|Overall Study|ineligible|1|||
33441416|NCT01110005|101509252|FG001|Overall Study|ineligible|2|||
33441417|NCT01110005|101509251|FG000|Overall Study|missing consent|3|||
33441418|NCT01110005|101509252|FG001|Overall Study|missing consent|2|||
33441419|NCT01110005|101509251|FG000|Overall Study|Withdrawal by Subject|0|||
33441420|NCT01110005|101509252|FG001|Overall Study|Withdrawal by Subject|1|||
33441421|NCT00620022|101509258|FG000|Treatment Period 1|Adverse Event|4|||
33441422|NCT00620022|101509259|FG001|Treatment Period 1|Adverse Event|6|||
33441423|NCT00620022|101509258|FG000|Treatment Period 1|Subject withdrew consent|1|||
33441424|NCT00620022|101509259|FG001|Treatment Period 1|Subject withdrew consent|0|||
33441425|NCT00620022|101509258|FG000|Treatment Period 2|Adverse Event|2|||
33441426|NCT00620022|101509259|FG001|Treatment Period 2|Adverse Event|2|||
33441427|NCT05275205|101509260|FG000|Overall Study|Adverse Event|1|||
33441428|NCT05275205|101509261|FG001|Overall Study|Adverse Event|2|||
33441429|NCT05275205|101509260|FG000|Overall Study|Physician Decision|1|||
33441430|NCT05275205|101509261|FG001|Overall Study|Physician Decision|1|||
33441431|NCT05275205|101509260|FG000|Overall Study|Withdrawal by Subject|2|||
33441432|NCT05275205|101509261|FG001|Overall Study|Withdrawal by Subject|3|||
33441433|NCT05275205|101509260|FG000|Overall Study|Death|1|||
33441434|NCT05275205|101509261|FG001|Overall Study|Death|0|||
33441435|NCT05275205|101509260|FG000|Overall Study|Patient unable to attend visits|1|||
33441436|NCT05275205|101509261|FG001|Overall Study|Patient unable to attend visits|0|||
33441437|NCT01035060|101509262|FG000|Overall Study|Lost to Follow-up|0|||
33441438|NCT01035060|101509263|FG001|Overall Study|Lost to Follow-up|7|||
33441439|NCT01035060|101509262|FG000|Overall Study|Did not quality after 2nd screening|14|||
33441440|NCT01035060|101509263|FG001|Overall Study|Did not quality after 2nd screening|1|||
33441441|NCT01035060|101509262|FG000|Overall Study|Withdrawal by Subject|8|||
33441442|NCT01035060|101509263|FG001|Overall Study|Withdrawal by Subject|6|||
33441443|NCT01035060|101509262|FG000|Overall Study|Physician Decision|2|||
33441444|NCT01035060|101509263|FG001|Overall Study|Physician Decision|0|||
33441445|NCT00856388|101509270|FG000|Overall Study|Other|1|||
33158771|NCT02059408|100494098|FG002|Overall Study|Did not get tested|358|||
33158772|NCT02980783|100494099|FG000|Overall Study|Lost to Follow-up|1|||
33388810|NCT00712933|101309349|FG000|Overall Study|Involved in Clinical research|3|||
33441446|NCT00096265|101509271|FG000|Overall Study|Ineligible|1|||
33441447|NCT00096265|101509272|FG001|Overall Study|Ineligible|0|||
33441448|NCT00096265|101509273|FG002|Overall Study|Ineligible|0|||
33441449|NCT03929393|101509274|FG000|Overall Study|Death|1|||
33441450|NCT03929393|101509275|FG001|Overall Study|Death|0|||
33441451|NCT03929393|101509274|FG000|Overall Study|Time Commitment|2|||
33441452|NCT03929393|101509275|FG001|Overall Study|Time Commitment|5|||
33441453|NCT03929393|101509274|FG000|Overall Study|Motor Vehicle Accident|0|||
33441454|NCT03929393|101509275|FG001|Overall Study|Motor Vehicle Accident|1|||
33441455|NCT03929393|101509274|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
33254163|NCT00311363|100830377|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
33441456|NCT03929393|101509275|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
33441457|NCT03929393|101509274|FG000|Overall Study|Other|1|||
33158773|NCT00492531|100494101|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
33158774|NCT00492531|100494102|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
33158775|NCT02538029|100494105|FG000|Overall Study|unable to complete cognitive assessments|1|||
33158776|NCT02538029|100494106|FG001|Overall Study|unable to complete cognitive assessments|0|||
33158777|NCT02538029|100494107|FG002|Overall Study|unable to complete cognitive assessments|1|||
33158778|NCT00615108|100494108|FG000|Overall Study|Adverse Event|122|||
33158779|NCT00615108|100494108|FG000|Overall Study|Other|370|||
33158780|NCT00615108|100494108|FG000|Overall Study|Lost to Follow-up|15|||
33158781|NCT05439941|100494112|FG000|Overall Study|Lack of Efficacy|8|||
33158782|NCT05439941|100494113|FG001|Overall Study|Lack of Efficacy|5|||
33158783|NCT05439941|100494114|FG002|Overall Study|Lack of Efficacy|3|||
33158784|NCT05439941|100494112|FG000|Overall Study|Treatment Failure|0|||
33158785|NCT05439941|100494113|FG001|Overall Study|Treatment Failure|1|||
33158786|NCT05439941|100494114|FG002|Overall Study|Treatment Failure|0|||
33158787|NCT05439941|100494112|FG000|Overall Study|Adverse Event|1|||
33158788|NCT05439941|100494113|FG001|Overall Study|Adverse Event|3|||
33158789|NCT05439941|100494114|FG002|Overall Study|Adverse Event|0|||
33158790|NCT05439941|100494112|FG000|Overall Study|Adverse Event - Parent Study|1|||
33158791|NCT05439941|100494113|FG001|Overall Study|Adverse Event - Parent Study|0|||
33158792|NCT05439941|100494114|FG002|Overall Study|Adverse Event - Parent Study|0|||
33441458|NCT03929393|101509275|FG001|Overall Study|Other|3|||
33158793|NCT05439941|100494112|FG000|Overall Study|Pregnancy|1|||
33158794|NCT05439941|100494113|FG001|Overall Study|Pregnancy|0|||
33254164|NCT00311363|100830378|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
33254165|NCT00311363|100830379|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
33254166|NCT00311363|100830377|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
33254167|NCT00311363|100830378|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
33254168|NCT00311363|100830379|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
33158795|NCT05439941|100494114|FG002|Overall Study|Pregnancy|0|||
33441459|NCT05341622|101509276|FG000|Overall Study|Death|0|||
33441460|NCT05341622|101509277|FG001|Overall Study|Death|0|||
33441461|NCT05341622|101509278|FG002|Overall Study|Death|0|||
33441462|NCT05341622|101509279|FG003|Overall Study|Death|0|||
33441463|NCT05341622|101509280|FG004|Overall Study|Death|1|||
33441464|NCT05341622|101509281|FG005|Overall Study|Death|0|||
33441465|NCT05341622|101509282|FG006|Overall Study|Death|0|||
33441466|NCT05341622|101509283|FG007|Overall Study|Death|1|||
33441467|NCT05341622|101509276|FG000|Overall Study|Invalid Address|0|||
33441468|NCT05341622|101509277|FG001|Overall Study|Invalid Address|1|||
33441469|NCT05341622|101509278|FG002|Overall Study|Invalid Address|0|||
33441470|NCT05341622|101509279|FG003|Overall Study|Invalid Address|0|||
33441471|NCT05341622|101509280|FG004|Overall Study|Invalid Address|0|||
33158796|NCT05439941|100494112|FG000|Overall Study|Withdrawal by Subject|9|||
33158797|NCT05439941|100494113|FG001|Overall Study|Withdrawal by Subject|6|||
33158798|NCT05439941|100494114|FG002|Overall Study|Withdrawal by Subject|10|||
33441472|NCT05341622|101509281|FG005|Overall Study|Invalid Address|0|||
33441473|NCT05341622|101509282|FG006|Overall Study|Invalid Address|0|||
33441474|NCT05341622|101509283|FG007|Overall Study|Invalid Address|0|||
33441475|NCT05341622|101509276|FG000|Overall Study|Ineligible|26|||
33441476|NCT05341622|101509277|FG001|Overall Study|Ineligible|21|||
33441477|NCT05341622|101509278|FG002|Overall Study|Ineligible|28|||
33441478|NCT05341622|101509279|FG003|Overall Study|Ineligible|24|||
33441479|NCT05341622|101509280|FG004|Overall Study|Ineligible|29|||
33441480|NCT05341622|101509281|FG005|Overall Study|Ineligible|31|||
33441481|NCT05341622|101509282|FG006|Overall Study|Ineligible|28|||
33441482|NCT05341622|101509283|FG007|Overall Study|Ineligible|26|||
33441483|NCT02327130|101509284|FG000|Overall Study|Discharged in less than 5 days|5|||
33441484|NCT02327130|101509284|FG000|Overall Study|Physician Decision|2|||
33441485|NCT02327130|101509284|FG000|Overall Study|Unable to provide breath sample|1|||
33441486|NCT02327130|101509284|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
33441487|NCT02327130|101509284|FG000|Overall Study|Met exclusion criteria|3|||
33441488|NCT00445003|101509285|FG000|Overall Study|Death|1|||
33441489|NCT00445003|101509286|FG001|Overall Study|Death|2|||
33441490|NCT00445003|101509287|FG002|Overall Study|Death|1|||
33441491|NCT00445003|101509285|FG000|Overall Study|Missed Visit|3|||
33441492|NCT00445003|101509286|FG001|Overall Study|Missed Visit|5|||
33441493|NCT00445003|101509287|FG002|Overall Study|Missed Visit|1|||
33441494|NCT00445003|101509285|FG000|Overall Study|Dropped|1|||
33441495|NCT00445003|101509286|FG001|Overall Study|Dropped|3|||
33441496|NCT00445003|101509287|FG002|Overall Study|Dropped|2|||
33441497|NCT03603314|101509288|FG000|Overall Study|Lost to Follow-up|0|||
33441498|NCT03603314|101509289|FG001|Overall Study|Lost to Follow-up|3|||
33441499|NCT03603314|101509290|FG002|Overall Study|Lost to Follow-up|0|||
33158799|NCT05439941|100494112|FG000|Overall Study|Non-Compliance|1|||
33388811|NCT00712933|101309349|FG000|Overall Study|Participant hospitalized|1|||
33441500|NCT03603314|101509288|FG000|Overall Study|Protocol Violation|0|||
33441501|NCT03603314|101509289|FG001|Overall Study|Protocol Violation|1|||
33441502|NCT03603314|101509290|FG002|Overall Study|Protocol Violation|0|||
33441503|NCT03603314|101509288|FG000|Overall Study|Adverse Event|2|||
33441504|NCT03603314|101509289|FG001|Overall Study|Adverse Event|0|||
33441505|NCT03603314|101509290|FG002|Overall Study|Adverse Event|0|||
33441506|NCT03603314|101509288|FG000|Overall Study|Physician Decision|1|||
33441507|NCT03603314|101509289|FG001|Overall Study|Physician Decision|1|||
33441508|NCT03603314|101509290|FG002|Overall Study|Physician Decision|0|||
33441509|NCT03603314|101509288|FG000|Overall Study|Withdrawal by Subject|4|||
33441510|NCT03603314|101509289|FG001|Overall Study|Withdrawal by Subject|5|||
33441511|NCT03603314|101509290|FG002|Overall Study|Withdrawal by Subject|3|||
33441512|NCT03603314|101509288|FG000|Overall Study|Other|0|||
33441513|NCT03603314|101509289|FG001|Overall Study|Other|1|||
33441514|NCT03603314|101509290|FG002|Overall Study|Other|0|||
33441515|NCT00528606|101509299|FG000|Overall Study|Withdrew consent|4|||
33441516|NCT00528606|101509300|FG001|Overall Study|Withdrew consent|3|||
33441517|NCT00528606|101509299|FG000|Overall Study|Lost to Follow-up|4|||
33441518|NCT00528606|101509300|FG001|Overall Study|Lost to Follow-up|1|||
33441519|NCT00528606|101509299|FG000|Overall Study|Adverse Event|3|||
33441520|NCT00528606|101509300|FG001|Overall Study|Adverse Event|0|||
33441521|NCT00528606|101509299|FG000|Overall Study|Other|2|||
33286465|NCT00092521|100943969|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
33441522|NCT00528606|101509300|FG001|Overall Study|Other|0|||
33441523|NCT01772537|101509301|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
33441524|NCT01772537|101509302|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
33441525|NCT01772537|101509303|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
33441526|NCT04646213|101511940|FG000|Overall Study|Physician Decision|3|||
33441527|NCT04646213|101511940|FG000|Overall Study|Withdrawal by Subject|2|||
33441528|NCT03136380|101511941|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
33441529|NCT03136380|101511942|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
33441530|NCT03136380|101511943|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
33441531|NCT03136380|101511944|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
33441532|NCT03136380|101511945|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
33441533|NCT03686033|101511946|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
33441534|NCT03686033|101511947|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
33441535|NCT03686033|101511948|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
33441536|NCT03686033|101511949|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
33441537|NCT03686033|101511950|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
33441538|NCT03686033|101511951|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
33441539|NCT02419937|101511952|FG000|Overall Study|Lost to Follow-up|1|||
33441540|NCT02419937|101511953|FG001|Overall Study|Lost to Follow-up|0|||
33441541|NCT02794974|101511956|FG000|Overall Study|Physician Decision|0|||
33441542|NCT02794974|101511957|FG001|Overall Study|Physician Decision|1|||
33441543|NCT02865122|101511958|FG000|Overall Study|Adverse Event|1|||
33158800|NCT05439941|100494113|FG001|Overall Study|Non-Compliance|1|||
33158801|NCT05439941|100494114|FG002|Overall Study|Non-Compliance|1|||
33158802|NCT05439941|100494112|FG000|Overall Study|Lost to Follow-up|2|||
33158803|NCT05439941|100494113|FG001|Overall Study|Lost to Follow-up|2|||
33158804|NCT05439941|100494114|FG002|Overall Study|Lost to Follow-up|0|||
33158805|NCT05439941|100494112|FG000|Overall Study|Physician Decision|1|||
33158806|NCT05439941|100494113|FG001|Overall Study|Physician Decision|0|||
33158807|NCT05439941|100494114|FG002|Overall Study|Physician Decision|0|||
33158808|NCT05439941|100494112|FG000|Overall Study|Trial Termination by Sponsor|78|||
33158809|NCT05439941|100494113|FG001|Overall Study|Trial Termination by Sponsor|83|||
33158810|NCT05439941|100494114|FG002|Overall Study|Trial Termination by Sponsor|65|||
33158811|NCT05439941|100494112|FG000|Overall Study|Other than Reasons Listed|2|||
33158812|NCT05439941|100494113|FG001|Overall Study|Other than Reasons Listed|1|||
33158813|NCT05439941|100494114|FG002|Overall Study|Other than Reasons Listed|0|||
33158814|NCT00450255|100494115|FG000|Overall Study|Prior RFA ablation of liver|1|||
33158815|NCT00573183|100494116|FG000|Overall Study|Lost to Follow-up|52|||
33158816|NCT00573183|100494117|FG001|Overall Study|Lost to Follow-up|50|||
33158817|NCT00573183|100494116|FG000|Overall Study|Withdrawal by Subject|8|||
33158818|NCT00573183|100494117|FG001|Overall Study|Withdrawal by Subject|2|||
33158819|NCT00573183|100494116|FG000|Overall Study|Death|0|||
33158820|NCT00573183|100494117|FG001|Overall Study|Death|1|||
33158821|NCT00573183|100494116|FG000|Overall Study|Adverse Event|2|||
33254169|NCT00311363|100830377|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
33158822|NCT00573183|100494117|FG001|Overall Study|Adverse Event|0|||
33158823|NCT00573183|100494116|FG000|Overall Study|Incarceration|5|||
33158824|NCT00573183|100494117|FG001|Overall Study|Incarceration|8|||
33158825|NCT00573183|100494116|FG000|Overall Study|Other|5|||
33158826|NCT00573183|100494117|FG001|Overall Study|Other|2|||
33158827|NCT03320057|100494120|FG000|Overall Study|Lost to Follow-up|4|||
33158828|NCT03320057|100494121|FG001|Overall Study|Lost to Follow-up|17|||
33441544|NCT02865122|101511959|FG001|Overall Study|Adverse Event|0|||
33158829|NCT03320057|100494120|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
33158830|NCT03320057|100494121|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
33158831|NCT00894166|100494122|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
33158832|NCT00894166|100494123|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
33158833|NCT00894166|100494124|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
33158834|NCT00894166|100494125|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
33158835|NCT00894166|100494126|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
33158836|NCT00894166|100494127|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
33158837|NCT00894166|100494128|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
33158838|NCT00894166|100494129|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
33158839|NCT00894166|100494122|FG000|Overall Study|Death|0|||
33158840|NCT00894166|100494123|FG001|Overall Study|Death|0|||
33158841|NCT00894166|100494124|FG002|Overall Study|Death|0|||
33158842|NCT00894166|100494125|FG003|Overall Study|Death|1|||
33158843|NCT00894166|100494126|FG004|Overall Study|Death|0|||
33158844|NCT00894166|100494127|FG005|Overall Study|Death|0|||
33254170|NCT00311363|100830378|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
33254171|NCT00311363|100830379|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
33158845|NCT00894166|100494128|FG006|Overall Study|Death|0|||
33158846|NCT00894166|100494129|FG007|Overall Study|Death|0|||
33158847|NCT05248867|100494130|FG000|Double-blind Period|Lost to Follow-up|0|||
33158848|NCT05248867|100494131|FG001|Double-blind Period|Lost to Follow-up|3|||
33158849|NCT05248867|100494132|FG002|Double-blind Period|Lost to Follow-up|0|||
33158850|NCT05248867|100494133|FG003|Double-blind Period|Lost to Follow-up|0|||
33158851|NCT05248867|100494134|FG004|Double-blind Period|Lost to Follow-up|0|||
33441545|NCT02865122|101511960|FG002|Overall Study|Adverse Event|0|||
33441546|NCT01576042|101511961|FG000|Overall Study|Physician Decision|2|||
33441547|NCT01576042|101511962|FG001|Overall Study|Physician Decision|0|||
33441548|NCT00468286|101511963|FG000|Overall Study|Adverse Event|1|||
33441549|NCT00468286|101511964|FG001|Overall Study|Adverse Event|6|||
33441550|NCT00468286|101511963|FG000|Overall Study|Protocol Violation|2|||
33441551|NCT00468286|101511964|FG001|Overall Study|Protocol Violation|2|||
33441552|NCT00468286|101511963|FG000|Overall Study|Withdrawal by Subject|4|||
33441553|NCT00468286|101511964|FG001|Overall Study|Withdrawal by Subject|3|||
33441554|NCT00468286|101511963|FG000|Overall Study|Physician Decision|0|||
33441555|NCT00468286|101511964|FG001|Overall Study|Physician Decision|1|||
33441556|NCT04320849|101511968|FG000|Overall Study|Withdrawal by Subject|4|||
33441557|NCT04320849|101511968|FG000|Overall Study|Imaging data unavailable|2|||
33441558|NCT04320849|101511968|FG000|Overall Study|Incomplete imaging|2|||
33441559|NCT00585689|101511969|FG000|Overall Study|Received different ABI-007 schedule|3|||
33441560|NCT00585689|101511969|FG000|Overall Study|Adverse Event|1|||
33441561|NCT00585689|101511969|FG000|Overall Study|Patient Declined Surgery|1|||
33441562|NCT00585689|101511969|FG000|Overall Study|Patient had unresectable disease|1|||
33441563|NCT00585689|101511969|FG000|Overall Study|Death|1|||
33441564|NCT04000815|101511977|FG000|Overall Study|Lost to Follow-up|9|||
33441565|NCT04000815|101511978|FG001|Overall Study|Lost to Follow-up|2|||
33441566|NCT04000815|101511979|FG002|Overall Study|Lost to Follow-up|3|||
33388812|NCT00712933|101309349|FG000|Overall Study|Participant travelled overseas|2|||
33158852|NCT05248867|100494135|FG005|Double-blind Period|Lost to Follow-up|0|||
33441567|NCT04000815|101511977|FG000|Overall Study|Withdrawal by Subject|4|||
33158853|NCT05248867|100494130|FG000|Double-blind Period|Withdrawal by Subject|5|||
33158854|NCT05248867|100494131|FG001|Double-blind Period|Withdrawal by Subject|14|||
33158855|NCT05248867|100494132|FG002|Double-blind Period|Withdrawal by Subject|0|||
33158856|NCT05248867|100494133|FG003|Double-blind Period|Withdrawal by Subject|0|||
33441568|NCT04000815|101511978|FG001|Overall Study|Withdrawal by Subject|3|||
33441569|NCT04000815|101511979|FG002|Overall Study|Withdrawal by Subject|2|||
33441570|NCT04000815|101511977|FG000|Overall Study|Right ovarian cyst occured|1|||
33441571|NCT04000815|101511978|FG001|Overall Study|Right ovarian cyst occured|0|||
33441572|NCT04000815|101511979|FG002|Overall Study|Right ovarian cyst occured|0|||
33441573|NCT04000815|101511977|FG000|Overall Study|Hypertension occured on follow up|0|||
33441574|NCT04000815|101511978|FG001|Overall Study|Hypertension occured on follow up|0|||
33441575|NCT04000815|101511979|FG002|Overall Study|Hypertension occured on follow up|2|||
33441576|NCT00086996|101511980|FG000|Overall Study|Adverse Event|29|||
33441577|NCT00086996|101511980|FG000|Overall Study|Death|4|||
33441578|NCT00086996|101511980|FG000|Overall Study|progression/relapse|7|||
33441579|NCT00086996|101511980|FG000|Overall Study|Withdrawal by Subject|13|||
33158857|NCT05248867|100494134|FG004|Double-blind Period|Withdrawal by Subject|0|||
33158858|NCT05248867|100494135|FG005|Double-blind Period|Withdrawal by Subject|0|||
33158859|NCT05248867|100494130|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
33158860|NCT05248867|100494131|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
33441580|NCT00086996|101511980|FG000|Overall Study|Other|6|||
33441581|NCT00086996|101511980|FG000|Overall Study|not eligible|5|||
33441582|NCT01591785|101511981|FG000|Overall Study|worsening condition|1|||
33441583|NCT01591785|101511982|FG001|Overall Study|worsening condition|2|||
33158861|NCT05248867|100494132|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
33158862|NCT05248867|100494133|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
33158863|NCT05248867|100494134|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
33158864|NCT05248867|100494135|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
33158865|NCT05248867|100494130|FG000|Double-blind Period|Other, not specified|3|||
33158866|NCT05248867|100494131|FG001|Double-blind Period|Other, not specified|8|||
33158867|NCT05248867|100494132|FG002|Double-blind Period|Other, not specified|0|||
33158868|NCT05248867|100494133|FG003|Double-blind Period|Other, not specified|0|||
33158869|NCT05248867|100494134|FG004|Double-blind Period|Other, not specified|0|||
33158870|NCT05248867|100494135|FG005|Double-blind Period|Other, not specified|0|||
33158871|NCT05248867|100494130|FG000|Open-label Period|Withdrawal by Subject|0|||
33158872|NCT05248867|100494131|FG001|Open-label Period|Withdrawal by Subject|0|||
33158873|NCT05248867|100494132|FG002|Open-label Period|Withdrawal by Subject|3|||
33158874|NCT05248867|100494133|FG003|Open-label Period|Withdrawal by Subject|1|||
33158875|NCT05248867|100494134|FG004|Open-label Period|Withdrawal by Subject|7|||
33158876|NCT05248867|100494135|FG005|Open-label Period|Withdrawal by Subject|9|||
33158877|NCT05248867|100494130|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
33158878|NCT05248867|100494131|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
33158879|NCT05248867|100494132|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
33158880|NCT05248867|100494133|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
33158881|NCT05248867|100494134|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
33158882|NCT05248867|100494135|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
33158883|NCT05248867|100494130|FG000|Open-label Period|Lost to Follow-up|0|||
33158884|NCT05248867|100494131|FG001|Open-label Period|Lost to Follow-up|0|||
33158885|NCT05248867|100494132|FG002|Open-label Period|Lost to Follow-up|0|||
33158886|NCT05248867|100494133|FG003|Open-label Period|Lost to Follow-up|0|||
33158887|NCT05248867|100494134|FG004|Open-label Period|Lost to Follow-up|5|||
33158888|NCT05248867|100494135|FG005|Open-label Period|Lost to Follow-up|2|||
33158889|NCT05248867|100494130|FG000|Open-label Period|COVID-19 Infection|0|||
33158890|NCT05248867|100494131|FG001|Open-label Period|COVID-19 Infection|0|||
33388813|NCT00712933|101309349|FG000|Overall Study|Death of patient|1|||
33441584|NCT01591785|101511981|FG000|Overall Study|Protocol Violation|2|||
33441585|NCT01591785|101511982|FG001|Overall Study|Protocol Violation|0|||
33158891|NCT05248867|100494132|FG002|Open-label Period|COVID-19 Infection|0|||
33158892|NCT05248867|100494133|FG003|Open-label Period|COVID-19 Infection|0|||
33158893|NCT05248867|100494134|FG004|Open-label Period|COVID-19 Infection|1|||
33441586|NCT01591785|101511981|FG000|Overall Study|Lost to Follow-up|1|||
33441587|NCT01591785|101511982|FG001|Overall Study|Lost to Follow-up|0|||
33158894|NCT05248867|100494135|FG005|Open-label Period|COVID-19 Infection|0|||
33158895|NCT05248867|100494130|FG000|Open-label Period|Other, not specified|0|||
33158896|NCT05248867|100494131|FG001|Open-label Period|Other, not specified|0|||
33158897|NCT05248867|100494132|FG002|Open-label Period|Other, not specified|0|||
33158898|NCT05248867|100494133|FG003|Open-label Period|Other, not specified|0|||
33158899|NCT05248867|100494134|FG004|Open-label Period|Other, not specified|4|||
33158900|NCT05248867|100494135|FG005|Open-label Period|Other, not specified|0|||
33158901|NCT00457301|100494138|FG000|Overall Study|Withdrawal by Subject|3|||
33158902|NCT00457301|100494139|FG001|Overall Study|Withdrawal by Subject|3|||
33158903|NCT00457301|100494138|FG000|Overall Study|Censored out of the study|15|||
33158904|NCT00457301|100494139|FG001|Overall Study|Censored out of the study|14|||
33158905|NCT00457301|100494138|FG000|Overall Study|Death|5|||
33158906|NCT00457301|100494139|FG001|Overall Study|Death|7|||
33158907|NCT01217801|100494143|FG000|Period 1|Protocol Violation|1|||
33158908|NCT01217801|100494144|FG001|Period 1|Protocol Violation|1|||
33158909|NCT01217801|100494143|FG000|Period 1|Withdrawal by Subject|0|||
33158910|NCT01217801|100494144|FG001|Period 1|Withdrawal by Subject|1|||
33158911|NCT03342963|100494146|FG000|Overall Study|Adverse Event|1|||
33158912|NCT03342963|100494147|FG001|Overall Study|Adverse Event|2|||
33158913|NCT03342963|100494148|FG002|Overall Study|Adverse Event|0|||
33158914|NCT03342963|100494149|FG003|Overall Study|Adverse Event|0|||
33158915|NCT03342963|100494146|FG000|Overall Study|Withdrawal by Subject|1|||
33441588|NCT02678286|101511983|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
33441589|NCT02678286|101511984|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
33441590|NCT02678286|101511983|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
33441591|NCT02678286|101511984|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
33441592|NCT02678286|101511983|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
33441593|NCT02678286|101511984|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
33441594|NCT02678286|101511983|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
33441595|NCT02678286|101511984|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
33441596|NCT02678286|101511983|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
33441597|NCT02678286|101511984|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
33441598|NCT03020641|101511985|FG000|Overall Study|Lost to Follow-up|0|||
33441599|NCT03020641|101511986|FG001|Overall Study|Lost to Follow-up|1|||
33441600|NCT03020641|101511985|FG000|Overall Study|Converted to open surgery|2|||
33441601|NCT03020641|101511986|FG001|Overall Study|Converted to open surgery|1|||
33441602|NCT03020641|101511985|FG000|Overall Study|for surgery not performed|0|||
33441603|NCT03020641|101511986|FG001|Overall Study|for surgery not performed|1|||
33441604|NCT03123471|101511987|FG000|Placebo-controlled Phase|Adverse Event|3|||
33158916|NCT03342963|100494147|FG001|Overall Study|Withdrawal by Subject|0|||
33158917|NCT03342963|100494148|FG002|Overall Study|Withdrawal by Subject|0|||
33158918|NCT03342963|100494149|FG003|Overall Study|Withdrawal by Subject|0|||
33158919|NCT03607487|100494150|FG000|Overall Study|Withdrawal by Subject|2|||
33254172|NCT00311363|100830377|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
33158920|NCT03607487|100494151|FG001|Overall Study|Withdrawal by Subject|0|||
33158921|NCT03607487|100494152|FG002|Overall Study|Withdrawal by Subject|0|||
33158922|NCT03607487|100494153|FG003|Overall Study|Withdrawal by Subject|1|||
33158923|NCT01696695|100494161|FG000|Overall Study|Disease progression|373|||
33158924|NCT01696695|100494161|FG000|Overall Study|Death|29|||
33158925|NCT01696695|100494161|FG000|Overall Study|Adverse Event|74|||
33158926|NCT01696695|100494161|FG000|Overall Study|Withdrawal by Subject|92|||
33158927|NCT01696695|100494161|FG000|Overall Study|Lost to Follow-up|48|||
33158928|NCT01696695|100494161|FG000|Overall Study|Other|74|||
33158929|NCT01696695|100494161|FG000|Overall Study|Major Protocol Violation|192|||
33158930|NCT01560403|100494162|FG000|Overall Study|Lost to Follow-up|0|||
33158931|NCT01560403|100494163|FG001|Overall Study|Lost to Follow-up|1|||
33158932|NCT01846104|100494165|FG000|Overall Study|Withdrawal by Subject|1|||
33158933|NCT01787331|100494173|FG000|Overall Study|Physician Decision|1|||
33158934|NCT01787331|100494173|FG000|Overall Study|Withdrawal by Subject|1|||
33158935|NCT04447794|100494176|FG000|Overall Study|Lost to Follow-up|2|||
33158936|NCT04447794|100494177|FG001|Overall Study|Lost to Follow-up|3|||
33158937|NCT04447794|100494178|FG002|Overall Study|Lost to Follow-up|8|||
33441605|NCT03123471|101511988|FG001|Placebo-controlled Phase|Adverse Event|8|||
33441606|NCT03123471|101511987|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
33441607|NCT03123471|101511988|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
33441608|NCT03123471|101511987|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
33441609|NCT03123471|101511988|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
33441610|NCT03123471|101511987|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
33441611|NCT03123471|101511988|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
33441612|NCT03123471|101511987|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
33441613|NCT03123471|101511988|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
33441614|NCT03123471|101511987|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
33441615|NCT03123471|101511988|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
33441616|NCT03123471|101511987|FG000|Placebo-controlled Phase|Miscellaneous|0|||
33441617|NCT03123471|101511988|FG001|Placebo-controlled Phase|Miscellaneous|1|||
33441618|NCT03123471|101511987|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
33441619|NCT03123471|101511988|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
33441620|NCT03123471|101511987|FG000|Apremilast Extension Phase|Adverse Event|1|||
33441621|NCT03123471|101511988|FG001|Apremilast Extension Phase|Adverse Event|5|||
33441622|NCT03123471|101511987|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
33441623|NCT03123471|101511988|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
33441624|NCT03123471|101511987|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
33441625|NCT03123471|101511988|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
33441626|NCT00857623|101511989|FG000|Overall Study|Adverse Event|5|||
33441627|NCT00857623|101511990|FG001|Overall Study|Adverse Event|2|||
33441628|NCT00857623|101511989|FG000|Overall Study|Study-specific discontinuation criteria|5|||
33441629|NCT00857623|101511990|FG001|Overall Study|Study-specific discontinuation criteria|3|||
33441630|NCT00857623|101511989|FG000|Overall Study|Withdrawal by Subject|2|||
33441631|NCT00857623|101511990|FG001|Overall Study|Withdrawal by Subject|1|||
33441632|NCT00857623|101511989|FG000|Overall Study|Lack of Efficacy|1|||
33441633|NCT00857623|101511990|FG001|Overall Study|Lack of Efficacy|1|||
33158938|NCT04447794|100494176|FG000|Overall Study|Withdrawal by Subject|1|||
33158939|NCT04447794|100494177|FG001|Overall Study|Withdrawal by Subject|1|||
33158940|NCT04447794|100494178|FG002|Overall Study|Withdrawal by Subject|0|||
33158941|NCT03000569|100494181|FG000|Overall Study|Withdrawal by Subject|1|||
33158942|NCT03000569|100494182|FG001|Overall Study|Withdrawal by Subject|0|||
33441634|NCT00857623|101511989|FG000|Overall Study|Severe non-compliance to protocol|1|||
33254173|NCT00311363|100830378|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
33254174|NCT00311363|100830379|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
33254175|NCT00311363|100830377|FG000|24-Week Single-Blind Treatment Period|Death|1|||
33254176|NCT00311363|100830378|FG001|24-Week Single-Blind Treatment Period|Death|0|||
33254177|NCT00311363|100830379|FG002|24-Week Single-Blind Treatment Period|Death|0|||
33254178|NCT00311363|100830377|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
33254179|NCT00311363|100830378|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
33254180|NCT00311363|100830379|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
33254181|NCT00311363|100830377|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
33254182|NCT00311363|100830378|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
33254183|NCT00311363|100830379|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
33254184|NCT00311363|100830377|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
33254185|NCT00311363|100830378|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
33254186|NCT00311363|100830379|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
33254187|NCT00311363|100830377|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
33254188|NCT00311363|100830378|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
33254189|NCT00311363|100830379|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
33254190|NCT00311363|100830377|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
33254191|NCT00311363|100830378|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
33254192|NCT00311363|100830379|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
33254193|NCT00311363|100830377|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
33254194|NCT00311363|100830378|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
33254195|NCT00311363|100830379|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
33254196|NCT00949975|100830384|FG000|Overall Study|Voluntary discontinuation|6|||
33254197|NCT00949975|100830385|FG001|Overall Study|Voluntary discontinuation|5|||
33254198|NCT00949975|100830386|FG002|Overall Study|Voluntary discontinuation|3|||
33254199|NCT00949975|100830387|FG003|Overall Study|Voluntary discontinuation|6|||
33254200|NCT00949975|100830384|FG000|Overall Study|Adverse Event|11|||
33254201|NCT00949975|100830385|FG001|Overall Study|Adverse Event|11|||
33254202|NCT00949975|100830386|FG002|Overall Study|Adverse Event|10|||
33254203|NCT00949975|100830387|FG003|Overall Study|Adverse Event|10|||
33254204|NCT00949975|100830384|FG000|Overall Study|Safety reason|0|||
33254205|NCT00949975|100830385|FG001|Overall Study|Safety reason|1|||
33254206|NCT00949975|100830386|FG002|Overall Study|Safety reason|0|||
33254207|NCT00949975|100830387|FG003|Overall Study|Safety reason|0|||
33254208|NCT00949975|100830384|FG000|Overall Study|Study-specific criteria|0|||
33254209|NCT00949975|100830385|FG001|Overall Study|Study-specific criteria|1|||
33254210|NCT00949975|100830386|FG002|Overall Study|Study-specific criteria|1|||
33254211|NCT00949975|100830387|FG003|Overall Study|Study-specific criteria|0|||
33254212|NCT00949975|100830384|FG000|Overall Study|Incorrect enrolment|5|||
33254213|NCT00949975|100830385|FG001|Overall Study|Incorrect enrolment|10|||
33254214|NCT00949975|100830386|FG002|Overall Study|Incorrect enrolment|4|||
33254215|NCT00949975|100830387|FG003|Overall Study|Incorrect enrolment|7|||
33254216|NCT00949975|100830384|FG000|Overall Study|Severe non-compliance|3|||
33254217|NCT00949975|100830385|FG001|Overall Study|Severe non-compliance|1|||
33254218|NCT00949975|100830386|FG002|Overall Study|Severe non-compliance|0|||
33254219|NCT00949975|100830387|FG003|Overall Study|Severe non-compliance|2|||
33254220|NCT00949975|100830384|FG000|Overall Study|Lost to Follow-up|1|||
33254221|NCT00949975|100830385|FG001|Overall Study|Lost to Follow-up|0|||
33254222|NCT00949975|100830386|FG002|Overall Study|Lost to Follow-up|1|||
33254223|NCT00949975|100830387|FG003|Overall Study|Lost to Follow-up|3|||
33254224|NCT00949975|100830384|FG000|Overall Study|Other|1|||
33441635|NCT00857623|101511990|FG001|Overall Study|Severe non-compliance to protocol|1|||
33441636|NCT00857623|101511989|FG000|Overall Study|Intake of prohibited medication|0|||
33441637|NCT00857623|101511990|FG001|Overall Study|Intake of prohibited medication|1|||
33441638|NCT00857623|101511989|FG000|Overall Study|Positive for HEP C|0|||
33441639|NCT00857623|101511990|FG001|Overall Study|Positive for HEP C|1|||
33441640|NCT00416520|101511993|FG000|Open-label Period|Adverse Event|28|||
33441641|NCT00416520|101511994|FG001|Open-label Period|Adverse Event|10|||
33158943|NCT01443078|100494184|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
33441642|NCT00416520|101511995|FG002|Open-label Period|Adverse Event|0|||
33441643|NCT00416520|101511996|FG003|Open-label Period|Adverse Event|0|||
33441644|NCT00416520|101511993|FG000|Open-label Period|Death|2|||
33441645|NCT00416520|101511994|FG001|Open-label Period|Death|1|||
33441646|NCT00416520|101511995|FG002|Open-label Period|Death|0|||
33158944|NCT01443078|100494184|FG000|Overall Study|Withdrawal by Subject|1|||
33158945|NCT01443078|100494184|FG000|Overall Study|Patient had brain mets|1|||
33158946|NCT01706146|100494185|FG000|Overall Study|Withdrawal by Subject|1|||
33158947|NCT01706146|100494185|FG000|Overall Study|Adverse Event|3|||
33158948|NCT01706146|100494185|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
33158949|NCT01797731|100494186|FG000|Overall Study|Didn't have proper radiographs required|3|||
33158950|NCT01797731|100494187|FG001|Overall Study|Didn't have proper radiographs required|3|||
33158951|NCT01773733|100494195|FG000|Overall Study|Adverse Event|3286|||
33158952|NCT01773733|100494196|FG001|Overall Study|Adverse Event|540|||
33158953|NCT01773733|100494195|FG000|Overall Study|Pregnancy|28|||
33158954|NCT01773733|100494196|FG001|Overall Study|Pregnancy|0|||
33158955|NCT01773733|100494195|FG000|Overall Study|Other different categories of not compl|55415|||
33158956|NCT01773733|100494196|FG001|Overall Study|Other different categories of not compl|7781|||
33158957|NCT02336373|100494201|FG000|Overall Study|Protocol closed early|4|||
33158958|NCT02336373|100494201|FG000|Overall Study|Physician Decision|14|||
33158959|NCT00108433|100494202|FG000|Overall Study|Lack of Efficacy|1|||
33158960|NCT00108433|100494203|FG001|Overall Study|Lack of Efficacy|2|||
33158961|NCT00108433|100494202|FG000|Overall Study|Death|3|||
33158962|NCT00108433|100494203|FG001|Overall Study|Death|0|||
33158963|NCT00108433|100494202|FG000|Overall Study|Adverse Event|3|||
33441647|NCT00416520|101511996|FG003|Open-label Period|Death|0|||
33441648|NCT00416520|101511993|FG000|Open-label Period|Lack of Efficacy|8|||
33441649|NCT00416520|101511994|FG001|Open-label Period|Lack of Efficacy|1|||
33441650|NCT00416520|101511995|FG002|Open-label Period|Lack of Efficacy|0|||
33441651|NCT00416520|101511996|FG003|Open-label Period|Lack of Efficacy|0|||
33441652|NCT00416520|101511993|FG000|Open-label Period|Protocol Violation|3|||
33441653|NCT00416520|101511994|FG001|Open-label Period|Protocol Violation|3|||
33441654|NCT00416520|101511995|FG002|Open-label Period|Protocol Violation|0|||
33441655|NCT00416520|101511996|FG003|Open-label Period|Protocol Violation|0|||
33158964|NCT00108433|100494203|FG001|Overall Study|Adverse Event|1|||
33158965|NCT00108433|100494202|FG000|Overall Study|Other|14|||
33158966|NCT00108433|100494203|FG001|Overall Study|Other|14|||
33158967|NCT00150709|100494204|FG000|Overall Study|Protocol Violation|7|||
33158968|NCT00150709|100494205|FG001|Overall Study|Protocol Violation|8|||
33158969|NCT00150709|100494206|FG002|Overall Study|Protocol Violation|3|||
33158970|NCT00150709|100494207|FG003|Overall Study|Protocol Violation|1|||
33158971|NCT00150709|100494204|FG000|Overall Study|Adverse Event|8|||
33158972|NCT00150709|100494205|FG001|Overall Study|Adverse Event|2|||
33158973|NCT00150709|100494206|FG002|Overall Study|Adverse Event|2|||
33158974|NCT00150709|100494207|FG003|Overall Study|Adverse Event|3|||
33158975|NCT00150709|100494204|FG000|Overall Study|Lack of Efficacy|6|||
33158976|NCT00150709|100494205|FG001|Overall Study|Lack of Efficacy|11|||
33158977|NCT00150709|100494206|FG002|Overall Study|Lack of Efficacy|9|||
33158978|NCT00150709|100494207|FG003|Overall Study|Lack of Efficacy|0|||
33158979|NCT00150709|100494204|FG000|Overall Study|Withdrawal by Subject|7|||
33158980|NCT00150709|100494205|FG001|Overall Study|Withdrawal by Subject|10|||
33158981|NCT00150709|100494206|FG002|Overall Study|Withdrawal by Subject|5|||
33158982|NCT00150709|100494207|FG003|Overall Study|Withdrawal by Subject|0|||
33158983|NCT00150709|100494204|FG000|Overall Study|Lost to Follow-up|3|||
33158984|NCT00150709|100494205|FG001|Overall Study|Lost to Follow-up|2|||
33254225|NCT00949975|100830385|FG001|Overall Study|Other|0|||
33254226|NCT00949975|100830386|FG002|Overall Study|Other|0|||
33158985|NCT00150709|100494206|FG002|Overall Study|Lost to Follow-up|0|||
33158986|NCT00150709|100494207|FG003|Overall Study|Lost to Follow-up|0|||
33158987|NCT00150709|100494204|FG000|Overall Study|Sponsor decision|0|||
33158988|NCT00150709|100494205|FG001|Overall Study|Sponsor decision|0|||
33158989|NCT00150709|100494206|FG002|Overall Study|Sponsor decision|0|||
33158990|NCT00150709|100494207|FG003|Overall Study|Sponsor decision|1|||
33158991|NCT00150709|100494204|FG000|Overall Study|Site/Investigator discontinued the study|5|||
33158992|NCT00150709|100494205|FG001|Overall Study|Site/Investigator discontinued the study|5|||
33158993|NCT00150709|100494206|FG002|Overall Study|Site/Investigator discontinued the study|2|||
33158994|NCT00150709|100494207|FG003|Overall Study|Site/Investigator discontinued the study|0|||
33158995|NCT00150709|100494204|FG000|Overall Study|Decision of parent(s)|1|||
33158996|NCT00150709|100494205|FG001|Overall Study|Decision of parent(s)|2|||
33158997|NCT00150709|100494206|FG002|Overall Study|Decision of parent(s)|0|||
33441656|NCT00416520|101511993|FG000|Open-label Period|Withdrawal by Subject|16|||
33441657|NCT00416520|101511994|FG001|Open-label Period|Withdrawal by Subject|5|||
33441658|NCT00416520|101511995|FG002|Open-label Period|Withdrawal by Subject|0|||
33441659|NCT00416520|101511996|FG003|Open-label Period|Withdrawal by Subject|0|||
33441660|NCT00416520|101511993|FG000|Open-label Period|Other Reasons|3|||
33441661|NCT00416520|101511994|FG001|Open-label Period|Other Reasons|12|||
33441662|NCT00416520|101511995|FG002|Open-label Period|Other Reasons|0|||
33441663|NCT00416520|101511996|FG003|Open-label Period|Other Reasons|0|||
33441664|NCT00416520|101511993|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
33441665|NCT00416520|101511994|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
33441666|NCT00416520|101511995|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
33441667|NCT00416520|101511996|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
33441668|NCT00416520|101511993|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
33441669|NCT00416520|101511994|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
33441670|NCT00416520|101511995|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
33441671|NCT00416520|101511996|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
33441672|NCT00416520|101511993|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
33441673|NCT00416520|101511994|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
33441674|NCT00416520|101511995|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
33441675|NCT00416520|101511996|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
33441676|NCT02336165|101512000|FG000|Overall Study|Death|3|||
33441677|NCT02336165|101512001|FG001|Overall Study|Death|0|||
33441678|NCT02336165|101512002|FG002|Overall Study|Death|0|||
33441679|NCT02336165|101512003|FG003|Overall Study|Death|0|||
33441680|NCT02336165|101512004|FG004|Overall Study|Death|1|||
33441681|NCT02336165|101512000|FG000|Overall Study|Physician Decision|2|||
33441682|NCT02336165|101512001|FG001|Overall Study|Physician Decision|2|||
33441683|NCT02336165|101512002|FG002|Overall Study|Physician Decision|1|||
33441684|NCT02336165|101512003|FG003|Overall Study|Physician Decision|1|||
33441685|NCT02336165|101512004|FG004|Overall Study|Physician Decision|0|||
33158998|NCT00150709|100494207|FG003|Overall Study|Decision of parent(s)|0|||
33158999|NCT00150709|100494204|FG000|Overall Study|Decision of parent(s) and investigator|3|||
33254227|NCT00949975|100830387|FG003|Overall Study|Other|0|||
33254228|NCT02754479|100830388|FG000|Overall Study|Lost to Follow-up|1|||
33441686|NCT02336165|101512000|FG000|Overall Study|Withdrawal by Subject|0|||
33441687|NCT02336165|101512001|FG001|Overall Study|Withdrawal by Subject|0|||
33159000|NCT00150709|100494205|FG001|Overall Study|Decision of parent(s) and investigator|0|||
33159001|NCT00150709|100494206|FG002|Overall Study|Decision of parent(s) and investigator|0|||
33159002|NCT00150709|100494207|FG003|Overall Study|Decision of parent(s) and investigator|0|||
33159003|NCT00150709|100494204|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
33159004|NCT00150709|100494205|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
33159005|NCT00150709|100494206|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
33159006|NCT00150709|100494207|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
33159007|NCT00150709|100494204|FG000|Overall Study|Investigator decision|1|||
33159008|NCT00150709|100494205|FG001|Overall Study|Investigator decision|0|||
33159009|NCT00150709|100494206|FG002|Overall Study|Investigator decision|0|||
33159010|NCT00150709|100494207|FG003|Overall Study|Investigator decision|1|||
33159011|NCT00150709|100494204|FG000|Overall Study|Subject relocated|2|||
33159012|NCT00150709|100494205|FG001|Overall Study|Subject relocated|2|||
33159013|NCT00150709|100494206|FG002|Overall Study|Subject relocated|1|||
33159014|NCT00150709|100494207|FG003|Overall Study|Subject relocated|0|||
33159015|NCT00150709|100494204|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
33159016|NCT00150709|100494205|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
33159017|NCT00150709|100494206|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
33159018|NCT00150709|100494207|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
33159019|NCT00150709|100494204|FG000|Overall Study|Convenience|0|||
33159020|NCT00150709|100494205|FG001|Overall Study|Convenience|1|||
33159021|NCT00150709|100494206|FG002|Overall Study|Convenience|0|||
33159022|NCT00150709|100494207|FG003|Overall Study|Convenience|0|||
33159023|NCT00150709|100494204|FG000|Overall Study|Subject entered new drug study|0|||
33159024|NCT00150709|100494205|FG001|Overall Study|Subject entered new drug study|1|||
33159025|NCT00150709|100494206|FG002|Overall Study|Subject entered new drug study|0|||
33159026|NCT00150709|100494207|FG003|Overall Study|Subject entered new drug study|0|||
33159027|NCT00150709|100494204|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
33159028|NCT00150709|100494205|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
33159029|NCT00150709|100494206|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
33159030|NCT00150709|100494207|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
33159031|NCT00150709|100494204|FG000|Overall Study|Lack of ease of swallowing|0|||
33159032|NCT00150709|100494205|FG001|Overall Study|Lack of ease of swallowing|1|||
33159033|NCT00150709|100494206|FG002|Overall Study|Lack of ease of swallowing|0|||
33159034|NCT00150709|100494207|FG003|Overall Study|Lack of ease of swallowing|0|||
33159035|NCT01065597|100494208|FG000|Overall Study|Adverse Event|1|||
33159036|NCT01387789|100494209|FG000|Overall Study|Adverse Event|5|||
33159037|NCT01387789|100494209|FG000|Overall Study|Lack of Efficacy|2|||
33159038|NCT01387789|100494209|FG000|Overall Study|Lost to Follow-up|1|||
33159039|NCT00850070|100494210|FG000|Overall Study|Lack of Efficacy|1|||
33159040|NCT00850070|100494211|FG001|Overall Study|Lack of Efficacy|1|||
33159041|NCT00850070|100494210|FG000|Overall Study|Adverse Event|2|||
33159042|NCT00850070|100494211|FG001|Overall Study|Adverse Event|0|||
33159043|NCT00412542|100494212|FG000|Overall Study|Withdrawal by Subject|0|||
33159044|NCT00412542|100494213|FG001|Overall Study|Withdrawal by Subject|2|||
33441688|NCT02336165|101512002|FG002|Overall Study|Withdrawal by Subject|1|||
33441689|NCT02336165|101512003|FG003|Overall Study|Withdrawal by Subject|0|||
33441690|NCT02336165|101512004|FG004|Overall Study|Withdrawal by Subject|1|||
33441691|NCT02336165|101512000|FG000|Overall Study|Adverse Event|4|||
33159045|NCT00412542|100494212|FG000|Overall Study|Not Eligible|0|||
33159046|NCT00412542|100494213|FG001|Overall Study|Not Eligible|1|||
33159047|NCT02187744|100494214|FG000|Study|Participant refused further follow-up|1|||
33159048|NCT02187744|100494215|FG001|Study|Participant refused further follow-up|0|||
33159049|NCT02187744|100494214|FG000|Study|Other|2|||
33441692|NCT02336165|101512001|FG001|Overall Study|Adverse Event|1|||
33159050|NCT02187744|100494215|FG001|Study|Other|1|||
33159051|NCT02187744|100494214|FG000|Study|Lost to Follow-up|0|||
33159052|NCT02187744|100494215|FG001|Study|Lost to Follow-up|2|||
33159053|NCT02187744|100494214|FG000|Study|Related adverse event, not serious|0|||
33159054|NCT02187744|100494215|FG001|Study|Related adverse event, not serious|2|||
33441693|NCT02336165|101512002|FG002|Overall Study|Adverse Event|2|||
33159055|NCT02187744|100494214|FG000|Study|Death|1|||
33159056|NCT02187744|100494215|FG001|Study|Death|0|||
33159057|NCT02187744|100494214|FG000|Study|Related adverse event, serious non-fatal|0|||
33159058|NCT02187744|100494215|FG001|Study|Related adverse event, serious non-fatal|1|||
33159059|NCT02187744|100494214|FG000|Treatment|Death|1|||
33159060|NCT02187744|100494215|FG001|Treatment|Death|0|||
33159061|NCT02187744|100494214|FG000|Treatment|Related adverse event, serious non-fatal|0|||
33441694|NCT02336165|101512003|FG003|Overall Study|Adverse Event|4|||
33254229|NCT01430611|100830389|FG000|Overall Study|Adverse Event|0|||
33159062|NCT02187744|100494215|FG001|Treatment|Related adverse event, serious non-fatal|1|||
33159063|NCT02187744|100494214|FG000|Treatment|Related adverse event, not serious|0|||
33159064|NCT02187744|100494215|FG001|Treatment|Related adverse event, not serious|2|||
33159065|NCT02187744|100494214|FG000|Treatment|Lost to Follow-up|0|||
33159066|NCT02187744|100494215|FG001|Treatment|Lost to Follow-up|1|||
33159067|NCT02187744|100494214|FG000|Treatment|Other|2|||
33159068|NCT02187744|100494215|FG001|Treatment|Other|0|||
33159069|NCT02187744|100494214|FG000|Treatment|Participant refused continued treatment|1|||
33159070|NCT02187744|100494215|FG001|Treatment|Participant refused continued treatment|1|||
33441695|NCT02336165|101512004|FG004|Overall Study|Adverse Event|1|||
33441696|NCT02336165|101512000|FG000|Overall Study|Progressive disease|23|||
33441697|NCT02336165|101512001|FG001|Overall Study|Progressive disease|22|||
33159071|NCT03689530|100494217|FG000|Overall Study|Withdrawal by Subject|53|||
33159072|NCT03689530|100494218|FG001|Overall Study|Withdrawal by Subject|16|||
33159073|NCT01622231|100494219|FG000|Overall Study|Physician Decision|1|||
33159074|NCT01622231|100494219|FG000|Overall Study|Withdrawal by Subject|1|||
33159075|NCT00114530|100494220|FG000|Overall Study|Death|3|||
33159076|NCT00114530|100494221|FG001|Overall Study|Death|11|||
33159077|NCT00114530|100494220|FG000|Overall Study|Lost to Follow-up|1|||
33159078|NCT00114530|100494221|FG001|Overall Study|Lost to Follow-up|1|||
33159079|NCT00114530|100494220|FG000|Overall Study|Physician Decision|1|||
33159080|NCT00114530|100494221|FG001|Overall Study|Physician Decision|1|||
33159081|NCT00114530|100494220|FG000|Overall Study|Withdrawal by Subject|2|||
33159082|NCT00114530|100494221|FG001|Overall Study|Withdrawal by Subject|6|||
33159083|NCT00114530|100494220|FG000|Overall Study|Breast Cancer|1|||
33159084|NCT00114530|100494221|FG001|Overall Study|Breast Cancer|0|||
33159085|NCT00114530|100494220|FG000|Overall Study|Subject decision after endpoint failure|0|||
33159086|NCT00114530|100494221|FG001|Overall Study|Subject decision after endpoint failure|1|||
33159087|NCT00114530|100494220|FG000|Overall Study|Ineligible|1|||
33159088|NCT00114530|100494221|FG001|Overall Study|Ineligible|0|||
33159089|NCT00843856|100494228|FG000|Overall Study|Lost to Follow-up|1|||
33159090|NCT00843856|100494229|FG001|Overall Study|Lost to Follow-up|2|||
33159091|NCT00478231|100494230|FG000|Overall Study|Death|7|||
33159092|NCT00478231|100494230|FG000|Overall Study|Lack of Efficacy|47|||
33159093|NCT00478231|100494230|FG000|Overall Study|Lost to Follow-up|7|||
33159094|NCT00478231|100494230|FG000|Overall Study|Withdrawal by Subject|6|||
33159095|NCT00478231|100494230|FG000|Overall Study|Other|9|||
33159096|NCT00478231|100494230|FG000|Overall Study|Adverse Event|5|||
33159097|NCT00478231|100494230|FG000|Overall Study|Randomized, not treated|3|||
33159098|NCT00850343|100494234|FG000|Overall Study|Withdrawal by Subject|11|||
33159099|NCT00850343|100494235|FG001|Overall Study|Withdrawal by Subject|0|||
33159100|NCT00850343|100494236|FG002|Overall Study|Withdrawal by Subject|3|||
33159101|NCT00850343|100494237|FG003|Overall Study|Withdrawal by Subject|2|||
33254230|NCT01430611|100830390|FG001|Overall Study|Adverse Event|1|||
33441698|NCT02336165|101512002|FG002|Overall Study|Progressive disease|27|||
33441699|NCT02336165|101512003|FG003|Overall Study|Progressive disease|24|||
33159102|NCT00850343|100494234|FG000|Overall Study|Adverse Event|15|||
33254231|NCT01430611|100830389|FG000|Overall Study|Protocol Violation|1|||
33159103|NCT00850343|100494235|FG001|Overall Study|Adverse Event|2|||
33159104|NCT00850343|100494236|FG002|Overall Study|Adverse Event|6|||
33159105|NCT00850343|100494237|FG003|Overall Study|Adverse Event|6|||
33159106|NCT00850343|100494234|FG000|Overall Study|Pregnancy|0|||
33441700|NCT02336165|101512004|FG004|Overall Study|Progressive disease|19|||
33159107|NCT00850343|100494235|FG001|Overall Study|Pregnancy|0|||
33159108|NCT00850343|100494236|FG002|Overall Study|Pregnancy|0|||
33159109|NCT00850343|100494237|FG003|Overall Study|Pregnancy|1|||
33441701|NCT02336165|101512000|FG000|Overall Study|Non-compliance|1|||
33159110|NCT00850343|100494234|FG000|Overall Study|Lack of Efficacy|17|||
33159111|NCT00850343|100494235|FG001|Overall Study|Lack of Efficacy|0|||
33159112|NCT00850343|100494236|FG002|Overall Study|Lack of Efficacy|3|||
33159113|NCT00850343|100494237|FG003|Overall Study|Lack of Efficacy|2|||
33159114|NCT00850343|100494234|FG000|Overall Study|Non-compliance with Study Procedures|1|||
33159115|NCT00850343|100494235|FG001|Overall Study|Non-compliance with Study Procedures|0|||
33441702|NCT02336165|101512001|FG001|Overall Study|Non-compliance|0|||
33441703|NCT02336165|101512002|FG002|Overall Study|Non-compliance|0|||
33441704|NCT02336165|101512003|FG003|Overall Study|Non-compliance|1|||
33441705|NCT02336165|101512004|FG004|Overall Study|Non-compliance|0|||
33441706|NCT02336165|101512000|FG000|Overall Study|Other|1|||
33441707|NCT02336165|101512001|FG001|Overall Study|Other|0|||
33441708|NCT02336165|101512002|FG002|Overall Study|Other|0|||
33441709|NCT02336165|101512003|FG003|Overall Study|Other|1|||
33159116|NCT00850343|100494236|FG002|Overall Study|Non-compliance with Study Procedures|1|||
33159117|NCT00850343|100494237|FG003|Overall Study|Non-compliance with Study Procedures|1|||
33159118|NCT00850343|100494234|FG000|Overall Study|Physician Decision|2|||
33159119|NCT00850343|100494235|FG001|Overall Study|Physician Decision|1|||
33159120|NCT00850343|100494236|FG002|Overall Study|Physician Decision|1|||
33159121|NCT00850343|100494237|FG003|Overall Study|Physician Decision|1|||
33159122|NCT03137537|100494238|FG000|Overall Study|Adverse Event|0|||
33159123|NCT03137537|100494239|FG001|Overall Study|Adverse Event|1|||
33159124|NCT02422303|100494240|FG000|Overall Study|Lost to Follow-up|1|||
33159125|NCT02422303|100494241|FG001|Overall Study|Lost to Follow-up|1|||
33159126|NCT01816074|100494242|FG000|Phase 1|Time commitment issues|0|||
33159127|NCT01816074|100494243|FG001|Phase 1|Time commitment issues|0|||
33159128|NCT01816074|100494244|FG002|Phase 1|Time commitment issues|1|||
33159129|NCT01816074|100494245|FG003|Phase 1|Time commitment issues|0|||
33159130|NCT01816074|100494242|FG000|Phase 2|Time commitment Issues|0|||
33159131|NCT01816074|100494243|FG001|Phase 2|Time commitment Issues|2|||
33159132|NCT01816074|100494244|FG002|Phase 2|Time commitment Issues|0|||
33159133|NCT01816074|100494245|FG003|Phase 2|Time commitment Issues|0|||
33159134|NCT01816074|100494242|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
33159135|NCT01816074|100494243|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
33159136|NCT01816074|100494244|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
33159137|NCT01816074|100494245|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
33159138|NCT01816074|100494242|FG000|Phase 2|Physician Decision|0|||
33159139|NCT01816074|100494243|FG001|Phase 2|Physician Decision|0|||
33159140|NCT01816074|100494244|FG002|Phase 2|Physician Decision|0|||
33159141|NCT01816074|100494245|FG003|Phase 2|Physician Decision|1|||
33159142|NCT01816074|100494242|FG000|Phase 2|Withdrawal by Subject|1|||
33159143|NCT01816074|100494243|FG001|Phase 2|Withdrawal by Subject|0|||
33159144|NCT01816074|100494244|FG002|Phase 2|Withdrawal by Subject|0|||
33159145|NCT01816074|100494245|FG003|Phase 2|Withdrawal by Subject|0|||
33159146|NCT00178633|100494247|FG000|Overall Study|Lost to Follow-up|6|||
33441710|NCT02336165|101512004|FG004|Overall Study|Other|0|||
33441711|NCT00262223|101512005|FG000|Treatment Phase|Withdrawal by Subject|3|||
33441712|NCT00262223|101512006|FG001|Treatment Phase|Withdrawal by Subject|6|||
33441713|NCT00262223|101512005|FG000|Treatment Phase|Adverse Event|1|||
33441714|NCT00262223|101512006|FG001|Treatment Phase|Adverse Event|2|||
33441715|NCT00262223|101512005|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
33441716|NCT00262223|101512006|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
33441717|NCT00262223|101512005|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
33441718|NCT00262223|101512006|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
33441719|NCT00262223|101512005|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
33441720|NCT00262223|101512006|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
33441721|NCT00537030|101512007|FG000|Overall Study|Physician Decision|2|||
33441722|NCT00537030|101512007|FG000|Overall Study|Withdrawal by Subject|2|||
33441723|NCT00537030|101512007|FG000|Overall Study|≥ Grade 2 allergy|7|||
33441724|NCT00537030|101512007|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
33441725|NCT00537030|101512007|FG000|Overall Study|Ineligible|2|||
33441726|NCT00537030|101512007|FG000|Overall Study|Inevaluable|2|||
33441727|NCT00986245|101512008|FG000|First Intervention|Poor compliance|8|||
33441728|NCT00986245|101512009|FG001|First Intervention|Poor compliance|4|||
33441729|NCT00986245|101512008|FG000|First Intervention|Lack of Efficacy|1|||
33441730|NCT00986245|101512009|FG001|First Intervention|Lack of Efficacy|2|||
33159147|NCT02877134|100494248|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
33159148|NCT02877134|100494249|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
33441731|NCT00986245|101512008|FG000|First Intervention|Withdrawal by Subject|0|||
33441732|NCT00986245|101512009|FG001|First Intervention|Withdrawal by Subject|1|||
33159149|NCT02877134|100494250|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
33159150|NCT02877134|100494251|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
33159151|NCT02877134|100494252|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
33159152|NCT02877134|100494253|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
33159153|NCT02877134|100494254|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
33159154|NCT02877134|100494255|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
33441733|NCT00986245|101512008|FG000|First Intervention|Protocol Violation|0|||
33159155|NCT02877134|100494256|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
33159156|NCT02877134|100494257|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
33159157|NCT02877134|100494258|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
33159158|NCT02877134|100494259|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
33159159|NCT02877134|100494248|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33159160|NCT02877134|100494249|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
33159161|NCT02877134|100494250|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33159162|NCT02877134|100494251|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
33159163|NCT02877134|100494252|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33159164|NCT02877134|100494253|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33159165|NCT02877134|100494254|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
33159166|NCT02877134|100494255|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33159167|NCT02877134|100494256|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33441734|NCT00986245|101512009|FG001|First Intervention|Protocol Violation|1|||
33441735|NCT00986245|101512008|FG000|First Intervention|Out of indication|1|||
33441736|NCT00986245|101512009|FG001|First Intervention|Out of indication|0|||
33441737|NCT00986245|101512008|FG000|Second Intervention|Poor compliance|1|||
33441738|NCT00986245|101512009|FG001|Second Intervention|Poor compliance|0|||
33441739|NCT00986245|101512008|FG000|Second Intervention|Lost to Follow-up|1|||
33441740|NCT00986245|101512009|FG001|Second Intervention|Lost to Follow-up|0|||
33441741|NCT00986245|101512008|FG000|Second Intervention|Protocol Violation|0|||
33441742|NCT00986245|101512009|FG001|Second Intervention|Protocol Violation|1|||
33441743|NCT02189941|101512010|FG000|Overall Study|Non-compliance|0|||
33441744|NCT02189941|101512011|FG001|Overall Study|Non-compliance|0|||
33441745|NCT02189941|101512012|FG002|Overall Study|Non-compliance|1|||
33441746|NCT00727961|101512024|FG000|Overall Study|Lost to Follow-up|1|||
33441747|NCT00727961|101512024|FG000|Overall Study|Adverse Event|4|||
33441748|NCT00727961|101512024|FG000|Overall Study|Patient's refusal|2|||
33441749|NCT00727961|101512024|FG000|Overall Study|Progression|30|||
33441750|NCT02780687|101512025|FG000|Overall Study|Adverse Event|1|||
33441751|NCT02780687|101512026|FG001|Overall Study|Adverse Event|1|||
33441752|NCT02780687|101512025|FG000|Overall Study|Withdrawal by Subject|2|||
33441753|NCT02780687|101512026|FG001|Overall Study|Withdrawal by Subject|1|||
33441754|NCT02780687|101512025|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
33441755|NCT02780687|101512026|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
33441756|NCT02780687|101512025|FG000|Overall Study|progressive disease|29|||
33441757|NCT02780687|101512026|FG001|Overall Study|progressive disease|6|||
33441758|NCT00301366|101512031|FG000|Overall Study|Adverse Event|1|||
33441759|NCT00624065|101512032|FG000|Overall Study|Adverse Event|5|||
33441760|NCT00624065|101512033|FG001|Overall Study|Adverse Event|6|||
33441761|NCT00624065|101512032|FG000|Overall Study|Lost to Follow-up|4|||
33441762|NCT00624065|101512033|FG001|Overall Study|Lost to Follow-up|1|||
33441763|NCT00624065|101512032|FG000|Overall Study|Consent withdrawn|6|||
33441764|NCT00624065|101512033|FG001|Overall Study|Consent withdrawn|5|||
33441765|NCT00624065|101512032|FG000|Overall Study|Lack of Efficacy|0|||
33441766|NCT00624065|101512033|FG001|Overall Study|Lack of Efficacy|3|||
33441767|NCT00624065|101512032|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
33441768|NCT00624065|101512033|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
33254232|NCT01430611|100830390|FG001|Overall Study|Protocol Violation|0|||
33441769|NCT01974141|101512035|FG000|Overall Study|Other Reasons|28|||
33159168|NCT02877134|100494257|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33159169|NCT02877134|100494258|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33441770|NCT01974141|101512036|FG001|Overall Study|Other Reasons|18|||
33159170|NCT02877134|100494259|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
33159171|NCT02877134|100494248|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
33159172|NCT02877134|100494249|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
33159173|NCT02877134|100494250|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
33159174|NCT02877134|100494251|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
33159175|NCT02877134|100494252|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
33159176|NCT02877134|100494253|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
33159177|NCT02877134|100494254|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
33159178|NCT02877134|100494255|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
33159179|NCT02877134|100494256|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
33159180|NCT02877134|100494257|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
33159181|NCT02877134|100494258|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
33159182|NCT02877134|100494259|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
33159183|NCT02877134|100494248|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
33159184|NCT02877134|100494249|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
33159185|NCT02877134|100494250|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
33159186|NCT02877134|100494251|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
33159187|NCT02877134|100494252|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
33159188|NCT02877134|100494253|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
33159189|NCT02877134|100494254|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
33159190|NCT02877134|100494255|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
33159191|NCT02877134|100494256|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
33159192|NCT02877134|100494257|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
33159193|NCT02877134|100494258|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
33159194|NCT02877134|100494259|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
33159195|NCT02877134|100494248|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33159196|NCT02877134|100494249|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33159197|NCT02877134|100494250|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33159198|NCT02877134|100494251|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33159199|NCT02877134|100494252|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33159200|NCT02877134|100494253|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33159201|NCT02877134|100494254|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33159202|NCT02877134|100494255|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33159203|NCT02877134|100494256|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
33159204|NCT02877134|100494257|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33159205|NCT02877134|100494258|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33159206|NCT02877134|100494259|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
33159207|NCT02877134|100494248|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
33159208|NCT02877134|100494249|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
33159209|NCT02877134|100494250|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
33159210|NCT02877134|100494251|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
33159211|NCT02877134|100494252|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
33159212|NCT02877134|100494253|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
33159213|NCT02877134|100494254|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
33159214|NCT02877134|100494255|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
33159215|NCT02877134|100494256|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
33159216|NCT02877134|100494257|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
33159217|NCT02877134|100494258|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
33159218|NCT02877134|100494259|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
33159219|NCT02877134|100494248|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33159220|NCT02877134|100494249|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33159221|NCT02877134|100494250|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33159222|NCT02877134|100494251|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33159223|NCT02877134|100494252|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33159224|NCT02877134|100494253|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33159225|NCT02877134|100494254|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33159226|NCT02877134|100494255|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
33159227|NCT02877134|100494256|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
33159228|NCT02877134|100494257|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
33159229|NCT02877134|100494258|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33159230|NCT02877134|100494259|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
33159231|NCT02877134|100494248|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
33159232|NCT02877134|100494249|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
33441771|NCT01974141|101512035|FG000|Overall Study|Protocol Violation|2|||
33441772|NCT01974141|101512036|FG001|Overall Study|Protocol Violation|6|||
33159233|NCT02877134|100494250|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
33159234|NCT02877134|100494251|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
33159235|NCT02877134|100494252|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
33159236|NCT02877134|100494253|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
33159237|NCT02877134|100494254|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
33159238|NCT02877134|100494255|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
33159239|NCT02877134|100494256|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
33159240|NCT02877134|100494257|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
33159241|NCT02877134|100494258|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
33159242|NCT02877134|100494259|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
33159243|NCT03719586|100494260|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
33159244|NCT03719586|100494261|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
33159245|NCT03719586|100494262|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
33159246|NCT03719586|100494263|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
33159247|NCT00428792|100494265|FG000|Overall Study|Lack of Efficacy|1|||
33159248|NCT00428792|100494266|FG001|Overall Study|Lack of Efficacy|3|||
33159249|NCT00428792|100494265|FG000|Overall Study|Lost to Follow-up|0|||
33159250|NCT00428792|100494266|FG001|Overall Study|Lost to Follow-up|1|||
33159251|NCT00437983|100494267|FG000|Overall Study|Adverse Event|6|||
33159252|NCT00437983|100494268|FG001|Overall Study|Adverse Event|6|||
33159253|NCT00437983|100494267|FG000|Overall Study|Protocol Violation|2|||
33159254|NCT00437983|100494268|FG001|Overall Study|Protocol Violation|1|||
33159255|NCT00437983|100494267|FG000|Overall Study|Withdrawal by Subject|5|||
33159256|NCT00437983|100494268|FG001|Overall Study|Withdrawal by Subject|6|||
33159257|NCT03583697|100494269|FG000|Overall Study|Withdrawal by Subject|0|||
33159258|NCT03583697|100494270|FG001|Overall Study|Withdrawal by Subject|0|||
33159259|NCT03583697|100494271|FG002|Overall Study|Withdrawal by Subject|1|||
33159260|NCT03583697|100494269|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
33159261|NCT03583697|100494270|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
33159262|NCT03583697|100494271|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
33159263|NCT01447433|100494273|FG000|Overall Study|Lost to Follow-up|0|||
33159264|NCT01447433|100494274|FG001|Overall Study|Lost to Follow-up|2|||
33159265|NCT01447433|100494273|FG000|Overall Study|Withdrawal by Subject|3|||
33159266|NCT01447433|100494274|FG001|Overall Study|Withdrawal by Subject|3|||
33159267|NCT01447433|100494273|FG000|Overall Study|Protocol Violation|1|||
33159268|NCT01447433|100494274|FG001|Overall Study|Protocol Violation|1|||
33159269|NCT02465515|100494275|FG000|Overall Study|Investigator site closed|4|||
33159270|NCT02465515|100494276|FG001|Overall Study|Investigator site closed|5|||
33159271|NCT02465515|100494275|FG000|Overall Study|Withdrawal by Subject|74|||
33159272|NCT02465515|100494276|FG001|Overall Study|Withdrawal by Subject|43|||
33159273|NCT02465515|100494275|FG000|Overall Study|Physician Decision|8|||
33159274|NCT02465515|100494276|FG001|Overall Study|Physician Decision|12|||
33159275|NCT02465515|100494275|FG000|Overall Study|Lost to Follow-up|68|||
33159276|NCT02465515|100494276|FG001|Overall Study|Lost to Follow-up|51|||
33159277|NCT00722423|100494277|FG000|Overall Study|Protocol Violation|0|||
33159278|NCT00722423|100494278|FG001|Overall Study|Protocol Violation|1|||
33159279|NCT01543958|100494281|FG000|Overall Study|Loss to follow-up|3|||
33159280|NCT01543958|100494281|FG000|Overall Study|ART initiation|1|||
33159281|NCT03641339|100494282|FG000|Overall Study|Physician Decision|1|||
33159282|NCT03641339|100494283|FG001|Overall Study|Physician Decision|0|||
33159283|NCT03641339|100494284|FG002|Overall Study|Physician Decision|0|||
33159284|NCT03641339|100494285|FG003|Overall Study|Physician Decision|0|||
33159285|NCT03641339|100494286|FG004|Overall Study|Physician Decision|0|||
33159286|NCT03641339|100494287|FG005|Overall Study|Physician Decision|0|||
33159287|NCT03641339|100494282|FG000|Overall Study|Withdrawal by Subject|0|||
33159288|NCT03641339|100494283|FG001|Overall Study|Withdrawal by Subject|2|||
33159289|NCT03641339|100494284|FG002|Overall Study|Withdrawal by Subject|0|||
33159290|NCT03641339|100494285|FG003|Overall Study|Withdrawal by Subject|2|||
33159291|NCT03641339|100494286|FG004|Overall Study|Withdrawal by Subject|0|||
33159292|NCT03641339|100494287|FG005|Overall Study|Withdrawal by Subject|1|||
33159293|NCT01390649|100494294|FG000|Overall Study|Physician Decision|1|||
33159294|NCT03095612|100494295|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
33441773|NCT01974141|101512035|FG000|Overall Study|Personal Reasons|21|||
33441774|NCT01974141|101512036|FG001|Overall Study|Personal Reasons|20|||
33441775|NCT01974141|101512035|FG000|Overall Study|Lost to Follow-up|38|||
33159295|NCT03095612|100494296|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
33159296|NCT03095612|100494297|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
33159297|NCT03095612|100494298|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
33159298|NCT03095612|100494299|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
33159299|NCT03095612|100494300|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
33159300|NCT03095612|100494301|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
33159301|NCT00001880|100494302|FG000|Overall Study|Death|14|||
33159302|NCT01686828|100494303|FG000|Overall Study|Physician Decision|1|||
33159303|NCT01686828|100494304|FG001|Overall Study|Physician Decision|0|||
33159304|NCT01686828|100494305|FG002|Overall Study|Physician Decision|0|||
33159305|NCT01686828|100494306|FG003|Overall Study|Physician Decision|0|||
33159306|NCT01686828|100494303|FG000|Overall Study|New Job|0|||
33159307|NCT01686828|100494304|FG001|Overall Study|New Job|1|||
33159308|NCT01686828|100494305|FG002|Overall Study|New Job|0|||
33159309|NCT01686828|100494306|FG003|Overall Study|New Job|0|||
33159310|NCT01686828|100494303|FG000|Overall Study|Weight Loss|0|||
33159311|NCT01686828|100494304|FG001|Overall Study|Weight Loss|0|||
33159312|NCT01686828|100494305|FG002|Overall Study|Weight Loss|1|||
33159313|NCT01686828|100494306|FG003|Overall Study|Weight Loss|0|||
33159314|NCT00354744|100494309|FG000|Overall Study|Adverse Event|2|||
33159315|NCT00354744|100494309|FG000|Overall Study|Death|2|||
33159316|NCT00354744|100494309|FG000|Overall Study|Lack of Efficacy|11|||
33159317|NCT00354744|100494309|FG000|Overall Study|Lost to Follow-up|2|||
33159318|NCT00354744|100494309|FG000|Overall Study|Physician Decision|11|||
33159319|NCT00354744|100494309|FG000|Overall Study|Withdrawal by Subject|14|||
33159320|NCT02369016|100494313|FG000|Overall Study|AE associated with clinical disease progression|2|||
33159321|NCT02369016|100494314|FG001|Overall Study|AE associated with clinical disease progression|1|||
33159322|NCT02369016|100494313|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
33159323|NCT02369016|100494314|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
33159324|NCT02369016|100494313|FG000|Overall Study|Progressive disease - clinical progression|1|||
33159325|NCT02369016|100494314|FG001|Overall Study|Progressive disease - clinical progression|4|||
33159326|NCT02369016|100494313|FG000|Overall Study|withdrawal by patient|4|||
33159327|NCT02369016|100494314|FG001|Overall Study|withdrawal by patient|0|||
33159328|NCT02369016|100494313|FG000|Overall Study|Progressive disease - radiological progression|6|||
33159329|NCT02369016|100494314|FG001|Overall Study|Progressive disease - radiological progression|2|||
33159330|NCT01313858|100494315|FG000|Overall Study|Premature Treatment Termination|251|||
33159331|NCT01313858|100494316|FG001|Overall Study|Premature Treatment Termination|219|||
33159332|NCT01313858|100494317|FG002|Overall Study|Premature Treatment Termination|191|||
33159333|NCT01313858|100494315|FG000|Overall Study|Lost to Follow-up|35|||
33159334|NCT01313858|100494316|FG001|Overall Study|Lost to Follow-up|51|||
33159335|NCT01313858|100494317|FG002|Overall Study|Lost to Follow-up|47|||
33159336|NCT02002091|100494318|FG000|Screening|Lost to Follow-up|10|||
33159337|NCT02002091|100494319|FG001|Screening|Lost to Follow-up|12|||
33159338|NCT02002091|100494318|FG000|Screening|Death|3|||
33159339|NCT02002091|100494319|FG001|Screening|Death|2|||
33159340|NCT01705730|100494320|FG000|Overall Study|Lack of Efficacy|1|||
33159341|NCT01705730|100494320|FG000|Overall Study|Adverse Event|3|||
33159342|NCT01705730|100494320|FG000|Overall Study|Lost to Follow-up|1|||
33159343|NCT01705730|100494320|FG000|Overall Study|Reason not Specified|4|||
33159344|NCT00825682|100497948|FG000|Overall Study|personal reasons/ inconvenience|13|||
33159345|NCT00825682|100497949|FG001|Overall Study|personal reasons/ inconvenience|5|||
33159346|NCT00675948|100497956|FG000|Overall Study|Adverse Event|23|||
33159347|NCT00675948|100497957|FG001|Overall Study|Adverse Event|1|||
33159348|NCT00675948|100497956|FG000|Overall Study|Lack of Efficacy|3|||
33159349|NCT00675948|100497957|FG001|Overall Study|Lack of Efficacy|0|||
33159350|NCT00675948|100497956|FG000|Overall Study|Withdrawal by Subject|7|||
33159351|NCT00675948|100497957|FG001|Overall Study|Withdrawal by Subject|0|||
33159352|NCT00675948|100497956|FG000|Overall Study|Lost to Follow-up|2|||
33159353|NCT00675948|100497957|FG001|Overall Study|Lost to Follow-up|0|||
33159354|NCT00675948|100497956|FG000|Overall Study|Protocol Violation|1|||
33159355|NCT00675948|100497957|FG001|Overall Study|Protocol Violation|0|||
33441776|NCT01974141|101512036|FG001|Overall Study|Lost to Follow-up|29|||
33441777|NCT01974141|101512035|FG000|Overall Study|Pregnancy|3|||
33159356|NCT00675948|100497956|FG000|Overall Study|Pain under control|1|||
33159357|NCT00675948|100497957|FG001|Overall Study|Pain under control|0|||
33159358|NCT00675948|100497956|FG000|Overall Study|Sponsor decision|0|||
33159359|NCT00675948|100497957|FG001|Overall Study|Sponsor decision|1|||
33159360|NCT00675948|100497956|FG000|Overall Study|Patient died|1|||
33159361|NCT00675948|100497957|FG001|Overall Study|Patient died|0|||
33159362|NCT00675948|100497956|FG000|Overall Study|Patient unable to comply with diaries|1|||
33159363|NCT00675948|100497957|FG001|Overall Study|Patient unable to comply with diaries|0|||
33159364|NCT00675948|100497956|FG000|Overall Study|Patient feels unable to take medication|0|||
33159365|NCT00675948|100497957|FG001|Overall Study|Patient feels unable to take medication|1|||
33159366|NCT00094172|100497958|FG000|Overall Study|Adverse Event|0|||
33159367|NCT00094172|100497959|FG001|Overall Study|Adverse Event|1|||
33159368|NCT00094172|100497958|FG000|Overall Study|Lost to Follow-up|2|||
33159369|NCT00094172|100497959|FG001|Overall Study|Lost to Follow-up|0|||
33159370|NCT00094172|100497958|FG000|Overall Study|Protocol Violation|0|||
33159371|NCT00094172|100497959|FG001|Overall Study|Protocol Violation|1|||
33159372|NCT00094172|100497958|FG000|Overall Study|Withdrawal by Subject|10|||
33159373|NCT00094172|100497959|FG001|Overall Study|Withdrawal by Subject|5|||
33159374|NCT00094172|100497958|FG000|Overall Study|Primary endpoint met.|1|||
33159375|NCT00094172|100497959|FG001|Overall Study|Primary endpoint met.|0|||
33159376|NCT00094172|100497958|FG000|Overall Study|Started other MS therapy due to disease|1|||
33159377|NCT00094172|100497959|FG001|Overall Study|Started other MS therapy due to disease|0|||
33159378|NCT00968201|100497960|FG000|Base Study - (Period II)|Adverse Event|8|||
33159379|NCT00968201|100497961|FG001|Base Study - (Period II)|Adverse Event|0|||
33159380|NCT00968201|100497962|FG002|Base Study - (Period II)|Adverse Event|16|||
33159381|NCT00968201|100497960|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
33159382|NCT00968201|100497961|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
33159383|NCT00968201|100497962|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
33159384|NCT00968201|100497960|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
33159385|NCT00968201|100497961|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
33159386|NCT00968201|100497962|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
33159387|NCT00968201|100497960|FG000|Base Study - (Period II)|Protocol Violation|12|||
33159388|NCT00968201|100497961|FG001|Base Study - (Period II)|Protocol Violation|0|||
33159389|NCT00968201|100497962|FG002|Base Study - (Period II)|Protocol Violation|12|||
33159390|NCT00968201|100497960|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
33159391|NCT00968201|100497961|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
33159392|NCT00968201|100497962|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
33254233|NCT01430611|100830389|FG000|Overall Study|Lost to Follow-up|1|||
33254234|NCT01430611|100830390|FG001|Overall Study|Lost to Follow-up|0|||
33254235|NCT01430611|100830389|FG000|Overall Study|Withdrawal by Subject|15|||
33254236|NCT01430611|100830390|FG001|Overall Study|Withdrawal by Subject|14|||
33254237|NCT00079183|100830394|FG000|Overall Study|Withdrawal by Subject|4|||
33254238|NCT00079183|100830394|FG000|Overall Study|Study medication non-compliance|2|||
33254239|NCT00079183|100830394|FG000|Overall Study|Specimen collection non-compliance|1|||
33254240|NCT00028769|100830395|FG000|Overall Study|Adverse Event|2|||
33254241|NCT00028769|100830395|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
33254242|NCT00028769|100830395|FG000|Overall Study|Progression or Death|31|||
33254243|NCT00028769|100830395|FG000|Overall Study|Other - Not Protocol Specified|1|||
33254244|NCT00028769|100830395|FG000|Overall Study|Ineligible|5|||
33254245|NCT00028769|100830395|FG000|Overall Study|Not Analyzable|1|||
33254246|NCT04305405|100830403|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33254247|NCT04305405|100830404|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33254248|NCT00723450|100830405|FG000|Open-Label Phase|Adverse Event|26|||
33254249|NCT00723450|100830406|FG001|Open-Label Phase|Adverse Event|0|||
33254250|NCT00723450|100830407|FG002|Open-Label Phase|Adverse Event|0|||
33254251|NCT00723450|100830405|FG000|Open-Label Phase|Lack of Efficacy|18|||
33254252|NCT00723450|100830406|FG001|Open-Label Phase|Lack of Efficacy|0|||
33159393|NCT00968201|100497960|FG000|Base Study - (Period II)|Site Error|0|||
33159394|NCT00968201|100497961|FG001|Base Study - (Period II)|Site Error|0|||
33254253|NCT00723450|100830407|FG002|Open-Label Phase|Lack of Efficacy|0|||
33254254|NCT00723450|100830405|FG000|Open-Label Phase|Protocol Violation|35|||
33254255|NCT00723450|100830406|FG001|Open-Label Phase|Protocol Violation|0|||
33254256|NCT00723450|100830407|FG002|Open-Label Phase|Protocol Violation|0|||
33254257|NCT00723450|100830405|FG000|Open-Label Phase|Lost to Follow-up|7|||
33254258|NCT00723450|100830406|FG001|Open-Label Phase|Lost to Follow-up|0|||
33254259|NCT00723450|100830407|FG002|Open-Label Phase|Lost to Follow-up|0|||
33254260|NCT00723450|100830405|FG000|Open-Label Phase|Physician Decision|2|||
33254261|NCT00723450|100830406|FG001|Open-Label Phase|Physician Decision|0|||
33254262|NCT00723450|100830407|FG002|Open-Label Phase|Physician Decision|0|||
33159395|NCT00968201|100497962|FG002|Base Study - (Period II)|Site Error|1|||
33159396|NCT00968201|100497960|FG000|Extension Study - (Period III)|Adverse Event|0|||
33159397|NCT00968201|100497961|FG001|Extension Study - (Period III)|Adverse Event|5|||
33159398|NCT00968201|100497962|FG002|Extension Study - (Period III)|Adverse Event|22|||
33159399|NCT00968201|100497960|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
33159400|NCT00968201|100497961|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
33159401|NCT00968201|100497962|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
33159402|NCT00968201|100497960|FG000|Extension Study - (Period III)|Protocol Violation|0|||
33159403|NCT00968201|100497961|FG001|Extension Study - (Period III)|Protocol Violation|17|||
33159404|NCT00968201|100497962|FG002|Extension Study - (Period III)|Protocol Violation|14|||
33159405|NCT00968201|100497960|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
33159406|NCT00968201|100497961|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
33159407|NCT00968201|100497962|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
33159408|NCT00968201|100497960|FG000|Extension Study - (Period III)|Patient Relocated|0|||
33159409|NCT00968201|100497961|FG001|Extension Study - (Period III)|Patient Relocated|1|||
33159410|NCT00968201|100497962|FG002|Extension Study - (Period III)|Patient Relocated|1|||
33159411|NCT00968201|100497960|FG000|Extension Study - (Period III)|Noncompliance|0|||
33159412|NCT00968201|100497961|FG001|Extension Study - (Period III)|Noncompliance|0|||
33159413|NCT00968201|100497962|FG002|Extension Study - (Period III)|Noncompliance|3|||
33159414|NCT00968201|100497960|FG000|Extension Study - (Period III)|Other|0|||
33159415|NCT00968201|100497961|FG001|Extension Study - (Period III)|Other|0|||
33159416|NCT00968201|100497962|FG002|Extension Study - (Period III)|Other|2|||
33159417|NCT00968201|100497960|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
33159418|NCT00968201|100497961|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
33159419|NCT00968201|100497962|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
33159420|NCT00474760|100497963|FG000|Overall Study|Death|0|||
33159421|NCT00474760|100497964|FG001|Overall Study|Death|0|||
33159422|NCT00474760|100497965|FG002|Overall Study|Death|0|||
33159423|NCT00474760|100497966|FG003|Overall Study|Death|0|||
33159424|NCT00474760|100497967|FG004|Overall Study|Death|2|||
33159425|NCT00474760|100497968|FG005|Overall Study|Death|0|||
33159426|NCT00474760|100497969|FG006|Overall Study|Death|0|||
33441778|NCT01974141|101512036|FG001|Overall Study|Pregnancy|3|||
33441779|NCT01974141|101512035|FG000|Overall Study|Lack of Efficacy|0|||
33159427|NCT00474760|100497963|FG000|Overall Study|Adverse Event|0|||
33159428|NCT00474760|100497964|FG001|Overall Study|Adverse Event|0|||
33159429|NCT00474760|100497965|FG002|Overall Study|Adverse Event|0|||
33441780|NCT01974141|101512036|FG001|Overall Study|Lack of Efficacy|1|||
33441781|NCT01974141|101512035|FG000|Overall Study|Adverse Event|4|||
33441782|NCT01974141|101512036|FG001|Overall Study|Adverse Event|5|||
33441783|NCT04006171|101512037|FG000|Overall Study|Withdrawal by Subject|8|||
33441784|NCT04006171|101512038|FG001|Overall Study|Withdrawal by Subject|7|||
33441785|NCT04006171|101512037|FG000|Overall Study|missing serum samples|2|||
33441786|NCT04006171|101512038|FG001|Overall Study|missing serum samples|2|||
33441787|NCT04006171|101512037|FG000|Overall Study|insufficient sample volume|2|||
33441788|NCT04006171|101512038|FG001|Overall Study|insufficient sample volume|3|||
33441789|NCT02475954|101512039|FG000|Overall Study|Withdrawal by Subject|2|||
33441790|NCT02475954|101512040|FG001|Overall Study|Withdrawal by Subject|2|||
33441791|NCT02475954|101512039|FG000|Overall Study|Lost to Follow-up|11|||
33254263|NCT00723450|100830405|FG000|Open-Label Phase|Withdrawal by Subject|37|||
33441792|NCT02475954|101512040|FG001|Overall Study|Lost to Follow-up|9|||
33441793|NCT02475954|101512039|FG000|Overall Study|Death|1|||
33441794|NCT02475954|101512040|FG001|Overall Study|Death|1|||
33441795|NCT01474551|101512041|FG000|Overall Study|Death|1|||
33441796|NCT00846495|101512042|FG000|Overall Study|Lost to Follow-up|1|||
33441797|NCT00846495|101512043|FG001|Overall Study|Lost to Follow-up|0|||
33441798|NCT00846495|101512042|FG000|Overall Study|Adverse Event|5|||
33254264|NCT00723450|100830406|FG001|Open-Label Phase|Withdrawal by Subject|0|||
33441799|NCT00846495|101512043|FG001|Overall Study|Adverse Event|1|||
33159430|NCT00474760|100497966|FG003|Overall Study|Adverse Event|0|||
33159431|NCT00474760|100497967|FG004|Overall Study|Adverse Event|1|||
33159432|NCT00474760|100497968|FG005|Overall Study|Adverse Event|7|||
33159433|NCT00474760|100497969|FG006|Overall Study|Adverse Event|0|||
33159434|NCT00474760|100497963|FG000|Overall Study|Laboratory abnormality|0|||
33159435|NCT00474760|100497964|FG001|Overall Study|Laboratory abnormality|0|||
33159436|NCT00474760|100497965|FG002|Overall Study|Laboratory abnormality|0|||
33159437|NCT00474760|100497966|FG003|Overall Study|Laboratory abnormality|0|||
33159438|NCT00474760|100497967|FG004|Overall Study|Laboratory abnormality|0|||
33159439|NCT00474760|100497968|FG005|Overall Study|Laboratory abnormality|1|||
33159440|NCT00474760|100497969|FG006|Overall Study|Laboratory abnormality|0|||
33159441|NCT00474760|100497963|FG000|Overall Study|Withdrawal by Subject|0|||
33159442|NCT00474760|100497964|FG001|Overall Study|Withdrawal by Subject|0|||
33159443|NCT00474760|100497965|FG002|Overall Study|Withdrawal by Subject|0|||
33159444|NCT00474760|100497966|FG003|Overall Study|Withdrawal by Subject|1|||
33159445|NCT00474760|100497967|FG004|Overall Study|Withdrawal by Subject|0|||
33159446|NCT00474760|100497968|FG005|Overall Study|Withdrawal by Subject|1|||
33159447|NCT00474760|100497969|FG006|Overall Study|Withdrawal by Subject|1|||
33159448|NCT00474760|100497963|FG000|Overall Study|Other|0|||
33159449|NCT00474760|100497964|FG001|Overall Study|Other|1|||
33159450|NCT00474760|100497965|FG002|Overall Study|Other|0|||
33159451|NCT00474760|100497966|FG003|Overall Study|Other|0|||
33159452|NCT00474760|100497967|FG004|Overall Study|Other|1|||
33159453|NCT00474760|100497968|FG005|Overall Study|Other|0|||
33159454|NCT00474760|100497969|FG006|Overall Study|Other|0|||
33159455|NCT00474760|100497963|FG000|Overall Study|Progressive disease|3|||
33159456|NCT00474760|100497964|FG001|Overall Study|Progressive disease|2|||
33159457|NCT00474760|100497965|FG002|Overall Study|Progressive disease|3|||
33159458|NCT00474760|100497966|FG003|Overall Study|Progressive disease|2|||
33159459|NCT00474760|100497967|FG004|Overall Study|Progressive disease|8|||
33159460|NCT00474760|100497968|FG005|Overall Study|Progressive disease|20|||
33159461|NCT00474760|100497969|FG006|Overall Study|Progressive disease|7|||
33159462|NCT00474760|100497963|FG000|Overall Study|Terminated by sponsor|0|||
33159463|NCT00474760|100497964|FG001|Overall Study|Terminated by sponsor|0|||
33159464|NCT00474760|100497965|FG002|Overall Study|Terminated by sponsor|0|||
33159465|NCT00474760|100497966|FG003|Overall Study|Terminated by sponsor|0|||
33159466|NCT00474760|100497967|FG004|Overall Study|Terminated by sponsor|0|||
33159467|NCT00474760|100497968|FG005|Overall Study|Terminated by sponsor|0|||
33159468|NCT00474760|100497969|FG006|Overall Study|Terminated by sponsor|2|||
33159469|NCT00389597|100497970|FG000|Overall Study|Lost to Follow-up|8|||
33159470|NCT00389597|100497971|FG001|Overall Study|Lost to Follow-up|6|||
33159471|NCT00389597|100497972|FG002|Overall Study|Lost to Follow-up|4|||
33159472|NCT00389597|100497973|FG003|Overall Study|Lost to Follow-up|6|||
33159473|NCT05085730|100497974|FG000|Overall Study|Withdrawal by Subject|4|||
33159474|NCT05085730|100497974|FG000|Overall Study|Physician Decision|1|||
33159475|NCT01233258|100497976|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
33159476|NCT01233258|100497977|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
33159477|NCT01233258|100497978|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
33159478|NCT01233258|100497979|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
33159479|NCT01233258|100497980|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
33159480|NCT01233258|100497981|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
33159481|NCT01233258|100497976|FG000|First Intervention (6 Months)|Protocol Violation|0|||
33159482|NCT01233258|100497977|FG001|First Intervention (6 Months)|Protocol Violation|0|||
33159483|NCT01233258|100497978|FG002|First Intervention (6 Months)|Protocol Violation|1|||
33159484|NCT01233258|100497979|FG003|First Intervention (6 Months)|Protocol Violation|0|||
33159485|NCT01233258|100497980|FG004|First Intervention (6 Months)|Protocol Violation|0|||
33159486|NCT01233258|100497981|FG005|First Intervention (6 Months)|Protocol Violation|0|||
33159487|NCT01233258|100497976|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
33159488|NCT01233258|100497977|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
33159489|NCT01233258|100497978|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
33159490|NCT01233258|100497979|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
33159491|NCT01233258|100497980|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
33159492|NCT01233258|100497981|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
33159493|NCT00781274|100497982|FG000|Overall Study|Withdrawal by Subject|2|||
33159494|NCT03750955|100497983|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
33159495|NCT03750955|100497984|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
33159496|NCT03750955|100497983|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
33159497|NCT03750955|100497984|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
33159498|NCT05047770|100497987|FG000|Overall Study|Withdrawal by Subject|15|||
33159499|NCT05047770|100497988|FG001|Overall Study|Withdrawal by Subject|10|||
33159500|NCT05047770|100497989|FG002|Overall Study|Withdrawal by Subject|6|||
33159501|NCT05047770|100497990|FG003|Overall Study|Withdrawal by Subject|12|||
33254265|NCT00723450|100830407|FG002|Open-Label Phase|Withdrawal by Subject|0|||
33159502|NCT05047770|100497987|FG000|Overall Study|Lost to Follow-up|7|||
33159503|NCT05047770|100497988|FG001|Overall Study|Lost to Follow-up|5|||
33159504|NCT05047770|100497989|FG002|Overall Study|Lost to Follow-up|12|||
33159505|NCT05047770|100497990|FG003|Overall Study|Lost to Follow-up|13|||
33159506|NCT05047770|100497987|FG000|Overall Study|Other|1|||
33159507|NCT05047770|100497988|FG001|Overall Study|Other|0|||
33159508|NCT05047770|100497989|FG002|Overall Study|Other|1|||
33159509|NCT05047770|100497990|FG003|Overall Study|Other|0|||
33159510|NCT01441180|100497991|FG000|Overall Study|Lost to Follow-up|1|||
33159511|NCT01441180|100497992|FG001|Overall Study|Lost to Follow-up|1|||
33159512|NCT01441180|100497993|FG002|Overall Study|Lost to Follow-up|1|||
33159513|NCT01441180|100497991|FG000|Overall Study|Discontinued|0|||
33159514|NCT01441180|100497992|FG001|Overall Study|Discontinued|0|||
33159515|NCT01441180|100497993|FG002|Overall Study|Discontinued|2|||
33159516|NCT03519178|100497994|FG000|PF-06873600 Treatment|Adverse Event|0|||
33159517|NCT03519178|100497995|FG001|PF-06873600 Treatment|Adverse Event|0|||
33159518|NCT03519178|100497996|FG002|PF-06873600 Treatment|Adverse Event|0|||
33159519|NCT03519178|100497997|FG003|PF-06873600 Treatment|Adverse Event|0|||
33159520|NCT03519178|100497998|FG004|PF-06873600 Treatment|Adverse Event|0|||
33159521|NCT03519178|100497999|FG005|PF-06873600 Treatment|Adverse Event|0|||
33159522|NCT03519178|100498000|FG006|PF-06873600 Treatment|Adverse Event|0|||
33159523|NCT03519178|100498001|FG007|PF-06873600 Treatment|Adverse Event|2|||
33159524|NCT03519178|100498002|FG008|PF-06873600 Treatment|Adverse Event|1|||
33159525|NCT03519178|100498003|FG009|PF-06873600 Treatment|Adverse Event|0|||
33159526|NCT03519178|100498004|FG010|PF-06873600 Treatment|Adverse Event|0|||
33159527|NCT03519178|100498005|FG011|PF-06873600 Treatment|Adverse Event|0|||
33159528|NCT03519178|100498006|FG012|PF-06873600 Treatment|Adverse Event|1|||
33159529|NCT03519178|100498007|FG013|PF-06873600 Treatment|Adverse Event|3|||
33254266|NCT00723450|100830405|FG000|Randomized Phase|Adverse Event|0|||
33254267|NCT00723450|100830406|FG001|Randomized Phase|Adverse Event|26|||
33254268|NCT00723450|100830407|FG002|Randomized Phase|Adverse Event|17|||
33254269|NCT00723450|100830405|FG000|Randomized Phase|Lack of Efficacy|0|||
33254270|NCT00723450|100830406|FG001|Randomized Phase|Lack of Efficacy|11|||
33254271|NCT00723450|100830407|FG002|Randomized Phase|Lack of Efficacy|11|||
33254272|NCT00723450|100830405|FG000|Randomized Phase|Protocol Violation|0|||
33254273|NCT00723450|100830406|FG001|Randomized Phase|Protocol Violation|9|||
33254274|NCT00723450|100830407|FG002|Randomized Phase|Protocol Violation|13|||
33254275|NCT00723450|100830405|FG000|Randomized Phase|Lost to Follow-up|0|||
33254276|NCT00723450|100830406|FG001|Randomized Phase|Lost to Follow-up|2|||
33254277|NCT00723450|100830407|FG002|Randomized Phase|Lost to Follow-up|3|||
33254278|NCT00723450|100830405|FG000|Randomized Phase|Physician Decision|0|||
33254279|NCT00723450|100830406|FG001|Randomized Phase|Physician Decision|3|||
33254280|NCT00723450|100830407|FG002|Randomized Phase|Physician Decision|1|||
33441800|NCT00846495|101512042|FG000|Overall Study|Lack of Efficacy|1|||
33441801|NCT00846495|101512043|FG001|Overall Study|Lack of Efficacy|2|||
33441802|NCT00846495|101512042|FG000|Overall Study|Physician Decision|1|||
33441803|NCT00846495|101512043|FG001|Overall Study|Physician Decision|0|||
33441804|NCT00319735|101512046|FG000|Overall Study|Death|2|||
33441805|NCT00119015|101512047|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
33441806|NCT00119015|101512048|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
33254281|NCT00723450|100830405|FG000|Randomized Phase|Withdrawal by Subject|0|||
33254282|NCT00723450|100830406|FG001|Randomized Phase|Withdrawal by Subject|14|||
33441807|NCT00119015|101512049|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
33441808|NCT03099538|101512050|FG000|Overall Study|Lack of Efficacy|3|||
33441809|NCT02140060|101512053|FG000|Overall Study|Adverse Event|0|||
33159530|NCT03519178|100498008|FG014|PF-06873600 Treatment|Adverse Event|2|||
33159531|NCT03519178|100497994|FG000|PF-06873600 Treatment|Death|0|||
33159532|NCT03519178|100497995|FG001|PF-06873600 Treatment|Death|0|||
33159533|NCT03519178|100497996|FG002|PF-06873600 Treatment|Death|0|||
33159534|NCT03519178|100497997|FG003|PF-06873600 Treatment|Death|0|||
33159535|NCT03519178|100497998|FG004|PF-06873600 Treatment|Death|0|||
33159536|NCT03519178|100497999|FG005|PF-06873600 Treatment|Death|0|||
33159537|NCT03519178|100498000|FG006|PF-06873600 Treatment|Death|0|||
33441810|NCT02140060|101512054|FG001|Overall Study|Adverse Event|0|||
33441811|NCT02140060|101512055|FG002|Overall Study|Adverse Event|0|||
33441812|NCT02140060|101512056|FG003|Overall Study|Adverse Event|1|||
33441813|NCT02140060|101512057|FG004|Overall Study|Adverse Event|1|||
33441814|NCT02140060|101512058|FG005|Overall Study|Adverse Event|1|||
33441815|NCT02140060|101512053|FG000|Overall Study|Lack of Efficacy|0|||
33441816|NCT02140060|101512054|FG001|Overall Study|Lack of Efficacy|0|||
33441817|NCT02140060|101512055|FG002|Overall Study|Lack of Efficacy|0|||
33441818|NCT02140060|101512056|FG003|Overall Study|Lack of Efficacy|1|||
33441819|NCT02140060|101512057|FG004|Overall Study|Lack of Efficacy|0|||
33441820|NCT02140060|101512058|FG005|Overall Study|Lack of Efficacy|0|||
33441821|NCT00905840|101512059|FG000|Overall Study|Lost to Follow-up|11|||
33441822|NCT00905840|101512059|FG000|Overall Study|Death|3|||
33441823|NCT00905840|101512059|FG000|Overall Study|Withdrawal by Subject|1|||
33441824|NCT00905840|101512059|FG000|Overall Study|Adverse Event|1|||
33441825|NCT03496623|101512060|FG000|Run-In Period (2 Weeks)|Death|1|||
33441826|NCT03496623|101512061|FG001|Run-In Period (2 Weeks)|Death|0|||
33441827|NCT03496623|101512062|FG002|Run-In Period (2 Weeks)|Death|0|||
33441828|NCT03496623|101512063|FG003|Run-In Period (2 Weeks)|Death|0|||
33441829|NCT03496623|101512064|FG004|Run-In Period (2 Weeks)|Death|0|||
33441830|NCT03496623|101512060|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
33441831|NCT03496623|101512061|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
33441832|NCT03496623|101512062|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
33441833|NCT03496623|101512063|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
33441834|NCT03496623|101512064|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
33441835|NCT03496623|101512060|FG000|Period 1 (12 Weeks)|Death|0|||
33441836|NCT03496623|101512061|FG001|Period 1 (12 Weeks)|Death|3|||
33441837|NCT03496623|101512062|FG002|Period 1 (12 Weeks)|Death|0|||
33441838|NCT03496623|101512063|FG003|Period 1 (12 Weeks)|Death|0|||
33441839|NCT03496623|101512064|FG004|Period 1 (12 Weeks)|Death|0|||
33441840|NCT03496623|101512060|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
33441841|NCT03496623|101512061|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
33441842|NCT03496623|101512062|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
33441843|NCT03496623|101512063|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
33441844|NCT03496623|101512064|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
33441845|NCT03496623|101512060|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33441846|NCT03496623|101512061|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
33441847|NCT03496623|101512062|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
33441848|NCT03496623|101512063|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33441849|NCT03496623|101512064|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
33441850|NCT03496623|101512060|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
33441851|NCT03496623|101512061|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
33441852|NCT03496623|101512062|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
33441853|NCT03496623|101512063|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
33159538|NCT03519178|100498001|FG007|PF-06873600 Treatment|Death|0|||
33159539|NCT03519178|100498002|FG008|PF-06873600 Treatment|Death|1|||
33159540|NCT03519178|100498003|FG009|PF-06873600 Treatment|Death|1|||
33254283|NCT00723450|100830407|FG002|Randomized Phase|Withdrawal by Subject|22|||
33441854|NCT03496623|101512064|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
33254284|NCT02425111|100830408|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
33441855|NCT03496623|101512060|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
33441856|NCT03496623|101512061|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
33441857|NCT03496623|101512062|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
33441858|NCT03496623|101512063|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
33441859|NCT03496623|101512064|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
33441860|NCT03496623|101512060|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
33441861|NCT03496623|101512061|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
33441862|NCT03496623|101512062|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
33441863|NCT03496623|101512063|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
33441864|NCT03496623|101512064|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
33441865|NCT03496623|101512060|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33441866|NCT03496623|101512061|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
33441867|NCT03496623|101512062|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
33441868|NCT03496623|101512063|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33254285|NCT02425111|100830408|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
33441869|NCT03496623|101512064|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
33441870|NCT02511782|101512065|FG000|Overall Study|Withdrawal by Subject|1|||
33441871|NCT02511782|101512066|FG001|Overall Study|Withdrawal by Subject|0|||
33441872|NCT02511782|101512067|FG002|Overall Study|Withdrawal by Subject|0|||
33441873|NCT03122457|101512068|FG000|Overall Study|Withdrawal by Subject|6|||
33441874|NCT00323882|101512084|FG000|Overall Study|Adverse Event|2|||
33441875|NCT00323882|101512085|FG001|Overall Study|Adverse Event|1|||
33441876|NCT00323882|101512086|FG002|Overall Study|Adverse Event|1|||
33441877|NCT00323882|101512087|FG003|Overall Study|Adverse Event|1|||
33441878|NCT00323882|101512088|FG004|Overall Study|Adverse Event|3|||
33254286|NCT02425111|100830408|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
33254287|NCT02425111|100830408|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
33254288|NCT02425111|100830408|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
33254289|NCT02425111|100830408|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
33254290|NCT03863834|100830409|FG000|Overall Study|Lost to Follow-up|3|||
33254291|NCT03720210|100830411|FG000|Overall Study|Lost to Follow-up|1|||
33254292|NCT02512965|100830414|FG000|Overall Study|Withdrawal by Subject|0|||
33254293|NCT02512965|100830415|FG001|Overall Study|Withdrawal by Subject|4|||
33254294|NCT00813904|100830426|FG000|Overall Study|Death|1|||
33254295|NCT03201562|100830427|FG000|Overall Study|Physician Decision|0|||
33159541|NCT03519178|100498004|FG010|PF-06873600 Treatment|Death|0|||
33159542|NCT03519178|100498005|FG011|PF-06873600 Treatment|Death|0|||
33159543|NCT03519178|100498006|FG012|PF-06873600 Treatment|Death|0|||
33159544|NCT03519178|100498007|FG013|PF-06873600 Treatment|Death|0|||
33159545|NCT03519178|100498008|FG014|PF-06873600 Treatment|Death|1|||
33159546|NCT03519178|100497994|FG000|PF-06873600 Treatment|Physician Decision|0|||
33159547|NCT03519178|100497995|FG001|PF-06873600 Treatment|Physician Decision|0|||
33159548|NCT03519178|100497996|FG002|PF-06873600 Treatment|Physician Decision|0|||
33159549|NCT03519178|100497997|FG003|PF-06873600 Treatment|Physician Decision|0|||
33254296|NCT03201562|100830428|FG001|Overall Study|Physician Decision|0|||
33254297|NCT03201562|100830429|FG002|Overall Study|Physician Decision|1|||
33254298|NCT03201562|100830427|FG000|Overall Study|Adverse Event|0|||
33254299|NCT03201562|100830428|FG001|Overall Study|Adverse Event|0|||
33254300|NCT03201562|100830429|FG002|Overall Study|Adverse Event|1|||
33254301|NCT03201562|100830427|FG000|Overall Study|Lost to Follow-up|0|||
33254302|NCT03201562|100830428|FG001|Overall Study|Lost to Follow-up|1|||
33254303|NCT03201562|100830429|FG002|Overall Study|Lost to Follow-up|2|||
33254304|NCT02139046|100830434|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
33254305|NCT02139046|100830435|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
33254306|NCT02139046|100830436|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
33254307|NCT02139046|100830437|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
33254308|NCT02139046|100830438|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
33254309|NCT02139046|100830434|FG000|Overall Study|Major Protocol Deviation|9|||
33254310|NCT02139046|100830435|FG001|Overall Study|Major Protocol Deviation|10|||
33254311|NCT02139046|100830436|FG002|Overall Study|Major Protocol Deviation|16|||
33254312|NCT02139046|100830437|FG003|Overall Study|Major Protocol Deviation|12|||
33254313|NCT02139046|100830438|FG004|Overall Study|Major Protocol Deviation|6|||
33254314|NCT02139046|100830434|FG000|Overall Study|Lost to Follow-up|13|||
33441879|NCT00323882|101512084|FG000|Overall Study|Disease Progression|6|||
33159550|NCT03519178|100497998|FG004|PF-06873600 Treatment|Physician Decision|0|||
33159551|NCT03519178|100497999|FG005|PF-06873600 Treatment|Physician Decision|0|||
33159552|NCT03519178|100498000|FG006|PF-06873600 Treatment|Physician Decision|0|||
33254315|NCT02139046|100830435|FG001|Overall Study|Lost to Follow-up|16|||
33254316|NCT02139046|100830436|FG002|Overall Study|Lost to Follow-up|16|||
33254317|NCT02139046|100830437|FG003|Overall Study|Lost to Follow-up|18|||
33254318|NCT02139046|100830438|FG004|Overall Study|Lost to Follow-up|13|||
33254319|NCT02139046|100830434|FG000|Overall Study|Voluntary Withdrawal|20|||
33254320|NCT02139046|100830435|FG001|Overall Study|Voluntary Withdrawal|8|||
33254321|NCT02139046|100830436|FG002|Overall Study|Voluntary Withdrawal|10|||
33254322|NCT02139046|100830437|FG003|Overall Study|Voluntary Withdrawal|15|||
33441880|NCT00323882|101512085|FG001|Overall Study|Disease Progression|4|||
33441881|NCT00323882|101512086|FG002|Overall Study|Disease Progression|10|||
33441882|NCT00323882|101512087|FG003|Overall Study|Disease Progression|5|||
33441883|NCT00323882|101512088|FG004|Overall Study|Disease Progression|22|||
33441884|NCT00323882|101512084|FG000|Overall Study|Death|0|||
33441885|NCT00323882|101512085|FG001|Overall Study|Death|1|||
33159553|NCT03519178|100498001|FG007|PF-06873600 Treatment|Physician Decision|1|||
33254323|NCT02139046|100830438|FG004|Overall Study|Voluntary Withdrawal|16|||
33254324|NCT02139046|100830434|FG000|Overall Study|Lack of Efficacy|0|||
33441886|NCT00323882|101512086|FG002|Overall Study|Death|1|||
33441887|NCT00323882|101512087|FG003|Overall Study|Death|0|||
33441888|NCT00323882|101512088|FG004|Overall Study|Death|5|||
33159554|NCT03519178|100498002|FG008|PF-06873600 Treatment|Physician Decision|0|||
33254325|NCT02139046|100830435|FG001|Overall Study|Lack of Efficacy|1|||
33254326|NCT02139046|100830436|FG002|Overall Study|Lack of Efficacy|2|||
33254327|NCT02139046|100830437|FG003|Overall Study|Lack of Efficacy|1|||
33254328|NCT02139046|100830438|FG004|Overall Study|Lack of Efficacy|2|||
33254329|NCT02139046|100830434|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
33254330|NCT02139046|100830435|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
33254331|NCT02139046|100830436|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
33254332|NCT02139046|100830437|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
33254333|NCT02139046|100830438|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
33254334|NCT02139046|100830434|FG000|Overall Study|Other Miscellaneous Reasons|10|||
33254335|NCT02139046|100830435|FG001|Overall Study|Other Miscellaneous Reasons|9|||
33254336|NCT02139046|100830436|FG002|Overall Study|Other Miscellaneous Reasons|4|||
33254337|NCT02139046|100830437|FG003|Overall Study|Other Miscellaneous Reasons|9|||
33254338|NCT02139046|100830438|FG004|Overall Study|Other Miscellaneous Reasons|12|||
33254339|NCT00004124|100830442|FG000|Overall Study|Received no protocol therapy|12|||
33254340|NCT00004124|100830443|FG001|Overall Study|Received no protocol therapy|20|||
33254341|NCT05283395|100830444|FG000|Overall Study|Adverse Event|4|||
33254342|NCT05283395|100830445|FG001|Overall Study|Adverse Event|4|||
33254343|NCT05283395|100830446|FG002|Overall Study|Adverse Event|0|||
33254344|NCT05283395|100830444|FG000|Overall Study|Patient Lost to Follow-Up|0|||
33254345|NCT05283395|100830445|FG001|Overall Study|Patient Lost to Follow-Up|0|||
33254346|NCT05283395|100830446|FG002|Overall Study|Patient Lost to Follow-Up|1|||
33254347|NCT05283395|100830444|FG000|Overall Study|Patient Withdrawal|2|||
33254348|NCT05283395|100830445|FG001|Overall Study|Patient Withdrawal|4|||
33254349|NCT05283395|100830446|FG002|Overall Study|Patient Withdrawal|2|||
33254350|NCT05283395|100830444|FG000|Overall Study|Investigator Decision|1|||
33254351|NCT05283395|100830445|FG001|Overall Study|Investigator Decision|0|||
33254352|NCT05283395|100830446|FG002|Overall Study|Investigator Decision|1|||
33254353|NCT05283395|100830444|FG000|Overall Study|Enrolled in error|0|||
33254354|NCT05283395|100830445|FG001|Overall Study|Enrolled in error|0|||
33254355|NCT05283395|100830446|FG002|Overall Study|Enrolled in error|1|||
33254356|NCT02738840|100830447|FG000|Overall Study|MRI Scan not Performed|5|||
33254357|NCT02738840|100830447|FG000|Overall Study|Lost to Follow-up|1|||
33254358|NCT02738840|100830447|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
33254359|NCT02738840|100830447|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
33254360|NCT00516386|100830448|FG000|Overall Study|not interested in the study|4|||
33254361|NCT00516386|100830448|FG000|Overall Study|Lost to Follow-up|2|||
33254362|NCT00114244|100830449|FG000|Overall Study|Adverse Event|2|||
33254363|NCT00114244|100830450|FG001|Overall Study|Adverse Event|5|||
33254364|NCT00114244|100830449|FG000|Overall Study|Withdrawal by Subject|0|||
33254365|NCT00114244|100830450|FG001|Overall Study|Withdrawal by Subject|2|||
33254366|NCT01239316|100830452|FG000|Overall Study|Progression/Relapse|11|||
33254367|NCT01239316|100830452|FG000|Overall Study|Adverse Event|1|||
33254368|NCT01104415|100830454|FG000|Core Phase|Consent withdrawn by subjects|1|||
33254369|NCT01104415|100830455|FG001|Core Phase|Consent withdrawn by subjects|0|||
33254370|NCT01104415|100830454|FG000|Extension Period|Progressive disease|0|||
33254371|NCT01104415|100830455|FG001|Extension Period|Progressive disease|4|||
33254372|NCT01104415|100830454|FG000|Extension Period|Death|0|||
33254373|NCT01104415|100830455|FG001|Extension Period|Death|1|||
33254374|NCT01104415|100830454|FG000|Extension Period|Physician Decision|0|||
33254375|NCT01104415|100830455|FG001|Extension Period|Physician Decision|1|||
33254376|NCT01104415|100830454|FG000|Extension Period|Transition to Study LX1606.302|0|||
33254377|NCT01104415|100830455|FG001|Extension Period|Transition to Study LX1606.302|4|||
33254378|NCT01104415|100830454|FG000|Extension Period|Heart surgery/feeling miserable|0|||
33254379|NCT01104415|100830455|FG001|Extension Period|Heart surgery/feeling miserable|1|||
33254380|NCT03923491|100830456|FG000|Overall Study|Lost to Follow-up|5|||
33254381|NCT03923491|100830457|FG001|Overall Study|Lost to Follow-up|8|||
33254382|NCT03923491|100830456|FG000|Overall Study|Withdrawal by Subject|4|||
33254383|NCT03923491|100830457|FG001|Overall Study|Withdrawal by Subject|6|||
33254384|NCT00094575|100830458|FG000|Overall Study|Death|146|||
33254385|NCT00094575|100830459|FG001|Overall Study|Death|146|||
33254386|NCT00082810|100830470|FG000|Overall Study|Adverse Event|3|||
33254387|NCT00082810|100830470|FG000|Overall Study|Progressive disease|24|||
33254388|NCT00082810|100830470|FG000|Overall Study|Withdrawal by Subject|4|||
33254389|NCT02814643|100830471|FG000|Overall Study|Lost to Follow-up|0|||
33254390|NCT02814643|100830472|FG001|Overall Study|Lost to Follow-up|1|||
33254391|NCT02814643|100830471|FG000|Overall Study|Withdrawal by Subject|1|||
33254392|NCT02814643|100830472|FG001|Overall Study|Withdrawal by Subject|2|||
33254393|NCT02471755|100830473|FG000|Overall Study|Withdrawal by Subject|1|||
33254394|NCT02471755|100830474|FG001|Overall Study|Withdrawal by Subject|0|||
33254395|NCT02471755|100830473|FG000|Overall Study|Lost to Follow-up|0|||
33254396|NCT02471755|100830474|FG001|Overall Study|Lost to Follow-up|1|||
33254397|NCT03830866|100830479|FG000|Overall Study|Death|90|||
33254398|NCT03830866|100830480|FG001|Overall Study|Death|111|||
33254399|NCT03830866|100830479|FG000|Overall Study|Lost to Follow-up|7|||
33254400|NCT03830866|100830480|FG001|Overall Study|Lost to Follow-up|7|||
33254401|NCT03830866|100830479|FG000|Overall Study|Withdrawal by Subject|19|||
33254402|NCT03830866|100830480|FG001|Overall Study|Withdrawal by Subject|16|||
33254403|NCT03830866|100830479|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
33254404|NCT03830866|100830480|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
33254405|NCT03830866|100830479|FG000|Overall Study|Other|1|||
33254406|NCT03830866|100830480|FG001|Overall Study|Other|1|||
33254407|NCT02045836|100830486|FG000|Overall Study|Adverse Event|4|||
33254408|NCT02045836|100830487|FG001|Overall Study|Adverse Event|4|||
33254409|NCT02045836|100830486|FG000|Overall Study|Withdrawal by Subject|1|||
33254410|NCT02045836|100830487|FG001|Overall Study|Withdrawal by Subject|1|||
33254411|NCT02045836|100830486|FG000|Overall Study|Lost to Follow-up|4|||
33254412|NCT02045836|100830487|FG001|Overall Study|Lost to Follow-up|7|||
33254413|NCT02045836|100830486|FG000|Overall Study|Migrated from study area|0|||
33254414|NCT02045836|100830487|FG001|Overall Study|Migrated from study area|2|||
33254415|NCT01064817|100830488|FG000|Study Completion|Physician Decision|1|||
33254416|NCT01064817|100830489|FG001|Study Completion|Physician Decision|0|||
33254417|NCT01064817|100830488|FG000|Study Completion|Withdrawal by Subject|1|||
33254418|NCT01064817|100830489|FG001|Study Completion|Withdrawal by Subject|0|||
33254419|NCT00639002|100830491|FG000|Overall Study|Death|1|||
33254420|NCT00639002|100830491|FG000|Overall Study|Adverse Event|1|||
33254421|NCT00639002|100830491|FG000|Overall Study|Protocol Violation|1|||
33254422|NCT00639002|100830491|FG000|Overall Study|Disease progression|3|||
33254423|NCT00639002|100830491|FG000|Overall Study|Physician Decision|6|||
33254424|NCT00639002|100830491|FG000|Overall Study|Lack of Efficacy|1|||
33254425|NCT00356265|100830492|FG000|Overall Study|Withdrawal by Subject|0|||
33254426|NCT00356265|100830493|FG001|Overall Study|Withdrawal by Subject|0|||
33254427|NCT00356265|100830494|FG002|Overall Study|Withdrawal by Subject|1|||
33254428|NCT01505881|100830497|FG000|Overall Study|Adverse Event|0|||
33254429|NCT01505881|100830498|FG001|Overall Study|Adverse Event|1|||
33254430|NCT01505881|100830497|FG000|Overall Study|Lost to Follow-up|2|||
33254431|NCT01505881|100830498|FG001|Overall Study|Lost to Follow-up|0|||
33254432|NCT01505881|100830497|FG000|Overall Study|Withdrawal by Subject|2|||
33254433|NCT01505881|100830498|FG001|Overall Study|Withdrawal by Subject|0|||
33254434|NCT02553460|100830499|FG000|Overall Study|Death|3|||
33254435|NCT02553460|100830499|FG000|Overall Study|Withdrawal by Subject|1|||
33254436|NCT02553460|100830499|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
33254437|NCT02553460|100830499|FG000|Overall Study|Relapse or Transplant|14|||
33254438|NCT02553460|100830499|FG000|Overall Study|No response to treatment|2|||
33254439|NCT02553460|100830499|FG000|Overall Study|Still on therapy|7|||
33254440|NCT02553460|100830499|FG000|Overall Study|CAR T cells|1|||
33254441|NCT03247543|100830500|FG000|Overall Study|Adverse Event|3|||
33254442|NCT03247543|100830501|FG001|Overall Study|Adverse Event|6|||
33254443|NCT03247543|100830502|FG002|Overall Study|Adverse Event|4|||
33254444|NCT03247543|100830500|FG000|Overall Study|Lost to Follow-up|10|||
33254445|NCT03247543|100830501|FG001|Overall Study|Lost to Follow-up|7|||
33254446|NCT03247543|100830502|FG002|Overall Study|Lost to Follow-up|8|||
33254447|NCT03247543|100830500|FG000|Overall Study|Consent withdrawn by caregiver|2|||
33254448|NCT03247543|100830501|FG001|Overall Study|Consent withdrawn by caregiver|2|||
33254449|NCT03247543|100830502|FG002|Overall Study|Consent withdrawn by caregiver|9|||
33254450|NCT03247543|100830500|FG000|Overall Study|Withdrawal by Subject|0|||
33254451|NCT03247543|100830501|FG001|Overall Study|Withdrawal by Subject|0|||
33254452|NCT03247543|100830502|FG002|Overall Study|Withdrawal by Subject|1|||
33254453|NCT03247543|100830500|FG000|Overall Study|Failure to Follow study procedures|1|||
33254454|NCT03247543|100830501|FG001|Overall Study|Failure to Follow study procedures|3|||
33254455|NCT03247543|100830502|FG002|Overall Study|Failure to Follow study procedures|1|||
33254456|NCT03247543|100830500|FG000|Overall Study|Lack of Efficacy|1|||
33254457|NCT03247543|100830501|FG001|Overall Study|Lack of Efficacy|0|||
33254458|NCT03247543|100830502|FG002|Overall Study|Lack of Efficacy|0|||
33254459|NCT03247543|100830500|FG000|Overall Study|Non-compliance with study visits|0|||
33254460|NCT03247543|100830501|FG001|Overall Study|Non-compliance with study visits|1|||
33254461|NCT03247543|100830502|FG002|Overall Study|Non-compliance with study visits|0|||
33254462|NCT01259102|100830505|FG000|Overall Study|Adverse Event|1|||
33254463|NCT01259102|100830506|FG001|Overall Study|Adverse Event|0|||
33254464|NCT01259102|100830507|FG002|Overall Study|Adverse Event|1|||
33254465|NCT01259102|100830508|FG003|Overall Study|Adverse Event|1|||
33254466|NCT01259102|100830509|FG004|Overall Study|Adverse Event|0|||
33254467|NCT01259102|100830505|FG000|Overall Study|Other|0|||
33254468|NCT01259102|100830506|FG001|Overall Study|Other|0|||
33254469|NCT01259102|100830507|FG002|Overall Study|Other|1|||
33254470|NCT01259102|100830508|FG003|Overall Study|Other|1|||
33254471|NCT01259102|100830509|FG004|Overall Study|Other|1|||
33254472|NCT00756730|100830512|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
33254473|NCT00756730|100830513|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
33254474|NCT00756730|100830512|FG000|Overall Study|persistent low-level viremmia|0|||
33254475|NCT00756730|100830513|FG001|Overall Study|persistent low-level viremmia|1|||
33254476|NCT02999477|100830515|FG000|Overall Study|found ineligible after first dose|0|||
33254477|NCT02999477|100830516|FG001|Overall Study|found ineligible after first dose|1|||
33254478|NCT02999477|100830515|FG000|Overall Study|Withdrawal by Subject|1|||
33254479|NCT02999477|100830516|FG001|Overall Study|Withdrawal by Subject|1|||
33254480|NCT02320123|100832967|FG000|Overall Study|Lost to Follow-up|4|||
33254481|NCT02320123|100832968|FG001|Overall Study|Lost to Follow-up|6|||
33254482|NCT02320123|100832967|FG000|Overall Study|Death|6|||
33254483|NCT02320123|100832968|FG001|Overall Study|Death|5|||
33254484|NCT03546907|100832969|FG000|Overall Study|Lack of Efficacy|1|||
33254485|NCT03546907|100832970|FG001|Overall Study|Lack of Efficacy|1|||
33254486|NCT03546907|100832969|FG000|Overall Study|Withdrawal by Subject|8|||
33254487|NCT03546907|100832970|FG001|Overall Study|Withdrawal by Subject|9|||
33254488|NCT03546907|100832969|FG000|Overall Study|Adverse events (AEs)|7|||
33254489|NCT03546907|100832970|FG001|Overall Study|Adverse events (AEs)|10|||
33254490|NCT03546907|100832969|FG000|Overall Study|Other-unspecified|1|||
33254491|NCT03546907|100832970|FG001|Overall Study|Other-unspecified|1|||
33254492|NCT00869323|100832974|FG000|Maintenance Therapy|concurrent illness|1|||
33254493|NCT00976937|100832977|FG000|Overall Study|Adverse Event|4|||
33254494|NCT00976937|100832978|FG001|Overall Study|Adverse Event|5|||
33254495|NCT00976937|100832977|FG000|Overall Study|Lost to Follow-up|2|||
33254496|NCT00976937|100832978|FG001|Overall Study|Lost to Follow-up|1|||
33254497|NCT00976937|100832977|FG000|Overall Study|Withdrawal by Subject|5|||
33254498|NCT00976937|100832978|FG001|Overall Study|Withdrawal by Subject|3|||
33254499|NCT00976937|100832977|FG000|Overall Study|Poor compliance to protocol|3|||
33254500|NCT00976937|100832978|FG001|Overall Study|Poor compliance to protocol|0|||
33254501|NCT00976937|100832977|FG000|Overall Study|Personal and Familial Reason|2|||
33254502|NCT00976937|100832978|FG001|Overall Study|Personal and Familial Reason|2|||
33254503|NCT03183518|100832979|FG000|Overall Study|Other (Not specified)|2|||
33254504|NCT03183518|100832979|FG000|Overall Study|Other (Withdrawal of consent)|1|||
33254505|NCT04740164|100832980|FG000|Overall Study|Lack of Efficacy|4|||
33254506|NCT04740164|100832981|FG001|Overall Study|Lack of Efficacy|0|||
33254507|NCT04740164|100832980|FG000|Overall Study|Physician Decision|3|||
33254508|NCT04740164|100832981|FG001|Overall Study|Physician Decision|3|||
33254509|NCT01147341|100832982|FG000|Double Blind Period|Lack of Efficacy|1|||
33254510|NCT01147341|100832983|FG001|Double Blind Period|Lack of Efficacy|1|||
33254511|NCT01147341|100832982|FG000|Double Blind Period|Withdrawal by Subject|0|||
33254512|NCT01147341|100832983|FG001|Double Blind Period|Withdrawal by Subject|1|||
33254513|NCT01147341|100832982|FG000|Open Label Period|Lack of Efficacy|3|||
33254514|NCT01147341|100832983|FG001|Open Label Period|Lack of Efficacy|0|||
33254515|NCT01147341|100832982|FG000|Open Label Period|Subject moved|1|||
33254516|NCT01147341|100832983|FG001|Open Label Period|Subject moved|0|||
33254517|NCT01199575|100832984|FG000|Overall Study|Withdrawal by Subject|5|||
33254518|NCT00390299|100832986|FG000|Overall Study|Cancellation|1|||
33254519|NCT00390299|100832987|FG001|Overall Study|Cancellation|0|||
33254520|NCT00390299|100832988|FG002|Overall Study|Cancellation|0|||
33254521|NCT00390299|100832989|FG003|Overall Study|Cancellation|0|||
33254522|NCT00390299|100832990|FG004|Overall Study|Cancellation|0|||
33254523|NCT01066923|100832992|FG000|Overall Study|Withdrawal by Subject|3|||
33254524|NCT01066923|100832993|FG001|Overall Study|Withdrawal by Subject|3|||
33254525|NCT01066923|100832994|FG002|Overall Study|Withdrawal by Subject|8|||
33254526|NCT01066923|100832995|FG003|Overall Study|Withdrawal by Subject|8|||
33254527|NCT00446550|100832996|FG000|Overall Study|Adverse Event|1|||
33254528|NCT00446550|100832997|FG001|Overall Study|Adverse Event|0|||
33254529|NCT01091454|100833001|FG000|Overall Study|Ineligible|1|||
33254530|NCT00346333|100833007|FG000|Overall Study|Death|1|||
33254531|NCT00346333|100833008|FG001|Overall Study|Death|0|||
33254532|NCT00346333|100833007|FG000|Overall Study|unwilling or unable to continue|4|||
33254533|NCT00346333|100833008|FG001|Overall Study|unwilling or unable to continue|8|||
33254534|NCT01560416|100833013|FG000|Randomized Phase|Crossover Participants|7|||
33254535|NCT01560416|100833014|FG001|Randomized Phase|Crossover Participants|0|||
33254536|NCT02020616|100833016|FG000|Overall Study|Adverse Event|0|||
33254537|NCT02020616|100833017|FG001|Overall Study|Adverse Event|0|||
33254538|NCT02020616|100833018|FG002|Overall Study|Adverse Event|0|||
33254539|NCT02020616|100833019|FG003|Overall Study|Adverse Event|0|||
33254540|NCT02020616|100833020|FG004|Overall Study|Adverse Event|0|||
33254541|NCT02020616|100833021|FG005|Overall Study|Adverse Event|1|||
33254542|NCT02020616|100833022|FG006|Overall Study|Adverse Event|1|||
33254543|NCT02020616|100833016|FG000|Overall Study|Physician Decision|0|||
33254544|NCT02020616|100833017|FG001|Overall Study|Physician Decision|0|||
33254545|NCT02020616|100833018|FG002|Overall Study|Physician Decision|0|||
33254546|NCT02020616|100833019|FG003|Overall Study|Physician Decision|0|||
33254547|NCT02020616|100833020|FG004|Overall Study|Physician Decision|0|||
33254548|NCT02020616|100833021|FG005|Overall Study|Physician Decision|1|||
33254549|NCT02020616|100833022|FG006|Overall Study|Physician Decision|2|||
33254550|NCT02020616|100833016|FG000|Overall Study|Withdrawal by Subject|0|||
33254551|NCT02020616|100833017|FG001|Overall Study|Withdrawal by Subject|0|||
33254552|NCT02020616|100833018|FG002|Overall Study|Withdrawal by Subject|1|||
33254553|NCT02020616|100833019|FG003|Overall Study|Withdrawal by Subject|0|||
33254554|NCT02020616|100833020|FG004|Overall Study|Withdrawal by Subject|0|||
33254555|NCT02020616|100833021|FG005|Overall Study|Withdrawal by Subject|1|||
33254556|NCT02020616|100833022|FG006|Overall Study|Withdrawal by Subject|1|||
33254557|NCT02020616|100833016|FG000|Overall Study|Lost to Follow-up|0|||
33159555|NCT03519178|100498003|FG009|PF-06873600 Treatment|Physician Decision|0|||
33159556|NCT03519178|100498004|FG010|PF-06873600 Treatment|Physician Decision|1|||
33159557|NCT03519178|100498005|FG011|PF-06873600 Treatment|Physician Decision|0|||
33159558|NCT03519178|100498006|FG012|PF-06873600 Treatment|Physician Decision|0|||
33159559|NCT03519178|100498007|FG013|PF-06873600 Treatment|Physician Decision|4|||
33159560|NCT03519178|100498008|FG014|PF-06873600 Treatment|Physician Decision|1|||
33159561|NCT03519178|100497994|FG000|PF-06873600 Treatment|Progressive disease|1|||
33159562|NCT03519178|100497995|FG001|PF-06873600 Treatment|Progressive disease|1|||
33159563|NCT03519178|100497996|FG002|PF-06873600 Treatment|Progressive disease|1|||
33159564|NCT03519178|100497997|FG003|PF-06873600 Treatment|Progressive disease|1|||
33159565|NCT03519178|100497998|FG004|PF-06873600 Treatment|Progressive disease|6|||
33159566|NCT03519178|100497999|FG005|PF-06873600 Treatment|Progressive disease|7|||
33159567|NCT03519178|100498000|FG006|PF-06873600 Treatment|Progressive disease|3|||
33159568|NCT03519178|100498001|FG007|PF-06873600 Treatment|Progressive disease|7|||
33159569|NCT03519178|100498002|FG008|PF-06873600 Treatment|Progressive disease|3|||
33159570|NCT03519178|100498003|FG009|PF-06873600 Treatment|Progressive disease|5|||
33159571|NCT03519178|100498004|FG010|PF-06873600 Treatment|Progressive disease|4|||
33159572|NCT03519178|100498005|FG011|PF-06873600 Treatment|Progressive disease|3|||
33159573|NCT03519178|100498006|FG012|PF-06873600 Treatment|Progressive disease|4|||
33159574|NCT03519178|100498007|FG013|PF-06873600 Treatment|Progressive disease|28|||
33159575|NCT03519178|100498008|FG014|PF-06873600 Treatment|Progressive disease|7|||
33159576|NCT03519178|100497994|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
33159577|NCT03519178|100497995|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
33159578|NCT03519178|100497996|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
33159579|NCT03519178|100497997|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
33159580|NCT03519178|100497998|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
33159581|NCT03519178|100497999|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
33159582|NCT03519178|100498000|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
33159583|NCT03519178|100498001|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
33159584|NCT03519178|100498002|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
33159585|NCT03519178|100498003|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
33159586|NCT03519178|100498004|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
33159587|NCT03519178|100498005|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
33159588|NCT03519178|100498006|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
33159589|NCT03519178|100498007|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
33159590|NCT03519178|100498008|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
33159591|NCT03519178|100497994|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
33159592|NCT03519178|100497995|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
33159593|NCT03519178|100497996|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
33159594|NCT03519178|100497997|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
33159595|NCT03519178|100497998|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
33159596|NCT03519178|100497999|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
33159597|NCT03519178|100498000|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
33159598|NCT03519178|100498001|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
33159599|NCT03519178|100498002|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
33159600|NCT03519178|100498003|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
33159601|NCT03519178|100498004|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
33159602|NCT03519178|100498005|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
33159603|NCT03519178|100498006|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
33159604|NCT03519178|100498007|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
33159605|NCT03519178|100498008|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
33159606|NCT03519178|100497994|FG000|PF-06873600 Treatment|Refused further treatment|0|||
33159607|NCT03519178|100497995|FG001|PF-06873600 Treatment|Refused further treatment|1|||
33159608|NCT03519178|100497996|FG002|PF-06873600 Treatment|Refused further treatment|0|||
33159609|NCT03519178|100497997|FG003|PF-06873600 Treatment|Refused further treatment|0|||
33159610|NCT03519178|100497998|FG004|PF-06873600 Treatment|Refused further treatment|1|||
33159611|NCT03519178|100497999|FG005|PF-06873600 Treatment|Refused further treatment|0|||
33441889|NCT00323882|101512084|FG000|Overall Study|Lost to Follow-up|0|||
33441890|NCT00323882|101512085|FG001|Overall Study|Lost to Follow-up|0|||
33441891|NCT00323882|101512086|FG002|Overall Study|Lost to Follow-up|1|||
33441892|NCT00323882|101512087|FG003|Overall Study|Lost to Follow-up|0|||
33441893|NCT00323882|101512088|FG004|Overall Study|Lost to Follow-up|1|||
33441894|NCT00323882|101512084|FG000|Overall Study|Other|0|||
33441895|NCT00323882|101512085|FG001|Overall Study|Other|0|||
33159612|NCT03519178|100498000|FG006|PF-06873600 Treatment|Refused further treatment|0|||
33254558|NCT02020616|100833017|FG001|Overall Study|Lost to Follow-up|1|||
33254559|NCT02020616|100833018|FG002|Overall Study|Lost to Follow-up|0|||
33159613|NCT03519178|100498001|FG007|PF-06873600 Treatment|Refused further treatment|0|||
33254560|NCT02020616|100833019|FG003|Overall Study|Lost to Follow-up|1|||
33159614|NCT03519178|100498002|FG008|PF-06873600 Treatment|Refused further treatment|0|||
33159615|NCT03519178|100498003|FG009|PF-06873600 Treatment|Refused further treatment|0|||
33159616|NCT03519178|100498004|FG010|PF-06873600 Treatment|Refused further treatment|0|||
33254561|NCT02020616|100833020|FG004|Overall Study|Lost to Follow-up|1|||
33254562|NCT02020616|100833021|FG005|Overall Study|Lost to Follow-up|1|||
33254563|NCT02020616|100833022|FG006|Overall Study|Lost to Follow-up|0|||
33254564|NCT02020616|100833016|FG000|Overall Study|Early Termination Criteria Met|0|||
33254565|NCT02020616|100833017|FG001|Overall Study|Early Termination Criteria Met|0|||
33254566|NCT02020616|100833018|FG002|Overall Study|Early Termination Criteria Met|1|||
33254567|NCT02020616|100833019|FG003|Overall Study|Early Termination Criteria Met|0|||
33254568|NCT02020616|100833020|FG004|Overall Study|Early Termination Criteria Met|0|||
33254569|NCT02020616|100833021|FG005|Overall Study|Early Termination Criteria Met|1|||
33441896|NCT00323882|101512086|FG002|Overall Study|Other|0|||
33254570|NCT02020616|100833022|FG006|Overall Study|Early Termination Criteria Met|0|||
33254571|NCT02020616|100833016|FG000|Overall Study|Randomized in Error|0|||
33441897|NCT00323882|101512087|FG003|Overall Study|Other|1|||
33441898|NCT00323882|101512088|FG004|Overall Study|Other|1|||
33441899|NCT01949662|101512089|FG000|Overall Study|Death|9|||
33441900|NCT01949662|101512090|FG001|Overall Study|Death|7|||
33441901|NCT01949662|101512089|FG000|Overall Study|Discharged before an agitation event|8|||
33441902|NCT01949662|101512090|FG001|Overall Study|Discharged before an agitation event|3|||
33441903|NCT01949662|101512089|FG000|Overall Study|Dropped out|1|||
33441904|NCT01949662|101512090|FG001|Overall Study|Dropped out|3|||
33441905|NCT01949662|101512089|FG000|Overall Study|Ineligible|0|||
33441906|NCT01949662|101512090|FG001|Overall Study|Ineligible|1|||
33441907|NCT02661295|101512095|FG000|Overall Study|Death|1|||
33441908|NCT02661295|101512095|FG000|Overall Study|Transferred Out|1|||
33441909|NCT02661295|101512095|FG000|Overall Study|Kidney Transplant|1|||
33441910|NCT02661295|101512095|FG000|Overall Study|Withdrawn due to side effects|8|||
33441911|NCT02661295|101512095|FG000|Overall Study|Withdrawn due to access type|1|||
33441912|NCT02661295|101512095|FG000|Overall Study|Withdrawn due to allergies|1|||
33441913|NCT02661295|101512095|FG000|Overall Study|Withdrawn due to non-compliance|1|||
33441914|NCT02661295|101512095|FG000|Overall Study|Withdrawal by Subject|3|||
33441915|NCT02661295|101512095|FG000|Overall Study|Failed screening|2|||
33441916|NCT01457053|101512099|FG000|Overall Study|Unable to undergo selected treatment|1|||
33441917|NCT01457053|101512100|FG001|Overall Study|Unable to undergo selected treatment|1|||
33441918|NCT04419311|101512102|FG000|Overall Study|Lost to Follow-up|1|||
33441919|NCT04419311|101512103|FG001|Overall Study|Lost to Follow-up|0|||
33441920|NCT01496183|101512104|FG000|Overall Study|Physician Decision|3|||
33441921|NCT01496183|101512105|FG001|Overall Study|Physician Decision|1|||
33441922|NCT01496183|101512104|FG000|Overall Study|Withdrawal by Subject|0|||
33441923|NCT01496183|101512105|FG001|Overall Study|Withdrawal by Subject|1|||
33441924|NCT02724462|101512106|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
33441925|NCT02724462|101512107|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
33441926|NCT02724462|101512106|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
33441927|NCT02724462|101512107|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
33441928|NCT02724462|101512106|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
33441929|NCT02724462|101512107|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
33441930|NCT02724462|101512106|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
33441931|NCT02724462|101512107|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
33441932|NCT02724462|101512106|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
33441933|NCT02724462|101512107|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
33441934|NCT02724462|101512106|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
33441935|NCT02724462|101512107|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
33441936|NCT01792635|101512110|FG000|Part B|Adverse Event|0|||
33441937|NCT01792635|101512111|FG001|Part B|Adverse Event|0|||
33441938|NCT01792635|101512112|FG002|Part B|Adverse Event|1|||
33441939|NCT01792635|101512110|FG000|Part B|Study terminated|0|||
33441940|NCT01792635|101512111|FG001|Part B|Study terminated|4|||
33441941|NCT01792635|101512112|FG002|Part B|Study terminated|3|||
33441942|NCT01667679|101512113|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
33441943|NCT01667679|101512114|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
33441944|NCT01667679|101512113|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
33441945|NCT01667679|101512114|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
33254572|NCT02020616|100833017|FG001|Overall Study|Randomized in Error|0|||
33254573|NCT02020616|100833018|FG002|Overall Study|Randomized in Error|0|||
33441946|NCT01667679|101512113|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
33441947|NCT01667679|101512114|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
33441948|NCT01667679|101512113|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
33441949|NCT01667679|101512114|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
33441950|NCT01667679|101512113|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
33441951|NCT01667679|101512114|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
33159617|NCT03519178|100498005|FG011|PF-06873600 Treatment|Refused further treatment|0|||
33159618|NCT03519178|100498006|FG012|PF-06873600 Treatment|Refused further treatment|0|||
33159619|NCT03519178|100498007|FG013|PF-06873600 Treatment|Refused further treatment|0|||
33159620|NCT03519178|100498008|FG014|PF-06873600 Treatment|Refused further treatment|1|||
33159621|NCT03519178|100497994|FG000|PF-06873600 Treatment|Other|0|||
33159622|NCT03519178|100497995|FG001|PF-06873600 Treatment|Other|0|||
33159623|NCT03519178|100497996|FG002|PF-06873600 Treatment|Other|0|||
33159624|NCT03519178|100497997|FG003|PF-06873600 Treatment|Other|0|||
33254574|NCT02020616|100833019|FG003|Overall Study|Randomized in Error|1|||
33254575|NCT02020616|100833020|FG004|Overall Study|Randomized in Error|0|||
33254576|NCT02020616|100833021|FG005|Overall Study|Randomized in Error|0|||
33254577|NCT02020616|100833022|FG006|Overall Study|Randomized in Error|0|||
33254578|NCT02020616|100833016|FG000|Overall Study|Lack of Efficacy|0|||
33254579|NCT02020616|100833017|FG001|Overall Study|Lack of Efficacy|0|||
33254580|NCT02020616|100833018|FG002|Overall Study|Lack of Efficacy|0|||
33254581|NCT02020616|100833019|FG003|Overall Study|Lack of Efficacy|0|||
33254582|NCT02020616|100833020|FG004|Overall Study|Lack of Efficacy|1|||
33254583|NCT02020616|100833021|FG005|Overall Study|Lack of Efficacy|0|||
33254584|NCT02020616|100833022|FG006|Overall Study|Lack of Efficacy|0|||
33254585|NCT02957136|100833023|FG000|Overall Study|Withdrawal by Subject|2|||
33254586|NCT02957136|100833024|FG001|Overall Study|Withdrawal by Subject|1|||
33254587|NCT03024606|100833025|FG000|Overall Study|Withdrawal by Subject|9|||
33254588|NCT03024606|100833026|FG001|Overall Study|Withdrawal by Subject|10|||
33254589|NCT03070483|100833027|FG000|Overall Study|Lost to Follow-up|2|||
33254590|NCT01331824|100833028|FG000|Overall Study|Adverse Event|2|||
33254591|NCT01331824|100833028|FG000|Overall Study|Death|1|||
33254592|NCT01331824|100833028|FG000|Overall Study|Disease Progression|9|||
33254593|NCT01331824|100833028|FG000|Overall Study|Withdrawal by Subject|1|||
33254594|NCT01832480|100833029|FG000|Overall Study|Lost to Follow-up|33|||
33254595|NCT01832480|100833030|FG001|Overall Study|Lost to Follow-up|30|||
33254596|NCT01832480|100833029|FG000|Overall Study|Withdrawal by Subject|0|||
33254597|NCT01832480|100833030|FG001|Overall Study|Withdrawal by Subject|2|||
33254598|NCT01832480|100833029|FG000|Overall Study|post randomization ineligible|8|||
33254599|NCT01832480|100833030|FG001|Overall Study|post randomization ineligible|10|||
33254600|NCT02202499|100833032|FG000|Overall Study|Cancer diagnosis|0|||
33254601|NCT02202499|100833033|FG001|Overall Study|Cancer diagnosis|0|||
33254602|NCT02202499|100833034|FG002|Overall Study|Cancer diagnosis|1|||
33254603|NCT02202499|100833032|FG000|Overall Study|Moved from area|0|||
33254604|NCT02202499|100833033|FG001|Overall Study|Moved from area|0|||
33254605|NCT02202499|100833034|FG002|Overall Study|Moved from area|1|||
33254606|NCT02202499|100833032|FG000|Overall Study|Declined before randomization|1|||
33254607|NCT02202499|100833033|FG001|Overall Study|Declined before randomization|0|||
33254608|NCT02202499|100833034|FG002|Overall Study|Declined before randomization|0|||
33254609|NCT02202499|100833032|FG000|Overall Study|Auto accident|1|||
33254610|NCT02202499|100833033|FG001|Overall Study|Auto accident|0|||
33254611|NCT02202499|100833034|FG002|Overall Study|Auto accident|0|||
33254612|NCT03227757|100833040|FG000|Overall Study|Death|25|||
33254613|NCT03227757|100833040|FG000|Overall Study|Withdrawal|10|||
33254614|NCT03227757|100833040|FG000|Overall Study|Missed visits|1|||
33254615|NCT03227757|100833040|FG000|Overall Study|Lost to Follow-up|2|||
33254616|NCT01081145|100833041|FG000|Open-Label Phase|Lack of Efficacy|56|||
33254617|NCT01081145|100833042|FG001|Open-Label Phase|Lack of Efficacy|0|||
33254618|NCT01081145|100833041|FG000|Open-Label Phase|Response criteria not met|46|||
33254619|NCT01081145|100833042|FG001|Open-Label Phase|Response criteria not met|0|||
33254620|NCT01081145|100833041|FG000|Open-Label Phase|Adverse Event|42|||
33254621|NCT01081145|100833042|FG001|Open-Label Phase|Adverse Event|0|||
33254622|NCT01081145|100833041|FG000|Open-Label Phase|Withdrawal by Subject|41|||
33254623|NCT01081145|100833042|FG001|Open-Label Phase|Withdrawal by Subject|0|||
33254624|NCT01081145|100833041|FG000|Open-Label Phase|Other|12|||
33254625|NCT01081145|100833042|FG001|Open-Label Phase|Other|0|||
33254626|NCT01081145|100833041|FG000|Open-Label Phase|Lost to Follow-up|11|||
33254627|NCT01081145|100833042|FG001|Open-Label Phase|Lost to Follow-up|0|||
33254628|NCT01081145|100833041|FG000|Open-Label Phase|Protocol Violation|4|||
33254629|NCT01081145|100833042|FG001|Open-Label Phase|Protocol Violation|0|||
33254630|NCT01081145|100833041|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
33254631|NCT01081145|100833042|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
33254632|NCT01081145|100833041|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
33254633|NCT01081145|100833042|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
33254634|NCT01081145|100833041|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
33254635|NCT01081145|100833042|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
33254636|NCT01081145|100833041|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
33254637|NCT01081145|100833042|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
33254638|NCT01081145|100833041|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
33254639|NCT01081145|100833042|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
33254640|NCT01081145|100833041|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
33254641|NCT01081145|100833042|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
33441952|NCT01667679|101512113|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
33159625|NCT03519178|100497998|FG004|PF-06873600 Treatment|Other|0|||
33441953|NCT01667679|101512114|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
33441954|NCT01667679|101512113|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
33441955|NCT01667679|101512114|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
33159626|NCT03519178|100497999|FG005|PF-06873600 Treatment|Other|0|||
33159627|NCT03519178|100498000|FG006|PF-06873600 Treatment|Other|0|||
33159628|NCT03519178|100498001|FG007|PF-06873600 Treatment|Other|0|||
33159629|NCT03519178|100498002|FG008|PF-06873600 Treatment|Other|1|||
33159630|NCT03519178|100498003|FG009|PF-06873600 Treatment|Other|0|||
33159631|NCT03519178|100498004|FG010|PF-06873600 Treatment|Other|0|||
33159632|NCT03519178|100498005|FG011|PF-06873600 Treatment|Other|0|||
33159633|NCT03519178|100498006|FG012|PF-06873600 Treatment|Other|0|||
33159634|NCT03519178|100498007|FG013|PF-06873600 Treatment|Other|1|||
33159635|NCT03519178|100498008|FG014|PF-06873600 Treatment|Other|3|||
33159636|NCT03519178|100497994|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
33159637|NCT03519178|100497995|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
33254642|NCT01081145|100833041|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
33254643|NCT01081145|100833042|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
33254644|NCT00736853|100833043|FG000|Open-Label Period|Physician Decision|2|||
33254645|NCT00736853|100833044|FG001|Open-Label Period|Physician Decision|0|||
33254646|NCT00736853|100833045|FG002|Open-Label Period|Physician Decision|0|||
33254647|NCT00736853|100833043|FG000|Open-Label Period|Adverse Event|31|||
33254648|NCT00736853|100833044|FG001|Open-Label Period|Adverse Event|0|||
33254649|NCT00736853|100833045|FG002|Open-Label Period|Adverse Event|0|||
33254650|NCT00736853|100833043|FG000|Open-Label Period|Withdrawal by Subject|16|||
33254651|NCT00736853|100833044|FG001|Open-Label Period|Withdrawal by Subject|0|||
33254652|NCT00736853|100833045|FG002|Open-Label Period|Withdrawal by Subject|0|||
33254653|NCT00736853|100833043|FG000|Open-Label Period|Started but not treated|42|||
33254654|NCT00736853|100833044|FG001|Open-Label Period|Started but not treated|0|||
33254655|NCT00736853|100833045|FG002|Open-Label Period|Started but not treated|0|||
33254656|NCT00736853|100833043|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
33254657|NCT00736853|100833044|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
33254658|NCT00736853|100833045|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
33254659|NCT00736853|100833043|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
33254660|NCT00736853|100833044|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
33254661|NCT00736853|100833045|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
33254662|NCT00736853|100833043|FG000|Double-Blind Period|Lack of Efficacy|0|||
33254663|NCT00736853|100833044|FG001|Double-Blind Period|Lack of Efficacy|19|||
33254664|NCT00736853|100833045|FG002|Double-Blind Period|Lack of Efficacy|42|||
33254665|NCT00736853|100833043|FG000|Double-Blind Period|Adverse Event|0|||
33254666|NCT00736853|100833044|FG001|Double-Blind Period|Adverse Event|3|||
33254667|NCT00736853|100833045|FG002|Double-Blind Period|Adverse Event|2|||
33254668|NCT00736853|100833043|FG000|Double-Blind Period|Withdrawal by Subject|0|||
33254669|NCT00736853|100833044|FG001|Double-Blind Period|Withdrawal by Subject|1|||
33254670|NCT00736853|100833045|FG002|Double-Blind Period|Withdrawal by Subject|4|||
33441956|NCT01667679|101512113|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
33159638|NCT03519178|100497996|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
33159639|NCT03519178|100497997|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
33159640|NCT03519178|100497998|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
33254671|NCT00736853|100833043|FG000|Double-Blind Period|Ineligible to participate the study|0|||
33254672|NCT00736853|100833044|FG001|Double-Blind Period|Ineligible to participate the study|1|||
33254673|NCT00736853|100833045|FG002|Double-Blind Period|Ineligible to participate the study|0|||
33254674|NCT05641311|100833046|FG000|Dosing Period 1|Adverse Event|1|||
33441957|NCT01667679|101512114|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
33254675|NCT05641311|100833047|FG001|Dosing Period 1|Adverse Event|0|||
33254676|NCT01117480|100833048|FG000|Overall Study|Protocol Violation|8|||
33441958|NCT01667679|101512113|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
33159641|NCT03519178|100497999|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
33159642|NCT03519178|100498000|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
33441959|NCT01667679|101512114|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
33159643|NCT03519178|100498001|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
33159644|NCT03519178|100498002|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
33159645|NCT03519178|100498003|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
33159646|NCT03519178|100498004|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
33159647|NCT03519178|100498005|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
33159648|NCT03519178|100498006|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
33159649|NCT03519178|100498007|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
33159650|NCT03519178|100498008|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
33159651|NCT03519178|100497994|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
33159652|NCT03519178|100497995|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
33441960|NCT01667679|101512113|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
33441961|NCT01667679|101512114|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
33441962|NCT01667679|101512113|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
33441963|NCT01667679|101512114|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
33441964|NCT01667679|101512113|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
33441965|NCT01667679|101512114|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
33441966|NCT01667679|101512113|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
33441967|NCT01667679|101512114|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
33441968|NCT01667679|101512113|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
33441969|NCT01667679|101512114|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
33441970|NCT01667679|101512113|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
33441971|NCT01667679|101512114|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
33441972|NCT01667679|101512113|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
33441973|NCT01667679|101512114|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
33441974|NCT01667679|101512113|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
33441975|NCT01667679|101512114|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
33441976|NCT01667679|101512113|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
33441977|NCT01667679|101512114|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
33159653|NCT03519178|100497996|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
33159654|NCT03519178|100497997|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
33159655|NCT03519178|100497998|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
33159656|NCT03519178|100497999|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
33159657|NCT03519178|100498000|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
33159658|NCT03519178|100498001|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
33159659|NCT03519178|100498002|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
33159660|NCT03519178|100498003|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
33159661|NCT03519178|100498004|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
33159662|NCT03519178|100498005|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
33159663|NCT03519178|100498006|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
33159664|NCT03519178|100498007|FG013|PF-06873600 Treatment|Study terminated by sponsor|4|||
33159665|NCT03519178|100498008|FG014|PF-06873600 Treatment|Study terminated by sponsor|4|||
33159666|NCT03519178|100497994|FG000|PF-06873600 Treatment|Ongoing|0|||
33159667|NCT03519178|100497995|FG001|PF-06873600 Treatment|Ongoing|0|||
33159668|NCT03519178|100497996|FG002|PF-06873600 Treatment|Ongoing|0|||
33159669|NCT03519178|100497997|FG003|PF-06873600 Treatment|Ongoing|0|||
33159670|NCT03519178|100497998|FG004|PF-06873600 Treatment|Ongoing|0|||
33159671|NCT03519178|100497999|FG005|PF-06873600 Treatment|Ongoing|0|||
33159672|NCT03519178|100498000|FG006|PF-06873600 Treatment|Ongoing|0|||
33159673|NCT03519178|100498001|FG007|PF-06873600 Treatment|Ongoing|0|||
33159674|NCT03519178|100498002|FG008|PF-06873600 Treatment|Ongoing|0|||
33159675|NCT03519178|100498003|FG009|PF-06873600 Treatment|Ongoing|0|||
33159676|NCT03519178|100498004|FG010|PF-06873600 Treatment|Ongoing|0|||
33159677|NCT03519178|100498005|FG011|PF-06873600 Treatment|Ongoing|0|||
33159678|NCT03519178|100498006|FG012|PF-06873600 Treatment|Ongoing|0|||
33159679|NCT03519178|100498007|FG013|PF-06873600 Treatment|Ongoing|1|||
33159680|NCT03519178|100498008|FG014|PF-06873600 Treatment|Ongoing|6|||
33159681|NCT03519178|100497994|FG000|Disposition for Fluvestrant Treatment|Adverse Event|0|||
33159682|NCT03519178|100497995|FG001|Disposition for Fluvestrant Treatment|Adverse Event|0|||
33159683|NCT03519178|100497996|FG002|Disposition for Fluvestrant Treatment|Adverse Event|0|||
33159684|NCT03519178|100497997|FG003|Disposition for Fluvestrant Treatment|Adverse Event|0|||
33159685|NCT03519178|100497998|FG004|Disposition for Fluvestrant Treatment|Adverse Event|0|||
33159686|NCT03519178|100497999|FG005|Disposition for Fluvestrant Treatment|Adverse Event|0|||
33159687|NCT03519178|100498000|FG006|Disposition for Fluvestrant Treatment|Adverse Event|0|||
33159688|NCT03519178|100498001|FG007|Disposition for Fluvestrant Treatment|Adverse Event|0|||
33159689|NCT03519178|100498002|FG008|Disposition for Fluvestrant Treatment|Adverse Event|0|||
33159690|NCT03519178|100498003|FG009|Disposition for Fluvestrant Treatment|Adverse Event|0|||
33159691|NCT03519178|100498004|FG010|Disposition for Fluvestrant Treatment|Adverse Event|0|||
33159692|NCT03519178|100498005|FG011|Disposition for Fluvestrant Treatment|Adverse Event|0|||
33159693|NCT03519178|100498006|FG012|Disposition for Fluvestrant Treatment|Adverse Event|0|||
33159694|NCT03519178|100498007|FG013|Disposition for Fluvestrant Treatment|Adverse Event|1|||
33159695|NCT03519178|100498008|FG014|Disposition for Fluvestrant Treatment|Adverse Event|0|||
33159696|NCT03519178|100497994|FG000|Disposition for Fluvestrant Treatment|Death|0|||
33159697|NCT03519178|100497995|FG001|Disposition for Fluvestrant Treatment|Death|0|||
33159698|NCT03519178|100497996|FG002|Disposition for Fluvestrant Treatment|Death|0|||
33159699|NCT03519178|100497997|FG003|Disposition for Fluvestrant Treatment|Death|0|||
33159700|NCT03519178|100497998|FG004|Disposition for Fluvestrant Treatment|Death|0|||
33159701|NCT03519178|100497999|FG005|Disposition for Fluvestrant Treatment|Death|0|||
33159702|NCT03519178|100498000|FG006|Disposition for Fluvestrant Treatment|Death|0|||
33159703|NCT03519178|100498001|FG007|Disposition for Fluvestrant Treatment|Death|0|||
33159704|NCT03519178|100498002|FG008|Disposition for Fluvestrant Treatment|Death|0|||
33159705|NCT03519178|100498003|FG009|Disposition for Fluvestrant Treatment|Death|1|||
33159706|NCT03519178|100498004|FG010|Disposition for Fluvestrant Treatment|Death|0|||
33159707|NCT03519178|100498005|FG011|Disposition for Fluvestrant Treatment|Death|0|||
33159708|NCT03519178|100498006|FG012|Disposition for Fluvestrant Treatment|Death|0|||
33159709|NCT03519178|100498007|FG013|Disposition for Fluvestrant Treatment|Death|0|||
33159710|NCT03519178|100498008|FG014|Disposition for Fluvestrant Treatment|Death|1|||
33159711|NCT03519178|100497994|FG000|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
33159712|NCT03519178|100497995|FG001|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
33159713|NCT03519178|100497996|FG002|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
33159714|NCT03519178|100497997|FG003|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
33159715|NCT03519178|100497998|FG004|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
33159716|NCT03519178|100497999|FG005|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
33159717|NCT03519178|100498000|FG006|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
33441978|NCT01667679|101512113|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
33159718|NCT03519178|100498001|FG007|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
33159719|NCT03519178|100498002|FG008|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
33159720|NCT03519178|100498003|FG009|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
33159721|NCT03519178|100498004|FG010|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
33159722|NCT03519178|100498005|FG011|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
33159723|NCT03519178|100498006|FG012|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
33159724|NCT03519178|100498007|FG013|Disposition for Fluvestrant Treatment|Lost to Follow-up|0|||
33159725|NCT03519178|100498008|FG014|Disposition for Fluvestrant Treatment|Lost to Follow-up|1|||
33159726|NCT03519178|100497994|FG000|Disposition for Fluvestrant Treatment|Physician Decision|0|||
33159727|NCT03519178|100497995|FG001|Disposition for Fluvestrant Treatment|Physician Decision|0|||
33159728|NCT03519178|100497996|FG002|Disposition for Fluvestrant Treatment|Physician Decision|0|||
33159729|NCT03519178|100497997|FG003|Disposition for Fluvestrant Treatment|Physician Decision|0|||
33159730|NCT03519178|100497998|FG004|Disposition for Fluvestrant Treatment|Physician Decision|0|||
33159731|NCT03519178|100497999|FG005|Disposition for Fluvestrant Treatment|Physician Decision|0|||
33159732|NCT03519178|100498000|FG006|Disposition for Fluvestrant Treatment|Physician Decision|0|||
33159733|NCT03519178|100498001|FG007|Disposition for Fluvestrant Treatment|Physician Decision|0|||
33159734|NCT03519178|100498002|FG008|Disposition for Fluvestrant Treatment|Physician Decision|0|||
33159735|NCT03519178|100498003|FG009|Disposition for Fluvestrant Treatment|Physician Decision|0|||
33159736|NCT03519178|100498004|FG010|Disposition for Fluvestrant Treatment|Physician Decision|0|||
33159737|NCT03519178|100498005|FG011|Disposition for Fluvestrant Treatment|Physician Decision|0|||
33159738|NCT03519178|100498006|FG012|Disposition for Fluvestrant Treatment|Physician Decision|0|||
33159739|NCT03519178|100498007|FG013|Disposition for Fluvestrant Treatment|Physician Decision|4|||
33159740|NCT03519178|100498008|FG014|Disposition for Fluvestrant Treatment|Physician Decision|2|||
33159741|NCT03519178|100497994|FG000|Disposition for Fluvestrant Treatment|Progressive disease|0|||
33159742|NCT03519178|100497995|FG001|Disposition for Fluvestrant Treatment|Progressive disease|0|||
33159743|NCT03519178|100497996|FG002|Disposition for Fluvestrant Treatment|Progressive disease|0|||
33159744|NCT03519178|100497997|FG003|Disposition for Fluvestrant Treatment|Progressive disease|0|||
33159745|NCT03519178|100497998|FG004|Disposition for Fluvestrant Treatment|Progressive disease|0|||
33159746|NCT03519178|100497999|FG005|Disposition for Fluvestrant Treatment|Progressive disease|0|||
33159747|NCT03519178|100498000|FG006|Disposition for Fluvestrant Treatment|Progressive disease|0|||
33159748|NCT03519178|100498001|FG007|Disposition for Fluvestrant Treatment|Progressive disease|0|||
33159749|NCT03519178|100498002|FG008|Disposition for Fluvestrant Treatment|Progressive disease|0|||
33159750|NCT03519178|100498003|FG009|Disposition for Fluvestrant Treatment|Progressive disease|5|||
33159751|NCT03519178|100498004|FG010|Disposition for Fluvestrant Treatment|Progressive disease|0|||
33159752|NCT03519178|100498005|FG011|Disposition for Fluvestrant Treatment|Progressive disease|0|||
33159753|NCT03519178|100498006|FG012|Disposition for Fluvestrant Treatment|Progressive disease|0|||
33159754|NCT03519178|100498007|FG013|Disposition for Fluvestrant Treatment|Progressive disease|30|||
33159755|NCT03519178|100498008|FG014|Disposition for Fluvestrant Treatment|Progressive disease|7|||
33254677|NCT01117480|100833048|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
33254678|NCT02139943|100833049|FG000|Overall Study|Adverse Event|0|||
33254679|NCT02139943|100833050|FG001|Overall Study|Adverse Event|1|||
33254680|NCT02139943|100833051|FG002|Overall Study|Adverse Event|2|||
33254681|NCT02139943|100833049|FG000|Overall Study|Lost to Follow-up|3|||
33254682|NCT02139943|100833050|FG001|Overall Study|Lost to Follow-up|2|||
33254683|NCT02139943|100833051|FG002|Overall Study|Lost to Follow-up|2|||
33254684|NCT02139943|100833049|FG000|Overall Study|Withdrawal by Subject|4|||
33254685|NCT02139943|100833050|FG001|Overall Study|Withdrawal by Subject|3|||
33254686|NCT02139943|100833051|FG002|Overall Study|Withdrawal by Subject|0|||
33254687|NCT02139943|100833049|FG000|Overall Study|Other|0|||
33159756|NCT03519178|100497994|FG000|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
33159757|NCT03519178|100497995|FG001|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
33159758|NCT03519178|100497996|FG002|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
33159759|NCT03519178|100497997|FG003|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
33159760|NCT03519178|100497998|FG004|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
33159761|NCT03519178|100497999|FG005|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
33159762|NCT03519178|100498000|FG006|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
33159763|NCT03519178|100498001|FG007|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
33159764|NCT03519178|100498002|FG008|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
33159765|NCT03519178|100498003|FG009|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
33441979|NCT01667679|101512114|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
33159766|NCT03519178|100498004|FG010|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
33159767|NCT03519178|100498005|FG011|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
33159768|NCT03519178|100498006|FG012|Disposition for Fluvestrant Treatment|Study terminated by sponsor|0|||
33159769|NCT03519178|100498007|FG013|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
33159770|NCT03519178|100498008|FG014|Disposition for Fluvestrant Treatment|Study terminated by sponsor|4|||
33159771|NCT03519178|100497994|FG000|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
33159772|NCT03519178|100497995|FG001|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
33159773|NCT03519178|100497996|FG002|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
33159774|NCT03519178|100497997|FG003|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
33159775|NCT03519178|100497998|FG004|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
33159776|NCT03519178|100497999|FG005|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
33159777|NCT03519178|100498000|FG006|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
33159778|NCT03519178|100498001|FG007|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
33441980|NCT01667679|101512113|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
33441981|NCT01667679|101512114|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
33159779|NCT03519178|100498002|FG008|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
33159780|NCT03519178|100498003|FG009|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
33159781|NCT03519178|100498004|FG010|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
33159782|NCT03519178|100498005|FG011|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
33159783|NCT03519178|100498006|FG012|Disposition for Fluvestrant Treatment|Withdrawal by Subject|0|||
33159784|NCT03519178|100498007|FG013|Disposition for Fluvestrant Treatment|Withdrawal by Subject|1|||
33159785|NCT03519178|100498008|FG014|Disposition for Fluvestrant Treatment|Withdrawal by Subject|2|||
33159786|NCT03519178|100497994|FG000|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
33159787|NCT03519178|100497995|FG001|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
33159788|NCT03519178|100497996|FG002|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
33159789|NCT03519178|100497997|FG003|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
33159790|NCT03519178|100497998|FG004|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
33159791|NCT03519178|100497999|FG005|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
33159792|NCT03519178|100498000|FG006|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
33159793|NCT03519178|100498001|FG007|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
33159794|NCT03519178|100498002|FG008|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
33159795|NCT03519178|100498003|FG009|Disposition for Fluvestrant Treatment|Global deterioration of health status|1|||
33159796|NCT03519178|100498004|FG010|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
33159797|NCT03519178|100498005|FG011|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
33441982|NCT01667679|101512113|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
33441983|NCT01667679|101512114|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
33441984|NCT03880266|101512115|FG000|Overall Study|Withdrawal by Subject|0|||
33441985|NCT03880266|101512116|FG001|Overall Study|Withdrawal by Subject|1|||
33441986|NCT03880266|101512117|FG002|Overall Study|Withdrawal by Subject|1|||
33441987|NCT03880266|101512118|FG003|Overall Study|Withdrawal by Subject|0|||
33441988|NCT03880266|101512119|FG004|Overall Study|Withdrawal by Subject|0|||
33441989|NCT03880266|101512120|FG005|Overall Study|Withdrawal by Subject|0|||
33441990|NCT03880266|101512121|FG006|Overall Study|Withdrawal by Subject|0|||
33441991|NCT03880266|101512122|FG007|Overall Study|Withdrawal by Subject|0|||
33441992|NCT03471078|101512123|FG000|Overall Study|Withdrawal by Subject|9|||
33441993|NCT03471078|101512124|FG001|Overall Study|Withdrawal by Subject|1|||
33441994|NCT03471078|101512123|FG000|Overall Study|Adverse Event|4|||
33441995|NCT03471078|101512124|FG001|Overall Study|Adverse Event|1|||
33441996|NCT03471078|101512123|FG000|Overall Study|Physician Decision|3|||
33441997|NCT03471078|101512124|FG001|Overall Study|Physician Decision|2|||
33441998|NCT03471078|101512123|FG000|Overall Study|Death|2|||
33441999|NCT03471078|101512124|FG001|Overall Study|Death|0|||
33442000|NCT03471078|101512123|FG000|Overall Study|Other|3|||
33442001|NCT03471078|101512124|FG001|Overall Study|Other|2|||
33442002|NCT03497897|101512125|FG000|Overall Study|Adverse Event|1|||
33442003|NCT03497897|101512126|FG001|Overall Study|Adverse Event|1|||
33442004|NCT03497897|101512127|FG002|Overall Study|Adverse Event|1|||
33442005|NCT03497897|101512125|FG000|Overall Study|Lost to Follow-up|2|||
33442006|NCT03497897|101512126|FG001|Overall Study|Lost to Follow-up|0|||
33442007|NCT03497897|101512127|FG002|Overall Study|Lost to Follow-up|2|||
33159798|NCT03519178|100498006|FG012|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
33159799|NCT03519178|100498007|FG013|Disposition for Fluvestrant Treatment|Global deterioration of health status|3|||
33442008|NCT03497897|101512125|FG000|Overall Study|Physician Decision|1|||
33442009|NCT03497897|101512126|FG001|Overall Study|Physician Decision|0|||
33442010|NCT03497897|101512127|FG002|Overall Study|Physician Decision|0|||
33442011|NCT03497897|101512125|FG000|Overall Study|Subject/Guardian Decision|2|||
33442012|NCT03497897|101512126|FG001|Overall Study|Subject/Guardian Decision|1|||
33254688|NCT02139943|100833050|FG001|Overall Study|Other|0|||
33254689|NCT02139943|100833051|FG002|Overall Study|Other|1|||
33254690|NCT02139943|100833049|FG000|Overall Study|Participant wishes to discontinue|2|||
33254691|NCT02139943|100833050|FG001|Overall Study|Participant wishes to discontinue|0|||
33254692|NCT02139943|100833051|FG002|Overall Study|Participant wishes to discontinue|0|||
33254693|NCT02139943|100833049|FG000|Overall Study|Participant in Poor Compliance|1|||
33254694|NCT02139943|100833050|FG001|Overall Study|Participant in Poor Compliance|0|||
33254695|NCT02139943|100833051|FG002|Overall Study|Participant in Poor Compliance|1|||
33254696|NCT02139943|100833049|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
33442013|NCT03497897|101512127|FG002|Overall Study|Subject/Guardian Decision|3|||
33442014|NCT00550537|101512130|FG000|Overall Study|Death|18|||
33442015|NCT00550537|101512130|FG000|Overall Study|Adverse Event|20|||
33442016|NCT00550537|101512130|FG000|Overall Study|Disease progression before|46|||
33442017|NCT00550537|101512130|FG000|Overall Study|Withdrawal by Subject|7|||
33442018|NCT00550537|101512130|FG000|Overall Study|Change in treatment plan|4|||
33442019|NCT00550537|101512130|FG000|Overall Study|Other complicating ilness|3|||
33442020|NCT00550537|101512130|FG000|Overall Study|Declining performance status|2|||
33442021|NCT00550537|101512130|FG000|Overall Study|Treated closer to home|4|||
33442022|NCT00004562|101512131|FG000|Overall Study|Lost to Follow-up|102|||
33442023|NCT00004562|101512132|FG001|Overall Study|Lost to Follow-up|91|||
33442024|NCT05214560|101512133|FG000|Overall Study|Screening Failure|1|||
33442025|NCT05214560|101512133|FG000|Overall Study|Physician Decision|4|||
33442026|NCT05214560|101512133|FG000|Overall Study|Withdrawal by Subject|1|||
33442027|NCT05214560|101512133|FG000|Overall Study|Lost to Follow-up|2|||
33442028|NCT05214560|101512133|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
33442029|NCT05214560|101512133|FG000|Overall Study|Study physician not available for the anesthesia|3|||
33442030|NCT05214560|101512133|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
33442031|NCT05214560|101512133|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
33442032|NCT05214560|101512133|FG000|Overall Study|Surgery not performed|3|||
33442033|NCT02039908|101512134|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
33442034|NCT02039908|101512135|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
33442035|NCT02039908|101512136|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
33442036|NCT02039908|101512137|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
33442037|NCT02039908|101512134|FG000|Phase 1-Summer|Protocol Violation|6|||
33442038|NCT02039908|101512135|FG001|Phase 1-Summer|Protocol Violation|0|||
33442039|NCT02039908|101512136|FG002|Phase 1-Summer|Protocol Violation|0|||
33442040|NCT02039908|101512137|FG003|Phase 1-Summer|Protocol Violation|0|||
33442041|NCT02039908|101512134|FG000|Phase 2-School Year|Lost to Follow-up|0|||
33442042|NCT02039908|101512135|FG001|Phase 2-School Year|Lost to Follow-up|0|||
33442043|NCT02039908|101512136|FG002|Phase 2-School Year|Lost to Follow-up|1|||
33442044|NCT02039908|101512137|FG003|Phase 2-School Year|Lost to Follow-up|3|||
33442045|NCT02039908|101512134|FG000|Phase 2-School Year|Protocol Violation|0|||
33442046|NCT02039908|101512135|FG001|Phase 2-School Year|Protocol Violation|0|||
33442047|NCT02039908|101512136|FG002|Phase 2-School Year|Protocol Violation|3|||
33442048|NCT02039908|101512137|FG003|Phase 2-School Year|Protocol Violation|0|||
33442049|NCT02039908|101512134|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
33254697|NCT02139943|100833050|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
33254698|NCT02139943|100833051|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
33254699|NCT01075217|100833056|FG000|Overall Study|Adverse Event|1|||
33254700|NCT01075217|100833057|FG001|Overall Study|Adverse Event|1|||
33254701|NCT01075217|100833056|FG000|Overall Study|Physician Decision|1|||
33254702|NCT01075217|100833057|FG001|Overall Study|Physician Decision|0|||
33254703|NCT02488980|100833060|FG000|Overall Study|Protocol Violation|2|||
33254704|NCT02488980|100833061|FG001|Overall Study|Protocol Violation|2|||
33254705|NCT02488980|100833062|FG002|Overall Study|Protocol Violation|2|||
33254706|NCT00807144|100833065|FG000|Overall Study|Lost to Follow-up|0|||
33254707|NCT00807144|100833066|FG001|Overall Study|Lost to Follow-up|1|||
33254708|NCT02960659|100833071|FG000|Overall Study|Withdrawal by Subject|1|||
33159800|NCT03519178|100498008|FG014|Disposition for Fluvestrant Treatment|Global deterioration of health status|0|||
33254709|NCT02960659|100833072|FG001|Overall Study|Withdrawal by Subject|0|||
33254710|NCT02960659|100833071|FG000|Overall Study|Poor compliance|0|||
33254711|NCT02960659|100833072|FG001|Overall Study|Poor compliance|1|||
33254712|NCT02705586|100833073|FG000|Overall Study|Health Issues|2|||
33254713|NCT02705586|100833073|FG000|Overall Study|Transportation Difficulties|5|||
33254714|NCT02705586|100833073|FG000|Overall Study|Vacation/Planned Absence|1|||
33254715|NCT02412748|100833076|FG000|Overall Study|Lost to Follow-up|38|||
33254716|NCT02412748|100833077|FG001|Overall Study|Lost to Follow-up|39|||
33254717|NCT04128319|100833078|FG000|Overall Study|Death|3|||
33254718|NCT00494780|100833079|FG000|Overall Study|Adverse Event|1|||
33254719|NCT00494780|100833080|FG001|Overall Study|Adverse Event|0|||
33254720|NCT00494780|100833079|FG000|Overall Study|Withdrew before Dosed|0|||
33254721|NCT00494780|100833080|FG001|Overall Study|Withdrew before Dosed|1|||
33254722|NCT00494780|100833079|FG000|Overall Study|Progression of Study Disease|7|||
33254723|NCT00494780|100833080|FG001|Overall Study|Progression of Study Disease|8|||
33254724|NCT00494780|100833079|FG000|Overall Study|New Treatment|2|||
33254725|NCT00494780|100833080|FG001|Overall Study|New Treatment|2|||
33254726|NCT00494780|100833079|FG000|Overall Study|Non-compliance|1|||
33254727|NCT00494780|100833080|FG001|Overall Study|Non-compliance|0|||
33254728|NCT00494780|100833079|FG000|Overall Study|Residual Tumour Mass|0|||
33254729|NCT00494780|100833080|FG001|Overall Study|Residual Tumour Mass|1|||
33254730|NCT00494780|100833079|FG000|Overall Study|Insurance Issues|0|||
33254731|NCT00494780|100833080|FG001|Overall Study|Insurance Issues|1|||
33254732|NCT02685488|100833090|FG000|Overall Study|Withdrawal by Subject|0|||
33254733|NCT02685488|100833091|FG001|Overall Study|Withdrawal by Subject|1|||
33254734|NCT02969863|100833092|FG000|Overall Study|Physician Decision|1|||
33254735|NCT02969863|100833093|FG001|Overall Study|Physician Decision|0|||
33254736|NCT02969863|100833094|FG002|Overall Study|Physician Decision|0|||
33254737|NCT02969863|100833095|FG003|Overall Study|Physician Decision|0|||
33254738|NCT02969863|100833096|FG004|Overall Study|Physician Decision|0|||
33254739|NCT02969863|100833097|FG005|Overall Study|Physician Decision|0|||
33442050|NCT02039908|101512135|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
33442051|NCT02039908|101512136|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
33442052|NCT02039908|101512137|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
33159801|NCT03519178|100497994|FG000|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
33254740|NCT02570711|100833099|FG000|Overall Study|Death|1|||
33254741|NCT02570711|100833100|FG001|Overall Study|Death|0|||
33254742|NCT02570711|100833099|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
33254743|NCT02570711|100833100|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
33442053|NCT03351335|101512138|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
33442054|NCT03351335|101512139|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
33442055|NCT03351335|101512140|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
33442056|NCT01363765|101512146|FG000|Overall Study|non-diagnostic|2621|||
33442057|NCT01363765|101512147|FG001|Overall Study|non-diagnostic|1124|||
33442058|NCT01363765|101512146|FG000|Overall Study|duplicate records|736|||
33442059|NCT01363765|101512147|FG001|Overall Study|duplicate records|3177|||
33442060|NCT01363765|101512146|FG000|Overall Study|non-resident|156|||
33442061|NCT01363765|101512147|FG001|Overall Study|non-resident|76|||
33442062|NCT01363765|101512146|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
33442063|NCT01363765|101512147|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
33442064|NCT01363765|101512146|FG000|Overall Study|smear during intervention|2170|||
33254744|NCT02448446|100833102|FG000|Overall Study|Withdrawal by Subject|1|||
33254745|NCT02448446|100833103|FG001|Overall Study|Withdrawal by Subject|0|||
33254746|NCT02059980|100833104|FG000|Overall Study|Lost to Follow-up|2|||
33254747|NCT02059980|100833105|FG001|Overall Study|Lost to Follow-up|1|||
33254748|NCT05190419|100833108|FG000|Overall Study|Lack of Efficacy|8|||
33254749|NCT05190419|100833109|FG001|Overall Study|Lack of Efficacy|0|||
33254750|NCT05190419|100833110|FG002|Overall Study|Lack of Efficacy|1|||
33254751|NCT05190419|100833111|FG003|Overall Study|Lack of Efficacy|0|||
33254752|NCT05190419|100833108|FG000|Overall Study|Withdrawal by Subject|7|||
33254753|NCT05190419|100833109|FG001|Overall Study|Withdrawal by Subject|1|||
33254754|NCT05190419|100833110|FG002|Overall Study|Withdrawal by Subject|2|||
33254755|NCT05190419|100833111|FG003|Overall Study|Withdrawal by Subject|2|||
33254756|NCT05190419|100833108|FG000|Overall Study|Adverse Event|2|||
33254757|NCT05190419|100833109|FG001|Overall Study|Adverse Event|10|||
33254758|NCT05190419|100833110|FG002|Overall Study|Adverse Event|11|||
33254759|NCT05190419|100833111|FG003|Overall Study|Adverse Event|21|||
33254760|NCT05190419|100833108|FG000|Overall Study|Lost to Follow-up|1|||
33254761|NCT05190419|100833109|FG001|Overall Study|Lost to Follow-up|2|||
33254762|NCT05190419|100833110|FG002|Overall Study|Lost to Follow-up|3|||
33254763|NCT05190419|100833111|FG003|Overall Study|Lost to Follow-up|1|||
33254764|NCT05190419|100833108|FG000|Overall Study|Other|1|||
33254765|NCT05190419|100833109|FG001|Overall Study|Other|1|||
33254766|NCT05190419|100833110|FG002|Overall Study|Other|0|||
33254767|NCT05190419|100833111|FG003|Overall Study|Other|3|||
33254768|NCT03557008|100833113|FG000|Overall Study|Withdrawal by Subject|2|||
33254769|NCT03557008|100833114|FG001|Overall Study|Withdrawal by Subject|2|||
33254770|NCT03557008|100833113|FG000|Overall Study|Early termination from study|3|||
33254771|NCT03557008|100833114|FG001|Overall Study|Early termination from study|1|||
33254772|NCT01266265|100833115|FG000|Overall Study|Death|95|||
33254773|NCT01266265|100833116|FG001|Overall Study|Death|73|||
33254774|NCT01266265|100833115|FG000|Overall Study|Lost to Follow-up|23|||
33254775|NCT01266265|100833116|FG001|Overall Study|Lost to Follow-up|28|||
33254776|NCT01266265|100833115|FG000|Overall Study|Withdrawal by Subject|13|||
33254777|NCT01266265|100833116|FG001|Overall Study|Withdrawal by Subject|11|||
33254778|NCT01266265|100833115|FG000|Overall Study|Respiratory-related adverse event|2|||
33254779|NCT01266265|100833116|FG001|Overall Study|Respiratory-related adverse event|1|||
33254780|NCT01266265|100833115|FG000|Overall Study|Transferred care to another provider|22|||
33254781|NCT01266265|100833116|FG001|Overall Study|Transferred care to another provider|28|||
33254782|NCT01266265|100833115|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
33254783|NCT01266265|100833116|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
33254784|NCT01266265|100833115|FG000|Overall Study|Enrolled in another clinical study|15|||
33254785|NCT01266265|100833116|FG001|Overall Study|Enrolled in another clinical study|26|||
33254786|NCT01266265|100833115|FG000|Overall Study|Non-compliance|8|||
33254787|NCT01266265|100833116|FG001|Overall Study|Non-compliance|5|||
33254788|NCT01266265|100833115|FG000|Overall Study|Lung transplant|6|||
33254789|NCT01266265|100833116|FG001|Overall Study|Lung transplant|5|||
33254790|NCT01266265|100833115|FG000|Overall Study|Site closed early|4|||
33254791|NCT01266265|100833116|FG001|Overall Study|Site closed early|3|||
33254792|NCT01266265|100833115|FG000|Overall Study|Clinical worsening|1|||
33254793|NCT01266265|100833116|FG001|Overall Study|Clinical worsening|1|||
33254794|NCT02794480|100833117|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
33254795|NCT02794480|100833118|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
33254796|NCT02794480|100833119|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
33254797|NCT02794480|100833120|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
33254798|NCT02794480|100833117|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
33254799|NCT02794480|100833118|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
33254800|NCT02794480|100833119|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
33254801|NCT02794480|100833120|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
33254802|NCT02794480|100833117|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33254803|NCT02794480|100833118|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33254804|NCT02794480|100833119|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33254805|NCT02794480|100833120|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
33254806|NCT02794480|100833117|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33254807|NCT02794480|100833118|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
33254808|NCT02794480|100833119|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33254809|NCT02794480|100833120|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
33254810|NCT02794480|100833117|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
33254811|NCT02794480|100833118|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33254812|NCT02794480|100833119|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33254813|NCT02794480|100833120|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
33254814|NCT02477670|100833121|FG000|Stage 1|Adverse Event|2|||
33254815|NCT02477670|100833122|FG001|Stage 1|Adverse Event|7|||
33254816|NCT02477670|100833123|FG002|Stage 1|Adverse Event|0|||
33442065|NCT01363765|101512147|FG001|Overall Study|smear during intervention|0|||
33442066|NCT02817841|101512148|FG000|Overall Study|Lost to Follow-up|287|||
33442067|NCT02817841|101512148|FG000|Overall Study|Withdrawal by Subject|183|||
33442068|NCT02817841|101512148|FG000|Overall Study|Adverse event not related to bleeding|131|||
33442069|NCT02817841|101512148|FG000|Overall Study|Adverse event related to bleeding|51|||
33442070|NCT02817841|101512148|FG000|Overall Study|Pregnancy|32|||
33442071|NCT02817841|101512148|FG000|Overall Study|Pregnancy wish|17|||
33442072|NCT02817841|101512148|FG000|Overall Study|Other reasons|53|||
33442073|NCT02817841|101512148|FG000|Overall Study|Protocol Violation|94|||
33254817|NCT02477670|100833124|FG003|Stage 1|Adverse Event|0|||
33254818|NCT02477670|100833125|FG004|Stage 1|Adverse Event|0|||
33442074|NCT03018249|101512152|FG000|Overall Study|Withdrawal by Subject|2|||
33254819|NCT02477670|100833126|FG005|Stage 1|Adverse Event|0|||
33254820|NCT02477670|100833127|FG006|Stage 1|Adverse Event|0|||
33254821|NCT02477670|100833121|FG000|Stage 1|Lost to Follow-up|0|||
33254822|NCT02477670|100833122|FG001|Stage 1|Lost to Follow-up|2|||
33442075|NCT03018249|101512153|FG001|Overall Study|Withdrawal by Subject|2|||
33254823|NCT02477670|100833123|FG002|Stage 1|Lost to Follow-up|0|||
33254824|NCT02477670|100833124|FG003|Stage 1|Lost to Follow-up|0|||
33442076|NCT02089997|101512157|FG000|Overall Study|Case report forms uncollected|99|||
33159802|NCT03519178|100497995|FG001|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
33159803|NCT03519178|100497996|FG002|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
33159804|NCT03519178|100497997|FG003|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
33159805|NCT03519178|100497998|FG004|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
33254825|NCT02477670|100833125|FG004|Stage 1|Lost to Follow-up|0|||
33442077|NCT02089997|101512157|FG000|Overall Study|Protocol Violation|147|||
33159806|NCT03519178|100497999|FG005|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
33159807|NCT03519178|100498000|FG006|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
33159808|NCT03519178|100498001|FG007|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
33159809|NCT03519178|100498002|FG008|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
33159810|NCT03519178|100498003|FG009|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
33159811|NCT03519178|100498004|FG010|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
33159812|NCT03519178|100498005|FG011|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
33159813|NCT03519178|100498006|FG012|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
33159814|NCT03519178|100498007|FG013|Disposition for Fluvestrant Treatment|Refused further treatment|0|||
33159815|NCT03519178|100498008|FG014|Disposition for Fluvestrant Treatment|Refused further treatment|2|||
33159816|NCT03519178|100497994|FG000|Disposition for Fluvestrant Treatment|Other|0|||
33159817|NCT03519178|100497995|FG001|Disposition for Fluvestrant Treatment|Other|0|||
33159818|NCT03519178|100497996|FG002|Disposition for Fluvestrant Treatment|Other|0|||
33159819|NCT03519178|100497997|FG003|Disposition for Fluvestrant Treatment|Other|0|||
33159820|NCT03519178|100497998|FG004|Disposition for Fluvestrant Treatment|Other|0|||
33159821|NCT03519178|100497999|FG005|Disposition for Fluvestrant Treatment|Other|0|||
33159822|NCT03519178|100498000|FG006|Disposition for Fluvestrant Treatment|Other|0|||
33159823|NCT03519178|100498001|FG007|Disposition for Fluvestrant Treatment|Other|0|||
33159824|NCT03519178|100498002|FG008|Disposition for Fluvestrant Treatment|Other|0|||
33159825|NCT03519178|100498003|FG009|Disposition for Fluvestrant Treatment|Other|0|||
33159826|NCT03519178|100498004|FG010|Disposition for Fluvestrant Treatment|Other|0|||
33159827|NCT03519178|100498005|FG011|Disposition for Fluvestrant Treatment|Other|0|||
33159828|NCT03519178|100498006|FG012|Disposition for Fluvestrant Treatment|Other|0|||
33159829|NCT03519178|100498007|FG013|Disposition for Fluvestrant Treatment|Other|1|||
33159830|NCT03519178|100498008|FG014|Disposition for Fluvestrant Treatment|Other|3|||
33159831|NCT03519178|100497994|FG000|Disposition for Fluvestrant Treatment|Ongoing|0|||
33159832|NCT03519178|100497995|FG001|Disposition for Fluvestrant Treatment|Ongoing|0|||
33159833|NCT03519178|100497996|FG002|Disposition for Fluvestrant Treatment|Ongoing|0|||
33254826|NCT02477670|100833126|FG005|Stage 1|Lost to Follow-up|0|||
33254827|NCT02477670|100833127|FG006|Stage 1|Lost to Follow-up|0|||
33254828|NCT02477670|100833121|FG000|Stage 1|Withdrawal by Subject|1|||
33442078|NCT02374853|101512158|FG000|Overall Study|Surgery Cancelled|5|||
33442079|NCT02374853|101512159|FG001|Overall Study|Surgery Cancelled|11|||
33442080|NCT00282048|101512162|FG000|Overall Study|Lack of Efficacy|30|||
33442081|NCT00282048|101512162|FG000|Overall Study|Adverse Event|22|||
33442082|NCT00282048|101512162|FG000|Overall Study|Withdrawal by Subject|1|||
33442083|NCT00282048|101512162|FG000|Overall Study|Other|8|||
33442084|NCT00282048|101512162|FG000|Overall Study|Ongoing|1|||
33442085|NCT04384978|101512163|FG000|Overall Study|Withdrawal by Subject|4|||
33442086|NCT04384978|101512164|FG001|Overall Study|Withdrawal by Subject|0|||
33442087|NCT03195491|101512165|FG000|Overall Study|Study drug toxicity|25|||
33442088|NCT03195491|101512166|FG001|Overall Study|Study drug toxicity|3|||
33442089|NCT03195491|101512165|FG000|Overall Study|Maximum clinical benefit|5|||
33442090|NCT03195491|101512166|FG001|Overall Study|Maximum clinical benefit|0|||
33442091|NCT03195491|101512165|FG000|Overall Study|Lost to Follow-up|1|||
33442092|NCT03195491|101512166|FG001|Overall Study|Lost to Follow-up|0|||
33442093|NCT03195491|101512165|FG000|Overall Study|Death|3|||
33442094|NCT03195491|101512166|FG001|Overall Study|Death|0|||
33442095|NCT03195491|101512165|FG000|Overall Study|Adverse event unrelated to study drug|19|||
33442096|NCT03195491|101512166|FG001|Overall Study|Adverse event unrelated to study drug|2|||
33159834|NCT03519178|100497997|FG003|Disposition for Fluvestrant Treatment|Ongoing|0|||
33159835|NCT03519178|100497998|FG004|Disposition for Fluvestrant Treatment|Ongoing|0|||
33159836|NCT03519178|100497999|FG005|Disposition for Fluvestrant Treatment|Ongoing|0|||
33159837|NCT03519178|100498000|FG006|Disposition for Fluvestrant Treatment|Ongoing|0|||
33159838|NCT03519178|100498001|FG007|Disposition for Fluvestrant Treatment|Ongoing|0|||
33254829|NCT02477670|100833122|FG001|Stage 1|Withdrawal by Subject|2|||
33254830|NCT02477670|100833123|FG002|Stage 1|Withdrawal by Subject|0|||
33442097|NCT03195491|101512165|FG000|Overall Study|Disease progression|266|||
33442098|NCT03195491|101512166|FG001|Overall Study|Disease progression|8|||
33442099|NCT03195491|101512165|FG000|Overall Study|Other reasons|10|||
33442100|NCT03195491|101512166|FG001|Overall Study|Other reasons|0|||
33159839|NCT03519178|100498002|FG008|Disposition for Fluvestrant Treatment|Ongoing|0|||
33159840|NCT03519178|100498003|FG009|Disposition for Fluvestrant Treatment|Ongoing|0|||
33159841|NCT03519178|100498004|FG010|Disposition for Fluvestrant Treatment|Ongoing|0|||
33159842|NCT03519178|100498005|FG011|Disposition for Fluvestrant Treatment|Ongoing|0|||
33159843|NCT03519178|100498006|FG012|Disposition for Fluvestrant Treatment|Ongoing|0|||
33159844|NCT03519178|100498007|FG013|Disposition for Fluvestrant Treatment|Ongoing|1|||
33159845|NCT03519178|100498008|FG014|Disposition for Fluvestrant Treatment|Ongoing|6|||
33159846|NCT03519178|100497994|FG000|Disposition for Letrozole Treatment|Physician Decision|0|||
33159847|NCT03519178|100497995|FG001|Disposition for Letrozole Treatment|Physician Decision|0|||
33159848|NCT03519178|100497996|FG002|Disposition for Letrozole Treatment|Physician Decision|0|||
33159849|NCT03519178|100497997|FG003|Disposition for Letrozole Treatment|Physician Decision|0|||
33159850|NCT03519178|100497998|FG004|Disposition for Letrozole Treatment|Physician Decision|0|||
33159851|NCT03519178|100497999|FG005|Disposition for Letrozole Treatment|Physician Decision|0|||
33159852|NCT03519178|100498000|FG006|Disposition for Letrozole Treatment|Physician Decision|0|||
33159853|NCT03519178|100498001|FG007|Disposition for Letrozole Treatment|Physician Decision|0|||
33159854|NCT03519178|100498002|FG008|Disposition for Letrozole Treatment|Physician Decision|0|||
33159855|NCT03519178|100498003|FG009|Disposition for Letrozole Treatment|Physician Decision|0|||
33159856|NCT03519178|100498004|FG010|Disposition for Letrozole Treatment|Physician Decision|1|||
33159857|NCT03519178|100498005|FG011|Disposition for Letrozole Treatment|Physician Decision|0|||
33159858|NCT03519178|100498006|FG012|Disposition for Letrozole Treatment|Physician Decision|0|||
33159859|NCT03519178|100498007|FG013|Disposition for Letrozole Treatment|Physician Decision|0|||
33159860|NCT03519178|100498008|FG014|Disposition for Letrozole Treatment|Physician Decision|0|||
33159861|NCT03519178|100497994|FG000|Disposition for Letrozole Treatment|Progressive disease|0|||
33159862|NCT03519178|100497995|FG001|Disposition for Letrozole Treatment|Progressive disease|0|||
33159863|NCT03519178|100497996|FG002|Disposition for Letrozole Treatment|Progressive disease|0|||
33159864|NCT03519178|100497997|FG003|Disposition for Letrozole Treatment|Progressive disease|0|||
33159865|NCT03519178|100497998|FG004|Disposition for Letrozole Treatment|Progressive disease|0|||
33159866|NCT03519178|100497999|FG005|Disposition for Letrozole Treatment|Progressive disease|0|||
33159867|NCT03519178|100498000|FG006|Disposition for Letrozole Treatment|Progressive disease|0|||
33159868|NCT03519178|100498001|FG007|Disposition for Letrozole Treatment|Progressive disease|0|||
33159869|NCT03519178|100498002|FG008|Disposition for Letrozole Treatment|Progressive disease|0|||
33159870|NCT03519178|100498003|FG009|Disposition for Letrozole Treatment|Progressive disease|0|||
33159871|NCT03519178|100498004|FG010|Disposition for Letrozole Treatment|Progressive disease|4|||
33159872|NCT03519178|100498005|FG011|Disposition for Letrozole Treatment|Progressive disease|0|||
33159873|NCT03519178|100498006|FG012|Disposition for Letrozole Treatment|Progressive disease|0|||
33159874|NCT03519178|100498007|FG013|Disposition for Letrozole Treatment|Progressive disease|0|||
33159875|NCT03519178|100498008|FG014|Disposition for Letrozole Treatment|Progressive disease|0|||
33159876|NCT03519178|100497994|FG000|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
33159877|NCT03519178|100497995|FG001|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
33159878|NCT03519178|100497996|FG002|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
33159879|NCT03519178|100497997|FG003|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
33159880|NCT03519178|100497998|FG004|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
33159881|NCT03519178|100497999|FG005|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
33159882|NCT03519178|100498000|FG006|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
33159883|NCT03519178|100498001|FG007|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
33159884|NCT03519178|100498002|FG008|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
33159885|NCT03519178|100498003|FG009|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
33159886|NCT03519178|100498004|FG010|Disposition for Letrozole Treatment|Global deterioration of health status|2|||
33159887|NCT03519178|100498005|FG011|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
33159888|NCT03519178|100498006|FG012|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
33159889|NCT03519178|100498007|FG013|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
33159890|NCT03519178|100498008|FG014|Disposition for Letrozole Treatment|Global deterioration of health status|0|||
33159891|NCT03519178|100497994|FG000|Follow-Up|Death|0|||
33159892|NCT03519178|100497995|FG001|Follow-Up|Death|0|||
33159893|NCT03519178|100497996|FG002|Follow-Up|Death|1|||
33159894|NCT03519178|100497997|FG003|Follow-Up|Death|0|||
33159895|NCT03519178|100497998|FG004|Follow-Up|Death|0|||
33159896|NCT03519178|100497999|FG005|Follow-Up|Death|0|||
33159897|NCT03519178|100498000|FG006|Follow-Up|Death|0|||
33159898|NCT03519178|100498001|FG007|Follow-Up|Death|0|||
33159899|NCT03519178|100498002|FG008|Follow-Up|Death|3|||
33159900|NCT03519178|100498003|FG009|Follow-Up|Death|1|||
33159901|NCT03519178|100498004|FG010|Follow-Up|Death|0|||
33159902|NCT03519178|100498005|FG011|Follow-Up|Death|0|||
33159903|NCT03519178|100498006|FG012|Follow-Up|Death|2|||
33159904|NCT03519178|100498007|FG013|Follow-Up|Death|0|||
33159905|NCT03519178|100498008|FG014|Follow-Up|Death|0|||
33442101|NCT03195491|101512165|FG000|Overall Study|Participant withdrew consent|8|||
33254831|NCT02477670|100833124|FG003|Stage 1|Withdrawal by Subject|0|||
33159906|NCT03519178|100497994|FG000|Follow-Up|Lost to Follow-up|0|||
33159907|NCT03519178|100497995|FG001|Follow-Up|Lost to Follow-up|0|||
33159908|NCT03519178|100497996|FG002|Follow-Up|Lost to Follow-up|0|||
33159909|NCT03519178|100497997|FG003|Follow-Up|Lost to Follow-up|0|||
33159910|NCT03519178|100497998|FG004|Follow-Up|Lost to Follow-up|0|||
33159911|NCT03519178|100497999|FG005|Follow-Up|Lost to Follow-up|3|||
33159912|NCT03519178|100498000|FG006|Follow-Up|Lost to Follow-up|1|||
33159913|NCT03519178|100498001|FG007|Follow-Up|Lost to Follow-up|4|||
33159914|NCT03519178|100498002|FG008|Follow-Up|Lost to Follow-up|1|||
33159915|NCT03519178|100498003|FG009|Follow-Up|Lost to Follow-up|0|||
33159916|NCT03519178|100498004|FG010|Follow-Up|Lost to Follow-up|0|||
33159917|NCT03519178|100498005|FG011|Follow-Up|Lost to Follow-up|0|||
33159918|NCT03519178|100498006|FG012|Follow-Up|Lost to Follow-up|0|||
33159919|NCT03519178|100498007|FG013|Follow-Up|Lost to Follow-up|0|||
33159920|NCT03519178|100498008|FG014|Follow-Up|Lost to Follow-up|0|||
33159921|NCT03519178|100497994|FG000|Follow-Up|Withdrawal by Subject|1|||
33159922|NCT03519178|100497995|FG001|Follow-Up|Withdrawal by Subject|2|||
33159923|NCT03519178|100497996|FG002|Follow-Up|Withdrawal by Subject|2|||
33159924|NCT03519178|100497997|FG003|Follow-Up|Withdrawal by Subject|3|||
33159925|NCT03519178|100497998|FG004|Follow-Up|Withdrawal by Subject|5|||
33159926|NCT03519178|100497999|FG005|Follow-Up|Withdrawal by Subject|1|||
33159927|NCT03519178|100498000|FG006|Follow-Up|Withdrawal by Subject|2|||
33159928|NCT03519178|100498001|FG007|Follow-Up|Withdrawal by Subject|6|||
33159929|NCT03519178|100498002|FG008|Follow-Up|Withdrawal by Subject|5|||
33159930|NCT03519178|100498003|FG009|Follow-Up|Withdrawal by Subject|2|||
33159931|NCT03519178|100498004|FG010|Follow-Up|Withdrawal by Subject|3|||
33159932|NCT03519178|100498005|FG011|Follow-Up|Withdrawal by Subject|5|||
33159933|NCT03519178|100498006|FG012|Follow-Up|Withdrawal by Subject|2|||
33254832|NCT02477670|100833125|FG004|Stage 1|Withdrawal by Subject|0|||
33159934|NCT03519178|100498007|FG013|Follow-Up|Withdrawal by Subject|0|||
33159935|NCT03519178|100498008|FG014|Follow-Up|Withdrawal by Subject|0|||
33159936|NCT03519178|100497994|FG000|Follow-Up|Other|0|||
33159937|NCT03519178|100497995|FG001|Follow-Up|Other|0|||
33159938|NCT03519178|100497996|FG002|Follow-Up|Other|0|||
33159939|NCT03519178|100497997|FG003|Follow-Up|Other|0|||
33159940|NCT03519178|100497998|FG004|Follow-Up|Other|0|||
33159941|NCT03519178|100497999|FG005|Follow-Up|Other|0|||
33159942|NCT03519178|100498000|FG006|Follow-Up|Other|0|||
33159943|NCT03519178|100498001|FG007|Follow-Up|Other|1|||
33159944|NCT03519178|100498002|FG008|Follow-Up|Other|0|||
33159945|NCT03519178|100498003|FG009|Follow-Up|Other|0|||
33159946|NCT03519178|100498004|FG010|Follow-Up|Other|0|||
33159947|NCT03519178|100498005|FG011|Follow-Up|Other|0|||
33159948|NCT03519178|100498006|FG012|Follow-Up|Other|0|||
33159949|NCT03519178|100498007|FG013|Follow-Up|Other|0|||
33159950|NCT03519178|100498008|FG014|Follow-Up|Other|0|||
33159951|NCT03519178|100497994|FG000|Long-term Follow-up|Death|0|||
33159952|NCT03519178|100497995|FG001|Long-term Follow-up|Death|0|||
33159953|NCT03519178|100497996|FG002|Long-term Follow-up|Death|0|||
33159954|NCT03519178|100497997|FG003|Long-term Follow-up|Death|0|||
33159955|NCT03519178|100497998|FG004|Long-term Follow-up|Death|0|||
33159956|NCT03519178|100497999|FG005|Long-term Follow-up|Death|0|||
33159957|NCT03519178|100498000|FG006|Long-term Follow-up|Death|0|||
33159958|NCT03519178|100498001|FG007|Long-term Follow-up|Death|0|||
33159959|NCT03519178|100498002|FG008|Long-term Follow-up|Death|0|||
33159960|NCT03519178|100498003|FG009|Long-term Follow-up|Death|0|||
33159961|NCT03519178|100498004|FG010|Long-term Follow-up|Death|0|||
33159962|NCT03519178|100498005|FG011|Long-term Follow-up|Death|0|||
33159963|NCT03519178|100498006|FG012|Long-term Follow-up|Death|0|||
33159964|NCT03519178|100498007|FG013|Long-term Follow-up|Death|4|||
33159965|NCT03519178|100498008|FG014|Long-term Follow-up|Death|4|||
33159966|NCT03519178|100497994|FG000|Long-term Follow-up|Lost to Follow-up|0|||
33159967|NCT03519178|100497995|FG001|Long-term Follow-up|Lost to Follow-up|0|||
33159968|NCT03519178|100497996|FG002|Long-term Follow-up|Lost to Follow-up|0|||
33159969|NCT03519178|100497997|FG003|Long-term Follow-up|Lost to Follow-up|0|||
33159970|NCT03519178|100497998|FG004|Long-term Follow-up|Lost to Follow-up|0|||
33159971|NCT03519178|100497999|FG005|Long-term Follow-up|Lost to Follow-up|0|||
33159972|NCT03519178|100498000|FG006|Long-term Follow-up|Lost to Follow-up|0|||
33159973|NCT03519178|100498001|FG007|Long-term Follow-up|Lost to Follow-up|0|||
33159974|NCT03519178|100498002|FG008|Long-term Follow-up|Lost to Follow-up|0|||
33159975|NCT03519178|100498003|FG009|Long-term Follow-up|Lost to Follow-up|0|||
33159976|NCT03519178|100498004|FG010|Long-term Follow-up|Lost to Follow-up|0|||
33159977|NCT03519178|100498005|FG011|Long-term Follow-up|Lost to Follow-up|0|||
33159978|NCT03519178|100498006|FG012|Long-term Follow-up|Lost to Follow-up|0|||
33159979|NCT03519178|100498007|FG013|Long-term Follow-up|Lost to Follow-up|1|||
33159980|NCT03519178|100498008|FG014|Long-term Follow-up|Lost to Follow-up|1|||
33159981|NCT03519178|100497994|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
33159982|NCT03519178|100497995|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
33159983|NCT03519178|100497996|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
33159984|NCT03519178|100497997|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
33159985|NCT03519178|100497998|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
33159986|NCT03519178|100497999|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
33159987|NCT03519178|100498000|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
33159988|NCT03519178|100498001|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
33159989|NCT03519178|100498002|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
33159990|NCT03519178|100498003|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
33159991|NCT03519178|100498004|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
33159992|NCT03519178|100498005|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
33159993|NCT03519178|100498006|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
33159994|NCT03519178|100498007|FG013|Long-term Follow-up|Study terminated by sponsor|31|||
33159995|NCT03519178|100498008|FG014|Long-term Follow-up|Study terminated by sponsor|13|||
33159996|NCT03519178|100497994|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
33159997|NCT03519178|100497995|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
33159998|NCT03519178|100497996|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
33159999|NCT03519178|100497997|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
33160000|NCT03519178|100497998|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
33160001|NCT03519178|100497999|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
33160002|NCT03519178|100498000|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
33160003|NCT03519178|100498001|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
33160004|NCT03519178|100498002|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
33160005|NCT03519178|100498003|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
33160006|NCT03519178|100498004|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
33160007|NCT03519178|100498005|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
33160008|NCT03519178|100498006|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
33160009|NCT03519178|100498007|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
33160010|NCT03519178|100498008|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
33160011|NCT03519178|100497994|FG000|Long-term Follow-up|Other|0|||
33160012|NCT03519178|100497995|FG001|Long-term Follow-up|Other|0|||
33160013|NCT03519178|100497996|FG002|Long-term Follow-up|Other|0|||
33160014|NCT03519178|100497997|FG003|Long-term Follow-up|Other|0|||
33160015|NCT03519178|100497998|FG004|Long-term Follow-up|Other|0|||
33160016|NCT03519178|100497999|FG005|Long-term Follow-up|Other|0|||
33160017|NCT03519178|100498000|FG006|Long-term Follow-up|Other|0|||
33160018|NCT03519178|100498001|FG007|Long-term Follow-up|Other|0|||
33160019|NCT03519178|100498002|FG008|Long-term Follow-up|Other|0|||
33160020|NCT03519178|100498003|FG009|Long-term Follow-up|Other|0|||
33160021|NCT03519178|100498004|FG010|Long-term Follow-up|Other|0|||
33160022|NCT03519178|100498005|FG011|Long-term Follow-up|Other|0|||
33160023|NCT03519178|100498006|FG012|Long-term Follow-up|Other|0|||
33160024|NCT03519178|100498007|FG013|Long-term Follow-up|Other|0|||
33160025|NCT03519178|100498008|FG014|Long-term Follow-up|Other|1|||
33160026|NCT03519178|100497994|FG000|Long-term Follow-up|Ongoing|0|||
33160027|NCT03519178|100497995|FG001|Long-term Follow-up|Ongoing|0|||
33160028|NCT03519178|100497996|FG002|Long-term Follow-up|Ongoing|0|||
33160029|NCT03519178|100497997|FG003|Long-term Follow-up|Ongoing|0|||
33160030|NCT03519178|100497998|FG004|Long-term Follow-up|Ongoing|0|||
33160031|NCT03519178|100497999|FG005|Long-term Follow-up|Ongoing|0|||
33160032|NCT03519178|100498000|FG006|Long-term Follow-up|Ongoing|0|||
33160033|NCT03519178|100498001|FG007|Long-term Follow-up|Ongoing|0|||
33160034|NCT03519178|100498002|FG008|Long-term Follow-up|Ongoing|0|||
33160035|NCT03519178|100498003|FG009|Long-term Follow-up|Ongoing|0|||
33160036|NCT03519178|100498004|FG010|Long-term Follow-up|Ongoing|0|||
33160037|NCT03519178|100498005|FG011|Long-term Follow-up|Ongoing|0|||
33160038|NCT03519178|100498006|FG012|Long-term Follow-up|Ongoing|0|||
33160039|NCT03519178|100498007|FG013|Long-term Follow-up|Ongoing|1|||
33160040|NCT03519178|100498008|FG014|Long-term Follow-up|Ongoing|0|||
33160041|NCT01090492|100498009|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
33160042|NCT01090492|100498010|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
33160043|NCT01090492|100498011|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
33160044|NCT01090492|100498012|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
33160045|NCT01090492|100498013|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
33160046|NCT01090492|100498014|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
33160047|NCT01090492|100498015|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
33160048|NCT01090492|100498016|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
33160049|NCT01090492|100498009|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
33160050|NCT01090492|100498010|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
33160051|NCT01090492|100498011|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
33160052|NCT01090492|100498012|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
33160053|NCT01090492|100498013|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
33160054|NCT01090492|100498014|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
33160055|NCT01090492|100498015|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
33160056|NCT01090492|100498016|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
33160057|NCT01090492|100498009|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33160058|NCT01090492|100498010|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33160059|NCT01090492|100498011|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
33254833|NCT02477670|100833126|FG005|Stage 1|Withdrawal by Subject|0|||
33160060|NCT01090492|100498012|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33254834|NCT02477670|100833127|FG006|Stage 1|Withdrawal by Subject|0|||
33254835|NCT02477670|100833121|FG000|Stage 1|Non-compliance with Study Drug|1|||
33254836|NCT02477670|100833122|FG001|Stage 1|Non-compliance with Study Drug|2|||
33388814|NCT00712933|101309349|FG000|Overall Study|Other Physician decision|1|||
33442102|NCT03195491|101512166|FG001|Overall Study|Participant withdrew consent|1|||
33442103|NCT03195491|101512165|FG000|Overall Study|Participant no longer meets study criteria|0|||
33160061|NCT01090492|100498013|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33160062|NCT01090492|100498014|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33160063|NCT01090492|100498015|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33160064|NCT01090492|100498016|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33160065|NCT01090492|100498009|FG000|First Intervention Period (4 Weeks)|Other|0|||
33160066|NCT01090492|100498010|FG001|First Intervention Period (4 Weeks)|Other|0|||
33160067|NCT01090492|100498011|FG002|First Intervention Period (4 Weeks)|Other|1|||
33160068|NCT01090492|100498012|FG003|First Intervention Period (4 Weeks)|Other|1|||
33160069|NCT01090492|100498013|FG004|First Intervention Period (4 Weeks)|Other|2|||
33160070|NCT01090492|100498014|FG005|First Intervention Period (4 Weeks)|Other|0|||
33160071|NCT01090492|100498015|FG006|First Intervention Period (4 Weeks)|Other|0|||
33160072|NCT01090492|100498016|FG007|First Intervention Period (4 Weeks)|Other|0|||
33160073|NCT01090492|100498009|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
33160074|NCT01090492|100498010|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
33160075|NCT01090492|100498011|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
33160076|NCT01090492|100498012|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
33160077|NCT01090492|100498013|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
33160078|NCT01090492|100498014|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
33160079|NCT01090492|100498015|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
33160080|NCT01090492|100498016|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
33160081|NCT01090492|100498009|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
33160082|NCT01090492|100498010|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
33160083|NCT01090492|100498011|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
33160084|NCT01090492|100498012|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
33160085|NCT01090492|100498013|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
33160086|NCT01090492|100498014|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
33160087|NCT01090492|100498015|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
33160088|NCT01090492|100498016|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
33160089|NCT01090492|100498009|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
33160090|NCT01090492|100498010|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
33160091|NCT01090492|100498011|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
33160092|NCT01090492|100498012|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
33160093|NCT01090492|100498013|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
33160094|NCT01090492|100498014|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
33160095|NCT01090492|100498015|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
33160096|NCT01090492|100498016|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
33160097|NCT01090492|100498009|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
33160098|NCT01090492|100498010|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
33160099|NCT01090492|100498011|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
33160100|NCT01090492|100498012|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
33160101|NCT01090492|100498013|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
33254837|NCT02477670|100833123|FG002|Stage 1|Non-compliance with Study Drug|0|||
33254838|NCT02477670|100833124|FG003|Stage 1|Non-compliance with Study Drug|0|||
33254839|NCT02477670|100833125|FG004|Stage 1|Non-compliance with Study Drug|0|||
33254840|NCT02477670|100833126|FG005|Stage 1|Non-compliance with Study Drug|0|||
33254841|NCT02477670|100833127|FG006|Stage 1|Non-compliance with Study Drug|0|||
33254842|NCT02477670|100833121|FG000|Stage 2|Adverse Event|0|||
33254843|NCT02477670|100833122|FG001|Stage 2|Adverse Event|0|||
33254844|NCT02477670|100833123|FG002|Stage 2|Adverse Event|1|||
33254845|NCT02477670|100833124|FG003|Stage 2|Adverse Event|0|||
33254846|NCT02477670|100833125|FG004|Stage 2|Adverse Event|0|||
33254847|NCT02477670|100833126|FG005|Stage 2|Adverse Event|0|||
33254848|NCT02477670|100833127|FG006|Stage 2|Adverse Event|0|||
33254849|NCT02477670|100833121|FG000|Stage 2|Antipsychotic Medication Changed|0|||
33254850|NCT02477670|100833122|FG001|Stage 2|Antipsychotic Medication Changed|0|||
33254851|NCT02477670|100833123|FG002|Stage 2|Antipsychotic Medication Changed|1|||
33254852|NCT02477670|100833124|FG003|Stage 2|Antipsychotic Medication Changed|0|||
33254853|NCT02477670|100833125|FG004|Stage 2|Antipsychotic Medication Changed|0|||
33254854|NCT02477670|100833126|FG005|Stage 2|Antipsychotic Medication Changed|0|||
33254855|NCT02477670|100833127|FG006|Stage 2|Antipsychotic Medication Changed|0|||
33254856|NCT02477670|100833121|FG000|Stage 2|Withdrawal by Subject|0|||
33254857|NCT02477670|100833122|FG001|Stage 2|Withdrawal by Subject|0|||
33254858|NCT02477670|100833123|FG002|Stage 2|Withdrawal by Subject|0|||
33254859|NCT02477670|100833124|FG003|Stage 2|Withdrawal by Subject|1|||
33254860|NCT02477670|100833125|FG004|Stage 2|Withdrawal by Subject|0|||
33254861|NCT02477670|100833126|FG005|Stage 2|Withdrawal by Subject|0|||
33254862|NCT02477670|100833127|FG006|Stage 2|Withdrawal by Subject|0|||
33254863|NCT00065260|100833128|FG000|Overall Study|Death|0|||
33254864|NCT00065260|100833129|FG001|Overall Study|Death|1|||
33254865|NCT03233633|100833130|FG000|Overall Study|Adverse Event|2|||
33254866|NCT03233633|100833130|FG000|Overall Study|Less Than 3 Days of Data|6|||
33254867|NCT00463788|100833131|FG000|Overall Study|Progressive Disease|86|||
33254868|NCT00463788|100833132|FG001|Overall Study|Progressive Disease|42|||
33160102|NCT01090492|100498014|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
33160103|NCT01090492|100498015|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
33160104|NCT01090492|100498016|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
33160105|NCT01090492|100498009|FG000|Second Intervention Period (4 Weeks)|Other|0|||
33160106|NCT01090492|100498010|FG001|Second Intervention Period (4 Weeks)|Other|1|||
33160107|NCT01090492|100498011|FG002|Second Intervention Period (4 Weeks)|Other|1|||
33160108|NCT01090492|100498012|FG003|Second Intervention Period (4 Weeks)|Other|0|||
33160109|NCT01090492|100498013|FG004|Second Intervention Period (4 Weeks)|Other|0|||
33160110|NCT01090492|100498014|FG005|Second Intervention Period (4 Weeks)|Other|0|||
33160111|NCT01090492|100498015|FG006|Second Intervention Period (4 Weeks)|Other|0|||
33160112|NCT01090492|100498016|FG007|Second Intervention Period (4 Weeks)|Other|0|||
33254869|NCT00463788|100833131|FG000|Overall Study|Adverse Event|6|||
33254870|NCT00463788|100833132|FG001|Overall Study|Adverse Event|2|||
33254871|NCT00463788|100833131|FG000|Overall Study|Withdrawal by Subject|6|||
33254872|NCT00463788|100833132|FG001|Overall Study|Withdrawal by Subject|2|||
33160113|NCT01090492|100498009|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
33254873|NCT00463788|100833131|FG000|Overall Study|Death|4|||
33254874|NCT00463788|100833132|FG001|Overall Study|Death|3|||
33442104|NCT03195491|101512166|FG001|Overall Study|Participant no longer meets study criteria|1|||
33442105|NCT03195491|101512165|FG000|Overall Study|Participant request to discontinue study treatment|10|||
33442106|NCT03195491|101512166|FG001|Overall Study|Participant request to discontinue study treatment|0|||
33442107|NCT03699020|101512167|FG000|Overall Study|Withdrawal by Subject|3|||
33442108|NCT03699020|101512168|FG001|Overall Study|Withdrawal by Subject|2|||
33160114|NCT01090492|100498010|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
33160115|NCT01090492|100498011|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
33160116|NCT01090492|100498012|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
33160117|NCT01090492|100498013|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
33160118|NCT01090492|100498014|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
33160119|NCT01090492|100498015|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
33160120|NCT01090492|100498016|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
33160121|NCT01090492|100498009|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33160122|NCT01090492|100498010|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33160123|NCT01090492|100498011|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33160124|NCT01090492|100498012|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33160125|NCT01090492|100498013|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33160126|NCT01090492|100498014|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33160127|NCT01090492|100498015|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
33160128|NCT01090492|100498016|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
33160129|NCT03334630|100498019|FG000|Overall Study|Withdrawal by Subject|7|||
33160130|NCT03334630|100498020|FG001|Overall Study|Withdrawal by Subject|7|||
33160131|NCT03334630|100498019|FG000|Overall Study|Lost to Follow-up|3|||
33160132|NCT03334630|100498020|FG001|Overall Study|Lost to Follow-up|1|||
33160133|NCT03334630|100498019|FG000|Overall Study|Adverse Event|0|||
33160134|NCT03334630|100498020|FG001|Overall Study|Adverse Event|1|||
33160135|NCT03334630|100498019|FG000|Overall Study|Physician Decision|1|||
33160136|NCT03334630|100498020|FG001|Overall Study|Physician Decision|1|||
33160137|NCT03334630|100498019|FG000|Overall Study|Enrollment closed|2|||
33160138|NCT03334630|100498020|FG001|Overall Study|Enrollment closed|1|||
33160139|NCT03334630|100498019|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
33160140|NCT03334630|100498020|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
33160141|NCT03334630|100498019|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
33160142|NCT03334630|100498020|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
33160143|NCT05213481|100498021|FG000|Overall Study|Adverse Event|3|||
33160144|NCT05213481|100498021|FG000|Overall Study|Lost to Follow-up|1|||
33160145|NCT00560105|100498026|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
33160146|NCT00560105|100498027|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
33160147|NCT00622284|100498028|FG000|Overall Study|Lack of Efficacy|45|||
33160148|NCT00622284|100498029|FG001|Overall Study|Lack of Efficacy|15|||
33160149|NCT00622284|100498028|FG000|Overall Study|Adverse Event|61|||
33160150|NCT00622284|100498029|FG001|Overall Study|Adverse Event|90|||
33160151|NCT00622284|100498028|FG000|Overall Study|Protocol Violation|12|||
33160152|NCT00622284|100498029|FG001|Overall Study|Protocol Violation|5|||
33160153|NCT00622284|100498028|FG000|Overall Study|Lost to Follow-up|11|||
33160154|NCT00622284|100498029|FG001|Overall Study|Lost to Follow-up|13|||
33160155|NCT00622284|100498028|FG000|Overall Study|Withdrawal by Subject|27|||
33160156|NCT00622284|100498029|FG001|Overall Study|Withdrawal by Subject|24|||
33388815|NCT00712933|101309349|FG000|Overall Study|Not committed to contraception|1|||
33254875|NCT00463788|100833131|FG000|Overall Study|Symptomatic Deterioration|2|||
33254876|NCT00463788|100833132|FG001|Overall Study|Symptomatic Deterioration|3|||
33254877|NCT00463788|100833131|FG000|Overall Study|Lost to Follow-up|1|||
33254878|NCT00463788|100833132|FG001|Overall Study|Lost to Follow-up|0|||
33254879|NCT00463788|100833131|FG000|Overall Study|Protocol Violation|0|||
33254880|NCT00463788|100833132|FG001|Overall Study|Protocol Violation|1|||
33254881|NCT00463788|100833131|FG000|Overall Study|Other|3|||
33254882|NCT00463788|100833132|FG001|Overall Study|Other|0|||
33254883|NCT00463788|100833131|FG000|Overall Study|Randomized but not treated|1|||
33254884|NCT00463788|100833132|FG001|Overall Study|Randomized but not treated|1|||
33254885|NCT02937831|100833133|FG000|Overall Study|Protocol Violation|4|||
33254886|NCT01400776|100833136|FG000|Overall Study|Adverse Event|7|||
33254887|NCT01400776|100833137|FG001|Overall Study|Adverse Event|2|||
33254888|NCT01400776|100833138|FG002|Overall Study|Adverse Event|9|||
33254889|NCT01400776|100833139|FG003|Overall Study|Adverse Event|2|||
33254890|NCT01400776|100833136|FG000|Overall Study|Lost to Follow-up|1|||
33254891|NCT01400776|100833137|FG001|Overall Study|Lost to Follow-up|0|||
33254892|NCT01400776|100833138|FG002|Overall Study|Lost to Follow-up|4|||
33254893|NCT01400776|100833139|FG003|Overall Study|Lost to Follow-up|1|||
33254894|NCT01400776|100833136|FG000|Overall Study|Withdrew Consent|4|||
33254895|NCT01400776|100833137|FG001|Overall Study|Withdrew Consent|2|||
33254896|NCT01400776|100833138|FG002|Overall Study|Withdrew Consent|6|||
33254897|NCT01400776|100833139|FG003|Overall Study|Withdrew Consent|1|||
33254898|NCT01400776|100833136|FG000|Overall Study|Protocol Deviation|6|||
33254899|NCT01400776|100833137|FG001|Overall Study|Protocol Deviation|1|||
33254900|NCT01400776|100833138|FG002|Overall Study|Protocol Deviation|5|||
33254901|NCT01400776|100833139|FG003|Overall Study|Protocol Deviation|2|||
33254902|NCT01400776|100833136|FG000|Overall Study|Reason not Specified|3|||
33254903|NCT01400776|100833137|FG001|Overall Study|Reason not Specified|0|||
33254904|NCT01400776|100833138|FG002|Overall Study|Reason not Specified|4|||
33254905|NCT01400776|100833139|FG003|Overall Study|Reason not Specified|3|||
33254906|NCT00101010|100833144|FG000|Overall Study|Physician Decision|1|||
33254907|NCT05510245|100833150|FG000|Overall Study|Withdrawal by Subject|1|||
33254908|NCT05510245|100833151|FG001|Overall Study|Withdrawal by Subject|0|||
33254909|NCT05510245|100833152|FG002|Overall Study|Withdrawal by Subject|0|||
33254910|NCT00507689|100833153|FG000|Pre-Randomization Period|Adverse Event|1|||
33254911|NCT00507689|100833154|FG001|Pre-Randomization Period|Adverse Event|0|||
33254912|NCT00507689|100833153|FG000|Pre-Randomization Period|Physician Decision|1|||
33254913|NCT00507689|100833154|FG001|Pre-Randomization Period|Physician Decision|0|||
33254914|NCT00507689|100833153|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
33254915|NCT00507689|100833154|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
33254916|NCT00507689|100833153|FG000|Randomized Period|Adverse Event|1|||
33254917|NCT00507689|100833154|FG001|Randomized Period|Adverse Event|1|||
33254918|NCT00507689|100833153|FG000|Randomized Period|Withdrawal by Subject|0|||
33254919|NCT00507689|100833154|FG001|Randomized Period|Withdrawal by Subject|1|||
33254920|NCT00841035|100833155|FG000|Phase 1 Overall Study|Physician Decision|13|||
33254921|NCT02341625|100833157|FG000|Overall Study|Disease Progression|2|||
33254922|NCT02341625|100833158|FG001|Overall Study|Disease Progression|2|||
33254923|NCT02341625|100833159|FG002|Overall Study|Disease Progression|3|||
33254924|NCT02341625|100833160|FG003|Overall Study|Disease Progression|6|||
33254925|NCT02341625|100833161|FG004|Overall Study|Disease Progression|7|||
33254926|NCT02341625|100833162|FG005|Overall Study|Disease Progression|7|||
33254927|NCT02341625|100833163|FG006|Overall Study|Disease Progression|28|||
33254928|NCT02341625|100833164|FG007|Overall Study|Disease Progression|5|||
33254929|NCT02341625|100833165|FG008|Overall Study|Disease Progression|4|||
33254930|NCT02341625|100833166|FG009|Overall Study|Disease Progression|19|||
33254931|NCT02341625|100833157|FG000|Overall Study|Study Drug Toxicity|0|||
33254932|NCT02341625|100833158|FG001|Overall Study|Study Drug Toxicity|0|||
33254933|NCT02341625|100833159|FG002|Overall Study|Study Drug Toxicity|0|||
33254934|NCT02341625|100833160|FG003|Overall Study|Study Drug Toxicity|1|||
33254935|NCT02341625|100833161|FG004|Overall Study|Study Drug Toxicity|0|||
33254936|NCT02341625|100833162|FG005|Overall Study|Study Drug Toxicity|3|||
33254937|NCT02341625|100833163|FG006|Overall Study|Study Drug Toxicity|10|||
33254938|NCT02341625|100833164|FG007|Overall Study|Study Drug Toxicity|0|||
33254939|NCT02341625|100833165|FG008|Overall Study|Study Drug Toxicity|0|||
33254940|NCT02341625|100833166|FG009|Overall Study|Study Drug Toxicity|3|||
33254941|NCT02341625|100833157|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33254942|NCT02341625|100833158|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33254943|NCT02341625|100833159|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33254944|NCT02341625|100833160|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33254945|NCT02341625|100833161|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33254946|NCT02341625|100833162|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33254947|NCT02341625|100833163|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
33254948|NCT02341625|100833164|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
33442109|NCT00184600|101512177|FG000|Overall Study|Adverse Event|9|||
33254949|NCT02341625|100833165|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
33254950|NCT02341625|100833166|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
33254951|NCT02341625|100833157|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33254952|NCT02341625|100833158|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33254953|NCT02341625|100833159|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33254954|NCT02341625|100833160|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33254955|NCT02341625|100833161|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33254956|NCT02341625|100833162|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33254957|NCT02341625|100833163|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
33254958|NCT02341625|100833164|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
33254959|NCT02341625|100833165|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33254960|NCT02341625|100833166|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
33254961|NCT02341625|100833157|FG000|Overall Study|Participant Withdrew Consent|0|||
33254962|NCT02341625|100833158|FG001|Overall Study|Participant Withdrew Consent|0|||
33254963|NCT02341625|100833159|FG002|Overall Study|Participant Withdrew Consent|0|||
33254964|NCT02341625|100833160|FG003|Overall Study|Participant Withdrew Consent|1|||
33254965|NCT02341625|100833161|FG004|Overall Study|Participant Withdrew Consent|0|||
33254966|NCT02341625|100833162|FG005|Overall Study|Participant Withdrew Consent|0|||
33254967|NCT02341625|100833163|FG006|Overall Study|Participant Withdrew Consent|0|||
33254968|NCT02341625|100833164|FG007|Overall Study|Participant Withdrew Consent|0|||
33254969|NCT02341625|100833165|FG008|Overall Study|Participant Withdrew Consent|0|||
33388816|NCT00712933|101309349|FG000|Overall Study|Participant received medication|1|||
33160157|NCT00622284|100498028|FG000|Overall Study|Other reason (not specified)|33|||
33160158|NCT00622284|100498029|FG001|Overall Study|Other reason (not specified)|24|||
33442110|NCT00184600|101512178|FG001|Overall Study|Adverse Event|0|||
33442111|NCT00184600|101512179|FG002|Overall Study|Adverse Event|5|||
33442112|NCT00184600|101512177|FG000|Overall Study|Death|3|||
33442113|NCT00184600|101512178|FG001|Overall Study|Death|9|||
33442114|NCT00184600|101512179|FG002|Overall Study|Death|7|||
33442115|NCT00184600|101512177|FG000|Overall Study|Lack of Efficacy|3|||
33442116|NCT00184600|101512178|FG001|Overall Study|Lack of Efficacy|1|||
33388817|NCT00712933|101309349|FG000|Overall Study|Physician Decision|36|||
33388818|NCT00712933|101309349|FG000|Overall Study|Protocol Violation|4|||
33442117|NCT00184600|101512179|FG002|Overall Study|Lack of Efficacy|3|||
33442118|NCT00184600|101512177|FG000|Overall Study|Lost to Follow-up|4|||
33254970|NCT02341625|100833166|FG009|Overall Study|Participant Withdrew Consent|0|||
33442119|NCT00184600|101512178|FG001|Overall Study|Lost to Follow-up|6|||
33442120|NCT00184600|101512179|FG002|Overall Study|Lost to Follow-up|1|||
33442121|NCT00184600|101512177|FG000|Overall Study|Protocol Violation|2|||
33254971|NCT02341625|100833157|FG000|Overall Study|Completed Treatment as per Protocol|0|||
33442122|NCT00184600|101512178|FG001|Overall Study|Protocol Violation|2|||
33442123|NCT00184600|101512179|FG002|Overall Study|Protocol Violation|3|||
33442124|NCT00184600|101512177|FG000|Overall Study|Withdrawal by Subject|20|||
33442125|NCT00184600|101512178|FG001|Overall Study|Withdrawal by Subject|28|||
33254972|NCT02341625|100833158|FG001|Overall Study|Completed Treatment as per Protocol|0|||
33254973|NCT02341625|100833159|FG002|Overall Study|Completed Treatment as per Protocol|0|||
33254974|NCT02341625|100833160|FG003|Overall Study|Completed Treatment as per Protocol|0|||
33254975|NCT02341625|100833161|FG004|Overall Study|Completed Treatment as per Protocol|0|||
33254976|NCT02341625|100833162|FG005|Overall Study|Completed Treatment as per Protocol|0|||
33254977|NCT02341625|100833163|FG006|Overall Study|Completed Treatment as per Protocol|0|||
33254978|NCT02341625|100833164|FG007|Overall Study|Completed Treatment as per Protocol|0|||
33254979|NCT02341625|100833165|FG008|Overall Study|Completed Treatment as per Protocol|0|||
33254980|NCT02341625|100833166|FG009|Overall Study|Completed Treatment as per Protocol|1|||
33442126|NCT00184600|101512179|FG002|Overall Study|Withdrawal by Subject|12|||
33442127|NCT00184600|101512177|FG000|Overall Study|Unclassified|4|||
33442128|NCT00184600|101512178|FG001|Overall Study|Unclassified|5|||
33442129|NCT00184600|101512179|FG002|Overall Study|Unclassified|3|||
33442130|NCT01387022|101512182|FG000|Overall Study|Death|1|||
33442131|NCT01387022|101512183|FG001|Overall Study|Death|1|||
33442132|NCT01387022|101512182|FG000|Overall Study|Lost to Follow-up|0|||
33442133|NCT01387022|101512183|FG001|Overall Study|Lost to Follow-up|3|||
33442134|NCT03707912|101512184|FG000|Overall Study|Violation of inclusion criteria|1|||
33442135|NCT03707912|101512185|FG001|Overall Study|Violation of inclusion criteria|0|||
33442136|NCT03447262|101512186|FG000|Overall Study|Adverse Event|7|||
33442137|NCT03447262|101512186|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
33442138|NCT03447262|101512186|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
33442139|NCT03447262|101512186|FG000|Overall Study|Death|2|||
33442140|NCT03447262|101512186|FG000|Overall Study|Study Termination by Sponsor|455|||
33442141|NCT03447262|101512186|FG000|Overall Study|Other|4|||
33442142|NCT03600376|101512187|FG000|Overall Study|Adverse Event|1|||
33442143|NCT03600376|101512188|FG001|Overall Study|Adverse Event|1|||
33442144|NCT03600376|101512187|FG000|Overall Study|Transferred to other facility|1|||
33442145|NCT03600376|101512188|FG001|Overall Study|Transferred to other facility|0|||
33442146|NCT03600376|101512187|FG000|Overall Study|Investigator Decision|0|||
33442147|NCT03600376|101512188|FG001|Overall Study|Investigator Decision|4|||
33442148|NCT03600376|101512187|FG000|Overall Study|Determined to be ineligible for study|0|||
33442149|NCT03600376|101512188|FG001|Overall Study|Determined to be ineligible for study|1|||
33442150|NCT01918397|101512189|FG000|Overall Study|Never started treatment|2|||
33442151|NCT01918397|101512190|FG001|Overall Study|Never started treatment|1|||
33160159|NCT00493025|100498030|FG000|Overall Study|Physician Decision|19|||
33160160|NCT00446251|100498036|FG000|Overall Study|On-study Transplants|2|||
33160161|NCT00446251|100498036|FG000|Overall Study|Rituximab Infusion Reaction|2|||
33160162|NCT00446251|100498036|FG000|Overall Study|Lost to Follow-up|1|||
33254981|NCT02341625|100833157|FG000|Overall Study|Other Reasons|0|||
33254982|NCT02341625|100833158|FG001|Overall Study|Other Reasons|0|||
33254983|NCT02341625|100833159|FG002|Overall Study|Other Reasons|0|||
33254984|NCT02341625|100833160|FG003|Overall Study|Other Reasons|0|||
33254985|NCT02341625|100833161|FG004|Overall Study|Other Reasons|1|||
33442152|NCT01918397|101512191|FG002|Overall Study|Never started treatment|0|||
33442153|NCT01918397|101512192|FG003|Overall Study|Never started treatment|0|||
33160163|NCT03953820|100498042|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
33160164|NCT03953820|100498043|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
33160165|NCT03953820|100498044|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
33160166|NCT03953820|100498042|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
33160167|NCT03953820|100498043|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
33160168|NCT03953820|100498044|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
33160169|NCT01488370|100498045|FG000|Overall Study|Protocol Violation|0|||
33160170|NCT01488370|100498046|FG001|Overall Study|Protocol Violation|1|||
33160171|NCT01488370|100498047|FG002|Overall Study|Protocol Violation|1|||
33160172|NCT01681472|100498048|FG000|Overall Study|Adverse Event|0|||
33160173|NCT01681472|100498049|FG001|Overall Study|Adverse Event|1|||
33160174|NCT01681472|100498050|FG002|Overall Study|Adverse Event|0|||
33160175|NCT01681472|100498051|FG003|Overall Study|Adverse Event|0|||
33160176|NCT00736944|100498052|FG000|Induction|Death|1|||
33160177|NCT00736944|100498052|FG000|Definitive Treatment|Physician Decision|1|||
33160178|NCT00566995|100498053|FG000|Overall Study|Toxicity|4|||
33160179|NCT00566995|100498053|FG000|Overall Study|Withdrew consent|3|||
33160180|NCT01330030|100498054|FG000|Overall Study|Lost to Follow-up|16|||
33160181|NCT01330030|100498055|FG001|Overall Study|Lost to Follow-up|17|||
33160182|NCT01945281|100498056|FG000|Overall Study|Adverse Event|1|||
33160183|NCT01945281|100498057|FG001|Overall Study|Adverse Event|0|||
33160184|NCT01945281|100498056|FG000|Overall Study|Death|3|||
33160185|NCT01945281|100498057|FG001|Overall Study|Death|3|||
33160186|NCT01945281|100498056|FG000|Overall Study|Physician Decision|1|||
33160187|NCT01945281|100498057|FG001|Overall Study|Physician Decision|1|||
33160188|NCT01945281|100498056|FG000|Overall Study|Technical Problems|1|||
33160189|NCT01945281|100498057|FG001|Overall Study|Technical Problems|0|||
33160190|NCT03345914|100498060|FG000|Overall Study|Transition to another study at week 16|80|||
33160191|NCT03345914|100498061|FG001|Overall Study|Transition to another study at week 16|86|||
33160192|NCT03345914|100498062|FG002|Overall Study|Transition to another study at week 16|78|||
33160193|NCT03345914|100498060|FG000|Overall Study|Transition to OLE during follow-up|37|||
33160194|NCT03345914|100498061|FG001|Overall Study|Transition to OLE during follow-up|33|||
33160195|NCT03345914|100498062|FG002|Overall Study|Transition to OLE during follow-up|39|||
33160196|NCT03345914|100498060|FG000|Overall Study|Physician Decision|0|||
33160197|NCT03345914|100498061|FG001|Overall Study|Physician Decision|1|||
33160198|NCT03345914|100498062|FG002|Overall Study|Physician Decision|1|||
33160199|NCT03345914|100498060|FG000|Overall Study|Withdrawal by Subject|5|||
33442154|NCT01918397|101512189|FG000|Overall Study|Adverse Event|1|||
33442155|NCT01918397|101512190|FG001|Overall Study|Adverse Event|1|||
33442156|NCT01918397|101512191|FG002|Overall Study|Adverse Event|1|||
33442157|NCT01918397|101512192|FG003|Overall Study|Adverse Event|0|||
33160200|NCT03345914|100498061|FG001|Overall Study|Withdrawal by Subject|1|||
33160201|NCT03345914|100498062|FG002|Overall Study|Withdrawal by Subject|2|||
33160202|NCT03345914|100498060|FG000|Overall Study|Other|1|||
33160203|NCT03345914|100498061|FG001|Overall Study|Other|1|||
33160204|NCT03345914|100498062|FG002|Overall Study|Other|1|||
33160205|NCT03345914|100498060|FG000|Overall Study|Ongoing|0|||
33160206|NCT03345914|100498061|FG001|Overall Study|Ongoing|0|||
33160207|NCT03345914|100498062|FG002|Overall Study|Ongoing|1|||
33160208|NCT02021773|100498066|FG000|Overall Study|Adverse Event|1|||
33160209|NCT02021773|100498067|FG001|Overall Study|Adverse Event|4|||
33160210|NCT02021773|100498068|FG002|Overall Study|Adverse Event|3|||
33160211|NCT02021773|100498066|FG000|Overall Study|Lack of Efficacy|2|||
33254986|NCT02341625|100833162|FG005|Overall Study|Other Reasons|0|||
33254987|NCT02341625|100833163|FG006|Overall Study|Other Reasons|5|||
33160212|NCT02021773|100498067|FG001|Overall Study|Lack of Efficacy|2|||
33160213|NCT02021773|100498068|FG002|Overall Study|Lack of Efficacy|2|||
33160214|NCT02021773|100498066|FG000|Overall Study|Protocol Violation|2|||
33160215|NCT02021773|100498067|FG001|Overall Study|Protocol Violation|3|||
33160216|NCT02021773|100498068|FG002|Overall Study|Protocol Violation|1|||
33160217|NCT02021773|100498066|FG000|Overall Study|Withdrawal by Subject|3|||
33160218|NCT02021773|100498067|FG001|Overall Study|Withdrawal by Subject|4|||
33442158|NCT01918397|101512189|FG000|Overall Study|Lack of compliance|2|||
33160219|NCT02021773|100498068|FG002|Overall Study|Withdrawal by Subject|5|||
33160220|NCT02021773|100498066|FG000|Overall Study|Lost to Follow-up|1|||
33160221|NCT02021773|100498067|FG001|Overall Study|Lost to Follow-up|3|||
33254988|NCT02341625|100833164|FG007|Overall Study|Other Reasons|0|||
33442159|NCT01918397|101512190|FG001|Overall Study|Lack of compliance|2|||
33160222|NCT02021773|100498068|FG002|Overall Study|Lost to Follow-up|0|||
33442160|NCT01918397|101512191|FG002|Overall Study|Lack of compliance|3|||
33442161|NCT01918397|101512192|FG003|Overall Study|Lack of compliance|0|||
33160223|NCT02021773|100498066|FG000|Overall Study|Reason not specified|3|||
33442162|NCT01918397|101512189|FG000|Overall Study|Pregnancy|0|||
33442163|NCT01918397|101512190|FG001|Overall Study|Pregnancy|1|||
33160224|NCT02021773|100498067|FG001|Overall Study|Reason not specified|0|||
33160225|NCT02021773|100498068|FG002|Overall Study|Reason not specified|0|||
33160226|NCT00633750|100498069|FG000|Overall Study|Adverse Event|2|||
33160227|NCT00633750|100498069|FG000|Overall Study|Withdrawal by Subject|3|||
33442164|NCT01918397|101512191|FG002|Overall Study|Pregnancy|0|||
33254989|NCT02341625|100833165|FG008|Overall Study|Other Reasons|0|||
33254990|NCT02341625|100833166|FG009|Overall Study|Other Reasons|2|||
33254991|NCT02341625|100833157|FG000|Overall Study|Not Reported|0|||
33254992|NCT02341625|100833158|FG001|Overall Study|Not Reported|0|||
33254993|NCT02341625|100833159|FG002|Overall Study|Not Reported|0|||
33254994|NCT02341625|100833160|FG003|Overall Study|Not Reported|0|||
33254995|NCT02341625|100833161|FG004|Overall Study|Not Reported|0|||
33254996|NCT02341625|100833162|FG005|Overall Study|Not Reported|0|||
33254997|NCT02341625|100833163|FG006|Overall Study|Not Reported|0|||
33254998|NCT02341625|100833164|FG007|Overall Study|Not Reported|0|||
33254999|NCT02341625|100833165|FG008|Overall Study|Not Reported|0|||
33255000|NCT02341625|100833166|FG009|Overall Study|Not Reported|3|||
33255001|NCT02115139|100833169|FG000|Overall Study|Protocol Violation|1|||
33255002|NCT02115139|100833169|FG000|Overall Study|treatment discontinuation|6|||
33255003|NCT01184508|100833179|FG000|Overall Study|Adverse Event|4|||
33442165|NCT01918397|101512192|FG003|Overall Study|Pregnancy|0|||
33255004|NCT01184508|100833180|FG001|Overall Study|Adverse Event|6|||
33255005|NCT01184508|100833179|FG000|Overall Study|Lack of Efficacy|1|||
33255006|NCT01184508|100833180|FG001|Overall Study|Lack of Efficacy|1|||
33255007|NCT01184508|100833179|FG000|Overall Study|Lost to Follow-up|1|||
33255008|NCT01184508|100833180|FG001|Overall Study|Lost to Follow-up|1|||
33442166|NCT01918397|101512189|FG000|Overall Study|Rifampin susceptible|0|||
33160228|NCT02527161|100498070|FG000|Overall Study|Failed MRI|52|||
33160229|NCT02527161|100498070|FG000|Overall Study|Withdrawal by Subject|19|||
33160230|NCT02527161|100498070|FG000|Overall Study|Delay in or unfit for surgery|16|||
33160231|NCT02527161|100498070|FG000|Overall Study|MRI contraindication|6|||
33160232|NCT02527161|100498070|FG000|Overall Study|Consent violation|4|||
33160233|NCT02527161|100498070|FG000|Overall Study|Only Recruited to Part A|27|||
33160234|NCT02527161|100498070|FG000|Overall Study|Physician Decision|1|||
33160235|NCT02527161|100498070|FG000|Overall Study|Adverse Event|1|||
33160236|NCT02527161|100498070|FG000|Overall Study|Lost to Follow-up|6|||
33160237|NCT00915278|100498073|FG000|Overall Study|Death|1|||
33160238|NCT00915278|100498074|FG001|Overall Study|Death|0|||
33160239|NCT00915278|100498075|FG002|Overall Study|Death|0|||
33160240|NCT00915278|100498076|FG003|Overall Study|Death|0|||
33160241|NCT00915278|100498077|FG004|Overall Study|Death|0|||
33160242|NCT00915278|100498078|FG005|Overall Study|Death|0|||
33160243|NCT00915278|100498073|FG000|Overall Study|Lost to Follow-up|0|||
33160244|NCT00915278|100498074|FG001|Overall Study|Lost to Follow-up|1|||
33255009|NCT01184508|100833179|FG000|Overall Study|Physician Decision|1|||
33255010|NCT01184508|100833180|FG001|Overall Study|Physician Decision|0|||
33255011|NCT01184508|100833179|FG000|Overall Study|Protocol Violation|3|||
33255012|NCT01184508|100833180|FG001|Overall Study|Protocol Violation|1|||
33255013|NCT01184508|100833179|FG000|Overall Study|Sponsor Decision|5|||
33255014|NCT01184508|100833180|FG001|Overall Study|Sponsor Decision|2|||
33255015|NCT01184508|100833179|FG000|Overall Study|Withdrawal by Subject|1|||
33255016|NCT01184508|100833180|FG001|Overall Study|Withdrawal by Subject|3|||
33255017|NCT01184508|100833179|FG000|Overall Study|Randomized, Not Treated|0|||
33255018|NCT01184508|100833180|FG001|Overall Study|Randomized, Not Treated|1|||
33255019|NCT00980330|100833181|FG000|Overall Study|Adverse Event|0|||
33255020|NCT00980330|100833182|FG001|Overall Study|Adverse Event|0|||
33255021|NCT00980330|100833183|FG002|Overall Study|Adverse Event|0|||
33255022|NCT00980330|100833184|FG003|Overall Study|Adverse Event|1|||
33255023|NCT00980330|100833185|FG004|Overall Study|Adverse Event|0|||
33255024|NCT00980330|100833186|FG005|Overall Study|Adverse Event|0|||
33255025|NCT00980330|100833187|FG006|Overall Study|Adverse Event|0|||
33255026|NCT00980330|100833181|FG000|Overall Study|Lost to Follow-up|1|||
33255027|NCT00980330|100833182|FG001|Overall Study|Lost to Follow-up|1|||
33255028|NCT00980330|100833183|FG002|Overall Study|Lost to Follow-up|4|||
33255029|NCT00980330|100833184|FG003|Overall Study|Lost to Follow-up|2|||
33160245|NCT00915278|100498075|FG002|Overall Study|Lost to Follow-up|0|||
33160246|NCT00915278|100498076|FG003|Overall Study|Lost to Follow-up|0|||
33160247|NCT00915278|100498077|FG004|Overall Study|Lost to Follow-up|0|||
33160248|NCT00915278|100498078|FG005|Overall Study|Lost to Follow-up|0|||
33160249|NCT00915278|100498073|FG000|Overall Study|Withdrawal by Subject|0|||
33160250|NCT00915278|100498074|FG001|Overall Study|Withdrawal by Subject|1|||
33255030|NCT00980330|100833185|FG004|Overall Study|Lost to Follow-up|1|||
33255031|NCT00980330|100833186|FG005|Overall Study|Lost to Follow-up|1|||
33255032|NCT00980330|100833187|FG006|Overall Study|Lost to Follow-up|2|||
33255033|NCT00980330|100833181|FG000|Overall Study|Withdrawal by Subject|2|||
33160251|NCT00915278|100498075|FG002|Overall Study|Withdrawal by Subject|0|||
33160252|NCT00915278|100498076|FG003|Overall Study|Withdrawal by Subject|0|||
33160253|NCT00915278|100498077|FG004|Overall Study|Withdrawal by Subject|1|||
33160254|NCT00915278|100498078|FG005|Overall Study|Withdrawal by Subject|4|||
33160255|NCT00915278|100498073|FG000|Overall Study|Adverse Event|4|||
33160256|NCT00915278|100498074|FG001|Overall Study|Adverse Event|1|||
33160257|NCT00915278|100498075|FG002|Overall Study|Adverse Event|0|||
33160258|NCT00915278|100498076|FG003|Overall Study|Adverse Event|0|||
33160259|NCT00915278|100498077|FG004|Overall Study|Adverse Event|0|||
33160260|NCT00915278|100498078|FG005|Overall Study|Adverse Event|0|||
33160261|NCT00915278|100498073|FG000|Overall Study|Progressive disease/clinical progression|0|||
33160262|NCT00915278|100498074|FG001|Overall Study|Progressive disease/clinical progression|0|||
33160263|NCT00915278|100498075|FG002|Overall Study|Progressive disease/clinical progression|0|||
33160264|NCT00915278|100498076|FG003|Overall Study|Progressive disease/clinical progression|3|||
33160265|NCT00915278|100498077|FG004|Overall Study|Progressive disease/clinical progression|1|||
33160266|NCT00915278|100498078|FG005|Overall Study|Progressive disease/clinical progression|2|||
33160267|NCT00915278|100498073|FG000|Overall Study|Infusion related AEs|0|||
33160268|NCT00915278|100498074|FG001|Overall Study|Infusion related AEs|0|||
33160269|NCT00915278|100498075|FG002|Overall Study|Infusion related AEs|0|||
33160270|NCT00915278|100498076|FG003|Overall Study|Infusion related AEs|0|||
33160271|NCT00915278|100498077|FG004|Overall Study|Infusion related AEs|0|||
33160272|NCT00915278|100498078|FG005|Overall Study|Infusion related AEs|2|||
33160273|NCT00915278|100498073|FG000|Overall Study|Admission to hospice|0|||
33160274|NCT00915278|100498074|FG001|Overall Study|Admission to hospice|0|||
33160275|NCT00915278|100498075|FG002|Overall Study|Admission to hospice|1|||
33255034|NCT00980330|100833182|FG001|Overall Study|Withdrawal by Subject|4|||
33255035|NCT00980330|100833183|FG002|Overall Study|Withdrawal by Subject|4|||
33255036|NCT00980330|100833184|FG003|Overall Study|Withdrawal by Subject|1|||
33255037|NCT00980330|100833185|FG004|Overall Study|Withdrawal by Subject|3|||
33255038|NCT00980330|100833186|FG005|Overall Study|Withdrawal by Subject|2|||
33255039|NCT00980330|100833187|FG006|Overall Study|Withdrawal by Subject|5|||
33255040|NCT00980330|100833181|FG000|Overall Study|(not specified)|2|||
33255041|NCT00980330|100833182|FG001|Overall Study|(not specified)|0|||
33255042|NCT00980330|100833183|FG002|Overall Study|(not specified)|0|||
33255043|NCT00980330|100833184|FG003|Overall Study|(not specified)|1|||
33255044|NCT00980330|100833185|FG004|Overall Study|(not specified)|1|||
33255045|NCT00980330|100833186|FG005|Overall Study|(not specified)|1|||
33255046|NCT00980330|100833187|FG006|Overall Study|(not specified)|0|||
33255047|NCT04504916|100833188|FG000|Overall Study|Study terminated|7|||
33255048|NCT04504916|100833189|FG001|Overall Study|Study terminated|8|||
33255049|NCT04504916|100833188|FG000|Overall Study|Death|54|||
33255050|NCT04504916|100833189|FG001|Overall Study|Death|18|||
33255051|NCT04504916|100833188|FG000|Overall Study|Lost to Follow-up|1|||
33255052|NCT04504916|100833189|FG001|Overall Study|Lost to Follow-up|1|||
33255053|NCT04504916|100833188|FG000|Overall Study|Withdrawal by Subject|8|||
33255054|NCT04504916|100833189|FG001|Overall Study|Withdrawal by Subject|4|||
33255055|NCT04504916|100833188|FG000|Overall Study|Did not agree to follow-up|0|||
33255056|NCT04504916|100833189|FG001|Overall Study|Did not agree to follow-up|1|||
33255057|NCT01161498|100833190|FG000|Overall Study|Disease Progression|0|||
33255058|NCT01161498|100833191|FG001|Overall Study|Disease Progression|1|||
33255059|NCT00703911|100833194|FG000|Overall Study|Death|1|||
33255060|NCT00703911|100833194|FG000|Overall Study|Physician Decision|6|||
33255061|NCT00703911|100833194|FG000|Overall Study|Lost to Follow-up|1|||
33255062|NCT00703911|100833194|FG000|Overall Study|Withdrawal by Subject|2|||
33255063|NCT04199728|100833195|FG000|Overall Study|Adverse Event|1|||
33255064|NCT04199728|100833196|FG001|Overall Study|Adverse Event|0|||
33255065|NCT04199728|100833195|FG000|Overall Study|Withdrawal by Subject|8|||
33255066|NCT04199728|100833196|FG001|Overall Study|Withdrawal by Subject|3|||
33255067|NCT04199728|100833195|FG000|Overall Study|Screen fail after consent|0|||
33255068|NCT04199728|100833196|FG001|Overall Study|Screen fail after consent|1|||
33160276|NCT00915278|100498076|FG003|Overall Study|Admission to hospice|0|||
33160277|NCT00915278|100498077|FG004|Overall Study|Admission to hospice|0|||
33160278|NCT00915278|100498078|FG005|Overall Study|Admission to hospice|0|||
33160279|NCT04094883|100498079|FG000|Overall Study|Withdrawal by Subject|1|||
33160280|NCT01854658|100498083|FG000|Overall Study|Protocol Violation|6|||
33160281|NCT01854658|100498084|FG001|Overall Study|Protocol Violation|2|||
33160282|NCT01854658|100498085|FG002|Overall Study|Protocol Violation|2|||
33160283|NCT01854658|100498086|FG003|Overall Study|Protocol Violation|1|||
33160284|NCT01854658|100498083|FG000|Overall Study|Physician Decision|7|||
33160285|NCT01854658|100498084|FG001|Overall Study|Physician Decision|5|||
33255069|NCT04199728|100833195|FG000|Overall Study|Early withdraw criteria met|0|||
33255070|NCT04199728|100833196|FG001|Overall Study|Early withdraw criteria met|1|||
33255071|NCT04199728|100833195|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
33255072|NCT04199728|100833196|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
33255073|NCT00704184|100837001|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
33255074|NCT00704184|100837002|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
33255075|NCT00704184|100837003|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
33255076|NCT00704184|100837004|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
33160286|NCT01854658|100498085|FG002|Overall Study|Physician Decision|2|||
33160287|NCT01854658|100498086|FG003|Overall Study|Physician Decision|4|||
33255077|NCT00704184|100837005|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
33160288|NCT01854658|100498083|FG000|Overall Study|Lost to Follow-up|8|||
33160289|NCT01854658|100498084|FG001|Overall Study|Lost to Follow-up|9|||
33255078|NCT00704184|100837001|FG000|Open-Label Treatment|Adverse Event|0|||
33255079|NCT00704184|100837002|FG001|Open-Label Treatment|Adverse Event|0|||
33255080|NCT00704184|100837003|FG002|Open-Label Treatment|Adverse Event|2|||
33255081|NCT00704184|100837004|FG003|Open-Label Treatment|Adverse Event|0|||
33442167|NCT01918397|101512190|FG001|Overall Study|Rifampin susceptible|0|||
33255082|NCT00704184|100837005|FG004|Open-Label Treatment|Adverse Event|1|||
33255083|NCT00704184|100837001|FG000|Open-Label Treatment|Lack of Efficacy|0|||
33255084|NCT00704184|100837002|FG001|Open-Label Treatment|Lack of Efficacy|2|||
33442168|NCT01918397|101512191|FG002|Overall Study|Rifampin susceptible|0|||
33255085|NCT00704184|100837003|FG002|Open-Label Treatment|Lack of Efficacy|2|||
33255086|NCT00704184|100837004|FG003|Open-Label Treatment|Lack of Efficacy|2|||
33255087|NCT00704184|100837005|FG004|Open-Label Treatment|Lack of Efficacy|1|||
33255088|NCT00704184|100837001|FG000|Open-Label Treatment|Physician Decision|0|||
33255089|NCT00704184|100837002|FG001|Open-Label Treatment|Physician Decision|0|||
33255090|NCT00704184|100837003|FG002|Open-Label Treatment|Physician Decision|0|||
33255091|NCT00704184|100837004|FG003|Open-Label Treatment|Physician Decision|0|||
33255092|NCT00704184|100837005|FG004|Open-Label Treatment|Physician Decision|1|||
33255093|NCT00704184|100837001|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
33255094|NCT00704184|100837002|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
33255095|NCT00704184|100837003|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
33255096|NCT00704184|100837004|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
33255097|NCT00704184|100837005|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
33255098|NCT03712930|100837006|FG000|Overall Study|Death|7|||
33255099|NCT03712930|100837006|FG000|Overall Study|Physician Decision|1|||
33255100|NCT03712930|100837006|FG000|Overall Study|Study Terminated by Sponsor|3|||
33255101|NCT03712930|100837006|FG000|Overall Study|Progressive Disease|2|||
33255102|NCT00457743|100837007|FG000|Overall Study|Adverse Event|0|||
33255103|NCT00457743|100837008|FG001|Overall Study|Adverse Event|4|||
33255104|NCT00457743|100837009|FG002|Overall Study|Adverse Event|0|||
33255105|NCT00457743|100837007|FG000|Overall Study|Lack of Efficacy|3|||
33255106|NCT00457743|100837008|FG001|Overall Study|Lack of Efficacy|23|||
33255107|NCT00457743|100837009|FG002|Overall Study|Lack of Efficacy|3|||
33255108|NCT01350804|100837010|FG000|Core Study|Withdrawal by Subject|11|||
33255109|NCT01350804|100837011|FG001|Core Study|Withdrawal by Subject|17|||
33255110|NCT01350804|100837012|FG002|Core Study|Withdrawal by Subject|16|||
33255111|NCT01350804|100837013|FG003|Core Study|Withdrawal by Subject|7|||
33255112|NCT01350804|100837010|FG000|Core Study|Study terminated by Sponsor|0|||
33255113|NCT01350804|100837011|FG001|Core Study|Study terminated by Sponsor|0|||
33255114|NCT01350804|100837012|FG002|Core Study|Study terminated by Sponsor|0|||
33255115|NCT01350804|100837013|FG003|Core Study|Study terminated by Sponsor|2|||
33442169|NCT01918397|101512192|FG003|Overall Study|Rifampin susceptible|2|||
33160290|NCT01854658|100498085|FG002|Overall Study|Lost to Follow-up|8|||
33160291|NCT01854658|100498086|FG003|Overall Study|Lost to Follow-up|4|||
33160292|NCT01854658|100498083|FG000|Overall Study|Withdrawal by Subject|28|||
33160293|NCT01854658|100498084|FG001|Overall Study|Withdrawal by Subject|21|||
33160294|NCT01854658|100498085|FG002|Overall Study|Withdrawal by Subject|29|||
33160295|NCT01854658|100498086|FG003|Overall Study|Withdrawal by Subject|15|||
33160296|NCT01854658|100498083|FG000|Overall Study|Protocol-specified criteria|15|||
33160297|NCT01854658|100498084|FG001|Overall Study|Protocol-specified criteria|15|||
33160298|NCT01854658|100498085|FG002|Overall Study|Protocol-specified criteria|10|||
33160299|NCT01854658|100498086|FG003|Overall Study|Protocol-specified criteria|7|||
33160300|NCT01854658|100498083|FG000|Overall Study|Lack of Efficacy|3|||
33160301|NCT01854658|100498084|FG001|Overall Study|Lack of Efficacy|8|||
33160302|NCT01854658|100498085|FG002|Overall Study|Lack of Efficacy|4|||
33160303|NCT01854658|100498086|FG003|Overall Study|Lack of Efficacy|7|||
33160304|NCT01854658|100498083|FG000|Overall Study|Adverse Event|21|||
33160305|NCT01854658|100498084|FG001|Overall Study|Adverse Event|14|||
33160306|NCT01854658|100498085|FG002|Overall Study|Adverse Event|23|||
33160307|NCT01854658|100498086|FG003|Overall Study|Adverse Event|19|||
33160308|NCT01854658|100498083|FG000|Overall Study|Administrative reasons|5|||
33160309|NCT01854658|100498084|FG001|Overall Study|Administrative reasons|1|||
33160310|NCT01854658|100498085|FG002|Overall Study|Administrative reasons|2|||
33160311|NCT01854658|100498086|FG003|Overall Study|Administrative reasons|2|||
33160312|NCT03817879|100498090|FG000|Overall Study|Drop out|5|||
33160313|NCT03817879|100498091|FG001|Overall Study|Drop out|12|||
33160314|NCT03817879|100498090|FG000|Overall Study|Withdrawal by Subject|0|||
33160315|NCT03817879|100498091|FG001|Overall Study|Withdrawal by Subject|1|||
33160316|NCT01197560|100498092|FG000|Overall Study|Adverse Event|6|||
33255116|NCT01350804|100837010|FG000|Core Study|Protocol deviation|1|||
33255117|NCT01350804|100837011|FG001|Core Study|Protocol deviation|0|||
33255118|NCT01350804|100837012|FG002|Core Study|Protocol deviation|1|||
33160317|NCT01197560|100498093|FG001|Overall Study|Adverse Event|8|||
33160318|NCT01197560|100498092|FG000|Overall Study|Death|3|||
33160319|NCT01197560|100498093|FG001|Overall Study|Death|5|||
33442170|NCT01918397|101512189|FG000|Overall Study|Treatment failure|0|||
33442171|NCT01918397|101512190|FG001|Overall Study|Treatment failure|0|||
33442172|NCT01918397|101512191|FG002|Overall Study|Treatment failure|0|||
33442173|NCT01918397|101512192|FG003|Overall Study|Treatment failure|1|||
33442174|NCT01918397|101512189|FG000|Overall Study|Withdrawal by Subject|3|||
33442175|NCT01918397|101512190|FG001|Overall Study|Withdrawal by Subject|2|||
33442176|NCT01918397|101512191|FG002|Overall Study|Withdrawal by Subject|1|||
33442177|NCT01918397|101512192|FG003|Overall Study|Withdrawal by Subject|1|||
33442178|NCT01918397|101512189|FG000|Overall Study|XDR at baseline|0|||
33442179|NCT01918397|101512190|FG001|Overall Study|XDR at baseline|0|||
33442180|NCT01918397|101512191|FG002|Overall Study|XDR at baseline|1|||
33442181|NCT01918397|101512192|FG003|Overall Study|XDR at baseline|0|||
33442182|NCT01918397|101512189|FG000|Overall Study|Lost to Follow-up|2|||
33442183|NCT01918397|101512190|FG001|Overall Study|Lost to Follow-up|1|||
33442184|NCT01918397|101512191|FG002|Overall Study|Lost to Follow-up|1|||
33442185|NCT01918397|101512192|FG003|Overall Study|Lost to Follow-up|1|||
33442186|NCT01918397|101512189|FG000|Overall Study|Increased QTc|1|||
33442187|NCT01918397|101512190|FG001|Overall Study|Increased QTc|0|||
33442188|NCT01918397|101512191|FG002|Overall Study|Increased QTc|0|||
33442189|NCT01918397|101512192|FG003|Overall Study|Increased QTc|1|||
33442190|NCT01918397|101512189|FG000|Overall Study|Death|0|||
33442191|NCT01918397|101512190|FG001|Overall Study|Death|0|||
33442192|NCT01918397|101512191|FG002|Overall Study|Death|1|||
33442193|NCT01918397|101512192|FG003|Overall Study|Death|0|||
33442194|NCT01918397|101512189|FG000|Overall Study|Involved in another investigative trial|0|||
33442195|NCT01918397|101512190|FG001|Overall Study|Involved in another investigative trial|0|||
33442196|NCT01918397|101512191|FG002|Overall Study|Involved in another investigative trial|0|||
33442197|NCT01918397|101512192|FG003|Overall Study|Involved in another investigative trial|1|||
33442198|NCT03161405|101512193|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
33255119|NCT01350804|100837013|FG003|Core Study|Protocol deviation|0|||
33442199|NCT01273805|101512194|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
33442200|NCT01273805|101512195|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
33442201|NCT02414152|101512196|FG000|Overall Study|Withdrawal by Subject|1|||
33442202|NCT02414152|101512196|FG000|Overall Study|Lack of Efficacy|1|||
33442203|NCT01448057|101512197|FG000|Overall Study|Protocol Violation|3|||
33442204|NCT01448057|101512198|FG001|Overall Study|Protocol Violation|2|||
33442205|NCT01448057|101512197|FG000|Overall Study|Lost to Follow-up|3|||
33442206|NCT01448057|101512198|FG001|Overall Study|Lost to Follow-up|0|||
33442207|NCT01448057|101512197|FG000|Overall Study|Adverse Event|0|||
33442208|NCT01448057|101512198|FG001|Overall Study|Adverse Event|2|||
33442209|NCT01448057|101512197|FG000|Overall Study|Withdrawal by Subject|2|||
33442210|NCT01448057|101512198|FG001|Overall Study|Withdrawal by Subject|0|||
33442211|NCT01061866|101512199|FG000|Overall Study|Adverse Event|2|||
33442212|NCT02937701|101512200|FG000|Day 1 to Week 22|Adverse Event|11|||
33442213|NCT02937701|101512201|FG001|Day 1 to Week 22|Adverse Event|14|||
33442214|NCT02937701|101512202|FG002|Day 1 to Week 22|Adverse Event|0|||
33442215|NCT02937701|101512203|FG003|Day 1 to Week 22|Adverse Event|0|||
33442216|NCT02937701|101512204|FG004|Day 1 to Week 22|Adverse Event|0|||
33442217|NCT02937701|101512200|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
33442218|NCT02937701|101512201|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
33442219|NCT02937701|101512202|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
33442220|NCT02937701|101512203|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
33442221|NCT02937701|101512204|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
33160320|NCT01197560|100498092|FG000|Overall Study|Withdrawal by Subject|1|||
33160321|NCT01197560|100498093|FG001|Overall Study|Withdrawal by Subject|1|||
33160322|NCT01197560|100498092|FG000|Overall Study|Disease progression|40|||
33160323|NCT01197560|100498093|FG001|Overall Study|Disease progression|35|||
33160324|NCT01197560|100498092|FG000|Overall Study|Miscellaneous|4|||
33160325|NCT01197560|100498093|FG001|Overall Study|Miscellaneous|3|||
33160326|NCT01197560|100498092|FG000|Overall Study|Missing|0|||
33442222|NCT02937701|101512200|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
33160327|NCT01197560|100498093|FG001|Overall Study|Missing|1|||
33442223|NCT02937701|101512201|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
33160328|NCT01189604|100498094|FG000|Overall Study|Impossible to visit|0|||
33160329|NCT01189604|100498095|FG001|Overall Study|Impossible to visit|0|||
33160330|NCT01189604|100498096|FG002|Overall Study|Impossible to visit|0|||
33160331|NCT01189604|100498097|FG003|Overall Study|Impossible to visit|0|||
33160332|NCT01189604|100498098|FG004|Overall Study|Impossible to visit|0|||
33160333|NCT01189604|100498099|FG005|Overall Study|Impossible to visit|1|||
33160334|NCT01189604|100498100|FG006|Overall Study|Impossible to visit|0|||
33160335|NCT01189604|100498094|FG000|Overall Study|Adverse Event|0|||
33160336|NCT01189604|100498095|FG001|Overall Study|Adverse Event|1|||
33160337|NCT01189604|100498096|FG002|Overall Study|Adverse Event|0|||
33160338|NCT01189604|100498097|FG003|Overall Study|Adverse Event|0|||
33160339|NCT01189604|100498098|FG004|Overall Study|Adverse Event|2|||
33160340|NCT01189604|100498099|FG005|Overall Study|Adverse Event|0|||
33160341|NCT01189604|100498100|FG006|Overall Study|Adverse Event|1|||
33160342|NCT01189604|100498094|FG000|Overall Study|Withdrawal by Subject|1|||
33160343|NCT01189604|100498095|FG001|Overall Study|Withdrawal by Subject|0|||
33160344|NCT01189604|100498096|FG002|Overall Study|Withdrawal by Subject|0|||
33160345|NCT01189604|100498097|FG003|Overall Study|Withdrawal by Subject|0|||
33442224|NCT02937701|101512202|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
33442225|NCT02937701|101512203|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
33442226|NCT02937701|101512204|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
33442227|NCT02937701|101512200|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
33442228|NCT02937701|101512201|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
33442229|NCT02937701|101512202|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
33442230|NCT02937701|101512203|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
33442231|NCT02937701|101512204|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
33442232|NCT02937701|101512200|FG000|Day 1 to Week 22|Death|1|||
33442233|NCT02937701|101512201|FG001|Day 1 to Week 22|Death|1|||
33442234|NCT02937701|101512202|FG002|Day 1 to Week 22|Death|0|||
33442235|NCT02937701|101512203|FG003|Day 1 to Week 22|Death|0|||
33442236|NCT02937701|101512204|FG004|Day 1 to Week 22|Death|0|||
33442237|NCT02937701|101512200|FG000|Day 1 to Week 22|Protocol Violation|1|||
33442238|NCT02937701|101512201|FG001|Day 1 to Week 22|Protocol Violation|1|||
33442239|NCT02937701|101512202|FG002|Day 1 to Week 22|Protocol Violation|0|||
33442240|NCT02937701|101512203|FG003|Day 1 to Week 22|Protocol Violation|0|||
33442241|NCT02937701|101512204|FG004|Day 1 to Week 22|Protocol Violation|0|||
33442242|NCT02937701|101512200|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
33160346|NCT01189604|100498098|FG004|Overall Study|Withdrawal by Subject|0|||
33160347|NCT01189604|100498099|FG005|Overall Study|Withdrawal by Subject|0|||
33160348|NCT01189604|100498100|FG006|Overall Study|Withdrawal by Subject|0|||
33160349|NCT01365052|100498101|FG000|Overall Study|Adverse Event|4|||
33160350|NCT01365052|100498102|FG001|Overall Study|Adverse Event|4|||
33160351|NCT03988088|100498103|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
33160352|NCT03988088|100498104|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
33160353|NCT03988088|100498105|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
33160354|NCT03988088|100498106|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
33160355|NCT03988088|100498103|FG000|Open-Label Addendum|Lost to Follow-up|0|||
33160356|NCT03988088|100498104|FG001|Open-Label Addendum|Lost to Follow-up|0|||
33160357|NCT03988088|100498105|FG002|Open-Label Addendum|Lost to Follow-up|1|||
33160358|NCT03988088|100498106|FG003|Open-Label Addendum|Lost to Follow-up|0|||
33160359|NCT02243696|100498107|FG000|Overall Study|Death|282|||
33160360|NCT02243696|100498107|FG000|Overall Study|Withdrawal by Subject|79|||
33160361|NCT02243696|100498107|FG000|Overall Study|Lost to Follow-up|57|||
33160362|NCT02243696|100498107|FG000|Overall Study|Subject No Longer has Study System|42|||
33160363|NCT02243696|100498107|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
33160364|NCT02243696|100498107|FG000|Overall Study|Study Terminated for EP PASSION|961|||
33160365|NCT00289133|100498114|FG000|Overall Study|Non-study device implanted|12|||
33160366|NCT00289133|100498115|FG001|Overall Study|Non-study device implanted|0|||
33160367|NCT00289133|100498114|FG000|Overall Study|Protocol Violation|32|||
33160368|NCT00289133|100498115|FG001|Overall Study|Protocol Violation|38|||
33160369|NCT00289133|100498114|FG000|Overall Study|Withdrawal by Subject|9|||
33160370|NCT00289133|100498115|FG001|Overall Study|Withdrawal by Subject|10|||
33160371|NCT00289133|100498114|FG000|Overall Study|Death|5|||
33255120|NCT01350804|100837010|FG000|Core Study|Physician Decision|1|||
33255121|NCT01350804|100837011|FG001|Core Study|Physician Decision|0|||
33255122|NCT01350804|100837012|FG002|Core Study|Physician Decision|1|||
33442243|NCT02937701|101512201|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
33160372|NCT00289133|100498115|FG001|Overall Study|Death|10|||
33160373|NCT00289133|100498114|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
33255123|NCT01350804|100837013|FG003|Core Study|Physician Decision|3|||
33160374|NCT00289133|100498115|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
33160375|NCT00289133|100498114|FG000|Overall Study|Physician Decision|41|||
33160376|NCT00289133|100498115|FG001|Overall Study|Physician Decision|45|||
33160377|NCT00289133|100498114|FG000|Overall Study|Revision|8|||
33255124|NCT01350804|100837010|FG000|Core Study|Lost to Follow-up|3|||
33442244|NCT02937701|101512202|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
33442245|NCT02937701|101512203|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
33442246|NCT02937701|101512204|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
33160378|NCT00289133|100498115|FG001|Overall Study|Revision|6|||
33160379|NCT00289133|100498114|FG000|Overall Study|Lost to Follow-up|92|||
33160380|NCT00289133|100498115|FG001|Overall Study|Lost to Follow-up|115|||
33160381|NCT01146665|100498116|FG000|Overall Study|Withdrawal by Subject|10|||
33160382|NCT01146665|100498117|FG001|Overall Study|Withdrawal by Subject|16|||
33160383|NCT04930965|100498132|FG000|Overall Study|Lost to Follow-up|7|||
33160384|NCT04930965|100498133|FG001|Overall Study|Lost to Follow-up|5|||
33160385|NCT05350410|100498136|FG000|Overall Study|Withdrawal by Subject|1|||
33160386|NCT03068455|100498139|FG000|Pre-treatment Period|Disease progression|0|||
33160387|NCT03068455|100498140|FG001|Pre-treatment Period|Disease progression|1|||
33160388|NCT03068455|100498139|FG000|Pre-treatment Period|Participant withdrew consent|1|||
33160389|NCT03068455|100498140|FG001|Pre-treatment Period|Participant withdrew consent|1|||
33160390|NCT03068455|100498139|FG000|Pre-treatment Period|Poor/non-compliance|0|||
33160391|NCT03068455|100498140|FG001|Pre-treatment Period|Poor/non-compliance|1|||
33160392|NCT03068455|100498139|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
33160393|NCT03068455|100498140|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
33160394|NCT03068455|100498139|FG000|Pre-treatment Period|Not reported|2|||
33160395|NCT03068455|100498140|FG001|Pre-treatment Period|Not reported|1|||
33160396|NCT03068455|100498139|FG000|Treatment Period|Disease progression|166|||
33160397|NCT03068455|100498140|FG001|Treatment Period|Disease progression|208|||
33160398|NCT03068455|100498139|FG000|Treatment Period|Study drug toxicity|317|||
33160399|NCT03068455|100498140|FG001|Treatment Period|Study drug toxicity|104|||
33160400|NCT03068455|100498139|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
33160401|NCT03068455|100498140|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
33160402|NCT03068455|100498139|FG000|Treatment Period|Participant request to stop therapy|33|||
33255125|NCT01350804|100837011|FG001|Core Study|Lost to Follow-up|0|||
33255126|NCT01350804|100837012|FG002|Core Study|Lost to Follow-up|2|||
33255127|NCT01350804|100837013|FG003|Core Study|Lost to Follow-up|1|||
33255128|NCT01350804|100837010|FG000|Core Study|Lack of Efficacy|16|||
33442247|NCT02937701|101512200|FG000|Day 1 to Week 22|Physician Decision|2|||
33255129|NCT01350804|100837011|FG001|Core Study|Lack of Efficacy|19|||
33160403|NCT03068455|100498140|FG001|Treatment Period|Participant request to stop therapy|20|||
33160404|NCT03068455|100498139|FG000|Treatment Period|Participant withdrew consent|5|||
33160405|NCT03068455|100498140|FG001|Treatment Period|Participant withdrew consent|10|||
33160406|NCT03068455|100498139|FG000|Treatment Period|Poor/non-compliance|3|||
33442248|NCT02937701|101512201|FG001|Day 1 to Week 22|Physician Decision|0|||
33160407|NCT03068455|100498140|FG001|Treatment Period|Poor/non-compliance|0|||
33160408|NCT03068455|100498139|FG000|Treatment Period|Participant no longer meets study criteria|1|||
33160409|NCT03068455|100498140|FG001|Treatment Period|Participant no longer meets study criteria|3|||
33160410|NCT03068455|100498139|FG000|Treatment Period|Other reasons|12|||
33160411|NCT03068455|100498140|FG001|Treatment Period|Other reasons|4|||
33160412|NCT04203797|100498141|FG000|Overall Study|Adverse Event|1|||
33160413|NCT04203797|100498142|FG001|Overall Study|Adverse Event|0|||
33160414|NCT04203797|100498141|FG000|Overall Study|Did not complete End of Study follow-up|1|||
33160415|NCT04203797|100498142|FG001|Overall Study|Did not complete End of Study follow-up|0|||
33160416|NCT02015754|100498143|FG000|Overall Study|Disease progression|5|||
33160417|NCT02015754|100498143|FG000|Overall Study|Change in treatment modality|5|||
33160418|NCT02015754|100498143|FG000|Overall Study|Lost to Follow-up|1|||
33160419|NCT02747875|100498147|FG000|Overall Study|Physician Decision|1|||
33160420|NCT02747875|100498148|FG001|Overall Study|Physician Decision|0|||
33160421|NCT02747875|100498147|FG000|Overall Study|Adverse Event|0|||
33160422|NCT02747875|100498148|FG001|Overall Study|Adverse Event|1|||
33160423|NCT04502433|100498149|FG000|Overall Study|Death|2|||
33160424|NCT04502433|100498150|FG001|Overall Study|Death|4|||
33160425|NCT04502433|100498149|FG000|Overall Study|Lost to Follow-up|1|||
33160426|NCT04502433|100498150|FG001|Overall Study|Lost to Follow-up|0|||
33160427|NCT04502433|100498149|FG000|Overall Study|Physician Decision|0|||
33160428|NCT04502433|100498150|FG001|Overall Study|Physician Decision|1|||
33160429|NCT00983437|100498151|FG000|Overall Study|Adverse Event|9|||
33160430|NCT00983437|100498151|FG000|Overall Study|Lack of Efficacy|1|||
33160431|NCT00983437|100498151|FG000|Overall Study|Withdrawal by Subject|8|||
33160432|NCT00983437|100498151|FG000|Overall Study|Noncompliance to Study Procedures|1|||
33160433|NCT00983437|100498151|FG000|Overall Study|Lost to Follow-up|2|||
33160434|NCT00983437|100498151|FG000|Overall Study|Other Reason|26|||
33160435|NCT01896050|100498152|FG000|Overall Study|Adverse Event|37|||
33160436|NCT01896050|100498153|FG001|Overall Study|Adverse Event|2|||
33160437|NCT01896050|100498152|FG000|Overall Study|Death|1|||
33160438|NCT01896050|100498153|FG001|Overall Study|Death|0|||
33160439|NCT02130297|100498154|FG000|Overall Study|Lost to Follow-up|4|||
33160440|NCT05306977|100498155|FG000|Overall Study|Withdrawal by Subject|1|||
33160441|NCT00392015|100498158|FG000|Overall Study|Lost to Follow-up|2|||
33160442|NCT00392015|100498159|FG001|Overall Study|Lost to Follow-up|0|||
33160443|NCT00392015|100498160|FG002|Overall Study|Lost to Follow-up|2|||
33160444|NCT00392015|100498161|FG003|Overall Study|Lost to Follow-up|1|||
33160445|NCT00392015|100498162|FG004|Overall Study|Lost to Follow-up|1|||
33160446|NCT00392015|100498163|FG005|Overall Study|Lost to Follow-up|0|||
33160447|NCT00392015|100498158|FG000|Overall Study|Withdrawal by Subject|0|||
33442249|NCT02937701|101512202|FG002|Day 1 to Week 22|Physician Decision|0|||
33442250|NCT02937701|101512203|FG003|Day 1 to Week 22|Physician Decision|0|||
33160448|NCT00392015|100498159|FG001|Overall Study|Withdrawal by Subject|0|||
33160449|NCT00392015|100498160|FG002|Overall Study|Withdrawal by Subject|2|||
33160450|NCT00392015|100498161|FG003|Overall Study|Withdrawal by Subject|0|||
33160451|NCT00392015|100498162|FG004|Overall Study|Withdrawal by Subject|0|||
33160452|NCT00392015|100498163|FG005|Overall Study|Withdrawal by Subject|0|||
33160453|NCT00392015|100498158|FG000|Overall Study|Adverse Event|0|||
33160454|NCT00392015|100498159|FG001|Overall Study|Adverse Event|0|||
33160455|NCT00392015|100498160|FG002|Overall Study|Adverse Event|0|||
33160456|NCT00392015|100498161|FG003|Overall Study|Adverse Event|0|||
33160457|NCT00392015|100498162|FG004|Overall Study|Adverse Event|1|||
33160458|NCT00392015|100498163|FG005|Overall Study|Adverse Event|0|||
33442251|NCT02937701|101512204|FG004|Day 1 to Week 22|Physician Decision|0|||
33160459|NCT00392015|100498158|FG000|Overall Study|Previous trial recipient|0|||
33160460|NCT00392015|100498159|FG001|Overall Study|Previous trial recipient|0|||
33160461|NCT00392015|100498160|FG002|Overall Study|Previous trial recipient|0|||
33160462|NCT00392015|100498161|FG003|Overall Study|Previous trial recipient|0|||
33160463|NCT00392015|100498162|FG004|Overall Study|Previous trial recipient|1|||
33160464|NCT00392015|100498163|FG005|Overall Study|Previous trial recipient|0|||
33160465|NCT01768286|100498167|FG000|Overall Study|Randomized But Not Treated|0|||
33160466|NCT01768286|100498168|FG001|Overall Study|Randomized But Not Treated|0|||
33160467|NCT01768286|100498169|FG002|Overall Study|Randomized But Not Treated|1|||
33160468|NCT01768286|100498170|FG003|Overall Study|Randomized But Not Treated|0|||
33160469|NCT01768286|100498167|FG000|Overall Study|Lack of Efficacy|7|||
33160470|NCT01768286|100498168|FG001|Overall Study|Lack of Efficacy|4|||
33160471|NCT01768286|100498169|FG002|Overall Study|Lack of Efficacy|0|||
33160472|NCT01768286|100498170|FG003|Overall Study|Lack of Efficacy|1|||
33160473|NCT01768286|100498167|FG000|Overall Study|Withdrew Consent|0|||
33160474|NCT01768286|100498168|FG001|Overall Study|Withdrew Consent|0|||
33160475|NCT01768286|100498169|FG002|Overall Study|Withdrew Consent|1|||
33160476|NCT01768286|100498170|FG003|Overall Study|Withdrew Consent|0|||
33160477|NCT01253408|100498178|FG000|Overall Study|Adverse Event|0|||
33160478|NCT01253408|100498179|FG001|Overall Study|Adverse Event|1|||
33160479|NCT01253408|100498180|FG002|Overall Study|Adverse Event|0|||
33160480|NCT03840174|100498181|FG000|Overall Study|Withdrawal by Subject|1|||
33160481|NCT03840174|100498182|FG001|Overall Study|Withdrawal by Subject|0|||
33160482|NCT03840174|100498183|FG002|Overall Study|Withdrawal by Subject|0|||
33160483|NCT03840174|100498184|FG003|Overall Study|Withdrawal by Subject|0|||
33160484|NCT01397890|100498185|FG000|Overall Study|Withdrawal by Subject|7|||
33160485|NCT01397890|100498186|FG001|Overall Study|Withdrawal by Subject|11|||
33160486|NCT01397890|100498185|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
33160487|NCT01397890|100498186|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
33160488|NCT01397890|100498185|FG000|Overall Study|Death|2|||
33160489|NCT01397890|100498186|FG001|Overall Study|Death|3|||
33160490|NCT01397890|100498185|FG000|Overall Study|Lost to Follow-up|1|||
33160491|NCT01397890|100498186|FG001|Overall Study|Lost to Follow-up|4|||
33160492|NCT01397890|100498185|FG000|Overall Study|Condition under Investigation Worsened|1|||
33160493|NCT01397890|100498186|FG001|Overall Study|Condition under Investigation Worsened|3|||
33160494|NCT01397890|100498185|FG000|Overall Study|Adverse Event|1|||
33160495|NCT01397890|100498186|FG001|Overall Study|Adverse Event|2|||
33160496|NCT01397890|100498185|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
33160497|NCT01397890|100498186|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
33160498|NCT01397890|100498185|FG000|Overall Study|Others|2|||
33160499|NCT01397890|100498186|FG001|Overall Study|Others|1|||
33160500|NCT03228433|100498187|FG000|Overall Study|Lost to Follow-up|1|||
33160501|NCT03228433|100498188|FG001|Overall Study|Lost to Follow-up|0|||
33160502|NCT03228433|100498189|FG002|Overall Study|Lost to Follow-up|0|||
33160503|NCT03228433|100498190|FG003|Overall Study|Lost to Follow-up|0|||
33160504|NCT03228433|100498191|FG004|Overall Study|Lost to Follow-up|0|||
33160505|NCT03228433|100498192|FG005|Overall Study|Lost to Follow-up|0|||
33160506|NCT03228433|100498187|FG000|Overall Study|Positive alcohol test|0|||
33160507|NCT03228433|100498188|FG001|Overall Study|Positive alcohol test|0|||
33160508|NCT03228433|100498189|FG002|Overall Study|Positive alcohol test|0|||
33160509|NCT03228433|100498190|FG003|Overall Study|Positive alcohol test|1|||
33160510|NCT03228433|100498191|FG004|Overall Study|Positive alcohol test|0|||
33160511|NCT03228433|100498192|FG005|Overall Study|Positive alcohol test|0|||
33160512|NCT00259610|100498194|FG000|Overall Study|Withdrawal by Subject|33|||
33160513|NCT00259610|100498195|FG001|Overall Study|Withdrawal by Subject|25|||
33160514|NCT00259610|100498196|FG002|Overall Study|Withdrawal by Subject|29|||
33160515|NCT00259610|100498197|FG003|Overall Study|Withdrawal by Subject|19|||
33160516|NCT00259610|100498194|FG000|Overall Study|Lost to Follow-up|19|||
33160517|NCT00259610|100498195|FG001|Overall Study|Lost to Follow-up|8|||
33160518|NCT00259610|100498196|FG002|Overall Study|Lost to Follow-up|18|||
33160519|NCT00259610|100498197|FG003|Overall Study|Lost to Follow-up|15|||
33160520|NCT00259610|100498194|FG000|Overall Study|Physician Decision|6|||
33160521|NCT00259610|100498195|FG001|Overall Study|Physician Decision|4|||
33160522|NCT00259610|100498196|FG002|Overall Study|Physician Decision|7|||
33160523|NCT00259610|100498197|FG003|Overall Study|Physician Decision|2|||
33160524|NCT00259610|100498194|FG000|Overall Study|Death|1|||
33160525|NCT00259610|100498195|FG001|Overall Study|Death|1|||
33388819|NCT00712933|101309349|FG000|Overall Study|Withdrawal by Subject|151|||
33442252|NCT02937701|101512200|FG000|Day 1 to Week 22|Other|1|||
33160526|NCT00259610|100498196|FG002|Overall Study|Death|2|||
33160527|NCT00259610|100498197|FG003|Overall Study|Death|0|||
33160528|NCT00259610|100498194|FG000|Overall Study|non medical reason|6|||
33160529|NCT00259610|100498195|FG001|Overall Study|non medical reason|2|||
33160530|NCT00259610|100498196|FG002|Overall Study|non medical reason|10|||
33160531|NCT00259610|100498197|FG003|Overall Study|non medical reason|3|||
33160532|NCT00259610|100498194|FG000|Overall Study|Adverse Event|3|||
33160533|NCT00259610|100498195|FG001|Overall Study|Adverse Event|4|||
33160534|NCT00259610|100498196|FG002|Overall Study|Adverse Event|5|||
33442253|NCT02937701|101512201|FG001|Day 1 to Week 22|Other|0|||
33160535|NCT00259610|100498197|FG003|Overall Study|Adverse Event|2|||
33160536|NCT00259610|100498194|FG000|Overall Study|Serious Adverse Event|8|||
33160537|NCT00259610|100498195|FG001|Overall Study|Serious Adverse Event|2|||
33160538|NCT00259610|100498196|FG002|Overall Study|Serious Adverse Event|2|||
33160539|NCT00259610|100498197|FG003|Overall Study|Serious Adverse Event|2|||
33160540|NCT01466153|100498198|FG000|Overall Study|Disease Progression|2|||
33442254|NCT02937701|101512202|FG002|Day 1 to Week 22|Other|0|||
33442255|NCT02937701|101512203|FG003|Day 1 to Week 22|Other|0|||
33442256|NCT02937701|101512204|FG004|Day 1 to Week 22|Other|0|||
33442257|NCT02937701|101512200|FG000|Week 22 to Week 50|Adverse Event|0|||
33442258|NCT02937701|101512201|FG001|Week 22 to Week 50|Adverse Event|0|||
33442259|NCT02937701|101512202|FG002|Week 22 to Week 50|Adverse Event|10|||
33442260|NCT02937701|101512203|FG003|Week 22 to Week 50|Adverse Event|3|||
33442261|NCT02937701|101512204|FG004|Week 22 to Week 50|Adverse Event|3|||
33442262|NCT02937701|101512200|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
33442263|NCT02937701|101512201|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
33442264|NCT02937701|101512202|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
33442265|NCT02937701|101512203|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
33442266|NCT02937701|101512204|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
33442267|NCT02937701|101512200|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
33442268|NCT02937701|101512201|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
33442269|NCT02937701|101512202|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
33442270|NCT02937701|101512203|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
33442271|NCT02937701|101512204|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
33442272|NCT02937701|101512200|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
33442273|NCT02937701|101512201|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
33442274|NCT02937701|101512202|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
33442275|NCT02937701|101512203|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
33442276|NCT02937701|101512204|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
33442277|NCT02937701|101512200|FG000|Week 22 to Week 50|Physician Decision|0|||
33442278|NCT02937701|101512201|FG001|Week 22 to Week 50|Physician Decision|0|||
33160541|NCT01466153|100498199|FG001|Overall Study|Disease Progression|2|||
33160542|NCT01466153|100498200|FG002|Overall Study|Disease Progression|0|||
33160543|NCT01466153|100498198|FG000|Overall Study|Adverse Event|14|||
33160544|NCT01466153|100498199|FG001|Overall Study|Adverse Event|13|||
33160545|NCT01466153|100498200|FG002|Overall Study|Adverse Event|17|||
33442279|NCT02937701|101512202|FG002|Week 22 to Week 50|Physician Decision|2|||
33442280|NCT02937701|101512203|FG003|Week 22 to Week 50|Physician Decision|0|||
33442281|NCT02937701|101512204|FG004|Week 22 to Week 50|Physician Decision|1|||
33442282|NCT02937701|101512200|FG000|Week 22 to Week 50|Other|0|||
33442283|NCT02937701|101512201|FG001|Week 22 to Week 50|Other|0|||
33442284|NCT02937701|101512202|FG002|Week 22 to Week 50|Other|0|||
33442285|NCT02937701|101512203|FG003|Week 22 to Week 50|Other|0|||
33442286|NCT02937701|101512204|FG004|Week 22 to Week 50|Other|1|||
33442287|NCT03601637|101512208|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
33442288|NCT03601637|101512209|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
33442289|NCT03601637|101512208|FG000|Overall Study|Adverse Event|1|||
33442290|NCT03601637|101512209|FG001|Overall Study|Adverse Event|1|||
33442291|NCT03601637|101512208|FG000|Overall Study|Other|0|||
33442292|NCT03601637|101512209|FG001|Overall Study|Other|1|||
33442293|NCT01029340|101512212|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
33442294|NCT01029340|101512213|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
33442295|NCT01029340|101512214|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
33160546|NCT01466153|100498198|FG000|Overall Study|Withdrawal of Consent|2|||
33160547|NCT01466153|100498199|FG001|Overall Study|Withdrawal of Consent|0|||
33160548|NCT01466153|100498200|FG002|Overall Study|Withdrawal of Consent|0|||
33160549|NCT01466153|100498198|FG000|Overall Study|Investigator Discretion|3|||
33160550|NCT01466153|100498199|FG001|Overall Study|Investigator Discretion|2|||
33160551|NCT01466153|100498200|FG002|Overall Study|Investigator Discretion|2|||
33160552|NCT01466153|100498198|FG000|Overall Study|Randomized-Not Treated|2|||
33160553|NCT01466153|100498199|FG001|Overall Study|Randomized-Not Treated|3|||
33160554|NCT01466153|100498200|FG002|Overall Study|Randomized-Not Treated|4|||
33160555|NCT01466153|100498198|FG000|Overall Study|Other-Unspecified|6|||
33160556|NCT01466153|100498199|FG001|Overall Study|Other-Unspecified|4|||
33160557|NCT01466153|100498200|FG002|Overall Study|Other-Unspecified|2|||
33160558|NCT01235689|100498201|FG000|Overall Study|Adverse Event|12|||
33160559|NCT01235689|100498202|FG001|Overall Study|Adverse Event|16|||
33160560|NCT01235689|100498201|FG000|Overall Study|Lack of Efficacy|12|||
33160561|NCT01235689|100498202|FG001|Overall Study|Lack of Efficacy|5|||
33160562|NCT01235689|100498201|FG000|Overall Study|Withdrawal by Subject|3|||
33160563|NCT01235689|100498202|FG001|Overall Study|Withdrawal by Subject|4|||
33160564|NCT01235689|100498201|FG000|Overall Study|Lost to Follow-up|1|||
33160565|NCT01235689|100498202|FG001|Overall Study|Lost to Follow-up|2|||
33160566|NCT01235689|100498201|FG000|Overall Study|Miscellaneous|1|||
33160567|NCT01235689|100498202|FG001|Overall Study|Miscellaneous|5|||
33160568|NCT03386448|100498205|FG000|Overall Study|Adverse Event|0|||
33160569|NCT03386448|100498206|FG001|Overall Study|Adverse Event|2|||
33160570|NCT01064310|100498214|FG000|Period 1|Adverse Event|7|||
33160571|NCT01064310|100498215|FG001|Period 1|Adverse Event|10|||
33160572|NCT01064310|100498216|FG002|Period 1|Adverse Event|0|||
33160573|NCT01064310|100498214|FG000|Period 1|Physician Decision|1|||
33160574|NCT01064310|100498215|FG001|Period 1|Physician Decision|0|||
33160575|NCT01064310|100498216|FG002|Period 1|Physician Decision|0|||
33160576|NCT01064310|100498214|FG000|Period 1|Withdrawal by Subject|2|||
33255130|NCT01350804|100837012|FG002|Core Study|Lack of Efficacy|18|||
33255131|NCT01350804|100837013|FG003|Core Study|Lack of Efficacy|5|||
33255132|NCT01350804|100837010|FG000|Core Study|Death|1|||
33255133|NCT01350804|100837011|FG001|Core Study|Death|1|||
33255134|NCT01350804|100837012|FG002|Core Study|Death|1|||
33255135|NCT01350804|100837013|FG003|Core Study|Death|0|||
33255136|NCT01350804|100837010|FG000|Core Study|Adverse Event|8|||
33160577|NCT01064310|100498215|FG001|Period 1|Withdrawal by Subject|2|||
33160578|NCT01064310|100498216|FG002|Period 1|Withdrawal by Subject|0|||
33160579|NCT01064310|100498214|FG000|Period 1|Lack of Efficacy|3|||
33255137|NCT01350804|100837011|FG001|Core Study|Adverse Event|10|||
33255138|NCT01350804|100837012|FG002|Core Study|Adverse Event|8|||
33255139|NCT01350804|100837013|FG003|Core Study|Adverse Event|8|||
33255140|NCT01350804|100837010|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
33255141|NCT01350804|100837011|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
33255142|NCT01350804|100837012|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
33255143|NCT01350804|100837013|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
33255144|NCT01350804|100837010|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
33255145|NCT01350804|100837011|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
33255146|NCT01350804|100837012|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
33255147|NCT01350804|100837013|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
33442296|NCT01029340|101512215|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
33442297|NCT01029340|101512216|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
33442298|NCT01029340|101512217|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
33442299|NCT01029340|101512212|FG000|Part B Treatment Period|Protocol Violation|0|||
33442300|NCT01029340|101512213|FG001|Part B Treatment Period|Protocol Violation|0|||
33442301|NCT01029340|101512214|FG002|Part B Treatment Period|Protocol Violation|1|||
33442302|NCT01029340|101512215|FG003|Part B Treatment Period|Protocol Violation|0|||
33442303|NCT01029340|101512216|FG004|Part B Treatment Period|Protocol Violation|0|||
33160580|NCT01064310|100498215|FG001|Period 1|Lack of Efficacy|5|||
33160581|NCT01064310|100498216|FG002|Period 1|Lack of Efficacy|0|||
33160582|NCT01064310|100498214|FG000|Period 1|Entered Open-label Period|1|||
33160583|NCT01064310|100498215|FG001|Period 1|Entered Open-label Period|1|||
33442304|NCT01029340|101512217|FG005|Part B Treatment Period|Protocol Violation|0|||
33160584|NCT01064310|100498216|FG002|Period 1|Entered Open-label Period|0|||
33160585|NCT01064310|100498214|FG000|Period 2|Adverse Event|2|||
33160586|NCT01064310|100498215|FG001|Period 2|Adverse Event|1|||
33255148|NCT01350804|100837010|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
33255149|NCT01350804|100837011|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
33255150|NCT01350804|100837012|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
33160587|NCT01064310|100498216|FG002|Period 2|Adverse Event|0|||
33160588|NCT01064310|100498214|FG000|Period 2|Physician Decision|0|||
33160589|NCT01064310|100498215|FG001|Period 2|Physician Decision|1|||
33160590|NCT01064310|100498216|FG002|Period 2|Physician Decision|0|||
33160591|NCT01064310|100498214|FG000|Period 2|Entered Open-label Period|1|||
33160592|NCT01064310|100498215|FG001|Period 2|Entered Open-label Period|0|||
33160593|NCT01064310|100498216|FG002|Period 2|Entered Open-label Period|0|||
33160594|NCT01064310|100498214|FG000|Period 2|Lack of Efficacy|1|||
33160595|NCT01064310|100498215|FG001|Period 2|Lack of Efficacy|4|||
33160596|NCT01064310|100498216|FG002|Period 2|Lack of Efficacy|0|||
33160597|NCT01064310|100498214|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
33160598|NCT01064310|100498215|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
33160599|NCT01064310|100498216|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
33160600|NCT01064310|100498214|FG000|Open Label Pazopinib|Adverse Event|0|||
33255151|NCT01350804|100837013|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
33255152|NCT01350804|100837010|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
33160601|NCT01064310|100498215|FG001|Open Label Pazopinib|Adverse Event|0|||
33160602|NCT01064310|100498216|FG002|Open Label Pazopinib|Adverse Event|12|||
33255153|NCT01350804|100837011|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
33160603|NCT01064310|100498214|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
33160604|NCT01064310|100498215|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
33255154|NCT01350804|100837012|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
33160605|NCT01064310|100498216|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
33160606|NCT01064310|100498214|FG000|Open Label Pazopinib|Physician Decision|0|||
33160607|NCT01064310|100498215|FG001|Open Label Pazopinib|Physician Decision|0|||
33160608|NCT01064310|100498216|FG002|Open Label Pazopinib|Physician Decision|20|||
33160609|NCT00316719|100498228|FG000|Overall Study|Adverse Event|0|||
33160610|NCT00316719|100498229|FG001|Overall Study|Adverse Event|6|||
33160611|NCT00316719|100498228|FG000|Overall Study|Consent withdrawn|2|||
33160612|NCT00316719|100498229|FG001|Overall Study|Consent withdrawn|0|||
33160613|NCT00282412|100498230|FG000|Overall Study|Death|2|||
33160614|NCT00533897|100498232|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
33160615|NCT00533897|100498233|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
33160616|NCT00533897|100498234|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
33160617|NCT00533897|100498235|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
33255155|NCT01350804|100837013|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
33255156|NCT01350804|100837010|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
33442305|NCT01029340|101512212|FG000|Extension Period|Adverse Event|0|||
33442306|NCT01029340|101512213|FG001|Extension Period|Adverse Event|0|||
33442307|NCT01029340|101512214|FG002|Extension Period|Adverse Event|0|||
33442308|NCT01029340|101512215|FG003|Extension Period|Adverse Event|0|||
33442309|NCT01029340|101512216|FG004|Extension Period|Adverse Event|0|||
33442310|NCT01029340|101512217|FG005|Extension Period|Adverse Event|1|||
33442311|NCT01029340|101512212|FG000|Extension Period|starting another study|0|||
33442312|NCT01029340|101512213|FG001|Extension Period|starting another study|0|||
33442313|NCT01029340|101512214|FG002|Extension Period|starting another study|0|||
33442314|NCT01029340|101512215|FG003|Extension Period|starting another study|0|||
33442315|NCT01029340|101512216|FG004|Extension Period|starting another study|0|||
33442316|NCT01029340|101512217|FG005|Extension Period|starting another study|8|||
33442317|NCT01029340|101512212|FG000|Extension Period|non-compliance|0|||
33442318|NCT01029340|101512213|FG001|Extension Period|non-compliance|0|||
33442319|NCT01029340|101512214|FG002|Extension Period|non-compliance|0|||
33442320|NCT01029340|101512215|FG003|Extension Period|non-compliance|0|||
33442321|NCT01029340|101512216|FG004|Extension Period|non-compliance|0|||
33442322|NCT01029340|101512217|FG005|Extension Period|non-compliance|1|||
33442323|NCT01029340|101512212|FG000|Extension Period|Withdrawal by Subject|0|||
33442324|NCT01029340|101512213|FG001|Extension Period|Withdrawal by Subject|0|||
33442325|NCT01029340|101512214|FG002|Extension Period|Withdrawal by Subject|0|||
33442326|NCT01029340|101512215|FG003|Extension Period|Withdrawal by Subject|0|||
33442327|NCT01029340|101512216|FG004|Extension Period|Withdrawal by Subject|0|||
33442328|NCT01029340|101512217|FG005|Extension Period|Withdrawal by Subject|1|||
33442329|NCT01029340|101512212|FG000|Extension Period|Physician Decision|0|||
33442330|NCT01029340|101512213|FG001|Extension Period|Physician Decision|0|||
33442331|NCT01029340|101512214|FG002|Extension Period|Physician Decision|0|||
33442332|NCT01029340|101512215|FG003|Extension Period|Physician Decision|0|||
33442333|NCT01029340|101512216|FG004|Extension Period|Physician Decision|0|||
33442334|NCT01029340|101512217|FG005|Extension Period|Physician Decision|1|||
33442335|NCT00576056|101512218|FG000|Overall Study|Adverse Event|1|||
33442336|NCT00576056|101512218|FG000|Overall Study|Death|1|||
33442337|NCT00576056|101512218|FG000|Overall Study|Lack of Efficacy|1|||
33442338|NCT00576056|101512218|FG000|Overall Study|Withdrawal by Subject|2|||
33442339|NCT00576056|101512218|FG000|Overall Study|did not meet eligibility criteria|8|||
33442340|NCT00576056|101512218|FG000|Overall Study|Physician Decision|1|||
33160618|NCT00533897|100498236|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
33160619|NCT00533897|100498237|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
33160620|NCT00533897|100498238|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
33442341|NCT04605094|101512220|FG000|Overall Study|Adverse Event|2|||
33442342|NCT04605094|101512221|FG001|Overall Study|Adverse Event|2|||
33442343|NCT04605094|101512220|FG000|Overall Study|Lost to Follow-up|1|||
33160621|NCT00533897|100498239|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
33160622|NCT00533897|100498232|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
33160623|NCT00533897|100498233|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
33160624|NCT00533897|100498234|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
33160625|NCT00533897|100498235|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
33160626|NCT00533897|100498236|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
33160627|NCT00533897|100498237|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
33160628|NCT00533897|100498238|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
33160629|NCT00533897|100498239|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
33160630|NCT00533897|100498232|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
33160631|NCT00533897|100498233|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
33160632|NCT00533897|100498234|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
33160633|NCT00533897|100498235|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
33160634|NCT00533897|100498236|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
33160635|NCT00533897|100498237|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
33160636|NCT00533897|100498238|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
33160637|NCT00533897|100498239|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
33160638|NCT00533897|100498232|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
33160639|NCT00533897|100498233|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
33160640|NCT00533897|100498234|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
33160641|NCT00533897|100498235|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
33160642|NCT00533897|100498236|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
33160643|NCT00533897|100498237|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
33160644|NCT00533897|100498238|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
33160645|NCT00533897|100498239|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
33255157|NCT01350804|100837011|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
33255158|NCT01350804|100837012|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
33255159|NCT01350804|100837013|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
33255160|NCT01350804|100837010|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
33255161|NCT01350804|100837011|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
33255162|NCT01350804|100837012|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
33255163|NCT01350804|100837013|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
33255164|NCT00891930|100837017|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
33255165|NCT00891930|100837017|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
33255166|NCT00891930|100837017|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
33255167|NCT00891930|100837017|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
33255168|NCT00891930|100837017|FG000|Part 2 Panitumumab + AMG479|Death|30|||
33255169|NCT03520413|100837021|FG000|Overall Study|Lost to Follow-up|1|||
33160646|NCT00533897|100498232|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
33160647|NCT00533897|100498233|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
33255170|NCT03520413|100837022|FG001|Overall Study|Lost to Follow-up|1|||
33255171|NCT03520413|100837021|FG000|Overall Study|Withdrawal by Subject|1|||
33255172|NCT03520413|100837022|FG001|Overall Study|Withdrawal by Subject|2|||
33255173|NCT03520413|100837021|FG000|Overall Study|Death|0|||
33442344|NCT04605094|101512221|FG001|Overall Study|Lost to Follow-up|4|||
33442345|NCT04605094|101512220|FG000|Overall Study|Physician Decision|2|||
33442346|NCT04605094|101512221|FG001|Overall Study|Physician Decision|2|||
33442347|NCT04605094|101512220|FG000|Overall Study|Study terminated by Sponsor|31|||
33442348|NCT04605094|101512221|FG001|Overall Study|Study terminated by Sponsor|33|||
33442349|NCT04605094|101512220|FG000|Overall Study|Withdrawal by Subject|22|||
33442350|NCT04605094|101512221|FG001|Overall Study|Withdrawal by Subject|19|||
33255174|NCT03520413|100837022|FG001|Overall Study|Death|1|||
33255175|NCT03520413|100837021|FG000|Overall Study|Physician Decision|3|||
33442351|NCT04605094|101512220|FG000|Overall Study|Other|1|||
33442352|NCT04605094|101512221|FG001|Overall Study|Other|1|||
33442353|NCT01185548|101512222|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
33442354|NCT02770820|101512223|FG000|Overall Study|Death|1|||
33442355|NCT02770820|101512223|FG000|Overall Study|Physician Decision|2|||
33442356|NCT02196675|101512224|FG000|Overall Study|Withdrawal by Subject|1|||
33255176|NCT03520413|100837022|FG001|Overall Study|Physician Decision|3|||
33442357|NCT02196675|101512225|FG001|Overall Study|Withdrawal by Subject|0|||
33442358|NCT02196675|101512226|FG002|Overall Study|Withdrawal by Subject|0|||
33255177|NCT03520413|100837021|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
33255178|NCT03520413|100837022|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
33255179|NCT00661778|100837023|FG000|Overall Study|Disease Progression|23|||
33255180|NCT00661778|100837023|FG000|Overall Study|Adverse Event|18|||
33255181|NCT00661778|100837023|FG000|Overall Study|Reason not Specified|6|||
33255182|NCT00661778|100837023|FG000|Overall Study|Protocol Violation|2|||
33255183|NCT00661778|100837023|FG000|Overall Study|Withdrawal of Consent|1|||
33255184|NCT00178399|100837024|FG000|Overall Study|Physician Decision|4|||
33442359|NCT02196675|101512224|FG000|Overall Study|Intra-operative surgical exclusion|1|||
33442360|NCT02196675|101512225|FG001|Overall Study|Intra-operative surgical exclusion|1|||
33442361|NCT02196675|101512226|FG002|Overall Study|Intra-operative surgical exclusion|0|||
33442362|NCT02196675|101512224|FG000|Overall Study|Protocol Violation|0|||
33442363|NCT02196675|101512225|FG001|Overall Study|Protocol Violation|1|||
33442364|NCT02196675|101512226|FG002|Overall Study|Protocol Violation|0|||
33442365|NCT02196675|101512224|FG000|Overall Study|Death|0|||
33442366|NCT02196675|101512225|FG001|Overall Study|Death|0|||
33442367|NCT02196675|101512226|FG002|Overall Study|Death|1|||
33442368|NCT03586726|101512227|FG000|Overall Study|Withdrawal by Subject|1|||
33442369|NCT02058498|101512228|FG000|Overall Study|Withdrawal by Subject|4|||
33442370|NCT02392000|101512229|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
33442371|NCT02392000|101512229|FG000|Overall Study|Withdrawal by Subject|1|||
33442372|NCT02392000|101512229|FG000|Overall Study|Lost to Follow-up|8|||
33442373|NCT01038856|101512230|FG000|Overall Study|Adverse Event|2|||
33442374|NCT04720664|101512232|FG000|Overall Study|Adverse Event|2|||
33160648|NCT00533897|100498234|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
33255185|NCT00178399|100837024|FG000|Overall Study|Withdrawal by Subject|8|||
33255186|NCT00178399|100837024|FG000|Overall Study|Lost to Follow-up|1|||
33255187|NCT00364013|100837025|FG000|Overall Study|Ineligibility determined|4|||
33255188|NCT00364013|100837026|FG001|Overall Study|Ineligibility determined|2|||
33442375|NCT04720664|101512232|FG000|Overall Study|Lack of Efficacy|9|||
33442376|NCT00705536|101512233|FG000|Start Period 1|Withdrawal by Subject|0|||
33442377|NCT00705536|101512234|FG001|Start Period 1|Withdrawal by Subject|0|||
33442378|NCT00705536|101512235|FG002|Start Period 1|Withdrawal by Subject|0|||
33442379|NCT00705536|101512236|FG003|Start Period 1|Withdrawal by Subject|1|||
33442380|NCT01367457|101512237|FG000|Overall Study|Death|2|||
33255189|NCT00364013|100837025|FG000|Overall Study|Adverse Event|4|||
33160649|NCT00533897|100498235|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
33160650|NCT00533897|100498236|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
33160651|NCT00533897|100498237|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
33160652|NCT00533897|100498238|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
33160653|NCT00533897|100498239|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
33160654|NCT00533897|100498232|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
33160655|NCT00533897|100498233|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
33160656|NCT00533897|100498234|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
33160657|NCT00533897|100498235|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
33160658|NCT00533897|100498236|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
33160659|NCT00533897|100498237|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
33160660|NCT00533897|100498238|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
33160661|NCT00533897|100498239|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
33160662|NCT00533897|100498232|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
33255190|NCT00364013|100837026|FG001|Overall Study|Adverse Event|3|||
33255191|NCT00364013|100837025|FG000|Overall Study|Withdrawal by Subject|13|||
33255192|NCT00364013|100837026|FG001|Overall Study|Withdrawal by Subject|18|||
33255193|NCT00364013|100837025|FG000|Overall Study|Physician Decision|3|||
33255194|NCT00364013|100837026|FG001|Overall Study|Physician Decision|3|||
33255195|NCT00364013|100837025|FG000|Overall Study|Lost to Follow-up|10|||
33255196|NCT00364013|100837026|FG001|Overall Study|Lost to Follow-up|3|||
33255197|NCT00364013|100837025|FG000|Overall Study|Protocol-specified criteria|6|||
33255198|NCT00364013|100837026|FG001|Overall Study|Protocol-specified criteria|6|||
33255199|NCT00364013|100837025|FG000|Overall Study|Other|41|||
33255200|NCT00364013|100837026|FG001|Overall Study|Other|47|||
33255201|NCT00364013|100837025|FG000|Overall Study|Ongoing|20|||
33255202|NCT00364013|100837026|FG001|Overall Study|Ongoing|13|||
33255203|NCT02709655|100837029|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
33255204|NCT02709655|100837030|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
33255205|NCT02709655|100837031|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
33255206|NCT02709655|100837032|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
33255207|NCT02709655|100837033|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
33255208|NCT02709655|100837029|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
33255209|NCT02709655|100837030|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
33255210|NCT02709655|100837031|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
33255211|NCT02709655|100837032|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
33255212|NCT02709655|100837033|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
33255213|NCT02709655|100837029|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
33255214|NCT02709655|100837030|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
33255215|NCT02709655|100837031|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
33255216|NCT02709655|100837032|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
33255217|NCT02709655|100837033|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
33255218|NCT02709655|100837029|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
33255219|NCT02709655|100837030|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
33255220|NCT02709655|100837031|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
33255221|NCT02709655|100837032|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
33255222|NCT02709655|100837033|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
33255223|NCT02709655|100837029|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
33255224|NCT02709655|100837030|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
33255225|NCT02709655|100837031|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
33255226|NCT02709655|100837032|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
33255227|NCT02709655|100837033|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
33255228|NCT02709655|100837029|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
33255229|NCT02709655|100837030|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
33255230|NCT02709655|100837031|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
33255231|NCT02709655|100837032|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
33255232|NCT02709655|100837033|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
33255233|NCT02709655|100837029|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
33160663|NCT00533897|100498233|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
33255234|NCT02709655|100837030|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
33255235|NCT02709655|100837031|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
33255236|NCT02709655|100837032|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
33160664|NCT00533897|100498234|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
33160665|NCT00533897|100498235|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
33160666|NCT00533897|100498236|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
33160667|NCT00533897|100498237|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
33286466|NCT00092521|100943970|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
33388820|NCT00653328|101309367|FG000|Overall Study|Withdrawal by Subject|1|||
33255237|NCT02709655|100837033|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
33255238|NCT02709655|100837029|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
33255239|NCT02709655|100837030|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
33255240|NCT02709655|100837031|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
33255241|NCT02709655|100837032|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
33255242|NCT02709655|100837033|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
33255243|NCT02709655|100837029|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
33255244|NCT02709655|100837030|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
33255245|NCT02709655|100837031|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
33255246|NCT02709655|100837032|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
33255247|NCT02709655|100837033|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
33255248|NCT02709655|100837029|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
33255249|NCT02709655|100837030|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
33255250|NCT02709655|100837031|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
33255251|NCT02709655|100837032|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
33255252|NCT02709655|100837033|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
33255253|NCT02709655|100837029|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
33442381|NCT01367457|101512238|FG001|Overall Study|Death|0|||
33442382|NCT01367457|101512239|FG002|Overall Study|Death|0|||
33442383|NCT01367457|101512237|FG000|Overall Study|Investigator's decision|2|||
33442384|NCT01367457|101512238|FG001|Overall Study|Investigator's decision|0|||
33442385|NCT01367457|101512239|FG002|Overall Study|Investigator's decision|0|||
33442386|NCT01367457|101512237|FG000|Overall Study|Clinical decline (CD)|2|||
33442387|NCT01367457|101512238|FG001|Overall Study|Clinical decline (CD)|0|||
33442388|NCT01367457|101512239|FG002|Overall Study|Clinical decline (CD)|0|||
33442389|NCT01367457|101512237|FG000|Overall Study|Progression and death|8|||
33442390|NCT01367457|101512238|FG001|Overall Study|Progression and death|0|||
33442391|NCT01367457|101512239|FG002|Overall Study|Progression and death|0|||
33442392|NCT01367457|101512237|FG000|Overall Study|Toxicity|16|||
33442393|NCT01367457|101512238|FG001|Overall Study|Toxicity|0|||
33442394|NCT01367457|101512239|FG002|Overall Study|Toxicity|0|||
33442395|NCT01367457|101512237|FG000|Overall Study|Progression|137|||
33442396|NCT01367457|101512238|FG001|Overall Study|Progression|0|||
33255254|NCT02709655|100837030|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
33255255|NCT02709655|100837031|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
33255256|NCT02709655|100837032|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
33442397|NCT01367457|101512239|FG002|Overall Study|Progression|0|||
33442398|NCT01367457|101512237|FG000|Overall Study|Patient asks for rest + slow progression|1|||
33442399|NCT01367457|101512238|FG001|Overall Study|Patient asks for rest + slow progression|0|||
33442400|NCT01367457|101512239|FG002|Overall Study|Patient asks for rest + slow progression|0|||
33442401|NCT01367457|101512237|FG000|Overall Study|Investigator's opinion, stable disease|1|||
33160668|NCT00533897|100498238|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
33160669|NCT00533897|100498239|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
33160670|NCT00533897|100498232|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
33160671|NCT00533897|100498233|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
33160672|NCT00533897|100498234|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
33160673|NCT00533897|100498235|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
33160674|NCT00533897|100498236|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
33160675|NCT00533897|100498237|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
33160676|NCT00533897|100498238|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
33160677|NCT00533897|100498239|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
33160678|NCT00533897|100498232|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
33160679|NCT00533897|100498233|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
33160680|NCT00533897|100498234|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
33160681|NCT00533897|100498235|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
33160682|NCT00533897|100498236|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
33160683|NCT00533897|100498237|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
33160684|NCT00533897|100498238|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
33160685|NCT00533897|100498239|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
33160686|NCT00533897|100498232|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
33160687|NCT00533897|100498233|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
33160688|NCT00533897|100498234|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
33160689|NCT00533897|100498235|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
33160690|NCT00533897|100498236|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
33160691|NCT00533897|100498237|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
33160692|NCT00533897|100498238|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
33160693|NCT00533897|100498239|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
33160694|NCT00533897|100498232|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
33160695|NCT00533897|100498233|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
33160696|NCT00533897|100498234|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
33160697|NCT00533897|100498235|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
33442402|NCT01367457|101512238|FG001|Overall Study|Investigator's opinion, stable disease|0|||
33442403|NCT01367457|101512239|FG002|Overall Study|Investigator's opinion, stable disease|0|||
33442404|NCT01367457|101512237|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
33442405|NCT01367457|101512238|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
33442406|NCT01367457|101512239|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
33442407|NCT01367457|101512237|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
33442408|NCT01367457|101512238|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
33442409|NCT01367457|101512239|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
33442410|NCT01367457|101512237|FG000|Overall Study|low grade toxicities + stable disease|1|||
33442411|NCT01367457|101512238|FG001|Overall Study|low grade toxicities + stable disease|0|||
33442412|NCT01367457|101512239|FG002|Overall Study|low grade toxicities + stable disease|0|||
33442413|NCT01367457|101512237|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
33442414|NCT01367457|101512238|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
33442415|NCT01367457|101512239|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
33442416|NCT01367457|101512237|FG000|Overall Study|Withdrawal by Subject|1|||
33442417|NCT01367457|101512238|FG001|Overall Study|Withdrawal by Subject|0|||
33442418|NCT01367457|101512239|FG002|Overall Study|Withdrawal by Subject|0|||
33442419|NCT01367457|101512237|FG000|Overall Study|CD, associated leukaemia|1|||
33442420|NCT01367457|101512238|FG001|Overall Study|CD, associated leukaemia|0|||
33442421|NCT01367457|101512239|FG002|Overall Study|CD, associated leukaemia|0|||
33442422|NCT01367457|101512237|FG000|Overall Study|Uncontrolled pain|1|||
33442423|NCT01367457|101512238|FG001|Overall Study|Uncontrolled pain|0|||
33442424|NCT01367457|101512239|FG002|Overall Study|Uncontrolled pain|0|||
33442425|NCT01367457|101512237|FG000|Overall Study|Overall status worsens to grade 4|1|||
33442426|NCT01367457|101512238|FG001|Overall Study|Overall status worsens to grade 4|0|||
33442427|NCT01367457|101512239|FG002|Overall Study|Overall status worsens to grade 4|0|||
33442428|NCT01367457|101512237|FG000|Overall Study|Stabilisation + frequent infections|1|||
33442429|NCT01367457|101512238|FG001|Overall Study|Stabilisation + frequent infections|0|||
33442430|NCT01367457|101512239|FG002|Overall Study|Stabilisation + frequent infections|0|||
33160698|NCT00533897|100498236|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
33160699|NCT00533897|100498237|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
33442431|NCT01367457|101512237|FG000|Overall Study|No clinical benefit|1|||
33442432|NCT01367457|101512238|FG001|Overall Study|No clinical benefit|0|||
33442433|NCT01367457|101512239|FG002|Overall Study|No clinical benefit|0|||
33442434|NCT01367457|101512237|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
33442435|NCT01367457|101512238|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
33442436|NCT01367457|101512239|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
33442437|NCT01367457|101512237|FG000|Overall Study|Overall decline|1|||
33442438|NCT01367457|101512238|FG001|Overall Study|Overall decline|0|||
33442439|NCT01367457|101512239|FG002|Overall Study|Overall decline|0|||
33442440|NCT01367457|101512237|FG000|Overall Study|Rejection of treatment|1|||
33442441|NCT01367457|101512238|FG001|Overall Study|Rejection of treatment|0|||
33442442|NCT01367457|101512239|FG002|Overall Study|Rejection of treatment|0|||
33442443|NCT01367457|101512237|FG000|Overall Study|Lost to Follow-up|1|||
33442444|NCT01367457|101512238|FG001|Overall Study|Lost to Follow-up|0|||
33442445|NCT01367457|101512239|FG002|Overall Study|Lost to Follow-up|0|||
33442446|NCT01367457|101512237|FG000|Overall Study|Death from septic shock|1|||
33442447|NCT01367457|101512238|FG001|Overall Study|Death from septic shock|0|||
33442448|NCT01367457|101512239|FG002|Overall Study|Death from septic shock|0|||
33442449|NCT01367457|101512237|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
33442450|NCT01367457|101512238|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
33442451|NCT01367457|101512239|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
33442452|NCT01367457|101512237|FG000|Overall Study|Patient's Wish|1|||
33255257|NCT02709655|100837033|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
33255258|NCT02709655|100837029|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
33255259|NCT02709655|100837030|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
33255260|NCT02709655|100837031|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
33255261|NCT02709655|100837032|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
33255262|NCT02709655|100837033|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
33255263|NCT02709655|100837029|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
33255264|NCT02709655|100837030|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
33255265|NCT02709655|100837031|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
33255266|NCT02709655|100837032|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
33255267|NCT02709655|100837033|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
33255268|NCT02709655|100837029|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
33255269|NCT02709655|100837030|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
33255270|NCT02709655|100837031|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
33255271|NCT02709655|100837032|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
33255272|NCT02709655|100837033|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
33255273|NCT02709655|100837029|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
33255274|NCT02709655|100837030|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
33255275|NCT02709655|100837031|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
33255276|NCT02709655|100837032|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
33255277|NCT02709655|100837033|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
33255278|NCT02709655|100837029|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
33255279|NCT02709655|100837030|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
33255280|NCT02709655|100837031|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
33255281|NCT02709655|100837032|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
33255282|NCT02709655|100837033|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
33255283|NCT00979992|100837034|FG000|Overall Study|Ineligible - inadequate pathology|1|||
33255284|NCT00979992|100837034|FG000|Overall Study|Ineligible - wrong cell type|2|||
33255285|NCT00979992|100837034|FG000|Overall Study|Refused - Never Treated|2|||
33255286|NCT01759771|100837035|FG000|Overall Study|Withdrawal by Subject|1|||
33255287|NCT01759771|100837036|FG001|Overall Study|Withdrawal by Subject|1|||
33255288|NCT01697969|100837042|FG000|Overall Study|Did not meet inc/exc criteria|3|||
33255289|NCT03473340|100837044|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
33255290|NCT03473340|100837045|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
33255291|NCT03473340|100837044|FG000|Overall Study|Withdrawal by Subject|1|||
33255292|NCT03473340|100837045|FG001|Overall Study|Withdrawal by Subject|0|||
33255293|NCT03473340|100837044|FG000|Overall Study|Lost to Follow-up|1|||
33255294|NCT03473340|100837045|FG001|Overall Study|Lost to Follow-up|2|||
33255295|NCT02496702|100837046|FG000|Overall Study|Lost to Follow-up|8|||
33255296|NCT02496702|100837047|FG001|Overall Study|Lost to Follow-up|6|||
33255297|NCT02496702|100837046|FG000|Overall Study|Only partially tested|0|||
33255298|NCT02496702|100837047|FG001|Overall Study|Only partially tested|2|||
33255299|NCT01135511|100837054|FG000|Overall Study|Adverse Event|0|||
33255300|NCT01135511|100837055|FG001|Overall Study|Adverse Event|1|||
33255301|NCT01135511|100837056|FG002|Overall Study|Adverse Event|2|||
33255302|NCT01135511|100837057|FG003|Overall Study|Adverse Event|0|||
33255303|NCT01135511|100837058|FG004|Overall Study|Adverse Event|0|||
33255304|NCT01135511|100837059|FG005|Overall Study|Adverse Event|1|||
33255305|NCT01135511|100837060|FG006|Overall Study|Adverse Event|0|||
33255306|NCT01135511|100837061|FG007|Overall Study|Adverse Event|1|||
33255307|NCT01135511|100837062|FG008|Overall Study|Adverse Event|0|||
33255308|NCT01135511|100837054|FG000|Overall Study|Lack of Efficacy|0|||
33255309|NCT01135511|100837055|FG001|Overall Study|Lack of Efficacy|1|||
33255310|NCT01135511|100837056|FG002|Overall Study|Lack of Efficacy|1|||
33255311|NCT01135511|100837057|FG003|Overall Study|Lack of Efficacy|2|||
33255312|NCT01135511|100837058|FG004|Overall Study|Lack of Efficacy|0|||
33255313|NCT01135511|100837059|FG005|Overall Study|Lack of Efficacy|0|||
33255314|NCT01135511|100837060|FG006|Overall Study|Lack of Efficacy|0|||
33255315|NCT01135511|100837061|FG007|Overall Study|Lack of Efficacy|0|||
33255316|NCT01135511|100837062|FG008|Overall Study|Lack of Efficacy|0|||
33255317|NCT01135511|100837054|FG000|Overall Study|Protocol Violation|0|||
33255318|NCT01135511|100837055|FG001|Overall Study|Protocol Violation|0|||
33255319|NCT01135511|100837056|FG002|Overall Study|Protocol Violation|3|||
33255320|NCT01135511|100837057|FG003|Overall Study|Protocol Violation|0|||
33255321|NCT01135511|100837058|FG004|Overall Study|Protocol Violation|0|||
33442453|NCT01367457|101512238|FG001|Overall Study|Patient's Wish|0|||
33442454|NCT01367457|101512239|FG002|Overall Study|Patient's Wish|0|||
33255322|NCT01135511|100837059|FG005|Overall Study|Protocol Violation|0|||
33255323|NCT01135511|100837060|FG006|Overall Study|Protocol Violation|0|||
33255324|NCT01135511|100837061|FG007|Overall Study|Protocol Violation|0|||
33255325|NCT01135511|100837062|FG008|Overall Study|Protocol Violation|0|||
33255326|NCT01135511|100837054|FG000|Overall Study|Pregnancy|0|||
33255327|NCT01135511|100837055|FG001|Overall Study|Pregnancy|0|||
33442455|NCT01367457|101512237|FG000|Overall Study|Palliative. Overall decline|1|||
33442456|NCT01367457|101512238|FG001|Overall Study|Palliative. Overall decline|0|||
33442457|NCT01367457|101512239|FG002|Overall Study|Palliative. Overall decline|0|||
33442458|NCT01367457|101512237|FG000|Overall Study|Suspected DP/suspected active infection|1|||
33442459|NCT01367457|101512238|FG001|Overall Study|Suspected DP/suspected active infection|0|||
33255328|NCT01135511|100837056|FG002|Overall Study|Pregnancy|0|||
33255329|NCT01135511|100837057|FG003|Overall Study|Pregnancy|1|||
33255330|NCT01135511|100837058|FG004|Overall Study|Pregnancy|0|||
33255331|NCT01135511|100837059|FG005|Overall Study|Pregnancy|0|||
33255332|NCT01135511|100837060|FG006|Overall Study|Pregnancy|0|||
33442460|NCT01367457|101512239|FG002|Overall Study|Suspected DP/suspected active infection|0|||
33442461|NCT00414765|101512241|FG000|Overall Study|Adverse Event|5|||
33442462|NCT00414765|101512242|FG001|Overall Study|Adverse Event|9|||
33442463|NCT00414765|101512241|FG000|Overall Study|Withdrawal by Subject|1|||
33442464|NCT00414765|101512242|FG001|Overall Study|Withdrawal by Subject|1|||
33442465|NCT00414765|101512241|FG000|Overall Study|Disease Progression|0|||
33442466|NCT00414765|101512242|FG001|Overall Study|Disease Progression|1|||
33160700|NCT00533897|100498238|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
33160701|NCT00533897|100498239|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
33160702|NCT00533897|100498232|FG000|Long Term Extension (LTE)|Death|0|||
33160703|NCT00533897|100498233|FG001|Long Term Extension (LTE)|Death|0|||
33160704|NCT00533897|100498234|FG002|Long Term Extension (LTE)|Death|0|||
33160705|NCT00533897|100498235|FG003|Long Term Extension (LTE)|Death|0|||
33160706|NCT00533897|100498236|FG004|Long Term Extension (LTE)|Death|0|||
33160707|NCT00533897|100498237|FG005|Long Term Extension (LTE)|Death|0|||
33160708|NCT00533897|100498238|FG006|Long Term Extension (LTE)|Death|1|||
33160709|NCT00533897|100498239|FG007|Long Term Extension (LTE)|Death|3|||
33160710|NCT00533897|100498232|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
33160711|NCT00533897|100498233|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
33442467|NCT01546545|101512243|FG000|Overall Study|Withdrawal by Subject|1|||
33442468|NCT03627091|101512248|FG000|Overall Study|Adverse Event|0|||
33442469|NCT03627091|101512249|FG001|Overall Study|Adverse Event|0|||
33442470|NCT03627091|101512250|FG002|Overall Study|Adverse Event|2|||
33442471|NCT03627091|101512248|FG000|Overall Study|Withdrawal by Subject|2|||
33442472|NCT03627091|101512249|FG001|Overall Study|Withdrawal by Subject|0|||
33442473|NCT03627091|101512250|FG002|Overall Study|Withdrawal by Subject|2|||
33442474|NCT03627091|101512248|FG000|Overall Study|Physician Decision|2|||
33442475|NCT03627091|101512249|FG001|Overall Study|Physician Decision|0|||
33442476|NCT03627091|101512250|FG002|Overall Study|Physician Decision|0|||
33442477|NCT03627091|101512248|FG000|Overall Study|Site terminated by sponsor|0|||
33442478|NCT03627091|101512249|FG001|Overall Study|Site terminated by sponsor|1|||
33442479|NCT03627091|101512250|FG002|Overall Study|Site terminated by sponsor|0|||
33442480|NCT03627091|101512248|FG000|Overall Study|Disease relapse|7|||
33255333|NCT01135511|100837061|FG007|Overall Study|Pregnancy|0|||
33160712|NCT00533897|100498234|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
33160713|NCT00533897|100498235|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
33160714|NCT00533897|100498236|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
33160715|NCT00533897|100498237|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
33160716|NCT00533897|100498238|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
33160717|NCT00533897|100498239|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
33160718|NCT00533897|100498232|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
33160719|NCT00533897|100498233|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
33160720|NCT00533897|100498234|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
33160721|NCT00533897|100498235|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
33160722|NCT00533897|100498236|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
33160723|NCT00533897|100498237|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
33160724|NCT00533897|100498238|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
33160725|NCT00533897|100498239|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
33160726|NCT00533897|100498232|FG000|Long Term Extension (LTE)|Adverse Event|0|||
33160727|NCT00533897|100498233|FG001|Long Term Extension (LTE)|Adverse Event|0|||
33160728|NCT00533897|100498234|FG002|Long Term Extension (LTE)|Adverse Event|0|||
33160729|NCT00533897|100498235|FG003|Long Term Extension (LTE)|Adverse Event|0|||
33160730|NCT00533897|100498236|FG004|Long Term Extension (LTE)|Adverse Event|0|||
33160731|NCT00533897|100498237|FG005|Long Term Extension (LTE)|Adverse Event|0|||
33160732|NCT00533897|100498238|FG006|Long Term Extension (LTE)|Adverse Event|2|||
33160733|NCT00533897|100498239|FG007|Long Term Extension (LTE)|Adverse Event|5|||
33160734|NCT00533897|100498232|FG000|Long Term Extension (LTE)|Pregnancy|0|||
33160735|NCT00533897|100498233|FG001|Long Term Extension (LTE)|Pregnancy|0|||
33160736|NCT00533897|100498234|FG002|Long Term Extension (LTE)|Pregnancy|0|||
33160737|NCT00533897|100498235|FG003|Long Term Extension (LTE)|Pregnancy|0|||
33160738|NCT00533897|100498236|FG004|Long Term Extension (LTE)|Pregnancy|0|||
33160739|NCT00533897|100498237|FG005|Long Term Extension (LTE)|Pregnancy|0|||
33160740|NCT00533897|100498238|FG006|Long Term Extension (LTE)|Pregnancy|0|||
33160741|NCT00533897|100498239|FG007|Long Term Extension (LTE)|Pregnancy|2|||
33160742|NCT00533897|100498232|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
33160743|NCT00533897|100498233|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
33160744|NCT00533897|100498234|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
33160745|NCT00533897|100498235|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
33160746|NCT00533897|100498236|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
33160747|NCT00533897|100498237|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
33160748|NCT00533897|100498238|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
33160749|NCT00533897|100498239|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
33442481|NCT03627091|101512249|FG001|Overall Study|Disease relapse|5|||
33442482|NCT03627091|101512250|FG002|Overall Study|Disease relapse|1|||
33442483|NCT03627091|101512248|FG000|Overall Study|Other|1|||
33442484|NCT03627091|101512249|FG001|Overall Study|Other|0|||
33442485|NCT03627091|101512250|FG002|Overall Study|Other|0|||
33160750|NCT00533897|100498232|FG000|Long Term Extension (LTE)|Other|0|||
33160751|NCT00533897|100498233|FG001|Long Term Extension (LTE)|Other|0|||
33160752|NCT00533897|100498234|FG002|Long Term Extension (LTE)|Other|0|||
33160753|NCT00533897|100498235|FG003|Long Term Extension (LTE)|Other|0|||
33442486|NCT00877032|101512251|FG000|Overall Study|Did not meet entrance criteria|0|||
33442487|NCT00877032|101512252|FG001|Overall Study|Did not meet entrance criteria|0|||
33160754|NCT00533897|100498236|FG004|Long Term Extension (LTE)|Other|0|||
33160755|NCT00533897|100498237|FG005|Long Term Extension (LTE)|Other|0|||
33160756|NCT00533897|100498238|FG006|Long Term Extension (LTE)|Other|1|||
33160757|NCT00533897|100498239|FG007|Long Term Extension (LTE)|Other|6|||
33160758|NCT01708161|100498242|FG000|Overall Study|Adverse Event|1|||
33160759|NCT01708161|100498243|FG001|Overall Study|Adverse Event|3|||
33160760|NCT01708161|100498244|FG002|Overall Study|Adverse Event|4|||
33160761|NCT01708161|100498245|FG003|Overall Study|Adverse Event|2|||
33160762|NCT01708161|100498246|FG004|Overall Study|Adverse Event|3|||
33160763|NCT01708161|100498247|FG005|Overall Study|Adverse Event|0|||
33160764|NCT01708161|100498242|FG000|Overall Study|Death|0|||
33160765|NCT01708161|100498243|FG001|Overall Study|Death|0|||
33160766|NCT01708161|100498244|FG002|Overall Study|Death|0|||
33160767|NCT01708161|100498245|FG003|Overall Study|Death|1|||
33160768|NCT01708161|100498246|FG004|Overall Study|Death|0|||
33160769|NCT01708161|100498247|FG005|Overall Study|Death|1|||
33160770|NCT01708161|100498242|FG000|Overall Study|Withdrawal by Subject|0|||
33160771|NCT01708161|100498243|FG001|Overall Study|Withdrawal by Subject|1|||
33160772|NCT01708161|100498244|FG002|Overall Study|Withdrawal by Subject|1|||
33160773|NCT01708161|100498245|FG003|Overall Study|Withdrawal by Subject|0|||
33160774|NCT01708161|100498246|FG004|Overall Study|Withdrawal by Subject|0|||
33160775|NCT01708161|100498247|FG005|Overall Study|Withdrawal by Subject|0|||
33160776|NCT01708161|100498242|FG000|Overall Study|Administrative problems|0|||
33160777|NCT01708161|100498243|FG001|Overall Study|Administrative problems|1|||
33442488|NCT00877032|101512253|FG002|Overall Study|Did not meet entrance criteria|0|||
33442489|NCT00877032|101512254|FG003|Overall Study|Did not meet entrance criteria|1|||
33442490|NCT00877032|101512255|FG004|Overall Study|Did not meet entrance criteria|0|||
33442491|NCT00877032|101512256|FG005|Overall Study|Did not meet entrance criteria|0|||
33442492|NCT00877032|101512257|FG006|Overall Study|Did not meet entrance criteria|2|||
33442493|NCT01037114|101515438|FG000|Year 20|Others|1|||
33442494|NCT00358449|101515440|FG000|Overall Study|Adverse Event|1|||
33442495|NCT00358449|101515441|FG001|Overall Study|Adverse Event|0|||
33442496|NCT00358449|101515442|FG002|Overall Study|Adverse Event|1|||
33442497|NCT00358449|101515440|FG000|Overall Study|Lost to Follow-up|1|||
33442498|NCT00358449|101515441|FG001|Overall Study|Lost to Follow-up|0|||
33442499|NCT00358449|101515442|FG002|Overall Study|Lost to Follow-up|0|||
33442500|NCT00358449|101515440|FG000|Overall Study|Withdrawal by Subject|2|||
33442501|NCT00358449|101515441|FG001|Overall Study|Withdrawal by Subject|0|||
33442502|NCT00358449|101515442|FG002|Overall Study|Withdrawal by Subject|0|||
33442503|NCT00358449|101515440|FG000|Overall Study|Lack of Efficacy|0|||
33442504|NCT00358449|101515441|FG001|Overall Study|Lack of Efficacy|1|||
33442505|NCT00358449|101515442|FG002|Overall Study|Lack of Efficacy|0|||
33442506|NCT00358449|101515440|FG000|Overall Study|Steriod Inhaler was Increased|0|||
33442507|NCT00358449|101515441|FG001|Overall Study|Steriod Inhaler was Increased|0|||
33442508|NCT00358449|101515442|FG002|Overall Study|Steriod Inhaler was Increased|1|||
33442509|NCT02017223|101515448|FG000|Overall Study|Algorithm problems|2|||
33442510|NCT01049334|101515449|FG000|Overall Study|Withdrawal by Subject|5|||
33442511|NCT01049334|101515450|FG001|Overall Study|Withdrawal by Subject|3|||
33160778|NCT01708161|100498244|FG002|Overall Study|Administrative problems|0|||
33160779|NCT01708161|100498245|FG003|Overall Study|Administrative problems|0|||
33442512|NCT01049334|101515449|FG000|Overall Study|Adverse Event|2|||
33442513|NCT01049334|101515450|FG001|Overall Study|Adverse Event|3|||
33442514|NCT01049334|101515449|FG000|Overall Study|Physician Decision|2|||
33442515|NCT01049334|101515450|FG001|Overall Study|Physician Decision|0|||
33442516|NCT01049334|101515449|FG000|Overall Study|Protocol Violation|0|||
33442517|NCT01049334|101515450|FG001|Overall Study|Protocol Violation|1|||
33160780|NCT01708161|100498246|FG004|Overall Study|Administrative problems|0|||
33160781|NCT01708161|100498247|FG005|Overall Study|Administrative problems|0|||
33160782|NCT01708161|100498242|FG000|Overall Study|Disease progression|3|||
33160783|NCT01708161|100498243|FG001|Overall Study|Disease progression|5|||
33160784|NCT01708161|100498244|FG002|Overall Study|Disease progression|5|||
33160785|NCT01708161|100498245|FG003|Overall Study|Disease progression|13|||
33160786|NCT01708161|100498246|FG004|Overall Study|Disease progression|3|||
33160787|NCT01708161|100498247|FG005|Overall Study|Disease progression|0|||
33160788|NCT02296320|100498249|FG000|Overall Study|Withdrawal by Subject|4|||
33160789|NCT02296320|100498250|FG001|Overall Study|Withdrawal by Subject|0|||
33160790|NCT02296320|100498251|FG002|Overall Study|Withdrawal by Subject|2|||
33160791|NCT02296320|100498249|FG000|Overall Study|Death|24|||
33160792|NCT02296320|100498250|FG001|Overall Study|Death|3|||
33160793|NCT02296320|100498251|FG002|Overall Study|Death|27|||
33160794|NCT02296320|100498249|FG000|Overall Study|Lost to Follow-up|5|||
33160795|NCT02296320|100498250|FG001|Overall Study|Lost to Follow-up|2|||
33160796|NCT02296320|100498251|FG002|Overall Study|Lost to Follow-up|7|||
33160797|NCT02296320|100498249|FG000|Overall Study|Not treated|2|||
33160798|NCT02296320|100498250|FG001|Overall Study|Not treated|0|||
33160799|NCT02296320|100498251|FG002|Overall Study|Not treated|0|||
33160800|NCT02296320|100498249|FG000|Overall Study|Not - specified|0|||
33160801|NCT02296320|100498250|FG001|Overall Study|Not - specified|0|||
33160802|NCT02296320|100498251|FG002|Overall Study|Not - specified|1|||
33160803|NCT01999114|100498252|FG000|Overall Study|Adverse Event|8|||
33160804|NCT01999114|100498253|FG001|Overall Study|Adverse Event|7|||
33160805|NCT01999114|100498254|FG002|Overall Study|Adverse Event|2|||
33160806|NCT01999114|100498255|FG003|Overall Study|Adverse Event|2|||
33160807|NCT01999114|100498256|FG004|Overall Study|Adverse Event|1|||
33160808|NCT01999114|100498252|FG000|Overall Study|Withdrawal by Subject|0|||
33160809|NCT01999114|100498253|FG001|Overall Study|Withdrawal by Subject|0|||
33160810|NCT01999114|100498254|FG002|Overall Study|Withdrawal by Subject|1|||
33160811|NCT01999114|100498255|FG003|Overall Study|Withdrawal by Subject|0|||
33160812|NCT01999114|100498256|FG004|Overall Study|Withdrawal by Subject|1|||
33160813|NCT01999114|100498252|FG000|Overall Study|Lost to Follow-up|0|||
33160814|NCT01999114|100498253|FG001|Overall Study|Lost to Follow-up|0|||
33160815|NCT01999114|100498254|FG002|Overall Study|Lost to Follow-up|1|||
33160816|NCT01999114|100498255|FG003|Overall Study|Lost to Follow-up|0|||
33160817|NCT01999114|100498256|FG004|Overall Study|Lost to Follow-up|0|||
33160818|NCT01999114|100498252|FG000|Overall Study|Administrative|0|||
33160819|NCT01999114|100498253|FG001|Overall Study|Administrative|0|||
33160820|NCT01999114|100498254|FG002|Overall Study|Administrative|1|||
33160821|NCT01999114|100498255|FG003|Overall Study|Administrative|1|||
33160822|NCT01999114|100498256|FG004|Overall Study|Administrative|2|||
33160823|NCT03478657|100500802|FG000|Overall Study|Withdrawal by Subject|0|||
33442518|NCT00420238|101515453|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
33160824|NCT03478657|100500803|FG001|Overall Study|Withdrawal by Subject|1|||
33160825|NCT01513343|100500804|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
33160826|NCT01513343|100500805|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
33160827|NCT01513343|100500804|FG000|Post Data Collection|Dropped/withdrew from study|7|||
33160828|NCT01513343|100500805|FG001|Post Data Collection|Dropped/withdrew from study|1|||
33160829|NCT01513343|100500804|FG000|Post Data Collection|Lost to Follow-up|10|||
33160830|NCT01513343|100500805|FG001|Post Data Collection|Lost to Follow-up|23|||
33160831|NCT01513343|100500804|FG000|6-month Follow-up|Lost to Follow-up|28|||
33160832|NCT01513343|100500805|FG001|6-month Follow-up|Lost to Follow-up|17|||
33160833|NCT01513343|100500804|FG000|12-month Follow-up|Lost to Follow-up|10|||
33160834|NCT01513343|100500805|FG001|12-month Follow-up|Lost to Follow-up|3|||
33160835|NCT03307967|100500806|FG000|Overall Study|Lost to Follow-up|4|||
33160836|NCT01972568|100500810|FG000|Overall Study|Other events|3|||
33160837|NCT01972568|100500811|FG001|Overall Study|Other events|0|||
33160838|NCT01972568|100500812|FG002|Overall Study|Other events|0|||
33160839|NCT01972568|100500810|FG000|Overall Study|Lack of Efficacy|0|||
33160840|NCT01972568|100500811|FG001|Overall Study|Lack of Efficacy|1|||
33160841|NCT01972568|100500812|FG002|Overall Study|Lack of Efficacy|2|||
33160842|NCT01972568|100500810|FG000|Overall Study|Protocol Violation|1|||
33160843|NCT01972568|100500811|FG001|Overall Study|Protocol Violation|2|||
33160844|NCT01972568|100500812|FG002|Overall Study|Protocol Violation|2|||
33160845|NCT01972568|100500810|FG000|Overall Study|Withdrawal by Subject|6|||
33160846|NCT01972568|100500811|FG001|Overall Study|Withdrawal by Subject|3|||
33160847|NCT01972568|100500812|FG002|Overall Study|Withdrawal by Subject|7|||
33160848|NCT01972568|100500810|FG000|Overall Study|Lost to Follow-up|1|||
33160849|NCT01972568|100500811|FG001|Overall Study|Lost to Follow-up|0|||
33160850|NCT01972568|100500812|FG002|Overall Study|Lost to Follow-up|0|||
33160851|NCT01972568|100500810|FG000|Overall Study|Adverse Event|5|||
33160852|NCT01972568|100500811|FG001|Overall Study|Adverse Event|6|||
33160853|NCT01972568|100500812|FG002|Overall Study|Adverse Event|5|||
33160854|NCT01449539|100500813|FG000|Overall Study|Withdrawal by Subject|3|||
33160855|NCT01449539|100500813|FG000|Overall Study|Toxicity not study related|1|||
33160856|NCT00705289|100500814|FG000|Overall Study|Subject or treating physician's choice|131|||
33160857|NCT03385564|100500815|FG000|Overall Study|Adverse Event|0|||
33160858|NCT03385564|100500816|FG001|Overall Study|Adverse Event|0|||
33160859|NCT03385564|100500817|FG002|Overall Study|Adverse Event|3|||
33160860|NCT03385564|100500818|FG003|Overall Study|Adverse Event|3|||
33160861|NCT03385564|100500815|FG000|Overall Study|Other than listed|0|||
33160862|NCT03385564|100500816|FG001|Overall Study|Other than listed|0|||
33160863|NCT03385564|100500817|FG002|Overall Study|Other than listed|0|||
33160864|NCT03385564|100500818|FG003|Overall Study|Other than listed|5|||
33160865|NCT03385564|100500815|FG000|Overall Study|Withdrawal by Subject|0|||
33160866|NCT03385564|100500816|FG001|Overall Study|Withdrawal by Subject|1|||
33160867|NCT03385564|100500817|FG002|Overall Study|Withdrawal by Subject|1|||
33160868|NCT03385564|100500818|FG003|Overall Study|Withdrawal by Subject|0|||
33160869|NCT03385564|100500815|FG000|Overall Study|Lack of Efficacy|0|||
33160870|NCT03385564|100500816|FG001|Overall Study|Lack of Efficacy|0|||
33160871|NCT03385564|100500817|FG002|Overall Study|Lack of Efficacy|0|||
33255334|NCT01135511|100837062|FG008|Overall Study|Pregnancy|0|||
33255335|NCT01135511|100837054|FG000|Overall Study|could not visit the clinic|0|||
33255336|NCT01135511|100837055|FG001|Overall Study|could not visit the clinic|1|||
33442519|NCT00420238|101515454|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
33160872|NCT03385564|100500818|FG003|Overall Study|Lack of Efficacy|1|||
33160873|NCT03385564|100500815|FG000|Overall Study|Death|0|||
33160874|NCT03385564|100500816|FG001|Overall Study|Death|0|||
33160875|NCT03385564|100500817|FG002|Overall Study|Death|1|||
33160876|NCT03385564|100500818|FG003|Overall Study|Death|0|||
33160877|NCT00036270|100500820|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
33160878|NCT00036270|100500821|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
33160879|NCT00036270|100500820|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
33160880|NCT00036270|100500821|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
33160881|NCT00036270|100500820|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
33160882|NCT00036270|100500821|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
33160883|NCT00036270|100500820|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
33255337|NCT01135511|100837056|FG002|Overall Study|could not visit the clinic|2|||
33160884|NCT00036270|100500821|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
33160885|NCT00036270|100500820|FG000|Study Treatment to 5 Year Report|Other|277|||
33160886|NCT00036270|100500821|FG001|Study Treatment to 5 Year Report|Other|288|||
33160887|NCT00036270|100500820|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
33160888|NCT00036270|100500821|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
33160889|NCT00036270|100500820|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
33160890|NCT00036270|100500821|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
33160891|NCT00036270|100500820|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
33160892|NCT00036270|100500821|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
33160893|NCT00036270|100500820|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
33160894|NCT00036270|100500821|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
33160895|NCT00036270|100500820|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
33160896|NCT00036270|100500821|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
33160897|NCT00036270|100500820|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
33160898|NCT00036270|100500821|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
33160899|NCT01781975|100500822|FG000|Overall Study|Death|1|||
33160900|NCT01781975|100500823|FG001|Overall Study|Death|0|||
33160901|NCT01781975|100500822|FG000|Overall Study|Withdrawal by Subject|1|||
33160902|NCT01781975|100500823|FG001|Overall Study|Withdrawal by Subject|1|||
33160903|NCT01999868|100500824|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
33160904|NCT01999868|100500825|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
33160905|NCT01999868|100500826|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
33160906|NCT01999868|100500824|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
33160907|NCT01999868|100500825|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
33160908|NCT01999868|100500826|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
33160909|NCT01999868|100500824|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
33255338|NCT01135511|100837057|FG003|Overall Study|could not visit the clinic|0|||
33255339|NCT01135511|100837058|FG004|Overall Study|could not visit the clinic|0|||
33255340|NCT01135511|100837059|FG005|Overall Study|could not visit the clinic|0|||
33442520|NCT00420238|101515453|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
33442521|NCT00420238|101515454|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
33442522|NCT00420238|101515453|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
33255341|NCT01135511|100837060|FG006|Overall Study|could not visit the clinic|0|||
33255342|NCT01135511|100837061|FG007|Overall Study|could not visit the clinic|0|||
33255343|NCT01135511|100837062|FG008|Overall Study|could not visit the clinic|0|||
33255344|NCT01135511|100837054|FG000|Overall Study|noncompliance with study drug taken|0|||
33255345|NCT01135511|100837055|FG001|Overall Study|noncompliance with study drug taken|0|||
33255346|NCT01135511|100837056|FG002|Overall Study|noncompliance with study drug taken|0|||
33255347|NCT01135511|100837057|FG003|Overall Study|noncompliance with study drug taken|0|||
33255348|NCT01135511|100837058|FG004|Overall Study|noncompliance with study drug taken|1|||
33255349|NCT01135511|100837059|FG005|Overall Study|noncompliance with study drug taken|0|||
33255350|NCT01135511|100837060|FG006|Overall Study|noncompliance with study drug taken|0|||
33255351|NCT01135511|100837061|FG007|Overall Study|noncompliance with study drug taken|0|||
33255352|NCT01135511|100837062|FG008|Overall Study|noncompliance with study drug taken|0|||
33255353|NCT01135511|100837054|FG000|Overall Study|Withdrawal by Subject|0|||
33255354|NCT01135511|100837055|FG001|Overall Study|Withdrawal by Subject|0|||
33255355|NCT01135511|100837056|FG002|Overall Study|Withdrawal by Subject|0|||
33255356|NCT01135511|100837057|FG003|Overall Study|Withdrawal by Subject|0|||
33255357|NCT01135511|100837058|FG004|Overall Study|Withdrawal by Subject|0|||
33255358|NCT01135511|100837059|FG005|Overall Study|Withdrawal by Subject|0|||
33255359|NCT01135511|100837060|FG006|Overall Study|Withdrawal by Subject|1|||
33255360|NCT01135511|100837061|FG007|Overall Study|Withdrawal by Subject|0|||
33255361|NCT01135511|100837062|FG008|Overall Study|Withdrawal by Subject|1|||
33255362|NCT01968226|100837072|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
33255363|NCT01616459|100837073|FG000|Overall Study|Adverse Event|1|||
33255364|NCT01616459|100837074|FG001|Overall Study|Adverse Event|1|||
33255365|NCT01616459|100837075|FG002|Overall Study|Adverse Event|2|||
33255366|NCT01616459|100837076|FG003|Overall Study|Adverse Event|0|||
33255367|NCT01616459|100837073|FG000|Overall Study|Lost to Follow-up|1|||
33255368|NCT01616459|100837074|FG001|Overall Study|Lost to Follow-up|11|||
33255369|NCT01616459|100837075|FG002|Overall Study|Lost to Follow-up|3|||
33255370|NCT01616459|100837076|FG003|Overall Study|Lost to Follow-up|2|||
33255371|NCT01616459|100837073|FG000|Overall Study|Protocol Violation|0|||
33255372|NCT01616459|100837074|FG001|Overall Study|Protocol Violation|0|||
33255373|NCT01616459|100837075|FG002|Overall Study|Protocol Violation|0|||
33255374|NCT01616459|100837076|FG003|Overall Study|Protocol Violation|2|||
33160910|NCT01999868|100500825|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
33160911|NCT01999868|100500826|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
33160912|NCT01999868|100500824|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
33160913|NCT01999868|100500825|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
33160914|NCT01999868|100500826|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
33160915|NCT01999868|100500824|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
33160916|NCT01999868|100500825|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
33160917|NCT01999868|100500826|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
33160918|NCT01999868|100500824|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
33160919|NCT01999868|100500825|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
33160920|NCT01999868|100500826|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
33160921|NCT01999868|100500824|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
33160922|NCT01999868|100500825|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
33160923|NCT01999868|100500826|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
33160924|NCT01999868|100500824|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
33160925|NCT01999868|100500825|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
33160926|NCT01999868|100500826|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
33255375|NCT01616459|100837073|FG000|Overall Study|Withdrawal by Subject|2|||
33255376|NCT01616459|100837074|FG001|Overall Study|Withdrawal by Subject|4|||
33255377|NCT01616459|100837075|FG002|Overall Study|Withdrawal by Subject|4|||
33255378|NCT01616459|100837076|FG003|Overall Study|Withdrawal by Subject|4|||
33255379|NCT01616459|100837073|FG000|Overall Study|Other reason|0|||
33255380|NCT01616459|100837074|FG001|Overall Study|Other reason|1|||
33255381|NCT01616459|100837075|FG002|Overall Study|Other reason|1|||
33255382|NCT01616459|100837076|FG003|Overall Study|Other reason|0|||
33255383|NCT02528188|100837077|FG000|Overall Study|Adverse Event|23|||
33255384|NCT02528188|100837078|FG001|Overall Study|Adverse Event|22|||
33255385|NCT02528188|100837079|FG002|Overall Study|Adverse Event|8|||
33255386|NCT02528188|100837077|FG000|Overall Study|Protocol Violation|4|||
33255387|NCT02528188|100837078|FG001|Overall Study|Protocol Violation|6|||
33255388|NCT02528188|100837079|FG002|Overall Study|Protocol Violation|4|||
33255389|NCT02528188|100837077|FG000|Overall Study|Lack of Efficacy|19|||
33255390|NCT02528188|100837078|FG001|Overall Study|Lack of Efficacy|21|||
33255391|NCT02528188|100837079|FG002|Overall Study|Lack of Efficacy|22|||
33255392|NCT02528188|100837077|FG000|Overall Study|Withdrawal by Subject|97|||
33255393|NCT02528188|100837078|FG001|Overall Study|Withdrawal by Subject|104|||
33255394|NCT02528188|100837079|FG002|Overall Study|Withdrawal by Subject|100|||
33255395|NCT02528188|100837077|FG000|Overall Study|Lost to Follow-up|25|||
33255396|NCT02528188|100837078|FG001|Overall Study|Lost to Follow-up|21|||
33255397|NCT02528188|100837079|FG002|Overall Study|Lost to Follow-up|31|||
33255398|NCT02528188|100837077|FG000|Overall Study|Death|4|||
33255399|NCT02528188|100837078|FG001|Overall Study|Death|4|||
33255400|NCT02528188|100837079|FG002|Overall Study|Death|0|||
33255401|NCT02528188|100837077|FG000|Overall Study|Other|89|||
33255402|NCT02528188|100837078|FG001|Overall Study|Other|91|||
33255403|NCT02528188|100837079|FG002|Overall Study|Other|74|||
33255404|NCT02528188|100837077|FG000|Overall Study|Randomized but not treated|6|||
33255405|NCT02528188|100837078|FG001|Overall Study|Randomized but not treated|7|||
33255406|NCT02528188|100837079|FG002|Overall Study|Randomized but not treated|12|||
33255407|NCT04054635|100837080|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
33255408|NCT04054635|100837081|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
33255409|NCT04054635|100837082|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
33255410|NCT04054635|100837080|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
33255411|NCT04054635|100837081|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
33255412|NCT04054635|100837082|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
33255413|NCT01087762|100837084|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
33255414|NCT01087762|100837085|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
33255415|NCT01087762|100837086|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
33255416|NCT01087762|100837087|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
33255417|NCT01087762|100837088|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
33255418|NCT01087762|100837084|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
33255419|NCT01087762|100837085|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
33255420|NCT01087762|100837086|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
33255421|NCT01087762|100837087|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
33255422|NCT01087762|100837088|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
33255423|NCT01087762|100837084|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
33255424|NCT01087762|100837085|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
33255425|NCT01087762|100837086|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
33255426|NCT01087762|100837087|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
33255427|NCT01087762|100837088|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
33255428|NCT01087762|100837084|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
33255429|NCT01087762|100837085|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
33255430|NCT01087762|100837086|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
33255431|NCT01087762|100837087|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
33255432|NCT01087762|100837088|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
33255433|NCT01087762|100837084|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
33255434|NCT01087762|100837085|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
33255435|NCT01087762|100837086|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
33255436|NCT01087762|100837087|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
33255437|NCT01087762|100837088|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
33255438|NCT01087762|100837084|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
33255439|NCT01087762|100837085|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
33255440|NCT01087762|100837086|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
33255441|NCT01087762|100837087|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
33255442|NCT01087762|100837088|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
33255443|NCT01087762|100837084|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
33255444|NCT01087762|100837085|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
33255445|NCT01087762|100837086|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
33255446|NCT01087762|100837087|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
33255447|NCT01087762|100837088|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
33255448|NCT01087762|100837084|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
33255449|NCT01087762|100837085|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
33255450|NCT01087762|100837086|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
33255451|NCT01087762|100837087|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
33255452|NCT01087762|100837088|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
33255453|NCT01087762|100837084|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
33255454|NCT01087762|100837085|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
33255455|NCT01087762|100837086|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
33255456|NCT01087762|100837087|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
33255457|NCT01087762|100837088|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
33255458|NCT01087762|100837084|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
33255459|NCT01087762|100837085|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
33255460|NCT01087762|100837086|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
33255461|NCT01087762|100837087|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
33255462|NCT01087762|100837088|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
33255463|NCT01087762|100837084|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
33255464|NCT01087762|100837085|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
33255465|NCT01087762|100837086|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
33255466|NCT01087762|100837087|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
33255467|NCT01087762|100837088|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
33255468|NCT01087762|100837084|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
33442523|NCT00420238|101515454|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
33442524|NCT00420238|101515453|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
33442525|NCT00420238|101515454|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
33442526|NCT00420238|101515453|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
33442527|NCT00420238|101515454|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
33442528|NCT00420238|101515453|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
33442529|NCT00420238|101515454|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
33442530|NCT00485472|101515455|FG000|Overall Study|Adverse Event|8|||
33442531|NCT00485472|101515456|FG001|Overall Study|Adverse Event|5|||
33442532|NCT00485472|101515455|FG000|Overall Study|Lack of Efficacy|5|||
33442533|NCT00485472|101515456|FG001|Overall Study|Lack of Efficacy|4|||
33442534|NCT00485472|101515455|FG000|Overall Study|Withdrawal by Subject|1|||
33442535|NCT00485472|101515456|FG001|Overall Study|Withdrawal by Subject|0|||
33442536|NCT00485472|101515455|FG000|Overall Study|Protocol Violation|0|||
33442537|NCT00485472|101515456|FG001|Overall Study|Protocol Violation|1|||
33442538|NCT00485472|101515455|FG000|Overall Study|Other|2|||
33442539|NCT00485472|101515456|FG001|Overall Study|Other|1|||
33442540|NCT00485472|101515455|FG000|Overall Study|Lost to Follow-up|0|||
33442541|NCT00485472|101515456|FG001|Overall Study|Lost to Follow-up|1|||
33442542|NCT00465270|101515457|FG000|Overall Study|Death|7|||
33442543|NCT00465270|101515458|FG001|Overall Study|Death|11|||
33442544|NCT00465270|101515457|FG000|Overall Study|Withdrawal by Subject|34|||
33442545|NCT00465270|101515458|FG001|Overall Study|Withdrawal by Subject|78|||
33442546|NCT00465270|101515457|FG000|Overall Study|Lost to Follow-up|60|||
33442547|NCT00465270|101515458|FG001|Overall Study|Lost to Follow-up|67|||
33442548|NCT00465270|101515457|FG000|Overall Study|Investigator request|3|||
33442549|NCT00465270|101515458|FG001|Overall Study|Investigator request|4|||
33442550|NCT03478397|101515460|FG000|Overall Study|Refused to participate|31|||
33442551|NCT03478397|101515461|FG001|Overall Study|Refused to participate|7|||
33442552|NCT02918877|101515462|FG000|Overall Study|Withdrawal by Subject|2|||
33442553|NCT02918877|101515463|FG001|Overall Study|Withdrawal by Subject|2|||
33442554|NCT02918877|101515462|FG000|Overall Study|Surgery cancelled|1|||
33442555|NCT02918877|101515463|FG001|Overall Study|Surgery cancelled|0|||
33442556|NCT02918877|101515462|FG000|Overall Study|Physician Decision|1|||
33255469|NCT01087762|100837085|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
33255470|NCT01087762|100837086|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
33255471|NCT01087762|100837087|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
33255472|NCT01087762|100837088|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
33255473|NCT01087762|100837084|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
33255474|NCT01087762|100837085|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
33255475|NCT01087762|100837086|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
33255476|NCT01087762|100837087|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
33255477|NCT01087762|100837088|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
33255478|NCT00529659|100837089|FG000|Overall Study|Adverse Event|8|||
33255479|NCT00529659|100837090|FG001|Overall Study|Adverse Event|7|||
33255480|NCT00529659|100837089|FG000|Overall Study|Lost to Follow-up|0|||
33255481|NCT00529659|100837090|FG001|Overall Study|Lost to Follow-up|2|||
33442557|NCT02918877|101515463|FG001|Overall Study|Physician Decision|0|||
33442558|NCT02918877|101515462|FG000|Overall Study|Received intraoperative steroids|1|||
33442559|NCT02918877|101515463|FG001|Overall Study|Received intraoperative steroids|0|||
33442560|NCT02918877|101515462|FG000|Overall Study|Unable to obtain lab samples|1|||
33442561|NCT02918877|101515463|FG001|Overall Study|Unable to obtain lab samples|0|||
33442562|NCT02918877|101515462|FG000|Overall Study|Unsafe to perform BAL|0|||
33442563|NCT02918877|101515463|FG001|Overall Study|Unsafe to perform BAL|1|||
33442564|NCT01675622|101515464|FG000|Overall Study|Withdrawal by Subject|2|||
33442565|NCT01675622|101515465|FG001|Overall Study|Withdrawal by Subject|2|||
33442566|NCT01675622|101515464|FG000|Overall Study|Adverse Event|12|||
33442567|NCT01675622|101515465|FG001|Overall Study|Adverse Event|10|||
33442568|NCT01675622|101515464|FG000|Overall Study|Protocol Violation|4|||
33442569|NCT01675622|101515465|FG001|Overall Study|Protocol Violation|1|||
33442570|NCT01675622|101515464|FG000|Overall Study|Lack of Efficacy|2|||
33255482|NCT00529659|100837089|FG000|Overall Study|Physician Decision|0|||
33255483|NCT00529659|100837090|FG001|Overall Study|Physician Decision|2|||
33255484|NCT00529659|100837089|FG000|Overall Study|Protocol Violation|2|||
33255485|NCT00529659|100837090|FG001|Overall Study|Protocol Violation|6|||
33255486|NCT00529659|100837089|FG000|Overall Study|Withdrawal by Subject|1|||
33255487|NCT00529659|100837090|FG001|Overall Study|Withdrawal by Subject|6|||
33255488|NCT01662336|100837097|FG000|Overall Study|Adverse Event|1|||
33255489|NCT01662336|100837097|FG000|Overall Study|No longer on LPV/r|30|||
33255490|NCT01662336|100837097|FG000|Overall Study|Other|29|||
33255491|NCT01662336|100837097|FG000|Overall Study|Withdrawal by Subject|6|||
33255492|NCT00566527|100837098|FG000|Overall Study|Reason not provided|3|||
33255493|NCT00566527|100837099|FG001|Overall Study|Reason not provided|11|||
33255494|NCT00566527|100837100|FG002|Overall Study|Reason not provided|10|||
33255495|NCT00566527|100837098|FG000|Overall Study|Adverse Event|2|||
33255496|NCT00566527|100837099|FG001|Overall Study|Adverse Event|0|||
33255497|NCT00566527|100837100|FG002|Overall Study|Adverse Event|1|||
33255498|NCT00566527|100837098|FG000|Overall Study|Physician Decision|3|||
33255499|NCT00566527|100837099|FG001|Overall Study|Physician Decision|8|||
33255500|NCT00566527|100837100|FG002|Overall Study|Physician Decision|20|||
33255501|NCT00566527|100837098|FG000|Overall Study|Lost to Follow-up|3|||
33255502|NCT00566527|100837099|FG001|Overall Study|Lost to Follow-up|4|||
33255503|NCT00566527|100837100|FG002|Overall Study|Lost to Follow-up|4|||
33255504|NCT00566527|100837098|FG000|Overall Study|Withdrawal by Subject|6|||
33255505|NCT00566527|100837099|FG001|Overall Study|Withdrawal by Subject|43|||
33255506|NCT00566527|100837100|FG002|Overall Study|Withdrawal by Subject|43|||
33255507|NCT01867216|100837101|FG000|Overall Study|Withdrawal by Subject|2|||
33255508|NCT01867216|100837102|FG001|Overall Study|Withdrawal by Subject|0|||
33255509|NCT01867216|100837103|FG002|Overall Study|Withdrawal by Subject|0|||
33255510|NCT01867216|100837104|FG003|Overall Study|Withdrawal by Subject|0|||
33255511|NCT01867216|100837105|FG004|Overall Study|Withdrawal by Subject|1|||
33255512|NCT01867216|100837106|FG005|Overall Study|Withdrawal by Subject|0|||
33255513|NCT01867216|100837107|FG006|Overall Study|Withdrawal by Subject|1|||
33255514|NCT01867216|100837101|FG000|Overall Study|Physician Decision|1|||
33255515|NCT01867216|100837102|FG001|Overall Study|Physician Decision|0|||
33255516|NCT01867216|100837103|FG002|Overall Study|Physician Decision|0|||
33255517|NCT01867216|100837104|FG003|Overall Study|Physician Decision|0|||
33255518|NCT01867216|100837105|FG004|Overall Study|Physician Decision|0|||
33255519|NCT01867216|100837106|FG005|Overall Study|Physician Decision|0|||
33255520|NCT01867216|100837107|FG006|Overall Study|Physician Decision|0|||
33255521|NCT01867216|100837101|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
33255522|NCT01867216|100837102|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
33255523|NCT01867216|100837103|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
33255524|NCT01867216|100837104|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
33255525|NCT01867216|100837105|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
33255526|NCT01867216|100837106|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
33160927|NCT01999868|100500824|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
33160928|NCT01999868|100500825|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
33160929|NCT01999868|100500826|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
33160930|NCT01999868|100500824|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
33160931|NCT01999868|100500825|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
33160932|NCT01999868|100500826|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
33160933|NCT01999868|100500824|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
33160934|NCT01999868|100500825|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
33160935|NCT01999868|100500826|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
33160936|NCT01999868|100500824|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
33160937|NCT01999868|100500825|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
33160938|NCT01999868|100500826|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
33160939|NCT01999868|100500824|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
33160940|NCT01999868|100500825|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
33160941|NCT01999868|100500826|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
33160942|NCT01999868|100500824|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
33255527|NCT01867216|100837107|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
33255528|NCT01458210|100837109|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
33255529|NCT01458210|100837109|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
33255530|NCT01458210|100837109|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
33255531|NCT01458210|100837109|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
33255532|NCT02506257|100837110|FG000|Overall Study|Adverse Event|0|||
33255533|NCT02506257|100837111|FG001|Overall Study|Adverse Event|2|||
33255534|NCT02506257|100837112|FG002|Overall Study|Adverse Event|3|||
33255535|NCT02506257|100837113|FG003|Overall Study|Adverse Event|0|||
33442571|NCT01675622|101515465|FG001|Overall Study|Lack of Efficacy|4|||
33442572|NCT01675622|101515464|FG000|Overall Study|Lost to Follow-up|1|||
33442573|NCT01675622|101515465|FG001|Overall Study|Lost to Follow-up|3|||
33442574|NCT01675622|101515464|FG000|Overall Study|Other|5|||
33442575|NCT01675622|101515465|FG001|Overall Study|Other|4|||
33442576|NCT02438722|101515468|FG000|Overall Study|Adverse Event|12|||
33442577|NCT02438722|101515469|FG001|Overall Study|Adverse Event|9|||
33442578|NCT02438722|101515468|FG000|Overall Study|Refusal unrelated to AE|2|||
33442579|NCT02438722|101515469|FG001|Overall Study|Refusal unrelated to AE|5|||
33442580|NCT02438722|101515468|FG000|Overall Study|Disease progression/relapse|46|||
33442581|NCT02438722|101515469|FG001|Overall Study|Disease progression/relapse|51|||
33442582|NCT02438722|101515468|FG000|Overall Study|Death|0|||
33442583|NCT02438722|101515469|FG001|Overall Study|Death|3|||
33160943|NCT01999868|100500825|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
33160944|NCT01999868|100500826|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
33160945|NCT01999868|100500824|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
33160946|NCT01999868|100500825|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
33160947|NCT01999868|100500826|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
33160948|NCT01034631|100500827|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
33160949|NCT01034631|100500828|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
33160950|NCT01034631|100500829|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
33160951|NCT01034631|100500827|FG000|Phase II|Not Evaluable per protocol|0|||
33160952|NCT01034631|100500828|FG001|Phase II|Not Evaluable per protocol|0|||
33160953|NCT01034631|100500829|FG002|Phase II|Not Evaluable per protocol|2|||
33442584|NCT02438722|101515468|FG000|Overall Study|Physician Decision|2|||
33442585|NCT02438722|101515469|FG001|Overall Study|Physician Decision|2|||
33160954|NCT01034631|100500827|FG000|Phase II|Determined Ineligible per protocol|0|||
33160955|NCT01034631|100500828|FG001|Phase II|Determined Ineligible per protocol|1|||
33255536|NCT02506257|100837110|FG000|Overall Study|Protocol Violation|0|||
33442586|NCT02438722|101515468|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
33442587|NCT02438722|101515469|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
33442588|NCT02438722|101515468|FG000|Overall Study|Withdrawal by Subject|0|||
33255537|NCT02506257|100837111|FG001|Overall Study|Protocol Violation|0|||
33255538|NCT02506257|100837112|FG002|Overall Study|Protocol Violation|1|||
33255539|NCT02506257|100837113|FG003|Overall Study|Protocol Violation|0|||
33255540|NCT01202955|100837114|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
33255541|NCT01202955|100837115|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
33255542|NCT04057196|100837116|FG000|Overall Study|Withdrawal by Subject|3|||
33255543|NCT04057196|100837116|FG000|Overall Study|Death|3|||
33255544|NCT01563354|100837118|FG000|Core Phase|Adverse Event|5|||
33255545|NCT01563354|100837119|FG001|Core Phase|Adverse Event|15|||
33255546|NCT01563354|100837120|FG002|Core Phase|Adverse Event|13|||
33255547|NCT01563354|100837118|FG000|Core Phase|Withdrawal by Subject|1|||
33255548|NCT01563354|100837119|FG001|Core Phase|Withdrawal by Subject|0|||
33255549|NCT01563354|100837120|FG002|Core Phase|Withdrawal by Subject|3|||
33255550|NCT01563354|100837118|FG000|Core Phase|Lost to Follow-up|1|||
33255551|NCT01563354|100837119|FG001|Core Phase|Lost to Follow-up|0|||
33255552|NCT01563354|100837120|FG002|Core Phase|Lost to Follow-up|0|||
33255553|NCT01563354|100837118|FG000|Core Phase|Death|1|||
33255554|NCT01563354|100837119|FG001|Core Phase|Death|5|||
33255555|NCT01563354|100837120|FG002|Core Phase|Death|2|||
33255556|NCT01563354|100837118|FG000|Core Phase|Diseasse progression|18|||
33255557|NCT01563354|100837119|FG001|Core Phase|Diseasse progression|7|||
33255558|NCT01563354|100837120|FG002|Core Phase|Diseasse progression|8|||
33255559|NCT01563354|100837118|FG000|Core Phase|Protocol deviation|2|||
33255560|NCT01563354|100837119|FG001|Core Phase|Protocol deviation|0|||
33255561|NCT01563354|100837120|FG002|Core Phase|Protocol deviation|0|||
33255562|NCT01563354|100837118|FG000|Core Phase|PI decision - did not enter extension|0|||
33255563|NCT01563354|100837119|FG001|Core Phase|PI decision - did not enter extension|1|||
33255564|NCT01563354|100837120|FG002|Core Phase|PI decision - did not enter extension|0|||
33255565|NCT01563354|100837118|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
33255566|NCT01563354|100837119|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
33255567|NCT01563354|100837120|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
33255568|NCT01563354|100837118|FG000|Extension Phase|Adverse Event|0|||
33255569|NCT01563354|100837119|FG001|Extension Phase|Adverse Event|3|||
33255570|NCT01563354|100837120|FG002|Extension Phase|Adverse Event|2|||
33255571|NCT01563354|100837118|FG000|Extension Phase|Withdrawal by Subject|0|||
33255572|NCT01563354|100837119|FG001|Extension Phase|Withdrawal by Subject|1|||
33255573|NCT01563354|100837120|FG002|Extension Phase|Withdrawal by Subject|0|||
33255574|NCT01563354|100837118|FG000|Extension Phase|Administration problems|3|||
33255575|NCT01563354|100837119|FG001|Extension Phase|Administration problems|2|||
33255576|NCT01563354|100837120|FG002|Extension Phase|Administration problems|3|||
33255577|NCT01563354|100837118|FG000|Extension Phase|Disease progression|9|||
33255578|NCT01563354|100837119|FG001|Extension Phase|Disease progression|8|||
33255579|NCT01563354|100837120|FG002|Extension Phase|Disease progression|10|||
33255580|NCT02200770|100837121|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
33255581|NCT02200770|100837122|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
33255582|NCT02200770|100837121|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
33255583|NCT02200770|100837122|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
33255584|NCT02200770|100837121|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
33255585|NCT02200770|100837122|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
33255586|NCT02200770|100837121|FG000|Randomized-controlled Period (RCP)|Other|1|||
33255587|NCT02200770|100837122|FG001|Randomized-controlled Period (RCP)|Other|2|||
33255588|NCT02200770|100837121|FG000|Open-label Period (OLP)|Adverse Event|1|||
33255589|NCT02200770|100837122|FG001|Open-label Period (OLP)|Adverse Event|2|||
33255590|NCT02200770|100837121|FG000|Open-label Period (OLP)|Death|1|||
33160956|NCT01034631|100500829|FG002|Phase II|Determined Ineligible per protocol|0|||
33160957|NCT00868608|100500832|FG000|Overall Study|Withdrawal by Subject|3|||
33255591|NCT02200770|100837122|FG001|Open-label Period (OLP)|Death|2|||
33255592|NCT02200770|100837121|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
33442589|NCT02438722|101515469|FG001|Overall Study|Withdrawal by Subject|1|||
33442590|NCT02438722|101515468|FG000|Overall Study|On protocol treatment|15|||
33442591|NCT02438722|101515469|FG001|Overall Study|On protocol treatment|14|||
33160958|NCT00868608|100500833|FG001|Overall Study|Withdrawal by Subject|1|||
33442592|NCT02438722|101515468|FG000|Overall Study|Did not receive protocol treatment|5|||
33255593|NCT02200770|100837122|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
33255594|NCT02200770|100837121|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
33255595|NCT02200770|100837122|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
33255596|NCT02200770|100837121|FG000|Open-label Period (OLP)|Other|6|||
33255597|NCT02200770|100837122|FG001|Open-label Period (OLP)|Other|15|||
33255598|NCT04833855|100837123|FG000|Overall Study|Decision by sponsor|0|||
33255599|NCT04833855|100837124|FG001|Overall Study|Decision by sponsor|1|||
33255600|NCT04833855|100837125|FG002|Overall Study|Decision by sponsor|0|||
33255601|NCT04833855|100837126|FG003|Overall Study|Decision by sponsor|0|||
33255602|NCT04833855|100837123|FG000|Overall Study|Withdrawal by Subject|4|||
33255603|NCT04833855|100837124|FG001|Overall Study|Withdrawal by Subject|1|||
33255604|NCT04833855|100837125|FG002|Overall Study|Withdrawal by Subject|3|||
33255605|NCT04833855|100837126|FG003|Overall Study|Withdrawal by Subject|1|||
33255606|NCT04833855|100837123|FG000|Overall Study|Lost to Follow-up|1|||
33255607|NCT04833855|100837124|FG001|Overall Study|Lost to Follow-up|0|||
33255608|NCT04833855|100837125|FG002|Overall Study|Lost to Follow-up|2|||
33255609|NCT04833855|100837126|FG003|Overall Study|Lost to Follow-up|2|||
33442593|NCT02438722|101515469|FG001|Overall Study|Did not receive protocol treatment|0|||
33442594|NCT03567174|101515470|FG000|Overall Study|Death|24|||
33442595|NCT03567174|101515471|FG001|Overall Study|Death|31|||
33442596|NCT03567174|101515470|FG000|Overall Study|Lost to Follow-up|165|||
33442597|NCT03567174|101515471|FG001|Overall Study|Lost to Follow-up|174|||
33442598|NCT00696020|101515472|FG000|Overall Study|Adverse Event|3|||
33442599|NCT00696020|101515473|FG001|Overall Study|Adverse Event|1|||
33442600|NCT00696020|101515474|FG002|Overall Study|Adverse Event|2|||
33442601|NCT00696020|101515475|FG003|Overall Study|Adverse Event|1|||
33442602|NCT00696020|101515472|FG000|Overall Study|Lack of Efficacy|1|||
33442603|NCT00696020|101515473|FG001|Overall Study|Lack of Efficacy|0|||
33255610|NCT04833855|100837123|FG000|Overall Study|Protocol specified criteria|0|||
33255611|NCT04833855|100837124|FG001|Overall Study|Protocol specified criteria|0|||
33255612|NCT04833855|100837125|FG002|Overall Study|Protocol specified criteria|2|||
33255613|NCT04833855|100837126|FG003|Overall Study|Protocol specified criteria|1|||
33255614|NCT02568683|100837127|FG000|Overall Study|Death|0|||
33255615|NCT02568683|100837128|FG001|Overall Study|Death|2|||
33255616|NCT02568683|100837127|FG000|Overall Study|Withdrew Consent|1|||
33255617|NCT02568683|100837128|FG001|Overall Study|Withdrew Consent|0|||
33255618|NCT02568683|100837127|FG000|Overall Study|Study Terminated By Sponsor|5|||
33255619|NCT02568683|100837128|FG001|Overall Study|Study Terminated By Sponsor|2|||
33255620|NCT02299375|100837129|FG000|Overall Study|Adverse Event, serious fatal|1|||
33255621|NCT02299375|100837130|FG001|Overall Study|Adverse Event, serious fatal|3|||
33255622|NCT02299375|100837129|FG000|Overall Study|Adverse Event, non-fatal|8|||
33255623|NCT02299375|100837130|FG001|Overall Study|Adverse Event, non-fatal|9|||
33255624|NCT02299375|100837129|FG000|Overall Study|Lack of Efficacy|1|||
33255625|NCT02299375|100837130|FG001|Overall Study|Lack of Efficacy|3|||
33442604|NCT00696020|101515474|FG002|Overall Study|Lack of Efficacy|0|||
33442605|NCT00696020|101515475|FG003|Overall Study|Lack of Efficacy|0|||
33442606|NCT00696020|101515472|FG000|Overall Study|Protocol Violation|0|||
33255626|NCT02299375|100837129|FG000|Overall Study|Protocol Violation|1|||
33442607|NCT00696020|101515473|FG001|Overall Study|Protocol Violation|0|||
33442608|NCT00696020|101515474|FG002|Overall Study|Protocol Violation|0|||
33442609|NCT00696020|101515475|FG003|Overall Study|Protocol Violation|1|||
33255627|NCT02299375|100837130|FG001|Overall Study|Protocol Violation|3|||
33255628|NCT02299375|100837129|FG000|Overall Study|Other: Met stopping criteria|1|||
33255629|NCT02299375|100837130|FG001|Overall Study|Other: Met stopping criteria|0|||
33442610|NCT00696020|101515472|FG000|Overall Study|Withdrawal by Subject|0|||
33160959|NCT00868608|100500834|FG002|Overall Study|Withdrawal by Subject|0|||
33160960|NCT00868608|100500832|FG000|Overall Study|Lost to Follow-up|3|||
33160961|NCT00868608|100500833|FG001|Overall Study|Lost to Follow-up|0|||
33160962|NCT00868608|100500834|FG002|Overall Study|Lost to Follow-up|1|||
33160963|NCT00868608|100500832|FG000|Overall Study|Death|16|||
33160964|NCT00868608|100500833|FG001|Overall Study|Death|2|||
33160965|NCT00868608|100500834|FG002|Overall Study|Death|4|||
33160966|NCT00868608|100500832|FG000|Overall Study|Other - Unspecified|1|||
33160967|NCT00868608|100500833|FG001|Overall Study|Other - Unspecified|0|||
33255630|NCT02299375|100837129|FG000|Overall Study|Other: Study closed/terminated|66|||
33255631|NCT02299375|100837130|FG001|Overall Study|Other: Study closed/terminated|55|||
33255632|NCT02299375|100837129|FG000|Overall Study|Lost to Follow-up|0|||
33255633|NCT02299375|100837130|FG001|Overall Study|Lost to Follow-up|2|||
33255634|NCT02299375|100837129|FG000|Overall Study|Physician Decision|1|||
33160968|NCT00868608|100500834|FG002|Overall Study|Other - Unspecified|0|||
33160969|NCT01849783|100500835|FG000|Overall Study|Adverse Event|5|||
33160970|NCT01849783|100500835|FG000|Overall Study|Death|2|||
33160971|NCT01849783|100500835|FG000|Overall Study|Physician Decision|1|||
33160972|NCT01849783|100500835|FG000|Overall Study|Withdrawal by Subject|1|||
33160973|NCT01849783|100500835|FG000|Overall Study|Unable to comply|2|||
33160974|NCT01849783|100500835|FG000|Overall Study|Disease progression|11|||
33160975|NCT00622401|100500836|FG000|Overall Study|Disease progression prior to treatment|3|||
33160976|NCT00622401|100500837|FG001|Overall Study|Disease progression prior to treatment|2|||
33160977|NCT00622401|100500838|FG002|Overall Study|Disease progression prior to treatment|0|||
33160978|NCT00003487|100500839|FG000|Overall Study|Not evaluable|2|||
33160979|NCT01552694|100500846|FG000|Overall Study|Lost to Follow-up|0|||
33160980|NCT01552694|100500847|FG001|Overall Study|Lost to Follow-up|1|||
33160981|NCT01552694|100500846|FG000|Overall Study|Protocol Violation|0|||
33160982|NCT01552694|100500847|FG001|Overall Study|Protocol Violation|1|||
33160983|NCT00762385|100500848|FG000|First Intervention|Lens Issue|1|||
33160984|NCT00762385|100500849|FG001|First Intervention|Lens Issue|1|||
33160985|NCT00762385|100500848|FG000|First Intervention|Lost to Follow-up|0|||
33160986|NCT00762385|100500849|FG001|First Intervention|Lost to Follow-up|2|||
33160987|NCT00762385|100500848|FG000|First Intervention|Ineligible|1|||
33160988|NCT00762385|100500849|FG001|First Intervention|Ineligible|0|||
33160989|NCT00762385|100500848|FG000|First Intervention|Protocol Violation|0|||
33160990|NCT00762385|100500849|FG001|First Intervention|Protocol Violation|1|||
33160991|NCT00762385|100500848|FG000|Second Intervention|Protocol Violation|3|||
33160992|NCT00762385|100500849|FG001|Second Intervention|Protocol Violation|3|||
33255635|NCT02299375|100837130|FG001|Overall Study|Physician Decision|1|||
33255636|NCT02299375|100837129|FG000|Overall Study|Withdrawal by Subject|1|||
33160993|NCT01702961|100500850|FG000|Overall Study|Additional treatment|3|||
33160994|NCT01702961|100500850|FG000|Overall Study|Progressive disease|5|||
33160995|NCT01702961|100500850|FG000|Overall Study|Relapse|20|||
33160996|NCT01702961|100500850|FG000|Overall Study|Death|6|||
33160997|NCT01702961|100500850|FG000|Overall Study|Lost to Follow-up|2|||
33160998|NCT01702961|100500850|FG000|Overall Study|Ongoing|11|||
33388821|NCT00653328|101309367|FG000|Overall Study|Adverse Event|2|||
33160999|NCT00668707|100500851|FG000|Overall Study|Cancer Recurrence|58|||
33161000|NCT00668707|100500852|FG001|Overall Study|Cancer Recurrence|58|||
33161001|NCT00668707|100500851|FG000|Overall Study|Withdrawal by Subject|117|||
33161002|NCT00668707|100500852|FG001|Overall Study|Withdrawal by Subject|100|||
33161003|NCT00668707|100500851|FG000|Overall Study|Lost to Follow-up|3|||
33161004|NCT00668707|100500852|FG001|Overall Study|Lost to Follow-up|6|||
33161005|NCT00668707|100500851|FG000|Overall Study|Protocol Violation|10|||
33161006|NCT00668707|100500852|FG001|Overall Study|Protocol Violation|12|||
33161007|NCT00668707|100500851|FG000|Overall Study|Death|11|||
33161008|NCT00668707|100500852|FG001|Overall Study|Death|4|||
33161009|NCT00986830|100500853|FG000|Overall Study|Death|1|||
33161010|NCT00986830|100500853|FG000|Overall Study|Lost to Follow-up|1|||
33161011|NCT00986830|100500853|FG000|Overall Study|Lack of Efficacy|1|||
33161012|NCT00986830|100500853|FG000|Overall Study|Unable to access sinus with device|5|||
33161013|NCT02657369|100500858|FG000|Overall Study|Death|27|||
33161014|NCT02657369|100500858|FG000|Overall Study|Study terminated by sponsor|7|||
33161015|NCT00300274|100500859|FG000|Overall Study|Withdrawal by Subject|12|||
33161016|NCT00300274|100500860|FG001|Overall Study|Withdrawal by Subject|3|||
33161017|NCT00300274|100500861|FG002|Overall Study|Withdrawal by Subject|14|||
33161018|NCT00300274|100500859|FG000|Overall Study|Lost to Follow-up|3|||
33161019|NCT00300274|100500860|FG001|Overall Study|Lost to Follow-up|4|||
33161020|NCT00300274|100500861|FG002|Overall Study|Lost to Follow-up|5|||
33161021|NCT00300274|100500859|FG000|Overall Study|Death|31|||
33161022|NCT00300274|100500860|FG001|Overall Study|Death|20|||
33161023|NCT00300274|100500861|FG002|Overall Study|Death|25|||
33161024|NCT00300274|100500859|FG000|Overall Study|Re-transplant|0|||
33161025|NCT00300274|100500860|FG001|Overall Study|Re-transplant|0|||
33161026|NCT00300274|100500861|FG002|Overall Study|Re-transplant|1|||
33161027|NCT03372096|100500864|FG000|Overall Study|Study Closed|8|||
33161028|NCT03128411|100500869|FG000|Treatment Phase|Adverse Event|21|||
33161029|NCT03128411|100500869|FG000|Treatment Phase|Physician Decision|1|||
33161030|NCT03128411|100500869|FG000|Treatment Phase|Other|2|||
33161031|NCT03128411|100500869|FG000|Long Term Follow-up Phase|Death|2|||
33161032|NCT02605824|100500870|FG000|Overall Study|Physician Decision|1|||
33161033|NCT02605824|100500871|FG001|Overall Study|Physician Decision|0|||
33161034|NCT00672646|100500874|FG000|Overall Study|Lost to Follow-up|0|||
33161035|NCT00672646|100500875|FG001|Overall Study|Lost to Follow-up|1|||
33161036|NCT00672646|100500876|FG002|Overall Study|Lost to Follow-up|2|||
33161037|NCT00672646|100500874|FG000|Overall Study|Withdrawal by Subject|0|||
33161038|NCT00672646|100500875|FG001|Overall Study|Withdrawal by Subject|0|||
33161039|NCT00672646|100500876|FG002|Overall Study|Withdrawal by Subject|1|||
33161040|NCT01397162|100500877|FG000|Overall Study|Adverse Event|4|||
33255637|NCT02299375|100837130|FG001|Overall Study|Withdrawal by Subject|4|||
33161041|NCT01397162|100500878|FG001|Overall Study|Adverse Event|0|||
33161042|NCT01397162|100500879|FG002|Overall Study|Adverse Event|0|||
33161043|NCT01397162|100500880|FG003|Overall Study|Adverse Event|0|||
33161044|NCT01397162|100500881|FG004|Overall Study|Adverse Event|0|||
33161045|NCT01397162|100500877|FG000|Overall Study|Not yet defined|3|||
33161046|NCT01397162|100500878|FG001|Overall Study|Not yet defined|4|||
33255638|NCT04048135|100837131|FG000|Overall Study|Withdrawal by Subject|1|||
33255639|NCT04048135|100837132|FG001|Overall Study|Withdrawal by Subject|1|||
33255640|NCT04048135|100837133|FG002|Overall Study|Withdrawal by Subject|1|||
33255641|NCT04048135|100837134|FG003|Overall Study|Withdrawal by Subject|2|||
33255642|NCT04048135|100837135|FG004|Overall Study|Withdrawal by Subject|0|||
33255643|NCT04048135|100837136|FG005|Overall Study|Withdrawal by Subject|0|||
33161047|NCT01397162|100500879|FG002|Overall Study|Not yet defined|3|||
33161048|NCT01397162|100500880|FG003|Overall Study|Not yet defined|5|||
33161049|NCT01397162|100500881|FG004|Overall Study|Not yet defined|3|||
33161050|NCT00087607|100500888|FG000|Overall Study|Adverse Event|14|||
33255644|NCT04048135|100837137|FG006|Overall Study|Withdrawal by Subject|1|||
33161051|NCT00087607|100500889|FG001|Overall Study|Adverse Event|24|||
33161052|NCT00087607|100500888|FG000|Overall Study|Death|0|||
33161053|NCT00087607|100500889|FG001|Overall Study|Death|1|||
33161054|NCT00087607|100500888|FG000|Overall Study|Insufficient Therapeutic Response|53|||
33161055|NCT00087607|100500889|FG001|Overall Study|Insufficient Therapeutic Response|42|||
33161056|NCT00087607|100500888|FG000|Overall Study|Failure to return|21|||
33161057|NCT00087607|100500889|FG001|Overall Study|Failure to return|17|||
33161058|NCT00087607|100500888|FG000|Overall Study|Withdrew Consent|12|||
33161059|NCT00087607|100500889|FG001|Overall Study|Withdrew Consent|16|||
33161060|NCT00087607|100500888|FG000|Overall Study|Administrative|12|||
33161061|NCT00087607|100500889|FG001|Overall Study|Administrative|12|||
33161062|NCT00087607|100500888|FG000|Overall Study|Refused Treatment|5|||
33161063|NCT00087607|100500889|FG001|Overall Study|Refused Treatment|7|||
33161064|NCT00087607|100500888|FG000|Overall Study|Other Protocol Violation|5|||
33161065|NCT00087607|100500889|FG001|Overall Study|Other Protocol Violation|2|||
33161066|NCT00087607|100500888|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
33161067|NCT00087607|100500889|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
33161068|NCT02925923|100500890|FG000|Overall Study|blood samples hemolyzed|0|||
33161069|NCT02925923|100500891|FG001|Overall Study|blood samples hemolyzed|2|||
33161070|NCT01348165|100500892|FG000|Overall Study|Adverse Event|0|||
33161071|NCT01348165|100500893|FG001|Overall Study|Adverse Event|0|||
33161072|NCT01348165|100500894|FG002|Overall Study|Adverse Event|0|||
33161073|NCT01348165|100500895|FG003|Overall Study|Adverse Event|0|||
33161074|NCT01348165|100500896|FG004|Overall Study|Adverse Event|0|||
33161075|NCT01348165|100500897|FG005|Overall Study|Adverse Event|0|||
33161076|NCT01348165|100500898|FG006|Overall Study|Adverse Event|1|||
33161077|NCT00751933|100500909|FG000|Overall Study|Withdrawal by Subject|0|||
33161078|NCT00751933|100500910|FG001|Overall Study|Withdrawal by Subject|1|||
33161079|NCT00751933|100500911|FG002|Overall Study|Withdrawal by Subject|0|||
33161080|NCT00751933|100500912|FG003|Overall Study|Withdrawal by Subject|0|||
33161081|NCT00751933|100500909|FG000|Overall Study|Physician Decision|0|||
33161082|NCT00751933|100500910|FG001|Overall Study|Physician Decision|0|||
33161083|NCT00751933|100500911|FG002|Overall Study|Physician Decision|1|||
33161084|NCT00751933|100500912|FG003|Overall Study|Physician Decision|1|||
33161085|NCT03087643|100500913|FG000|Overall Study|Withdrawal by Subject|2|||
33161086|NCT03087643|100500914|FG001|Overall Study|Withdrawal by Subject|4|||
33161087|NCT03087643|100500913|FG000|Overall Study|Death|2|||
33161088|NCT03087643|100500914|FG001|Overall Study|Death|2|||
33161089|NCT01402011|100500915|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
33161090|NCT01402011|100500916|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
33161091|NCT01402011|100500917|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
33161092|NCT01402011|100500915|FG000|Active Treatment Period|Withdrawal by Subject|1|||
33161093|NCT01402011|100500916|FG001|Active Treatment Period|Withdrawal by Subject|3|||
33161094|NCT01402011|100500917|FG002|Active Treatment Period|Withdrawal by Subject|0|||
33161095|NCT01402011|100500915|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
33161096|NCT01402011|100500916|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
33161097|NCT01402011|100500917|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
33161098|NCT01218243|100500918|FG000|Overall Study|Lack of Efficacy|1|||
33161099|NCT01218243|100500919|FG001|Overall Study|Lack of Efficacy|1|||
33161100|NCT01218243|100500918|FG000|Overall Study|Lost to Follow-up|3|||
33161101|NCT01218243|100500919|FG001|Overall Study|Lost to Follow-up|3|||
33161102|NCT01218243|100500918|FG000|Overall Study|Protocol Violation|5|||
33161103|NCT01218243|100500919|FG001|Overall Study|Protocol Violation|10|||
33161104|NCT05399641|100500920|FG000|Overall Study|Adverse Event|0|||
33161105|NCT05399641|100500921|FG001|Overall Study|Adverse Event|1|||
33161106|NCT05399641|100500922|FG002|Overall Study|Adverse Event|1|||
33161107|NCT05399641|100500920|FG000|Overall Study|Lost to Follow-up|1|||
33161108|NCT05399641|100500921|FG001|Overall Study|Lost to Follow-up|2|||
33161109|NCT05399641|100500922|FG002|Overall Study|Lost to Follow-up|2|||
33161110|NCT05399641|100500920|FG000|Overall Study|Physician Decision|1|||
33161111|NCT05399641|100500921|FG001|Overall Study|Physician Decision|3|||
33161112|NCT05399641|100500922|FG002|Overall Study|Physician Decision|3|||
33161113|NCT05399641|100500920|FG000|Overall Study|Withdrawal by Subject|4|||
33161114|NCT05399641|100500921|FG001|Overall Study|Withdrawal by Subject|11|||
33161115|NCT05399641|100500922|FG002|Overall Study|Withdrawal by Subject|7|||
33161116|NCT05399641|100500920|FG000|Overall Study|Reason not defined|3|||
33161117|NCT05399641|100500921|FG001|Overall Study|Reason not defined|5|||
33161118|NCT05399641|100500922|FG002|Overall Study|Reason not defined|6|||
33161119|NCT03724032|100500923|FG000|Overall Study|Physician Decision|1|||
33161120|NCT03724032|100500924|FG001|Overall Study|Physician Decision|0|||
33161121|NCT03724032|100500925|FG002|Overall Study|Physician Decision|0|||
33161122|NCT03724032|100500923|FG000|Overall Study|Protocol Violation|2|||
33161123|NCT03724032|100500924|FG001|Overall Study|Protocol Violation|2|||
33161124|NCT03724032|100500925|FG002|Overall Study|Protocol Violation|1|||
33161125|NCT01133522|100500926|FG000|Overall Study|Withdrawal by Subject|0|||
33161126|NCT01133522|100500927|FG001|Overall Study|Withdrawal by Subject|1|||
33161127|NCT01133522|100500928|FG002|Overall Study|Withdrawal by Subject|0|||
33388822|NCT00653328|101309367|FG000|Overall Study|Disease progression|10|||
33161128|NCT01133522|100500929|FG003|Overall Study|Withdrawal by Subject|1|||
33161129|NCT01133522|100500930|FG004|Overall Study|Withdrawal by Subject|0|||
33161130|NCT01133522|100500931|FG005|Overall Study|Withdrawal by Subject|0|||
33161131|NCT01133522|100500932|FG006|Overall Study|Withdrawal by Subject|0|||
33161132|NCT01133522|100500933|FG007|Overall Study|Withdrawal by Subject|0|||
33161133|NCT01133522|100500934|FG008|Overall Study|Withdrawal by Subject|0|||
33161134|NCT01133522|100500935|FG009|Overall Study|Withdrawal by Subject|0|||
33161135|NCT01133522|100500926|FG000|Overall Study|Physician Decision|0|||
33161136|NCT01133522|100500927|FG001|Overall Study|Physician Decision|0|||
33161137|NCT01133522|100500928|FG002|Overall Study|Physician Decision|0|||
33161138|NCT01133522|100500929|FG003|Overall Study|Physician Decision|0|||
33161139|NCT01133522|100500930|FG004|Overall Study|Physician Decision|1|||
33161140|NCT01133522|100500931|FG005|Overall Study|Physician Decision|0|||
33161141|NCT01133522|100500932|FG006|Overall Study|Physician Decision|0|||
33161142|NCT01133522|100500933|FG007|Overall Study|Physician Decision|0|||
33161143|NCT01133522|100500934|FG008|Overall Study|Physician Decision|0|||
33161144|NCT01133522|100500935|FG009|Overall Study|Physician Decision|0|||
33161145|NCT00705484|100500936|FG000|Overall Study|Adverse Event|28|||
33161146|NCT00705484|100500937|FG001|Overall Study|Adverse Event|27|||
33161147|NCT00705484|100500936|FG000|Overall Study|Lost to Follow-up|169|||
33161148|NCT00705484|100500937|FG001|Overall Study|Lost to Follow-up|250|||
33161149|NCT00705484|100500936|FG000|Overall Study|Withdrawal by Subject|96|||
33161150|NCT00705484|100500937|FG001|Overall Study|Withdrawal by Subject|72|||
33161151|NCT00705484|100500936|FG000|Overall Study|Administrative|89|||
33161152|NCT00705484|100500937|FG001|Overall Study|Administrative|59|||
33161153|NCT00702923|100500942|FG000|Overall Study|Adverse Event|1|||
33161154|NCT00679432|100500949|FG000|Overall Study|Adverse Event|5|||
33161155|NCT00679432|100500950|FG001|Overall Study|Adverse Event|6|||
33161156|NCT00679432|100500951|FG002|Overall Study|Adverse Event|10|||
33161157|NCT00679432|100500952|FG003|Overall Study|Adverse Event|7|||
33161158|NCT00679432|100500949|FG000|Overall Study|Protocol Violation|1|||
33161159|NCT00679432|100500950|FG001|Overall Study|Protocol Violation|1|||
33161160|NCT00679432|100500951|FG002|Overall Study|Protocol Violation|2|||
33161161|NCT00679432|100500952|FG003|Overall Study|Protocol Violation|1|||
33161162|NCT00679432|100500949|FG000|Overall Study|Withdrawal by Subject|8|||
33161163|NCT00679432|100500950|FG001|Overall Study|Withdrawal by Subject|11|||
33161164|NCT00679432|100500951|FG002|Overall Study|Withdrawal by Subject|10|||
33161165|NCT00679432|100500952|FG003|Overall Study|Withdrawal by Subject|9|||
33161166|NCT00679432|100500949|FG000|Overall Study|Lost to Follow-up|1|||
33161167|NCT00679432|100500950|FG001|Overall Study|Lost to Follow-up|5|||
33161168|NCT00679432|100500951|FG002|Overall Study|Lost to Follow-up|4|||
33161169|NCT00679432|100500952|FG003|Overall Study|Lost to Follow-up|2|||
33161170|NCT00679432|100500949|FG000|Overall Study|Physician Decision|3|||
33161171|NCT00679432|100500950|FG001|Overall Study|Physician Decision|2|||
33161172|NCT00679432|100500951|FG002|Overall Study|Physician Decision|2|||
33161173|NCT00679432|100500952|FG003|Overall Study|Physician Decision|2|||
33161174|NCT00679432|100500949|FG000|Overall Study|Sponsor decision|1|||
33161175|NCT00679432|100500950|FG001|Overall Study|Sponsor decision|0|||
33161176|NCT00679432|100500951|FG002|Overall Study|Sponsor decision|0|||
33161177|NCT00679432|100500952|FG003|Overall Study|Sponsor decision|0|||
33161178|NCT00679432|100500949|FG000|Overall Study|Lack of Efficacy|13|||
33161179|NCT00679432|100500950|FG001|Overall Study|Lack of Efficacy|9|||
33161180|NCT00679432|100500951|FG002|Overall Study|Lack of Efficacy|14|||
33161181|NCT00679432|100500952|FG003|Overall Study|Lack of Efficacy|8|||
33161182|NCT00679432|100500949|FG000|Overall Study|Infectious colitis, normal histology|5|||
33161183|NCT00679432|100500950|FG001|Overall Study|Infectious colitis, normal histology|4|||
33161184|NCT00679432|100500951|FG002|Overall Study|Infectious colitis, normal histology|8|||
33161185|NCT00679432|100500952|FG003|Overall Study|Infectious colitis, normal histology|3|||
33161186|NCT00679432|100500949|FG000|Overall Study|Randomization error, return to prior Rx|0|||
33161187|NCT00679432|100500950|FG001|Overall Study|Randomization error, return to prior Rx|0|||
33161188|NCT00679432|100500951|FG002|Overall Study|Randomization error, return to prior Rx|3|||
33161189|NCT00679432|100500952|FG003|Overall Study|Randomization error, return to prior Rx|0|||
33161190|NCT04431453|100500954|FG000|Overall Study|Withdrew Consent|0|||
33161191|NCT04431453|100500955|FG001|Overall Study|Withdrew Consent|1|||
33161192|NCT04431453|100500956|FG002|Overall Study|Withdrew Consent|0|||
33161193|NCT04431453|100500957|FG003|Overall Study|Withdrew Consent|2|||
33161194|NCT04431453|100500958|FG004|Overall Study|Withdrew Consent|0|||
33161195|NCT04431453|100500959|FG005|Overall Study|Withdrew Consent|0|||
33161196|NCT04431453|100500960|FG006|Overall Study|Withdrew Consent|0|||
33161197|NCT04431453|100500961|FG007|Overall Study|Withdrew Consent|0|||
33161198|NCT04431453|100500954|FG000|Overall Study|Death|1|||
33161199|NCT04431453|100500955|FG001|Overall Study|Death|0|||
33161200|NCT04431453|100500956|FG002|Overall Study|Death|0|||
33161201|NCT04431453|100500957|FG003|Overall Study|Death|0|||
33161202|NCT04431453|100500958|FG004|Overall Study|Death|0|||
33161203|NCT04431453|100500959|FG005|Overall Study|Death|0|||
33161204|NCT04431453|100500960|FG006|Overall Study|Death|0|||
33161205|NCT04431453|100500961|FG007|Overall Study|Death|1|||
33161206|NCT04431453|100500954|FG000|Overall Study|Lost to Follow-up|0|||
33161207|NCT04431453|100500955|FG001|Overall Study|Lost to Follow-up|0|||
33161208|NCT04431453|100500956|FG002|Overall Study|Lost to Follow-up|1|||
33161209|NCT04431453|100500957|FG003|Overall Study|Lost to Follow-up|1|||
33255645|NCT04048135|100837138|FG007|Overall Study|Withdrawal by Subject|1|||
33255646|NCT04048135|100837131|FG000|Overall Study|Adverse Event|0|||
33442611|NCT00696020|101515473|FG001|Overall Study|Withdrawal by Subject|1|||
33442612|NCT00696020|101515474|FG002|Overall Study|Withdrawal by Subject|0|||
33442613|NCT00696020|101515475|FG003|Overall Study|Withdrawal by Subject|1|||
33442614|NCT00696020|101515472|FG000|Overall Study|Other not stated above|0|||
33442615|NCT00696020|101515473|FG001|Overall Study|Other not stated above|0|||
33442616|NCT00696020|101515474|FG002|Overall Study|Other not stated above|1|||
33255647|NCT04048135|100837132|FG001|Overall Study|Adverse Event|0|||
33255648|NCT04048135|100837133|FG002|Overall Study|Adverse Event|0|||
33255649|NCT04048135|100837134|FG003|Overall Study|Adverse Event|1|||
33255650|NCT04048135|100837135|FG004|Overall Study|Adverse Event|1|||
33255651|NCT04048135|100837136|FG005|Overall Study|Adverse Event|0|||
33255652|NCT04048135|100837137|FG006|Overall Study|Adverse Event|0|||
33255653|NCT04048135|100837138|FG007|Overall Study|Adverse Event|0|||
33255654|NCT04048135|100837131|FG000|Overall Study|Protocol Violation|0|||
33442617|NCT00696020|101515475|FG003|Overall Study|Other not stated above|1|||
33442618|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Adverse Event|11|||
33442619|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Adverse Event|23|||
33442620|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Adverse Event|29|||
33442621|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Adverse Event|2|||
33442622|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Adverse Event|8|||
33442623|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
33442624|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
33442625|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
33442626|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
33442627|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
33442628|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
33442629|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
33442630|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
33442631|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
33442632|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
33442633|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
33442634|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
33442635|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
33442636|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
33442637|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
33442638|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
33442639|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
33442640|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
33442641|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
33442642|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
33442643|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
33442644|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
33442645|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
33442646|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
33442647|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
33442648|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
33442649|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
33442650|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
33442651|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
33442652|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
33442653|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Move|0|||
33442654|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Move|1|||
33442655|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Move|0|||
33442656|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Move|0|||
33442657|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Move|0|||
33442658|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
33161210|NCT04431453|100500958|FG004|Overall Study|Lost to Follow-up|0|||
33161211|NCT04431453|100500959|FG005|Overall Study|Lost to Follow-up|0|||
33161212|NCT04431453|100500960|FG006|Overall Study|Lost to Follow-up|0|||
33161213|NCT04431453|100500961|FG007|Overall Study|Lost to Follow-up|0|||
33161214|NCT04431453|100500954|FG000|Overall Study|Enrolled but Never Treated|0|||
33161215|NCT04431453|100500955|FG001|Overall Study|Enrolled but Never Treated|0|||
33161216|NCT04431453|100500956|FG002|Overall Study|Enrolled but Never Treated|0|||
33161217|NCT04431453|100500957|FG003|Overall Study|Enrolled but Never Treated|0|||
33161218|NCT04431453|100500958|FG004|Overall Study|Enrolled but Never Treated|1|||
33161219|NCT04431453|100500959|FG005|Overall Study|Enrolled but Never Treated|0|||
33161220|NCT04431453|100500960|FG006|Overall Study|Enrolled but Never Treated|0|||
33161221|NCT04431453|100500961|FG007|Overall Study|Enrolled but Never Treated|0|||
33161222|NCT00621582|100500965|FG000|Overall Study|Adverse Event|7|||
33161223|NCT00621582|100500965|FG000|Overall Study|Protocol Violation|57|||
33161224|NCT00621582|100500965|FG000|Overall Study|Lost to Follow-up|24|||
33161225|NCT00621582|100500965|FG000|Overall Study|issues not identified by investigators|18|||
33161226|NCT02572401|100500968|FG000|Overall Study|Lost to Follow-up|5|||
33161227|NCT02572401|100500969|FG001|Overall Study|Lost to Follow-up|8|||
33161228|NCT02572401|100500970|FG002|Overall Study|Lost to Follow-up|9|||
33161229|NCT02572401|100500971|FG003|Overall Study|Lost to Follow-up|9|||
33161230|NCT02572401|100500968|FG000|Overall Study|Death|0|||
33161231|NCT02572401|100500969|FG001|Overall Study|Death|0|||
33161232|NCT02572401|100500970|FG002|Overall Study|Death|0|||
33161233|NCT02572401|100500971|FG003|Overall Study|Death|1|||
33161234|NCT00845858|100500972|FG000|Overall Study|Withdrawal by Subject|5|||
33161235|NCT00845858|100500973|FG001|Overall Study|Withdrawal by Subject|1|||
33161236|NCT00845858|100500974|FG002|Overall Study|Withdrawal by Subject|1|||
33161237|NCT00845858|100500972|FG000|Overall Study|Adverse Event|3|||
33161238|NCT00845858|100500973|FG001|Overall Study|Adverse Event|8|||
33161239|NCT00845858|100500974|FG002|Overall Study|Adverse Event|4|||
33161240|NCT00845858|100500972|FG000|Overall Study|Protocol Violation|0|||
33161241|NCT00845858|100500973|FG001|Overall Study|Protocol Violation|0|||
33161242|NCT00845858|100500974|FG002|Overall Study|Protocol Violation|1|||
33161243|NCT00845858|100500972|FG000|Overall Study|not eligible|0|||
33161244|NCT00845858|100500973|FG001|Overall Study|not eligible|3|||
33161245|NCT00845858|100500974|FG002|Overall Study|not eligible|2|||
33161246|NCT03173313|100500979|FG000|Overall Study|Lost to Follow-up|2|||
33161247|NCT03173313|100500980|FG001|Overall Study|Lost to Follow-up|3|||
33161248|NCT03173313|100500979|FG000|Overall Study|Withdrawal by Subject|0|||
33161249|NCT03173313|100500980|FG001|Overall Study|Withdrawal by Subject|1|||
33161250|NCT03173313|100500979|FG000|Overall Study|Death|5|||
33161251|NCT03173313|100500980|FG001|Overall Study|Death|0|||
33161252|NCT03173313|100500979|FG000|Overall Study|Physician Decision|1|||
33161253|NCT03173313|100500980|FG001|Overall Study|Physician Decision|0|||
33161254|NCT03173313|100500979|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
33161255|NCT03173313|100500980|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
33161256|NCT03173313|100500979|FG000|Overall Study|Bone Fracture|1|||
33161257|NCT03173313|100500980|FG001|Overall Study|Bone Fracture|0|||
33161258|NCT01273597|100500985|FG000|Overall Study|Adverse Event|5|||
33161259|NCT01273597|100500985|FG000|Overall Study|Underwent Kidney Transplantation|2|||
33161260|NCT01273597|100500985|FG000|Overall Study|Reason Not Reported|1|||
33161261|NCT02339584|100500989|FG000|Overall Study|Adverse Event|11|||
33161262|NCT02339584|100500990|FG001|Overall Study|Adverse Event|7|||
33161263|NCT02339584|100500989|FG000|Overall Study|Lack of Efficacy|0|||
33161264|NCT02339584|100500990|FG001|Overall Study|Lack of Efficacy|1|||
33161265|NCT02339584|100500989|FG000|Overall Study|Physician Decision|1|||
33161266|NCT02339584|100500990|FG001|Overall Study|Physician Decision|2|||
33161267|NCT02339584|100500989|FG000|Overall Study|Protocol Violation|1|||
33161268|NCT02339584|100500990|FG001|Overall Study|Protocol Violation|1|||
33161269|NCT02339584|100500989|FG000|Overall Study|Withdrawal by Subject|2|||
33161270|NCT02339584|100500990|FG001|Overall Study|Withdrawal by Subject|4|||
33161271|NCT01786668|100500991|FG000|Overall Study|Adverse Event|0|||
33161272|NCT01786668|100500992|FG001|Overall Study|Adverse Event|1|||
33161273|NCT01786668|100500993|FG002|Overall Study|Adverse Event|1|||
33161274|NCT01786668|100500994|FG003|Overall Study|Adverse Event|2|||
33161275|NCT01786668|100500991|FG000|Overall Study|Withdrawal by Subject|0|||
33161276|NCT01786668|100500992|FG001|Overall Study|Withdrawal by Subject|0|||
33161277|NCT01786668|100500993|FG002|Overall Study|Withdrawal by Subject|3|||
33161278|NCT01786668|100500994|FG003|Overall Study|Withdrawal by Subject|1|||
33161279|NCT01786668|100500991|FG000|Overall Study|Pregnancy|0|||
33161280|NCT01786668|100500992|FG001|Overall Study|Pregnancy|0|||
33161281|NCT01786668|100500993|FG002|Overall Study|Pregnancy|0|||
33161282|NCT01786668|100500994|FG003|Overall Study|Pregnancy|1|||
33161283|NCT01786668|100500991|FG000|Overall Study|Lost to Follow-up|1|||
33161284|NCT01786668|100500992|FG001|Overall Study|Lost to Follow-up|0|||
33161285|NCT01786668|100500993|FG002|Overall Study|Lost to Follow-up|1|||
33161286|NCT01786668|100500994|FG003|Overall Study|Lost to Follow-up|0|||
33161287|NCT03338010|100500995|FG000|Overall Study|Withdrawal by Subject|14|||
33161288|NCT03338010|100500996|FG001|Overall Study|Withdrawal by Subject|8|||
33161289|NCT03338010|100500995|FG000|Overall Study|Lost to Follow-up|4|||
33161290|NCT03338010|100500996|FG001|Overall Study|Lost to Follow-up|2|||
33161291|NCT03338010|100500995|FG000|Overall Study|Adverse Event|3|||
33161292|NCT03338010|100500996|FG001|Overall Study|Adverse Event|2|||
33161293|NCT03338010|100500995|FG000|Overall Study|Physician Decision|2|||
33161294|NCT03338010|100500996|FG001|Overall Study|Physician Decision|2|||
33161295|NCT03338010|100500995|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33161296|NCT03338010|100500996|FG001|Overall Study|Non-Compliance with Study Drug|3|||
33161297|NCT03338010|100500995|FG000|Overall Study|Protocol Violation|0|||
33161298|NCT03338010|100500996|FG001|Overall Study|Protocol Violation|1|||
33161299|NCT00115739|100500997|FG000|Overall Study|Lost to Follow-up|3|||
33161300|NCT00538291|100500998|FG000|Overall Study|Adverse Event|2|||
33161301|NCT00538291|100500998|FG000|Overall Study|Withdrawal by Subject|1|||
33161302|NCT03741062|100500999|FG000|Overall Study|Protocol Violation|1|||
33161303|NCT03741062|100501000|FG001|Overall Study|Protocol Violation|0|||
33161304|NCT04066023|100501012|FG000|Overall Study|Adverse Event|0|||
33161305|NCT04066023|100501013|FG001|Overall Study|Adverse Event|0|||
33161306|NCT04066023|100501014|FG002|Overall Study|Adverse Event|1|||
33161307|NCT04066023|100501012|FG000|Overall Study|Sponsor decision|3|||
33161308|NCT04066023|100501013|FG001|Overall Study|Sponsor decision|6|||
33161309|NCT04066023|100501014|FG002|Overall Study|Sponsor decision|2|||
33161310|NCT04066023|100501012|FG000|Overall Study|Physician Decision|0|||
33161311|NCT04066023|100501013|FG001|Overall Study|Physician Decision|0|||
33161312|NCT04066023|100501014|FG002|Overall Study|Physician Decision|1|||
33161313|NCT04066023|100501012|FG000|Overall Study|Lost to Follow-up|0|||
33161314|NCT04066023|100501013|FG001|Overall Study|Lost to Follow-up|1|||
33161315|NCT04066023|100501014|FG002|Overall Study|Lost to Follow-up|1|||
33161316|NCT04066023|100501012|FG000|Overall Study|Noncompliance|0|||
33161317|NCT04066023|100501013|FG001|Overall Study|Noncompliance|1|||
33161318|NCT04066023|100501014|FG002|Overall Study|Noncompliance|1|||
33161319|NCT00378378|100501015|FG000|Overall Study|Withdrawal by Subject|0|||
33161320|NCT00378378|100501016|FG001|Overall Study|Withdrawal by Subject|1|||
33161321|NCT00378378|100501017|FG002|Overall Study|Withdrawal by Subject|0|||
33161322|NCT00378378|100501015|FG000|Overall Study|Treatment Failure|0|||
33161323|NCT00378378|100501016|FG001|Overall Study|Treatment Failure|0|||
33161324|NCT00378378|100501017|FG002|Overall Study|Treatment Failure|1|||
33161325|NCT00378378|100501015|FG000|Overall Study|Non-compliance with protocol|0|||
33161326|NCT00378378|100501016|FG001|Overall Study|Non-compliance with protocol|0|||
33161327|NCT00378378|100501017|FG002|Overall Study|Non-compliance with protocol|1|||
33161328|NCT00453063|100501018|FG000|Overall Study|Adverse Event|1|||
33161329|NCT00453063|100501019|FG001|Overall Study|Adverse Event|2|||
33161330|NCT00453063|100501018|FG000|Overall Study|Withdrawal by Subject|1|||
33161331|NCT00453063|100501019|FG001|Overall Study|Withdrawal by Subject|1|||
33161332|NCT00453063|100501018|FG000|Overall Study|Protocol Violation|1|||
33161333|NCT00453063|100501019|FG001|Overall Study|Protocol Violation|0|||
33161334|NCT02192359|100501020|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
33161335|NCT02192359|100501021|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
33161336|NCT02192359|100501022|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
33161337|NCT02192359|100501023|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
33161338|NCT02192359|100501020|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
33161339|NCT02192359|100501021|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
33161340|NCT02192359|100501022|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
33161341|NCT02192359|100501023|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
33161342|NCT02192359|100501020|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
33161343|NCT02192359|100501021|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
33161344|NCT02192359|100501022|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
33161345|NCT02192359|100501023|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
33161346|NCT00717093|100501034|FG000|Overall Study|Adverse Event|19|||
33161347|NCT00717093|100501035|FG001|Overall Study|Adverse Event|9|||
33161348|NCT00717093|100501034|FG000|Overall Study|Lack of Efficacy|3|||
33161349|NCT00717093|100501035|FG001|Overall Study|Lack of Efficacy|13|||
33161350|NCT00717093|100501034|FG000|Overall Study|Lost to Follow-up|9|||
33161351|NCT00717093|100501035|FG001|Overall Study|Lost to Follow-up|6|||
33161352|NCT00717093|100501034|FG000|Overall Study|Withdrawal by Subject|12|||
33161353|NCT00717093|100501035|FG001|Overall Study|Withdrawal by Subject|19|||
33161354|NCT00717093|100501034|FG000|Overall Study|Other|0|||
33161355|NCT00717093|100501035|FG001|Overall Study|Other|1|||
33161356|NCT00717093|100501034|FG000|Overall Study|Randomized but not treated|1|||
33161357|NCT00717093|100501035|FG001|Overall Study|Randomized but not treated|0|||
33161358|NCT03725852|100501039|FG000|Overall Study|Death|1|||
33161359|NCT03725852|100501040|FG001|Overall Study|Death|0|||
33161360|NCT03725852|100501039|FG000|Overall Study|Withdrawal by Subject|1|||
33161361|NCT03725852|100501040|FG001|Overall Study|Withdrawal by Subject|0|||
33161362|NCT03725852|100501039|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
33161363|NCT03725852|100501040|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
33161364|NCT01300650|100501043|FG000|Overall Study|Adverse Event|1|||
33161365|NCT00129272|100501045|FG000|Overall Study|Lost to Follow-up|12|||
33161366|NCT00129272|100501046|FG001|Overall Study|Lost to Follow-up|11|||
33161367|NCT00129272|100501045|FG000|Overall Study|Withdrawal by Subject|5|||
33161368|NCT00129272|100501046|FG001|Overall Study|Withdrawal by Subject|11|||
33161369|NCT00934089|100501047|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
33161370|NCT00934089|100501048|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
33161371|NCT00934089|100501047|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
33161372|NCT00934089|100501048|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
33161373|NCT00191139|100501051|FG000|Overall Study|Adverse Event|2|||
33161374|NCT00191139|100501052|FG001|Overall Study|Adverse Event|6|||
33161375|NCT00191139|100501051|FG000|Overall Study|Death|2|||
33161376|NCT00191139|100501052|FG001|Overall Study|Death|0|||
33161377|NCT00191139|100501051|FG000|Overall Study|Withdrawal by Subject|0|||
33161378|NCT00191139|100501052|FG001|Overall Study|Withdrawal by Subject|3|||
33161379|NCT00191139|100501051|FG000|Overall Study|Disease Progression|0|||
33161380|NCT00191139|100501052|FG001|Overall Study|Disease Progression|1|||
33161381|NCT00191139|100501051|FG000|Overall Study|Other|1|||
33161382|NCT00191139|100501052|FG001|Overall Study|Other|2|||
33161383|NCT00873015|100501054|FG000|Overall Study|Withdrawal by Subject|0|||
33161384|NCT00873015|100501055|FG001|Overall Study|Withdrawal by Subject|1|||
33161385|NCT00873015|100501056|FG002|Overall Study|Withdrawal by Subject|0|||
33161386|NCT00873015|100501057|FG003|Overall Study|Withdrawal by Subject|0|||
33161387|NCT02151110|100501064|FG000|Overall Study|Withdrawal by Subject|0|||
33255655|NCT04048135|100837132|FG001|Overall Study|Protocol Violation|0|||
33161388|NCT02151110|100501065|FG001|Overall Study|Withdrawal by Subject|0|||
33161389|NCT02151110|100501066|FG002|Overall Study|Withdrawal by Subject|0|||
33161390|NCT02151110|100501067|FG003|Overall Study|Withdrawal by Subject|0|||
33161391|NCT02151110|100501068|FG004|Overall Study|Withdrawal by Subject|0|||
33161392|NCT02151110|100501069|FG005|Overall Study|Withdrawal by Subject|0|||
33161393|NCT02151110|100501070|FG006|Overall Study|Withdrawal by Subject|0|||
33161394|NCT02151110|100501071|FG007|Overall Study|Withdrawal by Subject|1|||
33161395|NCT02151110|100501064|FG000|Overall Study|Lost to Follow-up|0|||
33161396|NCT02151110|100501065|FG001|Overall Study|Lost to Follow-up|0|||
33161397|NCT02151110|100501066|FG002|Overall Study|Lost to Follow-up|0|||
33161398|NCT02151110|100501067|FG003|Overall Study|Lost to Follow-up|0|||
33161399|NCT02151110|100501068|FG004|Overall Study|Lost to Follow-up|0|||
33161400|NCT02151110|100501069|FG005|Overall Study|Lost to Follow-up|0|||
33161401|NCT02151110|100501070|FG006|Overall Study|Lost to Follow-up|0|||
33161402|NCT02151110|100501071|FG007|Overall Study|Lost to Follow-up|2|||
33161403|NCT01976338|100504287|FG000|Overall Study|Physician Decision|0|||
33161404|NCT01976338|100504288|FG001|Overall Study|Physician Decision|1|||
33161405|NCT01976338|100504287|FG000|Overall Study|Lost to Follow-up|3|||
33161406|NCT01976338|100504288|FG001|Overall Study|Lost to Follow-up|0|||
33161407|NCT01976338|100504287|FG000|Overall Study|Withdrawal by Subject|5|||
33161408|NCT01976338|100504288|FG001|Overall Study|Withdrawal by Subject|2|||
33161409|NCT01976338|100504287|FG000|Overall Study|Adverse Event|5|||
33161410|NCT01976338|100504288|FG001|Overall Study|Adverse Event|1|||
33161411|NCT01091974|100504291|FG000|Overall Study|Did not start intervention|3|||
33161412|NCT01091974|100504292|FG001|Overall Study|Did not start intervention|1|||
33161413|NCT01091974|100504293|FG002|Overall Study|Did not start intervention|3|||
33161414|NCT01091974|100504294|FG003|Overall Study|Did not start intervention|1|||
33161415|NCT01091974|100504291|FG000|Overall Study|resumed sleep medication|0|||
33161416|NCT01091974|100504292|FG001|Overall Study|resumed sleep medication|0|||
33161417|NCT01091974|100504293|FG002|Overall Study|resumed sleep medication|1|||
33161418|NCT01091974|100504294|FG003|Overall Study|resumed sleep medication|2|||
33161419|NCT01091974|100504291|FG000|Overall Study|Withdrawal by Subject|1|||
33161420|NCT01091974|100504292|FG001|Overall Study|Withdrawal by Subject|3|||
33161421|NCT01091974|100504293|FG002|Overall Study|Withdrawal by Subject|2|||
33161422|NCT01091974|100504294|FG003|Overall Study|Withdrawal by Subject|2|||
33161423|NCT01091974|100504291|FG000|Overall Study|side-effects|1|||
33161424|NCT01091974|100504292|FG001|Overall Study|side-effects|1|||
33161425|NCT01091974|100504293|FG002|Overall Study|side-effects|0|||
33161426|NCT01091974|100504294|FG003|Overall Study|side-effects|2|||
33161427|NCT01921387|100504295|FG000|Overall Study|Adverse Event|1|||
33161428|NCT01471171|100504296|FG000|Treatment Period 1|Adverse Event|4|||
33161429|NCT01471171|100504297|FG001|Treatment Period 1|Adverse Event|1|||
33161430|NCT01471171|100504296|FG000|Treatment Period 2|Adverse Event|1|||
33161431|NCT01471171|100504297|FG001|Treatment Period 2|Adverse Event|0|||
33161432|NCT01218113|100504298|FG000|Overall Study|Withdrawal by Subject|1|||
33161433|NCT01218113|100504299|FG001|Overall Study|Withdrawal by Subject|0|||
33161434|NCT01218113|100504300|FG002|Overall Study|Withdrawal by Subject|1|||
33161435|NCT01218113|100504298|FG000|Overall Study|Lost to Follow-up|4|||
33161436|NCT01218113|100504299|FG001|Overall Study|Lost to Follow-up|1|||
33161437|NCT01218113|100504300|FG002|Overall Study|Lost to Follow-up|4|||
33161438|NCT01218113|100504298|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
33161439|NCT01218113|100504299|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
33161440|NCT01218113|100504300|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
33161441|NCT03302234|100504301|FG000|Overall Study|Death|191|||
33161442|NCT03302234|100504302|FG001|Overall Study|Death|192|||
33161443|NCT03302234|100504301|FG000|Overall Study|Withdrawal by Subject|2|||
33161444|NCT03302234|100504302|FG001|Overall Study|Withdrawal by Subject|2|||
33161445|NCT03302234|100504301|FG000|Overall Study|Sponsor Decision|90|||
33161446|NCT03302234|100504302|FG001|Overall Study|Sponsor Decision|89|||
33161447|NCT03302234|100504301|FG000|Overall Study|Laryngeal carcinoma|0|||
33161448|NCT03302234|100504302|FG001|Overall Study|Laryngeal carcinoma|1|||
33161449|NCT03302234|100504301|FG000|Overall Study|Not Reported|1|||
33161450|NCT03302234|100504302|FG001|Overall Study|Not Reported|0|||
33161451|NCT01086033|100504307|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
33161452|NCT01086033|100504307|FG000|Overall Study|Lost to Follow-up|86|||
33161453|NCT01086033|100504307|FG000|Overall Study|Adverse Event|42|||
33161454|NCT01086033|100504307|FG000|Overall Study|Withdrawal by Subject|41|||
33161455|NCT01086033|100504307|FG000|Overall Study|Other|14|||
33161456|NCT01086033|100504307|FG000|Overall Study|Other|13|||
33161457|NCT01086033|100504307|FG000|Overall Study|AE and Withdrew Consent|5|||
33161458|NCT01086033|100504307|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
33161459|NCT01086033|100504307|FG000|Overall Study|Withdrew consent and Other Reason|4|||
33161460|NCT01086033|100504307|FG000|Overall Study|AE and Lack of Efficacy|4|||
33161461|NCT01086033|100504307|FG000|Overall Study|Death|1|||
33161462|NCT01086033|100504307|FG000|Overall Study|AE and Lost to Follow-up|1|||
33161463|NCT01086033|100504307|FG000|Overall Study|AE and Other Reason|1|||
33161464|NCT01086033|100504307|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
33161465|NCT02915016|100504310|FG000|Overall Study|Lost to Follow-up|4|||
33161466|NCT02915016|100504311|FG001|Overall Study|Lost to Follow-up|2|||
33161467|NCT02915016|100504312|FG002|Overall Study|Lost to Follow-up|5|||
33161468|NCT02915016|100504313|FG003|Overall Study|Lost to Follow-up|3|||
33161469|NCT02915016|100504314|FG004|Overall Study|Lost to Follow-up|5|||
33161470|NCT02915016|100504315|FG005|Overall Study|Lost to Follow-up|2|||
33161471|NCT02915016|100504316|FG006|Overall Study|Lost to Follow-up|8|||
33161472|NCT02915016|100504317|FG007|Overall Study|Lost to Follow-up|2|||
33161473|NCT02915016|100504310|FG000|Overall Study|Physician Decision|0|||
33161474|NCT02915016|100504311|FG001|Overall Study|Physician Decision|0|||
33161475|NCT02915016|100504312|FG002|Overall Study|Physician Decision|1|||
33161476|NCT02915016|100504313|FG003|Overall Study|Physician Decision|0|||
33161477|NCT02915016|100504314|FG004|Overall Study|Physician Decision|0|||
33161478|NCT02915016|100504315|FG005|Overall Study|Physician Decision|1|||
33161479|NCT02915016|100504316|FG006|Overall Study|Physician Decision|2|||
33161480|NCT02915016|100504317|FG007|Overall Study|Physician Decision|0|||
33161481|NCT02915016|100504310|FG000|Overall Study|Withdrawal by Subject|2|||
33161482|NCT02915016|100504311|FG001|Overall Study|Withdrawal by Subject|0|||
33161483|NCT02915016|100504312|FG002|Overall Study|Withdrawal by Subject|1|||
33161484|NCT02915016|100504313|FG003|Overall Study|Withdrawal by Subject|0|||
33161485|NCT02915016|100504314|FG004|Overall Study|Withdrawal by Subject|1|||
33161486|NCT02915016|100504315|FG005|Overall Study|Withdrawal by Subject|3|||
33161487|NCT02915016|100504316|FG006|Overall Study|Withdrawal by Subject|1|||
33161488|NCT02915016|100504317|FG007|Overall Study|Withdrawal by Subject|1|||
33161489|NCT02915016|100504310|FG000|Overall Study|Elected not to continue|0|||
33161490|NCT02915016|100504311|FG001|Overall Study|Elected not to continue|0|||
33161491|NCT02915016|100504312|FG002|Overall Study|Elected not to continue|0|||
33161492|NCT02915016|100504313|FG003|Overall Study|Elected not to continue|1|||
33161493|NCT02915016|100504314|FG004|Overall Study|Elected not to continue|0|||
33161494|NCT02915016|100504315|FG005|Overall Study|Elected not to continue|0|||
33161495|NCT02915016|100504316|FG006|Overall Study|Elected not to continue|1|||
33161496|NCT02915016|100504317|FG007|Overall Study|Elected not to continue|0|||
33161497|NCT02915016|100504310|FG000|Overall Study|HIV infection|1|||
33161498|NCT02915016|100504311|FG001|Overall Study|HIV infection|1|||
33161499|NCT02915016|100504312|FG002|Overall Study|HIV infection|1|||
33161500|NCT02915016|100504313|FG003|Overall Study|HIV infection|0|||
33161501|NCT02915016|100504314|FG004|Overall Study|HIV infection|1|||
33161502|NCT02915016|100504315|FG005|Overall Study|HIV infection|0|||
33161503|NCT02915016|100504316|FG006|Overall Study|HIV infection|0|||
33161504|NCT02915016|100504317|FG007|Overall Study|HIV infection|0|||
33161505|NCT02915016|100504310|FG000|Overall Study|Participant unable to adhere|0|||
33161506|NCT02915016|100504311|FG001|Overall Study|Participant unable to adhere|0|||
33161507|NCT02915016|100504312|FG002|Overall Study|Participant unable to adhere|0|||
33161508|NCT02915016|100504313|FG003|Overall Study|Participant unable to adhere|0|||
33161509|NCT02915016|100504314|FG004|Overall Study|Participant unable to adhere|0|||
33161510|NCT02915016|100504315|FG005|Overall Study|Participant unable to adhere|0|||
33161511|NCT02915016|100504316|FG006|Overall Study|Participant unable to adhere|0|||
33161512|NCT02915016|100504317|FG007|Overall Study|Participant unable to adhere|1|||
33161513|NCT00799383|100504320|FG000|Overall Study|Protocol Violation|1|||
33161514|NCT00799383|100504321|FG001|Overall Study|Protocol Violation|1|||
33161515|NCT00799383|100504320|FG000|Overall Study|Adverse Event|0|||
33161516|NCT00799383|100504321|FG001|Overall Study|Adverse Event|1|||
33161517|NCT00799383|100504320|FG000|Overall Study|Lost to Follow-up|1|||
33161518|NCT00799383|100504321|FG001|Overall Study|Lost to Follow-up|2|||
33161519|NCT00799383|100504320|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
33161520|NCT00799383|100504321|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
33161521|NCT00799383|100504320|FG000|Overall Study|Withdrawal by Subject|0|||
33161522|NCT00799383|100504321|FG001|Overall Study|Withdrawal by Subject|1|||
33161523|NCT00334958|100504322|FG000|Overall Study|Medication Noncompliance|0|||
33161524|NCT00334958|100504323|FG001|Overall Study|Medication Noncompliance|3|||
33161525|NCT00334958|100504322|FG000|Overall Study|Protocol Violation|2|||
33161526|NCT00334958|100504323|FG001|Overall Study|Protocol Violation|2|||
33161527|NCT00334958|100504322|FG000|Overall Study|Request of the investigator or sponsor|0|||
33161528|NCT00334958|100504323|FG001|Overall Study|Request of the investigator or sponsor|1|||
33161529|NCT00334958|100504322|FG000|Overall Study|Withdrawal by Subject|7|||
33161530|NCT00334958|100504323|FG001|Overall Study|Withdrawal by Subject|4|||
33161531|NCT00334958|100504322|FG000|Overall Study|Adverse Event|27|||
33161532|NCT00334958|100504323|FG001|Overall Study|Adverse Event|12|||
33161533|NCT00334958|100504322|FG000|Overall Study|Other|1|||
33161534|NCT00334958|100504323|FG001|Overall Study|Other|2|||
33442659|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
33161535|NCT00674362|100504324|FG000|Double Blind|Adverse Event|6|||
33161536|NCT00674362|100504325|FG001|Double Blind|Adverse Event|6|||
33161537|NCT00674362|100504324|FG000|Double Blind|Lack of Efficacy|2|||
33442660|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
33161538|NCT00674362|100504325|FG001|Double Blind|Lack of Efficacy|6|||
33161539|NCT00674362|100504324|FG000|Double Blind|Loss of efficacy|0|||
33161540|NCT00674362|100504325|FG001|Double Blind|Loss of efficacy|1|||
33161541|NCT00674362|100504324|FG000|Double Blind|Withdrawal by Subject|4|||
33161542|NCT00674362|100504325|FG001|Double Blind|Withdrawal by Subject|3|||
33161543|NCT00674362|100504324|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
33161544|NCT00674362|100504325|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
33161545|NCT00674362|100504324|FG000|Double Blind|Other: Surgery|0|||
33161546|NCT00674362|100504325|FG001|Double Blind|Other: Surgery|1|||
33161547|NCT00674362|100504324|FG000|Open Label|Adverse Event|1|||
33161548|NCT00674362|100504325|FG001|Open Label|Adverse Event|0|||
33161549|NCT00674362|100504324|FG000|Open Label|Other: Subject moved to extension study|1|||
33161550|NCT00674362|100504325|FG001|Open Label|Other: Subject moved to extension study|0|||
33161551|NCT04401423|100504326|FG000|Overall Study|Withdrawal by Subject|3|||
33161552|NCT04401423|100504327|FG001|Overall Study|Withdrawal by Subject|1|||
33161553|NCT04401423|100504326|FG000|Overall Study|Physician Decision|2|||
33161554|NCT04401423|100504327|FG001|Overall Study|Physician Decision|1|||
33161555|NCT03758066|100504328|FG000|Overall Study|Lost to Follow-up|14|||
33442661|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
33442662|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
33442663|NCT00318461|101515478|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
33161556|NCT00816595|100504331|FG000|Overall Study|Withdrawal by Subject|2|||
33161557|NCT00816595|100504332|FG001|Overall Study|Withdrawal by Subject|0|||
33161558|NCT02639065|100504344|FG000|Study Treatment|Disease Progression|13|||
33161559|NCT02639065|100504344|FG000|Study Treatment|Adverse Event|9|||
33161560|NCT02639065|100504344|FG000|Study Treatment|Withdrawal by Subject|1|||
33161561|NCT02639065|100504344|FG000|Follow up|Subject refused to follow up|1|||
33161562|NCT02639065|100504344|FG000|Follow up|Symptomatic Deterioration|2|||
33161563|NCT02639065|100504344|FG000|Follow up|Death|2|||
33161564|NCT02639065|100504344|FG000|Follow up|Study Terminated|1|||
33161565|NCT02639065|100504344|FG000|Follow up|Disease Progression|3|||
33161566|NCT00945893|100504345|FG000|Overall Study|Lost to Follow-up|2|||
33161567|NCT00945893|100504346|FG001|Overall Study|Lost to Follow-up|8|||
33161568|NCT00945893|100504345|FG000|Overall Study|Withdrawal of consent|1|||
33161569|NCT00945893|100504346|FG001|Overall Study|Withdrawal of consent|2|||
33161570|NCT00385762|100504347|FG000|Overall Study|Adverse Event|1|||
33161571|NCT00385762|100504347|FG000|Overall Study|Lost to Follow-up|1|||
33161572|NCT02202980|100504348|FG000|Overall Study|Lack of Efficacy|1|||
33161573|NCT02202980|100504349|FG001|Overall Study|Lack of Efficacy|0|||
33161574|NCT02202980|100504350|FG002|Overall Study|Lack of Efficacy|7|||
33161575|NCT02202980|100504351|FG003|Overall Study|Lack of Efficacy|0|||
33161576|NCT02202980|100504352|FG004|Overall Study|Lack of Efficacy|3|||
33161577|NCT02202980|100504353|FG005|Overall Study|Lack of Efficacy|1|||
33161578|NCT02202980|100504354|FG006|Overall Study|Lack of Efficacy|11|||
33161579|NCT02202980|100504355|FG007|Overall Study|Lack of Efficacy|2|||
33161580|NCT02202980|100504356|FG008|Overall Study|Lack of Efficacy|2|||
33255656|NCT04048135|100837133|FG002|Overall Study|Protocol Violation|0|||
33255657|NCT04048135|100837134|FG003|Overall Study|Protocol Violation|0|||
33255658|NCT04048135|100837135|FG004|Overall Study|Protocol Violation|0|||
33255659|NCT04048135|100837136|FG005|Overall Study|Protocol Violation|1|||
33255660|NCT04048135|100837137|FG006|Overall Study|Protocol Violation|0|||
33255661|NCT04048135|100837138|FG007|Overall Study|Protocol Violation|0|||
33255662|NCT03737240|100837139|FG000|Overall Study|Lost to Follow-up|16|||
33255663|NCT03737240|100837140|FG001|Overall Study|Lost to Follow-up|15|||
33255664|NCT02296424|100837141|FG000|Part 1|New therapy for study indication|0|||
33255665|NCT02296424|100837142|FG001|Part 1|New therapy for study indication|1|||
33255666|NCT02296424|100837143|FG002|Part 1|New therapy for study indication|0|||
33255667|NCT02296424|100837144|FG003|Part 1|New therapy for study indication|0|||
33255668|NCT02296424|100837141|FG000|Part 1|Protocol Violation|0|||
33255669|NCT02296424|100837142|FG001|Part 1|Protocol Violation|1|||
33255670|NCT02296424|100837143|FG002|Part 1|Protocol Violation|0|||
33255671|NCT02296424|100837144|FG003|Part 1|Protocol Violation|0|||
33255672|NCT02296424|100837141|FG000|Part 1|Withdrawal by Subject|0|||
33255673|NCT02296424|100837142|FG001|Part 1|Withdrawal by Subject|2|||
33255674|NCT02296424|100837143|FG002|Part 1|Withdrawal by Subject|0|||
33442664|NCT00318461|101515479|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
33442665|NCT00318461|101515480|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
33161581|NCT02202980|100504357|FG009|Overall Study|Lack of Efficacy|0|||
33161582|NCT02202980|100504358|FG010|Overall Study|Lack of Efficacy|0|||
33255675|NCT02296424|100837144|FG003|Part 1|Withdrawal by Subject|0|||
33442666|NCT00318461|101515481|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
33442667|NCT00318461|101515482|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
33442668|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Work commitment|0|||
33161583|NCT02202980|100504359|FG011|Overall Study|Lack of Efficacy|3|||
33161584|NCT02202980|100504360|FG012|Overall Study|Lack of Efficacy|10|||
33442669|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Work commitment|0|||
33161585|NCT02202980|100504361|FG013|Overall Study|Lack of Efficacy|0|||
33161586|NCT02202980|100504348|FG000|Overall Study|Protocol Violation|0|||
33161587|NCT02202980|100504349|FG001|Overall Study|Protocol Violation|0|||
33161588|NCT02202980|100504350|FG002|Overall Study|Protocol Violation|0|||
33161589|NCT02202980|100504351|FG003|Overall Study|Protocol Violation|3|||
33161590|NCT02202980|100504352|FG004|Overall Study|Protocol Violation|3|||
33161591|NCT02202980|100504353|FG005|Overall Study|Protocol Violation|0|||
33161592|NCT02202980|100504354|FG006|Overall Study|Protocol Violation|0|||
33161593|NCT02202980|100504355|FG007|Overall Study|Protocol Violation|0|||
33161594|NCT02202980|100504356|FG008|Overall Study|Protocol Violation|0|||
33161595|NCT02202980|100504357|FG009|Overall Study|Protocol Violation|0|||
33161596|NCT02202980|100504358|FG010|Overall Study|Protocol Violation|0|||
33161597|NCT02202980|100504359|FG011|Overall Study|Protocol Violation|0|||
33161598|NCT02202980|100504360|FG012|Overall Study|Protocol Violation|0|||
33161599|NCT02202980|100504361|FG013|Overall Study|Protocol Violation|0|||
33161600|NCT02202980|100504348|FG000|Overall Study|Lost to Follow-up|0|||
33161601|NCT02202980|100504349|FG001|Overall Study|Lost to Follow-up|1|||
33161602|NCT02202980|100504350|FG002|Overall Study|Lost to Follow-up|1|||
33161603|NCT02202980|100504351|FG003|Overall Study|Lost to Follow-up|1|||
33161604|NCT02202980|100504352|FG004|Overall Study|Lost to Follow-up|0|||
33161605|NCT02202980|100504353|FG005|Overall Study|Lost to Follow-up|0|||
33161606|NCT02202980|100504354|FG006|Overall Study|Lost to Follow-up|0|||
33161607|NCT02202980|100504355|FG007|Overall Study|Lost to Follow-up|1|||
33161608|NCT02202980|100504356|FG008|Overall Study|Lost to Follow-up|1|||
33161609|NCT02202980|100504357|FG009|Overall Study|Lost to Follow-up|0|||
33161610|NCT02202980|100504358|FG010|Overall Study|Lost to Follow-up|0|||
33161611|NCT02202980|100504359|FG011|Overall Study|Lost to Follow-up|0|||
33161612|NCT02202980|100504360|FG012|Overall Study|Lost to Follow-up|1|||
33161613|NCT02202980|100504361|FG013|Overall Study|Lost to Follow-up|0|||
33161614|NCT02202980|100504348|FG000|Overall Study|Withdrew Consent|0|||
33161615|NCT02202980|100504349|FG001|Overall Study|Withdrew Consent|1|||
33161616|NCT02202980|100504350|FG002|Overall Study|Withdrew Consent|2|||
33161617|NCT02202980|100504351|FG003|Overall Study|Withdrew Consent|0|||
33442670|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Work commitment|0|||
33442671|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Work commitment|0|||
33442672|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Work commitment|1|||
33442673|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Investigator decision|0|||
33161618|NCT02202980|100504352|FG004|Overall Study|Withdrew Consent|0|||
33161619|NCT02202980|100504353|FG005|Overall Study|Withdrew Consent|0|||
33161620|NCT02202980|100504354|FG006|Overall Study|Withdrew Consent|0|||
33161621|NCT02202980|100504355|FG007|Overall Study|Withdrew Consent|0|||
33255676|NCT02296424|100837141|FG000|Part 1|Study terminated by sponsor|0|||
33255677|NCT02296424|100837142|FG001|Part 1|Study terminated by sponsor|1|||
33255678|NCT02296424|100837143|FG002|Part 1|Study terminated by sponsor|0|||
33255679|NCT02296424|100837144|FG003|Part 1|Study terminated by sponsor|0|||
33255680|NCT02296424|100837141|FG000|Part 1|Adverse Event|2|||
33255681|NCT02296424|100837142|FG001|Part 1|Adverse Event|11|||
33255682|NCT02296424|100837143|FG002|Part 1|Adverse Event|0|||
33255683|NCT02296424|100837144|FG003|Part 1|Adverse Event|0|||
33255684|NCT02296424|100837141|FG000|Part 1|Lack of Efficacy|5|||
33255685|NCT02296424|100837142|FG001|Part 1|Lack of Efficacy|17|||
33255686|NCT02296424|100837143|FG002|Part 1|Lack of Efficacy|0|||
33255687|NCT02296424|100837144|FG003|Part 1|Lack of Efficacy|0|||
33255688|NCT02296424|100837141|FG000|Part 1|16 directly started part II|16|||
33255689|NCT02296424|100837142|FG001|Part 1|16 directly started part II|0|||
33255690|NCT02296424|100837143|FG002|Part 1|16 directly started part II|0|||
33255691|NCT02296424|100837144|FG003|Part 1|16 directly started part II|0|||
33255692|NCT02296424|100837141|FG000|Part 2|Lack of Efficacy|0|||
33255693|NCT02296424|100837142|FG001|Part 2|Lack of Efficacy|0|||
33255694|NCT02296424|100837143|FG002|Part 2|Lack of Efficacy|1|||
33255695|NCT02296424|100837144|FG003|Part 2|Lack of Efficacy|0|||
33255696|NCT02296424|100837141|FG000|Part 2|Adverse Event|0|||
33255697|NCT02296424|100837142|FG001|Part 2|Adverse Event|0|||
33255698|NCT02296424|100837143|FG002|Part 2|Adverse Event|1|||
33255699|NCT02296424|100837144|FG003|Part 2|Adverse Event|0|||
33255700|NCT02296424|100837141|FG000|Part 2|Lost to Follow-up|0|||
33255701|NCT02296424|100837142|FG001|Part 2|Lost to Follow-up|0|||
33255702|NCT02296424|100837143|FG002|Part 2|Lost to Follow-up|1|||
33255703|NCT02296424|100837144|FG003|Part 2|Lost to Follow-up|0|||
33255704|NCT00177216|100837148|FG000|Overall Study|Withdrawal by Subject|6|||
33255705|NCT00177216|100837149|FG001|Overall Study|Withdrawal by Subject|3|||
33255706|NCT00177216|100837150|FG002|Overall Study|Withdrawal by Subject|1|||
33255707|NCT02192606|100837156|FG000|Overall Study|surgery type was changed|1|||
33255708|NCT02192606|100837157|FG001|Overall Study|surgery type was changed|1|||
33255709|NCT02192606|100837156|FG000|Overall Study|Physician Decision|1|||
33255710|NCT02192606|100837157|FG001|Overall Study|Physician Decision|2|||
33255711|NCT02192606|100837156|FG000|Overall Study|3D equipment rep unable to join|0|||
33255712|NCT02192606|100837157|FG001|Overall Study|3D equipment rep unable to join|1|||
33255713|NCT00997386|100837159|FG000|Overall Study|Death|7|||
33255714|NCT01118377|100837160|FG000|Overall Study|Did Not Receive Study Medication|1|||
33255715|NCT01118377|100837160|FG000|Overall Study|Death|38|||
33255716|NCT01118377|100837160|FG000|Overall Study|Failure to Return|3|||
33255717|NCT02988817|100837165|FG000|Overall Study|Withdrawal by Subject|1|||
33255718|NCT02988817|100837166|FG001|Overall Study|Withdrawal by Subject|0|||
33255719|NCT02988817|100837167|FG002|Overall Study|Withdrawal by Subject|0|||
33255720|NCT02988817|100837168|FG003|Overall Study|Withdrawal by Subject|1|||
33255721|NCT02988817|100837169|FG004|Overall Study|Withdrawal by Subject|3|||
33255722|NCT02988817|100837170|FG005|Overall Study|Withdrawal by Subject|1|||
33255723|NCT02988817|100837171|FG006|Overall Study|Withdrawal by Subject|2|||
33255724|NCT02988817|100837172|FG007|Overall Study|Withdrawal by Subject|1|||
33255725|NCT02988817|100837173|FG008|Overall Study|Withdrawal by Subject|1|||
33255726|NCT02988817|100837174|FG009|Overall Study|Withdrawal by Subject|1|||
33255727|NCT02988817|100837175|FG010|Overall Study|Withdrawal by Subject|1|||
33255728|NCT02988817|100837176|FG011|Overall Study|Withdrawal by Subject|12|||
33255729|NCT02988817|100837177|FG012|Overall Study|Withdrawal by Subject|6|||
33255730|NCT02988817|100837178|FG013|Overall Study|Withdrawal by Subject|6|||
33255731|NCT02988817|100837179|FG014|Overall Study|Withdrawal by Subject|4|||
33255732|NCT02988817|100837180|FG015|Overall Study|Withdrawal by Subject|5|||
33255733|NCT02988817|100837181|FG016|Overall Study|Withdrawal by Subject|4|||
33255734|NCT02988817|100837182|FG017|Overall Study|Withdrawal by Subject|11|||
33255735|NCT02988817|100837183|FG018|Overall Study|Withdrawal by Subject|4|||
33255736|NCT02988817|100837184|FG019|Overall Study|Withdrawal by Subject|2|||
33255737|NCT02988817|100837165|FG000|Overall Study|Death|0|||
33255738|NCT02988817|100837166|FG001|Overall Study|Death|1|||
33255739|NCT02988817|100837167|FG002|Overall Study|Death|3|||
33255740|NCT02988817|100837168|FG003|Overall Study|Death|1|||
33255741|NCT02988817|100837169|FG004|Overall Study|Death|6|||
33255742|NCT02988817|100837170|FG005|Overall Study|Death|10|||
33255743|NCT02988817|100837171|FG006|Overall Study|Death|1|||
33255744|NCT02988817|100837172|FG007|Overall Study|Death|2|||
33255745|NCT02988817|100837173|FG008|Overall Study|Death|1|||
33255746|NCT02988817|100837174|FG009|Overall Study|Death|5|||
33255747|NCT02988817|100837175|FG010|Overall Study|Death|1|||
33255748|NCT02988817|100837176|FG011|Overall Study|Death|8|||
33255749|NCT02988817|100837177|FG012|Overall Study|Death|9|||
33255750|NCT02988817|100837178|FG013|Overall Study|Death|17|||
33255751|NCT02988817|100837179|FG014|Overall Study|Death|18|||
33255752|NCT02988817|100837180|FG015|Overall Study|Death|30|||
33255753|NCT02988817|100837181|FG016|Overall Study|Death|17|||
33255754|NCT02988817|100837182|FG017|Overall Study|Death|38|||
33255755|NCT02988817|100837183|FG018|Overall Study|Death|14|||
33255756|NCT02988817|100837184|FG019|Overall Study|Death|16|||
33255757|NCT02988817|100837165|FG000|Overall Study|Other|0|||
33255758|NCT02988817|100837166|FG001|Overall Study|Other|0|||
33255759|NCT02988817|100837167|FG002|Overall Study|Other|0|||
33255760|NCT02988817|100837168|FG003|Overall Study|Other|1|||
33442674|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Investigator decision|0|||
33442675|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Investigator decision|0|||
33442676|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Investigator decision|0|||
33442677|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Investigator decision|1|||
33442678|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Lack of time|1|||
33255761|NCT02988817|100837169|FG004|Overall Study|Other|1|||
33255762|NCT02988817|100837170|FG005|Overall Study|Other|0|||
33255763|NCT02988817|100837171|FG006|Overall Study|Other|0|||
33255764|NCT02988817|100837172|FG007|Overall Study|Other|0|||
33255765|NCT02988817|100837173|FG008|Overall Study|Other|0|||
33255766|NCT02988817|100837174|FG009|Overall Study|Other|0|||
33255767|NCT02988817|100837175|FG010|Overall Study|Other|0|||
33255768|NCT02988817|100837176|FG011|Overall Study|Other|0|||
33255769|NCT02988817|100837177|FG012|Overall Study|Other|0|||
33255770|NCT02988817|100837178|FG013|Overall Study|Other|0|||
33255771|NCT02988817|100837179|FG014|Overall Study|Other|0|||
33255772|NCT02988817|100837180|FG015|Overall Study|Other|1|||
33255773|NCT02988817|100837181|FG016|Overall Study|Other|0|||
33255774|NCT02988817|100837182|FG017|Overall Study|Other|0|||
33255775|NCT02988817|100837183|FG018|Overall Study|Other|0|||
33255776|NCT02988817|100837184|FG019|Overall Study|Other|0|||
33255777|NCT02988817|100837165|FG000|Overall Study|Lost to Follow-up|0|||
33442679|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Lack of time|0|||
33161622|NCT02202980|100504356|FG008|Overall Study|Withdrew Consent|1|||
33161623|NCT02202980|100504357|FG009|Overall Study|Withdrew Consent|0|||
33161624|NCT02202980|100504358|FG010|Overall Study|Withdrew Consent|0|||
33161625|NCT02202980|100504359|FG011|Overall Study|Withdrew Consent|0|||
33255778|NCT02988817|100837166|FG001|Overall Study|Lost to Follow-up|0|||
33442680|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Lack of time|0|||
33442681|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Lack of time|0|||
33255779|NCT02988817|100837167|FG002|Overall Study|Lost to Follow-up|0|||
33255780|NCT02988817|100837168|FG003|Overall Study|Lost to Follow-up|0|||
33255781|NCT02988817|100837169|FG004|Overall Study|Lost to Follow-up|0|||
33255782|NCT02988817|100837170|FG005|Overall Study|Lost to Follow-up|0|||
33255783|NCT02988817|100837171|FG006|Overall Study|Lost to Follow-up|0|||
33255784|NCT02988817|100837172|FG007|Overall Study|Lost to Follow-up|0|||
33255785|NCT02988817|100837173|FG008|Overall Study|Lost to Follow-up|1|||
33255786|NCT02988817|100837174|FG009|Overall Study|Lost to Follow-up|0|||
33255787|NCT02988817|100837175|FG010|Overall Study|Lost to Follow-up|1|||
33442682|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Lack of time|0|||
33161626|NCT02202980|100504360|FG012|Overall Study|Withdrew Consent|0|||
33161627|NCT02202980|100504361|FG013|Overall Study|Withdrew Consent|0|||
33161628|NCT01926015|100504362|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33161629|NCT01926015|100504363|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33161630|NCT01926015|100504362|FG000|Overall Study|Randomized not treated|2|||
33161631|NCT01926015|100504363|FG001|Overall Study|Randomized not treated|0|||
33161632|NCT04138810|100504367|FG000|Overall Study|Withdrawal by Subject|0|||
33161633|NCT04138810|100504368|FG001|Overall Study|Withdrawal by Subject|1|||
33161634|NCT04138810|100504367|FG000|Overall Study|Subject cancelled surgery|1|||
33161635|NCT04138810|100504368|FG001|Overall Study|Subject cancelled surgery|0|||
33255788|NCT02988817|100837176|FG011|Overall Study|Lost to Follow-up|1|||
33255789|NCT02988817|100837177|FG012|Overall Study|Lost to Follow-up|0|||
33255790|NCT02988817|100837178|FG013|Overall Study|Lost to Follow-up|0|||
33255791|NCT02988817|100837179|FG014|Overall Study|Lost to Follow-up|1|||
33255792|NCT02988817|100837180|FG015|Overall Study|Lost to Follow-up|1|||
33255793|NCT02988817|100837181|FG016|Overall Study|Lost to Follow-up|2|||
33255794|NCT02988817|100837182|FG017|Overall Study|Lost to Follow-up|3|||
33255795|NCT02988817|100837183|FG018|Overall Study|Lost to Follow-up|0|||
33255796|NCT02988817|100837184|FG019|Overall Study|Lost to Follow-up|0|||
33255797|NCT02988817|100837165|FG000|Overall Study|Sponsor decision|0|||
33255798|NCT02988817|100837166|FG001|Overall Study|Sponsor decision|0|||
33255799|NCT02988817|100837167|FG002|Overall Study|Sponsor decision|0|||
33255800|NCT02988817|100837168|FG003|Overall Study|Sponsor decision|0|||
33255801|NCT02988817|100837169|FG004|Overall Study|Sponsor decision|0|||
33255802|NCT02988817|100837170|FG005|Overall Study|Sponsor decision|0|||
33255803|NCT02988817|100837171|FG006|Overall Study|Sponsor decision|0|||
33255804|NCT02988817|100837172|FG007|Overall Study|Sponsor decision|0|||
33255805|NCT02988817|100837173|FG008|Overall Study|Sponsor decision|0|||
33255806|NCT02988817|100837174|FG009|Overall Study|Sponsor decision|0|||
33255807|NCT02988817|100837175|FG010|Overall Study|Sponsor decision|0|||
33255808|NCT02988817|100837176|FG011|Overall Study|Sponsor decision|1|||
33255809|NCT02988817|100837177|FG012|Overall Study|Sponsor decision|1|||
33255810|NCT02988817|100837178|FG013|Overall Study|Sponsor decision|2|||
33255811|NCT02988817|100837179|FG014|Overall Study|Sponsor decision|2|||
33255812|NCT02988817|100837180|FG015|Overall Study|Sponsor decision|6|||
33255813|NCT02988817|100837181|FG016|Overall Study|Sponsor decision|2|||
33255814|NCT02988817|100837182|FG017|Overall Study|Sponsor decision|3|||
33255815|NCT02988817|100837183|FG018|Overall Study|Sponsor decision|2|||
33255816|NCT02988817|100837184|FG019|Overall Study|Sponsor decision|7|||
33255817|NCT02988817|100837165|FG000|Overall Study|Physician Decision|0|||
33255818|NCT02988817|100837166|FG001|Overall Study|Physician Decision|0|||
33255819|NCT02988817|100837167|FG002|Overall Study|Physician Decision|0|||
33255820|NCT02988817|100837168|FG003|Overall Study|Physician Decision|0|||
33255821|NCT02988817|100837169|FG004|Overall Study|Physician Decision|0|||
33255822|NCT02988817|100837170|FG005|Overall Study|Physician Decision|0|||
33255823|NCT02988817|100837171|FG006|Overall Study|Physician Decision|0|||
33255824|NCT02988817|100837172|FG007|Overall Study|Physician Decision|0|||
33255825|NCT02988817|100837173|FG008|Overall Study|Physician Decision|0|||
33255826|NCT02988817|100837174|FG009|Overall Study|Physician Decision|0|||
33255827|NCT02988817|100837175|FG010|Overall Study|Physician Decision|0|||
33255828|NCT02988817|100837176|FG011|Overall Study|Physician Decision|0|||
33161636|NCT05229406|100504369|FG000|Overall Study|Withdrawal by Subject|1|||
33161637|NCT05229406|100504370|FG001|Overall Study|Withdrawal by Subject|2|||
33161638|NCT00923156|100504376|FG000|Overall Study|Adverse Event|0|||
33161639|NCT00923156|100504377|FG001|Overall Study|Adverse Event|2|||
33161640|NCT00923156|100504378|FG002|Overall Study|Adverse Event|1|||
33161641|NCT00923156|100504376|FG000|Overall Study|Abnormal laboratory values|0|||
33161642|NCT00923156|100504377|FG001|Overall Study|Abnormal laboratory values|0|||
33161643|NCT00923156|100504378|FG002|Overall Study|Abnormal laboratory values|1|||
33255829|NCT02988817|100837177|FG012|Overall Study|Physician Decision|0|||
33255830|NCT02988817|100837178|FG013|Overall Study|Physician Decision|0|||
33255831|NCT02988817|100837179|FG014|Overall Study|Physician Decision|0|||
33255832|NCT02988817|100837180|FG015|Overall Study|Physician Decision|1|||
33255833|NCT02988817|100837181|FG016|Overall Study|Physician Decision|0|||
33255834|NCT02988817|100837182|FG017|Overall Study|Physician Decision|0|||
33255835|NCT02988817|100837183|FG018|Overall Study|Physician Decision|1|||
33255836|NCT02988817|100837184|FG019|Overall Study|Physician Decision|1|||
33255837|NCT00393848|100837185|FG000|Overall Study|Surgical schedule|0|||
33255838|NCT00393848|100837186|FG001|Overall Study|Surgical schedule|0|||
33255839|NCT00393848|100837187|FG002|Overall Study|Surgical schedule|0|||
33442683|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
33442684|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
33442685|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
33442686|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
33442687|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
33442688|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
33442689|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
33442690|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
33442691|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
33442692|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
33442693|NCT00318461|101515478|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
33442694|NCT00318461|101515479|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
33442695|NCT00318461|101515480|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
33442696|NCT00318461|101515481|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
33442697|NCT00318461|101515482|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
33442698|NCT00318461|101515478|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
33442699|NCT00318461|101515479|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
33442700|NCT00318461|101515480|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
33442701|NCT00318461|101515481|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
33442702|NCT00318461|101515482|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
33442703|NCT00318461|101515478|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
33442704|NCT00318461|101515479|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
33442705|NCT00318461|101515480|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
33442706|NCT00318461|101515481|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
33161644|NCT00923156|100504376|FG000|Overall Study|Withdrawal by Subject|0|||
33161645|NCT00923156|100504377|FG001|Overall Study|Withdrawal by Subject|1|||
33442707|NCT00318461|101515482|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
33442708|NCT00318461|101515478|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
33442709|NCT00318461|101515479|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
33442710|NCT00318461|101515480|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
33442711|NCT00318461|101515481|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
33442712|NCT00318461|101515482|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
33442713|NCT00318461|101515478|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
33442714|NCT00318461|101515479|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
33442715|NCT00318461|101515480|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
33442716|NCT00318461|101515481|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
33442717|NCT00318461|101515482|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
33442718|NCT00318461|101515478|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
33161646|NCT00923156|100504378|FG002|Overall Study|Withdrawal by Subject|0|||
33161647|NCT00923156|100504376|FG000|Overall Study|Death|0|||
33161648|NCT00923156|100504377|FG001|Overall Study|Death|1|||
33161649|NCT00923156|100504378|FG002|Overall Study|Death|0|||
33161650|NCT00923156|100504376|FG000|Overall Study|Lack of Efficacy|0|||
33161651|NCT00923156|100504377|FG001|Overall Study|Lack of Efficacy|0|||
33161652|NCT00923156|100504378|FG002|Overall Study|Lack of Efficacy|1|||
33161653|NCT01970397|100504379|FG000|Overall Study|Adverse Event|0|||
33161654|NCT01970397|100504380|FG001|Overall Study|Adverse Event|1|||
33161655|NCT01970397|100504379|FG000|Overall Study|Lost to Follow-up|0|||
33161656|NCT01970397|100504380|FG001|Overall Study|Lost to Follow-up|1|||
33161657|NCT01970397|100504379|FG000|Overall Study|Personal Reasons|1|||
33161658|NCT01970397|100504380|FG001|Overall Study|Personal Reasons|2|||
33161659|NCT01970397|100504379|FG000|Overall Study|Protocol Violation|1|||
33161660|NCT01970397|100504380|FG001|Overall Study|Protocol Violation|1|||
33161661|NCT00221403|100504381|FG000|Overall Study|Protocol Violation|1|||
33161662|NCT00221403|100504382|FG001|Overall Study|Protocol Violation|0|||
33161663|NCT00221403|100504383|FG002|Overall Study|Protocol Violation|0|||
33161664|NCT00221403|100504381|FG000|Overall Study|Physician Decision|1|||
33161665|NCT00221403|100504382|FG001|Overall Study|Physician Decision|0|||
33161666|NCT00221403|100504383|FG002|Overall Study|Physician Decision|0|||
33161667|NCT00221403|100504381|FG000|Overall Study|Withdrawal by Subject|0|||
33161668|NCT00221403|100504382|FG001|Overall Study|Withdrawal by Subject|3|||
33161669|NCT00221403|100504383|FG002|Overall Study|Withdrawal by Subject|0|||
33442719|NCT00318461|101515479|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
33442720|NCT00318461|101515480|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
33255840|NCT00393848|100837188|FG003|Overall Study|Surgical schedule|1|||
33255841|NCT00393848|100837185|FG000|Overall Study|Personal reasons|0|||
33161670|NCT00221403|100504381|FG000|Overall Study|Lack of Efficacy|0|||
33161671|NCT00221403|100504382|FG001|Overall Study|Lack of Efficacy|1|||
33161672|NCT00221403|100504383|FG002|Overall Study|Lack of Efficacy|0|||
33161673|NCT00221403|100504381|FG000|Overall Study|Adverse Event|0|||
33255842|NCT00393848|100837186|FG001|Overall Study|Personal reasons|0|||
33161674|NCT00221403|100504382|FG001|Overall Study|Adverse Event|1|||
33161675|NCT00221403|100504383|FG002|Overall Study|Adverse Event|0|||
33161676|NCT02590003|100504384|FG000|Overall Study|Death|1|||
33161677|NCT02590003|100504385|FG001|Overall Study|Death|2|||
33161678|NCT01180985|100504386|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
33161679|NCT01180985|100504387|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
33161680|NCT02349061|100504388|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
33161681|NCT02349061|100504389|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
33161682|NCT02349061|100504390|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
33161683|NCT02349061|100504388|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
33161684|NCT02349061|100504389|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
33161685|NCT02349061|100504390|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
33161686|NCT02349061|100504388|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
33161687|NCT02349061|100504389|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
33161688|NCT02349061|100504390|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
33161689|NCT02349061|100504388|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
33161690|NCT02349061|100504389|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
33161691|NCT02349061|100504390|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
33161692|NCT02349061|100504388|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
33161693|NCT02349061|100504389|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
33161694|NCT02349061|100504390|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
33161695|NCT02349061|100504388|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
33161696|NCT02349061|100504389|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
33161697|NCT02349061|100504390|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
33161698|NCT02349061|100504388|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
33161699|NCT02349061|100504389|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
33161700|NCT02349061|100504390|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
33161701|NCT02349061|100504388|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
33161702|NCT02349061|100504389|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
33161703|NCT02349061|100504390|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
33161704|NCT02349061|100504388|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
33161705|NCT02349061|100504389|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
33161706|NCT02349061|100504390|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
33161707|NCT02349061|100504388|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
33161708|NCT02349061|100504389|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
33161709|NCT02349061|100504390|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
33161710|NCT02349061|100504388|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
33161711|NCT02349061|100504389|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
33161712|NCT02349061|100504390|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
33161713|NCT02349061|100504388|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
33161714|NCT02349061|100504389|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
33161715|NCT02349061|100504390|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
33161716|NCT02349061|100504388|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
33161717|NCT02349061|100504389|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
33161718|NCT02349061|100504390|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
33161719|NCT02021331|100504393|FG000|Overall Study|Adverse Event|0|||
33161720|NCT02021331|100504394|FG001|Overall Study|Adverse Event|2|||
33161721|NCT04523220|100504395|FG000|Main Treatment Period|Physician Decision|1|||
33161722|NCT04523220|100504396|FG001|Main Treatment Period|Physician Decision|1|||
33161723|NCT04523220|100504397|FG002|Main Treatment Period|Physician Decision|0|||
33161724|NCT04523220|100504395|FG000|Main Treatment Period|Other|5|||
33161725|NCT04523220|100504396|FG001|Main Treatment Period|Other|2|||
33161726|NCT04523220|100504397|FG002|Main Treatment Period|Other|4|||
33161727|NCT04523220|100504395|FG000|Main Treatment Period|Subject Decision|5|||
33161728|NCT04523220|100504396|FG001|Main Treatment Period|Subject Decision|7|||
33161729|NCT04523220|100504397|FG002|Main Treatment Period|Subject Decision|3|||
33161730|NCT04523220|100504395|FG000|Main Treatment Period|Death|5|||
33161731|NCT04523220|100504396|FG001|Main Treatment Period|Death|11|||
33161732|NCT04523220|100504397|FG002|Main Treatment Period|Death|4|||
33161733|NCT04523220|100504395|FG000|Main Treatment Period|Adverse Event|11|||
33161734|NCT04523220|100504396|FG001|Main Treatment Period|Adverse Event|9|||
33161735|NCT04523220|100504397|FG002|Main Treatment Period|Adverse Event|9|||
33161736|NCT04523220|100504395|FG000|Main Treatment Period|Withdrawal by Subject|3|||
33161737|NCT04523220|100504396|FG001|Main Treatment Period|Withdrawal by Subject|3|||
33161738|NCT04523220|100504397|FG002|Main Treatment Period|Withdrawal by Subject|4|||
33161739|NCT04523220|100504395|FG000|Main Treatment Period|Study drug never adminstered|10|||
33161740|NCT04523220|100504396|FG001|Main Treatment Period|Study drug never adminstered|3|||
33161741|NCT04523220|100504397|FG002|Main Treatment Period|Study drug never adminstered|5|||
33161742|NCT04523220|100504395|FG000|Extension Treatment Period|Physician Decision|1|||
33161743|NCT04523220|100504396|FG001|Extension Treatment Period|Physician Decision|0|||
33255843|NCT00393848|100837187|FG002|Overall Study|Personal reasons|2|||
33161744|NCT04523220|100504397|FG002|Extension Treatment Period|Physician Decision|3|||
33161745|NCT04523220|100504395|FG000|Extension Treatment Period|Other|2|||
33161746|NCT04523220|100504396|FG001|Extension Treatment Period|Other|6|||
33161747|NCT04523220|100504397|FG002|Extension Treatment Period|Other|6|||
33161748|NCT04523220|100504395|FG000|Extension Treatment Period|Subject Decision|5|||
33161749|NCT04523220|100504396|FG001|Extension Treatment Period|Subject Decision|2|||
33161750|NCT04523220|100504397|FG002|Extension Treatment Period|Subject Decision|4|||
33161751|NCT04523220|100504395|FG000|Extension Treatment Period|Death|6|||
33161752|NCT04523220|100504396|FG001|Extension Treatment Period|Death|4|||
33161753|NCT04523220|100504397|FG002|Extension Treatment Period|Death|7|||
33161754|NCT04523220|100504395|FG000|Extension Treatment Period|Adverse Event|6|||
33161755|NCT04523220|100504396|FG001|Extension Treatment Period|Adverse Event|7|||
33161756|NCT04523220|100504397|FG002|Extension Treatment Period|Adverse Event|9|||
33161757|NCT04523220|100504395|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
33161758|NCT04523220|100504396|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
33161759|NCT04523220|100504397|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
33161760|NCT04523220|100504395|FG000|Extension Treatment Period|Study drug never administered|0|||
33161761|NCT04523220|100504396|FG001|Extension Treatment Period|Study drug never administered|1|||
33161762|NCT04523220|100504397|FG002|Extension Treatment Period|Study drug never administered|0|||
33161763|NCT00261807|100504401|FG000|Overall Study|Lost to Follow-up|2|||
33161764|NCT00261807|100504401|FG000|Overall Study|Adverse Event|2|||
33161765|NCT00261807|100504401|FG000|Overall Study|Death|1|||
33161766|NCT00261807|100504401|FG000|Overall Study|Protocol Violation|2|||
33161767|NCT02975336|100504408|FG000|DBPC (52 Weeks)|Adverse Event|16|||
33161768|NCT02975336|100504409|FG001|DBPC (52 Weeks)|Adverse Event|17|||
33161769|NCT02975336|100504410|FG002|DBPC (52 Weeks)|Adverse Event|13|||
33161770|NCT02975336|100504411|FG003|DBPC (52 Weeks)|Adverse Event|18|||
33161771|NCT02975336|100504412|FG004|DBPC (52 Weeks)|Adverse Event|0|||
33161772|NCT02975336|100504413|FG005|DBPC (52 Weeks)|Adverse Event|0|||
33161773|NCT02975336|100504414|FG006|DBPC (52 Weeks)|Adverse Event|0|||
33161774|NCT02975336|100504415|FG007|DBPC (52 Weeks)|Adverse Event|0|||
33161775|NCT02975336|100504408|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
33161776|NCT02975336|100504409|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
33161777|NCT02975336|100504410|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
33161778|NCT02975336|100504411|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
33161779|NCT02975336|100504412|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
33161780|NCT02975336|100504413|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
33161781|NCT02975336|100504414|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
33161782|NCT02975336|100504415|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
33161783|NCT02975336|100504408|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
33161784|NCT02975336|100504409|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
33161785|NCT02975336|100504410|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
33161786|NCT02975336|100504411|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
33161787|NCT02975336|100504412|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
33161788|NCT02975336|100504413|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
33161789|NCT02975336|100504414|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
33161790|NCT02975336|100504415|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
33161791|NCT02975336|100504408|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
33161792|NCT02975336|100504409|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
33161793|NCT02975336|100504410|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
33161794|NCT02975336|100504411|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
33161795|NCT02975336|100504412|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
33442721|NCT00318461|101515481|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
33442722|NCT00318461|101515482|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
33442723|NCT04089735|101515483|FG000|Overall Study|Adverse Event|1|||
33161796|NCT02975336|100504413|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
33161797|NCT02975336|100504414|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
33161798|NCT02975336|100504415|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
33161799|NCT02975336|100504408|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
33161800|NCT02975336|100504409|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
33161801|NCT02975336|100504410|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
33161802|NCT02975336|100504411|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
33161803|NCT02975336|100504412|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
33161804|NCT02975336|100504413|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
33161805|NCT02975336|100504414|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
33161806|NCT02975336|100504415|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
33161807|NCT02975336|100504408|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
33161808|NCT02975336|100504409|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
33161809|NCT02975336|100504410|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
33161810|NCT02975336|100504411|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
33161811|NCT02975336|100504412|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
33161812|NCT02975336|100504413|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
33161813|NCT02975336|100504414|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
33161814|NCT02975336|100504415|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
33161815|NCT02975336|100504408|FG000|LTE (104 Weeks)|Adverse Event|0|||
33161816|NCT02975336|100504409|FG001|LTE (104 Weeks)|Adverse Event|0|||
33161817|NCT02975336|100504410|FG002|LTE (104 Weeks)|Adverse Event|0|||
33161818|NCT02975336|100504411|FG003|LTE (104 Weeks)|Adverse Event|0|||
33161819|NCT02975336|100504412|FG004|LTE (104 Weeks)|Adverse Event|7|||
33161820|NCT02975336|100504413|FG005|LTE (104 Weeks)|Adverse Event|4|||
33161821|NCT02975336|100504414|FG006|LTE (104 Weeks)|Adverse Event|2|||
33161822|NCT02975336|100504415|FG007|LTE (104 Weeks)|Adverse Event|0|||
33161823|NCT02975336|100504408|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
33161824|NCT02975336|100504409|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
33161825|NCT02975336|100504410|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
33161826|NCT02975336|100504411|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
33161827|NCT02975336|100504412|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
33161828|NCT02975336|100504413|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
33161829|NCT02975336|100504414|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
33161830|NCT02975336|100504415|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
33161831|NCT02975336|100504408|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
33161832|NCT02975336|100504409|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
33161833|NCT02975336|100504410|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
33161834|NCT02975336|100504411|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
33161835|NCT02975336|100504412|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
33442724|NCT04089735|101515484|FG001|Overall Study|Adverse Event|0|||
33442725|NCT04089735|101515485|FG002|Overall Study|Adverse Event|1|||
33161836|NCT02975336|100504413|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
33161837|NCT02975336|100504414|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
33161838|NCT02975336|100504415|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
33161839|NCT02975336|100504408|FG000|LTE (104 Weeks)|Other|0|||
33161840|NCT02975336|100504409|FG001|LTE (104 Weeks)|Other|0|||
33161841|NCT02975336|100504410|FG002|LTE (104 Weeks)|Other|0|||
33255844|NCT00393848|100837188|FG003|Overall Study|Personal reasons|0|||
33161842|NCT02975336|100504411|FG003|LTE (104 Weeks)|Other|0|||
33161843|NCT02975336|100504412|FG004|LTE (104 Weeks)|Other|55|||
33161844|NCT02975336|100504413|FG005|LTE (104 Weeks)|Other|63|||
33161845|NCT02975336|100504414|FG006|LTE (104 Weeks)|Other|76|||
33161846|NCT02975336|100504415|FG007|LTE (104 Weeks)|Other|72|||
33255845|NCT02549170|100837189|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
33442726|NCT04089735|101515486|FG003|Overall Study|Adverse Event|1|||
33442727|NCT04089735|101515487|FG004|Overall Study|Adverse Event|0|||
33442728|NCT04089735|101515488|FG005|Overall Study|Adverse Event|0|||
33442729|NCT04089735|101515483|FG000|Overall Study|Physician Decision|0|||
33442730|NCT04089735|101515484|FG001|Overall Study|Physician Decision|3|||
33442731|NCT04089735|101515485|FG002|Overall Study|Physician Decision|0|||
33442732|NCT04089735|101515486|FG003|Overall Study|Physician Decision|0|||
33442733|NCT04089735|101515487|FG004|Overall Study|Physician Decision|0|||
33442734|NCT04089735|101515488|FG005|Overall Study|Physician Decision|0|||
33442735|NCT04089735|101515483|FG000|Overall Study|Withdrawal by Subject|0|||
33442736|NCT04089735|101515484|FG001|Overall Study|Withdrawal by Subject|0|||
33442737|NCT04089735|101515485|FG002|Overall Study|Withdrawal by Subject|1|||
33442738|NCT04089735|101515486|FG003|Overall Study|Withdrawal by Subject|0|||
33442739|NCT04089735|101515487|FG004|Overall Study|Withdrawal by Subject|0|||
33442740|NCT04089735|101515488|FG005|Overall Study|Withdrawal by Subject|0|||
33442741|NCT04089735|101515483|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
33161847|NCT02763462|100504418|FG000|Overall Study|Protocol Violation|6|||
33161848|NCT02207244|100504421|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
33161849|NCT02207244|100504422|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
33442742|NCT04089735|101515484|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
33161850|NCT02207244|100504423|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
33161851|NCT02207244|100504424|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33255846|NCT02549170|100837190|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
33255847|NCT02549170|100837191|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
33255848|NCT02549170|100837192|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
33255849|NCT02549170|100837193|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
33255850|NCT02549170|100837189|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
33255851|NCT02549170|100837190|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
33255852|NCT02549170|100837191|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
33255853|NCT02549170|100837192|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
33255854|NCT02549170|100837193|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
33255855|NCT02549170|100837189|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
33255856|NCT02549170|100837190|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
33255857|NCT02549170|100837191|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
33255858|NCT02549170|100837192|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
33255859|NCT02549170|100837193|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
33255860|NCT03997916|100837203|FG000|Overall Study|Protocol Violation|35|||
33255861|NCT01803555|100837204|FG000|Overall Study|Adverse Event|3|||
33255862|NCT01803555|100837205|FG001|Overall Study|Adverse Event|2|||
33255863|NCT01803555|100837204|FG000|Overall Study|Withdrawal by Subject|3|||
33255864|NCT01803555|100837205|FG001|Overall Study|Withdrawal by Subject|3|||
33255865|NCT01803555|100837204|FG000|Overall Study|Non-compliance|1|||
33255866|NCT01803555|100837205|FG001|Overall Study|Non-compliance|1|||
33255867|NCT01803555|100837204|FG000|Overall Study|Protocol Violation|3|||
33255868|NCT01803555|100837205|FG001|Overall Study|Protocol Violation|5|||
33255869|NCT01803555|100837204|FG000|Overall Study|Lost to Follow-up|0|||
33255870|NCT01803555|100837205|FG001|Overall Study|Lost to Follow-up|2|||
33255871|NCT01803555|100837204|FG000|Overall Study|Other than specified|3|||
33255872|NCT01803555|100837205|FG001|Overall Study|Other than specified|5|||
33255873|NCT00186186|100837208|FG000|Overall Study|Lack of Efficacy|3|||
33255874|NCT00186186|100837208|FG000|Overall Study|Withdrawal by Subject|3|||
33255875|NCT00186186|100837208|FG000|Overall Study|Not reported as to reason|2|||
33255876|NCT00666276|100837209|FG000|Overall Study|Protocol Violation|34|||
33255877|NCT00206375|100837212|FG000|Overall Study|Lost to Follow-up|1|||
33255878|NCT00206375|100837213|FG001|Overall Study|Lost to Follow-up|0|||
33255879|NCT00206375|100837214|FG002|Overall Study|Lost to Follow-up|0|||
33255880|NCT00206375|100837212|FG000|Overall Study|Withdrawal by Subject|2|||
33442743|NCT04089735|101515485|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
33442744|NCT04089735|101515486|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
33442745|NCT04089735|101515487|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
33442746|NCT04089735|101515488|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
33442747|NCT01880593|101515489|FG000|Overall Study|Adverse Event|1|||
33442748|NCT01880593|101515490|FG001|Overall Study|Adverse Event|0|||
33442749|NCT01880593|101515489|FG000|Overall Study|Lack of Efficacy|1|||
33442750|NCT01880593|101515490|FG001|Overall Study|Lack of Efficacy|5|||
33442751|NCT01880593|101515489|FG000|Overall Study|Withdrawal by Subject|6|||
33161852|NCT02207244|100504425|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33161853|NCT02207244|100504426|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33161854|NCT02207244|100504427|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33161855|NCT02207244|100504428|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33161856|NCT02207244|100504429|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33161857|NCT02207244|100504430|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33161858|NCT02207244|100504431|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
33161859|NCT02207244|100504421|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
33161860|NCT02207244|100504422|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33161861|NCT02207244|100504423|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
33161862|NCT02207244|100504424|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33161863|NCT02207244|100504425|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33161864|NCT02207244|100504426|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33161865|NCT02207244|100504427|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33161866|NCT02207244|100504428|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33161867|NCT02207244|100504429|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33161868|NCT02207244|100504430|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33255881|NCT00206375|100837213|FG001|Overall Study|Withdrawal by Subject|1|||
33255882|NCT00206375|100837214|FG002|Overall Study|Withdrawal by Subject|3|||
33442752|NCT01880593|101515490|FG001|Overall Study|Withdrawal by Subject|1|||
33442753|NCT01182415|101515491|FG000|Overall Study|Lost to Follow-up|1|||
33442754|NCT00830206|101515492|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
33442755|NCT00830206|101515493|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
33442756|NCT02739997|101515494|FG000|Overall Study|Death|1|||
33442757|NCT02739997|101515494|FG000|Overall Study|Withdrawal by Subject|1|||
33442758|NCT01511939|101515496|FG000|Overall Study|Withdrawal by Subject|2|||
33442759|NCT01511939|101515497|FG001|Overall Study|Withdrawal by Subject|1|||
33442760|NCT01511939|101515498|FG002|Overall Study|Withdrawal by Subject|0|||
33442761|NCT00864097|101515499|FG000|Overall Study|Death|0|||
33442762|NCT00864097|101515500|FG001|Overall Study|Death|1|||
33442763|NCT00864097|101515501|FG002|Overall Study|Death|0|||
33442764|NCT00864097|101515502|FG003|Overall Study|Death|0|||
33442765|NCT00864097|101515499|FG000|Overall Study|Adverse Event|6|||
33442766|NCT00864097|101515500|FG001|Overall Study|Adverse Event|8|||
33442767|NCT00864097|101515501|FG002|Overall Study|Adverse Event|11|||
33442768|NCT00864097|101515502|FG003|Overall Study|Adverse Event|9|||
33442769|NCT00864097|101515499|FG000|Overall Study|Lack of Efficacy|9|||
33442770|NCT00864097|101515500|FG001|Overall Study|Lack of Efficacy|3|||
33442771|NCT00864097|101515501|FG002|Overall Study|Lack of Efficacy|7|||
33255883|NCT00206375|100837212|FG000|Overall Study|Study terminated due to lack of funds|0|||
33255884|NCT00206375|100837213|FG001|Overall Study|Study terminated due to lack of funds|1|||
33255885|NCT00206375|100837214|FG002|Overall Study|Study terminated due to lack of funds|1|||
33255886|NCT01764464|100837219|FG000|First Intervention|Withdrawal by Subject|1|||
33442772|NCT00864097|101515502|FG003|Overall Study|Lack of Efficacy|2|||
33442773|NCT00864097|101515499|FG000|Overall Study|Lost to Follow-up|0|||
33255887|NCT01764464|100837220|FG001|First Intervention|Withdrawal by Subject|0|||
33255888|NCT01764464|100837219|FG000|First Intervention|Lost to Follow-up|1|||
33255889|NCT01764464|100837220|FG001|First Intervention|Lost to Follow-up|0|||
33442774|NCT00864097|101515500|FG001|Overall Study|Lost to Follow-up|1|||
33442775|NCT00864097|101515501|FG002|Overall Study|Lost to Follow-up|0|||
33442776|NCT00864097|101515502|FG003|Overall Study|Lost to Follow-up|1|||
33442777|NCT00864097|101515499|FG000|Overall Study|Withdrawal by Subject|15|||
33442778|NCT00864097|101515500|FG001|Overall Study|Withdrawal by Subject|11|||
33442779|NCT00864097|101515501|FG002|Overall Study|Withdrawal by Subject|11|||
33442780|NCT00864097|101515502|FG003|Overall Study|Withdrawal by Subject|12|||
33442781|NCT00864097|101515499|FG000|Overall Study|Protocol Violation|2|||
33442782|NCT00864097|101515500|FG001|Overall Study|Protocol Violation|1|||
33442783|NCT00864097|101515501|FG002|Overall Study|Protocol Violation|0|||
33442784|NCT00864097|101515502|FG003|Overall Study|Protocol Violation|1|||
33442785|NCT00864097|101515499|FG000|Overall Study|Terminated by sponsor|105|||
33442786|NCT00864097|101515500|FG001|Overall Study|Terminated by sponsor|112|||
33442787|NCT00864097|101515501|FG002|Overall Study|Terminated by sponsor|102|||
33442788|NCT00864097|101515502|FG003|Overall Study|Terminated by sponsor|99|||
33442789|NCT00864097|101515499|FG000|Overall Study|Randomized but not treated|2|||
33442790|NCT00864097|101515500|FG001|Overall Study|Randomized but not treated|0|||
33442791|NCT00864097|101515501|FG002|Overall Study|Randomized but not treated|1|||
33442792|NCT00864097|101515502|FG003|Overall Study|Randomized but not treated|0|||
33442793|NCT00864097|101515499|FG000|Overall Study|Other|0|||
33442794|NCT00864097|101515500|FG001|Overall Study|Other|0|||
33161869|NCT02207244|100504431|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
33161870|NCT02207244|100504421|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
33442795|NCT00864097|101515501|FG002|Overall Study|Other|0|||
33442796|NCT00864097|101515502|FG003|Overall Study|Other|1|||
33442797|NCT01864174|101515505|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
33255890|NCT01764464|100837219|FG000|First Intervention|Adverse Event|0|||
33255891|NCT01764464|100837220|FG001|First Intervention|Adverse Event|2|||
33442798|NCT01864174|101515506|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
33161871|NCT02207244|100504422|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
33161872|NCT02207244|100504423|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
33161873|NCT02207244|100504424|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33161874|NCT02207244|100504425|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33161875|NCT02207244|100504426|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33161876|NCT02207244|100504427|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33161877|NCT02207244|100504428|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33161878|NCT02207244|100504429|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33161879|NCT02207244|100504430|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33161880|NCT02207244|100504431|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
33161881|NCT02207244|100504421|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
33161882|NCT02207244|100504422|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
33161883|NCT02207244|100504423|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33161884|NCT02207244|100504424|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33161885|NCT02207244|100504425|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33161886|NCT02207244|100504426|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33161887|NCT02207244|100504427|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33161888|NCT02207244|100504428|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33161889|NCT02207244|100504429|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33161890|NCT02207244|100504430|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33161891|NCT02207244|100504431|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
33161892|NCT02207244|100504421|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
33161893|NCT02207244|100504422|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
33161894|NCT02207244|100504423|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
33161895|NCT02207244|100504424|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33161896|NCT02207244|100504425|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33161897|NCT02207244|100504426|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33161898|NCT02207244|100504427|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33161899|NCT02207244|100504428|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33161900|NCT02207244|100504429|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33161901|NCT02207244|100504430|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33161902|NCT02207244|100504431|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
33442799|NCT01864174|101515505|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
33161903|NCT02207244|100504421|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33161904|NCT02207244|100504422|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
33161905|NCT02207244|100504423|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
33161906|NCT02207244|100504424|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33161907|NCT02207244|100504425|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33161908|NCT02207244|100504426|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33161909|NCT02207244|100504427|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33161910|NCT02207244|100504428|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33161911|NCT02207244|100504429|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33161912|NCT02207244|100504430|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33161913|NCT02207244|100504431|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
33161914|NCT02207244|100504421|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
33161915|NCT02207244|100504422|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
33161916|NCT02207244|100504423|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
33161917|NCT02207244|100504424|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
33161918|NCT02207244|100504425|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
33161919|NCT02207244|100504426|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
33161920|NCT02207244|100504427|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
33161921|NCT02207244|100504428|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
33442800|NCT01864174|101515506|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
33442801|NCT01864174|101515505|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
33442802|NCT01864174|101515506|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
33442803|NCT01864174|101515505|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
33442804|NCT01864174|101515506|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
33442805|NCT01864174|101515505|FG000|Double Blind - Compliant Randomized|Death|1|||
33442806|NCT01864174|101515506|FG001|Double Blind - Compliant Randomized|Death|0|||
33442807|NCT01864174|101515505|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
33442808|NCT01864174|101515506|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
33442809|NCT01864174|101515505|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
33442810|NCT01864174|101515506|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
33442811|NCT01864174|101515505|FG000|Double Blind - Compliant Randomized|Other|6|||
33442812|NCT01864174|101515506|FG001|Double Blind - Compliant Randomized|Other|10|||
33442813|NCT01864174|101515505|FG000|Off Treatment Follow-Up|Other|2|||
33442814|NCT01864174|101515506|FG001|Off Treatment Follow-Up|Other|0|||
33442815|NCT01864174|101515505|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
33442816|NCT01864174|101515506|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
33442817|NCT00075478|101515507|FG000|Overall Study|not eligible|1|||
33442818|NCT00075478|101515508|FG001|Overall Study|not eligible|0|||
33442819|NCT00075478|101515507|FG000|Overall Study|Physician Decision|0|||
33442820|NCT00075478|101515508|FG001|Overall Study|Physician Decision|1|||
33442821|NCT00635492|101515509|FG000|Overall Study|Death|12|||
33442822|NCT00635492|101515510|FG001|Overall Study|Death|40|||
33442823|NCT00635492|101515509|FG000|Overall Study|Lost to Follow-up|151|||
33442824|NCT00635492|101515510|FG001|Overall Study|Lost to Follow-up|172|||
33442825|NCT00635492|101515509|FG000|Overall Study|Physician Decision|32|||
33442826|NCT00635492|101515510|FG001|Overall Study|Physician Decision|22|||
33442827|NCT00635492|101515509|FG000|Overall Study|Sponsor decision|2|||
33442828|NCT00635492|101515510|FG001|Overall Study|Sponsor decision|3|||
33442829|NCT00635492|101515509|FG000|Overall Study|Withdrawal by Subject|82|||
33442830|NCT00635492|101515510|FG001|Overall Study|Withdrawal by Subject|45|||
33442831|NCT03020615|101515512|FG000|Overall Study|Physician Decision|3|||
33442832|NCT03020615|101515513|FG001|Overall Study|Physician Decision|1|||
33442833|NCT03020615|101515514|FG002|Overall Study|Physician Decision|2|||
33442834|NCT03020615|101515512|FG000|Overall Study|Parent/guardian/patient choice|3|||
33442835|NCT03020615|101515513|FG001|Overall Study|Parent/guardian/patient choice|0|||
33442836|NCT03020615|101515514|FG002|Overall Study|Parent/guardian/patient choice|4|||
33442837|NCT03020615|101515512|FG000|Overall Study|Screen failure|0|||
33442838|NCT03020615|101515513|FG001|Overall Study|Screen failure|0|||
33442839|NCT03020615|101515514|FG002|Overall Study|Screen failure|1|||
33161922|NCT02207244|100504429|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
33161923|NCT02207244|100504430|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
33161924|NCT02207244|100504431|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
33161925|NCT02207244|100504421|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33161926|NCT02207244|100504422|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33161927|NCT02207244|100504423|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33161928|NCT02207244|100504424|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33161929|NCT02207244|100504425|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
33161930|NCT02207244|100504426|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
33161931|NCT02207244|100504427|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33161932|NCT02207244|100504428|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33161933|NCT02207244|100504429|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33161934|NCT02207244|100504430|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33161935|NCT02207244|100504431|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
33161936|NCT02207244|100504421|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33161937|NCT02207244|100504422|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33255892|NCT01764464|100837219|FG000|First Intervention|did not receive study drug|0|||
33255893|NCT01764464|100837220|FG001|First Intervention|did not receive study drug|1|||
33255894|NCT01764464|100837219|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
33255895|NCT01764464|100837220|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
33255896|NCT03020745|100837221|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
33255897|NCT03020745|100837222|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
33255898|NCT03020745|100837223|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
33255899|NCT03020745|100837224|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
33255900|NCT03020745|100837225|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
33255901|NCT03020745|100837226|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
33255902|NCT03020745|100837227|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
33255903|NCT03020745|100837228|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
33255904|NCT03020745|100837229|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
33255905|NCT03020745|100837230|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
33255906|NCT03020745|100837221|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33255907|NCT03020745|100837222|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33255908|NCT03020745|100837223|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33255909|NCT03020745|100837224|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33255910|NCT03020745|100837225|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33255911|NCT03020745|100837226|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33255912|NCT03020745|100837227|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33255913|NCT03020745|100837228|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
33255914|NCT03020745|100837229|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33442840|NCT03020615|101515512|FG000|Overall Study|Death|1|||
33442841|NCT03020615|101515513|FG001|Overall Study|Death|0|||
33442842|NCT03020615|101515514|FG002|Overall Study|Death|0|||
33442843|NCT03020615|101515512|FG000|Overall Study|Lost to Follow-up|0|||
33442844|NCT03020615|101515513|FG001|Overall Study|Lost to Follow-up|1|||
33442845|NCT03020615|101515514|FG002|Overall Study|Lost to Follow-up|0|||
33442846|NCT02605928|101515531|FG000|Overall Study|Model tuning phase|28|||
33442847|NCT02605928|101515531|FG000|Overall Study|Lack of Efficacy|5|||
33442848|NCT03233724|101515532|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
33442849|NCT03233724|101515533|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
33161938|NCT02207244|100504423|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33255915|NCT03020745|100837230|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
33442850|NCT03233724|101515534|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
33255916|NCT03020745|100837221|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33255917|NCT03020745|100837222|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33255918|NCT03020745|100837223|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33255919|NCT03020745|100837224|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33255920|NCT03020745|100837225|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33255921|NCT03020745|100837226|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
33255922|NCT03020745|100837227|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33255923|NCT03020745|100837228|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33255924|NCT03020745|100837229|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
33255925|NCT03020745|100837230|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
33255926|NCT03020745|100837221|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33255927|NCT03020745|100837222|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33255928|NCT03020745|100837223|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33255929|NCT03020745|100837224|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33255930|NCT03020745|100837225|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33255931|NCT03020745|100837226|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33255932|NCT03020745|100837227|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33255933|NCT03020745|100837228|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33255934|NCT03020745|100837229|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
33255935|NCT03020745|100837230|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
33255936|NCT00510887|100837233|FG000|Overall Study|Lost to Follow-up|1|||
33255937|NCT00712335|100837234|FG000|Overall Study|Withdrawal by Subject|0|||
33255938|NCT00712335|100837235|FG001|Overall Study|Withdrawal by Subject|7|||
33255939|NCT00712335|100837236|FG002|Overall Study|Withdrawal by Subject|2|||
33255940|NCT00712335|100837237|FG003|Overall Study|Withdrawal by Subject|3|||
33255941|NCT00712335|100837238|FG004|Overall Study|Withdrawal by Subject|0|||
33255942|NCT00712335|100837234|FG000|Overall Study|Lost to Follow-up|2|||
33255943|NCT00712335|100837235|FG001|Overall Study|Lost to Follow-up|5|||
33255944|NCT00712335|100837236|FG002|Overall Study|Lost to Follow-up|0|||
33255945|NCT00712335|100837237|FG003|Overall Study|Lost to Follow-up|1|||
33255946|NCT00712335|100837238|FG004|Overall Study|Lost to Follow-up|0|||
33255947|NCT00712335|100837234|FG000|Overall Study|Protocol Violation|1|||
33255948|NCT00712335|100837235|FG001|Overall Study|Protocol Violation|2|||
33255949|NCT00712335|100837236|FG002|Overall Study|Protocol Violation|1|||
33255950|NCT00712335|100837237|FG003|Overall Study|Protocol Violation|0|||
33255951|NCT00712335|100837238|FG004|Overall Study|Protocol Violation|0|||
33255952|NCT00712335|100837234|FG000|Overall Study|Lack of Efficacy|0|||
33255953|NCT00712335|100837235|FG001|Overall Study|Lack of Efficacy|0|||
33255954|NCT00712335|100837236|FG002|Overall Study|Lack of Efficacy|1|||
33255955|NCT00712335|100837237|FG003|Overall Study|Lack of Efficacy|1|||
33255956|NCT00712335|100837238|FG004|Overall Study|Lack of Efficacy|0|||
33255957|NCT00712335|100837234|FG000|Overall Study|Other Reason|0|||
33255958|NCT00712335|100837235|FG001|Overall Study|Other Reason|3|||
33255959|NCT00712335|100837236|FG002|Overall Study|Other Reason|1|||
33255960|NCT00712335|100837237|FG003|Overall Study|Other Reason|0|||
33255961|NCT00712335|100837238|FG004|Overall Study|Other Reason|0|||
33255962|NCT00970359|100837239|FG000|Overall Study|Not Treated|4|||
33255963|NCT02807493|100837240|FG000|Overall Study|Adverse Event|5|||
33255964|NCT02807493|100837241|FG001|Overall Study|Adverse Event|2|||
33255965|NCT02807493|100837240|FG000|Overall Study|Lost to Follow-up|6|||
33255966|NCT02807493|100837241|FG001|Overall Study|Lost to Follow-up|0|||
33255967|NCT02807493|100837240|FG000|Overall Study|Physician Decision|4|||
33255968|NCT02807493|100837241|FG001|Overall Study|Physician Decision|1|||
33255969|NCT02807493|100837240|FG000|Overall Study|Protocol Violation|7|||
33255970|NCT02807493|100837241|FG001|Overall Study|Protocol Violation|0|||
33255971|NCT02807493|100837240|FG000|Overall Study|Withdrawal by Subject|17|||
33255972|NCT02807493|100837241|FG001|Overall Study|Withdrawal by Subject|10|||
33255973|NCT02807493|100837240|FG000|Overall Study|Other withdrawal|17|||
33255974|NCT02807493|100837241|FG001|Overall Study|Other withdrawal|0|||
33255975|NCT02807493|100837240|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
33255976|NCT02807493|100837241|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
33255977|NCT02731755|100837242|FG000|First Intervention|Withdrawal by Subject|0|||
33255978|NCT02731755|100837243|FG001|First Intervention|Withdrawal by Subject|2|||
33255979|NCT00393484|100837244|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
33255980|NCT00393484|100837245|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
33255981|NCT00393484|100837244|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
33255982|NCT00393484|100837245|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
33255983|NCT00393484|100837244|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
33255984|NCT00393484|100837245|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
33255985|NCT00393484|100837244|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
33255986|NCT00393484|100837245|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
33255987|NCT00393484|100837244|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
33255988|NCT00393484|100837245|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
33255989|NCT00393484|100837244|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
33255990|NCT00393484|100837245|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
33255991|NCT00393484|100837244|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
33255992|NCT00393484|100837245|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
33255993|NCT00393484|100837244|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
33255994|NCT00393484|100837245|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
33255995|NCT00393484|100837244|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
33255996|NCT00393484|100837245|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
33255997|NCT00393484|100837244|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
33255998|NCT00393484|100837245|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
33255999|NCT01395758|100837246|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
33256000|NCT01395758|100837247|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
33256001|NCT01395758|100837248|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
33256002|NCT00444600|100837249|FG000|Overall Study|Death|7|||
33256003|NCT00444600|100837250|FG001|Overall Study|Death|5|||
33256004|NCT00444600|100837251|FG002|Overall Study|Death|3|||
33256005|NCT00444600|100837252|FG003|Overall Study|Death|2|||
33256006|NCT00444600|100837249|FG000|Overall Study|Dropped|11|||
33256007|NCT00444600|100837250|FG001|Overall Study|Dropped|11|||
33256008|NCT00444600|100837251|FG002|Overall Study|Dropped|7|||
33256009|NCT00444600|100837252|FG003|Overall Study|Dropped|7|||
33256010|NCT00444600|100837249|FG000|Overall Study|Missed visit|1|||
33256011|NCT00444600|100837250|FG001|Overall Study|Missed visit|0|||
33256012|NCT00444600|100837251|FG002|Overall Study|Missed visit|0|||
33256013|NCT00444600|100837252|FG003|Overall Study|Missed visit|1|||
33256014|NCT01580293|100837253|FG000|Part A_Main Trial|Adverse Event|0|||
33256015|NCT01580293|100837254|FG001|Part A_Main Trial|Adverse Event|2|||
33256016|NCT01580293|100837255|FG002|Part A_Main Trial|Adverse Event|0|||
33256017|NCT01580293|100837253|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
33256018|NCT01580293|100837254|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
33256019|NCT01580293|100837255|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
33256020|NCT01580293|100837253|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
33256021|NCT01580293|100837254|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
33256022|NCT01580293|100837255|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
33256023|NCT01580293|100837253|FG000|Part A_Extension|Adverse Event|0|||
33256024|NCT01580293|100837254|FG001|Part A_Extension|Adverse Event|2|||
33256025|NCT01580293|100837255|FG002|Part A_Extension|Adverse Event|0|||
33256026|NCT01580293|100837253|FG000|Part A_Extension|Withdrawal by Subject|0|||
33256027|NCT01580293|100837254|FG001|Part A_Extension|Withdrawal by Subject|3|||
33256028|NCT01580293|100837255|FG002|Part A_Extension|Withdrawal by Subject|0|||
33256029|NCT01580293|100837253|FG000|Part A_Extension|Lost to Follow-up|0|||
33256030|NCT01580293|100837254|FG001|Part A_Extension|Lost to Follow-up|1|||
33256031|NCT01580293|100837255|FG002|Part A_Extension|Lost to Follow-up|0|||
33256032|NCT01580293|100837253|FG000|Part A_Extension|Other Reason|0|||
33256033|NCT01580293|100837254|FG001|Part A_Extension|Other Reason|1|||
33256034|NCT01580293|100837255|FG002|Part A_Extension|Other Reason|0|||
33256035|NCT01580293|100837253|FG000|Part A_Extension|Completed Japan only|0|||
33256036|NCT01580293|100837254|FG001|Part A_Extension|Completed Japan only|5|||
33256037|NCT01580293|100837255|FG002|Part A_Extension|Completed Japan only|0|||
33256038|NCT01580293|100837253|FG000|Part B|Withdrawal by Subject|0|||
33256039|NCT01580293|100837254|FG001|Part B|Withdrawal by Subject|0|||
33256040|NCT01580293|100837255|FG002|Part B|Withdrawal by Subject|1|||
33256041|NCT01580293|100837253|FG000|Part B|Other reason|0|||
33256042|NCT01580293|100837254|FG001|Part B|Other reason|0|||
33256043|NCT01580293|100837255|FG002|Part B|Other reason|1|||
33256044|NCT03383146|100837258|FG000|Overall Study|Screen Failure|1|||
33256045|NCT03383146|100837259|FG001|Overall Study|Screen Failure|0|||
33256046|NCT03383146|100837258|FG000|Overall Study|Adverse Event|6|||
33256047|NCT03383146|100837259|FG001|Overall Study|Adverse Event|18|||
33256048|NCT03383146|100837258|FG000|Overall Study|Lack of Efficacy|0|||
33256049|NCT03383146|100837259|FG001|Overall Study|Lack of Efficacy|3|||
33256050|NCT03383146|100837258|FG000|Overall Study|Withdrawal by Subject|20|||
33256051|NCT03383146|100837259|FG001|Overall Study|Withdrawal by Subject|36|||
33256052|NCT03383146|100837258|FG000|Overall Study|Lost to Follow-up|5|||
33489733|NCT02899962|101686772|FG000|Maintenance Phase|Lack of Efficacy|0|||
33256053|NCT03383146|100837259|FG001|Overall Study|Lost to Follow-up|15|||
33256054|NCT03383146|100837258|FG000|Overall Study|Death|0|||
33256055|NCT03383146|100837259|FG001|Overall Study|Death|2|||
33256056|NCT03383146|100837258|FG000|Overall Study|Physician Decision|0|||
33256057|NCT03383146|100837259|FG001|Overall Study|Physician Decision|1|||
33256058|NCT03383146|100837258|FG000|Overall Study|Protocol Deviation|1|||
33256059|NCT03383146|100837259|FG001|Overall Study|Protocol Deviation|8|||
33256060|NCT03383146|100837258|FG000|Overall Study|Study Terminated by the Sponsor|48|||
33256061|NCT03383146|100837259|FG001|Overall Study|Study Terminated by the Sponsor|95|||
33256062|NCT03383146|100837258|FG000|Overall Study|Reason not Specified|4|||
33256063|NCT03383146|100837259|FG001|Overall Study|Reason not Specified|6|||
33256064|NCT03621696|100837260|FG000|Overall Study|Not eligible|0|||
33256065|NCT03621696|100837261|FG001|Overall Study|Not eligible|0|||
33256066|NCT03621696|100837262|FG002|Overall Study|Not eligible|0|||
33256067|NCT03621696|100837263|FG003|Overall Study|Not eligible|5|||
33256068|NCT03621696|100837260|FG000|Overall Study|Withdrawal by Subject|1|||
33256069|NCT03621696|100837261|FG001|Overall Study|Withdrawal by Subject|1|||
33256070|NCT03621696|100837262|FG002|Overall Study|Withdrawal by Subject|1|||
33256071|NCT03621696|100837263|FG003|Overall Study|Withdrawal by Subject|0|||
33256072|NCT03621696|100837260|FG000|Overall Study|Physician Decision|0|||
33256073|NCT03621696|100837261|FG001|Overall Study|Physician Decision|0|||
33256074|NCT03621696|100837262|FG002|Overall Study|Physician Decision|1|||
33256075|NCT03621696|100837263|FG003|Overall Study|Physician Decision|0|||
33256076|NCT00835770|100837267|FG000|Overall Study|MS Relapse|17|||
33256077|NCT00835770|100837268|FG001|Overall Study|MS Relapse|23|||
33256078|NCT00835770|100837267|FG000|Overall Study|MS Progression|14|||
33256079|NCT00835770|100837268|FG001|Overall Study|MS Progression|9|||
33256080|NCT00835770|100837267|FG000|Overall Study|Adverse Event|113|||
33256081|NCT00835770|100837268|FG001|Overall Study|Adverse Event|124|||
33256082|NCT00835770|100837267|FG000|Overall Study|Lost to Follow-up|22|||
33256083|NCT00835770|100837268|FG001|Overall Study|Lost to Follow-up|19|||
33256084|NCT00835770|100837267|FG000|Overall Study|Consent Withdrawn|144|||
33256085|NCT00835770|100837268|FG001|Overall Study|Consent Withdrawn|156|||
33256086|NCT00835770|100837267|FG000|Overall Study|Investigator Decision|42|||
33256087|NCT00835770|100837268|FG001|Overall Study|Investigator Decision|42|||
33256088|NCT00835770|100837267|FG000|Overall Study|Participant Non-Compliance|11|||
33256089|NCT00835770|100837268|FG001|Overall Study|Participant Non-Compliance|9|||
33256090|NCT00835770|100837267|FG000|Overall Study|Death|4|||
33256091|NCT00835770|100837268|FG001|Overall Study|Death|6|||
33256092|NCT00835770|100837267|FG000|Overall Study|Other|115|||
33256093|NCT00835770|100837268|FG001|Overall Study|Other|104|||
33256094|NCT00835770|100837267|FG000|Overall Study|Other|2|||
33256095|NCT00835770|100837268|FG001|Overall Study|Other|1|||
33256096|NCT02880241|100837271|FG000|Overall Study|Lack of Efficacy|1|||
33256097|NCT02880241|100837272|FG001|Overall Study|Lack of Efficacy|0|||
33256098|NCT02880241|100837273|FG002|Overall Study|Lack of Efficacy|0|||
33256099|NCT02880241|100837274|FG003|Overall Study|Lack of Efficacy|0|||
33256100|NCT02880241|100837275|FG004|Overall Study|Lack of Efficacy|0|||
33256101|NCT02880241|100837276|FG005|Overall Study|Lack of Efficacy|0|||
33256102|NCT04358549|100837277|FG000|Overall Study|Adverse Event|0|||
33256103|NCT04358549|100837278|FG001|Overall Study|Adverse Event|1|||
33256104|NCT04358549|100837277|FG000|Overall Study|Death|1|||
33256105|NCT04358549|100837278|FG001|Overall Study|Death|0|||
33256106|NCT04358549|100837277|FG000|Overall Study|Lost to Follow-up|2|||
33256107|NCT04358549|100837278|FG001|Overall Study|Lost to Follow-up|1|||
33256108|NCT04358549|100837277|FG000|Overall Study|Withdrawal by Subject|6|||
33256109|NCT04358549|100837278|FG001|Overall Study|Withdrawal by Subject|6|||
33256110|NCT04358549|100837277|FG000|Overall Study|Start remdesivir|1|||
33256111|NCT04358549|100837278|FG001|Overall Study|Start remdesivir|0|||
33256112|NCT00293293|100839907|FG000|Overall Study|Withdrawal by Subject|1|||
33256113|NCT00293293|100839908|FG001|Overall Study|Withdrawal by Subject|1|||
33256114|NCT00293293|100839907|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
33256115|NCT00293293|100839908|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
33256116|NCT00293293|100839907|FG000|Overall Study|Patient discontinued chemotherapy|0|||
33256117|NCT00293293|100839908|FG001|Overall Study|Patient discontinued chemotherapy|1|||
33256118|NCT04200365|100839909|FG000|Overall Study|Adverse Event|2|||
33256119|NCT04200365|100839909|FG000|Overall Study|Progressive Disease|4|||
33256120|NCT04200365|100839909|FG000|Overall Study|Lack of Efficacy|1|||
33256121|NCT04200365|100839909|FG000|Overall Study|Study Closure|4|||
33256122|NCT02983617|100839911|FG000|Overall Study|Adverse Event|0|||
33256123|NCT02983617|100839912|FG001|Overall Study|Adverse Event|7|||
33256124|NCT02983617|100839911|FG000|Overall Study|Death|0|||
33256125|NCT02983617|100839912|FG001|Overall Study|Death|1|||
33256126|NCT02983617|100839911|FG000|Overall Study|Investigator's Discretion|0|||
33256127|NCT02983617|100839912|FG001|Overall Study|Investigator's Discretion|1|||
33256128|NCT04722003|100839913|FG000|Overall Study|Lost to Follow-up|2|||
33256129|NCT04722003|100839914|FG001|Overall Study|Lost to Follow-up|0|||
33256130|NCT04722003|100839913|FG000|Overall Study|Physician Decision|1|||
33256131|NCT04722003|100839914|FG001|Overall Study|Physician Decision|0|||
33256132|NCT03074331|100839915|FG000|Overall Study|Enrolled but Not Treated|1|||
33256133|NCT03074331|100839915|FG000|Overall Study|Lost to Follow-up|5|||
33256134|NCT03074331|100839915|FG000|Overall Study|Withdrew Consent|1|||
33256135|NCT02092116|100839921|FG000|Overall Study|Withdrawal by Subject|0|||
33256136|NCT02092116|100839922|FG001|Overall Study|Withdrawal by Subject|3|||
33256137|NCT02092116|100839921|FG000|Overall Study|Adverse Event|0|||
33256138|NCT02092116|100839922|FG001|Overall Study|Adverse Event|1|||
33256139|NCT00433199|100839927|FG000|Double-Blind Period|Adverse Event|0|||
33256140|NCT00433199|100839928|FG001|Double-Blind Period|Adverse Event|25|||
33256141|NCT00433199|100839927|FG000|Double-Blind Period|Lack of Efficacy|0|||
33256142|NCT00433199|100839928|FG001|Double-Blind Period|Lack of Efficacy|2|||
33256143|NCT00433199|100839927|FG000|Double-Blind Period|Lost to Follow-up|2|||
33256144|NCT00433199|100839928|FG001|Double-Blind Period|Lost to Follow-up|5|||
33256145|NCT00433199|100839927|FG000|Double-Blind Period|Withdrawal by Subject|8|||
33256146|NCT00433199|100839928|FG001|Double-Blind Period|Withdrawal by Subject|19|||
33256147|NCT00433199|100839927|FG000|Double-Blind Period|Protocol Violation|1|||
33256148|NCT00433199|100839928|FG001|Double-Blind Period|Protocol Violation|10|||
33256149|NCT00433199|100839927|FG000|Double-Blind Period|Administrative|1|||
33256150|NCT00433199|100839928|FG001|Double-Blind Period|Administrative|5|||
33256151|NCT00433199|100839927|FG000|Open-Label Period|Adverse Event|0|||
33256152|NCT00433199|100839928|FG001|Open-Label Period|Adverse Event|19|||
33256153|NCT00433199|100839927|FG000|Open-Label Period|Lack of Efficacy|0|||
33256154|NCT00433199|100839928|FG001|Open-Label Period|Lack of Efficacy|2|||
33256155|NCT00433199|100839927|FG000|Open-Label Period|Lost to Follow-up|0|||
33256156|NCT00433199|100839928|FG001|Open-Label Period|Lost to Follow-up|3|||
33256157|NCT00433199|100839927|FG000|Open-Label Period|Withdrawal by Subject|0|||
33256158|NCT00433199|100839928|FG001|Open-Label Period|Withdrawal by Subject|7|||
33256159|NCT00433199|100839927|FG000|Open-Label Period|Protocol Violation|0|||
33256160|NCT00433199|100839928|FG001|Open-Label Period|Protocol Violation|2|||
33256161|NCT00433199|100839927|FG000|Open-Label Period|Administrative|0|||
33256162|NCT00433199|100839928|FG001|Open-Label Period|Administrative|1|||
33256163|NCT00585533|100839929|FG000|Overall Study|objective or symptomatic progression|9|||
33256164|NCT00951379|100839930|FG000|Overall Study|Adverse Event|4|||
33256165|NCT00951379|100839931|FG001|Overall Study|Adverse Event|1|||
33256166|NCT00951379|100839930|FG000|Overall Study|Withdrawal by Subject|1|||
33256167|NCT00951379|100839931|FG001|Overall Study|Withdrawal by Subject|0|||
33256168|NCT00951379|100839930|FG000|Overall Study|Noncompliance|1|||
33256169|NCT00951379|100839931|FG001|Overall Study|Noncompliance|0|||
33256170|NCT00951379|100839930|FG000|Overall Study|Disease Progression|0|||
33256171|NCT00951379|100839931|FG001|Overall Study|Disease Progression|1|||
33256172|NCT02556138|100839934|FG000|Overall Study|Withdrawal by Subject|1|||
33256173|NCT04035668|100839937|FG000|Overall Study|Adverse Event|3|||
33256174|NCT04035668|100839938|FG001|Overall Study|Adverse Event|4|||
33256175|NCT04035668|100839939|FG002|Overall Study|Adverse Event|2|||
33256176|NCT04035668|100839937|FG000|Overall Study|Lost to Follow-up|0|||
33256177|NCT04035668|100839938|FG001|Overall Study|Lost to Follow-up|1|||
33256178|NCT04035668|100839939|FG002|Overall Study|Lost to Follow-up|0|||
33256179|NCT04035668|100839937|FG000|Overall Study|Physician Decision|2|||
33256180|NCT04035668|100839938|FG001|Overall Study|Physician Decision|1|||
33256181|NCT04035668|100839939|FG002|Overall Study|Physician Decision|1|||
33256182|NCT04035668|100839937|FG000|Overall Study|Subject Decision|2|||
33256183|NCT04035668|100839938|FG001|Overall Study|Subject Decision|2|||
33256184|NCT04035668|100839939|FG002|Overall Study|Subject Decision|0|||
33256185|NCT01426269|100839944|FG000|Period 1: 12 Weeks|Adverse Event|5|||
33256186|NCT01426269|100839945|FG001|Period 1: 12 Weeks|Adverse Event|0|||
33256187|NCT01426269|100839946|FG002|Period 1: 12 Weeks|Adverse Event|0|||
33256188|NCT01426269|100839944|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
33256189|NCT01426269|100839945|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
33256190|NCT01426269|100839946|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
33256191|NCT01426269|100839944|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
33256192|NCT01426269|100839945|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
33256193|NCT01426269|100839946|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
33256194|NCT01426269|100839944|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
33256195|NCT01426269|100839945|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
33256196|NCT01426269|100839946|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
33256197|NCT01426269|100839944|FG000|Period 1: 12 Weeks|Pregnancy|1|||
33256198|NCT01426269|100839945|FG001|Period 1: 12 Weeks|Pregnancy|0|||
33256199|NCT01426269|100839946|FG002|Period 1: 12 Weeks|Pregnancy|0|||
33256200|NCT01426269|100839944|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
33256201|NCT01426269|100839945|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
33256202|NCT01426269|100839946|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
33442851|NCT03233724|101515535|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
33256203|NCT01426269|100839944|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
33256204|NCT01426269|100839945|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
33256205|NCT01426269|100839946|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
33256206|NCT01426269|100839944|FG000|Period 2: 40 Weeks|Adverse Event|0|||
33256207|NCT01426269|100839945|FG001|Period 2: 40 Weeks|Adverse Event|1|||
33256208|NCT01426269|100839946|FG002|Period 2: 40 Weeks|Adverse Event|2|||
33256209|NCT01426269|100839944|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
33256210|NCT01426269|100839945|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
33256211|NCT01426269|100839946|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
33256212|NCT01426269|100839944|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
33256213|NCT01426269|100839945|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
33256214|NCT01426269|100839946|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
33256215|NCT01426269|100839944|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
33256216|NCT01426269|100839945|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
33256217|NCT01426269|100839946|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
33256218|NCT01426269|100839944|FG000|Period 2: 40 Weeks|Site closed|0|||
33256219|NCT01426269|100839945|FG001|Period 2: 40 Weeks|Site closed|6|||
33256220|NCT01426269|100839946|FG002|Period 2: 40 Weeks|Site closed|5|||
33256221|NCT01426269|100839944|FG000|Period 2: 40 Weeks|Relapsed|0|||
33161939|NCT02207244|100504424|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33161940|NCT02207244|100504425|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33442852|NCT03233724|101515536|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
33442853|NCT03233724|101515532|FG000|Phase I Dose Escalation|Best interest of participant|1|||
33442854|NCT03233724|101515533|FG001|Phase I Dose Escalation|Best interest of participant|1|||
33442855|NCT03233724|101515534|FG002|Phase I Dose Escalation|Best interest of participant|1|||
33442856|NCT03233724|101515535|FG003|Phase I Dose Escalation|Best interest of participant|0|||
33442857|NCT03233724|101515536|FG004|Phase I Dose Escalation|Best interest of participant|0|||
33442858|NCT03233724|101515532|FG000|Phase I Dose Escalation|Physician Decision|0|||
33442859|NCT03233724|101515533|FG001|Phase I Dose Escalation|Physician Decision|0|||
33442860|NCT03233724|101515534|FG002|Phase I Dose Escalation|Physician Decision|1|||
33442861|NCT03233724|101515535|FG003|Phase I Dose Escalation|Physician Decision|0|||
33161941|NCT02207244|100504426|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
33161942|NCT02207244|100504427|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33161943|NCT02207244|100504428|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33161944|NCT02207244|100504429|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33161945|NCT02207244|100504430|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33161946|NCT02207244|100504431|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
33161947|NCT02207244|100504421|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33161948|NCT02207244|100504422|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33161949|NCT02207244|100504423|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33161950|NCT02207244|100504424|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
33161951|NCT02207244|100504425|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
33161952|NCT02207244|100504426|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
33161953|NCT02207244|100504427|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33161954|NCT02207244|100504428|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33161955|NCT02207244|100504429|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33161956|NCT02207244|100504430|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33161957|NCT02207244|100504431|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
33161958|NCT02207244|100504421|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33161959|NCT02207244|100504422|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33161960|NCT02207244|100504423|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33161961|NCT02207244|100504424|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
33161962|NCT02207244|100504425|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
33161963|NCT02207244|100504426|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
33161964|NCT02207244|100504427|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33161965|NCT02207244|100504428|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33161966|NCT02207244|100504429|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33161967|NCT02207244|100504430|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33161968|NCT02207244|100504431|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
33161969|NCT02207244|100504421|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33161970|NCT02207244|100504422|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33442862|NCT03233724|101515536|FG004|Phase I Dose Escalation|Physician Decision|0|||
33442863|NCT03233724|101515532|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
33442864|NCT03233724|101515533|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
33442865|NCT03233724|101515534|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
33442866|NCT03233724|101515535|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
33442867|NCT03233724|101515536|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
33442868|NCT01435265|101515537|FG000|Overall Study|Lost to Follow-up|0|||
33442869|NCT01435265|101515538|FG001|Overall Study|Lost to Follow-up|1|||
33442870|NCT01536574|101515539|FG000|Overall Study|Adverse Event|4|||
33442871|NCT01536574|101515540|FG001|Overall Study|Adverse Event|5|||
33442872|NCT01536574|101515539|FG000|Overall Study|Withdrawal by Subject|1|||
33442873|NCT01536574|101515540|FG001|Overall Study|Withdrawal by Subject|2|||
33442874|NCT01536574|101515539|FG000|Overall Study|Lack of Efficacy|1|||
33442875|NCT01536574|101515540|FG001|Overall Study|Lack of Efficacy|0|||
33442876|NCT01661686|101515541|FG000|Overall Study|Lost to Follow-up|2|||
33442877|NCT01661686|101515542|FG001|Overall Study|Lost to Follow-up|1|||
33442878|NCT01661686|101515541|FG000|Overall Study|did not receive allocated intervention|0|||
33442879|NCT01661686|101515542|FG001|Overall Study|did not receive allocated intervention|1|||
33442880|NCT00746798|101515543|FG000|Overall Study|Protocol Violation|0|||
33442881|NCT00746798|101515544|FG001|Overall Study|Protocol Violation|1|||
33442882|NCT00746798|101515545|FG002|Overall Study|Protocol Violation|0|||
33442883|NCT00746798|101515546|FG003|Overall Study|Protocol Violation|0|||
33442884|NCT00746798|101515543|FG000|Overall Study|Withdrawal by Subject|0|||
33442885|NCT00746798|101515544|FG001|Overall Study|Withdrawal by Subject|1|||
33442886|NCT00746798|101515545|FG002|Overall Study|Withdrawal by Subject|1|||
33442887|NCT00746798|101515546|FG003|Overall Study|Withdrawal by Subject|0|||
33442888|NCT00746798|101515543|FG000|Overall Study|Death|0|||
33442889|NCT00746798|101515544|FG001|Overall Study|Death|0|||
33442890|NCT00746798|101515545|FG002|Overall Study|Death|2|||
33442891|NCT00746798|101515546|FG003|Overall Study|Death|0|||
33442892|NCT00746798|101515543|FG000|Overall Study|Participant unable to return for visit|1|||
33161971|NCT02207244|100504423|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33442893|NCT00746798|101515544|FG001|Overall Study|Participant unable to return for visit|0|||
33442894|NCT00746798|101515545|FG002|Overall Study|Participant unable to return for visit|0|||
33442895|NCT00746798|101515546|FG003|Overall Study|Participant unable to return for visit|0|||
33442896|NCT02107092|101515547|FG000|Overall Study|Miscellaneous|3|||
33442897|NCT02107092|101515547|FG000|Overall Study|Subject compliance|3|||
33442898|NCT02107092|101515547|FG000|Overall Study|Hypo-or hyperkalemia|2|||
33442899|NCT02107092|101515547|FG000|Overall Study|Met ECG withdrawal criteria|3|||
33442900|NCT02107092|101515547|FG000|Overall Study|Physician Decision|3|||
33442901|NCT02107092|101515547|FG000|Overall Study|Lost to Follow-up|2|||
33442902|NCT02107092|101515547|FG000|Overall Study|Withdrawal by Subject|9|||
33442903|NCT02107092|101515547|FG000|Overall Study|Adverse Event|7|||
33442904|NCT02107092|101515547|FG000|Overall Study|Expected progression of CKD|12|||
33442905|NCT02549092|101515548|FG000|Treatment Period|Adverse Event|2|||
33442906|NCT02549092|101515549|FG001|Treatment Period|Adverse Event|2|||
33442907|NCT02549092|101515548|FG000|Treatment Period|Withdrawal by Subject|1|||
33161972|NCT02207244|100504424|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
33161973|NCT02207244|100504425|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33161974|NCT02207244|100504426|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
33161975|NCT02207244|100504427|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33161976|NCT02207244|100504428|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33161977|NCT02207244|100504429|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33161978|NCT02207244|100504430|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33161979|NCT02207244|100504431|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
33161980|NCT02207244|100504421|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
33161981|NCT02207244|100504422|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
33161982|NCT02207244|100504423|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
33161983|NCT02207244|100504424|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
33161984|NCT02207244|100504425|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
33161985|NCT02207244|100504426|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
33161986|NCT02207244|100504427|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
33161987|NCT02207244|100504428|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
33161988|NCT02207244|100504429|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
33161989|NCT02207244|100504430|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
33161990|NCT02207244|100504431|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
33161991|NCT02207244|100504421|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
33161992|NCT02207244|100504422|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
33161993|NCT02207244|100504423|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
33161994|NCT02207244|100504424|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
33161995|NCT02207244|100504425|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
33161996|NCT02207244|100504426|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
33161997|NCT02207244|100504427|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
33161998|NCT02207244|100504428|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
33161999|NCT02207244|100504429|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
33162000|NCT02207244|100504430|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
33162001|NCT02207244|100504431|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
33162002|NCT02207244|100504421|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33162003|NCT02207244|100504422|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33162004|NCT02207244|100504423|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33162005|NCT02207244|100504424|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33162006|NCT02207244|100504425|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33162007|NCT02207244|100504426|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33162008|NCT02207244|100504427|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33162009|NCT02207244|100504428|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
33162010|NCT02207244|100504429|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33162011|NCT02207244|100504430|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33162012|NCT02207244|100504431|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
33162013|NCT02207244|100504421|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
33162014|NCT02207244|100504422|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
33162015|NCT02207244|100504423|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
33162016|NCT02207244|100504424|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
33162017|NCT02207244|100504425|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
33162018|NCT02207244|100504426|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
33162019|NCT02207244|100504427|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
33162020|NCT02207244|100504428|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
33162021|NCT02207244|100504429|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
33162022|NCT02207244|100504430|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
33162023|NCT02207244|100504431|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
33162024|NCT02207244|100504421|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33162025|NCT02207244|100504422|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33162026|NCT02207244|100504423|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33162027|NCT02207244|100504424|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33162028|NCT02207244|100504425|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33162029|NCT02207244|100504426|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33162030|NCT02207244|100504427|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
33162031|NCT02207244|100504428|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
33162032|NCT02207244|100504429|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33162033|NCT02207244|100504430|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
33162034|NCT02207244|100504431|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
33162035|NCT02207244|100504421|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
33162036|NCT02207244|100504422|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
33256222|NCT01426269|100839945|FG001|Period 2: 40 Weeks|Relapsed|9|||
33256223|NCT01426269|100839946|FG002|Period 2: 40 Weeks|Relapsed|18|||
33162037|NCT02207244|100504423|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
33162038|NCT02207244|100504424|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
33162039|NCT02207244|100504425|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
33162040|NCT02207244|100504426|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
33162041|NCT02207244|100504427|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
33162042|NCT02207244|100504428|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
33162043|NCT02207244|100504429|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
33162044|NCT02207244|100504430|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
33162045|NCT02207244|100504431|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
33162046|NCT02207244|100504421|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33162047|NCT02207244|100504422|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33162048|NCT02207244|100504423|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33162049|NCT02207244|100504424|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33162050|NCT02207244|100504425|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33162051|NCT02207244|100504426|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33162052|NCT02207244|100504427|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33162053|NCT02207244|100504428|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
33162054|NCT02207244|100504429|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
33162055|NCT02207244|100504430|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33162056|NCT02207244|100504431|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
33162057|NCT02207244|100504421|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33162058|NCT02207244|100504422|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33162059|NCT02207244|100504423|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33162060|NCT02207244|100504424|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33162061|NCT02207244|100504425|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33162062|NCT02207244|100504426|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33162063|NCT02207244|100504427|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33162064|NCT02207244|100504428|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33162065|NCT02207244|100504429|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
33162066|NCT02207244|100504430|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33162067|NCT02207244|100504431|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
33162068|NCT02207244|100504421|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33162069|NCT02207244|100504422|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33162070|NCT02207244|100504423|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33162071|NCT02207244|100504424|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33162072|NCT02207244|100504425|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33162073|NCT02207244|100504426|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33162074|NCT02207244|100504427|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33162075|NCT02207244|100504428|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
33162076|NCT02207244|100504429|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33162077|NCT02207244|100504430|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33162078|NCT02207244|100504431|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
33162079|NCT02207244|100504421|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33162080|NCT02207244|100504422|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33162081|NCT02207244|100504423|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33162082|NCT02207244|100504424|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33162083|NCT02207244|100504425|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33162084|NCT02207244|100504426|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33162085|NCT02207244|100504427|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
33162086|NCT02207244|100504428|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33162087|NCT02207244|100504429|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33162088|NCT02207244|100504430|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33162089|NCT02207244|100504431|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
33162090|NCT02207244|100504421|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33162091|NCT02207244|100504422|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33162092|NCT02207244|100504423|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33162093|NCT02207244|100504424|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33162094|NCT02207244|100504425|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33162095|NCT02207244|100504426|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33162096|NCT02207244|100504427|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33442908|NCT02549092|101515549|FG001|Treatment Period|Withdrawal by Subject|3|||
33442909|NCT02549092|101515548|FG000|Treatment Period|Lack of Efficacy|0|||
33162097|NCT02207244|100504428|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33162098|NCT02207244|100504429|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
33162099|NCT02207244|100504430|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
33162100|NCT02207244|100504431|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
33162101|NCT02207244|100504421|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33162102|NCT02207244|100504422|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33162103|NCT02207244|100504423|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33162104|NCT02207244|100504424|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33162105|NCT02207244|100504425|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33162106|NCT02207244|100504426|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33162107|NCT02207244|100504427|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33256224|NCT01190007|100839947|FG000|Overall Study|Withdrawal by Subject|4|||
33256225|NCT01190007|100839947|FG000|Overall Study|Adverse Event|8|||
33256226|NCT01190007|100839947|FG000|Overall Study|Difficulty of visit for complications|1|||
33256227|NCT01190007|100839947|FG000|Overall Study|Participant was arrested|1|||
33162108|NCT02207244|100504428|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33442910|NCT02549092|101515549|FG001|Treatment Period|Lack of Efficacy|2|||
33442911|NCT02549092|101515548|FG000|Extension/Transition Period|Adverse Event|1|||
33442912|NCT02549092|101515549|FG001|Extension/Transition Period|Adverse Event|1|||
33442913|NCT02549092|101515548|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
33442914|NCT02549092|101515549|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
33442915|NCT02549092|101515548|FG000|Extension/Transition Period|Other, Not Specified|4|||
33442916|NCT02549092|101515549|FG001|Extension/Transition Period|Other, Not Specified|2|||
33442917|NCT02024932|101515550|FG000|Overall Study|Adverse Event|2|||
33442918|NCT02024932|101515551|FG001|Overall Study|Adverse Event|3|||
33442919|NCT02024932|101515552|FG002|Overall Study|Adverse Event|0|||
33442920|NCT02024932|101515553|FG003|Overall Study|Adverse Event|0|||
33442921|NCT02024932|101515554|FG004|Overall Study|Adverse Event|2|||
33442922|NCT02024932|101515555|FG005|Overall Study|Adverse Event|0|||
33442923|NCT02024932|101515550|FG000|Overall Study|Abnormal laboratory value|0|||
33442924|NCT02024932|101515551|FG001|Overall Study|Abnormal laboratory value|0|||
33442925|NCT02024932|101515552|FG002|Overall Study|Abnormal laboratory value|0|||
33442926|NCT02024932|101515553|FG003|Overall Study|Abnormal laboratory value|2|||
33442927|NCT02024932|101515554|FG004|Overall Study|Abnormal laboratory value|0|||
33442928|NCT02024932|101515555|FG005|Overall Study|Abnormal laboratory value|0|||
33442929|NCT01981720|101515556|FG000|Overall Study|Adverse Event|1|||
33442930|NCT01981720|101515556|FG000|Overall Study|Withdrawal by Subject|3|||
33442931|NCT01981720|101515556|FG000|Overall Study|Pregnancy|1|||
33442932|NCT01848938|101515557|FG000|Overall Study|Lost to Follow-up|1|||
33442933|NCT01848938|101515558|FG001|Overall Study|Lost to Follow-up|1|||
33442934|NCT03752528|101515559|FG000|Part A|Lost to Follow-up|1|||
33442935|NCT03752528|101515559|FG000|Part A|Protocol Violation|1|||
33442936|NCT03752528|101515559|FG000|Part B|Protocol Violation|1|||
33442937|NCT03752528|101515559|FG000|Part B|Study terminated by sponsor|3|||
33442938|NCT00286754|101515560|FG000|Overall Study|Adverse Event|2|||
33442939|NCT00286754|101515561|FG001|Overall Study|Adverse Event|2|||
33442940|NCT00286754|101515562|FG002|Overall Study|Adverse Event|3|||
33442941|NCT00286754|101515560|FG000|Overall Study|Withdrawal by Subject|6|||
33442942|NCT00286754|101515561|FG001|Overall Study|Withdrawal by Subject|2|||
33442943|NCT00286754|101515562|FG002|Overall Study|Withdrawal by Subject|0|||
33442944|NCT00286754|101515560|FG000|Overall Study|Lost to Follow-up|12|||
33442945|NCT00286754|101515561|FG001|Overall Study|Lost to Follow-up|14|||
33442946|NCT00286754|101515562|FG002|Overall Study|Lost to Follow-up|6|||
33442947|NCT00286754|101515560|FG000|Overall Study|Moved out of state|0|||
33442948|NCT00286754|101515561|FG001|Overall Study|Moved out of state|0|||
33442949|NCT00286754|101515562|FG002|Overall Study|Moved out of state|1|||
33442950|NCT00669942|101515563|FG000|Parts 2 and 3|Adverse Event|0|||
33442951|NCT00669942|101515564|FG001|Parts 2 and 3|Adverse Event|0|||
33442952|NCT00669942|101515565|FG002|Parts 2 and 3|Adverse Event|0|||
33442953|NCT00669942|101515566|FG003|Parts 2 and 3|Adverse Event|0|||
33442954|NCT00669942|101515567|FG004|Parts 2 and 3|Adverse Event|0|||
33442955|NCT00669942|101515568|FG005|Parts 2 and 3|Adverse Event|0|||
33442956|NCT00669942|101515569|FG006|Parts 2 and 3|Adverse Event|0|||
33442957|NCT00669942|101515570|FG007|Parts 2 and 3|Adverse Event|2|||
33442958|NCT00669942|101515571|FG008|Parts 2 and 3|Adverse Event|1|||
33442959|NCT00669942|101515572|FG009|Parts 2 and 3|Adverse Event|0|||
33442960|NCT00669942|101515573|FG010|Parts 2 and 3|Adverse Event|0|||
33442961|NCT00669942|101515574|FG011|Parts 2 and 3|Adverse Event|0|||
33442962|NCT00669942|101515563|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
33442963|NCT00669942|101515564|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
33442964|NCT00669942|101515565|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
33442965|NCT00669942|101515566|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
33442966|NCT00669942|101515567|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
33442967|NCT00669942|101515568|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
33442968|NCT00669942|101515569|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
33442969|NCT00669942|101515570|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
33442970|NCT00669942|101515571|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
33442971|NCT00669942|101515572|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
33442972|NCT00669942|101515573|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
33442973|NCT00669942|101515574|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
33442974|NCT00669942|101515563|FG000|Parts 2 and 3|Protocol Violation|0|||
33442975|NCT00669942|101515564|FG001|Parts 2 and 3|Protocol Violation|0|||
33442976|NCT00669942|101515565|FG002|Parts 2 and 3|Protocol Violation|0|||
33442977|NCT00669942|101515566|FG003|Parts 2 and 3|Protocol Violation|0|||
33442978|NCT00669942|101515567|FG004|Parts 2 and 3|Protocol Violation|0|||
33442979|NCT00669942|101515568|FG005|Parts 2 and 3|Protocol Violation|1|||
33442980|NCT00669942|101515569|FG006|Parts 2 and 3|Protocol Violation|0|||
33442981|NCT00669942|101515570|FG007|Parts 2 and 3|Protocol Violation|0|||
33442982|NCT00669942|101515571|FG008|Parts 2 and 3|Protocol Violation|0|||
33442983|NCT00669942|101515572|FG009|Parts 2 and 3|Protocol Violation|0|||
33442984|NCT00669942|101515573|FG010|Parts 2 and 3|Protocol Violation|0|||
33442985|NCT00669942|101515574|FG011|Parts 2 and 3|Protocol Violation|0|||
33442986|NCT01710657|101515579|FG000|Overall Study|Lost to Follow-up|2|||
33442987|NCT01710657|101515580|FG001|Overall Study|Lost to Follow-up|0|||
33442988|NCT01710657|101515581|FG002|Overall Study|Lost to Follow-up|1|||
33442989|NCT01710657|101515579|FG000|Overall Study|Protocol Violation|2|||
33442990|NCT01710657|101515580|FG001|Overall Study|Protocol Violation|2|||
33442991|NCT01710657|101515581|FG002|Overall Study|Protocol Violation|0|||
33442992|NCT01710657|101515579|FG000|Overall Study|Adverse Event|14|||
33442993|NCT01710657|101515580|FG001|Overall Study|Adverse Event|8|||
33442994|NCT01710657|101515581|FG002|Overall Study|Adverse Event|28|||
33442995|NCT01710657|101515579|FG000|Overall Study|Withdrawal by Subject|0|||
33442996|NCT01710657|101515580|FG001|Overall Study|Withdrawal by Subject|1|||
33442997|NCT01710657|101515581|FG002|Overall Study|Withdrawal by Subject|2|||
33442998|NCT01710657|101515579|FG000|Overall Study|Lack of Efficacy|0|||
33442999|NCT01710657|101515580|FG001|Overall Study|Lack of Efficacy|1|||
33443000|NCT01710657|101515581|FG002|Overall Study|Lack of Efficacy|1|||
33443001|NCT02373098|101515584|FG000|Overall Study|Lost to Follow-up|1|||
33443002|NCT02373098|101515585|FG001|Overall Study|Lost to Follow-up|0|||
33443003|NCT02373098|101515584|FG000|Overall Study|Protocol Violation|3|||
33443004|NCT02373098|101515585|FG001|Overall Study|Protocol Violation|0|||
33443005|NCT02373098|101515584|FG000|Overall Study|Withdrawal by Subject|5|||
33443006|NCT02373098|101515585|FG001|Overall Study|Withdrawal by Subject|0|||
33443007|NCT02373098|101515584|FG000|Overall Study|Adverse Event|3|||
33443008|NCT02373098|101515585|FG001|Overall Study|Adverse Event|0|||
33443009|NCT01993030|101515586|FG000|Overall Study|Adverse Event|0|||
33443010|NCT01993030|101515587|FG001|Overall Study|Adverse Event|4|||
33443011|NCT02098876|101515591|FG000|Overall Study|Withdrawal by Subject|5|||
33443012|NCT02098876|101515592|FG001|Overall Study|Withdrawal by Subject|5|||
33443013|NCT00453362|101515605|FG000|Overall Study|Adverse Event|5|||
33443014|NCT00453362|101515605|FG000|Overall Study|Death|7|||
33443015|NCT00453362|101515605|FG000|Overall Study|Physician Decision|2|||
33443016|NCT00453362|101515605|FG000|Overall Study|Withdrawal by Subject|3|||
33443017|NCT00453362|101515605|FG000|Overall Study|Progression of disease|56|||
33443018|NCT00453362|101515605|FG000|Overall Study|Screening Failure|14|||
33443019|NCT03002077|101515606|FG000|Overall Study|Non-compliance with Study Drug|4|||
33443020|NCT03002077|101515606|FG000|Overall Study|Non-compliance w/Background ADT|1|||
33443021|NCT03002077|101515606|FG000|Overall Study|Study Terminated by Sponsor|257|||
33443022|NCT03002077|101515606|FG000|Overall Study|Site Terminated by Sponsor|5|||
33443023|NCT03002077|101515606|FG000|Overall Study|Miscellaneous Reasons|10|||
33443024|NCT03002077|101515606|FG000|Overall Study|Adverse Event|23|||
33443025|NCT03002077|101515606|FG000|Overall Study|Lack of Efficacy|20|||
33443026|NCT03002077|101515606|FG000|Overall Study|Withdrawal by Subject|72|||
33443027|NCT03002077|101515606|FG000|Overall Study|Lost to Follow-up|21|||
33443028|NCT03002077|101515606|FG000|Overall Study|Pregnancy|4|||
33443029|NCT03002077|101515606|FG000|Overall Study|Protocol Violation|21|||
33443030|NCT00433147|101515619|FG000|Overall Study|Adverse Event|0|||
33443031|NCT00433147|101515620|FG001|Overall Study|Adverse Event|1|||
33443032|NCT00433147|101515621|FG002|Overall Study|Adverse Event|0|||
33443033|NCT00433147|101515622|FG003|Overall Study|Adverse Event|0|||
33443034|NCT02231749|101515623|FG000|Overall Study|Disease progression|229|||
33443035|NCT02231749|101515624|FG001|Overall Study|Disease progression|297|||
33443036|NCT02231749|101515623|FG000|Overall Study|Study Drug Toxicity|134|||
33443037|NCT02231749|101515624|FG001|Overall Study|Study Drug Toxicity|63|||
33443038|NCT02231749|101515623|FG000|Overall Study|Death|1|||
33443039|NCT02231749|101515624|FG001|Overall Study|Death|1|||
33443040|NCT02231749|101515623|FG000|Overall Study|AE unrelated to Study drug|32|||
33443041|NCT02231749|101515624|FG001|Overall Study|AE unrelated to Study drug|31|||
33443042|NCT02231749|101515623|FG000|Overall Study|Participant's request to discontinue|10|||
33443043|NCT02231749|101515624|FG001|Overall Study|Participant's request to discontinue|21|||
33443044|NCT02231749|101515623|FG000|Overall Study|Participant withdrew Consent|8|||
33443045|NCT02231749|101515624|FG001|Overall Study|Participant withdrew Consent|15|||
33443046|NCT02231749|101515623|FG000|Overall Study|Lost to Follow-up|1|||
33443047|NCT02231749|101515624|FG001|Overall Study|Lost to Follow-up|2|||
33443048|NCT02231749|101515623|FG000|Overall Study|Maximum Clinical Benefit|5|||
33443049|NCT02231749|101515624|FG001|Overall Study|Maximum Clinical Benefit|8|||
33443050|NCT02231749|101515623|FG000|Overall Study|Poor/Non-Compliance|0|||
33443051|NCT02231749|101515624|FG001|Overall Study|Poor/Non-Compliance|3|||
33443052|NCT02231749|101515623|FG000|Overall Study|Pregnancy|1|||
33256228|NCT01747486|100839948|FG000|Stage 1|Physician Decision|3|||
33256229|NCT01747486|100839949|FG001|Stage 1|Physician Decision|0|||
33256230|NCT01747486|100839948|FG000|Stage 1|Withdrawal by Subject|4|||
33256231|NCT01747486|100839949|FG001|Stage 1|Withdrawal by Subject|3|||
33443053|NCT02231749|101515624|FG001|Overall Study|Pregnancy|0|||
33443054|NCT02231749|101515623|FG000|Overall Study|other|0|||
33256232|NCT01747486|100839948|FG000|Stage 1|Disease progression|4|||
33162109|NCT02207244|100504429|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
33162110|NCT02207244|100504430|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
33162111|NCT02207244|100504431|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
33162112|NCT02207244|100504421|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33162113|NCT02207244|100504422|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33162114|NCT02207244|100504423|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33256233|NCT01747486|100839949|FG001|Stage 1|Disease progression|9|||
33256234|NCT01747486|100839948|FG000|Stage 1|Death|1|||
33256235|NCT01747486|100839949|FG001|Stage 1|Death|1|||
33256236|NCT01747486|100839948|FG000|Stage 2|Physician Decision|2|||
33256237|NCT01747486|100839949|FG001|Stage 2|Physician Decision|0|||
33256238|NCT01747486|100839948|FG000|Stage 2|Withdrawal by Subject|1|||
33256239|NCT01747486|100839949|FG001|Stage 2|Withdrawal by Subject|0|||
33256240|NCT01747486|100839948|FG000|Stage 2|New Cancer Therapy|3|||
33256241|NCT01747486|100839949|FG001|Stage 2|New Cancer Therapy|0|||
33256242|NCT01747486|100839948|FG000|Stage 2|Disease Progression|3|||
33256243|NCT01747486|100839949|FG001|Stage 2|Disease Progression|0|||
33256244|NCT03403413|100839950|FG000|Overall Study|Lack of Efficacy|2|||
33256245|NCT01278394|100839951|FG000|Overall Study|Lost to Follow-up|1|||
33256246|NCT00439569|100839956|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
33256247|NCT00439569|100839956|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
33256248|NCT00439569|100839956|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
33256249|NCT00632424|100839959|FG000|Overall Study|Disease Progression|17|||
33256250|NCT00632424|100839959|FG000|Overall Study|Study Drug Toxicity|1|||
33256251|NCT01264679|100839962|FG000|Overall Study|Participation in Another Clinical Trial|1|||
33256252|NCT01264679|100839962|FG000|Overall Study|Physician Decision|1|||
33256253|NCT01264679|100839962|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
33256254|NCT01264679|100839962|FG000|Overall Study|Withdrawal by Subject|1|||
33256255|NCT02810080|100839963|FG000|Overall Study|Adverse Event|3|||
33256256|NCT02810080|100839964|FG001|Overall Study|Adverse Event|0|||
33256257|NCT02810080|100839963|FG000|Overall Study|Death|0|||
33256258|NCT02810080|100839964|FG001|Overall Study|Death|2|||
33256259|NCT02810080|100839963|FG000|Overall Study|Physician Decision|4|||
33256260|NCT02810080|100839964|FG001|Overall Study|Physician Decision|0|||
33256261|NCT02810080|100839963|FG000|Overall Study|Withdrawal by Subject|0|||
33256262|NCT02810080|100839964|FG001|Overall Study|Withdrawal by Subject|2|||
33256263|NCT03194958|100839965|FG000|Overall Study|Death|0|||
33256264|NCT03194958|100839966|FG001|Overall Study|Death|1|||
33256265|NCT03194958|100839967|FG002|Overall Study|Death|1|||
33256266|NCT03194958|100839968|FG003|Overall Study|Death|1|||
33256267|NCT03194958|100839965|FG000|Overall Study|Withdrawal by Subject|24|||
33256268|NCT03194958|100839966|FG001|Overall Study|Withdrawal by Subject|27|||
33256269|NCT03194958|100839967|FG002|Overall Study|Withdrawal by Subject|7|||
33256270|NCT03194958|100839968|FG003|Overall Study|Withdrawal by Subject|22|||
33256271|NCT03194958|100839965|FG000|Overall Study|Lost to Follow-up|168|||
33256272|NCT03194958|100839966|FG001|Overall Study|Lost to Follow-up|196|||
33256273|NCT03194958|100839967|FG002|Overall Study|Lost to Follow-up|174|||
33256274|NCT03194958|100839968|FG003|Overall Study|Lost to Follow-up|186|||
33256275|NCT01124734|100839971|FG000|Overall Study|Disease progression|13|||
33256276|NCT01124734|100839971|FG000|Overall Study|Adverse Event|1|||
33256277|NCT01124734|100839971|FG000|Overall Study|Withdrawal by Subject|1|||
33256278|NCT01124734|100839971|FG000|Overall Study|Elected for alternative treatment|2|||
33256279|NCT02529995|100839975|FG000|Part A|Ongoing Study at Data Cut-off|14|||
33256280|NCT02529995|100839976|FG001|Part A|Ongoing Study at Data Cut-off|16|||
33443055|NCT02231749|101515624|FG001|Overall Study|other|8|||
33443056|NCT02231749|101515623|FG000|Overall Study|No longer meets Study Criteria|1|||
33443057|NCT02231749|101515624|FG001|Overall Study|No longer meets Study Criteria|0|||
33162115|NCT02207244|100504424|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33162116|NCT02207244|100504425|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33162117|NCT02207244|100504426|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33162118|NCT02207244|100504427|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33162119|NCT02207244|100504428|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33256281|NCT02529995|100839975|FG000|Part A|Discontinued Study|1|||
33256282|NCT02529995|100839976|FG001|Part A|Discontinued Study|0|||
33256283|NCT02529995|100839975|FG000|Part B|Ongoing Study at Data Cut-off|0|||
33256284|NCT02529995|100839976|FG001|Part B|Ongoing Study at Data Cut-off|7|||
33256285|NCT02529995|100839975|FG000|Part B|Discontinued Study|6|||
33256286|NCT02529995|100839976|FG001|Part B|Discontinued Study|5|||
33443058|NCT00089661|101515627|FG000|Overall Study|Adverse Event|0|||
33443059|NCT00089661|101515628|FG001|Overall Study|Adverse Event|2|||
33443060|NCT00089661|101515627|FG000|Overall Study|Death|1|||
33256287|NCT00665444|100839977|FG000|Overall Study|Physician Decision|1|||
33256288|NCT00665444|100839977|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
33256289|NCT00465816|100839978|FG000|Overall Study|Lost to Follow-up|0|||
33256290|NCT00465816|100839979|FG001|Overall Study|Lost to Follow-up|0|||
33256291|NCT00465816|100839980|FG002|Overall Study|Lost to Follow-up|2|||
33256292|NCT03452189|100839981|FG000|First Intervention (3 Months)|Adverse Event|1|||
33256293|NCT03452189|100839982|FG001|First Intervention (3 Months)|Adverse Event|0|||
33256294|NCT03452189|100839981|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
33256295|NCT03452189|100839982|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
33256296|NCT00539292|100839992|FG000|Overall Study|Physician Decision|1|||
33256297|NCT00539292|100839993|FG001|Overall Study|Physician Decision|0|||
33256298|NCT01170962|100839994|FG000|Treatment Period|Lack of Efficacy|96|||
33256299|NCT01170962|100839995|FG001|Treatment Period|Lack of Efficacy|91|||
33256300|NCT01170962|100839996|FG002|Treatment Period|Lack of Efficacy|7|||
33256301|NCT01170962|100839994|FG000|Treatment Period|Adverse Event|11|||
33256302|NCT01170962|100839995|FG001|Treatment Period|Adverse Event|12|||
33256303|NCT01170962|100839996|FG002|Treatment Period|Adverse Event|3|||
33256304|NCT01170962|100839994|FG000|Treatment Period|Withdrawal by Subject|2|||
33256305|NCT01170962|100839995|FG001|Treatment Period|Withdrawal by Subject|1|||
33256306|NCT01170962|100839996|FG002|Treatment Period|Withdrawal by Subject|0|||
33256307|NCT01170962|100839994|FG000|Treatment Period|Lost to Follow-up|1|||
33256308|NCT01170962|100839995|FG001|Treatment Period|Lost to Follow-up|1|||
33256309|NCT01170962|100839996|FG002|Treatment Period|Lost to Follow-up|1|||
33256310|NCT01170962|100839994|FG000|Treatment Period|Participant no longer meets criteria|0|||
33256311|NCT01170962|100839995|FG001|Treatment Period|Participant no longer meets criteria|1|||
33256312|NCT01170962|100839996|FG002|Treatment Period|Participant no longer meets criteria|0|||
33256313|NCT01170962|100839994|FG000|Treatment Period|Request to discontinue treatment|7|||
33256314|NCT01170962|100839995|FG001|Treatment Period|Request to discontinue treatment|3|||
33256315|NCT01170962|100839996|FG002|Treatment Period|Request to discontinue treatment|1|||
33256316|NCT01170962|100839994|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
33256317|NCT01170962|100839995|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
33256318|NCT01170962|100839996|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
33256319|NCT01170962|100839994|FG000|Follow up Period|Withdrawal by Subject|14|||
33256320|NCT01170962|100839995|FG001|Follow up Period|Withdrawal by Subject|10|||
33256321|NCT01170962|100839996|FG002|Follow up Period|Withdrawal by Subject|2|||
33256322|NCT01170962|100839994|FG000|Follow up Period|Lost to Follow-up|13|||
33256323|NCT01170962|100839995|FG001|Follow up Period|Lost to Follow-up|8|||
33256324|NCT01170962|100839996|FG002|Follow up Period|Lost to Follow-up|1|||
33256325|NCT01170962|100839994|FG000|Follow up Period|Death|2|||
33256326|NCT01170962|100839995|FG001|Follow up Period|Death|2|||
33256327|NCT01170962|100839996|FG002|Follow up Period|Death|0|||
33256328|NCT01170962|100839994|FG000|Follow up Period|Others|10|||
33443061|NCT00089661|101515628|FG001|Overall Study|Death|0|||
33443062|NCT00089661|101515627|FG000|Overall Study|Lost to Follow-up|0|||
33256329|NCT01170962|100839995|FG001|Follow up Period|Others|7|||
33256330|NCT01170962|100839996|FG002|Follow up Period|Others|3|||
33256331|NCT01875250|100839997|FG000|Overall Study|Adverse Event|2|||
33256332|NCT01875250|100839998|FG001|Overall Study|Adverse Event|0|||
33256333|NCT00738699|100840001|FG000|Overall Study|Withdrawal by Subject|5|||
33256334|NCT00738699|100840002|FG001|Overall Study|Withdrawal by Subject|0|||
33256335|NCT00738699|100840001|FG000|Overall Study|Lost to Follow-up|1|||
33256336|NCT00738699|100840002|FG001|Overall Study|Lost to Follow-up|0|||
33256337|NCT00738699|100840001|FG000|Overall Study|Death|144|||
33256338|NCT00738699|100840002|FG001|Overall Study|Death|68|||
33256339|NCT00738699|100840001|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
33256340|NCT00738699|100840002|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
33256341|NCT00738699|100840001|FG000|Overall Study|Other|2|||
33256342|NCT00738699|100840002|FG001|Overall Study|Other|0|||
33256343|NCT01713946|100840003|FG000|Overall Study|Death|0|||
33256344|NCT01713946|100840004|FG001|Overall Study|Death|2|||
33256345|NCT01713946|100840005|FG002|Overall Study|Death|2|||
33256346|NCT01713946|100840003|FG000|Overall Study|Adverse Event|19|||
33256347|NCT01713946|100840004|FG001|Overall Study|Adverse Event|14|||
33256348|NCT01713946|100840005|FG002|Overall Study|Adverse Event|13|||
33256349|NCT01713946|100840003|FG000|Overall Study|Withdrawal by Subject|12|||
33256350|NCT01713946|100840004|FG001|Overall Study|Withdrawal by Subject|12|||
33256351|NCT01713946|100840005|FG002|Overall Study|Withdrawal by Subject|8|||
33256352|NCT01713946|100840003|FG000|Overall Study|Lack of Efficacy|8|||
33256353|NCT01713946|100840004|FG001|Overall Study|Lack of Efficacy|8|||
33256354|NCT01713946|100840005|FG002|Overall Study|Lack of Efficacy|14|||
33256355|NCT01713946|100840003|FG000|Overall Study|Protocol Violation|2|||
33256356|NCT01713946|100840004|FG001|Overall Study|Protocol Violation|4|||
33256357|NCT01713946|100840005|FG002|Overall Study|Protocol Violation|1|||
33256358|NCT01713946|100840003|FG000|Overall Study|Lost to Follow-up|0|||
33256359|NCT01713946|100840004|FG001|Overall Study|Lost to Follow-up|0|||
33256360|NCT01713946|100840005|FG002|Overall Study|Lost to Follow-up|1|||
33256361|NCT01713946|100840003|FG000|Overall Study|Administrative problems|1|||
33256362|NCT01713946|100840004|FG001|Overall Study|Administrative problems|0|||
33256363|NCT01713946|100840005|FG002|Overall Study|Administrative problems|0|||
33256364|NCT01713946|100840003|FG000|Overall Study|Did not continue in Ext|0|||
33256365|NCT01713946|100840004|FG001|Overall Study|Did not continue in Ext|3|||
33256366|NCT01713946|100840005|FG002|Overall Study|Did not continue in Ext|0|||
33256367|NCT01713946|100840003|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
33256368|NCT01713946|100840004|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
33256369|NCT01713946|100840005|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
33443063|NCT00089661|101515628|FG001|Overall Study|Lost to Follow-up|3|||
33443064|NCT00089661|101515627|FG000|Overall Study|Withdrawal by Subject|11|||
33256370|NCT01713946|100840003|FG000|Overall Study|Patients never switched to everolimus|0|||
33256371|NCT01713946|100840004|FG001|Overall Study|Patients never switched to everolimus|0|||
33256372|NCT01713946|100840005|FG002|Overall Study|Patients never switched to everolimus|5|||
33256373|NCT01595061|100840008|FG000|Overall Study|Never Treated|3|||
33256374|NCT01595061|100840008|FG000|Overall Study|Inadequate Pathology|1|||
33256375|NCT04425629|100840013|FG000|Overall Study|Adverse Event|0|||
33256376|NCT04425629|100840014|FG001|Overall Study|Adverse Event|0|||
33443065|NCT00089661|101515628|FG001|Overall Study|Withdrawal by Subject|9|||
33443066|NCT00089661|101515627|FG000|Overall Study|Disease progression|1|||
33443067|NCT00089661|101515628|FG001|Overall Study|Disease progression|3|||
33443068|NCT00089661|101515627|FG000|Overall Study|Ineligibility determined|4|||
33443069|NCT00089661|101515628|FG001|Overall Study|Ineligibility determined|4|||
33443070|NCT00089661|101515627|FG000|Overall Study|Noncompliance|2|||
33443071|NCT00089661|101515628|FG001|Overall Study|Noncompliance|4|||
33443072|NCT00089661|101515627|FG000|Overall Study|Other|2|||
33256377|NCT04425629|100840015|FG002|Overall Study|Adverse Event|0|||
33443073|NCT00089661|101515628|FG001|Overall Study|Other|1|||
33443074|NCT00520130|101515632|FG000|Overall Study|Disease progression on study|4|||
33256378|NCT04425629|100840016|FG003|Overall Study|Adverse Event|0|||
33256379|NCT04425629|100840017|FG004|Overall Study|Adverse Event|1|||
33256380|NCT04425629|100840018|FG005|Overall Study|Adverse Event|0|||
33256381|NCT04425629|100840019|FG006|Overall Study|Adverse Event|0|||
33256382|NCT04425629|100840020|FG007|Overall Study|Adverse Event|0|||
33256383|NCT04425629|100840021|FG008|Overall Study|Adverse Event|0|||
33256384|NCT04425629|100840022|FG009|Overall Study|Adverse Event|3|||
33256385|NCT04425629|100840023|FG010|Overall Study|Adverse Event|2|||
33256386|NCT04425629|100840024|FG011|Overall Study|Adverse Event|1|||
33256387|NCT04425629|100840025|FG012|Overall Study|Adverse Event|1|||
33256388|NCT04425629|100840026|FG013|Overall Study|Adverse Event|0|||
33256389|NCT04425629|100840027|FG014|Overall Study|Adverse Event|0|||
33256390|NCT04425629|100840028|FG015|Overall Study|Adverse Event|0|||
33256391|NCT04425629|100840029|FG016|Overall Study|Adverse Event|0|||
33256392|NCT04425629|100840030|FG017|Overall Study|Adverse Event|0|||
33256393|NCT04425629|100840031|FG018|Overall Study|Adverse Event|0|||
33256394|NCT04425629|100840013|FG000|Overall Study|Lost to Follow-up|1|||
33256395|NCT04425629|100840014|FG001|Overall Study|Lost to Follow-up|3|||
33256396|NCT04425629|100840015|FG002|Overall Study|Lost to Follow-up|1|||
33256397|NCT04425629|100840016|FG003|Overall Study|Lost to Follow-up|7|||
33256398|NCT04425629|100840017|FG004|Overall Study|Lost to Follow-up|1|||
33256399|NCT04425629|100840018|FG005|Overall Study|Lost to Follow-up|2|||
33256400|NCT04425629|100840019|FG006|Overall Study|Lost to Follow-up|1|||
33256401|NCT04425629|100840020|FG007|Overall Study|Lost to Follow-up|0|||
33256402|NCT04425629|100840021|FG008|Overall Study|Lost to Follow-up|1|||
33256403|NCT04425629|100840022|FG009|Overall Study|Lost to Follow-up|64|||
33256404|NCT04425629|100840023|FG010|Overall Study|Lost to Follow-up|70|||
33256405|NCT04425629|100840024|FG011|Overall Study|Lost to Follow-up|98|||
33256406|NCT04425629|100840025|FG012|Overall Study|Lost to Follow-up|30|||
33256407|NCT04425629|100840026|FG013|Overall Study|Lost to Follow-up|0|||
33256408|NCT04425629|100840027|FG014|Overall Study|Lost to Follow-up|5|||
33256409|NCT04425629|100840028|FG015|Overall Study|Lost to Follow-up|4|||
33256410|NCT04425629|100840029|FG016|Overall Study|Lost to Follow-up|0|||
33256411|NCT04425629|100840030|FG017|Overall Study|Lost to Follow-up|3|||
33256412|NCT04425629|100840031|FG018|Overall Study|Lost to Follow-up|1|||
33256413|NCT04425629|100840013|FG000|Overall Study|Subject Decision|0|||
33162120|NCT02207244|100504429|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
33162121|NCT02207244|100504430|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
33162122|NCT02207244|100504431|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
33443075|NCT00520130|101515633|FG001|Overall Study|Disease progression on study|0|||
33162123|NCT02207244|100504421|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33162124|NCT02207244|100504422|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33162125|NCT02207244|100504423|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33162126|NCT02207244|100504424|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33162127|NCT02207244|100504425|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33162128|NCT02207244|100504426|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33162129|NCT02207244|100504427|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33162130|NCT02207244|100504428|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33162131|NCT02207244|100504429|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
33162132|NCT02207244|100504430|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
33162133|NCT02207244|100504431|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
33162134|NCT02207244|100504421|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
33162135|NCT02207244|100504422|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
33162136|NCT02207244|100504423|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
33162137|NCT02207244|100504424|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
33162138|NCT02207244|100504425|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
33162139|NCT02207244|100504426|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
33162140|NCT02207244|100504427|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
33162141|NCT02207244|100504428|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
33162142|NCT02207244|100504429|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
33162143|NCT02207244|100504430|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
33162144|NCT02207244|100504431|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
33162145|NCT02207244|100504421|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
33162146|NCT02207244|100504422|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
33162147|NCT02207244|100504423|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
33162148|NCT02207244|100504424|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
33162149|NCT02207244|100504425|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
33162150|NCT02207244|100504426|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
33162151|NCT02207244|100504427|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
33162152|NCT02207244|100504428|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
33162153|NCT02207244|100504429|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
33162154|NCT02207244|100504430|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
33162155|NCT02207244|100504431|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
33162156|NCT02207244|100504421|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33162157|NCT02207244|100504422|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33162158|NCT02207244|100504423|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33162159|NCT02207244|100504424|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33162160|NCT02207244|100504425|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33162161|NCT02207244|100504426|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33162162|NCT02207244|100504427|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33162163|NCT02207244|100504428|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33162164|NCT02207244|100504429|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33256414|NCT04425629|100840014|FG001|Overall Study|Subject Decision|2|||
33443076|NCT00520130|101515632|FG000|Overall Study|Physician Decision|1|||
33443077|NCT00520130|101515633|FG001|Overall Study|Physician Decision|1|||
33443078|NCT04627038|101515636|FG000|Overall Study|Adverse Event|36|||
33443079|NCT04627038|101515637|FG001|Overall Study|Adverse Event|8|||
33162165|NCT02207244|100504430|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
33162166|NCT02207244|100504431|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
33256415|NCT04425629|100840015|FG002|Overall Study|Subject Decision|1|||
33162167|NCT01964430|100504432|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
33162168|NCT01964430|100504433|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
33162169|NCT01964430|100504432|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
33256416|NCT04425629|100840016|FG003|Overall Study|Subject Decision|3|||
33443080|NCT04627038|101515636|FG000|Overall Study|Lost to Follow-up|1|||
33443081|NCT04627038|101515637|FG001|Overall Study|Lost to Follow-up|0|||
33443082|NCT04627038|101515636|FG000|Overall Study|Physician Decision|0|||
33443083|NCT04627038|101515637|FG001|Overall Study|Physician Decision|1|||
33443084|NCT04627038|101515636|FG000|Overall Study|Protocol Violation|3|||
33443085|NCT04627038|101515637|FG001|Overall Study|Protocol Violation|1|||
33443086|NCT04627038|101515636|FG000|Overall Study|Withdrawal by Subject|13|||
33443087|NCT04627038|101515637|FG001|Overall Study|Withdrawal by Subject|3|||
33443088|NCT04627038|101515636|FG000|Overall Study|Non-compliance with study drug|0|||
33443089|NCT04627038|101515637|FG001|Overall Study|Non-compliance with study drug|1|||
33443090|NCT04627038|101515636|FG000|Overall Study|Prohibited Concomitant Medication|1|||
33443091|NCT04627038|101515637|FG001|Overall Study|Prohibited Concomitant Medication|0|||
33443092|NCT00274937|101515638|FG000|Overall Study|Physician Decision|10|||
33443093|NCT00274937|101515638|FG000|Overall Study|Withdrawal by Subject|6|||
33443094|NCT00274937|101515638|FG000|Overall Study|Progressive Disease|4|||
33443095|NCT01882257|101515639|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
33443096|NCT01882257|101515640|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
33443097|NCT01882257|101515641|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
33443098|NCT01882257|101515639|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
33443099|NCT01882257|101515640|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
33443100|NCT01882257|101515641|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
33443101|NCT00251979|101515646|FG000|Overall Study|Protocol Violation|3|||
33443102|NCT00251979|101515647|FG001|Overall Study|Protocol Violation|5|||
33443103|NCT00251979|101515646|FG000|Overall Study|Adverse Event|11|||
33443104|NCT00251979|101515647|FG001|Overall Study|Adverse Event|17|||
33443105|NCT00251979|101515646|FG000|Overall Study|Withdrawal by Subject|13|||
33443106|NCT00251979|101515647|FG001|Overall Study|Withdrawal by Subject|7|||
33443107|NCT00251979|101515646|FG000|Overall Study|Lost to Follow-up|8|||
33443108|NCT00251979|101515647|FG001|Overall Study|Lost to Follow-up|6|||
33443109|NCT00251979|101515646|FG000|Overall Study|Death|3|||
33443110|NCT00251979|101515647|FG001|Overall Study|Death|5|||
33443111|NCT02458469|101515650|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
33443112|NCT02458469|101515651|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
33443113|NCT02458469|101515652|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
33443114|NCT02458469|101515653|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
33443115|NCT02458469|101515654|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
33443116|NCT02458469|101515655|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
33443117|NCT02458469|101515650|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
33443118|NCT02458469|101515651|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
33443119|NCT02458469|101515652|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
33443120|NCT02458469|101515653|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
33443121|NCT02458469|101515654|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
33443122|NCT02458469|101515655|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
33443123|NCT02458469|101515650|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
33443124|NCT02458469|101515651|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
33443125|NCT02458469|101515652|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
33443126|NCT02458469|101515653|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
33443127|NCT02458469|101515654|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
33443128|NCT02458469|101515655|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
33443129|NCT02057458|101515656|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
33443130|NCT02057458|101515657|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
33443131|NCT02057458|101515658|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
33443132|NCT02057458|101515656|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
33443133|NCT02057458|101515657|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
33443134|NCT02057458|101515658|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
33443135|NCT02057458|101515656|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
33443136|NCT02057458|101515657|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
33443137|NCT02057458|101515658|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
33443138|NCT00794963|101515659|FG000|Overall Study|Withdrawal by Subject|1|||
33443139|NCT00794963|101515660|FG001|Overall Study|Withdrawal by Subject|4|||
33443140|NCT03041025|101515663|FG000|Overall Study|Adverse Event|0|||
33443141|NCT03041025|101515664|FG001|Overall Study|Adverse Event|0|||
33443142|NCT03041025|101515665|FG002|Overall Study|Adverse Event|1|||
33443143|NCT03041025|101515663|FG000|Overall Study|Lost to Follow-up|1|||
33443144|NCT03041025|101515664|FG001|Overall Study|Lost to Follow-up|0|||
33443145|NCT03041025|101515665|FG002|Overall Study|Lost to Follow-up|0|||
33443146|NCT03041025|101515663|FG000|Overall Study|Withdrawal by Subject|0|||
33443147|NCT03041025|101515664|FG001|Overall Study|Withdrawal by Subject|0|||
33443148|NCT03041025|101515665|FG002|Overall Study|Withdrawal by Subject|1|||
33443149|NCT00396279|101515666|FG000|Overall Study|Ongoing in study|26|||
33443150|NCT00396279|101515666|FG000|Overall Study|Disease progression|2|||
33443151|NCT00396279|101515666|FG000|Overall Study|Withdrawal by Subject|1|||
33443152|NCT00396279|101515666|FG000|Overall Study|Physician Decision|1|||
33256417|NCT04425629|100840017|FG004|Overall Study|Subject Decision|6|||
33443153|NCT01313273|101515667|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
33443154|NCT01313273|101515668|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
33443155|NCT01313273|101515667|FG000|Overall Study|Withdrawal by Subject|1|||
33443156|NCT01313273|101515668|FG001|Overall Study|Withdrawal by Subject|0|||
33443157|NCT01313273|101515667|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
33443158|NCT01313273|101515668|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
33443159|NCT01108094|101515669|FG000|Overall Study|Adverse Event|2|||
33443160|NCT01108094|101515670|FG001|Overall Study|Adverse Event|0|||
33443161|NCT01108094|101515671|FG002|Overall Study|Adverse Event|0|||
33443162|NCT01108094|101515672|FG003|Overall Study|Adverse Event|0|||
33443163|NCT01108094|101515669|FG000|Overall Study|Withdrawal by Subject|1|||
33443164|NCT01108094|101515670|FG001|Overall Study|Withdrawal by Subject|0|||
33443165|NCT01108094|101515671|FG002|Overall Study|Withdrawal by Subject|0|||
33443166|NCT01108094|101515672|FG003|Overall Study|Withdrawal by Subject|0|||
33443167|NCT00424047|101515673|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
33443168|NCT00424047|101515674|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
33443169|NCT00424047|101515673|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
33443170|NCT00424047|101515674|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
33443171|NCT00424047|101515673|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
33443172|NCT00424047|101515674|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
33443173|NCT00424047|101515673|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
33443174|NCT00424047|101515674|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
33256418|NCT04425629|100840018|FG005|Overall Study|Subject Decision|6|||
33162170|NCT01964430|100504433|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
33256419|NCT04425629|100840019|FG006|Overall Study|Subject Decision|3|||
33256420|NCT04425629|100840020|FG007|Overall Study|Subject Decision|3|||
33256421|NCT04425629|100840021|FG008|Overall Study|Subject Decision|1|||
33256422|NCT04425629|100840022|FG009|Overall Study|Subject Decision|70|||
33256423|NCT04425629|100840023|FG010|Overall Study|Subject Decision|95|||
33256424|NCT04425629|100840024|FG011|Overall Study|Subject Decision|124|||
33256425|NCT04425629|100840025|FG012|Overall Study|Subject Decision|25|||
33256426|NCT04425629|100840026|FG013|Overall Study|Subject Decision|0|||
33256427|NCT04425629|100840027|FG014|Overall Study|Subject Decision|1|||
33256428|NCT04425629|100840028|FG015|Overall Study|Subject Decision|4|||
33256429|NCT04425629|100840029|FG016|Overall Study|Subject Decision|1|||
33256430|NCT04425629|100840030|FG017|Overall Study|Subject Decision|0|||
33256431|NCT04425629|100840031|FG018|Overall Study|Subject Decision|2|||
33256432|NCT04425629|100840013|FG000|Overall Study|Death|0|||
33256433|NCT04425629|100840014|FG001|Overall Study|Death|0|||
33256434|NCT04425629|100840015|FG002|Overall Study|Death|0|||
33256435|NCT04425629|100840016|FG003|Overall Study|Death|0|||
33256436|NCT04425629|100840017|FG004|Overall Study|Death|0|||
33256437|NCT04425629|100840018|FG005|Overall Study|Death|0|||
33256438|NCT04425629|100840019|FG006|Overall Study|Death|0|||
33256439|NCT04425629|100840020|FG007|Overall Study|Death|0|||
33256440|NCT04425629|100840021|FG008|Overall Study|Death|0|||
33256441|NCT04425629|100840022|FG009|Overall Study|Death|11|||
33256442|NCT04425629|100840023|FG010|Overall Study|Death|2|||
33256443|NCT04425629|100840024|FG011|Overall Study|Death|4|||
33256444|NCT04425629|100840025|FG012|Overall Study|Death|0|||
33256445|NCT04425629|100840026|FG013|Overall Study|Death|0|||
33256446|NCT04425629|100840027|FG014|Overall Study|Death|0|||
33256447|NCT04425629|100840028|FG015|Overall Study|Death|0|||
33256448|NCT04425629|100840029|FG016|Overall Study|Death|0|||
33256449|NCT04425629|100840030|FG017|Overall Study|Death|0|||
33256450|NCT04425629|100840031|FG018|Overall Study|Death|0|||
33256451|NCT04425629|100840013|FG000|Overall Study|Sponsor Request|0|||
33256452|NCT04425629|100840014|FG001|Overall Study|Sponsor Request|0|||
33256453|NCT04425629|100840015|FG002|Overall Study|Sponsor Request|0|||
33256454|NCT04425629|100840016|FG003|Overall Study|Sponsor Request|2|||
33256455|NCT04425629|100840017|FG004|Overall Study|Sponsor Request|2|||
33256456|NCT04425629|100840018|FG005|Overall Study|Sponsor Request|2|||
33256457|NCT04425629|100840019|FG006|Overall Study|Sponsor Request|1|||
33256458|NCT04425629|100840020|FG007|Overall Study|Sponsor Request|0|||
33256459|NCT04425629|100840021|FG008|Overall Study|Sponsor Request|0|||
33256460|NCT04425629|100840022|FG009|Overall Study|Sponsor Request|9|||
33256461|NCT04425629|100840023|FG010|Overall Study|Sponsor Request|9|||
33256462|NCT04425629|100840024|FG011|Overall Study|Sponsor Request|10|||
33256463|NCT04425629|100840025|FG012|Overall Study|Sponsor Request|8|||
33256464|NCT04425629|100840026|FG013|Overall Study|Sponsor Request|0|||
33256465|NCT04425629|100840027|FG014|Overall Study|Sponsor Request|0|||
33256466|NCT04425629|100840028|FG015|Overall Study|Sponsor Request|1|||
33256467|NCT04425629|100840029|FG016|Overall Study|Sponsor Request|0|||
33256468|NCT04425629|100840030|FG017|Overall Study|Sponsor Request|0|||
33256469|NCT04425629|100840031|FG018|Overall Study|Sponsor Request|0|||
33256470|NCT04425629|100840013|FG000|Overall Study|Physician Decision|0|||
33256471|NCT04425629|100840014|FG001|Overall Study|Physician Decision|0|||
33256472|NCT04425629|100840015|FG002|Overall Study|Physician Decision|0|||
33256473|NCT04425629|100840016|FG003|Overall Study|Physician Decision|0|||
33256474|NCT04425629|100840017|FG004|Overall Study|Physician Decision|0|||
33256475|NCT04425629|100840018|FG005|Overall Study|Physician Decision|0|||
33256476|NCT04425629|100840019|FG006|Overall Study|Physician Decision|0|||
33256477|NCT04425629|100840020|FG007|Overall Study|Physician Decision|0|||
33256478|NCT04425629|100840021|FG008|Overall Study|Physician Decision|0|||
33256479|NCT04425629|100840022|FG009|Overall Study|Physician Decision|4|||
33256480|NCT04425629|100840023|FG010|Overall Study|Physician Decision|3|||
33256481|NCT04425629|100840024|FG011|Overall Study|Physician Decision|5|||
33256482|NCT04425629|100840025|FG012|Overall Study|Physician Decision|1|||
33256483|NCT04425629|100840026|FG013|Overall Study|Physician Decision|0|||
33256484|NCT04425629|100840027|FG014|Overall Study|Physician Decision|0|||
33256485|NCT04425629|100840028|FG015|Overall Study|Physician Decision|1|||
33256486|NCT04425629|100840029|FG016|Overall Study|Physician Decision|0|||
33256487|NCT04425629|100840030|FG017|Overall Study|Physician Decision|0|||
33256488|NCT04425629|100840031|FG018|Overall Study|Physician Decision|0|||
33256489|NCT04425629|100840013|FG000|Overall Study|Lack of Efficacy|0|||
33443175|NCT00424047|101515673|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
33256490|NCT04425629|100840014|FG001|Overall Study|Lack of Efficacy|0|||
33256491|NCT04425629|100840015|FG002|Overall Study|Lack of Efficacy|0|||
33256492|NCT04425629|100840016|FG003|Overall Study|Lack of Efficacy|0|||
33256493|NCT04425629|100840017|FG004|Overall Study|Lack of Efficacy|0|||
33256494|NCT04425629|100840018|FG005|Overall Study|Lack of Efficacy|0|||
33256495|NCT04425629|100840019|FG006|Overall Study|Lack of Efficacy|0|||
33256496|NCT04425629|100840020|FG007|Overall Study|Lack of Efficacy|0|||
33256497|NCT04425629|100840021|FG008|Overall Study|Lack of Efficacy|0|||
33256498|NCT04425629|100840022|FG009|Overall Study|Lack of Efficacy|0|||
33162171|NCT01964430|100504432|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
33162172|NCT01964430|100504433|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
33162173|NCT01964430|100504432|FG000|Treatment Period|Adverse Event|71|||
33162174|NCT01964430|100504433|FG001|Treatment Period|Adverse Event|37|||
33162175|NCT01964430|100504432|FG000|Treatment Period|Withdrawal by Subject|36|||
33162176|NCT01964430|100504433|FG001|Treatment Period|Withdrawal by Subject|27|||
33162177|NCT01964430|100504432|FG000|Treatment Period|Death|1|||
33162178|NCT01964430|100504433|FG001|Treatment Period|Death|3|||
33162179|NCT01964430|100504432|FG000|Treatment Period|Protocol Deviation|0|||
33162180|NCT01964430|100504433|FG001|Treatment Period|Protocol Deviation|1|||
33162181|NCT01964430|100504432|FG000|Treatment Period|Physician Decision|5|||
33162182|NCT01964430|100504433|FG001|Treatment Period|Physician Decision|4|||
33162183|NCT01964430|100504432|FG000|Treatment Period|Disease Relapse|28|||
33162184|NCT01964430|100504433|FG001|Treatment Period|Disease Relapse|38|||
33162185|NCT01964430|100504432|FG000|Treatment Period|Other reasons|1|||
33162186|NCT01964430|100504433|FG001|Treatment Period|Other reasons|3|||
33162187|NCT00939770|100504436|FG000|Overall Study|Adverse Event|1|||
33162188|NCT00939770|100504437|FG001|Overall Study|Adverse Event|1|||
33162189|NCT00939770|100504438|FG002|Overall Study|Adverse Event|0|||
33162190|NCT00939770|100504439|FG003|Overall Study|Adverse Event|0|||
33162191|NCT00939770|100504440|FG004|Overall Study|Adverse Event|6|||
33162192|NCT00939770|100504441|FG005|Overall Study|Adverse Event|2|||
33162193|NCT00939770|100504442|FG006|Overall Study|Adverse Event|1|||
33162194|NCT00939770|100504443|FG007|Overall Study|Adverse Event|1|||
33162195|NCT00939770|100504436|FG000|Overall Study|Lack of Efficacy|4|||
33162196|NCT00939770|100504437|FG001|Overall Study|Lack of Efficacy|6|||
33162197|NCT00939770|100504438|FG002|Overall Study|Lack of Efficacy|13|||
33162198|NCT00939770|100504439|FG003|Overall Study|Lack of Efficacy|9|||
33162199|NCT00939770|100504440|FG004|Overall Study|Lack of Efficacy|16|||
33162200|NCT00939770|100504441|FG005|Overall Study|Lack of Efficacy|8|||
33162201|NCT00939770|100504442|FG006|Overall Study|Lack of Efficacy|11|||
33443176|NCT00424047|101515674|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
33443177|NCT00424047|101515673|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
33443178|NCT00424047|101515674|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
33443179|NCT00424047|101515673|FG000|On Study at Time of Unblinding|Adverse Event|22|||
33443180|NCT00424047|101515674|FG001|On Study at Time of Unblinding|Adverse Event|12|||
33443181|NCT00424047|101515673|FG000|On Study at Time of Unblinding|Progression of disease|92|||
33443182|NCT00424047|101515674|FG001|On Study at Time of Unblinding|Progression of disease|128|||
33443183|NCT00424047|101515673|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
33443184|NCT00424047|101515674|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
33162202|NCT00939770|100504443|FG007|Overall Study|Lack of Efficacy|1|||
33162203|NCT00939770|100504436|FG000|Overall Study|Lost to Follow-up|0|||
33162204|NCT00939770|100504437|FG001|Overall Study|Lost to Follow-up|0|||
33162205|NCT00939770|100504438|FG002|Overall Study|Lost to Follow-up|0|||
33162206|NCT00939770|100504439|FG003|Overall Study|Lost to Follow-up|0|||
33162207|NCT00939770|100504440|FG004|Overall Study|Lost to Follow-up|1|||
33443185|NCT00424047|101515673|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
33443186|NCT00424047|101515674|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
33443187|NCT00424047|101515673|FG000|On Study at Time of Unblinding|Death|11|||
33443188|NCT00424047|101515674|FG001|On Study at Time of Unblinding|Death|11|||
33443189|NCT00424047|101515673|FG000|On Study at Time of Unblinding|Other|5|||
33443190|NCT00424047|101515674|FG001|On Study at Time of Unblinding|Other|4|||
33443191|NCT00424047|101515673|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
33443192|NCT00424047|101515674|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
33162208|NCT00939770|100504441|FG005|Overall Study|Lost to Follow-up|0|||
33162209|NCT00939770|100504442|FG006|Overall Study|Lost to Follow-up|0|||
33162210|NCT00939770|100504443|FG007|Overall Study|Lost to Follow-up|0|||
33162211|NCT00939770|100504436|FG000|Overall Study|Physician Decision|0|||
33162212|NCT00939770|100504437|FG001|Overall Study|Physician Decision|0|||
33162213|NCT00939770|100504438|FG002|Overall Study|Physician Decision|2|||
33162214|NCT00939770|100504439|FG003|Overall Study|Physician Decision|0|||
33162215|NCT00939770|100504440|FG004|Overall Study|Physician Decision|7|||
33162216|NCT00939770|100504441|FG005|Overall Study|Physician Decision|1|||
33162217|NCT00939770|100504442|FG006|Overall Study|Physician Decision|0|||
33162218|NCT00939770|100504443|FG007|Overall Study|Physician Decision|6|||
33162219|NCT00939770|100504436|FG000|Overall Study|Protocol Violation|0|||
33162220|NCT00939770|100504437|FG001|Overall Study|Protocol Violation|0|||
33162221|NCT00939770|100504438|FG002|Overall Study|Protocol Violation|0|||
33162222|NCT00939770|100504439|FG003|Overall Study|Protocol Violation|0|||
33162223|NCT00939770|100504440|FG004|Overall Study|Protocol Violation|1|||
33162224|NCT00939770|100504441|FG005|Overall Study|Protocol Violation|0|||
33162225|NCT00939770|100504442|FG006|Overall Study|Protocol Violation|0|||
33162226|NCT00939770|100504443|FG007|Overall Study|Protocol Violation|0|||
33162227|NCT00939770|100504436|FG000|Overall Study|Withdrawal by Subject|0|||
33162228|NCT00939770|100504437|FG001|Overall Study|Withdrawal by Subject|1|||
33162229|NCT00939770|100504438|FG002|Overall Study|Withdrawal by Subject|5|||
33162230|NCT00939770|100504439|FG003|Overall Study|Withdrawal by Subject|2|||
33162231|NCT00939770|100504440|FG004|Overall Study|Withdrawal by Subject|6|||
33162232|NCT00939770|100504441|FG005|Overall Study|Withdrawal by Subject|0|||
33162233|NCT00939770|100504442|FG006|Overall Study|Withdrawal by Subject|2|||
33162234|NCT00939770|100504443|FG007|Overall Study|Withdrawal by Subject|2|||
33162235|NCT03693300|100504445|FG000|Overall Study|Withdrawal by Subject|6|||
33162236|NCT03693300|100504446|FG001|Overall Study|Withdrawal by Subject|0|||
33443193|NCT00424047|101515673|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
33162237|NCT03693300|100504445|FG000|Overall Study|Death|50|||
33162238|NCT03693300|100504446|FG001|Overall Study|Death|2|||
33162239|NCT03693300|100504445|FG000|Overall Study|Lost to Follow-up|2|||
33162240|NCT03693300|100504446|FG001|Overall Study|Lost to Follow-up|0|||
33162241|NCT00282984|100504447|FG000|Overall Study|Death|2|||
33443194|NCT00424047|101515674|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
33256499|NCT04425629|100840023|FG010|Overall Study|Lack of Efficacy|1|||
33256500|NCT04425629|100840024|FG011|Overall Study|Lack of Efficacy|0|||
33256501|NCT04425629|100840025|FG012|Overall Study|Lack of Efficacy|0|||
33256502|NCT04425629|100840026|FG013|Overall Study|Lack of Efficacy|0|||
33256503|NCT04425629|100840027|FG014|Overall Study|Lack of Efficacy|0|||
33256504|NCT04425629|100840028|FG015|Overall Study|Lack of Efficacy|0|||
33256505|NCT04425629|100840029|FG016|Overall Study|Lack of Efficacy|0|||
33256506|NCT04425629|100840030|FG017|Overall Study|Lack of Efficacy|0|||
33256507|NCT04425629|100840031|FG018|Overall Study|Lack of Efficacy|0|||
33256508|NCT01561989|100840032|FG000|Overall Study|accural target not met.|5|||
33443195|NCT00424047|101515673|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
33443196|NCT00424047|101515674|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
33443197|NCT00424047|101515673|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
33443198|NCT00424047|101515674|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
33443199|NCT00424047|101515673|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
33443200|NCT00424047|101515674|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
33443201|NCT02331394|101515676|FG000|Overall Study|Disease progression|1|||
33443202|NCT04060147|101515677|FG000|Overall Study|Withdrew consent|1|||
33443203|NCT00496964|101515683|FG000|Overall Study|Withdrawal by Subject|0|||
33443204|NCT00496964|101515684|FG001|Overall Study|Withdrawal by Subject|1|||
33443205|NCT00772941|101515688|FG000|Overall Study|CRFs not available|195|||
33256509|NCT01561989|100840033|FG001|Overall Study|accural target not met.|6|||
33256510|NCT03593213|100840040|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
33256511|NCT03593213|100840041|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
33256512|NCT03593213|100840042|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
33256513|NCT03593213|100840043|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
33256514|NCT03593213|100840040|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
33256515|NCT03593213|100840041|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
33256516|NCT03593213|100840042|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
33256517|NCT03593213|100840043|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
33256518|NCT03593213|100840040|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
33256519|NCT03593213|100840041|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
33256520|NCT03593213|100840042|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
33256521|NCT03593213|100840043|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
33256522|NCT03593213|100840040|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
33256523|NCT03593213|100840041|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
33256524|NCT03593213|100840042|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
33256525|NCT03593213|100840043|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
33256526|NCT03593213|100840040|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
33256527|NCT03593213|100840041|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
33256528|NCT03593213|100840042|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
33256529|NCT03593213|100840043|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
33256530|NCT03593213|100840040|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
33256531|NCT03593213|100840041|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
33256532|NCT03593213|100840042|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
33256533|NCT03593213|100840043|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
33256534|NCT03593213|100840040|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
33256535|NCT03593213|100840041|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
33256536|NCT03593213|100840042|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
33256537|NCT03593213|100840043|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
33256538|NCT03593213|100840040|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
33256539|NCT03593213|100840041|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
33256540|NCT03593213|100840042|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
33256541|NCT03593213|100840043|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
33256542|NCT03593213|100840040|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
33256543|NCT03593213|100840041|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
33256544|NCT03593213|100840042|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
33256545|NCT03593213|100840043|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
33256546|NCT03593213|100840040|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
33256547|NCT03593213|100840041|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
33256548|NCT03593213|100840042|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
33256549|NCT03593213|100840043|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
33256550|NCT03593213|100840040|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
33256551|NCT03593213|100840041|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
33256552|NCT03593213|100840042|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
33256553|NCT03593213|100840043|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
33256554|NCT03593213|100840040|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
33256555|NCT03593213|100840041|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
33256556|NCT03593213|100840042|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
33256557|NCT03593213|100840043|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
33256558|NCT03593213|100840040|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
33256559|NCT03593213|100840041|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
33443206|NCT00772941|101515688|FG000|Overall Study|Study not completed|16|||
33443207|NCT00772941|101515688|FG000|Overall Study|Missed Visits|374|||
33443208|NCT00772941|101515688|FG000|Overall Study|Poor Compliance|7|||
33443209|NCT00772941|101515688|FG000|Overall Study|GPSP Violation|90|||
33256560|NCT03593213|100840042|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
33256561|NCT03593213|100840043|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
33256562|NCT03593213|100840040|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
33256563|NCT03593213|100840041|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
33256564|NCT03593213|100840042|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
33256565|NCT03593213|100840043|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
33256566|NCT03593213|100840040|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
33256567|NCT03593213|100840041|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
33256568|NCT03593213|100840042|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
33256569|NCT03593213|100840043|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
33256570|NCT03593213|100840040|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
33256571|NCT03593213|100840041|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
33256572|NCT03593213|100840042|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
33256573|NCT03593213|100840043|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
33256574|NCT03593213|100840040|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
33256575|NCT03593213|100840041|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
33256576|NCT03593213|100840042|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
33256577|NCT03593213|100840043|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
33256578|NCT03593213|100840040|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
33256579|NCT03593213|100840041|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
33256580|NCT03593213|100840042|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
33256581|NCT03593213|100840043|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
33256582|NCT03593213|100840040|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
33256583|NCT03593213|100840041|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
33256584|NCT03593213|100840042|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
33256585|NCT03593213|100840043|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
33256586|NCT02879695|100840048|FG000|Overall Study|Did not start study treatment|2|||
33256587|NCT02879695|100840049|FG001|Overall Study|Did not start study treatment|0|||
33256588|NCT02879695|100840050|FG002|Overall Study|Did not start study treatment|3|||
33256589|NCT02879695|100840051|FG003|Overall Study|Did not start study treatment|0|||
33256590|NCT01677936|100840053|FG000|Overall Study|Lost to Follow-up|4|||
33256591|NCT01677936|100840054|FG001|Overall Study|Lost to Follow-up|1|||
33256592|NCT01677936|100840053|FG000|Overall Study|Protocol Violation|3|||
33256593|NCT01677936|100840054|FG001|Overall Study|Protocol Violation|0|||
33256594|NCT01677936|100840053|FG000|Overall Study|Adverse Event|1|||
33256595|NCT01677936|100840054|FG001|Overall Study|Adverse Event|0|||
33256596|NCT01677936|100840053|FG000|Overall Study|Lost to Follow-up|1|||
33443210|NCT01513174|101515692|FG000|Overall Study|Inclusion Error|1|||
33443211|NCT01513174|101515693|FG001|Overall Study|Inclusion Error|7|||
33443212|NCT01513174|101515692|FG000|Overall Study|Not receive study treatment|3|||
33443213|NCT01513174|101515693|FG001|Overall Study|Not receive study treatment|1|||
33256597|NCT01677936|100840054|FG001|Overall Study|Lost to Follow-up|0|||
33256598|NCT01677936|100840053|FG000|Overall Study|Protocol Violation|0|||
33256599|NCT01677936|100840054|FG001|Overall Study|Protocol Violation|4|||
33256600|NCT01041417|100840058|FG000|Overall Study|Adverse Event|5|||
33256601|NCT01041417|100840059|FG001|Overall Study|Adverse Event|2|||
33256602|NCT01041417|100840058|FG000|Overall Study|Lost to Follow-up|1|||
33256603|NCT01041417|100840059|FG001|Overall Study|Lost to Follow-up|1|||
33256604|NCT01041417|100840058|FG000|Overall Study|Death|1|||
33256605|NCT01041417|100840059|FG001|Overall Study|Death|0|||
33256606|NCT00360698|100840063|FG000|Run-In|Physician Decision|0|||
33256607|NCT00360698|100840064|FG001|Run-In|Physician Decision|1|||
33256608|NCT00360698|100840063|FG000|Run-In|Withdrawal by Subject|0|||
33256609|NCT00360698|100840064|FG001|Run-In|Withdrawal by Subject|2|||
33256610|NCT00360698|100840063|FG000|Run-In|Non compliance with treatment procedure|0|||
33256611|NCT00360698|100840064|FG001|Run-In|Non compliance with treatment procedure|1|||
33256612|NCT00360698|100840063|FG000|Run-In|Sponsor request|0|||
33256613|NCT00360698|100840064|FG001|Run-In|Sponsor request|2|||
33256614|NCT00360698|100840063|FG000|Run-In|Patient did not meet inclusion criteria|0|||
33256615|NCT00360698|100840064|FG001|Run-In|Patient did not meet inclusion criteria|1|||
33256616|NCT00360698|100840063|FG000|Run-In|Patient personal reasons|0|||
33256617|NCT00360698|100840064|FG001|Run-In|Patient personal reasons|2|||
33256618|NCT00360698|100840063|FG000|Run-In|Need of insulin with meals|0|||
33256619|NCT00360698|100840064|FG001|Run-In|Need of insulin with meals|1|||
33256620|NCT00360698|100840063|FG000|Treatment Period|Non compliance with treatment procedure|1|||
33443214|NCT03375463|101515694|FG000|Period 1|Lost to Follow-up|0|||
33256621|NCT00360698|100840064|FG001|Treatment Period|Non compliance with treatment procedure|0|||
33256622|NCT00360698|100840063|FG000|Treatment Period|Early termination by error|0|||
33256623|NCT00360698|100840064|FG001|Treatment Period|Early termination by error|1|||
33256624|NCT03050814|100840066|FG000|Overall Study|Screen failures|0|||
33256625|NCT03050814|100840067|FG001|Overall Study|Screen failures|0|||
33256626|NCT03050814|100840068|FG002|Overall Study|Screen failures|4|||
33256627|NCT01373346|100840069|FG000|Overall Study|Death|1|||
33256628|NCT02692417|100840078|FG000|Overall Study|Withdrawal by Subject|5|||
33256629|NCT02692417|100840079|FG001|Overall Study|Withdrawal by Subject|1|||
33256630|NCT02692417|100840078|FG000|Overall Study|Adverse Event|1|||
33256631|NCT02692417|100840079|FG001|Overall Study|Adverse Event|0|||
33256632|NCT02525796|100840083|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
33256633|NCT02525796|100840084|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
33256634|NCT02525796|100840085|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
33256635|NCT02525796|100840083|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
33256636|NCT02525796|100840084|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
33256637|NCT02525796|100840085|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
33256638|NCT02525796|100840083|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
33256639|NCT02525796|100840084|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
33256640|NCT02525796|100840085|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
33256641|NCT02525796|100840083|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
33256642|NCT02525796|100840084|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
33256643|NCT02525796|100840085|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
33256644|NCT02525796|100840083|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
33256645|NCT02525796|100840084|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
33256646|NCT02525796|100840085|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
33256647|NCT00542789|100840086|FG000|Overall Study|Adverse Event|18|||
33256648|NCT00542789|100840087|FG001|Overall Study|Adverse Event|17|||
33256649|NCT00542789|100840086|FG000|Overall Study|Withdrawal by Subject|7|||
33256650|NCT00542789|100840087|FG001|Overall Study|Withdrawal by Subject|3|||
33256651|NCT00542789|100840086|FG000|Overall Study|Protocol Violation|8|||
33256652|NCT00542789|100840087|FG001|Overall Study|Protocol Violation|1|||
33256653|NCT00542789|100840086|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
33256654|NCT00542789|100840087|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
33256655|NCT00869258|100840088|FG000|Overall Study|Physician Decision|1|||
33256656|NCT00668863|100840093|FG000|Overall Study|Objective Progression or Relapse|42|||
33256657|NCT00668863|100840093|FG000|Overall Study|Adverse Event|13|||
33256658|NCT00668863|100840093|FG000|Overall Study|Study Terminated by Sponsor|8|||
33256659|NCT00668863|100840093|FG000|Overall Study|Global Deterioration of Health Status|4|||
33256660|NCT00668863|100840093|FG000|Overall Study|Withdrawal by Subject|1|||
33256661|NCT00668863|100840093|FG000|Overall Study|Surgery|1|||
33256662|NCT00668863|100840093|FG000|Overall Study|Subject's work scheduling problem|1|||
33256663|NCT00668863|100840093|FG000|Overall Study|Physician Decision|1|||
33256664|NCT00638963|100840098|FG000|Overall Study|Withdrawal by Subject|1|||
33256665|NCT00638963|100840099|FG001|Overall Study|Withdrawal by Subject|0|||
33256666|NCT00636207|100840100|FG000|Overall Study|Adverse Event|1|||
33256667|NCT00636207|100840101|FG001|Overall Study|Adverse Event|0|||
33256668|NCT00636207|100840102|FG002|Overall Study|Adverse Event|0|||
33256669|NCT00636207|100840103|FG003|Overall Study|Adverse Event|0|||
33256670|NCT00636207|100840104|FG004|Overall Study|Adverse Event|0|||
33256671|NCT00636207|100840105|FG005|Overall Study|Adverse Event|0|||
33256672|NCT00636207|100840106|FG006|Overall Study|Adverse Event|0|||
33256673|NCT00636207|100840100|FG000|Overall Study|Withdrawal by Subject|0|||
33256674|NCT00636207|100840101|FG001|Overall Study|Withdrawal by Subject|1|||
33256675|NCT00636207|100840102|FG002|Overall Study|Withdrawal by Subject|0|||
33256676|NCT00636207|100840103|FG003|Overall Study|Withdrawal by Subject|0|||
33256677|NCT00636207|100840104|FG004|Overall Study|Withdrawal by Subject|1|||
33256678|NCT00636207|100840105|FG005|Overall Study|Withdrawal by Subject|0|||
33256679|NCT00636207|100840106|FG006|Overall Study|Withdrawal by Subject|0|||
33256680|NCT00933400|100840109|FG000|Overall Study|Withdrawal by Subject|21|||
33443215|NCT03375463|101515695|FG001|Period 1|Lost to Follow-up|0|||
33443216|NCT03375463|101515696|FG002|Period 1|Lost to Follow-up|1|||
33443217|NCT03375463|101515697|FG003|Period 1|Lost to Follow-up|0|||
33256681|NCT00933400|100840110|FG001|Overall Study|Withdrawal by Subject|1|||
33256682|NCT04723394|100840111|FG000|Overall Study|Adverse Event|0|||
33256683|NCT04723394|100840112|FG001|Overall Study|Adverse Event|3|||
33256684|NCT04723394|100840111|FG000|Overall Study|Death|8|||
33256685|NCT04723394|100840112|FG001|Overall Study|Death|8|||
33256686|NCT04723394|100840111|FG000|Overall Study|Lost to Follow-up|20|||
33256687|NCT04723394|100840112|FG001|Overall Study|Lost to Follow-up|17|||
33256688|NCT04723394|100840111|FG000|Overall Study|Physician Decision|1|||
33256689|NCT04723394|100840112|FG001|Overall Study|Physician Decision|0|||
33256690|NCT04723394|100840111|FG000|Overall Study|Withdrawal by Subject|20|||
33256691|NCT04723394|100840112|FG001|Overall Study|Withdrawal by Subject|34|||
33256692|NCT04723394|100840111|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
33256693|NCT04723394|100840112|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
33256694|NCT00357097|100840115|FG000|Overall Study|Did not meet inclusion criteria|5|||
33256695|NCT00357097|100840116|FG001|Overall Study|Did not meet inclusion criteria|3|||
33256696|NCT00357097|100840115|FG000|Overall Study|Adverse Event|34|||
33256697|NCT00357097|100840116|FG001|Overall Study|Adverse Event|6|||
33256698|NCT00357097|100840115|FG000|Overall Study|Withdrawal by Subject|8|||
33256699|NCT00357097|100840116|FG001|Overall Study|Withdrawal by Subject|7|||
33162242|NCT00282984|100504448|FG001|Overall Study|Death|5|||
33162243|NCT00282984|100504447|FG000|Overall Study|Adverse Event|8|||
33162244|NCT00282984|100504448|FG001|Overall Study|Adverse Event|5|||
33162245|NCT00282984|100504447|FG000|Overall Study|Lack of Efficacy|0|||
33162246|NCT00282984|100504448|FG001|Overall Study|Lack of Efficacy|2|||
33162247|NCT00282984|100504447|FG000|Overall Study|Lost to Follow-up|14|||
33162248|NCT00282984|100504448|FG001|Overall Study|Lost to Follow-up|10|||
33162249|NCT00282984|100504447|FG000|Overall Study|Withdrawal by Participant|22|||
33162250|NCT00282984|100504448|FG001|Overall Study|Withdrawal by Participant|34|||
33162251|NCT00282984|100504447|FG000|Overall Study|Participant stopped study medication|2|||
33162252|NCT00282984|100504448|FG001|Overall Study|Participant stopped study medication|2|||
33162253|NCT00282984|100504447|FG000|Overall Study|Participant only allowed phone follow-up|0|||
33162254|NCT00282984|100504448|FG001|Overall Study|Participant only allowed phone follow-up|1|||
33162255|NCT00282984|100504447|FG000|Overall Study|Participant used antipsychosis meds|0|||
33162256|NCT00282984|100504448|FG001|Overall Study|Participant used antipsychosis meds|1|||
33162257|NCT00282984|100504447|FG000|Overall Study|lack of motivation|1|||
33162258|NCT00282984|100504448|FG001|Overall Study|lack of motivation|0|||
33162259|NCT00282984|100504447|FG000|Overall Study|in prison|0|||
33162260|NCT00282984|100504448|FG001|Overall Study|in prison|1|||
33162261|NCT00282984|100504447|FG000|Overall Study|Protocol Violation|2|||
33162262|NCT00282984|100504448|FG001|Overall Study|Protocol Violation|0|||
33162263|NCT02400333|100504449|FG000|Overall Study|Withdrawal by Subject|0|||
33162264|NCT02400333|100504450|FG001|Overall Study|Withdrawal by Subject|1|||
33162265|NCT02400333|100504451|FG002|Overall Study|Withdrawal by Subject|0|||
33162266|NCT02400333|100504452|FG003|Overall Study|Withdrawal by Subject|1|||
33162267|NCT02400333|100504449|FG000|Overall Study|Protocol Violation|1|||
33162268|NCT02400333|100504450|FG001|Overall Study|Protocol Violation|0|||
33162269|NCT02400333|100504451|FG002|Overall Study|Protocol Violation|2|||
33162270|NCT02400333|100504452|FG003|Overall Study|Protocol Violation|1|||
33162271|NCT01084083|100504453|FG000|Overall Study|Adverse Event|5|||
33162272|NCT01084083|100504453|FG000|Overall Study|Death|1|||
33162273|NCT01084083|100504453|FG000|Overall Study|Withdrawal by Subject|2|||
33162274|NCT01084083|100504453|FG000|Overall Study|Complicating disease|1|||
33162275|NCT01084083|100504453|FG000|Overall Study|Other|2|||
33162276|NCT01084083|100504453|FG000|Overall Study|Never started assigned therapy|1|||
33162277|NCT00594659|100504454|FG000|Overall Study|Lost to Follow-up|13|||
33162278|NCT00594659|100504455|FG001|Overall Study|Lost to Follow-up|9|||
33162279|NCT00594659|100504456|FG002|Overall Study|Lost to Follow-up|7|||
33162280|NCT00730132|100504457|FG000|Overall Study|Protocol Violation|154|||
33162281|NCT00730132|100504457|FG000|Overall Study|Death|1|||
33162282|NCT02030041|100504461|FG000|Overall Study|Withdrawal by Subject|2|||
33162283|NCT02030041|100504462|FG001|Overall Study|Withdrawal by Subject|2|||
33162284|NCT02030041|100504463|FG002|Overall Study|Withdrawal by Subject|1|||
33162285|NCT02993757|100504466|FG000|Overall Study|Non compliance with the protocol|155|||
33162286|NCT02993757|100504467|FG001|Overall Study|Non compliance with the protocol|170|||
33162287|NCT02993757|100504466|FG000|Overall Study|Lost to Follow-up|1|||
33162288|NCT02993757|100504467|FG001|Overall Study|Lost to Follow-up|0|||
33162289|NCT02993757|100504466|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
33162290|NCT02993757|100504467|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
33162291|NCT00401531|100504471|FG000|Overall Study|Adverse Event|2|||
33162292|NCT00401531|100504472|FG001|Overall Study|Adverse Event|0|||
33256700|NCT00357097|100840115|FG000|Overall Study|Non-compliance|1|||
33256701|NCT00357097|100840116|FG001|Overall Study|Non-compliance|2|||
33256702|NCT00357097|100840115|FG000|Overall Study|Lack of Efficacy|2|||
33256703|NCT00357097|100840116|FG001|Overall Study|Lack of Efficacy|8|||
33162293|NCT00401531|100504471|FG000|Overall Study|Protocol Violation|3|||
33256704|NCT00357097|100840115|FG000|Overall Study|Met Exclusion Criteria|3|||
33256705|NCT00357097|100840116|FG001|Overall Study|Met Exclusion Criteria|1|||
33162294|NCT00401531|100504472|FG001|Overall Study|Protocol Violation|7|||
33162295|NCT00401531|100504471|FG000|Overall Study|Lost to Follow-up|1|||
33162296|NCT00401531|100504472|FG001|Overall Study|Lost to Follow-up|1|||
33162297|NCT00401531|100504471|FG000|Overall Study|Withdrawal by Subject|3|||
33162298|NCT00401531|100504472|FG001|Overall Study|Withdrawal by Subject|2|||
33162299|NCT00873912|100504473|FG000|Overall Study|Withdrawal by Subject|1|||
33162300|NCT00873912|100504474|FG001|Overall Study|Withdrawal by Subject|0|||
33162301|NCT00873912|100504473|FG000|Overall Study|Lost to Follow-up|2|||
33162302|NCT00873912|100504474|FG001|Overall Study|Lost to Follow-up|0|||
33256706|NCT00357097|100840115|FG000|Overall Study|Other|1|||
33256707|NCT00357097|100840116|FG001|Overall Study|Other|1|||
33256708|NCT00357097|100840115|FG000|Overall Study|Increase of RLS Symptoms|0|||
33256709|NCT00357097|100840116|FG001|Overall Study|Increase of RLS Symptoms|1|||
33256710|NCT03036813|100840117|FG000|Overall Study|Adverse Event|6|||
33256711|NCT03036813|100840118|FG001|Overall Study|Adverse Event|11|||
33256712|NCT03036813|100840119|FG002|Overall Study|Adverse Event|6|||
33256713|NCT03036813|100840117|FG000|Overall Study|Withdrawal by Subject|12|||
33256714|NCT03036813|100840118|FG001|Overall Study|Withdrawal by Subject|6|||
33256715|NCT03036813|100840119|FG002|Overall Study|Withdrawal by Subject|10|||
33256716|NCT03036813|100840117|FG000|Overall Study|Lost to Follow-up|1|||
33256717|NCT03036813|100840118|FG001|Overall Study|Lost to Follow-up|1|||
33256718|NCT03036813|100840119|FG002|Overall Study|Lost to Follow-up|0|||
33256719|NCT03036813|100840117|FG000|Overall Study|Physician Decision|2|||
33256720|NCT03036813|100840118|FG001|Overall Study|Physician Decision|1|||
33256721|NCT03036813|100840119|FG002|Overall Study|Physician Decision|1|||
33256722|NCT03036813|100840117|FG000|Overall Study|Non-Compliance|1|||
33256723|NCT03036813|100840118|FG001|Overall Study|Non-Compliance|5|||
33256724|NCT03036813|100840119|FG002|Overall Study|Non-Compliance|3|||
33256725|NCT03036813|100840117|FG000|Overall Study|Pregnancy|0|||
33256726|NCT03036813|100840118|FG001|Overall Study|Pregnancy|0|||
33256727|NCT03036813|100840119|FG002|Overall Study|Pregnancy|1|||
33256728|NCT03036813|100840117|FG000|Overall Study|Other|0|||
33256729|NCT03036813|100840118|FG001|Overall Study|Other|3|||
33256730|NCT03036813|100840119|FG002|Overall Study|Other|5|||
33256731|NCT03062358|100840120|FG000|Overall Study|Death|220|||
33256732|NCT03062358|100840121|FG001|Overall Study|Death|127|||
33256733|NCT03062358|100840120|FG000|Overall Study|Withdrawal by Subject|2|||
33443218|NCT03375463|101515698|FG004|Period 1|Lost to Follow-up|0|||
33443219|NCT03375463|101515699|FG005|Period 1|Lost to Follow-up|0|||
33443220|NCT03375463|101515694|FG000|Period 1|Adverse Event|0|||
33443221|NCT03375463|101515695|FG001|Period 1|Adverse Event|0|||
33443222|NCT03375463|101515696|FG002|Period 1|Adverse Event|0|||
33443223|NCT03375463|101515697|FG003|Period 1|Adverse Event|0|||
33443224|NCT03375463|101515698|FG004|Period 1|Adverse Event|1|||
33443225|NCT03375463|101515699|FG005|Period 1|Adverse Event|0|||
33443226|NCT03375463|101515694|FG000|Period 2|Lost to Follow-up|1|||
33443227|NCT03375463|101515695|FG001|Period 2|Lost to Follow-up|1|||
33443228|NCT03375463|101515696|FG002|Period 2|Lost to Follow-up|0|||
33443229|NCT03375463|101515697|FG003|Period 2|Lost to Follow-up|0|||
33443230|NCT03375463|101515698|FG004|Period 2|Lost to Follow-up|0|||
33256734|NCT03062358|100840121|FG001|Overall Study|Withdrawal by Subject|1|||
33443231|NCT03375463|101515699|FG005|Period 2|Lost to Follow-up|0|||
33443232|NCT02760368|101515702|FG000|Overall Study|Withdrawal by Subject|8|||
33443233|NCT02760368|101515703|FG001|Overall Study|Withdrawal by Subject|12|||
33443234|NCT02760368|101515704|FG002|Overall Study|Withdrawal by Subject|9|||
33443235|NCT02760368|101515702|FG000|Overall Study|Screen Failure|0|||
33443236|NCT02760368|101515703|FG001|Overall Study|Screen Failure|0|||
33443237|NCT02760368|101515704|FG002|Overall Study|Screen Failure|1|||
33443238|NCT02760368|101515702|FG000|Overall Study|Death|0|||
33443239|NCT02760368|101515703|FG001|Overall Study|Death|1|||
33443240|NCT02760368|101515704|FG002|Overall Study|Death|0|||
33443241|NCT02760368|101515702|FG000|Overall Study|Withdrawal by Sponsor|0|||
33443242|NCT02760368|101515703|FG001|Overall Study|Withdrawal by Sponsor|0|||
33443243|NCT02760368|101515704|FG002|Overall Study|Withdrawal by Sponsor|1|||
33443244|NCT03552393|101515709|FG000|Core Period|Kidney Transplant|1|||
33443245|NCT03552393|101515709|FG000|Core Period|Prohibited Medication|1|||
33443246|NCT03552393|101515709|FG000|Safety Extension Period|Kidney Transplant|4|||
33443247|NCT01279486|101515710|FG000|Overall Study|Lost to Follow-up|1|||
33443248|NCT01954394|101515711|FG000|Overall Study|Enrolled but not treated|1|||
33443249|NCT01954394|101515712|FG001|Overall Study|Enrolled but not treated|0|||
33443250|NCT01954394|101515711|FG000|Overall Study|Adverse Event|10|||
33256735|NCT03062358|100840120|FG000|Overall Study|Ongoing in Trial|78|||
33256736|NCT03062358|100840121|FG001|Overall Study|Ongoing in Trial|25|||
33256737|NCT00159783|100840122|FG000|Overall Study|Adverse Event|5|||
33256738|NCT00159783|100840123|FG001|Overall Study|Adverse Event|7|||
33443251|NCT01954394|101515712|FG001|Overall Study|Adverse Event|23|||
33443252|NCT01954394|101515711|FG000|Overall Study|Poor compliance to protocol|7|||
33443253|NCT01954394|101515712|FG001|Overall Study|Poor compliance to protocol|7|||
33256739|NCT00159783|100840124|FG002|Overall Study|Adverse Event|9|||
33256740|NCT00159783|100840122|FG000|Overall Study|Lack of Efficacy|1|||
33256741|NCT00159783|100840123|FG001|Overall Study|Lack of Efficacy|2|||
33256742|NCT00159783|100840124|FG002|Overall Study|Lack of Efficacy|3|||
33256743|NCT00159783|100840122|FG000|Overall Study|Withdrawal by Subject|7|||
33256744|NCT00159783|100840123|FG001|Overall Study|Withdrawal by Subject|11|||
33256745|NCT00159783|100840124|FG002|Overall Study|Withdrawal by Subject|12|||
33443254|NCT01954394|101515711|FG000|Overall Study|Participant Moved|0|||
33443255|NCT01954394|101515712|FG001|Overall Study|Participant Moved|4|||
33443256|NCT01954394|101515711|FG000|Overall Study|Related to Study Drug administration|2|||
33256746|NCT00159783|100840122|FG000|Overall Study|Lost to Follow-up|6|||
33256747|NCT00159783|100840123|FG001|Overall Study|Lost to Follow-up|5|||
33256748|NCT00159783|100840124|FG002|Overall Study|Lost to Follow-up|11|||
33256749|NCT00159783|100840122|FG000|Overall Study|Other|0|||
33256750|NCT00159783|100840123|FG001|Overall Study|Other|2|||
33256751|NCT00159783|100840124|FG002|Overall Study|Other|4|||
33256752|NCT03988023|100840125|FG000|Overall Study|Non-compliance|3|||
33256753|NCT03988023|100840126|FG001|Overall Study|Non-compliance|0|||
33256754|NCT03988023|100840125|FG000|Overall Study|Withdrawal by Subject|39|||
33256755|NCT03988023|100840126|FG001|Overall Study|Withdrawal by Subject|37|||
33256756|NCT03988023|100840125|FG000|Overall Study|Adverse Event|0|||
33256757|NCT03988023|100840126|FG001|Overall Study|Adverse Event|2|||
33256758|NCT03988023|100840125|FG000|Overall Study|Physician Decision|0|||
33256759|NCT03988023|100840126|FG001|Overall Study|Physician Decision|1|||
33256760|NCT03988023|100840125|FG000|Overall Study|Lost to Follow-up|5|||
33256761|NCT03988023|100840126|FG001|Overall Study|Lost to Follow-up|8|||
33256762|NCT03988023|100840125|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
33256763|NCT03988023|100840126|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
33256764|NCT03988023|100840125|FG000|Overall Study|Lack of Efficacy|3|||
33256765|NCT03988023|100840126|FG001|Overall Study|Lack of Efficacy|1|||
33256766|NCT03988023|100840125|FG000|Overall Study|COVID-19 pandemic|225|||
33256767|NCT03988023|100840126|FG001|Overall Study|COVID-19 pandemic|227|||
33256768|NCT00857649|100840127|FG000|Overall Study|Adverse Event|15|||
33256769|NCT00857649|100840128|FG001|Overall Study|Adverse Event|10|||
33256770|NCT00857649|100840127|FG000|Overall Study|Non-compliance|1|||
33256771|NCT00857649|100840128|FG001|Overall Study|Non-compliance|1|||
33256772|NCT00857649|100840127|FG000|Overall Study|Protocol Violation|2|||
33256773|NCT00857649|100840128|FG001|Overall Study|Protocol Violation|2|||
33256774|NCT00857649|100840127|FG000|Overall Study|Withdrawal of Consent|10|||
33256775|NCT00857649|100840128|FG001|Overall Study|Withdrawal of Consent|7|||
33256776|NCT00857649|100840127|FG000|Overall Study|Nursing Home Placement|2|||
33256777|NCT00857649|100840128|FG001|Overall Study|Nursing Home Placement|9|||
33443257|NCT01954394|101515712|FG001|Overall Study|Related to Study Drug administration|2|||
33443258|NCT01954394|101515711|FG000|Overall Study|Other than specified above|10|||
33443259|NCT01954394|101515712|FG001|Overall Study|Other than specified above|21|||
33443260|NCT00102440|101515713|FG000|Overall Study|Lost to Follow-up|25|||
33443261|NCT00102440|101515714|FG001|Overall Study|Lost to Follow-up|18|||
33443262|NCT00102440|101515715|FG002|Overall Study|Lost to Follow-up|21|||
33443263|NCT00102440|101515713|FG000|Overall Study|Adverse Event|16|||
33443264|NCT00102440|101515714|FG001|Overall Study|Adverse Event|23|||
33443265|NCT00102440|101515715|FG002|Overall Study|Adverse Event|8|||
33443266|NCT00102440|101515713|FG000|Overall Study|Gout Flare|10|||
33443267|NCT00102440|101515714|FG001|Overall Study|Gout Flare|28|||
33443268|NCT00102440|101515715|FG002|Overall Study|Gout Flare|9|||
33443269|NCT00102440|101515713|FG000|Overall Study|Personal Reason(s)|19|||
33443270|NCT00102440|101515714|FG001|Overall Study|Personal Reason(s)|13|||
33443271|NCT00102440|101515715|FG002|Overall Study|Personal Reason(s)|13|||
33443272|NCT00102440|101515713|FG000|Overall Study|Other|11|||
33443273|NCT00102440|101515714|FG001|Overall Study|Other|14|||
33256778|NCT00857649|100840127|FG000|Overall Study|Other Reasons|1|||
33256779|NCT00857649|100840128|FG001|Overall Study|Other Reasons|3|||
33256780|NCT03811574|100840129|FG000|Overall Study|Withdrawal by Subject|2|||
33443274|NCT00102440|101515715|FG002|Overall Study|Other|14|||
33443275|NCT00102440|101515713|FG000|Overall Study|Protocol Violation|7|||
33443276|NCT00102440|101515714|FG001|Overall Study|Protocol Violation|2|||
33256781|NCT03811574|100840130|FG001|Overall Study|Withdrawal by Subject|4|||
33256782|NCT03811574|100840131|FG002|Overall Study|Withdrawal by Subject|0|||
33443277|NCT00102440|101515715|FG002|Overall Study|Protocol Violation|1|||
33443278|NCT02543203|101515724|FG000|Overall Study|Unpalatable Fragrance|2|||
33256783|NCT01171625|100840132|FG000|Overall Study|On-Protocol|67|||
33256784|NCT01171625|100840132|FG000|Overall Study|Death|38|||
33443279|NCT02543203|101515725|FG001|Overall Study|Unpalatable Fragrance|2|||
33443280|NCT02543203|101515724|FG000|Overall Study|Lost to Follow-up|1|||
33256785|NCT01171625|100840132|FG000|Overall Study|Withdrawal by Subject|31|||
33256786|NCT01171625|100840132|FG000|Overall Study|Explanted|10|||
33256787|NCT01171625|100840132|FG000|Overall Study|Lost to Follow-up|5|||
33256788|NCT01171625|100840132|FG000|Overall Study|Patient received valve-in-valve|3|||
33256789|NCT01171625|100840132|FG000|Overall Study|Other|1|||
33256790|NCT01171625|100840132|FG000|Overall Study|Consented but did not receive device|25|||
33256791|NCT02974634|100840135|FG000|Overall Study|Advanced disease|12|||
33256792|NCT02974634|100840136|FG001|Overall Study|Advanced disease|3|||
33256793|NCT02974634|100840135|FG000|Overall Study|Noncompliance|3|||
33256794|NCT02974634|100840136|FG001|Overall Study|Noncompliance|7|||
33256795|NCT02974634|100840135|FG000|Overall Study|intervention technology related issues|5|||
33256796|NCT02974634|100840136|FG001|Overall Study|intervention technology related issues|0|||
33256797|NCT02974634|100840135|FG000|Overall Study|Death|8|||
33443281|NCT02543203|101515725|FG001|Overall Study|Lost to Follow-up|0|||
33443282|NCT02543203|101515724|FG000|Overall Study|Increased Irritability|1|||
33443283|NCT02543203|101515725|FG001|Overall Study|Increased Irritability|0|||
33443284|NCT02543203|101515724|FG000|Overall Study|Family|1|||
33443285|NCT02543203|101515725|FG001|Overall Study|Family|2|||
33443286|NCT02543203|101515724|FG000|Overall Study|Negative Behavior|1|||
33443287|NCT02543203|101515725|FG001|Overall Study|Negative Behavior|0|||
33443288|NCT02543203|101515724|FG000|Overall Study|Withdrawal by Subject|0|||
33256798|NCT02974634|100840136|FG001|Overall Study|Death|11|||
33443289|NCT02543203|101515725|FG001|Overall Study|Withdrawal by Subject|1|||
33443290|NCT04349917|101515728|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
33443291|NCT04349917|101515729|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
33443292|NCT04349917|101515728|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
33443293|NCT04349917|101515729|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
33443294|NCT00537979|101515730|FG000|Overall Study|Adverse Event|2|||
33443295|NCT00537979|101515731|FG001|Overall Study|Adverse Event|2|||
33443296|NCT00537979|101515730|FG000|Overall Study|Withdrawal by Subject|1|||
33443297|NCT00537979|101515731|FG001|Overall Study|Withdrawal by Subject|4|||
33443298|NCT00537979|101515730|FG000|Overall Study|Lost to Follow-up|1|||
33443299|NCT00537979|101515731|FG001|Overall Study|Lost to Follow-up|4|||
33443300|NCT00537979|101515730|FG000|Overall Study|Lack of Efficacy|0|||
33443301|NCT00537979|101515731|FG001|Overall Study|Lack of Efficacy|1|||
33443302|NCT00537979|101515730|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
33443303|NCT00537979|101515731|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
33443304|NCT00537979|101515730|FG000|Overall Study|Death|0|||
33443305|NCT00537979|101515731|FG001|Overall Study|Death|3|||
33443306|NCT00537979|101515730|FG000|Overall Study|Kidney transplant|0|||
33443307|NCT00537979|101515731|FG001|Overall Study|Kidney transplant|3|||
33443308|NCT00537979|101515730|FG000|Overall Study|Heart failure|0|||
33256799|NCT02396316|100840137|FG000|Overall Study|Physician Decision|1|||
33162303|NCT02610725|100504475|FG000|Overall Study|Lost to Follow-up|197|||
33162304|NCT02610725|100504475|FG000|Overall Study|self-reported contraindication|9|||
33443309|NCT00537979|101515731|FG001|Overall Study|Heart failure|1|||
33443310|NCT04078022|101515732|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
33443311|NCT04078022|101515733|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
33443312|NCT02996682|101515739|FG000|Overall Study|Death|0|||
33443313|NCT02996682|101515740|FG001|Overall Study|Death|3|||
33443314|NCT00312663|101515747|FG000|Immunization Phase|Adverse Event|0|||
33443315|NCT00312663|101515748|FG001|Immunization Phase|Adverse Event|1|||
33443316|NCT00312663|101515749|FG002|Immunization Phase|Adverse Event|0|||
33443317|NCT01873586|101515750|FG000|Overall Study|Lost to Follow-up|3|||
33443318|NCT01066143|101518811|FG000|Overall Study|ineligible for the study|8|||
33443319|NCT01404988|101518812|FG000|Overall Study|Death|2|||
33443320|NCT01404988|101518813|FG001|Overall Study|Death|0|||
33443321|NCT01404988|101518814|FG002|Overall Study|Death|2|||
33443322|NCT01404988|101518812|FG000|Overall Study|Adverse Event|1|||
33443323|NCT01404988|101518813|FG001|Overall Study|Adverse Event|0|||
33443324|NCT01404988|101518814|FG002|Overall Study|Adverse Event|0|||
33443325|NCT01404988|101518812|FG000|Overall Study|Withdrawal by Subject|2|||
33443326|NCT01404988|101518813|FG001|Overall Study|Withdrawal by Subject|2|||
33443327|NCT01404988|101518814|FG002|Overall Study|Withdrawal by Subject|0|||
33443328|NCT01404988|101518812|FG000|Overall Study|Lost to Follow-up|1|||
33443329|NCT01404988|101518813|FG001|Overall Study|Lost to Follow-up|2|||
33443330|NCT01404988|101518814|FG002|Overall Study|Lost to Follow-up|1|||
33443331|NCT01534520|101518815|FG000|Overall Study|Adverse Event|0|||
33443332|NCT01534520|101518816|FG001|Overall Study|Adverse Event|1|||
33443333|NCT01042522|101518823|FG000|Overall Study|Adverse Event|1|||
33443334|NCT01042522|101518824|FG001|Overall Study|Adverse Event|2|||
33443335|NCT01042522|101518823|FG000|Overall Study|Disease Progression|5|||
33443336|NCT01042522|101518824|FG001|Overall Study|Disease Progression|0|||
33443337|NCT01042522|101518823|FG000|Overall Study|Death|1|||
33443338|NCT01042522|101518824|FG001|Overall Study|Death|0|||
33443339|NCT01042522|101518823|FG000|Overall Study|Patient Refused|0|||
33443340|NCT01042522|101518824|FG001|Overall Study|Patient Refused|3|||
33443341|NCT01042522|101518823|FG000|Overall Study|Withdrawal by Subject|1|||
33443342|NCT01042522|101518824|FG001|Overall Study|Withdrawal by Subject|1|||
33443343|NCT02943447|101518825|FG000|Blinded Study Phase|Withdrew Consent|1|||
33162305|NCT01534962|100504478|FG000|Overall Study|Randomized but did not start treatment|2|||
33443344|NCT02943447|101518826|FG001|Blinded Study Phase|Withdrew Consent|2|||
33443345|NCT02943447|101518827|FG002|Blinded Study Phase|Withdrew Consent|1|||
33443346|NCT02943447|101518825|FG000|Blinded Study Phase|Adverse Event|3|||
33443347|NCT02943447|101518826|FG001|Blinded Study Phase|Adverse Event|0|||
33443348|NCT02943447|101518827|FG002|Blinded Study Phase|Adverse Event|0|||
33443349|NCT02943447|101518825|FG000|Blinded Study Phase|Investigator's discretion|1|||
33443350|NCT02943447|101518826|FG001|Blinded Study Phase|Investigator's discretion|0|||
33443351|NCT02943447|101518827|FG002|Blinded Study Phase|Investigator's discretion|0|||
33443352|NCT02943447|101518825|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
33443353|NCT02943447|101518826|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
33443354|NCT02943447|101518827|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
33443355|NCT02943447|101518825|FG000|Open-Label Extension Phase|Adverse Event|4|||
33443356|NCT02943447|101518826|FG001|Open-Label Extension Phase|Adverse Event|7|||
33443357|NCT02943447|101518827|FG002|Open-Label Extension Phase|Adverse Event|3|||
33162306|NCT01534962|100504479|FG001|Overall Study|Randomized but did not start treatment|0|||
33162307|NCT01534962|100504480|FG002|Overall Study|Randomized but did not start treatment|0|||
33443358|NCT02943447|101518825|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
33443359|NCT02943447|101518826|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
33443360|NCT02943447|101518827|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
33443361|NCT02943447|101518825|FG000|Open-Label Extension Phase|Withdrew consent|1|||
33443362|NCT02943447|101518826|FG001|Open-Label Extension Phase|Withdrew consent|1|||
33443363|NCT02943447|101518827|FG002|Open-Label Extension Phase|Withdrew consent|1|||
33443364|NCT02943447|101518825|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
33443365|NCT02943447|101518826|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
33443366|NCT02943447|101518827|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
33256800|NCT02396316|100840138|FG001|Overall Study|Physician Decision|0|||
33162308|NCT01534962|100504481|FG003|Overall Study|Randomized but did not start treatment|1|||
33162309|NCT01534962|100504478|FG000|Overall Study|Discontinued at AF recurrence|35|||
33162310|NCT01534962|100504479|FG001|Overall Study|Discontinued at AF recurrence|26|||
33162311|NCT01534962|100504480|FG002|Overall Study|Discontinued at AF recurrence|24|||
33162312|NCT01534962|100504481|FG003|Overall Study|Discontinued at AF recurrence|31|||
33162313|NCT01487200|100504484|FG000|Overall Study|Withdrawal by Subject|0|||
33162314|NCT01487200|100504485|FG001|Overall Study|Withdrawal by Subject|1|||
33162315|NCT01487200|100504486|FG002|Overall Study|Withdrawal by Subject|0|||
33162316|NCT01487200|100504487|FG003|Overall Study|Withdrawal by Subject|0|||
33162317|NCT00415168|100504488|FG000|Overall Study|Death|26|||
33162318|NCT00415168|100504488|FG000|Overall Study|Lost to Follow-up|3|||
33162319|NCT00415168|100504488|FG000|Overall Study|Physician Decision|13|||
33162320|NCT00415168|100504488|FG000|Overall Study|Sponsor Decision|4|||
33162321|NCT00415168|100504488|FG000|Overall Study|Withdrawal by Subject|6|||
33162322|NCT04377620|100504489|FG000|Overall Study|Death|42|||
33162323|NCT04377620|100504490|FG001|Overall Study|Death|48|||
33162324|NCT04377620|100504491|FG002|Overall Study|Death|36|||
33162325|NCT04377620|100504489|FG000|Overall Study|Withdrawal by Subject|0|||
33162326|NCT04377620|100504490|FG001|Overall Study|Withdrawal by Subject|2|||
33162327|NCT04377620|100504491|FG002|Overall Study|Withdrawal by Subject|0|||
33162328|NCT02587234|100504494|FG000|Overall Study|Withdrawal by Subject|1|||
33162329|NCT02587234|100504495|FG001|Overall Study|Withdrawal by Subject|1|||
33162330|NCT02587234|100504494|FG000|Overall Study|Lost to Follow-up|0|||
33162331|NCT02587234|100504495|FG001|Overall Study|Lost to Follow-up|2|||
33162332|NCT03298867|100504496|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
33162333|NCT03298867|100504497|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
33162334|NCT03298867|100504496|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
33162335|NCT03298867|100504497|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
33162336|NCT03298867|100504496|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
33162337|NCT03298867|100504497|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
33162338|NCT03298867|100504496|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
33162339|NCT03298867|100504497|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
33162340|NCT03298867|100504496|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
33162341|NCT03298867|100504497|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
33256801|NCT02396316|100840137|FG000|Overall Study|Progressive disease|6|||
33443367|NCT03290781|101518828|FG000|Overall Study|Adverse Event|5|||
33162342|NCT03298867|100504496|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
33162343|NCT03298867|100504497|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
33162344|NCT03298867|100504496|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
33162345|NCT03298867|100504497|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
33162346|NCT03298867|100504496|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
33162347|NCT03298867|100504497|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
33162348|NCT03298867|100504496|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
33443368|NCT03290781|101518829|FG001|Overall Study|Adverse Event|7|||
33443369|NCT03290781|101518830|FG002|Overall Study|Adverse Event|4|||
33443370|NCT03290781|101518831|FG003|Overall Study|Adverse Event|1|||
33443371|NCT03290781|101518832|FG004|Overall Study|Adverse Event|0|||
33443372|NCT03290781|101518833|FG005|Overall Study|Adverse Event|0|||
33443373|NCT03290781|101518834|FG006|Overall Study|Adverse Event|0|||
33443374|NCT03290781|101518828|FG000|Overall Study|Death|0|||
33443375|NCT03290781|101518829|FG001|Overall Study|Death|0|||
33162349|NCT03298867|100504497|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
33256802|NCT02396316|100840138|FG001|Overall Study|Progressive disease|3|||
33162350|NCT00190671|100504498|FG000|Overall Study|Satisfactory Response|4|||
33162351|NCT00190671|100504499|FG001|Overall Study|Satisfactory Response|7|||
33443376|NCT03290781|101518830|FG002|Overall Study|Death|1|||
33443377|NCT03290781|101518831|FG003|Overall Study|Death|0|||
33162352|NCT00190671|100504498|FG000|Overall Study|Lack of Efficacy|19|||
33162353|NCT00190671|100504499|FG001|Overall Study|Lack of Efficacy|24|||
33162354|NCT00190671|100504498|FG000|Overall Study|Death from Study Disease|1|||
33162355|NCT00190671|100504499|FG001|Overall Study|Death from Study Disease|1|||
33162356|NCT00190671|100504498|FG000|Overall Study|Adverse Event|3|||
33162357|NCT00190671|100504499|FG001|Overall Study|Adverse Event|2|||
33162358|NCT00190671|100504498|FG000|Overall Study|Clinical Relapse|0|||
33162359|NCT00190671|100504499|FG001|Overall Study|Clinical Relapse|1|||
33162360|NCT00190671|100504498|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
33162361|NCT00190671|100504499|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
33162362|NCT00190671|100504498|FG000|Overall Study|Death from Other Causes|0|||
33162363|NCT00190671|100504499|FG001|Overall Study|Death from Other Causes|2|||
33162364|NCT00190671|100504498|FG000|Overall Study|Protocol Violation|0|||
33162365|NCT00190671|100504499|FG001|Overall Study|Protocol Violation|1|||
33162366|NCT00190671|100504498|FG000|Overall Study|Withdrawal by Subject|0|||
33162367|NCT00190671|100504499|FG001|Overall Study|Withdrawal by Subject|2|||
33162368|NCT02728596|100504500|FG000|Overall Study|Refusal unrelated to adverse event|3|||
33162369|NCT02728596|100504501|FG001|Overall Study|Refusal unrelated to adverse event|6|||
33162370|NCT02728596|100504502|FG002|Overall Study|Refusal unrelated to adverse event|7|||
33162371|NCT02728596|100504503|FG003|Overall Study|Refusal unrelated to adverse event|7|||
33162372|NCT02728596|100504500|FG000|Overall Study|Death|44|||
33162373|NCT02728596|100504501|FG001|Overall Study|Death|42|||
33443378|NCT03290781|101518832|FG004|Overall Study|Death|1|||
33443379|NCT03290781|101518833|FG005|Overall Study|Death|0|||
33443380|NCT03290781|101518834|FG006|Overall Study|Death|0|||
33443381|NCT03290781|101518828|FG000|Overall Study|Withdrawal by Subject|6|||
33443382|NCT03290781|101518829|FG001|Overall Study|Withdrawal by Subject|5|||
33443383|NCT03290781|101518830|FG002|Overall Study|Withdrawal by Subject|9|||
33443384|NCT03290781|101518831|FG003|Overall Study|Withdrawal by Subject|10|||
33443385|NCT03290781|101518832|FG004|Overall Study|Withdrawal by Subject|1|||
33443386|NCT03290781|101518833|FG005|Overall Study|Withdrawal by Subject|2|||
33443387|NCT03290781|101518834|FG006|Overall Study|Withdrawal by Subject|0|||
33443388|NCT03290781|101518828|FG000|Overall Study|Physician Decision|0|||
33443389|NCT03290781|101518829|FG001|Overall Study|Physician Decision|1|||
33443390|NCT03290781|101518830|FG002|Overall Study|Physician Decision|0|||
33443391|NCT03290781|101518831|FG003|Overall Study|Physician Decision|0|||
33443392|NCT03290781|101518832|FG004|Overall Study|Physician Decision|0|||
33443393|NCT03290781|101518833|FG005|Overall Study|Physician Decision|0|||
33443394|NCT03290781|101518834|FG006|Overall Study|Physician Decision|0|||
33443395|NCT03290781|101518828|FG000|Overall Study|Site Terminated by Sponsor|1|||
33443396|NCT03290781|101518829|FG001|Overall Study|Site Terminated by Sponsor|0|||
33443397|NCT03290781|101518830|FG002|Overall Study|Site Terminated by Sponsor|2|||
33443398|NCT03290781|101518831|FG003|Overall Study|Site Terminated by Sponsor|1|||
33443399|NCT03290781|101518832|FG004|Overall Study|Site Terminated by Sponsor|0|||
33443400|NCT03290781|101518833|FG005|Overall Study|Site Terminated by Sponsor|0|||
33443401|NCT03290781|101518834|FG006|Overall Study|Site Terminated by Sponsor|0|||
33443402|NCT03290781|101518828|FG000|Overall Study|Lost to Follow-up|0|||
33443403|NCT03290781|101518829|FG001|Overall Study|Lost to Follow-up|0|||
33162374|NCT02728596|100504502|FG002|Overall Study|Death|123|||
33443404|NCT03290781|101518830|FG002|Overall Study|Lost to Follow-up|0|||
33443405|NCT03290781|101518831|FG003|Overall Study|Lost to Follow-up|1|||
33443406|NCT03290781|101518832|FG004|Overall Study|Lost to Follow-up|0|||
33443407|NCT03290781|101518833|FG005|Overall Study|Lost to Follow-up|0|||
33443408|NCT03290781|101518834|FG006|Overall Study|Lost to Follow-up|0|||
33443409|NCT03290781|101518828|FG000|Overall Study|Protocol Deviation|2|||
33162375|NCT02728596|100504503|FG003|Overall Study|Death|68|||
33162376|NCT00393029|100504512|FG000|Overall Study|Not treated|0|||
33162377|NCT00393029|100504513|FG001|Overall Study|Not treated|1|||
33162378|NCT01999179|100504518|FG000|Overall Study|Adverse Event|1|||
33162379|NCT01999179|100504518|FG000|Overall Study|Lost to Follow-up|1|||
33162380|NCT01999179|100504518|FG000|Overall Study|Change in Therapy|3|||
33162381|NCT01999179|100504518|FG000|Overall Study|New catheter|2|||
33162382|NCT01546883|100504519|FG000|Overall Study|Withdrawal by Subject|3|||
33256803|NCT02396316|100840137|FG000|Overall Study|Protocol Violation|0|||
33256804|NCT02396316|100840138|FG001|Overall Study|Protocol Violation|1|||
33256805|NCT02396316|100840137|FG000|Overall Study|Treatment unblinded|0|||
33256806|NCT02396316|100840138|FG001|Overall Study|Treatment unblinded|1|||
33256807|NCT01318382|100840139|FG000|Overall Study|Physician Decision|2|||
33256808|NCT01318382|100840139|FG000|Overall Study|Device Malfunction|10|||
33256809|NCT01318382|100840139|FG000|Overall Study|Protocol Violation|1|||
33256810|NCT04956575|100840143|FG000|Overall Study|Death|1|||
33256811|NCT04956575|100840144|FG001|Overall Study|Death|0|||
33256812|NCT04956575|100840145|FG002|Overall Study|Death|0|||
33256813|NCT04956575|100840146|FG003|Overall Study|Death|0|||
33256814|NCT04956575|100840147|FG004|Overall Study|Death|0|||
33256815|NCT04956575|100840148|FG005|Overall Study|Death|0|||
33256816|NCT04956575|100840149|FG006|Overall Study|Death|0|||
33256817|NCT04956575|100840150|FG007|Overall Study|Death|1|||
33256818|NCT04956575|100840151|FG008|Overall Study|Death|0|||
33256819|NCT04956575|100840152|FG009|Overall Study|Death|1|||
33443410|NCT03290781|101518829|FG001|Overall Study|Protocol Deviation|0|||
33443411|NCT03290781|101518830|FG002|Overall Study|Protocol Deviation|0|||
33443412|NCT03290781|101518831|FG003|Overall Study|Protocol Deviation|1|||
33443413|NCT03290781|101518832|FG004|Overall Study|Protocol Deviation|0|||
33443414|NCT03290781|101518833|FG005|Overall Study|Protocol Deviation|0|||
33443415|NCT03290781|101518834|FG006|Overall Study|Protocol Deviation|0|||
33162383|NCT01546883|100504519|FG000|Overall Study|Adverse Event|4|||
33162384|NCT01546883|100504519|FG000|Overall Study|Lost to Follow-up|2|||
33162385|NCT01546883|100504519|FG000|Overall Study|early closure of study|2|||
33162386|NCT01546883|100504519|FG000|Overall Study|other unrelated illness|1|||
33256820|NCT04956575|100840153|FG010|Overall Study|Death|0|||
33256821|NCT04956575|100840154|FG011|Overall Study|Death|0|||
33256822|NCT04956575|100840143|FG000|Overall Study|Lost to Follow-up|3|||
33162387|NCT01203098|100504520|FG000|Overall Study|Adverse Event|3|||
33162388|NCT01203098|100504521|FG001|Overall Study|Adverse Event|1|||
33256823|NCT04956575|100840144|FG001|Overall Study|Lost to Follow-up|4|||
33256824|NCT04956575|100840145|FG002|Overall Study|Lost to Follow-up|2|||
33256825|NCT04956575|100840146|FG003|Overall Study|Lost to Follow-up|3|||
33256826|NCT04956575|100840147|FG004|Overall Study|Lost to Follow-up|1|||
33256827|NCT04956575|100840148|FG005|Overall Study|Lost to Follow-up|10|||
33443416|NCT03290781|101518828|FG000|Overall Study|Disease Relapse|32|||
33162389|NCT01203098|100504522|FG002|Overall Study|Adverse Event|7|||
33162390|NCT01203098|100504520|FG000|Overall Study|Lost to Follow-up|0|||
33162391|NCT01203098|100504521|FG001|Overall Study|Lost to Follow-up|0|||
33162392|NCT01203098|100504522|FG002|Overall Study|Lost to Follow-up|1|||
33162393|NCT01203098|100504520|FG000|Overall Study|Physician Decision|2|||
33162394|NCT01203098|100504521|FG001|Overall Study|Physician Decision|2|||
33162395|NCT01203098|100504522|FG002|Overall Study|Physician Decision|0|||
33162396|NCT01203098|100504520|FG000|Overall Study|Withdrawal by Subject|1|||
33162397|NCT01203098|100504521|FG001|Overall Study|Withdrawal by Subject|1|||
33162398|NCT01203098|100504522|FG002|Overall Study|Withdrawal by Subject|3|||
33162399|NCT01387932|100504523|FG000|Randomized and Treated|Physician Decision|3|||
33162400|NCT01387932|100504524|FG001|Randomized and Treated|Physician Decision|2|||
33162401|NCT01387932|100504523|FG000|Randomized and Treated|Withdrawal by Subject|4|||
33162402|NCT01387932|100504524|FG001|Randomized and Treated|Withdrawal by Subject|2|||
33162403|NCT01387932|100504523|FG000|Survival Follow-up|Liver Transplant|24|||
33162404|NCT01387932|100504524|FG001|Survival Follow-up|Liver Transplant|28|||
33162405|NCT01387932|100504523|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
33162406|NCT01387932|100504524|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
33162407|NCT01387932|100504523|FG000|Survival Follow-up|Withdrawal by Subject|2|||
33162408|NCT01387932|100504524|FG001|Survival Follow-up|Withdrawal by Subject|4|||
33162409|NCT01387932|100504523|FG000|Survival Follow-up|Lost to Follow-up|6|||
33162410|NCT01387932|100504524|FG001|Survival Follow-up|Lost to Follow-up|5|||
33162411|NCT03673046|100504528|FG000|Overall Study|Adverse Event|1|||
33162412|NCT03673046|100504529|FG001|Overall Study|Adverse Event|1|||
33162413|NCT03673046|100504528|FG000|Overall Study|Withdrawal by Subject|8|||
33162414|NCT03673046|100504529|FG001|Overall Study|Withdrawal by Subject|2|||
33162415|NCT00003473|100504533|FG000|Overall Study|Three patients were not evaluable.|3|||
33162416|NCT03600818|100504534|FG000|Overall Study|Adverse Event|4|||
33162417|NCT03600818|100504535|FG001|Overall Study|Adverse Event|7|||
33162418|NCT03600818|100504534|FG000|Overall Study|Lack of Efficacy|9|||
33162419|NCT03600818|100504535|FG001|Overall Study|Lack of Efficacy|4|||
33162420|NCT03600818|100504534|FG000|Overall Study|Withdrawal by Subject|4|||
33162421|NCT03600818|100504535|FG001|Overall Study|Withdrawal by Subject|3|||
33162422|NCT03600818|100504534|FG000|Overall Study|Other-unspecified|5|||
33162423|NCT03600818|100504535|FG001|Overall Study|Other-unspecified|3|||
33162424|NCT03600818|100504534|FG000|Overall Study|Randomized and not treated|0|||
33162425|NCT03600818|100504535|FG001|Overall Study|Randomized and not treated|1|||
33162426|NCT03733470|100504536|FG000|Overall Study|PI Decision|1|||
33162427|NCT03733470|100504537|FG001|Overall Study|PI Decision|1|||
33162428|NCT01626456|100504538|FG000|Overall Study|Withdrawal by Subject|21|||
33162429|NCT01626456|100504539|FG001|Overall Study|Withdrawal by Subject|46|||
33162430|NCT01626456|100504538|FG000|Overall Study|Adverse Event|2|||
33162431|NCT01626456|100504539|FG001|Overall Study|Adverse Event|27|||
33162432|NCT01626456|100504538|FG000|Overall Study|Lost to Follow-up|2|||
33162433|NCT01626456|100504539|FG001|Overall Study|Lost to Follow-up|27|||
33162434|NCT01626456|100504538|FG000|Overall Study|Lack of Efficacy|6|||
33162435|NCT01626456|100504539|FG001|Overall Study|Lack of Efficacy|7|||
33162436|NCT01626456|100504538|FG000|Overall Study|Physician Decision|1|||
33162437|NCT01626456|100504539|FG001|Overall Study|Physician Decision|4|||
33256828|NCT04956575|100840149|FG006|Overall Study|Lost to Follow-up|11|||
33256829|NCT04956575|100840150|FG007|Overall Study|Lost to Follow-up|7|||
33256830|NCT04956575|100840151|FG008|Overall Study|Lost to Follow-up|4|||
33256831|NCT04956575|100840152|FG009|Overall Study|Lost to Follow-up|2|||
33256832|NCT04956575|100840153|FG010|Overall Study|Lost to Follow-up|3|||
33256833|NCT04956575|100840154|FG011|Overall Study|Lost to Follow-up|8|||
33256834|NCT04956575|100840143|FG000|Overall Study|Withdrawal by Subject|1|||
33256835|NCT04956575|100840144|FG001|Overall Study|Withdrawal by Subject|2|||
33256836|NCT04956575|100840145|FG002|Overall Study|Withdrawal by Subject|1|||
33256837|NCT04956575|100840146|FG003|Overall Study|Withdrawal by Subject|4|||
33256838|NCT04956575|100840147|FG004|Overall Study|Withdrawal by Subject|2|||
33256839|NCT04956575|100840148|FG005|Overall Study|Withdrawal by Subject|8|||
33162438|NCT01626456|100504538|FG000|Overall Study|Protocol Violation|1|||
33162439|NCT01626456|100504539|FG001|Overall Study|Protocol Violation|1|||
33162440|NCT01626456|100504538|FG000|Overall Study|Site Closure|2|||
33162441|NCT01626456|100504539|FG001|Overall Study|Site Closure|3|||
33162442|NCT01626456|100504538|FG000|Overall Study|Incarceration|0|||
33162443|NCT01626456|100504539|FG001|Overall Study|Incarceration|2|||
33162444|NCT01434667|100504542|FG000|Overall Study|Lost to Follow-up|5|||
33256840|NCT04956575|100840149|FG006|Overall Study|Withdrawal by Subject|5|||
33162445|NCT01434667|100504543|FG001|Overall Study|Lost to Follow-up|10|||
33162446|NCT01785069|100504545|FG000|Overall Study|Implanted with nonstudy device|1|||
33162447|NCT01785069|100504546|FG001|Overall Study|Implanted with nonstudy device|2|||
33162448|NCT01785069|100504547|FG002|Overall Study|Implanted with nonstudy device|1|||
33162449|NCT01785069|100504548|FG003|Overall Study|Implanted with nonstudy device|0|||
33162450|NCT01785069|100504545|FG000|Overall Study|Death|0|||
33256841|NCT04956575|100840150|FG007|Overall Study|Withdrawal by Subject|1|||
33256842|NCT04956575|100840151|FG008|Overall Study|Withdrawal by Subject|1|||
33256843|NCT04956575|100840152|FG009|Overall Study|Withdrawal by Subject|0|||
33256844|NCT04956575|100840153|FG010|Overall Study|Withdrawal by Subject|3|||
33256845|NCT04956575|100840154|FG011|Overall Study|Withdrawal by Subject|1|||
33256846|NCT01000480|100840155|FG000|Induction Phase|Adverse Event|2|||
33256847|NCT01000480|100840155|FG000|Induction Phase|Lost to Follow-up|1|||
33256848|NCT01000480|100840155|FG000|Induction Phase|Physician Decision|1|||
33256849|NCT01000480|100840155|FG000|Induction Phase|Entry Criteria Not Met|3|||
33256850|NCT01000480|100840155|FG000|Concurrent Therapy Phase|Adverse Event|4|||
33256851|NCT01000480|100840155|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
33256852|NCT01000480|100840155|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
33256853|NCT01000480|100840155|FG000|Concurrent Therapy Phase|Physician Decision|1|||
33256854|NCT00508924|100840156|FG000|Overall Study|Protocol Violation|0|||
33256855|NCT00508924|100840157|FG001|Overall Study|Protocol Violation|0|||
33256856|NCT00508924|100840158|FG002|Overall Study|Protocol Violation|1|||
33256857|NCT00508924|100840159|FG003|Overall Study|Protocol Violation|1|||
33256858|NCT01149369|100840160|FG000|Overall Study|Adverse Event|6|||
33256859|NCT01149369|100840161|FG001|Overall Study|Adverse Event|3|||
33256860|NCT01062126|100840162|FG000|Overall Study|Death|209|||
33256861|NCT01062126|100840162|FG000|Overall Study|All Withdrawals|324|||
33256862|NCT01415349|100840165|FG000|Treatment Period 1|Adverse Event|0|||
33256863|NCT01415349|100840166|FG001|Treatment Period 1|Adverse Event|1|||
33256864|NCT01415349|100840165|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33256865|NCT01415349|100840166|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33256866|NCT02751580|100842546|FG000|Overall Study|Lost to Follow-up|4|||
33256867|NCT02751580|100842546|FG000|Overall Study|Death|2|||
33256868|NCT00414544|100842558|FG000|Overall Study|Lost to Follow-up|14|||
33256869|NCT02918279|100842560|FG000|Overall Study|Lost to Follow-up|3|||
33256870|NCT02918279|100842561|FG001|Overall Study|Lost to Follow-up|6|||
33256871|NCT02918279|100842560|FG000|Overall Study|Withdrawal by Subject|5|||
33256872|NCT02918279|100842561|FG001|Overall Study|Withdrawal by Subject|15|||
33256873|NCT02918279|100842560|FG000|Overall Study|Withdrawal by parent/guardian|2|||
33256874|NCT02918279|100842561|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33256875|NCT02918279|100842560|FG000|Overall Study|Other|3|||
33256876|NCT02918279|100842561|FG001|Overall Study|Other|1|||
33256877|NCT03684044|100842562|FG000|Overall Study|Adverse Event|3|||
33256878|NCT03684044|100842563|FG001|Overall Study|Adverse Event|0|||
33256879|NCT03684044|100842562|FG000|Overall Study|Death|4|||
33256880|NCT03684044|100842563|FG001|Overall Study|Death|7|||
33256881|NCT03684044|100842562|FG000|Overall Study|Lost to Follow-up|3|||
33256882|NCT03684044|100842563|FG001|Overall Study|Lost to Follow-up|2|||
33256883|NCT03684044|100842562|FG000|Overall Study|Patient Not Available|0|||
33256884|NCT03684044|100842563|FG001|Overall Study|Patient Not Available|2|||
33256885|NCT03684044|100842562|FG000|Overall Study|Physician Decision|1|||
33256886|NCT03684044|100842563|FG001|Overall Study|Physician Decision|0|||
33256887|NCT03684044|100842562|FG000|Overall Study|Withdrawal by Subject|11|||
33256888|NCT03684044|100842563|FG001|Overall Study|Withdrawal by Subject|9|||
33256889|NCT01337635|100842564|FG000|Overall Study|Lost to Follow-up|0|||
33256890|NCT01337635|100842565|FG001|Overall Study|Lost to Follow-up|1|||
33256891|NCT04788641|100842566|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
33256892|NCT04788641|100842567|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
33256893|NCT04788641|100842568|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
33256894|NCT04788641|100842569|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
33256895|NCT04788641|100842566|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
33256896|NCT04788641|100842567|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
33256897|NCT04788641|100842568|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
33256898|NCT04788641|100842569|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
33256899|NCT04788641|100842566|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
33256900|NCT04788641|100842567|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
33256901|NCT04788641|100842568|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
33256902|NCT04788641|100842569|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
33256903|NCT00539734|100842570|FG000|Overall Study|Protocol Violation|1|||
33256904|NCT01063972|100842571|FG000|Overall Study|Death|12|||
33256905|NCT01063972|100842572|FG001|Overall Study|Death|11|||
33256906|NCT01063972|100842571|FG000|Overall Study|Incarcerated|2|||
33256907|NCT01063972|100842572|FG001|Overall Study|Incarcerated|1|||
33256908|NCT00589667|100842573|FG000|Overall Study|Adverse Event|2|||
33256909|NCT00589667|100842573|FG000|Overall Study|Withdrawal by Subject|1|||
33256910|NCT00955825|100842575|FG000|Overall Study|Adverse Event|15|||
33256911|NCT00955825|100842576|FG001|Overall Study|Adverse Event|2|||
33256912|NCT00955825|100842575|FG000|Overall Study|Withdrawal by Subject|4|||
33256913|NCT00955825|100842576|FG001|Overall Study|Withdrawal by Subject|6|||
33256914|NCT00955825|100842575|FG000|Overall Study|Any other reason not above-mentioned|7|||
33256915|NCT00955825|100842576|FG001|Overall Study|Any other reason not above-mentioned|9|||
33256916|NCT04530747|100842577|FG000|Overall Study|Withdrawal by Subject|1|||
33256917|NCT04530747|100842578|FG001|Overall Study|Withdrawal by Subject|0|||
33256918|NCT02318134|100842579|FG000|Overall Study|Withdrawal by Subject|2|||
33256919|NCT02318134|100842580|FG001|Overall Study|Withdrawal by Subject|1|||
33256920|NCT00941655|100842581|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
33256921|NCT00941655|100842582|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
33256922|NCT00941655|100842581|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
33256923|NCT00941655|100842582|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
33256924|NCT00941655|100842581|FG000|Overall Study|progressed while on chemo|0|||
33256925|NCT00941655|100842582|FG001|Overall Study|progressed while on chemo|2|||
33256926|NCT00941655|100842581|FG000|Overall Study|refused further treatment|0|||
33256927|NCT00941655|100842582|FG001|Overall Study|refused further treatment|1|||
33256928|NCT00941655|100842581|FG000|Overall Study|withdrew consent|0|||
33256929|NCT00941655|100842582|FG001|Overall Study|withdrew consent|1|||
33256930|NCT00941655|100842581|FG000|Overall Study|non-compliant|0|||
33256931|NCT00941655|100842582|FG001|Overall Study|non-compliant|1|||
33256932|NCT00520546|100842585|FG000|Overall Study|Withdrawal by Subject|1|||
33256933|NCT00520546|100842585|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
33256934|NCT00535145|100842586|FG000|Phase I|Adverse Event|3|||
33256935|NCT00535145|100842586|FG000|Phase I|Lost to Follow-up|7|||
33256936|NCT00535145|100842586|FG000|Phase I|Withdrawal by Subject|6|||
33256937|NCT00535145|100842586|FG000|Phase I|(eligibility)|8|||
33256938|NCT00535145|100842586|FG000|Phase I|(protocol violation)|1|||
33256939|NCT00535145|100842586|FG000|Phase I|(PI decision)|1|||
33256940|NCT00535145|100842586|FG000|Phase I|(diagnosis)|3|||
33256941|NCT00535145|100842586|FG000|Phase II|Adverse Event|2|||
33256942|NCT00535145|100842586|FG000|Phase II|Lack of Efficacy|1|||
33256943|NCT00535145|100842586|FG000|Phase II|Lost to Follow-up|5|||
33256944|NCT00535145|100842586|FG000|Phase II|Withdrawal by Subject|5|||
33256945|NCT00535145|100842586|FG000|Phase II|Subject non-compliance|2|||
33256946|NCT00001277|100842587|FG000|Overall Study|Adverse Event|0|||
33256947|NCT00001277|100842588|FG001|Overall Study|Adverse Event|0|||
33256948|NCT00001277|100842589|FG002|Overall Study|Adverse Event|1|||
33256949|NCT00001277|100842587|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
33256950|NCT00001277|100842588|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
33256951|NCT00001277|100842589|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
33256952|NCT05082935|100842590|FG000|Overall Study|Lost to Follow-up|549|||
33256953|NCT05082935|100842591|FG001|Overall Study|Lost to Follow-up|631|||
33256954|NCT05082935|100842590|FG000|Overall Study|Withdrawal by Subject|27|||
33256955|NCT05082935|100842591|FG001|Overall Study|Withdrawal by Subject|58|||
33256956|NCT01044303|100842592|FG000|Overall Study|Lost to Follow-up|2|||
33256957|NCT02544152|100842593|FG000|Overall Study|Adverse Event|0|||
33256958|NCT02544152|100842594|FG001|Overall Study|Adverse Event|4|||
33256959|NCT02544152|100842593|FG000|Overall Study|Withdrawal by Subject|0|||
33256960|NCT02544152|100842594|FG001|Overall Study|Withdrawal by Subject|3|||
33256961|NCT02544152|100842593|FG000|Overall Study|Other|1|||
33256962|NCT02544152|100842594|FG001|Overall Study|Other|0|||
33256963|NCT02015546|100842601|FG000|Overall Study|Withdrawal by Subject|1|||
33256964|NCT02015546|100842602|FG001|Overall Study|Withdrawal by Subject|1|||
33256965|NCT02015546|100842603|FG002|Overall Study|Withdrawal by Subject|1|||
33256966|NCT02015546|100842601|FG000|Overall Study|Screem Failure|2|||
33256967|NCT02015546|100842602|FG001|Overall Study|Screem Failure|1|||
33256968|NCT02015546|100842603|FG002|Overall Study|Screem Failure|3|||
33256969|NCT02178098|100842605|FG000|Overall Study|Withdrawal by Subject|0|||
33256970|NCT02178098|100842606|FG001|Overall Study|Withdrawal by Subject|6|||
33256971|NCT02178098|100842605|FG000|Overall Study|Adverse Event|1|||
33256972|NCT02178098|100842606|FG001|Overall Study|Adverse Event|2|||
33256973|NCT02178098|100842605|FG000|Overall Study|Protocol Violation|1|||
33256974|NCT02178098|100842606|FG001|Overall Study|Protocol Violation|1|||
33256975|NCT02178098|100842605|FG000|Overall Study|Lost to Follow-up|0|||
33256976|NCT02178098|100842606|FG001|Overall Study|Lost to Follow-up|1|||
33256977|NCT02178098|100842605|FG000|Overall Study|Sponsor Request|1|||
33256978|NCT02178098|100842606|FG001|Overall Study|Sponsor Request|0|||
33256979|NCT02178098|100842605|FG000|Overall Study|Other|2|||
33256980|NCT02178098|100842606|FG001|Overall Study|Other|2|||
33256981|NCT02539225|100842607|FG000|Part A|Adverse Event|13|||
33256982|NCT02539225|100842608|FG001|Part A|Adverse Event|4|||
33443417|NCT03290781|101518829|FG001|Overall Study|Disease Relapse|5|||
33443418|NCT03290781|101518830|FG002|Overall Study|Disease Relapse|38|||
33256983|NCT02539225|100842607|FG000|Part A|Withdrawal by Subject|2|||
33256984|NCT02539225|100842608|FG001|Part A|Withdrawal by Subject|4|||
33256985|NCT02539225|100842607|FG000|Part A|Physician Decision|4|||
33256986|NCT02539225|100842608|FG001|Part A|Physician Decision|7|||
33256987|NCT02539225|100842607|FG000|Part A|Did Not Receive study Drug|1|||
33256988|NCT02539225|100842608|FG001|Part A|Did Not Receive study Drug|1|||
33256989|NCT02539225|100842607|FG000|Pre Treatment for Part B|Progressive disease|1|||
33256990|NCT02539225|100842608|FG001|Pre Treatment for Part B|Progressive disease|1|||
33256991|NCT02539225|100842607|FG000|Pre Treatment for Part B|Adverse Event|1|||
33256992|NCT02539225|100842608|FG001|Pre Treatment for Part B|Adverse Event|1|||
33256993|NCT02539225|100842607|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
33256994|NCT02539225|100842608|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
33256995|NCT02539225|100842607|FG000|Pre Treatment for Part B|Physician Decision|2|||
33443419|NCT03290781|101518831|FG003|Overall Study|Disease Relapse|7|||
33443420|NCT03290781|101518832|FG004|Overall Study|Disease Relapse|3|||
33443421|NCT03290781|101518833|FG005|Overall Study|Disease Relapse|1|||
33443422|NCT03290781|101518834|FG006|Overall Study|Disease Relapse|4|||
33443423|NCT03290781|101518828|FG000|Overall Study|Other|3|||
33443424|NCT03290781|101518829|FG001|Overall Study|Other|0|||
33443425|NCT03290781|101518830|FG002|Overall Study|Other|2|||
33443426|NCT03290781|101518831|FG003|Overall Study|Other|2|||
33443427|NCT03290781|101518832|FG004|Overall Study|Other|0|||
33443428|NCT03290781|101518833|FG005|Overall Study|Other|0|||
33443429|NCT03290781|101518834|FG006|Overall Study|Other|0|||
33443430|NCT01878292|101518835|FG000|Randomized|Protocol Violation|1|||
33443431|NCT01878292|101518836|FG001|Randomized|Protocol Violation|0|||
33443432|NCT01878292|101518837|FG002|Randomized|Protocol Violation|0|||
33162451|NCT01785069|100504546|FG001|Overall Study|Death|0|||
33162452|NCT01785069|100504547|FG002|Overall Study|Death|2|||
33162453|NCT01785069|100504548|FG003|Overall Study|Death|0|||
33162454|NCT01785069|100504545|FG000|Overall Study|Subject choice|2|||
33162455|NCT01785069|100504546|FG001|Overall Study|Subject choice|2|||
33162456|NCT01785069|100504547|FG002|Overall Study|Subject choice|0|||
33162457|NCT01785069|100504548|FG003|Overall Study|Subject choice|1|||
33162458|NCT01785069|100504545|FG000|Overall Study|Lost to Follow-up|1|||
33162459|NCT01785069|100504546|FG001|Overall Study|Lost to Follow-up|2|||
33162460|NCT01785069|100504547|FG002|Overall Study|Lost to Follow-up|4|||
33162461|NCT01785069|100504548|FG003|Overall Study|Lost to Follow-up|1|||
33162462|NCT01785069|100504545|FG000|Overall Study|Reason not Specified|1|||
33162463|NCT01785069|100504546|FG001|Overall Study|Reason not Specified|2|||
33162464|NCT01785069|100504547|FG002|Overall Study|Reason not Specified|1|||
33162465|NCT01785069|100504548|FG003|Overall Study|Reason not Specified|4|||
33162466|NCT01785069|100504545|FG000|Overall Study|Not evaluable|7|||
33162467|NCT01785069|100504546|FG001|Overall Study|Not evaluable|4|||
33162468|NCT01785069|100504547|FG002|Overall Study|Not evaluable|5|||
33162469|NCT01785069|100504548|FG003|Overall Study|Not evaluable|8|||
33162470|NCT01392443|100504549|FG000|Overall Study|Disease progression|30|||
33162471|NCT01392443|100504549|FG000|Overall Study|Adverse Event|24|||
33162472|NCT01392443|100504549|FG000|Overall Study|Death|7|||
33162473|NCT01392443|100504549|FG000|Overall Study|Withdrawal by Subject|5|||
33162474|NCT01392443|100504549|FG000|Overall Study|Lost to Follow-up|1|||
33162475|NCT01392443|100504549|FG000|Overall Study|Protocol Violation|1|||
33162476|NCT02362269|100504550|FG000|Overall Study|Moved|1|||
33162477|NCT02362269|100504551|FG001|Overall Study|Moved|0|||
33162478|NCT02362269|100504550|FG000|Overall Study|Lost to Follow-up|0|||
33162479|NCT02362269|100504551|FG001|Overall Study|Lost to Follow-up|6|||
33162480|NCT00824720|100504552|FG000|Overall Study|failed plug insertion|3|||
33162481|NCT00824720|100504553|FG001|Overall Study|failed plug insertion|1|||
33162482|NCT00824720|100504554|FG002|Overall Study|failed plug insertion|0|||
33162483|NCT00824720|100504552|FG000|Overall Study|Protocol Violation|0|||
33162484|NCT00824720|100504553|FG001|Overall Study|Protocol Violation|0|||
33162485|NCT00824720|100504554|FG002|Overall Study|Protocol Violation|1|||
33162486|NCT04444895|100504555|FG000|Overall Study|Adverse Event|2|||
33162487|NCT04444895|100504555|FG000|Overall Study|Lost to Follow-up|2|||
33162488|NCT04444895|100504555|FG000|Overall Study|Withdrawal by Subject|5|||
33162489|NCT02166905|100504560|FG000|Overall Study|Withdrawal by Subject|1|||
33162490|NCT02166905|100504561|FG001|Overall Study|Withdrawal by Subject|0|||
33162491|NCT02166905|100504562|FG002|Overall Study|Withdrawal by Subject|0|||
33162492|NCT02166905|100504563|FG003|Overall Study|Withdrawal by Subject|0|||
33162493|NCT03978832|100504564|FG000|Overall Study|Adverse Event|1|||
33162494|NCT03978832|100504564|FG000|Overall Study|Lost to Follow-up|1|||
33162495|NCT03978832|100504564|FG000|Overall Study|Withdrawal by Subject|6|||
33443433|NCT01878292|101518835|FG000|Randomized|Lost to Follow-up|1|||
33443434|NCT01878292|101518836|FG001|Randomized|Lost to Follow-up|0|||
33443435|NCT01878292|101518837|FG002|Randomized|Lost to Follow-up|0|||
33162496|NCT03978832|100504564|FG000|Overall Study|Physician Decision|2|||
33162497|NCT03978832|100504564|FG000|Overall Study|did not pass screening criteria|44|||
33162498|NCT05209360|100504569|FG000|Overall Study|Withdrawal by Subject|0|||
33162499|NCT05209360|100504570|FG001|Overall Study|Withdrawal by Subject|0|||
33162500|NCT05209360|100504571|FG002|Overall Study|Withdrawal by Subject|1|||
33162501|NCT05209360|100504572|FG003|Overall Study|Withdrawal by Subject|0|||
33162502|NCT05209360|100504573|FG004|Overall Study|Withdrawal by Subject|0|||
33162503|NCT05209360|100504574|FG005|Overall Study|Withdrawal by Subject|0|||
33162504|NCT00134082|100504577|FG000|Overall Study|Adverse Event|2|||
33162505|NCT00134082|100504577|FG000|Overall Study|Death|1|||
33162506|NCT04706091|100504580|FG000|Treatment 2|Withdrawal by Subject|1|||
33162507|NCT04706091|100504581|FG001|Treatment 2|Withdrawal by Subject|0|||
33162508|NCT00443261|100504582|FG000|Overall Study|Death|1|||
33162509|NCT00709761|100504585|FG000|Overall Study|Withdrawal by Subject|8|||
33162510|NCT00709761|100504585|FG000|Overall Study|study closed/terminated|17|||
33162511|NCT00709761|100504585|FG000|Overall Study|Lost to Follow-up|2|||
33162512|NCT00926328|100504589|FG000|Overall Study|Lost to Follow-up|12|||
33162513|NCT00926328|100504590|FG001|Overall Study|Lost to Follow-up|14|||
33162514|NCT03706079|100504604|FG000|Predecessor Study|Death|0|||
33162515|NCT03706079|100504605|FG001|Predecessor Study|Death|2|||
33162516|NCT03706079|100504606|FG002|Predecessor Study|Death|0|||
33162517|NCT03706079|100504607|FG003|Predecessor Study|Death|1|||
33162518|NCT03706079|100504608|FG004|Predecessor Study|Death|0|||
33162519|NCT03706079|100504609|FG005|Predecessor Study|Death|0|||
33162520|NCT03706079|100504604|FG000|Predecessor Study|Lost to Follow-up|5|||
33162521|NCT03706079|100504605|FG001|Predecessor Study|Lost to Follow-up|2|||
33162522|NCT03706079|100504606|FG002|Predecessor Study|Lost to Follow-up|0|||
33162523|NCT03706079|100504607|FG003|Predecessor Study|Lost to Follow-up|0|||
33162524|NCT03706079|100504608|FG004|Predecessor Study|Lost to Follow-up|1|||
33162525|NCT03706079|100504609|FG005|Predecessor Study|Lost to Follow-up|0|||
33162526|NCT03706079|100504604|FG000|Predecessor Study|Withdrawal by Subject|8|||
33162527|NCT03706079|100504605|FG001|Predecessor Study|Withdrawal by Subject|15|||
33162528|NCT03706079|100504606|FG002|Predecessor Study|Withdrawal by Subject|0|||
33162529|NCT03706079|100504607|FG003|Predecessor Study|Withdrawal by Subject|5|||
33162530|NCT03706079|100504608|FG004|Predecessor Study|Withdrawal by Subject|2|||
33162531|NCT03706079|100504609|FG005|Predecessor Study|Withdrawal by Subject|0|||
33443436|NCT01878292|101518835|FG000|Randomized|Adverse Event|1|||
33443437|NCT01878292|101518836|FG001|Randomized|Adverse Event|0|||
33443438|NCT01878292|101518837|FG002|Randomized|Adverse Event|0|||
33443439|NCT01878292|101518835|FG000|Double-blind Treatment Period|Other Reasons|2|||
33443440|NCT01878292|101518836|FG001|Double-blind Treatment Period|Other Reasons|0|||
33443441|NCT01878292|101518837|FG002|Double-blind Treatment Period|Other Reasons|0|||
33443442|NCT01878292|101518835|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
33443443|NCT01878292|101518836|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
33443444|NCT01878292|101518837|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
33443445|NCT01878292|101518835|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
33443446|NCT01878292|101518836|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
33443447|NCT01878292|101518837|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
33443448|NCT01878292|101518835|FG000|Double-blind Treatment Period|Protocol Violation|3|||
33443449|NCT01878292|101518836|FG001|Double-blind Treatment Period|Protocol Violation|4|||
33443450|NCT01878292|101518837|FG002|Double-blind Treatment Period|Protocol Violation|2|||
33162532|NCT03706079|100504604|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
33162533|NCT03706079|100504605|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
33443451|NCT01878292|101518835|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
33162534|NCT03706079|100504606|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
33162535|NCT03706079|100504607|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
33162536|NCT03706079|100504608|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
33443452|NCT01878292|101518836|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
33443453|NCT01878292|101518837|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
33162537|NCT03706079|100504609|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
33162538|NCT03706079|100504604|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
33162539|NCT03706079|100504605|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
33162540|NCT03706079|100504606|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
33162541|NCT03706079|100504607|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
33162542|NCT03706079|100504608|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
33162543|NCT03706079|100504609|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
33162544|NCT03706079|100504604|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
33256996|NCT02539225|100842608|FG001|Pre Treatment for Part B|Physician Decision|0|||
33256997|NCT02539225|100842607|FG000|Part B|Adverse Event|4|||
33256998|NCT02539225|100842608|FG001|Part B|Adverse Event|4|||
33256999|NCT02539225|100842607|FG000|Part B|Withdrawal by Subject|0|||
33257000|NCT02539225|100842608|FG001|Part B|Withdrawal by Subject|3|||
33257001|NCT02539225|100842607|FG000|Part B|Physician Decision|0|||
33257002|NCT02539225|100842608|FG001|Part B|Physician Decision|9|||
33257003|NCT00785512|100842609|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
33257004|NCT00785512|100842610|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
33257005|NCT00785512|100842609|FG000|Overall Study|Adverse Event|0|||
33257006|NCT00785512|100842610|FG001|Overall Study|Adverse Event|0|||
33257007|NCT00785512|100842609|FG000|Overall Study|Lack of Efficacy|0|||
33257008|NCT00785512|100842610|FG001|Overall Study|Lack of Efficacy|2|||
33257009|NCT00785512|100842609|FG000|Overall Study|Withdrawal by Subject|0|||
33257010|NCT00785512|100842610|FG001|Overall Study|Withdrawal by Subject|1|||
33257011|NCT00785512|100842609|FG000|Overall Study|Lost to Follow-up|3|||
33257012|NCT00785512|100842610|FG001|Overall Study|Lost to Follow-up|0|||
33257013|NCT00785512|100842609|FG000|Overall Study|Precedure Refused|0|||
33257014|NCT00785512|100842610|FG001|Overall Study|Precedure Refused|0|||
33257015|NCT00785512|100842609|FG000|Overall Study|IVRS Programing Error|0|||
33257016|NCT00785512|100842610|FG001|Overall Study|IVRS Programing Error|0|||
33257017|NCT00785512|100842609|FG000|Overall Study|Physician Decision|0|||
33443454|NCT01878292|101518835|FG000|Double-blind Treatment Period|Adverse Event|4|||
33443455|NCT01878292|101518836|FG001|Double-blind Treatment Period|Adverse Event|9|||
33443456|NCT01878292|101518837|FG002|Double-blind Treatment Period|Adverse Event|8|||
33443457|NCT01878292|101518835|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
33443458|NCT01878292|101518836|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
33443459|NCT01878292|101518837|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
33443460|NCT00965185|101518838|FG000|Overall Study|Lost to Follow-up|2|||
33443461|NCT00965185|101518839|FG001|Overall Study|Lost to Follow-up|0|||
33443462|NCT00965185|101518838|FG000|Overall Study|Withdrawal by Subject|0|||
33443463|NCT00965185|101518839|FG001|Overall Study|Withdrawal by Subject|1|||
33443464|NCT01518972|101518840|FG000|Overall Study|Lost to Follow-up|2|||
33443465|NCT01518972|101518841|FG001|Overall Study|Lost to Follow-up|1|||
33443466|NCT01518972|101518840|FG000|Overall Study|Withdrawal by Subject|1|||
33443467|NCT01518972|101518841|FG001|Overall Study|Withdrawal by Subject|0|||
33443468|NCT01518972|101518840|FG000|Overall Study|Moved from area|1|||
33443469|NCT01518972|101518841|FG001|Overall Study|Moved from area|0|||
33443470|NCT01518972|101518840|FG000|Overall Study|Transportation problems|1|||
33443471|NCT01518972|101518841|FG001|Overall Study|Transportation problems|0|||
33443472|NCT01518972|101518840|FG000|Overall Study|Exclusionary medical condition|1|||
33257018|NCT00785512|100842610|FG001|Overall Study|Physician Decision|0|||
33257019|NCT00785512|100842609|FG000|Overall Study|Lack of compliance|0|||
33162545|NCT03706079|100504605|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
33162546|NCT03706079|100504606|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
33162547|NCT03706079|100504607|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
33162548|NCT03706079|100504608|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
33162549|NCT03706079|100504609|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
33162550|NCT03706079|100504604|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
33162551|NCT03706079|100504605|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
33162552|NCT03706079|100504606|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
33162553|NCT03706079|100504607|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
33162554|NCT03706079|100504608|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
33162555|NCT03706079|100504609|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
33162556|NCT03706079|100504604|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
33162557|NCT03706079|100504605|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
33162558|NCT03706079|100504606|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
33162559|NCT03706079|100504607|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
33162560|NCT03706079|100504608|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
33162561|NCT03706079|100504609|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
33162562|NCT03706079|100504604|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
33162563|NCT03706079|100504605|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
33162564|NCT03706079|100504606|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
33162565|NCT03706079|100504607|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
33162566|NCT03706079|100504608|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
33162567|NCT03706079|100504609|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
33162568|NCT03706079|100504604|FG000|Long Term Extension (DESTINATION)|Death|8|||
33162569|NCT03706079|100504605|FG001|Long Term Extension (DESTINATION)|Death|2|||
33162570|NCT03706079|100504606|FG002|Long Term Extension (DESTINATION)|Death|2|||
33162571|NCT03706079|100504607|FG003|Long Term Extension (DESTINATION)|Death|1|||
33162572|NCT03706079|100504608|FG004|Long Term Extension (DESTINATION)|Death|0|||
33162573|NCT03706079|100504609|FG005|Long Term Extension (DESTINATION)|Death|0|||
33162574|NCT01540838|100504610|FG000|Overall Study|Open nasogastric tube|9|||
33162575|NCT01540838|100504611|FG001|Overall Study|Open nasogastric tube|7|||
33162576|NCT01540838|100504610|FG000|Overall Study|Treatment doses missing|8|||
33162577|NCT01540838|100504611|FG001|Overall Study|Treatment doses missing|12|||
33162578|NCT01540838|100504610|FG000|Overall Study|Additional antibiotic treatment|1|||
33162579|NCT01540838|100504611|FG001|Overall Study|Additional antibiotic treatment|2|||
33162580|NCT01540838|100504610|FG000|Overall Study|Died before treatment initiation|1|||
33162581|NCT01540838|100504611|FG001|Overall Study|Died before treatment initiation|1|||
33162582|NCT01540838|100504610|FG000|Overall Study|Not BM. Other treatment|3|||
33162583|NCT01540838|100504611|FG001|Overall Study|Not BM. Other treatment|1|||
33162584|NCT02571075|100504612|FG000|Overall Study|Lost to Follow-up|20|||
33162585|NCT02571075|100504613|FG001|Overall Study|Lost to Follow-up|24|||
33162586|NCT00667875|100504619|FG000|Overall Study|Adverse Event|0|||
33162587|NCT00667875|100504620|FG001|Overall Study|Adverse Event|2|||
33162588|NCT00667875|100504621|FG002|Overall Study|Adverse Event|6|||
33162589|NCT00667875|100504619|FG000|Overall Study|Withdrawal by Subject|10|||
33162590|NCT00667875|100504620|FG001|Overall Study|Withdrawal by Subject|9|||
33162591|NCT00667875|100504621|FG002|Overall Study|Withdrawal by Subject|7|||
33162592|NCT03166735|100504622|FG000|Overall Study|Not Treated|1|||
33162593|NCT03166735|100504623|FG001|Overall Study|Not Treated|0|||
33162594|NCT03166735|100504624|FG002|Overall Study|Not Treated|0|||
33162595|NCT03166735|100504625|FG003|Overall Study|Not Treated|0|||
33162596|NCT03166735|100504626|FG004|Overall Study|Not Treated|0|||
33162597|NCT03166735|100504622|FG000|Overall Study|follow-up not completed as planned|0|||
33162598|NCT03166735|100504623|FG001|Overall Study|follow-up not completed as planned|1|||
33162599|NCT03166735|100504624|FG002|Overall Study|follow-up not completed as planned|1|||
33162600|NCT03166735|100504625|FG003|Overall Study|follow-up not completed as planned|0|||
33162601|NCT03166735|100504626|FG004|Overall Study|follow-up not completed as planned|1|||
33162602|NCT03166735|100504622|FG000|Overall Study|Withdrawal by Subject|0|||
33162603|NCT03166735|100504623|FG001|Overall Study|Withdrawal by Subject|0|||
33162604|NCT03166735|100504624|FG002|Overall Study|Withdrawal by Subject|1|||
33162605|NCT03166735|100504625|FG003|Overall Study|Withdrawal by Subject|1|||
33162606|NCT03166735|100504626|FG004|Overall Study|Withdrawal by Subject|2|||
33162607|NCT03166735|100504622|FG000|Overall Study|Lost to Follow-up|0|||
33162608|NCT03166735|100504623|FG001|Overall Study|Lost to Follow-up|2|||
33162609|NCT03166735|100504624|FG002|Overall Study|Lost to Follow-up|1|||
33257020|NCT00785512|100842610|FG001|Overall Study|Lack of compliance|1|||
33162610|NCT03166735|100504625|FG003|Overall Study|Lost to Follow-up|0|||
33162611|NCT03166735|100504626|FG004|Overall Study|Lost to Follow-up|1|||
33162612|NCT02570074|100504627|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
33162613|NCT02570074|100504628|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
33162614|NCT03727230|100504629|FG000|Overall Study|Lost to Follow-up|12|||
33162615|NCT00619177|100508018|FG000|Overall Study|Adverse Event|18|||
33162616|NCT00619177|100508018|FG000|Overall Study|Lost to Follow-up|2|||
33162617|NCT00619177|100508018|FG000|Overall Study|Lack of Efficacy|1|||
33162618|NCT00619177|100508018|FG000|Overall Study|Missing termination information|481|||
33162619|NCT00619177|100508018|FG000|Overall Study|Not specified reasons|6|||
33162620|NCT01578187|100508019|FG000|Usability Phase|Withdrawal by Subject|1|||
33162621|NCT02571777|100508020|FG000|Overall Study|Subject/guardian decision|34|||
33162622|NCT02571777|100508021|FG001|Overall Study|Subject/guardian decision|26|||
33162623|NCT02571777|100508022|FG002|Overall Study|Subject/guardian decision|26|||
33162624|NCT02571777|100508023|FG003|Overall Study|Subject/guardian decision|25|||
33162625|NCT02571777|100508024|FG004|Overall Study|Subject/guardian decision|27|||
33162626|NCT02571777|100508020|FG000|Overall Study|Protocol Deviation|2|||
33162627|NCT02571777|100508021|FG001|Overall Study|Protocol Deviation|3|||
33162628|NCT02571777|100508022|FG002|Overall Study|Protocol Deviation|4|||
33162629|NCT02571777|100508023|FG003|Overall Study|Protocol Deviation|8|||
33162630|NCT02571777|100508024|FG004|Overall Study|Protocol Deviation|4|||
33162631|NCT02571777|100508020|FG000|Overall Study|Death|1|||
33162632|NCT02571777|100508021|FG001|Overall Study|Death|1|||
33162633|NCT02571777|100508022|FG002|Overall Study|Death|4|||
33162634|NCT02571777|100508023|FG003|Overall Study|Death|0|||
33162635|NCT02571777|100508024|FG004|Overall Study|Death|0|||
33162636|NCT02571777|100508020|FG000|Overall Study|Lost to Follow-up|1|||
33162637|NCT02571777|100508021|FG001|Overall Study|Lost to Follow-up|1|||
33162638|NCT02571777|100508022|FG002|Overall Study|Lost to Follow-up|2|||
33162639|NCT02571777|100508023|FG003|Overall Study|Lost to Follow-up|0|||
33162640|NCT02571777|100508024|FG004|Overall Study|Lost to Follow-up|1|||
33162641|NCT02571777|100508020|FG000|Overall Study|Physician Decision|1|||
33162642|NCT02571777|100508021|FG001|Overall Study|Physician Decision|7|||
33162643|NCT02571777|100508022|FG002|Overall Study|Physician Decision|5|||
33162644|NCT02571777|100508023|FG003|Overall Study|Physician Decision|2|||
33162645|NCT02571777|100508024|FG004|Overall Study|Physician Decision|4|||
33162646|NCT02571777|100508020|FG000|Overall Study|Pregnancy|0|||
33162647|NCT02571777|100508021|FG001|Overall Study|Pregnancy|0|||
33162648|NCT02571777|100508022|FG002|Overall Study|Pregnancy|0|||
33162649|NCT02571777|100508023|FG003|Overall Study|Pregnancy|2|||
33162650|NCT02571777|100508024|FG004|Overall Study|Pregnancy|0|||
33162651|NCT02619175|100508025|FG000|Overall Study|Withdrawal by Subject|1|||
33162652|NCT02619175|100508026|FG001|Overall Study|Withdrawal by Subject|0|||
33162653|NCT02619175|100508025|FG000|Overall Study|foot pain|1|||
33162654|NCT02619175|100508026|FG001|Overall Study|foot pain|0|||
33162655|NCT00957580|100508027|FG000|Overall Study|Ongoing at data cut-off|0|||
33162656|NCT00957580|100508028|FG001|Overall Study|Ongoing at data cut-off|1|||
33162657|NCT00957580|100508029|FG002|Overall Study|Ongoing at data cut-off|0|||
33162658|NCT00957580|100508027|FG000|Overall Study|Enrolled but not treated|0|||
33162659|NCT00957580|100508028|FG001|Overall Study|Enrolled but not treated|1|||
33162660|NCT00957580|100508029|FG002|Overall Study|Enrolled but not treated|0|||
33162661|NCT01281865|100508032|FG000|Overall Study|Adverse Event|1|||
33162662|NCT01281865|100508033|FG001|Overall Study|Adverse Event|1|||
33162663|NCT01281865|100508032|FG000|Overall Study|Withdrawal by Subject|1|||
33162664|NCT01281865|100508033|FG001|Overall Study|Withdrawal by Subject|0|||
33162665|NCT01281865|100508032|FG000|Overall Study|Lack of Efficacy|1|||
33162666|NCT01281865|100508033|FG001|Overall Study|Lack of Efficacy|0|||
33162667|NCT00726986|100508034|FG000|Induction Phase|Adverse Event|4|||
33162668|NCT00726986|100508034|FG000|Induction Phase|Withdrawal by Subject|2|||
33162669|NCT00726986|100508034|FG000|Induction Phase|Death|2|||
33162670|NCT00726986|100508034|FG000|Induction Phase|Lack of Efficacy|5|||
33162671|NCT00726986|100508034|FG000|Induction Phase|Secondary Disease|2|||
33162672|NCT00726986|100508034|FG000|Maintenance Phase|Adverse Event|1|||
33162673|NCT00726986|100508034|FG000|Maintenance Phase|Lack of Efficacy|2|||
33162674|NCT01201850|100508038|FG000|Overall Study|Tumor progression|4|||
33162675|NCT01876420|100508039|FG000|Overall Study|Missed 30 day visit|1|||
33162676|NCT02742441|100508043|FG000|Overall Study|Lost to Follow-up|4|||
33162677|NCT02742441|100508044|FG001|Overall Study|Lost to Follow-up|4|||
33162678|NCT02742441|100508043|FG000|Overall Study|Withdrawal by Subject|2|||
33162679|NCT02742441|100508044|FG001|Overall Study|Withdrawal by Subject|2|||
33162680|NCT02742441|100508043|FG000|Overall Study|Adverse Event|0|||
33162681|NCT02742441|100508044|FG001|Overall Study|Adverse Event|2|||
33162682|NCT00481078|100508045|FG000|Overall Study|Progression of disease|11|||
33162683|NCT00481078|100508046|FG001|Overall Study|Progression of disease|11|||
33162684|NCT00481078|100508045|FG000|Overall Study|Adverse Event|15|||
33162685|NCT00481078|100508046|FG001|Overall Study|Adverse Event|3|||
33162686|NCT00481078|100508045|FG000|Overall Study|Death|5|||
33162687|NCT00481078|100508046|FG001|Overall Study|Death|3|||
33162688|NCT00481078|100508045|FG000|Overall Study|Intercurrent illness|1|||
33162689|NCT00481078|100508046|FG001|Overall Study|Intercurrent illness|0|||
33162690|NCT00481078|100508045|FG000|Overall Study|Withdrawal by Subject|7|||
33162691|NCT00481078|100508046|FG001|Overall Study|Withdrawal by Subject|1|||
33162692|NCT00481078|100508045|FG000|Overall Study|Information not available|1|||
33162693|NCT00481078|100508046|FG001|Overall Study|Information not available|0|||
33162694|NCT00481078|100508045|FG000|Overall Study|Received other treatment|2|||
33162695|NCT00481078|100508046|FG001|Overall Study|Received other treatment|1|||
33162696|NCT00481078|100508045|FG000|Overall Study|Brain metastasis|0|||
33162697|NCT00481078|100508046|FG001|Overall Study|Brain metastasis|1|||
33162698|NCT01744197|100508048|FG000|Overall Study|Received 1 patch|2|||
33162699|NCT01744197|100508049|FG001|Overall Study|Received 1 patch|1|||
33162700|NCT01744197|100508048|FG000|Overall Study|No patch received|2|||
33162701|NCT01744197|100508049|FG001|Overall Study|No patch received|2|||
33162702|NCT01539538|100508050|FG000|Overall Study|Adverse Event|13|||
33162703|NCT01539538|100508051|FG001|Overall Study|Adverse Event|18|||
33162704|NCT01539538|100508050|FG000|Overall Study|Lack of Efficacy|13|||
33162705|NCT01539538|100508051|FG001|Overall Study|Lack of Efficacy|16|||
33162706|NCT01539538|100508050|FG000|Overall Study|Withdrawal by Subject|2|||
33162707|NCT01539538|100508051|FG001|Overall Study|Withdrawal by Subject|3|||
33162708|NCT01539538|100508050|FG000|Overall Study|PCA no longer required or PCA problem|3|||
33162709|NCT01539538|100508051|FG001|Overall Study|PCA no longer required or PCA problem|7|||
33162710|NCT03322631|100508052|FG000|Overall Study|Withdrawal by Subject|0|||
33162711|NCT03322631|100508053|FG001|Overall Study|Withdrawal by Subject|1|||
33162712|NCT03322631|100508054|FG002|Overall Study|Withdrawal by Subject|0|||
33162713|NCT03322631|100508055|FG003|Overall Study|Withdrawal by Subject|0|||
33162714|NCT03322631|100508052|FG000|Overall Study|Adverse Event|0|||
33162715|NCT03322631|100508053|FG001|Overall Study|Adverse Event|0|||
33162716|NCT03322631|100508054|FG002|Overall Study|Adverse Event|1|||
33162717|NCT03322631|100508055|FG003|Overall Study|Adverse Event|0|||
33162718|NCT02969369|100508056|FG000|Study|Adverse Event|1|||
33162719|NCT02969369|100508057|FG001|Study|Adverse Event|6|||
33162720|NCT02969369|100508056|FG000|Study|Lack of Efficacy|0|||
33162721|NCT02969369|100508057|FG001|Study|Lack of Efficacy|1|||
33162722|NCT02969369|100508056|FG000|Study|Lost to Follow-up|0|||
33162723|NCT02969369|100508057|FG001|Study|Lost to Follow-up|1|||
33162724|NCT02969369|100508056|FG000|Study|Withdrawal by Subject|3|||
33162725|NCT02969369|100508057|FG001|Study|Withdrawal by Subject|5|||
33162726|NCT02969369|100508056|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
33162727|NCT02969369|100508057|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
33162728|NCT02969369|100508056|FG000|Double-blind Period|Adverse Event|1|||
33162729|NCT02969369|100508057|FG001|Double-blind Period|Adverse Event|5|||
33162730|NCT02969369|100508056|FG000|Double-blind Period|Lost to Follow-up|0|||
33162731|NCT02969369|100508057|FG001|Double-blind Period|Lost to Follow-up|1|||
33162732|NCT02969369|100508056|FG000|Double-blind Period|Withdrawal by Subject|2|||
33162733|NCT02969369|100508057|FG001|Double-blind Period|Withdrawal by Subject|3|||
33162734|NCT02969369|100508056|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
33162735|NCT02969369|100508057|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
33162736|NCT02969369|100508056|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
33162737|NCT02969369|100508057|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
33162738|NCT02969369|100508056|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
33162739|NCT02969369|100508057|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
33162740|NCT02969369|100508056|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
33162741|NCT02969369|100508057|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
33162742|NCT01427972|100508058|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33162743|NCT01427972|100508059|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33162744|NCT01427972|100508060|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33162745|NCT01427972|100508061|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33162746|NCT01427972|100508062|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33162747|NCT01427972|100508063|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33162748|NCT01427972|100508064|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33162749|NCT01427972|100508065|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
33162750|NCT01427972|100508066|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33162751|NCT01427972|100508067|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33162752|NCT01427972|100508068|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33162753|NCT01427972|100508069|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
33162754|NCT01427972|100508058|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33162755|NCT01427972|100508059|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33162756|NCT01427972|100508060|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33162757|NCT01427972|100508061|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33162758|NCT01427972|100508062|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33162759|NCT01427972|100508063|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
33162760|NCT01427972|100508064|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33162761|NCT01427972|100508065|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33162762|NCT01427972|100508066|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33162763|NCT01427972|100508067|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33162764|NCT01427972|100508068|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33162765|NCT01427972|100508069|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
33162766|NCT01427972|100508058|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33162767|NCT01427972|100508059|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
33162768|NCT01427972|100508060|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33162769|NCT01427972|100508061|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33162770|NCT01427972|100508062|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33162771|NCT01427972|100508063|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33162772|NCT01427972|100508064|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33162773|NCT01427972|100508065|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33162774|NCT01427972|100508066|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33162775|NCT01427972|100508067|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33162776|NCT01427972|100508068|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33162777|NCT01427972|100508069|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
33162778|NCT01325584|100508072|FG000|Overall Study|Death|1|||
33162779|NCT01845831|100508073|FG000|Inpatient Phase|Withdrawal by Subject|1|||
33162780|NCT01845831|100508074|FG001|Inpatient Phase|Withdrawal by Subject|1|||
33162781|NCT01845831|100508075|FG002|Inpatient Phase|Withdrawal by Subject|0|||
33162782|NCT01845831|100508076|FG003|Inpatient Phase|Withdrawal by Subject|0|||
33162783|NCT01845831|100508077|FG004|Inpatient Phase|Withdrawal by Subject|0|||
33162784|NCT04545060|100508078|FG000|Overall Study|Adverse Event|0|||
33162785|NCT04545060|100508079|FG001|Overall Study|Adverse Event|1|||
33162786|NCT04545060|100508078|FG000|Overall Study|Death|0|||
33162787|NCT04545060|100508079|FG001|Overall Study|Death|5|||
33162788|NCT04545060|100508078|FG000|Overall Study|Lost to Follow-up|10|||
33162789|NCT04545060|100508079|FG001|Overall Study|Lost to Follow-up|13|||
33162790|NCT04545060|100508078|FG000|Overall Study|Physician Decision|3|||
33162791|NCT04545060|100508079|FG001|Overall Study|Physician Decision|0|||
33162792|NCT04545060|100508078|FG000|Overall Study|Withdrawal by Subject|17|||
33162793|NCT04545060|100508079|FG001|Overall Study|Withdrawal by Subject|22|||
33162794|NCT03329573|100508082|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
33162795|NCT03329573|100508083|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
33162796|NCT03329573|100508084|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
33162797|NCT03329573|100508085|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
33162798|NCT03329573|100508082|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
33162799|NCT03329573|100508083|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
33162800|NCT03329573|100508084|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33162801|NCT03329573|100508085|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
33162802|NCT03329573|100508082|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
33162803|NCT03329573|100508083|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
33162804|NCT03329573|100508084|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
33162805|NCT03329573|100508085|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
33162806|NCT03329573|100508082|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
33162807|NCT03329573|100508083|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
33162808|NCT03329573|100508084|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
33162809|NCT03329573|100508085|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
33162810|NCT02985957|100508088|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33162811|NCT02985957|100508089|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33162812|NCT02985957|100508090|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33257021|NCT03887650|100842611|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
33257022|NCT03887650|100842612|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
33443473|NCT01518972|101518841|FG001|Overall Study|Exclusionary medical condition|0|||
33443474|NCT01518972|101518840|FG000|Overall Study|Missed safety visits|0|||
33443475|NCT01518972|101518841|FG001|Overall Study|Missed safety visits|1|||
33162813|NCT02985957|100508091|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33162814|NCT02985957|100508092|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
33257023|NCT03887650|100842611|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
33162815|NCT02985957|100508093|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33162816|NCT02985957|100508094|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33162817|NCT02985957|100508088|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
33162818|NCT02985957|100508089|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
33162819|NCT02985957|100508090|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
33162820|NCT02985957|100508091|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
33162821|NCT02985957|100508092|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
33162822|NCT02985957|100508093|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
33162823|NCT02985957|100508094|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
33162824|NCT02985957|100508088|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33162825|NCT02985957|100508089|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33162826|NCT02985957|100508090|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33162827|NCT02985957|100508091|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33162828|NCT02985957|100508092|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33162829|NCT02985957|100508093|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
33162830|NCT02985957|100508094|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
33162831|NCT02985957|100508088|FG000|Treatment Period|Death|0|||
33162832|NCT02985957|100508089|FG001|Treatment Period|Death|0|||
33162833|NCT02985957|100508090|FG002|Treatment Period|Death|0|||
33162834|NCT02985957|100508091|FG003|Treatment Period|Death|0|||
33162835|NCT02985957|100508092|FG004|Treatment Period|Death|1|||
33162836|NCT02985957|100508093|FG005|Treatment Period|Death|0|||
33162837|NCT02985957|100508094|FG006|Treatment Period|Death|0|||
33162838|NCT02985957|100508088|FG000|Treatment Period|Participant withdrew consent|0|||
33162839|NCT02985957|100508089|FG001|Treatment Period|Participant withdrew consent|0|||
33162840|NCT02985957|100508090|FG002|Treatment Period|Participant withdrew consent|0|||
33162841|NCT02985957|100508091|FG003|Treatment Period|Participant withdrew consent|1|||
33162842|NCT02985957|100508092|FG004|Treatment Period|Participant withdrew consent|3|||
33162843|NCT02985957|100508093|FG005|Treatment Period|Participant withdrew consent|0|||
33162844|NCT02985957|100508094|FG006|Treatment Period|Participant withdrew consent|1|||
33162845|NCT02985957|100508088|FG000|Treatment Period|Lost to Follow-up|0|||
33162846|NCT02985957|100508089|FG001|Treatment Period|Lost to Follow-up|0|||
33162847|NCT02985957|100508090|FG002|Treatment Period|Lost to Follow-up|0|||
33443476|NCT01518972|101518840|FG000|Overall Study|Exclusionary medication|0|||
33162848|NCT02985957|100508091|FG003|Treatment Period|Lost to Follow-up|0|||
33162849|NCT02985957|100508092|FG004|Treatment Period|Lost to Follow-up|1|||
33162850|NCT02985957|100508093|FG005|Treatment Period|Lost to Follow-up|0|||
33162851|NCT02985957|100508094|FG006|Treatment Period|Lost to Follow-up|0|||
33162852|NCT02985957|100508088|FG000|Treatment Period|Other reasons|0|||
33162853|NCT02985957|100508089|FG001|Treatment Period|Other reasons|0|||
33162854|NCT02985957|100508090|FG002|Treatment Period|Other reasons|1|||
33162855|NCT02985957|100508091|FG003|Treatment Period|Other reasons|3|||
33162856|NCT02985957|100508092|FG004|Treatment Period|Other reasons|6|||
33162857|NCT02985957|100508093|FG005|Treatment Period|Other reasons|0|||
33162858|NCT02985957|100508094|FG006|Treatment Period|Other reasons|1|||
33162859|NCT02985957|100508088|FG000|Treatment Period|Not reported|0|||
33162860|NCT02985957|100508089|FG001|Treatment Period|Not reported|1|||
33162861|NCT02985957|100508090|FG002|Treatment Period|Not reported|2|||
33443477|NCT01518972|101518841|FG001|Overall Study|Exclusionary medication|1|||
33443478|NCT01518972|101518840|FG000|Overall Study|Declined medication starting on day 12|0|||
33443479|NCT01518972|101518841|FG001|Overall Study|Declined medication starting on day 12|1|||
33443480|NCT01841554|101518848|FG000|Overall Study|Death|7|||
33443481|NCT01841554|101518848|FG000|Overall Study|No Implantation|1|||
33443482|NCT01841554|101518848|FG000|Overall Study|Discontinued Follow Up|5|||
33443483|NCT01841554|101518848|FG000|Overall Study|Study exit due to secondary intervention|6|||
33443484|NCT00473330|101518849|FG000|Core Study|Adverse Event|4|||
33443485|NCT00473330|101518850|FG001|Core Study|Adverse Event|4|||
33443486|NCT00473330|101518851|FG002|Core Study|Adverse Event|1|||
33443487|NCT00473330|101518849|FG000|Core Study|Death|6|||
33443488|NCT00473330|101518850|FG001|Core Study|Death|4|||
33443489|NCT00473330|101518851|FG002|Core Study|Death|4|||
33443490|NCT00473330|101518849|FG000|Core Study|Lost to Follow-up|5|||
33443491|NCT00473330|101518850|FG001|Core Study|Lost to Follow-up|5|||
33443492|NCT00473330|101518851|FG002|Core Study|Lost to Follow-up|10|||
33443493|NCT00473330|101518849|FG000|Core Study|Physician Decision|2|||
33443494|NCT00473330|101518850|FG001|Core Study|Physician Decision|1|||
33443495|NCT00473330|101518851|FG002|Core Study|Physician Decision|3|||
33443496|NCT00473330|101518849|FG000|Core Study|Subject Non-compliance|1|||
33443497|NCT00473330|101518850|FG001|Core Study|Subject Non-compliance|2|||
33443498|NCT00473330|101518851|FG002|Core Study|Subject Non-compliance|1|||
33443499|NCT00473330|101518849|FG000|Core Study|Subject Required Other Therapy|0|||
33443500|NCT00473330|101518850|FG001|Core Study|Subject Required Other Therapy|1|||
33443501|NCT00473330|101518851|FG002|Core Study|Subject Required Other Therapy|3|||
33443502|NCT00473330|101518849|FG000|Core Study|Subject's Decision|9|||
33162862|NCT02985957|100508091|FG003|Treatment Period|Not reported|5|||
33162863|NCT02985957|100508092|FG004|Treatment Period|Not reported|0|||
33257024|NCT03887650|100842612|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
33257025|NCT03887650|100842611|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
33257026|NCT03887650|100842612|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
33257027|NCT00150176|100842614|FG000|Overall Study|Adverse Event|16|||
33257028|NCT00150176|100842615|FG001|Overall Study|Adverse Event|53|||
33257029|NCT00150176|100842614|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
33257030|NCT00150176|100842615|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
33257031|NCT00150176|100842614|FG000|Overall Study|Withdrawal by Subject|19|||
33443503|NCT00473330|101518850|FG001|Core Study|Subject's Decision|8|||
33443504|NCT00473330|101518851|FG002|Core Study|Subject's Decision|19|||
33443505|NCT00473330|101518849|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
33443506|NCT00473330|101518850|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
33443507|NCT00473330|101518851|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
33443508|NCT00473330|101518849|FG000|Open-label Extension Through Month 48|Death|2|||
33443509|NCT00473330|101518850|FG001|Open-label Extension Through Month 48|Death|0|||
33443510|NCT00473330|101518851|FG002|Open-label Extension Through Month 48|Death|0|||
33443511|NCT00473330|101518849|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
33443512|NCT00473330|101518850|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
33443513|NCT00473330|101518851|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
33443514|NCT00473330|101518849|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
33443515|NCT00473330|101518850|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
33443516|NCT00473330|101518851|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
33443517|NCT00473330|101518849|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
33443518|NCT00473330|101518850|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
33443519|NCT00473330|101518851|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
33443520|NCT00473330|101518849|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
33443521|NCT00473330|101518850|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
33443522|NCT00473330|101518851|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
33257032|NCT00150176|100842615|FG001|Overall Study|Withdrawal by Subject|12|||
33257033|NCT00150176|100842614|FG000|Overall Study|Lost to Follow-up|3|||
33257034|NCT00150176|100842615|FG001|Overall Study|Lost to Follow-up|3|||
33257035|NCT00150176|100842614|FG000|Overall Study|OTHER|11|||
33257036|NCT00150176|100842615|FG001|Overall Study|OTHER|13|||
33257037|NCT03454529|100842616|FG000|Overall Study|Did not receive treatment|6|||
33257038|NCT03454529|100842616|FG000|Overall Study|Received < 80% doses|1|||
33257039|NCT01460446|100842618|FG000|Overall Study|Non-compliance|2|||
33257040|NCT01460446|100842619|FG001|Overall Study|Non-compliance|9|||
33257041|NCT01460446|100842618|FG000|Overall Study|Consent Withdrawn|0|||
33257042|NCT01460446|100842619|FG001|Overall Study|Consent Withdrawn|4|||
33257043|NCT01460446|100842618|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
33257044|NCT01460446|100842619|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
33257045|NCT01460446|100842618|FG000|Overall Study|Surgery/Illness|1|||
33257046|NCT01460446|100842619|FG001|Overall Study|Surgery/Illness|1|||
33257047|NCT01460446|100842618|FG000|Overall Study|Pregnancy|1|||
33257048|NCT01460446|100842619|FG001|Overall Study|Pregnancy|0|||
33257049|NCT01460446|100842618|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
33257050|NCT01460446|100842619|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
33257051|NCT03703336|100842621|FG000|Overall Study|Parent withdrew consent|29|||
33257052|NCT03703336|100842622|FG001|Overall Study|Parent withdrew consent|8|||
33257053|NCT03703336|100842621|FG000|Overall Study|Migration|3|||
33257054|NCT03703336|100842622|FG001|Overall Study|Migration|3|||
33257055|NCT03703336|100842621|FG000|Overall Study|Protocol Violation|3|||
33257056|NCT03703336|100842622|FG001|Overall Study|Protocol Violation|1|||
33257057|NCT03703336|100842621|FG000|Overall Study|Physician Decision|2|||
33257058|NCT03703336|100842622|FG001|Overall Study|Physician Decision|0|||
33257059|NCT03703336|100842621|FG000|Overall Study|Adverse Event|0|||
33257060|NCT03703336|100842622|FG001|Overall Study|Adverse Event|2|||
33257061|NCT03703336|100842621|FG000|Overall Study|Lost to Follow-up|1|||
33257062|NCT03703336|100842622|FG001|Overall Study|Lost to Follow-up|0|||
33257063|NCT00002842|100842627|FG000|Overall Study|ineligible for surgical resection|27|||
33257064|NCT02383472|100842632|FG000|Overall Study|Withdrawal by Subject|1|||
33257065|NCT02383472|100842633|FG001|Overall Study|Withdrawal by Subject|1|||
33257066|NCT01061671|100842634|FG000|Overall Study|Withdrawal by Subject|16|||
33257067|NCT01061671|100842635|FG001|Overall Study|Withdrawal by Subject|20|||
33257068|NCT01061671|100842634|FG000|Overall Study|Lost to Follow-up|3|||
33257069|NCT01061671|100842635|FG001|Overall Study|Lost to Follow-up|5|||
33257070|NCT01061671|100842634|FG000|Overall Study|Death|28|||
33257071|NCT01061671|100842635|FG001|Overall Study|Death|30|||
33257072|NCT01068743|100842636|FG000|Period 3|Adverse Event|0|||
33257073|NCT01068743|100842637|FG001|Period 3|Adverse Event|1|||
33257074|NCT01068743|100842638|FG002|Period 3|Adverse Event|0|||
33257075|NCT01068743|100842639|FG003|Period 3|Adverse Event|0|||
33257076|NCT01565148|100842640|FG000|Overall Study|Withdrawal by Subject|1|||
33257077|NCT01565148|100842641|FG001|Overall Study|Withdrawal by Subject|1|||
33257078|NCT01565148|100842642|FG002|Overall Study|Withdrawal by Subject|1|||
33257079|NCT01565148|100842643|FG003|Overall Study|Withdrawal by Subject|2|||
33257080|NCT01565148|100842640|FG000|Overall Study|Lost to Follow-up|4|||
33257081|NCT01565148|100842641|FG001|Overall Study|Lost to Follow-up|4|||
33257082|NCT01565148|100842642|FG002|Overall Study|Lost to Follow-up|0|||
33257083|NCT01565148|100842643|FG003|Overall Study|Lost to Follow-up|3|||
33257084|NCT01565148|100842640|FG000|Overall Study|Rescue Therapy|8|||
33257085|NCT01565148|100842641|FG001|Overall Study|Rescue Therapy|5|||
33443523|NCT00473330|101518849|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
33443524|NCT00473330|101518850|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
33443525|NCT00473330|101518851|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
33443526|NCT00473330|101518849|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
33443527|NCT00473330|101518850|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
33443528|NCT00473330|101518851|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
33443529|NCT00473330|101518849|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
33443530|NCT00473330|101518850|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
33443531|NCT00473330|101518851|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
33443532|NCT00473330|101518849|FG000|Open-label Extension Through Month 60|Death|2|||
33443533|NCT00473330|101518850|FG001|Open-label Extension Through Month 60|Death|2|||
33443534|NCT00473330|101518851|FG002|Open-label Extension Through Month 60|Death|1|||
33443535|NCT00473330|101518849|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
33257086|NCT01565148|100842642|FG002|Overall Study|Rescue Therapy|5|||
33257087|NCT01565148|100842643|FG003|Overall Study|Rescue Therapy|8|||
33257088|NCT01565148|100842640|FG000|Overall Study|Death|0|||
33257089|NCT01565148|100842641|FG001|Overall Study|Death|0|||
33257090|NCT01565148|100842642|FG002|Overall Study|Death|1|||
33257091|NCT01565148|100842643|FG003|Overall Study|Death|0|||
33257092|NCT01565148|100842640|FG000|Overall Study|Physician Decision|2|||
33257093|NCT01565148|100842641|FG001|Overall Study|Physician Decision|5|||
33257094|NCT01565148|100842642|FG002|Overall Study|Physician Decision|0|||
33257095|NCT01565148|100842643|FG003|Overall Study|Physician Decision|0|||
33257096|NCT00309907|100842644|FG000|Overall Study|Death|4|||
33257097|NCT00309907|100842644|FG000|Overall Study|Physician Decision|1|||
33257098|NCT00309907|100842644|FG000|Overall Study|Ineligible|11|||
33257099|NCT00309907|100842644|FG000|Overall Study|Major infectious event|4|||
33257100|NCT01198275|100842647|FG000|Overall Study|Adverse Event|2|||
33257101|NCT01198275|100842648|FG001|Overall Study|Adverse Event|3|||
33257102|NCT01198275|100842647|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
33257103|NCT01198275|100842648|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
33257104|NCT00332241|100842649|FG000|Overall Study|Lack of Efficacy|6|||
33257105|NCT00332241|100842650|FG001|Overall Study|Lack of Efficacy|1|||
33257106|NCT00332241|100842649|FG000|Overall Study|Adverse Event|3|||
33162864|NCT02985957|100508093|FG005|Treatment Period|Not reported|0|||
33162865|NCT02985957|100508094|FG006|Treatment Period|Not reported|0|||
33162866|NCT02985957|100508088|FG000|Treatment Period|Maximum clinical benefit|0|||
33162867|NCT02985957|100508089|FG001|Treatment Period|Maximum clinical benefit|0|||
33162868|NCT02985957|100508090|FG002|Treatment Period|Maximum clinical benefit|1|||
33162869|NCT02985957|100508091|FG003|Treatment Period|Maximum clinical benefit|1|||
33162870|NCT02985957|100508092|FG004|Treatment Period|Maximum clinical benefit|0|||
33162871|NCT02985957|100508093|FG005|Treatment Period|Maximum clinical benefit|0|||
33162872|NCT02985957|100508094|FG006|Treatment Period|Maximum clinical benefit|2|||
33162873|NCT02985957|100508088|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
33162874|NCT02985957|100508089|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
33162875|NCT02985957|100508090|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
33162876|NCT02985957|100508091|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
33162877|NCT02985957|100508092|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
33162878|NCT02985957|100508093|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
33162879|NCT02985957|100508094|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
33162880|NCT02985957|100508088|FG000|Treatment Period|Study drug toxicity|1|||
33162881|NCT02985957|100508089|FG001|Treatment Period|Study drug toxicity|23|||
33162882|NCT02985957|100508090|FG002|Treatment Period|Study drug toxicity|20|||
33257107|NCT00332241|100842650|FG001|Overall Study|Adverse Event|5|||
33257108|NCT00332241|100842649|FG000|Overall Study|Withdrawal by Subject|2|||
33257109|NCT00332241|100842650|FG001|Overall Study|Withdrawal by Subject|1|||
33257110|NCT00332241|100842649|FG000|Overall Study|Lost to Follow-up|4|||
33257111|NCT00332241|100842650|FG001|Overall Study|Lost to Follow-up|1|||
33257112|NCT03051165|100842651|FG000|Overall Study|Withdrawal by Subject|1|||
33257113|NCT03051165|100842651|FG000|Overall Study|Early termination of study|12|||
33257114|NCT00743444|100842656|FG000|First Intervention|Catheter placement problems|0|||
33443536|NCT00473330|101518850|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
33257115|NCT00743444|100842657|FG001|First Intervention|Catheter placement problems|1|||
33162883|NCT02985957|100508091|FG003|Treatment Period|Study drug toxicity|11|||
33162884|NCT02985957|100508092|FG004|Treatment Period|Study drug toxicity|19|||
33162885|NCT02985957|100508093|FG005|Treatment Period|Study drug toxicity|3|||
33162886|NCT02985957|100508094|FG006|Treatment Period|Study drug toxicity|5|||
33257116|NCT00743444|100842656|FG000|Washout Period|Adverse Event|0|||
33257117|NCT00743444|100842657|FG001|Washout Period|Adverse Event|1|||
33257118|NCT01084707|100842658|FG000|Overall Study|Withdrawal by Subject|6|||
33257119|NCT03069313|100842659|FG000|Overall Study|Adverse Event|5|||
33257120|NCT01641198|100842660|FG000|After 12 Months of Function|Lost to Follow-up|3|||
33257121|NCT01641198|100842661|FG001|After 12 Months of Function|Lost to Follow-up|2|||
33257122|NCT01641198|100842662|FG002|After 12 Months of Function|Lost to Follow-up|2|||
33257123|NCT01641198|100842660|FG000|After 12 Months of Function|Protocol Violation|1|||
33257124|NCT01641198|100842661|FG001|After 12 Months of Function|Protocol Violation|0|||
33443537|NCT00473330|101518851|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
33443538|NCT00473330|101518849|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
33443539|NCT00473330|101518850|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
33443540|NCT00473330|101518851|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
33443541|NCT00473330|101518849|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
33443542|NCT00473330|101518850|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
33443543|NCT00473330|101518851|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
33443544|NCT00473330|101518849|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
33443545|NCT00473330|101518850|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
33443546|NCT00473330|101518851|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
33443547|NCT00473330|101518849|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
33443548|NCT00473330|101518850|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
33443549|NCT00473330|101518851|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
33257125|NCT01641198|100842662|FG002|After 12 Months of Function|Protocol Violation|0|||
33162887|NCT02985957|100508088|FG000|Treatment Period|Disease progression|0|||
33257126|NCT01641198|100842660|FG000|After 12 Months of Function|Adverse Event|0|||
33257127|NCT01641198|100842661|FG001|After 12 Months of Function|Adverse Event|1|||
33257128|NCT01641198|100842662|FG002|After 12 Months of Function|Adverse Event|0|||
33257129|NCT01641198|100842660|FG000|After 24 Months of Function|Lost to Follow-up|4|||
33257130|NCT01641198|100842661|FG001|After 24 Months of Function|Lost to Follow-up|9|||
33257131|NCT01641198|100842662|FG002|After 24 Months of Function|Lost to Follow-up|6|||
33257132|NCT01641198|100842660|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
33257133|NCT01641198|100842661|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
33257134|NCT01641198|100842662|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
33257135|NCT01641198|100842660|FG000|At 15-20 Years of Function|Death|1|||
33257136|NCT01641198|100842661|FG001|At 15-20 Years of Function|Death|0|||
33257137|NCT01641198|100842662|FG002|At 15-20 Years of Function|Death|1|||
33257138|NCT01499199|100842663|FG000|Overall Study|Adverse Event|1|||
33257139|NCT01499199|100842663|FG000|Overall Study|Lack of Efficacy|1|||
33257140|NCT03175172|100842666|FG000|Overall Study|Death|3|||
33257141|NCT03175172|100842666|FG000|Overall Study|Withdrawal by Subject|3|||
33257142|NCT03175172|100842666|FG000|Overall Study|Lost to Follow-up|1|||
33257143|NCT03175172|100842666|FG000|Overall Study|Study Terminated by Sponsor|3|||
33257144|NCT00761605|100842672|FG000|Overall Study|Adverse Event|26|||
33257145|NCT00761605|100842672|FG000|Overall Study|Death|2|||
33257146|NCT00761605|100842672|FG000|Overall Study|Lack of Efficacy|26|||
33257147|NCT00761605|100842672|FG000|Overall Study|Lost to Follow-up|29|||
33257148|NCT00761605|100842672|FG000|Overall Study|Withdrawal by Subject|37|||
33257149|NCT00761605|100842672|FG000|Overall Study|Other|21|||
33257150|NCT00482729|100842673|FG000|Overall Study|Adverse Event|29|||
33257151|NCT00482729|100842674|FG001|Overall Study|Adverse Event|33|||
33257152|NCT00482729|100842673|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
33257153|NCT00482729|100842674|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
33257154|NCT00482729|100842673|FG000|Overall Study|Hyperglycemia Criteria|7|||
33257155|NCT00482729|100842674|FG001|Overall Study|Hyperglycemia Criteria|5|||
33257156|NCT00482729|100842673|FG000|Overall Study|Lack of Efficacy|4|||
33257157|NCT00482729|100842674|FG001|Overall Study|Lack of Efficacy|16|||
33257158|NCT00482729|100842673|FG000|Overall Study|Lost to Follow-up|86|||
33257159|NCT00482729|100842674|FG001|Overall Study|Lost to Follow-up|66|||
33443550|NCT00473330|101518849|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
33443551|NCT00473330|101518850|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
33443552|NCT00473330|101518851|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
33443553|NCT00837486|101518854|FG000|Blinded-treatment Phase|Physician Decision|1|||
33443554|NCT00837486|101518855|FG001|Blinded-treatment Phase|Physician Decision|0|||
33257160|NCT00482729|100842673|FG000|Overall Study|Physician Decision|10|||
33257161|NCT00482729|100842674|FG001|Overall Study|Physician Decision|7|||
33257162|NCT00482729|100842673|FG000|Overall Study|Pregnancy|4|||
33257163|NCT00482729|100842674|FG001|Overall Study|Pregnancy|2|||
33257164|NCT00482729|100842673|FG000|Overall Study|Protocol Violation|10|||
33257165|NCT00482729|100842674|FG001|Overall Study|Protocol Violation|18|||
33257166|NCT00482729|100842673|FG000|Overall Study|Withdrawal by Subject|67|||
33257167|NCT00482729|100842674|FG001|Overall Study|Withdrawal by Subject|69|||
33257168|NCT02272816|100842675|FG000|Overall Study|Adverse Event|1|||
33257169|NCT02538107|100842676|FG000|Overall Study|Did not receive any Mircera dose|11|||
33257170|NCT02538107|100842676|FG000|Overall Study|Missing|5|||
33257171|NCT02538107|100842676|FG000|Overall Study|Necessity of dialysis|20|||
33257172|NCT02538107|100842676|FG000|Overall Study|Administration of other ESA|11|||
33257173|NCT02538107|100842676|FG000|Overall Study|No further treatment necessary|18|||
33257174|NCT02538107|100842676|FG000|Overall Study|Withdrawal by Subject|17|||
33257175|NCT02538107|100842676|FG000|Overall Study|Death|4|||
33257176|NCT02538107|100842676|FG000|Overall Study|Administrative reason|5|||
33257177|NCT02538107|100842676|FG000|Overall Study|Adverse Event|4|||
33257178|NCT02538107|100842676|FG000|Overall Study|Surgery|1|||
33257179|NCT02538107|100842676|FG000|Overall Study|Other|7|||
33257180|NCT02538107|100842676|FG000|Overall Study|Not recorded|7|||
33257181|NCT02015520|100842687|FG000|Overall Study|Lack of Efficacy|1|||
33257182|NCT02015520|100842688|FG001|Overall Study|Lack of Efficacy|0|||
33257183|NCT02015520|100842689|FG002|Overall Study|Lack of Efficacy|3|||
33257184|NCT02015520|100842690|FG003|Overall Study|Lack of Efficacy|2|||
33257185|NCT02015520|100842687|FG000|Overall Study|Adverse Event|0|||
33257186|NCT02015520|100842688|FG001|Overall Study|Adverse Event|0|||
33257187|NCT02015520|100842689|FG002|Overall Study|Adverse Event|0|||
33257188|NCT02015520|100842690|FG003|Overall Study|Adverse Event|1|||
33257189|NCT02015520|100842687|FG000|Overall Study|Withdrawal by Subject|2|||
33257190|NCT02015520|100842688|FG001|Overall Study|Withdrawal by Subject|2|||
33257191|NCT02015520|100842689|FG002|Overall Study|Withdrawal by Subject|1|||
33257192|NCT02015520|100842690|FG003|Overall Study|Withdrawal by Subject|0|||
33257193|NCT02015520|100842687|FG000|Overall Study|Death|1|||
33257194|NCT02015520|100842688|FG001|Overall Study|Death|0|||
33257195|NCT02015520|100842689|FG002|Overall Study|Death|0|||
33257196|NCT02015520|100842690|FG003|Overall Study|Death|0|||
33257197|NCT02015520|100842687|FG000|Overall Study|Lost to Follow-up|0|||
33257198|NCT02015520|100842688|FG001|Overall Study|Lost to Follow-up|0|||
33257199|NCT02015520|100842689|FG002|Overall Study|Lost to Follow-up|1|||
33257200|NCT02015520|100842690|FG003|Overall Study|Lost to Follow-up|0|||
33257201|NCT02015520|100842687|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
33257202|NCT02015520|100842688|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
33257203|NCT02015520|100842689|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
33257204|NCT02015520|100842690|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
33257205|NCT02015520|100842687|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
33257206|NCT02015520|100842688|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
33443555|NCT00837486|101518854|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
33257207|NCT02015520|100842689|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
33257208|NCT02015520|100842690|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
33257209|NCT01771731|100842693|FG000|Overall Study|Physician Decision|1|||
33257210|NCT01771731|100842694|FG001|Overall Study|Physician Decision|0|||
33257211|NCT01771731|100842693|FG000|Overall Study|Protocol Violation|0|||
33257212|NCT01771731|100842694|FG001|Overall Study|Protocol Violation|1|||
33443556|NCT00837486|101518855|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
33257213|NCT01771731|100842693|FG000|Overall Study|Adverse event: Pain Crisis|1|||
33257214|NCT01771731|100842694|FG001|Overall Study|Adverse event: Pain Crisis|1|||
33257215|NCT04867902|100842695|FG000|Overall Study|Lost to Follow-up|1|||
33257216|NCT04867902|100842695|FG000|Overall Study|Withdrawal by Subject|2|||
33257217|NCT04867902|100842695|FG000|Overall Study|Protocol Violation|1|||
33257218|NCT01976312|100842696|FG000|Overall Study|Pregnancy|0|||
33257219|NCT01976312|100842697|FG001|Overall Study|Pregnancy|1|||
33257220|NCT01976312|100842696|FG000|Overall Study|Lost to Follow-up|2|||
33257221|NCT01976312|100842697|FG001|Overall Study|Lost to Follow-up|0|||
33257222|NCT01976312|100842696|FG000|Overall Study|Withdrawal by Subject|7|||
33257223|NCT01976312|100842697|FG001|Overall Study|Withdrawal by Subject|2|||
33257224|NCT01976312|100842696|FG000|Overall Study|Adverse Event|6|||
33257225|NCT01976312|100842697|FG001|Overall Study|Adverse Event|6|||
33257226|NCT01976312|100842696|FG000|Overall Study|Protocol Violation|2|||
33257227|NCT01976312|100842697|FG001|Overall Study|Protocol Violation|0|||
33257228|NCT04218110|100842700|FG000|Overall Study|Withdrawal by Subject|0|||
33257229|NCT04218110|100842701|FG001|Overall Study|Withdrawal by Subject|0|||
33257230|NCT04218110|100842702|FG002|Overall Study|Withdrawal by Subject|0|||
33257231|NCT04218110|100842703|FG003|Overall Study|Withdrawal by Subject|1|||
33257232|NCT04732338|100842704|FG000|Overall Study|Lost to Follow-up|3|||
33257233|NCT04732338|100842705|FG001|Overall Study|Lost to Follow-up|3|||
33257234|NCT02242487|100842706|FG000|Overall Study|Adverse Event|13|||
33257235|NCT02242487|100842707|FG001|Overall Study|Adverse Event|15|||
33257236|NCT02242487|100842706|FG000|Overall Study|Lack of Efficacy|4|||
33257237|NCT02242487|100842707|FG001|Overall Study|Lack of Efficacy|6|||
33257238|NCT02242487|100842706|FG000|Overall Study|Protocol Violation|2|||
33257239|NCT02242487|100842707|FG001|Overall Study|Protocol Violation|0|||
33257240|NCT02242487|100842706|FG000|Overall Study|Lost to Follow-up|2|||
33257241|NCT02242487|100842707|FG001|Overall Study|Lost to Follow-up|1|||
33257242|NCT02242487|100842706|FG000|Overall Study|Other - Miscellaneous|4|||
33257243|NCT02242487|100842707|FG001|Overall Study|Other - Miscellaneous|6|||
33257244|NCT02242487|100842706|FG000|Overall Study|Withdrawal by Subject|37|||
33257245|NCT02242487|100842707|FG001|Overall Study|Withdrawal by Subject|19|||
33257246|NCT00174382|100842708|FG000|Overall Study|Death|2|||
33257247|NCT00174382|100842708|FG000|Overall Study|Adverse Event|19|||
33257248|NCT00174382|100842708|FG000|Overall Study|Withdrawal by Subject|6|||
33257249|NCT00174382|100842708|FG000|Overall Study|Protocol Violation|3|||
33257250|NCT00174382|100842708|FG000|Overall Study|Arrived early for last visit in error|1|||
33257251|NCT00174382|100842708|FG000|Overall Study|Subject felt pill not effective enough|1|||
33443557|NCT00837486|101518854|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
33443558|NCT00837486|101518855|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
33443559|NCT00837486|101518854|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
33443560|NCT00837486|101518855|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
33443561|NCT01439880|101518856|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
33443562|NCT01439880|101518857|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
33443563|NCT01439880|101518856|FG000|SOC-controlled Period (Year 1)|Death|2|||
33443564|NCT01439880|101518857|FG001|SOC-controlled Period (Year 1)|Death|1|||
33443565|NCT01439880|101518856|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
33443566|NCT01439880|101518857|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
33257252|NCT00174382|100842708|FG000|Overall Study|Lost to Follow-up|1|||
33257253|NCT02423291|100842711|FG000|Overall Study|Lack of Efficacy|14|||
33257254|NCT02423291|100842711|FG000|Overall Study|Adverse Event|1|||
33257255|NCT03169244|100842712|FG000|Overall Study|Lost to Follow-up|1|||
33257256|NCT03169244|100842713|FG001|Overall Study|Lost to Follow-up|2|||
33257257|NCT03169244|100842712|FG000|Overall Study|Adverse Event|1|||
33257258|NCT03169244|100842713|FG001|Overall Study|Adverse Event|0|||
33443567|NCT01439880|101518856|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
33443568|NCT01439880|101518857|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
33443569|NCT01439880|101518856|FG000|SOC-controlled Period (Year 1)|Other|8|||
33443570|NCT01439880|101518857|FG001|SOC-controlled Period (Year 1)|Other|13|||
33443571|NCT01439880|101518856|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
33443572|NCT01439880|101518857|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
33443573|NCT01439880|101518856|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
33443574|NCT01439880|101518857|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
33443575|NCT01439880|101518856|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
33443576|NCT01439880|101518857|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
33443577|NCT01439880|101518856|FG000|All-IP Period (Years 2 to 5)|Death|3|||
33443578|NCT01439880|101518857|FG001|All-IP Period (Years 2 to 5)|Death|13|||
33257259|NCT03169244|100842712|FG000|Overall Study|Withdrawal by Subject|2|||
33257260|NCT03169244|100842713|FG001|Overall Study|Withdrawal by Subject|2|||
33257261|NCT03169244|100842712|FG000|Overall Study|Physician Decision|1|||
33257262|NCT03169244|100842713|FG001|Overall Study|Physician Decision|0|||
33257263|NCT01102231|100842714|FG000|Overall Study|Protocol Violation|3|||
33443579|NCT01439880|101518856|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
33443580|NCT01439880|101518857|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
33257264|NCT01102231|100842714|FG000|Overall Study|Lack of Efficacy|2|||
33257265|NCT01102231|100842714|FG000|Overall Study|Death|2|||
33257266|NCT01102231|100842714|FG000|Overall Study|Adverse Event|3|||
33162888|NCT02985957|100508089|FG001|Treatment Period|Disease progression|16|||
33162889|NCT02985957|100508090|FG002|Treatment Period|Disease progression|20|||
33257267|NCT01102231|100842714|FG000|Overall Study|Withdrawal by Subject|1|||
33257268|NCT01102231|100842714|FG000|Overall Study|Did not received the treatment|4|||
33257269|NCT01198028|100842717|FG000|Overall Study|Adverse Event|5|||
33257270|NCT01198028|100842717|FG000|Overall Study|Death|3|||
33257271|NCT01198028|100842717|FG000|Overall Study|Physician Decision|2|||
33443581|NCT01439880|101518856|FG000|All-IP Period (Years 2 to 5)|Other|14|||
33443582|NCT01439880|101518857|FG001|All-IP Period (Years 2 to 5)|Other|31|||
33443583|NCT01439880|101518856|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
33443584|NCT01439880|101518857|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
33443585|NCT03912337|101518861|FG000|Overall Study|Withdrawal of Consent From Study|1|||
33443586|NCT03912337|101518862|FG001|Overall Study|Withdrawal of Consent From Study|0|||
33443587|NCT03912337|101518861|FG000|Overall Study|Lost to Follow-up|1|||
33443588|NCT03912337|101518862|FG001|Overall Study|Lost to Follow-up|1|||
33443589|NCT03988803|101518869|FG000|Period 2|Prematurely discontinued from medication|2|||
33443590|NCT03988803|101518869|FG000|Period 2|Adverse Event|1|||
33443591|NCT02979522|101518876|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
33443592|NCT02979522|101518877|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
33443593|NCT02979522|101518876|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
33443594|NCT02979522|101518877|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
33443595|NCT02942264|101518879|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
33443596|NCT02942264|101518880|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
33443597|NCT02942264|101518881|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
33443598|NCT02942264|101518882|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
33443599|NCT02942264|101518883|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
33443600|NCT02942264|101518884|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
33443601|NCT02942264|101518885|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
33443602|NCT02942264|101518886|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
33443603|NCT02942264|101518887|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
33443604|NCT02942264|101518879|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33443605|NCT02942264|101518880|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33443606|NCT02942264|101518881|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33443607|NCT02942264|101518882|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33443608|NCT02942264|101518883|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33443609|NCT02942264|101518884|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33443610|NCT02942264|101518885|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33443611|NCT02942264|101518886|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
33443612|NCT02942264|101518887|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
33443613|NCT02682784|101518888|FG000|Overall Study|Withdrawal by Subject|0|||
33443614|NCT02682784|101518889|FG001|Overall Study|Withdrawal by Subject|2|||
33443615|NCT02682784|101518890|FG002|Overall Study|Withdrawal by Subject|1|||
33443616|NCT02682784|101518891|FG003|Overall Study|Withdrawal by Subject|2|||
33443617|NCT02682784|101518888|FG000|Overall Study|Physician Decision|1|||
33443618|NCT02682784|101518889|FG001|Overall Study|Physician Decision|0|||
33443619|NCT02682784|101518890|FG002|Overall Study|Physician Decision|1|||
33443620|NCT02682784|101518891|FG003|Overall Study|Physician Decision|1|||
33443621|NCT01629381|101518892|FG000|Overall Study|Withdrawal by Subject|2|||
33443622|NCT01629381|101518893|FG001|Overall Study|Withdrawal by Subject|5|||
33443623|NCT02453386|101518894|FG000|Overall Study|Adverse Event|22|||
33443624|NCT02453386|101518895|FG001|Overall Study|Adverse Event|30|||
33443625|NCT02453386|101518896|FG002|Overall Study|Adverse Event|15|||
33443626|NCT02453386|101518894|FG000|Overall Study|Protocol Violation|1|||
33443627|NCT02453386|101518895|FG001|Overall Study|Protocol Violation|0|||
33443628|NCT02453386|101518896|FG002|Overall Study|Protocol Violation|1|||
33443629|NCT02453386|101518894|FG000|Overall Study|Withdrawal by Subject|10|||
33443630|NCT02453386|101518895|FG001|Overall Study|Withdrawal by Subject|9|||
33443631|NCT02453386|101518896|FG002|Overall Study|Withdrawal by Subject|9|||
33443632|NCT02453386|101518894|FG000|Overall Study|Sponsor Terminated Study|14|||
33443633|NCT02453386|101518895|FG001|Overall Study|Sponsor Terminated Study|8|||
33443634|NCT02453386|101518896|FG002|Overall Study|Sponsor Terminated Study|11|||
33443635|NCT02453386|101518894|FG000|Overall Study|Subject Terminated by Sponsor|1|||
33443636|NCT02453386|101518895|FG001|Overall Study|Subject Terminated by Sponsor|1|||
33257272|NCT00296036|100842718|FG000|Overall Study|Withdrawal by Subject|1|||
33162890|NCT02985957|100508091|FG003|Treatment Period|Disease progression|39|||
33162891|NCT02985957|100508092|FG004|Treatment Period|Disease progression|29|||
33162892|NCT02985957|100508093|FG005|Treatment Period|Disease progression|11|||
33162893|NCT02985957|100508094|FG006|Treatment Period|Disease progression|28|||
33162894|NCT02985957|100508088|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
33162895|NCT02985957|100508089|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
33162896|NCT02985957|100508090|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
33443637|NCT02453386|101518896|FG002|Overall Study|Subject Terminated by Sponsor|1|||
33443638|NCT02453386|101518894|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
33443639|NCT02453386|101518895|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
33162897|NCT02985957|100508091|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
33162898|NCT02985957|100508092|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
33162899|NCT02985957|100508093|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
33162900|NCT02985957|100508094|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
33162901|NCT02985957|100508088|FG000|Treatment Period|Poor/Non-Compliance|0|||
33162902|NCT02985957|100508089|FG001|Treatment Period|Poor/Non-Compliance|0|||
33162903|NCT02985957|100508090|FG002|Treatment Period|Poor/Non-Compliance|0|||
33162904|NCT02985957|100508091|FG003|Treatment Period|Poor/Non-Compliance|0|||
33162905|NCT02985957|100508092|FG004|Treatment Period|Poor/Non-Compliance|1|||
33162906|NCT02985957|100508093|FG005|Treatment Period|Poor/Non-Compliance|1|||
33443640|NCT02453386|101518896|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
33162907|NCT02985957|100508094|FG006|Treatment Period|Poor/Non-Compliance|0|||
33162908|NCT02985957|100508088|FG000|Treatment Period|Continuing in Treatment Period|0|||
33162909|NCT02985957|100508089|FG001|Treatment Period|Continuing in Treatment Period|1|||
33162910|NCT02985957|100508090|FG002|Treatment Period|Continuing in Treatment Period|0|||
33162911|NCT02985957|100508091|FG003|Treatment Period|Continuing in Treatment Period|4|||
33162912|NCT02985957|100508092|FG004|Treatment Period|Continuing in Treatment Period|4|||
33162913|NCT02985957|100508093|FG005|Treatment Period|Continuing in Treatment Period|0|||
33162914|NCT02985957|100508094|FG006|Treatment Period|Continuing in Treatment Period|0|||
33257273|NCT00296036|100842719|FG001|Overall Study|Withdrawal by Subject|0|||
33443641|NCT02453386|101518894|FG000|Overall Study|Lost to Follow-up|0|||
33443642|NCT02453386|101518895|FG001|Overall Study|Lost to Follow-up|0|||
33443643|NCT02453386|101518896|FG002|Overall Study|Lost to Follow-up|1|||
33443644|NCT02453386|101518894|FG000|Overall Study|Other|1|||
33443645|NCT02453386|101518895|FG001|Overall Study|Other|0|||
33443646|NCT02453386|101518896|FG002|Overall Study|Other|1|||
33443647|NCT00316186|101518901|FG000|Overall Study|Adverse Event|6|||
33443648|NCT00316186|101518901|FG000|Overall Study|Disease Progression|4|||
33443649|NCT00316186|101518901|FG000|Overall Study|Lost to Follow-up|1|||
33443650|NCT00316186|101518901|FG000|Overall Study|Other|1|||
33443651|NCT00834795|101518902|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
33443652|NCT00834795|101518903|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
33443653|NCT00834795|101518902|FG000|Second Intervention|Adverse Event|1|||
33443654|NCT00834795|101518903|FG001|Second Intervention|Adverse Event|0|||
33443655|NCT01190930|101518904|FG000|Induction|Adverse Event|17|||
33443656|NCT01190930|101518905|FG001|Induction|Adverse Event|0|||
33162915|NCT01056653|100508097|FG000|Overall Study|Lost to Follow-up|0|||
33162916|NCT01056653|100508098|FG001|Overall Study|Lost to Follow-up|0|||
33162917|NCT01056653|100508099|FG002|Overall Study|Lost to Follow-up|2|||
33443657|NCT01190930|101518906|FG002|Induction|Adverse Event|0|||
33443658|NCT01190930|101518907|FG003|Induction|Adverse Event|0|||
33443659|NCT01190930|101518908|FG004|Induction|Adverse Event|0|||
33443660|NCT01190930|101518909|FG005|Induction|Adverse Event|0|||
33443661|NCT01190930|101518910|FG006|Induction|Adverse Event|0|||
33443662|NCT01190930|101518911|FG007|Induction|Adverse Event|0|||
33443663|NCT01190930|101518912|FG008|Induction|Adverse Event|0|||
33443664|NCT01190930|101518913|FG009|Induction|Adverse Event|0|||
33443665|NCT01190930|101518904|FG000|Induction|Death|34|||
33443666|NCT01190930|101518905|FG001|Induction|Death|0|||
33443667|NCT01190930|101518906|FG002|Induction|Death|0|||
33443668|NCT01190930|101518907|FG003|Induction|Death|0|||
33443669|NCT01190930|101518908|FG004|Induction|Death|0|||
33443670|NCT01190930|101518909|FG005|Induction|Death|0|||
33443671|NCT01190930|101518910|FG006|Induction|Death|0|||
33443672|NCT01190930|101518911|FG007|Induction|Death|0|||
33443673|NCT01190930|101518912|FG008|Induction|Death|0|||
33443674|NCT01190930|101518913|FG009|Induction|Death|0|||
33443675|NCT01190930|101518904|FG000|Induction|Lost to Follow-up|1|||
33443676|NCT01190930|101518905|FG001|Induction|Lost to Follow-up|0|||
33443677|NCT01190930|101518906|FG002|Induction|Lost to Follow-up|0|||
33443678|NCT01190930|101518907|FG003|Induction|Lost to Follow-up|0|||
33443679|NCT01190930|101518908|FG004|Induction|Lost to Follow-up|0|||
33443680|NCT01190930|101518909|FG005|Induction|Lost to Follow-up|0|||
33443681|NCT01190930|101518910|FG006|Induction|Lost to Follow-up|0|||
33443682|NCT01190930|101518911|FG007|Induction|Lost to Follow-up|0|||
33162918|NCT00365508|100508102|FG000|Overall Study|Lost to Follow-up|139|||
33443683|NCT01190930|101518912|FG008|Induction|Lost to Follow-up|0|||
33443684|NCT01190930|101518913|FG009|Induction|Lost to Follow-up|0|||
33443685|NCT01190930|101518904|FG000|Induction|Physician Decision|125|||
33443686|NCT01190930|101518905|FG001|Induction|Physician Decision|3|||
33443687|NCT01190930|101518906|FG002|Induction|Physician Decision|0|||
33443688|NCT01190930|101518907|FG003|Induction|Physician Decision|0|||
33443689|NCT01190930|101518908|FG004|Induction|Physician Decision|0|||
33443690|NCT01190930|101518909|FG005|Induction|Physician Decision|0|||
33443691|NCT01190930|101518910|FG006|Induction|Physician Decision|0|||
33443692|NCT01190930|101518911|FG007|Induction|Physician Decision|0|||
33443693|NCT01190930|101518912|FG008|Induction|Physician Decision|0|||
33443694|NCT01190930|101518913|FG009|Induction|Physician Decision|0|||
33443695|NCT01190930|101518904|FG000|Induction|Withdrawal by Subject|9|||
33443696|NCT01190930|101518905|FG001|Induction|Withdrawal by Subject|0|||
33443697|NCT01190930|101518906|FG002|Induction|Withdrawal by Subject|0|||
33443698|NCT01190930|101518907|FG003|Induction|Withdrawal by Subject|0|||
33443699|NCT01190930|101518908|FG004|Induction|Withdrawal by Subject|0|||
33443700|NCT01190930|101518909|FG005|Induction|Withdrawal by Subject|0|||
33443701|NCT01190930|101518910|FG006|Induction|Withdrawal by Subject|0|||
33443702|NCT01190930|101518911|FG007|Induction|Withdrawal by Subject|0|||
33443703|NCT01190930|101518912|FG008|Induction|Withdrawal by Subject|0|||
33257274|NCT00296036|100842720|FG002|Overall Study|Withdrawal by Subject|2|||
33257275|NCT00296036|100842721|FG003|Overall Study|Withdrawal by Subject|1|||
33257276|NCT00296036|100842722|FG004|Overall Study|Withdrawal by Subject|2|||
33257277|NCT00296036|100842723|FG005|Overall Study|Withdrawal by Subject|1|||
33257278|NCT00296036|100842718|FG000|Overall Study|Protocol Violation|0|||
33257279|NCT00296036|100842719|FG001|Overall Study|Protocol Violation|0|||
33257280|NCT00296036|100842720|FG002|Overall Study|Protocol Violation|0|||
33257281|NCT00296036|100842721|FG003|Overall Study|Protocol Violation|0|||
33257282|NCT00296036|100842722|FG004|Overall Study|Protocol Violation|0|||
33257283|NCT00296036|100842723|FG005|Overall Study|Protocol Violation|3|||
33257284|NCT00726596|100842724|FG000|Overall Study|Adverse Event|2|||
33257285|NCT00726596|100842725|FG001|Overall Study|Adverse Event|1|||
33257286|NCT00726596|100842724|FG000|Overall Study|Withdrawal by Subject|3|||
33257287|NCT00726596|100842725|FG001|Overall Study|Withdrawal by Subject|3|||
33257288|NCT01765543|100842726|FG000|Overall Study|Death|1|||
33257289|NCT01765543|100842726|FG000|Overall Study|Withdrawal by Subject|2|||
33257290|NCT05132478|100842727|FG000|Overall Study|did not complete survey after consent|1|||
33257291|NCT05132478|100842728|FG001|Overall Study|did not complete survey after consent|1|||
33257292|NCT05132478|100842727|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
33257293|NCT05132478|100842728|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
33257294|NCT03101930|100842729|FG000|Overall Study|Withdrawal by Subject|2|||
33257295|NCT03101930|100842730|FG001|Overall Study|Withdrawal by Subject|1|||
33257296|NCT03101930|100842731|FG002|Overall Study|Withdrawal by Subject|2|||
33257297|NCT00529516|100842732|FG000|Overall Study|Adverse Event|2|||
33257298|NCT00529516|100842733|FG001|Overall Study|Adverse Event|1|||
33257299|NCT00529516|100842734|FG002|Overall Study|Adverse Event|0|||
33257300|NCT00529516|100842732|FG000|Overall Study|Withdrawal by Subject|1|||
33257301|NCT00529516|100842733|FG001|Overall Study|Withdrawal by Subject|1|||
33257302|NCT00529516|100842734|FG002|Overall Study|Withdrawal by Subject|0|||
33257303|NCT00529516|100842732|FG000|Overall Study|Lost to Follow-up|0|||
33257304|NCT00529516|100842733|FG001|Overall Study|Lost to Follow-up|0|||
33257305|NCT00529516|100842734|FG002|Overall Study|Lost to Follow-up|1|||
33257306|NCT00068601|100842735|FG000|Overall Study|Ineligible|11|||
33257307|NCT00068601|100842736|FG001|Overall Study|Ineligible|13|||
33257308|NCT00068601|100842735|FG000|Overall Study|Not evaluable: withdrew consent|5|||
33257309|NCT00068601|100842736|FG001|Overall Study|Not evaluable: withdrew consent|4|||
33257310|NCT00068601|100842735|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
33257311|NCT00068601|100842736|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
33257312|NCT00068601|100842735|FG000|Overall Study|Death|11|||
33257313|NCT00068601|100842736|FG001|Overall Study|Death|3|||
33257314|NCT00068601|100842735|FG000|Overall Study|Lost to Follow-up|3|||
33257315|NCT00068601|100842736|FG001|Overall Study|Lost to Follow-up|2|||
33257316|NCT00068601|100842735|FG000|Overall Study|Missing primary outcome data|30|||
33257317|NCT00068601|100842736|FG001|Overall Study|Missing primary outcome data|34|||
33257318|NCT01359592|100842737|FG000|Initial Registration|Adverse Event|1|||
33257319|NCT01359592|100842738|FG001|Initial Registration|Adverse Event|0|||
33257320|NCT01359592|100842739|FG002|Initial Registration|Adverse Event|0|||
33257321|NCT01359592|100842740|FG003|Initial Registration|Adverse Event|0|||
33257322|NCT01359592|100842737|FG000|Initial Registration|Death|1|||
33257323|NCT01359592|100842738|FG001|Initial Registration|Death|0|||
33257324|NCT01359592|100842739|FG002|Initial Registration|Death|0|||
33257325|NCT01359592|100842740|FG003|Initial Registration|Death|0|||
33257326|NCT01359592|100842737|FG000|Initial Registration|Other reason not protocol specified|1|||
33257327|NCT01359592|100842738|FG001|Initial Registration|Other reason not protocol specified|0|||
33257328|NCT01359592|100842739|FG002|Initial Registration|Other reason not protocol specified|0|||
33257329|NCT01359592|100842740|FG003|Initial Registration|Other reason not protocol specified|0|||
33257330|NCT01359592|100842737|FG000|Initial Registration|Ineligible|26|||
33257331|NCT01359592|100842738|FG001|Initial Registration|Ineligible|0|||
33257332|NCT01359592|100842739|FG002|Initial Registration|Ineligible|0|||
33257333|NCT01359592|100842740|FG003|Initial Registration|Ineligible|0|||
33257334|NCT01359592|100842737|FG000|PET-Directed Therapy|Adverse Event|0|||
33257335|NCT01359592|100842738|FG001|PET-Directed Therapy|Adverse Event|0|||
33257336|NCT01359592|100842739|FG002|PET-Directed Therapy|Adverse Event|1|||
33443704|NCT01190930|101518913|FG009|Induction|Withdrawal by Subject|0|||
33443705|NCT01190930|101518904|FG000|Induction|Refusal|235|||
33443706|NCT01190930|101518905|FG001|Induction|Refusal|0|||
33443707|NCT01190930|101518906|FG002|Induction|Refusal|0|||
33443708|NCT01190930|101518907|FG003|Induction|Refusal|0|||
33443709|NCT01190930|101518908|FG004|Induction|Refusal|0|||
33443710|NCT01190930|101518909|FG005|Induction|Refusal|0|||
33443711|NCT01190930|101518910|FG006|Induction|Refusal|0|||
33443712|NCT01190930|101518911|FG007|Induction|Refusal|0|||
33443713|NCT01190930|101518912|FG008|Induction|Refusal|0|||
33443714|NCT01190930|101518913|FG009|Induction|Refusal|0|||
33443715|NCT01190930|101518904|FG000|Induction|Inevaluable|23|||
33443716|NCT01190930|101518905|FG001|Induction|Inevaluable|1|||
33443717|NCT01190930|101518906|FG002|Induction|Inevaluable|0|||
33443718|NCT01190930|101518907|FG003|Induction|Inevaluable|0|||
33443719|NCT01190930|101518908|FG004|Induction|Inevaluable|0|||
33162919|NCT00365508|100508103|FG001|Overall Study|Lost to Follow-up|154|||
33162920|NCT02412618|100508104|FG000|Overall Study|Withdrawal by Subject|1|||
33162921|NCT02412618|100508105|FG001|Overall Study|Withdrawal by Subject|1|||
33162922|NCT02412618|100508104|FG000|Overall Study|Expulsion|1|||
33162923|NCT02412618|100508105|FG001|Overall Study|Expulsion|1|||
33162924|NCT03334539|100508108|FG000|Overall Study|Adverse Event|3|||
33162925|NCT03334539|100508109|FG001|Overall Study|Adverse Event|5|||
33162926|NCT03334539|100508110|FG002|Overall Study|Adverse Event|0|||
33162927|NCT03334539|100508108|FG000|Overall Study|Withdrawal by Subject|0|||
33162928|NCT03334539|100508109|FG001|Overall Study|Withdrawal by Subject|1|||
33162929|NCT03334539|100508110|FG002|Overall Study|Withdrawal by Subject|1|||
33162930|NCT03334539|100508108|FG000|Overall Study|Administrative Reasons|1|||
33162931|NCT03334539|100508109|FG001|Overall Study|Administrative Reasons|0|||
33162932|NCT03334539|100508110|FG002|Overall Study|Administrative Reasons|0|||
33162933|NCT03334539|100508108|FG000|Overall Study|Hypertension Not Controlled|0|||
33162934|NCT03334539|100508109|FG001|Overall Study|Hypertension Not Controlled|1|||
33162935|NCT03334539|100508110|FG002|Overall Study|Hypertension Not Controlled|0|||
33443720|NCT01190930|101518909|FG005|Induction|Inevaluable|0|||
33443721|NCT01190930|101518910|FG006|Induction|Inevaluable|0|||
33443722|NCT01190930|101518911|FG007|Induction|Inevaluable|0|||
33443723|NCT01190930|101518912|FG008|Induction|Inevaluable|0|||
33443724|NCT01190930|101518913|FG009|Induction|Inevaluable|0|||
33443725|NCT01190930|101518904|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
33443726|NCT01190930|101518905|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33162936|NCT00518284|100508112|FG000|Overall Study|Adverse Event|0|||
33162937|NCT00518284|100508113|FG001|Overall Study|Adverse Event|1|||
33162938|NCT00518284|100508114|FG002|Overall Study|Adverse Event|0|||
33162939|NCT00518284|100508115|FG003|Overall Study|Adverse Event|0|||
33162940|NCT00518284|100508112|FG000|Overall Study|Study Termination|0|||
33443727|NCT01190930|101518906|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33443728|NCT01190930|101518907|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33443729|NCT01190930|101518908|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33443730|NCT01190930|101518909|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33257337|NCT01359592|100842740|FG003|PET-Directed Therapy|Adverse Event|0|||
33257338|NCT01359592|100842737|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
33257339|NCT01359592|100842738|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
33257340|NCT01359592|100842739|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
33257341|NCT01359592|100842740|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
33257342|NCT01359592|100842737|FG000|PET-Directed Therapy|Ineligible|0|||
33257343|NCT01359592|100842738|FG001|PET-Directed Therapy|Ineligible|0|||
33257344|NCT01359592|100842739|FG002|PET-Directed Therapy|Ineligible|24|||
33257345|NCT01359592|100842740|FG003|PET-Directed Therapy|Ineligible|0|||
33257346|NCT02531113|100842749|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
33257347|NCT02531113|100842749|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
33257348|NCT02531113|100842749|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
33257349|NCT02531113|100842749|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
33257350|NCT02531113|100842749|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
33257351|NCT02531113|100842749|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
33257352|NCT02531113|100842749|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
33257353|NCT02531113|100842749|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
33257354|NCT04210180|100842762|FG000|Overall Study|Withdrawal by Subject|2|||
33257355|NCT00761189|100842766|FG000|Overall Study|Adverse Event|42|||
33257356|NCT00761189|100842766|FG000|Overall Study|Lack of Efficacy|45|||
33257357|NCT00761189|100842766|FG000|Overall Study|Lost to Follow-up|36|||
33257358|NCT00761189|100842766|FG000|Overall Study|Withdrawal by Subject|49|||
33257359|NCT00761189|100842766|FG000|Overall Study|Other|13|||
33257360|NCT01061151|100842767|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
33257361|NCT01061151|100842768|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
33257362|NCT01061151|100842769|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
33257363|NCT01061151|100842770|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
33257364|NCT01061151|100842767|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
33257365|NCT01061151|100842768|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
33257366|NCT01061151|100842769|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
33257367|NCT01061151|100842770|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
33257368|NCT01061151|100842767|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
33257369|NCT01061151|100842768|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
33257370|NCT01061151|100842769|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
33257371|NCT01061151|100842770|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
33257372|NCT01061151|100842767|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
33257373|NCT01061151|100842768|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
33257374|NCT01061151|100842769|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
33257375|NCT01061151|100842770|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
33257376|NCT01061151|100842767|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
33257377|NCT01061151|100842768|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
33257378|NCT01061151|100842769|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
33257379|NCT01061151|100842770|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
33257380|NCT01061151|100842767|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
33257381|NCT01061151|100842768|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
33257382|NCT01061151|100842769|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
33257383|NCT01061151|100842770|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
33257384|NCT01061151|100842767|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
33257385|NCT01061151|100842768|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
33443731|NCT01190930|101518910|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33443732|NCT01190930|101518911|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33443733|NCT01190930|101518912|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33443734|NCT01190930|101518913|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
33443735|NCT01190930|101518904|FG000|Induction|High Risk Downs|80|||
33257386|NCT01061151|100842769|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
33257387|NCT01061151|100842770|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
33257388|NCT01061151|100842767|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
33257389|NCT01061151|100842768|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
33257390|NCT01061151|100842769|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
33257391|NCT01061151|100842770|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
33257392|NCT01061151|100842767|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
33257393|NCT01061151|100842768|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
33257394|NCT01061151|100842769|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
33257395|NCT01061151|100842770|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
33257396|NCT01061151|100842767|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
33257397|NCT01061151|100842768|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
33257398|NCT01061151|100842769|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
33257399|NCT01061151|100842770|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
33257400|NCT01061151|100842767|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
33257401|NCT01061151|100842768|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
33257402|NCT01061151|100842769|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
33257403|NCT01061151|100842770|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
33257404|NCT01061151|100842767|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
33257405|NCT01061151|100842768|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
33257406|NCT01061151|100842769|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
33257407|NCT01061151|100842770|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
33257408|NCT01061151|100842767|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
33257409|NCT01061151|100842768|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
33257410|NCT01061151|100842769|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
33257411|NCT01061151|100842770|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
33257412|NCT01061151|100842767|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
33162941|NCT00518284|100508113|FG001|Overall Study|Study Termination|2|||
33162942|NCT00518284|100508114|FG002|Overall Study|Study Termination|1|||
33162943|NCT00518284|100508115|FG003|Overall Study|Study Termination|2|||
33162944|NCT01929343|100508117|FG000|Overall Study|Physician Decision|0|||
33162945|NCT01929343|100508118|FG001|Overall Study|Physician Decision|2|||
33162946|NCT01929343|100508119|FG002|Overall Study|Physician Decision|0|||
33162947|NCT01929343|100508117|FG000|Overall Study|Withdrawal by Subject|1|||
33162948|NCT01929343|100508118|FG001|Overall Study|Withdrawal by Subject|0|||
33162949|NCT01929343|100508119|FG002|Overall Study|Withdrawal by Subject|0|||
33162950|NCT01847274|100508120|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
33162951|NCT01847274|100508121|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
33162952|NCT01847274|100508122|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
33162953|NCT01847274|100508123|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
33162954|NCT01847274|100508124|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
33162955|NCT01847274|100508125|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
33162956|NCT01847274|100508126|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
33162957|NCT01847274|100508127|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
33162958|NCT01847274|100508128|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
33162959|NCT01847274|100508129|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
33162960|NCT01847274|100508130|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
33162961|NCT01847274|100508120|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
33162962|NCT01847274|100508121|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
33162963|NCT01847274|100508122|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
33162964|NCT01847274|100508123|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
33162965|NCT01847274|100508124|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
33162966|NCT01847274|100508125|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
33162967|NCT01847274|100508126|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
33162968|NCT01847274|100508127|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
33162969|NCT01847274|100508128|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
33162970|NCT01847274|100508129|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
33162971|NCT01847274|100508130|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
33162972|NCT01847274|100508120|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
33162973|NCT01847274|100508121|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
33162974|NCT01847274|100508122|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
33162975|NCT01847274|100508123|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
33162976|NCT01847274|100508124|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
33162977|NCT01847274|100508125|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
33162978|NCT01847274|100508126|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
33162979|NCT01847274|100508127|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
33162980|NCT01847274|100508128|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
33162981|NCT01847274|100508129|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
33162982|NCT01847274|100508130|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
33162983|NCT01847274|100508120|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33162984|NCT01847274|100508121|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33162985|NCT01847274|100508122|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33162986|NCT01847274|100508123|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
33162987|NCT01847274|100508124|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33162988|NCT01847274|100508125|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33162989|NCT01847274|100508126|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33162990|NCT01847274|100508127|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33162991|NCT01847274|100508128|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33162992|NCT01847274|100508129|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33162993|NCT01847274|100508130|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
33162994|NCT01847274|100508120|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
33443736|NCT01190930|101518905|FG001|Induction|High Risk Downs|0|||
33443737|NCT01190930|101518906|FG002|Induction|High Risk Downs|0|||
33443738|NCT01190930|101518907|FG003|Induction|High Risk Downs|0|||
33443739|NCT01190930|101518908|FG004|Induction|High Risk Downs|0|||
33443740|NCT01190930|101518909|FG005|Induction|High Risk Downs|0|||
33162995|NCT01847274|100508121|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
33162996|NCT01847274|100508122|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
33162997|NCT01847274|100508123|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
33443741|NCT01190930|101518910|FG006|Induction|High Risk Downs|0|||
33162998|NCT01847274|100508124|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
33162999|NCT01847274|100508125|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
33163000|NCT01847274|100508126|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
33163001|NCT01847274|100508127|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
33163002|NCT01847274|100508128|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
33163003|NCT01847274|100508129|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
33163004|NCT01847274|100508130|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
33163005|NCT01847274|100508120|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
33163006|NCT01847274|100508121|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
33163007|NCT01847274|100508122|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
33163008|NCT01847274|100508123|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
33163009|NCT01847274|100508124|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
33163010|NCT01847274|100508125|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
33163011|NCT01847274|100508126|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
33163012|NCT01847274|100508127|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
33163013|NCT01847274|100508128|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
33163014|NCT01847274|100508129|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
33163015|NCT01847274|100508130|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
33163016|NCT01847274|100508120|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
33163017|NCT01847274|100508121|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
33163018|NCT01847274|100508122|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
33163019|NCT01847274|100508123|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
33163020|NCT01847274|100508124|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
33163021|NCT01847274|100508125|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
33163022|NCT01847274|100508126|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
33163023|NCT01847274|100508127|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
33163024|NCT01847274|100508128|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
33163025|NCT01847274|100508129|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
33163026|NCT01847274|100508130|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
33163027|NCT01847274|100508120|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33163028|NCT01847274|100508121|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33163029|NCT01847274|100508122|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33163030|NCT01847274|100508123|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33163031|NCT01847274|100508124|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33163032|NCT01847274|100508125|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
33163033|NCT01847274|100508126|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33163034|NCT01847274|100508127|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33163035|NCT01847274|100508128|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33163036|NCT01847274|100508129|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33163037|NCT01847274|100508130|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
33163038|NCT01847274|100508120|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33163039|NCT01847274|100508121|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33163040|NCT01847274|100508122|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33163041|NCT01847274|100508123|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33163042|NCT01847274|100508124|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
33163043|NCT01847274|100508125|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33163044|NCT01847274|100508126|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33163045|NCT01847274|100508127|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33443742|NCT01190930|101518911|FG007|Induction|High Risk Downs|0|||
33443743|NCT01190930|101518912|FG008|Induction|High Risk Downs|0|||
33163046|NCT01847274|100508128|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33163047|NCT01847274|100508129|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33163048|NCT01847274|100508130|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
33163049|NCT01847274|100508120|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33163050|NCT01847274|100508121|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33163051|NCT01847274|100508122|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33163052|NCT01847274|100508123|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33163053|NCT01847274|100508124|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33163054|NCT01847274|100508125|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33163055|NCT01847274|100508126|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
33163056|NCT01847274|100508127|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33163057|NCT01847274|100508128|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33163058|NCT01847274|100508129|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33163059|NCT01847274|100508130|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
33163060|NCT01847274|100508120|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33257413|NCT01061151|100842768|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
33163061|NCT01847274|100508121|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33163062|NCT01847274|100508122|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33163063|NCT01847274|100508123|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33257414|NCT01061151|100842769|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
33163064|NCT01847274|100508124|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33163065|NCT01847274|100508125|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33163066|NCT01847274|100508126|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
33163067|NCT01847274|100508127|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33163068|NCT01847274|100508128|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33163069|NCT01847274|100508129|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33163070|NCT01847274|100508130|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
33163071|NCT01847274|100508120|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33163072|NCT01847274|100508121|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33163073|NCT01847274|100508122|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33163074|NCT01847274|100508123|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33163075|NCT01847274|100508124|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33163076|NCT01847274|100508125|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33257415|NCT01061151|100842770|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
33257416|NCT01061151|100842767|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
33163077|NCT01847274|100508126|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
33163078|NCT01847274|100508127|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33163079|NCT01847274|100508128|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33163080|NCT01847274|100508129|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33163081|NCT01847274|100508130|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
33163082|NCT01847274|100508120|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
33163083|NCT01847274|100508121|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
33163084|NCT01847274|100508122|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
33163085|NCT01847274|100508123|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
33163086|NCT01847274|100508124|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
33163087|NCT01847274|100508125|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
33163088|NCT01847274|100508126|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
33163089|NCT01847274|100508127|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
33163090|NCT01847274|100508128|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
33163091|NCT01847274|100508129|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
33163092|NCT01847274|100508130|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
33163093|NCT01847274|100508120|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33163094|NCT01847274|100508121|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33163095|NCT01847274|100508122|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33163096|NCT01847274|100508123|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33163097|NCT01847274|100508124|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33163098|NCT01847274|100508125|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33163099|NCT01847274|100508126|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33163100|NCT01847274|100508127|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
33163101|NCT01847274|100508128|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33163102|NCT01847274|100508129|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
33163103|NCT01847274|100508130|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
33163104|NCT01847274|100508120|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33163105|NCT01847274|100508121|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33163106|NCT01847274|100508122|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33443744|NCT01190930|101518913|FG009|Induction|High Risk Downs|0|||
33163107|NCT01847274|100508123|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33163108|NCT01847274|100508124|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33163109|NCT01847274|100508125|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33163110|NCT01847274|100508126|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33163111|NCT01847274|100508127|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
33163112|NCT01847274|100508128|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
33163113|NCT01847274|100508129|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
33163114|NCT01847274|100508130|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
33163115|NCT01847274|100508120|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33163116|NCT01847274|100508121|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33163117|NCT01847274|100508122|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33163118|NCT01847274|100508123|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33163119|NCT01847274|100508124|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33163120|NCT01847274|100508125|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33163121|NCT01847274|100508126|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33163122|NCT01847274|100508127|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33163123|NCT01847274|100508128|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33163124|NCT01847274|100508129|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
33163125|NCT01847274|100508130|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
33163126|NCT00329238|100508141|FG000|Overall Study|Adverse Event|147|||
33163127|NCT00329238|100508142|FG001|Overall Study|Adverse Event|129|||
33257417|NCT01061151|100842768|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
33257418|NCT01061151|100842769|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
33257419|NCT01061151|100842770|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
33257420|NCT00818454|100842773|FG000|Treatment Period 1|Adverse Event|0|||
33257421|NCT00818454|100842774|FG001|Treatment Period 1|Adverse Event|1|||
33257422|NCT00818454|100842775|FG002|Treatment Period 1|Adverse Event|0|||
33257423|NCT00818454|100842776|FG003|Treatment Period 1|Adverse Event|0|||
33257424|NCT00818454|100842773|FG000|Treatment Period 1|Other|3|||
33257425|NCT00818454|100842774|FG001|Treatment Period 1|Other|0|||
33257426|NCT00818454|100842775|FG002|Treatment Period 1|Other|0|||
33257427|NCT00818454|100842776|FG003|Treatment Period 1|Other|0|||
33257428|NCT00818454|100842773|FG000|Washout Period of 1 Week|Adverse Event|1|||
33443745|NCT01190930|101518904|FG000|Induction|Enrollment onto another COG Protocol|1|||
33443746|NCT01190930|101518905|FG001|Induction|Enrollment onto another COG Protocol|0|||
33443747|NCT01190930|101518906|FG002|Induction|Enrollment onto another COG Protocol|0|||
33443748|NCT01190930|101518907|FG003|Induction|Enrollment onto another COG Protocol|0|||
33257429|NCT00818454|100842774|FG001|Washout Period of 1 Week|Adverse Event|1|||
33257430|NCT00818454|100842775|FG002|Washout Period of 1 Week|Adverse Event|0|||
33257431|NCT00818454|100842776|FG003|Washout Period of 1 Week|Adverse Event|0|||
33257432|NCT00818454|100842773|FG000|Washout Period of 1 Week|Protocol Violation|2|||
33257433|NCT00818454|100842774|FG001|Washout Period of 1 Week|Protocol Violation|0|||
33257434|NCT00818454|100842775|FG002|Washout Period of 1 Week|Protocol Violation|0|||
33257435|NCT00818454|100842776|FG003|Washout Period of 1 Week|Protocol Violation|0|||
33257436|NCT00818454|100842773|FG000|Washout Period of 1 Week|Other|1|||
33257437|NCT00818454|100842774|FG001|Washout Period of 1 Week|Other|2|||
33443749|NCT01190930|101518908|FG004|Induction|Enrollment onto another COG Protocol|0|||
33443750|NCT01190930|101518909|FG005|Induction|Enrollment onto another COG Protocol|0|||
33443751|NCT01190930|101518910|FG006|Induction|Enrollment onto another COG Protocol|0|||
33443752|NCT01190930|101518911|FG007|Induction|Enrollment onto another COG Protocol|0|||
33443753|NCT01190930|101518912|FG008|Induction|Enrollment onto another COG Protocol|0|||
33443754|NCT01190930|101518913|FG009|Induction|Enrollment onto another COG Protocol|0|||
33443755|NCT01190930|101518904|FG000|Induction|Average Risk|1847|||
33443756|NCT01190930|101518905|FG001|Induction|Average Risk|0|||
33443757|NCT01190930|101518906|FG002|Induction|Average Risk|0|||
33443758|NCT01190930|101518907|FG003|Induction|Average Risk|0|||
33443759|NCT01190930|101518908|FG004|Induction|Average Risk|0|||
33443760|NCT01190930|101518909|FG005|Induction|Average Risk|0|||
33443761|NCT01190930|101518910|FG006|Induction|Average Risk|0|||
33443762|NCT01190930|101518911|FG007|Induction|Average Risk|0|||
33443763|NCT01190930|101518912|FG008|Induction|Average Risk|0|||
33443764|NCT01190930|101518913|FG009|Induction|Average Risk|0|||
33443765|NCT01190930|101518904|FG000|Induction|High Risk|1227|||
33443766|NCT01190930|101518905|FG001|Induction|High Risk|0|||
33443767|NCT01190930|101518906|FG002|Induction|High Risk|0|||
33443768|NCT01190930|101518907|FG003|Induction|High Risk|0|||
33443769|NCT01190930|101518908|FG004|Induction|High Risk|0|||
33443770|NCT01190930|101518909|FG005|Induction|High Risk|0|||
33443771|NCT01190930|101518910|FG006|Induction|High Risk|0|||
33443772|NCT01190930|101518911|FG007|Induction|High Risk|0|||
33443773|NCT01190930|101518912|FG008|Induction|High Risk|0|||
33443774|NCT01190930|101518913|FG009|Induction|High Risk|0|||
33443775|NCT01190930|101518904|FG000|Induction|Low Risk|443|||
33443776|NCT01190930|101518905|FG001|Induction|Low Risk|0|||
33443777|NCT01190930|101518906|FG002|Induction|Low Risk|0|||
33443778|NCT01190930|101518907|FG003|Induction|Low Risk|0|||
33443779|NCT01190930|101518908|FG004|Induction|Low Risk|0|||
33443780|NCT01190930|101518909|FG005|Induction|Low Risk|0|||
33443781|NCT01190930|101518910|FG006|Induction|Low Risk|0|||
33443782|NCT01190930|101518911|FG007|Induction|Low Risk|0|||
33443783|NCT01190930|101518912|FG008|Induction|Low Risk|0|||
33443784|NCT01190930|101518913|FG009|Induction|Low Risk|0|||
33443785|NCT01190930|101518904|FG000|Induction|Very High Risk|1012|||
33443786|NCT01190930|101518905|FG001|Induction|Very High Risk|0|||
33443787|NCT01190930|101518906|FG002|Induction|Very High Risk|0|||
33443788|NCT01190930|101518907|FG003|Induction|Very High Risk|0|||
33443789|NCT01190930|101518908|FG004|Induction|Very High Risk|0|||
33443790|NCT01190930|101518909|FG005|Induction|Very High Risk|0|||
33443791|NCT01190930|101518910|FG006|Induction|Very High Risk|0|||
33443792|NCT01190930|101518911|FG007|Induction|Very High Risk|0|||
33443793|NCT01190930|101518912|FG008|Induction|Very High Risk|0|||
33443794|NCT01190930|101518913|FG009|Induction|Very High Risk|0|||
33443795|NCT01190930|101518904|FG000|Induction|Philadelphia chromosome-positive|99|||
33257438|NCT00818454|100842775|FG002|Washout Period of 1 Week|Other|0|||
33257439|NCT00818454|100842776|FG003|Washout Period of 1 Week|Other|0|||
33443796|NCT01190930|101518905|FG001|Induction|Philadelphia chromosome-positive|0|||
33443797|NCT01190930|101518906|FG002|Induction|Philadelphia chromosome-positive|0|||
33443798|NCT01190930|101518907|FG003|Induction|Philadelphia chromosome-positive|0|||
33443799|NCT01190930|101518908|FG004|Induction|Philadelphia chromosome-positive|0|||
33443800|NCT01190930|101518909|FG005|Induction|Philadelphia chromosome-positive|0|||
33163128|NCT00329238|100508141|FG000|Overall Study|Protocol Violation|23|||
33163129|NCT00329238|100508142|FG001|Overall Study|Protocol Violation|34|||
33163130|NCT00329238|100508141|FG000|Overall Study|Lost to Follow-up|2|||
33163131|NCT00329238|100508142|FG001|Overall Study|Lost to Follow-up|6|||
33163132|NCT00329238|100508141|FG000|Overall Study|Withdrawal by Subject|64|||
33163133|NCT00329238|100508142|FG001|Overall Study|Withdrawal by Subject|58|||
33163134|NCT00329238|100508141|FG000|Overall Study|Other reason (not specified)|40|||
33163135|NCT00329238|100508142|FG001|Overall Study|Other reason (not specified)|54|||
33163136|NCT02784431|100508143|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
33163137|NCT02784431|100508143|FG000|Overall Study|Early Study Termination|19|||
33163138|NCT00867568|100508146|FG000|Overall Study|Lack of Efficacy|10|||
33163139|NCT00867568|100508146|FG000|Overall Study|Adverse Event|4|||
33163140|NCT00867568|100508146|FG000|Overall Study|Withdrawal by Subject|1|||
33163141|NCT01858389|100508155|FG000|Overall Study|Death|1|||
33163142|NCT01858389|100508156|FG001|Overall Study|Death|3|||
33163143|NCT01858389|100508155|FG000|Overall Study|Study terminated by sponsor|0|||
33163144|NCT01858389|100508156|FG001|Overall Study|Study terminated by sponsor|2|||
33163145|NCT01858389|100508155|FG000|Overall Study|Withdrawal by Subject|0|||
33163146|NCT01858389|100508156|FG001|Overall Study|Withdrawal by Subject|1|||
33163147|NCT01858389|100508155|FG000|Overall Study|Progressive disease|10|||
33163148|NCT01858389|100508156|FG001|Overall Study|Progressive disease|11|||
33163149|NCT01858389|100508155|FG000|Overall Study|Other|2|||
33163150|NCT01858389|100508156|FG001|Overall Study|Other|4|||
33257440|NCT00818454|100842773|FG000|Treatment Period 2|Other|2|||
33257441|NCT00818454|100842774|FG001|Treatment Period 2|Other|1|||
33163151|NCT01858389|100508155|FG000|Overall Study|Adverse Event|3|||
33163152|NCT01858389|100508156|FG001|Overall Study|Adverse Event|1|||
33163153|NCT01858389|100508155|FG000|Overall Study|Did not receive treatment|0|||
33163154|NCT01858389|100508156|FG001|Overall Study|Did not receive treatment|3|||
33163155|NCT02217878|100508157|FG000|Overall Study|required morphine due to chest pain|1|||
33163156|NCT02217878|100508158|FG001|Overall Study|required morphine due to chest pain|2|||
33163157|NCT02217878|100508157|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
33163158|NCT02217878|100508158|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
33163159|NCT02468674|100508159|FG000|Overall Study|Adverse Event|0|||
33163160|NCT02468674|100508160|FG001|Overall Study|Adverse Event|0|||
33163161|NCT02468674|100508161|FG002|Overall Study|Adverse Event|0|||
33163162|NCT02468674|100508162|FG003|Overall Study|Adverse Event|1|||
33163163|NCT02468674|100508163|FG004|Overall Study|Adverse Event|0|||
33163164|NCT02468674|100508164|FG005|Overall Study|Adverse Event|1|||
33163165|NCT02468674|100508165|FG006|Overall Study|Adverse Event|0|||
33257442|NCT00818454|100842775|FG002|Treatment Period 2|Other|0|||
33163166|NCT02468674|100508166|FG007|Overall Study|Adverse Event|0|||
33163167|NCT02468674|100508167|FG008|Overall Study|Adverse Event|0|||
33163168|NCT02468674|100508159|FG000|Overall Study|Lost to Follow-up|1|||
33163169|NCT02468674|100508160|FG001|Overall Study|Lost to Follow-up|0|||
33163170|NCT02468674|100508161|FG002|Overall Study|Lost to Follow-up|0|||
33163171|NCT02468674|100508162|FG003|Overall Study|Lost to Follow-up|0|||
33163172|NCT02468674|100508163|FG004|Overall Study|Lost to Follow-up|0|||
33163173|NCT02468674|100508164|FG005|Overall Study|Lost to Follow-up|0|||
33163174|NCT02468674|100508165|FG006|Overall Study|Lost to Follow-up|0|||
33163175|NCT02468674|100508166|FG007|Overall Study|Lost to Follow-up|1|||
33163176|NCT02468674|100508167|FG008|Overall Study|Lost to Follow-up|1|||
33163177|NCT02468674|100508159|FG000|Overall Study|Physician Decision|0|||
33163178|NCT02468674|100508160|FG001|Overall Study|Physician Decision|0|||
33163179|NCT02468674|100508161|FG002|Overall Study|Physician Decision|0|||
33163180|NCT02468674|100508162|FG003|Overall Study|Physician Decision|0|||
33163181|NCT02468674|100508163|FG004|Overall Study|Physician Decision|0|||
33163182|NCT02468674|100508164|FG005|Overall Study|Physician Decision|0|||
33163183|NCT02468674|100508165|FG006|Overall Study|Physician Decision|1|||
33163184|NCT02468674|100508166|FG007|Overall Study|Physician Decision|0|||
33163185|NCT02468674|100508167|FG008|Overall Study|Physician Decision|0|||
33163186|NCT02468674|100508159|FG000|Overall Study|Patient/Guardian Decision|0|||
33257443|NCT00818454|100842776|FG003|Treatment Period 2|Other|0|||
33257444|NCT00818454|100842773|FG000|Treatment Period 3|Adverse Event|0|||
33257445|NCT00818454|100842774|FG001|Treatment Period 3|Adverse Event|0|||
33443801|NCT01190930|101518910|FG006|Induction|Philadelphia chromosome-positive|0|||
33163187|NCT02468674|100508160|FG001|Overall Study|Patient/Guardian Decision|0|||
33163188|NCT02468674|100508161|FG002|Overall Study|Patient/Guardian Decision|0|||
33163189|NCT02468674|100508162|FG003|Overall Study|Patient/Guardian Decision|0|||
33163190|NCT02468674|100508163|FG004|Overall Study|Patient/Guardian Decision|1|||
33163191|NCT02468674|100508164|FG005|Overall Study|Patient/Guardian Decision|0|||
33163192|NCT02468674|100508165|FG006|Overall Study|Patient/Guardian Decision|0|||
33163193|NCT02468674|100508166|FG007|Overall Study|Patient/Guardian Decision|2|||
33163194|NCT02468674|100508167|FG008|Overall Study|Patient/Guardian Decision|1|||
33163195|NCT02468674|100508159|FG000|Overall Study|Protocol Deviation|0|||
33163196|NCT02468674|100508160|FG001|Overall Study|Protocol Deviation|0|||
33163197|NCT02468674|100508161|FG002|Overall Study|Protocol Deviation|0|||
33163198|NCT02468674|100508162|FG003|Overall Study|Protocol Deviation|0|||
33163199|NCT02468674|100508163|FG004|Overall Study|Protocol Deviation|0|||
33163200|NCT02468674|100508164|FG005|Overall Study|Protocol Deviation|0|||
33163201|NCT02468674|100508165|FG006|Overall Study|Protocol Deviation|0|||
33163202|NCT02468674|100508166|FG007|Overall Study|Protocol Deviation|1|||
33163203|NCT02468674|100508167|FG008|Overall Study|Protocol Deviation|1|||
33257446|NCT00818454|100842775|FG002|Treatment Period 3|Adverse Event|0|||
33163204|NCT01637272|100508168|FG000|Overall Study|Adverse Event|6|||
33163205|NCT01637272|100508168|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33163206|NCT01637272|100508168|FG000|Overall Study|Withdrawal by Subject|3|||
33163207|NCT01637272|100508168|FG000|Overall Study|Lost to Follow-up|2|||
33163208|NCT01637272|100508168|FG000|Overall Study|completed core, did not enter ext. phase|4|||
33163209|NCT01637272|100508168|FG000|Overall Study|Administrative problems|1|||
33163210|NCT01637272|100508168|FG000|Overall Study|Protocol Violation|2|||
33163211|NCT01862874|100508169|FG000|Overall Study|Randomized not treated|1|||
33163212|NCT01862874|100508170|FG001|Overall Study|Randomized not treated|0|||
33163213|NCT01862874|100508169|FG000|Overall Study|Adverse Event|0|||
33163214|NCT01862874|100508170|FG001|Overall Study|Adverse Event|3|||
33163215|NCT01862874|100508169|FG000|Overall Study|Lost to Follow-up|26|||
33163216|NCT01862874|100508170|FG001|Overall Study|Lost to Follow-up|29|||
33163217|NCT01862874|100508169|FG000|Overall Study|Physician Decision|5|||
33163218|NCT01862874|100508170|FG001|Overall Study|Physician Decision|3|||
33163219|NCT01862874|100508169|FG000|Overall Study|Withdrawn by parent/guardian|1|||
33257447|NCT00818454|100842776|FG003|Treatment Period 3|Adverse Event|1|||
33257448|NCT01127373|100842777|FG000|Overall Study|Not Treated|3|||
33257449|NCT01127373|100842777|FG000|Overall Study|Lost to Follow-up|7|||
33257450|NCT01127373|100842777|FG000|Overall Study|Withdrawal by Subject|1|||
33257451|NCT01127373|100842777|FG000|Overall Study|Disease progression|1|||
33257452|NCT02759016|100842779|FG000|Overall Study|Not treated with BI 836826|1|||
33257453|NCT02759016|100842780|FG001|Overall Study|Not treated with BI 836826|0|||
33257454|NCT02759016|100842779|FG000|Overall Study|Progressive disease|1|||
33443802|NCT01190930|101518911|FG007|Induction|Philadelphia chromosome-positive|0|||
33443803|NCT01190930|101518912|FG008|Induction|Philadelphia chromosome-positive|0|||
33163220|NCT01862874|100508170|FG001|Overall Study|Withdrawn by parent/guardian|1|||
33163221|NCT01862874|100508169|FG000|Overall Study|Withdrawal by Subject|46|||
33163222|NCT01862874|100508170|FG001|Overall Study|Withdrawal by Subject|40|||
33163223|NCT01862874|100508169|FG000|Overall Study|Death|0|||
33163224|NCT01862874|100508170|FG001|Overall Study|Death|1|||
33163225|NCT02582983|100508171|FG000|Overall Study|Death|3|||
33163226|NCT02582983|100508171|FG000|Overall Study|Withdrawal by Subject|2|||
33163227|NCT02582983|100508171|FG000|Overall Study|Adverse Event|1|||
33163228|NCT01826604|100508172|FG000|Overall Study|Lost to Follow-up|8|||
33163229|NCT01826604|100508173|FG001|Overall Study|Lost to Follow-up|9|||
33163230|NCT00040365|100508174|FG000|Overall Study|Death|1|||
33163231|NCT00040365|100508174|FG000|Overall Study|Progressive disease|7|||
33257455|NCT02759016|100842780|FG001|Overall Study|Progressive disease|0|||
33257456|NCT02759016|100842779|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
33163232|NCT00040365|100508174|FG000|Overall Study|Lost to Follow-up|3|||
33163233|NCT00211510|100508175|FG000|Overall Study|Physician Decision|3|||
33163234|NCT00211510|100508176|FG001|Overall Study|Physician Decision|1|||
33163235|NCT00211510|100508175|FG000|Overall Study|Withdrawal by Subject|3|||
33163236|NCT00211510|100508176|FG001|Overall Study|Withdrawal by Subject|1|||
33163237|NCT01909674|100508177|FG000|Overall Study|Withdrawal by Subject|5|||
33163238|NCT01909674|100508178|FG001|Overall Study|Withdrawal by Subject|2|||
33163239|NCT01930123|100508183|FG000|Overall Study|Adverse Event|1|||
33163240|NCT01930123|100508184|FG001|Overall Study|Adverse Event|0|||
33163241|NCT01930123|100508183|FG000|Overall Study|Physician Decision|21|||
33163242|NCT01930123|100508184|FG001|Overall Study|Physician Decision|8|||
33163243|NCT01930123|100508183|FG000|Overall Study|Withdrawal by Subject|1|||
33163244|NCT01930123|100508184|FG001|Overall Study|Withdrawal by Subject|0|||
33163245|NCT01416272|100508185|FG000|Overall Study|Unacceptable distance visual acuity|2|||
33163246|NCT01416272|100508185|FG000|Overall Study|Lost to Follow-up|1|||
33163247|NCT01416272|100508185|FG000|Overall Study|Study related complaints|1|||
33163248|NCT03408483|100508188|FG000|Overall Study|Physician Decision|3|||
33163249|NCT03408483|100508189|FG001|Overall Study|Physician Decision|3|||
33163250|NCT03408483|100508188|FG000|Overall Study|Lost to Follow-up|3|||
33163251|NCT03408483|100508189|FG001|Overall Study|Lost to Follow-up|0|||
33257457|NCT02759016|100842780|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
33163252|NCT01364649|100508190|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
33163253|NCT01364649|100508191|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
33163254|NCT01364649|100508190|FG000|Overall Study|Lack of Efficacy|6|||
33163255|NCT01364649|100508191|FG001|Overall Study|Lack of Efficacy|0|||
33257458|NCT02759016|100842779|FG000|Overall Study|Other not defined above|2|||
33257459|NCT02759016|100842780|FG001|Overall Study|Other not defined above|1|||
33257460|NCT01443845|100842781|FG000|Overall Study|Protocol Violation|43|||
33257461|NCT01443845|100842782|FG001|Overall Study|Protocol Violation|45|||
33257462|NCT01443845|100842781|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
33257463|NCT01443845|100842782|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
33257464|NCT01443845|100842781|FG000|Overall Study|Deterioration in pulmonary function|1|||
33257465|NCT01443845|100842782|FG001|Overall Study|Deterioration in pulmonary function|4|||
33257466|NCT01443845|100842781|FG000|Overall Study|Lack of Efficacy|10|||
33257467|NCT01443845|100842782|FG001|Overall Study|Lack of Efficacy|5|||
33257468|NCT01443845|100842781|FG000|Overall Study|Adverse Event|64|||
33257469|NCT01443845|100842782|FG001|Overall Study|Adverse Event|138|||
33257470|NCT01443845|100842781|FG000|Overall Study|Withdrawal by Subject|63|||
33257471|NCT01443845|100842782|FG001|Overall Study|Withdrawal by Subject|67|||
33257472|NCT01443845|100842781|FG000|Overall Study|Military Conflict - Site Terminated|20|||
33257473|NCT01443845|100842782|FG001|Overall Study|Military Conflict - Site Terminated|21|||
33257474|NCT01443845|100842781|FG000|Overall Study|Lost to Follow-up|9|||
33257475|NCT01443845|100842782|FG001|Overall Study|Lost to Follow-up|13|||
33257476|NCT01875848|100842785|FG000|Overall Study|Withdrawal by Subject|2|||
33257477|NCT01875848|100842786|FG001|Overall Study|Withdrawal by Subject|0|||
33257478|NCT01109524|100842789|FG000|Overall Study|Disease Progression|29|||
33257479|NCT01109524|100842789|FG000|Overall Study|Study Drug toxicity|6|||
33257480|NCT01109524|100842789|FG000|Overall Study|Adverse Event|4|||
33257481|NCT01109524|100842789|FG000|Overall Study|Withdrawal by Subject|2|||
33257482|NCT01109524|100842789|FG000|Overall Study|Maximum clinical benefit|3|||
33257483|NCT01109524|100842789|FG000|Overall Study|Death|2|||
33257484|NCT01109524|100842789|FG000|Overall Study|No longer meets criteria|2|||
33257485|NCT01109524|100842789|FG000|Overall Study|Participant requested to end treatment|4|||
33257486|NCT01109524|100842789|FG000|Overall Study|Other|5|||
33257487|NCT00716859|100842790|FG000|Overall Study|Adverse Event|4|||
33257488|NCT00716859|100842791|FG001|Overall Study|Adverse Event|1|||
33163256|NCT01364649|100508190|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
33163257|NCT01364649|100508191|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
33163258|NCT01364649|100508190|FG000|Overall Study|Protocol Deviations|4|||
33163259|NCT01364649|100508191|FG001|Overall Study|Protocol Deviations|8|||
33163260|NCT01364649|100508190|FG000|Overall Study|Withdrawal of Consent|9|||
33257489|NCT00716859|100842790|FG000|Overall Study|Lack of Efficacy|3|||
33257490|NCT00716859|100842791|FG001|Overall Study|Lack of Efficacy|0|||
33257491|NCT00716859|100842790|FG000|Overall Study|Withdrawal by Subject|1|||
33163261|NCT01364649|100508191|FG001|Overall Study|Withdrawal of Consent|7|||
33163262|NCT01364649|100508190|FG000|Overall Study|Lost to Follow-up|12|||
33163263|NCT01364649|100508191|FG001|Overall Study|Lost to Follow-up|13|||
33163264|NCT01364649|100508190|FG000|Overall Study|Other|4|||
33163265|NCT01364649|100508191|FG001|Overall Study|Other|1|||
33163266|NCT01405456|100508192|FG000|Overall Study|Lost to Follow-up|2|||
33163267|NCT01405456|100508193|FG001|Overall Study|Lost to Follow-up|1|||
33163268|NCT01405456|100508192|FG000|Overall Study|Physician Decision|1|||
33163269|NCT01405456|100508193|FG001|Overall Study|Physician Decision|0|||
33163270|NCT01774968|100508194|FG000|Overall Study|Adverse Event|4|||
33163271|NCT01774968|100508195|FG001|Overall Study|Adverse Event|4|||
33163272|NCT01774968|100508194|FG000|Overall Study|Death|0|||
33163273|NCT01774968|100508195|FG001|Overall Study|Death|1|||
33163274|NCT01774968|100508194|FG000|Overall Study|Lost to Follow-up|1|||
33163275|NCT01774968|100508195|FG001|Overall Study|Lost to Follow-up|3|||
33163276|NCT01774968|100508194|FG000|Overall Study|Physician Decision|5|||
33163277|NCT01774968|100508195|FG001|Overall Study|Physician Decision|1|||
33163278|NCT01774968|100508194|FG000|Overall Study|Protocol Violation|14|||
33163279|NCT01774968|100508195|FG001|Overall Study|Protocol Violation|13|||
33163280|NCT01774968|100508194|FG000|Overall Study|Sponsor Decision|0|||
33443804|NCT01190930|101518913|FG009|Induction|Philadelphia chromosome-positive|0|||
33443805|NCT01190930|101518904|FG000|Induction|Incomplete Induction data|63|||
33443806|NCT01190930|101518905|FG001|Induction|Incomplete Induction data|0|||
33443807|NCT01190930|101518906|FG002|Induction|Incomplete Induction data|0|||
33443808|NCT01190930|101518907|FG003|Induction|Incomplete Induction data|0|||
33443809|NCT01190930|101518908|FG004|Induction|Incomplete Induction data|0|||
33163281|NCT01774968|100508195|FG001|Overall Study|Sponsor Decision|2|||
33163282|NCT01774968|100508194|FG000|Overall Study|Withdrawal by Subject|6|||
33257492|NCT00716859|100842791|FG001|Overall Study|Withdrawal by Subject|3|||
33257493|NCT00716859|100842790|FG000|Overall Study|Not treated|1|||
33257494|NCT00716859|100842791|FG001|Overall Study|Not treated|1|||
33443810|NCT01190930|101518909|FG005|Induction|Incomplete Induction data|0|||
33443811|NCT01190930|101518910|FG006|Induction|Incomplete Induction data|0|||
33443812|NCT01190930|101518911|FG007|Induction|Incomplete Induction data|0|||
33163283|NCT01774968|100508195|FG001|Overall Study|Withdrawal by Subject|11|||
33163284|NCT01702805|100508198|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
33163285|NCT01702805|100508199|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
33163286|NCT01702805|100508198|FG000|Overall Study|Incomplete Follow-up|18|||
33163287|NCT01702805|100508199|FG001|Overall Study|Incomplete Follow-up|15|||
33163288|NCT01702805|100508198|FG000|Overall Study|Vital Status Assessment Only|40|||
33163289|NCT01702805|100508199|FG001|Overall Study|Vital Status Assessment Only|39|||
33163290|NCT01702805|100508198|FG000|Overall Study|Lost to Follow-up|5|||
33163291|NCT01702805|100508199|FG001|Overall Study|Lost to Follow-up|5|||
33257495|NCT01493778|100842792|FG000|Overall Study|Withdrawal by Subject|8|||
33443813|NCT01190930|101518912|FG008|Induction|Incomplete Induction data|0|||
33163292|NCT01651039|100508200|FG000|Overall Study|Non-evaluables|5|||
33163293|NCT01651039|100508200|FG000|Overall Study|Physician Decision|2|||
33163294|NCT01651039|100508200|FG000|Overall Study|Withdrawal by Subject|1|||
33163295|NCT01651039|100508200|FG000|Overall Study|Progressive Disease|22|||
33163296|NCT03715530|100508205|FG000|Overall Study|Lost to Follow-up|3|||
33163297|NCT03715530|100508206|FG001|Overall Study|Lost to Follow-up|1|||
33443814|NCT01190930|101518913|FG009|Induction|Incomplete Induction data|0|||
33443815|NCT01190930|101518904|FG000|Induction|Progressive disease|0|||
33443816|NCT01190930|101518905|FG001|Induction|Progressive disease|1|||
33443817|NCT01190930|101518906|FG002|Induction|Progressive disease|0|||
33443818|NCT01190930|101518907|FG003|Induction|Progressive disease|0|||
33443819|NCT01190930|101518908|FG004|Induction|Progressive disease|0|||
33443820|NCT01190930|101518909|FG005|Induction|Progressive disease|0|||
33443821|NCT01190930|101518910|FG006|Induction|Progressive disease|0|||
33163298|NCT03715530|100508207|FG002|Overall Study|Lost to Follow-up|2|||
33443822|NCT01190930|101518911|FG007|Induction|Progressive disease|0|||
33443823|NCT01190930|101518912|FG008|Induction|Progressive disease|0|||
33163299|NCT00256750|100508208|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
33163300|NCT00256750|100508209|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
33163301|NCT00256750|100508210|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
33163302|NCT00256750|100508208|FG000|Transplanted Pre-Treatment|Other|2|||
33163303|NCT00256750|100508209|FG001|Transplanted Pre-Treatment|Other|0|||
33163304|NCT00256750|100508210|FG002|Transplanted Pre-Treatment|Other|0|||
33163305|NCT00256750|100508208|FG000|Transplanted Pre-Treatment|Death|1|||
33163306|NCT00256750|100508209|FG001|Transplanted Pre-Treatment|Death|0|||
33163307|NCT00256750|100508210|FG002|Transplanted Pre-Treatment|Death|0|||
33163308|NCT00256750|100508208|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
33163309|NCT00256750|100508209|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
33163310|NCT00256750|100508210|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
33163311|NCT00256750|100508208|FG000|Post-Transplant Treated (12 Months)|Death|3|||
33163312|NCT00256750|100508209|FG001|Post-Transplant Treated (12 Months)|Death|2|||
33163313|NCT00256750|100508210|FG002|Post-Transplant Treated (12 Months)|Death|4|||
33443824|NCT01190930|101518913|FG009|Induction|Progressive disease|0|||
33443825|NCT01190930|101518904|FG000|Induction|No treatment|3|||
33163314|NCT00256750|100508208|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
33163315|NCT00256750|100508209|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
33443826|NCT01190930|101518905|FG001|Induction|No treatment|0|||
33443827|NCT01190930|101518906|FG002|Induction|No treatment|0|||
33443828|NCT01190930|101518907|FG003|Induction|No treatment|0|||
33443829|NCT01190930|101518908|FG004|Induction|No treatment|0|||
33443830|NCT01190930|101518909|FG005|Induction|No treatment|0|||
33443831|NCT01190930|101518910|FG006|Induction|No treatment|0|||
33443832|NCT01190930|101518911|FG007|Induction|No treatment|0|||
33443833|NCT01190930|101518912|FG008|Induction|No treatment|0|||
33163316|NCT00256750|100508210|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
33163317|NCT00256750|100508208|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
33443834|NCT01190930|101518913|FG009|Induction|No treatment|0|||
33443835|NCT01190930|101518904|FG000|Induction|Ineligible|69|||
33443836|NCT01190930|101518905|FG001|Induction|Ineligible|4|||
33443837|NCT01190930|101518906|FG002|Induction|Ineligible|0|||
33443838|NCT01190930|101518907|FG003|Induction|Ineligible|0|||
33163318|NCT00256750|100508209|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
33163319|NCT00256750|100508210|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
33163320|NCT00256750|100508208|FG000|Post-Transplant Treated (12 Months)|Other|5|||
33163321|NCT00256750|100508209|FG001|Post-Transplant Treated (12 Months)|Other|4|||
33163322|NCT00256750|100508210|FG002|Post-Transplant Treated (12 Months)|Other|2|||
33163323|NCT00256750|100508208|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
33163324|NCT00256750|100508209|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
33163325|NCT00256750|100508210|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
33163326|NCT00256750|100508208|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
33163327|NCT00256750|100508209|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
33163328|NCT00256750|100508210|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
33163329|NCT00256750|100508208|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
33163330|NCT00256750|100508209|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
33163331|NCT00256750|100508210|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
33163332|NCT00256750|100508208|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
33163333|NCT00256750|100508209|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
33163334|NCT00256750|100508210|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
33163335|NCT00256750|100508208|FG000|Post-Transplant Treated (24 Months)|Death|3|||
33163336|NCT00256750|100508209|FG001|Post-Transplant Treated (24 Months)|Death|0|||
33163337|NCT00256750|100508210|FG002|Post-Transplant Treated (24 Months)|Death|0|||
33163338|NCT00256750|100508208|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
33163339|NCT00256750|100508209|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
33163340|NCT00256750|100508210|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
33163341|NCT00256750|100508208|FG000|Post-Transplant Treated (24 Months)|Other|2|||
33163342|NCT00256750|100508209|FG001|Post-Transplant Treated (24 Months)|Other|0|||
33163343|NCT00256750|100508210|FG002|Post-Transplant Treated (24 Months)|Other|1|||
33163344|NCT00256750|100508208|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
33163345|NCT00256750|100508209|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
33163346|NCT00256750|100508210|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
33163347|NCT00256750|100508208|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
33163348|NCT00256750|100508209|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
33163349|NCT00256750|100508210|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
33163350|NCT00256750|100508208|FG000|Post-Transplant Treated (36 Months)|Death|0|||
33163351|NCT00256750|100508209|FG001|Post-Transplant Treated (36 Months)|Death|2|||
33163352|NCT00256750|100508210|FG002|Post-Transplant Treated (36 Months)|Death|1|||
33163353|NCT00256750|100508208|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
33163354|NCT00256750|100508209|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
33163355|NCT00256750|100508210|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
33257496|NCT04600752|100842793|FG000|Overall Study|Physician Decision|0|||
33257497|NCT04600752|100842794|FG001|Overall Study|Physician Decision|0|||
33257498|NCT04600752|100842795|FG002|Overall Study|Physician Decision|1|||
33257499|NCT04600752|100842793|FG000|Overall Study|Adverse Event|0|||
33163356|NCT00256750|100508208|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
33163357|NCT00256750|100508209|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
33163358|NCT00256750|100508210|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
33257500|NCT04600752|100842794|FG001|Overall Study|Adverse Event|1|||
33257501|NCT04600752|100842795|FG002|Overall Study|Adverse Event|0|||
33163359|NCT00256750|100508208|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
33163360|NCT00256750|100508209|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
33163361|NCT00256750|100508210|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
33163362|NCT00256750|100508208|FG000|Post-Transplant Treated (36 Months)|Other|0|||
33163363|NCT00256750|100508209|FG001|Post-Transplant Treated (36 Months)|Other|1|||
33163364|NCT00256750|100508210|FG002|Post-Transplant Treated (36 Months)|Other|1|||
33163365|NCT00256750|100508208|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
33163366|NCT00256750|100508209|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
33163367|NCT00256750|100508210|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
33163368|NCT00256750|100508208|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
33163369|NCT00256750|100508209|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
33163370|NCT00256750|100508210|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
33163371|NCT00256750|100508208|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
33163372|NCT00256750|100508209|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
33163373|NCT00256750|100508210|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
33163374|NCT00256750|100508208|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
33163375|NCT00256750|100508209|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
33163376|NCT00256750|100508210|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
33163377|NCT00256750|100508208|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
33163378|NCT00256750|100508209|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
33163379|NCT00256750|100508210|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
33163380|NCT00256750|100508208|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
33163381|NCT00256750|100508209|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
33163382|NCT00256750|100508210|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
33163383|NCT00256750|100508208|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
33163384|NCT00256750|100508209|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
33163385|NCT00256750|100508210|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
33163386|NCT00256750|100508208|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
33163387|NCT00256750|100508209|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
33163388|NCT00256750|100508210|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
33163389|NCT00256750|100508208|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
33163390|NCT00256750|100508209|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
33163391|NCT00256750|100508210|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
33163392|NCT02100514|100508211|FG000|Treatment Period|Adverse Event|0|||
33163393|NCT02100514|100508212|FG001|Treatment Period|Adverse Event|5|||
33163394|NCT02100514|100508213|FG002|Treatment Period|Adverse Event|0|||
33163395|NCT02100514|100508214|FG003|Treatment Period|Adverse Event|0|||
33163396|NCT02100514|100508215|FG004|Treatment Period|Adverse Event|0|||
33163397|NCT02100514|100508211|FG000|Treatment Period|Death|2|||
33163398|NCT02100514|100508212|FG001|Treatment Period|Death|2|||
33163399|NCT02100514|100508213|FG002|Treatment Period|Death|0|||
33163400|NCT02100514|100508214|FG003|Treatment Period|Death|0|||
33163401|NCT02100514|100508215|FG004|Treatment Period|Death|0|||
33163402|NCT02100514|100508211|FG000|Treatment Period|Lost to Follow-up|5|||
33163403|NCT02100514|100508212|FG001|Treatment Period|Lost to Follow-up|17|||
33163404|NCT02100514|100508213|FG002|Treatment Period|Lost to Follow-up|0|||
33163405|NCT02100514|100508214|FG003|Treatment Period|Lost to Follow-up|0|||
33163406|NCT02100514|100508215|FG004|Treatment Period|Lost to Follow-up|0|||
33163407|NCT02100514|100508211|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
33163408|NCT02100514|100508212|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
33163409|NCT02100514|100508213|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
33163410|NCT02100514|100508214|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
33163411|NCT02100514|100508215|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
33163412|NCT02100514|100508211|FG000|Treatment Period|Protocol Violation|1|||
33163413|NCT02100514|100508212|FG001|Treatment Period|Protocol Violation|1|||
33163414|NCT02100514|100508213|FG002|Treatment Period|Protocol Violation|0|||
33163415|NCT02100514|100508214|FG003|Treatment Period|Protocol Violation|0|||
33163416|NCT02100514|100508215|FG004|Treatment Period|Protocol Violation|0|||
33163417|NCT02100514|100508211|FG000|Treatment Period|Withdrawal by Subject|12|||
33163418|NCT02100514|100508212|FG001|Treatment Period|Withdrawal by Subject|37|||
33163419|NCT02100514|100508213|FG002|Treatment Period|Withdrawal by Subject|0|||
33163420|NCT02100514|100508214|FG003|Treatment Period|Withdrawal by Subject|0|||
33163421|NCT02100514|100508215|FG004|Treatment Period|Withdrawal by Subject|0|||
33163422|NCT02100514|100508211|FG000|Treatment Period|Other|9|||
33163423|NCT02100514|100508212|FG001|Treatment Period|Other|11|||
33163424|NCT02100514|100508213|FG002|Treatment Period|Other|0|||
33163425|NCT02100514|100508214|FG003|Treatment Period|Other|0|||
33163426|NCT02100514|100508215|FG004|Treatment Period|Other|0|||
33163427|NCT02100514|100508211|FG000|Extension Period|Withdrew consent|0|||
33163428|NCT02100514|100508212|FG001|Extension Period|Withdrew consent|0|||
33163429|NCT02100514|100508213|FG002|Extension Period|Withdrew consent|2|||
33163430|NCT02100514|100508214|FG003|Extension Period|Withdrew consent|0|||
33163431|NCT02100514|100508215|FG004|Extension Period|Withdrew consent|0|||
33443839|NCT01190930|101518908|FG004|Induction|Ineligible|0|||
33443840|NCT01190930|101518909|FG005|Induction|Ineligible|0|||
33443841|NCT01190930|101518910|FG006|Induction|Ineligible|0|||
33443842|NCT01190930|101518911|FG007|Induction|Ineligible|0|||
33443843|NCT01190930|101518912|FG008|Induction|Ineligible|0|||
33443844|NCT01190930|101518913|FG009|Induction|Ineligible|0|||
33443845|NCT01190930|101518904|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
33443846|NCT01190930|101518905|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
33443847|NCT01190930|101518906|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
33443848|NCT01190930|101518907|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
33443849|NCT01190930|101518908|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
33443850|NCT01190930|101518909|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
33443851|NCT01190930|101518910|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
33443852|NCT01190930|101518911|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
33443853|NCT01190930|101518912|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
33443854|NCT01190930|101518913|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
33443855|NCT01190930|101518904|FG000|Post Induction Pre-Maintenance|Death|0|||
33443856|NCT01190930|101518905|FG001|Post Induction Pre-Maintenance|Death|0|||
33443857|NCT01190930|101518906|FG002|Post Induction Pre-Maintenance|Death|8|||
33443858|NCT01190930|101518907|FG003|Post Induction Pre-Maintenance|Death|4|||
33443859|NCT01190930|101518908|FG004|Post Induction Pre-Maintenance|Death|0|||
33443860|NCT01190930|101518909|FG005|Post Induction Pre-Maintenance|Death|0|||
33443861|NCT01190930|101518910|FG006|Post Induction Pre-Maintenance|Death|0|||
33443862|NCT01190930|101518911|FG007|Post Induction Pre-Maintenance|Death|0|||
33443863|NCT01190930|101518912|FG008|Post Induction Pre-Maintenance|Death|0|||
33443864|NCT01190930|101518913|FG009|Post Induction Pre-Maintenance|Death|0|||
33443865|NCT01190930|101518904|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
33443866|NCT01190930|101518905|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
33443867|NCT01190930|101518906|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
33443868|NCT01190930|101518907|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
33443869|NCT01190930|101518908|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
33443870|NCT01190930|101518909|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
33443871|NCT01190930|101518910|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
33443872|NCT01190930|101518911|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
33443873|NCT01190930|101518912|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
33443874|NCT01190930|101518913|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
33443875|NCT01190930|101518904|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
33443876|NCT01190930|101518905|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
33443877|NCT01190930|101518906|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
33443878|NCT01190930|101518907|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
33443879|NCT01190930|101518908|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
33443880|NCT01190930|101518909|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
33443881|NCT01190930|101518910|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
33443882|NCT01190930|101518911|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
33443883|NCT01190930|101518912|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
33443884|NCT01190930|101518913|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
33443885|NCT01190930|101518904|FG000|Post Induction Pre-Maintenance|Refusal|0|||
33443886|NCT01190930|101518905|FG001|Post Induction Pre-Maintenance|Refusal|2|||
33443887|NCT01190930|101518906|FG002|Post Induction Pre-Maintenance|Refusal|694|||
33443888|NCT01190930|101518907|FG003|Post Induction Pre-Maintenance|Refusal|4|||
33443889|NCT01190930|101518908|FG004|Post Induction Pre-Maintenance|Refusal|0|||
33443890|NCT01190930|101518909|FG005|Post Induction Pre-Maintenance|Refusal|3|||
33443891|NCT01190930|101518910|FG006|Post Induction Pre-Maintenance|Refusal|0|||
33443892|NCT01190930|101518911|FG007|Post Induction Pre-Maintenance|Refusal|0|||
33443893|NCT01190930|101518912|FG008|Post Induction Pre-Maintenance|Refusal|0|||
33443894|NCT01190930|101518913|FG009|Post Induction Pre-Maintenance|Refusal|0|||
33443895|NCT01190930|101518904|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
33443896|NCT01190930|101518905|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
33443897|NCT01190930|101518906|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
33443898|NCT01190930|101518907|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
33443899|NCT01190930|101518908|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
33443900|NCT01190930|101518909|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
33443901|NCT01190930|101518910|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
33443902|NCT01190930|101518911|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
33443903|NCT01190930|101518912|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
33443904|NCT01190930|101518913|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
33443905|NCT01190930|101518904|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33443906|NCT01190930|101518905|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
33443907|NCT01190930|101518906|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33443908|NCT01190930|101518907|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33443909|NCT01190930|101518908|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33443910|NCT01190930|101518909|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33443911|NCT01190930|101518910|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33443912|NCT01190930|101518911|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33443913|NCT01190930|101518912|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33443914|NCT01190930|101518913|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
33443915|NCT01190930|101518904|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
33443916|NCT01190930|101518905|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
33443917|NCT01190930|101518906|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
33443918|NCT01190930|101518907|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
33443919|NCT01190930|101518908|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
33443920|NCT01190930|101518909|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
33443921|NCT01190930|101518910|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
33443922|NCT01190930|101518911|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
33443923|NCT01190930|101518912|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
33443924|NCT01190930|101518913|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
33443925|NCT01190930|101518904|FG000|Post Induction Pre-Maintenance|Relapse|0|||
33443926|NCT01190930|101518905|FG001|Post Induction Pre-Maintenance|Relapse|0|||
33443927|NCT01190930|101518906|FG002|Post Induction Pre-Maintenance|Relapse|1|||
33443928|NCT01190930|101518907|FG003|Post Induction Pre-Maintenance|Relapse|0|||
33443929|NCT01190930|101518908|FG004|Post Induction Pre-Maintenance|Relapse|0|||
33443930|NCT01190930|101518909|FG005|Post Induction Pre-Maintenance|Relapse|0|||
33443931|NCT01190930|101518910|FG006|Post Induction Pre-Maintenance|Relapse|0|||
33443932|NCT01190930|101518911|FG007|Post Induction Pre-Maintenance|Relapse|0|||
33163432|NCT00288054|100508216|FG000|Overall Study|Protocol Violation|2|||
33163433|NCT00288054|100508216|FG000|Overall Study|Lack of Efficacy|16|||
33163434|NCT00288054|100508216|FG000|Overall Study|Adverse Event|3|||
33163435|NCT00288054|100508216|FG000|Overall Study|Withdrawal by Subject|1|||
33163436|NCT00288054|100508216|FG000|Overall Study|Not protocol specified|2|||
33163437|NCT01550289|100508217|FG000|Overall Study|Protocol Violation|1|||
33163438|NCT01550289|100508218|FG001|Overall Study|Protocol Violation|0|||
33163439|NCT01550289|100508217|FG000|Overall Study|Lost to Follow-up|1|||
33163440|NCT01550289|100508218|FG001|Overall Study|Lost to Follow-up|1|||
33163441|NCT01550289|100508217|FG000|Overall Study|Withdrawal by Subject|11|||
33163442|NCT01550289|100508218|FG001|Overall Study|Withdrawal by Subject|3|||
33163443|NCT02059395|100508219|FG000|Overall Study|Lost to Follow-up|2|||
33163444|NCT02059395|100508220|FG001|Overall Study|Lost to Follow-up|4|||
33163445|NCT01507298|100508221|FG000|Overall Study|Protocol Violation|0|||
33163446|NCT01507298|100508222|FG001|Overall Study|Protocol Violation|6|||
33163447|NCT02862171|100508229|FG000|Overall Study|Death|1|||
33163448|NCT02862171|100508229|FG000|Overall Study|Lost to Follow-up|13|||
33163449|NCT02862171|100508229|FG000|Overall Study|Withdrawal by Subject|57|||
33163450|NCT02862171|100508229|FG000|Overall Study|Non-compliance|4|||
33163451|NCT02862171|100508229|FG000|Overall Study|HIV-1 seroconversion|18|||
33163452|NCT00228384|100508230|FG000|Overall Study|Death|9|||
33443933|NCT01190930|101518912|FG008|Post Induction Pre-Maintenance|Relapse|0|||
33443934|NCT01190930|101518913|FG009|Post Induction Pre-Maintenance|Relapse|0|||
33257502|NCT04600752|100842793|FG000|Overall Study|Withdrawal by Subject|2|||
33257503|NCT04600752|100842794|FG001|Overall Study|Withdrawal by Subject|1|||
33257504|NCT04600752|100842795|FG002|Overall Study|Withdrawal by Subject|0|||
33257505|NCT04600752|100842793|FG000|Overall Study|Lack of Efficacy|1|||
33257506|NCT04600752|100842794|FG001|Overall Study|Lack of Efficacy|0|||
33257507|NCT04600752|100842795|FG002|Overall Study|Lack of Efficacy|0|||
33257508|NCT01376089|100845740|FG000|Overall Study|Patient received no contrast media|3|||
33257509|NCT01376089|100845741|FG001|Overall Study|Patient received no contrast media|4|||
33257510|NCT05382104|100845746|FG000|Period 2 (2 Days)|Adverse Event|0|||
33257511|NCT05382104|100845747|FG001|Period 2 (2 Days)|Adverse Event|1|||
33257512|NCT05382104|100845748|FG002|Period 2 (2 Days)|Adverse Event|0|||
33257513|NCT05382104|100845749|FG003|Period 2 (2 Days)|Adverse Event|0|||
33257514|NCT05382104|100845750|FG004|Period 2 (2 Days)|Adverse Event|0|||
33257515|NCT05382104|100845751|FG005|Period 2 (2 Days)|Adverse Event|0|||
33257516|NCT00262301|100845752|FG000|Double-blind Phase|Lost to Follow-up|1|||
33257517|NCT00262301|100845753|FG001|Double-blind Phase|Lost to Follow-up|0|||
33257518|NCT00262301|100845754|FG002|Double-blind Phase|Lost to Follow-up|0|||
33257519|NCT00262301|100845752|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
33257520|NCT00262301|100845753|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
33257521|NCT00262301|100845754|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
33257522|NCT01551355|100845755|FG000|Overall Study|Lost to Follow-up|51|||
33257523|NCT01551355|100845756|FG001|Overall Study|Lost to Follow-up|49|||
33257524|NCT01551355|100845757|FG002|Overall Study|Lost to Follow-up|34|||
33257525|NCT01551355|100845758|FG003|Overall Study|Lost to Follow-up|24|||
33257526|NCT01551355|100845759|FG004|Overall Study|Lost to Follow-up|9|||
33257527|NCT01551355|100845760|FG005|Overall Study|Lost to Follow-up|6|||
33257528|NCT02271854|100845761|FG000|Overall Study|Withdrawal by Subject|2|||
33257529|NCT02271854|100845761|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
33443935|NCT01190930|101518904|FG000|Maintenance|Adverse Event|0|||
33443936|NCT01190930|101518905|FG001|Maintenance|Adverse Event|0|||
33443937|NCT01190930|101518906|FG002|Maintenance|Adverse Event|0|||
33443938|NCT01190930|101518907|FG003|Maintenance|Adverse Event|0|||
33443939|NCT01190930|101518908|FG004|Maintenance|Adverse Event|0|||
33443940|NCT01190930|101518909|FG005|Maintenance|Adverse Event|1|||
33163453|NCT00228384|100508231|FG001|Overall Study|Death|3|||
33163454|NCT00228384|100508230|FG000|Overall Study|Lost to Follow-up|6|||
33163455|NCT00228384|100508231|FG001|Overall Study|Lost to Follow-up|10|||
33257530|NCT02271854|100845761|FG000|Overall Study|Lost to Follow-up|1|||
33257531|NCT03714815|100845762|FG000|Overall Study|Physician Decision|2|||
33257532|NCT03714815|100845762|FG000|Overall Study|Withdrawal by Subject|2|||
33257533|NCT03714815|100845762|FG000|Overall Study|Death|11|||
33443941|NCT01190930|101518910|FG006|Maintenance|Adverse Event|1|||
33443942|NCT01190930|101518911|FG007|Maintenance|Adverse Event|3|||
33443943|NCT01190930|101518912|FG008|Maintenance|Adverse Event|3|||
33257534|NCT00609336|100845763|FG000|Overall Study|Protocol Violation|3|||
33257535|NCT00609336|100845763|FG000|Overall Study|Death|1|||
33257536|NCT00609336|100845763|FG000|Overall Study|LA or Met at Surgery|9|||
33257537|NCT02706717|100845771|FG000|Overall Study|Withdrawal by Subject|1|||
33257538|NCT02706717|100845772|FG001|Overall Study|Withdrawal by Subject|8|||
33257539|NCT02706717|100845771|FG000|Overall Study|Lost to Follow-up|0|||
33257540|NCT02706717|100845772|FG001|Overall Study|Lost to Follow-up|1|||
33257541|NCT02706717|100845771|FG000|Overall Study|Physician Decision|0|||
33257542|NCT02706717|100845772|FG001|Overall Study|Physician Decision|1|||
33257543|NCT02706717|100845771|FG000|Overall Study|Death|0|||
33257544|NCT02706717|100845772|FG001|Overall Study|Death|1|||
33257545|NCT02466516|100845773|FG000|Overall Study|Adverse Event|1|||
33257546|NCT02466516|100845774|FG001|Overall Study|Adverse Event|1|||
33257547|NCT02466516|100845775|FG002|Overall Study|Adverse Event|0|||
33257548|NCT02466516|100845776|FG003|Overall Study|Adverse Event|0|||
33257549|NCT02466516|100845777|FG004|Overall Study|Adverse Event|0|||
33257550|NCT02466516|100845773|FG000|Overall Study|Withdrew Consent|1|||
33257551|NCT02466516|100845774|FG001|Overall Study|Withdrew Consent|0|||
33257552|NCT02466516|100845775|FG002|Overall Study|Withdrew Consent|0|||
33257553|NCT02466516|100845776|FG003|Overall Study|Withdrew Consent|0|||
33257554|NCT02466516|100845777|FG004|Overall Study|Withdrew Consent|0|||
33257555|NCT02466516|100845773|FG000|Overall Study|Lost to Follow-up|2|||
33257556|NCT02466516|100845774|FG001|Overall Study|Lost to Follow-up|0|||
33257557|NCT02466516|100845775|FG002|Overall Study|Lost to Follow-up|1|||
33257558|NCT02466516|100845776|FG003|Overall Study|Lost to Follow-up|0|||
33257559|NCT02466516|100845777|FG004|Overall Study|Lost to Follow-up|0|||
33257560|NCT03950622|100845778|FG000|Overall Study|Withdrawal by Subject|1|||
33257561|NCT03950622|100845779|FG001|Overall Study|Withdrawal by Subject|0|||
33257562|NCT03950622|100845778|FG000|Overall Study|Protocol Deviation|0|||
33257563|NCT03950622|100845779|FG001|Overall Study|Protocol Deviation|1|||
33257564|NCT03950622|100845778|FG000|Overall Study|Physician Decision|1|||
33257565|NCT03950622|100845779|FG001|Overall Study|Physician Decision|0|||
33257566|NCT03950622|100845778|FG000|Overall Study|Lost to Follow-up|5|||
33257567|NCT03950622|100845779|FG001|Overall Study|Lost to Follow-up|5|||
33257568|NCT03950622|100845778|FG000|Overall Study|Death|1|||
33257569|NCT03950622|100845779|FG001|Overall Study|Death|1|||
33257570|NCT01070069|100845782|FG000|Overall Study|Death|1|||
33257571|NCT01070069|100845783|FG001|Overall Study|Death|0|||
33257572|NCT01070069|100845784|FG002|Overall Study|Death|2|||
33257573|NCT01070069|100845785|FG003|Overall Study|Death|0|||
33257574|NCT01070069|100845786|FG004|Overall Study|Death|1|||
33257575|NCT01070069|100845782|FG000|Overall Study|Withdrawal by Subject|1|||
33257576|NCT01070069|100845783|FG001|Overall Study|Withdrawal by Subject|1|||
33257577|NCT01070069|100845784|FG002|Overall Study|Withdrawal by Subject|4|||
33257578|NCT01070069|100845785|FG003|Overall Study|Withdrawal by Subject|0|||
33257579|NCT01070069|100845786|FG004|Overall Study|Withdrawal by Subject|0|||
33257580|NCT01070069|100845782|FG000|Overall Study|Lost to Follow-up|4|||
33257581|NCT01070069|100845783|FG001|Overall Study|Lost to Follow-up|1|||
33257582|NCT01070069|100845784|FG002|Overall Study|Lost to Follow-up|0|||
33257583|NCT01070069|100845785|FG003|Overall Study|Lost to Follow-up|0|||
33257584|NCT01070069|100845786|FG004|Overall Study|Lost to Follow-up|3|||
33257585|NCT01579916|100845790|FG000|Overall Study|Lost to Follow-up|6|||
33257586|NCT01579916|100845791|FG001|Overall Study|Lost to Follow-up|1|||
33257587|NCT01579916|100845790|FG000|Overall Study|Withdrawal by Subject|1|||
33257588|NCT01579916|100845791|FG001|Overall Study|Withdrawal by Subject|1|||
33257589|NCT01579916|100845790|FG000|Overall Study|Death|1|||
33443944|NCT01190930|101518913|FG009|Maintenance|Adverse Event|0|||
33257590|NCT01579916|100845791|FG001|Overall Study|Death|0|||
33257591|NCT00411216|100845794|FG000|Overall Study|Ten participants were entered into the c|0|||
33443945|NCT01190930|101518904|FG000|Maintenance|Death|0|||
33257592|NCT00411216|100845795|FG001|Overall Study|Ten participants were entered into the c|2|||
33443946|NCT01190930|101518905|FG001|Maintenance|Death|0|||
33257593|NCT03260140|100845796|FG000|Overall Study|Death|4|||
33257594|NCT03260140|100845797|FG001|Overall Study|Death|1|||
33257595|NCT03260140|100845796|FG000|Overall Study|Withdrawal by Subject|1|||
33257596|NCT03260140|100845797|FG001|Overall Study|Withdrawal by Subject|4|||
33257597|NCT01546753|100845798|FG000|Overall Study|anxiety|1|||
33257598|NCT01546753|100845799|FG001|Overall Study|anxiety|1|||
33257599|NCT01546753|100845798|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
33257600|NCT01546753|100845799|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
33257601|NCT00595413|100845800|FG000|Overall Study|Adverse Event|0|||
33443947|NCT01190930|101518906|FG002|Maintenance|Death|0|||
33443948|NCT01190930|101518907|FG003|Maintenance|Death|1|||
33257602|NCT00595413|100845801|FG001|Overall Study|Adverse Event|2|||
33257603|NCT00595413|100845802|FG002|Overall Study|Adverse Event|1|||
33257604|NCT00595413|100845803|FG003|Overall Study|Adverse Event|1|||
33257605|NCT00595413|100845800|FG000|Overall Study|Lost to Follow-up|2|||
33257606|NCT00595413|100845801|FG001|Overall Study|Lost to Follow-up|2|||
33257607|NCT00595413|100845802|FG002|Overall Study|Lost to Follow-up|1|||
33257608|NCT00595413|100845803|FG003|Overall Study|Lost to Follow-up|3|||
33257609|NCT00595413|100845800|FG000|Overall Study|Death|0|||
33257610|NCT00595413|100845801|FG001|Overall Study|Death|0|||
33257611|NCT00595413|100845802|FG002|Overall Study|Death|1|||
33257612|NCT00595413|100845803|FG003|Overall Study|Death|0|||
33257613|NCT00595413|100845800|FG000|Overall Study|Other|5|||
33257614|NCT00595413|100845801|FG001|Overall Study|Other|1|||
33257615|NCT00595413|100845802|FG002|Overall Study|Other|5|||
33443949|NCT01190930|101518908|FG004|Maintenance|Death|0|||
33443950|NCT01190930|101518909|FG005|Maintenance|Death|0|||
33443951|NCT01190930|101518910|FG006|Maintenance|Death|2|||
33443952|NCT01190930|101518911|FG007|Maintenance|Death|2|||
33443953|NCT01190930|101518912|FG008|Maintenance|Death|2|||
33443954|NCT01190930|101518913|FG009|Maintenance|Death|2|||
33257616|NCT00595413|100845803|FG003|Overall Study|Other|0|||
33257617|NCT02886286|100845816|FG000|Overall Study|pump motor stall|0|||
33257618|NCT02886286|100845817|FG001|Overall Study|pump motor stall|1|||
33257619|NCT02079844|100845818|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
33257620|NCT02079844|100845819|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
33257621|NCT02079844|100845820|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
33257622|NCT02079844|100845818|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
33257623|NCT02079844|100845819|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
33257624|NCT02079844|100845820|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
33257625|NCT02224924|100845827|FG000|Overall Study|Withdrawal by Subject|7|||
33257626|NCT02224924|100845828|FG001|Overall Study|Withdrawal by Subject|6|||
33257627|NCT02224924|100845827|FG000|Overall Study|Biopsy cancelled|20|||
33257628|NCT02224924|100845828|FG001|Overall Study|Biopsy cancelled|14|||
33257629|NCT02224924|100845827|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
33257630|NCT02224924|100845828|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
33257631|NCT02224924|100845827|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
33257632|NCT02224924|100845828|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
33257633|NCT01837966|100845829|FG000|Overall Study|Withdrawal by Subject|2|||
33257634|NCT01837966|100845830|FG001|Overall Study|Withdrawal by Subject|1|||
33257635|NCT00391846|100845837|FG000|Overall Study|Adverse Event|4|||
33257636|NCT00391846|100845838|FG001|Overall Study|Adverse Event|1|||
33257637|NCT00391846|100845837|FG000|Overall Study|Did not meet the required elig. crit|2|||
33163456|NCT00228384|100508230|FG000|Overall Study|Surgical Intervention (bypass)|5|||
33163457|NCT00228384|100508231|FG001|Overall Study|Surgical Intervention (bypass)|5|||
33257638|NCT00391846|100845838|FG001|Overall Study|Did not meet the required elig. crit|2|||
33257639|NCT00391846|100845837|FG000|Overall Study|Withdrawal by Subject|2|||
33257640|NCT00391846|100845838|FG001|Overall Study|Withdrawal by Subject|3|||
33257641|NCT00391846|100845837|FG000|Overall Study|Developed study specific DC criteria|0|||
33257642|NCT00391846|100845838|FG001|Overall Study|Developed study specific DC criteria|1|||
33257643|NCT01248936|100845839|FG000|Overall Study|Sponsor Decision|259|||
33257644|NCT01248936|100845839|FG000|Overall Study|Progression of Disease|50|||
33257645|NCT01248936|100845839|FG000|Overall Study|Death|26|||
33257646|NCT01248936|100845839|FG000|Overall Study|Withdrawal of Consent|20|||
33257647|NCT01248936|100845839|FG000|Overall Study|Adverse Event|8|||
33257648|NCT01248936|100845839|FG000|Overall Study|Lost to Follow-up|7|||
33257649|NCT01248936|100845839|FG000|Overall Study|Refused Treatment|1|||
33257650|NCT01248936|100845839|FG000|Overall Study|Other reason|3|||
33257651|NCT01369498|100845841|FG000|Overall Study|Lack of Efficacy|9|||
33257652|NCT01369498|100845842|FG001|Overall Study|Lack of Efficacy|9|||
33257653|NCT01369498|100845843|FG002|Overall Study|Lack of Efficacy|1|||
33257654|NCT01369498|100845844|FG003|Overall Study|Lack of Efficacy|3|||
33257655|NCT01369498|100845841|FG000|Overall Study|Adverse Event|1|||
33257656|NCT01369498|100845842|FG001|Overall Study|Adverse Event|2|||
33257657|NCT01369498|100845843|FG002|Overall Study|Adverse Event|0|||
33257658|NCT01369498|100845844|FG003|Overall Study|Adverse Event|1|||
33257659|NCT01369498|100845841|FG000|Overall Study|Withdrawal of Consent|0|||
33257660|NCT01369498|100845842|FG001|Overall Study|Withdrawal of Consent|1|||
33257661|NCT01369498|100845843|FG002|Overall Study|Withdrawal of Consent|1|||
33257662|NCT01369498|100845844|FG003|Overall Study|Withdrawal of Consent|1|||
33257663|NCT01369498|100845841|FG000|Overall Study|Death|0|||
33257664|NCT01369498|100845842|FG001|Overall Study|Death|0|||
33257665|NCT01369498|100845843|FG002|Overall Study|Death|1|||
33257666|NCT01369498|100845844|FG003|Overall Study|Death|0|||
33257667|NCT01369498|100845841|FG000|Overall Study|Investigator's Discretion|1|||
33257668|NCT01369498|100845842|FG001|Overall Study|Investigator's Discretion|0|||
33257669|NCT01369498|100845843|FG002|Overall Study|Investigator's Discretion|1|||
33257670|NCT01369498|100845844|FG003|Overall Study|Investigator's Discretion|3|||
33443955|NCT01190930|101518904|FG000|Maintenance|Lost to Follow-up|0|||
33443956|NCT01190930|101518905|FG001|Maintenance|Lost to Follow-up|0|||
33257671|NCT01369498|100845841|FG000|Overall Study|Unknown Reason|1|||
33257672|NCT01369498|100845842|FG001|Overall Study|Unknown Reason|0|||
33257673|NCT01369498|100845843|FG002|Overall Study|Unknown Reason|11|||
33257674|NCT01369498|100845844|FG003|Overall Study|Unknown Reason|6|||
33257675|NCT01369498|100845841|FG000|Overall Study|Disease Progression|0|||
33257676|NCT01369498|100845842|FG001|Overall Study|Disease Progression|0|||
33257677|NCT01369498|100845843|FG002|Overall Study|Disease Progression|0|||
33257678|NCT01369498|100845844|FG003|Overall Study|Disease Progression|1|||
33257679|NCT01255670|100845855|FG000|Overall Study|Adverse Event|10|||
33257680|NCT01255670|100845856|FG001|Overall Study|Adverse Event|10|||
33257681|NCT01255670|100845855|FG000|Overall Study|Lost to Follow-up|16|||
33257682|NCT01255670|100845856|FG001|Overall Study|Lost to Follow-up|10|||
33257683|NCT02214160|100845857|FG000|Overall Study|Withdrawal by Subject|1|||
33257684|NCT02214160|100845858|FG001|Overall Study|Withdrawal by Subject|0|||
33257685|NCT02214160|100845859|FG002|Overall Study|Withdrawal by Subject|6|||
33257686|NCT02214160|100845857|FG000|Overall Study|Death|2|||
33257687|NCT02214160|100845858|FG001|Overall Study|Death|2|||
33257688|NCT02214160|100845859|FG002|Overall Study|Death|1|||
33257689|NCT02214160|100845857|FG000|Overall Study|Subject Non-Compliance|0|||
33443957|NCT01190930|101518906|FG002|Maintenance|Lost to Follow-up|0|||
33443958|NCT01190930|101518907|FG003|Maintenance|Lost to Follow-up|0|||
33443959|NCT01190930|101518908|FG004|Maintenance|Lost to Follow-up|0|||
33443960|NCT01190930|101518909|FG005|Maintenance|Lost to Follow-up|0|||
33443961|NCT01190930|101518910|FG006|Maintenance|Lost to Follow-up|1|||
33443962|NCT01190930|101518911|FG007|Maintenance|Lost to Follow-up|1|||
33443963|NCT01190930|101518912|FG008|Maintenance|Lost to Follow-up|1|||
33443964|NCT01190930|101518913|FG009|Maintenance|Lost to Follow-up|0|||
33443965|NCT01190930|101518904|FG000|Maintenance|Physician Decision|0|||
33443966|NCT01190930|101518905|FG001|Maintenance|Physician Decision|1|||
33443967|NCT01190930|101518906|FG002|Maintenance|Physician Decision|0|||
33443968|NCT01190930|101518907|FG003|Maintenance|Physician Decision|5|||
33443969|NCT01190930|101518908|FG004|Maintenance|Physician Decision|9|||
33443970|NCT01190930|101518909|FG005|Maintenance|Physician Decision|4|||
33443971|NCT01190930|101518910|FG006|Maintenance|Physician Decision|8|||
33443972|NCT01190930|101518911|FG007|Maintenance|Physician Decision|8|||
33443973|NCT01190930|101518912|FG008|Maintenance|Physician Decision|10|||
33443974|NCT01190930|101518913|FG009|Maintenance|Physician Decision|17|||
33443975|NCT01190930|101518904|FG000|Maintenance|Withdrawal by Subject|0|||
33163458|NCT00228384|100508230|FG000|Overall Study|Withdrawal by Subject|9|||
33163459|NCT00228384|100508231|FG001|Overall Study|Withdrawal by Subject|10|||
33443976|NCT01190930|101518905|FG001|Maintenance|Withdrawal by Subject|0|||
33163460|NCT00228384|100508230|FG000|Overall Study|Physician Decision|0|||
33163461|NCT00228384|100508231|FG001|Overall Study|Physician Decision|1|||
33163462|NCT02468232|100508232|FG000|Core Part of Study|Adverse Event|0|||
33163463|NCT02468232|100508233|FG001|Core Part of Study|Adverse Event|1|||
33163464|NCT02468232|100508234|FG002|Core Part of Study|Adverse Event|0|||
33163465|NCT02468232|100508235|FG003|Core Part of Study|Adverse Event|0|||
33163466|NCT02468232|100508232|FG000|Core Part of Study|Death|20|||
33163467|NCT02468232|100508233|FG001|Core Part of Study|Death|17|||
33163468|NCT02468232|100508234|FG002|Core Part of Study|Death|0|||
33163469|NCT02468232|100508235|FG003|Core Part of Study|Death|0|||
33163470|NCT02468232|100508232|FG000|Core Part of Study|Technical Problems|1|||
33163471|NCT02468232|100508233|FG001|Core Part of Study|Technical Problems|1|||
33163472|NCT02468232|100508234|FG002|Core Part of Study|Technical Problems|0|||
33163473|NCT02468232|100508235|FG003|Core Part of Study|Technical Problems|0|||
33163474|NCT02468232|100508232|FG000|OLE Part of Study|Adverse Event|0|||
33163475|NCT02468232|100508233|FG001|OLE Part of Study|Adverse Event|0|||
33163476|NCT02468232|100508234|FG002|OLE Part of Study|Adverse Event|4|||
33163477|NCT02468232|100508235|FG003|OLE Part of Study|Adverse Event|5|||
33163478|NCT02468232|100508232|FG000|OLE Part of Study|Death|0|||
33163479|NCT02468232|100508233|FG001|OLE Part of Study|Death|0|||
33163480|NCT02468232|100508234|FG002|OLE Part of Study|Death|4|||
33163481|NCT02468232|100508235|FG003|OLE Part of Study|Death|2|||
33163482|NCT02468232|100508232|FG000|OLE Part of Study|Physician Decision|0|||
33163483|NCT02468232|100508233|FG001|OLE Part of Study|Physician Decision|0|||
33163484|NCT02468232|100508234|FG002|OLE Part of Study|Physician Decision|4|||
33163485|NCT02468232|100508235|FG003|OLE Part of Study|Physician Decision|0|||
33163486|NCT02468232|100508232|FG000|OLE Part of Study|Subject/Guardian decision|0|||
33163487|NCT02468232|100508233|FG001|OLE Part of Study|Subject/Guardian decision|0|||
33163488|NCT02468232|100508234|FG002|OLE Part of Study|Subject/Guardian decision|2|||
33163489|NCT02468232|100508235|FG003|OLE Part of Study|Subject/Guardian decision|5|||
33443977|NCT01190930|101518906|FG002|Maintenance|Withdrawal by Subject|0|||
33443978|NCT01190930|101518907|FG003|Maintenance|Withdrawal by Subject|0|||
33443979|NCT01190930|101518908|FG004|Maintenance|Withdrawal by Subject|0|||
33443980|NCT01190930|101518909|FG005|Maintenance|Withdrawal by Subject|0|||
33443981|NCT01190930|101518910|FG006|Maintenance|Withdrawal by Subject|2|||
33443982|NCT01190930|101518911|FG007|Maintenance|Withdrawal by Subject|1|||
33443983|NCT01190930|101518912|FG008|Maintenance|Withdrawal by Subject|4|||
33443984|NCT01190930|101518913|FG009|Maintenance|Withdrawal by Subject|1|||
33443985|NCT01190930|101518904|FG000|Maintenance|Refusal|0|||
33443986|NCT01190930|101518905|FG001|Maintenance|Refusal|1|||
33443987|NCT01190930|101518906|FG002|Maintenance|Refusal|0|||
33443988|NCT01190930|101518907|FG003|Maintenance|Refusal|2|||
33443989|NCT01190930|101518908|FG004|Maintenance|Refusal|0|||
33443990|NCT01190930|101518909|FG005|Maintenance|Refusal|4|||
33443991|NCT01190930|101518910|FG006|Maintenance|Refusal|5|||
33443992|NCT01190930|101518911|FG007|Maintenance|Refusal|17|||
33443993|NCT01190930|101518912|FG008|Maintenance|Refusal|13|||
33163490|NCT04092582|100508236|FG000|Overall Study|Death|1|||
33163491|NCT04092582|100508237|FG001|Overall Study|Death|1|||
33163492|NCT04092582|100508236|FG000|Overall Study|Withdrawal by Subject|4|||
33163493|NCT04092582|100508237|FG001|Overall Study|Withdrawal by Subject|1|||
33163494|NCT04092582|100508236|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
33163495|NCT04092582|100508237|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
33163496|NCT02200211|100508238|FG000|Overall Study|Lost to Follow-up|7|||
33163497|NCT02200211|100508239|FG001|Overall Study|Lost to Follow-up|7|||
33163498|NCT02200211|100508240|FG002|Overall Study|Lost to Follow-up|1|||
33163499|NCT02200211|100508241|FG003|Overall Study|Lost to Follow-up|2|||
33163500|NCT02200211|100508238|FG000|Overall Study|Withdrawal by Subject|1|||
33163501|NCT02200211|100508239|FG001|Overall Study|Withdrawal by Subject|0|||
33163502|NCT02200211|100508240|FG002|Overall Study|Withdrawal by Subject|0|||
33163503|NCT02200211|100508241|FG003|Overall Study|Withdrawal by Subject|0|||
33163504|NCT00530946|100508242|FG000|Overall Study|Adverse Event|1|||
33163505|NCT00530946|100508243|FG001|Overall Study|Adverse Event|2|||
33163506|NCT00530946|100508244|FG002|Overall Study|Adverse Event|1|||
33257690|NCT02214160|100845858|FG001|Overall Study|Subject Non-Compliance|3|||
33443994|NCT01190930|101518913|FG009|Maintenance|Refusal|6|||
33443995|NCT01190930|101518904|FG000|Maintenance|second malignant neoplasm|0|||
33443996|NCT01190930|101518905|FG001|Maintenance|second malignant neoplasm|0|||
33443997|NCT01190930|101518906|FG002|Maintenance|second malignant neoplasm|0|||
33443998|NCT01190930|101518907|FG003|Maintenance|second malignant neoplasm|1|||
33443999|NCT01190930|101518908|FG004|Maintenance|second malignant neoplasm|0|||
33444000|NCT01190930|101518909|FG005|Maintenance|second malignant neoplasm|1|||
33444001|NCT01190930|101518910|FG006|Maintenance|second malignant neoplasm|0|||
33444002|NCT01190930|101518911|FG007|Maintenance|second malignant neoplasm|0|||
33444003|NCT01190930|101518912|FG008|Maintenance|second malignant neoplasm|1|||
33444004|NCT01190930|101518913|FG009|Maintenance|second malignant neoplasm|0|||
33444005|NCT01190930|101518904|FG000|Maintenance|Inevaluable|0|||
33444006|NCT01190930|101518905|FG001|Maintenance|Inevaluable|0|||
33444007|NCT01190930|101518906|FG002|Maintenance|Inevaluable|0|||
33444008|NCT01190930|101518907|FG003|Maintenance|Inevaluable|0|||
33444009|NCT01190930|101518908|FG004|Maintenance|Inevaluable|0|||
33444010|NCT01190930|101518909|FG005|Maintenance|Inevaluable|1|||
33444011|NCT01190930|101518910|FG006|Maintenance|Inevaluable|1|||
33444012|NCT01190930|101518911|FG007|Maintenance|Inevaluable|1|||
33444013|NCT01190930|101518912|FG008|Maintenance|Inevaluable|0|||
33444014|NCT01190930|101518913|FG009|Maintenance|Inevaluable|0|||
33444015|NCT01190930|101518904|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
33444016|NCT01190930|101518905|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
33444017|NCT01190930|101518906|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
33444018|NCT01190930|101518907|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
33444019|NCT01190930|101518908|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
33444020|NCT01190930|101518909|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
33444021|NCT01190930|101518910|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
33444022|NCT01190930|101518911|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
33444023|NCT01190930|101518912|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
33444024|NCT01190930|101518913|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
33257691|NCT02214160|100845859|FG002|Overall Study|Subject Non-Compliance|1|||
33257692|NCT02214160|100845857|FG000|Overall Study|Adverse Event|0|||
33444025|NCT01190930|101518904|FG000|Maintenance|Relapse|0|||
33257693|NCT02214160|100845858|FG001|Overall Study|Adverse Event|1|||
33444026|NCT01190930|101518905|FG001|Maintenance|Relapse|0|||
33444027|NCT01190930|101518906|FG002|Maintenance|Relapse|0|||
33444028|NCT01190930|101518907|FG003|Maintenance|Relapse|2|||
33444029|NCT01190930|101518908|FG004|Maintenance|Relapse|0|||
33444030|NCT01190930|101518909|FG005|Maintenance|Relapse|1|||
33444031|NCT01190930|101518910|FG006|Maintenance|Relapse|6|||
33444032|NCT01190930|101518911|FG007|Maintenance|Relapse|13|||
33444033|NCT01190930|101518912|FG008|Maintenance|Relapse|11|||
33444034|NCT01190930|101518913|FG009|Maintenance|Relapse|11|||
33444035|NCT01190930|101518904|FG000|Maintenance|Still on therapy|0|||
33444036|NCT01190930|101518905|FG001|Maintenance|Still on therapy|8|||
33444037|NCT01190930|101518906|FG002|Maintenance|Still on therapy|0|||
33444038|NCT01190930|101518907|FG003|Maintenance|Still on therapy|29|||
33444039|NCT01190930|101518908|FG004|Maintenance|Still on therapy|0|||
33444040|NCT01190930|101518909|FG005|Maintenance|Still on therapy|0|||
33444041|NCT01190930|101518910|FG006|Maintenance|Still on therapy|0|||
33444042|NCT01190930|101518911|FG007|Maintenance|Still on therapy|0|||
33444043|NCT01190930|101518912|FG008|Maintenance|Still on therapy|0|||
33444044|NCT01190930|101518913|FG009|Maintenance|Still on therapy|0|||
33444045|NCT02865850|101518922|FG000|Overall Study|Death|15|||
33444046|NCT02865850|101518923|FG001|Overall Study|Death|19|||
33444047|NCT02865850|101518922|FG000|Overall Study|Withdrawal by Subject|3|||
33444048|NCT02865850|101518923|FG001|Overall Study|Withdrawal by Subject|2|||
33444049|NCT02865850|101518922|FG000|Overall Study|Lost to Follow-up|3|||
33444050|NCT02865850|101518923|FG001|Overall Study|Lost to Follow-up|2|||
33444051|NCT00984126|101518924|FG000|Overall Study|Protocol Violation|0|||
33444052|NCT00984126|101518925|FG001|Overall Study|Protocol Violation|0|||
33444053|NCT00984126|101518926|FG002|Overall Study|Protocol Violation|1|||
33444054|NCT00984126|101518927|FG003|Overall Study|Protocol Violation|2|||
33444055|NCT00984126|101518924|FG000|Overall Study|Adverse Event|0|||
33444056|NCT00984126|101518925|FG001|Overall Study|Adverse Event|0|||
33444057|NCT00984126|101518926|FG002|Overall Study|Adverse Event|0|||
33444058|NCT00984126|101518927|FG003|Overall Study|Adverse Event|2|||
33444059|NCT00984126|101518924|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
33444060|NCT00984126|101518925|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
33444061|NCT00984126|101518926|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
33444062|NCT00984126|101518927|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
33444063|NCT00984126|101518924|FG000|Overall Study|Withdrawal criteria|0|||
33163507|NCT00530946|100508245|FG003|Overall Study|Adverse Event|1|||
33163508|NCT00530946|100508242|FG000|Overall Study|Protocol Violation|0|||
33163509|NCT00530946|100508243|FG001|Overall Study|Protocol Violation|0|||
33163510|NCT00530946|100508244|FG002|Overall Study|Protocol Violation|0|||
33163511|NCT00530946|100508245|FG003|Overall Study|Protocol Violation|1|||
33163512|NCT00530946|100508242|FG000|Overall Study|Noncompliance|1|||
33163513|NCT00530946|100508243|FG001|Overall Study|Noncompliance|0|||
33163514|NCT00530946|100508244|FG002|Overall Study|Noncompliance|0|||
33163515|NCT00530946|100508245|FG003|Overall Study|Noncompliance|0|||
33163516|NCT00283400|100508246|FG000|Overall Study|Withdrawal by Subject|1|||
33163517|NCT00283400|100508247|FG001|Overall Study|Withdrawal by Subject|1|||
33163518|NCT00283400|100508248|FG002|Overall Study|Withdrawal by Subject|0|||
33163519|NCT00283400|100508249|FG003|Overall Study|Withdrawal by Subject|0|||
33163520|NCT00283400|100508246|FG000|Overall Study|Death|1|||
33163521|NCT00283400|100508247|FG001|Overall Study|Death|0|||
33163522|NCT00283400|100508248|FG002|Overall Study|Death|1|||
33163523|NCT00283400|100508249|FG003|Overall Study|Death|0|||
33163524|NCT02256631|100508251|FG000|Overall Study|Lost to Follow-up|1|||
33163525|NCT02256631|100508252|FG001|Overall Study|Lost to Follow-up|1|||
33163526|NCT02256631|100508253|FG002|Overall Study|Lost to Follow-up|0|||
33163527|NCT02256631|100508254|FG003|Overall Study|Lost to Follow-up|2|||
33163528|NCT02256631|100508255|FG004|Overall Study|Lost to Follow-up|0|||
33444064|NCT00984126|101518925|FG001|Overall Study|Withdrawal criteria|1|||
33444065|NCT00984126|101518926|FG002|Overall Study|Withdrawal criteria|3|||
33444066|NCT00984126|101518927|FG003|Overall Study|Withdrawal criteria|9|||
33444067|NCT00312897|101518928|FG000|Overall Study|Adverse Event|1|||
33444068|NCT00312897|101518929|FG001|Overall Study|Adverse Event|0|||
33163529|NCT02256631|100508256|FG005|Overall Study|Lost to Follow-up|4|||
33163530|NCT02256631|100508257|FG006|Overall Study|Lost to Follow-up|1|||
33163531|NCT02256631|100508251|FG000|Overall Study|Withdrawal by Subject|0|||
33163532|NCT02256631|100508252|FG001|Overall Study|Withdrawal by Subject|0|||
33444069|NCT00312897|101518928|FG000|Overall Study|Lost to Follow-up|2|||
33444070|NCT00312897|101518929|FG001|Overall Study|Lost to Follow-up|0|||
33444071|NCT00312897|101518928|FG000|Overall Study|Physician Decision|1|||
33444072|NCT00312897|101518929|FG001|Overall Study|Physician Decision|0|||
33444073|NCT00312897|101518928|FG000|Overall Study|Withdrawal by Subject|1|||
33444074|NCT00312897|101518929|FG001|Overall Study|Withdrawal by Subject|3|||
33444075|NCT00312897|101518928|FG000|Overall Study|Pregnancy|1|||
33444076|NCT00312897|101518929|FG001|Overall Study|Pregnancy|0|||
33444077|NCT00312897|101518928|FG000|Overall Study|discontinued prior to getting treatment|0|||
33444078|NCT00312897|101518929|FG001|Overall Study|discontinued prior to getting treatment|3|||
33444079|NCT02445339|101518930|FG000|Overall Study|Physician Decision|1|||
33444080|NCT02445339|101518931|FG001|Overall Study|Physician Decision|0|||
33444081|NCT02445339|101518930|FG000|Overall Study|Lost to Follow-up|11|||
33444082|NCT02445339|101518931|FG001|Overall Study|Lost to Follow-up|15|||
33444083|NCT01348789|101518932|FG000|Overall Study|Protocol Violation|2|||
33444084|NCT01348789|101518932|FG000|Overall Study|Withdrawal by Subject|2|||
33444085|NCT01921062|101518937|FG000|Overall Study|Withdrawal by Subject|0|||
33444086|NCT01921062|101518938|FG001|Overall Study|Withdrawal by Subject|7|||
33444087|NCT01921062|101518937|FG000|Overall Study|Adverse Event|5|||
33444088|NCT01921062|101518938|FG001|Overall Study|Adverse Event|6|||
33444089|NCT01921062|101518937|FG000|Overall Study|Protocol Violation|0|||
33444090|NCT01921062|101518938|FG001|Overall Study|Protocol Violation|1|||
33444091|NCT01921062|101518937|FG000|Overall Study|VMIQ score > 72|4|||
33444092|NCT01921062|101518938|FG001|Overall Study|VMIQ score > 72|1|||
33444093|NCT01921062|101518937|FG000|Overall Study|Logistic error|0|||
33444094|NCT01921062|101518938|FG001|Overall Study|Logistic error|1|||
33444095|NCT01118312|101518939|FG000|Overall Study|Lost to Follow-up|33|||
33444096|NCT01118312|101518940|FG001|Overall Study|Lost to Follow-up|32|||
33444097|NCT01118312|101518939|FG000|Overall Study|Withdrawal by Subject|1|||
33444098|NCT01118312|101518940|FG001|Overall Study|Withdrawal by Subject|3|||
33444099|NCT00441467|101518941|FG000|Overall Study|Adverse Event|6|||
33444100|NCT00441467|101518941|FG000|Overall Study|Withdrawal by Subject|3|||
33444101|NCT00441467|101518941|FG000|Overall Study|Progressive disease|9|||
33444102|NCT00415363|101518942|FG000|Overall Study|Withdrawal by Subject|4|||
33444103|NCT00415363|101518943|FG001|Overall Study|Withdrawal by Subject|4|||
33444104|NCT00415363|101518942|FG000|Overall Study|Adverse Event|4|||
33444105|NCT00415363|101518943|FG001|Overall Study|Adverse Event|4|||
33444106|NCT00415363|101518942|FG000|Overall Study|Lost to Follow-up|2|||
33444107|NCT00415363|101518943|FG001|Overall Study|Lost to Follow-up|1|||
33444108|NCT00415363|101518942|FG000|Overall Study|Physician Decision|3|||
33444109|NCT00415363|101518943|FG001|Overall Study|Physician Decision|1|||
33444110|NCT00415363|101518942|FG000|Overall Study|Death|16|||
33444111|NCT00415363|101518943|FG001|Overall Study|Death|12|||
33444112|NCT00415363|101518942|FG000|Overall Study|Progressive disease|26|||
33444113|NCT00415363|101518943|FG001|Overall Study|Progressive disease|32|||
33444114|NCT01882647|101518944|FG000|Overall Study|Lost to Follow-up|2|||
33444115|NCT01882647|101518945|FG001|Overall Study|Lost to Follow-up|2|||
33444116|NCT01882647|101518944|FG000|Overall Study|Withdrawal by Subject|0|||
33444117|NCT01882647|101518945|FG001|Overall Study|Withdrawal by Subject|4|||
33444118|NCT03243630|101518949|FG000|Overall Study|Protocol Violation|1|||
33444119|NCT03243630|101518949|FG000|Overall Study|Physician Decision|1|||
33444120|NCT02645409|101518950|FG000|Overall Study|Withdrawal by Subject|3|||
33444121|NCT02645409|101518951|FG001|Overall Study|Withdrawal by Subject|0|||
33444122|NCT02645409|101518950|FG000|Overall Study|Physician Decision|1|||
33444123|NCT02645409|101518951|FG001|Overall Study|Physician Decision|0|||
33444124|NCT04407806|101518958|FG000|Overall Study|Withdrawal by Subject|1|||
33444125|NCT04407806|101518959|FG001|Overall Study|Withdrawal by Subject|2|||
33444126|NCT00657553|101518961|FG000|Overall Study|low accrual, no analysis run|5|||
33444127|NCT00657553|101518962|FG001|Overall Study|low accrual, no analysis run|5|||
33444128|NCT02289963|101518963|FG000|Overall Study|Adverse Event|1|||
33444129|NCT02289963|101518964|FG001|Overall Study|Adverse Event|2|||
33444130|NCT02289963|101518963|FG000|Overall Study|Poor compliance to protocol|1|||
33444131|NCT02289963|101518964|FG001|Overall Study|Poor compliance to protocol|0|||
33444132|NCT02289963|101518963|FG000|Overall Study|Withdrawal by Subject|1|||
33444133|NCT02289963|101518964|FG001|Overall Study|Withdrawal by Subject|0|||
33444134|NCT02289963|101518963|FG000|Overall Study|Last injection missed|2|||
33444135|NCT02289963|101518964|FG001|Overall Study|Last injection missed|2|||
33444136|NCT02289963|101518963|FG000|Overall Study|End treatment visit outside visit window|0|||
33444137|NCT02289963|101518964|FG001|Overall Study|End treatment visit outside visit window|4|||
33444138|NCT02289963|101518963|FG000|Overall Study|Other than specified above|0|||
33444139|NCT02289963|101518964|FG001|Overall Study|Other than specified above|2|||
33444140|NCT02914600|101518970|FG000|Overall Study|Adverse Event|298|||
33444141|NCT02914600|101518971|FG001|Overall Study|Adverse Event|35|||
33444142|NCT02914600|101518972|FG002|Overall Study|Adverse Event|25|||
33444143|NCT02914600|101518970|FG000|Overall Study|Sponsors decision|287|||
33444144|NCT02914600|101518971|FG001|Overall Study|Sponsors decision|41|||
33444145|NCT02914600|101518972|FG002|Overall Study|Sponsors decision|12|||
33444146|NCT02914600|101518970|FG000|Overall Study|Withdrawal by Subject|158|||
33444147|NCT02914600|101518971|FG001|Overall Study|Withdrawal by Subject|20|||
33444148|NCT02914600|101518972|FG002|Overall Study|Withdrawal by Subject|18|||
33444149|NCT02914600|101518970|FG000|Overall Study|Investigators discretion|169|||
33444150|NCT02914600|101518971|FG001|Overall Study|Investigators discretion|14|||
33444151|NCT02914600|101518972|FG002|Overall Study|Investigators discretion|13|||
33444152|NCT02914600|101518970|FG000|Overall Study|Lost to Follow-up|10|||
33444153|NCT02914600|101518971|FG001|Overall Study|Lost to Follow-up|4|||
33444154|NCT02914600|101518972|FG002|Overall Study|Lost to Follow-up|0|||
33444155|NCT02914600|101518970|FG000|Overall Study|Pregnancy|8|||
33444156|NCT02914600|101518971|FG001|Overall Study|Pregnancy|0|||
33444157|NCT02914600|101518972|FG002|Overall Study|Pregnancy|0|||
33444158|NCT02914600|101518970|FG000|Overall Study|Protocol Violation|5|||
33444159|NCT02914600|101518971|FG001|Overall Study|Protocol Violation|3|||
33163533|NCT02256631|100508253|FG002|Overall Study|Withdrawal by Subject|0|||
33163534|NCT02256631|100508254|FG003|Overall Study|Withdrawal by Subject|1|||
33163535|NCT02256631|100508255|FG004|Overall Study|Withdrawal by Subject|1|||
33444160|NCT02914600|101518972|FG002|Overall Study|Protocol Violation|0|||
33163536|NCT02256631|100508256|FG005|Overall Study|Withdrawal by Subject|0|||
33163537|NCT02256631|100508257|FG006|Overall Study|Withdrawal by Subject|1|||
33163538|NCT02256631|100508251|FG000|Overall Study|Unable to get to clinic|0|||
33163539|NCT02256631|100508252|FG001|Overall Study|Unable to get to clinic|2|||
33163540|NCT02256631|100508253|FG002|Overall Study|Unable to get to clinic|0|||
33163541|NCT02256631|100508254|FG003|Overall Study|Unable to get to clinic|1|||
33163542|NCT02256631|100508255|FG004|Overall Study|Unable to get to clinic|0|||
33163543|NCT02256631|100508256|FG005|Overall Study|Unable to get to clinic|1|||
33163544|NCT02256631|100508257|FG006|Overall Study|Unable to get to clinic|2|||
33163545|NCT02280304|100508260|FG000|Overall Study|Lost to Follow-up|7|||
33163546|NCT02280304|100508261|FG001|Overall Study|Lost to Follow-up|8|||
33163547|NCT02099708|100508262|FG000|Overall Study|Data Not Available|30|||
33163548|NCT02099708|100508262|FG000|Overall Study|Lost to Follow-up|141|||
33163549|NCT02099708|100508262|FG000|Overall Study|Other|29|||
33163550|NCT04805541|100508263|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
33163551|NCT03845985|100508264|FG000|Overall Study|Lost to Follow-up|2|||
33163552|NCT03845985|100508265|FG001|Overall Study|Lost to Follow-up|1|||
33163553|NCT03845985|100508264|FG000|Overall Study|Physician Decision|1|||
33163554|NCT03845985|100508265|FG001|Overall Study|Physician Decision|0|||
33163555|NCT03845985|100508264|FG000|Overall Study|Withdrawal by Subject|4|||
33163556|NCT03845985|100508265|FG001|Overall Study|Withdrawal by Subject|1|||
33163557|NCT00361569|100508266|FG000|Overall Study|Protocol Violation|3|||
33163558|NCT00361569|100508267|FG001|Overall Study|Protocol Violation|2|||
33163559|NCT00361569|100508268|FG002|Overall Study|Protocol Violation|4|||
33163560|NCT00361569|100508269|FG003|Overall Study|Protocol Violation|2|||
33163561|NCT00361569|100508266|FG000|Overall Study|Withdrawal by Subject|2|||
33163562|NCT00361569|100508267|FG001|Overall Study|Withdrawal by Subject|1|||
33163563|NCT00361569|100508268|FG002|Overall Study|Withdrawal by Subject|9|||
33163564|NCT00361569|100508269|FG003|Overall Study|Withdrawal by Subject|14|||
33163565|NCT00361569|100508266|FG000|Overall Study|Adverse Event|3|||
33163566|NCT00361569|100508267|FG001|Overall Study|Adverse Event|5|||
33163567|NCT00361569|100508268|FG002|Overall Study|Adverse Event|2|||
33163568|NCT00361569|100508269|FG003|Overall Study|Adverse Event|2|||
33163569|NCT00361569|100508266|FG000|Overall Study|Lost to Follow-up|2|||
33163570|NCT00361569|100508267|FG001|Overall Study|Lost to Follow-up|3|||
33163571|NCT00361569|100508268|FG002|Overall Study|Lost to Follow-up|3|||
33163572|NCT00361569|100508269|FG003|Overall Study|Lost to Follow-up|2|||
33163573|NCT00361569|100508266|FG000|Overall Study|Not specified by investigator|2|||
33163574|NCT00361569|100508267|FG001|Overall Study|Not specified by investigator|0|||
33163575|NCT00361569|100508268|FG002|Overall Study|Not specified by investigator|0|||
33163576|NCT00361569|100508269|FG003|Overall Study|Not specified by investigator|1|||
33444161|NCT02914600|101518970|FG000|Overall Study|Non-compliance with study drug|6|||
33444162|NCT02914600|101518971|FG001|Overall Study|Non-compliance with study drug|1|||
33444163|NCT02914600|101518972|FG002|Overall Study|Non-compliance with study drug|0|||
33444164|NCT02914600|101518970|FG000|Overall Study|Death|3|||
33444165|NCT02914600|101518971|FG001|Overall Study|Death|1|||
33444166|NCT02914600|101518972|FG002|Overall Study|Death|1|||
33444167|NCT02914600|101518970|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
33444168|NCT02914600|101518971|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
33163577|NCT00743483|100508272|FG000|Baseline Period|Physician Decision|1|||
33257694|NCT02214160|100845859|FG002|Overall Study|Adverse Event|1|||
33163578|NCT00743483|100508272|FG000|Treatment Period|Adverse Event|1|||
33163579|NCT03572062|100508274|FG000|Overall Study|Adverse Event|0|||
33163580|NCT03572062|100508275|FG001|Overall Study|Adverse Event|0|||
33163581|NCT03572062|100508276|FG002|Overall Study|Adverse Event|0|||
33163582|NCT03572062|100508277|FG003|Overall Study|Adverse Event|0|||
33257695|NCT02214160|100845857|FG000|Overall Study|Sponsor Decision|0|||
33163583|NCT03572062|100508278|FG004|Overall Study|Adverse Event|0|||
33163584|NCT03572062|100508279|FG005|Overall Study|Adverse Event|0|||
33257696|NCT02214160|100845858|FG001|Overall Study|Sponsor Decision|2|||
33444169|NCT02914600|101518972|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
33444170|NCT02914600|101518970|FG000|Overall Study|Enrolled but not treated|1|||
33163585|NCT03572062|100508280|FG006|Overall Study|Adverse Event|0|||
33163586|NCT03572062|100508281|FG007|Overall Study|Adverse Event|0|||
33163587|NCT03572062|100508282|FG008|Overall Study|Adverse Event|1|||
33163588|NCT03572062|100508283|FG009|Overall Study|Adverse Event|3|||
33163589|NCT03572062|100508274|FG000|Overall Study|Death|0|||
33163590|NCT03572062|100508275|FG001|Overall Study|Death|0|||
33444171|NCT02914600|101518971|FG001|Overall Study|Enrolled but not treated|0|||
33163591|NCT03572062|100508276|FG002|Overall Study|Death|0|||
33163592|NCT03572062|100508277|FG003|Overall Study|Death|0|||
33163593|NCT03572062|100508278|FG004|Overall Study|Death|0|||
33444172|NCT02914600|101518972|FG002|Overall Study|Enrolled but not treated|0|||
33444173|NCT02089685|101518973|FG000|Overall Study|Adverse Event|1|||
33444174|NCT02089685|101518974|FG001|Overall Study|Adverse Event|0|||
33444175|NCT02089685|101518975|FG002|Overall Study|Adverse Event|0|||
33444176|NCT02089685|101518976|FG003|Overall Study|Adverse Event|0|||
33444177|NCT02089685|101518977|FG004|Overall Study|Adverse Event|1|||
33444178|NCT02089685|101518978|FG005|Overall Study|Adverse Event|0|||
33444179|NCT02089685|101518973|FG000|Overall Study|Clinical Progression|4|||
33444180|NCT02089685|101518974|FG001|Overall Study|Clinical Progression|0|||
33444181|NCT02089685|101518975|FG002|Overall Study|Clinical Progression|0|||
33444182|NCT02089685|101518976|FG003|Overall Study|Clinical Progression|5|||
33444183|NCT02089685|101518977|FG004|Overall Study|Clinical Progression|1|||
33444184|NCT02089685|101518978|FG005|Overall Study|Clinical Progression|2|||
33444185|NCT02089685|101518973|FG000|Overall Study|Excluded Medication|1|||
33444186|NCT02089685|101518974|FG001|Overall Study|Excluded Medication|0|||
33444187|NCT02089685|101518975|FG002|Overall Study|Excluded Medication|0|||
33444188|NCT02089685|101518976|FG003|Overall Study|Excluded Medication|11|||
33444189|NCT02089685|101518977|FG004|Overall Study|Excluded Medication|2|||
33444190|NCT02089685|101518978|FG005|Overall Study|Excluded Medication|1|||
33444191|NCT02089685|101518973|FG000|Overall Study|Progressive disease|13|||
33444192|NCT02089685|101518974|FG001|Overall Study|Progressive disease|10|||
33444193|NCT02089685|101518975|FG002|Overall Study|Progressive disease|3|||
33444194|NCT02089685|101518976|FG003|Overall Study|Progressive disease|51|||
33444195|NCT02089685|101518977|FG004|Overall Study|Progressive disease|17|||
33444196|NCT02089685|101518978|FG005|Overall Study|Progressive disease|12|||
33444197|NCT02089685|101518973|FG000|Overall Study|Follow up ended by sponsor|2|||
33444198|NCT02089685|101518974|FG001|Overall Study|Follow up ended by sponsor|2|||
33444199|NCT02089685|101518975|FG002|Overall Study|Follow up ended by sponsor|0|||
33444200|NCT02089685|101518976|FG003|Overall Study|Follow up ended by sponsor|70|||
33444201|NCT02089685|101518977|FG004|Overall Study|Follow up ended by sponsor|26|||
33444202|NCT02089685|101518978|FG005|Overall Study|Follow up ended by sponsor|26|||
33444203|NCT02089685|101518973|FG000|Overall Study|Withdrawal by Subject|0|||
33444204|NCT02089685|101518974|FG001|Overall Study|Withdrawal by Subject|2|||
33444205|NCT02089685|101518975|FG002|Overall Study|Withdrawal by Subject|0|||
33444206|NCT02089685|101518976|FG003|Overall Study|Withdrawal by Subject|8|||
33444207|NCT02089685|101518977|FG004|Overall Study|Withdrawal by Subject|1|||
33444208|NCT02089685|101518978|FG005|Overall Study|Withdrawal by Subject|1|||
33444209|NCT02089685|101518973|FG000|Overall Study|Status not recorded|1|||
33444210|NCT02089685|101518974|FG001|Overall Study|Status not recorded|0|||
33444211|NCT02089685|101518975|FG002|Overall Study|Status not recorded|0|||
33444212|NCT02089685|101518976|FG003|Overall Study|Status not recorded|0|||
33444213|NCT02089685|101518977|FG004|Overall Study|Status not recorded|1|||
33444214|NCT02089685|101518978|FG005|Overall Study|Status not recorded|0|||
33444215|NCT02089685|101518973|FG000|Overall Study|Death|0|||
33444216|NCT02089685|101518974|FG001|Overall Study|Death|0|||
33444217|NCT02089685|101518975|FG002|Overall Study|Death|0|||
33444218|NCT02089685|101518976|FG003|Overall Study|Death|7|||
33444219|NCT02089685|101518977|FG004|Overall Study|Death|2|||
33444220|NCT02089685|101518978|FG005|Overall Study|Death|5|||
33444221|NCT02089685|101518973|FG000|Overall Study|Lost to Follow-up|0|||
33444222|NCT02089685|101518974|FG001|Overall Study|Lost to Follow-up|0|||
33444223|NCT02089685|101518975|FG002|Overall Study|Lost to Follow-up|0|||
33444224|NCT02089685|101518976|FG003|Overall Study|Lost to Follow-up|1|||
33444225|NCT02089685|101518977|FG004|Overall Study|Lost to Follow-up|0|||
33444226|NCT02089685|101518978|FG005|Overall Study|Lost to Follow-up|0|||
33444227|NCT02089685|101518973|FG000|Overall Study|Physician Decision|0|||
33444228|NCT02089685|101518974|FG001|Overall Study|Physician Decision|0|||
33444229|NCT02089685|101518975|FG002|Overall Study|Physician Decision|0|||
33444230|NCT02089685|101518976|FG003|Overall Study|Physician Decision|0|||
33444231|NCT02089685|101518977|FG004|Overall Study|Physician Decision|0|||
33444232|NCT02089685|101518978|FG005|Overall Study|Physician Decision|4|||
33444233|NCT02089685|101518973|FG000|Overall Study|Screen failure|1|||
33444234|NCT02089685|101518974|FG001|Overall Study|Screen failure|0|||
33444235|NCT02089685|101518975|FG002|Overall Study|Screen failure|0|||
33444236|NCT02089685|101518976|FG003|Overall Study|Screen failure|0|||
33444237|NCT02089685|101518977|FG004|Overall Study|Screen failure|0|||
33444238|NCT02089685|101518978|FG005|Overall Study|Screen failure|0|||
33444239|NCT02459951|101518981|FG000|Overall Study|Unable to meet holding requirement|1|||
33444240|NCT00773253|101518982|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
33444241|NCT00773253|101518983|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
33444242|NCT00448019|101518984|FG000|Overall Study|Withdrawal by Subject|3|||
33444243|NCT00448019|101518984|FG000|Overall Study|Disease progression|1|||
33444244|NCT00448019|101518984|FG000|Overall Study|Death|2|||
33444245|NCT00448019|101518984|FG000|Overall Study|Insurance Issues|1|||
33444246|NCT00651820|101518987|FG000|Overall Study|Lost to Follow-up|2|||
33444247|NCT03135834|101518991|FG000|Stage 1|Adverse Event|1|||
33444248|NCT03135834|101518992|FG001|Stage 1|Adverse Event|2|||
33444249|NCT03135834|101518993|FG002|Stage 1|Adverse Event|2|||
33163594|NCT03572062|100508279|FG005|Overall Study|Death|1|||
33163595|NCT03572062|100508280|FG006|Overall Study|Death|0|||
33163596|NCT03572062|100508281|FG007|Overall Study|Death|0|||
33163597|NCT03572062|100508282|FG008|Overall Study|Death|0|||
33163598|NCT03572062|100508283|FG009|Overall Study|Death|0|||
33163599|NCT03572062|100508274|FG000|Overall Study|Lost to Follow-up|0|||
33163600|NCT03572062|100508275|FG001|Overall Study|Lost to Follow-up|0|||
33163601|NCT03572062|100508276|FG002|Overall Study|Lost to Follow-up|0|||
33163602|NCT03572062|100508277|FG003|Overall Study|Lost to Follow-up|0|||
33163603|NCT03572062|100508278|FG004|Overall Study|Lost to Follow-up|0|||
33163604|NCT03572062|100508279|FG005|Overall Study|Lost to Follow-up|1|||
33444250|NCT03135834|101518994|FG003|Stage 1|Adverse Event|1|||
33444251|NCT03135834|101518991|FG000|Stage 1|Death|1|||
33444252|NCT03135834|101518992|FG001|Stage 1|Death|0|||
33444253|NCT03135834|101518993|FG002|Stage 1|Death|0|||
33444254|NCT03135834|101518994|FG003|Stage 1|Death|0|||
33163605|NCT03572062|100508280|FG006|Overall Study|Lost to Follow-up|1|||
33163606|NCT03572062|100508281|FG007|Overall Study|Lost to Follow-up|0|||
33163607|NCT03572062|100508282|FG008|Overall Study|Lost to Follow-up|0|||
33163608|NCT03572062|100508283|FG009|Overall Study|Lost to Follow-up|0|||
33163609|NCT03572062|100508274|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33163610|NCT03572062|100508275|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
33444255|NCT03135834|101518991|FG000|Stage 1|Lost to Follow-up|17|||
33163611|NCT03572062|100508276|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
33163612|NCT03572062|100508277|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
33163613|NCT03572062|100508278|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
33163614|NCT03572062|100508279|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
33163615|NCT03572062|100508280|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
33163616|NCT03572062|100508281|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
33163617|NCT03572062|100508282|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
33444256|NCT03135834|101518992|FG001|Stage 1|Lost to Follow-up|24|||
33163618|NCT03572062|100508283|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
33163619|NCT03572062|100508274|FG000|Overall Study|Study Terminated By Sponsor|0|||
33163620|NCT03572062|100508275|FG001|Overall Study|Study Terminated By Sponsor|0|||
33163621|NCT03572062|100508276|FG002|Overall Study|Study Terminated By Sponsor|0|||
33163622|NCT03572062|100508277|FG003|Overall Study|Study Terminated By Sponsor|0|||
33163623|NCT03572062|100508278|FG004|Overall Study|Study Terminated By Sponsor|0|||
33163624|NCT03572062|100508279|FG005|Overall Study|Study Terminated By Sponsor|0|||
33163625|NCT03572062|100508280|FG006|Overall Study|Study Terminated By Sponsor|0|||
33163626|NCT03572062|100508281|FG007|Overall Study|Study Terminated By Sponsor|0|||
33163627|NCT03572062|100508282|FG008|Overall Study|Study Terminated By Sponsor|29|||
33444257|NCT03135834|101518993|FG002|Stage 1|Lost to Follow-up|21|||
33444258|NCT03135834|101518994|FG003|Stage 1|Lost to Follow-up|38|||
33444259|NCT03135834|101518991|FG000|Stage 1|No longer met eligibility criteria|1|||
33444260|NCT03135834|101518992|FG001|Stage 1|No longer met eligibility criteria|6|||
33444261|NCT03135834|101518993|FG002|Stage 1|No longer met eligibility criteria|2|||
33444262|NCT03135834|101518994|FG003|Stage 1|No longer met eligibility criteria|5|||
33444263|NCT03135834|101518991|FG000|Stage 1|Other|0|||
33444264|NCT03135834|101518992|FG001|Stage 1|Other|2|||
33444265|NCT03135834|101518993|FG002|Stage 1|Other|1|||
33444266|NCT03135834|101518994|FG003|Stage 1|Other|0|||
33444267|NCT03135834|101518991|FG000|Stage 1|Physician Decision|0|||
33444268|NCT03135834|101518992|FG001|Stage 1|Physician Decision|1|||
33444269|NCT03135834|101518993|FG002|Stage 1|Physician Decision|0|||
33444270|NCT03135834|101518994|FG003|Stage 1|Physician Decision|0|||
33444271|NCT03135834|101518991|FG000|Stage 1|Pregnancy|0|||
33444272|NCT03135834|101518992|FG001|Stage 1|Pregnancy|4|||
33444273|NCT03135834|101518993|FG002|Stage 1|Pregnancy|2|||
33444274|NCT03135834|101518994|FG003|Stage 1|Pregnancy|4|||
33444275|NCT03135834|101518991|FG000|Stage 1|Protocol Violation|1|||
33444276|NCT03135834|101518992|FG001|Stage 1|Protocol Violation|1|||
33444277|NCT03135834|101518993|FG002|Stage 1|Protocol Violation|2|||
33444278|NCT03135834|101518994|FG003|Stage 1|Protocol Violation|1|||
33444279|NCT03135834|101518991|FG000|Stage 1|Withdrawal by parent/guardian|2|||
33444280|NCT03135834|101518992|FG001|Stage 1|Withdrawal by parent/guardian|10|||
33163628|NCT03572062|100508283|FG009|Overall Study|Study Terminated By Sponsor|27|||
33163629|NCT03572062|100508274|FG000|Overall Study|Physician Decision|0|||
33163630|NCT03572062|100508275|FG001|Overall Study|Physician Decision|0|||
33444281|NCT03135834|101518993|FG002|Stage 1|Withdrawal by parent/guardian|2|||
33444282|NCT03135834|101518994|FG003|Stage 1|Withdrawal by parent/guardian|1|||
33444283|NCT03135834|101518991|FG000|Stage 1|Withdrawal by Subject|16|||
33444284|NCT03135834|101518992|FG001|Stage 1|Withdrawal by Subject|22|||
33444285|NCT03135834|101518993|FG002|Stage 1|Withdrawal by Subject|7|||
33444286|NCT03135834|101518994|FG003|Stage 1|Withdrawal by Subject|10|||
33444287|NCT03135834|101518991|FG000|Stage 1|Randomized but not Vaccinated|0|||
33444288|NCT03135834|101518992|FG001|Stage 1|Randomized but not Vaccinated|3|||
33444289|NCT03135834|101518993|FG002|Stage 1|Randomized but not Vaccinated|1|||
33444290|NCT03135834|101518994|FG003|Stage 1|Randomized but not Vaccinated|6|||
33163631|NCT03572062|100508276|FG002|Overall Study|Physician Decision|0|||
33163632|NCT03572062|100508277|FG003|Overall Study|Physician Decision|0|||
33163633|NCT03572062|100508278|FG004|Overall Study|Physician Decision|0|||
33163634|NCT03572062|100508279|FG005|Overall Study|Physician Decision|0|||
33163635|NCT03572062|100508280|FG006|Overall Study|Physician Decision|0|||
33163636|NCT03572062|100508281|FG007|Overall Study|Physician Decision|0|||
33163637|NCT03572062|100508282|FG008|Overall Study|Physician Decision|1|||
33163638|NCT03572062|100508283|FG009|Overall Study|Physician Decision|0|||
33163639|NCT03572062|100508274|FG000|Overall Study|Withdrawal by Subject|0|||
33163640|NCT03572062|100508275|FG001|Overall Study|Withdrawal by Subject|0|||
33163641|NCT03572062|100508276|FG002|Overall Study|Withdrawal by Subject|0|||
33163642|NCT03572062|100508277|FG003|Overall Study|Withdrawal by Subject|0|||
33163643|NCT03572062|100508278|FG004|Overall Study|Withdrawal by Subject|0|||
33163644|NCT03572062|100508279|FG005|Overall Study|Withdrawal by Subject|0|||
33163645|NCT03572062|100508280|FG006|Overall Study|Withdrawal by Subject|0|||
33163646|NCT03572062|100508281|FG007|Overall Study|Withdrawal by Subject|0|||
33163647|NCT03572062|100508282|FG008|Overall Study|Withdrawal by Subject|0|||
33163648|NCT03572062|100508283|FG009|Overall Study|Withdrawal by Subject|1|||
33163649|NCT03572062|100508274|FG000|Overall Study|Randomized But Not Treated|0|||
33163650|NCT03572062|100508275|FG001|Overall Study|Randomized But Not Treated|0|||
33163651|NCT03572062|100508276|FG002|Overall Study|Randomized But Not Treated|0|||
33163652|NCT03572062|100508277|FG003|Overall Study|Randomized But Not Treated|0|||
33163653|NCT03572062|100508278|FG004|Overall Study|Randomized But Not Treated|1|||
33163654|NCT03572062|100508279|FG005|Overall Study|Randomized But Not Treated|2|||
33163655|NCT03572062|100508280|FG006|Overall Study|Randomized But Not Treated|0|||
33163656|NCT03572062|100508281|FG007|Overall Study|Randomized But Not Treated|1|||
33163657|NCT03572062|100508282|FG008|Overall Study|Randomized But Not Treated|0|||
33163658|NCT03572062|100508283|FG009|Overall Study|Randomized But Not Treated|0|||
33163659|NCT00826943|100508284|FG000|Overall Study|Withdrawal by Subject|0|||
33163660|NCT00826943|100508285|FG001|Overall Study|Withdrawal by Subject|0|||
33163661|NCT00826943|100508286|FG002|Overall Study|Withdrawal by Subject|0|||
33163662|NCT00826943|100508287|FG003|Overall Study|Withdrawal by Subject|0|||
33163663|NCT00826943|100508288|FG004|Overall Study|Withdrawal by Subject|1|||
33163664|NCT00826943|100508289|FG005|Overall Study|Withdrawal by Subject|0|||
33163665|NCT02795832|100508292|FG000|Overall Study|Adverse Event|0|||
33163666|NCT02795832|100508293|FG001|Overall Study|Adverse Event|0|||
33163667|NCT02795832|100508294|FG002|Overall Study|Adverse Event|0|||
33163668|NCT02795832|100508295|FG003|Overall Study|Adverse Event|0|||
33163669|NCT02795832|100508296|FG004|Overall Study|Adverse Event|0|||
33163670|NCT02795832|100508297|FG005|Overall Study|Adverse Event|3|||
33163671|NCT02955602|100508300|FG000|Overall Study|Adverse Event|0|||
33163672|NCT02955602|100508301|FG001|Overall Study|Adverse Event|3|||
33163673|NCT02955602|100508302|FG002|Overall Study|Adverse Event|0|||
33163674|NCT02955602|100508300|FG000|Overall Study|Withdrawal of informed consent|1|||
33163675|NCT02955602|100508301|FG001|Overall Study|Withdrawal of informed consent|3|||
33163676|NCT02955602|100508302|FG002|Overall Study|Withdrawal of informed consent|2|||
33163677|NCT02955602|100508300|FG000|Overall Study|Lost to Follow-up|0|||
33163678|NCT02955602|100508301|FG001|Overall Study|Lost to Follow-up|0|||
33163679|NCT02955602|100508302|FG002|Overall Study|Lost to Follow-up|1|||
33163680|NCT02955602|100508300|FG000|Overall Study|Other|0|||
33257697|NCT02214160|100845859|FG002|Overall Study|Sponsor Decision|0|||
33163681|NCT02955602|100508301|FG001|Overall Study|Other|1|||
33163682|NCT02955602|100508302|FG002|Overall Study|Other|3|||
33163683|NCT00713323|100508303|FG000|Overall Study|Adverse Event|75|||
33163684|NCT00713323|100508303|FG000|Overall Study|Withdrawal by Subject|15|||
33163685|NCT00713323|100508303|FG000|Overall Study|Lost to Follow-up|11|||
33163686|NCT00713323|100508303|FG000|Overall Study|Lack of Efficacy|36|||
33163687|NCT00713323|100508303|FG000|Overall Study|Low creatine clearance at screening|1|||
33163688|NCT00713323|100508303|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
33163689|NCT00713323|100508303|FG000|Overall Study|Surgery cured allodynic pain|1|||
33163690|NCT00713323|100508303|FG000|Overall Study|Pain free|1|||
33163691|NCT00713323|100508303|FG000|Overall Study|Non-compliance|1|||
33163692|NCT00713323|100508303|FG000|Overall Study|Pain resolved|1|||
33163693|NCT00713323|100508303|FG000|Overall Study|Subject travelling to USA|1|||
33163694|NCT00713323|100508303|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
33163695|NCT00713323|100508303|FG000|Overall Study|Treatment that may interact with Sativex|1|||
33163696|NCT02378961|100508307|FG000|Overall Study|Lack of Efficacy|4|||
33163697|NCT02378961|100508308|FG001|Overall Study|Lack of Efficacy|2|||
33163698|NCT02378961|100508309|FG002|Overall Study|Lack of Efficacy|0|||
33163699|NCT02378961|100508310|FG003|Overall Study|Lack of Efficacy|1|||
33163700|NCT02378961|100508307|FG000|Overall Study|Death|0|||
33163701|NCT02378961|100508308|FG001|Overall Study|Death|0|||
33163702|NCT02378961|100508309|FG002|Overall Study|Death|1|||
33163703|NCT02378961|100508310|FG003|Overall Study|Death|0|||
33163704|NCT00885846|100508313|FG000|Overall Study|Withdrawal by Subject|2|||
33163705|NCT00885846|100508314|FG001|Overall Study|Withdrawal by Subject|5|||
33163706|NCT00885846|100508315|FG002|Overall Study|Withdrawal by Subject|2|||
33163707|NCT01606800|100508318|FG000|Overall Study|Adverse Event|3|||
33163708|NCT01606800|100508319|FG001|Overall Study|Adverse Event|1|||
33163709|NCT01606800|100508318|FG000|Overall Study|Participant withdrew consent|0|||
33163710|NCT01606800|100508319|FG001|Overall Study|Participant withdrew consent|1|||
33163711|NCT01606800|100508318|FG000|Overall Study|Missing completion status|2|||
33163712|NCT01606800|100508319|FG001|Overall Study|Missing completion status|0|||
33163713|NCT01256008|100508320|FG000|Overall Study|Lost to Follow-up|6|||
33163714|NCT01256008|100508321|FG001|Overall Study|Lost to Follow-up|4|||
33163715|NCT01256008|100508322|FG002|Overall Study|Lost to Follow-up|11|||
33163716|NCT01256008|100508320|FG000|Overall Study|Withdrawal by Subject|2|||
33163717|NCT01256008|100508321|FG001|Overall Study|Withdrawal by Subject|3|||
33257698|NCT02214160|100845857|FG000|Overall Study|Protocol Violation|1|||
33257699|NCT02214160|100845858|FG001|Overall Study|Protocol Violation|0|||
33444291|NCT03135834|101518991|FG000|Stage 2|Lost to Follow-up|0|||
33163718|NCT01256008|100508322|FG002|Overall Study|Withdrawal by Subject|10|||
33163719|NCT00717197|100508323|FG000|Overall Study|Unable to purchase study drug|5|||
33163720|NCT00717197|100508323|FG000|Overall Study|Tumor Progression|1|||
33163721|NCT00717197|100508323|FG000|Overall Study|Physician Decision|1|||
33163722|NCT00006237|100508324|FG000|Overall Study|Adverse Event|39|||
33257700|NCT02214160|100845859|FG002|Overall Study|Protocol Violation|0|||
33163723|NCT00006237|100508325|FG001|Overall Study|Adverse Event|29|||
33163724|NCT00006237|100508324|FG000|Overall Study|Death|1|||
33163725|NCT00006237|100508325|FG001|Overall Study|Death|0|||
33163726|NCT00006237|100508324|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
33163727|NCT00006237|100508325|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
33163728|NCT00006237|100508324|FG000|Overall Study|Progression/relapse|54|||
33257701|NCT02214160|100845857|FG000|Overall Study|Physician Decision|0|||
33257702|NCT02214160|100845858|FG001|Overall Study|Physician Decision|0|||
33257703|NCT02214160|100845859|FG002|Overall Study|Physician Decision|1|||
33257704|NCT00232180|100845862|FG000|Double-blind (DB) Phase|Death|186|||
33257705|NCT00232180|100845863|FG001|Double-blind (DB) Phase|Death|222|||
33257706|NCT00232180|100845864|FG002|Double-blind (DB) Phase|Death|0|||
33257707|NCT00232180|100845862|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
33257708|NCT00232180|100845863|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
33257709|NCT00232180|100845864|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
33257710|NCT00232180|100845862|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
33257711|NCT00232180|100845863|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
33257712|NCT00232180|100845864|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
33257713|NCT00232180|100845862|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
33163729|NCT00006237|100508325|FG001|Overall Study|Progression/relapse|2|||
33163730|NCT00006237|100508324|FG000|Overall Study|Not eligible|9|||
33163731|NCT00006237|100508325|FG001|Overall Study|Not eligible|20|||
33163732|NCT00006237|100508324|FG000|Overall Study|Withdrawal by Subject|0|||
33163733|NCT00006237|100508325|FG001|Overall Study|Withdrawal by Subject|1|||
33163734|NCT00006237|100508324|FG000|Overall Study|Not protocol specified|14|||
33163735|NCT00006237|100508325|FG001|Overall Study|Not protocol specified|5|||
33163736|NCT04213079|100508327|FG000|Overall Study|Lost to Follow-up|0|||
33163737|NCT04213079|100508328|FG001|Overall Study|Lost to Follow-up|2|||
33163738|NCT03648983|100511142|FG000|Overall Study|Study was terminated due to PI departure|95|||
33163739|NCT00291577|100511144|FG000|Overall Study|Adverse Event|1|||
33163740|NCT00291577|100511144|FG000|Overall Study|Other|4|||
33163741|NCT00291577|100511144|FG000|Overall Study|Withdrawal by Subject|2|||
33163742|NCT00291577|100511144|FG000|Overall Study|Lack of Efficacy|14|||
33444292|NCT03135834|101518992|FG001|Stage 2|Lost to Follow-up|1|||
33444293|NCT03135834|101518993|FG002|Stage 2|Lost to Follow-up|0|||
33444294|NCT03135834|101518994|FG003|Stage 2|Lost to Follow-up|0|||
33444295|NCT03135834|101518991|FG000|Stage 2|Withdrawal by Subject|0|||
33444296|NCT03135834|101518992|FG001|Stage 2|Withdrawal by Subject|1|||
33163743|NCT00319553|100511145|FG000|Overall Study|Protocol Violation|1|||
33257714|NCT00232180|100845863|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
33257715|NCT00232180|100845864|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
33257716|NCT00232180|100845862|FG000|Double-blind (DB) Phase|Adverse Event|83|||
33444297|NCT03135834|101518993|FG002|Stage 2|Withdrawal by Subject|0|||
33163744|NCT00319553|100511146|FG001|Overall Study|Protocol Violation|2|||
33163745|NCT00319553|100511145|FG000|Overall Study|Lost to Follow-up|2|||
33163746|NCT00319553|100511146|FG001|Overall Study|Lost to Follow-up|1|||
33163747|NCT00319553|100511145|FG000|Overall Study|Withdrawal by Subject|1|||
33444298|NCT03135834|101518994|FG003|Stage 2|Withdrawal by Subject|0|||
33444299|NCT03135834|101518991|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
33444300|NCT03135834|101518992|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
33444301|NCT03135834|101518993|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
33444302|NCT03135834|101518994|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
33444303|NCT03135834|101518991|FG000|Stage 2|Did not receive Booster Vaccination|1|||
33444304|NCT03135834|101518992|FG001|Stage 2|Did not receive Booster Vaccination|1|||
33444305|NCT03135834|101518993|FG002|Stage 2|Did not receive Booster Vaccination|0|||
33444306|NCT03135834|101518994|FG003|Stage 2|Did not receive Booster Vaccination|0|||
33444307|NCT01804270|101518995|FG000|Overall Study|Withdrawal by Subject|1|||
33444308|NCT01804270|101518996|FG001|Overall Study|Withdrawal by Subject|1|||
33444309|NCT01940341|101518997|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
33444310|NCT01940341|101518998|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
33444311|NCT01940341|101518999|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
33444312|NCT01940341|101519000|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
33444313|NCT01940341|101518997|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
33444314|NCT01940341|101518998|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
33444315|NCT01940341|101518999|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
33444316|NCT01940341|101519000|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
33444317|NCT01940341|101518997|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
33444318|NCT01940341|101518998|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
33444319|NCT01940341|101518999|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
33444320|NCT01940341|101519000|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
33444321|NCT01940341|101518997|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
33444322|NCT01940341|101518998|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
33444323|NCT01940341|101518999|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
33444324|NCT01940341|101519000|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
33444325|NCT01940341|101518997|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
33257717|NCT00232180|100845863|FG001|Double-blind (DB) Phase|Adverse Event|100|||
33257718|NCT00232180|100845864|FG002|Double-blind (DB) Phase|Adverse Event|0|||
33257719|NCT00232180|100845862|FG000|Double-blind (DB) Phase|Other|70|||
33444326|NCT01940341|101518998|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
33444327|NCT01940341|101518999|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
33444328|NCT01940341|101519000|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
33444329|NCT01940341|101518997|FG000|Period 1: Double-blind Phase|Death|0|||
33444330|NCT01940341|101518998|FG001|Period 1: Double-blind Phase|Death|1|||
33444331|NCT01940341|101518999|FG002|Period 1: Double-blind Phase|Death|0|||
33444332|NCT01940341|101519000|FG003|Period 1: Double-blind Phase|Death|0|||
33444333|NCT01940341|101518997|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
33444334|NCT01940341|101518998|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
33444335|NCT01940341|101518999|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
33444336|NCT01940341|101519000|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
33444337|NCT01940341|101518997|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
33444338|NCT01940341|101518998|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
33444339|NCT01940341|101518999|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
33444340|NCT01940341|101519000|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
33444341|NCT01940341|101518997|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
33444342|NCT01940341|101518998|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
33444343|NCT01940341|101518999|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
33444344|NCT01940341|101519000|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
33444345|NCT01940341|101518997|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
33444346|NCT01940341|101518998|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
33444347|NCT01940341|101518999|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
33444348|NCT01940341|101519000|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
33444349|NCT01940341|101518997|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
33444350|NCT01940341|101518998|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
33444351|NCT01940341|101518999|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
33444352|NCT01940341|101519000|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
33444353|NCT01940341|101518997|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
33444354|NCT01940341|101518998|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
33444355|NCT01940341|101518999|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
33444356|NCT01940341|101519000|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
33444357|NCT01940341|101518997|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
33444358|NCT01940341|101518998|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
33444359|NCT01940341|101518999|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
33444360|NCT01940341|101519000|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
33444361|NCT01940341|101518997|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
33444362|NCT01940341|101518998|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
33444363|NCT01940341|101518999|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
33444364|NCT01940341|101519000|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
33444365|NCT01940341|101518997|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
33444366|NCT01940341|101518998|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
33444367|NCT01940341|101518999|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
33444368|NCT01940341|101519000|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
33444369|NCT01940341|101518997|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
33444370|NCT01940341|101518998|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
33444371|NCT01940341|101518999|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
33444372|NCT01940341|101519000|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
33444373|NCT01940341|101518997|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
33163748|NCT00319553|100511146|FG001|Overall Study|Withdrawal by Subject|1|||
33163749|NCT00259649|100511149|FG000|Overall Study|Lost to Follow-up|7|||
33163750|NCT00259649|100511149|FG000|Overall Study|irregular menses|3|||
33163751|NCT03943147|100511151|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
33163752|NCT03943147|100511152|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
33163753|NCT03943147|100511151|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
33163754|NCT03943147|100511152|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
33163755|NCT03943147|100511151|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
33163756|NCT03943147|100511152|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
33163757|NCT03943147|100511151|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
33163758|NCT03943147|100511152|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
33163759|NCT03943147|100511151|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
33163760|NCT03943147|100511152|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
33163761|NCT03943147|100511151|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
33163762|NCT03943147|100511152|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
33163763|NCT03478930|100511160|FG000|Overall Study|Adverse Event|0|||
33163764|NCT03478930|100511161|FG001|Overall Study|Adverse Event|1|||
33163765|NCT03478930|100511160|FG000|Overall Study|Lack of Efficacy|3|||
33163766|NCT03478930|100511161|FG001|Overall Study|Lack of Efficacy|3|||
33163767|NCT03478930|100511160|FG000|Overall Study|Withdrawal by Subject|6|||
33163768|NCT03478930|100511161|FG001|Overall Study|Withdrawal by Subject|5|||
33163769|NCT02756013|100511162|FG000|Overall Study|Adverse Event|1|||
33163770|NCT02756013|100511162|FG000|Overall Study|Hypersensitivity|1|||
33163771|NCT00496470|100511163|FG000|Overall Study|Adverse Event|8|||
33163772|NCT00496470|100511164|FG001|Overall Study|Adverse Event|10|||
33163773|NCT00496470|100511163|FG000|Overall Study|Withdrawal by Subject|5|||
33163774|NCT00496470|100511164|FG001|Overall Study|Withdrawal by Subject|12|||
33163775|NCT00496470|100511163|FG000|Overall Study|Incorrectly enrolled|13|||
33163776|NCT00496470|100511164|FG001|Overall Study|Incorrectly enrolled|5|||
33163777|NCT00496470|100511163|FG000|Overall Study|Other reason|0|||
33163778|NCT00496470|100511164|FG001|Overall Study|Other reason|2|||
33163779|NCT02197520|100511165|FG000|Period 1|Withdrawal by Subject|1|||
33163780|NCT02197520|100511166|FG001|Period 1|Withdrawal by Subject|0|||
33163781|NCT02197520|100511165|FG000|Period 2|Adverse Event|0|||
33163782|NCT02197520|100511166|FG001|Period 2|Adverse Event|2|||
33163783|NCT02197520|100511165|FG000|Period 2|Withdrawal by Subject|1|||
33163784|NCT02197520|100511166|FG001|Period 2|Withdrawal by Subject|0|||
33163785|NCT00571948|100511171|FG000|Overall Study|Lost to Follow-up|2|||
33163786|NCT00571948|100511172|FG001|Overall Study|Lost to Follow-up|0|||
33163787|NCT00571948|100511171|FG000|Overall Study|Withdrawal by Subject|1|||
33444374|NCT01940341|101518998|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
33444375|NCT01940341|101518999|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
33444376|NCT01940341|101519000|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
33444377|NCT01940341|101518997|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
33444378|NCT01940341|101518998|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
33444379|NCT01940341|101518999|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
33163788|NCT00571948|100511172|FG001|Overall Study|Withdrawal by Subject|2|||
33444380|NCT01940341|101519000|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
33444381|NCT01940341|101518997|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
33257720|NCT00232180|100845863|FG001|Double-blind (DB) Phase|Other|75|||
33163789|NCT00571948|100511171|FG000|Overall Study|Protocol Violation|3|||
33163790|NCT00571948|100511172|FG001|Overall Study|Protocol Violation|3|||
33163791|NCT00571948|100511171|FG000|Overall Study|infant refused study meal|3|||
33163792|NCT00571948|100511172|FG001|Overall Study|infant refused study meal|4|||
33444382|NCT01940341|101518998|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
33444383|NCT01940341|101518999|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
33444384|NCT01940341|101519000|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
33444385|NCT01244620|101519001|FG000|Overall Study|Study terminated|4|||
33444386|NCT01244620|101519002|FG001|Overall Study|Study terminated|4|||
33444387|NCT01244620|101519003|FG002|Overall Study|Study terminated|4|||
33444388|NCT01244620|101519004|FG003|Overall Study|Study terminated|4|||
33444389|NCT00950989|101519015|FG000|Overall Study|Death|0|||
33444390|NCT00950989|101519016|FG001|Overall Study|Death|0|||
33444391|NCT00950989|101519017|FG002|Overall Study|Death|1|||
33444392|NCT00950989|101519018|FG003|Overall Study|Death|0|||
33444393|NCT00950989|101519015|FG000|Overall Study|Administrative Decision|0|||
33444394|NCT00950989|101519016|FG001|Overall Study|Administrative Decision|1|||
33444395|NCT00950989|101519017|FG002|Overall Study|Administrative Decision|0|||
33444396|NCT00950989|101519018|FG003|Overall Study|Administrative Decision|0|||
33444397|NCT00950989|101519015|FG000|Overall Study|Disease Progression|0|||
33444398|NCT00950989|101519016|FG001|Overall Study|Disease Progression|0|||
33444399|NCT00950989|101519017|FG002|Overall Study|Disease Progression|1|||
33444400|NCT00950989|101519018|FG003|Overall Study|Disease Progression|0|||
33444401|NCT00950989|101519015|FG000|Overall Study|Withdrawal by Subject|2|||
33444402|NCT00950989|101519016|FG001|Overall Study|Withdrawal by Subject|1|||
33444403|NCT00950989|101519017|FG002|Overall Study|Withdrawal by Subject|0|||
33163793|NCT00571948|100511171|FG000|Overall Study|Parent were afraid of blood colection|2|||
33163794|NCT00571948|100511172|FG001|Overall Study|Parent were afraid of blood colection|5|||
33163795|NCT00541931|100511175|FG000|Overall Study|Adverse Event|1|||
33163796|NCT00541931|100511176|FG001|Overall Study|Adverse Event|0|||
33163797|NCT00541931|100511175|FG000|Overall Study|Lost to Follow-up|3|||
33163798|NCT00541931|100511176|FG001|Overall Study|Lost to Follow-up|3|||
33163799|NCT00541931|100511175|FG000|Overall Study|Withdrawal by Subject|1|||
33163800|NCT00541931|100511176|FG001|Overall Study|Withdrawal by Subject|0|||
33163801|NCT00541931|100511175|FG000|Overall Study|Transportation Issue|0|||
33163802|NCT00541931|100511176|FG001|Overall Study|Transportation Issue|1|||
33163803|NCT04786990|100511177|FG000|Overall Study|Withdrawal by Subject|1|||
33163804|NCT04786990|100511177|FG000|Overall Study|Adverse Event|1|||
33163805|NCT04786990|100511177|FG000|Overall Study|Lost to Follow-up|1|||
33163806|NCT04786990|100511177|FG000|Overall Study|Noncompliance|1|||
33163807|NCT04786990|100511177|FG000|Overall Study|Unable to complete site visits|1|||
33163808|NCT04786990|100511177|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
33163809|NCT00224042|100511182|FG000|Overall Study|Adverse Event|2|||
33163810|NCT00224042|100511183|FG001|Overall Study|Adverse Event|1|||
33163811|NCT00224042|100511182|FG000|Overall Study|Protocol Violation|0|||
33163812|NCT00224042|100511183|FG001|Overall Study|Protocol Violation|1|||
33163813|NCT00224042|100511182|FG000|Overall Study|Physician Decision|0|||
33163814|NCT00224042|100511183|FG001|Overall Study|Physician Decision|1|||
33163815|NCT00224042|100511182|FG000|Overall Study|Did not meet lab incusion criteria|2|||
33163816|NCT00224042|100511183|FG001|Overall Study|Did not meet lab incusion criteria|3|||
33163817|NCT00224042|100511182|FG000|Overall Study|Other|2|||
33163818|NCT00224042|100511183|FG001|Overall Study|Other|0|||
33163819|NCT03616600|100511184|FG000|Overall Study|Withdrawal by Subject|1|||
33163820|NCT03616600|100511185|FG001|Overall Study|Withdrawal by Subject|0|||
33163821|NCT02794883|100511186|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
33163822|NCT02794883|100511187|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
33163823|NCT02794883|100511188|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
33163824|NCT02794883|100511186|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
33163825|NCT02794883|100511187|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
33163826|NCT02794883|100511188|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
33163827|NCT02794883|100511186|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
33163828|NCT02794883|100511187|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
33163829|NCT02794883|100511188|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
33163830|NCT02794883|100511186|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
33163831|NCT02794883|100511187|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
33163832|NCT02794883|100511188|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
33163833|NCT02794883|100511186|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
33163834|NCT02794883|100511187|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
33163835|NCT02794883|100511188|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
33163836|NCT02794883|100511186|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
33163837|NCT02794883|100511187|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
33163838|NCT02794883|100511188|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
33163839|NCT02794883|100511186|FG000|Follow-up Period (up to 2 Years)|Death|12|||
33163840|NCT02794883|100511187|FG001|Follow-up Period (up to 2 Years)|Death|10|||
33163841|NCT02794883|100511188|FG002|Follow-up Period (up to 2 Years)|Death|10|||
33163842|NCT01687998|100511191|FG000|Overall Study|Withdrawal by Subject|49|||
33163843|NCT01687998|100511192|FG001|Overall Study|Withdrawal by Subject|51|||
33444404|NCT00950989|101519018|FG003|Overall Study|Withdrawal by Subject|0|||
33444405|NCT00950989|101519015|FG000|Overall Study|Adverse Event|2|||
33444406|NCT00950989|101519016|FG001|Overall Study|Adverse Event|1|||
33444407|NCT00950989|101519017|FG002|Overall Study|Adverse Event|1|||
33444408|NCT00950989|101519018|FG003|Overall Study|Adverse Event|0|||
33444409|NCT02481830|101519020|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
33444410|NCT02481830|101519021|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
33444411|NCT02481830|101519020|FG000|Pre-treatment|Withdrawal by Subject|0|||
33444412|NCT02481830|101519021|FG001|Pre-treatment|Withdrawal by Subject|10|||
33444413|NCT02481830|101519020|FG000|Pre-treatment|Disease Progression|1|||
33444414|NCT02481830|101519021|FG001|Pre-treatment|Disease Progression|1|||
33444415|NCT02481830|101519020|FG000|Pre-treatment|Other reasons|0|||
33444416|NCT02481830|101519021|FG001|Pre-treatment|Other reasons|1|||
33444417|NCT02481830|101519020|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
33444418|NCT02481830|101519021|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
33444419|NCT02481830|101519020|FG000|Treatment|Disease Progression|233|||
33163844|NCT01687998|100511191|FG000|Overall Study|Known to be Alive at Study End|54|||
33163845|NCT01687998|100511192|FG001|Overall Study|Known to be Alive at Study End|62|||
33163846|NCT01687998|100511191|FG000|Overall Study|Lost to Follow-up|9|||
33163847|NCT01687998|100511192|FG001|Overall Study|Lost to Follow-up|7|||
33444420|NCT02481830|101519021|FG001|Treatment|Disease Progression|171|||
33163848|NCT00299104|100511193|FG000|Treatment Period|Adverse Event|14|||
33163849|NCT00299104|100511194|FG001|Treatment Period|Adverse Event|9|||
33163850|NCT00299104|100511195|FG002|Treatment Period|Adverse Event|7|||
33444421|NCT02481830|101519020|FG000|Treatment|Study drug toxicity|18|||
33444422|NCT02481830|101519021|FG001|Treatment|Study drug toxicity|38|||
33444423|NCT02481830|101519020|FG000|Treatment|Death|1|||
33444424|NCT02481830|101519021|FG001|Treatment|Death|1|||
33444425|NCT02481830|101519020|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
33444426|NCT02481830|101519021|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
33444427|NCT02481830|101519020|FG000|Treatment|Participants request to discontinue Study treatment|6|||
33444428|NCT02481830|101519021|FG001|Treatment|Participants request to discontinue Study treatment|34|||
33444429|NCT02481830|101519020|FG000|Treatment|Withdrawal by Subject|2|||
33444430|NCT02481830|101519021|FG001|Treatment|Withdrawal by Subject|3|||
33444431|NCT02481830|101519020|FG000|Treatment|Lost to Follow-up|1|||
33444432|NCT02481830|101519021|FG001|Treatment|Lost to Follow-up|0|||
33444433|NCT02481830|101519020|FG000|Treatment|Maximum Clinical Benefit|0|||
33444434|NCT02481830|101519021|FG001|Treatment|Maximum Clinical Benefit|5|||
33444435|NCT02481830|101519020|FG000|Treatment|Administrative reason by sponsor|1|||
33444436|NCT02481830|101519021|FG001|Treatment|Administrative reason by sponsor|1|||
33444437|NCT02481830|101519020|FG000|Treatment|Other reasons|6|||
33444438|NCT02481830|101519021|FG001|Treatment|Other reasons|1|||
33444439|NCT00328926|101519024|FG000|Overall Study|Pregnancy|2|||
33444440|NCT00328926|101519025|FG001|Overall Study|Pregnancy|1|||
33444441|NCT00328926|101519026|FG002|Overall Study|Pregnancy|0|||
33444442|NCT00328926|101519024|FG000|Overall Study|Lost to Follow-up|0|||
33444443|NCT00328926|101519025|FG001|Overall Study|Lost to Follow-up|1|||
33444444|NCT00328926|101519026|FG002|Overall Study|Lost to Follow-up|0|||
33444445|NCT00328926|101519024|FG000|Overall Study|Death|0|||
33444446|NCT00328926|101519025|FG001|Overall Study|Death|0|||
33444447|NCT00328926|101519026|FG002|Overall Study|Death|1|||
33444448|NCT00328926|101519024|FG000|Overall Study|In vitro fertilization treatment|0|||
33444449|NCT00328926|101519025|FG001|Overall Study|In vitro fertilization treatment|0|||
33444450|NCT00328926|101519026|FG002|Overall Study|In vitro fertilization treatment|1|||
33444451|NCT00328926|101519024|FG000|Overall Study|Lack of ovarian response|0|||
33444452|NCT00328926|101519025|FG001|Overall Study|Lack of ovarian response|1|||
33444453|NCT00328926|101519026|FG002|Overall Study|Lack of ovarian response|0|||
33444454|NCT01328093|101519031|FG000|Double-Blind Phase|Adverse Event|78|||
33163851|NCT00299104|100511193|FG000|Treatment Period|Death|1|||
33444455|NCT01328093|101519032|FG001|Double-Blind Phase|Adverse Event|15|||
33444456|NCT01328093|101519031|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
33444457|NCT01328093|101519032|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
33444458|NCT01328093|101519031|FG000|Double-Blind Phase|Lost to Follow-up|39|||
33444459|NCT01328093|101519032|FG001|Double-Blind Phase|Lost to Follow-up|14|||
33444460|NCT01328093|101519031|FG000|Double-Blind Phase|Protocol Violation|30|||
33444461|NCT01328093|101519032|FG001|Double-Blind Phase|Protocol Violation|10|||
33444462|NCT01328093|101519031|FG000|Double-Blind Phase|Lack of Efficacy|55|||
33444463|NCT01328093|101519032|FG001|Double-Blind Phase|Lack of Efficacy|13|||
33444464|NCT01328093|101519031|FG000|Double-Blind Phase|Sponsor Decision|17|||
33444465|NCT01328093|101519032|FG001|Double-Blind Phase|Sponsor Decision|3|||
33444466|NCT01328093|101519031|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
33444467|NCT01328093|101519032|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
33444468|NCT01328093|101519031|FG000|Double-Blind Phase|Scheduling conflict|8|||
33444469|NCT01328093|101519032|FG001|Double-Blind Phase|Scheduling conflict|3|||
33444470|NCT01328093|101519031|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
33444471|NCT01328093|101519032|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
33444472|NCT01328093|101519031|FG000|Double-Blind Phase|Death|1|||
33444473|NCT01328093|101519032|FG001|Double-Blind Phase|Death|0|||
33444474|NCT01328093|101519031|FG000|Open-Label Phase|Sponsor Decision|98|||
33444475|NCT01328093|101519032|FG001|Open-Label Phase|Sponsor Decision|34|||
33444476|NCT01328093|101519031|FG000|Open-Label Phase|Protocol Violation|8|||
33444477|NCT01328093|101519032|FG001|Open-Label Phase|Protocol Violation|3|||
33444478|NCT01328093|101519031|FG000|Open-Label Phase|Lost to Follow-up|10|||
33444479|NCT01328093|101519032|FG001|Open-Label Phase|Lost to Follow-up|1|||
33444480|NCT01328093|101519031|FG000|Open-Label Phase|Adverse Event|10|||
33444481|NCT01328093|101519032|FG001|Open-Label Phase|Adverse Event|4|||
33444482|NCT01328093|101519031|FG000|Open-Label Phase|Lack of Efficacy|5|||
33444483|NCT01328093|101519032|FG001|Open-Label Phase|Lack of Efficacy|6|||
33444484|NCT01328093|101519031|FG000|Open-Label Phase|Withdrawal by Subject|4|||
33163852|NCT00299104|100511194|FG001|Treatment Period|Death|1|||
33163853|NCT00299104|100511195|FG002|Treatment Period|Death|1|||
33163854|NCT00299104|100511193|FG000|Treatment Period|Insufficient therapeutic response|34|||
33163855|NCT00299104|100511194|FG001|Treatment Period|Insufficient therapeutic response|13|||
33163856|NCT00299104|100511195|FG002|Treatment Period|Insufficient therapeutic response|8|||
33444485|NCT01328093|101519032|FG001|Open-Label Phase|Withdrawal by Subject|1|||
33444486|NCT01328093|101519031|FG000|Open-Label Phase|Scheduling conflict|2|||
33444487|NCT01328093|101519032|FG001|Open-Label Phase|Scheduling conflict|1|||
33444488|NCT01328093|101519031|FG000|Open-Label Phase|Subject is moving or has moved|2|||
33257721|NCT00232180|100845864|FG002|Double-blind (DB) Phase|Other|0|||
33444489|NCT01328093|101519032|FG001|Open-Label Phase|Subject is moving or has moved|0|||
33163857|NCT00299104|100511193|FG000|Treatment Period|Failure to return|9|||
33163858|NCT00299104|100511194|FG001|Treatment Period|Failure to return|8|||
33163859|NCT00299104|100511195|FG002|Treatment Period|Failure to return|8|||
33163860|NCT00299104|100511193|FG000|Treatment Period|Violation of selection criteria|1|||
33163861|NCT00299104|100511194|FG001|Treatment Period|Violation of selection criteria|2|||
33163862|NCT00299104|100511195|FG002|Treatment Period|Violation of selection criteria|0|||
33163863|NCT00299104|100511193|FG000|Treatment Period|Protocol Violation|1|||
33163864|NCT00299104|100511194|FG001|Treatment Period|Protocol Violation|1|||
33163865|NCT00299104|100511195|FG002|Treatment Period|Protocol Violation|0|||
33163866|NCT00299104|100511193|FG000|Treatment Period|Refused treatment|9|||
33163867|NCT00299104|100511194|FG001|Treatment Period|Refused treatment|2|||
33163868|NCT00299104|100511195|FG002|Treatment Period|Refused treatment|2|||
33163869|NCT00299104|100511193|FG000|Treatment Period|Withdrew consent|14|||
33163870|NCT00299104|100511194|FG001|Treatment Period|Withdrew consent|19|||
33163871|NCT00299104|100511195|FG002|Treatment Period|Withdrew consent|9|||
33163872|NCT00299104|100511193|FG000|Treatment Period|Administrative reasons|106|||
33163873|NCT00299104|100511194|FG001|Treatment Period|Administrative reasons|120|||
33163874|NCT00299104|100511195|FG002|Treatment Period|Administrative reasons|137|||
33163875|NCT00299104|100511193|FG000|Safety Follow-Up (SFU) Period|Death|3|||
33163876|NCT00299104|100511194|FG001|Safety Follow-Up (SFU) Period|Death|2|||
33163877|NCT00299104|100511195|FG002|Safety Follow-Up (SFU) Period|Death|1|||
33163878|NCT00299104|100511193|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
33163879|NCT00299104|100511194|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
33163880|NCT00299104|100511195|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
33163881|NCT00299104|100511193|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
33163882|NCT00299104|100511194|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
33163883|NCT00299104|100511195|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
33163884|NCT00299104|100511193|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
33163885|NCT00299104|100511194|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
33163886|NCT00299104|100511195|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
33163887|NCT00299104|100511193|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
33163888|NCT00299104|100511194|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
33163889|NCT00299104|100511195|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
33163890|NCT00299104|100511193|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
33163891|NCT00299104|100511194|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
33163892|NCT00299104|100511195|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
33163893|NCT00299104|100511193|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
33163894|NCT00299104|100511194|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
33163895|NCT00299104|100511195|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
33257722|NCT00232180|100845862|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
33257723|NCT00232180|100845863|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
33257724|NCT00232180|100845864|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
33257725|NCT00232180|100845862|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
33257726|NCT00232180|100845863|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
33257727|NCT00232180|100845864|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
33257728|NCT00232180|100845862|FG000|Open Label Phase|Death|0|||
33257729|NCT00232180|100845863|FG001|Open Label Phase|Death|0|||
33257730|NCT00232180|100845864|FG002|Open Label Phase|Death|48|||
33257731|NCT00232180|100845862|FG000|Open Label Phase|Lost to Follow-up|0|||
33257732|NCT00232180|100845863|FG001|Open Label Phase|Lost to Follow-up|0|||
33257733|NCT00232180|100845864|FG002|Open Label Phase|Lost to Follow-up|5|||
33257734|NCT00232180|100845862|FG000|Open Label Phase|Protocol Violation|0|||
33257735|NCT00232180|100845863|FG001|Open Label Phase|Protocol Violation|0|||
33257736|NCT00232180|100845864|FG002|Open Label Phase|Protocol Violation|3|||
33257737|NCT00232180|100845862|FG000|Open Label Phase|Study terminated by sponsor|0|||
33257738|NCT00232180|100845863|FG001|Open Label Phase|Study terminated by sponsor|0|||
33257739|NCT00232180|100845864|FG002|Open Label Phase|Study terminated by sponsor|3|||
33444490|NCT01328093|101519031|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
33444491|NCT01328093|101519032|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
33163896|NCT00299104|100511193|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
33257740|NCT00232180|100845862|FG000|Open Label Phase|Withdrawal by Subject|0|||
33257741|NCT00232180|100845863|FG001|Open Label Phase|Withdrawal by Subject|0|||
33163897|NCT00299104|100511194|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
33257742|NCT00232180|100845864|FG002|Open Label Phase|Withdrawal by Subject|37|||
33444492|NCT02388191|101519033|FG000|Overall Study|Patient did not receive IUD|1|||
33444493|NCT02388191|101519034|FG001|Overall Study|Patient did not receive IUD|0|||
33444494|NCT01376167|101519035|FG000|Overall Study|Lost to Follow-up|2|||
33444495|NCT01376167|101519036|FG001|Overall Study|Lost to Follow-up|4|||
33444496|NCT01376167|101519037|FG002|Overall Study|Lost to Follow-up|2|||
33444497|NCT01376167|101519035|FG000|Overall Study|Physician Decision|1|||
33444498|NCT01376167|101519036|FG001|Overall Study|Physician Decision|1|||
33444499|NCT01376167|101519037|FG002|Overall Study|Physician Decision|0|||
33444500|NCT01376167|101519035|FG000|Overall Study|Withdrawal by Subject|1|||
33444501|NCT01376167|101519036|FG001|Overall Study|Withdrawal by Subject|5|||
33444502|NCT01376167|101519037|FG002|Overall Study|Withdrawal by Subject|4|||
33444503|NCT00437658|101519038|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
33444504|NCT00437658|101519039|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
33444505|NCT00437658|101519040|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
33444506|NCT00437658|101519038|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
33444507|NCT00437658|101519039|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
33444508|NCT00437658|101519040|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
33444509|NCT00437658|101519038|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
33444510|NCT00437658|101519039|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
33444511|NCT00437658|101519040|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
33444512|NCT00437658|101519038|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
33444513|NCT00437658|101519039|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
33444514|NCT00437658|101519040|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
33444515|NCT00437658|101519038|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
33444516|NCT00437658|101519039|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
33444517|NCT00437658|101519040|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
33444518|NCT00437658|101519038|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
33444519|NCT00437658|101519039|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
33444520|NCT00437658|101519040|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
33444521|NCT00437658|101519038|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
33444522|NCT00437658|101519039|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
33444523|NCT00437658|101519040|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
33444524|NCT00437658|101519038|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
33444525|NCT00437658|101519039|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
33444526|NCT00437658|101519040|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
33444527|NCT00437658|101519038|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
33444528|NCT00437658|101519039|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
33444529|NCT00437658|101519040|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
33444530|NCT00437658|101519038|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
33444531|NCT00437658|101519039|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
33444532|NCT00437658|101519040|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
33444533|NCT00437658|101519038|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
33444534|NCT00437658|101519039|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
33444535|NCT00437658|101519040|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
33444536|NCT00437658|101519038|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
33444537|NCT00437658|101519039|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
33444538|NCT00437658|101519040|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
33444539|NCT03459807|101519044|FG000|Overall Study|Withdrawal due to transplant|0|||
33444540|NCT03459807|101519045|FG001|Overall Study|Withdrawal due to transplant|1|||
33444541|NCT00849901|101519049|FG000|Acute Treatment Phase|Adverse Event|9|||
33444542|NCT00849901|101519050|FG001|Acute Treatment Phase|Adverse Event|1|||
33444543|NCT00849901|101519051|FG002|Acute Treatment Phase|Adverse Event|3|||
33444544|NCT00849901|101519049|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
33444545|NCT00849901|101519050|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
33444546|NCT00849901|101519051|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
33444547|NCT00849901|101519049|FG000|Acute Treatment Phase|Protocol Violation|0|||
33444548|NCT00849901|101519050|FG001|Acute Treatment Phase|Protocol Violation|2|||
33444549|NCT00849901|101519051|FG002|Acute Treatment Phase|Protocol Violation|1|||
33444550|NCT00849901|101519049|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
33444551|NCT00849901|101519050|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
33444552|NCT00849901|101519051|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
33444553|NCT00849901|101519049|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
33444554|NCT00849901|101519050|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
33444555|NCT00849901|101519051|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
33444556|NCT00849901|101519049|FG000|Acute Treatment Phase|Physician Decision|1|||
33444557|NCT00849901|101519050|FG001|Acute Treatment Phase|Physician Decision|1|||
33444558|NCT00849901|101519051|FG002|Acute Treatment Phase|Physician Decision|1|||
33444559|NCT00849901|101519049|FG000|Acute Treatment Phase|Sponsor Decision|1|||
33163898|NCT00299104|100511195|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
33163899|NCT02801396|100511199|FG000|Period 1|Withdrawal by Subject|0|||
33163900|NCT02801396|100511200|FG001|Period 1|Withdrawal by Subject|0|||
33163901|NCT02801396|100511201|FG002|Period 1|Withdrawal by Subject|0|||
33163902|NCT02801396|100511202|FG003|Period 1|Withdrawal by Subject|0|||
33163903|NCT02801396|100511203|FG004|Period 1|Withdrawal by Subject|1|||
33163904|NCT02801396|100511204|FG005|Period 1|Withdrawal by Subject|0|||
33163905|NCT01947582|100511205|FG000|Overall Study|Withdrawal by Subject|1|||
33163906|NCT02555683|100511206|FG000|Overall Study|Physician Decision|1|||
33163907|NCT02555683|100511207|FG001|Overall Study|Physician Decision|0|||
33163908|NCT02555683|100511208|FG002|Overall Study|Physician Decision|2|||
33163909|NCT02555683|100511206|FG000|Overall Study|Lost to Follow-up|2|||
33163910|NCT02555683|100511207|FG001|Overall Study|Lost to Follow-up|1|||
33163911|NCT02555683|100511208|FG002|Overall Study|Lost to Follow-up|2|||
33163912|NCT02555683|100511206|FG000|Overall Study|Technical Problems|1|||
33163913|NCT02555683|100511207|FG001|Overall Study|Technical Problems|1|||
33163914|NCT02555683|100511208|FG002|Overall Study|Technical Problems|0|||
33163915|NCT02555683|100511206|FG000|Overall Study|Protocol deviation|0|||
33163916|NCT02555683|100511207|FG001|Overall Study|Protocol deviation|1|||
33163917|NCT02555683|100511208|FG002|Overall Study|Protocol deviation|0|||
33163918|NCT02555683|100511206|FG000|Overall Study|Lack of Efficacy|2|||
33163919|NCT02555683|100511207|FG001|Overall Study|Lack of Efficacy|0|||
33163920|NCT02555683|100511208|FG002|Overall Study|Lack of Efficacy|0|||
33163921|NCT02555683|100511206|FG000|Overall Study|Death|0|||
33163922|NCT02555683|100511207|FG001|Overall Study|Death|1|||
33163923|NCT02555683|100511208|FG002|Overall Study|Death|2|||
33163924|NCT02555683|100511206|FG000|Overall Study|Adverse Event|1|||
33257743|NCT00232180|100845862|FG000|Open Label Phase|Other|0|||
33257744|NCT00232180|100845863|FG001|Open Label Phase|Other|0|||
33257745|NCT00232180|100845864|FG002|Open Label Phase|Other|16|||
33257746|NCT00232180|100845862|FG000|Open Label Phase|Adverse Event|0|||
33257747|NCT00232180|100845863|FG001|Open Label Phase|Adverse Event|0|||
33257748|NCT00232180|100845864|FG002|Open Label Phase|Adverse Event|25|||
33257749|NCT00232180|100845862|FG000|Open Label Phase|Laboratory abnormality|0|||
33257750|NCT00232180|100845863|FG001|Open Label Phase|Laboratory abnormality|0|||
33257751|NCT00232180|100845864|FG002|Open Label Phase|Laboratory abnormality|10|||
33257752|NCT00232180|100845862|FG000|Open Label Phase|Randomized but not treated|0|||
33257753|NCT00232180|100845863|FG001|Open Label Phase|Randomized but not treated|0|||
33163925|NCT02555683|100511207|FG001|Overall Study|Adverse Event|0|||
33163926|NCT02555683|100511208|FG002|Overall Study|Adverse Event|1|||
33257754|NCT00232180|100845864|FG002|Open Label Phase|Randomized but not treated|1|||
33257755|NCT04056611|100845869|FG000|Overall Study|Physician Decision|1|||
33257756|NCT00371787|100845870|FG000|Overall Study|Withdrawal by Subject|3|||
33257757|NCT00371787|100845871|FG001|Overall Study|Withdrawal by Subject|1|||
33257758|NCT01610297|100845875|FG000|Overall Study|Lost to Follow-up|1|||
33257759|NCT00373529|100845878|FG000|Overall Study|Physician Decision|19|||
33257760|NCT00373529|100845878|FG000|Overall Study|Withdrawal by Subject|7|||
33257761|NCT00373529|100845878|FG000|Overall Study|Adverse Event|7|||
33257762|NCT00373529|100845878|FG000|Overall Study|Treatment failure|36|||
33163927|NCT02555683|100511206|FG000|Overall Study|Subject/guardian decision|12|||
33163928|NCT02555683|100511207|FG001|Overall Study|Subject/guardian decision|12|||
33163929|NCT02555683|100511208|FG002|Overall Study|Subject/guardian decision|22|||
33163930|NCT02555683|100511206|FG000|Overall Study|Death post Treatment/safety period|0|||
33163931|NCT02555683|100511207|FG001|Overall Study|Death post Treatment/safety period|1|||
33163932|NCT02555683|100511208|FG002|Overall Study|Death post Treatment/safety period|0|||
33163933|NCT00039130|100511209|FG000|Overall Study|Adverse Event|11|||
33163934|NCT00039130|100511209|FG000|Overall Study|Death|9|||
33163935|NCT00039130|100511209|FG000|Overall Study|Withdrawal by Subject|3|||
33163936|NCT00039130|100511209|FG000|Overall Study|Progression|2|||
33163937|NCT00039130|100511209|FG000|Overall Study|Subsequent treatment|2|||
33163938|NCT00039130|100511209|FG000|Overall Study|Physician Decision|3|||
33163939|NCT00126191|100511211|FG000|Overall Study|Physician Decision|0|||
33257763|NCT00373529|100845878|FG000|Overall Study|Disease recurrence|10|||
33257764|NCT00373529|100845878|FG000|Overall Study|Death|16|||
33257765|NCT00373529|100845878|FG000|Overall Study|Need for treatment prohibited by study|1|||
33163940|NCT00126191|100511212|FG001|Overall Study|Physician Decision|1|||
33163941|NCT00126191|100511211|FG000|Overall Study|Death|0|||
33163942|NCT00126191|100511212|FG001|Overall Study|Death|1|||
33163943|NCT00827502|100511213|FG000|Overall Study|randomized but not treated|11|||
33163944|NCT00827502|100511213|FG000|Overall Study|Adverse Event|1|||
33163945|NCT00827502|100511213|FG000|Overall Study|Lost to Follow-up|4|||
33163946|NCT00827502|100511213|FG000|Overall Study|Withdrawal by Subject|5|||
33257766|NCT00373529|100845878|FG000|Overall Study|Other|8|||
33257767|NCT00373529|100845878|FG000|Overall Study|Failed independent confirmation of AML|3|||
33163947|NCT00520936|100511214|FG000|Overall Study|Physician Decision|0|||
33163948|NCT00520936|100511215|FG001|Overall Study|Physician Decision|2|||
33257768|NCT00373529|100845878|FG000|Overall Study|Consent violation|1|||
33257769|NCT02965846|100845881|FG000|Overall Study|Lost to Follow-up|1|||
33257770|NCT02965846|100845882|FG001|Overall Study|Lost to Follow-up|0|||
33257771|NCT02965846|100845883|FG002|Overall Study|Lost to Follow-up|0|||
33257772|NCT02965846|100845881|FG000|Overall Study|Withdrawal by Subject|0|||
33257773|NCT02965846|100845882|FG001|Overall Study|Withdrawal by Subject|1|||
33257774|NCT02965846|100845883|FG002|Overall Study|Withdrawal by Subject|0|||
33257775|NCT02965846|100845881|FG000|Overall Study|Study Terminated By Sponsor|4|||
33257776|NCT02965846|100845882|FG001|Overall Study|Study Terminated By Sponsor|4|||
33257777|NCT02965846|100845883|FG002|Overall Study|Study Terminated By Sponsor|0|||
33257778|NCT02965846|100845881|FG000|Overall Study|Participants not randomized|0|||
33257779|NCT02965846|100845882|FG001|Overall Study|Participants not randomized|0|||
33257780|NCT02965846|100845883|FG002|Overall Study|Participants not randomized|33|||
33257781|NCT00440011|100845887|FG000|Overall Study|Adverse Event|2|||
33257782|NCT00440011|100845888|FG001|Overall Study|Adverse Event|0|||
33257783|NCT00440011|100845887|FG000|Overall Study|Lost to Follow-up|0|||
33257784|NCT00440011|100845888|FG001|Overall Study|Lost to Follow-up|2|||
33257785|NCT00440011|100845887|FG000|Overall Study|Protocol Violation|1|||
33257786|NCT00440011|100845888|FG001|Overall Study|Protocol Violation|1|||
33257787|NCT00440011|100845887|FG000|Overall Study|Withdrawal by Subject|1|||
33257788|NCT00440011|100845888|FG001|Overall Study|Withdrawal by Subject|0|||
33257789|NCT00683696|100845892|FG000|Overall Study|Withdrawn due to study closure|337|||
33257790|NCT00683696|100845893|FG001|Overall Study|Withdrawn due to study closure|338|||
33257791|NCT00683696|100845892|FG000|Overall Study|Withdrawn prior to study closure|13|||
33257792|NCT00683696|100845893|FG001|Overall Study|Withdrawn prior to study closure|28|||
33257793|NCT00683696|100845892|FG000|Overall Study|Lost to Follow-up|5|||
33257794|NCT00683696|100845893|FG001|Overall Study|Lost to Follow-up|6|||
33257795|NCT00683696|100845892|FG000|Overall Study|Vital status follow-up only|3|||
33257796|NCT00683696|100845893|FG001|Overall Study|Vital status follow-up only|3|||
33257797|NCT00683696|100845892|FG000|Overall Study|Death|46|||
33257798|NCT00683696|100845893|FG001|Overall Study|Death|30|||
33257799|NCT00493649|100845894|FG000|Overall Study|Adverse Event|44|||
33257800|NCT00493649|100845894|FG000|Overall Study|Patient Request|21|||
33257801|NCT00493649|100845894|FG000|Overall Study|Investigator Request|2|||
33257802|NCT00493649|100845894|FG000|Overall Study|Disease Progression|1|||
33257803|NCT00493649|100845894|FG000|Overall Study|Lost to Follow-up|1|||
33257804|NCT00493649|100845894|FG000|Overall Study|Other|13|||
33257805|NCT02423798|100845895|FG000|Overall Study|Withdrawal by Subject|3|||
33257806|NCT03482635|100845902|FG000|Overall Study|Lack of Efficacy|0|||
33257807|NCT03482635|100845903|FG001|Overall Study|Lack of Efficacy|0|||
33257808|NCT03482635|100845904|FG002|Overall Study|Lack of Efficacy|1|||
33257809|NCT03482635|100845905|FG003|Overall Study|Lack of Efficacy|3|||
33257810|NCT03482635|100845902|FG000|Overall Study|Adverse Event|2|||
33257811|NCT03482635|100845903|FG001|Overall Study|Adverse Event|2|||
33257812|NCT03482635|100845904|FG002|Overall Study|Adverse Event|0|||
33257813|NCT03482635|100845905|FG003|Overall Study|Adverse Event|3|||
33257814|NCT03482635|100845902|FG000|Overall Study|Withdrawal by Subject|2|||
33257815|NCT03482635|100845903|FG001|Overall Study|Withdrawal by Subject|1|||
33257816|NCT03482635|100845904|FG002|Overall Study|Withdrawal by Subject|0|||
33257817|NCT03482635|100845905|FG003|Overall Study|Withdrawal by Subject|1|||
33257818|NCT03482635|100845902|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
33257819|NCT03482635|100845903|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
33257820|NCT03482635|100845904|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
33257821|NCT03482635|100845905|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
33257822|NCT03482635|100845902|FG000|Overall Study|Not treated|0|||
33257823|NCT03482635|100845903|FG001|Overall Study|Not treated|0|||
33257824|NCT03482635|100845904|FG002|Overall Study|Not treated|0|||
33257825|NCT03482635|100845905|FG003|Overall Study|Not treated|1|||
33257826|NCT01254188|100845907|FG000|Overall Study|Disease Progression|6|||
33257827|NCT01254188|100845907|FG000|Overall Study|Protocol Violation|6|||
33257828|NCT01254188|100845907|FG000|Overall Study|Pregnancy|2|||
33257829|NCT01254188|100845907|FG000|Overall Study|Death|4|||
33257830|NCT01254188|100845907|FG000|Overall Study|Lost to Follow-up|5|||
33257831|NCT01254188|100845907|FG000|Overall Study|Withdrawal by Subject|7|||
33257832|NCT01254188|100845907|FG000|Overall Study|Adverse Event|43|||
33257833|NCT01254188|100845907|FG000|Overall Study|per investigator discretion|20|||
33257834|NCT01198145|100845909|FG000|Overall Study|Withdrawal by Subject|1|||
33257835|NCT01198145|100845910|FG001|Overall Study|Withdrawal by Subject|1|||
33257836|NCT02708108|100845913|FG000|Overall Study|Death|1|||
33257837|NCT02708108|100845914|FG001|Overall Study|Death|2|||
33257838|NCT02708108|100845913|FG000|Overall Study|Regimen change|1|||
33257839|NCT02708108|100845914|FG001|Overall Study|Regimen change|0|||
33257840|NCT02708108|100845913|FG000|Overall Study|No MRD and no imaging available|0|||
33257841|NCT02708108|100845914|FG001|Overall Study|No MRD and no imaging available|1|||
33257842|NCT01144468|100845915|FG000|Overall Study|Lost to Follow-up|4|||
33257843|NCT01144468|100845916|FG001|Overall Study|Lost to Follow-up|7|||
33257844|NCT01144468|100845915|FG000|Overall Study|Adverse Event|3|||
33257845|NCT01144468|100845916|FG001|Overall Study|Adverse Event|2|||
33257846|NCT01144468|100845915|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
33257847|NCT01144468|100845916|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
33257848|NCT00978042|100845922|FG000|Initial Treatment Period|Treated in Error|0|||
33257849|NCT00978042|100845923|FG001|Initial Treatment Period|Treated in Error|3|||
33257850|NCT00978042|100845922|FG000|Initial Treatment Period|Ineligibility|1|||
33257851|NCT00978042|100845923|FG001|Initial Treatment Period|Ineligibility|0|||
33257852|NCT00978042|100845922|FG000|Initial Treatment Period|Lost to Follow-up|21|||
33257853|NCT00978042|100845923|FG001|Initial Treatment Period|Lost to Follow-up|3|||
33257854|NCT00978042|100845922|FG000|Initial Treatment Period|Adverse Event|2|||
33257855|NCT00978042|100845923|FG001|Initial Treatment Period|Adverse Event|0|||
33257856|NCT00978042|100845922|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
33257857|NCT00978042|100845923|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
33257858|NCT00978042|100845922|FG000|Initial Treatment Period|Consent withdrawn|22|||
33257859|NCT00978042|100845923|FG001|Initial Treatment Period|Consent withdrawn|9|||
33257860|NCT00978042|100845922|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
33257861|NCT00978042|100845923|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
33257862|NCT00424645|100845934|FG000|Overall Study|Death|1|||
33257863|NCT00424645|100845935|FG001|Overall Study|Death|0|||
33257864|NCT00480077|100845942|FG000|Overall Study|Death|19|||
33257865|NCT00480077|100845943|FG001|Overall Study|Death|15|||
33257866|NCT00480077|100845942|FG000|Overall Study|early exit|12|||
33257867|NCT00480077|100845943|FG001|Overall Study|early exit|11|||
33444560|NCT00849901|101519050|FG001|Acute Treatment Phase|Sponsor Decision|0|||
33444561|NCT00849901|101519051|FG002|Acute Treatment Phase|Sponsor Decision|0|||
33444562|NCT00849901|101519049|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
33444563|NCT00849901|101519050|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
33444564|NCT00849901|101519051|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
33444565|NCT00849901|101519049|FG000|Extension Phase|Adverse Event|2|||
33444566|NCT00849901|101519050|FG001|Extension Phase|Adverse Event|8|||
33444567|NCT00849901|101519051|FG002|Extension Phase|Adverse Event|4|||
33444568|NCT00849901|101519049|FG000|Extension Phase|Lost to Follow-up|3|||
33444569|NCT00849901|101519050|FG001|Extension Phase|Lost to Follow-up|0|||
33444570|NCT00849901|101519051|FG002|Extension Phase|Lost to Follow-up|1|||
33444571|NCT00849901|101519049|FG000|Extension Phase|Protocol Violation|2|||
33444572|NCT00849901|101519050|FG001|Extension Phase|Protocol Violation|2|||
33444573|NCT00849901|101519051|FG002|Extension Phase|Protocol Violation|4|||
33444574|NCT00849901|101519049|FG000|Extension Phase|Withdrawal by Subject|7|||
33444575|NCT00849901|101519050|FG001|Extension Phase|Withdrawal by Subject|6|||
33444576|NCT00849901|101519051|FG002|Extension Phase|Withdrawal by Subject|3|||
33444577|NCT00849901|101519049|FG000|Extension Phase|Parent or Caregiver Decision|10|||
33444578|NCT00849901|101519050|FG001|Extension Phase|Parent or Caregiver Decision|4|||
33444579|NCT00849901|101519051|FG002|Extension Phase|Parent or Caregiver Decision|4|||
33444580|NCT00849901|101519049|FG000|Extension Phase|Physician Decision|1|||
33444581|NCT00849901|101519050|FG001|Extension Phase|Physician Decision|2|||
33444582|NCT00849901|101519051|FG002|Extension Phase|Physician Decision|0|||
33444583|NCT00849901|101519049|FG000|Extension Phase|Lack of Efficacy|2|||
33444584|NCT00849901|101519050|FG001|Extension Phase|Lack of Efficacy|4|||
33444585|NCT00849901|101519051|FG002|Extension Phase|Lack of Efficacy|1|||
33444586|NCT02422264|101519052|FG000|Overall Study|Serious Adverse Event|1|||
33444587|NCT02422264|101519053|FG001|Overall Study|Serious Adverse Event|0|||
33444588|NCT02422264|101519052|FG000|Overall Study|Withdrawal by Subject|1|||
33444589|NCT02422264|101519053|FG001|Overall Study|Withdrawal by Subject|2|||
33444590|NCT02422264|101519052|FG000|Overall Study|Migrated/moved from study area|3|||
33444591|NCT02422264|101519053|FG001|Overall Study|Migrated/moved from study area|1|||
33444592|NCT02422264|101519052|FG000|Overall Study|Subject vaccinated outside of the study|0|||
33444593|NCT02422264|101519053|FG001|Overall Study|Subject vaccinated outside of the study|1|||
33257868|NCT00774852|100845947|FG000|Overall Study|Adverse Event|9|||
33257869|NCT00774852|100845948|FG001|Overall Study|Adverse Event|6|||
33257870|NCT00774852|100845947|FG000|Overall Study|Death|2|||
33444594|NCT00436163|101519055|FG000|Overall Study|Lost to Follow-up|2|||
33257871|NCT00774852|100845948|FG001|Overall Study|Death|1|||
33444595|NCT00436163|101519055|FG000|Overall Study|Adverse Event|1|||
33444596|NCT03620747|101519056|FG000|Overall Study|Participant decision|7|||
33257872|NCT00774852|100845947|FG000|Overall Study|Lack of Efficacy|3|||
33444597|NCT03620747|101519056|FG000|Overall Study|Adverse Event|6|||
33444598|NCT03620747|101519056|FG000|Overall Study|Lack of Efficacy|1|||
33444599|NCT03620747|101519056|FG000|Overall Study|Poor compliance to protocol|2|||
33444600|NCT03620747|101519056|FG000|Overall Study|Other-unspecified|3|||
33257873|NCT00774852|100845948|FG001|Overall Study|Lack of Efficacy|7|||
33257874|NCT00774852|100845947|FG000|Overall Study|Lost to Follow-up|9|||
33257875|NCT00774852|100845948|FG001|Overall Study|Lost to Follow-up|5|||
33257876|NCT00774852|100845947|FG000|Overall Study|Physician Decision|2|||
33257877|NCT00774852|100845948|FG001|Overall Study|Physician Decision|6|||
33163949|NCT00520936|100511216|FG002|Overall Study|Physician Decision|1|||
33163950|NCT00520936|100511217|FG003|Overall Study|Physician Decision|0|||
33163951|NCT00520936|100511218|FG004|Overall Study|Physician Decision|0|||
33163952|NCT00520936|100511219|FG005|Overall Study|Physician Decision|0|||
33163953|NCT00520936|100511220|FG006|Overall Study|Physician Decision|0|||
33163954|NCT00520936|100511221|FG007|Overall Study|Physician Decision|0|||
33163955|NCT00520936|100511214|FG000|Overall Study|Withdrawal by Subject|0|||
33163956|NCT00520936|100511215|FG001|Overall Study|Withdrawal by Subject|0|||
33163957|NCT00520936|100511216|FG002|Overall Study|Withdrawal by Subject|0|||
33163958|NCT00520936|100511217|FG003|Overall Study|Withdrawal by Subject|0|||
33163959|NCT00520936|100511218|FG004|Overall Study|Withdrawal by Subject|0|||
33163960|NCT00520936|100511219|FG005|Overall Study|Withdrawal by Subject|0|||
33163961|NCT00520936|100511220|FG006|Overall Study|Withdrawal by Subject|0|||
33163962|NCT00520936|100511221|FG007|Overall Study|Withdrawal by Subject|1|||
33163963|NCT00520936|100511214|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
33163964|NCT00520936|100511215|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
33163965|NCT00520936|100511216|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
33163966|NCT00520936|100511217|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
33163967|NCT00520936|100511218|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
33163968|NCT00520936|100511219|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
33163969|NCT00520936|100511220|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
33163970|NCT00520936|100511221|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
33163971|NCT00520936|100511214|FG000|Overall Study|Death|0|||
33163972|NCT00520936|100511215|FG001|Overall Study|Death|0|||
33163973|NCT00520936|100511216|FG002|Overall Study|Death|0|||
33163974|NCT00520936|100511217|FG003|Overall Study|Death|0|||
33163975|NCT00520936|100511218|FG004|Overall Study|Death|0|||
33163976|NCT00520936|100511219|FG005|Overall Study|Death|0|||
33163977|NCT00520936|100511220|FG006|Overall Study|Death|1|||
33163978|NCT00520936|100511221|FG007|Overall Study|Death|0|||
33163979|NCT00520936|100511214|FG000|Overall Study|Protocol Violation|0|||
33163980|NCT00520936|100511215|FG001|Overall Study|Protocol Violation|1|||
33163981|NCT00520936|100511216|FG002|Overall Study|Protocol Violation|1|||
33163982|NCT00520936|100511217|FG003|Overall Study|Protocol Violation|0|||
33163983|NCT00520936|100511218|FG004|Overall Study|Protocol Violation|1|||
33163984|NCT00520936|100511219|FG005|Overall Study|Protocol Violation|0|||
33163985|NCT00520936|100511220|FG006|Overall Study|Protocol Violation|1|||
33163986|NCT00520936|100511221|FG007|Overall Study|Protocol Violation|0|||
33163987|NCT00289991|100511222|FG000|Overall Study|Death|35|||
33163988|NCT00289991|100511223|FG001|Overall Study|Death|38|||
33163989|NCT00289991|100511222|FG000|Overall Study|Adverse Event|15|||
33163990|NCT00289991|100511223|FG001|Overall Study|Adverse Event|13|||
33163991|NCT00289991|100511222|FG000|Overall Study|Failure of prophylaxis|1|||
33163992|NCT00289991|100511223|FG001|Overall Study|Failure of prophylaxis|1|||
33163993|NCT00289991|100511222|FG000|Overall Study|Fungal breakthrough infection|0|||
33163994|NCT00289991|100511223|FG001|Overall Study|Fungal breakthrough infection|1|||
33163995|NCT00289991|100511222|FG000|Overall Study|Lost to Follow-up|0|||
33163996|NCT00289991|100511223|FG001|Overall Study|Lost to Follow-up|1|||
33163997|NCT00289991|100511222|FG000|Overall Study|Withdrawal by Subject|2|||
33163998|NCT00289991|100511223|FG001|Overall Study|Withdrawal by Subject|12|||
33163999|NCT00289991|100511222|FG000|Overall Study|Other|5|||
33164000|NCT00289991|100511223|FG001|Overall Study|Other|14|||
33164001|NCT02165215|100511233|FG000|Induction Phase|Adverse Event|1|||
33164002|NCT02165215|100511234|FG001|Induction Phase|Adverse Event|0|||
33164003|NCT02165215|100511235|FG002|Induction Phase|Adverse Event|0|||
33164004|NCT02165215|100511233|FG000|Induction Phase|Withdrawal by Subject|10|||
33164005|NCT02165215|100511234|FG001|Induction Phase|Withdrawal by Subject|0|||
33164006|NCT02165215|100511235|FG002|Induction Phase|Withdrawal by Subject|0|||
33164007|NCT02165215|100511233|FG000|Induction Phase|Protocol Violation|1|||
33164008|NCT02165215|100511234|FG001|Induction Phase|Protocol Violation|0|||
33164009|NCT02165215|100511235|FG002|Induction Phase|Protocol Violation|0|||
33164010|NCT02165215|100511233|FG000|Induction Phase|Physician Decision|1|||
33164011|NCT02165215|100511234|FG001|Induction Phase|Physician Decision|0|||
33164012|NCT02165215|100511235|FG002|Induction Phase|Physician Decision|0|||
33164013|NCT02165215|100511233|FG000|Induction Phase|Lack of Efficacy|2|||
33164014|NCT02165215|100511234|FG001|Induction Phase|Lack of Efficacy|0|||
33164015|NCT02165215|100511235|FG002|Induction Phase|Lack of Efficacy|0|||
33164016|NCT02165215|100511233|FG000|Induction Phase|Non-Compliance|2|||
33164017|NCT02165215|100511234|FG001|Induction Phase|Non-Compliance|0|||
33164018|NCT02165215|100511235|FG002|Induction Phase|Non-Compliance|0|||
33164019|NCT02165215|100511233|FG000|Induction Phase|Lost to Follow-up|6|||
33164020|NCT02165215|100511234|FG001|Induction Phase|Lost to Follow-up|0|||
33164021|NCT02165215|100511235|FG002|Induction Phase|Lost to Follow-up|0|||
33257878|NCT00774852|100845947|FG000|Overall Study|Pregnancy|1|||
33257879|NCT00774852|100845948|FG001|Overall Study|Pregnancy|2|||
33257880|NCT00774852|100845947|FG000|Overall Study|Withdrawal by Subject|2|||
33257881|NCT00774852|100845948|FG001|Overall Study|Withdrawal by Subject|2|||
33257882|NCT00774852|100845947|FG000|Overall Study|Non-responder|15|||
33257883|NCT00774852|100845948|FG001|Overall Study|Non-responder|11|||
33257884|NCT00774852|100845947|FG000|Overall Study|Subject non-compliance|0|||
33257885|NCT00774852|100845948|FG001|Overall Study|Subject non-compliance|1|||
33257886|NCT00774852|100845947|FG000|Overall Study|Protocol Violation|1|||
33257887|NCT00774852|100845948|FG001|Overall Study|Protocol Violation|0|||
33257888|NCT00774852|100845947|FG000|Overall Study|Subject received prohibited medication|1|||
33257889|NCT00774852|100845948|FG001|Overall Study|Subject received prohibited medication|0|||
33257890|NCT01571596|100845949|FG000|Overall Study|Adverse Event|2|||
33257891|NCT01571596|100845950|FG001|Overall Study|Adverse Event|0|||
33257892|NCT01571596|100845951|FG002|Overall Study|Adverse Event|0|||
33257893|NCT01571596|100845949|FG000|Overall Study|Study Terminated by the Sponsor|0|||
33257894|NCT01571596|100845950|FG001|Overall Study|Study Terminated by the Sponsor|1|||
33257895|NCT01571596|100845951|FG002|Overall Study|Study Terminated by the Sponsor|1|||
33257896|NCT03475316|100845952|FG000|6 Month Intervention|Adverse Event|2|||
33257897|NCT03475316|100845953|FG001|6 Month Intervention|Adverse Event|1|||
33257898|NCT03475316|100845952|FG000|6 Month Intervention|Withdrawal by Subject|2|||
33257899|NCT03475316|100845953|FG001|6 Month Intervention|Withdrawal by Subject|0|||
33257900|NCT03475316|100845952|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
33257901|NCT03475316|100845953|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
33257902|NCT03475316|100845952|FG000|9 Months|Study stopped due to COVID pandemic|3|||
33257903|NCT03475316|100845953|FG001|9 Months|Study stopped due to COVID pandemic|4|||
33257904|NCT02616900|100845955|FG000|Overall Study|Lack of Efficacy|7|||
33257905|NCT02616900|100845955|FG000|Overall Study|Lost to Follow-up|2|||
33257906|NCT02616900|100845955|FG000|Overall Study|Protocol Violation|5|||
33257907|NCT02616900|100845955|FG000|Overall Study|Withdrawal by Subject|3|||
33257908|NCT02616900|100845955|FG000|Overall Study|Incomplete data|6|||
33257909|NCT03844269|100845960|FG000|Overall Study|Withdrawal pre-intervention|1|||
33257910|NCT03844269|100845960|FG000|Overall Study|Did not complete the intervention|2|||
33257911|NCT03482011|100845961|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
33257912|NCT03482011|100845962|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
33257913|NCT03482011|100845963|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
33257914|NCT03482011|100845964|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
33257915|NCT03482011|100845965|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
33257916|NCT03482011|100845966|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
33257917|NCT03482011|100845967|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
33257918|NCT03482011|100845968|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
33257919|NCT03482011|100845961|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
33257920|NCT03482011|100845962|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
33257921|NCT03482011|100845963|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33257922|NCT03482011|100845964|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33257923|NCT03482011|100845965|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33257924|NCT03482011|100845966|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33257925|NCT03482011|100845967|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33257926|NCT03482011|100845968|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
33257927|NCT03482011|100845961|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
33257928|NCT03482011|100845962|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
33257929|NCT03482011|100845963|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
33257930|NCT03482011|100845964|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
33257931|NCT03482011|100845965|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
33257932|NCT03482011|100845966|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
33257933|NCT03482011|100845967|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
33257934|NCT03482011|100845968|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
33257935|NCT03482011|100845961|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
33257936|NCT03482011|100845962|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
33257937|NCT03482011|100845963|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
33257938|NCT03482011|100845964|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
33257939|NCT03482011|100845965|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
33257940|NCT03482011|100845966|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
33257941|NCT03482011|100845967|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
33257942|NCT03482011|100845968|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
33257943|NCT03482011|100845961|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
33257944|NCT03482011|100845962|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
33164022|NCT02165215|100511233|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33164023|NCT02165215|100511234|FG001|Maintenance Phase|Withdrawal by Subject|7|||
33164024|NCT02165215|100511235|FG002|Maintenance Phase|Withdrawal by Subject|3|||
33164025|NCT02165215|100511233|FG000|Maintenance Phase|Multiple reasons|0|||
33164026|NCT02165215|100511234|FG001|Maintenance Phase|Multiple reasons|2|||
33164027|NCT02165215|100511235|FG002|Maintenance Phase|Multiple reasons|1|||
33164028|NCT02165215|100511233|FG000|Maintenance Phase|Lost to Follow-up|0|||
33164029|NCT02165215|100511234|FG001|Maintenance Phase|Lost to Follow-up|2|||
33164030|NCT02165215|100511235|FG002|Maintenance Phase|Lost to Follow-up|0|||
33257945|NCT03482011|100845963|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33257946|NCT03482011|100845964|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33257947|NCT03482011|100845965|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33257948|NCT03482011|100845966|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33388823|NCT00653328|101309367|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
33164031|NCT02165215|100511233|FG000|Maintenance Phase|Adverse Event|0|||
33164032|NCT02165215|100511234|FG001|Maintenance Phase|Adverse Event|1|||
33444601|NCT01900626|101519057|FG000|Overall Study|study was closed due to low enrollment|1|||
33444602|NCT01900626|101519058|FG001|Overall Study|study was closed due to low enrollment|1|||
33444603|NCT01602419|101519060|FG000|Overall Study|Not treated with Wilate|9|||
33444604|NCT01602419|101519060|FG000|Overall Study|Adverse Drug Reaction|4|||
33444605|NCT01602419|101519060|FG000|Overall Study|Insurance issues|3|||
33444606|NCT01602419|101519060|FG000|Overall Study|Changed treatment centre|1|||
33444607|NCT01602419|101519060|FG000|Overall Study|Treatment centre closed|1|||
33444608|NCT01602419|101519060|FG000|Overall Study|Withdrawal by Subject|5|||
33444609|NCT01602419|101519060|FG000|Overall Study|Lost to Follow-up|6|||
33444610|NCT02424097|101519061|FG000|Overall Study|Lost to Follow-up|1|||
33444611|NCT02424097|101519062|FG001|Overall Study|Lost to Follow-up|2|||
33444612|NCT01370317|101519066|FG000|Overall Study|Participant withdrew consent|1|||
33444613|NCT01370317|101519067|FG001|Overall Study|Participant withdrew consent|0|||
33444614|NCT01370317|101519066|FG000|Overall Study|Protocol deviation|0|||
33444615|NCT01370317|101519067|FG001|Overall Study|Protocol deviation|1|||
33444616|NCT01615198|101519070|FG000|Overall Study|Withdrawal by Subject|5|||
33444617|NCT01615198|101519071|FG001|Overall Study|Withdrawal by Subject|5|||
33444618|NCT01615198|101519070|FG000|Overall Study|Protocol deviation|1|||
33444619|NCT01615198|101519071|FG001|Overall Study|Protocol deviation|1|||
33444620|NCT01615198|101519070|FG000|Overall Study|Physician Decision|5|||
33444621|NCT01615198|101519071|FG001|Overall Study|Physician Decision|1|||
33444622|NCT01615198|101519070|FG000|Overall Study|Lost to Follow-up|1|||
33444623|NCT01615198|101519071|FG001|Overall Study|Lost to Follow-up|1|||
33444624|NCT01615198|101519070|FG000|Overall Study|Lack of Efficacy|1|||
33444625|NCT01615198|101519071|FG001|Overall Study|Lack of Efficacy|6|||
33444626|NCT01615198|101519070|FG000|Overall Study|Adverse Event|11|||
33444627|NCT01615198|101519071|FG001|Overall Study|Adverse Event|5|||
33444628|NCT00813592|101519072|FG000|Overall Study|Disease assessment was not completed per|2|||
33444629|NCT01045161|101519073|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
33444630|NCT01045161|101519074|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
33444631|NCT01045161|101519075|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
33444632|NCT01045161|101519073|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
33444633|NCT01045161|101519074|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
33444634|NCT01045161|101519075|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
33444635|NCT01045161|101519073|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
33444636|NCT01045161|101519074|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
33444637|NCT01045161|101519075|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
33444638|NCT01045161|101519073|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
33444639|NCT01045161|101519074|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
33444640|NCT01045161|101519075|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
33444641|NCT01045161|101519073|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
33257949|NCT03482011|100845967|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33257950|NCT03482011|100845968|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33257951|NCT03482011|100845961|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
33257952|NCT03482011|100845962|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
33257953|NCT03482011|100845963|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
33257954|NCT03482011|100845964|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
33257955|NCT03482011|100845965|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
33257956|NCT03482011|100845966|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
33257957|NCT03482011|100845967|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
33444642|NCT01045161|101519074|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
33444643|NCT01045161|101519075|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
33444644|NCT01045161|101519073|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
33444645|NCT01045161|101519074|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
33444646|NCT01045161|101519075|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
33444647|NCT01045161|101519073|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
33257958|NCT03482011|100845968|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
33257959|NCT03482011|100845961|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
33257960|NCT03482011|100845962|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
33257961|NCT03482011|100845963|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
33257962|NCT03482011|100845964|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
33257963|NCT03482011|100845965|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
33444648|NCT01045161|101519074|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
33444649|NCT01045161|101519075|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
33444650|NCT01045161|101519073|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
33444651|NCT01045161|101519074|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
33257964|NCT03482011|100845966|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
33257965|NCT03482011|100845967|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
33257966|NCT03482011|100845968|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
33257967|NCT03482011|100845961|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33444652|NCT01045161|101519075|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
33444653|NCT01045161|101519073|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
33444654|NCT01045161|101519074|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
33444655|NCT01045161|101519075|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
33444656|NCT01045161|101519073|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
33257968|NCT03482011|100845962|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33257969|NCT03482011|100845963|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33257970|NCT03482011|100845964|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33257971|NCT03482011|100845965|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
33257972|NCT03482011|100845966|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33257973|NCT03482011|100845967|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
33257974|NCT03482011|100845968|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
33257975|NCT03482011|100845961|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
33164033|NCT02165215|100511235|FG002|Maintenance Phase|Adverse Event|1|||
33164034|NCT01382212|100511237|FG000|Overall Study|Kidney transplant|1|||
33164035|NCT01382212|100511237|FG000|Overall Study|Withdrew consent|1|||
33164036|NCT00444912|100511239|FG000|Overall Study|Death|1|||
33164037|NCT00444912|100511240|FG001|Overall Study|Death|2|||
33164038|NCT00444912|100511239|FG000|Overall Study|Lost to Follow-up|1|||
33164039|NCT00444912|100511240|FG001|Overall Study|Lost to Follow-up|0|||
33164040|NCT00444912|100511239|FG000|Overall Study|Participant Failed Mobilization|1|||
33164041|NCT00444912|100511240|FG001|Overall Study|Participant Failed Mobilization|0|||
33164042|NCT02197247|100511247|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
33164043|NCT02197247|100511247|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
33164044|NCT02197247|100511247|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
33164045|NCT02197247|100511247|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
33164046|NCT02197247|100511247|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
33164047|NCT02197247|100511247|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
33164048|NCT02197247|100511247|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
33164049|NCT02197247|100511247|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
33164050|NCT02439138|100511249|FG000|Overall Study|Adverse Event|1|||
33164051|NCT02439138|100511249|FG000|Overall Study|PI decision to terminate the study|2|||
33164052|NCT00407797|100511256|FG000|Overall Study|Lost to Follow-up|2|||
33164053|NCT00407797|100511256|FG000|Overall Study|Adverse Event|6|||
33164054|NCT00407797|100511256|FG000|Overall Study|Other|7|||
33164055|NCT00407797|100511256|FG000|Overall Study|Withdrawal by Subject|3|||
33164056|NCT00843024|100511263|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
33164057|NCT00843024|100511264|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
33164058|NCT00843024|100511265|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
33164059|NCT00843024|100511266|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
33164060|NCT00843024|100511267|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
33164061|NCT00843024|100511268|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
33164062|NCT00843024|100511263|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
33164063|NCT00843024|100511264|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
33164064|NCT00843024|100511265|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
33164065|NCT00843024|100511266|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
33164066|NCT00843024|100511267|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
33164067|NCT00843024|100511268|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
33164068|NCT00843024|100511263|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
33164069|NCT00843024|100511264|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
33164070|NCT00843024|100511265|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
33257976|NCT03482011|100845962|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
33164071|NCT00843024|100511266|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
33257977|NCT03482011|100845963|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
33257978|NCT03482011|100845964|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
33164072|NCT00843024|100511267|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
33164073|NCT00843024|100511268|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
33164074|NCT00843024|100511263|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
33164075|NCT00843024|100511264|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
33164076|NCT00843024|100511265|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
33164077|NCT00843024|100511266|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
33164078|NCT00843024|100511267|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
33164079|NCT00843024|100511268|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
33164080|NCT00843024|100511263|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
33164081|NCT00843024|100511264|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
33164082|NCT00843024|100511265|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
33164083|NCT00843024|100511266|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
33164084|NCT00843024|100511267|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
33164085|NCT00843024|100511268|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
33164086|NCT00843024|100511263|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
33164087|NCT00843024|100511264|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
33164088|NCT00843024|100511265|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
33164089|NCT00843024|100511266|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
33164090|NCT00843024|100511267|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
33164091|NCT00843024|100511268|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
33164092|NCT00843024|100511263|FG000|Single-blind Placebo Run-In Phase|Other|0|||
33164093|NCT00843024|100511264|FG001|Single-blind Placebo Run-In Phase|Other|1|||
33164094|NCT00843024|100511265|FG002|Single-blind Placebo Run-In Phase|Other|0|||
33164095|NCT00843024|100511266|FG003|Single-blind Placebo Run-In Phase|Other|0|||
33257979|NCT03482011|100845965|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
33257980|NCT03482011|100845966|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
33257981|NCT03482011|100845967|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
33257982|NCT03482011|100845968|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
33257983|NCT03482011|100845961|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33257984|NCT03482011|100845962|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33257985|NCT03482011|100845963|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
33164096|NCT00843024|100511267|FG004|Single-blind Placebo Run-In Phase|Other|0|||
33388824|NCT03892707|101309368|FG000|Overall Study|Screen failure|6|||
33444657|NCT01045161|101519074|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
33444658|NCT01045161|101519075|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
33444659|NCT01045161|101519073|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
33444660|NCT01045161|101519074|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
33444661|NCT01045161|101519075|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
33444662|NCT01045161|101519073|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
33444663|NCT01045161|101519074|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
33444664|NCT01045161|101519075|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
33444665|NCT01045161|101519073|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
33444666|NCT01045161|101519074|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
33444667|NCT01045161|101519075|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
33444668|NCT01045161|101519073|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
33444669|NCT01045161|101519074|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
33444670|NCT01045161|101519075|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
33444671|NCT02159183|101519076|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
33164097|NCT00843024|100511268|FG005|Single-blind Placebo Run-In Phase|Other|0|||
33164098|NCT00843024|100511263|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
33164099|NCT00843024|100511264|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
33164100|NCT00843024|100511265|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
33388825|NCT03892707|101309369|FG001|Overall Study|Screen failure|0|||
33444672|NCT02159183|101519077|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
33388826|NCT03892707|101309368|FG000|Overall Study|Pain resolution|0|||
33444673|NCT02159183|101519076|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
33444674|NCT02159183|101519077|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
33444675|NCT02159183|101519076|FG000|Analysis After the 36 Months Follow-up|Death|0|||
33444676|NCT02159183|101519077|FG001|Analysis After the 36 Months Follow-up|Death|1|||
33444677|NCT02159183|101519076|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
33444678|NCT02159183|101519077|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
33444679|NCT02159183|101519076|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
33444680|NCT02159183|101519077|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
33444681|NCT02188303|101519082|FG000|Overall Study|Adverse Event|0|||
33444682|NCT02188303|101519083|FG001|Overall Study|Adverse Event|0|||
33444683|NCT02188303|101519084|FG002|Overall Study|Adverse Event|0|||
33444684|NCT02188303|101519085|FG003|Overall Study|Adverse Event|0|||
33444685|NCT02188303|101519086|FG004|Overall Study|Adverse Event|0|||
33444686|NCT02188303|101519087|FG005|Overall Study|Adverse Event|2|||
33444687|NCT02188303|101519088|FG006|Overall Study|Adverse Event|0|||
33444688|NCT02188303|101519089|FG007|Overall Study|Adverse Event|2|||
33444689|NCT02188303|101519082|FG000|Overall Study|Dose Termination Criteria Met|0|||
33444690|NCT02188303|101519083|FG001|Overall Study|Dose Termination Criteria Met|0|||
33444691|NCT02188303|101519084|FG002|Overall Study|Dose Termination Criteria Met|0|||
33444692|NCT02188303|101519085|FG003|Overall Study|Dose Termination Criteria Met|0|||
33444693|NCT02188303|101519086|FG004|Overall Study|Dose Termination Criteria Met|0|||
33444694|NCT02188303|101519087|FG005|Overall Study|Dose Termination Criteria Met|0|||
33444695|NCT02188303|101519088|FG006|Overall Study|Dose Termination Criteria Met|2|||
33444696|NCT02188303|101519089|FG007|Overall Study|Dose Termination Criteria Met|4|||
33444697|NCT03925532|101522431|FG000|Overall Study|Lost to Follow-up|1|||
33444698|NCT00392665|101522433|FG000|Overall Study|Death|16|||
33444699|NCT00392665|101522434|FG001|Overall Study|Death|14|||
33444700|NCT00392665|101522433|FG000|Overall Study|Lost to Follow-up|1|||
33444701|NCT00392665|101522434|FG001|Overall Study|Lost to Follow-up|1|||
33444702|NCT02255097|101522435|FG000|Overall Study|Death|151|||
33444703|NCT02255097|101522435|FG000|Overall Study|Lost to Follow-up|5|||
33444704|NCT02255097|101522435|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
33444705|NCT02255097|101522435|FG000|Overall Study|Withdrawal by Subject|7|||
33444706|NCT02255097|101522435|FG000|Overall Study|Allocated but not treated|1|||
33444707|NCT02911792|101522437|FG000|Overall Study|Lost to Follow-up|3|||
33444708|NCT02911792|101522438|FG001|Overall Study|Lost to Follow-up|3|||
33444709|NCT02911792|101522439|FG002|Overall Study|Lost to Follow-up|3|||
33444710|NCT02911792|101522440|FG003|Overall Study|Lost to Follow-up|3|||
33444711|NCT04408794|101522442|FG000|Overall Study|Adverse Event|43|||
33444712|NCT04408794|101522442|FG000|Overall Study|Infrequent study drug usage|43|||
33444713|NCT04408794|101522442|FG000|Overall Study|Lack of Efficacy|61|||
33257986|NCT03482011|100845964|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
33257987|NCT03482011|100845965|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
33257988|NCT03482011|100845966|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
33257989|NCT03482011|100845967|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
33257990|NCT03482011|100845968|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
33388827|NCT03892707|101309369|FG001|Overall Study|Pain resolution|4|||
33444714|NCT04408794|101522442|FG000|Overall Study|Lost to Follow-up|33|||
33444715|NCT04408794|101522442|FG000|Overall Study|Non-compliance|6|||
33444716|NCT04408794|101522442|FG000|Overall Study|Physician Decision|1|||
33444717|NCT04408794|101522442|FG000|Overall Study|Pregnancy|6|||
33444718|NCT04408794|101522442|FG000|Overall Study|Protocol Deviation|9|||
33444719|NCT04408794|101522442|FG000|Overall Study|Sheehan-STS Result|1|||
33444720|NCT04408794|101522442|FG000|Overall Study|Withdrawal by Subject|57|||
33444721|NCT04408794|101522442|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
33444722|NCT04408794|101522442|FG000|Overall Study|Never Treated Migraine|5|||
33444723|NCT00001703|101522443|FG000|Overall Study|progressed disease|2|||
33444724|NCT00001703|101522443|FG000|Overall Study|No evidence of disease|1|||
33444725|NCT00001703|101522443|FG000|Overall Study|recurrent disease|2|||
33444726|NCT00450190|101522444|FG000|Overall Study|Withdrawal by Subject|2|||
33444727|NCT02847650|101522445|FG000|Overall Study|Adverse Event|2|||
33444728|NCT02847650|101522446|FG001|Overall Study|Adverse Event|4|||
33444729|NCT02847650|101522445|FG000|Overall Study|Lost to Follow-up|1|||
33444730|NCT02847650|101522446|FG001|Overall Study|Lost to Follow-up|0|||
33444731|NCT02847650|101522445|FG000|Overall Study|Protocol Violation|0|||
33444732|NCT02847650|101522446|FG001|Overall Study|Protocol Violation|1|||
33444733|NCT02847650|101522445|FG000|Overall Study|Withdrawal by Subject|1|||
33444734|NCT02847650|101522446|FG001|Overall Study|Withdrawal by Subject|1|||
33444735|NCT02937870|101522448|FG000|Overall Study|Adverse Event|1|||
33444736|NCT02937870|101522448|FG000|Overall Study|Protocol Deviation|2|||
33444737|NCT00579670|101522449|FG000|Overall Study|Death|1|||
33444738|NCT00579670|101522450|FG001|Overall Study|Death|0|||
33444739|NCT00579670|101522451|FG002|Overall Study|Death|0|||
33444740|NCT00579670|101522452|FG003|Overall Study|Death|0|||
33444741|NCT00579670|101522453|FG004|Overall Study|Death|0|||
33444742|NCT00579670|101522449|FG000|Overall Study|Adverse Event|1|||
33444743|NCT00579670|101522450|FG001|Overall Study|Adverse Event|0|||
33444744|NCT00579670|101522451|FG002|Overall Study|Adverse Event|1|||
33164101|NCT00843024|100511266|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
33164102|NCT00843024|100511267|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
33164103|NCT00843024|100511268|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
33164104|NCT00843024|100511263|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
33164105|NCT00843024|100511264|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
33257991|NCT03482011|100845961|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33164106|NCT00843024|100511265|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
33257992|NCT03482011|100845962|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33257993|NCT03482011|100845963|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33257994|NCT03482011|100845964|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
33257995|NCT03482011|100845965|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
33257996|NCT03482011|100845966|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
33257997|NCT03482011|100845967|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
33257998|NCT03482011|100845968|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
33257999|NCT03482011|100845961|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
33258000|NCT03482011|100845962|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
33258001|NCT03482011|100845963|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
33258002|NCT03482011|100845964|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
33258003|NCT03482011|100845965|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
33258004|NCT03482011|100845966|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
33258005|NCT03482011|100845967|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
33258006|NCT03482011|100845968|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
33258007|NCT03482011|100845961|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
33258008|NCT03482011|100845962|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
33258009|NCT03482011|100845963|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
33258010|NCT03482011|100845964|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
33258011|NCT03482011|100845965|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
33258012|NCT03482011|100845966|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
33258013|NCT03482011|100845967|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
33164107|NCT00843024|100511266|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
33164108|NCT00843024|100511267|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
33164109|NCT00843024|100511268|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
33164110|NCT00843024|100511263|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33164111|NCT00843024|100511264|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33164112|NCT00843024|100511265|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33164113|NCT00843024|100511266|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
33164114|NCT00843024|100511267|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
33164115|NCT00843024|100511268|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
33258014|NCT03482011|100845968|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
33164116|NCT00843024|100511263|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
33164117|NCT00843024|100511264|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
33164118|NCT00843024|100511265|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
33258015|NCT03482011|100845961|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
33258016|NCT03482011|100845962|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
33164119|NCT00843024|100511266|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
33164120|NCT00843024|100511267|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
33164121|NCT00843024|100511268|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
33444745|NCT00579670|101522452|FG003|Overall Study|Adverse Event|2|||
33164122|NCT00843024|100511263|FG000|Double-blind Treatment Phase|Physician Decision|0|||
33164123|NCT00843024|100511264|FG001|Double-blind Treatment Phase|Physician Decision|0|||
33164124|NCT00843024|100511265|FG002|Double-blind Treatment Phase|Physician Decision|0|||
33164125|NCT00843024|100511266|FG003|Double-blind Treatment Phase|Physician Decision|3|||
33444746|NCT00579670|101522453|FG004|Overall Study|Adverse Event|0|||
33444747|NCT00579670|101522449|FG000|Overall Study|Lack of Efficacy|0|||
33444748|NCT00579670|101522450|FG001|Overall Study|Lack of Efficacy|0|||
33444749|NCT00579670|101522451|FG002|Overall Study|Lack of Efficacy|1|||
33444750|NCT00579670|101522452|FG003|Overall Study|Lack of Efficacy|14|||
33444751|NCT00579670|101522453|FG004|Overall Study|Lack of Efficacy|0|||
33444752|NCT00579670|101522449|FG000|Overall Study|Lost to Follow-up|0|||
33444753|NCT00579670|101522450|FG001|Overall Study|Lost to Follow-up|1|||
33444754|NCT00579670|101522451|FG002|Overall Study|Lost to Follow-up|0|||
33444755|NCT00579670|101522452|FG003|Overall Study|Lost to Follow-up|4|||
33444756|NCT00579670|101522453|FG004|Overall Study|Lost to Follow-up|0|||
33444757|NCT00579670|101522449|FG000|Overall Study|Other|0|||
33444758|NCT00579670|101522450|FG001|Overall Study|Other|0|||
33444759|NCT00579670|101522451|FG002|Overall Study|Other|1|||
33444760|NCT00579670|101522452|FG003|Overall Study|Other|2|||
33444761|NCT00579670|101522453|FG004|Overall Study|Other|0|||
33444762|NCT00579670|101522449|FG000|Overall Study|Withdrawal by Subject|0|||
33444763|NCT00579670|101522450|FG001|Overall Study|Withdrawal by Subject|0|||
33164126|NCT00843024|100511267|FG004|Double-blind Treatment Phase|Physician Decision|1|||
33164127|NCT00843024|100511268|FG005|Double-blind Treatment Phase|Physician Decision|1|||
33164128|NCT00843024|100511263|FG000|Double-blind Treatment Phase|Adverse Event|0|||
33164129|NCT00843024|100511264|FG001|Double-blind Treatment Phase|Adverse Event|0|||
33164130|NCT00843024|100511265|FG002|Double-blind Treatment Phase|Adverse Event|0|||
33164131|NCT00843024|100511266|FG003|Double-blind Treatment Phase|Adverse Event|0|||
33164132|NCT00843024|100511267|FG004|Double-blind Treatment Phase|Adverse Event|1|||
33164133|NCT00843024|100511268|FG005|Double-blind Treatment Phase|Adverse Event|1|||
33164134|NCT00843024|100511263|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
33164135|NCT00843024|100511264|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
33164136|NCT00843024|100511265|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
33164137|NCT00843024|100511266|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
33164138|NCT00843024|100511267|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
33258017|NCT03482011|100845963|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
33258018|NCT03482011|100845964|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
33258019|NCT03482011|100845965|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
33444764|NCT00579670|101522451|FG002|Overall Study|Withdrawal by Subject|1|||
33444765|NCT00579670|101522452|FG003|Overall Study|Withdrawal by Subject|0|||
33444766|NCT00579670|101522453|FG004|Overall Study|Withdrawal by Subject|0|||
33444767|NCT02159950|101522454|FG000|Overall Study|Adverse Event|0|||
33444768|NCT02159950|101522455|FG001|Overall Study|Adverse Event|1|||
33444769|NCT02159950|101522454|FG000|Overall Study|Progression|0|||
33444770|NCT02159950|101522455|FG001|Overall Study|Progression|1|||
33444771|NCT02128997|101522456|FG000|Overall Study|Lost to Follow-up|6|||
33444772|NCT02128997|101522457|FG001|Overall Study|Lost to Follow-up|11|||
33444773|NCT01289262|101522459|FG000|Overall Study|Lost to Follow-up|29|||
33444774|NCT01289262|101522460|FG001|Overall Study|Lost to Follow-up|16|||
33444775|NCT01289262|101522459|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
33444776|NCT01289262|101522460|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
33444777|NCT03673670|101522465|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
33164139|NCT00843024|100511268|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
33258020|NCT03482011|100845966|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
33444778|NCT03673670|101522466|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
33444779|NCT03673670|101522467|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
33444780|NCT03673670|101522468|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
33444781|NCT03673670|101522469|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
33444782|NCT03673670|101522470|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
33444783|NCT03673670|101522465|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
33444784|NCT03673670|101522466|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
33444785|NCT03673670|101522467|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
33444786|NCT03673670|101522468|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
33164140|NCT02469298|100511272|FG000|Overall Study|Protocol Violation|0|||
33164141|NCT02469298|100511273|FG001|Overall Study|Protocol Violation|1|||
33164142|NCT02469298|100511274|FG002|Overall Study|Protocol Violation|1|||
33164143|NCT02469298|100511275|FG003|Overall Study|Protocol Violation|0|||
33164144|NCT02469298|100511272|FG000|Overall Study|Lost to Follow-up|1|||
33164145|NCT02469298|100511273|FG001|Overall Study|Lost to Follow-up|0|||
33164146|NCT02469298|100511274|FG002|Overall Study|Lost to Follow-up|1|||
33164147|NCT02469298|100511275|FG003|Overall Study|Lost to Follow-up|0|||
33164148|NCT02469298|100511272|FG000|Overall Study|Physician Decision|0|||
33164149|NCT02469298|100511273|FG001|Overall Study|Physician Decision|0|||
33164150|NCT02469298|100511274|FG002|Overall Study|Physician Decision|0|||
33164151|NCT02469298|100511275|FG003|Overall Study|Physician Decision|1|||
33164152|NCT02469298|100511272|FG000|Overall Study|Withdrawal by Subject|0|||
33164153|NCT02469298|100511273|FG001|Overall Study|Withdrawal by Subject|0|||
33258021|NCT03482011|100845967|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
33258022|NCT03482011|100845968|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
33258023|NCT03482011|100845961|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33444787|NCT03673670|101522469|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
33444788|NCT03673670|101522470|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
33164154|NCT02469298|100511274|FG002|Overall Study|Withdrawal by Subject|0|||
33444789|NCT03673670|101522465|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
33444790|NCT03673670|101522466|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
33444791|NCT03673670|101522467|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
33444792|NCT03673670|101522468|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
33444793|NCT03673670|101522469|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
33444794|NCT03673670|101522470|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
33444795|NCT03673670|101522465|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
33444796|NCT03673670|101522466|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
33444797|NCT03673670|101522467|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
33444798|NCT03673670|101522468|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
33444799|NCT03673670|101522469|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
33444800|NCT03673670|101522470|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
33444801|NCT03673670|101522465|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
33444802|NCT03673670|101522466|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
33444803|NCT03673670|101522467|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
33444804|NCT03673670|101522468|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
33444805|NCT03673670|101522469|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
33444806|NCT03673670|101522470|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
33444807|NCT03673670|101522465|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
33444808|NCT03673670|101522466|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
33444809|NCT03673670|101522467|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
33444810|NCT03673670|101522468|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
33444811|NCT03673670|101522469|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
33444812|NCT03673670|101522470|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
33444813|NCT03673670|101522465|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
33444814|NCT03673670|101522466|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
33444815|NCT03673670|101522467|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
33444816|NCT03673670|101522468|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
33444817|NCT03673670|101522469|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
33444818|NCT03673670|101522470|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
33444819|NCT01353664|101522471|FG000|Overall Study|Other|3|||
33164155|NCT02469298|100511275|FG003|Overall Study|Withdrawal by Subject|1|||
33164156|NCT02083783|100511276|FG000|Overall Study|Withdrawal by Subject|1|||
33164157|NCT02083783|100511277|FG001|Overall Study|Withdrawal by Subject|0|||
33164158|NCT03200860|100511278|FG000|Overall Study|Withdrawal by Subject|1|||
33444820|NCT01353664|101522471|FG000|Overall Study|Disease Progression|16|||
33444821|NCT01401647|101522474|FG000|Overall Study|Withdrawal by Subject|1|||
33164159|NCT03200860|100511279|FG001|Overall Study|Withdrawal by Subject|0|||
33164160|NCT00621153|100511285|FG000|Overall Study|Safety Reason|8|||
33164161|NCT00621153|100511286|FG001|Overall Study|Safety Reason|7|||
33164162|NCT00621153|100511285|FG000|Overall Study|Adverse Event|3|||
33164163|NCT00621153|100511286|FG001|Overall Study|Adverse Event|2|||
33164164|NCT00621153|100511285|FG000|Overall Study|Lost to Follow-up|5|||
33164165|NCT00621153|100511286|FG001|Overall Study|Lost to Follow-up|1|||
33164166|NCT00621153|100511285|FG000|Overall Study|Withdrawal by Subject|4|||
33164167|NCT00621153|100511286|FG001|Overall Study|Withdrawal by Subject|5|||
33164168|NCT00119106|100511287|FG000|Overall Study|HIV infected at baseline|179|||
33164169|NCT00119106|100511288|FG001|Overall Study|HIV infected at baseline|178|||
33164170|NCT03208244|100511292|FG000|Overall Study|Death|1|||
33164171|NCT00602797|100511293|FG000|Overall Study|Adverse Event|1|||
33164172|NCT00217620|100511296|FG000|Overall Study|Adverse Event|2|||
33164173|NCT00217620|100511296|FG000|Overall Study|Progression|31|||
33164174|NCT00217620|100511296|FG000|Overall Study|Not Protocol Specified|4|||
33164175|NCT00217620|100511296|FG000|Overall Study|Ineligible|13|||
33164176|NCT00217620|100511296|FG000|Overall Study|Never received treatment|1|||
33164177|NCT01644565|100511297|FG000|Overall Study|Undisclosed Medical History|1|||
33164178|NCT01644565|100511298|FG001|Overall Study|Undisclosed Medical History|0|||
33164179|NCT01644565|100511299|FG002|Overall Study|Undisclosed Medical History|0|||
33164180|NCT01644565|100511300|FG003|Overall Study|Undisclosed Medical History|0|||
33164181|NCT01644565|100511301|FG004|Overall Study|Undisclosed Medical History|0|||
33164182|NCT01644565|100511302|FG005|Overall Study|Undisclosed Medical History|0|||
33164183|NCT01644565|100511303|FG006|Overall Study|Undisclosed Medical History|0|||
33164184|NCT01644565|100511304|FG007|Overall Study|Undisclosed Medical History|0|||
33164185|NCT01644565|100511305|FG008|Overall Study|Undisclosed Medical History|0|||
33164186|NCT01644565|100511297|FG000|Overall Study|Lost to Follow-up|0|||
33258024|NCT03482011|100845962|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33258025|NCT03482011|100845963|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33258026|NCT03482011|100845964|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33258027|NCT03482011|100845965|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33258028|NCT03482011|100845966|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33258029|NCT03482011|100845967|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33258030|NCT03482011|100845968|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
33258031|NCT01078116|100845969|FG000|Overall Study|Lost to Follow-up|17|||
33258032|NCT01078116|100845969|FG000|Overall Study|Adverse Event|5|||
33258033|NCT01078116|100845969|FG000|Overall Study|Withdrawal by Subject|8|||
33258034|NCT01078116|100845969|FG000|Overall Study|Lack of effectiveness|15|||
33258035|NCT01078116|100845969|FG000|Overall Study|Case report form not completed|3|||
33258036|NCT01420549|100845970|FG000|Overall Study|Adverse Event|1|||
33258037|NCT01420549|100845971|FG001|Overall Study|Adverse Event|1|||
33258038|NCT01420549|100845970|FG000|Overall Study|Lost to Follow-up|2|||
33258039|NCT01420549|100845971|FG001|Overall Study|Lost to Follow-up|2|||
33258040|NCT01420549|100845970|FG000|Overall Study|Protocol Violation|0|||
33258041|NCT01420549|100845971|FG001|Overall Study|Protocol Violation|1|||
33258042|NCT01420549|100845970|FG000|Overall Study|Non-adherence to medication|4|||
33258043|NCT01420549|100845971|FG001|Overall Study|Non-adherence to medication|1|||
33258044|NCT03565315|100845972|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
33258045|NCT03565315|100845973|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
33258046|NCT03565315|100845974|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
33258047|NCT03565315|100845975|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
33258048|NCT01227278|100845978|FG000|Overall Study|Withdrawal by Subject|4|||
33258049|NCT01227278|100845979|FG001|Overall Study|Withdrawal by Subject|4|||
33258050|NCT01227278|100845978|FG000|Overall Study|Death|0|||
33258051|NCT01227278|100845979|FG001|Overall Study|Death|2|||
33258052|NCT01227278|100845978|FG000|Overall Study|Other|1|||
33258053|NCT01227278|100845979|FG001|Overall Study|Other|2|||
33258054|NCT01613716|100845985|FG000|Overall Study|screen failures|3|||
33258055|NCT01613716|100845985|FG000|Overall Study|Lost to Follow-up|4|||
33258056|NCT00516321|100845986|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
33258057|NCT00516321|100845987|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
33258058|NCT00516321|100845988|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
33258059|NCT00516321|100845986|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
33258060|NCT00516321|100845987|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
33258061|NCT00516321|100845988|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
33258062|NCT00516321|100845986|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
33258063|NCT00516321|100845987|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
33164187|NCT01644565|100511298|FG001|Overall Study|Lost to Follow-up|0|||
33164188|NCT01644565|100511299|FG002|Overall Study|Lost to Follow-up|0|||
33164189|NCT01644565|100511300|FG003|Overall Study|Lost to Follow-up|1|||
33164190|NCT01644565|100511301|FG004|Overall Study|Lost to Follow-up|0|||
33258064|NCT00516321|100845988|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
33258065|NCT00516321|100845986|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
33258066|NCT00516321|100845987|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
33164191|NCT01644565|100511302|FG005|Overall Study|Lost to Follow-up|0|||
33164192|NCT01644565|100511303|FG006|Overall Study|Lost to Follow-up|0|||
33164193|NCT01644565|100511304|FG007|Overall Study|Lost to Follow-up|2|||
33164194|NCT01644565|100511305|FG008|Overall Study|Lost to Follow-up|0|||
33164195|NCT01644565|100511297|FG000|Overall Study|Family emergency|0|||
33164196|NCT01644565|100511298|FG001|Overall Study|Family emergency|0|||
33164197|NCT01644565|100511299|FG002|Overall Study|Family emergency|0|||
33164198|NCT01644565|100511300|FG003|Overall Study|Family emergency|0|||
33164199|NCT01644565|100511301|FG004|Overall Study|Family emergency|1|||
33164200|NCT01644565|100511302|FG005|Overall Study|Family emergency|0|||
33164201|NCT01644565|100511303|FG006|Overall Study|Family emergency|0|||
33164202|NCT01644565|100511304|FG007|Overall Study|Family emergency|0|||
33164203|NCT01644565|100511305|FG008|Overall Study|Family emergency|0|||
33164204|NCT01644565|100511297|FG000|Overall Study|Relocation|0|||
33164205|NCT01644565|100511298|FG001|Overall Study|Relocation|0|||
33164206|NCT01644565|100511299|FG002|Overall Study|Relocation|0|||
33164207|NCT01644565|100511300|FG003|Overall Study|Relocation|0|||
33164208|NCT01644565|100511301|FG004|Overall Study|Relocation|0|||
33164209|NCT01644565|100511302|FG005|Overall Study|Relocation|0|||
33164210|NCT01644565|100511303|FG006|Overall Study|Relocation|0|||
33164211|NCT01644565|100511304|FG007|Overall Study|Relocation|0|||
33164212|NCT01644565|100511305|FG008|Overall Study|Relocation|1|||
33164213|NCT01866293|100511306|FG000|Overall Study|Adverse Event|2|||
33164214|NCT00345839|100511307|FG000|Overall Study|Withdrawal by Subject|91|||
33164215|NCT00345839|100511308|FG001|Overall Study|Withdrawal by Subject|98|||
33164216|NCT00345839|100511307|FG000|Overall Study|Lost to Follow-up|58|||
33164217|NCT00345839|100511308|FG001|Overall Study|Lost to Follow-up|61|||
33164218|NCT00279305|100511309|FG000|Overall Study|Pregnancy|1|||
33164219|NCT00279305|100511310|FG001|Overall Study|Pregnancy|0|||
33164220|NCT00279305|100511309|FG000|Overall Study|Withdrawal by Subject|2|||
33164221|NCT00279305|100511310|FG001|Overall Study|Withdrawal by Subject|0|||
33164222|NCT00279305|100511309|FG000|Overall Study|Dificulting establishing IV|1|||
33164223|NCT00279305|100511310|FG001|Overall Study|Dificulting establishing IV|0|||
33164224|NCT00279305|100511309|FG000|Overall Study|FDA Safety Alert|4|||
33164225|NCT00279305|100511310|FG001|Overall Study|FDA Safety Alert|1|||
33164226|NCT01081678|100511311|FG000|Overall Study|Ineligibility Determined|0|||
33164227|NCT01081678|100511312|FG001|Overall Study|Ineligibility Determined|0|||
33164228|NCT01081678|100511313|FG002|Overall Study|Ineligibility Determined|1|||
33164229|NCT01081678|100511314|FG003|Overall Study|Ineligibility Determined|1|||
33164230|NCT01081678|100511311|FG000|Overall Study|Noncompliance|3|||
33164231|NCT01081678|100511312|FG001|Overall Study|Noncompliance|4|||
33164232|NCT01081678|100511313|FG002|Overall Study|Noncompliance|5|||
33164233|NCT01081678|100511314|FG003|Overall Study|Noncompliance|2|||
33164234|NCT01081678|100511311|FG000|Overall Study|Adverse Event|2|||
33164235|NCT01081678|100511312|FG001|Overall Study|Adverse Event|1|||
33164236|NCT01081678|100511313|FG002|Overall Study|Adverse Event|2|||
33164237|NCT01081678|100511314|FG003|Overall Study|Adverse Event|2|||
33164238|NCT01081678|100511311|FG000|Overall Study|Withdrawal by Subject|15|||
33164239|NCT01081678|100511312|FG001|Overall Study|Withdrawal by Subject|7|||
33164240|NCT01081678|100511313|FG002|Overall Study|Withdrawal by Subject|17|||
33164241|NCT01081678|100511314|FG003|Overall Study|Withdrawal by Subject|14|||
33164242|NCT01081678|100511311|FG000|Overall Study|Administrative Decision|1|||
33164243|NCT01081678|100511312|FG001|Overall Study|Administrative Decision|0|||
33164244|NCT01081678|100511313|FG002|Overall Study|Administrative Decision|0|||
33164245|NCT01081678|100511314|FG003|Overall Study|Administrative Decision|1|||
33164246|NCT01081678|100511311|FG000|Overall Study|Lost to Follow-up|4|||
33164247|NCT01081678|100511312|FG001|Overall Study|Lost to Follow-up|1|||
33164248|NCT01081678|100511313|FG002|Overall Study|Lost to Follow-up|4|||
33164249|NCT01081678|100511314|FG003|Overall Study|Lost to Follow-up|3|||
33164250|NCT01081678|100511311|FG000|Overall Study|Death|2|||
33258067|NCT00516321|100845988|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
33258068|NCT00516321|100845986|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
33164251|NCT01081678|100511312|FG001|Overall Study|Death|2|||
33164252|NCT01081678|100511313|FG002|Overall Study|Death|2|||
33164253|NCT01081678|100511314|FG003|Overall Study|Death|6|||
33164254|NCT01081678|100511311|FG000|Overall Study|Other|0|||
33164255|NCT01081678|100511312|FG001|Overall Study|Other|1|||
33164256|NCT01081678|100511313|FG002|Overall Study|Other|0|||
33164257|NCT01081678|100511314|FG003|Overall Study|Other|0|||
33164258|NCT00844831|100511334|FG000|Overall Study|Withdrawal by Subject|4|||
33164259|NCT00844831|100511334|FG000|Overall Study|Adverse Event|1|||
33164260|NCT00844831|100511334|FG000|Overall Study|Physician Decision|1|||
33164261|NCT03338998|100511339|FG000|Treatment Period|Withdrawal by Subject|1|||
33164262|NCT03338998|100511340|FG001|Treatment Period|Withdrawal by Subject|1|||
33164263|NCT03338998|100511339|FG000|Treatment Period|Adverse Event|0|||
33164264|NCT03338998|100511340|FG001|Treatment Period|Adverse Event|2|||
33164265|NCT03338998|100511339|FG000|Treatment Period|Protocol deviation|1|||
33164266|NCT03338998|100511340|FG001|Treatment Period|Protocol deviation|0|||
33164267|NCT03338998|100511339|FG000|Treatment Period|Physician Decision|2|||
33164268|NCT03338998|100511340|FG001|Treatment Period|Physician Decision|0|||
33164269|NCT03338998|100511339|FG000|Treatment Period|Subject failed swallow test|4|||
33164270|NCT03338998|100511340|FG001|Treatment Period|Subject failed swallow test|0|||
33164271|NCT03338998|100511339|FG000|Safety Follow-Up Period|Adverse Event|0|||
33164272|NCT03338998|100511340|FG001|Safety Follow-Up Period|Adverse Event|1|||
33164273|NCT03338998|100511339|FG000|Safety Follow-Up Period|Protocol deviation|1|||
33164274|NCT03338998|100511340|FG001|Safety Follow-Up Period|Protocol deviation|0|||
33164275|NCT03338998|100511339|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
33164276|NCT03338998|100511340|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
33164277|NCT02578316|100511343|FG000|Extension Phase|Progression of disease|6|||
33164278|NCT00680017|100511344|FG000|Overall Study|Adverse Event|13|||
33164279|NCT00680017|100511345|FG001|Overall Study|Adverse Event|7|||
33164280|NCT00680017|100511344|FG000|Overall Study|Withdrawal by Subject|2|||
33164281|NCT00680017|100511345|FG001|Overall Study|Withdrawal by Subject|5|||
33164282|NCT00680017|100511344|FG000|Overall Study|Lost to Follow-up|2|||
33164283|NCT00680017|100511345|FG001|Overall Study|Lost to Follow-up|0|||
33164284|NCT03039283|100511346|FG000|Overall Study|Protocol Violation|2|||
33164285|NCT00555971|100511356|FG000|Overall Study|Adverse Event|1|||
33164286|NCT00555971|100511357|FG001|Overall Study|Adverse Event|1|||
33164287|NCT03681405|100511362|FG000|Overall Study|Found to be ineligible after randomized|1|||
33164288|NCT03681405|100511363|FG001|Overall Study|Found to be ineligible after randomized|0|||
33164289|NCT03547583|100511368|FG000|Overall Study|Adverse Event|16|||
33164290|NCT03547583|100511369|FG001|Overall Study|Adverse Event|11|||
33164291|NCT03547583|100511370|FG002|Overall Study|Adverse Event|10|||
33164292|NCT03547583|100511368|FG000|Overall Study|Death|11|||
33164293|NCT03547583|100511369|FG001|Overall Study|Death|7|||
33164294|NCT03547583|100511370|FG002|Overall Study|Death|4|||
33164295|NCT03547583|100511368|FG000|Overall Study|Lost to Follow-up|1|||
33164296|NCT03547583|100511369|FG001|Overall Study|Lost to Follow-up|0|||
33164297|NCT03547583|100511370|FG002|Overall Study|Lost to Follow-up|0|||
33444822|NCT01401647|101522475|FG001|Overall Study|Withdrawal by Subject|5|||
33444823|NCT01401647|101522476|FG002|Overall Study|Withdrawal by Subject|2|||
33444824|NCT01401647|101522474|FG000|Overall Study|Lost to Follow-up|3|||
33444825|NCT01401647|101522475|FG001|Overall Study|Lost to Follow-up|3|||
33444826|NCT01401647|101522476|FG002|Overall Study|Lost to Follow-up|1|||
33444827|NCT03965091|101522477|FG000|Overall Study|Adverse Event|0|||
33164298|NCT03547583|100511368|FG000|Overall Study|Non-compliance with study drug|0|||
33164299|NCT03547583|100511369|FG001|Overall Study|Non-compliance with study drug|0|||
33164300|NCT03547583|100511370|FG002|Overall Study|Non-compliance with study drug|1|||
33164301|NCT03547583|100511368|FG000|Overall Study|Physician Decision|1|||
33164302|NCT03547583|100511369|FG001|Overall Study|Physician Decision|0|||
33164303|NCT03547583|100511370|FG002|Overall Study|Physician Decision|3|||
33164304|NCT03547583|100511368|FG000|Overall Study|Protocol Violation|2|||
33444828|NCT03965091|101522478|FG001|Overall Study|Adverse Event|2|||
33444829|NCT03965091|101522479|FG002|Overall Study|Adverse Event|3|||
33164305|NCT03547583|100511369|FG001|Overall Study|Protocol Violation|1|||
33164306|NCT03547583|100511370|FG002|Overall Study|Protocol Violation|1|||
33258069|NCT00516321|100845987|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
33258070|NCT00516321|100845988|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
33258071|NCT00516321|100845986|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
33258072|NCT00516321|100845987|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
33258073|NCT00516321|100845988|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
33258074|NCT00516321|100845986|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
33258075|NCT00516321|100845987|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
33258076|NCT00516321|100845988|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
33258077|NCT00516321|100845986|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
33444830|NCT03965091|101522477|FG000|Overall Study|Withdrawal by Subject|11|||
33164307|NCT03547583|100511368|FG000|Overall Study|Withdrawal by Subject|12|||
33164308|NCT03547583|100511369|FG001|Overall Study|Withdrawal by Subject|19|||
33164309|NCT03547583|100511370|FG002|Overall Study|Withdrawal by Subject|10|||
33164310|NCT03547583|100511368|FG000|Overall Study|Other|2|||
33164311|NCT03547583|100511369|FG001|Overall Study|Other|2|||
33164312|NCT03547583|100511370|FG002|Overall Study|Other|3|||
33164313|NCT01032837|100511371|FG000|Overall Study|Adverse event/internal illness|0|||
33164314|NCT01032837|100511372|FG001|Overall Study|Adverse event/internal illness|1|||
33164315|NCT01032837|100511373|FG002|Overall Study|Adverse event/internal illness|0|||
33164316|NCT01032837|100511374|FG003|Overall Study|Adverse event/internal illness|1|||
33164317|NCT01032837|100511371|FG000|Overall Study|Withdrew consent|0|||
33164318|NCT01032837|100511372|FG001|Overall Study|Withdrew consent|2|||
33164319|NCT01032837|100511373|FG002|Overall Study|Withdrew consent|0|||
33164320|NCT01032837|100511374|FG003|Overall Study|Withdrew consent|1|||
33164321|NCT01032837|100511371|FG000|Overall Study|Failed to return|0|||
33164322|NCT01032837|100511372|FG001|Overall Study|Failed to return|0|||
33164323|NCT01032837|100511373|FG002|Overall Study|Failed to return|1|||
33164324|NCT01032837|100511374|FG003|Overall Study|Failed to return|0|||
33164325|NCT01032837|100511371|FG000|Overall Study|Refused treatment|0|||
33164326|NCT01032837|100511372|FG001|Overall Study|Refused treatment|0|||
33164327|NCT01032837|100511373|FG002|Overall Study|Refused treatment|0|||
33164328|NCT01032837|100511374|FG003|Overall Study|Refused treatment|1|||
33444831|NCT03965091|101522478|FG001|Overall Study|Withdrawal by Subject|3|||
33444832|NCT03965091|101522479|FG002|Overall Study|Withdrawal by Subject|5|||
33444833|NCT03965091|101522477|FG000|Overall Study|Non-compliance with study drug|0|||
33444834|NCT03965091|101522478|FG001|Overall Study|Non-compliance with study drug|0|||
33444835|NCT03965091|101522479|FG002|Overall Study|Non-compliance with study drug|1|||
33444836|NCT03965091|101522477|FG000|Overall Study|Lost to Follow-up|1|||
33444837|NCT03965091|101522478|FG001|Overall Study|Lost to Follow-up|1|||
33444838|NCT03965091|101522479|FG002|Overall Study|Lost to Follow-up|1|||
33444839|NCT03965091|101522477|FG000|Overall Study|Lack of Efficacy|2|||
33164329|NCT00847379|100511375|FG000|Overall Study|Study terminated by Sponsor|59|||
33258078|NCT00516321|100845987|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
33258079|NCT00516321|100845988|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
33444840|NCT03965091|101522478|FG001|Overall Study|Lack of Efficacy|0|||
33444841|NCT03965091|101522479|FG002|Overall Study|Lack of Efficacy|0|||
33444842|NCT03965091|101522477|FG000|Overall Study|Other than specified|9|||
33444843|NCT03965091|101522478|FG001|Overall Study|Other than specified|11|||
33444844|NCT03965091|101522479|FG002|Overall Study|Other than specified|8|||
33164330|NCT00847379|100511376|FG001|Overall Study|Study terminated by Sponsor|57|||
33164331|NCT00847379|100511377|FG002|Overall Study|Study terminated by Sponsor|57|||
33164332|NCT04974697|100511379|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
33164333|NCT04974697|100511379|FG000|Overall Study|Lens discomfort|1|||
33164334|NCT00844896|100511380|FG000|Overall Study|Lost to Follow-up|12|||
33164335|NCT00844896|100511381|FG001|Overall Study|Lost to Follow-up|16|||
33164336|NCT00844896|100511380|FG000|Overall Study|Parents did not have time to complete|0|||
33164337|NCT00844896|100511381|FG001|Overall Study|Parents did not have time to complete|1|||
33164338|NCT01962896|100511382|FG000|Overall Study|Lack of Efficacy|4|||
33164339|NCT02695329|100511386|FG000|Overall Study|Adverse Event|1|||
33164340|NCT02695329|100511387|FG001|Overall Study|Adverse Event|0|||
33164341|NCT02695329|100511386|FG000|Overall Study|Poor X-ray quality for measurement|4|||
33258080|NCT00516321|100845986|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
33258081|NCT00516321|100845987|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
33258082|NCT00516321|100845988|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
33258083|NCT00516321|100845986|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
33258084|NCT00516321|100845987|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
33258085|NCT00516321|100845988|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
33258086|NCT00516321|100845986|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
33258087|NCT00516321|100845987|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
33258088|NCT00516321|100845988|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
33258089|NCT03527160|100845989|FG000|Overall Study|No urine collected|13|||
33258090|NCT03527160|100845989|FG000|Overall Study|No clinical serum creatinine collected|6|||
33258091|NCT03527160|100845989|FG000|Overall Study|Did not meet inclusion|2|||
33258092|NCT01011946|100845991|FG000|Overall Study|Transferred to another hospital|2|||
33258093|NCT01011946|100845991|FG000|Overall Study|No pathological lab value|1|||
33258094|NCT01925339|100845993|FG000|Overall Study|Adverse Event|2|||
33258095|NCT01925339|100845994|FG001|Overall Study|Adverse Event|0|||
33258096|NCT03485950|100845997|FG000|Overall Study|Adverse Event|1|||
33258097|NCT03485950|100845998|FG001|Overall Study|Adverse Event|0|||
33258098|NCT03485950|100845997|FG000|Overall Study|Death|3|||
33258099|NCT03485950|100845998|FG001|Overall Study|Death|2|||
33258100|NCT03485950|100845997|FG000|Overall Study|Withdrawal by Subject|3|||
33258101|NCT03485950|100845998|FG001|Overall Study|Withdrawal by Subject|0|||
33258102|NCT03903822|100845999|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
33258103|NCT03903822|100846000|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
33258104|NCT03903822|100846001|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
33258105|NCT03903822|100846002|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
33258106|NCT03903822|100846003|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
33258107|NCT03903822|100846004|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
33164342|NCT02695329|100511387|FG001|Overall Study|Poor X-ray quality for measurement|5|||
33164343|NCT04678661|100511388|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
33258108|NCT03903822|100846005|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
33258109|NCT03903822|100846006|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
33258110|NCT03903822|100845999|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
33258111|NCT03903822|100846000|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
33258112|NCT03903822|100846001|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
33258113|NCT03903822|100846002|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
33444845|NCT01746017|101522480|FG000|Period 1|Withdrawal by Subject|0|||
33444846|NCT01746017|101522481|FG001|Period 1|Withdrawal by Subject|0|||
33164344|NCT04678661|100511389|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
33164345|NCT04678661|100511388|FG000|Overall Study|Protocol Violation|2|||
33164346|NCT04678661|100511389|FG001|Overall Study|Protocol Violation|0|||
33164347|NCT04678661|100511388|FG000|Overall Study|Withdrawal by Subject|1|||
33164348|NCT04678661|100511389|FG001|Overall Study|Withdrawal by Subject|0|||
33164349|NCT04678661|100511388|FG000|Overall Study|Lost to Follow-up|2|||
33164350|NCT04678661|100511389|FG001|Overall Study|Lost to Follow-up|0|||
33164351|NCT04678661|100511388|FG000|Overall Study|Death|2|||
33164352|NCT04678661|100511389|FG001|Overall Study|Death|0|||
33164353|NCT00814164|100511390|FG000|Overall Study|Progression|7|||
33164354|NCT00814164|100511390|FG000|Overall Study|not stated|7|||
33164355|NCT00814164|100511390|FG000|Overall Study|Death|5|||
33164356|NCT00519831|100511394|FG000|Overall Study|Adverse Event|3|||
33164357|NCT02499783|100511395|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
33164358|NCT02499783|100511396|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
33164359|NCT02499783|100511397|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
33164360|NCT02499783|100511395|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
33164361|NCT02499783|100511396|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
33164362|NCT02499783|100511397|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
33164363|NCT02499783|100511395|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
33164364|NCT02499783|100511396|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
33164365|NCT02499783|100511397|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
33164366|NCT02499783|100511395|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
33164367|NCT02499783|100511396|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
33164368|NCT02499783|100511397|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
33164369|NCT02499783|100511395|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
33164370|NCT02499783|100511396|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
33164371|NCT02499783|100511397|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
33164372|NCT02499783|100511395|FG000|DB Period: Weeks 0-8|Other|1|||
33164373|NCT02499783|100511396|FG001|DB Period: Weeks 0-8|Other|1|||
33164374|NCT02499783|100511397|FG002|DB Period: Weeks 0-8|Other|0|||
33164375|NCT02499783|100511395|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
33164376|NCT02499783|100511396|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
33164377|NCT02499783|100511397|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
33164378|NCT02499783|100511395|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
33164379|NCT02499783|100511396|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
33164380|NCT02499783|100511397|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
33164381|NCT02499783|100511395|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
33164382|NCT02499783|100511396|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
33164383|NCT02499783|100511397|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
33164384|NCT02499783|100511395|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
33164385|NCT02499783|100511396|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
33164386|NCT02499783|100511397|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
33164387|NCT04112784|100511399|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
33164388|NCT04112784|100511399|FG000|Overall Study|Screen Failures|4|||
33164389|NCT02197130|100511400|FG000|Overall Study|Adverse Event|13|||
33164390|NCT02197130|100511401|FG001|Overall Study|Adverse Event|4|||
33164391|NCT02197130|100511402|FG002|Overall Study|Adverse Event|23|||
33164392|NCT02197130|100511400|FG000|Overall Study|Death|0|||
33164393|NCT02197130|100511401|FG001|Overall Study|Death|1|||
33164394|NCT02197130|100511402|FG002|Overall Study|Death|0|||
33164395|NCT02197130|100511400|FG000|Overall Study|Lost to Follow-up|2|||
33164396|NCT02197130|100511401|FG001|Overall Study|Lost to Follow-up|0|||
33164397|NCT02197130|100511402|FG002|Overall Study|Lost to Follow-up|1|||
33164398|NCT02197130|100511400|FG000|Overall Study|Does not meet entrance criteria|0|||
33164399|NCT02197130|100511401|FG001|Overall Study|Does not meet entrance criteria|0|||
33164400|NCT02197130|100511402|FG002|Overall Study|Does not meet entrance criteria|1|||
33164401|NCT02197130|100511400|FG000|Overall Study|Withdrawal by Subject|0|||
33258114|NCT03903822|100846003|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
33258115|NCT03903822|100846004|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
33258116|NCT03903822|100846005|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
33258117|NCT03903822|100846006|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
33258118|NCT03903822|100845999|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
33258119|NCT03903822|100846000|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
33258120|NCT03903822|100846001|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
33164402|NCT02197130|100511401|FG001|Overall Study|Withdrawal by Subject|3|||
33164403|NCT02197130|100511402|FG002|Overall Study|Withdrawal by Subject|4|||
33164404|NCT02197130|100511400|FG000|Overall Study|Other|1|||
33164405|NCT02197130|100511401|FG001|Overall Study|Other|0|||
33164406|NCT02197130|100511402|FG002|Overall Study|Other|3|||
33164407|NCT01626391|100511403|FG000|Overall Study|Physician Decision|1|||
33164408|NCT01626391|100511404|FG001|Overall Study|Physician Decision|0|||
33164409|NCT01626391|100511403|FG000|Overall Study|Withdrawal by Subject|1|||
33164410|NCT01626391|100511404|FG001|Overall Study|Withdrawal by Subject|0|||
33164411|NCT00639678|100511405|FG000|Overall Study|Withdrawal by Subject|3|||
33164412|NCT00639678|100511406|FG001|Overall Study|Withdrawal by Subject|0|||
33164413|NCT00639678|100511407|FG002|Overall Study|Withdrawal by Subject|4|||
33164414|NCT00639678|100511408|FG003|Overall Study|Withdrawal by Subject|0|||
33164415|NCT00639678|100511405|FG000|Overall Study|Lost to Follow-up|1|||
33164416|NCT00639678|100511406|FG001|Overall Study|Lost to Follow-up|0|||
33258121|NCT03903822|100846002|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
33258122|NCT03903822|100846003|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
33258123|NCT03903822|100846004|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
33258124|NCT03903822|100846005|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
33258125|NCT03903822|100846006|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
33258126|NCT03903822|100845999|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
33258127|NCT03903822|100846000|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
33258128|NCT03903822|100846001|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
33258129|NCT03903822|100846002|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
33164417|NCT00639678|100511407|FG002|Overall Study|Lost to Follow-up|6|||
33164418|NCT00639678|100511408|FG003|Overall Study|Lost to Follow-up|0|||
33164419|NCT00639678|100511405|FG000|Overall Study|Adverse Event|0|||
33164420|NCT00639678|100511406|FG001|Overall Study|Adverse Event|1|||
33164421|NCT00639678|100511407|FG002|Overall Study|Adverse Event|0|||
33164422|NCT00639678|100511408|FG003|Overall Study|Adverse Event|0|||
33164423|NCT00639678|100511405|FG000|Overall Study|Lack of Compliance|0|||
33164424|NCT00639678|100511406|FG001|Overall Study|Lack of Compliance|0|||
33164425|NCT00639678|100511407|FG002|Overall Study|Lack of Compliance|1|||
33164426|NCT00639678|100511408|FG003|Overall Study|Lack of Compliance|0|||
33164427|NCT01088997|100511410|FG000|Overall Study|Physician Decision|1|||
33164428|NCT01088997|100511411|FG001|Overall Study|Physician Decision|1|||
33164429|NCT01088997|100511410|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
33164430|NCT01088997|100511411|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
33164431|NCT01088997|100511410|FG000|Overall Study|Excluded prior to receiving drug|1|||
33164432|NCT01088997|100511411|FG001|Overall Study|Excluded prior to receiving drug|1|||
33164433|NCT04390191|100511412|FG000|Overall Study|Withdrawal by Subject|1|||
33164434|NCT04390191|100511413|FG001|Overall Study|Withdrawal by Subject|0|||
33164435|NCT01318993|100511414|FG000|Overall Study|Adverse Event|53|||
33164436|NCT01318993|100511414|FG000|Overall Study|Lack of Efficacy|121|||
33164437|NCT01318993|100511414|FG000|Overall Study|Protocol Violation|3|||
33164438|NCT01318993|100511414|FG000|Overall Study|Protocol based stopping criteria|6|||
33164439|NCT01318993|100511414|FG000|Overall Study|Study closed or terminated|174|||
33164440|NCT01318993|100511414|FG000|Overall Study|Lost to Follow-up|4|||
33164441|NCT01318993|100511414|FG000|Overall Study|Physician Decision|13|||
33164442|NCT01318993|100511414|FG000|Overall Study|Withdrawal by Subject|24|||
33164443|NCT02042183|100511415|FG000|Overall Study|Physician Decision|7|||
33164444|NCT02042183|100511416|FG001|Overall Study|Physician Decision|2|||
33258130|NCT03903822|100846003|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
33444847|NCT01746017|101522482|FG002|Period 1|Withdrawal by Subject|0|||
33444848|NCT01746017|101522483|FG003|Period 1|Withdrawal by Subject|0|||
33444849|NCT01746017|101522484|FG004|Period 1|Withdrawal by Subject|0|||
33164445|NCT02042183|100511415|FG000|Overall Study|Lack of Efficacy|4|||
33258131|NCT03903822|100846004|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
33164446|NCT02042183|100511416|FG001|Overall Study|Lack of Efficacy|3|||
33164447|NCT02042183|100511415|FG000|Overall Study|Non-compliance with Study Drug|2|||
33164448|NCT02042183|100511416|FG001|Overall Study|Non-compliance with Study Drug|3|||
33164449|NCT02042183|100511415|FG000|Overall Study|Adverse Event|17|||
33164450|NCT02042183|100511416|FG001|Overall Study|Adverse Event|6|||
33164451|NCT02042183|100511415|FG000|Overall Study|Other|3|||
33164452|NCT02042183|100511416|FG001|Overall Study|Other|3|||
33164453|NCT02042183|100511415|FG000|Overall Study|Withdrawal by Subject|21|||
33164454|NCT02042183|100511416|FG001|Overall Study|Withdrawal by Subject|16|||
33164455|NCT02042183|100511415|FG000|Overall Study|Site Terminated by Sponsor|2|||
33164456|NCT02042183|100511416|FG001|Overall Study|Site Terminated by Sponsor|1|||
33164457|NCT02042183|100511415|FG000|Overall Study|Lost to Follow-up|9|||
33164458|NCT02042183|100511416|FG001|Overall Study|Lost to Follow-up|2|||
33164459|NCT01269463|100511420|FG000|First Intervention|Withdrawal by Subject|1|||
33164460|NCT01269463|100511421|FG001|First Intervention|Withdrawal by Subject|0|||
33164461|NCT01269463|100511420|FG000|First Intervention|Adverse Event|1|||
33164462|NCT01269463|100511421|FG001|First Intervention|Adverse Event|0|||
33164463|NCT01269463|100511420|FG000|First Intervention|Lack of Efficacy|0|||
33164464|NCT01269463|100511421|FG001|First Intervention|Lack of Efficacy|1|||
33164465|NCT01269463|100511420|FG000|First Intervention|Physician Decision|0|||
33164466|NCT01269463|100511421|FG001|First Intervention|Physician Decision|1|||
33164467|NCT00880009|100515019|FG000|Overall Study|Study terminated by sponsor|14|||
33164468|NCT00880009|100515019|FG000|Overall Study|Withdrawal by Subject|1|||
33164469|NCT00880009|100515019|FG000|Overall Study|Protocol Violation|1|||
33164470|NCT02850965|100515020|FG000|Overall Study|Other than listed|3|||
33164471|NCT02850965|100515021|FG001|Overall Study|Other than listed|4|||
33164472|NCT02850965|100515020|FG000|Overall Study|Protocol Violation|0|||
33164473|NCT02850965|100515021|FG001|Overall Study|Protocol Violation|2|||
33164474|NCT02850965|100515020|FG000|Overall Study|Lost to Follow-up|5|||
33164475|NCT02850965|100515021|FG001|Overall Study|Lost to Follow-up|3|||
33164476|NCT02850965|100515020|FG000|Overall Study|Lack of Efficacy|4|||
33164477|NCT02850965|100515021|FG001|Overall Study|Lack of Efficacy|8|||
33164478|NCT02850965|100515020|FG000|Overall Study|Adverse Event|3|||
33164479|NCT02850965|100515021|FG001|Overall Study|Adverse Event|2|||
33164480|NCT02850965|100515020|FG000|Overall Study|Withdrawal by Subject|3|||
33164481|NCT02850965|100515021|FG001|Overall Study|Withdrawal by Subject|4|||
33164482|NCT02850965|100515020|FG000|Overall Study|Physician Decision|0|||
33164483|NCT02850965|100515021|FG001|Overall Study|Physician Decision|1|||
33164484|NCT02850965|100515020|FG000|Overall Study|Randomized but not treated|0|||
33164485|NCT02850965|100515021|FG001|Overall Study|Randomized but not treated|1|||
33164486|NCT04160195|100515022|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
33164487|NCT04160195|100515023|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
33164488|NCT01370356|100515024|FG000|Overall Study|Death|1|||
33164489|NCT01370356|100515025|FG001|Overall Study|Death|0|||
33164490|NCT01370356|100515024|FG000|Overall Study|Lack of Efficacy|6|||
33164491|NCT01370356|100515025|FG001|Overall Study|Lack of Efficacy|28|||
33164492|NCT01370356|100515024|FG000|Overall Study|Lost to Follow-up|76|||
33258132|NCT03903822|100846005|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
33164493|NCT01370356|100515025|FG001|Overall Study|Lost to Follow-up|81|||
33164494|NCT01370356|100515024|FG000|Overall Study|Withdrawal by Subject|54|||
33164495|NCT01370356|100515025|FG001|Overall Study|Withdrawal by Subject|59|||
33164496|NCT01370356|100515024|FG000|Overall Study|Reason not specified|39|||
33164497|NCT01370356|100515025|FG001|Overall Study|Reason not specified|43|||
33164498|NCT01370356|100515024|FG000|Overall Study|Protocol Violation|3|||
33164499|NCT01370356|100515025|FG001|Overall Study|Protocol Violation|3|||
33164500|NCT01370356|100515024|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
33164501|NCT01370356|100515025|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
33164502|NCT01370356|100515024|FG000|Overall Study|AE Not Related to Study Drug|1|||
33164503|NCT01370356|100515025|FG001|Overall Study|AE Not Related to Study Drug|4|||
33164504|NCT01425281|100515026|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
33164505|NCT01425281|100515027|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
33164506|NCT01425281|100515026|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
33164507|NCT01425281|100515027|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
33164508|NCT01425281|100515026|FG000|At 180-day Clinical Follow-up|Death|0|||
33164509|NCT01425281|100515027|FG001|At 180-day Clinical Follow-up|Death|1|||
33164510|NCT01425281|100515026|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
33164511|NCT01425281|100515027|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
33164512|NCT01425281|100515026|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
33164513|NCT01425281|100515027|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
33164514|NCT01425281|100515026|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
33164515|NCT01425281|100515027|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
33164516|NCT01425281|100515026|FG000|At 2-year Clinical Follow-up|Death|2|||
33164517|NCT01425281|100515027|FG001|At 2-year Clinical Follow-up|Death|0|||
33164518|NCT01425281|100515026|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
33164519|NCT01425281|100515027|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
33164520|NCT01425281|100515026|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
33164521|NCT01425281|100515027|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
33164522|NCT01425281|100515026|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
33164523|NCT01425281|100515027|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
33164524|NCT01425281|100515026|FG000|At 3-year Clinical Follow-up|Death|2|||
33164525|NCT01425281|100515027|FG001|At 3-year Clinical Follow-up|Death|3|||
33164526|NCT01425281|100515026|FG000|At 4-year Clinical Follow-up|Death|7|||
33164527|NCT01425281|100515027|FG001|At 4-year Clinical Follow-up|Death|3|||
33164528|NCT01425281|100515026|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
33164529|NCT01425281|100515027|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
33164530|NCT01425281|100515026|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
33164531|NCT01425281|100515027|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
33164532|NCT01425281|100515026|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
33164533|NCT01425281|100515027|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
33164534|NCT01425281|100515026|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
33164535|NCT01425281|100515027|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
33164536|NCT01425281|100515026|FG000|At 5-year Clinical Follow-up|Death|2|||
33164537|NCT01425281|100515027|FG001|At 5-year Clinical Follow-up|Death|0|||
33164538|NCT01425281|100515026|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
33164539|NCT01425281|100515027|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
33164540|NCT01425281|100515026|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
33164541|NCT01425281|100515027|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
33164542|NCT01425281|100515026|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
33164543|NCT01425281|100515027|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
33164544|NCT01727297|100515028|FG000|Overall Study|Death|13|||
33164545|NCT01727297|100515029|FG001|Overall Study|Death|0|||
33164546|NCT01727297|100515028|FG000|Overall Study|Protocol Violation|1|||
33164547|NCT01727297|100515029|FG001|Overall Study|Protocol Violation|10|||
33164548|NCT01727297|100515028|FG000|Overall Study|Adverse Event|3|||
33164549|NCT01727297|100515029|FG001|Overall Study|Adverse Event|1|||
33164550|NCT01727297|100515028|FG000|Overall Study|Lost to Follow-up|11|||
33164551|NCT01727297|100515029|FG001|Overall Study|Lost to Follow-up|0|||
33164552|NCT01727297|100515028|FG000|Overall Study|Withdrawal by Subject|26|||
33164553|NCT01727297|100515029|FG001|Overall Study|Withdrawal by Subject|27|||
33164554|NCT01727297|100515028|FG000|Overall Study|Physician Decision|19|||
33164555|NCT01727297|100515029|FG001|Overall Study|Physician Decision|5|||
33164556|NCT01727297|100515028|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
33164557|NCT01727297|100515029|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
33164558|NCT01683383|100515031|FG000|Overall Study|Infant was not transported|1|||
33164559|NCT01683383|100515032|FG001|Overall Study|Infant was not transported|0|||
33164560|NCT01587001|100515033|FG000|Overall Study|Lost to Follow-up|2|||
33164561|NCT01587001|100515034|FG001|Overall Study|Lost to Follow-up|0|||
33164562|NCT01587001|100515033|FG000|Overall Study|Insufficient samples to complete testing|4|||
33258133|NCT03903822|100846006|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
33164563|NCT01587001|100515034|FG001|Overall Study|Insufficient samples to complete testing|1|||
33164564|NCT03602482|100515040|FG000|Overall Study|Withdrawal by Subject|6|||
33164565|NCT03602482|100515041|FG001|Overall Study|Withdrawal by Subject|7|||
33164566|NCT03602482|100515042|FG002|Overall Study|Withdrawal by Subject|0|||
33164567|NCT03602482|100515043|FG003|Overall Study|Withdrawal by Subject|0|||
33164568|NCT02516163|100515044|FG000|Overall Study|Withdrawal by Subject|1|||
33164569|NCT02516163|100515044|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
33164570|NCT02516163|100515044|FG000|Overall Study|Unfit/delay in surgery|3|||
33164571|NCT02516163|100515044|FG000|Overall Study|Use of incorrect measurement technique|5|||
33164572|NCT02516163|100515044|FG000|Overall Study|Data not recorded|2|||
33164573|NCT02516163|100515044|FG000|Overall Study|MRI contraindication exclusion|6|||
33164574|NCT01898806|100515046|FG000|Overall Study|Withdrawal by Subject|2|||
33164575|NCT01898806|100515046|FG000|Overall Study|Physician Decision|1|||
33164576|NCT02521870|100515059|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33164577|NCT02521870|100515060|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
33164578|NCT02521870|100515061|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33164579|NCT02521870|100515062|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33164580|NCT02521870|100515063|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33164581|NCT02521870|100515064|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33164582|NCT02521870|100515065|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33164583|NCT02521870|100515066|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33164584|NCT02521870|100515067|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33164585|NCT02521870|100515068|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33164586|NCT02521870|100515069|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33164587|NCT02521870|100515070|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
33164588|NCT02521870|100515059|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
33164589|NCT02521870|100515060|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
33164590|NCT02521870|100515061|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
33164591|NCT02521870|100515062|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
33164592|NCT02521870|100515063|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
33164593|NCT02521870|100515064|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
33164594|NCT02521870|100515065|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
33164595|NCT02521870|100515066|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
33164596|NCT02521870|100515067|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
33164597|NCT02521870|100515068|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
33164598|NCT02521870|100515069|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
33164599|NCT02521870|100515070|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
33164600|NCT02521870|100515059|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
33164601|NCT02521870|100515060|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
33164602|NCT02521870|100515061|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
33164603|NCT02521870|100515062|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
33164604|NCT02521870|100515063|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
33164605|NCT02521870|100515064|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
33164606|NCT02521870|100515065|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
33164607|NCT02521870|100515066|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
33164608|NCT02521870|100515067|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
33164609|NCT02521870|100515068|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
33164610|NCT02521870|100515069|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
33164611|NCT02521870|100515070|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
33444850|NCT01746017|101522485|FG005|Period 1|Withdrawal by Subject|0|||
33444851|NCT01746017|101522486|FG006|Period 1|Withdrawal by Subject|1|||
33164612|NCT02521870|100515059|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
33164613|NCT02521870|100515060|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
33164614|NCT02521870|100515061|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
33164615|NCT02521870|100515062|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
33164616|NCT02521870|100515063|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
33164617|NCT02521870|100515064|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
33164618|NCT02521870|100515065|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
33164619|NCT02521870|100515066|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
33444852|NCT01746017|101522487|FG007|Period 1|Withdrawal by Subject|0|||
33258134|NCT03903822|100845999|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
33388828|NCT03892707|101309368|FG000|Overall Study|Withdrawal by Subject|0|||
33164620|NCT02521870|100515067|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
33164621|NCT02521870|100515068|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
33164622|NCT02521870|100515069|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
33164623|NCT02521870|100515070|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
33164624|NCT02521870|100515059|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
33164625|NCT02521870|100515060|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
33164626|NCT02521870|100515061|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
33164627|NCT02521870|100515062|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
33164628|NCT02521870|100515063|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
33164629|NCT02521870|100515064|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
33164630|NCT02521870|100515065|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
33164631|NCT02521870|100515066|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
33164632|NCT02521870|100515067|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
33164633|NCT02521870|100515068|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
33164634|NCT02521870|100515069|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
33164635|NCT02521870|100515070|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
33164636|NCT02521870|100515059|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
33164637|NCT02521870|100515060|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
33164638|NCT02521870|100515061|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
33164639|NCT02521870|100515062|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
33164640|NCT02521870|100515063|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
33164641|NCT02521870|100515064|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
33164642|NCT02521870|100515065|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
33164643|NCT02521870|100515066|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
33164644|NCT02521870|100515067|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
33164645|NCT02521870|100515068|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
33164646|NCT02521870|100515069|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
33164647|NCT02521870|100515070|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
33164648|NCT02521870|100515059|FG000|Phase 2: Dose Expansion|Death|0|||
33164649|NCT02521870|100515060|FG001|Phase 2: Dose Expansion|Death|0|||
33164650|NCT02521870|100515061|FG002|Phase 2: Dose Expansion|Death|0|||
33164651|NCT02521870|100515062|FG003|Phase 2: Dose Expansion|Death|0|||
33164652|NCT02521870|100515063|FG004|Phase 2: Dose Expansion|Death|1|||
33164653|NCT02521870|100515064|FG005|Phase 2: Dose Expansion|Death|1|||
33164654|NCT02521870|100515065|FG006|Phase 2: Dose Expansion|Death|3|||
33164655|NCT02521870|100515066|FG007|Phase 2: Dose Expansion|Death|1|||
33164656|NCT02521870|100515067|FG008|Phase 2: Dose Expansion|Death|1|||
33164657|NCT02521870|100515068|FG009|Phase 2: Dose Expansion|Death|5|||
33164658|NCT02521870|100515069|FG010|Phase 2: Dose Expansion|Death|2|||
33164659|NCT02521870|100515070|FG011|Phase 2: Dose Expansion|Death|2|||
33164660|NCT02521870|100515059|FG000|Phase 2: Dose Expansion|Other|0|||
33164661|NCT02521870|100515060|FG001|Phase 2: Dose Expansion|Other|0|||
33164662|NCT02521870|100515061|FG002|Phase 2: Dose Expansion|Other|0|||
33164663|NCT02521870|100515062|FG003|Phase 2: Dose Expansion|Other|0|||
33444853|NCT01746017|101522488|FG008|Period 1|Withdrawal by Subject|0|||
33164664|NCT02521870|100515063|FG004|Phase 2: Dose Expansion|Other|10|||
33164665|NCT02521870|100515064|FG005|Phase 2: Dose Expansion|Other|3|||
33164666|NCT02521870|100515065|FG006|Phase 2: Dose Expansion|Other|2|||
33164667|NCT02521870|100515066|FG007|Phase 2: Dose Expansion|Other|0|||
33164668|NCT02521870|100515067|FG008|Phase 2: Dose Expansion|Other|10|||
33164669|NCT02521870|100515068|FG009|Phase 2: Dose Expansion|Other|5|||
33164670|NCT02521870|100515069|FG010|Phase 2: Dose Expansion|Other|1|||
33164671|NCT02521870|100515070|FG011|Phase 2: Dose Expansion|Other|7|||
33444854|NCT01746017|101522489|FG009|Period 1|Withdrawal by Subject|0|||
33444855|NCT01746017|101522490|FG010|Period 1|Withdrawal by Subject|0|||
33444856|NCT01746017|101522480|FG000|Period 3|Withdrawal by Subject|0|||
33444857|NCT01746017|101522481|FG001|Period 3|Withdrawal by Subject|0|||
33444858|NCT01746017|101522482|FG002|Period 3|Withdrawal by Subject|0|||
33444859|NCT01746017|101522483|FG003|Period 3|Withdrawal by Subject|0|||
33444860|NCT01746017|101522484|FG004|Period 3|Withdrawal by Subject|0|||
33444861|NCT01746017|101522485|FG005|Period 3|Withdrawal by Subject|1|||
33444862|NCT01746017|101522486|FG006|Period 3|Withdrawal by Subject|0|||
33444863|NCT01746017|101522487|FG007|Period 3|Withdrawal by Subject|0|||
33444864|NCT01746017|101522488|FG008|Period 3|Withdrawal by Subject|0|||
33444865|NCT01746017|101522489|FG009|Period 3|Withdrawal by Subject|0|||
33444866|NCT01746017|101522490|FG010|Period 3|Withdrawal by Subject|0|||
33444867|NCT00933686|101522493|FG000|Overall Study|Protocol Violation|0|||
33444868|NCT00933686|101522494|FG001|Overall Study|Protocol Violation|1|||
33444869|NCT00933686|101522493|FG000|Overall Study|Lost to Follow-up|2|||
33444870|NCT00933686|101522494|FG001|Overall Study|Lost to Follow-up|2|||
33444871|NCT00933686|101522493|FG000|Overall Study|Withdrawal by Subject|6|||
33444872|NCT00933686|101522494|FG001|Overall Study|Withdrawal by Subject|5|||
33444873|NCT00933686|101522493|FG000|Overall Study|Adverse Event|1|||
33444874|NCT00933686|101522494|FG001|Overall Study|Adverse Event|1|||
33444875|NCT00933686|101522493|FG000|Overall Study|Physician Decision|1|||
33444876|NCT00933686|101522494|FG001|Overall Study|Physician Decision|0|||
33444877|NCT00933686|101522493|FG000|Overall Study|Failure to show up at endpoint visits|0|||
33444878|NCT00933686|101522494|FG001|Overall Study|Failure to show up at endpoint visits|2|||
33444879|NCT00239577|101522495|FG000|Primary Phase|Adverse Event|0|||
33444880|NCT00239577|101522496|FG001|Primary Phase|Adverse Event|0|||
33444881|NCT00239577|101522497|FG002|Primary Phase|Adverse Event|1|||
33444882|NCT00239577|101522498|FG003|Primary Phase|Adverse Event|0|||
33444883|NCT00239577|101522495|FG000|Primary Phase|Other|5|||
33444884|NCT00239577|101522496|FG001|Primary Phase|Other|3|||
33444885|NCT00239577|101522497|FG002|Primary Phase|Other|2|||
33444886|NCT00239577|101522498|FG003|Primary Phase|Other|0|||
33444887|NCT04175808|101522507|FG000|Part A|Miscellaneous|2|||
33444888|NCT04175808|101522508|FG001|Part A|Miscellaneous|0|||
33164672|NCT02521870|100515059|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33164673|NCT02521870|100515060|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33444889|NCT04175808|101522509|FG002|Part A|Miscellaneous|0|||
33444890|NCT04175808|101522510|FG003|Part A|Miscellaneous|0|||
33444891|NCT04175808|101522511|FG004|Part A|Miscellaneous|0|||
33444892|NCT04175808|101522512|FG005|Part A|Miscellaneous|0|||
33444893|NCT04175808|101522513|FG006|Part A|Miscellaneous|0|||
33164674|NCT02521870|100515061|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33444894|NCT01838941|101522514|FG000|Overall Study|Adverse Event|1|||
33258135|NCT03903822|100846000|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
33258136|NCT03903822|100846001|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
33258137|NCT03903822|100846002|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
33258138|NCT03903822|100846003|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
33258139|NCT03903822|100846004|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
33258140|NCT03903822|100846005|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
33258141|NCT03903822|100846006|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
33258142|NCT03903822|100845999|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
33258143|NCT03903822|100846000|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
33258144|NCT03903822|100846001|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
33258145|NCT03903822|100846002|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
33258146|NCT03903822|100846003|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
33258147|NCT03903822|100846004|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
33258148|NCT03903822|100846005|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
33258149|NCT03903822|100846006|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
33258150|NCT03903822|100845999|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
33258151|NCT03903822|100846000|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
33258152|NCT03903822|100846001|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
33258153|NCT03903822|100846002|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
33258154|NCT03903822|100846003|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
33258155|NCT03903822|100846004|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
33258156|NCT03903822|100846005|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
33258157|NCT03903822|100846006|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
33258158|NCT03903822|100845999|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
33258159|NCT03903822|100846000|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
33258160|NCT03903822|100846001|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
33258161|NCT03903822|100846002|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
33258162|NCT03903822|100846003|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
33258163|NCT03903822|100846004|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
33258164|NCT03903822|100846005|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
33258165|NCT03903822|100846006|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
33258166|NCT03903822|100845999|FG000|Treatment Phase (6 Weeks)|Other|2|||
33258167|NCT03903822|100846000|FG001|Treatment Phase (6 Weeks)|Other|1|||
33258168|NCT03903822|100846001|FG002|Treatment Phase (6 Weeks)|Other|0|||
33258169|NCT03903822|100846002|FG003|Treatment Phase (6 Weeks)|Other|0|||
33258170|NCT03903822|100846003|FG004|Treatment Phase (6 Weeks)|Other|1|||
33258171|NCT03903822|100846004|FG005|Treatment Phase (6 Weeks)|Other|1|||
33258172|NCT03903822|100846005|FG006|Treatment Phase (6 Weeks)|Other|0|||
33258173|NCT03903822|100846006|FG007|Treatment Phase (6 Weeks)|Other|0|||
33258174|NCT03903822|100845999|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
33258175|NCT03903822|100846000|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
33258176|NCT03903822|100846001|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
33258177|NCT03903822|100846002|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
33258178|NCT03903822|100846003|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
33258179|NCT03903822|100846004|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
33258180|NCT03903822|100846005|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
33258181|NCT03903822|100846006|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
33258182|NCT03903822|100845999|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
33258183|NCT03903822|100846000|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
33258184|NCT03903822|100846001|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
33258185|NCT03903822|100846002|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
33258186|NCT03903822|100846003|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
33258187|NCT03903822|100846004|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
33258188|NCT03903822|100846005|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
33258189|NCT03903822|100846006|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
33258190|NCT03903822|100845999|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
33258191|NCT03903822|100846000|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
33258192|NCT03903822|100846001|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
33258193|NCT03903822|100846002|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
33258194|NCT03903822|100846003|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
33258195|NCT03903822|100846004|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
33258196|NCT03903822|100846005|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
33258197|NCT03903822|100846006|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
33258198|NCT03903822|100845999|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
33258199|NCT03903822|100846000|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
33258200|NCT03903822|100846001|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
33258201|NCT03903822|100846002|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
33258202|NCT03903822|100846003|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
33258203|NCT03903822|100846004|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
33258204|NCT03903822|100846005|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
33258205|NCT03903822|100846006|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
33258206|NCT03903822|100845999|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
33258207|NCT03903822|100846000|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
33258208|NCT03903822|100846001|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
33258209|NCT03903822|100846002|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
33258210|NCT03903822|100846003|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
33258211|NCT03903822|100846004|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
33258212|NCT03903822|100846005|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
33258213|NCT03903822|100846006|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
33258214|NCT03903822|100845999|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
33258215|NCT03903822|100846000|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
33258216|NCT03903822|100846001|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
33258217|NCT03903822|100846002|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
33258218|NCT03903822|100846003|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
33258219|NCT03903822|100846004|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
33258220|NCT03903822|100846005|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
33258221|NCT03903822|100846006|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
33258222|NCT03903822|100845999|FG000|Follow up Phase (4 Weeks)|Other|1|||
33258223|NCT03903822|100846000|FG001|Follow up Phase (4 Weeks)|Other|1|||
33258224|NCT03903822|100846001|FG002|Follow up Phase (4 Weeks)|Other|0|||
33258225|NCT03903822|100846002|FG003|Follow up Phase (4 Weeks)|Other|0|||
33258226|NCT03903822|100846003|FG004|Follow up Phase (4 Weeks)|Other|0|||
33258227|NCT03903822|100846004|FG005|Follow up Phase (4 Weeks)|Other|0|||
33258228|NCT03903822|100846005|FG006|Follow up Phase (4 Weeks)|Other|0|||
33258229|NCT03903822|100846006|FG007|Follow up Phase (4 Weeks)|Other|0|||
33258230|NCT03762668|100846011|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
33258231|NCT03762668|100846012|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
33258232|NCT03648762|100846021|FG000|Overall Study|Lost to Follow-up|1|||
33258233|NCT03648762|100846022|FG001|Overall Study|Lost to Follow-up|2|||
33258234|NCT03648762|100846023|FG002|Overall Study|Lost to Follow-up|0|||
33258235|NCT03648762|100846021|FG000|Overall Study|Withdrawal by Subject|5|||
33258236|NCT03648762|100846022|FG001|Overall Study|Withdrawal by Subject|2|||
33258237|NCT03648762|100846023|FG002|Overall Study|Withdrawal by Subject|1|||
33258238|NCT00203411|100846024|FG000|Follow-up|Progressive Disease|4|||
33258239|NCT00925899|100846025|FG000|Part 1|Death|1|||
33258240|NCT00925899|100846026|FG001|Part 1|Death|2|||
33258241|NCT00925899|100846025|FG000|Part 1|Withdrawal by Subject|10|||
33258242|NCT00925899|100846026|FG001|Part 1|Withdrawal by Subject|9|||
33258243|NCT02928224|100846027|FG000|Overall Study|Lost to Follow-up|1|||
33258244|NCT02928224|100846028|FG001|Overall Study|Lost to Follow-up|1|||
33258245|NCT02928224|100846029|FG002|Overall Study|Lost to Follow-up|3|||
33258246|NCT02928224|100846030|FG003|Overall Study|Lost to Follow-up|0|||
33258247|NCT02928224|100846027|FG000|Overall Study|Death|30|||
33258248|NCT02928224|100846028|FG001|Overall Study|Death|209|||
33258249|NCT02928224|100846029|FG002|Overall Study|Death|193|||
33258250|NCT02928224|100846030|FG003|Overall Study|Death|198|||
33258251|NCT02928224|100846027|FG000|Overall Study|Withdrawal by Subject|0|||
33258252|NCT02928224|100846028|FG001|Overall Study|Withdrawal by Subject|3|||
33258253|NCT02928224|100846029|FG002|Overall Study|Withdrawal by Subject|7|||
33258254|NCT02928224|100846030|FG003|Overall Study|Withdrawal by Subject|20|||
33258255|NCT02928224|100846027|FG000|Overall Study|Study participation terminated by sponsor|3|||
33258256|NCT02928224|100846028|FG001|Overall Study|Study participation terminated by sponsor|8|||
33258257|NCT02928224|100846029|FG002|Overall Study|Study participation terminated by sponsor|12|||
33258258|NCT02928224|100846030|FG003|Overall Study|Study participation terminated by sponsor|3|||
33258259|NCT02928224|100846027|FG000|Overall Study|Other|3|||
33258260|NCT02928224|100846028|FG001|Overall Study|Other|3|||
33258261|NCT02928224|100846029|FG002|Overall Study|Other|5|||
33258262|NCT02928224|100846030|FG003|Overall Study|Other|0|||
33258263|NCT00585052|100846031|FG000|Overall Study|Withdrawal by Subject|1|||
33258264|NCT02769858|100846035|FG000|Overall Study|Withdrawal by Subject|2|||
33258265|NCT01424670|100846036|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
33258266|NCT01424670|100846037|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
33258267|NCT01424670|100846036|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
33258268|NCT01424670|100846037|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
33258269|NCT01424670|100846036|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
33258270|NCT01424670|100846037|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
33258271|NCT01424670|100846036|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
33258272|NCT01424670|100846037|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
33258273|NCT01424670|100846036|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
33258274|NCT01424670|100846037|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
33258275|NCT01424670|100846036|FG000|Continuation Period|Adverse Event|13|||
33258276|NCT01424670|100846037|FG001|Continuation Period|Adverse Event|5|||
33258277|NCT01424670|100846036|FG000|Continuation Period|Lost to Follow-up|2|||
33258278|NCT01424670|100846037|FG001|Continuation Period|Lost to Follow-up|0|||
33258279|NCT01424670|100846036|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
33258280|NCT01424670|100846037|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
33258281|NCT01424670|100846036|FG000|Continuation Period|Physician Decision|5|||
33258282|NCT01424670|100846037|FG001|Continuation Period|Physician Decision|4|||
33444895|NCT01838941|101522514|FG000|Overall Study|Withdrawal by Subject|1|||
33444896|NCT02646124|101522519|FG000|Overall Study|Lost to Follow-up|0|||
33164675|NCT02521870|100515062|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33164676|NCT02521870|100515063|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
33164677|NCT02521870|100515064|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33164678|NCT02521870|100515065|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33164679|NCT02521870|100515066|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33164680|NCT02521870|100515067|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33164681|NCT02521870|100515068|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33164682|NCT02521870|100515069|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33164683|NCT02521870|100515070|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
33164684|NCT02521870|100515059|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33164685|NCT02521870|100515060|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33164686|NCT02521870|100515061|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33164687|NCT02521870|100515062|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33164688|NCT02521870|100515063|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
33164689|NCT02521870|100515064|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33164690|NCT02521870|100515065|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33164691|NCT02521870|100515066|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33164692|NCT02521870|100515067|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33164693|NCT02521870|100515068|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33164694|NCT02521870|100515069|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33164695|NCT02521870|100515070|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
33164696|NCT02849678|100515073|FG000|Overall Study|Protocol Violation|3|||
33164697|NCT02849678|100515074|FG001|Overall Study|Protocol Violation|6|||
33164698|NCT01405742|100515075|FG000|Overall Study|Lost to Follow-up|1|||
33164699|NCT01405742|100515076|FG001|Overall Study|Lost to Follow-up|0|||
33164700|NCT00640601|100515078|FG000|Overall Study|Adverse Event|43|||
33164701|NCT00640601|100515078|FG000|Overall Study|Withdrawal by Subject|20|||
33164702|NCT00640601|100515078|FG000|Overall Study|Protocol Violation|6|||
33164703|NCT00640601|100515078|FG000|Overall Study|Lack of Efficacy|16|||
33164704|NCT00640601|100515078|FG000|Overall Study|Lost to Follow-up|9|||
33164705|NCT00640601|100515078|FG000|Overall Study|Physician Decision|8|||
33164706|NCT00640601|100515078|FG000|Overall Study|treatment naive, combination therapy|10|||
33164707|NCT01496612|100515079|FG000|1st Intervention|Adverse Event|1|||
33164708|NCT01496612|100515080|FG001|1st Intervention|Adverse Event|0|||
33258283|NCT01424670|100846036|FG000|Continuation Period|Withdrawal by Subject|13|||
33164709|NCT01496612|100515079|FG000|1st Intervention|Withdrawal by Subject|1|||
33164710|NCT01496612|100515080|FG001|1st Intervention|Withdrawal by Subject|0|||
33164711|NCT01619423|100515081|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
33164712|NCT01619423|100515082|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
33164713|NCT01619423|100515083|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
33444897|NCT02646124|101522520|FG001|Overall Study|Lost to Follow-up|2|||
33444898|NCT01648582|101522523|FG000|Overall Study|Adverse Event|6|||
33444899|NCT01648582|101522524|FG001|Overall Study|Adverse Event|11|||
33444900|NCT01648582|101522525|FG002|Overall Study|Adverse Event|2|||
33444901|NCT01648582|101522523|FG000|Overall Study|Lost to Follow-up|9|||
33444902|NCT01648582|101522524|FG001|Overall Study|Lost to Follow-up|6|||
33444903|NCT01648582|101522525|FG002|Overall Study|Lost to Follow-up|8|||
33444904|NCT01648582|101522523|FG000|Overall Study|Protocol Violation|1|||
33444905|NCT01648582|101522524|FG001|Overall Study|Protocol Violation|2|||
33444906|NCT01648582|101522525|FG002|Overall Study|Protocol Violation|1|||
33444907|NCT01648582|101522523|FG000|Overall Study|Withdrawal by Subject|15|||
33444908|NCT01648582|101522524|FG001|Overall Study|Withdrawal by Subject|17|||
33444909|NCT01648582|101522525|FG002|Overall Study|Withdrawal by Subject|17|||
33444910|NCT01648582|101522523|FG000|Overall Study|Physician Decision|0|||
33444911|NCT01648582|101522524|FG001|Overall Study|Physician Decision|1|||
33444912|NCT01648582|101522525|FG002|Overall Study|Physician Decision|3|||
33444913|NCT01648582|101522523|FG000|Overall Study|Death|1|||
33444914|NCT01648582|101522524|FG001|Overall Study|Death|0|||
33444915|NCT01648582|101522525|FG002|Overall Study|Death|0|||
33444916|NCT01648582|101522523|FG000|Overall Study|Sponsor Decision|0|||
33444917|NCT01648582|101522524|FG001|Overall Study|Sponsor Decision|1|||
33444918|NCT01648582|101522525|FG002|Overall Study|Sponsor Decision|1|||
33444919|NCT01215981|101522528|FG000|Overall Study|Physician Decision|0|||
33444920|NCT01215981|101522529|FG001|Overall Study|Physician Decision|1|||
33444921|NCT01215981|101522528|FG000|Overall Study|Protocol Violation|1|||
33444922|NCT01215981|101522529|FG001|Overall Study|Protocol Violation|0|||
33444923|NCT01215981|101522528|FG000|Overall Study|Withdrawal by Subject|1|||
33444924|NCT01215981|101522529|FG001|Overall Study|Withdrawal by Subject|0|||
33444925|NCT02909907|101522530|FG000|Overall Study|Withdrawal by Subject|0|||
33444926|NCT02909907|101522531|FG001|Overall Study|Withdrawal by Subject|1|||
33444927|NCT01173692|101522534|FG000|Overall Study|Adverse Event|1|||
33444928|NCT01173692|101522535|FG001|Overall Study|Adverse Event|2|||
33444929|NCT01173692|101522534|FG000|Overall Study|Withdrawal by Subject|1|||
33444930|NCT01173692|101522535|FG001|Overall Study|Withdrawal by Subject|3|||
33444931|NCT02246166|101522536|FG000|Overall Study|Protocol Violation|1|||
33444932|NCT02246166|101522537|FG001|Overall Study|Protocol Violation|0|||
33444933|NCT00909610|101522540|FG000|Period: First Intervention|Adverse Event|0|||
33444934|NCT00909610|101522541|FG001|Period: First Intervention|Adverse Event|1|||
33444935|NCT00909610|101522540|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
33444936|NCT00909610|101522541|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
33444937|NCT00909610|101522540|FG000|Period: Second Intervention|Adverse Event|1|||
33444938|NCT00909610|101522541|FG001|Period: Second Intervention|Adverse Event|0|||
33444939|NCT01294917|101522542|FG000|Overall Study|Relocation|5|||
33444940|NCT01294917|101522542|FG000|Overall Study|Inconvenience|1|||
33444941|NCT03197883|101522547|FG000|Overall Study|Adverse Event|1|||
33444942|NCT03197883|101522548|FG001|Overall Study|Adverse Event|1|||
33444943|NCT03197883|101522547|FG000|Overall Study|Lost to Follow-up|1|||
33444944|NCT03197883|101522548|FG001|Overall Study|Lost to Follow-up|0|||
33444945|NCT03197883|101522547|FG000|Overall Study|Protocol Violation|1|||
33444946|NCT03197883|101522548|FG001|Overall Study|Protocol Violation|0|||
33444947|NCT03197883|101522547|FG000|Overall Study|Other (Not Specified)|0|||
33444948|NCT03197883|101522548|FG001|Overall Study|Other (Not Specified)|5|||
33444949|NCT01204294|101522551|FG000|Overall Study|Adverse Event|2|||
33444950|NCT01204294|101522552|FG001|Overall Study|Adverse Event|6|||
33444951|NCT01204294|101522553|FG002|Overall Study|Adverse Event|0|||
33444952|NCT01204294|101522554|FG003|Overall Study|Adverse Event|7|||
33444953|NCT01204294|101522555|FG004|Overall Study|Adverse Event|1|||
33444954|NCT01204294|101522556|FG005|Overall Study|Adverse Event|4|||
33444955|NCT01204294|101522557|FG006|Overall Study|Adverse Event|0|||
33444956|NCT01204294|101522551|FG000|Overall Study|Protocol Violation|1|||
33444957|NCT01204294|101522552|FG001|Overall Study|Protocol Violation|0|||
33444958|NCT01204294|101522553|FG002|Overall Study|Protocol Violation|2|||
33444959|NCT01204294|101522554|FG003|Overall Study|Protocol Violation|1|||
33444960|NCT01204294|101522555|FG004|Overall Study|Protocol Violation|0|||
33444961|NCT01204294|101522556|FG005|Overall Study|Protocol Violation|0|||
33444962|NCT01204294|101522557|FG006|Overall Study|Protocol Violation|0|||
33444963|NCT01204294|101522551|FG000|Overall Study|Withdrawal by Subject|0|||
33444964|NCT01204294|101522552|FG001|Overall Study|Withdrawal by Subject|2|||
33444965|NCT01204294|101522553|FG002|Overall Study|Withdrawal by Subject|2|||
33444966|NCT01204294|101522554|FG003|Overall Study|Withdrawal by Subject|1|||
33444967|NCT01204294|101522555|FG004|Overall Study|Withdrawal by Subject|1|||
33444968|NCT01204294|101522556|FG005|Overall Study|Withdrawal by Subject|1|||
33444969|NCT01204294|101522557|FG006|Overall Study|Withdrawal by Subject|2|||
33444970|NCT01204294|101522551|FG000|Overall Study|Lack of Efficacy|0|||
33444971|NCT01204294|101522552|FG001|Overall Study|Lack of Efficacy|0|||
33444972|NCT01204294|101522553|FG002|Overall Study|Lack of Efficacy|0|||
33444973|NCT01204294|101522554|FG003|Overall Study|Lack of Efficacy|2|||
33444974|NCT01204294|101522555|FG004|Overall Study|Lack of Efficacy|0|||
33444975|NCT01204294|101522556|FG005|Overall Study|Lack of Efficacy|0|||
33444976|NCT01204294|101522557|FG006|Overall Study|Lack of Efficacy|0|||
33444977|NCT01204294|101522551|FG000|Overall Study|Other (house moving)|0|||
33444978|NCT01204294|101522552|FG001|Overall Study|Other (house moving)|0|||
33444979|NCT01204294|101522553|FG002|Overall Study|Other (house moving)|1|||
33444980|NCT01204294|101522554|FG003|Overall Study|Other (house moving)|0|||
33444981|NCT01204294|101522555|FG004|Overall Study|Other (house moving)|0|||
33444982|NCT01204294|101522556|FG005|Overall Study|Other (house moving)|0|||
33444983|NCT01204294|101522557|FG006|Overall Study|Other (house moving)|0|||
33444984|NCT00296647|101522558|FG000|Overall Study|Death|4|||
33444985|NCT00296647|101522559|FG001|Overall Study|Death|1|||
33444986|NCT00296647|101522560|FG002|Overall Study|Death|2|||
33444987|NCT00296647|101522561|FG003|Overall Study|Death|1|||
33444988|NCT00296647|101522562|FG004|Overall Study|Death|1|||
33444989|NCT00296647|101522558|FG000|Overall Study|Withdrawal by Subject|28|||
33258284|NCT01424670|100846037|FG001|Continuation Period|Withdrawal by Subject|4|||
33258285|NCT03086369|100846038|FG000|Overall Study|Lost to Follow-up|1|||
33258286|NCT03086369|100846039|FG001|Overall Study|Lost to Follow-up|0|||
33258287|NCT03086369|100846040|FG002|Overall Study|Lost to Follow-up|0|||
33258288|NCT03086369|100846041|FG003|Overall Study|Lost to Follow-up|2|||
33258289|NCT03086369|100846042|FG004|Overall Study|Lost to Follow-up|1|||
33258290|NCT03086369|100846038|FG000|Overall Study|Physician Decision|0|||
33258291|NCT03086369|100846039|FG001|Overall Study|Physician Decision|0|||
33258292|NCT03086369|100846040|FG002|Overall Study|Physician Decision|0|||
33258293|NCT03086369|100846041|FG003|Overall Study|Physician Decision|1|||
33258294|NCT03086369|100846042|FG004|Overall Study|Physician Decision|2|||
33258295|NCT03086369|100846038|FG000|Overall Study|Withdrawal by Subject|0|||
33258296|NCT03086369|100846039|FG001|Overall Study|Withdrawal by Subject|0|||
33258297|NCT03086369|100846040|FG002|Overall Study|Withdrawal by Subject|0|||
33444990|NCT00296647|101522559|FG001|Overall Study|Withdrawal by Subject|27|||
33444991|NCT00296647|101522560|FG002|Overall Study|Withdrawal by Subject|32|||
33444992|NCT00296647|101522561|FG003|Overall Study|Withdrawal by Subject|16|||
33444993|NCT00296647|101522562|FG004|Overall Study|Withdrawal by Subject|19|||
33444994|NCT00467896|101522563|FG000|Overall Study|Consent Withdrawal|18|||
33444995|NCT00467896|101522563|FG000|Overall Study|Adverse Event|7|||
33444996|NCT00467896|101522563|FG000|Overall Study|Serious Adverse Event|13|||
33444997|NCT00467896|101522563|FG000|Overall Study|Non-compliance|3|||
33444998|NCT00467896|101522563|FG000|Overall Study|Changed therapy|2|||
33444999|NCT00467896|101522563|FG000|Overall Study|Patient received transplant|2|||
33445000|NCT00467896|101522563|FG000|Overall Study|Patient had atrial septostomy|1|||
33445001|NCT00467896|101522563|FG000|Overall Study|Patient weaned off iloprost|1|||
33445002|NCT00467896|101522563|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
33445003|NCT00467896|101522563|FG000|Overall Study|Started intravenous prostacyclin|1|||
33445004|NCT00467896|101522563|FG000|Overall Study|Started inhaled Remodulin|1|||
33445005|NCT00467896|101522563|FG000|Overall Study|Patient had no improvement|1|||
33445006|NCT02301975|101522566|FG000|Overall Study|Adverse Event|8|||
33445007|NCT02301975|101522567|FG001|Overall Study|Adverse Event|3|||
33445008|NCT02301975|101522568|FG002|Overall Study|Adverse Event|2|||
33445009|NCT02301975|101522566|FG000|Overall Study|Lack of Efficacy|1|||
33445010|NCT02301975|101522567|FG001|Overall Study|Lack of Efficacy|1|||
33445011|NCT02301975|101522568|FG002|Overall Study|Lack of Efficacy|1|||
33445012|NCT02301975|101522566|FG000|Overall Study|Protocol Violation|3|||
33445013|NCT02301975|101522567|FG001|Overall Study|Protocol Violation|5|||
33445014|NCT02301975|101522568|FG002|Overall Study|Protocol Violation|3|||
33445015|NCT02301975|101522566|FG000|Overall Study|Lost to Follow-up|0|||
33445016|NCT02301975|101522567|FG001|Overall Study|Lost to Follow-up|2|||
33445017|NCT02301975|101522568|FG002|Overall Study|Lost to Follow-up|2|||
33445018|NCT02301975|101522566|FG000|Overall Study|Physician Decision|4|||
33445019|NCT02301975|101522567|FG001|Overall Study|Physician Decision|2|||
33445020|NCT02301975|101522568|FG002|Overall Study|Physician Decision|3|||
33445021|NCT02301975|101522566|FG000|Overall Study|Withdrawal by Subject|15|||
33258298|NCT03086369|100846041|FG003|Overall Study|Withdrawal by Subject|5|||
33258299|NCT03086369|100846042|FG004|Overall Study|Withdrawal by Subject|3|||
33258300|NCT03086369|100846038|FG000|Overall Study|Progressive Disease|0|||
33258301|NCT03086369|100846039|FG001|Overall Study|Progressive Disease|0|||
33258302|NCT03086369|100846040|FG002|Overall Study|Progressive Disease|0|||
33258303|NCT03086369|100846041|FG003|Overall Study|Progressive Disease|1|||
33445022|NCT02301975|101522567|FG001|Overall Study|Withdrawal by Subject|12|||
33445023|NCT02301975|101522568|FG002|Overall Study|Withdrawal by Subject|11|||
33445024|NCT04405570|101522569|FG000|Overall Study|Adverse Event|0|||
33445025|NCT04405570|101522570|FG001|Overall Study|Adverse Event|1|||
33445026|NCT04405570|101522571|FG002|Overall Study|Adverse Event|1|||
33445027|NCT04405570|101522572|FG003|Overall Study|Adverse Event|1|||
33445028|NCT04405570|101522569|FG000|Overall Study|Lost to Follow-up|0|||
33445029|NCT04405570|101522570|FG001|Overall Study|Lost to Follow-up|1|||
33445030|NCT04405570|101522571|FG002|Overall Study|Lost to Follow-up|0|||
33445031|NCT04405570|101522572|FG003|Overall Study|Lost to Follow-up|0|||
33258304|NCT03086369|100846042|FG004|Overall Study|Progressive Disease|1|||
33258305|NCT01811706|100846043|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
33258306|NCT01811706|100846044|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
33258307|NCT00799396|100846045|FG000|Clopidogrel Treatment|Adverse Event|6|||
33258308|NCT00799396|100846045|FG000|Clopidogrel Treatment|Physician Decision|5|||
33258309|NCT00799396|100846045|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
33258310|NCT00799396|100846045|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
33258311|NCT00799396|100846045|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
33164714|NCT01619423|100515084|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
33164715|NCT00558558|100515085|FG000|Overall Study|Unable to swallow|1|||
33164716|NCT00558558|100515085|FG000|Overall Study|Withdrawal by Subject|1|||
33164717|NCT00558558|100515085|FG000|Overall Study|Lack of Efficacy|4|||
33164718|NCT00838578|100515086|FG000|Overall Study|Protocol Violation|2|||
33258312|NCT03764475|100846048|FG000|Overall Study|Adverse Event|11|||
33258313|NCT03764475|100846049|FG001|Overall Study|Adverse Event|2|||
33258314|NCT03764475|100846048|FG000|Overall Study|Lost to Follow-up|24|||
33258315|NCT03764475|100846049|FG001|Overall Study|Lost to Follow-up|10|||
33258316|NCT03764475|100846048|FG000|Overall Study|Withdrawal by Subject|26|||
33258317|NCT03764475|100846049|FG001|Overall Study|Withdrawal by Subject|10|||
33258318|NCT03764475|100846048|FG000|Overall Study|Lack of Efficacy|3|||
33258319|NCT03764475|100846049|FG001|Overall Study|Lack of Efficacy|0|||
33258320|NCT03764475|100846048|FG000|Overall Study|COVID-19 Disruption|2|||
33258321|NCT03764475|100846049|FG001|Overall Study|COVID-19 Disruption|0|||
33258322|NCT01424397|100846050|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
33258323|NCT01424397|100846051|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
33258324|NCT01424397|100846052|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
33258325|NCT01424397|100846053|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
33258326|NCT01424397|100846054|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
33445032|NCT04405570|101522569|FG000|Overall Study|Physician Decision|0|||
33164719|NCT00833794|100515087|FG000|Open-label Phase|Adverse Event|225|||
33164720|NCT00833794|100515088|FG001|Open-label Phase|Adverse Event|0|||
33445033|NCT04405570|101522570|FG001|Overall Study|Physician Decision|0|||
33445034|NCT04405570|101522571|FG002|Overall Study|Physician Decision|1|||
33445035|NCT04405570|101522572|FG003|Overall Study|Physician Decision|0|||
33445036|NCT04405570|101522569|FG000|Overall Study|Withdrawal by Subject|0|||
33445037|NCT04405570|101522570|FG001|Overall Study|Withdrawal by Subject|1|||
33445038|NCT04405570|101522571|FG002|Overall Study|Withdrawal by Subject|1|||
33445039|NCT04405570|101522572|FG003|Overall Study|Withdrawal by Subject|0|||
33445040|NCT04405570|101522569|FG000|Overall Study|Randomized not dosed|0|||
33445041|NCT04405570|101522570|FG001|Overall Study|Randomized not dosed|2|||
33445042|NCT04405570|101522571|FG002|Overall Study|Randomized not dosed|0|||
33445043|NCT04405570|101522572|FG003|Overall Study|Randomized not dosed|0|||
33445044|NCT02158663|101522573|FG000|Overall Study|Withdrawal by Subject|5|||
33445045|NCT02158663|101522574|FG001|Overall Study|Withdrawal by Subject|4|||
33445046|NCT00469417|101522575|FG000|Overall Study|Treatment failure all lesions|18|||
33445047|NCT00469417|101522576|FG001|Overall Study|Treatment failure all lesions|11|||
33445048|NCT00469417|101522575|FG000|Overall Study|Consent withdrawn|1|||
33445049|NCT00469417|101522576|FG001|Overall Study|Consent withdrawn|1|||
33445050|NCT00469417|101522575|FG000|Overall Study|Adverse Event|8|||
33445051|NCT00469417|101522576|FG001|Overall Study|Adverse Event|2|||
33445052|NCT00469417|101522575|FG000|Overall Study|Lost to Follow-up|1|||
33445053|NCT00469417|101522576|FG001|Overall Study|Lost to Follow-up|2|||
33445054|NCT00469417|101522575|FG000|Overall Study|Intercurrent disease|0|||
33445055|NCT00469417|101522576|FG001|Overall Study|Intercurrent disease|1|||
33445056|NCT00469417|101522575|FG000|Overall Study|Randomized but not treated|2|||
33445057|NCT00469417|101522576|FG001|Overall Study|Randomized but not treated|0|||
33445058|NCT01136382|101522577|FG000|Overall Study|Other|8|||
33445059|NCT01136382|101522578|FG001|Overall Study|Other|3|||
33445060|NCT01136382|101522577|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
33445061|NCT01136382|101522578|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
33445062|NCT01136382|101522577|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
33445063|NCT01136382|101522578|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
33445064|NCT01136382|101522577|FG000|Overall Study|Withdrawal by Subject|4|||
33445065|NCT01136382|101522578|FG001|Overall Study|Withdrawal by Subject|1|||
33445066|NCT03084471|101522579|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
33445067|NCT03084471|101522579|FG000|Overall Study|Condition under investigation worsened|84|||
33445068|NCT03084471|101522579|FG000|Overall Study|Lack of therapeutic response|2|||
33445069|NCT03084471|101522579|FG000|Overall Study|Protocol Violation|1|||
33445070|NCT03084471|101522579|FG000|Overall Study|Adverse Event|73|||
33445071|NCT03084471|101522579|FG000|Overall Study|Withdrawal by Subject|12|||
33445072|NCT03084471|101522579|FG000|Overall Study|Disease relapse|181|||
33445073|NCT03084471|101522579|FG000|Overall Study|Subjective disease progression|359|||
33445074|NCT03084471|101522579|FG000|Overall Study|Other (as recorded)|33|||
33445075|NCT03084471|101522579|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
33445076|NCT01745120|101522580|FG000|Overall Study|Investigator decision|1|||
33445077|NCT01745120|101522581|FG001|Overall Study|Investigator decision|0|||
33445078|NCT02077465|101522585|FG000|Overall Study|Withdrew Consent|0|||
33445079|NCT02077465|101522586|FG001|Overall Study|Withdrew Consent|1|||
33445080|NCT02077465|101522585|FG000|Overall Study|Lost to Follow-up|1|||
33445081|NCT02077465|101522586|FG001|Overall Study|Lost to Follow-up|0|||
33445082|NCT02530905|101522587|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
33445083|NCT02530905|101522588|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
33445084|NCT02530905|101522589|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
33445085|NCT01265056|101522590|FG000|Initial Study Period|Withdrawal by Subject|1|||
33445086|NCT01265056|101522591|FG001|Initial Study Period|Withdrawal by Subject|1|||
33445087|NCT01265056|101522590|FG000|Initial Study Period|Withdrawal by Subject|1|||
33445088|NCT01265056|101522591|FG001|Initial Study Period|Withdrawal by Subject|1|||
33445089|NCT01265056|101522590|FG000|Follow up|Lost to Follow-up|7|||
33445090|NCT01265056|101522591|FG001|Follow up|Lost to Follow-up|3|||
33445091|NCT01854047|101522592|FG000|Overall Study|Lack of Efficacy|1|||
33445092|NCT01854047|101522593|FG001|Overall Study|Lack of Efficacy|0|||
33445093|NCT01854047|101522594|FG002|Overall Study|Lack of Efficacy|0|||
33445094|NCT01854047|101522595|FG003|Overall Study|Lack of Efficacy|0|||
33445095|NCT01854047|101522596|FG004|Overall Study|Lack of Efficacy|0|||
33445096|NCT01854047|101522592|FG000|Overall Study|Poor compliance to protocol|3|||
33445097|NCT01854047|101522593|FG001|Overall Study|Poor compliance to protocol|0|||
33445098|NCT01854047|101522594|FG002|Overall Study|Poor compliance to protocol|2|||
33445099|NCT01854047|101522595|FG003|Overall Study|Poor compliance to protocol|0|||
33445100|NCT01854047|101522596|FG004|Overall Study|Poor compliance to protocol|0|||
33445101|NCT01854047|101522592|FG000|Overall Study|Adverse Event|5|||
33445102|NCT01854047|101522593|FG001|Overall Study|Adverse Event|4|||
33445103|NCT01854047|101522594|FG002|Overall Study|Adverse Event|6|||
33164721|NCT00833794|100515087|FG000|Open-label Phase|Lack of Efficacy|28|||
33164722|NCT00833794|100515088|FG001|Open-label Phase|Lack of Efficacy|0|||
33164723|NCT00833794|100515087|FG000|Open-label Phase|Withdrawal by Subject|48|||
33164724|NCT00833794|100515088|FG001|Open-label Phase|Withdrawal by Subject|0|||
33164725|NCT00833794|100515087|FG000|Open-label Phase|Physician Decision|20|||
33164726|NCT00833794|100515088|FG001|Open-label Phase|Physician Decision|0|||
33164727|NCT00833794|100515087|FG000|Open-label Phase|Administrative reason|1|||
33164728|NCT00833794|100515088|FG001|Open-label Phase|Administrative reason|0|||
33164729|NCT00833794|100515087|FG000|Open-label Phase|Protocol Violation|47|||
33164730|NCT00833794|100515088|FG001|Open-label Phase|Protocol Violation|0|||
33164731|NCT00833794|100515087|FG000|Open-label Phase|Did not complete wash-out period|12|||
33164732|NCT00833794|100515088|FG001|Open-label Phase|Did not complete wash-out period|0|||
33164733|NCT00833794|100515087|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
33164734|NCT00833794|100515088|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
33164735|NCT00833794|100515087|FG000|Double-blind Phase|Adverse Event|44|||
33164736|NCT00833794|100515088|FG001|Double-blind Phase|Adverse Event|11|||
33164737|NCT00833794|100515087|FG000|Double-blind Phase|Lack of Efficacy|34|||
33164738|NCT00833794|100515088|FG001|Double-blind Phase|Lack of Efficacy|22|||
33164739|NCT00833794|100515087|FG000|Double-blind Phase|Withdrawal by Subject|23|||
33164740|NCT00833794|100515088|FG001|Double-blind Phase|Withdrawal by Subject|6|||
33164741|NCT00833794|100515087|FG000|Double-blind Phase|Physician Decision|4|||
33164742|NCT00833794|100515088|FG001|Double-blind Phase|Physician Decision|7|||
33164743|NCT00833794|100515087|FG000|Double-blind Phase|Administrative reason|1|||
33164744|NCT00833794|100515088|FG001|Double-blind Phase|Administrative reason|3|||
33164745|NCT01169493|100515091|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
33164746|NCT01169493|100515092|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
33164747|NCT01169493|100515093|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
33164748|NCT01169493|100515094|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
33164749|NCT01169493|100515095|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
33164750|NCT01169493|100515096|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
33164751|NCT01169493|100515091|FG000|Period 3 (6 Months)|Adverse Event|0|||
33164752|NCT01169493|100515092|FG001|Period 3 (6 Months)|Adverse Event|1|||
33164753|NCT01169493|100515093|FG002|Period 3 (6 Months)|Adverse Event|0|||
33164754|NCT01169493|100515094|FG003|Period 3 (6 Months)|Adverse Event|0|||
33164755|NCT01169493|100515095|FG004|Period 3 (6 Months)|Adverse Event|0|||
33164756|NCT01169493|100515096|FG005|Period 3 (6 Months)|Adverse Event|0|||
33164757|NCT01169493|100515091|FG000|Period 3 (6 Months)|Physician Decision|0|||
33164758|NCT01169493|100515092|FG001|Period 3 (6 Months)|Physician Decision|1|||
33164759|NCT01169493|100515093|FG002|Period 3 (6 Months)|Physician Decision|1|||
33164760|NCT01169493|100515094|FG003|Period 3 (6 Months)|Physician Decision|0|||
33164761|NCT01169493|100515095|FG004|Period 3 (6 Months)|Physician Decision|0|||
33164762|NCT01169493|100515096|FG005|Period 3 (6 Months)|Physician Decision|0|||
33164763|NCT03230097|100515097|FG000|Overall Study|Adverse Event|2|||
33164764|NCT03230097|100515098|FG001|Overall Study|Adverse Event|1|||
33164765|NCT03230097|100515097|FG000|Overall Study|non-compliance|0|||
33258327|NCT01424397|100846055|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
33258328|NCT01424397|100846056|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
33258329|NCT01424397|100846057|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
33258330|NCT01424397|100846058|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
33258331|NCT01424397|100846059|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
33258332|NCT01424397|100846060|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
33258333|NCT01424397|100846061|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
33258334|NCT00088413|100846063|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
33258335|NCT00088413|100846064|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
33258336|NCT00088413|100846065|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
33258337|NCT00088413|100846066|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
33258338|NCT00088413|100846063|FG000|Overall Study|Adverse Events/Side Effects|0|||
33258339|NCT00088413|100846064|FG001|Overall Study|Adverse Events/Side Effects|1|||
33258340|NCT00088413|100846065|FG002|Overall Study|Adverse Events/Side Effects|1|||
33258341|NCT00088413|100846066|FG003|Overall Study|Adverse Events/Side Effects|0|||
33258342|NCT00088413|100846063|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
33258343|NCT00088413|100846064|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
33258344|NCT00088413|100846065|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
33258345|NCT00088413|100846066|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
33258346|NCT00088413|100846063|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
33258347|NCT00088413|100846064|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
33258348|NCT00088413|100846065|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
33258349|NCT00088413|100846066|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
33258350|NCT00088413|100846063|FG000|Overall Study|Death|0|||
33258351|NCT00088413|100846064|FG001|Overall Study|Death|1|||
33258352|NCT00088413|100846065|FG002|Overall Study|Death|0|||
33258353|NCT00088413|100846066|FG003|Overall Study|Death|0|||
33258354|NCT00088413|100846063|FG000|Overall Study|Progressive disease|9|||
33258355|NCT00088413|100846064|FG001|Overall Study|Progressive disease|11|||
33258356|NCT00088413|100846065|FG002|Overall Study|Progressive disease|8|||
33258357|NCT00088413|100846066|FG003|Overall Study|Progressive disease|14|||
33258358|NCT00088413|100846063|FG000|Overall Study|Other|0|||
33258359|NCT00088413|100846064|FG001|Overall Study|Other|1|||
33258360|NCT00088413|100846065|FG002|Overall Study|Other|0|||
33258361|NCT00088413|100846066|FG003|Overall Study|Other|0|||
33258362|NCT00088413|100846063|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
33258363|NCT00088413|100846064|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
33258364|NCT00088413|100846065|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
33258365|NCT00088413|100846066|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
33258366|NCT03740009|100846069|FG000|Overall Study|Physician Decision|9|||
33258367|NCT03740009|100846069|FG000|Overall Study|Lost to Follow-up|1|||
33258368|NCT00807937|100846070|FG000|Overall Study|Adverse Event|12|||
33445104|NCT01854047|101522595|FG003|Overall Study|Adverse Event|10|||
33445105|NCT01854047|101522596|FG004|Overall Study|Adverse Event|7|||
33164766|NCT03230097|100515098|FG001|Overall Study|non-compliance|1|||
33164767|NCT03230097|100515097|FG000|Overall Study|Lost to Follow-up|2|||
33164768|NCT03230097|100515098|FG001|Overall Study|Lost to Follow-up|4|||
33164769|NCT03230097|100515097|FG000|Overall Study|Withdrawal by Subject|7|||
33164770|NCT03230097|100515098|FG001|Overall Study|Withdrawal by Subject|3|||
33164771|NCT03230097|100515097|FG000|Overall Study|Trial termination|4|||
33164772|NCT03230097|100515098|FG001|Overall Study|Trial termination|5|||
33164773|NCT03230097|100515097|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
33164774|NCT03230097|100515098|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
33164775|NCT03230097|100515097|FG000|Overall Study|outcome event|0|||
33164776|NCT03230097|100515098|FG001|Overall Study|outcome event|1|||
33258369|NCT00807937|100846071|FG001|Overall Study|Adverse Event|12|||
33258370|NCT00807937|100846072|FG002|Overall Study|Adverse Event|5|||
33258371|NCT00807937|100846073|FG003|Overall Study|Adverse Event|4|||
33258372|NCT00807937|100846070|FG000|Overall Study|Protocol Violation|4|||
33258373|NCT00807937|100846071|FG001|Overall Study|Protocol Violation|5|||
33258374|NCT00807937|100846072|FG002|Overall Study|Protocol Violation|3|||
33258375|NCT00807937|100846073|FG003|Overall Study|Protocol Violation|3|||
33258376|NCT00807937|100846070|FG000|Overall Study|Withdrawal by Subject|5|||
33258377|NCT00807937|100846071|FG001|Overall Study|Withdrawal by Subject|4|||
33258378|NCT00807937|100846072|FG002|Overall Study|Withdrawal by Subject|1|||
33258379|NCT00807937|100846073|FG003|Overall Study|Withdrawal by Subject|4|||
33258380|NCT00807937|100846070|FG000|Overall Study|Lost to Follow-up|4|||
33258381|NCT00807937|100846071|FG001|Overall Study|Lost to Follow-up|0|||
33258382|NCT00807937|100846072|FG002|Overall Study|Lost to Follow-up|2|||
33258383|NCT00807937|100846073|FG003|Overall Study|Lost to Follow-up|1|||
33445106|NCT01854047|101522592|FG000|Overall Study|Randomized but not treated|0|||
33445107|NCT01854047|101522593|FG001|Overall Study|Randomized but not treated|1|||
33164777|NCT00395304|100515099|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33164778|NCT00395304|100515100|FG001|Treatment Period 1|Withdrawal by Subject|3|||
33164779|NCT00395304|100515101|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33164780|NCT00395304|100515102|FG003|Treatment Period 1|Withdrawal by Subject|2|||
33164781|NCT00395304|100515103|FG004|Treatment Period 1|Withdrawal by Subject|1|||
33164782|NCT00395304|100515104|FG005|Treatment Period 1|Withdrawal by Subject|1|||
33164783|NCT00395304|100515099|FG000|Treatment Period 1|Lost to Follow-up|1|||
33164784|NCT00395304|100515100|FG001|Treatment Period 1|Lost to Follow-up|0|||
33164785|NCT00395304|100515101|FG002|Treatment Period 1|Lost to Follow-up|0|||
33164786|NCT00395304|100515102|FG003|Treatment Period 1|Lost to Follow-up|1|||
33164787|NCT00395304|100515103|FG004|Treatment Period 1|Lost to Follow-up|0|||
33164788|NCT00395304|100515104|FG005|Treatment Period 1|Lost to Follow-up|1|||
33164789|NCT00395304|100515099|FG000|Treatment Period 1|Physician Decision|0|||
33164790|NCT00395304|100515100|FG001|Treatment Period 1|Physician Decision|1|||
33164791|NCT00395304|100515101|FG002|Treatment Period 1|Physician Decision|0|||
33164792|NCT00395304|100515102|FG003|Treatment Period 1|Physician Decision|0|||
33164793|NCT00395304|100515103|FG004|Treatment Period 1|Physician Decision|0|||
33164794|NCT00395304|100515104|FG005|Treatment Period 1|Physician Decision|0|||
33164795|NCT00395304|100515099|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33164796|NCT00395304|100515100|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33164797|NCT00395304|100515101|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33164798|NCT00395304|100515102|FG003|Treatment Period 2|Withdrawal by Subject|1|||
33164799|NCT00395304|100515103|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33164800|NCT00395304|100515104|FG005|Treatment Period 2|Withdrawal by Subject|2|||
33164801|NCT00395304|100515099|FG000|Treatment Period 2|Lost to Follow-up|0|||
33164802|NCT00395304|100515100|FG001|Treatment Period 2|Lost to Follow-up|3|||
33164803|NCT00395304|100515101|FG002|Treatment Period 2|Lost to Follow-up|0|||
33164804|NCT00395304|100515102|FG003|Treatment Period 2|Lost to Follow-up|0|||
33164805|NCT00395304|100515103|FG004|Treatment Period 2|Lost to Follow-up|0|||
33164806|NCT00395304|100515104|FG005|Treatment Period 2|Lost to Follow-up|0|||
33258384|NCT00807937|100846070|FG000|Overall Study|Lack of Efficacy|0|||
33258385|NCT00807937|100846071|FG001|Overall Study|Lack of Efficacy|0|||
33164807|NCT00395304|100515099|FG000|Treatment Period 2|Physician Decision|0|||
33164808|NCT00395304|100515100|FG001|Treatment Period 2|Physician Decision|0|||
33164809|NCT00395304|100515101|FG002|Treatment Period 2|Physician Decision|1|||
33164810|NCT00395304|100515102|FG003|Treatment Period 2|Physician Decision|0|||
33164811|NCT00395304|100515103|FG004|Treatment Period 2|Physician Decision|0|||
33164812|NCT00395304|100515104|FG005|Treatment Period 2|Physician Decision|0|||
33258386|NCT00807937|100846072|FG002|Overall Study|Lack of Efficacy|1|||
33258387|NCT00807937|100846073|FG003|Overall Study|Lack of Efficacy|2|||
33258388|NCT00807937|100846070|FG000|Overall Study|Intake of prohibited medicine|0|||
33258389|NCT00807937|100846071|FG001|Overall Study|Intake of prohibited medicine|0|||
33258390|NCT00807937|100846072|FG002|Overall Study|Intake of prohibited medicine|2|||
33258391|NCT00807937|100846073|FG003|Overall Study|Intake of prohibited medicine|0|||
33258392|NCT00807937|100846070|FG000|Overall Study|All other reasons (not provided)|2|||
33258393|NCT00807937|100846071|FG001|Overall Study|All other reasons (not provided)|4|||
33258394|NCT00807937|100846072|FG002|Overall Study|All other reasons (not provided)|0|||
33258395|NCT00807937|100846073|FG003|Overall Study|All other reasons (not provided)|1|||
33258396|NCT01444417|100846075|FG000|Overall Study|Ineligibility Determined|0|||
33258397|NCT01444417|100846076|FG001|Overall Study|Ineligibility Determined|1|||
33258398|NCT01444417|100846075|FG000|Overall Study|Withdrawal by Subject|2|||
33258399|NCT01444417|100846076|FG001|Overall Study|Withdrawal by Subject|0|||
33258400|NCT01736215|100846077|FG000|Overall Study|Early termination of erythropoietin use|1|||
33445108|NCT01854047|101522594|FG002|Overall Study|Randomized but not treated|2|||
33445109|NCT01854047|101522595|FG003|Overall Study|Randomized but not treated|0|||
33445110|NCT01854047|101522596|FG004|Overall Study|Randomized but not treated|4|||
33445111|NCT01854047|101522592|FG000|Overall Study|Other than specified above|3|||
33445112|NCT01854047|101522593|FG001|Overall Study|Other than specified above|3|||
33445113|NCT01854047|101522594|FG002|Overall Study|Other than specified above|3|||
33445114|NCT01854047|101522595|FG003|Overall Study|Other than specified above|5|||
33445115|NCT01854047|101522596|FG004|Overall Study|Other than specified above|8|||
33445116|NCT01171989|101522597|FG000|Overall Study|Lost to Follow-up|0|||
33445117|NCT01171989|101522598|FG001|Overall Study|Lost to Follow-up|0|||
33445118|NCT01171989|101522599|FG002|Overall Study|Lost to Follow-up|1|||
33445119|NCT00910663|101522600|FG000|Period 1|Withdrawal by Subject|0|||
33445120|NCT00910663|101522601|FG001|Period 1|Withdrawal by Subject|1|||
33445121|NCT02139826|101522602|FG000|Overall Study|Adverse Event|1|||
33445122|NCT01214850|101522612|FG000|Overall Study|Withdrawal by Subject|38|||
33445123|NCT01214850|101522613|FG001|Overall Study|Withdrawal by Subject|31|||
33445124|NCT01214850|101522614|FG002|Overall Study|Withdrawal by Subject|28|||
33445125|NCT01214850|101522612|FG000|Overall Study|Lost to Follow-up|124|||
33445126|NCT01214850|101522613|FG001|Overall Study|Lost to Follow-up|98|||
33445127|NCT01214850|101522614|FG002|Overall Study|Lost to Follow-up|123|||
33445128|NCT01214850|101522612|FG000|Overall Study|Protocol Violation|5|||
33445129|NCT01214850|101522613|FG001|Overall Study|Protocol Violation|5|||
33258401|NCT01736215|100846077|FG000|Overall Study|Adverse Event|4|||
33445130|NCT01214850|101522614|FG002|Overall Study|Protocol Violation|6|||
33445131|NCT01214850|101522612|FG000|Overall Study|Adverse event or death|11|||
33445132|NCT01214850|101522613|FG001|Overall Study|Adverse event or death|8|||
33164813|NCT00395304|100515099|FG000|Treatment Period 2|Other|0|||
33164814|NCT00395304|100515100|FG001|Treatment Period 2|Other|1|||
33164815|NCT00395304|100515101|FG002|Treatment Period 2|Other|0|||
33164816|NCT00395304|100515102|FG003|Treatment Period 2|Other|0|||
33164817|NCT00395304|100515103|FG004|Treatment Period 2|Other|0|||
33164818|NCT00395304|100515104|FG005|Treatment Period 2|Other|0|||
33164819|NCT00395304|100515099|FG000|Treatment Period 3|Withdrawal by Subject|0|||
33164820|NCT00395304|100515100|FG001|Treatment Period 3|Withdrawal by Subject|0|||
33164821|NCT00395304|100515101|FG002|Treatment Period 3|Withdrawal by Subject|0|||
33164822|NCT00395304|100515102|FG003|Treatment Period 3|Withdrawal by Subject|1|||
33164823|NCT00395304|100515103|FG004|Treatment Period 3|Withdrawal by Subject|0|||
33164824|NCT00395304|100515104|FG005|Treatment Period 3|Withdrawal by Subject|1|||
33164825|NCT00395304|100515099|FG000|Treatment Period 3|Lost to Follow-up|1|||
33164826|NCT00395304|100515100|FG001|Treatment Period 3|Lost to Follow-up|1|||
33164827|NCT00395304|100515101|FG002|Treatment Period 3|Lost to Follow-up|0|||
33164828|NCT00395304|100515102|FG003|Treatment Period 3|Lost to Follow-up|0|||
33164829|NCT00395304|100515103|FG004|Treatment Period 3|Lost to Follow-up|0|||
33164830|NCT00395304|100515104|FG005|Treatment Period 3|Lost to Follow-up|0|||
33164831|NCT00395304|100515099|FG000|Treatment Period 3|Physician Decision|0|||
33164832|NCT00395304|100515100|FG001|Treatment Period 3|Physician Decision|1|||
33164833|NCT00395304|100515101|FG002|Treatment Period 3|Physician Decision|0|||
33164834|NCT00395304|100515102|FG003|Treatment Period 3|Physician Decision|0|||
33164835|NCT00395304|100515103|FG004|Treatment Period 3|Physician Decision|0|||
33164836|NCT00395304|100515104|FG005|Treatment Period 3|Physician Decision|0|||
33164837|NCT00395304|100515099|FG000|Treatment Period 3|Other|0|||
33164838|NCT00395304|100515100|FG001|Treatment Period 3|Other|0|||
33164839|NCT00395304|100515101|FG002|Treatment Period 3|Other|0|||
33164840|NCT00395304|100515102|FG003|Treatment Period 3|Other|1|||
33164841|NCT00395304|100515103|FG004|Treatment Period 3|Other|0|||
33164842|NCT00395304|100515104|FG005|Treatment Period 3|Other|0|||
33164843|NCT03486223|100515107|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
33164844|NCT03486223|100515108|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
33164845|NCT00687323|100515109|FG000|Overall Study|Death|25|||
33164846|NCT00687323|100515109|FG000|Overall Study|Withdrawal by Subject|1|||
33164847|NCT00687323|100515109|FG000|Overall Study|Excluded from efficacy evaluations|6|||
33164848|NCT00687323|100515109|FG000|Overall Study|Screen failure|148|||
33164849|NCT01782222|100515112|FG000|Overall Study|Adverse Event|4|||
33164850|NCT01782222|100515113|FG001|Overall Study|Adverse Event|5|||
33164851|NCT01782222|100515114|FG002|Overall Study|Adverse Event|3|||
33164852|NCT01782222|100515112|FG000|Overall Study|Lack of Efficacy|2|||
33164853|NCT01782222|100515113|FG001|Overall Study|Lack of Efficacy|1|||
33164854|NCT01782222|100515114|FG002|Overall Study|Lack of Efficacy|0|||
33164855|NCT01782222|100515112|FG000|Overall Study|Protocol Violation|1|||
33164856|NCT01782222|100515113|FG001|Overall Study|Protocol Violation|0|||
33164857|NCT01782222|100515114|FG002|Overall Study|Protocol Violation|0|||
33164858|NCT01782222|100515112|FG000|Overall Study|Withdrawal by Subject|1|||
33164859|NCT01782222|100515113|FG001|Overall Study|Withdrawal by Subject|4|||
33164860|NCT01782222|100515114|FG002|Overall Study|Withdrawal by Subject|1|||
33164861|NCT01782222|100515112|FG000|Overall Study|Moved to other state|0|||
33164862|NCT01782222|100515113|FG001|Overall Study|Moved to other state|1|||
33164863|NCT01782222|100515114|FG002|Overall Study|Moved to other state|0|||
33164864|NCT03310775|100515115|FG000|Overall Study|Lost to Follow-up|2|||
33164865|NCT03310775|100515116|FG001|Overall Study|Lost to Follow-up|3|||
33164866|NCT03310775|100515115|FG000|Overall Study|aggravation of depression|0|||
33164867|NCT03310775|100515116|FG001|Overall Study|aggravation of depression|1|||
33164868|NCT02321800|100515127|FG000|Overall Study|Withdrawal by Subject|3|||
33164869|NCT02321800|100515128|FG001|Overall Study|Withdrawal by Subject|3|||
33164870|NCT02321800|100515127|FG000|Overall Study|Death|1|||
33164871|NCT02321800|100515128|FG001|Overall Study|Death|0|||
33164872|NCT02321800|100515127|FG000|Overall Study|Protocol Violation|1|||
33164873|NCT02321800|100515128|FG001|Overall Study|Protocol Violation|0|||
33164874|NCT02321800|100515127|FG000|Overall Study|Lost to Follow-up|10|||
33164875|NCT02321800|100515128|FG001|Overall Study|Lost to Follow-up|4|||
33164876|NCT02321800|100515127|FG000|Overall Study|Adverse Event|2|||
33164877|NCT02321800|100515128|FG001|Overall Study|Adverse Event|3|||
33258402|NCT01736215|100846077|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
33164878|NCT02321800|100515127|FG000|Overall Study|Other, Miscellaneous|3|||
33164879|NCT02321800|100515128|FG001|Overall Study|Other, Miscellaneous|1|||
33258403|NCT01736215|100846077|FG000|Overall Study|Insufficient data to perform analysis|8|||
33258404|NCT03451721|100846080|FG000|Overall Study|Death|1|||
33164880|NCT04404361|100515129|FG000|Overall Study|Death|12|||
33164881|NCT04404361|100515130|FG001|Overall Study|Death|12|||
33164882|NCT04404361|100515129|FG000|Overall Study|Withdrawal by Subject|13|||
33164883|NCT04404361|100515130|FG001|Overall Study|Withdrawal by Subject|5|||
33164884|NCT04404361|100515129|FG000|Overall Study|Lost to Follow-up|6|||
33164885|NCT04404361|100515130|FG001|Overall Study|Lost to Follow-up|3|||
33164886|NCT04404361|100515129|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
33164887|NCT04404361|100515130|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
33164888|NCT04659161|100515131|FG000|Overall Study|Adverse Event|10|||
33164889|NCT04659161|100515132|FG001|Overall Study|Adverse Event|6|||
33164890|NCT04659161|100515131|FG000|Overall Study|Withdrawal by Subject|13|||
33164891|NCT04659161|100515132|FG001|Overall Study|Withdrawal by Subject|12|||
33164892|NCT04659161|100515131|FG000|Overall Study|Other|9|||
33164893|NCT04659161|100515132|FG001|Overall Study|Other|8|||
33164894|NCT05074667|100515133|FG000|Overall Study|Death|1|||
33164895|NCT05074667|100515133|FG000|Overall Study|Withdrawal by Subject|4|||
33164896|NCT05074667|100515133|FG000|Overall Study|Lost to Follow-up|10|||
33164897|NCT02591290|100515134|FG000|Overall Study|Withdrawal by Subject|2|||
33164898|NCT04661839|100515135|FG000|Overall Study|Not Treated|0|||
33164899|NCT04661839|100515136|FG001|Overall Study|Not Treated|0|||
33164900|NCT04661839|100515137|FG002|Overall Study|Not Treated|1|||
33164901|NCT04661839|100515138|FG003|Overall Study|Not Treated|0|||
33164902|NCT04661839|100515135|FG000|Overall Study|Lost to Follow-up|1|||
33164903|NCT04661839|100515136|FG001|Overall Study|Lost to Follow-up|0|||
33164904|NCT04661839|100515137|FG002|Overall Study|Lost to Follow-up|0|||
33164905|NCT04661839|100515138|FG003|Overall Study|Lost to Follow-up|1|||
33164906|NCT02195583|100515139|FG000|Overall Study|Lost to Follow-up|1|||
33164907|NCT02195583|100515139|FG000|Overall Study|Withdrawal by Subject|4|||
33164908|NCT02195583|100515139|FG000|Overall Study|Adverse Event|2|||
33164909|NCT02195583|100515139|FG000|Overall Study|Other Reason|2|||
33164910|NCT00458211|100515143|FG000|Overall Study|Lack of Efficacy|12|||
33164911|NCT00458211|100515143|FG000|Overall Study|Withdrawal by Subject|2|||
33164912|NCT00458211|100515143|FG000|Overall Study|Protocol Violation|2|||
33164913|NCT00297830|100515147|FG000|6 Month Visit|Death|1|||
33164914|NCT00297830|100515148|FG001|6 Month Visit|Death|0|||
33164915|NCT00297830|100515149|FG002|6 Month Visit|Death|2|||
33258405|NCT03447249|100846085|FG000|Overall Study|Adverse Event|1|||
33164916|NCT00297830|100515147|FG000|6 Month Visit|Withdrawal by Subject|2|||
33164917|NCT00297830|100515148|FG001|6 Month Visit|Withdrawal by Subject|1|||
33164918|NCT00297830|100515149|FG002|6 Month Visit|Withdrawal by Subject|1|||
33164919|NCT00297830|100515147|FG000|6 Month Visit|Adverse Event|0|||
33164920|NCT00297830|100515148|FG001|6 Month Visit|Adverse Event|1|||
33164921|NCT00297830|100515149|FG002|6 Month Visit|Adverse Event|0|||
33164922|NCT00297830|100515147|FG000|12 Month Visit|Lost to Follow-up|1|||
33164923|NCT00297830|100515148|FG001|12 Month Visit|Lost to Follow-up|0|||
33164924|NCT00297830|100515149|FG002|12 Month Visit|Lost to Follow-up|0|||
33164925|NCT00297830|100515147|FG000|12 Month Visit|Adverse Event|0|||
33164926|NCT00297830|100515148|FG001|12 Month Visit|Adverse Event|3|||
33445133|NCT01214850|101522614|FG002|Overall Study|Adverse event or death|3|||
33445134|NCT01214850|101522612|FG000|Overall Study|Inappropriate enrollment|2|||
33445135|NCT01214850|101522613|FG001|Overall Study|Inappropriate enrollment|1|||
33445136|NCT01214850|101522614|FG002|Overall Study|Inappropriate enrollment|0|||
33445137|NCT01214850|101522612|FG000|Overall Study|Administrative reason|1|||
33445138|NCT01214850|101522613|FG001|Overall Study|Administrative reason|0|||
33445139|NCT01214850|101522614|FG002|Overall Study|Administrative reason|0|||
33445140|NCT01214850|101522612|FG000|Overall Study|Unable to classify|2|||
33445141|NCT01214850|101522613|FG001|Overall Study|Unable to classify|1|||
33445142|NCT01214850|101522614|FG002|Overall Study|Unable to classify|1|||
33445143|NCT03503318|101522615|FG000|Overall Study|Death|1|||
33445144|NCT03503318|101522616|FG001|Overall Study|Death|0|||
33445145|NCT03503318|101522617|FG002|Overall Study|Death|4|||
33445146|NCT03503318|101522615|FG000|Overall Study|Adverse Event|3|||
33445147|NCT03503318|101522616|FG001|Overall Study|Adverse Event|4|||
33445148|NCT03503318|101522617|FG002|Overall Study|Adverse Event|2|||
33445149|NCT03503318|101522615|FG000|Overall Study|Withdrawal by Subject|12|||
33445150|NCT03503318|101522616|FG001|Overall Study|Withdrawal by Subject|17|||
33164927|NCT00297830|100515149|FG002|12 Month Visit|Adverse Event|0|||
33164928|NCT00297830|100515147|FG000|12 Month Visit|Withdrawal by Subject|0|||
33164929|NCT00297830|100515148|FG001|12 Month Visit|Withdrawal by Subject|3|||
33164930|NCT00297830|100515149|FG002|12 Month Visit|Withdrawal by Subject|0|||
33164931|NCT01896102|100515150|FG000|Overall Study|Death|1|||
33445151|NCT03503318|101522617|FG002|Overall Study|Withdrawal by Subject|16|||
33445152|NCT03503318|101522615|FG000|Overall Study|Protocol Violation|5|||
33445153|NCT03503318|101522616|FG001|Overall Study|Protocol Violation|0|||
33445154|NCT03503318|101522617|FG002|Overall Study|Protocol Violation|3|||
33445155|NCT03503318|101522615|FG000|Overall Study|Lost to Follow-up|17|||
33258406|NCT03447249|100846086|FG001|Overall Study|Adverse Event|0|||
33445156|NCT03503318|101522616|FG001|Overall Study|Lost to Follow-up|15|||
33445157|NCT03503318|101522617|FG002|Overall Study|Lost to Follow-up|12|||
33445158|NCT03503318|101522615|FG000|Overall Study|Other than specified|1|||
33445159|NCT03503318|101522616|FG001|Overall Study|Other than specified|3|||
33164932|NCT01896102|100515150|FG000|Overall Study|Participant to receive allogenic transplant|2|||
33164933|NCT01537393|100515151|FG000|Overall Study|Exclude prior to study|32|||
33164934|NCT01537393|100515152|FG001|Overall Study|Exclude prior to study|44|||
33164935|NCT01537393|100515151|FG000|Overall Study|Death|20|||
33164936|NCT01537393|100515152|FG001|Overall Study|Death|32|||
33164937|NCT01537393|100515151|FG000|Overall Study|Withdrawal by Subject|18|||
33164938|NCT01537393|100515152|FG001|Overall Study|Withdrawal by Subject|17|||
33164939|NCT01537393|100515151|FG000|Overall Study|Lost to Follow-up|53|||
33164940|NCT01537393|100515152|FG001|Overall Study|Lost to Follow-up|48|||
33164941|NCT01537393|100515151|FG000|Overall Study|Failure - Regrafted|28|||
33164942|NCT01537393|100515152|FG001|Overall Study|Failure - Regrafted|43|||
33164943|NCT01537393|100515151|FG000|Overall Study|Failure - Not regrafted|2|||
33164944|NCT01537393|100515152|FG001|Overall Study|Failure - Not regrafted|6|||
33164945|NCT01537393|100515151|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
33164946|NCT01537393|100515152|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
33164947|NCT03130257|100515157|FG000|Overall Study|Withdrawal by Subject|1|||
33164948|NCT03130257|100515158|FG001|Overall Study|Withdrawal by Subject|0|||
33445160|NCT03503318|101522617|FG002|Overall Study|Other than specified|3|||
33445161|NCT02659150|101522628|FG000|Subject Enrollment|Physician Decision|3|||
33445162|NCT02659150|101522628|FG000|Subject Enrollment|Withdrawal by Subject|2|||
33164949|NCT03130257|100515159|FG002|Overall Study|Withdrawal by Subject|2|||
33164950|NCT01516437|100515160|FG000|Overall Study|Reason not specified|0|||
33258407|NCT03447249|100846085|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
33164951|NCT01516437|100515161|FG001|Overall Study|Reason not specified|0|||
33164952|NCT01516437|100515162|FG002|Overall Study|Reason not specified|1|||
33164953|NCT01516437|100515163|FG003|Overall Study|Reason not specified|1|||
33164954|NCT03470441|100515164|FG000|Overall Study|Death|0|||
33258408|NCT03447249|100846086|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
33164955|NCT03470441|100515165|FG001|Overall Study|Death|1|||
33258409|NCT03447249|100846085|FG000|Overall Study|Other|3|||
33258410|NCT03447249|100846086|FG001|Overall Study|Other|0|||
33258411|NCT01943916|100846087|FG000|Overall Study|Technically invalid images|10|||
33258412|NCT01943916|100846087|FG000|Overall Study|Enrollment Failure|23|||
33164956|NCT03470441|100515166|FG002|Overall Study|Death|1|||
33164957|NCT03470441|100515167|FG003|Overall Study|Death|0|||
33164958|NCT03470441|100515164|FG000|Overall Study|Adverse Event|0|||
33164959|NCT03470441|100515165|FG001|Overall Study|Adverse Event|0|||
33164960|NCT03470441|100515166|FG002|Overall Study|Adverse Event|0|||
33164961|NCT03470441|100515167|FG003|Overall Study|Adverse Event|1|||
33164962|NCT03470441|100515164|FG000|Overall Study|Withdrawal by Subject|1|||
33164963|NCT03470441|100515165|FG001|Overall Study|Withdrawal by Subject|4|||
33164964|NCT03470441|100515166|FG002|Overall Study|Withdrawal by Subject|1|||
33164965|NCT03470441|100515167|FG003|Overall Study|Withdrawal by Subject|3|||
33164966|NCT01737697|100515168|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33164967|NCT01737697|100515169|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
33164968|NCT01737697|100515170|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33164969|NCT01737697|100515171|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
33164970|NCT01737697|100515172|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
33164971|NCT01737697|100515173|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33164972|NCT01737697|100515174|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33164973|NCT01737697|100515175|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33164974|NCT01737697|100515176|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33164975|NCT01737697|100515177|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33164976|NCT01737697|100515178|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33164977|NCT01737697|100515179|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33164978|NCT01737697|100515180|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33164979|NCT01737697|100515181|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33164980|NCT01737697|100515182|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
33164981|NCT01737697|100515168|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
33164982|NCT01737697|100515169|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
33164983|NCT01737697|100515170|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
33164984|NCT01737697|100515171|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33164985|NCT01737697|100515172|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33164986|NCT01737697|100515173|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33164987|NCT01737697|100515174|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33164988|NCT01737697|100515175|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33164989|NCT01737697|100515176|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33164990|NCT01737697|100515177|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33164991|NCT01737697|100515178|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33164992|NCT01737697|100515179|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33164993|NCT01737697|100515180|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33164994|NCT01737697|100515181|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33164995|NCT01737697|100515182|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
33164996|NCT01737697|100515168|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
33164997|NCT01737697|100515169|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
33164998|NCT01737697|100515170|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
33164999|NCT01737697|100515171|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
33165000|NCT01737697|100515172|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
33445163|NCT02659150|101522628|FG000|Baseline Imaging|Withdrawal by Subject|1|||
33445164|NCT02659150|101522628|FG000|Baseline Imaging|Physician Decision|1|||
33445165|NCT02659150|101522628|FG000|Study Drug Dosing|Adverse Event|1|||
33445166|NCT00268905|101522629|FG000|Overall Study|Adverse Event|3|||
33445167|NCT00268905|101522630|FG001|Overall Study|Adverse Event|0|||
33445168|NCT00268905|101522631|FG002|Overall Study|Adverse Event|4|||
33445169|NCT00268905|101522629|FG000|Overall Study|Lost to Follow-up|0|||
33445170|NCT00268905|101522630|FG001|Overall Study|Lost to Follow-up|1|||
33445171|NCT00268905|101522631|FG002|Overall Study|Lost to Follow-up|0|||
33445172|NCT00268905|101522629|FG000|Overall Study|Withdrawal by Subject|0|||
33445173|NCT00268905|101522630|FG001|Overall Study|Withdrawal by Subject|0|||
33445174|NCT00268905|101522631|FG002|Overall Study|Withdrawal by Subject|3|||
33445175|NCT00268905|101522629|FG000|Overall Study|Progressive Disease|28|||
33445176|NCT00268905|101522630|FG001|Overall Study|Progressive Disease|4|||
33445177|NCT00268905|101522631|FG002|Overall Study|Progressive Disease|3|||
33445178|NCT00268905|101522629|FG000|Overall Study|Physician Decision|3|||
33445179|NCT00268905|101522630|FG001|Overall Study|Physician Decision|0|||
33165001|NCT01737697|100515173|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
33165002|NCT01737697|100515174|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
33165003|NCT01737697|100515175|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
33165004|NCT01737697|100515176|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
33165005|NCT01737697|100515177|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
33165006|NCT01737697|100515178|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
33165007|NCT01737697|100515179|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
33445180|NCT00268905|101522631|FG002|Overall Study|Physician Decision|1|||
33445181|NCT00268905|101522629|FG000|Overall Study|Clinical Progression|9|||
33445182|NCT00268905|101522630|FG001|Overall Study|Clinical Progression|4|||
33445183|NCT00268905|101522631|FG002|Overall Study|Clinical Progression|1|||
33445184|NCT00519194|101522633|FG000|Overall Study|Withdrawal by Subject|9|||
33445185|NCT00519194|101522633|FG000|Overall Study|Death|9|||
33445186|NCT00519194|101522633|FG000|Overall Study|Lost to Follow-up|3|||
33445187|NCT02682238|101522634|FG000|Overall Study|Lost to Follow-up|0|||
33445188|NCT02682238|101522635|FG001|Overall Study|Lost to Follow-up|2|||
33445189|NCT02682238|101522634|FG000|Overall Study|Withdrawal by Subject|1|||
33445190|NCT02682238|101522635|FG001|Overall Study|Withdrawal by Subject|0|||
33445191|NCT02682238|101522634|FG000|Overall Study|Adverse Event|1|||
33445192|NCT02682238|101522635|FG001|Overall Study|Adverse Event|0|||
33445193|NCT02682238|101522634|FG000|Overall Study|Non-compliance with Study Drug|1|||
33445194|NCT02682238|101522635|FG001|Overall Study|Non-compliance with Study Drug|0|||
33445195|NCT02682238|101522634|FG000|Overall Study|Non-compliance with Protocol|0|||
33445196|NCT02682238|101522635|FG001|Overall Study|Non-compliance with Protocol|2|||
33445197|NCT03804983|101522638|FG000|Overall Study|Adverse Event|0|||
33445198|NCT03804983|101522639|FG001|Overall Study|Adverse Event|1|||
33445199|NCT03804983|101522638|FG000|Overall Study|Family Obligation|1|||
33445200|NCT03804983|101522639|FG001|Overall Study|Family Obligation|0|||
33445201|NCT00609674|101522640|FG000|Overall Study|Adverse Event|1|||
33445202|NCT00609674|101522641|FG001|Overall Study|Adverse Event|1|||
33445203|NCT00609674|101522640|FG000|Overall Study|Protocol Violation|3|||
33445204|NCT00609674|101522641|FG001|Overall Study|Protocol Violation|5|||
33445205|NCT00609674|101522640|FG000|Overall Study|Lost to Follow-up|1|||
33445206|NCT00609674|101522641|FG001|Overall Study|Lost to Follow-up|0|||
33445207|NCT00609674|101522640|FG000|Overall Study|Withdrew consent|2|||
33445208|NCT00609674|101522641|FG001|Overall Study|Withdrew consent|1|||
33165008|NCT01737697|100515180|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
33165009|NCT01737697|100515181|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
33165010|NCT01737697|100515182|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
33165011|NCT01737697|100515168|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33165012|NCT01737697|100515169|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
33165013|NCT01737697|100515170|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33165014|NCT01737697|100515171|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33165015|NCT01737697|100515172|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33165016|NCT01737697|100515173|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33165017|NCT01737697|100515174|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33165018|NCT01737697|100515175|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33165019|NCT01737697|100515176|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33445209|NCT02412852|101522644|FG000|Overall Study|Withdrawal by Subject|0|||
33445210|NCT02412852|101522645|FG001|Overall Study|Withdrawal by Subject|1|||
33445211|NCT02412852|101522646|FG002|Overall Study|Withdrawal by Subject|0|||
33445212|NCT02412852|101522647|FG003|Overall Study|Withdrawal by Subject|0|||
33165020|NCT01737697|100515177|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33445213|NCT02412852|101522644|FG000|Overall Study|Physician Decision|0|||
33445214|NCT02412852|101522645|FG001|Overall Study|Physician Decision|0|||
33445215|NCT02412852|101522646|FG002|Overall Study|Physician Decision|0|||
33445216|NCT02412852|101522647|FG003|Overall Study|Physician Decision|1|||
33445217|NCT01844375|101522650|FG000|Overall Study|Protocol Violation|1|||
33445218|NCT01844375|101522651|FG001|Overall Study|Protocol Violation|1|||
33445219|NCT00610363|101522653|FG000|Overall Study|Non-compliance with protocol|0|||
33445220|NCT00610363|101522654|FG001|Overall Study|Non-compliance with protocol|1|||
33445221|NCT00610363|101522653|FG000|Overall Study|Adverse Event|3|||
33445222|NCT00610363|101522654|FG001|Overall Study|Adverse Event|1|||
33445223|NCT00610363|101522653|FG000|Overall Study|Lack of Efficacy|2|||
33445224|NCT00610363|101522654|FG001|Overall Study|Lack of Efficacy|0|||
33445225|NCT00610363|101522653|FG000|Overall Study|Lost to Follow-up|4|||
33445226|NCT00610363|101522654|FG001|Overall Study|Lost to Follow-up|0|||
33445227|NCT00610363|101522653|FG000|Overall Study|Withdrawal by Subject|1|||
33445228|NCT00610363|101522654|FG001|Overall Study|Withdrawal by Subject|0|||
33445229|NCT00610363|101522653|FG000|Overall Study|Other than specified above|1|||
33445230|NCT00610363|101522654|FG001|Overall Study|Other than specified above|1|||
33445231|NCT03236311|101522655|FG000|Overall Study|Study terminated by sponsor|0|||
33445232|NCT03236311|101522656|FG001|Overall Study|Study terminated by sponsor|2|||
33445233|NCT03236311|101522655|FG000|Overall Study|Adverse Event|0|||
33445234|NCT03236311|101522656|FG001|Overall Study|Adverse Event|1|||
33445235|NCT01597245|101522659|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
33445236|NCT01597245|101522660|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
33445237|NCT01597245|101522661|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
33445238|NCT01597245|101522662|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
33445239|NCT01597245|101522663|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445240|NCT01597245|101522664|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445241|NCT01597245|101522665|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445242|NCT01597245|101522666|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445243|NCT01597245|101522667|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445244|NCT01597245|101522668|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445245|NCT01597245|101522669|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445246|NCT01597245|101522670|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445247|NCT01597245|101522671|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445248|NCT01597245|101522672|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445249|NCT01597245|101522673|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445250|NCT01597245|101522674|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445251|NCT01597245|101522675|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445252|NCT01597245|101522676|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445253|NCT01597245|101522677|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445254|NCT01597245|101522678|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445255|NCT01597245|101522679|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
33445256|NCT01597245|101522659|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
33445257|NCT01597245|101522660|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
33445258|NCT01597245|101522661|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
33445259|NCT01597245|101522662|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
33445260|NCT01597245|101522663|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445261|NCT01597245|101522664|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445262|NCT01597245|101522665|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445263|NCT01597245|101522666|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445264|NCT01597245|101522667|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445265|NCT01597245|101522668|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445266|NCT01597245|101522669|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445267|NCT01597245|101522670|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445268|NCT01597245|101522671|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445269|NCT01597245|101522672|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445270|NCT01597245|101522673|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445271|NCT01597245|101522674|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445272|NCT01597245|101522675|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445273|NCT01597245|101522676|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445274|NCT01597245|101522677|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445275|NCT01597245|101522678|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445276|NCT01597245|101522679|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
33445277|NCT01597245|101522659|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
33445278|NCT01597245|101522660|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
33445279|NCT01597245|101522661|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
33445280|NCT01597245|101522662|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
33445281|NCT01597245|101522663|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445282|NCT01597245|101522664|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445283|NCT01597245|101522665|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445284|NCT01597245|101522666|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445285|NCT01597245|101522667|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445286|NCT01597245|101522668|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445287|NCT01597245|101522669|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445288|NCT01597245|101522670|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445289|NCT01597245|101522671|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445290|NCT01597245|101522672|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445291|NCT01597245|101522673|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445292|NCT01597245|101522674|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445293|NCT01597245|101522675|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445294|NCT01597245|101522676|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33165021|NCT01737697|100515178|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33165022|NCT01737697|100515179|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33165023|NCT01737697|100515180|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33165024|NCT01737697|100515181|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33165025|NCT01737697|100515182|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
33165026|NCT01737697|100515168|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33165027|NCT01737697|100515169|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33165028|NCT01737697|100515170|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33165029|NCT01737697|100515171|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33165030|NCT01737697|100515172|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
33165031|NCT01737697|100515173|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33165032|NCT01737697|100515174|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33165033|NCT01737697|100515175|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33165034|NCT01737697|100515176|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33165035|NCT01737697|100515177|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33165036|NCT01737697|100515178|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33165037|NCT01737697|100515179|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33165038|NCT01737697|100515180|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33165039|NCT01737697|100515181|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33165040|NCT01737697|100515182|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
33165041|NCT01737697|100515168|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33165042|NCT01737697|100515169|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
33165043|NCT01737697|100515170|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
33165044|NCT01737697|100515171|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
33165045|NCT01737697|100515172|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
33165046|NCT01737697|100515173|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33165047|NCT01737697|100515174|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33165048|NCT01737697|100515175|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33165049|NCT01737697|100515176|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33165050|NCT01737697|100515177|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33165051|NCT01737697|100515178|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33165052|NCT01737697|100515179|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33165053|NCT01737697|100515180|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33165054|NCT01737697|100515181|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33165055|NCT01737697|100515182|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
33165056|NCT01737697|100515168|FG000|Subacute Phase|Adverse Event|0|||
33165057|NCT01737697|100515169|FG001|Subacute Phase|Adverse Event|0|||
33165058|NCT01737697|100515170|FG002|Subacute Phase|Adverse Event|0|||
33165059|NCT01737697|100515171|FG003|Subacute Phase|Adverse Event|0|||
33165060|NCT01737697|100515172|FG004|Subacute Phase|Adverse Event|0|||
33165061|NCT01737697|100515173|FG005|Subacute Phase|Adverse Event|1|||
33445295|NCT01597245|101522677|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445296|NCT01597245|101522678|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445297|NCT01597245|101522679|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
33445298|NCT01597245|101522659|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
33445299|NCT01597245|101522660|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
33165062|NCT01737697|100515174|FG006|Subacute Phase|Adverse Event|1|||
33165063|NCT01737697|100515175|FG007|Subacute Phase|Adverse Event|1|||
33165064|NCT01737697|100515176|FG008|Subacute Phase|Adverse Event|1|||
33165065|NCT01737697|100515177|FG009|Subacute Phase|Adverse Event|1|||
33165066|NCT01737697|100515178|FG010|Subacute Phase|Adverse Event|4|||
33165067|NCT01737697|100515179|FG011|Subacute Phase|Adverse Event|1|||
33165068|NCT01737697|100515180|FG012|Subacute Phase|Adverse Event|1|||
33445300|NCT01597245|101522661|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
33165069|NCT01737697|100515181|FG013|Subacute Phase|Adverse Event|0|||
33165070|NCT01737697|100515182|FG014|Subacute Phase|Adverse Event|0|||
33445301|NCT01597245|101522662|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445302|NCT01597245|101522663|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33165071|NCT01737697|100515168|FG000|Subacute Phase|Withdrawal by Subject|0|||
33165072|NCT01737697|100515169|FG001|Subacute Phase|Withdrawal by Subject|0|||
33165073|NCT01737697|100515170|FG002|Subacute Phase|Withdrawal by Subject|0|||
33165074|NCT01737697|100515171|FG003|Subacute Phase|Withdrawal by Subject|0|||
33165075|NCT01737697|100515172|FG004|Subacute Phase|Withdrawal by Subject|0|||
33165076|NCT01737697|100515173|FG005|Subacute Phase|Withdrawal by Subject|1|||
33165077|NCT01737697|100515174|FG006|Subacute Phase|Withdrawal by Subject|0|||
33165078|NCT01737697|100515175|FG007|Subacute Phase|Withdrawal by Subject|2|||
33165079|NCT01737697|100515176|FG008|Subacute Phase|Withdrawal by Subject|0|||
33165080|NCT01737697|100515177|FG009|Subacute Phase|Withdrawal by Subject|1|||
33165081|NCT01737697|100515178|FG010|Subacute Phase|Withdrawal by Subject|0|||
33165082|NCT01737697|100515179|FG011|Subacute Phase|Withdrawal by Subject|1|||
33165083|NCT01737697|100515180|FG012|Subacute Phase|Withdrawal by Subject|1|||
33165084|NCT01737697|100515181|FG013|Subacute Phase|Withdrawal by Subject|1|||
33165085|NCT01737697|100515182|FG014|Subacute Phase|Withdrawal by Subject|0|||
33165086|NCT01737697|100515168|FG000|Subacute Phase|Lost to Follow-up|0|||
33165087|NCT01737697|100515169|FG001|Subacute Phase|Lost to Follow-up|0|||
33165088|NCT01737697|100515170|FG002|Subacute Phase|Lost to Follow-up|0|||
33165089|NCT01737697|100515171|FG003|Subacute Phase|Lost to Follow-up|0|||
33165090|NCT01737697|100515172|FG004|Subacute Phase|Lost to Follow-up|0|||
33165091|NCT01737697|100515173|FG005|Subacute Phase|Lost to Follow-up|0|||
33165092|NCT01737697|100515174|FG006|Subacute Phase|Lost to Follow-up|0|||
33165093|NCT01737697|100515175|FG007|Subacute Phase|Lost to Follow-up|0|||
33165094|NCT01737697|100515176|FG008|Subacute Phase|Lost to Follow-up|0|||
33165095|NCT01737697|100515177|FG009|Subacute Phase|Lost to Follow-up|0|||
33165096|NCT01737697|100515178|FG010|Subacute Phase|Lost to Follow-up|0|||
33165097|NCT01737697|100515179|FG011|Subacute Phase|Lost to Follow-up|0|||
33165098|NCT01737697|100515180|FG012|Subacute Phase|Lost to Follow-up|0|||
33165099|NCT01737697|100515181|FG013|Subacute Phase|Lost to Follow-up|0|||
33165100|NCT01737697|100515182|FG014|Subacute Phase|Lost to Follow-up|1|||
33165101|NCT01737697|100515168|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
33165102|NCT01737697|100515169|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
33165103|NCT01737697|100515170|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
33165104|NCT01737697|100515171|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
33165105|NCT01737697|100515172|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
33165106|NCT01737697|100515173|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
33165107|NCT01737697|100515174|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
33165108|NCT01737697|100515175|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
33165109|NCT01737697|100515176|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
33165110|NCT01737697|100515177|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
33165111|NCT01737697|100515178|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
33165112|NCT01737697|100515179|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
33165113|NCT01737697|100515180|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
33165114|NCT01737697|100515181|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
33165115|NCT01737697|100515182|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
33165116|NCT01737697|100515168|FG000|Subacute Phase|Protocol Violation|0|||
33165117|NCT01737697|100515169|FG001|Subacute Phase|Protocol Violation|0|||
33165118|NCT01737697|100515170|FG002|Subacute Phase|Protocol Violation|0|||
33165119|NCT01737697|100515171|FG003|Subacute Phase|Protocol Violation|0|||
33165120|NCT01737697|100515172|FG004|Subacute Phase|Protocol Violation|0|||
33165121|NCT01737697|100515173|FG005|Subacute Phase|Protocol Violation|1|||
33165122|NCT01737697|100515174|FG006|Subacute Phase|Protocol Violation|0|||
33165123|NCT01737697|100515175|FG007|Subacute Phase|Protocol Violation|0|||
33165124|NCT01737697|100515176|FG008|Subacute Phase|Protocol Violation|0|||
33165125|NCT01737697|100515177|FG009|Subacute Phase|Protocol Violation|0|||
33165126|NCT01737697|100515178|FG010|Subacute Phase|Protocol Violation|1|||
33165127|NCT01737697|100515179|FG011|Subacute Phase|Protocol Violation|0|||
33165128|NCT01737697|100515180|FG012|Subacute Phase|Protocol Violation|0|||
33165129|NCT01737697|100515181|FG013|Subacute Phase|Protocol Violation|0|||
33165130|NCT01737697|100515182|FG014|Subacute Phase|Protocol Violation|0|||
33165131|NCT01737697|100515168|FG000|Subacute Phase|Physician Decision|0|||
33165132|NCT01737697|100515169|FG001|Subacute Phase|Physician Decision|0|||
33165133|NCT01737697|100515170|FG002|Subacute Phase|Physician Decision|0|||
33165134|NCT01737697|100515171|FG003|Subacute Phase|Physician Decision|0|||
33165135|NCT01737697|100515172|FG004|Subacute Phase|Physician Decision|0|||
33165136|NCT01737697|100515173|FG005|Subacute Phase|Physician Decision|0|||
33165137|NCT01737697|100515174|FG006|Subacute Phase|Physician Decision|0|||
33165138|NCT01737697|100515175|FG007|Subacute Phase|Physician Decision|0|||
33165139|NCT01737697|100515176|FG008|Subacute Phase|Physician Decision|1|||
33165140|NCT01737697|100515177|FG009|Subacute Phase|Physician Decision|0|||
33165141|NCT01737697|100515178|FG010|Subacute Phase|Physician Decision|0|||
33165142|NCT01737697|100515179|FG011|Subacute Phase|Physician Decision|0|||
33165143|NCT01737697|100515180|FG012|Subacute Phase|Physician Decision|0|||
33165144|NCT01737697|100515181|FG013|Subacute Phase|Physician Decision|0|||
33165145|NCT01737697|100515182|FG014|Subacute Phase|Physician Decision|0|||
33165146|NCT01737697|100515168|FG000|Subacute Phase|Death|0|||
33165147|NCT01737697|100515169|FG001|Subacute Phase|Death|0|||
33165148|NCT01737697|100515170|FG002|Subacute Phase|Death|0|||
33165149|NCT01737697|100515171|FG003|Subacute Phase|Death|0|||
33165150|NCT01737697|100515172|FG004|Subacute Phase|Death|0|||
33165151|NCT01737697|100515173|FG005|Subacute Phase|Death|0|||
33165152|NCT01737697|100515174|FG006|Subacute Phase|Death|0|||
33165153|NCT01737697|100515175|FG007|Subacute Phase|Death|0|||
33165154|NCT01737697|100515176|FG008|Subacute Phase|Death|0|||
33165155|NCT01737697|100515177|FG009|Subacute Phase|Death|0|||
33165156|NCT01737697|100515178|FG010|Subacute Phase|Death|1|||
33258413|NCT01943916|100846087|FG000|Overall Study|Pilot Phase exclusion|100|||
33165157|NCT01737697|100515179|FG011|Subacute Phase|Death|0|||
33258414|NCT01943916|100846087|FG000|Overall Study|Quality Assurance Reader Fail|130|||
33258415|NCT01943916|100846087|FG000|Overall Study|Technical Failure|39|||
33258416|NCT01943916|100846087|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
33258417|NCT01943916|100846087|FG000|Overall Study|No Truth Panel Review|38|||
33258418|NCT01943916|100846087|FG000|Overall Study|Protocol Deviation|1|||
33258419|NCT02554786|100849468|FG000|Overall Study|Subject/guardian decision|29|||
33258420|NCT02554786|100849469|FG001|Overall Study|Subject/guardian decision|17|||
33258421|NCT02554786|100849470|FG002|Overall Study|Subject/guardian decision|18|||
33258422|NCT02554786|100849471|FG003|Overall Study|Subject/guardian decision|30|||
33258423|NCT02554786|100849472|FG004|Overall Study|Subject/guardian decision|20|||
33258424|NCT02554786|100849468|FG000|Overall Study|Lost to Follow-up|4|||
33445303|NCT01597245|101522664|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445304|NCT01597245|101522665|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445305|NCT01597245|101522666|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445306|NCT01597245|101522667|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445307|NCT01597245|101522668|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445308|NCT01597245|101522669|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445309|NCT01597245|101522670|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445310|NCT01597245|101522671|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445311|NCT01597245|101522672|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445312|NCT01597245|101522673|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445313|NCT01597245|101522674|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33258425|NCT02554786|100849469|FG001|Overall Study|Lost to Follow-up|3|||
33165158|NCT01737697|100515180|FG012|Subacute Phase|Death|0|||
33165159|NCT01737697|100515181|FG013|Subacute Phase|Death|0|||
33165160|NCT01737697|100515182|FG014|Subacute Phase|Death|0|||
33165161|NCT00289783|100515184|FG000|Primary Phase|Adverse Event|10|||
33165162|NCT00289783|100515185|FG001|Primary Phase|Adverse Event|1|||
33165163|NCT00289783|100515184|FG000|Primary Phase|Protocol Violation|27|||
33165164|NCT00289783|100515185|FG001|Primary Phase|Protocol Violation|6|||
33165165|NCT00289783|100515184|FG000|Primary Phase|Withdrawal by Subject|93|||
33258426|NCT02554786|100849470|FG002|Overall Study|Lost to Follow-up|4|||
33445314|NCT01597245|101522675|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445315|NCT01597245|101522676|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33165166|NCT00289783|100515185|FG001|Primary Phase|Withdrawal by Subject|40|||
33165167|NCT00289783|100515184|FG000|Primary Phase|Lost to Follow-up|60|||
33165168|NCT00289783|100515185|FG001|Primary Phase|Lost to Follow-up|14|||
33445316|NCT01597245|101522677|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445317|NCT01597245|101522678|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445318|NCT01597245|101522679|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
33445319|NCT01597245|101522659|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
33445320|NCT01597245|101522660|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445321|NCT01597245|101522661|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445322|NCT01597245|101522662|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
33445323|NCT01597245|101522663|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445324|NCT01597245|101522664|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445325|NCT01597245|101522665|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445326|NCT01597245|101522666|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445327|NCT01597245|101522667|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445328|NCT01597245|101522668|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445329|NCT01597245|101522669|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33165169|NCT00289783|100515184|FG000|Primary Phase|Migration from the study area|26|||
33165170|NCT00289783|100515185|FG001|Primary Phase|Migration from the study area|10|||
33165171|NCT00289783|100515184|FG000|Primary Phase|Other|32|||
33165172|NCT00289783|100515185|FG001|Primary Phase|Other|12|||
33165173|NCT00289783|100515184|FG000|Fourth Dose Phase|Adverse Event|1|||
33165174|NCT00289783|100515185|FG001|Fourth Dose Phase|Adverse Event|0|||
33165175|NCT00289783|100515184|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
33165176|NCT00289783|100515185|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
33165177|NCT00289783|100515184|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
33445330|NCT01597245|101522670|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33165178|NCT00289783|100515185|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
33445331|NCT01597245|101522671|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33258427|NCT02554786|100849471|FG003|Overall Study|Lost to Follow-up|2|||
33258428|NCT02554786|100849472|FG004|Overall Study|Lost to Follow-up|2|||
33258429|NCT02554786|100849468|FG000|Overall Study|Protocol deviation|1|||
33258430|NCT02554786|100849469|FG001|Overall Study|Protocol deviation|3|||
33258431|NCT02554786|100849470|FG002|Overall Study|Protocol deviation|3|||
33258432|NCT02554786|100849471|FG003|Overall Study|Protocol deviation|4|||
33258433|NCT02554786|100849472|FG004|Overall Study|Protocol deviation|2|||
33258434|NCT02554786|100849468|FG000|Overall Study|Technical problems|1|||
33258435|NCT02554786|100849469|FG001|Overall Study|Technical problems|1|||
33258436|NCT02554786|100849470|FG002|Overall Study|Technical problems|0|||
33258437|NCT02554786|100849471|FG003|Overall Study|Technical problems|2|||
33258438|NCT02554786|100849472|FG004|Overall Study|Technical problems|1|||
33258439|NCT02554786|100849468|FG000|Overall Study|Adverse Event|0|||
33258440|NCT02554786|100849469|FG001|Overall Study|Adverse Event|0|||
33258441|NCT02554786|100849470|FG002|Overall Study|Adverse Event|0|||
33258442|NCT02554786|100849471|FG003|Overall Study|Adverse Event|0|||
33258443|NCT02554786|100849472|FG004|Overall Study|Adverse Event|2|||
33258444|NCT02554786|100849468|FG000|Overall Study|Death|0|||
33258445|NCT02554786|100849469|FG001|Overall Study|Death|0|||
33258446|NCT02554786|100849470|FG002|Overall Study|Death|0|||
33258447|NCT02554786|100849471|FG003|Overall Study|Death|1|||
33258448|NCT02554786|100849472|FG004|Overall Study|Death|0|||
33258449|NCT02554786|100849468|FG000|Overall Study|Non-compliance with study treatment|0|||
33258450|NCT02554786|100849469|FG001|Overall Study|Non-compliance with study treatment|1|||
33258451|NCT02554786|100849470|FG002|Overall Study|Non-compliance with study treatment|1|||
33258452|NCT02554786|100849471|FG003|Overall Study|Non-compliance with study treatment|0|||
33258453|NCT02554786|100849472|FG004|Overall Study|Non-compliance with study treatment|1|||
33258454|NCT02554786|100849468|FG000|Overall Study|Physician Decision|0|||
33258455|NCT02554786|100849469|FG001|Overall Study|Physician Decision|1|||
33258456|NCT02554786|100849470|FG002|Overall Study|Physician Decision|4|||
33258457|NCT02554786|100849471|FG003|Overall Study|Physician Decision|1|||
33258458|NCT02554786|100849472|FG004|Overall Study|Physician Decision|1|||
33258459|NCT02554786|100849468|FG000|Overall Study|Pregnancy|0|||
33258460|NCT02554786|100849469|FG001|Overall Study|Pregnancy|0|||
33258461|NCT02554786|100849470|FG002|Overall Study|Pregnancy|0|||
33258462|NCT02554786|100849471|FG003|Overall Study|Pregnancy|1|||
33258463|NCT02554786|100849472|FG004|Overall Study|Pregnancy|1|||
33258464|NCT01007396|100849473|FG000|Overall Study|Lost to Follow-up|47|||
33258465|NCT00812461|100849480|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
33258466|NCT00812461|100849481|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
33258467|NCT00812461|100849480|FG000|All Treated Patients|Adverse Event|8|||
33258468|NCT00812461|100849481|FG001|All Treated Patients|Adverse Event|15|||
33258469|NCT00812461|100849480|FG000|All Treated Patients|Lack of Efficacy|13|||
33258470|NCT00812461|100849481|FG001|All Treated Patients|Lack of Efficacy|7|||
33258471|NCT00812461|100849480|FG000|All Treated Patients|Non-compliance|6|||
33258472|NCT00812461|100849481|FG001|All Treated Patients|Non-compliance|9|||
33258473|NCT00812461|100849480|FG000|All Treated Patients|Protocol Violation|36|||
33258474|NCT00812461|100849481|FG001|All Treated Patients|Protocol Violation|27|||
33258475|NCT00812461|100849480|FG000|All Treated Patients|Withdrawal by Subject|45|||
33258476|NCT00812461|100849481|FG001|All Treated Patients|Withdrawal by Subject|54|||
33258477|NCT00812461|100849480|FG000|All Treated Patients|Lost to Follow-up|11|||
33258478|NCT00812461|100849481|FG001|All Treated Patients|Lost to Follow-up|14|||
33258479|NCT00812461|100849480|FG000|All Treated Patients|Other Reason|13|||
33258480|NCT00812461|100849481|FG001|All Treated Patients|Other Reason|21|||
33258481|NCT03292913|100849482|FG000|Overall Study|Death|9|||
33258482|NCT03292913|100849483|FG001|Overall Study|Death|3|||
33258483|NCT03292913|100849482|FG000|Overall Study|Lost to Follow-up|49|||
33258484|NCT03292913|100849483|FG001|Overall Study|Lost to Follow-up|49|||
33258485|NCT03292913|100849482|FG000|Overall Study|Withdrawal by Subject|2|||
33258486|NCT03292913|100849483|FG001|Overall Study|Withdrawal by Subject|0|||
33258487|NCT03292913|100849482|FG000|Overall Study|Clinic closed due to COVID|22|||
33258488|NCT03292913|100849483|FG001|Overall Study|Clinic closed due to COVID|36|||
33258489|NCT03481816|100849486|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
33445332|NCT01597245|101522672|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445333|NCT01597245|101522673|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33165179|NCT00289783|100515184|FG000|Fourth Dose Phase|Migration from the study area|1|||
33165180|NCT00289783|100515185|FG001|Fourth Dose Phase|Migration from the study area|1|||
33165181|NCT00289783|100515184|FG000|Fourth Dose Phase|Other|22|||
33165182|NCT00289783|100515185|FG001|Fourth Dose Phase|Other|10|||
33165183|NCT00851747|100515186|FG000|Overall Study|Physician Decision|6|||
33165184|NCT00851747|100515187|FG001|Overall Study|Physician Decision|6|||
33165185|NCT00851747|100515188|FG002|Overall Study|Physician Decision|6|||
33165186|NCT02094677|100515189|FG000|Overall Study|Screening|3|||
33165187|NCT02094677|100515190|FG001|Overall Study|Screening|1|||
33165188|NCT02871297|100515191|FG000|Overall Study|Adverse Event|34|||
33165189|NCT02871297|100515191|FG000|Overall Study|Lack of Efficacy|10|||
33165190|NCT02871297|100515191|FG000|Overall Study|Non-compliance with study drug|15|||
33165191|NCT02871297|100515191|FG000|Overall Study|Protocol Violation|3|||
33165192|NCT02871297|100515191|FG000|Overall Study|Withdrawal by Subject|20|||
33165193|NCT02871297|100515191|FG000|Overall Study|Lost to Follow-up|13|||
33165194|NCT02871297|100515191|FG000|Overall Study|Rolled over to 13546A|2|||
33165195|NCT02871297|100515191|FG000|Overall Study|Other than specified|39|||
33165196|NCT02549937|100515192|FG000|Overall Study|Death|0|||
33165197|NCT02549937|100515193|FG001|Overall Study|Death|1|||
33165198|NCT02549937|100515194|FG002|Overall Study|Death|0|||
33165199|NCT02549937|100515195|FG003|Overall Study|Death|1|||
33165200|NCT02549937|100515196|FG004|Overall Study|Death|0|||
33445334|NCT01597245|101522674|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445335|NCT01597245|101522675|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445336|NCT01597245|101522676|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445337|NCT01597245|101522677|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445338|NCT01597245|101522678|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445339|NCT01597245|101522679|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
33445340|NCT01597245|101522659|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
33445341|NCT01597245|101522660|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
33445342|NCT01597245|101522661|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
33445343|NCT01597245|101522662|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445344|NCT01597245|101522663|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445345|NCT01597245|101522664|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445346|NCT01597245|101522665|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445347|NCT01597245|101522666|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445348|NCT01597245|101522667|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445349|NCT01597245|101522668|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445350|NCT01597245|101522669|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445351|NCT01597245|101522670|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445352|NCT01597245|101522671|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445353|NCT01597245|101522672|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445354|NCT01597245|101522673|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445355|NCT01597245|101522674|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445356|NCT01597245|101522675|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445357|NCT01597245|101522676|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445358|NCT01597245|101522677|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445359|NCT01597245|101522678|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33445360|NCT01597245|101522679|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
33165201|NCT02549937|100515197|FG005|Overall Study|Death|8|||
33258490|NCT03481816|100849487|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
33165202|NCT02549937|100515198|FG006|Overall Study|Death|0|||
33165203|NCT02549937|100515199|FG007|Overall Study|Death|0|||
33165204|NCT02549937|100515200|FG008|Overall Study|Death|19|||
33165205|NCT02549937|100515192|FG000|Overall Study|No follow up required|3|||
33165206|NCT02549937|100515193|FG001|Overall Study|No follow up required|6|||
33165207|NCT02549937|100515194|FG002|Overall Study|No follow up required|3|||
33165208|NCT02549937|100515195|FG003|Overall Study|No follow up required|8|||
33165209|NCT02549937|100515196|FG004|Overall Study|No follow up required|12|||
33165210|NCT02549937|100515197|FG005|Overall Study|No follow up required|21|||
33165211|NCT02549937|100515198|FG006|Overall Study|No follow up required|9|||
33165212|NCT02549937|100515199|FG007|Overall Study|No follow up required|11|||
33165213|NCT02549937|100515200|FG008|Overall Study|No follow up required|0|||
33165214|NCT02549937|100515192|FG000|Overall Study|Other|0|||
33165215|NCT02549937|100515193|FG001|Overall Study|Other|0|||
33445361|NCT01597245|101522659|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445362|NCT01597245|101522660|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445363|NCT01597245|101522661|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445364|NCT01597245|101522662|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445365|NCT01597245|101522663|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445366|NCT01597245|101522664|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
33445367|NCT01597245|101522665|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
33445368|NCT01597245|101522666|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445369|NCT01597245|101522667|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445370|NCT01597245|101522668|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445371|NCT01597245|101522669|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445372|NCT01597245|101522670|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445373|NCT01597245|101522671|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445374|NCT01597245|101522672|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445375|NCT01597245|101522673|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445376|NCT01597245|101522674|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445377|NCT01597245|101522675|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445378|NCT01597245|101522676|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445379|NCT01597245|101522677|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445380|NCT01597245|101522678|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445381|NCT01597245|101522679|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
33445382|NCT01597245|101522659|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445383|NCT01597245|101522660|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445384|NCT01597245|101522661|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445385|NCT01597245|101522662|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445386|NCT01597245|101522663|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
33445387|NCT01597245|101522664|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
33445388|NCT01597245|101522665|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
33445389|NCT01597245|101522666|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
33445390|NCT01597245|101522667|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445391|NCT01597245|101522668|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
33165216|NCT02549937|100515194|FG002|Overall Study|Other|0|||
33165217|NCT02549937|100515195|FG003|Overall Study|Other|0|||
33445392|NCT01597245|101522669|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445393|NCT01597245|101522670|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445394|NCT01597245|101522671|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445395|NCT01597245|101522672|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445396|NCT01597245|101522673|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445397|NCT01597245|101522674|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445398|NCT01597245|101522675|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445399|NCT01597245|101522676|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445400|NCT01597245|101522677|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445401|NCT01597245|101522678|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445402|NCT01597245|101522679|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
33445403|NCT01597245|101522659|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445404|NCT01597245|101522660|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445405|NCT01597245|101522661|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445406|NCT01597245|101522662|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445407|NCT01597245|101522663|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445408|NCT01597245|101522664|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
33445409|NCT01597245|101522665|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445410|NCT01597245|101522666|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445411|NCT01597245|101522667|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
33445412|NCT01597245|101522668|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445413|NCT01597245|101522669|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
33445414|NCT01597245|101522670|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
33445415|NCT01597245|101522671|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
33445416|NCT01597245|101522672|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445417|NCT01597245|101522673|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445418|NCT01597245|101522674|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445419|NCT01597245|101522675|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445420|NCT01597245|101522676|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445421|NCT01597245|101522677|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445422|NCT01597245|101522678|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445423|NCT01597245|101522679|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
33445424|NCT01597245|101522659|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33445425|NCT01597245|101522660|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33445426|NCT01597245|101522661|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33445427|NCT01597245|101522662|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33445428|NCT01597245|101522663|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
33445429|NCT01597245|101522664|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
33445430|NCT01597245|101522665|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
33445431|NCT01597245|101522666|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
33258491|NCT03481816|100849486|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
33258492|NCT03481816|100849487|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
33258493|NCT03481816|100849486|FG000|Dose Expansion|Withdrawal by Subject|0|||
33258494|NCT03481816|100849487|FG001|Dose Expansion|Withdrawal by Subject|2|||
33258495|NCT03481816|100849486|FG000|Dose Expansion|Physician Decision|0|||
33258496|NCT03481816|100849487|FG001|Dose Expansion|Physician Decision|5|||
33258497|NCT04766034|100849488|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
33258498|NCT04766034|100849489|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
33286467|NCT00092521|100943971|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
33445432|NCT01597245|101522667|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
33258499|NCT04766034|100849490|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
33258500|NCT04766034|100849491|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
33258501|NCT04766034|100849492|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
33258502|NCT04766034|100849488|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
33258503|NCT04766034|100849489|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
33258504|NCT04766034|100849490|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
33258505|NCT04766034|100849491|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
33258506|NCT04766034|100849492|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
33258507|NCT04766034|100849488|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
33258508|NCT04766034|100849489|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
33258509|NCT04766034|100849490|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
33258510|NCT04766034|100849491|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
33258511|NCT04766034|100849492|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
33258512|NCT04766034|100849488|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
33258513|NCT04766034|100849489|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
33258514|NCT04766034|100849490|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
33258515|NCT04766034|100849491|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
33258516|NCT04766034|100849492|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
33258517|NCT00714714|100849493|FG000|Overall Study|Adverse Event|1|||
33258518|NCT02755116|100849494|FG000|Overall Study|surgery converted to open, pt admitted|3|||
33258519|NCT02755116|100849495|FG001|Overall Study|surgery converted to open, pt admitted|1|||
33258520|NCT02742519|100849496|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
33258521|NCT02742519|100849497|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
33258522|NCT02742519|100849498|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
33258523|NCT02742519|100849496|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
33258524|NCT02742519|100849497|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
33258525|NCT02742519|100849498|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
33258526|NCT02742519|100849496|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
33258527|NCT02742519|100849497|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
33258528|NCT02742519|100849498|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
33258529|NCT00111813|100849499|FG000|Overall Study|Adverse Event|1|||
33258530|NCT00111813|100849500|FG001|Overall Study|Adverse Event|2|||
33258531|NCT00111813|100849501|FG002|Overall Study|Adverse Event|4|||
33258532|NCT00111813|100849502|FG003|Overall Study|Adverse Event|2|||
33258533|NCT00111813|100849503|FG004|Overall Study|Adverse Event|2|||
33258534|NCT00111813|100849504|FG005|Overall Study|Adverse Event|2|||
33258535|NCT00111813|100849499|FG000|Overall Study|Progressive disease|2|||
33258536|NCT00111813|100849500|FG001|Overall Study|Progressive disease|1|||
33258537|NCT00111813|100849501|FG002|Overall Study|Progressive disease|5|||
33258538|NCT00111813|100849502|FG003|Overall Study|Progressive disease|3|||
33258539|NCT00111813|100849503|FG004|Overall Study|Progressive disease|4|||
33258540|NCT00111813|100849504|FG005|Overall Study|Progressive disease|3|||
33258541|NCT00111813|100849499|FG000|Overall Study|Lack of Efficacy|0|||
33258542|NCT00111813|100849500|FG001|Overall Study|Lack of Efficacy|0|||
33258543|NCT00111813|100849501|FG002|Overall Study|Lack of Efficacy|0|||
33258544|NCT00111813|100849502|FG003|Overall Study|Lack of Efficacy|0|||
33258545|NCT00111813|100849503|FG004|Overall Study|Lack of Efficacy|0|||
33258546|NCT00111813|100849504|FG005|Overall Study|Lack of Efficacy|1|||
33258547|NCT00111813|100849499|FG000|Overall Study|Other|0|||
33258548|NCT00111813|100849500|FG001|Overall Study|Other|0|||
33258549|NCT00111813|100849501|FG002|Overall Study|Other|1|||
33258550|NCT00111813|100849502|FG003|Overall Study|Other|0|||
33258551|NCT00111813|100849503|FG004|Overall Study|Other|0|||
33258552|NCT00111813|100849504|FG005|Overall Study|Other|0|||
33258553|NCT00529100|100849505|FG000|Overall Study|Adverse Event|0|||
33258554|NCT00529100|100849506|FG001|Overall Study|Adverse Event|5|||
33165218|NCT02549937|100515196|FG004|Overall Study|Other|1|||
33165219|NCT02549937|100515197|FG005|Overall Study|Other|0|||
33165220|NCT02549937|100515198|FG006|Overall Study|Other|3|||
33165221|NCT02549937|100515199|FG007|Overall Study|Other|2|||
33165222|NCT02549937|100515200|FG008|Overall Study|Other|3|||
33165223|NCT02549937|100515192|FG000|Overall Study|Lost to Follow-up|0|||
33165224|NCT02549937|100515193|FG001|Overall Study|Lost to Follow-up|0|||
33165225|NCT02549937|100515194|FG002|Overall Study|Lost to Follow-up|0|||
33165226|NCT02549937|100515195|FG003|Overall Study|Lost to Follow-up|0|||
33165227|NCT02549937|100515196|FG004|Overall Study|Lost to Follow-up|0|||
33165228|NCT02549937|100515197|FG005|Overall Study|Lost to Follow-up|0|||
33165229|NCT02549937|100515198|FG006|Overall Study|Lost to Follow-up|0|||
33165230|NCT02549937|100515199|FG007|Overall Study|Lost to Follow-up|0|||
33445433|NCT01597245|101522668|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
33445434|NCT01597245|101522669|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
33445435|NCT01597245|101522670|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
33445436|NCT01597245|101522671|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
33445437|NCT01597245|101522672|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33445438|NCT01597245|101522673|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33445439|NCT01597245|101522674|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33445440|NCT01597245|101522675|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33445441|NCT01597245|101522676|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33165231|NCT02549937|100515200|FG008|Overall Study|Lost to Follow-up|3|||
33165232|NCT02549937|100515192|FG000|Overall Study|Withdrawal by Subject|0|||
33165233|NCT02549937|100515193|FG001|Overall Study|Withdrawal by Subject|0|||
33165234|NCT02549937|100515194|FG002|Overall Study|Withdrawal by Subject|0|||
33165235|NCT02549937|100515195|FG003|Overall Study|Withdrawal by Subject|0|||
33165236|NCT02549937|100515196|FG004|Overall Study|Withdrawal by Subject|0|||
33165237|NCT02549937|100515197|FG005|Overall Study|Withdrawal by Subject|1|||
33165238|NCT02549937|100515198|FG006|Overall Study|Withdrawal by Subject|4|||
33165239|NCT02549937|100515199|FG007|Overall Study|Withdrawal by Subject|3|||
33445442|NCT01597245|101522677|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33445443|NCT01597245|101522678|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33445444|NCT01597245|101522679|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
33445445|NCT01597245|101522659|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33445446|NCT01597245|101522660|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33445447|NCT01597245|101522661|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33445448|NCT01597245|101522662|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33445449|NCT01597245|101522663|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
33445450|NCT01597245|101522664|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
33445451|NCT01597245|101522665|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
33445452|NCT01597245|101522666|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33445453|NCT01597245|101522667|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
33445454|NCT01597245|101522668|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
33445455|NCT01597245|101522669|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
33445456|NCT01597245|101522670|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
33445457|NCT01597245|101522671|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
33445458|NCT01597245|101522672|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33445459|NCT01597245|101522673|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33445460|NCT01597245|101522674|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33445461|NCT01597245|101522675|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33445462|NCT01597245|101522676|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33445463|NCT01597245|101522677|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33445464|NCT01597245|101522678|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33445465|NCT01597245|101522679|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
33445466|NCT01597245|101522659|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445467|NCT01597245|101522660|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445468|NCT01597245|101522661|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445469|NCT01597245|101522662|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445470|NCT01597245|101522663|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
33165240|NCT02549937|100515200|FG008|Overall Study|Withdrawal by Subject|2|||
33165241|NCT02549937|100515192|FG000|Overall Study|Sponsor Decision|0|||
33165242|NCT02549937|100515193|FG001|Overall Study|Sponsor Decision|0|||
33165243|NCT02549937|100515194|FG002|Overall Study|Sponsor Decision|0|||
33165244|NCT02549937|100515195|FG003|Overall Study|Sponsor Decision|0|||
33165245|NCT02549937|100515196|FG004|Overall Study|Sponsor Decision|0|||
33165246|NCT02549937|100515197|FG005|Overall Study|Sponsor Decision|0|||
33165247|NCT02549937|100515198|FG006|Overall Study|Sponsor Decision|0|||
33165248|NCT02549937|100515199|FG007|Overall Study|Sponsor Decision|0|||
33165249|NCT02549937|100515200|FG008|Overall Study|Sponsor Decision|6|||
33445471|NCT01597245|101522664|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445472|NCT01597245|101522665|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445473|NCT01597245|101522666|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445474|NCT01597245|101522667|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
33445475|NCT01597245|101522668|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
33165250|NCT02216591|100515209|FG000|Overall Study|Lost to Follow-up|0|||
33165251|NCT02216591|100515210|FG001|Overall Study|Lost to Follow-up|1|||
33165252|NCT03288129|100515212|FG000|Overall Study|Adverse Event|10|||
33165253|NCT03288129|100515212|FG000|Overall Study|Lost to Follow-up|3|||
33445476|NCT01597245|101522669|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
33445477|NCT01597245|101522670|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33165254|NCT03288129|100515212|FG000|Overall Study|Withdrawal by Subject|3|||
33165255|NCT03288129|100515212|FG000|Overall Study|Withdrawal of consent/assent|1|||
33445478|NCT01597245|101522671|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
33165256|NCT03288129|100515212|FG000|Overall Study|Other|5|||
33258555|NCT00529100|100849505|FG000|Overall Study|Protocol Violation|0|||
33258556|NCT00529100|100849506|FG001|Overall Study|Protocol Violation|1|||
33258557|NCT00529100|100849505|FG000|Overall Study|Progressive Disease|0|||
33258558|NCT00529100|100849506|FG001|Overall Study|Progressive Disease|1|||
33258559|NCT00529100|100849505|FG000|Overall Study|Withdrawal by Subject|0|||
33258560|NCT00529100|100849506|FG001|Overall Study|Withdrawal by Subject|1|||
33258561|NCT00529100|100849505|FG000|Overall Study|Participant Ineligibility|0|||
33258562|NCT00529100|100849506|FG001|Overall Study|Participant Ineligibility|1|||
33258563|NCT01622868|100849509|FG000|Overall Study|Protocol Violation|7|||
33258564|NCT01622868|100849510|FG001|Overall Study|Protocol Violation|0|||
33258565|NCT00802464|100849511|FG000|Month 0 - Month 8|Adverse Event|0|||
33258566|NCT00802464|100849512|FG001|Month 0 - Month 8|Adverse Event|1|||
33258567|NCT00802464|100849513|FG002|Month 0 - Month 8|Adverse Event|1|||
33258568|NCT00802464|100849514|FG003|Month 0 - Month 8|Adverse Event|2|||
33258569|NCT00802464|100849511|FG000|Month 0 - Month 8|Protocol Violation|0|||
33258570|NCT00802464|100849512|FG001|Month 0 - Month 8|Protocol Violation|0|||
33258571|NCT00802464|100849513|FG002|Month 0 - Month 8|Protocol Violation|1|||
33258572|NCT00802464|100849514|FG003|Month 0 - Month 8|Protocol Violation|0|||
33258573|NCT00802464|100849511|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
33258574|NCT00802464|100849512|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
33258575|NCT00802464|100849513|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
33258576|NCT00802464|100849514|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
33258577|NCT00802464|100849511|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
33258578|NCT00802464|100849512|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
33258579|NCT00802464|100849513|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
33258580|NCT00802464|100849514|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
33258581|NCT00802464|100849511|FG000|Month 0 - Month 8|Other|0|||
33258582|NCT00802464|100849512|FG001|Month 0 - Month 8|Other|0|||
33258583|NCT00802464|100849513|FG002|Month 0 - Month 8|Other|1|||
33258584|NCT00802464|100849514|FG003|Month 0 - Month 8|Other|0|||
33258585|NCT00802464|100849511|FG000|Month 8 - Month 14|Adverse Event|0|||
33258586|NCT00802464|100849512|FG001|Month 8 - Month 14|Adverse Event|1|||
33258587|NCT00802464|100849513|FG002|Month 8 - Month 14|Adverse Event|0|||
33258588|NCT00802464|100849514|FG003|Month 8 - Month 14|Adverse Event|0|||
33258589|NCT00802464|100849511|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
33258590|NCT00802464|100849512|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
33258591|NCT00802464|100849513|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
33258592|NCT00802464|100849514|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
33258593|NCT00802464|100849511|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
33258594|NCT00802464|100849512|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
33258595|NCT00802464|100849513|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
33258596|NCT00802464|100849514|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
33258597|NCT02574455|100849515|FG000|Overall Study|Death|197|||
33258598|NCT02574455|100849516|FG001|Overall Study|Death|210|||
33258599|NCT02574455|100849515|FG000|Overall Study|Withdrawal of Consent|11|||
33258600|NCT02574455|100849516|FG001|Overall Study|Withdrawal of Consent|28|||
33258601|NCT02574455|100849515|FG000|Overall Study|Lost to Follow-up|4|||
33258602|NCT02574455|100849516|FG001|Overall Study|Lost to Follow-up|4|||
33258603|NCT02574455|100849515|FG000|Overall Study|Sponsor's Decision|55|||
33258604|NCT02574455|100849516|FG001|Overall Study|Sponsor's Decision|20|||
33258605|NCT01236001|100849521|FG000|Overall Study|Adverse Event|5|||
33258606|NCT01236001|100849522|FG001|Overall Study|Adverse Event|14|||
33258607|NCT01236001|100849521|FG000|Overall Study|Lack of Efficacy|6|||
33258608|NCT01236001|100849522|FG001|Overall Study|Lack of Efficacy|6|||
33258609|NCT01236001|100849521|FG000|Overall Study|Lost to Follow-up|6|||
33258610|NCT01236001|100849522|FG001|Overall Study|Lost to Follow-up|1|||
33258611|NCT01236001|100849521|FG000|Overall Study|Incompliance|1|||
33258612|NCT01236001|100849522|FG001|Overall Study|Incompliance|0|||
33258613|NCT01236001|100849521|FG000|Overall Study|Planned Visit After End of Study|0|||
33258614|NCT01236001|100849522|FG001|Overall Study|Planned Visit After End of Study|1|||
33258615|NCT04048382|100849527|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
33258616|NCT04048382|100849528|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
33165257|NCT01606007|100515220|FG000|Overall Study|Reason 'Other' in the protocol|0|||
33165258|NCT01606007|100515221|FG001|Overall Study|Reason 'Other' in the protocol|1|||
33165259|NCT01606007|100515222|FG002|Overall Study|Reason 'Other' in the protocol|1|||
33165260|NCT01606007|100515220|FG000|Overall Study|Pregnancy|0|||
33165261|NCT01606007|100515221|FG001|Overall Study|Pregnancy|1|||
33165262|NCT01606007|100515222|FG002|Overall Study|Pregnancy|1|||
33165263|NCT01606007|100515220|FG000|Overall Study|Withdrawal by Subject|8|||
33165264|NCT01606007|100515221|FG001|Overall Study|Withdrawal by Subject|6|||
33258617|NCT04048382|100849527|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
33258618|NCT04048382|100849528|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
33258619|NCT04048382|100849527|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
33258620|NCT04048382|100849528|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
33258621|NCT01184326|100849531|FG000|Overall Study|Adverse Event|1|||
33258622|NCT01184326|100849532|FG001|Overall Study|Adverse Event|2|||
33258623|NCT01184326|100849533|FG002|Overall Study|Adverse Event|0|||
33258624|NCT01184326|100849531|FG000|Overall Study|Death|0|||
33445479|NCT01597245|101522672|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445480|NCT01597245|101522673|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445481|NCT01597245|101522674|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445482|NCT01597245|101522675|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445483|NCT01597245|101522676|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445484|NCT01597245|101522677|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445485|NCT01597245|101522678|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445486|NCT01597245|101522679|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
33445487|NCT01597245|101522659|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33445488|NCT01597245|101522660|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33445489|NCT01597245|101522661|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33445490|NCT01597245|101522662|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33445491|NCT01597245|101522663|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
33445492|NCT01597245|101522664|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
33445493|NCT01597245|101522665|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
33445494|NCT01597245|101522666|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33445495|NCT01597245|101522667|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
33445496|NCT01597245|101522668|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
33445497|NCT01597245|101522669|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
33445498|NCT01597245|101522670|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
33445499|NCT01597245|101522671|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
33445500|NCT01597245|101522672|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33445501|NCT01597245|101522673|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33258625|NCT01184326|100849532|FG001|Overall Study|Death|0|||
33258626|NCT01184326|100849533|FG002|Overall Study|Death|1|||
33258627|NCT01184326|100849531|FG000|Overall Study|Withdrawal by Subject|0|||
33445502|NCT01597245|101522674|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33445503|NCT01597245|101522675|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33445504|NCT01597245|101522676|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33445505|NCT01597245|101522677|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33445506|NCT01597245|101522678|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33445507|NCT01597245|101522679|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
33445508|NCT01597245|101522659|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33445509|NCT01597245|101522660|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33445510|NCT01597245|101522661|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33445511|NCT01597245|101522662|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33445512|NCT01597245|101522663|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33445513|NCT01597245|101522664|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
33445514|NCT01597245|101522665|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33445515|NCT01597245|101522666|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33445516|NCT01597245|101522667|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
33445517|NCT01597245|101522668|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
33445518|NCT01597245|101522669|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
33445519|NCT01597245|101522670|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
33445520|NCT01597245|101522671|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33445521|NCT01597245|101522672|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33445522|NCT01597245|101522673|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33445523|NCT01597245|101522674|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33445524|NCT01597245|101522675|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33445525|NCT01597245|101522676|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33258628|NCT01184326|100849532|FG001|Overall Study|Withdrawal by Subject|0|||
33165265|NCT01606007|100515222|FG002|Overall Study|Withdrawal by Subject|1|||
33165266|NCT01606007|100515220|FG000|Overall Study|Adverse Event|0|||
33165267|NCT01606007|100515221|FG001|Overall Study|Adverse Event|1|||
33165268|NCT01606007|100515222|FG002|Overall Study|Adverse Event|1|||
33165269|NCT01606007|100515220|FG000|Overall Study|discontinue study treatment|0|||
33165270|NCT01606007|100515221|FG001|Overall Study|discontinue study treatment|2|||
33165271|NCT01606007|100515222|FG002|Overall Study|discontinue study treatment|1|||
33165272|NCT01606007|100515220|FG000|Overall Study|Lost to Follow-up|6|||
33165273|NCT01606007|100515221|FG001|Overall Study|Lost to Follow-up|8|||
33165274|NCT01606007|100515222|FG002|Overall Study|Lost to Follow-up|5|||
33165275|NCT01606007|100515220|FG000|Overall Study|Poor/Non-compliance|1|||
33165276|NCT01606007|100515221|FG001|Overall Study|Poor/Non-compliance|0|||
33165277|NCT01606007|100515222|FG002|Overall Study|Poor/Non-compliance|0|||
33165278|NCT04015336|100515228|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
33165279|NCT01546207|100515229|FG000|Overall Study|Death|1|||
33165280|NCT01666782|100515234|FG000|Overall Study|Received 2 doses of vaccine|0|||
33165281|NCT01666782|100515235|FG001|Overall Study|Received 2 doses of vaccine|1|||
33165282|NCT01666782|100515234|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
33165283|NCT01666782|100515235|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
33165284|NCT02289417|100515236|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
33165285|NCT02289417|100515237|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
33165286|NCT02289417|100515238|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
33165287|NCT02289417|100515239|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
33165288|NCT02289417|100515240|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
33165289|NCT02289417|100515241|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
33165290|NCT02289417|100515242|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
33165291|NCT02289417|100515243|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
33165292|NCT02289417|100515244|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
33165293|NCT02289417|100515236|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
33165294|NCT02289417|100515237|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
33165295|NCT02289417|100515238|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
33165296|NCT02289417|100515239|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
33165297|NCT02289417|100515240|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
33165298|NCT02289417|100515241|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
33165299|NCT02289417|100515242|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
33165300|NCT02289417|100515243|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
33165301|NCT02289417|100515244|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
33165302|NCT02289417|100515236|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33165303|NCT02289417|100515237|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
33165304|NCT02289417|100515238|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33165305|NCT02289417|100515239|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33165306|NCT02289417|100515240|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33165307|NCT02289417|100515241|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33165308|NCT02289417|100515242|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33165309|NCT02289417|100515243|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33165310|NCT02289417|100515244|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
33165311|NCT02289417|100515236|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
33165312|NCT02289417|100515237|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33165313|NCT02289417|100515238|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33165314|NCT02289417|100515239|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33165315|NCT02289417|100515240|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33286468|NCT03918447|100943975|FG000|Overall Study|Death|1|||
33165316|NCT02289417|100515241|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33165317|NCT02289417|100515242|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33165318|NCT02289417|100515243|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33165319|NCT02289417|100515244|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
33165320|NCT02289417|100515236|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
33286469|NCT03918447|100943976|FG001|Overall Study|Death|0|||
33445526|NCT01597245|101522677|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33445527|NCT01597245|101522678|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33258629|NCT01184326|100849533|FG002|Overall Study|Withdrawal by Subject|1|||
33258630|NCT01184326|100849531|FG000|Overall Study|Physician Decision|1|||
33258631|NCT01184326|100849532|FG001|Overall Study|Physician Decision|1|||
33258632|NCT01184326|100849533|FG002|Overall Study|Physician Decision|0|||
33258633|NCT01184326|100849531|FG000|Overall Study|Disease Progression|1|||
33258634|NCT01184326|100849532|FG001|Overall Study|Disease Progression|3|||
33258635|NCT01184326|100849533|FG002|Overall Study|Disease Progression|12|||
33258636|NCT00522951|100849534|FG000|Period 1|body motion|0|||
33258637|NCT00522951|100849535|FG001|Period 1|body motion|1|||
33258638|NCT00522951|100849534|FG000|Washout Period|Adverse Event|0|||
33258639|NCT00522951|100849535|FG001|Washout Period|Adverse Event|1|||
33445528|NCT01597245|101522679|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
33445529|NCT01597245|101522659|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445530|NCT01597245|101522660|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445531|NCT01597245|101522661|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445532|NCT01597245|101522662|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445533|NCT01597245|101522663|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445534|NCT01597245|101522664|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445535|NCT01597245|101522665|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445536|NCT01597245|101522666|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445537|NCT01597245|101522667|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33165321|NCT02289417|100515237|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
33165322|NCT02289417|100515238|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
33165323|NCT02289417|100515239|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
33258640|NCT00522951|100849534|FG000|Washout Period|Death|0|||
33445538|NCT01597245|101522668|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445539|NCT01597245|101522669|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
33445540|NCT01597245|101522670|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33165324|NCT02289417|100515240|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
33258641|NCT00522951|100849535|FG001|Washout Period|Death|1|||
33258642|NCT00522951|100849534|FG000|Period 2|Withdrawal by Subject|1|||
33258643|NCT00522951|100849535|FG001|Period 2|Withdrawal by Subject|0|||
33258644|NCT00522951|100849534|FG000|Period 2|residual contrast medium|1|||
33258645|NCT00522951|100849535|FG001|Period 2|residual contrast medium|1|||
33258646|NCT04218266|100849536|FG000|Overall Study|Death|1|||
33258647|NCT04218266|100849537|FG001|Overall Study|Death|2|||
33258648|NCT04218266|100849538|FG002|Overall Study|Death|3|||
33258649|NCT04218266|100849536|FG000|Overall Study|Adverse Event|13|||
33258650|NCT04218266|100849537|FG001|Overall Study|Adverse Event|14|||
33258651|NCT04218266|100849538|FG002|Overall Study|Adverse Event|11|||
33258652|NCT04218266|100849536|FG000|Overall Study|Other|7|||
33258653|NCT04218266|100849537|FG001|Overall Study|Other|5|||
33258654|NCT04218266|100849538|FG002|Overall Study|Other|14|||
33258655|NCT04218266|100849536|FG000|Overall Study|Physician Decision|1|||
33258656|NCT04218266|100849537|FG001|Overall Study|Physician Decision|3|||
33258657|NCT04218266|100849538|FG002|Overall Study|Physician Decision|2|||
33258658|NCT04218266|100849536|FG000|Overall Study|Non-compliance with study drug|0|||
33258659|NCT04218266|100849537|FG001|Overall Study|Non-compliance with study drug|0|||
33258660|NCT04218266|100849538|FG002|Overall Study|Non-compliance with study drug|1|||
33258661|NCT04218266|100849536|FG000|Overall Study|Withdrawal by Subject|1|||
33258662|NCT04218266|100849537|FG001|Overall Study|Withdrawal by Subject|3|||
33258663|NCT04218266|100849538|FG002|Overall Study|Withdrawal by Subject|1|||
33258664|NCT04218266|100849536|FG000|Overall Study|Study drug never administered|2|||
33258665|NCT04218266|100849537|FG001|Overall Study|Study drug never administered|0|||
33258666|NCT04218266|100849538|FG002|Overall Study|Study drug never administered|0|||
33258667|NCT04820686|100849539|FG000|Overall Study|Withdrawal by Subject|5|||
33258668|NCT04820686|100849540|FG001|Overall Study|Withdrawal by Subject|2|||
33258669|NCT04820686|100849541|FG002|Overall Study|Withdrawal by Subject|3|||
33258670|NCT04820686|100849539|FG000|Overall Study|Study Termination|25|||
33258671|NCT04820686|100849540|FG001|Overall Study|Study Termination|13|||
33258672|NCT04820686|100849541|FG002|Overall Study|Study Termination|14|||
33258673|NCT04820686|100849539|FG000|Overall Study|Adverse Event|0|||
33258674|NCT04820686|100849540|FG001|Overall Study|Adverse Event|1|||
33258675|NCT04820686|100849541|FG002|Overall Study|Adverse Event|0|||
33258676|NCT03101371|100849542|FG000|Overall Study|Physician Decision|0|||
33258677|NCT03101371|100849543|FG001|Overall Study|Physician Decision|1|||
33258678|NCT03101371|100849542|FG000|Overall Study|Lost to Follow-up|1|||
33258679|NCT03101371|100849543|FG001|Overall Study|Lost to Follow-up|4|||
33258680|NCT03101371|100849542|FG000|Overall Study|Did not meet eligibility criteria|2|||
33258681|NCT03101371|100849543|FG001|Overall Study|Did not meet eligibility criteria|1|||
33258682|NCT02374307|100849545|FG000|3-months Follow-up|Lost to Follow-up|1|||
33258683|NCT02374307|100849546|FG001|3-months Follow-up|Lost to Follow-up|2|||
33258684|NCT02374307|100849545|FG000|3-months Follow-up|Withdrawal by Subject|1|||
33258685|NCT02374307|100849546|FG001|3-months Follow-up|Withdrawal by Subject|4|||
33258686|NCT02374307|100849545|FG000|3-months Follow-up|Death|1|||
33258687|NCT02374307|100849546|FG001|3-months Follow-up|Death|2|||
33258688|NCT02374307|100849545|FG000|3-months Follow-up|Missed first follow-up|5|||
33258689|NCT02374307|100849546|FG001|3-months Follow-up|Missed first follow-up|1|||
33445541|NCT01597245|101522671|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445542|NCT01597245|101522672|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445543|NCT01597245|101522673|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445544|NCT01597245|101522674|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445545|NCT01597245|101522675|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445546|NCT01597245|101522676|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445547|NCT01597245|101522677|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445548|NCT01597245|101522678|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445549|NCT01597245|101522679|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
33445550|NCT01597245|101522659|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445551|NCT01597245|101522660|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445552|NCT01597245|101522661|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445553|NCT01597245|101522662|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445554|NCT01597245|101522663|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445555|NCT01597245|101522664|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445556|NCT01597245|101522665|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445557|NCT01597245|101522666|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445558|NCT01597245|101522667|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445559|NCT01597245|101522668|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445560|NCT01597245|101522669|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445561|NCT01597245|101522670|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445562|NCT01597245|101522671|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445563|NCT01597245|101522672|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
33445564|NCT01597245|101522673|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
33258690|NCT02374307|100849545|FG000|6-months Follow-up|Lost to Follow-up|1|||
33445565|NCT01597245|101522674|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
33445566|NCT01597245|101522675|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33258691|NCT02374307|100849546|FG001|6-months Follow-up|Lost to Follow-up|2|||
33258692|NCT02374307|100849545|FG000|6-months Follow-up|Death|2|||
33258693|NCT02374307|100849546|FG001|6-months Follow-up|Death|1|||
33258694|NCT02374307|100849545|FG000|6-months Follow-up|Withdrawal by Subject|0|||
33258695|NCT02374307|100849546|FG001|6-months Follow-up|Withdrawal by Subject|3|||
33165325|NCT02289417|100515241|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
33165326|NCT02289417|100515242|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
33165327|NCT02289417|100515243|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
33165328|NCT02289417|100515244|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
33165329|NCT02289417|100515236|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33165330|NCT02289417|100515237|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33165331|NCT02289417|100515238|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
33165332|NCT02289417|100515239|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33165333|NCT02289417|100515240|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33165334|NCT02289417|100515241|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33165335|NCT02289417|100515242|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33165336|NCT02289417|100515243|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33165337|NCT02289417|100515244|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
33165338|NCT02289417|100515236|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
33165339|NCT02289417|100515237|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
33165340|NCT02289417|100515238|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
33165341|NCT02289417|100515239|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
33165342|NCT02289417|100515240|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
33165343|NCT02289417|100515241|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
33165344|NCT02289417|100515242|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
33165345|NCT02289417|100515243|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
33165346|NCT02289417|100515244|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
33165347|NCT02289417|100515236|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
33165348|NCT02289417|100515237|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
33165349|NCT02289417|100515238|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
33165350|NCT02289417|100515239|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
33165351|NCT02289417|100515240|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
33165352|NCT02289417|100515241|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
33165353|NCT02289417|100515242|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
33165354|NCT02289417|100515243|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
33165355|NCT02289417|100515244|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
33165356|NCT02289417|100515236|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33165357|NCT02289417|100515237|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33165358|NCT02289417|100515238|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33165359|NCT02289417|100515239|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33165360|NCT02289417|100515240|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33165361|NCT02289417|100515241|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33165362|NCT02289417|100515242|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
33165363|NCT02289417|100515243|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33258696|NCT00686855|100849547|FG000|Overall Study|Lost to Follow-up|1|||
33258697|NCT00686855|100849548|FG001|Overall Study|Lost to Follow-up|0|||
33258698|NCT00686855|100849547|FG000|Overall Study|Progressive GVHD|0|||
33258699|NCT00686855|100849548|FG001|Overall Study|Progressive GVHD|1|||
33258700|NCT04110054|100849560|FG000|Overall Study|COVID-19 reason other than AE|0|||
33445567|NCT01597245|101522676|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445568|NCT01597245|101522677|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445569|NCT01597245|101522678|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445570|NCT01597245|101522679|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
33445571|NCT01597245|101522659|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33258701|NCT04110054|100849561|FG001|Overall Study|COVID-19 reason other than AE|0|||
33165364|NCT02289417|100515244|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
33165365|NCT02289417|100515236|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
33165366|NCT02289417|100515237|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
33165367|NCT02289417|100515238|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
33165368|NCT02289417|100515239|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
33165369|NCT02289417|100515240|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
33165370|NCT02289417|100515241|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
33165371|NCT02289417|100515242|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
33165372|NCT02289417|100515243|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
33165373|NCT02289417|100515244|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
33165374|NCT02289417|100515236|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
33165375|NCT02289417|100515237|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
33165376|NCT02289417|100515238|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
33165377|NCT02289417|100515239|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
33165378|NCT02289417|100515240|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
33165379|NCT02289417|100515241|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
33165380|NCT02289417|100515242|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
33165381|NCT02289417|100515243|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
33165382|NCT02289417|100515244|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
33165383|NCT02289417|100515236|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
33165384|NCT02289417|100515237|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
33165385|NCT02289417|100515238|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
33165386|NCT02289417|100515239|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
33165387|NCT02289417|100515240|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
33165388|NCT02289417|100515241|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
33165389|NCT02289417|100515242|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
33165390|NCT02289417|100515243|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
33165391|NCT02289417|100515244|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
33165392|NCT02289417|100515236|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
33165393|NCT02289417|100515237|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
33165394|NCT02289417|100515238|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
33165395|NCT02289417|100515239|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
33165396|NCT02289417|100515240|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
33258702|NCT04110054|100849562|FG002|Overall Study|COVID-19 reason other than AE|2|||
33258703|NCT04110054|100849563|FG003|Overall Study|COVID-19 reason other than AE|0|||
33258704|NCT04110054|100849560|FG000|Overall Study|Withdrawal by Subject|0|||
33258705|NCT04110054|100849561|FG001|Overall Study|Withdrawal by Subject|3|||
33258706|NCT04110054|100849562|FG002|Overall Study|Withdrawal by Subject|2|||
33445572|NCT01597245|101522660|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33165397|NCT02289417|100515241|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
33165398|NCT02289417|100515242|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
33258707|NCT04110054|100849563|FG003|Overall Study|Withdrawal by Subject|0|||
33165399|NCT02289417|100515243|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
33165400|NCT02289417|100515244|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
33165401|NCT02289417|100515236|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
33165402|NCT02289417|100515237|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
33165403|NCT02289417|100515238|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
33165404|NCT02289417|100515239|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
33165405|NCT02289417|100515240|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
33165406|NCT02289417|100515241|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
33165407|NCT02289417|100515242|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
33165408|NCT02289417|100515243|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
33165409|NCT02289417|100515244|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
33165410|NCT01051323|100515245|FG000|Overall Study|Discontinuation of treatment|103|||
33165411|NCT01051323|100515245|FG000|Overall Study|Transplantation|28|||
33165412|NCT01051323|100515245|FG000|Overall Study|Dialysis dependency|22|||
33165413|NCT01051323|100515245|FG000|Overall Study|Withdrawal by Subject|13|||
33165414|NCT01051323|100515245|FG000|Overall Study|Lost to Follow-up|31|||
33165415|NCT01051323|100515245|FG000|Overall Study|Death|129|||
33165416|NCT01051323|100515245|FG000|Overall Study|Hospitalization|28|||
33165417|NCT01051323|100515245|FG000|Overall Study|Other|148|||
33165418|NCT01051323|100515245|FG000|Overall Study|Missing|37|||
33165419|NCT05570500|100515246|FG000|Overall Study|Lost to Follow-up|7|||
33165420|NCT05570500|100515247|FG001|Overall Study|Lost to Follow-up|5|||
33165421|NCT02854631|100515248|FG000|Overall Study|Adverse Event|1|||
33165422|NCT02854631|100515249|FG001|Overall Study|Adverse Event|2|||
33165423|NCT02854631|100515248|FG000|Overall Study|Withdrew Consent|3|||
33165424|NCT02854631|100515249|FG001|Overall Study|Withdrew Consent|2|||
33165425|NCT02854631|100515248|FG000|Overall Study|Investigator's Discretion|2|||
33165426|NCT02854631|100515249|FG001|Overall Study|Investigator's Discretion|0|||
33445573|NCT01597245|101522661|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33445574|NCT01597245|101522662|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33445575|NCT01597245|101522663|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33445576|NCT01597245|101522664|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33165427|NCT02854631|100515248|FG000|Overall Study|Death|12|||
33165428|NCT02854631|100515249|FG001|Overall Study|Death|8|||
33258708|NCT04110054|100849560|FG000|Overall Study|Adverse Event|1|||
33445577|NCT01597245|101522665|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33445578|NCT01597245|101522666|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33445579|NCT01597245|101522667|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33445580|NCT01597245|101522668|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33445581|NCT01597245|101522669|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33445582|NCT01597245|101522670|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33445583|NCT01597245|101522671|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33445584|NCT01597245|101522672|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
33445585|NCT01597245|101522673|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
33445586|NCT01597245|101522674|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
33445587|NCT01597245|101522675|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33445588|NCT01597245|101522676|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33445589|NCT01597245|101522677|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33165429|NCT02854631|100515248|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
33165430|NCT02854631|100515249|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
33165431|NCT02854631|100515248|FG000|Overall Study|Protocol Violation|0|||
33165432|NCT02854631|100515249|FG001|Overall Study|Protocol Violation|1|||
33445590|NCT01597245|101522678|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33445591|NCT01597245|101522679|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
33445592|NCT01597245|101522659|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445593|NCT01597245|101522660|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445594|NCT01597245|101522661|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445595|NCT01597245|101522662|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445596|NCT01597245|101522663|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445597|NCT01597245|101522664|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445598|NCT01597245|101522665|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445599|NCT01597245|101522666|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445600|NCT01597245|101522667|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445601|NCT01597245|101522668|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445602|NCT01597245|101522669|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445603|NCT01597245|101522670|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445604|NCT01597245|101522671|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445605|NCT01597245|101522672|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445606|NCT01597245|101522673|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
33445607|NCT01597245|101522674|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
33445608|NCT01597245|101522675|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445609|NCT01597245|101522676|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445610|NCT01597245|101522677|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445611|NCT01597245|101522678|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445612|NCT01597245|101522679|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
33445613|NCT01597245|101522659|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445614|NCT01597245|101522660|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445615|NCT01597245|101522661|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445616|NCT01597245|101522662|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445617|NCT01597245|101522663|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445618|NCT01597245|101522664|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445619|NCT01597245|101522665|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445620|NCT01597245|101522666|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445621|NCT01597245|101522667|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445622|NCT01597245|101522668|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445623|NCT01597245|101522669|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445624|NCT01597245|101522670|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445625|NCT01597245|101522671|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445626|NCT01597245|101522672|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445627|NCT01597245|101522673|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
33445628|NCT01597245|101522674|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
33445629|NCT01597245|101522675|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445630|NCT01597245|101522676|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33258709|NCT04110054|100849561|FG001|Overall Study|Adverse Event|1|||
33258710|NCT04110054|100849562|FG002|Overall Study|Adverse Event|4|||
33445631|NCT01597245|101522677|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445632|NCT01597245|101522678|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445633|NCT01597245|101522679|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
33445634|NCT01597245|101522659|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445635|NCT01597245|101522660|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445636|NCT01597245|101522661|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445637|NCT01597245|101522662|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445638|NCT01597245|101522663|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445639|NCT01597245|101522664|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445640|NCT01597245|101522665|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445641|NCT01597245|101522666|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445642|NCT01597245|101522667|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445643|NCT01597245|101522668|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445644|NCT01597245|101522669|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445645|NCT01597245|101522670|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33258711|NCT04110054|100849563|FG003|Overall Study|Adverse Event|3|||
33258712|NCT02601820|100849564|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
33258713|NCT02601820|100849564|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
33258714|NCT02601820|100849564|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
33258715|NCT02601820|100849564|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
33258716|NCT03531840|100849565|FG000|Overall Study|Death on study|3|||
33258717|NCT03531840|100849566|FG001|Overall Study|Death on study|2|||
33258718|NCT03531840|100849567|FG002|Overall Study|Death on study|1|||
33258719|NCT03531840|100849568|FG003|Overall Study|Death on study|2|||
33258720|NCT03531840|100849565|FG000|Overall Study|Death during follow up|2|||
33258721|NCT03531840|100849566|FG001|Overall Study|Death during follow up|3|||
33258722|NCT03531840|100849567|FG002|Overall Study|Death during follow up|4|||
33258723|NCT03531840|100849568|FG003|Overall Study|Death during follow up|1|||
33258724|NCT02252042|100849569|FG000|Overall Study|Adverse Event|9|||
33258725|NCT02252042|100849570|FG001|Overall Study|Adverse Event|6|||
33258726|NCT02252042|100849569|FG000|Overall Study|Death|209|||
33258727|NCT02252042|100849570|FG001|Overall Study|Death|217|||
33258728|NCT02252042|100849569|FG000|Overall Study|Physician Decision|0|||
33258729|NCT02252042|100849570|FG001|Overall Study|Physician Decision|2|||
33258730|NCT02252042|100849569|FG000|Overall Study|Transferred to Extension Study|7|||
33258731|NCT02252042|100849570|FG001|Overall Study|Transferred to Extension Study|1|||
33258732|NCT02252042|100849569|FG000|Overall Study|Did Not Continue on Extension Study|7|||
33258733|NCT02252042|100849570|FG001|Overall Study|Did Not Continue on Extension Study|2|||
33258734|NCT02252042|100849569|FG000|Overall Study|Withdrawal by Subject|15|||
33258735|NCT02252042|100849570|FG001|Overall Study|Withdrawal by Subject|20|||
33258736|NCT02140645|100849571|FG000|Overall Study|Not linked|5489|||
33258737|NCT02140645|100849572|FG001|Overall Study|Not linked|61654|||
33258738|NCT02140645|100849573|FG002|Overall Study|Not linked|4236|||
33258739|NCT02140645|100849574|FG003|Overall Study|Not linked|13833|||
33258740|NCT02140645|100849575|FG004|Overall Study|Not linked|3286|||
33258741|NCT02140645|100849576|FG005|Overall Study|Not linked|70896|||
33258742|NCT00089544|100849582|FG000|Overall Study|Ineligible|1|||
33258743|NCT00089544|100849583|FG001|Overall Study|Ineligible|0|||
33258744|NCT03892564|100849586|FG000|Overall Study|Withdrawal by Subject|2|||
33258745|NCT01599104|100849589|FG000|Overall Study|Withdrawal by Subject|1|||
33258746|NCT01599104|100849590|FG001|Overall Study|Withdrawal by Subject|1|||
33258747|NCT01599104|100849591|FG002|Overall Study|Withdrawal by Subject|2|||
33258748|NCT01599104|100849589|FG000|Overall Study|Technical Problems|1|||
33258749|NCT01599104|100849590|FG001|Overall Study|Technical Problems|0|||
33258750|NCT01599104|100849591|FG002|Overall Study|Technical Problems|0|||
33258751|NCT01599104|100849589|FG000|Overall Study|Physician Decision|3|||
33258752|NCT01599104|100849590|FG001|Overall Study|Physician Decision|2|||
33258753|NCT01599104|100849591|FG002|Overall Study|Physician Decision|2|||
33445646|NCT01597245|101522671|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445647|NCT01597245|101522672|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
33445648|NCT01597245|101522673|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
33445649|NCT01597245|101522674|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
33445650|NCT01597245|101522675|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445651|NCT01597245|101522676|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445652|NCT01597245|101522677|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445653|NCT01597245|101522678|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445654|NCT01597245|101522679|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
33445655|NCT01597245|101522659|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445656|NCT01597245|101522660|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445657|NCT01597245|101522661|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445658|NCT01597245|101522662|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445659|NCT01597245|101522663|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445660|NCT01597245|101522664|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445661|NCT01597245|101522665|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445662|NCT01597245|101522666|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445663|NCT01597245|101522667|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445664|NCT01597245|101522668|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445665|NCT01597245|101522669|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445666|NCT01597245|101522670|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445667|NCT01597245|101522671|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445668|NCT01597245|101522672|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
33165433|NCT02854631|100515248|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
33165434|NCT02854631|100515249|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
33165435|NCT02854631|100515248|FG000|Overall Study|Lost to Follow-up|4|||
33165436|NCT02854631|100515249|FG001|Overall Study|Lost to Follow-up|2|||
33165437|NCT01977794|100515254|FG000|Overall Study|Adverse Event|2|||
33165438|NCT01977794|100515255|FG001|Overall Study|Adverse Event|2|||
33165439|NCT01977794|100515254|FG000|Overall Study|Lost to Follow-up|2|||
33165440|NCT01977794|100515255|FG001|Overall Study|Lost to Follow-up|1|||
33165441|NCT01977794|100515254|FG000|Overall Study|Protocol Violation|1|||
33165442|NCT01977794|100515255|FG001|Overall Study|Protocol Violation|0|||
33165443|NCT01977794|100515254|FG000|Overall Study|Death|1|||
33165444|NCT01977794|100515255|FG001|Overall Study|Death|1|||
33165445|NCT01977794|100515254|FG000|Overall Study|Withdrew consent|2|||
33165446|NCT01977794|100515255|FG001|Overall Study|Withdrew consent|1|||
33165447|NCT01977794|100515254|FG000|Overall Study|Other|0|||
33165448|NCT01977794|100515255|FG001|Overall Study|Other|1|||
33165449|NCT01446289|100515256|FG000|Overall Study|Withdrawal by Subject|1|||
33165450|NCT01446289|100515257|FG001|Overall Study|Withdrawal by Subject|0|||
33165451|NCT01446289|100515258|FG002|Overall Study|Withdrawal by Subject|1|||
33165452|NCT01446289|100515259|FG003|Overall Study|Withdrawal by Subject|0|||
33165453|NCT01819831|100515260|FG000|Overall Study|Withdrawal by Subject|1|||
33165454|NCT01350492|100515261|FG000|Intervention|Lost to Follow-up|2|||
33165455|NCT01350492|100515262|FG001|Intervention|Lost to Follow-up|5|||
33165456|NCT01350492|100515261|FG000|Intervention|Withdrawal by Subject|3|||
33165457|NCT01350492|100515262|FG001|Intervention|Withdrawal by Subject|1|||
33165458|NCT01350492|100515261|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
33165459|NCT01350492|100515262|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
33165460|NCT01350492|100515261|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
33165461|NCT01350492|100515262|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
33165462|NCT01496807|100515263|FG000|Overall Study|Progressive Disease|21|||
33165463|NCT01496807|100515263|FG000|Overall Study|Participant preference/toxicity|8|||
33165464|NCT01496807|100515263|FG000|Overall Study|Change in diagnosis|1|||
33165465|NCT02130570|100515266|FG000|Overall Study|Death|3|||
33165466|NCT02130570|100515267|FG001|Overall Study|Death|5|||
33165467|NCT02130570|100515266|FG000|Overall Study|Withdrawal by Subject|6|||
33165468|NCT02130570|100515267|FG001|Overall Study|Withdrawal by Subject|3|||
33165469|NCT02130570|100515266|FG000|Overall Study|Part of practice that discontinued study|0|||
33165470|NCT02130570|100515267|FG001|Overall Study|Part of practice that discontinued study|5|||
33165471|NCT01866930|100515268|FG000|Treatment Period|Other|1|||
33165472|NCT01866930|100515269|FG001|Treatment Period|Other|0|||
33165473|NCT01866930|100515268|FG000|Treatment Period|Death|0|||
33165474|NCT01866930|100515269|FG001|Treatment Period|Death|2|||
33165475|NCT01866930|100515268|FG000|Treatment Period|Poor/non compliance|0|||
33165476|NCT01866930|100515269|FG001|Treatment Period|Poor/non compliance|2|||
33165477|NCT01866930|100515268|FG000|Treatment Period|No longer meets study criteria|0|||
33165478|NCT01866930|100515269|FG001|Treatment Period|No longer meets study criteria|1|||
33165479|NCT01866930|100515268|FG000|Treatment Period|Withdrawal by Subject|2|||
33165480|NCT01866930|100515269|FG001|Treatment Period|Withdrawal by Subject|8|||
33165481|NCT01866930|100515268|FG000|Treatment Period|Lack of Efficacy|1|||
33165482|NCT01866930|100515269|FG001|Treatment Period|Lack of Efficacy|9|||
33165483|NCT01866930|100515268|FG000|Treatment Period|Adverse Event|4|||
33165484|NCT01866930|100515269|FG001|Treatment Period|Adverse Event|12|||
33165485|NCT01866930|100515268|FG000|Treatment Period|Lost to Follow-up|1|||
33165486|NCT01866930|100515269|FG001|Treatment Period|Lost to Follow-up|1|||
33165487|NCT01866930|100515268|FG000|Follow-up Period|Lost to Follow-up|1|||
33165488|NCT01866930|100515269|FG001|Follow-up Period|Lost to Follow-up|1|||
33165489|NCT01866930|100515268|FG000|Follow-up Period|Other|1|||
33165490|NCT01866930|100515269|FG001|Follow-up Period|Other|5|||
33165491|NCT01866930|100515268|FG000|Follow-up Period|No longer required per protocol|1|||
33165492|NCT01866930|100515269|FG001|Follow-up Period|No longer required per protocol|0|||
33165493|NCT01866930|100515268|FG000|Follow-up Period|Withdrawal by Subject|3|||
33165494|NCT01866930|100515269|FG001|Follow-up Period|Withdrawal by Subject|3|||
33165495|NCT03797014|100515270|FG000|Overall Study|Withdrawal by Subject|1|||
33165496|NCT03797014|100515270|FG000|Overall Study|Lost to Follow-up|1|||
33165497|NCT03797014|100515270|FG000|Overall Study|Protocol Violation|1|||
33165498|NCT00582166|100515274|FG000|Overall Study|Death|1|||
33165499|NCT00582166|100515274|FG000|Overall Study|Ineligible pathology|1|||
33165500|NCT02706691|100515275|FG000|Overall Study|Adverse Event|1|||
33165501|NCT00967668|100515276|FG000|Overall Study|Withdrawal by Subject|13|||
33165502|NCT00967668|100515277|FG001|Overall Study|Withdrawal by Subject|8|||
33165503|NCT00967668|100515278|FG002|Overall Study|Withdrawal by Subject|8|||
33165504|NCT00967668|100515276|FG000|Overall Study|Death|0|||
33165505|NCT00967668|100515277|FG001|Overall Study|Death|2|||
33165506|NCT00967668|100515278|FG002|Overall Study|Death|4|||
33165507|NCT00967668|100515276|FG000|Overall Study|Removed due to behavior|1|||
33165508|NCT00967668|100515277|FG001|Overall Study|Removed due to behavior|1|||
33165509|NCT00967668|100515278|FG002|Overall Study|Removed due to behavior|2|||
33165510|NCT00967668|100515276|FG000|Overall Study|Refused Year 2|11|||
33165511|NCT00967668|100515277|FG001|Overall Study|Refused Year 2|6|||
33165512|NCT00967668|100515278|FG002|Overall Study|Refused Year 2|4|||
33165513|NCT00967668|100515276|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
33165514|NCT00967668|100515277|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
33165515|NCT00967668|100515278|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
33165516|NCT00967668|100515276|FG000|Overall Study|Lost to Follow-up|15|||
33165517|NCT00967668|100515277|FG001|Overall Study|Lost to Follow-up|9|||
33165518|NCT00967668|100515278|FG002|Overall Study|Lost to Follow-up|16|||
33165519|NCT00967668|100515276|FG000|Overall Study|Refused 12-mo assessment|3|||
33165520|NCT00967668|100515277|FG001|Overall Study|Refused 12-mo assessment|1|||
33165521|NCT00967668|100515278|FG002|Overall Study|Refused 12-mo assessment|9|||
33165522|NCT00967668|100515276|FG000|Overall Study|Pregnancy|1|||
33165523|NCT00967668|100515277|FG001|Overall Study|Pregnancy|0|||
33165524|NCT00967668|100515278|FG002|Overall Study|Pregnancy|0|||
33165525|NCT01306942|100515279|FG000|Phase I|Adverse Event|2|||
33165526|NCT01306942|100515280|FG001|Phase I|Adverse Event|2|||
33165527|NCT01306942|100515281|FG002|Phase I|Adverse Event|0|||
33165528|NCT01306942|100515282|FG003|Phase I|Adverse Event|0|||
33165529|NCT01306942|100515279|FG000|Phase I|Physician Decision|3|||
33165530|NCT01306942|100515280|FG001|Phase I|Physician Decision|1|||
33165531|NCT01306942|100515281|FG002|Phase I|Physician Decision|0|||
33165532|NCT01306942|100515282|FG003|Phase I|Physician Decision|0|||
33165533|NCT01306942|100515279|FG000|Phase II|Adverse Event|0|||
33165534|NCT01306942|100515280|FG001|Phase II|Adverse Event|0|||
33165535|NCT01306942|100515281|FG002|Phase II|Adverse Event|0|||
33165536|NCT01306942|100515282|FG003|Phase II|Adverse Event|6|||
33165537|NCT01306942|100515279|FG000|Phase II|Physician Decision|2|||
33165538|NCT01306942|100515280|FG001|Phase II|Physician Decision|0|||
33165539|NCT01306942|100515281|FG002|Phase II|Physician Decision|0|||
33165540|NCT01306942|100515282|FG003|Phase II|Physician Decision|5|||
33165541|NCT01306942|100515279|FG000|Phase II|Withdrawal by Subject|0|||
33165542|NCT01306942|100515280|FG001|Phase II|Withdrawal by Subject|0|||
33165543|NCT01306942|100515281|FG002|Phase II|Withdrawal by Subject|0|||
33165544|NCT01306942|100515282|FG003|Phase II|Withdrawal by Subject|2|||
33165545|NCT01306942|100515279|FG000|Phase II|Death|0|||
33165546|NCT01306942|100515280|FG001|Phase II|Death|0|||
33165547|NCT01306942|100515281|FG002|Phase II|Death|0|||
33165548|NCT01306942|100515282|FG003|Phase II|Death|1|||
33165549|NCT01306942|100515279|FG000|Phase II|Not finished treatment|0|||
33165550|NCT01306942|100515280|FG001|Phase II|Not finished treatment|0|||
33165551|NCT01306942|100515281|FG002|Phase II|Not finished treatment|0|||
33165552|NCT01306942|100515282|FG003|Phase II|Not finished treatment|1|||
33165553|NCT01306942|100515279|FG000|Phase II|Protocol Violation|0|||
33165554|NCT01306942|100515280|FG001|Phase II|Protocol Violation|0|||
33165555|NCT01306942|100515281|FG002|Phase II|Protocol Violation|0|||
33165556|NCT01306942|100515282|FG003|Phase II|Protocol Violation|1|||
33165557|NCT02505867|100515285|FG000|Overall Study|Lack of Efficacy|6|||
33165558|NCT02505867|100515286|FG001|Overall Study|Lack of Efficacy|6|||
33165559|NCT00753415|100515287|FG000|Part A|Disease progression|1|||
33165560|NCT00753415|100515288|FG001|Part A|Disease progression|0|||
33165561|NCT00753415|100515289|FG002|Part A|Disease progression|1|||
33165562|NCT00753415|100515290|FG003|Part A|Disease progression|2|||
33165563|NCT00753415|100515291|FG004|Part A|Disease progression|0|||
33165564|NCT00753415|100515292|FG005|Part A|Disease progression|0|||
33165565|NCT00753415|100515293|FG006|Part A|Disease progression|0|||
33165566|NCT00753415|100515294|FG007|Part A|Disease progression|0|||
33165567|NCT00753415|100515295|FG008|Part A|Disease progression|0|||
33165568|NCT00753415|100515296|FG009|Part A|Disease progression|0|||
33165569|NCT00753415|100515287|FG000|Part A|Withdrawal by Subject|0|||
33165570|NCT00753415|100515288|FG001|Part A|Withdrawal by Subject|0|||
33165571|NCT00753415|100515289|FG002|Part A|Withdrawal by Subject|1|||
33165572|NCT00753415|100515290|FG003|Part A|Withdrawal by Subject|0|||
33165573|NCT00753415|100515291|FG004|Part A|Withdrawal by Subject|0|||
33165574|NCT00753415|100515292|FG005|Part A|Withdrawal by Subject|0|||
33165575|NCT00753415|100515293|FG006|Part A|Withdrawal by Subject|0|||
33165576|NCT00753415|100515294|FG007|Part A|Withdrawal by Subject|0|||
33165577|NCT00753415|100515295|FG008|Part A|Withdrawal by Subject|0|||
33165578|NCT00753415|100515296|FG009|Part A|Withdrawal by Subject|0|||
33165579|NCT00753415|100515287|FG000|Part B|Lost to Follow-up|0|||
33165580|NCT00753415|100515288|FG001|Part B|Lost to Follow-up|0|||
33165581|NCT00753415|100515289|FG002|Part B|Lost to Follow-up|0|||
33165582|NCT00753415|100515290|FG003|Part B|Lost to Follow-up|0|||
33165583|NCT00753415|100515291|FG004|Part B|Lost to Follow-up|0|||
33165584|NCT00753415|100515292|FG005|Part B|Lost to Follow-up|0|||
33165585|NCT00753415|100515293|FG006|Part B|Lost to Follow-up|0|||
33165586|NCT00753415|100515294|FG007|Part B|Lost to Follow-up|1|||
33165587|NCT00753415|100515295|FG008|Part B|Lost to Follow-up|1|||
33165588|NCT00753415|100515296|FG009|Part B|Lost to Follow-up|0|||
33165589|NCT00753415|100515287|FG000|Part B|Disease progression|0|||
33165590|NCT00753415|100515288|FG001|Part B|Disease progression|0|||
33165591|NCT00753415|100515289|FG002|Part B|Disease progression|0|||
33165592|NCT00753415|100515290|FG003|Part B|Disease progression|0|||
33165593|NCT00753415|100515291|FG004|Part B|Disease progression|0|||
33165594|NCT00753415|100515292|FG005|Part B|Disease progression|0|||
33258754|NCT01599104|100849589|FG000|Overall Study|Non-compliance with study treatment|0|||
33165595|NCT00753415|100515293|FG006|Part B|Disease progression|0|||
33165596|NCT00753415|100515294|FG007|Part B|Disease progression|0|||
33165597|NCT00753415|100515295|FG008|Part B|Disease progression|2|||
33258755|NCT01599104|100849590|FG001|Overall Study|Non-compliance with study treatment|1|||
33165598|NCT00753415|100515296|FG009|Part B|Disease progression|1|||
33165599|NCT03060629|100515298|FG000|Overall Study|Death|4|||
33165600|NCT03060629|100515299|FG001|Overall Study|Death|5|||
33165601|NCT03060629|100515298|FG000|Overall Study|Withdrawal by Subject|50|||
33165602|NCT03060629|100515299|FG001|Overall Study|Withdrawal by Subject|35|||
33165603|NCT03060629|100515298|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
33165604|NCT03060629|100515299|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
33165605|NCT03060629|100515298|FG000|Overall Study|Participant Relocate|15|||
33165606|NCT03060629|100515299|FG001|Overall Study|Participant Relocate|15|||
33165607|NCT03060629|100515298|FG000|Overall Study|Unable to Contact Participant|34|||
33165608|NCT03060629|100515299|FG001|Overall Study|Unable to Contact Participant|23|||
33165609|NCT03060629|100515298|FG000|Overall Study|Investigator Decision|7|||
33165610|NCT03060629|100515299|FG001|Overall Study|Investigator Decision|7|||
33165611|NCT03060629|100515298|FG000|Overall Study|Study Terminated by Sponsor|1100|||
33165612|NCT03060629|100515299|FG001|Overall Study|Study Terminated by Sponsor|1123|||
33165613|NCT03060629|100515298|FG000|Overall Study|Other|4|||
33165614|NCT03060629|100515299|FG001|Overall Study|Other|4|||
33165615|NCT00042289|100515300|FG000|Overall Study|Lost to Follow-up|3|||
33165616|NCT00042289|100515301|FG001|Overall Study|Lost to Follow-up|0|||
33165617|NCT00042289|100515302|FG002|Overall Study|Lost to Follow-up|0|||
33165618|NCT00042289|100515303|FG003|Overall Study|Lost to Follow-up|1|||
33165619|NCT00042289|100515304|FG004|Overall Study|Lost to Follow-up|3|||
33165620|NCT00042289|100515305|FG005|Overall Study|Lost to Follow-up|3|||
33165621|NCT00042289|100515306|FG006|Overall Study|Lost to Follow-up|6|||
33165622|NCT00042289|100515307|FG007|Overall Study|Lost to Follow-up|1|||
33165623|NCT00042289|100515308|FG008|Overall Study|Lost to Follow-up|1|||
33445669|NCT01597245|101522673|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
33445670|NCT01597245|101522674|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
33445671|NCT01597245|101522675|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445672|NCT01597245|101522676|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445673|NCT01597245|101522677|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445674|NCT01597245|101522678|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445675|NCT01597245|101522679|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
33445676|NCT01597245|101522659|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445677|NCT01597245|101522660|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445678|NCT01597245|101522661|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445679|NCT01597245|101522662|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445680|NCT01597245|101522663|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445681|NCT01597245|101522664|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445682|NCT01597245|101522665|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445683|NCT01597245|101522666|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445684|NCT01597245|101522667|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445685|NCT01597245|101522668|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445686|NCT01597245|101522669|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445687|NCT01597245|101522670|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445688|NCT01597245|101522671|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445689|NCT01597245|101522672|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445690|NCT01597245|101522673|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
33445691|NCT01597245|101522674|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
33445692|NCT01597245|101522675|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445693|NCT01597245|101522676|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445694|NCT01597245|101522677|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445695|NCT01597245|101522678|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445696|NCT01597245|101522679|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
33445697|NCT01597245|101522659|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33165624|NCT00042289|100515309|FG009|Overall Study|Lost to Follow-up|0|||
33165625|NCT00042289|100515310|FG010|Overall Study|Lost to Follow-up|0|||
33165626|NCT00042289|100515311|FG011|Overall Study|Lost to Follow-up|0|||
33445698|NCT01597245|101522660|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445699|NCT01597245|101522661|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445700|NCT01597245|101522662|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445701|NCT01597245|101522663|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445702|NCT01597245|101522664|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445703|NCT01597245|101522665|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445704|NCT01597245|101522666|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445705|NCT01597245|101522667|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445706|NCT01597245|101522668|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445707|NCT01597245|101522669|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445708|NCT01597245|101522670|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445709|NCT01597245|101522671|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445710|NCT01597245|101522672|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445711|NCT01597245|101522673|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
33445712|NCT01597245|101522674|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
33445713|NCT01597245|101522675|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445714|NCT01597245|101522676|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445715|NCT01597245|101522677|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445716|NCT01597245|101522678|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445717|NCT01597245|101522679|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
33445718|NCT01597245|101522659|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445719|NCT01597245|101522660|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445720|NCT01597245|101522661|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445721|NCT01597245|101522662|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445722|NCT01597245|101522663|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445723|NCT01597245|101522664|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445724|NCT01597245|101522665|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445725|NCT01597245|101522666|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33258756|NCT01599104|100849591|FG002|Overall Study|Non-compliance with study treatment|0|||
33258757|NCT01599104|100849589|FG000|Overall Study|Lack of Efficacy|4|||
33165627|NCT00042289|100515312|FG012|Overall Study|Lost to Follow-up|0|||
33445726|NCT01597245|101522667|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445727|NCT01597245|101522668|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445728|NCT01597245|101522669|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445729|NCT01597245|101522670|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445730|NCT01597245|101522671|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445731|NCT01597245|101522672|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445732|NCT01597245|101522673|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
33445733|NCT01597245|101522674|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
33445734|NCT01597245|101522675|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445735|NCT01597245|101522676|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445736|NCT01597245|101522677|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33445737|NCT01597245|101522678|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33258758|NCT01599104|100849590|FG001|Overall Study|Lack of Efficacy|4|||
33258759|NCT01599104|100849591|FG002|Overall Study|Lack of Efficacy|10|||
33445738|NCT01597245|101522679|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
33258760|NCT01599104|100849589|FG000|Overall Study|Adverse Event|7|||
33258761|NCT01599104|100849590|FG001|Overall Study|Adverse Event|6|||
33258762|NCT01599104|100849591|FG002|Overall Study|Adverse Event|12|||
33258763|NCT03262935|100849592|FG000|Overall Study|Withdrawal by Subject|6|||
33165628|NCT00042289|100515313|FG013|Overall Study|Lost to Follow-up|0|||
33165629|NCT00042289|100515314|FG014|Overall Study|Lost to Follow-up|0|||
33165630|NCT00042289|100515315|FG015|Overall Study|Lost to Follow-up|1|||
33165631|NCT00042289|100515316|FG016|Overall Study|Lost to Follow-up|1|||
33165632|NCT00042289|100515317|FG017|Overall Study|Lost to Follow-up|0|||
33165633|NCT00042289|100515318|FG018|Overall Study|Lost to Follow-up|3|||
33165634|NCT00042289|100515319|FG019|Overall Study|Lost to Follow-up|2|||
33165635|NCT00042289|100515320|FG020|Overall Study|Lost to Follow-up|0|||
33165636|NCT00042289|100515321|FG021|Overall Study|Lost to Follow-up|0|||
33165637|NCT00042289|100515322|FG022|Overall Study|Lost to Follow-up|0|||
33165638|NCT00042289|100515323|FG023|Overall Study|Lost to Follow-up|0|||
33165639|NCT00042289|100515324|FG024|Overall Study|Lost to Follow-up|0|||
33165640|NCT00042289|100515325|FG025|Overall Study|Lost to Follow-up|0|||
33165641|NCT00042289|100515326|FG026|Overall Study|Lost to Follow-up|2|||
33165642|NCT00042289|100515327|FG027|Overall Study|Lost to Follow-up|2|||
33165643|NCT00042289|100515328|FG028|Overall Study|Lost to Follow-up|2|||
33165644|NCT00042289|100515329|FG029|Overall Study|Lost to Follow-up|0|||
33165645|NCT00042289|100515330|FG030|Overall Study|Lost to Follow-up|0|||
33165646|NCT00042289|100515331|FG031|Overall Study|Lost to Follow-up|2|||
33165647|NCT00042289|100515332|FG032|Overall Study|Lost to Follow-up|1|||
33165648|NCT00042289|100515333|FG033|Overall Study|Lost to Follow-up|1|||
33165649|NCT00042289|100515334|FG034|Overall Study|Lost to Follow-up|1|||
33165650|NCT00042289|100515335|FG035|Overall Study|Lost to Follow-up|2|||
33165651|NCT00042289|100515336|FG036|Overall Study|Lost to Follow-up|1|||
33165652|NCT00042289|100515337|FG037|Overall Study|Lost to Follow-up|1|||
33165653|NCT00042289|100515338|FG038|Overall Study|Lost to Follow-up|0|||
33165654|NCT00042289|100515339|FG039|Overall Study|Lost to Follow-up|5|||
33165655|NCT00042289|100515340|FG040|Overall Study|Lost to Follow-up|0|||
33165656|NCT00042289|100515341|FG041|Overall Study|Lost to Follow-up|2|||
33165657|NCT00042289|100515342|FG042|Overall Study|Lost to Follow-up|2|||
33165658|NCT00042289|100515343|FG043|Overall Study|Lost to Follow-up|0|||
33165659|NCT00042289|100515344|FG044|Overall Study|Lost to Follow-up|0|||
33165660|NCT00042289|100515345|FG045|Overall Study|Lost to Follow-up|1|||
33165661|NCT00042289|100515346|FG046|Overall Study|Lost to Follow-up|0|||
33165662|NCT00042289|100515300|FG000|Overall Study|Other reason|0|||
33165663|NCT00042289|100515301|FG001|Overall Study|Other reason|0|||
33165664|NCT00042289|100515302|FG002|Overall Study|Other reason|0|||
33258764|NCT03262935|100849593|FG001|Overall Study|Withdrawal by Subject|7|||
33165665|NCT00042289|100515303|FG003|Overall Study|Other reason|2|||
33258765|NCT03262935|100849592|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
33258766|NCT03262935|100849593|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
33165666|NCT00042289|100515304|FG004|Overall Study|Other reason|0|||
33258767|NCT03262935|100849592|FG000|Overall Study|Death|181|||
33258768|NCT03262935|100849593|FG001|Overall Study|Death|94|||
33258769|NCT03262935|100849592|FG000|Overall Study|Lost to Follow-up|9|||
33258770|NCT03262935|100849593|FG001|Overall Study|Lost to Follow-up|4|||
33258771|NCT03262935|100849592|FG000|Overall Study|Other reason|5|||
33258772|NCT03262935|100849593|FG001|Overall Study|Other reason|0|||
33258773|NCT03733119|100849594|FG000|Overall Study|Physician Decision|2|||
33258774|NCT03733119|100849595|FG001|Overall Study|Physician Decision|1|||
33258775|NCT03733119|100849594|FG000|Overall Study|ineligible to treat per protocol|0|||
33258776|NCT03733119|100849595|FG001|Overall Study|ineligible to treat per protocol|1|||
33258777|NCT01599793|100849596|FG000|Overall Study|Adverse Event|2|||
33258778|NCT01414738|100849597|FG000|Overall Study|Death|26|||
33258779|NCT01414738|100849597|FG000|Overall Study|Refused testing|5|||
33258780|NCT01414738|100849597|FG000|Overall Study|Lost to Follow-up|2|||
33258781|NCT01414738|100849597|FG000|Overall Study|Refused, disease progression|8|||
33258782|NCT01414738|100849597|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
33258783|NCT01037985|100849598|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
33258784|NCT01037985|100849599|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
33258785|NCT01037985|100849598|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
33258786|NCT01037985|100849599|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
33258787|NCT01037985|100849598|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
33258788|NCT01037985|100849599|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
33258789|NCT01037985|100849598|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
33258790|NCT01037985|100849599|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
33258791|NCT00446459|100849600|FG000|8 Months|Protocol Violation|12|||
33258792|NCT00446459|100849600|FG000|12 Months|Protocol Violation|4|||
33258793|NCT00446459|100849600|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
33258794|NCT00549848|100849601|FG000|Overall Study|Death|1|||
33258795|NCT00549848|100849602|FG001|Overall Study|Death|4|||
33258796|NCT00549848|100849603|FG002|Overall Study|Death|13|||
33258797|NCT00549848|100849601|FG000|Overall Study|Physician Decision|0|||
33258798|NCT00549848|100849602|FG001|Overall Study|Physician Decision|0|||
33258799|NCT00549848|100849603|FG002|Overall Study|Physician Decision|4|||
33258800|NCT00549848|100849601|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
33258801|NCT00549848|100849602|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
33258802|NCT00549848|100849603|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
33258803|NCT00549848|100849601|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
33258804|NCT00549848|100849602|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
33258805|NCT00549848|100849603|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
33258806|NCT00549848|100849601|FG000|Overall Study|Participant/Family Withdraw|2|||
33258807|NCT00549848|100849602|FG001|Overall Study|Participant/Family Withdraw|3|||
33258808|NCT00549848|100849603|FG002|Overall Study|Participant/Family Withdraw|5|||
33258809|NCT00549848|100849601|FG000|Overall Study|Second Malignancy|1|||
33258810|NCT00549848|100849602|FG001|Overall Study|Second Malignancy|0|||
33258811|NCT00549848|100849603|FG002|Overall Study|Second Malignancy|0|||
33258812|NCT00549848|100849601|FG000|Overall Study|Transplant|3|||
33258813|NCT00549848|100849602|FG001|Overall Study|Transplant|3|||
33258814|NCT00549848|100849603|FG002|Overall Study|Transplant|18|||
33258815|NCT00549848|100849601|FG000|Overall Study|Unacceptable Toxicity|1|||
33258816|NCT00549848|100849602|FG001|Overall Study|Unacceptable Toxicity|6|||
33258817|NCT00549848|100849603|FG002|Overall Study|Unacceptable Toxicity|6|||
33258818|NCT01494922|100849606|FG000|Overall Study|Adverse Event|1|||
33258819|NCT05368831|100849607|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
33258820|NCT02121002|100849608|FG000|Overall Study|Physician Decision|2|||
33258821|NCT02121002|100849609|FG001|Overall Study|Physician Decision|0|||
33258822|NCT02121002|100849610|FG002|Overall Study|Physician Decision|0|||
33258823|NCT02121002|100849608|FG000|Overall Study|Withdrawal by Subject|3|||
33258824|NCT02121002|100849609|FG001|Overall Study|Withdrawal by Subject|1|||
33165667|NCT00042289|100515305|FG005|Overall Study|Other reason|0|||
33165668|NCT00042289|100515306|FG006|Overall Study|Other reason|0|||
33165669|NCT00042289|100515307|FG007|Overall Study|Other reason|0|||
33165670|NCT00042289|100515308|FG008|Overall Study|Other reason|0|||
33165671|NCT00042289|100515309|FG009|Overall Study|Other reason|0|||
33165672|NCT00042289|100515310|FG010|Overall Study|Other reason|0|||
33165673|NCT00042289|100515311|FG011|Overall Study|Other reason|0|||
33165674|NCT00042289|100515312|FG012|Overall Study|Other reason|0|||
33165675|NCT00042289|100515313|FG013|Overall Study|Other reason|0|||
33165676|NCT00042289|100515314|FG014|Overall Study|Other reason|0|||
33165677|NCT00042289|100515315|FG015|Overall Study|Other reason|0|||
33165678|NCT00042289|100515316|FG016|Overall Study|Other reason|0|||
33165679|NCT00042289|100515317|FG017|Overall Study|Other reason|0|||
33165680|NCT00042289|100515318|FG018|Overall Study|Other reason|1|||
33165681|NCT00042289|100515319|FG019|Overall Study|Other reason|0|||
33165682|NCT00042289|100515320|FG020|Overall Study|Other reason|0|||
33165683|NCT00042289|100515321|FG021|Overall Study|Other reason|0|||
33165684|NCT00042289|100515322|FG022|Overall Study|Other reason|0|||
33165685|NCT00042289|100515323|FG023|Overall Study|Other reason|1|||
33165686|NCT00042289|100515324|FG024|Overall Study|Other reason|0|||
33165687|NCT00042289|100515325|FG025|Overall Study|Other reason|0|||
33165688|NCT00042289|100515326|FG026|Overall Study|Other reason|1|||
33165689|NCT00042289|100515327|FG027|Overall Study|Other reason|0|||
33165690|NCT00042289|100515328|FG028|Overall Study|Other reason|3|||
33165691|NCT00042289|100515329|FG029|Overall Study|Other reason|0|||
33165692|NCT00042289|100515330|FG030|Overall Study|Other reason|0|||
33165693|NCT00042289|100515331|FG031|Overall Study|Other reason|1|||
33165694|NCT00042289|100515332|FG032|Overall Study|Other reason|0|||
33165695|NCT00042289|100515333|FG033|Overall Study|Other reason|1|||
33165696|NCT00042289|100515334|FG034|Overall Study|Other reason|0|||
33165697|NCT00042289|100515335|FG035|Overall Study|Other reason|2|||
33165698|NCT00042289|100515336|FG036|Overall Study|Other reason|0|||
33165699|NCT00042289|100515337|FG037|Overall Study|Other reason|0|||
33165700|NCT00042289|100515338|FG038|Overall Study|Other reason|0|||
33165701|NCT00042289|100515339|FG039|Overall Study|Other reason|0|||
33165702|NCT00042289|100515340|FG040|Overall Study|Other reason|0|||
33165703|NCT00042289|100515341|FG041|Overall Study|Other reason|0|||
33165704|NCT00042289|100515342|FG042|Overall Study|Other reason|0|||
33165705|NCT00042289|100515343|FG043|Overall Study|Other reason|1|||
33165706|NCT00042289|100515344|FG044|Overall Study|Other reason|0|||
33165707|NCT00042289|100515345|FG045|Overall Study|Other reason|0|||
33165708|NCT00042289|100515346|FG046|Overall Study|Other reason|0|||
33165709|NCT00042289|100515300|FG000|Overall Study|Severe debilitation, unable to continue|0|||
33165710|NCT00042289|100515301|FG001|Overall Study|Severe debilitation, unable to continue|0|||
33165711|NCT00042289|100515302|FG002|Overall Study|Severe debilitation, unable to continue|0|||
33165712|NCT00042289|100515303|FG003|Overall Study|Severe debilitation, unable to continue|0|||
33165713|NCT00042289|100515304|FG004|Overall Study|Severe debilitation, unable to continue|0|||
33165714|NCT00042289|100515305|FG005|Overall Study|Severe debilitation, unable to continue|0|||
33165715|NCT00042289|100515306|FG006|Overall Study|Severe debilitation, unable to continue|0|||
33165716|NCT00042289|100515307|FG007|Overall Study|Severe debilitation, unable to continue|0|||
33165717|NCT00042289|100515308|FG008|Overall Study|Severe debilitation, unable to continue|0|||
33165718|NCT00042289|100515309|FG009|Overall Study|Severe debilitation, unable to continue|0|||
33165719|NCT00042289|100515310|FG010|Overall Study|Severe debilitation, unable to continue|0|||
33165720|NCT00042289|100515311|FG011|Overall Study|Severe debilitation, unable to continue|0|||
33165721|NCT00042289|100515312|FG012|Overall Study|Severe debilitation, unable to continue|0|||
33165722|NCT00042289|100515313|FG013|Overall Study|Severe debilitation, unable to continue|0|||
33165723|NCT00042289|100515314|FG014|Overall Study|Severe debilitation, unable to continue|0|||
33165724|NCT00042289|100515315|FG015|Overall Study|Severe debilitation, unable to continue|0|||
33165725|NCT00042289|100515316|FG016|Overall Study|Severe debilitation, unable to continue|0|||
33165726|NCT00042289|100515317|FG017|Overall Study|Severe debilitation, unable to continue|0|||
33165727|NCT00042289|100515318|FG018|Overall Study|Severe debilitation, unable to continue|0|||
33165728|NCT00042289|100515319|FG019|Overall Study|Severe debilitation, unable to continue|0|||
33165729|NCT00042289|100515320|FG020|Overall Study|Severe debilitation, unable to continue|0|||
33165730|NCT00042289|100515321|FG021|Overall Study|Severe debilitation, unable to continue|1|||
33165731|NCT00042289|100515322|FG022|Overall Study|Severe debilitation, unable to continue|0|||
33165732|NCT00042289|100515323|FG023|Overall Study|Severe debilitation, unable to continue|1|||
33165733|NCT00042289|100515324|FG024|Overall Study|Severe debilitation, unable to continue|0|||
33258825|NCT02121002|100849610|FG002|Overall Study|Withdrawal by Subject|4|||
33258826|NCT02121002|100849608|FG000|Overall Study|Protocol Violation|1|||
33258827|NCT02121002|100849609|FG001|Overall Study|Protocol Violation|2|||
33258828|NCT02121002|100849610|FG002|Overall Study|Protocol Violation|4|||
33258829|NCT02121002|100849608|FG000|Overall Study|Concomitant therapy|0|||
33258830|NCT02121002|100849609|FG001|Overall Study|Concomitant therapy|1|||
33445739|NCT01597245|101522659|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445740|NCT01597245|101522660|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445741|NCT01597245|101522661|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445742|NCT01597245|101522662|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445743|NCT01597245|101522663|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445744|NCT01597245|101522664|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445745|NCT01597245|101522665|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445746|NCT01597245|101522666|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445747|NCT01597245|101522667|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445748|NCT01597245|101522668|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445749|NCT01597245|101522669|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445750|NCT01597245|101522670|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445751|NCT01597245|101522671|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33165734|NCT00042289|100515325|FG025|Overall Study|Severe debilitation, unable to continue|0|||
33165735|NCT00042289|100515326|FG026|Overall Study|Severe debilitation, unable to continue|0|||
33165736|NCT00042289|100515327|FG027|Overall Study|Severe debilitation, unable to continue|1|||
33165737|NCT00042289|100515328|FG028|Overall Study|Severe debilitation, unable to continue|0|||
33165738|NCT00042289|100515329|FG029|Overall Study|Severe debilitation, unable to continue|0|||
33165739|NCT00042289|100515330|FG030|Overall Study|Severe debilitation, unable to continue|0|||
33165740|NCT00042289|100515331|FG031|Overall Study|Severe debilitation, unable to continue|1|||
33165741|NCT00042289|100515332|FG032|Overall Study|Severe debilitation, unable to continue|1|||
33258831|NCT02121002|100849610|FG002|Overall Study|Concomitant therapy|1|||
33258832|NCT02121002|100849608|FG000|Overall Study|Others|1|||
33258833|NCT02121002|100849609|FG001|Overall Study|Others|0|||
33258834|NCT02121002|100849610|FG002|Overall Study|Others|1|||
33258835|NCT02372253|100849617|FG000|Overall Study|Non Compliance|2|||
33258836|NCT02372253|100849618|FG001|Overall Study|Non Compliance|0|||
33258837|NCT00566735|100849619|FG000|Overall Study|Withdrawal by Subject|0|||
33258838|NCT00566735|100849620|FG001|Overall Study|Withdrawal by Subject|1|||
33258839|NCT00566735|100849619|FG000|Overall Study|Refused neuropsychological testing|2|||
33258840|NCT00566735|100849620|FG001|Overall Study|Refused neuropsychological testing|5|||
33258841|NCT00566735|100849619|FG000|Overall Study|Switched into a manic episode|0|||
33258842|NCT00566735|100849620|FG001|Overall Study|Switched into a manic episode|1|||
33258843|NCT01636687|100849622|FG000|Induction Period|Withdrawal by Subject|1|||
33258844|NCT01636687|100849623|FG001|Induction Period|Withdrawal by Subject|0|||
33258845|NCT01636687|100849624|FG002|Induction Period|Withdrawal by Subject|0|||
33258846|NCT01636687|100849625|FG003|Induction Period|Withdrawal by Subject|0|||
33258847|NCT01636687|100849626|FG004|Induction Period|Withdrawal by Subject|0|||
33258848|NCT01636687|100849622|FG000|Induction Period|Adverse Event|1|||
33445752|NCT01597245|101522672|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
33445753|NCT01597245|101522673|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445754|NCT01597245|101522674|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445755|NCT01597245|101522675|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33258849|NCT01636687|100849623|FG001|Induction Period|Adverse Event|0|||
33258850|NCT01636687|100849624|FG002|Induction Period|Adverse Event|0|||
33165742|NCT00042289|100515333|FG033|Overall Study|Severe debilitation, unable to continue|0|||
33165743|NCT00042289|100515334|FG034|Overall Study|Severe debilitation, unable to continue|0|||
33165744|NCT00042289|100515335|FG035|Overall Study|Severe debilitation, unable to continue|0|||
33165745|NCT00042289|100515336|FG036|Overall Study|Severe debilitation, unable to continue|0|||
33165746|NCT00042289|100515337|FG037|Overall Study|Severe debilitation, unable to continue|0|||
33165747|NCT00042289|100515338|FG038|Overall Study|Severe debilitation, unable to continue|0|||
33165748|NCT00042289|100515339|FG039|Overall Study|Severe debilitation, unable to continue|0|||
33165749|NCT00042289|100515340|FG040|Overall Study|Severe debilitation, unable to continue|0|||
33165750|NCT00042289|100515341|FG041|Overall Study|Severe debilitation, unable to continue|0|||
33165751|NCT00042289|100515342|FG042|Overall Study|Severe debilitation, unable to continue|0|||
33165752|NCT00042289|100515343|FG043|Overall Study|Severe debilitation, unable to continue|0|||
33165753|NCT00042289|100515344|FG044|Overall Study|Severe debilitation, unable to continue|0|||
33165754|NCT00042289|100515345|FG045|Overall Study|Severe debilitation, unable to continue|0|||
33165755|NCT00042289|100515346|FG046|Overall Study|Severe debilitation, unable to continue|0|||
33165756|NCT00042289|100515300|FG000|Overall Study|Site closed|0|||
33165757|NCT00042289|100515301|FG001|Overall Study|Site closed|0|||
33165758|NCT00042289|100515302|FG002|Overall Study|Site closed|0|||
33165759|NCT00042289|100515303|FG003|Overall Study|Site closed|0|||
33165760|NCT00042289|100515304|FG004|Overall Study|Site closed|0|||
33445756|NCT01597245|101522676|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445757|NCT01597245|101522677|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445758|NCT01597245|101522678|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445759|NCT01597245|101522679|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
33445760|NCT01597245|101522659|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33445761|NCT01597245|101522660|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33445762|NCT01597245|101522661|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33445763|NCT01597245|101522662|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33445764|NCT01597245|101522663|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33445765|NCT01597245|101522664|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33445766|NCT01597245|101522665|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33445767|NCT01597245|101522666|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33445768|NCT01597245|101522667|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33445769|NCT01597245|101522668|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33445770|NCT01597245|101522669|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33445771|NCT01597245|101522670|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33445772|NCT01597245|101522671|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33445773|NCT01597245|101522672|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33445774|NCT01597245|101522673|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33165761|NCT00042289|100515305|FG005|Overall Study|Site closed|0|||
33165762|NCT00042289|100515306|FG006|Overall Study|Site closed|0|||
33445775|NCT01597245|101522674|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
33165763|NCT00042289|100515307|FG007|Overall Study|Site closed|0|||
33165764|NCT00042289|100515308|FG008|Overall Study|Site closed|0|||
33165765|NCT00042289|100515309|FG009|Overall Study|Site closed|0|||
33165766|NCT00042289|100515310|FG010|Overall Study|Site closed|0|||
33165767|NCT00042289|100515311|FG011|Overall Study|Site closed|0|||
33165768|NCT00042289|100515312|FG012|Overall Study|Site closed|0|||
33165769|NCT00042289|100515313|FG013|Overall Study|Site closed|0|||
33165770|NCT00042289|100515314|FG014|Overall Study|Site closed|0|||
33165771|NCT00042289|100515315|FG015|Overall Study|Site closed|0|||
33165772|NCT00042289|100515316|FG016|Overall Study|Site closed|0|||
33165773|NCT00042289|100515317|FG017|Overall Study|Site closed|0|||
33165774|NCT00042289|100515318|FG018|Overall Study|Site closed|0|||
33165775|NCT00042289|100515319|FG019|Overall Study|Site closed|0|||
33165776|NCT00042289|100515320|FG020|Overall Study|Site closed|0|||
33165777|NCT00042289|100515321|FG021|Overall Study|Site closed|0|||
33165778|NCT00042289|100515322|FG022|Overall Study|Site closed|0|||
33165779|NCT00042289|100515323|FG023|Overall Study|Site closed|0|||
33165780|NCT00042289|100515324|FG024|Overall Study|Site closed|0|||
33165781|NCT00042289|100515325|FG025|Overall Study|Site closed|0|||
33165782|NCT00042289|100515326|FG026|Overall Study|Site closed|0|||
33165783|NCT00042289|100515327|FG027|Overall Study|Site closed|0|||
33165784|NCT00042289|100515328|FG028|Overall Study|Site closed|0|||
33165785|NCT00042289|100515329|FG029|Overall Study|Site closed|0|||
33165786|NCT00042289|100515330|FG030|Overall Study|Site closed|0|||
33165787|NCT00042289|100515331|FG031|Overall Study|Site closed|3|||
33165788|NCT00042289|100515332|FG032|Overall Study|Site closed|0|||
33165789|NCT00042289|100515333|FG033|Overall Study|Site closed|0|||
33165790|NCT00042289|100515334|FG034|Overall Study|Site closed|0|||
33165791|NCT00042289|100515335|FG035|Overall Study|Site closed|0|||
33165792|NCT00042289|100515336|FG036|Overall Study|Site closed|1|||
33165793|NCT00042289|100515337|FG037|Overall Study|Site closed|0|||
33165794|NCT00042289|100515338|FG038|Overall Study|Site closed|0|||
33165795|NCT00042289|100515339|FG039|Overall Study|Site closed|0|||
33165796|NCT00042289|100515340|FG040|Overall Study|Site closed|0|||
33165797|NCT00042289|100515341|FG041|Overall Study|Site closed|0|||
33165798|NCT00042289|100515342|FG042|Overall Study|Site closed|1|||
33165799|NCT00042289|100515343|FG043|Overall Study|Site closed|0|||
33165800|NCT00042289|100515344|FG044|Overall Study|Site closed|0|||
33165801|NCT00042289|100515345|FG045|Overall Study|Site closed|0|||
33165802|NCT00042289|100515346|FG046|Overall Study|Site closed|0|||
33165803|NCT00042289|100515300|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
33165804|NCT00042289|100515301|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
33165805|NCT00042289|100515302|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
33165806|NCT00042289|100515303|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
33165807|NCT00042289|100515304|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
33165808|NCT00042289|100515305|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
33165809|NCT00042289|100515306|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
33165810|NCT00042289|100515307|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
33165811|NCT00042289|100515308|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
33165812|NCT00042289|100515309|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
33165813|NCT00042289|100515310|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
33258851|NCT01636687|100849625|FG003|Induction Period|Adverse Event|0|||
33258852|NCT01636687|100849626|FG004|Induction Period|Adverse Event|1|||
33258853|NCT01636687|100849622|FG000|Induction Period|Lack of Efficacy|0|||
33258854|NCT01636687|100849623|FG001|Induction Period|Lack of Efficacy|0|||
33258855|NCT01636687|100849624|FG002|Induction Period|Lack of Efficacy|0|||
33258856|NCT01636687|100849625|FG003|Induction Period|Lack of Efficacy|0|||
33258857|NCT01636687|100849626|FG004|Induction Period|Lack of Efficacy|1|||
33258858|NCT01636687|100849622|FG000|Induction Period|Physician Decision|1|||
33258859|NCT01636687|100849623|FG001|Induction Period|Physician Decision|0|||
33258860|NCT01636687|100849624|FG002|Induction Period|Physician Decision|0|||
33258861|NCT01636687|100849625|FG003|Induction Period|Physician Decision|0|||
33165814|NCT00042289|100515311|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
33165815|NCT00042289|100515312|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
33165816|NCT00042289|100515313|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
33165817|NCT00042289|100515314|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
33165818|NCT00042289|100515315|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
33165819|NCT00042289|100515316|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
33165820|NCT00042289|100515317|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
33165821|NCT00042289|100515318|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
33165822|NCT00042289|100515319|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
33165823|NCT00042289|100515320|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
33165824|NCT00042289|100515321|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
33165825|NCT00042289|100515322|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
33165826|NCT00042289|100515323|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
33258862|NCT01636687|100849626|FG004|Induction Period|Physician Decision|0|||
33258863|NCT01636687|100849622|FG000|Maintenance Period|Withdrawal by Subject|2|||
33258864|NCT01636687|100849623|FG001|Maintenance Period|Withdrawal by Subject|0|||
33258865|NCT01636687|100849624|FG002|Maintenance Period|Withdrawal by Subject|2|||
33258866|NCT01636687|100849625|FG003|Maintenance Period|Withdrawal by Subject|0|||
33258867|NCT01636687|100849626|FG004|Maintenance Period|Withdrawal by Subject|0|||
33258868|NCT01636687|100849622|FG000|Maintenance Period|Adverse Event|1|||
33258869|NCT01636687|100849623|FG001|Maintenance Period|Adverse Event|0|||
33258870|NCT01636687|100849624|FG002|Maintenance Period|Adverse Event|0|||
33258871|NCT01636687|100849625|FG003|Maintenance Period|Adverse Event|0|||
33258872|NCT01636687|100849626|FG004|Maintenance Period|Adverse Event|0|||
33445776|NCT01597245|101522675|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
33445777|NCT01597245|101522676|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
33445778|NCT01597245|101522677|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
33445779|NCT01597245|101522678|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
33445780|NCT01597245|101522679|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
33445781|NCT01597245|101522659|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445782|NCT01597245|101522660|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445783|NCT01597245|101522661|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445784|NCT01597245|101522662|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445785|NCT01597245|101522663|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445786|NCT01597245|101522664|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445787|NCT01597245|101522665|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445788|NCT01597245|101522666|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445789|NCT01597245|101522667|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445790|NCT01597245|101522668|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445791|NCT01597245|101522669|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445792|NCT01597245|101522670|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445793|NCT01597245|101522671|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445794|NCT01597245|101522672|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445795|NCT01597245|101522673|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445796|NCT01597245|101522674|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445797|NCT01597245|101522675|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
33445798|NCT01597245|101522676|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
33445799|NCT01597245|101522677|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
33445800|NCT01597245|101522678|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
33445801|NCT01597245|101522679|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
33445802|NCT01597245|101522659|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445803|NCT01597245|101522660|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445804|NCT01597245|101522661|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445805|NCT01597245|101522662|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445806|NCT01597245|101522663|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445807|NCT01597245|101522664|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445808|NCT01597245|101522665|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445809|NCT01597245|101522666|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33258873|NCT01636687|100849622|FG000|Maintenance Period|Lack of Efficacy|4|||
33258874|NCT01636687|100849623|FG001|Maintenance Period|Lack of Efficacy|1|||
33445810|NCT01597245|101522667|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445811|NCT01597245|101522668|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445812|NCT01597245|101522669|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445813|NCT01597245|101522670|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445814|NCT01597245|101522671|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33258875|NCT01636687|100849624|FG002|Maintenance Period|Lack of Efficacy|0|||
33258876|NCT01636687|100849625|FG003|Maintenance Period|Lack of Efficacy|0|||
33165827|NCT00042289|100515324|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
33165828|NCT00042289|100515325|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
33165829|NCT00042289|100515326|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
33165830|NCT00042289|100515327|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
33165831|NCT00042289|100515328|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
33258877|NCT01636687|100849626|FG004|Maintenance Period|Lack of Efficacy|0|||
33445815|NCT01597245|101522672|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445816|NCT01597245|101522673|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445817|NCT01597245|101522674|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445818|NCT01597245|101522675|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
33445819|NCT01597245|101522676|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445820|NCT01597245|101522677|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
33445821|NCT01597245|101522678|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
33445822|NCT01597245|101522679|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
33445823|NCT01597245|101522659|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445824|NCT01597245|101522660|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445825|NCT01597245|101522661|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445826|NCT01597245|101522662|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445827|NCT01597245|101522663|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445828|NCT01597245|101522664|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445829|NCT01597245|101522665|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445830|NCT01597245|101522666|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445831|NCT01597245|101522667|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445832|NCT01597245|101522668|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445833|NCT01597245|101522669|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445834|NCT01597245|101522670|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445835|NCT01597245|101522671|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445836|NCT01597245|101522672|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445837|NCT01597245|101522673|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445838|NCT01597245|101522674|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445839|NCT01597245|101522675|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445840|NCT01597245|101522676|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
33445841|NCT01597245|101522677|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
33445842|NCT01597245|101522678|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
33445843|NCT01597245|101522679|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
33445844|NCT01597245|101522659|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445845|NCT01597245|101522660|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445846|NCT01597245|101522661|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445847|NCT01597245|101522662|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445848|NCT01597245|101522663|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445849|NCT01597245|101522664|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445850|NCT01597245|101522665|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445851|NCT01597245|101522666|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445852|NCT01597245|101522667|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445853|NCT01597245|101522668|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445854|NCT01597245|101522669|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445855|NCT01597245|101522670|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445856|NCT01597245|101522671|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445857|NCT01597245|101522672|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445858|NCT01597245|101522673|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445859|NCT01597245|101522674|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445860|NCT01597245|101522675|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
33445861|NCT01597245|101522676|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445862|NCT01597245|101522677|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
33445863|NCT01597245|101522678|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
33445864|NCT01597245|101522679|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
33445865|NCT01597245|101522659|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33165832|NCT00042289|100515329|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
33165833|NCT00042289|100515330|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
33165834|NCT00042289|100515331|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
33165835|NCT00042289|100515332|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
33165836|NCT00042289|100515333|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
33165837|NCT00042289|100515334|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
33165838|NCT00042289|100515335|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
33165839|NCT00042289|100515336|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
33165840|NCT00042289|100515337|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
33165841|NCT00042289|100515338|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
33165842|NCT00042289|100515339|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
33165843|NCT00042289|100515340|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
33165844|NCT00042289|100515341|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
33165845|NCT00042289|100515342|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
33165846|NCT00042289|100515343|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
33165847|NCT00042289|100515344|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
33165848|NCT00042289|100515345|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
33165849|NCT00042289|100515346|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
33165850|NCT00042289|100515300|FG000|Overall Study|Protocol Violation|0|||
33165851|NCT00042289|100515301|FG001|Overall Study|Protocol Violation|0|||
33165852|NCT00042289|100515302|FG002|Overall Study|Protocol Violation|0|||
33165853|NCT00042289|100515303|FG003|Overall Study|Protocol Violation|0|||
33165854|NCT00042289|100515304|FG004|Overall Study|Protocol Violation|0|||
33445866|NCT01597245|101522660|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445867|NCT01597245|101522661|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445868|NCT01597245|101522662|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445869|NCT01597245|101522663|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445870|NCT01597245|101522664|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445871|NCT01597245|101522665|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445872|NCT01597245|101522666|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445873|NCT01597245|101522667|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445874|NCT01597245|101522668|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445875|NCT01597245|101522669|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445876|NCT01597245|101522670|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445877|NCT01597245|101522671|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445878|NCT01597245|101522672|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445879|NCT01597245|101522673|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445880|NCT01597245|101522674|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445881|NCT01597245|101522675|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
33445882|NCT01597245|101522676|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445883|NCT01597245|101522677|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
33445884|NCT01597245|101522678|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
33445885|NCT01597245|101522679|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
33445886|NCT01597245|101522659|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33165855|NCT00042289|100515305|FG005|Overall Study|Protocol Violation|1|||
33165856|NCT00042289|100515306|FG006|Overall Study|Protocol Violation|0|||
33165857|NCT00042289|100515307|FG007|Overall Study|Protocol Violation|1|||
33165858|NCT00042289|100515308|FG008|Overall Study|Protocol Violation|0|||
33165859|NCT00042289|100515309|FG009|Overall Study|Protocol Violation|0|||
33165860|NCT00042289|100515310|FG010|Overall Study|Protocol Violation|0|||
33445887|NCT01597245|101522660|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445888|NCT01597245|101522661|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445889|NCT01597245|101522662|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445890|NCT01597245|101522663|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445891|NCT01597245|101522664|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445892|NCT01597245|101522665|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445893|NCT01597245|101522666|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445894|NCT01597245|101522667|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445895|NCT01597245|101522668|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445896|NCT01597245|101522669|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445897|NCT01597245|101522670|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445898|NCT01597245|101522671|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445899|NCT01597245|101522672|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445900|NCT01597245|101522673|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445901|NCT01597245|101522674|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445902|NCT01597245|101522675|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
33445903|NCT01597245|101522676|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445904|NCT01597245|101522677|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445905|NCT01597245|101522678|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
33445906|NCT01597245|101522679|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
33445907|NCT01597245|101522659|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445908|NCT01597245|101522660|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445909|NCT01597245|101522661|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445910|NCT01597245|101522662|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445911|NCT01597245|101522663|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445912|NCT01597245|101522664|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445913|NCT01597245|101522665|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445914|NCT01597245|101522666|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445915|NCT01597245|101522667|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445916|NCT01597245|101522668|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445917|NCT01597245|101522669|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445918|NCT01597245|101522670|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445919|NCT01597245|101522671|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445920|NCT01597245|101522672|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445921|NCT01597245|101522673|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445922|NCT01597245|101522674|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445923|NCT01597245|101522675|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
33445924|NCT01597245|101522676|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445925|NCT01597245|101522677|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445926|NCT01597245|101522678|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
33445927|NCT01597245|101522679|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
33445928|NCT01597245|101522659|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445929|NCT01597245|101522660|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445930|NCT01597245|101522661|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445931|NCT01597245|101522662|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445932|NCT01597245|101522663|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445933|NCT01597245|101522664|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445934|NCT01597245|101522665|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445935|NCT01597245|101522666|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445936|NCT01597245|101522667|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33258878|NCT01636687|100849622|FG000|Maintenance Period|Lost to Follow-up|1|||
33445937|NCT01597245|101522668|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33258879|NCT01636687|100849623|FG001|Maintenance Period|Lost to Follow-up|1|||
33258880|NCT01636687|100849624|FG002|Maintenance Period|Lost to Follow-up|0|||
33258881|NCT01636687|100849625|FG003|Maintenance Period|Lost to Follow-up|0|||
33258882|NCT01636687|100849626|FG004|Maintenance Period|Lost to Follow-up|1|||
33258883|NCT01636687|100849622|FG000|Maintenance Period|Physician Decision|0|||
33258884|NCT01636687|100849623|FG001|Maintenance Period|Physician Decision|0|||
33258885|NCT01636687|100849624|FG002|Maintenance Period|Physician Decision|0|||
33258886|NCT01636687|100849625|FG003|Maintenance Period|Physician Decision|0|||
33258887|NCT01636687|100849626|FG004|Maintenance Period|Physician Decision|1|||
33258888|NCT01636687|100849622|FG000|Extension Period|technical problems|0|||
33258889|NCT01636687|100849623|FG001|Extension Period|technical problems|1|||
33258890|NCT01636687|100849624|FG002|Extension Period|technical problems|2|||
33258891|NCT01636687|100849625|FG003|Extension Period|technical problems|1|||
33258892|NCT01636687|100849626|FG004|Extension Period|technical problems|0|||
33258893|NCT01636687|100849622|FG000|Extension Period|Adverse Event|4|||
33258894|NCT01636687|100849623|FG001|Extension Period|Adverse Event|3|||
33258895|NCT01636687|100849624|FG002|Extension Period|Adverse Event|2|||
33258896|NCT01636687|100849625|FG003|Extension Period|Adverse Event|1|||
33258897|NCT01636687|100849626|FG004|Extension Period|Adverse Event|0|||
33258898|NCT01636687|100849622|FG000|Extension Period|Lack of Efficacy|7|||
33258899|NCT01636687|100849623|FG001|Extension Period|Lack of Efficacy|0|||
33258900|NCT01636687|100849624|FG002|Extension Period|Lack of Efficacy|2|||
33258901|NCT01636687|100849625|FG003|Extension Period|Lack of Efficacy|1|||
33258902|NCT01636687|100849626|FG004|Extension Period|Lack of Efficacy|0|||
33258903|NCT01636687|100849622|FG000|Extension Period|Lost to Follow-up|1|||
33258904|NCT01636687|100849623|FG001|Extension Period|Lost to Follow-up|0|||
33258905|NCT01636687|100849624|FG002|Extension Period|Lost to Follow-up|1|||
33258906|NCT01636687|100849625|FG003|Extension Period|Lost to Follow-up|0|||
33258907|NCT01636687|100849626|FG004|Extension Period|Lost to Follow-up|0|||
33258908|NCT01636687|100849622|FG000|Extension Period|Physician Decision|1|||
33258909|NCT01636687|100849623|FG001|Extension Period|Physician Decision|0|||
33258910|NCT01636687|100849624|FG002|Extension Period|Physician Decision|0|||
33258911|NCT01636687|100849625|FG003|Extension Period|Physician Decision|1|||
33258912|NCT01636687|100849626|FG004|Extension Period|Physician Decision|0|||
33258913|NCT01636687|100849622|FG000|Extension Period|study terminated by sponsor|33|||
33258914|NCT01636687|100849623|FG001|Extension Period|study terminated by sponsor|50|||
33258915|NCT01636687|100849624|FG002|Extension Period|study terminated by sponsor|17|||
33258916|NCT01636687|100849625|FG003|Extension Period|study terminated by sponsor|23|||
33445938|NCT01597245|101522669|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445939|NCT01597245|101522670|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445940|NCT01597245|101522671|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445941|NCT01597245|101522672|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445942|NCT01597245|101522673|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445943|NCT01597245|101522674|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445944|NCT01597245|101522675|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445945|NCT01597245|101522676|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445946|NCT01597245|101522677|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445947|NCT01597245|101522678|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
33445948|NCT01597245|101522679|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
33445949|NCT01839279|101522680|FG000|Overall Study|Adverse Event|4|||
33445950|NCT01839279|101522681|FG001|Overall Study|Adverse Event|1|||
33445951|NCT01839279|101522682|FG002|Overall Study|Adverse Event|1|||
33445952|NCT01839279|101522680|FG000|Overall Study|Withdrawal by Subject|4|||
33445953|NCT01839279|101522681|FG001|Overall Study|Withdrawal by Subject|1|||
33445954|NCT01839279|101522682|FG002|Overall Study|Withdrawal by Subject|1|||
33445955|NCT01839279|101522680|FG000|Overall Study|Classified as 'Other'|5|||
33445956|NCT01839279|101522681|FG001|Overall Study|Classified as 'Other'|0|||
33445957|NCT01839279|101522682|FG002|Overall Study|Classified as 'Other'|0|||
33445958|NCT05376319|101522685|FG000|Overall Study|Funding termination|2|||
33445959|NCT05376319|101522686|FG001|Overall Study|Funding termination|4|||
33445960|NCT03792477|101522689|FG000|Overall Study|Adverse Event|0|||
33445961|NCT03792477|101522690|FG001|Overall Study|Adverse Event|0|||
33445962|NCT03792477|101522691|FG002|Overall Study|Adverse Event|0|||
33445963|NCT03792477|101522692|FG003|Overall Study|Adverse Event|1|||
33445964|NCT03792477|101522693|FG004|Overall Study|Adverse Event|0|||
33445965|NCT03792477|101522689|FG000|Overall Study|Lost to Follow-up|0|||
33445966|NCT03792477|101522690|FG001|Overall Study|Lost to Follow-up|0|||
33445967|NCT03792477|101522691|FG002|Overall Study|Lost to Follow-up|2|||
33258917|NCT01636687|100849626|FG004|Extension Period|study terminated by sponsor|0|||
33258918|NCT01636687|100849622|FG000|Extension Period|Withdrawal by Subject|1|||
33258919|NCT01636687|100849623|FG001|Extension Period|Withdrawal by Subject|0|||
33258920|NCT01636687|100849624|FG002|Extension Period|Withdrawal by Subject|1|||
33445968|NCT03792477|101522692|FG003|Overall Study|Lost to Follow-up|0|||
33445969|NCT03792477|101522693|FG004|Overall Study|Lost to Follow-up|0|||
33445970|NCT03792477|101522689|FG000|Overall Study|Other|0|||
33445971|NCT03792477|101522690|FG001|Overall Study|Other|0|||
33445972|NCT03792477|101522691|FG002|Overall Study|Other|0|||
33445973|NCT03792477|101522692|FG003|Overall Study|Other|0|||
33445974|NCT03792477|101522693|FG004|Overall Study|Other|1|||
33445975|NCT02514122|101522694|FG000|Overall Study|Withdrawal by Subject|2|||
33445976|NCT02514122|101522695|FG001|Overall Study|Withdrawal by Subject|0|||
33445977|NCT03204539|101522696|FG000|Overall Study|Loss of funding|0|||
33445978|NCT03204539|101522697|FG001|Overall Study|Loss of funding|1|||
33445979|NCT03522675|101522698|FG000|Overall Study|Screen fail|1|||
33445980|NCT03522675|101522698|FG000|Overall Study|Non-reactive to histamine|1|||
33445981|NCT03247972|101522699|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
33445982|NCT03247972|101522699|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
33445983|NCT04239872|101522700|FG000|Overall Study|Lost to Follow-up|0|||
33445984|NCT04239872|101522701|FG001|Overall Study|Lost to Follow-up|1|||
33445985|NCT01675765|101522703|FG000|Overall Study|Progressive disease|4|||
33445986|NCT01675765|101522704|FG001|Overall Study|Progressive disease|4|||
33445987|NCT01675765|101522703|FG000|Overall Study|Adverse Event|1|||
33445988|NCT01675765|101522704|FG001|Overall Study|Adverse Event|2|||
33445989|NCT01675765|101522703|FG000|Overall Study|Withdrawal by Subject|2|||
33445990|NCT01675765|101522704|FG001|Overall Study|Withdrawal by Subject|0|||
33258921|NCT01636687|100849625|FG003|Extension Period|Withdrawal by Subject|1|||
33258922|NCT01636687|100849626|FG004|Extension Period|Withdrawal by Subject|0|||
33258923|NCT01636687|100849622|FG000|Follow-up Period|Withdrawal by Subject|1|||
33258924|NCT01636687|100849623|FG001|Follow-up Period|Withdrawal by Subject|0|||
33258925|NCT01636687|100849624|FG002|Follow-up Period|Withdrawal by Subject|0|||
33258926|NCT01636687|100849625|FG003|Follow-up Period|Withdrawal by Subject|0|||
33258927|NCT01636687|100849626|FG004|Follow-up Period|Withdrawal by Subject|1|||
33258928|NCT00925587|100849631|FG000|Overall Study|Protocol Specified Criteria|6|||
33258929|NCT00925587|100849632|FG001|Overall Study|Protocol Specified Criteria|6|||
33258930|NCT00925587|100849631|FG000|Overall Study|Physician Decision|4|||
33258931|NCT00925587|100849632|FG001|Overall Study|Physician Decision|1|||
33258932|NCT00925587|100849631|FG000|Overall Study|Protocol Violation|6|||
33258933|NCT00925587|100849632|FG001|Overall Study|Protocol Violation|4|||
33258934|NCT00925587|100849631|FG000|Overall Study|Withdrawal by Subject|9|||
33258935|NCT00925587|100849632|FG001|Overall Study|Withdrawal by Subject|6|||
33445991|NCT01675765|101522703|FG000|Overall Study|Death|1|||
33445992|NCT01675765|101522704|FG001|Overall Study|Death|0|||
33445993|NCT01675765|101522703|FG000|Overall Study|Clinical progression|3|||
33445994|NCT01675765|101522704|FG001|Overall Study|Clinical progression|2|||
33258936|NCT00925587|100849631|FG000|Overall Study|Death|5|||
33258937|NCT00925587|100849632|FG001|Overall Study|Death|5|||
33258938|NCT00925587|100849631|FG000|Overall Study|Adverse Event|6|||
33258939|NCT00925587|100849632|FG001|Overall Study|Adverse Event|2|||
33258940|NCT00925587|100849631|FG000|Overall Study|Lost to Follow-up|0|||
33258941|NCT00925587|100849632|FG001|Overall Study|Lost to Follow-up|1|||
33258942|NCT01136876|100849633|FG000|Overall Study|Lost to Follow-up|0|||
33258943|NCT01136876|100849634|FG001|Overall Study|Lost to Follow-up|1|||
33258944|NCT01136876|100849633|FG000|Overall Study|Physician Decision|3|||
33258945|NCT01136876|100849634|FG001|Overall Study|Physician Decision|5|||
33258946|NCT01136876|100849633|FG000|Overall Study|Missing NGAL measurement|2|||
33258947|NCT01136876|100849634|FG001|Overall Study|Missing NGAL measurement|5|||
33258948|NCT00840177|100849635|FG000|Overall Study|Adverse Event|5|||
33258949|NCT00840177|100849636|FG001|Overall Study|Adverse Event|1|||
33258950|NCT00840177|100849637|FG002|Overall Study|Adverse Event|1|||
33258951|NCT00840177|100849635|FG000|Overall Study|Refusal unrelated to adverse events|1|||
33258952|NCT00840177|100849636|FG001|Overall Study|Refusal unrelated to adverse events|0|||
33258953|NCT00840177|100849637|FG002|Overall Study|Refusal unrelated to adverse events|1|||
33445995|NCT02178787|101522705|FG000|Overall Study|Lost to Follow-up|1|||
33445996|NCT02178787|101522706|FG001|Overall Study|Lost to Follow-up|0|||
33445997|NCT02178787|101522705|FG000|Overall Study|Withdrawal by Subject|0|||
33445998|NCT02178787|101522706|FG001|Overall Study|Withdrawal by Subject|2|||
33445999|NCT02178787|101522705|FG000|Overall Study|No TCD window|3|||
33258954|NCT00840177|100849635|FG000|Overall Study|Progression/relapse|2|||
33258955|NCT00840177|100849636|FG001|Overall Study|Progression/relapse|0|||
33258956|NCT00840177|100849637|FG002|Overall Study|Progression/relapse|0|||
33258957|NCT00840177|100849635|FG000|Overall Study|Death|4|||
33258958|NCT00840177|100849636|FG001|Overall Study|Death|5|||
33446000|NCT02178787|101522706|FG001|Overall Study|No TCD window|7|||
33446001|NCT02178787|101522705|FG000|Overall Study|Physician Decision|1|||
33446002|NCT02178787|101522706|FG001|Overall Study|Physician Decision|0|||
33258959|NCT00840177|100849637|FG002|Overall Study|Death|5|||
33258960|NCT00840177|100849635|FG000|Overall Study|not protocol specified|6|||
33258961|NCT00840177|100849636|FG001|Overall Study|not protocol specified|3|||
33258962|NCT00840177|100849637|FG002|Overall Study|not protocol specified|0|||
33258963|NCT00840177|100849635|FG000|Overall Study|Ineligible|0|||
33258964|NCT00840177|100849636|FG001|Overall Study|Ineligible|0|||
33258965|NCT00840177|100849637|FG002|Overall Study|Ineligible|3|||
33258966|NCT00840177|100849635|FG000|Overall Study|Did not start treatment|0|||
33258967|NCT00840177|100849636|FG001|Overall Study|Did not start treatment|0|||
33258968|NCT00840177|100849637|FG002|Overall Study|Did not start treatment|1|||
33258969|NCT01049503|100849638|FG000|Overall Study|Lost to Follow-up|11|||
33258970|NCT01049503|100849639|FG001|Overall Study|Lost to Follow-up|12|||
33258971|NCT01049503|100849640|FG002|Overall Study|Lost to Follow-up|24|||
33258972|NCT01049503|100849641|FG003|Overall Study|Lost to Follow-up|26|||
33258973|NCT01049503|100849642|FG004|Overall Study|Lost to Follow-up|27|||
33258974|NCT01049503|100849643|FG005|Overall Study|Lost to Follow-up|8|||
33258975|NCT00529789|100849644|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
33258976|NCT00529789|100849644|FG000|Study Period II/III|Adverse Event|3|||
33258977|NCT00529789|100849644|FG000|Study Period II/III|Lack of Efficacy|2|||
33258978|NCT00529789|100849644|FG000|Study Period II/III|Withdrawal by Subject|1|||
33258979|NCT00529789|100849644|FG000|Study Period II/III|Protocol Violation|3|||
33258980|NCT00529789|100849644|FG000|Study Period II/III|Physician Decision|3|||
33258981|NCT00529789|100849644|FG000|Study Period II/III|Lost to Follow-up|3|||
33258982|NCT00529789|100849644|FG000|Study Period IV|Parent/Caregiver Decision|1|||
33446003|NCT01963728|101522710|FG000|Overall Study|Study terminated early|0|||
33446004|NCT01963728|101522711|FG001|Overall Study|Study terminated early|1|||
33446005|NCT00207090|101522712|FG000|Overall Study|Study drug toxicity|3|||
33446006|NCT00207090|101522712|FG000|Overall Study|Chest wall mass larger|1|||
33446007|NCT00207090|101522712|FG000|Overall Study|Disease progression/relapse|2|||
33446008|NCT00207090|101522712|FG000|Overall Study|Physician Decision|1|||
33446009|NCT00834522|101522713|FG000|Washout|Adverse Event|1|||
33446010|NCT00834522|101522714|FG001|Washout|Adverse Event|0|||
33446011|NCT00834522|101522713|FG000|Washout|Withdrawal by Subject|2|||
33165861|NCT00042289|100515311|FG011|Overall Study|Protocol Violation|0|||
33165862|NCT00042289|100515312|FG012|Overall Study|Protocol Violation|0|||
33165863|NCT00042289|100515313|FG013|Overall Study|Protocol Violation|0|||
33165864|NCT00042289|100515314|FG014|Overall Study|Protocol Violation|0|||
33165865|NCT00042289|100515315|FG015|Overall Study|Protocol Violation|0|||
33165866|NCT00042289|100515316|FG016|Overall Study|Protocol Violation|0|||
33165867|NCT00042289|100515317|FG017|Overall Study|Protocol Violation|0|||
33165868|NCT00042289|100515318|FG018|Overall Study|Protocol Violation|0|||
33165869|NCT00042289|100515319|FG019|Overall Study|Protocol Violation|0|||
33165870|NCT00042289|100515320|FG020|Overall Study|Protocol Violation|0|||
33165871|NCT00042289|100515321|FG021|Overall Study|Protocol Violation|0|||
33165872|NCT00042289|100515322|FG022|Overall Study|Protocol Violation|0|||
33165873|NCT00042289|100515323|FG023|Overall Study|Protocol Violation|1|||
33165874|NCT00042289|100515324|FG024|Overall Study|Protocol Violation|1|||
33165875|NCT00042289|100515325|FG025|Overall Study|Protocol Violation|0|||
33165876|NCT00042289|100515326|FG026|Overall Study|Protocol Violation|2|||
33165877|NCT00042289|100515327|FG027|Overall Study|Protocol Violation|0|||
33165878|NCT00042289|100515328|FG028|Overall Study|Protocol Violation|0|||
33165879|NCT00042289|100515329|FG029|Overall Study|Protocol Violation|0|||
33165880|NCT00042289|100515330|FG030|Overall Study|Protocol Violation|1|||
33165881|NCT00042289|100515331|FG031|Overall Study|Protocol Violation|0|||
33165882|NCT00042289|100515332|FG032|Overall Study|Protocol Violation|0|||
33165883|NCT00042289|100515333|FG033|Overall Study|Protocol Violation|0|||
33165884|NCT00042289|100515334|FG034|Overall Study|Protocol Violation|0|||
33165885|NCT00042289|100515335|FG035|Overall Study|Protocol Violation|0|||
33165886|NCT00042289|100515336|FG036|Overall Study|Protocol Violation|0|||
33165887|NCT00042289|100515337|FG037|Overall Study|Protocol Violation|0|||
33165888|NCT00042289|100515338|FG038|Overall Study|Protocol Violation|0|||
33165889|NCT00042289|100515339|FG039|Overall Study|Protocol Violation|0|||
33165890|NCT00042289|100515340|FG040|Overall Study|Protocol Violation|0|||
33165891|NCT00042289|100515341|FG041|Overall Study|Protocol Violation|1|||
33165892|NCT00042289|100515342|FG042|Overall Study|Protocol Violation|1|||
33165893|NCT00042289|100515343|FG043|Overall Study|Protocol Violation|1|||
33165894|NCT00042289|100515344|FG044|Overall Study|Protocol Violation|0|||
33165895|NCT00042289|100515345|FG045|Overall Study|Protocol Violation|0|||
33165896|NCT00042289|100515346|FG046|Overall Study|Protocol Violation|0|||
33258983|NCT00529789|100849644|FG000|Study Period IV|Adverse Event|1|||
33165897|NCT00042289|100515300|FG000|Overall Study|Withdrawal by Subject|4|||
33165898|NCT00042289|100515301|FG001|Overall Study|Withdrawal by Subject|1|||
33165899|NCT00042289|100515302|FG002|Overall Study|Withdrawal by Subject|0|||
33165900|NCT00042289|100515303|FG003|Overall Study|Withdrawal by Subject|2|||
33165901|NCT00042289|100515304|FG004|Overall Study|Withdrawal by Subject|0|||
33165902|NCT00042289|100515305|FG005|Overall Study|Withdrawal by Subject|2|||
33165903|NCT00042289|100515306|FG006|Overall Study|Withdrawal by Subject|0|||
33165904|NCT00042289|100515307|FG007|Overall Study|Withdrawal by Subject|0|||
33165905|NCT00042289|100515308|FG008|Overall Study|Withdrawal by Subject|0|||
33165906|NCT00042289|100515309|FG009|Overall Study|Withdrawal by Subject|1|||
33165907|NCT00042289|100515310|FG010|Overall Study|Withdrawal by Subject|0|||
33165908|NCT00042289|100515311|FG011|Overall Study|Withdrawal by Subject|0|||
33165909|NCT00042289|100515312|FG012|Overall Study|Withdrawal by Subject|2|||
33165910|NCT00042289|100515313|FG013|Overall Study|Withdrawal by Subject|0|||
33165911|NCT00042289|100515314|FG014|Overall Study|Withdrawal by Subject|0|||
33165912|NCT00042289|100515315|FG015|Overall Study|Withdrawal by Subject|0|||
33165913|NCT00042289|100515316|FG016|Overall Study|Withdrawal by Subject|0|||
33165914|NCT00042289|100515317|FG017|Overall Study|Withdrawal by Subject|0|||
33165915|NCT00042289|100515318|FG018|Overall Study|Withdrawal by Subject|0|||
33165916|NCT00042289|100515319|FG019|Overall Study|Withdrawal by Subject|0|||
33165917|NCT00042289|100515320|FG020|Overall Study|Withdrawal by Subject|0|||
33165918|NCT00042289|100515321|FG021|Overall Study|Withdrawal by Subject|1|||
33165919|NCT00042289|100515322|FG022|Overall Study|Withdrawal by Subject|1|||
33165920|NCT00042289|100515323|FG023|Overall Study|Withdrawal by Subject|1|||
33165921|NCT00042289|100515324|FG024|Overall Study|Withdrawal by Subject|0|||
33165922|NCT00042289|100515325|FG025|Overall Study|Withdrawal by Subject|0|||
33165923|NCT00042289|100515326|FG026|Overall Study|Withdrawal by Subject|1|||
33165924|NCT00042289|100515327|FG027|Overall Study|Withdrawal by Subject|0|||
33165925|NCT00042289|100515328|FG028|Overall Study|Withdrawal by Subject|2|||
33165926|NCT00042289|100515329|FG029|Overall Study|Withdrawal by Subject|0|||
33165927|NCT00042289|100515330|FG030|Overall Study|Withdrawal by Subject|0|||
33165928|NCT00042289|100515331|FG031|Overall Study|Withdrawal by Subject|1|||
33165929|NCT00042289|100515332|FG032|Overall Study|Withdrawal by Subject|2|||
33165930|NCT00042289|100515333|FG033|Overall Study|Withdrawal by Subject|1|||
33165931|NCT00042289|100515334|FG034|Overall Study|Withdrawal by Subject|0|||
33165932|NCT00042289|100515335|FG035|Overall Study|Withdrawal by Subject|0|||
33165933|NCT00042289|100515336|FG036|Overall Study|Withdrawal by Subject|0|||
33165934|NCT00042289|100515337|FG037|Overall Study|Withdrawal by Subject|1|||
33165935|NCT00042289|100515338|FG038|Overall Study|Withdrawal by Subject|0|||
33165936|NCT00042289|100515339|FG039|Overall Study|Withdrawal by Subject|0|||
33165937|NCT00042289|100515340|FG040|Overall Study|Withdrawal by Subject|0|||
33165938|NCT00042289|100515341|FG041|Overall Study|Withdrawal by Subject|0|||
33165939|NCT00042289|100515342|FG042|Overall Study|Withdrawal by Subject|1|||
33165940|NCT00042289|100515343|FG043|Overall Study|Withdrawal by Subject|0|||
33165941|NCT00042289|100515344|FG044|Overall Study|Withdrawal by Subject|0|||
33258984|NCT00529789|100849644|FG000|Study Period IV|Lack of Efficacy|1|||
33258985|NCT00529789|100849644|FG000|Study Period IV|Lost to Follow-up|3|||
33258986|NCT02477605|100849645|FG000|Overall Study|Discontinued prior to treatment|1|||
33258987|NCT02477605|100849646|FG001|Overall Study|Discontinued prior to treatment|0|||
33258988|NCT02477605|100849645|FG000|Overall Study|Lost to Follow-up|0|||
33258989|NCT02477605|100849646|FG001|Overall Study|Lost to Follow-up|2|||
33258990|NCT02477605|100849645|FG000|Overall Study|Withdrawal by Subject|0|||
33258991|NCT02477605|100849646|FG001|Overall Study|Withdrawal by Subject|1|||
33258992|NCT02477605|100849645|FG000|Overall Study|Administered gas during surgery|0|||
33258993|NCT02477605|100849646|FG001|Overall Study|Administered gas during surgery|1|||
33258994|NCT00431834|100849650|FG000|Overall Study|Withdrawal by Subject|7|||
33258995|NCT00431834|100849650|FG000|Overall Study|Death|3|||
33258996|NCT00431834|100849650|FG000|Overall Study|Missed Endpoint Visit|2|||
33258997|NCT00431834|100849650|FG000|Overall Study|Lost to Follow-up|1|||
33258998|NCT00106080|100849653|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
33446012|NCT00834522|101522714|FG001|Washout|Withdrawal by Subject|1|||
33446013|NCT03235739|101522715|FG000|Overall Study|Withdrawal by Subject|2|||
33165942|NCT00042289|100515345|FG045|Overall Study|Withdrawal by Subject|0|||
33165943|NCT00042289|100515346|FG046|Overall Study|Withdrawal by Subject|0|||
33165944|NCT01594762|100515347|FG000|Overall Study|Withdrawal by Subject|1|||
33165945|NCT01594762|100515348|FG001|Overall Study|Withdrawal by Subject|0|||
33165946|NCT01594762|100515347|FG000|Overall Study|Lost to Follow-up|10|||
33165947|NCT01594762|100515348|FG001|Overall Study|Lost to Follow-up|10|||
33165948|NCT02478632|100515351|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
33165949|NCT02478632|100515352|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
33165950|NCT02478632|100515351|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
33165951|NCT02478632|100515352|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
33165952|NCT02478632|100515351|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
33258999|NCT00106080|100849654|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
33446014|NCT03235739|101522716|FG001|Overall Study|Withdrawal by Subject|2|||
33446015|NCT03235739|101522715|FG000|Overall Study|Physician Decision|0|||
33446016|NCT03235739|101522716|FG001|Overall Study|Physician Decision|1|||
33446017|NCT03021018|101522717|FG000|Overall Study|Adverse Event|1|||
33165953|NCT02478632|100515352|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
33446018|NCT03021018|101522718|FG001|Overall Study|Adverse Event|0|||
33446019|NCT03021018|101522719|FG002|Overall Study|Adverse Event|0|||
33446020|NCT03021018|101522717|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
33446021|NCT03021018|101522718|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
33446022|NCT03021018|101522719|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
33446023|NCT01175018|101522727|FG000|Overall Study|Adverse Event|3|||
33446024|NCT01175018|101522728|FG001|Overall Study|Adverse Event|1|||
33446025|NCT01237054|101522729|FG000|Overall Study|imaging 10C0096|1|||
33446026|NCT00073307|101522732|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
33446027|NCT00073307|101522733|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
33446028|NCT00073307|101522734|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
33446029|NCT00073307|101522732|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
33446030|NCT00073307|101522733|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
33446031|NCT00073307|101522734|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
33446032|NCT00073307|101522732|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
33446033|NCT00073307|101522733|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
33446034|NCT00073307|101522734|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
33446035|NCT00073307|101522732|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
33165954|NCT05059600|100515353|FG000|Overall Study|Enrolled but not Treated|10|||
33165955|NCT03736447|100515354|FG000|Overall Study|Adverse Event|5|||
33165956|NCT03736447|100515355|FG001|Overall Study|Adverse Event|1|||
33165957|NCT03736447|100515354|FG000|Overall Study|Withdrawal by Subject|5|||
33165958|NCT03736447|100515355|FG001|Overall Study|Withdrawal by Subject|1|||
33165959|NCT03736447|100515354|FG000|Overall Study|Lost to Follow-up|1|||
33165960|NCT03736447|100515355|FG001|Overall Study|Lost to Follow-up|0|||
33165961|NCT03736447|100515354|FG000|Overall Study|Physician Decision|1|||
33165962|NCT03736447|100515355|FG001|Overall Study|Physician Decision|0|||
33165963|NCT03736447|100515354|FG000|Overall Study|Continued commitment to study treatment|3|||
33165964|NCT03736447|100515355|FG001|Overall Study|Continued commitment to study treatment|0|||
33165965|NCT03736447|100515354|FG000|Overall Study|Taste aversion to study product|0|||
33165966|NCT03736447|100515355|FG001|Overall Study|Taste aversion to study product|1|||
33165967|NCT00612040|100515356|FG000|Overall Study|Adverse Event|0|||
33165968|NCT00612040|100515357|FG001|Overall Study|Adverse Event|2|||
33446036|NCT00073307|101522733|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
33446037|NCT00073307|101522734|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
33446038|NCT00073307|101522732|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
33165969|NCT00612040|100515358|FG002|Overall Study|Adverse Event|1|||
33165970|NCT00612040|100515356|FG000|Overall Study|Protocol Violation|1|||
33165971|NCT00612040|100515357|FG001|Overall Study|Protocol Violation|2|||
33165972|NCT00612040|100515358|FG002|Overall Study|Protocol Violation|1|||
33165973|NCT00612040|100515356|FG000|Overall Study|Lack of Efficacy|2|||
33165974|NCT00612040|100515357|FG001|Overall Study|Lack of Efficacy|1|||
33165975|NCT00612040|100515358|FG002|Overall Study|Lack of Efficacy|0|||
33165976|NCT00612040|100515356|FG000|Overall Study|Unclassified|2|||
33165977|NCT00612040|100515357|FG001|Overall Study|Unclassified|2|||
33165978|NCT00612040|100515358|FG002|Overall Study|Unclassified|5|||
33165979|NCT01061177|100515362|FG000|Overall Study|Adverse Event|117|||
33165980|NCT01061177|100515362|FG000|Overall Study|Withdrawal by Subject|27|||
33165981|NCT01061177|100515362|FG000|Overall Study|Disease progression|17|||
33165982|NCT01061177|100515362|FG000|Overall Study|Protocol Violation|11|||
33165983|NCT01061177|100515362|FG000|Overall Study|Lost to Follow-up|9|||
33165984|NCT01061177|100515362|FG000|Overall Study|New cancer therapy|9|||
33165985|NCT01061177|100515362|FG000|Overall Study|Abnormal laboratory values|6|||
33165986|NCT01061177|100515362|FG000|Overall Study|Abnormal test procedure results|4|||
33165987|NCT01061177|100515362|FG000|Overall Study|Administratie problems|4|||
33165988|NCT01061177|100515362|FG000|Overall Study|Death|4|||
33165989|NCT03311724|100515364|FG000|Overall Study|Physician Decision|0|||
33165990|NCT03311724|100515365|FG001|Overall Study|Physician Decision|0|||
33165991|NCT03311724|100515366|FG002|Overall Study|Physician Decision|0|||
33165992|NCT03311724|100515367|FG003|Overall Study|Physician Decision|1|||
33165993|NCT03311724|100515364|FG000|Overall Study|Protocol Violation|1|||
33165994|NCT03311724|100515365|FG001|Overall Study|Protocol Violation|0|||
33165995|NCT03311724|100515366|FG002|Overall Study|Protocol Violation|1|||
33165996|NCT03311724|100515367|FG003|Overall Study|Protocol Violation|0|||
33165997|NCT03311724|100515364|FG000|Overall Study|Withdrawal by Subject|1|||
33165998|NCT03311724|100515365|FG001|Overall Study|Withdrawal by Subject|1|||
33165999|NCT03311724|100515366|FG002|Overall Study|Withdrawal by Subject|0|||
33166000|NCT03311724|100515367|FG003|Overall Study|Withdrawal by Subject|0|||
33166001|NCT03311724|100515364|FG000|Overall Study|Lost to Follow-up|1|||
33166002|NCT03311724|100515365|FG001|Overall Study|Lost to Follow-up|0|||
33166003|NCT03311724|100515366|FG002|Overall Study|Lost to Follow-up|0|||
33166004|NCT03311724|100515367|FG003|Overall Study|Lost to Follow-up|0|||
33166005|NCT03311724|100515364|FG000|Overall Study|Sponsor Decision|0|||
33166006|NCT03311724|100515365|FG001|Overall Study|Sponsor Decision|0|||
33166007|NCT03311724|100515366|FG002|Overall Study|Sponsor Decision|1|||
33166008|NCT03311724|100515367|FG003|Overall Study|Sponsor Decision|0|||
33166009|NCT03167411|100515374|FG000|Overall Study|Adverse Event|0|||
33166010|NCT03167411|100515375|FG001|Overall Study|Adverse Event|1|||
33166011|NCT00629707|100515376|FG000|Overall Study|Withdrawal by Subject|0|||
33166012|NCT00629707|100515377|FG001|Overall Study|Withdrawal by Subject|1|||
33166013|NCT00629707|100515376|FG000|Overall Study|Physician Decision|0|||
33166014|NCT00629707|100515377|FG001|Overall Study|Physician Decision|1|||
33166015|NCT02144012|100515378|FG000|Overall Study|Adverse Event|1|||
33166016|NCT02144012|100515379|FG001|Overall Study|Adverse Event|0|||
33166017|NCT02144012|100515378|FG000|Overall Study|Death|1|||
33166018|NCT02144012|100515379|FG001|Overall Study|Death|0|||
33166019|NCT02144012|100515378|FG000|Overall Study|Withdrawal by Subject|11|||
33166020|NCT02144012|100515379|FG001|Overall Study|Withdrawal by Subject|3|||
33166021|NCT02144012|100515378|FG000|Overall Study|Study Terminated by Sponsor|18|||
33166022|NCT02144012|100515379|FG001|Overall Study|Study Terminated by Sponsor|12|||
33166023|NCT02144012|100515378|FG000|Overall Study|Other|3|||
33166024|NCT02144012|100515379|FG001|Overall Study|Other|0|||
33166025|NCT00745823|100515383|FG000|Overall Study|Adverse Event|5|||
33166026|NCT00745823|100515384|FG001|Overall Study|Adverse Event|3|||
33166027|NCT00745823|100515383|FG000|Overall Study|Lack of Efficacy|20|||
33166028|NCT00745823|100515384|FG001|Overall Study|Lack of Efficacy|6|||
33446039|NCT00073307|101522733|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
33446040|NCT00073307|101522734|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
33446041|NCT00073307|101522732|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
33446042|NCT00073307|101522733|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
33446043|NCT00073307|101522734|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
33446044|NCT00073307|101522732|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
33446045|NCT00073307|101522733|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
33446046|NCT00073307|101522734|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
33446047|NCT00073307|101522732|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
33446048|NCT00073307|101522733|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
33446049|NCT00073307|101522734|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
33446050|NCT00073307|101522732|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
33446051|NCT00073307|101522733|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
33446052|NCT00073307|101522734|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
33446053|NCT00073307|101522732|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
33446054|NCT00073307|101522733|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
33446055|NCT00073307|101522734|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
33446056|NCT00073307|101522732|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
33446057|NCT00073307|101522733|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
33446058|NCT00073307|101522734|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
33446059|NCT00073307|101522732|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
33446060|NCT00073307|101522733|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
33446061|NCT00073307|101522734|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
33446062|NCT00073307|101522732|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
33446063|NCT00073307|101522733|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
33446064|NCT00073307|101522734|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
33446065|NCT00073307|101522732|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
33446066|NCT00073307|101522733|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
33446067|NCT00073307|101522734|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
33446068|NCT00073307|101522732|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
33446069|NCT00073307|101522733|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
33446070|NCT00073307|101522734|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
33446071|NCT00073307|101522732|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
33446072|NCT00073307|101522733|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
33446073|NCT00073307|101522734|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
33446074|NCT00073307|101522732|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
33446075|NCT00073307|101522733|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
33446076|NCT00073307|101522734|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
33446077|NCT00073307|101522732|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
33446078|NCT00073307|101522733|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
33446079|NCT00073307|101522734|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
33446080|NCT00073307|101522732|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
33446081|NCT00073307|101522733|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
33446082|NCT00073307|101522734|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
33446083|NCT04263649|101522739|FG000|Overall Study|Adverse Event|53|||
33446084|NCT04263649|101522739|FG000|Overall Study|Lost to Follow-up|3|||
33446085|NCT04263649|101522739|FG000|Overall Study|Death|29|||
33446086|NCT04263649|101522739|FG000|Overall Study|Device deficiency|19|||
33446087|NCT04263649|101522739|FG000|Overall Study|other reasons|11|||
33446088|NCT01900691|101522742|FG000|Overall Study|Death|7|||
33446089|NCT01900691|101522742|FG000|Overall Study|Lost to Follow-up|4|||
33446090|NCT01900691|101522742|FG000|Overall Study|Study Device Not Placed|3|||
33446091|NCT01900691|101522742|FG000|Overall Study|Non study stent placed|2|||
33446092|NCT01900691|101522742|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
33446093|NCT01900691|101522742|FG000|Overall Study|Complete stent migration through digestive tract|1|||
33446094|NCT01702987|101522743|FG000|Overall Study|Withdrawal by Subject|1|||
33446095|NCT01702987|101522744|FG001|Overall Study|Withdrawal by Subject|0|||
33446096|NCT01473953|101522745|FG000|Overall Study|Other|1|||
33446097|NCT01473953|101522746|FG001|Overall Study|Other|0|||
33446098|NCT01473953|101522747|FG002|Overall Study|Other|0|||
33446099|NCT01473953|101522748|FG003|Overall Study|Other|0|||
33446100|NCT01473953|101522749|FG004|Overall Study|Other|0|||
33259000|NCT01985334|100849657|FG000|Overall Study|Administrative problems|1|||
33259001|NCT01985334|100849658|FG001|Overall Study|Administrative problems|1|||
33446101|NCT02286739|101522750|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
33446102|NCT02286739|101522751|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
33446103|NCT02286739|101522750|FG000|Overall Study|No Verasense type documented|0|||
33446104|NCT02286739|101522751|FG001|Overall Study|No Verasense type documented|23|||
33446105|NCT02286739|101522750|FG000|Overall Study|Adverse Event|1|||
33446106|NCT02286739|101522751|FG001|Overall Study|Adverse Event|2|||
33446107|NCT02286739|101522750|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
33446108|NCT02286739|101522751|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
33446109|NCT00163657|101522754|FG000|Overall Study|Death|12|||
33446110|NCT00163657|101522755|FG001|Overall Study|Death|14|||
33446111|NCT00163657|101522756|FG002|Overall Study|Death|19|||
33446112|NCT00163657|101522754|FG000|Overall Study|graft loss|4|||
33166029|NCT00745823|100515383|FG000|Overall Study|Lost to Follow-up|10|||
33166030|NCT00745823|100515384|FG001|Overall Study|Lost to Follow-up|11|||
33166031|NCT00745823|100515383|FG000|Overall Study|Physician Decision|10|||
33166032|NCT00745823|100515384|FG001|Overall Study|Physician Decision|5|||
33166033|NCT00745823|100515383|FG000|Overall Study|Pregnancy|0|||
33166034|NCT00745823|100515384|FG001|Overall Study|Pregnancy|4|||
33166035|NCT00745823|100515383|FG000|Overall Study|Withdrawal by Subject|14|||
33166036|NCT00745823|100515384|FG001|Overall Study|Withdrawal by Subject|8|||
33166037|NCT00745823|100515383|FG000|Overall Study|Study Terminated by Sponsor|326|||
33166038|NCT00745823|100515384|FG001|Overall Study|Study Terminated by Sponsor|349|||
33166039|NCT00133952|100515387|FG000|Overall Study|Adverse Event|1|||
33166040|NCT00133952|100515388|FG001|Overall Study|Adverse Event|2|||
33166041|NCT00133952|100515387|FG000|Overall Study|Death|3|||
33166042|NCT00133952|100515388|FG001|Overall Study|Death|2|||
33166043|NCT00133952|100515387|FG000|Overall Study|Lost to Follow-up|9|||
33166044|NCT00133952|100515388|FG001|Overall Study|Lost to Follow-up|14|||
33166045|NCT00133952|100515387|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
33166046|NCT00133952|100515388|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
33166047|NCT00133952|100515387|FG000|Overall Study|Protocol Violation|1|||
33166048|NCT00133952|100515388|FG001|Overall Study|Protocol Violation|1|||
33166049|NCT00133952|100515387|FG000|Overall Study|Withdrawal by Subject|20|||
33166050|NCT00133952|100515388|FG001|Overall Study|Withdrawal by Subject|4|||
33166051|NCT00133952|100515387|FG000|Overall Study|Physician Decision|4|||
33166052|NCT00133952|100515388|FG001|Overall Study|Physician Decision|3|||
33166053|NCT00133952|100515387|FG000|Overall Study|Sponsor Decision|0|||
33446113|NCT00163657|101522755|FG001|Overall Study|graft loss|1|||
33446114|NCT00163657|101522756|FG002|Overall Study|graft loss|2|||
33446115|NCT00163657|101522754|FG000|Overall Study|Withdrawal by Subject|2|||
33446116|NCT00163657|101522755|FG001|Overall Study|Withdrawal by Subject|3|||
33446117|NCT00163657|101522756|FG002|Overall Study|Withdrawal by Subject|2|||
33446118|NCT00163657|101522754|FG000|Overall Study|Physician Decision|0|||
33446119|NCT00163657|101522755|FG001|Overall Study|Physician Decision|1|||
33446120|NCT00163657|101522756|FG002|Overall Study|Physician Decision|1|||
33446121|NCT00163657|101522754|FG000|Overall Study|Non Compliance|1|||
33166054|NCT00133952|100515388|FG001|Overall Study|Sponsor Decision|1|||
33166055|NCT04189081|100515393|FG000|Overall Study|Lost to Follow-up|1|||
33166056|NCT04189081|100515394|FG001|Overall Study|Lost to Follow-up|0|||
33166057|NCT04189081|100515395|FG002|Overall Study|Lost to Follow-up|0|||
33166058|NCT04189081|100515393|FG000|Overall Study|Withdrawal by Subject|0|||
33446122|NCT00163657|101522755|FG001|Overall Study|Non Compliance|0|||
33446123|NCT00163657|101522756|FG002|Overall Study|Non Compliance|0|||
33446124|NCT00163657|101522754|FG000|Overall Study|Lost to Follow-up|1|||
33446125|NCT00163657|101522755|FG001|Overall Study|Lost to Follow-up|3|||
33446126|NCT00163657|101522756|FG002|Overall Study|Lost to Follow-up|10|||
33166059|NCT04189081|100515394|FG001|Overall Study|Withdrawal by Subject|0|||
33166060|NCT04189081|100515395|FG002|Overall Study|Withdrawal by Subject|1|||
33166061|NCT00980057|100515398|FG000|Overall Study|Death|13|||
33166062|NCT00980057|100515399|FG001|Overall Study|Death|3|||
33166063|NCT00980057|100515398|FG000|Overall Study|Adverse Event|0|||
33166064|NCT00980057|100515399|FG001|Overall Study|Adverse Event|1|||
33166065|NCT00980057|100515398|FG000|Overall Study|Physician Decision|4|||
33166066|NCT00980057|100515399|FG001|Overall Study|Physician Decision|0|||
33166067|NCT00980057|100515398|FG000|Overall Study|Lost to Follow-up|1|||
33166068|NCT00980057|100515399|FG001|Overall Study|Lost to Follow-up|0|||
33166069|NCT00980057|100515398|FG000|Overall Study|Withdrawal by Subject|1|||
33166070|NCT00980057|100515399|FG001|Overall Study|Withdrawal by Subject|1|||
33166071|NCT01731990|100515400|FG000|Overall Study|Adverse Event|1|||
33166072|NCT01731990|100515401|FG001|Overall Study|Adverse Event|5|||
33166073|NCT01731990|100515400|FG000|Overall Study|Withdrawal by Subject|1|||
33166074|NCT01731990|100515401|FG001|Overall Study|Withdrawal by Subject|1|||
33166075|NCT01731990|100515400|FG000|Overall Study|Protocol deviation|1|||
33166076|NCT01731990|100515401|FG001|Overall Study|Protocol deviation|2|||
33166077|NCT01731990|100515400|FG000|Overall Study|Death|1|||
33166078|NCT01731990|100515401|FG001|Overall Study|Death|0|||
33166079|NCT01558271|100515403|FG000|Overall Study|Adverse Event|6|||
33166080|NCT01558271|100515404|FG001|Overall Study|Adverse Event|3|||
33166081|NCT01558271|100515405|FG002|Overall Study|Adverse Event|4|||
33446127|NCT00163657|101522754|FG000|Overall Study|Other reason|0|||
33446128|NCT00163657|101522755|FG001|Overall Study|Other reason|1|||
33166082|NCT01558271|100515403|FG000|Overall Study|Lost to Follow-up|1|||
33166083|NCT01558271|100515404|FG001|Overall Study|Lost to Follow-up|0|||
33166084|NCT01558271|100515405|FG002|Overall Study|Lost to Follow-up|0|||
33166085|NCT01558271|100515403|FG000|Overall Study|Protocol Violation|1|||
33166086|NCT01558271|100515404|FG001|Overall Study|Protocol Violation|0|||
33166087|NCT01558271|100515405|FG002|Overall Study|Protocol Violation|0|||
33166088|NCT01558271|100515403|FG000|Overall Study|Withdrawal by Subject|10|||
33166089|NCT01558271|100515404|FG001|Overall Study|Withdrawal by Subject|6|||
33166090|NCT01558271|100515405|FG002|Overall Study|Withdrawal by Subject|12|||
33166091|NCT01558271|100515403|FG000|Overall Study|Physician Decision|0|||
33166092|NCT01558271|100515404|FG001|Overall Study|Physician Decision|2|||
33166093|NCT01558271|100515405|FG002|Overall Study|Physician Decision|1|||
33446129|NCT00163657|101522756|FG002|Overall Study|Other reason|3|||
33166094|NCT03851705|100515412|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
33259002|NCT01985334|100849659|FG002|Overall Study|Administrative problems|0|||
33166095|NCT03851705|100515413|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
33166096|NCT03851705|100515414|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
33166097|NCT03851705|100515415|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
33166098|NCT03851705|100515412|FG000|Part 1: Double-Blind Period|Other reason|1|||
33166099|NCT03851705|100515413|FG001|Part 1: Double-Blind Period|Other reason|0|||
33166100|NCT03851705|100515414|FG002|Part 1: Double-Blind Period|Other reason|0|||
33259003|NCT01985334|100849660|FG003|Overall Study|Administrative problems|2|||
33259004|NCT01985334|100849661|FG004|Overall Study|Administrative problems|0|||
33259005|NCT01985334|100849662|FG005|Overall Study|Administrative problems|1|||
33446130|NCT02152163|101522757|FG000|Overall Study|Physician Decision|12|||
33166101|NCT03851705|100515415|FG003|Part 1: Double-Blind Period|Other reason|0|||
33166102|NCT03851705|100515412|FG000|Part 2: Open-Label Period|Other reason|0|||
33446131|NCT02152163|101522758|FG001|Overall Study|Physician Decision|13|||
33446132|NCT00905346|101525329|FG000|Period 1|Withdrawal by Subject|1|||
33446133|NCT00905346|101525330|FG001|Period 1|Withdrawal by Subject|0|||
33446134|NCT00858845|101525331|FG000|Overall Study|Patient underwent heart transplant.|0|||
33446135|NCT00858845|101525332|FG001|Overall Study|Patient underwent heart transplant.|1|||
33446136|NCT00834340|101525333|FG000|Washout|Adverse Event|1|||
33446137|NCT00834340|101525334|FG001|Washout|Adverse Event|0|||
33446138|NCT00834340|101525333|FG000|Washout|Withdrawal by Subject|1|||
33446139|NCT00834340|101525334|FG001|Washout|Withdrawal by Subject|0|||
33446140|NCT03165994|101525338|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
33446141|NCT03165994|101525338|FG000|Overall Study|Death|2|||
33446142|NCT03165994|101525338|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
33446143|NCT03165994|101525338|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
33166103|NCT03851705|100515413|FG001|Part 2: Open-Label Period|Other reason|0|||
33166104|NCT03851705|100515414|FG002|Part 2: Open-Label Period|Other reason|0|||
33166105|NCT03851705|100515415|FG003|Part 2: Open-Label Period|Other reason|1|||
33446144|NCT03165994|101525338|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
33446145|NCT03165994|101525338|FG000|Overall Study|Miscellaneous|1|||
33446146|NCT01757392|101525339|FG000|Overall Study|Withdrawal by Subject|1|||
33446147|NCT01757392|101525339|FG000|Overall Study|Screen Fail|3|||
33446148|NCT04129346|101525340|FG000|Overall Study|Death|1|||
33446149|NCT04129346|101525341|FG001|Overall Study|Death|0|||
33446150|NCT00834756|101525342|FG000|First Intervention|Adverse Event|1|||
33446151|NCT00834756|101525343|FG001|First Intervention|Adverse Event|0|||
33446152|NCT00834756|101525342|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
33446153|NCT00834756|101525343|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
33446154|NCT00252720|101525344|FG000|Overall Study|Withdrawal by Subject|95|||
33446155|NCT00252720|101525345|FG001|Overall Study|Withdrawal by Subject|97|||
33446156|NCT00252720|101525344|FG000|Overall Study|Death|7|||
33446157|NCT00252720|101525345|FG001|Overall Study|Death|8|||
33446158|NCT00252720|101525344|FG000|Overall Study|Moving|23|||
33446159|NCT00252720|101525345|FG001|Overall Study|Moving|42|||
33446160|NCT00252720|101525344|FG000|Overall Study|Mainly patients lost to follow-up|7|||
33446161|NCT00252720|101525345|FG001|Overall Study|Mainly patients lost to follow-up|18|||
33446162|NCT02106156|101525350|FG000|Overall Study|Patient Died|19|||
33446163|NCT02106156|101525351|FG001|Overall Study|Patient Died|0|||
33446164|NCT02106156|101525352|FG002|Overall Study|Patient Died|0|||
33166106|NCT03851705|100515412|FG000|Part 2: Open-Label Period|Death|0|||
33166107|NCT03851705|100515413|FG001|Part 2: Open-Label Period|Death|0|||
33166108|NCT03851705|100515414|FG002|Part 2: Open-Label Period|Death|3|||
33166109|NCT03851705|100515415|FG003|Part 2: Open-Label Period|Death|0|||
33166110|NCT03851705|100515412|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
33166111|NCT03851705|100515413|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
33166112|NCT03851705|100515414|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
33166113|NCT03851705|100515415|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
33166114|NCT01408485|100515416|FG000|Overall Study|Withdrawal by Subject|21|||
33166115|NCT00963937|100515417|FG000|Overall Study|Protocol Violation|1|||
33166116|NCT00963937|100515418|FG001|Overall Study|Protocol Violation|1|||
33166117|NCT00963937|100515419|FG002|Overall Study|Protocol Violation|0|||
33166118|NCT00963937|100515417|FG000|Overall Study|Physician Decision|18|||
33446165|NCT02106156|101525350|FG000|Overall Study|Lack of Tolerability|305|||
33166119|NCT00963937|100515418|FG001|Overall Study|Physician Decision|10|||
33166120|NCT00963937|100515419|FG002|Overall Study|Physician Decision|4|||
33446166|NCT02106156|101525351|FG001|Overall Study|Lack of Tolerability|3|||
33446167|NCT02106156|101525352|FG002|Overall Study|Lack of Tolerability|0|||
33446168|NCT02106156|101525350|FG000|Overall Study|Lack of Virological Response|1044|||
33446169|NCT02106156|101525351|FG001|Overall Study|Lack of Virological Response|8|||
33446170|NCT02106156|101525352|FG002|Overall Study|Lack of Virological Response|0|||
33446171|NCT02106156|101525350|FG000|Overall Study|Concomitant Disease|74|||
33446172|NCT02106156|101525351|FG001|Overall Study|Concomitant Disease|2|||
33446173|NCT02106156|101525352|FG002|Overall Study|Concomitant Disease|0|||
33446174|NCT02106156|101525350|FG000|Overall Study|Lack of Compliance|211|||
33446175|NCT02106156|101525351|FG001|Overall Study|Lack of Compliance|7|||
33446176|NCT02106156|101525352|FG002|Overall Study|Lack of Compliance|0|||
33446177|NCT02106156|101525350|FG000|Overall Study|Patients Request|307|||
33446178|NCT02106156|101525351|FG001|Overall Study|Patients Request|9|||
33446179|NCT02106156|101525352|FG002|Overall Study|Patients Request|0|||
33446180|NCT02106156|101525350|FG000|Overall Study|Lost to Follow-up|451|||
33446181|NCT02106156|101525351|FG001|Overall Study|Lost to Follow-up|8|||
33446182|NCT02106156|101525352|FG002|Overall Study|Lost to Follow-up|0|||
33446183|NCT02106156|101525350|FG000|Overall Study|Unplanned Event|82|||
33446184|NCT02106156|101525351|FG001|Overall Study|Unplanned Event|2|||
33446185|NCT02106156|101525352|FG002|Overall Study|Unplanned Event|0|||
33446186|NCT02106156|101525350|FG000|Overall Study|Change of Laboratory Parameter|10|||
33446187|NCT02106156|101525351|FG001|Overall Study|Change of Laboratory Parameter|0|||
33446188|NCT02106156|101525352|FG002|Overall Study|Change of Laboratory Parameter|0|||
33446189|NCT02106156|101525350|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
33446190|NCT02106156|101525351|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
33446191|NCT02106156|101525352|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
33446192|NCT02106156|101525350|FG000|Overall Study|Relocation/Change of Physician|40|||
33446193|NCT02106156|101525351|FG001|Overall Study|Relocation/Change of Physician|1|||
33166121|NCT01389817|100515420|FG000|Overall Study|Physician Decision|1|||
33166122|NCT01389817|100515421|FG001|Overall Study|Physician Decision|0|||
33166123|NCT01389817|100515420|FG000|Overall Study|Lost to Follow-up|1|||
33166124|NCT01389817|100515421|FG001|Overall Study|Lost to Follow-up|0|||
33166125|NCT01389817|100515420|FG000|Overall Study|Withdrawal by Subject|2|||
33166126|NCT01389817|100515421|FG001|Overall Study|Withdrawal by Subject|0|||
33166127|NCT02430311|100515424|FG000|Part A|Adverse Event|0|||
33166128|NCT02430311|100515425|FG001|Part A|Adverse Event|1|||
33166129|NCT02430311|100515424|FG000|Part A|Withdrawal by Subject|1|||
33166130|NCT02430311|100515425|FG001|Part A|Withdrawal by Subject|0|||
33166131|NCT02430311|100515424|FG000|Part B|Meet study-specific withdrawal criteria|6|||
33166132|NCT02430311|100515425|FG001|Part B|Meet study-specific withdrawal criteria|6|||
33166133|NCT02430311|100515424|FG000|Part B|Withdrawal by Subject|2|||
33166134|NCT02430311|100515425|FG001|Part B|Withdrawal by Subject|2|||
33166135|NCT02430311|100515424|FG000|Part B|Adverse Event|1|||
33166136|NCT02430311|100515425|FG001|Part B|Adverse Event|0|||
33166137|NCT02430311|100515424|FG000|Part B|Death|1|||
33166138|NCT02430311|100515425|FG001|Part B|Death|0|||
33259006|NCT01985334|100849663|FG006|Overall Study|Administrative problems|1|||
33259007|NCT01985334|100849664|FG007|Overall Study|Administrative problems|3|||
33259008|NCT01985334|100849657|FG000|Overall Study|Death|1|||
33259009|NCT01985334|100849658|FG001|Overall Study|Death|0|||
33259010|NCT01985334|100849659|FG002|Overall Study|Death|0|||
33259011|NCT01985334|100849660|FG003|Overall Study|Death|3|||
33259012|NCT01985334|100849661|FG004|Overall Study|Death|0|||
33259013|NCT01985334|100849662|FG005|Overall Study|Death|0|||
33259014|NCT01985334|100849663|FG006|Overall Study|Death|1|||
33259015|NCT01985334|100849664|FG007|Overall Study|Death|2|||
33259016|NCT01985334|100849657|FG000|Overall Study|Worsening of disease|0|||
33259017|NCT01985334|100849658|FG001|Overall Study|Worsening of disease|0|||
33259018|NCT01985334|100849659|FG002|Overall Study|Worsening of disease|0|||
33446194|NCT02106156|101525352|FG002|Overall Study|Relocation/Change of Physician|0|||
33446195|NCT04499963|101525353|FG000|Overall Study|Adverse Event|3|||
33259019|NCT01985334|100849660|FG003|Overall Study|Worsening of disease|1|||
33259020|NCT01985334|100849661|FG004|Overall Study|Worsening of disease|0|||
33259021|NCT01985334|100849662|FG005|Overall Study|Worsening of disease|3|||
33446196|NCT04499963|101525354|FG001|Overall Study|Adverse Event|0|||
33446197|NCT04499963|101525353|FG000|Overall Study|Death|3|||
33446198|NCT04499963|101525354|FG001|Overall Study|Death|0|||
33446199|NCT04499963|101525353|FG000|Overall Study|Lack of Efficacy|7|||
33166139|NCT01594281|100518598|FG000|Interventional Core Phase|Protocol Deviation|1|||
33166140|NCT01594281|100518599|FG001|Interventional Core Phase|Protocol Deviation|0|||
33166141|NCT01594281|100518600|FG002|Interventional Core Phase|Protocol Deviation|0|||
33166142|NCT01594281|100518598|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
33166143|NCT01594281|100518599|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
33166144|NCT01594281|100518600|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
33166145|NCT01594281|100518598|FG000|Interventional Core Phase|Death|1|||
33166146|NCT01594281|100518599|FG001|Interventional Core Phase|Death|1|||
33166147|NCT01594281|100518600|FG002|Interventional Core Phase|Death|2|||
33166148|NCT01594281|100518598|FG000|Interventional Core Phase|Lost to Follow-up|1|||
33166149|NCT01594281|100518599|FG001|Interventional Core Phase|Lost to Follow-up|4|||
33166150|NCT01594281|100518600|FG002|Interventional Core Phase|Lost to Follow-up|1|||
33166151|NCT01594281|100518598|FG000|Interventional Core Phase|Adverse Event|4|||
33166152|NCT01594281|100518599|FG001|Interventional Core Phase|Adverse Event|4|||
33166153|NCT01594281|100518600|FG002|Interventional Core Phase|Adverse Event|4|||
33166154|NCT01594281|100518598|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
33166155|NCT01594281|100518599|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
33166156|NCT01594281|100518600|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
33166157|NCT01594281|100518598|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
33166158|NCT01594281|100518599|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
33166159|NCT01594281|100518600|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
33166160|NCT01594281|100518598|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
33166161|NCT01594281|100518599|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
33166162|NCT01594281|100518600|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
33166163|NCT03521934|100518601|FG000|Overall Study|Death|65|||
33446200|NCT04499963|101525354|FG001|Overall Study|Lack of Efficacy|0|||
33446201|NCT04499963|101525353|FG000|Overall Study|Lost to Follow-up|2|||
33446202|NCT04499963|101525354|FG001|Overall Study|Lost to Follow-up|0|||
33446203|NCT00851877|101525361|FG000|Phase I-1|Death|1|||
33446204|NCT00851877|101525362|FG001|Phase I-1|Death|0|||
33446205|NCT00851877|101525363|FG002|Phase I-1|Death|0|||
33446206|NCT00851877|101525361|FG000|Phase II|Withdrawal by Subject|0|||
33446207|NCT00851877|101525362|FG001|Phase II|Withdrawal by Subject|0|||
33446208|NCT00851877|101525363|FG002|Phase II|Withdrawal by Subject|3|||
33446209|NCT00263588|101525364|FG000|Overall Study|Death|54|||
33446210|NCT00263588|101525365|FG001|Overall Study|Death|90|||
33446211|NCT00263588|101525364|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
33446212|NCT00263588|101525365|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
33446213|NCT00263588|101525364|FG000|Overall Study|Lost to Follow-up|7|||
33446214|NCT00263588|101525365|FG001|Overall Study|Lost to Follow-up|10|||
33446215|NCT00263588|101525364|FG000|Overall Study|Withdrawal by Subject|3|||
33259022|NCT01985334|100849663|FG006|Overall Study|Worsening of disease|0|||
33259023|NCT01985334|100849664|FG007|Overall Study|Worsening of disease|1|||
33259024|NCT01985334|100849657|FG000|Overall Study|Other|2|||
33259025|NCT01985334|100849658|FG001|Overall Study|Other|9|||
33259026|NCT01985334|100849659|FG002|Overall Study|Other|7|||
33259027|NCT01985334|100849660|FG003|Overall Study|Other|17|||
33259028|NCT01985334|100849661|FG004|Overall Study|Other|4|||
33259029|NCT01985334|100849662|FG005|Overall Study|Other|8|||
33259030|NCT01985334|100849663|FG006|Overall Study|Other|4|||
33259031|NCT01985334|100849664|FG007|Overall Study|Other|7|||
33259032|NCT01985334|100849657|FG000|Overall Study|Protocol deviation|6|||
33259033|NCT01985334|100849658|FG001|Overall Study|Protocol deviation|31|||
33259034|NCT01985334|100849659|FG002|Overall Study|Protocol deviation|25|||
33259035|NCT01985334|100849660|FG003|Overall Study|Protocol deviation|84|||
33259036|NCT01985334|100849661|FG004|Overall Study|Protocol deviation|17|||
33259037|NCT01985334|100849662|FG005|Overall Study|Protocol deviation|47|||
33259038|NCT01985334|100849663|FG006|Overall Study|Protocol deviation|15|||
33259039|NCT01985334|100849664|FG007|Overall Study|Protocol deviation|42|||
33259040|NCT01985334|100849657|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
33259041|NCT01985334|100849658|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
33259042|NCT01985334|100849659|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
33259043|NCT01985334|100849660|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
33259044|NCT01985334|100849661|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
33259045|NCT01985334|100849662|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
33259046|NCT01985334|100849663|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
33259047|NCT01985334|100849664|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
33259048|NCT01985334|100849657|FG000|Overall Study|Subject withdrawal of consent|3|||
33259049|NCT01985334|100849658|FG001|Overall Study|Subject withdrawal of consent|6|||
33446216|NCT00263588|101525365|FG001|Overall Study|Withdrawal by Subject|4|||
33446217|NCT00263588|101525364|FG000|Overall Study|Protocol Violation|0|||
33446218|NCT00263588|101525365|FG001|Overall Study|Protocol Violation|1|||
33446219|NCT00263588|101525364|FG000|Overall Study|Investigator decision|7|||
33446220|NCT00263588|101525365|FG001|Overall Study|Investigator decision|15|||
33446221|NCT00263588|101525364|FG000|Overall Study|Sponsor terminated study|0|||
33446222|NCT00263588|101525365|FG001|Overall Study|Sponsor terminated study|1|||
33446223|NCT00747565|101525366|FG000|Overall Study|Withdrawal by Subject|10|||
33446224|NCT00747565|101525367|FG001|Overall Study|Withdrawal by Subject|6|||
33259050|NCT01985334|100849659|FG002|Overall Study|Subject withdrawal of consent|2|||
33259051|NCT01985334|100849660|FG003|Overall Study|Subject withdrawal of consent|28|||
33259052|NCT01985334|100849661|FG004|Overall Study|Subject withdrawal of consent|4|||
33259053|NCT01985334|100849662|FG005|Overall Study|Subject withdrawal of consent|19|||
33259054|NCT01985334|100849663|FG006|Overall Study|Subject withdrawal of consent|0|||
33446225|NCT00747565|101525366|FG000|Overall Study|Lost to Follow-up|4|||
33166164|NCT03521934|100518602|FG001|Overall Study|Death|73|||
33446226|NCT00747565|101525367|FG001|Overall Study|Lost to Follow-up|1|||
33259055|NCT01985334|100849664|FG007|Overall Study|Subject withdrawal of consent|20|||
33259056|NCT01985334|100849657|FG000|Overall Study|Adverse Event|0|||
33446227|NCT01097577|101525373|FG000|Overall Study|Adverse Event|0|||
33446228|NCT01097577|101525374|FG001|Overall Study|Adverse Event|1|||
33446229|NCT03733730|101525375|FG000|Overall Study|Lost to Follow-up|1|||
33446230|NCT03733730|101525376|FG001|Overall Study|Lost to Follow-up|32|||
33259057|NCT01985334|100849658|FG001|Overall Study|Adverse Event|8|||
33259058|NCT01985334|100849659|FG002|Overall Study|Adverse Event|2|||
33259059|NCT01985334|100849660|FG003|Overall Study|Adverse Event|26|||
33259060|NCT01985334|100849661|FG004|Overall Study|Adverse Event|3|||
33259061|NCT01985334|100849662|FG005|Overall Study|Adverse Event|18|||
33259062|NCT01985334|100849663|FG006|Overall Study|Adverse Event|3|||
33259063|NCT01985334|100849664|FG007|Overall Study|Adverse Event|15|||
33259064|NCT01985334|100849657|FG000|Overall Study|Other|4|||
33259065|NCT01985334|100849658|FG001|Overall Study|Other|2|||
33259066|NCT01985334|100849659|FG002|Overall Study|Other|3|||
33259067|NCT01985334|100849660|FG003|Overall Study|Other|10|||
33259068|NCT01985334|100849661|FG004|Overall Study|Other|1|||
33259069|NCT01985334|100849662|FG005|Overall Study|Other|6|||
33259070|NCT01985334|100849663|FG006|Overall Study|Other|2|||
33259071|NCT01985334|100849664|FG007|Overall Study|Other|2|||
33259072|NCT01985334|100849657|FG000|Overall Study|Medication non-compliance|0|||
33446231|NCT03733730|101525375|FG000|Overall Study|Other|1|||
33446232|NCT03733730|101525376|FG001|Overall Study|Other|0|||
33446233|NCT03733730|101525375|FG000|Overall Study|Adverse Event|0|||
33446234|NCT03733730|101525376|FG001|Overall Study|Adverse Event|4|||
33446235|NCT03733730|101525375|FG000|Overall Study|Death|0|||
33446236|NCT03733730|101525376|FG001|Overall Study|Death|5|||
33446237|NCT03733730|101525375|FG000|Overall Study|Withdrawal by Subject|0|||
33446238|NCT03733730|101525376|FG001|Overall Study|Withdrawal by Subject|8|||
33446239|NCT03134222|101525377|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
33446240|NCT03134222|101525378|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
33446241|NCT03134222|101525379|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
33446242|NCT03134222|101525380|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
33446243|NCT03134222|101525381|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
33446244|NCT03134222|101525377|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
33446245|NCT03134222|101525378|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
33446246|NCT03134222|101525379|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
33446247|NCT03134222|101525380|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
33446248|NCT03134222|101525381|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
33446249|NCT03134222|101525377|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
33446250|NCT03134222|101525378|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
33446251|NCT03134222|101525379|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
33446252|NCT03134222|101525380|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
33446253|NCT03134222|101525381|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
33446254|NCT03134222|101525377|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
33446255|NCT03134222|101525378|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
33446256|NCT03134222|101525379|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
33446257|NCT03134222|101525380|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
33446258|NCT03134222|101525381|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
33446259|NCT03134222|101525377|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
33446260|NCT03134222|101525378|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
33446261|NCT03134222|101525379|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
33446262|NCT03134222|101525380|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
33446263|NCT03134222|101525381|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
33446264|NCT03134222|101525377|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
33446265|NCT03134222|101525378|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
33446266|NCT03134222|101525379|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
33446267|NCT03134222|101525380|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
33446268|NCT03134222|101525381|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
33446269|NCT03134222|101525377|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
33446270|NCT03134222|101525378|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
33446271|NCT03134222|101525379|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
33446272|NCT03134222|101525380|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
33446273|NCT03134222|101525381|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
33446274|NCT03134222|101525377|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
33259073|NCT01985334|100849658|FG001|Overall Study|Medication non-compliance|4|||
33259074|NCT01985334|100849659|FG002|Overall Study|Medication non-compliance|1|||
33259075|NCT01985334|100849660|FG003|Overall Study|Medication non-compliance|6|||
33259076|NCT01985334|100849661|FG004|Overall Study|Medication non-compliance|2|||
33259077|NCT01985334|100849662|FG005|Overall Study|Medication non-compliance|3|||
33259078|NCT01985334|100849663|FG006|Overall Study|Medication non-compliance|1|||
33259079|NCT01985334|100849664|FG007|Overall Study|Medication non-compliance|3|||
33259080|NCT01985334|100849657|FG000|Overall Study|Use of prohibited treatment|1|||
33259081|NCT01985334|100849658|FG001|Overall Study|Use of prohibited treatment|4|||
33259082|NCT01985334|100849659|FG002|Overall Study|Use of prohibited treatment|1|||
33259083|NCT01985334|100849660|FG003|Overall Study|Use of prohibited treatment|2|||
33259084|NCT01985334|100849661|FG004|Overall Study|Use of prohibited treatment|1|||
33259085|NCT01985334|100849662|FG005|Overall Study|Use of prohibited treatment|6|||
33259086|NCT01985334|100849663|FG006|Overall Study|Use of prohibited treatment|2|||
33259087|NCT01985334|100849664|FG007|Overall Study|Use of prohibited treatment|0|||
33259088|NCT01985334|100849657|FG000|Overall Study|Investigator decision|0|||
33166165|NCT03521934|100518601|FG000|Overall Study|Withdrawal by Subject|18|||
33259089|NCT01985334|100849658|FG001|Overall Study|Investigator decision|3|||
33259090|NCT01985334|100849659|FG002|Overall Study|Investigator decision|0|||
33259091|NCT01985334|100849660|FG003|Overall Study|Investigator decision|7|||
33259092|NCT01985334|100849661|FG004|Overall Study|Investigator decision|1|||
33259093|NCT01985334|100849662|FG005|Overall Study|Investigator decision|1|||
33259094|NCT01985334|100849663|FG006|Overall Study|Investigator decision|0|||
33259095|NCT01985334|100849664|FG007|Overall Study|Investigator decision|4|||
33446275|NCT03134222|101525378|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
33259096|NCT01985334|100849657|FG000|Overall Study|Lost to Follow-up|0|||
33259097|NCT01985334|100849658|FG001|Overall Study|Lost to Follow-up|2|||
33259098|NCT01985334|100849659|FG002|Overall Study|Lost to Follow-up|0|||
33259099|NCT01985334|100849660|FG003|Overall Study|Lost to Follow-up|3|||
33446276|NCT03134222|101525379|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
33446277|NCT03134222|101525380|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
33446278|NCT03134222|101525381|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
33446279|NCT01139047|101525382|FG000|Overall Study|Withdrawal by Subject|1|||
33446280|NCT01313780|101525386|FG000|Overall Study|Lack of Efficacy|4|||
33446281|NCT01313780|101525387|FG001|Overall Study|Lack of Efficacy|2|||
33446282|NCT01313780|101525386|FG000|Overall Study|Adverse Event|6|||
33446283|NCT01313780|101525387|FG001|Overall Study|Adverse Event|11|||
33446284|NCT01313780|101525386|FG000|Overall Study|Withdrawal by Subject|2|||
33446285|NCT01313780|101525387|FG001|Overall Study|Withdrawal by Subject|8|||
33446286|NCT01313780|101525386|FG000|Overall Study|Protocol Violation|10|||
33446287|NCT01313780|101525387|FG001|Overall Study|Protocol Violation|4|||
33446288|NCT01313780|101525386|FG000|Overall Study|missing data|3|||
33446289|NCT01313780|101525387|FG001|Overall Study|missing data|3|||
33446290|NCT02409355|101525388|FG000|Overall Study|Withdrawal by Subject|1|||
33446291|NCT02409355|101525389|FG001|Overall Study|Withdrawal by Subject|0|||
33446292|NCT02409355|101525388|FG000|Overall Study|Death|1|||
33446293|NCT02409355|101525389|FG001|Overall Study|Death|1|||
33446294|NCT02409355|101525388|FG000|Overall Study|Study terminated by Sponsor|2|||
33446295|NCT02409355|101525389|FG001|Overall Study|Study terminated by Sponsor|3|||
33446296|NCT03173547|101525392|FG000|Overall Study|Adverse Event|2|||
33446297|NCT03173547|101525393|FG001|Overall Study|Adverse Event|0|||
33446298|NCT03173547|101525392|FG000|Overall Study|Withdrawal by Subject|2|||
33446299|NCT03173547|101525393|FG001|Overall Study|Withdrawal by Subject|2|||
33446300|NCT00934050|101525394|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
33446301|NCT00934050|101525395|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
33446302|NCT00934050|101525396|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
33446303|NCT00934050|101525397|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
33446304|NCT00934050|101525398|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
33446305|NCT00934050|101525399|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
33446306|NCT00934050|101525394|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
33446307|NCT00934050|101525395|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
33446308|NCT00934050|101525396|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
33446309|NCT00934050|101525397|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
33446310|NCT00934050|101525398|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
33446311|NCT00934050|101525399|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
33446312|NCT00934050|101525394|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
33446313|NCT00934050|101525395|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
33446314|NCT00934050|101525396|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
33166166|NCT03521934|100518602|FG001|Overall Study|Withdrawal by Subject|23|||
33446315|NCT00934050|101525397|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
33446316|NCT00934050|101525398|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
33166167|NCT03521934|100518601|FG000|Overall Study|Site Terminated by Sponsor|39|||
33166168|NCT03521934|100518602|FG001|Overall Study|Site Terminated by Sponsor|35|||
33166169|NCT03521934|100518601|FG000|Overall Study|Study Terminated by Sponsor|483|||
33166170|NCT03521934|100518602|FG001|Overall Study|Study Terminated by Sponsor|477|||
33166171|NCT03521934|100518601|FG000|Overall Study|Reason not Specified|3|||
33166172|NCT03521934|100518602|FG001|Overall Study|Reason not Specified|6|||
33166173|NCT02859454|100518603|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
33166174|NCT01756898|100518609|FG000|Overall Study|Adverse Event|7|||
33166175|NCT01756898|100518610|FG001|Overall Study|Adverse Event|1|||
33166176|NCT01756898|100518611|FG002|Overall Study|Adverse Event|0|||
33166177|NCT01756898|100518612|FG003|Overall Study|Adverse Event|0|||
33166178|NCT01756898|100518609|FG000|Overall Study|Lack of Efficacy|4|||
33166179|NCT01756898|100518610|FG001|Overall Study|Lack of Efficacy|7|||
33166180|NCT01756898|100518611|FG002|Overall Study|Lack of Efficacy|6|||
33166181|NCT01756898|100518612|FG003|Overall Study|Lack of Efficacy|6|||
33166182|NCT01756898|100518609|FG000|Overall Study|Lost to Follow-up|2|||
33166183|NCT01756898|100518610|FG001|Overall Study|Lost to Follow-up|4|||
33166184|NCT01756898|100518611|FG002|Overall Study|Lost to Follow-up|2|||
33166185|NCT01756898|100518612|FG003|Overall Study|Lost to Follow-up|3|||
33166186|NCT01756898|100518609|FG000|Overall Study|Protocol Violation|1|||
33166187|NCT01756898|100518610|FG001|Overall Study|Protocol Violation|2|||
33166188|NCT01756898|100518611|FG002|Overall Study|Protocol Violation|2|||
33166189|NCT01756898|100518612|FG003|Overall Study|Protocol Violation|1|||
33166190|NCT01756898|100518609|FG000|Overall Study|Withdrew Consent|5|||
33166191|NCT01756898|100518610|FG001|Overall Study|Withdrew Consent|3|||
33166192|NCT01756898|100518611|FG002|Overall Study|Withdrew Consent|5|||
33166193|NCT01756898|100518612|FG003|Overall Study|Withdrew Consent|6|||
33446317|NCT00934050|101525399|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
33446318|NCT00934050|101525394|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
33166194|NCT01756898|100518609|FG000|Overall Study|Other|0|||
33166195|NCT01756898|100518610|FG001|Overall Study|Other|2|||
33166196|NCT01756898|100518611|FG002|Overall Study|Other|2|||
33166197|NCT01756898|100518612|FG003|Overall Study|Other|0|||
33166198|NCT02161731|100518613|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
33166199|NCT02161731|100518614|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
33446319|NCT00934050|101525395|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
33166200|NCT02161731|100518613|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
33166201|NCT02161731|100518614|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
33166202|NCT01844518|100518628|FG000|Overall Study|Adverse Event|7|||
33166203|NCT01844518|100518629|FG001|Overall Study|Adverse Event|1|||
33166204|NCT01844518|100518628|FG000|Overall Study|Lack of Efficacy|17|||
33166205|NCT01844518|100518629|FG001|Overall Study|Lack of Efficacy|5|||
33166206|NCT01844518|100518628|FG000|Overall Study|Participant's request to discontinue|4|||
33166207|NCT01844518|100518629|FG001|Overall Study|Participant's request to discontinue|1|||
33166208|NCT01844518|100518628|FG000|Overall Study|Poor/Non-compliance|1|||
33166209|NCT01844518|100518629|FG001|Overall Study|Poor/Non-compliance|0|||
33166210|NCT01844518|100518628|FG000|Overall Study|No Longer Met Study Criteria|2|||
33166211|NCT01844518|100518629|FG001|Overall Study|No Longer Met Study Criteria|0|||
33166212|NCT01844518|100518628|FG000|Overall Study|Withdrawal by Subject|9|||
33166213|NCT01844518|100518629|FG001|Overall Study|Withdrawal by Subject|0|||
33166214|NCT01844518|100518628|FG000|Overall Study|Pregnancy|1|||
33166215|NCT01844518|100518629|FG001|Overall Study|Pregnancy|0|||
33166216|NCT02725710|100518634|FG000|Overall Study|Lost to Follow-up|1|||
33166217|NCT02725710|100518635|FG001|Overall Study|Lost to Follow-up|0|||
33166218|NCT00074152|100518636|FG000|Overall Study|Death|21|||
33166219|NCT00074152|100518637|FG001|Overall Study|Death|9|||
33166220|NCT00074152|100518636|FG000|Overall Study|Lack of Efficacy|34|||
33166221|NCT00074152|100518637|FG001|Overall Study|Lack of Efficacy|24|||
33166222|NCT01806298|100518638|FG000|Overall Study|Adverse Event|3|||
33166223|NCT01806298|100518638|FG000|Overall Study|Protocol Non-compliance|1|||
33166224|NCT01806298|100518638|FG000|Overall Study|Withdrawal by Subject|1|||
33166225|NCT01806298|100518638|FG000|Overall Study|Other|5|||
33166226|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
33166227|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
33166228|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
33166229|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
33166230|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
33166231|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
33166232|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
33166233|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
33166234|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
33166235|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
33166236|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
33166237|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
33166238|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
33166239|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
33166240|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
33166241|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
33166242|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
33166243|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
33166244|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
33166245|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
33166246|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
33166247|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
33166248|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
33166249|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
33166250|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
33166251|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
33166252|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
33166253|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
33166254|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
33166255|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
33166256|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
33166257|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
33166258|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
33166259|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
33166260|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
33166261|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
33166262|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
33166263|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
33166264|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
33166265|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
33166266|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
33166267|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
33259100|NCT01985334|100849661|FG004|Overall Study|Lost to Follow-up|1|||
33259101|NCT01985334|100849662|FG005|Overall Study|Lost to Follow-up|4|||
33166268|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
33166269|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
33166270|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
33166271|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
33166272|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
33166273|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
33166274|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
33166275|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
33166276|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
33166277|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
33166278|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
33166279|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
33166280|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
33166281|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
33166282|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
33166283|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
33166284|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
33166285|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
33166286|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
33166287|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
33166288|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
33166289|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
33166290|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
33166291|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
33166292|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
33259102|NCT01985334|100849663|FG006|Overall Study|Lost to Follow-up|0|||
33259103|NCT01985334|100849664|FG007|Overall Study|Lost to Follow-up|3|||
33446320|NCT00934050|101525396|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
33446321|NCT00934050|101525397|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
33446322|NCT00934050|101525398|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
33446323|NCT00934050|101525399|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
33446324|NCT00934050|101525394|FG000|Enrolled After 15 Dec 2009|Death|0|||
33446325|NCT00934050|101525395|FG001|Enrolled After 15 Dec 2009|Death|0|||
33446326|NCT00934050|101525396|FG002|Enrolled After 15 Dec 2009|Death|0|||
33446327|NCT00934050|101525397|FG003|Enrolled After 15 Dec 2009|Death|0|||
33446328|NCT00934050|101525398|FG004|Enrolled After 15 Dec 2009|Death|0|||
33446329|NCT00934050|101525399|FG005|Enrolled After 15 Dec 2009|Death|1|||
33446330|NCT00934050|101525394|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
33446331|NCT00934050|101525395|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
33446332|NCT00934050|101525396|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
33446333|NCT00934050|101525397|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
33446334|NCT00934050|101525398|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
33446335|NCT00934050|101525399|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
33446336|NCT00934050|101525394|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
33446337|NCT00934050|101525395|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
33446338|NCT00934050|101525396|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
33446339|NCT00934050|101525397|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
33446340|NCT00934050|101525398|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
33446341|NCT00934050|101525399|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
33446342|NCT00185458|101525403|FG000|Contraception Phase|Adverse Event|37|||
33446343|NCT00185458|101525403|FG000|Contraception Phase|Lost to Follow-up|10|||
33446344|NCT00185458|101525403|FG000|Contraception Phase|Protocol Violation|2|||
33446345|NCT00185458|101525403|FG000|Contraception Phase|Physician Decision|2|||
33446346|NCT00185458|101525403|FG000|Contraception Phase|Withdrawal by Subject|7|||
33446347|NCT00185458|101525403|FG000|HRT Phase|Adverse Event|18|||
33166293|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
33259104|NCT02594735|100849665|FG000|Overall Study|Adverse Event|1|||
33259105|NCT00999167|100849668|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
33446348|NCT00185458|101525403|FG000|HRT Phase|Lost to Follow-up|4|||
33446349|NCT00185458|101525403|FG000|HRT Phase|Protocol Violation|2|||
33446350|NCT00185458|101525403|FG000|HRT Phase|Withdrawal by Subject|3|||
33446351|NCT01370733|101525404|FG000|Overall Study|Withdrawal by Subject|8|||
33446352|NCT01370733|101525405|FG001|Overall Study|Withdrawal by Subject|8|||
33446353|NCT01370733|101525404|FG000|Overall Study|Lost to Follow-up|3|||
33446354|NCT01370733|101525405|FG001|Overall Study|Lost to Follow-up|0|||
33446355|NCT01370733|101525404|FG000|Overall Study|Adverse Event|2|||
33446356|NCT01370733|101525405|FG001|Overall Study|Adverse Event|4|||
33446357|NCT01370733|101525404|FG000|Overall Study|Lack of Efficacy|3|||
33446358|NCT01370733|101525405|FG001|Overall Study|Lack of Efficacy|5|||
33446359|NCT01370733|101525404|FG000|Overall Study|Physician Decision|0|||
33446360|NCT01370733|101525405|FG001|Overall Study|Physician Decision|2|||
33446361|NCT01370733|101525404|FG000|Overall Study|Protocol Violation|1|||
33446362|NCT01370733|101525405|FG001|Overall Study|Protocol Violation|3|||
33446363|NCT00359281|101525406|FG000|Overall Study|Adverse Event|1|||
33446364|NCT00359281|101525407|FG001|Overall Study|Adverse Event|0|||
33446365|NCT00359281|101525408|FG002|Overall Study|Adverse Event|0|||
33446366|NCT00359281|101525409|FG003|Overall Study|Adverse Event|0|||
33446367|NCT00359281|101525410|FG004|Overall Study|Adverse Event|0|||
33446368|NCT00359281|101525411|FG005|Overall Study|Adverse Event|0|||
33446369|NCT00359281|101525412|FG006|Overall Study|Adverse Event|1|||
33446370|NCT00359281|101525413|FG007|Overall Study|Adverse Event|0|||
33446371|NCT00359281|101525414|FG008|Overall Study|Adverse Event|0|||
33446372|NCT00359281|101525406|FG000|Overall Study|Withdrawal by Subject|0|||
33446373|NCT00359281|101525407|FG001|Overall Study|Withdrawal by Subject|0|||
33446374|NCT00359281|101525408|FG002|Overall Study|Withdrawal by Subject|0|||
33446375|NCT00359281|101525409|FG003|Overall Study|Withdrawal by Subject|0|||
33446376|NCT00359281|101525410|FG004|Overall Study|Withdrawal by Subject|0|||
33446377|NCT00359281|101525411|FG005|Overall Study|Withdrawal by Subject|0|||
33446378|NCT00359281|101525412|FG006|Overall Study|Withdrawal by Subject|1|||
33446379|NCT00359281|101525413|FG007|Overall Study|Withdrawal by Subject|0|||
33166294|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
33166295|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
33166296|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Change of location|0|||
33166297|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Change of location|0|||
33166298|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Change of location|0|||
33166299|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Change of location|1|||
33166300|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Change of location|0|||
33166301|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
33166302|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
33166303|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
33166304|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
33446380|NCT00359281|101525414|FG008|Overall Study|Withdrawal by Subject|0|||
33446381|NCT00549718|101525418|FG000|Overall Study|Insufficient clinical response|20|||
33446382|NCT00549718|101525419|FG001|Overall Study|Insufficient clinical response|7|||
33446383|NCT00549718|101525420|FG002|Overall Study|Insufficient clinical response|18|||
33446384|NCT00549718|101525421|FG003|Overall Study|Insufficient clinical response|32|||
33446385|NCT00549718|101525418|FG000|Overall Study|Adverse Event|6|||
33446386|NCT00549718|101525419|FG001|Overall Study|Adverse Event|8|||
33446387|NCT00549718|101525420|FG002|Overall Study|Adverse Event|7|||
33446388|NCT00549718|101525421|FG003|Overall Study|Adverse Event|3|||
33446389|NCT00549718|101525418|FG000|Overall Study|Lost to Follow-up|4|||
33446390|NCT00549718|101525419|FG001|Overall Study|Lost to Follow-up|2|||
33446391|NCT00549718|101525420|FG002|Overall Study|Lost to Follow-up|0|||
33446392|NCT00549718|101525421|FG003|Overall Study|Lost to Follow-up|6|||
33446393|NCT00549718|101525418|FG000|Overall Study|Withdrawal by Subject|9|||
33446394|NCT00549718|101525419|FG001|Overall Study|Withdrawal by Subject|18|||
33446395|NCT00549718|101525420|FG002|Overall Study|Withdrawal by Subject|12|||
33446396|NCT00549718|101525421|FG003|Overall Study|Withdrawal by Subject|13|||
33446397|NCT00549718|101525418|FG000|Overall Study|Administrative|2|||
33446398|NCT00549718|101525419|FG001|Overall Study|Administrative|2|||
33446399|NCT00549718|101525420|FG002|Overall Study|Administrative|2|||
33446400|NCT00549718|101525421|FG003|Overall Study|Administrative|1|||
33446401|NCT01383486|101525427|FG000|Overall Study|Lost to Follow-up|10|||
33446402|NCT01383486|101525427|FG000|Overall Study|Incomplete information for analysis|2|||
33446403|NCT01383486|101525427|FG000|Overall Study|Did not take any product|6|||
33446404|NCT05041361|101525428|FG000|Overall Study|Lost to Follow-up|1|||
33446405|NCT05041361|101525429|FG001|Overall Study|Lost to Follow-up|3|||
33166305|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
33166306|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
33446406|NCT02146105|101525431|FG000|Overall Study|Adverse Event|1|||
33446407|NCT02146105|101525431|FG000|Overall Study|Withdrawal by Subject|5|||
33446408|NCT01136174|101525440|FG000|Overall Study|Adverse Event|0|||
33446409|NCT01136174|101525441|FG001|Overall Study|Adverse Event|0|||
33446410|NCT01136174|101525442|FG002|Overall Study|Adverse Event|0|||
33446411|NCT01136174|101525443|FG003|Overall Study|Adverse Event|4|||
33446412|NCT00420303|101525444|FG000|Overall Study|Serious Adverse Event|1|||
33446413|NCT00420303|101525445|FG001|Overall Study|Serious Adverse Event|0|||
33166307|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
33166308|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
33166309|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
33166310|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
33166311|NCT00730405|100518639|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
33166312|NCT00730405|100518640|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
33166313|NCT00730405|100518641|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
33166314|NCT00730405|100518642|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
33166315|NCT00730405|100518643|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
33166316|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
33166317|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
33166318|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
33166319|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
33166320|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
33166321|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
33166322|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
33166323|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
33166324|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
33166325|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
33166326|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
33166327|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
33166328|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
33166329|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
33166330|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
33166331|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Death|0|||
33166332|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Death|1|||
33166333|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Death|0|||
33166334|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Death|1|||
33166335|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Death|0|||
33166336|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Change of location|1|||
33166337|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Change of location|1|||
33166338|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Change of location|0|||
33166339|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Change of location|1|||
33166340|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Change of location|0|||
33166341|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
33166342|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
33166343|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
33446414|NCT00420303|101525444|FG000|Overall Study|Lack of Efficacy|0|||
33446415|NCT00420303|101525445|FG001|Overall Study|Lack of Efficacy|3|||
33446416|NCT00420303|101525444|FG000|Overall Study|Physician Decision|0|||
33446417|NCT00420303|101525445|FG001|Overall Study|Physician Decision|1|||
33446418|NCT02632344|101525446|FG000|Overall Study|Adverse Event|3|||
33446419|NCT02632344|101525446|FG000|Overall Study|Lack of Efficacy|3|||
33446420|NCT02632344|101525446|FG000|Overall Study|Withdrawal by Subject|2|||
33446421|NCT01456221|101525447|FG000|Overall Study|Withdrawal by Subject|56|||
33446422|NCT01456221|101525448|FG001|Overall Study|Withdrawal by Subject|49|||
33446423|NCT01456221|101525447|FG000|Overall Study|Lost to Follow-up|1|||
33446424|NCT01456221|101525448|FG001|Overall Study|Lost to Follow-up|4|||
33446425|NCT01456221|101525447|FG000|Overall Study|Received medication|3|||
33446426|NCT01456221|101525448|FG001|Overall Study|Received medication|2|||
33446427|NCT01456221|101525447|FG000|Overall Study|Incomplete data|4|||
33446428|NCT01456221|101525448|FG001|Overall Study|Incomplete data|2|||
33166344|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
33166345|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
33166346|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
33286470|NCT03918447|100943975|FG000|Overall Study|Lost to Follow-up|13|||
33446429|NCT01802320|101525454|FG000|Overall Study|Death|1|||
33446430|NCT01802320|101525454|FG000|Overall Study|Withdrawal by Subject|1|||
33446431|NCT02335658|101525455|FG000|Overall Study|Adverse Event|18|||
33446432|NCT02335658|101525456|FG001|Overall Study|Adverse Event|12|||
33446433|NCT02335658|101525455|FG000|Overall Study|Lack of Efficacy|4|||
33446434|NCT02335658|101525456|FG001|Overall Study|Lack of Efficacy|5|||
33446435|NCT02335658|101525455|FG000|Overall Study|Pregnancy|1|||
33446436|NCT02335658|101525456|FG001|Overall Study|Pregnancy|0|||
33446437|NCT02335658|101525455|FG000|Overall Study|Withdrawal by Subject|13|||
33446438|NCT02335658|101525456|FG001|Overall Study|Withdrawal by Subject|21|||
33446439|NCT02335658|101525455|FG000|Overall Study|non-compliance|2|||
33446440|NCT02335658|101525456|FG001|Overall Study|non-compliance|3|||
33446441|NCT02335658|101525455|FG000|Overall Study|other reason|2|||
33446442|NCT02335658|101525456|FG001|Overall Study|other reason|3|||
33446443|NCT01111461|101525463|FG000|Overall Study|Adverse Event|32|||
33446444|NCT01111461|101525463|FG000|Overall Study|Participant choice|11|||
33446445|NCT01111461|101525463|FG000|Overall Study|Lost to Follow-up|1|||
33446446|NCT01111461|101525463|FG000|Overall Study|Withdrawal by Subject|1|||
33446447|NCT01111461|101525463|FG000|Overall Study|Other|6|||
33446448|NCT03663179|101525464|FG000|Overall Study|Withdrawal by Subject|2|||
33446449|NCT03663179|101525465|FG001|Overall Study|Withdrawal by Subject|0|||
33446450|NCT03663179|101525464|FG000|Overall Study|Lost to Follow-up|1|||
33446451|NCT03663179|101525465|FG001|Overall Study|Lost to Follow-up|1|||
33446452|NCT03663179|101525464|FG000|Overall Study|Revealed exclusionary condition|1|||
33446453|NCT03663179|101525465|FG001|Overall Study|Revealed exclusionary condition|0|||
33446454|NCT02563561|101525466|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
33446455|NCT02563561|101525467|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
33446456|NCT02563561|101525468|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
33446457|NCT02563561|101525466|FG000|Overall Study|Withdrew of Consent|1|||
33446458|NCT02563561|101525467|FG001|Overall Study|Withdrew of Consent|1|||
33446459|NCT02563561|101525468|FG002|Overall Study|Withdrew of Consent|2|||
33446460|NCT02563561|101525466|FG000|Overall Study|Lost to Follow-up|1|||
33446461|NCT02563561|101525467|FG001|Overall Study|Lost to Follow-up|1|||
33446462|NCT02563561|101525468|FG002|Overall Study|Lost to Follow-up|0|||
33446463|NCT02563561|101525466|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
33446464|NCT02563561|101525467|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
33446465|NCT02563561|101525468|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
33446466|NCT02563561|101525466|FG000|Overall Study|Investigator Decision|3|||
33446467|NCT02563561|101525467|FG001|Overall Study|Investigator Decision|4|||
33446468|NCT02563561|101525468|FG002|Overall Study|Investigator Decision|2|||
33446469|NCT02563561|101525466|FG000|Overall Study|Sponsor Decision|5|||
33446470|NCT02563561|101525467|FG001|Overall Study|Sponsor Decision|2|||
33446471|NCT02563561|101525468|FG002|Overall Study|Sponsor Decision|4|||
33446472|NCT02563561|101525466|FG000|Overall Study|Other|1|||
33446473|NCT02563561|101525467|FG001|Overall Study|Other|5|||
33446474|NCT02563561|101525468|FG002|Overall Study|Other|2|||
33446475|NCT01188681|101525469|FG000|Overall Study|bladder cancer|0|||
33446476|NCT01188681|101525470|FG001|Overall Study|bladder cancer|0|||
33446477|NCT01188681|101525471|FG002|Overall Study|bladder cancer|1|||
33446478|NCT01188681|101525472|FG003|Overall Study|bladder cancer|0|||
33446479|NCT01188681|101525469|FG000|Overall Study|Withdrawal by Subject|0|||
33446480|NCT01188681|101525470|FG001|Overall Study|Withdrawal by Subject|0|||
33166347|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
33446481|NCT01188681|101525471|FG002|Overall Study|Withdrawal by Subject|0|||
33446482|NCT01188681|101525472|FG003|Overall Study|Withdrawal by Subject|1|||
33446483|NCT01472341|101525475|FG000|Overall Study|Started insulin therapy|55|||
33446484|NCT01472341|101525475|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
33446485|NCT01472341|101525475|FG000|Overall Study|Withdrawal by Subject|39|||
33446486|NCT01472341|101525475|FG000|Overall Study|Lost to Follow-up|52|||
33446487|NCT01472341|101525475|FG000|Overall Study|Laboratory parameters unavailable|25|||
33446488|NCT01472341|101525475|FG000|Overall Study|Death|9|||
33446489|NCT02880761|101525476|FG000|Overall Study|Death|6|||
33446490|NCT02880761|101525477|FG001|Overall Study|Death|8|||
33446491|NCT02880761|101525476|FG000|Overall Study|Withdrawal by Subject|3|||
33446492|NCT02880761|101525477|FG001|Overall Study|Withdrawal by Subject|6|||
33446493|NCT02880761|101525476|FG000|Overall Study|Protocol Violation|4|||
33446494|NCT02880761|101525477|FG001|Overall Study|Protocol Violation|3|||
33446495|NCT02880761|101525476|FG000|Overall Study|Lost to Follow-up|3|||
33446496|NCT02880761|101525477|FG001|Overall Study|Lost to Follow-up|4|||
33446497|NCT00859430|101525478|FG000|First Intervention|Withdrawal by Subject|0|||
33446498|NCT00859430|101525479|FG001|First Intervention|Withdrawal by Subject|1|||
33446499|NCT00440518|101525480|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
33446500|NCT00440518|101525481|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
33446501|NCT00440518|101525482|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
33446502|NCT00440518|101525480|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
33166348|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
33166349|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
33166350|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
33166351|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
33166352|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
33166353|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
33166354|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
33166355|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
33166356|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
33166357|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
33166358|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
33166359|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
33166360|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
33166361|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
33166362|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
33166363|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
33166364|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
33166365|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
33166366|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
33166367|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
33166368|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
33166369|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
33166370|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
33166371|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
33166372|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
33166373|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
33166374|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
33166375|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
33166376|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
33166377|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
33166378|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
33166379|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
33166380|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
33166381|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
33286471|NCT03918447|100943976|FG001|Overall Study|Lost to Follow-up|6|||
33446503|NCT00440518|101525481|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
33446504|NCT00440518|101525482|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
33446505|NCT00440518|101525480|FG000|Randomized /Titration Period|Protocol Deviation|1|||
33446506|NCT00440518|101525481|FG001|Randomized /Titration Period|Protocol Deviation|0|||
33446507|NCT00440518|101525482|FG002|Randomized /Titration Period|Protocol Deviation|0|||
33446508|NCT00440518|101525480|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
33446509|NCT00440518|101525481|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
33446510|NCT00440518|101525482|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
33446511|NCT00440518|101525480|FG000|Randomized /Titration Period|Other|1|||
33446512|NCT00440518|101525481|FG001|Randomized /Titration Period|Other|0|||
33446513|NCT00440518|101525482|FG002|Randomized /Titration Period|Other|0|||
33446514|NCT00440518|101525480|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
33446515|NCT00440518|101525481|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
33446516|NCT00440518|101525482|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
33446517|NCT00440518|101525480|FG000|Randomized /Titration Period|Adverse Event|2|||
33446518|NCT00440518|101525481|FG001|Randomized /Titration Period|Adverse Event|3|||
33446519|NCT00440518|101525482|FG002|Randomized /Titration Period|Adverse Event|0|||
33446520|NCT00440518|101525480|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
33446521|NCT00440518|101525481|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
33446522|NCT00440518|101525482|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
33446523|NCT00440518|101525480|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
33446524|NCT00440518|101525481|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
33446525|NCT00440518|101525482|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
33446526|NCT00440518|101525480|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
33446527|NCT00440518|101525481|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
33446528|NCT00440518|101525482|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
33446529|NCT00440518|101525480|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
33446530|NCT00440518|101525481|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
33446531|NCT00440518|101525482|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
33446532|NCT00440518|101525480|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
33446533|NCT00440518|101525481|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
33446534|NCT00440518|101525482|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
33446535|NCT00440518|101525480|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
33446536|NCT00440518|101525481|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
33446537|NCT00440518|101525482|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
33446538|NCT05017480|101525486|FG000|Stage 1 Study|Withdrawal by Subject|8|||
33446539|NCT05017480|101525487|FG001|Stage 1 Study|Withdrawal by Subject|6|||
33446540|NCT05017480|101525488|FG002|Stage 1 Study|Withdrawal by Subject|0|||
33446541|NCT05017480|101525489|FG003|Stage 1 Study|Withdrawal by Subject|0|||
33446542|NCT05017480|101525490|FG004|Stage 1 Study|Withdrawal by Subject|0|||
33446543|NCT05017480|101525486|FG000|Stage 1 Study|Adverse Event|1|||
33446544|NCT05017480|101525487|FG001|Stage 1 Study|Adverse Event|1|||
33446545|NCT05017480|101525488|FG002|Stage 1 Study|Adverse Event|0|||
33446546|NCT05017480|101525489|FG003|Stage 1 Study|Adverse Event|0|||
33166382|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
33446547|NCT05017480|101525490|FG004|Stage 1 Study|Adverse Event|0|||
33446548|NCT05017480|101525486|FG000|Stage 1 Study|Poor Compliance|1|||
33446549|NCT05017480|101525487|FG001|Stage 1 Study|Poor Compliance|1|||
33446550|NCT05017480|101525488|FG002|Stage 1 Study|Poor Compliance|0|||
33446551|NCT05017480|101525489|FG003|Stage 1 Study|Poor Compliance|0|||
33446552|NCT05017480|101525490|FG004|Stage 1 Study|Poor Compliance|0|||
33446553|NCT05017480|101525486|FG000|Stage 1 Study|Physician Decision|0|||
33446554|NCT05017480|101525487|FG001|Stage 1 Study|Physician Decision|1|||
33446555|NCT05017480|101525488|FG002|Stage 1 Study|Physician Decision|0|||
33446556|NCT05017480|101525489|FG003|Stage 1 Study|Physician Decision|0|||
33446557|NCT05017480|101525490|FG004|Stage 1 Study|Physician Decision|0|||
33166383|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
33166384|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
33166385|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
33166386|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
33166387|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
33166388|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
33166389|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
33166390|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
33166391|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Missing|0|||
33166392|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Missing|0|||
33166393|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Missing|2|||
33166394|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Missing|0|||
33166395|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Missing|0|||
33166396|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
33446558|NCT05017480|101525486|FG000|Stage 2 Study|Withdrawal by Subject|0|||
33166397|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
33166398|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
33166399|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
33259106|NCT00999167|100849669|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
33446559|NCT05017480|101525487|FG001|Stage 2 Study|Withdrawal by Subject|0|||
33446560|NCT05017480|101525488|FG002|Stage 2 Study|Withdrawal by Subject|6|||
33446561|NCT05017480|101525489|FG003|Stage 2 Study|Withdrawal by Subject|9|||
33166400|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
33166401|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
33166402|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
33166403|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
33166404|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
33166405|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
33166406|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
33166407|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
33166408|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
33166409|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
33166410|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
33166411|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
33166412|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
33166413|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
33166414|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
33166415|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
33166416|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
33166417|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
33166418|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
33166419|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
33166420|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
33166421|NCT00730405|100518639|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
33166422|NCT00730405|100518640|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
33166423|NCT00730405|100518641|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
33166424|NCT00730405|100518642|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
33166425|NCT00730405|100518643|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
33166426|NCT01010061|100518646|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
33166427|NCT01010061|100518647|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
33166428|NCT01010061|100518646|FG000|Overall Study|Disease Progression|2|||
33166429|NCT01010061|100518647|FG001|Overall Study|Disease Progression|8|||
33166430|NCT01010061|100518646|FG000|Overall Study|Withdrew Consent|5|||
33166431|NCT01010061|100518647|FG001|Overall Study|Withdrew Consent|1|||
33166432|NCT01010061|100518646|FG000|Overall Study|Death|3|||
33166433|NCT01010061|100518647|FG001|Overall Study|Death|6|||
33166434|NCT01010061|100518646|FG000|Overall Study|Administrative/Other|0|||
33166435|NCT01010061|100518647|FG001|Overall Study|Administrative/Other|1|||
33166436|NCT01010061|100518646|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
33166437|NCT01010061|100518647|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
33166438|NCT01010061|100518646|FG000|Overall Study|Insufficient Therapeutic Response|1|||
33166439|NCT01010061|100518647|FG001|Overall Study|Insufficient Therapeutic Response|5|||
33166440|NCT01010061|100518646|FG000|Overall Study|Violation of Selection Criteria|0|||
33166441|NCT01010061|100518647|FG001|Overall Study|Violation of Selection Criteria|1|||
33166442|NCT01010061|100518646|FG000|Overall Study|Did Not Receive Treatment|2|||
33166443|NCT01010061|100518647|FG001|Overall Study|Did Not Receive Treatment|2|||
33166444|NCT01918774|100518652|FG000|Overall Study|Lost prior to first CBTw session|4|||
33166445|NCT01918774|100518652|FG000|Overall Study|Lost to Follow-up|1|||
33166446|NCT02837783|100518653|FG000|Overall Study|Adverse Event|1|||
33166447|NCT02837783|100518654|FG001|Overall Study|Adverse Event|0|||
33166448|NCT02837783|100518653|FG000|Overall Study|Other, Not Specified|1|||
33166449|NCT02837783|100518654|FG001|Overall Study|Other, Not Specified|2|||
33166450|NCT03706456|100518655|FG000|Overall Study|Adverse Event|1|||
33166451|NCT03706456|100518655|FG000|Overall Study|Lack of Efficacy|2|||
33166452|NCT02550106|100518658|FG000|Overall Study|Adverse Event|1|||
33166453|NCT02550106|100518658|FG000|Overall Study|Lack of Efficacy|3|||
33166454|NCT02550106|100518658|FG000|Overall Study|Protocol Violation|6|||
33166455|NCT02550106|100518658|FG000|Overall Study|Withdrawal by Subject|2|||
33166456|NCT01751178|100518659|FG000|Overall Study|Adverse Event|2|||
33166457|NCT01751178|100518660|FG001|Overall Study|Adverse Event|0|||
33166458|NCT01751178|100518661|FG002|Overall Study|Adverse Event|0|||
33166459|NCT01751178|100518659|FG000|Overall Study|Other Reason (unknown)|1|||
33166460|NCT01751178|100518660|FG001|Overall Study|Other Reason (unknown)|0|||
33166461|NCT01751178|100518661|FG002|Overall Study|Other Reason (unknown)|2|||
33166462|NCT02480114|100518662|FG000|Overall Study|Not completing surveys|3|||
33166463|NCT02480114|100518663|FG001|Overall Study|Not completing surveys|2|||
33166464|NCT02480114|100518662|FG000|Overall Study|Withdrawal by Subject|2|||
33166465|NCT02480114|100518663|FG001|Overall Study|Withdrawal by Subject|4|||
33166466|NCT02480114|100518662|FG000|Overall Study|Disease progression|3|||
33166467|NCT02480114|100518663|FG001|Overall Study|Disease progression|0|||
33286472|NCT03918447|100943975|FG000|Overall Study|Withdrawal by Subject|19|||
33166468|NCT02480114|100518662|FG000|Overall Study|Improper completion of survey|1|||
33166469|NCT02480114|100518663|FG001|Overall Study|Improper completion of survey|1|||
33446562|NCT05017480|101525490|FG004|Stage 2 Study|Withdrawal by Subject|11|||
33446563|NCT05017480|101525486|FG000|Stage 2 Study|Lost to Follow-up|0|||
33446564|NCT05017480|101525487|FG001|Stage 2 Study|Lost to Follow-up|0|||
33446565|NCT05017480|101525488|FG002|Stage 2 Study|Lost to Follow-up|0|||
33446566|NCT05017480|101525489|FG003|Stage 2 Study|Lost to Follow-up|2|||
33259107|NCT00999167|100849670|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
33259108|NCT00999167|100849668|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
33259109|NCT00999167|100849669|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
33259110|NCT00999167|100849670|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
33259111|NCT00999167|100849668|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
33259112|NCT00999167|100849669|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
33259113|NCT00999167|100849670|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
33259114|NCT00999167|100849668|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
33259115|NCT00999167|100849669|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
33259116|NCT00999167|100849670|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
33259117|NCT00999167|100849668|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
33259118|NCT00999167|100849669|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
33259119|NCT00999167|100849670|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
33259120|NCT00999167|100849668|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
33259121|NCT00999167|100849669|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
33259122|NCT00999167|100849670|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
33446567|NCT05017480|101525490|FG004|Stage 2 Study|Lost to Follow-up|1|||
33446568|NCT05017480|101525486|FG000|Stage 2 Study|Adverse Event|0|||
33446569|NCT05017480|101525487|FG001|Stage 2 Study|Adverse Event|0|||
33259123|NCT00999167|100849668|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
33259124|NCT00999167|100849669|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
33259125|NCT00999167|100849670|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
33259126|NCT00999167|100849668|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
33259127|NCT00999167|100849669|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
33259128|NCT00999167|100849670|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
33259129|NCT00914589|100849671|FG000|Overall Study|Adverse Event|1|||
33259130|NCT00914589|100849672|FG001|Overall Study|Adverse Event|0|||
33259131|NCT00914589|100849673|FG002|Overall Study|Adverse Event|1|||
33259132|NCT00914589|100849671|FG000|Overall Study|Protocol Violation|8|||
33259133|NCT00914589|100849672|FG001|Overall Study|Protocol Violation|6|||
33259134|NCT00914589|100849673|FG002|Overall Study|Protocol Violation|3|||
33259135|NCT00914589|100849671|FG000|Overall Study|unclassified|16|||
33259136|NCT00914589|100849672|FG001|Overall Study|unclassified|9|||
33446570|NCT05017480|101525488|FG002|Stage 2 Study|Adverse Event|0|||
33446571|NCT05017480|101525489|FG003|Stage 2 Study|Adverse Event|1|||
33259137|NCT00914589|100849673|FG002|Overall Study|unclassified|7|||
33259138|NCT00914589|100849671|FG000|Overall Study|Death|0|||
33259139|NCT00914589|100849672|FG001|Overall Study|Death|1|||
33259140|NCT00914589|100849673|FG002|Overall Study|Death|1|||
33259141|NCT00858117|100849674|FG000|Treatment on Study|Adverse Event|2|||
33259142|NCT00858117|100849674|FG000|Follow up for 5 Years|Death|4|||
33259143|NCT00858117|100849674|FG000|Follow up for 5 Years|No further data collected for study|9|||
33259144|NCT01017146|100849683|FG000|Overall Study|Adverse Event|11|||
33259145|NCT01017146|100849684|FG001|Overall Study|Adverse Event|1|||
33259146|NCT01017146|100849683|FG000|Overall Study|Lost to Follow-up|14|||
33259147|NCT01017146|100849684|FG001|Overall Study|Lost to Follow-up|14|||
33259148|NCT01017146|100849683|FG000|Overall Study|Noncompliance with Study Product|1|||
33259149|NCT01017146|100849684|FG001|Overall Study|Noncompliance with Study Product|1|||
33259150|NCT01017146|100849683|FG000|Overall Study|Withdrawal by Subject|32|||
33259151|NCT01017146|100849684|FG001|Overall Study|Withdrawal by Subject|16|||
33259152|NCT01017146|100849683|FG000|Overall Study|Relocation|0|||
33259153|NCT01017146|100849684|FG001|Overall Study|Relocation|4|||
33259154|NCT01017146|100849683|FG000|Overall Study|Pregnancy|2|||
33259155|NCT01017146|100849684|FG001|Overall Study|Pregnancy|1|||
33259156|NCT01017146|100849683|FG000|Overall Study|Protocol Violation|2|||
33259157|NCT01017146|100849684|FG001|Overall Study|Protocol Violation|0|||
33259158|NCT01017146|100849683|FG000|Overall Study|Took Excluded Medication|2|||
33259159|NCT01017146|100849684|FG001|Overall Study|Took Excluded Medication|0|||
33259160|NCT01017146|100849683|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
33259161|NCT01017146|100849684|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
33259162|NCT01017146|100849683|FG000|Overall Study|Change in Work Situation|1|||
33259163|NCT01017146|100849684|FG001|Overall Study|Change in Work Situation|0|||
33166470|NCT02480114|100518662|FG000|Overall Study|Not eligible|0|||
33166471|NCT02480114|100518663|FG001|Overall Study|Not eligible|1|||
33166472|NCT00370032|100518664|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
33166473|NCT00370032|100518665|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
33166474|NCT00370032|100518664|FG000|Washout Period|Withdrawal by Subject|0|||
33166475|NCT00370032|100518665|FG001|Washout Period|Withdrawal by Subject|1|||
33166476|NCT00370032|100518664|FG000|Washout Period|Lost to Follow-up|0|||
33166477|NCT00370032|100518665|FG001|Washout Period|Lost to Follow-up|1|||
33166478|NCT00370032|100518664|FG000|Washout Period|Adverse Event|1|||
33166479|NCT00370032|100518665|FG001|Washout Period|Adverse Event|0|||
33166480|NCT00370032|100518664|FG000|Follow-up Period|Withdrawal by Subject|1|||
33259164|NCT02238483|100849689|FG000|Overall Study|Withdrawal by Subject|2|||
33259165|NCT02238483|100849690|FG001|Overall Study|Withdrawal by Subject|7|||
33259166|NCT02238483|100849689|FG000|Overall Study|Lost to Follow-up|1|||
33446572|NCT05017480|101525490|FG004|Stage 2 Study|Adverse Event|0|||
33166481|NCT00370032|100518665|FG001|Follow-up Period|Withdrawal by Subject|0|||
33166482|NCT00630396|100518668|FG000|Overall Study|Death|4|||
33446573|NCT05017480|101525486|FG000|Stage 2 Study|COVID-19|0|||
33446574|NCT05017480|101525487|FG001|Stage 2 Study|COVID-19|0|||
33446575|NCT05017480|101525488|FG002|Stage 2 Study|COVID-19|0|||
33446576|NCT05017480|101525489|FG003|Stage 2 Study|COVID-19|1|||
33446577|NCT05017480|101525490|FG004|Stage 2 Study|COVID-19|0|||
33446578|NCT05017480|101525486|FG000|Stage 2 Study|Pregnancy|0|||
33166483|NCT00630396|100518668|FG000|Overall Study|Lost to Follow-up|3|||
33166484|NCT00205881|100518669|FG000|Overall Study|Withdrawal by Subject|16|||
33166485|NCT03334903|100518671|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
33166486|NCT03334903|100518672|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
33166487|NCT03334903|100518671|FG000|Overall Study|Protocol Violation|1|||
33166488|NCT03334903|100518672|FG001|Overall Study|Protocol Violation|3|||
33166489|NCT03334903|100518671|FG000|Overall Study|Surgery postponed|1|||
33166490|NCT03334903|100518672|FG001|Overall Study|Surgery postponed|0|||
33166491|NCT03334903|100518671|FG000|Overall Study|Adverse Event|1|||
33166492|NCT03334903|100518672|FG001|Overall Study|Adverse Event|1|||
33166493|NCT03334903|100518671|FG000|Overall Study|Withdrawal by Subject|0|||
33166494|NCT03334903|100518672|FG001|Overall Study|Withdrawal by Subject|1|||
33166495|NCT00787891|100518673|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
33166496|NCT00787891|100518674|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
33166497|NCT00787891|100518673|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
33166498|NCT00787891|100518674|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
33166499|NCT00787891|100518673|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
33166500|NCT00787891|100518674|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
33166501|NCT00787891|100518673|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
33166502|NCT00787891|100518674|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
33166503|NCT00787891|100518673|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
33166504|NCT00787891|100518674|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
33166505|NCT00787891|100518673|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
33166506|NCT00787891|100518674|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
33166507|NCT00787891|100518673|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
33166508|NCT00787891|100518674|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
33166509|NCT00787891|100518673|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
33166510|NCT00787891|100518674|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
33166511|NCT00787891|100518673|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
33166512|NCT00787891|100518674|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
33166513|NCT00787891|100518673|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
33166514|NCT00787891|100518674|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
33166515|NCT04649060|100518679|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
33166516|NCT04649060|100518680|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
33166517|NCT04649060|100518679|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
33166518|NCT04649060|100518680|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
33166519|NCT04649060|100518679|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
33166520|NCT04649060|100518680|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
33166521|NCT04649060|100518679|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
33166522|NCT04649060|100518680|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
33446579|NCT05017480|101525487|FG001|Stage 2 Study|Pregnancy|0|||
33446580|NCT05017480|101525488|FG002|Stage 2 Study|Pregnancy|0|||
33446581|NCT05017480|101525489|FG003|Stage 2 Study|Pregnancy|0|||
33446582|NCT05017480|101525490|FG004|Stage 2 Study|Pregnancy|1|||
33446583|NCT00731783|101525494|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
33446584|NCT00731783|101525495|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
33446585|NCT00731783|101525494|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
33446586|NCT00731783|101525495|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
33446587|NCT00731783|101525494|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
33446588|NCT00731783|101525495|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
33446589|NCT00731783|101525494|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
33446590|NCT00731783|101525495|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
33259167|NCT02238483|100849690|FG001|Overall Study|Lost to Follow-up|1|||
33259168|NCT02238483|100849689|FG000|Overall Study|Protocol Violation|1|||
33259169|NCT02238483|100849690|FG001|Overall Study|Protocol Violation|2|||
33446591|NCT01959672|101525496|FG000|Overall Study|Death|1|||
33446592|NCT00365846|101525497|FG000|Overall Study|Lost to Follow-up|1|||
33166523|NCT04649060|100518679|FG000|Arm A/Arm B Treatment|Patient Request|1|||
33166524|NCT04649060|100518680|FG001|Arm A/Arm B Treatment|Patient Request|0|||
33166525|NCT04649060|100518679|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
33166526|NCT04649060|100518680|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
33166527|NCT04649060|100518679|FG000|Arm A/Arm B Treatment|Other|1|||
33166528|NCT04649060|100518680|FG001|Arm A/Arm B Treatment|Other|0|||
33259170|NCT02238483|100849689|FG000|Overall Study|Death|1|||
33166529|NCT04649060|100518679|FG000|Crossover (Arm B)|Adverse Event|0|||
33166530|NCT04649060|100518680|FG001|Crossover (Arm B)|Adverse Event|1|||
33166531|NCT04649060|100518679|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
33166532|NCT04649060|100518680|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
33166533|NCT02006719|100518681|FG000|Overall Study|Withdrawal by Subject|10|||
33166534|NCT02006719|100518682|FG001|Overall Study|Withdrawal by Subject|2|||
33166535|NCT02006719|100518681|FG000|Overall Study|Lost to Follow-up|5|||
33166536|NCT02006719|100518682|FG001|Overall Study|Lost to Follow-up|1|||
33166537|NCT02006719|100518681|FG000|Overall Study|Protocol Violation|2|||
33166538|NCT02006719|100518682|FG001|Overall Study|Protocol Violation|0|||
33166539|NCT02006719|100518681|FG000|Overall Study|Adverse Event|1|||
33166540|NCT02006719|100518682|FG001|Overall Study|Adverse Event|1|||
33166541|NCT02006719|100518681|FG000|Overall Study|Other/Unknown|0|||
33166542|NCT02006719|100518682|FG001|Overall Study|Other/Unknown|1|||
33166543|NCT00317356|100518683|FG000|Overall Study|Adverse Event|0|||
33166544|NCT00317356|100518684|FG001|Overall Study|Adverse Event|0|||
33166545|NCT00317356|100518685|FG002|Overall Study|Adverse Event|1|||
33166546|NCT00317356|100518686|FG003|Overall Study|Adverse Event|0|||
33166547|NCT00317356|100518683|FG000|Overall Study|Lack of Efficacy|1|||
33166548|NCT00317356|100518684|FG001|Overall Study|Lack of Efficacy|1|||
33166549|NCT00317356|100518685|FG002|Overall Study|Lack of Efficacy|0|||
33166550|NCT00317356|100518686|FG003|Overall Study|Lack of Efficacy|3|||
33166551|NCT00317356|100518683|FG000|Overall Study|Physician Decision|0|||
33166552|NCT00317356|100518684|FG001|Overall Study|Physician Decision|1|||
33446593|NCT00707161|101525498|FG000|Overall Study|Physician Decision|6|||
33446594|NCT01403194|101525501|FG000|Overall Study|Screen Failure|2|||
33446595|NCT01403194|101525501|FG000|Overall Study|Lost to Follow-up|8|||
33446596|NCT02655679|101525502|FG000|Overall Study|Adverse Event|0|||
33446597|NCT02655679|101525503|FG001|Overall Study|Adverse Event|1|||
33446598|NCT02655679|101525504|FG002|Overall Study|Adverse Event|0|||
33446599|NCT02655679|101525505|FG003|Overall Study|Adverse Event|0|||
33446600|NCT02655679|101525506|FG004|Overall Study|Adverse Event|0|||
33446601|NCT02655679|101525502|FG000|Overall Study|Withdrawal by Subject|1|||
33446602|NCT02655679|101525503|FG001|Overall Study|Withdrawal by Subject|1|||
33446603|NCT02655679|101525504|FG002|Overall Study|Withdrawal by Subject|0|||
33446604|NCT02655679|101525505|FG003|Overall Study|Withdrawal by Subject|3|||
33446605|NCT02655679|101525506|FG004|Overall Study|Withdrawal by Subject|1|||
33446606|NCT02655679|101525502|FG000|Overall Study|Inability to Comply with the Protocol|1|||
33446607|NCT02655679|101525503|FG001|Overall Study|Inability to Comply with the Protocol|0|||
33446608|NCT02655679|101525504|FG002|Overall Study|Inability to Comply with the Protocol|0|||
33259171|NCT02238483|100849690|FG001|Overall Study|Death|0|||
33446609|NCT02655679|101525505|FG003|Overall Study|Inability to Comply with the Protocol|0|||
33446610|NCT02655679|101525506|FG004|Overall Study|Inability to Comply with the Protocol|0|||
33446611|NCT02655679|101525502|FG000|Overall Study|Lost to Follow-up|0|||
33446612|NCT02655679|101525503|FG001|Overall Study|Lost to Follow-up|1|||
33446613|NCT02655679|101525504|FG002|Overall Study|Lost to Follow-up|1|||
33446614|NCT02655679|101525505|FG003|Overall Study|Lost to Follow-up|1|||
33446615|NCT02655679|101525506|FG004|Overall Study|Lost to Follow-up|0|||
33446616|NCT02655679|101525502|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33446617|NCT02655679|101525503|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33446618|NCT02655679|101525504|FG002|Overall Study|Other Miscellaneous Reasons|0|||
33446619|NCT02655679|101525505|FG003|Overall Study|Other Miscellaneous Reasons|0|||
33446620|NCT02655679|101525506|FG004|Overall Study|Other Miscellaneous Reasons|0|||
33446621|NCT01190865|101525509|FG000|Overall Study|Withdrawal by Subject|1|||
33446622|NCT01190865|101525509|FG000|Overall Study|Non-compliance|2|||
33446623|NCT04032977|101525510|FG000|Overall Study|Withdrawal by Subject|6|||
33446624|NCT04032977|101525511|FG001|Overall Study|Withdrawal by Subject|1|||
33446625|NCT04032977|101525510|FG000|Overall Study|Lost to Follow-up|2|||
33446626|NCT04032977|101525511|FG001|Overall Study|Lost to Follow-up|7|||
33446627|NCT04032977|101525510|FG000|Overall Study|Pregnancy|1|||
33446628|NCT04032977|101525511|FG001|Overall Study|Pregnancy|0|||
33446629|NCT03238781|101525512|FG000|Overall Study|Adverse Event|1|||
33446630|NCT03238781|101525513|FG001|Overall Study|Adverse Event|1|||
33446631|NCT03238781|101525514|FG002|Overall Study|Adverse Event|2|||
33446632|NCT03238781|101525512|FG000|Overall Study|Lost to Follow-up|2|||
33446633|NCT03238781|101525513|FG001|Overall Study|Lost to Follow-up|1|||
33446634|NCT03238781|101525514|FG002|Overall Study|Lost to Follow-up|2|||
33446635|NCT03238781|101525512|FG000|Overall Study|Withdrawal by Subject|23|||
33446636|NCT03238781|101525513|FG001|Overall Study|Withdrawal by Subject|14|||
33446637|NCT03238781|101525514|FG002|Overall Study|Withdrawal by Subject|16|||
33446638|NCT03238781|101525512|FG000|Overall Study|Decision by sponsor|0|||
33446639|NCT03238781|101525513|FG001|Overall Study|Decision by sponsor|1|||
33446640|NCT03238781|101525514|FG002|Overall Study|Decision by sponsor|0|||
33446641|NCT02193165|101525515|FG000|4 Week Product Use|Lost to Follow-up|1|||
33446642|NCT02193165|101525516|FG001|4 Week Product Use|Lost to Follow-up|1|||
33446643|NCT02193165|101525517|FG002|4 Week Product Use|Lost to Follow-up|1|||
33446644|NCT02193165|101525515|FG000|6 Week Product Use|Lost to Follow-up|0|||
33446645|NCT02193165|101525516|FG001|6 Week Product Use|Lost to Follow-up|1|||
33446646|NCT02193165|101525517|FG002|6 Week Product Use|Lost to Follow-up|0|||
33446647|NCT01723397|101525518|FG000|Study Period 1|Protocol Violation|0|||
33446648|NCT01723397|101525519|FG001|Study Period 1|Protocol Violation|1|||
33446649|NCT01723397|101525518|FG000|Study Period 2|Protocol Violation|0|||
33446650|NCT01723397|101525519|FG001|Study Period 2|Protocol Violation|1|||
33446651|NCT00505622|101525520|FG000|Overall Study|Adverse Event|5|||
33446652|NCT00505622|101525521|FG001|Overall Study|Adverse Event|6|||
33446653|NCT00505622|101525522|FG002|Overall Study|Adverse Event|4|||
33446654|NCT00505622|101525520|FG000|Overall Study|Protocol Violation|1|||
33446655|NCT00505622|101525521|FG001|Overall Study|Protocol Violation|1|||
33446656|NCT00505622|101525522|FG002|Overall Study|Protocol Violation|0|||
33446657|NCT00505622|101525520|FG000|Overall Study|Withdrawal by Subject|0|||
33446658|NCT00505622|101525521|FG001|Overall Study|Withdrawal by Subject|3|||
33446659|NCT00505622|101525522|FG002|Overall Study|Withdrawal by Subject|2|||
33446660|NCT00505622|101525520|FG000|Overall Study|Study termination by sponsor|115|||
33446661|NCT00505622|101525521|FG001|Overall Study|Study termination by sponsor|98|||
33446662|NCT00505622|101525522|FG002|Overall Study|Study termination by sponsor|90|||
33446663|NCT00088829|101525523|FG000|Overall Study|PI left institution and study was close|22|||
33446664|NCT01929863|101525524|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
33446665|NCT01929863|101525525|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
33446666|NCT01929863|101525524|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
33446667|NCT01929863|101525525|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
33446668|NCT01929863|101525524|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
33446669|NCT01929863|101525525|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
33446670|NCT02294786|101525526|FG000|Overall Study|Withdrawal by Subject|0|||
33446671|NCT02294786|101525527|FG001|Overall Study|Withdrawal by Subject|1|||
33446672|NCT02294786|101525526|FG000|Overall Study|Physician Decision|6|||
33446673|NCT02294786|101525527|FG001|Overall Study|Physician Decision|7|||
33446674|NCT02294786|101525526|FG000|Overall Study|Lost to Follow-up|1|||
33446675|NCT02294786|101525527|FG001|Overall Study|Lost to Follow-up|2|||
33446676|NCT02294786|101525526|FG000|Overall Study|Protocol Violation|1|||
33446677|NCT02294786|101525527|FG001|Overall Study|Protocol Violation|0|||
33446678|NCT02294786|101525526|FG000|Overall Study|Adverse Event|1|||
33446679|NCT02294786|101525527|FG001|Overall Study|Adverse Event|1|||
33446680|NCT02294786|101525526|FG000|Overall Study|Death|2|||
33446681|NCT02294786|101525527|FG001|Overall Study|Death|3|||
33446682|NCT03649477|101525528|FG000|Overall Study|Adverse Event|2|||
33446683|NCT03649477|101525529|FG001|Overall Study|Adverse Event|0|||
33446684|NCT03649477|101525530|FG002|Overall Study|Adverse Event|0|||
33446685|NCT00850174|101525531|FG000|Washout: One Week|Withdrawal by Subject|0|||
33446686|NCT00850174|101525532|FG001|Washout: One Week|Withdrawal by Subject|2|||
33446687|NCT00850174|101525531|FG000|Second Intervention|Withdrawal by Subject|1|||
33446688|NCT00850174|101525532|FG001|Second Intervention|Withdrawal by Subject|0|||
33446689|NCT02476994|101525533|FG000|Overall Study|Based on feedback from FDA|1|||
33446690|NCT02476994|101525534|FG001|Overall Study|Based on feedback from FDA|0|||
33446691|NCT02624050|101525537|FG000|Overall Study|Physician Decision|4|||
33446692|NCT02624050|101525538|FG001|Overall Study|Physician Decision|0|||
33446693|NCT02624050|101525537|FG000|Overall Study|Protocol Violation|2|||
33446694|NCT02624050|101525538|FG001|Overall Study|Protocol Violation|0|||
33446695|NCT01149473|101525541|FG000|First Intervention|Adverse Event|1|||
33446696|NCT01149473|101525542|FG001|First Intervention|Adverse Event|1|||
33446697|NCT01149473|101525541|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
33446698|NCT01149473|101525542|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
33446699|NCT03075761|101525543|FG000|Overall Study|Lost to Follow-up|1|||
33446700|NCT03075761|101525544|FG001|Overall Study|Lost to Follow-up|6|||
33446701|NCT04608188|101525545|FG000|Overall Study|Withdrawal by Subject|4|||
33446702|NCT04608188|101525546|FG001|Overall Study|Withdrawal by Subject|8|||
33446703|NCT01494532|101525547|FG000|Overall Study|Adverse Event|4|||
33446704|NCT01494532|101525548|FG001|Overall Study|Adverse Event|1|||
33446705|NCT01494532|101525549|FG002|Overall Study|Adverse Event|8|||
33446706|NCT01494532|101525550|FG003|Overall Study|Adverse Event|6|||
33446707|NCT01494532|101525551|FG004|Overall Study|Adverse Event|5|||
33446708|NCT01494532|101525552|FG005|Overall Study|Adverse Event|0|||
33446709|NCT01494532|101525547|FG000|Overall Study|Lack of Efficacy|0|||
33259172|NCT02238483|100849689|FG000|Overall Study|Adverse Event|7|||
33446710|NCT01494532|101525548|FG001|Overall Study|Lack of Efficacy|0|||
33446711|NCT01494532|101525549|FG002|Overall Study|Lack of Efficacy|0|||
33446712|NCT01494532|101525550|FG003|Overall Study|Lack of Efficacy|0|||
33259173|NCT02238483|100849690|FG001|Overall Study|Adverse Event|3|||
33446713|NCT01494532|101525551|FG004|Overall Study|Lack of Efficacy|2|||
33446714|NCT01494532|101525552|FG005|Overall Study|Lack of Efficacy|0|||
33446715|NCT01494532|101525547|FG000|Overall Study|Protocol deviation|2|||
33446716|NCT01494532|101525548|FG001|Overall Study|Protocol deviation|1|||
33446717|NCT01494532|101525549|FG002|Overall Study|Protocol deviation|3|||
33446718|NCT01494532|101525550|FG003|Overall Study|Protocol deviation|2|||
33446719|NCT01494532|101525551|FG004|Overall Study|Protocol deviation|3|||
33446720|NCT01494532|101525552|FG005|Overall Study|Protocol deviation|0|||
33446721|NCT01494532|101525547|FG000|Overall Study|Protocol-defined stopping criteria|0|||
33446722|NCT01494532|101525548|FG001|Overall Study|Protocol-defined stopping criteria|0|||
33446723|NCT01494532|101525549|FG002|Overall Study|Protocol-defined stopping criteria|1|||
33446724|NCT01494532|101525550|FG003|Overall Study|Protocol-defined stopping criteria|0|||
33446725|NCT01494532|101525551|FG004|Overall Study|Protocol-defined stopping criteria|0|||
33446726|NCT01494532|101525552|FG005|Overall Study|Protocol-defined stopping criteria|0|||
33446727|NCT01494532|101525547|FG000|Overall Study|Lost to Follow-up|1|||
33446728|NCT01494532|101525548|FG001|Overall Study|Lost to Follow-up|0|||
33446729|NCT01494532|101525549|FG002|Overall Study|Lost to Follow-up|0|||
33446730|NCT01494532|101525550|FG003|Overall Study|Lost to Follow-up|2|||
33446731|NCT01494532|101525551|FG004|Overall Study|Lost to Follow-up|0|||
33446732|NCT01494532|101525552|FG005|Overall Study|Lost to Follow-up|0|||
33446733|NCT01494532|101525547|FG000|Overall Study|Physician Decision|0|||
33446734|NCT01494532|101525548|FG001|Overall Study|Physician Decision|1|||
33446735|NCT01494532|101525549|FG002|Overall Study|Physician Decision|1|||
33446736|NCT01494532|101525550|FG003|Overall Study|Physician Decision|2|||
33446737|NCT01494532|101525551|FG004|Overall Study|Physician Decision|0|||
33446738|NCT01494532|101525552|FG005|Overall Study|Physician Decision|0|||
33446739|NCT01494532|101525547|FG000|Overall Study|Withdrawal by Subject|3|||
33446740|NCT01494532|101525548|FG001|Overall Study|Withdrawal by Subject|1|||
33446741|NCT01494532|101525549|FG002|Overall Study|Withdrawal by Subject|4|||
33446742|NCT01494532|101525550|FG003|Overall Study|Withdrawal by Subject|3|||
33446743|NCT01494532|101525551|FG004|Overall Study|Withdrawal by Subject|2|||
33446744|NCT01494532|101525552|FG005|Overall Study|Withdrawal by Subject|0|||
33446745|NCT01827163|101525556|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
33446746|NCT01827163|101525556|FG000|Overall Study|Adverse Event|9|||
33446747|NCT02009163|101525557|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
33446748|NCT02009163|101525558|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
33446749|NCT02009163|101525559|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
33446750|NCT02009163|101525557|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
33259174|NCT02238483|100849689|FG000|Overall Study|Withdrawn due to physician decision|1|||
33259175|NCT02238483|100849690|FG001|Overall Study|Withdrawn due to physician decision|0|||
33259176|NCT02238483|100849689|FG000|Overall Study|Completion status not recorded|1|||
33446751|NCT02009163|101525558|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
33166553|NCT00317356|100518685|FG002|Overall Study|Physician Decision|0|||
33166554|NCT00317356|100518686|FG003|Overall Study|Physician Decision|0|||
33166555|NCT00390468|100518691|FG000|Overall Study|Protocol Violation|2|||
33166556|NCT00390468|100518691|FG000|Overall Study|Lack of Efficacy|1|||
33166557|NCT03727347|100518698|FG000|Overall Study|Withdrawal by Subject|2|||
33166558|NCT03727347|100518698|FG000|Overall Study|Lost to Follow-up|1|||
33166559|NCT01812174|100518701|FG000|Overall Study|Death|1|||
33166560|NCT01812174|100518702|FG001|Overall Study|Death|0|||
33166561|NCT01812174|100518701|FG000|Overall Study|Protocol Violation|2|||
33166562|NCT01812174|100518702|FG001|Overall Study|Protocol Violation|0|||
33166563|NCT03782792|100518705|FG000|Overall Study|Patient left the country|0|||
33446752|NCT02009163|101525559|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
33446753|NCT02009163|101525557|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
33446754|NCT02009163|101525558|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
33446755|NCT02009163|101525559|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
33446756|NCT02009163|101525557|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
33446757|NCT02009163|101525558|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
33259177|NCT02238483|100849690|FG001|Overall Study|Completion status not recorded|1|||
33259178|NCT02238483|100849689|FG000|Overall Study|Illness in family member|1|||
33259179|NCT02238483|100849690|FG001|Overall Study|Illness in family member|0|||
33259180|NCT01510717|100849691|FG000|Overall Study|Adverse Event|1|||
33259181|NCT01510717|100849692|FG001|Overall Study|Adverse Event|2|||
33259182|NCT01510717|100849691|FG000|Overall Study|Death|1|||
33259183|NCT01510717|100849692|FG001|Overall Study|Death|0|||
33259184|NCT01510717|100849691|FG000|Overall Study|Lost to Follow-up|0|||
33259185|NCT01510717|100849692|FG001|Overall Study|Lost to Follow-up|1|||
33259186|NCT01510717|100849691|FG000|Overall Study|Withdrawal by Subject|0|||
33166564|NCT03782792|100518706|FG001|Overall Study|Patient left the country|1|||
33259187|NCT01510717|100849692|FG001|Overall Study|Withdrawal by Subject|2|||
33446758|NCT02009163|101525559|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
33446759|NCT02009163|101525557|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
33166565|NCT03782792|100518705|FG000|Overall Study|Withdrawal by Subject|1|||
33259188|NCT02101281|100849693|FG000|Overall Study|Adverse Event|0|||
33166566|NCT03782792|100518706|FG001|Overall Study|Withdrawal by Subject|2|||
33166567|NCT05201703|100518707|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
33259189|NCT02101281|100849694|FG001|Overall Study|Adverse Event|1|||
33446760|NCT02009163|101525558|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
33446761|NCT02009163|101525559|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
33259190|NCT00093015|100849695|FG000|Overall Study|Withdrawal by Subject|194|||
33446762|NCT02009163|101525557|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
33446763|NCT02009163|101525558|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
33446764|NCT02009163|101525559|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
33446765|NCT02009163|101525557|FG000|Open-label Period (Non-randomized)|Other|13|||
33446766|NCT02009163|101525558|FG001|Open-label Period (Non-randomized)|Other|0|||
33446767|NCT02009163|101525559|FG002|Open-label Period (Non-randomized)|Other|0|||
33446768|NCT02009163|101525557|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
33446769|NCT02009163|101525558|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
33446770|NCT02009163|101525559|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
33446771|NCT02009163|101525557|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
33446772|NCT02009163|101525558|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
33446773|NCT02009163|101525559|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
33446774|NCT02009163|101525557|FG000|Randomized-withdrawal Period|Adverse Event|0|||
33446775|NCT02009163|101525558|FG001|Randomized-withdrawal Period|Adverse Event|0|||
33446776|NCT02009163|101525559|FG002|Randomized-withdrawal Period|Adverse Event|6|||
33446777|NCT02009163|101525557|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
33446778|NCT02009163|101525558|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
33446779|NCT02009163|101525559|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
33446780|NCT02009163|101525557|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
33446781|NCT02009163|101525558|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
33446782|NCT02009163|101525559|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
33446783|NCT02009163|101525557|FG000|Randomized-withdrawal Period|Pregnancy|0|||
33446784|NCT02009163|101525558|FG001|Randomized-withdrawal Period|Pregnancy|0|||
33446785|NCT02009163|101525559|FG002|Randomized-withdrawal Period|Pregnancy|2|||
33446786|NCT02009163|101525557|FG000|Randomized-withdrawal Period|Other|0|||
33446787|NCT02009163|101525558|FG001|Randomized-withdrawal Period|Other|9|||
33446788|NCT02009163|101525559|FG002|Randomized-withdrawal Period|Other|5|||
33446789|NCT02075463|101525562|FG000|Overall Study|Adverse Event|3|||
33446790|NCT02075463|101525562|FG000|Overall Study|Par. reached stopping criteria|4|||
33259191|NCT00093015|100849696|FG001|Overall Study|Withdrawal by Subject|171|||
33446791|NCT02075463|101525562|FG000|Overall Study|Withdrawal by Subject|1|||
33446792|NCT03194217|101525563|FG000|Overall Study|Adverse Event|0|||
33446793|NCT03194217|101525564|FG001|Overall Study|Adverse Event|2|||
33166568|NCT05201703|100518708|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
33166569|NCT05201703|100518707|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
33166570|NCT05201703|100518708|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
33166571|NCT00506662|100518709|FG000|Overall Study|Adverse Event|0|||
33446794|NCT03194217|101525565|FG002|Overall Study|Adverse Event|3|||
33446795|NCT03194217|101525566|FG003|Overall Study|Adverse Event|3|||
33446796|NCT03194217|101525563|FG000|Overall Study|Failure to meet randomisation criteria|0|||
33446797|NCT03194217|101525564|FG001|Overall Study|Failure to meet randomisation criteria|0|||
33446798|NCT03194217|101525565|FG002|Overall Study|Failure to meet randomisation criteria|0|||
33446799|NCT03194217|101525566|FG003|Overall Study|Failure to meet randomisation criteria|1|||
33446800|NCT03194217|101525563|FG000|Overall Study|Other|0|||
33446801|NCT03194217|101525564|FG001|Overall Study|Other|1|||
33446802|NCT03194217|101525565|FG002|Overall Study|Other|1|||
33446803|NCT03194217|101525566|FG003|Overall Study|Other|0|||
33446804|NCT00840411|101525567|FG000|First Intervention|Adverse Event|1|||
33446805|NCT00840411|101525568|FG001|First Intervention|Adverse Event|0|||
33446806|NCT00840411|101525567|FG000|Washout|Withdrawal by Subject|1|||
33446807|NCT00840411|101525568|FG001|Washout|Withdrawal by Subject|0|||
33446808|NCT03818581|101525569|FG000|Overall Study|Adverse Event|1|||
33446809|NCT03818581|101525570|FG001|Overall Study|Adverse Event|0|||
33446810|NCT03818581|101525571|FG002|Overall Study|Adverse Event|0|||
33446811|NCT03818581|101525572|FG003|Overall Study|Adverse Event|0|||
33446812|NCT03818581|101525573|FG004|Overall Study|Adverse Event|0|||
33446813|NCT03818581|101525569|FG000|Overall Study|Covid-19|2|||
33446814|NCT03818581|101525570|FG001|Overall Study|Covid-19|0|||
33446815|NCT03818581|101525571|FG002|Overall Study|Covid-19|0|||
33446816|NCT03818581|101525572|FG003|Overall Study|Covid-19|0|||
33446817|NCT03818581|101525573|FG004|Overall Study|Covid-19|1|||
33446818|NCT03818581|101525569|FG000|Overall Study|Withdrawal by Subject|0|||
33446819|NCT03818581|101525570|FG001|Overall Study|Withdrawal by Subject|0|||
33446820|NCT03818581|101525571|FG002|Overall Study|Withdrawal by Subject|0|||
33446821|NCT03818581|101525572|FG003|Overall Study|Withdrawal by Subject|0|||
33446822|NCT03818581|101525573|FG004|Overall Study|Withdrawal by Subject|1|||
33446823|NCT03818581|101525569|FG000|Overall Study|No longer met study criteria|0|||
33166572|NCT00506662|100518710|FG001|Overall Study|Adverse Event|2|||
33166573|NCT00506662|100518709|FG000|Overall Study|Lack of Efficacy|1|||
33166574|NCT00506662|100518710|FG001|Overall Study|Lack of Efficacy|0|||
33166575|NCT00506662|100518709|FG000|Overall Study|Protocol Violation|2|||
33166576|NCT00506662|100518710|FG001|Overall Study|Protocol Violation|4|||
33166577|NCT00506662|100518709|FG000|Overall Study|Trial terminated|10|||
33166578|NCT00506662|100518710|FG001|Overall Study|Trial terminated|16|||
33166579|NCT00506662|100518709|FG000|Overall Study|Not recorded|4|||
33166580|NCT00506662|100518710|FG001|Overall Study|Not recorded|6|||
33166581|NCT02627144|100518711|FG000|Overall Study|Serious adverse event|32|||
33166582|NCT02627144|100518711|FG000|Overall Study|Cancer progression|171|||
33446824|NCT03818581|101525570|FG001|Overall Study|No longer met study criteria|0|||
33166583|NCT02627144|100518711|FG000|Overall Study|Death from cancer|20|||
33166584|NCT02627144|100518711|FG000|Overall Study|Death from other cause|8|||
33446825|NCT03818581|101525571|FG002|Overall Study|No longer met study criteria|0|||
33446826|NCT03818581|101525572|FG003|Overall Study|No longer met study criteria|0|||
33446827|NCT03818581|101525573|FG004|Overall Study|No longer met study criteria|1|||
33446828|NCT01498120|101525577|FG000|Overall Study|Lost to Follow-up|1|||
33446829|NCT01498120|101525577|FG000|Overall Study|Withdrawal by Subject|5|||
33446830|NCT01498120|101525577|FG000|Overall Study|AE, non-serious non-fatal|3|||
33446831|NCT01498120|101525577|FG000|Overall Study|Other|4|||
33446832|NCT00395694|101525580|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
33166585|NCT02627144|100518711|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
33166586|NCT02627144|100518711|FG000|Overall Study|Administrative reasons|65|||
33166587|NCT02627144|100518711|FG000|Overall Study|Lost to Follow-up|8|||
33166588|NCT02627144|100518711|FG000|Overall Study|Enrolled, not treated|6|||
33166589|NCT02627144|100518711|FG000|Overall Study|Other|17|||
33166590|NCT03066804|100518712|FG000|Overall Study|Physician Decision|0|||
33166591|NCT03066804|100518713|FG001|Overall Study|Physician Decision|4|||
33166592|NCT03066804|100518712|FG000|Overall Study|Death|23|||
33166593|NCT03066804|100518713|FG001|Overall Study|Death|17|||
33166594|NCT03066804|100518712|FG000|Overall Study|Withdrawal by Subject|19|||
33166595|NCT03066804|100518713|FG001|Overall Study|Withdrawal by Subject|25|||
33166596|NCT03066804|100518712|FG000|Overall Study|Lost to Follow-up|2|||
33166597|NCT03066804|100518713|FG001|Overall Study|Lost to Follow-up|0|||
33446833|NCT00395694|101525581|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
33446834|NCT00395694|101525580|FG000|Continuation Phase|Adverse Event|1|||
33446835|NCT00395694|101525581|FG001|Continuation Phase|Adverse Event|0|||
33166598|NCT03066804|100518712|FG000|Overall Study|Adverse Event|2|||
33446836|NCT00395694|101525580|FG000|Continuation Phase|Lack of Efficacy|12|||
33446837|NCT00395694|101525581|FG001|Continuation Phase|Lack of Efficacy|11|||
33446838|NCT00395694|101525580|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
33446839|NCT00395694|101525581|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
33446840|NCT00395694|101525580|FG000|Continuation Phase|Poor Compliance|1|||
33446841|NCT00395694|101525581|FG001|Continuation Phase|Poor Compliance|0|||
33446842|NCT00395694|101525580|FG000|Continuation Phase|Withdrawal by Subject|0|||
33446843|NCT00395694|101525581|FG001|Continuation Phase|Withdrawal by Subject|2|||
33446844|NCT03181594|101525582|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
33446845|NCT03181594|101525582|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
33446846|NCT03181594|101525582|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
33446847|NCT03181594|101525582|FG000|Initial Study Protocol (12-month FU)|Death|1|||
33446848|NCT03181594|101525582|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
33446849|NCT03181594|101525582|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
33446850|NCT00787254|101525585|FG000|Overall Study|Adverse Event|24|||
33446851|NCT00787254|101525586|FG001|Overall Study|Adverse Event|23|||
33446852|NCT00787254|101525585|FG000|Overall Study|Protocol Violation|26|||
33446853|NCT00787254|101525586|FG001|Overall Study|Protocol Violation|23|||
33446854|NCT00787254|101525585|FG000|Overall Study|Withdrawal by Subject|16|||
33446855|NCT00787254|101525586|FG001|Overall Study|Withdrawal by Subject|11|||
33446856|NCT00787254|101525585|FG000|Overall Study|Lack of Efficacy|4|||
33446857|NCT00787254|101525586|FG001|Overall Study|Lack of Efficacy|15|||
33446858|NCT00787254|101525585|FG000|Overall Study|NSAIDs discontinuation|1|||
33446859|NCT00787254|101525586|FG001|Overall Study|NSAIDs discontinuation|2|||
33446860|NCT00787254|101525585|FG000|Overall Study|Institution closed|1|||
33446861|NCT00787254|101525586|FG001|Overall Study|Institution closed|0|||
33446862|NCT00787254|101525585|FG000|Overall Study|Physician Decision|4|||
33446863|NCT00787254|101525586|FG001|Overall Study|Physician Decision|8|||
33446864|NCT03987191|101525592|FG000|Overall Study|COVID-19 related research disruption|0|||
33446865|NCT03987191|101525593|FG001|Overall Study|COVID-19 related research disruption|2|||
33446866|NCT01577381|101525597|FG000|Overall Study|Discontinued|2|||
33446867|NCT01577381|101525598|FG001|Overall Study|Discontinued|1|||
33446868|NCT01577381|101525599|FG002|Overall Study|Discontinued|2|||
33446869|NCT01577381|101525600|FG003|Overall Study|Discontinued|2|||
33446870|NCT01577381|101525597|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
33446871|NCT01577381|101525598|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
33446872|NCT01577381|101525599|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
33446873|NCT01577381|101525600|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
33166599|NCT03066804|100518713|FG001|Overall Study|Adverse Event|3|||
33166600|NCT03066804|100518712|FG000|Overall Study|Technical problems|5|||
33166601|NCT03066804|100518713|FG001|Overall Study|Technical problems|1|||
33166602|NCT03031678|100518714|FG000|Overall Study|Study closed prior to completion|1|||
33166603|NCT01709513|100518720|FG000|Overall Study|Randomized but not treated|0|||
33446874|NCT00244764|101525604|FG000|Overall Study|Adverse Event|37|||
33446875|NCT00244764|101525604|FG000|Overall Study|Lost to Follow-up|23|||
33446876|NCT00244764|101525604|FG000|Overall Study|Withdrawal by Subject|12|||
33166604|NCT01709513|100518721|FG001|Overall Study|Randomized but not treated|1|||
33166605|NCT01709513|100518722|FG002|Overall Study|Randomized but not treated|0|||
33166606|NCT01709513|100518720|FG000|Overall Study|Adverse Event|16|||
33259192|NCT00093015|100849695|FG000|Overall Study|Lost to Follow-up|96|||
33166607|NCT01709513|100518721|FG001|Overall Study|Adverse Event|31|||
33446877|NCT00244764|101525604|FG000|Overall Study|Disease Progression|13|||
33446878|NCT00244764|101525604|FG000|Overall Study|Protocol Violation|2|||
33446879|NCT00244764|101525604|FG000|Overall Study|Death|1|||
33166608|NCT01709513|100518722|FG002|Overall Study|Adverse Event|23|||
33166609|NCT01709513|100518720|FG000|Overall Study|Poor compliance to protocol|2|||
33166610|NCT01709513|100518721|FG001|Overall Study|Poor compliance to protocol|0|||
33166611|NCT01709513|100518722|FG002|Overall Study|Poor compliance to protocol|0|||
33166612|NCT01709513|100518720|FG000|Overall Study|Other|3|||
33166613|NCT01709513|100518721|FG001|Overall Study|Other|11|||
33166614|NCT01709513|100518722|FG002|Overall Study|Other|7|||
33166615|NCT05228132|100518723|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
33166616|NCT05228132|100518723|FG000|Overall Study|Adverse Event|3|||
33166617|NCT05228132|100518723|FG000|Overall Study|Lost to Follow-up|1|||
33166618|NCT05228132|100518723|FG000|Overall Study|Arteriovenous-fistula mature|1|||
33166619|NCT01877265|100518724|FG000|Treatment Period 1|Sponsor Decision|0|||
33166620|NCT01877265|100518725|FG001|Treatment Period 1|Sponsor Decision|0|||
33166621|NCT01877265|100518726|FG002|Treatment Period 1|Sponsor Decision|1|||
33166622|NCT01877265|100518727|FG003|Treatment Period 1|Sponsor Decision|0|||
33166623|NCT01877265|100518728|FG004|Treatment Period 1|Sponsor Decision|0|||
33166624|NCT01877265|100518729|FG005|Treatment Period 1|Sponsor Decision|0|||
33166625|NCT01877265|100518724|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
33166626|NCT01877265|100518725|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
33166627|NCT01877265|100518726|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
33166628|NCT01877265|100518727|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
33166629|NCT01877265|100518728|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
33166630|NCT01877265|100518729|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
33166631|NCT01877265|100518724|FG000|Treatment Period 3|Lost to Follow-up|1|||
33446880|NCT00244764|101525604|FG000|Overall Study|Off Study Medication for >21 Days|1|||
33446881|NCT00244764|101525604|FG000|Overall Study|Declining Performance Status|1|||
33446882|NCT00244764|101525604|FG000|Overall Study|Participant was Hospitalized until Death|1|||
33446883|NCT00244764|101525604|FG000|Overall Study|Primary Investigator Discretion|2|||
33446884|NCT00244764|101525604|FG000|Overall Study|Sponsor Terminated Study|2|||
33446885|NCT00244764|101525604|FG000|Overall Study|Developed Secondary Malignancy|1|||
33446886|NCT05099380|101528959|FG000|Overall Study|Subject enrolled in error|1|||
33446887|NCT05099380|101528960|FG001|Overall Study|Subject enrolled in error|0|||
33446888|NCT05099380|101528959|FG000|Overall Study|Study Procedure|1|||
33446889|NCT05099380|101528960|FG001|Overall Study|Study Procedure|0|||
33446890|NCT05099380|101528959|FG000|Overall Study|Protocol Violation|1|||
33446891|NCT05099380|101528960|FG001|Overall Study|Protocol Violation|0|||
33446892|NCT05099380|101528959|FG000|Overall Study|Adverse Event|1|||
33446893|NCT05099380|101528960|FG001|Overall Study|Adverse Event|1|||
33446894|NCT05099380|101528959|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
33166632|NCT01877265|100518725|FG001|Treatment Period 3|Lost to Follow-up|0|||
33166633|NCT01877265|100518726|FG002|Treatment Period 3|Lost to Follow-up|0|||
33446895|NCT05099380|101528960|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
33166634|NCT01877265|100518727|FG003|Treatment Period 3|Lost to Follow-up|0|||
33166635|NCT01877265|100518728|FG004|Treatment Period 3|Lost to Follow-up|0|||
33166636|NCT01877265|100518729|FG005|Treatment Period 3|Lost to Follow-up|0|||
33446896|NCT03128723|101528965|FG000|Overall Study|Withdrawal by Subject|2|||
33166637|NCT01897454|100518737|FG000|Overall Study|Withdrawal by Subject|1|||
33166638|NCT01950741|100518738|FG000|Overall Study|Lost to Follow-up|1|||
33166639|NCT01950741|100518738|FG000|Overall Study|Death|1|||
33166640|NCT01950741|100518738|FG000|Overall Study|Withdrawal by Subject|1|||
33259193|NCT00093015|100849696|FG001|Overall Study|Lost to Follow-up|108|||
33446897|NCT00461786|101528969|FG000|Overall Study|Entry Criteria Not Met|2|||
33446898|NCT00461786|101528969|FG000|Overall Study|Inevaluable (Never Treated)|1|||
33446899|NCT01642277|101528971|FG000|Overall Study|Adverse Event|10|||
33446900|NCT01642277|101528972|FG001|Overall Study|Adverse Event|0|||
33446901|NCT01642277|101528971|FG000|Overall Study|Physician Decision|2|||
33446902|NCT01642277|101528972|FG001|Overall Study|Physician Decision|0|||
33446903|NCT01642277|101528971|FG000|Overall Study|Protocol Violation|1|||
33446904|NCT01642277|101528972|FG001|Overall Study|Protocol Violation|0|||
33446905|NCT01642277|101528971|FG000|Overall Study|Withdrawal by Subject|11|||
33446906|NCT01642277|101528972|FG001|Overall Study|Withdrawal by Subject|0|||
33446907|NCT00113386|101528973|FG000|Overall Study|Withdrawal by Subject|1|||
33446908|NCT00113386|101528974|FG001|Overall Study|Withdrawal by Subject|0|||
33446909|NCT00113386|101528973|FG000|Overall Study|Physician Decision|0|||
33446910|NCT00113386|101528974|FG001|Overall Study|Physician Decision|1|||
33446911|NCT00113386|101528973|FG000|Overall Study|Toxicity|3|||
33446912|NCT00113386|101528974|FG001|Overall Study|Toxicity|0|||
33446913|NCT00113386|101528973|FG000|Overall Study|Ineligible|1|||
33446914|NCT00113386|101528974|FG001|Overall Study|Ineligible|2|||
33446915|NCT00113386|101528973|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
33446916|NCT00113386|101528974|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
33446917|NCT02043132|101528977|FG000|Overall Study|Lost to Follow-up|1|||
33446918|NCT02043132|101528978|FG001|Overall Study|Lost to Follow-up|1|||
33446919|NCT02043132|101528977|FG000|Overall Study|screen failures|4|||
33446920|NCT02043132|101528978|FG001|Overall Study|screen failures|8|||
33446921|NCT01319383|101528981|FG000|Overall Study|No ex vivo or in vivo response|4|||
33446922|NCT01319383|101528982|FG001|Overall Study|No ex vivo or in vivo response|0|||
33446923|NCT01319383|101528981|FG000|Overall Study|Physician Decision|3|||
33446924|NCT01319383|101528982|FG001|Overall Study|Physician Decision|0|||
33446925|NCT01319383|101528981|FG000|Overall Study|Lack of Efficacy|5|||
33446926|NCT01319383|101528982|FG001|Overall Study|Lack of Efficacy|9|||
33259194|NCT00093015|100849695|FG000|Overall Study|Death|375|||
33446927|NCT01319383|101528981|FG000|Overall Study|No in vivo response to interval doses|0|||
33446928|NCT01319383|101528982|FG001|Overall Study|No in vivo response to interval doses|1|||
33259195|NCT00093015|100849696|FG001|Overall Study|Death|385|||
33259196|NCT02730871|100849697|FG000|Overall Study|Adverse Event|6|||
33259197|NCT02730871|100849698|FG001|Overall Study|Adverse Event|0|||
33259198|NCT00546754|100849699|FG000|Overall Study|Serious Adverse Event|1|||
33259199|NCT00546754|100849700|FG001|Overall Study|Serious Adverse Event|1|||
33259200|NCT00546754|100849699|FG000|Overall Study|Adverse Event|11|||
33259201|NCT00546754|100849700|FG001|Overall Study|Adverse Event|16|||
33259202|NCT00546754|100849699|FG000|Overall Study|Lack of Efficacy|1|||
33259203|NCT00546754|100849700|FG001|Overall Study|Lack of Efficacy|1|||
33259204|NCT00546754|100849699|FG000|Overall Study|Lost to Follow-up|9|||
33259205|NCT00546754|100849700|FG001|Overall Study|Lost to Follow-up|15|||
33259206|NCT00546754|100849699|FG000|Overall Study|Protocol Violation|3|||
33259207|NCT00546754|100849700|FG001|Overall Study|Protocol Violation|0|||
33259208|NCT00546754|100849699|FG000|Overall Study|Withdrawal by Subject|6|||
33259209|NCT00546754|100849700|FG001|Overall Study|Withdrawal by Subject|7|||
33259210|NCT00546754|100849699|FG000|Overall Study|Dyspnea|1|||
33259211|NCT00546754|100849700|FG001|Overall Study|Dyspnea|0|||
33259212|NCT00546754|100849699|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
33259213|NCT00546754|100849700|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
33446929|NCT00579345|101528984|FG000|Overall Study|Withdrawal by Subject|2|||
33446930|NCT00579345|101528985|FG001|Overall Study|Withdrawal by Subject|0|||
33446931|NCT00579345|101528986|FG002|Overall Study|Withdrawal by Subject|0|||
33446932|NCT00579345|101528987|FG003|Overall Study|Withdrawal by Subject|0|||
33446933|NCT00579345|101528988|FG004|Overall Study|Withdrawal by Subject|0|||
33446934|NCT00579345|101528989|FG005|Overall Study|Withdrawal by Subject|0|||
33446935|NCT00579345|101528990|FG006|Overall Study|Withdrawal by Subject|0|||
33446936|NCT00579345|101528991|FG007|Overall Study|Withdrawal by Subject|1|||
33446937|NCT00579345|101528984|FG000|Overall Study|Lost to Follow-up|1|||
33446938|NCT00579345|101528985|FG001|Overall Study|Lost to Follow-up|0|||
33446939|NCT00579345|101528986|FG002|Overall Study|Lost to Follow-up|0|||
33446940|NCT00579345|101528987|FG003|Overall Study|Lost to Follow-up|0|||
33446941|NCT00579345|101528988|FG004|Overall Study|Lost to Follow-up|0|||
33446942|NCT00579345|101528989|FG005|Overall Study|Lost to Follow-up|0|||
33446943|NCT00579345|101528990|FG006|Overall Study|Lost to Follow-up|0|||
33446944|NCT00579345|101528991|FG007|Overall Study|Lost to Follow-up|0|||
33446945|NCT00579345|101528984|FG000|Overall Study|Adverse Event|0|||
33446946|NCT00579345|101528985|FG001|Overall Study|Adverse Event|0|||
33446947|NCT00579345|101528986|FG002|Overall Study|Adverse Event|1|||
33446948|NCT00579345|101528987|FG003|Overall Study|Adverse Event|0|||
33446949|NCT00579345|101528988|FG004|Overall Study|Adverse Event|0|||
33446950|NCT00579345|101528989|FG005|Overall Study|Adverse Event|0|||
33446951|NCT00579345|101528990|FG006|Overall Study|Adverse Event|0|||
33446952|NCT00579345|101528991|FG007|Overall Study|Adverse Event|0|||
33446953|NCT00579345|101528984|FG000|Overall Study|Protocol Violation|1|||
33446954|NCT00579345|101528985|FG001|Overall Study|Protocol Violation|0|||
33446955|NCT00579345|101528986|FG002|Overall Study|Protocol Violation|0|||
33446956|NCT00579345|101528987|FG003|Overall Study|Protocol Violation|0|||
33446957|NCT00579345|101528988|FG004|Overall Study|Protocol Violation|0|||
33446958|NCT00579345|101528989|FG005|Overall Study|Protocol Violation|0|||
33446959|NCT00579345|101528990|FG006|Overall Study|Protocol Violation|0|||
33446960|NCT00579345|101528991|FG007|Overall Study|Protocol Violation|1|||
33446961|NCT00579345|101528984|FG000|Overall Study|Death|1|||
33446962|NCT00579345|101528985|FG001|Overall Study|Death|1|||
33446963|NCT00579345|101528986|FG002|Overall Study|Death|1|||
33446964|NCT00579345|101528987|FG003|Overall Study|Death|1|||
33446965|NCT00579345|101528988|FG004|Overall Study|Death|0|||
33446966|NCT00579345|101528989|FG005|Overall Study|Death|0|||
33446967|NCT00579345|101528990|FG006|Overall Study|Death|0|||
33446968|NCT00579345|101528991|FG007|Overall Study|Death|0|||
33446969|NCT02820350|101528993|FG000|Overall Study|Withdrawal by Subject|3|||
33446970|NCT02820350|101528993|FG000|Overall Study|Death|4|||
33259214|NCT00546754|100849699|FG000|Overall Study|Hip Replacement|1|||
33259215|NCT00546754|100849700|FG001|Overall Study|Hip Replacement|0|||
33446971|NCT05038293|101528998|FG000|Overall Study|device was not operating properly for one subject.|1|||
33446972|NCT05038293|101528999|FG001|Overall Study|device was not operating properly for one subject.|0|||
33446973|NCT05038293|101528998|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
33446974|NCT05038293|101528999|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
33446975|NCT04206332|101529000|FG000|Part A|Lost to Follow-up|0|||
33446976|NCT04206332|101529001|FG001|Part A|Lost to Follow-up|1|||
33259216|NCT00546754|100849699|FG000|Overall Study|Suicide|1|||
33259217|NCT00546754|100849700|FG001|Overall Study|Suicide|0|||
33259218|NCT00546754|100849699|FG000|Overall Study|Missing Cooperation|1|||
33446977|NCT04206332|101529002|FG002|Part A|Lost to Follow-up|0|||
33259219|NCT00546754|100849700|FG001|Overall Study|Missing Cooperation|0|||
33259220|NCT00546754|100849699|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
33259221|NCT00546754|100849700|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
33259222|NCT00546754|100849699|FG000|Overall Study|Patient's Decision|0|||
33259223|NCT00546754|100849700|FG001|Overall Study|Patient's Decision|1|||
33259224|NCT00546754|100849699|FG000|Overall Study|Missing|14|||
33259225|NCT00546754|100849700|FG001|Overall Study|Missing|7|||
33259226|NCT04149002|100849701|FG000|Overall Study|Lost to Follow-up|1|||
33259227|NCT04149002|100849702|FG001|Overall Study|Lost to Follow-up|0|||
33259228|NCT04149002|100849701|FG000|Overall Study|Withdrawal by Subject|1|||
33259229|NCT04149002|100849702|FG001|Overall Study|Withdrawal by Subject|0|||
33446978|NCT04206332|101529003|FG003|Part A|Lost to Follow-up|0|||
33446979|NCT04206332|101529004|FG004|Part A|Lost to Follow-up|0|||
33259230|NCT01808339|100849718|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33259231|NCT01808339|100849719|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33259232|NCT01808339|100849720|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33259233|NCT01808339|100849721|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
33259234|NCT01808339|100849722|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
33259235|NCT01808339|100849723|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
33259236|NCT01808339|100849718|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33259237|NCT01808339|100849719|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33259238|NCT01808339|100849720|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33259239|NCT01808339|100849721|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
33259240|NCT01808339|100849722|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33259241|NCT01808339|100849723|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
33259242|NCT01808339|100849718|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33259243|NCT01808339|100849719|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33259244|NCT01808339|100849720|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
33259245|NCT01808339|100849721|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33259246|NCT01808339|100849722|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33259247|NCT01808339|100849723|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
33259248|NCT03582722|100849726|FG000|Overall Study|Lost to Follow-up|1|||
33259249|NCT03582722|100849727|FG001|Overall Study|Lost to Follow-up|4|||
33259250|NCT03582722|100849726|FG000|Overall Study|Withdrawal by Subject|3|||
33259251|NCT03582722|100849727|FG001|Overall Study|Withdrawal by Subject|3|||
33259252|NCT01303445|100849728|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
33259253|NCT01303445|100849729|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
33259254|NCT01303445|100849728|FG000|Second Intervention (7 Days)|Adverse Event|0|||
33259255|NCT01303445|100849729|FG001|Second Intervention (7 Days)|Adverse Event|2|||
33446980|NCT04206332|101529005|FG005|Part A|Lost to Follow-up|0|||
33446981|NCT04206332|101529006|FG006|Part A|Lost to Follow-up|0|||
33446982|NCT04206332|101529007|FG007|Part A|Lost to Follow-up|0|||
33446983|NCT04206332|101529008|FG008|Part A|Lost to Follow-up|0|||
33446984|NCT04206332|101529009|FG009|Part A|Lost to Follow-up|0|||
33446985|NCT04206332|101529010|FG010|Part A|Lost to Follow-up|0|||
33446986|NCT04206332|101529011|FG011|Part A|Lost to Follow-up|0|||
33446987|NCT04206332|101529012|FG012|Part A|Lost to Follow-up|0|||
33446988|NCT04206332|101529013|FG013|Part A|Lost to Follow-up|0|||
33446989|NCT04206332|101529014|FG014|Part A|Lost to Follow-up|0|||
33446990|NCT04206332|101529015|FG015|Part A|Lost to Follow-up|0|||
33446991|NCT04206332|101529016|FG016|Part A|Lost to Follow-up|0|||
33446992|NCT04206332|101529000|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33446993|NCT04206332|101529001|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33446994|NCT04206332|101529002|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33446995|NCT04206332|101529003|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33446996|NCT04206332|101529004|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33446997|NCT04206332|101529005|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
33446998|NCT04206332|101529006|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33446999|NCT04206332|101529007|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33447000|NCT04206332|101529008|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33447001|NCT04206332|101529009|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33447002|NCT04206332|101529010|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33447003|NCT04206332|101529011|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33447004|NCT04206332|101529012|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33447005|NCT04206332|101529013|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33447006|NCT04206332|101529014|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33447007|NCT04206332|101529015|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33447008|NCT04206332|101529016|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
33447009|NCT04206332|101529000|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447010|NCT04206332|101529001|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447011|NCT04206332|101529002|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447012|NCT04206332|101529003|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447013|NCT04206332|101529004|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447014|NCT04206332|101529005|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447015|NCT04206332|101529006|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447016|NCT04206332|101529007|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
33447017|NCT04206332|101529008|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447018|NCT04206332|101529009|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447019|NCT04206332|101529010|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
33447020|NCT04206332|101529011|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447021|NCT04206332|101529012|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447022|NCT04206332|101529013|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447023|NCT04206332|101529014|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447024|NCT04206332|101529015|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447025|NCT04206332|101529016|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447026|NCT04206332|101529000|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447027|NCT04206332|101529001|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447028|NCT04206332|101529002|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447029|NCT04206332|101529003|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447030|NCT04206332|101529004|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447031|NCT04206332|101529005|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447032|NCT04206332|101529006|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447033|NCT04206332|101529007|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447034|NCT04206332|101529008|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447035|NCT04206332|101529009|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447036|NCT04206332|101529010|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33259256|NCT01303445|100849728|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
33259257|NCT01303445|100849729|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
33447037|NCT04206332|101529011|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447038|NCT04206332|101529012|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33166641|NCT03003390|100518739|FG000|Overall Study|Physician Decision|2|||
33166642|NCT03003390|100518740|FG001|Overall Study|Physician Decision|0|||
33166643|NCT03003390|100518739|FG000|Overall Study|Parent refused intervention|2|||
33166644|NCT03003390|100518740|FG001|Overall Study|Parent refused intervention|0|||
33166645|NCT03930797|100518742|FG000|Overall Study|Lost to Follow-up|3|||
33166646|NCT03930797|100518743|FG001|Overall Study|Lost to Follow-up|10|||
33166647|NCT02864498|100518744|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
33166648|NCT02864498|100518745|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
33166649|NCT02864498|100518746|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
33166650|NCT02864498|100518744|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
33166651|NCT02864498|100518745|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
33166652|NCT02864498|100518746|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
33166653|NCT02864498|100518744|FG000|Overall Study|Investigator Discretion|0|||
33166654|NCT02864498|100518745|FG001|Overall Study|Investigator Discretion|2|||
33166655|NCT02864498|100518746|FG002|Overall Study|Investigator Discretion|1|||
33166656|NCT02864498|100518744|FG000|Overall Study|Lost to Follow-up|8|||
33166657|NCT02864498|100518745|FG001|Overall Study|Lost to Follow-up|6|||
33166658|NCT02864498|100518746|FG002|Overall Study|Lost to Follow-up|3|||
33166659|NCT02864498|100518744|FG000|Overall Study|Lack of Efficacy|5|||
33166660|NCT02864498|100518745|FG001|Overall Study|Lack of Efficacy|3|||
33166661|NCT02864498|100518746|FG002|Overall Study|Lack of Efficacy|3|||
33166662|NCT02864498|100518744|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
33166663|NCT02864498|100518745|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
33166664|NCT02864498|100518746|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
33166665|NCT02864498|100518744|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
33166666|NCT02864498|100518745|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
33166667|NCT02864498|100518746|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
33166668|NCT02864498|100518744|FG000|Overall Study|Subject moved out of the country.|0|||
33166669|NCT02864498|100518745|FG001|Overall Study|Subject moved out of the country.|0|||
33166670|NCT02864498|100518746|FG002|Overall Study|Subject moved out of the country.|1|||
33166671|NCT04502693|100518747|FG000|Overall Study|Adverse Event|7|||
33166672|NCT04502693|100518748|FG001|Overall Study|Adverse Event|6|||
33166673|NCT04502693|100518749|FG002|Overall Study|Adverse Event|11|||
33166674|NCT04502693|100518750|FG003|Overall Study|Adverse Event|1|||
33166675|NCT04502693|100518747|FG000|Overall Study|Lost to Follow-up|32|||
33166676|NCT04502693|100518748|FG001|Overall Study|Lost to Follow-up|36|||
33166677|NCT04502693|100518749|FG002|Overall Study|Lost to Follow-up|69|||
33166678|NCT04502693|100518750|FG003|Overall Study|Lost to Follow-up|4|||
33166679|NCT04502693|100518747|FG000|Overall Study|Protocol Violation|8|||
33166680|NCT04502693|100518748|FG001|Overall Study|Protocol Violation|8|||
33166681|NCT04502693|100518749|FG002|Overall Study|Protocol Violation|16|||
33166682|NCT04502693|100518750|FG003|Overall Study|Protocol Violation|1|||
33166683|NCT04502693|100518747|FG000|Overall Study|Withdrawal by Subject|46|||
33166684|NCT04502693|100518748|FG001|Overall Study|Withdrawal by Subject|38|||
33166685|NCT04502693|100518749|FG002|Overall Study|Withdrawal by Subject|54|||
33166686|NCT04502693|100518750|FG003|Overall Study|Withdrawal by Subject|7|||
33166687|NCT04502693|100518747|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
33166688|NCT04502693|100518748|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
33166689|NCT04502693|100518749|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
33166690|NCT04502693|100518750|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33166691|NCT04502693|100518747|FG000|Overall Study|Other|1|||
33166692|NCT04502693|100518748|FG001|Overall Study|Other|0|||
33166693|NCT04502693|100518749|FG002|Overall Study|Other|1|||
33166694|NCT04502693|100518750|FG003|Overall Study|Other|1|||
33166695|NCT02853604|100518751|FG000|Overall Study|Withdrawal by Subject|12|||
33166696|NCT02853604|100518752|FG001|Overall Study|Withdrawal by Subject|35|||
33166697|NCT02853604|100518751|FG000|Overall Study|Lost to Follow-up|4|||
33166698|NCT02853604|100518752|FG001|Overall Study|Lost to Follow-up|8|||
33166699|NCT02853604|100518751|FG000|Overall Study|Death|1|||
33166700|NCT02853604|100518752|FG001|Overall Study|Death|5|||
33166701|NCT02853604|100518751|FG000|Overall Study|Miscellaneous|11|||
33166702|NCT02853604|100518752|FG001|Overall Study|Miscellaneous|2|||
33166703|NCT02853604|100518751|FG000|Overall Study|Progressive Disease|0|||
33166704|NCT02853604|100518752|FG001|Overall Study|Progressive Disease|2|||
33166705|NCT02244606|100518753|FG000|Overall Study|Adverse Event|0|||
33166706|NCT02244606|100518754|FG001|Overall Study|Adverse Event|1|||
33166707|NCT02244606|100518755|FG002|Overall Study|Adverse Event|1|||
33166708|NCT02244606|100518756|FG003|Overall Study|Adverse Event|0|||
33166709|NCT02244606|100518753|FG000|Overall Study|Lost to Follow-up|2|||
33166710|NCT02244606|100518754|FG001|Overall Study|Lost to Follow-up|2|||
33166711|NCT02244606|100518755|FG002|Overall Study|Lost to Follow-up|1|||
33166712|NCT02244606|100518756|FG003|Overall Study|Lost to Follow-up|0|||
33166713|NCT02244606|100518753|FG000|Overall Study|Protocol Violation|0|||
33166714|NCT02244606|100518754|FG001|Overall Study|Protocol Violation|0|||
33166715|NCT02244606|100518755|FG002|Overall Study|Protocol Violation|0|||
33166716|NCT02244606|100518756|FG003|Overall Study|Protocol Violation|1|||
33166717|NCT02244606|100518753|FG000|Overall Study|Withdrawal by Subject|1|||
33166718|NCT02244606|100518754|FG001|Overall Study|Withdrawal by Subject|1|||
33166719|NCT02244606|100518755|FG002|Overall Study|Withdrawal by Subject|0|||
33166720|NCT02244606|100518756|FG003|Overall Study|Withdrawal by Subject|0|||
33166721|NCT02244606|100518753|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
33166722|NCT02244606|100518754|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
33166723|NCT02244606|100518755|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
33166724|NCT02244606|100518756|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
33166725|NCT01049308|100518768|FG000|Pill Counts|Withdrawal by Subject|83|||
33166726|NCT03064451|100518777|FG000|Overall Study|Lost to Follow-up|1|||
33166727|NCT03064451|100518777|FG000|Overall Study|Mapping Failure|4|||
33166728|NCT03064451|100518777|FG000|Overall Study|Exited prior to procedure|8|||
33166729|NCT03064451|100518777|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
33166730|NCT01663532|100518778|FG000|Overall Study|Lost to Follow-up|9|||
33166731|NCT01663532|100518779|FG001|Overall Study|Lost to Follow-up|10|||
33166732|NCT01663532|100518778|FG000|Overall Study|Adverse Event|7|||
33166733|NCT01663532|100518779|FG001|Overall Study|Adverse Event|13|||
33166734|NCT01663532|100518778|FG000|Overall Study|Met Withdrawal Criteria|7|||
33166735|NCT01663532|100518779|FG001|Overall Study|Met Withdrawal Criteria|6|||
33166736|NCT01663532|100518778|FG000|Overall Study|Physician Decision|1|||
33166737|NCT01663532|100518779|FG001|Overall Study|Physician Decision|1|||
33166738|NCT01663532|100518778|FG000|Overall Study|Withdrawal by Subject|35|||
33166739|NCT01663532|100518779|FG001|Overall Study|Withdrawal by Subject|17|||
33166740|NCT01663532|100518778|FG000|Overall Study|Lack of Efficacy|15|||
33166741|NCT01663532|100518779|FG001|Overall Study|Lack of Efficacy|60|||
33166742|NCT04115839|100518780|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
33166743|NCT04115839|100518781|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
33166744|NCT04115839|100518782|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
33166745|NCT04115839|100518783|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
33166746|NCT04115839|100518784|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
33166747|NCT04115839|100518785|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
33166748|NCT04115839|100518786|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
33166749|NCT04115839|100518780|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
33166750|NCT04115839|100518781|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
33166751|NCT04115839|100518782|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
33166752|NCT04115839|100518783|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
33166753|NCT04115839|100518784|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
33166754|NCT04115839|100518785|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
33166755|NCT04115839|100518786|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
33259258|NCT01303445|100849728|FG000|Washout (14 Days)|Protocol Violation|1|||
33259259|NCT01303445|100849729|FG001|Washout (14 Days)|Protocol Violation|0|||
33166756|NCT04115839|100518780|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
33166757|NCT04115839|100518781|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
33166758|NCT04115839|100518782|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
33166759|NCT04115839|100518783|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
33166760|NCT04115839|100518784|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
33166761|NCT04115839|100518785|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
33166762|NCT04115839|100518786|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
33166763|NCT04115839|100518780|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
33166764|NCT04115839|100518781|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
33166765|NCT04115839|100518782|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
33166766|NCT04115839|100518783|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
33166767|NCT04115839|100518784|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
33166768|NCT04115839|100518785|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
33166769|NCT04115839|100518786|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
33166770|NCT04115839|100518780|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
33166771|NCT04115839|100518781|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
33166772|NCT04115839|100518782|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
33166773|NCT04115839|100518783|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
33166774|NCT04115839|100518784|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
33166775|NCT04115839|100518785|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
33166776|NCT04115839|100518786|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
33166777|NCT04115839|100518780|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
33166778|NCT04115839|100518781|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
33166779|NCT04115839|100518782|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
33166780|NCT04115839|100518783|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
33166781|NCT04115839|100518784|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
33166782|NCT04115839|100518785|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
33166783|NCT04115839|100518786|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
33166784|NCT00662012|100518787|FG000|Overall Study|Lost to Follow-up|85|||
33166785|NCT00662012|100518787|FG000|Overall Study|Death|1|||
33166786|NCT00662012|100518787|FG000|Overall Study|Withdrawal by Subject|1|||
33166787|NCT03633695|100518788|FG000|Overall Study|Lost to Follow-up|4|||
33166788|NCT03633695|100518789|FG001|Overall Study|Lost to Follow-up|5|||
33166789|NCT03633695|100518788|FG000|Overall Study|Discontinued|8|||
33166790|NCT03633695|100518789|FG001|Overall Study|Discontinued|4|||
33166791|NCT00982137|100518794|FG000|Overall Study|Lost to Follow-up|0|||
33166792|NCT00982137|100518795|FG001|Overall Study|Lost to Follow-up|0|||
33166793|NCT00982137|100518796|FG002|Overall Study|Lost to Follow-up|0|||
33166794|NCT00982137|100518797|FG003|Overall Study|Lost to Follow-up|1|||
33166795|NCT00982137|100518794|FG000|Overall Study|Withdrawal by Subject|0|||
33166796|NCT00982137|100518795|FG001|Overall Study|Withdrawal by Subject|1|||
33166797|NCT00982137|100518796|FG002|Overall Study|Withdrawal by Subject|0|||
33166798|NCT00982137|100518797|FG003|Overall Study|Withdrawal by Subject|0|||
33166799|NCT02206048|100518798|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
33166800|NCT00003499|100518801|FG000|Overall Study|Not evaluable|8|||
33166801|NCT03305575|100518802|FG000|Overall Study|Physician Decision|1|||
33166802|NCT03305575|100518803|FG001|Overall Study|Physician Decision|0|||
33166803|NCT00887978|100518806|FG000|Overall Study|Adverse Event|18|||
33166804|NCT00887978|100518807|FG001|Overall Study|Adverse Event|5|||
33166805|NCT00887978|100518806|FG000|Overall Study|Clinical Worsening|4|||
33166806|NCT00887978|100518807|FG001|Overall Study|Clinical Worsening|4|||
33166807|NCT00887978|100518806|FG000|Overall Study|Death|2|||
33166808|NCT00887978|100518807|FG001|Overall Study|Death|3|||
33166809|NCT00887978|100518806|FG000|Overall Study|Withdrawal by Subject|1|||
33166810|NCT00887978|100518807|FG001|Overall Study|Withdrawal by Subject|2|||
33166811|NCT00887978|100518806|FG000|Overall Study|Lost to Follow-up|0|||
33166812|NCT00887978|100518807|FG001|Overall Study|Lost to Follow-up|1|||
33166813|NCT03539081|100518808|FG000|Overall Study|Withdrawal by Subject|2|||
33166814|NCT03539081|100518809|FG001|Overall Study|Withdrawal by Subject|3|||
33166815|NCT03539081|100518810|FG002|Overall Study|Withdrawal by Subject|0|||
33166816|NCT03539081|100518808|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
33166817|NCT03539081|100518809|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
33166818|NCT03539081|100518810|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
33166819|NCT01243892|100518811|FG000|Overall Study|Did not meet eligibility criteria|2|||
33259260|NCT01303445|100849728|FG000|Washout (14 Days)|Lost to Follow-up|0|||
33259261|NCT01303445|100849729|FG001|Washout (14 Days)|Lost to Follow-up|2|||
33259262|NCT01303445|100849728|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
33259263|NCT01303445|100849729|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
33259264|NCT01303445|100849728|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
33259265|NCT01303445|100849729|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
33259266|NCT02724592|100849732|FG000|Overall Study|Lost to Follow-up|4|||
33259267|NCT02724592|100849733|FG001|Overall Study|Lost to Follow-up|1|||
33259268|NCT02740231|100849744|FG000|Overall Study|Withdrawal by Subject|1|||
33259269|NCT02740231|100849745|FG001|Overall Study|Withdrawal by Subject|1|||
33259270|NCT02740231|100849746|FG002|Overall Study|Withdrawal by Subject|1|||
33166820|NCT01243892|100518812|FG001|Overall Study|Did not meet eligibility criteria|0|||
33166821|NCT02220205|100518816|FG000|Overall Study|Withdrawal by Subject|1|||
33166822|NCT02220205|100518817|FG001|Overall Study|Withdrawal by Subject|0|||
33259271|NCT02740231|100849747|FG003|Overall Study|Withdrawal by Subject|0|||
33166823|NCT00064337|100518818|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
33166824|NCT00064337|100518818|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
33166825|NCT00064337|100518818|FG000|PBSCC or Induction/PBSCC|Progression|3|||
33447039|NCT04206332|101529013|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447040|NCT04206332|101529014|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447041|NCT04206332|101529015|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
33447042|NCT04206332|101529016|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
33447043|NCT04206332|101529000|FG000|Part C|Withdrawal by Subject|0|||
33447044|NCT04206332|101529001|FG001|Part C|Withdrawal by Subject|0|||
33447045|NCT04206332|101529002|FG002|Part C|Withdrawal by Subject|0|||
33447046|NCT04206332|101529003|FG003|Part C|Withdrawal by Subject|0|||
33447047|NCT04206332|101529004|FG004|Part C|Withdrawal by Subject|0|||
33447048|NCT04206332|101529005|FG005|Part C|Withdrawal by Subject|0|||
33447049|NCT04206332|101529006|FG006|Part C|Withdrawal by Subject|0|||
33447050|NCT04206332|101529007|FG007|Part C|Withdrawal by Subject|0|||
33447051|NCT04206332|101529008|FG008|Part C|Withdrawal by Subject|0|||
33447052|NCT04206332|101529009|FG009|Part C|Withdrawal by Subject|0|||
33447053|NCT04206332|101529010|FG010|Part C|Withdrawal by Subject|0|||
33447054|NCT04206332|101529011|FG011|Part C|Withdrawal by Subject|0|||
33447055|NCT04206332|101529012|FG012|Part C|Withdrawal by Subject|0|||
33447056|NCT04206332|101529013|FG013|Part C|Withdrawal by Subject|0|||
33447057|NCT04206332|101529014|FG014|Part C|Withdrawal by Subject|2|||
33447058|NCT04206332|101529015|FG015|Part C|Withdrawal by Subject|0|||
33447059|NCT04206332|101529016|FG016|Part C|Withdrawal by Subject|0|||
33447060|NCT01566721|101529020|FG000|Treatment Period|Withdrawal by Subject|35|||
33447061|NCT01566721|101529021|FG001|Treatment Period|Withdrawal by Subject|9|||
33447062|NCT01566721|101529020|FG000|Treatment Period|Disease Progression/Recurrence|37|||
33447063|NCT01566721|101529021|FG001|Treatment Period|Disease Progression/Recurrence|13|||
33447064|NCT01566721|101529020|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
33447065|NCT01566721|101529021|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
33447066|NCT01566721|101529020|FG000|Treatment Period|Other|13|||
33447067|NCT01566721|101529021|FG001|Treatment Period|Other|2|||
33447068|NCT01566721|101529020|FG000|Treatment Period|Lack of Compliance|5|||
33447069|NCT01566721|101529021|FG001|Treatment Period|Lack of Compliance|1|||
33447070|NCT01566721|101529020|FG000|Treatment Period|Adverse Event|100|||
33447071|NCT01566721|101529021|FG001|Treatment Period|Adverse Event|30|||
33447072|NCT01566721|101529020|FG000|Treatment Period|Pregnancy|1|||
33447073|NCT01566721|101529021|FG001|Treatment Period|Pregnancy|0|||
33447074|NCT01566721|101529020|FG000|Safety Follow-up|Physician Decision|6|||
33447075|NCT01566721|101529021|FG001|Safety Follow-up|Physician Decision|4|||
33447076|NCT01566721|101529020|FG000|Safety Follow-up|Lost to Follow-up|101|||
33447077|NCT01566721|101529021|FG001|Safety Follow-up|Lost to Follow-up|48|||
33447078|NCT01566721|101529020|FG000|Safety Follow-up|Withdrawal by Subject|155|||
33447079|NCT01566721|101529021|FG001|Safety Follow-up|Withdrawal by Subject|49|||
33447080|NCT01566721|101529020|FG000|Safety Follow-up|Death|28|||
33447081|NCT01566721|101529021|FG001|Safety Follow-up|Death|4|||
33447082|NCT01566721|101529020|FG000|Safety Follow-up|Non-compliance|7|||
33447083|NCT01566721|101529021|FG001|Safety Follow-up|Non-compliance|3|||
33447084|NCT01566721|101529020|FG000|Safety Follow-up|Protocol Violation|7|||
33447085|NCT01566721|101529021|FG001|Safety Follow-up|Protocol Violation|0|||
33447086|NCT01566721|101529020|FG000|Safety Follow-up|Site closure|2|||
33447087|NCT01566721|101529021|FG001|Safety Follow-up|Site closure|3|||
33447088|NCT01566721|101529020|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
33447089|NCT01566721|101529021|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
33447090|NCT01566721|101529020|FG000|Safety Follow-up|Missing|7|||
33447091|NCT01566721|101529021|FG001|Safety Follow-up|Missing|2|||
33447092|NCT01566721|101529020|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
33447093|NCT01566721|101529021|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
33447094|NCT01566721|101529020|FG000|Safety Follow-up|Sponsor decision|1|||
33447095|NCT01566721|101529021|FG001|Safety Follow-up|Sponsor decision|0|||
33447096|NCT01566721|101529020|FG000|Safety Follow-up|Adverse Event|8|||
33447097|NCT01566721|101529021|FG001|Safety Follow-up|Adverse Event|4|||
33447098|NCT02294604|101529023|FG000|Overall Study|Did not provide samples for culture|0|||
33447099|NCT02294604|101529024|FG001|Overall Study|Did not provide samples for culture|1|||
33447100|NCT02294604|101529025|FG002|Overall Study|Did not provide samples for culture|0|||
33447101|NCT02294604|101529023|FG000|Overall Study|Culture contamination|1|||
33447102|NCT02294604|101529024|FG001|Overall Study|Culture contamination|2|||
33447103|NCT02294604|101529025|FG002|Overall Study|Culture contamination|0|||
33447104|NCT03450057|101529026|FG000|Overall Study|Death|17|||
33447105|NCT03450057|101529026|FG000|Overall Study|ICF withdrawal|4|||
33447106|NCT03450057|101529026|FG000|Overall Study|Lost to Follow-up|2|||
33447107|NCT00836056|101529028|FG000|First Intervention|Adverse Event|1|||
33447108|NCT00836056|101529029|FG001|First Intervention|Adverse Event|0|||
33447109|NCT02493868|101529032|FG000|Induction Phase: DE Participants|Adverse Event|22|||
33447110|NCT02493868|101529033|FG001|Induction Phase: DE Participants|Adverse Event|0|||
33447111|NCT02493868|101529032|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
33447112|NCT02493868|101529033|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
33447113|NCT02493868|101529032|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
33447114|NCT02493868|101529033|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
33447115|NCT02493868|101529032|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
33447116|NCT02493868|101529033|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
33447117|NCT02493868|101529032|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
33447118|NCT02493868|101529033|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
33447119|NCT02493868|101529032|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
33447120|NCT02493868|101529033|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
33447121|NCT02493868|101529032|FG000|Induction Phase: DE Participants|Other|8|||
33447122|NCT02493868|101529033|FG001|Induction Phase: DE Participants|Other|0|||
33447123|NCT02493868|101529032|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
33447124|NCT02493868|101529033|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
33447125|NCT02493868|101529032|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
33447126|NCT02493868|101529033|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
33447127|NCT02493868|101529032|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
33447128|NCT02493868|101529033|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
33447129|NCT02493868|101529032|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
33447130|NCT02493868|101529033|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
33447131|NCT02493868|101529032|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
33447132|NCT02493868|101529033|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
33447133|NCT02493868|101529032|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
33447134|NCT02493868|101529033|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
33447135|NCT02493868|101529032|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
33447136|NCT02493868|101529033|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
33447137|NCT02493868|101529032|FG000|Optimization Phase: DE+TE Participants|Other|10|||
33447138|NCT02493868|101529033|FG001|Optimization Phase: DE+TE Participants|Other|2|||
33447139|NCT02493868|101529032|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
33447140|NCT02493868|101529033|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
33447141|NCT02493868|101529032|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
33447142|NCT02493868|101529033|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
33447143|NCT02493868|101529032|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
33447144|NCT02493868|101529033|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
33447145|NCT02493868|101529032|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
33447146|NCT02493868|101529033|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
33447147|NCT02493868|101529032|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
33447148|NCT02493868|101529033|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
33447149|NCT02493868|101529032|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
33447150|NCT02493868|101529033|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
33447151|NCT02493868|101529032|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
33447152|NCT02493868|101529033|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
33447153|NCT02493868|101529032|FG000|Follow-up Phase|Lost to Follow-up|1|||
33447154|NCT02493868|101529033|FG001|Follow-up Phase|Lost to Follow-up|0|||
33447155|NCT02493868|101529032|FG000|Follow-up Phase|Withdrawal by Subject|3|||
33447156|NCT02493868|101529033|FG001|Follow-up Phase|Withdrawal by Subject|0|||
33447157|NCT02493868|101529032|FG000|Follow-up Phase|Investigator Decision|5|||
33447158|NCT02493868|101529033|FG001|Follow-up Phase|Investigator Decision|1|||
33447159|NCT02493868|101529032|FG000|Follow-up Phase|Other|2|||
33447160|NCT02493868|101529033|FG001|Follow-up Phase|Other|1|||
33447161|NCT03769025|101529035|FG000|Overall Study|Withdrawal by Subject|1|||
33447162|NCT03769025|101529036|FG001|Overall Study|Withdrawal by Subject|1|||
33447163|NCT03769025|101529035|FG000|Overall Study|Lost to Follow-up|4|||
33447164|NCT03769025|101529036|FG001|Overall Study|Lost to Follow-up|3|||
33447165|NCT00573066|101529044|FG000|Overall Study|Exclusion criteria|18|||
33447166|NCT00573066|101529044|FG000|Overall Study|IV malfunction|1|||
33447167|NCT00573066|101529044|FG000|Overall Study|Postoperative bleeding|1|||
33447168|NCT01421277|101529045|FG000|Overall Study|Lack of qualifying event|0|||
33447169|NCT01421277|101529046|FG001|Overall Study|Lack of qualifying event|61|||
33447170|NCT01421277|101529045|FG000|Overall Study|Incomplete baseline data|0|||
33447171|NCT01421277|101529046|FG001|Overall Study|Incomplete baseline data|31|||
33447172|NCT03874715|101529051|FG000|Overall Study|Adverse Event|2|||
33447173|NCT03874715|101529052|FG001|Overall Study|Adverse Event|0|||
33447174|NCT03874715|101529051|FG000|Overall Study|Poor compliance to protocol|5|||
33447175|NCT03874715|101529052|FG001|Overall Study|Poor compliance to protocol|1|||
33447176|NCT03874715|101529051|FG000|Overall Study|Withdrawal by Subject|1|||
33447177|NCT03874715|101529052|FG001|Overall Study|Withdrawal by Subject|0|||
33447178|NCT03874715|101529051|FG000|Overall Study|Other-unspecified|1|||
33447179|NCT03874715|101529052|FG001|Overall Study|Other-unspecified|0|||
33447180|NCT03733444|101529060|FG000|Overall Study|Adverse Event|8|||
33447181|NCT03733444|101529061|FG001|Overall Study|Adverse Event|10|||
33447182|NCT03733444|101529062|FG002|Overall Study|Adverse Event|5|||
33166826|NCT00064337|100518818|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
33166827|NCT00064337|100518818|FG000|PBSCC or Induction/PBSCC|Death|2|||
33166828|NCT00064337|100518818|FG000|Transplant|Adverse Event|9|||
33166829|NCT00064337|100518818|FG000|Transplant|Not protocol-specified|5|||
33259272|NCT02740231|100849744|FG000|Overall Study|Lack of Efficacy|0|||
33166830|NCT00064337|100518818|FG000|Transplant|Death|3|||
33447183|NCT03733444|101529060|FG000|Overall Study|Death|20|||
33447184|NCT03733444|101529061|FG001|Overall Study|Death|19|||
33447185|NCT03733444|101529062|FG002|Overall Study|Death|11|||
33447186|NCT03733444|101529060|FG000|Overall Study|Lost to Follow-up|3|||
33447187|NCT03733444|101529061|FG001|Overall Study|Lost to Follow-up|0|||
33447188|NCT03733444|101529062|FG002|Overall Study|Lost to Follow-up|1|||
33447189|NCT03733444|101529060|FG000|Overall Study|Lack of Efficacy|0|||
33259273|NCT02740231|100849745|FG001|Overall Study|Lack of Efficacy|1|||
33259274|NCT02740231|100849746|FG002|Overall Study|Lack of Efficacy|0|||
33259275|NCT02740231|100849747|FG003|Overall Study|Lack of Efficacy|4|||
33259276|NCT02740231|100849744|FG000|Overall Study|Lost to Follow-up|1|||
33259277|NCT02740231|100849745|FG001|Overall Study|Lost to Follow-up|3|||
33259278|NCT02740231|100849746|FG002|Overall Study|Lost to Follow-up|0|||
33259279|NCT02740231|100849747|FG003|Overall Study|Lost to Follow-up|3|||
33259280|NCT02740231|100849744|FG000|Overall Study|Adverse Event|0|||
33259281|NCT02740231|100849745|FG001|Overall Study|Adverse Event|1|||
33259282|NCT02740231|100849746|FG002|Overall Study|Adverse Event|0|||
33259283|NCT02740231|100849747|FG003|Overall Study|Adverse Event|1|||
33259284|NCT04484935|100849749|FG000|Overall Study|Other|0|||
33259285|NCT04484935|100849750|FG001|Overall Study|Other|1|||
33259286|NCT04484935|100849749|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33259287|NCT04484935|100849750|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33259288|NCT04484935|100849749|FG000|Overall Study|Lost to Follow-up|1|||
33259289|NCT04484935|100849750|FG001|Overall Study|Lost to Follow-up|0|||
33259290|NCT04484935|100849749|FG000|Overall Study|Death|2|||
33259291|NCT04484935|100849750|FG001|Overall Study|Death|1|||
33259292|NCT00423098|100849751|FG000|Overall Study|Adverse Event|1|||
33259293|NCT00423098|100849752|FG001|Overall Study|Adverse Event|2|||
33259294|NCT00423098|100849751|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33259295|NCT00423098|100849752|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33259296|NCT00423098|100849751|FG000|Overall Study|Administrative problems|0|||
33259297|NCT00423098|100849752|FG001|Overall Study|Administrative problems|1|||
33259298|NCT00423098|100849751|FG000|Overall Study|Death|2|||
33259299|NCT00423098|100849752|FG001|Overall Study|Death|0|||
33259300|NCT02584829|100849757|FG000|Overall Study|Physician Decision|1|||
33259301|NCT02584829|100849758|FG001|Overall Study|Physician Decision|0|||
33259302|NCT02584829|100849757|FG000|Overall Study|Withdrawal by Subject|0|||
33259303|NCT02584829|100849758|FG001|Overall Study|Withdrawal by Subject|1|||
33259304|NCT02584829|100849757|FG000|Overall Study|Progressive Disease|0|||
33259305|NCT02584829|100849758|FG001|Overall Study|Progressive Disease|3|||
33259306|NCT02555215|100849760|FG000|Overall Study|Other|1|||
33259307|NCT02555215|100849760|FG000|Overall Study|Investigator Decision|2|||
33259308|NCT01759264|100849761|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
33259309|NCT01759264|100849761|FG000|Overall Study|Adverse Event|1|||
33259310|NCT01759264|100849761|FG000|Overall Study|Other|2|||
33259311|NCT01759264|100849761|FG000|Overall Study|Lost to Follow-up|2|||
33259312|NCT01759264|100849761|FG000|Overall Study|Withdrawal by Subject|3|||
33259313|NCT01759264|100849761|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
33259314|NCT04252586|100849764|FG000|Overall Study|Withdrawal by parent/guardian|3|||
33259315|NCT04252586|100849764|FG000|Overall Study|Adverse Event|1|||
33259316|NCT04252586|100849764|FG000|Overall Study|Death|2|||
33259317|NCT04252586|100849764|FG000|Overall Study|Study terminated by sponsor|4|||
33447190|NCT03733444|101529061|FG001|Overall Study|Lack of Efficacy|1|||
33447191|NCT03733444|101529062|FG002|Overall Study|Lack of Efficacy|1|||
33447192|NCT03733444|101529060|FG000|Overall Study|Physician Decision|2|||
33447193|NCT03733444|101529061|FG001|Overall Study|Physician Decision|1|||
33259318|NCT04252586|100849764|FG000|Overall Study|Sponsor request|10|||
33259319|NCT04252586|100849764|FG000|Overall Study|Did not complete treatment period|1|||
33259320|NCT03432858|100853289|FG000|Overall Study|Protocol Violation|2|||
33166831|NCT00064337|100518818|FG000|Transplant|Patient Refusal|2|||
33166832|NCT00064337|100518818|FG000|Transplant|Progression|2|||
33166833|NCT00064337|100518818|FG000|Maintenance|Adverse Event|3|||
33166834|NCT00064337|100518818|FG000|Maintenance|Progression|2|||
33166835|NCT00064337|100518818|FG000|Maintenance|On treatment at time of analysis|2|||
33166836|NCT00064337|100518818|FG000|Maintenance|Not protocol-specified|2|||
33166837|NCT00064337|100518818|FG000|Maintenance|Death|1|||
33166838|NCT01465997|100518819|FG000|Overall Study|Adverse Event|12|||
33166839|NCT01465997|100518820|FG001|Overall Study|Adverse Event|22|||
33166840|NCT01465997|100518819|FG000|Overall Study|Lack of Efficacy|13|||
33166841|NCT01465997|100518820|FG001|Overall Study|Lack of Efficacy|1|||
33166842|NCT01465997|100518819|FG000|Overall Study|Protocol Violation|1|||
33166843|NCT01465997|100518820|FG001|Overall Study|Protocol Violation|4|||
33166844|NCT01465997|100518819|FG000|Overall Study|Lost to Follow-up|6|||
33166845|NCT01465997|100518820|FG001|Overall Study|Lost to Follow-up|9|||
33166846|NCT01465997|100518819|FG000|Overall Study|Withdrawal by Subject|32|||
33166847|NCT01465997|100518820|FG001|Overall Study|Withdrawal by Subject|35|||
33166848|NCT01465997|100518819|FG000|Overall Study|investigator's decision|1|||
33166849|NCT01465997|100518820|FG001|Overall Study|investigator's decision|1|||
33166850|NCT01465997|100518819|FG000|Overall Study|Death|0|||
33166851|NCT01465997|100518820|FG001|Overall Study|Death|1|||
33166852|NCT01465997|100518819|FG000|Overall Study|sponsor's decision|1|||
33166853|NCT01465997|100518820|FG001|Overall Study|sponsor's decision|1|||
33166854|NCT01465997|100518819|FG000|Overall Study|subject withdrew consent|1|||
33166855|NCT01465997|100518820|FG001|Overall Study|subject withdrew consent|0|||
33166856|NCT01465997|100518819|FG000|Overall Study|local lab unblinded site|1|||
33166857|NCT01465997|100518820|FG001|Overall Study|local lab unblinded site|0|||
33166858|NCT01465997|100518819|FG000|Overall Study|withdrew before follow-up|0|||
33166859|NCT01465997|100518820|FG001|Overall Study|withdrew before follow-up|13|||
33166860|NCT01465997|100518819|FG000|Overall Study|decision by site staff|0|||
33166861|NCT01465997|100518820|FG001|Overall Study|decision by site staff|1|||
33166862|NCT01465997|100518819|FG000|Overall Study|subject left participation SP0993|0|||
33166863|NCT01465997|100518820|FG001|Overall Study|subject left participation SP0993|1|||
33166864|NCT00743340|100518821|FG000|Overall Study|Study medication non-compliance|1|||
33166865|NCT00743340|100518821|FG000|Overall Study|Lost to Follow-up|1|||
33166866|NCT00743340|100518821|FG000|Overall Study|Withdrawal from the Study|5|||
33166867|NCT00743340|100518821|FG000|Overall Study|Protocol Violation|1|||
33166868|NCT00743340|100518821|FG000|Overall Study|Virologic failure|8|||
33166869|NCT00743340|100518821|FG000|Overall Study|Pregnancy|1|||
33166870|NCT00743340|100518821|FG000|Overall Study|Rolled over to other Gilead Study|23|||
33166871|NCT00743340|100518821|FG000|Overall Study|Participant Relocated|1|||
33166872|NCT01235351|100518822|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
33166873|NCT01235351|100518823|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
33166874|NCT01749137|100518826|FG000|Overall Study|Adverse Event|4|||
33166875|NCT01749137|100518827|FG001|Overall Study|Adverse Event|4|||
33166876|NCT01749137|100518826|FG000|Overall Study|Lost to Follow-up|2|||
33166877|NCT01749137|100518827|FG001|Overall Study|Lost to Follow-up|3|||
33166878|NCT01749137|100518826|FG000|Overall Study|Physician Decision|1|||
33166879|NCT01749137|100518827|FG001|Overall Study|Physician Decision|0|||
33166880|NCT01749137|100518826|FG000|Overall Study|Withdrawal by Subject|8|||
33166881|NCT01749137|100518827|FG001|Overall Study|Withdrawal by Subject|4|||
33166882|NCT00471328|100518828|FG000|Core Phase|Adverse Event|18|||
33166883|NCT00471328|100518829|FG001|Core Phase|Adverse Event|6|||
33166884|NCT00471328|100518828|FG000|Core Phase|Death|8|||
33166885|NCT00471328|100518829|FG001|Core Phase|Death|4|||
33166886|NCT00471328|100518828|FG000|Core Phase|Withdrawal by Subject|2|||
33166887|NCT00471328|100518829|FG001|Core Phase|Withdrawal by Subject|2|||
33166888|NCT00471328|100518828|FG000|Core Phase|Abnormal laboratory value|1|||
33166889|NCT00471328|100518829|FG001|Core Phase|Abnormal laboratory value|0|||
33166890|NCT00471328|100518828|FG000|Core Phase|Disease Progression|78|||
33166891|NCT00471328|100518829|FG001|Core Phase|Disease Progression|53|||
33166892|NCT00471328|100518828|FG000|Core Phase|Administrative Problem|0|||
33166893|NCT00471328|100518829|FG001|Core Phase|Administrative Problem|1|||
33166894|NCT00471328|100518828|FG000|Core Phase|Protocol Deviation|0|||
33166895|NCT00471328|100518829|FG001|Core Phase|Protocol Deviation|1|||
33166896|NCT00471328|100518828|FG000|Extension Phase|Adverse Event|3|||
33166897|NCT00471328|100518829|FG001|Extension Phase|Adverse Event|12|||
33166898|NCT00471328|100518828|FG000|Extension Phase|Withdrawal by Subject|0|||
33166899|NCT00471328|100518829|FG001|Extension Phase|Withdrawal by Subject|2|||
33166900|NCT00471328|100518828|FG000|Extension Phase|Death|1|||
33166901|NCT00471328|100518829|FG001|Extension Phase|Death|7|||
33166902|NCT00471328|100518828|FG000|Extension Phase|Protocol Deviation|3|||
33166903|NCT00471328|100518829|FG001|Extension Phase|Protocol Deviation|1|||
33166904|NCT00471328|100518828|FG000|Extension Phase|Treatment duration as per protocol|0|||
33166905|NCT00471328|100518829|FG001|Extension Phase|Treatment duration as per protocol|1|||
33166906|NCT00471328|100518828|FG000|Extension Phase|Disease Progression|32|||
33166907|NCT00471328|100518829|FG001|Extension Phase|Disease Progression|44|||
33166908|NCT00471328|100518828|FG000|Extension Phase|New cancer Therapy|1|||
33166909|NCT00471328|100518829|FG001|Extension Phase|New cancer Therapy|0|||
33166910|NCT00471328|100518828|FG000|Extension Phase|Administrative Problem|1|||
33166911|NCT00471328|100518829|FG001|Extension Phase|Administrative Problem|0|||
33166912|NCT01385566|100518830|FG000|Overall Study|Lost to Follow-up|1|||
33166913|NCT01385566|100518831|FG001|Overall Study|Lost to Follow-up|0|||
33166914|NCT01385566|100518832|FG002|Overall Study|Lost to Follow-up|0|||
33166915|NCT01385566|100518833|FG003|Overall Study|Lost to Follow-up|0|||
33166916|NCT01385566|100518834|FG004|Overall Study|Lost to Follow-up|0|||
33166917|NCT01385566|100518835|FG005|Overall Study|Lost to Follow-up|0|||
33166918|NCT01385566|100518830|FG000|Overall Study|Withdrawal by Subject|0|||
33166919|NCT01385566|100518831|FG001|Overall Study|Withdrawal by Subject|0|||
33166920|NCT01385566|100518832|FG002|Overall Study|Withdrawal by Subject|0|||
33166921|NCT01385566|100518833|FG003|Overall Study|Withdrawal by Subject|1|||
33166922|NCT01385566|100518834|FG004|Overall Study|Withdrawal by Subject|0|||
33166923|NCT01385566|100518835|FG005|Overall Study|Withdrawal by Subject|0|||
33166924|NCT03132220|100518838|FG000|Overall Study|Lost to Follow-up|17|||
33166925|NCT03132220|100518839|FG001|Overall Study|Lost to Follow-up|8|||
33166926|NCT03132220|100518838|FG000|Overall Study|Withdrawal by Subject|1|||
33166927|NCT03132220|100518839|FG001|Overall Study|Withdrawal by Subject|4|||
33166928|NCT01603355|100518840|FG000|Overall Study|Lack of Efficacy|2|||
33166929|NCT03808545|100518841|FG000|Overall Study|Withdrawal by Subject|1|||
33166930|NCT03808545|100518842|FG001|Overall Study|Withdrawal by Subject|1|||
33166931|NCT02036294|100518845|FG000|Overall Study|Death|7|||
33166932|NCT02036294|100518846|FG001|Overall Study|Death|8|||
33166933|NCT02036294|100518845|FG000|Overall Study|Withdrawal by Subject|2|||
33166934|NCT02036294|100518846|FG001|Overall Study|Withdrawal by Subject|3|||
33166935|NCT00381485|100518847|FG000|Open-Label Run-In Period|Adverse Event|9|||
33166936|NCT00381485|100518848|FG001|Open-Label Run-In Period|Adverse Event|0|||
33166937|NCT00381485|100518849|FG002|Open-Label Run-In Period|Adverse Event|0|||
33166938|NCT00381485|100518850|FG003|Open-Label Run-In Period|Adverse Event|0|||
33166939|NCT00381485|100518847|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
33166940|NCT00381485|100518848|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
33166941|NCT00381485|100518849|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
33166942|NCT00381485|100518850|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
33166943|NCT00381485|100518847|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
33166944|NCT00381485|100518848|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
33166945|NCT00381485|100518849|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
33166946|NCT00381485|100518850|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
33166947|NCT00381485|100518847|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
33166948|NCT00381485|100518848|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
33166949|NCT00381485|100518849|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
33166950|NCT00381485|100518850|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
33166951|NCT00381485|100518847|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
33166952|NCT00381485|100518848|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
33166953|NCT00381485|100518849|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
33166954|NCT00381485|100518850|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
33166955|NCT00381485|100518847|FG000|Open-Label Run-In Period|Treatment failure|1|||
33166956|NCT00381485|100518848|FG001|Open-Label Run-In Period|Treatment failure|0|||
33166957|NCT00381485|100518849|FG002|Open-Label Run-In Period|Treatment failure|0|||
33166958|NCT00381485|100518850|FG003|Open-Label Run-In Period|Treatment failure|0|||
33166959|NCT00381485|100518847|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33166960|NCT00381485|100518848|FG001|Double-Blind Treatment Period|Adverse Event|2|||
33166961|NCT00381485|100518849|FG002|Double-Blind Treatment Period|Adverse Event|2|||
33166962|NCT00381485|100518850|FG003|Double-Blind Treatment Period|Adverse Event|5|||
33166963|NCT00381485|100518847|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
33166964|NCT00381485|100518848|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
33259321|NCT03432858|100853290|FG001|Overall Study|Protocol Violation|1|||
33259322|NCT03432858|100853291|FG002|Overall Study|Protocol Violation|9|||
33259323|NCT03432858|100853289|FG000|Overall Study|Withdrawal by Subject|0|||
33259324|NCT03432858|100853290|FG001|Overall Study|Withdrawal by Subject|1|||
33259325|NCT03432858|100853291|FG002|Overall Study|Withdrawal by Subject|1|||
33259326|NCT03432858|100853289|FG000|Overall Study|Procedure canceled/rescheduled|0|||
33259327|NCT03432858|100853290|FG001|Overall Study|Procedure canceled/rescheduled|9|||
33259328|NCT03432858|100853291|FG002|Overall Study|Procedure canceled/rescheduled|6|||
33259329|NCT03432858|100853289|FG000|Overall Study|Required postop mobilization with splinting|0|||
33259330|NCT03432858|100853290|FG001|Overall Study|Required postop mobilization with splinting|0|||
33259331|NCT03432858|100853291|FG002|Overall Study|Required postop mobilization with splinting|1|||
33259332|NCT03338816|100853292|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
33259333|NCT03338816|100853293|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
33259334|NCT03338816|100853294|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
33259335|NCT03338816|100853295|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
33259336|NCT03338816|100853292|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
33447194|NCT03733444|101529062|FG002|Overall Study|Physician Decision|0|||
33447195|NCT03733444|101529060|FG000|Overall Study|Protocol Violation|2|||
33447196|NCT03733444|101529061|FG001|Overall Study|Protocol Violation|1|||
33259337|NCT03338816|100853293|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
33259338|NCT03338816|100853294|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
33259339|NCT03338816|100853295|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
33259340|NCT03338816|100853292|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
33259341|NCT03338816|100853293|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
33259342|NCT03338816|100853294|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
33259343|NCT03338816|100853295|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
33259344|NCT03338816|100853292|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
33259345|NCT03338816|100853293|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
33259346|NCT03338816|100853294|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
33259347|NCT03338816|100853295|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
33259348|NCT03338816|100853292|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
33259349|NCT03338816|100853293|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
33259350|NCT03338816|100853294|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
33259351|NCT03338816|100853295|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
33259352|NCT03338816|100853292|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
33259353|NCT03338816|100853293|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
33259354|NCT03338816|100853294|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
33259355|NCT03338816|100853295|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
33259356|NCT03338816|100853292|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
33259357|NCT03338816|100853293|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
33259358|NCT03338816|100853294|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
33259359|NCT03338816|100853295|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
33259360|NCT03990649|100853296|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
33259361|NCT03990649|100853297|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
33259362|NCT03990649|100853298|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
33259363|NCT03990649|100853296|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
33259364|NCT03990649|100853297|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
33259365|NCT03990649|100853298|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
33259366|NCT03990649|100853296|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
33259367|NCT03990649|100853297|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
33259368|NCT03990649|100853298|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
33259369|NCT03990649|100853296|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
33259370|NCT03990649|100853297|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
33447197|NCT03733444|101529062|FG002|Overall Study|Protocol Violation|0|||
33447198|NCT03733444|101529060|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
33259371|NCT03990649|100853298|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
33259372|NCT03990649|100853296|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
33447199|NCT03733444|101529061|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
33447200|NCT03733444|101529062|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
33447201|NCT03733444|101529060|FG000|Overall Study|Study Terminated by Sponsor|203|||
33447202|NCT03733444|101529061|FG001|Overall Study|Study Terminated by Sponsor|209|||
33447203|NCT03733444|101529062|FG002|Overall Study|Study Terminated by Sponsor|221|||
33447204|NCT03733444|101529060|FG000|Overall Study|Withdrawal by Subject|19|||
33447205|NCT03733444|101529061|FG001|Overall Study|Withdrawal by Subject|18|||
33447206|NCT03733444|101529062|FG002|Overall Study|Withdrawal by Subject|16|||
33447207|NCT03733444|101529060|FG000|Overall Study|Miscellaneous|1|||
33447208|NCT03733444|101529061|FG001|Overall Study|Miscellaneous|0|||
33447209|NCT03733444|101529062|FG002|Overall Study|Miscellaneous|1|||
33447210|NCT03733444|101529060|FG000|Overall Study|Not Treated|1|||
33447211|NCT03733444|101529061|FG001|Overall Study|Not Treated|2|||
33447212|NCT03733444|101529062|FG002|Overall Study|Not Treated|1|||
33447213|NCT00838630|101529067|FG000|First Intervention|Adverse Event|1|||
33447214|NCT00838630|101529068|FG001|First Intervention|Adverse Event|0|||
33447215|NCT00838630|101529067|FG000|Washout: 7 Days|Protocol Violation|1|||
33447216|NCT00838630|101529068|FG001|Washout: 7 Days|Protocol Violation|0|||
33447217|NCT00811655|101529069|FG000|Overall Study|Physician Decision|1|||
33447218|NCT00829673|101529073|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
33166965|NCT00381485|100518849|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
33166966|NCT00381485|100518850|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
33166967|NCT00381485|100518847|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
33166968|NCT00381485|100518848|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
33166969|NCT00381485|100518849|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
33166970|NCT00381485|100518850|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
33166971|NCT00381485|100518847|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
33166972|NCT00381485|100518848|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
33166973|NCT00381485|100518849|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
33166974|NCT00381485|100518850|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
33166975|NCT00381485|100518847|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
33166976|NCT00381485|100518848|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
33166977|NCT00381485|100518849|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
33166978|NCT00381485|100518850|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
33166979|NCT00381485|100518847|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
33166980|NCT00381485|100518848|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
33166981|NCT00381485|100518849|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
33166982|NCT00381485|100518850|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
33166983|NCT00381485|100518847|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
33166984|NCT00381485|100518848|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
33166985|NCT00381485|100518849|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
33166986|NCT00381485|100518850|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
33166987|NCT00381485|100518847|FG000|Double-Blind Treatment Period|Administrative|0|||
33166988|NCT00381485|100518848|FG001|Double-Blind Treatment Period|Administrative|1|||
33166989|NCT00381485|100518849|FG002|Double-Blind Treatment Period|Administrative|0|||
33166990|NCT00381485|100518850|FG003|Double-Blind Treatment Period|Administrative|1|||
33166991|NCT01317160|100518853|FG000|Overall Study|Incorrect inclusion|1|||
33166992|NCT01317160|100518854|FG001|Overall Study|Incorrect inclusion|1|||
33166993|NCT01317160|100518853|FG000|Overall Study|Lost to Follow-up|3|||
33166994|NCT01317160|100518854|FG001|Overall Study|Lost to Follow-up|3|||
33166995|NCT01317160|100518853|FG000|Overall Study|Withdrawal by Subject|0|||
33259373|NCT03990649|100853297|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
33259374|NCT03990649|100853298|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
33259375|NCT03990649|100853296|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
33259376|NCT03990649|100853297|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
33259377|NCT03990649|100853298|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
33259378|NCT03990649|100853296|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
33259379|NCT03990649|100853297|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
33259380|NCT03990649|100853298|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
33259381|NCT01266122|100853299|FG000|Overall Study|Lost to Follow-up|6|||
33259382|NCT01266122|100853300|FG001|Overall Study|Lost to Follow-up|6|||
33259383|NCT02267824|100853301|FG000|Overall Study|Pregnancy|1|||
33259384|NCT02267824|100853302|FG001|Overall Study|Pregnancy|1|||
33259385|NCT02267824|100853301|FG000|Overall Study|Lost to Follow-up|4|||
33259386|NCT02267824|100853302|FG001|Overall Study|Lost to Follow-up|0|||
33259387|NCT02267824|100853301|FG000|Overall Study|Protocol Violation|3|||
33259388|NCT02267824|100853302|FG001|Overall Study|Protocol Violation|0|||
33259389|NCT02267824|100853301|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
33259390|NCT02267824|100853302|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
33166996|NCT01317160|100518854|FG001|Overall Study|Withdrawal by Subject|2|||
33166997|NCT01835587|100518855|FG000|Overall Study|Disease Recurrence or Relapse|0|||
33166998|NCT01835587|100518856|FG001|Overall Study|Disease Recurrence or Relapse|3|||
33166999|NCT01835587|100518857|FG002|Overall Study|Disease Recurrence or Relapse|0|||
33167000|NCT01835587|100518858|FG003|Overall Study|Disease Recurrence or Relapse|3|||
33167001|NCT01835587|100518855|FG000|Overall Study|Withdrawal by Subject|2|||
33167002|NCT01835587|100518856|FG001|Overall Study|Withdrawal by Subject|0|||
33167003|NCT01835587|100518857|FG002|Overall Study|Withdrawal by Subject|0|||
33167004|NCT01835587|100518858|FG003|Overall Study|Withdrawal by Subject|3|||
33167005|NCT01835587|100518855|FG000|Overall Study|Adverse Event|0|||
33167006|NCT01835587|100518856|FG001|Overall Study|Adverse Event|0|||
33167007|NCT01835587|100518857|FG002|Overall Study|Adverse Event|2|||
33167008|NCT01835587|100518858|FG003|Overall Study|Adverse Event|2|||
33167009|NCT01835587|100518855|FG000|Overall Study|Death|0|||
33167010|NCT01835587|100518856|FG001|Overall Study|Death|0|||
33167011|NCT01835587|100518857|FG002|Overall Study|Death|0|||
33167012|NCT01835587|100518858|FG003|Overall Study|Death|1|||
33167013|NCT01835587|100518855|FG000|Overall Study|Miscellaneous|0|||
33167014|NCT01835587|100518856|FG001|Overall Study|Miscellaneous|1|||
33167015|NCT01835587|100518857|FG002|Overall Study|Miscellaneous|0|||
33167016|NCT01835587|100518858|FG003|Overall Study|Miscellaneous|0|||
33167017|NCT04051008|100518864|FG000|Overall Study|Withdrawal by Subject|2|||
33167018|NCT04051008|100518865|FG001|Overall Study|Withdrawal by Subject|0|||
33167019|NCT04051008|100518866|FG002|Overall Study|Withdrawal by Subject|1|||
33167020|NCT05466682|100518867|FG000|Overall Study|Withdrawal by Subject|0|||
33167021|NCT05466682|100518868|FG001|Overall Study|Withdrawal by Subject|2|||
33167022|NCT05466682|100518867|FG000|Overall Study|Lost to Follow-up|2|||
33167023|NCT05466682|100518868|FG001|Overall Study|Lost to Follow-up|1|||
33167024|NCT01001377|100518871|FG000|Overall Study|Ineligibility determined|2|||
33167025|NCT01001377|100518872|FG001|Overall Study|Ineligibility determined|0|||
33167026|NCT01001377|100518871|FG000|Overall Study|Withdrawal by Subject|19|||
33167027|NCT01001377|100518872|FG001|Overall Study|Withdrawal by Subject|20|||
33167028|NCT01001377|100518871|FG000|Overall Study|Lost to Follow-up|14|||
33167029|NCT01001377|100518872|FG001|Overall Study|Lost to Follow-up|17|||
33167030|NCT01001377|100518871|FG000|Overall Study|Death|391|||
33259391|NCT00277355|100853303|FG000|Overall Study|Withdrawal by Subject|3|||
33259392|NCT00277355|100853304|FG001|Overall Study|Withdrawal by Subject|3|||
33259393|NCT00277355|100853303|FG000|Overall Study|Lost to Follow-up|2|||
33167031|NCT01001377|100518872|FG001|Overall Study|Death|384|||
33447219|NCT00829673|101529074|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
33447220|NCT01913405|101529077|FG000|Overall Study|Withdrawal by Subject|1|||
33447221|NCT01913405|101529077|FG000|Overall Study|Adverse Event|1|||
33447222|NCT00467363|101529079|FG000|Overall Study|Lost to Follow-up|80|||
33167032|NCT00996307|100518881|FG000|Overall Study|Adverse Event|0|||
33167033|NCT00996307|100518882|FG001|Overall Study|Adverse Event|1|||
33167034|NCT00996307|100518883|FG002|Overall Study|Adverse Event|0|||
33167035|NCT00996307|100518884|FG003|Overall Study|Adverse Event|0|||
33167036|NCT00996307|100518881|FG000|Overall Study|Withdrawal by Subject|3|||
33167037|NCT00996307|100518882|FG001|Overall Study|Withdrawal by Subject|2|||
33167038|NCT00996307|100518883|FG002|Overall Study|Withdrawal by Subject|5|||
33167039|NCT00996307|100518884|FG003|Overall Study|Withdrawal by Subject|5|||
33167040|NCT00996307|100518881|FG000|Overall Study|Lost to Follow-up|13|||
33167041|NCT00996307|100518882|FG001|Overall Study|Lost to Follow-up|13|||
33167042|NCT00996307|100518883|FG002|Overall Study|Lost to Follow-up|7|||
33167043|NCT00996307|100518884|FG003|Overall Study|Lost to Follow-up|15|||
33167044|NCT00996307|100518881|FG000|Overall Study|Administrative reason|0|||
33167045|NCT00996307|100518882|FG001|Overall Study|Administrative reason|1|||
33167046|NCT00996307|100518883|FG002|Overall Study|Administrative reason|0|||
33167047|NCT00996307|100518884|FG003|Overall Study|Administrative reason|0|||
33167048|NCT00996307|100518881|FG000|Overall Study|Unable to classify|4|||
33167049|NCT00996307|100518882|FG001|Overall Study|Unable to classify|0|||
33167050|NCT00996307|100518883|FG002|Overall Study|Unable to classify|2|||
33167051|NCT00996307|100518884|FG003|Overall Study|Unable to classify|1|||
33167052|NCT02025621|100518885|FG000|Overall Study|Withdrawal by Subject|1|||
33167053|NCT02025621|100518886|FG001|Overall Study|Withdrawal by Subject|0|||
33167054|NCT02025621|100518885|FG000|Overall Study|Death|0|||
33167055|NCT02025621|100518886|FG001|Overall Study|Death|1|||
33167056|NCT02025621|100518885|FG000|Overall Study|No longer eligible|10|||
33167057|NCT02025621|100518886|FG001|Overall Study|No longer eligible|15|||
33167058|NCT02025621|100518885|FG000|Overall Study|Surgery initiated before infusion|3|||
33167059|NCT02025621|100518886|FG001|Overall Study|Surgery initiated before infusion|3|||
33167060|NCT00729651|100518887|FG000|Overall Study|Withdrawal by Subject|5|||
33167061|NCT00729651|100518888|FG001|Overall Study|Withdrawal by Subject|6|||
33167062|NCT00729651|100518887|FG000|Overall Study|Lost to Follow-up|5|||
33167063|NCT00729651|100518888|FG001|Overall Study|Lost to Follow-up|4|||
33167064|NCT00729651|100518887|FG000|Overall Study|Protocol Violation|0|||
33167065|NCT00729651|100518888|FG001|Overall Study|Protocol Violation|1|||
33167066|NCT00729651|100518887|FG000|Overall Study|Adverse Event|7|||
33167067|NCT00729651|100518888|FG001|Overall Study|Adverse Event|3|||
33167068|NCT00729651|100518887|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
33167069|NCT00729651|100518888|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
33167070|NCT00729651|100518887|FG000|Overall Study|Subject's private reason|2|||
33167071|NCT00729651|100518888|FG001|Overall Study|Subject's private reason|0|||
33167072|NCT00382252|100518889|FG000|Overall Study|Death|4|||
33167073|NCT00382252|100518889|FG000|Overall Study|Protocol Violation|8|||
33167074|NCT00382252|100518889|FG000|Overall Study|Not treated by RFA|1|||
33167075|NCT00357968|100518891|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
33167076|NCT00357968|100518892|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
33167077|NCT00357968|100518891|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
33167078|NCT00357968|100518892|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
33167079|NCT02615145|100518895|FG000|Overall Study|Did Not Start Treatment|0|||
33167080|NCT02615145|100518896|FG001|Overall Study|Did Not Start Treatment|0|||
33167081|NCT02615145|100518897|FG002|Overall Study|Did Not Start Treatment|1|||
33167082|NCT02615145|100518898|FG003|Overall Study|Did Not Start Treatment|1|||
33167083|NCT02615145|100518895|FG000|Overall Study|Failure to Return|20|||
33167084|NCT02615145|100518896|FG001|Overall Study|Failure to Return|10|||
33167085|NCT02615145|100518897|FG002|Overall Study|Failure to Return|7|||
33167086|NCT02615145|100518898|FG003|Overall Study|Failure to Return|0|||
33167087|NCT02615145|100518895|FG000|Overall Study|Death|2|||
33167088|NCT02615145|100518896|FG001|Overall Study|Death|3|||
33167089|NCT02615145|100518897|FG002|Overall Study|Death|0|||
33167090|NCT02615145|100518898|FG003|Overall Study|Death|0|||
33167091|NCT02615145|100518895|FG000|Overall Study|Other, Not Specified|5|||
33167092|NCT02615145|100518896|FG001|Overall Study|Other, Not Specified|2|||
33167093|NCT02615145|100518897|FG002|Overall Study|Other, Not Specified|0|||
33167094|NCT02615145|100518898|FG003|Overall Study|Other, Not Specified|0|||
33167095|NCT03033394|100521598|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
33167096|NCT03033394|100521598|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
33167097|NCT03033394|100521598|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
33167098|NCT03033394|100521598|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
33167099|NCT03033394|100521598|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
33167100|NCT02732119|100521599|FG000|Phase I|Adverse Event|1|||
33167101|NCT02732119|100521600|FG001|Phase I|Adverse Event|3|||
33167102|NCT02732119|100521601|FG002|Phase I|Adverse Event|1|||
33167103|NCT02732119|100521602|FG003|Phase I|Adverse Event|0|||
33167104|NCT02732119|100521603|FG004|Phase I|Adverse Event|0|||
33167105|NCT02732119|100521599|FG000|Phase I|Progressive disease|7|||
33167106|NCT02732119|100521600|FG001|Phase I|Progressive disease|3|||
33167107|NCT02732119|100521601|FG002|Phase I|Progressive disease|2|||
33167108|NCT02732119|100521602|FG003|Phase I|Progressive disease|0|||
33167109|NCT02732119|100521603|FG004|Phase I|Progressive disease|0|||
33167110|NCT02732119|100521599|FG000|Phase I|Protocol deviation|0|||
33167111|NCT02732119|100521600|FG001|Phase I|Protocol deviation|1|||
33167112|NCT02732119|100521601|FG002|Phase I|Protocol deviation|0|||
33167113|NCT02732119|100521602|FG003|Phase I|Protocol deviation|0|||
33167114|NCT02732119|100521603|FG004|Phase I|Protocol deviation|0|||
33167115|NCT02732119|100521599|FG000|Phase I|Physician Decision|0|||
33167116|NCT02732119|100521600|FG001|Phase I|Physician Decision|3|||
33167117|NCT02732119|100521601|FG002|Phase I|Physician Decision|4|||
33167118|NCT02732119|100521602|FG003|Phase I|Physician Decision|0|||
33167119|NCT02732119|100521603|FG004|Phase I|Physician Decision|0|||
33167120|NCT02732119|100521599|FG000|Phase II|Adverse Event|0|||
33167121|NCT02732119|100521600|FG001|Phase II|Adverse Event|0|||
33167122|NCT02732119|100521601|FG002|Phase II|Adverse Event|0|||
33167123|NCT02732119|100521602|FG003|Phase II|Adverse Event|3|||
33167124|NCT02732119|100521603|FG004|Phase II|Adverse Event|3|||
33167125|NCT02732119|100521599|FG000|Phase II|Death|0|||
33167126|NCT02732119|100521600|FG001|Phase II|Death|0|||
33167127|NCT02732119|100521601|FG002|Phase II|Death|0|||
33167128|NCT02732119|100521602|FG003|Phase II|Death|1|||
33167129|NCT02732119|100521603|FG004|Phase II|Death|0|||
33167130|NCT02732119|100521599|FG000|Phase II|Progressive dissease|0|||
33167131|NCT02732119|100521600|FG001|Phase II|Progressive dissease|0|||
33167132|NCT02732119|100521601|FG002|Phase II|Progressive dissease|0|||
33167133|NCT02732119|100521602|FG003|Phase II|Progressive dissease|30|||
33167134|NCT02732119|100521603|FG004|Phase II|Progressive dissease|23|||
33167135|NCT02732119|100521599|FG000|Phase II|Study terminated by sponsor|0|||
33167136|NCT02732119|100521600|FG001|Phase II|Study terminated by sponsor|0|||
33167137|NCT02732119|100521601|FG002|Phase II|Study terminated by sponsor|0|||
33167138|NCT02732119|100521602|FG003|Phase II|Study terminated by sponsor|2|||
33167139|NCT02732119|100521603|FG004|Phase II|Study terminated by sponsor|2|||
33167140|NCT02732119|100521599|FG000|Phase II|Other|0|||
33167141|NCT02732119|100521600|FG001|Phase II|Other|0|||
33167142|NCT02732119|100521601|FG002|Phase II|Other|0|||
33167143|NCT02732119|100521602|FG003|Phase II|Other|2|||
33167144|NCT02732119|100521603|FG004|Phase II|Other|0|||
33167145|NCT02732119|100521599|FG000|Phase II|Physician Decision|0|||
33167146|NCT02732119|100521600|FG001|Phase II|Physician Decision|0|||
33167147|NCT02732119|100521601|FG002|Phase II|Physician Decision|0|||
33167148|NCT02732119|100521602|FG003|Phase II|Physician Decision|8|||
33167149|NCT02732119|100521603|FG004|Phase II|Physician Decision|5|||
33167150|NCT02228460|100521604|FG000|Overall Study|Adverse Event|1|||
33167151|NCT02228460|100521604|FG000|Overall Study|Lost to Follow-up|1|||
33167152|NCT01473836|100521609|FG000|Overall Study|Adverse Event|4|||
33167153|NCT01473836|100521609|FG000|Overall Study|Lack of Efficacy|1|||
33167154|NCT01473836|100521609|FG000|Overall Study|Does not meet entrance criteria|1|||
33167155|NCT02760069|100521610|FG000|Overall Study|Withdrawal by Subject|0|||
33167156|NCT02760069|100521611|FG001|Overall Study|Withdrawal by Subject|1|||
33167157|NCT02760069|100521612|FG002|Overall Study|Withdrawal by Subject|1|||
33167158|NCT03129100|100521613|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
33167159|NCT03129100|100521614|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
33167160|NCT03129100|100521615|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
33447223|NCT00467363|101529080|FG001|Overall Study|Lost to Follow-up|70|||
33447224|NCT04852978|101529081|FG000|Overall Study|Physician Decision|0|||
33447225|NCT04852978|101529082|FG001|Overall Study|Physician Decision|1|||
33167161|NCT03129100|100521616|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
33167162|NCT03129100|100521617|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
33167163|NCT03129100|100521618|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
33167164|NCT03129100|100521619|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
33167165|NCT03129100|100521620|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
33167166|NCT03129100|100521621|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
33447226|NCT04852978|101529083|FG002|Overall Study|Physician Decision|0|||
33447227|NCT04852978|101529084|FG003|Overall Study|Physician Decision|0|||
33447228|NCT04852978|101529085|FG004|Overall Study|Physician Decision|0|||
33447229|NCT04852978|101529086|FG005|Overall Study|Physician Decision|0|||
33447230|NCT04852978|101529087|FG006|Overall Study|Physician Decision|0|||
33447231|NCT04852978|101529088|FG007|Overall Study|Physician Decision|2|||
33447232|NCT04852978|101529089|FG008|Overall Study|Physician Decision|0|||
33447233|NCT04852978|101529081|FG000|Overall Study|Sponsor request|0|||
33447234|NCT04852978|101529082|FG001|Overall Study|Sponsor request|0|||
33447235|NCT04852978|101529083|FG002|Overall Study|Sponsor request|1|||
33447236|NCT04852978|101529084|FG003|Overall Study|Sponsor request|0|||
33447237|NCT04852978|101529085|FG004|Overall Study|Sponsor request|0|||
33447238|NCT04852978|101529086|FG005|Overall Study|Sponsor request|0|||
33447239|NCT04852978|101529087|FG006|Overall Study|Sponsor request|0|||
33447240|NCT04852978|101529088|FG007|Overall Study|Sponsor request|0|||
33447241|NCT04852978|101529089|FG008|Overall Study|Sponsor request|0|||
33447242|NCT04852978|101529081|FG000|Overall Study|Death|0|||
33447243|NCT04852978|101529082|FG001|Overall Study|Death|0|||
33447244|NCT04852978|101529083|FG002|Overall Study|Death|0|||
33447245|NCT04852978|101529084|FG003|Overall Study|Death|0|||
33447246|NCT04852978|101529085|FG004|Overall Study|Death|0|||
33447247|NCT04852978|101529086|FG005|Overall Study|Death|0|||
33447248|NCT04852978|101529087|FG006|Overall Study|Death|1|||
33447249|NCT04852978|101529088|FG007|Overall Study|Death|0|||
33447250|NCT04852978|101529089|FG008|Overall Study|Death|0|||
33447251|NCT04852978|101529081|FG000|Overall Study|Lost to Follow-up|3|||
33447252|NCT04852978|101529082|FG001|Overall Study|Lost to Follow-up|2|||
33447253|NCT04852978|101529083|FG002|Overall Study|Lost to Follow-up|2|||
33447254|NCT04852978|101529084|FG003|Overall Study|Lost to Follow-up|0|||
33447255|NCT04852978|101529085|FG004|Overall Study|Lost to Follow-up|2|||
33447256|NCT04852978|101529086|FG005|Overall Study|Lost to Follow-up|4|||
33447257|NCT04852978|101529087|FG006|Overall Study|Lost to Follow-up|1|||
33447258|NCT04852978|101529088|FG007|Overall Study|Lost to Follow-up|2|||
33447259|NCT04852978|101529089|FG008|Overall Study|Lost to Follow-up|2|||
33447260|NCT04852978|101529081|FG000|Overall Study|Withdrawal by Subject|4|||
33447261|NCT04852978|101529082|FG001|Overall Study|Withdrawal by Subject|2|||
33447262|NCT04852978|101529083|FG002|Overall Study|Withdrawal by Subject|2|||
33447263|NCT04852978|101529084|FG003|Overall Study|Withdrawal by Subject|1|||
33447264|NCT04852978|101529085|FG004|Overall Study|Withdrawal by Subject|5|||
33447265|NCT04852978|101529086|FG005|Overall Study|Withdrawal by Subject|3|||
33447266|NCT04852978|101529087|FG006|Overall Study|Withdrawal by Subject|2|||
33447267|NCT04852978|101529088|FG007|Overall Study|Withdrawal by Subject|2|||
33447268|NCT04852978|101529089|FG008|Overall Study|Withdrawal by Subject|1|||
33447269|NCT03772522|101529092|FG000|Pre-intervention|Withdrawal by Subject|3|||
33447270|NCT03772522|101529093|FG001|Pre-intervention|Withdrawal by Subject|4|||
33447271|NCT03772522|101529092|FG000|Intervention|Withdrawal by Subject|1|||
33447272|NCT03772522|101529093|FG001|Intervention|Withdrawal by Subject|0|||
33447273|NCT03772522|101529092|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
33447274|NCT03772522|101529093|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
33447275|NCT00448591|101529096|FG000|Overall Study|Withdrawal by Subject|178|||
33447276|NCT00448591|101529096|FG000|Overall Study|Progressive Disease|1382|||
33447277|NCT00448591|101529096|FG000|Overall Study|Adverse Event|382|||
33447278|NCT00448591|101529096|FG000|Overall Study|Protocol Violation|41|||
33447279|NCT00448591|101529096|FG000|Overall Study|Lost to Follow-up|19|||
33447280|NCT00448591|101529096|FG000|Overall Study|Treatment Regimen Completed|70|||
33447281|NCT00448591|101529096|FG000|Overall Study|Other|154|||
33447282|NCT00448591|101529096|FG000|Overall Study|Termination of Study|70|||
33447283|NCT01507051|101529097|FG000|Overall Study|Withdrawal by Subject|1|||
33447284|NCT01507051|101529098|FG001|Overall Study|Withdrawal by Subject|3|||
33447285|NCT01507051|101529099|FG002|Overall Study|Withdrawal by Subject|1|||
33447286|NCT01507051|101529100|FG003|Overall Study|Withdrawal by Subject|6|||
33447287|NCT01507051|101529097|FG000|Overall Study|Physician Decision|0|||
33447288|NCT01507051|101529098|FG001|Overall Study|Physician Decision|0|||
33447289|NCT01507051|101529099|FG002|Overall Study|Physician Decision|0|||
33447290|NCT01507051|101529100|FG003|Overall Study|Physician Decision|1|||
33447291|NCT01507051|101529097|FG000|Overall Study|Adverse Event|1|||
33447292|NCT01507051|101529098|FG001|Overall Study|Adverse Event|0|||
33447293|NCT01507051|101529099|FG002|Overall Study|Adverse Event|0|||
33167167|NCT03129100|100521622|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
33167168|NCT03129100|100521623|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
33167169|NCT03129100|100521624|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
33167170|NCT03129100|100521625|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
33167171|NCT03129100|100521626|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
33167172|NCT03129100|100521627|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
33167173|NCT03129100|100521628|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
33167174|NCT03129100|100521629|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
33167175|NCT03129100|100521630|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
33259394|NCT00277355|100853304|FG001|Overall Study|Lost to Follow-up|2|||
33447294|NCT01507051|101529100|FG003|Overall Study|Adverse Event|0|||
33447295|NCT01705574|101529102|FG000|Double-Blind Phase|Lost to Follow-up|12|||
33447296|NCT01705574|101529103|FG001|Double-Blind Phase|Lost to Follow-up|16|||
33447297|NCT01705574|101529104|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33447298|NCT01705574|101529105|FG003|Double-Blind Phase|Lost to Follow-up|0|||
33447299|NCT01705574|101529102|FG000|Double-Blind Phase|Adverse Event|3|||
33447300|NCT01705574|101529103|FG001|Double-Blind Phase|Adverse Event|10|||
33447301|NCT01705574|101529104|FG002|Double-Blind Phase|Adverse Event|0|||
33447302|NCT01705574|101529105|FG003|Double-Blind Phase|Adverse Event|0|||
33447303|NCT01705574|101529102|FG000|Double-Blind Phase|Withdrew Consent|8|||
33447304|NCT01705574|101529103|FG001|Double-Blind Phase|Withdrew Consent|5|||
33447305|NCT01705574|101529104|FG002|Double-Blind Phase|Withdrew Consent|0|||
33167176|NCT03129100|100521631|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
33167177|NCT03129100|100521632|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
33259395|NCT00277355|100853303|FG000|Overall Study|Adverse Event|5|||
33259396|NCT00277355|100853304|FG001|Overall Study|Adverse Event|0|||
33259397|NCT00277355|100853303|FG000|Overall Study|Death|3|||
33259398|NCT00277355|100853304|FG001|Overall Study|Death|0|||
33259399|NCT00277355|100853303|FG000|Overall Study|Physician Decision|1|||
33259400|NCT00277355|100853304|FG001|Overall Study|Physician Decision|0|||
33259401|NCT02622568|100853305|FG000|Overall Study|Lost to Follow-up|5|||
33259402|NCT02622568|100853306|FG001|Overall Study|Lost to Follow-up|5|||
33259403|NCT01872078|100853310|FG000|Overall Study|Adverse Event|0|||
33259404|NCT01872078|100853311|FG001|Overall Study|Adverse Event|0|||
33259405|NCT01872078|100853312|FG002|Overall Study|Adverse Event|1|||
33259406|NCT01872078|100853313|FG003|Overall Study|Adverse Event|0|||
33259407|NCT01872078|100853310|FG000|Overall Study|Dose administration non-compliance|0|||
33259408|NCT01872078|100853311|FG001|Overall Study|Dose administration non-compliance|0|||
33259409|NCT01872078|100853312|FG002|Overall Study|Dose administration non-compliance|0|||
33259410|NCT01872078|100853313|FG003|Overall Study|Dose administration non-compliance|1|||
33259411|NCT01872078|100853310|FG000|Overall Study|Protocol Violation|0|||
33259412|NCT01872078|100853311|FG001|Overall Study|Protocol Violation|0|||
33259413|NCT01872078|100853312|FG002|Overall Study|Protocol Violation|1|||
33259414|NCT01872078|100853313|FG003|Overall Study|Protocol Violation|0|||
33259415|NCT01872078|100853310|FG000|Overall Study|Withdrawal by Subject|0|||
33259416|NCT01872078|100853311|FG001|Overall Study|Withdrawal by Subject|0|||
33259417|NCT01872078|100853312|FG002|Overall Study|Withdrawal by Subject|1|||
33259418|NCT01872078|100853313|FG003|Overall Study|Withdrawal by Subject|0|||
33259419|NCT01872078|100853310|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
33259420|NCT01872078|100853311|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
33259421|NCT01872078|100853312|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
33259422|NCT01872078|100853313|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
33259423|NCT00205179|100853314|FG000|Overall Study|Death|0|||
33259424|NCT00205179|100853315|FG001|Overall Study|Death|2|||
33259425|NCT00205179|100853314|FG000|Overall Study|Physician Decision|1|||
33259426|NCT00205179|100853315|FG001|Overall Study|Physician Decision|1|||
33259427|NCT00205179|100853314|FG000|Overall Study|Adverse Event|1|||
33259428|NCT00205179|100853315|FG001|Overall Study|Adverse Event|1|||
33259429|NCT00632749|100853316|FG000|Overall Study|Progressive disease|3|||
33259430|NCT00632749|100853317|FG001|Overall Study|Progressive disease|2|||
33259431|NCT00632749|100853318|FG002|Overall Study|Progressive disease|2|||
33259432|NCT00632749|100853319|FG003|Overall Study|Progressive disease|2|||
33259433|NCT00632749|100853320|FG004|Overall Study|Progressive disease|4|||
33259434|NCT00632749|100853321|FG005|Overall Study|Progressive disease|4|||
33259435|NCT00632749|100853322|FG006|Overall Study|Progressive disease|3|||
33259436|NCT00632749|100853323|FG007|Overall Study|Progressive disease|2|||
33259437|NCT00632749|100853324|FG008|Overall Study|Progressive disease|3|||
33259438|NCT00632749|100853325|FG009|Overall Study|Progressive disease|2|||
33259439|NCT00632749|100853326|FG010|Overall Study|Progressive disease|4|||
33259440|NCT00632749|100853327|FG011|Overall Study|Progressive disease|3|||
33259441|NCT00632749|100853328|FG012|Overall Study|Progressive disease|2|||
33259442|NCT00632749|100853329|FG013|Overall Study|Progressive disease|4|||
33259443|NCT00632749|100853316|FG000|Overall Study|Other Adverse event|1|||
33259444|NCT00632749|100853317|FG001|Overall Study|Other Adverse event|1|||
33259445|NCT00632749|100853318|FG002|Overall Study|Other Adverse event|1|||
33259446|NCT00632749|100853319|FG003|Overall Study|Other Adverse event|1|||
33259447|NCT00632749|100853320|FG004|Overall Study|Other Adverse event|2|||
33259448|NCT00632749|100853321|FG005|Overall Study|Other Adverse event|4|||
33259449|NCT00632749|100853322|FG006|Overall Study|Other Adverse event|1|||
33259450|NCT00632749|100853323|FG007|Overall Study|Other Adverse event|2|||
33259451|NCT00632749|100853324|FG008|Overall Study|Other Adverse event|2|||
33259452|NCT00632749|100853325|FG009|Overall Study|Other Adverse event|0|||
33259453|NCT00632749|100853326|FG010|Overall Study|Other Adverse event|1|||
33259454|NCT00632749|100853327|FG011|Overall Study|Other Adverse event|0|||
33259455|NCT00632749|100853328|FG012|Overall Study|Other Adverse event|1|||
33259456|NCT00632749|100853329|FG013|Overall Study|Other Adverse event|0|||
33259457|NCT00632749|100853316|FG000|Overall Study|Refuse to continue medication|0|||
33259458|NCT00632749|100853317|FG001|Overall Study|Refuse to continue medication|0|||
33259459|NCT00632749|100853318|FG002|Overall Study|Refuse to continue medication|0|||
33259460|NCT00632749|100853319|FG003|Overall Study|Refuse to continue medication|1|||
33259461|NCT00632749|100853320|FG004|Overall Study|Refuse to continue medication|0|||
33259462|NCT00632749|100853321|FG005|Overall Study|Refuse to continue medication|0|||
33259463|NCT00632749|100853322|FG006|Overall Study|Refuse to continue medication|0|||
33259464|NCT00632749|100853323|FG007|Overall Study|Refuse to continue medication|0|||
33259465|NCT00632749|100853324|FG008|Overall Study|Refuse to continue medication|0|||
33259466|NCT00632749|100853325|FG009|Overall Study|Refuse to continue medication|1|||
33259467|NCT00632749|100853326|FG010|Overall Study|Refuse to continue medication|0|||
33259468|NCT00632749|100853327|FG011|Overall Study|Refuse to continue medication|0|||
33259469|NCT00632749|100853328|FG012|Overall Study|Refuse to continue medication|0|||
33259470|NCT00632749|100853329|FG013|Overall Study|Refuse to continue medication|0|||
33259471|NCT00632749|100853316|FG000|Overall Study|Reason other than those specified above|0|||
33259472|NCT00632749|100853317|FG001|Overall Study|Reason other than those specified above|2|||
33167178|NCT03129100|100521633|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
33167179|NCT03129100|100521634|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
33167180|NCT03129100|100521635|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
33167181|NCT03129100|100521636|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
33167182|NCT03129100|100521637|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
33167183|NCT03129100|100521638|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
33167184|NCT03129100|100521613|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
33167185|NCT03129100|100521614|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167186|NCT03129100|100521615|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167187|NCT03129100|100521616|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167188|NCT03129100|100521617|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167189|NCT03129100|100521618|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167190|NCT03129100|100521619|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167191|NCT03129100|100521620|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167192|NCT03129100|100521621|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167193|NCT03129100|100521622|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33259473|NCT00632749|100853318|FG002|Overall Study|Reason other than those specified above|0|||
33259474|NCT00632749|100853319|FG003|Overall Study|Reason other than those specified above|0|||
33259475|NCT00632749|100853320|FG004|Overall Study|Reason other than those specified above|1|||
33259476|NCT00632749|100853321|FG005|Overall Study|Reason other than those specified above|0|||
33259477|NCT00632749|100853322|FG006|Overall Study|Reason other than those specified above|1|||
33259478|NCT00632749|100853323|FG007|Overall Study|Reason other than those specified above|0|||
33259479|NCT00632749|100853324|FG008|Overall Study|Reason other than those specified above|0|||
33259480|NCT00632749|100853325|FG009|Overall Study|Reason other than those specified above|0|||
33259481|NCT00632749|100853326|FG010|Overall Study|Reason other than those specified above|2|||
33259482|NCT00632749|100853327|FG011|Overall Study|Reason other than those specified above|1|||
33259483|NCT00632749|100853328|FG012|Overall Study|Reason other than those specified above|0|||
33259484|NCT00632749|100853329|FG013|Overall Study|Reason other than those specified above|2|||
33259485|NCT01839331|100853350|FG000|Overall Study|Early Termination|3|||
33259486|NCT01839331|100853351|FG001|Overall Study|Early Termination|0|||
33259487|NCT01839331|100853352|FG002|Overall Study|Early Termination|1|||
33259488|NCT01839331|100853353|FG003|Overall Study|Early Termination|2|||
33259489|NCT01839331|100853350|FG000|Overall Study|Protocol Violation|1|||
33259490|NCT01839331|100853351|FG001|Overall Study|Protocol Violation|6|||
33259491|NCT01839331|100853352|FG002|Overall Study|Protocol Violation|4|||
33259492|NCT01839331|100853353|FG003|Overall Study|Protocol Violation|3|||
33259493|NCT04377308|100853354|FG000|Overall Study|Withdrawal by Subject|0|||
33259494|NCT04377308|100853355|FG001|Overall Study|Withdrawal by Subject|1|||
33167194|NCT03129100|100521623|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167195|NCT03129100|100521624|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167196|NCT03129100|100521625|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167197|NCT03129100|100521626|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33259495|NCT04512482|100853359|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
33259496|NCT04512482|100853360|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
33259497|NCT02814838|100853361|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
33259498|NCT02814838|100853362|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
33447306|NCT01705574|101529105|FG003|Double-Blind Phase|Withdrew Consent|0|||
33447307|NCT01705574|101529102|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
33447308|NCT01705574|101529103|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
33447309|NCT01705574|101529104|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
33447310|NCT01705574|101529105|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
33447311|NCT01705574|101529102|FG000|Double-Blind Phase|Pregnancy|1|||
33447312|NCT01705574|101529103|FG001|Double-Blind Phase|Pregnancy|1|||
33447313|NCT01705574|101529104|FG002|Double-Blind Phase|Pregnancy|0|||
33447314|NCT01705574|101529105|FG003|Double-Blind Phase|Pregnancy|0|||
33447315|NCT01705574|101529102|FG000|Double-Blind Phase|Protocol Violation|1|||
33447316|NCT01705574|101529103|FG001|Double-Blind Phase|Protocol Violation|0|||
33447317|NCT01705574|101529104|FG002|Double-Blind Phase|Protocol Violation|0|||
33447318|NCT01705574|101529105|FG003|Double-Blind Phase|Protocol Violation|0|||
33447319|NCT01705574|101529102|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
33447320|NCT01705574|101529103|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
33167198|NCT03129100|100521627|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167199|NCT03129100|100521628|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167200|NCT03129100|100521629|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167201|NCT03129100|100521630|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167202|NCT03129100|100521631|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167203|NCT03129100|100521632|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167204|NCT03129100|100521633|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167205|NCT03129100|100521634|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167206|NCT03129100|100521635|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167207|NCT03129100|100521636|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167208|NCT03129100|100521637|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167209|NCT03129100|100521638|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
33167210|NCT03129100|100521613|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
33167211|NCT03129100|100521614|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
33167212|NCT03129100|100521615|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167213|NCT03129100|100521616|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33447321|NCT01705574|101529104|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
33447322|NCT01705574|101529105|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
33447323|NCT01705574|101529102|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
33447324|NCT01705574|101529103|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
33447325|NCT01705574|101529104|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
33447326|NCT01705574|101529105|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
33167214|NCT03129100|100521617|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33447327|NCT01705574|101529102|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
33167215|NCT03129100|100521618|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167216|NCT03129100|100521619|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167217|NCT03129100|100521620|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167218|NCT03129100|100521621|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167219|NCT03129100|100521622|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167220|NCT03129100|100521623|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167221|NCT03129100|100521624|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33447328|NCT01705574|101529103|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
33447329|NCT01705574|101529104|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
33447330|NCT01705574|101529105|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
33447331|NCT01705574|101529102|FG000|Open-Label Extension Phase|Adverse Event|3|||
33447332|NCT01705574|101529103|FG001|Open-Label Extension Phase|Adverse Event|0|||
33447333|NCT01705574|101529104|FG002|Open-Label Extension Phase|Adverse Event|0|||
33447334|NCT01705574|101529105|FG003|Open-Label Extension Phase|Adverse Event|1|||
33447335|NCT01705574|101529102|FG000|Open-Label Extension Phase|Death|2|||
33447336|NCT01705574|101529103|FG001|Open-Label Extension Phase|Death|0|||
33447337|NCT01705574|101529104|FG002|Open-Label Extension Phase|Death|1|||
33447338|NCT01705574|101529105|FG003|Open-Label Extension Phase|Death|0|||
33447339|NCT01705574|101529102|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
33447340|NCT01705574|101529103|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
33447341|NCT01705574|101529104|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
33447342|NCT01705574|101529105|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
33447343|NCT01705574|101529102|FG000|Open-Label Extension Phase|Physician Decision|0|||
33167222|NCT03129100|100521625|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33447344|NCT01705574|101529103|FG001|Open-Label Extension Phase|Physician Decision|0|||
33447345|NCT01705574|101529104|FG002|Open-Label Extension Phase|Physician Decision|2|||
33447346|NCT01705574|101529105|FG003|Open-Label Extension Phase|Physician Decision|0|||
33447347|NCT01705574|101529102|FG000|Open-Label Extension Phase|Pregnancy|0|||
33447348|NCT01705574|101529103|FG001|Open-Label Extension Phase|Pregnancy|0|||
33447349|NCT01705574|101529104|FG002|Open-Label Extension Phase|Pregnancy|1|||
33447350|NCT01705574|101529105|FG003|Open-Label Extension Phase|Pregnancy|1|||
33447351|NCT04400890|101529106|FG000|Overall Study|Withdrawal by Subject|3|||
33447352|NCT04400890|101529107|FG001|Overall Study|Withdrawal by Subject|2|||
33447353|NCT03956862|101529108|FG000|Overall Study|Lost to Follow-up|1|||
33447354|NCT03956862|101529109|FG001|Overall Study|Lost to Follow-up|1|||
33167223|NCT03129100|100521626|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167224|NCT03129100|100521627|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167225|NCT03129100|100521628|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167226|NCT03129100|100521629|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167227|NCT03129100|100521630|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167228|NCT03129100|100521631|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167229|NCT03129100|100521632|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167230|NCT03129100|100521633|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167231|NCT03129100|100521634|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167232|NCT03129100|100521635|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167233|NCT03129100|100521636|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33167234|NCT03129100|100521637|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33447355|NCT03956862|101529108|FG000|Overall Study|Withdrawal by Subject|1|||
33447356|NCT03956862|101529109|FG001|Overall Study|Withdrawal by Subject|1|||
33447357|NCT00960297|101529112|FG000|Overall Study|Physician Decision|1|||
33447358|NCT00960297|101529112|FG000|Overall Study|Venous port infection|1|||
33447359|NCT00960297|101529112|FG000|Overall Study|Disease progression|1|||
33447360|NCT03098394|101529113|FG000|Overall Study|Pregnancy|0|||
33447361|NCT03098394|101529114|FG001|Overall Study|Pregnancy|1|||
33447362|NCT00833937|101529115|FG000|Washout|Withdrawal by Subject|1|||
33447363|NCT00833937|101529116|FG001|Washout|Withdrawal by Subject|0|||
33447364|NCT02714062|101529117|FG000|Overall Study|Adverse Event|0|||
33447365|NCT02714062|101529118|FG001|Overall Study|Adverse Event|0|||
33167235|NCT03129100|100521638|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
33259499|NCT02814838|100853361|FG000|Overall Study|Consent withdrawal|1|||
33259500|NCT02814838|100853362|FG001|Overall Study|Consent withdrawal|1|||
33259501|NCT02029235|100853363|FG000|Overall Study|Non-compliance with study meds or diary|4|||
33447366|NCT02714062|101529119|FG002|Overall Study|Adverse Event|2|||
33447367|NCT02714062|101529117|FG000|Overall Study|Withdrawal by Subject|1|||
33447368|NCT02714062|101529118|FG001|Overall Study|Withdrawal by Subject|0|||
33447369|NCT02714062|101529119|FG002|Overall Study|Withdrawal by Subject|1|||
33447370|NCT02714062|101529117|FG000|Overall Study|Protocol Violation|0|||
33447371|NCT02714062|101529118|FG001|Overall Study|Protocol Violation|1|||
33447372|NCT02714062|101529119|FG002|Overall Study|Protocol Violation|0|||
33447373|NCT00840632|101529120|FG000|First Intervention|Withdrawal by Subject|0|||
33447374|NCT00840632|101529121|FG001|First Intervention|Withdrawal by Subject|1|||
33447375|NCT00840632|101529120|FG000|Washout|Withdrawal by Subject|1|||
33447376|NCT00840632|101529121|FG001|Washout|Withdrawal by Subject|1|||
33447377|NCT00834067|101529123|FG000|Washout of 21 Days|Protocol Violation|0|||
33447378|NCT00834067|101529124|FG001|Washout of 21 Days|Protocol Violation|1|||
33447379|NCT03447353|101529125|FG000|Overall Study|Failure at Screening Visit|2|||
33447380|NCT03447353|101529125|FG000|Overall Study|Lost to Follow-up|4|||
33447381|NCT03447353|101529125|FG000|Overall Study|Scheduling Conflicts|3|||
33447382|NCT03447353|101529125|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
33447383|NCT01250912|101529126|FG000|Overall Study|Lost to Follow-up|1|||
33447384|NCT00446563|101529127|FG000|Overall Study|Adverse Event|4|||
33447385|NCT00446563|101529128|FG001|Overall Study|Adverse Event|3|||
33447386|NCT00446563|101529127|FG000|Overall Study|Abnormal laboratory value(s)|0|||
33447387|NCT00446563|101529128|FG001|Overall Study|Abnormal laboratory value(s)|1|||
33447388|NCT00446563|101529127|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33447389|NCT00446563|101529128|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33447390|NCT00446563|101529127|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33447391|NCT00446563|101529128|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
33447392|NCT00446563|101529127|FG000|Overall Study|Withdrawal by Subject|2|||
33447393|NCT00446563|101529128|FG001|Overall Study|Withdrawal by Subject|1|||
33447394|NCT00446563|101529127|FG000|Overall Study|Administrative problems|0|||
33447395|NCT00446563|101529128|FG001|Overall Study|Administrative problems|1|||
33447396|NCT03017885|101529130|FG000|Overall Study|Adverse Event|2|||
33447397|NCT03017885|101529131|FG001|Overall Study|Adverse Event|0|||
33447398|NCT03017885|101529132|FG002|Overall Study|Adverse Event|0|||
33447399|NCT03017885|101529133|FG003|Overall Study|Adverse Event|0|||
33447400|NCT03017885|101529134|FG004|Overall Study|Adverse Event|0|||
33447401|NCT03017885|101529135|FG005|Overall Study|Adverse Event|0|||
33447402|NCT03017885|101529130|FG000|Overall Study|Progression of disease|4|||
33447403|NCT03017885|101529131|FG001|Overall Study|Progression of disease|3|||
33447404|NCT03017885|101529132|FG002|Overall Study|Progression of disease|4|||
33167236|NCT03129100|100521613|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
33447405|NCT03017885|101529133|FG003|Overall Study|Progression of disease|0|||
33447406|NCT03017885|101529134|FG004|Overall Study|Progression of disease|0|||
33447407|NCT03017885|101529135|FG005|Overall Study|Progression of disease|0|||
33167237|NCT03129100|100521614|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
33167238|NCT03129100|100521615|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167239|NCT03129100|100521616|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167240|NCT03129100|100521617|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167241|NCT03129100|100521618|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167242|NCT03129100|100521619|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167243|NCT03129100|100521620|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33447408|NCT03017885|101529130|FG000|Overall Study|Other than listed|1|||
33447409|NCT03017885|101529131|FG001|Overall Study|Other than listed|2|||
33447410|NCT03017885|101529132|FG002|Overall Study|Other than listed|1|||
33447411|NCT03017885|101529133|FG003|Overall Study|Other than listed|0|||
33447412|NCT03017885|101529134|FG004|Overall Study|Other than listed|0|||
33447413|NCT03017885|101529135|FG005|Overall Study|Other than listed|0|||
33447414|NCT03017885|101529130|FG000|Overall Study|Lost to Follow-up|2|||
33447415|NCT03017885|101529131|FG001|Overall Study|Lost to Follow-up|0|||
33447416|NCT03017885|101529132|FG002|Overall Study|Lost to Follow-up|3|||
33447417|NCT03017885|101529133|FG003|Overall Study|Lost to Follow-up|0|||
33447418|NCT03017885|101529134|FG004|Overall Study|Lost to Follow-up|0|||
33447419|NCT03017885|101529135|FG005|Overall Study|Lost to Follow-up|0|||
33447420|NCT03017885|101529130|FG000|Overall Study|Change to other anti-cancer therapy|0|||
33447421|NCT03017885|101529131|FG001|Overall Study|Change to other anti-cancer therapy|0|||
33447422|NCT03017885|101529132|FG002|Overall Study|Change to other anti-cancer therapy|1|||
33447423|NCT03017885|101529133|FG003|Overall Study|Change to other anti-cancer therapy|0|||
33447424|NCT03017885|101529134|FG004|Overall Study|Change to other anti-cancer therapy|0|||
33447425|NCT03017885|101529135|FG005|Overall Study|Change to other anti-cancer therapy|0|||
33447426|NCT00096447|101529136|FG000|Overall Study|Never treated|1|||
33447427|NCT03114891|101529137|FG000|First Treatment Round|Lost to Follow-up|0|||
33447428|NCT03114891|101529138|FG001|First Treatment Round|Lost to Follow-up|1|||
33447429|NCT03114891|101529139|FG002|First Treatment Round|Lost to Follow-up|1|||
33447430|NCT03114891|101529140|FG003|First Treatment Round|Lost to Follow-up|0|||
33447431|NCT03114891|101529137|FG000|First Treatment Round|Withdrawal by Subject|0|||
33447432|NCT03114891|101529138|FG001|First Treatment Round|Withdrawal by Subject|2|||
33447433|NCT03114891|101529139|FG002|First Treatment Round|Withdrawal by Subject|0|||
33447434|NCT03114891|101529140|FG003|First Treatment Round|Withdrawal by Subject|1|||
33447435|NCT03114891|101529137|FG000|3 Week Break|Lost to Follow-up|1|||
33447436|NCT03114891|101529138|FG001|3 Week Break|Lost to Follow-up|0|||
33447437|NCT03114891|101529139|FG002|3 Week Break|Lost to Follow-up|0|||
33447438|NCT03114891|101529140|FG003|3 Week Break|Lost to Follow-up|1|||
33447439|NCT03114891|101529137|FG000|3 Week Break|Withdrawal by Subject|0|||
33167244|NCT03129100|100521621|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167245|NCT03129100|100521622|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33447440|NCT03114891|101529138|FG001|3 Week Break|Withdrawal by Subject|1|||
33447441|NCT03114891|101529139|FG002|3 Week Break|Withdrawal by Subject|0|||
33447442|NCT03114891|101529140|FG003|3 Week Break|Withdrawal by Subject|0|||
33447443|NCT03114891|101529137|FG000|Second Treatment Round|Lost to Follow-up|1|||
33447444|NCT03114891|101529138|FG001|Second Treatment Round|Lost to Follow-up|0|||
33447445|NCT03114891|101529139|FG002|Second Treatment Round|Lost to Follow-up|0|||
33447446|NCT03114891|101529140|FG003|Second Treatment Round|Lost to Follow-up|0|||
33447447|NCT03114891|101529137|FG000|Second Treatment Round|Physician Decision|1|||
33447448|NCT03114891|101529138|FG001|Second Treatment Round|Physician Decision|0|||
33447449|NCT03114891|101529139|FG002|Second Treatment Round|Physician Decision|0|||
33167246|NCT03129100|100521623|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167247|NCT03129100|100521624|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167248|NCT03129100|100521625|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33447450|NCT03114891|101529140|FG003|Second Treatment Round|Physician Decision|0|||
33447451|NCT01171963|101529141|FG000|Overall Study|Adverse Event|10|||
33447452|NCT01171963|101529142|FG001|Overall Study|Adverse Event|15|||
33447453|NCT01171963|101529141|FG000|Overall Study|Lost to Follow-up|23|||
33447454|NCT01171963|101529142|FG001|Overall Study|Lost to Follow-up|24|||
33447455|NCT01171963|101529141|FG000|Overall Study|Other - diarrhoea|1|||
33447456|NCT01171963|101529142|FG001|Overall Study|Other - diarrhoea|0|||
33447457|NCT01171963|101529141|FG000|Overall Study|Withdrawal by Subject|114|||
33447458|NCT01171963|101529142|FG001|Overall Study|Withdrawal by Subject|129|||
33447459|NCT00796653|101529143|FG000|Overall Study|Adverse Event|19|||
33447460|NCT00796653|101529144|FG001|Overall Study|Adverse Event|16|||
33447461|NCT00796653|101529145|FG002|Overall Study|Adverse Event|16|||
33447462|NCT00796653|101529146|FG003|Overall Study|Adverse Event|16|||
33447463|NCT00796653|101529143|FG000|Overall Study|Lost to Follow-up|2|||
33447464|NCT00796653|101529144|FG001|Overall Study|Lost to Follow-up|1|||
33447465|NCT00796653|101529145|FG002|Overall Study|Lost to Follow-up|2|||
33447466|NCT00796653|101529146|FG003|Overall Study|Lost to Follow-up|3|||
33447467|NCT00796653|101529143|FG000|Overall Study|Withdrawal by Subject|16|||
33447468|NCT00796653|101529144|FG001|Overall Study|Withdrawal by Subject|8|||
33447469|NCT00796653|101529145|FG002|Overall Study|Withdrawal by Subject|8|||
33447470|NCT00796653|101529146|FG003|Overall Study|Withdrawal by Subject|13|||
33447471|NCT00796653|101529143|FG000|Overall Study|Lack of Efficacy|8|||
33447472|NCT00796653|101529144|FG001|Overall Study|Lack of Efficacy|1|||
33447473|NCT00796653|101529145|FG002|Overall Study|Lack of Efficacy|3|||
33447474|NCT00796653|101529146|FG003|Overall Study|Lack of Efficacy|2|||
33447475|NCT00796653|101529143|FG000|Overall Study|Non compliance with protocol|2|||
33447476|NCT00796653|101529144|FG001|Overall Study|Non compliance with protocol|2|||
33447477|NCT00796653|101529145|FG002|Overall Study|Non compliance with protocol|0|||
33447478|NCT00796653|101529146|FG003|Overall Study|Non compliance with protocol|2|||
33447479|NCT00796653|101529143|FG000|Overall Study|Other reason not described above|4|||
33447480|NCT00796653|101529144|FG001|Overall Study|Other reason not described above|9|||
33447481|NCT00796653|101529145|FG002|Overall Study|Other reason not described above|7|||
33447482|NCT00796653|101529146|FG003|Overall Study|Other reason not described above|4|||
33447483|NCT02832063|101529147|FG000|Overall Study|Adverse Event|2|||
33447484|NCT02832063|101529148|FG001|Overall Study|Adverse Event|1|||
33447485|NCT02832063|101529147|FG000|Overall Study|Physician Decision|5|||
33447486|NCT02832063|101529148|FG001|Overall Study|Physician Decision|7|||
33447487|NCT02832063|101529147|FG000|Overall Study|Lost to Follow-up|15|||
33447488|NCT02832063|101529148|FG001|Overall Study|Lost to Follow-up|8|||
33447489|NCT02832063|101529147|FG000|Overall Study|Withdrawal by Subject|10|||
33447490|NCT02832063|101529148|FG001|Overall Study|Withdrawal by Subject|21|||
33447491|NCT02832063|101529147|FG000|Overall Study|Other|2|||
33447492|NCT02832063|101529148|FG001|Overall Study|Other|1|||
33167249|NCT03129100|100521626|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167250|NCT03129100|100521627|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167251|NCT03129100|100521628|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167252|NCT03129100|100521629|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167253|NCT03129100|100521630|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167254|NCT03129100|100521631|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167255|NCT03129100|100521632|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33447493|NCT02392195|101529152|FG000|Overall Study|Lost to Follow-up|4|||
33447494|NCT02392195|101529152|FG000|Overall Study|Withdrawal by Subject|4|||
33447495|NCT03351244|101529156|FG000|Overall Study|Adverse Event|7|||
33447496|NCT03351244|101529157|FG001|Overall Study|Adverse Event|11|||
33447497|NCT03351244|101529158|FG002|Overall Study|Adverse Event|12|||
33447498|NCT03351244|101529156|FG000|Overall Study|Investigator's decision|0|||
33447499|NCT03351244|101529157|FG001|Overall Study|Investigator's decision|0|||
33447500|NCT03351244|101529158|FG002|Overall Study|Investigator's decision|2|||
33447501|NCT03351244|101529156|FG000|Overall Study|System error|0|||
33447502|NCT03351244|101529157|FG001|Overall Study|System error|0|||
33447503|NCT03351244|101529158|FG002|Overall Study|System error|2|||
33447504|NCT03351244|101529156|FG000|Overall Study|COVID-19 restrictions|3|||
33447505|NCT03351244|101529157|FG001|Overall Study|COVID-19 restrictions|0|||
33447506|NCT03351244|101529158|FG002|Overall Study|COVID-19 restrictions|1|||
33447507|NCT03351244|101529156|FG000|Overall Study|Non-compliance|2|||
33447508|NCT03351244|101529157|FG001|Overall Study|Non-compliance|5|||
33447509|NCT03351244|101529158|FG002|Overall Study|Non-compliance|0|||
33447510|NCT03351244|101529156|FG000|Overall Study|Withdrawal by Subject|11|||
33447511|NCT03351244|101529157|FG001|Overall Study|Withdrawal by Subject|16|||
33447512|NCT03351244|101529158|FG002|Overall Study|Withdrawal by Subject|13|||
33447513|NCT03351244|101529156|FG000|Overall Study|Lost to Follow-up|2|||
33447514|NCT03351244|101529157|FG001|Overall Study|Lost to Follow-up|6|||
33447515|NCT03351244|101529158|FG002|Overall Study|Lost to Follow-up|4|||
33447516|NCT03351244|101529156|FG000|Overall Study|Protocol Violation|2|||
33447517|NCT03351244|101529157|FG001|Overall Study|Protocol Violation|2|||
33447518|NCT03351244|101529158|FG002|Overall Study|Protocol Violation|0|||
33447519|NCT04533594|101529159|FG000|Overall Study|Death|26|||
33447520|NCT01124175|101529162|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
33447521|NCT01124175|101529163|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
33447522|NCT04166630|101529164|FG000|Overall Study|Withdrawal by Subject|0|||
33167256|NCT03129100|100521633|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167257|NCT03129100|100521634|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167258|NCT03129100|100521635|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167259|NCT03129100|100521636|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167260|NCT03129100|100521637|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167261|NCT03129100|100521638|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
33167262|NCT03129100|100521613|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167263|NCT03129100|100521614|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
33167264|NCT03129100|100521615|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167265|NCT03129100|100521616|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167266|NCT03129100|100521617|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167267|NCT03129100|100521618|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167268|NCT03129100|100521619|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167269|NCT03129100|100521620|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167270|NCT03129100|100521621|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167271|NCT03129100|100521622|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167272|NCT03129100|100521623|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167273|NCT03129100|100521624|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
33447523|NCT04166630|101529165|FG001|Overall Study|Withdrawal by Subject|1|||
33447524|NCT05327491|101529166|FG000|Periods 1 & 2|Miscellaneous|0|||
33447525|NCT05327491|101529167|FG001|Periods 1 & 2|Miscellaneous|1|||
33447526|NCT05327491|101529168|FG002|Periods 1 & 2|Miscellaneous|0|||
33447527|NCT05327491|101529169|FG003|Periods 1 & 2|Miscellaneous|0|||
33447528|NCT05327491|101529166|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
33167274|NCT03129100|100521625|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
33447529|NCT05327491|101529167|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
33447530|NCT05327491|101529168|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
33447531|NCT05327491|101529169|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
33447532|NCT04827394|101529170|FG000|Overall Study|Physician Decision|0|||
33447533|NCT04827394|101529171|FG001|Overall Study|Physician Decision|2|||
33259502|NCT02029235|100853364|FG001|Overall Study|Non-compliance with study meds or diary|1|||
33259503|NCT00150813|100853367|FG000|Overall Study|Adverse Event|1|||
33259504|NCT00150813|100853367|FG000|Overall Study|Lack of Efficacy|1|||
33259505|NCT00150813|100853367|FG000|Overall Study|Lost to Follow-up|5|||
33259506|NCT00150813|100853367|FG000|Overall Study|Withdrawal by Subject|5|||
33259507|NCT00150813|100853367|FG000|Overall Study|Remission|3|||
33259508|NCT00150813|100853367|FG000|Overall Study|Planned pregancy|1|||
33259509|NCT00150813|100853367|FG000|Overall Study|Switch to commercially available LEV|2|||
33259510|NCT03580369|100853368|FG000|Overall Study|No treatment due to mis-randomization|1|||
33259511|NCT03580369|100853369|FG001|Overall Study|No treatment due to mis-randomization|0|||
33259512|NCT03580369|100853370|FG002|Overall Study|No treatment due to mis-randomization|0|||
33259513|NCT03580369|100853371|FG003|Overall Study|No treatment due to mis-randomization|0|||
33259514|NCT03580369|100853372|FG004|Overall Study|No treatment due to mis-randomization|3|||
33259515|NCT03580369|100853373|FG005|Overall Study|No treatment due to mis-randomization|0|||
33259516|NCT03580369|100853374|FG006|Overall Study|No treatment due to mis-randomization|0|||
33259517|NCT03580369|100853375|FG007|Overall Study|No treatment due to mis-randomization|0|||
33259518|NCT03580369|100853368|FG000|Overall Study|Reason unknown|0|||
33259519|NCT03580369|100853369|FG001|Overall Study|Reason unknown|0|||
33259520|NCT03580369|100853370|FG002|Overall Study|Reason unknown|1|||
33259521|NCT03580369|100853371|FG003|Overall Study|Reason unknown|0|||
33259522|NCT03580369|100853372|FG004|Overall Study|Reason unknown|0|||
33259523|NCT03580369|100853373|FG005|Overall Study|Reason unknown|0|||
33259524|NCT03580369|100853374|FG006|Overall Study|Reason unknown|0|||
33259525|NCT03580369|100853375|FG007|Overall Study|Reason unknown|0|||
33259526|NCT03580369|100853368|FG000|Overall Study|Technical problems|0|||
33259527|NCT03580369|100853369|FG001|Overall Study|Technical problems|0|||
33259528|NCT03580369|100853370|FG002|Overall Study|Technical problems|0|||
33259529|NCT03580369|100853371|FG003|Overall Study|Technical problems|0|||
33259530|NCT03580369|100853372|FG004|Overall Study|Technical problems|1|||
33259531|NCT03580369|100853373|FG005|Overall Study|Technical problems|0|||
33259532|NCT03580369|100853374|FG006|Overall Study|Technical problems|2|||
33259533|NCT03580369|100853375|FG007|Overall Study|Technical problems|0|||
33259534|NCT03580369|100853368|FG000|Overall Study|Pregnancy|2|||
33259535|NCT03580369|100853369|FG001|Overall Study|Pregnancy|0|||
33259536|NCT03580369|100853370|FG002|Overall Study|Pregnancy|3|||
33259537|NCT03580369|100853371|FG003|Overall Study|Pregnancy|0|||
33259538|NCT03580369|100853372|FG004|Overall Study|Pregnancy|2|||
33259539|NCT03580369|100853373|FG005|Overall Study|Pregnancy|0|||
33259540|NCT03580369|100853374|FG006|Overall Study|Pregnancy|0|||
33259541|NCT03580369|100853375|FG007|Overall Study|Pregnancy|0|||
33259542|NCT03580369|100853368|FG000|Overall Study|Lost to Follow-up|2|||
33259543|NCT03580369|100853369|FG001|Overall Study|Lost to Follow-up|0|||
33259544|NCT03580369|100853370|FG002|Overall Study|Lost to Follow-up|2|||
33259545|NCT03580369|100853371|FG003|Overall Study|Lost to Follow-up|0|||
33259546|NCT03580369|100853372|FG004|Overall Study|Lost to Follow-up|3|||
33259547|NCT03580369|100853373|FG005|Overall Study|Lost to Follow-up|0|||
33259548|NCT03580369|100853374|FG006|Overall Study|Lost to Follow-up|1|||
33259549|NCT03580369|100853375|FG007|Overall Study|Lost to Follow-up|0|||
33259550|NCT03580369|100853368|FG000|Overall Study|Physician Decision|4|||
33167275|NCT03129100|100521626|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167276|NCT03129100|100521627|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167277|NCT03129100|100521628|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
33259551|NCT03580369|100853369|FG001|Overall Study|Physician Decision|0|||
33259552|NCT03580369|100853370|FG002|Overall Study|Physician Decision|4|||
33259553|NCT03580369|100853371|FG003|Overall Study|Physician Decision|1|||
33259554|NCT03580369|100853372|FG004|Overall Study|Physician Decision|1|||
33259555|NCT03580369|100853373|FG005|Overall Study|Physician Decision|0|||
33259556|NCT03580369|100853374|FG006|Overall Study|Physician Decision|0|||
33259557|NCT03580369|100853375|FG007|Overall Study|Physician Decision|0|||
33259558|NCT03580369|100853368|FG000|Overall Study|Lack of Efficacy|3|||
33259559|NCT03580369|100853369|FG001|Overall Study|Lack of Efficacy|0|||
33259560|NCT03580369|100853370|FG002|Overall Study|Lack of Efficacy|7|||
33259561|NCT03580369|100853371|FG003|Overall Study|Lack of Efficacy|0|||
33259562|NCT03580369|100853372|FG004|Overall Study|Lack of Efficacy|2|||
33259563|NCT03580369|100853373|FG005|Overall Study|Lack of Efficacy|0|||
33259564|NCT03580369|100853374|FG006|Overall Study|Lack of Efficacy|3|||
33259565|NCT03580369|100853375|FG007|Overall Study|Lack of Efficacy|0|||
33259566|NCT03580369|100853368|FG000|Overall Study|Protocol Violation|6|||
33259567|NCT03580369|100853369|FG001|Overall Study|Protocol Violation|0|||
33259568|NCT03580369|100853370|FG002|Overall Study|Protocol Violation|6|||
33259569|NCT03580369|100853371|FG003|Overall Study|Protocol Violation|1|||
33259570|NCT03580369|100853372|FG004|Overall Study|Protocol Violation|8|||
33259571|NCT03580369|100853373|FG005|Overall Study|Protocol Violation|2|||
33259572|NCT03580369|100853374|FG006|Overall Study|Protocol Violation|1|||
33259573|NCT03580369|100853375|FG007|Overall Study|Protocol Violation|0|||
33259574|NCT03580369|100853368|FG000|Overall Study|Adverse Event|7|||
33259575|NCT03580369|100853369|FG001|Overall Study|Adverse Event|0|||
33259576|NCT03580369|100853370|FG002|Overall Study|Adverse Event|14|||
33259577|NCT03580369|100853371|FG003|Overall Study|Adverse Event|1|||
33259578|NCT03580369|100853372|FG004|Overall Study|Adverse Event|6|||
33259579|NCT03580369|100853373|FG005|Overall Study|Adverse Event|0|||
33259580|NCT03580369|100853374|FG006|Overall Study|Adverse Event|1|||
33259581|NCT03580369|100853375|FG007|Overall Study|Adverse Event|0|||
33259582|NCT03580369|100853368|FG000|Overall Study|Withdrawal by Subject|19|||
33259583|NCT03580369|100853369|FG001|Overall Study|Withdrawal by Subject|0|||
33259584|NCT03580369|100853370|FG002|Overall Study|Withdrawal by Subject|17|||
33259585|NCT03580369|100853371|FG003|Overall Study|Withdrawal by Subject|0|||
33259586|NCT03580369|100853372|FG004|Overall Study|Withdrawal by Subject|16|||
33259587|NCT03580369|100853373|FG005|Overall Study|Withdrawal by Subject|1|||
33259588|NCT03580369|100853374|FG006|Overall Study|Withdrawal by Subject|7|||
33259589|NCT03580369|100853375|FG007|Overall Study|Withdrawal by Subject|0|||
33259590|NCT01376700|100853376|FG000|Overall Study|Sponsor terminated study early|8|||
33259591|NCT01376700|100853376|FG000|Overall Study|Low or high titer inhibitor|8|||
33259592|NCT02058108|100853377|FG000|Overall Study|Abnormal Laboratory Values|0|||
33259593|NCT02058108|100853378|FG001|Overall Study|Abnormal Laboratory Values|1|||
33259594|NCT02058108|100853377|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
33259595|NCT02058108|100853378|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
33259596|NCT02058108|100853377|FG000|Overall Study|No longer requires study drug|0|||
33259597|NCT02058108|100853378|FG001|Overall Study|No longer requires study drug|1|||
33259598|NCT02058108|100853377|FG000|Overall Study|Withdrawal by Subject|1|||
33259599|NCT02058108|100853378|FG001|Overall Study|Withdrawal by Subject|0|||
33259600|NCT02058108|100853377|FG000|Overall Study|Administrative problems|3|||
33259601|NCT02058108|100853378|FG001|Overall Study|Administrative problems|3|||
33259602|NCT02058108|100853377|FG000|Overall Study|Protocol Violation|0|||
33259603|NCT02058108|100853378|FG001|Overall Study|Protocol Violation|1|||
33259604|NCT00610649|100853379|FG000|Overall Study|Adverse Event|1|||
33259605|NCT00610649|100853380|FG001|Overall Study|Adverse Event|0|||
33259606|NCT00610649|100853381|FG002|Overall Study|Adverse Event|0|||
33259607|NCT00610649|100853382|FG003|Overall Study|Adverse Event|0|||
33259608|NCT00610649|100853383|FG004|Overall Study|Adverse Event|0|||
33259609|NCT00610649|100853384|FG005|Overall Study|Adverse Event|0|||
33259610|NCT00610649|100853385|FG006|Overall Study|Adverse Event|0|||
33259611|NCT00610649|100853386|FG007|Overall Study|Adverse Event|0|||
33259612|NCT00610649|100853387|FG008|Overall Study|Adverse Event|0|||
33259613|NCT00610649|100853388|FG009|Overall Study|Adverse Event|0|||
33259614|NCT00610649|100853389|FG010|Overall Study|Adverse Event|1|||
33259615|NCT00610649|100853379|FG000|Overall Study|Family Emergency|0|||
33259616|NCT00610649|100853380|FG001|Overall Study|Family Emergency|1|||
33259617|NCT00610649|100853381|FG002|Overall Study|Family Emergency|0|||
33259618|NCT00610649|100853382|FG003|Overall Study|Family Emergency|0|||
33259619|NCT00610649|100853383|FG004|Overall Study|Family Emergency|0|||
33259620|NCT00610649|100853384|FG005|Overall Study|Family Emergency|0|||
33259621|NCT00610649|100853385|FG006|Overall Study|Family Emergency|0|||
33259622|NCT00610649|100853386|FG007|Overall Study|Family Emergency|0|||
33259623|NCT00610649|100853387|FG008|Overall Study|Family Emergency|0|||
33259624|NCT00610649|100853388|FG009|Overall Study|Family Emergency|0|||
33259625|NCT00610649|100853389|FG010|Overall Study|Family Emergency|0|||
33259626|NCT00610649|100853379|FG000|Overall Study|Withdrawal by Subject|0|||
33259627|NCT00610649|100853380|FG001|Overall Study|Withdrawal by Subject|0|||
33259628|NCT00610649|100853381|FG002|Overall Study|Withdrawal by Subject|0|||
33259629|NCT00610649|100853382|FG003|Overall Study|Withdrawal by Subject|0|||
33447534|NCT01987765|101529172|FG000|Overall Study|Protocol Violation|65|||
33259630|NCT00610649|100853383|FG004|Overall Study|Withdrawal by Subject|0|||
33259631|NCT00610649|100853384|FG005|Overall Study|Withdrawal by Subject|0|||
33259632|NCT00610649|100853385|FG006|Overall Study|Withdrawal by Subject|0|||
33259633|NCT00610649|100853386|FG007|Overall Study|Withdrawal by Subject|0|||
33259634|NCT00610649|100853387|FG008|Overall Study|Withdrawal by Subject|0|||
33259635|NCT00610649|100853388|FG009|Overall Study|Withdrawal by Subject|1|||
33259636|NCT00610649|100853389|FG010|Overall Study|Withdrawal by Subject|0|||
33259637|NCT01227265|100853394|FG000|Overall Study|Did Not Receive Treatment|1|||
33259638|NCT01227265|100853395|FG001|Overall Study|Did Not Receive Treatment|2|||
33259639|NCT01227265|100853396|FG002|Overall Study|Did Not Receive Treatment|0|||
33259640|NCT01227265|100853394|FG000|Overall Study|Administrative|1|||
33259641|NCT01227265|100853395|FG001|Overall Study|Administrative|0|||
33259642|NCT01227265|100853396|FG002|Overall Study|Administrative|2|||
33259643|NCT01227265|100853394|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
33259644|NCT01227265|100853395|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
33259645|NCT01227265|100853396|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
33259646|NCT01227265|100853394|FG000|Overall Study|Protocol Violation|2|||
33259647|NCT01227265|100853395|FG001|Overall Study|Protocol Violation|1|||
33259648|NCT01227265|100853396|FG002|Overall Study|Protocol Violation|0|||
33259649|NCT01227265|100853394|FG000|Overall Study|Withdrawal by Subject|7|||
33259650|NCT01227265|100853395|FG001|Overall Study|Withdrawal by Subject|7|||
33259651|NCT01227265|100853396|FG002|Overall Study|Withdrawal by Subject|3|||
33259652|NCT01227265|100853394|FG000|Overall Study|Lost to Follow-up|2|||
33259653|NCT01227265|100853395|FG001|Overall Study|Lost to Follow-up|0|||
33259654|NCT01227265|100853396|FG002|Overall Study|Lost to Follow-up|3|||
33259655|NCT01227265|100853394|FG000|Overall Study|Adverse Event|6|||
33259656|NCT01227265|100853395|FG001|Overall Study|Adverse Event|10|||
33259657|NCT01227265|100853396|FG002|Overall Study|Adverse Event|5|||
33259658|NCT00557492|100853397|FG000|Overall Study|Change in health insurance|1|||
33259659|NCT01094184|100853398|FG000|Overall Study|Death|35|||
33259660|NCT01094184|100853399|FG001|Overall Study|Death|11|||
33259661|NCT02379819|100853400|FG000|Overall Study|Withdrawal by Subject|10|||
33259662|NCT02379819|100853400|FG000|Overall Study|Death|2|||
33259663|NCT02379819|100853400|FG000|Overall Study|Lack of Efficacy|1|||
33259664|NCT02379819|100853400|FG000|Overall Study|Lost to Follow-up|1|||
33259665|NCT00676091|100853401|FG000|Infant Series|Parent or legal guardian request|10|||
33259666|NCT00676091|100853402|FG001|Infant Series|Parent or legal guardian request|8|||
33259667|NCT00676091|100853401|FG000|Infant Series|Protocol Violation|6|||
33259668|NCT00676091|100853402|FG001|Infant Series|Protocol Violation|3|||
33259669|NCT00676091|100853401|FG000|Infant Series|Adverse Event|2|||
33259670|NCT00676091|100853402|FG001|Infant Series|Adverse Event|3|||
33259671|NCT00676091|100853401|FG000|Infant Series|Failed to return|1|||
33259672|NCT00676091|100853402|FG001|Infant Series|Failed to return|3|||
33259673|NCT00676091|100853401|FG000|Infant Series|Lost to Follow-up|1|||
33259674|NCT00676091|100853402|FG001|Infant Series|Lost to Follow-up|0|||
33259675|NCT00676091|100853401|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
33259676|NCT00676091|100853402|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
33259677|NCT00676091|100853401|FG000|After Infant Series|Adverse Event|0|||
33259678|NCT00676091|100853402|FG001|After Infant Series|Adverse Event|1|||
33259679|NCT00676091|100853401|FG000|After Infant Series|Protocol Violation|0|||
33259680|NCT00676091|100853402|FG001|After Infant Series|Protocol Violation|1|||
33259681|NCT00676091|100853401|FG000|After Infant Series|Failed to return|1|||
33259682|NCT00676091|100853402|FG001|After Infant Series|Failed to return|1|||
33259683|NCT00676091|100853401|FG000|Toddler Dose|Failed to return|2|||
33259684|NCT00676091|100853402|FG001|Toddler Dose|Failed to return|0|||
33259685|NCT00676091|100853401|FG000|Toddler Dose|Parent or legal guardian request|1|||
33259686|NCT00676091|100853402|FG001|Toddler Dose|Parent or legal guardian request|0|||
33259687|NCT02538341|100853403|FG000|Overall Study|Lost to Follow-up|51|||
33259688|NCT02538341|100853404|FG001|Overall Study|Lost to Follow-up|46|||
33259689|NCT02538341|100853403|FG000|Overall Study|Withdrawal by Subject|3|||
33259690|NCT02538341|100853404|FG001|Overall Study|Withdrawal by Subject|1|||
33259691|NCT02538341|100853403|FG000|Overall Study|Death|2|||
33259692|NCT02538341|100853404|FG001|Overall Study|Death|0|||
33259693|NCT01307267|100853405|FG000|Overall Study|Death|4|||
33167278|NCT03129100|100521629|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167279|NCT03129100|100521630|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167280|NCT03129100|100521631|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167281|NCT03129100|100521632|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167282|NCT03129100|100521633|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167283|NCT03129100|100521634|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167284|NCT03129100|100521635|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167285|NCT03129100|100521636|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167286|NCT03129100|100521637|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167287|NCT03129100|100521638|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
33167288|NCT03129100|100521613|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33259694|NCT01307267|100853406|FG001|Overall Study|Death|3|||
33259695|NCT01307267|100853407|FG002|Overall Study|Death|5|||
33259696|NCT01307267|100853408|FG003|Overall Study|Death|3|||
33259697|NCT01307267|100853409|FG004|Overall Study|Death|1|||
33259698|NCT01307267|100853410|FG005|Overall Study|Death|26|||
33259699|NCT01307267|100853411|FG006|Overall Study|Death|2|||
33259700|NCT01307267|100853412|FG007|Overall Study|Death|2|||
33259701|NCT01307267|100853413|FG008|Overall Study|Death|21|||
33259702|NCT01307267|100853414|FG009|Overall Study|Death|2|||
33259703|NCT01307267|100853415|FG010|Overall Study|Death|3|||
33259704|NCT01307267|100853416|FG011|Overall Study|Death|9|||
33259705|NCT01307267|100853417|FG012|Overall Study|Death|0|||
33259706|NCT01307267|100853418|FG013|Overall Study|Death|0|||
33259707|NCT01307267|100853419|FG014|Overall Study|Death|0|||
33259708|NCT01307267|100853420|FG015|Overall Study|Death|0|||
33167289|NCT03129100|100521614|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167290|NCT03129100|100521615|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
33167291|NCT03129100|100521616|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
33167292|NCT03129100|100521617|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167293|NCT03129100|100521618|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
33167294|NCT03129100|100521619|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167295|NCT03129100|100521620|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167296|NCT03129100|100521621|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167297|NCT03129100|100521622|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167298|NCT03129100|100521623|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167299|NCT03129100|100521624|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167300|NCT03129100|100521625|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167301|NCT03129100|100521626|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167302|NCT03129100|100521627|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167303|NCT03129100|100521628|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167304|NCT03129100|100521629|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167305|NCT03129100|100521630|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167306|NCT03129100|100521631|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167307|NCT03129100|100521632|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167308|NCT03129100|100521633|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167309|NCT03129100|100521634|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167310|NCT03129100|100521635|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167311|NCT03129100|100521636|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167312|NCT03129100|100521637|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167313|NCT03129100|100521638|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
33167314|NCT03129100|100521613|FG000|Period2 Extension Period (Group A and B)|Death|0|||
33167315|NCT03129100|100521614|FG001|Period2 Extension Period (Group A and B)|Death|0|||
33167316|NCT03129100|100521615|FG002|Period2 Extension Period (Group A and B)|Death|1|||
33167317|NCT03129100|100521616|FG003|Period2 Extension Period (Group A and B)|Death|0|||
33167318|NCT03129100|100521617|FG004|Period2 Extension Period (Group A and B)|Death|0|||
33167319|NCT03129100|100521618|FG005|Period2 Extension Period (Group A and B)|Death|0|||
33167320|NCT03129100|100521619|FG006|Period2 Extension Period (Group A and B)|Death|0|||
33167321|NCT03129100|100521620|FG007|Period2 Extension Period (Group A and B)|Death|0|||
33167322|NCT03129100|100521621|FG008|Period2 Extension Period (Group A and B)|Death|0|||
33167323|NCT03129100|100521622|FG009|Period2 Extension Period (Group A and B)|Death|0|||
33167324|NCT03129100|100521623|FG010|Period2 Extension Period (Group A and B)|Death|0|||
33167325|NCT03129100|100521624|FG011|Period2 Extension Period (Group A and B)|Death|0|||
33167326|NCT03129100|100521625|FG012|Period2 Extension Period (Group A and B)|Death|0|||
33167327|NCT03129100|100521626|FG013|Period2 Extension Period (Group A and B)|Death|0|||
33167328|NCT03129100|100521627|FG014|Period2 Extension Period (Group A and B)|Death|0|||
33167329|NCT03129100|100521628|FG015|Period2 Extension Period (Group A and B)|Death|0|||
33167330|NCT03129100|100521629|FG016|Period2 Extension Period (Group A and B)|Death|0|||
33167331|NCT03129100|100521630|FG017|Period2 Extension Period (Group A and B)|Death|0|||
33167332|NCT03129100|100521631|FG018|Period2 Extension Period (Group A and B)|Death|0|||
33167333|NCT03129100|100521632|FG019|Period2 Extension Period (Group A and B)|Death|0|||
33167334|NCT03129100|100521633|FG020|Period2 Extension Period (Group A and B)|Death|0|||
33167335|NCT03129100|100521634|FG021|Period2 Extension Period (Group A and B)|Death|0|||
33167336|NCT03129100|100521635|FG022|Period2 Extension Period (Group A and B)|Death|0|||
33167337|NCT03129100|100521636|FG023|Period2 Extension Period (Group A and B)|Death|0|||
33167338|NCT03129100|100521637|FG024|Period2 Extension Period (Group A and B)|Death|0|||
33167339|NCT03129100|100521638|FG025|Period2 Extension Period (Group A and B)|Death|0|||
33167340|NCT03129100|100521613|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167341|NCT03129100|100521614|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167342|NCT03129100|100521615|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
33167343|NCT03129100|100521616|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
33167344|NCT03129100|100521617|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
33167345|NCT03129100|100521618|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
33167346|NCT03129100|100521619|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
33167347|NCT03129100|100521620|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167348|NCT03129100|100521621|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167349|NCT03129100|100521622|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167350|NCT03129100|100521623|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33259709|NCT01307267|100853421|FG016|Overall Study|Death|1|||
33167351|NCT03129100|100521624|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167352|NCT03129100|100521625|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167353|NCT03129100|100521626|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167354|NCT03129100|100521627|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167355|NCT03129100|100521628|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167356|NCT03129100|100521629|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167357|NCT03129100|100521630|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167358|NCT03129100|100521631|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167359|NCT03129100|100521632|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167360|NCT03129100|100521633|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167361|NCT03129100|100521634|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167362|NCT03129100|100521635|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167363|NCT03129100|100521636|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167364|NCT03129100|100521637|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167365|NCT03129100|100521638|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
33167366|NCT03129100|100521613|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167367|NCT03129100|100521614|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167368|NCT03129100|100521615|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
33167369|NCT03129100|100521616|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167370|NCT03129100|100521617|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167371|NCT03129100|100521618|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167372|NCT03129100|100521619|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167373|NCT03129100|100521620|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167374|NCT03129100|100521621|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167375|NCT03129100|100521622|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167376|NCT03129100|100521623|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167377|NCT03129100|100521624|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33259710|NCT01307267|100853422|FG017|Overall Study|Death|1|||
33259711|NCT01307267|100853423|FG018|Overall Study|Death|2|||
33259712|NCT01307267|100853424|FG019|Overall Study|Death|8|||
33259713|NCT01307267|100853425|FG020|Overall Study|Death|1|||
33259714|NCT01307267|100853426|FG021|Overall Study|Death|2|||
33259715|NCT01307267|100853427|FG022|Overall Study|Death|2|||
33259716|NCT01307267|100853405|FG000|Overall Study|Lost to Follow-up|0|||
33259717|NCT01307267|100853406|FG001|Overall Study|Lost to Follow-up|0|||
33259718|NCT01307267|100853407|FG002|Overall Study|Lost to Follow-up|0|||
33259719|NCT01307267|100853408|FG003|Overall Study|Lost to Follow-up|0|||
33259720|NCT01307267|100853409|FG004|Overall Study|Lost to Follow-up|0|||
33259721|NCT01307267|100853410|FG005|Overall Study|Lost to Follow-up|7|||
33259722|NCT01307267|100853411|FG006|Overall Study|Lost to Follow-up|0|||
33259723|NCT01307267|100853412|FG007|Overall Study|Lost to Follow-up|0|||
33259724|NCT01307267|100853413|FG008|Overall Study|Lost to Follow-up|1|||
33259725|NCT01307267|100853414|FG009|Overall Study|Lost to Follow-up|2|||
33259726|NCT01307267|100853415|FG010|Overall Study|Lost to Follow-up|1|||
33259727|NCT01307267|100853416|FG011|Overall Study|Lost to Follow-up|0|||
33259728|NCT01307267|100853417|FG012|Overall Study|Lost to Follow-up|0|||
33447535|NCT01987765|101529172|FG000|Overall Study|Lost to Follow-up|37|||
33447536|NCT01519661|101529176|FG000|Overall Study|Protocol deviation|6|||
33259729|NCT01307267|100853418|FG013|Overall Study|Lost to Follow-up|0|||
33259730|NCT01307267|100853419|FG014|Overall Study|Lost to Follow-up|0|||
33447537|NCT01519661|101529176|FG000|Overall Study|Lost to Follow-up|3|||
33447538|NCT01519661|101529176|FG000|Overall Study|Withdrawal by Subject|17|||
33259731|NCT01307267|100853420|FG015|Overall Study|Lost to Follow-up|0|||
33259732|NCT01307267|100853421|FG016|Overall Study|Lost to Follow-up|0|||
33259733|NCT01307267|100853422|FG017|Overall Study|Lost to Follow-up|0|||
33259734|NCT01307267|100853423|FG018|Overall Study|Lost to Follow-up|0|||
33259735|NCT01307267|100853424|FG019|Overall Study|Lost to Follow-up|2|||
33259736|NCT01307267|100853425|FG020|Overall Study|Lost to Follow-up|0|||
33259737|NCT01307267|100853426|FG021|Overall Study|Lost to Follow-up|0|||
33259738|NCT01307267|100853427|FG022|Overall Study|Lost to Follow-up|0|||
33259739|NCT01307267|100853405|FG000|Overall Study|Withdrawal by Subject|0|||
33259740|NCT01307267|100853406|FG001|Overall Study|Withdrawal by Subject|0|||
33259741|NCT01307267|100853407|FG002|Overall Study|Withdrawal by Subject|0|||
33259742|NCT01307267|100853408|FG003|Overall Study|Withdrawal by Subject|0|||
33259743|NCT01307267|100853409|FG004|Overall Study|Withdrawal by Subject|0|||
33447539|NCT01519661|101529176|FG000|Overall Study|Lack of Efficacy|6|||
33447540|NCT01519661|101529176|FG000|Overall Study|Adverse Event|29|||
33447541|NCT00633594|101529177|FG000|Overall Study|Adverse Event|0|||
33447542|NCT00633594|101529178|FG001|Overall Study|Adverse Event|4|||
33259744|NCT01307267|100853410|FG005|Overall Study|Withdrawal by Subject|1|||
33259745|NCT01307267|100853411|FG006|Overall Study|Withdrawal by Subject|0|||
33447543|NCT00633594|101529179|FG002|Overall Study|Adverse Event|7|||
33447544|NCT00633594|101529177|FG000|Overall Study|Death|0|||
33447545|NCT00633594|101529178|FG001|Overall Study|Death|1|||
33447546|NCT00633594|101529179|FG002|Overall Study|Death|2|||
33447547|NCT00633594|101529177|FG000|Overall Study|Disease Progression|0|||
33447548|NCT00633594|101529178|FG001|Overall Study|Disease Progression|0|||
33447549|NCT00633594|101529179|FG002|Overall Study|Disease Progression|1|||
33447550|NCT05093205|101529185|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
33447551|NCT05093205|101529186|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
33447552|NCT05093205|101529187|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
33447553|NCT05093205|101529188|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
33447554|NCT05093205|101529189|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
33447555|NCT05093205|101529190|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
33447556|NCT05093205|101529191|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
33447557|NCT05093205|101529192|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
33447558|NCT05093205|101529193|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
33447559|NCT05093205|101529194|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
33447560|NCT05093205|101529195|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
33447561|NCT05093205|101529196|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
33447562|NCT05093205|101529197|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
33447563|NCT05093205|101529185|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
33447564|NCT05093205|101529186|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
33447565|NCT05093205|101529187|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
33447566|NCT05093205|101529188|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
33447567|NCT05093205|101529189|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
33447568|NCT05093205|101529190|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
33447569|NCT05093205|101529191|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
33447570|NCT05093205|101529192|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
33447571|NCT05093205|101529193|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
33447572|NCT05093205|101529194|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
33447573|NCT05093205|101529195|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
33447574|NCT05093205|101529196|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
33447575|NCT05093205|101529197|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
33447576|NCT05093205|101529185|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
33447577|NCT05093205|101529186|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
33447578|NCT05093205|101529187|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
33447579|NCT05093205|101529188|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
33447580|NCT05093205|101529189|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
33447581|NCT05093205|101529190|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
33447582|NCT05093205|101529191|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
33259746|NCT01307267|100853412|FG007|Overall Study|Withdrawal by Subject|1|||
33259747|NCT01307267|100853413|FG008|Overall Study|Withdrawal by Subject|5|||
33259748|NCT01307267|100853414|FG009|Overall Study|Withdrawal by Subject|1|||
33259749|NCT01307267|100853415|FG010|Overall Study|Withdrawal by Subject|1|||
33447583|NCT05093205|101529192|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
33447584|NCT05093205|101529193|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
33447585|NCT05093205|101529194|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
33447586|NCT05093205|101529195|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
33447587|NCT05093205|101529196|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
33447588|NCT05093205|101529197|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
33447589|NCT05093205|101529185|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
33447590|NCT05093205|101529186|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
33447591|NCT05093205|101529187|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
33447592|NCT05093205|101529188|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
33447593|NCT05093205|101529189|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
33447594|NCT05093205|101529190|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
33447595|NCT05093205|101529191|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
33447596|NCT05093205|101529192|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
33447597|NCT05093205|101529193|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
33447598|NCT05093205|101529194|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
33447599|NCT05093205|101529195|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
33447600|NCT05093205|101529196|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
33447601|NCT05093205|101529197|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
33447602|NCT05093205|101529185|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
33447603|NCT05093205|101529186|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
33447604|NCT05093205|101529187|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
33447605|NCT05093205|101529188|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
33447606|NCT05093205|101529189|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
33447607|NCT05093205|101529190|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
33447608|NCT05093205|101529191|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
33447609|NCT05093205|101529192|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
33447610|NCT05093205|101529193|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
33447611|NCT05093205|101529194|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
33447612|NCT05093205|101529195|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
33447613|NCT05093205|101529196|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
33447614|NCT05093205|101529197|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
33447615|NCT05093205|101529185|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
33447616|NCT05093205|101529186|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
33447617|NCT05093205|101529187|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
33447618|NCT05093205|101529188|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
33447619|NCT05093205|101529189|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
33167378|NCT03129100|100521625|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33447620|NCT05093205|101529190|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
33447621|NCT05093205|101529191|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
33447622|NCT05093205|101529192|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
33447623|NCT05093205|101529193|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
33447624|NCT05093205|101529194|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
33447625|NCT05093205|101529195|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
33447626|NCT05093205|101529196|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
33167379|NCT03129100|100521626|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33447627|NCT05093205|101529197|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
33447628|NCT05093205|101529185|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
33447629|NCT05093205|101529186|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
33447630|NCT05093205|101529187|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
33447631|NCT05093205|101529188|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
33447632|NCT05093205|101529189|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
33447633|NCT05093205|101529190|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
33447634|NCT05093205|101529191|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
33447635|NCT05093205|101529192|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
33447636|NCT05093205|101529193|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
33447637|NCT05093205|101529194|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
33447638|NCT05093205|101529195|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
33447639|NCT05093205|101529196|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
33447640|NCT05093205|101529197|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
33447641|NCT05093205|101529185|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
33447642|NCT05093205|101529186|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
33447643|NCT05093205|101529187|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
33447644|NCT05093205|101529188|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
33447645|NCT05093205|101529189|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
33447646|NCT05093205|101529190|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
33447647|NCT05093205|101529191|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
33447648|NCT05093205|101529192|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
33447649|NCT05093205|101529193|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
33447650|NCT05093205|101529194|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
33447651|NCT05093205|101529195|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
33447652|NCT05093205|101529196|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
33447653|NCT05093205|101529197|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
33167380|NCT03129100|100521627|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167381|NCT03129100|100521628|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167382|NCT03129100|100521629|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167383|NCT03129100|100521630|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167384|NCT03129100|100521631|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167385|NCT03129100|100521632|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167386|NCT03129100|100521633|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167387|NCT03129100|100521634|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167388|NCT03129100|100521635|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167389|NCT03129100|100521636|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167390|NCT03129100|100521637|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167391|NCT03129100|100521638|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
33167392|NCT03129100|100521613|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167393|NCT03129100|100521614|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167394|NCT03129100|100521615|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
33167395|NCT03129100|100521616|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167396|NCT03129100|100521617|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167397|NCT03129100|100521618|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167398|NCT03129100|100521619|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167399|NCT03129100|100521620|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167400|NCT03129100|100521621|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167401|NCT03129100|100521622|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167402|NCT03129100|100521623|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167403|NCT03129100|100521624|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167404|NCT03129100|100521625|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167405|NCT03129100|100521626|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167406|NCT03129100|100521627|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167407|NCT03129100|100521628|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167408|NCT03129100|100521629|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167409|NCT03129100|100521630|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167410|NCT03129100|100521631|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33447654|NCT05093205|101529185|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
33447655|NCT05093205|101529186|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
33447656|NCT05093205|101529187|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
33447657|NCT05093205|101529188|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
33447658|NCT05093205|101529189|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
33167411|NCT03129100|100521632|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33447659|NCT05093205|101529190|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
33447660|NCT05093205|101529191|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
33447661|NCT05093205|101529192|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
33447662|NCT05093205|101529193|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
33447663|NCT05093205|101529194|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
33447664|NCT05093205|101529195|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
33447665|NCT05093205|101529196|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
33447666|NCT05093205|101529197|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
33447667|NCT05093205|101529185|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
33447668|NCT05093205|101529186|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
33447669|NCT05093205|101529187|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
33447670|NCT05093205|101529188|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
33447671|NCT05093205|101529189|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
33447672|NCT05093205|101529190|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
33447673|NCT05093205|101529191|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
33167412|NCT03129100|100521633|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167413|NCT03129100|100521634|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33447674|NCT05093205|101529192|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
33447675|NCT05093205|101529193|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
33447676|NCT05093205|101529194|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
33447677|NCT05093205|101529195|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
33447678|NCT05093205|101529196|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
33447679|NCT05093205|101529197|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
33447680|NCT05093205|101529185|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
33447681|NCT05093205|101529186|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
33447682|NCT05093205|101529187|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
33447683|NCT05093205|101529188|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
33447684|NCT05093205|101529189|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
33447685|NCT05093205|101529190|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
33447686|NCT05093205|101529191|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
33447687|NCT05093205|101529192|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
33447688|NCT05093205|101529193|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
33447689|NCT05093205|101529194|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
33447690|NCT05093205|101529195|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
33447691|NCT05093205|101529196|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
33447692|NCT05093205|101529197|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
33447693|NCT05093205|101529185|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
33447694|NCT05093205|101529186|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
33447695|NCT05093205|101529187|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
33447696|NCT05093205|101529188|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
33447697|NCT05093205|101529189|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
33447698|NCT05093205|101529190|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
33167414|NCT03129100|100521635|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167415|NCT03129100|100521636|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167416|NCT03129100|100521637|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167417|NCT03129100|100521638|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
33167418|NCT03129100|100521613|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167419|NCT03129100|100521614|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167420|NCT03129100|100521615|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
33447699|NCT05093205|101529191|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
33447700|NCT05093205|101529192|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
33447701|NCT05093205|101529193|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
33447702|NCT05093205|101529194|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
33447703|NCT05093205|101529195|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
33447704|NCT05093205|101529196|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
33447705|NCT05093205|101529197|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
33447706|NCT05093205|101529185|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
33447707|NCT05093205|101529186|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
33447708|NCT05093205|101529187|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
33447709|NCT05093205|101529188|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
33447710|NCT05093205|101529189|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
33447711|NCT05093205|101529190|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
33447712|NCT05093205|101529191|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
33447713|NCT05093205|101529192|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
33447714|NCT05093205|101529193|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
33447715|NCT05093205|101529194|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
33447716|NCT05093205|101529195|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
33447717|NCT05093205|101529196|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
33447718|NCT05093205|101529197|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
33447719|NCT05093205|101529185|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
33447720|NCT05093205|101529186|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
33447721|NCT05093205|101529187|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
33447722|NCT05093205|101529188|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
33447723|NCT05093205|101529189|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
33447724|NCT05093205|101529190|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
33447725|NCT05093205|101529191|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
33447726|NCT05093205|101529192|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
33447727|NCT05093205|101529193|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
33447728|NCT05093205|101529194|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
33447729|NCT05093205|101529195|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
33447730|NCT05093205|101529196|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
33447731|NCT05093205|101529197|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
33447732|NCT03276754|101529204|FG000|Overall Study|Withdrawal of informed consent|4|||
33447733|NCT03276754|101529204|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
33447734|NCT03276754|101529204|FG000|Overall Study|Lost to Follow-up|27|||
33447735|NCT03276754|101529204|FG000|Overall Study|No data reported at Month 24|31|||
33447736|NCT03276754|101529204|FG000|Overall Study|Death|39|||
33447737|NCT02849457|101529205|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
33447738|NCT02849457|101529206|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
33447739|NCT02849457|101529207|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
33447740|NCT02849457|101529208|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
33447741|NCT04123548|101529209|FG000|Overall Study|Withdrawal by Subject|1|||
33447742|NCT04123548|101529209|FG000|Overall Study|Lost to Follow-up|8|||
33447743|NCT04123548|101529209|FG000|Overall Study|Death|4|||
33447744|NCT04123548|101529209|FG000|Overall Study|Reason Not Specified|1|||
33447745|NCT00824291|101529210|FG000|Overall Study|Adverse Event|15|||
33447746|NCT00824291|101529211|FG001|Overall Study|Adverse Event|6|||
33447747|NCT00824291|101529210|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
33447748|NCT00824291|101529211|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
33447749|NCT00824291|101529210|FG000|Overall Study|Lost to Follow-up|11|||
33447750|NCT00824291|101529211|FG001|Overall Study|Lost to Follow-up|9|||
33447751|NCT00824291|101529210|FG000|Overall Study|Non-compliance|1|||
33447752|NCT00824291|101529211|FG001|Overall Study|Non-compliance|1|||
33447753|NCT00824291|101529210|FG000|Overall Study|Protocol Violation|4|||
33447754|NCT00824291|101529211|FG001|Overall Study|Protocol Violation|1|||
33447755|NCT00824291|101529210|FG000|Overall Study|Withdrawal by Subject|14|||
33447756|NCT00824291|101529211|FG001|Overall Study|Withdrawal by Subject|8|||
33447757|NCT00824291|101529210|FG000|Overall Study|Lack of Efficacy|7|||
33447758|NCT00824291|101529211|FG001|Overall Study|Lack of Efficacy|8|||
33447759|NCT00824291|101529210|FG000|Overall Study|Participant on prohibited medication|1|||
33447760|NCT00824291|101529211|FG001|Overall Study|Participant on prohibited medication|0|||
33447761|NCT04238754|101529216|FG000|Washout - 1 Week|Lost to Follow-up|1|||
33447762|NCT04238754|101529217|FG001|Washout - 1 Week|Lost to Follow-up|0|||
33447763|NCT02902211|101529225|FG000|First Three Months|Withdrawal by Subject|7|||
33447764|NCT02902211|101529226|FG001|First Three Months|Withdrawal by Subject|3|||
33447765|NCT01794845|101529229|FG000|Overall Study|Withdrawal by Subject|1|||
33447766|NCT00927069|101529237|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
33447767|NCT00927069|101529238|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
33447768|NCT00927069|101529239|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
33447769|NCT00927069|101529240|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
33447770|NCT00927069|101529237|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
33447771|NCT00927069|101529238|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
33447772|NCT00927069|101529239|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
33447773|NCT00927069|101529240|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
33447774|NCT00927069|101529237|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
33447775|NCT00927069|101529238|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
33447776|NCT00927069|101529239|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
33447777|NCT00927069|101529240|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
33447778|NCT00927069|101529237|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
33447779|NCT00927069|101529238|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
33447780|NCT00927069|101529239|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
33447781|NCT00927069|101529240|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
33447782|NCT00927069|101529237|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
33447783|NCT00927069|101529238|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
33447784|NCT00927069|101529239|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
33447785|NCT00927069|101529240|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
33447786|NCT01527006|101529244|FG000|Core Study|Adverse Event|0|||
33447787|NCT01527006|101529245|FG001|Core Study|Adverse Event|2|||
33447788|NCT01527006|101529244|FG000|Core Study|Lost to Follow-up|0|||
33447789|NCT01527006|101529245|FG001|Core Study|Lost to Follow-up|1|||
33447790|NCT01527006|101529244|FG000|Core Study|Subject Choice|1|||
33447791|NCT01527006|101529245|FG001|Core Study|Subject Choice|0|||
33447792|NCT01527006|101529244|FG000|Core Study|Inadequate Therapeutic Effect|1|||
33447793|NCT01527006|101529245|FG001|Core Study|Inadequate Therapeutic Effect|0|||
33447794|NCT01527006|101529244|FG000|Core Study|Withdrawal by Subject|0|||
33447795|NCT01527006|101529245|FG001|Core Study|Withdrawal by Subject|1|||
33447796|NCT01527006|101529244|FG000|Core Study|Other|0|||
33167421|NCT03129100|100521616|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33447797|NCT01527006|101529245|FG001|Core Study|Other|2|||
33447798|NCT01527006|101529244|FG000|Extension Phase|Adverse Event|4|||
33447799|NCT01527006|101529245|FG001|Extension Phase|Adverse Event|2|||
33447800|NCT01527006|101529244|FG000|Extension Phase|Lost to Follow-up|0|||
33447801|NCT01527006|101529245|FG001|Extension Phase|Lost to Follow-up|1|||
33447802|NCT01527006|101529244|FG000|Extension Phase|Subject Choice|1|||
33447803|NCT01527006|101529245|FG001|Extension Phase|Subject Choice|1|||
33447804|NCT01527006|101529244|FG000|Extension Phase|Inadequate therapeutic effect|1|||
33447805|NCT01527006|101529245|FG001|Extension Phase|Inadequate therapeutic effect|1|||
33447806|NCT01527006|101529244|FG000|Extension Phase|Other|0|||
33447807|NCT01527006|101529245|FG001|Extension Phase|Other|3|||
33447808|NCT00804856|101529252|FG000|Overall Study|Progressive Disease|3|||
33447809|NCT00804856|101529253|FG001|Overall Study|Progressive Disease|2|||
33447810|NCT00804856|101529254|FG002|Overall Study|Progressive Disease|4|||
33259750|NCT01307267|100853416|FG011|Overall Study|Withdrawal by Subject|1|||
33259751|NCT01307267|100853417|FG012|Overall Study|Withdrawal by Subject|0|||
33259752|NCT01307267|100853418|FG013|Overall Study|Withdrawal by Subject|0|||
33259753|NCT01307267|100853419|FG014|Overall Study|Withdrawal by Subject|0|||
33259754|NCT01307267|100853420|FG015|Overall Study|Withdrawal by Subject|0|||
33447811|NCT00804856|101529255|FG003|Overall Study|Progressive Disease|6|||
33447812|NCT00804856|101529256|FG004|Overall Study|Progressive Disease|4|||
33259755|NCT01307267|100853421|FG016|Overall Study|Withdrawal by Subject|0|||
33259756|NCT01307267|100853422|FG017|Overall Study|Withdrawal by Subject|0|||
33259757|NCT01307267|100853423|FG018|Overall Study|Withdrawal by Subject|0|||
33259758|NCT01307267|100853424|FG019|Overall Study|Withdrawal by Subject|3|||
33259759|NCT01307267|100853425|FG020|Overall Study|Withdrawal by Subject|0|||
33259760|NCT01307267|100853426|FG021|Overall Study|Withdrawal by Subject|0|||
33447813|NCT00804856|101529257|FG005|Overall Study|Progressive Disease|1|||
33447814|NCT00804856|101529258|FG006|Overall Study|Progressive Disease|8|||
33447815|NCT00804856|101529259|FG007|Overall Study|Progressive Disease|2|||
33447816|NCT00804856|101529260|FG008|Overall Study|Progressive Disease|4|||
33447817|NCT00804856|101529261|FG009|Overall Study|Progressive Disease|5|||
33447818|NCT00804856|101529262|FG010|Overall Study|Progressive Disease|12|||
33447819|NCT00804856|101529263|FG011|Overall Study|Progressive Disease|2|||
33447820|NCT00804856|101529264|FG012|Overall Study|Progressive Disease|2|||
33447821|NCT00804856|101529265|FG013|Overall Study|Progressive Disease|26|||
33447822|NCT00804856|101529266|FG014|Overall Study|Progressive Disease|20|||
33447823|NCT00804856|101529252|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33447824|NCT00804856|101529253|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33447825|NCT00804856|101529254|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33447826|NCT00804856|101529255|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33447827|NCT00804856|101529256|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
33447828|NCT00804856|101529257|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33259761|NCT01307267|100853427|FG022|Overall Study|Withdrawal by Subject|0|||
33259762|NCT01307267|100853405|FG000|Overall Study|Other|0|||
33259763|NCT01307267|100853406|FG001|Overall Study|Other|0|||
33259764|NCT01307267|100853407|FG002|Overall Study|Other|0|||
33259765|NCT01307267|100853408|FG003|Overall Study|Other|0|||
33259766|NCT01307267|100853409|FG004|Overall Study|Other|0|||
33447829|NCT00804856|101529258|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33447830|NCT00804856|101529259|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33447831|NCT00804856|101529260|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33447832|NCT00804856|101529261|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33447833|NCT00804856|101529262|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33447834|NCT00804856|101529263|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33447835|NCT00804856|101529264|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33259767|NCT01307267|100853410|FG005|Overall Study|Other|7|||
33259768|NCT01307267|100853411|FG006|Overall Study|Other|0|||
33447836|NCT00804856|101529265|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
33447837|NCT00804856|101529266|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
33259769|NCT01307267|100853412|FG007|Overall Study|Other|1|||
33447838|NCT00804856|101529252|FG000|Overall Study|Other Adverse Event|1|||
33167422|NCT03129100|100521617|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167423|NCT03129100|100521618|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167424|NCT03129100|100521619|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167425|NCT03129100|100521620|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167426|NCT03129100|100521621|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167427|NCT03129100|100521622|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167428|NCT03129100|100521623|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167429|NCT03129100|100521624|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167430|NCT03129100|100521625|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167431|NCT03129100|100521626|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167432|NCT03129100|100521627|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167433|NCT03129100|100521628|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167434|NCT03129100|100521629|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167435|NCT03129100|100521630|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167436|NCT03129100|100521631|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167437|NCT03129100|100521632|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167438|NCT03129100|100521633|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167439|NCT03129100|100521634|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167440|NCT03129100|100521635|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167441|NCT03129100|100521636|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167442|NCT03129100|100521637|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33167443|NCT03129100|100521638|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
33259770|NCT01307267|100853413|FG008|Overall Study|Other|3|||
33447839|NCT00804856|101529253|FG001|Overall Study|Other Adverse Event|1|||
33447840|NCT00804856|101529254|FG002|Overall Study|Other Adverse Event|1|||
33447841|NCT00804856|101529255|FG003|Overall Study|Other Adverse Event|2|||
33447842|NCT00804856|101529256|FG004|Overall Study|Other Adverse Event|2|||
33447843|NCT00804856|101529257|FG005|Overall Study|Other Adverse Event|1|||
33447844|NCT00804856|101529258|FG006|Overall Study|Other Adverse Event|3|||
33447845|NCT00804856|101529259|FG007|Overall Study|Other Adverse Event|0|||
33447846|NCT00804856|101529260|FG008|Overall Study|Other Adverse Event|0|||
33447847|NCT00804856|101529261|FG009|Overall Study|Other Adverse Event|1|||
33447848|NCT00804856|101529262|FG010|Overall Study|Other Adverse Event|5|||
33447849|NCT00804856|101529263|FG011|Overall Study|Other Adverse Event|2|||
33447850|NCT00804856|101529264|FG012|Overall Study|Other Adverse Event|0|||
33447851|NCT00804856|101529265|FG013|Overall Study|Other Adverse Event|6|||
33447852|NCT00804856|101529266|FG014|Overall Study|Other Adverse Event|13|||
33447853|NCT00804856|101529252|FG000|Overall Study|Non compliance with protocol|0|||
33447854|NCT00804856|101529253|FG001|Overall Study|Non compliance with protocol|0|||
33447855|NCT00804856|101529254|FG002|Overall Study|Non compliance with protocol|0|||
33447856|NCT00804856|101529255|FG003|Overall Study|Non compliance with protocol|0|||
33447857|NCT00804856|101529256|FG004|Overall Study|Non compliance with protocol|0|||
33447858|NCT00804856|101529257|FG005|Overall Study|Non compliance with protocol|0|||
33447859|NCT00804856|101529258|FG006|Overall Study|Non compliance with protocol|0|||
33447860|NCT00804856|101529259|FG007|Overall Study|Non compliance with protocol|0|||
33447861|NCT00804856|101529260|FG008|Overall Study|Non compliance with protocol|0|||
33447862|NCT00804856|101529261|FG009|Overall Study|Non compliance with protocol|0|||
33447863|NCT00804856|101529262|FG010|Overall Study|Non compliance with protocol|0|||
33447864|NCT00804856|101529263|FG011|Overall Study|Non compliance with protocol|0|||
33447865|NCT00804856|101529264|FG012|Overall Study|Non compliance with protocol|0|||
33447866|NCT00804856|101529265|FG013|Overall Study|Non compliance with protocol|2|||
33447867|NCT00804856|101529266|FG014|Overall Study|Non compliance with protocol|0|||
33447868|NCT00804856|101529252|FG000|Overall Study|Refused to continue medication|0|||
33447869|NCT00804856|101529253|FG001|Overall Study|Refused to continue medication|0|||
33447870|NCT00804856|101529254|FG002|Overall Study|Refused to continue medication|0|||
33447871|NCT00804856|101529255|FG003|Overall Study|Refused to continue medication|1|||
33447872|NCT00804856|101529256|FG004|Overall Study|Refused to continue medication|1|||
33447873|NCT00804856|101529257|FG005|Overall Study|Refused to continue medication|0|||
33167444|NCT03129100|100521613|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167445|NCT03129100|100521614|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167446|NCT03129100|100521615|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167447|NCT03129100|100521616|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167448|NCT03129100|100521617|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
33167449|NCT03129100|100521618|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
33167450|NCT03129100|100521619|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
33167451|NCT03129100|100521620|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167452|NCT03129100|100521621|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167453|NCT03129100|100521622|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167454|NCT03129100|100521623|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167455|NCT03129100|100521624|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167456|NCT03129100|100521625|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167457|NCT03129100|100521626|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167458|NCT03129100|100521627|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167459|NCT03129100|100521628|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167460|NCT03129100|100521629|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167461|NCT03129100|100521630|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167462|NCT03129100|100521631|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167463|NCT03129100|100521632|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167464|NCT03129100|100521633|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167465|NCT03129100|100521634|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167466|NCT03129100|100521635|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33447874|NCT00804856|101529258|FG006|Overall Study|Refused to continue medication|0|||
33447875|NCT00804856|101529259|FG007|Overall Study|Refused to continue medication|0|||
33447876|NCT00804856|101529260|FG008|Overall Study|Refused to continue medication|0|||
33447877|NCT00804856|101529261|FG009|Overall Study|Refused to continue medication|0|||
33167467|NCT03129100|100521636|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167468|NCT03129100|100521637|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167469|NCT03129100|100521638|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
33167470|NCT03129100|100521613|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167471|NCT03129100|100521614|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167472|NCT03129100|100521615|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167473|NCT03129100|100521616|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167474|NCT03129100|100521617|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167475|NCT03129100|100521618|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167476|NCT03129100|100521619|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167477|NCT03129100|100521620|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167478|NCT03129100|100521621|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167479|NCT03129100|100521622|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
33167480|NCT03129100|100521623|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167481|NCT03129100|100521624|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167482|NCT03129100|100521625|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167483|NCT03129100|100521626|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33447878|NCT00804856|101529262|FG010|Overall Study|Refused to continue medication|3|||
33167484|NCT03129100|100521627|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167485|NCT03129100|100521628|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167486|NCT03129100|100521629|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167487|NCT03129100|100521630|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167488|NCT03129100|100521631|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167489|NCT03129100|100521632|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33447879|NCT00804856|101529263|FG011|Overall Study|Refused to continue medication|0|||
33447880|NCT00804856|101529264|FG012|Overall Study|Refused to continue medication|1|||
33447881|NCT00804856|101529265|FG013|Overall Study|Refused to continue medication|1|||
33447882|NCT00804856|101529266|FG014|Overall Study|Refused to continue medication|5|||
33447883|NCT00804856|101529252|FG000|Overall Study|Other reason than listed above|0|||
33447884|NCT00804856|101529253|FG001|Overall Study|Other reason than listed above|0|||
33167490|NCT03129100|100521633|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167491|NCT03129100|100521634|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167492|NCT03129100|100521635|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167493|NCT03129100|100521636|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167494|NCT03129100|100521637|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167495|NCT03129100|100521638|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
33167496|NCT03129100|100521613|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167497|NCT03129100|100521614|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167498|NCT03129100|100521615|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167499|NCT03129100|100521616|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167500|NCT03129100|100521617|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167501|NCT03129100|100521618|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167502|NCT03129100|100521619|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167503|NCT03129100|100521620|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167504|NCT03129100|100521621|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167505|NCT03129100|100521622|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167506|NCT03129100|100521623|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167507|NCT03129100|100521624|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
33167508|NCT03129100|100521625|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33447885|NCT00804856|101529254|FG002|Overall Study|Other reason than listed above|0|||
33447886|NCT00804856|101529255|FG003|Overall Study|Other reason than listed above|0|||
33447887|NCT00804856|101529256|FG004|Overall Study|Other reason than listed above|0|||
33167509|NCT03129100|100521626|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33447888|NCT00804856|101529257|FG005|Overall Study|Other reason than listed above|1|||
33447889|NCT00804856|101529258|FG006|Overall Study|Other reason than listed above|0|||
33447890|NCT00804856|101529259|FG007|Overall Study|Other reason than listed above|0|||
33167510|NCT03129100|100521627|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167511|NCT03129100|100521628|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167512|NCT03129100|100521629|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167513|NCT03129100|100521630|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167514|NCT03129100|100521631|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167515|NCT03129100|100521632|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167516|NCT03129100|100521633|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167517|NCT03129100|100521634|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167518|NCT03129100|100521635|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167519|NCT03129100|100521636|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167520|NCT03129100|100521637|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167521|NCT03129100|100521638|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
33167522|NCT03129100|100521613|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167523|NCT03129100|100521614|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167524|NCT03129100|100521615|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167525|NCT03129100|100521616|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167526|NCT03129100|100521617|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167527|NCT03129100|100521618|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167528|NCT03129100|100521619|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167529|NCT03129100|100521620|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167530|NCT03129100|100521621|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33447891|NCT00804856|101529260|FG008|Overall Study|Other reason than listed above|1|||
33447892|NCT00804856|101529261|FG009|Overall Study|Other reason than listed above|0|||
33447893|NCT00804856|101529262|FG010|Overall Study|Other reason than listed above|3|||
33447894|NCT00804856|101529263|FG011|Overall Study|Other reason than listed above|1|||
33447895|NCT00804856|101529264|FG012|Overall Study|Other reason than listed above|1|||
33447896|NCT00804856|101529265|FG013|Overall Study|Other reason than listed above|10|||
33447897|NCT00804856|101529266|FG014|Overall Study|Other reason than listed above|3|||
33447898|NCT02186821|101529269|FG000|Overall Study|Adverse Event|9|||
33447899|NCT02186821|101529269|FG000|Overall Study|Death|2|||
33447900|NCT02186821|101529269|FG000|Overall Study|Disease progression|32|||
33447901|NCT02186821|101529269|FG000|Overall Study|Protocol Violation|1|||
33447902|NCT02186821|101529269|FG000|Overall Study|Physician Decision|1|||
33447903|NCT02186821|101529269|FG000|Overall Study|Study terminated by sponsor|2|||
33447904|NCT02890992|101529272|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
33447905|NCT02890992|101529273|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
33447906|NCT02890992|101529274|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
33447907|NCT02890992|101529275|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
33447908|NCT02890992|101529276|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
33447909|NCT02890992|101529277|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
33447910|NCT02890992|101529278|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
33447911|NCT02890992|101529279|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
33447912|NCT02890992|101529272|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
33447913|NCT02890992|101529273|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
33447914|NCT02890992|101529274|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
33447915|NCT02890992|101529275|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
33447916|NCT02890992|101529276|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
33447917|NCT02890992|101529277|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
33447918|NCT02890992|101529278|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
33447919|NCT02890992|101529279|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
33167531|NCT03129100|100521622|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167532|NCT03129100|100521623|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33447920|NCT02890992|101529272|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
33447921|NCT02890992|101529273|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
33447922|NCT02890992|101529274|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
33447923|NCT02890992|101529275|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
33447924|NCT02890992|101529276|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
33447925|NCT02890992|101529277|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
33447926|NCT02890992|101529278|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
33447927|NCT02890992|101529279|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
33259771|NCT01307267|100853414|FG009|Overall Study|Other|0|||
33259772|NCT01307267|100853415|FG010|Overall Study|Other|1|||
33259773|NCT01307267|100853416|FG011|Overall Study|Other|1|||
33259774|NCT01307267|100853417|FG012|Overall Study|Other|1|||
33259775|NCT01307267|100853418|FG013|Overall Study|Other|0|||
33259776|NCT01307267|100853419|FG014|Overall Study|Other|2|||
33259777|NCT01307267|100853420|FG015|Overall Study|Other|1|||
33259778|NCT01307267|100853421|FG016|Overall Study|Other|0|||
33259779|NCT01307267|100853422|FG017|Overall Study|Other|0|||
33259780|NCT01307267|100853423|FG018|Overall Study|Other|0|||
33259781|NCT01307267|100853424|FG019|Overall Study|Other|19|||
33259782|NCT01307267|100853425|FG020|Overall Study|Other|2|||
33259783|NCT01307267|100853426|FG021|Overall Study|Other|3|||
33259784|NCT01307267|100853427|FG022|Overall Study|Other|2|||
33259785|NCT02204982|100853428|FG000|Overall Study|Patient ineligible-medical monitor|1|||
33259786|NCT02204982|100853429|FG001|Overall Study|Patient ineligible-medical monitor|0|||
33259787|NCT02204982|100853428|FG000|Overall Study|Withdrawal by Subject|1|||
33259788|NCT02204982|100853429|FG001|Overall Study|Withdrawal by Subject|0|||
33259789|NCT02204982|100853428|FG000|Overall Study|Adverse Event|1|||
33259790|NCT02204982|100853429|FG001|Overall Study|Adverse Event|0|||
33259791|NCT02204982|100853428|FG000|Overall Study|Adverse Event and Investigator decision|1|||
33259792|NCT02204982|100853429|FG001|Overall Study|Adverse Event and Investigator decision|0|||
33259793|NCT02204982|100853428|FG000|Overall Study|Physician Decision|0|||
33447928|NCT02545283|101532502|FG000|Overall Study|Lost to Follow-up|2|||
33447929|NCT02545283|101532503|FG001|Overall Study|Lost to Follow-up|4|||
33447930|NCT02545283|101532502|FG000|Overall Study|Withdrawal by Subject|5|||
33447931|NCT02545283|101532503|FG001|Overall Study|Withdrawal by Subject|9|||
33447932|NCT02545283|101532502|FG000|Overall Study|Death|109|||
33447933|NCT02545283|101532503|FG001|Overall Study|Death|211|||
33447934|NCT02545283|101532502|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
33447935|NCT02545283|101532503|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
33447936|NCT02545283|101532502|FG000|Overall Study|Study Terminated By Sponsor|33|||
33447937|NCT02545283|101532503|FG001|Overall Study|Study Terminated By Sponsor|71|||
33447938|NCT03154047|101532504|FG000|Overall Study|Death|1|||
33447939|NCT03154047|101532504|FG000|Overall Study|Study terminated by sponsor|76|||
33167533|NCT03129100|100521624|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
33259794|NCT02204982|100853429|FG001|Overall Study|Physician Decision|2|||
33259795|NCT02204982|100853428|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
33259796|NCT02204982|100853429|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
33259797|NCT02204982|100853428|FG000|Overall Study|Termination of Study bySponsor|0|||
33259798|NCT02204982|100853429|FG001|Overall Study|Termination of Study bySponsor|1|||
33259799|NCT03287622|100853430|FG000|Overall Study|Withdrawal by Subject|1|||
33259800|NCT03287622|100853431|FG001|Overall Study|Withdrawal by Subject|0|||
33259801|NCT03287622|100853430|FG000|Overall Study|Lost to Follow-up|27|||
33259802|NCT03287622|100853431|FG001|Overall Study|Lost to Follow-up|15|||
33259803|NCT03287622|100853430|FG000|Overall Study|No prescripion after surgery|28|||
33259804|NCT03287622|100853431|FG001|Overall Study|No prescripion after surgery|31|||
33259805|NCT03287622|100853430|FG000|Overall Study|prolonged Length of stay|2|||
33259806|NCT03287622|100853431|FG001|Overall Study|prolonged Length of stay|0|||
33259807|NCT03287622|100853430|FG000|Overall Study|surgery related|0|||
33259808|NCT03287622|100853431|FG001|Overall Study|surgery related|2|||
33259809|NCT03345901|100853432|FG000|Overall Study|The study was terminated|18|||
33259810|NCT03544515|100853436|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
33259811|NCT03544515|100853437|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
33259812|NCT03544515|100853436|FG000|Overall Study|Lost to Follow-up|2|||
33259813|NCT03544515|100853437|FG001|Overall Study|Lost to Follow-up|0|||
33259814|NCT02724956|100853438|FG000|Overall Study|Physician Decision|1|||
33259815|NCT02724956|100853439|FG001|Overall Study|Physician Decision|0|||
33259816|NCT02724956|100853438|FG000|Overall Study|Lack of Efficacy|0|||
33259817|NCT02724956|100853439|FG001|Overall Study|Lack of Efficacy|1|||
33259818|NCT02724956|100853438|FG000|Overall Study|Withdrawal by Subject|0|||
33259819|NCT02724956|100853439|FG001|Overall Study|Withdrawal by Subject|1|||
33259820|NCT00031694|100853442|FG000|Overall Study|Adverse Event|12|||
33259821|NCT00031694|100853442|FG000|Overall Study|Death|2|||
33259822|NCT00031694|100853442|FG000|Overall Study|Withdrawal by Subject|5|||
33259823|NCT04093752|100853443|FG000|Overall Study|Adverse Event|7|||
33259824|NCT04093752|100853444|FG001|Overall Study|Adverse Event|19|||
33259825|NCT04093752|100853445|FG002|Overall Study|Adverse Event|18|||
33259826|NCT04093752|100853446|FG003|Overall Study|Adverse Event|4|||
33259827|NCT04093752|100853443|FG000|Overall Study|Withdrawal by Subject|6|||
33259828|NCT04093752|100853444|FG001|Overall Study|Withdrawal by Subject|6|||
33259829|NCT04093752|100853445|FG002|Overall Study|Withdrawal by Subject|8|||
33259830|NCT04093752|100853446|FG003|Overall Study|Withdrawal by Subject|20|||
33259831|NCT04093752|100853443|FG000|Overall Study|Lost to Follow-up|2|||
33259832|NCT04093752|100853444|FG001|Overall Study|Lost to Follow-up|1|||
33259833|NCT04093752|100853445|FG002|Overall Study|Lost to Follow-up|1|||
33259834|NCT04093752|100853446|FG003|Overall Study|Lost to Follow-up|1|||
33259835|NCT04093752|100853443|FG000|Overall Study|Death|0|||
33259836|NCT04093752|100853444|FG001|Overall Study|Death|0|||
33259837|NCT04093752|100853445|FG002|Overall Study|Death|1|||
33259838|NCT04093752|100853446|FG003|Overall Study|Death|2|||
33259839|NCT04093752|100853443|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
33259840|NCT04093752|100853444|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
33259841|NCT04093752|100853445|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
33259842|NCT04093752|100853446|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
33259843|NCT04093752|100853443|FG000|Overall Study|Covid 19|0|||
33259844|NCT04093752|100853444|FG001|Overall Study|Covid 19|0|||
33259845|NCT04093752|100853445|FG002|Overall Study|Covid 19|0|||
33259846|NCT04093752|100853446|FG003|Overall Study|Covid 19|1|||
33259847|NCT04093752|100853443|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
33259848|NCT04093752|100853444|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
33447940|NCT03154047|101532504|FG000|Overall Study|Withdrawal by Subject|3|||
33447941|NCT00003659|101532505|FG000|Overall Study|Withdrawal by Subject|3|||
33447942|NCT01948258|101532506|FG000|Overall Study|Pregnancy|41|||
33447943|NCT01948258|101532506|FG000|Overall Study|Did not complete by cut-off date|35|||
33447944|NCT01948258|101532506|FG000|Overall Study|Lost to Follow-up|27|||
33447945|NCT01948258|101532506|FG000|Overall Study|Withdrawal by SPD|8|||
33447946|NCT01948258|101532506|FG000|Overall Study|Withdrawal by Subject|6|||
33447947|NCT01948258|101532506|FG000|Overall Study|Health Care Professional|43|||
33447948|NCT01948258|101532506|FG000|Overall Study|Removed from statistical analysis|2|||
33447949|NCT00834418|101532507|FG000|Overall Study|Adverse Event|0|||
33447950|NCT00834418|101532508|FG001|Overall Study|Adverse Event|2|||
33447951|NCT00968812|101532509|FG000|Overall Study|Adverse Event|30|||
33447952|NCT00968812|101532510|FG001|Overall Study|Adverse Event|46|||
33447953|NCT00968812|101532511|FG002|Overall Study|Adverse Event|33|||
33447954|NCT00968812|101532509|FG000|Overall Study|Death|2|||
33447955|NCT00968812|101532510|FG001|Overall Study|Death|2|||
33259849|NCT04093752|100853445|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
33259850|NCT04093752|100853446|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
33259851|NCT04093752|100853443|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
33259852|NCT04093752|100853444|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
33259853|NCT04093752|100853445|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
33259854|NCT04093752|100853446|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
33447956|NCT00968812|101532511|FG002|Overall Study|Death|1|||
33447957|NCT00968812|101532509|FG000|Overall Study|Lack of Efficacy|9|||
33447958|NCT00968812|101532510|FG001|Overall Study|Lack of Efficacy|7|||
33447959|NCT00968812|101532511|FG002|Overall Study|Lack of Efficacy|16|||
33447960|NCT00968812|101532509|FG000|Overall Study|Lost to Follow-up|17|||
33447961|NCT00968812|101532510|FG001|Overall Study|Lost to Follow-up|12|||
33447962|NCT00968812|101532511|FG002|Overall Study|Lost to Follow-up|11|||
33447963|NCT00968812|101532509|FG000|Overall Study|Physician Decision|8|||
33447964|NCT00968812|101532510|FG001|Overall Study|Physician Decision|5|||
33447965|NCT00968812|101532511|FG002|Overall Study|Physician Decision|9|||
33447966|NCT00968812|101532509|FG000|Overall Study|Protocol Violation|7|||
33447967|NCT00968812|101532510|FG001|Overall Study|Protocol Violation|4|||
33447968|NCT00968812|101532511|FG002|Overall Study|Protocol Violation|3|||
33447969|NCT00968812|101532509|FG000|Overall Study|Withdrawal by Subject|17|||
33447970|NCT00968812|101532510|FG001|Overall Study|Withdrawal by Subject|23|||
33447971|NCT00968812|101532511|FG002|Overall Study|Withdrawal by Subject|25|||
33447972|NCT00968812|101532509|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
33447973|NCT00968812|101532510|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
33447974|NCT00968812|101532511|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
33447975|NCT00968812|101532509|FG000|Overall Study|Noncompliance with study drug|4|||
33447976|NCT00968812|101532510|FG001|Overall Study|Noncompliance with study drug|1|||
33447977|NCT00968812|101532511|FG002|Overall Study|Noncompliance with study drug|6|||
33447978|NCT00968812|101532509|FG000|Overall Study|Unable to take rescue therapy|12|||
33447979|NCT00968812|101532510|FG001|Overall Study|Unable to take rescue therapy|12|||
33447980|NCT00968812|101532511|FG002|Overall Study|Unable to take rescue therapy|17|||
33447981|NCT00968812|101532509|FG000|Overall Study|Other|25|||
33447982|NCT00968812|101532510|FG001|Overall Study|Other|37|||
33447983|NCT00968812|101532511|FG002|Overall Study|Other|40|||
33447984|NCT00112463|101532512|FG000|Overall Study|Physician Decision|1|||
33447985|NCT00112463|101532512|FG000|Overall Study|Progression|30|||
33447986|NCT00112463|101532512|FG000|Overall Study|Second Primary|1|||
33447987|NCT00112463|101532512|FG000|Overall Study|Toxicity|3|||
33447988|NCT00112463|101532512|FG000|Overall Study|Withdrawal by Subject|2|||
33447989|NCT00112463|101532512|FG000|Overall Study|Never started treatment|2|||
33447990|NCT01415986|101532515|FG000|Overall Study|Lost to Follow-up|1|||
33447991|NCT00272779|101532520|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
33447992|NCT00272779|101532521|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
33447993|NCT00272779|101532520|FG000|Baseline Through Week 48|Death before Week 48|4|||
33447994|NCT00272779|101532521|FG001|Baseline Through Week 48|Death before Week 48|4|||
33447995|NCT00272779|101532520|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
33447996|NCT00272779|101532521|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
33447997|NCT00272779|101532520|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
33447998|NCT00272779|101532521|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
33447999|NCT00272779|101532520|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
33448000|NCT00272779|101532521|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
33448001|NCT00272779|101532520|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
33448002|NCT00272779|101532521|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
33448003|NCT00272779|101532520|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
33448004|NCT00272779|101532521|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
33448005|NCT00272779|101532520|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
33448006|NCT00272779|101532521|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
33448007|NCT00272779|101532520|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
33448008|NCT00272779|101532521|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
33448009|NCT00272779|101532520|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
33448010|NCT00272779|101532521|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
33167534|NCT03129100|100521625|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
33167535|NCT03129100|100521626|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
33167536|NCT03129100|100521627|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
33259855|NCT04093752|100853443|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
33448011|NCT00272779|101532520|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
33448012|NCT00272779|101532521|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
33448013|NCT00272779|101532520|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
33448014|NCT00272779|101532521|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
33448015|NCT00272779|101532520|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
33448016|NCT00272779|101532521|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
33448017|NCT00272779|101532520|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
33448018|NCT00272779|101532521|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
33448019|NCT00272779|101532520|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
33448020|NCT00272779|101532521|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
33259856|NCT04093752|100853444|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
33448021|NCT00272779|101532520|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
33448022|NCT00272779|101532521|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
33448023|NCT00272779|101532520|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
33448024|NCT00272779|101532521|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
33448025|NCT00272779|101532520|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
33448026|NCT00272779|101532521|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
33448027|NCT00272779|101532520|FG000|Baseline Through Week 48|Continuing treatment|385|||
33448028|NCT00272779|101532521|FG001|Baseline Through Week 48|Continuing treatment|368|||
33448029|NCT00272779|101532520|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
33448030|NCT00272779|101532521|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
33448031|NCT00272779|101532520|FG000|Baseline Through Week 48|Never treated|2|||
33448032|NCT00272779|101532521|FG001|Baseline Through Week 48|Never treated|3|||
33448033|NCT00272779|101532520|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
33448034|NCT00272779|101532521|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
33448035|NCT00272779|101532520|FG000|Baseline Through Week 96|Death before Week 96|6|||
33448036|NCT00272779|101532521|FG001|Baseline Through Week 96|Death before Week 96|5|||
33448037|NCT00272779|101532520|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
33448038|NCT00272779|101532521|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
33448039|NCT00272779|101532520|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
33448040|NCT00272779|101532521|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
33448041|NCT00272779|101532520|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
33448042|NCT00272779|101532521|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
33448043|NCT00272779|101532520|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
33448044|NCT00272779|101532521|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
33448045|NCT00272779|101532520|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
33448046|NCT00272779|101532521|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
33448047|NCT00272779|101532520|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
33448048|NCT00272779|101532521|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
33448049|NCT00272779|101532520|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
33448050|NCT00272779|101532521|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
33448051|NCT00272779|101532520|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
33448052|NCT00272779|101532521|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
33448053|NCT00272779|101532520|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
33448054|NCT00272779|101532521|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
33448055|NCT00272779|101532520|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
33448056|NCT00272779|101532521|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
33448057|NCT00272779|101532520|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
33448058|NCT00272779|101532521|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
33448059|NCT00272779|101532520|FG000|Baseline Through Week 96|Never treated|2|||
33448060|NCT00272779|101532521|FG001|Baseline Through Week 96|Never treated|3|||
33448061|NCT00272779|101532520|FG000|Baseline Through Week 96|Continuing on treatment|61|||
33448062|NCT00272779|101532521|FG001|Baseline Through Week 96|Continuing on treatment|38|||
33448063|NCT00840073|101532535|FG000|Second Intervention|Missed 72 hour blood draw|1|||
33448064|NCT00840073|101532536|FG001|Second Intervention|Missed 72 hour blood draw|1|||
33448065|NCT04194801|101532540|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
33448066|NCT04194801|101532541|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
33448067|NCT04194801|101532542|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
33448068|NCT04194801|101532540|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
33448069|NCT04194801|101532541|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
33448070|NCT04194801|101532542|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
33448071|NCT04194801|101532540|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
33448072|NCT04194801|101532541|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
33448073|NCT04194801|101532542|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
33448074|NCT04194801|101532540|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
33448075|NCT04194801|101532541|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
33448076|NCT04194801|101532542|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
33448077|NCT04194801|101532540|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
33448078|NCT04194801|101532541|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
33448079|NCT04194801|101532542|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
33448080|NCT04194801|101532540|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
33448081|NCT04194801|101532541|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
33448082|NCT04194801|101532542|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
33448083|NCT04194801|101532540|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
33448084|NCT04194801|101532541|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
33448085|NCT04194801|101532542|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
33448086|NCT04194801|101532540|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
33448087|NCT04194801|101532541|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
33448088|NCT04194801|101532542|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
33448089|NCT04194801|101532540|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
33448090|NCT04194801|101532541|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
33448091|NCT04194801|101532542|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
33448092|NCT04194801|101532540|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
33448093|NCT04194801|101532541|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
33448094|NCT04194801|101532542|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
33448095|NCT04194801|101532540|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
33448096|NCT04194801|101532541|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
33448097|NCT04194801|101532542|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
33167537|NCT03129100|100521628|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167538|NCT03129100|100521629|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33448098|NCT04194801|101532540|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
33448099|NCT04194801|101532541|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
33448100|NCT04194801|101532542|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
33448101|NCT04194801|101532540|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
33448102|NCT04194801|101532541|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
33448103|NCT04194801|101532542|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
33448104|NCT04194801|101532540|FG000|Part Ib/II End of Study|Death|2|||
33448105|NCT04194801|101532541|FG001|Part Ib/II End of Study|Death|3|||
33448106|NCT04194801|101532542|FG002|Part Ib/II End of Study|Death|3|||
33448107|NCT04194801|101532540|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
33448108|NCT04194801|101532541|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
33448109|NCT04194801|101532542|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
33448110|NCT04194801|101532540|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
33448111|NCT04194801|101532541|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
33448112|NCT04194801|101532542|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
33448113|NCT04194801|101532540|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
33448114|NCT04194801|101532541|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
33448115|NCT04194801|101532542|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
33448116|NCT04194801|101532540|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
33448117|NCT04194801|101532541|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
33448118|NCT04194801|101532542|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
33448119|NCT01926119|101532543|FG000|Overall Study|Withdrawal by Subject|1|||
33448120|NCT00477594|101532544|FG000|Year 1 and Year 2|Adverse Event|4|||
33448121|NCT00477594|101532545|FG001|Year 1 and Year 2|Adverse Event|2|||
33448122|NCT00477594|101532544|FG000|Year 1 and Year 2|Physician Decision|2|||
33448123|NCT00477594|101532545|FG001|Year 1 and Year 2|Physician Decision|1|||
33448124|NCT00477594|101532544|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
33448125|NCT00477594|101532545|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
33448126|NCT00477594|101532544|FG000|Year 1 and Year 2|Other|1|||
33448127|NCT00477594|101532545|FG001|Year 1 and Year 2|Other|0|||
33448128|NCT00477594|101532544|FG000|Year 3|Adverse Event|1|||
33448129|NCT00477594|101532545|FG001|Year 3|Adverse Event|0|||
33448130|NCT00477594|101532544|FG000|Year 3|Withdrawal by Subject|1|||
33448131|NCT00477594|101532545|FG001|Year 3|Withdrawal by Subject|0|||
33448132|NCT00477594|101532544|FG000|Follow-up Period|Withdrawal by Subject|2|||
33448133|NCT00477594|101532545|FG001|Follow-up Period|Withdrawal by Subject|1|||
33448134|NCT00477594|101532544|FG000|Follow-up Period|Other|1|||
33448135|NCT00477594|101532545|FG001|Follow-up Period|Other|0|||
33448136|NCT00829764|101532546|FG000|First Intervention|Adverse Event|1|||
33448137|NCT00829764|101532547|FG001|First Intervention|Adverse Event|0|||
33448138|NCT00829764|101532546|FG000|First Intervention|Withdrawal by Subject|1|||
33448139|NCT00829764|101532547|FG001|First Intervention|Withdrawal by Subject|1|||
33448140|NCT00556322|101532548|FG000|Overall Study|Insufficient therapeutic response|158|||
33448141|NCT00556322|101532549|FG001|Overall Study|Insufficient therapeutic response|168|||
33448142|NCT00556322|101532548|FG000|Overall Study|Adverse Event|7|||
33448143|NCT00556322|101532549|FG001|Overall Study|Adverse Event|4|||
33448144|NCT00556322|101532548|FG000|Overall Study|Other|4|||
33448145|NCT00556322|101532549|FG001|Overall Study|Other|1|||
33448146|NCT00556322|101532548|FG000|Overall Study|Lost to Follow-up|5|||
33448147|NCT00556322|101532549|FG001|Overall Study|Lost to Follow-up|3|||
33448148|NCT00556322|101532548|FG000|Overall Study|Withdrawal by Subject|19|||
33448149|NCT00556322|101532549|FG001|Overall Study|Withdrawal by Subject|7|||
33448150|NCT00556322|101532548|FG000|Overall Study|Protocol Violation|5|||
33448151|NCT00556322|101532549|FG001|Overall Study|Protocol Violation|1|||
33448152|NCT00556322|101532548|FG000|Overall Study|Ongoing at data cutoff|3|||
33448153|NCT00556322|101532549|FG001|Overall Study|Ongoing at data cutoff|5|||
33448154|NCT00556322|101532548|FG000|Overall Study|Death|20|||
33448155|NCT00556322|101532549|FG001|Overall Study|Death|14|||
33448156|NCT00147498|101532550|FG000|Overall Study|Adverse Event|1|||
33448157|NCT00147498|101532551|FG001|Overall Study|Adverse Event|6|||
33448158|NCT00147498|101532552|FG002|Overall Study|Adverse Event|7|||
33448159|NCT00147498|101532553|FG003|Overall Study|Adverse Event|3|||
33448160|NCT00147498|101532550|FG000|Overall Study|Lack of Efficacy|1|||
33448161|NCT00147498|101532551|FG001|Overall Study|Lack of Efficacy|1|||
33448162|NCT00147498|101532552|FG002|Overall Study|Lack of Efficacy|1|||
33259857|NCT04093752|100853445|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
33448163|NCT00147498|101532553|FG003|Overall Study|Lack of Efficacy|8|||
33448164|NCT00147498|101532550|FG000|Overall Study|Laboratory abnormality|0|||
33448165|NCT00147498|101532551|FG001|Overall Study|Laboratory abnormality|0|||
33448166|NCT00147498|101532552|FG002|Overall Study|Laboratory abnormality|2|||
33448167|NCT00147498|101532553|FG003|Overall Study|Laboratory abnormality|0|||
33448168|NCT00147498|101532550|FG000|Overall Study|Participant defaulted|0|||
33448169|NCT00147498|101532551|FG001|Overall Study|Participant defaulted|1|||
33448170|NCT00147498|101532552|FG002|Overall Study|Participant defaulted|4|||
33448171|NCT00147498|101532553|FG003|Overall Study|Participant defaulted|3|||
33448172|NCT00147498|101532550|FG000|Overall Study|Other|1|||
33448173|NCT00147498|101532551|FG001|Overall Study|Other|1|||
33448174|NCT00147498|101532552|FG002|Overall Study|Other|3|||
33448175|NCT00147498|101532553|FG003|Overall Study|Other|3|||
33448176|NCT00723710|101532554|FG000|Overall Study|Disease progression|48|||
33448177|NCT00723710|101532554|FG000|Overall Study|Adverse Event|88|||
33448178|NCT00723710|101532554|FG000|Overall Study|Withdrawal by Subject|36|||
33448179|NCT00723710|101532554|FG000|Overall Study|Physician Decision|2|||
33448180|NCT03803774|101532557|FG000|Dose Escalation|Withdrawal by Subject|0|||
33448181|NCT03803774|101532558|FG001|Dose Escalation|Withdrawal by Subject|0|||
33448182|NCT03803774|101532559|FG002|Dose Escalation|Withdrawal by Subject|0|||
33448183|NCT03803774|101532560|FG003|Dose Escalation|Withdrawal by Subject|1|||
33448184|NCT03803774|101532561|FG004|Dose Escalation|Withdrawal by Subject|0|||
33448185|NCT00678639|101532562|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
33448186|NCT00678639|101532563|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
33448187|NCT00834743|101532564|FG000|Second Intervention|Withdrawal by Subject|1|||
33448188|NCT00834743|101532565|FG001|Second Intervention|Withdrawal by Subject|0|||
33448189|NCT00123734|101532566|FG000|Overall Study|Death|3|||
33448190|NCT00123734|101532566|FG000|Overall Study|Lost to Follow-up|3|||
33448191|NCT00123734|101532566|FG000|Overall Study|Dropout|1|||
33448192|NCT00123734|101532566|FG000|Overall Study|Withdrawal by Subject|1|||
33448193|NCT00561015|101532569|FG000|Overall Study|Adverse Event|0|||
33448194|NCT00561015|101532570|FG001|Overall Study|Adverse Event|0|||
33448195|NCT00561015|101532571|FG002|Overall Study|Adverse Event|0|||
33448196|NCT00561015|101532572|FG003|Overall Study|Adverse Event|0|||
33448197|NCT00561015|101532573|FG004|Overall Study|Adverse Event|1|||
33448198|NCT00561015|101532574|FG005|Overall Study|Adverse Event|0|||
33448199|NCT00561015|101532569|FG000|Overall Study|Lost to Follow-up|2|||
33448200|NCT00561015|101532570|FG001|Overall Study|Lost to Follow-up|0|||
33448201|NCT00561015|101532571|FG002|Overall Study|Lost to Follow-up|0|||
33448202|NCT00561015|101532572|FG003|Overall Study|Lost to Follow-up|1|||
33448203|NCT00561015|101532573|FG004|Overall Study|Lost to Follow-up|0|||
33448204|NCT00561015|101532574|FG005|Overall Study|Lost to Follow-up|3|||
33448205|NCT00561015|101532569|FG000|Overall Study|Participant non-compliance|2|||
33448206|NCT00561015|101532570|FG001|Overall Study|Participant non-compliance|0|||
33448207|NCT00561015|101532571|FG002|Overall Study|Participant non-compliance|0|||
33448208|NCT00561015|101532572|FG003|Overall Study|Participant non-compliance|0|||
33448209|NCT00561015|101532573|FG004|Overall Study|Participant non-compliance|0|||
33448210|NCT00561015|101532574|FG005|Overall Study|Participant non-compliance|0|||
33448211|NCT02281084|101532575|FG000|Overall Study|Death|21|||
33448212|NCT02281084|101532576|FG001|Overall Study|Death|18|||
33448213|NCT02281084|101532577|FG002|Overall Study|Death|3|||
33448214|NCT02281084|101532578|FG003|Overall Study|Death|5|||
33448215|NCT02281084|101532575|FG000|Overall Study|Adverse Event|1|||
33448216|NCT02281084|101532576|FG001|Overall Study|Adverse Event|0|||
33448217|NCT02281084|101532577|FG002|Overall Study|Adverse Event|0|||
33448218|NCT02281084|101532578|FG003|Overall Study|Adverse Event|0|||
33448219|NCT02281084|101532575|FG000|Overall Study|Withdrawal by Subject|2|||
33448220|NCT02281084|101532576|FG001|Overall Study|Withdrawal by Subject|2|||
33448221|NCT02281084|101532577|FG002|Overall Study|Withdrawal by Subject|0|||
33448222|NCT02281084|101532578|FG003|Overall Study|Withdrawal by Subject|0|||
33448223|NCT02281084|101532575|FG000|Overall Study|Site Closure by Sponsor|5|||
33448224|NCT02281084|101532576|FG001|Overall Study|Site Closure by Sponsor|1|||
33448225|NCT02281084|101532577|FG002|Overall Study|Site Closure by Sponsor|2|||
33448226|NCT02281084|101532578|FG003|Overall Study|Site Closure by Sponsor|0|||
33448227|NCT00905606|101532580|FG000|Period 1|Adverse Event|0|||
33448228|NCT00905606|101532581|FG001|Period 1|Adverse Event|1|||
33448229|NCT00905606|101532580|FG000|Washout|Withdrawal by Subject|1|||
33448230|NCT00905606|101532581|FG001|Washout|Withdrawal by Subject|0|||
33448231|NCT02601560|101532584|FG000|Overall Study|Other|0|||
33448232|NCT02601560|101532585|FG001|Overall Study|Other|0|||
33448233|NCT02601560|101532586|FG002|Overall Study|Other|0|||
33448234|NCT02601560|101532587|FG003|Overall Study|Other|0|||
33448235|NCT02601560|101532588|FG004|Overall Study|Other|0|||
33448236|NCT02601560|101532589|FG005|Overall Study|Other|0|||
33448237|NCT02601560|101532590|FG006|Overall Study|Other|1|||
33448238|NCT02601560|101532591|FG007|Overall Study|Other|0|||
33448239|NCT01247701|101532592|FG000|Overall Study|Death|2|||
33448240|NCT01247701|101532592|FG000|Overall Study|Relapsed|8|||
33448241|NCT01911676|101532593|FG000|Period 1 of Study|Withdrawal by Subject|4|||
33448242|NCT01911676|101532594|FG001|Period 1 of Study|Withdrawal by Subject|2|||
33448243|NCT01911676|101532595|FG002|Period 1 of Study|Withdrawal by Subject|1|||
33448244|NCT01911676|101532596|FG003|Period 1 of Study|Withdrawal by Subject|2|||
33448245|NCT01911676|101532593|FG000|Period 1 of Study|Physician Decision|2|||
33448246|NCT01911676|101532594|FG001|Period 1 of Study|Physician Decision|0|||
33448247|NCT01911676|101532595|FG002|Period 1 of Study|Physician Decision|0|||
33448248|NCT01911676|101532596|FG003|Period 1 of Study|Physician Decision|1|||
33448249|NCT01911676|101532593|FG000|Period 2 of Study|Physician Decision|2|||
33448250|NCT01911676|101532594|FG001|Period 2 of Study|Physician Decision|0|||
33448251|NCT01911676|101532595|FG002|Period 2 of Study|Physician Decision|0|||
33448252|NCT01911676|101532596|FG003|Period 2 of Study|Physician Decision|1|||
33448253|NCT01911676|101532593|FG000|Period 2 of Study|Lost to Follow-up|0|||
33448254|NCT01911676|101532594|FG001|Period 2 of Study|Lost to Follow-up|0|||
33448255|NCT01911676|101532595|FG002|Period 2 of Study|Lost to Follow-up|0|||
33448256|NCT01911676|101532596|FG003|Period 2 of Study|Lost to Follow-up|1|||
33448257|NCT00834249|101532597|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
33448258|NCT00834249|101532598|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
33448259|NCT00834249|101532597|FG000|Second Intervention|Adverse Event|1|||
33448260|NCT00834249|101532598|FG001|Second Intervention|Adverse Event|0|||
33448261|NCT01725529|101532599|FG000|Overall Study|Adverse Event|1|||
33448262|NCT01725529|101532600|FG001|Overall Study|Adverse Event|0|||
33448263|NCT01725529|101532601|FG002|Overall Study|Adverse Event|0|||
33448264|NCT01725529|101532599|FG000|Overall Study|Lost to Follow-up|2|||
33448265|NCT01725529|101532600|FG001|Overall Study|Lost to Follow-up|1|||
33448266|NCT01725529|101532601|FG002|Overall Study|Lost to Follow-up|1|||
33448267|NCT01725529|101532599|FG000|Overall Study|Protocol Violation|0|||
33448268|NCT01725529|101532600|FG001|Overall Study|Protocol Violation|1|||
33448269|NCT01725529|101532601|FG002|Overall Study|Protocol Violation|1|||
33448270|NCT01725529|101532599|FG000|Overall Study|Withdrawal by Subject|12|||
33448271|NCT01725529|101532600|FG001|Overall Study|Withdrawal by Subject|14|||
33448272|NCT01725529|101532601|FG002|Overall Study|Withdrawal by Subject|8|||
33448273|NCT00906399|101532606|FG000|Year 1|Randomized But Not Treated|0|||
33448274|NCT00906399|101532607|FG001|Year 1|Randomized But Not Treated|1|||
33448275|NCT00906399|101532608|FG002|Year 1|Randomized But Not Treated|3|||
33448276|NCT00906399|101532609|FG003|Year 1|Randomized But Not Treated|0|||
33448277|NCT00906399|101532610|FG004|Year 1|Randomized But Not Treated|0|||
33448278|NCT00906399|101532611|FG005|Year 1|Randomized But Not Treated|0|||
33448279|NCT00906399|101532612|FG006|Year 1|Randomized But Not Treated|0|||
33448280|NCT00906399|101532606|FG000|Year 1|Adverse Event|4|||
33448281|NCT00906399|101532607|FG001|Year 1|Adverse Event|22|||
33448282|NCT00906399|101532608|FG002|Year 1|Adverse Event|24|||
33448283|NCT00906399|101532609|FG003|Year 1|Adverse Event|0|||
33448284|NCT00906399|101532610|FG004|Year 1|Adverse Event|0|||
33448285|NCT00906399|101532611|FG005|Year 1|Adverse Event|0|||
33448286|NCT00906399|101532612|FG006|Year 1|Adverse Event|0|||
33448287|NCT00906399|101532606|FG000|Year 1|Lost to Follow-up|4|||
33448288|NCT00906399|101532607|FG001|Year 1|Lost to Follow-up|4|||
33448289|NCT00906399|101532608|FG002|Year 1|Lost to Follow-up|2|||
33448290|NCT00906399|101532609|FG003|Year 1|Lost to Follow-up|0|||
33448291|NCT00906399|101532610|FG004|Year 1|Lost to Follow-up|0|||
33448292|NCT00906399|101532611|FG005|Year 1|Lost to Follow-up|0|||
33448293|NCT00906399|101532612|FG006|Year 1|Lost to Follow-up|0|||
33448294|NCT00906399|101532606|FG000|Year 1|Withdrawal by Subject|30|||
33448295|NCT00906399|101532607|FG001|Year 1|Withdrawal by Subject|32|||
33448296|NCT00906399|101532608|FG002|Year 1|Withdrawal by Subject|36|||
33448297|NCT00906399|101532609|FG003|Year 1|Withdrawal by Subject|0|||
33448298|NCT00906399|101532610|FG004|Year 1|Withdrawal by Subject|0|||
33448299|NCT00906399|101532611|FG005|Year 1|Withdrawal by Subject|0|||
33448300|NCT00906399|101532612|FG006|Year 1|Withdrawal by Subject|0|||
33448301|NCT00906399|101532606|FG000|Year 1|Physician Decision|0|||
33448302|NCT00906399|101532607|FG001|Year 1|Physician Decision|1|||
33448303|NCT00906399|101532608|FG002|Year 1|Physician Decision|3|||
33448304|NCT00906399|101532609|FG003|Year 1|Physician Decision|0|||
33448305|NCT00906399|101532610|FG004|Year 1|Physician Decision|0|||
33448306|NCT00906399|101532611|FG005|Year 1|Physician Decision|0|||
33448307|NCT00906399|101532612|FG006|Year 1|Physician Decision|0|||
33448308|NCT00906399|101532606|FG000|Year 1|Death|2|||
33448309|NCT00906399|101532607|FG001|Year 1|Death|1|||
33448310|NCT00906399|101532608|FG002|Year 1|Death|1|||
33448311|NCT00906399|101532609|FG003|Year 1|Death|0|||
33448312|NCT00906399|101532610|FG004|Year 1|Death|0|||
33448313|NCT00906399|101532611|FG005|Year 1|Death|0|||
33448314|NCT00906399|101532612|FG006|Year 1|Death|0|||
33448315|NCT00906399|101532606|FG000|Year 1|Other|4|||
33448316|NCT00906399|101532607|FG001|Year 1|Other|2|||
33448317|NCT00906399|101532608|FG002|Year 1|Other|7|||
33448318|NCT00906399|101532609|FG003|Year 1|Other|0|||
33448319|NCT00906399|101532610|FG004|Year 1|Other|0|||
33448320|NCT00906399|101532611|FG005|Year 1|Other|0|||
33448321|NCT00906399|101532612|FG006|Year 1|Other|0|||
33448322|NCT00906399|101532606|FG000|Year 2|Adverse Event|0|||
33448323|NCT00906399|101532607|FG001|Year 2|Adverse Event|0|||
33448324|NCT00906399|101532608|FG002|Year 2|Adverse Event|0|||
33448325|NCT00906399|101532609|FG003|Year 2|Adverse Event|9|||
33167539|NCT03129100|100521630|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167540|NCT03129100|100521631|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167541|NCT03129100|100521632|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167542|NCT03129100|100521633|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167543|NCT03129100|100521634|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167544|NCT03129100|100521635|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33448326|NCT00906399|101532610|FG004|Year 2|Adverse Event|8|||
33448327|NCT00906399|101532611|FG005|Year 2|Adverse Event|11|||
33448328|NCT00906399|101532612|FG006|Year 2|Adverse Event|6|||
33448329|NCT00906399|101532606|FG000|Year 2|Lost to Follow-up|0|||
33448330|NCT00906399|101532607|FG001|Year 2|Lost to Follow-up|0|||
33448331|NCT00906399|101532608|FG002|Year 2|Lost to Follow-up|0|||
33448332|NCT00906399|101532609|FG003|Year 2|Lost to Follow-up|1|||
33448333|NCT00906399|101532610|FG004|Year 2|Lost to Follow-up|4|||
33448334|NCT00906399|101532611|FG005|Year 2|Lost to Follow-up|2|||
33448335|NCT00906399|101532612|FG006|Year 2|Lost to Follow-up|4|||
33448336|NCT00906399|101532606|FG000|Year 2|Withdrawal by Subject|0|||
33448337|NCT00906399|101532607|FG001|Year 2|Withdrawal by Subject|0|||
33167545|NCT03129100|100521636|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167546|NCT03129100|100521637|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167547|NCT03129100|100521638|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
33167548|NCT03129100|100521613|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167549|NCT03129100|100521614|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167550|NCT03129100|100521615|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167551|NCT03129100|100521616|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167552|NCT03129100|100521617|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167553|NCT03129100|100521618|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167554|NCT03129100|100521619|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167555|NCT03129100|100521620|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167556|NCT03129100|100521621|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167557|NCT03129100|100521622|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167558|NCT03129100|100521623|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167559|NCT03129100|100521624|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
33167560|NCT03129100|100521625|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167561|NCT03129100|100521626|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
33167562|NCT03129100|100521627|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
33167563|NCT03129100|100521628|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167564|NCT03129100|100521629|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33448338|NCT00906399|101532608|FG002|Year 2|Withdrawal by Subject|0|||
33448339|NCT00906399|101532609|FG003|Year 2|Withdrawal by Subject|17|||
33448340|NCT00906399|101532610|FG004|Year 2|Withdrawal by Subject|18|||
33448341|NCT00906399|101532611|FG005|Year 2|Withdrawal by Subject|27|||
33448342|NCT00906399|101532612|FG006|Year 2|Withdrawal by Subject|13|||
33448343|NCT00906399|101532606|FG000|Year 2|Physician Decision|0|||
33448344|NCT00906399|101532607|FG001|Year 2|Physician Decision|0|||
33448345|NCT00906399|101532608|FG002|Year 2|Physician Decision|0|||
33448346|NCT00906399|101532609|FG003|Year 2|Physician Decision|0|||
33448347|NCT00906399|101532610|FG004|Year 2|Physician Decision|2|||
33448348|NCT00906399|101532611|FG005|Year 2|Physician Decision|6|||
33448349|NCT00906399|101532612|FG006|Year 2|Physician Decision|3|||
33448350|NCT00906399|101532606|FG000|Year 2|Death|0|||
33448351|NCT00906399|101532607|FG001|Year 2|Death|0|||
33167565|NCT03129100|100521630|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167566|NCT03129100|100521631|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167567|NCT03129100|100521632|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167568|NCT03129100|100521633|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167569|NCT03129100|100521634|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33448352|NCT00906399|101532608|FG002|Year 2|Death|0|||
33448353|NCT00906399|101532609|FG003|Year 2|Death|1|||
33448354|NCT00906399|101532610|FG004|Year 2|Death|0|||
33448355|NCT00906399|101532611|FG005|Year 2|Death|0|||
33448356|NCT00906399|101532612|FG006|Year 2|Death|3|||
33448357|NCT00906399|101532606|FG000|Year 2|Other|0|||
33448358|NCT00906399|101532607|FG001|Year 2|Other|0|||
33448359|NCT00906399|101532608|FG002|Year 2|Other|0|||
33448360|NCT00906399|101532609|FG003|Year 2|Other|2|||
33448361|NCT00906399|101532610|FG004|Year 2|Other|3|||
33448362|NCT00906399|101532611|FG005|Year 2|Other|1|||
33448363|NCT00906399|101532612|FG006|Year 2|Other|0|||
33448364|NCT00365365|101532617|FG000|Overall Study|Randomized but not treated|0|||
33448365|NCT00365365|101532618|FG001|Overall Study|Randomized but not treated|2|||
33448366|NCT00365365|101532619|FG002|Overall Study|Randomized but not treated|0|||
33448367|NCT00365365|101532617|FG000|Overall Study|Poor compliance to protocol|0|||
33448368|NCT00365365|101532618|FG001|Overall Study|Poor compliance to protocol|1|||
33448369|NCT00365365|101532619|FG002|Overall Study|Poor compliance to protocol|0|||
33448370|NCT00365365|101532617|FG000|Overall Study|Lost to Follow-up|3|||
33448371|NCT00365365|101532618|FG001|Overall Study|Lost to Follow-up|3|||
33448372|NCT00365365|101532619|FG002|Overall Study|Lost to Follow-up|3|||
33448373|NCT00365365|101532617|FG000|Overall Study|Death|1|||
33448374|NCT00365365|101532618|FG001|Overall Study|Death|3|||
33448375|NCT00365365|101532619|FG002|Overall Study|Death|0|||
33448376|NCT00365365|101532617|FG000|Overall Study|Subject's request|11|||
33448377|NCT00365365|101532618|FG001|Overall Study|Subject's request|13|||
33448378|NCT00365365|101532619|FG002|Overall Study|Subject's request|1|||
33448379|NCT00365365|101532617|FG000|Overall Study|Disease progression/relapse|9|||
33448380|NCT00365365|101532618|FG001|Overall Study|Disease progression/relapse|6|||
33448381|NCT00365365|101532619|FG002|Overall Study|Disease progression/relapse|7|||
33448382|NCT00365365|101532617|FG000|Overall Study|Adverse Event|6|||
33448383|NCT00365365|101532618|FG001|Overall Study|Adverse Event|6|||
33448384|NCT00365365|101532619|FG002|Overall Study|Adverse Event|3|||
33448385|NCT00365365|101532617|FG000|Overall Study|Moved|2|||
33448386|NCT00365365|101532618|FG001|Overall Study|Moved|0|||
33448387|NCT00365365|101532619|FG002|Overall Study|Moved|0|||
33448388|NCT00365365|101532617|FG000|Overall Study|New cancer|1|||
33448389|NCT00365365|101532618|FG001|Overall Study|New cancer|0|||
33448390|NCT00365365|101532619|FG002|Overall Study|New cancer|0|||
33448391|NCT00365365|101532617|FG000|Overall Study|Withdrew consent|1|||
33448392|NCT00365365|101532618|FG001|Overall Study|Withdrew consent|1|||
33448393|NCT00365365|101532619|FG002|Overall Study|Withdrew consent|0|||
33448394|NCT00365365|101532617|FG000|Overall Study|Second malignancy|0|||
33448395|NCT00365365|101532618|FG001|Overall Study|Second malignancy|1|||
33448396|NCT00365365|101532619|FG002|Overall Study|Second malignancy|0|||
33448397|NCT00365365|101532617|FG000|Overall Study|Patient/physician decision|0|||
33448398|NCT00365365|101532618|FG001|Overall Study|Patient/physician decision|0|||
33448399|NCT00365365|101532619|FG002|Overall Study|Patient/physician decision|1|||
33448400|NCT03500341|101532631|FG000|Overall Study|Withdrawn prior to Completion|2|||
33448401|NCT02601625|101532632|FG000|Overall Study|Lost to Follow-up|0|||
33448402|NCT02601625|101532633|FG001|Overall Study|Lost to Follow-up|0|||
33448403|NCT02601625|101532634|FG002|Overall Study|Lost to Follow-up|1|||
33448404|NCT02601625|101532635|FG003|Overall Study|Lost to Follow-up|1|||
33448405|NCT00124618|101532638|FG000|Overall Study|Ineligible|1|||
33448406|NCT01309672|101532639|FG000|Overall Study|Lack of Efficacy|20|||
33448407|NCT01309672|101532639|FG000|Overall Study|Other|9|||
33448408|NCT01309672|101532639|FG000|Overall Study|Adverse Event|5|||
33448409|NCT01309672|101532639|FG000|Overall Study|Withdrawal by Subject|3|||
33448410|NCT02321098|101532640|FG000|12 Weeks Treament|Lost to Follow-up|1|||
33448411|NCT02321098|101532641|FG001|12 Weeks Treament|Lost to Follow-up|1|||
33448412|NCT02321098|101532642|FG002|12 Weeks Treament|Lost to Follow-up|0|||
33448413|NCT02321098|101532640|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
33448414|NCT02321098|101532641|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
33448415|NCT02321098|101532642|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
33448416|NCT02321098|101532640|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
33448417|NCT02321098|101532641|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
33448418|NCT02321098|101532642|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
33448419|NCT02321098|101532640|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
33448420|NCT02321098|101532641|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
33448421|NCT02321098|101532642|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
33448422|NCT03100344|101532650|FG000|Overall Study|Adverse Event|0|||
33448423|NCT03100344|101532651|FG001|Overall Study|Adverse Event|3|||
33448424|NCT03100344|101532652|FG002|Overall Study|Adverse Event|2|||
33448425|NCT03100344|101532653|FG003|Overall Study|Adverse Event|3|||
33448426|NCT03100344|101532650|FG000|Overall Study|Lack of Efficacy|2|||
33448427|NCT03100344|101532651|FG001|Overall Study|Lack of Efficacy|0|||
33448428|NCT03100344|101532652|FG002|Overall Study|Lack of Efficacy|0|||
33448429|NCT03100344|101532653|FG003|Overall Study|Lack of Efficacy|0|||
33448430|NCT03100344|101532650|FG000|Overall Study|Protocol Violation|1|||
33448431|NCT03100344|101532651|FG001|Overall Study|Protocol Violation|0|||
33448432|NCT03100344|101532652|FG002|Overall Study|Protocol Violation|0|||
33448433|NCT03100344|101532653|FG003|Overall Study|Protocol Violation|0|||
33448434|NCT03100344|101532650|FG000|Overall Study|Withdrawal by Subject|10|||
33448435|NCT03100344|101532651|FG001|Overall Study|Withdrawal by Subject|7|||
33448436|NCT03100344|101532652|FG002|Overall Study|Withdrawal by Subject|4|||
33448437|NCT03100344|101532653|FG003|Overall Study|Withdrawal by Subject|8|||
33448438|NCT03100344|101532650|FG000|Overall Study|Lost to Follow-up|1|||
33448439|NCT03100344|101532651|FG001|Overall Study|Lost to Follow-up|1|||
33448440|NCT03100344|101532652|FG002|Overall Study|Lost to Follow-up|1|||
33448441|NCT03100344|101532653|FG003|Overall Study|Lost to Follow-up|1|||
33448442|NCT00838279|101532666|FG000|Washout|Protocol Violation|1|||
33448443|NCT00838279|101532667|FG001|Washout|Protocol Violation|0|||
33448444|NCT00838279|101532666|FG000|Washout|Withdrawal by Subject|0|||
33448445|NCT00838279|101532667|FG001|Washout|Withdrawal by Subject|1|||
33448446|NCT01294787|101532673|FG000|Period 1|Adverse Event|0|||
33448447|NCT01294787|101532674|FG001|Period 1|Adverse Event|0|||
33448448|NCT01294787|101532675|FG002|Period 1|Adverse Event|0|||
33448449|NCT01294787|101532676|FG003|Period 1|Adverse Event|0|||
33448450|NCT01294787|101532677|FG004|Period 1|Adverse Event|1|||
33167570|NCT03129100|100521635|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33448451|NCT01294787|101532678|FG005|Period 1|Adverse Event|0|||
33448452|NCT01294787|101532673|FG000|Period 1|Withdrawal by Subject|0|||
33448453|NCT01294787|101532674|FG001|Period 1|Withdrawal by Subject|0|||
33448454|NCT01294787|101532675|FG002|Period 1|Withdrawal by Subject|0|||
33448455|NCT01294787|101532676|FG003|Period 1|Withdrawal by Subject|1|||
33448456|NCT01294787|101532677|FG004|Period 1|Withdrawal by Subject|1|||
33448457|NCT01294787|101532678|FG005|Period 1|Withdrawal by Subject|1|||
33167571|NCT03129100|100521636|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167572|NCT03129100|100521637|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167573|NCT03129100|100521638|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
33167574|NCT03129100|100521613|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167575|NCT03129100|100521614|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167576|NCT03129100|100521615|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167577|NCT03129100|100521616|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167578|NCT03129100|100521617|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167579|NCT03129100|100521618|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167580|NCT03129100|100521619|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167581|NCT03129100|100521620|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167582|NCT03129100|100521621|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167583|NCT03129100|100521622|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167584|NCT03129100|100521623|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167585|NCT03129100|100521624|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167586|NCT03129100|100521625|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167587|NCT03129100|100521626|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167588|NCT03129100|100521627|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167589|NCT03129100|100521628|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
33167590|NCT03129100|100521629|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167591|NCT03129100|100521630|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167592|NCT03129100|100521631|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167593|NCT03129100|100521632|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167594|NCT03129100|100521633|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167595|NCT03129100|100521634|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167596|NCT03129100|100521635|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167597|NCT03129100|100521636|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167598|NCT03129100|100521637|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167599|NCT03129100|100521638|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
33167600|NCT03129100|100521613|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167601|NCT03129100|100521614|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167602|NCT03129100|100521615|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167603|NCT03129100|100521616|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167604|NCT03129100|100521617|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167605|NCT03129100|100521618|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167606|NCT03129100|100521619|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167607|NCT03129100|100521620|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167608|NCT03129100|100521621|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167609|NCT03129100|100521622|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167610|NCT03129100|100521623|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33259858|NCT04093752|100853446|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
33259859|NCT03655262|100853453|FG000|Overall Study|Withdrawal by Subject|0|||
33259860|NCT03655262|100853454|FG001|Overall Study|Withdrawal by Subject|0|||
33259861|NCT03655262|100853455|FG002|Overall Study|Withdrawal by Subject|1|||
33259862|NCT03593876|100853458|FG000|Overall Study|Withdrawal by Subject|1|||
33259863|NCT03593876|100853458|FG000|Overall Study|Discharged home before intervention completion|2|||
33259864|NCT00998881|100853459|FG000|Overall Study|Adverse Event|2|||
33259865|NCT00998881|100853460|FG001|Overall Study|Adverse Event|2|||
33259866|NCT00998881|100853459|FG000|Overall Study|Lack of Efficacy|1|||
33259867|NCT00998881|100853460|FG001|Overall Study|Lack of Efficacy|0|||
33259868|NCT00998881|100853459|FG000|Overall Study|Physician Decision|3|||
33259869|NCT00998881|100853460|FG001|Overall Study|Physician Decision|0|||
33259870|NCT00998881|100853459|FG000|Overall Study|Withdrawal by Subject|1|||
33259871|NCT00998881|100853460|FG001|Overall Study|Withdrawal by Subject|0|||
33259872|NCT00998881|100853459|FG000|Overall Study|Personal matter|1|||
33259873|NCT00998881|100853460|FG001|Overall Study|Personal matter|0|||
33259874|NCT02222493|100853461|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
33259875|NCT02222493|100853462|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
33259876|NCT02222493|100853461|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
33259877|NCT02222493|100853462|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
33259878|NCT02222493|100853461|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
33259879|NCT02222493|100853462|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
33259880|NCT02222493|100853461|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
33259881|NCT02222493|100853462|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
33448458|NCT01294787|101532673|FG000|Period 1|Administrative problem|0|||
33448459|NCT01294787|101532674|FG001|Period 1|Administrative problem|0|||
33448460|NCT01294787|101532675|FG002|Period 1|Administrative problem|1|||
33448461|NCT01294787|101532676|FG003|Period 1|Administrative problem|0|||
33448462|NCT01294787|101532677|FG004|Period 1|Administrative problem|0|||
33448463|NCT01294787|101532678|FG005|Period 1|Administrative problem|1|||
33448464|NCT01294787|101532673|FG000|Period 2|Adverse Event|0|||
33448465|NCT01294787|101532674|FG001|Period 2|Adverse Event|3|||
33448466|NCT01294787|101532675|FG002|Period 2|Adverse Event|0|||
33448467|NCT01294787|101532676|FG003|Period 2|Adverse Event|1|||
33448468|NCT01294787|101532677|FG004|Period 2|Adverse Event|0|||
33448469|NCT01294787|101532678|FG005|Period 2|Adverse Event|0|||
33448470|NCT01294787|101532673|FG000|Period 2|No longer needs study drug|0|||
33448471|NCT01294787|101532674|FG001|Period 2|No longer needs study drug|0|||
33448472|NCT01294787|101532675|FG002|Period 2|No longer needs study drug|0|||
33448473|NCT01294787|101532676|FG003|Period 2|No longer needs study drug|1|||
33448474|NCT01294787|101532677|FG004|Period 2|No longer needs study drug|0|||
33448475|NCT01294787|101532678|FG005|Period 2|No longer needs study drug|0|||
33448476|NCT01294787|101532673|FG000|Period 3|Adverse Event|0|||
33448477|NCT01294787|101532674|FG001|Period 3|Adverse Event|0|||
33448478|NCT01294787|101532675|FG002|Period 3|Adverse Event|0|||
33167611|NCT03129100|100521624|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167612|NCT03129100|100521625|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
33167613|NCT03129100|100521626|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167614|NCT03129100|100521627|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
33167615|NCT03129100|100521628|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
33167616|NCT03129100|100521629|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167617|NCT03129100|100521630|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167618|NCT03129100|100521631|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167619|NCT03129100|100521632|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167620|NCT03129100|100521633|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167621|NCT03129100|100521634|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167622|NCT03129100|100521635|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167623|NCT03129100|100521636|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167624|NCT03129100|100521637|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167625|NCT03129100|100521638|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
33167626|NCT03129100|100521613|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167627|NCT03129100|100521614|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167628|NCT03129100|100521615|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167629|NCT03129100|100521616|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167630|NCT03129100|100521617|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167631|NCT03129100|100521618|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167632|NCT03129100|100521619|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167633|NCT03129100|100521620|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167634|NCT03129100|100521621|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167635|NCT03129100|100521622|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33448479|NCT01294787|101532676|FG003|Period 3|Adverse Event|0|||
33167636|NCT03129100|100521623|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167637|NCT03129100|100521624|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167638|NCT03129100|100521625|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167639|NCT03129100|100521626|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167640|NCT03129100|100521627|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33448480|NCT01294787|101532677|FG004|Period 3|Adverse Event|1|||
33448481|NCT01294787|101532678|FG005|Period 3|Adverse Event|0|||
33448482|NCT02642653|101532681|FG000|Overall Study|Adverse Event|2|||
33167641|NCT03129100|100521628|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167642|NCT03129100|100521629|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167643|NCT03129100|100521630|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
33167644|NCT03129100|100521631|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167645|NCT03129100|100521632|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
33167646|NCT03129100|100521633|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167647|NCT03129100|100521634|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167648|NCT03129100|100521635|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167649|NCT03129100|100521636|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167650|NCT03129100|100521637|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33167651|NCT03129100|100521638|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
33448483|NCT02642653|101532682|FG001|Overall Study|Adverse Event|0|||
33448484|NCT00835081|101532687|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
33448485|NCT00835081|101532688|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
33167652|NCT03129100|100521613|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167653|NCT03129100|100521614|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33259882|NCT02222493|100853461|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
33167654|NCT03129100|100521615|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167655|NCT03129100|100521616|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167656|NCT03129100|100521617|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167657|NCT03129100|100521618|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167658|NCT03129100|100521619|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167659|NCT03129100|100521620|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167660|NCT03129100|100521621|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167661|NCT03129100|100521622|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167662|NCT03129100|100521623|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167663|NCT03129100|100521624|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167664|NCT03129100|100521625|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167665|NCT03129100|100521626|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33259883|NCT02222493|100853462|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
33259884|NCT02222493|100853461|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
33259885|NCT02222493|100853462|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
33259886|NCT02222493|100853461|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
33259887|NCT02222493|100853462|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
33259888|NCT02222493|100853461|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
33259889|NCT02222493|100853462|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
33259890|NCT02222493|100853461|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
33259891|NCT02222493|100853462|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
33259892|NCT02222493|100853461|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
33259893|NCT02222493|100853462|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
33259894|NCT02222493|100853461|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
33259895|NCT02222493|100853462|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
33259896|NCT02222493|100853461|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
33259897|NCT02222493|100853462|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
33259898|NCT02222493|100853461|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
33259899|NCT02222493|100853462|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
33448486|NCT01534663|101532689|FG000|Overall Study|Lost to Follow-up|0|||
33448487|NCT01534663|101532690|FG001|Overall Study|Lost to Follow-up|2|||
33259900|NCT02222493|100853461|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
33259901|NCT02222493|100853462|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
33259902|NCT02222493|100853461|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
33259903|NCT02222493|100853462|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
33259904|NCT02222493|100853461|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
33259905|NCT02222493|100853462|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
33259906|NCT02222493|100853461|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
33259907|NCT02222493|100853462|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
33259908|NCT02222493|100853461|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
33259909|NCT02222493|100853462|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
33259910|NCT02222493|100853461|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
33259911|NCT02222493|100853462|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
33259912|NCT02222493|100853461|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
33448488|NCT01534663|101532689|FG000|Overall Study|Adverse Event|2|||
33448489|NCT01534663|101532690|FG001|Overall Study|Adverse Event|1|||
33448490|NCT04278560|101532691|FG000|Overall Study|Adverse Event|1|||
33448491|NCT04278560|101532692|FG001|Overall Study|Adverse Event|2|||
33448492|NCT04278560|101532691|FG000|Overall Study|Withdrawal by Subject|0|||
33448493|NCT04278560|101532692|FG001|Overall Study|Withdrawal by Subject|1|||
33448494|NCT00829452|101532693|FG000|First Intervention|Withdrawal by Subject|0|||
33448495|NCT00829452|101532694|FG001|First Intervention|Withdrawal by Subject|1|||
33448496|NCT00829452|101532693|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
33448497|NCT00829452|101532694|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
33448498|NCT00829452|101532693|FG000|Second Intervention|Physician Decision|0|||
33448499|NCT00829452|101532694|FG001|Second Intervention|Physician Decision|1|||
33167666|NCT03129100|100521627|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167667|NCT03129100|100521628|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167668|NCT03129100|100521629|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167669|NCT03129100|100521630|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167670|NCT03129100|100521631|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167671|NCT03129100|100521632|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167672|NCT03129100|100521633|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
33167673|NCT03129100|100521634|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167674|NCT03129100|100521635|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167675|NCT03129100|100521636|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167676|NCT03129100|100521637|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167677|NCT03129100|100521638|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
33167678|NCT03129100|100521613|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
33167679|NCT03129100|100521614|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
33167680|NCT03129100|100521615|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
33167681|NCT03129100|100521616|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
33167682|NCT03129100|100521617|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
33167683|NCT03129100|100521618|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
33167684|NCT03129100|100521619|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
33167685|NCT03129100|100521620|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
33167686|NCT03129100|100521621|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
33167687|NCT03129100|100521622|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
33448500|NCT02956460|101532695|FG000|Lens 1|Lost to Follow-up|1|||
33167688|NCT03129100|100521623|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
33167689|NCT03129100|100521624|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
33167690|NCT03129100|100521625|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
33167691|NCT03129100|100521626|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
33167692|NCT03129100|100521627|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
33167693|NCT03129100|100521628|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
33167694|NCT03129100|100521629|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
33167695|NCT03129100|100521630|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
33167696|NCT03129100|100521631|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
33167697|NCT03129100|100521632|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
33167698|NCT03129100|100521633|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
33167699|NCT03129100|100521634|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
33167700|NCT03129100|100521635|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
33167701|NCT03129100|100521636|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
33167702|NCT03129100|100521637|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
33167703|NCT03129100|100521638|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
33167704|NCT03129100|100521613|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167705|NCT03129100|100521614|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167706|NCT03129100|100521615|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167707|NCT03129100|100521616|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167708|NCT03129100|100521617|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167709|NCT03129100|100521618|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167710|NCT03129100|100521619|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167711|NCT03129100|100521620|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167712|NCT03129100|100521621|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167713|NCT03129100|100521622|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167714|NCT03129100|100521623|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167715|NCT03129100|100521624|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167716|NCT03129100|100521625|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167717|NCT03129100|100521626|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167718|NCT03129100|100521627|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167719|NCT03129100|100521628|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167720|NCT03129100|100521629|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167721|NCT03129100|100521630|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167722|NCT03129100|100521631|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167723|NCT03129100|100521632|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167724|NCT03129100|100521633|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
33167725|NCT03129100|100521634|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167726|NCT03129100|100521635|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167727|NCT03129100|100521636|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167728|NCT03129100|100521637|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167729|NCT03129100|100521638|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
33167730|NCT03129100|100521613|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
33259913|NCT02222493|100853462|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
33259914|NCT02222493|100853461|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
33259915|NCT02222493|100853462|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
33259916|NCT02222493|100853461|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
33167731|NCT03129100|100521614|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
33167732|NCT03129100|100521615|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
33167733|NCT03129100|100521616|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
33167734|NCT03129100|100521617|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
33167735|NCT03129100|100521618|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
33167736|NCT03129100|100521619|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
33167737|NCT03129100|100521620|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
33167738|NCT03129100|100521621|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
33167739|NCT03129100|100521622|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
33167740|NCT03129100|100521623|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
33167741|NCT03129100|100521624|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
33167742|NCT03129100|100521625|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
33259917|NCT02222493|100853462|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
33448501|NCT02956460|101532696|FG001|Lens 1|Lost to Follow-up|0|||
33448502|NCT00904215|101532697|FG000|Overall Study|Adverse Event|25|||
33448503|NCT00904215|101532697|FG000|Overall Study|Protocol Violation|10|||
33448504|NCT00904215|101532697|FG000|Overall Study|Lost to Follow-up|63|||
33448505|NCT00904215|101532697|FG000|Overall Study|Withdrawal by Subject|9|||
33448506|NCT00904215|101532697|FG000|Overall Study|Other|28|||
33448507|NCT03868891|101532698|FG000|Overall Study|Adverse Event|1|||
33448508|NCT03868891|101532699|FG001|Overall Study|Adverse Event|0|||
33448509|NCT03868891|101532698|FG000|Overall Study|Lost to Follow-up|2|||
33448510|NCT03868891|101532699|FG001|Overall Study|Lost to Follow-up|1|||
33448511|NCT03868891|101532698|FG000|Overall Study|COVID-19 Restrictions|1|||
33448512|NCT03868891|101532699|FG001|Overall Study|COVID-19 Restrictions|2|||
33448513|NCT01058668|101532700|FG000|Double-blind Treatment Phase|Adverse Event|8|||
33448514|NCT01058668|101532701|FG001|Double-blind Treatment Phase|Adverse Event|15|||
33448515|NCT01058668|101532702|FG002|Double-blind Treatment Phase|Adverse Event|25|||
33448516|NCT01058668|101532700|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
33448517|NCT01058668|101532701|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
33448518|NCT01058668|101532702|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
33448519|NCT01058668|101532700|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
33448520|NCT01058668|101532701|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
33448521|NCT01058668|101532702|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
33448522|NCT01058668|101532700|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
33448523|NCT01058668|101532701|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
33448524|NCT01058668|101532702|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
33448525|NCT01058668|101532700|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
33448526|NCT01058668|101532701|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
33448527|NCT01058668|101532702|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
33167743|NCT03129100|100521626|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
33259918|NCT00709098|100853463|FG000|Double-blind Period|Withdrawal of consent|3|||
33448528|NCT01058668|101532700|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
33448529|NCT01058668|101532701|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
33448530|NCT01058668|101532702|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
33448531|NCT06195579|101532703|FG000|Overall Study|Withdrawal by Subject|1|||
33448532|NCT01208337|101532704|FG000|Overall Study|Death|3|||
33448533|NCT04594252|101532708|FG000|Overall Study|Adverse Event|0|||
33448534|NCT04594252|101532709|FG001|Overall Study|Adverse Event|2|||
33448535|NCT00857454|101532710|FG000|Overall Study|Withdrawal by Subject|2|||
33448536|NCT00857454|101532710|FG000|Overall Study|Lost to Follow-up|1|||
33448537|NCT00857454|101532710|FG000|Overall Study|Adverse Event|2|||
33448538|NCT00857454|101532710|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
33448539|NCT00857454|101532710|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
33448540|NCT00857454|101532710|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
33448541|NCT00245063|101532711|FG000|Overall Study|Adverse Event|6|||
33448542|NCT00245063|101532712|FG001|Overall Study|Adverse Event|5|||
33448543|NCT00245063|101532711|FG000|Overall Study|Death|1|||
33448544|NCT00245063|101532712|FG001|Overall Study|Death|0|||
33448545|NCT02213263|101532713|FG000|Overall Study|Insufficient clinical response|4|||
33448546|NCT02213263|101532714|FG001|Overall Study|Insufficient clinical response|3|||
33448547|NCT02213263|101532713|FG000|Overall Study|Lost to Follow-up|0|||
33448548|NCT02213263|101532714|FG001|Overall Study|Lost to Follow-up|1|||
33448549|NCT02213263|101532713|FG000|Overall Study|No longer willing to participate|3|||
33448550|NCT02213263|101532714|FG001|Overall Study|No longer willing to participate|4|||
33448551|NCT02213263|101532713|FG000|Overall Study|Progressive disease|20|||
33448552|NCT02213263|101532714|FG001|Overall Study|Progressive disease|14|||
33448553|NCT02213263|101532713|FG000|Overall Study|Protocol Violation|0|||
33448554|NCT02213263|101532714|FG001|Overall Study|Protocol Violation|1|||
33448555|NCT02213263|101532713|FG000|Overall Study|Adverse Event|1|||
33448556|NCT02213263|101532714|FG001|Overall Study|Adverse Event|3|||
33448557|NCT01975948|101532715|FG000|Overall Study|Withdrawal by Subject|17|||
33448558|NCT01975948|101532716|FG001|Overall Study|Withdrawal by Subject|21|||
33448559|NCT01975948|101532717|FG002|Overall Study|Withdrawal by Subject|7|||
33448560|NCT01975948|101532718|FG003|Overall Study|Withdrawal by Subject|6|||
33448561|NCT01380782|101532725|FG000|Overall Study|Adverse Event|0|||
33448562|NCT01380782|101532726|FG001|Overall Study|Adverse Event|1|||
33448563|NCT01380782|101532727|FG002|Overall Study|Adverse Event|0|||
33448564|NCT01380782|101532728|FG003|Overall Study|Adverse Event|0|||
33448565|NCT01380782|101532725|FG000|Overall Study|Death|1|||
33448566|NCT01380782|101532726|FG001|Overall Study|Death|0|||
33448567|NCT01380782|101532727|FG002|Overall Study|Death|0|||
33448568|NCT01380782|101532728|FG003|Overall Study|Death|0|||
33448569|NCT01380782|101532725|FG000|Overall Study|Lack of Efficacy|10|||
33448570|NCT01380782|101532726|FG001|Overall Study|Lack of Efficacy|9|||
33448571|NCT01380782|101532727|FG002|Overall Study|Lack of Efficacy|10|||
33448572|NCT01380782|101532728|FG003|Overall Study|Lack of Efficacy|3|||
33448573|NCT01380782|101532725|FG000|Overall Study|Physician Decision|1|||
33448574|NCT01380782|101532726|FG001|Overall Study|Physician Decision|0|||
33448575|NCT01380782|101532727|FG002|Overall Study|Physician Decision|0|||
33448576|NCT01380782|101532728|FG003|Overall Study|Physician Decision|0|||
33448577|NCT01380782|101532725|FG000|Overall Study|Withdrawal by Subject|0|||
33448578|NCT01380782|101532726|FG001|Overall Study|Withdrawal by Subject|0|||
33448579|NCT01380782|101532727|FG002|Overall Study|Withdrawal by Subject|1|||
33448580|NCT01380782|101532728|FG003|Overall Study|Withdrawal by Subject|1|||
33448581|NCT01686477|101532732|FG000|Feeding Intervention|Death|1|||
33448582|NCT01686477|101532733|FG001|Feeding Intervention|Death|0|||
33448583|NCT01686477|101532734|FG002|Feeding Intervention|Death|1|||
33448584|NCT01686477|101532732|FG000|Feeding Intervention|Withdrawal by Subject|0|||
33448585|NCT01686477|101532733|FG001|Feeding Intervention|Withdrawal by Subject|6|||
33448586|NCT01686477|101532734|FG002|Feeding Intervention|Withdrawal by Subject|0|||
33448587|NCT01686477|101532732|FG000|Feeding Intervention|Physician Decision|1|||
33448588|NCT01686477|101532733|FG001|Feeding Intervention|Physician Decision|2|||
33448589|NCT01686477|101532734|FG002|Feeding Intervention|Physician Decision|0|||
33448590|NCT01686477|101532732|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
33448591|NCT01686477|101532733|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
33448592|NCT01686477|101532734|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
33448593|NCT01686477|101532732|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
33448594|NCT01686477|101532733|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
33448595|NCT01686477|101532734|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
33448596|NCT01686477|101532732|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
33448597|NCT01686477|101532733|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
33448598|NCT01686477|101532734|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
33448599|NCT01686477|101532732|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
33448600|NCT01686477|101532733|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
33448601|NCT01686477|101532734|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
33448602|NCT01686477|101532732|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
33448603|NCT01686477|101532733|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
33448604|NCT01686477|101532734|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
33448605|NCT01686477|101532732|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
33448606|NCT01686477|101532733|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
33448607|NCT01686477|101532734|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
33448608|NCT01686477|101532732|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
33448609|NCT01686477|101532733|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
33448610|NCT01686477|101532734|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
33448611|NCT00274651|101532735|FG000|Overall Study|Adverse Event|6|||
33448612|NCT00274651|101532736|FG001|Overall Study|Adverse Event|3|||
33448613|NCT00274651|101532735|FG000|Overall Study|Lack of Efficacy|13|||
33448614|NCT00274651|101532736|FG001|Overall Study|Lack of Efficacy|6|||
33448615|NCT00274651|101532735|FG000|Overall Study|Death|1|||
33448616|NCT00274651|101532736|FG001|Overall Study|Death|3|||
33448617|NCT00274651|101532735|FG000|Overall Study|Withdrawal by Subject|0|||
33448618|NCT00274651|101532736|FG001|Overall Study|Withdrawal by Subject|1|||
33448619|NCT00274651|101532735|FG000|Overall Study|Physician Decision|8|||
33448620|NCT00274651|101532736|FG001|Overall Study|Physician Decision|7|||
33448621|NCT02647944|101532737|FG000|Overall Study|Withdrawal by Subject|0|||
33448622|NCT02647944|101532738|FG001|Overall Study|Withdrawal by Subject|3|||
33448623|NCT02647944|101532737|FG000|Overall Study|Adverse Event|2|||
33448624|NCT02647944|101532738|FG001|Overall Study|Adverse Event|0|||
33167744|NCT03129100|100521627|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
33167745|NCT03129100|100521628|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
33167746|NCT03129100|100521629|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
33167747|NCT03129100|100521630|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
33167748|NCT03129100|100521631|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
33167749|NCT03129100|100521632|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
33167750|NCT03129100|100521633|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
33167751|NCT03129100|100521634|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
33167752|NCT03129100|100521635|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
33167753|NCT03129100|100521636|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
33167754|NCT03129100|100521637|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
33167755|NCT03129100|100521638|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
33167756|NCT03129100|100521613|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167757|NCT03129100|100521614|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167758|NCT03129100|100521615|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167759|NCT03129100|100521616|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167760|NCT03129100|100521617|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167761|NCT03129100|100521618|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167762|NCT03129100|100521619|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167763|NCT03129100|100521620|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167764|NCT03129100|100521621|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167765|NCT03129100|100521622|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167766|NCT03129100|100521623|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167767|NCT03129100|100521624|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167768|NCT03129100|100521625|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167769|NCT03129100|100521626|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167770|NCT03129100|100521627|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167771|NCT03129100|100521628|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167772|NCT03129100|100521629|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167773|NCT03129100|100521630|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167774|NCT03129100|100521631|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167775|NCT03129100|100521632|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167776|NCT03129100|100521633|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167777|NCT03129100|100521634|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167778|NCT03129100|100521635|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167779|NCT03129100|100521636|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
33167780|NCT03129100|100521637|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
33167781|NCT03129100|100521638|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
33167782|NCT03129100|100521613|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167783|NCT03129100|100521614|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167784|NCT03129100|100521615|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167785|NCT03129100|100521616|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167786|NCT03129100|100521617|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167787|NCT03129100|100521618|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167788|NCT03129100|100521619|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33448625|NCT01218867|101532740|FG000|Overall Study|Death during treatment|0|||
33448626|NCT01218867|101532741|FG001|Overall Study|Death during treatment|0|||
33448627|NCT01218867|101532742|FG002|Overall Study|Death during treatment|0|||
33448628|NCT01218867|101532743|FG003|Overall Study|Death during treatment|0|||
33448629|NCT01218867|101532744|FG004|Overall Study|Death during treatment|0|||
33448630|NCT01218867|101532745|FG005|Overall Study|Death during treatment|0|||
33448631|NCT01218867|101532746|FG006|Overall Study|Death during treatment|1|||
33448632|NCT01218867|101532747|FG007|Overall Study|Death during treatment|0|||
33448633|NCT01218867|101532748|FG008|Overall Study|Death during treatment|0|||
33448634|NCT01218867|101532749|FG009|Overall Study|Death during treatment|0|||
33448635|NCT01218867|101532750|FG010|Overall Study|Death during treatment|0|||
33448636|NCT00772603|101532755|FG000|Overall Study|Withdrawal by Subject|11|||
33448637|NCT00772603|101532756|FG001|Overall Study|Withdrawal by Subject|10|||
33448638|NCT00772603|101532757|FG002|Overall Study|Withdrawal by Subject|6|||
33448639|NCT00772603|101532755|FG000|Overall Study|Adverse Event|37|||
33448640|NCT00772603|101532756|FG001|Overall Study|Adverse Event|18|||
33448641|NCT00772603|101532757|FG002|Overall Study|Adverse Event|10|||
33448642|NCT00772603|101532755|FG000|Overall Study|Subject Non-compliance|1|||
33167789|NCT03129100|100521620|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167790|NCT03129100|100521621|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33448643|NCT00772603|101532756|FG001|Overall Study|Subject Non-compliance|6|||
33448644|NCT00772603|101532757|FG002|Overall Study|Subject Non-compliance|4|||
33448645|NCT00772603|101532755|FG000|Overall Study|Protocol Violation|0|||
33448646|NCT00772603|101532756|FG001|Overall Study|Protocol Violation|1|||
33448647|NCT00772603|101532757|FG002|Overall Study|Protocol Violation|1|||
33448648|NCT00772603|101532755|FG000|Overall Study|Lost to Follow-up|1|||
33448649|NCT00772603|101532756|FG001|Overall Study|Lost to Follow-up|5|||
33448650|NCT00772603|101532757|FG002|Overall Study|Lost to Follow-up|2|||
33448651|NCT00772603|101532755|FG000|Overall Study|Physician Decision|0|||
33448652|NCT00772603|101532756|FG001|Overall Study|Physician Decision|0|||
33448653|NCT00772603|101532757|FG002|Overall Study|Physician Decision|1|||
33448654|NCT00772603|101532755|FG000|Overall Study|Other|2|||
33448655|NCT00772603|101532756|FG001|Overall Study|Other|0|||
33448656|NCT00772603|101532757|FG002|Overall Study|Other|2|||
33448657|NCT01030133|101532758|FG000|Overall Study|failed to experience pain at level 7/10|2|||
33448658|NCT01030133|101532759|FG001|Overall Study|failed to experience pain at level 7/10|2|||
33448659|NCT01316055|101532760|FG000|Overall Study|Lost to Follow-up|1|||
33448660|NCT01316055|101532761|FG001|Overall Study|Lost to Follow-up|0|||
33448661|NCT01316055|101532762|FG002|Overall Study|Lost to Follow-up|0|||
33448662|NCT04887415|101532768|FG000|Overall Study|Lost to Follow-up|2|||
33448663|NCT00152451|101532769|FG000|Overall Study|Adverse Event|4|||
33448664|NCT04173247|101532770|FG000|Overall Study|Withdrawal by Subject|0|||
33448665|NCT04173247|101532771|FG001|Overall Study|Withdrawal by Subject|2|||
33448666|NCT04173247|101532770|FG000|Overall Study|Death|1|||
33448667|NCT04173247|101532771|FG001|Overall Study|Death|0|||
33448668|NCT04173247|101532770|FG000|Overall Study|Physician Decision|1|||
33448669|NCT04173247|101532771|FG001|Overall Study|Physician Decision|0|||
33448670|NCT00841698|101532778|FG000|First Intervention|Withdrawal by Subject|1|||
33448671|NCT00841698|101532779|FG001|First Intervention|Withdrawal by Subject|0|||
33448672|NCT00218257|101532784|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
33448673|NCT00218257|101532785|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
33448674|NCT01466166|101532790|FG000|Overall Study|Death|1|||
33448675|NCT01466166|101532790|FG000|Overall Study|Lost to Follow-up|7|||
33448676|NCT01466166|101532790|FG000|Overall Study|Infusion Reaction (IR)|27|||
33448677|NCT01466166|101532790|FG000|Overall Study|Adverse Event (Other than IR)|11|||
33448678|NCT01466166|101532790|FG000|Overall Study|Elevated Serum Uric Acid|78|||
33448679|NCT01466166|101532790|FG000|Overall Study|Withdrawal by Subject|13|||
33448680|NCT01466166|101532790|FG000|Overall Study|Sponsor Decision|4|||
33448681|NCT01466166|101532790|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
33448682|NCT01466166|101532790|FG000|Overall Study|Other|20|||
33448683|NCT00640562|101532791|FG000|Overall Study|Adverse Event|8|||
33448684|NCT00640562|101532792|FG001|Overall Study|Adverse Event|5|||
33448685|NCT00640562|101532791|FG000|Overall Study|Lack of Efficacy|1|||
33448686|NCT00640562|101532792|FG001|Overall Study|Lack of Efficacy|4|||
33448687|NCT00640562|101532791|FG000|Overall Study|Protocol Violation|2|||
33448688|NCT00640562|101532792|FG001|Overall Study|Protocol Violation|4|||
33448689|NCT00640562|101532791|FG000|Overall Study|Withdrawal by Subject|6|||
33448690|NCT00640562|101532792|FG001|Overall Study|Withdrawal by Subject|10|||
33448691|NCT00640562|101532791|FG000|Overall Study|Known risperidone intolerance|0|||
33448692|NCT00640562|101532792|FG001|Overall Study|Known risperidone intolerance|1|||
33448693|NCT00640562|101532791|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
33448694|NCT00640562|101532792|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
33448695|NCT00640562|101532791|FG000|Overall Study|Low study drug dose|0|||
33448696|NCT00640562|101532792|FG001|Overall Study|Low study drug dose|1|||
33448697|NCT00640562|101532791|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
33448698|NCT00640562|101532792|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
33448699|NCT02554890|101532793|FG000|Double-blind|Adverse Event|45|||
33448700|NCT02554890|101532794|FG001|Double-blind|Adverse Event|51|||
33448701|NCT02554890|101532793|FG000|Double-blind|Death|6|||
33448702|NCT02554890|101532794|FG001|Double-blind|Death|4|||
33448703|NCT02554890|101532793|FG000|Double-blind|Protocol Violation|1|||
33448704|NCT02554890|101532794|FG001|Double-blind|Protocol Violation|1|||
33448705|NCT02554890|101532793|FG000|Double-blind|Physician Decision|4|||
33448706|NCT02554890|101532794|FG001|Double-blind|Physician Decision|3|||
33448707|NCT02554890|101532793|FG000|Double-blind|Subject/Guardian decision|21|||
33448708|NCT02554890|101532794|FG001|Double-blind|Subject/Guardian decision|16|||
33448709|NCT02554890|101532793|FG000|Double-blind|Lost to Follow-up|7|||
33448710|NCT02554890|101532794|FG001|Double-blind|Lost to Follow-up|5|||
33448711|NCT02554890|101532793|FG000|Double-blind|Technical problems|1|||
33448712|NCT02554890|101532794|FG001|Double-blind|Technical problems|0|||
33448713|NCT02554890|101532793|FG000|Double-blind|Withdrawal by Subject|5|||
33448714|NCT02554890|101532794|FG001|Double-blind|Withdrawal by Subject|6|||
33448715|NCT02554890|101532793|FG000|Double-blind|Noncompliance with study treatment|6|||
33448716|NCT02554890|101532794|FG001|Double-blind|Noncompliance with study treatment|5|||
33448717|NCT02554890|101532793|FG000|Open-label|Adverse Event|0|||
33448718|NCT02554890|101532794|FG001|Open-label|Adverse Event|30|||
33448719|NCT02554890|101532793|FG000|Open-label|Death|0|||
33448720|NCT02554890|101532794|FG001|Open-label|Death|1|||
33448721|NCT02554890|101532793|FG000|Open-label|Physician Decision|0|||
33448722|NCT02554890|101532794|FG001|Open-label|Physician Decision|1|||
33167791|NCT03129100|100521622|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167792|NCT03129100|100521623|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167793|NCT03129100|100521624|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167794|NCT03129100|100521625|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167795|NCT03129100|100521626|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167796|NCT03129100|100521627|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167797|NCT03129100|100521628|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167798|NCT03129100|100521629|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167799|NCT03129100|100521630|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167800|NCT03129100|100521631|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167801|NCT03129100|100521632|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167802|NCT03129100|100521633|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167803|NCT03129100|100521634|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167804|NCT03129100|100521635|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
33167805|NCT03129100|100521636|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
33167806|NCT03129100|100521637|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
33167807|NCT03129100|100521638|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
33167808|NCT03129100|100521613|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167809|NCT03129100|100521614|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167810|NCT03129100|100521615|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167811|NCT03129100|100521616|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167812|NCT03129100|100521617|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167813|NCT03129100|100521618|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167814|NCT03129100|100521619|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167815|NCT03129100|100521620|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167816|NCT03129100|100521621|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167817|NCT03129100|100521622|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167818|NCT03129100|100521623|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167819|NCT03129100|100521624|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167820|NCT03129100|100521625|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167821|NCT03129100|100521626|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167822|NCT03129100|100521627|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167823|NCT03129100|100521628|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167824|NCT03129100|100521629|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167825|NCT03129100|100521630|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167826|NCT03129100|100521631|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167827|NCT03129100|100521632|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167828|NCT03129100|100521633|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167829|NCT03129100|100521634|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167830|NCT03129100|100521635|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167831|NCT03129100|100521636|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167832|NCT03129100|100521637|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
33167833|NCT03129100|100521638|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
33167834|NCT03129100|100521613|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167835|NCT03129100|100521614|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167836|NCT03129100|100521615|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33448723|NCT02554890|101532793|FG000|Open-label|Subject/Guardian decision|0|||
33448724|NCT02554890|101532794|FG001|Open-label|Subject/Guardian decision|11|||
33448725|NCT02554890|101532793|FG000|Open-label|Lost to Follow-up|0|||
33167837|NCT03129100|100521616|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167838|NCT03129100|100521617|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167839|NCT03129100|100521618|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167840|NCT03129100|100521619|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167841|NCT03129100|100521620|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167842|NCT03129100|100521621|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167843|NCT03129100|100521622|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167844|NCT03129100|100521623|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167845|NCT03129100|100521624|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167846|NCT03129100|100521625|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167847|NCT03129100|100521626|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167848|NCT03129100|100521627|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167849|NCT03129100|100521628|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167850|NCT03129100|100521629|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167851|NCT03129100|100521630|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167852|NCT03129100|100521631|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167853|NCT03129100|100521632|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167854|NCT03129100|100521633|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167855|NCT03129100|100521634|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33448726|NCT02554890|101532794|FG001|Open-label|Lost to Follow-up|7|||
33448727|NCT02554890|101532793|FG000|Open-label|Technical problems|0|||
33448728|NCT02554890|101532794|FG001|Open-label|Technical problems|1|||
33448729|NCT02554890|101532793|FG000|Open-label|Withdrawal by Subject|0|||
33448730|NCT02554890|101532794|FG001|Open-label|Withdrawal by Subject|1|||
33448731|NCT02963259|101532795|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
33448732|NCT02963259|101532795|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
33448733|NCT02963259|101532795|FG000|Overall Study|Death|1|||
33448734|NCT02963259|101532795|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
33448735|NCT03597256|101532797|FG000|Overall Study|Lost to Follow-up|3|||
33448736|NCT03597256|101532798|FG001|Overall Study|Lost to Follow-up|1|||
33448737|NCT03597256|101532797|FG000|Overall Study|Withdrawal by Subject|0|||
33448738|NCT03597256|101532798|FG001|Overall Study|Withdrawal by Subject|1|||
33448739|NCT03597256|101532797|FG000|Overall Study|Could not return for treatment|0|||
33448740|NCT03597256|101532798|FG001|Overall Study|Could not return for treatment|1|||
33448741|NCT03597256|101532797|FG000|Overall Study|Moved from location|0|||
33448742|NCT03597256|101532798|FG001|Overall Study|Moved from location|1|||
33448743|NCT03597256|101532797|FG000|Overall Study|Not accepted the treatment|0|||
33448744|NCT03597256|101532798|FG001|Overall Study|Not accepted the treatment|1|||
33448745|NCT03437265|101532799|FG000|Overall Study|Protocol Violation|6|||
33448746|NCT01686438|101532800|FG000|Overall Study|Lost to Follow-up|8|||
33448747|NCT01686438|101532801|FG001|Overall Study|Lost to Follow-up|9|||
33448748|NCT01686438|101532802|FG002|Overall Study|Lost to Follow-up|10|||
33448749|NCT01686438|101532800|FG000|Overall Study|Adverse Event|0|||
33448750|NCT01686438|101532801|FG001|Overall Study|Adverse Event|0|||
33448751|NCT01686438|101532802|FG002|Overall Study|Adverse Event|1|||
33448752|NCT01686438|101532800|FG000|Overall Study|Protocol Violation|0|||
33448753|NCT01686438|101532801|FG001|Overall Study|Protocol Violation|0|||
33448754|NCT01686438|101532802|FG002|Overall Study|Protocol Violation|1|||
33167856|NCT03129100|100521635|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167857|NCT03129100|100521636|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167858|NCT03129100|100521637|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
33167859|NCT03129100|100521638|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
33167860|NCT03129100|100521613|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
33167861|NCT03129100|100521614|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
33167862|NCT03129100|100521615|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
33167863|NCT03129100|100521616|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
33167864|NCT03129100|100521617|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
33167865|NCT03129100|100521618|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
33167866|NCT03129100|100521619|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
33448755|NCT01686438|101532800|FG000|Overall Study|Withdrawal by Subject|0|||
33448756|NCT01686438|101532801|FG001|Overall Study|Withdrawal by Subject|0|||
33448757|NCT01686438|101532802|FG002|Overall Study|Withdrawal by Subject|1|||
33448758|NCT01863745|101532803|FG000|Overall Study|Disease Progression|9|||
33448759|NCT01863745|101532803|FG000|Overall Study|Adverse Event|2|||
33448760|NCT01863745|101532803|FG000|Overall Study|Death|1|||
33448761|NCT01863745|101532803|FG000|Overall Study|Withdrawal by Subject|1|||
33448762|NCT03256695|101532804|FG000|Overall Study|Adverse Event|8|||
33448763|NCT03256695|101532804|FG000|Overall Study|Death|2|||
33448764|NCT03256695|101532804|FG000|Overall Study|Withdrawal by Subject|14|||
33448765|NCT03256695|101532804|FG000|Overall Study|Non-compliance with study drug|1|||
33448766|NCT03256695|101532804|FG000|Overall Study|Lost to Follow-up|3|||
33448767|NCT03256695|101532804|FG000|Overall Study|Lack of Efficacy|3|||
33167867|NCT03129100|100521620|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
33448768|NCT03256695|101532804|FG000|Overall Study|Protocol Violation|5|||
33448769|NCT03256695|101532804|FG000|Overall Study|Other than specified|3|||
33448770|NCT00003470|101532805|FG000|Overall Study|Not evaluable|6|||
33448771|NCT01015625|101535873|FG000|Overall Study|Lost to Follow-up|3|||
33448772|NCT01015625|101535874|FG001|Overall Study|Lost to Follow-up|1|||
33448773|NCT01015625|101535873|FG000|Overall Study|Withdrawal by Subject|2|||
33448774|NCT01015625|101535874|FG001|Overall Study|Withdrawal by Subject|3|||
33448775|NCT01015625|101535873|FG000|Overall Study|Physician Decision|2|||
33448776|NCT01015625|101535874|FG001|Overall Study|Physician Decision|0|||
33448777|NCT01015625|101535873|FG000|Overall Study|Death|30|||
33448778|NCT01015625|101535874|FG001|Overall Study|Death|22|||
33448779|NCT02622386|101535881|FG000|First Assignment|Withdrawal by Subject|3|||
33448780|NCT02622386|101535882|FG001|First Assignment|Withdrawal by Subject|2|||
33448781|NCT02622386|101535881|FG000|Washout|Withdrawal by Subject|4|||
33448782|NCT02622386|101535882|FG001|Washout|Withdrawal by Subject|4|||
33448783|NCT02622386|101535881|FG000|Second Assignment|Withdrawal by Subject|0|||
33448784|NCT02622386|101535882|FG001|Second Assignment|Withdrawal by Subject|2|||
33448785|NCT01796171|101535883|FG000|Enrolled|Death|0|||
33448786|NCT01796171|101535884|FG001|Enrolled|Death|0|||
33448787|NCT01796171|101535885|FG002|Enrolled|Death|0|||
33448788|NCT01796171|101535886|FG003|Enrolled|Death|0|||
33448789|NCT01796171|101535887|FG004|Enrolled|Death|0|||
33448790|NCT01796171|101535888|FG005|Enrolled|Death|0|||
33448791|NCT01796171|101535889|FG006|Enrolled|Death|0|||
33448792|NCT01796171|101535890|FG007|Enrolled|Death|0|||
33448793|NCT01796171|101535891|FG008|Enrolled|Death|0|||
33448794|NCT01796171|101535892|FG009|Enrolled|Death|0|||
33448795|NCT01796171|101535893|FG010|Enrolled|Death|0|||
33448796|NCT01796171|101535894|FG011|Enrolled|Death|0|||
33448797|NCT01796171|101535895|FG012|Enrolled|Death|0|||
33448798|NCT01796171|101535896|FG013|Enrolled|Death|0|||
33448799|NCT01796171|101535897|FG014|Enrolled|Death|1|||
33448800|NCT01796171|101535883|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
33448801|NCT01796171|101535884|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
33448802|NCT01796171|101535885|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
33448803|NCT01796171|101535886|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
33448804|NCT01796171|101535887|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
33448805|NCT01796171|101535888|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
33448806|NCT01796171|101535889|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
33448807|NCT01796171|101535890|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
33448808|NCT01796171|101535891|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
33448809|NCT01796171|101535892|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
33448810|NCT01796171|101535893|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
33448811|NCT01796171|101535894|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
33167868|NCT03129100|100521621|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
33167869|NCT03129100|100521622|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
33167870|NCT03129100|100521623|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
33167871|NCT03129100|100521624|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
33167872|NCT03129100|100521625|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
33167873|NCT03129100|100521626|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
33167874|NCT03129100|100521627|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
33167875|NCT03129100|100521628|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
33448812|NCT01796171|101535895|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
33167876|NCT03129100|100521629|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
33167877|NCT03129100|100521630|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
33448813|NCT01796171|101535896|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
33448814|NCT01796171|101535897|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
33448815|NCT01796171|101535883|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
33448816|NCT01796171|101535884|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
33448817|NCT01796171|101535885|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
33448818|NCT01796171|101535886|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
33448819|NCT01796171|101535887|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
33448820|NCT01796171|101535888|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
33448821|NCT01796171|101535889|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
33448822|NCT01796171|101535890|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
33448823|NCT01796171|101535891|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
33448824|NCT01796171|101535892|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
33448825|NCT01796171|101535893|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
33167878|NCT03129100|100521631|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
33167879|NCT03129100|100521632|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
33167880|NCT03129100|100521633|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
33167881|NCT03129100|100521634|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
33167882|NCT03129100|100521635|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
33167883|NCT03129100|100521636|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
33167884|NCT03129100|100521637|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
33167885|NCT03129100|100521638|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
33167886|NCT03281577|100521643|FG000|Overall Study|Adverse Event|0|||
33167887|NCT03281577|100521644|FG001|Overall Study|Adverse Event|0|||
33167888|NCT03281577|100521645|FG002|Overall Study|Adverse Event|0|||
33167889|NCT03281577|100521646|FG003|Overall Study|Adverse Event|1|||
33167890|NCT03281577|100521643|FG000|Overall Study|Withdrawal by Subject|1|||
33167891|NCT03281577|100521644|FG001|Overall Study|Withdrawal by Subject|0|||
33167892|NCT03281577|100521645|FG002|Overall Study|Withdrawal by Subject|0|||
33167893|NCT03281577|100521646|FG003|Overall Study|Withdrawal by Subject|0|||
33167894|NCT01192516|100521647|FG000|Overall Study|Lost to Follow-up|7|||
33167895|NCT01192516|100521648|FG001|Overall Study|Lost to Follow-up|10|||
33167896|NCT01192516|100521649|FG002|Overall Study|Lost to Follow-up|7|||
33167897|NCT01192516|100521647|FG000|Overall Study|Withdrawal by Subject|4|||
33167898|NCT01192516|100521648|FG001|Overall Study|Withdrawal by Subject|4|||
33167899|NCT01192516|100521649|FG002|Overall Study|Withdrawal by Subject|1|||
33167900|NCT01192516|100521647|FG000|Overall Study|started new treatment|5|||
33167901|NCT01192516|100521648|FG001|Overall Study|started new treatment|1|||
33167902|NCT01192516|100521649|FG002|Overall Study|started new treatment|0|||
33167903|NCT01192516|100521647|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
33167904|NCT01192516|100521648|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
33167905|NCT01192516|100521649|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
33167906|NCT05048784|100521652|FG000|Period 1|Adverse Event|3|||
33167907|NCT05048784|100521653|FG001|Period 1|Adverse Event|1|||
33167908|NCT05048784|100521654|FG002|Period 1|Adverse Event|0|||
33167909|NCT05048784|100521655|FG003|Period 1|Adverse Event|0|||
33167910|NCT05048784|100521652|FG000|Period 2|Lost to Follow-up|0|||
33167911|NCT05048784|100521653|FG001|Period 2|Lost to Follow-up|1|||
33167912|NCT05048784|100521654|FG002|Period 2|Lost to Follow-up|0|||
33167913|NCT05048784|100521655|FG003|Period 2|Lost to Follow-up|0|||
33167914|NCT03217175|100521656|FG000|Overall Study|Physician Decision|4|||
33167915|NCT03217175|100521657|FG001|Overall Study|Physician Decision|1|||
33167916|NCT00777608|100521667|FG000|Overall Study|Lost to Follow-up|1|||
33167917|NCT00777608|100521668|FG001|Overall Study|Lost to Follow-up|1|||
33167918|NCT00777608|100521667|FG000|Overall Study|Withdrawal by Subject|1|||
33167919|NCT00777608|100521668|FG001|Overall Study|Withdrawal by Subject|3|||
33167920|NCT00777608|100521667|FG000|Overall Study|Protocol Violation|1|||
33167921|NCT00777608|100521668|FG001|Overall Study|Protocol Violation|0|||
33167922|NCT00777608|100521667|FG000|Overall Study|Investigator Decision|1|||
33167923|NCT00777608|100521668|FG001|Overall Study|Investigator Decision|2|||
33167924|NCT01063868|100521670|FG000|Overall Study|Adverse Event|9|||
33167925|NCT01063868|100521671|FG001|Overall Study|Adverse Event|7|||
33167926|NCT01063868|100521670|FG000|Overall Study|Withdrawal by Subject|3|||
33167927|NCT01063868|100521671|FG001|Overall Study|Withdrawal by Subject|1|||
33167928|NCT01063868|100521670|FG000|Overall Study|Study Terminated By Sponsor|23|||
33167929|NCT01063868|100521671|FG001|Overall Study|Study Terminated By Sponsor|4|||
33167930|NCT01397084|100521674|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
33167931|NCT01397084|100521674|FG000|Overall Study|Protocol Violation|2|||
33167932|NCT01397084|100521674|FG000|Overall Study|Adverse Event|2|||
33167933|NCT01397084|100521674|FG000|Overall Study|Withdrawal by Subject|1|||
33167934|NCT01397084|100521674|FG000|Overall Study|Lost to Follow-up|1|||
33167935|NCT01397084|100521674|FG000|Overall Study|Used other proton pump inhibitor|1|||
33167936|NCT00105469|100521675|FG000|Overall Study|Adverse Event|9|||
33167937|NCT00105469|100521676|FG001|Overall Study|Adverse Event|8|||
33167938|NCT00105469|100521675|FG000|Overall Study|Protocol Violation|4|||
33167939|NCT00105469|100521676|FG001|Overall Study|Protocol Violation|0|||
33167940|NCT00105469|100521675|FG000|Overall Study|Withdrawal by Subject|2|||
33448826|NCT01796171|101535894|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
33448827|NCT01796171|101535895|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
33448828|NCT01796171|101535896|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
33448829|NCT01796171|101535897|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
33448830|NCT01796171|101535883|FG000|Treatment Period With Betalutin|Progressive disease|0|||
33448831|NCT01796171|101535884|FG001|Treatment Period With Betalutin|Progressive disease|1|||
33448832|NCT01796171|101535885|FG002|Treatment Period With Betalutin|Progressive disease|0|||
33259919|NCT00709098|100853464|FG001|Double-blind Period|Withdrawal of consent|3|||
33259920|NCT00709098|100853465|FG002|Double-blind Period|Withdrawal of consent|0|||
33259921|NCT00709098|100853463|FG000|Double-blind Period|Administrative reason|1|||
33259922|NCT00709098|100853464|FG001|Double-blind Period|Administrative reason|3|||
33259923|NCT00709098|100853465|FG002|Double-blind Period|Administrative reason|0|||
33259924|NCT00709098|100853463|FG000|Double-blind Period|Death|1|||
33259925|NCT00709098|100853464|FG001|Double-blind Period|Death|1|||
33259926|NCT00709098|100853465|FG002|Double-blind Period|Death|0|||
33259927|NCT00709098|100853463|FG000|Double-blind Period|Lost to Follow-up|1|||
33259928|NCT00709098|100853464|FG001|Double-blind Period|Lost to Follow-up|1|||
33259929|NCT00709098|100853465|FG002|Double-blind Period|Lost to Follow-up|0|||
33259930|NCT00709098|100853463|FG000|Open-label Period|Withdrawal of consent|0|||
33259931|NCT00709098|100853464|FG001|Open-label Period|Withdrawal of consent|0|||
33259932|NCT00709098|100853465|FG002|Open-label Period|Withdrawal of consent|7|||
33259933|NCT00709098|100853463|FG000|Open-label Period|Administrative reason|0|||
33259934|NCT00709098|100853464|FG001|Open-label Period|Administrative reason|0|||
33259935|NCT00709098|100853465|FG002|Open-label Period|Administrative reason|5|||
33259936|NCT00709098|100853463|FG000|Open-label Period|Death|0|||
33259937|NCT00709098|100853464|FG001|Open-label Period|Death|0|||
33259938|NCT00709098|100853465|FG002|Open-label Period|Death|1|||
33259939|NCT00709098|100853463|FG000|Open-label Period|Lost to Follow-up|0|||
33259940|NCT00709098|100853464|FG001|Open-label Period|Lost to Follow-up|0|||
33259941|NCT00709098|100853465|FG002|Open-label Period|Lost to Follow-up|1|||
33259942|NCT02590432|100853466|FG000|Open-label Treatment Period|Adverse Event|97|||
33259943|NCT02590432|100853467|FG001|Open-label Treatment Period|Adverse Event|79|||
33259944|NCT02590432|100853468|FG002|Open-label Treatment Period|Adverse Event|0|||
33259945|NCT02590432|100853469|FG003|Open-label Treatment Period|Adverse Event|0|||
33448833|NCT01796171|101535886|FG003|Treatment Period With Betalutin|Progressive disease|0|||
33448834|NCT01796171|101535887|FG004|Treatment Period With Betalutin|Progressive disease|0|||
33448835|NCT01796171|101535888|FG005|Treatment Period With Betalutin|Progressive disease|0|||
33448836|NCT01796171|101535889|FG006|Treatment Period With Betalutin|Progressive disease|0|||
33167941|NCT00105469|100521676|FG001|Overall Study|Withdrawal by Subject|3|||
33167942|NCT00105469|100521675|FG000|Overall Study|Lost to Follow-up|1|||
33167943|NCT00105469|100521676|FG001|Overall Study|Lost to Follow-up|0|||
33259946|NCT02590432|100853470|FG004|Open-label Treatment Period|Adverse Event|0|||
33259947|NCT02590432|100853471|FG005|Open-label Treatment Period|Adverse Event|0|||
33448837|NCT01796171|101535890|FG007|Treatment Period With Betalutin|Progressive disease|0|||
33448838|NCT01796171|101535891|FG008|Treatment Period With Betalutin|Progressive disease|0|||
33448839|NCT01796171|101535892|FG009|Treatment Period With Betalutin|Progressive disease|0|||
33448840|NCT01796171|101535893|FG010|Treatment Period With Betalutin|Progressive disease|0|||
33448841|NCT01796171|101535894|FG011|Treatment Period With Betalutin|Progressive disease|0|||
33259948|NCT02590432|100853472|FG006|Open-label Treatment Period|Adverse Event|0|||
33259949|NCT02590432|100853473|FG007|Open-label Treatment Period|Adverse Event|0|||
33259950|NCT02590432|100853474|FG008|Open-label Treatment Period|Adverse Event|0|||
33448842|NCT01796171|101535895|FG012|Treatment Period With Betalutin|Progressive disease|0|||
33448843|NCT01796171|101535896|FG013|Treatment Period With Betalutin|Progressive disease|0|||
33448844|NCT01796171|101535897|FG014|Treatment Period With Betalutin|Progressive disease|0|||
33448845|NCT01796171|101535883|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
33448846|NCT01796171|101535884|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
33448847|NCT01796171|101535885|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
33448848|NCT01796171|101535886|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
33448849|NCT01796171|101535887|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
33448850|NCT01796171|101535888|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
33448851|NCT01796171|101535889|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
33448852|NCT01796171|101535890|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
33448853|NCT01796171|101535891|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
33167944|NCT00105469|100521675|FG000|Overall Study|Lack of Efficacy|2|||
33167945|NCT00105469|100521676|FG001|Overall Study|Lack of Efficacy|0|||
33167946|NCT00105469|100521675|FG000|Overall Study|Other Reason|4|||
33167947|NCT00105469|100521676|FG001|Overall Study|Other Reason|0|||
33167948|NCT00127660|100521677|FG000|Overall Study|Protocol Violation|3|||
33167949|NCT00127660|100521678|FG001|Overall Study|Protocol Violation|3|||
33167950|NCT00127660|100521679|FG002|Overall Study|Protocol Violation|5|||
33167951|NCT00127660|100521680|FG003|Overall Study|Protocol Violation|0|||
33167952|NCT02007109|100521681|FG000|Overall Study|Diary not returned or excluded|102|||
33167953|NCT02007109|100521681|FG000|Overall Study|Excluded - Age<7yo|9|||
33167954|NCT00752232|100521682|FG000|Overall Study|Protocol Violation|0|||
33167955|NCT00752232|100521683|FG001|Overall Study|Protocol Violation|0|||
33167956|NCT00752232|100521684|FG002|Overall Study|Protocol Violation|0|||
33167957|NCT00752232|100521685|FG003|Overall Study|Protocol Violation|0|||
33167958|NCT00752232|100521686|FG004|Overall Study|Protocol Violation|0|||
33167959|NCT00752232|100521687|FG005|Overall Study|Protocol Violation|1|||
33167960|NCT00752232|100521688|FG006|Overall Study|Protocol Violation|0|||
33167961|NCT00752232|100521682|FG000|Overall Study|Caregiver request|2|||
33448854|NCT01796171|101535892|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
33167962|NCT00752232|100521683|FG001|Overall Study|Caregiver request|0|||
33167963|NCT00752232|100521684|FG002|Overall Study|Caregiver request|0|||
33167964|NCT00752232|100521685|FG003|Overall Study|Caregiver request|0|||
33167965|NCT00752232|100521686|FG004|Overall Study|Caregiver request|1|||
33167966|NCT00752232|100521687|FG005|Overall Study|Caregiver request|0|||
33167967|NCT00752232|100521688|FG006|Overall Study|Caregiver request|0|||
33167968|NCT00752232|100521682|FG000|Overall Study|Investigator request|0|||
33167969|NCT00752232|100521683|FG001|Overall Study|Investigator request|0|||
33167970|NCT00752232|100521684|FG002|Overall Study|Investigator request|0|||
33167971|NCT00752232|100521685|FG003|Overall Study|Investigator request|0|||
33167972|NCT00752232|100521686|FG004|Overall Study|Investigator request|1|||
33167973|NCT00752232|100521687|FG005|Overall Study|Investigator request|0|||
33167974|NCT00752232|100521688|FG006|Overall Study|Investigator request|0|||
33167975|NCT00752232|100521682|FG000|Overall Study|Subject request|0|||
33167976|NCT00752232|100521683|FG001|Overall Study|Subject request|0|||
33167977|NCT00752232|100521684|FG002|Overall Study|Subject request|1|||
33167978|NCT00752232|100521685|FG003|Overall Study|Subject request|0|||
33167979|NCT00752232|100521686|FG004|Overall Study|Subject request|0|||
33167980|NCT00752232|100521687|FG005|Overall Study|Subject request|0|||
33167981|NCT00752232|100521688|FG006|Overall Study|Subject request|0|||
33167982|NCT00752232|100521682|FG000|Overall Study|Group home admission|0|||
33167983|NCT00752232|100521683|FG001|Overall Study|Group home admission|0|||
33167984|NCT00752232|100521684|FG002|Overall Study|Group home admission|0|||
33167985|NCT00752232|100521685|FG003|Overall Study|Group home admission|1|||
33259951|NCT02590432|100853466|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
33167986|NCT00752232|100521686|FG004|Overall Study|Group home admission|0|||
33167987|NCT00752232|100521687|FG005|Overall Study|Group home admission|0|||
33167988|NCT00752232|100521688|FG006|Overall Study|Group home admission|0|||
33167989|NCT00752232|100521682|FG000|Overall Study|Caregiver could not attend the subject|0|||
33167990|NCT00752232|100521683|FG001|Overall Study|Caregiver could not attend the subject|0|||
33167991|NCT00752232|100521684|FG002|Overall Study|Caregiver could not attend the subject|0|||
33167992|NCT00752232|100521685|FG003|Overall Study|Caregiver could not attend the subject|0|||
33167993|NCT00752232|100521686|FG004|Overall Study|Caregiver could not attend the subject|1|||
33167994|NCT00752232|100521687|FG005|Overall Study|Caregiver could not attend the subject|0|||
33167995|NCT00752232|100521688|FG006|Overall Study|Caregiver could not attend the subject|0|||
33167996|NCT02634320|100521689|FG000|Overall Study|Adverse Event|2|||
33167997|NCT02634320|100521689|FG000|Overall Study|Lost to Follow-up|3|||
33167998|NCT02634320|100521689|FG000|Overall Study|Moved out of area|2|||
33167999|NCT02634320|100521689|FG000|Overall Study|Out of window for study visits|1|||
33168000|NCT02634320|100521689|FG000|Overall Study|Protocol Violation|1|||
33168001|NCT02634320|100521689|FG000|Overall Study|Withdrawal by Subject|5|||
33168002|NCT02634320|100521689|FG000|Overall Study|Lack of Efficacy|2|||
33168003|NCT00496054|100521694|FG000|Overall Study|Adverse Event|1|||
33168004|NCT00496054|100521694|FG000|Overall Study|Lost to Follow-up|7|||
33168005|NCT04584645|100521699|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
33168006|NCT04584645|100521700|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
33168007|NCT02820753|100521701|FG000|2 Month|Withdrawal by Subject|3|||
33168008|NCT02820753|100521702|FG001|2 Month|Withdrawal by Subject|3|||
33168009|NCT02820753|100521701|FG000|2 Month|Lost to Follow-up|24|||
33168010|NCT02820753|100521702|FG001|2 Month|Lost to Follow-up|26|||
33168011|NCT02820753|100521701|FG000|2 Month|Stopped per NIH Hold|51|||
33168012|NCT02820753|100521702|FG001|2 Month|Stopped per NIH Hold|13|||
33168013|NCT02820753|100521701|FG000|6 Month|Withdrawal by Subject|2|||
33168014|NCT02820753|100521702|FG001|6 Month|Withdrawal by Subject|2|||
33168015|NCT02820753|100521701|FG000|6 Month|Lost to Follow-up|20|||
33168016|NCT02820753|100521702|FG001|6 Month|Lost to Follow-up|27|||
33168017|NCT02820753|100521701|FG000|6 Month|Stopped per NIH Hold|81|||
33168018|NCT02820753|100521702|FG001|6 Month|Stopped per NIH Hold|81|||
33168019|NCT02820753|100521701|FG000|6 Month|Death|0|||
33168020|NCT02820753|100521702|FG001|6 Month|Death|1|||
33168021|NCT00840450|100521705|FG000|Overall Study|Adverse Event|1|||
33168022|NCT00840450|100521705|FG000|Overall Study|Lack of Efficacy|2|||
33168023|NCT00160693|100521706|FG000|Overall Study|Adverse Event|97|||
33168024|NCT00160693|100521706|FG000|Overall Study|Lack of Efficacy|30|||
33448855|NCT01796171|101535893|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
33448856|NCT01796171|101535894|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
33448857|NCT01796171|101535895|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
33448858|NCT01796171|101535896|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
33448859|NCT01796171|101535897|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
33448860|NCT01796171|101535883|FG000|Treatment Period With Betalutin|Physician Decision|0|||
33448861|NCT01796171|101535884|FG001|Treatment Period With Betalutin|Physician Decision|0|||
33448862|NCT01796171|101535885|FG002|Treatment Period With Betalutin|Physician Decision|0|||
33448863|NCT01796171|101535886|FG003|Treatment Period With Betalutin|Physician Decision|0|||
33448864|NCT01796171|101535887|FG004|Treatment Period With Betalutin|Physician Decision|0|||
33168025|NCT00160693|100521706|FG000|Overall Study|Protocol Violation|24|||
33168026|NCT00160693|100521706|FG000|Overall Study|Lost to Follow-up|15|||
33168027|NCT00160693|100521706|FG000|Overall Study|Withdrawal by Subject|54|||
33168028|NCT00160693|100521706|FG000|Overall Study|Study terminated by sponsor|15|||
33168029|NCT00801632|100521707|FG000|Overall Study|Re-transplant|1|||
33168030|NCT01691781|100521708|FG000|Overall Study|Withdrawal by Subject|4|||
33168031|NCT01691781|100521709|FG001|Overall Study|Withdrawal by Subject|3|||
33168032|NCT01691781|100521708|FG000|Overall Study|Physician Decision|1|||
33168033|NCT01691781|100521709|FG001|Overall Study|Physician Decision|1|||
33168034|NCT01691781|100521708|FG000|Overall Study|Protocol Violation|2|||
33168035|NCT01691781|100521709|FG001|Overall Study|Protocol Violation|2|||
33168036|NCT01691781|100521708|FG000|Overall Study|Adverse Event|0|||
33168037|NCT01691781|100521709|FG001|Overall Study|Adverse Event|1|||
33168038|NCT02944968|100521710|FG000|Overall Study|Subject excluded before study procedure|1|||
33168039|NCT02944968|100521710|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
33168040|NCT01830972|100521711|FG000|Part II|Withdrawal by Subject|2|||
33168041|NCT01830972|100521712|FG001|Part II|Withdrawal by Subject|2|||
33168042|NCT01830972|100521711|FG000|Part III|Withdrawal by Subject|1|||
33168043|NCT01830972|100521712|FG001|Part III|Withdrawal by Subject|0|||
33168044|NCT01830972|100521711|FG000|Part III|Noncompliance|1|||
33168045|NCT01830972|100521712|FG001|Part III|Noncompliance|0|||
33168046|NCT01830972|100521711|FG000|Part IV|Withdrawal by Subject|2|||
33168047|NCT01830972|100521712|FG001|Part IV|Withdrawal by Subject|1|||
33168048|NCT01830972|100521711|FG000|Part IV|Non-Compliance|1|||
33168049|NCT01830972|100521712|FG001|Part IV|Non-Compliance|0|||
33168050|NCT02340975|100521716|FG000|Overall Study|Death|6|||
33168051|NCT02340975|100521717|FG001|Overall Study|Death|23|||
33168052|NCT02340975|100521718|FG002|Overall Study|Death|21|||
33168053|NCT02340975|100521719|FG003|Overall Study|Death|7|||
33448865|NCT01796171|101535888|FG005|Treatment Period With Betalutin|Physician Decision|0|||
33448866|NCT01796171|101535889|FG006|Treatment Period With Betalutin|Physician Decision|0|||
33168054|NCT02340975|100521720|FG004|Overall Study|Death|21|||
33168055|NCT02340975|100521721|FG005|Overall Study|Death|13|||
33168056|NCT02340975|100521716|FG000|Overall Study|Lost to Follow-up|0|||
33168057|NCT02340975|100521717|FG001|Overall Study|Lost to Follow-up|0|||
33168058|NCT02340975|100521718|FG002|Overall Study|Lost to Follow-up|0|||
33168059|NCT02340975|100521719|FG003|Overall Study|Lost to Follow-up|0|||
33168060|NCT02340975|100521720|FG004|Overall Study|Lost to Follow-up|2|||
33259952|NCT02590432|100853467|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
33259953|NCT02590432|100853468|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
33168061|NCT02340975|100521721|FG005|Overall Study|Lost to Follow-up|0|||
33168062|NCT02340975|100521716|FG000|Overall Study|Withdrawal by Subject|0|||
33168063|NCT02340975|100521717|FG001|Overall Study|Withdrawal by Subject|0|||
33168064|NCT02340975|100521718|FG002|Overall Study|Withdrawal by Subject|3|||
33168065|NCT02340975|100521719|FG003|Overall Study|Withdrawal by Subject|3|||
33168066|NCT02340975|100521720|FG004|Overall Study|Withdrawal by Subject|2|||
33168067|NCT02340975|100521721|FG005|Overall Study|Withdrawal by Subject|0|||
33168068|NCT02340975|100521716|FG000|Overall Study|Other|0|||
33168069|NCT02340975|100521717|FG001|Overall Study|Other|4|||
33168070|NCT02340975|100521718|FG002|Overall Study|Other|0|||
33168071|NCT02340975|100521719|FG003|Overall Study|Other|2|||
33168072|NCT02340975|100521720|FG004|Overall Study|Other|0|||
33168073|NCT02340975|100521721|FG005|Overall Study|Other|6|||
33168074|NCT03428360|100521724|FG000|Overall Study|Informed consent withdrawn|5|||
33168075|NCT03428360|100521724|FG000|Overall Study|Withdrawal by Subject|4|||
33168076|NCT03428360|100521724|FG000|Overall Study|Lost to Follow-up|5|||
33168077|NCT03428360|100521724|FG000|Overall Study|Physician Decision|2|||
33168078|NCT03428360|100521724|FG000|Overall Study|Informed consent withdrawn|5|||
33168079|NCT03428360|100521724|FG000|Overall Study|Study terminated by sponsor|10|||
33168080|NCT03428360|100521724|FG000|Overall Study|Non-compliant with study|1|||
33168081|NCT03428360|100521724|FG000|Overall Study|Non-compliant with study drug|3|||
33168082|NCT03428360|100521724|FG000|Overall Study|Death|3|||
33168083|NCT03428360|100521724|FG000|Overall Study|Adverse Event|1|||
33168084|NCT03428360|100521724|FG000|Overall Study|Not on antiepileptic drug|1|||
33168085|NCT03310021|100521729|FG000|Overall Study|Withdrawal by Subject|0|||
33168086|NCT03310021|100521730|FG001|Overall Study|Withdrawal by Subject|0|||
33168087|NCT03310021|100521731|FG002|Overall Study|Withdrawal by Subject|0|||
33168088|NCT03310021|100521732|FG003|Overall Study|Withdrawal by Subject|0|||
33168089|NCT03310021|100521733|FG004|Overall Study|Withdrawal by Subject|0|||
33168090|NCT03310021|100521734|FG005|Overall Study|Withdrawal by Subject|0|||
33168091|NCT03310021|100521735|FG006|Overall Study|Withdrawal by Subject|1|||
33168092|NCT03310021|100521736|FG007|Overall Study|Withdrawal by Subject|0|||
33168093|NCT03310021|100521737|FG008|Overall Study|Withdrawal by Subject|0|||
33168094|NCT03310021|100521738|FG009|Overall Study|Withdrawal by Subject|0|||
33168095|NCT03310021|100521739|FG010|Overall Study|Withdrawal by Subject|0|||
33168096|NCT03310021|100521740|FG011|Overall Study|Withdrawal by Subject|0|||
33168097|NCT03310021|100521741|FG012|Overall Study|Withdrawal by Subject|0|||
33168098|NCT03310021|100521742|FG013|Overall Study|Withdrawal by Subject|0|||
33168099|NCT03310021|100521743|FG014|Overall Study|Withdrawal by Subject|0|||
33168100|NCT03310021|100521744|FG015|Overall Study|Withdrawal by Subject|0|||
33168101|NCT03310021|100521745|FG016|Overall Study|Withdrawal by Subject|0|||
33168102|NCT03310021|100521746|FG017|Overall Study|Withdrawal by Subject|0|||
33168103|NCT03310021|100521747|FG018|Overall Study|Withdrawal by Subject|0|||
33168104|NCT03310021|100521748|FG019|Overall Study|Withdrawal by Subject|0|||
33168105|NCT03310021|100521729|FG000|Overall Study|Lost to Follow-up|0|||
33168106|NCT03310021|100521730|FG001|Overall Study|Lost to Follow-up|0|||
33168107|NCT03310021|100521731|FG002|Overall Study|Lost to Follow-up|0|||
33168108|NCT03310021|100521732|FG003|Overall Study|Lost to Follow-up|0|||
33168109|NCT03310021|100521733|FG004|Overall Study|Lost to Follow-up|0|||
33168110|NCT03310021|100521734|FG005|Overall Study|Lost to Follow-up|0|||
33168111|NCT03310021|100521735|FG006|Overall Study|Lost to Follow-up|0|||
33168112|NCT03310021|100521736|FG007|Overall Study|Lost to Follow-up|0|||
33168113|NCT03310021|100521737|FG008|Overall Study|Lost to Follow-up|0|||
33168114|NCT03310021|100521738|FG009|Overall Study|Lost to Follow-up|0|||
33168115|NCT03310021|100521739|FG010|Overall Study|Lost to Follow-up|1|||
33168116|NCT03310021|100521740|FG011|Overall Study|Lost to Follow-up|0|||
33168117|NCT03310021|100521741|FG012|Overall Study|Lost to Follow-up|0|||
33168118|NCT03310021|100521742|FG013|Overall Study|Lost to Follow-up|0|||
33168119|NCT03310021|100521743|FG014|Overall Study|Lost to Follow-up|0|||
33168120|NCT03310021|100521744|FG015|Overall Study|Lost to Follow-up|0|||
33168121|NCT03310021|100521745|FG016|Overall Study|Lost to Follow-up|0|||
33168122|NCT03310021|100521746|FG017|Overall Study|Lost to Follow-up|0|||
33168123|NCT03310021|100521747|FG018|Overall Study|Lost to Follow-up|0|||
33168124|NCT03310021|100521748|FG019|Overall Study|Lost to Follow-up|0|||
33168125|NCT02848651|100521749|FG000|Overall Study|Death|85|||
33168126|NCT02848651|100521749|FG000|Overall Study|Lost to Follow-up|1|||
33168127|NCT02848651|100521749|FG000|Overall Study|Non-Compliance|1|||
33168128|NCT02848651|100521749|FG000|Overall Study|Symptomatic Deterioration|1|||
33168129|NCT02848651|100521749|FG000|Overall Study|Physician Decision|4|||
33168130|NCT02848651|100521749|FG000|Overall Study|Withdrawal by Subject|14|||
33168131|NCT00576927|100521750|FG000|Clinical Assessment|Lack of Efficacy|24|||
33168132|NCT00576927|100521750|FG000|Clinical Assessment|Death|1|||
33168133|NCT00576927|100521750|FG000|Clinical Assessment|Withdrawal by Subject|10|||
33168134|NCT00576927|100521750|FG000|Clinical Assessment|Physician Decision|1|||
33168135|NCT00576927|100521750|FG000|Baseline|Physician Decision|9|||
33168136|NCT00576927|100521750|FG000|Baseline|Medication Change by PCP of subject|1|||
33168137|NCT00576927|100521750|FG000|Baseline|Withdrawal by Subject|3|||
33168138|NCT00576927|100521750|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
33168139|NCT00576927|100521750|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
33168140|NCT00576927|100521750|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
33168141|NCT00576927|100521750|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
33168142|NCT00576927|100521750|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
33168143|NCT00536198|100521753|FG000|Overall Study|Lost to Follow-up|15|||
33168144|NCT00536198|100521754|FG001|Overall Study|Lost to Follow-up|14|||
33168145|NCT00536198|100521753|FG000|Overall Study|Withdrawal by Subject|16|||
33168146|NCT00536198|100521754|FG001|Overall Study|Withdrawal by Subject|12|||
33168147|NCT00536198|100521753|FG000|Overall Study|Adverse Event|2|||
33168148|NCT00536198|100521754|FG001|Overall Study|Adverse Event|2|||
33168149|NCT00536198|100521753|FG000|Overall Study|Rescue|3|||
33168150|NCT00536198|100521754|FG001|Overall Study|Rescue|9|||
33168151|NCT00536198|100521753|FG000|Overall Study|Pregnancy|1|||
33168152|NCT00536198|100521754|FG001|Overall Study|Pregnancy|1|||
33168153|NCT00536198|100521753|FG000|Overall Study|Protocol Violation|0|||
33168154|NCT00536198|100521754|FG001|Overall Study|Protocol Violation|1|||
33168155|NCT02268084|100521756|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
33168156|NCT02268084|100521757|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
33168157|NCT02268084|100521756|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
33168158|NCT02268084|100521757|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
33168159|NCT02380677|100521761|FG000|Overall Study|Adverse Event|0|||
33168160|NCT02380677|100521762|FG001|Overall Study|Adverse Event|0|||
33259954|NCT02590432|100853469|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
33448867|NCT01796171|101535890|FG007|Treatment Period With Betalutin|Physician Decision|0|||
33448868|NCT01796171|101535891|FG008|Treatment Period With Betalutin|Physician Decision|0|||
33448869|NCT01796171|101535892|FG009|Treatment Period With Betalutin|Physician Decision|0|||
33168161|NCT02380677|100521763|FG002|Overall Study|Adverse Event|0|||
33168162|NCT02380677|100521764|FG003|Overall Study|Adverse Event|1|||
33168163|NCT02380677|100521765|FG004|Overall Study|Adverse Event|1|||
33168164|NCT02380677|100521766|FG005|Overall Study|Adverse Event|4|||
33168165|NCT02380677|100521767|FG006|Overall Study|Adverse Event|2|||
33168166|NCT02380677|100521768|FG007|Overall Study|Adverse Event|2|||
33168167|NCT02380677|100521769|FG008|Overall Study|Adverse Event|2|||
33168168|NCT02380677|100521770|FG009|Overall Study|Adverse Event|1|||
33168169|NCT02380677|100521771|FG010|Overall Study|Adverse Event|2|||
33259955|NCT02590432|100853470|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
33259956|NCT02590432|100853471|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
33259957|NCT02590432|100853472|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
33259958|NCT02590432|100853473|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
33259959|NCT02590432|100853474|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
33259960|NCT02590432|100853466|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
33259961|NCT02590432|100853467|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
33259962|NCT02590432|100853468|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
33259963|NCT02590432|100853469|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
33259964|NCT02590432|100853470|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
33259965|NCT02590432|100853471|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
33259966|NCT02590432|100853472|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
33259967|NCT02590432|100853473|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
33259968|NCT02590432|100853474|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
33259969|NCT02590432|100853466|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
33259970|NCT02590432|100853467|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
33259971|NCT02590432|100853468|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
33259972|NCT02590432|100853469|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
33259973|NCT02590432|100853470|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
33259974|NCT02590432|100853471|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
33259975|NCT02590432|100853472|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
33259976|NCT02590432|100853473|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
33259977|NCT02590432|100853474|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
33259978|NCT02590432|100853466|FG000|Open-label Treatment Period|Protocol Violation|10|||
33259979|NCT02590432|100853467|FG001|Open-label Treatment Period|Protocol Violation|4|||
33259980|NCT02590432|100853468|FG002|Open-label Treatment Period|Protocol Violation|0|||
33259981|NCT02590432|100853469|FG003|Open-label Treatment Period|Protocol Violation|0|||
33259982|NCT02590432|100853470|FG004|Open-label Treatment Period|Protocol Violation|0|||
33259983|NCT02590432|100853471|FG005|Open-label Treatment Period|Protocol Violation|0|||
33259984|NCT02590432|100853472|FG006|Open-label Treatment Period|Protocol Violation|0|||
33259985|NCT02590432|100853473|FG007|Open-label Treatment Period|Protocol Violation|0|||
33259986|NCT02590432|100853474|FG008|Open-label Treatment Period|Protocol Violation|0|||
33259987|NCT02590432|100853466|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
33259988|NCT02590432|100853467|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
33259989|NCT02590432|100853468|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
33259990|NCT02590432|100853469|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
33448870|NCT01796171|101535893|FG010|Treatment Period With Betalutin|Physician Decision|5|||
33448871|NCT01796171|101535894|FG011|Treatment Period With Betalutin|Physician Decision|1|||
33448872|NCT01796171|101535895|FG012|Treatment Period With Betalutin|Physician Decision|1|||
33448873|NCT01796171|101535896|FG013|Treatment Period With Betalutin|Physician Decision|0|||
33448874|NCT01796171|101535897|FG014|Treatment Period With Betalutin|Physician Decision|0|||
33448875|NCT01796171|101535883|FG000|Treatment Period With Betalutin|Death|0|||
33448876|NCT01796171|101535884|FG001|Treatment Period With Betalutin|Death|0|||
33448877|NCT01796171|101535885|FG002|Treatment Period With Betalutin|Death|0|||
33448878|NCT01796171|101535886|FG003|Treatment Period With Betalutin|Death|0|||
33448879|NCT01796171|101535887|FG004|Treatment Period With Betalutin|Death|0|||
33448880|NCT01796171|101535888|FG005|Treatment Period With Betalutin|Death|0|||
33448881|NCT01796171|101535889|FG006|Treatment Period With Betalutin|Death|0|||
33448882|NCT01796171|101535890|FG007|Treatment Period With Betalutin|Death|0|||
33448883|NCT01796171|101535891|FG008|Treatment Period With Betalutin|Death|0|||
33448884|NCT01796171|101535892|FG009|Treatment Period With Betalutin|Death|0|||
33448885|NCT01796171|101535893|FG010|Treatment Period With Betalutin|Death|2|||
33448886|NCT01796171|101535894|FG011|Treatment Period With Betalutin|Death|0|||
33448887|NCT01796171|101535895|FG012|Treatment Period With Betalutin|Death|0|||
33448888|NCT01796171|101535896|FG013|Treatment Period With Betalutin|Death|0|||
33448889|NCT01796171|101535897|FG014|Treatment Period With Betalutin|Death|0|||
33448890|NCT01796171|101535883|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
33448891|NCT01796171|101535884|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
33448892|NCT01796171|101535885|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
33448893|NCT01796171|101535886|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
33448894|NCT01796171|101535887|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
33448895|NCT01796171|101535888|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
33448896|NCT01796171|101535889|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
33448897|NCT01796171|101535890|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
33259991|NCT02590432|100853470|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
33168170|NCT02380677|100521772|FG011|Overall Study|Adverse Event|1|||
33168171|NCT02380677|100521761|FG000|Overall Study|Physician Decision|1|||
33448898|NCT01796171|101535891|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
33448899|NCT01796171|101535892|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
33448900|NCT01796171|101535893|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
33448901|NCT01796171|101535894|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
33448902|NCT01796171|101535895|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
33448903|NCT01796171|101535896|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
33448904|NCT01796171|101535897|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
33168172|NCT02380677|100521762|FG001|Overall Study|Physician Decision|0|||
33168173|NCT02380677|100521763|FG002|Overall Study|Physician Decision|1|||
33168174|NCT02380677|100521764|FG003|Overall Study|Physician Decision|1|||
33168175|NCT02380677|100521765|FG004|Overall Study|Physician Decision|0|||
33168176|NCT02380677|100521766|FG005|Overall Study|Physician Decision|0|||
33168177|NCT02380677|100521767|FG006|Overall Study|Physician Decision|0|||
33168178|NCT02380677|100521768|FG007|Overall Study|Physician Decision|0|||
33259992|NCT02590432|100853471|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
33259993|NCT02590432|100853472|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
33259994|NCT02590432|100853473|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
33259995|NCT02590432|100853474|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
33259996|NCT02590432|100853466|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
33259997|NCT02590432|100853467|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
33259998|NCT02590432|100853468|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
33259999|NCT02590432|100853469|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
33260000|NCT02590432|100853470|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
33260001|NCT02590432|100853471|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
33260002|NCT02590432|100853472|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
33260003|NCT02590432|100853473|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
33260004|NCT02590432|100853474|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
33260005|NCT02590432|100853466|FG000|Double-blind Treatment Period|Adverse Event|0|||
33260006|NCT02590432|100853467|FG001|Double-blind Treatment Period|Adverse Event|0|||
33260007|NCT02590432|100853468|FG002|Double-blind Treatment Period|Adverse Event|14|||
33260008|NCT02590432|100853469|FG003|Double-blind Treatment Period|Adverse Event|12|||
33260009|NCT02590432|100853470|FG004|Double-blind Treatment Period|Adverse Event|6|||
33260010|NCT02590432|100853471|FG005|Double-blind Treatment Period|Adverse Event|22|||
33260011|NCT02590432|100853472|FG006|Double-blind Treatment Period|Adverse Event|20|||
33260012|NCT02590432|100853473|FG007|Double-blind Treatment Period|Adverse Event|0|||
33260013|NCT02590432|100853474|FG008|Double-blind Treatment Period|Adverse Event|0|||
33260014|NCT02590432|100853466|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
33260015|NCT02590432|100853467|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
33448905|NCT01796171|101535883|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
33448906|NCT01796171|101535884|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
33448907|NCT01796171|101535885|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
33448908|NCT01796171|101535886|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
33448909|NCT01796171|101535887|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
33448910|NCT01796171|101535888|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
33448911|NCT01796171|101535889|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
33448912|NCT01796171|101535890|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
33448913|NCT01796171|101535891|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
33448914|NCT01796171|101535892|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
33448915|NCT01796171|101535893|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
33448916|NCT01796171|101535894|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
33448917|NCT01796171|101535895|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
33448918|NCT01796171|101535896|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
33448919|NCT01796171|101535897|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
33260016|NCT02590432|100853468|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
33260017|NCT02590432|100853469|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
33260018|NCT02590432|100853470|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
33260019|NCT02590432|100853471|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
33260020|NCT02590432|100853472|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
33260021|NCT02590432|100853473|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
33260022|NCT02590432|100853474|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
33260023|NCT02590432|100853466|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
33260024|NCT02590432|100853467|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
33260025|NCT02590432|100853468|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
33260026|NCT02590432|100853469|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
33260027|NCT02590432|100853470|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
33260028|NCT02590432|100853471|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
33260029|NCT02590432|100853472|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
33260030|NCT02590432|100853473|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
33260031|NCT02590432|100853474|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
33260032|NCT02590432|100853466|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
33260033|NCT02590432|100853467|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
33260034|NCT02590432|100853468|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
33260035|NCT02590432|100853469|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
33260036|NCT02590432|100853470|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
33260037|NCT02590432|100853471|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
33260038|NCT02590432|100853472|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
33260039|NCT02590432|100853473|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
33260040|NCT02590432|100853474|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
33260041|NCT02590432|100853466|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33260042|NCT02590432|100853467|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33260043|NCT02590432|100853468|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33260044|NCT02590432|100853469|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33260045|NCT02590432|100853470|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33260046|NCT02590432|100853471|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
33260047|NCT02590432|100853472|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33260048|NCT02590432|100853473|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33260049|NCT02590432|100853474|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
33260050|NCT02590432|100853466|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
33260051|NCT02590432|100853467|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
33260052|NCT02590432|100853468|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
33260053|NCT02590432|100853469|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
33260054|NCT02590432|100853470|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
33260055|NCT02590432|100853471|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
33260056|NCT02590432|100853472|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
33260057|NCT02590432|100853473|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
33260058|NCT02590432|100853474|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
33260059|NCT02590432|100853466|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33260060|NCT02590432|100853467|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33260061|NCT02590432|100853468|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33260062|NCT02590432|100853469|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33260063|NCT02590432|100853470|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33260064|NCT02590432|100853471|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33260065|NCT02590432|100853472|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33168179|NCT02380677|100521769|FG008|Overall Study|Physician Decision|0|||
33168180|NCT02380677|100521770|FG009|Overall Study|Physician Decision|0|||
33168181|NCT02380677|100521771|FG010|Overall Study|Physician Decision|0|||
33168182|NCT02380677|100521772|FG011|Overall Study|Physician Decision|0|||
33168183|NCT02380677|100521761|FG000|Overall Study|Lack of Efficacy|0|||
33168184|NCT02380677|100521762|FG001|Overall Study|Lack of Efficacy|1|||
33168185|NCT02380677|100521763|FG002|Overall Study|Lack of Efficacy|2|||
33168186|NCT02380677|100521764|FG003|Overall Study|Lack of Efficacy|0|||
33168187|NCT02380677|100521765|FG004|Overall Study|Lack of Efficacy|4|||
33168188|NCT02380677|100521766|FG005|Overall Study|Lack of Efficacy|1|||
33168189|NCT02380677|100521767|FG006|Overall Study|Lack of Efficacy|1|||
33168190|NCT02380677|100521768|FG007|Overall Study|Lack of Efficacy|2|||
33168191|NCT02380677|100521769|FG008|Overall Study|Lack of Efficacy|2|||
33168192|NCT02380677|100521770|FG009|Overall Study|Lack of Efficacy|0|||
33168193|NCT02380677|100521771|FG010|Overall Study|Lack of Efficacy|2|||
33168194|NCT02380677|100521772|FG011|Overall Study|Lack of Efficacy|1|||
33168195|NCT02380677|100521761|FG000|Overall Study|Withdrawal by Subject|0|||
33168196|NCT02380677|100521762|FG001|Overall Study|Withdrawal by Subject|0|||
33168197|NCT02380677|100521763|FG002|Overall Study|Withdrawal by Subject|0|||
33168198|NCT02380677|100521764|FG003|Overall Study|Withdrawal by Subject|0|||
33168199|NCT02380677|100521765|FG004|Overall Study|Withdrawal by Subject|0|||
33168200|NCT02380677|100521766|FG005|Overall Study|Withdrawal by Subject|0|||
33168201|NCT02380677|100521767|FG006|Overall Study|Withdrawal by Subject|0|||
33168202|NCT02380677|100521768|FG007|Overall Study|Withdrawal by Subject|0|||
33168203|NCT02380677|100521769|FG008|Overall Study|Withdrawal by Subject|0|||
33168204|NCT02380677|100521770|FG009|Overall Study|Withdrawal by Subject|1|||
33448920|NCT01796171|101535883|FG000|Follow-up Period|Start of further anticancer therapy|4|||
33168205|NCT02380677|100521771|FG010|Overall Study|Withdrawal by Subject|0|||
33168206|NCT02380677|100521772|FG011|Overall Study|Withdrawal by Subject|3|||
33168207|NCT02380677|100521761|FG000|Overall Study|Other|0|||
33448921|NCT01796171|101535884|FG001|Follow-up Period|Start of further anticancer therapy|25|||
33448922|NCT01796171|101535885|FG002|Follow-up Period|Start of further anticancer therapy|2|||
33448923|NCT01796171|101535886|FG003|Follow-up Period|Start of further anticancer therapy|1|||
33448924|NCT01796171|101535887|FG004|Follow-up Period|Start of further anticancer therapy|2|||
33448925|NCT01796171|101535888|FG005|Follow-up Period|Start of further anticancer therapy|2|||
33448926|NCT01796171|101535889|FG006|Follow-up Period|Start of further anticancer therapy|1|||
33448927|NCT01796171|101535890|FG007|Follow-up Period|Start of further anticancer therapy|15|||
33448928|NCT01796171|101535891|FG008|Follow-up Period|Start of further anticancer therapy|2|||
33448929|NCT01796171|101535892|FG009|Follow-up Period|Start of further anticancer therapy|0|||
33448930|NCT01796171|101535893|FG010|Follow-up Period|Start of further anticancer therapy|0|||
33448931|NCT01796171|101535894|FG011|Follow-up Period|Start of further anticancer therapy|0|||
33448932|NCT01796171|101535895|FG012|Follow-up Period|Start of further anticancer therapy|0|||
33448933|NCT01796171|101535896|FG013|Follow-up Period|Start of further anticancer therapy|0|||
33168208|NCT02380677|100521762|FG001|Overall Study|Other|0|||
33260066|NCT02590432|100853473|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
33260067|NCT02590432|100853474|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
33260068|NCT02590432|100853466|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
33260069|NCT02590432|100853467|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
33260070|NCT02590432|100853468|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
33260071|NCT02590432|100853469|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
33260072|NCT02590432|100853470|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
33260073|NCT02590432|100853471|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
33260074|NCT02590432|100853472|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
33260075|NCT02590432|100853473|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
33260076|NCT02590432|100853474|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
33260077|NCT02590432|100853466|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33260078|NCT02590432|100853467|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33260079|NCT02590432|100853468|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33168209|NCT02380677|100521763|FG002|Overall Study|Other|0|||
33168210|NCT02380677|100521764|FG003|Overall Study|Other|1|||
33168211|NCT02380677|100521765|FG004|Overall Study|Other|1|||
33168212|NCT02380677|100521766|FG005|Overall Study|Other|1|||
33168213|NCT02380677|100521767|FG006|Overall Study|Other|0|||
33168214|NCT02380677|100521768|FG007|Overall Study|Other|0|||
33168215|NCT02380677|100521769|FG008|Overall Study|Other|0|||
33168216|NCT02380677|100521770|FG009|Overall Study|Other|0|||
33168217|NCT02380677|100521771|FG010|Overall Study|Other|0|||
33168218|NCT02380677|100521772|FG011|Overall Study|Other|0|||
33168219|NCT00660023|100521773|FG000|Overall Study|Adverse Event|2|||
33168220|NCT00660023|100521773|FG000|Overall Study|Death|8|||
33168221|NCT00660023|100521773|FG000|Overall Study|Blood Transfusion|5|||
33168222|NCT00660023|100521773|FG000|Overall Study|Renal Transplantation|3|||
33168223|NCT00660023|100521773|FG000|Overall Study|Withdrawal by Subject|1|||
33168224|NCT00660023|100521773|FG000|Overall Study|Missed Pregnancy Test|1|||
33168225|NCT00660023|100521773|FG000|Overall Study|Other Screening Failure|9|||
33168226|NCT00403234|100521774|FG000|Overall Study|Withdrawal by Subject|0|||
33168227|NCT00403234|100521775|FG001|Overall Study|Withdrawal by Subject|1|||
33168228|NCT00403234|100521776|FG002|Overall Study|Withdrawal by Subject|0|||
33260080|NCT02590432|100853469|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33260081|NCT02590432|100853470|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33260082|NCT02590432|100853471|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33260083|NCT02590432|100853472|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33260084|NCT02590432|100853473|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
33260085|NCT02590432|100853474|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
33260086|NCT02590432|100853466|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33260087|NCT02590432|100853467|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33260088|NCT02590432|100853468|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33260089|NCT02590432|100853469|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33260090|NCT02590432|100853470|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33260091|NCT02590432|100853471|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33260092|NCT02590432|100853472|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33260093|NCT02590432|100853473|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
33260094|NCT02590432|100853474|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
33260095|NCT02590432|100853466|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33260096|NCT02590432|100853467|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33286473|NCT03918447|100943976|FG001|Overall Study|Withdrawal by Subject|17|||
33168229|NCT00403234|100521777|FG003|Overall Study|Withdrawal by Subject|0|||
33168230|NCT00403234|100521774|FG000|Overall Study|Adverse Event|1|||
33168231|NCT00403234|100521775|FG001|Overall Study|Adverse Event|0|||
33168232|NCT00403234|100521776|FG002|Overall Study|Adverse Event|1|||
33168233|NCT00403234|100521777|FG003|Overall Study|Adverse Event|0|||
33168234|NCT00521014|100521781|FG000|Overall Study|Inevaluable, not treated|1|||
33168235|NCT02193867|100521784|FG000|Overall Study|Death|2|||
33168236|NCT02193867|100521784|FG000|Overall Study|Sponsor Study Termination|2|||
33168237|NCT01678911|100521785|FG000|Second Intervention|Lost to Follow-up|2|||
33168238|NCT01678911|100521786|FG001|Second Intervention|Lost to Follow-up|0|||
33168239|NCT00598832|100521790|FG000|Overall Study|Lack of Efficacy|3|||
33168240|NCT00598832|100521791|FG001|Overall Study|Lack of Efficacy|7|||
33168241|NCT00598832|100521790|FG000|Overall Study|Adverse Event|6|||
33168242|NCT00598832|100521791|FG001|Overall Study|Adverse Event|2|||
33168243|NCT00598832|100521790|FG000|Overall Study|Withdrawal by Subject|25|||
33168244|NCT00598832|100521791|FG001|Overall Study|Withdrawal by Subject|36|||
33168245|NCT00598832|100521790|FG000|Overall Study|Protocol Violation|0|||
33168246|NCT00598832|100521791|FG001|Overall Study|Protocol Violation|2|||
33168247|NCT00598832|100521790|FG000|Overall Study|Lost to Follow-up|24|||
33168248|NCT00598832|100521791|FG001|Overall Study|Lost to Follow-up|29|||
33168249|NCT00598832|100521790|FG000|Overall Study|Pregnancy|2|||
33168250|NCT00598832|100521791|FG001|Overall Study|Pregnancy|2|||
33168251|NCT00598832|100521790|FG000|Overall Study|Physician Decision|1|||
33168252|NCT00598832|100521791|FG001|Overall Study|Physician Decision|4|||
33168253|NCT00598832|100521790|FG000|Overall Study|Non compliance|1|||
33168254|NCT00598832|100521791|FG001|Overall Study|Non compliance|0|||
33168255|NCT00578812|100521795|FG000|Overall Study|Not treated|6|||
33168256|NCT00578812|100521796|FG001|Overall Study|Not treated|7|||
33260097|NCT02590432|100853468|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33260098|NCT02590432|100853469|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33260099|NCT02590432|100853470|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33260100|NCT02590432|100853471|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33260101|NCT02590432|100853472|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33260102|NCT02590432|100853473|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
33260103|NCT02590432|100853474|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
33260104|NCT02590432|100853466|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33260105|NCT02590432|100853467|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33260106|NCT02590432|100853468|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33260107|NCT02590432|100853469|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33260108|NCT02590432|100853470|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33260109|NCT02590432|100853471|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33260110|NCT02590432|100853472|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33260111|NCT02590432|100853473|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
33260112|NCT02590432|100853474|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
33260113|NCT00722046|100853478|FG000|Overall Study|Adverse Event|0|||
33260114|NCT00722046|100853479|FG001|Overall Study|Adverse Event|1|||
33260115|NCT00722046|100853480|FG002|Overall Study|Adverse Event|2|||
33260116|NCT00722046|100853481|FG003|Overall Study|Adverse Event|1|||
33260117|NCT00722046|100853482|FG004|Overall Study|Adverse Event|2|||
33260118|NCT00722046|100853483|FG005|Overall Study|Adverse Event|1|||
33260119|NCT00722046|100853484|FG006|Overall Study|Adverse Event|0|||
33260120|NCT00722046|100853478|FG000|Overall Study|Death|0|||
33260121|NCT00722046|100853479|FG001|Overall Study|Death|1|||
33260122|NCT00722046|100853480|FG002|Overall Study|Death|0|||
33260123|NCT00722046|100853481|FG003|Overall Study|Death|0|||
33260124|NCT00722046|100853482|FG004|Overall Study|Death|0|||
33260125|NCT00722046|100853483|FG005|Overall Study|Death|0|||
33260126|NCT00722046|100853484|FG006|Overall Study|Death|2|||
33260127|NCT00722046|100853478|FG000|Overall Study|Protocol Violation|1|||
33260128|NCT00722046|100853479|FG001|Overall Study|Protocol Violation|0|||
33260129|NCT00722046|100853480|FG002|Overall Study|Protocol Violation|0|||
33260130|NCT00722046|100853481|FG003|Overall Study|Protocol Violation|0|||
33260131|NCT00722046|100853482|FG004|Overall Study|Protocol Violation|0|||
33260132|NCT00722046|100853483|FG005|Overall Study|Protocol Violation|1|||
33260133|NCT00722046|100853484|FG006|Overall Study|Protocol Violation|0|||
33260134|NCT00722046|100853478|FG000|Overall Study|Withdrawal by Subject|3|||
33260135|NCT00722046|100853479|FG001|Overall Study|Withdrawal by Subject|3|||
33260136|NCT00722046|100853480|FG002|Overall Study|Withdrawal by Subject|4|||
33260137|NCT00722046|100853481|FG003|Overall Study|Withdrawal by Subject|4|||
33260138|NCT00722046|100853482|FG004|Overall Study|Withdrawal by Subject|4|||
33260139|NCT00722046|100853483|FG005|Overall Study|Withdrawal by Subject|7|||
33260140|NCT00722046|100853484|FG006|Overall Study|Withdrawal by Subject|3|||
33260141|NCT00722046|100853478|FG000|Overall Study|Randomized, but not treated|1|||
33260142|NCT00722046|100853479|FG001|Overall Study|Randomized, but not treated|1|||
33260143|NCT00722046|100853480|FG002|Overall Study|Randomized, but not treated|0|||
33260144|NCT00722046|100853481|FG003|Overall Study|Randomized, but not treated|2|||
33260145|NCT00722046|100853482|FG004|Overall Study|Randomized, but not treated|0|||
33260146|NCT00722046|100853483|FG005|Overall Study|Randomized, but not treated|0|||
33260147|NCT00722046|100853484|FG006|Overall Study|Randomized, but not treated|0|||
33260148|NCT00722046|100853478|FG000|Overall Study|Other|0|||
33448934|NCT01796171|101535897|FG014|Follow-up Period|Start of further anticancer therapy|0|||
33448935|NCT01796171|101535883|FG000|Follow-up Period|Progressive disease|0|||
33260149|NCT00722046|100853479|FG001|Overall Study|Other|0|||
33260150|NCT00722046|100853480|FG002|Overall Study|Other|1|||
33260151|NCT00722046|100853481|FG003|Overall Study|Other|1|||
33260152|NCT00722046|100853482|FG004|Overall Study|Other|3|||
33260153|NCT00722046|100853483|FG005|Overall Study|Other|2|||
33260154|NCT00722046|100853484|FG006|Overall Study|Other|1|||
33260155|NCT04056624|100853485|FG000|Overall Study|Withdrawal by Subject|0|||
33260156|NCT04056624|100853486|FG001|Overall Study|Withdrawal by Subject|0|||
33260157|NCT04056624|100853487|FG002|Overall Study|Withdrawal by Subject|1|||
33260158|NCT04056624|100853485|FG000|Overall Study|Protocol Violation|1|||
33260159|NCT04056624|100853486|FG001|Overall Study|Protocol Violation|2|||
33260160|NCT04056624|100853487|FG002|Overall Study|Protocol Violation|0|||
33260161|NCT03752151|100853488|FG000|Overall Study|Withdrawal by Subject|1|||
33260162|NCT03752151|100853488|FG000|Overall Study|Protocol Violation|1|||
33260163|NCT01188655|100853489|FG000|Overall Study|Lack of Efficacy|1|||
33260164|NCT01188655|100853489|FG000|Overall Study|Lost to Follow-up|1|||
33260165|NCT01188655|100853489|FG000|Overall Study|Other|11|||
33260166|NCT01609218|100853494|FG000|Period 1|Adverse Event|3|||
33260167|NCT01609218|100853495|FG001|Period 1|Adverse Event|5|||
33260168|NCT01609218|100853494|FG000|Period 1|Sponsor Decision|0|||
33260169|NCT01609218|100853495|FG001|Period 1|Sponsor Decision|1|||
33260170|NCT01609218|100853494|FG000|Period 2|Adverse Event|1|||
33260171|NCT01609218|100853495|FG001|Period 2|Adverse Event|0|||
33260172|NCT03785405|100853496|FG000|Overall Study|Adverse Event|16|||
33260173|NCT03785405|100853497|FG001|Overall Study|Adverse Event|1|||
33260174|NCT03785405|100853496|FG000|Overall Study|Death|6|||
33260175|NCT03785405|100853497|FG001|Overall Study|Death|4|||
33260176|NCT03785405|100853496|FG000|Overall Study|Guardian decision|4|||
33260177|NCT03785405|100853497|FG001|Overall Study|Guardian decision|1|||
33260178|NCT03785405|100853496|FG000|Overall Study|Lost to Follow-up|1|||
33260179|NCT03785405|100853497|FG001|Overall Study|Lost to Follow-up|0|||
33260180|NCT03785405|100853496|FG000|Overall Study|Physician Decision|8|||
33260181|NCT03785405|100853497|FG001|Overall Study|Physician Decision|5|||
33448936|NCT01796171|101535884|FG001|Follow-up Period|Progressive disease|1|||
33448937|NCT01796171|101535885|FG002|Follow-up Period|Progressive disease|0|||
33448938|NCT01796171|101535886|FG003|Follow-up Period|Progressive disease|0|||
33448939|NCT01796171|101535887|FG004|Follow-up Period|Progressive disease|0|||
33448940|NCT01796171|101535888|FG005|Follow-up Period|Progressive disease|0|||
33448941|NCT01796171|101535889|FG006|Follow-up Period|Progressive disease|0|||
33448942|NCT01796171|101535890|FG007|Follow-up Period|Progressive disease|3|||
33448943|NCT01796171|101535891|FG008|Follow-up Period|Progressive disease|0|||
33448944|NCT01796171|101535892|FG009|Follow-up Period|Progressive disease|0|||
33448945|NCT01796171|101535893|FG010|Follow-up Period|Progressive disease|0|||
33448946|NCT01796171|101535894|FG011|Follow-up Period|Progressive disease|0|||
33448947|NCT01796171|101535895|FG012|Follow-up Period|Progressive disease|0|||
33448948|NCT01796171|101535896|FG013|Follow-up Period|Progressive disease|0|||
33448949|NCT01796171|101535897|FG014|Follow-up Period|Progressive disease|0|||
33448950|NCT01796171|101535883|FG000|Follow-up Period|Physician Decision|0|||
33448951|NCT01796171|101535884|FG001|Follow-up Period|Physician Decision|2|||
33448952|NCT01796171|101535885|FG002|Follow-up Period|Physician Decision|0|||
33448953|NCT01796171|101535886|FG003|Follow-up Period|Physician Decision|0|||
33448954|NCT01796171|101535887|FG004|Follow-up Period|Physician Decision|0|||
33448955|NCT01796171|101535888|FG005|Follow-up Period|Physician Decision|0|||
33448956|NCT01796171|101535889|FG006|Follow-up Period|Physician Decision|0|||
33448957|NCT01796171|101535890|FG007|Follow-up Period|Physician Decision|0|||
33448958|NCT01796171|101535891|FG008|Follow-up Period|Physician Decision|0|||
33448959|NCT01796171|101535892|FG009|Follow-up Period|Physician Decision|0|||
33448960|NCT01796171|101535893|FG010|Follow-up Period|Physician Decision|5|||
33448961|NCT01796171|101535894|FG011|Follow-up Period|Physician Decision|0|||
33448962|NCT01796171|101535895|FG012|Follow-up Period|Physician Decision|0|||
33448963|NCT01796171|101535896|FG013|Follow-up Period|Physician Decision|0|||
33448964|NCT01796171|101535897|FG014|Follow-up Period|Physician Decision|0|||
33448965|NCT01796171|101535883|FG000|Follow-up Period|Withdrawal by Subject|0|||
33448966|NCT01796171|101535884|FG001|Follow-up Period|Withdrawal by Subject|1|||
33448967|NCT01796171|101535885|FG002|Follow-up Period|Withdrawal by Subject|0|||
33448968|NCT01796171|101535886|FG003|Follow-up Period|Withdrawal by Subject|0|||
33448969|NCT01796171|101535887|FG004|Follow-up Period|Withdrawal by Subject|0|||
33448970|NCT01796171|101535888|FG005|Follow-up Period|Withdrawal by Subject|1|||
33448971|NCT01796171|101535889|FG006|Follow-up Period|Withdrawal by Subject|0|||
33168257|NCT01854710|100521797|FG000|Overall Study|Withdrawal by Subject|2|||
33168258|NCT01854710|100521798|FG001|Overall Study|Withdrawal by Subject|1|||
33168259|NCT01854710|100521799|FG002|Overall Study|Withdrawal by Subject|0|||
33168260|NCT01854710|100521800|FG003|Overall Study|Withdrawal by Subject|0|||
33168261|NCT01854710|100521801|FG004|Overall Study|Withdrawal by Subject|0|||
33168262|NCT01854710|100521802|FG005|Overall Study|Withdrawal by Subject|0|||
33168263|NCT01854710|100521797|FG000|Overall Study|CRI procedural error|2|||
33168264|NCT01854710|100521798|FG001|Overall Study|CRI procedural error|2|||
33168265|NCT01854710|100521799|FG002|Overall Study|CRI procedural error|2|||
33168266|NCT01854710|100521800|FG003|Overall Study|CRI procedural error|2|||
33168267|NCT01854710|100521801|FG004|Overall Study|CRI procedural error|2|||
33168268|NCT01854710|100521802|FG005|Overall Study|CRI procedural error|2|||
33168269|NCT02370160|100521803|FG000|Overall Study|Death|3|||
33448972|NCT01796171|101535890|FG007|Follow-up Period|Withdrawal by Subject|0|||
33448973|NCT01796171|101535891|FG008|Follow-up Period|Withdrawal by Subject|0|||
33448974|NCT01796171|101535892|FG009|Follow-up Period|Withdrawal by Subject|0|||
33448975|NCT01796171|101535893|FG010|Follow-up Period|Withdrawal by Subject|3|||
33448976|NCT01796171|101535894|FG011|Follow-up Period|Withdrawal by Subject|1|||
33448977|NCT01796171|101535895|FG012|Follow-up Period|Withdrawal by Subject|0|||
33168270|NCT02370160|100521804|FG001|Overall Study|Death|4|||
33168271|NCT02370160|100521805|FG002|Overall Study|Death|1|||
33168272|NCT00850564|100521808|FG000|Overall Study|Withdrawal by Subject|2|||
33168273|NCT00913497|100521809|FG000|Overall Study|Adverse Event|1|||
33168274|NCT00913497|100521809|FG000|Overall Study|Withdrawal by Subject|2|||
33168275|NCT00790023|100521810|FG000|Overall Study|Adverse Event|2|||
33168276|NCT00790023|100521811|FG001|Overall Study|Adverse Event|1|||
33168277|NCT00790023|100521812|FG002|Overall Study|Adverse Event|4|||
33168278|NCT00790023|100521810|FG000|Overall Study|Protocol Violation|2|||
33168279|NCT00790023|100521811|FG001|Overall Study|Protocol Violation|4|||
33168280|NCT00790023|100521812|FG002|Overall Study|Protocol Violation|2|||
33168281|NCT00790023|100521810|FG000|Overall Study|Withdrawal by Subject|2|||
33260182|NCT03785405|100853496|FG000|Overall Study|Participant decision|2|||
33260183|NCT03785405|100853497|FG001|Overall Study|Participant decision|0|||
33260184|NCT03785405|100853496|FG000|Overall Study|Other|1|||
33260185|NCT03785405|100853497|FG001|Overall Study|Other|0|||
33260186|NCT03785405|100853496|FG000|Overall Study|No treatment was received|0|||
33260187|NCT03785405|100853497|FG001|Overall Study|No treatment was received|1|||
33260188|NCT00650104|100853498|FG000|Overall Study|Adverse Event|17|||
33260189|NCT00650104|100853498|FG000|Overall Study|Death|2|||
33260190|NCT00650104|100853498|FG000|Overall Study|Withdrawal by Subject|11|||
33448978|NCT01796171|101535896|FG013|Follow-up Period|Withdrawal by Subject|0|||
33448979|NCT01796171|101535897|FG014|Follow-up Period|Withdrawal by Subject|0|||
33448980|NCT01796171|101535883|FG000|Follow-up Period|Death|0|||
33448981|NCT01796171|101535884|FG001|Follow-up Period|Death|0|||
33448982|NCT01796171|101535885|FG002|Follow-up Period|Death|0|||
33448983|NCT01796171|101535886|FG003|Follow-up Period|Death|0|||
33448984|NCT01796171|101535887|FG004|Follow-up Period|Death|0|||
33448985|NCT01796171|101535888|FG005|Follow-up Period|Death|0|||
33448986|NCT01796171|101535889|FG006|Follow-up Period|Death|1|||
33448987|NCT01796171|101535890|FG007|Follow-up Period|Death|0|||
33448988|NCT01796171|101535891|FG008|Follow-up Period|Death|0|||
33448989|NCT01796171|101535892|FG009|Follow-up Period|Death|0|||
33448990|NCT01796171|101535893|FG010|Follow-up Period|Death|17|||
33168282|NCT00790023|100521811|FG001|Overall Study|Withdrawal by Subject|0|||
33260191|NCT00650104|100853498|FG000|Overall Study|Physician Decision|7|||
33168283|NCT00790023|100521812|FG002|Overall Study|Withdrawal by Subject|6|||
33168284|NCT00790023|100521810|FG000|Overall Study|Lost to Follow-up|0|||
33168285|NCT00790023|100521811|FG001|Overall Study|Lost to Follow-up|0|||
33168286|NCT00790023|100521812|FG002|Overall Study|Lost to Follow-up|1|||
33168287|NCT00790023|100521810|FG000|Overall Study|Other|5|||
33448991|NCT01796171|101535894|FG011|Follow-up Period|Death|9|||
33448992|NCT01796171|101535895|FG012|Follow-up Period|Death|1|||
33168288|NCT00790023|100521811|FG001|Overall Study|Other|5|||
33260192|NCT00650104|100853498|FG000|Overall Study|Lost to Follow-up|1|||
33448993|NCT01796171|101535896|FG013|Follow-up Period|Death|0|||
33448994|NCT01796171|101535897|FG014|Follow-up Period|Death|0|||
33168289|NCT00790023|100521812|FG002|Overall Study|Other|8|||
33168290|NCT01367002|100521813|FG000|Overall Study|Withdrawal by Subject|1|||
33168291|NCT01367002|100521814|FG001|Overall Study|Withdrawal by Subject|0|||
33168292|NCT01367002|100521813|FG000|Overall Study|Physician Decision|0|||
33168293|NCT01367002|100521814|FG001|Overall Study|Physician Decision|2|||
33168294|NCT02601469|100521821|FG000|Overall Study|Enrolled in Error|1|||
33168295|NCT02601469|100521822|FG001|Overall Study|Enrolled in Error|0|||
33168296|NCT00587054|100521823|FG000|Overall Study|Patient not treated|9|||
33168297|NCT01365910|100521828|FG000|Overall Study|Withdrawal by Subject|7|||
33168298|NCT01365910|100521828|FG000|Overall Study|disease progression|18|||
33168299|NCT01365910|100521828|FG000|Overall Study|Adverse Event|3|||
33168300|NCT01365910|100521828|FG000|Overall Study|other complicating disease|1|||
33168301|NCT01365910|100521828|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
33168302|NCT00439244|100521829|FG000|Overall Study|Adverse Event|5|||
33168303|NCT00439244|100521830|FG001|Overall Study|Adverse Event|2|||
33168304|NCT00439244|100521831|FG002|Overall Study|Adverse Event|3|||
33168305|NCT00439244|100521829|FG000|Overall Study|Withdrawal by Subject|3|||
33168306|NCT00439244|100521830|FG001|Overall Study|Withdrawal by Subject|1|||
33168307|NCT00439244|100521831|FG002|Overall Study|Withdrawal by Subject|2|||
33168308|NCT00439244|100521829|FG000|Overall Study|Lost to Follow-up|2|||
33168309|NCT00439244|100521830|FG001|Overall Study|Lost to Follow-up|1|||
33168310|NCT00439244|100521831|FG002|Overall Study|Lost to Follow-up|2|||
33168311|NCT00439244|100521829|FG000|Overall Study|Death|0|||
33168312|NCT00439244|100521830|FG001|Overall Study|Death|1|||
33168313|NCT00439244|100521831|FG002|Overall Study|Death|0|||
33168314|NCT00439244|100521829|FG000|Overall Study|Protocol Violation|0|||
33168315|NCT00439244|100521830|FG001|Overall Study|Protocol Violation|1|||
33168316|NCT00439244|100521831|FG002|Overall Study|Protocol Violation|0|||
33168317|NCT00439244|100521829|FG000|Overall Study|Administrative problems|1|||
33168318|NCT00439244|100521830|FG001|Overall Study|Administrative problems|0|||
33448995|NCT01796171|101535883|FG000|Follow-up Period|Patient transferred to other hospital|0|||
33448996|NCT01796171|101535884|FG001|Follow-up Period|Patient transferred to other hospital|1|||
33448997|NCT01796171|101535885|FG002|Follow-up Period|Patient transferred to other hospital|0|||
33448998|NCT01796171|101535886|FG003|Follow-up Period|Patient transferred to other hospital|0|||
33448999|NCT01796171|101535887|FG004|Follow-up Period|Patient transferred to other hospital|0|||
33449000|NCT01796171|101535888|FG005|Follow-up Period|Patient transferred to other hospital|0|||
33449001|NCT01796171|101535889|FG006|Follow-up Period|Patient transferred to other hospital|0|||
33449002|NCT01796171|101535890|FG007|Follow-up Period|Patient transferred to other hospital|0|||
33449003|NCT01796171|101535891|FG008|Follow-up Period|Patient transferred to other hospital|0|||
33449004|NCT01796171|101535892|FG009|Follow-up Period|Patient transferred to other hospital|0|||
33449005|NCT01796171|101535893|FG010|Follow-up Period|Patient transferred to other hospital|0|||
33449006|NCT01796171|101535894|FG011|Follow-up Period|Patient transferred to other hospital|0|||
33449007|NCT01796171|101535895|FG012|Follow-up Period|Patient transferred to other hospital|0|||
33168319|NCT00439244|100521831|FG002|Overall Study|Administrative problems|0|||
33168320|NCT03032705|100521839|FG000|Overall Study|Lost to Follow-up|16|||
33168321|NCT03032705|100521840|FG001|Overall Study|Lost to Follow-up|17|||
33168322|NCT03032705|100521839|FG000|Overall Study|did not quality|6|||
33168323|NCT03032705|100521840|FG001|Overall Study|did not quality|6|||
33168324|NCT04502589|100521841|FG000|Overall Study|Physician Decision|1|||
33168325|NCT04502589|100521842|FG001|Overall Study|Physician Decision|0|||
33168326|NCT03766581|100521843|FG000|Randomization|Other reasons|2|||
33168327|NCT03766581|100521844|FG001|Randomization|Other reasons|1|||
33168328|NCT03766581|100521845|FG002|Randomization|Other reasons|0|||
33168329|NCT03766581|100521846|FG003|Randomization|Other reasons|1|||
33168330|NCT03766581|100521847|FG004|Randomization|Other reasons|0|||
33168331|NCT03766581|100521848|FG005|Randomization|Other reasons|0|||
33168332|NCT03766581|100521849|FG006|Randomization|Other reasons|0|||
33168333|NCT03766581|100521850|FG007|Randomization|Other reasons|0|||
33168334|NCT03766581|100521843|FG000|Randomization|Participant no longer meets study criteria|5|||
33168335|NCT03766581|100521844|FG001|Randomization|Participant no longer meets study criteria|3|||
33168336|NCT03766581|100521845|FG002|Randomization|Participant no longer meets study criteria|4|||
33168337|NCT03766581|100521846|FG003|Randomization|Participant no longer meets study criteria|0|||
33168338|NCT03766581|100521847|FG004|Randomization|Participant no longer meets study criteria|2|||
33168339|NCT03766581|100521848|FG005|Randomization|Participant no longer meets study criteria|3|||
33168340|NCT03766581|100521849|FG006|Randomization|Participant no longer meets study criteria|0|||
33168341|NCT03766581|100521850|FG007|Randomization|Participant no longer meets study criteria|1|||
33168342|NCT03766581|100521843|FG000|Randomization|Participant request to discontinue study treatment|1|||
33168343|NCT03766581|100521844|FG001|Randomization|Participant request to discontinue study treatment|0|||
33168344|NCT03766581|100521845|FG002|Randomization|Participant request to discontinue study treatment|0|||
33168345|NCT03766581|100521846|FG003|Randomization|Participant request to discontinue study treatment|0|||
33168346|NCT03766581|100521847|FG004|Randomization|Participant request to discontinue study treatment|1|||
33168347|NCT03766581|100521848|FG005|Randomization|Participant request to discontinue study treatment|2|||
33168348|NCT03766581|100521849|FG006|Randomization|Participant request to discontinue study treatment|0|||
33168349|NCT03766581|100521850|FG007|Randomization|Participant request to discontinue study treatment|0|||
33168350|NCT03766581|100521843|FG000|Randomization|Participant withdrew consent|1|||
33168351|NCT03766581|100521844|FG001|Randomization|Participant withdrew consent|0|||
33168352|NCT03766581|100521845|FG002|Randomization|Participant withdrew consent|1|||
33168353|NCT03766581|100521846|FG003|Randomization|Participant withdrew consent|2|||
33168354|NCT03766581|100521847|FG004|Randomization|Participant withdrew consent|1|||
33168355|NCT03766581|100521848|FG005|Randomization|Participant withdrew consent|1|||
33168356|NCT03766581|100521849|FG006|Randomization|Participant withdrew consent|0|||
33168357|NCT03766581|100521850|FG007|Randomization|Participant withdrew consent|0|||
33168358|NCT03766581|100521843|FG000|Treatment|Adverse Event|82|||
33168359|NCT03766581|100521844|FG001|Treatment|Adverse Event|44|||
33168360|NCT03766581|100521845|FG002|Treatment|Adverse Event|47|||
33168361|NCT03766581|100521846|FG003|Treatment|Adverse Event|46|||
33449008|NCT01796171|101535896|FG013|Follow-up Period|Patient transferred to other hospital|0|||
33449009|NCT01796171|101535897|FG014|Follow-up Period|Patient transferred to other hospital|0|||
33449010|NCT01796171|101535883|FG000|Follow-up Period|Sponsor Decision|0|||
33449011|NCT01796171|101535884|FG001|Follow-up Period|Sponsor Decision|0|||
33449012|NCT01796171|101535885|FG002|Follow-up Period|Sponsor Decision|0|||
33449013|NCT01796171|101535886|FG003|Follow-up Period|Sponsor Decision|0|||
33449014|NCT01796171|101535887|FG004|Follow-up Period|Sponsor Decision|0|||
33449015|NCT01796171|101535888|FG005|Follow-up Period|Sponsor Decision|0|||
33449016|NCT01796171|101535889|FG006|Follow-up Period|Sponsor Decision|0|||
33449017|NCT01796171|101535890|FG007|Follow-up Period|Sponsor Decision|0|||
33449018|NCT01796171|101535891|FG008|Follow-up Period|Sponsor Decision|0|||
33449019|NCT01796171|101535892|FG009|Follow-up Period|Sponsor Decision|0|||
33449020|NCT01796171|101535893|FG010|Follow-up Period|Sponsor Decision|40|||
33449021|NCT01796171|101535894|FG011|Follow-up Period|Sponsor Decision|15|||
33449022|NCT01796171|101535895|FG012|Follow-up Period|Sponsor Decision|7|||
33449023|NCT01796171|101535896|FG013|Follow-up Period|Sponsor Decision|0|||
33449024|NCT01796171|101535897|FG014|Follow-up Period|Sponsor Decision|0|||
33449025|NCT01249651|101535898|FG000|Overall Study|Withdrawal by Subject|4|||
33449026|NCT01249651|101535898|FG000|Overall Study|Adverse Event|1|||
33449027|NCT01249651|101535898|FG000|Overall Study|Protocol Violation|1|||
33449028|NCT01249651|101535898|FG000|Overall Study|Sponsor Decision|1|||
33168362|NCT03766581|100521847|FG004|Treatment|Adverse Event|50|||
33449029|NCT02822235|101535899|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
33449030|NCT02822235|101535900|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
33449031|NCT02822235|101535899|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
33449032|NCT02822235|101535900|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
33168363|NCT03766581|100521848|FG005|Treatment|Adverse Event|77|||
33168364|NCT03766581|100521849|FG006|Treatment|Adverse Event|5|||
33168365|NCT03766581|100521850|FG007|Treatment|Adverse Event|2|||
33168366|NCT03766581|100521843|FG000|Treatment|Participant request to discontinue treatment|34|||
33168367|NCT03766581|100521844|FG001|Treatment|Participant request to discontinue treatment|6|||
33168368|NCT03766581|100521845|FG002|Treatment|Participant request to discontinue treatment|10|||
33168369|NCT03766581|100521846|FG003|Treatment|Participant request to discontinue treatment|10|||
33168370|NCT03766581|100521847|FG004|Treatment|Participant request to discontinue treatment|14|||
33449033|NCT02822235|101535899|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
33168371|NCT03766581|100521848|FG005|Treatment|Participant request to discontinue treatment|15|||
33168372|NCT03766581|100521849|FG006|Treatment|Participant request to discontinue treatment|0|||
33168373|NCT03766581|100521850|FG007|Treatment|Participant request to discontinue treatment|1|||
33168374|NCT03766581|100521843|FG000|Treatment|Participant withdrew consent|11|||
33168375|NCT03766581|100521844|FG001|Treatment|Participant withdrew consent|4|||
33168376|NCT03766581|100521845|FG002|Treatment|Participant withdrew consent|5|||
33449034|NCT02822235|101535900|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
33449035|NCT02822235|101535899|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
33449036|NCT02822235|101535900|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
33449037|NCT02822235|101535899|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
33449038|NCT02822235|101535900|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
33449039|NCT02822235|101535899|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
33449040|NCT02822235|101535900|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
33449041|NCT01919112|101535901|FG000|Secondary Analysis-day 30|Death|1|||
33449042|NCT01919112|101535902|FG001|Secondary Analysis-day 30|Death|1|||
33449043|NCT01919112|101535903|FG002|Secondary Analysis-day 30|Death|1|||
33449044|NCT01919112|101535901|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
33449045|NCT01919112|101535902|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
33449046|NCT01919112|101535903|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
33449047|NCT00682461|101535904|FG000|Overall Study|Adverse Event|5|||
33449048|NCT00682461|101535905|FG001|Overall Study|Adverse Event|7|||
33449049|NCT00682461|101535904|FG000|Overall Study|Lost to Follow-up|8|||
33449050|NCT00682461|101535905|FG001|Overall Study|Lost to Follow-up|5|||
33449051|NCT00682461|101535904|FG000|Overall Study|Withdrawal by Subject|12|||
33449052|NCT00682461|101535905|FG001|Overall Study|Withdrawal by Subject|19|||
33449053|NCT00571064|101535908|FG000|Overall Study|Adverse Event|13|||
33449054|NCT00571064|101535908|FG000|Overall Study|Protocol Violation|4|||
33449055|NCT00571064|101535908|FG000|Overall Study|Withdrawal by Subject|2|||
33449056|NCT00571064|101535908|FG000|Overall Study|Other|2|||
33449057|NCT01547286|101535909|FG000|Overall Study|Did not meet all eligibility criteria|1|||
33449058|NCT01547286|101535909|FG000|Overall Study|Physician Decision|1|||
33449059|NCT00840216|101535910|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
33449060|NCT00840216|101535911|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
33449061|NCT00418145|101535912|FG000|Overall Study|study terminated|6|||
33168377|NCT03766581|100521846|FG003|Treatment|Participant withdrew consent|5|||
33168378|NCT03766581|100521847|FG004|Treatment|Participant withdrew consent|4|||
33168379|NCT03766581|100521848|FG005|Treatment|Participant withdrew consent|4|||
33168380|NCT03766581|100521849|FG006|Treatment|Participant withdrew consent|0|||
33168381|NCT03766581|100521850|FG007|Treatment|Participant withdrew consent|0|||
33168382|NCT03766581|100521843|FG000|Treatment|Death|1|||
33168383|NCT03766581|100521844|FG001|Treatment|Death|0|||
33168384|NCT03766581|100521845|FG002|Treatment|Death|0|||
33168385|NCT03766581|100521846|FG003|Treatment|Death|0|||
33168386|NCT03766581|100521847|FG004|Treatment|Death|0|||
33168387|NCT03766581|100521848|FG005|Treatment|Death|0|||
33168388|NCT03766581|100521849|FG006|Treatment|Death|0|||
33168389|NCT03766581|100521850|FG007|Treatment|Death|0|||
33168390|NCT03766581|100521843|FG000|Treatment|Lost to Follow-up|1|||
33168391|NCT03766581|100521844|FG001|Treatment|Lost to Follow-up|0|||
33168392|NCT03766581|100521845|FG002|Treatment|Lost to Follow-up|0|||
33168393|NCT03766581|100521846|FG003|Treatment|Lost to Follow-up|1|||
33168394|NCT03766581|100521847|FG004|Treatment|Lost to Follow-up|0|||
33168395|NCT03766581|100521848|FG005|Treatment|Lost to Follow-up|0|||
33168396|NCT03766581|100521849|FG006|Treatment|Lost to Follow-up|0|||
33168397|NCT03766581|100521850|FG007|Treatment|Lost to Follow-up|0|||
33168398|NCT03766581|100521843|FG000|Treatment|Poor/Non compliance|2|||
33168399|NCT03766581|100521844|FG001|Treatment|Poor/Non compliance|2|||
33168400|NCT03766581|100521845|FG002|Treatment|Poor/Non compliance|1|||
33168401|NCT03766581|100521846|FG003|Treatment|Poor/Non compliance|1|||
33168402|NCT03766581|100521847|FG004|Treatment|Poor/Non compliance|1|||
33168403|NCT03766581|100521848|FG005|Treatment|Poor/Non compliance|1|||
33168404|NCT03766581|100521849|FG006|Treatment|Poor/Non compliance|0|||
33168405|NCT03766581|100521850|FG007|Treatment|Poor/Non compliance|0|||
33168406|NCT03766581|100521843|FG000|Treatment|Participant no longer meets study criteria|9|||
33168407|NCT03766581|100521844|FG001|Treatment|Participant no longer meets study criteria|1|||
33168408|NCT03766581|100521845|FG002|Treatment|Participant no longer meets study criteria|5|||
33168409|NCT03766581|100521846|FG003|Treatment|Participant no longer meets study criteria|4|||
33168410|NCT03766581|100521847|FG004|Treatment|Participant no longer meets study criteria|4|||
33168411|NCT03766581|100521848|FG005|Treatment|Participant no longer meets study criteria|4|||
33168412|NCT03766581|100521849|FG006|Treatment|Participant no longer meets study criteria|2|||
33168413|NCT03766581|100521850|FG007|Treatment|Participant no longer meets study criteria|0|||
33168414|NCT03766581|100521843|FG000|Treatment|Other reasons|13|||
33168415|NCT03766581|100521844|FG001|Treatment|Other reasons|8|||
33168416|NCT03766581|100521845|FG002|Treatment|Other reasons|3|||
33168417|NCT03766581|100521846|FG003|Treatment|Other reasons|7|||
33168418|NCT03766581|100521847|FG004|Treatment|Other reasons|3|||
33168419|NCT03766581|100521848|FG005|Treatment|Other reasons|3|||
33168420|NCT03766581|100521849|FG006|Treatment|Other reasons|0|||
33168421|NCT03766581|100521850|FG007|Treatment|Other reasons|0|||
33168422|NCT01606436|100521851|FG000|Overall Study|Withdrawal by Subject|0|||
33168423|NCT01606436|100521852|FG001|Overall Study|Withdrawal by Subject|0|||
33168424|NCT01606436|100521853|FG002|Overall Study|Withdrawal by Subject|1|||
33168425|NCT01606436|100521854|FG003|Overall Study|Withdrawal by Subject|1|||
33168426|NCT01606436|100521855|FG004|Overall Study|Withdrawal by Subject|1|||
33168427|NCT01606436|100521856|FG005|Overall Study|Withdrawal by Subject|0|||
33168428|NCT01606436|100521851|FG000|Overall Study|Adverse Event|0|||
33168429|NCT01606436|100521852|FG001|Overall Study|Adverse Event|0|||
33168430|NCT01606436|100521853|FG002|Overall Study|Adverse Event|1|||
33168431|NCT01606436|100521854|FG003|Overall Study|Adverse Event|0|||
33449062|NCT02300103|101535913|FG000|Overall Study|Lack of Efficacy|3|||
33449063|NCT02300103|101535913|FG000|Overall Study|Protocol Violation|1|||
33449064|NCT02300103|101535913|FG000|Overall Study|Withdrew Consent|2|||
33168432|NCT01606436|100521855|FG004|Overall Study|Adverse Event|0|||
33168433|NCT01606436|100521856|FG005|Overall Study|Adverse Event|0|||
33168434|NCT01606436|100521851|FG000|Overall Study|Sponsor Decision|0|||
33168435|NCT01606436|100521852|FG001|Overall Study|Sponsor Decision|0|||
33168436|NCT01606436|100521853|FG002|Overall Study|Sponsor Decision|0|||
33168437|NCT01606436|100521854|FG003|Overall Study|Sponsor Decision|1|||
33168438|NCT01606436|100521855|FG004|Overall Study|Sponsor Decision|0|||
33168439|NCT01606436|100521856|FG005|Overall Study|Sponsor Decision|0|||
33168440|NCT02028065|100521857|FG000|Randomization Through Start Treatment|Not treated|1|||
33168441|NCT02028065|100521858|FG001|Randomization Through Start Treatment|Not treated|3|||
33168442|NCT02028065|100521859|FG002|Randomization Through Start Treatment|Not treated|3|||
33260193|NCT00650104|100853498|FG000|Overall Study|Non-compliance|2|||
33260194|NCT00650104|100853498|FG000|Overall Study|Sponsor Terminated Dosing|1|||
33260195|NCT00823472|100853500|FG000|Overall Study|Physician Decision|24|||
33449065|NCT01855750|101535914|FG000|Overall Study|Death|78|||
33449066|NCT01855750|101535915|FG001|Overall Study|Death|78|||
33449067|NCT01855750|101535914|FG000|Overall Study|Lost to Follow-up|9|||
33449068|NCT01855750|101535915|FG001|Overall Study|Lost to Follow-up|23|||
33260196|NCT00823472|100853501|FG001|Overall Study|Physician Decision|28|||
33260197|NCT03771352|100853504|FG000|Overall Study|Screen failure|2|||
33260198|NCT03771352|100853504|FG000|Overall Study|Withdrawal by Subject|2|||
33260199|NCT01040689|100853505|FG000|Overall Study|Adverse Event|0|||
33260200|NCT01040689|100853506|FG001|Overall Study|Adverse Event|0|||
33260201|NCT01040689|100853507|FG002|Overall Study|Adverse Event|2|||
33260202|NCT01040689|100853508|FG003|Overall Study|Adverse Event|4|||
33260203|NCT01040689|100853505|FG000|Overall Study|Lack of Efficacy|0|||
33260204|NCT01040689|100853506|FG001|Overall Study|Lack of Efficacy|0|||
33260205|NCT01040689|100853507|FG002|Overall Study|Lack of Efficacy|1|||
33260206|NCT01040689|100853508|FG003|Overall Study|Lack of Efficacy|0|||
33260207|NCT01040689|100853505|FG000|Overall Study|Lost to Follow-up|1|||
33260208|NCT01040689|100853506|FG001|Overall Study|Lost to Follow-up|0|||
33260209|NCT01040689|100853507|FG002|Overall Study|Lost to Follow-up|0|||
33260210|NCT01040689|100853508|FG003|Overall Study|Lost to Follow-up|0|||
33260211|NCT01040689|100853505|FG000|Overall Study|Withdrawal by Subject|2|||
33260212|NCT01040689|100853506|FG001|Overall Study|Withdrawal by Subject|1|||
33260213|NCT01040689|100853507|FG002|Overall Study|Withdrawal by Subject|1|||
33260214|NCT01040689|100853508|FG003|Overall Study|Withdrawal by Subject|0|||
33260215|NCT01040689|100853505|FG000|Overall Study|Other reasons not listed above|0|||
33260216|NCT01040689|100853506|FG001|Overall Study|Other reasons not listed above|1|||
33260217|NCT01040689|100853507|FG002|Overall Study|Other reasons not listed above|0|||
33260218|NCT01040689|100853508|FG003|Overall Study|Other reasons not listed above|0|||
33260219|NCT01953692|100853511|FG000|Overall Study|Adverse Event|5|||
33260220|NCT01953692|100853512|FG001|Overall Study|Adverse Event|2|||
33260221|NCT01953692|100853513|FG002|Overall Study|Adverse Event|4|||
33260222|NCT01953692|100853514|FG003|Overall Study|Adverse Event|2|||
33260223|NCT01953692|100853515|FG004|Overall Study|Adverse Event|1|||
33260224|NCT01953692|100853516|FG005|Overall Study|Adverse Event|2|||
33260225|NCT01953692|100853517|FG006|Overall Study|Adverse Event|0|||
33260226|NCT01953692|100853518|FG007|Overall Study|Adverse Event|0|||
33260227|NCT01953692|100853519|FG008|Overall Study|Adverse Event|0|||
33260228|NCT01953692|100853511|FG000|Overall Study|Clinical Progression|0|||
33260229|NCT01953692|100853512|FG001|Overall Study|Clinical Progression|15|||
33260230|NCT01953692|100853513|FG002|Overall Study|Clinical Progression|7|||
33260231|NCT01953692|100853514|FG003|Overall Study|Clinical Progression|5|||
33260232|NCT01953692|100853515|FG004|Overall Study|Clinical Progression|0|||
33260233|NCT01953692|100853516|FG005|Overall Study|Clinical Progression|7|||
33260234|NCT01953692|100853517|FG006|Overall Study|Clinical Progression|20|||
33260235|NCT01953692|100853518|FG007|Overall Study|Clinical Progression|3|||
33260236|NCT01953692|100853519|FG008|Overall Study|Clinical Progression|3|||
33260237|NCT01953692|100853511|FG000|Overall Study|Death|5|||
33260238|NCT01953692|100853512|FG001|Overall Study|Death|0|||
33260239|NCT01953692|100853513|FG002|Overall Study|Death|2|||
33260240|NCT01953692|100853514|FG003|Overall Study|Death|2|||
33260241|NCT01953692|100853515|FG004|Overall Study|Death|1|||
33260242|NCT01953692|100853516|FG005|Overall Study|Death|3|||
33260243|NCT01953692|100853517|FG006|Overall Study|Death|6|||
33260244|NCT01953692|100853518|FG007|Overall Study|Death|2|||
33260245|NCT01953692|100853519|FG008|Overall Study|Death|1|||
33449069|NCT01855750|101535914|FG000|Overall Study|Withdrawal by Subject|35|||
33449070|NCT01855750|101535915|FG001|Overall Study|Withdrawal by Subject|28|||
33260246|NCT01953692|100853511|FG000|Overall Study|Excluded Medication|1|||
33260247|NCT01953692|100853512|FG001|Overall Study|Excluded Medication|0|||
33260248|NCT01953692|100853513|FG002|Overall Study|Excluded Medication|0|||
33449071|NCT01855750|101535914|FG000|Overall Study|Sponsor ends the study|297|||
33260249|NCT01953692|100853514|FG003|Overall Study|Excluded Medication|0|||
33260250|NCT01953692|100853515|FG004|Overall Study|Excluded Medication|0|||
33260251|NCT01953692|100853516|FG005|Overall Study|Excluded Medication|0|||
33260252|NCT01953692|100853517|FG006|Overall Study|Excluded Medication|0|||
33260253|NCT01953692|100853518|FG007|Overall Study|Excluded Medication|0|||
33260254|NCT01953692|100853519|FG008|Overall Study|Excluded Medication|0|||
33260255|NCT01953692|100853511|FG000|Overall Study|Lost to Follow-up|1|||
33260256|NCT01953692|100853512|FG001|Overall Study|Lost to Follow-up|0|||
33260257|NCT01953692|100853513|FG002|Overall Study|Lost to Follow-up|3|||
33260258|NCT01953692|100853514|FG003|Overall Study|Lost to Follow-up|1|||
33260259|NCT01953692|100853515|FG004|Overall Study|Lost to Follow-up|0|||
33260260|NCT01953692|100853516|FG005|Overall Study|Lost to Follow-up|1|||
33260261|NCT01953692|100853517|FG006|Overall Study|Lost to Follow-up|0|||
33449072|NCT01855750|101535915|FG001|Overall Study|Sponsor ends the study|290|||
33260262|NCT01953692|100853518|FG007|Overall Study|Lost to Follow-up|0|||
33260263|NCT01953692|100853519|FG008|Overall Study|Lost to Follow-up|0|||
33260264|NCT01953692|100853511|FG000|Overall Study|Physician Decision|11|||
33260265|NCT01953692|100853512|FG001|Overall Study|Physician Decision|4|||
33260266|NCT01953692|100853513|FG002|Overall Study|Physician Decision|2|||
33260267|NCT01953692|100853514|FG003|Overall Study|Physician Decision|2|||
33449073|NCT02576938|101535916|FG000|Overall Study|Adverse Event|5|||
33449074|NCT02576938|101535917|FG001|Overall Study|Adverse Event|3|||
33449075|NCT02576938|101535918|FG002|Overall Study|Adverse Event|6|||
33449076|NCT02576938|101535916|FG000|Overall Study|Protocol Violation|1|||
33260268|NCT01953692|100853515|FG004|Overall Study|Physician Decision|1|||
33260269|NCT01953692|100853516|FG005|Overall Study|Physician Decision|2|||
33260270|NCT01953692|100853517|FG006|Overall Study|Physician Decision|4|||
33260271|NCT01953692|100853518|FG007|Overall Study|Physician Decision|1|||
33449077|NCT02576938|101535917|FG001|Overall Study|Protocol Violation|1|||
33449078|NCT02576938|101535918|FG002|Overall Study|Protocol Violation|1|||
33449079|NCT02576938|101535916|FG000|Overall Study|Withdrawal by Subject|3|||
33449080|NCT02576938|101535917|FG001|Overall Study|Withdrawal by Subject|2|||
33449081|NCT02576938|101535918|FG002|Overall Study|Withdrawal by Subject|4|||
33449082|NCT02576938|101535916|FG000|Overall Study|Lack of Efficacy|9|||
33449083|NCT02576938|101535917|FG001|Overall Study|Lack of Efficacy|4|||
33449084|NCT02576938|101535918|FG002|Overall Study|Lack of Efficacy|0|||
33260272|NCT01953692|100853519|FG008|Overall Study|Physician Decision|0|||
33260273|NCT01953692|100853511|FG000|Overall Study|Protocol Violation|0|||
33260274|NCT01953692|100853512|FG001|Overall Study|Protocol Violation|2|||
33260275|NCT01953692|100853513|FG002|Overall Study|Protocol Violation|1|||
33260276|NCT01953692|100853514|FG003|Overall Study|Protocol Violation|0|||
33260277|NCT01953692|100853515|FG004|Overall Study|Protocol Violation|0|||
33260278|NCT01953692|100853516|FG005|Overall Study|Protocol Violation|0|||
33260279|NCT01953692|100853517|FG006|Overall Study|Protocol Violation|0|||
33260280|NCT01953692|100853518|FG007|Overall Study|Protocol Violation|1|||
33260281|NCT01953692|100853519|FG008|Overall Study|Protocol Violation|0|||
33260282|NCT01953692|100853511|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33260283|NCT01953692|100853512|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33260284|NCT01953692|100853513|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33260285|NCT01953692|100853514|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33449085|NCT02576938|101535916|FG000|Overall Study|Lost to Follow-up|2|||
33449086|NCT02576938|101535917|FG001|Overall Study|Lost to Follow-up|0|||
33449087|NCT02576938|101535918|FG002|Overall Study|Lost to Follow-up|1|||
33449088|NCT02576938|101535916|FG000|Overall Study|Physician Decision|0|||
33449089|NCT02576938|101535917|FG001|Overall Study|Physician Decision|1|||
33449090|NCT02576938|101535918|FG002|Overall Study|Physician Decision|0|||
33260286|NCT01953692|100853515|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33449091|NCT02576938|101535916|FG000|Overall Study|Met Exclusion Criteria|0|||
33449092|NCT02576938|101535917|FG001|Overall Study|Met Exclusion Criteria|1|||
33260287|NCT01953692|100853516|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33449093|NCT02576938|101535918|FG002|Overall Study|Met Exclusion Criteria|0|||
33449094|NCT00745420|101535919|FG000|Overall Study|Ineligible|1|||
33449095|NCT03679598|101535923|FG000|Overall Study|Adverse Event|2|||
33449096|NCT03679598|101535924|FG001|Overall Study|Adverse Event|0|||
33449097|NCT04198363|101535925|FG000|Overall Study|Adverse Event|1|||
33449098|NCT04198363|101535926|FG001|Overall Study|Adverse Event|1|||
33260288|NCT01953692|100853517|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33260289|NCT01953692|100853518|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
33449099|NCT04198363|101535925|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
33168443|NCT02028065|100521857|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
33168444|NCT02028065|100521858|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
33168445|NCT02028065|100521859|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
33168446|NCT02028065|100521857|FG000|Treatment Through Study Completion|Physician Decision|1|||
33168447|NCT02028065|100521858|FG001|Treatment Through Study Completion|Physician Decision|0|||
33168448|NCT02028065|100521859|FG002|Treatment Through Study Completion|Physician Decision|0|||
33168449|NCT02028065|100521857|FG000|Treatment Through Study Completion|Protocol Violation|1|||
33168450|NCT02028065|100521858|FG001|Treatment Through Study Completion|Protocol Violation|4|||
33168451|NCT02028065|100521859|FG002|Treatment Through Study Completion|Protocol Violation|0|||
33168452|NCT02028065|100521857|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
33168453|NCT02028065|100521858|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
33168454|NCT02028065|100521859|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
33168455|NCT02028065|100521857|FG000|Treatment Through Study Completion|Adverse Event|3|||
33168456|NCT02028065|100521858|FG001|Treatment Through Study Completion|Adverse Event|3|||
33168457|NCT02028065|100521859|FG002|Treatment Through Study Completion|Adverse Event|5|||
33168458|NCT00601458|100521860|FG000|Overall Study|Dosing Error|1|||
33168459|NCT00601458|100521861|FG001|Overall Study|Dosing Error|0|||
33168460|NCT00601458|100521862|FG002|Overall Study|Dosing Error|0|||
33168461|NCT00601458|100521860|FG000|Overall Study|Incomplete Data|0|||
33168462|NCT00601458|100521861|FG001|Overall Study|Incomplete Data|2|||
33449100|NCT04198363|101535926|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
33449101|NCT04198363|101535925|FG000|Overall Study|Reason not Specified|1|||
33449102|NCT04198363|101535926|FG001|Overall Study|Reason not Specified|0|||
33449103|NCT03107091|101535929|FG000|Overall Study|Physician Decision|1|||
33449104|NCT02378935|101535930|FG000|Overall Study|Lack of Efficacy|10|||
33449105|NCT02378935|101535931|FG001|Overall Study|Lack of Efficacy|0|||
33449106|NCT02378935|101535932|FG002|Overall Study|Lack of Efficacy|2|||
33168463|NCT00601458|100521862|FG002|Overall Study|Incomplete Data|0|||
33168464|NCT00601458|100521860|FG000|Overall Study|Protocol Violation|3|||
33449107|NCT02378935|101535933|FG003|Overall Study|Lack of Efficacy|6|||
33449108|NCT02378935|101535934|FG004|Overall Study|Lack of Efficacy|0|||
33168465|NCT00601458|100521861|FG001|Overall Study|Protocol Violation|2|||
33168466|NCT00601458|100521862|FG002|Overall Study|Protocol Violation|1|||
33168467|NCT00601458|100521860|FG000|Overall Study|Early Termination|0|||
33168468|NCT00601458|100521861|FG001|Overall Study|Early Termination|1|||
33168469|NCT00601458|100521862|FG002|Overall Study|Early Termination|1|||
33168470|NCT01007812|100521867|FG000|Period 1, One Week|Lost to Follow-up|0|||
33168471|NCT01007812|100521868|FG001|Period 1, One Week|Lost to Follow-up|1|||
33449109|NCT02378935|101535935|FG005|Overall Study|Lack of Efficacy|0|||
33449110|NCT02378935|101535936|FG006|Overall Study|Lack of Efficacy|0|||
33449111|NCT02378935|101535930|FG000|Overall Study|Death|0|||
33449112|NCT02378935|101535931|FG001|Overall Study|Death|0|||
33449113|NCT02378935|101535932|FG002|Overall Study|Death|1|||
33449114|NCT02378935|101535933|FG003|Overall Study|Death|0|||
33449115|NCT02378935|101535934|FG004|Overall Study|Death|0|||
33449116|NCT02378935|101535935|FG005|Overall Study|Death|0|||
33168472|NCT01007812|100521867|FG000|Period 1, One Week|Discomfort|1|||
33168473|NCT01007812|100521868|FG001|Period 1, One Week|Discomfort|0|||
33449117|NCT02378935|101535936|FG006|Overall Study|Death|0|||
33449118|NCT00835991|101535937|FG000|First Intervention|Adverse Event|0|||
33449119|NCT00835991|101535938|FG001|First Intervention|Adverse Event|1|||
33449120|NCT00835991|101535937|FG000|Washout|Protocol Violation|0|||
33449121|NCT00835991|101535938|FG001|Washout|Protocol Violation|2|||
33449122|NCT00835991|101535937|FG000|Washout|Withdrawal by Subject|3|||
33449123|NCT00835991|101535938|FG001|Washout|Withdrawal by Subject|1|||
33449124|NCT01838681|101535939|FG000|Period A|Adverse Event|39|||
33449125|NCT01838681|101535940|FG001|Period A|Adverse Event|0|||
33449126|NCT01838681|101535941|FG002|Period A|Adverse Event|0|||
33449127|NCT01838681|101535942|FG003|Period A|Adverse Event|0|||
33449128|NCT01838681|101535939|FG000|Period A|Lack of Efficacy|21|||
33449129|NCT01838681|101535940|FG001|Period A|Lack of Efficacy|0|||
33168474|NCT02879305|100521870|FG000|Overall Study|Investigator Site Closed|55|||
33168475|NCT02879305|100521871|FG001|Overall Study|Investigator Site Closed|57|||
33168476|NCT02879305|100521870|FG000|Overall Study|Withdrawal by Subject|44|||
33168477|NCT02879305|100521871|FG001|Overall Study|Withdrawal by Subject|42|||
33168478|NCT02879305|100521870|FG000|Overall Study|Lost to Follow-up|17|||
33168479|NCT02879305|100521871|FG001|Overall Study|Lost to Follow-up|12|||
33168480|NCT02879305|100521870|FG000|Overall Study|Other|1|||
33449130|NCT01838681|101535941|FG002|Period A|Lack of Efficacy|0|||
33449131|NCT01838681|101535942|FG003|Period A|Lack of Efficacy|0|||
33449132|NCT01838681|101535939|FG000|Period A|Early response|148|||
33449133|NCT01838681|101535940|FG001|Period A|Early response|0|||
33168481|NCT02879305|100521871|FG001|Overall Study|Other|0|||
33168482|NCT01217814|100521877|FG000|Overall Study|Adverse Event|1|||
33168483|NCT01217814|100521878|FG001|Overall Study|Adverse Event|1|||
33168484|NCT01217814|100521879|FG002|Overall Study|Adverse Event|0|||
33168485|NCT01217814|100521877|FG000|Overall Study|Lack of Efficacy|0|||
33168486|NCT01217814|100521878|FG001|Overall Study|Lack of Efficacy|0|||
33168487|NCT01217814|100521879|FG002|Overall Study|Lack of Efficacy|1|||
33449134|NCT01838681|101535941|FG002|Period A|Early response|0|||
33449135|NCT01838681|101535942|FG003|Period A|Early response|0|||
33449136|NCT01838681|101535939|FG000|Period A|Withdrawal by Subject|70|||
33449137|NCT01838681|101535940|FG001|Period A|Withdrawal by Subject|0|||
33449138|NCT01838681|101535941|FG002|Period A|Withdrawal by Subject|0|||
33449139|NCT01838681|101535942|FG003|Period A|Withdrawal by Subject|0|||
33449140|NCT01838681|101535939|FG000|Period A|Protocol Violation|16|||
33449141|NCT01838681|101535940|FG001|Period A|Protocol Violation|0|||
33449142|NCT01838681|101535941|FG002|Period A|Protocol Violation|0|||
33449143|NCT01838681|101535942|FG003|Period A|Protocol Violation|0|||
33260290|NCT01953692|100853519|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
33260291|NCT01953692|100853511|FG000|Overall Study|Withdrawal by Subject|4|||
33260292|NCT01953692|100853512|FG001|Overall Study|Withdrawal by Subject|2|||
33260293|NCT01953692|100853513|FG002|Overall Study|Withdrawal by Subject|1|||
33260294|NCT01953692|100853514|FG003|Overall Study|Withdrawal by Subject|2|||
33260295|NCT01953692|100853515|FG004|Overall Study|Withdrawal by Subject|0|||
33260296|NCT01953692|100853516|FG005|Overall Study|Withdrawal by Subject|3|||
33260297|NCT01953692|100853517|FG006|Overall Study|Withdrawal by Subject|2|||
33260298|NCT01953692|100853518|FG007|Overall Study|Withdrawal by Subject|1|||
33260299|NCT01953692|100853519|FG008|Overall Study|Withdrawal by Subject|1|||
33260300|NCT00434304|100853523|FG000|Overall Study|Adverse Event|14|||
33260301|NCT00434304|100853523|FG000|Overall Study|Lack of Efficacy|2|||
33260302|NCT00434304|100853523|FG000|Overall Study|Withdrawal by Subject|4|||
33260303|NCT00419341|100853527|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
33260304|NCT00419341|100853527|FG000|Wash in/Wash Out Period|Adverse Event|2|||
33260305|NCT00419341|100853527|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
33260306|NCT00419341|100853527|FG000|Efficacy Period|Withdrawal by Subject|6|||
33260307|NCT00419341|100853527|FG000|Efficacy Period|Protocol Violation|1|||
33449144|NCT01838681|101535939|FG000|Period A|Non-compliance with IMP|6|||
33449145|NCT01838681|101535940|FG001|Period A|Non-compliance with IMP|0|||
33449146|NCT01838681|101535941|FG002|Period A|Non-compliance with IMP|0|||
33449147|NCT01838681|101535942|FG003|Period A|Non-compliance with IMP|0|||
33449148|NCT01838681|101535939|FG000|Period A|Lost to Follow-up|4|||
33449149|NCT01838681|101535940|FG001|Period A|Lost to Follow-up|0|||
33449150|NCT01838681|101535941|FG002|Period A|Lost to Follow-up|0|||
33449151|NCT01838681|101535942|FG003|Period A|Lost to Follow-up|0|||
33449152|NCT01838681|101535939|FG000|Period A|Withdrawal before treatment|4|||
33449153|NCT01838681|101535940|FG001|Period A|Withdrawal before treatment|0|||
33449154|NCT01838681|101535941|FG002|Period A|Withdrawal before treatment|0|||
33449155|NCT01838681|101535942|FG003|Period A|Withdrawal before treatment|0|||
33449156|NCT01838681|101535939|FG000|Period A|Administrative or other reasons|17|||
33260308|NCT00419341|100853527|FG000|Efficacy Period|Lost to Follow-up|1|||
33449157|NCT01838681|101535940|FG001|Period A|Administrative or other reasons|0|||
33449158|NCT01838681|101535941|FG002|Period A|Administrative or other reasons|0|||
33449159|NCT01838681|101535942|FG003|Period A|Administrative or other reasons|0|||
33449160|NCT01838681|101535939|FG000|Period B/A+|Adverse Event|0|||
33260309|NCT00419341|100853527|FG000|Efficacy Period|Non-compliance|1|||
33260310|NCT00419341|100853527|FG000|Efficacy Period|Termination of study site|1|||
33449161|NCT01838681|101535940|FG001|Period B/A+|Adverse Event|13|||
33449162|NCT01838681|101535941|FG002|Period B/A+|Adverse Event|27|||
33449163|NCT01838681|101535942|FG003|Period B/A+|Adverse Event|16|||
33449164|NCT01838681|101535939|FG000|Period B/A+|Lack of Efficacy|0|||
33449165|NCT01838681|101535940|FG001|Period B/A+|Lack of Efficacy|9|||
33449166|NCT01838681|101535941|FG002|Period B/A+|Lack of Efficacy|11|||
33449167|NCT01838681|101535942|FG003|Period B/A+|Lack of Efficacy|6|||
33449168|NCT01838681|101535939|FG000|Period B/A+|Withdrawal by Subject|0|||
33449169|NCT01838681|101535940|FG001|Period B/A+|Withdrawal by Subject|28|||
33449170|NCT01838681|101535941|FG002|Period B/A+|Withdrawal by Subject|35|||
33449171|NCT01838681|101535942|FG003|Period B/A+|Withdrawal by Subject|47|||
33449172|NCT01838681|101535939|FG000|Period B/A+|Protocol Violation|0|||
33449173|NCT01838681|101535940|FG001|Period B/A+|Protocol Violation|1|||
33449174|NCT01838681|101535941|FG002|Period B/A+|Protocol Violation|4|||
33449175|NCT01838681|101535942|FG003|Period B/A+|Protocol Violation|6|||
33449176|NCT01838681|101535939|FG000|Period B/A+|Non-compliance with IMP|0|||
33449177|NCT01838681|101535940|FG001|Period B/A+|Non-compliance with IMP|2|||
33449178|NCT01838681|101535941|FG002|Period B/A+|Non-compliance with IMP|3|||
33449179|NCT01838681|101535942|FG003|Period B/A+|Non-compliance with IMP|3|||
33449180|NCT01838681|101535939|FG000|Period B/A+|Lost to Follow-up|0|||
33449181|NCT01838681|101535940|FG001|Period B/A+|Lost to Follow-up|2|||
33449182|NCT01838681|101535941|FG002|Period B/A+|Lost to Follow-up|5|||
33449183|NCT01838681|101535942|FG003|Period B/A+|Lost to Follow-up|11|||
33449184|NCT01838681|101535939|FG000|Period B/A+|Withdrawal before treatment|0|||
33449185|NCT01838681|101535940|FG001|Period B/A+|Withdrawal before treatment|1|||
33449186|NCT01838681|101535941|FG002|Period B/A+|Withdrawal before treatment|0|||
33449187|NCT01838681|101535942|FG003|Period B/A+|Withdrawal before treatment|0|||
33449188|NCT01838681|101535939|FG000|Period B/A+|Administrative or other reasons|0|||
33449189|NCT01838681|101535940|FG001|Period B/A+|Administrative or other reasons|6|||
33449190|NCT01838681|101535941|FG002|Period B/A+|Administrative or other reasons|10|||
33449191|NCT01838681|101535942|FG003|Period B/A+|Administrative or other reasons|28|||
33449192|NCT02440711|101535943|FG000|Second Intervention|Lost to Follow-up|1|||
33449193|NCT02440711|101535944|FG001|Second Intervention|Lost to Follow-up|0|||
33449194|NCT03707587|101535947|FG000|Overall Study|Death|0|||
33449195|NCT03707587|101535948|FG001|Overall Study|Death|1|||
33449196|NCT02057835|101535949|FG000|Overall Study|Withdrawal by Subject|0|||
33449197|NCT02057835|101535950|FG001|Overall Study|Withdrawal by Subject|2|||
33449198|NCT02057835|101535951|FG002|Overall Study|Withdrawal by Subject|0|||
33449199|NCT02057835|101535952|FG003|Overall Study|Withdrawal by Subject|0|||
33449200|NCT02057835|101535953|FG004|Overall Study|Withdrawal by Subject|0|||
33449201|NCT02057835|101535954|FG005|Overall Study|Withdrawal by Subject|0|||
33449202|NCT02057835|101535955|FG006|Overall Study|Withdrawal by Subject|0|||
33449203|NCT02057835|101535956|FG007|Overall Study|Withdrawal by Subject|0|||
33449204|NCT02057835|101535957|FG008|Overall Study|Withdrawal by Subject|0|||
33449205|NCT02057835|101535958|FG009|Overall Study|Withdrawal by Subject|0|||
33449206|NCT00316277|101535974|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
33449207|NCT00316277|101535975|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
33449208|NCT00316277|101535974|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
33449209|NCT00316277|101535975|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
33449210|NCT00316277|101535974|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
33449211|NCT00316277|101535975|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
33449212|NCT00316277|101535974|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
33449213|NCT00316277|101535975|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
33449214|NCT00316277|101535974|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
33449215|NCT00316277|101535975|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
33449216|NCT00545792|101535976|FG000|Overall Study|Withdrawal by Subject|1|||
33449217|NCT02436005|101535978|FG000|Second Intervention|Adverse Event|0|||
33449218|NCT02436005|101535979|FG001|Second Intervention|Adverse Event|1|||
33449219|NCT01535222|101535981|FG000|Overall Study|Inclusion/exclusion|0|||
33168488|NCT02925494|100521881|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
33449220|NCT01535222|101535982|FG001|Overall Study|Inclusion/exclusion|0|||
33449221|NCT01535222|101535983|FG002|Overall Study|Inclusion/exclusion|1|||
33449222|NCT01535222|101535984|FG003|Overall Study|Inclusion/exclusion|0|||
33449223|NCT01535222|101535985|FG004|Overall Study|Inclusion/exclusion|0|||
33449224|NCT01535222|101535986|FG005|Overall Study|Inclusion/exclusion|0|||
33449225|NCT01531894|101535987|FG000|Overall Study|Physician Decision|8|||
33449226|NCT01531894|101535987|FG000|Overall Study|Death|1|||
33449227|NCT01101022|101535990|FG000|Overall Study|Adverse Event|6|||
33449228|NCT01101022|101535991|FG001|Overall Study|Adverse Event|2|||
33449229|NCT01101022|101535990|FG000|Overall Study|Protocol Violation|4|||
33449230|NCT01101022|101535991|FG001|Overall Study|Protocol Violation|3|||
33449231|NCT01101022|101535990|FG000|Overall Study|Withdrawal by Subject|3|||
33168489|NCT02925494|100521882|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
33449232|NCT01101022|101535991|FG001|Overall Study|Withdrawal by Subject|8|||
33449233|NCT01101022|101535990|FG000|Overall Study|Lost to Follow-up|1|||
33168490|NCT02925494|100521883|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
33449234|NCT01101022|101535991|FG001|Overall Study|Lost to Follow-up|4|||
33449235|NCT01101022|101535990|FG000|Overall Study|Lack of Efficacy|0|||
33449236|NCT01101022|101535991|FG001|Overall Study|Lack of Efficacy|7|||
33449237|NCT01101022|101535990|FG000|Overall Study|Sponsor decision|1|||
33449238|NCT01101022|101535991|FG001|Overall Study|Sponsor decision|1|||
33449239|NCT01101022|101535990|FG000|Overall Study|Non-compliance|1|||
33449240|NCT01101022|101535991|FG001|Overall Study|Non-compliance|0|||
33449241|NCT01101022|101535990|FG000|Overall Study|Work schedule|1|||
33449242|NCT01101022|101535991|FG001|Overall Study|Work schedule|1|||
33449243|NCT01101022|101535990|FG000|Overall Study|Vacation|0|||
33449244|NCT01101022|101535991|FG001|Overall Study|Vacation|1|||
33449245|NCT00834431|101535999|FG000|First Intervention|Adverse Event|0|||
33449246|NCT00834431|101536000|FG001|First Intervention|Adverse Event|1|||
33449247|NCT00834431|101535999|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
33449248|NCT00834431|101536000|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
33449249|NCT03600805|101536003|FG000|Overall Study|Adverse Event|2|||
33449250|NCT03600805|101536004|FG001|Overall Study|Adverse Event|1|||
33449251|NCT03600805|101536005|FG002|Overall Study|Adverse Event|1|||
33449252|NCT03600805|101536006|FG003|Overall Study|Adverse Event|7|||
33449253|NCT03600805|101536003|FG000|Overall Study|Lack of Efficacy|2|||
33168491|NCT02925494|100521884|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
33449254|NCT03600805|101536004|FG001|Overall Study|Lack of Efficacy|1|||
33168492|NCT02925494|100521881|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
33168493|NCT02925494|100521882|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
33168494|NCT02925494|100521883|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
33168495|NCT02925494|100521884|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
33168496|NCT02925494|100521881|FG000|Post-Treatment Follow-Up Period|Other|1|||
33168497|NCT02925494|100521882|FG001|Post-Treatment Follow-Up Period|Other|4|||
33168498|NCT02925494|100521883|FG002|Post-Treatment Follow-Up Period|Other|3|||
33168499|NCT02925494|100521884|FG003|Post-Treatment Follow-Up Period|Other|6|||
33168500|NCT02925494|100521881|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
33168501|NCT02925494|100521882|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
33168502|NCT02925494|100521883|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
33168503|NCT02925494|100521884|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
33168504|NCT02925494|100521881|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
33168505|NCT02925494|100521882|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
33168506|NCT02925494|100521883|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
33168507|NCT02925494|100521884|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
33168508|NCT02925494|100521881|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
33168509|NCT02925494|100521882|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
33168510|NCT02925494|100521883|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
33168511|NCT02925494|100521884|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
33168512|NCT02925494|100521881|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
33168513|NCT02925494|100521882|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
33168514|NCT02925494|100521883|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
33168515|NCT02925494|100521884|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
33168516|NCT04997161|100521885|FG000|Overall Study|Study terminated by sponsor|3|||
33168517|NCT00230607|100521886|FG000|Overall Study|Other|3|||
33168518|NCT00353262|100521896|FG000|Overall Study|Adverse Event|8|||
33168519|NCT00353262|100521896|FG000|Overall Study|Withdrawal by Subject|2|||
33168520|NCT00353262|100521896|FG000|Overall Study|Insufficient Therapeutic Response|13|||
33168521|NCT00353262|100521896|FG000|Overall Study|Progression|1|||
33168522|NCT00353262|100521896|FG000|Overall Study|Surgery|4|||
33449255|NCT03600805|101536005|FG002|Overall Study|Lack of Efficacy|0|||
33449256|NCT03600805|101536006|FG003|Overall Study|Lack of Efficacy|0|||
33449257|NCT03600805|101536003|FG000|Overall Study|Withdrawal by Subject|1|||
33449258|NCT03600805|101536004|FG001|Overall Study|Withdrawal by Subject|0|||
33449259|NCT03600805|101536005|FG002|Overall Study|Withdrawal by Subject|0|||
33449260|NCT03600805|101536006|FG003|Overall Study|Withdrawal by Subject|1|||
33449261|NCT03600805|101536003|FG000|Overall Study|Other unspecified|14|||
33449262|NCT03600805|101536004|FG001|Overall Study|Other unspecified|6|||
33449263|NCT03600805|101536005|FG002|Overall Study|Other unspecified|7|||
33449264|NCT03600805|101536006|FG003|Overall Study|Other unspecified|11|||
33449265|NCT00835536|101536009|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
33449266|NCT00835536|101536010|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
33449267|NCT00573443|101536011|FG000|Double-Blind Phase|Lost to Follow-up|1|||
33449268|NCT00573443|101536012|FG001|Double-Blind Phase|Lost to Follow-up|3|||
33449269|NCT00573443|101536013|FG002|Double-Blind Phase|Lost to Follow-up|2|||
33449270|NCT00573443|101536011|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
33449271|NCT00573443|101536012|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
33449272|NCT00573443|101536013|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
33449273|NCT00573443|101536011|FG000|Double-Blind Phase|Adverse Event|1|||
33449274|NCT00573443|101536012|FG001|Double-Blind Phase|Adverse Event|5|||
33449275|NCT00573443|101536013|FG002|Double-Blind Phase|Adverse Event|0|||
33449276|NCT00573443|101536011|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
33449277|NCT00573443|101536012|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
33449278|NCT00573443|101536013|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
33449279|NCT00573443|101536011|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
33449280|NCT00573443|101536012|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
33449281|NCT00573443|101536013|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
33449282|NCT00573443|101536011|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
33449283|NCT00573443|101536012|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
33449284|NCT00573443|101536013|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
33449285|NCT00573443|101536011|FG000|Double-Blind Phase|Protocol Violation|0|||
33449286|NCT00573443|101536012|FG001|Double-Blind Phase|Protocol Violation|2|||
33449287|NCT00573443|101536013|FG002|Double-Blind Phase|Protocol Violation|1|||
33449288|NCT00573443|101536011|FG000|Double-Blind Phase|Other|0|||
33449289|NCT00573443|101536012|FG001|Double-Blind Phase|Other|2|||
33449290|NCT00573443|101536013|FG002|Double-Blind Phase|Other|3|||
33449291|NCT00573443|101536011|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
33449292|NCT00573443|101536012|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
33449293|NCT00573443|101536013|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
33449294|NCT00573443|101536011|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
33449295|NCT00573443|101536012|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
33449296|NCT00573443|101536013|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
33449297|NCT00573443|101536011|FG000|Open-Label Extension Phase|Adverse Event|3|||
33449298|NCT00573443|101536012|FG001|Open-Label Extension Phase|Adverse Event|0|||
33449299|NCT00573443|101536013|FG002|Open-Label Extension Phase|Adverse Event|0|||
33449300|NCT00573443|101536011|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
33449301|NCT00573443|101536012|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
33449302|NCT00573443|101536013|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
33449303|NCT00573443|101536011|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
33449304|NCT00573443|101536012|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
33449305|NCT00573443|101536013|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
33449306|NCT00573443|101536011|FG000|Open-Label Extension Phase|Protocol Violation|2|||
33449307|NCT00573443|101536012|FG001|Open-Label Extension Phase|Protocol Violation|0|||
33449308|NCT00573443|101536013|FG002|Open-Label Extension Phase|Protocol Violation|0|||
33449309|NCT00573443|101536011|FG000|Open-Label Extension Phase|Other|2|||
33449310|NCT00573443|101536012|FG001|Open-Label Extension Phase|Other|0|||
33449311|NCT00573443|101536013|FG002|Open-Label Extension Phase|Other|0|||
33449312|NCT03031847|101536016|FG000|Overall Study|Death|1|||
33449313|NCT03031847|101536017|FG001|Overall Study|Death|1|||
33449314|NCT03031847|101536018|FG002|Overall Study|Death|2|||
33449315|NCT03031847|101536019|FG003|Overall Study|Death|3|||
33449316|NCT03031847|101536016|FG000|Overall Study|Lost to Follow-up|1|||
33449317|NCT03031847|101536017|FG001|Overall Study|Lost to Follow-up|1|||
33449318|NCT03031847|101536018|FG002|Overall Study|Lost to Follow-up|2|||
33449319|NCT03031847|101536019|FG003|Overall Study|Lost to Follow-up|3|||
33449320|NCT01020474|101536020|FG000|Overall Study|Adverse Event|4|||
33449321|NCT01020474|101536021|FG001|Overall Study|Adverse Event|4|||
33449322|NCT01020474|101536020|FG000|Overall Study|Protocol Violation|0|||
33449323|NCT01020474|101536021|FG001|Overall Study|Protocol Violation|2|||
33449324|NCT01020474|101536020|FG000|Overall Study|Withdrawal by Subject|5|||
33449325|NCT01020474|101536021|FG001|Overall Study|Withdrawal by Subject|7|||
33449326|NCT01020474|101536020|FG000|Overall Study|Other Reasons|1|||
33449327|NCT01020474|101536021|FG001|Overall Study|Other Reasons|1|||
33449328|NCT01020474|101536020|FG000|Overall Study|Insufficient Clinical Response|0|||
33449329|NCT01020474|101536021|FG001|Overall Study|Insufficient Clinical Response|3|||
33449330|NCT02566850|101536022|FG000|Overall Study|Protocol Violation|1|||
33449331|NCT00777023|101536023|FG000|Overall Study|Adverse Event|15|||
33449332|NCT00777023|101536024|FG001|Overall Study|Adverse Event|21|||
33449333|NCT00777023|101536025|FG002|Overall Study|Adverse Event|8|||
33449334|NCT00777023|101536023|FG000|Overall Study|Lack of Efficacy|1|||
33449335|NCT00777023|101536024|FG001|Overall Study|Lack of Efficacy|0|||
33449336|NCT00777023|101536025|FG002|Overall Study|Lack of Efficacy|14|||
33449337|NCT00777023|101536023|FG000|Overall Study|Protocol Violation|2|||
33449338|NCT00777023|101536024|FG001|Overall Study|Protocol Violation|1|||
33449339|NCT00777023|101536025|FG002|Overall Study|Protocol Violation|1|||
33260311|NCT01388361|100853530|FG000|Overall Study|Adverse Event|0|||
33260312|NCT01388361|100853531|FG001|Overall Study|Adverse Event|5|||
33260313|NCT01388361|100853532|FG002|Overall Study|Adverse Event|1|||
33260314|NCT01388361|100853530|FG000|Overall Study|Protocol Violation|0|||
33449340|NCT00777023|101536023|FG000|Overall Study|Lost to Follow-up|2|||
33260315|NCT01388361|100853531|FG001|Overall Study|Protocol Violation|0|||
33449341|NCT00777023|101536024|FG001|Overall Study|Lost to Follow-up|3|||
33260316|NCT01388361|100853532|FG002|Overall Study|Protocol Violation|2|||
33168523|NCT00353262|100521896|FG000|Overall Study|Break from Chemotherapy|1|||
33168524|NCT00491075|100521897|FG000|Overall Study|Withdrawal by Subject|1|||
33168525|NCT00491075|100521897|FG000|Overall Study|Physician Decision|1|||
33168526|NCT03978520|100521901|FG000|Overall Study|Adverse Event|2|||
33168527|NCT03978520|100521902|FG001|Overall Study|Adverse Event|5|||
33168528|NCT03978520|100521903|FG002|Overall Study|Adverse Event|3|||
33168529|NCT03978520|100521904|FG003|Overall Study|Adverse Event|5|||
33168530|NCT03978520|100521905|FG004|Overall Study|Adverse Event|6|||
33168531|NCT03978520|100521901|FG000|Overall Study|Withdrawal by Subject|10|||
33168532|NCT03978520|100521902|FG001|Overall Study|Withdrawal by Subject|4|||
33168533|NCT03978520|100521903|FG002|Overall Study|Withdrawal by Subject|5|||
33168534|NCT03978520|100521904|FG003|Overall Study|Withdrawal by Subject|6|||
33168535|NCT03978520|100521905|FG004|Overall Study|Withdrawal by Subject|5|||
33168536|NCT03978520|100521901|FG000|Overall Study|Lost to Follow-up|2|||
33168537|NCT03978520|100521902|FG001|Overall Study|Lost to Follow-up|2|||
33168538|NCT03978520|100521903|FG002|Overall Study|Lost to Follow-up|2|||
33168539|NCT03978520|100521904|FG003|Overall Study|Lost to Follow-up|0|||
33168540|NCT03978520|100521905|FG004|Overall Study|Lost to Follow-up|1|||
33168541|NCT03978520|100521901|FG000|Overall Study|COVID-19 infection|0|||
33168542|NCT03978520|100521902|FG001|Overall Study|COVID-19 infection|1|||
33168543|NCT03978520|100521903|FG002|Overall Study|COVID-19 infection|0|||
33168544|NCT03978520|100521904|FG003|Overall Study|COVID-19 infection|0|||
33168545|NCT03978520|100521905|FG004|Overall Study|COVID-19 infection|0|||
33168546|NCT03978520|100521901|FG000|Overall Study|Other, not specified|9|||
33168547|NCT03978520|100521902|FG001|Overall Study|Other, not specified|4|||
33168548|NCT03978520|100521903|FG002|Overall Study|Other, not specified|1|||
33168549|NCT03978520|100521904|FG003|Overall Study|Other, not specified|1|||
33168550|NCT03978520|100521905|FG004|Overall Study|Other, not specified|2|||
33260317|NCT01388361|100853530|FG000|Overall Study|Withdrawal criteria|12|||
33260318|NCT01388361|100853531|FG001|Overall Study|Withdrawal criteria|7|||
33260319|NCT01388361|100853532|FG002|Overall Study|Withdrawal criteria|10|||
33260320|NCT01388361|100853530|FG000|Overall Study|Unclassified|0|||
33260321|NCT01388361|100853531|FG001|Overall Study|Unclassified|0|||
33449342|NCT00777023|101536025|FG002|Overall Study|Lost to Follow-up|3|||
33449343|NCT00777023|101536023|FG000|Overall Study|Death|0|||
33168551|NCT03978520|100521901|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
33168552|NCT03978520|100521902|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
33168553|NCT03978520|100521903|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
33168554|NCT03978520|100521904|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
33449344|NCT00777023|101536024|FG001|Overall Study|Death|1|||
33260322|NCT01388361|100853532|FG002|Overall Study|Unclassified|1|||
33449345|NCT00777023|101536025|FG002|Overall Study|Death|0|||
33168555|NCT03978520|100521905|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
33168556|NCT00590720|100521908|FG000|Overall Study|Lost to Follow-up|1|||
33168557|NCT00590720|100521909|FG001|Overall Study|Lost to Follow-up|0|||
33168558|NCT00590720|100521908|FG000|Overall Study|Withdrawal by Subject|0|||
33168559|NCT00590720|100521909|FG001|Overall Study|Withdrawal by Subject|1|||
33168560|NCT02310568|100521915|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
33168561|NCT02310568|100521916|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
33168562|NCT02310568|100521917|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
33168563|NCT02310568|100521918|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
33168564|NCT02310568|100521919|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
33168565|NCT02310568|100521915|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
33168566|NCT02310568|100521916|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
33168567|NCT02310568|100521917|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
33168568|NCT02310568|100521918|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
33168569|NCT02310568|100521919|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
33168570|NCT02310568|100521915|FG000|Stage 1 ( 4 Weeks)|Other|1|||
33168571|NCT02310568|100521916|FG001|Stage 1 ( 4 Weeks)|Other|1|||
33260323|NCT00901901|100853533|FG000|Treatment Period|Adverse Event|120|||
33260324|NCT00901901|100853534|FG001|Treatment Period|Adverse Event|128|||
33260325|NCT00901901|100853533|FG000|Treatment Period|Withdrawal by Subject|26|||
33260326|NCT00901901|100853534|FG001|Treatment Period|Withdrawal by Subject|24|||
33260327|NCT00901901|100853533|FG000|Treatment Period|Physician Decision|2|||
33260328|NCT00901901|100853534|FG001|Treatment Period|Physician Decision|2|||
33260329|NCT00901901|100853533|FG000|Treatment Period|Lost to Follow-up|3|||
33260330|NCT00901901|100853534|FG001|Treatment Period|Lost to Follow-up|5|||
33260331|NCT00901901|100853533|FG000|Treatment Period|Noncompliance with study medication|4|||
33260332|NCT00901901|100853534|FG001|Treatment Period|Noncompliance with study medication|1|||
33449346|NCT00777023|101536023|FG000|Overall Study|Withdrawal by Subject|7|||
33449347|NCT00777023|101536024|FG001|Overall Study|Withdrawal by Subject|7|||
33449348|NCT00777023|101536025|FG002|Overall Study|Withdrawal by Subject|8|||
33449349|NCT00777023|101536023|FG000|Overall Study|Missing data|1|||
33449350|NCT00777023|101536024|FG001|Overall Study|Missing data|1|||
33449351|NCT00777023|101536025|FG002|Overall Study|Missing data|0|||
33449352|NCT00777023|101536023|FG000|Overall Study|Reasons not specified|4|||
33449353|NCT00777023|101536024|FG001|Overall Study|Reasons not specified|4|||
33449354|NCT00777023|101536025|FG002|Overall Study|Reasons not specified|2|||
33449355|NCT00777023|101536023|FG000|Overall Study|Last dose date unknown|3|||
33449356|NCT00777023|101536024|FG001|Overall Study|Last dose date unknown|3|||
33449357|NCT00777023|101536025|FG002|Overall Study|Last dose date unknown|1|||
33449358|NCT01370083|101536028|FG000|Overall Study|Lost to Follow-up|2|||
33168572|NCT02310568|100521917|FG002|Stage 1 ( 4 Weeks)|Other|0|||
33168573|NCT02310568|100521918|FG003|Stage 1 ( 4 Weeks)|Other|0|||
33168574|NCT02310568|100521919|FG004|Stage 1 ( 4 Weeks)|Other|0|||
33168575|NCT02310568|100521915|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
33260333|NCT00901901|100853533|FG000|Treatment Period|Missing|1|||
33449359|NCT01370083|101536029|FG001|Overall Study|Lost to Follow-up|0|||
33449360|NCT01370083|101536028|FG000|Overall Study|Adverse Event|0|||
33449361|NCT01370083|101536029|FG001|Overall Study|Adverse Event|1|||
33449362|NCT02736721|101536030|FG000|Overall Study|Adverse Event|8|||
33449363|NCT02736721|101536030|FG000|Overall Study|Lost to Follow-up|3|||
33449364|NCT02736721|101536030|FG000|Overall Study|Other|5|||
33449365|NCT03214952|101536031|FG000|Overall Study|Protocol Deviation|45|||
33449366|NCT03214952|101536031|FG000|Overall Study|Case Report Forms Uncollected|13|||
33449367|NCT03086460|101536032|FG000|Study Participants|Lost to Follow-up|2|||
33449368|NCT03086460|101536032|FG000|Study Participants|Protocol Violation|1|||
33449369|NCT03086460|101536032|FG000|Study Participants|Withdrawal by Subject|6|||
33449370|NCT03086460|101536032|FG000|Treatment A|Lost to Follow-up|1|||
33449371|NCT03086460|101536032|FG000|Treatment A|Protocol Violation|1|||
33449372|NCT03086460|101536032|FG000|Treatment A|Withdrawal by Subject|2|||
33449373|NCT03086460|101536032|FG000|Treatment C|Withdrawal by Subject|2|||
33449374|NCT03086460|101536032|FG000|Treatment E|Lost to Follow-up|1|||
33449375|NCT03086460|101536032|FG000|Treatment E|Withdrawal by Subject|3|||
33260334|NCT00901901|100853534|FG001|Treatment Period|Missing|0|||
33260335|NCT00901901|100853533|FG000|Treatment Period|Never treated|0|||
33260336|NCT00901901|100853534|FG001|Treatment Period|Never treated|3|||
33260337|NCT00901901|100853533|FG000|Treatment Period|Protocol driven decision point|0|||
33260338|NCT00901901|100853534|FG001|Treatment Period|Protocol driven decision point|2|||
33260339|NCT00901901|100853533|FG000|Treatment Period|Study terminated by sponsor|2|||
33260340|NCT00901901|100853534|FG001|Treatment Period|Study terminated by sponsor|0|||
33260341|NCT00901901|100853533|FG000|Treatment Period|Protocol Violation|5|||
33260342|NCT00901901|100853534|FG001|Treatment Period|Protocol Violation|9|||
33260343|NCT00901901|100853533|FG000|Treatment Period|Switch to commercial drug|1|||
33260344|NCT00901901|100853534|FG001|Treatment Period|Switch to commercial drug|1|||
33260345|NCT00901901|100853533|FG000|Treatment Period|Transfer to treatment continuation study|5|||
33260346|NCT00901901|100853534|FG001|Treatment Period|Transfer to treatment continuation study|2|||
33260347|NCT00901901|100853533|FG000|Follow-up Period|Death|181|||
33260348|NCT00901901|100853534|FG001|Follow-up Period|Death|208|||
33260349|NCT00901901|100853533|FG000|Follow-up Period|Protocol driven decision point|47|||
33260350|NCT00901901|100853534|FG001|Follow-up Period|Protocol driven decision point|36|||
33260351|NCT00901901|100853533|FG000|Follow-up Period|Withdrawal by Subject|6|||
33260352|NCT00901901|100853534|FG001|Follow-up Period|Withdrawal by Subject|9|||
33260353|NCT00901901|100853533|FG000|Follow-up Period|Lost to Follow-up|12|||
33260354|NCT00901901|100853534|FG001|Follow-up Period|Lost to Follow-up|8|||
33260355|NCT00901901|100853533|FG000|Follow-up Period|Missing|94|||
33260356|NCT00901901|100853534|FG001|Follow-up Period|Missing|80|||
33260357|NCT01185561|100853537|FG000|Overall Study|Lost to Follow-up|0|||
33260358|NCT01185561|100853538|FG001|Overall Study|Lost to Follow-up|4|||
33260359|NCT01185561|100853537|FG000|Overall Study|Withdrawal by Subject|2|||
33260360|NCT01185561|100853538|FG001|Overall Study|Withdrawal by Subject|8|||
33260361|NCT01972724|100853545|FG000|Double-Blind|Rescue Criteria Met|1|||
33260362|NCT01972724|100853546|FG001|Double-Blind|Rescue Criteria Met|0|||
33260363|NCT01972724|100853547|FG002|Double-Blind|Rescue Criteria Met|0|||
33260364|NCT01972724|100853545|FG000|Double-Blind|Adverse Event|1|||
33260365|NCT01972724|100853546|FG001|Double-Blind|Adverse Event|0|||
33260366|NCT01972724|100853547|FG002|Double-Blind|Adverse Event|0|||
33260367|NCT01972724|100853545|FG000|Double-Blind|Withdrawal of Consent|2|||
33260368|NCT01972724|100853546|FG001|Double-Blind|Withdrawal of Consent|1|||
33260369|NCT01972724|100853547|FG002|Double-Blind|Withdrawal of Consent|0|||
33260370|NCT01972724|100853545|FG000|Double-Blind|Significant Protocol Deviation|5|||
33260371|NCT01972724|100853546|FG001|Double-Blind|Significant Protocol Deviation|8|||
33260372|NCT01972724|100853547|FG002|Double-Blind|Significant Protocol Deviation|0|||
33260373|NCT01972724|100853545|FG000|Open-Label|Withdrew Consent|0|||
33260374|NCT01972724|100853546|FG001|Open-Label|Withdrew Consent|0|||
33260375|NCT01972724|100853547|FG002|Open-Label|Withdrew Consent|3|||
33260376|NCT01972724|100853545|FG000|Open-Label|Significant Protocol Deviation|0|||
33449376|NCT01034358|101536033|FG000|Overall Study|Withdrawal by Subject|1|||
33449377|NCT01034358|101536033|FG000|Overall Study|Protocol Violation|1|||
33168576|NCT02310568|100521916|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
33260377|NCT01972724|100853546|FG001|Open-Label|Significant Protocol Deviation|0|||
33260378|NCT01972724|100853547|FG002|Open-Label|Significant Protocol Deviation|2|||
33260379|NCT01236560|100853548|FG000|Overall Study|Adverse Event|0|||
33260380|NCT01236560|100853549|FG001|Overall Study|Adverse Event|2|||
33260381|NCT01236560|100853550|FG002|Overall Study|Adverse Event|1|||
33449378|NCT00620074|101536034|FG000|Overall Study|Adverse Event|1|||
33449379|NCT01200810|101536035|FG000|Overall Study|Physician Decision|1|||
33449380|NCT01200810|101536036|FG001|Overall Study|Physician Decision|0|||
33449381|NCT01200810|101536035|FG000|Overall Study|Withdrawal by Subject|1|||
33260382|NCT01236560|100853551|FG003|Overall Study|Adverse Event|3|||
33260383|NCT01236560|100853552|FG004|Overall Study|Adverse Event|0|||
33260384|NCT01236560|100853553|FG005|Overall Study|Adverse Event|0|||
33260385|NCT01236560|100853548|FG000|Overall Study|Death|0|||
33260386|NCT01236560|100853549|FG001|Overall Study|Death|1|||
33260387|NCT01236560|100853550|FG002|Overall Study|Death|0|||
33260388|NCT01236560|100853551|FG003|Overall Study|Death|1|||
33260389|NCT01236560|100853552|FG004|Overall Study|Death|0|||
33260390|NCT01236560|100853553|FG005|Overall Study|Death|0|||
33260391|NCT01236560|100853548|FG000|Overall Study|Lost to Follow-up|0|||
33260392|NCT01236560|100853549|FG001|Overall Study|Lost to Follow-up|1|||
33260393|NCT01236560|100853550|FG002|Overall Study|Lost to Follow-up|1|||
33260394|NCT01236560|100853551|FG003|Overall Study|Lost to Follow-up|0|||
33260395|NCT01236560|100853552|FG004|Overall Study|Lost to Follow-up|0|||
33260396|NCT01236560|100853553|FG005|Overall Study|Lost to Follow-up|0|||
33260397|NCT01236560|100853548|FG000|Overall Study|Physician Decision|0|||
33260398|NCT01236560|100853549|FG001|Overall Study|Physician Decision|1|||
33260399|NCT01236560|100853550|FG002|Overall Study|Physician Decision|8|||
33260400|NCT01236560|100853551|FG003|Overall Study|Physician Decision|0|||
33260401|NCT01236560|100853552|FG004|Overall Study|Physician Decision|0|||
33260402|NCT01236560|100853553|FG005|Overall Study|Physician Decision|0|||
33260403|NCT01236560|100853548|FG000|Overall Study|Withdrawal by Subject|0|||
33260404|NCT01236560|100853549|FG001|Overall Study|Withdrawal by Subject|0|||
33260405|NCT01236560|100853550|FG002|Overall Study|Withdrawal by Subject|1|||
33260406|NCT01236560|100853551|FG003|Overall Study|Withdrawal by Subject|2|||
33260407|NCT01236560|100853552|FG004|Overall Study|Withdrawal by Subject|0|||
33260408|NCT01236560|100853553|FG005|Overall Study|Withdrawal by Subject|0|||
33260409|NCT01236560|100853548|FG000|Overall Study|Progressive disease|5|||
33260410|NCT01236560|100853549|FG001|Overall Study|Progressive disease|19|||
33260411|NCT01236560|100853550|FG002|Overall Study|Progressive disease|9|||
33260412|NCT01236560|100853551|FG003|Overall Study|Progressive disease|16|||
33260413|NCT01236560|100853552|FG004|Overall Study|Progressive disease|0|||
33260414|NCT01236560|100853553|FG005|Overall Study|Progressive disease|0|||
33260415|NCT03988842|100853554|FG000|Overall Study|Death|1|||
33260416|NCT03664960|100853555|FG000|Overall Study|Adverse Event|0|||
33260417|NCT03664960|100853556|FG001|Overall Study|Adverse Event|3|||
33260418|NCT03664960|100853555|FG000|Overall Study|Lost to Follow-up|3|||
33260419|NCT03664960|100853556|FG001|Overall Study|Lost to Follow-up|2|||
33260420|NCT03664960|100853555|FG000|Overall Study|Physician Decision|1|||
33260421|NCT03664960|100853556|FG001|Overall Study|Physician Decision|0|||
33260422|NCT03664960|100853555|FG000|Overall Study|Withdrawal by Subject|3|||
33260423|NCT03664960|100853556|FG001|Overall Study|Withdrawal by Subject|14|||
33260424|NCT03664960|100853555|FG000|Overall Study|Sponsor Decision|1|||
33260425|NCT03664960|100853556|FG001|Overall Study|Sponsor Decision|1|||
33260426|NCT03664960|100853555|FG000|Overall Study|Other|1|||
33260427|NCT03664960|100853556|FG001|Overall Study|Other|2|||
33260428|NCT00304031|100853557|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
33260429|NCT00304031|100853558|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
33260430|NCT00304031|100853559|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
33260431|NCT00304031|100853557|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
33260432|NCT00304031|100853558|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
33260433|NCT00304031|100853559|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
33260434|NCT00304031|100853557|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
33260435|NCT00304031|100853558|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
33260436|NCT00304031|100853559|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
33260437|NCT00304031|100853557|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
33260438|NCT00304031|100853558|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
33260439|NCT00304031|100853559|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
33260440|NCT00304031|100853557|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
33260441|NCT00304031|100853558|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
33260442|NCT00304031|100853559|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
33260443|NCT00304031|100853557|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
33260444|NCT00304031|100853558|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
33260445|NCT00304031|100853559|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
33260446|NCT00304031|100853557|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
33260447|NCT00304031|100853558|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
33260448|NCT00304031|100853559|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
33260449|NCT00304031|100853557|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
33260450|NCT00304031|100853558|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
33260451|NCT00304031|100853559|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
33260452|NCT00304031|100853557|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
33260453|NCT00304031|100853558|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
33260454|NCT00304031|100853559|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
33260455|NCT02919449|100853566|FG000|Overall Study|Withdrawal by Subject|1|||
33260456|NCT02919449|100853566|FG000|Overall Study|Investigator decision|1|||
33260457|NCT01534494|100853567|FG000|Overall Study|Withdrawal by Subject|1|||
33260458|NCT00632203|100853568|FG000|Overall Study|Did not start study treatment|1|||
33260459|NCT00632203|100853569|FG001|Overall Study|Did not start study treatment|0|||
33260460|NCT00243503|100853570|FG000|Overall Study|Adverse Event|11|||
33260461|NCT00243503|100853570|FG000|Overall Study|Withdrawal by Subject|1|||
33260462|NCT00243503|100853570|FG000|Overall Study|Lack of Efficacy|44|||
33260463|NCT00243503|100853570|FG000|Overall Study|Death|1|||
33260464|NCT00243503|100853570|FG000|Overall Study|Other|1|||
33260465|NCT01582100|100853571|FG000|Overall Study|Adverse Event|1|||
33260466|NCT01582100|100853571|FG000|Overall Study|Withdrawal by Subject|1|||
33260467|NCT00350792|100853575|FG000|Overall Study|Adverse Event|11|||
33260468|NCT00350792|100853575|FG000|Overall Study|Death from Study Disease|1|||
33260469|NCT00350792|100853575|FG000|Overall Study|Death from Study Drug Toxicity|1|||
33260470|NCT00350792|100853575|FG000|Overall Study|Death Not Study Drug Related|2|||
33260471|NCT00350792|100853575|FG000|Overall Study|Protocol Violation|1|||
33260472|NCT00350792|100853575|FG000|Overall Study|Withdrawal by Subject|4|||
33260473|NCT00350792|100853575|FG000|Overall Study|Physician Decision|2|||
33260474|NCT00350792|100853575|FG000|Overall Study|Lack of Efficacy|11|||
33260475|NCT00087139|100853576|FG000|Overall Study|Adverse Event|18|||
33260476|NCT00087139|100853577|FG001|Overall Study|Adverse Event|17|||
33260477|NCT00087139|100853578|FG002|Overall Study|Adverse Event|13|||
33260478|NCT00087139|100853576|FG000|Overall Study|Death|2|||
33260479|NCT00087139|100853577|FG001|Overall Study|Death|1|||
33260480|NCT00087139|100853578|FG002|Overall Study|Death|0|||
33260481|NCT00087139|100853576|FG000|Overall Study|Withdrawal by Subject|3|||
33260482|NCT00087139|100853577|FG001|Overall Study|Withdrawal by Subject|2|||
33260483|NCT00087139|100853578|FG002|Overall Study|Withdrawal by Subject|2|||
33260484|NCT00087139|100853576|FG000|Overall Study|Physician Decision|1|||
33260485|NCT00087139|100853577|FG001|Overall Study|Physician Decision|1|||
33260486|NCT00087139|100853578|FG002|Overall Study|Physician Decision|1|||
33260487|NCT00087139|100853576|FG000|Overall Study|Disease progression|9|||
33260488|NCT00087139|100853577|FG001|Overall Study|Disease progression|19|||
33260489|NCT00087139|100853578|FG002|Overall Study|Disease progression|12|||
33260490|NCT00087139|100853576|FG000|Overall Study|Ineligible|4|||
33260491|NCT00087139|100853577|FG001|Overall Study|Ineligible|7|||
33260492|NCT00087139|100853578|FG002|Overall Study|Ineligible|4|||
33260493|NCT00087139|100853576|FG000|Overall Study|Symptomatic deterioration|1|||
33260494|NCT00087139|100853577|FG001|Overall Study|Symptomatic deterioration|1|||
33260495|NCT00087139|100853578|FG002|Overall Study|Symptomatic deterioration|3|||
33260496|NCT00087139|100853576|FG000|Overall Study|Use of coumadin|1|||
33260497|NCT00087139|100853577|FG001|Overall Study|Use of coumadin|0|||
33260498|NCT00087139|100853578|FG002|Overall Study|Use of coumadin|0|||
33260499|NCT00087139|100853576|FG000|Overall Study|Response achieved|0|||
33260500|NCT00087139|100853577|FG001|Overall Study|Response achieved|1|||
33260501|NCT00087139|100853578|FG002|Overall Study|Response achieved|0|||
33260502|NCT00087139|100853576|FG000|Overall Study|Extradural disease|0|||
33260503|NCT00087139|100853577|FG001|Overall Study|Extradural disease|0|||
33260504|NCT00087139|100853578|FG002|Overall Study|Extradural disease|1|||
33260505|NCT02407249|100853581|FG000|Overall Study|Did not complete 12-month follow-up|13|||
33449382|NCT01200810|101536036|FG001|Overall Study|Withdrawal by Subject|2|||
33449383|NCT01200810|101536035|FG000|Overall Study|Sponsor stopped making study drug|3|||
33449384|NCT01200810|101536036|FG001|Overall Study|Sponsor stopped making study drug|3|||
33449385|NCT02149420|101536039|FG000|Core Study|Administrative problems|0|||
33449386|NCT02149420|101536040|FG001|Core Study|Administrative problems|1|||
33449387|NCT02149420|101536041|FG002|Core Study|Administrative problems|2|||
33449388|NCT02149420|101536039|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
33260506|NCT02407249|100853581|FG000|Overall Study|Not treated|13|||
33260507|NCT02411084|100853582|FG000|Overall Study|Lack of Efficacy|6|||
33449389|NCT02149420|101536040|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
33260508|NCT02411084|100853583|FG001|Overall Study|Lack of Efficacy|3|||
33449390|NCT02149420|101536041|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
33449391|NCT01471353|101536052|FG000|Overall Study|remain on study|3|||
33449392|NCT03935880|101536053|FG000|Overall Study|Lost to Follow-up|0|||
33449393|NCT03935880|101536054|FG001|Overall Study|Lost to Follow-up|1|||
33449394|NCT02269657|101536055|FG000|Overall Study|Protocol Violation|3|||
33449395|NCT03719040|101536056|FG000|Overall Study|Withdrawal by Subject|177|||
33449396|NCT03719040|101536056|FG000|Overall Study|Lost to Follow-up|26|||
33449397|NCT03872128|101536057|FG000|Overall Study|Dropped out before treatment|1|||
33449398|NCT03872128|101536058|FG001|Overall Study|Dropped out before treatment|0|||
33449399|NCT03872128|101536059|FG002|Overall Study|Dropped out before treatment|4|||
33449400|NCT03872128|101536057|FG000|Overall Study|Lost to Follow-up|2|||
33449401|NCT03872128|101536058|FG001|Overall Study|Lost to Follow-up|5|||
33449402|NCT03872128|101536059|FG002|Overall Study|Lost to Follow-up|8|||
33449403|NCT00830258|101536060|FG000|First Intervention|Adverse Event|1|||
33449404|NCT00830258|101536061|FG001|First Intervention|Adverse Event|0|||
33449405|NCT00830258|101536060|FG000|Washout: 7 Days|Protocol Violation|1|||
33449406|NCT00830258|101536061|FG001|Washout: 7 Days|Protocol Violation|0|||
33449407|NCT03158727|101536063|FG000|Overall Study|Withdrawal by Subject|2|||
33449408|NCT03158727|101536064|FG001|Overall Study|Withdrawal by Subject|6|||
33449409|NCT03158727|101536063|FG000|Overall Study|Death|11|||
33449410|NCT03158727|101536064|FG001|Overall Study|Death|12|||
33168577|NCT02310568|100521917|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
33168578|NCT02310568|100521918|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
33168579|NCT02310568|100521919|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
33168580|NCT02310568|100521915|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
33168581|NCT02310568|100521916|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
33168582|NCT02310568|100521917|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
33168583|NCT02310568|100521918|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
33168584|NCT02310568|100521919|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
33168585|NCT02310568|100521915|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
33168586|NCT02310568|100521916|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
33168587|NCT02310568|100521917|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
33168588|NCT02310568|100521918|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
33168589|NCT02310568|100521919|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
33168590|NCT02310568|100521915|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
33168591|NCT02310568|100521916|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
33168592|NCT02310568|100521917|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
33168593|NCT02310568|100521918|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
33168594|NCT02310568|100521919|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
33168595|NCT02310568|100521915|FG000|Stage 2 (4 Weeks)|Other|0|||
33168596|NCT02310568|100521916|FG001|Stage 2 (4 Weeks)|Other|1|||
33168597|NCT02310568|100521917|FG002|Stage 2 (4 Weeks)|Other|1|||
33168598|NCT02310568|100521918|FG003|Stage 2 (4 Weeks)|Other|0|||
33168599|NCT02310568|100521919|FG004|Stage 2 (4 Weeks)|Other|0|||
33168600|NCT02310568|100521915|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
33168601|NCT02310568|100521916|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
33168602|NCT02310568|100521917|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
33168603|NCT02310568|100521918|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
33168604|NCT02310568|100521919|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
33168605|NCT02310568|100521915|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
33168606|NCT02310568|100521916|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
33168607|NCT02310568|100521917|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
33168608|NCT02310568|100521918|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
33168609|NCT02310568|100521919|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
33168610|NCT02310568|100521915|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
33168611|NCT02310568|100521916|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
33168612|NCT02310568|100521917|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
33168613|NCT02310568|100521918|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
33168614|NCT02310568|100521919|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
33449411|NCT03158727|101536063|FG000|Overall Study|Lost to Follow-up|1|||
33449412|NCT03158727|101536064|FG001|Overall Study|Lost to Follow-up|0|||
33449413|NCT03158727|101536063|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
33449414|NCT03158727|101536064|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
33449415|NCT03158727|101536063|FG000|Overall Study|Visit 11 not done by mistake|0|||
33449416|NCT03158727|101536064|FG001|Overall Study|Visit 11 not done by mistake|1|||
33449417|NCT03158727|101536063|FG000|Overall Study|Enrolled, not treated|1|||
33449418|NCT03158727|101536064|FG001|Overall Study|Enrolled, not treated|0|||
33168615|NCT02101060|100521922|FG000|Overall Study|Adverse Event|1|||
33168616|NCT02101060|100521923|FG001|Overall Study|Adverse Event|0|||
33168617|NCT02101060|100521922|FG000|Overall Study|Withdrawal by Subject|1|||
33168618|NCT02101060|100521923|FG001|Overall Study|Withdrawal by Subject|1|||
33168619|NCT02101060|100521922|FG000|Overall Study|Lost to Follow-up|3|||
33168620|NCT02101060|100521923|FG001|Overall Study|Lost to Follow-up|3|||
33168621|NCT02599129|100525459|FG000|Overall Study|Lack of Efficacy|2|||
33168622|NCT02599129|100525460|FG001|Overall Study|Lack of Efficacy|2|||
33168623|NCT02599129|100525459|FG000|Overall Study|Lost to Follow-up|1|||
33168624|NCT02599129|100525460|FG001|Overall Study|Lost to Follow-up|0|||
33260509|NCT02411084|100853582|FG000|Overall Study|Death|5|||
33260510|NCT02411084|100853583|FG001|Overall Study|Death|4|||
33260511|NCT02411084|100853582|FG000|Overall Study|Adverse Event|2|||
33260512|NCT02411084|100853583|FG001|Overall Study|Adverse Event|1|||
33260513|NCT02411084|100853582|FG000|Overall Study|Other reasons|0|||
33260514|NCT02411084|100853583|FG001|Overall Study|Other reasons|5|||
33168625|NCT02599129|100525459|FG000|Overall Study|Withdrawal by Subject|2|||
33168626|NCT02599129|100525460|FG001|Overall Study|Withdrawal by Subject|1|||
33168627|NCT00621985|100525465|FG000|Dexamethasone Admission|Adverse Event|1|||
33168628|NCT02990910|100525466|FG000|Overall Study|Lack of Efficacy|6|||
33168629|NCT02990910|100525467|FG001|Overall Study|Lack of Efficacy|10|||
33168630|NCT03919799|100525468|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
33168631|NCT03919799|100525469|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
33168632|NCT03919799|100525470|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
33168633|NCT03919799|100525471|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
33168634|NCT03919799|100525472|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
33168635|NCT03919799|100525468|FG000|DB Period (28 Weeks)|Adverse Event|1|||
33168636|NCT03919799|100525469|FG001|DB Period (28 Weeks)|Adverse Event|1|||
33168637|NCT03919799|100525470|FG002|DB Period (28 Weeks)|Adverse Event|1|||
33168638|NCT03919799|100525471|FG003|DB Period (28 Weeks)|Adverse Event|0|||
33168639|NCT03919799|100525472|FG004|DB Period (28 Weeks)|Adverse Event|0|||
33168640|NCT03919799|100525468|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
33168641|NCT03919799|100525469|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
33168642|NCT03919799|100525470|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
33168643|NCT03919799|100525471|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
33168644|NCT03919799|100525472|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
33168645|NCT03919799|100525468|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
33168646|NCT03919799|100525469|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
33168647|NCT03919799|100525470|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
33168648|NCT03919799|100525471|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
33168649|NCT03919799|100525472|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
33168650|NCT03919799|100525468|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
33168651|NCT03919799|100525469|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
33168652|NCT03919799|100525470|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
33168653|NCT03919799|100525471|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
33168654|NCT03919799|100525472|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
33168655|NCT01867424|100525477|FG000|Overall Study|Patient noncompliance|2|||
33168656|NCT01867424|100525478|FG001|Overall Study|Patient noncompliance|1|||
33168657|NCT03694821|100525479|FG000|Overall Study|Study terminated|4|||
33168658|NCT03694821|100525480|FG001|Overall Study|Study terminated|8|||
33168659|NCT03694821|100525481|FG002|Overall Study|Study terminated|4|||
33168660|NCT03798483|100525483|FG000|Overall Study|Lost to Follow-up|2|||
33168661|NCT03648541|100525484|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
33168662|NCT03648541|100525485|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
33168663|NCT03648541|100525484|FG000|Re-induction Period Only|Lack of Efficacy|7|||
33168664|NCT03648541|100525485|FG001|Re-induction Period Only|Lack of Efficacy|0|||
33168665|NCT03648541|100525484|FG000|Maintenance Period Only|Missing|0|||
33168666|NCT03648541|100525485|FG001|Maintenance Period Only|Missing|1|||
33168667|NCT03648541|100525484|FG000|Maintenance Period Only|Other not listed below|0|||
33449419|NCT00354835|101536067|FG000|Overall Study|Death|1|||
33449420|NCT00354835|101536068|FG001|Overall Study|Death|1|||
33449421|NCT00354835|101536067|FG000|Overall Study|Physician Decision|8|||
33449422|NCT00354835|101536068|FG001|Overall Study|Physician Decision|13|||
33449423|NCT00354835|101536067|FG000|Overall Study|Withdrawal by Subject|2|||
33449424|NCT00354835|101536068|FG001|Overall Study|Withdrawal by Subject|1|||
33449425|NCT00354835|101536067|FG000|Overall Study|Ineligible|17|||
33168668|NCT03648541|100525485|FG001|Maintenance Period Only|Other not listed below|4|||
33168669|NCT03648541|100525484|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
33168670|NCT03648541|100525485|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
33168671|NCT03648541|100525484|FG000|Maintenance Period Only|Protocol Violation|0|||
33449426|NCT00354835|101536068|FG001|Overall Study|Ineligible|16|||
33168672|NCT03648541|100525485|FG001|Maintenance Period Only|Protocol Violation|1|||
33168673|NCT03648541|100525484|FG000|Maintenance Period Only|Lack of Efficacy|0|||
33168674|NCT03648541|100525485|FG001|Maintenance Period Only|Lack of Efficacy|18|||
33449427|NCT00354835|101536067|FG000|Overall Study|Disease progression or relapse|15|||
33168675|NCT03648541|100525484|FG000|Maintenance Period Only|Adverse Event|0|||
33168676|NCT03648541|100525485|FG001|Maintenance Period Only|Adverse Event|4|||
33168677|NCT03648541|100525484|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
33168678|NCT03648541|100525485|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
33168679|NCT02651922|100525487|FG000|Overall Study|due to exclusion criteria|2|||
33168680|NCT03761277|100525496|FG000|Enrollment to Implant|Screen Failure|17|||
33168681|NCT03761277|100525496|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
33168682|NCT03761277|100525496|FG000|Enrollment to Implant|Physician Decision|2|||
33168683|NCT03761277|100525496|FG000|Enrollment to Implant|Site Closure|3|||
33168684|NCT03761277|100525496|FG000|Enrollment to Implant|Sponsor Request|2|||
33168685|NCT03761277|100525496|FG000|Post-Implant to 6 Months|Adverse Event|2|||
33168686|NCT03761277|100525496|FG000|Post-Implant to 6 Months|Death|1|||
33168687|NCT03761277|100525496|FG000|Post-Implant to 6 Months|Site Closure|2|||
33168688|NCT03761277|100525496|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
33168689|NCT03761277|100525496|FG000|6 Months to 12 Months|Physician Decision|2|||
33168690|NCT03761277|100525496|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
33168691|NCT00660309|100525497|FG000|Overall Study|Adverse Event|2|||
33168692|NCT00660309|100525498|FG001|Overall Study|Adverse Event|0|||
33168693|NCT00660309|100525497|FG000|Overall Study|Withdrawal by Subject|0|||
33168694|NCT00660309|100525498|FG001|Overall Study|Withdrawal by Subject|3|||
33168695|NCT02495168|100525499|FG000|Overall Study|Other than Specified|18|||
33168696|NCT02495168|100525500|FG001|Overall Study|Other than Specified|22|||
33168697|NCT02495168|100525501|FG002|Overall Study|Other than Specified|5|||
33168698|NCT02495168|100525499|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
33168699|NCT02495168|100525500|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
33168700|NCT02495168|100525501|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
33168701|NCT02495168|100525499|FG000|Overall Study|Physician Decision|1|||
33168702|NCT02495168|100525500|FG001|Overall Study|Physician Decision|1|||
33260515|NCT04048681|100856309|FG000|Overall Study|family emergency|0|||
33168703|NCT02495168|100525501|FG002|Overall Study|Physician Decision|0|||
33168704|NCT02495168|100525499|FG000|Overall Study|Lost to Follow-up|10|||
33168705|NCT02495168|100525500|FG001|Overall Study|Lost to Follow-up|6|||
33168706|NCT02495168|100525501|FG002|Overall Study|Lost to Follow-up|1|||
33168707|NCT02495168|100525499|FG000|Overall Study|Withdrawal by Subject|1|||
33168708|NCT02495168|100525500|FG001|Overall Study|Withdrawal by Subject|4|||
33168709|NCT02495168|100525501|FG002|Overall Study|Withdrawal by Subject|2|||
33168710|NCT02495168|100525499|FG000|Overall Study|Protocol Violation|0|||
33168711|NCT02495168|100525500|FG001|Overall Study|Protocol Violation|10|||
33168712|NCT02495168|100525501|FG002|Overall Study|Protocol Violation|1|||
33168713|NCT02495168|100525499|FG000|Overall Study|Adverse Event|4|||
33168714|NCT02495168|100525500|FG001|Overall Study|Adverse Event|8|||
33168715|NCT02495168|100525501|FG002|Overall Study|Adverse Event|3|||
33168716|NCT02495168|100525499|FG000|Overall Study|Lack of Efficacy|0|||
33168717|NCT02495168|100525500|FG001|Overall Study|Lack of Efficacy|0|||
33168718|NCT02495168|100525501|FG002|Overall Study|Lack of Efficacy|3|||
33168719|NCT02670837|100525502|FG000|Overall Study|Death|2|||
33260516|NCT04048681|100856310|FG001|Overall Study|family emergency|0|||
33260517|NCT04048681|100856311|FG002|Overall Study|family emergency|0|||
33260518|NCT04048681|100856312|FG003|Overall Study|family emergency|1|||
33260519|NCT04048681|100856313|FG004|Overall Study|family emergency|0|||
33260520|NCT02034916|100856321|FG000|Overall Study|Death|39|||
33260521|NCT02034916|100856322|FG001|Overall Study|Death|28|||
33260522|NCT02034916|100856321|FG000|Overall Study|Withdrawal by Subject|2|||
33260523|NCT02034916|100856322|FG001|Overall Study|Withdrawal by Subject|1|||
33260524|NCT02034916|100856321|FG000|Overall Study|Lost to Follow-up|4|||
33260525|NCT02034916|100856322|FG001|Overall Study|Lost to Follow-up|1|||
33260526|NCT02034916|100856321|FG000|Overall Study|Study terminated by sponsor|4|||
33260527|NCT02034916|100856322|FG001|Overall Study|Study terminated by sponsor|5|||
33449428|NCT00354835|101536068|FG001|Overall Study|Disease progression or relapse|22|||
33449429|NCT00354835|101536067|FG000|Overall Study|Adverse Event|6|||
33449430|NCT00354835|101536068|FG001|Overall Study|Adverse Event|0|||
33168720|NCT02670837|100525503|FG001|Overall Study|Death|0|||
33168721|NCT02670837|100525504|FG002|Overall Study|Death|0|||
33168722|NCT01484197|100525505|FG000|Treatment Period 1|Adverse Event|1|||
33168723|NCT01484197|100525506|FG001|Treatment Period 1|Adverse Event|0|||
33168724|NCT01484197|100525507|FG002|Treatment Period 1|Adverse Event|0|||
33168725|NCT01484197|100525508|FG003|Treatment Period 1|Adverse Event|0|||
33168726|NCT01484197|100525505|FG000|Treatment Period 2|Subject withdrew consent|0|||
33168727|NCT01484197|100525506|FG001|Treatment Period 2|Subject withdrew consent|0|||
33168728|NCT01484197|100525507|FG002|Treatment Period 2|Subject withdrew consent|0|||
33168729|NCT01484197|100525508|FG003|Treatment Period 2|Subject withdrew consent|1|||
33168730|NCT02233647|100525509|FG000|Overall Study|Adverse Event|1|||
33168731|NCT02612727|100525512|FG000|Overall Study|Parent request|4|||
33260528|NCT00331136|100856325|FG000|Overall Study|Adverse Event|3|||
33168732|NCT02612727|100525513|FG001|Overall Study|Parent request|1|||
33260529|NCT00331136|100856326|FG001|Overall Study|Adverse Event|5|||
33260530|NCT00331136|100856327|FG002|Overall Study|Adverse Event|0|||
33168733|NCT02612727|100525512|FG000|Overall Study|Needed treatment incompatible with PT|1|||
33168734|NCT02612727|100525513|FG001|Overall Study|Needed treatment incompatible with PT|1|||
33168735|NCT02612727|100525512|FG000|Overall Study|Direct hyperbilirubinemia|0|||
33168736|NCT02612727|100525513|FG001|Overall Study|Direct hyperbilirubinemia|2|||
33168737|NCT00727025|100525514|FG000|Overall Study|Physician Decision|23|||
33168738|NCT00739674|100525515|FG000|Overall Study|Screening failures|19|||
33168739|NCT00739674|100525516|FG001|Overall Study|Screening failures|17|||
33168740|NCT00739674|100525515|FG000|Overall Study|Site 212 removal|19|||
33168741|NCT00739674|100525516|FG001|Overall Study|Site 212 removal|13|||
33168742|NCT00739674|100525515|FG000|Overall Study|No follow-up data|33|||
33168743|NCT00739674|100525516|FG001|Overall Study|No follow-up data|18|||
33168744|NCT00739674|100525515|FG000|Overall Study|Dietician consultation >30 days|1|||
33168745|NCT00739674|100525516|FG001|Overall Study|Dietician consultation >30 days|9|||
33168746|NCT00739674|100525515|FG000|Overall Study|Adverse Event|22|||
33168747|NCT00739674|100525516|FG001|Overall Study|Adverse Event|13|||
33168748|NCT00739674|100525515|FG000|Overall Study|Death|1|||
33168749|NCT00739674|100525516|FG001|Overall Study|Death|0|||
33168750|NCT00739674|100525515|FG000|Overall Study|Lack of Efficacy|1|||
33168751|NCT00739674|100525516|FG001|Overall Study|Lack of Efficacy|0|||
33168752|NCT00739674|100525515|FG000|Overall Study|Lost to Follow-up|52|||
33168753|NCT00739674|100525516|FG001|Overall Study|Lost to Follow-up|30|||
33168754|NCT00739674|100525515|FG000|Overall Study|Protocol Violation|5|||
33168755|NCT00739674|100525516|FG001|Overall Study|Protocol Violation|5|||
33168756|NCT00739674|100525515|FG000|Overall Study|Withdrawal by Subject|9|||
33168757|NCT00739674|100525516|FG001|Overall Study|Withdrawal by Subject|9|||
33168758|NCT00739674|100525515|FG000|Overall Study|Reason missing|2|||
33168759|NCT00739674|100525516|FG001|Overall Study|Reason missing|0|||
33168760|NCT00739674|100525515|FG000|Overall Study|Clinic closed|6|||
33168761|NCT00739674|100525516|FG001|Overall Study|Clinic closed|4|||
33168762|NCT00739674|100525515|FG000|Overall Study|Patient moved|3|||
33168763|NCT00739674|100525516|FG001|Overall Study|Patient moved|2|||
33168764|NCT00739674|100525515|FG000|Overall Study|Non compliant|4|||
33168765|NCT00739674|100525516|FG001|Overall Study|Non compliant|0|||
33168766|NCT00739674|100525515|FG000|Overall Study|Unable to attend visit|3|||
33260531|NCT00331136|100856328|FG003|Overall Study|Adverse Event|1|||
33260532|NCT00331136|100856325|FG000|Overall Study|Withdrawal by Subject|0|||
33260533|NCT00331136|100856326|FG001|Overall Study|Withdrawal by Subject|1|||
33260534|NCT00331136|100856327|FG002|Overall Study|Withdrawal by Subject|0|||
33260535|NCT00331136|100856328|FG003|Overall Study|Withdrawal by Subject|0|||
33260536|NCT00331136|100856325|FG000|Overall Study|Lost to Follow-up|0|||
33260537|NCT00331136|100856326|FG001|Overall Study|Lost to Follow-up|1|||
33260538|NCT00331136|100856327|FG002|Overall Study|Lost to Follow-up|0|||
33260539|NCT00331136|100856328|FG003|Overall Study|Lost to Follow-up|0|||
33260540|NCT00331136|100856325|FG000|Overall Study|Protocol Violation|1|||
33260541|NCT00331136|100856326|FG001|Overall Study|Protocol Violation|0|||
33260542|NCT00331136|100856327|FG002|Overall Study|Protocol Violation|0|||
33260543|NCT00331136|100856328|FG003|Overall Study|Protocol Violation|0|||
33260544|NCT00331136|100856325|FG000|Overall Study|Not treated|1|||
33260545|NCT00331136|100856326|FG001|Overall Study|Not treated|0|||
33260546|NCT00331136|100856327|FG002|Overall Study|Not treated|0|||
33260547|NCT00331136|100856328|FG003|Overall Study|Not treated|0|||
33449431|NCT00354835|101536067|FG000|Overall Study|Refusal of further therapy|3|||
33449432|NCT00354835|101536068|FG001|Overall Study|Refusal of further therapy|8|||
33449433|NCT01168856|101536074|FG000|Overall Study|Lost to Follow-up|4|||
33449434|NCT01168856|101536075|FG001|Overall Study|Lost to Follow-up|34|||
33449435|NCT01168856|101536074|FG000|Overall Study|Withdrawal by Subject|6|||
33449436|NCT01168856|101536075|FG001|Overall Study|Withdrawal by Subject|8|||
33449437|NCT01168856|101536074|FG000|Overall Study|Physician Decision|2|||
33449438|NCT01168856|101536075|FG001|Overall Study|Physician Decision|1|||
33449439|NCT01168856|101536074|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
33449440|NCT01168856|101536075|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
33449441|NCT01168856|101536074|FG000|Overall Study|Participant received anti-HCV treatment|1|||
33449442|NCT01168856|101536075|FG001|Overall Study|Participant received anti-HCV treatment|0|||
33168767|NCT00739674|100525516|FG001|Overall Study|Unable to attend visit|1|||
33168768|NCT00739674|100525515|FG000|Overall Study|Home monitoring off meds|1|||
33168769|NCT00739674|100525516|FG001|Overall Study|Home monitoring off meds|0|||
33168770|NCT00739674|100525515|FG000|Overall Study|Erectile dysfunction|0|||
33168771|NCT00739674|100525516|FG001|Overall Study|Erectile dysfunction|1|||
33168772|NCT02014597|100525517|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
33168773|NCT02014597|100525518|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
33168774|NCT04656691|100525519|FG000|Overall Study|Adverse Event|1|||
33168775|NCT01937559|100525520|FG000|Overall Study|Physician Decision|3|||
33168776|NCT01937559|100525521|FG001|Overall Study|Physician Decision|3|||
33260548|NCT01639131|100856332|FG000|Overall Study|Disease Progression|6|||
33260549|NCT02075554|100856335|FG000|Overall Study|Lost to Follow-up|7|||
33260550|NCT02075554|100856335|FG000|Overall Study|Withdrawal by Subject|5|||
33260551|NCT02075554|100856335|FG000|Overall Study|Physician Decision|3|||
33260552|NCT02647905|100856337|FG000|Overall Study|Lost to Follow-up|1|||
33260553|NCT02647905|100856337|FG000|Overall Study|Withdrawal by Subject|2|||
33449443|NCT01168856|101536074|FG000|Overall Study|Death|0|||
33449444|NCT01168856|101536075|FG001|Overall Study|Death|2|||
33449445|NCT01168856|101536074|FG000|Overall Study|Other|1|||
33449446|NCT01168856|101536075|FG001|Overall Study|Other|291|||
33449447|NCT01168856|101536074|FG000|Overall Study|Protocol Violation|4|||
33449448|NCT01168856|101536075|FG001|Overall Study|Protocol Violation|6|||
33449449|NCT01895335|101536076|FG000|Overall Study|Adverse Event|106|||
33449450|NCT01895335|101536076|FG000|Overall Study|Lack of Efficacy|53|||
33449451|NCT01895335|101536076|FG000|Overall Study|Poor Compliance to Protocol|11|||
33449452|NCT01895335|101536076|FG000|Overall Study|Included But Not treated|1|||
33449453|NCT01895335|101536076|FG000|Overall Study|Other than Specified Above|44|||
33449454|NCT00838539|101536078|FG000|Overall Study|Disease Progression|2|||
33449455|NCT00838539|101536079|FG001|Overall Study|Disease Progression|4|||
33449456|NCT00838539|101536080|FG002|Overall Study|Disease Progression|3|||
33449457|NCT00838539|101536081|FG003|Overall Study|Disease Progression|2|||
33260554|NCT02422615|100856338|FG000|Treatment Period|Progressive disease|314|||
33449458|NCT00838539|101536082|FG004|Overall Study|Disease Progression|4|||
33449459|NCT00838539|101536083|FG005|Overall Study|Disease Progression|2|||
33449460|NCT00838539|101536084|FG006|Overall Study|Disease Progression|3|||
33449461|NCT00838539|101536085|FG007|Overall Study|Disease Progression|4|||
33449462|NCT00838539|101536086|FG008|Overall Study|Disease Progression|4|||
33449463|NCT00838539|101536087|FG009|Overall Study|Disease Progression|5|||
33449464|NCT00838539|101536088|FG010|Overall Study|Disease Progression|1|||
33449465|NCT00838539|101536089|FG011|Overall Study|Disease Progression|4|||
33449466|NCT00838539|101536078|FG000|Overall Study|Adverse Event|1|||
33449467|NCT00838539|101536079|FG001|Overall Study|Adverse Event|1|||
33449468|NCT00838539|101536080|FG002|Overall Study|Adverse Event|1|||
33449469|NCT00838539|101536081|FG003|Overall Study|Adverse Event|1|||
33449470|NCT00838539|101536082|FG004|Overall Study|Adverse Event|2|||
33449471|NCT00838539|101536083|FG005|Overall Study|Adverse Event|1|||
33449472|NCT00838539|101536084|FG006|Overall Study|Adverse Event|0|||
33449473|NCT00838539|101536085|FG007|Overall Study|Adverse Event|2|||
33449474|NCT00838539|101536086|FG008|Overall Study|Adverse Event|0|||
33449475|NCT00838539|101536087|FG009|Overall Study|Adverse Event|1|||
33449476|NCT00838539|101536088|FG010|Overall Study|Adverse Event|2|||
33449477|NCT00838539|101536089|FG011|Overall Study|Adverse Event|0|||
33449478|NCT00838539|101536078|FG000|Overall Study|Withdrawal by Subject|0|||
33449479|NCT00838539|101536079|FG001|Overall Study|Withdrawal by Subject|1|||
33449480|NCT00838539|101536080|FG002|Overall Study|Withdrawal by Subject|0|||
33449481|NCT00838539|101536081|FG003|Overall Study|Withdrawal by Subject|0|||
33449482|NCT00838539|101536082|FG004|Overall Study|Withdrawal by Subject|0|||
33449483|NCT00838539|101536083|FG005|Overall Study|Withdrawal by Subject|0|||
33449484|NCT00838539|101536084|FG006|Overall Study|Withdrawal by Subject|0|||
33449485|NCT00838539|101536085|FG007|Overall Study|Withdrawal by Subject|0|||
33260555|NCT02422615|100856339|FG001|Treatment Period|Progressive disease|200|||
33260556|NCT02422615|100856338|FG000|Treatment Period|Adverse Event|51|||
33260557|NCT02422615|100856339|FG001|Treatment Period|Adverse Event|9|||
33260558|NCT02422615|100856338|FG000|Treatment Period|Physician Decision|32|||
33260559|NCT02422615|100856339|FG001|Treatment Period|Physician Decision|8|||
33260560|NCT02422615|100856338|FG000|Treatment Period|Subject/guardian decision|38|||
33260561|NCT02422615|100856339|FG001|Treatment Period|Subject/guardian decision|8|||
33260562|NCT02422615|100856338|FG000|Treatment Period|Death|2|||
33260563|NCT02422615|100856339|FG001|Treatment Period|Death|1|||
33260564|NCT02422615|100856338|FG000|Treatment Period|Technical problems|0|||
33260565|NCT02422615|100856339|FG001|Treatment Period|Technical problems|1|||
33260566|NCT02422615|100856338|FG000|Treatment Period|Protocol deviation|1|||
33260567|NCT02422615|100856339|FG001|Treatment Period|Protocol deviation|1|||
33260568|NCT02422615|100856338|FG000|Treatment Period|Study terminated as per protocol|46|||
33260569|NCT02422615|100856339|FG001|Treatment Period|Study terminated as per protocol|14|||
33260570|NCT02422615|100856338|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
33449486|NCT00838539|101536086|FG008|Overall Study|Withdrawal by Subject|0|||
33449487|NCT00838539|101536087|FG009|Overall Study|Withdrawal by Subject|1|||
33449488|NCT00838539|101536088|FG010|Overall Study|Withdrawal by Subject|2|||
33449489|NCT00838539|101536089|FG011|Overall Study|Withdrawal by Subject|0|||
33449490|NCT00838539|101536078|FG000|Overall Study|Death|0|||
33449491|NCT00838539|101536079|FG001|Overall Study|Death|0|||
33449492|NCT00838539|101536080|FG002|Overall Study|Death|0|||
33260571|NCT02422615|100856339|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
33260572|NCT02422615|100856338|FG000|Post-treatment Efficacy Follow-up|Death|2|||
33449493|NCT00838539|101536081|FG003|Overall Study|Death|0|||
33449494|NCT00838539|101536082|FG004|Overall Study|Death|0|||
33168777|NCT01937559|100525522|FG002|Overall Study|Physician Decision|0|||
33168778|NCT01937559|100525520|FG000|Overall Study|Withdrawal by Subject|6|||
33168779|NCT01937559|100525521|FG001|Overall Study|Withdrawal by Subject|4|||
33168780|NCT01937559|100525522|FG002|Overall Study|Withdrawal by Subject|0|||
33168781|NCT01937559|100525520|FG000|Overall Study|screen fail|2|||
33168782|NCT01937559|100525521|FG001|Overall Study|screen fail|4|||
33168783|NCT01937559|100525522|FG002|Overall Study|screen fail|0|||
33168784|NCT00165776|100525525|FG000|Overall Study|Lack of Efficacy|0|||
33168785|NCT00165776|100525526|FG001|Overall Study|Lack of Efficacy|0|||
33168786|NCT00165776|100525527|FG002|Overall Study|Lack of Efficacy|0|||
33168787|NCT00165776|100525528|FG003|Overall Study|Lack of Efficacy|1|||
33168788|NCT00165776|100525525|FG000|Overall Study|Withdrawal by Subject|4|||
33168789|NCT00165776|100525526|FG001|Overall Study|Withdrawal by Subject|1|||
33168790|NCT00165776|100525527|FG002|Overall Study|Withdrawal by Subject|2|||
33168791|NCT00165776|100525528|FG003|Overall Study|Withdrawal by Subject|0|||
33168792|NCT00165776|100525525|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
33168793|NCT00165776|100525526|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
33168794|NCT00165776|100525527|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
33168795|NCT00165776|100525528|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
33168796|NCT00434330|100525529|FG000|Overall Study|Adverse Event|0|||
33168797|NCT00434330|100525530|FG001|Overall Study|Adverse Event|0|||
33168798|NCT00434330|100525531|FG002|Overall Study|Adverse Event|1|||
33168799|NCT00434330|100525532|FG003|Overall Study|Adverse Event|0|||
33168800|NCT00434330|100525533|FG004|Overall Study|Adverse Event|0|||
33168801|NCT00434330|100525534|FG005|Overall Study|Adverse Event|0|||
33168802|NCT00434330|100525529|FG000|Overall Study|Death|1|||
33168803|NCT00434330|100525530|FG001|Overall Study|Death|0|||
33168804|NCT00434330|100525531|FG002|Overall Study|Death|0|||
33168805|NCT00434330|100525532|FG003|Overall Study|Death|0|||
33168806|NCT00434330|100525533|FG004|Overall Study|Death|1|||
33168807|NCT00434330|100525534|FG005|Overall Study|Death|1|||
33168808|NCT00434330|100525529|FG000|Overall Study|Withdrawal by Subject|0|||
33168809|NCT00434330|100525530|FG001|Overall Study|Withdrawal by Subject|0|||
33168810|NCT00434330|100525531|FG002|Overall Study|Withdrawal by Subject|1|||
33168811|NCT00434330|100525532|FG003|Overall Study|Withdrawal by Subject|1|||
33260573|NCT02422615|100856339|FG001|Post-treatment Efficacy Follow-up|Death|1|||
33260574|NCT02422615|100856338|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
33260575|NCT02422615|100856339|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
33260576|NCT02422615|100856338|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
33260577|NCT02422615|100856339|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
33260578|NCT02422615|100856338|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
33449495|NCT00838539|101536083|FG005|Overall Study|Death|0|||
33449496|NCT00838539|101536084|FG006|Overall Study|Death|1|||
33449497|NCT00838539|101536085|FG007|Overall Study|Death|0|||
33449498|NCT00838539|101536086|FG008|Overall Study|Death|0|||
33449499|NCT00838539|101536087|FG009|Overall Study|Death|0|||
33449500|NCT00838539|101536088|FG010|Overall Study|Death|0|||
33449501|NCT00838539|101536089|FG011|Overall Study|Death|0|||
33449502|NCT00838539|101536078|FG000|Overall Study|Physician Decision|0|||
33449503|NCT00838539|101536079|FG001|Overall Study|Physician Decision|0|||
33449504|NCT00838539|101536080|FG002|Overall Study|Physician Decision|0|||
33449505|NCT00838539|101536081|FG003|Overall Study|Physician Decision|0|||
33449506|NCT00838539|101536082|FG004|Overall Study|Physician Decision|0|||
33449507|NCT00838539|101536083|FG005|Overall Study|Physician Decision|0|||
33449508|NCT00838539|101536084|FG006|Overall Study|Physician Decision|0|||
33449509|NCT00838539|101536085|FG007|Overall Study|Physician Decision|0|||
33449510|NCT00838539|101536086|FG008|Overall Study|Physician Decision|1|||
33449511|NCT00838539|101536087|FG009|Overall Study|Physician Decision|0|||
33449512|NCT00838539|101536088|FG010|Overall Study|Physician Decision|0|||
33449513|NCT00838539|101536089|FG011|Overall Study|Physician Decision|0|||
33449514|NCT00838539|101536078|FG000|Overall Study|Clinical Progression|0|||
33449515|NCT00838539|101536079|FG001|Overall Study|Clinical Progression|0|||
33449516|NCT00838539|101536080|FG002|Overall Study|Clinical Progression|0|||
33168812|NCT00434330|100525533|FG004|Overall Study|Withdrawal by Subject|0|||
33168813|NCT00434330|100525534|FG005|Overall Study|Withdrawal by Subject|0|||
33449517|NCT00838539|101536081|FG003|Overall Study|Clinical Progression|0|||
33449518|NCT00838539|101536082|FG004|Overall Study|Clinical Progression|0|||
33449519|NCT00838539|101536083|FG005|Overall Study|Clinical Progression|0|||
33449520|NCT00838539|101536084|FG006|Overall Study|Clinical Progression|1|||
33449521|NCT00838539|101536085|FG007|Overall Study|Clinical Progression|0|||
33168814|NCT00434330|100525529|FG000|Overall Study|Renal transplant|0|||
33168815|NCT00434330|100525530|FG001|Overall Study|Renal transplant|0|||
33168816|NCT00434330|100525531|FG002|Overall Study|Renal transplant|0|||
33168817|NCT00434330|100525532|FG003|Overall Study|Renal transplant|1|||
33168818|NCT00434330|100525533|FG004|Overall Study|Renal transplant|0|||
33168819|NCT00434330|100525534|FG005|Overall Study|Renal transplant|0|||
33449522|NCT00838539|101536086|FG008|Overall Study|Clinical Progression|0|||
33168820|NCT00434330|100525529|FG000|Overall Study|Subject Not Compliant With Study|0|||
33260579|NCT02422615|100856339|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
33260580|NCT02422615|100856338|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
33260581|NCT02422615|100856339|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
33260582|NCT04287985|100856340|FG000|Overall Study|Adverse Event|1|||
33260583|NCT04287985|100856341|FG001|Overall Study|Adverse Event|0|||
33260584|NCT04287985|100856342|FG002|Overall Study|Adverse Event|0|||
33260585|NCT04287985|100856343|FG003|Overall Study|Adverse Event|0|||
33260586|NCT04287985|100856340|FG000|Overall Study|Protocol Violation|0|||
33260587|NCT04287985|100856341|FG001|Overall Study|Protocol Violation|1|||
33260588|NCT04287985|100856342|FG002|Overall Study|Protocol Violation|0|||
33260589|NCT04287985|100856343|FG003|Overall Study|Protocol Violation|0|||
33260590|NCT04287985|100856340|FG000|Overall Study|Physician Decision|0|||
33260591|NCT04287985|100856341|FG001|Overall Study|Physician Decision|0|||
33260592|NCT04287985|100856342|FG002|Overall Study|Physician Decision|0|||
33260593|NCT04287985|100856343|FG003|Overall Study|Physician Decision|1|||
33260594|NCT04287985|100856340|FG000|Overall Study|Withdrawal by Subject|2|||
33260595|NCT04287985|100856341|FG001|Overall Study|Withdrawal by Subject|1|||
33260596|NCT04287985|100856342|FG002|Overall Study|Withdrawal by Subject|1|||
33260597|NCT04287985|100856343|FG003|Overall Study|Withdrawal by Subject|2|||
33260598|NCT02567656|100856344|FG000|Overall Study|Premature discontinuation due to PD|1|||
33260599|NCT02567656|100856345|FG001|Overall Study|Premature discontinuation due to PD|1|||
33260600|NCT02567656|100856346|FG002|Overall Study|Premature discontinuation due to PD|2|||
33260601|NCT02567656|100856347|FG003|Overall Study|Premature discontinuation due to PD|0|||
33260602|NCT02567656|100856348|FG004|Overall Study|Premature discontinuation due to PD|0|||
33260603|NCT02567656|100856349|FG005|Overall Study|Premature discontinuation due to PD|0|||
33260604|NCT00603954|100856350|FG000|Overall Study|Protocol Violation|1|||
33260605|NCT00603954|100856351|FG001|Overall Study|Protocol Violation|2|||
33260606|NCT00611559|100856357|FG000|Overall Study|Lost to Follow-up|0|||
33260607|NCT00611559|100856358|FG001|Overall Study|Lost to Follow-up|1|||
33260608|NCT00611559|100856359|FG002|Overall Study|Lost to Follow-up|0|||
33260609|NCT00611559|100856357|FG000|Overall Study|Protocol Violation|1|||
33260610|NCT00611559|100856358|FG001|Overall Study|Protocol Violation|0|||
33260611|NCT00611559|100856359|FG002|Overall Study|Protocol Violation|1|||
33449523|NCT00838539|101536087|FG009|Overall Study|Clinical Progression|0|||
33449524|NCT00838539|101536088|FG010|Overall Study|Clinical Progression|0|||
33449525|NCT00838539|101536089|FG011|Overall Study|Clinical Progression|0|||
33449526|NCT00838539|101536078|FG000|Overall Study|Symptomatic Deterioration|0|||
33449527|NCT00838539|101536079|FG001|Overall Study|Symptomatic Deterioration|0|||
33449528|NCT00838539|101536080|FG002|Overall Study|Symptomatic Deterioration|1|||
33449529|NCT00838539|101536081|FG003|Overall Study|Symptomatic Deterioration|1|||
33449530|NCT00838539|101536082|FG004|Overall Study|Symptomatic Deterioration|0|||
33449531|NCT00838539|101536083|FG005|Overall Study|Symptomatic Deterioration|1|||
33449532|NCT00838539|101536084|FG006|Overall Study|Symptomatic Deterioration|0|||
33449533|NCT00838539|101536085|FG007|Overall Study|Symptomatic Deterioration|0|||
33449534|NCT00838539|101536086|FG008|Overall Study|Symptomatic Deterioration|0|||
33449535|NCT00838539|101536087|FG009|Overall Study|Symptomatic Deterioration|1|||
33449536|NCT00838539|101536088|FG010|Overall Study|Symptomatic Deterioration|0|||
33449537|NCT00838539|101536089|FG011|Overall Study|Symptomatic Deterioration|0|||
33449538|NCT00418561|101536090|FG000|Overall Study|Participant's (guardian's) decision|0|||
33449539|NCT00418561|101536091|FG001|Overall Study|Participant's (guardian's) decision|1|||
33449540|NCT00418561|101536092|FG002|Overall Study|Participant's (guardian's) decision|0|||
33449541|NCT01701063|101536093|FG000|Overall Study|Lost to Follow-up|0|||
33449542|NCT01701063|101536094|FG001|Overall Study|Lost to Follow-up|1|||
33449543|NCT01701063|101536095|FG002|Overall Study|Lost to Follow-up|0|||
33449544|NCT01701063|101536093|FG000|Overall Study|Withdrawal by Subject|0|||
33449545|NCT01701063|101536094|FG001|Overall Study|Withdrawal by Subject|0|||
33449546|NCT01701063|101536095|FG002|Overall Study|Withdrawal by Subject|1|||
33449547|NCT01701063|101536093|FG000|Overall Study|Other|0|||
33449548|NCT01701063|101536094|FG001|Overall Study|Other|0|||
33449549|NCT01701063|101536095|FG002|Overall Study|Other|1|||
33449550|NCT00942968|101536096|FG000|Overall Study|Adverse Event|60|||
33449551|NCT00942968|101536096|FG000|Overall Study|Death|76|||
33449552|NCT00942968|101536096|FG000|Overall Study|Protocol Violation|9|||
33449553|NCT00942968|101536096|FG000|Overall Study|Lost to Follow-up|4|||
33449554|NCT00942968|101536096|FG000|Overall Study|Withdrawal by Subject|44|||
33449555|NCT00942968|101536096|FG000|Overall Study|Sponsor request|5|||
33449556|NCT00942968|101536096|FG000|Overall Study|Physician Decision|11|||
33449557|NCT00942968|101536096|FG000|Overall Study|Progression of disease|12|||
33260612|NCT00894543|100856363|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
33260613|NCT00894543|100856364|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
33260614|NCT00894543|100856363|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
33260615|NCT00894543|100856364|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
33260616|NCT03394885|100856371|FG000|Overall Study|Adverse Event|4|||
33260617|NCT03394885|100856371|FG000|Overall Study|Lack of Efficacy|1|||
33449558|NCT00942968|101536096|FG000|Overall Study|Inferior vena cava filter placement|4|||
33449559|NCT00942968|101536096|FG000|Overall Study|Pulmonary embolism (PE)|1|||
33449560|NCT00942968|101536096|FG000|Overall Study|Participant required pancreatic biopsy|1|||
33449561|NCT00942968|101536096|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
33449562|NCT00462345|101536097|FG000|Overall Study|Withdrawal by Subject|2|||
33449563|NCT00462345|101536097|FG000|Overall Study|Did not complete second course|1|||
33449564|NCT02157974|101536105|FG000|Overall Study|Withdrawal by Subject|0|||
33449565|NCT02157974|101536106|FG001|Overall Study|Withdrawal by Subject|1|||
33449566|NCT02157974|101536107|FG002|Overall Study|Withdrawal by Subject|0|||
33449567|NCT02157974|101536108|FG003|Overall Study|Withdrawal by Subject|0|||
33449568|NCT02157974|101536109|FG004|Overall Study|Withdrawal by Subject|0|||
33449569|NCT02157974|101536105|FG000|Overall Study|Screen Failure|0|||
33449570|NCT02157974|101536106|FG001|Overall Study|Screen Failure|1|||
33449571|NCT02157974|101536107|FG002|Overall Study|Screen Failure|0|||
33449572|NCT02157974|101536108|FG003|Overall Study|Screen Failure|0|||
33449573|NCT02157974|101536109|FG004|Overall Study|Screen Failure|0|||
33449574|NCT02157974|101536105|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
33449575|NCT02157974|101536106|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
33449576|NCT02157974|101536107|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
33449577|NCT02157974|101536108|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
33449578|NCT02157974|101536109|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
33449579|NCT02358538|101536113|FG000|Through Week 26|Adverse Event|0|||
33449580|NCT02358538|101536114|FG001|Through Week 26|Adverse Event|1|||
33449581|NCT02358538|101536115|FG002|Through Week 26|Adverse Event|1|||
33449582|NCT02358538|101536116|FG003|Through Week 26|Adverse Event|2|||
33449583|NCT02358538|101536113|FG000|Through Week 26|Lack of Efficacy|1|||
33449584|NCT02358538|101536114|FG001|Through Week 26|Lack of Efficacy|1|||
33449585|NCT02358538|101536115|FG002|Through Week 26|Lack of Efficacy|3|||
33449586|NCT02358538|101536116|FG003|Through Week 26|Lack of Efficacy|3|||
33449587|NCT02358538|101536113|FG000|Through Week 26|Withdrawal by Subject|1|||
33449588|NCT02358538|101536114|FG001|Through Week 26|Withdrawal by Subject|0|||
33449589|NCT02358538|101536115|FG002|Through Week 26|Withdrawal by Subject|0|||
33449590|NCT02358538|101536116|FG003|Through Week 26|Withdrawal by Subject|0|||
33449591|NCT02358538|101536113|FG000|Through Week 26|Non-Compliance|0|||
33449592|NCT02358538|101536114|FG001|Through Week 26|Non-Compliance|0|||
33449593|NCT02358538|101536115|FG002|Through Week 26|Non-Compliance|1|||
33449594|NCT02358538|101536116|FG003|Through Week 26|Non-Compliance|0|||
33449595|NCT02358538|101536113|FG000|Through Week 26|Family did not see benefit from IP|1|||
33449596|NCT02358538|101536114|FG001|Through Week 26|Family did not see benefit from IP|0|||
33449597|NCT02358538|101536115|FG002|Through Week 26|Family did not see benefit from IP|0|||
33449598|NCT02358538|101536116|FG003|Through Week 26|Family did not see benefit from IP|0|||
33449599|NCT02358538|101536113|FG000|52 Week Extension Period|Lack of Efficacy|0|||
33449600|NCT02358538|101536114|FG001|52 Week Extension Period|Lack of Efficacy|0|||
33449601|NCT02358538|101536115|FG002|52 Week Extension Period|Lack of Efficacy|2|||
33449602|NCT02358538|101536116|FG003|52 Week Extension Period|Lack of Efficacy|4|||
33449603|NCT00583453|101536117|FG000|Overall Study|discontinued intervention|0|||
33449604|NCT00583453|101536118|FG001|Overall Study|discontinued intervention|2|||
33449605|NCT02488408|101536119|FG000|Part A|Adverse Event|2|||
33449606|NCT02488408|101536120|FG001|Part A|Adverse Event|0|||
33449607|NCT02488408|101536121|FG002|Part A|Adverse Event|0|||
33449608|NCT02488408|101536122|FG003|Part A|Adverse Event|0|||
33449609|NCT02488408|101536123|FG004|Part A|Adverse Event|0|||
33449610|NCT02488408|101536124|FG005|Part A|Adverse Event|0|||
33449611|NCT02488408|101536125|FG006|Part A|Adverse Event|0|||
33449612|NCT02488408|101536126|FG007|Part A|Adverse Event|0|||
33449613|NCT02488408|101536127|FG008|Part A|Adverse Event|0|||
33449614|NCT02488408|101536128|FG009|Part A|Adverse Event|0|||
33449615|NCT02488408|101536119|FG000|Part A|Death|1|||
33449616|NCT02488408|101536120|FG001|Part A|Death|5|||
33449617|NCT02488408|101536121|FG002|Part A|Death|0|||
33449618|NCT02488408|101536122|FG003|Part A|Death|0|||
33449619|NCT02488408|101536123|FG004|Part A|Death|3|||
33449620|NCT02488408|101536124|FG005|Part A|Death|0|||
33449621|NCT02488408|101536125|FG006|Part A|Death|0|||
33449622|NCT02488408|101536126|FG007|Part A|Death|0|||
33449623|NCT02488408|101536127|FG008|Part A|Death|0|||
33449624|NCT02488408|101536128|FG009|Part A|Death|0|||
33449625|NCT02488408|101536119|FG000|Part A|Disease Progression|2|||
33449626|NCT02488408|101536120|FG001|Part A|Disease Progression|8|||
33449627|NCT02488408|101536121|FG002|Part A|Disease Progression|2|||
33260618|NCT03394885|100856371|FG000|Overall Study|Physician Decision|1|||
33449628|NCT02488408|101536122|FG003|Part A|Disease Progression|3|||
33449629|NCT02488408|101536123|FG004|Part A|Disease Progression|4|||
33449630|NCT02488408|101536124|FG005|Part A|Disease Progression|0|||
33449631|NCT02488408|101536125|FG006|Part A|Disease Progression|0|||
33449632|NCT02488408|101536126|FG007|Part A|Disease Progression|0|||
33449633|NCT02488408|101536127|FG008|Part A|Disease Progression|0|||
33449634|NCT02488408|101536128|FG009|Part A|Disease Progression|0|||
33449635|NCT02488408|101536119|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
33449636|NCT02488408|101536120|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
33260619|NCT03394885|100856371|FG000|Overall Study|Withdrawal by Subject|8|||
33260620|NCT03394885|100856371|FG000|Overall Study|Alternative Therapy|1|||
33260621|NCT03014453|100856372|FG000|Overall Study|Lost to Follow-up|12|||
33260622|NCT03014453|100856372|FG000|Overall Study|Discontinued GER|3|||
33260623|NCT03014453|100856372|FG000|Overall Study|Excluded|19|||
33260624|NCT03014453|100856372|FG000|Overall Study|Refused to take part in|37|||
33260625|NCT02006758|100856373|FG000|Overall Study|Protocol Violation|1|||
33260626|NCT02006758|100856373|FG000|Overall Study|Death|1|||
33260627|NCT02006758|100856373|FG000|Overall Study|Lost to Follow-up|4|||
33260628|NCT02006758|100856373|FG000|Overall Study|Withdrawal by Subject|4|||
33260629|NCT02006758|100856373|FG000|Overall Study|Procedurally excluded|1|||
33449637|NCT02488408|101536121|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
33449638|NCT02488408|101536122|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
33449639|NCT02488408|101536123|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
33449640|NCT02488408|101536124|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
33449641|NCT02488408|101536125|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
33449642|NCT02488408|101536126|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
33449643|NCT02488408|101536127|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
33449644|NCT02488408|101536128|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
33449645|NCT02488408|101536119|FG000|Part A|Investigator Decision|0|||
33449646|NCT02488408|101536120|FG001|Part A|Investigator Decision|1|||
33449647|NCT02488408|101536121|FG002|Part A|Investigator Decision|1|||
33449648|NCT02488408|101536122|FG003|Part A|Investigator Decision|0|||
33449649|NCT02488408|101536123|FG004|Part A|Investigator Decision|0|||
33449650|NCT02488408|101536124|FG005|Part A|Investigator Decision|0|||
33449651|NCT02488408|101536125|FG006|Part A|Investigator Decision|0|||
33449652|NCT02488408|101536126|FG007|Part A|Investigator Decision|0|||
33449653|NCT02488408|101536127|FG008|Part A|Investigator Decision|0|||
33449654|NCT02488408|101536128|FG009|Part A|Investigator Decision|0|||
33449655|NCT02488408|101536119|FG000|Part A|Withdrawal by Subject|0|||
33449656|NCT02488408|101536120|FG001|Part A|Withdrawal by Subject|0|||
33449657|NCT02488408|101536121|FG002|Part A|Withdrawal by Subject|2|||
33449658|NCT02488408|101536122|FG003|Part A|Withdrawal by Subject|0|||
33449659|NCT02488408|101536123|FG004|Part A|Withdrawal by Subject|0|||
33449660|NCT02488408|101536124|FG005|Part A|Withdrawal by Subject|0|||
33449661|NCT02488408|101536125|FG006|Part A|Withdrawal by Subject|0|||
33449662|NCT02488408|101536126|FG007|Part A|Withdrawal by Subject|0|||
33449663|NCT02488408|101536127|FG008|Part A|Withdrawal by Subject|0|||
33449664|NCT02488408|101536128|FG009|Part A|Withdrawal by Subject|0|||
33449665|NCT02488408|101536119|FG000|Part A|Other|1|||
33449666|NCT02488408|101536120|FG001|Part A|Other|0|||
33449667|NCT02488408|101536121|FG002|Part A|Other|0|||
33449668|NCT02488408|101536122|FG003|Part A|Other|0|||
33449669|NCT02488408|101536123|FG004|Part A|Other|0|||
33449670|NCT02488408|101536124|FG005|Part A|Other|0|||
33260630|NCT02006758|100856373|FG000|Overall Study|Other|2|||
33449671|NCT02488408|101536125|FG006|Part A|Other|0|||
33449672|NCT02488408|101536126|FG007|Part A|Other|0|||
33449673|NCT02488408|101536127|FG008|Part A|Other|0|||
33449674|NCT02488408|101536128|FG009|Part A|Other|0|||
33449675|NCT02488408|101536119|FG000|Part B|Adverse Event|0|||
33449676|NCT02488408|101536120|FG001|Part B|Adverse Event|0|||
33449677|NCT02488408|101536121|FG002|Part B|Adverse Event|0|||
33449678|NCT02488408|101536122|FG003|Part B|Adverse Event|0|||
33449679|NCT02488408|101536123|FG004|Part B|Adverse Event|0|||
33449680|NCT02488408|101536124|FG005|Part B|Adverse Event|2|||
33449681|NCT02488408|101536125|FG006|Part B|Adverse Event|2|||
33449682|NCT02488408|101536126|FG007|Part B|Adverse Event|7|||
33449683|NCT02488408|101536127|FG008|Part B|Adverse Event|2|||
33449684|NCT02488408|101536128|FG009|Part B|Adverse Event|2|||
33449685|NCT02488408|101536119|FG000|Part B|Death|0|||
33449686|NCT02488408|101536120|FG001|Part B|Death|0|||
33449687|NCT02488408|101536121|FG002|Part B|Death|0|||
33449688|NCT02488408|101536122|FG003|Part B|Death|0|||
33449689|NCT02488408|101536123|FG004|Part B|Death|0|||
33449690|NCT02488408|101536124|FG005|Part B|Death|3|||
33449691|NCT02488408|101536125|FG006|Part B|Death|1|||
33449692|NCT02488408|101536126|FG007|Part B|Death|2|||
33449693|NCT02488408|101536127|FG008|Part B|Death|2|||
33449694|NCT02488408|101536128|FG009|Part B|Death|2|||
33449695|NCT02488408|101536119|FG000|Part B|Death due to Disease Progression|0|||
33449696|NCT02488408|101536120|FG001|Part B|Death due to Disease Progression|0|||
33449697|NCT02488408|101536121|FG002|Part B|Death due to Disease Progression|0|||
33449698|NCT02488408|101536122|FG003|Part B|Death due to Disease Progression|0|||
33449699|NCT02488408|101536123|FG004|Part B|Death due to Disease Progression|0|||
33260631|NCT02564744|100856378|FG000|Overall Study|Investigator decision|0|||
33449700|NCT02488408|101536124|FG005|Part B|Death due to Disease Progression|2|||
33260632|NCT02564744|100856379|FG001|Overall Study|Investigator decision|0|||
33260633|NCT02564744|100856380|FG002|Overall Study|Investigator decision|0|||
33260634|NCT02564744|100856381|FG003|Overall Study|Investigator decision|0|||
33449701|NCT02488408|101536125|FG006|Part B|Death due to Disease Progression|2|||
33449702|NCT02488408|101536126|FG007|Part B|Death due to Disease Progression|1|||
33449703|NCT02488408|101536127|FG008|Part B|Death due to Disease Progression|1|||
33449704|NCT02488408|101536128|FG009|Part B|Death due to Disease Progression|1|||
33449705|NCT02488408|101536119|FG000|Part B|Disease Progression|0|||
33449706|NCT02488408|101536120|FG001|Part B|Disease Progression|0|||
33168821|NCT00434330|100525530|FG001|Overall Study|Subject Not Compliant With Study|0|||
33168822|NCT00434330|100525531|FG002|Overall Study|Subject Not Compliant With Study|1|||
33168823|NCT00434330|100525532|FG003|Overall Study|Subject Not Compliant With Study|0|||
33449707|NCT02488408|101536121|FG002|Part B|Disease Progression|0|||
33449708|NCT02488408|101536122|FG003|Part B|Disease Progression|0|||
33449709|NCT02488408|101536123|FG004|Part B|Disease Progression|0|||
33168824|NCT00434330|100525533|FG004|Overall Study|Subject Not Compliant With Study|0|||
33168825|NCT00434330|100525534|FG005|Overall Study|Subject Not Compliant With Study|0|||
33168826|NCT01532414|100525541|FG000|Overall Study|Lost to Follow-up|3|||
33168827|NCT01532414|100525542|FG001|Overall Study|Lost to Follow-up|0|||
33168828|NCT01532414|100525543|FG002|Overall Study|Lost to Follow-up|1|||
33168829|NCT01532414|100525541|FG000|Overall Study|Withdrawal by Subject|3|||
33168830|NCT01532414|100525542|FG001|Overall Study|Withdrawal by Subject|0|||
33168831|NCT01532414|100525543|FG002|Overall Study|Withdrawal by Subject|0|||
33168832|NCT01532414|100525541|FG000|Overall Study|No V6 semen sample|0|||
33168833|NCT01532414|100525542|FG001|Overall Study|No V6 semen sample|1|||
33260635|NCT02564744|100856382|FG004|Overall Study|Investigator decision|1|||
33260636|NCT02564744|100856378|FG000|Overall Study|Death|10|||
33449710|NCT02488408|101536124|FG005|Part B|Disease Progression|6|||
33449711|NCT02488408|101536125|FG006|Part B|Disease Progression|9|||
33449712|NCT02488408|101536126|FG007|Part B|Disease Progression|7|||
33449713|NCT02488408|101536127|FG008|Part B|Disease Progression|9|||
33449714|NCT02488408|101536128|FG009|Part B|Disease Progression|11|||
33449715|NCT02488408|101536119|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
33449716|NCT02488408|101536120|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
33449717|NCT02488408|101536121|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
33449718|NCT02488408|101536122|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
33449719|NCT02488408|101536123|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
33449720|NCT02488408|101536124|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
33449721|NCT02488408|101536125|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
33449722|NCT02488408|101536126|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
33449723|NCT02488408|101536127|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
33449724|NCT02488408|101536128|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
33449725|NCT02488408|101536119|FG000|Part B|Investigator Decision|0|||
33449726|NCT02488408|101536120|FG001|Part B|Investigator Decision|0|||
33449727|NCT02488408|101536121|FG002|Part B|Investigator Decision|0|||
33449728|NCT02488408|101536122|FG003|Part B|Investigator Decision|0|||
33449729|NCT02488408|101536123|FG004|Part B|Investigator Decision|0|||
33449730|NCT02488408|101536124|FG005|Part B|Investigator Decision|0|||
33449731|NCT02488408|101536125|FG006|Part B|Investigator Decision|1|||
33449732|NCT02488408|101536126|FG007|Part B|Investigator Decision|0|||
33449733|NCT02488408|101536127|FG008|Part B|Investigator Decision|2|||
33449734|NCT02488408|101536128|FG009|Part B|Investigator Decision|1|||
33449735|NCT04076059|101536129|FG000|Double Blind Phase|Progressive disease|22|||
33449736|NCT04076059|101536130|FG001|Double Blind Phase|Progressive disease|26|||
33449737|NCT04076059|101536131|FG002|Double Blind Phase|Progressive disease|0|||
33449738|NCT04076059|101536129|FG000|Double Blind Phase|Withdrawal by Subject|4|||
33449739|NCT04076059|101536130|FG001|Double Blind Phase|Withdrawal by Subject|11|||
33449740|NCT04076059|101536131|FG002|Double Blind Phase|Withdrawal by Subject|0|||
33168834|NCT01532414|100525543|FG002|Overall Study|No V6 semen sample|0|||
33260637|NCT02564744|100856379|FG001|Overall Study|Death|5|||
33449741|NCT04076059|101536129|FG000|Double Blind Phase|Death|1|||
33168835|NCT01532414|100525541|FG000|Overall Study|Adverse Event|0|||
33168836|NCT01532414|100525542|FG001|Overall Study|Adverse Event|1|||
33168837|NCT01532414|100525543|FG002|Overall Study|Adverse Event|1|||
33168838|NCT01532414|100525541|FG000|Overall Study|Unable to complete 24 hour PK|0|||
33168839|NCT01532414|100525542|FG001|Overall Study|Unable to complete 24 hour PK|0|||
33168840|NCT01532414|100525543|FG002|Overall Study|Unable to complete 24 hour PK|1|||
33168841|NCT01532414|100525541|FG000|Overall Study|Withdrawn by sponsor|1|||
33168842|NCT01532414|100525542|FG001|Overall Study|Withdrawn by sponsor|0|||
33168843|NCT01532414|100525543|FG002|Overall Study|Withdrawn by sponsor|0|||
33168844|NCT00837811|100525544|FG000|Overall Study|Adverse Event|4|||
33168845|NCT00837811|100525545|FG001|Overall Study|Adverse Event|6|||
33168846|NCT00837811|100525546|FG002|Overall Study|Adverse Event|0|||
33168847|NCT00837811|100525544|FG000|Overall Study|Death|1|||
33168848|NCT00837811|100525545|FG001|Overall Study|Death|1|||
33168849|NCT00837811|100525546|FG002|Overall Study|Death|0|||
33168850|NCT00837811|100525544|FG000|Overall Study|Lack of Efficacy|0|||
33168851|NCT00837811|100525545|FG001|Overall Study|Lack of Efficacy|11|||
33168852|NCT00837811|100525546|FG002|Overall Study|Lack of Efficacy|0|||
33168853|NCT00837811|100525544|FG000|Overall Study|Lost to Follow-up|1|||
33168854|NCT00837811|100525545|FG001|Overall Study|Lost to Follow-up|3|||
33168855|NCT00837811|100525546|FG002|Overall Study|Lost to Follow-up|0|||
33168856|NCT00837811|100525544|FG000|Overall Study|Physician Decision|0|||
33168857|NCT00837811|100525545|FG001|Overall Study|Physician Decision|2|||
33168858|NCT00837811|100525546|FG002|Overall Study|Physician Decision|1|||
33168859|NCT00837811|100525544|FG000|Overall Study|Withdrawal by Subject|1|||
33168860|NCT00837811|100525545|FG001|Overall Study|Withdrawal by Subject|9|||
33168861|NCT00837811|100525546|FG002|Overall Study|Withdrawal by Subject|0|||
33168862|NCT00837811|100525544|FG000|Overall Study|Sponsor Decision|0|||
33168863|NCT00837811|100525545|FG001|Overall Study|Sponsor Decision|2|||
33168864|NCT00837811|100525546|FG002|Overall Study|Sponsor Decision|0|||
33168865|NCT00855920|100525551|FG000|Overall Study|Protocol Violation|0|||
33168866|NCT00855920|100525552|FG001|Overall Study|Protocol Violation|0|||
33168867|NCT00855920|100525553|FG002|Overall Study|Protocol Violation|2|||
33168868|NCT00855920|100525551|FG000|Overall Study|Adverse Event|2|||
33168869|NCT00855920|100525552|FG001|Overall Study|Adverse Event|1|||
33168870|NCT00855920|100525553|FG002|Overall Study|Adverse Event|1|||
33168871|NCT00855920|100525551|FG000|Overall Study|Lack of Efficacy|2|||
33168872|NCT00855920|100525552|FG001|Overall Study|Lack of Efficacy|2|||
33168873|NCT00855920|100525553|FG002|Overall Study|Lack of Efficacy|2|||
33168874|NCT00855920|100525551|FG000|Overall Study|Withdrawal by Subject|2|||
33168875|NCT00855920|100525552|FG001|Overall Study|Withdrawal by Subject|3|||
33168876|NCT00855920|100525553|FG002|Overall Study|Withdrawal by Subject|2|||
33168877|NCT00855920|100525551|FG000|Overall Study|Lost to Follow-up|1|||
33168878|NCT00855920|100525552|FG001|Overall Study|Lost to Follow-up|0|||
33168879|NCT00855920|100525553|FG002|Overall Study|Lost to Follow-up|2|||
33168880|NCT00855920|100525551|FG000|Overall Study|Death|0|||
33168881|NCT00855920|100525552|FG001|Overall Study|Death|1|||
33168882|NCT00855920|100525553|FG002|Overall Study|Death|0|||
33168883|NCT00855920|100525551|FG000|Overall Study|Decision by the sponsor|0|||
33168884|NCT00855920|100525552|FG001|Overall Study|Decision by the sponsor|1|||
33168885|NCT00855920|100525553|FG002|Overall Study|Decision by the sponsor|1|||
33168886|NCT00855920|100525551|FG000|Overall Study|Other than specified above|1|||
33168887|NCT00855920|100525552|FG001|Overall Study|Other than specified above|1|||
33168888|NCT00855920|100525553|FG002|Overall Study|Other than specified above|1|||
33168889|NCT04343261|100525558|FG000|Overall Study|Adverse Event|1|||
33168890|NCT04343261|100525558|FG000|Overall Study|received inadequate amount of antibodies|7|||
33168891|NCT02927431|100525561|FG000|Overall Study|Withdrawal by Subject|0|||
33168892|NCT02927431|100525562|FG001|Overall Study|Withdrawal by Subject|0|||
33168893|NCT02927431|100525563|FG002|Overall Study|Withdrawal by Subject|1|||
33168894|NCT00599924|100525566|FG000|Overall Study|Lack of Efficacy|3|||
33168895|NCT00599924|100525567|FG001|Overall Study|Lack of Efficacy|5|||
33260638|NCT02564744|100856380|FG002|Overall Study|Death|4|||
33260639|NCT02564744|100856381|FG003|Overall Study|Death|16|||
33449742|NCT04076059|101536130|FG001|Double Blind Phase|Death|1|||
33168896|NCT00599924|100525568|FG002|Overall Study|Lack of Efficacy|1|||
33168897|NCT00599924|100525569|FG003|Overall Study|Lack of Efficacy|2|||
33168898|NCT00599924|100525570|FG004|Overall Study|Lack of Efficacy|3|||
33168899|NCT00599924|100525571|FG005|Overall Study|Lack of Efficacy|2|||
33168900|NCT00599924|100525572|FG006|Overall Study|Lack of Efficacy|0|||
33168901|NCT00599924|100525566|FG000|Overall Study|Adverse Event|0|||
33168902|NCT00599924|100525567|FG001|Overall Study|Adverse Event|0|||
33168903|NCT00599924|100525568|FG002|Overall Study|Adverse Event|0|||
33168904|NCT00599924|100525569|FG003|Overall Study|Adverse Event|2|||
33168905|NCT00599924|100525570|FG004|Overall Study|Adverse Event|0|||
33168906|NCT00599924|100525571|FG005|Overall Study|Adverse Event|0|||
33168907|NCT00599924|100525572|FG006|Overall Study|Adverse Event|2|||
33168908|NCT00599924|100525566|FG000|Overall Study|Death|0|||
33168909|NCT00599924|100525567|FG001|Overall Study|Death|0|||
33260640|NCT02564744|100856382|FG004|Overall Study|Death|16|||
33168910|NCT00599924|100525568|FG002|Overall Study|Death|0|||
33168911|NCT00599924|100525569|FG003|Overall Study|Death|2|||
33168912|NCT00599924|100525570|FG004|Overall Study|Death|0|||
33168913|NCT00599924|100525571|FG005|Overall Study|Death|2|||
33168914|NCT00599924|100525572|FG006|Overall Study|Death|1|||
33168915|NCT00599924|100525566|FG000|Overall Study|Protocol Violation|0|||
33168916|NCT00599924|100525567|FG001|Overall Study|Protocol Violation|0|||
33168917|NCT00599924|100525568|FG002|Overall Study|Protocol Violation|0|||
33168918|NCT00599924|100525569|FG003|Overall Study|Protocol Violation|1|||
33168919|NCT00599924|100525570|FG004|Overall Study|Protocol Violation|0|||
33168920|NCT00599924|100525571|FG005|Overall Study|Protocol Violation|0|||
33168921|NCT00599924|100525572|FG006|Overall Study|Protocol Violation|0|||
33168922|NCT00599924|100525566|FG000|Overall Study|Withdrawal by Subject|0|||
33168923|NCT00599924|100525567|FG001|Overall Study|Withdrawal by Subject|0|||
33168924|NCT00599924|100525568|FG002|Overall Study|Withdrawal by Subject|1|||
33168925|NCT00599924|100525569|FG003|Overall Study|Withdrawal by Subject|0|||
33168926|NCT00599924|100525570|FG004|Overall Study|Withdrawal by Subject|1|||
33168927|NCT00599924|100525571|FG005|Overall Study|Withdrawal by Subject|0|||
33168928|NCT00599924|100525572|FG006|Overall Study|Withdrawal by Subject|0|||
33168929|NCT00599924|100525566|FG000|Overall Study|Other|0|||
33168930|NCT00599924|100525567|FG001|Overall Study|Other|0|||
33168931|NCT00599924|100525568|FG002|Overall Study|Other|0|||
33168932|NCT00599924|100525569|FG003|Overall Study|Other|1|||
33168933|NCT00599924|100525570|FG004|Overall Study|Other|2|||
33168934|NCT00599924|100525571|FG005|Overall Study|Other|0|||
33168935|NCT00599924|100525572|FG006|Overall Study|Other|2|||
33168936|NCT01500694|100525573|FG000|Overall Study|Adverse Event|4|||
33168937|NCT01500694|100525574|FG001|Overall Study|Adverse Event|3|||
33168938|NCT01500694|100525573|FG000|Overall Study|Protocol Violation|0|||
33168939|NCT01500694|100525574|FG001|Overall Study|Protocol Violation|1|||
33168940|NCT01500694|100525573|FG000|Overall Study|Withdrawal by Subject|23|||
33168941|NCT01500694|100525574|FG001|Overall Study|Withdrawal by Subject|14|||
33168942|NCT01500694|100525573|FG000|Overall Study|Lost to Follow-up|2|||
33168943|NCT01500694|100525574|FG001|Overall Study|Lost to Follow-up|3|||
33168944|NCT01500694|100525573|FG000|Overall Study|Lack of Efficacy|14|||
33168945|NCT01500694|100525574|FG001|Overall Study|Lack of Efficacy|5|||
33168946|NCT01500694|100525573|FG000|Overall Study|Other|9|||
33168947|NCT01500694|100525574|FG001|Overall Study|Other|3|||
33168948|NCT00062374|100525575|FG000|Overall Study|Not treated|12|||
33168949|NCT01350414|100525578|FG000|Overall Study|Lost to Follow-up|13|||
33168950|NCT01350414|100525578|FG000|Overall Study|Withdrawal by Subject|4|||
33168951|NCT01350414|100525578|FG000|Overall Study|Physician Decision|2|||
33168952|NCT00897104|100525586|FG000|Overall Study|Lost to Follow-up|12|||
33168953|NCT00897104|100525587|FG001|Overall Study|Lost to Follow-up|17|||
33168954|NCT00897104|100525588|FG002|Overall Study|Lost to Follow-up|2|||
33168955|NCT00897104|100525586|FG000|Overall Study|Pregnancy|0|||
33168956|NCT00897104|100525587|FG001|Overall Study|Pregnancy|1|||
33168957|NCT00897104|100525588|FG002|Overall Study|Pregnancy|0|||
33168958|NCT00897104|100525586|FG000|Overall Study|Protocol Violation|0|||
33168959|NCT00897104|100525587|FG001|Overall Study|Protocol Violation|1|||
33168960|NCT00897104|100525588|FG002|Overall Study|Protocol Violation|0|||
33168961|NCT00897104|100525586|FG000|Overall Study|Withdrawal by Subject|23|||
33168962|NCT00897104|100525587|FG001|Overall Study|Withdrawal by Subject|27|||
33168963|NCT00897104|100525588|FG002|Overall Study|Withdrawal by Subject|3|||
33168964|NCT00897104|100525586|FG000|Overall Study|Abnormal Prestudy Labs|2|||
33168965|NCT00897104|100525587|FG001|Overall Study|Abnormal Prestudy Labs|0|||
33168966|NCT00897104|100525588|FG002|Overall Study|Abnormal Prestudy Labs|0|||
33168967|NCT00897104|100525586|FG000|Overall Study|Abnormal Baseline ECG|2|||
33168968|NCT00897104|100525587|FG001|Overall Study|Abnormal Baseline ECG|2|||
33168969|NCT00897104|100525588|FG002|Overall Study|Abnormal Baseline ECG|0|||
33168970|NCT00897104|100525586|FG000|Overall Study|Need for Concom. Med.|0|||
33168971|NCT00897104|100525587|FG001|Overall Study|Need for Concom. Med.|1|||
33168972|NCT00897104|100525588|FG002|Overall Study|Need for Concom. Med.|1|||
33168973|NCT00897104|100525586|FG000|Overall Study|Lack of Migraine Attack|20|||
33168974|NCT00897104|100525587|FG001|Overall Study|Lack of Migraine Attack|22|||
33168975|NCT00897104|100525588|FG002|Overall Study|Lack of Migraine Attack|1|||
33168976|NCT00897104|100525586|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
33168977|NCT00897104|100525587|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33168978|NCT00897104|100525588|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33168979|NCT00897104|100525586|FG000|Overall Study|Other|3|||
33168980|NCT00897104|100525587|FG001|Overall Study|Other|0|||
33168981|NCT00897104|100525588|FG002|Overall Study|Other|0|||
33168982|NCT00897104|100525586|FG000|Overall Study|Protocol Violation|1|||
33168983|NCT00897104|100525587|FG001|Overall Study|Protocol Violation|0|||
33168984|NCT00897104|100525588|FG002|Overall Study|Protocol Violation|0|||
33168985|NCT00897104|100525586|FG000|Overall Study|Withdrawal by Subject|0|||
33168986|NCT00897104|100525587|FG001|Overall Study|Withdrawal by Subject|0|||
33168987|NCT00897104|100525588|FG002|Overall Study|Withdrawal by Subject|1|||
33168988|NCT00482612|100525592|FG000|In-treatment Period|No study medication administered|0|||
33168989|NCT00482612|100525593|FG001|In-treatment Period|No study medication administered|0|||
33168990|NCT00482612|100525594|FG002|In-treatment Period|No study medication administered|1|||
33168991|NCT00482612|100525595|FG003|In-treatment Period|No study medication administered|0|||
33168992|NCT00482612|100525592|FG000|Follow-up Period|Other|4|||
33168993|NCT00482612|100525593|FG001|Follow-up Period|Other|2|||
33168994|NCT00482612|100525594|FG002|Follow-up Period|Other|1|||
33168995|NCT00482612|100525595|FG003|Follow-up Period|Other|2|||
33168996|NCT00482612|100525592|FG000|Follow-up Period|Lack of compliance|0|||
33168997|NCT00482612|100525593|FG001|Follow-up Period|Lack of compliance|0|||
33168998|NCT00482612|100525594|FG002|Follow-up Period|Lack of compliance|1|||
33168999|NCT00482612|100525595|FG003|Follow-up Period|Lack of compliance|0|||
33169000|NCT00482612|100525592|FG000|Follow-up Period|Lost to Follow-up|0|||
33169001|NCT00482612|100525593|FG001|Follow-up Period|Lost to Follow-up|4|||
33169002|NCT00482612|100525594|FG002|Follow-up Period|Lost to Follow-up|2|||
33169003|NCT00482612|100525595|FG003|Follow-up Period|Lost to Follow-up|1|||
33169004|NCT00482612|100525592|FG000|Follow-up Period|Adverse Event|4|||
33169005|NCT00482612|100525593|FG001|Follow-up Period|Adverse Event|7|||
33449743|NCT04076059|101536131|FG002|Double Blind Phase|Death|0|||
33449744|NCT04076059|101536129|FG000|Double Blind Phase|Lost to Follow-up|1|||
33449745|NCT04076059|101536130|FG001|Double Blind Phase|Lost to Follow-up|0|||
33449746|NCT04076059|101536131|FG002|Double Blind Phase|Lost to Follow-up|0|||
33449747|NCT04076059|101536129|FG000|Double Blind Phase|Adverse Event|5|||
33449748|NCT04076059|101536130|FG001|Double Blind Phase|Adverse Event|1|||
33449749|NCT04076059|101536131|FG002|Double Blind Phase|Adverse Event|0|||
33449750|NCT04076059|101536129|FG000|Double Blind Phase|Ongoing Participants|82|||
33449751|NCT04076059|101536130|FG001|Double Blind Phase|Ongoing Participants|18|||
33449752|NCT04076059|101536131|FG002|Double Blind Phase|Ongoing Participants|0|||
33449753|NCT04076059|101536129|FG000|Double Blind Phase|Miscellaneous|3|||
33449754|NCT04076059|101536130|FG001|Double Blind Phase|Miscellaneous|1|||
33449755|NCT04076059|101536131|FG002|Double Blind Phase|Miscellaneous|0|||
33449756|NCT04076059|101536129|FG000|Double Blind Phase|Protocol Deviation|1|||
33449757|NCT04076059|101536130|FG001|Double Blind Phase|Protocol Deviation|1|||
33449758|NCT04076059|101536131|FG002|Double Blind Phase|Protocol Deviation|0|||
33449759|NCT04076059|101536129|FG000|Double Blind Phase|Did not take study drug|1|||
33449760|NCT04076059|101536130|FG001|Double Blind Phase|Did not take study drug|1|||
33449761|NCT04076059|101536131|FG002|Double Blind Phase|Did not take study drug|0|||
33449762|NCT04076059|101536129|FG000|Open Label Phase|Progressive disease|0|||
33449763|NCT04076059|101536130|FG001|Open Label Phase|Progressive disease|0|||
33449764|NCT04076059|101536131|FG002|Open Label Phase|Progressive disease|7|||
33449765|NCT04076059|101536129|FG000|Open Label Phase|Withdrawal by Subject|0|||
33449766|NCT04076059|101536130|FG001|Open Label Phase|Withdrawal by Subject|0|||
33449767|NCT04076059|101536131|FG002|Open Label Phase|Withdrawal by Subject|3|||
33449768|NCT04076059|101536129|FG000|Open Label Phase|Death|0|||
33449769|NCT04076059|101536130|FG001|Open Label Phase|Death|0|||
33449770|NCT04076059|101536131|FG002|Open Label Phase|Death|2|||
33449771|NCT04076059|101536129|FG000|Open Label Phase|Ongoing Participants|0|||
33449772|NCT04076059|101536130|FG001|Open Label Phase|Ongoing Participants|0|||
33449773|NCT04076059|101536131|FG002|Open Label Phase|Ongoing Participants|11|||
33449774|NCT01528696|101536132|FG000|Overall Study|See detailed description|18|||
33449775|NCT01528696|101536133|FG001|Overall Study|See detailed description|19|||
33449776|NCT02861300|101536136|FG000|Overall Study|Death|0|||
33169006|NCT00482612|100525594|FG002|Follow-up Period|Adverse Event|9|||
33169007|NCT00482612|100525595|FG003|Follow-up Period|Adverse Event|0|||
33449777|NCT02861300|101536137|FG001|Overall Study|Death|0|||
33449778|NCT02861300|101536138|FG002|Overall Study|Death|0|||
33449779|NCT02861300|101536139|FG003|Overall Study|Death|0|||
33449780|NCT02861300|101536140|FG004|Overall Study|Death|0|||
33449781|NCT02861300|101536141|FG005|Overall Study|Death|0|||
33449782|NCT02861300|101536142|FG006|Overall Study|Death|24|||
33449783|NCT02861300|101536136|FG000|Overall Study|Delay in treatment|0|||
33449784|NCT02861300|101536137|FG001|Overall Study|Delay in treatment|0|||
33449785|NCT02861300|101536138|FG002|Overall Study|Delay in treatment|0|||
33449786|NCT02861300|101536139|FG003|Overall Study|Delay in treatment|0|||
33449787|NCT02861300|101536140|FG004|Overall Study|Delay in treatment|0|||
33169008|NCT00482612|100525592|FG000|Follow-up Period|Lack of Efficacy|2|||
33169009|NCT00482612|100525593|FG001|Follow-up Period|Lack of Efficacy|0|||
33260641|NCT02564744|100856378|FG000|Overall Study|End of study Page Missing|0|||
33169010|NCT00482612|100525594|FG002|Follow-up Period|Lack of Efficacy|1|||
33169011|NCT00482612|100525595|FG003|Follow-up Period|Lack of Efficacy|0|||
33169012|NCT00482612|100525592|FG000|Follow-up Period|Withdrawal by Subject|3|||
33169013|NCT00482612|100525593|FG001|Follow-up Period|Withdrawal by Subject|5|||
33169014|NCT00482612|100525594|FG002|Follow-up Period|Withdrawal by Subject|7|||
33169015|NCT00482612|100525595|FG003|Follow-up Period|Withdrawal by Subject|2|||
33169016|NCT00482612|100525592|FG000|Follow-up Period|Reasons not related to trial|1|||
33169017|NCT00482612|100525593|FG001|Follow-up Period|Reasons not related to trial|0|||
33169018|NCT00482612|100525594|FG002|Follow-up Period|Reasons not related to trial|1|||
33169019|NCT00482612|100525595|FG003|Follow-up Period|Reasons not related to trial|3|||
33169020|NCT02496611|100525596|FG000|Overall Study|Lost to Follow-up|2|||
33169021|NCT02496611|100525597|FG001|Overall Study|Lost to Follow-up|1|||
33169022|NCT02496611|100525596|FG000|Overall Study|Withdrawal by Subject|5|||
33169023|NCT02496611|100525597|FG001|Overall Study|Withdrawal by Subject|2|||
33169024|NCT02270957|100525598|FG000|Overall Study|Lack of Efficacy|2|||
33169025|NCT02270957|100525599|FG001|Overall Study|Lack of Efficacy|4|||
33169026|NCT02270957|100525598|FG000|Overall Study|Adverse Event|2|||
33169027|NCT02270957|100525599|FG001|Overall Study|Adverse Event|0|||
33169028|NCT02573350|100525600|FG000|Overall Study|Lost to Follow-up|2|||
33169029|NCT02573350|100525601|FG001|Overall Study|Lost to Follow-up|1|||
33169030|NCT02573350|100525600|FG000|Overall Study|Adverse Event|3|||
33169031|NCT02573350|100525601|FG001|Overall Study|Adverse Event|4|||
33169032|NCT02573350|100525600|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
33169033|NCT02573350|100525601|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
33260642|NCT02564744|100856379|FG001|Overall Study|End of study Page Missing|0|||
33260643|NCT02564744|100856380|FG002|Overall Study|End of study Page Missing|3|||
33169034|NCT02573350|100525600|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
33169035|NCT02573350|100525601|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
33169036|NCT02573350|100525600|FG000|Overall Study|Subject withdrew consent to participate|6|||
33260644|NCT02564744|100856381|FG003|Overall Study|End of study Page Missing|3|||
33260645|NCT02564744|100856382|FG004|Overall Study|End of study Page Missing|0|||
33449788|NCT02861300|101536141|FG005|Overall Study|Delay in treatment|1|||
33169037|NCT02573350|100525601|FG001|Overall Study|Subject withdrew consent to participate|1|||
33169038|NCT02573350|100525600|FG000|Overall Study|Protocol Deviation|1|||
33169039|NCT02573350|100525601|FG001|Overall Study|Protocol Deviation|1|||
33169040|NCT03555591|100525602|FG000|Overall Study|Protocol Violation|77|||
33169041|NCT00187486|100525609|FG000|Overall Study|Protocol Violation|1|||
33169042|NCT01828281|100525614|FG000|Overall Study|Withdrawal by Subject|1|||
33169043|NCT01828281|100525615|FG001|Overall Study|Withdrawal by Subject|0|||
33169044|NCT02835820|100525616|FG000|Overall Study|Baseline Screen Failure|0|||
33169045|NCT02835820|100525617|FG001|Overall Study|Baseline Screen Failure|3|||
33260646|NCT02564744|100856378|FG000|Overall Study|Subject Withdrew Consent|1|||
33169046|NCT01513473|100525618|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
33169047|NCT01513473|100525619|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
33169048|NCT01513473|100525618|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
33449789|NCT02861300|101536142|FG006|Overall Study|Delay in treatment|0|||
33449790|NCT02861300|101536136|FG000|Overall Study|Disease Progression|0|||
33449791|NCT02861300|101536137|FG001|Overall Study|Disease Progression|1|||
33449792|NCT02861300|101536138|FG002|Overall Study|Disease Progression|0|||
33449793|NCT02861300|101536139|FG003|Overall Study|Disease Progression|0|||
33449794|NCT02861300|101536140|FG004|Overall Study|Disease Progression|0|||
33449795|NCT02861300|101536141|FG005|Overall Study|Disease Progression|0|||
33449796|NCT02861300|101536142|FG006|Overall Study|Disease Progression|2|||
33449797|NCT02861300|101536136|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
33449798|NCT02861300|101536137|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
33169049|NCT01513473|100525619|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
33169050|NCT01513473|100525618|FG000|Main Trial (26 Weeks)|Unclassified|0|||
33169051|NCT01513473|100525619|FG001|Main Trial (26 Weeks)|Unclassified|2|||
33169052|NCT01513473|100525618|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
33169053|NCT01513473|100525619|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
33169054|NCT01513473|100525618|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
33169055|NCT01513473|100525619|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
33169056|NCT04212650|100525624|FG000|Overall Study|Withdrawal by Subject|1|||
33169057|NCT04212650|100525625|FG001|Overall Study|Withdrawal by Subject|0|||
33169058|NCT03247530|100525628|FG000|Overall Study|Withdrawal by caregiver|19|||
33169059|NCT03247530|100525629|FG001|Overall Study|Withdrawal by caregiver|8|||
33169060|NCT03247530|100525630|FG002|Overall Study|Withdrawal by caregiver|10|||
33169061|NCT03247530|100525628|FG000|Overall Study|Lost to Follow-up|3|||
33169062|NCT03247530|100525629|FG001|Overall Study|Lost to Follow-up|9|||
33169063|NCT03247530|100525630|FG002|Overall Study|Lost to Follow-up|6|||
33169064|NCT03247530|100525628|FG000|Overall Study|Adverse Event|2|||
33169065|NCT03247530|100525629|FG001|Overall Study|Adverse Event|5|||
33169066|NCT03247530|100525630|FG002|Overall Study|Adverse Event|2|||
33169067|NCT03247530|100525628|FG000|Overall Study|Failure to follow procedure|1|||
33169068|NCT03247530|100525629|FG001|Overall Study|Failure to follow procedure|1|||
33169069|NCT03247530|100525630|FG002|Overall Study|Failure to follow procedure|1|||
33169070|NCT03247530|100525628|FG000|Overall Study|Withdrawal by Subject|1|||
33169071|NCT03247530|100525629|FG001|Overall Study|Withdrawal by Subject|1|||
33169072|NCT03247530|100525630|FG002|Overall Study|Withdrawal by Subject|0|||
33169073|NCT03247530|100525628|FG000|Overall Study|Study medication misuse|0|||
33169074|NCT03247530|100525629|FG001|Overall Study|Study medication misuse|1|||
33169075|NCT03247530|100525630|FG002|Overall Study|Study medication misuse|0|||
33169076|NCT03247530|100525628|FG000|Overall Study|Other, multiple categories|1|||
33169077|NCT03247530|100525629|FG001|Overall Study|Other, multiple categories|3|||
33169078|NCT03247530|100525630|FG002|Overall Study|Other, multiple categories|1|||
33169079|NCT03535844|100525631|FG000|Overall Study|Withdrawal by Subject|0|||
33169080|NCT03535844|100525632|FG001|Overall Study|Withdrawal by Subject|1|||
33169081|NCT00331682|100525633|FG000|Overall Study|Adverse Event|1|||
33169082|NCT05227027|100525634|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
33169083|NCT05227027|100525635|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
33169084|NCT02980601|100525636|FG000|Overall Study|Lost to Follow-up|2|||
33169085|NCT02980601|100525637|FG001|Overall Study|Lost to Follow-up|2|||
33169086|NCT02980601|100525636|FG000|Overall Study|Death|0|||
33169087|NCT02980601|100525637|FG001|Overall Study|Death|1|||
33169088|NCT02980601|100525636|FG000|Overall Study|Graft loss|1|||
33169089|NCT02980601|100525637|FG001|Overall Study|Graft loss|0|||
33169090|NCT02980601|100525636|FG000|Overall Study|Failed to sign consent|2|||
33169091|NCT02980601|100525637|FG001|Overall Study|Failed to sign consent|0|||
33449799|NCT02861300|101536138|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
33449800|NCT02861300|101536139|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
33169092|NCT01709162|100525638|FG000|Overall Study|Disease progression|3|||
33169093|NCT01709162|100525639|FG001|Overall Study|Disease progression|3|||
33169094|NCT01709162|100525638|FG000|Overall Study|Study drug toxicity|2|||
33169095|NCT01709162|100525639|FG001|Overall Study|Study drug toxicity|0|||
33169096|NCT01709162|100525638|FG000|Overall Study|Administrative reason by sponsor|0|||
33169097|NCT01709162|100525639|FG001|Overall Study|Administrative reason by sponsor|1|||
33169098|NCT01709162|100525638|FG000|Overall Study|Other|1|||
33169099|NCT01709162|100525639|FG001|Overall Study|Other|0|||
33169100|NCT01709162|100525638|FG000|Overall Study|Withdrawal by Subject|0|||
33169101|NCT01709162|100525639|FG001|Overall Study|Withdrawal by Subject|1|||
33169102|NCT03982368|100525640|FG000|Overall Study|Adverse Event|6|||
33169103|NCT03982368|100525641|FG001|Overall Study|Adverse Event|4|||
33169104|NCT03982368|100525642|FG002|Overall Study|Adverse Event|3|||
33169105|NCT03982368|100525640|FG000|Overall Study|Lost to Follow-up|2|||
33169106|NCT03982368|100525641|FG001|Overall Study|Lost to Follow-up|1|||
33169107|NCT03982368|100525642|FG002|Overall Study|Lost to Follow-up|0|||
33169108|NCT03982368|100525640|FG000|Overall Study|Withdrawal by Subject|1|||
33169109|NCT03982368|100525641|FG001|Overall Study|Withdrawal by Subject|2|||
33169110|NCT03982368|100525642|FG002|Overall Study|Withdrawal by Subject|0|||
33169111|NCT03982368|100525640|FG000|Overall Study|unknow|4|||
33169112|NCT03982368|100525641|FG001|Overall Study|unknow|0|||
33169113|NCT03982368|100525642|FG002|Overall Study|unknow|2|||
33169114|NCT01575769|100525643|FG000|Overall Study|Adverse Event|1|||
33169115|NCT01575769|100525643|FG000|Overall Study|Study terminated by sponsor|40|||
33169116|NCT02155608|100525646|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
33169117|NCT02155608|100525647|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
33169118|NCT02155608|100525646|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
33169119|NCT02155608|100525647|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
33169120|NCT03672747|100525652|FG000|Overall Study|Lost to Follow-up|1|||
33169121|NCT03672747|100525653|FG001|Overall Study|Lost to Follow-up|1|||
33169122|NCT03672747|100525654|FG002|Overall Study|Lost to Follow-up|2|||
33169123|NCT03672747|100525655|FG003|Overall Study|Lost to Follow-up|2|||
33169124|NCT03672747|100525656|FG004|Overall Study|Lost to Follow-up|2|||
33449801|NCT02861300|101536140|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
33449802|NCT02861300|101536141|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
33449803|NCT02861300|101536142|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
33449804|NCT02861300|101536136|FG000|Overall Study|Clinical Complications|0|||
33449805|NCT02861300|101536137|FG001|Overall Study|Clinical Complications|0|||
33449806|NCT02861300|101536138|FG002|Overall Study|Clinical Complications|0|||
33449807|NCT02861300|101536139|FG003|Overall Study|Clinical Complications|0|||
33449808|NCT02861300|101536140|FG004|Overall Study|Clinical Complications|0|||
33449809|NCT02861300|101536141|FG005|Overall Study|Clinical Complications|0|||
33449810|NCT02861300|101536142|FG006|Overall Study|Clinical Complications|1|||
33169125|NCT03672747|100525657|FG005|Overall Study|Lost to Follow-up|1|||
33449811|NCT00829530|101536143|FG000|First Intervention|Adverse Event|0|||
33449812|NCT00829530|101536144|FG001|First Intervention|Adverse Event|1|||
33449813|NCT00829530|101536143|FG000|First Intervention|Intolerance to Venopuncture|0|||
33449814|NCT00829530|101536144|FG001|First Intervention|Intolerance to Venopuncture|1|||
33169126|NCT00646776|100525658|FG000|Overall Study|Adverse Event|1|||
33169127|NCT00646776|100525659|FG001|Overall Study|Adverse Event|9|||
33169128|NCT00646776|100525658|FG000|Overall Study|Investigator discretion|0|||
33169129|NCT00646776|100525659|FG001|Overall Study|Investigator discretion|4|||
33169130|NCT03667924|100525660|FG000|Baseline Completed|Lost to Follow-up|0|||
33169131|NCT03667924|100525661|FG001|Baseline Completed|Lost to Follow-up|2|||
33449815|NCT00829530|101536143|FG000|Second Intervention|Intolerance to Venopuncture|1|||
33260647|NCT02564744|100856379|FG001|Overall Study|Subject Withdrew Consent|1|||
33260648|NCT02564744|100856380|FG002|Overall Study|Subject Withdrew Consent|1|||
33260649|NCT02564744|100856381|FG003|Overall Study|Subject Withdrew Consent|0|||
33260650|NCT02564744|100856382|FG004|Overall Study|Subject Withdrew Consent|2|||
33260651|NCT02564744|100856378|FG000|Overall Study|Lost to Follow-up|0|||
33260652|NCT02564744|100856379|FG001|Overall Study|Lost to Follow-up|1|||
33260653|NCT02564744|100856380|FG002|Overall Study|Lost to Follow-up|0|||
33260654|NCT02564744|100856381|FG003|Overall Study|Lost to Follow-up|0|||
33260655|NCT02564744|100856382|FG004|Overall Study|Lost to Follow-up|1|||
33260656|NCT02564744|100856378|FG000|Overall Study|Reason not specified|1|||
33260657|NCT02564744|100856379|FG001|Overall Study|Reason not specified|0|||
33260658|NCT02564744|100856380|FG002|Overall Study|Reason not specified|0|||
33260659|NCT02564744|100856381|FG003|Overall Study|Reason not specified|0|||
33260660|NCT02564744|100856382|FG004|Overall Study|Reason not specified|0|||
33260661|NCT03578536|100856383|FG000|Overall Study|Lost to Follow-up|1|||
33260662|NCT01932970|100856384|FG000|Overall Study|Withdrawal by Subject|5|||
33260663|NCT01932970|100856384|FG000|Overall Study|Death|1|||
33260664|NCT01932970|100856384|FG000|Overall Study|Lost to Follow-up|2|||
33260665|NCT01932970|100856384|FG000|Overall Study|Protocol Specified Criteria|10|||
33260666|NCT02291913|100856385|FG000|Overall Study|Progressive Disease|32|||
33260667|NCT02291913|100856385|FG000|Overall Study|Adverse Event|11|||
33260668|NCT02291913|100856385|FG000|Overall Study|Death|2|||
33260669|NCT02291913|100856385|FG000|Overall Study|Physician Decision|1|||
33260670|NCT02291913|100856385|FG000|Overall Study|Withdrawal by Subject|1|||
33260671|NCT02291913|100856385|FG000|Overall Study|Protocol Violation|1|||
33260672|NCT00174252|100856389|FG000|Overall Study|Protocol Violation|2|||
33260673|NCT04019444|100856391|FG000|Overall Study|Withdrawal by Subject|0|||
33260674|NCT04019444|100856392|FG001|Overall Study|Withdrawal by Subject|1|||
33260675|NCT04019444|100856393|FG002|Overall Study|Withdrawal by Subject|0|||
33260676|NCT04019444|100856394|FG003|Overall Study|Withdrawal by Subject|1|||
33260677|NCT04019444|100856391|FG000|Overall Study|Solicited Event|0|||
33260678|NCT04019444|100856392|FG001|Overall Study|Solicited Event|0|||
33260679|NCT04019444|100856393|FG002|Overall Study|Solicited Event|2|||
33260680|NCT04019444|100856394|FG003|Overall Study|Solicited Event|0|||
33260681|NCT00939510|100856395|FG000|Overall Study|Withdrawal by Subject|1|||
33260682|NCT00818246|100856401|FG000|Overall Study|Impossible to match pictures|5|||
33260683|NCT02008916|100856407|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
33260684|NCT02008916|100856408|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
33260685|NCT02008916|100856409|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
33260686|NCT02008916|100856407|FG000|Week 16 - 156|Adverse Event|4|||
33260687|NCT02008916|100856408|FG001|Week 16 - 156|Adverse Event|2|||
33260688|NCT02008916|100856409|FG002|Week 16 - 156|Adverse Event|3|||
33260689|NCT02008916|100856407|FG000|Week 16 - 156|Withdrawal by Subject|7|||
33260690|NCT02008916|100856408|FG001|Week 16 - 156|Withdrawal by Subject|3|||
33260691|NCT02008916|100856409|FG002|Week 16 - 156|Withdrawal by Subject|5|||
33260692|NCT02008916|100856407|FG000|Week 16 - 156|No longer requires treatment|0|||
33260693|NCT02008916|100856408|FG001|Week 16 - 156|No longer requires treatment|1|||
33260694|NCT02008916|100856409|FG002|Week 16 - 156|No longer requires treatment|0|||
33260695|NCT02008916|100856407|FG000|Week 16 - 156|Lost to Follow-up|5|||
33260696|NCT02008916|100856408|FG001|Week 16 - 156|Lost to Follow-up|0|||
33260697|NCT02008916|100856409|FG002|Week 16 - 156|Lost to Follow-up|0|||
33169132|NCT03667924|100525662|FG002|Baseline Completed|Lost to Follow-up|0|||
33169133|NCT03667924|100525660|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
33169134|NCT03667924|100525661|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
33169135|NCT03667924|100525662|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
33169136|NCT03667924|100525660|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
33169137|NCT03667924|100525661|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
33169138|NCT03667924|100525662|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
33169139|NCT03667924|100525660|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
33169140|NCT03667924|100525661|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
33169141|NCT03667924|100525662|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
33169142|NCT03667924|100525660|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
33169143|NCT03667924|100525661|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
33169144|NCT03667924|100525662|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
33169145|NCT03667924|100525660|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
33169146|NCT03667924|100525661|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
33169147|NCT03667924|100525662|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
33169148|NCT03667924|100525660|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
33169149|NCT03667924|100525661|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
33169150|NCT03667924|100525662|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
33260698|NCT02008916|100856407|FG000|Week 16 - 156|Lack of Efficacy|3|||
33260699|NCT02008916|100856408|FG001|Week 16 - 156|Lack of Efficacy|5|||
33260700|NCT02008916|100856409|FG002|Week 16 - 156|Lack of Efficacy|2|||
33260701|NCT02008916|100856407|FG000|Week 16 - 156|Pregnancy|0|||
33260702|NCT02008916|100856408|FG001|Week 16 - 156|Pregnancy|1|||
33260703|NCT02008916|100856409|FG002|Week 16 - 156|Pregnancy|0|||
33260704|NCT02008916|100856407|FG000|Week 16 - 156|Physician Decision|0|||
33260705|NCT02008916|100856408|FG001|Week 16 - 156|Physician Decision|1|||
33260706|NCT02008916|100856409|FG002|Week 16 - 156|Physician Decision|0|||
33260707|NCT00642850|100856415|FG000|Overall Study|Death|7|||
33260708|NCT00642850|100856415|FG000|Overall Study|Adverse Event|2|||
33260709|NCT00642850|100856415|FG000|Overall Study|Lack of Efficacy|1|||
33260710|NCT00642850|100856415|FG000|Overall Study|Protocol Violation|2|||
33260711|NCT00642850|100856415|FG000|Overall Study|Kidney transplantation|8|||
33260712|NCT00642850|100856415|FG000|Overall Study|Blood transfusion|6|||
33260713|NCT00642850|100856415|FG000|Overall Study|Other reasons|7|||
33260714|NCT00077675|100856416|FG000|Overall Study|Adverse Event|1|||
33260715|NCT00077675|100856417|FG001|Overall Study|Adverse Event|2|||
33260716|NCT00077675|100856416|FG000|Overall Study|Lost to Follow-up|6|||
33260717|NCT00077675|100856417|FG001|Overall Study|Lost to Follow-up|3|||
33260718|NCT00077675|100856416|FG000|Overall Study|Withdrawal by Subject|1|||
33260719|NCT00077675|100856417|FG001|Overall Study|Withdrawal by Subject|0|||
33260720|NCT00077675|100856416|FG000|Overall Study|Other|0|||
33260721|NCT00077675|100856417|FG001|Overall Study|Other|1|||
33260722|NCT00077675|100856416|FG000|Overall Study|Never received study treatment|3|||
33260723|NCT00077675|100856417|FG001|Overall Study|Never received study treatment|3|||
33260724|NCT01095796|100856418|FG000|Overall Study|Randomized but Not Treated|5|||
33260725|NCT01095796|100856419|FG001|Overall Study|Randomized but Not Treated|2|||
33260726|NCT01095796|100856418|FG000|Overall Study|Adverse Event|9|||
33260727|NCT01095796|100856419|FG001|Overall Study|Adverse Event|19|||
33260728|NCT01095796|100856418|FG000|Overall Study|Death|3|||
33260729|NCT01095796|100856419|FG001|Overall Study|Death|2|||
33260730|NCT01095796|100856418|FG000|Overall Study|Pregnancy|2|||
33260731|NCT01095796|100856419|FG001|Overall Study|Pregnancy|0|||
33260732|NCT01095796|100856418|FG000|Overall Study|Lack of Efficacy|5|||
33260733|NCT01095796|100856419|FG001|Overall Study|Lack of Efficacy|3|||
33260734|NCT01095796|100856418|FG000|Overall Study|Investigator's Discretion|7|||
33260735|NCT01095796|100856419|FG001|Overall Study|Investigator's Discretion|2|||
33260736|NCT01095796|100856418|FG000|Overall Study|Withdrew Consent|16|||
33260737|NCT01095796|100856419|FG001|Overall Study|Withdrew Consent|22|||
33260738|NCT01095796|100856418|FG000|Overall Study|Lost to Follow-up|27|||
33260739|NCT01095796|100856419|FG001|Overall Study|Lost to Follow-up|29|||
33260740|NCT01095796|100856418|FG000|Overall Study|Participant Noncompliance|5|||
33260741|NCT01095796|100856419|FG001|Overall Study|Participant Noncompliance|10|||
33260742|NCT01095796|100856418|FG000|Overall Study|Protocol Violation|1|||
33260743|NCT01095796|100856419|FG001|Overall Study|Protocol Violation|0|||
33260744|NCT01095796|100856418|FG000|Overall Study|Participant Transferred to Another Study|215|||
33260745|NCT01095796|100856419|FG001|Overall Study|Participant Transferred to Another Study|200|||
33260746|NCT00976495|100856420|FG000|Overall Study|Withdrawal by Subject|0|||
33260747|NCT00976495|100856421|FG001|Overall Study|Withdrawal by Subject|1|||
33260748|NCT00976495|100856422|FG002|Overall Study|Withdrawal by Subject|0|||
33260749|NCT00593489|100856423|FG000|Allocation|did not attend workshop; allocation not|2|||
33260750|NCT00593489|100856424|FG001|Allocation|did not attend workshop; allocation not|1|||
33260751|NCT04121546|100856425|FG000|Overall Study|Lost to Follow-up|1|||
33260752|NCT04121546|100856426|FG001|Overall Study|Lost to Follow-up|3|||
33260753|NCT04638816|100856427|FG000|Overall Study|Withdrawal by Subject|0|||
33260754|NCT04638816|100856428|FG001|Overall Study|Withdrawal by Subject|1|||
33260755|NCT04638816|100856427|FG000|Overall Study|Lost to Follow-up|0|||
33260756|NCT04638816|100856428|FG001|Overall Study|Lost to Follow-up|1|||
33260757|NCT02538900|100856430|FG000|Overall Study|Death|2|||
33260758|NCT02538900|100856431|FG001|Overall Study|Death|2|||
33260759|NCT02538900|100856432|FG002|Overall Study|Death|2|||
33260760|NCT02538900|100856430|FG000|Overall Study|Withdrawal by Subject|18|||
33260761|NCT02538900|100856431|FG001|Overall Study|Withdrawal by Subject|16|||
33260762|NCT02538900|100856432|FG002|Overall Study|Withdrawal by Subject|15|||
33449816|NCT00829530|101536144|FG001|Second Intervention|Intolerance to Venopuncture|0|||
33260763|NCT00589875|100856433|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
33260764|NCT00589875|100856433|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
33260765|NCT01074294|100856434|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
33260766|NCT01074294|100856435|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
33260767|NCT01074294|100856436|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
33260768|NCT01074294|100856437|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
33260769|NCT01074294|100856434|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
33260770|NCT01074294|100856435|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
33260771|NCT01074294|100856436|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
33260772|NCT01074294|100856437|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
33260773|NCT01074294|100856434|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
33260774|NCT01074294|100856435|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
33260775|NCT01074294|100856436|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
33260776|NCT01074294|100856437|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
33449817|NCT00909753|101536147|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
33449818|NCT00909753|101536148|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
33449819|NCT00909753|101536147|FG000|Period: Second Intervention|Protocol Violation|1|||
33449820|NCT00909753|101536148|FG001|Period: Second Intervention|Protocol Violation|0|||
33449821|NCT02554877|101536149|FG000|Overall Study|Adverse Event|2|||
33449822|NCT02554877|101536150|FG001|Overall Study|Adverse Event|0|||
33449823|NCT02554877|101536151|FG002|Overall Study|Adverse Event|0|||
33169151|NCT01153347|100525663|FG000|Overall Study|Withdrawal by Subject|7|||
33169152|NCT01153347|100525664|FG001|Overall Study|Withdrawal by Subject|7|||
33169153|NCT01153347|100525665|FG002|Overall Study|Withdrawal by Subject|7|||
33169154|NCT01153347|100525666|FG003|Overall Study|Withdrawal by Subject|7|||
33169155|NCT01153347|100525663|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33169156|NCT01153347|100525664|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33169157|NCT01153347|100525665|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
33169158|NCT01153347|100525666|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
33169159|NCT01153347|100525663|FG000|Overall Study|Adverse Event|3|||
33169160|NCT01153347|100525664|FG001|Overall Study|Adverse Event|9|||
33169161|NCT01153347|100525665|FG002|Overall Study|Adverse Event|21|||
33169162|NCT01153347|100525666|FG003|Overall Study|Adverse Event|7|||
33169163|NCT01153347|100525663|FG000|Overall Study|Severe non-compliance to protocol|6|||
33169164|NCT01153347|100525664|FG001|Overall Study|Severe non-compliance to protocol|7|||
33169165|NCT01153347|100525665|FG002|Overall Study|Severe non-compliance to protocol|4|||
33169166|NCT01153347|100525666|FG003|Overall Study|Severe non-compliance to protocol|3|||
33169167|NCT01153347|100525663|FG000|Overall Study|Condition under investigation worsened|1|||
33169168|NCT01153347|100525664|FG001|Overall Study|Condition under investigation worsened|1|||
33169169|NCT01153347|100525665|FG002|Overall Study|Condition under investigation worsened|0|||
33169170|NCT01153347|100525666|FG003|Overall Study|Condition under investigation worsened|0|||
33169171|NCT01153347|100525663|FG000|Overall Study|Lack of Efficacy|2|||
33169172|NCT01153347|100525664|FG001|Overall Study|Lack of Efficacy|2|||
33169173|NCT01153347|100525665|FG002|Overall Study|Lack of Efficacy|0|||
33169174|NCT01153347|100525666|FG003|Overall Study|Lack of Efficacy|4|||
33169175|NCT01153347|100525663|FG000|Overall Study|Study-specific withdrawal criteria|4|||
33169176|NCT01153347|100525664|FG001|Overall Study|Study-specific withdrawal criteria|3|||
33169177|NCT01153347|100525665|FG002|Overall Study|Study-specific withdrawal criteria|1|||
33169178|NCT01153347|100525666|FG003|Overall Study|Study-specific withdrawal criteria|2|||
33169179|NCT01153347|100525663|FG000|Overall Study|Lost to Follow-up|4|||
33169180|NCT01153347|100525664|FG001|Overall Study|Lost to Follow-up|9|||
33169181|NCT01153347|100525665|FG002|Overall Study|Lost to Follow-up|11|||
33169182|NCT01153347|100525666|FG003|Overall Study|Lost to Follow-up|8|||
33169183|NCT01153347|100525663|FG000|Overall Study|Other|5|||
33169184|NCT01153347|100525664|FG001|Overall Study|Other|5|||
33169185|NCT01153347|100525665|FG002|Overall Study|Other|4|||
33169186|NCT01153347|100525666|FG003|Overall Study|Other|0|||
33169187|NCT01153347|100525663|FG000|Overall Study|Death|1|||
33169188|NCT01153347|100525664|FG001|Overall Study|Death|0|||
33169189|NCT01153347|100525665|FG002|Overall Study|Death|0|||
33169190|NCT01153347|100525666|FG003|Overall Study|Death|0|||
33169191|NCT04669600|100525671|FG000|Overall Study|Withdrawal by Subject|1|||
33260777|NCT01074294|100856434|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
33260778|NCT01074294|100856435|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
33260779|NCT01074294|100856436|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
33260780|NCT01074294|100856437|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
33260781|NCT01074294|100856434|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
33260782|NCT01074294|100856435|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
33260783|NCT01074294|100856436|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
33449824|NCT02554877|101536152|FG003|Overall Study|Adverse Event|1|||
33169192|NCT04669600|100525671|FG000|Overall Study|Other|6|||
33169193|NCT02279420|100525675|FG000|Overall Study|Lost to Follow-up|23|||
33169194|NCT01833520|100525676|FG000|Overall Study|Lack of Efficacy|3|||
33169195|NCT01833520|100525677|FG001|Overall Study|Lack of Efficacy|3|||
33169196|NCT01833520|100525678|FG002|Overall Study|Lack of Efficacy|8|||
33169197|NCT01833520|100525679|FG003|Overall Study|Lack of Efficacy|3|||
33169198|NCT01949506|100525680|FG000|Overall Study|Physician Decision|1|||
33169199|NCT01846416|100525681|FG000|Treatment Phase|Death|2|||
33169200|NCT01846416|100525682|FG001|Treatment Phase|Death|9|||
33169201|NCT01846416|100525683|FG002|Treatment Phase|Death|1|||
33169202|NCT01846416|100525681|FG000|Treatment Phase|Withdrawal by Subject|2|||
33169203|NCT01846416|100525682|FG001|Treatment Phase|Withdrawal by Subject|4|||
33169204|NCT01846416|100525683|FG002|Treatment Phase|Withdrawal by Subject|2|||
33169205|NCT01846416|100525681|FG000|Treatment Phase|Other|1|||
33169206|NCT01846416|100525682|FG001|Treatment Phase|Other|5|||
33169207|NCT01846416|100525683|FG002|Treatment Phase|Other|1|||
33169208|NCT01846416|100525681|FG000|Treatment Phase|Physician Decision|1|||
33169209|NCT01846416|100525682|FG001|Treatment Phase|Physician Decision|2|||
33169210|NCT01846416|100525683|FG002|Treatment Phase|Physician Decision|0|||
33169211|NCT01846416|100525681|FG000|Treatment Phase|Adverse Event|3|||
33169212|NCT01846416|100525682|FG001|Treatment Phase|Adverse Event|4|||
33169213|NCT01846416|100525683|FG002|Treatment Phase|Adverse Event|0|||
33169214|NCT01846416|100525681|FG000|Treatment Phase|Non-compliance|0|||
33169215|NCT01846416|100525682|FG001|Treatment Phase|Non-compliance|2|||
33169216|NCT01846416|100525683|FG002|Treatment Phase|Non-compliance|0|||
33169217|NCT01846416|100525681|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
33169218|NCT01846416|100525682|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
33169219|NCT01846416|100525683|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
33169220|NCT01846416|100525681|FG000|Treatment Phase|Progressive Disease|21|||
33169221|NCT01846416|100525682|FG001|Treatment Phase|Progressive Disease|63|||
33169222|NCT01846416|100525683|FG002|Treatment Phase|Progressive Disease|9|||
33169223|NCT01846416|100525681|FG000|Survival Follow-up|Death|21|||
33169224|NCT01846416|100525682|FG001|Survival Follow-up|Death|62|||
33169225|NCT01846416|100525683|FG002|Survival Follow-up|Death|9|||
33169226|NCT01846416|100525681|FG000|Survival Follow-up|Lost to Follow-up|0|||
33169227|NCT01846416|100525682|FG001|Survival Follow-up|Lost to Follow-up|2|||
33169228|NCT01846416|100525683|FG002|Survival Follow-up|Lost to Follow-up|2|||
33169229|NCT01846416|100525681|FG000|Survival Follow-up|Withdrawal by Subject|2|||
33169230|NCT01846416|100525682|FG001|Survival Follow-up|Withdrawal by Subject|7|||
33169231|NCT01846416|100525683|FG002|Survival Follow-up|Withdrawal by Subject|0|||
33169232|NCT01846416|100525681|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
33169233|NCT01846416|100525682|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
33169234|NCT01846416|100525683|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
33169235|NCT01846416|100525681|FG000|Survival Follow-up|Other|3|||
33169236|NCT01846416|100525682|FG001|Survival Follow-up|Other|1|||
33169237|NCT01846416|100525683|FG002|Survival Follow-up|Other|1|||
33169238|NCT02397278|100525685|FG000|Overall Study|Withdrawal by Subject|0|||
33169239|NCT02397278|100525686|FG001|Overall Study|Withdrawal by Subject|2|||
33169240|NCT02397278|100525685|FG000|Overall Study|Deemed ineligible following surgery|1|||
33169241|NCT02397278|100525686|FG001|Overall Study|Deemed ineligible following surgery|1|||
33169242|NCT03926169|100525687|FG000|Period A|Adverse Event|2|||
33169243|NCT03926169|100525688|FG001|Period A|Adverse Event|2|||
33169244|NCT03926169|100525689|FG002|Period A|Adverse Event|1|||
33169245|NCT03926169|100525687|FG000|Period A|Withdrawal by Subject|2|||
33169246|NCT03926169|100525688|FG001|Period A|Withdrawal by Subject|2|||
33260784|NCT01074294|100856437|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
33260785|NCT01074294|100856434|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
33260786|NCT01074294|100856435|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
33260787|NCT01074294|100856436|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
33260788|NCT01074294|100856437|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
33260789|NCT01074294|100856434|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
33260790|NCT01074294|100856435|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
33260791|NCT01074294|100856436|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
33260792|NCT01074294|100856437|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
33260793|NCT01074294|100856434|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
33260794|NCT01074294|100856435|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
33260795|NCT01074294|100856436|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
33260796|NCT01074294|100856437|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
33260797|NCT01074294|100856434|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
33260798|NCT01074294|100856435|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
33260799|NCT01074294|100856436|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
33260800|NCT01074294|100856437|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
33260801|NCT01074294|100856434|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
33260802|NCT01074294|100856435|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
33260803|NCT01074294|100856436|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
33260804|NCT01074294|100856437|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
33449825|NCT02554877|101536149|FG000|Overall Study|Lost to Follow-up|1|||
33260805|NCT01074294|100856434|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
33449826|NCT02554877|101536150|FG001|Overall Study|Lost to Follow-up|1|||
33449827|NCT02554877|101536151|FG002|Overall Study|Lost to Follow-up|1|||
33449828|NCT02554877|101536152|FG003|Overall Study|Lost to Follow-up|2|||
33260806|NCT01074294|100856435|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
33260807|NCT01074294|100856436|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
33260808|NCT01074294|100856437|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
33260809|NCT01074294|100856434|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
33260810|NCT01074294|100856435|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
33260811|NCT01074294|100856436|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
33260812|NCT01074294|100856437|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
33449829|NCT02554877|101536149|FG000|Overall Study|Did not meet entrance criteria|0|||
33449830|NCT02554877|101536150|FG001|Overall Study|Did not meet entrance criteria|0|||
33449831|NCT02554877|101536151|FG002|Overall Study|Did not meet entrance criteria|1|||
33449832|NCT02554877|101536152|FG003|Overall Study|Did not meet entrance criteria|0|||
33449833|NCT02554877|101536149|FG000|Overall Study|No longer met eligibility criteria|1|||
33449834|NCT02554877|101536150|FG001|Overall Study|No longer met eligibility criteria|0|||
33449835|NCT02554877|101536151|FG002|Overall Study|No longer met eligibility criteria|1|||
33449836|NCT02554877|101536152|FG003|Overall Study|No longer met eligibility criteria|1|||
33449837|NCT02554877|101536149|FG000|Overall Study|Protocol Violation|3|||
33449838|NCT02554877|101536150|FG001|Overall Study|Protocol Violation|1|||
33449839|NCT02554877|101536151|FG002|Overall Study|Protocol Violation|1|||
33449840|NCT02554877|101536152|FG003|Overall Study|Protocol Violation|0|||
33449841|NCT02554877|101536149|FG000|Overall Study|Other|1|||
33449842|NCT02554877|101536150|FG001|Overall Study|Other|3|||
33449843|NCT02554877|101536151|FG002|Overall Study|Other|0|||
33449844|NCT02554877|101536152|FG003|Overall Study|Other|3|||
33449845|NCT02554877|101536149|FG000|Overall Study|Insufficient clinical response|4|||
33449846|NCT02554877|101536150|FG001|Overall Study|Insufficient clinical response|0|||
33449847|NCT02554877|101536151|FG002|Overall Study|Insufficient clinical response|0|||
33449848|NCT02554877|101536152|FG003|Overall Study|Insufficient clinical response|0|||
33449849|NCT02554877|101536149|FG000|Overall Study|No longer willing to participate|0|||
33449850|NCT02554877|101536150|FG001|Overall Study|No longer willing to participate|2|||
33449851|NCT02554877|101536151|FG002|Overall Study|No longer willing to participate|2|||
33449852|NCT02554877|101536152|FG003|Overall Study|No longer willing to participate|0|||
33449853|NCT02334722|101536153|FG000|Overall Study|Lost to Follow-up|4|||
33449854|NCT02334722|101536154|FG001|Overall Study|Lost to Follow-up|0|||
33449855|NCT02334722|101536153|FG000|Overall Study|6 week questionnaire not completed|2|||
33449856|NCT02334722|101536154|FG001|Overall Study|6 week questionnaire not completed|0|||
33169247|NCT03926169|100525689|FG002|Period A|Withdrawal by Subject|2|||
33169248|NCT03926169|100525687|FG000|Period A|Lost to Follow-up|3|||
33169249|NCT03926169|100525688|FG001|Period A|Lost to Follow-up|1|||
33169250|NCT03926169|100525689|FG002|Period A|Lost to Follow-up|0|||
33169251|NCT03926169|100525687|FG000|Period A|Lack of Efficacy|0|||
33449857|NCT02334722|101536153|FG000|Overall Study|Unable to obtain medication|1|||
33449858|NCT02334722|101536154|FG001|Overall Study|Unable to obtain medication|1|||
33449859|NCT02334722|101536153|FG000|Overall Study|Withdrawal by Subject|0|||
33449860|NCT02334722|101536154|FG001|Overall Study|Withdrawal by Subject|3|||
33169252|NCT03926169|100525688|FG001|Period A|Lack of Efficacy|2|||
33169253|NCT03926169|100525689|FG002|Period A|Lack of Efficacy|2|||
33169254|NCT03926169|100525687|FG000|Period A|COVID-19 Infection|0|||
33169255|NCT03926169|100525688|FG001|Period A|COVID-19 Infection|1|||
33169256|NCT03926169|100525689|FG002|Period A|COVID-19 Infection|0|||
33169257|NCT03926169|100525687|FG000|Period A|COVID-19 Logistical Restrictions|0|||
33449861|NCT02334722|101536153|FG000|Overall Study|Adverse Event|0|||
33449862|NCT02334722|101536154|FG001|Overall Study|Adverse Event|2|||
33449863|NCT02334722|101536153|FG000|Overall Study|Physician Decision|0|||
33449864|NCT02334722|101536154|FG001|Overall Study|Physician Decision|1|||
33449865|NCT00875524|101536157|FG000|Overall Study|Serious adverse event|0|||
33449866|NCT00875524|101536158|FG001|Overall Study|Serious adverse event|1|||
33449867|NCT00875524|101536157|FG000|Overall Study|Protocol Violation|4|||
33169258|NCT03926169|100525688|FG001|Period A|COVID-19 Logistical Restrictions|2|||
33169259|NCT03926169|100525689|FG002|Period A|COVID-19 Logistical Restrictions|1|||
33169260|NCT03926169|100525687|FG000|Period A|Other, Not Specified|1|||
33169261|NCT03926169|100525688|FG001|Period A|Other, Not Specified|0|||
33169262|NCT03926169|100525689|FG002|Period A|Other, Not Specified|0|||
33169263|NCT03926169|100525687|FG000|Period B|Adverse Event|3|||
33169264|NCT03926169|100525688|FG001|Period B|Adverse Event|1|||
33169265|NCT03926169|100525689|FG002|Period B|Adverse Event|1|||
33169266|NCT03926169|100525687|FG000|Period B|Withdrawal by Subject|1|||
33169267|NCT03926169|100525688|FG001|Period B|Withdrawal by Subject|3|||
33169268|NCT03926169|100525689|FG002|Period B|Withdrawal by Subject|0|||
33169269|NCT03926169|100525687|FG000|Period B|Lack of Efficacy|3|||
33169270|NCT03926169|100525688|FG001|Period B|Lack of Efficacy|1|||
33169271|NCT03926169|100525689|FG002|Period B|Lack of Efficacy|1|||
33169272|NCT03926169|100525687|FG000|Period B|Lost to Follow-up|1|||
33169273|NCT03926169|100525688|FG001|Period B|Lost to Follow-up|1|||
33169274|NCT03926169|100525689|FG002|Period B|Lost to Follow-up|4|||
33449868|NCT00875524|101536158|FG001|Overall Study|Protocol Violation|0|||
33449869|NCT00875524|101536157|FG000|Overall Study|Lost to Follow-up|1|||
33449870|NCT00875524|101536158|FG001|Overall Study|Lost to Follow-up|0|||
33449871|NCT00875524|101536157|FG000|Overall Study|Withdrawal by Subject|3|||
33449872|NCT00875524|101536158|FG001|Overall Study|Withdrawal by Subject|5|||
33449873|NCT01663233|101536166|FG000|Overall Study|Withdrawal by Subject|3|||
33449874|NCT01663233|101536167|FG001|Overall Study|Withdrawal by Subject|2|||
33449875|NCT01663233|101536166|FG000|Overall Study|Protocol Deviation|1|||
33449876|NCT01663233|101536167|FG001|Overall Study|Protocol Deviation|4|||
33449877|NCT01663233|101536166|FG000|Overall Study|Lost to Follow-up|0|||
33449878|NCT01663233|101536167|FG001|Overall Study|Lost to Follow-up|1|||
33449879|NCT05755282|101536171|FG000|Overall Study|Protocol Violation|0|||
33449880|NCT05755282|101536172|FG001|Overall Study|Protocol Violation|1|||
33449881|NCT00627016|101536173|FG000|Overall Study|Adverse Event|1|||
33449882|NCT00627016|101536174|FG001|Overall Study|Adverse Event|1|||
33449883|NCT00627016|101536173|FG000|Overall Study|Protocol Violation|0|||
33449884|NCT00627016|101536174|FG001|Overall Study|Protocol Violation|2|||
33449885|NCT00627016|101536173|FG000|Overall Study|Lost to Follow-up|0|||
33449886|NCT00627016|101536174|FG001|Overall Study|Lost to Follow-up|1|||
33449887|NCT00627016|101536173|FG000|Overall Study|Withdrawal by Subject|2|||
33449888|NCT00627016|101536174|FG001|Overall Study|Withdrawal by Subject|1|||
33449889|NCT00627016|101536173|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
33449890|NCT00627016|101536174|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
33449891|NCT00627016|101536173|FG000|Overall Study|Lack of Efficacy|1|||
33449892|NCT00627016|101536174|FG001|Overall Study|Lack of Efficacy|0|||
33449893|NCT00627016|101536173|FG000|Overall Study|Placed on Excluded Drugs|1|||
33449894|NCT00627016|101536174|FG001|Overall Study|Placed on Excluded Drugs|0|||
33169275|NCT03926169|100525687|FG000|Period B|Other, Not Specified|62|||
33169276|NCT03926169|100525688|FG001|Period B|Other, Not Specified|57|||
33449895|NCT00627016|101536173|FG000|Overall Study|Pregnancy|1|||
33449896|NCT00627016|101536174|FG001|Overall Study|Pregnancy|0|||
33449897|NCT00829790|101536175|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
33449898|NCT00829790|101536176|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
33449899|NCT01778010|101536177|FG000|Overall Study|Withdrawal by Subject|2|||
33449900|NCT01778010|101536177|FG000|Overall Study|abnormal ECG before meds|1|||
33449901|NCT01778010|101536177|FG000|Overall Study|Arrested|1|||
33449902|NCT01778010|101536177|FG000|Overall Study|rash while on placebo|1|||
33449903|NCT00443651|101538649|FG000|Overall Study|Death|1|||
33169277|NCT03926169|100525689|FG002|Period B|Other, Not Specified|65|||
33449904|NCT00443651|101538650|FG001|Overall Study|Death|5|||
33449905|NCT00443651|101538649|FG000|Overall Study|Adverse Event|5|||
33449906|NCT00443651|101538650|FG001|Overall Study|Adverse Event|6|||
33449907|NCT00443651|101538649|FG000|Overall Study|Lost to Follow-up|18|||
33449908|NCT00443651|101538650|FG001|Overall Study|Lost to Follow-up|12|||
33169278|NCT02323113|100525690|FG000|Overall Study|Adverse Event|3|||
33260813|NCT01074294|100856434|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
33260814|NCT01074294|100856435|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
33260815|NCT01074294|100856436|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
33260816|NCT01074294|100856437|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
33260817|NCT00774397|100856443|FG000|Overall Study|Adverse Event|1|||
33260818|NCT00774397|100856444|FG001|Overall Study|Adverse Event|3|||
33260819|NCT00774397|100856445|FG002|Overall Study|Adverse Event|16|||
33260820|NCT00774397|100856446|FG003|Overall Study|Adverse Event|8|||
33260821|NCT00774397|100856447|FG004|Overall Study|Adverse Event|8|||
33260822|NCT00774397|100856448|FG005|Overall Study|Adverse Event|3|||
33260823|NCT00774397|100856449|FG006|Overall Study|Adverse Event|16|||
33260824|NCT00774397|100856443|FG000|Overall Study|Lack of Efficacy|11|||
33260825|NCT00774397|100856444|FG001|Overall Study|Lack of Efficacy|4|||
33260826|NCT00774397|100856445|FG002|Overall Study|Lack of Efficacy|5|||
33260827|NCT00774397|100856446|FG003|Overall Study|Lack of Efficacy|3|||
33260828|NCT00774397|100856447|FG004|Overall Study|Lack of Efficacy|27|||
33260829|NCT00774397|100856448|FG005|Overall Study|Lack of Efficacy|15|||
33260830|NCT00774397|100856449|FG006|Overall Study|Lack of Efficacy|9|||
33260831|NCT00774397|100856443|FG000|Overall Study|Protocol Violation|0|||
33260832|NCT00774397|100856444|FG001|Overall Study|Protocol Violation|1|||
33260833|NCT00774397|100856445|FG002|Overall Study|Protocol Violation|3|||
33260834|NCT00774397|100856446|FG003|Overall Study|Protocol Violation|1|||
33260835|NCT00774397|100856447|FG004|Overall Study|Protocol Violation|2|||
33260836|NCT00774397|100856448|FG005|Overall Study|Protocol Violation|1|||
33260837|NCT00774397|100856449|FG006|Overall Study|Protocol Violation|0|||
33260838|NCT00774397|100856443|FG000|Overall Study|Lost to Follow-up|0|||
33260839|NCT00774397|100856444|FG001|Overall Study|Lost to Follow-up|1|||
33260840|NCT00774397|100856445|FG002|Overall Study|Lost to Follow-up|1|||
33260841|NCT00774397|100856446|FG003|Overall Study|Lost to Follow-up|1|||
33260842|NCT00774397|100856447|FG004|Overall Study|Lost to Follow-up|0|||
33260843|NCT00774397|100856448|FG005|Overall Study|Lost to Follow-up|1|||
33260844|NCT00774397|100856449|FG006|Overall Study|Lost to Follow-up|0|||
33260845|NCT00774397|100856443|FG000|Overall Study|Refused to continue trial medication|1|||
33260846|NCT00774397|100856444|FG001|Overall Study|Refused to continue trial medication|3|||
33260847|NCT00774397|100856445|FG002|Overall Study|Refused to continue trial medication|2|||
33260848|NCT00774397|100856446|FG003|Overall Study|Refused to continue trial medication|2|||
33260849|NCT00774397|100856447|FG004|Overall Study|Refused to continue trial medication|6|||
33260850|NCT00774397|100856448|FG005|Overall Study|Refused to continue trial medication|2|||
33260851|NCT00774397|100856449|FG006|Overall Study|Refused to continue trial medication|3|||
33260852|NCT00774397|100856443|FG000|Overall Study|Not treated|0|||
33260853|NCT00774397|100856444|FG001|Overall Study|Not treated|0|||
33260854|NCT00774397|100856445|FG002|Overall Study|Not treated|0|||
33260855|NCT00774397|100856446|FG003|Overall Study|Not treated|0|||
33260856|NCT00774397|100856447|FG004|Overall Study|Not treated|1|||
33260857|NCT00774397|100856448|FG005|Overall Study|Not treated|0|||
33260858|NCT00774397|100856449|FG006|Overall Study|Not treated|1|||
33260859|NCT00774397|100856443|FG000|Overall Study|Other than those stated above|1|||
33260860|NCT00774397|100856444|FG001|Overall Study|Other than those stated above|1|||
33260861|NCT00774397|100856445|FG002|Overall Study|Other than those stated above|3|||
33260862|NCT00774397|100856446|FG003|Overall Study|Other than those stated above|2|||
33260863|NCT00774397|100856447|FG004|Overall Study|Other than those stated above|2|||
33260864|NCT00774397|100856448|FG005|Overall Study|Other than those stated above|0|||
33260865|NCT00774397|100856449|FG006|Overall Study|Other than those stated above|1|||
33260866|NCT02462759|100856456|FG000|Part 1: Double Blind|Death|1|||
33260867|NCT02462759|100856457|FG001|Part 1: Double Blind|Death|0|||
33260868|NCT02462759|100856458|FG002|Part 1: Double Blind|Death|0|||
33260869|NCT00366249|100856459|FG000|Overall Study|Adverse Event|53|||
33260870|NCT00366249|100856460|FG001|Overall Study|Adverse Event|28|||
33260871|NCT00366249|100856459|FG000|Overall Study|Death|0|||
33260872|NCT00366249|100856460|FG001|Overall Study|Death|1|||
33260873|NCT00366249|100856459|FG000|Overall Study|Physician Decision|5|||
33260874|NCT00366249|100856460|FG001|Overall Study|Physician Decision|2|||
33260875|NCT00366249|100856459|FG000|Overall Study|Lost to Follow-up|2|||
33260876|NCT00366249|100856460|FG001|Overall Study|Lost to Follow-up|0|||
33260877|NCT00366249|100856459|FG000|Overall Study|Protocol Violation|1|||
33260878|NCT00366249|100856460|FG001|Overall Study|Protocol Violation|2|||
33260879|NCT00366249|100856459|FG000|Overall Study|Withdrawal by Subject|18|||
33260880|NCT00366249|100856460|FG001|Overall Study|Withdrawal by Subject|4|||
33260881|NCT00366249|100856459|FG000|Overall Study|Lack of Efficacy|21|||
33260882|NCT00366249|100856460|FG001|Overall Study|Lack of Efficacy|21|||
33449909|NCT00443651|101538649|FG000|Overall Study|Patient's/Guardian's Decision|58|||
33449910|NCT00443651|101538650|FG001|Overall Study|Patient's/Guardian's Decision|30|||
33449911|NCT00443651|101538649|FG000|Overall Study|Physician Decision|13|||
33449912|NCT00443651|101538650|FG001|Overall Study|Physician Decision|4|||
33449913|NCT00443651|101538649|FG000|Overall Study|Pregnancy|0|||
33449914|NCT00443651|101538650|FG001|Overall Study|Pregnancy|1|||
33449915|NCT04132518|101538651|FG000|Overall Study|Prematurely withdrawn from the study|0|||
33449916|NCT04132518|101538652|FG001|Overall Study|Prematurely withdrawn from the study|9|||
33449917|NCT04132518|101538653|FG002|Overall Study|Prematurely withdrawn from the study|1|||
33449918|NCT03713086|101538654|FG000|Overall Study|Withdrawal by Subject|0|||
33449919|NCT03713086|101538655|FG001|Overall Study|Withdrawal by Subject|2|||
33449920|NCT03713086|101538656|FG002|Overall Study|Withdrawal by Subject|1|||
33449921|NCT03713086|101538657|FG003|Overall Study|Withdrawal by Subject|0|||
33169279|NCT02323113|100525691|FG001|Overall Study|Adverse Event|3|||
33169280|NCT02323113|100525692|FG002|Overall Study|Adverse Event|2|||
33169281|NCT02323113|100525693|FG003|Overall Study|Adverse Event|5|||
33169282|NCT02323113|100525694|FG004|Overall Study|Adverse Event|8|||
33169283|NCT02323113|100525695|FG005|Overall Study|Adverse Event|3|||
33169284|NCT02323113|100525696|FG006|Overall Study|Adverse Event|6|||
33169285|NCT02323113|100525697|FG007|Overall Study|Adverse Event|0|||
33169286|NCT02323113|100525690|FG000|Overall Study|Progressive Disease|0|||
33169287|NCT02323113|100525691|FG001|Overall Study|Progressive Disease|1|||
33169288|NCT02323113|100525692|FG002|Overall Study|Progressive Disease|1|||
33169289|NCT02323113|100525693|FG003|Overall Study|Progressive Disease|0|||
33169290|NCT02323113|100525694|FG004|Overall Study|Progressive Disease|0|||
33169291|NCT02323113|100525695|FG005|Overall Study|Progressive Disease|3|||
33169292|NCT02323113|100525696|FG006|Overall Study|Progressive Disease|0|||
33169293|NCT02323113|100525697|FG007|Overall Study|Progressive Disease|0|||
33169294|NCT02323113|100525690|FG000|Overall Study|Symptomatic Deterioration|0|||
33169295|NCT02323113|100525691|FG001|Overall Study|Symptomatic Deterioration|0|||
33260883|NCT00366249|100856459|FG000|Overall Study|Most due to osteomylitis status|31|||
33260884|NCT00366249|100856460|FG001|Overall Study|Most due to osteomylitis status|20|||
33260885|NCT00249769|100856461|FG000|Overall Study|Withdrawal by Subject|1|||
33260886|NCT00249769|100856462|FG001|Overall Study|Withdrawal by Subject|10|||
33260887|NCT00249769|100856463|FG002|Overall Study|Withdrawal by Subject|6|||
33260888|NCT00249769|100856461|FG000|Overall Study|Migration from Study Area|1|||
33260889|NCT00249769|100856462|FG001|Overall Study|Migration from Study Area|3|||
33260890|NCT00249769|100856463|FG002|Overall Study|Migration from Study Area|14|||
33260891|NCT00249769|100856461|FG000|Overall Study|Miscellaneous|0|||
33169296|NCT02323113|100525692|FG002|Overall Study|Symptomatic Deterioration|1|||
33169297|NCT02323113|100525693|FG003|Overall Study|Symptomatic Deterioration|0|||
33260892|NCT00249769|100856462|FG001|Overall Study|Miscellaneous|2|||
33260893|NCT00249769|100856463|FG002|Overall Study|Miscellaneous|2|||
33449922|NCT03713086|101538654|FG000|Overall Study|Lost to Follow-up|0|||
33169298|NCT02323113|100525694|FG004|Overall Study|Symptomatic Deterioration|1|||
33169299|NCT02323113|100525695|FG005|Overall Study|Symptomatic Deterioration|0|||
33260894|NCT00249769|100856461|FG000|Overall Study|Adverse Event|0|||
33260895|NCT00249769|100856462|FG001|Overall Study|Adverse Event|0|||
33260896|NCT00249769|100856463|FG002|Overall Study|Adverse Event|1|||
33169300|NCT02323113|100525696|FG006|Overall Study|Symptomatic Deterioration|0|||
33169301|NCT02323113|100525697|FG007|Overall Study|Symptomatic Deterioration|0|||
33169302|NCT02323113|100525690|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
33169303|NCT02323113|100525691|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
33169304|NCT02323113|100525692|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
33169305|NCT02323113|100525693|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
33169306|NCT02323113|100525694|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
33169307|NCT02323113|100525695|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
33169308|NCT02323113|100525696|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
33169309|NCT02323113|100525697|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
33169310|NCT02323113|100525690|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
33169311|NCT02323113|100525691|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
33169312|NCT02323113|100525692|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
33169313|NCT02323113|100525693|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
33260897|NCT00249769|100856461|FG000|Overall Study|Physician Decision|0|||
33260898|NCT00249769|100856462|FG001|Overall Study|Physician Decision|0|||
33260899|NCT00249769|100856463|FG002|Overall Study|Physician Decision|2|||
33260900|NCT00249769|100856461|FG000|Overall Study|Lost to Follow-up|0|||
33260901|NCT00249769|100856462|FG001|Overall Study|Lost to Follow-up|0|||
33260902|NCT00249769|100856463|FG002|Overall Study|Lost to Follow-up|3|||
33260903|NCT00988858|100856468|FG000|Overall Study|Adverse Event|7|||
33260904|NCT00988858|100856468|FG000|Overall Study|Death|1|||
33260905|NCT00988858|100856468|FG000|Overall Study|Physician Decision|1|||
33260906|NCT00988858|100856468|FG000|Overall Study|Sponsor Decision|1|||
33260907|NCT01619410|100856469|FG000|Overall Study|Lost to Follow-up|7|||
33260908|NCT01619410|100856470|FG001|Overall Study|Lost to Follow-up|4|||
33260909|NCT02891915|100856475|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
33260910|NCT02891915|100856476|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
33260911|NCT02891915|100856475|FG000|Overall Study|Withdrawal by Subject|3|||
33449923|NCT03713086|101538655|FG001|Overall Study|Lost to Follow-up|1|||
33449924|NCT03713086|101538656|FG002|Overall Study|Lost to Follow-up|0|||
33449925|NCT03713086|101538657|FG003|Overall Study|Lost to Follow-up|1|||
33449926|NCT03199963|101538666|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
33449927|NCT03199963|101538667|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
33449928|NCT03199963|101538666|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
33449929|NCT03199963|101538667|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
33449930|NCT03199963|101538666|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
33449931|NCT03199963|101538667|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
33449932|NCT03199963|101538666|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
33449933|NCT03199963|101538667|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
33449934|NCT03199963|101538666|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
33489734|NCT02899962|101686773|FG001|Maintenance Phase|Lack of Efficacy|20|||
33449935|NCT03199963|101538667|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
33449936|NCT03199963|101538666|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
33449937|NCT03199963|101538667|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
33449938|NCT01340495|101538668|FG000|Overall Study|Withdrawal by Subject|1|||
33449939|NCT00984022|101538670|FG000|Overall Study|Lost to Follow-up|10|||
33449940|NCT00984022|101538671|FG001|Overall Study|Lost to Follow-up|14|||
33449941|NCT01857934|101538672|FG000|Overall Study|Relapse or progression|2|||
33449942|NCT01857934|101538672|FG000|Overall Study|Unacceptable toxicity|3|||
33449943|NCT01857934|101538672|FG000|Overall Study|Unwillingness or inability to comply|2|||
33449944|NCT01857934|101538672|FG000|Overall Study|Physician Decision|3|||
33449945|NCT03606174|101538675|FG000|Overall Study|Death|37|||
33449946|NCT03606174|101538676|FG001|Overall Study|Death|15|||
33449947|NCT03606174|101538677|FG002|Overall Study|Death|15|||
33449948|NCT03606174|101538678|FG003|Overall Study|Death|7|||
33449949|NCT03606174|101538679|FG004|Overall Study|Death|35|||
33449950|NCT03606174|101538680|FG005|Overall Study|Death|12|||
33449951|NCT03606174|101538681|FG006|Overall Study|Death|35|||
33449952|NCT03606174|101538682|FG007|Overall Study|Death|8|||
33449953|NCT03606174|101538683|FG008|Overall Study|Death|5|||
33449954|NCT03606174|101538684|FG009|Overall Study|Death|3|||
33449955|NCT03606174|101538685|FG010|Overall Study|Death|0|||
33449956|NCT03606174|101538675|FG000|Overall Study|Lost to Follow-up|0|||
33449957|NCT03606174|101538676|FG001|Overall Study|Lost to Follow-up|0|||
33449958|NCT03606174|101538677|FG002|Overall Study|Lost to Follow-up|0|||
33449959|NCT03606174|101538678|FG003|Overall Study|Lost to Follow-up|0|||
33449960|NCT03606174|101538679|FG004|Overall Study|Lost to Follow-up|1|||
33449961|NCT03606174|101538680|FG005|Overall Study|Lost to Follow-up|1|||
33449962|NCT03606174|101538681|FG006|Overall Study|Lost to Follow-up|0|||
33449963|NCT03606174|101538682|FG007|Overall Study|Lost to Follow-up|0|||
33449964|NCT03606174|101538683|FG008|Overall Study|Lost to Follow-up|0|||
33449965|NCT03606174|101538684|FG009|Overall Study|Lost to Follow-up|0|||
33449966|NCT03606174|101538685|FG010|Overall Study|Lost to Follow-up|0|||
33449967|NCT03606174|101538675|FG000|Overall Study|Withdrawal by Subject|6|||
33449968|NCT03606174|101538676|FG001|Overall Study|Withdrawal by Subject|0|||
33449969|NCT03606174|101538677|FG002|Overall Study|Withdrawal by Subject|0|||
33449970|NCT03606174|101538678|FG003|Overall Study|Withdrawal by Subject|1|||
33449971|NCT03606174|101538679|FG004|Overall Study|Withdrawal by Subject|2|||
33449972|NCT03606174|101538680|FG005|Overall Study|Withdrawal by Subject|1|||
33449973|NCT03606174|101538681|FG006|Overall Study|Withdrawal by Subject|4|||
33449974|NCT03606174|101538682|FG007|Overall Study|Withdrawal by Subject|0|||
33169314|NCT02323113|100525694|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
33169315|NCT02323113|100525695|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
33169316|NCT02323113|100525696|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
33169317|NCT02323113|100525697|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
33169318|NCT00299975|100525702|FG000|Overall Study|Adverse Event|1|||
33169319|NCT00299975|100525703|FG001|Overall Study|Adverse Event|0|||
33169320|NCT00299975|100525704|FG002|Overall Study|Adverse Event|2|||
33169321|NCT00299975|100525702|FG000|Overall Study|Pregnancy|0|||
33169322|NCT00299975|100525703|FG001|Overall Study|Pregnancy|0|||
33169323|NCT00299975|100525704|FG002|Overall Study|Pregnancy|1|||
33169324|NCT00299975|100525702|FG000|Overall Study|Lack of Efficacy|1|||
33169325|NCT00299975|100525703|FG001|Overall Study|Lack of Efficacy|0|||
33169326|NCT00299975|100525704|FG002|Overall Study|Lack of Efficacy|1|||
33169327|NCT00299975|100525702|FG000|Overall Study|Lost to Follow-up|1|||
33169328|NCT00299975|100525703|FG001|Overall Study|Lost to Follow-up|0|||
33169329|NCT00299975|100525704|FG002|Overall Study|Lost to Follow-up|0|||
33169330|NCT00299975|100525702|FG000|Overall Study|Withdrawal by Subject|0|||
33169331|NCT00299975|100525703|FG001|Overall Study|Withdrawal by Subject|1|||
33169332|NCT00299975|100525704|FG002|Overall Study|Withdrawal by Subject|3|||
33169333|NCT00299975|100525702|FG000|Overall Study|Physician Decision|0|||
33169334|NCT00299975|100525703|FG001|Overall Study|Physician Decision|0|||
33169335|NCT00299975|100525704|FG002|Overall Study|Physician Decision|1|||
33169336|NCT03098550|100525705|FG000|Overall Study|Disease Progression|30|||
33169337|NCT03098550|100525706|FG001|Overall Study|Disease Progression|19|||
33169338|NCT03098550|100525707|FG002|Overall Study|Disease Progression|41|||
33169339|NCT03098550|100525705|FG000|Overall Study|Study Drug Toxicity|2|||
33169340|NCT03098550|100525706|FG001|Overall Study|Study Drug Toxicity|1|||
33169341|NCT03098550|100525707|FG002|Overall Study|Study Drug Toxicity|0|||
33169342|NCT03098550|100525705|FG000|Overall Study|Death|1|||
33169343|NCT03098550|100525706|FG001|Overall Study|Death|0|||
33169344|NCT03098550|100525707|FG002|Overall Study|Death|0|||
33169345|NCT03098550|100525705|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
33169346|NCT03098550|100525706|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
33169347|NCT03098550|100525707|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
33169348|NCT03098550|100525705|FG000|Overall Study|Administrative reason by sponsor|0|||
33169349|NCT03098550|100525706|FG001|Overall Study|Administrative reason by sponsor|0|||
33169350|NCT03098550|100525707|FG002|Overall Study|Administrative reason by sponsor|1|||
33169351|NCT03098550|100525705|FG000|Overall Study|Other reasons|2|||
33169352|NCT03098550|100525706|FG001|Overall Study|Other reasons|0|||
33169353|NCT03098550|100525707|FG002|Overall Study|Other reasons|0|||
33169354|NCT01673867|100525708|FG000|Randomization|Adverse event unrelated to study drug|1|||
33169355|NCT01673867|100525709|FG001|Randomization|Adverse event unrelated to study drug|0|||
33169356|NCT01673867|100525708|FG000|Randomization|Participant request to discontinue study treatment|0|||
33169357|NCT01673867|100525709|FG001|Randomization|Participant request to discontinue study treatment|4|||
33169358|NCT01673867|100525708|FG000|Randomization|Withdrawal by participant|0|||
33169359|NCT01673867|100525709|FG001|Randomization|Withdrawal by participant|12|||
33169360|NCT01673867|100525708|FG000|Randomization|Lost to Follow-up|0|||
33169361|NCT01673867|100525709|FG001|Randomization|Lost to Follow-up|1|||
33169362|NCT01673867|100525708|FG000|Randomization|Participant no longer meets study criteria|4|||
33169363|NCT01673867|100525709|FG001|Randomization|Participant no longer meets study criteria|5|||
33169364|NCT01673867|100525708|FG000|Treatment|Disease Progression|208|||
33169365|NCT01673867|100525709|FG001|Treatment|Disease Progression|178|||
33169366|NCT01673867|100525708|FG000|Treatment|Study Drug Toxicity|23|||
33169367|NCT01673867|100525709|FG001|Treatment|Study Drug Toxicity|43|||
33169368|NCT01673867|100525708|FG000|Treatment|Death|2|||
33169369|NCT01673867|100525709|FG001|Treatment|Death|3|||
33169370|NCT01673867|100525708|FG000|Treatment|Adverse event unrelated to study drug|23|||
33169371|NCT01673867|100525709|FG001|Treatment|Adverse event unrelated to study drug|10|||
33169372|NCT01673867|100525708|FG000|Treatment|Participant request to discontinue study treatment|7|||
33169373|NCT01673867|100525709|FG001|Treatment|Participant request to discontinue study treatment|17|||
33169374|NCT01673867|100525708|FG000|Treatment|Withdrawal by participant|5|||
33169375|NCT01673867|100525709|FG001|Treatment|Withdrawal by participant|5|||
33169376|NCT01673867|100525708|FG000|Treatment|Maximum clinical benefit|1|||
33169377|NCT01673867|100525709|FG001|Treatment|Maximum clinical benefit|10|||
33449975|NCT03606174|101538683|FG008|Overall Study|Withdrawal by Subject|0|||
33169378|NCT01673867|100525708|FG000|Treatment|Participant no longer meets study criteria|2|||
33169379|NCT01673867|100525709|FG001|Treatment|Participant no longer meets study criteria|0|||
33169380|NCT01673867|100525708|FG000|Treatment|Administrative reason by sponsor|3|||
33169381|NCT01673867|100525709|FG001|Treatment|Administrative reason by sponsor|0|||
33169382|NCT01673867|100525708|FG000|Treatment|Other reason|11|||
33169383|NCT01673867|100525709|FG001|Treatment|Other reason|2|||
33169384|NCT01874054|100525710|FG000|Overall Study|Withdrawal by Subject|3|||
33169385|NCT01874054|100525710|FG000|Overall Study|Study Termination by Sponsor|42|||
33169386|NCT01874054|100525710|FG000|Overall Study|Lost to Follow-up|5|||
33169387|NCT01874054|100525710|FG000|Overall Study|Death|5|||
33169388|NCT01433991|100525712|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
33169389|NCT01433991|100525713|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
33169390|NCT01433991|100525714|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
33169391|NCT01433991|100525715|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
33169392|NCT01433991|100525712|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
33169393|NCT01433991|100525713|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
33169394|NCT01433991|100525714|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
33169395|NCT01433991|100525715|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
33169396|NCT01433991|100525712|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
33169397|NCT01433991|100525713|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
33169398|NCT01433991|100525714|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
33169399|NCT01433991|100525715|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
33169400|NCT01433991|100525712|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
33169401|NCT01433991|100525713|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
33169402|NCT01433991|100525714|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
33169403|NCT01433991|100525715|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
33169404|NCT01433991|100525712|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
33169405|NCT01433991|100525713|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
33169406|NCT01433991|100525714|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
33169407|NCT01433991|100525715|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
33169408|NCT01433991|100525712|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
33169409|NCT01433991|100525713|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
33169410|NCT01433991|100525714|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
33169411|NCT01433991|100525715|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
33169412|NCT01433991|100525712|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
33169413|NCT01433991|100525713|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
33169414|NCT01433991|100525714|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
33169415|NCT01433991|100525715|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
33169416|NCT04342897|100525716|FG000|Overall Study|Death|7|||
33169417|NCT04342897|100525717|FG001|Overall Study|Death|4|||
33169418|NCT04342897|100525716|FG000|Overall Study|Lost to Follow-up|6|||
33169419|NCT04342897|100525717|FG001|Overall Study|Lost to Follow-up|6|||
33169420|NCT04342897|100525716|FG000|Overall Study|Withdrawal by Subject|1|||
33169421|NCT04342897|100525717|FG001|Overall Study|Withdrawal by Subject|2|||
33169422|NCT01384760|100525720|FG000|Overall Study|Lost to Follow-up|0|||
33169423|NCT01384760|100525721|FG001|Overall Study|Lost to Follow-up|6|||
33169424|NCT01384760|100525720|FG000|Overall Study|Protocol Violation|16|||
33169425|NCT01384760|100525721|FG001|Overall Study|Protocol Violation|0|||
33169426|NCT00023764|100525728|FG000|Overall Study|Other|1|||
33169427|NCT00023764|100525728|FG000|Overall Study|Adverse Event|4|||
33169428|NCT00023764|100525728|FG000|Overall Study|Withdrawal by Subject|1|||
33169429|NCT00023764|100525728|FG000|Overall Study|Progression of disease|6|||
33169430|NCT00023764|100525728|FG000|Overall Study|patient received other treatment|1|||
33169431|NCT00023764|100525728|FG000|Overall Study|delay in obtaining staging images|1|||
33169432|NCT00056316|100525729|FG000|Overall Study|Withdrawal by Subject|2|||
33169433|NCT00056316|100525730|FG001|Overall Study|Withdrawal by Subject|2|||
33169434|NCT00056316|100525729|FG000|Overall Study|Death/NH placement of pt|1|||
33169435|NCT00056316|100525730|FG001|Overall Study|Death/NH placement of pt|1|||
33169436|NCT04980040|100525731|FG000|Overall Study|Violated the Inclusion Criteria|260|||
33169437|NCT04980040|100525731|FG000|Overall Study|Violated the Administration & Dosage|225|||
33169438|NCT04980040|100525731|FG000|Overall Study|Lost to Safety-Follow-up|4|||
33169439|NCT04980040|100525731|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
33169440|NCT02088047|100525757|FG000|Overall Study|Withdrawal by Subject|1|||
33169441|NCT02088047|100525758|FG001|Overall Study|Withdrawal by Subject|0|||
33169442|NCT01927367|100525759|FG000|Overall Study|Withdrawal by Subject|7|||
33169443|NCT01927367|100525760|FG001|Overall Study|Withdrawal by Subject|4|||
33169444|NCT01927367|100525759|FG000|Overall Study|No baseline data|0|||
33169445|NCT01927367|100525760|FG001|Overall Study|No baseline data|1|||
33169446|NCT01654536|100525761|FG000|Overall Study|Lost to Follow-up|5|||
33169447|NCT01654536|100525762|FG001|Overall Study|Lost to Follow-up|5|||
33169448|NCT01654536|100525761|FG000|Overall Study|Physician Decision|12|||
33169449|NCT01654536|100525762|FG001|Overall Study|Physician Decision|8|||
33169450|NCT01654536|100525761|FG000|Overall Study|Withdrawal by Subject|27|||
33169451|NCT01654536|100525762|FG001|Overall Study|Withdrawal by Subject|25|||
33260912|NCT02891915|100856476|FG001|Overall Study|Withdrawal by Subject|3|||
33260913|NCT02891915|100856475|FG000|Overall Study|Became Ineligible After Enrollment|2|||
33169452|NCT03902574|100525763|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
33260914|NCT02891915|100856476|FG001|Overall Study|Became Ineligible After Enrollment|1|||
33260915|NCT02891915|100856475|FG000|Overall Study|Lost to Follow-up|1|||
33169453|NCT03902574|100525764|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
33169454|NCT03902574|100525765|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
33169455|NCT01191801|100525767|FG000|Overall Study|Death|36|||
33169456|NCT01191801|100525768|FG001|Overall Study|Death|12|||
33169457|NCT01191801|100525767|FG000|Overall Study|Lack of Efficacy|176|||
33169458|NCT01191801|100525768|FG001|Overall Study|Lack of Efficacy|258|||
33169459|NCT01191801|100525767|FG000|Overall Study|Adverse Event|9|||
33169460|NCT01191801|100525768|FG001|Overall Study|Adverse Event|8|||
33169461|NCT01191801|100525767|FG000|Overall Study|Protocol Violation|2|||
33260916|NCT02891915|100856476|FG001|Overall Study|Lost to Follow-up|4|||
33260917|NCT02891915|100856475|FG000|Overall Study|Physician Decision|1|||
33260918|NCT02891915|100856476|FG001|Overall Study|Physician Decision|0|||
33260919|NCT00792636|100856480|FG000|Overall Study|Protocol Violation|17|||
33260920|NCT00792636|100856481|FG001|Overall Study|Protocol Violation|23|||
33260921|NCT00792636|100856482|FG002|Overall Study|Protocol Violation|20|||
33260922|NCT00792636|100856480|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
33260923|NCT00792636|100856481|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
33260924|NCT00792636|100856482|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
33260925|NCT00792636|100856480|FG000|Overall Study|Lost to Follow-up|13|||
33260926|NCT00792636|100856481|FG001|Overall Study|Lost to Follow-up|19|||
33260927|NCT00792636|100856482|FG002|Overall Study|Lost to Follow-up|14|||
33260928|NCT00792636|100856480|FG000|Overall Study|Withdrew Consent|10|||
33260929|NCT00792636|100856481|FG001|Overall Study|Withdrew Consent|13|||
33260930|NCT00792636|100856482|FG002|Overall Study|Withdrew Consent|9|||
33260931|NCT00792636|100856480|FG000|Overall Study|Lack of Efficacy|3|||
33260932|NCT00792636|100856481|FG001|Overall Study|Lack of Efficacy|4|||
33260933|NCT00792636|100856482|FG002|Overall Study|Lack of Efficacy|13|||
33260934|NCT00792636|100856480|FG000|Overall Study|Adverse Event|4|||
33260935|NCT00792636|100856481|FG001|Overall Study|Adverse Event|2|||
33260936|NCT00792636|100856482|FG002|Overall Study|Adverse Event|3|||
33260937|NCT00792636|100856480|FG000|Overall Study|Investigator Discretion|2|||
33260938|NCT00792636|100856481|FG001|Overall Study|Investigator Discretion|0|||
33260939|NCT00792636|100856482|FG002|Overall Study|Investigator Discretion|2|||
33260940|NCT03951805|100856483|FG000|Overall Study|Adverse Event|1|||
33260941|NCT03951805|100856484|FG001|Overall Study|Adverse Event|0|||
33260942|NCT03951805|100856485|FG002|Overall Study|Adverse Event|0|||
33260943|NCT03951805|100856486|FG003|Overall Study|Adverse Event|0|||
33449976|NCT03606174|101538684|FG009|Overall Study|Withdrawal by Subject|0|||
33449977|NCT03606174|101538685|FG010|Overall Study|Withdrawal by Subject|1|||
33449978|NCT03606174|101538675|FG000|Overall Study|Study Terminated by Sponsor|5|||
33169462|NCT01191801|100525768|FG001|Overall Study|Protocol Violation|4|||
33260944|NCT00073749|100856487|FG000|Overall Study|Disease Progression|2|||
33260945|NCT00073749|100856488|FG001|Overall Study|Disease Progression|0|||
33260946|NCT00073749|100856489|FG002|Overall Study|Disease Progression|3|||
33260947|NCT00073749|100856490|FG003|Overall Study|Disease Progression|2|||
33449979|NCT03606174|101538676|FG001|Overall Study|Study Terminated by Sponsor|7|||
33449980|NCT03606174|101538677|FG002|Overall Study|Study Terminated by Sponsor|3|||
33449981|NCT03606174|101538678|FG003|Overall Study|Study Terminated by Sponsor|0|||
33449982|NCT03606174|101538679|FG004|Overall Study|Study Terminated by Sponsor|11|||
33449983|NCT03606174|101538680|FG005|Overall Study|Study Terminated by Sponsor|6|||
33449984|NCT03606174|101538681|FG006|Overall Study|Study Terminated by Sponsor|12|||
33449985|NCT03606174|101538682|FG007|Overall Study|Study Terminated by Sponsor|1|||
33449986|NCT03606174|101538683|FG008|Overall Study|Study Terminated by Sponsor|3|||
33449987|NCT03606174|101538684|FG009|Overall Study|Study Terminated by Sponsor|1|||
33449988|NCT03606174|101538685|FG010|Overall Study|Study Terminated by Sponsor|2|||
33449989|NCT03606174|101538675|FG000|Overall Study|Miscellaneous|1|||
33449990|NCT03606174|101538676|FG001|Overall Study|Miscellaneous|1|||
33449991|NCT03606174|101538677|FG002|Overall Study|Miscellaneous|0|||
33449992|NCT03606174|101538678|FG003|Overall Study|Miscellaneous|1|||
33449993|NCT03606174|101538679|FG004|Overall Study|Miscellaneous|4|||
33449994|NCT03606174|101538680|FG005|Overall Study|Miscellaneous|7|||
33449995|NCT03606174|101538681|FG006|Overall Study|Miscellaneous|5|||
33449996|NCT03606174|101538682|FG007|Overall Study|Miscellaneous|0|||
33449997|NCT03606174|101538683|FG008|Overall Study|Miscellaneous|0|||
33169463|NCT01191801|100525767|FG000|Overall Study|Physician Decision|47|||
33169464|NCT01191801|100525768|FG001|Overall Study|Physician Decision|24|||
33260948|NCT00073749|100856491|FG004|Overall Study|Disease Progression|3|||
33449998|NCT03606174|101538684|FG009|Overall Study|Miscellaneous|0|||
33449999|NCT03606174|101538685|FG010|Overall Study|Miscellaneous|1|||
33450000|NCT00574847|101538688|FG000|Overall Study|Adverse Event|2|||
33450001|NCT00574847|101538689|FG001|Overall Study|Adverse Event|0|||
33260949|NCT00073749|100856492|FG005|Overall Study|Disease Progression|1|||
33260950|NCT00073749|100856493|FG006|Overall Study|Disease Progression|3|||
33260951|NCT00073749|100856487|FG000|Overall Study|Death|0|||
33260952|NCT00073749|100856488|FG001|Overall Study|Death|1|||
33260953|NCT00073749|100856489|FG002|Overall Study|Death|1|||
33260954|NCT00073749|100856490|FG003|Overall Study|Death|0|||
33260955|NCT00073749|100856491|FG004|Overall Study|Death|0|||
33450002|NCT00574847|101538688|FG000|Overall Study|Death|1|||
33260956|NCT00073749|100856492|FG005|Overall Study|Death|0|||
33260957|NCT00073749|100856493|FG006|Overall Study|Death|29|||
33260958|NCT00073749|100856487|FG000|Overall Study|Adverse Event|0|||
33260959|NCT00073749|100856488|FG001|Overall Study|Adverse Event|3|||
33260960|NCT00073749|100856489|FG002|Overall Study|Adverse Event|6|||
33260961|NCT00073749|100856490|FG003|Overall Study|Adverse Event|4|||
33260962|NCT00073749|100856491|FG004|Overall Study|Adverse Event|2|||
33260963|NCT00073749|100856492|FG005|Overall Study|Adverse Event|1|||
33260964|NCT00073749|100856493|FG006|Overall Study|Adverse Event|0|||
33260965|NCT00073749|100856487|FG000|Overall Study|Physician Decision|0|||
33260966|NCT00073749|100856488|FG001|Overall Study|Physician Decision|0|||
33260967|NCT00073749|100856489|FG002|Overall Study|Physician Decision|1|||
33260968|NCT00073749|100856490|FG003|Overall Study|Physician Decision|0|||
33260969|NCT00073749|100856491|FG004|Overall Study|Physician Decision|0|||
33260970|NCT00073749|100856492|FG005|Overall Study|Physician Decision|2|||
33260971|NCT00073749|100856493|FG006|Overall Study|Physician Decision|0|||
33260972|NCT00073749|100856487|FG000|Overall Study|Withdrawal by Subject|0|||
33260973|NCT00073749|100856488|FG001|Overall Study|Withdrawal by Subject|1|||
33260974|NCT00073749|100856489|FG002|Overall Study|Withdrawal by Subject|0|||
33260975|NCT00073749|100856490|FG003|Overall Study|Withdrawal by Subject|0|||
33260976|NCT00073749|100856491|FG004|Overall Study|Withdrawal by Subject|1|||
33450003|NCT00574847|101538689|FG001|Overall Study|Death|0|||
33450004|NCT00574847|101538688|FG000|Overall Study|Withdrawal by Subject|2|||
33260977|NCT00073749|100856492|FG005|Overall Study|Withdrawal by Subject|0|||
33260978|NCT00073749|100856493|FG006|Overall Study|Withdrawal by Subject|2|||
33260979|NCT00073749|100856487|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
33260980|NCT00073749|100856488|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
33260981|NCT00073749|100856489|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
33450005|NCT00574847|101538689|FG001|Overall Study|Withdrawal by Subject|2|||
33450006|NCT00574847|101538688|FG000|Overall Study|Physician Decision|1|||
33169465|NCT01191801|100525767|FG000|Overall Study|Withdrawal by Subject|1|||
33169466|NCT01191801|100525768|FG001|Overall Study|Withdrawal by Subject|4|||
33169467|NCT01191801|100525767|FG000|Overall Study|Not Provided|45|||
33169468|NCT01191801|100525768|FG001|Overall Study|Not Provided|27|||
33169469|NCT02860169|100525769|FG000|Part A|Withdrawal by Subject|1|||
33169470|NCT02860169|100525769|FG000|Part A|Other (Screening failure)|6|||
33169471|NCT02860169|100525769|FG000|Part A|Other (Survey not completed)|3|||
33169472|NCT02860169|100525769|FG000|Part A|Other (did not completed consent)|1|||
33169473|NCT02860169|100525769|FG000|Part B|Other (Screening failure)|10|||
33169474|NCT02860169|100525769|FG000|Part B|Withdrawal by Subject|1|||
33169475|NCT02860169|100525769|FG000|Part C|Other (Screening failure)|1|||
33169476|NCT01402544|100525770|FG000|Overall Study|Withdrawal by Subject|6|||
33169477|NCT00982878|100525771|FG000|Overall Study|Physician Decision|1|||
33169478|NCT01482884|100525772|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
33169479|NCT01482884|100525773|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
33169480|NCT01482884|100525772|FG000|Overall Study|Protocol Violation|1|||
33169481|NCT01482884|100525773|FG001|Overall Study|Protocol Violation|0|||
33169482|NCT01482884|100525772|FG000|Overall Study|Lost to Follow-up|2|||
33169483|NCT01482884|100525773|FG001|Overall Study|Lost to Follow-up|2|||
33169484|NCT01482884|100525772|FG000|Overall Study|Lack of Efficacy|0|||
33450007|NCT00574847|101538689|FG001|Overall Study|Physician Decision|0|||
33450008|NCT00574847|101538688|FG000|Overall Study|Did not receive medication (declined)|2|||
33450009|NCT00574847|101538689|FG001|Overall Study|Did not receive medication (declined)|5|||
33450010|NCT00841542|101538690|FG000|Period 1|Adverse Event|1|||
33450011|NCT00841542|101538691|FG001|Period 1|Adverse Event|0|||
33450012|NCT03122535|101538692|FG000|Overall Study|Lost to Follow-up|68|||
33450013|NCT03122535|101538693|FG001|Overall Study|Lost to Follow-up|68|||
33450014|NCT03122535|101538692|FG000|Overall Study|Physician Decision|3|||
33450015|NCT03122535|101538693|FG001|Overall Study|Physician Decision|3|||
33450016|NCT03122535|101538692|FG000|Overall Study|Withdrawal by Subject|2|||
33450017|NCT03122535|101538693|FG001|Overall Study|Withdrawal by Subject|2|||
33450018|NCT02311361|101538696|FG000|Overall Study|Did not receive treatment|0|||
33450019|NCT02311361|101538697|FG001|Overall Study|Did not receive treatment|1|||
33450020|NCT02311361|101538698|FG002|Overall Study|Did not receive treatment|0|||
33450021|NCT02311361|101538699|FG003|Overall Study|Did not receive treatment|1|||
33450022|NCT02588339|101538700|FG000|Overall Study|Withdrawal by Subject|1|||
33450023|NCT02588339|101538700|FG000|Overall Study|GVHD Progression prior to treatment|2|||
33450024|NCT00463684|101538705|FG000|Overall Study|Withdrawal by Subject|1|||
33450025|NCT00463684|101538705|FG000|Overall Study|Lost to Follow-up|3|||
33450026|NCT04547192|101538708|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
33450027|NCT04547192|101538709|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
33450028|NCT04547192|101538710|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
33450029|NCT04547192|101538711|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
33450030|NCT04547192|101538708|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
33450031|NCT04547192|101538709|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
33169485|NCT01482884|100525773|FG001|Overall Study|Lack of Efficacy|1|||
33169486|NCT01482884|100525772|FG000|Overall Study|Adverse Event|2|||
33169487|NCT01482884|100525773|FG001|Overall Study|Adverse Event|1|||
33169488|NCT01482884|100525772|FG000|Overall Study|Withdrawal by Subject|8|||
33169489|NCT01482884|100525773|FG001|Overall Study|Withdrawal by Subject|13|||
33450032|NCT04547192|101538710|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
33450033|NCT04547192|101538711|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
33450034|NCT04547192|101538708|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
33450035|NCT04547192|101538709|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
33450036|NCT04547192|101538710|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
33450037|NCT04547192|101538711|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
33450038|NCT04547192|101538708|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
33450039|NCT04547192|101538709|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
33450040|NCT04547192|101538710|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
33450041|NCT04547192|101538711|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
33169490|NCT02010775|100525776|FG000|Overall Study|Adverse Event|0|||
33450042|NCT04547192|101538708|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
33450043|NCT04547192|101538709|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
33450044|NCT04547192|101538710|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
33450045|NCT04547192|101538711|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
33450046|NCT00429416|101538712|FG000|Overall Study|Death|1|||
33450047|NCT05746455|101538713|FG000|Overall Study|Discharged from Clinical Service|1|||
33450048|NCT05746455|101538713|FG000|Overall Study|Lost to Follow-up|1|||
33169491|NCT02010775|100525777|FG001|Overall Study|Adverse Event|0|||
33169492|NCT02010775|100525778|FG002|Overall Study|Adverse Event|0|||
33169493|NCT02010775|100525779|FG003|Overall Study|Adverse Event|0|||
33169494|NCT02010775|100525780|FG004|Overall Study|Adverse Event|1|||
33169495|NCT02010775|100525776|FG000|Overall Study|Pregnancy|0|||
33169496|NCT02010775|100525777|FG001|Overall Study|Pregnancy|0|||
33169497|NCT02010775|100525778|FG002|Overall Study|Pregnancy|2|||
33169498|NCT02010775|100525779|FG003|Overall Study|Pregnancy|0|||
33169499|NCT02010775|100525780|FG004|Overall Study|Pregnancy|0|||
33169500|NCT02010775|100525776|FG000|Overall Study|Lost to Follow-up|2|||
33169501|NCT02010775|100525777|FG001|Overall Study|Lost to Follow-up|0|||
33169502|NCT02010775|100525778|FG002|Overall Study|Lost to Follow-up|0|||
33169503|NCT02010775|100525779|FG003|Overall Study|Lost to Follow-up|1|||
33169504|NCT02010775|100525780|FG004|Overall Study|Lost to Follow-up|1|||
33169505|NCT02010775|100525776|FG000|Overall Study|Personal Reasons|3|||
33169506|NCT02010775|100525777|FG001|Overall Study|Personal Reasons|3|||
33169507|NCT02010775|100525778|FG002|Overall Study|Personal Reasons|1|||
33450049|NCT00835666|101538716|FG000|Washout|Protocol Violation|1|||
33169508|NCT02010775|100525779|FG003|Overall Study|Personal Reasons|2|||
33169509|NCT02010775|100525780|FG004|Overall Study|Personal Reasons|4|||
33450050|NCT00835666|101538717|FG001|Washout|Protocol Violation|0|||
33450051|NCT00835666|101538716|FG000|Washout|Withdrawal by Subject|1|||
33450052|NCT00835666|101538717|FG001|Washout|Withdrawal by Subject|0|||
33450053|NCT01564394|101538718|FG000|Overall Study|Withdrawal by Subject|6|||
33450054|NCT01564394|101538719|FG001|Overall Study|Withdrawal by Subject|10|||
33450055|NCT02257528|101538720|FG000|Overall Study|Never received study treatment|1|||
33450056|NCT02151981|101538721|FG000|Overall Study|Death|184|||
33450057|NCT02151981|101538722|FG001|Overall Study|Death|88|||
33450058|NCT02151981|101538721|FG000|Overall Study|Lost to Follow-up|7|||
33450059|NCT02151981|101538722|FG001|Overall Study|Lost to Follow-up|1|||
33450060|NCT02151981|101538721|FG000|Overall Study|Withdrawal by Subject|27|||
33450061|NCT02151981|101538722|FG001|Overall Study|Withdrawal by Subject|21|||
33450062|NCT02151981|101538721|FG000|Overall Study|Ongoing Study at Data Cut-off|60|||
33450063|NCT02151981|101538722|FG001|Overall Study|Ongoing Study at Data Cut-off|27|||
33450064|NCT02151981|101538721|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33450065|NCT02151981|101538722|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
33450066|NCT02151981|101538721|FG000|Overall Study|Patient had no clinical benefit|1|||
33450067|NCT02151981|101538722|FG001|Overall Study|Patient had no clinical benefit|0|||
33450068|NCT02151981|101538721|FG000|Overall Study|Unwilling to continue to follow up visit|0|||
33450069|NCT02151981|101538722|FG001|Overall Study|Unwilling to continue to follow up visit|1|||
33450070|NCT02151981|101538721|FG000|Overall Study|Study terminated|0|||
33450071|NCT02151981|101538722|FG001|Overall Study|Study terminated|1|||
33450072|NCT03249454|101538723|FG000|Overall Study|Withdrawal by Subject|0|||
33450073|NCT03249454|101538724|FG001|Overall Study|Withdrawal by Subject|0|||
33450074|NCT03249454|101538725|FG002|Overall Study|Withdrawal by Subject|0|||
33450075|NCT03249454|101538726|FG003|Overall Study|Withdrawal by Subject|0|||
33450076|NCT03249454|101538727|FG004|Overall Study|Withdrawal by Subject|0|||
33450077|NCT03249454|101538728|FG005|Overall Study|Withdrawal by Subject|0|||
33450078|NCT03249454|101538729|FG006|Overall Study|Withdrawal by Subject|0|||
33450079|NCT03249454|101538730|FG007|Overall Study|Withdrawal by Subject|0|||
33450080|NCT03249454|101538731|FG008|Overall Study|Withdrawal by Subject|0|||
33450081|NCT03249454|101538732|FG009|Overall Study|Withdrawal by Subject|1|||
33450082|NCT03249454|101538733|FG010|Overall Study|Withdrawal by Subject|1|||
33450083|NCT03285594|101538734|FG000|Overall Study|At the Participant's Own Request|10|||
33450084|NCT03285594|101538735|FG001|Overall Study|At the Participant's Own Request|5|||
33450085|NCT03285594|101538736|FG002|Overall Study|At the Participant's Own Request|21|||
33450086|NCT03285594|101538734|FG000|Overall Study|Adverse Event|2|||
33450087|NCT03285594|101538735|FG001|Overall Study|Adverse Event|2|||
33450088|NCT03285594|101538736|FG002|Overall Study|Adverse Event|6|||
33450089|NCT03285594|101538734|FG000|Overall Study|Poor Compliance to Protocol|0|||
33450090|NCT03285594|101538735|FG001|Overall Study|Poor Compliance to Protocol|0|||
33450091|NCT03285594|101538736|FG002|Overall Study|Poor Compliance to Protocol|1|||
33450092|NCT03285594|101538734|FG000|Overall Study|Lost to Follow-up|0|||
33450093|NCT03285594|101538735|FG001|Overall Study|Lost to Follow-up|0|||
33450094|NCT03285594|101538736|FG002|Overall Study|Lost to Follow-up|1|||
33450095|NCT03285594|101538734|FG000|Overall Study|Reason Not Specified|3|||
33450096|NCT03285594|101538735|FG001|Overall Study|Reason Not Specified|4|||
33450097|NCT03285594|101538736|FG002|Overall Study|Reason Not Specified|8|||
33450098|NCT02642042|101538737|FG000|Overall Study|Adverse Event|22|||
33450099|NCT02642042|101538737|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
33450100|NCT02642042|101538737|FG000|Overall Study|Progression/Relapse|28|||
33450101|NCT02642042|101538737|FG000|Overall Study|Death|1|||
33450102|NCT02642042|101538737|FG000|Overall Study|Not Protocol Specified|2|||
33450103|NCT03343535|101538745|FG000|Overall Study|Lost to Follow-up|1|||
33450104|NCT03343535|101538745|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
33169510|NCT00618072|100525781|FG000|Overall Study|Lost to Follow-up|2|||
33169511|NCT00618072|100525782|FG001|Overall Study|Lost to Follow-up|0|||
33169512|NCT00618072|100525783|FG002|Overall Study|Lost to Follow-up|3|||
33169513|NCT00618072|100525781|FG000|Overall Study|Physician Decision|0|||
33169514|NCT00618072|100525782|FG001|Overall Study|Physician Decision|1|||
33169515|NCT00618072|100525783|FG002|Overall Study|Physician Decision|1|||
33169516|NCT02170298|100525784|FG000|Overall Study|Withdrawal by Subject|0|||
33169517|NCT02170298|100525785|FG001|Overall Study|Withdrawal by Subject|1|||
33169518|NCT02170298|100525784|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
33169519|NCT02170298|100525785|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
33169520|NCT02151591|100528750|FG000|Overall Study|Lost to Follow-up|6|||
33169521|NCT02151591|100528751|FG001|Overall Study|Lost to Follow-up|3|||
33169522|NCT01224431|100528755|FG000|Overall Study|not randomized|0|||
33169523|NCT01224431|100528756|FG001|Overall Study|not randomized|4|||
33169524|NCT01224431|100528755|FG000|Overall Study|no video record|0|||
33169525|NCT01224431|100528756|FG001|Overall Study|no video record|1|||
33169526|NCT03462082|100528757|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
33169527|NCT03462082|100528758|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
33169528|NCT03462082|100528759|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
33169529|NCT03462082|100528760|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
33169530|NCT03462082|100528761|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
33169531|NCT03462082|100528762|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
33169532|NCT03462082|100528763|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
33169533|NCT03462082|100528764|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
33169534|NCT03292588|100528765|FG000|Overall Study|Death|1|||
33169535|NCT03292588|100528766|FG001|Overall Study|Death|0|||
33169536|NCT03292588|100528765|FG000|Overall Study|Lost to Follow-up|12|||
33169537|NCT03292588|100528766|FG001|Overall Study|Lost to Follow-up|16|||
33169538|NCT03292588|100528765|FG000|Overall Study|Physician Decision|0|||
33169539|NCT03292588|100528766|FG001|Overall Study|Physician Decision|1|||
33169540|NCT03292588|100528765|FG000|Overall Study|Withdrawal by Subject|4|||
33169541|NCT03292588|100528766|FG001|Overall Study|Withdrawal by Subject|4|||
33169542|NCT03292588|100528765|FG000|Overall Study|Move out of town|1|||
33169543|NCT03292588|100528766|FG001|Overall Study|Move out of town|0|||
33169544|NCT03292588|100528765|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
33169545|NCT03292588|100528766|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
33169546|NCT01658072|100528768|FG000|Overall Study|Protocol Violation|4|||
33169547|NCT01658072|100528769|FG001|Overall Study|Protocol Violation|2|||
33169548|NCT02132130|100528771|FG000|Overall Study|Lost to Follow-up|0|||
33169549|NCT02132130|100528772|FG001|Overall Study|Lost to Follow-up|2|||
33169550|NCT02132130|100528773|FG002|Overall Study|Lost to Follow-up|0|||
33169551|NCT02132130|100528774|FG003|Overall Study|Lost to Follow-up|0|||
33169552|NCT02132130|100528771|FG000|Overall Study|Withdrawal by Subject|0|||
33169553|NCT02132130|100528772|FG001|Overall Study|Withdrawal by Subject|0|||
33169554|NCT02132130|100528773|FG002|Overall Study|Withdrawal by Subject|0|||
33169555|NCT02132130|100528774|FG003|Overall Study|Withdrawal by Subject|1|||
33169556|NCT00203996|100528775|FG000|Overall Study|Lost to Follow-up|0|||
33169557|NCT00203996|100528776|FG001|Overall Study|Lost to Follow-up|0|||
33169558|NCT00203996|100528777|FG002|Overall Study|Lost to Follow-up|0|||
33169559|NCT00203996|100528778|FG003|Overall Study|Lost to Follow-up|1|||
33169560|NCT00203996|100528779|FG004|Overall Study|Lost to Follow-up|0|||
33169561|NCT00203996|100528780|FG005|Overall Study|Lost to Follow-up|0|||
33169562|NCT00203996|100528781|FG006|Overall Study|Lost to Follow-up|0|||
33169563|NCT00203996|100528782|FG007|Overall Study|Lost to Follow-up|0|||
33169564|NCT00203996|100528783|FG008|Overall Study|Lost to Follow-up|0|||
33169565|NCT00203996|100528784|FG009|Overall Study|Lost to Follow-up|0|||
33169566|NCT00203996|100528775|FG000|Overall Study|Protocol Violation|0|||
33169567|NCT00203996|100528776|FG001|Overall Study|Protocol Violation|0|||
33169568|NCT00203996|100528777|FG002|Overall Study|Protocol Violation|0|||
33169569|NCT00203996|100528778|FG003|Overall Study|Protocol Violation|6|||
33169570|NCT00203996|100528779|FG004|Overall Study|Protocol Violation|1|||
33169571|NCT00203996|100528780|FG005|Overall Study|Protocol Violation|0|||
33169572|NCT00203996|100528781|FG006|Overall Study|Protocol Violation|0|||
33169573|NCT00203996|100528782|FG007|Overall Study|Protocol Violation|0|||
33450105|NCT03343535|101538745|FG000|Overall Study|Death|12|||
33450106|NCT01444378|101538747|FG000|Overall Study|Lost to Follow-up|1|||
33450107|NCT01444378|101538747|FG000|Overall Study|Withdrawal by Subject|1|||
33169574|NCT00203996|100528783|FG008|Overall Study|Protocol Violation|0|||
33169575|NCT00203996|100528784|FG009|Overall Study|Protocol Violation|0|||
33169576|NCT00203996|100528775|FG000|Overall Study|Physician Decision|0|||
33169577|NCT00203996|100528776|FG001|Overall Study|Physician Decision|0|||
33169578|NCT00203996|100528777|FG002|Overall Study|Physician Decision|0|||
33169579|NCT00203996|100528778|FG003|Overall Study|Physician Decision|2|||
33169580|NCT00203996|100528779|FG004|Overall Study|Physician Decision|0|||
33169581|NCT00203996|100528780|FG005|Overall Study|Physician Decision|0|||
33169582|NCT00203996|100528781|FG006|Overall Study|Physician Decision|0|||
33169583|NCT00203996|100528782|FG007|Overall Study|Physician Decision|0|||
33169584|NCT00203996|100528783|FG008|Overall Study|Physician Decision|0|||
33450108|NCT01444378|101538747|FG000|Overall Study|Death|3|||
33169585|NCT00203996|100528784|FG009|Overall Study|Physician Decision|1|||
33169586|NCT00203996|100528775|FG000|Overall Study|CPAP machine malfunction|0|||
33169587|NCT00203996|100528776|FG001|Overall Study|CPAP machine malfunction|0|||
33169588|NCT00203996|100528777|FG002|Overall Study|CPAP machine malfunction|0|||
33169589|NCT00203996|100528778|FG003|Overall Study|CPAP machine malfunction|1|||
33169590|NCT00203996|100528779|FG004|Overall Study|CPAP machine malfunction|0|||
33169591|NCT00203996|100528780|FG005|Overall Study|CPAP machine malfunction|0|||
33169592|NCT00203996|100528781|FG006|Overall Study|CPAP machine malfunction|0|||
33169593|NCT00203996|100528782|FG007|Overall Study|CPAP machine malfunction|0|||
33169594|NCT00203996|100528783|FG008|Overall Study|CPAP machine malfunction|0|||
33169595|NCT00203996|100528784|FG009|Overall Study|CPAP machine malfunction|0|||
33169596|NCT00203996|100528775|FG000|Overall Study|Scheduling issue|0|||
33169597|NCT00203996|100528776|FG001|Overall Study|Scheduling issue|0|||
33260982|NCT00073749|100856490|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
33260983|NCT00073749|100856491|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
33260984|NCT00073749|100856492|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
33260985|NCT00073749|100856493|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
33260986|NCT00073749|100856487|FG000|Overall Study|Lost to Follow-up|0|||
33260987|NCT00073749|100856488|FG001|Overall Study|Lost to Follow-up|0|||
33260988|NCT00073749|100856489|FG002|Overall Study|Lost to Follow-up|0|||
33260989|NCT00073749|100856490|FG003|Overall Study|Lost to Follow-up|0|||
33260990|NCT00073749|100856491|FG004|Overall Study|Lost to Follow-up|0|||
33260991|NCT00073749|100856492|FG005|Overall Study|Lost to Follow-up|0|||
33260992|NCT00073749|100856493|FG006|Overall Study|Lost to Follow-up|2|||
33260993|NCT00073749|100856487|FG000|Overall Study|Other|0|||
33260994|NCT00073749|100856488|FG001|Overall Study|Other|0|||
33260995|NCT00073749|100856489|FG002|Overall Study|Other|0|||
33260996|NCT00073749|100856490|FG003|Overall Study|Other|0|||
33260997|NCT00073749|100856491|FG004|Overall Study|Other|0|||
33260998|NCT00073749|100856492|FG005|Overall Study|Other|2|||
33260999|NCT00073749|100856493|FG006|Overall Study|Other|0|||
33261000|NCT03283371|100856494|FG000|Placebo-controlled|Adverse Event|1|||
33261001|NCT03283371|100856495|FG001|Placebo-controlled|Adverse Event|1|||
33261002|NCT03283371|100856496|FG002|Placebo-controlled|Adverse Event|0|||
33261003|NCT03283371|100856497|FG003|Placebo-controlled|Adverse Event|0|||
33261004|NCT03283371|100856494|FG000|Placebo-controlled|Lack of Efficacy|1|||
33261005|NCT03283371|100856495|FG001|Placebo-controlled|Lack of Efficacy|0|||
33261006|NCT03283371|100856496|FG002|Placebo-controlled|Lack of Efficacy|0|||
33261007|NCT03283371|100856497|FG003|Placebo-controlled|Lack of Efficacy|0|||
33261008|NCT03283371|100856494|FG000|Placebo-controlled|Withdrawal by Subject|1|||
33261009|NCT03283371|100856495|FG001|Placebo-controlled|Withdrawal by Subject|1|||
33261010|NCT03283371|100856496|FG002|Placebo-controlled|Withdrawal by Subject|0|||
33261011|NCT03283371|100856497|FG003|Placebo-controlled|Withdrawal by Subject|0|||
33261012|NCT03283371|100856494|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
33261013|NCT03283371|100856495|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
33261014|NCT03283371|100856496|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
33261015|NCT03283371|100856497|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
33169598|NCT00203996|100528777|FG002|Overall Study|Scheduling issue|0|||
33169599|NCT00203996|100528778|FG003|Overall Study|Scheduling issue|0|||
33169600|NCT00203996|100528779|FG004|Overall Study|Scheduling issue|0|||
33261016|NCT03283371|100856494|FG000|Open-label Phase|Adverse Event|0|||
33261017|NCT03283371|100856495|FG001|Open-label Phase|Adverse Event|0|||
33261018|NCT03283371|100856496|FG002|Open-label Phase|Adverse Event|2|||
33261019|NCT03283371|100856497|FG003|Open-label Phase|Adverse Event|0|||
33169601|NCT00203996|100528780|FG005|Overall Study|Scheduling issue|0|||
33169602|NCT00203996|100528781|FG006|Overall Study|Scheduling issue|0|||
33169603|NCT00203996|100528782|FG007|Overall Study|Scheduling issue|2|||
33261020|NCT03283371|100856494|FG000|Open-label Phase|Withdrawal by Subject|0|||
33261021|NCT03283371|100856495|FG001|Open-label Phase|Withdrawal by Subject|0|||
33261022|NCT03283371|100856496|FG002|Open-label Phase|Withdrawal by Subject|1|||
33261023|NCT03283371|100856497|FG003|Open-label Phase|Withdrawal by Subject|0|||
33261024|NCT03283371|100856494|FG000|Open-label Phase|Other|0|||
33261025|NCT03283371|100856495|FG001|Open-label Phase|Other|0|||
33261026|NCT03283371|100856496|FG002|Open-label Phase|Other|1|||
33261027|NCT03283371|100856497|FG003|Open-label Phase|Other|1|||
33261028|NCT03939312|100856503|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
33261029|NCT03939312|100856503|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
33261030|NCT03939312|100856503|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
33261031|NCT03939312|100856503|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
33261032|NCT03939312|100856503|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
33261033|NCT03939312|100856503|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
33261034|NCT03939312|100856503|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
33261035|NCT03939312|100856503|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
33261036|NCT03939312|100856503|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
33261037|NCT03939312|100856503|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
33261038|NCT03939312|100856503|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
33261039|NCT03939312|100856503|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
33261040|NCT02748317|100856504|FG000|Overall Study|Withdrawal by Subject|14|||
33261041|NCT02748317|100856504|FG000|Overall Study|Lost to Follow-up|8|||
33261042|NCT02748317|100856504|FG000|Overall Study|Death|1|||
33261043|NCT02269475|100856507|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
33261044|NCT02269475|100856508|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
33261045|NCT02269475|100856507|FG000|Overall Study|Withdrawal by Subject|0|||
33261046|NCT02269475|100856508|FG001|Overall Study|Withdrawal by Subject|1|||
33261047|NCT01079949|100856509|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
33261048|NCT01079949|100856510|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
33261049|NCT01079949|100856509|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
33261050|NCT01079949|100856510|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
33261051|NCT01079949|100856509|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
33261052|NCT01079949|100856510|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
33261053|NCT01079949|100856509|FG000|Overall Study|Randomized but not treated|1|||
33261054|NCT01079949|100856510|FG001|Overall Study|Randomized but not treated|0|||
33261055|NCT02928172|100856511|FG000|Overall Study|Device did not record data|1|||
33261056|NCT00975585|100856512|FG000|Overall Study|Adverse Event|0|||
33261057|NCT00975585|100856513|FG001|Overall Study|Adverse Event|4|||
33261058|NCT00975585|100856512|FG000|Overall Study|Lost to Follow-up|3|||
33261059|NCT00975585|100856513|FG001|Overall Study|Lost to Follow-up|5|||
33261060|NCT00975585|100856512|FG000|Overall Study|Withdrawal by Subject|2|||
33261061|NCT00975585|100856513|FG001|Overall Study|Withdrawal by Subject|1|||
33261062|NCT00975585|100856512|FG000|Overall Study|Lens issue|2|||
33261063|NCT00975585|100856513|FG001|Overall Study|Lens issue|2|||
33261064|NCT02463448|100856514|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
33261065|NCT02463448|100856514|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
33261066|NCT02463448|100856514|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
33261067|NCT02463448|100856514|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
33261068|NCT00421889|100856515|FG000|Overall Study|Adverse Event|1|||
33261069|NCT00421889|100856516|FG001|Overall Study|Adverse Event|0|||
33261070|NCT00421889|100856517|FG002|Overall Study|Adverse Event|1|||
33261071|NCT00421889|100856518|FG003|Overall Study|Adverse Event|1|||
33261072|NCT00421889|100856519|FG004|Overall Study|Adverse Event|1|||
33261073|NCT00421889|100856520|FG005|Overall Study|Adverse Event|4|||
33261074|NCT00421889|100856521|FG006|Overall Study|Adverse Event|1|||
33261075|NCT00421889|100856522|FG007|Overall Study|Adverse Event|0|||
33261076|NCT00421889|100856523|FG008|Overall Study|Adverse Event|2|||
33261077|NCT00421889|100856515|FG000|Overall Study|Withdrawal by Subject|1|||
33261078|NCT00421889|100856516|FG001|Overall Study|Withdrawal by Subject|3|||
33261079|NCT00421889|100856517|FG002|Overall Study|Withdrawal by Subject|0|||
33261080|NCT00421889|100856518|FG003|Overall Study|Withdrawal by Subject|0|||
33261081|NCT00421889|100856519|FG004|Overall Study|Withdrawal by Subject|2|||
33261082|NCT00421889|100856520|FG005|Overall Study|Withdrawal by Subject|0|||
33261083|NCT00421889|100856521|FG006|Overall Study|Withdrawal by Subject|0|||
33261084|NCT00421889|100856522|FG007|Overall Study|Withdrawal by Subject|0|||
33261085|NCT00421889|100856523|FG008|Overall Study|Withdrawal by Subject|0|||
33261086|NCT00421889|100856515|FG000|Overall Study|Death|0|||
33261087|NCT00421889|100856516|FG001|Overall Study|Death|0|||
33261088|NCT00421889|100856517|FG002|Overall Study|Death|0|||
33261089|NCT00421889|100856518|FG003|Overall Study|Death|0|||
33261090|NCT00421889|100856519|FG004|Overall Study|Death|1|||
33261091|NCT00421889|100856520|FG005|Overall Study|Death|1|||
33261092|NCT00421889|100856521|FG006|Overall Study|Death|0|||
33261093|NCT00421889|100856522|FG007|Overall Study|Death|0|||
33261094|NCT00421889|100856523|FG008|Overall Study|Death|0|||
33261095|NCT00421889|100856515|FG000|Overall Study|Progressive disease|3|||
33261096|NCT00421889|100856516|FG001|Overall Study|Progressive disease|2|||
33261097|NCT00421889|100856517|FG002|Overall Study|Progressive disease|2|||
33261098|NCT00421889|100856518|FG003|Overall Study|Progressive disease|3|||
33261099|NCT00421889|100856519|FG004|Overall Study|Progressive disease|2|||
33261100|NCT00421889|100856520|FG005|Overall Study|Progressive disease|21|||
33261101|NCT00421889|100856521|FG006|Overall Study|Progressive disease|3|||
33261102|NCT00421889|100856522|FG007|Overall Study|Progressive disease|1|||
33261103|NCT00421889|100856523|FG008|Overall Study|Progressive disease|5|||
33261104|NCT00421889|100856515|FG000|Overall Study|Patient/Investigator request|0|||
33261105|NCT00421889|100856516|FG001|Overall Study|Patient/Investigator request|0|||
33261106|NCT00421889|100856517|FG002|Overall Study|Patient/Investigator request|0|||
33261107|NCT00421889|100856518|FG003|Overall Study|Patient/Investigator request|0|||
33261108|NCT00421889|100856519|FG004|Overall Study|Patient/Investigator request|0|||
33261109|NCT00421889|100856520|FG005|Overall Study|Patient/Investigator request|9|||
33261110|NCT00421889|100856521|FG006|Overall Study|Patient/Investigator request|0|||
33261111|NCT00421889|100856522|FG007|Overall Study|Patient/Investigator request|1|||
33261112|NCT00421889|100856523|FG008|Overall Study|Patient/Investigator request|3|||
33261113|NCT00421889|100856515|FG000|Overall Study|Lost to Follow-up|0|||
33261114|NCT00421889|100856516|FG001|Overall Study|Lost to Follow-up|0|||
33261115|NCT00421889|100856517|FG002|Overall Study|Lost to Follow-up|0|||
33261116|NCT00421889|100856518|FG003|Overall Study|Lost to Follow-up|0|||
33261117|NCT00421889|100856519|FG004|Overall Study|Lost to Follow-up|0|||
33261118|NCT00421889|100856520|FG005|Overall Study|Lost to Follow-up|0|||
33261119|NCT00421889|100856521|FG006|Overall Study|Lost to Follow-up|0|||
33261120|NCT00421889|100856522|FG007|Overall Study|Lost to Follow-up|0|||
33261121|NCT00421889|100856523|FG008|Overall Study|Lost to Follow-up|1|||
33261122|NCT02119650|100856524|FG000|Overall Study|Adverse Event|3|||
33261123|NCT02119650|100856525|FG001|Overall Study|Adverse Event|4|||
33261124|NCT02119650|100856524|FG000|Overall Study|Subject decision|2|||
33261125|NCT02119650|100856525|FG001|Overall Study|Subject decision|3|||
33169604|NCT00203996|100528783|FG008|Overall Study|Scheduling issue|0|||
33169605|NCT00203996|100528784|FG009|Overall Study|Scheduling issue|0|||
33169606|NCT04967443|100528785|FG000|Open Label Treatment|Death|1|||
33169607|NCT04967443|100528786|FG001|Open Label Treatment|Death|0|||
33169608|NCT04967443|100528787|FG002|Open Label Treatment|Death|0|||
33169609|NCT04967443|100528788|FG003|Open Label Treatment|Death|0|||
33169610|NCT04967443|100528789|FG004|Open Label Treatment|Death|0|||
33169611|NCT04967443|100528790|FG005|Open Label Treatment|Death|0|||
33169612|NCT04967443|100528791|FG006|Open Label Treatment|Death|0|||
33169613|NCT04967443|100528792|FG007|Open Label Treatment|Death|0|||
33169614|NCT04967443|100528785|FG000|Open Label Treatment|Lost to Follow-up|0|||
33169615|NCT04967443|100528786|FG001|Open Label Treatment|Lost to Follow-up|0|||
33169616|NCT04967443|100528787|FG002|Open Label Treatment|Lost to Follow-up|1|||
33169617|NCT04967443|100528788|FG003|Open Label Treatment|Lost to Follow-up|0|||
33169618|NCT04967443|100528789|FG004|Open Label Treatment|Lost to Follow-up|0|||
33169619|NCT04967443|100528790|FG005|Open Label Treatment|Lost to Follow-up|0|||
33169620|NCT04967443|100528791|FG006|Open Label Treatment|Lost to Follow-up|0|||
33169621|NCT04967443|100528792|FG007|Open Label Treatment|Lost to Follow-up|0|||
33261126|NCT02119650|100856524|FG000|Overall Study|Disease progression|11|||
33261127|NCT02119650|100856525|FG001|Overall Study|Disease progression|14|||
33261128|NCT02119650|100856524|FG000|Overall Study|Death|5|||
33261129|NCT02119650|100856525|FG001|Overall Study|Death|1|||
33261130|NCT02119650|100856524|FG000|Overall Study|Noncompliance with study treatment|1|||
33261131|NCT02119650|100856525|FG001|Overall Study|Noncompliance with study treatment|1|||
33169622|NCT04967443|100528785|FG000|Open Label Treatment|Withdrawal by Subject|0|||
33450109|NCT01444378|101538747|FG000|Overall Study|Administrative Closure Of The Study|2|||
33450110|NCT01444378|101538747|FG000|Overall Study|Missed Visits|10|||
33450111|NCT03677141|101538750|FG000|Overall Study|Death|2|||
33450112|NCT03677141|101538751|FG001|Overall Study|Death|1|||
33450113|NCT03677141|101538752|FG002|Overall Study|Death|6|||
33450114|NCT03677141|101538753|FG003|Overall Study|Death|9|||
33450115|NCT03677141|101538754|FG004|Overall Study|Death|5|||
33450116|NCT03677141|101538755|FG005|Overall Study|Death|3|||
33450117|NCT03677141|101538750|FG000|Overall Study|Lost to Follow-up|0|||
33450118|NCT03677141|101538751|FG001|Overall Study|Lost to Follow-up|0|||
33450119|NCT03677141|101538752|FG002|Overall Study|Lost to Follow-up|0|||
33450120|NCT03677141|101538753|FG003|Overall Study|Lost to Follow-up|2|||
33450121|NCT03677141|101538754|FG004|Overall Study|Lost to Follow-up|0|||
33450122|NCT03677141|101538755|FG005|Overall Study|Lost to Follow-up|0|||
33169623|NCT04967443|100528786|FG001|Open Label Treatment|Withdrawal by Subject|1|||
33169624|NCT04967443|100528787|FG002|Open Label Treatment|Withdrawal by Subject|0|||
33169625|NCT04967443|100528788|FG003|Open Label Treatment|Withdrawal by Subject|1|||
33169626|NCT04967443|100528789|FG004|Open Label Treatment|Withdrawal by Subject|0|||
33169627|NCT04967443|100528790|FG005|Open Label Treatment|Withdrawal by Subject|1|||
33169628|NCT04967443|100528791|FG006|Open Label Treatment|Withdrawal by Subject|2|||
33169629|NCT04967443|100528792|FG007|Open Label Treatment|Withdrawal by Subject|3|||
33169630|NCT04967443|100528785|FG000|Follow-Up|Death|1|||
33169631|NCT04967443|100528786|FG001|Follow-Up|Death|0|||
33169632|NCT04967443|100528787|FG002|Follow-Up|Death|0|||
33169633|NCT04967443|100528788|FG003|Follow-Up|Death|0|||
33169634|NCT04967443|100528789|FG004|Follow-Up|Death|0|||
33169635|NCT04967443|100528790|FG005|Follow-Up|Death|0|||
33169636|NCT04967443|100528791|FG006|Follow-Up|Death|0|||
33169637|NCT04967443|100528792|FG007|Follow-Up|Death|0|||
33169638|NCT04967443|100528785|FG000|Follow-Up|Lost to Follow-up|0|||
33169639|NCT04967443|100528786|FG001|Follow-Up|Lost to Follow-up|0|||
33169640|NCT04967443|100528787|FG002|Follow-Up|Lost to Follow-up|1|||
33169641|NCT04967443|100528788|FG003|Follow-Up|Lost to Follow-up|1|||
33169642|NCT04967443|100528789|FG004|Follow-Up|Lost to Follow-up|0|||
33169643|NCT04967443|100528790|FG005|Follow-Up|Lost to Follow-up|0|||
33169644|NCT04967443|100528791|FG006|Follow-Up|Lost to Follow-up|0|||
33169645|NCT04967443|100528792|FG007|Follow-Up|Lost to Follow-up|0|||
33169646|NCT04967443|100528785|FG000|Follow-Up|Withdrawal by Subject|0|||
33169647|NCT04967443|100528786|FG001|Follow-Up|Withdrawal by Subject|1|||
33169648|NCT04967443|100528787|FG002|Follow-Up|Withdrawal by Subject|0|||
33169649|NCT04967443|100528788|FG003|Follow-Up|Withdrawal by Subject|1|||
33169650|NCT04967443|100528789|FG004|Follow-Up|Withdrawal by Subject|0|||
33169651|NCT04967443|100528790|FG005|Follow-Up|Withdrawal by Subject|1|||
33169652|NCT04967443|100528791|FG006|Follow-Up|Withdrawal by Subject|2|||
33169653|NCT04967443|100528792|FG007|Follow-Up|Withdrawal by Subject|3|||
33169654|NCT00907777|100528796|FG000|Overall Study|Withdrawal by Subject|0|||
33169655|NCT00907777|100528797|FG001|Overall Study|Withdrawal by Subject|1|||
33169656|NCT02532972|100528800|FG000|Overall Study|Withdrawal by Subject|1|||
33169657|NCT00553644|100528802|FG000|Overall Study|Adverse Event|17|||
33169658|NCT00553644|100528802|FG000|Overall Study|Withdrawal by Subject|4|||
33169659|NCT00553644|100528802|FG000|Overall Study|Physician Decision|1|||
33169660|NCT00553644|100528802|FG000|Overall Study|Alternative therapy|6|||
33169661|NCT00963547|100528805|FG000|Overall Study|Adverse Event|0|||
33169662|NCT00963547|100528806|FG001|Overall Study|Adverse Event|1|||
33169663|NCT00963547|100528807|FG002|Overall Study|Adverse Event|0|||
33169664|NCT00963547|100528808|FG003|Overall Study|Adverse Event|1|||
33169665|NCT00963547|100528809|FG004|Overall Study|Adverse Event|0|||
33169666|NCT00963547|100528810|FG005|Overall Study|Adverse Event|0|||
33169667|NCT00963547|100528811|FG006|Overall Study|Adverse Event|0|||
33169668|NCT00963547|100528805|FG000|Overall Study|Physician Decision|1|||
33169669|NCT00963547|100528806|FG001|Overall Study|Physician Decision|1|||
33169670|NCT00963547|100528807|FG002|Overall Study|Physician Decision|0|||
33169671|NCT00963547|100528808|FG003|Overall Study|Physician Decision|0|||
33450123|NCT03677141|101538750|FG000|Overall Study|Screen failure or enrolled in error|0|||
33169672|NCT00963547|100528809|FG004|Overall Study|Physician Decision|0|||
33169673|NCT00963547|100528810|FG005|Overall Study|Physician Decision|0|||
33169674|NCT00963547|100528811|FG006|Overall Study|Physician Decision|0|||
33169675|NCT00963547|100528805|FG000|Overall Study|Progressive Disease|3|||
33169676|NCT00963547|100528806|FG001|Overall Study|Progressive Disease|8|||
33169677|NCT00963547|100528807|FG002|Overall Study|Progressive Disease|9|||
33169678|NCT00963547|100528808|FG003|Overall Study|Progressive Disease|5|||
33169679|NCT00963547|100528809|FG004|Overall Study|Progressive Disease|0|||
33169680|NCT00963547|100528810|FG005|Overall Study|Progressive Disease|0|||
33169681|NCT00963547|100528811|FG006|Overall Study|Progressive Disease|0|||
33169682|NCT00963547|100528805|FG000|Overall Study|Withdrawal by Subject|0|||
33169683|NCT00963547|100528806|FG001|Overall Study|Withdrawal by Subject|0|||
33169684|NCT00963547|100528807|FG002|Overall Study|Withdrawal by Subject|3|||
33169685|NCT00963547|100528808|FG003|Overall Study|Withdrawal by Subject|0|||
33169686|NCT00963547|100528809|FG004|Overall Study|Withdrawal by Subject|0|||
33169687|NCT00963547|100528810|FG005|Overall Study|Withdrawal by Subject|0|||
33169688|NCT00963547|100528811|FG006|Overall Study|Withdrawal by Subject|0|||
33169689|NCT00963547|100528805|FG000|Overall Study|Reason Unknown|0|||
33169690|NCT00963547|100528806|FG001|Overall Study|Reason Unknown|1|||
33169691|NCT00963547|100528807|FG002|Overall Study|Reason Unknown|0|||
33169692|NCT00963547|100528808|FG003|Overall Study|Reason Unknown|0|||
33169693|NCT00963547|100528809|FG004|Overall Study|Reason Unknown|0|||
33450124|NCT03677141|101538751|FG001|Overall Study|Screen failure or enrolled in error|0|||
33450125|NCT03677141|101538752|FG002|Overall Study|Screen failure or enrolled in error|0|||
33450126|NCT03677141|101538753|FG003|Overall Study|Screen failure or enrolled in error|0|||
33450127|NCT03677141|101538754|FG004|Overall Study|Screen failure or enrolled in error|2|||
33169694|NCT00963547|100528810|FG005|Overall Study|Reason Unknown|0|||
33450128|NCT03677141|101538755|FG005|Overall Study|Screen failure or enrolled in error|0|||
33450129|NCT03677141|101538750|FG000|Overall Study|Physician Decision|0|||
33450130|NCT03677141|101538751|FG001|Overall Study|Physician Decision|0|||
33450131|NCT03677141|101538752|FG002|Overall Study|Physician Decision|0|||
33450132|NCT03677141|101538753|FG003|Overall Study|Physician Decision|0|||
33169695|NCT00963547|100528811|FG006|Overall Study|Reason Unknown|0|||
33169696|NCT01918085|100528812|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
33169697|NCT01918085|100528813|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
33169698|NCT00320411|100528814|FG000|Overall Study|No investigational product admin.|4|||
33169699|NCT02692703|100528816|FG000|Overall Study|Lost to Follow-up|1|||
33169700|NCT02692703|100528816|FG000|Overall Study|Other|1|||
33169701|NCT00553514|100528817|FG000|Overall Study|Protocol deviation|0|||
33169702|NCT00553514|100528818|FG001|Overall Study|Protocol deviation|0|||
33169703|NCT00553514|100528819|FG002|Overall Study|Protocol deviation|0|||
33169704|NCT00553514|100528820|FG003|Overall Study|Protocol deviation|1|||
33169705|NCT00553514|100528821|FG004|Overall Study|Protocol deviation|0|||
33169706|NCT00553514|100528817|FG000|Overall Study|Lack of ovarian response|4|||
33169707|NCT00553514|100528818|FG001|Overall Study|Lack of ovarian response|5|||
33169708|NCT00553514|100528819|FG002|Overall Study|Lack of ovarian response|5|||
33169709|NCT00553514|100528820|FG003|Overall Study|Lack of ovarian response|5|||
33169710|NCT00553514|100528821|FG004|Overall Study|Lack of ovarian response|6|||
33169711|NCT00553514|100528817|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
33169712|NCT00553514|100528818|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
33169713|NCT00553514|100528819|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
33169714|NCT00553514|100528820|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
33169715|NCT00553514|100528821|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
33169716|NCT00553514|100528817|FG000|Overall Study|Risk of multiple pregnancy|0|||
33169717|NCT00553514|100528818|FG001|Overall Study|Risk of multiple pregnancy|2|||
33169718|NCT00553514|100528819|FG002|Overall Study|Risk of multiple pregnancy|0|||
33169719|NCT00553514|100528820|FG003|Overall Study|Risk of multiple pregnancy|1|||
33169720|NCT00553514|100528821|FG004|Overall Study|Risk of multiple pregnancy|0|||
33261132|NCT02119650|100856524|FG000|Overall Study|Study terminated by the sponsor|1|||
33450133|NCT03677141|101538754|FG004|Overall Study|Physician Decision|1|||
33450134|NCT03677141|101538755|FG005|Overall Study|Physician Decision|0|||
33169721|NCT00553514|100528817|FG000|Overall Study|Other|1|||
33169722|NCT00553514|100528818|FG001|Overall Study|Other|1|||
33169723|NCT00553514|100528819|FG002|Overall Study|Other|0|||
33169724|NCT00553514|100528820|FG003|Overall Study|Other|0|||
33169725|NCT00553514|100528821|FG004|Overall Study|Other|1|||
33450135|NCT03677141|101538750|FG000|Overall Study|Withdrawal by Subject|0|||
33450136|NCT03677141|101538751|FG001|Overall Study|Withdrawal by Subject|0|||
33450137|NCT03677141|101538752|FG002|Overall Study|Withdrawal by Subject|1|||
33450138|NCT03677141|101538753|FG003|Overall Study|Withdrawal by Subject|1|||
33450139|NCT03677141|101538754|FG004|Overall Study|Withdrawal by Subject|1|||
33450140|NCT03677141|101538755|FG005|Overall Study|Withdrawal by Subject|0|||
33450141|NCT02718326|101538756|FG000|Overall Study|Adverse Event|4|||
33450142|NCT02718326|101538757|FG001|Overall Study|Adverse Event|9|||
33450143|NCT02718326|101538758|FG002|Overall Study|Adverse Event|0|||
33450144|NCT02718326|101538756|FG000|Overall Study|Death|8|||
33450145|NCT02718326|101538757|FG001|Overall Study|Death|1|||
33450146|NCT02718326|101538758|FG002|Overall Study|Death|2|||
33450147|NCT02718326|101538756|FG000|Overall Study|Withdrawal by Subject|4|||
33450148|NCT02718326|101538757|FG001|Overall Study|Withdrawal by Subject|9|||
33450149|NCT02718326|101538758|FG002|Overall Study|Withdrawal by Subject|6|||
33450150|NCT02718326|101538756|FG000|Overall Study|Lost to Follow-up|18|||
33450151|NCT02718326|101538757|FG001|Overall Study|Lost to Follow-up|5|||
33450152|NCT02718326|101538758|FG002|Overall Study|Lost to Follow-up|14|||
33450153|NCT02718326|101538756|FG000|Overall Study|Protocol Deviation|1|||
33450154|NCT02718326|101538757|FG001|Overall Study|Protocol Deviation|0|||
33450155|NCT02718326|101538758|FG002|Overall Study|Protocol Deviation|0|||
33450156|NCT02718326|101538756|FG000|Overall Study|Pregnancy|1|||
33450157|NCT02718326|101538757|FG001|Overall Study|Pregnancy|0|||
33450158|NCT02718326|101538758|FG002|Overall Study|Pregnancy|0|||
33450159|NCT04639219|101538761|FG000|Overall Study|Withdrawal by Subject|8|||
33450160|NCT04639219|101538761|FG000|Overall Study|Lost to Follow-up|6|||
33450161|NCT04639219|101538761|FG000|Overall Study|Death|55|||
33450162|NCT01180634|101538762|FG000|Overall Study|Adverse Event|4|||
33450163|NCT01180634|101538763|FG001|Overall Study|Adverse Event|1|||
33450164|NCT01180634|101538762|FG000|Overall Study|Miscellaneous|2|||
33450165|NCT01180634|101538763|FG001|Overall Study|Miscellaneous|0|||
33450166|NCT01180634|101538762|FG000|Overall Study|Withdrawal by Subject|4|||
33450167|NCT01180634|101538763|FG001|Overall Study|Withdrawal by Subject|0|||
33450168|NCT01442155|101538764|FG000|Overall Study|Complete remission|35|||
33450169|NCT01442155|101538764|FG000|Overall Study|Recurrence|26|||
33450170|NCT01442155|101538764|FG000|Overall Study|Adverse Event|2|||
33450171|NCT01442155|101538764|FG000|Overall Study|Lost to Follow-up|2|||
33450172|NCT01788423|101538765|FG000|Overall Study|See Comments in Completed (above)|0|||
33450173|NCT01788423|101538766|FG001|Overall Study|See Comments in Completed (above)|4|||
33450174|NCT01788423|101538767|FG002|Overall Study|See Comments in Completed (above)|5|||
33450175|NCT02558491|101538768|FG000|First Invention|Withdrawal by Subject|3|||
33450176|NCT02558491|101538769|FG001|First Invention|Withdrawal by Subject|1|||
33450177|NCT02558491|101538768|FG000|First Invention|Data collection issues|1|||
33450178|NCT02558491|101538769|FG001|First Invention|Data collection issues|0|||
33450179|NCT02558491|101538768|FG000|First Invention|Stopping criteria|0|||
33450180|NCT02558491|101538769|FG001|First Invention|Stopping criteria|1|||
33450181|NCT02558491|101538768|FG000|First Invention|Changed parameters during trial|1|||
33450182|NCT02558491|101538769|FG001|First Invention|Changed parameters during trial|0|||
33450183|NCT02558491|101538768|FG000|Second Intervention|Withdrawal by Subject|1|||
33450184|NCT02558491|101538769|FG001|Second Intervention|Withdrawal by Subject|0|||
33450185|NCT02558491|101538768|FG000|Second Intervention|Stopping Criteria|1|||
33450186|NCT02558491|101538769|FG001|Second Intervention|Stopping Criteria|0|||
33450187|NCT04022954|101538771|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
33450188|NCT04022954|101538771|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
33450189|NCT04022954|101538771|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
33169726|NCT04605484|100528822|FG000|Overall Study|Lost to Follow-up|0|||
33169727|NCT04605484|100528823|FG001|Overall Study|Lost to Follow-up|1|||
33169728|NCT04605484|100528824|FG002|Overall Study|Lost to Follow-up|1|||
33169729|NCT04605484|100528822|FG000|Overall Study|Other|0|||
33169730|NCT04605484|100528823|FG001|Overall Study|Other|1|||
33169731|NCT04605484|100528824|FG002|Overall Study|Other|0|||
33169732|NCT00368355|100528827|FG000|Overall Study|Adverse Event|1|||
33169733|NCT00368355|100528828|FG001|Overall Study|Adverse Event|0|||
33169734|NCT00368355|100528827|FG000|Overall Study|Death|2|||
33169735|NCT00368355|100528828|FG001|Overall Study|Death|4|||
33169736|NCT00368355|100528827|FG000|Overall Study|Relapse|6|||
33169737|NCT00368355|100528828|FG001|Overall Study|Relapse|10|||
33169738|NCT00368355|100528827|FG000|Overall Study|Subsequent transplant|0|||
33169739|NCT00368355|100528828|FG001|Overall Study|Subsequent transplant|3|||
33169740|NCT00368355|100528827|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
33169741|NCT00368355|100528828|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
33169742|NCT00759031|100528829|FG000|First Intervention (1 Day)|Physician Decision|1|||
33169743|NCT00759031|100528830|FG001|First Intervention (1 Day)|Physician Decision|0|||
33169744|NCT00759031|100528829|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
33169745|NCT00759031|100528830|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
33169746|NCT00759031|100528829|FG000|First Intervention (1 Day)|Screening failure|1|||
33169747|NCT00759031|100528830|FG001|First Intervention (1 Day)|Screening failure|0|||
33169748|NCT00691015|100528836|FG000|Overall Study|Refused further treatment|1|||
33169749|NCT00160251|100528837|FG000|Prior to Amendment 2|Adverse Event|2|||
33169750|NCT00160251|100528838|FG001|Prior to Amendment 2|Adverse Event|1|||
33169751|NCT00160251|100528839|FG002|Prior to Amendment 2|Adverse Event|3|||
33169752|NCT00160251|100528840|FG003|Prior to Amendment 2|Adverse Event|1|||
33450190|NCT03322267|101538772|FG000|Overall Study|Lack of Efficacy|11|||
33450191|NCT03322267|101538772|FG000|Overall Study|Adverse Event|1|||
33450192|NCT03322267|101538772|FG000|Overall Study|Withdrawal by Subject|2|||
33450193|NCT03873272|101538773|FG000|Overall Study|Withdrawal by Subject|2|||
33450194|NCT03873272|101538774|FG001|Overall Study|Withdrawal by Subject|0|||
33450195|NCT03873272|101538775|FG002|Overall Study|Withdrawal by Subject|1|||
33450196|NCT03873272|101538773|FG000|Overall Study|Death|0|||
33450197|NCT03873272|101538774|FG001|Overall Study|Death|2|||
33450198|NCT03873272|101538775|FG002|Overall Study|Death|1|||
33450199|NCT02842853|101538776|FG000|Overall Study|Non-compliance with the protocol|3|||
33450200|NCT02842853|101538777|FG001|Overall Study|Non-compliance with the protocol|7|||
33450201|NCT02842853|101538778|FG002|Overall Study|Non-compliance with the protocol|2|||
33450202|NCT02842853|101538779|FG003|Overall Study|Non-compliance with the protocol|5|||
33450203|NCT02842853|101538776|FG000|Overall Study|Subject met exclusion criteria|0|||
33450204|NCT02842853|101538777|FG001|Overall Study|Subject met exclusion criteria|1|||
33450205|NCT02842853|101538778|FG002|Overall Study|Subject met exclusion criteria|0|||
33450206|NCT02842853|101538779|FG003|Overall Study|Subject met exclusion criteria|0|||
33450207|NCT02842853|101538776|FG000|Overall Study|Withdrawal by Subject|11|||
33450208|NCT02842853|101538777|FG001|Overall Study|Withdrawal by Subject|13|||
33450209|NCT02842853|101538778|FG002|Overall Study|Withdrawal by Subject|9|||
33450210|NCT02842853|101538779|FG003|Overall Study|Withdrawal by Subject|8|||
33450211|NCT02842853|101538776|FG000|Overall Study|Lost to Follow-up|9|||
33450212|NCT02842853|101538777|FG001|Overall Study|Lost to Follow-up|13|||
33450213|NCT02842853|101538778|FG002|Overall Study|Lost to Follow-up|10|||
33450214|NCT02842853|101538779|FG003|Overall Study|Lost to Follow-up|11|||
33450215|NCT04739800|101538783|FG000|Overall Study|Adverse Event|2|||
33450216|NCT04739800|101538784|FG001|Overall Study|Adverse Event|1|||
33450217|NCT04739800|101538785|FG002|Overall Study|Adverse Event|4|||
33450218|NCT04739800|101538786|FG003|Overall Study|Adverse Event|5|||
33450219|NCT04739800|101538783|FG000|Overall Study|Never Treated|2|||
33450220|NCT04739800|101538784|FG001|Overall Study|Never Treated|0|||
33450221|NCT04739800|101538785|FG002|Overall Study|Never Treated|1|||
33450222|NCT04739800|101538786|FG003|Overall Study|Never Treated|1|||
33450223|NCT04739800|101538783|FG000|Overall Study|On Treatment|5|||
33450224|NCT04739800|101538784|FG001|Overall Study|On Treatment|9|||
33450225|NCT04739800|101538785|FG002|Overall Study|On Treatment|9|||
33450226|NCT04739800|101538786|FG003|Overall Study|On Treatment|9|||
33450227|NCT04739800|101538783|FG000|Overall Study|Symptomatic Deterioration|1|||
33450228|NCT04739800|101538784|FG001|Overall Study|Symptomatic Deterioration|1|||
33169753|NCT00160251|100528841|FG004|Prior to Amendment 2|Adverse Event|1|||
33169754|NCT00160251|100528842|FG005|Prior to Amendment 2|Adverse Event|1|||
33169755|NCT00160251|100528843|FG006|Prior to Amendment 2|Adverse Event|1|||
33169756|NCT00160251|100528844|FG007|Prior to Amendment 2|Adverse Event|0|||
33169757|NCT00160251|100528837|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
33169758|NCT00160251|100528838|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
33169759|NCT00160251|100528839|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
33450229|NCT04739800|101538785|FG002|Overall Study|Symptomatic Deterioration|3|||
33450230|NCT04739800|101538786|FG003|Overall Study|Symptomatic Deterioration|0|||
33450231|NCT04739800|101538783|FG000|Overall Study|Withdrawal by Subject|1|||
33450232|NCT04739800|101538784|FG001|Overall Study|Withdrawal by Subject|2|||
33450233|NCT04739800|101538785|FG002|Overall Study|Withdrawal by Subject|1|||
33450234|NCT04739800|101538786|FG003|Overall Study|Withdrawal by Subject|3|||
33450235|NCT04739800|101538783|FG000|Overall Study|Other Reason|1|||
33450236|NCT04739800|101538784|FG001|Overall Study|Other Reason|3|||
33450237|NCT04739800|101538785|FG002|Overall Study|Other Reason|5|||
33169760|NCT00160251|100528840|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
33169761|NCT00160251|100528841|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
33169762|NCT00160251|100528842|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
33169763|NCT00160251|100528843|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
33169764|NCT00160251|100528844|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
33169765|NCT00160251|100528837|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
33169766|NCT00160251|100528838|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
33169767|NCT00160251|100528839|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
33169768|NCT00160251|100528840|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
33169769|NCT00160251|100528841|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
33169770|NCT00160251|100528842|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
33169771|NCT00160251|100528843|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
33261133|NCT02119650|100856525|FG001|Overall Study|Study terminated by the sponsor|0|||
33261134|NCT02119650|100856524|FG000|Overall Study|Physician Decision|0|||
33261135|NCT02119650|100856525|FG001|Overall Study|Physician Decision|2|||
33261136|NCT02119650|100856524|FG000|Overall Study|Multiple reasons for termination|2|||
33261137|NCT02119650|100856525|FG001|Overall Study|Multiple reasons for termination|1|||
33261138|NCT03750968|100856527|FG000|Overall Study|Adverse Event|2|||
33261139|NCT03750968|100856528|FG001|Overall Study|Adverse Event|0|||
33261140|NCT03750968|100856527|FG000|Overall Study|Lost to Follow-up|1|||
33261141|NCT03750968|100856528|FG001|Overall Study|Lost to Follow-up|3|||
33261142|NCT00586313|100856529|FG000|Overall Study|Lack of Efficacy|2|||
33261143|NCT01964300|100856530|FG000|Overall Study|Ineligible after enrollment|0|||
33261144|NCT01964300|100856531|FG001|Overall Study|Ineligible after enrollment|1|||
33261145|NCT01964300|100856530|FG000|Overall Study|Adverse Event|1|||
33261146|NCT01964300|100856531|FG001|Overall Study|Adverse Event|1|||
33261147|NCT01964300|100856530|FG000|Overall Study|Lack of Efficacy|3|||
33261148|NCT01964300|100856531|FG001|Overall Study|Lack of Efficacy|5|||
33261149|NCT01964300|100856530|FG000|Overall Study|Withdrawal by Subject|0|||
33261150|NCT01964300|100856531|FG001|Overall Study|Withdrawal by Subject|1|||
33261151|NCT01964300|100856530|FG000|Overall Study|To receive alternative therapy|1|||
33261152|NCT01964300|100856531|FG001|Overall Study|To receive alternative therapy|2|||
33261153|NCT01964300|100856530|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
33261154|NCT01964300|100856531|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
33450238|NCT04739800|101538786|FG003|Overall Study|Other Reason|4|||
33450239|NCT00191815|101538789|FG000|Overall Study|Adverse Event|2|||
33450240|NCT00191815|101538789|FG000|Overall Study|Disease progression or relapse|24|||
33450241|NCT00191815|101538789|FG000|Overall Study|Death|2|||
33450242|NCT00191815|101538789|FG000|Overall Study|Protocol Violation|3|||
33450243|NCT00191815|101538789|FG000|Overall Study|Physician Decision|2|||
33450244|NCT00191815|101538789|FG000|Overall Study|Withdrawal by Subject|7|||
33450245|NCT03292484|101538790|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
33450246|NCT03292484|101538790|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
33450247|NCT03292484|101538790|FG000|Overall Study|Protocol Violation|2|||
33450248|NCT03292484|101538790|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
33450249|NCT03292484|101538790|FG000|Overall Study|Sponsor decision|349|||
33450250|NCT03292484|101538790|FG000|Overall Study|Lost to Follow-up|7|||
33450251|NCT03292484|101538790|FG000|Overall Study|Coronavirus Disease 2019|1|||
33450252|NCT03292484|101538790|FG000|Overall Study|Other|20|||
33450253|NCT01171898|101538791|FG000|Overall Study|Death|0|||
33450254|NCT01171898|101538792|FG001|Overall Study|Death|0|||
33450255|NCT01171898|101538793|FG002|Overall Study|Death|2|||
33450256|NCT01171898|101538794|FG003|Overall Study|Death|0|||
33450257|NCT01171898|101538791|FG000|Overall Study|Lost to Follow-up|0|||
33450258|NCT01171898|101538792|FG001|Overall Study|Lost to Follow-up|1|||
33450259|NCT01171898|101538793|FG002|Overall Study|Lost to Follow-up|1|||
33450260|NCT01171898|101538794|FG003|Overall Study|Lost to Follow-up|1|||
33450261|NCT01171898|101538791|FG000|Overall Study|Withdrawal by Subject|1|||
33450262|NCT01171898|101538792|FG001|Overall Study|Withdrawal by Subject|4|||
33169772|NCT00160251|100528844|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
33169773|NCT00160251|100528837|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
33169774|NCT00160251|100528838|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
33450263|NCT01171898|101538793|FG002|Overall Study|Withdrawal by Subject|6|||
33450264|NCT01171898|101538794|FG003|Overall Study|Withdrawal by Subject|3|||
33169775|NCT00160251|100528839|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
33261155|NCT01964300|100856530|FG000|Overall Study|Weight criteria not met|0|||
33261156|NCT01964300|100856531|FG001|Overall Study|Weight criteria not met|1|||
33261157|NCT00274469|100856532|FG000|Overall Study|Death|63|||
33261158|NCT00274469|100856533|FG001|Overall Study|Death|74|||
33261159|NCT00274469|100856532|FG000|Overall Study|Did not consent to OS follow-up|16|||
33169776|NCT00160251|100528840|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
33169777|NCT00160251|100528841|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
33169778|NCT00160251|100528842|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
33169779|NCT00160251|100528843|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
33169780|NCT00160251|100528844|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
33169781|NCT00160251|100528837|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
33169782|NCT00160251|100528838|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
33169783|NCT00160251|100528839|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
33169784|NCT00160251|100528840|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
33169785|NCT00160251|100528841|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
33169786|NCT00160251|100528842|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
33450265|NCT01171898|101538791|FG000|Overall Study|Terminated by Sponsor|1|||
33450266|NCT01171898|101538792|FG001|Overall Study|Terminated by Sponsor|0|||
33450267|NCT01171898|101538793|FG002|Overall Study|Terminated by Sponsor|0|||
33450268|NCT01171898|101538794|FG003|Overall Study|Terminated by Sponsor|0|||
33450269|NCT01171898|101538791|FG000|Overall Study|Ongoing|1|||
33450270|NCT01171898|101538792|FG001|Overall Study|Ongoing|9|||
33450271|NCT01171898|101538793|FG002|Overall Study|Ongoing|3|||
33450272|NCT01171898|101538794|FG003|Overall Study|Ongoing|0|||
33450273|NCT01171898|101538791|FG000|Overall Study|Other|1|||
33450274|NCT01171898|101538792|FG001|Overall Study|Other|5|||
33450275|NCT01171898|101538793|FG002|Overall Study|Other|0|||
33450276|NCT01171898|101538794|FG003|Overall Study|Other|2|||
33450277|NCT00835692|101538797|FG000|First Intervention|Withdrawal by Subject|1|||
33450278|NCT00835692|101538798|FG001|First Intervention|Withdrawal by Subject|0|||
33450279|NCT03605342|101538799|FG000|Overall Study|Withdrawal by Subject|9|||
33450280|NCT03605342|101538800|FG001|Overall Study|Withdrawal by Subject|7|||
33450281|NCT03605342|101538799|FG000|Overall Study|Lost to Follow-up|1|||
33450282|NCT03605342|101538800|FG001|Overall Study|Lost to Follow-up|1|||
33450283|NCT02760927|101538801|FG000|Overall Study|Tube Slippage from Device|1|||
33450284|NCT02993159|101538802|FG000|Overall Study|Withdrawal by Subject|1|||
33450285|NCT02993159|101538803|FG001|Overall Study|Withdrawal by Subject|3|||
33450286|NCT02993159|101538802|FG000|Overall Study|Protocol Violation|1|||
33450287|NCT02993159|101538803|FG001|Overall Study|Protocol Violation|0|||
33450288|NCT02993159|101538802|FG000|Overall Study|Opted out of surgery|2|||
33450289|NCT02993159|101538803|FG001|Overall Study|Opted out of surgery|0|||
33450290|NCT02993159|101538802|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
33450291|NCT02993159|101538803|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
33450292|NCT02993159|101538802|FG000|Overall Study|Physician Decision|0|||
33450293|NCT02993159|101538803|FG001|Overall Study|Physician Decision|1|||
33450294|NCT00455312|101538804|FG000|Overall Study|Death|0|||
33450295|NCT00455312|101538805|FG001|Overall Study|Death|1|||
33450296|NCT01010503|101538806|FG000|Overall Study|Adverse Event|1|||
33450297|NCT01010503|101538806|FG000|Overall Study|Death|1|||
33450298|NCT05292365|101538807|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
33169787|NCT00160251|100528843|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
33169788|NCT00160251|100528844|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
33169789|NCT00160251|100528837|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
33169790|NCT00160251|100528838|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
33169791|NCT00160251|100528839|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
33169792|NCT00160251|100528840|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
33169793|NCT00160251|100528841|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
33169794|NCT00160251|100528842|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
33169795|NCT00160251|100528843|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
33169796|NCT00160251|100528844|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
33169797|NCT00160251|100528837|FG000|Post-amendment 2|Adverse Event|0|||
33169798|NCT00160251|100528838|FG001|Post-amendment 2|Adverse Event|0|||
33169799|NCT00160251|100528839|FG002|Post-amendment 2|Adverse Event|0|||
33169800|NCT00160251|100528840|FG003|Post-amendment 2|Adverse Event|0|||
33169801|NCT00160251|100528841|FG004|Post-amendment 2|Adverse Event|0|||
33169802|NCT00160251|100528842|FG005|Post-amendment 2|Adverse Event|0|||
33169803|NCT00160251|100528843|FG006|Post-amendment 2|Adverse Event|0|||
33169804|NCT00160251|100528844|FG007|Post-amendment 2|Adverse Event|20|||
33169805|NCT00160251|100528837|FG000|Post-amendment 2|Lack of Efficacy|0|||
33169806|NCT00160251|100528838|FG001|Post-amendment 2|Lack of Efficacy|0|||
33169807|NCT00160251|100528839|FG002|Post-amendment 2|Lack of Efficacy|0|||
33169808|NCT00160251|100528840|FG003|Post-amendment 2|Lack of Efficacy|0|||
33169809|NCT00160251|100528841|FG004|Post-amendment 2|Lack of Efficacy|0|||
33169810|NCT00160251|100528842|FG005|Post-amendment 2|Lack of Efficacy|0|||
33169811|NCT00160251|100528843|FG006|Post-amendment 2|Lack of Efficacy|0|||
33169812|NCT00160251|100528844|FG007|Post-amendment 2|Lack of Efficacy|24|||
33169813|NCT00160251|100528837|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
33169814|NCT00160251|100528838|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
33169815|NCT00160251|100528839|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
33169816|NCT00160251|100528840|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
33169817|NCT00160251|100528841|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
33169818|NCT00160251|100528842|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
33169819|NCT00160251|100528843|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
33169820|NCT00160251|100528844|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
33169821|NCT02617628|100528852|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
33169822|NCT02617628|100528853|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
33169823|NCT00612690|100528856|FG000|Overall Study|Lost to Follow-up|72|||
33169824|NCT00612690|100528857|FG001|Overall Study|Lost to Follow-up|98|||
33169825|NCT00612690|100528856|FG000|Overall Study|Withdrawal by Subject|32|||
33169826|NCT00612690|100528857|FG001|Overall Study|Withdrawal by Subject|20|||
33169827|NCT00612690|100528856|FG000|Overall Study|Withdrawal by Site|11|||
33169828|NCT00612690|100528857|FG001|Overall Study|Withdrawal by Site|0|||
33169829|NCT02622321|100528858|FG000|Overall Study|Withdrawal by Subject|2|||
33169830|NCT02622321|100528859|FG001|Overall Study|Withdrawal by Subject|0|||
33169831|NCT02622321|100528860|FG002|Overall Study|Withdrawal by Subject|0|||
33169832|NCT02622321|100528861|FG003|Overall Study|Withdrawal by Subject|0|||
33169833|NCT02622321|100528858|FG000|Overall Study|Death|0|||
33169834|NCT02622321|100528859|FG001|Overall Study|Death|0|||
33169835|NCT02622321|100528860|FG002|Overall Study|Death|1|||
33169836|NCT02622321|100528861|FG003|Overall Study|Death|0|||
33169837|NCT02622321|100528858|FG000|Overall Study|Physician Decision|1|||
33169838|NCT02622321|100528859|FG001|Overall Study|Physician Decision|0|||
33169839|NCT02622321|100528860|FG002|Overall Study|Physician Decision|0|||
33169840|NCT02622321|100528861|FG003|Overall Study|Physician Decision|0|||
33169841|NCT00600483|100528862|FG000|Overall Study|Lost to Follow-up|26|||
33169842|NCT00600483|100528863|FG001|Overall Study|Lost to Follow-up|47|||
33169843|NCT00600483|100528862|FG000|Overall Study|Randomized but not treated|10|||
33169844|NCT00600483|100528863|FG001|Overall Study|Randomized but not treated|0|||
33450299|NCT05292365|101538808|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
33450300|NCT05292365|101538809|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
33450301|NCT05292365|101538810|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
33450302|NCT01272037|101538811|FG000|Overall Study|Death|25|||
33450303|NCT01272037|101538812|FG001|Overall Study|Death|28|||
33261160|NCT00274469|100856533|FG001|Overall Study|Did not consent to OS follow-up|19|||
33261161|NCT00623194|100856537|FG000|Overall Study|Lack of Efficacy|1|||
33169845|NCT01985867|100528875|FG000|Overall Study|Lost to Follow-up|3|||
33169846|NCT01985867|100528876|FG001|Overall Study|Lost to Follow-up|4|||
33169847|NCT01985867|100528875|FG000|Overall Study|Adverse Event|3|||
33169848|NCT01985867|100528876|FG001|Overall Study|Adverse Event|2|||
33169849|NCT01985867|100528875|FG000|Overall Study|Lack of Efficacy|1|||
33169850|NCT01985867|100528876|FG001|Overall Study|Lack of Efficacy|0|||
33169851|NCT01340898|100528877|FG000|Primary Phase|Serious Adverse Events|0|||
33169852|NCT01340898|100528878|FG001|Primary Phase|Serious Adverse Events|0|||
33169853|NCT01340898|100528879|FG002|Primary Phase|Serious Adverse Events|1|||
33169854|NCT01340898|100528877|FG000|Primary Phase|Withdrawal by Subject|8|||
33169855|NCT01340898|100528878|FG001|Primary Phase|Withdrawal by Subject|7|||
33169856|NCT01340898|100528879|FG002|Primary Phase|Withdrawal by Subject|5|||
33169857|NCT01340898|100528877|FG000|Primary Phase|Migrated/moved from study area|4|||
33169858|NCT01340898|100528878|FG001|Primary Phase|Migrated/moved from study area|1|||
33169859|NCT01340898|100528879|FG002|Primary Phase|Migrated/moved from study area|0|||
33169860|NCT01340898|100528877|FG000|Primary Phase|Lost to Follow-up|4|||
33169861|NCT01340898|100528878|FG001|Primary Phase|Lost to Follow-up|1|||
33169862|NCT01340898|100528879|FG002|Primary Phase|Lost to Follow-up|0|||
33169863|NCT01340898|100528877|FG000|Booster Phase|Withdrawal by Subject|3|||
33169864|NCT01340898|100528878|FG001|Booster Phase|Withdrawal by Subject|0|||
33169865|NCT01340898|100528879|FG002|Booster Phase|Withdrawal by Subject|4|||
33169866|NCT01340898|100528877|FG000|Booster Phase|Migrated/moved from study area|3|||
33169867|NCT01340898|100528878|FG001|Booster Phase|Migrated/moved from study area|0|||
33450304|NCT01272037|101538811|FG000|Overall Study|Adverse Event|12|||
33169868|NCT01340898|100528879|FG002|Booster Phase|Migrated/moved from study area|0|||
33169869|NCT01340898|100528877|FG000|Booster Phase|Lost to Follow-up|4|||
33169870|NCT01340898|100528878|FG001|Booster Phase|Lost to Follow-up|2|||
33169871|NCT01340898|100528879|FG002|Booster Phase|Lost to Follow-up|3|||
33450305|NCT01272037|101538812|FG001|Overall Study|Adverse Event|7|||
33450306|NCT01272037|101538811|FG000|Overall Study|Withdrawal by Subject|175|||
33450307|NCT01272037|101538812|FG001|Overall Study|Withdrawal by Subject|93|||
33450308|NCT01272037|101538811|FG000|Overall Study|Disease progression|70|||
33450309|NCT01272037|101538812|FG001|Overall Study|Disease progression|111|||
33450310|NCT01272037|101538811|FG000|Overall Study|Other reason|42|||
33450311|NCT01272037|101538812|FG001|Overall Study|Other reason|41|||
33450312|NCT01272037|101538811|FG000|Overall Study|Delinquent data|24|||
33450313|NCT01272037|101538812|FG001|Overall Study|Delinquent data|19|||
33450314|NCT01272037|101538811|FG000|Overall Study|Reason under review|33|||
33450315|NCT01272037|101538812|FG001|Overall Study|Reason under review|29|||
33450316|NCT01272037|101538811|FG000|Overall Study|On treatment|626|||
33450317|NCT01272037|101538812|FG001|Overall Study|On treatment|632|||
33450318|NCT00835575|101538813|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
33450319|NCT00835575|101538814|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
33450320|NCT01811953|101538816|FG000|Overall Study|Adverse Event|0|||
33450321|NCT01811953|101538817|FG001|Overall Study|Adverse Event|0|||
33450322|NCT01811953|101538818|FG002|Overall Study|Adverse Event|0|||
33450323|NCT01811953|101538819|FG003|Overall Study|Adverse Event|1|||
33450324|NCT01811953|101538820|FG004|Overall Study|Adverse Event|0|||
33450325|NCT01811953|101538821|FG005|Overall Study|Adverse Event|1|||
33450326|NCT01811953|101538816|FG000|Overall Study|Protocol Violation|0|||
33450327|NCT01811953|101538817|FG001|Overall Study|Protocol Violation|0|||
33450328|NCT01811953|101538818|FG002|Overall Study|Protocol Violation|0|||
33450329|NCT01811953|101538819|FG003|Overall Study|Protocol Violation|0|||
33450330|NCT01811953|101538820|FG004|Overall Study|Protocol Violation|1|||
33450331|NCT01811953|101538821|FG005|Overall Study|Protocol Violation|0|||
33450332|NCT04678856|101538827|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
33450333|NCT04678856|101538828|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
33450334|NCT04678856|101538827|FG000|Overall Study|Withdrawal by Subject|5|||
33450335|NCT04678856|101538828|FG001|Overall Study|Withdrawal by Subject|1|||
33450336|NCT03769896|101538833|FG000|Open-label Phase|Lack of Efficacy|5|||
33450337|NCT03769896|101538834|FG001|Open-label Phase|Lack of Efficacy|0|||
33450338|NCT03769896|101538833|FG000|Open-label Phase|Adverse Event|3|||
33450339|NCT03769896|101538834|FG001|Open-label Phase|Adverse Event|0|||
33261162|NCT00623194|100856537|FG000|Overall Study|Protocol Violation|3|||
33450340|NCT03769896|101538833|FG000|Open-label Phase|Withdrawal by Subject|1|||
33450341|NCT03769896|101538834|FG001|Open-label Phase|Withdrawal by Subject|0|||
33450342|NCT00679081|101538835|FG000|Overall Study|Lost to Follow-up|1|||
33450343|NCT04236596|101538836|FG000|Overall Study|Withdrawal by Subject|1|||
33450344|NCT04236596|101538836|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
33450345|NCT04236596|101538836|FG000|Overall Study|Participants did not receive implant at all|4|||
33450346|NCT02635750|101538837|FG000|Part 1, Period 2|Adverse Event|1|||
33450347|NCT02635750|101538838|FG001|Part 1, Period 2|Adverse Event|0|||
33450348|NCT02635750|101538839|FG002|Part 1, Period 2|Adverse Event|0|||
33450349|NCT01169558|101538840|FG000|Overall Study|Disease progression|98|||
33450350|NCT01169558|101538840|FG000|Overall Study|Adverse Event|25|||
33450351|NCT01169558|101538840|FG000|Overall Study|Withdrawal of Consent|8|||
33450352|NCT01169558|101538840|FG000|Overall Study|Medical Decision|7|||
33450353|NCT01169558|101538840|FG000|Overall Study|Stable Disease|4|||
33450354|NCT01169558|101538840|FG000|Overall Study|Lost to Follow-up|4|||
33450355|NCT01169558|101538840|FG000|Overall Study|Need for Surgery|4|||
33450356|NCT01169558|101538840|FG000|Overall Study|Non-compliance|2|||
33169872|NCT00563381|100528880|FG000|Overall Study|Adverse Event|264|||
33169873|NCT00563381|100528881|FG001|Overall Study|Adverse Event|292|||
33169874|NCT00563381|100528880|FG000|Overall Study|Protocol Violation|66|||
33450357|NCT01169558|101538840|FG000|Overall Study|Protocol Violation|2|||
33450358|NCT01169558|101538840|FG000|Overall Study|Partial response|2|||
33450359|NCT01013649|101538841|FG000|First Step|Withdrawal by Subject|36|||
33450360|NCT01013649|101538842|FG001|First Step|Withdrawal by Subject|19|||
33450361|NCT01013649|101538843|FG002|First Step|Withdrawal by Subject|0|||
33450362|NCT01013649|101538844|FG003|First Step|Withdrawal by Subject|0|||
33450363|NCT01013649|101538841|FG000|First Step|Progression|58|||
33450364|NCT01013649|101538842|FG001|First Step|Progression|23|||
33450365|NCT01013649|101538843|FG002|First Step|Progression|0|||
33450366|NCT01013649|101538844|FG003|First Step|Progression|0|||
33450367|NCT01013649|101538841|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
33450368|NCT01013649|101538842|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
33450369|NCT01013649|101538843|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
33450370|NCT01013649|101538844|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
33450371|NCT01013649|101538841|FG000|First Step|Death|3|||
33450372|NCT01013649|101538842|FG001|First Step|Death|4|||
33450373|NCT01013649|101538843|FG002|First Step|Death|0|||
33450374|NCT01013649|101538844|FG003|First Step|Death|0|||
33450375|NCT01013649|101538841|FG000|First Step|Adverse Event|9|||
33450376|NCT01013649|101538842|FG001|First Step|Adverse Event|5|||
33450377|NCT01013649|101538843|FG002|First Step|Adverse Event|0|||
33450378|NCT01013649|101538844|FG003|First Step|Adverse Event|0|||
33450379|NCT01013649|101538841|FG000|First Step|Other|4|||
33450380|NCT01013649|101538842|FG001|First Step|Other|6|||
33450381|NCT01013649|101538843|FG002|First Step|Other|0|||
33450382|NCT01013649|101538844|FG003|First Step|Other|0|||
33450383|NCT01056484|101538845|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
33450384|NCT01056484|101538846|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
33450385|NCT01056484|101538845|FG000|Randomized Controlled Trial|Physician Decision|1|||
33450386|NCT01056484|101538846|FG001|Randomized Controlled Trial|Physician Decision|0|||
33450387|NCT01056484|101538845|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
33450388|NCT01056484|101538846|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
33450389|NCT00840879|101538849|FG000|Second Intervention|Withdrawal by Subject|1|||
33450390|NCT00840879|101538850|FG001|Second Intervention|Withdrawal by Subject|0|||
33450391|NCT02267187|101538851|FG000|Overall Study|Physician Decision|2|||
33450392|NCT02267187|101538851|FG000|Overall Study|Screen fail|3|||
33450393|NCT01537887|101538852|FG000|Period 1|Physician Decision|0|||
33450394|NCT01537887|101538853|FG001|Period 1|Physician Decision|0|||
33450395|NCT01537887|101538854|FG002|Period 1|Physician Decision|0|||
33169875|NCT00563381|100528881|FG001|Overall Study|Protocol Violation|74|||
33169876|NCT00563381|100528880|FG000|Overall Study|Lost to Follow-up|7|||
33169877|NCT00563381|100528881|FG001|Overall Study|Lost to Follow-up|15|||
33169878|NCT00563381|100528880|FG000|Overall Study|Withdrawal by Subject|192|||
33169879|NCT00563381|100528881|FG001|Overall Study|Withdrawal by Subject|209|||
33169880|NCT00563381|100528880|FG000|Overall Study|Lack of Efficacy|32|||
33169881|NCT00563381|100528881|FG001|Overall Study|Lack of Efficacy|24|||
33169882|NCT00563381|100528880|FG000|Overall Study|Individual different reasons|24|||
33169883|NCT00563381|100528881|FG001|Overall Study|Individual different reasons|34|||
33169884|NCT04016285|100528882|FG000|Overall Study|Did not progress to surgery|2|||
33169885|NCT04016285|100528883|FG001|Overall Study|Did not progress to surgery|5|||
33169886|NCT04016285|100528882|FG000|Overall Study|Failed to collect outcome data|5|||
33169887|NCT04016285|100528883|FG001|Overall Study|Failed to collect outcome data|3|||
33169888|NCT00276744|100528898|FG000|PART A|Reason unknown|98|||
33169889|NCT00688753|100528899|FG000|Overall Study|Disease progression|55|||
33169890|NCT00688753|100528899|FG000|Overall Study|Missing|1|||
33169891|NCT00688753|100528899|FG000|Overall Study|Death|9|||
33169892|NCT00688753|100528899|FG000|Overall Study|Withdrawal by Subject|3|||
33169893|NCT00688753|100528899|FG000|Overall Study|Adverse Event|20|||
33169894|NCT00688753|100528899|FG000|Overall Study|Protocol Violation|1|||
33169895|NCT00688753|100528899|FG000|Overall Study|Lost to Follow-up|3|||
33169896|NCT04221009|100528900|FG000|Overall Study|Withdrawal by Subject|4|||
33169897|NCT01336764|100528901|FG000|Overall Study|Withdrawal by Subject|5|||
33169898|NCT01336764|100528902|FG001|Overall Study|Withdrawal by Subject|5|||
33169899|NCT02966028|100528903|FG000|Overall Study|Adverse Event|7|||
33169900|NCT02966028|100528904|FG001|Overall Study|Adverse Event|13|||
33169901|NCT02966028|100528905|FG002|Overall Study|Adverse Event|10|||
33169902|NCT02966028|100528903|FG000|Overall Study|Physician Decision|1|||
33169903|NCT02966028|100528904|FG001|Overall Study|Physician Decision|0|||
33169904|NCT02966028|100528905|FG002|Overall Study|Physician Decision|2|||
33169905|NCT02966028|100528903|FG000|Overall Study|Withdrawal by Subject|7|||
33169906|NCT02966028|100528904|FG001|Overall Study|Withdrawal by Subject|5|||
33169907|NCT02966028|100528905|FG002|Overall Study|Withdrawal by Subject|5|||
33169908|NCT02966028|100528903|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
33450396|NCT01537887|101538855|FG003|Period 1|Physician Decision|0|||
33261163|NCT00623194|100856537|FG000|Overall Study|Unclassified|1|||
33450397|NCT01537887|101538856|FG004|Period 1|Physician Decision|1|||
33450398|NCT01537887|101538857|FG005|Period 1|Physician Decision|1|||
33450399|NCT01537887|101538852|FG000|Period 1|Did not receive treatment|0|||
33169909|NCT02966028|100528904|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
33169910|NCT02966028|100528905|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
33450400|NCT01537887|101538853|FG001|Period 1|Did not receive treatment|0|||
33169911|NCT00848081|100528906|FG000|Overall Study|Adverse Event|6|||
33261164|NCT01952366|100856540|FG000|Overall Study|Death|22|||
33169912|NCT00848081|100528907|FG001|Overall Study|Adverse Event|7|||
33169913|NCT00848081|100528906|FG000|Overall Study|Protocol Violation|8|||
33169914|NCT00848081|100528907|FG001|Overall Study|Protocol Violation|5|||
33169915|NCT00848081|100528906|FG000|Overall Study|Lost to Follow-up|1|||
33169916|NCT00848081|100528907|FG001|Overall Study|Lost to Follow-up|0|||
33169917|NCT00848081|100528906|FG000|Overall Study|Physician Decision|0|||
33169918|NCT00848081|100528907|FG001|Overall Study|Physician Decision|3|||
33169919|NCT00848081|100528906|FG000|Overall Study|Withdrawal by Subject|5|||
33169920|NCT00848081|100528907|FG001|Overall Study|Withdrawal by Subject|3|||
33169921|NCT05131646|100528908|FG000|Overall Study|Withdrawal by Subject|1|||
33169922|NCT05131646|100528909|FG001|Overall Study|Withdrawal by Subject|0|||
33169923|NCT05131646|100528910|FG002|Overall Study|Withdrawal by Subject|0|||
33169924|NCT01919723|100528911|FG000|Overall Study|Blood Samples Hemolyzed|2|||
33450401|NCT01537887|101538854|FG002|Period 1|Did not receive treatment|1|||
33450402|NCT01537887|101538855|FG003|Period 1|Did not receive treatment|0|||
33450403|NCT01537887|101538856|FG004|Period 1|Did not receive treatment|0|||
33450404|NCT01537887|101538857|FG005|Period 1|Did not receive treatment|0|||
33169925|NCT01919723|100528912|FG001|Overall Study|Blood Samples Hemolyzed|2|||
33169926|NCT01958008|100528913|FG000|Overall Study|Worsening of disease under study|0|||
33169927|NCT01958008|100528914|FG001|Overall Study|Worsening of disease under study|0|||
33450405|NCT01537887|101538852|FG000|Period 2|Withdrawal by Subject|0|||
33450406|NCT01537887|101538853|FG001|Period 2|Withdrawal by Subject|1|||
33450407|NCT01537887|101538854|FG002|Period 2|Withdrawal by Subject|0|||
33450408|NCT01537887|101538855|FG003|Period 2|Withdrawal by Subject|0|||
33169928|NCT01958008|100528915|FG002|Overall Study|Worsening of disease under study|1|||
33169929|NCT01958008|100528916|FG003|Overall Study|Worsening of disease under study|0|||
33169930|NCT01958008|100528913|FG000|Overall Study|Other adverse event|1|||
33450409|NCT01537887|101538856|FG004|Period 2|Withdrawal by Subject|0|||
33450410|NCT01537887|101538857|FG005|Period 2|Withdrawal by Subject|0|||
33450411|NCT01537887|101538852|FG000|Period 3|Adverse Event|0|||
33450412|NCT01537887|101538853|FG001|Period 3|Adverse Event|0|||
33450413|NCT01537887|101538854|FG002|Period 3|Adverse Event|1|||
33450414|NCT01537887|101538855|FG003|Period 3|Adverse Event|0|||
33169931|NCT01958008|100528914|FG001|Overall Study|Other adverse event|0|||
33169932|NCT01958008|100528915|FG002|Overall Study|Other adverse event|0|||
33169933|NCT01958008|100528916|FG003|Overall Study|Other adverse event|0|||
33169934|NCT02509156|100528917|FG000|Randomized Phase|Death|1|||
33169935|NCT02509156|100528918|FG001|Randomized Phase|Death|0|||
33169936|NCT02509156|100528917|FG000|Randomized Phase|Withdrawal by Subject|1|||
33169937|NCT02509156|100528918|FG001|Randomized Phase|Withdrawal by Subject|1|||
33169938|NCT03789318|100528919|FG000|Overall Study|Adverse Event|0|||
33169939|NCT03789318|100528920|FG001|Overall Study|Adverse Event|0|||
33169940|NCT03789318|100528921|FG002|Overall Study|Adverse Event|1|||
33169941|NCT03789318|100528922|FG003|Overall Study|Adverse Event|1|||
33169942|NCT03789318|100528923|FG004|Overall Study|Adverse Event|0|||
33169943|NCT03789318|100528919|FG000|Overall Study|Lost to Follow-up|0|||
33169944|NCT03789318|100528920|FG001|Overall Study|Lost to Follow-up|0|||
33169945|NCT03789318|100528921|FG002|Overall Study|Lost to Follow-up|1|||
33169946|NCT03789318|100528922|FG003|Overall Study|Lost to Follow-up|0|||
33169947|NCT03789318|100528923|FG004|Overall Study|Lost to Follow-up|0|||
33169948|NCT03789318|100528919|FG000|Overall Study|Withdrawal by Subject|0|||
33169949|NCT03789318|100528920|FG001|Overall Study|Withdrawal by Subject|0|||
33169950|NCT03789318|100528921|FG002|Overall Study|Withdrawal by Subject|1|||
33169951|NCT03789318|100528922|FG003|Overall Study|Withdrawal by Subject|0|||
33169952|NCT03789318|100528923|FG004|Overall Study|Withdrawal by Subject|0|||
33169953|NCT01276353|100528924|FG000|Double-blind|Adverse Event|2|||
33169954|NCT01276353|100528925|FG001|Double-blind|Adverse Event|0|||
33169955|NCT01276353|100528924|FG000|Double-blind|Withdrawal by Subject|1|||
33169956|NCT01276353|100528925|FG001|Double-blind|Withdrawal by Subject|0|||
33169957|NCT01276353|100528924|FG000|Extension|Adverse Event|2|||
33169958|NCT01276353|100528925|FG001|Extension|Adverse Event|5|||
33169959|NCT01276353|100528924|FG000|Extension|Withdrawal by Subject|1|||
33169960|NCT01276353|100528925|FG001|Extension|Withdrawal by Subject|2|||
33169961|NCT01276353|100528924|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
33169962|NCT01276353|100528925|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
33169963|NCT01276353|100528924|FG000|Extension|Physician Decision|1|||
33169964|NCT01276353|100528925|FG001|Extension|Physician Decision|0|||
33169965|NCT01276353|100528924|FG000|Extension|Prohibited concomitant medications|0|||
33169966|NCT01276353|100528925|FG001|Extension|Prohibited concomitant medications|1|||
33169967|NCT04203238|100528928|FG000|Overall Study|Withdrawal by Subject|1|||
33169968|NCT04203238|100528929|FG001|Overall Study|Withdrawal by Subject|1|||
33169969|NCT04203238|100528928|FG000|Overall Study|Covid-19|3|||
33169970|NCT04203238|100528929|FG001|Overall Study|Covid-19|0|||
33169971|NCT02324569|100528930|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
33169972|NCT02324569|100528931|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
33169973|NCT02324569|100528930|FG000|Overall Study|Voluntary Withdrawal|3|||
33169974|NCT02324569|100528931|FG001|Overall Study|Voluntary Withdrawal|6|||
33169975|NCT02324569|100528930|FG000|Overall Study|Lack of Efficacy|2|||
33169976|NCT02324569|100528931|FG001|Overall Study|Lack of Efficacy|3|||
33169977|NCT02324569|100528930|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
33169978|NCT02324569|100528931|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
33169979|NCT02324569|100528930|FG000|Overall Study|Inconvenient Schedule|2|||
33169980|NCT02324569|100528931|FG001|Overall Study|Inconvenient Schedule|0|||
33169981|NCT02954237|100528933|FG000|Overall Study|Withdrawal by Subject|25|||
33169982|NCT02954237|100528933|FG000|Overall Study|Missed visit|16|||
33169983|NCT02954237|100528933|FG000|Overall Study|Death|2|||
33169984|NCT04851314|100528934|FG000|Overall Study|Unable to complete research set-up procedures|0|||
33169985|NCT04851314|100528935|FG001|Overall Study|Unable to complete research set-up procedures|2|||
33450415|NCT01537887|101538856|FG004|Period 3|Adverse Event|0|||
33450416|NCT01537887|101538857|FG005|Period 3|Adverse Event|0|||
33169986|NCT04851314|100528934|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
33169987|NCT04851314|100528935|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
33169988|NCT01664533|100528942|FG000|Overall Study|Death|42|||
33169989|NCT01664533|100528942|FG000|Overall Study|Lost to Follow-up|3|||
33450417|NCT01537887|101538852|FG000|Period 3|Withdrawal by Subject|0|||
33450418|NCT01537887|101538853|FG001|Period 3|Withdrawal by Subject|1|||
33450419|NCT01537887|101538854|FG002|Period 3|Withdrawal by Subject|0|||
33169990|NCT01664533|100528942|FG000|Overall Study|Study termination|9|||
33169991|NCT01664533|100528942|FG000|Overall Study|Protocol Violation|3|||
33169992|NCT01850524|100528944|FG000|Overall Study|Lost to Follow-up|5|||
33261165|NCT01952366|100856540|FG000|Overall Study|Withdrawal by Subject|9|||
33450420|NCT01537887|101538855|FG003|Period 3|Withdrawal by Subject|0|||
33450421|NCT01537887|101538856|FG004|Period 3|Withdrawal by Subject|0|||
33169993|NCT01850524|100528945|FG001|Overall Study|Lost to Follow-up|10|||
33450422|NCT01537887|101538857|FG005|Period 3|Withdrawal by Subject|0|||
33261166|NCT02932579|100856549|FG000|Overall Study|Withdrawal by Subject|4|||
33261167|NCT02932579|100856550|FG001|Overall Study|Withdrawal by Subject|1|||
33261168|NCT01113931|100856554|FG000|Overall Study|Adverse Event|2|||
33261169|NCT01113931|100856555|FG001|Overall Study|Adverse Event|2|||
33450423|NCT00489307|101538862|FG000|Overall Study|Death|1|||
33450424|NCT00489307|101538863|FG001|Overall Study|Death|1|||
33450425|NCT00489307|101538862|FG000|Overall Study|Lost to Follow-up|2|||
33450426|NCT00489307|101538863|FG001|Overall Study|Lost to Follow-up|2|||
33450427|NCT00489307|101538862|FG000|Overall Study|Physician Decision|1|||
33450428|NCT00489307|101538863|FG001|Overall Study|Physician Decision|0|||
33450429|NCT00489307|101538862|FG000|Overall Study|Withdrawal by Subject|2|||
33450430|NCT00489307|101538863|FG001|Overall Study|Withdrawal by Subject|4|||
33450431|NCT00489307|101538862|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
33450432|NCT00489307|101538863|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
33450433|NCT00489307|101538862|FG000|Overall Study|Surgery after assignment|1|||
33450434|NCT00489307|101538863|FG001|Overall Study|Surgery after assignment|0|||
33450435|NCT00489307|101538862|FG000|Overall Study|Did not fill up the forms|2|||
33450436|NCT00489307|101538863|FG001|Overall Study|Did not fill up the forms|1|||
33450437|NCT00489307|101538862|FG000|Overall Study|Patient or family refusal|5|||
33450438|NCT00489307|101538863|FG001|Overall Study|Patient or family refusal|9|||
33450439|NCT00418938|101538864|FG000|Overall Study|Reimbursement|1|||
33450440|NCT00418938|101538865|FG001|Overall Study|Reimbursement|0|||
33450441|NCT00418938|101538864|FG000|Overall Study|Administrative decision|3|||
33261170|NCT01113931|100856554|FG000|Overall Study|Physician Decision|0|||
33261171|NCT01113931|100856555|FG001|Overall Study|Physician Decision|2|||
33261172|NCT01113931|100856554|FG000|Overall Study|Lost to Follow-up|12|||
33261173|NCT01113931|100856555|FG001|Overall Study|Lost to Follow-up|9|||
33261174|NCT01113931|100856554|FG000|Overall Study|Various|2|||
33261175|NCT01113931|100856555|FG001|Overall Study|Various|4|||
33261176|NCT01113931|100856554|FG000|Overall Study|Withdrawal by Subject|3|||
33261177|NCT01113931|100856555|FG001|Overall Study|Withdrawal by Subject|0|||
33261178|NCT02652442|100856556|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
33261179|NCT00739908|100856563|FG000|Overall Study|Adverse Event|5|||
33450442|NCT00418938|101538865|FG001|Overall Study|Administrative decision|3|||
33450443|NCT00418938|101538864|FG000|Overall Study|Withdrawal by Subject|16|||
33450444|NCT00418938|101538865|FG001|Overall Study|Withdrawal by Subject|15|||
33450445|NCT00418938|101538864|FG000|Overall Study|Lost to Follow-up|1|||
33261180|NCT00739908|100856564|FG001|Overall Study|Adverse Event|6|||
33450446|NCT00418938|101538865|FG001|Overall Study|Lost to Follow-up|3|||
33450447|NCT00418938|101538864|FG000|Overall Study|Adverse Event|1|||
33450448|NCT00418938|101538865|FG001|Overall Study|Adverse Event|1|||
33261181|NCT00739908|100856563|FG000|Overall Study|Withdrawal by Subject|4|||
33450449|NCT00418938|101538864|FG000|Overall Study|On-going|1|||
33450450|NCT00418938|101538865|FG001|Overall Study|On-going|1|||
33450451|NCT00418938|101538864|FG000|Overall Study|Ineligibility Determined|1|||
33450452|NCT00418938|101538865|FG001|Overall Study|Ineligibility Determined|0|||
33450453|NCT03939897|101538866|FG000|Overall Study|Still receiving active treatment|0|||
33450454|NCT03939897|101538867|FG001|Overall Study|Still receiving active treatment|0|||
33450455|NCT03939897|101538868|FG002|Overall Study|Still receiving active treatment|1|||
33450456|NCT03939897|101538869|FG003|Overall Study|Still receiving active treatment|0|||
33450457|NCT03939897|101538870|FG004|Overall Study|Still receiving active treatment|0|||
33450458|NCT03939897|101538871|FG005|Overall Study|Still receiving active treatment|0|||
33450459|NCT03106415|101538872|FG000|Phase 1|Withdrawal by Subject|1|||
33450460|NCT03106415|101538873|FG001|Phase 1|Withdrawal by Subject|0|||
33450461|NCT03106415|101538874|FG002|Phase 1|Withdrawal by Subject|0|||
33450462|NCT03106415|101538872|FG000|Phase 1|Adverse Event|1|||
33450463|NCT03106415|101538873|FG001|Phase 1|Adverse Event|1|||
33450464|NCT03106415|101538874|FG002|Phase 1|Adverse Event|0|||
33450465|NCT03106415|101538872|FG000|Phase 1|Protocol Violation|0|||
33450466|NCT03106415|101538873|FG001|Phase 1|Protocol Violation|1|||
33450467|NCT03106415|101538874|FG002|Phase 1|Protocol Violation|0|||
33450468|NCT03325881|101538879|FG000|Overall Study|Protocol Violation|0|||
33450469|NCT03325881|101538880|FG001|Overall Study|Protocol Violation|1|||
33450470|NCT03325881|101538879|FG000|Overall Study|Withdrawal by Subject|0|||
33450471|NCT03325881|101538880|FG001|Overall Study|Withdrawal by Subject|2|||
33450472|NCT03325881|101538879|FG000|Overall Study|Lack of Efficacy|2|||
33450473|NCT03325881|101538880|FG001|Overall Study|Lack of Efficacy|0|||
33450474|NCT03325881|101538879|FG000|Overall Study|Not treated|1|||
33450475|NCT03325881|101538880|FG001|Overall Study|Not treated|0|||
33450476|NCT01983969|101538885|FG000|Overall Study|Disease Progression|0|||
33450477|NCT01983969|101538886|FG001|Overall Study|Disease Progression|1|||
33450478|NCT01983969|101538887|FG002|Overall Study|Disease Progression|0|||
33450479|NCT00377260|101538888|FG000|Overall Study|Lost to Follow-up|0|||
33450480|NCT00377260|101538889|FG001|Overall Study|Lost to Follow-up|1|||
33450481|NCT00377260|101538888|FG000|Overall Study|Withdrawal by Subject|2|||
33450482|NCT00377260|101538889|FG001|Overall Study|Withdrawal by Subject|4|||
33450483|NCT02272803|101538892|FG000|Overall Study|Disease progression|16|||
33450484|NCT02272803|101538893|FG001|Overall Study|Disease progression|8|||
33450485|NCT02272803|101538892|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
33450486|NCT02272803|101538893|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
33450487|NCT02272803|101538892|FG000|Overall Study|Study drug toxicity|4|||
33450488|NCT02272803|101538893|FG001|Overall Study|Study drug toxicity|9|||
33450489|NCT02272803|101538892|FG000|Overall Study|Participant request to discontinue study treatment|3|||
33450490|NCT02272803|101538893|FG001|Overall Study|Participant request to discontinue study treatment|7|||
33450491|NCT02272803|101538892|FG000|Overall Study|Maximum clinical benefit|4|||
33450492|NCT02272803|101538893|FG001|Overall Study|Maximum clinical benefit|2|||
33450493|NCT02272803|101538892|FG000|Overall Study|Poor/non-compliance|2|||
33450494|NCT02272803|101538893|FG001|Overall Study|Poor/non-compliance|2|||
33450495|NCT02272803|101538892|FG000|Overall Study|Withdrawal by Subject|2|||
33450496|NCT02272803|101538893|FG001|Overall Study|Withdrawal by Subject|1|||
33450497|NCT02272803|101538892|FG000|Overall Study|Death|0|||
33450498|NCT02272803|101538893|FG001|Overall Study|Death|1|||
33450499|NCT02272803|101538892|FG000|Overall Study|Other reasons|1|||
33450500|NCT02272803|101538893|FG001|Overall Study|Other reasons|3|||
33450501|NCT02272803|101538892|FG000|Overall Study|Administrative reason by sponsor|5|||
33450502|NCT02272803|101538893|FG001|Overall Study|Administrative reason by sponsor|4|||
33450503|NCT00470704|101538898|FG000|Overall Study|Withdrawal by Subject|4|||
33450504|NCT00470704|101538899|FG001|Overall Study|Withdrawal by Subject|3|||
33450505|NCT00470704|101538898|FG000|Overall Study|Relapse/Progression|37|||
33450506|NCT00470704|101538899|FG001|Overall Study|Relapse/Progression|42|||
33450507|NCT00470704|101538898|FG000|Overall Study|toxicity|0|||
33450508|NCT00470704|101538899|FG001|Overall Study|toxicity|1|||
33450509|NCT02815566|101538900|FG000|Overall Study|Adverse Event|1|||
33450510|NCT02815566|101538901|FG001|Overall Study|Adverse Event|1|||
33450511|NCT02815566|101538900|FG000|Overall Study|Withdrawal by Subject|1|||
33450512|NCT02815566|101538901|FG001|Overall Study|Withdrawal by Subject|0|||
33450513|NCT02815566|101538900|FG000|Overall Study|Lost to Follow-up|0|||
33169994|NCT01850524|100528944|FG000|Overall Study|Withdrawal by Subject|24|||
33450514|NCT02815566|101538901|FG001|Overall Study|Lost to Follow-up|1|||
33450515|NCT03904147|101538902|FG000|Overall Study|Death|15|||
33450516|NCT03904147|101538903|FG001|Overall Study|Death|13|||
33450517|NCT03904147|101538904|FG002|Overall Study|Death|15|||
33450518|NCT03904147|101538902|FG000|Overall Study|Withdrawal by Subject|7|||
33450519|NCT03904147|101538903|FG001|Overall Study|Withdrawal by Subject|12|||
33450520|NCT03904147|101538904|FG002|Overall Study|Withdrawal by Subject|1|||
33450521|NCT03904147|101538902|FG000|Overall Study|1Y visit completed after 365 days|1|||
33169995|NCT01850524|100528945|FG001|Overall Study|Withdrawal by Subject|22|||
33169996|NCT01850524|100528944|FG000|Overall Study|Reason not Specified|142|||
33450522|NCT03904147|101538903|FG001|Overall Study|1Y visit completed after 365 days|1|||
33450523|NCT03904147|101538904|FG002|Overall Study|1Y visit completed after 365 days|0|||
33450524|NCT02890355|101538905|FG000|Overall Study|Adverse Event|5|||
33169997|NCT01850524|100528945|FG001|Overall Study|Reason not Specified|141|||
33169998|NCT02034110|100528946|FG000|Overall Study|Physician Decision|0|||
33169999|NCT02034110|100528947|FG001|Overall Study|Physician Decision|0|||
33170000|NCT02034110|100528948|FG002|Overall Study|Physician Decision|0|||
33170001|NCT02034110|100528949|FG003|Overall Study|Physician Decision|0|||
33170002|NCT02034110|100528950|FG004|Overall Study|Physician Decision|2|||
33170003|NCT02034110|100528951|FG005|Overall Study|Physician Decision|0|||
33170004|NCT02034110|100528952|FG006|Overall Study|Physician Decision|1|||
33170005|NCT02034110|100528953|FG007|Overall Study|Physician Decision|0|||
33170006|NCT02034110|100528946|FG000|Overall Study|Lost to Follow-up|1|||
33170007|NCT02034110|100528947|FG001|Overall Study|Lost to Follow-up|0|||
33170008|NCT02034110|100528948|FG002|Overall Study|Lost to Follow-up|0|||
33170009|NCT02034110|100528949|FG003|Overall Study|Lost to Follow-up|0|||
33170010|NCT02034110|100528950|FG004|Overall Study|Lost to Follow-up|1|||
33170011|NCT02034110|100528951|FG005|Overall Study|Lost to Follow-up|0|||
33170012|NCT02034110|100528952|FG006|Overall Study|Lost to Follow-up|1|||
33170013|NCT02034110|100528953|FG007|Overall Study|Lost to Follow-up|0|||
33170014|NCT02034110|100528946|FG000|Overall Study|Withdrawal by Subject|5|||
33170015|NCT02034110|100528947|FG001|Overall Study|Withdrawal by Subject|7|||
33170016|NCT02034110|100528948|FG002|Overall Study|Withdrawal by Subject|0|||
33170017|NCT02034110|100528949|FG003|Overall Study|Withdrawal by Subject|3|||
33170018|NCT02034110|100528950|FG004|Overall Study|Withdrawal by Subject|7|||
33170019|NCT02034110|100528951|FG005|Overall Study|Withdrawal by Subject|0|||
33170020|NCT02034110|100528952|FG006|Overall Study|Withdrawal by Subject|3|||
33170021|NCT02034110|100528953|FG007|Overall Study|Withdrawal by Subject|1|||
33170022|NCT02034110|100528946|FG000|Overall Study|Study closed by sponsor|6|||
33170023|NCT02034110|100528947|FG001|Overall Study|Study closed by sponsor|2|||
33170024|NCT02034110|100528948|FG002|Overall Study|Study closed by sponsor|0|||
33170025|NCT02034110|100528949|FG003|Overall Study|Study closed by sponsor|6|||
33170026|NCT02034110|100528950|FG004|Overall Study|Study closed by sponsor|7|||
33170027|NCT02034110|100528951|FG005|Overall Study|Study closed by sponsor|0|||
33170028|NCT02034110|100528952|FG006|Overall Study|Study closed by sponsor|42|||
33170029|NCT02034110|100528953|FG007|Overall Study|Study closed by sponsor|0|||
33170030|NCT00964860|100528957|FG000|Overall Study|Withdrawal by Subject|0|||
33170031|NCT00964860|100528958|FG001|Overall Study|Withdrawal by Subject|1|||
33170032|NCT00171730|100528959|FG000|Overall Study|Adverse Event|3|||
33170033|NCT00171730|100528959|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
33170034|NCT00171730|100528959|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
33170035|NCT00171730|100528959|FG000|Overall Study|Withdrawal by Subject|3|||
33170036|NCT01906008|100528960|FG000|Overall Study|Lost to Follow-up|2|||
33170037|NCT01906008|100528961|FG001|Overall Study|Lost to Follow-up|0|||
33170038|NCT01906008|100528960|FG000|Overall Study|Oxaliplatin toxicity|2|||
33170039|NCT01906008|100528961|FG001|Overall Study|Oxaliplatin toxicity|0|||
33170040|NCT01906008|100528960|FG000|Overall Study|Protocol Violation|0|||
33170041|NCT01906008|100528961|FG001|Overall Study|Protocol Violation|1|||
33170042|NCT01906008|100528960|FG000|Overall Study|Withdrawal by Subject|1|||
33170043|NCT01906008|100528961|FG001|Overall Study|Withdrawal by Subject|5|||
33170044|NCT01906008|100528960|FG000|Overall Study|Did not start study med|3|||
33170045|NCT01906008|100528961|FG001|Overall Study|Did not start study med|4|||
33170046|NCT01906008|100528960|FG000|Overall Study|Oxaliplatin stops|10|||
33170047|NCT01906008|100528961|FG001|Overall Study|Oxaliplatin stops|8|||
33170048|NCT01906008|100528960|FG000|Overall Study|Hospice|1|||
33170049|NCT01906008|100528961|FG001|Overall Study|Hospice|0|||
33170050|NCT01906008|100528960|FG000|Overall Study|Physician Decision|3|||
33170051|NCT01906008|100528961|FG001|Overall Study|Physician Decision|3|||
33170052|NCT01906008|100528960|FG000|Overall Study|Lack of compliance of study med|5|||
33170053|NCT01906008|100528961|FG001|Overall Study|Lack of compliance of study med|3|||
33170054|NCT01906008|100528960|FG000|Overall Study|Adverse Event|0|||
33170055|NCT01906008|100528961|FG001|Overall Study|Adverse Event|3|||
33170056|NCT00673465|100528964|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
33170057|NCT00673465|100528965|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
33170058|NCT00673465|100528966|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
33170059|NCT00673465|100528967|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
33170060|NCT00673465|100528968|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
33170061|NCT00673465|100528969|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
33170062|NCT00673465|100528970|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
33170063|NCT00673465|100528971|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
33170064|NCT00673465|100528972|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
33170065|NCT00673465|100528973|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
33170066|NCT00673465|100528974|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
33170067|NCT00673465|100528975|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
33170068|NCT00673465|100528964|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
33170069|NCT00673465|100528965|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
33170070|NCT00673465|100528966|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
33170071|NCT00673465|100528967|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
33170072|NCT00673465|100528968|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
33170073|NCT00673465|100528969|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
33170074|NCT00673465|100528970|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
33170075|NCT00673465|100528971|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
33170076|NCT00673465|100528972|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
33170077|NCT00673465|100528973|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
33170078|NCT00673465|100528974|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
33170079|NCT00673465|100528975|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
33170080|NCT02573311|100528980|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
33170081|NCT02573311|100528981|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
33170082|NCT02573311|100528980|FG000|Disposition for Part 2|Physician Decision|25|||
33170083|NCT02573311|100528981|FG001|Disposition for Part 2|Physician Decision|7|||
33170084|NCT02573311|100528980|FG000|Disposition for Part 2|Adverse Event|36|||
33450525|NCT02890355|101538906|FG001|Overall Study|Adverse Event|5|||
33450526|NCT02890355|101538905|FG000|Overall Study|Refusal unrelated to adverse event|5|||
33450527|NCT02890355|101538906|FG001|Overall Study|Refusal unrelated to adverse event|10|||
33450528|NCT02890355|101538905|FG000|Overall Study|Progression/relapse|46|||
33450529|NCT02890355|101538906|FG001|Overall Study|Progression/relapse|39|||
33450530|NCT02890355|101538905|FG000|Overall Study|Not protocol specified|3|||
33450531|NCT02890355|101538906|FG001|Overall Study|Not protocol specified|4|||
33450532|NCT02476916|101538909|FG000|Core Period|Adverse Event|2|||
33450533|NCT02476916|101538910|FG001|Core Period|Adverse Event|2|||
33450534|NCT02476916|101538909|FG000|Core Period|Investigator decision|1|||
33450535|NCT02476916|101538910|FG001|Core Period|Investigator decision|1|||
33450536|NCT02476916|101538909|FG000|Core Period|Withdrawal by Subject|3|||
33450537|NCT02476916|101538910|FG001|Core Period|Withdrawal by Subject|0|||
33450538|NCT02476916|101538909|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
33450539|NCT02476916|101538910|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
33450540|NCT02476916|101538909|FG000|Extension Period|On Treatment|12|||
33450541|NCT02476916|101538910|FG001|Extension Period|On Treatment|17|||
33450542|NCT03307343|101538913|FG000|Overall Study|Withdrawal by Subject|1|||
33450543|NCT03307343|101538914|FG001|Overall Study|Withdrawal by Subject|2|||
33450544|NCT03307343|101538913|FG000|Overall Study|Pregnancy|0|||
33450545|NCT03307343|101538914|FG001|Overall Study|Pregnancy|2|||
33450546|NCT03307343|101538913|FG000|Overall Study|Physician Decision|1|||
33450547|NCT03307343|101538914|FG001|Overall Study|Physician Decision|0|||
33450548|NCT03307343|101538913|FG000|Overall Study|Lost to Follow-up|0|||
33450549|NCT03307343|101538914|FG001|Overall Study|Lost to Follow-up|2|||
33450550|NCT01501955|101538917|FG000|Overall Study|Withdrawal by Subject|1|||
33450551|NCT01501955|101538918|FG001|Overall Study|Withdrawal by Subject|0|||
33450552|NCT01501955|101538917|FG000|Overall Study|Adverse Event|1|||
33450553|NCT01501955|101538918|FG001|Overall Study|Adverse Event|3|||
33450554|NCT03279978|101538919|FG000|Overall Study|Withdrawal by Subject|0|||
33450555|NCT03279978|101538920|FG001|Overall Study|Withdrawal by Subject|1|||
33450556|NCT03279978|101538921|FG002|Overall Study|Withdrawal by Subject|0|||
33450557|NCT03279978|101538922|FG003|Overall Study|Withdrawal by Subject|0|||
33450558|NCT03279978|101538923|FG004|Overall Study|Withdrawal by Subject|0|||
33450559|NCT03279978|101538924|FG005|Overall Study|Withdrawal by Subject|0|||
33450560|NCT03279978|101538925|FG006|Overall Study|Withdrawal by Subject|0|||
33450561|NCT03279978|101538926|FG007|Overall Study|Withdrawal by Subject|0|||
33450562|NCT03279978|101538927|FG008|Overall Study|Withdrawal by Subject|0|||
33450563|NCT03279978|101538928|FG009|Overall Study|Withdrawal by Subject|1|||
33450564|NCT03279978|101538919|FG000|Overall Study|Lost to Follow-up|1|||
33450565|NCT03279978|101538920|FG001|Overall Study|Lost to Follow-up|0|||
33450566|NCT03279978|101538921|FG002|Overall Study|Lost to Follow-up|1|||
33450567|NCT03279978|101538922|FG003|Overall Study|Lost to Follow-up|0|||
33450568|NCT03279978|101538923|FG004|Overall Study|Lost to Follow-up|0|||
33450569|NCT03279978|101538924|FG005|Overall Study|Lost to Follow-up|0|||
33450570|NCT03279978|101538925|FG006|Overall Study|Lost to Follow-up|0|||
33450571|NCT03279978|101538926|FG007|Overall Study|Lost to Follow-up|0|||
33450572|NCT03279978|101538927|FG008|Overall Study|Lost to Follow-up|0|||
33450573|NCT03279978|101538928|FG009|Overall Study|Lost to Follow-up|0|||
33450574|NCT03279978|101538919|FG000|Overall Study|Other than stated above|0|||
33450575|NCT03279978|101538920|FG001|Overall Study|Other than stated above|0|||
33450576|NCT03279978|101538921|FG002|Overall Study|Other than stated above|0|||
33450577|NCT03279978|101538922|FG003|Overall Study|Other than stated above|0|||
33450578|NCT03279978|101538923|FG004|Overall Study|Other than stated above|0|||
33450579|NCT03279978|101538924|FG005|Overall Study|Other than stated above|0|||
33450580|NCT03279978|101538925|FG006|Overall Study|Other than stated above|1|||
33450581|NCT03279978|101538926|FG007|Overall Study|Other than stated above|0|||
33450582|NCT03279978|101538927|FG008|Overall Study|Other than stated above|0|||
33450583|NCT03279978|101538928|FG009|Overall Study|Other than stated above|0|||
33489735|NCT02899962|101686774|FG002|Maintenance Phase|Lack of Efficacy|16|||
33489736|NCT02899962|101686772|FG000|Maintenance Phase|Lost to Follow-up|0|||
33489737|NCT02899962|101686773|FG001|Maintenance Phase|Lost to Follow-up|12|||
33489738|NCT02899962|101686774|FG002|Maintenance Phase|Lost to Follow-up|14|||
33489739|NCT02899962|101686772|FG000|Maintenance Phase|Other reasons|0|||
33489740|NCT02899962|101686773|FG001|Maintenance Phase|Other reasons|9|||
33489741|NCT02899962|101686774|FG002|Maintenance Phase|Other reasons|13|||
33489742|NCT02899962|101686772|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
33489743|NCT02899962|101686773|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
33489744|NCT02899962|101686774|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
33489745|NCT02899962|101686772|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
33489746|NCT02899962|101686773|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
33489747|NCT02899962|101686774|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
33489748|NCT02899962|101686772|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33489749|NCT02899962|101686773|FG001|Maintenance Phase|Withdrawal by Subject|30|||
33489750|NCT02899962|101686774|FG002|Maintenance Phase|Withdrawal by Subject|36|||
33489751|NCT02952586|101686778|FG000|Lead-In Phase (7 Days)|Death|0|||
33170085|NCT02573311|100528981|FG001|Disposition for Part 2|Adverse Event|5|||
33170086|NCT02573311|100528980|FG000|Disposition for Part 2|Lost to Follow-up|76|||
33170087|NCT02573311|100528981|FG001|Disposition for Part 2|Lost to Follow-up|7|||
33170088|NCT02573311|100528980|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
33170089|NCT02573311|100528981|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
33170090|NCT02573311|100528980|FG000|Disposition for Part 2|Investigator decision|0|||
33170091|NCT02573311|100528981|FG001|Disposition for Part 2|Investigator decision|1|||
33170092|NCT02573311|100528980|FG000|Disposition for Part 2|Other than specified above|13|||
33170093|NCT02573311|100528981|FG001|Disposition for Part 2|Other than specified above|3|||
33170094|NCT03700671|100528982|FG000|Overall Study|Lack of Efficacy|1|||
33170095|NCT03700671|100528983|FG001|Overall Study|Lack of Efficacy|2|||
33170096|NCT01244425|100528984|FG000|Overall Study|Withdrawal by Subject|2|||
33170097|NCT01244425|100528985|FG001|Overall Study|Withdrawal by Subject|2|||
33170098|NCT01244425|100528984|FG000|Overall Study|Adverse Event|1|||
33170099|NCT01244425|100528985|FG001|Overall Study|Adverse Event|1|||
33170100|NCT00284050|100528986|FG000|Overall Study|Adverse Event|1|||
33170101|NCT00284050|100528987|FG001|Overall Study|Adverse Event|1|||
33170102|NCT00284050|100528988|FG002|Overall Study|Adverse Event|1|||
33170103|NCT00284050|100528986|FG000|Overall Study|Lack of Efficacy|0|||
33170104|NCT00284050|100528987|FG001|Overall Study|Lack of Efficacy|1|||
33170105|NCT00284050|100528988|FG002|Overall Study|Lack of Efficacy|3|||
33170106|NCT00284050|100528986|FG000|Overall Study|Protocol Violation|0|||
33170107|NCT00284050|100528987|FG001|Overall Study|Protocol Violation|1|||
33170108|NCT00284050|100528988|FG002|Overall Study|Protocol Violation|2|||
33170109|NCT00284050|100528986|FG000|Overall Study|Withdrawal by Subject|2|||
33170110|NCT00284050|100528987|FG001|Overall Study|Withdrawal by Subject|2|||
33170111|NCT00284050|100528988|FG002|Overall Study|Withdrawal by Subject|2|||
33170112|NCT00284050|100528986|FG000|Overall Study|Lost to Follow-up|1|||
33170113|NCT00284050|100528987|FG001|Overall Study|Lost to Follow-up|0|||
33170114|NCT00284050|100528988|FG002|Overall Study|Lost to Follow-up|1|||
33170115|NCT00284050|100528986|FG000|Overall Study|Death|1|||
33170116|NCT00284050|100528987|FG001|Overall Study|Death|0|||
33170117|NCT00284050|100528988|FG002|Overall Study|Death|0|||
33170118|NCT02468414|100528992|FG000|Overall Study|Early Study Termination by Sponsor|1|||
33170119|NCT02468414|100528993|FG001|Overall Study|Early Study Termination by Sponsor|0|||
33170120|NCT02468414|100528992|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
33170121|NCT02468414|100528993|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
33170122|NCT02468414|100528992|FG000|Overall Study|Screen Failure|1|||
33170123|NCT02468414|100528993|FG001|Overall Study|Screen Failure|0|||
33170124|NCT01291173|100528996|FG000|Overall Study|Adverse Event|0|||
33170125|NCT01291173|100528997|FG001|Overall Study|Adverse Event|3|||
33170126|NCT01291173|100528998|FG002|Overall Study|Adverse Event|1|||
33170127|NCT01291173|100528999|FG003|Overall Study|Adverse Event|3|||
33170128|NCT01291173|100528996|FG000|Overall Study|Protocol Violation|7|||
33170129|NCT01291173|100528997|FG001|Overall Study|Protocol Violation|2|||
33170130|NCT01291173|100528998|FG002|Overall Study|Protocol Violation|2|||
33170131|NCT01291173|100528999|FG003|Overall Study|Protocol Violation|5|||
33170132|NCT01291173|100528996|FG000|Overall Study|Withdrawal by Subject|6|||
33170133|NCT01291173|100528997|FG001|Overall Study|Withdrawal by Subject|4|||
33170134|NCT01291173|100528998|FG002|Overall Study|Withdrawal by Subject|4|||
33170135|NCT01291173|100528999|FG003|Overall Study|Withdrawal by Subject|2|||
33170136|NCT01291173|100528996|FG000|Overall Study|Lost to Follow-up|4|||
33170137|NCT01291173|100528997|FG001|Overall Study|Lost to Follow-up|6|||
33170138|NCT01291173|100528998|FG002|Overall Study|Lost to Follow-up|3|||
33170139|NCT01291173|100528999|FG003|Overall Study|Lost to Follow-up|2|||
33170140|NCT01291173|100528996|FG000|Overall Study|Unable to meet visit schedule|0|||
33170141|NCT01291173|100528997|FG001|Overall Study|Unable to meet visit schedule|0|||
33170142|NCT01291173|100528998|FG002|Overall Study|Unable to meet visit schedule|1|||
33170143|NCT01291173|100528999|FG003|Overall Study|Unable to meet visit schedule|0|||
33170144|NCT01291173|100528996|FG000|Overall Study|Lack of compliance|0|||
33170145|NCT01291173|100528997|FG001|Overall Study|Lack of compliance|0|||
33170146|NCT01291173|100528998|FG002|Overall Study|Lack of compliance|0|||
33170147|NCT01291173|100528999|FG003|Overall Study|Lack of compliance|1|||
33170148|NCT01291173|100528996|FG000|Overall Study|Subject was unblinded|0|||
33170149|NCT01291173|100528997|FG001|Overall Study|Subject was unblinded|0|||
33170150|NCT01291173|100528998|FG002|Overall Study|Subject was unblinded|1|||
33170151|NCT01291173|100528999|FG003|Overall Study|Subject was unblinded|0|||
33170152|NCT01291173|100528996|FG000|Overall Study|Excluded therapy|0|||
33170153|NCT01291173|100528997|FG001|Overall Study|Excluded therapy|0|||
33170154|NCT01291173|100528998|FG002|Overall Study|Excluded therapy|1|||
33170155|NCT01291173|100528999|FG003|Overall Study|Excluded therapy|0|||
33170156|NCT02269241|100529000|FG000|Overall Study|Lost to Follow-up|269|||
33170157|NCT02269241|100529000|FG000|Overall Study|Withdrawal by Subject|155|||
33170158|NCT02269241|100529000|FG000|Overall Study|Protocol Violation|1|||
33170159|NCT02269241|100529000|FG000|Overall Study|Physician Decision|7|||
33170160|NCT02269241|100529000|FG000|Overall Study|Pregnancy|15|||
33170161|NCT02269241|100529000|FG000|Overall Study|Wish for pregnancy|5|||
33170162|NCT02269241|100529000|FG000|Overall Study|Development of an exclusion criteria|16|||
33450584|NCT00243347|101541630|FG000|Overall Study|Lack of Efficacy|4|||
33170163|NCT02269241|100529000|FG000|Overall Study|Adverse Event|113|||
33450585|NCT00243347|101541630|FG000|Overall Study|Adverse Event|2|||
33450586|NCT00243347|101541630|FG000|Overall Study|Death|1|||
33170164|NCT02269241|100529000|FG000|Overall Study|At the specific request of the sponsor|20|||
33170165|NCT02269241|100529000|FG000|Overall Study|Several reasons not classified|53|||
33170166|NCT02269241|100529000|FG000|Overall Study|Screening failures|546|||
33170167|NCT02254486|100529004|FG000|Overall Study|Adverse Event|1|||
33170168|NCT02254486|100529005|FG001|Overall Study|Adverse Event|1|||
33170169|NCT02254486|100529004|FG000|Overall Study|Lack of Efficacy|1|||
33170170|NCT02254486|100529005|FG001|Overall Study|Lack of Efficacy|0|||
33170171|NCT02254486|100529004|FG000|Overall Study|Lost to Follow-up|2|||
33170172|NCT02254486|100529005|FG001|Overall Study|Lost to Follow-up|4|||
33170173|NCT02254486|100529004|FG000|Overall Study|Protocol Violation|1|||
33170174|NCT02254486|100529005|FG001|Overall Study|Protocol Violation|2|||
33170175|NCT02254486|100529004|FG000|Overall Study|Withdrawal by Subject|17|||
33170176|NCT02254486|100529005|FG001|Overall Study|Withdrawal by Subject|15|||
33170177|NCT02254486|100529004|FG000|Overall Study|GFR<60mL/min|16|||
33170178|NCT02254486|100529005|FG001|Overall Study|GFR<60mL/min|21|||
33170179|NCT02254486|100529004|FG000|Overall Study|Various|12|||
33170180|NCT02254486|100529005|FG001|Overall Study|Various|12|||
33170181|NCT01535053|100529006|FG000|Overall Study|Ineligible|1|||
33170182|NCT01535053|100529007|FG001|Overall Study|Ineligible|2|||
33170183|NCT00793598|100529008|FG000|Overall Study|Patient Request|0|||
33170184|NCT00793598|100529009|FG001|Overall Study|Patient Request|1|||
33170185|NCT00793598|100529010|FG002|Overall Study|Patient Request|0|||
33170186|NCT00793598|100529011|FG003|Overall Study|Patient Request|0|||
33170187|NCT00793598|100529012|FG004|Overall Study|Patient Request|0|||
33170188|NCT00793598|100529013|FG005|Overall Study|Patient Request|0|||
33170189|NCT00793598|100529014|FG006|Overall Study|Patient Request|0|||
33170190|NCT00793598|100529015|FG007|Overall Study|Patient Request|0|||
33170191|NCT00793598|100529008|FG000|Overall Study|Protocol Violation|0|||
33170192|NCT00793598|100529009|FG001|Overall Study|Protocol Violation|0|||
33170193|NCT00793598|100529010|FG002|Overall Study|Protocol Violation|0|||
33170194|NCT00793598|100529011|FG003|Overall Study|Protocol Violation|0|||
33170195|NCT00793598|100529012|FG004|Overall Study|Protocol Violation|0|||
33170196|NCT00793598|100529013|FG005|Overall Study|Protocol Violation|0|||
33170197|NCT00793598|100529014|FG006|Overall Study|Protocol Violation|0|||
33170198|NCT00793598|100529015|FG007|Overall Study|Protocol Violation|1|||
33170199|NCT00793598|100529008|FG000|Overall Study|Subject not dosed|0|||
33170200|NCT00793598|100529009|FG001|Overall Study|Subject not dosed|0|||
33170201|NCT00793598|100529010|FG002|Overall Study|Subject not dosed|0|||
33170202|NCT00793598|100529011|FG003|Overall Study|Subject not dosed|0|||
33450587|NCT00243347|101541630|FG000|Overall Study|Withdrawal by Subject|5|||
33450588|NCT00243347|101541630|FG000|Overall Study|Condition worsened|7|||
33450589|NCT00798603|101541641|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
33450590|NCT00798603|101541641|FG000|Overall Study|Withdrawal by Subject|10|||
33450591|NCT00798603|101541641|FG000|Overall Study|Adverse Event|22|||
33450592|NCT00798603|101541641|FG000|Overall Study|Physician Decision|1|||
33450593|NCT00798603|101541641|FG000|Overall Study|Lack of insurance coverage|1|||
33450594|NCT03273153|101541643|FG000|Overall Study|Adverse Event|1|||
33450595|NCT03273153|101541644|FG001|Overall Study|Adverse Event|2|||
33450596|NCT03273153|101541643|FG000|Overall Study|Missing|0|||
33450597|NCT03273153|101541644|FG001|Overall Study|Missing|2|||
33450598|NCT03273153|101541643|FG000|Overall Study|Other|3|||
33450599|NCT03273153|101541644|FG001|Overall Study|Other|2|||
33170203|NCT00793598|100529012|FG004|Overall Study|Subject not dosed|0|||
33170204|NCT00793598|100529013|FG005|Overall Study|Subject not dosed|1|||
33450600|NCT03273153|101541643|FG000|Overall Study|Symptomatic Deterioration|0|||
33170205|NCT00793598|100529014|FG006|Overall Study|Subject not dosed|0|||
33170206|NCT00793598|100529015|FG007|Overall Study|Subject not dosed|0|||
33170207|NCT01414855|100529019|FG000|Overall Study|Death|17|||
33170208|NCT01414855|100529019|FG000|Overall Study|Lost to Follow-up|5|||
33170209|NCT01414855|100529019|FG000|Overall Study|Withdrawal by Subject|7|||
33170210|NCT01634360|100529020|FG000|Overall Study|Adverse Event|10|||
33170211|NCT01634360|100529021|FG001|Overall Study|Adverse Event|34|||
33170212|NCT01634360|100529020|FG000|Overall Study|subject withdrew consent|13|||
33170213|NCT01634360|100529021|FG001|Overall Study|subject withdrew consent|23|||
33450601|NCT03273153|101541644|FG001|Overall Study|Symptomatic Deterioration|1|||
33261182|NCT00739908|100856564|FG001|Overall Study|Withdrawal by Subject|2|||
33450602|NCT03273153|101541643|FG000|Overall Study|Progressive Disease|6|||
33170214|NCT01634360|100529020|FG000|Overall Study|Protocol Violation|1|||
33170215|NCT01634360|100529021|FG001|Overall Study|Protocol Violation|1|||
33170216|NCT01634360|100529020|FG000|Overall Study|Lack of Efficacy|4|||
33170217|NCT01634360|100529021|FG001|Overall Study|Lack of Efficacy|14|||
33170218|NCT01634360|100529020|FG000|Overall Study|Other|3|||
33170219|NCT01634360|100529021|FG001|Overall Study|Other|20|||
33170220|NCT01634360|100529020|FG000|Overall Study|Study termination by sponsor|18|||
33170221|NCT01634360|100529021|FG001|Overall Study|Study termination by sponsor|44|||
33170222|NCT03020160|100529028|FG000|Overall Study|Withdrawal by Subject|1|||
33170223|NCT03020160|100529029|FG001|Overall Study|Withdrawal by Subject|0|||
33170224|NCT01083576|100529037|FG000|Overall Study|Treatment Failure|6|||
33170225|NCT01083576|100529038|FG001|Overall Study|Treatment Failure|1|||
33170226|NCT00592384|100529039|FG000|Overall Study|Withdrawal by Subject|5|||
33170227|NCT00592384|100529040|FG001|Overall Study|Withdrawal by Subject|6|||
33170228|NCT03198234|100529041|FG000|Overall Study|Relapse of primary disease|0|||
33170229|NCT03198234|100529042|FG001|Overall Study|Relapse of primary disease|1|||
33170230|NCT03198234|100529043|FG002|Overall Study|Relapse of primary disease|0|||
33170231|NCT03364023|100529050|FG000|Overall Study|Lost to Follow-up|3|||
33170232|NCT03364023|100529050|FG000|Overall Study|Death|14|||
33170233|NCT02057406|100529059|FG000|Overall Study|Physician Decision|0|||
33170234|NCT02057406|100529060|FG001|Overall Study|Physician Decision|0|||
33170235|NCT02057406|100529061|FG002|Overall Study|Physician Decision|2|||
33170236|NCT02057406|100529059|FG000|Overall Study|Withdrawal by Subject|0|||
33170237|NCT02057406|100529060|FG001|Overall Study|Withdrawal by Subject|2|||
33170238|NCT02057406|100529061|FG002|Overall Study|Withdrawal by Subject|0|||
33170239|NCT02057406|100529059|FG000|Overall Study|Lost to Follow-up|0|||
33170240|NCT02057406|100529060|FG001|Overall Study|Lost to Follow-up|0|||
33170241|NCT02057406|100529061|FG002|Overall Study|Lost to Follow-up|1|||
33170242|NCT02057406|100529059|FG000|Overall Study|Death|1|||
33170243|NCT02057406|100529060|FG001|Overall Study|Death|0|||
33170244|NCT02057406|100529061|FG002|Overall Study|Death|0|||
33170245|NCT02057406|100529059|FG000|Overall Study|Protocol Violation|0|||
33170246|NCT02057406|100529060|FG001|Overall Study|Protocol Violation|1|||
33170247|NCT02057406|100529061|FG002|Overall Study|Protocol Violation|0|||
33170248|NCT02057406|100529059|FG000|Overall Study|Patient transportation issues|0|||
33170249|NCT02057406|100529060|FG001|Overall Study|Patient transportation issues|0|||
33170250|NCT02057406|100529061|FG002|Overall Study|Patient transportation issues|1|||
33170251|NCT02056340|100529065|FG000|Overall Study|Lost to Follow-up|5|||
33170252|NCT02056340|100529066|FG001|Overall Study|Lost to Follow-up|5|||
33170253|NCT02056340|100529065|FG000|Overall Study|Withdrawal by Subject|2|||
33261183|NCT00739908|100856563|FG000|Overall Study|Lost to Follow-up|14|||
33261184|NCT00739908|100856564|FG001|Overall Study|Lost to Follow-up|9|||
33170254|NCT02056340|100529066|FG001|Overall Study|Withdrawal by Subject|6|||
33170255|NCT02547649|100529067|FG000|Overall Study|Lost to Follow-up|3|||
33170256|NCT02547649|100529068|FG001|Overall Study|Lost to Follow-up|1|||
33170257|NCT02547649|100529069|FG002|Overall Study|Lost to Follow-up|1|||
33170258|NCT02547649|100529067|FG000|Overall Study|Not vaccinated|0|||
33170259|NCT02547649|100529068|FG001|Overall Study|Not vaccinated|0|||
33170260|NCT02547649|100529069|FG002|Overall Study|Not vaccinated|1|||
33170261|NCT02547649|100529067|FG000|Overall Study|Withdrawal by Subject|0|||
33170262|NCT02547649|100529068|FG001|Overall Study|Withdrawal by Subject|4|||
33170263|NCT02547649|100529069|FG002|Overall Study|Withdrawal by Subject|2|||
33170264|NCT04983264|100529087|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
33170265|NCT04983264|100529088|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
33170266|NCT04983264|100529089|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
33170267|NCT04983264|100529087|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
33170268|NCT04983264|100529088|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
33170269|NCT04983264|100529089|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
33170270|NCT00965718|100529090|FG000|Overall Study|Withdrawal by Subject|4|||
33170271|NCT00938639|100533010|FG000|Overall Study|Moved away from study area|0|||
33170272|NCT00938639|100533011|FG001|Overall Study|Moved away from study area|1|||
33450603|NCT03273153|101541644|FG001|Overall Study|Progressive Disease|5|||
33450604|NCT03273153|101541643|FG000|Overall Study|Physician Decision|1|||
33450605|NCT03273153|101541644|FG001|Overall Study|Physician Decision|3|||
33450606|NCT03273153|101541643|FG000|Overall Study|Study Terminated by Sponsor|112|||
33450607|NCT03273153|101541644|FG001|Overall Study|Study Terminated by Sponsor|102|||
33450608|NCT03273153|101541643|FG000|Overall Study|Withdrawal by Subject|26|||
33450609|NCT03273153|101541644|FG001|Overall Study|Withdrawal by Subject|25|||
33450610|NCT03273153|101541643|FG000|Overall Study|Protocol Deviation|3|||
33450611|NCT03273153|101541644|FG001|Overall Study|Protocol Deviation|0|||
33450612|NCT03273153|101541643|FG000|Overall Study|Lost to Follow-up|6|||
33170273|NCT00938639|100533010|FG000|Overall Study|Lost to Follow-up|1|||
33170274|NCT00938639|100533011|FG001|Overall Study|Lost to Follow-up|2|||
33170275|NCT00938639|100533010|FG000|Overall Study|Family issues|1|||
33170276|NCT00938639|100533011|FG001|Overall Study|Family issues|1|||
33170277|NCT00938639|100533010|FG000|Overall Study|Participant noncompliance|1|||
33170278|NCT00938639|100533011|FG001|Overall Study|Participant noncompliance|0|||
33170279|NCT00679302|100533012|FG000|Overall Study|Lost to Follow-up|8|||
33170280|NCT00679302|100533013|FG001|Overall Study|Lost to Follow-up|4|||
33170281|NCT02669433|100533014|FG000|Overall Study|Protocol Violation|0|||
33170282|NCT02669433|100533015|FG001|Overall Study|Protocol Violation|4|||
33170283|NCT02669433|100533016|FG002|Overall Study|Protocol Violation|1|||
33170284|NCT02669433|100533014|FG000|Overall Study|Disease Progression|1|||
33170285|NCT02669433|100533015|FG001|Overall Study|Disease Progression|0|||
33170286|NCT02669433|100533016|FG002|Overall Study|Disease Progression|0|||
33170287|NCT02669433|100533014|FG000|Overall Study|Physician Decision|1|||
33170288|NCT02669433|100533015|FG001|Overall Study|Physician Decision|1|||
33170289|NCT02669433|100533016|FG002|Overall Study|Physician Decision|0|||
33170290|NCT02669433|100533014|FG000|Overall Study|Adverse Event|6|||
33170291|NCT02669433|100533015|FG001|Overall Study|Adverse Event|7|||
33170292|NCT02669433|100533016|FG002|Overall Study|Adverse Event|10|||
33170293|NCT02669433|100533014|FG000|Overall Study|Sponsor Termination|1|||
33170294|NCT02669433|100533015|FG001|Overall Study|Sponsor Termination|0|||
33170295|NCT02669433|100533016|FG002|Overall Study|Sponsor Termination|1|||
33170296|NCT02669433|100533014|FG000|Overall Study|Withdrawal by Subject|5|||
33170297|NCT02669433|100533015|FG001|Overall Study|Withdrawal by Subject|1|||
33170298|NCT02669433|100533016|FG002|Overall Study|Withdrawal by Subject|0|||
33170299|NCT02669433|100533014|FG000|Overall Study|Withdrawal by Caregiver|1|||
33170300|NCT02669433|100533015|FG001|Overall Study|Withdrawal by Caregiver|0|||
33170301|NCT02669433|100533016|FG002|Overall Study|Withdrawal by Caregiver|2|||
33170302|NCT02669433|100533014|FG000|Overall Study|Death|0|||
33170303|NCT02669433|100533015|FG001|Overall Study|Death|1|||
33170304|NCT02669433|100533016|FG002|Overall Study|Death|1|||
33170305|NCT01442493|100533017|FG000|Overall Study|withdrawn from study|3|||
33170306|NCT01442493|100533018|FG001|Overall Study|withdrawn from study|2|||
33170307|NCT03018704|100533019|FG000|Overall Study|Lost to Follow-up|1|||
33170308|NCT03018704|100533020|FG001|Overall Study|Lost to Follow-up|1|||
33170309|NCT02246660|100533025|FG000|Overall Study|Withdrawal by Subject|0|||
33170310|NCT02246660|100533026|FG001|Overall Study|Withdrawal by Subject|1|||
33170311|NCT02246660|100533027|FG002|Overall Study|Withdrawal by Subject|0|||
33170312|NCT02246660|100533025|FG000|Overall Study|Death|0|||
33170313|NCT02246660|100533026|FG001|Overall Study|Death|0|||
33170314|NCT02246660|100533027|FG002|Overall Study|Death|1|||
33170315|NCT02433483|100533028|FG000|Overall Study|Unacceptable toxicity|1|||
33170316|NCT02433483|100533028|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
33170317|NCT04532164|100533035|FG000|Overall Study|Adverse Event|1|||
33170318|NCT04532164|100533035|FG000|Overall Study|Protocol Violation|5|||
33170319|NCT04532164|100533035|FG000|Overall Study|Lost to Follow-up|1|||
33450613|NCT03273153|101541644|FG001|Overall Study|Lost to Follow-up|11|||
33450614|NCT03273153|101541643|FG000|Overall Study|Death|66|||
33170320|NCT04532164|100533035|FG000|Overall Study|Found to be Ineligible|3|||
33170321|NCT04532164|100533035|FG000|Overall Study|Withdrawal by Subject|14|||
33170322|NCT00684307|100533036|FG000|Overall Study|Adverse Event|11|||
33170323|NCT00684307|100533037|FG001|Overall Study|Adverse Event|6|||
33170324|NCT00684307|100533038|FG002|Overall Study|Adverse Event|15|||
33170325|NCT00684307|100533039|FG003|Overall Study|Adverse Event|16|||
33170326|NCT00684307|100533040|FG004|Overall Study|Adverse Event|8|||
33170327|NCT00684307|100533036|FG000|Overall Study|Development of increasing Liver Function|0|||
33170328|NCT00684307|100533037|FG001|Overall Study|Development of increasing Liver Function|2|||
33170329|NCT00684307|100533038|FG002|Overall Study|Development of increasing Liver Function|0|||
33170330|NCT00684307|100533039|FG003|Overall Study|Development of increasing Liver Function|1|||
33170331|NCT00684307|100533040|FG004|Overall Study|Development of increasing Liver Function|0|||
33450615|NCT03273153|101541644|FG001|Overall Study|Death|69|||
33450616|NCT00665925|101541648|FG000|Overall Study|Lack of Efficacy|10|||
33450617|NCT00665925|101541649|FG001|Overall Study|Lack of Efficacy|8|||
33450618|NCT00665925|101541650|FG002|Overall Study|Lack of Efficacy|9|||
33450619|NCT00665925|101541651|FG003|Overall Study|Lack of Efficacy|8|||
33450620|NCT00665925|101541648|FG000|Overall Study|Lost to Follow-up|1|||
33450621|NCT00665925|101541649|FG001|Overall Study|Lost to Follow-up|2|||
33450622|NCT00665925|101541650|FG002|Overall Study|Lost to Follow-up|2|||
33450623|NCT00665925|101541651|FG003|Overall Study|Lost to Follow-up|2|||
33450624|NCT00665925|101541648|FG000|Overall Study|Withdrawal by Subject|2|||
33450625|NCT00665925|101541649|FG001|Overall Study|Withdrawal by Subject|2|||
33450626|NCT00665925|101541650|FG002|Overall Study|Withdrawal by Subject|3|||
33450627|NCT00665925|101541651|FG003|Overall Study|Withdrawal by Subject|2|||
33450628|NCT00665925|101541648|FG000|Overall Study|Physician Decision|0|||
33450629|NCT00665925|101541649|FG001|Overall Study|Physician Decision|0|||
33450630|NCT00665925|101541650|FG002|Overall Study|Physician Decision|1|||
33450631|NCT00665925|101541651|FG003|Overall Study|Physician Decision|2|||
33450632|NCT00665925|101541648|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
33450633|NCT00665925|101541649|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
33450634|NCT00665925|101541650|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
33450635|NCT00665925|101541651|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
33450636|NCT00665925|101541648|FG000|Overall Study|Adverse Event|1|||
33450637|NCT00665925|101541649|FG001|Overall Study|Adverse Event|5|||
33450638|NCT00665925|101541650|FG002|Overall Study|Adverse Event|10|||
33450639|NCT00665925|101541651|FG003|Overall Study|Adverse Event|5|||
33450640|NCT00665925|101541648|FG000|Overall Study|Enrolled by mistake|0|||
33450641|NCT00665925|101541649|FG001|Overall Study|Enrolled by mistake|0|||
33450642|NCT00665925|101541650|FG002|Overall Study|Enrolled by mistake|0|||
33450643|NCT00665925|101541651|FG003|Overall Study|Enrolled by mistake|1|||
33450644|NCT00665925|101541648|FG000|Overall Study|Due to exclusion criteria|1|||
33450645|NCT00665925|101541649|FG001|Overall Study|Due to exclusion criteria|0|||
33170332|NCT00684307|100533036|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
33170333|NCT00684307|100533037|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
33170334|NCT00684307|100533038|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
33450646|NCT00665925|101541650|FG002|Overall Study|Due to exclusion criteria|0|||
33450647|NCT00665925|101541651|FG003|Overall Study|Due to exclusion criteria|0|||
33450648|NCT00672984|101541656|FG000|First Intervention|Adverse Event|5|||
33450649|NCT00672984|101541657|FG001|First Intervention|Adverse Event|0|||
33170335|NCT00684307|100533039|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
33170336|NCT00684307|100533040|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
33170337|NCT00684307|100533036|FG000|Overall Study|Incorrect enrolment or randomization|4|||
33170338|NCT00684307|100533037|FG001|Overall Study|Incorrect enrolment or randomization|0|||
33170339|NCT00684307|100533038|FG002|Overall Study|Incorrect enrolment or randomization|0|||
33170340|NCT00684307|100533039|FG003|Overall Study|Incorrect enrolment or randomization|0|||
33170341|NCT00684307|100533040|FG004|Overall Study|Incorrect enrolment or randomization|0|||
33170342|NCT00684307|100533036|FG000|Overall Study|Interupted IP for more than 7 days|0|||
33170343|NCT00684307|100533037|FG001|Overall Study|Interupted IP for more than 7 days|4|||
33170344|NCT00684307|100533038|FG002|Overall Study|Interupted IP for more than 7 days|1|||
33170345|NCT00684307|100533039|FG003|Overall Study|Interupted IP for more than 7 days|3|||
33170346|NCT00684307|100533040|FG004|Overall Study|Interupted IP for more than 7 days|3|||
33170347|NCT00684307|100533036|FG000|Overall Study|Severe non compliance to protocol|1|||
33170348|NCT00684307|100533037|FG001|Overall Study|Severe non compliance to protocol|0|||
33170349|NCT00684307|100533038|FG002|Overall Study|Severe non compliance to protocol|0|||
33170350|NCT00684307|100533039|FG003|Overall Study|Severe non compliance to protocol|1|||
33170351|NCT00684307|100533040|FG004|Overall Study|Severe non compliance to protocol|2|||
33170352|NCT00684307|100533036|FG000|Overall Study|Participant not willing to continue|7|||
33170353|NCT00684307|100533037|FG001|Overall Study|Participant not willing to continue|10|||
33170354|NCT00684307|100533038|FG002|Overall Study|Participant not willing to continue|11|||
33170355|NCT00684307|100533039|FG003|Overall Study|Participant not willing to continue|5|||
33170356|NCT00684307|100533040|FG004|Overall Study|Participant not willing to continue|8|||
33170357|NCT00684307|100533036|FG000|Overall Study|Criteria from the CSR|0|||
33170358|NCT00684307|100533037|FG001|Overall Study|Criteria from the CSR|0|||
33170359|NCT00684307|100533038|FG002|Overall Study|Criteria from the CSR|1|||
33170360|NCT00684307|100533039|FG003|Overall Study|Criteria from the CSR|3|||
33170361|NCT00684307|100533040|FG004|Overall Study|Criteria from the CSR|3|||
33170362|NCT04118166|100533049|FG000|Overall Study|Adverse Event|1|||
33170363|NCT01652703|100533055|FG000|Overall Study|Withdrawal by Subject|0|||
33170364|NCT01652703|100533056|FG001|Overall Study|Withdrawal by Subject|1|||
33170365|NCT01652703|100533057|FG002|Overall Study|Withdrawal by Subject|3|||
33170366|NCT01652703|100533058|FG003|Overall Study|Withdrawal by Subject|1|||
33170367|NCT01652703|100533059|FG004|Overall Study|Withdrawal by Subject|0|||
33170368|NCT01652703|100533060|FG005|Overall Study|Withdrawal by Subject|1|||
33170369|NCT01652703|100533055|FG000|Overall Study|Other|0|||
33170370|NCT01652703|100533056|FG001|Overall Study|Other|0|||
33170371|NCT01652703|100533057|FG002|Overall Study|Other|0|||
33170372|NCT01652703|100533058|FG003|Overall Study|Other|1|||
33170373|NCT01652703|100533059|FG004|Overall Study|Other|1|||
33170374|NCT01652703|100533060|FG005|Overall Study|Other|1|||
33170375|NCT02548650|100533063|FG000|Triple Therapy|Adverse Event|1|||
33170376|NCT02548650|100533064|FG001|Triple Therapy|Adverse Event|0|||
33170377|NCT02548650|100533063|FG000|Triple Therapy|Withdrawal by Subject|0|||
33170378|NCT02548650|100533064|FG001|Triple Therapy|Withdrawal by Subject|4|||
33170379|NCT02548650|100533063|FG000|Double Therapy|Adverse Event|1|||
33170380|NCT02548650|100533064|FG001|Double Therapy|Adverse Event|1|||
33170381|NCT02548650|100533063|FG000|Double Therapy|Withdrawal by Subject|0|||
33170382|NCT02548650|100533064|FG001|Double Therapy|Withdrawal by Subject|1|||
33450650|NCT00672984|101541658|FG002|First Intervention|Adverse Event|0|||
33450651|NCT00672984|101541656|FG000|First Intervention|Withdrawal by Subject|1|||
33170383|NCT01025752|100533065|FG000|Overall Study|Lost to Follow-up|7|||
33170384|NCT01025752|100533066|FG001|Overall Study|Lost to Follow-up|10|||
33170385|NCT01025752|100533065|FG000|Overall Study|Physician Decision|1|||
33170386|NCT01025752|100533066|FG001|Overall Study|Physician Decision|3|||
33170387|NCT01508650|100533069|FG000|Overall Study|Lost to Follow-up|0|||
33170388|NCT01508650|100533070|FG001|Overall Study|Lost to Follow-up|3|||
33170389|NCT02013791|100533073|FG000|Period 1|Lost to Follow-up|0|||
33450652|NCT00672984|101541657|FG001|First Intervention|Withdrawal by Subject|2|||
33170390|NCT02013791|100533074|FG001|Period 1|Lost to Follow-up|0|||
33170391|NCT02013791|100533075|FG002|Period 1|Lost to Follow-up|0|||
33170392|NCT02013791|100533076|FG003|Period 1|Lost to Follow-up|1|||
33170393|NCT02013791|100533077|FG004|Period 1|Lost to Follow-up|0|||
33170394|NCT02013791|100533078|FG005|Period 1|Lost to Follow-up|0|||
33170395|NCT02013791|100533079|FG006|Period 1|Lost to Follow-up|1|||
33170396|NCT02013791|100533080|FG007|Period 1|Lost to Follow-up|1|||
33170397|NCT02013791|100533081|FG008|Period 1|Lost to Follow-up|0|||
33170398|NCT02013791|100533073|FG000|Period 1|Other Miscellaneous Reasons|0|||
33170399|NCT02013791|100533074|FG001|Period 1|Other Miscellaneous Reasons|2|||
33170400|NCT02013791|100533075|FG002|Period 1|Other Miscellaneous Reasons|0|||
33170401|NCT02013791|100533076|FG003|Period 1|Other Miscellaneous Reasons|0|||
33170402|NCT02013791|100533077|FG004|Period 1|Other Miscellaneous Reasons|0|||
33170403|NCT02013791|100533078|FG005|Period 1|Other Miscellaneous Reasons|0|||
33170404|NCT02013791|100533079|FG006|Period 1|Other Miscellaneous Reasons|0|||
33170405|NCT02013791|100533080|FG007|Period 1|Other Miscellaneous Reasons|0|||
33170406|NCT02013791|100533081|FG008|Period 1|Other Miscellaneous Reasons|0|||
33170407|NCT03547687|100533082|FG000|Overall Study|Withdrawal by Subject|1|||
33170408|NCT03547687|100533082|FG000|Overall Study|Death|1|||
33170409|NCT00191789|100533083|FG000|Overall Study|Adverse Event|5|||
33170410|NCT00191789|100533083|FG000|Overall Study|Patient: Satisfactory Response|5|||
33170411|NCT00191789|100533083|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
33170412|NCT00191789|100533083|FG000|Overall Study|Withdrawal by Subject|4|||
33170413|NCT00191789|100533083|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
33170414|NCT00191789|100533083|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
33170415|NCT00191789|100533083|FG000|Overall Study|Death - Not Study-Drug Related|1|||
33170416|NCT03655691|100533084|FG000|Overall Study|Adverse Event|0|||
33170417|NCT03655691|100533085|FG001|Overall Study|Adverse Event|0|||
33170418|NCT03655691|100533086|FG002|Overall Study|Adverse Event|1|||
33170419|NCT03655691|100533084|FG000|Overall Study|Lost to Follow-up|1|||
33170420|NCT03655691|100533085|FG001|Overall Study|Lost to Follow-up|1|||
33170421|NCT03655691|100533086|FG002|Overall Study|Lost to Follow-up|2|||
33170422|NCT03655691|100533084|FG000|Overall Study|Protocol Violation|0|||
33170423|NCT03655691|100533085|FG001|Overall Study|Protocol Violation|1|||
33170424|NCT03655691|100533086|FG002|Overall Study|Protocol Violation|0|||
33170425|NCT03655691|100533084|FG000|Overall Study|Withdrawal by Subject|1|||
33450653|NCT00672984|101541658|FG002|First Intervention|Withdrawal by Subject|2|||
33450654|NCT00672984|101541656|FG000|First Intervention|Sponsor decision|3|||
33450655|NCT00672984|101541657|FG001|First Intervention|Sponsor decision|0|||
33450656|NCT00672984|101541658|FG002|First Intervention|Sponsor decision|0|||
33450657|NCT00672984|101541656|FG000|Second Intervention|Non-compliance with facility policies|0|||
33450658|NCT00672984|101541657|FG001|Second Intervention|Non-compliance with facility policies|2|||
33450659|NCT00672984|101541658|FG002|Second Intervention|Non-compliance with facility policies|0|||
33170426|NCT03655691|100533085|FG001|Overall Study|Withdrawal by Subject|1|||
33170427|NCT03655691|100533086|FG002|Overall Study|Withdrawal by Subject|0|||
33170428|NCT03716024|100533087|FG000|Overall Study|Randomized, not Treated|7|||
33170429|NCT03716024|100533088|FG001|Overall Study|Randomized, not Treated|8|||
33170430|NCT03716024|100533087|FG000|Overall Study|Adverse Event|1|||
33170431|NCT03716024|100533088|FG001|Overall Study|Adverse Event|2|||
33261185|NCT00739908|100856563|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
33450660|NCT00672984|101541656|FG000|Second Intervention|Withdrawal by Subject|0|||
33170432|NCT03716024|100533087|FG000|Overall Study|Treatment Failure|1|||
33170433|NCT03716024|100533088|FG001|Overall Study|Treatment Failure|0|||
33170434|NCT03716024|100533087|FG000|Overall Study|Lost to Follow-up|2|||
33170435|NCT03716024|100533088|FG001|Overall Study|Lost to Follow-up|6|||
33170436|NCT03716024|100533087|FG000|Overall Study|Withdrawal by Subject|0|||
33170437|NCT03716024|100533088|FG001|Overall Study|Withdrawal by Subject|1|||
33170438|NCT03716024|100533087|FG000|Overall Study|Missing Reason|0|||
33450661|NCT00672984|101541657|FG001|Second Intervention|Withdrawal by Subject|3|||
33450662|NCT00672984|101541658|FG002|Second Intervention|Withdrawal by Subject|0|||
33450663|NCT00672984|101541656|FG000|Second Intervention|Protocol Violation|0|||
33450664|NCT00672984|101541657|FG001|Second Intervention|Protocol Violation|1|||
33450665|NCT00672984|101541658|FG002|Second Intervention|Protocol Violation|1|||
33450666|NCT00672984|101541656|FG000|Third Intervention|Adverse Event|1|||
33450667|NCT00672984|101541657|FG001|Third Intervention|Adverse Event|0|||
33450668|NCT00672984|101541658|FG002|Third Intervention|Adverse Event|1|||
33450669|NCT02854800|101541659|FG000|Overall Study|Protocol Violation|16|||
33450670|NCT02854800|101541660|FG001|Overall Study|Protocol Violation|11|||
33450671|NCT02854800|101541661|FG002|Overall Study|Protocol Violation|3|||
33450672|NCT02854800|101541659|FG000|Overall Study|Withdrawal by Subject|4|||
33450673|NCT02854800|101541660|FG001|Overall Study|Withdrawal by Subject|2|||
33450674|NCT02854800|101541661|FG002|Overall Study|Withdrawal by Subject|3|||
33450675|NCT03945773|101541671|FG000|Overall Study|Consent Withdrawn|1|||
33450676|NCT03945773|101541672|FG001|Overall Study|Consent Withdrawn|1|||
33450677|NCT03945773|101541671|FG000|Overall Study|Lost to Follow-up|1|||
33450678|NCT03945773|101541672|FG001|Overall Study|Lost to Follow-up|0|||
33450679|NCT03945773|101541671|FG000|Overall Study|Death|46|||
33450680|NCT03945773|101541672|FG001|Overall Study|Death|22|||
33450681|NCT03945773|101541671|FG000|Overall Study|Physician Decision|1|||
33450682|NCT03945773|101541672|FG001|Overall Study|Physician Decision|0|||
33450683|NCT03945773|101541671|FG000|Overall Study|Other|1|||
33450684|NCT03945773|101541672|FG001|Overall Study|Other|0|||
33450685|NCT03945773|101541671|FG000|Overall Study|Ongoing at the time of DCO|4|||
33450686|NCT03945773|101541672|FG001|Overall Study|Ongoing at the time of DCO|3|||
33450687|NCT03637764|101541673|FG000|Overall Study|Adverse Event|2|||
33450688|NCT03637764|101541674|FG001|Overall Study|Adverse Event|0|||
33450689|NCT03637764|101541675|FG002|Overall Study|Adverse Event|0|||
33450690|NCT03637764|101541676|FG003|Overall Study|Adverse Event|1|||
33450691|NCT03637764|101541673|FG000|Overall Study|Progressive Disease|23|||
33450692|NCT03637764|101541674|FG001|Overall Study|Progressive Disease|23|||
33450693|NCT03637764|101541675|FG002|Overall Study|Progressive Disease|18|||
33450694|NCT03637764|101541676|FG003|Overall Study|Progressive Disease|31|||
33450695|NCT03637764|101541673|FG000|Overall Study|Withdrawal by Subject|1|||
33450696|NCT03637764|101541674|FG001|Overall Study|Withdrawal by Subject|3|||
33450697|NCT03637764|101541675|FG002|Overall Study|Withdrawal by Subject|0|||
33450698|NCT03637764|101541676|FG003|Overall Study|Withdrawal by Subject|1|||
33450699|NCT02087423|101541678|FG000|Overall Study|Withdrawal by Subject|20|||
33450700|NCT02087423|101541679|FG001|Overall Study|Withdrawal by Subject|20|||
33450701|NCT02087423|101541680|FG002|Overall Study|Withdrawal by Subject|3|||
33450702|NCT02087423|101541678|FG000|Overall Study|Death|68|||
33450703|NCT02087423|101541679|FG001|Overall Study|Death|207|||
33450704|NCT02087423|101541680|FG002|Overall Study|Death|40|||
33450705|NCT02087423|101541678|FG000|Overall Study|Lost to Follow-up|0|||
33450706|NCT02087423|101541679|FG001|Overall Study|Lost to Follow-up|2|||
33450707|NCT02087423|101541680|FG002|Overall Study|Lost to Follow-up|0|||
33450708|NCT02087423|101541678|FG000|Overall Study|Terminated from study at final DCO|23|||
33450709|NCT02087423|101541679|FG001|Overall Study|Terminated from study at final DCO|36|||
33450710|NCT02087423|101541680|FG002|Overall Study|Terminated from study at final DCO|25|||
33450711|NCT02222818|101541681|FG000|Period 1|Eligibility criteria not met|0|||
33450712|NCT02222818|101541682|FG001|Period 1|Eligibility criteria not met|3|||
33450713|NCT03913377|101541683|FG000|Period 1|Test Article no longer available|0|||
33450714|NCT03913377|101541684|FG001|Period 1|Test Article no longer available|1|||
33450715|NCT03913377|101541685|FG002|Period 1|Test Article no longer available|0|||
33450716|NCT03913377|101541683|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
33450717|NCT03913377|101541684|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
33450718|NCT03913377|101541685|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
33450719|NCT04230681|101541686|FG000|Overall Study|Physician Decision|2|||
33450720|NCT04230681|101541687|FG001|Overall Study|Physician Decision|3|||
33450721|NCT04230681|101541686|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
33450722|NCT04230681|101541687|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
33450723|NCT04230681|101541686|FG000|Overall Study|IV inadvertently removed|0|||
33450724|NCT04230681|101541687|FG001|Overall Study|IV inadvertently removed|1|||
33450725|NCT02593773|101541688|FG000|Overall Study|Voluntary Withdrawal|3|||
33450726|NCT02593773|101541688|FG000|Overall Study|Study Terminated by Sponsor|31|||
33450727|NCT02593773|101541688|FG000|Overall Study|Death|1|||
33450728|NCT02905435|101541692|FG000|Overall Study|Death|2|||
33450729|NCT02905435|101541692|FG000|Overall Study|Physician Decision|1|||
33450730|NCT02905435|101541692|FG000|Overall Study|Lost to Follow-up|4|||
33450731|NCT01000961|101541695|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
33450732|NCT01000961|101541696|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
33450733|NCT01000961|101541695|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
33450734|NCT01000961|101541696|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
33450735|NCT02475681|101541707|FG000|Overall Study|Death|16|||
33450736|NCT02475681|101541708|FG001|Overall Study|Death|6|||
33450737|NCT02475681|101541709|FG002|Overall Study|Death|9|||
33450738|NCT02475681|101541707|FG000|Overall Study|Physician Decision|0|||
33450739|NCT02475681|101541708|FG001|Overall Study|Physician Decision|3|||
33450740|NCT02475681|101541709|FG002|Overall Study|Physician Decision|1|||
33450741|NCT02475681|101541707|FG000|Overall Study|Withdrawal by Subject|12|||
33450742|NCT02475681|101541708|FG001|Overall Study|Withdrawal by Subject|6|||
33450743|NCT02475681|101541709|FG002|Overall Study|Withdrawal by Subject|9|||
33450744|NCT02475681|101541707|FG000|Overall Study|Lost to Follow-up|2|||
33450745|NCT02475681|101541708|FG001|Overall Study|Lost to Follow-up|1|||
33450746|NCT02475681|101541709|FG002|Overall Study|Lost to Follow-up|3|||
33450747|NCT02475681|101541707|FG000|Overall Study|Ongoing in Study|0|||
33450748|NCT02475681|101541708|FG001|Overall Study|Ongoing in Study|163|||
33450749|NCT02475681|101541709|FG002|Overall Study|Ongoing in Study|157|||
33450750|NCT02475681|101541707|FG000|Overall Study|Reasons other than above listed|2|||
33450751|NCT02475681|101541708|FG001|Overall Study|Reasons other than above listed|0|||
33450752|NCT02475681|101541709|FG002|Overall Study|Reasons other than above listed|0|||
33450753|NCT01410227|101541713|FG000|Overall Study|Adverse Event|1|||
33450754|NCT01410227|101541714|FG001|Overall Study|Adverse Event|0|||
33450755|NCT01410227|101541715|FG002|Overall Study|Adverse Event|0|||
33450756|NCT01410227|101541716|FG003|Overall Study|Adverse Event|0|||
33450757|NCT01410227|101541713|FG000|Overall Study|Withdrawal by Subject|3|||
33450758|NCT01410227|101541714|FG001|Overall Study|Withdrawal by Subject|0|||
33450759|NCT01410227|101541715|FG002|Overall Study|Withdrawal by Subject|1|||
33450760|NCT01410227|101541716|FG003|Overall Study|Withdrawal by Subject|0|||
33450761|NCT01410227|101541713|FG000|Overall Study|Pregnancy|0|||
33450762|NCT01410227|101541714|FG001|Overall Study|Pregnancy|0|||
33450763|NCT01410227|101541715|FG002|Overall Study|Pregnancy|0|||
33450764|NCT01410227|101541716|FG003|Overall Study|Pregnancy|1|||
33450765|NCT01410227|101541713|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
33450766|NCT01410227|101541714|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
33450767|NCT01410227|101541715|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
33450768|NCT01410227|101541716|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
33450769|NCT00835263|101541717|FG000|Second Intervention|Adverse Event|1|||
33450770|NCT00835263|101541718|FG001|Second Intervention|Adverse Event|0|||
33450771|NCT00115063|101541719|FG000|Overall Study|Lost to Follow-up|98|||
33450772|NCT00115063|101541720|FG001|Overall Study|Lost to Follow-up|104|||
33450773|NCT00115063|101541719|FG000|Overall Study|Death|1|||
33450774|NCT00115063|101541720|FG001|Overall Study|Death|0|||
33450775|NCT05387408|101541721|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
33450776|NCT00294047|101541722|FG000|Month 48|Adverse Event|28|||
33450777|NCT00294047|101541723|FG001|Month 48|Adverse Event|13|||
33450778|NCT00294047|101541722|FG000|Month 48|Protocol Violation|4|||
33450779|NCT00294047|101541723|FG001|Month 48|Protocol Violation|4|||
33450780|NCT00294047|101541722|FG000|Month 48|Withdrawal by Subject|111|||
33450781|NCT00294047|101541723|FG001|Month 48|Withdrawal by Subject|115|||
33450782|NCT00294047|101541722|FG000|Month 48|Lost to Follow-up|272|||
33450783|NCT00294047|101541723|FG001|Month 48|Lost to Follow-up|287|||
33450784|NCT00294047|101541722|FG000|Month 48|Other|10|||
33450785|NCT00294047|101541723|FG001|Month 48|Other|14|||
33450786|NCT00294047|101541722|FG000|Month 84|Adverse Event|4|||
33450787|NCT00294047|101541723|FG001|Month 84|Adverse Event|2|||
33450788|NCT00294047|101541722|FG000|Month 84|Protocol Violation|1|||
33450789|NCT00294047|101541723|FG001|Month 84|Protocol Violation|1|||
33450790|NCT00294047|101541722|FG000|Month 84|Withdrawal by Subject|33|||
33450791|NCT00294047|101541723|FG001|Month 84|Withdrawal by Subject|31|||
33450792|NCT00294047|101541722|FG000|Month 84|Lost to Follow-up|187|||
33450793|NCT00294047|101541723|FG001|Month 84|Lost to Follow-up|190|||
33450794|NCT00294047|101541722|FG000|Month 84|Absent Cervix|2|||
33450795|NCT00294047|101541723|FG001|Month 84|Absent Cervix|0|||
33450796|NCT00294047|101541722|FG000|Month 84|Work related reasons|4|||
33450797|NCT00294047|101541723|FG001|Month 84|Work related reasons|2|||
33450798|NCT00294047|101541722|FG000|Month 84|Center closed, subject did not transfer|1|||
33450799|NCT00294047|101541723|FG001|Month 84|Center closed, subject did not transfer|0|||
33450800|NCT00294047|101541722|FG000|Month 84|Family problems|2|||
33450801|NCT00294047|101541723|FG001|Month 84|Family problems|2|||
33450802|NCT00294047|101541722|FG000|Month 84|Lack of time|3|||
33450803|NCT00294047|101541723|FG001|Month 84|Lack of time|1|||
33450804|NCT00294047|101541722|FG000|Month 84|Personal reason|2|||
33450805|NCT00294047|101541723|FG001|Month 84|Personal reason|4|||
33450806|NCT00294047|101541722|FG000|Month 84|Subject does not want male physician|1|||
33450807|NCT00294047|101541723|FG001|Month 84|Subject does not want male physician|0|||
33450808|NCT00294047|101541722|FG000|Month 84|Transport reimbursement delayed|0|||
33450809|NCT00294047|101541723|FG001|Month 84|Transport reimbursement delayed|1|||
33450810|NCT00294047|101541722|FG000|Month 84|Unable to reach study site|1|||
33450811|NCT00294047|101541723|FG001|Month 84|Unable to reach study site|0|||
33450812|NCT00294047|101541722|FG000|Month 84|Under investigation locally|1|||
33450813|NCT00294047|101541723|FG001|Month 84|Under investigation locally|0|||
33450814|NCT00294047|101541722|FG000|Month 84|Visit missed|0|||
33450815|NCT00294047|101541723|FG001|Month 84|Visit missed|1|||
33450816|NCT00294047|101541722|FG000|Month 84|No consent for Month 84 Follow-up|731|||
33450817|NCT00294047|101541723|FG001|Month 84|No consent for Month 84 Follow-up|754|||
33450818|NCT03629054|101541724|FG000|Period 2 (4 Days)|Not treated|0|||
33450819|NCT03629054|101541725|FG001|Period 2 (4 Days)|Not treated|1|||
33450820|NCT02415127|101541726|FG000|Overall Study|Adverse Event|1|||
33170439|NCT03716024|100533088|FG001|Overall Study|Missing Reason|1|||
33450821|NCT02415127|101541727|FG001|Overall Study|Adverse Event|0|||
33450822|NCT03606408|101541728|FG000|Overall Study|Adverse Event|13|||
33450823|NCT03606408|101541728|FG000|Overall Study|Withdrawal by Subject|7|||
33450824|NCT03606408|101541728|FG000|Overall Study|Physician Decision|4|||
33450825|NCT03606408|101541728|FG000|Overall Study|Lack of Efficacy|2|||
33450826|NCT03606408|101541728|FG000|Overall Study|Death|1|||
33450827|NCT03606408|101541728|FG000|Overall Study|new therapy for study indication|1|||
33170440|NCT03052725|100533091|FG000|Overall Study|Adverse Event|2|||
33450828|NCT02264977|101541731|FG000|Overall Study|Death|3|||
33450829|NCT02264977|101541731|FG000|Overall Study|Physician Decision|1|||
33450830|NCT02264977|101541731|FG000|Overall Study|Refuse to return|1|||
33450831|NCT05239195|101541732|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
33450832|NCT05239195|101541733|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
33450833|NCT00830024|101541737|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
33450834|NCT00830024|101541738|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
33450835|NCT02875392|101541741|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
33450836|NCT02875392|101541742|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
33450837|NCT01274338|101541743|FG000|Overall Study|Lack of Efficacy|72|||
33450838|NCT01274338|101541744|FG001|Overall Study|Lack of Efficacy|108|||
33450839|NCT01274338|101541745|FG002|Overall Study|Lack of Efficacy|116|||
33450840|NCT01274338|101541746|FG003|Overall Study|Lack of Efficacy|0|||
33450841|NCT01274338|101541747|FG004|Overall Study|Lack of Efficacy|0|||
33450842|NCT01274338|101541748|FG005|Overall Study|Lack of Efficacy|0|||
33450843|NCT01274338|101541743|FG000|Overall Study|Adverse Event|272|||
33450844|NCT01274338|101541744|FG001|Overall Study|Adverse Event|105|||
33450845|NCT01274338|101541745|FG002|Overall Study|Adverse Event|180|||
33450846|NCT01274338|101541746|FG003|Overall Study|Adverse Event|1|||
33450847|NCT01274338|101541747|FG004|Overall Study|Adverse Event|0|||
33450848|NCT01274338|101541748|FG005|Overall Study|Adverse Event|0|||
33450849|NCT01274338|101541743|FG000|Overall Study|Death|8|||
33450850|NCT01274338|101541744|FG001|Overall Study|Death|1|||
33450851|NCT01274338|101541745|FG002|Overall Study|Death|0|||
33450852|NCT01274338|101541746|FG003|Overall Study|Death|0|||
33450853|NCT01274338|101541747|FG004|Overall Study|Death|0|||
33450854|NCT01274338|101541748|FG005|Overall Study|Death|0|||
33450855|NCT01274338|101541743|FG000|Overall Study|Withdrawal by Subject|27|||
33450856|NCT01274338|101541744|FG001|Overall Study|Withdrawal by Subject|99|||
33450857|NCT01274338|101541745|FG002|Overall Study|Withdrawal by Subject|17|||
33450858|NCT01274338|101541746|FG003|Overall Study|Withdrawal by Subject|0|||
33450859|NCT01274338|101541747|FG004|Overall Study|Withdrawal by Subject|0|||
33450860|NCT01274338|101541748|FG005|Overall Study|Withdrawal by Subject|0|||
33450861|NCT01274338|101541743|FG000|Overall Study|Did not start treatment|8|||
33450862|NCT01274338|101541744|FG001|Overall Study|Did not start treatment|116|||
33450863|NCT01274338|101541745|FG002|Overall Study|Did not start treatment|7|||
33450864|NCT01274338|101541746|FG003|Overall Study|Did not start treatment|0|||
33450865|NCT01274338|101541747|FG004|Overall Study|Did not start treatment|0|||
33450866|NCT01274338|101541748|FG005|Overall Study|Did not start treatment|0|||
33450867|NCT01274338|101541743|FG000|Overall Study|Alternative therapy|0|||
33450868|NCT01274338|101541744|FG001|Overall Study|Alternative therapy|1|||
33450869|NCT01274338|101541745|FG002|Overall Study|Alternative therapy|0|||
33450870|NCT01274338|101541746|FG003|Overall Study|Alternative therapy|0|||
33450871|NCT01274338|101541747|FG004|Overall Study|Alternative therapy|0|||
33450872|NCT01274338|101541748|FG005|Overall Study|Alternative therapy|0|||
33450873|NCT01274338|101541743|FG000|Overall Study|Other complicating diseases|0|||
33450874|NCT01274338|101541744|FG001|Overall Study|Other complicating diseases|3|||
33450875|NCT01274338|101541745|FG002|Overall Study|Other complicating diseases|1|||
33450876|NCT01274338|101541746|FG003|Overall Study|Other complicating diseases|0|||
33450877|NCT01274338|101541747|FG004|Overall Study|Other complicating diseases|0|||
33450878|NCT01274338|101541748|FG005|Overall Study|Other complicating diseases|0|||
33450879|NCT01274338|101541743|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
33450880|NCT01274338|101541744|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
33450881|NCT01274338|101541745|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
33450882|NCT01274338|101541746|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
33450883|NCT01274338|101541747|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
33450884|NCT01274338|101541748|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
33450885|NCT01274338|101541743|FG000|Overall Study|Pregnancy|0|||
33450886|NCT01274338|101541744|FG001|Overall Study|Pregnancy|0|||
33450887|NCT01274338|101541745|FG002|Overall Study|Pregnancy|1|||
33450888|NCT01274338|101541746|FG003|Overall Study|Pregnancy|0|||
33450889|NCT01274338|101541747|FG004|Overall Study|Pregnancy|0|||
33450890|NCT01274338|101541748|FG005|Overall Study|Pregnancy|0|||
33450891|NCT01274338|101541743|FG000|Overall Study|Reason not reported|12|||
33450892|NCT01274338|101541744|FG001|Overall Study|Reason not reported|21|||
33450893|NCT01274338|101541745|FG002|Overall Study|Reason not reported|3|||
33450894|NCT01274338|101541746|FG003|Overall Study|Reason not reported|0|||
33450895|NCT01274338|101541747|FG004|Overall Study|Reason not reported|1|||
33450896|NCT01274338|101541748|FG005|Overall Study|Reason not reported|0|||
33450897|NCT05752721|101541749|FG000|Overall Study|Lost to Follow-up|22|||
33450898|NCT05752721|101541750|FG001|Overall Study|Lost to Follow-up|20|||
33450899|NCT05752721|101541749|FG000|Overall Study|Withdrawal by Subject|15|||
33450900|NCT05752721|101541750|FG001|Overall Study|Withdrawal by Subject|12|||
33450901|NCT02648438|101541753|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33450902|NCT02648438|101541754|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
33450903|NCT02648438|101541755|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
33450904|NCT02648438|101541753|FG000|Overall Study|Protocol Violation|2|||
33450905|NCT02648438|101541754|FG001|Overall Study|Protocol Violation|0|||
33450906|NCT02648438|101541755|FG002|Overall Study|Protocol Violation|0|||
33450907|NCT02648438|101541753|FG000|Overall Study|Withdrawal by Subject|1|||
33450908|NCT02648438|101541754|FG001|Overall Study|Withdrawal by Subject|1|||
33450909|NCT02648438|101541755|FG002|Overall Study|Withdrawal by Subject|0|||
33450910|NCT03364192|101541756|FG000|Overall Study|Ineligible|10|||
33450911|NCT03364192|101541756|FG000|Overall Study|Withdrawal by Subject|5|||
33450912|NCT03364192|101541756|FG000|Overall Study|Lost to Follow-up|1|||
33450913|NCT04633564|101541757|FG000|Period 1|Adverse Event|28|||
33450914|NCT04633564|101541758|FG001|Period 1|Adverse Event|19|||
33450915|NCT04633564|101541757|FG000|Period 1|Death|8|||
33450916|NCT04633564|101541758|FG001|Period 1|Death|7|||
33450917|NCT04633564|101541757|FG000|Period 1|Lost to Follow-up|3|||
33450918|NCT04633564|101541758|FG001|Period 1|Lost to Follow-up|5|||
33450919|NCT04633564|101541757|FG000|Period 1|Physician Decision|4|||
33450920|NCT04633564|101541758|FG001|Period 1|Physician Decision|12|||
33450921|NCT04633564|101541757|FG000|Period 1|Protocol Violation|0|||
33450922|NCT04633564|101541758|FG001|Period 1|Protocol Violation|1|||
33450923|NCT04633564|101541757|FG000|Period 1|Withdrawal by Subject|10|||
33450924|NCT04633564|101541758|FG001|Period 1|Withdrawal by Subject|8|||
33450925|NCT04633564|101541757|FG000|Period 1|Progressive disease|47|||
33450926|NCT04633564|101541758|FG001|Period 1|Progressive disease|51|||
33450927|NCT04633564|101541757|FG000|Period 1|Terminated by Sponsor|8|||
33450928|NCT04633564|101541758|FG001|Period 1|Terminated by Sponsor|6|||
33450929|NCT04633564|101541757|FG000|Period 2|Adverse Event|3|||
33450930|NCT04633564|101541758|FG001|Period 2|Adverse Event|4|||
33450931|NCT04633564|101541757|FG000|Period 2|Death|0|||
33450932|NCT04633564|101541758|FG001|Period 2|Death|2|||
33450933|NCT04633564|101541757|FG000|Period 2|Lost to Follow-up|0|||
33450934|NCT04633564|101541758|FG001|Period 2|Lost to Follow-up|1|||
33450935|NCT04633564|101541757|FG000|Period 2|Physician Decision|2|||
33450936|NCT04633564|101541758|FG001|Period 2|Physician Decision|4|||
33450937|NCT04633564|101541757|FG000|Period 2|Withdrawal by Subject|5|||
33450938|NCT04633564|101541758|FG001|Period 2|Withdrawal by Subject|1|||
33450939|NCT04633564|101541757|FG000|Period 2|Progressive Disease|74|||
33450940|NCT04633564|101541758|FG001|Period 2|Progressive Disease|82|||
33450941|NCT04633564|101541757|FG000|Period 2|Terminated by Sponsor|9|||
33450942|NCT04633564|101541758|FG001|Period 2|Terminated by Sponsor|3|||
33450943|NCT01018862|101541759|FG000|Overall Study|Adverse Event|2|||
33450944|NCT01018862|101541760|FG001|Overall Study|Adverse Event|0|||
33450945|NCT01018862|101541761|FG002|Overall Study|Adverse Event|6|||
33450946|NCT01018862|101541759|FG000|Overall Study|Lack of Efficacy|1|||
33450947|NCT01018862|101541760|FG001|Overall Study|Lack of Efficacy|0|||
33450948|NCT01018862|101541761|FG002|Overall Study|Lack of Efficacy|2|||
33450949|NCT01018862|101541759|FG000|Overall Study|Lost to Follow-up|3|||
33450950|NCT01018862|101541760|FG001|Overall Study|Lost to Follow-up|1|||
33450951|NCT01018862|101541761|FG002|Overall Study|Lost to Follow-up|0|||
33450952|NCT01018862|101541759|FG000|Overall Study|Protocol Violation|1|||
33450953|NCT01018862|101541760|FG001|Overall Study|Protocol Violation|3|||
33450954|NCT01018862|101541761|FG002|Overall Study|Protocol Violation|3|||
33450955|NCT01018862|101541759|FG000|Overall Study|Withdrawal by Subject|1|||
33450956|NCT01018862|101541760|FG001|Overall Study|Withdrawal by Subject|2|||
33450957|NCT01018862|101541761|FG002|Overall Study|Withdrawal by Subject|1|||
33450958|NCT01018862|101541759|FG000|Overall Study|administrative problems|5|||
33450959|NCT01018862|101541760|FG001|Overall Study|administrative problems|4|||
33450960|NCT01018862|101541761|FG002|Overall Study|administrative problems|4|||
33450961|NCT00421304|101541764|FG000|Overall Study|Lost to Follow-up|5|||
33450962|NCT00421304|101541765|FG001|Overall Study|Lost to Follow-up|2|||
33450963|NCT00421304|101541766|FG002|Overall Study|Lost to Follow-up|5|||
33450964|NCT00421304|101541764|FG000|Overall Study|Withdrawal by Subject|2|||
33450965|NCT00421304|101541765|FG001|Overall Study|Withdrawal by Subject|2|||
33450966|NCT00421304|101541766|FG002|Overall Study|Withdrawal by Subject|2|||
33450967|NCT00421304|101541764|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
33450968|NCT00421304|101541765|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
33489752|NCT02952586|101686779|FG001|Lead-In Phase (7 Days)|Death|1|||
33170441|NCT03052725|100533092|FG001|Overall Study|Adverse Event|0|||
33170442|NCT03052725|100533091|FG000|Overall Study|Withdrawal by Subject|3|||
33170443|NCT03052725|100533092|FG001|Overall Study|Withdrawal by Subject|4|||
33170444|NCT03052725|100533091|FG000|Overall Study|Pregnancy|0|||
33170445|NCT03052725|100533092|FG001|Overall Study|Pregnancy|1|||
33170446|NCT03052725|100533091|FG000|Overall Study|Site closure|0|||
33170447|NCT03052725|100533092|FG001|Overall Study|Site closure|1|||
33170448|NCT03052725|100533091|FG000|Overall Study|Study terminated by sponsor|143|||
33170449|NCT03052725|100533092|FG001|Overall Study|Study terminated by sponsor|144|||
33170450|NCT03171415|100533095|FG000|Overall Study|Lost to Follow-up|0|||
33170451|NCT03171415|100533096|FG001|Overall Study|Lost to Follow-up|0|||
33170452|NCT03171415|100533097|FG002|Overall Study|Lost to Follow-up|0|||
33170453|NCT03171415|100533098|FG003|Overall Study|Lost to Follow-up|0|||
33170454|NCT03171415|100533099|FG004|Overall Study|Lost to Follow-up|2|||
33170455|NCT02603419|100533107|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
33170456|NCT02603419|100533108|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
33170457|NCT02603419|100533109|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
33170458|NCT02603419|100533110|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
33170459|NCT02603419|100533111|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
33170460|NCT02603419|100533112|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
33170461|NCT02603419|100533107|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
33170462|NCT02603419|100533108|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
33170463|NCT02603419|100533109|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
33170464|NCT02603419|100533110|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
33450969|NCT00421304|101541766|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
33450970|NCT00421304|101541764|FG000|Overall Study|Did not attend Day 360 visit|0|||
33450971|NCT00421304|101541765|FG001|Overall Study|Did not attend Day 360 visit|0|||
33450972|NCT00421304|101541766|FG002|Overall Study|Did not attend Day 360 visit|1|||
33450973|NCT01302548|101541767|FG000|Overall Study|Lost to Follow-up|2|||
33450974|NCT01302548|101541768|FG001|Overall Study|Lost to Follow-up|1|||
33450975|NCT01609257|101541769|FG000|Overall Study|Lost to Follow-up|2|||
33450976|NCT01609257|101541770|FG001|Overall Study|Lost to Follow-up|1|||
33450977|NCT01609257|101541769|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
33450978|NCT01609257|101541770|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
33450979|NCT01609257|101541769|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
33450980|NCT01609257|101541770|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
33450981|NCT00402103|101541771|FG000|Overall Study|Adverse Event|60|||
33450982|NCT00402103|101541772|FG001|Overall Study|Adverse Event|7|||
33450983|NCT00402103|101541771|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33450984|NCT00402103|101541772|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33450985|NCT00402103|101541771|FG000|Overall Study|Condition no longer requires study drug|2|||
33450986|NCT00402103|101541772|FG001|Overall Study|Condition no longer requires study drug|0|||
33450987|NCT00402103|101541771|FG000|Overall Study|Protocol Deviation|8|||
33450988|NCT00402103|101541772|FG001|Overall Study|Protocol Deviation|0|||
33450989|NCT00402103|101541771|FG000|Overall Study|Patient withdrew consent|12|||
33450990|NCT00402103|101541772|FG001|Overall Study|Patient withdrew consent|1|||
33450991|NCT00402103|101541771|FG000|Overall Study|Lost to Follow-up|6|||
33450992|NCT00402103|101541772|FG001|Overall Study|Lost to Follow-up|3|||
33450993|NCT00402103|101541771|FG000|Overall Study|Administrative problems|2|||
33450994|NCT00402103|101541772|FG001|Overall Study|Administrative problems|0|||
33450995|NCT00216736|101541777|FG000|Overall Study|Lost to Follow-up|1|||
33450996|NCT00216736|101541778|FG001|Overall Study|Lost to Follow-up|1|||
33450997|NCT00371839|101541781|FG000|Overall Study|Death|4|||
33170465|NCT02603419|100533111|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
33170466|NCT02603419|100533112|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
33170467|NCT02603419|100533107|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
33450998|NCT00371839|101541782|FG001|Overall Study|Death|0|||
33450999|NCT00371839|101541783|FG002|Overall Study|Death|0|||
33451000|NCT00371839|101541781|FG000|Overall Study|Withdrawal by Subject|7|||
33451001|NCT00371839|101541782|FG001|Overall Study|Withdrawal by Subject|4|||
33451002|NCT00371839|101541783|FG002|Overall Study|Withdrawal by Subject|0|||
33451003|NCT00371839|101541781|FG000|Overall Study|Lost to Follow-up|6|||
33170468|NCT02603419|100533108|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
33451004|NCT00371839|101541782|FG001|Overall Study|Lost to Follow-up|3|||
33451005|NCT00371839|101541783|FG002|Overall Study|Lost to Follow-up|2|||
33451006|NCT02679729|101541786|FG000|Overall Study|Lost to Follow-up|0|||
33451007|NCT02679729|101541787|FG001|Overall Study|Lost to Follow-up|1|||
33451008|NCT02679729|101541788|FG002|Overall Study|Lost to Follow-up|0|||
33451009|NCT02679729|101541789|FG003|Overall Study|Lost to Follow-up|0|||
33451010|NCT02679729|101541790|FG004|Overall Study|Lost to Follow-up|1|||
33451011|NCT02679729|101541791|FG005|Overall Study|Lost to Follow-up|0|||
33451012|NCT02679729|101541792|FG006|Overall Study|Lost to Follow-up|0|||
33451013|NCT02679729|101541793|FG007|Overall Study|Lost to Follow-up|0|||
33451014|NCT02679729|101541794|FG008|Overall Study|Lost to Follow-up|0|||
33451015|NCT02679729|101541786|FG000|Overall Study|Participant decision|0|||
33451016|NCT02679729|101541787|FG001|Overall Study|Participant decision|1|||
33451017|NCT02679729|101541788|FG002|Overall Study|Participant decision|0|||
33451018|NCT02679729|101541789|FG003|Overall Study|Participant decision|0|||
33451019|NCT02679729|101541790|FG004|Overall Study|Participant decision|0|||
33451020|NCT02679729|101541791|FG005|Overall Study|Participant decision|0|||
33451021|NCT02679729|101541792|FG006|Overall Study|Participant decision|1|||
33451022|NCT02679729|101541793|FG007|Overall Study|Participant decision|0|||
33451023|NCT02679729|101541794|FG008|Overall Study|Participant decision|0|||
33451024|NCT02615249|101541795|FG000|Overall Study|Withdrawal by Subject|1|||
33451025|NCT01576705|101541798|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
33451026|NCT01576705|101541799|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
33451027|NCT01576705|101541800|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
33451028|NCT01576705|101541801|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
33451029|NCT01576705|101541798|FG000|Overall Study|invalid ICF|0|||
33451030|NCT01576705|101541799|FG001|Overall Study|invalid ICF|1|||
33451031|NCT01576705|101541800|FG002|Overall Study|invalid ICF|0|||
33451032|NCT01576705|101541801|FG003|Overall Study|invalid ICF|0|||
33451033|NCT00834717|101541802|FG000|First Intervention|Adverse Event|1|||
33451034|NCT00834717|101541803|FG001|First Intervention|Adverse Event|0|||
33451035|NCT00834717|101541802|FG000|First Intervention|Withdrawal by Subject|0|||
33451036|NCT00834717|101541803|FG001|First Intervention|Withdrawal by Subject|1|||
33451037|NCT04035187|101541804|FG000|Overall Study|Withdrawal by Subject|2|||
33451038|NCT04035187|101541805|FG001|Overall Study|Withdrawal by Subject|1|||
33451039|NCT04035187|101541806|FG002|Overall Study|Withdrawal by Subject|0|||
33451040|NCT04035187|101541807|FG003|Overall Study|Withdrawal by Subject|0|||
33451041|NCT04035187|101541804|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
33451042|NCT04035187|101541805|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
33451043|NCT04035187|101541806|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
33451044|NCT04035187|101541807|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
33451045|NCT00859521|101541808|FG000|Washout|Withdrawal by Subject|0|||
33451046|NCT00859521|101541809|FG001|Washout|Withdrawal by Subject|1|||
33451047|NCT02957942|101541816|FG000|Overall Study|Withdrawal by Subject|0|||
33451048|NCT02957942|101541817|FG001|Overall Study|Withdrawal by Subject|1|||
33451049|NCT02957942|101541816|FG000|Overall Study|Practicing experiment protocol|0|||
33451050|NCT02957942|101541817|FG001|Overall Study|Practicing experiment protocol|6|||
33451051|NCT03635320|101541819|FG000|Overall Study|not implanted the device|1|||
33451052|NCT03635320|101541820|FG001|Overall Study|not implanted the device|2|||
33451053|NCT03635320|101541819|FG000|Overall Study|Withdrawal by Subject|11|||
33451054|NCT03635320|101541820|FG001|Overall Study|Withdrawal by Subject|6|||
33451055|NCT01015703|101541823|FG000|Overall Study|Withdrawal by Subject|0|||
33451056|NCT01015703|101541824|FG001|Overall Study|Withdrawal by Subject|1|||
33451057|NCT01015703|101541825|FG002|Overall Study|Withdrawal by Subject|0|||
33451058|NCT01015703|101541826|FG003|Overall Study|Withdrawal by Subject|0|||
33451059|NCT01015703|101541827|FG004|Overall Study|Withdrawal by Subject|0|||
33451060|NCT01015703|101541823|FG000|Overall Study|Adverse Event|1|||
33451061|NCT01015703|101541824|FG001|Overall Study|Adverse Event|0|||
33451062|NCT01015703|101541825|FG002|Overall Study|Adverse Event|0|||
33451063|NCT01015703|101541826|FG003|Overall Study|Adverse Event|0|||
33451064|NCT01015703|101541827|FG004|Overall Study|Adverse Event|0|||
33451065|NCT01015703|101541823|FG000|Overall Study|Protocol Violation|1|||
33451066|NCT01015703|101541824|FG001|Overall Study|Protocol Violation|0|||
33451067|NCT01015703|101541825|FG002|Overall Study|Protocol Violation|0|||
33451068|NCT01015703|101541826|FG003|Overall Study|Protocol Violation|0|||
33451069|NCT01015703|101541827|FG004|Overall Study|Protocol Violation|0|||
33451070|NCT02055547|101541828|FG000|Overall Study|Protocol Violation|0|||
33451071|NCT02055547|101541829|FG001|Overall Study|Protocol Violation|0|||
33451072|NCT02055547|101541830|FG002|Overall Study|Protocol Violation|1|||
33451073|NCT02055547|101541831|FG003|Overall Study|Protocol Violation|0|||
33451074|NCT02055547|101541832|FG004|Overall Study|Protocol Violation|0|||
33451075|NCT02055547|101541833|FG005|Overall Study|Protocol Violation|0|||
33170469|NCT02603419|100533109|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
33170470|NCT02603419|100533110|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
33170471|NCT02603419|100533111|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
33170472|NCT02603419|100533112|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
33170473|NCT02603419|100533107|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
33170474|NCT02603419|100533108|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
33170475|NCT02603419|100533109|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
33170476|NCT02603419|100533110|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
33170477|NCT02603419|100533111|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
33170478|NCT02603419|100533112|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
33170479|NCT02603419|100533107|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
33170480|NCT02603419|100533108|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
33170481|NCT02603419|100533109|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
33170482|NCT02603419|100533110|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
33170483|NCT02603419|100533111|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
33170484|NCT02603419|100533112|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
33170485|NCT02603419|100533107|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
33451076|NCT02055547|101541834|FG006|Overall Study|Protocol Violation|1|||
33451077|NCT02055547|101541835|FG007|Overall Study|Protocol Violation|0|||
33451078|NCT02055547|101541836|FG008|Overall Study|Protocol Violation|0|||
33451079|NCT02055547|101541837|FG009|Overall Study|Protocol Violation|0|||
33451080|NCT02055547|101541838|FG010|Overall Study|Protocol Violation|0|||
33451081|NCT02055547|101541839|FG011|Overall Study|Protocol Violation|0|||
33451082|NCT02055547|101541840|FG012|Overall Study|Protocol Violation|0|||
33451083|NCT02055547|101541841|FG013|Overall Study|Protocol Violation|0|||
33451084|NCT02055547|101541842|FG014|Overall Study|Protocol Violation|0|||
33451085|NCT02055547|101541843|FG015|Overall Study|Protocol Violation|0|||
33451086|NCT02055547|101541844|FG016|Overall Study|Protocol Violation|0|||
33451087|NCT02055547|101541845|FG017|Overall Study|Protocol Violation|0|||
33451088|NCT02055547|101541846|FG018|Overall Study|Protocol Violation|0|||
33451089|NCT02055547|101541828|FG000|Overall Study|Physician Decision|0|||
33451090|NCT02055547|101541829|FG001|Overall Study|Physician Decision|1|||
33451091|NCT02055547|101541830|FG002|Overall Study|Physician Decision|1|||
33451092|NCT02055547|101541831|FG003|Overall Study|Physician Decision|0|||
33451093|NCT02055547|101541832|FG004|Overall Study|Physician Decision|1|||
33451094|NCT02055547|101541833|FG005|Overall Study|Physician Decision|0|||
33451095|NCT02055547|101541834|FG006|Overall Study|Physician Decision|0|||
33451096|NCT02055547|101541835|FG007|Overall Study|Physician Decision|0|||
33451097|NCT02055547|101541836|FG008|Overall Study|Physician Decision|0|||
33451098|NCT02055547|101541837|FG009|Overall Study|Physician Decision|1|||
33451099|NCT02055547|101541838|FG010|Overall Study|Physician Decision|1|||
33451100|NCT02055547|101541839|FG011|Overall Study|Physician Decision|0|||
33451101|NCT02055547|101541840|FG012|Overall Study|Physician Decision|0|||
33451102|NCT02055547|101541841|FG013|Overall Study|Physician Decision|0|||
33451103|NCT02055547|101541842|FG014|Overall Study|Physician Decision|0|||
33451104|NCT02055547|101541843|FG015|Overall Study|Physician Decision|0|||
33451105|NCT02055547|101541844|FG016|Overall Study|Physician Decision|0|||
33451106|NCT02055547|101541845|FG017|Overall Study|Physician Decision|0|||
33451107|NCT02055547|101541846|FG018|Overall Study|Physician Decision|0|||
33451108|NCT02055547|101541828|FG000|Overall Study|Adverse Event|0|||
33451109|NCT02055547|101541829|FG001|Overall Study|Adverse Event|0|||
33451110|NCT02055547|101541830|FG002|Overall Study|Adverse Event|0|||
33451111|NCT02055547|101541831|FG003|Overall Study|Adverse Event|0|||
33451112|NCT02055547|101541832|FG004|Overall Study|Adverse Event|0|||
33451113|NCT02055547|101541833|FG005|Overall Study|Adverse Event|0|||
33451114|NCT02055547|101541834|FG006|Overall Study|Adverse Event|1|||
33451115|NCT02055547|101541835|FG007|Overall Study|Adverse Event|0|||
33451116|NCT02055547|101541836|FG008|Overall Study|Adverse Event|1|||
33451117|NCT02055547|101541837|FG009|Overall Study|Adverse Event|0|||
33451118|NCT02055547|101541838|FG010|Overall Study|Adverse Event|0|||
33451119|NCT02055547|101541839|FG011|Overall Study|Adverse Event|0|||
33451120|NCT02055547|101541840|FG012|Overall Study|Adverse Event|0|||
33451121|NCT02055547|101541841|FG013|Overall Study|Adverse Event|0|||
33451122|NCT02055547|101541842|FG014|Overall Study|Adverse Event|0|||
33451123|NCT02055547|101541843|FG015|Overall Study|Adverse Event|0|||
33451124|NCT02055547|101541844|FG016|Overall Study|Adverse Event|0|||
33451125|NCT02055547|101541845|FG017|Overall Study|Adverse Event|0|||
33451126|NCT02055547|101541846|FG018|Overall Study|Adverse Event|0|||
33451127|NCT02055547|101541828|FG000|Overall Study|Withdrawal by Subject|0|||
33451128|NCT02055547|101541829|FG001|Overall Study|Withdrawal by Subject|0|||
33451129|NCT02055547|101541830|FG002|Overall Study|Withdrawal by Subject|0|||
33451130|NCT02055547|101541831|FG003|Overall Study|Withdrawal by Subject|0|||
33451131|NCT02055547|101541832|FG004|Overall Study|Withdrawal by Subject|0|||
33451132|NCT02055547|101541833|FG005|Overall Study|Withdrawal by Subject|1|||
33451133|NCT02055547|101541834|FG006|Overall Study|Withdrawal by Subject|0|||
33451134|NCT02055547|101541835|FG007|Overall Study|Withdrawal by Subject|0|||
33451135|NCT02055547|101541836|FG008|Overall Study|Withdrawal by Subject|1|||
33451136|NCT02055547|101541837|FG009|Overall Study|Withdrawal by Subject|0|||
33451137|NCT02055547|101541838|FG010|Overall Study|Withdrawal by Subject|0|||
33451138|NCT02055547|101541839|FG011|Overall Study|Withdrawal by Subject|0|||
33451139|NCT02055547|101541840|FG012|Overall Study|Withdrawal by Subject|0|||
33451140|NCT02055547|101541841|FG013|Overall Study|Withdrawal by Subject|1|||
33451141|NCT02055547|101541842|FG014|Overall Study|Withdrawal by Subject|0|||
33451142|NCT02055547|101541843|FG015|Overall Study|Withdrawal by Subject|1|||
33451143|NCT02055547|101541844|FG016|Overall Study|Withdrawal by Subject|0|||
33451144|NCT02055547|101541845|FG017|Overall Study|Withdrawal by Subject|0|||
33451145|NCT02055547|101541846|FG018|Overall Study|Withdrawal by Subject|0|||
33451146|NCT02055547|101541828|FG000|Overall Study|Lost to Follow-up|0|||
33451147|NCT02055547|101541829|FG001|Overall Study|Lost to Follow-up|0|||
33451148|NCT02055547|101541830|FG002|Overall Study|Lost to Follow-up|1|||
33451149|NCT02055547|101541831|FG003|Overall Study|Lost to Follow-up|0|||
33451150|NCT02055547|101541832|FG004|Overall Study|Lost to Follow-up|0|||
33451151|NCT02055547|101541833|FG005|Overall Study|Lost to Follow-up|0|||
33451152|NCT02055547|101541834|FG006|Overall Study|Lost to Follow-up|0|||
33451153|NCT02055547|101541835|FG007|Overall Study|Lost to Follow-up|0|||
33451154|NCT02055547|101541836|FG008|Overall Study|Lost to Follow-up|0|||
33451155|NCT02055547|101541837|FG009|Overall Study|Lost to Follow-up|0|||
33451156|NCT02055547|101541838|FG010|Overall Study|Lost to Follow-up|0|||
33451157|NCT02055547|101541839|FG011|Overall Study|Lost to Follow-up|0|||
33451158|NCT02055547|101541840|FG012|Overall Study|Lost to Follow-up|0|||
33451159|NCT02055547|101541841|FG013|Overall Study|Lost to Follow-up|0|||
33451160|NCT02055547|101541842|FG014|Overall Study|Lost to Follow-up|0|||
33451161|NCT02055547|101541843|FG015|Overall Study|Lost to Follow-up|0|||
33451162|NCT02055547|101541844|FG016|Overall Study|Lost to Follow-up|0|||
33451163|NCT02055547|101541845|FG017|Overall Study|Lost to Follow-up|0|||
33451164|NCT02055547|101541846|FG018|Overall Study|Lost to Follow-up|0|||
33451165|NCT02028715|101541855|FG000|Overall Study|Adverse Event|2|||
33451166|NCT02028715|101541856|FG001|Overall Study|Adverse Event|2|||
33451167|NCT02028715|101541855|FG000|Overall Study|Physician Decision|1|||
33451168|NCT02028715|101541856|FG001|Overall Study|Physician Decision|0|||
33451169|NCT02028715|101541855|FG000|Overall Study|Did not complete satisfaction surveys|2|||
33451170|NCT02028715|101541856|FG001|Overall Study|Did not complete satisfaction surveys|2|||
33261186|NCT00739908|100856564|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
33261187|NCT00739908|100856563|FG000|Overall Study|Non-Compliance With Study Medication|0|||
33261188|NCT00739908|100856564|FG001|Overall Study|Non-Compliance With Study Medication|3|||
33261189|NCT00739908|100856563|FG000|Overall Study|Lack of Efficacy|0|||
33261190|NCT00739908|100856564|FG001|Overall Study|Lack of Efficacy|1|||
33261191|NCT00739908|100856563|FG000|Overall Study|Relocation|0|||
33261192|NCT00739908|100856564|FG001|Overall Study|Relocation|1|||
33261193|NCT02107261|100856565|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
33261194|NCT02107261|100856566|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
33261195|NCT02107261|100856565|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
33261196|NCT02107261|100856566|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
33261197|NCT00931710|100856568|FG000|Overall Study|Adverse Event|16|||
33261198|NCT00931710|100856569|FG001|Overall Study|Adverse Event|10|||
33261199|NCT00931710|100856568|FG000|Overall Study|Abnormal test procedure results|2|||
33261200|NCT00931710|100856569|FG001|Overall Study|Abnormal test procedure results|0|||
33261201|NCT00931710|100856568|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
33489753|NCT02952586|101686778|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
33489754|NCT02952586|101686779|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
33261202|NCT00931710|100856569|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
33489755|NCT02952586|101686778|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
33489756|NCT02952586|101686779|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
33489757|NCT02952586|101686778|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
33489758|NCT02952586|101686779|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
33489759|NCT02952586|101686778|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
33170486|NCT02603419|100533108|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
33170487|NCT02603419|100533109|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
33170488|NCT02603419|100533110|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
33170489|NCT02603419|100533111|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
33170490|NCT02603419|100533112|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
33170491|NCT02603419|100533107|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
33170492|NCT02603419|100533108|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
33170493|NCT02603419|100533109|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
33170494|NCT02603419|100533110|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
33170495|NCT02603419|100533111|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
33170496|NCT02603419|100533112|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
33170497|NCT02603419|100533107|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
33170498|NCT02603419|100533108|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
33170499|NCT02603419|100533109|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
33170500|NCT02603419|100533110|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
33170501|NCT02603419|100533111|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
33170502|NCT02603419|100533112|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
33170503|NCT02603419|100533107|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
33170504|NCT02603419|100533108|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
33170505|NCT02603419|100533109|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
33170506|NCT02603419|100533110|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
33170507|NCT02603419|100533111|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
33261203|NCT00931710|100856568|FG000|Overall Study|Patient withdrew consent|4|||
33261204|NCT00931710|100856569|FG001|Overall Study|Patient withdrew consent|9|||
33261205|NCT00931710|100856568|FG000|Overall Study|Lost to Follow-up|6|||
33261206|NCT00931710|100856569|FG001|Overall Study|Lost to Follow-up|5|||
33170508|NCT02603419|100533112|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
33170509|NCT02603419|100533107|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
33170510|NCT02603419|100533108|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
33170511|NCT02603419|100533109|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
33170512|NCT02603419|100533110|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
33170513|NCT02603419|100533111|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
33170514|NCT02603419|100533112|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
33170515|NCT02373202|100533114|FG000|Overall Study|Adverse Event|2|||
33170516|NCT02373202|100533115|FG001|Overall Study|Adverse Event|5|||
33170517|NCT02373202|100533116|FG002|Overall Study|Adverse Event|2|||
33170518|NCT02373202|100533117|FG003|Overall Study|Adverse Event|1|||
33170519|NCT02373202|100533114|FG000|Overall Study|Lack of Efficacy|0|||
33170520|NCT02373202|100533115|FG001|Overall Study|Lack of Efficacy|0|||
33170521|NCT02373202|100533116|FG002|Overall Study|Lack of Efficacy|1|||
33170522|NCT02373202|100533117|FG003|Overall Study|Lack of Efficacy|0|||
33170523|NCT02373202|100533114|FG000|Overall Study|Other|0|||
33170524|NCT02373202|100533115|FG001|Overall Study|Other|1|||
33170525|NCT02373202|100533116|FG002|Overall Study|Other|0|||
33170526|NCT02373202|100533117|FG003|Overall Study|Other|0|||
33170527|NCT01892293|100533129|FG000|Overall Study|Apheresed but not treated|4|||
33170528|NCT02170051|100533130|FG000|Overall Study|Withdrawal by Subject|10|||
33170529|NCT02170051|100533131|FG001|Overall Study|Withdrawal by Subject|10|||
33170530|NCT02170051|100533130|FG000|Overall Study|Lost to Follow-up|1|||
33170531|NCT02170051|100533131|FG001|Overall Study|Lost to Follow-up|3|||
33170532|NCT01605877|100533132|FG000|Overall Study|Withdrawal by Subject|1|||
33170533|NCT02375113|100533133|FG000|Overall Study|Undisclosed Reason(s).|1|||
33170534|NCT02375113|100533134|FG001|Overall Study|Undisclosed Reason(s).|1|||
33170535|NCT02375113|100533133|FG000|Overall Study|Poor adherence (<70%).|1|||
33170536|NCT02375113|100533134|FG001|Overall Study|Poor adherence (<70%).|0|||
33170537|NCT02375113|100533133|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
33170538|NCT02375113|100533134|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
33170539|NCT01129960|100533144|FG000|Overall Study|Withdrawal by Subject|3|||
33170540|NCT01129960|100533145|FG001|Overall Study|Withdrawal by Subject|0|||
33170541|NCT01129960|100533146|FG002|Overall Study|Withdrawal by Subject|3|||
33170542|NCT01129960|100533147|FG003|Overall Study|Withdrawal by Subject|2|||
33170543|NCT01129960|100533144|FG000|Overall Study|Lack of Efficacy|1|||
33261207|NCT00931710|100856568|FG000|Overall Study|Protocol deviation|1|||
33170544|NCT01129960|100533145|FG001|Overall Study|Lack of Efficacy|1|||
33261208|NCT00931710|100856569|FG001|Overall Study|Protocol deviation|2|||
33261209|NCT01308567|100856570|FG000|Overall Study|Lost to Follow-up|2|||
33261210|NCT01308567|100856571|FG001|Overall Study|Lost to Follow-up|4|||
33261211|NCT01308567|100856572|FG002|Overall Study|Lost to Follow-up|4|||
33261212|NCT03840902|100856573|FG000|Overall Study|Randomized but not treated|1|||
33261213|NCT03840902|100856574|FG001|Overall Study|Randomized but not treated|1|||
33261214|NCT00308997|100856575|FG000|Overall Study|Subject feigned clinical data|0|||
33170545|NCT01129960|100533146|FG002|Overall Study|Lack of Efficacy|1|||
33170546|NCT01129960|100533147|FG003|Overall Study|Lack of Efficacy|1|||
33170547|NCT01129960|100533144|FG000|Overall Study|Adverse Event|23|||
33170548|NCT01129960|100533145|FG001|Overall Study|Adverse Event|16|||
33170549|NCT01129960|100533146|FG002|Overall Study|Adverse Event|16|||
33261215|NCT00308997|100856576|FG001|Overall Study|Subject feigned clinical data|1|||
33261216|NCT00308997|100856575|FG000|Overall Study|Unable to tolerate intervention|1|||
33261217|NCT00308997|100856576|FG001|Overall Study|Unable to tolerate intervention|0|||
33170550|NCT01129960|100533147|FG003|Overall Study|Adverse Event|7|||
33170551|NCT01129960|100533144|FG000|Overall Study|Protocol Violation|1|||
33170552|NCT01129960|100533145|FG001|Overall Study|Protocol Violation|2|||
33170553|NCT01129960|100533146|FG002|Overall Study|Protocol Violation|3|||
33170554|NCT01129960|100533147|FG003|Overall Study|Protocol Violation|0|||
33170555|NCT01129960|100533144|FG000|Overall Study|Lost to Follow-up|0|||
33170556|NCT01129960|100533145|FG001|Overall Study|Lost to Follow-up|2|||
33170557|NCT01129960|100533146|FG002|Overall Study|Lost to Follow-up|3|||
33170558|NCT01129960|100533147|FG003|Overall Study|Lost to Follow-up|3|||
33170559|NCT01129960|100533144|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
33170560|NCT01129960|100533145|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
33170561|NCT01129960|100533146|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
33170562|NCT01129960|100533147|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
33170563|NCT01129960|100533144|FG000|Overall Study|Physician Decision|1|||
33170564|NCT01129960|100533145|FG001|Overall Study|Physician Decision|0|||
33170565|NCT01129960|100533146|FG002|Overall Study|Physician Decision|0|||
33170566|NCT01129960|100533147|FG003|Overall Study|Physician Decision|0|||
33170567|NCT01129960|100533144|FG000|Overall Study|Pregnancy|1|||
33170568|NCT01129960|100533145|FG001|Overall Study|Pregnancy|0|||
33170569|NCT01129960|100533146|FG002|Overall Study|Pregnancy|0|||
33451171|NCT02699463|101545008|FG000|Overall Study|Lost to Follow-up|11|||
33451172|NCT02699463|101545009|FG001|Overall Study|Lost to Follow-up|8|||
33451173|NCT02699463|101545008|FG000|Overall Study|Withdrawal by Subject|4|||
33451174|NCT02699463|101545009|FG001|Overall Study|Withdrawal by Subject|1|||
33451175|NCT00841659|101545010|FG000|Washout: 2 Weeks|Protocol Violation|1|||
33451176|NCT00841659|101545011|FG001|Washout: 2 Weeks|Protocol Violation|0|||
33451177|NCT01604941|101545026|FG000|Overall Study|Adverse Event|1|||
33451178|NCT01604941|101545027|FG001|Overall Study|Adverse Event|2|||
33451179|NCT01604941|101545028|FG002|Overall Study|Adverse Event|0|||
33451180|NCT01604941|101545029|FG003|Overall Study|Adverse Event|0|||
33261218|NCT00703820|100856577|FG000|Overall Study|Adverse Event|12|||
33170570|NCT01129960|100533147|FG003|Overall Study|Pregnancy|0|||
33170571|NCT02547454|100533152|FG000|Overall Study|Due to hemodialysis|53|||
33170572|NCT02547454|100533152|FG000|Overall Study|Due to transplantation|1|||
33451181|NCT01604941|101545030|FG004|Overall Study|Adverse Event|1|||
33170573|NCT02547454|100533152|FG000|Overall Study|Due to no further need to treat|4|||
33170574|NCT02547454|100533152|FG000|Overall Study|Death|38|||
33170575|NCT02547454|100533152|FG000|Overall Study|Lost to Follow-up|26|||
33170576|NCT02547454|100533152|FG000|Overall Study|Other|39|||
33451182|NCT01604941|101545031|FG005|Overall Study|Adverse Event|5|||
33170577|NCT02547454|100533152|FG000|Overall Study|No data|11|||
33170578|NCT00720434|100533153|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
33451183|NCT01604941|101545026|FG000|Overall Study|Non-compliance|1|||
33451184|NCT01604941|101545027|FG001|Overall Study|Non-compliance|0|||
33451185|NCT01604941|101545028|FG002|Overall Study|Non-compliance|0|||
33451186|NCT01604941|101545029|FG003|Overall Study|Non-compliance|0|||
33451187|NCT01604941|101545030|FG004|Overall Study|Non-compliance|0|||
33451188|NCT01604941|101545031|FG005|Overall Study|Non-compliance|0|||
33451189|NCT01604941|101545026|FG000|Overall Study|Participant Decision|0|||
33451190|NCT01604941|101545027|FG001|Overall Study|Participant Decision|0|||
33451191|NCT01604941|101545028|FG002|Overall Study|Participant Decision|0|||
33451192|NCT01604941|101545029|FG003|Overall Study|Participant Decision|0|||
33451193|NCT01604941|101545030|FG004|Overall Study|Participant Decision|0|||
33451194|NCT01604941|101545031|FG005|Overall Study|Participant Decision|2|||
33451195|NCT01604941|101545026|FG000|Overall Study|Early Study Termination|9|||
33451196|NCT01604941|101545027|FG001|Overall Study|Early Study Termination|2|||
33451197|NCT01604941|101545028|FG002|Overall Study|Early Study Termination|3|||
33451198|NCT01604941|101545029|FG003|Overall Study|Early Study Termination|3|||
33451199|NCT01604941|101545030|FG004|Overall Study|Early Study Termination|0|||
33451200|NCT01604941|101545031|FG005|Overall Study|Early Study Termination|0|||
33451201|NCT03138967|101545032|FG000|Overall Study|Death|0|||
33451202|NCT03138967|101545033|FG001|Overall Study|Death|1|||
33451203|NCT03138967|101545032|FG000|Overall Study|Physician Decision|1|||
33451204|NCT03138967|101545033|FG001|Overall Study|Physician Decision|3|||
33451205|NCT04281472|101545034|FG000|Stage A|Lack of Efficacy|8|||
33451206|NCT04281472|101545035|FG001|Stage A|Lack of Efficacy|0|||
33451207|NCT04281472|101545036|FG002|Stage A|Lack of Efficacy|0|||
33451208|NCT04281472|101545034|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
33451209|NCT04281472|101545035|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
33451210|NCT04281472|101545036|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
33451211|NCT04281472|101545034|FG000|Stage A|Adverse Event|20|||
33451212|NCT04281472|101545035|FG001|Stage A|Adverse Event|0|||
33451213|NCT04281472|101545036|FG002|Stage A|Adverse Event|0|||
33451214|NCT04281472|101545034|FG000|Stage A|Death|1|||
33451215|NCT04281472|101545035|FG001|Stage A|Death|0|||
33451216|NCT04281472|101545036|FG002|Stage A|Death|0|||
33451217|NCT04281472|101545034|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
33451218|NCT04281472|101545035|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
33451219|NCT04281472|101545036|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
33451220|NCT04281472|101545034|FG000|Stage A|Lost to Follow-up|2|||
33451221|NCT04281472|101545035|FG001|Stage A|Lost to Follow-up|0|||
33451222|NCT04281472|101545036|FG002|Stage A|Lost to Follow-up|0|||
33451223|NCT04281472|101545034|FG000|Stage A|Non-compliance with study drug|1|||
33451224|NCT04281472|101545035|FG001|Stage A|Non-compliance with study drug|0|||
33451225|NCT04281472|101545036|FG002|Stage A|Non-compliance with study drug|0|||
33451226|NCT04281472|101545034|FG000|Stage A|Physician Decision|1|||
33451227|NCT04281472|101545035|FG001|Stage A|Physician Decision|0|||
33451228|NCT04281472|101545036|FG002|Stage A|Physician Decision|0|||
33451229|NCT04281472|101545034|FG000|Stage A|Prohibited medications|2|||
33451230|NCT04281472|101545035|FG001|Stage A|Prohibited medications|0|||
33451231|NCT04281472|101545036|FG002|Stage A|Prohibited medications|0|||
33451232|NCT04281472|101545034|FG000|Stage A|Withdrawal by Subject|11|||
33451233|NCT04281472|101545035|FG001|Stage A|Withdrawal by Subject|0|||
33451234|NCT04281472|101545036|FG002|Stage A|Withdrawal by Subject|0|||
33451235|NCT04281472|101545034|FG000|Stage A|Other|5|||
33451236|NCT04281472|101545035|FG001|Stage A|Other|0|||
33451237|NCT04281472|101545036|FG002|Stage A|Other|0|||
33451238|NCT04281472|101545034|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
33451239|NCT04281472|101545035|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
33451240|NCT04281472|101545036|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
33451241|NCT04281472|101545034|FG000|Stage B|Adverse Event|0|||
33451242|NCT04281472|101545035|FG001|Stage B|Adverse Event|3|||
33451243|NCT04281472|101545036|FG002|Stage B|Adverse Event|0|||
33451244|NCT04281472|101545034|FG000|Stage B|Death|0|||
33451245|NCT04281472|101545035|FG001|Stage B|Death|0|||
33451246|NCT04281472|101545036|FG002|Stage B|Death|1|||
33451247|NCT04281472|101545034|FG000|Stage B|Lack of Efficacy|0|||
33451248|NCT04281472|101545035|FG001|Stage B|Lack of Efficacy|0|||
33451249|NCT04281472|101545036|FG002|Stage B|Lack of Efficacy|1|||
33451250|NCT04281472|101545034|FG000|Stage B|Lost to Follow-up|0|||
33451251|NCT04281472|101545035|FG001|Stage B|Lost to Follow-up|0|||
33451252|NCT04281472|101545036|FG002|Stage B|Lost to Follow-up|2|||
33451253|NCT04281472|101545034|FG000|Stage B|Prohibited medications|0|||
33451254|NCT04281472|101545035|FG001|Stage B|Prohibited medications|2|||
33451255|NCT04281472|101545036|FG002|Stage B|Prohibited medications|1|||
33451256|NCT04281472|101545034|FG000|Stage B|Protocol Violation|0|||
33451257|NCT04281472|101545035|FG001|Stage B|Protocol Violation|1|||
33451258|NCT04281472|101545036|FG002|Stage B|Protocol Violation|1|||
33451259|NCT04281472|101545034|FG000|Stage B|Sponsor decision|0|||
33451260|NCT04281472|101545035|FG001|Stage B|Sponsor decision|0|||
33451261|NCT04281472|101545036|FG002|Stage B|Sponsor decision|1|||
33451262|NCT04281472|101545034|FG000|Stage B|Withdrawal by Subject|0|||
33451263|NCT04281472|101545035|FG001|Stage B|Withdrawal by Subject|3|||
33451264|NCT04281472|101545036|FG002|Stage B|Withdrawal by Subject|3|||
33451265|NCT04281472|101545034|FG000|Stage B|Other|0|||
33451266|NCT04281472|101545035|FG001|Stage B|Other|3|||
33451267|NCT04281472|101545036|FG002|Stage B|Other|0|||
33451268|NCT01960296|101545037|FG000|Overall Study|Postponed surgery|1|||
33451269|NCT01960296|101545038|FG001|Overall Study|Postponed surgery|0|||
33451270|NCT01960296|101545037|FG000|Overall Study|Received different procedure|1|||
33451271|NCT01960296|101545038|FG001|Overall Study|Received different procedure|3|||
33451272|NCT00836472|101545039|FG000|Washout|Adverse Event|1|||
33451273|NCT00836472|101545040|FG001|Washout|Adverse Event|2|||
33451274|NCT00836472|101545039|FG000|Washout|Withdrawal by Subject|1|||
33451275|NCT00836472|101545040|FG001|Washout|Withdrawal by Subject|1|||
33451276|NCT01693523|101545041|FG000|Overall Study|Adverse Event|2|||
33451277|NCT01693523|101545042|FG001|Overall Study|Adverse Event|1|||
33451278|NCT01693523|101545043|FG002|Overall Study|Adverse Event|0|||
33170579|NCT00720434|100533154|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
33170580|NCT00720434|100533155|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
33170581|NCT00720434|100533156|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
33170582|NCT00720434|100533153|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
33170583|NCT00720434|100533154|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
33170584|NCT00720434|100533155|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
33170585|NCT00720434|100533156|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
33170586|NCT00720434|100533153|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
33170587|NCT00720434|100533154|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
33170588|NCT00720434|100533155|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
33170589|NCT00720434|100533156|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
33170590|NCT00720434|100533153|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
33170591|NCT00720434|100533154|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
33170592|NCT00720434|100533155|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
33170593|NCT00720434|100533156|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
33170594|NCT00720434|100533153|FG000|Open-Label Period (Week 5-72)|Other|4|||
33261219|NCT00703820|100856578|FG001|Overall Study|Adverse Event|17|||
33261220|NCT00703820|100856577|FG000|Overall Study|Death|5|||
33451279|NCT01693523|101545041|FG000|Overall Study|Death|0|||
33451280|NCT01693523|101545042|FG001|Overall Study|Death|1|||
33451281|NCT01693523|101545043|FG002|Overall Study|Death|1|||
33451282|NCT01693523|101545041|FG000|Overall Study|Lost to Follow-up|0|||
33451283|NCT01693523|101545042|FG001|Overall Study|Lost to Follow-up|0|||
33451284|NCT01693523|101545043|FG002|Overall Study|Lost to Follow-up|4|||
33451285|NCT01693523|101545041|FG000|Overall Study|Physician Decision|0|||
33451286|NCT01693523|101545042|FG001|Overall Study|Physician Decision|0|||
33451287|NCT01693523|101545043|FG002|Overall Study|Physician Decision|1|||
33451288|NCT01693523|101545041|FG000|Overall Study|Withdrawal by Subject|1|||
33451289|NCT01693523|101545042|FG001|Overall Study|Withdrawal by Subject|2|||
33451290|NCT01693523|101545043|FG002|Overall Study|Withdrawal by Subject|2|||
33451291|NCT01693523|101545041|FG000|Overall Study|Lack of compliance study medication|1|||
33170595|NCT00720434|100533154|FG001|Open-Label Period (Week 5-72)|Other|3|||
33451292|NCT01693523|101545042|FG001|Overall Study|Lack of compliance study medication|2|||
33451293|NCT01693523|101545043|FG002|Overall Study|Lack of compliance study medication|0|||
33261221|NCT00703820|100856578|FG001|Overall Study|Death|0|||
33261222|NCT00703820|100856577|FG000|Overall Study|Lack of Efficacy|11|||
33261223|NCT00703820|100856578|FG001|Overall Study|Lack of Efficacy|11|||
33261224|NCT00703820|100856577|FG000|Overall Study|Received non-protocol therapy|1|||
33170596|NCT00720434|100533155|FG002|Open-Label Period (Week 5-72)|Other|3|||
33170597|NCT00720434|100533156|FG003|Open-Label Period (Week 5-72)|Other|2|||
33170598|NCT01995825|100533161|FG000|Overall Study|Withdrawal by Subject|1|||
33170599|NCT01995825|100533162|FG001|Overall Study|Withdrawal by Subject|0|||
33170600|NCT01366521|100533165|FG000|Overall Study|Adverse Event|1|||
33170601|NCT01366521|100533166|FG001|Overall Study|Adverse Event|0|||
33170602|NCT01366521|100533167|FG002|Overall Study|Adverse Event|0|||
33170603|NCT01366521|100533168|FG003|Overall Study|Adverse Event|0|||
33170604|NCT01366521|100533165|FG000|Overall Study|Protocol Violation|0|||
33170605|NCT01366521|100533166|FG001|Overall Study|Protocol Violation|0|||
33170606|NCT01366521|100533167|FG002|Overall Study|Protocol Violation|1|||
33170607|NCT01366521|100533168|FG003|Overall Study|Protocol Violation|0|||
33170608|NCT01366521|100533165|FG000|Overall Study|Physician Decision|0|||
33170609|NCT01366521|100533166|FG001|Overall Study|Physician Decision|0|||
33170610|NCT01366521|100533167|FG002|Overall Study|Physician Decision|1|||
33170611|NCT01366521|100533168|FG003|Overall Study|Physician Decision|0|||
33451294|NCT01693523|101545041|FG000|Overall Study|Chemotherapy was held|1|||
33451295|NCT01693523|101545042|FG001|Overall Study|Chemotherapy was held|2|||
33451296|NCT01693523|101545043|FG002|Overall Study|Chemotherapy was held|0|||
33451297|NCT00107991|101545044|FG000|Eligibility Assessment|Disease not severe enough|7|||
33451298|NCT00107991|101545044|FG000|Eligibility Assessment|Unwilling to participate|7|||
33451299|NCT00107991|101545044|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
33451300|NCT00107991|101545044|FG000|Eligibility Assessment|Abnormal labs|2|||
33451301|NCT00107991|101545044|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
33451302|NCT00107991|101545044|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
33451303|NCT00107991|101545044|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
33451304|NCT00107991|101545044|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
33451305|NCT00107991|101545044|FG000|12 Week Treatment Period|Adverse Event|1|||
33451306|NCT00107991|101545044|FG000|12 Week Treatment Period|Protocol Violation|1|||
33451307|NCT00107991|101545044|FG000|12 Week Treatment Period|Incarcerated|1|||
33451308|NCT00107991|101545044|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
33451309|NCT00446966|101545045|FG000|Overall Study|Lost to Follow-up|10|||
33451310|NCT00446966|101545046|FG001|Overall Study|Lost to Follow-up|7|||
33451311|NCT02316223|101545047|FG000|Overall Study|Lack of Efficacy|0|||
33451312|NCT02316223|101545048|FG001|Overall Study|Lack of Efficacy|1|||
33451313|NCT02316223|101545049|FG002|Overall Study|Lack of Efficacy|1|||
33451314|NCT02316223|101545047|FG000|Overall Study|Lost to Follow-up|27|||
33451315|NCT02316223|101545048|FG001|Overall Study|Lost to Follow-up|34|||
33451316|NCT02316223|101545049|FG002|Overall Study|Lost to Follow-up|36|||
33451317|NCT02316223|101545047|FG000|Overall Study|COPD Diagnosis|3|||
33451318|NCT02316223|101545048|FG001|Overall Study|COPD Diagnosis|2|||
33451319|NCT02316223|101545049|FG002|Overall Study|COPD Diagnosis|3|||
33451320|NCT02316223|101545047|FG000|Overall Study|Reside outside study area|1|||
33451321|NCT02316223|101545048|FG001|Overall Study|Reside outside study area|1|||
33451322|NCT02316223|101545049|FG002|Overall Study|Reside outside study area|1|||
33451323|NCT02316223|101545047|FG000|Overall Study|No asthma|2|||
33451324|NCT02316223|101545048|FG001|Overall Study|No asthma|0|||
33451325|NCT02316223|101545049|FG002|Overall Study|No asthma|0|||
33451326|NCT02316223|101545047|FG000|Overall Study|Discontinued by PI|11|||
33451327|NCT02316223|101545048|FG001|Overall Study|Discontinued by PI|19|||
33451328|NCT02316223|101545049|FG002|Overall Study|Discontinued by PI|3|||
33451329|NCT01117623|101545052|FG000|Overall Study|Adverse Event|0|||
33170612|NCT01366521|100533165|FG000|Overall Study|Withdrawal by Subject|0|||
33170613|NCT01366521|100533166|FG001|Overall Study|Withdrawal by Subject|1|||
33170614|NCT01366521|100533167|FG002|Overall Study|Withdrawal by Subject|0|||
33170615|NCT01366521|100533168|FG003|Overall Study|Withdrawal by Subject|0|||
33451330|NCT01117623|101545053|FG001|Overall Study|Adverse Event|2|||
33170616|NCT04876274|100533169|FG000|Overall Study|Lost to Follow-up|9|||
33170617|NCT04876274|100533170|FG001|Overall Study|Lost to Follow-up|12|||
33170618|NCT01085591|100533171|FG000|Overall Study|Adverse Event|0|||
33170619|NCT01085591|100533172|FG001|Overall Study|Adverse Event|1|||
33170620|NCT01085591|100533173|FG002|Overall Study|Adverse Event|3|||
33170621|NCT01085591|100533171|FG000|Overall Study|Physician Decision|1|||
33170622|NCT01085591|100533172|FG001|Overall Study|Physician Decision|0|||
33451331|NCT01117623|101545054|FG002|Overall Study|Adverse Event|4|||
33451332|NCT01117623|101545055|FG003|Overall Study|Adverse Event|0|||
33451333|NCT01117623|101545056|FG004|Overall Study|Adverse Event|2|||
33451334|NCT01117623|101545057|FG005|Overall Study|Adverse Event|0|||
33451335|NCT01117623|101545058|FG006|Overall Study|Adverse Event|0|||
33451336|NCT01117623|101545059|FG007|Overall Study|Adverse Event|2|||
33451337|NCT01117623|101545052|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
33170623|NCT01085591|100533173|FG002|Overall Study|Physician Decision|1|||
33170624|NCT01085591|100533171|FG000|Overall Study|Withdrawal by Subject|0|||
33170625|NCT01085591|100533172|FG001|Overall Study|Withdrawal by Subject|2|||
33170626|NCT01085591|100533173|FG002|Overall Study|Withdrawal by Subject|1|||
33170627|NCT01085591|100533171|FG000|Overall Study|Lost to Follow-up|0|||
33170628|NCT01085591|100533172|FG001|Overall Study|Lost to Follow-up|1|||
33170629|NCT01085591|100533173|FG002|Overall Study|Lost to Follow-up|1|||
33170630|NCT01085591|100533171|FG000|Overall Study|Protocol Violation|1|||
33170631|NCT01085591|100533172|FG001|Overall Study|Protocol Violation|1|||
33170632|NCT01085591|100533173|FG002|Overall Study|Protocol Violation|1|||
33170633|NCT01085591|100533171|FG000|Overall Study|Other|0|||
33170634|NCT01085591|100533172|FG001|Overall Study|Other|1|||
33170635|NCT01085591|100533173|FG002|Overall Study|Other|0|||
33170636|NCT01085591|100533171|FG000|Overall Study|Not Properly Consented|1|||
33451338|NCT01117623|101545053|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
33451339|NCT01117623|101545054|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
33451340|NCT01117623|101545055|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
33451341|NCT01117623|101545056|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
33451342|NCT01117623|101545057|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
33170637|NCT01085591|100533172|FG001|Overall Study|Not Properly Consented|0|||
33170638|NCT01085591|100533173|FG002|Overall Study|Not Properly Consented|0|||
33170639|NCT01339429|100533174|FG000|Overall Study|Withdrawal by Subject|1|||
33170640|NCT01339429|100533174|FG000|Overall Study|Physician Decision|3|||
33170641|NCT01053221|100533179|FG000|Overall Study|The study was closed prematurely|5|||
33170642|NCT01053221|100533180|FG001|Overall Study|The study was closed prematurely|9|||
33170643|NCT02501473|100533181|FG000|Overall Study|Study Terminated|2|||
33170644|NCT02501473|100533182|FG001|Overall Study|Study Terminated|3|||
33170645|NCT02501473|100533183|FG002|Overall Study|Study Terminated|7|||
33170646|NCT02501473|100533184|FG003|Overall Study|Study Terminated|9|||
33170647|NCT02501473|100533185|FG004|Overall Study|Study Terminated|2|||
33170648|NCT02501473|100533186|FG005|Overall Study|Study Terminated|10|||
33170649|NCT02501473|100533187|FG006|Overall Study|Study Terminated|1|||
33170650|NCT02501473|100533188|FG007|Overall Study|Study Terminated|0|||
33170651|NCT02501473|100533181|FG000|Overall Study|Withdrawal by Subject|0|||
33170652|NCT02501473|100533182|FG001|Overall Study|Withdrawal by Subject|0|||
33170653|NCT02501473|100533183|FG002|Overall Study|Withdrawal by Subject|3|||
33170654|NCT02501473|100533184|FG003|Overall Study|Withdrawal by Subject|3|||
33170655|NCT02501473|100533185|FG004|Overall Study|Withdrawal by Subject|2|||
33170656|NCT02501473|100533186|FG005|Overall Study|Withdrawal by Subject|2|||
33170657|NCT02501473|100533187|FG006|Overall Study|Withdrawal by Subject|0|||
33170658|NCT02501473|100533188|FG007|Overall Study|Withdrawal by Subject|0|||
33170659|NCT02501473|100533181|FG000|Overall Study|Death|0|||
33170660|NCT02501473|100533182|FG001|Overall Study|Death|0|||
33170661|NCT02501473|100533183|FG002|Overall Study|Death|1|||
33170662|NCT02501473|100533184|FG003|Overall Study|Death|1|||
33170663|NCT02501473|100533185|FG004|Overall Study|Death|0|||
33170664|NCT02501473|100533186|FG005|Overall Study|Death|1|||
33170665|NCT02501473|100533187|FG006|Overall Study|Death|0|||
33170666|NCT02501473|100533188|FG007|Overall Study|Death|0|||
33170667|NCT02501473|100533181|FG000|Overall Study|Lost to Follow-up|1|||
33170668|NCT02501473|100533182|FG001|Overall Study|Lost to Follow-up|0|||
33170669|NCT02501473|100533183|FG002|Overall Study|Lost to Follow-up|1|||
33170670|NCT02501473|100533184|FG003|Overall Study|Lost to Follow-up|0|||
33170671|NCT02501473|100533185|FG004|Overall Study|Lost to Follow-up|0|||
33170672|NCT02501473|100533186|FG005|Overall Study|Lost to Follow-up|1|||
33170673|NCT02501473|100533187|FG006|Overall Study|Lost to Follow-up|0|||
33170674|NCT02501473|100533188|FG007|Overall Study|Lost to Follow-up|0|||
33170675|NCT02501473|100533181|FG000|Overall Study|Reason not specified|0|||
33261225|NCT00703820|100856578|FG001|Overall Study|Received non-protocol therapy|0|||
33451343|NCT01117623|101545058|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
33170676|NCT02501473|100533182|FG001|Overall Study|Reason not specified|0|||
33170677|NCT02501473|100533183|FG002|Overall Study|Reason not specified|1|||
33170678|NCT02501473|100533184|FG003|Overall Study|Reason not specified|1|||
33170679|NCT02501473|100533185|FG004|Overall Study|Reason not specified|0|||
33170680|NCT02501473|100533186|FG005|Overall Study|Reason not specified|0|||
33170681|NCT02501473|100533187|FG006|Overall Study|Reason not specified|0|||
33170682|NCT02501473|100533188|FG007|Overall Study|Reason not specified|0|||
33170683|NCT02670083|100533192|FG000|Overall Study|Adverse Event|16|||
33170684|NCT02670083|100533193|FG001|Overall Study|Adverse Event|13|||
33170685|NCT02670083|100533192|FG000|Overall Study|Death|4|||
33170686|NCT02670083|100533193|FG001|Overall Study|Death|6|||
33451344|NCT01117623|101545059|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
33451345|NCT01117623|101545052|FG000|Overall Study|Withdrawal by Subject|0|||
33451346|NCT01117623|101545053|FG001|Overall Study|Withdrawal by Subject|0|||
33451347|NCT01117623|101545054|FG002|Overall Study|Withdrawal by Subject|2|||
33451348|NCT01117623|101545055|FG003|Overall Study|Withdrawal by Subject|0|||
33451349|NCT01117623|101545056|FG004|Overall Study|Withdrawal by Subject|0|||
33451350|NCT01117623|101545057|FG005|Overall Study|Withdrawal by Subject|1|||
33261226|NCT00703820|100856577|FG000|Overall Study|Physician Decision|4|||
33261227|NCT00703820|100856578|FG001|Overall Study|Physician Decision|5|||
33451351|NCT01117623|101545058|FG006|Overall Study|Withdrawal by Subject|1|||
33451352|NCT01117623|101545059|FG007|Overall Study|Withdrawal by Subject|1|||
33451353|NCT01117623|101545052|FG000|Overall Study|Non-compliance with study medication|0|||
33451354|NCT01117623|101545053|FG001|Overall Study|Non-compliance with study medication|0|||
33451355|NCT01117623|101545054|FG002|Overall Study|Non-compliance with study medication|0|||
33451356|NCT01117623|101545055|FG003|Overall Study|Non-compliance with study medication|0|||
33451357|NCT01117623|101545056|FG004|Overall Study|Non-compliance with study medication|0|||
33451358|NCT01117623|101545057|FG005|Overall Study|Non-compliance with study medication|0|||
33451359|NCT01117623|101545058|FG006|Overall Study|Non-compliance with study medication|0|||
33451360|NCT01117623|101545059|FG007|Overall Study|Non-compliance with study medication|1|||
33451361|NCT01117623|101545052|FG000|Overall Study|Invest. text: completed all planned txs|0|||
33451362|NCT01117623|101545053|FG001|Overall Study|Invest. text: completed all planned txs|0|||
33451363|NCT01117623|101545054|FG002|Overall Study|Invest. text: completed all planned txs|0|||
33451364|NCT01117623|101545055|FG003|Overall Study|Invest. text: completed all planned txs|0|||
33451365|NCT01117623|101545056|FG004|Overall Study|Invest. text: completed all planned txs|0|||
33451366|NCT01117623|101545057|FG005|Overall Study|Invest. text: completed all planned txs|1|||
33451367|NCT01117623|101545058|FG006|Overall Study|Invest. text: completed all planned txs|0|||
33451368|NCT01117623|101545059|FG007|Overall Study|Invest. text: completed all planned txs|0|||
33451369|NCT00903877|101545068|FG000|Overall Study|Did not meet study criteria|33|||
33451370|NCT00903877|101545068|FG000|Overall Study|Withdrawal by Subject|3|||
33451371|NCT00903877|101545068|FG000|Overall Study|Adverse Event|2|||
33451372|NCT00903877|101545068|FG000|Overall Study|Lost to Follow-up|1|||
33451373|NCT00903877|101545068|FG000|Overall Study|Participation put on hold|4|||
33451374|NCT05068284|101545069|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
33451375|NCT05068284|101545070|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
33451376|NCT05068284|101545071|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
33451377|NCT05068284|101545072|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
33451378|NCT05068284|101545073|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
33451379|NCT05068284|101545074|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
33451380|NCT05068284|101545075|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
33451381|NCT05068284|101545076|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
33261228|NCT00703820|100856577|FG000|Overall Study|Withdrawal by Subject|2|||
33261229|NCT00703820|100856578|FG001|Overall Study|Withdrawal by Subject|1|||
33451382|NCT05068284|101545069|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
33451383|NCT05068284|101545070|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
33451384|NCT05068284|101545071|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
33170687|NCT02670083|100533192|FG000|Overall Study|Lost to Follow-up|2|||
33170688|NCT02670083|100533193|FG001|Overall Study|Lost to Follow-up|2|||
33170689|NCT02670083|100533192|FG000|Overall Study|Multiple Reasons|9|||
33170690|NCT02670083|100533193|FG001|Overall Study|Multiple Reasons|9|||
33170691|NCT02670083|100533192|FG000|Overall Study|Physician Decision|0|||
33170692|NCT02670083|100533193|FG001|Overall Study|Physician Decision|2|||
33170693|NCT02670083|100533192|FG000|Overall Study|Study Terminated By Sponsor|257|||
33170694|NCT02670083|100533193|FG001|Overall Study|Study Terminated By Sponsor|254|||
33170695|NCT02670083|100533192|FG000|Overall Study|Symptomatic Deterioration|0|||
33170696|NCT02670083|100533193|FG001|Overall Study|Symptomatic Deterioration|2|||
33170697|NCT02670083|100533192|FG000|Overall Study|Withdrawal by Subject|32|||
33170698|NCT02670083|100533193|FG001|Overall Study|Withdrawal by Subject|31|||
33170699|NCT02670083|100533192|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33170700|NCT02670083|100533193|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33170701|NCT00642941|100533194|FG000|Overall Study|Physician Decision|3|||
33170702|NCT00642941|100533195|FG001|Overall Study|Physician Decision|1|||
33170703|NCT00642941|100533196|FG002|Overall Study|Physician Decision|0|||
33170704|NCT00642941|100533197|FG003|Overall Study|Physician Decision|0|||
33170705|NCT00642941|100533198|FG004|Overall Study|Physician Decision|0|||
33170706|NCT00642941|100533199|FG005|Overall Study|Physician Decision|0|||
33170707|NCT00642941|100533200|FG006|Overall Study|Physician Decision|1|||
33170708|NCT00642941|100533201|FG007|Overall Study|Physician Decision|0|||
33170709|NCT00642941|100533202|FG008|Overall Study|Physician Decision|0|||
33170710|NCT00642941|100533203|FG009|Overall Study|Physician Decision|1|||
33170711|NCT00642941|100533204|FG010|Overall Study|Physician Decision|0|||
33170712|NCT00642941|100533205|FG011|Overall Study|Physician Decision|1|||
33170713|NCT00642941|100533194|FG000|Overall Study|Death|4|||
33170714|NCT00642941|100533195|FG001|Overall Study|Death|0|||
33451385|NCT05068284|101545072|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
33170715|NCT00642941|100533196|FG002|Overall Study|Death|1|||
33170716|NCT00642941|100533197|FG003|Overall Study|Death|1|||
33170717|NCT00642941|100533198|FG004|Overall Study|Death|2|||
33451386|NCT05068284|101545073|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
33451387|NCT05068284|101545074|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
33451388|NCT05068284|101545075|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
33451389|NCT05068284|101545076|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
33451390|NCT05068284|101545069|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
33451391|NCT05068284|101545070|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
33451392|NCT05068284|101545071|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
33451393|NCT05068284|101545072|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
33451394|NCT05068284|101545073|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
33451395|NCT05068284|101545074|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
33451396|NCT05068284|101545075|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
33451397|NCT05068284|101545076|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
33451398|NCT05068284|101545069|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
33451399|NCT05068284|101545070|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
33451400|NCT05068284|101545071|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
33451401|NCT05068284|101545072|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
33451402|NCT05068284|101545073|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
33451403|NCT05068284|101545074|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
33451404|NCT05068284|101545075|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
33451405|NCT05068284|101545076|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
33451406|NCT05068284|101545069|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
33451407|NCT05068284|101545070|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
33451408|NCT05068284|101545071|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
33451409|NCT05068284|101545072|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
33451410|NCT05068284|101545073|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
33451411|NCT05068284|101545074|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
33451412|NCT05068284|101545075|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
33451413|NCT05068284|101545076|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
33451414|NCT05068284|101545069|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
33451415|NCT05068284|101545070|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
33451416|NCT05068284|101545071|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
33170718|NCT00642941|100533199|FG005|Overall Study|Death|1|||
33170719|NCT00642941|100533200|FG006|Overall Study|Death|0|||
33170720|NCT00642941|100533201|FG007|Overall Study|Death|0|||
33170721|NCT00642941|100533202|FG008|Overall Study|Death|0|||
33170722|NCT00642941|100533203|FG009|Overall Study|Death|0|||
33170723|NCT00642941|100533204|FG010|Overall Study|Death|0|||
33170724|NCT00642941|100533205|FG011|Overall Study|Death|1|||
33170725|NCT00642941|100533194|FG000|Overall Study|Study closed by Sponsor|0|||
33170726|NCT00642941|100533195|FG001|Overall Study|Study closed by Sponsor|1|||
33170727|NCT00642941|100533196|FG002|Overall Study|Study closed by Sponsor|0|||
33451417|NCT05068284|101545072|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
33451418|NCT05068284|101545073|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
33451419|NCT05068284|101545074|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
33451420|NCT05068284|101545075|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
33451421|NCT05068284|101545076|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
33261230|NCT03644849|100856581|FG000|Overall Study|Lost to Follow-up|1|||
33261231|NCT03644849|100856582|FG001|Overall Study|Lost to Follow-up|3|||
33451422|NCT05068284|101545069|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
33451423|NCT05068284|101545070|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
33451424|NCT05068284|101545071|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
33451425|NCT05068284|101545072|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
33451426|NCT05068284|101545073|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
33451427|NCT05068284|101545074|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
33451428|NCT05068284|101545075|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
33451429|NCT05068284|101545076|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
33451430|NCT05068284|101545069|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
33261232|NCT01391832|100856583|FG000|Overall Study|Withdrawal by Subject|21|||
33261233|NCT01391832|100856584|FG001|Overall Study|Withdrawal by Subject|22|||
33261234|NCT01391832|100856583|FG000|Overall Study|Lost to Follow-up|0|||
33261235|NCT01391832|100856584|FG001|Overall Study|Lost to Follow-up|1|||
33261236|NCT04154384|100856585|FG000|Overall Study|Lost to Follow-up|24|||
33261237|NCT04154384|100856586|FG001|Overall Study|Lost to Follow-up|33|||
33261238|NCT04154384|100856587|FG002|Overall Study|Lost to Follow-up|0|||
33261239|NCT04154384|100856585|FG000|Overall Study|Withdrawal by Subject|7|||
33261240|NCT04154384|100856586|FG001|Overall Study|Withdrawal by Subject|18|||
33261241|NCT04154384|100856587|FG002|Overall Study|Withdrawal by Subject|0|||
33261242|NCT04154384|100856585|FG000|Overall Study|Missing outcome data|1|||
33261243|NCT04154384|100856586|FG001|Overall Study|Missing outcome data|0|||
33261244|NCT04154384|100856587|FG002|Overall Study|Missing outcome data|0|||
33261245|NCT00879333|100856588|FG000|Overall Study|Adverse Event|94|||
33261246|NCT00879333|100856589|FG001|Overall Study|Adverse Event|34|||
33261247|NCT00879333|100856588|FG000|Overall Study|Abnormal Laboratory Value|1|||
33170728|NCT00642941|100533197|FG003|Overall Study|Study closed by Sponsor|0|||
33170729|NCT00642941|100533198|FG004|Overall Study|Study closed by Sponsor|0|||
33170730|NCT00642941|100533199|FG005|Overall Study|Study closed by Sponsor|0|||
33170731|NCT00642941|100533200|FG006|Overall Study|Study closed by Sponsor|0|||
33170732|NCT00642941|100533201|FG007|Overall Study|Study closed by Sponsor|0|||
33170733|NCT00642941|100533202|FG008|Overall Study|Study closed by Sponsor|0|||
33170734|NCT00642941|100533203|FG009|Overall Study|Study closed by Sponsor|0|||
33170735|NCT00642941|100533204|FG010|Overall Study|Study closed by Sponsor|0|||
33170736|NCT00642941|100533205|FG011|Overall Study|Study closed by Sponsor|0|||
33170737|NCT00642941|100533194|FG000|Overall Study|Withdrawal by Subject|1|||
33170738|NCT00642941|100533195|FG001|Overall Study|Withdrawal by Subject|0|||
33170739|NCT00642941|100533196|FG002|Overall Study|Withdrawal by Subject|0|||
33170740|NCT00642941|100533197|FG003|Overall Study|Withdrawal by Subject|2|||
33170741|NCT00642941|100533198|FG004|Overall Study|Withdrawal by Subject|0|||
33170742|NCT00642941|100533199|FG005|Overall Study|Withdrawal by Subject|0|||
33170743|NCT00642941|100533200|FG006|Overall Study|Withdrawal by Subject|2|||
33170744|NCT00642941|100533201|FG007|Overall Study|Withdrawal by Subject|0|||
33170745|NCT00642941|100533202|FG008|Overall Study|Withdrawal by Subject|1|||
33170746|NCT00642941|100533203|FG009|Overall Study|Withdrawal by Subject|0|||
33170747|NCT00642941|100533204|FG010|Overall Study|Withdrawal by Subject|0|||
33170748|NCT00642941|100533205|FG011|Overall Study|Withdrawal by Subject|1|||
33170749|NCT00642941|100533194|FG000|Overall Study|Protocol Violation|0|||
33170750|NCT00642941|100533195|FG001|Overall Study|Protocol Violation|0|||
33170751|NCT00642941|100533196|FG002|Overall Study|Protocol Violation|0|||
33261248|NCT00879333|100856589|FG001|Overall Study|Abnormal Laboratory Value|0|||
33170752|NCT00642941|100533197|FG003|Overall Study|Protocol Violation|0|||
33170753|NCT00642941|100533198|FG004|Overall Study|Protocol Violation|0|||
33170754|NCT00642941|100533199|FG005|Overall Study|Protocol Violation|0|||
33170755|NCT00642941|100533200|FG006|Overall Study|Protocol Violation|1|||
33170756|NCT00642941|100533201|FG007|Overall Study|Protocol Violation|0|||
33261249|NCT00879333|100856588|FG000|Overall Study|Withdrawal by Subject|20|||
33261250|NCT00879333|100856589|FG001|Overall Study|Withdrawal by Subject|7|||
33261251|NCT00879333|100856588|FG000|Overall Study|Lost to Follow-up|2|||
33261252|NCT00879333|100856589|FG001|Overall Study|Lost to Follow-up|1|||
33451431|NCT05068284|101545070|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
33451432|NCT05068284|101545071|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
33451433|NCT05068284|101545072|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
33451434|NCT05068284|101545073|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
33451435|NCT05068284|101545074|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
33451436|NCT05068284|101545075|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
33451437|NCT05068284|101545076|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
33451438|NCT05068284|101545069|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
33451439|NCT05068284|101545070|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
33451440|NCT05068284|101545071|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
33451441|NCT05068284|101545072|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
33451442|NCT05068284|101545073|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
33451443|NCT05068284|101545074|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
33451444|NCT05068284|101545075|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
33451445|NCT05068284|101545076|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
33451446|NCT05068284|101545069|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
33451447|NCT05068284|101545070|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
33451448|NCT05068284|101545071|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
33451449|NCT05068284|101545072|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
33451450|NCT05068284|101545073|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
33451451|NCT05068284|101545074|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
33451452|NCT05068284|101545075|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
33451453|NCT05068284|101545076|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
33451454|NCT05068284|101545069|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
33451455|NCT05068284|101545070|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
33451456|NCT05068284|101545071|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
33451457|NCT05068284|101545072|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
33451458|NCT05068284|101545073|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
33451459|NCT05068284|101545074|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
33451460|NCT05068284|101545075|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
33451461|NCT05068284|101545076|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
33451462|NCT05068284|101545069|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
33451463|NCT05068284|101545070|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
33451464|NCT05068284|101545071|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
33451465|NCT05068284|101545072|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
33451466|NCT05068284|101545073|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
33451467|NCT05068284|101545074|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
33451468|NCT05068284|101545075|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
33451469|NCT05068284|101545076|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
33451470|NCT05068284|101545069|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
33451471|NCT05068284|101545070|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
33451472|NCT05068284|101545071|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
33451473|NCT05068284|101545072|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
33451474|NCT05068284|101545073|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
33451475|NCT05068284|101545074|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
33451476|NCT05068284|101545075|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
33451477|NCT05068284|101545076|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
33451478|NCT05068284|101545069|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
33451479|NCT05068284|101545070|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
33451480|NCT05068284|101545071|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
33451481|NCT05068284|101545072|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
33261253|NCT00879333|100856588|FG000|Overall Study|Administrative Problems|2|||
33261254|NCT00879333|100856589|FG001|Overall Study|Administrative Problems|0|||
33451482|NCT05068284|101545073|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
33451483|NCT05068284|101545074|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
33451484|NCT05068284|101545075|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
33451485|NCT05068284|101545076|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
33451486|NCT01440803|101545081|FG000|Overall Study|Met study stopping rule|2|||
33451487|NCT01440803|101545082|FG001|Overall Study|Met study stopping rule|1|||
33451488|NCT01440803|101545081|FG000|Overall Study|Lost to Follow-up|0|||
33451489|NCT01440803|101545082|FG001|Overall Study|Lost to Follow-up|2|||
33451490|NCT01440803|101545081|FG000|Overall Study|Withdrawal by Subject|0|||
33451491|NCT01440803|101545082|FG001|Overall Study|Withdrawal by Subject|1|||
33451492|NCT02175095|101545083|FG000|Overall Study|Withdrawal by Subject|3|||
33451493|NCT00957021|101545084|FG000|Overall Study|Death|5|||
33451494|NCT00957021|101545084|FG000|Overall Study|Lost to Follow-up|8|||
33451495|NCT00957021|101545084|FG000|Overall Study|Withdrawal by Subject|34|||
33451496|NCT00957021|101545084|FG000|Overall Study|No 2 yr ROM data|35|||
33451497|NCT00957021|101545084|FG000|Overall Study|Revised study component by 2 yr visit|8|||
33451498|NCT00957021|101545084|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
33451499|NCT00957021|101545084|FG000|Overall Study|Surgery Cancelled|9|||
33451500|NCT00957021|101545084|FG000|Overall Study|Termination due to language issue|2|||
33170757|NCT00642941|100533202|FG008|Overall Study|Protocol Violation|0|||
33170758|NCT00642941|100533203|FG009|Overall Study|Protocol Violation|0|||
33170759|NCT00642941|100533204|FG010|Overall Study|Protocol Violation|0|||
33170760|NCT00642941|100533205|FG011|Overall Study|Protocol Violation|0|||
33170761|NCT00642941|100533194|FG000|Overall Study|Adverse Event|1|||
33170762|NCT00642941|100533195|FG001|Overall Study|Adverse Event|1|||
33170763|NCT00642941|100533196|FG002|Overall Study|Adverse Event|0|||
33170764|NCT00642941|100533197|FG003|Overall Study|Adverse Event|0|||
33170765|NCT00642941|100533198|FG004|Overall Study|Adverse Event|0|||
33170766|NCT00642941|100533199|FG005|Overall Study|Adverse Event|0|||
33170767|NCT00642941|100533200|FG006|Overall Study|Adverse Event|1|||
33170768|NCT00642941|100533201|FG007|Overall Study|Adverse Event|1|||
33170769|NCT00642941|100533202|FG008|Overall Study|Adverse Event|0|||
33170770|NCT00642941|100533203|FG009|Overall Study|Adverse Event|1|||
33170771|NCT00642941|100533204|FG010|Overall Study|Adverse Event|0|||
33170772|NCT00642941|100533205|FG011|Overall Study|Adverse Event|0|||
33170773|NCT00642941|100533194|FG000|Overall Study|Other|1|||
33170774|NCT00642941|100533195|FG001|Overall Study|Other|1|||
33170775|NCT00642941|100533196|FG002|Overall Study|Other|1|||
33170776|NCT00642941|100533197|FG003|Overall Study|Other|1|||
33170777|NCT00642941|100533198|FG004|Overall Study|Other|0|||
33170778|NCT00642941|100533199|FG005|Overall Study|Other|1|||
33170779|NCT00642941|100533200|FG006|Overall Study|Other|0|||
33170780|NCT00642941|100533201|FG007|Overall Study|Other|1|||
33170781|NCT00642941|100533202|FG008|Overall Study|Other|0|||
33170782|NCT00642941|100533203|FG009|Overall Study|Other|0|||
33170783|NCT00642941|100533204|FG010|Overall Study|Other|0|||
33170784|NCT00642941|100533205|FG011|Overall Study|Other|1|||
33170785|NCT00642941|100533194|FG000|Overall Study|Disease progression|60|||
33170786|NCT00642941|100533195|FG001|Overall Study|Disease progression|50|||
33170787|NCT00642941|100533196|FG002|Overall Study|Disease progression|5|||
33170788|NCT00642941|100533197|FG003|Overall Study|Disease progression|36|||
33170789|NCT00642941|100533198|FG004|Overall Study|Disease progression|23|||
33170790|NCT00642941|100533199|FG005|Overall Study|Disease progression|39|||
33170791|NCT00642941|100533200|FG006|Overall Study|Disease progression|18|||
33170792|NCT00642941|100533201|FG007|Overall Study|Disease progression|12|||
33170793|NCT00642941|100533202|FG008|Overall Study|Disease progression|10|||
33170794|NCT00642941|100533203|FG009|Overall Study|Disease progression|7|||
33170795|NCT00642941|100533204|FG010|Overall Study|Disease progression|12|||
33170796|NCT00642941|100533205|FG011|Overall Study|Disease progression|7|||
33170797|NCT01442675|100533206|FG000|Overall Study|Protocol Violation|6|||
33170798|NCT01442675|100533206|FG000|Overall Study|Lost to Follow-up|2|||
33170799|NCT01442675|100533206|FG000|Overall Study|Withdrawal by Subject|4|||
33170800|NCT00071513|100533207|FG000|Intervention Component|Withdrawal by Subject|2|||
33261255|NCT00879333|100856588|FG000|Overall Study|Death|16|||
33451501|NCT00227370|101545085|FG000|Overall Study|Withdrawal by Subject|1|||
33170801|NCT00071513|100533208|FG001|Intervention Component|Withdrawal by Subject|3|||
33170802|NCT00071513|100533207|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
33170803|NCT00071513|100533208|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
33170804|NCT01543698|100533209|FG000|Phase 1b|Disease progression|2|||
33170805|NCT01543698|100533210|FG001|Phase 1b|Disease progression|4|||
33170806|NCT01543698|100533211|FG002|Phase 1b|Disease progression|3|||
33451502|NCT00227370|101545086|FG001|Overall Study|Withdrawal by Subject|2|||
33451503|NCT00227370|101545085|FG000|Overall Study|Death|3|||
33170807|NCT01543698|100533212|FG003|Phase 1b|Disease progression|2|||
33170808|NCT01543698|100533213|FG004|Phase 1b|Disease progression|10|||
33170809|NCT01543698|100533214|FG005|Phase 1b|Disease progression|6|||
33170810|NCT01543698|100533215|FG006|Phase 1b|Disease progression|5|||
33170811|NCT01543698|100533216|FG007|Phase 1b|Disease progression|3|||
33170812|NCT01543698|100533217|FG008|Phase 1b|Disease progression|4|||
33170813|NCT01543698|100533218|FG009|Phase 1b|Disease progression|5|||
33170814|NCT01543698|100533219|FG010|Phase 1b|Disease progression|1|||
33170815|NCT01543698|100533220|FG011|Phase 1b|Disease progression|0|||
33170816|NCT01543698|100533221|FG012|Phase 1b|Disease progression|0|||
33170817|NCT01543698|100533222|FG013|Phase 1b|Disease progression|0|||
33170818|NCT01543698|100533223|FG014|Phase 1b|Disease progression|0|||
33170819|NCT01543698|100533209|FG000|Phase 1b|Death|0|||
33170820|NCT01543698|100533210|FG001|Phase 1b|Death|0|||
33170821|NCT01543698|100533211|FG002|Phase 1b|Death|1|||
33170822|NCT01543698|100533212|FG003|Phase 1b|Death|1|||
33170823|NCT01543698|100533213|FG004|Phase 1b|Death|0|||
33170824|NCT01543698|100533214|FG005|Phase 1b|Death|0|||
33170825|NCT01543698|100533215|FG006|Phase 1b|Death|0|||
33170826|NCT01543698|100533216|FG007|Phase 1b|Death|0|||
33170827|NCT01543698|100533217|FG008|Phase 1b|Death|0|||
33170828|NCT01543698|100533218|FG009|Phase 1b|Death|0|||
33170829|NCT01543698|100533219|FG010|Phase 1b|Death|1|||
33170830|NCT01543698|100533220|FG011|Phase 1b|Death|0|||
33170831|NCT01543698|100533221|FG012|Phase 1b|Death|0|||
33170832|NCT01543698|100533222|FG013|Phase 1b|Death|0|||
33170833|NCT01543698|100533223|FG014|Phase 1b|Death|0|||
33170834|NCT01543698|100533209|FG000|Phase 1b|Withdrawal by Subject|0|||
33170835|NCT01543698|100533210|FG001|Phase 1b|Withdrawal by Subject|1|||
33170836|NCT01543698|100533211|FG002|Phase 1b|Withdrawal by Subject|0|||
33170837|NCT01543698|100533212|FG003|Phase 1b|Withdrawal by Subject|1|||
33170838|NCT01543698|100533213|FG004|Phase 1b|Withdrawal by Subject|0|||
33170839|NCT01543698|100533214|FG005|Phase 1b|Withdrawal by Subject|0|||
33170840|NCT01543698|100533215|FG006|Phase 1b|Withdrawal by Subject|1|||
33170841|NCT01543698|100533216|FG007|Phase 1b|Withdrawal by Subject|0|||
33170842|NCT01543698|100533217|FG008|Phase 1b|Withdrawal by Subject|0|||
33170843|NCT01543698|100533218|FG009|Phase 1b|Withdrawal by Subject|0|||
33170844|NCT01543698|100533219|FG010|Phase 1b|Withdrawal by Subject|0|||
33170845|NCT01543698|100533220|FG011|Phase 1b|Withdrawal by Subject|0|||
33170846|NCT01543698|100533221|FG012|Phase 1b|Withdrawal by Subject|0|||
33170847|NCT01543698|100533222|FG013|Phase 1b|Withdrawal by Subject|0|||
33170848|NCT01543698|100533223|FG014|Phase 1b|Withdrawal by Subject|0|||
33170849|NCT01543698|100533209|FG000|Phase 1b|Adverse Event|1|||
33170850|NCT01543698|100533210|FG001|Phase 1b|Adverse Event|0|||
33170851|NCT01543698|100533211|FG002|Phase 1b|Adverse Event|0|||
33170852|NCT01543698|100533212|FG003|Phase 1b|Adverse Event|1|||
33170853|NCT01543698|100533213|FG004|Phase 1b|Adverse Event|2|||
33170854|NCT01543698|100533214|FG005|Phase 1b|Adverse Event|2|||
33170855|NCT01543698|100533215|FG006|Phase 1b|Adverse Event|0|||
33170856|NCT01543698|100533216|FG007|Phase 1b|Adverse Event|0|||
33170857|NCT01543698|100533217|FG008|Phase 1b|Adverse Event|1|||
33170858|NCT01543698|100533218|FG009|Phase 1b|Adverse Event|1|||
33170859|NCT01543698|100533219|FG010|Phase 1b|Adverse Event|2|||
33170860|NCT01543698|100533220|FG011|Phase 1b|Adverse Event|0|||
33170861|NCT01543698|100533221|FG012|Phase 1b|Adverse Event|0|||
33170862|NCT01543698|100533222|FG013|Phase 1b|Adverse Event|0|||
33170863|NCT01543698|100533223|FG014|Phase 1b|Adverse Event|0|||
33170864|NCT01543698|100533209|FG000|Phase 1b|Administrative problems|1|||
33170865|NCT01543698|100533210|FG001|Phase 1b|Administrative problems|0|||
33170866|NCT01543698|100533211|FG002|Phase 1b|Administrative problems|0|||
33170867|NCT01543698|100533212|FG003|Phase 1b|Administrative problems|0|||
33170868|NCT01543698|100533213|FG004|Phase 1b|Administrative problems|1|||
33170869|NCT01543698|100533214|FG005|Phase 1b|Administrative problems|0|||
33170870|NCT01543698|100533215|FG006|Phase 1b|Administrative problems|0|||
33170871|NCT01543698|100533216|FG007|Phase 1b|Administrative problems|1|||
33170872|NCT01543698|100533217|FG008|Phase 1b|Administrative problems|0|||
33170873|NCT01543698|100533218|FG009|Phase 1b|Administrative problems|0|||
33170874|NCT01543698|100533219|FG010|Phase 1b|Administrative problems|2|||
33170875|NCT01543698|100533220|FG011|Phase 1b|Administrative problems|0|||
33170876|NCT01543698|100533221|FG012|Phase 1b|Administrative problems|0|||
33170877|NCT01543698|100533222|FG013|Phase 1b|Administrative problems|0|||
33170878|NCT01543698|100533223|FG014|Phase 1b|Administrative problems|0|||
33170879|NCT01543698|100533209|FG000|Phase 1b|Protocol Violation|2|||
33170880|NCT01543698|100533210|FG001|Phase 1b|Protocol Violation|0|||
33170881|NCT01543698|100533211|FG002|Phase 1b|Protocol Violation|0|||
33170882|NCT01543698|100533212|FG003|Phase 1b|Protocol Violation|0|||
33170883|NCT01543698|100533213|FG004|Phase 1b|Protocol Violation|0|||
33170884|NCT01543698|100533214|FG005|Phase 1b|Protocol Violation|0|||
33170885|NCT01543698|100533215|FG006|Phase 1b|Protocol Violation|0|||
33170886|NCT01543698|100533216|FG007|Phase 1b|Protocol Violation|0|||
33451504|NCT00227370|101545086|FG001|Overall Study|Death|4|||
33451505|NCT00227370|101545085|FG000|Overall Study|Adverse Event|6|||
33451506|NCT00227370|101545086|FG001|Overall Study|Adverse Event|11|||
33451507|NCT00227370|101545085|FG000|Overall Study|Physician Decision|9|||
33451508|NCT00227370|101545086|FG001|Overall Study|Physician Decision|6|||
33451509|NCT00227370|101545085|FG000|Overall Study|Other reasons|2|||
33451510|NCT00227370|101545086|FG001|Overall Study|Other reasons|1|||
33451511|NCT01116739|101545087|FG000|Overall Study|Child had 2 years of HS|110|||
33451512|NCT01116739|101545088|FG001|Overall Study|Child had 2 years of HS|128|||
33451513|NCT01116739|101545087|FG000|Overall Study|Withdrawal by Subject|6|||
33451514|NCT01116739|101545088|FG001|Overall Study|Withdrawal by Subject|0|||
33451515|NCT01116739|101545087|FG000|Overall Study|child too young|2|||
33451516|NCT01116739|101545088|FG001|Overall Study|child too young|6|||
33451517|NCT01116739|101545087|FG000|Overall Study|child not enrolled in head start|10|||
33451518|NCT01116739|101545088|FG001|Overall Study|child not enrolled in head start|2|||
33451519|NCT01116739|101545087|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
33451520|NCT01116739|101545088|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
33451521|NCT04112823|101545089|FG000|Overall Study|Lost to Follow-up|2|||
33451522|NCT04112823|101545090|FG001|Overall Study|Lost to Follow-up|3|||
33170887|NCT01543698|100533217|FG008|Phase 1b|Protocol Violation|0|||
33170888|NCT01543698|100533218|FG009|Phase 1b|Protocol Violation|0|||
33170889|NCT01543698|100533219|FG010|Phase 1b|Protocol Violation|0|||
33170890|NCT01543698|100533220|FG011|Phase 1b|Protocol Violation|0|||
33170891|NCT01543698|100533221|FG012|Phase 1b|Protocol Violation|0|||
33451523|NCT01175135|101545093|FG000|Overall Study|Adverse Event|2|||
33451524|NCT01175135|101545094|FG001|Overall Study|Adverse Event|5|||
33170892|NCT01543698|100533222|FG013|Phase 1b|Protocol Violation|0|||
33451525|NCT01175135|101545095|FG002|Overall Study|Adverse Event|3|||
33170893|NCT01543698|100533223|FG014|Phase 1b|Protocol Violation|0|||
33170894|NCT01543698|100533209|FG000|Phase 2|Protocol Violation|0|||
33451526|NCT01175135|101545096|FG003|Overall Study|Adverse Event|4|||
33451527|NCT01175135|101545093|FG000|Overall Study|Death|1|||
33451528|NCT01175135|101545094|FG001|Overall Study|Death|0|||
33451529|NCT01175135|101545095|FG002|Overall Study|Death|0|||
33451530|NCT01175135|101545096|FG003|Overall Study|Death|0|||
33451531|NCT01175135|101545093|FG000|Overall Study|Lack of Efficacy|4|||
33451532|NCT01175135|101545094|FG001|Overall Study|Lack of Efficacy|5|||
33451533|NCT01175135|101545095|FG002|Overall Study|Lack of Efficacy|0|||
33451534|NCT01175135|101545096|FG003|Overall Study|Lack of Efficacy|5|||
33451535|NCT01175135|101545093|FG000|Overall Study|Lost to Follow-up|1|||
33451536|NCT01175135|101545094|FG001|Overall Study|Lost to Follow-up|2|||
33451537|NCT01175135|101545095|FG002|Overall Study|Lost to Follow-up|0|||
33451538|NCT01175135|101545096|FG003|Overall Study|Lost to Follow-up|0|||
33451539|NCT01175135|101545093|FG000|Overall Study|Protocol Violation|1|||
33451540|NCT01175135|101545094|FG001|Overall Study|Protocol Violation|1|||
33451541|NCT01175135|101545095|FG002|Overall Study|Protocol Violation|0|||
33451542|NCT01175135|101545096|FG003|Overall Study|Protocol Violation|0|||
33451543|NCT01175135|101545093|FG000|Overall Study|Withdrawal by Subject|4|||
33451544|NCT01175135|101545094|FG001|Overall Study|Withdrawal by Subject|8|||
33451545|NCT01175135|101545095|FG002|Overall Study|Withdrawal by Subject|5|||
33451546|NCT01175135|101545096|FG003|Overall Study|Withdrawal by Subject|5|||
33451547|NCT01175135|101545093|FG000|Overall Study|Other|3|||
33451548|NCT01175135|101545094|FG001|Overall Study|Other|1|||
33451549|NCT01175135|101545095|FG002|Overall Study|Other|3|||
33451550|NCT01175135|101545096|FG003|Overall Study|Other|0|||
33451551|NCT01175135|101545093|FG000|Overall Study|Randomized But Not Treated|0|||
33451552|NCT01175135|101545094|FG001|Overall Study|Randomized But Not Treated|0|||
33451553|NCT01175135|101545095|FG002|Overall Study|Randomized But Not Treated|1|||
33451554|NCT01175135|101545096|FG003|Overall Study|Randomized But Not Treated|0|||
33451555|NCT02625974|101545097|FG000|Part 1|Lost to Follow-up|9|||
33451556|NCT02625974|101545098|FG001|Part 1|Lost to Follow-up|3|||
33451557|NCT02625974|101545097|FG000|Part 2|Lost to Follow-up|4|||
33451558|NCT02625974|101545098|FG001|Part 2|Lost to Follow-up|6|||
33451559|NCT02625974|101545097|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
33451560|NCT02625974|101545098|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
33451561|NCT04223791|101545099|FG000|Overall Study|Lost to Follow-up|0|||
33451562|NCT04223791|101545100|FG001|Overall Study|Lost to Follow-up|4|||
33451563|NCT04223791|101545099|FG000|Overall Study|Physician Decision|5|||
33451564|NCT04223791|101545100|FG001|Overall Study|Physician Decision|1|||
33451565|NCT04223791|101545099|FG000|Overall Study|Protocol Violation|1|||
33451566|NCT04223791|101545100|FG001|Overall Study|Protocol Violation|1|||
33451567|NCT04223791|101545099|FG000|Overall Study|Withdrawal by Subject|10|||
33451568|NCT04223791|101545100|FG001|Overall Study|Withdrawal by Subject|12|||
33451569|NCT04223791|101545099|FG000|Overall Study|Pregnancy|1|||
33451570|NCT04223791|101545100|FG001|Overall Study|Pregnancy|1|||
33451571|NCT04223791|101545099|FG000|Overall Study|Ongoing in Study|305|||
33451572|NCT04223791|101545100|FG001|Overall Study|Ongoing in Study|302|||
33451573|NCT05315713|101545103|FG000|Overall Study|Death|5|||
33451574|NCT05315713|101545103|FG000|Overall Study|Progressive disease|1|||
33451575|NCT05315713|101545103|FG000|Overall Study|Withdrawal by Subject|1|||
33451576|NCT05315713|101545103|FG000|Overall Study|Study terminated by sponsor|1|||
33451577|NCT00881751|101545104|FG000|Overall Study|Physician Decision|0|||
33451578|NCT00881751|101545105|FG001|Overall Study|Physician Decision|1|||
33451579|NCT00881751|101545104|FG000|Overall Study|Adverse Event|0|||
33451580|NCT00881751|101545105|FG001|Overall Study|Adverse Event|2|||
33451581|NCT00881751|101545104|FG000|Overall Study|Withdrawal by Subject|0|||
33451582|NCT00881751|101545105|FG001|Overall Study|Withdrawal by Subject|2|||
33451583|NCT00935012|101545112|FG000|Overall Study|Death|19|||
33451584|NCT00935012|101545112|FG000|Overall Study|Withdrawal by Subject|3|||
33451585|NCT00935012|101545112|FG000|Overall Study|Other|5|||
33451586|NCT00935012|101545112|FG000|Overall Study|Adverse Event|2|||
33451587|NCT00205777|101545115|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
33451588|NCT00205777|101545116|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
33451589|NCT00205777|101545117|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
33451590|NCT00205777|101545118|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
33451591|NCT00205777|101545119|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
33451592|NCT00205777|101545120|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
33451593|NCT00205777|101545115|FG000|Core Study (Up to 3 Years)|Death|9|||
33451594|NCT00205777|101545116|FG001|Core Study (Up to 3 Years)|Death|7|||
33451595|NCT00205777|101545117|FG002|Core Study (Up to 3 Years)|Death|14|||
33451596|NCT00205777|101545118|FG003|Core Study (Up to 3 Years)|Death|7|||
33451597|NCT00205777|101545119|FG004|Core Study (Up to 3 Years)|Death|0|||
33451598|NCT00205777|101545120|FG005|Core Study (Up to 3 Years)|Death|0|||
33451599|NCT00205777|101545115|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
33451600|NCT00205777|101545116|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
33451601|NCT00205777|101545117|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
33451602|NCT00205777|101545118|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
33170895|NCT01543698|100533210|FG001|Phase 2|Protocol Violation|0|||
33451603|NCT00205777|101545119|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
33451604|NCT00205777|101545120|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
33451605|NCT00205777|101545115|FG000|Core Study (Up to 3 Years)|Other Event|49|||
33451606|NCT00205777|101545116|FG001|Core Study (Up to 3 Years)|Other Event|52|||
33451607|NCT00205777|101545117|FG002|Core Study (Up to 3 Years)|Other Event|41|||
33451608|NCT00205777|101545118|FG003|Core Study (Up to 3 Years)|Other Event|58|||
33451609|NCT00205777|101545119|FG004|Core Study (Up to 3 Years)|Other Event|0|||
33451610|NCT00205777|101545120|FG005|Core Study (Up to 3 Years)|Other Event|0|||
33451611|NCT00205777|101545115|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
33451612|NCT00205777|101545116|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
33451613|NCT00205777|101545117|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
33451614|NCT00205777|101545118|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
33451615|NCT00205777|101545119|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
33451616|NCT00205777|101545120|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
33451617|NCT00205777|101545115|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
33451618|NCT00205777|101545116|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
33451619|NCT00205777|101545117|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
33451620|NCT00205777|101545118|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
33451621|NCT00205777|101545119|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
33451622|NCT00205777|101545120|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
33451623|NCT00205777|101545115|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
33451624|NCT00205777|101545116|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
33170896|NCT01543698|100533211|FG002|Phase 2|Protocol Violation|0|||
33170897|NCT01543698|100533212|FG003|Phase 2|Protocol Violation|0|||
33170898|NCT01543698|100533213|FG004|Phase 2|Protocol Violation|0|||
33170899|NCT01543698|100533214|FG005|Phase 2|Protocol Violation|0|||
33170900|NCT01543698|100533215|FG006|Phase 2|Protocol Violation|0|||
33170901|NCT01543698|100533216|FG007|Phase 2|Protocol Violation|0|||
33170902|NCT01543698|100533217|FG008|Phase 2|Protocol Violation|0|||
33170903|NCT01543698|100533218|FG009|Phase 2|Protocol Violation|0|||
33170904|NCT01543698|100533219|FG010|Phase 2|Protocol Violation|0|||
33170905|NCT01543698|100533220|FG011|Phase 2|Protocol Violation|0|||
33170906|NCT01543698|100533221|FG012|Phase 2|Protocol Violation|1|||
33170907|NCT01543698|100533222|FG013|Phase 2|Protocol Violation|0|||
33170908|NCT01543698|100533223|FG014|Phase 2|Protocol Violation|0|||
33170909|NCT01543698|100533209|FG000|Phase 2|Disease progression|0|||
33170910|NCT01543698|100533210|FG001|Phase 2|Disease progression|0|||
33170911|NCT01543698|100533211|FG002|Phase 2|Disease progression|0|||
33170912|NCT01543698|100533212|FG003|Phase 2|Disease progression|0|||
33170913|NCT01543698|100533213|FG004|Phase 2|Disease progression|0|||
33170914|NCT01543698|100533214|FG005|Phase 2|Disease progression|0|||
33451625|NCT00205777|101545117|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
33451626|NCT00205777|101545118|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
33451627|NCT00205777|101545119|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
33451628|NCT00205777|101545120|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
33451629|NCT00205777|101545115|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
33451630|NCT00205777|101545116|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
33451631|NCT00205777|101545117|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
33451632|NCT00205777|101545118|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
33451633|NCT00205777|101545119|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
33451634|NCT00205777|101545120|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
33451635|NCT00205777|101545115|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
33451636|NCT00205777|101545116|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
33170915|NCT01543698|100533215|FG006|Phase 2|Disease progression|0|||
33170916|NCT01543698|100533216|FG007|Phase 2|Disease progression|0|||
33170917|NCT01543698|100533217|FG008|Phase 2|Disease progression|0|||
33451637|NCT00205777|101545117|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
33451638|NCT00205777|101545118|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
33451639|NCT00205777|101545119|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
33170918|NCT01543698|100533218|FG009|Phase 2|Disease progression|0|||
33170919|NCT01543698|100533219|FG010|Phase 2|Disease progression|0|||
33451640|NCT00205777|101545120|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
33170920|NCT01543698|100533220|FG011|Phase 2|Disease progression|10|||
33170921|NCT01543698|100533221|FG012|Phase 2|Disease progression|21|||
33170922|NCT01543698|100533222|FG013|Phase 2|Disease progression|30|||
33170923|NCT01543698|100533223|FG014|Phase 2|Disease progression|25|||
33170924|NCT01543698|100533209|FG000|Phase 2|Death|0|||
33170925|NCT01543698|100533210|FG001|Phase 2|Death|0|||
33170926|NCT01543698|100533211|FG002|Phase 2|Death|0|||
33170927|NCT01543698|100533212|FG003|Phase 2|Death|0|||
33170928|NCT01543698|100533213|FG004|Phase 2|Death|0|||
33170929|NCT01543698|100533214|FG005|Phase 2|Death|0|||
33170930|NCT01543698|100533215|FG006|Phase 2|Death|0|||
33170931|NCT01543698|100533216|FG007|Phase 2|Death|0|||
33170932|NCT01543698|100533217|FG008|Phase 2|Death|0|||
33170933|NCT01543698|100533218|FG009|Phase 2|Death|0|||
33170934|NCT01543698|100533219|FG010|Phase 2|Death|0|||
33170935|NCT01543698|100533220|FG011|Phase 2|Death|0|||
33170936|NCT01543698|100533221|FG012|Phase 2|Death|1|||
33170937|NCT01543698|100533222|FG013|Phase 2|Death|1|||
33170938|NCT01543698|100533223|FG014|Phase 2|Death|1|||
33170939|NCT01543698|100533209|FG000|Phase 2|Administrative problems|0|||
33170940|NCT01543698|100533210|FG001|Phase 2|Administrative problems|0|||
33170941|NCT01543698|100533211|FG002|Phase 2|Administrative problems|0|||
33170942|NCT01543698|100533212|FG003|Phase 2|Administrative problems|0|||
33170943|NCT01543698|100533213|FG004|Phase 2|Administrative problems|0|||
33170944|NCT01543698|100533214|FG005|Phase 2|Administrative problems|0|||
33170945|NCT01543698|100533215|FG006|Phase 2|Administrative problems|0|||
33170946|NCT01543698|100533216|FG007|Phase 2|Administrative problems|0|||
33170947|NCT01543698|100533217|FG008|Phase 2|Administrative problems|0|||
33170948|NCT01543698|100533218|FG009|Phase 2|Administrative problems|0|||
33170949|NCT01543698|100533219|FG010|Phase 2|Administrative problems|0|||
33170950|NCT01543698|100533220|FG011|Phase 2|Administrative problems|0|||
33170951|NCT01543698|100533221|FG012|Phase 2|Administrative problems|0|||
33170952|NCT01543698|100533222|FG013|Phase 2|Administrative problems|3|||
33170953|NCT01543698|100533223|FG014|Phase 2|Administrative problems|1|||
33170954|NCT01543698|100533209|FG000|Phase 2|Withdrawal by Subject|0|||
33170955|NCT01543698|100533210|FG001|Phase 2|Withdrawal by Subject|0|||
33170956|NCT01543698|100533211|FG002|Phase 2|Withdrawal by Subject|0|||
33170957|NCT01543698|100533212|FG003|Phase 2|Withdrawal by Subject|0|||
33170958|NCT01543698|100533213|FG004|Phase 2|Withdrawal by Subject|0|||
33170959|NCT01543698|100533214|FG005|Phase 2|Withdrawal by Subject|0|||
33170960|NCT01543698|100533215|FG006|Phase 2|Withdrawal by Subject|0|||
33170961|NCT01543698|100533216|FG007|Phase 2|Withdrawal by Subject|0|||
33170962|NCT01543698|100533217|FG008|Phase 2|Withdrawal by Subject|0|||
33170963|NCT01543698|100533218|FG009|Phase 2|Withdrawal by Subject|0|||
33170964|NCT01543698|100533219|FG010|Phase 2|Withdrawal by Subject|0|||
33170965|NCT01543698|100533220|FG011|Phase 2|Withdrawal by Subject|0|||
33170966|NCT01543698|100533221|FG012|Phase 2|Withdrawal by Subject|0|||
33170967|NCT01543698|100533222|FG013|Phase 2|Withdrawal by Subject|3|||
33170968|NCT01543698|100533223|FG014|Phase 2|Withdrawal by Subject|1|||
33170969|NCT01543698|100533209|FG000|Phase 2|Adverse Event|0|||
33170970|NCT01543698|100533210|FG001|Phase 2|Adverse Event|0|||
33170971|NCT01543698|100533211|FG002|Phase 2|Adverse Event|0|||
33451641|NCT00205777|101545115|FG000|Completed Core Study, Entered SE I|Other Event|52|||
33451642|NCT00205777|101545116|FG001|Completed Core Study, Entered SE I|Other Event|46|||
33451643|NCT00205777|101545117|FG002|Completed Core Study, Entered SE I|Other Event|47|||
33451644|NCT00205777|101545118|FG003|Completed Core Study, Entered SE I|Other Event|50|||
33451645|NCT00205777|101545119|FG004|Completed Core Study, Entered SE I|Other Event|0|||
33451646|NCT00205777|101545120|FG005|Completed Core Study, Entered SE I|Other Event|0|||
33451647|NCT00205777|101545115|FG000|Study Extension I|Adverse Event|57|||
33451648|NCT00205777|101545116|FG001|Study Extension I|Adverse Event|0|||
33451649|NCT00205777|101545117|FG002|Study Extension I|Adverse Event|0|||
33451650|NCT00205777|101545118|FG003|Study Extension I|Adverse Event|61|||
33451651|NCT00205777|101545119|FG004|Study Extension I|Adverse Event|58|||
33451652|NCT00205777|101545120|FG005|Study Extension I|Adverse Event|0|||
33451653|NCT00205777|101545115|FG000|Study Extension I|Death|5|||
33451654|NCT00205777|101545116|FG001|Study Extension I|Death|0|||
33451655|NCT00205777|101545117|FG002|Study Extension I|Death|0|||
33451656|NCT00205777|101545118|FG003|Study Extension I|Death|1|||
33451657|NCT00205777|101545119|FG004|Study Extension I|Death|2|||
33451658|NCT00205777|101545120|FG005|Study Extension I|Death|0|||
33451659|NCT00205777|101545115|FG000|Study Extension I|Withdrawal by Subject|99|||
33451660|NCT00205777|101545116|FG001|Study Extension I|Withdrawal by Subject|0|||
33451661|NCT00205777|101545117|FG002|Study Extension I|Withdrawal by Subject|0|||
33451662|NCT00205777|101545118|FG003|Study Extension I|Withdrawal by Subject|106|||
33451663|NCT00205777|101545119|FG004|Study Extension I|Withdrawal by Subject|89|||
33451664|NCT00205777|101545120|FG005|Study Extension I|Withdrawal by Subject|0|||
33451665|NCT00205777|101545115|FG000|Study Extension I|Protocol Violation|4|||
33451666|NCT00205777|101545116|FG001|Study Extension I|Protocol Violation|0|||
33451667|NCT00205777|101545117|FG002|Study Extension I|Protocol Violation|0|||
33451668|NCT00205777|101545118|FG003|Study Extension I|Protocol Violation|8|||
33451669|NCT00205777|101545119|FG004|Study Extension I|Protocol Violation|8|||
33451670|NCT00205777|101545120|FG005|Study Extension I|Protocol Violation|0|||
33451671|NCT00205777|101545115|FG000|Study Extension I|Lack of Efficacy|0|||
33451672|NCT00205777|101545116|FG001|Study Extension I|Lack of Efficacy|0|||
33451673|NCT00205777|101545117|FG002|Study Extension I|Lack of Efficacy|0|||
33451674|NCT00205777|101545118|FG003|Study Extension I|Lack of Efficacy|1|||
33451675|NCT00205777|101545119|FG004|Study Extension I|Lack of Efficacy|2|||
33451676|NCT00205777|101545120|FG005|Study Extension I|Lack of Efficacy|0|||
33451677|NCT00205777|101545115|FG000|Study Extension I|Failed to return|15|||
33451678|NCT00205777|101545116|FG001|Study Extension I|Failed to return|0|||
33451679|NCT00205777|101545117|FG002|Study Extension I|Failed to return|0|||
33451680|NCT00205777|101545118|FG003|Study Extension I|Failed to return|17|||
33451681|NCT00205777|101545119|FG004|Study Extension I|Failed to return|13|||
33451682|NCT00205777|101545120|FG005|Study Extension I|Failed to return|0|||
33451683|NCT00205777|101545115|FG000|Study Extension I|Other Event|34|||
33451684|NCT00205777|101545116|FG001|Study Extension I|Other Event|0|||
33451685|NCT00205777|101545117|FG002|Study Extension I|Other Event|0|||
33451686|NCT00205777|101545118|FG003|Study Extension I|Other Event|34|||
33451687|NCT00205777|101545119|FG004|Study Extension I|Other Event|29|||
33451688|NCT00205777|101545120|FG005|Study Extension I|Other Event|0|||
33451689|NCT00205777|101545115|FG000|Study Extension I|Withdrawn as per protocol|0|||
33451690|NCT00205777|101545116|FG001|Study Extension I|Withdrawn as per protocol|0|||
33451691|NCT00205777|101545117|FG002|Study Extension I|Withdrawn as per protocol|1070|||
33451692|NCT00205777|101545118|FG003|Study Extension I|Withdrawn as per protocol|0|||
33451693|NCT00205777|101545119|FG004|Study Extension I|Withdrawn as per protocol|0|||
33451694|NCT00205777|101545120|FG005|Study Extension I|Withdrawn as per protocol|0|||
33451695|NCT00205777|101545115|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
33451696|NCT00205777|101545116|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
33451697|NCT00205777|101545117|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
33451698|NCT00205777|101545118|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
33489760|NCT02952586|101686779|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
33451699|NCT00205777|101545119|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
33451700|NCT00205777|101545120|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
33451701|NCT00205777|101545115|FG000|Study Extension II|Adverse Event|0|||
33451702|NCT00205777|101545116|FG001|Study Extension II|Adverse Event|0|||
33451703|NCT00205777|101545117|FG002|Study Extension II|Adverse Event|0|||
33451704|NCT00205777|101545118|FG003|Study Extension II|Adverse Event|14|||
33451705|NCT00205777|101545119|FG004|Study Extension II|Adverse Event|0|||
33451706|NCT00205777|101545120|FG005|Study Extension II|Adverse Event|30|||
33451707|NCT00205777|101545115|FG000|Study Extension II|Death|0|||
33451708|NCT00205777|101545116|FG001|Study Extension II|Death|0|||
33451709|NCT00205777|101545117|FG002|Study Extension II|Death|0|||
33451710|NCT00205777|101545118|FG003|Study Extension II|Death|2|||
33451711|NCT00205777|101545119|FG004|Study Extension II|Death|0|||
33451712|NCT00205777|101545120|FG005|Study Extension II|Death|5|||
33451713|NCT00205777|101545115|FG000|Study Extension II|Withdrawal by Subject|0|||
33451714|NCT00205777|101545116|FG001|Study Extension II|Withdrawal by Subject|0|||
33451715|NCT00205777|101545117|FG002|Study Extension II|Withdrawal by Subject|0|||
33451716|NCT00205777|101545118|FG003|Study Extension II|Withdrawal by Subject|35|||
33451717|NCT00205777|101545119|FG004|Study Extension II|Withdrawal by Subject|0|||
33451718|NCT00205777|101545120|FG005|Study Extension II|Withdrawal by Subject|59|||
33451719|NCT00205777|101545115|FG000|Study Extension II|Protocol Violation|0|||
33451720|NCT00205777|101545116|FG001|Study Extension II|Protocol Violation|0|||
33451721|NCT00205777|101545117|FG002|Study Extension II|Protocol Violation|0|||
33451722|NCT00205777|101545118|FG003|Study Extension II|Protocol Violation|1|||
33451723|NCT00205777|101545119|FG004|Study Extension II|Protocol Violation|0|||
33451724|NCT00205777|101545120|FG005|Study Extension II|Protocol Violation|10|||
33451725|NCT00205777|101545115|FG000|Study Extension II|Lack of Efficacy|0|||
33451726|NCT00205777|101545116|FG001|Study Extension II|Lack of Efficacy|0|||
33451727|NCT00205777|101545117|FG002|Study Extension II|Lack of Efficacy|0|||
33451728|NCT00205777|101545118|FG003|Study Extension II|Lack of Efficacy|0|||
33451729|NCT00205777|101545119|FG004|Study Extension II|Lack of Efficacy|0|||
33451730|NCT00205777|101545120|FG005|Study Extension II|Lack of Efficacy|1|||
33451731|NCT00205777|101545115|FG000|Study Extension II|Failed to return|0|||
33170972|NCT01543698|100533212|FG003|Phase 2|Adverse Event|0|||
33170973|NCT01543698|100533213|FG004|Phase 2|Adverse Event|0|||
33170974|NCT01543698|100533214|FG005|Phase 2|Adverse Event|0|||
33170975|NCT01543698|100533215|FG006|Phase 2|Adverse Event|0|||
33170976|NCT01543698|100533216|FG007|Phase 2|Adverse Event|0|||
33170977|NCT01543698|100533217|FG008|Phase 2|Adverse Event|0|||
33170978|NCT01543698|100533218|FG009|Phase 2|Adverse Event|0|||
33170979|NCT01543698|100533219|FG010|Phase 2|Adverse Event|0|||
33170980|NCT01543698|100533220|FG011|Phase 2|Adverse Event|1|||
33170981|NCT01543698|100533221|FG012|Phase 2|Adverse Event|3|||
33170982|NCT01543698|100533222|FG013|Phase 2|Adverse Event|5|||
33170983|NCT01543698|100533223|FG014|Phase 2|Adverse Event|14|||
33170984|NCT01648101|100533225|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
33170985|NCT01648101|100533226|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
33170986|NCT01648101|100533227|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
33170987|NCT01648101|100533225|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
33170988|NCT01648101|100533226|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
33170989|NCT01648101|100533227|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
33170990|NCT01648101|100533225|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
33170991|NCT01648101|100533226|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
33170992|NCT01648101|100533227|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
33170993|NCT01648101|100533225|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
33170994|NCT01648101|100533226|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
33170995|NCT01648101|100533227|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
33170996|NCT01648101|100533225|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
33170997|NCT01648101|100533226|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
33170998|NCT01648101|100533227|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
33170999|NCT01648101|100533225|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
33171000|NCT01648101|100533226|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
33171001|NCT01648101|100533227|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
33171002|NCT01648101|100533225|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
33171003|NCT01648101|100533226|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
33171004|NCT01648101|100533227|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
33171005|NCT01648101|100533225|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
33171006|NCT01648101|100533226|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
33171007|NCT01648101|100533227|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
33171008|NCT01648101|100533225|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
33171009|NCT01648101|100533226|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
33171010|NCT01648101|100533227|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
33171011|NCT01648101|100533225|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
33171012|NCT01648101|100533226|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
33171013|NCT01648101|100533227|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
33171014|NCT01648101|100533225|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
33171015|NCT01648101|100533226|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
33171016|NCT01648101|100533227|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
33171017|NCT01871532|100533230|FG000|Overall Study|Withdrawal by Subject|1|||
33171018|NCT01871532|100533231|FG001|Overall Study|Withdrawal by Subject|2|||
33171019|NCT03998189|100533237|FG000|Overall Study|Lack of Efficacy|0|||
33171020|NCT03998189|100533238|FG001|Overall Study|Lack of Efficacy|1|||
33171021|NCT02051608|100533239|FG000|Part 1: Double Blind Treatment|Death|3|||
33171022|NCT02051608|100533240|FG001|Part 1: Double Blind Treatment|Death|3|||
33171023|NCT02051608|100533241|FG002|Part 1: Double Blind Treatment|Death|0|||
33171024|NCT02051608|100533242|FG003|Part 1: Double Blind Treatment|Death|0|||
33171025|NCT02051608|100533239|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
33171026|NCT02051608|100533240|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
33171027|NCT02051608|100533241|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
33171028|NCT02051608|100533242|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
33171029|NCT02051608|100533239|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
33171030|NCT02051608|100533240|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
33171031|NCT02051608|100533241|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
33171032|NCT02051608|100533242|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
33171033|NCT02051608|100533239|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
33171034|NCT02051608|100533240|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
33171035|NCT02051608|100533241|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
33171036|NCT02051608|100533242|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
33451732|NCT00205777|101545116|FG001|Study Extension II|Failed to return|0|||
33171037|NCT02051608|100533239|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
33171038|NCT02051608|100533240|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
33171039|NCT02051608|100533241|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
33171040|NCT02051608|100533242|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
33171041|NCT02051608|100533239|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
33451733|NCT00205777|101545117|FG002|Study Extension II|Failed to return|0|||
33451734|NCT00205777|101545118|FG003|Study Extension II|Failed to return|14|||
33451735|NCT00205777|101545119|FG004|Study Extension II|Failed to return|0|||
33451736|NCT00205777|101545120|FG005|Study Extension II|Failed to return|26|||
33451737|NCT00205777|101545115|FG000|Study Extension II|Other Event|0|||
33451738|NCT00205777|101545116|FG001|Study Extension II|Other Event|0|||
33451739|NCT00205777|101545117|FG002|Study Extension II|Other Event|0|||
33451740|NCT00205777|101545118|FG003|Study Extension II|Other Event|12|||
33451741|NCT00205777|101545119|FG004|Study Extension II|Other Event|0|||
33451742|NCT00205777|101545120|FG005|Study Extension II|Other Event|20|||
33451743|NCT00205777|101545115|FG000|Study Extension II|Enrolled but not treated|0|||
33451744|NCT00205777|101545116|FG001|Study Extension II|Enrolled but not treated|0|||
33451745|NCT00205777|101545117|FG002|Study Extension II|Enrolled but not treated|0|||
33451746|NCT00205777|101545118|FG003|Study Extension II|Enrolled but not treated|71|||
33451747|NCT00205777|101545119|FG004|Study Extension II|Enrolled but not treated|0|||
33451748|NCT00205777|101545120|FG005|Study Extension II|Enrolled but not treated|131|||
33451749|NCT01484912|101545121|FG000|Overall Study|Withdrawal by Subject|1|||
33451750|NCT01484912|101545122|FG001|Overall Study|Withdrawal by Subject|0|||
33451751|NCT01484912|101545121|FG000|Overall Study|Physician Decision|0|||
33451752|NCT01484912|101545122|FG001|Overall Study|Physician Decision|1|||
33451753|NCT02072096|101545123|FG000|Overall Study|Lack of Efficacy|18|||
33451754|NCT02072096|101545124|FG001|Overall Study|Lack of Efficacy|29|||
33451755|NCT02072096|101545123|FG000|Overall Study|Protocol Violation|7|||
33451756|NCT02072096|101545124|FG001|Overall Study|Protocol Violation|7|||
33451757|NCT02072096|101545123|FG000|Overall Study|Withdrawal by Subject|5|||
33451758|NCT02072096|101545124|FG001|Overall Study|Withdrawal by Subject|7|||
33451759|NCT02072096|101545123|FG000|Overall Study|Adverse Event|5|||
33451760|NCT02072096|101545124|FG001|Overall Study|Adverse Event|2|||
33451761|NCT02072096|101545123|FG000|Overall Study|No Reason Provided|4|||
33451762|NCT02072096|101545124|FG001|Overall Study|No Reason Provided|2|||
33451763|NCT02072096|101545123|FG000|Overall Study|Death|2|||
33451764|NCT02072096|101545124|FG001|Overall Study|Death|0|||
33451765|NCT02072096|101545123|FG000|Overall Study|Physician Decision|0|||
33451766|NCT02072096|101545124|FG001|Overall Study|Physician Decision|1|||
33451767|NCT02072096|101545123|FG000|Overall Study|Study Terminated by Sponsor|43|||
33451768|NCT02072096|101545124|FG001|Overall Study|Study Terminated by Sponsor|30|||
33451769|NCT02072096|101545123|FG000|Overall Study|Lost to Follow-up|1|||
33451770|NCT02072096|101545124|FG001|Overall Study|Lost to Follow-up|0|||
33451771|NCT02125461|101545127|FG000|Overall Study|Withdrawal by Subject|30|||
33451772|NCT02125461|101545128|FG001|Overall Study|Withdrawal by Subject|16|||
33451773|NCT02125461|101545127|FG000|Overall Study|Lost to Follow-up|8|||
33451774|NCT02125461|101545128|FG001|Overall Study|Lost to Follow-up|3|||
33451775|NCT02125461|101545127|FG000|Overall Study|Death|260|||
33451776|NCT02125461|101545128|FG001|Overall Study|Death|149|||
33451777|NCT02125461|101545127|FG000|Overall Study|Missing Termination Reason|0|||
33451778|NCT02125461|101545128|FG001|Overall Study|Missing Termination Reason|1|||
33451779|NCT03889639|101545129|FG000|Overall Study|Withdrawal by Subject|0|||
33451780|NCT03889639|101545130|FG001|Overall Study|Withdrawal by Subject|0|||
33451781|NCT03889639|101545131|FG002|Overall Study|Withdrawal by Subject|0|||
33451782|NCT03889639|101545132|FG003|Overall Study|Withdrawal by Subject|0|||
33451783|NCT03889639|101545133|FG004|Overall Study|Withdrawal by Subject|0|||
33451784|NCT03889639|101545134|FG005|Overall Study|Withdrawal by Subject|0|||
33451785|NCT03889639|101545135|FG006|Overall Study|Withdrawal by Subject|0|||
33451786|NCT03889639|101545136|FG007|Overall Study|Withdrawal by Subject|1|||
33451787|NCT02974621|101545137|FG000|Overall Study|Didn't receive study treatment|1|||
33451788|NCT02974621|101545138|FG001|Overall Study|Didn't receive study treatment|10|||
33451789|NCT00367133|101545143|FG000|2 Years|Death|20|||
33451790|NCT00367133|101545144|FG001|2 Years|Death|12|||
33451791|NCT00367133|101545145|FG002|2 Years|Death|12|||
33451792|NCT00367133|101545143|FG000|2 Years|Dropped|34|||
33451793|NCT00367133|101545144|FG001|2 Years|Dropped|19|||
33451794|NCT00367133|101545145|FG002|2 Years|Dropped|33|||
33451795|NCT00367133|101545143|FG000|2 Years|Missed visit|4|||
33451796|NCT00367133|101545144|FG001|2 Years|Missed visit|5|||
33451797|NCT00367133|101545145|FG002|2 Years|Missed visit|4|||
33451798|NCT05133180|101545146|FG000|Overall Study|Withdrawal of consent|1|||
33451799|NCT05133180|101545147|FG001|Overall Study|Withdrawal of consent|1|||
33451800|NCT05133180|101545146|FG000|Overall Study|Lost to Follow-up|1|||
33451801|NCT05133180|101545147|FG001|Overall Study|Lost to Follow-up|1|||
33451802|NCT05133180|101545146|FG000|Overall Study|Documented disease progression|0|||
33451803|NCT05133180|101545147|FG001|Overall Study|Documented disease progression|1|||
33451804|NCT01075282|101545148|FG000|Overall Study|Withdrawal by Subject|11|||
33451805|NCT01075282|101545149|FG001|Overall Study|Withdrawal by Subject|7|||
33451806|NCT01075282|101545150|FG002|Overall Study|Withdrawal by Subject|11|||
33451807|NCT01075282|101545148|FG000|Overall Study|Adverse Event|9|||
33451808|NCT01075282|101545149|FG001|Overall Study|Adverse Event|8|||
33451809|NCT01075282|101545150|FG002|Overall Study|Adverse Event|5|||
33451810|NCT01075282|101545148|FG000|Overall Study|Entry Criteria Not Met|3|||
33451811|NCT01075282|101545149|FG001|Overall Study|Entry Criteria Not Met|2|||
33451812|NCT01075282|101545150|FG002|Overall Study|Entry Criteria Not Met|0|||
33451813|NCT01075282|101545148|FG000|Overall Study|Lost to Follow-up|3|||
33451814|NCT01075282|101545149|FG001|Overall Study|Lost to Follow-up|3|||
33451815|NCT01075282|101545150|FG002|Overall Study|Lost to Follow-up|3|||
33451816|NCT01075282|101545148|FG000|Overall Study|Physician Decision|3|||
33451817|NCT01075282|101545149|FG001|Overall Study|Physician Decision|3|||
33451818|NCT01075282|101545150|FG002|Overall Study|Physician Decision|3|||
33451819|NCT01075282|101545148|FG000|Overall Study|Lack of Efficacy|1|||
33451820|NCT01075282|101545149|FG001|Overall Study|Lack of Efficacy|1|||
33451821|NCT01075282|101545150|FG002|Overall Study|Lack of Efficacy|0|||
33451822|NCT01075282|101545148|FG000|Overall Study|Treatment Non-compliance|1|||
33451823|NCT01075282|101545149|FG001|Overall Study|Treatment Non-compliance|2|||
33451824|NCT01075282|101545150|FG002|Overall Study|Treatment Non-compliance|2|||
33451825|NCT01075282|101545148|FG000|Overall Study|Protocol Violation|0|||
33451826|NCT01075282|101545149|FG001|Overall Study|Protocol Violation|2|||
33451827|NCT01075282|101545150|FG002|Overall Study|Protocol Violation|1|||
33451828|NCT01075282|101545148|FG000|Overall Study|Death|0|||
33451829|NCT01075282|101545149|FG001|Overall Study|Death|1|||
33451830|NCT01075282|101545150|FG002|Overall Study|Death|2|||
33451831|NCT03681470|101545152|FG000|Overall Study|Lack of Efficacy|3|||
33451832|NCT03681470|101545152|FG000|Overall Study|Lost to Follow-up|1|||
33451833|NCT03681470|101545152|FG000|Overall Study|Protocol Violation|3|||
33451834|NCT03681470|101545152|FG000|Overall Study|Withdrawal by Subject|1|||
33451835|NCT04466111|101545156|FG000|Prior to Trial Phase|Physician Decision|1|||
33451836|NCT00829309|101545157|FG000|Washout: 7 Days|Protocol Violation|1|||
33451837|NCT00829309|101545158|FG001|Washout: 7 Days|Protocol Violation|0|||
33451838|NCT00918645|101545162|FG000|Overall Study|Withdrawal by Subject|1|||
33451839|NCT02258074|101545163|FG000|Overall Study|Withdrawal by Subject|1|||
33451840|NCT02258074|101545164|FG001|Overall Study|Withdrawal by Subject|0|||
33451841|NCT02258074|101545165|FG002|Overall Study|Withdrawal by Subject|0|||
33451842|NCT02258074|101545166|FG003|Overall Study|Withdrawal by Subject|0|||
33451843|NCT02653664|101545167|FG000|Post-Treatment|Withdrawal by Subject|6|||
33451844|NCT02653664|101545168|FG001|Post-Treatment|Withdrawal by Subject|5|||
33451845|NCT02653664|101545169|FG002|Post-Treatment|Withdrawal by Subject|7|||
33451846|NCT02653664|101545167|FG000|Post-Treatment|Lost to Follow-up|8|||
33451847|NCT02653664|101545168|FG001|Post-Treatment|Lost to Follow-up|1|||
33451848|NCT02653664|101545169|FG002|Post-Treatment|Lost to Follow-up|7|||
33451849|NCT02653664|101545167|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
33451850|NCT02653664|101545168|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
33451851|NCT02653664|101545169|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
33451852|NCT02653664|101545167|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
33171042|NCT02051608|100533240|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
33171043|NCT02051608|100533241|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
33171044|NCT02051608|100533242|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
33171045|NCT02051608|100533239|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
33171046|NCT02051608|100533240|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
33451853|NCT02653664|101545168|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
33451854|NCT02653664|101545169|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
33451855|NCT02653664|101545167|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
33171047|NCT02051608|100533241|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
33171048|NCT02051608|100533242|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
33171049|NCT02051608|100533239|FG000|Part 1: Double Blind Treatment|Other|6|||
33171050|NCT02051608|100533240|FG001|Part 1: Double Blind Treatment|Other|3|||
33171051|NCT02051608|100533241|FG002|Part 1: Double Blind Treatment|Other|0|||
33171052|NCT02051608|100533242|FG003|Part 1: Double Blind Treatment|Other|0|||
33171053|NCT02051608|100533239|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
33171054|NCT02051608|100533240|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
33171055|NCT02051608|100533241|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
33171056|NCT02051608|100533242|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
33171057|NCT02051608|100533239|FG000|Part 2: Open-label Extension|Adverse Event|0|||
33171058|NCT02051608|100533240|FG001|Part 2: Open-label Extension|Adverse Event|0|||
33171059|NCT02051608|100533241|FG002|Part 2: Open-label Extension|Adverse Event|6|||
33451856|NCT02653664|101545168|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
33451857|NCT02653664|101545169|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
33451858|NCT02653664|101545167|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
33451859|NCT02653664|101545168|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
33451860|NCT02653664|101545169|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
33451861|NCT02653664|101545167|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
33451862|NCT02653664|101545168|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
33451863|NCT02653664|101545169|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
33451864|NCT02653664|101545167|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
33451865|NCT02653664|101545168|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
33451866|NCT02653664|101545169|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
33451867|NCT02653664|101545167|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
33451868|NCT02653664|101545168|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
33451869|NCT02653664|101545169|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
33451870|NCT02653664|101545167|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
33451871|NCT02653664|101545168|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
33451872|NCT02653664|101545169|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
33451873|NCT01634139|101545171|FG000|Overall Study|Non compliant with protocol|1|||
33451874|NCT01634139|101545172|FG001|Overall Study|Non compliant with protocol|0|||
33171060|NCT02051608|100533242|FG003|Part 2: Open-label Extension|Adverse Event|8|||
33171061|NCT02051608|100533239|FG000|Part 2: Open-label Extension|Death|0|||
33171062|NCT02051608|100533240|FG001|Part 2: Open-label Extension|Death|0|||
33451875|NCT01634139|101545173|FG002|Overall Study|Non compliant with protocol|0|||
33451876|NCT01634139|101545171|FG000|Overall Study|Consent withdrawn not due to AE|4|||
33451877|NCT01634139|101545172|FG001|Overall Study|Consent withdrawn not due to AE|3|||
33451878|NCT01634139|101545173|FG002|Overall Study|Consent withdrawn not due to AE|2|||
33451879|NCT01634139|101545171|FG000|Overall Study|Other|4|||
33451880|NCT01634139|101545172|FG001|Overall Study|Other|0|||
33451881|NCT01634139|101545173|FG002|Overall Study|Other|3|||
33451882|NCT01634139|101545171|FG000|Overall Study|Lost to Follow-up|0|||
33451883|NCT01634139|101545172|FG001|Overall Study|Lost to Follow-up|2|||
33451884|NCT01634139|101545173|FG002|Overall Study|Lost to Follow-up|0|||
33451885|NCT01634139|101545171|FG000|Overall Study|Not treated|1|||
33451886|NCT01634139|101545172|FG001|Overall Study|Not treated|1|||
33451887|NCT01634139|101545173|FG002|Overall Study|Not treated|0|||
33451888|NCT02535923|101545175|FG000|Overall Study|Lost to Follow-up|5|||
33451889|NCT02535923|101545176|FG001|Overall Study|Lost to Follow-up|5|||
33451890|NCT02535923|101545175|FG000|Overall Study|Withdrawal by Subject|4|||
33451891|NCT02535923|101545176|FG001|Overall Study|Withdrawal by Subject|3|||
33451892|NCT03552484|101545178|FG000|Overall Study|Death|6|||
33451893|NCT03552484|101545179|FG001|Overall Study|Death|4|||
33451894|NCT03552484|101545178|FG000|Overall Study|Lost to Follow-up|0|||
33451895|NCT03552484|101545179|FG001|Overall Study|Lost to Follow-up|16|||
33451896|NCT03123094|101545180|FG000|Overall Study|Withdrawal by Subject|0|||
33451897|NCT03123094|101545181|FG001|Overall Study|Withdrawal by Subject|2|||
33451898|NCT03123094|101545182|FG002|Overall Study|Withdrawal by Subject|1|||
33451899|NCT03123094|101545183|FG003|Overall Study|Withdrawal by Subject|0|||
33451900|NCT03123094|101545184|FG004|Overall Study|Withdrawal by Subject|1|||
33451901|NCT00585286|101545185|FG000|Overall Study|Lost to Follow-up|1|||
33451902|NCT03446768|101545186|FG000|Overall Study|Withdrawal by Subject|0|||
33451903|NCT03446768|101545187|FG001|Overall Study|Withdrawal by Subject|1|||
33451904|NCT04345653|101545193|FG000|Overall Study|Withdrawal by Subject|2|||
33451905|NCT00373256|101545194|FG000|Overall Study|Adverse Event (AE)|1|||
33451906|NCT00373256|101545195|FG001|Overall Study|Adverse Event (AE)|5|||
33451907|NCT00373256|101545194|FG000|Overall Study|Lost to Follow-up|2|||
33451908|NCT00373256|101545195|FG001|Overall Study|Lost to Follow-up|1|||
33451909|NCT00373256|101545194|FG000|Overall Study|Death|9|||
33451910|NCT00373256|101545195|FG001|Overall Study|Death|8|||
33451911|NCT00373256|101545194|FG000|Overall Study|Objective Progression or Relapse|111|||
33451912|NCT00373256|101545195|FG001|Overall Study|Objective Progression or Relapse|104|||
33451913|NCT00373256|101545194|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
33451914|NCT00373256|101545195|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
33451915|NCT00373256|101545194|FG000|Overall Study|Other|73|||
33451916|NCT00373256|101545195|FG001|Overall Study|Other|107|||
33451917|NCT00373256|101545194|FG000|Overall Study|Protocol Violation|0|||
33451918|NCT00373256|101545195|FG001|Overall Study|Protocol Violation|2|||
33451919|NCT00373256|101545194|FG000|Overall Study|Study Terminated by Sponsor|41|||
33451920|NCT00373256|101545195|FG001|Overall Study|Study Terminated by Sponsor|13|||
33451921|NCT00573313|101545199|FG000|Overall Study|Protocol Violation|5|||
33451922|NCT00573313|101545200|FG001|Overall Study|Protocol Violation|0|||
33451923|NCT00573313|101545201|FG002|Overall Study|Protocol Violation|6|||
33451924|NCT00573313|101545202|FG003|Overall Study|Protocol Violation|0|||
33451925|NCT03214588|101545208|FG000|Overall Study|Adverse Event|1|||
33451926|NCT03214588|101545209|FG001|Overall Study|Adverse Event|0|||
33451927|NCT03214588|101545210|FG002|Overall Study|Adverse Event|2|||
33451928|NCT03214588|101545208|FG000|Overall Study|Reason Not Specified|0|||
33451929|NCT03214588|101545209|FG001|Overall Study|Reason Not Specified|1|||
33451930|NCT03214588|101545210|FG002|Overall Study|Reason Not Specified|0|||
33451931|NCT04474405|101545212|FG000|Overall Study|Withdrawal by Subject|0|||
33451932|NCT04474405|101545213|FG001|Overall Study|Withdrawal by Subject|0|||
33451933|NCT04474405|101545214|FG002|Overall Study|Withdrawal by Subject|1|||
33451934|NCT04474405|101545215|FG003|Overall Study|Withdrawal by Subject|0|||
33451935|NCT04474405|101545216|FG004|Overall Study|Withdrawal by Subject|1|||
33451936|NCT04474405|101545217|FG005|Overall Study|Withdrawal by Subject|0|||
33451937|NCT04474405|101545212|FG000|Overall Study|Other|0|||
33451938|NCT04474405|101545213|FG001|Overall Study|Other|0|||
33451939|NCT04474405|101545214|FG002|Overall Study|Other|0|||
33451940|NCT04474405|101545215|FG003|Overall Study|Other|0|||
33451941|NCT04474405|101545216|FG004|Overall Study|Other|3|||
33451942|NCT04474405|101545217|FG005|Overall Study|Other|0|||
33451943|NCT02441686|101545225|FG000|Induction|Adverse Event|4|||
33451944|NCT02441686|101545225|FG000|Induction|Complicating disease|1|||
33451945|NCT02441686|101545225|FG000|Induction|Physician Decision|1|||
33451946|NCT02441686|101545225|FG000|Induction|Withdrawal by Subject|1|||
33451947|NCT02441686|101545225|FG000|Induction|Did not receive treatment|1|||
33451948|NCT02441686|101545225|FG000|Maintenance|Remaining on Treatment|23|||
33451949|NCT02441686|101545225|FG000|Maintenance|Physician Decision|1|||
33451950|NCT02441686|101545225|FG000|Maintenance|Adverse Event|3|||
33451951|NCT02441686|101545225|FG000|Maintenance|Progressive Disease|10|||
33451952|NCT02441686|101545225|FG000|Maintenance|Withdrawal by Subject|1|||
33451953|NCT02450539|101545227|FG000|Overall Study|Withdrawal by Subject|12|||
33451954|NCT02450539|101545228|FG001|Overall Study|Withdrawal by Subject|6|||
33451955|NCT02450539|101545227|FG000|Overall Study|Lost to Follow-up|4|||
33451956|NCT02450539|101545228|FG001|Overall Study|Lost to Follow-up|1|||
33451957|NCT05616728|101545229|FG000|Overall Study|Lost to Follow-up|0|||
33451958|NCT05616728|101545230|FG001|Overall Study|Lost to Follow-up|0|||
33451959|NCT05616728|101545231|FG002|Overall Study|Lost to Follow-up|1|||
33451960|NCT05616728|101545229|FG000|Overall Study|Withdrawal by Subject|1|||
33451961|NCT05616728|101545230|FG001|Overall Study|Withdrawal by Subject|1|||
33451962|NCT05616728|101545231|FG002|Overall Study|Withdrawal by Subject|0|||
33451963|NCT05616728|101545229|FG000|Overall Study|Physician Decision|1|||
33451964|NCT05616728|101545230|FG001|Overall Study|Physician Decision|1|||
33451965|NCT05616728|101545231|FG002|Overall Study|Physician Decision|1|||
33451966|NCT05616728|101545229|FG000|Overall Study|Other|0|||
33451967|NCT05616728|101545230|FG001|Overall Study|Other|2|||
33451968|NCT05616728|101545231|FG002|Overall Study|Other|0|||
33451969|NCT01735994|101545232|FG000|Overall Study|Withdrawal by Subject|6|||
33451970|NCT01735994|101545233|FG001|Overall Study|Withdrawal by Subject|4|||
33451971|NCT01735994|101545232|FG000|Overall Study|Injury|2|||
33451972|NCT01735994|101545233|FG001|Overall Study|Injury|0|||
33451973|NCT01735994|101545232|FG000|Overall Study|Kicked off team|5|||
33451974|NCT01735994|101545233|FG001|Overall Study|Kicked off team|0|||
33171063|NCT02051608|100533241|FG002|Part 2: Open-label Extension|Death|7|||
33171064|NCT02051608|100533242|FG003|Part 2: Open-label Extension|Death|4|||
33451975|NCT01735994|101545232|FG000|Overall Study|Lost to Follow-up|50|||
33451976|NCT01735994|101545233|FG001|Overall Study|Lost to Follow-up|62|||
33451977|NCT05740098|101545234|FG000|Overall Study|Lost to Follow-up|26|||
33451978|NCT05740098|101545235|FG001|Overall Study|Lost to Follow-up|17|||
33451979|NCT05740098|101545236|FG002|Overall Study|Lost to Follow-up|21|||
33451980|NCT03261167|101545239|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
33451981|NCT03261167|101545240|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
33451982|NCT03261167|101545239|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
33451983|NCT03261167|101545240|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
33451984|NCT03261167|101545239|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
33451985|NCT03261167|101545240|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
33451986|NCT03261167|101545239|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
33451987|NCT03261167|101545240|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
33451988|NCT03261167|101545239|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
33451989|NCT03261167|101545240|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
33451990|NCT03419403|101545245|FG000|Overall Study|Withdrawal by Subject|5|||
33451991|NCT03419403|101545246|FG001|Overall Study|Withdrawal by Subject|2|||
33451992|NCT03419403|101545247|FG002|Overall Study|Withdrawal by Subject|5|||
33451993|NCT03419403|101545248|FG003|Overall Study|Withdrawal by Subject|1|||
33451994|NCT03419403|101545245|FG000|Overall Study|Progressive disease (per protocol)|0|||
33451995|NCT03419403|101545246|FG001|Overall Study|Progressive disease (per protocol)|2|||
33451996|NCT03419403|101545247|FG002|Overall Study|Progressive disease (per protocol)|2|||
33451997|NCT03419403|101545248|FG003|Overall Study|Progressive disease (per protocol)|0|||
33451998|NCT03419403|101545245|FG000|Overall Study|Other, not specified|6|||
33451999|NCT03419403|101545246|FG001|Overall Study|Other, not specified|4|||
33452000|NCT03419403|101545247|FG002|Overall Study|Other, not specified|5|||
33452001|NCT03419403|101545248|FG003|Overall Study|Other, not specified|1|||
33452002|NCT03419403|101545245|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
33452003|NCT03419403|101545246|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
33171065|NCT02051608|100533239|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
33171066|NCT02051608|100533240|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
33452004|NCT03419403|101545247|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
33452005|NCT03419403|101545248|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
33452006|NCT00624286|101545252|FG000|Overall Study|Protocol Deviation|7|||
33452007|NCT00624286|101545253|FG001|Overall Study|Protocol Deviation|9|||
33452008|NCT00624286|101545252|FG000|Overall Study|Adverse Event|6|||
33452009|NCT00624286|101545253|FG001|Overall Study|Adverse Event|3|||
33452010|NCT00624286|101545252|FG000|Overall Study|Withdrawal by Subject|5|||
33452011|NCT00624286|101545253|FG001|Overall Study|Withdrawal by Subject|4|||
33452012|NCT00624286|101545252|FG000|Overall Study|Lost to Follow-up|3|||
33452013|NCT00624286|101545253|FG001|Overall Study|Lost to Follow-up|2|||
33452014|NCT00624286|101545252|FG000|Overall Study|Administrative problems|3|||
33452015|NCT00624286|101545253|FG001|Overall Study|Administrative problems|0|||
33452016|NCT00624286|101545252|FG000|Overall Study|Lack of Efficacy|1|||
33452017|NCT00624286|101545253|FG001|Overall Study|Lack of Efficacy|6|||
33452018|NCT00624286|101545252|FG000|Overall Study|Not stated|0|||
33452019|NCT00624286|101545253|FG001|Overall Study|Not stated|1|||
33452020|NCT00624286|101545252|FG000|Overall Study|Abnormal test procedure result(s)|0|||
33452021|NCT00624286|101545253|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33171067|NCT02051608|100533241|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
33452022|NCT00624286|101545252|FG000|Overall Study|Death|0|||
33452023|NCT00624286|101545253|FG001|Overall Study|Death|1|||
33452024|NCT00081653|101545254|FG000|Overall Study|Adverse Event|23|||
33452025|NCT00081653|101545255|FG001|Overall Study|Adverse Event|17|||
33452026|NCT00081653|101545254|FG000|Overall Study|Lost to Follow-up|2|||
33452027|NCT00081653|101545255|FG001|Overall Study|Lost to Follow-up|4|||
33171068|NCT02051608|100533242|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
33171069|NCT02051608|100533239|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
33171070|NCT02051608|100533240|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
33452028|NCT00081653|101545254|FG000|Overall Study|Refused Treatment|18|||
33452029|NCT00081653|101545255|FG001|Overall Study|Refused Treatment|14|||
33452030|NCT00081653|101545254|FG000|Overall Study|Low bone mineral density|1|||
33452031|NCT00081653|101545255|FG001|Overall Study|Low bone mineral density|0|||
33452032|NCT00081653|101545254|FG000|Overall Study|Bone loss|2|||
33452033|NCT00081653|101545255|FG001|Overall Study|Bone loss|0|||
33452034|NCT00081653|101545254|FG000|Overall Study|Participant leaving country|1|||
33452035|NCT00081653|101545255|FG001|Overall Study|Participant leaving country|0|||
33452036|NCT00081653|101545254|FG000|Overall Study|Loss of bone mass|0|||
33452037|NCT00081653|101545255|FG001|Overall Study|Loss of bone mass|2|||
33452038|NCT04994535|101545256|FG000|Overall Study|Lost to Follow-up|7|||
33452039|NCT04994535|101545257|FG001|Overall Study|Lost to Follow-up|7|||
33452040|NCT04994535|101545256|FG000|Overall Study|Withdrawal by Subject|10|||
33452041|NCT04994535|101545257|FG001|Overall Study|Withdrawal by Subject|7|||
33452042|NCT04994535|101545256|FG000|Overall Study|Other|1|||
33452043|NCT04994535|101545257|FG001|Overall Study|Other|1|||
33452044|NCT02336074|101545263|FG000|Overall Study|Adverse Event|0|||
33452045|NCT02336074|101545264|FG001|Overall Study|Adverse Event|2|||
33452046|NCT04577651|101545265|FG000|Overall Study|Screen Failure|7|||
33452047|NCT04577651|101545265|FG000|Overall Study|Adverse Event|1|||
33452048|NCT04577651|101545265|FG000|Overall Study|Death|1|||
33452049|NCT04577651|101545265|FG000|Overall Study|Physician Decision|1|||
33452050|NCT04577651|101545265|FG000|Overall Study|Withdrawal by Subject|3|||
33452051|NCT00101439|101545266|FG000|Period 2|Withdrawal by Subject|0|||
33452052|NCT00101439|101545267|FG001|Period 2|Withdrawal by Subject|2|||
33452053|NCT00594035|101545268|FG000|Overall Study|Lost to Follow-up|1|||
33452054|NCT00594035|101545269|FG001|Overall Study|Lost to Follow-up|1|||
33452055|NCT00594035|101545268|FG000|Overall Study|Withdrawal by Subject|1|||
33452056|NCT00594035|101545269|FG001|Overall Study|Withdrawal by Subject|0|||
33452057|NCT00594035|101545268|FG000|Overall Study|Subject transferred to nursing home|0|||
33452058|NCT00594035|101545269|FG001|Overall Study|Subject transferred to nursing home|1|||
33452059|NCT00594035|101545268|FG000|Overall Study|Subject couldn't return due to job|0|||
33452060|NCT00594035|101545269|FG001|Overall Study|Subject couldn't return due to job|1|||
33452061|NCT01103713|101545270|FG000|Overall Study|Lost to Follow-up|2|||
33171071|NCT02051608|100533241|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
33171072|NCT02051608|100533242|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
33171073|NCT02051608|100533239|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
33171074|NCT02051608|100533240|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
33171075|NCT02051608|100533241|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
33171076|NCT02051608|100533242|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
33171077|NCT02051608|100533239|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
33171078|NCT02051608|100533240|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
33171079|NCT02051608|100533241|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
33452062|NCT01103713|101545270|FG000|Overall Study|Withdrawal by Subject|8|||
33452063|NCT01103713|101545270|FG000|Overall Study|Study terminated by sponsor|2|||
33452064|NCT01103713|101545270|FG000|Overall Study|Other|1|||
33452065|NCT02911025|101545273|FG000|Overall Study|Lost to Follow-up|3|||
33452066|NCT00848536|101545274|FG000|Overall Study|Adverse Event|2|||
33452067|NCT00848536|101545275|FG001|Overall Study|Adverse Event|2|||
33452068|NCT00848536|101545274|FG000|Overall Study|Withdrawal by Subject|0|||
33452069|NCT00848536|101545275|FG001|Overall Study|Withdrawal by Subject|1|||
33452070|NCT00848536|101545274|FG000|Overall Study|Protocol Violation|0|||
33452071|NCT00848536|101545275|FG001|Overall Study|Protocol Violation|1|||
33452072|NCT00848536|101545274|FG000|Overall Study|Noncompliance|1|||
33452073|NCT00848536|101545275|FG001|Overall Study|Noncompliance|0|||
33452074|NCT00848536|101545274|FG000|Overall Study|Inadequate Control of IOP|1|||
33452075|NCT00848536|101545275|FG001|Overall Study|Inadequate Control of IOP|1|||
33452076|NCT00848536|101545274|FG000|Overall Study|Patient Moved|0|||
33452077|NCT00848536|101545275|FG001|Overall Study|Patient Moved|2|||
33452078|NCT00268203|101545276|FG000|Overall Study|Lost to Follow-up|92|||
33452079|NCT00268203|101545276|FG000|Overall Study|Withdrawal by Subject|9|||
33452080|NCT00268203|101545276|FG000|Overall Study|Received Other NHL Therapy|7|||
33452081|NCT00268203|101545276|FG000|Overall Study|Progressive Disease|359|||
33452082|NCT00268203|101545276|FG000|Overall Study|Death|84|||
33452083|NCT00268203|101545276|FG000|Overall Study|Reason Not Specified|34|||
33452084|NCT00268203|101545276|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
33452085|NCT04631562|101545277|FG000|Overall Study|Withdrawal by Subject|0|||
33452086|NCT04631562|101545278|FG001|Overall Study|Withdrawal by Subject|0|||
33452087|NCT04631562|101545279|FG002|Overall Study|Withdrawal by Subject|0|||
33452088|NCT04631562|101545280|FG003|Overall Study|Withdrawal by Subject|0|||
33261256|NCT00879333|100856589|FG001|Overall Study|Death|5|||
33171080|NCT02051608|100533242|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
33171081|NCT02051608|100533239|FG000|Part 2: Open-label Extension|Physician Decision|0|||
33171082|NCT02051608|100533240|FG001|Part 2: Open-label Extension|Physician Decision|0|||
33171083|NCT02051608|100533241|FG002|Part 2: Open-label Extension|Physician Decision|8|||
33171084|NCT02051608|100533242|FG003|Part 2: Open-label Extension|Physician Decision|5|||
33171085|NCT02051608|100533239|FG000|Part 2: Open-label Extension|Other|0|||
33171086|NCT02051608|100533240|FG001|Part 2: Open-label Extension|Other|0|||
33171087|NCT02051608|100533241|FG002|Part 2: Open-label Extension|Other|9|||
33171088|NCT02051608|100533242|FG003|Part 2: Open-label Extension|Other|9|||
33171089|NCT01411774|100533244|FG000|Overall Study|Withdrawal by Subject|0|||
33171090|NCT01411774|100533245|FG001|Overall Study|Withdrawal by Subject|3|||
33171091|NCT01104493|100533246|FG000|Overall Study|Lost to Follow-up|0|||
33171092|NCT01104493|100533247|FG001|Overall Study|Lost to Follow-up|2|||
33171093|NCT02708121|100533253|FG000|Overall Study|Withdrawn by Study Team|1|||
33171094|NCT02708121|100533254|FG001|Overall Study|Withdrawn by Study Team|1|||
33171095|NCT02708121|100533253|FG000|Overall Study|Withdrawal by Subject|0|||
33171096|NCT02708121|100533254|FG001|Overall Study|Withdrawal by Subject|4|||
33171097|NCT02407704|100533256|FG000|Overall Study|Lost to Follow-up|0|||
33171098|NCT02407704|100533257|FG001|Overall Study|Lost to Follow-up|0|||
33171099|NCT02407704|100533258|FG002|Overall Study|Lost to Follow-up|0|||
33171100|NCT02407704|100533259|FG003|Overall Study|Lost to Follow-up|2|||
33171101|NCT02407704|100533256|FG000|Overall Study|Protocol Violation|0|||
33171102|NCT02407704|100533257|FG001|Overall Study|Protocol Violation|0|||
33171103|NCT02407704|100533258|FG002|Overall Study|Protocol Violation|0|||
33171104|NCT02407704|100533259|FG003|Overall Study|Protocol Violation|1|||
33171105|NCT02407704|100533256|FG000|Overall Study|Withdrawal by Subject|0|||
33171106|NCT02407704|100533257|FG001|Overall Study|Withdrawal by Subject|0|||
33171107|NCT02407704|100533258|FG002|Overall Study|Withdrawal by Subject|1|||
33171108|NCT02407704|100533259|FG003|Overall Study|Withdrawal by Subject|0|||
33171109|NCT04868890|100533260|FG000|Overall Study|Death|2|||
33452089|NCT04631562|101545281|FG004|Overall Study|Withdrawal by Subject|0|||
33452090|NCT04631562|101545282|FG005|Overall Study|Withdrawal by Subject|0|||
33452091|NCT04631562|101545283|FG006|Overall Study|Withdrawal by Subject|0|||
33452092|NCT04631562|101545284|FG007|Overall Study|Withdrawal by Subject|1|||
33452093|NCT04631562|101545285|FG008|Overall Study|Withdrawal by Subject|0|||
33452094|NCT04631562|101545277|FG000|Overall Study|Other|0|||
33452095|NCT04631562|101545278|FG001|Overall Study|Other|0|||
33452096|NCT04631562|101545279|FG002|Overall Study|Other|0|||
33171110|NCT04868890|100533261|FG001|Overall Study|Death|1|||
33171111|NCT04868890|100533260|FG000|Overall Study|Withdrawal by Subject|1|||
33171112|NCT04868890|100533261|FG001|Overall Study|Withdrawal by Subject|5|||
33171113|NCT01401283|100533262|FG000|Overall Study|surgery cancelled|5|||
33171114|NCT01401283|100533263|FG001|Overall Study|surgery cancelled|8|||
33171115|NCT01401283|100533262|FG000|Overall Study|preoperative arrhythmia|5|||
33171116|NCT01401283|100533263|FG001|Overall Study|preoperative arrhythmia|0|||
33171117|NCT01401283|100533262|FG000|Overall Study|no central venous access|0|||
33171118|NCT01401283|100533263|FG001|Overall Study|no central venous access|1|||
33171119|NCT01401283|100533262|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
33452097|NCT04631562|101545280|FG003|Overall Study|Other|0|||
33452098|NCT04631562|101545281|FG004|Overall Study|Other|0|||
33452099|NCT04631562|101545282|FG005|Overall Study|Other|0|||
33452100|NCT04631562|101545283|FG006|Overall Study|Other|0|||
33452101|NCT04631562|101545284|FG007|Overall Study|Other|0|||
33452102|NCT04631562|101545285|FG008|Overall Study|Other|1|||
33452103|NCT04631562|101545277|FG000|Overall Study|Lost to Follow-up|0|||
33452104|NCT04631562|101545278|FG001|Overall Study|Lost to Follow-up|0|||
33452105|NCT04631562|101545279|FG002|Overall Study|Lost to Follow-up|0|||
33452106|NCT04631562|101545280|FG003|Overall Study|Lost to Follow-up|1|||
33452107|NCT04631562|101545281|FG004|Overall Study|Lost to Follow-up|0|||
33452108|NCT04631562|101545282|FG005|Overall Study|Lost to Follow-up|0|||
33452109|NCT04631562|101545283|FG006|Overall Study|Lost to Follow-up|0|||
33171120|NCT01401283|100533263|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
33171121|NCT01599234|100533264|FG000|Overall Study|Adverse Event|9|||
33171122|NCT01599234|100533265|FG001|Overall Study|Adverse Event|5|||
33171123|NCT01599234|100533264|FG000|Overall Study|Withdrawal by Subject|2|||
33171124|NCT01599234|100533265|FG001|Overall Study|Withdrawal by Subject|1|||
33171125|NCT01599234|100533264|FG000|Overall Study|Lost to Follow-up|1|||
33171126|NCT01599234|100533265|FG001|Overall Study|Lost to Follow-up|2|||
33171127|NCT01599234|100533264|FG000|Overall Study|Lack of Efficacy|2|||
33171128|NCT01599234|100533265|FG001|Overall Study|Lack of Efficacy|4|||
33171129|NCT01599234|100533264|FG000|Overall Study|Unable to operate spray|1|||
33171130|NCT01599234|100533265|FG001|Overall Study|Unable to operate spray|0|||
33452110|NCT04631562|101545284|FG007|Overall Study|Lost to Follow-up|0|||
33452111|NCT04631562|101545285|FG008|Overall Study|Lost to Follow-up|0|||
33452112|NCT04631562|101545277|FG000|Overall Study|Adverse Event|0|||
33452113|NCT04631562|101545278|FG001|Overall Study|Adverse Event|0|||
33452114|NCT04631562|101545279|FG002|Overall Study|Adverse Event|0|||
33452115|NCT04631562|101545280|FG003|Overall Study|Adverse Event|0|||
33452116|NCT04631562|101545281|FG004|Overall Study|Adverse Event|0|||
33452117|NCT04631562|101545282|FG005|Overall Study|Adverse Event|0|||
33452118|NCT04631562|101545283|FG006|Overall Study|Adverse Event|1|||
33452119|NCT04631562|101545284|FG007|Overall Study|Adverse Event|0|||
33452120|NCT04631562|101545285|FG008|Overall Study|Adverse Event|0|||
33452121|NCT00725322|101545286|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
33452122|NCT00725322|101545287|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
33452123|NCT00725322|101545286|FG000|Washout (28 Days)|Protocol Violation|0|||
33452124|NCT00725322|101545287|FG001|Washout (28 Days)|Protocol Violation|1|||
33452125|NCT03218787|101545292|FG000|Overall Study|Lost to Follow-up|12|||
33452126|NCT03218787|101545292|FG000|Overall Study|Withdrawal by Subject|72|||
33452127|NCT03218787|101545292|FG000|Overall Study|Physician Decision|11|||
33452128|NCT03218787|101545292|FG000|Overall Study|Death|111|||
33171131|NCT01599234|100533264|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
33171132|NCT01599234|100533265|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
33261257|NCT00879333|100856588|FG000|Overall Study|Disease Progression|292|||
33452129|NCT00730691|101545296|FG000|Overall Study|Adverse Event|4|||
33452130|NCT00730691|101545297|FG001|Overall Study|Adverse Event|8|||
33452131|NCT00730691|101545298|FG002|Overall Study|Adverse Event|11|||
33452132|NCT00730691|101545299|FG003|Overall Study|Adverse Event|11|||
33452133|NCT00730691|101545300|FG004|Overall Study|Adverse Event|23|||
33452134|NCT00730691|101545296|FG000|Overall Study|Lack of Efficacy|4|||
33452135|NCT00730691|101545297|FG001|Overall Study|Lack of Efficacy|4|||
33452136|NCT00730691|101545298|FG002|Overall Study|Lack of Efficacy|2|||
33452137|NCT00730691|101545299|FG003|Overall Study|Lack of Efficacy|1|||
33171133|NCT01599234|100533264|FG000|Overall Study|Death|1|||
33452138|NCT00730691|101545300|FG004|Overall Study|Lack of Efficacy|1|||
33452139|NCT00730691|101545296|FG000|Overall Study|Non-compliance with Study Drug|6|||
33452140|NCT00730691|101545297|FG001|Overall Study|Non-compliance with Study Drug|1|||
33452141|NCT00730691|101545298|FG002|Overall Study|Non-compliance with Study Drug|6|||
33452142|NCT00730691|101545299|FG003|Overall Study|Non-compliance with Study Drug|3|||
33452143|NCT00730691|101545300|FG004|Overall Study|Non-compliance with Study Drug|3|||
33452144|NCT00730691|101545296|FG000|Overall Study|Protocol Deviations|3|||
33452145|NCT00730691|101545297|FG001|Overall Study|Protocol Deviations|5|||
33452146|NCT00730691|101545298|FG002|Overall Study|Protocol Deviations|3|||
33452147|NCT00730691|101545299|FG003|Overall Study|Protocol Deviations|7|||
33452148|NCT00730691|101545300|FG004|Overall Study|Protocol Deviations|5|||
33171134|NCT01599234|100533265|FG001|Overall Study|Death|0|||
33171135|NCT01599234|100533264|FG000|Overall Study|Patient would not stop driving|1|||
33261258|NCT00879333|100856589|FG001|Overall Study|Disease Progression|169|||
33261259|NCT00879333|100856588|FG000|Overall Study|Protocol Violation|1|||
33261260|NCT00879333|100856589|FG001|Overall Study|Protocol Violation|1|||
33452149|NCT00730691|101545296|FG000|Overall Study|Withdrawal of Consent|7|||
33452150|NCT00730691|101545297|FG001|Overall Study|Withdrawal of Consent|9|||
33171136|NCT01599234|100533265|FG001|Overall Study|Patient would not stop driving|0|||
33171137|NCT01599234|100533264|FG000|Overall Study|Contra-indication discovered|0|||
33171138|NCT01599234|100533265|FG001|Overall Study|Contra-indication discovered|1|||
33171139|NCT01599234|100533264|FG000|Overall Study|Pregnancy|0|||
33171140|NCT01599234|100533265|FG001|Overall Study|Pregnancy|1|||
33171141|NCT02663674|100533266|FG000|Overall Study|Lost to Follow-up|5|||
33171142|NCT02663674|100533267|FG001|Overall Study|Lost to Follow-up|4|||
33171143|NCT02663674|100533266|FG000|Overall Study|Withdrawal by Subject|1|||
33171144|NCT02663674|100533267|FG001|Overall Study|Withdrawal by Subject|4|||
33171145|NCT02663674|100533266|FG000|Overall Study|Physician Decision|1|||
33171146|NCT02663674|100533267|FG001|Overall Study|Physician Decision|1|||
33171147|NCT02663674|100533266|FG000|Overall Study|Other Event (Health Related)|0|||
33171148|NCT02663674|100533267|FG001|Overall Study|Other Event (Health Related)|1|||
33171149|NCT00580606|100533270|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
33171150|NCT00580606|100533271|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
33171151|NCT00580606|100533270|FG000|Open Label (OL)|Withdrawal by Subject|4|||
33171152|NCT00580606|100533271|FG001|Open Label (OL)|Withdrawal by Subject|6|||
33171153|NCT00580606|100533270|FG000|Open Label (OL)|Dosing Symptoms|0|||
33171154|NCT00580606|100533271|FG001|Open Label (OL)|Dosing Symptoms|1|||
33171155|NCT00580606|100533270|FG000|Open Label (OL)|Lost to Follow-up|0|||
33171156|NCT00580606|100533271|FG001|Open Label (OL)|Lost to Follow-up|1|||
33171157|NCT00580606|100533270|FG000|Open Label (OL)|Pregnancy|0|||
33171158|NCT00580606|100533271|FG001|Open Label (OL)|Pregnancy|1|||
33171159|NCT00580606|100533270|FG000|Open Label (OL)|Non-compliance|2|||
33171160|NCT00580606|100533271|FG001|Open Label (OL)|Non-compliance|0|||
33171161|NCT00580606|100533270|FG000|Open Label (OL)|Physician Decision|1|||
33171162|NCT00580606|100533271|FG001|Open Label (OL)|Physician Decision|1|||
33171163|NCT00580606|100533270|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
33171164|NCT00580606|100533271|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
33171165|NCT02585960|100533272|FG000|PK/Safety Assessment Period|Physician Decision|0|||
33171166|NCT02585960|100533273|FG001|PK/Safety Assessment Period|Physician Decision|1|||
33171167|NCT02585960|100533274|FG002|PK/Safety Assessment Period|Physician Decision|0|||
33171168|NCT02585960|100533272|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
33171169|NCT02585960|100533273|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
33171170|NCT02585960|100533274|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
33171171|NCT02585960|100533272|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
33171172|NCT02585960|100533273|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
33171173|NCT02585960|100533274|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
33171174|NCT02585960|100533272|FG000|PK/Safety Assessment Period|Other|4|||
33171175|NCT02585960|100533273|FG001|PK/Safety Assessment Period|Other|4|||
33171176|NCT02585960|100533274|FG002|PK/Safety Assessment Period|Other|0|||
33452151|NCT00730691|101545298|FG002|Overall Study|Withdrawal of Consent|3|||
33452152|NCT00730691|101545299|FG003|Overall Study|Withdrawal of Consent|6|||
33452153|NCT00730691|101545300|FG004|Overall Study|Withdrawal of Consent|3|||
33452154|NCT00730691|101545296|FG000|Overall Study|Lost to Follow-up|11|||
33452155|NCT00730691|101545297|FG001|Overall Study|Lost to Follow-up|8|||
33452156|NCT00730691|101545298|FG002|Overall Study|Lost to Follow-up|13|||
33452157|NCT00730691|101545299|FG003|Overall Study|Lost to Follow-up|15|||
33452158|NCT00730691|101545300|FG004|Overall Study|Lost to Follow-up|13|||
33452159|NCT00730691|101545296|FG000|Overall Study|Other|1|||
33452160|NCT00730691|101545297|FG001|Overall Study|Other|1|||
33452161|NCT00730691|101545298|FG002|Overall Study|Other|1|||
33452162|NCT00730691|101545299|FG003|Overall Study|Other|2|||
33452163|NCT00730691|101545300|FG004|Overall Study|Other|2|||
33452164|NCT00540423|101545301|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33452165|NCT00540423|101545302|FG001|Double-Blind Treatment Period|Adverse Event|1|||
33452166|NCT00540423|101545303|FG002|Double-Blind Treatment Period|Adverse Event|0|||
33452167|NCT00540423|101545301|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
33452168|NCT00540423|101545302|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
33452169|NCT00540423|101545303|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
33452170|NCT03961204|101545306|FG000|Overall Study|Withdrawal by Subject|2|||
33452171|NCT03961204|101545306|FG000|Overall Study|Lost to Follow-up|3|||
33452172|NCT03961204|101545306|FG000|Overall Study|Other|1|||
33452173|NCT03961204|101545306|FG000|Overall Study|Missing|1|||
33171177|NCT02585960|100533272|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
33171178|NCT02585960|100533273|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
33171179|NCT02585960|100533274|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
33171180|NCT02585960|100533272|FG000|PK/Safety Assessment Period|Screen Failure|0|||
33171181|NCT02585960|100533273|FG001|PK/Safety Assessment Period|Screen Failure|0|||
33171182|NCT02585960|100533274|FG002|PK/Safety Assessment Period|Screen Failure|1|||
33171183|NCT02585960|100533272|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
33171184|NCT02585960|100533273|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
33171185|NCT02585960|100533274|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
33261261|NCT02275611|100860031|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
33171186|NCT02585960|100533272|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
33171187|NCT02585960|100533273|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
33171188|NCT02585960|100533274|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
33171189|NCT01315678|100533276|FG000|Overall Study|Withdrawal by Subject|7|||
33171190|NCT01315678|100533277|FG001|Overall Study|Withdrawal by Subject|3|||
33171191|NCT01315678|100533276|FG000|Overall Study|Adverse Event|3|||
33171192|NCT01315678|100533277|FG001|Overall Study|Adverse Event|1|||
33171193|NCT01315678|100533276|FG000|Overall Study|Lost to Follow-up|1|||
33171194|NCT01315678|100533277|FG001|Overall Study|Lost to Follow-up|0|||
33171195|NCT01315678|100533276|FG000|Overall Study|similar reason to those listed above|3|||
33171196|NCT01315678|100533277|FG001|Overall Study|similar reason to those listed above|2|||
33171197|NCT00546637|100533278|FG000|Overall Study|Adverse Event|46|||
33171198|NCT00546637|100533279|FG001|Overall Study|Adverse Event|20|||
33171199|NCT00546637|100533278|FG000|Overall Study|Lack of Efficacy|5|||
33171200|NCT00546637|100533279|FG001|Overall Study|Lack of Efficacy|5|||
33171201|NCT00546637|100533278|FG000|Overall Study|Lost to Follow-up|2|||
33171202|NCT00546637|100533279|FG001|Overall Study|Lost to Follow-up|2|||
33171203|NCT00546637|100533278|FG000|Overall Study|Other|10|||
33171204|NCT00546637|100533279|FG001|Overall Study|Other|12|||
33171205|NCT00546637|100533278|FG000|Overall Study|Withdrawal by Subject|7|||
33171206|NCT00546637|100533279|FG001|Overall Study|Withdrawal by Subject|9|||
33171207|NCT00546637|100533278|FG000|Overall Study|Randomized, but not treated|3|||
33171208|NCT00546637|100533279|FG001|Overall Study|Randomized, but not treated|1|||
33171209|NCT03187197|100533286|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
33171210|NCT03187197|100533287|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
33171211|NCT03187197|100533288|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
33171212|NCT03187197|100533286|FG000|Overall Study|Withdrawal by Subject|8|||
33171213|NCT03187197|100533287|FG001|Overall Study|Withdrawal by Subject|63|||
33171214|NCT03187197|100533288|FG002|Overall Study|Withdrawal by Subject|4|||
33171215|NCT03187197|100533286|FG000|Overall Study|Lost to Follow-up|1|||
33171216|NCT03187197|100533287|FG001|Overall Study|Lost to Follow-up|60|||
33171217|NCT03187197|100533288|FG002|Overall Study|Lost to Follow-up|7|||
33171218|NCT03187197|100533286|FG000|Overall Study|Adverse Event|6|||
33171219|NCT03187197|100533287|FG001|Overall Study|Adverse Event|29|||
33171220|NCT03187197|100533288|FG002|Overall Study|Adverse Event|0|||
33171221|NCT03187197|100533286|FG000|Overall Study|Death|0|||
33171222|NCT03187197|100533287|FG001|Overall Study|Death|11|||
33171223|NCT03187197|100533288|FG002|Overall Study|Death|0|||
33171224|NCT03187197|100533286|FG000|Overall Study|Administrative problem|1|||
33171225|NCT03187197|100533287|FG001|Overall Study|Administrative problem|1|||
33171226|NCT03187197|100533288|FG002|Overall Study|Administrative problem|0|||
33171227|NCT03187197|100533286|FG000|Overall Study|Reason not listed|2|||
33171228|NCT03187197|100533287|FG001|Overall Study|Reason not listed|54|||
33171229|NCT03187197|100533288|FG002|Overall Study|Reason not listed|1|||
33171230|NCT03187197|100533286|FG000|Overall Study|Missing|1|||
33171231|NCT03187197|100533287|FG001|Overall Study|Missing|32|||
33171232|NCT03187197|100533288|FG002|Overall Study|Missing|3|||
33171233|NCT03187197|100533286|FG000|Overall Study|Status missing|2|||
33171234|NCT03187197|100533287|FG001|Overall Study|Status missing|33|||
33171235|NCT03187197|100533288|FG002|Overall Study|Status missing|3|||
33171236|NCT03187197|100533286|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
33171237|NCT03187197|100533287|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
33171238|NCT03187197|100533288|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
33171239|NCT03291808|100533289|FG000|Overall Study|Lost to Follow-up|6|||
33171240|NCT03291808|100533289|FG000|Overall Study|Research burden|4|||
33171241|NCT02239978|100533290|FG000|Overall Study|Withdrawal by Subject|2|||
33171242|NCT02239978|100533291|FG001|Overall Study|Withdrawal by Subject|0|||
33171243|NCT00667368|100533292|FG000|Overall Study|Lost to Follow-up|176|||
33171244|NCT00667368|100533293|FG001|Overall Study|Lost to Follow-up|155|||
33171245|NCT00667368|100533292|FG000|Overall Study|Discontinued early|24|||
33171246|NCT00667368|100533293|FG001|Overall Study|Discontinued early|17|||
33171247|NCT00003479|100533294|FG000|Overall Study|Not evaluable|3|||
33452174|NCT03480763|101545307|FG000|Overall Study|Withdrawal by Subject|18|||
33452175|NCT03480763|101545308|FG001|Overall Study|Withdrawal by Subject|10|||
33452176|NCT03480763|101545307|FG000|Overall Study|Lost to Follow-up|4|||
33452177|NCT03480763|101545308|FG001|Overall Study|Lost to Follow-up|7|||
33452178|NCT03480763|101545307|FG000|Overall Study|non-study pneumococcal vaccine|1|||
33452179|NCT03480763|101545308|FG001|Overall Study|non-study pneumococcal vaccine|0|||
33452180|NCT03480763|101545307|FG000|Overall Study|oncological treatment|0|||
33452181|NCT03480763|101545308|FG001|Overall Study|oncological treatment|2|||
33452182|NCT03480763|101545307|FG000|Overall Study|pain with vaccination|1|||
33452183|NCT03480763|101545308|FG001|Overall Study|pain with vaccination|0|||
33452184|NCT03406156|101545311|FG000|Overall Study|Death|9|||
33452185|NCT03406156|101545312|FG001|Overall Study|Death|3|||
33452186|NCT03406156|101545311|FG000|Overall Study|Withdrawal by Subject|1|||
33452187|NCT03406156|101545312|FG001|Overall Study|Withdrawal by Subject|2|||
33452188|NCT03406156|101545311|FG000|Overall Study|COVID-19 infection|1|||
33452189|NCT03406156|101545312|FG001|Overall Study|COVID-19 infection|0|||
33452190|NCT03406156|101545311|FG000|Overall Study|Non-compliance with study procedures|1|||
33452191|NCT03406156|101545312|FG001|Overall Study|Non-compliance with study procedures|1|||
33452192|NCT03406156|101545311|FG000|Overall Study|Lost to Follow-up|0|||
33452193|NCT03406156|101545312|FG001|Overall Study|Lost to Follow-up|2|||
33452194|NCT03406156|101545311|FG000|Overall Study|Other, not specified|72|||
33452195|NCT03406156|101545312|FG001|Overall Study|Other, not specified|28|||
33452196|NCT02061280|101545313|FG000|Overall Study|Protocol Violation|12|||
33452197|NCT02061280|101545314|FG001|Overall Study|Protocol Violation|8|||
33452198|NCT02061280|101545313|FG000|Overall Study|moved out of state|0|||
33452199|NCT02061280|101545314|FG001|Overall Study|moved out of state|1|||
33452200|NCT02061280|101545313|FG000|Overall Study|Withdrawal by Subject|1|||
33452201|NCT02061280|101545314|FG001|Overall Study|Withdrawal by Subject|2|||
33452202|NCT02061280|101545313|FG000|Overall Study|Lost to Follow-up|5|||
33452203|NCT02061280|101545314|FG001|Overall Study|Lost to Follow-up|1|||
33452204|NCT00633022|101547819|FG000|Overall Study|Adverse Event|1|||
33452205|NCT00633022|101547820|FG001|Overall Study|Adverse Event|0|||
33452206|NCT00633022|101547821|FG002|Overall Study|Adverse Event|5|||
33452207|NCT00633022|101547819|FG000|Overall Study|Physician Decision|0|||
33452208|NCT00633022|101547820|FG001|Overall Study|Physician Decision|1|||
33452209|NCT00633022|101547821|FG002|Overall Study|Physician Decision|0|||
33261262|NCT02275611|100860032|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
33452210|NCT00521586|101547822|FG000|Initial Vaccination (Year 0)|Subject request|8|||
33452211|NCT00521586|101547823|FG001|Initial Vaccination (Year 0)|Subject request|11|||
33452212|NCT00521586|101547822|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
33452213|NCT00521586|101547823|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
33452214|NCT00521586|101547822|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
33452215|NCT00521586|101547823|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
33452216|NCT00521586|101547822|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
33452217|NCT00521586|101547823|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
33452218|NCT00521586|101547822|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
33452219|NCT00521586|101547823|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
33452220|NCT00521586|101547822|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
33452221|NCT00521586|101547823|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
33452222|NCT00521586|101547822|FG000|Initial Vaccination (Year 0)|Death|1|||
33452223|NCT00521586|101547823|FG001|Initial Vaccination (Year 0)|Death|0|||
33452224|NCT00521586|101547822|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
33452225|NCT00521586|101547823|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
33452226|NCT00521586|101547822|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
33452227|NCT00521586|101547823|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
33452228|NCT00521586|101547822|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
33452229|NCT00521586|101547823|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
33452230|NCT00521586|101547822|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
33452231|NCT00521586|101547823|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
33452232|NCT00521586|101547822|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
33452233|NCT00521586|101547823|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
33452234|NCT00521586|101547822|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
33452235|NCT00521586|101547823|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
33452236|NCT00521586|101547822|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
33452237|NCT00521586|101547823|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
33452238|NCT00521586|101547822|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
33452239|NCT00521586|101547823|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
33452240|NCT00521586|101547822|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
33452241|NCT00521586|101547823|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
33452242|NCT00521586|101547822|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
33171248|NCT02709785|100533298|FG000|Overall Study|Withdrawal by Subject|1|||
33171249|NCT02709785|100533299|FG001|Overall Study|Withdrawal by Subject|2|||
33452243|NCT00521586|101547823|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
33452244|NCT00521586|101547822|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
33452245|NCT00521586|101547823|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
33452246|NCT00521586|101547822|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
33452247|NCT00521586|101547823|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
33452248|NCT00606281|101547826|FG000|Overall Study|Adverse Event|11|||
33171250|NCT02709785|100533300|FG002|Overall Study|Withdrawal by Subject|1|||
33171251|NCT01214629|100533301|FG000|Overall Study|Progressive Disease|1|||
33171252|NCT01214629|100533302|FG001|Overall Study|Progressive Disease|1|||
33171253|NCT01214629|100533303|FG002|Overall Study|Progressive Disease|0|||
33171254|NCT01214629|100533304|FG003|Overall Study|Progressive Disease|1|||
33171255|NCT01214629|100533305|FG004|Overall Study|Progressive Disease|2|||
33171256|NCT01214629|100533306|FG005|Overall Study|Progressive Disease|3|||
33171257|NCT01214629|100533307|FG006|Overall Study|Progressive Disease|1|||
33171258|NCT01214629|100533308|FG007|Overall Study|Progressive Disease|1|||
33171259|NCT01214629|100533309|FG008|Overall Study|Progressive Disease|1|||
33171260|NCT01214629|100533310|FG009|Overall Study|Progressive Disease|5|||
33171261|NCT01214629|100533311|FG010|Overall Study|Progressive Disease|1|||
33171262|NCT01214629|100533301|FG000|Overall Study|Adverse Event|0|||
33171263|NCT01214629|100533302|FG001|Overall Study|Adverse Event|0|||
33171264|NCT01214629|100533303|FG002|Overall Study|Adverse Event|0|||
33171265|NCT01214629|100533304|FG003|Overall Study|Adverse Event|1|||
33171266|NCT01214629|100533305|FG004|Overall Study|Adverse Event|0|||
33171267|NCT01214629|100533306|FG005|Overall Study|Adverse Event|1|||
33171268|NCT01214629|100533307|FG006|Overall Study|Adverse Event|0|||
33171269|NCT01214629|100533308|FG007|Overall Study|Adverse Event|0|||
33171270|NCT01214629|100533309|FG008|Overall Study|Adverse Event|0|||
33452249|NCT00606281|101547827|FG001|Overall Study|Adverse Event|12|||
33171271|NCT01214629|100533310|FG009|Overall Study|Adverse Event|1|||
33171272|NCT01214629|100533311|FG010|Overall Study|Adverse Event|0|||
33171273|NCT01214629|100533301|FG000|Overall Study|Physician Decision|0|||
33171274|NCT01214629|100533302|FG001|Overall Study|Physician Decision|0|||
33171275|NCT01214629|100533303|FG002|Overall Study|Physician Decision|0|||
33171276|NCT01214629|100533304|FG003|Overall Study|Physician Decision|0|||
33171277|NCT01214629|100533305|FG004|Overall Study|Physician Decision|0|||
33171278|NCT01214629|100533306|FG005|Overall Study|Physician Decision|0|||
33171279|NCT01214629|100533307|FG006|Overall Study|Physician Decision|0|||
33171280|NCT01214629|100533308|FG007|Overall Study|Physician Decision|0|||
33171281|NCT01214629|100533309|FG008|Overall Study|Physician Decision|0|||
33171282|NCT01214629|100533310|FG009|Overall Study|Physician Decision|0|||
33171283|NCT01214629|100533311|FG010|Overall Study|Physician Decision|1|||
33171284|NCT01214629|100533301|FG000|Overall Study|Withdrawal by Subject|0|||
33171285|NCT01214629|100533302|FG001|Overall Study|Withdrawal by Subject|0|||
33171286|NCT01214629|100533303|FG002|Overall Study|Withdrawal by Subject|0|||
33171287|NCT01214629|100533304|FG003|Overall Study|Withdrawal by Subject|0|||
33171288|NCT01214629|100533305|FG004|Overall Study|Withdrawal by Subject|0|||
33171289|NCT01214629|100533306|FG005|Overall Study|Withdrawal by Subject|0|||
33171290|NCT01214629|100533307|FG006|Overall Study|Withdrawal by Subject|0|||
33171291|NCT01214629|100533308|FG007|Overall Study|Withdrawal by Subject|0|||
33171292|NCT01214629|100533309|FG008|Overall Study|Withdrawal by Subject|0|||
33171293|NCT01214629|100533310|FG009|Overall Study|Withdrawal by Subject|1|||
33171294|NCT01214629|100533311|FG010|Overall Study|Withdrawal by Subject|0|||
33171295|NCT01987505|100533312|FG000|Overall Study|Other|9|||
33171296|NCT01987505|100533312|FG000|Overall Study|Withdrawal by Subject|2|||
33171297|NCT01987505|100533312|FG000|Overall Study|Other Reason|2|||
33171298|NCT01987505|100533312|FG000|Overall Study|Lost to Follow-up|15|||
33171299|NCT01987505|100533312|FG000|Overall Study|Investigator Decision|2|||
33171300|NCT01987505|100533312|FG000|Overall Study|Death|4|||
33171301|NCT02674529|100533313|FG000|Overall Study|Lost to Follow-up|1|||
33171302|NCT02674529|100533314|FG001|Overall Study|Lost to Follow-up|2|||
33171303|NCT02674529|100533313|FG000|Overall Study|Withdrawal by Subject|2|||
33171304|NCT02674529|100533314|FG001|Overall Study|Withdrawal by Subject|1|||
33171305|NCT02674529|100533313|FG000|Overall Study|Physician Decision|0|||
33171306|NCT02674529|100533314|FG001|Overall Study|Physician Decision|1|||
33171307|NCT02674529|100533313|FG000|Overall Study|Protocol Violation|0|||
33171308|NCT02674529|100533314|FG001|Overall Study|Protocol Violation|1|||
33171309|NCT02728076|100533317|FG000|Overall Study|Physician Decision|4|||
33171310|NCT00543140|100533318|FG000|Overall Study|Lost to Follow-up|33|||
33171311|NCT00543140|100533318|FG000|Overall Study|Withdrawal by Subject|13|||
33171312|NCT00543140|100533318|FG000|Overall Study|Protocol Violation|10|||
33171313|NCT00543140|100533318|FG000|Overall Study|Insufficient weight loss|10|||
33171314|NCT00543140|100533318|FG000|Overall Study|SAE leading to explant of SAGB|3|||
33171315|NCT00543140|100533318|FG000|Overall Study|Death|1|||
33452250|NCT00606281|101547826|FG000|Overall Study|Death|1|||
33171316|NCT00543140|100533318|FG000|Overall Study|Subject moved|1|||
33171317|NCT00543140|100533318|FG000|Overall Study|Conversion to different procedure|1|||
33452251|NCT00606281|101547827|FG001|Overall Study|Death|0|||
33452252|NCT00606281|101547826|FG000|Overall Study|Lack of Efficacy|28|||
33452253|NCT00606281|101547827|FG001|Overall Study|Lack of Efficacy|35|||
33452254|NCT00606281|101547826|FG000|Overall Study|Physician Decision|0|||
33452255|NCT00606281|101547827|FG001|Overall Study|Physician Decision|1|||
33452256|NCT00606281|101547826|FG000|Overall Study|Protocol Violation|3|||
33452257|NCT00606281|101547827|FG001|Overall Study|Protocol Violation|3|||
33452258|NCT00606281|101547826|FG000|Overall Study|Withdrawal by Subject|11|||
33452259|NCT00606281|101547827|FG001|Overall Study|Withdrawal by Subject|13|||
33452260|NCT00606281|101547826|FG000|Overall Study|Progression to depressive phase|1|||
33452261|NCT00606281|101547827|FG001|Overall Study|Progression to depressive phase|1|||
33452262|NCT00606281|101547826|FG000|Overall Study|Change of residence or other commitments|1|||
33452263|NCT00606281|101547827|FG001|Overall Study|Change of residence or other commitments|1|||
33452264|NCT03499353|101547828|FG000|Treatment|Adverse Event|3|||
33452265|NCT03499353|101547828|FG000|Treatment|Progressive Disease|10|||
33452266|NCT03499353|101547828|FG000|Treatment|Other|1|||
33452267|NCT03499353|101547828|FG000|Treatment|Withdrawal by Subject|2|||
33452268|NCT03499353|101547828|FG000|Long-Term Follow-up|Death|2|||
33452269|NCT03499353|101547828|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
33452270|NCT03499353|101547828|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
33452271|NCT04583423|101547829|FG000|Overall Study|Lost to Follow-up|0|||
33452272|NCT04583423|101547830|FG001|Overall Study|Lost to Follow-up|1|||
33452273|NCT04583423|101547831|FG002|Overall Study|Lost to Follow-up|0|||
33452274|NCT04583423|101547832|FG003|Overall Study|Lost to Follow-up|2|||
33452275|NCT04583423|101547829|FG000|Overall Study|Study Terminated by Sponsor|32|||
33452276|NCT04583423|101547830|FG001|Overall Study|Study Terminated by Sponsor|35|||
33452277|NCT04583423|101547831|FG002|Overall Study|Study Terminated by Sponsor|36|||
33452278|NCT04583423|101547832|FG003|Overall Study|Study Terminated by Sponsor|33|||
33452279|NCT04583423|101547829|FG000|Overall Study|Withdrawal by Subject|3|||
33452280|NCT04583423|101547830|FG001|Overall Study|Withdrawal by Subject|1|||
33171318|NCT04952402|100533319|FG000|Overall Study|Lost to Follow-up|1|||
33171319|NCT04952402|100533320|FG001|Overall Study|Lost to Follow-up|3|||
33171320|NCT04952402|100533319|FG000|Overall Study|Lack Of Venous Access|0|||
33171321|NCT04952402|100533320|FG001|Overall Study|Lack Of Venous Access|1|||
33171322|NCT01907815|100533321|FG000|Overall Study|Withdrawal by Subject|1|||
33452281|NCT04583423|101547831|FG002|Overall Study|Withdrawal by Subject|2|||
33171323|NCT01907815|100533322|FG001|Overall Study|Withdrawal by Subject|0|||
33171324|NCT05035550|100533324|FG000|Overall Study|Withdrawal by Subject|3|||
33452282|NCT04583423|101547832|FG003|Overall Study|Withdrawal by Subject|1|||
33452283|NCT03808376|101547833|FG000|Overall Study|Withdrawal by Subject|10|||
33171325|NCT05035550|100533325|FG001|Overall Study|Withdrawal by Subject|0|||
33171326|NCT03266094|100533328|FG000|Overall Study|Lost to Follow-up|1|||
33171327|NCT03266094|100533328|FG000|Overall Study|Withdrawal by Subject|1|||
33171328|NCT02788357|100533333|FG000|Overall Study|Lost to Follow-up|3|||
33171329|NCT02788357|100533334|FG001|Overall Study|Lost to Follow-up|0|||
33171330|NCT00573469|100533335|FG000|Overall Study|Adverse Event|1|||
33171331|NCT00573469|100533336|FG001|Overall Study|Adverse Event|1|||
33171332|NCT00573469|100533337|FG002|Overall Study|Adverse Event|1|||
33171333|NCT00573469|100533335|FG000|Overall Study|Withdrawal by Subject|0|||
33171334|NCT00573469|100533336|FG001|Overall Study|Withdrawal by Subject|2|||
33171335|NCT00573469|100533337|FG002|Overall Study|Withdrawal by Subject|0|||
33171336|NCT00573469|100533335|FG000|Overall Study|Other|5|||
33171337|NCT00573469|100533336|FG001|Overall Study|Other|1|||
33171338|NCT00573469|100533337|FG002|Overall Study|Other|3|||
33171339|NCT03274440|100533338|FG000|Overall Study|Time commitment too great|1|||
33171340|NCT03274440|100533339|FG001|Overall Study|Time commitment too great|0|||
33171341|NCT03274440|100533340|FG002|Overall Study|Time commitment too great|0|||
33171342|NCT03274440|100533341|FG003|Overall Study|Time commitment too great|1|||
33171343|NCT03274440|100533342|FG004|Overall Study|Time commitment too great|0|||
33261263|NCT02275611|100860033|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
33261264|NCT02275611|100860034|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
33261265|NCT01574716|100860042|FG000|Part 1|Death|3|||
33171344|NCT03274440|100533343|FG005|Overall Study|Time commitment too great|0|||
33261266|NCT01574716|100860043|FG001|Part 1|Death|1|||
33171345|NCT04160091|100533344|FG000|Overall Study|Terminated by Sponsor|7|||
33171346|NCT04160091|100533345|FG001|Overall Study|Terminated by Sponsor|3|||
33261267|NCT01574716|100860044|FG002|Part 1|Death|8|||
33171347|NCT04160091|100533346|FG002|Overall Study|Terminated by Sponsor|5|||
33171348|NCT04160091|100533347|FG003|Overall Study|Terminated by Sponsor|2|||
33171349|NCT04160091|100533344|FG000|Overall Study|Noncompliance|0|||
33171350|NCT04160091|100533345|FG001|Overall Study|Noncompliance|0|||
33171351|NCT04160091|100533346|FG002|Overall Study|Noncompliance|0|||
33171352|NCT04160091|100533347|FG003|Overall Study|Noncompliance|1|||
33171353|NCT04160091|100533344|FG000|Overall Study|Withdrawal by Subject|0|||
33171354|NCT04160091|100533345|FG001|Overall Study|Withdrawal by Subject|0|||
33171355|NCT04160091|100533346|FG002|Overall Study|Withdrawal by Subject|0|||
33171356|NCT04160091|100533347|FG003|Overall Study|Withdrawal by Subject|1|||
33171357|NCT01962207|100533351|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
33171358|NCT01962207|100533352|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
33171359|NCT01962207|100533353|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
33171360|NCT01962207|100533354|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
33171361|NCT01962207|100533351|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
33171362|NCT01962207|100533352|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
33171363|NCT01962207|100533353|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
33452284|NCT04723693|101547838|FG000|Overall Study|Withdrawal by Subject|2|||
33171364|NCT01962207|100533354|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
33171365|NCT01962207|100533351|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
33171366|NCT01962207|100533352|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
33171367|NCT01962207|100533353|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
33171368|NCT01962207|100533354|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
33171369|NCT01962207|100533351|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
33171370|NCT01962207|100533352|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
33171371|NCT01962207|100533353|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
33171372|NCT01962207|100533354|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
33171373|NCT01962207|100533351|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
33171374|NCT01962207|100533352|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
33171375|NCT01962207|100533353|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
33171376|NCT01962207|100533354|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
33171377|NCT01962207|100533351|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
33171378|NCT01962207|100533352|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
33171379|NCT01962207|100533353|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
33171380|NCT01962207|100533354|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
33171381|NCT01417234|100533355|FG000|Overall Study|Subject non-compliant|3|||
33171382|NCT00211809|100537047|FG000|Overall Study|Lack of Efficacy|1|||
33171383|NCT00211809|100537047|FG000|Overall Study|Lost to Follow-up|2|||
33171384|NCT00211809|100537047|FG000|Overall Study|Pregnancy|1|||
33171385|NCT00211809|100537047|FG000|Overall Study|side effects|2|||
33171386|NCT02329730|100537048|FG000|Overall Study|Protocol Violation|0|||
33171387|NCT02329730|100537049|FG001|Overall Study|Protocol Violation|0|||
33171388|NCT02329730|100537050|FG002|Overall Study|Protocol Violation|0|||
33171389|NCT02329730|100537051|FG003|Overall Study|Protocol Violation|0|||
33171390|NCT02329730|100537052|FG004|Overall Study|Protocol Violation|2|||
33171391|NCT02329730|100537053|FG005|Overall Study|Protocol Violation|2|||
33171392|NCT02329730|100537054|FG006|Overall Study|Protocol Violation|0|||
33171393|NCT02329730|100537055|FG007|Overall Study|Protocol Violation|0|||
33171394|NCT02329730|100537056|FG008|Overall Study|Protocol Violation|0|||
33171395|NCT02329730|100537057|FG009|Overall Study|Protocol Violation|0|||
33171396|NCT02329730|100537058|FG010|Overall Study|Protocol Violation|0|||
33171397|NCT02329730|100537059|FG011|Overall Study|Protocol Violation|0|||
33171398|NCT02329730|100537048|FG000|Overall Study|Withdrawal by Subject|0|||
33171399|NCT02329730|100537049|FG001|Overall Study|Withdrawal by Subject|0|||
33171400|NCT02329730|100537050|FG002|Overall Study|Withdrawal by Subject|0|||
33171401|NCT02329730|100537051|FG003|Overall Study|Withdrawal by Subject|0|||
33171402|NCT02329730|100537052|FG004|Overall Study|Withdrawal by Subject|1|||
33171403|NCT02329730|100537053|FG005|Overall Study|Withdrawal by Subject|0|||
33171404|NCT02329730|100537054|FG006|Overall Study|Withdrawal by Subject|1|||
33171405|NCT02329730|100537055|FG007|Overall Study|Withdrawal by Subject|1|||
33171406|NCT02329730|100537056|FG008|Overall Study|Withdrawal by Subject|1|||
33171407|NCT02329730|100537057|FG009|Overall Study|Withdrawal by Subject|1|||
33171408|NCT02329730|100537058|FG010|Overall Study|Withdrawal by Subject|0|||
33171409|NCT02329730|100537059|FG011|Overall Study|Withdrawal by Subject|0|||
33171410|NCT05255068|100537060|FG000|Overall Study|Lost to Follow-up|0|||
33261268|NCT01574716|100860045|FG003|Part 1|Death|0|||
33261269|NCT01574716|100860046|FG004|Part 1|Death|0|||
33171411|NCT05255068|100537061|FG001|Overall Study|Lost to Follow-up|1|||
33171412|NCT01438424|100537062|FG000|Overall Study|Continuing treatment|29|||
33171413|NCT01438424|100537062|FG000|Overall Study|Minimal virologic response|95|||
33171414|NCT01438424|100537062|FG000|Overall Study|Not identified|55|||
33171415|NCT01438424|100537062|FG000|Overall Study|Withdrawal by Subject|104|||
33171416|NCT01438424|100537062|FG000|Overall Study|Progression of chronic hepatitis B|22|||
33171417|NCT01438424|100537062|FG000|Overall Study|Death|22|||
33171418|NCT01438424|100537062|FG000|Overall Study|Adverse Event|17|||
33171419|NCT01438424|100537062|FG000|Overall Study|Lost to Follow-up|17|||
33171420|NCT01438424|100537062|FG000|Overall Study|Abnormal laboratory test result|14|||
33452285|NCT03502811|101547842|FG000|Overall Study|Death|157|||
33171421|NCT01438424|100537062|FG000|Overall Study|Need for drug prohibited by protocol|14|||
33171422|NCT01438424|100537062|FG000|Overall Study|Pregnancy|7|||
33171423|NCT01438424|100537062|FG000|Overall Study|No longer met inclusion criteria|1|||
33171424|NCT01438424|100537062|FG000|Overall Study|Participant noncompliance|20|||
33171425|NCT03715764|100537063|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
33171426|NCT03715764|100537064|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
33171427|NCT03715764|100537063|FG000|3 Month Follow-up|Lost to Follow-up|2|||
33171428|NCT03715764|100537064|FG001|3 Month Follow-up|Lost to Follow-up|2|||
33171429|NCT03715764|100537063|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
33171430|NCT03715764|100537064|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
33171431|NCT03715764|100537063|FG000|6 Month Follow-up|Lost to Follow-up|3|||
33171432|NCT03715764|100537064|FG001|6 Month Follow-up|Lost to Follow-up|0|||
33171433|NCT03715764|100537063|FG000|12 Month Follow-up|Lost to Follow-up|2|||
33171434|NCT03715764|100537064|FG001|12 Month Follow-up|Lost to Follow-up|3|||
33171435|NCT03715764|100537063|FG000|12 Month Follow-up|Pregnancy|0|||
33171436|NCT03715764|100537064|FG001|12 Month Follow-up|Pregnancy|1|||
33171437|NCT03715764|100537063|FG000|12 Month Follow-up|Surgery|2|||
33171438|NCT03715764|100537064|FG001|12 Month Follow-up|Surgery|0|||
33171439|NCT03715764|100537063|FG000|12 Month Follow-up|Wrong address|1|||
33171440|NCT03715764|100537064|FG001|12 Month Follow-up|Wrong address|0|||
33171441|NCT03715764|100537063|FG000|12 Month Follow-up|No symptoms|1|||
33171442|NCT03715764|100537064|FG001|12 Month Follow-up|No symptoms|0|||
33171443|NCT03715764|100537063|FG000|12 Month Follow-up|Changed primary care centre|0|||
33171444|NCT03715764|100537064|FG001|12 Month Follow-up|Changed primary care centre|1|||
33452286|NCT03502811|101547842|FG000|Overall Study|Withdrawal by Subject|105|||
33452287|NCT03502811|101547842|FG000|Overall Study|Lost to Follow-up|26|||
33171445|NCT02743871|100537067|FG000|Overall Study|Lost to Follow-up|0|||
33452288|NCT03502811|101547842|FG000|Overall Study|No Visits (Missed)|31|||
33171446|NCT02743871|100537068|FG001|Overall Study|Lost to Follow-up|0|||
33171447|NCT02743871|100537069|FG002|Overall Study|Lost to Follow-up|0|||
33171448|NCT02743871|100537070|FG003|Overall Study|Lost to Follow-up|1|||
33171449|NCT02743871|100537071|FG004|Overall Study|Lost to Follow-up|0|||
33171450|NCT02743871|100537072|FG005|Overall Study|Lost to Follow-up|0|||
33171451|NCT02743871|100537073|FG006|Overall Study|Lost to Follow-up|1|||
33452289|NCT01808651|101547845|FG000|Study Period 1|Lost to Follow-up|1|||
33171452|NCT02743871|100537074|FG007|Overall Study|Lost to Follow-up|0|||
33171453|NCT02743871|100537075|FG008|Overall Study|Lost to Follow-up|0|||
33171454|NCT02743871|100537076|FG009|Overall Study|Lost to Follow-up|0|||
33171455|NCT02743871|100537077|FG010|Overall Study|Lost to Follow-up|0|||
33171456|NCT02743871|100537078|FG011|Overall Study|Lost to Follow-up|2|||
33171457|NCT02743871|100537079|FG012|Overall Study|Lost to Follow-up|0|||
33171458|NCT02743871|100537080|FG013|Overall Study|Lost to Follow-up|0|||
33171459|NCT02743871|100537067|FG000|Overall Study|Withdrawal by Subject|0|||
33171460|NCT02743871|100537068|FG001|Overall Study|Withdrawal by Subject|0|||
33171461|NCT02743871|100537069|FG002|Overall Study|Withdrawal by Subject|0|||
33171462|NCT02743871|100537070|FG003|Overall Study|Withdrawal by Subject|0|||
33171463|NCT02743871|100537071|FG004|Overall Study|Withdrawal by Subject|0|||
33171464|NCT02743871|100537072|FG005|Overall Study|Withdrawal by Subject|0|||
33171465|NCT02743871|100537073|FG006|Overall Study|Withdrawal by Subject|0|||
33171466|NCT02743871|100537074|FG007|Overall Study|Withdrawal by Subject|0|||
33171467|NCT02743871|100537075|FG008|Overall Study|Withdrawal by Subject|0|||
33171468|NCT02743871|100537076|FG009|Overall Study|Withdrawal by Subject|0|||
33171469|NCT02743871|100537077|FG010|Overall Study|Withdrawal by Subject|1|||
33171470|NCT02743871|100537078|FG011|Overall Study|Withdrawal by Subject|0|||
33171471|NCT02743871|100537079|FG012|Overall Study|Withdrawal by Subject|12|||
33171472|NCT02743871|100537080|FG013|Overall Study|Withdrawal by Subject|6|||
33452290|NCT01808651|101547846|FG001|Study Period 1|Lost to Follow-up|3|||
33452291|NCT01808651|101547847|FG002|Study Period 1|Lost to Follow-up|0|||
33452292|NCT01808651|101547845|FG000|Study Period 1|Protocol Violation|1|||
33452293|NCT01808651|101547846|FG001|Study Period 1|Protocol Violation|0|||
33452294|NCT01808651|101547847|FG002|Study Period 1|Protocol Violation|1|||
33452295|NCT01808651|101547845|FG000|Study Period 1|Physician Decision|3|||
33452296|NCT01808651|101547846|FG001|Study Period 1|Physician Decision|2|||
33452297|NCT01808651|101547847|FG002|Study Period 1|Physician Decision|0|||
33452298|NCT01808651|101547845|FG000|Study Period 1|Lack of Efficacy|2|||
33452299|NCT01808651|101547846|FG001|Study Period 1|Lack of Efficacy|1|||
33452300|NCT01808651|101547847|FG002|Study Period 1|Lack of Efficacy|0|||
33452301|NCT01808651|101547845|FG000|Study Period 1|Adverse Event|10|||
33452302|NCT01808651|101547846|FG001|Study Period 1|Adverse Event|4|||
33452303|NCT01808651|101547847|FG002|Study Period 1|Adverse Event|1|||
33452304|NCT01808651|101547845|FG000|Study Period 1|Participant Decision|9|||
33452305|NCT01808651|101547846|FG001|Study Period 1|Participant Decision|7|||
33452306|NCT01808651|101547847|FG002|Study Period 1|Participant Decision|3|||
33452307|NCT02658487|101547848|FG000|Overall Study|Death|2|||
33171473|NCT02743871|100537067|FG000|Overall Study|Adverse Event|1|||
33171474|NCT02743871|100537068|FG001|Overall Study|Adverse Event|0|||
33171475|NCT02743871|100537069|FG002|Overall Study|Adverse Event|0|||
33171476|NCT02743871|100537070|FG003|Overall Study|Adverse Event|0|||
33171477|NCT02743871|100537071|FG004|Overall Study|Adverse Event|0|||
33171478|NCT02743871|100537072|FG005|Overall Study|Adverse Event|0|||
33452308|NCT02658487|101547848|FG000|Overall Study|Disease progression|10|||
33452309|NCT02658487|101547848|FG000|Overall Study|Alternative therapy|1|||
33452310|NCT02658487|101547848|FG000|Overall Study|Adverse Event|1|||
33452311|NCT02658487|101547848|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
33452312|NCT02658487|101547848|FG000|Overall Study|Refractory AML|1|||
33452313|NCT04183335|101547849|FG000|Overall Study|Adverse Event|1|||
33452314|NCT04183335|101547850|FG001|Overall Study|Adverse Event|0|||
33452315|NCT04183335|101547849|FG000|Overall Study|Withdrawal by Subject|12|||
33452316|NCT04183335|101547850|FG001|Overall Study|Withdrawal by Subject|3|||
33452317|NCT04089553|101547855|FG000|Overall Study|Death|1|||
33452318|NCT04089553|101547856|FG001|Overall Study|Death|1|||
33452319|NCT04089553|101547855|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
33452320|NCT04089553|101547856|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
33452321|NCT04089553|101547855|FG000|Overall Study|Withdrawal by Subject|3|||
33452322|NCT04089553|101547856|FG001|Overall Study|Withdrawal by Subject|3|||
33452323|NCT04089553|101547855|FG000|Overall Study|Physician Decision|1|||
33452324|NCT04089553|101547856|FG001|Overall Study|Physician Decision|0|||
33452325|NCT04089553|101547855|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
33452326|NCT04089553|101547856|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
33452327|NCT04089553|101547855|FG000|Overall Study|Other|1|||
33452328|NCT04089553|101547856|FG001|Overall Study|Other|0|||
33452329|NCT04089553|101547855|FG000|Overall Study|Adverse Event|1|||
33452330|NCT04089553|101547856|FG001|Overall Study|Adverse Event|1|||
33452331|NCT05034874|101547859|FG000|Overall Study|Withdrawal by Subject|6|||
33452332|NCT05034874|101547860|FG001|Overall Study|Withdrawal by Subject|6|||
33452333|NCT05034874|101547859|FG000|Overall Study|Lost to Follow-up|18|||
33452334|NCT05034874|101547860|FG001|Overall Study|Lost to Follow-up|8|||
33452335|NCT05034874|101547859|FG000|Overall Study|Physician Decision|0|||
33452336|NCT05034874|101547860|FG001|Overall Study|Physician Decision|1|||
33452337|NCT05034874|101547859|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
33452338|NCT05034874|101547860|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
33452339|NCT02105272|101547861|FG000|Overall Study|Adverse Event|1|||
33452340|NCT02105272|101547862|FG001|Overall Study|Adverse Event|2|||
33452341|NCT02105272|101547861|FG000|Overall Study|Physician Decision|0|||
33452342|NCT02105272|101547862|FG001|Overall Study|Physician Decision|1|||
33452343|NCT02105272|101547861|FG000|Overall Study|Protocol Violation|2|||
33452344|NCT02105272|101547862|FG001|Overall Study|Protocol Violation|0|||
33452345|NCT02105272|101547861|FG000|Overall Study|Withdrawal by Subject|2|||
33452346|NCT02105272|101547862|FG001|Overall Study|Withdrawal by Subject|0|||
33452347|NCT03676634|101547863|FG000|Overall Study|Red blood cell loss|1|||
33452348|NCT03676634|101547863|FG000|Overall Study|Out-of-limit pulse|2|||
33452349|NCT03867760|101547864|FG000|Overall Study|Lost to Follow-up|2|||
33452350|NCT03867760|101547865|FG001|Overall Study|Lost to Follow-up|3|||
33452351|NCT03867760|101547864|FG000|Overall Study|Withdrawal by Subject|1|||
33452352|NCT03867760|101547865|FG001|Overall Study|Withdrawal by Subject|2|||
33452353|NCT03867760|101547864|FG000|Overall Study|subject could not meet study logistics|3|||
33452354|NCT03867760|101547865|FG001|Overall Study|subject could not meet study logistics|3|||
33452355|NCT03684928|101547866|FG000|First Intervention|Lost to Follow-up|0|||
33452356|NCT03684928|101547867|FG001|First Intervention|Lost to Follow-up|1|||
33452357|NCT03684928|101547866|FG000|First Intervention|Withdrawal by Subject|0|||
33452358|NCT03684928|101547867|FG001|First Intervention|Withdrawal by Subject|2|||
33171479|NCT02743871|100537073|FG006|Overall Study|Adverse Event|0|||
33452359|NCT03684928|101547866|FG000|Second Intervention|Soft Tissue Injury|1|||
33452360|NCT03684928|101547867|FG001|Second Intervention|Soft Tissue Injury|0|||
33452361|NCT00537095|101547868|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
33452362|NCT00537095|101547869|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
33452363|NCT00537095|101547868|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
33452364|NCT00537095|101547869|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
33452365|NCT00537095|101547868|FG000|Randomized Treatment Period (433 Days)|Death|3|||
33452366|NCT00537095|101547869|FG001|Randomized Treatment Period (433 Days)|Death|1|||
33171480|NCT02743871|100537074|FG007|Overall Study|Adverse Event|0|||
33171481|NCT02743871|100537075|FG008|Overall Study|Adverse Event|0|||
33171482|NCT02743871|100537076|FG009|Overall Study|Adverse Event|0|||
33171483|NCT02743871|100537077|FG010|Overall Study|Adverse Event|0|||
33171484|NCT02743871|100537078|FG011|Overall Study|Adverse Event|0|||
33171485|NCT02743871|100537079|FG012|Overall Study|Adverse Event|0|||
33171486|NCT02743871|100537080|FG013|Overall Study|Adverse Event|0|||
33171487|NCT02743871|100537067|FG000|Overall Study|Other|0|||
33171488|NCT02743871|100537068|FG001|Overall Study|Other|0|||
33171489|NCT02743871|100537069|FG002|Overall Study|Other|0|||
33171490|NCT02743871|100537070|FG003|Overall Study|Other|0|||
33452367|NCT00537095|101547868|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
33171491|NCT02743871|100537071|FG004|Overall Study|Other|0|||
33171492|NCT02743871|100537072|FG005|Overall Study|Other|0|||
33171493|NCT02743871|100537073|FG006|Overall Study|Other|0|||
33171494|NCT02743871|100537074|FG007|Overall Study|Other|0|||
33171495|NCT02743871|100537075|FG008|Overall Study|Other|0|||
33171496|NCT02743871|100537076|FG009|Overall Study|Other|0|||
33171497|NCT02743871|100537077|FG010|Overall Study|Other|0|||
33171498|NCT02743871|100537078|FG011|Overall Study|Other|1|||
33171499|NCT02743871|100537079|FG012|Overall Study|Other|1|||
33171500|NCT02743871|100537080|FG013|Overall Study|Other|1|||
33171501|NCT02743871|100537067|FG000|Overall Study|Protocol Violation|0|||
33171502|NCT02743871|100537068|FG001|Overall Study|Protocol Violation|0|||
33171503|NCT02743871|100537069|FG002|Overall Study|Protocol Violation|0|||
33171504|NCT02743871|100537070|FG003|Overall Study|Protocol Violation|0|||
33171505|NCT02743871|100537071|FG004|Overall Study|Protocol Violation|0|||
33171506|NCT02743871|100537072|FG005|Overall Study|Protocol Violation|0|||
33171507|NCT02743871|100537073|FG006|Overall Study|Protocol Violation|0|||
33171508|NCT02743871|100537074|FG007|Overall Study|Protocol Violation|0|||
33171509|NCT02743871|100537075|FG008|Overall Study|Protocol Violation|0|||
33171510|NCT02743871|100537076|FG009|Overall Study|Protocol Violation|0|||
33171511|NCT02743871|100537077|FG010|Overall Study|Protocol Violation|0|||
33171512|NCT02743871|100537078|FG011|Overall Study|Protocol Violation|0|||
33171513|NCT02743871|100537079|FG012|Overall Study|Protocol Violation|2|||
33171514|NCT02743871|100537080|FG013|Overall Study|Protocol Violation|0|||
33171515|NCT00644995|100537081|FG000|Overall Study|Lost to Follow-up|1|||
33171516|NCT00644995|100537082|FG001|Overall Study|Lost to Follow-up|4|||
33171517|NCT00644995|100537081|FG000|Overall Study|Refused|1|||
33171518|NCT00644995|100537082|FG001|Overall Study|Refused|0|||
33171519|NCT00004978|100537083|FG000|Overall Study|Death|107|||
33171520|NCT00004978|100537084|FG001|Overall Study|Death|116|||
33171521|NCT00004978|100537083|FG000|Overall Study|Lost to Follow-up|101|||
33171522|NCT00004978|100537084|FG001|Overall Study|Lost to Follow-up|108|||
33171523|NCT00004978|100537083|FG000|Overall Study|Withdrawal by Subject|17|||
33171524|NCT00004978|100537084|FG001|Overall Study|Withdrawal by Subject|26|||
33171525|NCT00004978|100537083|FG000|Overall Study|site closure - not in analysis cohort|19|||
33171526|NCT00004978|100537084|FG001|Overall Study|site closure - not in analysis cohort|20|||
33171527|NCT02507505|100537085|FG000|Overall Study|Withdrawal by Subject|13|||
33452368|NCT00537095|101547869|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
33452369|NCT00537095|101547868|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
33452370|NCT00537095|101547869|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
33452371|NCT00537095|101547868|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
33452372|NCT00537095|101547869|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
33452373|NCT00537095|101547868|FG000|Open-label Period (590 Days)|Adverse Event|2|||
33452374|NCT00537095|101547869|FG001|Open-label Period (590 Days)|Adverse Event|11|||
33452375|NCT00537095|101547868|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
33452376|NCT00537095|101547869|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
33452377|NCT00537095|101547868|FG000|Open-label Period (590 Days)|Death|2|||
33452378|NCT00537095|101547869|FG001|Open-label Period (590 Days)|Death|2|||
33452379|NCT00537095|101547868|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
33452380|NCT00537095|101547869|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
33452381|NCT00537095|101547868|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
33171528|NCT02507505|100537086|FG001|Overall Study|Withdrawal by Subject|11|||
33452382|NCT00537095|101547869|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
33171529|NCT02507505|100537085|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
33171530|NCT02507505|100537086|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
33171531|NCT02507505|100537085|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
33171532|NCT02507505|100537086|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
33171533|NCT02507505|100537085|FG000|Overall Study|Death before receipt of anesthesia|0|||
33171534|NCT02507505|100537086|FG001|Overall Study|Death before receipt of anesthesia|1|||
33171535|NCT02707991|100537089|FG000|Overall Study|Protocol Violation|1|||
33171536|NCT02707991|100537090|FG001|Overall Study|Protocol Violation|0|||
33171537|NCT02707991|100537089|FG000|Overall Study|Became ineligible|0|||
33171538|NCT02707991|100537090|FG001|Overall Study|Became ineligible|1|||
33171539|NCT03454893|100537093|FG000|Overall Study|Study Terminated by the Sponsor|5|||
33171540|NCT03454893|100537093|FG000|Overall Study|Did not pass screening|4|||
33171541|NCT00587639|100537094|FG000|Overall Study|Withdrawal by Subject|1|||
33171542|NCT02692716|100537095|FG000|Overall Study|Lost to Follow-up|2|||
33171543|NCT02692716|100537096|FG001|Overall Study|Lost to Follow-up|5|||
33171544|NCT02692716|100537095|FG000|Overall Study|Withdrawal by Subject|3|||
33171545|NCT02692716|100537096|FG001|Overall Study|Withdrawal by Subject|1|||
33171546|NCT01549860|100537097|FG000|Overall Study|Withdrawal by Subject|1|||
33171547|NCT01549860|100537098|FG001|Overall Study|Withdrawal by Subject|0|||
33171548|NCT01549860|100537097|FG000|Overall Study|Physician Decision|1|||
33171549|NCT01549860|100537098|FG001|Overall Study|Physician Decision|1|||
33171550|NCT01581931|100537100|FG000|Washout|Adverse Event|0|||
33171551|NCT01581931|100537101|FG001|Washout|Adverse Event|1|||
33171552|NCT01411228|100537102|FG000|Overall Study|Lost to Follow-up|0|||
33171553|NCT01411228|100537103|FG001|Overall Study|Lost to Follow-up|0|||
33171554|NCT01411228|100537104|FG002|Overall Study|Lost to Follow-up|1|||
33171555|NCT01411228|100537102|FG000|Overall Study|Withdrawal by Subject|1|||
33171556|NCT01411228|100537103|FG001|Overall Study|Withdrawal by Subject|0|||
33171557|NCT01411228|100537104|FG002|Overall Study|Withdrawal by Subject|0|||
33171558|NCT00867009|100537105|FG000|Induction Period|Nonserious Adverse Event|5|||
33171559|NCT00867009|100537105|FG000|Induction Period|Serious Adverse Event|10|||
33171560|NCT00867009|100537105|FG000|Induction Period|Death due to serious adverse event|6|||
33171561|NCT00867009|100537105|FG000|Induction Period|Death due to Study Disease|4|||
33171562|NCT00867009|100537105|FG000|Induction Period|Protocol Violation|1|||
33171563|NCT00867009|100537105|FG000|Induction Period|Withdrawal by Subject|8|||
33171564|NCT00867009|100537105|FG000|Induction Period|Physician Decision|3|||
33171565|NCT00867009|100537105|FG000|Induction Period|Progressive Disease (PD)|25|||
33171566|NCT00867009|100537105|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
33261270|NCT01574716|100860042|FG000|Part 1|Discontinuation of study by sponsor|0|||
33261271|NCT01574716|100860043|FG001|Part 1|Discontinuation of study by sponsor|0|||
33261272|NCT01574716|100860044|FG002|Part 1|Discontinuation of study by sponsor|1|||
33261273|NCT01574716|100860045|FG003|Part 1|Discontinuation of study by sponsor|0|||
33261274|NCT01574716|100860046|FG004|Part 1|Discontinuation of study by sponsor|0|||
33261275|NCT01574716|100860042|FG000|Part 1|Withdrawal by Subject|0|||
33261276|NCT01574716|100860043|FG001|Part 1|Withdrawal by Subject|2|||
33261277|NCT01574716|100860044|FG002|Part 1|Withdrawal by Subject|0|||
33261278|NCT01574716|100860045|FG003|Part 1|Withdrawal by Subject|0|||
33261279|NCT01574716|100860046|FG004|Part 1|Withdrawal by Subject|0|||
33261280|NCT01574716|100860042|FG000|Part 1|Lost to Follow-up|0|||
33261281|NCT01574716|100860043|FG001|Part 1|Lost to Follow-up|1|||
33261282|NCT01574716|100860044|FG002|Part 1|Lost to Follow-up|0|||
33261283|NCT01574716|100860045|FG003|Part 1|Lost to Follow-up|0|||
33261284|NCT01574716|100860046|FG004|Part 1|Lost to Follow-up|0|||
33261285|NCT01574716|100860042|FG000|Part 2|Progressive disease|0|||
33261286|NCT01574716|100860043|FG001|Part 2|Progressive disease|0|||
33261287|NCT01574716|100860044|FG002|Part 2|Progressive disease|0|||
33261288|NCT01574716|100860045|FG003|Part 2|Progressive disease|1|||
33261289|NCT01574716|100860046|FG004|Part 2|Progressive disease|0|||
33261290|NCT01574716|100860042|FG000|Part 2|Death|0|||
33261291|NCT01574716|100860043|FG001|Part 2|Death|0|||
33261292|NCT01574716|100860044|FG002|Part 2|Death|0|||
33261293|NCT01574716|100860045|FG003|Part 2|Death|76|||
33261294|NCT01574716|100860046|FG004|Part 2|Death|35|||
33261295|NCT01574716|100860042|FG000|Part 2|Discontinuation of study by sponsor|0|||
33261296|NCT01574716|100860043|FG001|Part 2|Discontinuation of study by sponsor|0|||
33261297|NCT01574716|100860044|FG002|Part 2|Discontinuation of study by sponsor|0|||
33261298|NCT01574716|100860045|FG003|Part 2|Discontinuation of study by sponsor|51|||
33261299|NCT01574716|100860046|FG004|Part 2|Discontinuation of study by sponsor|31|||
33261300|NCT01574716|100860042|FG000|Part 2|Withdrawal by Subject|0|||
33261301|NCT01574716|100860043|FG001|Part 2|Withdrawal by Subject|0|||
33261302|NCT01574716|100860044|FG002|Part 2|Withdrawal by Subject|0|||
33261303|NCT01574716|100860045|FG003|Part 2|Withdrawal by Subject|5|||
33261304|NCT01574716|100860046|FG004|Part 2|Withdrawal by Subject|4|||
33261305|NCT01574716|100860042|FG000|Part 2|Brain metastases|0|||
33261306|NCT01574716|100860043|FG001|Part 2|Brain metastases|0|||
33261307|NCT01574716|100860044|FG002|Part 2|Brain metastases|0|||
33261308|NCT01574716|100860045|FG003|Part 2|Brain metastases|1|||
33171567|NCT00642460|100537106|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
33261309|NCT01574716|100860046|FG004|Part 2|Brain metastases|0|||
33261310|NCT01574716|100860042|FG000|Part 2|Lost to Follow-up|0|||
33261311|NCT01574716|100860043|FG001|Part 2|Lost to Follow-up|0|||
33261312|NCT01574716|100860044|FG002|Part 2|Lost to Follow-up|0|||
33261313|NCT01574716|100860045|FG003|Part 2|Lost to Follow-up|3|||
33261314|NCT01574716|100860046|FG004|Part 2|Lost to Follow-up|0|||
33261315|NCT00467272|100860047|FG000|Overall Study|Pneumonia|2|||
33261316|NCT00467272|100860047|FG000|Overall Study|Thrombophlebitis|1|||
33261317|NCT01075152|100860048|FG000|Overall Study|Withdrawal by Subject|1|||
33261318|NCT01075152|100860049|FG001|Overall Study|Withdrawal by Subject|0|||
33171568|NCT00642460|100537107|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
33261319|NCT04452318|100860050|FG000|Overall Study|Physician Decision|1|||
33261320|NCT04452318|100860051|FG001|Overall Study|Physician Decision|2|||
33261321|NCT04452318|100860052|FG002|Overall Study|Physician Decision|0|||
33261322|NCT04452318|100860053|FG003|Overall Study|Physician Decision|2|||
33261323|NCT04452318|100860054|FG004|Overall Study|Physician Decision|0|||
33261324|NCT04452318|100860055|FG005|Overall Study|Physician Decision|2|||
33261325|NCT04452318|100860056|FG006|Overall Study|Physician Decision|5|||
33261326|NCT04452318|100860050|FG000|Overall Study|Death|2|||
33261327|NCT04452318|100860051|FG001|Overall Study|Death|3|||
33261328|NCT04452318|100860052|FG002|Overall Study|Death|0|||
33261329|NCT04452318|100860053|FG003|Overall Study|Death|0|||
33261330|NCT04452318|100860054|FG004|Overall Study|Death|0|||
33261331|NCT04452318|100860055|FG005|Overall Study|Death|0|||
33261332|NCT04452318|100860056|FG006|Overall Study|Death|0|||
33261333|NCT04452318|100860050|FG000|Overall Study|Lost to Follow-up|38|||
33261334|NCT04452318|100860051|FG001|Overall Study|Lost to Follow-up|28|||
33261335|NCT04452318|100860052|FG002|Overall Study|Lost to Follow-up|0|||
33261336|NCT04452318|100860053|FG003|Overall Study|Lost to Follow-up|3|||
33261337|NCT04452318|100860054|FG004|Overall Study|Lost to Follow-up|3|||
33261338|NCT04452318|100860055|FG005|Overall Study|Lost to Follow-up|2|||
33261339|NCT04452318|100860056|FG006|Overall Study|Lost to Follow-up|1|||
33261340|NCT04452318|100860050|FG000|Overall Study|Withdrawal by Subject|46|||
33261341|NCT04452318|100860051|FG001|Overall Study|Withdrawal by Subject|40|||
33261342|NCT04452318|100860052|FG002|Overall Study|Withdrawal by Subject|0|||
33261343|NCT04452318|100860053|FG003|Overall Study|Withdrawal by Subject|18|||
33261344|NCT04452318|100860054|FG004|Overall Study|Withdrawal by Subject|6|||
33261345|NCT04452318|100860055|FG005|Overall Study|Withdrawal by Subject|8|||
33261346|NCT04452318|100860056|FG006|Overall Study|Withdrawal by Subject|6|||
33261347|NCT02461628|100860057|FG000|Overall Study|Refused to complete survey|4|||
33261348|NCT02461628|100860058|FG001|Overall Study|Refused to complete survey|7|||
33452383|NCT03599362|101547876|FG000|Overall Study|Screen Failure|3|||
33452384|NCT01051349|101547880|FG000|Overall Study|Adverse Event|88|||
33171569|NCT00642460|100537108|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
33171570|NCT00642460|100537109|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
33171571|NCT00642460|100537110|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
33171572|NCT00642460|100537111|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
33171573|NCT00642460|100537106|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
33171574|NCT00642460|100537107|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
33171575|NCT00642460|100537108|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
33171576|NCT00642460|100537109|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
33171577|NCT00642460|100537110|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
33171578|NCT00642460|100537111|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
33171579|NCT00642460|100537106|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
33171580|NCT00642460|100537107|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
33171581|NCT00642460|100537108|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
33171582|NCT00642460|100537109|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
33171583|NCT00642460|100537110|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
33261349|NCT01823536|100860059|FG000|Overall Study|Lost to Follow-up|1|||
33261350|NCT01823536|100860060|FG001|Overall Study|Lost to Follow-up|0|||
33261351|NCT01823536|100860061|FG002|Overall Study|Lost to Follow-up|0|||
33261352|NCT01823536|100860062|FG003|Overall Study|Lost to Follow-up|1|||
33261353|NCT01823536|100860063|FG004|Overall Study|Lost to Follow-up|1|||
33261354|NCT01823536|100860064|FG005|Overall Study|Lost to Follow-up|0|||
33261355|NCT01823536|100860059|FG000|Overall Study|Protocol Violation|0|||
33261356|NCT01823536|100860060|FG001|Overall Study|Protocol Violation|1|||
33261357|NCT01823536|100860061|FG002|Overall Study|Protocol Violation|0|||
33261358|NCT01823536|100860062|FG003|Overall Study|Protocol Violation|0|||
33171584|NCT00642460|100537111|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
33171585|NCT00642460|100537106|FG000|Part II: Open-Label Up to Week 92|Death|0|||
33171586|NCT00642460|100537107|FG001|Part II: Open-Label Up to Week 92|Death|1|||
33171587|NCT00642460|100537108|FG002|Part II: Open-Label Up to Week 92|Death|0|||
33171588|NCT00642460|100537109|FG003|Part II: Open-Label Up to Week 92|Death|2|||
33171589|NCT00642460|100537110|FG004|Part II: Open-Label Up to Week 92|Death|0|||
33171590|NCT00642460|100537111|FG005|Part II: Open-Label Up to Week 92|Death|0|||
33171591|NCT00642460|100537106|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
33171592|NCT00642460|100537107|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
33171593|NCT00642460|100537108|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
33171594|NCT00642460|100537109|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
33171595|NCT00642460|100537110|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
33171596|NCT00642460|100537111|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
33171597|NCT00642460|100537106|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
33171598|NCT00642460|100537107|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
33171599|NCT00642460|100537108|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
33171600|NCT00642460|100537109|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
33171601|NCT00642460|100537110|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
33171602|NCT00642460|100537111|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
33171603|NCT00642460|100537106|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
33171604|NCT00642460|100537107|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
33171605|NCT00642460|100537108|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
33171606|NCT00642460|100537109|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
33171607|NCT00642460|100537110|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
33171608|NCT00642460|100537111|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
33171609|NCT00642460|100537106|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
33171610|NCT00642460|100537107|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
33171611|NCT00642460|100537108|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
33171612|NCT00642460|100537109|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
33171613|NCT00642460|100537110|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
33171614|NCT00642460|100537111|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
33171615|NCT00642460|100537106|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
33171616|NCT00642460|100537107|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
33171617|NCT00642460|100537108|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
33171618|NCT00642460|100537109|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
33452385|NCT01051349|101547880|FG000|Overall Study|Consent Withdrawn|54|||
33452386|NCT01051349|101547880|FG000|Overall Study|Investigator Decision|6|||
33452387|NCT01051349|101547880|FG000|Overall Study|Lost to Follow-up|6|||
33452388|NCT01051349|101547880|FG000|Overall Study|Subject non-compliance|7|||
33452389|NCT01051349|101547880|FG000|Overall Study|Reason not Specified|12|||
33452390|NCT01958294|101547881|FG000|Overall Study|Clinical Circumstances|2|||
33452391|NCT01660243|101547883|FG000|Overall Study|Adverse Event|1|||
33452392|NCT01660243|101547884|FG001|Overall Study|Adverse Event|0|||
33452393|NCT01660243|101547885|FG002|Overall Study|Adverse Event|1|||
33452394|NCT01660243|101547886|FG003|Overall Study|Adverse Event|0|||
33452395|NCT01660243|101547883|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
33452396|NCT01660243|101547884|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
33452397|NCT01660243|101547885|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
33452398|NCT01660243|101547886|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
33452399|NCT01660243|101547883|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
33452400|NCT01660243|101547884|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
33452401|NCT01660243|101547885|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
33452402|NCT01660243|101547886|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
33452403|NCT01660243|101547883|FG000|Overall Study|Randomization error|0|||
33452404|NCT01660243|101547884|FG001|Overall Study|Randomization error|0|||
33452405|NCT01660243|101547885|FG002|Overall Study|Randomization error|0|||
33452406|NCT01660243|101547886|FG003|Overall Study|Randomization error|1|||
33452407|NCT00819169|101547887|FG000|Overall Study|Withdrawal by Subject|2|||
33452408|NCT00819169|101547888|FG001|Overall Study|Withdrawal by Subject|0|||
33452409|NCT00819169|101547889|FG002|Overall Study|Withdrawal by Subject|0|||
33452410|NCT00819169|101547890|FG003|Overall Study|Withdrawal by Subject|1|||
33452411|NCT00819169|101547891|FG004|Overall Study|Withdrawal by Subject|1|||
33452412|NCT00819169|101547892|FG005|Overall Study|Withdrawal by Subject|1|||
33452413|NCT00819169|101547893|FG006|Overall Study|Withdrawal by Subject|5|||
33452414|NCT00819169|101547894|FG007|Overall Study|Withdrawal by Subject|1|||
33452415|NCT00819169|101547895|FG008|Overall Study|Withdrawal by Subject|4|||
33452416|NCT00819169|101547887|FG000|Overall Study|Lost to Follow-up|0|||
33452417|NCT00819169|101547888|FG001|Overall Study|Lost to Follow-up|2|||
33452418|NCT00819169|101547889|FG002|Overall Study|Lost to Follow-up|0|||
33452419|NCT00819169|101547890|FG003|Overall Study|Lost to Follow-up|1|||
33452420|NCT00819169|101547891|FG004|Overall Study|Lost to Follow-up|0|||
33452421|NCT00819169|101547892|FG005|Overall Study|Lost to Follow-up|6|||
33452422|NCT00819169|101547893|FG006|Overall Study|Lost to Follow-up|2|||
33452423|NCT00819169|101547894|FG007|Overall Study|Lost to Follow-up|2|||
33452424|NCT00819169|101547895|FG008|Overall Study|Lost to Follow-up|1|||
33452425|NCT00819169|101547887|FG000|Overall Study|Death|1|||
33452426|NCT00819169|101547888|FG001|Overall Study|Death|1|||
33452427|NCT00819169|101547889|FG002|Overall Study|Death|3|||
33452428|NCT00819169|101547890|FG003|Overall Study|Death|8|||
33452429|NCT00819169|101547891|FG004|Overall Study|Death|5|||
33452430|NCT00819169|101547892|FG005|Overall Study|Death|7|||
33452431|NCT00819169|101547893|FG006|Overall Study|Death|9|||
33452432|NCT00819169|101547894|FG007|Overall Study|Death|4|||
33452433|NCT00819169|101547895|FG008|Overall Study|Death|7|||
33452434|NCT00819169|101547887|FG000|Overall Study|Ineligibility determined|0|||
33452435|NCT00819169|101547888|FG001|Overall Study|Ineligibility determined|0|||
33452436|NCT00819169|101547889|FG002|Overall Study|Ineligibility determined|0|||
33452437|NCT00819169|101547890|FG003|Overall Study|Ineligibility determined|2|||
33452438|NCT00819169|101547891|FG004|Overall Study|Ineligibility determined|0|||
33452439|NCT00819169|101547892|FG005|Overall Study|Ineligibility determined|0|||
33171619|NCT00642460|100537110|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
33452440|NCT00819169|101547893|FG006|Overall Study|Ineligibility determined|0|||
33452441|NCT00819169|101547894|FG007|Overall Study|Ineligibility determined|0|||
33171620|NCT00642460|100537111|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
33452442|NCT00819169|101547895|FG008|Overall Study|Ineligibility determined|1|||
33452443|NCT00819169|101547887|FG000|Overall Study|Adverse Event|0|||
33452444|NCT00819169|101547888|FG001|Overall Study|Adverse Event|0|||
33452445|NCT00819169|101547889|FG002|Overall Study|Adverse Event|0|||
33452446|NCT00819169|101547890|FG003|Overall Study|Adverse Event|0|||
33452447|NCT00819169|101547891|FG004|Overall Study|Adverse Event|1|||
33171621|NCT00642460|100537106|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
33171622|NCT00642460|100537107|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
33171623|NCT00642460|100537108|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
33171624|NCT00642460|100537109|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
33171625|NCT00642460|100537110|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
33171626|NCT00642460|100537111|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
33171627|NCT00642460|100537106|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
33171628|NCT00642460|100537107|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
33171629|NCT00642460|100537108|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
33171630|NCT00642460|100537109|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
33171631|NCT00642460|100537110|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
33171632|NCT00642460|100537111|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
33171633|NCT00642460|100537106|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
33171634|NCT00642460|100537107|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
33171635|NCT00642460|100537108|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
33171636|NCT00642460|100537109|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
33171637|NCT00642460|100537110|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
33171638|NCT00642460|100537111|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
33171639|NCT00642460|100537106|FG000|Part III: Open-Label Up to Week 260|Other|0|||
33171640|NCT00642460|100537107|FG001|Part III: Open-Label Up to Week 260|Other|0|||
33171641|NCT00642460|100537108|FG002|Part III: Open-Label Up to Week 260|Other|0|||
33171642|NCT00642460|100537109|FG003|Part III: Open-Label Up to Week 260|Other|0|||
33171643|NCT00642460|100537110|FG004|Part III: Open-Label Up to Week 260|Other|2|||
33171644|NCT00642460|100537111|FG005|Part III: Open-Label Up to Week 260|Other|2|||
33171645|NCT00642460|100537106|FG000|Part III: Open-Label Up to Week 260|Death|0|||
33171646|NCT00642460|100537107|FG001|Part III: Open-Label Up to Week 260|Death|0|||
33171647|NCT00642460|100537108|FG002|Part III: Open-Label Up to Week 260|Death|0|||
33171648|NCT00642460|100537109|FG003|Part III: Open-Label Up to Week 260|Death|0|||
33171649|NCT00642460|100537110|FG004|Part III: Open-Label Up to Week 260|Death|0|||
33171650|NCT00642460|100537111|FG005|Part III: Open-Label Up to Week 260|Death|3|||
33171651|NCT00642460|100537106|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
33171652|NCT00642460|100537107|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
33171653|NCT00642460|100537108|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
33171654|NCT00642460|100537109|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
33171655|NCT00642460|100537110|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
33171656|NCT00642460|100537111|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
33171657|NCT00642460|100537106|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
33171658|NCT00642460|100537107|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
33171659|NCT00642460|100537108|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
33171660|NCT00642460|100537109|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
33171661|NCT00642460|100537110|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
33171662|NCT00642460|100537111|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
33171663|NCT01134783|100537112|FG000|Overall Study|Pregnancy|16|||
33171664|NCT01134783|100537113|FG001|Overall Study|Pregnancy|8|||
33452448|NCT00819169|101547892|FG005|Overall Study|Adverse Event|0|||
33452449|NCT00819169|101547893|FG006|Overall Study|Adverse Event|0|||
33261359|NCT01823536|100860063|FG004|Overall Study|Protocol Violation|0|||
33452450|NCT00819169|101547894|FG007|Overall Study|Adverse Event|0|||
33452451|NCT00819169|101547895|FG008|Overall Study|Adverse Event|0|||
33452452|NCT00819169|101547887|FG000|Overall Study|Administrative Decision|0|||
33452453|NCT00819169|101547888|FG001|Overall Study|Administrative Decision|0|||
33452454|NCT00819169|101547889|FG002|Overall Study|Administrative Decision|0|||
33452455|NCT00819169|101547890|FG003|Overall Study|Administrative Decision|0|||
33452456|NCT00819169|101547891|FG004|Overall Study|Administrative Decision|1|||
33452457|NCT00819169|101547892|FG005|Overall Study|Administrative Decision|2|||
33452458|NCT00819169|101547893|FG006|Overall Study|Administrative Decision|0|||
33452459|NCT00819169|101547894|FG007|Overall Study|Administrative Decision|2|||
33452460|NCT00819169|101547895|FG008|Overall Study|Administrative Decision|0|||
33452461|NCT01906372|101547897|FG000|Overall Study|Withdrawal by Subject|2|||
33452462|NCT03049748|101547898|FG000|Overall Study|Lost to Follow-up|1|||
33452463|NCT03049748|101547899|FG001|Overall Study|Lost to Follow-up|0|||
33452464|NCT03049748|101547898|FG000|Overall Study|Death|3|||
33452465|NCT03049748|101547899|FG001|Overall Study|Death|0|||
33452466|NCT03049748|101547898|FG000|Overall Study|Withdrawal by Subject|0|||
33452467|NCT03049748|101547899|FG001|Overall Study|Withdrawal by Subject|3|||
33452468|NCT03049748|101547898|FG000|Overall Study|Protocol Violation|0|||
33452469|NCT03049748|101547899|FG001|Overall Study|Protocol Violation|2|||
33452470|NCT03049748|101547898|FG000|Overall Study|Moved out of state (relocation)|0|||
33452471|NCT03049748|101547899|FG001|Overall Study|Moved out of state (relocation)|1|||
33452472|NCT00319696|101547900|FG000|Overall Study|Adverse Event|36|||
33452473|NCT00319696|101547900|FG000|Overall Study|withdrawal of consent|14|||
33452474|NCT00319696|101547900|FG000|Overall Study|administrative|7|||
33452475|NCT00319696|101547900|FG000|Overall Study|Lost to Follow-up|3|||
33452476|NCT05169710|101547911|FG000|Overall Study|Adverse Event|1|||
33452477|NCT05169710|101547912|FG001|Overall Study|Adverse Event|2|||
33452478|NCT05169710|101547913|FG002|Overall Study|Adverse Event|2|||
33452479|NCT05169710|101547911|FG000|Overall Study|Lost to Follow-up|0|||
33452480|NCT05169710|101547912|FG001|Overall Study|Lost to Follow-up|0|||
33452481|NCT05169710|101547913|FG002|Overall Study|Lost to Follow-up|1|||
33452482|NCT05169710|101547911|FG000|Overall Study|Withdrawal by Subject|2|||
33452483|NCT05169710|101547912|FG001|Overall Study|Withdrawal by Subject|1|||
33452484|NCT05169710|101547913|FG002|Overall Study|Withdrawal by Subject|0|||
33452485|NCT05169710|101547911|FG000|Overall Study|Other Study Discontinuation Reason|0|||
33452486|NCT05169710|101547912|FG001|Overall Study|Other Study Discontinuation Reason|2|||
33452487|NCT05169710|101547913|FG002|Overall Study|Other Study Discontinuation Reason|0|||
33452488|NCT04692155|101547922|FG000|Overall Study|Death|1|||
33452489|NCT00700739|101547925|FG000|Overall Study|Lost to Follow-up|4|||
33452490|NCT00700739|101547926|FG001|Overall Study|Lost to Follow-up|4|||
33452491|NCT01075516|101547930|FG000|Overall Study|Death|5|||
33452492|NCT01075516|101547931|FG001|Overall Study|Death|9|||
33452493|NCT01075516|101547930|FG000|Overall Study|Lost to Follow-up|10|||
33452494|NCT01075516|101547931|FG001|Overall Study|Lost to Follow-up|2|||
33452495|NCT01075516|101547930|FG000|Overall Study|Withdrawal by Subject|3|||
33452496|NCT01075516|101547931|FG001|Overall Study|Withdrawal by Subject|5|||
33452497|NCT03073798|101547938|FG000|Overall Study|Adverse Event|1|||
33452498|NCT03073798|101547938|FG000|Overall Study|Withdrawal by Subject|1|||
33452499|NCT02640235|101547941|FG000|Overall Study|Withdrawal by Subject|7|||
33452500|NCT02640235|101547942|FG001|Overall Study|Withdrawal by Subject|6|||
33452501|NCT02640235|101547941|FG000|Overall Study|Lost to Follow-up|4|||
33452502|NCT02640235|101547942|FG001|Overall Study|Lost to Follow-up|3|||
33452503|NCT02640235|101547941|FG000|Overall Study|Death|2|||
33452504|NCT02640235|101547942|FG001|Overall Study|Death|3|||
33452505|NCT02640235|101547941|FG000|Overall Study|Other|1|||
33452506|NCT02640235|101547942|FG001|Overall Study|Other|2|||
33452507|NCT02313558|101547943|FG000|Overall Study|Withdrawal by Subject|2|||
33452508|NCT02313558|101547944|FG001|Overall Study|Withdrawal by Subject|0|||
33452509|NCT02313558|101547943|FG000|Overall Study|Lost to Follow-up|4|||
33452510|NCT02313558|101547944|FG001|Overall Study|Lost to Follow-up|4|||
33452511|NCT00796562|101547945|FG000|Overall Study|Death|49|||
33452512|NCT03196284|101547949|FG000|Main Part|Withdrawal by Subject|0|||
33452513|NCT03196284|101547950|FG001|Main Part|Withdrawal by Subject|1|||
33452514|NCT03196284|101547951|FG002|Main Part|Withdrawal by Subject|0|||
33452515|NCT03196284|101547949|FG000|Extension Part|Lack of Efficacy|0|||
33452516|NCT03196284|101547950|FG001|Extension Part|Lack of Efficacy|0|||
33452517|NCT03196284|101547951|FG002|Extension Part|Lack of Efficacy|1|||
33452518|NCT03196284|101547949|FG000|Extension Part|Withdrawal by Subject|0|||
33452519|NCT03196284|101547950|FG001|Extension Part|Withdrawal by Subject|0|||
33452520|NCT03196284|101547951|FG002|Extension Part|Withdrawal by Subject|1|||
33452521|NCT03196284|101547949|FG000|Extension Part|Physician Decision|0|||
33452522|NCT03196284|101547950|FG001|Extension Part|Physician Decision|0|||
33452523|NCT03196284|101547951|FG002|Extension Part|Physician Decision|1|||
33452524|NCT02462837|101547952|FG000|Overall Study|pt developed hives|1|||
33452525|NCT02462837|101547953|FG001|Overall Study|pt developed hives|0|||
33452526|NCT02462837|101547952|FG000|Overall Study|Withdrawal by Subject|1|||
33452527|NCT02462837|101547953|FG001|Overall Study|Withdrawal by Subject|0|||
33452528|NCT02385708|101547956|FG000|Overall Study|Withdrawal by Subject|0|||
33452529|NCT02385708|101547957|FG001|Overall Study|Withdrawal by Subject|2|||
33452530|NCT02385708|101547956|FG000|Overall Study|Withdrawn - surgery canceled|2|||
33452531|NCT02385708|101547957|FG001|Overall Study|Withdrawn - surgery canceled|5|||
33452532|NCT02385708|101547956|FG000|Overall Study|Investigator decision|5|||
33452533|NCT02385708|101547957|FG001|Overall Study|Investigator decision|7|||
33452534|NCT02385708|101547956|FG000|Overall Study|Protocol Violation|1|||
33452535|NCT02385708|101547957|FG001|Overall Study|Protocol Violation|1|||
33452536|NCT02611687|101547961|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
33452537|NCT02611687|101547962|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
33452538|NCT03025087|101547965|FG000|Overall Study|Physician Decision|3|||
33452539|NCT03025087|101547966|FG001|Overall Study|Physician Decision|3|||
33452540|NCT03025087|101547967|FG002|Overall Study|Physician Decision|0|||
33452541|NCT03025087|101547968|FG003|Overall Study|Physician Decision|0|||
33452542|NCT03025087|101547969|FG004|Overall Study|Physician Decision|0|||
33452543|NCT03025087|101547965|FG000|Overall Study|Withdrawal by Subject|1|||
33452544|NCT03025087|101547966|FG001|Overall Study|Withdrawal by Subject|1|||
33452545|NCT03025087|101547967|FG002|Overall Study|Withdrawal by Subject|0|||
33452546|NCT03025087|101547968|FG003|Overall Study|Withdrawal by Subject|0|||
33452547|NCT03025087|101547969|FG004|Overall Study|Withdrawal by Subject|0|||
33452548|NCT03025087|101547965|FG000|Overall Study|Unable to complete MRI|2|||
33452549|NCT03025087|101547966|FG001|Overall Study|Unable to complete MRI|2|||
33452550|NCT03025087|101547967|FG002|Overall Study|Unable to complete MRI|0|||
33452551|NCT03025087|101547968|FG003|Overall Study|Unable to complete MRI|0|||
33452552|NCT03025087|101547969|FG004|Overall Study|Unable to complete MRI|0|||
33452553|NCT02426918|101547970|FG000|Overall Study|Adverse Event|2|||
33452554|NCT02426918|101547971|FG001|Overall Study|Adverse Event|2|||
33452555|NCT02426918|101547972|FG002|Overall Study|Adverse Event|0|||
33452556|NCT02426918|101547970|FG000|Overall Study|Physician Decision|1|||
33452557|NCT02426918|101547971|FG001|Overall Study|Physician Decision|1|||
33452558|NCT02426918|101547972|FG002|Overall Study|Physician Decision|1|||
33452559|NCT02426918|101547970|FG000|Overall Study|Withdrawal by Subject|5|||
33452560|NCT02426918|101547971|FG001|Overall Study|Withdrawal by Subject|5|||
33452561|NCT02426918|101547972|FG002|Overall Study|Withdrawal by Subject|4|||
33452562|NCT02426918|101547970|FG000|Overall Study|Other|9|||
33452563|NCT02426918|101547971|FG001|Overall Study|Other|11|||
33452564|NCT02426918|101547972|FG002|Overall Study|Other|9|||
33452565|NCT01741545|101547973|FG000|Treatment Period|Lack of Efficacy|0|||
33452566|NCT01741545|101547974|FG001|Treatment Period|Lack of Efficacy|1|||
33452567|NCT01741545|101547973|FG000|Treatment Period|Adverse event, non-fatal|1|||
33452568|NCT01741545|101547974|FG001|Treatment Period|Adverse event, non-fatal|3|||
33452569|NCT01741545|101547973|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
33452570|NCT01741545|101547974|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
33452571|NCT01741545|101547973|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
33452572|NCT01741545|101547974|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
33452573|NCT02286466|101547975|FG000|Overall Study|Death|1|||
33452574|NCT02286466|101547976|FG001|Overall Study|Death|3|||
33452575|NCT02286466|101547975|FG000|Overall Study|Withdrawal by Subject|5|||
33452576|NCT02286466|101547976|FG001|Overall Study|Withdrawal by Subject|2|||
33452577|NCT02286466|101547975|FG000|Overall Study|Lost to Follow-up|1|||
33452578|NCT02286466|101547976|FG001|Overall Study|Lost to Follow-up|4|||
33452579|NCT02286466|101547975|FG000|Overall Study|Declined Clinician Assessment|0|||
33452580|NCT02286466|101547976|FG001|Overall Study|Declined Clinician Assessment|1|||
33452581|NCT04773600|101547977|FG000|Overall Study|Withdrawal by Subject|15|||
33452582|NCT04773600|101547978|FG001|Overall Study|Withdrawal by Subject|9|||
33452583|NCT04773600|101547977|FG000|Overall Study|Lost to Follow-up|10|||
33452584|NCT04773600|101547978|FG001|Overall Study|Lost to Follow-up|6|||
33452585|NCT04773600|101547977|FG000|Overall Study|Adverse Event|8|||
33452586|NCT04773600|101547978|FG001|Overall Study|Adverse Event|2|||
33452587|NCT04773600|101547977|FG000|Overall Study|Lack of Efficacy|2|||
33452588|NCT04773600|101547978|FG001|Overall Study|Lack of Efficacy|3|||
33452589|NCT04773600|101547977|FG000|Overall Study|Noncompliance|2|||
33452590|NCT04773600|101547978|FG001|Overall Study|Noncompliance|0|||
33452591|NCT04773600|101547977|FG000|Overall Study|Protocol Violation|2|||
33452592|NCT04773600|101547978|FG001|Overall Study|Protocol Violation|0|||
33452593|NCT04773600|101547977|FG000|Overall Study|Physician Decision|0|||
33452594|NCT04773600|101547978|FG001|Overall Study|Physician Decision|1|||
33452595|NCT04773600|101547977|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
33452596|NCT04773600|101547978|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
33452597|NCT04773600|101547977|FG000|Overall Study|Emergency Travel Out of Country|1|||
33452598|NCT04773600|101547978|FG001|Overall Study|Emergency Travel Out of Country|0|||
33452599|NCT00881569|101547979|FG000|Overall Study|Disease progression|1|||
33452600|NCT00881569|101547980|FG001|Overall Study|Disease progression|1|||
33452601|NCT00506831|101547981|FG000|Overall Study|Death|1|||
33452602|NCT00506831|101547981|FG000|Overall Study|Withdrawal by Subject|1|||
33452603|NCT05098743|101547982|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
33452604|NCT05098743|101547983|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
33452605|NCT05098743|101547982|FG000|Overall Study|Lost to Follow-up|1|||
33452606|NCT05098743|101547983|FG001|Overall Study|Lost to Follow-up|2|||
33452607|NCT00705666|101547984|FG000|Overall Study|No post-treatment questionnaire|279|||
33452608|NCT00705666|101547984|FG000|Overall Study|Withdrawal by Subject|21|||
33452609|NCT00705666|101547984|FG000|Overall Study|Physician Decision|7|||
33452610|NCT00705666|101547984|FG000|Overall Study|Lost to Follow-up|5|||
33452611|NCT00705666|101547984|FG000|Overall Study|Death|1|||
33452612|NCT00705666|101547984|FG000|Overall Study|Adverse Event|4|||
33452613|NCT00705666|101547984|FG000|Overall Study|Other|12|||
33452614|NCT00705666|101547984|FG000|Overall Study|Other|2|||
33452615|NCT00705666|101547984|FG000|Overall Study|Lack of data|3|||
33452616|NCT00705666|101547984|FG000|Overall Study|Untreated|5|||
33452617|NCT00425308|101547985|FG000|Overall Study|Adverse Event|2|||
33452618|NCT00425308|101547986|FG001|Overall Study|Adverse Event|1|||
33452619|NCT00425308|101547985|FG000|Overall Study|Withdrawal by Subject|1|||
33452620|NCT00425308|101547986|FG001|Overall Study|Withdrawal by Subject|0|||
33452621|NCT00425308|101547985|FG000|Overall Study|Death|1|||
33452622|NCT00425308|101547986|FG001|Overall Study|Death|0|||
33452623|NCT00989950|101547987|FG000|Randomized Phase|Protocol Violation|1|||
33452624|NCT00989950|101547988|FG001|Randomized Phase|Protocol Violation|0|||
33452625|NCT00989950|101547989|FG002|Randomized Phase|Protocol Violation|0|||
33452626|NCT00989950|101547990|FG003|Randomized Phase|Protocol Violation|0|||
33452627|NCT00989950|101547987|FG000|Randomized Phase|Adverse Event|0|||
33452628|NCT00989950|101547988|FG001|Randomized Phase|Adverse Event|1|||
33452629|NCT00989950|101547989|FG002|Randomized Phase|Adverse Event|0|||
33452630|NCT00989950|101547990|FG003|Randomized Phase|Adverse Event|0|||
33452631|NCT00087529|101547991|FG000|Overall Study|Death|1|||
33452632|NCT00087529|101547992|FG001|Overall Study|Death|0|||
33452633|NCT00087529|101547991|FG000|Overall Study|Adverse Event|0|||
33452634|NCT00087529|101547992|FG001|Overall Study|Adverse Event|8|||
33452635|NCT00087529|101547991|FG000|Overall Study|Pregnancy|0|||
33452636|NCT00087529|101547992|FG001|Overall Study|Pregnancy|1|||
33452637|NCT00087529|101547991|FG000|Overall Study|Lost to Follow-up|2|||
33452638|NCT00087529|101547992|FG001|Overall Study|Lost to Follow-up|3|||
33452639|NCT00087529|101547991|FG000|Overall Study|Participant Decision|14|||
33452640|NCT00087529|101547992|FG001|Overall Study|Participant Decision|37|||
33452641|NCT00087529|101547991|FG000|Overall Study|Physician Decision|4|||
33452642|NCT00087529|101547992|FG001|Overall Study|Physician Decision|8|||
33452643|NCT00087529|101547991|FG000|Overall Study|Initiation of Excluded Therapy|0|||
33452644|NCT00087529|101547992|FG001|Overall Study|Initiation of Excluded Therapy|1|||
33452645|NCT00087529|101547991|FG000|Overall Study|Participant Noncompliance|0|||
33452646|NCT00087529|101547992|FG001|Overall Study|Participant Noncompliance|1|||
33452647|NCT00087529|101547991|FG000|Overall Study|Disease Progression|5|||
33452648|NCT00087529|101547992|FG001|Overall Study|Disease Progression|4|||
33452649|NCT00087529|101547991|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
33452650|NCT00087529|101547992|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
33452651|NCT03131895|101547993|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
33452652|NCT03131895|101547994|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
33452653|NCT03131895|101547995|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
33452654|NCT03131895|101547996|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
33452655|NCT03131895|101547993|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
33452656|NCT03131895|101547994|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
33452657|NCT03131895|101547995|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
33452658|NCT03131895|101547996|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
33452659|NCT03131895|101547993|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33452660|NCT03131895|101547994|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
33452661|NCT03131895|101547995|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33452662|NCT03131895|101547996|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
33452663|NCT03131895|101547993|FG000|Washout Period (at Least 5 Days)|Other|0|||
33452664|NCT03131895|101547994|FG001|Washout Period (at Least 5 Days)|Other|0|||
33452665|NCT03131895|101547995|FG002|Washout Period (at Least 5 Days)|Other|2|||
33452666|NCT03131895|101547996|FG003|Washout Period (at Least 5 Days)|Other|0|||
33452667|NCT03131895|101547993|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
33452668|NCT03131895|101547994|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
33452669|NCT03131895|101547995|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
33452670|NCT03131895|101547996|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
33452671|NCT03131895|101547993|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
33452672|NCT03131895|101547994|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
33452673|NCT03131895|101547995|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
33452674|NCT03131895|101547996|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
33452675|NCT02654145|101547997|FG000|Overall Study|Lack of Efficacy|1|||
33452676|NCT02654145|101547997|FG000|Overall Study|Protocol Violation|1|||
33452677|NCT02654145|101547997|FG000|Overall Study|Withdrawal by Subject|5|||
33452678|NCT03930732|101547998|FG000|Overall Study|Adverse Event|9|||
33452679|NCT03930732|101547999|FG001|Overall Study|Adverse Event|7|||
33452680|NCT03930732|101547998|FG000|Overall Study|Poor compliance to protocol|0|||
33452681|NCT03930732|101547999|FG001|Overall Study|Poor compliance to protocol|1|||
33452682|NCT03930732|101547998|FG000|Overall Study|Withdrawal by Subject|23|||
33452683|NCT03930732|101547999|FG001|Overall Study|Withdrawal by Subject|11|||
33452684|NCT03930732|101547998|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
33452685|NCT03930732|101547999|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
33452686|NCT03930732|101547998|FG000|Overall Study|Other reason not related to COVID-19|5|||
33452687|NCT03930732|101547999|FG001|Overall Study|Other reason not related to COVID-19|8|||
33452688|NCT00828321|101548000|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
33452689|NCT00828321|101548001|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
33452690|NCT00828321|101548000|FG000|Second Intervention|Protocol Violation|0|||
33452691|NCT00828321|101548001|FG001|Second Intervention|Protocol Violation|1|||
33452692|NCT00834873|101548002|FG000|First Intervention|Adverse Event|0|||
33452693|NCT00834873|101548003|FG001|First Intervention|Adverse Event|1|||
33452694|NCT00835705|101548005|FG000|First Intervention|Difficulty with vein|1|||
33452695|NCT00835705|101548006|FG001|First Intervention|Difficulty with vein|0|||
33452696|NCT00835705|101548005|FG000|Second Intervention|Difficulty with vein|1|||
33452697|NCT00835705|101548006|FG001|Second Intervention|Difficulty with vein|0|||
33452698|NCT00669162|101548009|FG000|Overall Study|Withdrawal by Subject|1|||
33452699|NCT00712959|101548012|FG000|Overall Study|Protocol Violation|3|||
33452700|NCT00712959|101548013|FG001|Overall Study|Protocol Violation|1|||
33452701|NCT00712959|101548012|FG000|Overall Study|Lost to Follow-up|13|||
33452702|NCT00712959|101548013|FG001|Overall Study|Lost to Follow-up|2|||
33452703|NCT00712959|101548012|FG000|Overall Study|Withdrawal by Subject|3|||
33452704|NCT00712959|101548013|FG001|Overall Study|Withdrawal by Subject|0|||
33452705|NCT00847535|101548014|FG000|Overall Study|Withdrawal by Subject|2|||
33452706|NCT00847535|101548015|FG001|Overall Study|Withdrawal by Subject|1|||
33452707|NCT00847535|101548016|FG002|Overall Study|Withdrawal by Subject|1|||
33452708|NCT00847535|101548014|FG000|Overall Study|Lost to Follow-up|0|||
33452709|NCT00847535|101548015|FG001|Overall Study|Lost to Follow-up|1|||
33452710|NCT00847535|101548016|FG002|Overall Study|Lost to Follow-up|0|||
33452711|NCT01968551|101548020|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
33452712|NCT01968551|101548021|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
33452713|NCT01968551|101548022|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
33452714|NCT01968551|101548020|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
33452715|NCT01968551|101548021|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
33452716|NCT01968551|101548022|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
33452717|NCT01968551|101548020|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
33452718|NCT01968551|101548021|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
33452719|NCT01968551|101548022|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
33452720|NCT01968551|101548020|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
33452721|NCT01968551|101548021|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
33452722|NCT01968551|101548022|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
33452723|NCT01968551|101548020|FG000|Extension Phase|Adverse Event|0|||
33452724|NCT01968551|101548021|FG001|Extension Phase|Adverse Event|0|||
33452725|NCT01968551|101548022|FG002|Extension Phase|Adverse Event|2|||
33452726|NCT01968551|101548020|FG000|Extension Phase|Death|0|||
33452727|NCT01968551|101548021|FG001|Extension Phase|Death|1|||
33452728|NCT01968551|101548022|FG002|Extension Phase|Death|0|||
33452729|NCT01968551|101548020|FG000|Extension Phase|Withdrew Consent|0|||
33452730|NCT01968551|101548021|FG001|Extension Phase|Withdrew Consent|0|||
33452731|NCT01968551|101548022|FG002|Extension Phase|Withdrew Consent|1|||
33452732|NCT01968551|101548020|FG000|Extension Phase|Lost to Follow-up|1|||
33452733|NCT01968551|101548021|FG001|Extension Phase|Lost to Follow-up|0|||
33452734|NCT01968551|101548022|FG002|Extension Phase|Lost to Follow-up|1|||
33452735|NCT03789110|101548023|FG000|Overall Study|Adverse Event|2|||
33452736|NCT03789110|101548023|FG000|Overall Study|Physician Decision|1|||
33452737|NCT03789110|101548023|FG000|Overall Study|Withdrawal by Subject|2|||
33452738|NCT03789110|101548023|FG000|Overall Study|Lack of Efficacy|22|||
33452739|NCT03789110|101548023|FG000|Overall Study|still on treatment|3|||
33452740|NCT01874535|101548029|FG000|Overall Study|Lost to Follow-up|10|||
33452741|NCT01874535|101548030|FG001|Overall Study|Lost to Follow-up|9|||
33452742|NCT01874535|101548029|FG000|Overall Study|incomplete symptom resolution|45|||
33452743|NCT01874535|101548030|FG001|Overall Study|incomplete symptom resolution|35|||
33452744|NCT01252953|101548033|FG000|Overall Study|Withdrawal by Subject|16|||
33452745|NCT01252953|101548034|FG001|Overall Study|Withdrawal by Subject|17|||
33452746|NCT01252953|101548033|FG000|Overall Study|Lost to Follow-up|22|||
33452747|NCT01252953|101548034|FG001|Overall Study|Lost to Follow-up|21|||
33452748|NCT01572662|101548035|FG000|Overall Study|Withdrawal by Subject|1|||
33171665|NCT01134783|100537112|FG000|Overall Study|Withdrawal by Subject|15|||
33171666|NCT01134783|100537113|FG001|Overall Study|Withdrawal by Subject|9|||
33452749|NCT01572662|101548036|FG001|Overall Study|Withdrawal by Subject|0|||
33452750|NCT01572662|101548035|FG000|Overall Study|Physician Decision|0|||
33452751|NCT01572662|101548036|FG001|Overall Study|Physician Decision|1|||
33452752|NCT03599193|101548037|FG000|Overall Study|Adverse Event|0|||
33452753|NCT03599193|101548038|FG001|Overall Study|Adverse Event|2|||
33452754|NCT03599193|101548037|FG000|Overall Study|Withdrawal by Subject|1|||
33171667|NCT01134783|100537112|FG000|Overall Study|Lost to Follow-up|5|||
33171668|NCT01134783|100537113|FG001|Overall Study|Lost to Follow-up|20|||
33171669|NCT02782780|100537114|FG000|Overall Study|dropped out after randomization.|7|||
33171670|NCT02782780|100537115|FG001|Overall Study|dropped out after randomization.|5|||
33171671|NCT02782780|100537114|FG000|Overall Study|Protocol Violation|0|||
33171672|NCT02782780|100537115|FG001|Overall Study|Protocol Violation|2|||
33171673|NCT04900220|100537118|FG000|Overall Study|Lost to Follow-up|1|||
33171674|NCT04900220|100537119|FG001|Overall Study|Lost to Follow-up|1|||
33171675|NCT00429273|100537125|FG000|Overall Study|Lost to Follow-up|1|||
33171676|NCT00429273|100537126|FG001|Overall Study|Lost to Follow-up|2|||
33171677|NCT00429273|100537127|FG002|Overall Study|Lost to Follow-up|2|||
33171678|NCT00429273|100537125|FG000|Overall Study|Physician Decision|6|||
33171679|NCT00429273|100537126|FG001|Overall Study|Physician Decision|5|||
33171680|NCT00429273|100537127|FG002|Overall Study|Physician Decision|5|||
33171681|NCT00429273|100537125|FG000|Overall Study|Adverse Event|1|||
33171682|NCT00429273|100537126|FG001|Overall Study|Adverse Event|1|||
33171683|NCT00429273|100537127|FG002|Overall Study|Adverse Event|2|||
33171684|NCT03510884|100537130|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
33171685|NCT03510884|100537131|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
33171686|NCT03510884|100537132|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
33171687|NCT03510884|100537133|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
33261360|NCT01823536|100860064|FG005|Overall Study|Protocol Violation|0|||
33452755|NCT03599193|101548038|FG001|Overall Study|Withdrawal by Subject|0|||
33452756|NCT03599193|101548037|FG000|Overall Study|Protocol Violation|1|||
33452757|NCT03599193|101548038|FG001|Overall Study|Protocol Violation|0|||
33452758|NCT03599193|101548037|FG000|Overall Study|Lost to Follow-up|0|||
33452759|NCT03599193|101548038|FG001|Overall Study|Lost to Follow-up|1|||
33452760|NCT02241551|101548039|FG000|Overall Study|Adverse Event|1|||
33452761|NCT02241551|101548040|FG001|Overall Study|Adverse Event|0|||
33452762|NCT05479058|101548043|FG000|Overall Study|Withdrawal by Subject|1|||
33452763|NCT05479058|101548044|FG001|Overall Study|Withdrawal by Subject|1|||
33452764|NCT05479058|101548043|FG000|Overall Study|Study terminated by sponsor|10|||
33452765|NCT05479058|101548044|FG001|Overall Study|Study terminated by sponsor|10|||
33452766|NCT01923740|101548051|FG000|Overall Study|Lost to Follow-up|4|||
33452767|NCT01923740|101548052|FG001|Overall Study|Lost to Follow-up|9|||
33452768|NCT01923740|101548051|FG000|Overall Study|Withdrawal by Subject|2|||
33452769|NCT01923740|101548052|FG001|Overall Study|Withdrawal by Subject|0|||
33452770|NCT00654186|101548053|FG000|Overall Study|Withdrawal by Subject|5|||
33452771|NCT04697173|101548054|FG000|Overall Study|Withdrawal by Subject|34|||
33452772|NCT04697173|101548055|FG001|Overall Study|Withdrawal by Subject|38|||
33452773|NCT00829712|101548056|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
33452774|NCT00829712|101548057|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
33452775|NCT01539239|101548058|FG000|Overall Study|Death|5|||
33452776|NCT01539239|101548059|FG001|Overall Study|Death|5|||
33452777|NCT01539239|101548058|FG000|Overall Study|Lost to Follow-up|7|||
33452778|NCT01539239|101548059|FG001|Overall Study|Lost to Follow-up|12|||
33452779|NCT01559363|101548060|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
33452780|NCT01559363|101548061|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
33452781|NCT01559363|101548062|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
33452782|NCT01559363|101548063|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
33452783|NCT01559363|101548064|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
33452784|NCT01559363|101548065|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
33452785|NCT01559363|101548060|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
33452786|NCT01559363|101548061|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
33452787|NCT01559363|101548062|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
33452788|NCT01559363|101548063|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
33452789|NCT01559363|101548064|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
33452790|NCT01559363|101548065|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
33452791|NCT01559363|101548060|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
33452792|NCT01559363|101548061|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
33452793|NCT01559363|101548062|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
33452794|NCT01559363|101548063|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
33452795|NCT01559363|101548064|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
33452796|NCT01559363|101548065|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
33452797|NCT01559363|101548060|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
33452798|NCT01559363|101548061|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
33452799|NCT01559363|101548062|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
33452800|NCT01559363|101548063|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
33452801|NCT01559363|101548064|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
33452802|NCT01559363|101548065|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
33452803|NCT01559363|101548060|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
33452804|NCT01559363|101548061|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
33452805|NCT01559363|101548062|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
33452806|NCT01559363|101548063|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
33452807|NCT01559363|101548064|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
33452808|NCT01559363|101548065|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
33452809|NCT01559363|101548060|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
33452810|NCT01559363|101548061|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
33171688|NCT03510884|100537130|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
33171689|NCT03510884|100537131|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
33171690|NCT03510884|100537132|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
33171691|NCT03510884|100537133|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
33171692|NCT03510884|100537130|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
33171693|NCT03510884|100537131|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
33171694|NCT03510884|100537132|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
33171695|NCT03510884|100537133|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
33171696|NCT03510884|100537130|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
33171697|NCT03510884|100537131|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
33171698|NCT03510884|100537132|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
33171699|NCT03510884|100537133|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
33171700|NCT03510884|100537130|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
33171701|NCT03510884|100537131|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
33171702|NCT03510884|100537132|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
33171703|NCT03510884|100537133|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
33171704|NCT03510884|100537130|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
33171705|NCT03510884|100537131|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
33171706|NCT03510884|100537132|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
33171707|NCT03510884|100537133|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
33171708|NCT03510884|100537130|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
33171709|NCT03510884|100537131|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
33171710|NCT03510884|100537132|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
33171711|NCT03510884|100537133|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
33171712|NCT03510884|100537130|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
33171713|NCT03510884|100537131|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
33171714|NCT03510884|100537132|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
33171715|NCT03510884|100537133|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
33171716|NCT03510884|100537130|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
33171717|NCT03510884|100537131|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
33171718|NCT03510884|100537132|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
33171719|NCT03510884|100537133|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
33171720|NCT03510884|100537130|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
33171721|NCT03510884|100537131|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
33171722|NCT03510884|100537132|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
33452811|NCT01559363|101548062|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
33452812|NCT01559363|101548063|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
33452813|NCT01559363|101548064|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
33452814|NCT01559363|101548065|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
33171723|NCT03510884|100537133|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
33171724|NCT02846779|100537134|FG000|Overall Study|Lost Enrollment|83|||
33171725|NCT02846779|100537135|FG001|Overall Study|Lost Enrollment|82|||
33171726|NCT02846779|100537136|FG002|Overall Study|Lost Enrollment|86|||
33171727|NCT02846779|100537134|FG000|Overall Study|Less than 31 days of follow-up|56|||
33171728|NCT02846779|100537135|FG001|Overall Study|Less than 31 days of follow-up|45|||
33171729|NCT02846779|100537136|FG002|Overall Study|Less than 31 days of follow-up|52|||
33171730|NCT00085631|100537148|FG000|Overall Study|Missing Data|4|||
33171731|NCT00085631|100537149|FG001|Overall Study|Missing Data|11|||
33171732|NCT00085631|100537150|FG002|Overall Study|Missing Data|7|||
33171733|NCT02743520|100537151|FG000|Overall Study|Withdrawal by Subject|1|||
33171734|NCT01574326|100537154|FG000|Overall Study|Randomized but not treated|0|||
33171735|NCT01574326|100537155|FG001|Overall Study|Randomized but not treated|1|||
33171736|NCT01574326|100537154|FG000|Overall Study|Withdrawal by Participant|2|||
33171737|NCT01574326|100537155|FG001|Overall Study|Withdrawal by Participant|4|||
33171738|NCT01574326|100537154|FG000|Overall Study|Physician Decision|5|||
33171739|NCT01574326|100537155|FG001|Overall Study|Physician Decision|3|||
33171740|NCT01574326|100537154|FG000|Overall Study|Adverse Event|1|||
33171741|NCT01574326|100537155|FG001|Overall Study|Adverse Event|3|||
33171742|NCT01574326|100537154|FG000|Overall Study|Other: Mainly kidney transplant|8|||
33171743|NCT01574326|100537155|FG001|Overall Study|Other: Mainly kidney transplant|8|||
33171744|NCT01386554|100537156|FG000|Overall Study|Lost to Follow-up|0|||
33171745|NCT01386554|100537157|FG001|Overall Study|Lost to Follow-up|0|||
33171746|NCT01386554|100537158|FG002|Overall Study|Lost to Follow-up|1|||
33171747|NCT01386554|100537156|FG000|Overall Study|Adverse Event|2|||
33171748|NCT01386554|100537157|FG001|Overall Study|Adverse Event|5|||
33171749|NCT01386554|100537158|FG002|Overall Study|Adverse Event|2|||
33171750|NCT01386554|100537156|FG000|Overall Study|Progressive disease|1|||
33171751|NCT01386554|100537157|FG001|Overall Study|Progressive disease|2|||
33171752|NCT01386554|100537158|FG002|Overall Study|Progressive disease|2|||
33171753|NCT01386554|100537156|FG000|Overall Study|Administration of live vaccines|0|||
33171754|NCT01386554|100537157|FG001|Overall Study|Administration of live vaccines|1|||
33171755|NCT01386554|100537158|FG002|Overall Study|Administration of live vaccines|0|||
33171756|NCT01386554|100537156|FG000|Overall Study|Investigator discretion|0|||
33171757|NCT01386554|100537157|FG001|Overall Study|Investigator discretion|0|||
33171758|NCT01386554|100537158|FG002|Overall Study|Investigator discretion|1|||
33171759|NCT01386554|100537156|FG000|Overall Study|Reason not collected|0|||
33171760|NCT01386554|100537157|FG001|Overall Study|Reason not collected|1|||
33171761|NCT01386554|100537158|FG002|Overall Study|Reason not collected|0|||
33171762|NCT01342796|100537159|FG000|Overall Study|Withdrawal by Subject|2|||
33171763|NCT01342796|100537160|FG001|Overall Study|Withdrawal by Subject|0|||
33171764|NCT01342796|100537159|FG000|Overall Study|Lost to Follow-up|0|||
33171765|NCT01342796|100537160|FG001|Overall Study|Lost to Follow-up|3|||
33171766|NCT01342796|100537159|FG000|Overall Study|Inappropriate enrollment|1|||
33171767|NCT01342796|100537160|FG001|Overall Study|Inappropriate enrollment|0|||
33171768|NCT02345850|100537161|FG000|Overall Study|Not transplanted|10|||
33171769|NCT02345850|100537162|FG001|Overall Study|Not transplanted|5|||
33171770|NCT02345850|100537163|FG002|Overall Study|Not transplanted|4|||
33171771|NCT02345850|100537161|FG000|Overall Study|Lost to Follow-up|2|||
33171772|NCT02345850|100537162|FG001|Overall Study|Lost to Follow-up|3|||
33171773|NCT02345850|100537163|FG002|Overall Study|Lost to Follow-up|2|||
33171774|NCT02345850|100537161|FG000|Overall Study|Withdrawal by Subject|1|||
33171775|NCT02345850|100537162|FG001|Overall Study|Withdrawal by Subject|0|||
33171776|NCT02345850|100537163|FG002|Overall Study|Withdrawal by Subject|0|||
33171777|NCT03266107|100537164|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
33171778|NCT03266107|100537164|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
33171779|NCT03266107|100537164|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
33171780|NCT03266107|100537164|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
33171781|NCT00309387|100537165|FG000|Overall Study|Death|72|||
33171782|NCT00309387|100537166|FG001|Overall Study|Death|73|||
33171783|NCT00309387|100537165|FG000|Overall Study|Lost to Follow-up|70|||
33171784|NCT00309387|100537166|FG001|Overall Study|Lost to Follow-up|86|||
33171785|NCT01195415|100537168|FG000|Overall Study|No repeat biopsy due to progression|2|||
33171786|NCT00696696|100537178|FG000|Overall Study|Adverse Event|5|||
33171787|NCT00696696|100537178|FG000|Overall Study|Withdrawal by Subject|8|||
33171788|NCT00696696|100537178|FG000|Overall Study|Physician Decision|2|||
33171789|NCT00696696|100537178|FG000|Overall Study|Death|3|||
33171790|NCT01396148|100537183|FG000|Overall Study|Patient Decision|1|||
33171791|NCT00733408|100537189|FG000|Overall Study|Adverse Event|4|||
33171792|NCT02927080|100537192|FG000|Overall Study|Withdrawal by Subject|0|||
33171793|NCT02927080|100537193|FG001|Overall Study|Withdrawal by Subject|0|||
33171794|NCT02927080|100537194|FG002|Overall Study|Withdrawal by Subject|0|||
33171795|NCT02927080|100537195|FG003|Overall Study|Withdrawal by Subject|0|||
33171796|NCT02927080|100537196|FG004|Overall Study|Withdrawal by Subject|1|||
33171797|NCT02927080|100537197|FG005|Overall Study|Withdrawal by Subject|0|||
33171798|NCT02927080|100537198|FG006|Overall Study|Withdrawal by Subject|1|||
33171799|NCT02927080|100537199|FG007|Overall Study|Withdrawal by Subject|1|||
33171800|NCT02927080|100537200|FG008|Overall Study|Withdrawal by Subject|0|||
33171801|NCT02927080|100537201|FG009|Overall Study|Withdrawal by Subject|2|||
33171802|NCT02927080|100537192|FG000|Overall Study|Willingness to comply with protocol|0|||
33171803|NCT02927080|100537193|FG001|Overall Study|Willingness to comply with protocol|0|||
33171804|NCT02927080|100537194|FG002|Overall Study|Willingness to comply with protocol|0|||
33171805|NCT02927080|100537195|FG003|Overall Study|Willingness to comply with protocol|0|||
33171806|NCT02927080|100537196|FG004|Overall Study|Willingness to comply with protocol|0|||
33171807|NCT02927080|100537197|FG005|Overall Study|Willingness to comply with protocol|0|||
33171808|NCT02927080|100537198|FG006|Overall Study|Willingness to comply with protocol|0|||
33171809|NCT02927080|100537199|FG007|Overall Study|Willingness to comply with protocol|0|||
33171810|NCT02927080|100537200|FG008|Overall Study|Willingness to comply with protocol|0|||
33171811|NCT02927080|100537201|FG009|Overall Study|Willingness to comply with protocol|1|||
33171812|NCT02927080|100537192|FG000|Overall Study|Study terminated by Sponsor|0|||
33171813|NCT02927080|100537193|FG001|Overall Study|Study terminated by Sponsor|0|||
33171814|NCT02927080|100537194|FG002|Overall Study|Study terminated by Sponsor|0|||
33171815|NCT02927080|100537195|FG003|Overall Study|Study terminated by Sponsor|0|||
33171816|NCT02927080|100537196|FG004|Overall Study|Study terminated by Sponsor|0|||
33171817|NCT02927080|100537197|FG005|Overall Study|Study terminated by Sponsor|0|||
33171818|NCT02927080|100537198|FG006|Overall Study|Study terminated by Sponsor|6|||
33171819|NCT02927080|100537199|FG007|Overall Study|Study terminated by Sponsor|7|||
33171820|NCT02927080|100537200|FG008|Overall Study|Study terminated by Sponsor|2|||
33171821|NCT02927080|100537201|FG009|Overall Study|Study terminated by Sponsor|3|||
33171822|NCT02927080|100537192|FG000|Overall Study|Adverse Event|0|||
33171823|NCT02927080|100537193|FG001|Overall Study|Adverse Event|1|||
33171824|NCT02927080|100537194|FG002|Overall Study|Adverse Event|0|||
33171825|NCT02927080|100537195|FG003|Overall Study|Adverse Event|0|||
33171826|NCT02927080|100537196|FG004|Overall Study|Adverse Event|0|||
33171827|NCT02927080|100537197|FG005|Overall Study|Adverse Event|0|||
33171828|NCT02927080|100537198|FG006|Overall Study|Adverse Event|0|||
33171829|NCT02927080|100537199|FG007|Overall Study|Adverse Event|1|||
33171830|NCT02927080|100537200|FG008|Overall Study|Adverse Event|0|||
33171831|NCT02927080|100537201|FG009|Overall Study|Adverse Event|1|||
33171832|NCT02927080|100537192|FG000|Overall Study|Other|0|||
33171833|NCT02927080|100537193|FG001|Overall Study|Other|0|||
33171834|NCT02927080|100537194|FG002|Overall Study|Other|0|||
33171835|NCT02927080|100537195|FG003|Overall Study|Other|0|||
33171836|NCT02927080|100537196|FG004|Overall Study|Other|0|||
33171837|NCT02927080|100537197|FG005|Overall Study|Other|0|||
33171838|NCT02927080|100537198|FG006|Overall Study|Other|1|||
33171839|NCT02927080|100537199|FG007|Overall Study|Other|0|||
33171840|NCT02927080|100537200|FG008|Overall Study|Other|1|||
33171841|NCT02927080|100537201|FG009|Overall Study|Other|0|||
33171842|NCT02260921|100537202|FG000|Overall Study|Adverse Event|1|||
33171843|NCT02260921|100537203|FG001|Overall Study|Adverse Event|0|||
33171844|NCT02260921|100537202|FG000|Overall Study|Lost to Follow-up|4|||
33171845|NCT02260921|100537203|FG001|Overall Study|Lost to Follow-up|3|||
33171846|NCT02260921|100537202|FG000|Overall Study|Withdraw Consent|4|||
33171847|NCT02260921|100537203|FG001|Overall Study|Withdraw Consent|1|||
33171848|NCT02260921|100537202|FG000|Overall Study|Death|1|||
33171849|NCT02260921|100537203|FG001|Overall Study|Death|0|||
33171850|NCT02260921|100537202|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
33171851|NCT02260921|100537203|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
33171852|NCT00903695|100537204|FG000|Overall Study|medical exclusion after 1st testing|1|||
33171853|NCT00903695|100537205|FG001|Overall Study|medical exclusion after 1st testing|0|||
33171854|NCT00903695|100537204|FG000|Overall Study|lung cancer|1|||
33171855|NCT00903695|100537205|FG001|Overall Study|lung cancer|0|||
33171856|NCT00684593|100537206|FG000|Overall Study|Adverse Event|0|||
33171857|NCT00684593|100537207|FG001|Overall Study|Adverse Event|2|||
33171858|NCT00429104|100537213|FG000|Overall Study|Protocol Violation|1|||
33171859|NCT01074450|100537214|FG000|First Intervention|Emesis in Dosing Interval|0|||
33171860|NCT01074450|100537215|FG001|First Intervention|Emesis in Dosing Interval|2|||
33171861|NCT01074450|100537214|FG000|Second Intervention|Protocol Violation|1|||
33171862|NCT01074450|100537215|FG001|Second Intervention|Protocol Violation|0|||
33171863|NCT01074450|100537214|FG000|Second Intervention|Physician Decision|0|||
33171864|NCT01074450|100537215|FG001|Second Intervention|Physician Decision|1|||
33171865|NCT03552198|100537216|FG000|Overall Study|Lost to Follow-up|42|||
33171866|NCT03552198|100537217|FG001|Overall Study|Lost to Follow-up|48|||
33171867|NCT03552198|100537218|FG002|Overall Study|Lost to Follow-up|15|||
33171868|NCT03552198|100537219|FG003|Overall Study|Lost to Follow-up|19|||
33171869|NCT03552198|100537216|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
33171870|NCT03552198|100537217|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
33171871|NCT03552198|100537218|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
33171872|NCT03552198|100537219|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
33171873|NCT03552198|100537216|FG000|Overall Study|Did not receive air alerts|1|||
33171874|NCT03552198|100537217|FG001|Overall Study|Did not receive air alerts|0|||
33171875|NCT03552198|100537218|FG002|Overall Study|Did not receive air alerts|0|||
33171876|NCT03552198|100537219|FG003|Overall Study|Did not receive air alerts|1|||
33171877|NCT02279173|100537220|FG000|Overall Study|Protocol-specified Criteria|67|||
33171878|NCT02279173|100537220|FG000|Overall Study|Withdrawal by Subject|20|||
33171879|NCT02279173|100537220|FG000|Overall Study|Decision by Sponsor|4|||
33171880|NCT02279173|100537220|FG000|Overall Study|Lost to Follow-up|3|||
33171881|NCT01426373|100537221|FG000|Overall Study|Adverse Event|6|||
33171882|NCT01426373|100537221|FG000|Overall Study|Lost to Follow-up|14|||
33171883|NCT01426373|100537221|FG000|Overall Study|Participant Convenience|10|||
33171884|NCT01426373|100537221|FG000|Overall Study|Miscellaneous Reasons|4|||
33171885|NCT01713686|100537222|FG000|Overall Study|Lost to Follow-up|9|||
33171886|NCT01713686|100537222|FG000|Overall Study|Withdrawal by Subject|6|||
33171887|NCT02483520|100537223|FG000|Overall Study|Lost to Follow-up|3|||
33171888|NCT02483520|100537224|FG001|Overall Study|Lost to Follow-up|4|||
33171889|NCT02483520|100537223|FG000|Overall Study|Withdrawal by Subject|4|||
33171890|NCT02483520|100537224|FG001|Overall Study|Withdrawal by Subject|14|||
33171891|NCT02483520|100537223|FG000|Overall Study|Hospitalized|2|||
33171892|NCT02483520|100537224|FG001|Overall Study|Hospitalized|3|||
33171893|NCT02483520|100537223|FG000|Overall Study|Moved to LTC|2|||
33171894|NCT02483520|100537224|FG001|Overall Study|Moved to LTC|3|||
33171895|NCT00489541|100537225|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
33171896|NCT00489541|100537226|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
33171897|NCT00489541|100537225|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
33171898|NCT00489541|100537226|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
33452815|NCT01559363|101548060|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
33452816|NCT01559363|101548061|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
33452817|NCT01559363|101548062|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
33452818|NCT01559363|101548063|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
33452819|NCT01559363|101548064|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
33452820|NCT01559363|101548065|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
33452821|NCT02451358|101548066|FG000|Overall Study|Withdrawal by Subject|1|||
33452822|NCT02451358|101548067|FG001|Overall Study|Withdrawal by Subject|1|||
33452823|NCT02451358|101548068|FG002|Overall Study|Withdrawal by Subject|0|||
33452824|NCT02451358|101548069|FG003|Overall Study|Withdrawal by Subject|0|||
33452825|NCT02451358|101548066|FG000|Overall Study|Protocol Violation|0|||
33452826|NCT02451358|101548067|FG001|Overall Study|Protocol Violation|1|||
33452827|NCT02451358|101548068|FG002|Overall Study|Protocol Violation|1|||
33452828|NCT02451358|101548069|FG003|Overall Study|Protocol Violation|0|||
33452829|NCT00472212|101548070|FG000|Overall Study|Lost to Follow-up|6|||
33452830|NCT00472212|101548071|FG001|Overall Study|Lost to Follow-up|4|||
33452831|NCT01558635|101548072|FG000|Overall Study|Death|1|||
33171899|NCT00489541|100537225|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
33171900|NCT00489541|100537226|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
33171901|NCT00489541|100537225|FG000|12-Month Clinical Follow-up|Death|3|||
33171902|NCT00489541|100537226|FG001|12-Month Clinical Follow-up|Death|2|||
33171903|NCT00489541|100537225|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
33171904|NCT00489541|100537226|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
33452832|NCT01558635|101548072|FG000|Overall Study|Withdrawal by Subject|2|||
33452833|NCT01558635|101548072|FG000|Overall Study|Physician Decision|1|||
33452834|NCT01558635|101548072|FG000|Overall Study|Subject received other treatment|1|||
33452835|NCT01558635|101548072|FG000|Overall Study|Reveal XT was explanted|1|||
33452836|NCT03669250|101548073|FG000|Overall Study|Adverse Event|0|||
33452837|NCT03669250|101548074|FG001|Overall Study|Adverse Event|0|||
33452838|NCT03669250|101548075|FG002|Overall Study|Adverse Event|0|||
33452839|NCT03669250|101548076|FG003|Overall Study|Adverse Event|0|||
33452840|NCT03669250|101548077|FG004|Overall Study|Adverse Event|1|||
33452841|NCT03669250|101548078|FG005|Overall Study|Adverse Event|0|||
33452842|NCT03669250|101548073|FG000|Overall Study|Withdrawal by Subject|0|||
33452843|NCT03669250|101548074|FG001|Overall Study|Withdrawal by Subject|1|||
33452844|NCT03669250|101548075|FG002|Overall Study|Withdrawal by Subject|0|||
33452845|NCT03669250|101548076|FG003|Overall Study|Withdrawal by Subject|1|||
33452846|NCT03669250|101548077|FG004|Overall Study|Withdrawal by Subject|0|||
33452847|NCT03669250|101548078|FG005|Overall Study|Withdrawal by Subject|0|||
33452848|NCT03644550|101548081|FG000|Overall Study|Withdrawal by Subject|3|||
33452849|NCT03644550|101548081|FG000|Overall Study|Progressive disease|15|||
33452850|NCT00635648|101548085|FG000|Overall Study|Adverse Event|12|||
33452851|NCT00635648|101548085|FG000|Overall Study|Withdrawal by Subject|9|||
33452852|NCT00635648|101548085|FG000|Overall Study|Physician Decision|4|||
33452853|NCT00635648|101548085|FG000|Overall Study|Rapid progression of baseline disease|4|||
33452854|NCT00635648|101548085|FG000|Overall Study|Use of other antifungal agent needed|1|||
33452855|NCT00635648|101548085|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
33452856|NCT00635648|101548085|FG000|Overall Study|Noncompliance with protocol|1|||
33452857|NCT00635648|101548085|FG000|Overall Study|Other reason|2|||
33452858|NCT01266902|101550918|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
33452859|NCT01266902|101550919|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
33452860|NCT01266902|101550920|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
33452861|NCT01266902|101550918|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
33452862|NCT01266902|101550919|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
33452863|NCT01266902|101550920|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
33452864|NCT01266902|101550918|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
33452865|NCT01266902|101550919|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
33452866|NCT01266902|101550920|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
33452867|NCT01266902|101550918|FG000|Period 1 (Main Study)|Adverse Event|3|||
33452868|NCT01266902|101550919|FG001|Period 1 (Main Study)|Adverse Event|11|||
33452869|NCT01266902|101550920|FG002|Period 1 (Main Study)|Adverse Event|0|||
33452870|NCT01266902|101550918|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
33452871|NCT01266902|101550919|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
33452872|NCT01266902|101550920|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
33452873|NCT01266902|101550918|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
33452874|NCT01266902|101550919|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
33452875|NCT01266902|101550920|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
33452876|NCT01266902|101550918|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
33452877|NCT01266902|101550919|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
33452878|NCT01266902|101550920|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
33452879|NCT01266902|101550918|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
33452880|NCT01266902|101550919|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
33171905|NCT00489541|100537225|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
33171906|NCT00489541|100537226|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
33452881|NCT01266902|101550920|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
33452882|NCT01266902|101550918|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
33452883|NCT01266902|101550919|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
33452884|NCT01266902|101550920|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
33452885|NCT01266902|101550918|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
33452886|NCT01266902|101550919|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
33452887|NCT01266902|101550920|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
33171907|NCT01980992|100537227|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
33452888|NCT02436200|101550921|FG000|Overall Study|Significant outlier|1|||
33452889|NCT00807495|101550922|FG000|Overall Study|Adverse Event|6|||
33452890|NCT00807495|101550923|FG001|Overall Study|Adverse Event|3|||
33452891|NCT00807495|101550924|FG002|Overall Study|Adverse Event|1|||
33452892|NCT00807495|101550925|FG003|Overall Study|Adverse Event|1|||
33452893|NCT00807495|101550926|FG004|Overall Study|Adverse Event|2|||
33452894|NCT00807495|101550922|FG000|Overall Study|Withdrawal by Patient|2|||
33452895|NCT00807495|101550923|FG001|Overall Study|Withdrawal by Patient|0|||
33452896|NCT00807495|101550924|FG002|Overall Study|Withdrawal by Patient|1|||
33452897|NCT00807495|101550925|FG003|Overall Study|Withdrawal by Patient|0|||
33171908|NCT01980992|100537228|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
33171909|NCT01980992|100537227|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
33171910|NCT01980992|100537228|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
33171911|NCT01980992|100537227|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
33171912|NCT01980992|100537228|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
33171913|NCT01980992|100537227|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
33171914|NCT01980992|100537228|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
33171915|NCT01980992|100537227|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
33171916|NCT01980992|100537228|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
33171917|NCT01980992|100537227|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
33171918|NCT01980992|100537228|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
33171919|NCT01749514|100537229|FG000|Overall Study|Lost to Follow-up|0|||
33171920|NCT01749514|100537230|FG001|Overall Study|Lost to Follow-up|0|||
33171921|NCT01749514|100537231|FG002|Overall Study|Lost to Follow-up|0|||
33171922|NCT01749514|100537232|FG003|Overall Study|Lost to Follow-up|0|||
33171923|NCT01749514|100537233|FG004|Overall Study|Lost to Follow-up|0|||
33171924|NCT01749514|100537234|FG005|Overall Study|Lost to Follow-up|0|||
33171925|NCT01749514|100537235|FG006|Overall Study|Lost to Follow-up|0|||
33171926|NCT01749514|100537236|FG007|Overall Study|Lost to Follow-up|1|||
33171927|NCT01749514|100537229|FG000|Overall Study|Withdrawal by Subject|0|||
33171928|NCT01749514|100537230|FG001|Overall Study|Withdrawal by Subject|0|||
33171929|NCT01749514|100537231|FG002|Overall Study|Withdrawal by Subject|0|||
33171930|NCT01749514|100537232|FG003|Overall Study|Withdrawal by Subject|0|||
33171931|NCT01749514|100537233|FG004|Overall Study|Withdrawal by Subject|0|||
33171932|NCT01749514|100537234|FG005|Overall Study|Withdrawal by Subject|1|||
33171933|NCT01749514|100537235|FG006|Overall Study|Withdrawal by Subject|0|||
33171934|NCT01749514|100537236|FG007|Overall Study|Withdrawal by Subject|1|||
33171935|NCT01749514|100537229|FG000|Overall Study|Not Reported|0|||
33171936|NCT01749514|100537230|FG001|Overall Study|Not Reported|0|||
33452898|NCT00807495|101550926|FG004|Overall Study|Withdrawal by Patient|0|||
33171937|NCT01749514|100537231|FG002|Overall Study|Not Reported|0|||
33171938|NCT01749514|100537232|FG003|Overall Study|Not Reported|0|||
33171939|NCT01749514|100537233|FG004|Overall Study|Not Reported|0|||
33171940|NCT01749514|100537234|FG005|Overall Study|Not Reported|0|||
33171941|NCT01749514|100537235|FG006|Overall Study|Not Reported|0|||
33171942|NCT01749514|100537236|FG007|Overall Study|Not Reported|5|||
33171943|NCT01806545|100537237|FG000|Overall Study|Adverse Event|2|||
33171944|NCT01806545|100537238|FG001|Overall Study|Adverse Event|3|||
33171945|NCT01806545|100537237|FG000|Overall Study|Lost to Follow-up|1|||
33171946|NCT01806545|100537238|FG001|Overall Study|Lost to Follow-up|0|||
33171947|NCT01806545|100537237|FG000|Overall Study|Withdrawal by Subject|3|||
33171948|NCT01806545|100537238|FG001|Overall Study|Withdrawal by Subject|2|||
33171949|NCT00420927|100537239|FG000|Period 1|Adverse Event|19|||
33171950|NCT00420927|100537240|FG001|Period 1|Adverse Event|15|||
33452899|NCT00807495|101550922|FG000|Overall Study|Reason Not Specified|0|||
33452900|NCT00807495|101550923|FG001|Overall Study|Reason Not Specified|3|||
33452901|NCT00807495|101550924|FG002|Overall Study|Reason Not Specified|2|||
33452902|NCT00807495|101550925|FG003|Overall Study|Reason Not Specified|0|||
33171951|NCT00420927|100537241|FG002|Period 1|Adverse Event|0|||
33171952|NCT00420927|100537242|FG003|Period 1|Adverse Event|0|||
33171953|NCT00420927|100537243|FG004|Period 1|Adverse Event|0|||
33171954|NCT00420927|100537244|FG005|Period 1|Adverse Event|0|||
33171955|NCT00420927|100537245|FG006|Period 1|Adverse Event|0|||
33171956|NCT00420927|100537239|FG000|Period 1|Withdrawal by Subject|7|||
33171957|NCT00420927|100537240|FG001|Period 1|Withdrawal by Subject|12|||
33171958|NCT00420927|100537241|FG002|Period 1|Withdrawal by Subject|0|||
33171959|NCT00420927|100537242|FG003|Period 1|Withdrawal by Subject|0|||
33171960|NCT00420927|100537243|FG004|Period 1|Withdrawal by Subject|0|||
33171961|NCT00420927|100537244|FG005|Period 1|Withdrawal by Subject|0|||
33171962|NCT00420927|100537245|FG006|Period 1|Withdrawal by Subject|0|||
33171963|NCT00420927|100537239|FG000|Period 1|Lost to Follow-up|8|||
33171964|NCT00420927|100537240|FG001|Period 1|Lost to Follow-up|6|||
33171965|NCT00420927|100537241|FG002|Period 1|Lost to Follow-up|0|||
33261361|NCT01823536|100860059|FG000|Overall Study|Withdrawal by Subject|1|||
33261362|NCT01823536|100860060|FG001|Overall Study|Withdrawal by Subject|1|||
33452903|NCT00807495|101550926|FG004|Overall Study|Reason Not Specified|3|||
33452904|NCT03499873|101550929|FG000|Overall Study|Withdrawal by Subject|4|||
33452905|NCT03499873|101550930|FG001|Overall Study|Withdrawal by Subject|6|||
33452906|NCT03499873|101550931|FG002|Overall Study|Withdrawal by Subject|1|||
33452907|NCT03499873|101550929|FG000|Overall Study|Subjects condition worsened|0|||
33452908|NCT03499873|101550930|FG001|Overall Study|Subjects condition worsened|3|||
33452909|NCT03499873|101550931|FG002|Overall Study|Subjects condition worsened|11|||
33452910|NCT03499873|101550929|FG000|Overall Study|Adverse Event|8|||
33452911|NCT03499873|101550930|FG001|Overall Study|Adverse Event|3|||
33452912|NCT03499873|101550931|FG002|Overall Study|Adverse Event|6|||
33452913|NCT03499873|101550929|FG000|Overall Study|Physician Decision|1|||
33452914|NCT03499873|101550930|FG001|Overall Study|Physician Decision|0|||
33171966|NCT00420927|100537242|FG003|Period 1|Lost to Follow-up|0|||
33452915|NCT03499873|101550931|FG002|Overall Study|Physician Decision|0|||
33452916|NCT03499873|101550929|FG000|Overall Study|Administrative reasons|0|||
33452917|NCT03499873|101550930|FG001|Overall Study|Administrative reasons|1|||
33452918|NCT03499873|101550931|FG002|Overall Study|Administrative reasons|0|||
33452919|NCT03499873|101550929|FG000|Overall Study|Concomitant therapy|5|||
33452920|NCT03499873|101550930|FG001|Overall Study|Concomitant therapy|4|||
33452921|NCT03499873|101550931|FG002|Overall Study|Concomitant therapy|7|||
33452922|NCT03499873|101550929|FG000|Overall Study|Miscellaneous|1|||
33452923|NCT03499873|101550930|FG001|Overall Study|Miscellaneous|2|||
33452924|NCT03499873|101550931|FG002|Overall Study|Miscellaneous|2|||
33452925|NCT03499873|101550929|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
33452926|NCT03499873|101550930|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
33452927|NCT03499873|101550931|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
33452928|NCT00604162|101550934|FG000|Overall Study|Physician Decision|3|||
33452929|NCT00604162|101550934|FG000|Overall Study|Withdrawal by Subject|1|||
33452930|NCT00663234|101550945|FG000|Overall Study|Not willing to adhere to requirements|1|||
33452931|NCT02637141|101550949|FG000|Overall Study|Adverse Event|1|||
33452932|NCT02637141|101550950|FG001|Overall Study|Adverse Event|1|||
33452933|NCT02637141|101550951|FG002|Overall Study|Adverse Event|0|||
33452934|NCT02637141|101550949|FG000|Overall Study|Withdrawal by Subject|1|||
33452935|NCT02637141|101550950|FG001|Overall Study|Withdrawal by Subject|1|||
33452936|NCT02637141|101550951|FG002|Overall Study|Withdrawal by Subject|1|||
33452937|NCT01196390|101550952|FG000|Overall Study|Protocol Violation|4|||
33452938|NCT01196390|101550953|FG001|Overall Study|Protocol Violation|5|||
33452939|NCT03827395|101550954|FG000|Overall Study|Lost to Follow-up|1|||
33452940|NCT03827395|101550955|FG001|Overall Study|Lost to Follow-up|0|||
33452941|NCT03827395|101550954|FG000|Overall Study|Protocol Violation|1|||
33452942|NCT03827395|101550955|FG001|Overall Study|Protocol Violation|0|||
33452943|NCT03827395|101550954|FG000|Overall Study|Became ineligible after enrollment|1|||
33452944|NCT03827395|101550955|FG001|Overall Study|Became ineligible after enrollment|2|||
33452945|NCT00918684|101550956|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
33452946|NCT00918684|101550956|FG000|Treatment Phase|Lack of Efficacy|6|||
33452947|NCT00918684|101550956|FG000|Treatment Phase|Lost to Follow-up|2|||
33452948|NCT00918684|101550956|FG000|Treatment Phase|Physician Decision|8|||
33452949|NCT00918684|101550956|FG000|Treatment Phase|Protocol Violation|1|||
33452950|NCT00918684|101550956|FG000|Treatment Phase|Withdrawal by Subject|8|||
33452951|NCT01867658|101550957|FG000|Overall Study|Withdrawal by Subject|6|||
33452952|NCT01867658|101550957|FG000|Overall Study|Death|2|||
33452953|NCT01867658|101550957|FG000|Overall Study|Subject could not be contacted|1|||
33171967|NCT00420927|100537243|FG004|Period 1|Lost to Follow-up|0|||
33171968|NCT00420927|100537244|FG005|Period 1|Lost to Follow-up|0|||
33171969|NCT00420927|100537245|FG006|Period 1|Lost to Follow-up|0|||
33171970|NCT00420927|100537239|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
33171971|NCT00420927|100537240|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
33452954|NCT00840203|101550958|FG000|First Intervention|Protocol Violation|1|||
33171972|NCT00420927|100537241|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
33261363|NCT01823536|100860061|FG002|Overall Study|Withdrawal by Subject|0|||
33452955|NCT00840203|101550959|FG001|First Intervention|Protocol Violation|1|||
33452956|NCT00840203|101550958|FG000|Washout|Protocol Violation|1|||
33452957|NCT00840203|101550959|FG001|Washout|Protocol Violation|0|||
33452958|NCT02888756|101550960|FG000|Analytical Treatment Interruption|Physician Decision|10|||
33452959|NCT02888756|101550961|FG001|Analytical Treatment Interruption|Physician Decision|6|||
33452960|NCT02888756|101550962|FG002|Analytical Treatment Interruption|Physician Decision|5|||
33452961|NCT01566435|101550979|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
33452962|NCT00731939|101550980|FG000|Overall Study|Adverse Event|6|||
33452963|NCT00731939|101550980|FG000|Overall Study|Lost to Follow-up|15|||
33452964|NCT00731939|101550980|FG000|Overall Study|Not implanted with study device|9|||
33452965|NCT00731939|101550980|FG000|Overall Study|Withdrawal by Subject|2|||
33452966|NCT00731939|101550980|FG000|Overall Study|Did not meet enrollment criteria|2|||
33452967|NCT01490190|101550981|FG000|Overall Study|Withdrawal by Subject|9|||
33452968|NCT01490190|101550981|FG000|Overall Study|Adverse Event|17|||
33452969|NCT01490190|101550981|FG000|Overall Study|Protocol Violation|5|||
33452970|NCT01490190|101550981|FG000|Overall Study|Lost to Follow-up|13|||
33452971|NCT01490190|101550981|FG000|Overall Study|Relocation|1|||
33452972|NCT01490190|101550981|FG000|Overall Study|Inconvenience|1|||
33452973|NCT01490190|101550981|FG000|Overall Study|Ring expulsion|2|||
33452974|NCT01046084|101550982|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
33452975|NCT01046084|101550983|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
33452976|NCT04299087|101550984|FG000|Overall Study|Lost to Follow-up|2|||
33452977|NCT04299087|101550985|FG001|Overall Study|Lost to Follow-up|1|||
33452978|NCT01174186|101550990|FG000|Overall Study|Lost to Follow-up|0|||
33452979|NCT01174186|101550991|FG001|Overall Study|Lost to Follow-up|1|||
33452980|NCT01174186|101550990|FG000|Overall Study|Withdrawal by Subject|0|||
33452981|NCT01174186|101550991|FG001|Overall Study|Withdrawal by Subject|2|||
33452982|NCT01083693|101550994|FG000|Overall Study|Adverse Event|1|||
33452983|NCT01083693|101550995|FG001|Overall Study|Adverse Event|1|||
33452984|NCT01083693|101550996|FG002|Overall Study|Adverse Event|0|||
33452985|NCT01083693|101550994|FG000|Overall Study|Lost to Follow-up|2|||
33452986|NCT01083693|101550995|FG001|Overall Study|Lost to Follow-up|0|||
33452987|NCT01083693|101550996|FG002|Overall Study|Lost to Follow-up|2|||
33452988|NCT01083693|101550994|FG000|Overall Study|Lack of effectiveness|13|||
33452989|NCT01083693|101550995|FG001|Overall Study|Lack of effectiveness|2|||
33452990|NCT01083693|101550996|FG002|Overall Study|Lack of effectiveness|2|||
33452991|NCT01083693|101550994|FG000|Overall Study|Patient Moved|0|||
33452992|NCT01083693|101550995|FG001|Overall Study|Patient Moved|1|||
33452993|NCT01083693|101550996|FG002|Overall Study|Patient Moved|0|||
33452994|NCT01083693|101550994|FG000|Overall Study|Complete remission|0|||
33452995|NCT01083693|101550995|FG001|Overall Study|Complete remission|1|||
33452996|NCT01083693|101550996|FG002|Overall Study|Complete remission|0|||
33452997|NCT01083693|101550994|FG000|Overall Study|Other medical condition/surgery|1|||
33452998|NCT01083693|101550995|FG001|Overall Study|Other medical condition/surgery|1|||
33452999|NCT01083693|101550996|FG002|Overall Study|Other medical condition/surgery|0|||
33453000|NCT01083693|101550994|FG000|Overall Study|Withdrawal by Subject|3|||
33453001|NCT01083693|101550995|FG001|Overall Study|Withdrawal by Subject|0|||
33453002|NCT01083693|101550996|FG002|Overall Study|Withdrawal by Subject|2|||
33453003|NCT01083693|101550994|FG000|Overall Study|Reason unknown|0|||
33453004|NCT01083693|101550995|FG001|Overall Study|Reason unknown|0|||
33453005|NCT01083693|101550996|FG002|Overall Study|Reason unknown|1|||
33453006|NCT01442376|101550997|FG000|Overall Study|Adverse Event|0|||
33453007|NCT01442376|101550998|FG001|Overall Study|Adverse Event|3|||
33453008|NCT01442376|101550999|FG002|Overall Study|Adverse Event|2|||
33453009|NCT01442376|101550997|FG000|Overall Study|Death|0|||
33453010|NCT01442376|101550998|FG001|Overall Study|Death|1|||
33453011|NCT01442376|101550999|FG002|Overall Study|Death|1|||
33453012|NCT01442376|101550997|FG000|Overall Study|Withdrawal of consent|0|||
33453013|NCT01442376|101550998|FG001|Overall Study|Withdrawal of consent|0|||
33453014|NCT01442376|101550999|FG002|Overall Study|Withdrawal of consent|1|||
33453015|NCT01442376|101550997|FG000|Overall Study|Patients not treated|2|||
33453016|NCT01442376|101550998|FG001|Overall Study|Patients not treated|3|||
33453017|NCT01442376|101550999|FG002|Overall Study|Patients not treated|1|||
33453018|NCT01442376|101550997|FG000|Overall Study|Not eligible for subsequent cycles|1|||
33453019|NCT01442376|101550998|FG001|Overall Study|Not eligible for subsequent cycles|2|||
33453020|NCT01442376|101550999|FG002|Overall Study|Not eligible for subsequent cycles|0|||
33453021|NCT01562613|101551000|FG000|Overall Study|Lost to Follow-up|2|||
33453022|NCT01562613|101551000|FG000|Overall Study|Withdrawal by Subject|2|||
33453023|NCT00070291|101551002|FG000|Step 1|Withdrawal by Subject|1|||
33453024|NCT00070291|101551002|FG000|Step 1|Adverse Event|1|||
33171973|NCT00420927|100537242|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
33453025|NCT00070291|101551002|FG000|Step 2|Adverse Event|1|||
33453026|NCT01597791|101551005|FG000|Overall Study|Physician Decision|2|||
33453027|NCT01597791|101551006|FG001|Overall Study|Physician Decision|1|||
33453028|NCT01597791|101551005|FG000|Overall Study|Cesarean Section|6|||
33453029|NCT01597791|101551006|FG001|Overall Study|Cesarean Section|7|||
33453030|NCT01597791|101551005|FG000|Overall Study|Subject withdrawal|0|||
33453031|NCT01597791|101551006|FG001|Overall Study|Subject withdrawal|1|||
33453032|NCT01597791|101551005|FG000|Overall Study|Protocol Violation|0|||
33453033|NCT01597791|101551006|FG001|Overall Study|Protocol Violation|1|||
33453034|NCT00834444|101551007|FG000|First Intervention|Adverse Event|1|||
33453035|NCT00834444|101551008|FG001|First Intervention|Adverse Event|0|||
33453036|NCT00834444|101551007|FG000|First Intervention|Intolerance to Venopuncture|0|||
33453037|NCT00834444|101551008|FG001|First Intervention|Intolerance to Venopuncture|1|||
33453038|NCT00834444|101551007|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
33453039|NCT00834444|101551008|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
33453040|NCT00834444|101551007|FG000|Second Intervention|Adverse Event|1|||
33453041|NCT00834444|101551008|FG001|Second Intervention|Adverse Event|0|||
33453042|NCT01751087|101551009|FG000|Overall Study|Withdrawal by Subject|1|||
33453043|NCT01751087|101551010|FG001|Overall Study|Withdrawal by Subject|0|||
33453044|NCT01751087|101551011|FG002|Overall Study|Withdrawal by Subject|0|||
33453045|NCT01751087|101551009|FG000|Overall Study|Physician Decision|0|||
33453046|NCT01751087|101551010|FG001|Overall Study|Physician Decision|0|||
33453047|NCT01751087|101551011|FG002|Overall Study|Physician Decision|1|||
33453048|NCT00728754|101551012|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
33453049|NCT00728754|101551013|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
33453050|NCT00728754|101551012|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
33453051|NCT00728754|101551013|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
33453052|NCT00728754|101551012|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
33453053|NCT00728754|101551013|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
33453054|NCT00795821|101551017|FG000|Acute Treatment Phase|Adverse Event|23|||
33453055|NCT00795821|101551018|FG001|Acute Treatment Phase|Adverse Event|4|||
33453056|NCT00795821|101551017|FG000|Acute Treatment Phase|Death|1|||
33453057|NCT00795821|101551018|FG001|Acute Treatment Phase|Death|0|||
33453058|NCT00795821|101551017|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
33453059|NCT00795821|101551018|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
33453060|NCT00795821|101551017|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
33453061|NCT00795821|101551018|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
33453062|NCT00795821|101551017|FG000|Acute Treatment Phase|Physician Decision|1|||
33453063|NCT00795821|101551018|FG001|Acute Treatment Phase|Physician Decision|1|||
33453064|NCT00795821|101551017|FG000|Acute Treatment Phase|Protocol Violation|1|||
33453065|NCT00795821|101551018|FG001|Acute Treatment Phase|Protocol Violation|2|||
33453066|NCT00795821|101551017|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
33453067|NCT00795821|101551018|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
33453068|NCT00795821|101551017|FG000|Long-term Extension Phase|Adverse Event|25|||
33453069|NCT00795821|101551018|FG001|Long-term Extension Phase|Adverse Event|32|||
33453070|NCT00795821|101551017|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
33453071|NCT00795821|101551018|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
33453072|NCT00795821|101551017|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
33453073|NCT00795821|101551018|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
33453074|NCT00795821|101551017|FG000|Long-term Extension Phase|Physician Decision|1|||
33453075|NCT00795821|101551018|FG001|Long-term Extension Phase|Physician Decision|2|||
33453076|NCT00795821|101551017|FG000|Long-term Extension Phase|Protocol Violation|3|||
33453077|NCT00795821|101551018|FG001|Long-term Extension Phase|Protocol Violation|5|||
33453078|NCT00795821|101551017|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
33171974|NCT00420927|100537243|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
33453079|NCT00795821|101551018|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
33453080|NCT00795821|101551017|FG000|Taper Phase|Adverse Event|2|||
33453081|NCT00795821|101551018|FG001|Taper Phase|Adverse Event|0|||
33453082|NCT00795821|101551017|FG000|Taper Phase|Lost to Follow-up|1|||
33453083|NCT00795821|101551018|FG001|Taper Phase|Lost to Follow-up|0|||
33453084|NCT00795821|101551017|FG000|Taper Phase|Physician Decision|2|||
33453085|NCT00795821|101551018|FG001|Taper Phase|Physician Decision|0|||
33453086|NCT00795821|101551017|FG000|Taper Phase|Withdrawal by Subject|4|||
33453087|NCT00795821|101551018|FG001|Taper Phase|Withdrawal by Subject|0|||
33453088|NCT01647828|101551029|FG000|Overall Study|Death|3|||
33453089|NCT01647828|101551030|FG001|Overall Study|Death|4|||
33453090|NCT01647828|101551031|FG002|Overall Study|Death|4|||
33453091|NCT01647828|101551032|FG003|Overall Study|Death|5|||
33453092|NCT01647828|101551033|FG004|Overall Study|Death|6|||
33453093|NCT01647828|101551034|FG005|Overall Study|Death|3|||
33453094|NCT01647828|101551035|FG006|Overall Study|Death|10|||
33453095|NCT01647828|101551036|FG007|Overall Study|Death|60|||
33453096|NCT01647828|101551037|FG008|Overall Study|Death|71|||
33453097|NCT01647828|101551029|FG000|Overall Study|Withdrawal by Subject|2|||
33453098|NCT01647828|101551030|FG001|Overall Study|Withdrawal by Subject|0|||
33453099|NCT01647828|101551031|FG002|Overall Study|Withdrawal by Subject|0|||
33453100|NCT01647828|101551032|FG003|Overall Study|Withdrawal by Subject|1|||
33453101|NCT01647828|101551033|FG004|Overall Study|Withdrawal by Subject|0|||
33453102|NCT01647828|101551034|FG005|Overall Study|Withdrawal by Subject|0|||
33453103|NCT01647828|101551035|FG006|Overall Study|Withdrawal by Subject|1|||
33453104|NCT01647828|101551036|FG007|Overall Study|Withdrawal by Subject|0|||
33453105|NCT01647828|101551037|FG008|Overall Study|Withdrawal by Subject|2|||
33453106|NCT01647828|101551029|FG000|Overall Study|Study terminated by Sponsor|0|||
33453107|NCT01647828|101551030|FG001|Overall Study|Study terminated by Sponsor|0|||
33453108|NCT01647828|101551031|FG002|Overall Study|Study terminated by Sponsor|0|||
33453109|NCT01647828|101551032|FG003|Overall Study|Study terminated by Sponsor|0|||
33453110|NCT01647828|101551033|FG004|Overall Study|Study terminated by Sponsor|0|||
33453111|NCT01647828|101551034|FG005|Overall Study|Study terminated by Sponsor|0|||
33453112|NCT01647828|101551035|FG006|Overall Study|Study terminated by Sponsor|1|||
33453113|NCT01647828|101551036|FG007|Overall Study|Study terminated by Sponsor|26|||
33453114|NCT01647828|101551037|FG008|Overall Study|Study terminated by Sponsor|16|||
33453115|NCT01647828|101551029|FG000|Overall Study|Lost to Follow-up|0|||
33453116|NCT01647828|101551030|FG001|Overall Study|Lost to Follow-up|0|||
33453117|NCT01647828|101551031|FG002|Overall Study|Lost to Follow-up|0|||
33453118|NCT01647828|101551032|FG003|Overall Study|Lost to Follow-up|0|||
33453119|NCT01647828|101551033|FG004|Overall Study|Lost to Follow-up|0|||
33453120|NCT01647828|101551034|FG005|Overall Study|Lost to Follow-up|0|||
33453121|NCT01647828|101551035|FG006|Overall Study|Lost to Follow-up|0|||
33453122|NCT01647828|101551036|FG007|Overall Study|Lost to Follow-up|2|||
33453123|NCT01647828|101551037|FG008|Overall Study|Lost to Follow-up|0|||
33453124|NCT00673660|101551038|FG000|Overall Study|Lost to Follow-up|107|||
33453125|NCT01456962|101551039|FG000|Overall Study|Lost to Follow-up|2|||
33453126|NCT01456962|101551040|FG001|Overall Study|Lost to Follow-up|1|||
33453127|NCT02280863|101551041|FG000|Integrated Platform|Met stopping criteria|0|||
33453128|NCT02280863|101551042|FG001|Integrated Platform|Met stopping criteria|1|||
33453129|NCT04590027|101551058|FG000|Overall Study|Lost to Follow-up|17|||
33453130|NCT04590027|101551059|FG001|Overall Study|Lost to Follow-up|14|||
33453131|NCT04590027|101551058|FG000|Overall Study|Protocol Violation|0|||
33453132|NCT04590027|101551059|FG001|Overall Study|Protocol Violation|3|||
33453133|NCT01859598|101551060|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
33453134|NCT01488448|101551063|FG000|Overall Study|Withdrawal by Subject|3|||
33453135|NCT01488448|101551064|FG001|Overall Study|Withdrawal by Subject|1|||
33453136|NCT01488448|101551063|FG000|Overall Study|Adverse Event|9|||
33453137|NCT01488448|101551064|FG001|Overall Study|Adverse Event|4|||
33453138|NCT01488448|101551063|FG000|Overall Study|Physician Decision|4|||
33453139|NCT01488448|101551064|FG001|Overall Study|Physician Decision|9|||
33453140|NCT01488448|101551063|FG000|Overall Study|Protocol Violation|4|||
33453141|NCT01488448|101551064|FG001|Overall Study|Protocol Violation|3|||
33453142|NCT04442503|101551068|FG000|Overall Study|Adverse Event|1|||
33453143|NCT04442503|101551069|FG001|Overall Study|Adverse Event|1|||
33453144|NCT04442503|101551068|FG000|Overall Study|Lost to Follow-up|8|||
33453145|NCT04442503|101551069|FG001|Overall Study|Lost to Follow-up|6|||
33453146|NCT04442503|101551068|FG000|Overall Study|Physician Decision|0|||
33453147|NCT04442503|101551069|FG001|Overall Study|Physician Decision|2|||
33453148|NCT04442503|101551068|FG000|Overall Study|Withdrawal by Subject|3|||
33453149|NCT04442503|101551069|FG001|Overall Study|Withdrawal by Subject|4|||
33453150|NCT04442503|101551068|FG000|Overall Study|Reason not Specified|0|||
33453151|NCT04442503|101551069|FG001|Overall Study|Reason not Specified|1|||
33453152|NCT04442503|101551068|FG000|Overall Study|Randomized but not Treated|3|||
33453153|NCT04442503|101551069|FG001|Overall Study|Randomized but not Treated|1|||
33453154|NCT00849797|101551072|FG000|First Intervention|bad veins|1|||
33453155|NCT00849797|101551073|FG001|First Intervention|bad veins|0|||
33453156|NCT00849797|101551072|FG000|First Intervention|Adverse Event|0|||
33453157|NCT00849797|101551073|FG001|First Intervention|Adverse Event|1|||
33453158|NCT00849797|101551072|FG000|Washout: One Week|Withdrawal by Subject|0|||
33453159|NCT00849797|101551073|FG001|Washout: One Week|Withdrawal by Subject|2|||
33453160|NCT01592240|101551076|FG000|Overall Study|Adverse Event|1|||
33453161|NCT01592240|101551077|FG001|Overall Study|Adverse Event|0|||
33453162|NCT01592240|101551078|FG002|Overall Study|Adverse Event|0|||
33453163|NCT01592240|101551079|FG003|Overall Study|Adverse Event|1|||
33453164|NCT01592240|101551080|FG004|Overall Study|Adverse Event|1|||
33453165|NCT01592240|101551081|FG005|Overall Study|Adverse Event|0|||
33453166|NCT01592240|101551082|FG006|Overall Study|Adverse Event|0|||
33453167|NCT01592240|101551076|FG000|Overall Study|Death|0|||
33453168|NCT01592240|101551077|FG001|Overall Study|Death|1|||
33453169|NCT01592240|101551078|FG002|Overall Study|Death|0|||
33453170|NCT01592240|101551079|FG003|Overall Study|Death|0|||
33453171|NCT01592240|101551080|FG004|Overall Study|Death|0|||
33453172|NCT01592240|101551081|FG005|Overall Study|Death|0|||
33453173|NCT01592240|101551082|FG006|Overall Study|Death|0|||
33453174|NCT01592240|101551076|FG000|Overall Study|Lost to Follow-up|1|||
33453175|NCT01592240|101551077|FG001|Overall Study|Lost to Follow-up|3|||
33453176|NCT01592240|101551078|FG002|Overall Study|Lost to Follow-up|1|||
33453177|NCT01592240|101551079|FG003|Overall Study|Lost to Follow-up|0|||
33453178|NCT01592240|101551080|FG004|Overall Study|Lost to Follow-up|3|||
33453179|NCT01592240|101551081|FG005|Overall Study|Lost to Follow-up|2|||
33453180|NCT01592240|101551082|FG006|Overall Study|Lost to Follow-up|0|||
33453181|NCT01592240|101551076|FG000|Overall Study|Protocol Violation|0|||
33453182|NCT01592240|101551077|FG001|Overall Study|Protocol Violation|0|||
33453183|NCT01592240|101551078|FG002|Overall Study|Protocol Violation|0|||
33453184|NCT01592240|101551079|FG003|Overall Study|Protocol Violation|0|||
33453185|NCT01592240|101551080|FG004|Overall Study|Protocol Violation|0|||
33453186|NCT01592240|101551081|FG005|Overall Study|Protocol Violation|1|||
33453187|NCT01592240|101551082|FG006|Overall Study|Protocol Violation|0|||
33453188|NCT01592240|101551076|FG000|Overall Study|Withdrawal by Subject|0|||
33453189|NCT01592240|101551077|FG001|Overall Study|Withdrawal by Subject|4|||
33453190|NCT01592240|101551078|FG002|Overall Study|Withdrawal by Subject|4|||
33453191|NCT01592240|101551079|FG003|Overall Study|Withdrawal by Subject|1|||
33453192|NCT01592240|101551080|FG004|Overall Study|Withdrawal by Subject|3|||
33453193|NCT01592240|101551081|FG005|Overall Study|Withdrawal by Subject|0|||
33453194|NCT01592240|101551082|FG006|Overall Study|Withdrawal by Subject|2|||
33453195|NCT01592240|101551076|FG000|Overall Study|Other|0|||
33453196|NCT01592240|101551077|FG001|Overall Study|Other|3|||
33453197|NCT01592240|101551078|FG002|Overall Study|Other|1|||
33453198|NCT01592240|101551079|FG003|Overall Study|Other|1|||
33453199|NCT01592240|101551080|FG004|Overall Study|Other|0|||
33453200|NCT01592240|101551081|FG005|Overall Study|Other|0|||
33453201|NCT01592240|101551082|FG006|Overall Study|Other|1|||
33453202|NCT01592240|101551076|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
33453203|NCT01592240|101551077|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
33453204|NCT01592240|101551078|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
33453205|NCT01592240|101551079|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
33453206|NCT01592240|101551080|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
33453207|NCT01592240|101551081|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
33453208|NCT01592240|101551082|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
33453209|NCT03497130|101551083|FG000|Overall Study|Lost to Follow-up|1|||
33261364|NCT01823536|100860062|FG003|Overall Study|Withdrawal by Subject|0|||
33453210|NCT03497130|101551084|FG001|Overall Study|Lost to Follow-up|1|||
33453211|NCT04277507|101551087|FG000|Overall Study|Lost to Follow-up|17|||
33453212|NCT04277507|101551087|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
33453213|NCT04277507|101551087|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
33171975|NCT00420927|100537244|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
33261365|NCT01823536|100860063|FG004|Overall Study|Withdrawal by Subject|0|||
33453214|NCT04277507|101551087|FG000|Overall Study|Withdrawal by Subject|3|||
33453215|NCT04277507|101551087|FG000|Overall Study|Death due to COVID-19|1|||
33453216|NCT04277507|101551087|FG000|Overall Study|Data missing for full evaluation|5|||
33453217|NCT02651987|101551088|FG000|Overall Study|Adverse Event|2|||
33453218|NCT02651987|101551089|FG001|Overall Study|Adverse Event|2|||
33453219|NCT02651987|101551088|FG000|Overall Study|Consent Withdrawn|2|||
33453220|NCT02651987|101551089|FG001|Overall Study|Consent Withdrawn|0|||
33453221|NCT02651987|101551088|FG000|Overall Study|Local PD|0|||
33453222|NCT02651987|101551089|FG001|Overall Study|Local PD|2|||
33453223|NCT02651987|101551088|FG000|Overall Study|Investigator Decision|1|||
33453224|NCT02651987|101551089|FG001|Overall Study|Investigator Decision|1|||
33453225|NCT03807440|101551090|FG000|Overall Study|No documentation of index date 2|320|||
33453226|NCT03807440|101551090|FG000|Overall Study|No informed consent for index date 2|117|||
33453227|NCT01297504|101551091|FG000|Overall Study|Invalid Consent|1|||
33453228|NCT01297504|101551091|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
33453229|NCT01297504|101551091|FG000|Overall Study|No Study Visits|4|||
33453230|NCT01297504|101551091|FG000|Overall Study|Death|3|||
33453231|NCT01297504|101551091|FG000|Overall Study|Lost to Follow-up|43|||
33453232|NCT01297504|101551091|FG000|Overall Study|Withdrawal by Subject|9|||
33453233|NCT01297504|101551091|FG000|Overall Study|Site Closure|3|||
33453234|NCT01297504|101551091|FG000|Overall Study|Protocol Violation|3|||
33453235|NCT01695239|101551095|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
33453236|NCT01695239|101551096|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
33453237|NCT01695239|101551097|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
33453238|NCT01695239|101551098|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
33453239|NCT01695239|101551099|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33453240|NCT01695239|101551100|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33453241|NCT01695239|101551101|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33453242|NCT01695239|101551102|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33453243|NCT01695239|101551103|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33453244|NCT01695239|101551104|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33453245|NCT01695239|101551105|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33453246|NCT01695239|101551106|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33453247|NCT01695239|101551107|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33453248|NCT01695239|101551108|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
33453249|NCT01695239|101551095|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
33453250|NCT01695239|101551096|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
33453251|NCT01695239|101551097|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
33453252|NCT01695239|101551098|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
33453253|NCT01695239|101551099|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33453254|NCT01695239|101551100|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33453255|NCT01695239|101551101|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33453256|NCT01695239|101551102|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33453257|NCT01695239|101551103|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33453258|NCT01695239|101551104|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33453259|NCT01695239|101551105|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33453260|NCT01695239|101551106|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33453261|NCT01695239|101551107|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33453262|NCT01695239|101551108|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
33453263|NCT01695239|101551095|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
33453264|NCT01695239|101551096|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33453265|NCT01695239|101551097|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
33453266|NCT01695239|101551098|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33453267|NCT01695239|101551099|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33453268|NCT01695239|101551100|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33453269|NCT01695239|101551101|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33453270|NCT01695239|101551102|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33453271|NCT01695239|101551103|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33453272|NCT01695239|101551104|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33453273|NCT01695239|101551105|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33453274|NCT01695239|101551106|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33453275|NCT01695239|101551107|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33453276|NCT01695239|101551108|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
33453277|NCT01695239|101551095|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
33171976|NCT00420927|100537245|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
33171977|NCT00420927|100537239|FG000|Period 1|Death|2|||
33171978|NCT00420927|100537240|FG001|Period 1|Death|0|||
33171979|NCT00420927|100537241|FG002|Period 1|Death|0|||
33171980|NCT00420927|100537242|FG003|Period 1|Death|0|||
33453278|NCT01695239|101551096|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
33453279|NCT01695239|101551097|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
33171981|NCT00420927|100537243|FG004|Period 1|Death|0|||
33171982|NCT00420927|100537244|FG005|Period 1|Death|0|||
33171983|NCT00420927|100537245|FG006|Period 1|Death|0|||
33171984|NCT00420927|100537239|FG000|Period 1|Subject moved/relocated|0|||
33171985|NCT00420927|100537240|FG001|Period 1|Subject moved/relocated|2|||
33171986|NCT00420927|100537241|FG002|Period 1|Subject moved/relocated|0|||
33171987|NCT00420927|100537242|FG003|Period 1|Subject moved/relocated|0|||
33171988|NCT00420927|100537243|FG004|Period 1|Subject moved/relocated|0|||
33171989|NCT00420927|100537244|FG005|Period 1|Subject moved/relocated|0|||
33171990|NCT00420927|100537245|FG006|Period 1|Subject moved/relocated|0|||
33171991|NCT00420927|100537239|FG000|Period 1|Noncompliant with study drug|1|||
33171992|NCT00420927|100537240|FG001|Period 1|Noncompliant with study drug|1|||
33171993|NCT00420927|100537241|FG002|Period 1|Noncompliant with study drug|0|||
33171994|NCT00420927|100537242|FG003|Period 1|Noncompliant with study drug|0|||
33171995|NCT00420927|100537243|FG004|Period 1|Noncompliant with study drug|0|||
33171996|NCT00420927|100537244|FG005|Period 1|Noncompliant with study drug|0|||
33171997|NCT00420927|100537245|FG006|Period 1|Noncompliant with study drug|0|||
33171998|NCT00420927|100537239|FG000|Period 1|Randomization error|1|||
33171999|NCT00420927|100537240|FG001|Period 1|Randomization error|0|||
33172000|NCT00420927|100537241|FG002|Period 1|Randomization error|0|||
33172001|NCT00420927|100537242|FG003|Period 1|Randomization error|0|||
33172002|NCT00420927|100537243|FG004|Period 1|Randomization error|0|||
33453280|NCT01695239|101551098|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33453281|NCT01695239|101551099|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33453282|NCT01695239|101551100|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33453283|NCT01695239|101551101|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33453284|NCT01695239|101551102|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33453285|NCT01695239|101551103|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33453286|NCT01695239|101551104|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33453287|NCT01695239|101551105|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33453288|NCT01695239|101551106|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33453289|NCT01695239|101551107|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33453290|NCT01695239|101551108|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
33453291|NCT01695239|101551095|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
33453292|NCT01695239|101551096|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33453293|NCT01695239|101551097|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
33453294|NCT01695239|101551098|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33453295|NCT01695239|101551099|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33453296|NCT01695239|101551100|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33172003|NCT00420927|100537244|FG005|Period 1|Randomization error|0|||
33172004|NCT00420927|100537245|FG006|Period 1|Randomization error|0|||
33172005|NCT00420927|100537239|FG000|Period 1|Suspected tuberculosis/positive test|1|||
33172006|NCT00420927|100537240|FG001|Period 1|Suspected tuberculosis/positive test|1|||
33172007|NCT00420927|100537241|FG002|Period 1|Suspected tuberculosis/positive test|0|||
33172008|NCT00420927|100537242|FG003|Period 1|Suspected tuberculosis/positive test|0|||
33172009|NCT00420927|100537243|FG004|Period 1|Suspected tuberculosis/positive test|0|||
33172010|NCT00420927|100537244|FG005|Period 1|Suspected tuberculosis/positive test|0|||
33172011|NCT00420927|100537245|FG006|Period 1|Suspected tuberculosis/positive test|0|||
33172012|NCT00420927|100537239|FG000|Period 1|Study site closure|0|||
33172013|NCT00420927|100537240|FG001|Period 1|Study site closure|1|||
33453297|NCT01695239|101551101|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33453298|NCT01695239|101551102|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33453299|NCT01695239|101551103|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33453300|NCT01695239|101551104|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33453301|NCT01695239|101551105|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33453302|NCT01695239|101551106|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33453303|NCT01695239|101551107|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33453304|NCT01695239|101551108|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
33453305|NCT01695239|101551095|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
33453306|NCT01695239|101551096|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33453307|NCT01695239|101551097|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
33453308|NCT01695239|101551098|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33453309|NCT01695239|101551099|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33453310|NCT01695239|101551100|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33453311|NCT01695239|101551101|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33453312|NCT01695239|101551102|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33453313|NCT01695239|101551103|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33453314|NCT01695239|101551104|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33453315|NCT01695239|101551105|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33453316|NCT01695239|101551106|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33453317|NCT01695239|101551107|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33453318|NCT01695239|101551108|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
33453319|NCT01695239|101551095|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
33453320|NCT01695239|101551096|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33453321|NCT01695239|101551097|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33453322|NCT01695239|101551098|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33453323|NCT01695239|101551099|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33453324|NCT01695239|101551100|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33453325|NCT01695239|101551101|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33453326|NCT01695239|101551102|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33453327|NCT01695239|101551103|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33453328|NCT01695239|101551104|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33453329|NCT01695239|101551105|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33453330|NCT01695239|101551106|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33453331|NCT01695239|101551107|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33453332|NCT01695239|101551108|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
33453333|NCT01695239|101551095|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33453334|NCT01695239|101551096|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33453335|NCT01695239|101551097|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33453336|NCT01695239|101551098|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33453337|NCT01695239|101551099|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33453338|NCT01695239|101551100|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33453339|NCT01695239|101551101|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33453340|NCT01695239|101551102|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
33453341|NCT01695239|101551103|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33453342|NCT01695239|101551104|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33453343|NCT01695239|101551105|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33453344|NCT01695239|101551106|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33453345|NCT01695239|101551107|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33453346|NCT01695239|101551108|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
33453347|NCT01695239|101551095|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33453348|NCT01695239|101551096|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33453349|NCT01695239|101551097|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33453350|NCT01695239|101551098|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33453351|NCT01695239|101551099|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33453352|NCT01695239|101551100|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33172014|NCT00420927|100537241|FG002|Period 1|Study site closure|0|||
33172015|NCT00420927|100537242|FG003|Period 1|Study site closure|0|||
33453353|NCT01695239|101551101|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33453354|NCT01695239|101551102|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
33453355|NCT01695239|101551103|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33453356|NCT01695239|101551104|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33453357|NCT01695239|101551105|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33453358|NCT01695239|101551106|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33453359|NCT01695239|101551107|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33453360|NCT01695239|101551108|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
33453361|NCT01695239|101551095|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33453362|NCT01695239|101551096|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33453363|NCT01695239|101551097|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33453364|NCT01695239|101551098|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33453365|NCT01695239|101551099|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33453366|NCT01695239|101551100|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33453367|NCT01695239|101551101|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33453368|NCT01695239|101551102|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
33453369|NCT01695239|101551103|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33453370|NCT01695239|101551104|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33453371|NCT01695239|101551105|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33453372|NCT01695239|101551106|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33453373|NCT01695239|101551107|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33453374|NCT01695239|101551108|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
33453375|NCT01695239|101551095|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33453376|NCT01695239|101551096|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33453377|NCT01695239|101551097|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33453378|NCT01695239|101551098|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33453379|NCT01695239|101551099|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33453380|NCT01695239|101551100|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33453381|NCT01695239|101551101|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33453382|NCT01695239|101551102|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33453383|NCT01695239|101551103|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
33453384|NCT01695239|101551104|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
33453385|NCT01695239|101551105|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33453386|NCT01695239|101551106|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33453387|NCT01695239|101551107|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33453388|NCT01695239|101551108|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
33453389|NCT01695239|101551095|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
33453390|NCT01695239|101551096|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
33453391|NCT01695239|101551097|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
33453392|NCT01695239|101551098|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
33453393|NCT01695239|101551099|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
33453394|NCT01695239|101551100|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
33453395|NCT01695239|101551101|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
33453396|NCT01695239|101551102|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
33453397|NCT01695239|101551103|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
33453398|NCT01695239|101551104|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
33453399|NCT01695239|101551105|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
33453400|NCT01695239|101551106|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
33453401|NCT01695239|101551107|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
33453402|NCT01695239|101551108|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
33453403|NCT01695239|101551095|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33453404|NCT01695239|101551096|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33453405|NCT01695239|101551097|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33453406|NCT01695239|101551098|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33453407|NCT01695239|101551099|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33453408|NCT01695239|101551100|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33453409|NCT01695239|101551101|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33453410|NCT01695239|101551102|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33172016|NCT00420927|100537243|FG004|Period 1|Study site closure|0|||
33172017|NCT00420927|100537244|FG005|Period 1|Study site closure|0|||
33172018|NCT00420927|100537245|FG006|Period 1|Study site closure|0|||
33172019|NCT00420927|100537239|FG000|Period 1|Subject received new diagnosis|0|||
33172020|NCT00420927|100537240|FG001|Period 1|Subject received new diagnosis|2|||
33172021|NCT00420927|100537241|FG002|Period 1|Subject received new diagnosis|0|||
33172022|NCT00420927|100537242|FG003|Period 1|Subject received new diagnosis|0|||
33453411|NCT01695239|101551103|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
33453412|NCT01695239|101551104|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
33453413|NCT01695239|101551105|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33453414|NCT01695239|101551106|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33453415|NCT01695239|101551107|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33453416|NCT01695239|101551108|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
33453417|NCT01695239|101551095|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
33453418|NCT01695239|101551096|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
33453419|NCT01695239|101551097|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
33453420|NCT01695239|101551098|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
33453421|NCT01695239|101551099|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
33453422|NCT01695239|101551100|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
33453423|NCT01695239|101551101|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
33453424|NCT01695239|101551102|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
33453425|NCT01695239|101551103|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
33453426|NCT01695239|101551104|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
33453427|NCT01695239|101551105|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
33453428|NCT01695239|101551106|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
33453429|NCT01695239|101551107|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
33453430|NCT01695239|101551108|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
33453431|NCT01695239|101551095|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33453432|NCT01695239|101551096|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33453433|NCT01695239|101551097|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33453434|NCT01695239|101551098|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33453435|NCT01695239|101551099|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33453436|NCT01695239|101551100|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33453437|NCT01695239|101551101|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33453438|NCT01695239|101551102|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33172023|NCT00420927|100537243|FG004|Period 1|Subject received new diagnosis|0|||
33172024|NCT00420927|100537244|FG005|Period 1|Subject received new diagnosis|0|||
33172025|NCT00420927|100537245|FG006|Period 1|Subject received new diagnosis|0|||
33453439|NCT01695239|101551103|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
33453440|NCT01695239|101551104|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
33453441|NCT01695239|101551105|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33453442|NCT01695239|101551106|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33453443|NCT01695239|101551107|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33453444|NCT01695239|101551108|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
33453445|NCT01695239|101551095|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33453446|NCT01695239|101551096|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33453447|NCT01695239|101551097|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33453448|NCT01695239|101551098|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33453449|NCT01695239|101551099|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33453450|NCT01695239|101551100|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33453451|NCT01695239|101551101|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33453452|NCT01695239|101551102|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33453453|NCT01695239|101551103|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
33453454|NCT01695239|101551104|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
33453455|NCT01695239|101551105|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33453456|NCT01695239|101551106|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33453457|NCT01695239|101551107|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33453458|NCT01695239|101551108|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
33453459|NCT01695239|101551095|FG000|Extension Long-Term Extension Periods|Death|0|||
33453460|NCT01695239|101551096|FG001|Extension Long-Term Extension Periods|Death|0|||
33453461|NCT01695239|101551097|FG002|Extension Long-Term Extension Periods|Death|0|||
33453462|NCT01695239|101551098|FG003|Extension Long-Term Extension Periods|Death|0|||
33453463|NCT01695239|101551099|FG004|Extension Long-Term Extension Periods|Death|0|||
33453464|NCT01695239|101551100|FG005|Extension Long-Term Extension Periods|Death|0|||
33453465|NCT01695239|101551101|FG006|Extension Long-Term Extension Periods|Death|0|||
33453466|NCT01695239|101551102|FG007|Extension Long-Term Extension Periods|Death|0|||
33453467|NCT01695239|101551103|FG008|Extension Long-Term Extension Periods|Death|1|||
33453468|NCT01695239|101551104|FG009|Extension Long-Term Extension Periods|Death|0|||
33453469|NCT01695239|101551105|FG010|Extension Long-Term Extension Periods|Death|0|||
33453470|NCT01695239|101551106|FG011|Extension Long-Term Extension Periods|Death|0|||
33453471|NCT01695239|101551107|FG012|Extension Long-Term Extension Periods|Death|0|||
33453472|NCT01695239|101551108|FG013|Extension Long-Term Extension Periods|Death|0|||
33453473|NCT01695239|101551095|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33453474|NCT01695239|101551096|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33453475|NCT01695239|101551097|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33453476|NCT01695239|101551098|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33453477|NCT01695239|101551099|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33453478|NCT01695239|101551100|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33453479|NCT01695239|101551101|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33453480|NCT01695239|101551102|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33453481|NCT01695239|101551103|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33453482|NCT01695239|101551104|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33453483|NCT01695239|101551105|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33453484|NCT01695239|101551106|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
33453485|NCT01695239|101551107|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
33453486|NCT01695239|101551108|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
33453487|NCT01695239|101551095|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33453488|NCT01695239|101551096|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33453489|NCT01695239|101551097|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33453490|NCT01695239|101551098|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33453491|NCT01695239|101551099|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33453492|NCT01695239|101551100|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33453493|NCT01695239|101551101|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33453494|NCT01695239|101551102|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33453495|NCT01695239|101551103|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33453496|NCT01695239|101551104|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33453497|NCT01695239|101551105|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33453498|NCT01695239|101551106|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
33453499|NCT01695239|101551107|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
33453500|NCT01695239|101551108|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
33453501|NCT01695239|101551095|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
33172026|NCT00420927|100537239|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
33172027|NCT00420927|100537240|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
33172028|NCT00420927|100537241|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
33172029|NCT00420927|100537242|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
33172030|NCT00420927|100537243|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
33172031|NCT00420927|100537244|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
33172032|NCT00420927|100537245|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
33172033|NCT00420927|100537239|FG000|Period 1|Failed to meet entry criteria|8|||
33172034|NCT00420927|100537240|FG001|Period 1|Failed to meet entry criteria|7|||
33172035|NCT00420927|100537241|FG002|Period 1|Failed to meet entry criteria|0|||
33172036|NCT00420927|100537242|FG003|Period 1|Failed to meet entry criteria|0|||
33172037|NCT00420927|100537243|FG004|Period 1|Failed to meet entry criteria|0|||
33172038|NCT00420927|100537244|FG005|Period 1|Failed to meet entry criteria|0|||
33172039|NCT00420927|100537245|FG006|Period 1|Failed to meet entry criteria|0|||
33172040|NCT00420927|100537239|FG000|Period 1|Took prohibited medication|1|||
33172041|NCT00420927|100537240|FG001|Period 1|Took prohibited medication|3|||
33172042|NCT00420927|100537241|FG002|Period 1|Took prohibited medication|0|||
33172043|NCT00420927|100537242|FG003|Period 1|Took prohibited medication|0|||
33172044|NCT00420927|100537243|FG004|Period 1|Took prohibited medication|0|||
33172045|NCT00420927|100537244|FG005|Period 1|Took prohibited medication|0|||
33172046|NCT00420927|100537245|FG006|Period 1|Took prohibited medication|0|||
33172047|NCT00420927|100537239|FG000|Period 2|Adverse Event|0|||
33453502|NCT01695239|101551096|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
33453503|NCT01695239|101551097|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
33453504|NCT01695239|101551098|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
33453505|NCT01695239|101551099|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
33453506|NCT01695239|101551100|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
33453507|NCT01695239|101551101|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
33453508|NCT01695239|101551102|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
33172048|NCT00420927|100537240|FG001|Period 2|Adverse Event|0|||
33172049|NCT00420927|100537241|FG002|Period 2|Adverse Event|7|||
33172050|NCT00420927|100537242|FG003|Period 2|Adverse Event|3|||
33172051|NCT00420927|100537243|FG004|Period 2|Adverse Event|17|||
33172052|NCT00420927|100537244|FG005|Period 2|Adverse Event|6|||
33172053|NCT00420927|100537245|FG006|Period 2|Adverse Event|20|||
33172054|NCT00420927|100537239|FG000|Period 2|Withdrawal by Subject|0|||
33172055|NCT00420927|100537240|FG001|Period 2|Withdrawal by Subject|0|||
33453509|NCT01695239|101551103|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
33172056|NCT00420927|100537241|FG002|Period 2|Withdrawal by Subject|1|||
33172057|NCT00420927|100537242|FG003|Period 2|Withdrawal by Subject|3|||
33172058|NCT00420927|100537243|FG004|Period 2|Withdrawal by Subject|11|||
33172059|NCT00420927|100537244|FG005|Period 2|Withdrawal by Subject|2|||
33172060|NCT00420927|100537245|FG006|Period 2|Withdrawal by Subject|12|||
33172061|NCT00420927|100537239|FG000|Period 2|Lost to Follow-up|0|||
33172062|NCT00420927|100537240|FG001|Period 2|Lost to Follow-up|0|||
33172063|NCT00420927|100537241|FG002|Period 2|Lost to Follow-up|2|||
33172064|NCT00420927|100537242|FG003|Period 2|Lost to Follow-up|2|||
33172065|NCT00420927|100537243|FG004|Period 2|Lost to Follow-up|6|||
33172066|NCT00420927|100537244|FG005|Period 2|Lost to Follow-up|3|||
33172067|NCT00420927|100537245|FG006|Period 2|Lost to Follow-up|9|||
33172068|NCT00420927|100537239|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
33172069|NCT00420927|100537240|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
33172070|NCT00420927|100537241|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
33172071|NCT00420927|100537242|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
33172072|NCT00420927|100537243|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
33172073|NCT00420927|100537244|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
33172074|NCT00420927|100537245|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
33172075|NCT00420927|100537239|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
33172076|NCT00420927|100537240|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
33172077|NCT00420927|100537241|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
33172078|NCT00420927|100537242|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
33172079|NCT00420927|100537243|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
33172080|NCT00420927|100537244|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
33172081|NCT00420927|100537245|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
33172082|NCT00420927|100537239|FG000|Period 2|Subject unable to find transportation|0|||
33172083|NCT00420927|100537240|FG001|Period 2|Subject unable to find transportation|0|||
33172084|NCT00420927|100537241|FG002|Period 2|Subject unable to find transportation|0|||
33172085|NCT00420927|100537242|FG003|Period 2|Subject unable to find transportation|0|||
33172086|NCT00420927|100537243|FG004|Period 2|Subject unable to find transportation|0|||
33172087|NCT00420927|100537244|FG005|Period 2|Subject unable to find transportation|0|||
33172088|NCT00420927|100537245|FG006|Period 2|Subject unable to find transportation|1|||
33172089|NCT00420927|100537239|FG000|Period 2|Physician Decision|0|||
33172090|NCT00420927|100537240|FG001|Period 2|Physician Decision|0|||
33172091|NCT00420927|100537241|FG002|Period 2|Physician Decision|0|||
33172092|NCT00420927|100537242|FG003|Period 2|Physician Decision|0|||
33172093|NCT00420927|100537243|FG004|Period 2|Physician Decision|1|||
33172094|NCT00420927|100537244|FG005|Period 2|Physician Decision|1|||
33172095|NCT00420927|100537245|FG006|Period 2|Physician Decision|0|||
33172096|NCT00420927|100537239|FG000|Period 2|Sponsor decision|0|||
33172097|NCT00420927|100537240|FG001|Period 2|Sponsor decision|0|||
33172098|NCT00420927|100537241|FG002|Period 2|Sponsor decision|1|||
33172099|NCT00420927|100537242|FG003|Period 2|Sponsor decision|0|||
33172100|NCT00420927|100537243|FG004|Period 2|Sponsor decision|0|||
33172101|NCT00420927|100537244|FG005|Period 2|Sponsor decision|0|||
33172102|NCT00420927|100537245|FG006|Period 2|Sponsor decision|1|||
33172103|NCT00420927|100537239|FG000|Period 2|Randomization error|0|||
33172104|NCT00420927|100537240|FG001|Period 2|Randomization error|0|||
33172105|NCT00420927|100537241|FG002|Period 2|Randomization error|0|||
33172106|NCT00420927|100537242|FG003|Period 2|Randomization error|0|||
33172107|NCT00420927|100537243|FG004|Period 2|Randomization error|1|||
33172108|NCT00420927|100537244|FG005|Period 2|Randomization error|1|||
33172109|NCT00420927|100537245|FG006|Period 2|Randomization error|0|||
33172110|NCT00420927|100537239|FG000|Period 2|Noncompliant with study drug|0|||
33172111|NCT00420927|100537240|FG001|Period 2|Noncompliant with study drug|0|||
33172112|NCT00420927|100537241|FG002|Period 2|Noncompliant with study drug|0|||
33172113|NCT00420927|100537242|FG003|Period 2|Noncompliant with study drug|1|||
33172114|NCT00420927|100537243|FG004|Period 2|Noncompliant with study drug|0|||
33172115|NCT00420927|100537244|FG005|Period 2|Noncompliant with study drug|0|||
33172116|NCT00420927|100537245|FG006|Period 2|Noncompliant with study drug|2|||
33172117|NCT00420927|100537239|FG000|Period 2|Methotrexate intolerance|0|||
33172118|NCT00420927|100537240|FG001|Period 2|Methotrexate intolerance|0|||
33172119|NCT00420927|100537241|FG002|Period 2|Methotrexate intolerance|0|||
33172120|NCT00420927|100537242|FG003|Period 2|Methotrexate intolerance|0|||
33172121|NCT00420927|100537243|FG004|Period 2|Methotrexate intolerance|0|||
33172122|NCT00420927|100537244|FG005|Period 2|Methotrexate intolerance|0|||
33172123|NCT00420927|100537245|FG006|Period 2|Methotrexate intolerance|1|||
33172124|NCT00420927|100537239|FG000|Period 2|Took prohibited medication|0|||
33172125|NCT00420927|100537240|FG001|Period 2|Took prohibited medication|0|||
33172126|NCT00420927|100537241|FG002|Period 2|Took prohibited medication|0|||
33172127|NCT00420927|100537242|FG003|Period 2|Took prohibited medication|0|||
33172128|NCT00420927|100537243|FG004|Period 2|Took prohibited medication|1|||
33172129|NCT00420927|100537244|FG005|Period 2|Took prohibited medication|0|||
33172130|NCT00420927|100537245|FG006|Period 2|Took prohibited medication|0|||
33172131|NCT00885105|100537246|FG000|Overall Study|Withdrawal by Subject|0|||
33172132|NCT00885105|100537247|FG001|Overall Study|Withdrawal by Subject|8|||
33172133|NCT00885105|100537246|FG000|Overall Study|Adverse Event|1|||
33172134|NCT00885105|100537247|FG001|Overall Study|Adverse Event|0|||
33172135|NCT00885105|100537246|FG000|Overall Study|Protocol Violation|0|||
33172136|NCT00885105|100537247|FG001|Overall Study|Protocol Violation|2|||
33172137|NCT00715078|100537248|FG000|Overall Study|Death|29|||
33172138|NCT00715078|100537249|FG001|Overall Study|Death|36|||
33172139|NCT00715078|100537250|FG002|Overall Study|Death|36|||
33172140|NCT00715078|100537248|FG000|Overall Study|Withdrawal by Subject|1|||
33172141|NCT00715078|100537249|FG001|Overall Study|Withdrawal by Subject|0|||
33172142|NCT00715078|100537250|FG002|Overall Study|Withdrawal by Subject|1|||
33172143|NCT00715078|100537248|FG000|Overall Study|Unable to start due to disease prog.|0|||
33172144|NCT00715078|100537249|FG001|Overall Study|Unable to start due to disease prog.|0|||
33172145|NCT00715078|100537250|FG002|Overall Study|Unable to start due to disease prog.|1|||
33172146|NCT00847704|100537251|FG000|Overall Study|Withdrawal by Subject|1|||
33172147|NCT00381095|100537254|FG000|Overall Study|Death|3|||
33172148|NCT00381095|100537255|FG001|Overall Study|Death|4|||
33172149|NCT00381095|100537254|FG000|Overall Study|Lack of Efficacy|2|||
33172150|NCT00381095|100537255|FG001|Overall Study|Lack of Efficacy|4|||
33172151|NCT00381095|100537254|FG000|Overall Study|Other|2|||
33172152|NCT00381095|100537255|FG001|Overall Study|Other|2|||
33172153|NCT00381095|100537254|FG000|Overall Study|Protocol Violation|1|||
33172154|NCT00381095|100537255|FG001|Overall Study|Protocol Violation|1|||
33172155|NCT00381095|100537254|FG000|Overall Study|Withdrawal by Subject|3|||
33172156|NCT00381095|100537255|FG001|Overall Study|Withdrawal by Subject|3|||
33172157|NCT00381095|100537254|FG000|Overall Study|Adverse Event|2|||
33172158|NCT00381095|100537255|FG001|Overall Study|Adverse Event|7|||
33172159|NCT01031069|100537258|FG000|Overall Study|Serious Adverse Event|0|||
33172160|NCT01031069|100537259|FG001|Overall Study|Serious Adverse Event|1|||
33172161|NCT01031069|100537260|FG002|Overall Study|Serious Adverse Event|0|||
33172162|NCT01031069|100537261|FG003|Overall Study|Serious Adverse Event|0|||
33172163|NCT01031069|100537258|FG000|Overall Study|Withdrawal by Subject|2|||
33172164|NCT01031069|100537259|FG001|Overall Study|Withdrawal by Subject|3|||
33172165|NCT01031069|100537260|FG002|Overall Study|Withdrawal by Subject|18|||
33172166|NCT01031069|100537261|FG003|Overall Study|Withdrawal by Subject|18|||
33172167|NCT01031069|100537258|FG000|Overall Study|Migrated/moved from study area|1|||
33172168|NCT01031069|100537259|FG001|Overall Study|Migrated/moved from study area|2|||
33172169|NCT01031069|100537260|FG002|Overall Study|Migrated/moved from study area|1|||
33172170|NCT01031069|100537261|FG003|Overall Study|Migrated/moved from study area|1|||
33172171|NCT01031069|100537258|FG000|Overall Study|Lost to Follow-up|9|||
33172172|NCT01031069|100537259|FG001|Overall Study|Lost to Follow-up|5|||
33172173|NCT01031069|100537260|FG002|Overall Study|Lost to Follow-up|21|||
33172174|NCT01031069|100537261|FG003|Overall Study|Lost to Follow-up|15|||
33172175|NCT01031069|100537258|FG000|Overall Study|Other|0|||
33453510|NCT01695239|101551104|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
33453511|NCT01695239|101551105|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
33172176|NCT01031069|100537259|FG001|Overall Study|Other|0|||
33172177|NCT01031069|100537260|FG002|Overall Study|Other|1|||
33172178|NCT01031069|100537261|FG003|Overall Study|Other|0|||
33453512|NCT01695239|101551106|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
33453513|NCT01695239|101551107|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
33453514|NCT01695239|101551108|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
33172179|NCT03334448|100537262|FG000|Washout|Personal Reason|0|||
33172180|NCT03334448|100537263|FG001|Washout|Personal Reason|1|||
33172181|NCT03334448|100537264|FG002|Washout|Personal Reason|0|||
33172182|NCT03334448|100537265|FG003|Washout|Personal Reason|0|||
33172183|NCT03334448|100537262|FG000|Washout|Protocol Violation|0|||
33172184|NCT03334448|100537263|FG001|Washout|Protocol Violation|0|||
33172185|NCT03334448|100537264|FG002|Washout|Protocol Violation|0|||
33172186|NCT03334448|100537265|FG003|Washout|Protocol Violation|1|||
33172187|NCT00911820|100537266|FG000|Overall Study|RECIST progression|12|||
33453515|NCT01695239|101551095|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33453516|NCT01695239|101551096|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33172188|NCT00911820|100537267|FG001|Overall Study|RECIST progression|8|||
33261366|NCT01823536|100860064|FG005|Overall Study|Withdrawal by Subject|0|||
33261367|NCT01823536|100860059|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
33172189|NCT00911820|100537266|FG000|Overall Study|Adverse Event|8|||
33261368|NCT01823536|100860060|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
33261369|NCT01823536|100860061|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
33172190|NCT00911820|100537267|FG001|Overall Study|Adverse Event|8|||
33172191|NCT00911820|100537266|FG000|Overall Study|Clinical Progression|7|||
33172192|NCT00911820|100537267|FG001|Overall Study|Clinical Progression|5|||
33172193|NCT00911820|100537266|FG000|Overall Study|Physician Decision|5|||
33172194|NCT00911820|100537267|FG001|Overall Study|Physician Decision|9|||
33172195|NCT00911820|100537266|FG000|Overall Study|Decline in Performance Status|4|||
33172196|NCT00911820|100537267|FG001|Overall Study|Decline in Performance Status|2|||
33172197|NCT00911820|100537266|FG000|Overall Study|Withdrawal by Subject|3|||
33172198|NCT00911820|100537267|FG001|Overall Study|Withdrawal by Subject|4|||
33172199|NCT00911820|100537266|FG000|Overall Study|Death|1|||
33172200|NCT00911820|100537267|FG001|Overall Study|Death|2|||
33172201|NCT00911820|100537266|FG000|Overall Study|Pursue surgery|1|||
33172202|NCT00911820|100537267|FG001|Overall Study|Pursue surgery|1|||
33172203|NCT00911820|100537266|FG000|Overall Study|Pursue Radiation|1|||
33172204|NCT00911820|100537267|FG001|Overall Study|Pursue Radiation|0|||
33172205|NCT00911820|100537266|FG000|Overall Study|Still on Therapy|2|||
33172206|NCT00911820|100537267|FG001|Overall Study|Still on Therapy|2|||
33172207|NCT00911820|100537266|FG000|Overall Study|Pathology Not Confirmed|1|||
33172208|NCT00911820|100537267|FG001|Overall Study|Pathology Not Confirmed|0|||
33172209|NCT00911820|100537266|FG000|Overall Study|Withdraw before Receive Treatment|0|||
33172210|NCT00911820|100537267|FG001|Overall Study|Withdraw before Receive Treatment|2|||
33172211|NCT03519932|100537268|FG000|First Intervention|Adverse Event|1|||
33172212|NCT03519932|100537269|FG001|First Intervention|Adverse Event|3|||
33172213|NCT00459953|100537271|FG000|Overall Study|not analyzed-household member in study|1|||
33172214|NCT00459953|100537272|FG001|Overall Study|not analyzed-household member in study|1|||
33172215|NCT02899988|100537273|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
33172216|NCT02899988|100537274|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
33172217|NCT02899988|100537275|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33172218|NCT02899988|100537276|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33172219|NCT02899988|100537277|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33172220|NCT02899988|100537278|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33172221|NCT02899988|100537279|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33172222|NCT02899988|100537280|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33172223|NCT02899988|100537281|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33172224|NCT02899988|100537282|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33172225|NCT02899988|100537283|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
33172226|NCT02899988|100537273|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
33172227|NCT02899988|100537274|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
33172228|NCT02899988|100537275|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
33172229|NCT02899988|100537276|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
33172230|NCT02899988|100537277|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
33172231|NCT02899988|100537278|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
33172232|NCT02899988|100537279|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
33172233|NCT02899988|100537280|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
33172234|NCT02899988|100537281|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
33172235|NCT02899988|100537282|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
33172236|NCT02899988|100537283|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
33172237|NCT02899988|100537273|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
33172238|NCT02899988|100537274|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
33172239|NCT02899988|100537275|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
33172240|NCT02899988|100537276|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
33172241|NCT02899988|100537277|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
33172242|NCT02899988|100537278|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
33172243|NCT02899988|100537279|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
33172244|NCT02899988|100537280|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
33172245|NCT02899988|100537281|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
33453517|NCT01695239|101551097|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33453518|NCT01695239|101551098|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33453519|NCT01695239|101551099|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33453520|NCT01695239|101551100|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33453521|NCT01695239|101551101|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33453522|NCT01695239|101551102|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33453523|NCT01695239|101551103|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33453524|NCT01695239|101551104|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33453525|NCT01695239|101551105|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33453526|NCT01695239|101551106|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33453527|NCT01695239|101551107|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
33453528|NCT01695239|101551108|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
33453529|NCT00645853|101551109|FG000|Overall Study|Adverse Event|18|||
33453530|NCT00645853|101551110|FG001|Overall Study|Adverse Event|7|||
33453531|NCT00645853|101551109|FG000|Overall Study|AZ study closure in Hungary|60|||
33453532|NCT00645853|101551110|FG001|Overall Study|AZ study closure in Hungary|40|||
33453533|NCT00645853|101551109|FG000|Overall Study|Withdrawal by Subject|5|||
33453534|NCT00645853|101551110|FG001|Overall Study|Withdrawal by Subject|2|||
33453535|NCT00645853|101551109|FG000|Overall Study|Protocol Violation|0|||
33453536|NCT00645853|101551110|FG001|Overall Study|Protocol Violation|2|||
33453537|NCT00645853|101551109|FG000|Overall Study|Discontinuation criteria|2|||
33453538|NCT00645853|101551110|FG001|Overall Study|Discontinuation criteria|2|||
33453539|NCT00645853|101551109|FG000|Overall Study|recall of ICF, planned operation, death|7|||
33453540|NCT00645853|101551110|FG001|Overall Study|recall of ICF, planned operation, death|4|||
33453541|NCT00239005|101551111|FG000|Overall Study|Adverse Event|6|||
33453542|NCT00239005|101551112|FG001|Overall Study|Adverse Event|6|||
33453543|NCT00239005|101551111|FG000|Overall Study|Withdrawal by Subject|3|||
33453544|NCT00239005|101551112|FG001|Overall Study|Withdrawal by Subject|4|||
33453545|NCT00239005|101551111|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
33453546|NCT00239005|101551112|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
33453547|NCT00239005|101551111|FG000|Overall Study|Protocol Violation|1|||
33453548|NCT00239005|101551112|FG001|Overall Study|Protocol Violation|0|||
33453549|NCT00239005|101551111|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
33453550|NCT00239005|101551112|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
33453551|NCT00239005|101551111|FG000|Overall Study|Lost to Follow-up|0|||
33453552|NCT00239005|101551112|FG001|Overall Study|Lost to Follow-up|1|||
33453553|NCT04411680|101551113|FG000|Treatment Period|Adverse Event|3|||
33453554|NCT04411680|101551114|FG001|Treatment Period|Adverse Event|0|||
33453555|NCT04411680|101551113|FG000|Treatment Period|Discharged from hospital|18|||
33453556|NCT04411680|101551114|FG001|Treatment Period|Discharged from hospital|7|||
33453557|NCT04411680|101551113|FG000|Treatment Period|Missed 1 or more doses|8|||
33453558|NCT04411680|101551114|FG001|Treatment Period|Missed 1 or more doses|0|||
33453559|NCT04411680|101551113|FG000|Treatment Period|Transferred to another hospital|0|||
33453560|NCT04411680|101551114|FG001|Treatment Period|Transferred to another hospital|1|||
33453561|NCT04411680|101551113|FG000|Follow up Period|Withdrawal by Subject|2|||
33453562|NCT04411680|101551114|FG001|Follow up Period|Withdrawal by Subject|0|||
33453563|NCT04411680|101551113|FG000|Follow up Period|Lost to Follow-up|5|||
33453564|NCT04411680|101551114|FG001|Follow up Period|Lost to Follow-up|6|||
33453565|NCT04411680|101551113|FG000|Follow up Period|Death|11|||
33453566|NCT04411680|101551114|FG001|Follow up Period|Death|8|||
33453567|NCT02488239|101551115|FG000|Overall Study|Death|3|||
33453568|NCT02488239|101551115|FG000|Overall Study|Withdrawal by Subject|3|||
33453569|NCT02488239|101551115|FG000|Overall Study|Physician Decision|2|||
33453570|NCT02488239|101551115|FG000|Overall Study|Consent ineligible|1|||
33453571|NCT02488239|101551115|FG000|Overall Study|Did not undergo implant procedure|1|||
33453572|NCT00387153|101551116|FG000|Overall Study|Adverse Event|1|||
33453573|NCT00387153|101551116|FG000|Overall Study|Disease Progression|3|||
33453574|NCT00387153|101551116|FG000|Overall Study|Lack of Response|4|||
33453575|NCT00985439|101551117|FG000|Overall Study|Adverse Event|0|||
33453576|NCT00985439|101551118|FG001|Overall Study|Adverse Event|0|||
33453577|NCT00985439|101551119|FG002|Overall Study|Adverse Event|1|||
33453578|NCT00985439|101551120|FG003|Overall Study|Adverse Event|0|||
33453579|NCT04025021|101551121|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
33453580|NCT04025021|101551122|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
33453581|NCT00608322|101551125|FG000|Overall Study|Death|2|||
33453582|NCT00608322|101551126|FG001|Overall Study|Death|1|||
33453583|NCT03694197|101551127|FG000|Overall Study|Adverse Event|9|||
33453584|NCT03694197|101551127|FG000|Overall Study|Protocol became inconvenient to participate|1|||
33453585|NCT03694197|101551127|FG000|Overall Study|Physician Decision|4|||
33453586|NCT03694197|101551127|FG000|Overall Study|Study terminated by sponsor|1350|||
33453587|NCT03694197|101551127|FG000|Overall Study|Participant moved|5|||
33453588|NCT03694197|101551127|FG000|Overall Study|Participant withdrew consent|10|||
33453589|NCT03694197|101551127|FG000|Overall Study|Related to IMP administration|1|||
33453590|NCT03694197|101551127|FG000|Overall Study|Not disclosed|5|||
33453591|NCT03966911|101551132|FG000|Overall Study|Adverse Event|1|||
33453592|NCT03966911|101551133|FG001|Overall Study|Adverse Event|1|||
33172246|NCT02899988|100537282|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
33172247|NCT02899988|100537283|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
33172248|NCT02899988|100537273|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
33172249|NCT02899988|100537274|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
33172250|NCT02899988|100537275|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
33172251|NCT02899988|100537276|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
33172252|NCT02899988|100537277|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
33172253|NCT02899988|100537278|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
33172254|NCT02899988|100537279|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
33172255|NCT02899988|100537280|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
33172256|NCT02899988|100537281|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
33172257|NCT02899988|100537282|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
33172258|NCT02899988|100537283|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
33172259|NCT02899988|100537273|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33172260|NCT02899988|100537274|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33172261|NCT02899988|100537275|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33172262|NCT02899988|100537276|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33172263|NCT02899988|100537277|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33172264|NCT02899988|100537278|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
33172265|NCT02899988|100537279|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33172266|NCT02899988|100537280|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
33453593|NCT03966911|101551132|FG000|Overall Study|Withdrawal by Subject|8|||
33453594|NCT03966911|101551133|FG001|Overall Study|Withdrawal by Subject|2|||
33172267|NCT02899988|100537281|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33172268|NCT02899988|100537282|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33172269|NCT02899988|100537283|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
33172270|NCT02899988|100537273|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
33172271|NCT02899988|100537274|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
33172272|NCT02899988|100537275|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
33172273|NCT02899988|100537276|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
33453595|NCT03966911|101551132|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
33453596|NCT03966911|101551133|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
33453597|NCT02627963|101551134|FG000|Overall Study|Randomized but not treated|2|||
33453598|NCT02627963|101551135|FG001|Overall Study|Randomized but not treated|6|||
33453599|NCT03259165|101551136|FG000|Overall Study|COVID 19 pandemic|1|||
33453600|NCT03259165|101551137|FG001|Overall Study|COVID 19 pandemic|1|||
33453601|NCT04133311|101551138|FG000|Period 1 Double Masked Treatment Period|Death|1|||
33453602|NCT04133311|101551139|FG001|Period 1 Double Masked Treatment Period|Death|0|||
33453603|NCT04133311|101551140|FG002|Period 1 Double Masked Treatment Period|Death|0|||
33172274|NCT02899988|100537277|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
33261370|NCT01823536|100860062|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
33261371|NCT01823536|100860063|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
33453604|NCT04133311|101551141|FG003|Period 1 Double Masked Treatment Period|Death|0|||
33453605|NCT04133311|101551138|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
33453606|NCT04133311|101551139|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
33453607|NCT04133311|101551140|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
33453608|NCT04133311|101551141|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
33453609|NCT04133311|101551138|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
33453610|NCT04133311|101551139|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
33453611|NCT04133311|101551140|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
33453612|NCT04133311|101551141|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
33453613|NCT04133311|101551138|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
33453614|NCT04133311|101551139|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
33453615|NCT04133311|101551140|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
33453616|NCT04133311|101551141|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
33453617|NCT04133311|101551138|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
33453618|NCT04133311|101551139|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
33453619|NCT04133311|101551140|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
33453620|NCT04133311|101551141|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
33453621|NCT04133311|101551138|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
33453622|NCT04133311|101551139|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
33453623|NCT04133311|101551140|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
33453624|NCT04133311|101551141|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
33453625|NCT04133311|101551138|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
33453626|NCT04133311|101551139|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
33453627|NCT04133311|101551140|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
33453628|NCT04133311|101551141|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
33453629|NCT04133311|101551138|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
33453630|NCT04133311|101551139|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
33453631|NCT04133311|101551140|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
33453632|NCT04133311|101551141|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
33453633|NCT03669861|101551142|FG000|Overall Study|Disease Flare|5|||
33453634|NCT03669861|101551142|FG000|Overall Study|Lack of Efficacy|2|||
33453635|NCT00796328|101551143|FG000|Overall Study|experienced hypotension requiring tx|6|||
33453636|NCT02471807|101551144|FG000|Overall Study|Death|14|||
33453637|NCT02471807|101551144|FG000|Overall Study|Withdrawal by Subject|2|||
33453638|NCT02471807|101551144|FG000|Overall Study|Explant|5|||
33453639|NCT02471807|101551144|FG000|Overall Study|Lost to Follow-up|1|||
33453640|NCT03500094|101551151|FG000|Overall Study|Withdrawal by Subject|1|||
33453641|NCT03500094|101551151|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
33453642|NCT03500094|101551151|FG000|Overall Study|Lost to Follow-up|1|||
33453643|NCT01912807|101551152|FG000|Overall Study|Did not meet elegibility criteria|6|||
33453644|NCT01912807|101551153|FG001|Overall Study|Did not meet elegibility criteria|4|||
33453645|NCT01912807|101551152|FG000|Overall Study|Lost to Follow-up|36|||
33453646|NCT01912807|101551153|FG001|Overall Study|Lost to Follow-up|37|||
33453647|NCT02964039|101551154|FG000|Overall Study|Medical reason unrelated to study participation|1|||
33453648|NCT02964039|101551155|FG001|Overall Study|Medical reason unrelated to study participation|0|||
33453649|NCT02964039|101551156|FG002|Overall Study|Medical reason unrelated to study participation|3|||
33453650|NCT02964039|101551154|FG000|Overall Study|Research shutdown due to pandemic|2|||
33453651|NCT02964039|101551155|FG001|Overall Study|Research shutdown due to pandemic|0|||
33172275|NCT02899988|100537278|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
33172276|NCT02899988|100537279|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
33453652|NCT02964039|101551156|FG002|Overall Study|Research shutdown due to pandemic|1|||
33453653|NCT02964039|101551154|FG000|Overall Study|Withdrawal by Subject|0|||
33453654|NCT02964039|101551155|FG001|Overall Study|Withdrawal by Subject|1|||
33172277|NCT02899988|100537280|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
33172278|NCT02899988|100537281|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
33172279|NCT02899988|100537282|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
33453655|NCT02964039|101551156|FG002|Overall Study|Withdrawal by Subject|0|||
33453656|NCT02964039|101551154|FG000|Overall Study|Lost to Follow-up|1|||
33172280|NCT02899988|100537283|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
33172281|NCT00573534|100537284|FG000|Overall Study|oppositional behavior|3|||
33172282|NCT01463878|100537285|FG000|Overall Study|no longer met criteria for tube feed|2|||
33172283|NCT01463878|100537286|FG001|Overall Study|no longer met criteria for tube feed|2|||
33172284|NCT01782495|100537289|FG000|Overall Study|Adverse Event|0|||
33172285|NCT01782495|100537290|FG001|Overall Study|Adverse Event|0|||
33172286|NCT01782495|100537291|FG002|Overall Study|Adverse Event|0|||
33172287|NCT01782495|100537292|FG003|Overall Study|Adverse Event|0|||
33261372|NCT01823536|100860064|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
33453657|NCT02964039|101551155|FG001|Overall Study|Lost to Follow-up|0|||
33453658|NCT02964039|101551156|FG002|Overall Study|Lost to Follow-up|1|||
33453659|NCT00484679|101551157|FG000|Overall Study|Withdrawal by Subject|3|||
33453660|NCT01149057|101551158|FG000|Overall Study|Lack of Efficacy|16|||
33453661|NCT01149057|101551158|FG000|Overall Study|Adverse Event|13|||
33453662|NCT01149057|101551158|FG000|Overall Study|Withdrawal by Subject|9|||
33453663|NCT01149057|101551158|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
33453664|NCT01149057|101551158|FG000|Overall Study|B Cell Depletion|4|||
33453665|NCT01149057|101551158|FG000|Overall Study|Participant Non-Compliance|2|||
33453666|NCT01149057|101551158|FG000|Overall Study|Lost to Follow-up|1|||
33453667|NCT01149057|101551158|FG000|Overall Study|High Parathyroid Hormone Value|1|||
33453668|NCT01149057|101551158|FG000|Overall Study|Other|6|||
33453669|NCT01253564|101551161|FG000|Overall Study|Disease Progression|22|||
33453670|NCT01253564|101551161|FG000|Overall Study|Withdrawal by Subject|1|||
33453671|NCT01253564|101551161|FG000|Overall Study|Serious Adverse Event|1|||
33453672|NCT00736190|101551166|FG000|Overall Study|Pregnancy|1|||
33453673|NCT00736190|101551166|FG000|Overall Study|Withdrawal by Subject|1|||
33453674|NCT00736190|101551166|FG000|Overall Study|Adverse Event|1|||
33453675|NCT01374451|101551167|FG000|Overall Study|Administrative problems|1|||
33453676|NCT01374451|101551168|FG001|Overall Study|Administrative problems|0|||
33453677|NCT01151280|101551169|FG000|Overall Study|Adverse Event|1|||
33453678|NCT01151280|101551169|FG000|Overall Study|Lack of Efficacy|3|||
33453679|NCT01528735|101551171|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
33453680|NCT01528735|101551172|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
33453681|NCT01528735|101551171|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
33453682|NCT01528735|101551172|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
33453683|NCT02911701|101551173|FG000|Overall Study|Withdrawal by Subject|2|||
33453684|NCT02911701|101551174|FG001|Overall Study|Withdrawal by Subject|4|||
33453685|NCT02911701|101551173|FG000|Overall Study|Adverse Event|1|||
33172288|NCT01782495|100537293|FG004|Overall Study|Adverse Event|0|||
33453686|NCT02911701|101551174|FG001|Overall Study|Adverse Event|0|||
33453687|NCT05274763|101551175|FG000|Overall Study|Lost to Follow-up|1|||
33453688|NCT00452348|101551176|FG000|Overall Study|Adverse Event|6|||
33453689|NCT00452348|101551177|FG001|Overall Study|Adverse Event|9|||
33453690|NCT00452348|101551176|FG000|Overall Study|Lack of Efficacy|10|||
33453691|NCT00452348|101551177|FG001|Overall Study|Lack of Efficacy|9|||
33261373|NCT01823536|100860059|FG000|Overall Study|Met exclusion criterion No 6|0|||
33453692|NCT00452348|101551176|FG000|Overall Study|Lost to Follow-up|14|||
33453693|NCT00452348|101551177|FG001|Overall Study|Lost to Follow-up|8|||
33453694|NCT00452348|101551176|FG000|Overall Study|Protocol Violation|22|||
33453695|NCT00452348|101551177|FG001|Overall Study|Protocol Violation|28|||
33453696|NCT00452348|101551176|FG000|Overall Study|Withdrawal by Subject|18|||
33453697|NCT00452348|101551177|FG001|Overall Study|Withdrawal by Subject|21|||
33453698|NCT00452348|101551176|FG000|Overall Study|Other|9|||
33453699|NCT00452348|101551177|FG001|Overall Study|Other|9|||
33453700|NCT00396162|101551178|FG000|Overall Study|Withdrawal by Subject|2|||
33453701|NCT00396162|101551179|FG001|Overall Study|Withdrawal by Subject|3|||
33453702|NCT02311894|101554166|FG000|Overall Study|Discontinued in error|1|||
33453703|NCT02311894|101554166|FG000|Overall Study|Lost to Follow-up|1|||
33453704|NCT02311894|101554166|FG000|Overall Study|Adverse Event|1|||
33453705|NCT02311894|101554166|FG000|Overall Study|Withdrawal by Subject|1|||
33453706|NCT01378962|101554167|FG000|Overall Study|Death|14|||
33453707|NCT01378962|101554167|FG000|Overall Study|Lost to Follow-up|1|||
33453708|NCT01378962|101554167|FG000|Overall Study|Other|2|||
33453709|NCT05604014|101554168|FG000|Overall Study|Lost to Follow-up|13|||
33453710|NCT03167606|101554169|FG000|Overall Study|Lost to Follow-up|73|||
33453711|NCT03167606|101554170|FG001|Overall Study|Lost to Follow-up|64|||
33453712|NCT03167606|101554169|FG000|Overall Study|Withdrawal by Subject|6|||
33453713|NCT03167606|101554170|FG001|Overall Study|Withdrawal by Subject|5|||
33453714|NCT03167606|101554169|FG000|Overall Study|Withdrawal by Investigator|0|||
33453715|NCT03167606|101554170|FG001|Overall Study|Withdrawal by Investigator|2|||
33453716|NCT02294981|101554175|FG000|Overall Study|Lost to Follow-up|1|||
33453717|NCT01024855|101554177|FG000|Overall Study|Inclusion/exclusion criteria|1|||
33453718|NCT03067987|101554178|FG000|Overall Study|Lost to Follow-up|7|||
33453719|NCT03067987|101554179|FG001|Overall Study|Lost to Follow-up|10|||
33453720|NCT03067987|101554178|FG000|Overall Study|Protocol Violation|1|||
33453721|NCT03067987|101554179|FG001|Overall Study|Protocol Violation|2|||
33172289|NCT01782495|100537294|FG005|Overall Study|Adverse Event|0|||
33172290|NCT01782495|100537295|FG006|Overall Study|Adverse Event|0|||
33172291|NCT01782495|100537296|FG007|Overall Study|Adverse Event|2|||
33172292|NCT01782495|100537297|FG008|Overall Study|Adverse Event|0|||
33261374|NCT01823536|100860060|FG001|Overall Study|Met exclusion criterion No 6|0|||
33453722|NCT03067987|101554178|FG000|Overall Study|Withdrawal by Subject|2|||
33453723|NCT03067987|101554179|FG001|Overall Study|Withdrawal by Subject|1|||
33453724|NCT01139762|101554187|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
33453725|NCT01139762|101554188|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
33453726|NCT01139762|101554189|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
33453727|NCT01139762|101554187|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
33453728|NCT01139762|101554188|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
33172293|NCT01782495|100537298|FG009|Overall Study|Adverse Event|0|||
33172294|NCT01782495|100537299|FG010|Overall Study|Adverse Event|0|||
33172295|NCT01782495|100537289|FG000|Overall Study|Withdrew Consent|0|||
33172296|NCT01782495|100537290|FG001|Overall Study|Withdrew Consent|1|||
33172297|NCT01782495|100537291|FG002|Overall Study|Withdrew Consent|0|||
33172298|NCT01782495|100537292|FG003|Overall Study|Withdrew Consent|0|||
33172299|NCT01782495|100537293|FG004|Overall Study|Withdrew Consent|0|||
33453729|NCT01139762|101554189|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
33172300|NCT01782495|100537294|FG005|Overall Study|Withdrew Consent|0|||
33172301|NCT01782495|100537295|FG006|Overall Study|Withdrew Consent|0|||
33172302|NCT01782495|100537296|FG007|Overall Study|Withdrew Consent|1|||
33172303|NCT01782495|100537297|FG008|Overall Study|Withdrew Consent|0|||
33172304|NCT01782495|100537298|FG009|Overall Study|Withdrew Consent|0|||
33172305|NCT01782495|100537299|FG010|Overall Study|Withdrew Consent|0|||
33172306|NCT00001723|100537305|FG000|Overall Study|Lack of Efficacy|6|||
33172307|NCT00001723|100537306|FG001|Overall Study|Lack of Efficacy|7|||
33172308|NCT00001723|100537305|FG000|Overall Study|Lack of family interest|4|||
33172309|NCT00001723|100537306|FG001|Overall Study|Lack of family interest|5|||
33172310|NCT00001723|100537305|FG000|Overall Study|Lost to Follow-up|2|||
33172311|NCT00001723|100537306|FG001|Overall Study|Lost to Follow-up|2|||
33172312|NCT00001723|100537305|FG000|Overall Study|medication intolerance|1|||
33172313|NCT00001723|100537306|FG001|Overall Study|medication intolerance|2|||
33172314|NCT03585504|100537307|FG000|Overall Study|Lost to Follow-up|26|||
33172315|NCT03585504|100537308|FG001|Overall Study|Lost to Follow-up|29|||
33172316|NCT01955733|100537317|FG000|Period 1|Lost to Follow-up|1|||
33172317|NCT01955733|100537318|FG001|Period 1|Lost to Follow-up|0|||
33172318|NCT01955733|100537319|FG002|Period 1|Lost to Follow-up|0|||
33172319|NCT01955733|100537317|FG000|Period 2|Adverse Event|1|||
33172320|NCT01955733|100537318|FG001|Period 2|Adverse Event|0|||
33172321|NCT01955733|100537319|FG002|Period 2|Adverse Event|0|||
33172322|NCT01955733|100537317|FG000|Period 2|Physician Decision|0|||
33172323|NCT01955733|100537318|FG001|Period 2|Physician Decision|0|||
33172324|NCT01955733|100537319|FG002|Period 2|Physician Decision|1|||
33172325|NCT01955733|100537317|FG000|Period 2|Withdrawal by Subject|1|||
33172326|NCT01955733|100537318|FG001|Period 2|Withdrawal by Subject|3|||
33172327|NCT01955733|100537319|FG002|Period 2|Withdrawal by Subject|2|||
33172328|NCT01955733|100537317|FG000|Period 2|Study terminated by sponsor|8|||
33172329|NCT01955733|100537318|FG001|Period 2|Study terminated by sponsor|14|||
33172330|NCT01955733|100537319|FG002|Period 2|Study terminated by sponsor|16|||
33172331|NCT01955733|100537317|FG000|Period 2|Lost to Follow-up|2|||
33172332|NCT01955733|100537318|FG001|Period 2|Lost to Follow-up|0|||
33172333|NCT01955733|100537319|FG002|Period 2|Lost to Follow-up|0|||
33172334|NCT01955733|100537317|FG000|Period 2|Other not defined above|0|||
33172335|NCT01955733|100537318|FG001|Period 2|Other not defined above|2|||
33172336|NCT01955733|100537319|FG002|Period 2|Other not defined above|2|||
33172337|NCT03915496|100537320|FG000|Overall Study|Adverse Event|2|||
33172338|NCT03915496|100537321|FG001|Overall Study|Adverse Event|1|||
33453730|NCT01139762|101554187|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
33453731|NCT01139762|101554188|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
33453732|NCT01139762|101554189|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
33453733|NCT01139762|101554187|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
33453734|NCT01139762|101554188|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
33453735|NCT01139762|101554189|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
33453736|NCT01139762|101554187|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
33453737|NCT01139762|101554188|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
33453738|NCT01139762|101554189|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
33453739|NCT01139762|101554187|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
33453740|NCT01139762|101554188|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
33453741|NCT01139762|101554189|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
33453742|NCT01139762|101554187|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
33453743|NCT01139762|101554188|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
33453744|NCT01139762|101554189|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
33453745|NCT01139762|101554187|FG000|Double-Blind Randomized Active Treatment|Death|0|||
33172339|NCT03915496|100537322|FG002|Overall Study|Adverse Event|2|||
33172340|NCT03049280|100537323|FG000|Overall Study|Physician Decision|1|||
33172341|NCT01524692|100537324|FG000|Overall Study|Withdrawal by Subject|3|||
33453746|NCT01139762|101554188|FG001|Double-Blind Randomized Active Treatment|Death|1|||
33172342|NCT00307294|100537325|FG000|Overall Study|Withdrawal by Subject|1|||
33172343|NCT04140292|100537326|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
33172344|NCT04140292|100537327|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
33172345|NCT00126568|100537328|FG000|Overall Study|Death|2|||
33172346|NCT00883116|100537333|FG000|Overall Study|Adverse event unrelated to study drug|5|||
33172347|NCT00883116|100537334|FG001|Overall Study|Adverse event unrelated to study drug|10|||
33172348|NCT00883116|100537333|FG000|Overall Study|Death|6|||
33172349|NCT00883116|100537334|FG001|Overall Study|Death|2|||
33172350|NCT00883116|100537333|FG000|Overall Study|Disease progression|130|||
33172351|NCT00883116|100537334|FG001|Overall Study|Disease progression|128|||
33172352|NCT00883116|100537333|FG000|Overall Study|Lost to Follow-up|0|||
33172353|NCT00883116|100537334|FG001|Overall Study|Lost to Follow-up|1|||
33172354|NCT00883116|100537333|FG000|Overall Study|Maximum clinical benefit|13|||
33172355|NCT00883116|100537334|FG001|Overall Study|Maximum clinical benefit|46|||
33172356|NCT00883116|100537333|FG000|Overall Study|Not identified|3|||
33172357|NCT00883116|100537334|FG001|Overall Study|Not identified|6|||
33172358|NCT00883116|100537333|FG000|Overall Study|Study drug toxicity|36|||
33172359|NCT00883116|100537334|FG001|Overall Study|Study drug toxicity|16|||
33172360|NCT00883116|100537333|FG000|Overall Study|Withdrawal by Subject|14|||
33172361|NCT00883116|100537334|FG001|Overall Study|Withdrawal by Subject|8|||
33172362|NCT00883116|100537333|FG000|Overall Study|No longer meets study criteria|2|||
33172363|NCT00883116|100537334|FG001|Overall Study|No longer meets study criteria|2|||
33172364|NCT00371137|100537335|FG000|Overall Study|Adverse Event|20|||
33172365|NCT00371137|100537336|FG001|Overall Study|Adverse Event|35|||
33172366|NCT00371137|100537337|FG002|Overall Study|Adverse Event|42|||
33172367|NCT00371137|100537335|FG000|Overall Study|Withdrawal by Subject|11|||
33172368|NCT00371137|100537336|FG001|Overall Study|Withdrawal by Subject|10|||
33261375|NCT01823536|100860061|FG002|Overall Study|Met exclusion criterion No 6|0|||
33261376|NCT01823536|100860062|FG003|Overall Study|Met exclusion criterion No 6|1|||
33261377|NCT01823536|100860063|FG004|Overall Study|Met exclusion criterion No 6|0|||
33261378|NCT01823536|100860064|FG005|Overall Study|Met exclusion criterion No 6|0|||
33261379|NCT01823536|100860059|FG000|Overall Study|Subject moved out of the state|0|||
33261380|NCT01823536|100860060|FG001|Overall Study|Subject moved out of the state|0|||
33261381|NCT01823536|100860061|FG002|Overall Study|Subject moved out of the state|0|||
33261382|NCT01823536|100860062|FG003|Overall Study|Subject moved out of the state|0|||
33261383|NCT01823536|100860063|FG004|Overall Study|Subject moved out of the state|1|||
33261384|NCT01823536|100860064|FG005|Overall Study|Subject moved out of the state|0|||
33261385|NCT01121991|100860065|FG000|Overall Study|Lack of Ovarian Response|2|||
33261386|NCT01121991|100860065|FG000|Overall Study|No Oocytes Retrieved|3|||
33261387|NCT01121991|100860065|FG000|Overall Study|No Fertilization|1|||
33261388|NCT01260896|100860066|FG000|First Intervention|Withdrawn Due to Emesis|2|||
33261389|NCT01260896|100860067|FG001|First Intervention|Withdrawn Due to Emesis|0|||
33261390|NCT01057433|100860073|FG000|Overall Study|Adverse Event|1|||
33261391|NCT02374463|100860074|FG000|Overall Study|Withdrawal by Subject|3|||
33261392|NCT02374463|100860075|FG001|Overall Study|Withdrawal by Subject|3|||
33261393|NCT01939899|100860076|FG000|Lead-in Dose Finding Phase|Death|0|||
33261394|NCT01939899|100860077|FG001|Lead-in Dose Finding Phase|Death|3|||
33261395|NCT01939899|100860078|FG002|Lead-in Dose Finding Phase|Death|1|||
33261396|NCT01939899|100860079|FG003|Lead-in Dose Finding Phase|Death|0|||
33261397|NCT01939899|100860080|FG004|Lead-in Dose Finding Phase|Death|0|||
33261398|NCT01939899|100860076|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
33261399|NCT01939899|100860077|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
33261400|NCT01939899|100860078|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
33261401|NCT01939899|100860079|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
33261402|NCT01939899|100860080|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
33261403|NCT01939899|100860076|FG000|Lead-in Dose Finding Phase|Other|0|||
33261404|NCT01939899|100860077|FG001|Lead-in Dose Finding Phase|Other|0|||
33261405|NCT01939899|100860078|FG002|Lead-in Dose Finding Phase|Other|1|||
33261406|NCT01939899|100860079|FG003|Lead-in Dose Finding Phase|Other|0|||
33261407|NCT01939899|100860080|FG004|Lead-in Dose Finding Phase|Other|0|||
33261408|NCT01939899|100860076|FG000|Phase 2|Withdrawal by Subject|0|||
33261409|NCT01939899|100860077|FG001|Phase 2|Withdrawal by Subject|0|||
33261410|NCT01939899|100860078|FG002|Phase 2|Withdrawal by Subject|0|||
33261411|NCT01939899|100860079|FG003|Phase 2|Withdrawal by Subject|2|||
33261412|NCT01939899|100860080|FG004|Phase 2|Withdrawal by Subject|0|||
33261413|NCT01939899|100860076|FG000|Phase 2|Disease Progression|0|||
33261414|NCT01939899|100860077|FG001|Phase 2|Disease Progression|0|||
33453747|NCT01139762|101554189|FG002|Double-Blind Randomized Active Treatment|Death|1|||
33172369|NCT00371137|100537337|FG002|Overall Study|Withdrawal by Subject|15|||
33172370|NCT00371137|100537335|FG000|Overall Study|Lost to Follow-up|6|||
33172371|NCT00371137|100537336|FG001|Overall Study|Lost to Follow-up|3|||
33261415|NCT01939899|100860078|FG002|Phase 2|Disease Progression|0|||
33261416|NCT01939899|100860079|FG003|Phase 2|Disease Progression|9|||
33261417|NCT01939899|100860080|FG004|Phase 2|Disease Progression|1|||
33172372|NCT00371137|100537337|FG002|Overall Study|Lost to Follow-up|5|||
33172373|NCT00371137|100537335|FG000|Overall Study|Lack of Efficacy|30|||
33172374|NCT00371137|100537336|FG001|Overall Study|Lack of Efficacy|12|||
33172375|NCT00371137|100537337|FG002|Overall Study|Lack of Efficacy|13|||
33261418|NCT00982644|100860083|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
33261419|NCT00982644|100860084|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
33261420|NCT00982644|100860083|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
33261421|NCT00982644|100860084|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
33261422|NCT00982644|100860083|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
33261423|NCT00982644|100860084|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
33261424|NCT00982644|100860083|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
33261425|NCT00982644|100860084|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
33261426|NCT00982644|100860083|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
33261427|NCT00982644|100860084|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
33172376|NCT00371137|100537335|FG000|Overall Study|Sponsor Decision|2|||
33172377|NCT00371137|100537336|FG001|Overall Study|Sponsor Decision|1|||
33172378|NCT00371137|100537337|FG002|Overall Study|Sponsor Decision|2|||
33172379|NCT00371137|100537335|FG000|Overall Study|Physician Decision|1|||
33172380|NCT00371137|100537336|FG001|Overall Study|Physician Decision|1|||
33172381|NCT00371137|100537337|FG002|Overall Study|Physician Decision|1|||
33172382|NCT00371137|100537335|FG000|Overall Study|Protocol Violation|2|||
33172383|NCT00371137|100537336|FG001|Overall Study|Protocol Violation|1|||
33172384|NCT00371137|100537337|FG002|Overall Study|Protocol Violation|1|||
33172385|NCT00674700|100537338|FG000|Year 1|Adverse Event|17|||
33172386|NCT00674700|100537339|FG001|Year 1|Adverse Event|20|||
33172387|NCT00674700|100537340|FG002|Year 1|Adverse Event|5|||
33172388|NCT00674700|100537338|FG000|Year 1|Withdrawal by Subject|7|||
33172389|NCT00674700|100537339|FG001|Year 1|Withdrawal by Subject|7|||
33172390|NCT00674700|100537340|FG002|Year 1|Withdrawal by Subject|6|||
33172391|NCT00674700|100537338|FG000|Year 1|Any other reason not above-mentioned|7|||
33172392|NCT00674700|100537339|FG001|Year 1|Any other reason not above-mentioned|7|||
33453748|NCT01139762|101554187|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
33453749|NCT01139762|101554188|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
33453750|NCT01139762|101554189|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
33453751|NCT01139762|101554187|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
33453752|NCT01139762|101554188|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
33453753|NCT01139762|101554189|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
33453754|NCT01139762|101554187|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
33453755|NCT01139762|101554188|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
33453756|NCT01139762|101554189|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
33453757|NCT01139762|101554187|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
33453758|NCT01139762|101554188|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
33453759|NCT01139762|101554189|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
33453760|NCT01139762|101554187|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
33453761|NCT01139762|101554188|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
33453762|NCT01139762|101554189|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
33453763|NCT01139762|101554187|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
33453764|NCT01139762|101554188|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
33453765|NCT01139762|101554189|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
33453766|NCT01139762|101554187|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
33453767|NCT01139762|101554188|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
33453768|NCT01139762|101554189|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
33453769|NCT02623218|101554200|FG000|Overall Study|Lost to Follow-up|0|||
33453770|NCT02623218|101554201|FG001|Overall Study|Lost to Follow-up|1|||
33453771|NCT02623218|101554202|FG002|Overall Study|Lost to Follow-up|0|||
33453772|NCT02623218|101554203|FG003|Overall Study|Lost to Follow-up|0|||
33453773|NCT02623218|101554204|FG004|Overall Study|Lost to Follow-up|0|||
33453774|NCT00503867|101554205|FG000|Overall Study|Lost to Follow-up|1|||
33453775|NCT00503867|101554205|FG000|Overall Study|Adverse Event|1|||
33453776|NCT02664415|101554206|FG000|Overall Study|Adverse Event|1|||
33453777|NCT02664415|101554207|FG001|Overall Study|Adverse Event|0|||
33453778|NCT01438060|101554208|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
33453779|NCT01438060|101554209|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
33453780|NCT01438060|101554208|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
33453781|NCT01438060|101554209|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
33453782|NCT01438060|101554208|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
33453783|NCT01438060|101554209|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
33453784|NCT01438060|101554208|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
33453785|NCT01438060|101554209|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
33453786|NCT01438060|101554208|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
33453787|NCT01438060|101554209|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
33453788|NCT01438060|101554208|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
33261428|NCT00982644|100860083|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
33261429|NCT00982644|100860084|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
33453789|NCT01438060|101554209|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
33453790|NCT01438060|101554208|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
33453791|NCT01438060|101554209|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
33453792|NCT01438060|101554208|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
33453793|NCT01438060|101554209|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
33453794|NCT01438060|101554208|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
33453795|NCT01438060|101554209|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
33453796|NCT01438060|101554208|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
33453797|NCT01438060|101554209|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
33453798|NCT01438060|101554208|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
33453799|NCT01438060|101554209|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
33453800|NCT01438060|101554208|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
33453801|NCT01438060|101554209|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
33453802|NCT01438060|101554208|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
33453803|NCT01438060|101554209|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
33453804|NCT01438060|101554208|FG000|On Study Beyond Week 140|Adverse Event|0|||
33453805|NCT01438060|101554209|FG001|On Study Beyond Week 140|Adverse Event|2|||
33453806|NCT01438060|101554208|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
33453807|NCT01438060|101554209|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
33453808|NCT01438060|101554208|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
33453809|NCT01438060|101554209|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
33453810|NCT01438060|101554208|FG000|On Study Beyond Week 140|Death|0|||
33453811|NCT01438060|101554209|FG001|On Study Beyond Week 140|Death|1|||
33453812|NCT01438060|101554208|FG000|On Study Beyond Week 140|Other Reason|0|||
33453813|NCT01438060|101554209|FG001|On Study Beyond Week 140|Other Reason|3|||
33453814|NCT03498560|101554210|FG000|Overall Study|Found Ineligible|2|||
33453815|NCT03498560|101554210|FG000|Overall Study|Withdrawal by Subject|14|||
33453816|NCT03498560|101554210|FG000|Overall Study|Lost to Follow-up|4|||
33453817|NCT03498560|101554210|FG000|Overall Study|Death|1|||
33453818|NCT01717313|101554211|FG000|Phase A (Weeks 0 to 24)|Death|0|||
33453819|NCT01717313|101554212|FG001|Phase A (Weeks 0 to 24)|Death|1|||
33453820|NCT01717313|101554211|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
33453821|NCT01717313|101554212|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
33453822|NCT01717313|101554211|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
33453823|NCT01717313|101554212|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
33453824|NCT01717313|101554211|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
33453825|NCT01717313|101554212|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
33453826|NCT01717313|101554211|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
33453827|NCT01717313|101554212|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
33453828|NCT01717313|101554211|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
33453829|NCT01717313|101554212|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
33453830|NCT01717313|101554211|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
33453831|NCT01717313|101554212|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
33453832|NCT01717313|101554211|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
33453833|NCT01717313|101554212|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
33453834|NCT01717313|101554211|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
33453835|NCT01717313|101554212|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
33453836|NCT02452463|101554213|FG000|Overall Study|Death|1|||
33453837|NCT02452463|101554214|FG001|Overall Study|Death|0|||
33453838|NCT02452463|101554215|FG002|Overall Study|Death|0|||
33453839|NCT02452463|101554213|FG000|Overall Study|Study Suspended|1|||
33453840|NCT02452463|101554214|FG001|Overall Study|Study Suspended|0|||
33453841|NCT02452463|101554215|FG002|Overall Study|Study Suspended|0|||
33453842|NCT02452463|101554213|FG000|Overall Study|Recommended by DSMB|0|||
33453843|NCT02452463|101554214|FG001|Overall Study|Recommended by DSMB|1|||
33453844|NCT02452463|101554215|FG002|Overall Study|Recommended by DSMB|0|||
33453845|NCT02452463|101554213|FG000|Overall Study|Withdrawal by Subject|0|||
33453846|NCT02452463|101554214|FG001|Overall Study|Withdrawal by Subject|1|||
33453847|NCT02452463|101554215|FG002|Overall Study|Withdrawal by Subject|0|||
33453848|NCT01087502|101554220|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
33453849|NCT01087502|101554221|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
33453850|NCT01087502|101554220|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
33453851|NCT01087502|101554221|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
33453852|NCT01087502|101554220|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
33453853|NCT01087502|101554221|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
33453854|NCT01087502|101554220|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
33453855|NCT01087502|101554221|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
33453856|NCT01087502|101554220|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
33453857|NCT01087502|101554221|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
33453858|NCT01087502|101554220|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
33453859|NCT01087502|101554221|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
33453860|NCT01087502|101554220|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
33453861|NCT01087502|101554221|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
33453862|NCT01087502|101554220|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
33453863|NCT01087502|101554221|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
33453864|NCT01087502|101554220|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
33453865|NCT01087502|101554221|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
33453866|NCT01087502|101554220|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
33453867|NCT01087502|101554221|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
33453868|NCT01087502|101554220|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
33453869|NCT01087502|101554221|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
33453870|NCT01087502|101554220|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
33453871|NCT01087502|101554221|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
33453872|NCT04435782|101554222|FG000|Overall Study|Study terminated by sponsor|4|||
33453873|NCT03101358|101554223|FG000|Overall Study|Non-compliance with study schedule|1|||
33453874|NCT03101358|101554224|FG001|Overall Study|Non-compliance with study schedule|0|||
33453875|NCT03101358|101554225|FG002|Overall Study|Non-compliance with study schedule|0|||
33453876|NCT03101358|101554226|FG003|Overall Study|Non-compliance with study schedule|1|||
33453877|NCT03101358|101554223|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
33453878|NCT03101358|101554224|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
33453879|NCT03101358|101554225|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
33453880|NCT03101358|101554226|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
33453881|NCT03101358|101554223|FG000|Overall Study|Physician Decision|1|||
33453882|NCT03101358|101554224|FG001|Overall Study|Physician Decision|0|||
33453883|NCT03101358|101554225|FG002|Overall Study|Physician Decision|0|||
33453884|NCT03101358|101554226|FG003|Overall Study|Physician Decision|3|||
33453885|NCT03101358|101554223|FG000|Overall Study|Adverse Event|0|||
33453886|NCT03101358|101554224|FG001|Overall Study|Adverse Event|0|||
33453887|NCT03101358|101554225|FG002|Overall Study|Adverse Event|1|||
33453888|NCT03101358|101554226|FG003|Overall Study|Adverse Event|0|||
33453889|NCT03101358|101554223|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
33453890|NCT03101358|101554224|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
33453891|NCT03101358|101554225|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
33453892|NCT03101358|101554226|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
33453893|NCT03101358|101554223|FG000|Overall Study|Lost to Follow-up|1|||
33453894|NCT03101358|101554224|FG001|Overall Study|Lost to Follow-up|0|||
33453895|NCT03101358|101554225|FG002|Overall Study|Lost to Follow-up|0|||
33453896|NCT03101358|101554226|FG003|Overall Study|Lost to Follow-up|1|||
33453897|NCT04608448|101554227|FG000|Overall Study|Withdrawal by Subject|1|||
33453898|NCT04608448|101554227|FG000|Overall Study|Adverse Event|1|||
33453899|NCT00660660|101554230|FG000|Overall Study|Adverse Event|1|||
33453900|NCT00660660|101554231|FG001|Overall Study|Adverse Event|0|||
33453901|NCT00660660|101554230|FG000|Overall Study|Lost to Follow-up|0|||
33453902|NCT00660660|101554231|FG001|Overall Study|Lost to Follow-up|6|||
33453903|NCT00660660|101554230|FG000|Overall Study|Lack of Efficacy|0|||
33453904|NCT00660660|101554231|FG001|Overall Study|Lack of Efficacy|2|||
33453905|NCT00660660|101554230|FG000|Overall Study|Withdrawal by Subject|3|||
33453906|NCT00660660|101554231|FG001|Overall Study|Withdrawal by Subject|0|||
33453907|NCT00660660|101554230|FG000|Overall Study|Incorrect enrollment and other|0|||
33453908|NCT00660660|101554231|FG001|Overall Study|Incorrect enrollment and other|1|||
33453909|NCT00660660|101554230|FG000|Overall Study|New medication after randomization|1|||
33453910|NCT00660660|101554231|FG001|Overall Study|New medication after randomization|0|||
33453911|NCT00533507|101554232|FG000|Overall Study|Withdrawal by Subject|1|||
33453912|NCT02616380|101554236|FG000|Overall Study|Lost to Follow-up|1|||
33453913|NCT02616380|101554236|FG000|Overall Study|Other|2|||
33453914|NCT03555695|101554237|FG000|Overall Study|Withdrawal by Subject|1|||
33453915|NCT03555695|101554237|FG000|Overall Study|Lost to Follow-up|1|||
33453916|NCT03555695|101554237|FG000|Overall Study|appendicitis (unrelated)|1|||
33453917|NCT03555695|101554237|FG000|Overall Study|pre-existing sciatica|1|||
33453918|NCT01709903|101554240|FG000|Overall Study|administrative problems|2|||
33453919|NCT01709903|101554241|FG001|Overall Study|administrative problems|6|||
33453920|NCT01709903|101554240|FG000|Overall Study|Abnormal test procedure results|1|||
33453921|NCT01709903|101554241|FG001|Overall Study|Abnormal test procedure results|0|||
33453922|NCT01709903|101554240|FG000|Overall Study|In ability to use device|1|||
33453923|NCT01709903|101554241|FG001|Overall Study|In ability to use device|1|||
33453924|NCT01709903|101554240|FG000|Overall Study|no longer needed study drug|0|||
33453925|NCT01709903|101554241|FG001|Overall Study|no longer needed study drug|1|||
33453926|NCT01709903|101554240|FG000|Overall Study|Lost to Follow-up|0|||
33453927|NCT01709903|101554241|FG001|Overall Study|Lost to Follow-up|2|||
33453928|NCT01709903|101554240|FG000|Overall Study|Death|2|||
33453929|NCT01709903|101554241|FG001|Overall Study|Death|0|||
33453930|NCT01709903|101554240|FG000|Overall Study|Protocol Violation|3|||
33453931|NCT01709903|101554241|FG001|Overall Study|Protocol Violation|2|||
33453932|NCT01709903|101554240|FG000|Overall Study|Lack of Efficacy|3|||
33453933|NCT01709903|101554241|FG001|Overall Study|Lack of Efficacy|3|||
33453934|NCT01709903|101554240|FG000|Overall Study|Withdrawal by Subject|6|||
33453935|NCT01709903|101554241|FG001|Overall Study|Withdrawal by Subject|6|||
33453936|NCT01709903|101554240|FG000|Overall Study|Adverse Event|11|||
33453937|NCT01709903|101554241|FG001|Overall Study|Adverse Event|18|||
33453938|NCT01370863|101554242|FG000|Overall Study|Adverse Event|1|||
33453939|NCT01370863|101554243|FG001|Overall Study|Adverse Event|1|||
33453940|NCT01370863|101554242|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
33453941|NCT01370863|101554243|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
33453942|NCT01370863|101554242|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
33453943|NCT01370863|101554243|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
33453944|NCT02997176|101554244|FG000|Overall Study|Adverse Event|0|||
33453945|NCT02997176|101554245|FG001|Overall Study|Adverse Event|0|||
33453946|NCT02997176|101554246|FG002|Overall Study|Adverse Event|0|||
33453947|NCT02997176|101554247|FG003|Overall Study|Adverse Event|8|||
33453948|NCT02997176|101554244|FG000|Overall Study|Progressive Disease|1|||
33453949|NCT02997176|101554245|FG001|Overall Study|Progressive Disease|0|||
33453950|NCT02997176|101554246|FG002|Overall Study|Progressive Disease|1|||
33453951|NCT02997176|101554247|FG003|Overall Study|Progressive Disease|1|||
33453952|NCT02997176|101554244|FG000|Overall Study|Death|0|||
33453953|NCT02997176|101554245|FG001|Overall Study|Death|0|||
33453954|NCT02997176|101554246|FG002|Overall Study|Death|1|||
33453955|NCT02997176|101554247|FG003|Overall Study|Death|1|||
33453956|NCT02997176|101554244|FG000|Overall Study|Withdrawal by Subject|0|||
33453957|NCT02997176|101554245|FG001|Overall Study|Withdrawal by Subject|2|||
33453958|NCT02997176|101554246|FG002|Overall Study|Withdrawal by Subject|0|||
33453959|NCT02997176|101554247|FG003|Overall Study|Withdrawal by Subject|1|||
33453960|NCT01131260|101554248|FG000|Overall Study|Randomization error|5|||
33453961|NCT01131260|101554249|FG001|Overall Study|Randomization error|1|||
33453962|NCT01131260|101554248|FG000|Overall Study|Declined to continue participation|8|||
33453963|NCT01131260|101554249|FG001|Overall Study|Declined to continue participation|13|||
33453964|NCT01131260|101554248|FG000|Overall Study|Physician Decision|22|||
33453965|NCT01131260|101554249|FG001|Overall Study|Physician Decision|24|||
33453966|NCT01131260|101554248|FG000|Overall Study|Technical problems|7|||
33453967|NCT01131260|101554249|FG001|Overall Study|Technical problems|6|||
33453968|NCT01131260|101554248|FG000|Overall Study|Staff error|2|||
33453969|NCT01131260|101554249|FG001|Overall Study|Staff error|1|||
33453970|NCT01131260|101554248|FG000|Overall Study|Ineligible|0|||
33453971|NCT01131260|101554249|FG001|Overall Study|Ineligible|2|||
33453972|NCT01513239|101554252|FG000|Period 1: Main Phase|Adverse Event|1|||
33453973|NCT01513239|101554253|FG001|Period 1: Main Phase|Adverse Event|1|||
33453974|NCT01513239|101554254|FG002|Period 1: Main Phase|Adverse Event|2|||
33172393|NCT00674700|100537340|FG002|Year 1|Any other reason not above-mentioned|6|||
33453975|NCT01513239|101554255|FG003|Period 1: Main Phase|Adverse Event|0|||
33453976|NCT01513239|101554256|FG004|Period 1: Main Phase|Adverse Event|0|||
33453977|NCT01513239|101554257|FG005|Period 1: Main Phase|Adverse Event|0|||
33453978|NCT01513239|101554252|FG000|Period 1: Main Phase|Death|29|||
33453979|NCT01513239|101554253|FG001|Period 1: Main Phase|Death|22|||
33453980|NCT01513239|101554254|FG002|Period 1: Main Phase|Death|32|||
33453981|NCT01513239|101554255|FG003|Period 1: Main Phase|Death|0|||
33453982|NCT01513239|101554256|FG004|Period 1: Main Phase|Death|0|||
33453983|NCT01513239|101554257|FG005|Period 1: Main Phase|Death|0|||
33453984|NCT01513239|101554252|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
33453985|NCT01513239|101554253|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
33453986|NCT01513239|101554254|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
33453987|NCT01513239|101554255|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
33453988|NCT01513239|101554256|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
33453989|NCT01513239|101554257|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
33453990|NCT01513239|101554252|FG000|Period 1: Main Phase|Physician Decision|4|||
33453991|NCT01513239|101554253|FG001|Period 1: Main Phase|Physician Decision|4|||
33453992|NCT01513239|101554254|FG002|Period 1: Main Phase|Physician Decision|4|||
33453993|NCT01513239|101554255|FG003|Period 1: Main Phase|Physician Decision|0|||
33453994|NCT01513239|101554256|FG004|Period 1: Main Phase|Physician Decision|0|||
33453995|NCT01513239|101554257|FG005|Period 1: Main Phase|Physician Decision|0|||
33453996|NCT01513239|101554252|FG000|Period 1: Main Phase|Protocol Violation|2|||
33453997|NCT01513239|101554253|FG001|Period 1: Main Phase|Protocol Violation|2|||
33453998|NCT01513239|101554254|FG002|Period 1: Main Phase|Protocol Violation|2|||
33453999|NCT01513239|101554255|FG003|Period 1: Main Phase|Protocol Violation|0|||
33454000|NCT01513239|101554256|FG004|Period 1: Main Phase|Protocol Violation|0|||
33454001|NCT01513239|101554257|FG005|Period 1: Main Phase|Protocol Violation|0|||
33454002|NCT01513239|101554252|FG000|Period 1: Main Phase|Technical Problems|1|||
33454003|NCT01513239|101554253|FG001|Period 1: Main Phase|Technical Problems|2|||
33454004|NCT01513239|101554254|FG002|Period 1: Main Phase|Technical Problems|0|||
33454005|NCT01513239|101554255|FG003|Period 1: Main Phase|Technical Problems|0|||
33454006|NCT01513239|101554256|FG004|Period 1: Main Phase|Technical Problems|0|||
33454007|NCT01513239|101554257|FG005|Period 1: Main Phase|Technical Problems|0|||
33454008|NCT01513239|101554252|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
33454009|NCT01513239|101554253|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
33454010|NCT01513239|101554254|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
33454011|NCT01513239|101554255|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
33454012|NCT01513239|101554256|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
33454013|NCT01513239|101554257|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
33454014|NCT01513239|101554252|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
33454015|NCT01513239|101554253|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
33454016|NCT01513239|101554254|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
33454017|NCT01513239|101554255|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
33454018|NCT01513239|101554256|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
33454019|NCT01513239|101554257|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
33454020|NCT01513239|101554252|FG000|Period 2: 9 Month Extension Phase|Death|0|||
33454021|NCT01513239|101554253|FG001|Period 2: 9 Month Extension Phase|Death|0|||
33454022|NCT01513239|101554254|FG002|Period 2: 9 Month Extension Phase|Death|0|||
33454023|NCT01513239|101554255|FG003|Period 2: 9 Month Extension Phase|Death|2|||
33454024|NCT01513239|101554256|FG004|Period 2: 9 Month Extension Phase|Death|5|||
33454025|NCT01513239|101554257|FG005|Period 2: 9 Month Extension Phase|Death|2|||
33454026|NCT01513239|101554252|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
33454027|NCT01513239|101554253|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
33454028|NCT01513239|101554254|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
33454029|NCT01513239|101554255|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
33454030|NCT01513239|101554256|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
33454031|NCT01513239|101554257|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
33454032|NCT01513239|101554252|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
33454033|NCT01513239|101554253|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
33454034|NCT01513239|101554254|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
33454035|NCT01513239|101554255|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
33454036|NCT01513239|101554256|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
33454037|NCT01513239|101554257|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
33454038|NCT01513239|101554252|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
33454039|NCT01513239|101554253|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
33454040|NCT01513239|101554254|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
33454041|NCT01513239|101554255|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
33454042|NCT01513239|101554256|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
33454043|NCT01513239|101554257|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
33261430|NCT00982644|100860083|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
33261431|NCT00982644|100860084|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
33261432|NCT00982644|100860083|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
33454044|NCT00177164|101554258|FG000|Overall Study|Protocol Violation|0|||
33454045|NCT00177164|101554259|FG001|Overall Study|Protocol Violation|7|||
33454046|NCT00177164|101554258|FG000|Overall Study|Lost to Follow-up|4|||
33454047|NCT00177164|101554259|FG001|Overall Study|Lost to Follow-up|5|||
33454048|NCT00177164|101554258|FG000|Overall Study|increase in alcohol and drug use|1|||
33454049|NCT00177164|101554259|FG001|Overall Study|increase in alcohol and drug use|2|||
33454050|NCT00177164|101554258|FG000|Overall Study|Adverse Event|1|||
33454051|NCT00177164|101554259|FG001|Overall Study|Adverse Event|0|||
33454052|NCT00177164|101554258|FG000|Overall Study|discharge from hospital|1|||
33454053|NCT00177164|101554259|FG001|Overall Study|discharge from hospital|0|||
33454054|NCT00177164|101554258|FG000|Overall Study|Lack of Efficacy|2|||
33454055|NCT00177164|101554259|FG001|Overall Study|Lack of Efficacy|1|||
33454056|NCT00177164|101554258|FG000|Overall Study|Pregnancy|0|||
33454057|NCT00177164|101554259|FG001|Overall Study|Pregnancy|1|||
33454058|NCT01993186|101554260|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
33454059|NCT01993186|101554261|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
33454060|NCT01993186|101554260|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
33454061|NCT01993186|101554261|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
33454062|NCT01993186|101554260|FG000|Open-Label Extension Period|Other, Not Specified|0|||
33454063|NCT01993186|101554261|FG001|Open-Label Extension Period|Other, Not Specified|1|||
33454064|NCT01993186|101554260|FG000|Open-Label Extension Period|Adverse Event|1|||
33454065|NCT01993186|101554261|FG001|Open-Label Extension Period|Adverse Event|0|||
33454066|NCT01993186|101554260|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
33454067|NCT01993186|101554261|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
33454068|NCT01993186|101554260|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
33454069|NCT01993186|101554261|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
33454070|NCT01993186|101554260|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
33454071|NCT01993186|101554261|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
33454072|NCT01158118|101554264|FG000|Overall Study|Screen failure|1|||
33454073|NCT01158118|101554265|FG001|Overall Study|Screen failure|0|||
33454074|NCT01158118|101554264|FG000|Overall Study|Donor match was a screen failure|0|||
33454075|NCT01158118|101554265|FG001|Overall Study|Donor match was a screen failure|1|||
33454076|NCT01158118|101554264|FG000|Overall Study|Suffered stroke prior to transplant|0|||
33454077|NCT01158118|101554265|FG001|Overall Study|Suffered stroke prior to transplant|1|||
33454078|NCT01158118|101554264|FG000|Overall Study|Death|0|||
33454079|NCT01158118|101554265|FG001|Overall Study|Death|1|||
33454080|NCT01215721|101554266|FG000|Overall Study|Adverse Event|2|||
33454081|NCT03193021|101554269|FG000|Overall Study|Lost to Follow-up|1|||
33454082|NCT03193021|101554270|FG001|Overall Study|Lost to Follow-up|1|||
33454083|NCT00474058|101554271|FG000|Overall Study|Adverse Event|11|||
33454084|NCT00474058|101554272|FG001|Overall Study|Adverse Event|6|||
33454085|NCT00474058|101554271|FG000|Overall Study|Lack of Efficacy|0|||
33454086|NCT00474058|101554272|FG001|Overall Study|Lack of Efficacy|4|||
33454087|NCT00474058|101554271|FG000|Overall Study|Withdrawal by Subject|11|||
33454088|NCT00474058|101554272|FG001|Overall Study|Withdrawal by Subject|7|||
33454089|NCT00474058|101554271|FG000|Overall Study|Other|2|||
33454090|NCT00474058|101554272|FG001|Overall Study|Other|0|||
33454091|NCT01942135|101554279|FG000|Overall Study|Adverse Event|21|||
33454092|NCT01942135|101554280|FG001|Overall Study|Adverse Event|7|||
33454093|NCT01942135|101554279|FG000|Overall Study|Global Deterioration of Health Status|9|||
33454094|NCT01942135|101554280|FG001|Overall Study|Global Deterioration of Health Status|6|||
33454095|NCT01942135|101554279|FG000|Overall Study|Randomized Not Treated|2|||
33454096|NCT01942135|101554280|FG001|Overall Study|Randomized Not Treated|2|||
33454097|NCT01942135|101554279|FG000|Overall Study|Death|2|||
33454098|NCT01942135|101554280|FG001|Overall Study|Death|1|||
33454099|NCT01942135|101554279|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
33454100|NCT01942135|101554280|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
33454101|NCT01942135|101554279|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
33454102|NCT01942135|101554280|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
33454103|NCT01942135|101554279|FG000|Overall Study|Withdrawal by Subject|4|||
33454104|NCT01942135|101554280|FG001|Overall Study|Withdrawal by Subject|3|||
33454105|NCT01942135|101554279|FG000|Overall Study|Protocol Violation|1|||
33454106|NCT01942135|101554280|FG001|Overall Study|Protocol Violation|0|||
33454107|NCT01942135|101554279|FG000|Overall Study|Other|19|||
33454108|NCT01942135|101554280|FG001|Overall Study|Other|4|||
33454109|NCT00354159|101554281|FG000|Randomized Study Period|Withdrawal by Subject|5|||
33454110|NCT00354159|101554282|FG001|Randomized Study Period|Withdrawal by Subject|3|||
33454111|NCT00354159|101554281|FG000|Randomized Study Period|Physician Decision|6|||
33454112|NCT00354159|101554282|FG001|Randomized Study Period|Physician Decision|10|||
33454113|NCT00354159|101554281|FG000|Randomized Study Period|Lost to Follow-up|4|||
33454114|NCT00354159|101554282|FG001|Randomized Study Period|Lost to Follow-up|0|||
33454115|NCT00354159|101554281|FG000|Randomized Study Period|Death|7|||
33454116|NCT00354159|101554282|FG001|Randomized Study Period|Death|9|||
33454117|NCT00354159|101554281|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
33454118|NCT00354159|101554282|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
33454119|NCT00354159|101554281|FG000|Long-term Follow-up|Physician Decision|127|||
33454120|NCT00354159|101554282|FG001|Long-term Follow-up|Physician Decision|122|||
33454121|NCT00354159|101554281|FG000|Long-term Follow-up|Lost to Follow-up|1|||
33454122|NCT00354159|101554282|FG001|Long-term Follow-up|Lost to Follow-up|0|||
33454123|NCT00354159|101554281|FG000|Long-term Follow-up|Death|14|||
33454124|NCT00354159|101554282|FG001|Long-term Follow-up|Death|11|||
33454125|NCT00354159|101554281|FG000|Long-term Follow-up|Study Closed|29|||
33454126|NCT00354159|101554282|FG001|Long-term Follow-up|Study Closed|34|||
33454127|NCT00295490|101554284|FG000|Overall Study|Protocol Violation|0|||
33454128|NCT00295490|101554285|FG001|Overall Study|Protocol Violation|0|||
33454129|NCT00295490|101554286|FG002|Overall Study|Protocol Violation|3|||
33454130|NCT00295490|101554287|FG003|Overall Study|Protocol Violation|3|||
33454131|NCT00295490|101554284|FG000|Overall Study|Withdrawal by Subject|0|||
33454132|NCT00295490|101554285|FG001|Overall Study|Withdrawal by Subject|2|||
33454133|NCT00295490|101554286|FG002|Overall Study|Withdrawal by Subject|0|||
33454134|NCT00295490|101554287|FG003|Overall Study|Withdrawal by Subject|1|||
33454135|NCT00295490|101554284|FG000|Overall Study|Lost to Follow-up|0|||
33454136|NCT00295490|101554285|FG001|Overall Study|Lost to Follow-up|0|||
33454137|NCT00295490|101554286|FG002|Overall Study|Lost to Follow-up|1|||
33454138|NCT00295490|101554287|FG003|Overall Study|Lost to Follow-up|0|||
33454139|NCT00295490|101554284|FG000|Overall Study|Adverse Event|1|||
33454140|NCT00295490|101554285|FG001|Overall Study|Adverse Event|0|||
33454141|NCT00295490|101554286|FG002|Overall Study|Adverse Event|0|||
33454142|NCT00295490|101554287|FG003|Overall Study|Adverse Event|0|||
33454143|NCT00295490|101554284|FG000|Overall Study|Other|0|||
33454144|NCT00295490|101554285|FG001|Overall Study|Other|2|||
33454145|NCT00295490|101554286|FG002|Overall Study|Other|0|||
33454146|NCT00295490|101554287|FG003|Overall Study|Other|1|||
33454147|NCT02255149|101554288|FG000|Overall Study|Lost to Follow-up|2|||
33454148|NCT02255149|101554288|FG000|Overall Study|Withdrawal by Subject|1|||
33454149|NCT02255149|101554288|FG000|Overall Study|Withdrawal by PI|1|||
33454150|NCT02255149|101554288|FG000|Overall Study|Implant Failure|1|||
33454151|NCT03366792|101554289|FG000|Overall Study|Withdrawal by Subject|7|||
33454152|NCT03366792|101554289|FG000|Overall Study|Lost to Follow-up|2|||
33454153|NCT03366792|101554289|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
33454154|NCT03366792|101554289|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
33454155|NCT02760433|101554290|FG000|Overall Study|Lost to Follow-up|1|||
33454156|NCT02760433|101554291|FG001|Overall Study|Lost to Follow-up|0|||
33454157|NCT02760433|101554292|FG002|Overall Study|Lost to Follow-up|1|||
33454158|NCT02760433|101554293|FG003|Overall Study|Lost to Follow-up|0|||
33454159|NCT02760433|101554294|FG004|Overall Study|Lost to Follow-up|0|||
33454160|NCT02760433|101554290|FG000|Overall Study|Withdrawal by Subject|23|||
33454161|NCT02760433|101554291|FG001|Overall Study|Withdrawal by Subject|9|||
33454162|NCT02760433|101554292|FG002|Overall Study|Withdrawal by Subject|0|||
33454163|NCT02760433|101554293|FG003|Overall Study|Withdrawal by Subject|2|||
33454164|NCT02760433|101554294|FG004|Overall Study|Withdrawal by Subject|9|||
33454165|NCT02760433|101554290|FG000|Overall Study|Lack of Response At Week 14|0|||
33454166|NCT02760433|101554291|FG001|Overall Study|Lack of Response At Week 14|0|||
33454167|NCT02760433|101554292|FG002|Overall Study|Lack of Response At Week 14|0|||
33454168|NCT02760433|101554293|FG003|Overall Study|Lack of Response At Week 14|0|||
33454169|NCT02760433|101554294|FG004|Overall Study|Lack of Response At Week 14|1|||
33454170|NCT02760433|101554290|FG000|Overall Study|Subject refused to continue the study|1|||
33454171|NCT02760433|101554291|FG001|Overall Study|Subject refused to continue the study|0|||
33454172|NCT02760433|101554292|FG002|Overall Study|Subject refused to continue the study|0|||
33454173|NCT02760433|101554293|FG003|Overall Study|Subject refused to continue the study|0|||
33454174|NCT02760433|101554294|FG004|Overall Study|Subject refused to continue the study|0|||
33454175|NCT02760433|101554290|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
33454176|NCT02760433|101554291|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
33454177|NCT02760433|101554292|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
33454178|NCT02760433|101554293|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
33454179|NCT02760433|101554294|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
33454180|NCT02760433|101554290|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
33454181|NCT02760433|101554291|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
33454182|NCT02760433|101554292|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
33454183|NCT02760433|101554293|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
33454184|NCT02760433|101554294|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
33454185|NCT01911429|101554295|FG000|Overall Study|Adverse Event|5|||
33454186|NCT01911429|101554296|FG001|Overall Study|Adverse Event|3|||
33454187|NCT01911429|101554297|FG002|Overall Study|Adverse Event|9|||
33454188|NCT01911429|101554295|FG000|Overall Study|Lack of Efficacy|1|||
33454189|NCT01911429|101554296|FG001|Overall Study|Lack of Efficacy|2|||
33454190|NCT01911429|101554297|FG002|Overall Study|Lack of Efficacy|4|||
33454191|NCT01911429|101554295|FG000|Overall Study|Lost to Follow-up|0|||
33454192|NCT01911429|101554296|FG001|Overall Study|Lost to Follow-up|0|||
33454193|NCT01911429|101554297|FG002|Overall Study|Lost to Follow-up|1|||
33454194|NCT01911429|101554295|FG000|Overall Study|Protocol Violation|0|||
33454195|NCT01911429|101554296|FG001|Overall Study|Protocol Violation|0|||
33454196|NCT01911429|101554297|FG002|Overall Study|Protocol Violation|1|||
33454197|NCT01911429|101554295|FG000|Overall Study|Withdrawal by Subject|5|||
33454198|NCT01911429|101554296|FG001|Overall Study|Withdrawal by Subject|5|||
33454199|NCT01911429|101554297|FG002|Overall Study|Withdrawal by Subject|4|||
33454200|NCT01911429|101554295|FG000|Overall Study|Accidental randomization|0|||
33454201|NCT01911429|101554296|FG001|Overall Study|Accidental randomization|0|||
33454202|NCT01911429|101554297|FG002|Overall Study|Accidental randomization|1|||
33454203|NCT01911429|101554295|FG000|Overall Study|subject left study|1|||
33454204|NCT01911429|101554296|FG001|Overall Study|subject left study|0|||
33172394|NCT00674700|100537338|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
33172395|NCT00674700|100537339|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
33172396|NCT00674700|100537340|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
33172397|NCT00674700|100537338|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
33172398|NCT00674700|100537339|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
33172399|NCT00674700|100537340|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
33172400|NCT00674700|100537338|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
33172401|NCT00674700|100537339|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
33172402|NCT00674700|100537340|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
33172403|NCT00936910|100537343|FG000|Overall Study|Lack of Efficacy|3|||
33172404|NCT00884312|100537344|FG000|Overall Study|Non-fatal Progressive Disease|0|||
33172405|NCT00884312|100537345|FG001|Overall Study|Non-fatal Progressive Disease|8|||
33172406|NCT00884312|100537344|FG000|Overall Study|Fatal Progressive Disease|0|||
33172407|NCT00884312|100537345|FG001|Overall Study|Fatal Progressive Disease|1|||
33172408|NCT00884312|100537344|FG000|Overall Study|Non-fatal Adverse Event|1|||
33172409|NCT00884312|100537345|FG001|Overall Study|Non-fatal Adverse Event|0|||
33261433|NCT00982644|100860084|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
33261434|NCT00982644|100860083|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
33261435|NCT00982644|100860084|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
33261436|NCT00982644|100860083|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
33261437|NCT00982644|100860084|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
33261438|NCT00687219|100860085|FG000|Overall Study|Adverse Event|8|||
33261439|NCT00687219|100860085|FG000|Overall Study|Discontinuance criteria met|7|||
33261440|NCT00687219|100860085|FG000|Overall Study|HCV-RNA positive conversion|34|||
33261441|NCT00687219|100860085|FG000|Overall Study|Withdrawal by Subject|1|||
33261442|NCT00687219|100860085|FG000|Overall Study|Lack of Efficacy|1|||
33261443|NCT02426138|100860086|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
33261444|NCT02426138|100860087|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
33261445|NCT05262738|100860090|FG000|Overall Study|Withdrawal by Subject|1|||
33261446|NCT05262738|100860091|FG001|Overall Study|Withdrawal by Subject|0|||
33261447|NCT03093428|100860094|FG000|Overall Study|Not eligible for treatment|2|||
33261448|NCT03093428|100860095|FG001|Overall Study|Not eligible for treatment|1|||
33454205|NCT01911429|101554297|FG002|Overall Study|subject left study|0|||
33454206|NCT01401062|101554302|FG000|Overall Study|Death|9|||
33172410|NCT00884312|100537344|FG000|Overall Study|Fatal Adverse Event|1|||
33172411|NCT00884312|100537345|FG001|Overall Study|Fatal Adverse Event|4|||
33172412|NCT00884312|100537344|FG000|Overall Study|Withdrawal by Subject|0|||
33172413|NCT00884312|100537345|FG001|Overall Study|Withdrawal by Subject|6|||
33172414|NCT00884312|100537344|FG000|Overall Study|Physician Decision|0|||
33172415|NCT00884312|100537345|FG001|Overall Study|Physician Decision|1|||
33172416|NCT00884312|100537344|FG000|Overall Study|Other|0|||
33172417|NCT00884312|100537345|FG001|Overall Study|Other|4|||
33172418|NCT00884312|100537344|FG000|Overall Study|Did Not Receive Study Drug|0|||
33172419|NCT00884312|100537345|FG001|Overall Study|Did Not Receive Study Drug|1|||
33172420|NCT01741701|100537346|FG000|Overall Study|Adverse Event|5|||
33172421|NCT01741701|100537347|FG001|Overall Study|Adverse Event|1|||
33172422|NCT01741701|100537346|FG000|Overall Study|Withdrawal by Subject|0|||
33172423|NCT01741701|100537347|FG001|Overall Study|Withdrawal by Subject|1|||
33172424|NCT00750204|100537348|FG000|Overall Study|study halted prematurely|1|||
33172425|NCT00750204|100537349|FG001|Overall Study|study halted prematurely|1|||
33172426|NCT01402492|100537356|FG000|Overall Study|Withdrawal by Subject|17|||
33172427|NCT01402492|100537357|FG001|Overall Study|Withdrawal by Subject|11|||
33172428|NCT01402492|100537358|FG002|Overall Study|Withdrawal by Subject|11|||
33172429|NCT01402492|100537356|FG000|Overall Study|Adverse Event|2|||
33172430|NCT01402492|100537357|FG001|Overall Study|Adverse Event|3|||
33172431|NCT01402492|100537358|FG002|Overall Study|Adverse Event|4|||
33172432|NCT01402492|100537356|FG000|Overall Study|Physician Decision|0|||
33172433|NCT01402492|100537357|FG001|Overall Study|Physician Decision|3|||
33172434|NCT01402492|100537358|FG002|Overall Study|Physician Decision|0|||
33172435|NCT01402492|100537356|FG000|Overall Study|Incarcerated (N=3)|2|||
33172436|NCT01402492|100537357|FG001|Overall Study|Incarcerated (N=3)|0|||
33172437|NCT01402492|100537358|FG002|Overall Study|Incarcerated (N=3)|1|||
33172438|NCT03965962|100537359|FG000|Overall Study|Adverse Event|1|||
33172439|NCT03965962|100537360|FG001|Overall Study|Adverse Event|0|||
33172440|NCT03965962|100537361|FG002|Overall Study|Adverse Event|0|||
33172441|NCT03965962|100537362|FG003|Overall Study|Adverse Event|0|||
33172442|NCT03965962|100537359|FG000|Overall Study|Protocol Violation|21|||
33172443|NCT03965962|100537360|FG001|Overall Study|Protocol Violation|4|||
33172444|NCT03965962|100537361|FG002|Overall Study|Protocol Violation|10|||
33172445|NCT03965962|100537362|FG003|Overall Study|Protocol Violation|5|||
33172446|NCT03965962|100537359|FG000|Overall Study|Lost to Follow-up|0|||
33172447|NCT03965962|100537360|FG001|Overall Study|Lost to Follow-up|1|||
33172448|NCT03965962|100537361|FG002|Overall Study|Lost to Follow-up|0|||
33172449|NCT03965962|100537362|FG003|Overall Study|Lost to Follow-up|0|||
33172450|NCT03965962|100537359|FG000|Overall Study|Withdrawal by Subject|3|||
33172451|NCT03965962|100537360|FG001|Overall Study|Withdrawal by Subject|0|||
33172452|NCT03965962|100537361|FG002|Overall Study|Withdrawal by Subject|0|||
33172453|NCT03965962|100537362|FG003|Overall Study|Withdrawal by Subject|1|||
33172454|NCT01753856|100537363|FG000|Overall Study|Adverse Event|1|||
33172455|NCT01753856|100537364|FG001|Overall Study|Adverse Event|0|||
33454207|NCT01401062|101554303|FG001|Overall Study|Death|7|||
33454208|NCT01401062|101554302|FG000|Overall Study|Physician Decision|1|||
33454209|NCT01401062|101554303|FG001|Overall Study|Physician Decision|0|||
33454210|NCT01401062|101554302|FG000|Overall Study|Withdrawal by Subject|1|||
33172456|NCT01753856|100537363|FG000|Overall Study|Withdrawal by Subject|0|||
33172457|NCT01753856|100537364|FG001|Overall Study|Withdrawal by Subject|2|||
33454211|NCT01401062|101554303|FG001|Overall Study|Withdrawal by Subject|1|||
33454212|NCT00909038|101554304|FG000|Overall Study|Protocol Violation|187|||
33454213|NCT00909038|101554304|FG000|Overall Study|Non-evaluable Subjects|230|||
33454214|NCT03602339|101554307|FG000|Overall Study|Withdrawal by Subject|9|||
33454215|NCT03602339|101554307|FG000|Overall Study|Physician Decision|2|||
33172458|NCT01753856|100537363|FG000|Overall Study|Sponsor Decision|2|||
33172459|NCT01753856|100537364|FG001|Overall Study|Sponsor Decision|0|||
33172460|NCT00540514|100537365|FG000|Overall Study|Still on treatment|3|||
33172461|NCT00540514|100537366|FG001|Overall Study|Still on treatment|0|||
33454216|NCT03602339|101554307|FG000|Overall Study|Other reason|4|||
33172462|NCT00540514|100537365|FG000|Overall Study|Unacceptable Toxicity|61|||
33454217|NCT00863330|101554308|FG000|Overall Study|study terminated early due to administra|6|||
33172463|NCT00540514|100537366|FG001|Overall Study|Unacceptable Toxicity|62|||
33172464|NCT00540514|100537365|FG000|Overall Study|Adverse Event|20|||
33454218|NCT00301964|101554315|FG000|Overall Study|Second primary|2|||
33454219|NCT00301964|101554315|FG000|Overall Study|Wrong primary|1|||
33454220|NCT00301964|101554315|FG000|Overall Study|Inadequate pathology|1|||
33454221|NCT03801707|101554316|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
33454222|NCT00858780|101554317|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
33454223|NCT00858780|101554318|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
33454224|NCT00858780|101554319|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
33454225|NCT00858780|101554320|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
33454226|NCT00858780|101554321|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
33454227|NCT00858780|101554317|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
33454228|NCT00858780|101554318|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
33454229|NCT00858780|101554319|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
33454230|NCT00858780|101554320|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
33454231|NCT00858780|101554321|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
33454232|NCT00858780|101554317|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
33454233|NCT00858780|101554318|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
33454234|NCT00858780|101554319|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
33454235|NCT00858780|101554320|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
33454236|NCT00858780|101554321|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
33454237|NCT00858780|101554317|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
33454238|NCT00858780|101554318|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
33454239|NCT00858780|101554319|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
33454240|NCT00858780|101554320|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
33454241|NCT00858780|101554321|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
33454242|NCT00858780|101554317|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
33454243|NCT00858780|101554318|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
33454244|NCT00858780|101554319|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
33454245|NCT00858780|101554320|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
33454246|NCT00858780|101554321|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
33454247|NCT00858780|101554317|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
33454248|NCT00858780|101554318|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
33454249|NCT00858780|101554319|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
33454250|NCT00858780|101554320|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
33454251|NCT00858780|101554321|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
33454252|NCT04388787|101554322|FG000|Blinded Period|Patient could not follow instructions|1|||
33454253|NCT04388787|101554322|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
33454254|NCT04750239|101554323|FG000|Overall Study|Withdrawal by Subject|2|||
33454255|NCT04750239|101554323|FG000|Overall Study|Trial terminated by sponsor|1|||
33454256|NCT04002648|101554324|FG000|Overall Study|Lost to Follow-up|2|||
33454257|NCT04002648|101554325|FG001|Overall Study|Lost to Follow-up|0|||
33454258|NCT00924638|101554329|FG000|Overall Study|Death|3|||
33454259|NCT00924638|101554330|FG001|Overall Study|Death|2|||
33454260|NCT00924638|101554329|FG000|Overall Study|Lost to Follow-up|1|||
33454261|NCT00924638|101554330|FG001|Overall Study|Lost to Follow-up|1|||
33454262|NCT00924638|101554329|FG000|Overall Study|Withdrawal by Subject|5|||
33454263|NCT00924638|101554330|FG001|Overall Study|Withdrawal by Subject|7|||
33454264|NCT00924638|101554329|FG000|Overall Study|Physician Decision|3|||
33454265|NCT00924638|101554330|FG001|Overall Study|Physician Decision|3|||
33454266|NCT02011945|101554331|FG000|Overall Study|Participant requested to Discontinue|0|||
33454267|NCT02011945|101554332|FG001|Overall Study|Participant requested to Discontinue|1|||
33454268|NCT02011945|101554333|FG002|Overall Study|Participant requested to Discontinue|1|||
33454269|NCT02011945|101554331|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
33454270|NCT02011945|101554332|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
33454271|NCT02011945|101554333|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
33454272|NCT02011945|101554331|FG000|Overall Study|Study Drug Toxicity|0|||
33454273|NCT02011945|101554332|FG001|Overall Study|Study Drug Toxicity|0|||
33454274|NCT02011945|101554333|FG002|Overall Study|Study Drug Toxicity|1|||
33454275|NCT02011945|101554331|FG000|Overall Study|Treatment Failure|0|||
33454276|NCT02011945|101554332|FG001|Overall Study|Treatment Failure|7|||
33454277|NCT02011945|101554333|FG002|Overall Study|Treatment Failure|6|||
33454278|NCT02011945|101554331|FG000|Overall Study|No Longer Meets Study Criteria|1|||
33454279|NCT02011945|101554332|FG001|Overall Study|No Longer Meets Study Criteria|0|||
33454280|NCT02011945|101554333|FG002|Overall Study|No Longer Meets Study Criteria|0|||
33454281|NCT02011945|101554331|FG000|Overall Study|Proceeded to stem cell transplant|0|||
33454282|NCT02011945|101554332|FG001|Overall Study|Proceeded to stem cell transplant|0|||
33454283|NCT02011945|101554333|FG002|Overall Study|Proceeded to stem cell transplant|1|||
33454284|NCT02011945|101554331|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
33454285|NCT02011945|101554332|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
33454286|NCT02011945|101554333|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
33172465|NCT00540514|100537366|FG001|Overall Study|Adverse Event|24|||
33454287|NCT02704091|101554334|FG000|Overall Study|Adverse Event|4|||
33454288|NCT02704091|101554335|FG001|Overall Study|Adverse Event|3|||
33454289|NCT02704091|101554334|FG000|Overall Study|Protocol Violation|5|||
33454290|NCT02704091|101554335|FG001|Overall Study|Protocol Violation|3|||
33454291|NCT02704091|101554334|FG000|Overall Study|Consent withdrawn|4|||
33454292|NCT02704091|101554335|FG001|Overall Study|Consent withdrawn|4|||
33172466|NCT00540514|100537365|FG000|Overall Study|Physician Decision|86|||
33172467|NCT00540514|100537366|FG001|Overall Study|Physician Decision|99|||
33172468|NCT00540514|100537365|FG000|Overall Study|Protocol Deviation|3|||
33172469|NCT00540514|100537366|FG001|Overall Study|Protocol Deviation|4|||
33172470|NCT00540514|100537365|FG000|Overall Study|Lost to Follow-up|1|||
33172471|NCT00540514|100537366|FG001|Overall Study|Lost to Follow-up|1|||
33172472|NCT00540514|100537365|FG000|Overall Study|Withdrawal by Subject|65|||
33172473|NCT00540514|100537366|FG001|Overall Study|Withdrawal by Subject|67|||
33172474|NCT00540514|100537365|FG000|Overall Study|Excluded prior to treatment|7|||
33172475|NCT00540514|100537366|FG001|Overall Study|Excluded prior to treatment|7|||
33172476|NCT00540514|100537365|FG000|Overall Study|Paclitaxel not available|0|||
33172477|NCT00540514|100537366|FG001|Overall Study|Paclitaxel not available|2|||
33172478|NCT03944954|100537367|FG000|Overall Study|Withdrawal by Subject|22|||
33172479|NCT03944954|100537368|FG001|Overall Study|Withdrawal by Subject|4|||
33172480|NCT03944954|100537367|FG000|Overall Study|Lost to Follow-up|18|||
33172481|NCT03944954|100537368|FG001|Overall Study|Lost to Follow-up|0|||
33454293|NCT02704091|101554334|FG000|Overall Study|Lost to Follow-up|13|||
33454294|NCT02704091|101554335|FG001|Overall Study|Lost to Follow-up|5|||
33454295|NCT02704091|101554334|FG000|Overall Study|Other|2|||
33454296|NCT02704091|101554335|FG001|Overall Study|Other|8|||
33454297|NCT03531827|101554336|FG000|Overall Study|Adverse Event|2|||
33454298|NCT03531827|101554337|FG001|Overall Study|Adverse Event|0|||
33454299|NCT03531827|101554336|FG000|Overall Study|Progressive disease|1|||
33454300|NCT03531827|101554337|FG001|Overall Study|Progressive disease|0|||
33454301|NCT00965757|101554340|FG000|Double-blind Phase|Progression of concomitant disease|1|||
33454302|NCT00965757|101554341|FG001|Double-blind Phase|Progression of concomitant disease|2|||
33454303|NCT00965757|101554342|FG002|Double-blind Phase|Progression of concomitant disease|0|||
33454304|NCT00965757|101554343|FG003|Double-blind Phase|Progression of concomitant disease|0|||
33454305|NCT00965757|101554340|FG000|Double-blind Phase|Adverse drug reaction|2|||
33454306|NCT00965757|101554341|FG001|Double-blind Phase|Adverse drug reaction|1|||
33454307|NCT00965757|101554342|FG002|Double-blind Phase|Adverse drug reaction|0|||
33454308|NCT00965757|101554343|FG003|Double-blind Phase|Adverse drug reaction|0|||
33454309|NCT00965757|101554340|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
33454310|NCT00965757|101554341|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
33454311|NCT00965757|101554342|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
33454312|NCT00965757|101554343|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
33454313|NCT00965757|101554340|FG000|Double-blind Phase|Lack of Efficacy|7|||
33454314|NCT00965757|101554341|FG001|Double-blind Phase|Lack of Efficacy|11|||
33454315|NCT00965757|101554342|FG002|Double-blind Phase|Lack of Efficacy|0|||
33454316|NCT00965757|101554343|FG003|Double-blind Phase|Lack of Efficacy|0|||
33454317|NCT00965757|101554340|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
33454318|NCT00965757|101554341|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
33454319|NCT00965757|101554342|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
33454320|NCT00965757|101554343|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
33454321|NCT00965757|101554340|FG000|Double-blind Phase|Lost to Follow-up|0|||
33454322|NCT00965757|101554341|FG001|Double-blind Phase|Lost to Follow-up|1|||
33454323|NCT00965757|101554342|FG002|Double-blind Phase|Lost to Follow-up|0|||
33454324|NCT00965757|101554343|FG003|Double-blind Phase|Lost to Follow-up|0|||
33454325|NCT00965757|101554340|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
33454326|NCT00965757|101554341|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
33454327|NCT00965757|101554342|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
33454328|NCT00965757|101554343|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
33454329|NCT00965757|101554340|FG000|Double-blind Phase|Other|1|||
33454330|NCT00965757|101554341|FG001|Double-blind Phase|Other|0|||
33454331|NCT00965757|101554342|FG002|Double-blind Phase|Other|0|||
33454332|NCT00965757|101554343|FG003|Double-blind Phase|Other|0|||
33454333|NCT00965757|101554340|FG000|Extension Phase|Progression of concomitant disease|0|||
33454334|NCT00965757|101554341|FG001|Extension Phase|Progression of concomitant disease|0|||
33454335|NCT00965757|101554342|FG002|Extension Phase|Progression of concomitant disease|4|||
33454336|NCT00965757|101554343|FG003|Extension Phase|Progression of concomitant disease|2|||
33454337|NCT00965757|101554340|FG000|Extension Phase|Adverse drug reaction|0|||
33454338|NCT00965757|101554341|FG001|Extension Phase|Adverse drug reaction|0|||
33454339|NCT00965757|101554342|FG002|Extension Phase|Adverse drug reaction|6|||
33454340|NCT00965757|101554343|FG003|Extension Phase|Adverse drug reaction|3|||
33454341|NCT00965757|101554340|FG000|Extension Phase|Abnormal Laboratory Value|0|||
33454342|NCT00965757|101554341|FG001|Extension Phase|Abnormal Laboratory Value|0|||
33454343|NCT00965757|101554342|FG002|Extension Phase|Abnormal Laboratory Value|6|||
33454344|NCT00965757|101554343|FG003|Extension Phase|Abnormal Laboratory Value|1|||
33454345|NCT00965757|101554340|FG000|Extension Phase|Lack of Efficacy|0|||
33454346|NCT00965757|101554341|FG001|Extension Phase|Lack of Efficacy|0|||
33454347|NCT00965757|101554342|FG002|Extension Phase|Lack of Efficacy|8|||
33454348|NCT00965757|101554343|FG003|Extension Phase|Lack of Efficacy|12|||
33454349|NCT00965757|101554340|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
33454350|NCT00965757|101554341|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
33454351|NCT00965757|101554342|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
33454352|NCT00965757|101554343|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
33454353|NCT00965757|101554340|FG000|Extension Phase|Lost to Follow-up|0|||
33454354|NCT00965757|101554341|FG001|Extension Phase|Lost to Follow-up|0|||
33454355|NCT00965757|101554342|FG002|Extension Phase|Lost to Follow-up|0|||
33454356|NCT00965757|101554343|FG003|Extension Phase|Lost to Follow-up|1|||
33454357|NCT00965757|101554340|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
33454358|NCT00965757|101554341|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
33454359|NCT00965757|101554342|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
33261449|NCT03093428|100860094|FG000|Overall Study|Progression|14|||
33261450|NCT03093428|100860095|FG001|Overall Study|Progression|4|||
33172482|NCT03944954|100537367|FG000|Overall Study|Failed Medical Screening|7|||
33172483|NCT03944954|100537368|FG001|Overall Study|Failed Medical Screening|0|||
33172484|NCT01338792|100537370|FG000|Overall Study|Adverse Event|2|||
33172485|NCT01338792|100537370|FG000|Overall Study|Death|1|||
33172486|NCT01338792|100537370|FG000|Overall Study|Withdrawal by Subject|1|||
33172487|NCT03128892|100537374|FG000|Overall Study|Withdrawal by Subject|2|||
33172488|NCT03128892|100537374|FG000|Overall Study|Physician Decision|1|||
33172489|NCT00545168|100537375|FG000|Overall Study|Lost to Follow-up|5|||
33172490|NCT00545168|100537376|FG001|Overall Study|Lost to Follow-up|5|||
33172491|NCT00545168|100537377|FG002|Overall Study|Lost to Follow-up|5|||
33172492|NCT00545168|100537375|FG000|Overall Study|Withdrawal by Subject|9|||
33454360|NCT00965757|101554343|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
33454361|NCT00965757|101554340|FG000|Extension Phase|Protocol Violation|0|||
33454362|NCT00965757|101554341|FG001|Extension Phase|Protocol Violation|0|||
33454363|NCT00965757|101554342|FG002|Extension Phase|Protocol Violation|0|||
33454364|NCT00965757|101554343|FG003|Extension Phase|Protocol Violation|1|||
33454365|NCT00965757|101554340|FG000|Extension Phase|Other|0|||
33454366|NCT00965757|101554341|FG001|Extension Phase|Other|0|||
33454367|NCT00965757|101554342|FG002|Extension Phase|Other|2|||
33454368|NCT00965757|101554343|FG003|Extension Phase|Other|1|||
33454369|NCT03255733|101554344|FG000|Overall Study|Lost to Follow-up|4|||
33454370|NCT00112437|101554345|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
33454371|NCT00112437|101554346|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
33454372|NCT00112437|101554347|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
33454373|NCT00112437|101554348|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
33454374|NCT00112437|101554349|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
33454375|NCT00112437|101554350|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454376|NCT00112437|101554351|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454377|NCT00112437|101554352|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454378|NCT00112437|101554353|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454379|NCT00112437|101554354|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454380|NCT00112437|101554355|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454381|NCT00112437|101554356|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454382|NCT00112437|101554357|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454383|NCT00112437|101554358|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454384|NCT00112437|101554359|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
33172493|NCT00545168|100537376|FG001|Overall Study|Withdrawal by Subject|0|||
33172494|NCT00545168|100537377|FG002|Overall Study|Withdrawal by Subject|13|||
33172495|NCT00545168|100537375|FG000|Overall Study|Protocol Violation|1|||
33454385|NCT00112437|101554360|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454386|NCT00112437|101554361|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454387|NCT00112437|101554362|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454388|NCT00112437|101554363|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454389|NCT00112437|101554364|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
33172496|NCT00545168|100537376|FG001|Overall Study|Protocol Violation|0|||
33172497|NCT00545168|100537377|FG002|Overall Study|Protocol Violation|1|||
33172498|NCT00545168|100537375|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
33454390|NCT00112437|101554365|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454391|NCT00112437|101554366|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
33172499|NCT00545168|100537376|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
33172500|NCT00545168|100537377|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
33172501|NCT02005445|100537378|FG000|Overall Study|Dual study enrollment|0|||
33172502|NCT02005445|100537379|FG001|Overall Study|Dual study enrollment|1|||
33172503|NCT02733991|100537383|FG000|Overall Study|Adverse Event|1|||
33172504|NCT02733991|100537384|FG001|Overall Study|Adverse Event|0|||
33172505|NCT02733991|100537383|FG000|Overall Study|Withdrawal by Subject|0|||
33172506|NCT02733991|100537384|FG001|Overall Study|Withdrawal by Subject|5|||
33172507|NCT04501666|100537385|FG000|Overall Study|Physician Decision|0|||
33172508|NCT04501666|100537386|FG001|Overall Study|Physician Decision|1|||
33172509|NCT04501666|100537385|FG000|Overall Study|Adverse Event|12|||
33172510|NCT04501666|100537386|FG001|Overall Study|Adverse Event|4|||
33172511|NCT04501666|100537385|FG000|Overall Study|Subject's request|10|||
33172512|NCT04501666|100537386|FG001|Overall Study|Subject's request|6|||
33172513|NCT04501666|100537385|FG000|Overall Study|Protocol Deviation|2|||
33172514|NCT04501666|100537386|FG001|Overall Study|Protocol Deviation|1|||
33172515|NCT04501666|100537385|FG000|Overall Study|Other-- site permanently closing|0|||
33172516|NCT04501666|100537386|FG001|Overall Study|Other-- site permanently closing|1|||
33172517|NCT00005937|100537387|FG000|Overall Study|Lack of Efficacy|5|||
33172518|NCT01979016|100537388|FG000|Overall Study|Withdrawal by Subject|2|||
33172519|NCT01979016|100537389|FG001|Overall Study|Withdrawal by Subject|0|||
33172520|NCT01979016|100537388|FG000|Overall Study|Adverse Event|0|||
33172521|NCT01979016|100537389|FG001|Overall Study|Adverse Event|1|||
33172522|NCT00737282|100537390|FG000|Overall Study|Study prematurely terminated|175|||
33172523|NCT01714635|100537391|FG000|Overall Study|Discontinued|1|||
33172524|NCT01714635|100537392|FG001|Overall Study|Discontinued|0|||
33172525|NCT01714635|100537393|FG002|Overall Study|Discontinued|2|||
33172526|NCT01714635|100537391|FG000|Overall Study|Missed 6-month exam|1|||
33172527|NCT01714635|100537392|FG001|Overall Study|Missed 6-month exam|0|||
33172528|NCT01714635|100537393|FG002|Overall Study|Missed 6-month exam|0|||
33172529|NCT02450903|100537394|FG000|Overall Study|Adverse Event|3|||
33172530|NCT02450903|100537394|FG000|Overall Study|Progressive disease|15|||
33172531|NCT02450903|100537394|FG000|Overall Study|Switched to commercial drug|1|||
33172532|NCT02450903|100537394|FG000|Overall Study|Subject/guardian decision|1|||
33172533|NCT00241280|100537395|FG000|Overall Study|Adverse Event|2|||
33172534|NCT00241280|100537396|FG001|Overall Study|Adverse Event|6|||
33172535|NCT00241280|100537395|FG000|Overall Study|Discomfort|11|||
33172536|NCT00241280|100537396|FG001|Overall Study|Discomfort|16|||
33172537|NCT00241280|100537395|FG000|Overall Study|Pregnancy|1|||
33261451|NCT03093428|100860094|FG000|Overall Study|Death|1|||
33261452|NCT03093428|100860095|FG001|Overall Study|Death|0|||
33261453|NCT03093428|100860094|FG000|Overall Study|Adverse Event|1|||
33261454|NCT03093428|100860095|FG001|Overall Study|Adverse Event|0|||
33261455|NCT03093428|100860094|FG000|Overall Study|Withdrawal by Subject|1|||
33172538|NCT00241280|100537396|FG001|Overall Study|Pregnancy|5|||
33172539|NCT00241280|100537395|FG000|Overall Study|Lost to Follow-up|5|||
33172540|NCT00241280|100537396|FG001|Overall Study|Lost to Follow-up|8|||
33172541|NCT00241280|100537395|FG000|Overall Study|Withdrawal by Subject|7|||
33172542|NCT00241280|100537396|FG001|Overall Study|Withdrawal by Subject|4|||
33172543|NCT00241280|100537395|FG000|Overall Study|Protocol Violation|4|||
33172544|NCT00241280|100537396|FG001|Overall Study|Protocol Violation|10|||
33172545|NCT00241280|100537395|FG000|Overall Study|Relocation|4|||
33172546|NCT00241280|100537396|FG001|Overall Study|Relocation|4|||
33261456|NCT03093428|100860095|FG001|Overall Study|Withdrawal by Subject|1|||
33261457|NCT00582972|100860096|FG000|Overall Study|Protocol Violation|2|||
33454392|NCT00112437|101554367|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454393|NCT00112437|101554368|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454394|NCT00112437|101554369|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454395|NCT00112437|101554370|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
33454396|NCT00112437|101554345|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454397|NCT00112437|101554346|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
33454398|NCT00112437|101554347|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454399|NCT00112437|101554348|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454400|NCT00112437|101554349|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33172547|NCT00241280|100537395|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
33172548|NCT00241280|100537396|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
33172549|NCT00241280|100537395|FG000|Overall Study|Unsatisfactory Visual Response|1|||
33172550|NCT00241280|100537396|FG001|Overall Study|Unsatisfactory Visual Response|1|||
33172551|NCT00241280|100537395|FG000|Overall Study|Diabetic|1|||
33172552|NCT00241280|100537396|FG001|Overall Study|Diabetic|0|||
33172553|NCT00241280|100537395|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
33172554|NCT00241280|100537396|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
33172555|NCT00241280|100537395|FG000|Overall Study|Dispensed incorrect test article|1|||
33172556|NCT00241280|100537396|FG001|Overall Study|Dispensed incorrect test article|2|||
33172557|NCT00241280|100537395|FG000|Overall Study|Unacceptable Fit|0|||
33172558|NCT00241280|100537396|FG001|Overall Study|Unacceptable Fit|1|||
33172559|NCT00241280|100537395|FG000|Overall Study|Scheduling Conflict|0|||
33454401|NCT00112437|101554350|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454402|NCT00112437|101554351|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33172560|NCT00241280|100537396|FG001|Overall Study|Scheduling Conflict|2|||
33172561|NCT00241280|100537395|FG000|Overall Study|History of Ocular Surgery|0|||
33454403|NCT00112437|101554352|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33172562|NCT00241280|100537396|FG001|Overall Study|History of Ocular Surgery|1|||
33172563|NCT00241280|100537395|FG000|Overall Study|Coating on Lens|1|||
33172564|NCT00241280|100537396|FG001|Overall Study|Coating on Lens|0|||
33172565|NCT00241280|100537395|FG000|Overall Study|Excessive Dryness|0|||
33172566|NCT00241280|100537396|FG001|Overall Study|Excessive Dryness|1|||
33172567|NCT01366209|100537401|FG000|Overall Study|Adverse Event|6|||
33172568|NCT01366209|100537402|FG001|Overall Study|Adverse Event|7|||
33172569|NCT01366209|100537401|FG000|Overall Study|Withdrawal by Subject|4|||
33172570|NCT01366209|100537402|FG001|Overall Study|Withdrawal by Subject|4|||
33172571|NCT01366209|100537401|FG000|Overall Study|Death|12|||
33172572|NCT01366209|100537402|FG001|Overall Study|Death|19|||
33172573|NCT01366209|100537401|FG000|Overall Study|Lung transplantation|6|||
33172574|NCT01366209|100537402|FG001|Overall Study|Lung transplantation|1|||
33172575|NCT01366209|100537401|FG000|Overall Study|Lost to Follow-up|2|||
33172576|NCT01366209|100537402|FG001|Overall Study|Lost to Follow-up|1|||
33172577|NCT01366209|100537401|FG000|Overall Study|Physician Decision|1|||
33172578|NCT01366209|100537402|FG001|Overall Study|Physician Decision|0|||
33172579|NCT01366209|100537401|FG000|Overall Study|Sponsors decision|0|||
33172580|NCT01366209|100537402|FG001|Overall Study|Sponsors decision|1|||
33172581|NCT01366209|100537401|FG000|Overall Study|Withdrew consent|4|||
33172582|NCT01366209|100537402|FG001|Overall Study|Withdrew consent|3|||
33172583|NCT02891850|100541049|FG000|Overall Study|Adverse Event|3|||
33172584|NCT02891850|100541050|FG001|Overall Study|Adverse Event|0|||
33172585|NCT02891850|100541049|FG000|Overall Study|Death|0|||
33172586|NCT02891850|100541050|FG001|Overall Study|Death|4|||
33172587|NCT02891850|100541049|FG000|Overall Study|Physician Decision|1|||
33172588|NCT02891850|100541050|FG001|Overall Study|Physician Decision|0|||
33454404|NCT00112437|101554353|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454405|NCT00112437|101554354|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454406|NCT00112437|101554355|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454407|NCT00112437|101554356|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454408|NCT00112437|101554357|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454409|NCT00112437|101554358|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33172589|NCT02891850|100541049|FG000|Overall Study|Pregnancy|1|||
33172590|NCT02891850|100541050|FG001|Overall Study|Pregnancy|0|||
33172591|NCT02891850|100541049|FG000|Overall Study|Withdrawal by Subject|2|||
33172592|NCT02891850|100541050|FG001|Overall Study|Withdrawal by Subject|3|||
33172593|NCT03241342|100541052|FG000|Overall Study|Adverse Event|5|||
33172594|NCT03241342|100541053|FG001|Overall Study|Adverse Event|8|||
33172595|NCT03241342|100541054|FG002|Overall Study|Adverse Event|4|||
33172596|NCT03241342|100541052|FG000|Overall Study|Lack of Efficacy|0|||
33172597|NCT03241342|100541053|FG001|Overall Study|Lack of Efficacy|0|||
33172598|NCT03241342|100541054|FG002|Overall Study|Lack of Efficacy|1|||
33172599|NCT03241342|100541052|FG000|Overall Study|noncompliance with study drug|2|||
33454410|NCT00112437|101554359|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454411|NCT00112437|101554360|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454412|NCT00112437|101554361|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454413|NCT00112437|101554362|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454414|NCT00112437|101554363|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454415|NCT00112437|101554364|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454416|NCT00112437|101554365|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454417|NCT00112437|101554366|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454418|NCT00112437|101554367|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454419|NCT00112437|101554368|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454420|NCT00112437|101554369|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454421|NCT00112437|101554370|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
33454422|NCT00112437|101554345|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454423|NCT00112437|101554346|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
33454424|NCT00112437|101554347|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454425|NCT00112437|101554348|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454426|NCT00112437|101554349|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454427|NCT00112437|101554350|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454428|NCT00112437|101554351|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33172600|NCT03241342|100541053|FG001|Overall Study|noncompliance with study drug|1|||
33172601|NCT03241342|100541054|FG002|Overall Study|noncompliance with study drug|1|||
33172602|NCT03241342|100541052|FG000|Overall Study|sponsor decision|0|||
33172603|NCT03241342|100541053|FG001|Overall Study|sponsor decision|1|||
33172604|NCT03241342|100541054|FG002|Overall Study|sponsor decision|2|||
33172605|NCT03241342|100541052|FG000|Overall Study|not reported|15|||
33261458|NCT01701401|100860097|FG000|Overall Study|Randomized But Not Treated|3|||
33261459|NCT01701401|100860098|FG001|Overall Study|Randomized But Not Treated|1|||
33261460|NCT01701401|100860099|FG002|Overall Study|Randomized But Not Treated|0|||
33261461|NCT01701401|100860100|FG003|Overall Study|Randomized But Not Treated|1|||
33261462|NCT01701401|100860097|FG000|Overall Study|Lost to Follow-up|5|||
33261463|NCT01701401|100860098|FG001|Overall Study|Lost to Follow-up|5|||
33261464|NCT01701401|100860099|FG002|Overall Study|Lost to Follow-up|1|||
33261465|NCT01701401|100860100|FG003|Overall Study|Lost to Follow-up|3|||
33261466|NCT01701401|100860097|FG000|Overall Study|Withdrew Consent|0|||
33261467|NCT01701401|100860098|FG001|Overall Study|Withdrew Consent|3|||
33261468|NCT01701401|100860099|FG002|Overall Study|Withdrew Consent|1|||
33261469|NCT01701401|100860100|FG003|Overall Study|Withdrew Consent|2|||
33261470|NCT01701401|100860097|FG000|Overall Study|Lack of Efficacy|1|||
33261471|NCT01701401|100860098|FG001|Overall Study|Lack of Efficacy|0|||
33261472|NCT01701401|100860099|FG002|Overall Study|Lack of Efficacy|2|||
33454429|NCT00112437|101554352|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454430|NCT00112437|101554353|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33172606|NCT03241342|100541053|FG001|Overall Study|not reported|21|||
33261473|NCT01701401|100860100|FG003|Overall Study|Lack of Efficacy|0|||
33261474|NCT01701401|100860097|FG000|Overall Study|Adverse Event|1|||
33261475|NCT01701401|100860098|FG001|Overall Study|Adverse Event|0|||
33261476|NCT01701401|100860099|FG002|Overall Study|Adverse Event|0|||
33261477|NCT01701401|100860100|FG003|Overall Study|Adverse Event|0|||
33454431|NCT00112437|101554354|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454432|NCT00112437|101554355|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454433|NCT00112437|101554356|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454434|NCT00112437|101554357|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454435|NCT00112437|101554358|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454436|NCT00112437|101554359|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454437|NCT00112437|101554360|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454438|NCT00112437|101554361|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454439|NCT00112437|101554362|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454440|NCT00112437|101554363|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454441|NCT00112437|101554364|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454442|NCT00112437|101554365|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454443|NCT00112437|101554366|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454444|NCT00112437|101554367|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454445|NCT00112437|101554368|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454446|NCT00112437|101554369|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454447|NCT00112437|101554370|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
33454448|NCT00112437|101554345|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
33454449|NCT00112437|101554346|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454450|NCT00112437|101554347|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
33454451|NCT00112437|101554348|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
33454452|NCT00112437|101554349|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
33454453|NCT00112437|101554350|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454454|NCT00112437|101554351|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454455|NCT00112437|101554352|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454456|NCT00112437|101554353|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454457|NCT00112437|101554354|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454458|NCT00112437|101554355|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454459|NCT00112437|101554356|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454460|NCT00112437|101554357|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454461|NCT00112437|101554358|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454462|NCT00112437|101554359|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454463|NCT00112437|101554360|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454464|NCT00112437|101554361|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454465|NCT00112437|101554362|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454466|NCT00112437|101554363|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454467|NCT00112437|101554364|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454468|NCT00112437|101554365|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454469|NCT00112437|101554366|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454470|NCT00112437|101554367|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454471|NCT00112437|101554368|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454472|NCT00112437|101554369|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454473|NCT00112437|101554370|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
33454474|NCT00112437|101554345|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
33454475|NCT00112437|101554346|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
33454476|NCT00112437|101554347|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
33454477|NCT00112437|101554348|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
33454478|NCT00112437|101554349|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
33454479|NCT00112437|101554350|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454480|NCT00112437|101554351|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454481|NCT00112437|101554352|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454482|NCT00112437|101554353|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454483|NCT00112437|101554354|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454484|NCT00112437|101554355|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454485|NCT00112437|101554356|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454486|NCT00112437|101554357|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454487|NCT00112437|101554358|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33261478|NCT01701401|100860097|FG000|Overall Study|Protocol Violation|0|||
33454488|NCT00112437|101554359|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454489|NCT00112437|101554360|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33261479|NCT01701401|100860098|FG001|Overall Study|Protocol Violation|0|||
33454490|NCT00112437|101554361|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454491|NCT00112437|101554362|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454492|NCT00112437|101554363|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454493|NCT00112437|101554364|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454494|NCT00112437|101554365|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454495|NCT00112437|101554366|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454496|NCT00112437|101554367|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454497|NCT00112437|101554368|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454498|NCT00112437|101554369|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454499|NCT00112437|101554370|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
33454500|NCT00112437|101554345|FG000|Year 1 (12-Month Base Study)|moved|0|||
33454501|NCT00112437|101554346|FG001|Year 1 (12-Month Base Study)|moved|1|||
33454502|NCT00112437|101554347|FG002|Year 1 (12-Month Base Study)|moved|1|||
33454503|NCT00112437|101554348|FG003|Year 1 (12-Month Base Study)|moved|0|||
33454504|NCT00112437|101554349|FG004|Year 1 (12-Month Base Study)|moved|0|||
33454505|NCT00112437|101554350|FG005|Year 1 (12-Month Base Study)|moved|0|||
33454506|NCT00112437|101554351|FG006|Year 1 (12-Month Base Study)|moved|0|||
33454507|NCT00112437|101554352|FG007|Year 1 (12-Month Base Study)|moved|0|||
33454508|NCT00112437|101554353|FG008|Year 1 (12-Month Base Study)|moved|0|||
33454509|NCT00112437|101554354|FG009|Year 1 (12-Month Base Study)|moved|0|||
33454510|NCT00112437|101554355|FG010|Year 1 (12-Month Base Study)|moved|0|||
33454511|NCT00112437|101554356|FG011|Year 1 (12-Month Base Study)|moved|0|||
33454512|NCT00112437|101554357|FG012|Year 1 (12-Month Base Study)|moved|0|||
33454513|NCT00112437|101554358|FG013|Year 1 (12-Month Base Study)|moved|0|||
33454514|NCT00112437|101554359|FG014|Year 1 (12-Month Base Study)|moved|0|||
33454515|NCT00112437|101554360|FG015|Year 1 (12-Month Base Study)|moved|0|||
33454516|NCT00112437|101554361|FG016|Year 1 (12-Month Base Study)|moved|0|||
33454517|NCT00112437|101554362|FG017|Year 1 (12-Month Base Study)|moved|0|||
33454518|NCT00112437|101554363|FG018|Year 1 (12-Month Base Study)|moved|0|||
33454519|NCT00112437|101554364|FG019|Year 1 (12-Month Base Study)|moved|0|||
33454520|NCT00112437|101554365|FG020|Year 1 (12-Month Base Study)|moved|0|||
33454521|NCT00112437|101554366|FG021|Year 1 (12-Month Base Study)|moved|0|||
33454522|NCT00112437|101554367|FG022|Year 1 (12-Month Base Study)|moved|0|||
33454523|NCT00112437|101554368|FG023|Year 1 (12-Month Base Study)|moved|0|||
33454524|NCT00112437|101554369|FG024|Year 1 (12-Month Base Study)|moved|0|||
33454525|NCT00112437|101554370|FG025|Year 1 (12-Month Base Study)|moved|0|||
33454526|NCT00112437|101554345|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454527|NCT00112437|101554346|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454528|NCT00112437|101554347|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454529|NCT00112437|101554348|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
33454530|NCT00112437|101554349|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454531|NCT00112437|101554350|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454532|NCT00112437|101554351|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454533|NCT00112437|101554352|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454534|NCT00112437|101554353|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454535|NCT00112437|101554354|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454536|NCT00112437|101554355|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454537|NCT00112437|101554356|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454538|NCT00112437|101554357|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454539|NCT00112437|101554358|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454540|NCT00112437|101554359|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454541|NCT00112437|101554360|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454542|NCT00112437|101554361|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33172607|NCT03241342|100541054|FG002|Overall Study|not reported|19|||
33172608|NCT03402386|100541056|FG000|Overall Study|Adverse Event|3|||
33172609|NCT03402386|100541056|FG000|Overall Study|Physician Decision|1|||
33172610|NCT03402386|100541056|FG000|Overall Study|Difficult to control Hb|2|||
33172611|NCT02064868|100541057|FG000|Overall Study|Lost to Follow-up|14|||
33172612|NCT02064868|100541058|FG001|Overall Study|Lost to Follow-up|8|||
33172613|NCT02064868|100541057|FG000|Overall Study|Physician Decision|1|||
33172614|NCT02064868|100541058|FG001|Overall Study|Physician Decision|0|||
33172615|NCT02064868|100541057|FG000|Overall Study|Withdrawal by Subject|14|||
33172616|NCT02064868|100541058|FG001|Overall Study|Withdrawal by Subject|3|||
33172617|NCT02064868|100541057|FG000|Overall Study|Technical Problems or Missing|5|||
33454543|NCT00112437|101554362|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454544|NCT00112437|101554363|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33172618|NCT02064868|100541058|FG001|Overall Study|Technical Problems or Missing|2|||
33172619|NCT01113801|100541059|FG000|Overall Study|Adverse Event|4|||
33172620|NCT01113801|100541060|FG001|Overall Study|Adverse Event|0|||
33172621|NCT01113801|100541061|FG002|Overall Study|Adverse Event|2|||
33172622|NCT01113801|100541062|FG003|Overall Study|Adverse Event|6|||
33172623|NCT01113801|100541059|FG000|Overall Study|Death|4|||
33172624|NCT01113801|100541060|FG001|Overall Study|Death|5|||
33172625|NCT01113801|100541061|FG002|Overall Study|Death|3|||
33172626|NCT01113801|100541062|FG003|Overall Study|Death|4|||
33172627|NCT01113801|100541059|FG000|Overall Study|Protocol Violation|0|||
33172628|NCT01113801|100541060|FG001|Overall Study|Protocol Violation|1|||
33172629|NCT01113801|100541061|FG002|Overall Study|Protocol Violation|0|||
33172630|NCT01113801|100541062|FG003|Overall Study|Protocol Violation|0|||
33172631|NCT01113801|100541059|FG000|Overall Study|Withdrawal by Subject|9|||
33172632|NCT01113801|100541060|FG001|Overall Study|Withdrawal by Subject|7|||
33172633|NCT01113801|100541061|FG002|Overall Study|Withdrawal by Subject|7|||
33172634|NCT01113801|100541062|FG003|Overall Study|Withdrawal by Subject|8|||
33172635|NCT01113801|100541059|FG000|Overall Study|Physician Decision|2|||
33172636|NCT01113801|100541060|FG001|Overall Study|Physician Decision|2|||
33172637|NCT01113801|100541061|FG002|Overall Study|Physician Decision|3|||
33454545|NCT00112437|101554364|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454546|NCT00112437|101554365|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454547|NCT00112437|101554366|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454548|NCT00112437|101554367|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454549|NCT00112437|101554368|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454550|NCT00112437|101554369|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454551|NCT00112437|101554370|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
33454552|NCT00112437|101554345|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454553|NCT00112437|101554346|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454554|NCT00112437|101554347|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454555|NCT00112437|101554348|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454556|NCT00112437|101554349|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
33454557|NCT00112437|101554350|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454558|NCT00112437|101554351|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454559|NCT00112437|101554352|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454560|NCT00112437|101554353|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454561|NCT00112437|101554354|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454562|NCT00112437|101554355|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454563|NCT00112437|101554356|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454564|NCT00112437|101554357|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454565|NCT00112437|101554358|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454566|NCT00112437|101554359|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454567|NCT00112437|101554360|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454568|NCT00112437|101554361|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454569|NCT00112437|101554362|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454570|NCT00112437|101554363|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454571|NCT00112437|101554364|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454572|NCT00112437|101554365|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454573|NCT00112437|101554366|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454574|NCT00112437|101554367|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454575|NCT00112437|101554368|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454576|NCT00112437|101554369|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454577|NCT00112437|101554370|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
33454578|NCT00112437|101554345|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
33454579|NCT00112437|101554346|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
33454580|NCT00112437|101554347|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
33454581|NCT00112437|101554348|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
33454582|NCT00112437|101554349|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
33454583|NCT00112437|101554350|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
33454584|NCT00112437|101554351|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
33454585|NCT00112437|101554352|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
33454586|NCT00112437|101554353|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
33454587|NCT00112437|101554354|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
33454588|NCT00112437|101554355|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
33454589|NCT00112437|101554356|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
33454590|NCT00112437|101554357|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
33454591|NCT00112437|101554358|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
33454592|NCT00112437|101554359|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
33454593|NCT00112437|101554360|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
33454594|NCT00112437|101554361|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
33454595|NCT00112437|101554362|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
33454596|NCT00112437|101554363|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
33454597|NCT00112437|101554364|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
33454598|NCT00112437|101554365|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
33454599|NCT00112437|101554366|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
33454600|NCT00112437|101554367|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
33454601|NCT00112437|101554368|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
33454602|NCT00112437|101554369|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
33454603|NCT00112437|101554370|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
33454604|NCT00112437|101554345|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454605|NCT00112437|101554346|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454606|NCT00112437|101554347|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454607|NCT00112437|101554348|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454608|NCT00112437|101554349|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454609|NCT00112437|101554350|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
33454610|NCT00112437|101554351|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
33454611|NCT00112437|101554352|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454612|NCT00112437|101554353|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454613|NCT00112437|101554354|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
33454614|NCT00112437|101554355|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454615|NCT00112437|101554356|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454616|NCT00112437|101554357|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454617|NCT00112437|101554358|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454618|NCT00112437|101554359|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454619|NCT00112437|101554360|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454620|NCT00112437|101554361|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454621|NCT00112437|101554362|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454622|NCT00112437|101554363|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454623|NCT00112437|101554364|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454624|NCT00112437|101554365|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454625|NCT00112437|101554366|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454626|NCT00112437|101554367|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454627|NCT00112437|101554368|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454628|NCT00112437|101554369|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454629|NCT00112437|101554370|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
33454630|NCT00112437|101554345|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454631|NCT00112437|101554346|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454632|NCT00112437|101554347|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454633|NCT00112437|101554348|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454634|NCT00112437|101554349|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454635|NCT00112437|101554350|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454636|NCT00112437|101554351|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454637|NCT00112437|101554352|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454638|NCT00112437|101554353|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
33454639|NCT00112437|101554354|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454640|NCT00112437|101554355|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454641|NCT00112437|101554356|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454642|NCT00112437|101554357|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454643|NCT00112437|101554358|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454644|NCT00112437|101554359|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454645|NCT00112437|101554360|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454646|NCT00112437|101554361|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454647|NCT00112437|101554362|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454648|NCT00112437|101554363|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454649|NCT00112437|101554364|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454650|NCT00112437|101554365|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454651|NCT00112437|101554366|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454652|NCT00112437|101554367|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454653|NCT00112437|101554368|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454654|NCT00112437|101554369|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454655|NCT00112437|101554370|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
33454656|NCT00112437|101554345|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454657|NCT00112437|101554346|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454658|NCT00112437|101554347|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454659|NCT00112437|101554348|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454660|NCT00112437|101554349|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454661|NCT00112437|101554350|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454662|NCT00112437|101554351|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454663|NCT00112437|101554352|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454664|NCT00112437|101554353|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
33454665|NCT00112437|101554354|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454666|NCT00112437|101554355|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454667|NCT00112437|101554356|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454668|NCT00112437|101554357|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454669|NCT00112437|101554358|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454670|NCT00112437|101554359|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454671|NCT00112437|101554360|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454672|NCT00112437|101554361|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454673|NCT00112437|101554362|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454674|NCT00112437|101554363|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454675|NCT00112437|101554364|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454676|NCT00112437|101554365|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454677|NCT00112437|101554366|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454678|NCT00112437|101554367|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454679|NCT00112437|101554368|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454680|NCT00112437|101554369|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454681|NCT00112437|101554370|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
33454682|NCT00112437|101554345|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454683|NCT00112437|101554346|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454684|NCT00112437|101554347|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454685|NCT00112437|101554348|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454686|NCT00112437|101554349|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454687|NCT00112437|101554350|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
33454688|NCT00112437|101554351|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
33454689|NCT00112437|101554352|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
33454690|NCT00112437|101554353|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
33454691|NCT00112437|101554354|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
33454692|NCT00112437|101554355|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454693|NCT00112437|101554356|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454694|NCT00112437|101554357|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454695|NCT00112437|101554358|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454696|NCT00112437|101554359|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454697|NCT00112437|101554360|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454698|NCT00112437|101554361|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454699|NCT00112437|101554362|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454700|NCT00112437|101554363|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454701|NCT00112437|101554364|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454702|NCT00112437|101554365|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454703|NCT00112437|101554366|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454704|NCT00112437|101554367|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454705|NCT00112437|101554368|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454706|NCT00112437|101554369|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454707|NCT00112437|101554370|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
33454708|NCT00112437|101554345|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454709|NCT00112437|101554346|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454710|NCT00112437|101554347|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454711|NCT00112437|101554348|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454712|NCT00112437|101554349|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454713|NCT00112437|101554350|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454714|NCT00112437|101554351|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454715|NCT00112437|101554352|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454716|NCT00112437|101554353|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454717|NCT00112437|101554354|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
33454718|NCT00112437|101554355|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454719|NCT00112437|101554356|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454720|NCT00112437|101554357|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454721|NCT00112437|101554358|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454722|NCT00112437|101554359|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454723|NCT00112437|101554360|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454724|NCT00112437|101554361|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454725|NCT00112437|101554362|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454726|NCT00112437|101554363|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454727|NCT00112437|101554364|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454728|NCT00112437|101554365|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454729|NCT00112437|101554366|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454730|NCT00112437|101554367|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454731|NCT00112437|101554368|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454732|NCT00112437|101554369|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33454733|NCT00112437|101554370|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
33261480|NCT01701401|100860099|FG002|Overall Study|Protocol Violation|1|||
33261481|NCT01701401|100860100|FG003|Overall Study|Protocol Violation|0|||
33261482|NCT03539952|100860101|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
33261483|NCT03539952|100860102|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
33261484|NCT03539952|100860101|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
33261485|NCT03539952|100860102|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
33261486|NCT03539952|100860101|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
33261487|NCT03539952|100860102|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
33261488|NCT03539952|100860101|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
33261489|NCT03539952|100860102|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
33261490|NCT03539952|100860101|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
33261491|NCT03539952|100860102|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
33261492|NCT03539952|100860101|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
33261493|NCT03539952|100860102|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
33261494|NCT03539952|100860101|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
33261495|NCT03539952|100860102|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
33261496|NCT00409838|100860109|FG000|Short-term Period|Adverse Event|0|||
33454734|NCT00112437|101554345|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454735|NCT00112437|101554346|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454736|NCT00112437|101554347|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454737|NCT00112437|101554348|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454738|NCT00112437|101554349|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454739|NCT00112437|101554350|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454740|NCT00112437|101554351|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454741|NCT00112437|101554352|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454742|NCT00112437|101554353|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454743|NCT00112437|101554354|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
33454744|NCT00112437|101554355|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454745|NCT00112437|101554356|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454746|NCT00112437|101554357|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454747|NCT00112437|101554358|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
33172638|NCT01113801|100541062|FG003|Overall Study|Physician Decision|3|||
33172639|NCT01113801|100541059|FG000|Overall Study|Sponsor Decision|15|||
33172640|NCT01113801|100541060|FG001|Overall Study|Sponsor Decision|21|||
33172641|NCT01113801|100541061|FG002|Overall Study|Sponsor Decision|20|||
33172642|NCT01113801|100541062|FG003|Overall Study|Sponsor Decision|15|||
33172643|NCT01113801|100541059|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
33172644|NCT01113801|100541060|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
33172645|NCT01113801|100541061|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
33172646|NCT01113801|100541062|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
33172647|NCT03211416|100541063|FG000|Overall Study|Adverse Event|7|||
33172648|NCT03211416|100541063|FG000|Overall Study|Lack of Efficacy|2|||
33172649|NCT03211416|100541063|FG000|Overall Study|Physician Decision|1|||
33172650|NCT01648205|100541064|FG000|Placebo|Pregnancy|1|||
33172651|NCT01648205|100541064|FG000|Placebo|Withdrawal by Subject|1|||
33172652|NCT01648205|100541064|FG000|Placebo|Protocol Violation|2|||
33454748|NCT00112437|101554359|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454749|NCT00112437|101554360|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454750|NCT00112437|101554361|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454751|NCT00112437|101554362|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454752|NCT00112437|101554363|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454753|NCT00112437|101554364|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454754|NCT00112437|101554365|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454755|NCT00112437|101554366|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454756|NCT00112437|101554367|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454757|NCT00112437|101554368|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454758|NCT00112437|101554369|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454759|NCT00112437|101554370|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
33454760|NCT00112437|101554345|FG000|Year 2 (12-Month Extension)|Moved|0|||
33454761|NCT00112437|101554346|FG001|Year 2 (12-Month Extension)|Moved|0|||
33454762|NCT00112437|101554347|FG002|Year 2 (12-Month Extension)|Moved|0|||
33454763|NCT00112437|101554348|FG003|Year 2 (12-Month Extension)|Moved|0|||
33454764|NCT00112437|101554349|FG004|Year 2 (12-Month Extension)|Moved|0|||
33454765|NCT00112437|101554350|FG005|Year 2 (12-Month Extension)|Moved|0|||
33454766|NCT00112437|101554351|FG006|Year 2 (12-Month Extension)|Moved|0|||
33454767|NCT00112437|101554352|FG007|Year 2 (12-Month Extension)|Moved|0|||
33454768|NCT00112437|101554353|FG008|Year 2 (12-Month Extension)|Moved|0|||
33454769|NCT00112437|101554354|FG009|Year 2 (12-Month Extension)|Moved|1|||
33454770|NCT00112437|101554355|FG010|Year 2 (12-Month Extension)|Moved|0|||
33454771|NCT00112437|101554356|FG011|Year 2 (12-Month Extension)|Moved|0|||
33454772|NCT00112437|101554357|FG012|Year 2 (12-Month Extension)|Moved|0|||
33454773|NCT00112437|101554358|FG013|Year 2 (12-Month Extension)|Moved|0|||
33454774|NCT00112437|101554359|FG014|Year 2 (12-Month Extension)|Moved|0|||
33454775|NCT00112437|101554360|FG015|Year 2 (12-Month Extension)|Moved|0|||
33454776|NCT00112437|101554361|FG016|Year 2 (12-Month Extension)|Moved|0|||
33454777|NCT00112437|101554362|FG017|Year 2 (12-Month Extension)|Moved|0|||
33454778|NCT00112437|101554363|FG018|Year 2 (12-Month Extension)|Moved|0|||
33454779|NCT00112437|101554364|FG019|Year 2 (12-Month Extension)|Moved|0|||
33454780|NCT00112437|101554365|FG020|Year 2 (12-Month Extension)|Moved|0|||
33454781|NCT00112437|101554366|FG021|Year 2 (12-Month Extension)|Moved|0|||
33454782|NCT00112437|101554367|FG022|Year 2 (12-Month Extension)|Moved|0|||
33454783|NCT00112437|101554368|FG023|Year 2 (12-Month Extension)|Moved|0|||
33454784|NCT00112437|101554369|FG024|Year 2 (12-Month Extension)|Moved|0|||
33454785|NCT00112437|101554370|FG025|Year 2 (12-Month Extension)|Moved|0|||
33454786|NCT00112437|101554345|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
33454787|NCT00112437|101554346|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
33454788|NCT00112437|101554347|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
33261497|NCT00409838|100860110|FG001|Short-term Period|Adverse Event|1|||
33454789|NCT00112437|101554348|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
33454790|NCT00112437|101554349|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
33454791|NCT00112437|101554350|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
33454792|NCT00112437|101554351|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
33454793|NCT00112437|101554352|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
33454794|NCT00112437|101554353|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
33454795|NCT00112437|101554354|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
33454796|NCT00112437|101554355|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
33454797|NCT00112437|101554356|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
33454798|NCT00112437|101554357|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
33454799|NCT00112437|101554358|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
33454800|NCT00112437|101554359|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
33454801|NCT00112437|101554360|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
33454802|NCT00112437|101554361|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
33454803|NCT00112437|101554362|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
33454804|NCT00112437|101554363|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
33454805|NCT00112437|101554364|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
33454806|NCT00112437|101554365|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
33454807|NCT00112437|101554366|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
33454808|NCT00112437|101554367|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
33454809|NCT00112437|101554368|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
33454810|NCT00112437|101554369|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
33454811|NCT00112437|101554370|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
33454812|NCT00112437|101554345|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454813|NCT00112437|101554346|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454814|NCT00112437|101554347|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454815|NCT00112437|101554348|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454816|NCT00112437|101554349|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454817|NCT00112437|101554350|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454818|NCT00112437|101554351|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454819|NCT00112437|101554352|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454820|NCT00112437|101554353|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454821|NCT00112437|101554354|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454822|NCT00112437|101554355|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454823|NCT00112437|101554356|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
33454824|NCT00112437|101554357|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454825|NCT00112437|101554358|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
33454826|NCT00112437|101554359|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454827|NCT00112437|101554360|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
33454828|NCT00112437|101554361|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454829|NCT00112437|101554362|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454830|NCT00112437|101554363|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
33454831|NCT00112437|101554364|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454832|NCT00112437|101554365|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454833|NCT00112437|101554366|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454834|NCT00112437|101554367|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454835|NCT00112437|101554368|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454836|NCT00112437|101554369|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454837|NCT00112437|101554370|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
33454838|NCT00112437|101554345|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454839|NCT00112437|101554346|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454840|NCT00112437|101554347|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454841|NCT00112437|101554348|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454842|NCT00112437|101554349|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454843|NCT00112437|101554350|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454844|NCT00112437|101554351|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454845|NCT00112437|101554352|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454846|NCT00112437|101554353|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454847|NCT00112437|101554354|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454848|NCT00112437|101554355|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454849|NCT00112437|101554356|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454850|NCT00112437|101554357|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454851|NCT00112437|101554358|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454852|NCT00112437|101554359|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454853|NCT00112437|101554360|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
33454854|NCT00112437|101554361|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454855|NCT00112437|101554362|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454856|NCT00112437|101554363|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454857|NCT00112437|101554364|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454858|NCT00112437|101554365|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454859|NCT00112437|101554366|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454860|NCT00112437|101554367|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454861|NCT00112437|101554368|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454862|NCT00112437|101554369|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454863|NCT00112437|101554370|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
33454864|NCT00112437|101554345|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454865|NCT00112437|101554346|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454866|NCT00112437|101554347|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454867|NCT00112437|101554348|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454868|NCT00112437|101554349|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454869|NCT00112437|101554350|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454870|NCT00112437|101554351|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454871|NCT00112437|101554352|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454872|NCT00112437|101554353|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454873|NCT00112437|101554354|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454874|NCT00112437|101554355|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454875|NCT00112437|101554356|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454876|NCT00112437|101554357|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454877|NCT00112437|101554358|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454878|NCT00112437|101554359|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454879|NCT00112437|101554360|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
33454880|NCT00112437|101554361|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454881|NCT00112437|101554362|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454882|NCT00112437|101554363|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454883|NCT00112437|101554364|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454884|NCT00112437|101554365|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454885|NCT00112437|101554366|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454886|NCT00112437|101554367|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454887|NCT00112437|101554368|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454888|NCT00112437|101554369|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454889|NCT00112437|101554370|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
33454890|NCT00112437|101554345|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454891|NCT00112437|101554346|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454892|NCT00112437|101554347|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454893|NCT00112437|101554348|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454894|NCT00112437|101554349|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454895|NCT00112437|101554350|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454896|NCT00112437|101554351|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454897|NCT00112437|101554352|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454898|NCT00112437|101554353|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454899|NCT00112437|101554354|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454900|NCT00112437|101554355|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454901|NCT00112437|101554356|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
33454902|NCT00112437|101554357|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454903|NCT00112437|101554358|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454904|NCT00112437|101554359|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
33454905|NCT00112437|101554360|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454906|NCT00112437|101554361|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454907|NCT00112437|101554362|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454908|NCT00112437|101554363|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454909|NCT00112437|101554364|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454910|NCT00112437|101554365|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454911|NCT00112437|101554366|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454912|NCT00112437|101554367|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454913|NCT00112437|101554368|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454914|NCT00112437|101554369|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454915|NCT00112437|101554370|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
33454916|NCT00112437|101554345|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454917|NCT00112437|101554346|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454918|NCT00112437|101554347|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454919|NCT00112437|101554348|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454920|NCT00112437|101554349|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454921|NCT00112437|101554350|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454922|NCT00112437|101554351|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454923|NCT00112437|101554352|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454924|NCT00112437|101554353|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454925|NCT00112437|101554354|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454926|NCT00112437|101554355|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
33454927|NCT00112437|101554356|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
33454928|NCT00112437|101554357|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454929|NCT00112437|101554358|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454930|NCT00112437|101554359|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454931|NCT00112437|101554360|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454932|NCT00112437|101554361|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454933|NCT00112437|101554362|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454934|NCT00112437|101554363|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454935|NCT00112437|101554364|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454936|NCT00112437|101554365|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454937|NCT00112437|101554366|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454938|NCT00112437|101554367|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454939|NCT00112437|101554368|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454940|NCT00112437|101554369|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454941|NCT00112437|101554370|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
33454942|NCT00112437|101554345|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454943|NCT00112437|101554346|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454944|NCT00112437|101554347|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454945|NCT00112437|101554348|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454946|NCT00112437|101554349|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454947|NCT00112437|101554350|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454948|NCT00112437|101554351|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454949|NCT00112437|101554352|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454950|NCT00112437|101554353|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454951|NCT00112437|101554354|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454952|NCT00112437|101554355|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454953|NCT00112437|101554356|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454954|NCT00112437|101554357|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454955|NCT00112437|101554358|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454956|NCT00112437|101554359|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454957|NCT00112437|101554360|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454958|NCT00112437|101554361|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454959|NCT00112437|101554362|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454960|NCT00112437|101554363|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454961|NCT00112437|101554364|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454962|NCT00112437|101554365|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
33454963|NCT00112437|101554366|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
33454964|NCT00112437|101554367|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454965|NCT00112437|101554368|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454966|NCT00112437|101554369|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454967|NCT00112437|101554370|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
33454968|NCT00112437|101554345|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454969|NCT00112437|101554346|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454970|NCT00112437|101554347|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454971|NCT00112437|101554348|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454972|NCT00112437|101554349|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33261498|NCT00409838|100860109|FG000|Short-term Period|Lost to Follow-up|0|||
33454973|NCT00112437|101554350|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454974|NCT00112437|101554351|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454975|NCT00112437|101554352|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454976|NCT00112437|101554353|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454977|NCT00112437|101554354|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454978|NCT00112437|101554355|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454979|NCT00112437|101554356|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454980|NCT00112437|101554357|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454981|NCT00112437|101554358|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454982|NCT00112437|101554359|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454983|NCT00112437|101554360|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454984|NCT00112437|101554361|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454985|NCT00112437|101554362|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454986|NCT00112437|101554363|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454987|NCT00112437|101554364|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454988|NCT00112437|101554365|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
33454989|NCT00112437|101554366|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33261499|NCT00409838|100860110|FG001|Short-term Period|Lost to Follow-up|1|||
33261500|NCT00409838|100860109|FG000|Short-term Period|Withdrawal by Subject|2|||
33261501|NCT00409838|100860110|FG001|Short-term Period|Withdrawal by Subject|3|||
33261502|NCT00409838|100860109|FG000|Short-term Period|Never Treated|1|||
33261503|NCT00409838|100860110|FG001|Short-term Period|Never Treated|0|||
33261504|NCT00409838|100860109|FG000|Long-term Extension Period|Adverse Event|10|||
33261505|NCT00409838|100860110|FG001|Long-term Extension Period|Adverse Event|0|||
33261506|NCT00409838|100860109|FG000|Long-term Extension Period|Death|1|||
33261507|NCT00409838|100860110|FG001|Long-term Extension Period|Death|0|||
33261508|NCT00409838|100860109|FG000|Long-term Extension Period|Lack of Efficacy|2|||
33261509|NCT00409838|100860110|FG001|Long-term Extension Period|Lack of Efficacy|0|||
33261510|NCT00409838|100860109|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
33261511|NCT00409838|100860110|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
33261512|NCT00409838|100860109|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
33261513|NCT00409838|100860110|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
33261514|NCT00409838|100860109|FG000|Long-term Extension Period|Pregnancy|1|||
33261515|NCT00409838|100860110|FG001|Long-term Extension Period|Pregnancy|0|||
33261516|NCT02874534|100860111|FG000|Overall Study|Withdrawal by Subject|5|||
33261517|NCT02874534|100860112|FG001|Overall Study|Withdrawal by Subject|8|||
33261518|NCT02874534|100860111|FG000|Overall Study|Lost to Follow-up|2|||
33261519|NCT02874534|100860112|FG001|Overall Study|Lost to Follow-up|2|||
33261520|NCT02874534|100860111|FG000|Overall Study|Ongoing in study|1|||
33261521|NCT02874534|100860112|FG001|Overall Study|Ongoing in study|1|||
33261522|NCT00220740|100860113|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
33261523|NCT00220740|100860114|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
33261524|NCT00220740|100860113|FG000|Efficacy Period|Adverse Event|1|||
33261525|NCT00220740|100860114|FG001|Efficacy Period|Adverse Event|1|||
33261526|NCT00220740|100860113|FG000|Efficacy Period|Withdrawal by Subject|1|||
33261527|NCT00220740|100860114|FG001|Efficacy Period|Withdrawal by Subject|0|||
33261528|NCT00220740|100860113|FG000|Efficacy Period|Protocol Violation|1|||
33261529|NCT00220740|100860114|FG001|Efficacy Period|Protocol Violation|0|||
33261530|NCT00220740|100860113|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
33261531|NCT00220740|100860114|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
33261532|NCT01989455|100860115|FG000|Overall Study|Adverse Event|0|||
33261533|NCT01989455|100860116|FG001|Overall Study|Adverse Event|1|||
33261534|NCT01989455|100860117|FG002|Overall Study|Adverse Event|0|||
33261535|NCT01989455|100860118|FG003|Overall Study|Adverse Event|0|||
33261536|NCT01989455|100860119|FG004|Overall Study|Adverse Event|0|||
33261537|NCT01989455|100860115|FG000|Overall Study|Withdrawal by Subject|0|||
33261538|NCT01989455|100860116|FG001|Overall Study|Withdrawal by Subject|1|||
33261539|NCT01989455|100860117|FG002|Overall Study|Withdrawal by Subject|0|||
33261540|NCT01989455|100860118|FG003|Overall Study|Withdrawal by Subject|0|||
33261541|NCT01989455|100860119|FG004|Overall Study|Withdrawal by Subject|0|||
33454990|NCT00112437|101554367|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454991|NCT00112437|101554368|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454992|NCT00112437|101554369|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33454993|NCT00112437|101554370|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
33261542|NCT01989455|100860115|FG000|Overall Study|Technical problems with infusion|0|||
33261543|NCT01989455|100860116|FG001|Overall Study|Technical problems with infusion|0|||
33261544|NCT01989455|100860117|FG002|Overall Study|Technical problems with infusion|1|||
33261545|NCT01989455|100860118|FG003|Overall Study|Technical problems with infusion|0|||
33261546|NCT01989455|100860119|FG004|Overall Study|Technical problems with infusion|1|||
33261547|NCT00505934|100860120|FG000|Overall Study|Adverse Event|1|||
33454994|NCT00112437|101554345|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33454995|NCT00112437|101554346|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33454996|NCT00112437|101554347|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33454997|NCT00112437|101554348|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33454998|NCT00112437|101554349|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33454999|NCT00112437|101554350|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455000|NCT00112437|101554351|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455001|NCT00112437|101554352|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455002|NCT00112437|101554353|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455003|NCT00112437|101554354|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33261548|NCT00505934|100860120|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
33261549|NCT00505934|100860120|FG000|Overall Study|Other: IV dose needed to be changed|1|||
33261550|NCT01721291|100860121|FG000|Overall Study|Withdrawal by Subject|1|||
33261551|NCT01721291|100860122|FG001|Overall Study|Withdrawal by Subject|0|||
33261552|NCT01721291|100860121|FG000|Overall Study|did not like the treatment|1|||
33261553|NCT01721291|100860122|FG001|Overall Study|did not like the treatment|0|||
33261554|NCT00448669|100860123|FG000|Overall Study|Lost to Follow-up|52|||
33261555|NCT00448669|100860124|FG001|Overall Study|Lost to Follow-up|63|||
33261556|NCT00448669|100860123|FG000|Overall Study|Withdrawal by Subject|90|||
33261557|NCT00448669|100860124|FG001|Overall Study|Withdrawal by Subject|74|||
33455004|NCT00112437|101554355|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455005|NCT00112437|101554356|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455006|NCT00112437|101554357|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455007|NCT00112437|101554358|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455008|NCT00112437|101554359|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455009|NCT00112437|101554360|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455010|NCT00112437|101554361|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455011|NCT00112437|101554362|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455012|NCT00112437|101554363|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455013|NCT00112437|101554364|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455014|NCT00112437|101554365|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455015|NCT00112437|101554366|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
33455016|NCT00112437|101554367|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455017|NCT00112437|101554368|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455018|NCT00112437|101554369|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455019|NCT00112437|101554370|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
33455020|NCT00112437|101554345|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455021|NCT00112437|101554346|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455022|NCT00112437|101554347|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455023|NCT00112437|101554348|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455024|NCT00112437|101554349|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455025|NCT00112437|101554350|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
33261558|NCT00448669|100860123|FG000|Overall Study|Relocated|49|||
33261559|NCT00448669|100860124|FG001|Overall Study|Relocated|36|||
33455026|NCT00112437|101554351|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455027|NCT00112437|101554352|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455028|NCT00112437|101554353|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455029|NCT00112437|101554354|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
33172653|NCT01648205|100541064|FG000|Ranolazine|Death|1|||
33261560|NCT00448669|100860123|FG000|Overall Study|Were withdrawn by investigator|10|||
33261561|NCT00448669|100860124|FG001|Overall Study|Were withdrawn by investigator|6|||
33261562|NCT00448669|100860123|FG000|Overall Study|Death|2|||
33261563|NCT00448669|100860124|FG001|Overall Study|Death|4|||
33261564|NCT00448669|100860123|FG000|Overall Study|Had other reasons|5|||
33455030|NCT00112437|101554355|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455031|NCT00112437|101554356|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455032|NCT00112437|101554357|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455033|NCT00112437|101554358|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455034|NCT00112437|101554359|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455035|NCT00112437|101554360|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
33261565|NCT00448669|100860124|FG001|Overall Study|Had other reasons|6|||
33261566|NCT00448669|100860123|FG000|Overall Study|HIV-infected at enrollment|1|||
33261567|NCT00448669|100860124|FG001|Overall Study|HIV-infected at enrollment|2|||
33261568|NCT00448669|100860123|FG000|Overall Study|Never started drug|9|||
33261569|NCT00448669|100860124|FG001|Overall Study|Never started drug|7|||
33455036|NCT00112437|101554361|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
33172654|NCT01648205|100541064|FG000|Ranolazine|Withdrawal by Subject|1|||
33172655|NCT01648205|100541064|FG000|Ranolazine|Protocol Violation|3|||
33172656|NCT02289898|100541065|FG000|Overall Study|Death|5|||
33172657|NCT02289898|100541066|FG001|Overall Study|Death|4|||
33172658|NCT02289898|100541067|FG002|Overall Study|Death|3|||
33172659|NCT02289898|100541065|FG000|Overall Study|Physician Decision|2|||
33172660|NCT02289898|100541066|FG001|Overall Study|Physician Decision|5|||
33172661|NCT02289898|100541067|FG002|Overall Study|Physician Decision|2|||
33172662|NCT02289898|100541065|FG000|Overall Study|Withdrawal by Subject|0|||
33172663|NCT02289898|100541066|FG001|Overall Study|Withdrawal by Subject|4|||
33172664|NCT02289898|100541067|FG002|Overall Study|Withdrawal by Subject|1|||
33172665|NCT02289898|100541065|FG000|Overall Study|Adverse Event|3|||
33172666|NCT02289898|100541066|FG001|Overall Study|Adverse Event|5|||
33172667|NCT02289898|100541067|FG002|Overall Study|Adverse Event|5|||
33172668|NCT02289898|100541065|FG000|Overall Study|Disease progression|34|||
33172669|NCT02289898|100541066|FG001|Overall Study|Disease progression|28|||
33172670|NCT02289898|100541067|FG002|Overall Study|Disease progression|34|||
33172671|NCT02289898|100541065|FG000|Overall Study|Use of another anticancer therapy|0|||
33172672|NCT02289898|100541066|FG001|Overall Study|Use of another anticancer therapy|0|||
33172673|NCT02289898|100541067|FG002|Overall Study|Use of another anticancer therapy|1|||
33172674|NCT02289898|100541065|FG000|Overall Study|Other|8|||
33172675|NCT02289898|100541066|FG001|Overall Study|Other|7|||
33172676|NCT02289898|100541067|FG002|Overall Study|Other|10|||
33172677|NCT01585194|100541068|FG000|Overall Study|Withdrawal by Subject|1|||
33172678|NCT01585194|100541068|FG000|Overall Study|Physician Decision|2|||
33261570|NCT01485887|100860125|FG000|Overall Study|Withdrawal by Subject|2|||
33261571|NCT01485887|100860125|FG000|Overall Study|Adverse Event|8|||
33261572|NCT01485887|100860125|FG000|Overall Study|Deterioration of primary disease|1|||
33261573|NCT01485887|100860125|FG000|Overall Study|Primary disease markedly improved|1|||
33172679|NCT01585194|100541068|FG000|Overall Study|Lack of insurance|1|||
33172680|NCT03070782|100541070|FG000|Overall Study|Adverse Event|3|||
33172681|NCT03070782|100541071|FG001|Overall Study|Adverse Event|0|||
33172682|NCT03070782|100541072|FG002|Overall Study|Adverse Event|3|||
33261574|NCT01998958|100860126|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261575|NCT01998958|100860127|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
33261576|NCT01998958|100860128|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261577|NCT01998958|100860129|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261578|NCT01998958|100860130|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261579|NCT01998958|100860131|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261580|NCT01998958|100860132|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261581|NCT01998958|100860133|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261582|NCT01998958|100860134|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33455037|NCT00112437|101554362|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455038|NCT00112437|101554363|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455039|NCT00112437|101554364|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455040|NCT00112437|101554365|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455041|NCT00112437|101554366|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
33455042|NCT00112437|101554367|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
33172683|NCT03070782|100541073|FG003|Overall Study|Adverse Event|1|||
33172684|NCT03070782|100541074|FG004|Overall Study|Adverse Event|6|||
33172685|NCT03070782|100541075|FG005|Overall Study|Adverse Event|2|||
33172686|NCT03070782|100541070|FG000|Overall Study|Withdrawal by Subject|2|||
33172687|NCT03070782|100541071|FG001|Overall Study|Withdrawal by Subject|1|||
33172688|NCT03070782|100541072|FG002|Overall Study|Withdrawal by Subject|1|||
33172689|NCT03070782|100541073|FG003|Overall Study|Withdrawal by Subject|0|||
33172690|NCT03070782|100541074|FG004|Overall Study|Withdrawal by Subject|4|||
33172691|NCT03070782|100541075|FG005|Overall Study|Withdrawal by Subject|3|||
33172692|NCT03070782|100541070|FG000|Overall Study|Reason Not Specified|2|||
33172693|NCT03070782|100541071|FG001|Overall Study|Reason Not Specified|0|||
33172694|NCT03070782|100541072|FG002|Overall Study|Reason Not Specified|0|||
33172695|NCT03070782|100541073|FG003|Overall Study|Reason Not Specified|1|||
33172696|NCT03070782|100541074|FG004|Overall Study|Reason Not Specified|2|||
33172697|NCT03070782|100541075|FG005|Overall Study|Reason Not Specified|1|||
33172698|NCT03070782|100541070|FG000|Overall Study|Ineligibility|0|||
33172699|NCT03070782|100541071|FG001|Overall Study|Ineligibility|0|||
33172700|NCT03070782|100541072|FG002|Overall Study|Ineligibility|0|||
33172701|NCT03070782|100541073|FG003|Overall Study|Ineligibility|1|||
33172702|NCT03070782|100541074|FG004|Overall Study|Ineligibility|0|||
33172703|NCT03070782|100541075|FG005|Overall Study|Ineligibility|1|||
33172704|NCT03070782|100541070|FG000|Overall Study|Pregnancy|0|||
33172705|NCT03070782|100541071|FG001|Overall Study|Pregnancy|0|||
33172706|NCT03070782|100541072|FG002|Overall Study|Pregnancy|0|||
33261583|NCT01998958|100860135|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33455043|NCT00112437|101554368|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455044|NCT00112437|101554369|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455045|NCT00112437|101554370|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
33455046|NCT00112437|101554345|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455047|NCT00112437|101554346|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455048|NCT00112437|101554347|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455049|NCT00112437|101554348|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455050|NCT00112437|101554349|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455051|NCT00112437|101554350|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455052|NCT00112437|101554351|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455053|NCT00112437|101554352|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455054|NCT00112437|101554353|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455055|NCT00112437|101554354|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455056|NCT00112437|101554355|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455057|NCT00112437|101554356|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455058|NCT00112437|101554357|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455059|NCT00112437|101554358|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455060|NCT00112437|101554359|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455061|NCT00112437|101554360|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455062|NCT00112437|101554361|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455063|NCT00112437|101554362|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455064|NCT00112437|101554363|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455065|NCT00112437|101554364|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455066|NCT00112437|101554365|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
33455067|NCT00112437|101554366|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
33455068|NCT00112437|101554367|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455069|NCT00112437|101554368|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455070|NCT00112437|101554369|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455071|NCT00112437|101554370|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
33455072|NCT00112437|101554345|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455073|NCT00112437|101554346|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455074|NCT00112437|101554347|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455075|NCT00112437|101554348|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455076|NCT00112437|101554349|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455077|NCT00112437|101554350|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455078|NCT00112437|101554351|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455079|NCT00112437|101554352|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455080|NCT00112437|101554353|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33172707|NCT03070782|100541073|FG003|Overall Study|Pregnancy|1|||
33172708|NCT03070782|100541074|FG004|Overall Study|Pregnancy|0|||
33172709|NCT03070782|100541075|FG005|Overall Study|Pregnancy|0|||
33172710|NCT03070782|100541070|FG000|Overall Study|Investigator Judgement|0|||
33172711|NCT03070782|100541071|FG001|Overall Study|Investigator Judgement|0|||
33172712|NCT03070782|100541072|FG002|Overall Study|Investigator Judgement|0|||
33261584|NCT01998958|100860136|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261585|NCT01998958|100860137|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261586|NCT01998958|100860138|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33455081|NCT00112437|101554354|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455082|NCT00112437|101554355|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455083|NCT00112437|101554356|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455084|NCT00112437|101554357|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455085|NCT00112437|101554358|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33172713|NCT03070782|100541073|FG003|Overall Study|Investigator Judgement|1|||
33172714|NCT03070782|100541074|FG004|Overall Study|Investigator Judgement|0|||
33172715|NCT03070782|100541075|FG005|Overall Study|Investigator Judgement|0|||
33172716|NCT04232124|100541076|FG000|Overall Study|Lost to Follow-up|3|||
33172717|NCT03934931|100541077|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
33172718|NCT03934931|100541078|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
33172719|NCT03934931|100541079|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
33172720|NCT01029795|100541086|FG000|Overall Study|Entry Criteria Not Met|2|||
33261587|NCT01998958|100860139|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33172721|NCT01029795|100541087|FG001|Overall Study|Entry Criteria Not Met|1|||
33172722|NCT01029795|100541086|FG000|Overall Study|Physician Decision|2|||
33172723|NCT01029795|100541087|FG001|Overall Study|Physician Decision|1|||
33172724|NCT01029795|100541086|FG000|Overall Study|Sponsor Decision|11|||
33172725|NCT01029795|100541087|FG001|Overall Study|Sponsor Decision|17|||
33172726|NCT01029795|100541086|FG000|Overall Study|Withdrawal by Subject|1|||
33172727|NCT01029795|100541087|FG001|Overall Study|Withdrawal by Subject|3|||
33172728|NCT02117648|100541088|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
33172729|NCT02117648|100541088|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
33172730|NCT02117648|100541088|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
33172731|NCT02117648|100541088|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
33172732|NCT02117648|100541088|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
33172733|NCT02117648|100541088|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
33172734|NCT02117648|100541088|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
33172735|NCT02117648|100541088|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
33172736|NCT02117648|100541088|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
33172737|NCT02117648|100541088|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
33172738|NCT02117648|100541088|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
33172739|NCT02049957|100541089|FG000|Overall Study|Progressive Disease|5|||
33172740|NCT02049957|100541090|FG001|Overall Study|Progressive Disease|4|||
33172741|NCT02049957|100541091|FG002|Overall Study|Progressive Disease|2|||
33172742|NCT02049957|100541092|FG003|Overall Study|Progressive Disease|2|||
33172743|NCT02049957|100541093|FG004|Overall Study|Progressive Disease|6|||
33172744|NCT02049957|100541094|FG005|Overall Study|Progressive Disease|35|||
33172745|NCT02049957|100541095|FG006|Overall Study|Progressive Disease|7|||
33172746|NCT02049957|100541096|FG007|Overall Study|Progressive Disease|26|||
33172747|NCT02049957|100541097|FG008|Overall Study|Progressive Disease|6|||
33172748|NCT02049957|100541089|FG000|Overall Study|Adverse Event|1|||
33172749|NCT02049957|100541090|FG001|Overall Study|Adverse Event|1|||
33172750|NCT02049957|100541091|FG002|Overall Study|Adverse Event|1|||
33172751|NCT02049957|100541092|FG003|Overall Study|Adverse Event|0|||
33172752|NCT02049957|100541093|FG004|Overall Study|Adverse Event|0|||
33172753|NCT02049957|100541094|FG005|Overall Study|Adverse Event|5|||
33261588|NCT01998958|100860140|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261589|NCT01998958|100860141|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261590|NCT01998958|100860142|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261591|NCT01998958|100860143|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261592|NCT01998958|100860144|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261593|NCT01998958|100860145|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261594|NCT01998958|100860146|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261595|NCT01998958|100860147|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33172754|NCT02049957|100541095|FG006|Overall Study|Adverse Event|0|||
33172755|NCT02049957|100541096|FG007|Overall Study|Adverse Event|6|||
33261596|NCT01998958|100860148|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261597|NCT01998958|100860149|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261598|NCT01998958|100860150|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261599|NCT01998958|100860151|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261600|NCT01998958|100860152|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261601|NCT01998958|100860153|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261602|NCT01998958|100860154|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261603|NCT01998958|100860155|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261604|NCT01998958|100860156|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261605|NCT01998958|100860157|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
33261606|NCT01998958|100860126|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261607|NCT01998958|100860127|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
33261608|NCT01998958|100860128|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261609|NCT01998958|100860129|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33172756|NCT02049957|100541097|FG008|Overall Study|Adverse Event|1|||
33172757|NCT02049957|100541089|FG000|Overall Study|Study Terminated by Sponsor|0|||
33172758|NCT02049957|100541090|FG001|Overall Study|Study Terminated by Sponsor|1|||
33172759|NCT02049957|100541091|FG002|Overall Study|Study Terminated by Sponsor|0|||
33172760|NCT02049957|100541092|FG003|Overall Study|Study Terminated by Sponsor|0|||
33172761|NCT02049957|100541093|FG004|Overall Study|Study Terminated by Sponsor|0|||
33172762|NCT02049957|100541094|FG005|Overall Study|Study Terminated by Sponsor|0|||
33172763|NCT02049957|100541095|FG006|Overall Study|Study Terminated by Sponsor|1|||
33172764|NCT02049957|100541096|FG007|Overall Study|Study Terminated by Sponsor|0|||
33455086|NCT00112437|101554359|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455087|NCT00112437|101554360|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455088|NCT00112437|101554361|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455089|NCT00112437|101554362|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455090|NCT00112437|101554363|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455091|NCT00112437|101554364|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455092|NCT00112437|101554365|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455093|NCT00112437|101554366|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455094|NCT00112437|101554367|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
33455095|NCT00112437|101554368|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
33455096|NCT00112437|101554369|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
33455097|NCT00112437|101554370|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
33455098|NCT00112437|101554345|FG000|Years 6-10 (60-Month Extension)|Death|0|||
33455099|NCT00112437|101554346|FG001|Years 6-10 (60-Month Extension)|Death|0|||
33455100|NCT00112437|101554347|FG002|Years 6-10 (60-Month Extension)|Death|0|||
33455101|NCT00112437|101554348|FG003|Years 6-10 (60-Month Extension)|Death|0|||
33455102|NCT00112437|101554349|FG004|Years 6-10 (60-Month Extension)|Death|0|||
33455103|NCT00112437|101554350|FG005|Years 6-10 (60-Month Extension)|Death|0|||
33455104|NCT00112437|101554351|FG006|Years 6-10 (60-Month Extension)|Death|0|||
33455105|NCT00112437|101554352|FG007|Years 6-10 (60-Month Extension)|Death|0|||
33455106|NCT00112437|101554353|FG008|Years 6-10 (60-Month Extension)|Death|0|||
33455107|NCT00112437|101554354|FG009|Years 6-10 (60-Month Extension)|Death|0|||
33455108|NCT00112437|101554355|FG010|Years 6-10 (60-Month Extension)|Death|0|||
33455109|NCT00112437|101554356|FG011|Years 6-10 (60-Month Extension)|Death|0|||
33455110|NCT00112437|101554357|FG012|Years 6-10 (60-Month Extension)|Death|0|||
33455111|NCT00112437|101554358|FG013|Years 6-10 (60-Month Extension)|Death|0|||
33455112|NCT00112437|101554359|FG014|Years 6-10 (60-Month Extension)|Death|0|||
33455113|NCT00112437|101554360|FG015|Years 6-10 (60-Month Extension)|Death|0|||
33455114|NCT00112437|101554361|FG016|Years 6-10 (60-Month Extension)|Death|0|||
33455115|NCT00112437|101554362|FG017|Years 6-10 (60-Month Extension)|Death|0|||
33455116|NCT00112437|101554363|FG018|Years 6-10 (60-Month Extension)|Death|0|||
33455117|NCT00112437|101554364|FG019|Years 6-10 (60-Month Extension)|Death|0|||
33455118|NCT00112437|101554365|FG020|Years 6-10 (60-Month Extension)|Death|0|||
33455119|NCT00112437|101554366|FG021|Years 6-10 (60-Month Extension)|Death|0|||
33455120|NCT00112437|101554367|FG022|Years 6-10 (60-Month Extension)|Death|0|||
33455121|NCT00112437|101554368|FG023|Years 6-10 (60-Month Extension)|Death|2|||
33455122|NCT00112437|101554369|FG024|Years 6-10 (60-Month Extension)|Death|0|||
33455123|NCT00112437|101554370|FG025|Years 6-10 (60-Month Extension)|Death|0|||
33455124|NCT00112437|101554345|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455125|NCT00112437|101554346|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455126|NCT00112437|101554347|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455127|NCT00112437|101554348|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455128|NCT00112437|101554349|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455129|NCT00112437|101554350|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455130|NCT00112437|101554351|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455131|NCT00112437|101554352|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455132|NCT00112437|101554353|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33172765|NCT02049957|100541097|FG008|Overall Study|Study Terminated by Sponsor|0|||
33455133|NCT00112437|101554354|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455134|NCT00112437|101554355|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455135|NCT00112437|101554356|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455136|NCT00112437|101554357|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455137|NCT00112437|101554358|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455138|NCT00112437|101554359|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455139|NCT00112437|101554360|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455140|NCT00112437|101554361|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455141|NCT00112437|101554362|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455142|NCT00112437|101554363|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455143|NCT00112437|101554364|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455144|NCT00112437|101554365|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455145|NCT00112437|101554366|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455146|NCT00112437|101554367|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455147|NCT00112437|101554368|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455148|NCT00112437|101554369|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
33455149|NCT00112437|101554370|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
33455150|NCT00112437|101554345|FG000|Years 6-10 (60-Month Extension)|Other|0|||
33455151|NCT00112437|101554346|FG001|Years 6-10 (60-Month Extension)|Other|0|||
33455152|NCT00112437|101554347|FG002|Years 6-10 (60-Month Extension)|Other|0|||
33455153|NCT00112437|101554348|FG003|Years 6-10 (60-Month Extension)|Other|0|||
33455154|NCT00112437|101554349|FG004|Years 6-10 (60-Month Extension)|Other|0|||
33455155|NCT00112437|101554350|FG005|Years 6-10 (60-Month Extension)|Other|0|||
33455156|NCT00112437|101554351|FG006|Years 6-10 (60-Month Extension)|Other|0|||
33455157|NCT00112437|101554352|FG007|Years 6-10 (60-Month Extension)|Other|0|||
33455158|NCT00112437|101554353|FG008|Years 6-10 (60-Month Extension)|Other|0|||
33455159|NCT00112437|101554354|FG009|Years 6-10 (60-Month Extension)|Other|0|||
33455160|NCT00112437|101554355|FG010|Years 6-10 (60-Month Extension)|Other|0|||
33455161|NCT00112437|101554356|FG011|Years 6-10 (60-Month Extension)|Other|0|||
33455162|NCT00112437|101554357|FG012|Years 6-10 (60-Month Extension)|Other|0|||
33455163|NCT00112437|101554358|FG013|Years 6-10 (60-Month Extension)|Other|0|||
33455164|NCT00112437|101554359|FG014|Years 6-10 (60-Month Extension)|Other|0|||
33455165|NCT00112437|101554360|FG015|Years 6-10 (60-Month Extension)|Other|0|||
33455166|NCT00112437|101554361|FG016|Years 6-10 (60-Month Extension)|Other|0|||
33455167|NCT00112437|101554362|FG017|Years 6-10 (60-Month Extension)|Other|0|||
33455168|NCT00112437|101554363|FG018|Years 6-10 (60-Month Extension)|Other|0|||
33455169|NCT00112437|101554364|FG019|Years 6-10 (60-Month Extension)|Other|0|||
33455170|NCT00112437|101554365|FG020|Years 6-10 (60-Month Extension)|Other|0|||
33455171|NCT00112437|101554366|FG021|Years 6-10 (60-Month Extension)|Other|0|||
33455172|NCT00112437|101554367|FG022|Years 6-10 (60-Month Extension)|Other|0|||
33455173|NCT00112437|101554368|FG023|Years 6-10 (60-Month Extension)|Other|0|||
33455174|NCT00112437|101554369|FG024|Years 6-10 (60-Month Extension)|Other|1|||
33455175|NCT00112437|101554370|FG025|Years 6-10 (60-Month Extension)|Other|0|||
33455176|NCT00112437|101554345|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455177|NCT00112437|101554346|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455178|NCT00112437|101554347|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455179|NCT00112437|101554348|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455180|NCT00112437|101554349|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455181|NCT00112437|101554350|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455182|NCT00112437|101554351|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455183|NCT00112437|101554352|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455184|NCT00112437|101554353|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455185|NCT00112437|101554354|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455186|NCT00112437|101554355|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455187|NCT00112437|101554356|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455188|NCT00112437|101554357|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455189|NCT00112437|101554358|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455190|NCT00112437|101554359|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455191|NCT00112437|101554360|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455192|NCT00112437|101554361|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455193|NCT00112437|101554362|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455194|NCT00112437|101554363|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455195|NCT00112437|101554364|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455196|NCT00112437|101554365|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455197|NCT00112437|101554366|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455198|NCT00112437|101554367|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455199|NCT00112437|101554368|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
33455200|NCT00112437|101554369|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455201|NCT00112437|101554370|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
33455202|NCT00112437|101554345|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455203|NCT00112437|101554346|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455204|NCT00112437|101554347|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455205|NCT00112437|101554348|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455206|NCT00112437|101554349|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455207|NCT00112437|101554350|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455208|NCT00112437|101554351|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455209|NCT00112437|101554352|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455210|NCT00112437|101554353|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455211|NCT00112437|101554354|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455212|NCT00112437|101554355|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455213|NCT00112437|101554356|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455214|NCT00112437|101554357|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455215|NCT00112437|101554358|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455216|NCT00112437|101554359|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455217|NCT00112437|101554360|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455218|NCT00112437|101554361|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455219|NCT00112437|101554362|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455220|NCT00112437|101554363|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455221|NCT00112437|101554364|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455222|NCT00112437|101554365|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455223|NCT00112437|101554366|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455224|NCT00112437|101554367|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
33455225|NCT00112437|101554368|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
33455226|NCT00112437|101554369|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
33455227|NCT00112437|101554370|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
33455228|NCT03541252|101554371|FG000|Overall Study|Withdrawal by Subject|1|||
33455229|NCT01229150|101554377|FG000|Overall Study|Toxicity|2|||
33455230|NCT01229150|101554378|FG001|Overall Study|Toxicity|2|||
33455231|NCT01229150|101554379|FG002|Overall Study|Toxicity|0|||
33455232|NCT01229150|101554380|FG003|Overall Study|Toxicity|0|||
33455233|NCT02663349|101554381|FG000|Overall Study|Withdrawal by Subject|6|||
33455234|NCT00874276|101554382|FG000|Overall Study|Withdrawal by Subject|1|||
33455235|NCT00874276|101554383|FG001|Overall Study|Withdrawal by Subject|1|||
33455236|NCT00642993|101554388|FG000|Overall Study|Adverse Event|85|||
33455237|NCT00642993|101554389|FG001|Overall Study|Adverse Event|4|||
33455238|NCT00642993|101554388|FG000|Overall Study|Lost to Follow-up|8|||
33455239|NCT00642993|101554389|FG001|Overall Study|Lost to Follow-up|4|||
33455240|NCT00642993|101554388|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
33455241|NCT00642993|101554389|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
33455242|NCT00642993|101554388|FG000|Overall Study|Protocol Violation|1|||
33455243|NCT00642993|101554389|FG001|Overall Study|Protocol Violation|4|||
33455244|NCT00642993|101554388|FG000|Overall Study|Did not meet protocol eligibility|0|||
33455245|NCT00642993|101554389|FG001|Overall Study|Did not meet protocol eligibility|1|||
33455246|NCT00642993|101554388|FG000|Overall Study|Administrative|1|||
33455247|NCT00642993|101554389|FG001|Overall Study|Administrative|0|||
33455248|NCT03415308|101554390|FG000|Overall Study|Lost to Follow-up|0|||
33455249|NCT03415308|101554391|FG001|Overall Study|Lost to Follow-up|0|||
33455250|NCT03415308|101554392|FG002|Overall Study|Lost to Follow-up|1|||
33455251|NCT03415308|101554390|FG000|Overall Study|Scheduling Conflicts|0|||
33455252|NCT03415308|101554391|FG001|Overall Study|Scheduling Conflicts|0|||
33455253|NCT03415308|101554392|FG002|Overall Study|Scheduling Conflicts|7|||
33455254|NCT01460628|101554393|FG000|Overall Study|Adverse Event|3|||
33455255|NCT01460628|101554393|FG000|Overall Study|Withdrawal by Subject|2|||
33455256|NCT01963260|101554394|FG000|Overall Study|Withdrawal by Subject|2|||
33172766|NCT02049957|100541089|FG000|Overall Study|Withdrawal by Subject|0|||
33172767|NCT02049957|100541090|FG001|Overall Study|Withdrawal by Subject|0|||
33172768|NCT02049957|100541091|FG002|Overall Study|Withdrawal by Subject|0|||
33172769|NCT02049957|100541092|FG003|Overall Study|Withdrawal by Subject|1|||
33172770|NCT02049957|100541093|FG004|Overall Study|Withdrawal by Subject|0|||
33172771|NCT02049957|100541094|FG005|Overall Study|Withdrawal by Subject|2|||
33172772|NCT02049957|100541095|FG006|Overall Study|Withdrawal by Subject|0|||
33172773|NCT02049957|100541096|FG007|Overall Study|Withdrawal by Subject|3|||
33172774|NCT02049957|100541097|FG008|Overall Study|Withdrawal by Subject|1|||
33172775|NCT02049957|100541089|FG000|Overall Study|Physician Decision|0|||
33172776|NCT02049957|100541090|FG001|Overall Study|Physician Decision|0|||
33172777|NCT02049957|100541091|FG002|Overall Study|Physician Decision|0|||
33172778|NCT02049957|100541092|FG003|Overall Study|Physician Decision|0|||
33261610|NCT01998958|100860130|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261611|NCT01998958|100860131|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261612|NCT01998958|100860132|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261613|NCT01998958|100860133|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261614|NCT01998958|100860134|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261615|NCT01998958|100860135|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261616|NCT01998958|100860136|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261617|NCT01998958|100860137|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261618|NCT01998958|100860138|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261619|NCT01998958|100860139|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33172779|NCT02049957|100541093|FG004|Overall Study|Physician Decision|0|||
33261620|NCT01998958|100860140|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33455257|NCT01963260|101554395|FG001|Overall Study|Withdrawal by Subject|0|||
33261621|NCT01998958|100860141|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261622|NCT01998958|100860142|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33455258|NCT01963260|101554396|FG002|Overall Study|Withdrawal by Subject|0|||
33455259|NCT01963260|101554397|FG003|Overall Study|Withdrawal by Subject|1|||
33455260|NCT01963260|101554398|FG004|Overall Study|Withdrawal by Subject|2|||
33455261|NCT01963260|101554399|FG005|Overall Study|Withdrawal by Subject|0|||
33455262|NCT01963260|101554400|FG006|Overall Study|Withdrawal by Subject|0|||
33172780|NCT02049957|100541094|FG005|Overall Study|Physician Decision|1|||
33172781|NCT02049957|100541095|FG006|Overall Study|Physician Decision|0|||
33455263|NCT01963260|101554401|FG007|Overall Study|Withdrawal by Subject|0|||
33455264|NCT01963260|101554402|FG008|Overall Study|Withdrawal by Subject|0|||
33455265|NCT01963260|101554403|FG009|Overall Study|Withdrawal by Subject|0|||
33455266|NCT01049581|101554404|FG000|Overall Study|Lost to Follow-up|2|||
33172782|NCT02049957|100541096|FG007|Overall Study|Physician Decision|0|||
33172783|NCT02049957|100541097|FG008|Overall Study|Physician Decision|0|||
33172784|NCT00617773|100541099|FG000|Overall Study|Physician Decision|1|||
33172785|NCT00617773|100541099|FG000|Overall Study|Lack of compliance with the protocol|1|||
33172786|NCT00617773|100541099|FG000|Overall Study|Withdrawal by Subject|1|||
33172787|NCT00617773|100541099|FG000|Overall Study|Death|1|||
33172788|NCT00617773|100541099|FG000|Overall Study|Progressive disease|19|||
33172789|NCT00617773|100541099|FG000|Overall Study|Protocol Violation|1|||
33172790|NCT02266225|100541100|FG000|Overall Study|Lost to Follow-up|2|||
33172791|NCT02266225|100541100|FG000|Overall Study|Death|1|||
33172792|NCT02266225|100541100|FG000|Overall Study|Withdrawal by Subject|13|||
33172793|NCT02205814|100541101|FG000|Overall Study|Lost to Follow-up|0|||
33261623|NCT01998958|100860143|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261624|NCT01998958|100860144|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261625|NCT01998958|100860145|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261626|NCT01998958|100860146|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261627|NCT01998958|100860147|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33455267|NCT01049581|101554405|FG001|Overall Study|Lost to Follow-up|1|||
33455268|NCT01426854|101554406|FG000|Overall Study|Adverse Event|1|||
33455269|NCT01426854|101554407|FG001|Overall Study|Adverse Event|5|||
33455270|NCT01426854|101554406|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
33261628|NCT01998958|100860148|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261629|NCT01998958|100860149|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261630|NCT01998958|100860150|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33455271|NCT01426854|101554407|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
33455272|NCT01426854|101554406|FG000|Overall Study|Lost to Follow-up|3|||
33261631|NCT01998958|100860151|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261632|NCT01998958|100860152|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33455273|NCT01426854|101554407|FG001|Overall Study|Lost to Follow-up|0|||
33455274|NCT01426854|101554406|FG000|Overall Study|Noncompliance|0|||
33455275|NCT01426854|101554407|FG001|Overall Study|Noncompliance|1|||
33455276|NCT01426854|101554406|FG000|Overall Study|Treatment Failure|0|||
33455277|NCT01426854|101554407|FG001|Overall Study|Treatment Failure|16|||
33455278|NCT01426854|101554406|FG000|Overall Study|Protocol Deviation|0|||
33455279|NCT01426854|101554407|FG001|Overall Study|Protocol Deviation|1|||
33455280|NCT01426854|101554406|FG000|Overall Study|Other|3|||
33455281|NCT01426854|101554407|FG001|Overall Study|Other|2|||
33455282|NCT02030535|101554408|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
33455283|NCT01945580|101554409|FG000|Overall Study|Withdrawal by Subject|13|||
33455284|NCT01945580|101554410|FG001|Overall Study|Withdrawal by Subject|35|||
33455285|NCT01945580|101554409|FG000|Overall Study|Physician Decision|3|||
33172794|NCT02205814|100541102|FG001|Overall Study|Lost to Follow-up|0|||
33261633|NCT01998958|100860153|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33455286|NCT01945580|101554410|FG001|Overall Study|Physician Decision|2|||
33455287|NCT01945580|101554409|FG000|Overall Study|Lost to Follow-up|26|||
33455288|NCT01945580|101554410|FG001|Overall Study|Lost to Follow-up|39|||
33455289|NCT01945580|101554409|FG000|Overall Study|Death|7|||
33455290|NCT01945580|101554410|FG001|Overall Study|Death|2|||
33172795|NCT02205814|100541103|FG002|Overall Study|Lost to Follow-up|0|||
33172796|NCT02205814|100541104|FG003|Overall Study|Lost to Follow-up|1|||
33455291|NCT01945580|101554409|FG000|Overall Study|Patient moved out of state|0|||
33455292|NCT01945580|101554410|FG001|Overall Study|Patient moved out of state|1|||
33455293|NCT01945580|101554409|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
33455294|NCT01945580|101554410|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
33455295|NCT01945580|101554409|FG000|Overall Study|Family illness - unable to return|0|||
33455296|NCT01945580|101554410|FG001|Overall Study|Family illness - unable to return|1|||
33455297|NCT01945580|101554409|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
33455298|NCT01945580|101554410|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
33455299|NCT01945580|101554409|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
33455300|NCT01945580|101554410|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
33455301|NCT01945580|101554409|FG000|Overall Study|Noncompliance with 36 month visit|1|||
33455302|NCT01945580|101554410|FG001|Overall Study|Noncompliance with 36 month visit|0|||
33455303|NCT01945580|101554409|FG000|Overall Study|The patient moved.|1|||
33455304|NCT01945580|101554410|FG001|Overall Study|The patient moved.|0|||
33455305|NCT01945580|101554409|FG000|Overall Study|No data available|0|||
33455306|NCT01945580|101554410|FG001|Overall Study|No data available|2|||
33455307|NCT00577655|101554411|FG000|Overall Study|Patient Request|0|||
33172797|NCT02205814|100541101|FG000|Overall Study|Lack of Efficacy|1|||
33455308|NCT00577655|101554412|FG001|Overall Study|Patient Request|2|||
33455309|NCT00577655|101554411|FG000|Overall Study|Protocol Violation|0|||
33455310|NCT00577655|101554412|FG001|Overall Study|Protocol Violation|1|||
33455311|NCT00577655|101554411|FG000|Overall Study|Lost to Follow-up|1|||
33455312|NCT00577655|101554412|FG001|Overall Study|Lost to Follow-up|1|||
33455313|NCT02761915|101554413|FG000|Overall Study|Death|3|||
33455314|NCT02761915|101554414|FG001|Overall Study|Death|1|||
33455315|NCT02761915|101554415|FG002|Overall Study|Death|1|||
33455316|NCT02761915|101554416|FG003|Overall Study|Death|1|||
33455317|NCT02761915|101554417|FG004|Overall Study|Death|0|||
33455318|NCT02761915|101554418|FG005|Overall Study|Death|1|||
33455319|NCT02761915|101554413|FG000|Overall Study|Withdrawal by Subject|1|||
33455320|NCT02761915|101554414|FG001|Overall Study|Withdrawal by Subject|0|||
33455321|NCT02761915|101554415|FG002|Overall Study|Withdrawal by Subject|0|||
33455322|NCT02761915|101554416|FG003|Overall Study|Withdrawal by Subject|0|||
33261634|NCT01998958|100860154|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261635|NCT01998958|100860155|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261636|NCT01998958|100860156|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261637|NCT01998958|100860157|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
33261638|NCT01998958|100860126|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
33261639|NCT01998958|100860127|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
33261640|NCT01998958|100860128|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
33261641|NCT01998958|100860129|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
33261642|NCT01998958|100860130|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
33261643|NCT01998958|100860131|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
33261644|NCT01998958|100860132|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
33261645|NCT01998958|100860133|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
33261646|NCT01998958|100860134|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
33261647|NCT01998958|100860135|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
33261648|NCT01998958|100860136|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
33261649|NCT01998958|100860137|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
33261650|NCT01998958|100860138|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
33261651|NCT01998958|100860139|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
33261652|NCT01998958|100860140|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
33261653|NCT01998958|100860141|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
33261654|NCT01998958|100860142|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
33455323|NCT02761915|101554417|FG004|Overall Study|Withdrawal by Subject|1|||
33455324|NCT02761915|101554418|FG005|Overall Study|Withdrawal by Subject|2|||
33261655|NCT01998958|100860143|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
33261656|NCT01998958|100860144|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
33261657|NCT01998958|100860145|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
33261658|NCT01998958|100860146|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
33455325|NCT02761915|101554413|FG000|Overall Study|Disease Progression|0|||
33455326|NCT02761915|101554414|FG001|Overall Study|Disease Progression|0|||
33455327|NCT02761915|101554415|FG002|Overall Study|Disease Progression|0|||
33455328|NCT02761915|101554416|FG003|Overall Study|Disease Progression|2|||
33455329|NCT02761915|101554417|FG004|Overall Study|Disease Progression|2|||
33455330|NCT02761915|101554418|FG005|Overall Study|Disease Progression|2|||
33455331|NCT00323258|101554419|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
33455332|NCT00323258|101554420|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
33455333|NCT00323258|101554419|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
33455334|NCT00323258|101554420|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
33455335|NCT00323258|101554419|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
33455336|NCT00323258|101554420|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
33455337|NCT00323258|101554419|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
33455338|NCT00323258|101554420|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
33455339|NCT00323258|101554419|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
33455340|NCT00323258|101554420|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
33455341|NCT00323258|101554419|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
33455342|NCT00323258|101554420|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
33455343|NCT00323258|101554419|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
33455344|NCT00323258|101554420|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
33455345|NCT03573544|101554421|FG000|Overall Study|Adverse Event|0|||
33455346|NCT03573544|101554422|FG001|Overall Study|Adverse Event|0|||
33455347|NCT03573544|101554423|FG002|Overall Study|Adverse Event|0|||
33455348|NCT03573544|101554424|FG003|Overall Study|Adverse Event|3|||
33455349|NCT03573544|101554425|FG004|Overall Study|Adverse Event|1|||
33455350|NCT03573544|101554426|FG005|Overall Study|Adverse Event|0|||
33455351|NCT03573544|101554427|FG006|Overall Study|Adverse Event|2|||
33455352|NCT03573544|101554428|FG007|Overall Study|Adverse Event|0|||
33172798|NCT02205814|100541102|FG001|Overall Study|Lack of Efficacy|0|||
33172799|NCT02205814|100541103|FG002|Overall Study|Lack of Efficacy|1|||
33455353|NCT03573544|101554421|FG000|Overall Study|Physician Decision|0|||
33455354|NCT03573544|101554422|FG001|Overall Study|Physician Decision|0|||
33172800|NCT02205814|100541104|FG003|Overall Study|Lack of Efficacy|1|||
33455355|NCT03573544|101554423|FG002|Overall Study|Physician Decision|0|||
33455356|NCT03573544|101554424|FG003|Overall Study|Physician Decision|0|||
33455357|NCT03573544|101554425|FG004|Overall Study|Physician Decision|0|||
33455358|NCT03573544|101554426|FG005|Overall Study|Physician Decision|0|||
33455359|NCT03573544|101554427|FG006|Overall Study|Physician Decision|1|||
33455360|NCT03573544|101554428|FG007|Overall Study|Physician Decision|0|||
33455361|NCT03573544|101554421|FG000|Overall Study|Withdrawal by Subject|2|||
33455362|NCT03573544|101554422|FG001|Overall Study|Withdrawal by Subject|0|||
33455363|NCT03573544|101554423|FG002|Overall Study|Withdrawal by Subject|0|||
33455364|NCT03573544|101554424|FG003|Overall Study|Withdrawal by Subject|1|||
33455365|NCT03573544|101554425|FG004|Overall Study|Withdrawal by Subject|1|||
33455366|NCT03573544|101554426|FG005|Overall Study|Withdrawal by Subject|1|||
33455367|NCT03573544|101554427|FG006|Overall Study|Withdrawal by Subject|0|||
33455368|NCT03573544|101554428|FG007|Overall Study|Withdrawal by Subject|1|||
33455369|NCT03573544|101554421|FG000|Overall Study|Disease progression|3|||
33455370|NCT03573544|101554422|FG001|Overall Study|Disease progression|3|||
33455371|NCT03573544|101554423|FG002|Overall Study|Disease progression|6|||
33455372|NCT03573544|101554424|FG003|Overall Study|Disease progression|4|||
33455373|NCT03573544|101554425|FG004|Overall Study|Disease progression|5|||
33455374|NCT03573544|101554426|FG005|Overall Study|Disease progression|7|||
33455375|NCT03573544|101554427|FG006|Overall Study|Disease progression|6|||
33455376|NCT03573544|101554428|FG007|Overall Study|Disease progression|7|||
33455377|NCT03885934|101554432|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
33455378|NCT03885934|101554433|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
33455379|NCT03885934|101554434|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
33455380|NCT03885934|101554435|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
33455381|NCT03885934|101554436|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
33455382|NCT03885934|101554437|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
33455383|NCT00487435|101554438|FG000|Overall Study|Adverse Event|146|||
33455384|NCT00487435|101554438|FG000|Overall Study|Death|2|||
33455385|NCT00487435|101554438|FG000|Overall Study|Lack of Efficacy|33|||
33455386|NCT00487435|101554438|FG000|Overall Study|Lost to Follow-up|54|||
33455387|NCT00487435|101554438|FG000|Overall Study|Pregnancy|2|||
33455388|NCT00487435|101554438|FG000|Overall Study|Withdrawal by Subject|132|||
33455389|NCT00487435|101554438|FG000|Overall Study|Resolution Of Pain|1|||
33455390|NCT00487435|101554438|FG000|Overall Study|Study Medication Non-Compliant|32|||
33455391|NCT00487435|101554438|FG000|Overall Study|Other|83|||
33455392|NCT00516295|101554439|FG000|Overall Study|Lack of Efficacy|2|||
33455393|NCT00516295|101554440|FG001|Overall Study|Lack of Efficacy|0|||
33455394|NCT00516295|101554441|FG002|Overall Study|Lack of Efficacy|0|||
33455395|NCT00516295|101554439|FG000|Overall Study|Ineligible|1|||
33455396|NCT00516295|101554440|FG001|Overall Study|Ineligible|0|||
33455397|NCT00516295|101554441|FG002|Overall Study|Ineligible|0|||
33455398|NCT00874822|101554442|FG000|Overall Study|excluded by criteria|8|||
33455399|NCT01456949|101554443|FG000|Enrollment|PI death- incomplete data|6|||
33455400|NCT01456949|101554443|FG000|Enrollment|Death|1|||
33455401|NCT01456949|101554443|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
33455402|NCT01456949|101554443|FG000|Enrollment|Physician Decision|10|||
33455403|NCT01456949|101554443|FG000|Enrollment|Withdrawal by Subject|7|||
33455404|NCT01456949|101554443|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
33455405|NCT01456949|101554443|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
33455406|NCT01456949|101554443|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
33455407|NCT01456949|101554443|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
33455408|NCT01456949|101554443|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
33455409|NCT01456949|101554443|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
33455410|NCT01456949|101554443|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
33455411|NCT01456949|101554443|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
33455412|NCT00529763|101554444|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
33261659|NCT01998958|100860147|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
33261660|NCT01998958|100860148|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
33261661|NCT01998958|100860149|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
33261662|NCT01998958|100860150|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
33261663|NCT01998958|100860151|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
33261664|NCT01998958|100860152|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
33261665|NCT01998958|100860153|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
33261666|NCT01998958|100860154|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
33455413|NCT00529763|101554445|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
33455414|NCT00529763|101554446|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
33455415|NCT00529763|101554444|FG000|Overall Study|Death|1|||
33455416|NCT00529763|101554445|FG001|Overall Study|Death|1|||
33455417|NCT00529763|101554446|FG002|Overall Study|Death|1|||
33455418|NCT00529763|101554444|FG000|Overall Study|Disease Progression|10|||
33455419|NCT00529763|101554445|FG001|Overall Study|Disease Progression|16|||
33455420|NCT00529763|101554446|FG002|Overall Study|Disease Progression|11|||
33261667|NCT01998958|100860155|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
33261668|NCT01998958|100860156|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
33261669|NCT01998958|100860157|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
33455421|NCT00529763|101554444|FG000|Overall Study|Lost to Follow-up|1|||
33455422|NCT00529763|101554445|FG001|Overall Study|Lost to Follow-up|2|||
33261670|NCT01998958|100860126|FG000|Period 1 (Panel A and B)|Other|1|||
33261671|NCT01998958|100860127|FG001|Period 1 (Panel A and B)|Other|0|||
33261672|NCT01998958|100860128|FG002|Period 1 (Panel A and B)|Other|0|||
33261673|NCT01998958|100860129|FG003|Period 1 (Panel A and B)|Other|0|||
33261674|NCT01998958|100860130|FG004|Period 1 (Panel A and B)|Other|0|||
33261675|NCT01998958|100860131|FG005|Period 1 (Panel A and B)|Other|0|||
33261676|NCT01998958|100860132|FG006|Period 1 (Panel A and B)|Other|0|||
33261677|NCT01998958|100860133|FG007|Period 1 (Panel A and B)|Other|0|||
33261678|NCT01998958|100860134|FG008|Period 1 (Panel A and B)|Other|0|||
33261679|NCT01998958|100860135|FG009|Period 1 (Panel A and B)|Other|0|||
33261680|NCT01998958|100860136|FG010|Period 1 (Panel A and B)|Other|0|||
33261681|NCT01998958|100860137|FG011|Period 1 (Panel A and B)|Other|0|||
33261682|NCT01998958|100860138|FG012|Period 1 (Panel A and B)|Other|0|||
33261683|NCT01998958|100860139|FG013|Period 1 (Panel A and B)|Other|0|||
33261684|NCT01998958|100860140|FG014|Period 1 (Panel A and B)|Other|0|||
33261685|NCT01998958|100860141|FG015|Period 1 (Panel A and B)|Other|0|||
33261686|NCT01998958|100860142|FG016|Period 1 (Panel A and B)|Other|0|||
33261687|NCT01998958|100860143|FG017|Period 1 (Panel A and B)|Other|0|||
33261688|NCT01998958|100860144|FG018|Period 1 (Panel A and B)|Other|0|||
33261689|NCT01998958|100860145|FG019|Period 1 (Panel A and B)|Other|0|||
33261690|NCT01998958|100860146|FG020|Period 1 (Panel A and B)|Other|0|||
33261691|NCT01998958|100860147|FG021|Period 1 (Panel A and B)|Other|0|||
33261692|NCT01998958|100860148|FG022|Period 1 (Panel A and B)|Other|0|||
33261693|NCT01998958|100860149|FG023|Period 1 (Panel A and B)|Other|0|||
33261694|NCT01998958|100860150|FG024|Period 1 (Panel A and B)|Other|0|||
33261695|NCT01998958|100860151|FG025|Period 1 (Panel A and B)|Other|0|||
33261696|NCT01998958|100860152|FG026|Period 1 (Panel A and B)|Other|0|||
33261697|NCT01998958|100860153|FG027|Period 1 (Panel A and B)|Other|0|||
33261698|NCT01998958|100860154|FG028|Period 1 (Panel A and B)|Other|0|||
33261699|NCT01998958|100860155|FG029|Period 1 (Panel A and B)|Other|0|||
33261700|NCT01998958|100860156|FG030|Period 1 (Panel A and B)|Other|0|||
33261701|NCT01998958|100860157|FG031|Period 1 (Panel A and B)|Other|0|||
33261702|NCT01998958|100860126|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
33261703|NCT01998958|100860127|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
33261704|NCT01998958|100860128|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
33261705|NCT01998958|100860129|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
33261706|NCT01998958|100860130|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
33261707|NCT01998958|100860131|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
33261708|NCT01998958|100860132|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
33455423|NCT00529763|101554446|FG002|Overall Study|Lost to Follow-up|3|||
33455424|NCT00529763|101554444|FG000|Overall Study|Stem Cell Transplant|0|||
33455425|NCT00529763|101554445|FG001|Overall Study|Stem Cell Transplant|3|||
33455426|NCT00529763|101554446|FG002|Overall Study|Stem Cell Transplant|1|||
33455427|NCT00529763|101554444|FG000|Overall Study|Study Drug Toxicity|3|||
33455428|NCT00529763|101554445|FG001|Overall Study|Study Drug Toxicity|6|||
33455429|NCT00529763|101554446|FG002|Overall Study|Study Drug Toxicity|4|||
33455430|NCT00529763|101554444|FG000|Overall Study|Participant Withdrew Consent|2|||
33261709|NCT01998958|100860133|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
33261710|NCT01998958|100860134|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
33261711|NCT01998958|100860135|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
33261712|NCT01998958|100860136|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
33261713|NCT01998958|100860137|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
33261714|NCT01998958|100860138|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
33261715|NCT01998958|100860139|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
33261716|NCT01998958|100860140|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
33261717|NCT01998958|100860141|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
33261718|NCT01998958|100860142|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
33455431|NCT00529763|101554445|FG001|Overall Study|Participant Withdrew Consent|3|||
33455432|NCT00529763|101554446|FG002|Overall Study|Participant Withdrew Consent|4|||
33455433|NCT00529763|101554444|FG000|Overall Study|Other reasons|2|||
33261719|NCT01998958|100860143|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
33261720|NCT01998958|100860144|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
33261721|NCT01998958|100860145|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
33455434|NCT00529763|101554445|FG001|Overall Study|Other reasons|0|||
33455435|NCT00529763|101554446|FG002|Overall Study|Other reasons|2|||
33172801|NCT02205814|100541101|FG000|Overall Study|Physician Decision|0|||
33261722|NCT01998958|100860146|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
33261723|NCT01998958|100860147|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
33261724|NCT01998958|100860148|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
33261725|NCT01998958|100860149|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
33261726|NCT01998958|100860150|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
33261727|NCT01998958|100860151|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
33455436|NCT00529763|101554444|FG000|Overall Study|Participant request to discontinue treatment|1|||
33455437|NCT00529763|101554445|FG001|Overall Study|Participant request to discontinue treatment|1|||
33455438|NCT00529763|101554446|FG002|Overall Study|Participant request to discontinue treatment|3|||
33455439|NCT01120028|101554449|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
33455440|NCT01120028|101554450|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
33455441|NCT01120028|101554451|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
33455442|NCT01120028|101554452|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
33455443|NCT01120028|101554449|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
33455444|NCT01120028|101554450|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
33455445|NCT01120028|101554451|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
33455446|NCT01120028|101554452|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
33455447|NCT01750294|101554453|FG000|Overall Study|Withdrawal by Subject|1|||
33172802|NCT02205814|100541102|FG001|Overall Study|Physician Decision|0|||
33261728|NCT01998958|100860152|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
33261729|NCT01998958|100860153|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
33261730|NCT01998958|100860154|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
33261731|NCT01998958|100860155|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
33261732|NCT01998958|100860156|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
33261733|NCT01998958|100860157|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
33261734|NCT01998958|100860126|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261735|NCT01998958|100860127|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261736|NCT01998958|100860128|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261737|NCT01998958|100860129|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261738|NCT01998958|100860130|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261739|NCT01998958|100860131|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261740|NCT01998958|100860132|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261741|NCT01998958|100860133|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261742|NCT01998958|100860134|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33455448|NCT01750294|101554453|FG000|Overall Study|Safety Endpoint|1|||
33455449|NCT00057941|101554457|FG000|Overall Study|Death|1|||
33455450|NCT00057941|101554458|FG001|Overall Study|Death|2|||
33455451|NCT00057941|101554457|FG000|Overall Study|Adverse Event|7|||
33455452|NCT00057941|101554458|FG001|Overall Study|Adverse Event|9|||
33455453|NCT00057941|101554457|FG000|Overall Study|Lack of Efficacy|54|||
33455454|NCT00057941|101554458|FG001|Overall Study|Lack of Efficacy|53|||
33455455|NCT00057941|101554457|FG000|Overall Study|Withdrawal by Subject|6|||
33455456|NCT00057941|101554458|FG001|Overall Study|Withdrawal by Subject|1|||
33455457|NCT00057941|101554457|FG000|Overall Study|still on treatment|3|||
33455458|NCT00057941|101554458|FG001|Overall Study|still on treatment|1|||
33455459|NCT00057941|101554457|FG000|Overall Study|insurance, symptomatic deterioration|1|||
33455460|NCT00057941|101554458|FG001|Overall Study|insurance, symptomatic deterioration|3|||
33455461|NCT00057941|101554457|FG000|Overall Study|Ineligible|2|||
33455462|NCT00057941|101554458|FG001|Overall Study|Ineligible|5|||
33172803|NCT02205814|100541103|FG002|Overall Study|Physician Decision|1|||
33172804|NCT02205814|100541104|FG003|Overall Study|Physician Decision|0|||
33172805|NCT02205814|100541101|FG000|Overall Study|Protocol Violation|1|||
33172806|NCT02205814|100541102|FG001|Overall Study|Protocol Violation|0|||
33172807|NCT02205814|100541103|FG002|Overall Study|Protocol Violation|0|||
33172808|NCT02205814|100541104|FG003|Overall Study|Protocol Violation|1|||
33172809|NCT02205814|100541101|FG000|Overall Study|Withdrawal by Subject|0|||
33172810|NCT02205814|100541102|FG001|Overall Study|Withdrawal by Subject|1|||
33172811|NCT02205814|100541103|FG002|Overall Study|Withdrawal by Subject|2|||
33172812|NCT02205814|100541104|FG003|Overall Study|Withdrawal by Subject|1|||
33172813|NCT02205814|100541101|FG000|Overall Study|not compliant with study procedures|0|||
33172814|NCT02205814|100541102|FG001|Overall Study|not compliant with study procedures|0|||
33172815|NCT02205814|100541103|FG002|Overall Study|not compliant with study procedures|1|||
33261743|NCT01998958|100860135|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261744|NCT01998958|100860136|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261745|NCT01998958|100860137|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261746|NCT01998958|100860138|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261747|NCT01998958|100860139|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261748|NCT01998958|100860140|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
33261749|NCT01998958|100860141|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261750|NCT01998958|100860142|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261751|NCT01998958|100860143|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261752|NCT01998958|100860144|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
33261753|NCT01998958|100860145|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261754|NCT01998958|100860146|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33455463|NCT01943435|101554461|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
33455464|NCT01943435|101554462|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
33455465|NCT01943435|101554463|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
33455466|NCT01943435|101554461|FG000|Intervention Period|Withdrawal by Subject|3|||
33172816|NCT02205814|100541104|FG003|Overall Study|not compliant with study procedures|0|||
33172817|NCT02167893|100541105|FG000|Overall Study|Investigator transferred|85|||
33172818|NCT02167893|100541105|FG000|Overall Study|Investigator health reasons|10|||
33172819|NCT02167893|100541105|FG000|Overall Study|Case report forms not collected|68|||
33455467|NCT01943435|101554462|FG001|Intervention Period|Withdrawal by Subject|3|||
33455468|NCT01943435|101554463|FG002|Intervention Period|Withdrawal by Subject|4|||
33455469|NCT01943435|101554461|FG000|2 Month Follow up|Lost to Follow-up|2|||
33455470|NCT01943435|101554462|FG001|2 Month Follow up|Lost to Follow-up|3|||
33455471|NCT01943435|101554463|FG002|2 Month Follow up|Lost to Follow-up|0|||
33455472|NCT01943435|101554461|FG000|6 Month Follow up|Lost to Follow-up|12|||
33455473|NCT01943435|101554462|FG001|6 Month Follow up|Lost to Follow-up|7|||
33455474|NCT01943435|101554463|FG002|6 Month Follow up|Lost to Follow-up|15|||
33455475|NCT03008005|101554466|FG000|Overall Study|Physician Decision|1|||
33455476|NCT03008005|101554467|FG001|Overall Study|Physician Decision|0|||
33455477|NCT03008005|101554468|FG002|Overall Study|Physician Decision|0|||
33455478|NCT03008005|101554466|FG000|Overall Study|Withdrawal by Subject|1|||
33455479|NCT03008005|101554467|FG001|Overall Study|Withdrawal by Subject|0|||
33455480|NCT03008005|101554468|FG002|Overall Study|Withdrawal by Subject|0|||
33455481|NCT03008005|101554466|FG000|Overall Study|Ineligible|0|||
33455482|NCT03008005|101554467|FG001|Overall Study|Ineligible|1|||
33455483|NCT03008005|101554468|FG002|Overall Study|Ineligible|0|||
33455484|NCT00958724|101554471|FG000|Overall Study|Disease Progression|6|||
33455485|NCT01004510|101554472|FG000|Overall Study|Adverse Event|1|||
33455486|NCT00469898|101557632|FG000|Overall Study|Adverse Event|7|||
33455487|NCT00469898|101557632|FG000|Overall Study|Withdrawal by Subject|4|||
33172820|NCT00512707|100541108|FG000|Overall Study|Lost to Follow-up|5|||
33172821|NCT00512707|100541109|FG001|Overall Study|Lost to Follow-up|11|||
33172822|NCT00512707|100541108|FG000|Overall Study|Developed skin irritation|2|||
33261755|NCT01998958|100860147|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33172823|NCT00512707|100541109|FG001|Overall Study|Developed skin irritation|1|||
33261756|NCT01998958|100860148|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261757|NCT01998958|100860149|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261758|NCT01998958|100860150|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33455488|NCT00469898|101557632|FG000|Overall Study|Death|4|||
33455489|NCT00469898|101557632|FG000|Overall Study|Disease progression|9|||
33455490|NCT00469898|101557632|FG000|Overall Study|Decreased performance status|1|||
33172824|NCT00512707|100541108|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
33172825|NCT00512707|100541109|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
33172826|NCT00512707|100541108|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
33172827|NCT00512707|100541109|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
33172828|NCT00662363|100541112|FG000|Overall Study|Withdrawal by Subject|6|||
33172829|NCT00662363|100541113|FG001|Overall Study|Withdrawal by Subject|5|||
33172830|NCT00662363|100541112|FG000|Overall Study|Adverse Event|0|||
33172831|NCT00662363|100541113|FG001|Overall Study|Adverse Event|3|||
33172832|NCT00662363|100541112|FG000|Overall Study|Discharged early from rehab|4|||
33172833|NCT00662363|100541113|FG001|Overall Study|Discharged early from rehab|1|||
33172834|NCT00662363|100541112|FG000|Overall Study|Protocol Violation|1|||
33172835|NCT00662363|100541113|FG001|Overall Study|Protocol Violation|1|||
33172836|NCT01124422|100541124|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
33455491|NCT02372006|101557633|FG000|Overall Study|Progressive disease|8|||
33455492|NCT02372006|101557634|FG001|Overall Study|Progressive disease|7|||
33455493|NCT02372006|101557635|FG002|Overall Study|Progressive disease|34|||
33455494|NCT02372006|101557633|FG000|Overall Study|Dose limiting toxicity|0|||
33455495|NCT02372006|101557634|FG001|Overall Study|Dose limiting toxicity|1|||
33455496|NCT02372006|101557635|FG002|Overall Study|Dose limiting toxicity|0|||
33455497|NCT02372006|101557633|FG000|Overall Study|Adverse Event|0|||
33455498|NCT02372006|101557634|FG001|Overall Study|Adverse Event|0|||
33455499|NCT02372006|101557635|FG002|Overall Study|Adverse Event|3|||
33455500|NCT02372006|101557633|FG000|Overall Study|Withdrawal by Subject|0|||
33455501|NCT02372006|101557634|FG001|Overall Study|Withdrawal by Subject|1|||
33455502|NCT02372006|101557635|FG002|Overall Study|Withdrawal by Subject|1|||
33455503|NCT02372006|101557633|FG000|Overall Study|Other reason for not completing|0|||
33455504|NCT02372006|101557634|FG001|Overall Study|Other reason for not completing|0|||
33455505|NCT02372006|101557635|FG002|Overall Study|Other reason for not completing|1|||
33455506|NCT01891357|101557636|FG000|Overall Study|Protocol Violation|3|||
33455507|NCT04968925|101557639|FG000|Phase I- Period 1|COVID-19 related|0|||
33455508|NCT04968925|101557640|FG001|Phase I- Period 1|COVID-19 related|1|||
33455509|NCT04968925|101557641|FG002|Phase I- Period 1|COVID-19 related|0|||
33455510|NCT04968925|101557642|FG003|Phase I- Period 1|COVID-19 related|0|||
33455511|NCT04968925|101557639|FG000|Phase I- Period 1|Subject enrolled in error|1|||
33455512|NCT04968925|101557640|FG001|Phase I- Period 1|Subject enrolled in error|1|||
33455513|NCT04968925|101557641|FG002|Phase I- Period 1|Subject enrolled in error|0|||
33172837|NCT01124422|100541125|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
33455514|NCT04968925|101557642|FG003|Phase I- Period 1|Subject enrolled in error|0|||
33455515|NCT04968925|101557639|FG000|Phase II- Period 1|COVID-19 Related|0|||
33455516|NCT04968925|101557640|FG001|Phase II- Period 1|COVID-19 Related|0|||
33455517|NCT04968925|101557641|FG002|Phase II- Period 1|COVID-19 Related|6|||
33455518|NCT04968925|101557642|FG003|Phase II- Period 1|COVID-19 Related|6|||
33455519|NCT04968925|101557639|FG000|Phase II- Period 1|Subject enrolled in error|0|||
33455520|NCT04968925|101557640|FG001|Phase II- Period 1|Subject enrolled in error|0|||
33455521|NCT04968925|101557641|FG002|Phase II- Period 1|Subject enrolled in error|1|||
33455522|NCT04968925|101557642|FG003|Phase II- Period 1|Subject enrolled in error|0|||
33455523|NCT04968925|101557639|FG000|Phase II -Period 2|COVID-19 related|0|||
33455524|NCT04968925|101557640|FG001|Phase II -Period 2|COVID-19 related|0|||
33455525|NCT04968925|101557641|FG002|Phase II -Period 2|COVID-19 related|4|||
33455526|NCT04968925|101557642|FG003|Phase II -Period 2|COVID-19 related|3|||
33455527|NCT04968925|101557639|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
33455528|NCT04968925|101557640|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
33172838|NCT01124422|100541126|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
33455529|NCT04968925|101557641|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
33455530|NCT04968925|101557642|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
33455531|NCT00406393|101557643|FG000|Overall Study|Did not undergo transplantation|2|||
33455532|NCT00406393|101557644|FG001|Overall Study|Did not undergo transplantation|1|||
33455533|NCT03224624|101557648|FG000|Overall Study|Lost to Follow-up|9|||
33455534|NCT03224624|101557649|FG001|Overall Study|Lost to Follow-up|4|||
33455535|NCT03224624|101557648|FG000|Overall Study|Death|1|||
33455536|NCT03224624|101557649|FG001|Overall Study|Death|0|||
33455537|NCT00999687|101557650|FG000|First Intervention|Withdrawal by Subject|1|||
33455538|NCT00999687|101557650|FG000|Second Intervention|Withdrawal by Subject|2|||
33455539|NCT00999687|101557650|FG000|Second Intervention|Lack of Efficacy|1|||
33455540|NCT03306277|101557657|FG000|Overall Study|Death|1|||
33455541|NCT03306277|101557657|FG000|Overall Study|Adverse Event|1|||
33455542|NCT03306277|101557657|FG000|Overall Study|Withdrawal by Subject|1|||
33455543|NCT00748566|101557658|FG000|Overall Study|Adverse Event|49|||
33455544|NCT00748566|101557658|FG000|Overall Study|Death|1|||
33455545|NCT00748566|101557658|FG000|Overall Study|Lack of Efficacy|12|||
33455546|NCT00748566|101557658|FG000|Overall Study|Lost to Follow-up|1|||
33455547|NCT00748566|101557658|FG000|Overall Study|Protocol Violation|13|||
33455548|NCT00748566|101557658|FG000|Overall Study|Withdrawal by Subject|22|||
33455549|NCT00748566|101557658|FG000|Overall Study|Study terminated by sponsor|5|||
33455550|NCT00748566|101557658|FG000|Overall Study|Other|9|||
33455551|NCT01986647|101557661|FG000|Overall Study|Lost to Follow-up|4|||
33455552|NCT01986647|101557662|FG001|Overall Study|Lost to Follow-up|1|||
33172839|NCT01124422|100541124|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
33172840|NCT01124422|100541125|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
33172841|NCT01124422|100541126|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
33172842|NCT01124422|100541124|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
33172843|NCT01124422|100541125|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
33172844|NCT01124422|100541126|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
33172845|NCT01124422|100541124|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
33172846|NCT01124422|100541125|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
33172847|NCT01124422|100541126|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
33172848|NCT01124422|100541124|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
33172849|NCT01124422|100541125|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
33172850|NCT01124422|100541126|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
33455553|NCT01986647|101557663|FG002|Overall Study|Lost to Follow-up|4|||
33455554|NCT01986647|101557664|FG003|Overall Study|Lost to Follow-up|4|||
33455555|NCT01986647|101557661|FG000|Overall Study|Withdrawal by Subject|1|||
33455556|NCT01986647|101557662|FG001|Overall Study|Withdrawal by Subject|3|||
33455557|NCT01986647|101557663|FG002|Overall Study|Withdrawal by Subject|2|||
33455558|NCT01986647|101557664|FG003|Overall Study|Withdrawal by Subject|3|||
33455559|NCT01986647|101557661|FG000|Overall Study|Health|5|||
33455560|NCT01986647|101557662|FG001|Overall Study|Health|3|||
33172851|NCT01124422|100541124|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
33172852|NCT01124422|100541125|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
33172853|NCT01124422|100541126|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
33261759|NCT01998958|100860151|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33172854|NCT01124422|100541124|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
33172855|NCT01124422|100541125|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
33172856|NCT01124422|100541126|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
33172857|NCT01124422|100541124|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
33455561|NCT01986647|101557663|FG002|Overall Study|Health|6|||
33455562|NCT01986647|101557664|FG003|Overall Study|Health|4|||
33455563|NCT00642811|101557666|FG000|Overall Study|Adverse Event|2|||
33455564|NCT00642811|101557667|FG001|Overall Study|Adverse Event|3|||
33455565|NCT00642811|101557668|FG002|Overall Study|Adverse Event|0|||
33455566|NCT00642811|101557669|FG003|Overall Study|Adverse Event|0|||
33455567|NCT00642811|101557670|FG004|Overall Study|Adverse Event|0|||
33455568|NCT00642811|101557671|FG005|Overall Study|Adverse Event|1|||
33455569|NCT00642811|101557666|FG000|Overall Study|Developement of discontinuation criteria|0|||
33455570|NCT00642811|101557667|FG001|Overall Study|Developement of discontinuation criteria|0|||
33455571|NCT00642811|101557668|FG002|Overall Study|Developement of discontinuation criteria|0|||
33455572|NCT00642811|101557669|FG003|Overall Study|Developement of discontinuation criteria|0|||
33455573|NCT00642811|101557670|FG004|Overall Study|Developement of discontinuation criteria|1|||
33455574|NCT00642811|101557671|FG005|Overall Study|Developement of discontinuation criteria|0|||
33455575|NCT00642811|101557666|FG000|Overall Study|Severe Non-compliance to protocol|1|||
33455576|NCT00642811|101557667|FG001|Overall Study|Severe Non-compliance to protocol|0|||
33455577|NCT00642811|101557668|FG002|Overall Study|Severe Non-compliance to protocol|0|||
33455578|NCT00642811|101557669|FG003|Overall Study|Severe Non-compliance to protocol|0|||
33455579|NCT00642811|101557670|FG004|Overall Study|Severe Non-compliance to protocol|0|||
33455580|NCT00642811|101557671|FG005|Overall Study|Severe Non-compliance to protocol|0|||
33455581|NCT00642811|101557666|FG000|Overall Study|Other|0|||
33455582|NCT00642811|101557667|FG001|Overall Study|Other|1|||
33172858|NCT01124422|100541125|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
33172859|NCT01124422|100541126|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
33172860|NCT01124422|100541124|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
33172861|NCT01124422|100541125|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
33172862|NCT01124422|100541126|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
33172863|NCT01124422|100541124|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
33172864|NCT01124422|100541125|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
33172865|NCT01124422|100541126|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
33172866|NCT04007094|100541127|FG000|Overall Study|Lost to Follow-up|1|||
33172867|NCT04007094|100541128|FG001|Overall Study|Lost to Follow-up|1|||
33455583|NCT00642811|101557668|FG002|Overall Study|Other|0|||
33455584|NCT00642811|101557669|FG003|Overall Study|Other|1|||
33455585|NCT00642811|101557670|FG004|Overall Study|Other|0|||
33455586|NCT00642811|101557671|FG005|Overall Study|Other|0|||
33172868|NCT02989194|100541129|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
33455587|NCT02670551|101557674|FG000|Overall Study|Adverse Event|4|||
33455588|NCT02670551|101557675|FG001|Overall Study|Adverse Event|7|||
33455589|NCT02670551|101557676|FG002|Overall Study|Adverse Event|9|||
33455590|NCT02670551|101557674|FG000|Overall Study|Lack of Efficacy|2|||
33455591|NCT02670551|101557675|FG001|Overall Study|Lack of Efficacy|0|||
33455592|NCT02670551|101557676|FG002|Overall Study|Lack of Efficacy|3|||
33455593|NCT02670551|101557674|FG000|Overall Study|Withdrawal of Consent|6|||
33261760|NCT01998958|100860152|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261761|NCT01998958|100860153|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33172869|NCT02989194|100541130|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
33172870|NCT02989194|100541131|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
33172871|NCT02989194|100541129|FG000|Overall Study|Lost to Follow-up|0|||
33172872|NCT02989194|100541130|FG001|Overall Study|Lost to Follow-up|1|||
33172873|NCT02989194|100541131|FG002|Overall Study|Lost to Follow-up|0|||
33172874|NCT02989194|100541129|FG000|Overall Study|Withdrawal by Subject|0|||
33172875|NCT02989194|100541130|FG001|Overall Study|Withdrawal by Subject|1|||
33172876|NCT02989194|100541131|FG002|Overall Study|Withdrawal by Subject|0|||
33172877|NCT02514447|100541132|FG000|Overall Study|Withdrawal by Subject|3|||
33172878|NCT02514447|100541133|FG001|Overall Study|Withdrawal by Subject|1|||
33172879|NCT02514447|100541134|FG002|Overall Study|Withdrawal by Subject|1|||
33172880|NCT02514447|100541135|FG003|Overall Study|Withdrawal by Subject|0|||
33172881|NCT02514447|100541136|FG004|Overall Study|Withdrawal by Subject|0|||
33172882|NCT02514447|100541137|FG005|Overall Study|Withdrawal by Subject|0|||
33172883|NCT02514447|100541138|FG006|Overall Study|Withdrawal by Subject|0|||
33172884|NCT02514447|100541139|FG007|Overall Study|Withdrawal by Subject|1|||
33172885|NCT02514447|100541140|FG008|Overall Study|Withdrawal by Subject|1|||
33172886|NCT02514447|100541132|FG000|Overall Study|Death|24|||
33172887|NCT02514447|100541133|FG001|Overall Study|Death|28|||
33172888|NCT02514447|100541134|FG002|Overall Study|Death|29|||
33172889|NCT02514447|100541135|FG003|Overall Study|Death|0|||
33261762|NCT01998958|100860154|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33172890|NCT02514447|100541136|FG004|Overall Study|Death|3|||
33172891|NCT02514447|100541137|FG005|Overall Study|Death|4|||
33172892|NCT02514447|100541138|FG006|Overall Study|Death|8|||
33172893|NCT02514447|100541139|FG007|Overall Study|Death|6|||
33172894|NCT02514447|100541140|FG008|Overall Study|Death|5|||
33172895|NCT02514447|100541132|FG000|Overall Study|Lost to Follow-up|1|||
33172896|NCT02514447|100541133|FG001|Overall Study|Lost to Follow-up|0|||
33172897|NCT02514447|100541134|FG002|Overall Study|Lost to Follow-up|0|||
33172898|NCT02514447|100541135|FG003|Overall Study|Lost to Follow-up|0|||
33172899|NCT02514447|100541136|FG004|Overall Study|Lost to Follow-up|0|||
33172900|NCT02514447|100541137|FG005|Overall Study|Lost to Follow-up|0|||
33172901|NCT02514447|100541138|FG006|Overall Study|Lost to Follow-up|0|||
33172902|NCT02514447|100541139|FG007|Overall Study|Lost to Follow-up|0|||
33172903|NCT02514447|100541140|FG008|Overall Study|Lost to Follow-up|1|||
33172904|NCT02514447|100541132|FG000|Overall Study|Sponsor Termination of Study|0|||
33172905|NCT02514447|100541133|FG001|Overall Study|Sponsor Termination of Study|1|||
33172906|NCT02514447|100541134|FG002|Overall Study|Sponsor Termination of Study|1|||
33172907|NCT02514447|100541135|FG003|Overall Study|Sponsor Termination of Study|0|||
33172908|NCT02514447|100541136|FG004|Overall Study|Sponsor Termination of Study|0|||
33172909|NCT02514447|100541137|FG005|Overall Study|Sponsor Termination of Study|0|||
33172910|NCT02514447|100541138|FG006|Overall Study|Sponsor Termination of Study|0|||
33172911|NCT02514447|100541139|FG007|Overall Study|Sponsor Termination of Study|0|||
33172912|NCT02514447|100541140|FG008|Overall Study|Sponsor Termination of Study|0|||
33172913|NCT02514447|100541132|FG000|Overall Study|Study completion per Investigator|1|||
33172914|NCT02514447|100541133|FG001|Overall Study|Study completion per Investigator|0|||
33172915|NCT02514447|100541134|FG002|Overall Study|Study completion per Investigator|1|||
33172916|NCT02514447|100541135|FG003|Overall Study|Study completion per Investigator|2|||
33172917|NCT02514447|100541136|FG004|Overall Study|Study completion per Investigator|0|||
33172918|NCT02514447|100541137|FG005|Overall Study|Study completion per Investigator|0|||
33172919|NCT02514447|100541138|FG006|Overall Study|Study completion per Investigator|0|||
33172920|NCT02514447|100541139|FG007|Overall Study|Study completion per Investigator|0|||
33172921|NCT02514447|100541140|FG008|Overall Study|Study completion per Investigator|1|||
33172922|NCT01285310|100541141|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
33172923|NCT01285310|100541142|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
33172924|NCT01285310|100541143|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
33172925|NCT01285310|100541144|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
33172926|NCT01285310|100541145|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
33172927|NCT01285310|100541141|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
33172928|NCT01285310|100541142|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
33455594|NCT02670551|101557675|FG001|Overall Study|Withdrawal of Consent|3|||
33172929|NCT01285310|100541143|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
33172930|NCT01285310|100541144|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
33172931|NCT01285310|100541145|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
33172932|NCT01285310|100541141|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
33172933|NCT01285310|100541142|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
33172934|NCT01285310|100541143|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
33172935|NCT01285310|100541144|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
33172936|NCT01285310|100541145|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
33172937|NCT01285310|100541141|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
33172938|NCT01285310|100541142|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
33172939|NCT01285310|100541143|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
33172940|NCT01285310|100541144|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
33172941|NCT01285310|100541145|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
33172942|NCT01285310|100541141|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
33172943|NCT01285310|100541142|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
33172944|NCT01285310|100541143|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
33172945|NCT01285310|100541144|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
33172946|NCT01285310|100541145|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
33172947|NCT01285310|100541141|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
33172948|NCT01285310|100541142|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
33172949|NCT01285310|100541143|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
33172950|NCT01285310|100541144|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
33172951|NCT01285310|100541145|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
33172952|NCT01285310|100541141|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
33172953|NCT01285310|100541142|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
33172954|NCT01285310|100541143|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
33172955|NCT01285310|100541144|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
33172956|NCT01285310|100541145|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
33172957|NCT01285310|100541141|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
33172958|NCT01285310|100541142|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
33172959|NCT01285310|100541143|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
33172960|NCT01285310|100541144|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
33172961|NCT01285310|100541145|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
33172962|NCT01285310|100541141|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
33172963|NCT01285310|100541142|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
33172964|NCT01285310|100541143|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
33172965|NCT01285310|100541144|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
33172966|NCT01285310|100541145|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
33172967|NCT01285310|100541141|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
33172968|NCT01285310|100541142|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
33172969|NCT01285310|100541143|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
33172970|NCT01285310|100541144|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
33172971|NCT01285310|100541145|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
33172972|NCT01285310|100541141|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
33172973|NCT01285310|100541142|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
33172974|NCT01285310|100541143|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
33172975|NCT01285310|100541144|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
33172976|NCT01285310|100541145|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
33172977|NCT01285310|100541141|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
33172978|NCT01285310|100541142|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
33172979|NCT01285310|100541143|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
33172980|NCT01285310|100541144|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
33172981|NCT01285310|100541145|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
33172982|NCT00456521|100541146|FG000|Overall Study|Adverse Event|150|||
33455595|NCT02670551|101557676|FG002|Overall Study|Withdrawal of Consent|8|||
33172983|NCT00456521|100541147|FG001|Overall Study|Adverse Event|25|||
33172984|NCT00456521|100541146|FG000|Overall Study|Withdrawal by Subject|43|||
33172985|NCT00456521|100541147|FG001|Overall Study|Withdrawal by Subject|24|||
33172986|NCT00456521|100541146|FG000|Overall Study|Lost to Follow-up|22|||
33172987|NCT00456521|100541147|FG001|Overall Study|Lost to Follow-up|17|||
33172988|NCT00456521|100541146|FG000|Overall Study|Lack of Efficacy|3|||
33172989|NCT00456521|100541147|FG001|Overall Study|Lack of Efficacy|6|||
33172990|NCT00456521|100541146|FG000|Overall Study|Protocol Violation|4|||
33172991|NCT00456521|100541147|FG001|Overall Study|Protocol Violation|0|||
33172992|NCT00456521|100541146|FG000|Overall Study|Pregnancy|1|||
33172993|NCT00456521|100541147|FG001|Overall Study|Pregnancy|1|||
33172994|NCT00456521|100541146|FG000|Overall Study|Drug non-compliance, moved, other|26|||
33172995|NCT00456521|100541147|FG001|Overall Study|Drug non-compliance, moved, other|11|||
33172996|NCT01218204|100541148|FG000|Part B Washout|Adverse Event|0|||
33172997|NCT01218204|100541149|FG001|Part B Washout|Adverse Event|1|||
33172998|NCT01218204|100541150|FG002|Part B Washout|Adverse Event|0|||
33172999|NCT01218204|100541151|FG003|Part B Washout|Adverse Event|0|||
33173000|NCT01218204|100541148|FG000|Part B Washout|Lost to Follow-up|0|||
33173001|NCT01218204|100541149|FG001|Part B Washout|Lost to Follow-up|2|||
33173002|NCT01218204|100541150|FG002|Part B Washout|Lost to Follow-up|0|||
33173003|NCT01218204|100541151|FG003|Part B Washout|Lost to Follow-up|0|||
33173004|NCT01218204|100541148|FG000|Part B Washout|Physician Decision|0|||
33173005|NCT01218204|100541149|FG001|Part B Washout|Physician Decision|14|||
33173006|NCT01218204|100541150|FG002|Part B Washout|Physician Decision|0|||
33173007|NCT01218204|100541151|FG003|Part B Washout|Physician Decision|0|||
33173008|NCT01218204|100541148|FG000|Part B Washout|Withdrawal by Subject|0|||
33173009|NCT01218204|100541149|FG001|Part B Washout|Withdrawal by Subject|14|||
33173010|NCT01218204|100541150|FG002|Part B Washout|Withdrawal by Subject|0|||
33261763|NCT01998958|100860155|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261764|NCT01998958|100860156|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33173011|NCT01218204|100541151|FG003|Part B Washout|Withdrawal by Subject|0|||
33173012|NCT01218204|100541148|FG000|Part B Washout|Reached defined stopping criteria|0|||
33173013|NCT01218204|100541149|FG001|Part B Washout|Reached defined stopping criteria|2|||
33173014|NCT01218204|100541150|FG002|Part B Washout|Reached defined stopping criteria|0|||
33173015|NCT01218204|100541151|FG003|Part B Washout|Reached defined stopping criteria|0|||
33173016|NCT01218204|100541148|FG000|Part B Washout|Did not meet continuation criteria|0|||
33455596|NCT02670551|101557674|FG000|Overall Study|Lost to Follow-up|5|||
33455597|NCT02670551|101557675|FG001|Overall Study|Lost to Follow-up|7|||
33455598|NCT02670551|101557676|FG002|Overall Study|Lost to Follow-up|6|||
33455599|NCT02670551|101557674|FG000|Overall Study|Protocol Violation|1|||
33455600|NCT02670551|101557675|FG001|Overall Study|Protocol Violation|0|||
33455601|NCT02670551|101557676|FG002|Overall Study|Protocol Violation|0|||
33455602|NCT02670551|101557674|FG000|Overall Study|Noncompliance with study drug|3|||
33455603|NCT02670551|101557675|FG001|Overall Study|Noncompliance with study drug|3|||
33455604|NCT02670551|101557676|FG002|Overall Study|Noncompliance with study drug|2|||
33455605|NCT02670551|101557674|FG000|Overall Study|Other Miscellaneous Reasons|2|||
33455606|NCT02670551|101557675|FG001|Overall Study|Other Miscellaneous Reasons|3|||
33455607|NCT02670551|101557676|FG002|Overall Study|Other Miscellaneous Reasons|3|||
33455608|NCT02670551|101557674|FG000|Overall Study|Did Not Receive Treatment|5|||
33455609|NCT02670551|101557675|FG001|Overall Study|Did Not Receive Treatment|3|||
33455610|NCT02670551|101557676|FG002|Overall Study|Did Not Receive Treatment|0|||
33455611|NCT01685008|101557677|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
33455612|NCT01685008|101557678|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
33455613|NCT01685008|101557679|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
33455614|NCT01685008|101557680|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
33455615|NCT01685008|101557677|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
33455616|NCT01685008|101557678|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
33455617|NCT01685008|101557679|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
33455618|NCT01685008|101557680|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
33455619|NCT01685008|101557677|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
33455620|NCT01685008|101557678|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
33455621|NCT01685008|101557679|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
33455622|NCT01685008|101557680|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
33455623|NCT01685008|101557677|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
33173017|NCT01218204|100541149|FG001|Part B Washout|Did not meet continuation criteria|112|||
33173018|NCT01218204|100541150|FG002|Part B Washout|Did not meet continuation criteria|0|||
33173019|NCT01218204|100541151|FG003|Part B Washout|Did not meet continuation criteria|0|||
33173020|NCT01218204|100541148|FG000|Part B Run-in|Adverse Event|0|||
33173021|NCT01218204|100541149|FG001|Part B Run-in|Adverse Event|0|||
33455624|NCT01685008|101557678|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
33455625|NCT01685008|101557679|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
33455626|NCT01685008|101557680|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
33455627|NCT01685008|101557677|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
33173022|NCT01218204|100541150|FG002|Part B Run-in|Adverse Event|1|||
33173023|NCT01218204|100541151|FG003|Part B Run-in|Adverse Event|0|||
33173024|NCT01218204|100541148|FG000|Part B Run-in|Protocol Violation|0|||
33173025|NCT01218204|100541149|FG001|Part B Run-in|Protocol Violation|0|||
33455628|NCT01685008|101557678|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
33455629|NCT01685008|101557679|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
33455630|NCT01685008|101557680|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
33455631|NCT00826241|101557683|FG000|Overall Study|Withdrawal from Follow-up|1|||
33455632|NCT00826241|101557683|FG000|Overall Study|Withdrew consent|2|||
33455633|NCT00826241|101557683|FG000|Overall Study|Death|4|||
33455634|NCT00826241|101557683|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
33455635|NCT00826241|101557683|FG000|Overall Study|Non-compliance|1|||
33455636|NCT00826241|101557683|FG000|Overall Study|Progression of disease|1|||
33455637|NCT00826241|101557683|FG000|Overall Study|Patient refused follow-up|3|||
33455638|NCT00826241|101557683|FG000|Overall Study|Lost to Follow-up|9|||
33455639|NCT00826241|101557683|FG000|Overall Study|Could not obtain records|1|||
33455640|NCT00826241|101557683|FG000|Overall Study|Screen failure|2|||
33455641|NCT00826241|101557683|FG000|Overall Study|Pt unable to proceed to registration|1|||
33455642|NCT00826241|101557683|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
33455643|NCT02167594|101557689|FG000|Overall Study|Withdrawal by Subject|2|||
33455644|NCT02167594|101557690|FG001|Overall Study|Withdrawal by Subject|0|||
33455645|NCT02167594|101557691|FG002|Overall Study|Withdrawal by Subject|0|||
33455646|NCT02167594|101557689|FG000|Overall Study|Death|0|||
33455647|NCT02167594|101557690|FG001|Overall Study|Death|1|||
33455648|NCT02167594|101557691|FG002|Overall Study|Death|0|||
33455649|NCT00876265|101557693|FG000|Overall Study|Miscellaneous reasons|4|||
33455650|NCT00876265|101557693|FG000|Overall Study|Lost to Follow-up|6|||
33455651|NCT00876265|101557693|FG000|Overall Study|Withdrawal by Subject|2|||
33455652|NCT02957331|101557694|FG000|Overall Study|Protocol Violation|1|||
33455653|NCT02957331|101557695|FG001|Overall Study|Protocol Violation|0|||
33455654|NCT01598896|101557696|FG000|Overall Study|Withdrawal by Subject|0|||
33455655|NCT01598896|101557697|FG001|Overall Study|Withdrawal by Subject|1|||
33455656|NCT01598896|101557696|FG000|Overall Study|Lack of Efficacy|0|||
33455657|NCT01598896|101557697|FG001|Overall Study|Lack of Efficacy|1|||
33455658|NCT01590563|101557699|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
33455659|NCT02416934|101557701|FG000|Overall Study|given steroids|1|||
33455660|NCT02416934|101557702|FG001|Overall Study|given steroids|2|||
33455661|NCT02416934|101557701|FG000|Overall Study|Lost to Follow-up|0|||
33455662|NCT02416934|101557702|FG001|Overall Study|Lost to Follow-up|2|||
33455663|NCT02416934|101557701|FG000|Overall Study|Withdrawal by Subject|1|||
33455664|NCT02416934|101557702|FG001|Overall Study|Withdrawal by Subject|0|||
33455665|NCT02416934|101557701|FG000|Overall Study|recruited during continuing renewal proc|0|||
33455666|NCT02416934|101557702|FG001|Overall Study|recruited during continuing renewal proc|1|||
33455667|NCT02416934|101557701|FG000|Overall Study|Protocol Violation|0|||
33173026|NCT01218204|100541150|FG002|Part B Run-in|Protocol Violation|2|||
33173027|NCT01218204|100541151|FG003|Part B Run-in|Protocol Violation|0|||
33173028|NCT01218204|100541148|FG000|Part B Run-in|Withdrawal by Subject|0|||
33173029|NCT01218204|100541149|FG001|Part B Run-in|Withdrawal by Subject|0|||
33173030|NCT01218204|100541150|FG002|Part B Run-in|Withdrawal by Subject|3|||
33173031|NCT01218204|100541151|FG003|Part B Run-in|Withdrawal by Subject|0|||
33173032|NCT01218204|100541148|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
33173033|NCT01218204|100541149|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
33173034|NCT01218204|100541150|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
33173035|NCT01218204|100541151|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
33173036|NCT01218204|100541148|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
33173037|NCT01218204|100541149|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
33173038|NCT01218204|100541150|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
33173039|NCT01218204|100541151|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
33173040|NCT02759471|100541152|FG000|Overall Study|discomfort|2|||
33173041|NCT03156543|100541153|FG000|Overall Study|Withdrawal by Subject|1|||
33173042|NCT03156543|100541154|FG001|Overall Study|Withdrawal by Subject|0|||
33173043|NCT00511667|100541155|FG000|Overall Study|Adverse Event|1|||
33455668|NCT02416934|101557702|FG001|Overall Study|Protocol Violation|1|||
33455669|NCT02416934|101557701|FG000|Overall Study|surgery started late|0|||
33455670|NCT02416934|101557702|FG001|Overall Study|surgery started late|1|||
33173044|NCT00511667|100541156|FG001|Overall Study|Adverse Event|0|||
33173045|NCT00511667|100541155|FG000|Overall Study|Protocol Violation|1|||
33173046|NCT00511667|100541156|FG001|Overall Study|Protocol Violation|1|||
33173047|NCT00511667|100541155|FG000|Overall Study|Withdrawal by Subject|2|||
33173048|NCT00511667|100541156|FG001|Overall Study|Withdrawal by Subject|0|||
33455671|NCT02416934|101557701|FG000|Overall Study|re-operation|1|||
33455672|NCT02416934|101557702|FG001|Overall Study|re-operation|0|||
33455673|NCT00466167|101557703|FG000|Overall Study|Adverse Event|8|||
33455674|NCT00466167|101557704|FG001|Overall Study|Adverse Event|8|||
33455675|NCT00466167|101557705|FG002|Overall Study|Adverse Event|7|||
33455676|NCT00466167|101557703|FG000|Overall Study|Lack of Efficacy|2|||
33455677|NCT00466167|101557704|FG001|Overall Study|Lack of Efficacy|0|||
33455678|NCT00466167|101557705|FG002|Overall Study|Lack of Efficacy|3|||
33455679|NCT00466167|101557703|FG000|Overall Study|Protocol Violation|1|||
33455680|NCT00466167|101557704|FG001|Overall Study|Protocol Violation|1|||
33173049|NCT00511667|100541155|FG000|Overall Study|Site terminated|6|||
33173050|NCT00511667|100541156|FG001|Overall Study|Site terminated|1|||
33173051|NCT00511667|100541155|FG000|Overall Study|Other|2|||
33173052|NCT00511667|100541156|FG001|Overall Study|Other|1|||
33173053|NCT01824394|100541157|FG000|Overall Study|Early Termination|1|||
33173054|NCT01824394|100541158|FG001|Overall Study|Early Termination|1|||
33173055|NCT01824394|100541159|FG002|Overall Study|Early Termination|3|||
33173056|NCT01824394|100541157|FG000|Overall Study|Withdrawn due to Study Termination|91|||
33173057|NCT01824394|100541158|FG001|Overall Study|Withdrawn due to Study Termination|83|||
33173058|NCT01824394|100541159|FG002|Overall Study|Withdrawn due to Study Termination|41|||
33173059|NCT01824394|100541157|FG000|Overall Study|Lost to Follow-up|0|||
33173060|NCT01824394|100541158|FG001|Overall Study|Lost to Follow-up|9|||
33173061|NCT01824394|100541159|FG002|Overall Study|Lost to Follow-up|3|||
33173062|NCT01824394|100541157|FG000|Overall Study|Death|3|||
33173063|NCT01824394|100541158|FG001|Overall Study|Death|2|||
33173064|NCT01824394|100541159|FG002|Overall Study|Death|4|||
33173065|NCT01824394|100541157|FG000|Overall Study|Discontinued Subjects|1|||
33173066|NCT01824394|100541158|FG001|Overall Study|Discontinued Subjects|1|||
33173067|NCT01824394|100541159|FG002|Overall Study|Discontinued Subjects|2|||
33173068|NCT01824394|100541157|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
33173069|NCT01824394|100541158|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
33173070|NCT01824394|100541159|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
33173071|NCT04128267|100541160|FG000|Overall Study|Withdrawal by Subject|6|||
33173072|NCT04128267|100541160|FG000|Overall Study|Death|2|||
33173073|NCT04128267|100541160|FG000|Overall Study|Disease progression|1|||
33173074|NCT04128267|100541160|FG000|Overall Study|Participant had other medical issues|4|||
33173075|NCT04128267|100541160|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
33173076|NCT00881712|100541163|FG000|Overall Study|Death|1|||
33173077|NCT00881712|100541164|FG001|Overall Study|Death|0|||
33173078|NCT00881712|100541165|FG002|Overall Study|Death|0|||
33173079|NCT00881712|100541163|FG000|Overall Study|Withdrawal by Subject|1|||
33173080|NCT00881712|100541164|FG001|Overall Study|Withdrawal by Subject|0|||
33173081|NCT00881712|100541165|FG002|Overall Study|Withdrawal by Subject|0|||
33173082|NCT02999854|100541166|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
33173083|NCT02999854|100541167|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
33173084|NCT02999854|100541166|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
33173085|NCT02999854|100541167|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
33173086|NCT02999854|100541166|FG000|Active Study Phase (up to 18 Months)|Death|7|||
33173087|NCT02999854|100541167|FG001|Active Study Phase (up to 18 Months)|Death|5|||
33173088|NCT02999854|100541166|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
33173089|NCT02999854|100541167|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
33173090|NCT02999854|100541166|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
33173091|NCT02999854|100541167|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
33173092|NCT02999854|100541166|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
33173093|NCT02999854|100541167|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
33173094|NCT02999854|100541166|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
33173095|NCT02999854|100541167|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
33173096|NCT02999854|100541166|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
33173097|NCT02999854|100541167|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
33173098|NCT00736723|100541168|FG000|Overall Study|Withdrawal by Subject|4|||
33173099|NCT00736723|100541169|FG001|Overall Study|Withdrawal by Subject|3|||
33173100|NCT04772755|100541170|FG000|Overall Study|Withdrawal by Subject|1|||
33173101|NCT04772755|100541171|FG001|Overall Study|Withdrawal by Subject|0|||
33173102|NCT04772755|100541170|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
33173103|NCT04772755|100541171|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
33173104|NCT00459667|100541178|FG000|Overall Study|Adverse Event|9|||
33173105|NCT00459667|100541179|FG001|Overall Study|Adverse Event|12|||
33173106|NCT00459667|100541180|FG002|Overall Study|Adverse Event|8|||
33173107|NCT00459667|100541178|FG000|Overall Study|Lost to Follow-up|5|||
33173108|NCT00459667|100541179|FG001|Overall Study|Lost to Follow-up|9|||
33173109|NCT00459667|100541180|FG002|Overall Study|Lost to Follow-up|3|||
33173110|NCT00459667|100541178|FG000|Overall Study|Pregnancy|1|||
33173111|NCT00459667|100541179|FG001|Overall Study|Pregnancy|1|||
33173112|NCT00459667|100541180|FG002|Overall Study|Pregnancy|1|||
33173113|NCT00459667|100541178|FG000|Overall Study|Protocol Violation|1|||
33173114|NCT00459667|100541179|FG001|Overall Study|Protocol Violation|0|||
33173115|NCT00459667|100541180|FG002|Overall Study|Protocol Violation|0|||
33173116|NCT00459667|100541178|FG000|Overall Study|Withdrawal by Subject|3|||
33173117|NCT00459667|100541179|FG001|Overall Study|Withdrawal by Subject|5|||
33173118|NCT00459667|100541180|FG002|Overall Study|Withdrawal by Subject|5|||
33173119|NCT00459667|100541178|FG000|Overall Study|Other disease modifying treatment|1|||
33455681|NCT00466167|101557705|FG002|Overall Study|Protocol Violation|2|||
33455682|NCT00466167|101557703|FG000|Overall Study|Lost to Follow-up|3|||
33455683|NCT00466167|101557704|FG001|Overall Study|Lost to Follow-up|2|||
33455684|NCT00466167|101557705|FG002|Overall Study|Lost to Follow-up|2|||
33455685|NCT00466167|101557703|FG000|Overall Study|Withdrawal by Subject|4|||
33455686|NCT00466167|101557704|FG001|Overall Study|Withdrawal by Subject|1|||
33455687|NCT00466167|101557705|FG002|Overall Study|Withdrawal by Subject|6|||
33455688|NCT00466167|101557703|FG000|Overall Study|patient did not meet inclusion criteria|1|||
33455689|NCT00466167|101557704|FG001|Overall Study|patient did not meet inclusion criteria|0|||
33455690|NCT00466167|101557705|FG002|Overall Study|patient did not meet inclusion criteria|1|||
33455691|NCT00466167|101557703|FG000|Overall Study|Not treated|1|||
33455692|NCT00466167|101557704|FG001|Overall Study|Not treated|0|||
33455693|NCT00466167|101557705|FG002|Overall Study|Not treated|0|||
33455694|NCT00059332|101557706|FG000|Overall Study|Withdrawal by Subject|2|||
33455695|NCT00059332|101557707|FG001|Overall Study|Withdrawal by Subject|1|||
33455696|NCT00059332|101557706|FG000|Overall Study|Lost to Follow-up|1|||
33455697|NCT00059332|101557707|FG001|Overall Study|Lost to Follow-up|1|||
33455698|NCT00508651|101557714|FG000|Overall Study|Lost to Follow-up|3|||
33455699|NCT00508651|101557715|FG001|Overall Study|Lost to Follow-up|1|||
33173120|NCT00459667|100541179|FG001|Overall Study|Other disease modifying treatment|2|||
33173121|NCT00459667|100541180|FG002|Overall Study|Other disease modifying treatment|1|||
33173122|NCT00459667|100541178|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
33455700|NCT00508651|101557714|FG000|Overall Study|Withdrawal by Subject|1|||
33455701|NCT00508651|101557715|FG001|Overall Study|Withdrawal by Subject|1|||
33455702|NCT02050321|101557719|FG000|Overall Study|Withdrawal by Subject|1|||
33173123|NCT00459667|100541179|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
33173124|NCT00459667|100541180|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
33173125|NCT00459667|100541178|FG000|Overall Study|No treatment administered|6|||
33173126|NCT00459667|100541179|FG001|Overall Study|No treatment administered|3|||
33173127|NCT00459667|100541180|FG002|Overall Study|No treatment administered|1|||
33173128|NCT00726661|100541183|FG000|Overall Study|Lost to Follow-up|36|||
33173129|NCT00726661|100541184|FG001|Overall Study|Lost to Follow-up|11|||
33173130|NCT00726661|100541183|FG000|Overall Study|Withdrawal by Subject|17|||
33173131|NCT00726661|100541184|FG001|Overall Study|Withdrawal by Subject|13|||
33173132|NCT00726661|100541183|FG000|Overall Study|Trial terminated by sponsor|214|||
33173133|NCT00726661|100541184|FG001|Overall Study|Trial terminated by sponsor|187|||
33173134|NCT00726661|100541183|FG000|Overall Study|Death|475|||
33173135|NCT00726661|100541184|FG001|Overall Study|Death|159|||
33173136|NCT00726661|100541183|FG000|Overall Study|Physician Decision|25|||
33455703|NCT02050321|101557719|FG000|Overall Study|Adverse Event|1|||
33455704|NCT00757172|101557723|FG000|Overall Study|Withdrawal by Subject|4|||
33455705|NCT00757172|101557723|FG000|Overall Study|Physician Decision|3|||
33455706|NCT00757172|101557723|FG000|Overall Study|Progression|4|||
33455707|NCT01151618|101557726|FG000|Overall Study|Adverse Event|2|||
33455708|NCT01151618|101557726|FG000|Overall Study|Withdrawal by Subject|7|||
33455709|NCT02845336|101557733|FG000|Overall Study|Lost to Follow-up|3|||
33455710|NCT02845336|101557734|FG001|Overall Study|Lost to Follow-up|1|||
33455711|NCT02845336|101557733|FG000|Overall Study|Inability to get medication|2|||
33455712|NCT02845336|101557734|FG001|Overall Study|Inability to get medication|0|||
33455713|NCT00884390|101557735|FG000|Overall Study|Adverse Event|0|||
33455714|NCT00884390|101557736|FG001|Overall Study|Adverse Event|1|||
33455715|NCT00884390|101557735|FG000|Overall Study|Lost to Follow-up|0|||
33455716|NCT00884390|101557736|FG001|Overall Study|Lost to Follow-up|1|||
33455717|NCT00884390|101557735|FG000|Overall Study|Physician Decision|2|||
33455718|NCT00884390|101557736|FG001|Overall Study|Physician Decision|1|||
33455719|NCT00884390|101557735|FG000|Overall Study|Protocol Violation|4|||
33173137|NCT00726661|100541184|FG001|Overall Study|Physician Decision|13|||
33173138|NCT00726661|100541183|FG000|Overall Study|Other|47|||
33173139|NCT00726661|100541184|FG001|Overall Study|Other|35|||
33173140|NCT02625259|100541188|FG000|First Intervention (Day 1)|Other|0|||
33173141|NCT02625259|100541189|FG001|First Intervention (Day 1)|Other|0|||
33173142|NCT02625259|100541190|FG002|First Intervention (Day 1)|Other|1|||
33455720|NCT00884390|101557736|FG001|Overall Study|Protocol Violation|1|||
33455721|NCT00884390|101557735|FG000|Overall Study|Withdrawal by Subject|4|||
33455722|NCT00884390|101557736|FG001|Overall Study|Withdrawal by Subject|1|||
33455723|NCT00884390|101557735|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
33455724|NCT00884390|101557736|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
33455725|NCT00884390|101557735|FG000|Overall Study|Other|11|||
33455726|NCT00884390|101557736|FG001|Overall Study|Other|1|||
33455727|NCT03980522|101557744|FG000|Treatment Period|Adverse Event|1|||
33455728|NCT03980522|101557745|FG001|Treatment Period|Adverse Event|0|||
33455729|NCT03980522|101557746|FG002|Treatment Period|Adverse Event|0|||
33173143|NCT02625259|100541191|FG003|First Intervention (Day 1)|Other|0|||
33173144|NCT02625259|100541192|FG004|First Intervention (Day 1)|Other|0|||
33455730|NCT03980522|101557747|FG003|Treatment Period|Adverse Event|0|||
33455731|NCT03980522|101557748|FG004|Treatment Period|Adverse Event|0|||
33173145|NCT02625259|100541188|FG000|First Intervention (Day 1)|Adverse Event|2|||
33173146|NCT02625259|100541189|FG001|First Intervention (Day 1)|Adverse Event|1|||
33455732|NCT03201003|101557749|FG000|Overall Study|Adverse Event|14|||
33455733|NCT03201003|101557750|FG001|Overall Study|Adverse Event|1|||
33455734|NCT03201003|101557749|FG000|Overall Study|Other reasons|5|||
33173147|NCT02625259|100541190|FG002|First Intervention (Day 1)|Adverse Event|0|||
33455735|NCT03201003|101557750|FG001|Overall Study|Other reasons|1|||
33455736|NCT03201003|101557749|FG000|Overall Study|Withdrawal by Subject|4|||
33455737|NCT03201003|101557750|FG001|Overall Study|Withdrawal by Subject|1|||
33455738|NCT03201003|101557749|FG000|Overall Study|Lost to Follow-up|2|||
33455739|NCT03201003|101557750|FG001|Overall Study|Lost to Follow-up|0|||
33455740|NCT03201003|101557749|FG000|Overall Study|Protocol Violation|1|||
33455741|NCT03201003|101557750|FG001|Overall Study|Protocol Violation|0|||
33455742|NCT00252564|101557751|FG000|Overall Study|Adverse Event|17|||
33455743|NCT00252564|101557752|FG001|Overall Study|Adverse Event|13|||
33455744|NCT00252564|101557751|FG000|Overall Study|Unrelated Complication|2|||
33455745|NCT00252564|101557752|FG001|Overall Study|Unrelated Complication|1|||
33455746|NCT00252564|101557751|FG000|Overall Study|Disease Progression|14|||
33455747|NCT00252564|101557752|FG001|Overall Study|Disease Progression|20|||
33455748|NCT00252564|101557751|FG000|Overall Study|Death|0|||
33455749|NCT00252564|101557752|FG001|Overall Study|Death|3|||
33455750|NCT00252564|101557751|FG000|Overall Study|Physician Decision|1|||
33455751|NCT00252564|101557752|FG001|Overall Study|Physician Decision|0|||
33455752|NCT00252564|101557751|FG000|Overall Study|Lost to Follow-up|1|||
33455753|NCT00252564|101557752|FG001|Overall Study|Lost to Follow-up|0|||
33455754|NCT00252564|101557751|FG000|Overall Study|Patient Request|4|||
33455755|NCT00252564|101557752|FG001|Overall Study|Patient Request|5|||
33455756|NCT00252564|101557751|FG000|Overall Study|Withdrawal by Subject|0|||
33455757|NCT00252564|101557752|FG001|Overall Study|Withdrawal by Subject|2|||
33455758|NCT01970592|101557756|FG000|Overall Study|Withdrawal by Subject|4|||
33455759|NCT01970592|101557756|FG000|Overall Study|Physician Decision|1|||
33455760|NCT01970592|101557756|FG000|Overall Study|Adverse Event|1|||
33455761|NCT03828539|101557757|FG000|Overall Study|Adverse Event|3|||
33455762|NCT03828539|101557758|FG001|Overall Study|Adverse Event|12|||
33455763|NCT03828539|101557757|FG000|Overall Study|Patient's/guardian's decision|3|||
33455764|NCT03828539|101557758|FG001|Overall Study|Patient's/guardian's decision|5|||
33455765|NCT03828539|101557757|FG000|Overall Study|Lost to Follow-up|4|||
33455766|NCT03828539|101557758|FG001|Overall Study|Lost to Follow-up|2|||
33455767|NCT03828539|101557757|FG000|Overall Study|Protocol Violation|3|||
33455768|NCT03828539|101557758|FG001|Overall Study|Protocol Violation|2|||
33455769|NCT03828539|101557757|FG000|Overall Study|Withdrawal of informed consent|2|||
33455770|NCT03828539|101557758|FG001|Overall Study|Withdrawal of informed consent|1|||
33455771|NCT03828539|101557757|FG000|Overall Study|New therapy for study indication|1|||
33455772|NCT03828539|101557758|FG001|Overall Study|New therapy for study indication|0|||
33455773|NCT00858403|101557768|FG000|Overall Study|Withdrawal by Subject|1|||
33455774|NCT00858403|101557768|FG000|Overall Study|Death|3|||
33455775|NCT00858403|101557768|FG000|Overall Study|Disease Progression|1|||
33455776|NCT02420353|101557771|FG000|Overall Study|Withdrawal by Subject|0|||
33455777|NCT02420353|101557772|FG001|Overall Study|Withdrawal by Subject|1|||
33455778|NCT00045162|101557777|FG000|Overall Study|Ineligible|12|||
33455779|NCT00045162|101557778|FG001|Overall Study|Ineligible|8|||
33455780|NCT00045162|101557777|FG000|Overall Study|Not treated|7|||
33455781|NCT00045162|101557778|FG001|Overall Study|Not treated|2|||
33455782|NCT00045162|101557777|FG000|Overall Study|Adverse Event|55|||
33455783|NCT00045162|101557778|FG001|Overall Study|Adverse Event|50|||
33455784|NCT00045162|101557777|FG000|Overall Study|Lack of Efficacy|32|||
33455785|NCT00045162|101557778|FG001|Overall Study|Lack of Efficacy|29|||
33455786|NCT00045162|101557777|FG000|Overall Study|Death|10|||
33455787|NCT00045162|101557778|FG001|Overall Study|Death|10|||
33455788|NCT00045162|101557777|FG000|Overall Study|Withdrawal by Subject|5|||
33455789|NCT00045162|101557778|FG001|Overall Study|Withdrawal by Subject|3|||
33455790|NCT00045162|101557777|FG000|Overall Study|Other|21|||
33455791|NCT00045162|101557778|FG001|Overall Study|Other|16|||
33455792|NCT01698554|101557785|FG000|Overall Study|Adverse Event|2|||
33455793|NCT01698554|101557786|FG001|Overall Study|Adverse Event|5|||
33173148|NCT02625259|100541191|FG003|First Intervention (Day 1)|Adverse Event|0|||
33173149|NCT02625259|100541192|FG004|First Intervention (Day 1)|Adverse Event|0|||
33173150|NCT02625259|100541188|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
33173151|NCT02625259|100541189|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
33173152|NCT02625259|100541190|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
33173153|NCT02625259|100541191|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
33173154|NCT02625259|100541192|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
33173155|NCT00290888|100541194|FG000|Overall Study|Physician Decision|3|||
33173156|NCT00290888|100541195|FG001|Overall Study|Physician Decision|1|||
33173157|NCT01949051|100541196|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
33173158|NCT01949051|100541197|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
33173159|NCT01949051|100541198|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
33173160|NCT01949051|100541199|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
33173161|NCT01949051|100541200|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
33173162|NCT01949051|100541201|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
33173163|NCT01949051|100541196|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
33173164|NCT01949051|100541197|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33173165|NCT01949051|100541198|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33173166|NCT01949051|100541199|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33173167|NCT01949051|100541200|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33173168|NCT01949051|100541201|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
33173169|NCT01949051|100541196|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
33173170|NCT01949051|100541197|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
33173171|NCT01949051|100541198|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
33173172|NCT01949051|100541199|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
33173173|NCT01949051|100541200|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
33173174|NCT01949051|100541201|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
33173175|NCT01949051|100541196|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
33173176|NCT01949051|100541197|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
33173177|NCT01949051|100541198|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
33173178|NCT01949051|100541199|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
33173179|NCT01949051|100541200|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
33173180|NCT01949051|100541201|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
33173181|NCT01949051|100541196|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
33173182|NCT01949051|100541197|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
33173183|NCT01949051|100541198|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
33173184|NCT01949051|100541199|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
33173185|NCT01949051|100541200|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
33173186|NCT01949051|100541201|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
33173187|NCT02664441|100541202|FG000|Randomization|Withdrawal by Subject|0|||
33173188|NCT02664441|100541203|FG001|Randomization|Withdrawal by Subject|1|||
33173189|NCT02664441|100541202|FG000|36-week Randomized Trial|Adverse Event|2|||
33173190|NCT02664441|100541203|FG001|36-week Randomized Trial|Adverse Event|0|||
33173191|NCT02664441|100541202|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
33173192|NCT02664441|100541203|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
33173193|NCT02664441|100541202|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
33173194|NCT02664441|100541203|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
33173195|NCT02664441|100541202|FG000|18-week Open Label Extension|Adverse Event|1|||
33173196|NCT02664441|100541203|FG001|18-week Open Label Extension|Adverse Event|0|||
33173197|NCT02664441|100541202|FG000|18-week Open Label Extension|Physician Decision|1|||
33173198|NCT02664441|100541203|FG001|18-week Open Label Extension|Physician Decision|0|||
33173199|NCT02664441|100541202|FG000|18-week Open Label Extension|Death|1|||
33173200|NCT02664441|100541203|FG001|18-week Open Label Extension|Death|0|||
33173201|NCT02664441|100541202|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
33173202|NCT02664441|100541203|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
33173203|NCT00477971|100541204|FG000|Overall Study|Disease progression|6|||
33173204|NCT00477971|100541205|FG001|Overall Study|Disease progression|0|||
33173205|NCT00477971|100541204|FG000|Overall Study|Withdrawal by Subject|3|||
33173206|NCT00477971|100541205|FG001|Overall Study|Withdrawal by Subject|1|||
33173207|NCT00477971|100541204|FG000|Overall Study|Adverse Event|3|||
33173208|NCT00477971|100541205|FG001|Overall Study|Adverse Event|0|||
33173209|NCT00477971|100541204|FG000|Overall Study|Death|2|||
33455794|NCT01698554|101557787|FG002|Overall Study|Adverse Event|0|||
33455795|NCT01698554|101557788|FG003|Overall Study|Adverse Event|1|||
33455796|NCT01698554|101557785|FG000|Overall Study|Lost to Follow-up|1|||
33455797|NCT01698554|101557786|FG001|Overall Study|Lost to Follow-up|0|||
33455798|NCT01698554|101557787|FG002|Overall Study|Lost to Follow-up|0|||
33455799|NCT01698554|101557788|FG003|Overall Study|Lost to Follow-up|0|||
33455800|NCT01698554|101557785|FG000|Overall Study|Personal Reasons|0|||
33455801|NCT01698554|101557786|FG001|Overall Study|Personal Reasons|5|||
33455802|NCT01698554|101557787|FG002|Overall Study|Personal Reasons|1|||
33455803|NCT01698554|101557788|FG003|Overall Study|Personal Reasons|1|||
33455804|NCT01698554|101557785|FG000|Overall Study|Protocol Violation|2|||
33455805|NCT01698554|101557786|FG001|Overall Study|Protocol Violation|0|||
33455806|NCT01698554|101557787|FG002|Overall Study|Protocol Violation|1|||
33455807|NCT01698554|101557788|FG003|Overall Study|Protocol Violation|0|||
33455808|NCT01698554|101557785|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33455809|NCT01698554|101557786|FG001|Overall Study|Other Miscellaneous Reasons|0|||
33455810|NCT01698554|101557787|FG002|Overall Study|Other Miscellaneous Reasons|0|||
33455811|NCT01698554|101557788|FG003|Overall Study|Other Miscellaneous Reasons|0|||
33455812|NCT01993940|101557793|FG000|Overall Study|Adverse Event|16|||
33455813|NCT01993940|101557794|FG001|Overall Study|Adverse Event|11|||
33455814|NCT01993940|101557793|FG000|Overall Study|Withdrawal by Subject|15|||
33455815|NCT01993940|101557794|FG001|Overall Study|Withdrawal by Subject|19|||
33455816|NCT01993940|101557793|FG000|Overall Study|Lost to Follow-up|2|||
33455817|NCT01993940|101557794|FG001|Overall Study|Lost to Follow-up|5|||
33455818|NCT01993940|101557793|FG000|Overall Study|Protocol Violation|5|||
33455819|NCT01993940|101557794|FG001|Overall Study|Protocol Violation|8|||
33455820|NCT01993940|101557793|FG000|Overall Study|Death|1|||
33455821|NCT01993940|101557794|FG001|Overall Study|Death|0|||
33455822|NCT01993940|101557793|FG000|Overall Study|Other - Miscellaneous|1|||
33455823|NCT01993940|101557794|FG001|Overall Study|Other - Miscellaneous|1|||
33455824|NCT03246503|101557795|FG000|Overall Study|Lost to Follow-up|23|||
33455825|NCT03246503|101557795|FG000|Overall Study|Withdrawal by Subject|20|||
33455826|NCT03246503|101557795|FG000|Overall Study|Physician Decision|5|||
33455827|NCT03246503|101557795|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
33455828|NCT01320722|101557797|FG000|Overall Study|Did not Receive Intervention|3|||
33455829|NCT01320722|101557798|FG001|Overall Study|Did not Receive Intervention|2|||
33455830|NCT01320722|101557799|FG002|Overall Study|Did not Receive Intervention|1|||
33455831|NCT01320722|101557800|FG003|Overall Study|Did not Receive Intervention|1|||
33455832|NCT01320722|101557801|FG004|Overall Study|Did not Receive Intervention|2|||
33455833|NCT01320722|101557797|FG000|Overall Study|Lost to Follow-up|0|||
33455834|NCT01320722|101557798|FG001|Overall Study|Lost to Follow-up|1|||
33455835|NCT01320722|101557799|FG002|Overall Study|Lost to Follow-up|0|||
33455836|NCT01320722|101557800|FG003|Overall Study|Lost to Follow-up|1|||
33455837|NCT01320722|101557801|FG004|Overall Study|Lost to Follow-up|3|||
33455838|NCT01320722|101557797|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
33455839|NCT01320722|101557798|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
33261765|NCT01998958|100860157|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
33261766|NCT01998958|100860126|FG000|Open Label Phase (Optional)|Adverse Event|0|||
33261767|NCT01998958|100860127|FG001|Open Label Phase (Optional)|Adverse Event|0|||
33261768|NCT01998958|100860128|FG002|Open Label Phase (Optional)|Adverse Event|0|||
33455840|NCT01320722|101557799|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
33455841|NCT01320722|101557800|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
33455842|NCT01320722|101557801|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
33455843|NCT01320722|101557797|FG000|Overall Study|Participant Developed a Rash|0|||
33455844|NCT01320722|101557798|FG001|Overall Study|Participant Developed a Rash|0|||
33455845|NCT01320722|101557799|FG002|Overall Study|Participant Developed a Rash|2|||
33455846|NCT01320722|101557800|FG003|Overall Study|Participant Developed a Rash|1|||
33455847|NCT01320722|101557801|FG004|Overall Study|Participant Developed a Rash|1|||
33455848|NCT01320722|101557797|FG000|Overall Study|Non-compliant with Medication|0|||
33455849|NCT01320722|101557798|FG001|Overall Study|Non-compliant with Medication|0|||
33455850|NCT01320722|101557799|FG002|Overall Study|Non-compliant with Medication|1|||
33455851|NCT01320722|101557800|FG003|Overall Study|Non-compliant with Medication|0|||
33455852|NCT01320722|101557801|FG004|Overall Study|Non-compliant with Medication|0|||
33455853|NCT01320722|101557797|FG000|Overall Study|Adverse Event|0|||
33455854|NCT01320722|101557798|FG001|Overall Study|Adverse Event|0|||
33455855|NCT01320722|101557799|FG002|Overall Study|Adverse Event|3|||
33455856|NCT01320722|101557800|FG003|Overall Study|Adverse Event|6|||
33455857|NCT01320722|101557801|FG004|Overall Study|Adverse Event|0|||
33455858|NCT01320722|101557797|FG000|Overall Study|Not Compliant with Study Procedures|0|||
33455859|NCT01320722|101557798|FG001|Overall Study|Not Compliant with Study Procedures|0|||
33455860|NCT01320722|101557799|FG002|Overall Study|Not Compliant with Study Procedures|0|||
33455861|NCT01320722|101557800|FG003|Overall Study|Not Compliant with Study Procedures|4|||
33455862|NCT01320722|101557801|FG004|Overall Study|Not Compliant with Study Procedures|0|||
33455863|NCT01320722|101557797|FG000|Overall Study|Pregnancy|0|||
33455864|NCT01320722|101557798|FG001|Overall Study|Pregnancy|0|||
33455865|NCT01320722|101557799|FG002|Overall Study|Pregnancy|0|||
33455866|NCT01320722|101557800|FG003|Overall Study|Pregnancy|1|||
33455867|NCT01320722|101557801|FG004|Overall Study|Pregnancy|0|||
33455868|NCT01320722|101557797|FG000|Overall Study|Started an Exclusionary Medication|0|||
33455869|NCT01320722|101557798|FG001|Overall Study|Started an Exclusionary Medication|0|||
33455870|NCT01320722|101557799|FG002|Overall Study|Started an Exclusionary Medication|0|||
33455871|NCT01320722|101557800|FG003|Overall Study|Started an Exclusionary Medication|0|||
33455872|NCT01320722|101557801|FG004|Overall Study|Started an Exclusionary Medication|1|||
33455873|NCT01320722|101557797|FG000|Overall Study|Withdrew due to Health Condition|0|||
33455874|NCT01320722|101557798|FG001|Overall Study|Withdrew due to Health Condition|0|||
33455875|NCT01320722|101557799|FG002|Overall Study|Withdrew due to Health Condition|0|||
33455876|NCT01320722|101557800|FG003|Overall Study|Withdrew due to Health Condition|0|||
33455877|NCT01320722|101557801|FG004|Overall Study|Withdrew due to Health Condition|1|||
33455878|NCT00867360|101557802|FG000|Overall Study|Withdrawal by Subject|1|||
33455879|NCT00867360|101557803|FG001|Overall Study|Withdrawal by Subject|0|||
33455880|NCT00867360|101557802|FG000|Overall Study|Physician Decision|0|||
33455881|NCT00867360|101557803|FG001|Overall Study|Physician Decision|1|||
33455882|NCT02054715|101557804|FG000|Baseline/Follow-up 1|Refused|1|||
33455883|NCT02054715|101557805|FG001|Baseline/Follow-up 1|Refused|3|||
33455884|NCT02054715|101557804|FG000|Baseline/Follow-up 1|Medical|0|||
33455885|NCT02054715|101557805|FG001|Baseline/Follow-up 1|Medical|1|||
33455886|NCT02054715|101557804|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
33455887|NCT02054715|101557805|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
33455888|NCT02054715|101557804|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
33455889|NCT02054715|101557805|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
33455890|NCT02054715|101557804|FG000|Baseline/Follow-up 1|No Reason|0|||
33455891|NCT02054715|101557805|FG001|Baseline/Follow-up 1|No Reason|1|||
33455892|NCT02054715|101557804|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
33455893|NCT02054715|101557805|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
33455894|NCT02054715|101557804|FG000|Baseline/Follow-up 1|Ineligible|3|||
33455895|NCT02054715|101557805|FG001|Baseline/Follow-up 1|Ineligible|0|||
33455896|NCT02054715|101557804|FG000|Baseline/Follow-up 1|Hospitalization|1|||
33455897|NCT02054715|101557805|FG001|Baseline/Follow-up 1|Hospitalization|0|||
33455898|NCT02054715|101557804|FG000|Baseline/Follow-up 1|Changed Mind|1|||
33455899|NCT02054715|101557805|FG001|Baseline/Follow-up 1|Changed Mind|0|||
33455900|NCT02054715|101557804|FG000|Follow-up 2|Lost to Followup|3|||
33455901|NCT02054715|101557805|FG001|Follow-up 2|Lost to Followup|1|||
33455902|NCT02054715|101557804|FG000|Follow-up 2|Refused|3|||
33455903|NCT02054715|101557805|FG001|Follow-up 2|Refused|2|||
33455904|NCT02054715|101557804|FG000|Follow-up 2|Followup Not Completed|3|||
33455905|NCT02054715|101557805|FG001|Follow-up 2|Followup Not Completed|4|||
33455906|NCT02054715|101557804|FG000|Follow-up 2|Ineligible|4|||
33455907|NCT02054715|101557805|FG001|Follow-up 2|Ineligible|5|||
33455908|NCT02054715|101557804|FG000|Follow-up 2|Death|3|||
33455909|NCT02054715|101557805|FG001|Follow-up 2|Death|3|||
33455910|NCT02054715|101557804|FG000|Follow-up 2|Hospitalization|0|||
33455911|NCT02054715|101557805|FG001|Follow-up 2|Hospitalization|2|||
33455912|NCT02054715|101557804|FG000|Follow-up 2|Changed MD/Facility|0|||
33455913|NCT02054715|101557805|FG001|Follow-up 2|Changed MD/Facility|1|||
33455914|NCT02054715|101557804|FG000|Follow-up 2|Changed Mind|0|||
33455915|NCT02054715|101557805|FG001|Follow-up 2|Changed Mind|1|||
33455916|NCT02054715|101557804|FG000|Follow-up 2|No Reason|2|||
33455917|NCT02054715|101557805|FG001|Follow-up 2|No Reason|0|||
33455918|NCT02054715|101557804|FG000|Follow-up 2|Treatment Change or Delay|1|||
33455919|NCT02054715|101557805|FG001|Follow-up 2|Treatment Change or Delay|0|||
33455920|NCT00438633|101557810|FG000|Overall Study|Withdrawal by Subject|1|||
33455921|NCT00438633|101557811|FG001|Overall Study|Withdrawal by Subject|0|||
33455922|NCT00438633|101557810|FG000|Overall Study|Lost to Follow-up|15|||
33455923|NCT00438633|101557811|FG001|Overall Study|Lost to Follow-up|17|||
33173210|NCT00477971|100541205|FG001|Overall Study|Death|4|||
33173211|NCT00477971|100541204|FG000|Overall Study|Alternative treatment|3|||
33173212|NCT00477971|100541205|FG001|Overall Study|Alternative treatment|1|||
33173213|NCT01414114|100541206|FG000|Overall Study|Adverse Event|2|||
33173214|NCT01414114|100541206|FG000|Overall Study|Withdrawal by Subject|1|||
33173215|NCT01414114|100541206|FG000|Overall Study|Other|2|||
33173216|NCT01059799|100541207|FG000|Overall Study|Adverse Event|2|||
33173217|NCT01059799|100541208|FG001|Overall Study|Adverse Event|3|||
33173218|NCT01059799|100541207|FG000|Overall Study|Lack of Efficacy|1|||
33173219|NCT01059799|100541208|FG001|Overall Study|Lack of Efficacy|0|||
33173220|NCT01059799|100541207|FG000|Overall Study|Protocol Violation|3|||
33173221|NCT01059799|100541208|FG001|Overall Study|Protocol Violation|2|||
33173222|NCT01059799|100541207|FG000|Overall Study|Withdrawal criteria|13|||
33261769|NCT01998958|100860129|FG003|Open Label Phase (Optional)|Adverse Event|0|||
33261770|NCT01998958|100860130|FG004|Open Label Phase (Optional)|Adverse Event|0|||
33261771|NCT01998958|100860131|FG005|Open Label Phase (Optional)|Adverse Event|0|||
33261772|NCT01998958|100860132|FG006|Open Label Phase (Optional)|Adverse Event|0|||
33261773|NCT01998958|100860133|FG007|Open Label Phase (Optional)|Adverse Event|0|||
33261774|NCT01998958|100860134|FG008|Open Label Phase (Optional)|Adverse Event|0|||
33455924|NCT04567329|101557814|FG000|Overall Study|Withdrawal by Subject|5|||
33455925|NCT04567329|101557815|FG001|Overall Study|Withdrawal by Subject|6|||
33455926|NCT04567329|101557814|FG000|Overall Study|Protocol Violation|2|||
33455927|NCT04567329|101557815|FG001|Overall Study|Protocol Violation|3|||
33455928|NCT04567329|101557814|FG000|Overall Study|Discontinued|2|||
33455929|NCT04567329|101557815|FG001|Overall Study|Discontinued|2|||
33455930|NCT04567329|101557814|FG000|Overall Study|Lost to Follow-up|0|||
33455931|NCT04567329|101557815|FG001|Overall Study|Lost to Follow-up|1|||
33455932|NCT04567329|101557814|FG000|Overall Study|Lack of Efficacy|0|||
33455933|NCT04567329|101557815|FG001|Overall Study|Lack of Efficacy|1|||
33455934|NCT02614898|101557816|FG000|Overall Study|Participated until study termination|10|||
33455935|NCT02614898|101557817|FG001|Overall Study|Participated until study termination|26|||
33455936|NCT02614898|101557816|FG000|Overall Study|Lost to Follow-up|0|||
33455937|NCT02614898|101557817|FG001|Overall Study|Lost to Follow-up|2|||
33455938|NCT02614898|101557816|FG000|Overall Study|Physician Decision|1|||
33455939|NCT02614898|101557817|FG001|Overall Study|Physician Decision|8|||
33455940|NCT02614898|101557816|FG000|Overall Study|Study Terminated by Sponsor|3|||
33455941|NCT02614898|101557817|FG001|Overall Study|Study Terminated by Sponsor|0|||
33455942|NCT02614898|101557816|FG000|Overall Study|Withdrawal by Subject|0|||
33455943|NCT02614898|101557817|FG001|Overall Study|Withdrawal by Subject|2|||
33455944|NCT02614898|101557816|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
33455945|NCT02614898|101557817|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33455946|NCT02614898|101557816|FG000|Overall Study|Other-Additional Information Unavailable|0|||
33455947|NCT02614898|101557817|FG001|Overall Study|Other-Additional Information Unavailable|11|||
33455948|NCT02614898|101557816|FG000|Overall Study|Missing|0|||
33173223|NCT01059799|100541208|FG001|Overall Study|Withdrawal criteria|2|||
33173224|NCT01059799|100541207|FG000|Overall Study|Other|12|||
33173225|NCT01059799|100541208|FG001|Overall Study|Other|3|||
33173226|NCT03138889|100541211|FG000|Overall Study|Withdrawal by Subject|5|||
33455949|NCT02614898|101557817|FG001|Overall Study|Missing|1|||
33455950|NCT01155531|101557825|FG000|Overall Study|Adverse Event|0|||
33455951|NCT01155531|101557826|FG001|Overall Study|Adverse Event|0|||
33173227|NCT03138889|100541212|FG001|Overall Study|Withdrawal by Subject|5|||
33173228|NCT03138889|100541213|FG002|Overall Study|Withdrawal by Subject|0|||
33261775|NCT01998958|100860135|FG009|Open Label Phase (Optional)|Adverse Event|0|||
33455952|NCT01155531|101557827|FG002|Overall Study|Adverse Event|1|||
33261776|NCT01998958|100860136|FG010|Open Label Phase (Optional)|Adverse Event|0|||
33261777|NCT01998958|100860137|FG011|Open Label Phase (Optional)|Adverse Event|0|||
33261778|NCT01998958|100860138|FG012|Open Label Phase (Optional)|Adverse Event|0|||
33261779|NCT01998958|100860139|FG013|Open Label Phase (Optional)|Adverse Event|0|||
33261780|NCT01998958|100860140|FG014|Open Label Phase (Optional)|Adverse Event|0|||
33261781|NCT01998958|100860141|FG015|Open Label Phase (Optional)|Adverse Event|0|||
33261782|NCT01998958|100860142|FG016|Open Label Phase (Optional)|Adverse Event|0|||
33261783|NCT01998958|100860143|FG017|Open Label Phase (Optional)|Adverse Event|0|||
33261784|NCT01998958|100860144|FG018|Open Label Phase (Optional)|Adverse Event|0|||
33261785|NCT01998958|100860145|FG019|Open Label Phase (Optional)|Adverse Event|0|||
33173229|NCT03138889|100541214|FG003|Overall Study|Withdrawal by Subject|2|||
33173230|NCT03138889|100541215|FG004|Overall Study|Withdrawal by Subject|1|||
33173231|NCT03138889|100541216|FG005|Overall Study|Withdrawal by Subject|3|||
33173232|NCT03138889|100541217|FG006|Overall Study|Withdrawal by Subject|0|||
33173233|NCT03138889|100541218|FG007|Overall Study|Withdrawal by Subject|1|||
33173234|NCT01500629|100541219|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
33173235|NCT01500629|100541220|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
33173236|NCT00754624|100541225|FG000|Overall Study|Adverse Event|16|||
33173237|NCT00754624|100541225|FG000|Overall Study|Death|1|||
33173238|NCT00754624|100541225|FG000|Overall Study|Physician Decision|8|||
33173239|NCT00754624|100541225|FG000|Overall Study|Protocol Violation|1|||
33173240|NCT00754624|100541225|FG000|Overall Study|Withdrawal by Subject|28|||
33173241|NCT00754624|100541225|FG000|Overall Study|Various|12|||
33173242|NCT00754624|100541225|FG000|Overall Study|Lost to Follow-up|3|||
33173243|NCT02961751|100541226|FG000|Overall Study|Lost to Follow-up|11|||
33173244|NCT02961751|100541226|FG000|Overall Study|Physician Decision|2|||
33173245|NCT02961751|100541226|FG000|Overall Study|Not Eligible at Enrollment|1|||
33261786|NCT01998958|100860146|FG020|Open Label Phase (Optional)|Adverse Event|0|||
33261787|NCT01998958|100860147|FG021|Open Label Phase (Optional)|Adverse Event|0|||
33455953|NCT01155531|101557828|FG003|Overall Study|Adverse Event|0|||
33455954|NCT01155531|101557825|FG000|Overall Study|Lost to Follow-up|0|||
33455955|NCT01155531|101557826|FG001|Overall Study|Lost to Follow-up|0|||
33173246|NCT02961751|100541226|FG000|Overall Study|Protocol Violation|1|||
33173247|NCT00931762|100541227|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
33261788|NCT01998958|100860148|FG022|Open Label Phase (Optional)|Adverse Event|0|||
33455956|NCT01155531|101557827|FG002|Overall Study|Lost to Follow-up|0|||
33173248|NCT00931762|100541227|FG000|Overall Study|Administrative Problems|5|||
33173249|NCT00931762|100541227|FG000|Overall Study|Death|1|||
33173250|NCT00931762|100541227|FG000|Overall Study|Disease Progression|3|||
33173251|NCT00931762|100541227|FG000|Overall Study|Adverse Event (s)|11|||
33173252|NCT00931762|100541227|FG000|Overall Study|Subject withdrew consent|13|||
33173253|NCT00390858|100541228|FG000|Overall Study|Adverse Event|6|||
33173254|NCT00390858|100541229|FG001|Overall Study|Adverse Event|2|||
33173255|NCT00390858|100541228|FG000|Overall Study|Lack of Efficacy|0|||
33173256|NCT00390858|100541229|FG001|Overall Study|Lack of Efficacy|1|||
33173257|NCT00390858|100541228|FG000|Overall Study|Withdrawal by Subject|3|||
33173258|NCT00390858|100541229|FG001|Overall Study|Withdrawal by Subject|4|||
33173259|NCT00877383|100541230|FG000|Overall Study|Adverse Event|13|||
33173260|NCT00877383|100541231|FG001|Overall Study|Adverse Event|14|||
33173261|NCT00877383|100541230|FG000|Overall Study|Lost to Follow-up|5|||
33173262|NCT00877383|100541231|FG001|Overall Study|Lost to Follow-up|3|||
33173263|NCT00877383|100541230|FG000|Overall Study|Subject withdrew consent|3|||
33455957|NCT01155531|101557828|FG003|Overall Study|Lost to Follow-up|1|||
33455958|NCT01155531|101557825|FG000|Overall Study|Withdrawal by Subject|1|||
33173264|NCT00877383|100541231|FG001|Overall Study|Subject withdrew consent|12|||
33173265|NCT00877383|100541230|FG000|Overall Study|Subject no longer requires study drug|2|||
33173266|NCT00877383|100541231|FG001|Overall Study|Subject no longer requires study drug|0|||
33173267|NCT00877383|100541230|FG000|Overall Study|Administrative problems|2|||
33173268|NCT00877383|100541231|FG001|Overall Study|Administrative problems|0|||
33173269|NCT00877383|100541230|FG000|Overall Study|Protocol deviation|2|||
33173270|NCT00877383|100541231|FG001|Overall Study|Protocol deviation|6|||
33173271|NCT00877383|100541230|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33173272|NCT00877383|100541231|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33261789|NCT01998958|100860149|FG023|Open Label Phase (Optional)|Adverse Event|1|||
33455959|NCT01155531|101557826|FG001|Overall Study|Withdrawal by Subject|0|||
33455960|NCT01155531|101557827|FG002|Overall Study|Withdrawal by Subject|1|||
33455961|NCT01155531|101557828|FG003|Overall Study|Withdrawal by Subject|0|||
33455962|NCT03314857|101557832|FG000|Overall Study|Death|4|||
33455963|NCT03314857|101557832|FG000|Overall Study|Physician Decision|1|||
33455964|NCT01186458|101557833|FG000|Overall Study|Adverse Event|1|||
33455965|NCT03488108|101557852|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
33455966|NCT03488108|101557853|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
33455967|NCT03488108|101557852|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
33455968|NCT03488108|101557853|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
33455969|NCT02227238|101557854|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
33455970|NCT02227238|101557855|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
33455971|NCT02227238|101557856|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
33455972|NCT02227238|101557854|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
33455973|NCT02227238|101557855|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
33455974|NCT02227238|101557856|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
33455975|NCT02227238|101557854|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
33173273|NCT00877383|100541230|FG000|Overall Study|Death|1|||
33455976|NCT02227238|101557855|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
33173274|NCT00877383|100541231|FG001|Overall Study|Death|2|||
33173275|NCT02825992|100541235|FG000|Overall Study|Withdrawal by Subject|4|||
33455977|NCT02227238|101557856|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
33455978|NCT02227238|101557854|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
33173276|NCT02825992|100541235|FG000|Overall Study|Lost to Follow-up|2|||
33173277|NCT02825992|100541235|FG000|Overall Study|Procedure terminated|2|||
33455979|NCT02227238|101557855|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
33173278|NCT02196558|100541239|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
33455980|NCT02227238|101557856|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
33173279|NCT02196558|100541240|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
33173280|NCT02196558|100541241|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
33173281|NCT02196558|100541239|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
33173282|NCT02196558|100541240|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
33173283|NCT02196558|100541241|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
33173284|NCT02196558|100541239|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
33173285|NCT02196558|100541240|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
33173286|NCT02196558|100541241|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
33173287|NCT02196558|100541239|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
33261790|NCT01998958|100860150|FG024|Open Label Phase (Optional)|Adverse Event|0|||
33261791|NCT01998958|100860151|FG025|Open Label Phase (Optional)|Adverse Event|0|||
33261792|NCT01998958|100860152|FG026|Open Label Phase (Optional)|Adverse Event|0|||
33261793|NCT01998958|100860153|FG027|Open Label Phase (Optional)|Adverse Event|0|||
33261794|NCT01998958|100860154|FG028|Open Label Phase (Optional)|Adverse Event|0|||
33261795|NCT01998958|100860155|FG029|Open Label Phase (Optional)|Adverse Event|0|||
33261796|NCT01998958|100860156|FG030|Open Label Phase (Optional)|Adverse Event|0|||
33261797|NCT01998958|100860157|FG031|Open Label Phase (Optional)|Adverse Event|0|||
33261798|NCT01998958|100860126|FG000|Open Label Phase (Optional)|Other|0|||
33261799|NCT01998958|100860127|FG001|Open Label Phase (Optional)|Other|0|||
33261800|NCT01998958|100860128|FG002|Open Label Phase (Optional)|Other|0|||
33261801|NCT01998958|100860129|FG003|Open Label Phase (Optional)|Other|0|||
33261802|NCT01998958|100860130|FG004|Open Label Phase (Optional)|Other|0|||
33261803|NCT01998958|100860131|FG005|Open Label Phase (Optional)|Other|0|||
33261804|NCT01998958|100860132|FG006|Open Label Phase (Optional)|Other|0|||
33261805|NCT01998958|100860133|FG007|Open Label Phase (Optional)|Other|0|||
33261806|NCT01998958|100860134|FG008|Open Label Phase (Optional)|Other|0|||
33261807|NCT01998958|100860135|FG009|Open Label Phase (Optional)|Other|0|||
33261808|NCT01998958|100860136|FG010|Open Label Phase (Optional)|Other|0|||
33261809|NCT01998958|100860137|FG011|Open Label Phase (Optional)|Other|0|||
33261810|NCT01998958|100860138|FG012|Open Label Phase (Optional)|Other|0|||
33261811|NCT01998958|100860139|FG013|Open Label Phase (Optional)|Other|0|||
33261812|NCT01998958|100860140|FG014|Open Label Phase (Optional)|Other|0|||
33261813|NCT01998958|100860141|FG015|Open Label Phase (Optional)|Other|0|||
33261814|NCT01998958|100860142|FG016|Open Label Phase (Optional)|Other|0|||
33261815|NCT01998958|100860143|FG017|Open Label Phase (Optional)|Other|0|||
33261816|NCT01998958|100860144|FG018|Open Label Phase (Optional)|Other|0|||
33261817|NCT01998958|100860145|FG019|Open Label Phase (Optional)|Other|0|||
33261818|NCT01998958|100860146|FG020|Open Label Phase (Optional)|Other|0|||
33261819|NCT01998958|100860147|FG021|Open Label Phase (Optional)|Other|0|||
33261820|NCT01998958|100860148|FG022|Open Label Phase (Optional)|Other|5|||
33261821|NCT01998958|100860149|FG023|Open Label Phase (Optional)|Other|1|||
33261822|NCT01998958|100860150|FG024|Open Label Phase (Optional)|Other|0|||
33261823|NCT01998958|100860151|FG025|Open Label Phase (Optional)|Other|0|||
33261824|NCT01998958|100860152|FG026|Open Label Phase (Optional)|Other|0|||
33261825|NCT01998958|100860153|FG027|Open Label Phase (Optional)|Other|0|||
33261826|NCT01998958|100860154|FG028|Open Label Phase (Optional)|Other|0|||
33261827|NCT01998958|100860155|FG029|Open Label Phase (Optional)|Other|0|||
33261828|NCT01998958|100860156|FG030|Open Label Phase (Optional)|Other|0|||
33261829|NCT01998958|100860157|FG031|Open Label Phase (Optional)|Other|0|||
33261830|NCT01998958|100860126|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261831|NCT01998958|100860127|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261832|NCT01998958|100860128|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261833|NCT01998958|100860129|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261834|NCT01998958|100860130|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261835|NCT01998958|100860131|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261836|NCT01998958|100860132|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261837|NCT01998958|100860133|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
33455981|NCT02227238|101557854|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
33455982|NCT02227238|101557855|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
33173288|NCT02196558|100541240|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
33173289|NCT02196558|100541241|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
33261838|NCT01998958|100860134|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261839|NCT01998958|100860135|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261840|NCT01998958|100860136|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261841|NCT01998958|100860137|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261842|NCT01998958|100860138|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
33173290|NCT02196558|100541239|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
33261843|NCT01998958|100860139|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261844|NCT01998958|100860140|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261845|NCT01998958|100860141|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261846|NCT01998958|100860142|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261847|NCT01998958|100860143|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261848|NCT01998958|100860144|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261849|NCT01998958|100860145|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261850|NCT01998958|100860146|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261851|NCT01998958|100860147|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261852|NCT01998958|100860148|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
33261853|NCT01998958|100860149|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261854|NCT01998958|100860150|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261855|NCT01998958|100860151|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261856|NCT01998958|100860152|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261857|NCT01998958|100860153|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261858|NCT01998958|100860154|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261859|NCT01998958|100860155|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261860|NCT01998958|100860156|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261861|NCT01998958|100860157|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
33261862|NCT01998958|100860126|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261863|NCT01998958|100860127|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261864|NCT01998958|100860128|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261865|NCT01998958|100860129|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261866|NCT01998958|100860130|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261867|NCT01998958|100860131|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261868|NCT01998958|100860132|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261869|NCT01998958|100860133|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261870|NCT01998958|100860134|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261871|NCT01998958|100860135|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261872|NCT01998958|100860136|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261873|NCT01998958|100860137|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261874|NCT01998958|100860138|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261875|NCT01998958|100860139|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261876|NCT01998958|100860140|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261877|NCT01998958|100860141|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261878|NCT01998958|100860142|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
33455983|NCT02227238|101557856|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
33261879|NCT01998958|100860143|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261880|NCT01998958|100860144|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261881|NCT01998958|100860145|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
33455984|NCT02227238|101557854|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
33455985|NCT02227238|101557855|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
33455986|NCT02227238|101557856|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
33455987|NCT02227238|101557854|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
33455988|NCT02227238|101557855|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
33455989|NCT02227238|101557856|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
33455990|NCT02227238|101557854|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
33455991|NCT02227238|101557855|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
33455992|NCT02227238|101557856|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
33455993|NCT02227238|101557854|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
33261882|NCT01998958|100860146|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261883|NCT01998958|100860147|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
33261884|NCT01998958|100860148|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
33261885|NCT01998958|100860149|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
33455994|NCT02227238|101557855|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
33455995|NCT02227238|101557856|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
33455996|NCT02227238|101557854|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
33455997|NCT02227238|101557855|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
33455998|NCT02227238|101557856|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
33455999|NCT02227238|101557854|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
33456000|NCT02227238|101557855|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
33456001|NCT02227238|101557856|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
33456002|NCT02227238|101557854|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
33261886|NCT01998958|100860150|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261887|NCT01998958|100860151|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261888|NCT01998958|100860152|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261889|NCT01998958|100860153|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261890|NCT01998958|100860154|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261891|NCT01998958|100860155|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261892|NCT01998958|100860156|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261893|NCT01998958|100860157|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
33261894|NCT01998958|100860126|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261895|NCT01998958|100860127|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33456003|NCT02227238|101557855|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
33456004|NCT02227238|101557856|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
33456005|NCT02227238|101557854|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
33456006|NCT02227238|101557855|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
33456007|NCT02227238|101557856|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
33456008|NCT02227238|101557854|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
33456009|NCT02227238|101557855|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
33456010|NCT02227238|101557856|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
33456011|NCT00467597|101557868|FG000|Overall Study|Withdrawal by Subject|2|||
33173291|NCT02196558|100541240|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
33173292|NCT02196558|100541241|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
33456012|NCT00467597|101557869|FG001|Overall Study|Withdrawal by Subject|0|||
33456013|NCT02121184|101557870|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
33456014|NCT02121184|101557871|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
33456015|NCT02121184|101557870|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
33456016|NCT02121184|101557871|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
33456017|NCT02121184|101557870|FG000|Overall Study|Emergency cesarean section required|0|||
33456018|NCT02121184|101557871|FG001|Overall Study|Emergency cesarean section required|2|||
33456019|NCT02121184|101557870|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
33456020|NCT02121184|101557871|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
33456021|NCT00009945|101557872|FG000|Overall Study|no follow up data|7|||
33456022|NCT00009945|101557873|FG001|Overall Study|no follow up data|5|||
33456023|NCT02252016|101557876|FG000|Overall Study|Lost to Follow-up|2|||
33456024|NCT02252016|101557877|FG001|Overall Study|Lost to Follow-up|1|||
33456025|NCT02252016|101557876|FG000|Overall Study|Physician Decision|1|||
33456026|NCT02252016|101557877|FG001|Overall Study|Physician Decision|0|||
33456027|NCT02252016|101557876|FG000|Overall Study|Withdrawal by Subject|0|||
33456028|NCT02252016|101557877|FG001|Overall Study|Withdrawal by Subject|2|||
33456029|NCT01971554|101557878|FG000|Overall Study|Lost to Follow-up|1|||
33456030|NCT01971554|101557879|FG001|Overall Study|Lost to Follow-up|0|||
33456031|NCT01971554|101557880|FG002|Overall Study|Lost to Follow-up|0|||
33456032|NCT01971554|101557881|FG003|Overall Study|Lost to Follow-up|0|||
33456033|NCT03382041|101557884|FG000|Overall Study|Consent Form Lost|2|||
33456034|NCT03382041|101557885|FG001|Overall Study|Consent Form Lost|1|||
33456035|NCT03382041|101557884|FG000|Overall Study|Withdrawal by Subject|1|||
33456036|NCT03382041|101557885|FG001|Overall Study|Withdrawal by Subject|4|||
33456037|NCT03382041|101557884|FG000|Overall Study|Lost to Follow-up|1|||
33456038|NCT03382041|101557885|FG001|Overall Study|Lost to Follow-up|4|||
33456039|NCT03248128|101557888|FG000|Overall Study|Lost to Follow-up|1|||
33456040|NCT03248128|101557889|FG001|Overall Study|Lost to Follow-up|0|||
33456041|NCT03248128|101557888|FG000|Overall Study|Withdrawal by Subject|16|||
33456042|NCT03248128|101557889|FG001|Overall Study|Withdrawal by Subject|14|||
33456043|NCT03248128|101557888|FG000|Overall Study|Site Closed|4|||
33456044|NCT03248128|101557889|FG001|Overall Study|Site Closed|3|||
33456045|NCT03248128|101557888|FG000|Overall Study|Randomized, but did not receive treatment|1|||
33456046|NCT03248128|101557889|FG001|Overall Study|Randomized, but did not receive treatment|3|||
33456047|NCT01675596|101557890|FG000|Overall Study|Death|6|||
33456048|NCT01675596|101557890|FG000|Overall Study|Exit with other reason|1|||
33456049|NCT01675596|101557890|FG000|Overall Study|Missed Visit|1|||
33456050|NCT04060251|101557891|FG000|Overall Study|Study terminated due to low enrollment.|7|||
33456051|NCT04060251|101557892|FG001|Overall Study|Study terminated due to low enrollment.|5|||
33456052|NCT04060251|101557893|FG002|Overall Study|Study terminated due to low enrollment.|7|||
33456053|NCT04060251|101557891|FG000|Overall Study|Adverse Event|1|||
33456054|NCT04060251|101557892|FG001|Overall Study|Adverse Event|1|||
33456055|NCT04060251|101557893|FG002|Overall Study|Adverse Event|0|||
33456056|NCT00950300|101557896|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
33456057|NCT00950300|101557897|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
33456058|NCT00950300|101557896|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
33456059|NCT00950300|101557897|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
33456060|NCT00950300|101557896|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
33456061|NCT00950300|101557897|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
33456062|NCT00950300|101557896|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
33456063|NCT00950300|101557897|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
33261896|NCT01998958|100860128|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261897|NCT01998958|100860129|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261898|NCT01998958|100860130|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33456064|NCT00950300|101557896|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
33456065|NCT00950300|101557897|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
33456066|NCT00950300|101557896|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
33456067|NCT00950300|101557897|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
33261899|NCT01998958|100860131|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261900|NCT01998958|100860132|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261901|NCT01998958|100860133|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261902|NCT01998958|100860134|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261903|NCT01998958|100860135|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261904|NCT01998958|100860136|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261905|NCT01998958|100860137|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261906|NCT01998958|100860138|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261907|NCT01998958|100860139|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261908|NCT01998958|100860140|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261909|NCT01998958|100860141|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261910|NCT01998958|100860142|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261911|NCT01998958|100860143|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261912|NCT01998958|100860144|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261913|NCT01998958|100860145|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261914|NCT01998958|100860146|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261915|NCT01998958|100860147|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
33261916|NCT01998958|100860148|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
33261917|NCT01998958|100860149|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
33261918|NCT01998958|100860150|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261919|NCT01998958|100860151|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261920|NCT01998958|100860152|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261921|NCT01998958|100860153|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261922|NCT01998958|100860154|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261923|NCT01998958|100860155|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261924|NCT01998958|100860156|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261925|NCT01998958|100860157|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
33261926|NCT00402246|100860158|FG000|Overall Study|Death|62|||
33261927|NCT00402246|100860159|FG001|Overall Study|Death|58|||
33261928|NCT00402246|100860158|FG000|Overall Study|Lost to Follow-up|20|||
33261929|NCT00402246|100860159|FG001|Overall Study|Lost to Follow-up|28|||
33261930|NCT00402246|100860158|FG000|Overall Study|Withdrawal by Subject|72|||
33261931|NCT00402246|100860159|FG001|Overall Study|Withdrawal by Subject|87|||
33261932|NCT00402246|100860158|FG000|Overall Study|Physician Decision|24|||
33261933|NCT00402246|100860159|FG001|Overall Study|Physician Decision|26|||
33261934|NCT00402246|100860158|FG000|Overall Study|Protocol Violation|25|||
33261935|NCT00402246|100860159|FG001|Overall Study|Protocol Violation|24|||
33261936|NCT00402246|100860158|FG000|Overall Study|Missed Final Visit|1|||
33261937|NCT00402246|100860159|FG001|Overall Study|Missed Final Visit|2|||
33261938|NCT00402246|100860158|FG000|Overall Study|Insurance Issues|2|||
33261939|NCT00402246|100860159|FG001|Overall Study|Insurance Issues|1|||
33261940|NCT00402246|100860158|FG000|Overall Study|Heart Transplant|0|||
33261941|NCT00402246|100860159|FG001|Overall Study|Heart Transplant|1|||
33261942|NCT00402246|100860158|FG000|Overall Study|Patient's device explanted|6|||
33261943|NCT00402246|100860159|FG001|Overall Study|Patient's device explanted|2|||
33261944|NCT00402246|100860158|FG000|Overall Study|Center Closure|5|||
33261945|NCT00402246|100860159|FG001|Overall Study|Center Closure|3|||
33261946|NCT00402246|100860158|FG000|Overall Study|Deterioriating Condition|3|||
33261947|NCT00402246|100860159|FG001|Overall Study|Deterioriating Condition|2|||
33261948|NCT04425863|100860160|FG000|Overall Study|Death|0|||
33261949|NCT04425863|100860161|FG001|Overall Study|Death|0|||
33261950|NCT04425863|100860162|FG002|Overall Study|Death|1|||
33261951|NCT01083316|100860164|FG000|Overall Study|Adverse Event|2|||
33261952|NCT01083316|100860164|FG000|Overall Study|Withdrawal by Subject|1|||
33261953|NCT04579250|100860167|FG000|Overall Study|Withdrawal by Subject|1|||
33261954|NCT04579250|100860168|FG001|Overall Study|Withdrawal by Subject|1|||
33261955|NCT04579250|100860169|FG002|Overall Study|Withdrawal by Subject|0|||
33261956|NCT04579250|100860167|FG000|Overall Study|Lost to Follow-up|1|||
33261957|NCT04579250|100860168|FG001|Overall Study|Lost to Follow-up|1|||
33261958|NCT04579250|100860169|FG002|Overall Study|Lost to Follow-up|0|||
33261959|NCT04579250|100860167|FG000|Overall Study|Moved from area|0|||
33261960|NCT04579250|100860168|FG001|Overall Study|Moved from area|1|||
33261961|NCT04579250|100860169|FG002|Overall Study|Moved from area|2|||
33261962|NCT02285114|100860171|FG000|Overall Study|Investigator's Discretion|0|||
33261963|NCT02285114|100860172|FG001|Overall Study|Investigator's Discretion|2|||
33261964|NCT02285114|100860173|FG002|Overall Study|Investigator's Discretion|0|||
33261965|NCT02285114|100860171|FG000|Overall Study|Withdrew Consent|0|||
33261966|NCT02285114|100860172|FG001|Overall Study|Withdrew Consent|0|||
33261967|NCT02285114|100860173|FG002|Overall Study|Withdrew Consent|1|||
33261968|NCT02285114|100860171|FG000|Overall Study|Enrolled but not treated|1|||
33261969|NCT02285114|100860172|FG001|Overall Study|Enrolled but not treated|0|||
33261970|NCT02285114|100860173|FG002|Overall Study|Enrolled but not treated|0|||
33261971|NCT02285114|100860171|FG000|Overall Study|Still on study|21|||
33261972|NCT02285114|100860172|FG001|Overall Study|Still on study|5|||
33388829|NCT03892707|101309369|FG001|Overall Study|Withdrawal by Subject|1|||
33261973|NCT02285114|100860173|FG002|Overall Study|Still on study|2|||
33261974|NCT02409667|100860174|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
33261975|NCT02409667|100860175|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
33261976|NCT02409667|100860176|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
33261977|NCT02409667|100860177|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
33261978|NCT02409667|100860178|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
33261979|NCT02409667|100860174|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
33261980|NCT02409667|100860175|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
33261981|NCT02409667|100860176|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
33261982|NCT02409667|100860177|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
33261983|NCT02409667|100860178|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
33173293|NCT04294472|100541242|FG000|Overall Study|Adverse Event|0|||
33173294|NCT04294472|100541243|FG001|Overall Study|Adverse Event|1|||
33173295|NCT04294472|100541244|FG002|Overall Study|Adverse Event|1|||
33173296|NCT04294472|100541242|FG000|Overall Study|Randomized but not treated|0|||
33173297|NCT04294472|100541243|FG001|Overall Study|Randomized but not treated|1|||
33173298|NCT04294472|100541244|FG002|Overall Study|Randomized but not treated|1|||
33173299|NCT00137046|100541245|FG000|Overall Study|Death|2|||
33173300|NCT00137046|100541246|FG001|Overall Study|Death|1|||
33173301|NCT00137046|100541245|FG000|Overall Study|Adverse Event|16|||
33173302|NCT00137046|100541246|FG001|Overall Study|Adverse Event|5|||
33173303|NCT00137046|100541245|FG000|Overall Study|Laboratory Abnormality|2|||
33173304|NCT00137046|100541246|FG001|Overall Study|Laboratory Abnormality|0|||
33173305|NCT00137046|100541245|FG000|Overall Study|Lack of Efficacy|13|||
33173306|NCT00137046|100541246|FG001|Overall Study|Lack of Efficacy|1|||
33173307|NCT00137046|100541245|FG000|Overall Study|Lost to Follow-up|8|||
33173308|NCT00137046|100541246|FG001|Overall Study|Lost to Follow-up|24|||
33173309|NCT00137046|100541245|FG000|Overall Study|Other|23|||
33173310|NCT00137046|100541246|FG001|Overall Study|Other|19|||
33173311|NCT00137046|100541245|FG000|Overall Study|Withdrawal by Subject|33|||
33173312|NCT00137046|100541246|FG001|Overall Study|Withdrawal by Subject|42|||
33173313|NCT00137046|100541245|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
33173314|NCT00137046|100541246|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
33173315|NCT00137046|100541245|FG000|Overall Study|Withdrew prior to study treatment|1|||
33173316|NCT00137046|100541246|FG001|Overall Study|Withdrew prior to study treatment|1|||
33173317|NCT01896531|100541247|FG000|Overall Study|Death|57|||
33173318|NCT01896531|100541248|FG001|Overall Study|Death|59|||
33173319|NCT01896531|100541247|FG000|Overall Study|Lost to Follow-up|3|||
33173320|NCT01896531|100541248|FG001|Overall Study|Lost to Follow-up|0|||
33173321|NCT01896531|100541247|FG000|Overall Study|Non-compliance|0|||
33173322|NCT01896531|100541248|FG001|Overall Study|Non-compliance|1|||
33173323|NCT01896531|100541247|FG000|Overall Study|Study Ended by Sponsor|7|||
33173324|NCT01896531|100541248|FG001|Overall Study|Study Ended by Sponsor|20|||
33173325|NCT01896531|100541247|FG000|Overall Study|Withdrawal by Subject|3|||
33173326|NCT01896531|100541248|FG001|Overall Study|Withdrawal by Subject|2|||
33173327|NCT01896531|100541247|FG000|Overall Study|Death Prior to Treatment|1|||
33173328|NCT01896531|100541248|FG001|Overall Study|Death Prior to Treatment|0|||
33173329|NCT04840615|100541253|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
33173330|NCT04840615|100541254|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
33173331|NCT04840615|100541255|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
33173332|NCT00609492|100541257|FG000|Overall Study|Withdrawal by Subject|0|||
33173333|NCT00609492|100541258|FG001|Overall Study|Withdrawal by Subject|2|||
33173334|NCT00609492|100541259|FG002|Overall Study|Withdrawal by Subject|3|||
33173335|NCT00609492|100541257|FG000|Overall Study|Lost to Follow-up|1|||
33173336|NCT00609492|100541258|FG001|Overall Study|Lost to Follow-up|1|||
33173337|NCT00609492|100541259|FG002|Overall Study|Lost to Follow-up|4|||
33173338|NCT01829191|100541260|FG000|Overall Study|Relocation|0|||
33173339|NCT01829191|100541261|FG001|Overall Study|Relocation|1|||
33173340|NCT01829191|100541260|FG000|Overall Study|Lens discomfort|0|||
33173341|NCT01829191|100541261|FG001|Overall Study|Lens discomfort|3|||
33173342|NCT01829191|100541260|FG000|Overall Study|Lens handling difficulty|1|||
33173343|NCT01829191|100541261|FG001|Overall Study|Lens handling difficulty|4|||
33173344|NCT01829191|100541260|FG000|Overall Study|Protocol Violation|4|||
33456068|NCT00950300|101557896|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
33456069|NCT00950300|101557897|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
33456070|NCT00950300|101557896|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
33456071|NCT00950300|101557897|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
33456072|NCT00950300|101557896|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
33456073|NCT00950300|101557897|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
33456074|NCT00950300|101557896|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
33456075|NCT00950300|101557897|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
33456076|NCT00950300|101557896|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
33456077|NCT00950300|101557897|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
33456078|NCT00950300|101557896|FG000|TFFU Period|Death|4|||
33456079|NCT00950300|101557897|FG001|TFFU Period|Death|1|||
33456080|NCT00950300|101557896|FG000|TFFU Period|Refused Treatment|10|||
33456081|NCT00950300|101557897|FG001|TFFU Period|Refused Treatment|11|||
33456082|NCT00950300|101557896|FG000|TFFU Period|Failure to Return|16|||
33456083|NCT00950300|101557897|FG001|TFFU Period|Failure to Return|16|||
33173345|NCT01829191|100541261|FG001|Overall Study|Protocol Violation|1|||
33173346|NCT01829191|100541260|FG000|Overall Study|Withdrawal by Subject|2|||
33173347|NCT01829191|100541261|FG001|Overall Study|Withdrawal by Subject|3|||
33173348|NCT01829191|100541260|FG000|Overall Study|Lost to Follow-up|0|||
33173349|NCT01829191|100541261|FG001|Overall Study|Lost to Follow-up|1|||
33456084|NCT00950300|101557896|FG000|TFFU Period|Recurrence of Disease|63|||
33456085|NCT00950300|101557897|FG001|TFFU Period|Recurrence of Disease|72|||
33456086|NCT00950300|101557896|FG000|TFFU Period|Other|4|||
33456087|NCT00950300|101557897|FG001|TFFU Period|Other|3|||
33456088|NCT00950300|101557896|FG000|SFU Period|Death|44|||
33456089|NCT00950300|101557897|FG001|SFU Period|Death|42|||
33456090|NCT00950300|101557896|FG000|SFU Period|Lost to Follow-up|30|||
33456091|NCT00950300|101557897|FG001|SFU Period|Lost to Follow-up|28|||
33456092|NCT00950300|101557896|FG000|SFU Period|Withdrawal by Subject|4|||
33456093|NCT00950300|101557897|FG001|SFU Period|Withdrawal by Subject|8|||
33173350|NCT01829191|100541260|FG000|Overall Study|Subject was fit for ortho - k|0|||
33173351|NCT01829191|100541261|FG001|Overall Study|Subject was fit for ortho - k|1|||
33173352|NCT00865124|100541269|FG000|Overall Study|Physician Decision|2|||
33173353|NCT00865124|100541270|FG001|Overall Study|Physician Decision|1|||
33173354|NCT00865124|100541271|FG002|Overall Study|Physician Decision|0|||
33173355|NCT00865124|100541269|FG000|Overall Study|Withdrawn consent|2|||
33173356|NCT00865124|100541270|FG001|Overall Study|Withdrawn consent|0|||
33173357|NCT00865124|100541271|FG002|Overall Study|Withdrawn consent|0|||
33173358|NCT04080297|100541278|FG000|Overall Study|Adverse Event|1|||
33173359|NCT04080297|100541279|FG001|Overall Study|Adverse Event|3|||
33173360|NCT04080297|100541278|FG000|Overall Study|concurrent illness|1|||
33173361|NCT04080297|100541279|FG001|Overall Study|concurrent illness|0|||
33173362|NCT02598076|100541280|FG000|Overall Study|Lost to Follow-up|2|||
33173363|NCT02598076|100541281|FG001|Overall Study|Lost to Follow-up|3|||
33173364|NCT00617123|100541286|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
33261984|NCT02409667|100860174|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
33456094|NCT00902538|101557901|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
33173365|NCT00617123|100541287|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
33173366|NCT00617123|100541286|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
33173367|NCT00617123|100541287|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
33173368|NCT00617123|100541286|FG000|Referral Screening Period|Adverse Event|0|||
33173369|NCT00617123|100541287|FG001|Referral Screening Period|Adverse Event|1|||
33456095|NCT00902538|101557902|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
33456096|NCT00902538|101557903|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
33456097|NCT00902538|101557904|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
33456098|NCT00902538|101557905|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
33456099|NCT00902538|101557906|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
33456100|NCT00902538|101557901|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
33456101|NCT00902538|101557902|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
33456102|NCT00902538|101557903|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
33173370|NCT00617123|100541286|FG000|Study Treatment Period|Withdrawal by Subject|8|||
33173371|NCT00617123|100541287|FG001|Study Treatment Period|Withdrawal by Subject|12|||
33173372|NCT00617123|100541286|FG000|Study Treatment Period|Adverse Event|7|||
33173373|NCT00617123|100541287|FG001|Study Treatment Period|Adverse Event|3|||
33173374|NCT00617123|100541286|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
33173375|NCT00617123|100541287|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
33173376|NCT00617123|100541286|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
33173377|NCT00617123|100541287|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
33173378|NCT04533438|100541292|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
33173379|NCT04533438|100541293|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
33173380|NCT00742001|100541298|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
33173381|NCT00742001|100541299|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
33173382|NCT00742001|100541300|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
33173383|NCT01996982|100541301|FG000|Overall Study|PI/team left institution|7|||
33173384|NCT00856284|100541302|FG000|Overall Study|Hyperglycemic rescue|231|||
33173385|NCT00856284|100541303|FG001|Overall Study|Hyperglycemic rescue|201|||
33173386|NCT00856284|100541304|FG002|Overall Study|Hyperglycemic rescue|235|||
33173387|NCT00856284|100541302|FG000|Overall Study|Adverse Event|60|||
33173388|NCT00856284|100541303|FG001|Overall Study|Adverse Event|74|||
33173389|NCT00856284|100541304|FG002|Overall Study|Adverse Event|82|||
33173390|NCT00856284|100541302|FG000|Overall Study|Major protocol deviation|24|||
33173391|NCT00856284|100541303|FG001|Overall Study|Major protocol deviation|16|||
33173392|NCT00856284|100541304|FG002|Overall Study|Major protocol deviation|15|||
33173393|NCT00856284|100541302|FG000|Overall Study|Lost to Follow-up|20|||
33173394|NCT00856284|100541303|FG001|Overall Study|Lost to Follow-up|22|||
33173395|NCT00856284|100541304|FG002|Overall Study|Lost to Follow-up|28|||
33173396|NCT00856284|100541302|FG000|Overall Study|Voluntary withdrawal|48|||
33173397|NCT00856284|100541303|FG001|Overall Study|Voluntary withdrawal|52|||
33173398|NCT00856284|100541304|FG002|Overall Study|Voluntary withdrawal|62|||
33173399|NCT00856284|100541302|FG000|Overall Study|Pregnancy|1|||
33173400|NCT00856284|100541303|FG001|Overall Study|Pregnancy|2|||
33173401|NCT00856284|100541304|FG002|Overall Study|Pregnancy|0|||
33173402|NCT00856284|100541302|FG000|Overall Study|Investigator discretion|9|||
33173403|NCT00856284|100541303|FG001|Overall Study|Investigator discretion|8|||
33173404|NCT00856284|100541304|FG002|Overall Study|Investigator discretion|10|||
33173405|NCT00856284|100541302|FG000|Overall Study|Other|15|||
33173406|NCT00856284|100541303|FG001|Overall Study|Other|17|||
33173407|NCT00856284|100541304|FG002|Overall Study|Other|14|||
33173408|NCT00856284|100541302|FG000|Overall Study|Randomized in error|0|||
33173409|NCT00856284|100541303|FG001|Overall Study|Randomized in error|0|||
33173410|NCT00856284|100541304|FG002|Overall Study|Randomized in error|1|||
33173411|NCT03338855|100541305|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
33173412|NCT03338855|100541306|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
33173413|NCT01314443|100541307|FG000|Overall Study|Withdrawal by Subject|2|||
33173414|NCT01314443|100541308|FG001|Overall Study|Withdrawal by Subject|1|||
33173415|NCT01314443|100541309|FG002|Overall Study|Withdrawal by Subject|1|||
33173416|NCT01314443|100541310|FG003|Overall Study|Withdrawal by Subject|1|||
33173417|NCT01314443|100541307|FG000|Overall Study|Protocol Violation|2|||
33173418|NCT01314443|100541308|FG001|Overall Study|Protocol Violation|2|||
33173419|NCT01314443|100541309|FG002|Overall Study|Protocol Violation|1|||
33173420|NCT01314443|100541310|FG003|Overall Study|Protocol Violation|1|||
33173421|NCT00793403|100541311|FG000|Overall Study|Other|73|||
33173422|NCT02643082|100541312|FG000|Period 1|Adverse Event|1|||
33173423|NCT02643082|100541313|FG001|Period 1|Adverse Event|0|||
33173424|NCT01698801|100541314|FG000|Treatment Phase|Adverse Event|4|||
33173425|NCT01698801|100541314|FG000|Treatment Phase|Protocol Violation|1|||
33456103|NCT00902538|101557904|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
33456104|NCT00902538|101557905|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
33456105|NCT00902538|101557906|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
33173426|NCT01698801|100541314|FG000|Treatment Phase|Other|4|||
33173427|NCT01698801|100541314|FG000|Treatment Phase|Withdrawal by Subject|1|||
33173428|NCT01698801|100541314|FG000|Treatment Phase|Disease progression|1|||
33173429|NCT01698801|100541314|FG000|Follow Up Phase|Withdrawal by Subject|1|||
33173430|NCT01698801|100541314|FG000|Follow Up Phase|Death|4|||
33173431|NCT01943292|100541315|FG000|Overall Study|Withdrawal by Subject|1|||
33173432|NCT01943292|100541316|FG001|Overall Study|Withdrawal by Subject|0|||
33173433|NCT01943292|100541317|FG002|Overall Study|Withdrawal by Subject|0|||
33173434|NCT02064894|100541318|FG000|Overall Study|Withdrawal by Subject|43|||
33173435|NCT02064894|100541319|FG001|Overall Study|Withdrawal by Subject|102|||
33173436|NCT02064894|100541320|FG002|Overall Study|Withdrawal by Subject|115|||
33173437|NCT04285879|100541321|FG000|Overall Study|Lost to Follow-up|1|||
33173438|NCT04285879|100541322|FG001|Overall Study|Lost to Follow-up|8|||
33173439|NCT04285879|100541321|FG000|Overall Study|medical/surgical exclusion|16|||
33173440|NCT04285879|100541322|FG001|Overall Study|medical/surgical exclusion|0|||
33173441|NCT00592839|100541323|FG000|Overall Study|Withdrawal by Subject|1|||
33173442|NCT00592839|100541324|FG001|Overall Study|Withdrawal by Subject|1|||
33173443|NCT00592839|100541325|FG002|Overall Study|Withdrawal by Subject|3|||
33173444|NCT00592839|100541323|FG000|Overall Study|Protocol Violation|1|||
33173445|NCT00592839|100541324|FG001|Overall Study|Protocol Violation|1|||
33173446|NCT00592839|100541325|FG002|Overall Study|Protocol Violation|2|||
33173447|NCT00592839|100541323|FG000|Overall Study|Adverse Event|0|||
33173448|NCT00592839|100541324|FG001|Overall Study|Adverse Event|1|||
33173449|NCT00592839|100541325|FG002|Overall Study|Adverse Event|0|||
33173450|NCT00592839|100541323|FG000|Overall Study|Lost to Follow-up|0|||
33261985|NCT02409667|100860175|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
33261986|NCT02409667|100860176|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
33261987|NCT02409667|100860177|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
33261988|NCT02409667|100860178|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
33261989|NCT02409667|100860174|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
33261990|NCT02409667|100860175|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
33261991|NCT02409667|100860176|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
33261992|NCT02409667|100860177|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
33261993|NCT02409667|100860178|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
33261994|NCT02409667|100860174|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
33261995|NCT02409667|100860175|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
33261996|NCT02409667|100860176|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
33261997|NCT02409667|100860177|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
33261998|NCT02409667|100860178|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
33261999|NCT02409667|100860174|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
33262000|NCT02409667|100860175|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
33262001|NCT02409667|100860176|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
33262002|NCT02409667|100860177|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
33262003|NCT02409667|100860178|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
33262004|NCT02409667|100860174|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
33262005|NCT02409667|100860175|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
33262006|NCT02409667|100860176|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
33262007|NCT02409667|100860177|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
33262008|NCT02409667|100860178|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
33262009|NCT02409667|100860174|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
33262010|NCT02409667|100860175|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
33262011|NCT02409667|100860176|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
33388830|NCT03892707|101309368|FG000|Overall Study|Other (long business trip)|0|||
33456106|NCT00902538|101557901|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
33456107|NCT00902538|101557902|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
33173451|NCT00592839|100541324|FG001|Overall Study|Lost to Follow-up|1|||
33173452|NCT00592839|100541325|FG002|Overall Study|Lost to Follow-up|1|||
33173453|NCT00518986|100541326|FG000|Overall Study|Adverse Event|12|||
33173454|NCT00518986|100541327|FG001|Overall Study|Adverse Event|7|||
33173455|NCT00518986|100541326|FG000|Overall Study|Lack of Efficacy|0|||
33173456|NCT00518986|100541327|FG001|Overall Study|Lack of Efficacy|2|||
33173457|NCT00518986|100541326|FG000|Overall Study|Lost to Follow-up|3|||
33173458|NCT00518986|100541327|FG001|Overall Study|Lost to Follow-up|2|||
33173459|NCT00518986|100541326|FG000|Overall Study|Physician Decision|0|||
33173460|NCT00518986|100541327|FG001|Overall Study|Physician Decision|3|||
33173461|NCT00518986|100541326|FG000|Overall Study|Protocol Violation|5|||
33173462|NCT00518986|100541327|FG001|Overall Study|Protocol Violation|7|||
33173463|NCT00518986|100541326|FG000|Overall Study|Withdrawal by Subject|4|||
33173464|NCT00518986|100541327|FG001|Overall Study|Withdrawal by Subject|4|||
33173465|NCT00518986|100541326|FG000|Overall Study|Non-Specific|2|||
33173466|NCT00518986|100541327|FG001|Overall Study|Non-Specific|1|||
33173467|NCT00296374|100541329|FG000|Overall Study|Adverse Event|14|||
33173468|NCT00296374|100541330|FG001|Overall Study|Adverse Event|10|||
33173469|NCT00296374|100541331|FG002|Overall Study|Adverse Event|7|||
33173470|NCT00296374|100541329|FG000|Overall Study|Withdrawal by Subject|3|||
33173471|NCT00296374|100541330|FG001|Overall Study|Withdrawal by Subject|5|||
33173472|NCT00296374|100541331|FG002|Overall Study|Withdrawal by Subject|11|||
33173473|NCT00296374|100541329|FG000|Overall Study|Incorrect enrollment|3|||
33173474|NCT00296374|100541330|FG001|Overall Study|Incorrect enrollment|3|||
33173475|NCT00296374|100541331|FG002|Overall Study|Incorrect enrollment|4|||
33173476|NCT00296374|100541329|FG000|Overall Study|Protocol Violation|1|||
33173477|NCT00296374|100541330|FG001|Overall Study|Protocol Violation|2|||
33262012|NCT02409667|100860177|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
33262013|NCT02409667|100860178|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
33262014|NCT02409667|100860174|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
33262015|NCT02409667|100860175|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
33173478|NCT00296374|100541331|FG002|Overall Study|Protocol Violation|3|||
33173479|NCT00296374|100541329|FG000|Overall Study|Lost to Follow-up|3|||
33173480|NCT00296374|100541330|FG001|Overall Study|Lost to Follow-up|1|||
33173481|NCT00296374|100541331|FG002|Overall Study|Lost to Follow-up|1|||
33456108|NCT00902538|101557903|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
33173482|NCT00296374|100541329|FG000|Overall Study|Relocated to another state|1|||
33173483|NCT00296374|100541330|FG001|Overall Study|Relocated to another state|0|||
33173484|NCT00296374|100541331|FG002|Overall Study|Relocated to another state|0|||
33456109|NCT00902538|101557904|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
33456110|NCT00902538|101557905|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
33456111|NCT00902538|101557906|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
33456112|NCT00902538|101557901|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
33456113|NCT00902538|101557902|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
33456114|NCT00902538|101557903|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
33456115|NCT00902538|101557904|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
33456116|NCT00902538|101557905|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
33173485|NCT00296374|100541329|FG000|Overall Study|Stopped drug before end of study visit|0|||
33456117|NCT00902538|101557906|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
33456118|NCT00902538|101557901|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
33456119|NCT00902538|101557902|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
33456120|NCT00902538|101557903|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
33456121|NCT00902538|101557904|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
33456122|NCT00902538|101557905|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
33262016|NCT02409667|100860176|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
33262017|NCT02409667|100860177|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
33262018|NCT02409667|100860178|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
33262019|NCT02409667|100860174|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
33262020|NCT02409667|100860175|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
33262021|NCT02409667|100860176|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
33262022|NCT02409667|100860177|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
33262023|NCT02409667|100860178|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
33262024|NCT02409667|100860174|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
33262025|NCT02409667|100860175|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
33456123|NCT00902538|101557906|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
33456124|NCT00902538|101557901|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
33456125|NCT00902538|101557902|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
33456126|NCT00902538|101557903|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
33173486|NCT00296374|100541330|FG001|Overall Study|Stopped drug before end of study visit|1|||
33173487|NCT00296374|100541331|FG002|Overall Study|Stopped drug before end of study visit|0|||
33173488|NCT00296374|100541329|FG000|Overall Study|Nephrologist introduced ACE|0|||
33173489|NCT00296374|100541330|FG001|Overall Study|Nephrologist introduced ACE|1|||
33173490|NCT00296374|100541331|FG002|Overall Study|Nephrologist introduced ACE|0|||
33173491|NCT00296374|100541329|FG000|Overall Study|Pregnancy|0|||
33173492|NCT00296374|100541330|FG001|Overall Study|Pregnancy|0|||
33173493|NCT00296374|100541331|FG002|Overall Study|Pregnancy|2|||
33456127|NCT00902538|101557904|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
33456128|NCT00902538|101557905|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
33456129|NCT00902538|101557906|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
33456130|NCT00902538|101557901|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
33456131|NCT00902538|101557902|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
33456132|NCT00902538|101557903|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
33456133|NCT00902538|101557904|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
33456134|NCT00902538|101557905|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
33456135|NCT00902538|101557906|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
33456136|NCT00902538|101557901|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
33456137|NCT00902538|101557902|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
33456138|NCT00902538|101557903|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
33456139|NCT00902538|101557904|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
33456140|NCT00902538|101557905|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
33456141|NCT00902538|101557906|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
33456142|NCT00902538|101557901|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
33456143|NCT00902538|101557902|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
33456144|NCT00902538|101557903|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
33456145|NCT00902538|101557904|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
33456146|NCT00902538|101557905|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
33262026|NCT02409667|100860176|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
33262027|NCT02409667|100860177|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
33262028|NCT02409667|100860178|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
33262029|NCT02409667|100860174|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
33262030|NCT02409667|100860175|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
33262031|NCT02409667|100860176|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
33262032|NCT02409667|100860177|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
33262033|NCT02409667|100860178|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
33262034|NCT02409667|100860174|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
33262035|NCT02409667|100860175|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
33262036|NCT02409667|100860176|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
33262037|NCT02409667|100860177|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
33262038|NCT02409667|100860178|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
33262039|NCT02409667|100860174|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
33262040|NCT02409667|100860175|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
33262041|NCT02409667|100860176|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
33262042|NCT02409667|100860177|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
33262043|NCT02409667|100860178|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
33262044|NCT02409667|100860174|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
33262045|NCT02409667|100860175|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
33262046|NCT02409667|100860176|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
33262047|NCT02409667|100860177|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
33262048|NCT02409667|100860178|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
33262049|NCT02409667|100860174|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
33262050|NCT02409667|100860175|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
33262051|NCT02409667|100860176|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
33262052|NCT02409667|100860177|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
33262053|NCT02409667|100860178|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
33262054|NCT03333109|100860180|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
33456147|NCT00902538|101557906|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
33456148|NCT00902538|101557901|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
33456149|NCT00902538|101557902|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
33456150|NCT00902538|101557903|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
33456151|NCT00902538|101557904|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
33456152|NCT00902538|101557905|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
33456153|NCT00902538|101557906|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
33456154|NCT00902538|101557901|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
33262055|NCT03333109|100860181|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
33262056|NCT03333109|100860182|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
33262057|NCT03333109|100860180|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33262058|NCT03333109|100860181|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
33262059|NCT03333109|100860182|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
33262060|NCT03333109|100860180|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
33262061|NCT03333109|100860181|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
33262062|NCT03333109|100860182|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
33262063|NCT03333109|100860180|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
33262064|NCT03333109|100860181|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
33262065|NCT03333109|100860182|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
33262066|NCT03333109|100860180|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
33262067|NCT03333109|100860181|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
33262068|NCT03333109|100860182|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
33262069|NCT03333109|100860180|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
33262070|NCT03333109|100860181|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
33262071|NCT03333109|100860182|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
33262072|NCT03333109|100860180|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
33262073|NCT03333109|100860181|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
33262074|NCT03333109|100860182|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
33262075|NCT03333109|100860180|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
33262076|NCT03333109|100860181|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
33262077|NCT03333109|100860182|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
33262078|NCT02675244|100860193|FG000|Overall Study|Death|9|||
33262079|NCT02675244|100860194|FG001|Overall Study|Death|6|||
33262080|NCT02675244|100860193|FG000|Overall Study|Withdrawal by Subject|3|||
33262081|NCT02675244|100860194|FG001|Overall Study|Withdrawal by Subject|6|||
33262082|NCT02675244|100860193|FG000|Overall Study|Lost to Follow-up|1|||
33262083|NCT02675244|100860194|FG001|Overall Study|Lost to Follow-up|1|||
33262084|NCT02675244|100860193|FG000|Overall Study|Ongoing at 2 Years|190|||
33262085|NCT02675244|100860194|FG001|Overall Study|Ongoing at 2 Years|185|||
33262086|NCT01737021|100860195|FG000|Overall Study|Lost to Follow-up|5|||
33262087|NCT01737021|100860196|FG001|Overall Study|Lost to Follow-up|3|||
33262088|NCT02754596|100860200|FG000|Overall Study|Withdrawal by Subject|3|||
33262089|NCT02754596|100860201|FG001|Overall Study|Withdrawal by Subject|4|||
33262090|NCT02754596|100860202|FG002|Overall Study|Withdrawal by Subject|0|||
33262091|NCT02754596|100860200|FG000|Overall Study|Physician Decision|1|||
33262092|NCT02754596|100860201|FG001|Overall Study|Physician Decision|1|||
33262093|NCT02754596|100860202|FG002|Overall Study|Physician Decision|1|||
33262094|NCT02754596|100860200|FG000|Overall Study|Lost to Follow-up|1|||
33262095|NCT02754596|100860201|FG001|Overall Study|Lost to Follow-up|1|||
33262096|NCT02754596|100860202|FG002|Overall Study|Lost to Follow-up|2|||
33262097|NCT02754596|100860200|FG000|Overall Study|Death|0|||
33262098|NCT02754596|100860201|FG001|Overall Study|Death|2|||
33262099|NCT02754596|100860202|FG002|Overall Study|Death|0|||
33262100|NCT02754596|100860200|FG000|Overall Study|Adverse Event|1|||
33262101|NCT02754596|100860201|FG001|Overall Study|Adverse Event|0|||
33262102|NCT02754596|100860202|FG002|Overall Study|Adverse Event|1|||
33262103|NCT02754596|100860200|FG000|Overall Study|Other|1|||
33262104|NCT02754596|100860201|FG001|Overall Study|Other|0|||
33262105|NCT02754596|100860202|FG002|Overall Study|Other|0|||
33262106|NCT03257410|100860210|FG000|Overall Study|Adverse Event|2|||
33262107|NCT03257410|100860211|FG001|Overall Study|Adverse Event|3|||
33262108|NCT03257410|100860210|FG000|Overall Study|Protocol Violation|1|||
33262109|NCT03257410|100860211|FG001|Overall Study|Protocol Violation|2|||
33262110|NCT03257410|100860210|FG000|Overall Study|Lost to Follow-up|1|||
33262111|NCT03257410|100860211|FG001|Overall Study|Lost to Follow-up|0|||
33262112|NCT03257410|100860210|FG000|Overall Study|Withdrawal by Subject|1|||
33262113|NCT03257410|100860211|FG001|Overall Study|Withdrawal by Subject|2|||
33262114|NCT03257410|100860210|FG000|Overall Study|Physician Decision|1|||
33262115|NCT03257410|100860211|FG001|Overall Study|Physician Decision|1|||
33262116|NCT03257410|100860210|FG000|Overall Study|Renal transplantation|2|||
33262117|NCT03257410|100860211|FG001|Overall Study|Renal transplantation|0|||
33262118|NCT03257410|100860210|FG000|Overall Study|Switch to peritoneal dialysis|1|||
33262119|NCT03257410|100860211|FG001|Overall Study|Switch to peritoneal dialysis|0|||
33262120|NCT03257410|100860210|FG000|Overall Study|Death|3|||
33262121|NCT03257410|100860211|FG001|Overall Study|Death|2|||
33262122|NCT03257410|100860210|FG000|Overall Study|Change to another dialysis center|2|||
33262123|NCT03257410|100860211|FG001|Overall Study|Change to another dialysis center|2|||
33262124|NCT03257410|100860210|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
33262125|NCT03257410|100860211|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
33262126|NCT03257410|100860210|FG000|Overall Study|Miscellaneous|2|||
33262127|NCT03257410|100860211|FG001|Overall Study|Miscellaneous|2|||
33262128|NCT03257410|100860210|FG000|Overall Study|Other|0|||
33456155|NCT00902538|101557902|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
33262129|NCT03257410|100860211|FG001|Overall Study|Other|1|||
33262130|NCT02438137|100860218|FG000|Overall Study|Lost to Follow-up|3|||
33262131|NCT02438137|100860219|FG001|Overall Study|Lost to Follow-up|2|||
33262132|NCT02438137|100860218|FG000|Overall Study|Adverse Event|1|||
33262133|NCT02438137|100860219|FG001|Overall Study|Adverse Event|0|||
33262134|NCT02438137|100860218|FG000|Overall Study|Withdrawal by Subject|4|||
33262135|NCT02438137|100860219|FG001|Overall Study|Withdrawal by Subject|3|||
33262136|NCT02438137|100860218|FG000|Overall Study|Physician Decision|0|||
33262137|NCT02438137|100860219|FG001|Overall Study|Physician Decision|1|||
33262138|NCT02500758|100860220|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
33262139|NCT02500758|100860221|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
33262140|NCT02500758|100860220|FG000|Washout (1 Week)|Lost to Follow-up|2|||
33262141|NCT02500758|100860221|FG001|Washout (1 Week)|Lost to Follow-up|2|||
33262142|NCT02500758|100860220|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
33262143|NCT02500758|100860221|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
33262144|NCT02500758|100860220|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
33262145|NCT02500758|100860221|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
33262146|NCT02500758|100860220|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
33262147|NCT02500758|100860221|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
33262148|NCT01205048|100860226|FG000|Overall Study|Withdrawal by Subject|14|||
33262149|NCT01205048|100860226|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
33262150|NCT01205048|100860226|FG000|Overall Study|Lost to Follow-up|4|||
33262151|NCT01205048|100860226|FG000|Overall Study|Other|2|||
33262152|NCT01036724|100860240|FG000|Overall Study|Adverse Event|1|||
33262153|NCT01036724|100860241|FG001|Overall Study|Adverse Event|2|||
33262154|NCT01036724|100860240|FG000|Overall Study|Lack of Efficacy|1|||
33262155|NCT01036724|100860241|FG001|Overall Study|Lack of Efficacy|1|||
33262156|NCT01036724|100860240|FG000|Overall Study|Protocol Violation|4|||
33262157|NCT01036724|100860241|FG001|Overall Study|Protocol Violation|5|||
33262158|NCT00071799|100860242|FG000|Overall Study|Adverse Event|19|||
33262159|NCT00071799|100860243|FG001|Overall Study|Adverse Event|10|||
33262160|NCT00071799|100860242|FG000|Overall Study|Protocol Violation|1|||
33262161|NCT00071799|100860243|FG001|Overall Study|Protocol Violation|7|||
33262162|NCT00071799|100860242|FG000|Overall Study|Lost to Follow-up|1|||
33262163|NCT00071799|100860243|FG001|Overall Study|Lost to Follow-up|1|||
33262164|NCT00071799|100860242|FG000|Overall Study|Withdrawal by Subject|15|||
33262165|NCT00071799|100860243|FG001|Overall Study|Withdrawal by Subject|37|||
33262166|NCT00071799|100860242|FG000|Overall Study|Physician Decision|0|||
33262167|NCT00071799|100860243|FG001|Overall Study|Physician Decision|2|||
33262168|NCT00071799|100860242|FG000|Overall Study|Lack of Efficacy|11|||
33262169|NCT00071799|100860243|FG001|Overall Study|Lack of Efficacy|18|||
33262170|NCT00071799|100860242|FG000|Overall Study|Disease Progression|23|||
33262171|NCT00071799|100860243|FG001|Overall Study|Disease Progression|20|||
33262172|NCT00071799|100860242|FG000|Overall Study|Different Central+Local Pathology Review|0|||
33456156|NCT00902538|101557903|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
33456157|NCT00902538|101557904|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
33456158|NCT00902538|101557905|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
33456159|NCT00902538|101557906|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
33456160|NCT00902538|101557901|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
33456161|NCT00902538|101557902|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
33173494|NCT00296374|100541329|FG000|Overall Study|Other|0|||
33173495|NCT00296374|100541330|FG001|Overall Study|Other|0|||
33173496|NCT00296374|100541331|FG002|Overall Study|Other|1|||
33173497|NCT00010374|100541332|FG000|Overall Study|False positive phrenic nerve test|1|||
33173498|NCT00556712|100541333|FG000|Overall Study|Adverse Event|7|||
33173499|NCT00556712|100541334|FG001|Overall Study|Adverse Event|19|||
33456162|NCT00902538|101557903|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
33456163|NCT00902538|101557904|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
33456164|NCT00902538|101557905|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
33456165|NCT00902538|101557906|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
33456166|NCT00902538|101557901|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
33456167|NCT00902538|101557902|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
33456168|NCT00902538|101557903|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
33456169|NCT00902538|101557904|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
33456170|NCT00902538|101557905|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
33456171|NCT00902538|101557906|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
33456172|NCT00902538|101557901|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
33173500|NCT00556712|100541333|FG000|Overall Study|Death|5|||
33173501|NCT00556712|100541334|FG001|Overall Study|Death|10|||
33173502|NCT00556712|100541333|FG000|Overall Study|Progressive Disease|383|||
33262173|NCT00071799|100860243|FG001|Overall Study|Different Central+Local Pathology Review|1|||
33262174|NCT00071799|100860242|FG000|Overall Study|Not Documented|0|||
33262175|NCT00071799|100860243|FG001|Overall Study|Not Documented|2|||
33262176|NCT01532388|100860247|FG000|3-month Follow-up|Lost to Follow-up|68|||
33262177|NCT01532388|100860248|FG001|3-month Follow-up|Lost to Follow-up|68|||
33262178|NCT01532388|100860247|FG000|6-month Follow-up|Lost to Follow-up|74|||
33262179|NCT01532388|100860248|FG001|6-month Follow-up|Lost to Follow-up|66|||
33262180|NCT01532388|100860247|FG000|12-month Follow-up|Lost to Follow-up|69|||
33262181|NCT01532388|100860248|FG001|12-month Follow-up|Lost to Follow-up|67|||
33262182|NCT02638337|100860251|FG000|Overall Study|Adverse Event|6|||
33262183|NCT02638337|100860252|FG001|Overall Study|Adverse Event|10|||
33262184|NCT02638337|100860251|FG000|Overall Study|Protocol Violation|3|||
33262185|NCT02638337|100860252|FG001|Overall Study|Protocol Violation|0|||
33262186|NCT02638337|100860251|FG000|Overall Study|Withdrawal by Subject|13|||
33262187|NCT02638337|100860252|FG001|Overall Study|Withdrawal by Subject|16|||
33262188|NCT02638337|100860251|FG000|Overall Study|Lost to Follow-up|7|||
33262189|NCT02638337|100860252|FG001|Overall Study|Lost to Follow-up|7|||
33262190|NCT02638337|100860251|FG000|Overall Study|Other - Miscellaneous|4|||
33262191|NCT02638337|100860252|FG001|Overall Study|Other - Miscellaneous|3|||
33262192|NCT02978716|100860253|FG000|Overall Study|Death|25|||
33262193|NCT02978716|100860254|FG001|Overall Study|Death|13|||
33262194|NCT02978716|100860255|FG002|Overall Study|Death|20|||
33262195|NCT02978716|100860253|FG000|Overall Study|Lost to Follow-up|0|||
33262196|NCT02978716|100860254|FG001|Overall Study|Lost to Follow-up|0|||
33262197|NCT02978716|100860255|FG002|Overall Study|Lost to Follow-up|1|||
33262198|NCT02978716|100860253|FG000|Overall Study|Withdrawal by Subject|6|||
33262199|NCT02978716|100860254|FG001|Overall Study|Withdrawal by Subject|4|||
33262200|NCT02978716|100860255|FG002|Overall Study|Withdrawal by Subject|5|||
33262201|NCT02978716|100860253|FG000|Overall Study|Sponsor terminated|2|||
33262202|NCT02978716|100860254|FG001|Overall Study|Sponsor terminated|13|||
33262203|NCT02978716|100860255|FG002|Overall Study|Sponsor terminated|9|||
33262204|NCT02978716|100860253|FG000|Overall Study|Other|1|||
33262205|NCT02978716|100860254|FG001|Overall Study|Other|3|||
33456173|NCT00902538|101557902|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
33456174|NCT00902538|101557903|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
33456175|NCT00902538|101557904|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
33456176|NCT00902538|101557905|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
33456177|NCT00902538|101557906|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
33456178|NCT00902538|101557901|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
33456179|NCT00902538|101557902|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
33456180|NCT00902538|101557903|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
33456181|NCT00902538|101557904|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
33456182|NCT00902538|101557905|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
33456183|NCT00902538|101557906|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
33456184|NCT00902538|101557901|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
33456185|NCT00902538|101557902|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
33456186|NCT00902538|101557903|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
33456187|NCT00902538|101557904|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
33456188|NCT00902538|101557905|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
33456189|NCT00902538|101557906|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
33456190|NCT00902538|101557901|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
33456191|NCT00902538|101557902|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
33456192|NCT00902538|101557903|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
33456193|NCT00902538|101557904|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
33456194|NCT00902538|101557905|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
33456195|NCT00902538|101557906|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
33262206|NCT02978716|100860255|FG002|Overall Study|Other|0|||
33262207|NCT00604669|100860256|FG000|Overall Study|lack of information in chart|7|||
33262208|NCT01171976|100860257|FG000|Overall Study|Protocol Violation|0|||
33262209|NCT01171976|100860258|FG001|Overall Study|Protocol Violation|0|||
33262210|NCT01171976|100860259|FG002|Overall Study|Protocol Violation|1|||
33262211|NCT01171976|100860257|FG000|Overall Study|Death|2|||
33262212|NCT01171976|100860258|FG001|Overall Study|Death|4|||
33262213|NCT01171976|100860259|FG002|Overall Study|Death|1|||
33388831|NCT03892707|101309369|FG001|Overall Study|Other (long business trip)|1|||
33262214|NCT01171976|100860257|FG000|Overall Study|Lost to Follow-up|4|||
33456196|NCT01949532|101557907|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
33456197|NCT01949532|101557908|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
33456198|NCT03428750|101557910|FG000|Overall Study|Withdrawal by Subject|11|||
33456199|NCT03428750|101557911|FG001|Overall Study|Withdrawal by Subject|10|||
33456200|NCT03428750|101557910|FG000|Overall Study|Lost to Follow-up|3|||
33456201|NCT03428750|101557911|FG001|Overall Study|Lost to Follow-up|9|||
33456202|NCT03428750|101557910|FG000|Overall Study|Adverse Event|9|||
33262215|NCT01171976|100860258|FG001|Overall Study|Lost to Follow-up|0|||
33262216|NCT01171976|100860259|FG002|Overall Study|Lost to Follow-up|2|||
33262217|NCT01171976|100860257|FG000|Overall Study|Withdrawal by Subject|1|||
33262218|NCT01171976|100860258|FG001|Overall Study|Withdrawal by Subject|5|||
33262219|NCT01171976|100860259|FG002|Overall Study|Withdrawal by Subject|6|||
33262220|NCT01171976|100860257|FG000|Overall Study|Abnormal test result|1|||
33262221|NCT01171976|100860258|FG001|Overall Study|Abnormal test result|0|||
33262222|NCT01171976|100860259|FG002|Overall Study|Abnormal test result|0|||
33262223|NCT01171976|100860257|FG000|Overall Study|Adverse Event|6|||
33262224|NCT01171976|100860258|FG001|Overall Study|Adverse Event|2|||
33456203|NCT03428750|101557911|FG001|Overall Study|Adverse Event|1|||
33456204|NCT03428750|101557910|FG000|Overall Study|Protocol Violation|1|||
33456205|NCT03428750|101557911|FG001|Overall Study|Protocol Violation|0|||
33456206|NCT03428750|101557910|FG000|Overall Study|Administrative|0|||
33456207|NCT03428750|101557911|FG001|Overall Study|Administrative|1|||
33456208|NCT02611362|101557914|FG000|Overall Study|Withdrawal by Subject|7|||
33456209|NCT02611362|101557915|FG001|Overall Study|Withdrawal by Subject|2|||
33456210|NCT02611362|101557914|FG000|Overall Study|Lost to Follow-up|2|||
33456211|NCT02611362|101557915|FG001|Overall Study|Lost to Follow-up|4|||
33262225|NCT01171976|100860259|FG002|Overall Study|Adverse Event|5|||
33456212|NCT05562011|101557916|FG000|Overall Study|Withdrawal by Subject|3|||
33456213|NCT05562011|101557916|FG000|Overall Study|Lost to Follow-up|1|||
33456214|NCT05562011|101557916|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
33456215|NCT05562011|101557916|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
33456216|NCT05562011|101557916|FG000|Overall Study|Device malfunction|13|||
33456217|NCT01205035|101557917|FG000|Overall Study|Withdrawal by Subject|1|||
33456218|NCT01205035|101557918|FG001|Overall Study|Withdrawal by Subject|0|||
33456219|NCT01205035|101557917|FG000|Overall Study|Physician Decision|1|||
33456220|NCT01205035|101557918|FG001|Overall Study|Physician Decision|0|||
33456221|NCT01243151|101557919|FG000|Overall Study|Adverse Event|0|||
33456222|NCT01243151|101557920|FG001|Overall Study|Adverse Event|1|||
33456223|NCT01243151|101557921|FG002|Overall Study|Adverse Event|0|||
33456224|NCT01243151|101557922|FG003|Overall Study|Adverse Event|0|||
33456225|NCT01243151|101557923|FG004|Overall Study|Adverse Event|0|||
33456226|NCT01243151|101557919|FG000|Overall Study|Protocol Violation|0|||
33456227|NCT01243151|101557920|FG001|Overall Study|Protocol Violation|0|||
33456228|NCT01243151|101557921|FG002|Overall Study|Protocol Violation|1|||
33456229|NCT01243151|101557922|FG003|Overall Study|Protocol Violation|0|||
33262226|NCT04436289|100860266|FG000|Overall Study|Death prior to hospital discharge|8|||
33262227|NCT04436289|100860267|FG001|Overall Study|Death prior to hospital discharge|5|||
33262228|NCT04436289|100860268|FG002|Overall Study|Death prior to hospital discharge|0|||
33262229|NCT04436289|100860269|FG003|Overall Study|Death prior to hospital discharge|1|||
33173503|NCT00556712|100541334|FG001|Overall Study|Progressive Disease|320|||
33173504|NCT00556712|100541333|FG000|Overall Study|Protocol Violation|3|||
33173505|NCT00556712|100541334|FG001|Overall Study|Protocol Violation|2|||
33173506|NCT00556712|100541333|FG000|Overall Study|Refused Treatment|17|||
33173507|NCT00556712|100541334|FG001|Overall Study|Refused Treatment|16|||
33173508|NCT00556712|100541333|FG000|Overall Study|Failure to Return|2|||
33173509|NCT00556712|100541334|FG001|Overall Study|Failure to Return|3|||
33173510|NCT00556712|100541333|FG000|Overall Study|Other|2|||
33262230|NCT04436289|100860266|FG000|Overall Study|Withdrawal by Subject|0|||
33262231|NCT04436289|100860267|FG001|Overall Study|Withdrawal by Subject|1|||
33456230|NCT01243151|101557923|FG004|Overall Study|Protocol Violation|0|||
33456231|NCT01243151|101557919|FG000|Overall Study|Other|0|||
33456232|NCT01243151|101557920|FG001|Overall Study|Other|0|||
33456233|NCT01243151|101557921|FG002|Overall Study|Other|0|||
33456234|NCT01243151|101557922|FG003|Overall Study|Other|1|||
33173511|NCT00556712|100541334|FG001|Overall Study|Other|2|||
33173512|NCT00556712|100541333|FG000|Overall Study|Ongoing at Data Cutoff|32|||
33262232|NCT04436289|100860268|FG002|Overall Study|Withdrawal by Subject|4|||
33173513|NCT00556712|100541334|FG001|Overall Study|Ongoing at Data Cutoff|66|||
33173514|NCT01385202|100541335|FG000|Overall Study|Lost to Follow-up|6|||
33173515|NCT01385202|100541335|FG000|Overall Study|Not Eligible|11|||
33173516|NCT01385202|100541335|FG000|Overall Study|Withdrawn|1|||
33173517|NCT03227029|100541336|FG000|Overall Study|Child Wheezed (no treatment)|0|||
33173518|NCT03227029|100541337|FG001|Overall Study|Child Wheezed (no treatment)|1|||
33173519|NCT03227029|100541338|FG002|Overall Study|Child Wheezed (no treatment)|0|||
33173520|NCT03227029|100541336|FG000|Overall Study|No post RSV season visit due to COVID|3|||
33173521|NCT03227029|100541337|FG001|Overall Study|No post RSV season visit due to COVID|3|||
33173522|NCT03227029|100541338|FG002|Overall Study|No post RSV season visit due to COVID|2|||
33173523|NCT03227029|100541336|FG000|Overall Study|Not able to get to clinic|0|||
33173524|NCT03227029|100541337|FG001|Overall Study|Not able to get to clinic|0|||
33173525|NCT03227029|100541338|FG002|Overall Study|Not able to get to clinic|1|||
33173526|NCT03227029|100541336|FG000|Overall Study|Withdrawal by Subject|1|||
33173527|NCT03227029|100541337|FG001|Overall Study|Withdrawal by Subject|0|||
33173528|NCT03227029|100541338|FG002|Overall Study|Withdrawal by Subject|0|||
33173529|NCT03227029|100541336|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
33173530|NCT03227029|100541337|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
33262233|NCT04436289|100860269|FG003|Overall Study|Withdrawal by Subject|0|||
33262234|NCT04436289|100860266|FG000|Overall Study|Extended hospital stay|0|||
33262235|NCT04436289|100860267|FG001|Overall Study|Extended hospital stay|1|||
33262236|NCT04436289|100860268|FG002|Overall Study|Extended hospital stay|0|||
33262237|NCT04436289|100860269|FG003|Overall Study|Extended hospital stay|0|||
33262238|NCT04436289|100860266|FG000|Overall Study|Lost to Follow-up|0|||
33262239|NCT04436289|100860267|FG001|Overall Study|Lost to Follow-up|4|||
33262240|NCT04436289|100860268|FG002|Overall Study|Lost to Follow-up|1|||
33262241|NCT04436289|100860269|FG003|Overall Study|Lost to Follow-up|3|||
33262242|NCT01695954|100860281|FG000|Overall Study|Withdrawal by Subject|4|||
33262243|NCT01695954|100860282|FG001|Overall Study|Withdrawal by Subject|0|||
33262244|NCT01695954|100860281|FG000|Overall Study|Adverse Event|0|||
33262245|NCT01695954|100860282|FG001|Overall Study|Adverse Event|2|||
33262246|NCT01421667|100860283|FG000|Overall Study|Withdrawal by Subject|0|||
33456235|NCT01243151|101557923|FG004|Overall Study|Other|0|||
33173531|NCT03227029|100541338|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
33173532|NCT01948050|100541341|FG000|Overall Study|Withdrawal by Subject|0|||
33173533|NCT01948050|100541342|FG001|Overall Study|Withdrawal by Subject|1|||
33173534|NCT02485574|100541343|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
33173535|NCT00110149|100541346|FG000|Overall Study|Physician Decision|3|||
33173536|NCT01852110|100541347|FG000|Overall Study|Adverse Event|12|||
33173537|NCT01852110|100541348|FG001|Overall Study|Adverse Event|5|||
33173538|NCT01852110|100541349|FG002|Overall Study|Adverse Event|0|||
33173539|NCT01852110|100541350|FG003|Overall Study|Adverse Event|0|||
33173540|NCT01852110|100541351|FG004|Overall Study|Adverse Event|0|||
33173541|NCT01852110|100541352|FG005|Overall Study|Adverse Event|0|||
33173542|NCT01852110|100541347|FG000|Overall Study|Lost to Follow-up|1|||
33173543|NCT01852110|100541348|FG001|Overall Study|Lost to Follow-up|3|||
33456236|NCT01243151|101557919|FG000|Overall Study|Randomized but not treated|0|||
33456237|NCT01243151|101557920|FG001|Overall Study|Randomized but not treated|0|||
33173544|NCT01852110|100541349|FG002|Overall Study|Lost to Follow-up|0|||
33173545|NCT01852110|100541350|FG003|Overall Study|Lost to Follow-up|0|||
33173546|NCT01852110|100541351|FG004|Overall Study|Lost to Follow-up|0|||
33173547|NCT01852110|100541352|FG005|Overall Study|Lost to Follow-up|0|||
33173548|NCT01852110|100541347|FG000|Overall Study|Non-compliance with Study Drug|2|||
33173549|NCT01852110|100541348|FG001|Overall Study|Non-compliance with Study Drug|1|||
33173550|NCT01852110|100541349|FG002|Overall Study|Non-compliance with Study Drug|0|||
33173551|NCT01852110|100541350|FG003|Overall Study|Non-compliance with Study Drug|0|||
33173552|NCT01852110|100541351|FG004|Overall Study|Non-compliance with Study Drug|0|||
33173553|NCT01852110|100541352|FG005|Overall Study|Non-compliance with Study Drug|0|||
33173554|NCT01852110|100541347|FG000|Overall Study|Physician Decision|1|||
33173555|NCT01852110|100541348|FG001|Overall Study|Physician Decision|0|||
33173556|NCT01852110|100541349|FG002|Overall Study|Physician Decision|0|||
33173557|NCT01852110|100541350|FG003|Overall Study|Physician Decision|0|||
33262247|NCT01421667|100860284|FG001|Overall Study|Withdrawal by Subject|1|||
33456238|NCT01243151|101557921|FG002|Overall Study|Randomized but not treated|0|||
33456239|NCT01243151|101557922|FG003|Overall Study|Randomized but not treated|1|||
33262248|NCT01421667|100860285|FG002|Overall Study|Withdrawal by Subject|2|||
33262249|NCT01421667|100860286|FG003|Overall Study|Withdrawal by Subject|1|||
33262250|NCT01421667|100860283|FG000|Overall Study|Lost to Follow-up|0|||
33262251|NCT01421667|100860284|FG001|Overall Study|Lost to Follow-up|1|||
33262252|NCT01421667|100860285|FG002|Overall Study|Lost to Follow-up|0|||
33262253|NCT01421667|100860286|FG003|Overall Study|Lost to Follow-up|0|||
33173558|NCT01852110|100541351|FG004|Overall Study|Physician Decision|0|||
33173559|NCT01852110|100541352|FG005|Overall Study|Physician Decision|0|||
33173560|NCT01852110|100541347|FG000|Overall Study|Protocol Violation|0|||
33262254|NCT01250769|100860287|FG000|Overall Study|Withdrawal by Subject|0|||
33173561|NCT01852110|100541348|FG001|Overall Study|Protocol Violation|1|||
33173562|NCT01852110|100541349|FG002|Overall Study|Protocol Violation|0|||
33173563|NCT01852110|100541350|FG003|Overall Study|Protocol Violation|0|||
33173564|NCT01852110|100541351|FG004|Overall Study|Protocol Violation|0|||
33173565|NCT01852110|100541352|FG005|Overall Study|Protocol Violation|0|||
33173566|NCT01852110|100541347|FG000|Overall Study|Study Terminated by Sponsor|30|||
33173567|NCT01852110|100541348|FG001|Overall Study|Study Terminated by Sponsor|32|||
33173568|NCT01852110|100541349|FG002|Overall Study|Study Terminated by Sponsor|0|||
33173569|NCT01852110|100541350|FG003|Overall Study|Study Terminated by Sponsor|0|||
33173570|NCT01852110|100541351|FG004|Overall Study|Study Terminated by Sponsor|0|||
33173571|NCT01852110|100541352|FG005|Overall Study|Study Terminated by Sponsor|0|||
33173572|NCT01852110|100541347|FG000|Overall Study|Withdrawal by Subject|4|||
33173573|NCT01852110|100541348|FG001|Overall Study|Withdrawal by Subject|4|||
33173574|NCT01852110|100541349|FG002|Overall Study|Withdrawal by Subject|0|||
33173575|NCT01852110|100541350|FG003|Overall Study|Withdrawal by Subject|0|||
33173576|NCT01852110|100541351|FG004|Overall Study|Withdrawal by Subject|0|||
33173577|NCT01852110|100541352|FG005|Overall Study|Withdrawal by Subject|0|||
33173578|NCT01957553|100541353|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
33173579|NCT01957553|100541354|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
33173580|NCT01957553|100541353|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
33173581|NCT01957553|100541354|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
33173582|NCT01957553|100541353|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
33173583|NCT01957553|100541354|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
33173584|NCT01957553|100541353|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
33173585|NCT01957553|100541354|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
33173586|NCT01957553|100541353|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
33173587|NCT01957553|100541354|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
33173588|NCT01957553|100541353|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
33173589|NCT01957553|100541354|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
33173590|NCT01957553|100541353|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
33173591|NCT01957553|100541354|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
33173592|NCT01957553|100541353|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
33173593|NCT01957553|100541354|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
33173594|NCT01957553|100541353|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
33173595|NCT01957553|100541354|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
33173596|NCT01288469|100541359|FG000|Overall Study|Adverse Event|4|||
33173597|NCT01288469|100541360|FG001|Overall Study|Adverse Event|1|||
33173598|NCT01288469|100541361|FG002|Overall Study|Adverse Event|1|||
33173599|NCT01288469|100541359|FG000|Overall Study|Poor compliance to protocol|0|||
33173600|NCT01288469|100541360|FG001|Overall Study|Poor compliance to protocol|1|||
33173601|NCT01288469|100541361|FG002|Overall Study|Poor compliance to protocol|0|||
33173602|NCT01288469|100541359|FG000|Overall Study|Participant Moved|1|||
33173603|NCT01288469|100541360|FG001|Overall Study|Participant Moved|0|||
33173604|NCT01288469|100541361|FG002|Overall Study|Participant Moved|0|||
33173605|NCT01288469|100541359|FG000|Overall Study|Consent withdrawn by subject|1|||
33173606|NCT01288469|100541360|FG001|Overall Study|Consent withdrawn by subject|1|||
33456240|NCT01243151|101557923|FG004|Overall Study|Randomized but not treated|0|||
33456241|NCT04428645|101560671|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
33456242|NCT01944722|101560672|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
33456243|NCT01944722|101560672|FG000|Overall Study|Specimen Shipping Issues|34|||
33456244|NCT01944722|101560672|FG000|Overall Study|Improper Storage/Transport|5|||
33456245|NCT01944722|101560672|FG000|Overall Study|Insufficient Volume for Test|1|||
33456246|NCT01944722|101560672|FG000|Overall Study|Missing Specimens|3|||
33456247|NCT01944722|101560672|FG000|Overall Study|Specimens Mislabeled|2|||
33456248|NCT01944722|101560672|FG000|Overall Study|Withdrawal by Subject|8|||
33456249|NCT01944722|101560672|FG000|Overall Study|NILM Subjects <30 years old|8106|||
33456250|NCT01944722|101560672|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
33456251|NCT01944722|101560672|FG000|Overall Study|>ASCUS Cytology|1122|||
33456252|NCT01143337|101560675|FG000|Overall Study|Adverse Event|3|||
33456253|NCT01143337|101560676|FG001|Overall Study|Adverse Event|9|||
33456254|NCT01143337|101560677|FG002|Overall Study|Adverse Event|5|||
33456255|NCT01143337|101560675|FG000|Overall Study|Lack of Efficacy|6|||
33456256|NCT01143337|101560676|FG001|Overall Study|Lack of Efficacy|2|||
33456257|NCT01143337|101560677|FG002|Overall Study|Lack of Efficacy|1|||
33456258|NCT01143337|101560675|FG000|Overall Study|Protocol Violation|1|||
33456259|NCT01143337|101560676|FG001|Overall Study|Protocol Violation|0|||
33456260|NCT01143337|101560677|FG002|Overall Study|Protocol Violation|0|||
33456261|NCT01143337|101560675|FG000|Overall Study|Withdrawal by Subject|0|||
33456262|NCT01143337|101560676|FG001|Overall Study|Withdrawal by Subject|0|||
33456263|NCT01143337|101560677|FG002|Overall Study|Withdrawal by Subject|1|||
33456264|NCT01143337|101560675|FG000|Overall Study|Other reason|0|||
33456265|NCT01143337|101560676|FG001|Overall Study|Other reason|0|||
33456266|NCT01143337|101560677|FG002|Overall Study|Other reason|5|||
33456267|NCT03141151|101560678|FG000|Overall Study|Lost to Follow-up|3|||
33456268|NCT03141151|101560679|FG001|Overall Study|Lost to Follow-up|2|||
33456269|NCT03141151|101560678|FG000|Overall Study|Withdrawal by Subject|3|||
33456270|NCT03141151|101560679|FG001|Overall Study|Withdrawal by Subject|2|||
33456271|NCT00835796|101560680|FG000|First Intervention|Withdrawal by Subject|0|||
33456272|NCT00835796|101560681|FG001|First Intervention|Withdrawal by Subject|1|||
33456273|NCT05070754|101560682|FG000|Overall Study|Withdrawal by Subject|0|||
33456274|NCT05070754|101560683|FG001|Overall Study|Withdrawal by Subject|0|||
33456275|NCT05070754|101560684|FG002|Overall Study|Withdrawal by Subject|0|||
33456276|NCT05070754|101560685|FG003|Overall Study|Withdrawal by Subject|1|||
33456277|NCT05070754|101560682|FG000|Overall Study|Protocol Violation|0|||
33456278|NCT05070754|101560683|FG001|Overall Study|Protocol Violation|0|||
33456279|NCT05070754|101560684|FG002|Overall Study|Protocol Violation|0|||
33456280|NCT05070754|101560685|FG003|Overall Study|Protocol Violation|1|||
33456281|NCT04010227|101560687|FG000|Overall Study|Death|1|||
33456282|NCT04010227|101560688|FG001|Overall Study|Death|2|||
33456283|NCT04010227|101560687|FG000|Overall Study|Medical Reasons|4|||
33456284|NCT04010227|101560688|FG001|Overall Study|Medical Reasons|3|||
33456285|NCT04010227|101560687|FG000|Overall Study|Withdrawal by Subject|2|||
33456286|NCT04010227|101560688|FG001|Overall Study|Withdrawal by Subject|0|||
33456287|NCT04010227|101560687|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
33456288|NCT04010227|101560688|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
33456289|NCT02661022|101560689|FG000|Overall Study|Withdrawal by Subject|3|||
33456290|NCT02661022|101560690|FG001|Overall Study|Withdrawal by Subject|0|||
33456291|NCT02661022|101560689|FG000|Overall Study|Adverse Event|1|||
33456292|NCT02661022|101560690|FG001|Overall Study|Adverse Event|1|||
33456293|NCT02661022|101560689|FG000|Overall Study|Physician Decision|1|||
33456294|NCT02661022|101560690|FG001|Overall Study|Physician Decision|0|||
33456295|NCT02661022|101560689|FG000|Overall Study|Progressive Disease|2|||
33262255|NCT01250769|100860288|FG001|Overall Study|Withdrawal by Subject|1|||
33262256|NCT01250769|100860289|FG002|Overall Study|Withdrawal by Subject|1|||
33262257|NCT01250769|100860290|FG003|Overall Study|Withdrawal by Subject|0|||
33262258|NCT01250769|100860287|FG000|Overall Study|Adverse Event|0|||
33456296|NCT02661022|101560690|FG001|Overall Study|Progressive Disease|1|||
33456297|NCT01496118|101560691|FG000|Overall Study|Disease progression|3|||
33456298|NCT01496118|101560692|FG001|Overall Study|Disease progression|2|||
33456299|NCT01496118|101560693|FG002|Overall Study|Disease progression|3|||
33456300|NCT01496118|101560694|FG003|Overall Study|Disease progression|1|||
33456301|NCT01496118|101560695|FG004|Overall Study|Disease progression|2|||
33262259|NCT01250769|100860288|FG001|Overall Study|Adverse Event|0|||
33262260|NCT01250769|100860289|FG002|Overall Study|Adverse Event|1|||
33262261|NCT01250769|100860290|FG003|Overall Study|Adverse Event|0|||
33262262|NCT05512962|100860291|FG000|Overall Study|Withdrawal by Subject|1|||
33262263|NCT05512962|100860292|FG001|Overall Study|Withdrawal by Subject|0|||
33262264|NCT03102034|100860293|FG000|Overall Study|Withdrawal by Subject|1|||
33262265|NCT03102034|100860294|FG001|Overall Study|Withdrawal by Subject|0|||
33456302|NCT01496118|101560696|FG005|Overall Study|Disease progression|2|||
33456303|NCT01496118|101560697|FG006|Overall Study|Disease progression|14|||
33262266|NCT00468052|100860295|FG000|Overall Study|Protocol Violation|7|||
33262267|NCT00468052|100860296|FG001|Overall Study|Protocol Violation|8|||
33456304|NCT01496118|101560698|FG007|Overall Study|Disease progression|10|||
33173607|NCT01288469|100541361|FG002|Overall Study|Consent withdrawn by subject|1|||
33173608|NCT01288469|100541359|FG000|Overall Study|Exclusion criteria finally met|1|||
33173609|NCT01288469|100541360|FG001|Overall Study|Exclusion criteria finally met|0|||
33173610|NCT01288469|100541361|FG002|Overall Study|Exclusion criteria finally met|0|||
33173611|NCT00001596|100541362|FG000|Overall Study|Death|1|||
33173612|NCT00001596|100541363|FG001|Overall Study|Death|0|||
33173613|NCT00001596|100541362|FG000|Overall Study|Withdrawal by Subject|3|||
33173614|NCT00001596|100541363|FG001|Overall Study|Withdrawal by Subject|1|||
33173615|NCT00001596|100541362|FG000|Overall Study|Study Termination|12|||
33173616|NCT00001596|100541363|FG001|Overall Study|Study Termination|9|||
33173617|NCT00001596|100541362|FG000|Overall Study|Adverse Event|1|||
33173618|NCT00001596|100541363|FG001|Overall Study|Adverse Event|0|||
33173619|NCT01798004|100541364|FG000|Overall Study|Death|2|||
33173620|NCT01798004|100541364|FG000|Overall Study|Lack of Efficacy|8|||
33173621|NCT01798004|100541364|FG000|Overall Study|Physician Decision|25|||
33173622|NCT01798004|100541364|FG000|Overall Study|Withdrawal by Subject|4|||
33173623|NCT01798004|100541364|FG000|Overall Study|Ineligible|4|||
33173624|NCT01798004|100541364|FG000|Overall Study|Patient/parent refusal|7|||
33173625|NCT01798004|100541364|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
33173626|NCT01798004|100541364|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
33173627|NCT04557371|100545505|FG000|Overall Study|Covid-19-related|0|||
33173628|NCT04557371|100545506|FG001|Overall Study|Covid-19-related|1|||
33173629|NCT04557371|100545507|FG002|Overall Study|Covid-19-related|0|||
33173630|NCT04557371|100545505|FG000|Overall Study|Withdrawal by Subject|0|||
33173631|NCT04557371|100545506|FG001|Overall Study|Withdrawal by Subject|1|||
33173632|NCT04557371|100545507|FG002|Overall Study|Withdrawal by Subject|0|||
33173633|NCT04557371|100545505|FG000|Overall Study|Adverse Event|1|||
33173634|NCT04557371|100545506|FG001|Overall Study|Adverse Event|0|||
33173635|NCT04557371|100545507|FG002|Overall Study|Adverse Event|0|||
33173636|NCT03506815|100545508|FG000|Overall Study|Adverse Event|8|||
33173637|NCT03506815|100545509|FG001|Overall Study|Adverse Event|0|||
33456305|NCT01496118|101560691|FG000|Overall Study|Physician Decision|0|||
33456306|NCT01496118|101560692|FG001|Overall Study|Physician Decision|0|||
33456307|NCT01496118|101560693|FG002|Overall Study|Physician Decision|0|||
33456308|NCT01496118|101560694|FG003|Overall Study|Physician Decision|0|||
33456309|NCT01496118|101560695|FG004|Overall Study|Physician Decision|1|||
33456310|NCT01496118|101560696|FG005|Overall Study|Physician Decision|0|||
33456311|NCT01496118|101560697|FG006|Overall Study|Physician Decision|3|||
33456312|NCT01496118|101560698|FG007|Overall Study|Physician Decision|6|||
33456313|NCT01496118|101560691|FG000|Overall Study|Adverse Event|1|||
33456314|NCT01496118|101560692|FG001|Overall Study|Adverse Event|1|||
33456315|NCT01496118|101560693|FG002|Overall Study|Adverse Event|0|||
33456316|NCT01496118|101560694|FG003|Overall Study|Adverse Event|0|||
33456317|NCT01496118|101560695|FG004|Overall Study|Adverse Event|0|||
33456318|NCT01496118|101560696|FG005|Overall Study|Adverse Event|0|||
33456319|NCT01496118|101560697|FG006|Overall Study|Adverse Event|6|||
33456320|NCT01496118|101560698|FG007|Overall Study|Adverse Event|10|||
33456321|NCT01496118|101560691|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
33456322|NCT01496118|101560692|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
33456323|NCT01496118|101560693|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
33456324|NCT01496118|101560694|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
33456325|NCT01496118|101560695|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
33173638|NCT03506815|100545508|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
33456326|NCT01496118|101560696|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
33173639|NCT03506815|100545509|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
33173640|NCT03506815|100545508|FG000|Overall Study|Protocol Violation|1|||
33456327|NCT01496118|101560697|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
33456328|NCT01496118|101560698|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
33456329|NCT01496118|101560691|FG000|Overall Study|Death|0|||
33456330|NCT01496118|101560692|FG001|Overall Study|Death|0|||
33456331|NCT01496118|101560693|FG002|Overall Study|Death|0|||
33456332|NCT01496118|101560694|FG003|Overall Study|Death|0|||
33456333|NCT01496118|101560695|FG004|Overall Study|Death|0|||
33456334|NCT01496118|101560696|FG005|Overall Study|Death|0|||
33456335|NCT01496118|101560697|FG006|Overall Study|Death|1|||
33456336|NCT01496118|101560698|FG007|Overall Study|Death|1|||
33456337|NCT01496118|101560691|FG000|Overall Study|Withdrawal by Subject|0|||
33456338|NCT01496118|101560692|FG001|Overall Study|Withdrawal by Subject|0|||
33456339|NCT01496118|101560693|FG002|Overall Study|Withdrawal by Subject|0|||
33456340|NCT01496118|101560694|FG003|Overall Study|Withdrawal by Subject|2|||
33456341|NCT01496118|101560695|FG004|Overall Study|Withdrawal by Subject|0|||
33456342|NCT01496118|101560696|FG005|Overall Study|Withdrawal by Subject|1|||
33456343|NCT01496118|101560697|FG006|Overall Study|Withdrawal by Subject|6|||
33456344|NCT01496118|101560698|FG007|Overall Study|Withdrawal by Subject|3|||
33456345|NCT04408924|101560700|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
33456346|NCT04408924|101560700|FG000|Overall Study|Lost to Follow-up|3|||
33456347|NCT04408924|101560700|FG000|Overall Study|Withdrawal by Subject|5|||
33456348|NCT04408924|101560700|FG000|Overall Study|Sponsor Decision|2|||
33456349|NCT04878211|101560704|FG000|Overall Study|Lost to Follow-up|0|||
33456350|NCT04878211|101560705|FG001|Overall Study|Lost to Follow-up|0|||
33456351|NCT04878211|101560706|FG002|Overall Study|Lost to Follow-up|0|||
33456352|NCT04878211|101560707|FG003|Overall Study|Lost to Follow-up|1|||
33456353|NCT04878211|101560708|FG004|Overall Study|Lost to Follow-up|0|||
33456354|NCT04878211|101560709|FG005|Overall Study|Lost to Follow-up|1|||
33456355|NCT04878211|101560704|FG000|Overall Study|Protocol deviation|1|||
33456356|NCT04878211|101560705|FG001|Overall Study|Protocol deviation|0|||
33456357|NCT04878211|101560706|FG002|Overall Study|Protocol deviation|0|||
33456358|NCT04878211|101560707|FG003|Overall Study|Protocol deviation|0|||
33456359|NCT04878211|101560708|FG004|Overall Study|Protocol deviation|0|||
33456360|NCT04878211|101560709|FG005|Overall Study|Protocol deviation|0|||
33456361|NCT04878211|101560704|FG000|Overall Study|Study terminated by sponsor|0|||
33456362|NCT04878211|101560705|FG001|Overall Study|Study terminated by sponsor|0|||
33456363|NCT04878211|101560706|FG002|Overall Study|Study terminated by sponsor|0|||
33456364|NCT04878211|101560707|FG003|Overall Study|Study terminated by sponsor|0|||
33456365|NCT04878211|101560708|FG004|Overall Study|Study terminated by sponsor|9|||
33456366|NCT04878211|101560709|FG005|Overall Study|Study terminated by sponsor|4|||
33456367|NCT04878211|101560704|FG000|Overall Study|Subject decision|0|||
33456368|NCT04878211|101560705|FG001|Overall Study|Subject decision|0|||
33456369|NCT04878211|101560706|FG002|Overall Study|Subject decision|0|||
33456370|NCT04878211|101560707|FG003|Overall Study|Subject decision|0|||
33456371|NCT04878211|101560708|FG004|Overall Study|Subject decision|1|||
33456372|NCT04878211|101560709|FG005|Overall Study|Subject decision|0|||
33456373|NCT04535986|101560710|FG000|Overall Study|Death|4|||
33456374|NCT04535986|101560711|FG001|Overall Study|Death|5|||
33456375|NCT04535986|101560710|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
33456376|NCT04535986|101560711|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
33456377|NCT04535986|101560710|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
33456378|NCT04535986|101560711|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
33456379|NCT04535986|101560710|FG000|Overall Study|Adverse Event|10|||
33456380|NCT04535986|101560711|FG001|Overall Study|Adverse Event|1|||
33456381|NCT04535986|101560710|FG000|Overall Study|Lack of Efficacy|3|||
33456382|NCT04535986|101560711|FG001|Overall Study|Lack of Efficacy|2|||
33456383|NCT04535986|101560710|FG000|Overall Study|Investigator discretion|3|||
33456384|NCT04535986|101560711|FG001|Overall Study|Investigator discretion|0|||
33456385|NCT04535986|101560710|FG000|Overall Study|Withdrawal by Subject|32|||
33456386|NCT04535986|101560711|FG001|Overall Study|Withdrawal by Subject|14|||
33456387|NCT04535986|101560710|FG000|Overall Study|Lost to Follow-up|5|||
33456388|NCT04535986|101560711|FG001|Overall Study|Lost to Follow-up|3|||
33456389|NCT04535986|101560710|FG000|Overall Study|Other|7|||
33456390|NCT04535986|101560711|FG001|Overall Study|Other|3|||
33456391|NCT04203667|101560715|FG000|Overall Study|Withdrawal by Subject|1|||
33456392|NCT04203667|101560715|FG000|Overall Study|Lost to Follow-up|1|||
33456393|NCT04203667|101560715|FG000|Overall Study|Death|1|||
33456394|NCT04203667|101560715|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
33173641|NCT03506815|100545509|FG001|Overall Study|Protocol Violation|0|||
33173642|NCT03506815|100545508|FG000|Overall Study|Elective Surgery|1|||
33173643|NCT03506815|100545509|FG001|Overall Study|Elective Surgery|0|||
33173644|NCT00779467|100545512|FG000|Overall Study|Lack of Efficacy|11|||
33173645|NCT00779467|100545513|FG001|Overall Study|Lack of Efficacy|2|||
33173646|NCT00779467|100545514|FG002|Overall Study|Lack of Efficacy|6|||
33173647|NCT00779467|100545515|FG003|Overall Study|Lack of Efficacy|11|||
33173648|NCT00779467|100545512|FG000|Overall Study|failed inclusion criteria|3|||
33173649|NCT00779467|100545513|FG001|Overall Study|failed inclusion criteria|3|||
33173650|NCT00779467|100545514|FG002|Overall Study|failed inclusion criteria|1|||
33173651|NCT00779467|100545515|FG003|Overall Study|failed inclusion criteria|2|||
33173652|NCT00779467|100545512|FG000|Overall Study|missing data|1|||
33173653|NCT00779467|100545513|FG001|Overall Study|missing data|0|||
33173654|NCT00779467|100545514|FG002|Overall Study|missing data|1|||
33173655|NCT00779467|100545515|FG003|Overall Study|missing data|4|||
33173656|NCT00779467|100545512|FG000|Overall Study|technical issue|0|||
33456395|NCT00486434|101560722|FG000|Overall Study|Withdrawal by Subject|34|||
33456396|NCT00486434|101560723|FG001|Overall Study|Withdrawal by Subject|39|||
33456397|NCT00486434|101560722|FG000|Overall Study|Adverse Event|118|||
33456398|NCT00486434|101560723|FG001|Overall Study|Adverse Event|44|||
33456399|NCT00486434|101560722|FG000|Overall Study|Protocol Violation|22|||
33456400|NCT00486434|101560723|FG001|Overall Study|Protocol Violation|21|||
33456401|NCT00486434|101560722|FG000|Overall Study|Lack of Efficacy|12|||
33456402|NCT00486434|101560723|FG001|Overall Study|Lack of Efficacy|19|||
33456403|NCT00486434|101560722|FG000|Overall Study|Lost to Follow-up|2|||
33456404|NCT00486434|101560723|FG001|Overall Study|Lost to Follow-up|3|||
33456405|NCT00486434|101560722|FG000|Overall Study|Death|1|||
33456406|NCT00486434|101560723|FG001|Overall Study|Death|2|||
33456407|NCT00486434|101560722|FG000|Overall Study|Personal reasons|5|||
33456408|NCT00486434|101560723|FG001|Overall Study|Personal reasons|6|||
33456409|NCT00288704|101560724|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
33456410|NCT00288704|101560725|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
33456411|NCT00288704|101560726|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
33173657|NCT00779467|100545513|FG001|Overall Study|technical issue|0|||
33456412|NCT00288704|101560724|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
33456413|NCT00288704|101560725|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
33456414|NCT00288704|101560726|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
33173658|NCT00779467|100545514|FG002|Overall Study|technical issue|2|||
33173659|NCT00779467|100545515|FG003|Overall Study|technical issue|1|||
33456415|NCT00288704|101560724|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
33173660|NCT00779467|100545512|FG000|Overall Study|unavailable research staff|0|||
33173661|NCT00779467|100545513|FG001|Overall Study|unavailable research staff|0|||
33173662|NCT00779467|100545514|FG002|Overall Study|unavailable research staff|0|||
33173663|NCT00779467|100545515|FG003|Overall Study|unavailable research staff|1|||
33173664|NCT00459108|100545521|FG000|Overall Study|Withdrawal by Subject|5|||
33173665|NCT00459108|100545521|FG000|Overall Study|Adverse Event|3|||
33173666|NCT00459108|100545521|FG000|Overall Study|Death|2|||
33173667|NCT00459108|100545521|FG000|Overall Study|Progression|1|||
33173668|NCT01601626|100545525|FG000|Overall Study|Death|1|||
33173669|NCT01601626|100545526|FG001|Overall Study|Death|1|||
33173670|NCT01601626|100545527|FG002|Overall Study|Death|1|||
33173671|NCT01601626|100545525|FG000|Overall Study|Lost to Follow-up|1|||
33173672|NCT01601626|100545526|FG001|Overall Study|Lost to Follow-up|2|||
33173673|NCT01601626|100545527|FG002|Overall Study|Lost to Follow-up|0|||
33173674|NCT01601626|100545525|FG000|Overall Study|Unable to Get to Clinic|0|||
33173675|NCT01601626|100545526|FG001|Overall Study|Unable to Get to Clinic|1|||
33173676|NCT01601626|100545527|FG002|Overall Study|Unable to Get to Clinic|0|||
33173677|NCT01601626|100545525|FG000|Overall Study|Withdrawal by Subject|0|||
33173678|NCT01601626|100545526|FG001|Overall Study|Withdrawal by Subject|1|||
33173679|NCT01601626|100545527|FG002|Overall Study|Withdrawal by Subject|1|||
33173680|NCT01601626|100545525|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
33173681|NCT01601626|100545526|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
33388832|NCT04685538|101309376|FG000|Overall Study|Adverse Event|0|||
33173682|NCT01601626|100545527|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
33262268|NCT03912831|100860297|FG000|Overall Study|Death|1|||
33262269|NCT03912831|100860298|FG001|Overall Study|Death|1|||
33262270|NCT03912831|100860299|FG002|Overall Study|Death|1|||
33262271|NCT03912831|100860300|FG003|Overall Study|Death|1|||
33262272|NCT03912831|100860301|FG004|Overall Study|Death|1|||
33173683|NCT00418314|100545530|FG000|Overall Study|Withdrawal by Subject|1|||
33173684|NCT00418314|100545531|FG001|Overall Study|Withdrawal by Subject|2|||
33173685|NCT04044716|100545534|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
33173686|NCT04044716|100545535|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
33173687|NCT04044716|100545536|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
33173688|NCT04044716|100545534|FG000|Overall Study|Lost to Follow-up|2|||
33173689|NCT04044716|100545535|FG001|Overall Study|Lost to Follow-up|3|||
33173690|NCT04044716|100545536|FG002|Overall Study|Lost to Follow-up|0|||
33173691|NCT03187262|100545537|FG000|Induction|Lack of Efficacy|2|||
33173692|NCT03187262|100545537|FG000|Induction|Progressive Disease|4|||
33173693|NCT03187262|100545537|FG000|Consolidation|Progressive Disease|5|||
33173694|NCT02282020|100545542|FG000|Overall Study|Objective Disease Progression|128|||
33262273|NCT03912831|100860302|FG005|Overall Study|Death|1|||
33262274|NCT03912831|100860297|FG000|Overall Study|Reason not Specified|0|||
33456416|NCT00288704|101560725|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
33456417|NCT00288704|101560726|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
33456418|NCT00288704|101560724|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
33456419|NCT00288704|101560725|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
33456420|NCT00288704|101560726|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
33456421|NCT00288704|101560724|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
33456422|NCT00288704|101560725|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
33456423|NCT00288704|101560726|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
33456424|NCT00288704|101560724|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
33456425|NCT00288704|101560725|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
33456426|NCT00288704|101560726|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
33456427|NCT00288704|101560724|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
33456428|NCT00288704|101560725|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
33456429|NCT00288704|101560726|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
33456430|NCT03888235|101560727|FG000|Overall Study|Lost to Follow-up|1|||
33456431|NCT03888235|101560728|FG001|Overall Study|Lost to Follow-up|1|||
33456432|NCT03888235|101560729|FG002|Overall Study|Lost to Follow-up|0|||
33456433|NCT01015287|101560736|FG000|Overall Study|Death|21|||
33456434|NCT01015287|101560737|FG001|Overall Study|Death|16|||
33456435|NCT01015287|101560736|FG000|Overall Study|Adverse Event|1|||
33456436|NCT01015287|101560737|FG001|Overall Study|Adverse Event|0|||
33456437|NCT01015287|101560736|FG000|Overall Study|Sponsor Decision|3|||
33456438|NCT01015287|101560737|FG001|Overall Study|Sponsor Decision|7|||
33456439|NCT01015287|101560736|FG000|Overall Study|Physician Decision|19|||
33456440|NCT01015287|101560737|FG001|Overall Study|Physician Decision|21|||
33456441|NCT01015287|101560736|FG000|Overall Study|Withdrawal by Subject|14|||
33456442|NCT01015287|101560737|FG001|Overall Study|Withdrawal by Subject|19|||
33456443|NCT01015287|101560736|FG000|Overall Study|Entry Criteria not Met|11|||
33456444|NCT01015287|101560737|FG001|Overall Study|Entry Criteria not Met|14|||
33456445|NCT01015287|101560736|FG000|Overall Study|Lost to Follow-up|2|||
33456446|NCT01015287|101560737|FG001|Overall Study|Lost to Follow-up|1|||
33456447|NCT01015287|101560736|FG000|Overall Study|Protocol Violation|1|||
33456448|NCT01015287|101560737|FG001|Overall Study|Protocol Violation|1|||
33456449|NCT03234907|101560738|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
33456450|NCT03234907|101560739|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
33456451|NCT03234907|101560740|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
33456452|NCT03234907|101560741|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
33456453|NCT03234907|101560742|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
33456454|NCT03234907|101560743|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
33456455|NCT03234907|101560738|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
33456456|NCT03234907|101560739|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
33456457|NCT03234907|101560740|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
33456458|NCT03234907|101560741|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
33456459|NCT03234907|101560742|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
33456460|NCT03234907|101560743|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
33456461|NCT03234907|101560738|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
33456462|NCT03234907|101560739|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
33456463|NCT03234907|101560740|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
33456464|NCT03234907|101560741|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
33456465|NCT03234907|101560742|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
33456466|NCT03234907|101560743|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
33456467|NCT03234907|101560738|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
33456468|NCT03234907|101560739|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
33456469|NCT03234907|101560740|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
33456470|NCT03234907|101560741|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
33456471|NCT03234907|101560742|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
33456472|NCT03234907|101560743|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
33456473|NCT03234907|101560738|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
33456474|NCT03234907|101560739|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
33456475|NCT03234907|101560740|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
33456476|NCT03234907|101560741|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
33456477|NCT03234907|101560742|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
33456478|NCT03234907|101560743|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
33456479|NCT03234907|101560738|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
33456480|NCT03234907|101560739|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
33456481|NCT03234907|101560740|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
33456482|NCT03234907|101560741|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
33456483|NCT03234907|101560742|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
33456484|NCT03234907|101560743|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
33456485|NCT03234907|101560738|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
33456486|NCT03234907|101560739|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
33388833|NCT04685538|101309377|FG001|Overall Study|Adverse Event|1|||
33388834|NCT04685538|101309376|FG000|Overall Study|Lost to Follow-up|0|||
33388835|NCT04685538|101309377|FG001|Overall Study|Lost to Follow-up|2|||
33456487|NCT03234907|101560740|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
33456488|NCT03234907|101560741|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
33456489|NCT03234907|101560742|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
33456490|NCT03234907|101560743|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
33456491|NCT04768114|101560744|FG000|Overall Study|Lost to Follow-up|5|||
33456492|NCT04768114|101560745|FG001|Overall Study|Lost to Follow-up|10|||
33456493|NCT04768114|101560744|FG000|Overall Study|Withdrawal by Subject|0|||
33456494|NCT04768114|101560745|FG001|Overall Study|Withdrawal by Subject|1|||
33456495|NCT00697827|101560748|FG000|Overall Study|enrolled but not treated|2|||
33456496|NCT00697827|101560749|FG001|Overall Study|enrolled but not treated|1|||
33456497|NCT00385736|101560750|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
33456498|NCT00385736|101560751|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
33456499|NCT00385736|101560752|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
33456500|NCT00385736|101560750|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
33456501|NCT00385736|101560751|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
33456502|NCT00385736|101560752|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
33456503|NCT00385736|101560750|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
33456504|NCT00385736|101560751|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
33456505|NCT00385736|101560752|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
33456506|NCT00385736|101560750|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
33456507|NCT00385736|101560751|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
33456508|NCT00385736|101560752|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
33456509|NCT00385736|101560750|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
33456510|NCT00385736|101560751|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
33456511|NCT00385736|101560752|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
33456512|NCT00385736|101560750|FG000|Efficacy Analysis Set - Induction|Other|0|||
33456513|NCT00385736|101560751|FG001|Efficacy Analysis Set - Induction|Other|0|||
33456514|NCT00385736|101560752|FG002|Efficacy Analysis Set - Induction|Other|1|||
33456515|NCT00385736|101560750|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
33456516|NCT00385736|101560751|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
33456517|NCT00385736|101560752|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
33456518|NCT00385736|101560750|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
33456519|NCT00385736|101560751|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
33456520|NCT00385736|101560752|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
33456521|NCT00385736|101560750|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
33456522|NCT00385736|101560751|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
33456523|NCT00385736|101560752|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
33456524|NCT00385736|101560750|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
33456525|NCT00385736|101560751|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
33456526|NCT00385736|101560752|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
33456527|NCT00385736|101560750|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
33456528|NCT00385736|101560751|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
33456529|NCT00385736|101560752|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
33456530|NCT00385736|101560750|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
33456531|NCT00385736|101560751|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
33456532|NCT00385736|101560752|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
33456533|NCT00385736|101560750|FG000|Safety Analysis Set|Adverse Event|23|||
33456534|NCT00385736|101560751|FG001|Safety Analysis Set|Adverse Event|15|||
33456535|NCT00385736|101560752|FG002|Safety Analysis Set|Adverse Event|23|||
33456536|NCT00385736|101560750|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
33456537|NCT00385736|101560751|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
33456538|NCT00385736|101560752|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
33456539|NCT00385736|101560750|FG000|Safety Analysis Set|Lost to Follow-up|0|||
33456540|NCT00385736|101560751|FG001|Safety Analysis Set|Lost to Follow-up|2|||
33456541|NCT00385736|101560752|FG002|Safety Analysis Set|Lost to Follow-up|2|||
33456542|NCT00385736|101560750|FG000|Safety Analysis Set|Lack of Efficacy|38|||
33456543|NCT00385736|101560751|FG001|Safety Analysis Set|Lack of Efficacy|16|||
33456544|NCT00385736|101560752|FG002|Safety Analysis Set|Lack of Efficacy|31|||
33456545|NCT00385736|101560750|FG000|Safety Analysis Set|Protocol Violation|2|||
33456546|NCT00385736|101560751|FG001|Safety Analysis Set|Protocol Violation|1|||
33456547|NCT00385736|101560752|FG002|Safety Analysis Set|Protocol Violation|6|||
33456548|NCT00385736|101560750|FG000|Safety Analysis Set|Other|1|||
33456549|NCT00385736|101560751|FG001|Safety Analysis Set|Other|4|||
33456550|NCT00385736|101560752|FG002|Safety Analysis Set|Other|4|||
33456551|NCT02483416|101560755|FG000|Overall Study|Other reason|0|||
33456552|NCT02483416|101560756|FG001|Overall Study|Other reason|1|||
33456553|NCT02483416|101560755|FG000|Overall Study|Treatment stop|3|||
33456554|NCT02483416|101560756|FG001|Overall Study|Treatment stop|0|||
33456555|NCT01492439|101560758|FG000|Overall Study|Withdrew from RTE|4|||
33456556|NCT01492439|101560759|FG001|Overall Study|Withdrew from RTE|9|||
33456557|NCT05665387|101560760|FG000|Overall Study|Withdrawal by Subject|1|||
33456558|NCT05665387|101560761|FG001|Overall Study|Withdrawal by Subject|0|||
33173695|NCT02282020|100545543|FG001|Overall Study|Objective Disease Progression|30|||
33173696|NCT02282020|100545542|FG000|Overall Study|Adverse Event|18|||
33173697|NCT02282020|100545543|FG001|Overall Study|Adverse Event|15|||
33173698|NCT02282020|100545542|FG000|Overall Study|Withdrawal by Subject|7|||
33173699|NCT02282020|100545543|FG001|Overall Study|Withdrawal by Subject|10|||
33173700|NCT02282020|100545542|FG000|Overall Study|Miscellaneous|5|||
33173701|NCT02282020|100545543|FG001|Overall Study|Miscellaneous|19|||
33173702|NCT02282020|100545542|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
33173703|NCT02282020|100545543|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
33173704|NCT02282020|100545542|FG000|Overall Study|Developed Discontinuation Criteria|0|||
33173705|NCT02282020|100545543|FG001|Overall Study|Developed Discontinuation Criteria|2|||
33173706|NCT02282020|100545542|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
33173707|NCT02282020|100545543|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
33456559|NCT05665387|101560762|FG002|Overall Study|Withdrawal by Subject|1|||
33456560|NCT05278858|101560763|FG000|Overall Study|Withdrawal by Subject|1|||
33456561|NCT03504085|101560764|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
33456562|NCT03504085|101560765|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
33456563|NCT03504085|101560764|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
33456564|NCT03504085|101560765|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
33456565|NCT02705716|101560767|FG000|Overall Study|Adverse Event|0|||
33456566|NCT02705716|101560768|FG001|Overall Study|Adverse Event|1|||
33456567|NCT02705716|101560767|FG000|Overall Study|Protocol Violation|3|||
33456568|NCT02705716|101560768|FG001|Overall Study|Protocol Violation|0|||
33456569|NCT02705716|101560767|FG000|Overall Study|Withdrawal of Consent|1|||
33456570|NCT02705716|101560768|FG001|Overall Study|Withdrawal of Consent|1|||
33456571|NCT01050764|101560769|FG000|Overall Study|Death, before HSCT|1|||
33456572|NCT01050764|101560769|FG000|Overall Study|Donor mobilization failure, death|1|||
33456573|NCT01050764|101560769|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
33456574|NCT03439085|101560770|FG000|Overall Study|Death|2|||
33456575|NCT03439085|101560770|FG000|Overall Study|Screen Failure|20|||
33456576|NCT01169038|101560774|FG000|Overall Study|Death|1|||
33456577|NCT01169038|101560774|FG000|Overall Study|Adverse Event|5|||
33456578|NCT01169038|101560774|FG000|Overall Study|Required antibiotic administration|1|||
33456579|NCT00414726|101560777|FG000|Overall Study|Withdrawal by Subject|0|||
33456580|NCT00414726|101560778|FG001|Overall Study|Withdrawal by Subject|1|||
33456581|NCT02005276|101560779|FG000|Overall Study|No longer interested|5|||
33456582|NCT02005276|101560780|FG001|Overall Study|No longer interested|2|||
33456583|NCT02005276|101560781|FG002|Overall Study|No longer interested|3|||
33456584|NCT02005276|101560782|FG003|Overall Study|No longer interested|3|||
33456585|NCT02694536|101560785|FG000|Overall Study|Progressive Disease|40|||
33456586|NCT02694536|101560785|FG000|Overall Study|Lost to Follow-up|1|||
33456587|NCT02694536|101560785|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
33456588|NCT02694536|101560785|FG000|Overall Study|Withdrawal by Subject|8|||
33456589|NCT02694536|101560785|FG000|Overall Study|Death|8|||
33456590|NCT02694536|101560785|FG000|Overall Study|Other|22|||
33456591|NCT02003391|101560787|FG000|Overall Study|Withdrawal by Subject|2|||
33173708|NCT03958955|100545563|FG000|Overall Study|Adverse Event|1|||
33456592|NCT02003391|101560788|FG001|Overall Study|Withdrawal by Subject|1|||
33456593|NCT02003391|101560787|FG000|Overall Study|Protocol Violation|0|||
33173709|NCT02763189|100545570|FG000|Overall Study|Device failure|0|||
33456594|NCT02003391|101560788|FG001|Overall Study|Protocol Violation|1|||
33456595|NCT02003391|101560787|FG000|Overall Study|Adverse Event|1|||
33456596|NCT02003391|101560788|FG001|Overall Study|Adverse Event|0|||
33456597|NCT00420095|101560789|FG000|Overall Study|Adverse Event|1|||
33456598|NCT00420095|101560790|FG001|Overall Study|Adverse Event|0|||
33173710|NCT02763189|100545571|FG001|Overall Study|Device failure|2|||
33173711|NCT03055260|100545576|FG000|Overall Study|Withdrawal by Subject|1|||
33173712|NCT03055260|100545577|FG001|Overall Study|Withdrawal by Subject|0|||
33173713|NCT04059094|100545582|FG000|Overall Study|Adverse Event|0|||
33173714|NCT04059094|100545583|FG001|Overall Study|Adverse Event|0|||
33173715|NCT04059094|100545584|FG002|Overall Study|Adverse Event|0|||
33173716|NCT04059094|100545585|FG003|Overall Study|Adverse Event|0|||
33173717|NCT04059094|100545586|FG004|Overall Study|Adverse Event|1|||
33173718|NCT04059094|100545582|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
33173719|NCT04059094|100545583|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
33173720|NCT04059094|100545584|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
33173721|NCT04059094|100545585|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
33173722|NCT04059094|100545586|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
33173723|NCT01438957|100545587|FG000|Overall Study|Physician Decision|1|||
33173724|NCT01438957|100545588|FG001|Overall Study|Physician Decision|1|||
33173725|NCT01438957|100545589|FG002|Overall Study|Physician Decision|0|||
33173726|NCT01438957|100545590|FG003|Overall Study|Physician Decision|1|||
33173727|NCT01438957|100545591|FG004|Overall Study|Physician Decision|0|||
33173728|NCT00748033|100545592|FG000|Overall Study|Adverse Event|0|||
33173729|NCT00748033|100545593|FG001|Overall Study|Adverse Event|1|||
33173730|NCT00386776|100545595|FG000|Overall Study|Withdrawal by Subject|8|||
33173731|NCT03068130|100545596|FG000|Overall Study|Adverse Event|19|||
33173732|NCT03068130|100545596|FG000|Overall Study|Death|14|||
33173733|NCT03068130|100545596|FG000|Overall Study|Lost to Follow-up|4|||
33173734|NCT03068130|100545596|FG000|Overall Study|Withdrawal by Subject|26|||
33173735|NCT03068130|100545596|FG000|Overall Study|Administrative Reasons|3|||
33173736|NCT03068130|100545596|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
33173737|NCT03068130|100545596|FG000|Overall Study|Study terminated by sponsor|194|||
33173738|NCT01750242|100545599|FG000|Overall Study|Unreadable Images|3|||
33173739|NCT02744391|100545607|FG000|Overall Study|Lost to Follow-up|9|||
33173740|NCT02744391|100545607|FG000|Overall Study|Physician Decision|2|||
33173741|NCT02744391|100545607|FG000|Overall Study|Withdrawal by Subject|3|||
33173742|NCT01170091|100545608|FG000|Overall Study|Missing efficacy evaluation|3|||
33173743|NCT01170091|100545608|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
33173744|NCT00975481|100545609|FG000|Second Intervention Period|Adverse Event|2|||
33173745|NCT00975481|100545610|FG001|Second Intervention Period|Adverse Event|1|||
33173746|NCT00975481|100545611|FG002|Second Intervention Period|Adverse Event|0|||
33173747|NCT00975481|100545612|FG003|Second Intervention Period|Adverse Event|0|||
33173748|NCT00975481|100545613|FG004|Second Intervention Period|Adverse Event|0|||
33173749|NCT00975481|100545614|FG005|Second Intervention Period|Adverse Event|0|||
33173750|NCT00975481|100545609|FG000|Second Intervention Period|Withdrawal by Subject|0|||
33173751|NCT00975481|100545610|FG001|Second Intervention Period|Withdrawal by Subject|0|||
33173752|NCT00975481|100545611|FG002|Second Intervention Period|Withdrawal by Subject|1|||
33173753|NCT00975481|100545612|FG003|Second Intervention Period|Withdrawal by Subject|0|||
33173754|NCT00975481|100545613|FG004|Second Intervention Period|Withdrawal by Subject|0|||
33456599|NCT00420095|101560789|FG000|Overall Study|Protocol Violation|1|||
33456600|NCT00420095|101560790|FG001|Overall Study|Protocol Violation|1|||
33456601|NCT00420095|101560789|FG000|Overall Study|Lost to Follow-up|1|||
33456602|NCT00420095|101560790|FG001|Overall Study|Lost to Follow-up|0|||
33456603|NCT01055834|101560791|FG000|Treatment Period I|Adverse Event|1|||
33456604|NCT01055834|101560792|FG001|Treatment Period I|Adverse Event|0|||
33456605|NCT00688844|101560793|FG000|Overall Study|Lost to Follow-up|10|||
33456606|NCT04476277|101560796|FG000|Overall Study|Withdrawal by Subject|0|||
33456607|NCT04476277|101560797|FG001|Overall Study|Withdrawal by Subject|0|||
33456608|NCT04476277|101560798|FG002|Overall Study|Withdrawal by Subject|1|||
33456609|NCT04476277|101560799|FG003|Overall Study|Withdrawal by Subject|0|||
33456610|NCT01483820|101560802|FG000|Overall Study|Lack of Efficacy|6|||
33456611|NCT01483820|101560802|FG000|Overall Study|Adverse Event|1|||
33456612|NCT01483820|101560802|FG000|Overall Study|Death|1|||
33456613|NCT02369458|101560803|FG000|Overall Study|Determined to be not eligible|1|||
33456614|NCT02369458|101560804|FG001|Overall Study|Determined to be not eligible|0|||
33456615|NCT00198133|101560807|FG000|Overall Study|Disease progression|2|||
33456616|NCT00198133|101560808|FG001|Overall Study|Disease progression|5|||
33456617|NCT00198133|101560807|FG000|Overall Study|Adverse Event|1|||
33173755|NCT00975481|100545614|FG005|Second Intervention Period|Withdrawal by Subject|0|||
33173756|NCT00975481|100545609|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
33173757|NCT00975481|100545610|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
33173758|NCT00975481|100545611|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
33173759|NCT00975481|100545612|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
33173760|NCT00975481|100545613|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
33173761|NCT00975481|100545614|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
33456618|NCT00198133|101560808|FG001|Overall Study|Adverse Event|3|||
33456619|NCT00198133|101560807|FG000|Overall Study|Withdrawal by Subject|1|||
33456620|NCT00198133|101560808|FG001|Overall Study|Withdrawal by Subject|0|||
33456621|NCT00198133|101560807|FG000|Overall Study|Physician Decision|1|||
33456622|NCT00198133|101560808|FG001|Overall Study|Physician Decision|0|||
33456623|NCT01828112|101560809|FG000|Overall Study|Adverse Event|6|||
33456624|NCT01828112|101560810|FG001|Overall Study|Adverse Event|8|||
33456625|NCT01828112|101560809|FG000|Overall Study|Death|9|||
33456626|NCT01828112|101560810|FG001|Overall Study|Death|5|||
33456627|NCT01828112|101560809|FG000|Overall Study|Physician Decision|5|||
33456628|NCT01828112|101560810|FG001|Overall Study|Physician Decision|5|||
33456629|NCT01828112|101560809|FG000|Overall Study|Progressive disease|56|||
33456630|NCT01828112|101560810|FG001|Overall Study|Progressive disease|82|||
33456631|NCT01828112|101560809|FG000|Overall Study|Subject/guardian decision|6|||
33456632|NCT01828112|101560810|FG001|Overall Study|Subject/guardian decision|8|||
33456633|NCT00919711|101560813|FG000|Overall Study|Withdrawal by Subject|15|||
33456634|NCT00919711|101560814|FG001|Overall Study|Withdrawal by Subject|7|||
33456635|NCT00919711|101560813|FG000|Overall Study|Adverse Event|13|||
33456636|NCT00919711|101560814|FG001|Overall Study|Adverse Event|3|||
33456637|NCT00919711|101560813|FG000|Overall Study|Other|1|||
33456638|NCT00919711|101560814|FG001|Overall Study|Other|2|||
33456639|NCT00919711|101560813|FG000|Overall Study|Administrative Decision|0|||
33456640|NCT00919711|101560814|FG001|Overall Study|Administrative Decision|1|||
33456641|NCT00919711|101560813|FG000|Overall Study|Lost to Follow-up|2|||
33456642|NCT00919711|101560814|FG001|Overall Study|Lost to Follow-up|0|||
33456643|NCT00919711|101560813|FG000|Overall Study|Death|1|||
33456644|NCT00919711|101560814|FG001|Overall Study|Death|0|||
33456645|NCT00919711|101560813|FG000|Overall Study|Noncompliance|1|||
33456646|NCT00919711|101560814|FG001|Overall Study|Noncompliance|0|||
33456647|NCT04892147|101560815|FG000|Overall Study|Withdrawal by Subject|2|||
33456648|NCT04892147|101560816|FG001|Overall Study|Withdrawal by Subject|0|||
33456649|NCT01525628|101560827|FG000|Overall Study|Adverse Event|1|||
33456650|NCT01525628|101560828|FG001|Overall Study|Adverse Event|1|||
33456651|NCT01525628|101560829|FG002|Overall Study|Adverse Event|2|||
33456652|NCT01525628|101560830|FG003|Overall Study|Adverse Event|0|||
33456653|NCT01525628|101560831|FG004|Overall Study|Adverse Event|1|||
33456654|NCT01525628|101560827|FG000|Overall Study|Lack of Efficacy|0|||
33456655|NCT01525628|101560828|FG001|Overall Study|Lack of Efficacy|2|||
33456656|NCT01525628|101560829|FG002|Overall Study|Lack of Efficacy|2|||
33456657|NCT01525628|101560830|FG003|Overall Study|Lack of Efficacy|1|||
33456658|NCT01525628|101560831|FG004|Overall Study|Lack of Efficacy|2|||
33456659|NCT01525628|101560827|FG000|Overall Study|Protocol Violation|0|||
33456660|NCT01525628|101560828|FG001|Overall Study|Protocol Violation|0|||
33456661|NCT01525628|101560829|FG002|Overall Study|Protocol Violation|1|||
33456662|NCT01525628|101560830|FG003|Overall Study|Protocol Violation|0|||
33456663|NCT01525628|101560831|FG004|Overall Study|Protocol Violation|0|||
33456664|NCT01525628|101560827|FG000|Overall Study|Lost to Follow-up|1|||
33456665|NCT01525628|101560828|FG001|Overall Study|Lost to Follow-up|1|||
33456666|NCT01525628|101560829|FG002|Overall Study|Lost to Follow-up|0|||
33456667|NCT01525628|101560830|FG003|Overall Study|Lost to Follow-up|0|||
33456668|NCT01525628|101560831|FG004|Overall Study|Lost to Follow-up|0|||
33456669|NCT01525628|101560827|FG000|Overall Study|Withdrawal by Subject|0|||
33456670|NCT01525628|101560828|FG001|Overall Study|Withdrawal by Subject|1|||
33456671|NCT01525628|101560829|FG002|Overall Study|Withdrawal by Subject|0|||
33456672|NCT01525628|101560830|FG003|Overall Study|Withdrawal by Subject|0|||
33456673|NCT01525628|101560831|FG004|Overall Study|Withdrawal by Subject|0|||
33456674|NCT01525628|101560827|FG000|Overall Study|Other reason not defined above|0|||
33456675|NCT01525628|101560828|FG001|Overall Study|Other reason not defined above|0|||
33456676|NCT01525628|101560829|FG002|Overall Study|Other reason not defined above|0|||
33456677|NCT01525628|101560830|FG003|Overall Study|Other reason not defined above|3|||
33456678|NCT01525628|101560831|FG004|Overall Study|Other reason not defined above|0|||
33456679|NCT01971645|101560834|FG000|Overall Study|Adverse Event|1|||
33456680|NCT01971645|101560835|FG001|Overall Study|Adverse Event|0|||
33456681|NCT01971645|101560836|FG002|Overall Study|Adverse Event|0|||
33456682|NCT01971645|101560834|FG000|Overall Study|Lost to Follow-up|1|||
33456683|NCT01971645|101560835|FG001|Overall Study|Lost to Follow-up|0|||
33456684|NCT01971645|101560836|FG002|Overall Study|Lost to Follow-up|1|||
33456685|NCT01971645|101560834|FG000|Overall Study|Protocol Violation|0|||
33456686|NCT01971645|101560835|FG001|Overall Study|Protocol Violation|0|||
33456687|NCT01971645|101560836|FG002|Overall Study|Protocol Violation|1|||
33456688|NCT04203823|101560839|FG000|Overall Study|Withdrawal by Subject|2|||
33456689|NCT04203823|101560840|FG001|Overall Study|Withdrawal by Subject|2|||
33456690|NCT04203823|101560839|FG000|Overall Study|Adverse Event|1|||
33456691|NCT04203823|101560840|FG001|Overall Study|Adverse Event|1|||
33456692|NCT04203823|101560839|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33456693|NCT04203823|101560840|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
33456694|NCT02472639|101560841|FG000|Overall Study|Physician Decision|4|||
33456695|NCT02472639|101560842|FG001|Overall Study|Physician Decision|3|||
33456696|NCT01958476|101560846|FG000|Overall Study|Parent requested exclusion from analysis|1|||
33456697|NCT01958476|101560847|FG001|Overall Study|Parent requested exclusion from analysis|0|||
33456698|NCT02151149|101560849|FG000|Treatment Period|Death|2|||
33456699|NCT02151149|101560850|FG001|Treatment Period|Death|3|||
33456700|NCT02151149|101560849|FG000|Treatment Period|Adverse Event|17|||
33456701|NCT02151149|101560850|FG001|Treatment Period|Adverse Event|14|||
33456702|NCT02151149|101560849|FG000|Treatment Period|Progressive Disease|25|||
33456703|NCT02151149|101560850|FG001|Treatment Period|Progressive Disease|24|||
33456704|NCT02151149|101560849|FG000|Treatment Period|Symptomatic Deterioration|2|||
33456705|NCT02151149|101560850|FG001|Treatment Period|Symptomatic Deterioration|10|||
33456706|NCT02151149|101560849|FG000|Treatment Period|Withdrawal by Subject|13|||
33456707|NCT02151149|101560850|FG001|Treatment Period|Withdrawal by Subject|11|||
33456708|NCT02151149|101560849|FG000|Treatment Period|Miscellaneous|8|||
33456709|NCT02151149|101560850|FG001|Treatment Period|Miscellaneous|7|||
33456710|NCT02151149|101560849|FG000|Treatment Period|Participants randomized but not treated|3|||
33456711|NCT02151149|101560850|FG001|Treatment Period|Participants randomized but not treated|2|||
33456712|NCT02151149|101560849|FG000|Follow-Up Period|Lost to Follow-up|2|||
33456713|NCT02151149|101560850|FG001|Follow-Up Period|Lost to Follow-up|3|||
33456714|NCT02151149|101560849|FG000|Follow-Up Period|Death|37|||
33456715|NCT02151149|101560850|FG001|Follow-Up Period|Death|34|||
33456716|NCT01395017|101560852|FG000|Overall Study|Lost to Follow-up|1|||
33456717|NCT01395017|101560853|FG001|Overall Study|Lost to Follow-up|0|||
33456718|NCT01395017|101560852|FG000|Overall Study|Adverse Event|26|||
33456719|NCT01395017|101560853|FG001|Overall Study|Adverse Event|12|||
33456720|NCT01395017|101560852|FG000|Overall Study|Physician Decision|11|||
33456721|NCT01395017|101560853|FG001|Overall Study|Physician Decision|15|||
33173762|NCT00975481|100545609|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
33173763|NCT00975481|100545610|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
33173764|NCT00975481|100545611|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
33173765|NCT00975481|100545612|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
33173766|NCT00975481|100545613|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
33173767|NCT00975481|100545614|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
33173768|NCT02436889|100545623|FG000|Overall Study|No improvement in symptoms|1|||
33173769|NCT02436889|100545624|FG001|Overall Study|No improvement in symptoms|0|||
33173770|NCT02436889|100545623|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
33173771|NCT02436889|100545624|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
33173772|NCT00105482|100545625|FG000|Overall Study|Adverse Event|1|||
33173773|NCT00105482|100545626|FG001|Overall Study|Adverse Event|1|||
33173774|NCT00105482|100545625|FG000|Overall Study|Lost to Follow-up|26|||
33173775|NCT00105482|100545626|FG001|Overall Study|Lost to Follow-up|17|||
33173776|NCT00105482|100545625|FG000|Overall Study|Withdrawal by Subject|0|||
33173777|NCT00105482|100545626|FG001|Overall Study|Withdrawal by Subject|1|||
33173778|NCT00105482|100545625|FG000|Overall Study|Lost Interest|29|||
33173779|NCT00105482|100545626|FG001|Overall Study|Lost Interest|32|||
33173780|NCT00105482|100545625|FG000|Overall Study|Scheduling Conflict|2|||
33173781|NCT00105482|100545626|FG001|Overall Study|Scheduling Conflict|3|||
33173782|NCT00105482|100545625|FG000|Overall Study|Withdrawn by PI|1|||
33456722|NCT01395017|101560852|FG000|Overall Study|Withdrawal by Subject|14|||
33456723|NCT01395017|101560853|FG001|Overall Study|Withdrawal by Subject|8|||
33456724|NCT01395017|101560852|FG000|Overall Study|Protocol deviation|1|||
33456725|NCT01395017|101560853|FG001|Overall Study|Protocol deviation|2|||
33456726|NCT01395017|101560852|FG000|Overall Study|Death|4|||
33456727|NCT01395017|101560853|FG001|Overall Study|Death|3|||
33456728|NCT01395017|101560852|FG000|Overall Study|Disease progression|42|||
33456729|NCT01395017|101560853|FG001|Overall Study|Disease progression|58|||
33456730|NCT01395017|101560852|FG000|Overall Study|Sponsor discontinued study|1|||
33456731|NCT01395017|101560853|FG001|Overall Study|Sponsor discontinued study|4|||
33173783|NCT00105482|100545626|FG001|Overall Study|Withdrawn by PI|1|||
33173784|NCT02392247|100545627|FG000|Overall Study|Withdrawal by Subject|1|||
33173785|NCT02392247|100545627|FG000|Overall Study|Surgery cancelled; no data|1|||
33456732|NCT01499043|101560858|FG000|Overall Study|Progressive disease (radiographic)|2|||
33456733|NCT01499043|101560858|FG000|Overall Study|Progressive disease (clinical)|1|||
33456734|NCT01499043|101560858|FG000|Overall Study|Withdrawal by Subject|2|||
33456735|NCT01499043|101560858|FG000|Overall Study|Adverse Event|1|||
33456736|NCT00487695|101560859|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
33456737|NCT00487695|101560860|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
33456738|NCT00487695|101560859|FG000|First Procedure|active wheezing (did not have procedure)|1|||
33456739|NCT00487695|101560860|FG001|First Procedure|active wheezing (did not have procedure)|0|||
33456740|NCT00487695|101560859|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
33456741|NCT00487695|101560860|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
33456742|NCT00487695|101560859|FG000|Second Procedure|active wheezing|0|||
33456743|NCT00487695|101560860|FG001|Second Procedure|active wheezing|1|||
33456744|NCT00487695|101560859|FG000|Second Procedure|Withdrawal by Subject|1|||
33456745|NCT00487695|101560860|FG001|Second Procedure|Withdrawal by Subject|2|||
33456746|NCT00715676|101560861|FG000|Overall Study|Adverse Event|3|||
33456747|NCT00715676|101560862|FG001|Overall Study|Adverse Event|5|||
33456748|NCT00715676|101560863|FG002|Overall Study|Adverse Event|21|||
33456749|NCT00715676|101560861|FG000|Overall Study|Withdrawal by Subject|1|||
33456750|NCT00715676|101560862|FG001|Overall Study|Withdrawal by Subject|3|||
33456751|NCT00715676|101560863|FG002|Overall Study|Withdrawal by Subject|8|||
33456752|NCT00715676|101560861|FG000|Overall Study|Lost to Follow-up|1|||
33456753|NCT00715676|101560862|FG001|Overall Study|Lost to Follow-up|2|||
33456754|NCT00715676|101560863|FG002|Overall Study|Lost to Follow-up|1|||
33456755|NCT00715676|101560861|FG000|Overall Study|Terminated by Sponsor|1|||
33456756|NCT00715676|101560862|FG001|Overall Study|Terminated by Sponsor|0|||
33456757|NCT00715676|101560863|FG002|Overall Study|Terminated by Sponsor|0|||
33173786|NCT03194321|100545628|FG000|Overall Study|Withdrawal by Subject|1|||
33173787|NCT03194321|100545628|FG000|Overall Study|Lost to Follow-up|1|||
33173788|NCT03194321|100545628|FG000|Overall Study|Travel for Follow-up|1|||
33173789|NCT01324999|100545629|FG000|Overall Study|Adverse Event|3|||
33173790|NCT01324999|100545629|FG000|Overall Study|Withdrawal by Subject|2|||
33173791|NCT04481750|100545644|FG000|Period 1 (Fasted)|Adverse Event|0|||
33456758|NCT00715676|101560861|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
33456759|NCT00715676|101560862|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
33456760|NCT00715676|101560863|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
33456761|NCT00715676|101560861|FG000|Overall Study|Use of Exclusionary Medication|0|||
33456762|NCT00715676|101560862|FG001|Overall Study|Use of Exclusionary Medication|0|||
33456763|NCT00715676|101560863|FG002|Overall Study|Use of Exclusionary Medication|1|||
33456764|NCT00715676|101560861|FG000|Overall Study|Elevated Blood Glucose|0|||
33456765|NCT00715676|101560862|FG001|Overall Study|Elevated Blood Glucose|1|||
33456766|NCT00715676|101560863|FG002|Overall Study|Elevated Blood Glucose|0|||
33456767|NCT03614728|101560864|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
33456768|NCT03614728|101560865|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
33456769|NCT03614728|101560866|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
33456770|NCT03614728|101560867|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
33456771|NCT03614728|101560864|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
33456772|NCT03614728|101560865|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
33456773|NCT03614728|101560866|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
33456774|NCT03614728|101560867|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
33456775|NCT01670097|101560868|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
33456776|NCT01670097|101560869|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
33456777|NCT01670097|101560868|FG000|Overall Study|Study burden|1|||
33456778|NCT01670097|101560869|FG001|Overall Study|Study burden|0|||
33173792|NCT04481750|100545645|FG001|Period 1 (Fasted)|Adverse Event|0|||
33173793|NCT04481750|100545646|FG002|Period 1 (Fasted)|Adverse Event|1|||
33173794|NCT04481750|100545647|FG003|Period 1 (Fasted)|Adverse Event|0|||
33173795|NCT04481750|100545648|FG004|Period 1 (Fasted)|Adverse Event|0|||
33173796|NCT04481750|100545649|FG005|Period 1 (Fasted)|Adverse Event|0|||
33173797|NCT04481750|100545650|FG006|Period 1 (Fasted)|Adverse Event|0|||
33173798|NCT04481750|100545651|FG007|Period 1 (Fasted)|Adverse Event|0|||
33173799|NCT04481750|100545652|FG008|Period 1 (Fasted)|Adverse Event|0|||
33173800|NCT04481750|100545653|FG009|Period 1 (Fasted)|Adverse Event|0|||
33456779|NCT01670097|101560868|FG000|Overall Study|COPD exacerbation|0|||
33456780|NCT01670097|101560869|FG001|Overall Study|COPD exacerbation|1|||
33456781|NCT01670097|101560868|FG000|Overall Study|Neutropenia|0|||
33456782|NCT01670097|101560869|FG001|Overall Study|Neutropenia|1|||
33456783|NCT01670097|101560868|FG000|Overall Study|Clinical deterioration|0|||
33456784|NCT01670097|101560869|FG001|Overall Study|Clinical deterioration|1|||
33456785|NCT01670097|101560868|FG000|Overall Study|Disease progression|0|||
33456786|NCT01670097|101560869|FG001|Overall Study|Disease progression|1|||
33456787|NCT02587143|101560870|FG000|Overall Study|Adverse Event|1|||
33456788|NCT02587143|101560871|FG001|Overall Study|Adverse Event|0|||
33456789|NCT05004649|101560872|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
33456790|NCT05004649|101560872|FG000|Overall Study|Lost to Follow-up|1|||
33456791|NCT05004649|101560872|FG000|Overall Study|Withdrawal by Subject|2|||
33456792|NCT05004649|101560872|FG000|Overall Study|COVID-19|1|||
33456793|NCT02699866|101560873|FG000|Overall Study|Withdrawal by Subject|3|||
33456794|NCT02699866|101560873|FG000|Overall Study|Physician Decision|2|||
33456795|NCT02699866|101560873|FG000|Overall Study|Adverse Event|3|||
33456796|NCT02933060|101560874|FG000|Overall Study|Withdrawal by Subject|0|||
33456797|NCT02933060|101560875|FG001|Overall Study|Withdrawal by Subject|1|||
33456798|NCT00860262|101560877|FG000|Overall Study|Adverse Event|9|||
33456799|NCT00860262|101560878|FG001|Overall Study|Adverse Event|6|||
33456800|NCT00860262|101560879|FG002|Overall Study|Adverse Event|7|||
33456801|NCT00860262|101560877|FG000|Overall Study|Protocol Violation|0|||
33456802|NCT00860262|101560878|FG001|Overall Study|Protocol Violation|1|||
33173801|NCT04481750|100545654|FG010|Period 1 (Fasted)|Adverse Event|0|||
33456803|NCT00860262|101560879|FG002|Overall Study|Protocol Violation|0|||
33456804|NCT00860262|101560877|FG000|Overall Study|Lost to Follow-up|2|||
33456805|NCT00860262|101560878|FG001|Overall Study|Lost to Follow-up|0|||
33456806|NCT00860262|101560879|FG002|Overall Study|Lost to Follow-up|1|||
33173802|NCT00759954|100545657|FG000|Overall Study|Personal reason|1|||
33173803|NCT00759954|100545658|FG001|Overall Study|Personal reason|0|||
33173804|NCT00759954|100545657|FG000|Overall Study|Adverse Event|1|||
33456807|NCT00860262|101560877|FG000|Overall Study|Withdrawal by Subject|4|||
33456808|NCT00860262|101560878|FG001|Overall Study|Withdrawal by Subject|8|||
33456809|NCT00860262|101560879|FG002|Overall Study|Withdrawal by Subject|6|||
33456810|NCT00860262|101560877|FG000|Overall Study|Lack of Efficacy|0|||
33456811|NCT00860262|101560878|FG001|Overall Study|Lack of Efficacy|4|||
33456812|NCT00860262|101560879|FG002|Overall Study|Lack of Efficacy|3|||
33456813|NCT00860262|101560877|FG000|Overall Study|Other|5|||
33173805|NCT00759954|100545658|FG001|Overall Study|Adverse Event|2|||
33173806|NCT00996216|100545659|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
33456814|NCT00860262|101560878|FG001|Overall Study|Other|3|||
33456815|NCT00860262|101560879|FG002|Overall Study|Other|1|||
33456816|NCT00714051|101560880|FG000|Overall Study|Withdrawal by Subject|1|||
33456817|NCT00714051|101560881|FG001|Overall Study|Withdrawal by Subject|0|||
33456818|NCT00714051|101560880|FG000|Overall Study|Death|0|||
33456819|NCT00714051|101560881|FG001|Overall Study|Death|1|||
33456820|NCT02218216|101560882|FG000|Overall Study|Study terminated before completed|6|||
33456821|NCT02218216|101560883|FG001|Overall Study|Study terminated before completed|0|||
33456822|NCT02218216|101560884|FG002|Overall Study|Study terminated before completed|0|||
33456823|NCT00613730|101560885|FG000|Overall Study|Disease progression|2|||
33456824|NCT00613730|101560885|FG000|Overall Study|Administrative decision|1|||
33456825|NCT00702507|101560890|FG000|Initial Treatment Phase|Adverse Event|2|||
33456826|NCT00702507|101560890|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
33456827|NCT00702507|101560890|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
33456828|NCT00702507|101560890|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
33456829|NCT00702507|101560890|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
33456830|NCT00702507|101560890|FG000|Follow-up Phase|Protocol Violation|2|||
33456831|NCT00702507|101560890|FG000|Follow-up Phase|Lost to Follow-up|23|||
33456832|NCT00702507|101560890|FG000|Follow-up Phase|Late Enrollment|1|||
33456833|NCT02028455|101560891|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
33456834|NCT02028455|101560892|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
33456835|NCT02028455|101560893|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
33456836|NCT02028455|101560894|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
33456837|NCT02028455|101560895|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
33456838|NCT02028455|101560896|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
33456839|NCT02028455|101560897|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
33456840|NCT02028455|101560898|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
33456841|NCT02028455|101560891|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
33456842|NCT02028455|101560892|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
33456843|NCT02028455|101560893|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
33456844|NCT02028455|101560894|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
33456845|NCT02028455|101560895|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
33456846|NCT02028455|101560896|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
33456847|NCT02028455|101560897|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
33456848|NCT02028455|101560898|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
33456849|NCT02028455|101560891|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
33456850|NCT02028455|101560892|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
33173807|NCT00996216|100545659|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
33173808|NCT00996216|100545659|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
33173809|NCT03277105|100545660|FG000|Overall Study|Death|129|||
33456851|NCT02028455|101560893|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
33456852|NCT02028455|101560894|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
33456853|NCT02028455|101560895|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
33456854|NCT02028455|101560896|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
33456855|NCT02028455|101560897|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
33456856|NCT02028455|101560898|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
33456857|NCT02028455|101560891|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
33456858|NCT02028455|101560892|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
33456859|NCT02028455|101560893|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
33456860|NCT02028455|101560894|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
33456861|NCT02028455|101560895|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
33456862|NCT02028455|101560896|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
33456863|NCT02028455|101560897|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
33456864|NCT02028455|101560898|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
33456865|NCT03366428|101560899|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
33456866|NCT03366428|101560899|FG000|Overall Study|Adverse Event|12|||
33456867|NCT03366428|101560899|FG000|Overall Study|Clinical progression|2|||
33456868|NCT03366428|101560899|FG000|Overall Study|Withdrawal by Subject|4|||
33456869|NCT01653704|101560900|FG000|Overall Study|Technical failure during recording|1|||
33456870|NCT01653704|101560901|FG001|Overall Study|Technical failure during recording|1|||
33456871|NCT01653704|101560900|FG000|Overall Study|Performance not reflective of training|1|||
33173810|NCT03277105|100545661|FG001|Overall Study|Death|124|||
33173811|NCT03277105|100545660|FG000|Overall Study|Lost to Follow-up|2|||
33456872|NCT01653704|101560901|FG001|Overall Study|Performance not reflective of training|0|||
33456873|NCT01977456|101560902|FG000|Overall Study|Death|5|||
33456874|NCT00834613|101560910|FG000|First Intervention|Protocol Violation|1|||
33456875|NCT00834613|101560911|FG001|First Intervention|Protocol Violation|0|||
33456876|NCT00840658|101560912|FG000|Overall Study|Death|2|||
33456877|NCT00840658|101560913|FG001|Overall Study|Death|2|||
33456878|NCT00840658|101560914|FG002|Overall Study|Death|3|||
33456879|NCT00840658|101560915|FG003|Overall Study|Death|3|||
33456880|NCT00840658|101560912|FG000|Overall Study|Lost to Follow-up|3|||
33456881|NCT00840658|101560913|FG001|Overall Study|Lost to Follow-up|1|||
33173812|NCT03277105|100545661|FG001|Overall Study|Lost to Follow-up|4|||
33173813|NCT03277105|100545660|FG000|Overall Study|Withdrawal by Subject|10|||
33173814|NCT03277105|100545661|FG001|Overall Study|Withdrawal by Subject|10|||
33173815|NCT03277105|100545660|FG000|Overall Study|Other|118|||
33173816|NCT03277105|100545661|FG001|Overall Study|Other|125|||
33173817|NCT02259582|100545664|FG000|Overall Study|Physician Decision|0|||
33173818|NCT02259582|100545665|FG001|Overall Study|Physician Decision|1|||
33173819|NCT02259582|100545666|FG002|Overall Study|Physician Decision|0|||
33173820|NCT02259582|100545664|FG000|Overall Study|Death|0|||
33173821|NCT02259582|100545665|FG001|Overall Study|Death|0|||
33173822|NCT02259582|100545666|FG002|Overall Study|Death|1|||
33173823|NCT02259582|100545664|FG000|Overall Study|Adverse Event|1|||
33173824|NCT02259582|100545665|FG001|Overall Study|Adverse Event|0|||
33173825|NCT02259582|100545666|FG002|Overall Study|Adverse Event|1|||
33173826|NCT02259582|100545664|FG000|Overall Study|Withdrawal by Subject|0|||
33173827|NCT02259582|100545665|FG001|Overall Study|Withdrawal by Subject|0|||
33456882|NCT00840658|101560914|FG002|Overall Study|Lost to Follow-up|2|||
33456883|NCT00840658|101560915|FG003|Overall Study|Lost to Follow-up|1|||
33173828|NCT02259582|100545666|FG002|Overall Study|Withdrawal by Subject|1|||
33173829|NCT02259582|100545664|FG000|Overall Study|Disease progression|14|||
33173830|NCT02259582|100545665|FG001|Overall Study|Disease progression|15|||
33173831|NCT02259582|100545666|FG002|Overall Study|Disease progression|17|||
33456884|NCT01583530|101560923|FG000|Overall Study|Adverse Event|0|||
33456885|NCT01583530|101560924|FG001|Overall Study|Adverse Event|0|||
33456886|NCT01583530|101560925|FG002|Overall Study|Adverse Event|0|||
33456887|NCT01583530|101560926|FG003|Overall Study|Adverse Event|0|||
33456888|NCT01583530|101560927|FG004|Overall Study|Adverse Event|0|||
33456889|NCT01583530|101560928|FG005|Overall Study|Adverse Event|1|||
33456890|NCT01583530|101560923|FG000|Overall Study|Withdrawal by Subject|0|||
33456891|NCT01583530|101560924|FG001|Overall Study|Withdrawal by Subject|3|||
33456892|NCT01583530|101560925|FG002|Overall Study|Withdrawal by Subject|0|||
33456893|NCT01583530|101560926|FG003|Overall Study|Withdrawal by Subject|1|||
33456894|NCT01583530|101560927|FG004|Overall Study|Withdrawal by Subject|1|||
33456895|NCT01583530|101560928|FG005|Overall Study|Withdrawal by Subject|2|||
33173832|NCT02259582|100545664|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
33173833|NCT02259582|100545665|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
33456896|NCT01583530|101560923|FG000|Overall Study|Lost to Follow-up|0|||
33262275|NCT03912831|100860298|FG001|Overall Study|Reason not Specified|0|||
33262276|NCT03912831|100860299|FG002|Overall Study|Reason not Specified|0|||
33262277|NCT03912831|100860300|FG003|Overall Study|Reason not Specified|0|||
33262278|NCT03912831|100860301|FG004|Overall Study|Reason not Specified|1|||
33262279|NCT03912831|100860302|FG005|Overall Study|Reason not Specified|0|||
33262280|NCT03912831|100860297|FG000|Overall Study|Withdrawal by Participant|0|||
33262281|NCT03912831|100860298|FG001|Overall Study|Withdrawal by Participant|0|||
33262282|NCT03912831|100860299|FG002|Overall Study|Withdrawal by Participant|0|||
33262283|NCT03912831|100860300|FG003|Overall Study|Withdrawal by Participant|0|||
33262284|NCT03912831|100860301|FG004|Overall Study|Withdrawal by Participant|1|||
33262285|NCT03912831|100860302|FG005|Overall Study|Withdrawal by Participant|0|||
33262286|NCT00246805|100860303|FG000|Phase 1|Lost to Follow-up|1|||
33262287|NCT00246805|100860304|FG001|Phase 1|Lost to Follow-up|0|||
33262288|NCT02797184|100860305|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
33262289|NCT02797184|100860306|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
33262290|NCT01426412|100860314|FG000|Overall Study|Withdrawal by Subject|1|||
33262291|NCT01426412|100860315|FG001|Overall Study|Withdrawal by Subject|0|||
33262292|NCT01426412|100860316|FG002|Overall Study|Withdrawal by Subject|0|||
33262293|NCT01426412|100860317|FG003|Overall Study|Withdrawal by Subject|0|||
33262294|NCT01426412|100860318|FG004|Overall Study|Withdrawal by Subject|1|||
33262295|NCT01426412|100860319|FG005|Overall Study|Withdrawal by Subject|0|||
33262296|NCT01426412|100860320|FG006|Overall Study|Withdrawal by Subject|0|||
33262297|NCT01426412|100860321|FG007|Overall Study|Withdrawal by Subject|3|||
33262298|NCT01426412|100860322|FG008|Overall Study|Withdrawal by Subject|1|||
33262299|NCT00701701|100860324|FG000|Overall Study|Withdrawal by Subject|0|||
33262300|NCT00701701|100860325|FG001|Overall Study|Withdrawal by Subject|1|||
33262301|NCT00701701|100860324|FG000|Overall Study|Adverse Event|0|||
33262302|NCT00701701|100860325|FG001|Overall Study|Adverse Event|1|||
33262303|NCT03621735|100860327|FG000|Overall Study|Withdrawal by Subject|13|||
33262304|NCT03621735|100860328|FG001|Overall Study|Withdrawal by Subject|13|||
33262305|NCT03476798|100860329|FG000|Overall Study|Death|1|||
33262306|NCT03476798|100860329|FG000|Overall Study|Withdrawal by Subject|2|||
33262307|NCT03476798|100860329|FG000|Overall Study|Protocol Violation|2|||
33262308|NCT03801148|100860330|FG000|Period 1 (2 Days)|Adverse Event|1|||
33262309|NCT03801148|100860331|FG001|Period 1 (2 Days)|Adverse Event|1|||
33262310|NCT03801148|100860332|FG002|Period 1 (2 Days)|Adverse Event|0|||
33262311|NCT03801148|100860333|FG003|Period 1 (2 Days)|Adverse Event|0|||
33262312|NCT03801148|100860330|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
33262313|NCT03801148|100860331|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
33262314|NCT03801148|100860332|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
33262315|NCT03801148|100860333|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
33262316|NCT03801148|100860330|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33262317|NCT03801148|100860331|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33262318|NCT03801148|100860332|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
33262319|NCT03801148|100860333|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33262320|NCT03801148|100860330|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
33262321|NCT03801148|100860331|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
33262322|NCT03801148|100860332|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
33262323|NCT03801148|100860333|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
33262324|NCT01290341|100860335|FG000|Overall Study|Protocol Violation|7|||
33262325|NCT01290341|100860336|FG001|Overall Study|Protocol Violation|3|||
33262326|NCT01290341|100860335|FG000|Overall Study|Adverse Event|1|||
33262327|NCT01290341|100860336|FG001|Overall Study|Adverse Event|0|||
33262328|NCT01290341|100860335|FG000|Overall Study|Lost to Follow-up|21|||
33262329|NCT01290341|100860336|FG001|Overall Study|Lost to Follow-up|10|||
33262330|NCT01290341|100860335|FG000|Overall Study|Withdrawal by Subject|19|||
33262331|NCT01290341|100860336|FG001|Overall Study|Withdrawal by Subject|5|||
33262332|NCT01290341|100860335|FG000|Overall Study|Negative baseline culture and others|44|||
33262333|NCT01290341|100860336|FG001|Overall Study|Negative baseline culture and others|11|||
33262334|NCT02789020|100860338|FG000|Overall Study|Withdrawal by Subject|6|||
33262335|NCT02789020|100860339|FG001|Overall Study|Withdrawal by Subject|5|||
33262336|NCT02765100|100860340|FG000|Overall Study|subject found ineligible after baseline|1|||
33262337|NCT02765100|100860341|FG001|Overall Study|subject found ineligible after baseline|1|||
33262338|NCT02765100|100860340|FG000|Overall Study|Lost to Follow-up|0|||
33262339|NCT02765100|100860341|FG001|Overall Study|Lost to Follow-up|1|||
33262340|NCT01738438|100860342|FG000|Overall Study|Disease Progression|32|||
33262341|NCT01738438|100860342|FG000|Overall Study|Adverse Event|3|||
33262342|NCT00391898|100860343|FG000|Overall Study|Adverse Event|3|||
33262343|NCT00391898|100860344|FG001|Overall Study|Adverse Event|0|||
33262344|NCT00391898|100860343|FG000|Overall Study|Other|8|||
33262345|NCT00391898|100860344|FG001|Overall Study|Other|10|||
33262346|NCT01951170|100860345|FG000|Overall Study|Investigator decision|1|||
33262347|NCT01627561|100860346|FG000|Overall Study|Lost to Follow-up|1|||
33173834|NCT02259582|100545666|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
33173835|NCT03824912|100545667|FG000|Overall Study|Lost to Follow-up|18|||
33173836|NCT03824912|100545668|FG001|Overall Study|Lost to Follow-up|15|||
33173837|NCT03824912|100545669|FG002|Overall Study|Lost to Follow-up|8|||
33173838|NCT03824912|100545667|FG000|Overall Study|Negative Baseline Culture Result|118|||
33173839|NCT03824912|100545668|FG001|Overall Study|Negative Baseline Culture Result|112|||
33173840|NCT03824912|100545669|FG002|Overall Study|Negative Baseline Culture Result|57|||
33173841|NCT03824912|100545667|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33173842|NCT03824912|100545668|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33456897|NCT01583530|101560924|FG001|Overall Study|Lost to Follow-up|0|||
33456898|NCT01583530|101560925|FG002|Overall Study|Lost to Follow-up|0|||
33456899|NCT01583530|101560926|FG003|Overall Study|Lost to Follow-up|0|||
33456900|NCT01583530|101560927|FG004|Overall Study|Lost to Follow-up|3|||
33456901|NCT01583530|101560928|FG005|Overall Study|Lost to Follow-up|0|||
33456902|NCT01583530|101560923|FG000|Overall Study|Lack of compliance|0|||
33456903|NCT01583530|101560924|FG001|Overall Study|Lack of compliance|0|||
33456904|NCT01583530|101560925|FG002|Overall Study|Lack of compliance|0|||
33456905|NCT01583530|101560926|FG003|Overall Study|Lack of compliance|0|||
33456906|NCT01583530|101560927|FG004|Overall Study|Lack of compliance|1|||
33456907|NCT01583530|101560928|FG005|Overall Study|Lack of compliance|0|||
33456908|NCT01055886|101560929|FG000|Overall Study|Withdrawal by Subject|4|||
33456909|NCT01055886|101560930|FG001|Overall Study|Withdrawal by Subject|9|||
33456910|NCT01055886|101560929|FG000|Overall Study|Lost to Follow-up|1|||
33456911|NCT01055886|101560930|FG001|Overall Study|Lost to Follow-up|1|||
33456912|NCT01055886|101560929|FG000|Overall Study|Withdrawal by PI|0|||
33456913|NCT01055886|101560930|FG001|Overall Study|Withdrawal by PI|1|||
33456914|NCT00868998|101560931|FG000|Overall Study|Screen Failure|1|||
33456915|NCT00868998|101560931|FG000|Overall Study|Withdrawal by Subject|1|||
33456916|NCT00868998|101560931|FG000|Overall Study|Progression of disease|2|||
33456917|NCT00868998|101560931|FG000|Overall Study|Death|1|||
33456918|NCT01781234|101560934|FG000|Overall Study|Adverse Event|2|||
33456919|NCT01781234|101560935|FG001|Overall Study|Adverse Event|0|||
33456920|NCT01781234|101560934|FG000|Overall Study|Protocol Violation|3|||
33456921|NCT01781234|101560935|FG001|Overall Study|Protocol Violation|0|||
33456922|NCT01781234|101560934|FG000|Overall Study|Withdrawal by Subject|4|||
33456923|NCT01781234|101560935|FG001|Overall Study|Withdrawal by Subject|3|||
33173843|NCT03824912|100545669|FG002|Overall Study|Non-Compliance with Study Drug|1|||
33173844|NCT03824912|100545667|FG000|Overall Study|Protocol Violation|1|||
33173845|NCT03824912|100545668|FG001|Overall Study|Protocol Violation|4|||
33456924|NCT01868243|101560936|FG000|Overall Study|Death|0|||
33456925|NCT01868243|101560937|FG001|Overall Study|Death|1|||
33456926|NCT01964950|101560938|FG000|Overall Study|Protocol Violation|25|||
33173846|NCT03824912|100545669|FG002|Overall Study|Protocol Violation|1|||
33173847|NCT03824912|100545667|FG000|Overall Study|Withdrawal by Subject|3|||
33173848|NCT03824912|100545668|FG001|Overall Study|Withdrawal by Subject|2|||
33173849|NCT03824912|100545669|FG002|Overall Study|Withdrawal by Subject|1|||
33456927|NCT03922750|101560941|FG000|Overall Study|Unclassified|0|||
33456928|NCT03922750|101560942|FG001|Overall Study|Unclassified|0|||
33456929|NCT03922750|101560943|FG002|Overall Study|Unclassified|1|||
33456930|NCT03922750|101560941|FG000|Overall Study|Adverse Event|0|||
33173850|NCT03824912|100545667|FG000|Overall Study|Participation in another study|0|||
33173851|NCT03824912|100545668|FG001|Overall Study|Participation in another study|1|||
33173852|NCT03824912|100545669|FG002|Overall Study|Participation in another study|0|||
33173853|NCT02554812|100545670|FG000|Overall Study|Adverse Event|2|||
33173854|NCT02554812|100545671|FG001|Overall Study|Adverse Event|5|||
33173855|NCT02554812|100545672|FG002|Overall Study|Adverse Event|3|||
33173856|NCT02554812|100545673|FG003|Overall Study|Adverse Event|0|||
33173857|NCT02554812|100545674|FG004|Overall Study|Adverse Event|5|||
33173858|NCT02554812|100545675|FG005|Overall Study|Adverse Event|0|||
33173859|NCT02554812|100545676|FG006|Overall Study|Adverse Event|1|||
33173860|NCT02554812|100545677|FG007|Overall Study|Adverse Event|6|||
33456931|NCT03922750|101560942|FG001|Overall Study|Adverse Event|1|||
33456932|NCT03922750|101560943|FG002|Overall Study|Adverse Event|0|||
33456933|NCT01728116|101560944|FG000|Overall Study|Sponsor Terminated Study|106|||
33456934|NCT01728116|101560945|FG001|Overall Study|Sponsor Terminated Study|35|||
33456935|NCT01728116|101560944|FG000|Overall Study|Withdrawal by Subject|16|||
33456936|NCT01728116|101560945|FG001|Overall Study|Withdrawal by Subject|9|||
33456937|NCT01728116|101560944|FG000|Overall Study|Adverse Event|13|||
33456938|NCT01728116|101560945|FG001|Overall Study|Adverse Event|0|||
33456939|NCT01728116|101560944|FG000|Overall Study|Procedure/device failure|7|||
33456940|NCT01728116|101560945|FG001|Overall Study|Procedure/device failure|0|||
33456941|NCT01728116|101560944|FG000|Overall Study|Lost to Follow-up|9|||
33456942|NCT01728116|101560945|FG001|Overall Study|Lost to Follow-up|2|||
33456943|NCT01728116|101560944|FG000|Overall Study|Physician Decision|2|||
33456944|NCT01728116|101560945|FG001|Overall Study|Physician Decision|0|||
33456945|NCT01728116|101560944|FG000|Overall Study|Subject Non-Compliance|2|||
33456946|NCT01728116|101560945|FG001|Overall Study|Subject Non-Compliance|0|||
33456947|NCT01728116|101560944|FG000|Overall Study|Inter-current finding at procedure|1|||
33456948|NCT01728116|101560945|FG001|Overall Study|Inter-current finding at procedure|0|||
33456949|NCT01728116|101560944|FG000|Overall Study|Incorrectly enrolled in Study|0|||
33456950|NCT01728116|101560945|FG001|Overall Study|Incorrectly enrolled in Study|1|||
33456951|NCT01728116|101560944|FG000|Overall Study|various not noted previously|5|||
33456952|NCT01728116|101560945|FG001|Overall Study|various not noted previously|0|||
33456953|NCT02416180|101560946|FG000|Overall Study|Withdrawal by Subject|1|||
33456954|NCT02096705|101560947|FG000|Treatment|Adverse Event|6|||
33456955|NCT02096705|101560948|FG001|Treatment|Adverse Event|3|||
33456956|NCT02096705|101560947|FG000|Treatment|Subject request to discontinue treatment|1|||
33456957|NCT02096705|101560948|FG001|Treatment|Subject request to discontinue treatment|1|||
33456958|NCT02096705|101560947|FG000|Treatment|Withdrawal by Subject|1|||
33173861|NCT02554812|100545678|FG008|Overall Study|Adverse Event|2|||
33262348|NCT01627561|100860347|FG001|Overall Study|Lost to Follow-up|0|||
33262349|NCT01627561|100860346|FG000|Overall Study|Withdrawal by Subject|0|||
33262350|NCT01627561|100860347|FG001|Overall Study|Withdrawal by Subject|1|||
33262351|NCT01627561|100860346|FG000|Overall Study|Migrated/moved from study area|0|||
33262352|NCT01627561|100860347|FG001|Overall Study|Migrated/moved from study area|2|||
33262353|NCT01948661|100860352|FG000|Overall Study|Withdrawal by Subject|2|||
33262354|NCT01948661|100860353|FG001|Overall Study|Withdrawal by Subject|4|||
33262355|NCT00411151|100860362|FG000|Overall Study|Death|38|||
33262356|NCT00411151|100860362|FG000|Overall Study|Withdrawal by Subject|2|||
33173862|NCT02554812|100545679|FG009|Overall Study|Adverse Event|2|||
33262357|NCT00411151|100860362|FG000|Overall Study|Lost to Follow-up|2|||
33262358|NCT00411151|100860362|FG000|Overall Study|Protocol Violation|1|||
33456959|NCT02096705|101560948|FG001|Treatment|Withdrawal by Subject|0|||
33456960|NCT02096705|101560947|FG000|Treatment|Other|1|||
33456961|NCT02096705|101560948|FG001|Treatment|Other|1|||
33456962|NCT02096705|101560947|FG000|Follow-up|Withdrawal by Subject|1|||
33173863|NCT02554812|100545680|FG010|Overall Study|Adverse Event|1|||
33173864|NCT02554812|100545681|FG011|Overall Study|Adverse Event|2|||
33262359|NCT00411151|100860362|FG000|Overall Study|Trial prematurely closed|4|||
33456963|NCT02096705|101560948|FG001|Follow-up|Withdrawal by Subject|0|||
33456964|NCT02096705|101560947|FG000|Follow-up|Adverse Event|2|||
33456965|NCT02096705|101560948|FG001|Follow-up|Adverse Event|2|||
33456966|NCT02096705|101560947|FG000|Follow-up|Subjects not reporting status|1|||
33456967|NCT02096705|101560948|FG001|Follow-up|Subjects not reporting status|2|||
33456968|NCT04129554|101560949|FG000|Overall Study|Withdrawal by Subject|4|||
33456969|NCT04129554|101560950|FG001|Overall Study|Withdrawal by Subject|3|||
33456970|NCT04129554|101560949|FG000|Overall Study|Other|0|||
33456971|NCT04129554|101560950|FG001|Overall Study|Other|2|||
33456972|NCT04561115|101560954|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
33456973|NCT04561115|101560955|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
33456974|NCT04561115|101560954|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
33456975|NCT04561115|101560955|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
33173865|NCT02554812|100545682|FG012|Overall Study|Adverse Event|0|||
33173866|NCT02554812|100545683|FG013|Overall Study|Adverse Event|3|||
33173867|NCT02554812|100545684|FG014|Overall Study|Adverse Event|2|||
33173868|NCT02554812|100545685|FG015|Overall Study|Adverse Event|1|||
33173869|NCT02554812|100545686|FG016|Overall Study|Adverse Event|0|||
33173870|NCT02554812|100545687|FG017|Overall Study|Adverse Event|1|||
33173871|NCT02554812|100545688|FG018|Overall Study|Adverse Event|0|||
33173872|NCT02554812|100545689|FG019|Overall Study|Adverse Event|0|||
33173873|NCT02554812|100545690|FG020|Overall Study|Adverse Event|0|||
33173874|NCT02554812|100545691|FG021|Overall Study|Adverse Event|2|||
33173875|NCT02554812|100545692|FG022|Overall Study|Adverse Event|1|||
33173876|NCT02554812|100545693|FG023|Overall Study|Adverse Event|1|||
33173877|NCT02554812|100545694|FG024|Overall Study|Adverse Event|1|||
33173878|NCT02554812|100545695|FG025|Overall Study|Adverse Event|2|||
33173879|NCT02554812|100545696|FG026|Overall Study|Adverse Event|1|||
33173880|NCT02554812|100545670|FG000|Overall Study|Death|1|||
33173881|NCT02554812|100545671|FG001|Overall Study|Death|2|||
33173882|NCT02554812|100545672|FG002|Overall Study|Death|2|||
33173883|NCT02554812|100545673|FG003|Overall Study|Death|2|||
33173884|NCT02554812|100545674|FG004|Overall Study|Death|0|||
33173885|NCT02554812|100545675|FG005|Overall Study|Death|1|||
33173886|NCT02554812|100545676|FG006|Overall Study|Death|1|||
33173887|NCT02554812|100545677|FG007|Overall Study|Death|1|||
33173888|NCT02554812|100545678|FG008|Overall Study|Death|0|||
33173889|NCT02554812|100545679|FG009|Overall Study|Death|0|||
33173890|NCT02554812|100545680|FG010|Overall Study|Death|0|||
33173891|NCT02554812|100545681|FG011|Overall Study|Death|0|||
33173892|NCT02554812|100545682|FG012|Overall Study|Death|0|||
33173893|NCT02554812|100545683|FG013|Overall Study|Death|0|||
33173894|NCT02554812|100545684|FG014|Overall Study|Death|1|||
33173895|NCT02554812|100545685|FG015|Overall Study|Death|1|||
33173896|NCT02554812|100545686|FG016|Overall Study|Death|1|||
33173897|NCT02554812|100545687|FG017|Overall Study|Death|0|||
33173898|NCT02554812|100545688|FG018|Overall Study|Death|1|||
33173899|NCT02554812|100545689|FG019|Overall Study|Death|2|||
33173900|NCT02554812|100545690|FG020|Overall Study|Death|0|||
33173901|NCT02554812|100545691|FG021|Overall Study|Death|1|||
33173902|NCT02554812|100545692|FG022|Overall Study|Death|1|||
33173903|NCT02554812|100545693|FG023|Overall Study|Death|0|||
33456976|NCT04561115|101560954|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
33489761|NCT02952586|101686778|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
33173904|NCT02554812|100545694|FG024|Overall Study|Death|0|||
33173905|NCT02554812|100545695|FG025|Overall Study|Death|0|||
33173906|NCT02554812|100545696|FG026|Overall Study|Death|0|||
33173907|NCT02554812|100545670|FG000|Overall Study|Lost to Follow-up|0|||
33173908|NCT02554812|100545671|FG001|Overall Study|Lost to Follow-up|1|||
33173909|NCT02554812|100545672|FG002|Overall Study|Lost to Follow-up|0|||
33173910|NCT02554812|100545673|FG003|Overall Study|Lost to Follow-up|0|||
33173911|NCT02554812|100545674|FG004|Overall Study|Lost to Follow-up|0|||
33173912|NCT02554812|100545675|FG005|Overall Study|Lost to Follow-up|0|||
33173913|NCT02554812|100545676|FG006|Overall Study|Lost to Follow-up|0|||
33456977|NCT04561115|101560955|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
33456978|NCT02858037|101560956|FG000|Overall Study|Death|1|||
33456979|NCT02858037|101560956|FG000|Overall Study|Withdrawal by Subject|18|||
33456980|NCT02858037|101560956|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
33456981|NCT02858037|101560956|FG000|Overall Study|Lost to Follow-up|3|||
33456982|NCT02858037|101560956|FG000|Overall Study|Other|4|||
33456983|NCT02387762|101560957|FG000|Overall Study|Withdrawal by Subject|1|||
33456984|NCT02387762|101560958|FG001|Overall Study|Withdrawal by Subject|0|||
33456985|NCT00550147|101560959|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
33456986|NCT00550147|101560959|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
33456987|NCT00550147|101560959|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
33456988|NCT00550147|101560959|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
33456989|NCT00550147|101560959|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
33456990|NCT03185741|101560960|FG000|Baseline|Withdrawal by Subject|1|||
33456991|NCT03185741|101560961|FG001|Baseline|Withdrawal by Subject|3|||
33456992|NCT03185741|101560962|FG002|Baseline|Withdrawal by Subject|2|||
33456993|NCT03185741|101560960|FG000|Baseline|Lost to Follow-up|1|||
33456994|NCT03185741|101560961|FG001|Baseline|Lost to Follow-up|2|||
33456995|NCT03185741|101560962|FG002|Baseline|Lost to Follow-up|3|||
33456996|NCT03185741|101560960|FG000|3Month|Death|1|||
33456997|NCT03185741|101560961|FG001|3Month|Death|1|||
33456998|NCT03185741|101560962|FG002|3Month|Death|2|||
33456999|NCT03185741|101560960|FG000|3Month|Withdrawal by Subject|1|||
33173914|NCT02554812|100545677|FG007|Overall Study|Lost to Follow-up|0|||
33173915|NCT02554812|100545678|FG008|Overall Study|Lost to Follow-up|0|||
33173916|NCT02554812|100545679|FG009|Overall Study|Lost to Follow-up|0|||
33173917|NCT02554812|100545680|FG010|Overall Study|Lost to Follow-up|0|||
33173918|NCT02554812|100545681|FG011|Overall Study|Lost to Follow-up|0|||
33173919|NCT02554812|100545682|FG012|Overall Study|Lost to Follow-up|0|||
33173920|NCT02554812|100545683|FG013|Overall Study|Lost to Follow-up|0|||
33173921|NCT02554812|100545684|FG014|Overall Study|Lost to Follow-up|0|||
33173922|NCT02554812|100545685|FG015|Overall Study|Lost to Follow-up|0|||
33262360|NCT03756571|100860363|FG000|Overall Study|Lost to Follow-up|1|||
33262361|NCT03756571|100860364|FG001|Overall Study|Lost to Follow-up|1|||
33457000|NCT03185741|101560961|FG001|3Month|Withdrawal by Subject|5|||
33457001|NCT03185741|101560962|FG002|3Month|Withdrawal by Subject|1|||
33457002|NCT03185741|101560960|FG000|3Month|Lost to Follow-up|7|||
33173923|NCT02554812|100545686|FG016|Overall Study|Lost to Follow-up|0|||
33173924|NCT02554812|100545687|FG017|Overall Study|Lost to Follow-up|0|||
33457003|NCT03185741|101560961|FG001|3Month|Lost to Follow-up|9|||
33457004|NCT03185741|101560962|FG002|3Month|Lost to Follow-up|8|||
33173925|NCT02554812|100545688|FG018|Overall Study|Lost to Follow-up|0|||
33457005|NCT03185741|101560960|FG000|3Month|Unavailable for 3Month|11|||
33457006|NCT03185741|101560961|FG001|3Month|Unavailable for 3Month|10|||
33457007|NCT03185741|101560962|FG002|3Month|Unavailable for 3Month|11|||
33457008|NCT03185741|101560960|FG000|3Month|Protocol Violation|0|||
33457009|NCT03185741|101560961|FG001|3Month|Protocol Violation|0|||
33457010|NCT03185741|101560962|FG002|3Month|Protocol Violation|3|||
33457011|NCT03185741|101560960|FG000|6Month|Death|1|||
33173926|NCT02554812|100545689|FG019|Overall Study|Lost to Follow-up|0|||
33173927|NCT02554812|100545690|FG020|Overall Study|Lost to Follow-up|0|||
33262362|NCT02910713|100860365|FG000|Overall Study|Protocol Violation|2|||
33262363|NCT02910713|100860365|FG000|Overall Study|Subject Choice|4|||
33457012|NCT03185741|101560961|FG001|6Month|Death|1|||
33457013|NCT03185741|101560962|FG002|6Month|Death|2|||
33457014|NCT03185741|101560960|FG000|6Month|Withdrawal by Subject|2|||
33457015|NCT03185741|101560961|FG001|6Month|Withdrawal by Subject|3|||
33457016|NCT03185741|101560962|FG002|6Month|Withdrawal by Subject|1|||
33457017|NCT03185741|101560960|FG000|6Month|Lost to Follow-up|16|||
33457018|NCT03185741|101560961|FG001|6Month|Lost to Follow-up|15|||
33457019|NCT03185741|101560962|FG002|6Month|Lost to Follow-up|16|||
33457020|NCT00283842|101560963|FG000|Overall Study|Adverse Event|8|||
33457021|NCT00283842|101560964|FG001|Overall Study|Adverse Event|7|||
33457022|NCT00283842|101560965|FG002|Overall Study|Adverse Event|21|||
33457023|NCT00283842|101560966|FG003|Overall Study|Adverse Event|21|||
33457024|NCT00283842|101560967|FG004|Overall Study|Adverse Event|5|||
33457025|NCT00283842|101560963|FG000|Overall Study|Protocol Violation|1|||
33457026|NCT00283842|101560964|FG001|Overall Study|Protocol Violation|5|||
33457027|NCT00283842|101560965|FG002|Overall Study|Protocol Violation|4|||
33457028|NCT00283842|101560966|FG003|Overall Study|Protocol Violation|0|||
33457029|NCT00283842|101560967|FG004|Overall Study|Protocol Violation|0|||
33457030|NCT00283842|101560963|FG000|Overall Study|Protocol deviation|0|||
33457031|NCT00283842|101560964|FG001|Overall Study|Protocol deviation|0|||
33457032|NCT00283842|101560965|FG002|Overall Study|Protocol deviation|0|||
33457033|NCT00283842|101560966|FG003|Overall Study|Protocol deviation|0|||
33457034|NCT00283842|101560967|FG004|Overall Study|Protocol deviation|2|||
33457035|NCT00283842|101560963|FG000|Overall Study|Withdrawal by Subject|2|||
33457036|NCT00283842|101560964|FG001|Overall Study|Withdrawal by Subject|1|||
33457037|NCT00283842|101560965|FG002|Overall Study|Withdrawal by Subject|1|||
33457038|NCT00283842|101560966|FG003|Overall Study|Withdrawal by Subject|5|||
33457039|NCT00283842|101560967|FG004|Overall Study|Withdrawal by Subject|4|||
33457040|NCT00283842|101560963|FG000|Overall Study|Lack of Efficacy|1|||
33457041|NCT00283842|101560964|FG001|Overall Study|Lack of Efficacy|3|||
33457042|NCT00283842|101560965|FG002|Overall Study|Lack of Efficacy|1|||
33173928|NCT02554812|100545691|FG021|Overall Study|Lost to Follow-up|0|||
33173929|NCT02554812|100545692|FG022|Overall Study|Lost to Follow-up|0|||
33173930|NCT02554812|100545693|FG023|Overall Study|Lost to Follow-up|0|||
33173931|NCT02554812|100545694|FG024|Overall Study|Lost to Follow-up|0|||
33173932|NCT02554812|100545695|FG025|Overall Study|Lost to Follow-up|0|||
33457043|NCT00283842|101560966|FG003|Overall Study|Lack of Efficacy|0|||
33457044|NCT00283842|101560967|FG004|Overall Study|Lack of Efficacy|3|||
33173933|NCT02554812|100545696|FG026|Overall Study|Lost to Follow-up|0|||
33173934|NCT02554812|100545670|FG000|Overall Study|Global deterioration of health status|4|||
33173935|NCT02554812|100545671|FG001|Overall Study|Global deterioration of health status|3|||
33173936|NCT02554812|100545672|FG002|Overall Study|Global deterioration of health status|3|||
33173937|NCT02554812|100545673|FG003|Overall Study|Global deterioration of health status|2|||
33457045|NCT00283842|101560963|FG000|Overall Study|Lost to Follow-up|0|||
33457046|NCT00283842|101560964|FG001|Overall Study|Lost to Follow-up|2|||
33457047|NCT00283842|101560965|FG002|Overall Study|Lost to Follow-up|4|||
33457048|NCT00283842|101560966|FG003|Overall Study|Lost to Follow-up|1|||
33457049|NCT00283842|101560967|FG004|Overall Study|Lost to Follow-up|1|||
33457050|NCT00562718|101560968|FG000|Overall Study|Death|1|||
33173938|NCT02554812|100545674|FG004|Overall Study|Global deterioration of health status|5|||
33457051|NCT00562718|101560968|FG000|Overall Study|Withdrawal by Subject|3|||
33457052|NCT00562718|101560968|FG000|Overall Study|Adverse Event|4|||
33457053|NCT00562718|101560968|FG000|Overall Study|Lack of Efficacy|2|||
33173939|NCT02554812|100545675|FG005|Overall Study|Global deterioration of health status|0|||
33173940|NCT02554812|100545676|FG006|Overall Study|Global deterioration of health status|2|||
33173941|NCT02554812|100545677|FG007|Overall Study|Global deterioration of health status|1|||
33173942|NCT02554812|100545678|FG008|Overall Study|Global deterioration of health status|1|||
33173943|NCT02554812|100545679|FG009|Overall Study|Global deterioration of health status|1|||
33173944|NCT02554812|100545680|FG010|Overall Study|Global deterioration of health status|2|||
33173945|NCT02554812|100545681|FG011|Overall Study|Global deterioration of health status|1|||
33173946|NCT02554812|100545682|FG012|Overall Study|Global deterioration of health status|0|||
33173947|NCT02554812|100545683|FG013|Overall Study|Global deterioration of health status|0|||
33173948|NCT02554812|100545684|FG014|Overall Study|Global deterioration of health status|0|||
33173949|NCT02554812|100545685|FG015|Overall Study|Global deterioration of health status|1|||
33173950|NCT02554812|100545686|FG016|Overall Study|Global deterioration of health status|0|||
33173951|NCT02554812|100545687|FG017|Overall Study|Global deterioration of health status|0|||
33173952|NCT02554812|100545688|FG018|Overall Study|Global deterioration of health status|0|||
33173953|NCT02554812|100545689|FG019|Overall Study|Global deterioration of health status|0|||
33173954|NCT02554812|100545690|FG020|Overall Study|Global deterioration of health status|0|||
33173955|NCT02554812|100545691|FG021|Overall Study|Global deterioration of health status|0|||
33173956|NCT02554812|100545692|FG022|Overall Study|Global deterioration of health status|0|||
33173957|NCT02554812|100545693|FG023|Overall Study|Global deterioration of health status|0|||
33173958|NCT02554812|100545694|FG024|Overall Study|Global deterioration of health status|0|||
33173959|NCT02554812|100545695|FG025|Overall Study|Global deterioration of health status|0|||
33173960|NCT02554812|100545696|FG026|Overall Study|Global deterioration of health status|0|||
33173961|NCT02554812|100545670|FG000|Overall Study|Progressive disease|20|||
33173962|NCT02554812|100545671|FG001|Overall Study|Progressive disease|16|||
33173963|NCT02554812|100545672|FG002|Overall Study|Progressive disease|19|||
33173964|NCT02554812|100545673|FG003|Overall Study|Progressive disease|18|||
33173965|NCT02554812|100545674|FG004|Overall Study|Progressive disease|21|||
33173966|NCT02554812|100545675|FG005|Overall Study|Progressive disease|15|||
33173967|NCT02554812|100545676|FG006|Overall Study|Progressive disease|6|||
33173968|NCT02554812|100545677|FG007|Overall Study|Progressive disease|13|||
33173969|NCT02554812|100545678|FG008|Overall Study|Progressive disease|6|||
33173970|NCT02554812|100545679|FG009|Overall Study|Progressive disease|6|||
33173971|NCT02554812|100545680|FG010|Overall Study|Progressive disease|8|||
33173972|NCT02554812|100545681|FG011|Overall Study|Progressive disease|8|||
33173973|NCT02554812|100545682|FG012|Overall Study|Progressive disease|6|||
33173974|NCT02554812|100545683|FG013|Overall Study|Progressive disease|10|||
33173975|NCT02554812|100545684|FG014|Overall Study|Progressive disease|20|||
33173976|NCT02554812|100545685|FG015|Overall Study|Progressive disease|6|||
33173977|NCT02554812|100545686|FG016|Overall Study|Progressive disease|3|||
33173978|NCT02554812|100545687|FG017|Overall Study|Progressive disease|3|||
33173979|NCT02554812|100545688|FG018|Overall Study|Progressive disease|11|||
33173980|NCT02554812|100545689|FG019|Overall Study|Progressive disease|7|||
33173981|NCT02554812|100545690|FG020|Overall Study|Progressive disease|11|||
33173982|NCT02554812|100545691|FG021|Overall Study|Progressive disease|6|||
33173983|NCT02554812|100545692|FG022|Overall Study|Progressive disease|9|||
33173984|NCT02554812|100545693|FG023|Overall Study|Progressive disease|9|||
33173985|NCT02554812|100545694|FG024|Overall Study|Progressive disease|4|||
33173986|NCT02554812|100545695|FG025|Overall Study|Progressive disease|5|||
33173987|NCT02554812|100545696|FG026|Overall Study|Progressive disease|5|||
33173988|NCT02554812|100545670|FG000|Overall Study|Other|0|||
33173989|NCT02554812|100545671|FG001|Overall Study|Other|0|||
33173990|NCT02554812|100545672|FG002|Overall Study|Other|2|||
33173991|NCT02554812|100545673|FG003|Overall Study|Other|3|||
33173992|NCT02554812|100545674|FG004|Overall Study|Other|2|||
33173993|NCT02554812|100545675|FG005|Overall Study|Other|1|||
33173994|NCT02554812|100545676|FG006|Overall Study|Other|0|||
33173995|NCT02554812|100545677|FG007|Overall Study|Other|0|||
33173996|NCT02554812|100545678|FG008|Overall Study|Other|1|||
33173997|NCT02554812|100545679|FG009|Overall Study|Other|1|||
33173998|NCT02554812|100545680|FG010|Overall Study|Other|0|||
33173999|NCT02554812|100545681|FG011|Overall Study|Other|0|||
33262364|NCT02910713|100860365|FG000|Overall Study|Received One Application|10|||
33174000|NCT02554812|100545682|FG012|Overall Study|Other|1|||
33174001|NCT02554812|100545683|FG013|Overall Study|Other|0|||
33174002|NCT02554812|100545684|FG014|Overall Study|Other|1|||
33174003|NCT02554812|100545685|FG015|Overall Study|Other|0|||
33174004|NCT02554812|100545686|FG016|Overall Study|Other|0|||
33174005|NCT02554812|100545687|FG017|Overall Study|Other|0|||
33174006|NCT02554812|100545688|FG018|Overall Study|Other|0|||
33174007|NCT02554812|100545689|FG019|Overall Study|Other|0|||
33174008|NCT02554812|100545690|FG020|Overall Study|Other|0|||
33262365|NCT02910713|100860365|FG000|Overall Study|Received Neither Application|18|||
33174009|NCT02554812|100545691|FG021|Overall Study|Other|2|||
33262366|NCT02910713|100860365|FG000|Overall Study|Enrollment cap|7|||
33174010|NCT02554812|100545692|FG022|Overall Study|Other|0|||
33174011|NCT02554812|100545693|FG023|Overall Study|Other|0|||
33174012|NCT02554812|100545694|FG024|Overall Study|Other|0|||
33174013|NCT02554812|100545695|FG025|Overall Study|Other|0|||
33457054|NCT00562718|101560968|FG000|Overall Study|not stated|1|||
33457055|NCT01292837|101560969|FG000|Overall Study|Adverse Event|1|||
33174014|NCT02554812|100545696|FG026|Overall Study|Other|0|||
33174015|NCT02554812|100545670|FG000|Overall Study|Withdrawal by Subject|1|||
33174016|NCT02554812|100545671|FG001|Overall Study|Withdrawal by Subject|0|||
33457056|NCT01292837|101560969|FG000|Overall Study|Further treatment determined|1|||
33457057|NCT02308241|101560970|FG000|Overall Study|Withdrawal by Subject|3|||
33457058|NCT00494013|101560971|FG000|Overall Study|Adverse Event|0|||
33174017|NCT02554812|100545672|FG002|Overall Study|Withdrawal by Subject|0|||
33174018|NCT02554812|100545673|FG003|Overall Study|Withdrawal by Subject|2|||
33174019|NCT02554812|100545674|FG004|Overall Study|Withdrawal by Subject|2|||
33174020|NCT02554812|100545675|FG005|Overall Study|Withdrawal by Subject|3|||
33174021|NCT02554812|100545676|FG006|Overall Study|Withdrawal by Subject|0|||
33174022|NCT02554812|100545677|FG007|Overall Study|Withdrawal by Subject|0|||
33174023|NCT02554812|100545678|FG008|Overall Study|Withdrawal by Subject|1|||
33174024|NCT02554812|100545679|FG009|Overall Study|Withdrawal by Subject|1|||
33174025|NCT02554812|100545680|FG010|Overall Study|Withdrawal by Subject|0|||
33174026|NCT02554812|100545681|FG011|Overall Study|Withdrawal by Subject|1|||
33174027|NCT02554812|100545682|FG012|Overall Study|Withdrawal by Subject|1|||
33174028|NCT02554812|100545683|FG013|Overall Study|Withdrawal by Subject|1|||
33174029|NCT02554812|100545684|FG014|Overall Study|Withdrawal by Subject|1|||
33174030|NCT02554812|100545685|FG015|Overall Study|Withdrawal by Subject|1|||
33174031|NCT02554812|100545686|FG016|Overall Study|Withdrawal by Subject|3|||
33174032|NCT02554812|100545687|FG017|Overall Study|Withdrawal by Subject|1|||
33174033|NCT02554812|100545688|FG018|Overall Study|Withdrawal by Subject|0|||
33174034|NCT02554812|100545689|FG019|Overall Study|Withdrawal by Subject|2|||
33174035|NCT02554812|100545690|FG020|Overall Study|Withdrawal by Subject|0|||
33174036|NCT02554812|100545691|FG021|Overall Study|Withdrawal by Subject|1|||
33174037|NCT02554812|100545692|FG022|Overall Study|Withdrawal by Subject|0|||
33174038|NCT02554812|100545693|FG023|Overall Study|Withdrawal by Subject|1|||
33174039|NCT02554812|100545694|FG024|Overall Study|Withdrawal by Subject|0|||
33174040|NCT02554812|100545695|FG025|Overall Study|Withdrawal by Subject|0|||
33174041|NCT02554812|100545696|FG026|Overall Study|Withdrawal by Subject|1|||
33174042|NCT02554812|100545670|FG000|Overall Study|Physician Decision|1|||
33174043|NCT02554812|100545671|FG001|Overall Study|Physician Decision|0|||
33174044|NCT02554812|100545672|FG002|Overall Study|Physician Decision|0|||
33174045|NCT02554812|100545673|FG003|Overall Study|Physician Decision|1|||
33174046|NCT02554812|100545674|FG004|Overall Study|Physician Decision|0|||
33174047|NCT02554812|100545675|FG005|Overall Study|Physician Decision|1|||
33174048|NCT02554812|100545676|FG006|Overall Study|Physician Decision|0|||
33174049|NCT02554812|100545677|FG007|Overall Study|Physician Decision|0|||
33174050|NCT02554812|100545678|FG008|Overall Study|Physician Decision|0|||
33174051|NCT02554812|100545679|FG009|Overall Study|Physician Decision|0|||
33174052|NCT02554812|100545680|FG010|Overall Study|Physician Decision|1|||
33174053|NCT02554812|100545681|FG011|Overall Study|Physician Decision|0|||
33457059|NCT00494013|101560972|FG001|Overall Study|Adverse Event|1|||
33457060|NCT00494013|101560971|FG000|Overall Study|Entry Criteria Not Met|1|||
33457061|NCT00494013|101560972|FG001|Overall Study|Entry Criteria Not Met|4|||
33457062|NCT00494013|101560971|FG000|Overall Study|Lost to Follow-up|5|||
33457063|NCT00494013|101560972|FG001|Overall Study|Lost to Follow-up|6|||
33457064|NCT00494013|101560971|FG000|Overall Study|Physician Decision|3|||
33457065|NCT00494013|101560972|FG001|Overall Study|Physician Decision|5|||
33457066|NCT00494013|101560971|FG000|Overall Study|Protocol Violation|8|||
33457067|NCT00494013|101560972|FG001|Overall Study|Protocol Violation|5|||
33457068|NCT00494013|101560971|FG000|Overall Study|Withdrawal by Subject|13|||
33457069|NCT00494013|101560972|FG001|Overall Study|Withdrawal by Subject|14|||
33457070|NCT00494013|101560971|FG000|Overall Study|Sponsor Decision|0|||
33457071|NCT00494013|101560972|FG001|Overall Study|Sponsor Decision|1|||
33457072|NCT00393705|101560973|FG000|Overall Study|Adverse Event|0|||
33457073|NCT00393705|101560974|FG001|Overall Study|Adverse Event|2|||
33457074|NCT00393705|101560973|FG000|Overall Study|Death|0|||
33174054|NCT02554812|100545682|FG012|Overall Study|Physician Decision|0|||
33174055|NCT02554812|100545683|FG013|Overall Study|Physician Decision|0|||
33174056|NCT02554812|100545684|FG014|Overall Study|Physician Decision|0|||
33174057|NCT02554812|100545685|FG015|Overall Study|Physician Decision|0|||
33457075|NCT00393705|101560974|FG001|Overall Study|Death|1|||
33457076|NCT00393705|101560973|FG000|Overall Study|Lost to Follow-up|2|||
33174058|NCT02554812|100545686|FG016|Overall Study|Physician Decision|1|||
33174059|NCT02554812|100545687|FG017|Overall Study|Physician Decision|1|||
33174060|NCT02554812|100545688|FG018|Overall Study|Physician Decision|0|||
33174061|NCT02554812|100545689|FG019|Overall Study|Physician Decision|1|||
33174062|NCT02554812|100545690|FG020|Overall Study|Physician Decision|1|||
33174063|NCT02554812|100545691|FG021|Overall Study|Physician Decision|0|||
33174064|NCT02554812|100545692|FG022|Overall Study|Physician Decision|1|||
33457077|NCT00393705|101560974|FG001|Overall Study|Lost to Follow-up|2|||
33457078|NCT00393705|101560973|FG000|Overall Study|Entry Criteria Not Met|10|||
33457079|NCT00393705|101560974|FG001|Overall Study|Entry Criteria Not Met|10|||
33174065|NCT02554812|100545693|FG023|Overall Study|Physician Decision|0|||
33174066|NCT02554812|100545694|FG024|Overall Study|Physician Decision|0|||
33174067|NCT02554812|100545695|FG025|Overall Study|Physician Decision|0|||
33174068|NCT02554812|100545696|FG026|Overall Study|Physician Decision|0|||
33174069|NCT02554812|100545670|FG000|Overall Study|Study terminated by sponsor|0|||
33174070|NCT02554812|100545671|FG001|Overall Study|Study terminated by sponsor|0|||
33174071|NCT02554812|100545672|FG002|Overall Study|Study terminated by sponsor|0|||
33174072|NCT02554812|100545673|FG003|Overall Study|Study terminated by sponsor|0|||
33174073|NCT02554812|100545674|FG004|Overall Study|Study terminated by sponsor|0|||
33174074|NCT02554812|100545675|FG005|Overall Study|Study terminated by sponsor|0|||
33174075|NCT02554812|100545676|FG006|Overall Study|Study terminated by sponsor|0|||
33174076|NCT02554812|100545677|FG007|Overall Study|Study terminated by sponsor|0|||
33174077|NCT02554812|100545678|FG008|Overall Study|Study terminated by sponsor|0|||
33174078|NCT02554812|100545679|FG009|Overall Study|Study terminated by sponsor|0|||
33174079|NCT02554812|100545680|FG010|Overall Study|Study terminated by sponsor|0|||
33174080|NCT02554812|100545681|FG011|Overall Study|Study terminated by sponsor|0|||
33174081|NCT02554812|100545682|FG012|Overall Study|Study terminated by sponsor|0|||
33174082|NCT02554812|100545683|FG013|Overall Study|Study terminated by sponsor|0|||
33174083|NCT02554812|100545684|FG014|Overall Study|Study terminated by sponsor|0|||
33174084|NCT02554812|100545685|FG015|Overall Study|Study terminated by sponsor|0|||
33174085|NCT02554812|100545686|FG016|Overall Study|Study terminated by sponsor|0|||
33174086|NCT02554812|100545687|FG017|Overall Study|Study terminated by sponsor|0|||
33174087|NCT02554812|100545688|FG018|Overall Study|Study terminated by sponsor|0|||
33174088|NCT02554812|100545689|FG019|Overall Study|Study terminated by sponsor|0|||
33174089|NCT02554812|100545690|FG020|Overall Study|Study terminated by sponsor|0|||
33174090|NCT02554812|100545691|FG021|Overall Study|Study terminated by sponsor|0|||
33174091|NCT02554812|100545692|FG022|Overall Study|Study terminated by sponsor|0|||
33174092|NCT02554812|100545693|FG023|Overall Study|Study terminated by sponsor|0|||
33174093|NCT02554812|100545694|FG024|Overall Study|Study terminated by sponsor|1|||
33174094|NCT02554812|100545695|FG025|Overall Study|Study terminated by sponsor|0|||
33174095|NCT02554812|100545696|FG026|Overall Study|Study terminated by sponsor|0|||
33457080|NCT00393705|101560973|FG000|Overall Study|Protocol Violation|4|||
33457081|NCT00393705|101560974|FG001|Overall Study|Protocol Violation|3|||
33457082|NCT00393705|101560973|FG000|Overall Study|Withdrawal by Subject|5|||
33457083|NCT00393705|101560974|FG001|Overall Study|Withdrawal by Subject|3|||
33457084|NCT00393705|101560973|FG000|Overall Study|Physician Decision|2|||
33457085|NCT00393705|101560974|FG001|Overall Study|Physician Decision|2|||
33457086|NCT01624233|101560975|FG000|Period 2 - Induction|Adverse Event|1|||
33457087|NCT01624233|101560975|FG000|Period 3 - Maintenance|Adverse Event|2|||
33457088|NCT01624233|101560975|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
33457089|NCT01624233|101560975|FG000|Period 3 - Maintenance|Physician Decision|2|||
33457090|NCT01624233|101560975|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
33457091|NCT01624233|101560975|FG000|Period 4 - Drug Free Period|Relapsed|61|||
33174096|NCT02554812|100545670|FG000|Overall Study|No longer meets eligibility criteria|0|||
33174097|NCT02554812|100545671|FG001|Overall Study|No longer meets eligibility criteria|1|||
33174098|NCT02554812|100545672|FG002|Overall Study|No longer meets eligibility criteria|0|||
33174099|NCT02554812|100545673|FG003|Overall Study|No longer meets eligibility criteria|0|||
33174100|NCT02554812|100545674|FG004|Overall Study|No longer meets eligibility criteria|0|||
33174101|NCT02554812|100545675|FG005|Overall Study|No longer meets eligibility criteria|0|||
33174102|NCT02554812|100545676|FG006|Overall Study|No longer meets eligibility criteria|0|||
33457092|NCT01624233|101560975|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
33174103|NCT02554812|100545677|FG007|Overall Study|No longer meets eligibility criteria|0|||
33174104|NCT02554812|100545678|FG008|Overall Study|No longer meets eligibility criteria|0|||
33174105|NCT02554812|100545679|FG009|Overall Study|No longer meets eligibility criteria|0|||
33174106|NCT02554812|100545680|FG010|Overall Study|No longer meets eligibility criteria|0|||
33174107|NCT02554812|100545681|FG011|Overall Study|No longer meets eligibility criteria|0|||
33174108|NCT02554812|100545682|FG012|Overall Study|No longer meets eligibility criteria|0|||
33174109|NCT02554812|100545683|FG013|Overall Study|No longer meets eligibility criteria|0|||
33174110|NCT02554812|100545684|FG014|Overall Study|No longer meets eligibility criteria|0|||
33174111|NCT02554812|100545685|FG015|Overall Study|No longer meets eligibility criteria|0|||
33174112|NCT02554812|100545686|FG016|Overall Study|No longer meets eligibility criteria|0|||
33174113|NCT02554812|100545687|FG017|Overall Study|No longer meets eligibility criteria|0|||
33174114|NCT02554812|100545688|FG018|Overall Study|No longer meets eligibility criteria|0|||
33174115|NCT02554812|100545689|FG019|Overall Study|No longer meets eligibility criteria|0|||
33174116|NCT02554812|100545690|FG020|Overall Study|No longer meets eligibility criteria|0|||
33174117|NCT02554812|100545691|FG021|Overall Study|No longer meets eligibility criteria|0|||
33174118|NCT02554812|100545692|FG022|Overall Study|No longer meets eligibility criteria|0|||
33174119|NCT02554812|100545693|FG023|Overall Study|No longer meets eligibility criteria|0|||
33174120|NCT02554812|100545694|FG024|Overall Study|No longer meets eligibility criteria|0|||
33174121|NCT02554812|100545695|FG025|Overall Study|No longer meets eligibility criteria|0|||
33174122|NCT02554812|100545696|FG026|Overall Study|No longer meets eligibility criteria|0|||
33174123|NCT02446990|100545698|FG000|Overall Study|Death|485|||
33174124|NCT02446990|100545699|FG001|Overall Study|Death|458|||
33174125|NCT02446990|100545698|FG000|Overall Study|Lost to Follow-up|3|||
33174126|NCT02446990|100545699|FG001|Overall Study|Lost to Follow-up|1|||
33174127|NCT02446990|100545698|FG000|Overall Study|Physician Decision|1|||
33174128|NCT02446990|100545699|FG001|Overall Study|Physician Decision|0|||
33174129|NCT02446990|100545698|FG000|Overall Study|Withdrawal by Subject|231|||
33174130|NCT02446990|100545699|FG001|Overall Study|Withdrawal by Subject|199|||
33174131|NCT02887521|100545700|FG000|Overall Study|Withdrawal by Subject|0|||
33174132|NCT02887521|100545701|FG001|Overall Study|Withdrawal by Subject|3|||
33174133|NCT02626520|100545715|FG000|Overall Study|Physician Decision|1|||
33174134|NCT02626520|100545716|FG001|Overall Study|Physician Decision|1|||
33174135|NCT02626520|100545715|FG000|Overall Study|Adverse Event|0|||
33174136|NCT02626520|100545716|FG001|Overall Study|Adverse Event|4|||
33174137|NCT02626520|100545715|FG000|Overall Study|Lack of Efficacy|0|||
33174138|NCT02626520|100545716|FG001|Overall Study|Lack of Efficacy|2|||
33174139|NCT02626520|100545715|FG000|Overall Study|Did not start protocol therapy|0|||
33174140|NCT02626520|100545716|FG001|Overall Study|Did not start protocol therapy|2|||
33174141|NCT02626520|100545715|FG000|Overall Study|Study terminated|0|||
33174142|NCT02626520|100545716|FG001|Overall Study|Study terminated|1|||
33174143|NCT01244906|100545717|FG000|Overall Study|Death|2|||
33174144|NCT01244906|100545717|FG000|Overall Study|Progression of disease post treatment|6|||
33174145|NCT02111850|100545719|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33174146|NCT02111850|100545720|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33174147|NCT02111850|100545721|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33174148|NCT02111850|100545722|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33174149|NCT02111850|100545723|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
33174150|NCT02111850|100545724|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33174151|NCT02111850|100545725|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33174152|NCT02111850|100545726|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33174153|NCT02111850|100545727|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33174154|NCT02111850|100545728|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33174155|NCT02111850|100545729|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
33174156|NCT01320085|100545738|FG000|Overall Study|Disease Progression|26|||
33174157|NCT01320085|100545739|FG001|Overall Study|Disease Progression|93|||
33174158|NCT01320085|100545740|FG002|Overall Study|Disease Progression|17|||
33174159|NCT01320085|100545738|FG000|Overall Study|Adverse Event|12|||
33174160|NCT01320085|100545739|FG001|Overall Study|Adverse Event|20|||
33174161|NCT01320085|100545740|FG002|Overall Study|Adverse Event|5|||
33174162|NCT01320085|100545738|FG000|Overall Study|Withdrawal by Subject|2|||
33174163|NCT01320085|100545739|FG001|Overall Study|Withdrawal by Subject|4|||
33174164|NCT01320085|100545740|FG002|Overall Study|Withdrawal by Subject|1|||
33174165|NCT01320085|100545738|FG000|Overall Study|Protocol Deviation|1|||
33174166|NCT01320085|100545739|FG001|Overall Study|Protocol Deviation|0|||
33174167|NCT01320085|100545740|FG002|Overall Study|Protocol Deviation|1|||
33174168|NCT01320085|100545738|FG000|Overall Study|Administrative problems|0|||
33174169|NCT01320085|100545739|FG001|Overall Study|Administrative problems|0|||
33174170|NCT01320085|100545740|FG002|Overall Study|Administrative problems|1|||
33174171|NCT02154490|100545741|FG000|Overall Study|No tissue submitted|23|||
33174172|NCT02154490|100545741|FG000|Overall Study|No biomarker results|167|||
33174173|NCT02154490|100545741|FG000|Overall Study|Not assigned to a sub-study|270|||
33174174|NCT02154490|100545741|FG000|Overall Study|Did not register to a sub-study|749|||
33174175|NCT00619801|100545744|FG000|Overall Study|Lack of Efficacy|0|||
33174176|NCT00619801|100545745|FG001|Overall Study|Lack of Efficacy|1|||
33174177|NCT00619801|100545744|FG000|Overall Study|Withdrawal by Subject|1|||
33174178|NCT00619801|100545745|FG001|Overall Study|Withdrawal by Subject|1|||
33174179|NCT00619801|100545744|FG000|Overall Study|Loss of efficacy|0|||
33174180|NCT00619801|100545745|FG001|Overall Study|Loss of efficacy|1|||
33174181|NCT03336333|100545746|FG000|Overall Study|Remained on study at time of data cut-off|202|||
33174182|NCT03336333|100545747|FG001|Overall Study|Remained on study at time of data cut-off|219|||
33174183|NCT03336333|100545748|FG002|Overall Study|Remained on study at time of data cut-off|102|||
33174184|NCT03336333|100545746|FG000|Overall Study|Death|14|||
33174185|NCT03336333|100545747|FG001|Overall Study|Death|16|||
33174186|NCT03336333|100545748|FG002|Overall Study|Death|8|||
33174187|NCT03336333|100545746|FG000|Overall Study|Withdrawal by Subject|16|||
33174188|NCT03336333|100545747|FG001|Overall Study|Withdrawal by Subject|5|||
33174189|NCT03336333|100545748|FG002|Overall Study|Withdrawal by Subject|1|||
33174190|NCT03336333|100545746|FG000|Overall Study|Physician Decision|5|||
33174191|NCT03336333|100545747|FG001|Overall Study|Physician Decision|1|||
33174192|NCT03336333|100545748|FG002|Overall Study|Physician Decision|0|||
33174193|NCT03336333|100545746|FG000|Overall Study|Lost to Follow-up|1|||
33174194|NCT03336333|100545747|FG001|Overall Study|Lost to Follow-up|0|||
33174195|NCT03336333|100545748|FG002|Overall Study|Lost to Follow-up|0|||
33174196|NCT03042533|100545749|FG000|Overall Study|MD left program|1|||
33174197|NCT03042533|100545750|FG001|Overall Study|MD left program|4|||
33174198|NCT03042533|100545751|FG002|Overall Study|MD left program|1|||
33174199|NCT01957644|100545754|FG000|Overall Study|Adverse Event|4|||
33174200|NCT01957644|100545755|FG001|Overall Study|Adverse Event|2|||
33174201|NCT01957644|100545756|FG002|Overall Study|Adverse Event|0|||
33174202|NCT01957644|100545757|FG003|Overall Study|Adverse Event|0|||
33174203|NCT01957644|100545758|FG004|Overall Study|Adverse Event|1|||
33174204|NCT01957644|100545754|FG000|Overall Study|Progressive disease / relapse|0|||
33174205|NCT01957644|100545755|FG001|Overall Study|Progressive disease / relapse|1|||
33174206|NCT01957644|100545756|FG002|Overall Study|Progressive disease / relapse|0|||
33174207|NCT01957644|100545757|FG003|Overall Study|Progressive disease / relapse|1|||
33174208|NCT01957644|100545758|FG004|Overall Study|Progressive disease / relapse|0|||
33174209|NCT01957644|100545754|FG000|Overall Study|Other reason|1|||
33174210|NCT01957644|100545755|FG001|Overall Study|Other reason|2|||
33174211|NCT01957644|100545756|FG002|Overall Study|Other reason|1|||
33174212|NCT01957644|100545757|FG003|Overall Study|Other reason|1|||
33174213|NCT01957644|100545758|FG004|Overall Study|Other reason|0|||
33174214|NCT01957644|100545754|FG000|Overall Study|Withdrawal by Subject|1|||
33174215|NCT01957644|100545755|FG001|Overall Study|Withdrawal by Subject|0|||
33174216|NCT01957644|100545756|FG002|Overall Study|Withdrawal by Subject|0|||
33457093|NCT01624233|101560975|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
33174217|NCT01957644|100545757|FG003|Overall Study|Withdrawal by Subject|0|||
33174218|NCT01957644|100545758|FG004|Overall Study|Withdrawal by Subject|0|||
33174219|NCT01957644|100545754|FG000|Overall Study|Protocol Violation|0|||
33457094|NCT01624233|101560975|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
33174220|NCT01957644|100545755|FG001|Overall Study|Protocol Violation|1|||
33457095|NCT01624233|101560975|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
33457096|NCT01624233|101560975|FG000|Period 6: Follow-up|Adverse Event|3|||
33457097|NCT01624233|101560975|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
33457098|NCT01624233|101560975|FG000|Period 6: Follow-up|Physician Decision|1|||
33457099|NCT01624233|101560975|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
33457100|NCT00556673|101560976|FG000|Overall Study|Protocol deviation|3|||
33457101|NCT00556673|101560977|FG001|Overall Study|Protocol deviation|2|||
33457102|NCT00735696|101560978|FG000|Overall Study|Withdrawal by Subject|1|||
33457103|NCT00735696|101560978|FG000|Overall Study|Enrolled but never Treated|1|||
33457104|NCT02896296|101564184|FG000|Overall Study|Adverse Event|1|||
33457105|NCT02896296|101564184|FG000|Overall Study|Lost to Follow-up|19|||
33457106|NCT02896296|101564184|FG000|Overall Study|Pregnancy|1|||
33457107|NCT02896296|101564184|FG000|Overall Study|Physician Decision|2|||
33457108|NCT02896296|101564184|FG000|Overall Study|Withdrawal by Subject|10|||
33457109|NCT02896296|101564184|FG000|Overall Study|Site closing|7|||
33457110|NCT02896296|101564184|FG000|Overall Study|Incarceration|1|||
33457111|NCT02896296|101564184|FG000|Overall Study|Relocation|1|||
33457112|NCT02218541|101564185|FG000|Overall Study|Lost to Follow-up|2|||
33457113|NCT02218541|101564186|FG001|Overall Study|Lost to Follow-up|1|||
33457114|NCT02218541|101564185|FG000|Overall Study|Implant Failure|4|||
33457115|NCT02218541|101564186|FG001|Overall Study|Implant Failure|1|||
33457116|NCT02614196|101564187|FG000|Double Blind Treatment Phase|Adverse Event|8|||
33457117|NCT02614196|101564188|FG001|Double Blind Treatment Phase|Adverse Event|5|||
33457118|NCT02614196|101564189|FG002|Double Blind Treatment Phase|Adverse Event|9|||
33457119|NCT02614196|101564190|FG003|Double Blind Treatment Phase|Adverse Event|0|||
33457120|NCT02614196|101564191|FG004|Double Blind Treatment Phase|Adverse Event|0|||
33457121|NCT02614196|101564192|FG005|Double Blind Treatment Phase|Adverse Event|0|||
33457122|NCT02614196|101564187|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
33457123|NCT02614196|101564188|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
33457124|NCT02614196|101564189|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
33457125|NCT02614196|101564190|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
33457126|NCT02614196|101564191|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
33457127|NCT02614196|101564192|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
33457128|NCT02614196|101564187|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
33457129|NCT02614196|101564188|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
33457130|NCT02614196|101564189|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
33457131|NCT02614196|101564190|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
33457132|NCT02614196|101564191|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
33457133|NCT02614196|101564192|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
33457134|NCT02614196|101564187|FG000|Double Blind Treatment Phase|Physician Decision|4|||
33457135|NCT02614196|101564188|FG001|Double Blind Treatment Phase|Physician Decision|0|||
33457136|NCT02614196|101564189|FG002|Double Blind Treatment Phase|Physician Decision|2|||
33457137|NCT02614196|101564190|FG003|Double Blind Treatment Phase|Physician Decision|0|||
33457138|NCT02614196|101564191|FG004|Double Blind Treatment Phase|Physician Decision|0|||
33457139|NCT02614196|101564192|FG005|Double Blind Treatment Phase|Physician Decision|0|||
33457140|NCT02614196|101564187|FG000|Double Blind Treatment Phase|Pregnancy|1|||
33457141|NCT02614196|101564188|FG001|Double Blind Treatment Phase|Pregnancy|2|||
33457142|NCT02614196|101564189|FG002|Double Blind Treatment Phase|Pregnancy|0|||
33457143|NCT02614196|101564190|FG003|Double Blind Treatment Phase|Pregnancy|0|||
33457144|NCT02614196|101564191|FG004|Double Blind Treatment Phase|Pregnancy|0|||
33457145|NCT02614196|101564192|FG005|Double Blind Treatment Phase|Pregnancy|0|||
33457146|NCT02614196|101564187|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
33174221|NCT01957644|100545756|FG002|Overall Study|Protocol Violation|0|||
33174222|NCT01957644|100545757|FG003|Overall Study|Protocol Violation|0|||
33174223|NCT01957644|100545758|FG004|Overall Study|Protocol Violation|0|||
33174224|NCT01018186|100545759|FG000|2-week Run-in Period|Protocol Violation|1|||
33174225|NCT01018186|100545760|FG001|2-week Run-in Period|Protocol Violation|0|||
33457147|NCT02614196|101564188|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
33457148|NCT02614196|101564189|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
33457149|NCT02614196|101564190|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
33174226|NCT01018186|100545761|FG002|2-week Run-in Period|Protocol Violation|0|||
33457150|NCT02614196|101564191|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
33457151|NCT02614196|101564192|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
33457152|NCT02614196|101564187|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
33457153|NCT02614196|101564188|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
33457154|NCT02614196|101564189|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
33457155|NCT02614196|101564190|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
33457156|NCT02614196|101564191|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
33457157|NCT02614196|101564192|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
33174227|NCT01018186|100545762|FG003|2-week Run-in Period|Protocol Violation|0|||
33174228|NCT01018186|100545759|FG000|2-week Run-in Period|Lost to Follow-up|2|||
33262367|NCT02910713|100860365|FG000|Overall Study|Investigator Discretion|1|||
33262368|NCT02376790|100860371|FG000|Overall Study|Withdrawal by Subject|43|||
33457158|NCT02614196|101564187|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
33457159|NCT02614196|101564188|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
33457160|NCT02614196|101564189|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
33457161|NCT02614196|101564190|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
33457162|NCT02614196|101564191|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
33457163|NCT02614196|101564192|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
33457164|NCT02614196|101564187|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
33457165|NCT02614196|101564188|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
33457166|NCT02614196|101564189|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
33457167|NCT02614196|101564190|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
33457168|NCT02614196|101564191|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
33457169|NCT02614196|101564192|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
33457170|NCT02614196|101564187|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
33457171|NCT02614196|101564188|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
33457172|NCT02614196|101564189|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
33457173|NCT02614196|101564190|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
33457174|NCT02614196|101564191|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
33457175|NCT02614196|101564192|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
33457176|NCT02614196|101564187|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
33457177|NCT02614196|101564188|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
33457178|NCT02614196|101564189|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
33457179|NCT02614196|101564190|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
33457180|NCT02614196|101564191|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
33457181|NCT02614196|101564192|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
33457182|NCT02614196|101564187|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
33457183|NCT02614196|101564188|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
33457184|NCT02614196|101564189|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
33457185|NCT02614196|101564190|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
33457186|NCT02614196|101564191|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
33457187|NCT02614196|101564192|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
33457188|NCT02614196|101564187|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
33457189|NCT02614196|101564188|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
33457190|NCT02614196|101564189|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
33457191|NCT02614196|101564190|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
33457192|NCT02614196|101564191|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
33457193|NCT02614196|101564192|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
33457194|NCT03493919|101564194|FG000|Overall Study|Other|2|||
33174229|NCT01018186|100545760|FG001|2-week Run-in Period|Lost to Follow-up|0|||
33174230|NCT01018186|100545761|FG002|2-week Run-in Period|Lost to Follow-up|0|||
33174231|NCT01018186|100545762|FG003|2-week Run-in Period|Lost to Follow-up|0|||
33174232|NCT01018186|100545759|FG000|2-week Run-in Period|Physician Decision|3|||
33174233|NCT01018186|100545760|FG001|2-week Run-in Period|Physician Decision|0|||
33174234|NCT01018186|100545761|FG002|2-week Run-in Period|Physician Decision|0|||
33174235|NCT01018186|100545762|FG003|2-week Run-in Period|Physician Decision|0|||
33174236|NCT01018186|100545759|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
33174237|NCT01018186|100545760|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
33174238|NCT01018186|100545761|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
33174239|NCT01018186|100545762|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
33174240|NCT01018186|100545759|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
33174241|NCT01018186|100545760|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
33174242|NCT01018186|100545761|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
33174243|NCT01018186|100545762|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
33174244|NCT01018186|100545759|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
33174245|NCT01018186|100545760|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
33174246|NCT01018186|100545761|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
33174247|NCT01018186|100545762|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
33174248|NCT01018186|100545759|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
33174249|NCT01018186|100545760|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
33174250|NCT01018186|100545761|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
33174251|NCT01018186|100545762|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
33174252|NCT01018186|100545759|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
33174253|NCT01018186|100545760|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
33174254|NCT01018186|100545761|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
33174255|NCT01018186|100545762|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
33174256|NCT01018186|100545759|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
33174257|NCT01018186|100545760|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
33174258|NCT01018186|100545761|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
33174259|NCT01018186|100545762|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
33174260|NCT01018186|100545759|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
33174261|NCT01018186|100545760|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
33174262|NCT01018186|100545761|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
33174263|NCT01018186|100545762|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
33174264|NCT01018186|100545759|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
33174265|NCT01018186|100545760|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
33174266|NCT01018186|100545761|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
33174267|NCT01018186|100545762|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
33174268|NCT01018186|100545759|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
33174269|NCT01018186|100545760|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
33174270|NCT01018186|100545761|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
33174271|NCT01018186|100545762|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
33174272|NCT00142584|100545763|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
33174273|NCT00142584|100545764|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
33174274|NCT00142584|100545763|FG000|Overall Study|Withdrawal by Subject|30|||
33174275|NCT00142584|100545764|FG001|Overall Study|Withdrawal by Subject|16|||
33174276|NCT00142584|100545763|FG000|Overall Study|Lost to Follow-up|22|||
33174277|NCT00142584|100545764|FG001|Overall Study|Lost to Follow-up|12|||
33174278|NCT00142584|100545763|FG000|Overall Study|Adverse Event|14|||
33174279|NCT00142584|100545764|FG001|Overall Study|Adverse Event|5|||
33174280|NCT00142584|100545763|FG000|Overall Study|Protocol Violation|4|||
33174281|NCT00142584|100545764|FG001|Overall Study|Protocol Violation|7|||
33457195|NCT03493919|101564195|FG001|Overall Study|Other|0|||
33457196|NCT03493919|101564196|FG002|Overall Study|Other|1|||
33457197|NCT03493919|101564197|FG003|Overall Study|Other|0|||
33174282|NCT00142584|100545763|FG000|Overall Study|Treatment Failure|2|||
33174283|NCT00142584|100545764|FG001|Overall Study|Treatment Failure|0|||
33174284|NCT01722071|100545765|FG000|Overall Study|Protocol Violation|1|||
33457198|NCT03493919|101564194|FG000|Overall Study|Withdrawal by Subject|9|||
33174285|NCT01722071|100545766|FG001|Overall Study|Protocol Violation|0|||
33262369|NCT02376790|100860372|FG001|Overall Study|Withdrawal by Subject|36|||
33262370|NCT02376790|100860373|FG002|Overall Study|Withdrawal by Subject|37|||
33262371|NCT02376790|100860371|FG000|Overall Study|Decision by Sponsor|2|||
33262372|NCT02376790|100860372|FG001|Overall Study|Decision by Sponsor|1|||
33262373|NCT02376790|100860373|FG002|Overall Study|Decision by Sponsor|4|||
33457199|NCT03493919|101564195|FG001|Overall Study|Withdrawal by Subject|3|||
33457200|NCT03493919|101564196|FG002|Overall Study|Withdrawal by Subject|1|||
33457201|NCT03493919|101564197|FG003|Overall Study|Withdrawal by Subject|1|||
33262374|NCT02376790|100860371|FG000|Overall Study|Lost to Follow-up|15|||
33262375|NCT02376790|100860372|FG001|Overall Study|Lost to Follow-up|10|||
33262376|NCT02376790|100860373|FG002|Overall Study|Lost to Follow-up|12|||
33262377|NCT03631407|100863670|FG000|Overall Study|Withdrawal by Subject|3|||
33262378|NCT03631407|100863671|FG001|Overall Study|Withdrawal by Subject|2|||
33262379|NCT03631407|100863670|FG000|Overall Study|Sponsor Decision|0|||
33262380|NCT03631407|100863671|FG001|Overall Study|Sponsor Decision|2|||
33262381|NCT03631407|100863670|FG000|Overall Study|Death|16|||
33262382|NCT03631407|100863671|FG001|Overall Study|Death|16|||
33262383|NCT03631407|100863670|FG000|Overall Study|Randomized by mistake without study treatment|1|||
33262384|NCT03631407|100863671|FG001|Overall Study|Randomized by mistake without study treatment|0|||
33457202|NCT03493919|101564194|FG000|Overall Study|Lost to Follow-up|5|||
33457203|NCT03493919|101564195|FG001|Overall Study|Lost to Follow-up|0|||
33457204|NCT03493919|101564196|FG002|Overall Study|Lost to Follow-up|0|||
33457205|NCT03493919|101564197|FG003|Overall Study|Lost to Follow-up|3|||
33457206|NCT03493919|101564194|FG000|Overall Study|Adverse Event|0|||
33457207|NCT03493919|101564195|FG001|Overall Study|Adverse Event|1|||
33457208|NCT03493919|101564196|FG002|Overall Study|Adverse Event|0|||
33457209|NCT03493919|101564197|FG003|Overall Study|Adverse Event|0|||
33457210|NCT02179190|101564203|FG000|Enrollment|Exit Prior to Device Attempt|11|||
33457211|NCT02179190|101564203|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
33457212|NCT02179190|101564203|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
33457213|NCT02179190|101564203|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
33262385|NCT00439270|100863672|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
33262386|NCT00439270|100863673|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
33262387|NCT00439270|100863674|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
33262388|NCT00439270|100863675|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
33262389|NCT00439270|100863676|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
33262390|NCT00439270|100863672|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
33262391|NCT00439270|100863673|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
33262392|NCT00439270|100863674|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
33262393|NCT00439270|100863675|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
33262394|NCT00439270|100863676|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
33262395|NCT00439270|100863672|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
33262396|NCT00439270|100863673|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
33262397|NCT00439270|100863674|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
33262398|NCT00439270|100863675|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
33262399|NCT00439270|100863676|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
33262400|NCT00439270|100863672|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
33262401|NCT00439270|100863673|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
33262402|NCT00439270|100863674|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
33262403|NCT00439270|100863675|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
33262404|NCT00439270|100863676|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
33262405|NCT00439270|100863672|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
33262406|NCT00439270|100863673|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
33262407|NCT00439270|100863674|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
33262408|NCT00439270|100863675|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
33262409|NCT00439270|100863676|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
33262410|NCT00439270|100863672|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
33262411|NCT00439270|100863673|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
33262412|NCT00439270|100863674|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
33262413|NCT00439270|100863675|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
33262414|NCT00439270|100863676|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
33262415|NCT00439270|100863672|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
33262416|NCT00439270|100863673|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
33262417|NCT00439270|100863674|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
33262418|NCT00439270|100863675|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
33262419|NCT00439270|100863676|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
33262420|NCT00439270|100863672|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
33262421|NCT00439270|100863673|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
33262422|NCT00439270|100863674|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
33262423|NCT00439270|100863675|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
33262424|NCT00439270|100863676|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
33262425|NCT00439270|100863672|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
33262426|NCT00439270|100863673|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
33262427|NCT00439270|100863674|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
33262428|NCT00439270|100863675|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
33262429|NCT00439270|100863676|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
33262430|NCT00439270|100863672|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
33262431|NCT00439270|100863673|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
33262432|NCT00439270|100863674|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
33262433|NCT00439270|100863675|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
33262434|NCT00439270|100863676|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
33262435|NCT00670046|100863679|FG000|Overall Study|Lost to Follow-up|1|||
33262436|NCT00670046|100863680|FG001|Overall Study|Lost to Follow-up|1|||
33262437|NCT00670046|100863679|FG000|Overall Study|Withdrawal by Subject|0|||
33262438|NCT00670046|100863680|FG001|Overall Study|Withdrawal by Subject|1|||
33262439|NCT02767765|100863681|FG000|Overall Study|Adverse Event|4|||
33262440|NCT02767765|100863681|FG000|Overall Study|Death|1|||
33262441|NCT02767765|100863681|FG000|Overall Study|Insufficient response|1|||
33262442|NCT02767765|100863681|FG000|Overall Study|Lost to Follow-up|2|||
33457214|NCT02179190|101564203|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
33457215|NCT02179190|101564203|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
33262443|NCT02767765|100863681|FG000|Overall Study|Investigator decision|1|||
33262444|NCT02767765|100863681|FG000|Overall Study|Non-Compliance|1|||
33262445|NCT02767765|100863681|FG000|Overall Study|Withdrawal by Subject|1|||
33262446|NCT02962284|100863683|FG000|Overall Study|Death|2|||
33262447|NCT02962284|100863684|FG001|Overall Study|Death|0|||
33262448|NCT02962284|100863683|FG000|Overall Study|Progressive disease|2|||
33262449|NCT02962284|100863684|FG001|Overall Study|Progressive disease|3|||
33262450|NCT02962284|100863683|FG000|Overall Study|Withdrawal by Subject|1|||
33262451|NCT02962284|100863684|FG001|Overall Study|Withdrawal by Subject|0|||
33262452|NCT02566902|100863685|FG000|Overall Study|Protocol Violation|2|||
33262453|NCT02566902|100863686|FG001|Overall Study|Protocol Violation|1|||
33262454|NCT03689946|100863687|FG000|Overall Study|Withdrawal by Subject|3|||
33262455|NCT03689946|100863687|FG000|Overall Study|Lost to Follow-up|3|||
33262456|NCT03689946|100863687|FG000|Overall Study|Data corruption|2|||
33262457|NCT01532648|100863688|FG000|Overall Study|Lost to Follow-up|3|||
33262458|NCT01532648|100863689|FG001|Overall Study|Lost to Follow-up|4|||
33262459|NCT01532648|100863688|FG000|Overall Study|Lack of Efficacy|4|||
33262460|NCT01532648|100863689|FG001|Overall Study|Lack of Efficacy|1|||
33262461|NCT01532648|100863688|FG000|Overall Study|Protocol Violation|1|||
33262462|NCT01532648|100863689|FG001|Overall Study|Protocol Violation|1|||
33262463|NCT01532648|100863688|FG000|Overall Study|Adverse Event|12|||
33262464|NCT01532648|100863689|FG001|Overall Study|Adverse Event|9|||
33262465|NCT01532648|100863688|FG000|Overall Study|Withdrawal by Subject|16|||
33262466|NCT01532648|100863689|FG001|Overall Study|Withdrawal by Subject|2|||
33262467|NCT01596972|100863691|FG000|Overall Study|Physician Decision|1|||
33262468|NCT01596972|100863692|FG001|Overall Study|Physician Decision|9|||
33262469|NCT01596972|100863691|FG000|Overall Study|Lost to Follow-up|0|||
33262470|NCT01596972|100863692|FG001|Overall Study|Lost to Follow-up|4|||
33262471|NCT01596972|100863691|FG000|Overall Study|Withdrawal by Subject|0|||
33262472|NCT01596972|100863692|FG001|Overall Study|Withdrawal by Subject|1|||
33262473|NCT00491894|100863693|FG000|Overall Study|Adverse Event|14|||
33262474|NCT00491894|100863693|FG000|Overall Study|Withdrawal by Subject|5|||
33262475|NCT00491894|100863693|FG000|Overall Study|Death|3|||
33262476|NCT00491894|100863693|FG000|Overall Study|Lost to Follow-up|3|||
33457216|NCT03257254|101564204|FG000|Overall Study|Withdrawal by Subject|7|||
33457217|NCT03257254|101564204|FG000|Overall Study|Lost to Follow-up|9|||
33457218|NCT03257254|101564204|FG000|Overall Study|Study discontinued by sponsor|5|||
33457219|NCT02473393|101564205|FG000|Overall Study|Adverse Event|0|||
33457220|NCT02473393|101564206|FG001|Overall Study|Adverse Event|0|||
33457221|NCT02473393|101564207|FG002|Overall Study|Adverse Event|1|||
33457222|NCT02473393|101564208|FG003|Overall Study|Adverse Event|0|||
33457223|NCT02473393|101564205|FG000|Overall Study|Withdrawal by Subject|0|||
33457224|NCT02473393|101564206|FG001|Overall Study|Withdrawal by Subject|0|||
33457225|NCT02473393|101564207|FG002|Overall Study|Withdrawal by Subject|1|||
33457226|NCT02473393|101564208|FG003|Overall Study|Withdrawal by Subject|1|||
33457227|NCT04974580|101564209|FG000|Overall Study|Lost to Follow-up|33|||
33457228|NCT04974580|101564210|FG001|Overall Study|Lost to Follow-up|39|||
33457229|NCT04974580|101564211|FG002|Overall Study|Lost to Follow-up|30|||
33457230|NCT04974580|101564212|FG003|Overall Study|Lost to Follow-up|29|||
33262477|NCT00491894|100863693|FG000|Overall Study|Lack of Efficacy|2|||
33262478|NCT00491894|100863693|FG000|Overall Study|Other-Failed to meet any criteria|2|||
33262479|NCT00491894|100863693|FG000|Overall Study|Physician Decision|2|||
33262480|NCT00491894|100863693|FG000|Overall Study|Protocol Violation|2|||
33262481|NCT00491894|100863693|FG000|Overall Study|Other-Intake of prohibited medication|1|||
33262482|NCT02251652|100863694|FG000|Overall Study|Withdrawal by Subject|1|||
33262483|NCT01637402|100863695|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
33262484|NCT01637402|100863696|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
33262485|NCT01637402|100863695|FG000|Standard Dose Regimen|Adverse Event|1|||
33262486|NCT01637402|100863696|FG001|Standard Dose Regimen|Adverse Event|0|||
33457231|NCT00413049|101564213|FG000|Overall Study|Adverse Event|10|||
33457232|NCT00413049|101564214|FG001|Overall Study|Adverse Event|8|||
33457233|NCT00413049|101564213|FG000|Overall Study|Withdrawal by Subject|7|||
33262487|NCT01637402|100863695|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
33262488|NCT01637402|100863696|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
33262489|NCT01637402|100863695|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
33262490|NCT01637402|100863696|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
33262491|NCT01637402|100863695|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
33262492|NCT01637402|100863696|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
33262493|NCT01637402|100863695|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
33262494|NCT01637402|100863696|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
33262495|NCT05824559|100863697|FG000|Overall Study|Adverse Event|2|||
33262496|NCT05824559|100863697|FG000|Overall Study|Physician Decision|2|||
33262497|NCT05824559|100863697|FG000|Overall Study|Progressive Disease|16|||
33262498|NCT05824559|100863697|FG000|Overall Study|Study Terminated by Sponsor|1|||
33262499|NCT05824559|100863697|FG000|Overall Study|Withdrawal by Subject|2|||
33262500|NCT01629589|100863698|FG000|Overall Study|Protocol Violation|4|||
33262501|NCT01629589|100863699|FG001|Overall Study|Protocol Violation|2|||
33262502|NCT01629589|100863698|FG000|Overall Study|Lost to Follow-up|2|||
33262503|NCT01629589|100863699|FG001|Overall Study|Lost to Follow-up|1|||
33457234|NCT00413049|101564214|FG001|Overall Study|Withdrawal by Subject|5|||
33262504|NCT01629589|100863698|FG000|Overall Study|Withdrawal by Subject|2|||
33262505|NCT01629589|100863699|FG001|Overall Study|Withdrawal by Subject|3|||
33262506|NCT01629589|100863698|FG000|Overall Study|Did not receive study vaccine|0|||
33262507|NCT01629589|100863699|FG001|Overall Study|Did not receive study vaccine|1|||
33262508|NCT02852824|100863700|FG000|Overall Study|Withdrawal by Subject|1|||
33262509|NCT02852824|100863701|FG001|Overall Study|Withdrawal by Subject|0|||
33262510|NCT02852824|100863702|FG002|Overall Study|Withdrawal by Subject|0|||
33262511|NCT02852824|100863703|FG003|Overall Study|Withdrawal by Subject|0|||
33262512|NCT02852824|100863704|FG004|Overall Study|Withdrawal by Subject|0|||
33262513|NCT02852824|100863705|FG005|Overall Study|Withdrawal by Subject|0|||
33262514|NCT02852824|100863706|FG006|Overall Study|Withdrawal by Subject|0|||
33262515|NCT02852824|100863700|FG000|Overall Study|Adverse Event|0|||
33262516|NCT02852824|100863701|FG001|Overall Study|Adverse Event|0|||
33457235|NCT00413049|101564213|FG000|Overall Study|Lost to Follow-up|2|||
33457236|NCT00413049|101564214|FG001|Overall Study|Lost to Follow-up|3|||
33457237|NCT00413049|101564213|FG000|Overall Study|Protocol Violation|3|||
33457238|NCT00413049|101564214|FG001|Overall Study|Protocol Violation|1|||
33457239|NCT00413049|101564213|FG000|Overall Study|Subject no longer requires study drug|0|||
33457240|NCT00413049|101564214|FG001|Overall Study|Subject no longer requires study drug|1|||
33262517|NCT02852824|100863702|FG002|Overall Study|Adverse Event|0|||
33262518|NCT02852824|100863703|FG003|Overall Study|Adverse Event|0|||
33457241|NCT00413049|101564213|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33457242|NCT00413049|101564214|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33262519|NCT02852824|100863704|FG004|Overall Study|Adverse Event|2|||
33262520|NCT02852824|100863705|FG005|Overall Study|Adverse Event|0|||
33262521|NCT02852824|100863706|FG006|Overall Study|Adverse Event|0|||
33262522|NCT03803475|100863707|FG000|Overall Study|Physician Decision|1|||
33262523|NCT02499159|100863708|FG000|Randomization|Protocol Violation|1|||
33262524|NCT02499159|100863709|FG001|Randomization|Protocol Violation|1|||
33262525|NCT02499159|100863708|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
33262526|NCT02499159|100863709|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
33262527|NCT02499159|100863708|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
33262528|NCT02499159|100863709|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
33262529|NCT02499159|100863708|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
33262530|NCT02499159|100863709|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
33262531|NCT02499159|100863708|FG000|30-Day Follow-Up Phone Call|Other|1|||
33262532|NCT02499159|100863709|FG001|30-Day Follow-Up Phone Call|Other|0|||
33262533|NCT03509909|100863710|FG000|Overall Study|Withdrawal by Subject|16|||
33262534|NCT03509909|100863711|FG001|Overall Study|Withdrawal by Subject|9|||
33262535|NCT03509909|100863710|FG000|Overall Study|Lost to Follow-up|3|||
33262536|NCT03509909|100863711|FG001|Overall Study|Lost to Follow-up|4|||
33262537|NCT03509909|100863710|FG000|Overall Study|Adverse Event|2|||
33262538|NCT03509909|100863711|FG001|Overall Study|Adverse Event|0|||
33457243|NCT00413049|101564213|FG000|Overall Study|Lack of Efficacy|1|||
33457244|NCT00413049|101564214|FG001|Overall Study|Lack of Efficacy|0|||
33457245|NCT02817828|101564215|FG000|Overall Study|Lost to Follow-up|41|||
33457246|NCT02817828|101564215|FG000|Overall Study|Adverse event not related to bleeding|104|||
33457247|NCT02817828|101564215|FG000|Overall Study|Adverse event related to bleeding|53|||
33457248|NCT02817828|101564215|FG000|Overall Study|Protocol Violation|11|||
33457249|NCT02817828|101564215|FG000|Overall Study|Pregnancy|7|||
33457250|NCT02817828|101564215|FG000|Overall Study|Pregnancy wish|15|||
33457251|NCT02817828|101564215|FG000|Overall Study|Withdrawal by Subject|78|||
33457252|NCT02817828|101564215|FG000|Overall Study|Other|26|||
33457253|NCT01617096|101564216|FG000|Overall Study|Withdrawal by Subject|96|||
33457254|NCT01617096|101564217|FG001|Overall Study|Withdrawal by Subject|81|||
33457255|NCT01617096|101564216|FG000|Overall Study|Lost to Follow-up|37|||
33457256|NCT01617096|101564217|FG001|Overall Study|Lost to Follow-up|32|||
33457257|NCT01617096|101564216|FG000|Overall Study|Physician Decision|10|||
33457258|NCT01617096|101564217|FG001|Overall Study|Physician Decision|18|||
33457259|NCT01617096|101564216|FG000|Overall Study|Death|4|||
33457260|NCT01617096|101564217|FG001|Overall Study|Death|3|||
33457261|NCT01617096|101564216|FG000|Overall Study|Other|1|||
33457262|NCT01617096|101564217|FG001|Overall Study|Other|3|||
33457263|NCT02161549|101564220|FG000|Overall Study|Physician Decision|6|||
33457264|NCT02161549|101564221|FG001|Overall Study|Physician Decision|2|||
33457265|NCT00751023|101564224|FG000|Overall Study|Lost to Follow-up|11|||
33457266|NCT00751023|101564225|FG001|Overall Study|Lost to Follow-up|7|||
33457267|NCT02727192|101564228|FG000|Overall Study|Lost to Follow-up|1|||
33457268|NCT02727192|101564229|FG001|Overall Study|Lost to Follow-up|0|||
33457269|NCT02727192|101564230|FG002|Overall Study|Lost to Follow-up|0|||
33457270|NCT01835548|101564231|FG000|Dose Optimization Period|Adverse Event|0|||
33457271|NCT01835548|101564232|FG001|Dose Optimization Period|Adverse Event|0|||
33457272|NCT01835548|101564233|FG002|Dose Optimization Period|Adverse Event|1|||
33457273|NCT01835548|101564231|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
33457274|NCT01835548|101564232|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
33457275|NCT01835548|101564233|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
33457276|NCT01835548|101564231|FG000|Double-Blind Treatment Period|Adverse Event|0|||
33262539|NCT00879710|100863720|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
33262540|NCT00879710|100863721|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
33457277|NCT01835548|101564232|FG001|Double-Blind Treatment Period|Adverse Event|1|||
33457278|NCT01835548|101564233|FG002|Double-Blind Treatment Period|Adverse Event|0|||
33457279|NCT01835548|101564231|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33457280|NCT01835548|101564232|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
33262541|NCT00879710|100863722|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
33457281|NCT01835548|101564233|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
33457282|NCT03540160|101564236|FG000|Overall Study|Protocol Violation|1|||
33457283|NCT03540160|101564236|FG000|Overall Study|Physician Decision|8|||
33457284|NCT03540160|101564236|FG000|Overall Study|Lack of Efficacy|60|||
33457285|NCT03540160|101564236|FG000|Overall Study|Pregnancy|1|||
33457286|NCT03540160|101564236|FG000|Overall Study|Adverse Event|20|||
33457287|NCT03540160|101564236|FG000|Overall Study|Withdrawal by Subject|68|||
33457288|NCT03540160|101564236|FG000|Overall Study|COVID-19|2|||
33457289|NCT03540160|101564236|FG000|Overall Study|Study Closure|10|||
33457290|NCT03540160|101564236|FG000|Overall Study|Lost to Follow-up|18|||
33457291|NCT03540160|101564236|FG000|Overall Study|Sponsor decision|191|||
33457292|NCT04148287|101564240|FG000|Overall Study|Death|2|||
33457293|NCT00879684|101564241|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
33457294|NCT00879684|101564242|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
33457295|NCT00879684|101564243|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
33457296|NCT00879684|101564244|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
33457297|NCT00879684|101564245|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
33457298|NCT00879684|101564246|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
33457299|NCT00879684|101564247|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
33457300|NCT00879684|101564241|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
33457301|NCT00879684|101564242|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
33457302|NCT00879684|101564243|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
33457303|NCT00879684|101564244|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
33457304|NCT00879684|101564245|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
33457305|NCT00879684|101564246|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
33457306|NCT00879684|101564247|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
33457307|NCT00879684|101564241|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
33457308|NCT00879684|101564242|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
33457309|NCT00879684|101564243|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
33457310|NCT00879684|101564244|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
33457311|NCT00879684|101564245|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
33457312|NCT00879684|101564246|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
33457313|NCT00879684|101564247|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
33457314|NCT00879684|101564241|FG000|Stage 1: Dose Escalation|Death|0|||
33457315|NCT00879684|101564242|FG001|Stage 1: Dose Escalation|Death|0|||
33457316|NCT00879684|101564243|FG002|Stage 1: Dose Escalation|Death|1|||
33457317|NCT00879684|101564244|FG003|Stage 1: Dose Escalation|Death|0|||
33457318|NCT00879684|101564245|FG004|Stage 1: Dose Escalation|Death|0|||
33457319|NCT00879684|101564246|FG005|Stage 1: Dose Escalation|Death|0|||
33457320|NCT00879684|101564247|FG006|Stage 1: Dose Escalation|Death|0|||
33457321|NCT00879684|101564241|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
33457322|NCT00879684|101564242|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
33457323|NCT00879684|101564243|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
33457324|NCT00879684|101564244|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
33457325|NCT00879684|101564245|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
33174286|NCT01414075|100545768|FG000|Overall Study|Adverse Event|1|||
33457326|NCT00879684|101564246|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
33457327|NCT00879684|101564247|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
33457328|NCT00879684|101564241|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
33457329|NCT00879684|101564242|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
33457330|NCT00879684|101564243|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
33457331|NCT00879684|101564244|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
33174287|NCT01414075|100545769|FG001|Overall Study|Adverse Event|0|||
33457332|NCT00879684|101564245|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
33174288|NCT01414075|100545770|FG002|Overall Study|Adverse Event|1|||
33174289|NCT01414075|100545771|FG003|Overall Study|Adverse Event|0|||
33174290|NCT01414075|100545768|FG000|Overall Study|Death|1|||
33457333|NCT00879684|101564246|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
33457334|NCT00879684|101564247|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
33457335|NCT00879684|101564241|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
33457336|NCT00879684|101564242|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
33457337|NCT00879684|101564243|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
33174291|NCT01414075|100545769|FG001|Overall Study|Death|0|||
33262542|NCT00879710|100863723|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
33262543|NCT00879710|100863720|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
33262544|NCT00879710|100863721|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
33262545|NCT00879710|100863722|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
33262546|NCT00879710|100863723|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
33262547|NCT04876417|100863724|FG000|Overall Study|Lost to Follow-up|5|||
33262548|NCT04876417|100863725|FG001|Overall Study|Lost to Follow-up|8|||
33262549|NCT04876417|100863726|FG002|Overall Study|Lost to Follow-up|0|||
33262550|NCT04876417|100863727|FG003|Overall Study|Lost to Follow-up|0|||
33262551|NCT00918203|100863728|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
33262552|NCT00918203|100863729|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
33262553|NCT00918203|100863730|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
33457338|NCT00879684|101564244|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
33457339|NCT00879684|101564245|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
33457340|NCT00879684|101564246|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
33457341|NCT00879684|101564247|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
33457342|NCT03294317|101564248|FG000|Overall Study|Physician Decision|1|||
33457343|NCT03294317|101564248|FG000|Overall Study|Withdrawal by Subject|6|||
33457344|NCT03294317|101564248|FG000|Overall Study|Lost to Follow-up|1|||
33457345|NCT03294317|101564248|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
33457346|NCT03294317|101564248|FG000|Overall Study|Failed HB lead implant|8|||
33457347|NCT03294317|101564248|FG000|Overall Study|Received CRT instead|1|||
33457348|NCT03294317|101564248|FG000|Overall Study|Exited after lead revision|2|||
33457349|NCT02119936|101564249|FG000|Overall Study|Lost to Follow-up|10|||
33457350|NCT01968031|101564250|FG000|Overall Study|Adverse Event|13|||
33457351|NCT01968031|101564251|FG001|Overall Study|Adverse Event|10|||
33457352|NCT01968031|101564252|FG002|Overall Study|Adverse Event|22|||
33457353|NCT01968031|101564250|FG000|Overall Study|Withdrawal by Subject|3|||
33457354|NCT01968031|101564251|FG001|Overall Study|Withdrawal by Subject|7|||
33457355|NCT01968031|101564252|FG002|Overall Study|Withdrawal by Subject|3|||
33457356|NCT01968031|101564250|FG000|Overall Study|Did not meet entry criteria|1|||
33457357|NCT01968031|101564251|FG001|Overall Study|Did not meet entry criteria|1|||
33457358|NCT01968031|101564252|FG002|Overall Study|Did not meet entry criteria|1|||
33457359|NCT01968031|101564250|FG000|Overall Study|Noncompliance|0|||
33457360|NCT01968031|101564251|FG001|Overall Study|Noncompliance|0|||
33457361|NCT01968031|101564252|FG002|Overall Study|Noncompliance|2|||
33457362|NCT01968031|101564250|FG000|Overall Study|Failed inclusion criteria|0|||
33457363|NCT01968031|101564251|FG001|Overall Study|Failed inclusion criteria|2|||
33457364|NCT01968031|101564252|FG002|Overall Study|Failed inclusion criteria|0|||
33457365|NCT01968031|101564250|FG000|Overall Study|Death|0|||
33457366|NCT01968031|101564251|FG001|Overall Study|Death|0|||
33457367|NCT01968031|101564252|FG002|Overall Study|Death|1|||
33457368|NCT01968031|101564250|FG000|Overall Study|Prohibited concomitant medication|1|||
33457369|NCT01968031|101564251|FG001|Overall Study|Prohibited concomitant medication|0|||
33457370|NCT01968031|101564252|FG002|Overall Study|Prohibited concomitant medication|0|||
33457371|NCT02046122|101564253|FG000|Overall Study|Physician Decision|8|||
33457372|NCT02046122|101564253|FG000|Overall Study|Withdrawal by Subject|1|||
33457373|NCT02725515|101564264|FG000|Overall Study|Refused infusion (no study treatment)|1|||
33457374|NCT02725515|101564265|FG001|Overall Study|Refused infusion (no study treatment)|0|||
33457375|NCT02725515|101564264|FG000|Overall Study|Loss of Improvement per Protocol|14|||
33457376|NCT02725515|101564265|FG001|Overall Study|Loss of Improvement per Protocol|25|||
33457377|NCT02725515|101564264|FG000|Overall Study|Withdrawal by Subject|2|||
33457378|NCT02725515|101564265|FG001|Overall Study|Withdrawal by Subject|1|||
33457379|NCT02725515|101564264|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33457380|NCT02725515|101564265|FG001|Overall Study|Non-Compliance With Study Drug|3|||
33262554|NCT00918203|100863728|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
33262555|NCT00918203|100863729|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
33262556|NCT00918203|100863730|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
33262557|NCT00918203|100863728|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
33262558|NCT00918203|100863729|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
33457381|NCT02725515|101564264|FG000|Overall Study|Lost to Follow-up|1|||
33457382|NCT02725515|101564265|FG001|Overall Study|Lost to Follow-up|1|||
33457383|NCT02725515|101564264|FG000|Overall Study|Adverse Event|7|||
33457384|NCT02725515|101564265|FG001|Overall Study|Adverse Event|2|||
33457385|NCT02725515|101564264|FG000|Overall Study|No Documented Disease Improvement|0|||
33457386|NCT02725515|101564265|FG001|Overall Study|No Documented Disease Improvement|1|||
33262559|NCT00918203|100863730|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
33262560|NCT00918203|100863728|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
33457387|NCT02725515|101564264|FG000|Overall Study|Completed Study Under Original Protocol|0|||
33457388|NCT02725515|101564265|FG001|Overall Study|Completed Study Under Original Protocol|1|||
33457389|NCT02725515|101564264|FG000|Overall Study|Lack of Response|0|||
33457390|NCT02725515|101564265|FG001|Overall Study|Lack of Response|1|||
33457391|NCT01881737|101564268|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
33457392|NCT01881737|101564268|FG000|Overall Study|Withdrawal by Subject|1|||
33457393|NCT01881737|101564268|FG000|Overall Study|Worsening of baseline behavior|1|||
33457394|NCT01519947|101564269|FG000|Overall Study|Death|0|||
33457395|NCT01519947|101564270|FG001|Overall Study|Death|0|||
33457396|NCT01519947|101564271|FG002|Overall Study|Death|0|||
33457397|NCT01519947|101564272|FG003|Overall Study|Death|1|||
33457398|NCT01519947|101564269|FG000|Overall Study|Protocol Violation|0|||
33457399|NCT01519947|101564270|FG001|Overall Study|Protocol Violation|0|||
33457400|NCT01519947|101564271|FG002|Overall Study|Protocol Violation|2|||
33457401|NCT01519947|101564272|FG003|Overall Study|Protocol Violation|1|||
33457402|NCT01519947|101564269|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
33457403|NCT01519947|101564270|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
33457404|NCT01519947|101564271|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
33457405|NCT01519947|101564272|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
33457406|NCT01519947|101564269|FG000|Overall Study|Development of Anemia|0|||
33457407|NCT01519947|101564270|FG001|Overall Study|Development of Anemia|1|||
33457408|NCT01519947|101564271|FG002|Overall Study|Development of Anemia|0|||
33457409|NCT01519947|101564272|FG003|Overall Study|Development of Anemia|1|||
33457410|NCT01519947|101564269|FG000|Overall Study|Blood Transfusion|0|||
33457411|NCT01519947|101564270|FG001|Overall Study|Blood Transfusion|1|||
33457412|NCT01519947|101564271|FG002|Overall Study|Blood Transfusion|1|||
33457413|NCT01519947|101564272|FG003|Overall Study|Blood Transfusion|0|||
33457414|NCT01519947|101564269|FG000|Overall Study|Withdrawal by Subject|0|||
33457415|NCT01519947|101564270|FG001|Overall Study|Withdrawal by Subject|1|||
33457416|NCT01519947|101564271|FG002|Overall Study|Withdrawal by Subject|0|||
33457417|NCT01519947|101564272|FG003|Overall Study|Withdrawal by Subject|1|||
33457418|NCT01519947|101564269|FG000|Overall Study|Lost to Follow-up|0|||
33457419|NCT01519947|101564270|FG001|Overall Study|Lost to Follow-up|0|||
33457420|NCT01519947|101564271|FG002|Overall Study|Lost to Follow-up|3|||
33457421|NCT01519947|101564272|FG003|Overall Study|Lost to Follow-up|2|||
33457422|NCT01519947|101564269|FG000|Overall Study|Poor Response|1|||
33457423|NCT01519947|101564270|FG001|Overall Study|Poor Response|0|||
33457424|NCT01519947|101564271|FG002|Overall Study|Poor Response|0|||
33457425|NCT01519947|101564272|FG003|Overall Study|Poor Response|1|||
33457426|NCT01519947|101564269|FG000|Overall Study|Adverse Event|1|||
33262561|NCT00918203|100863729|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
33262562|NCT00918203|100863730|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
33457427|NCT01519947|101564270|FG001|Overall Study|Adverse Event|0|||
33457428|NCT01519947|101564271|FG002|Overall Study|Adverse Event|1|||
33457429|NCT01519947|101564272|FG003|Overall Study|Adverse Event|1|||
33457430|NCT01507662|101564273|FG000|Overall Study|Death|26|||
33457431|NCT01507662|101564274|FG001|Overall Study|Death|18|||
33457432|NCT01507662|101564273|FG000|Overall Study|Withdrawal by Subject|290|||
33457433|NCT01507662|101564274|FG001|Overall Study|Withdrawal by Subject|287|||
33457434|NCT01507662|101564273|FG000|Overall Study|Lost to Follow-up|498|||
33457435|NCT01507662|101564274|FG001|Overall Study|Lost to Follow-up|523|||
33457436|NCT01507662|101564273|FG000|Overall Study|Proxy interview done|2|||
33457437|NCT01507662|101564274|FG001|Overall Study|Proxy interview done|3|||
33457438|NCT01596127|101564275|FG000|Overall Study|Patient Ineligible|1|||
33457439|NCT04404725|101564277|FG000|First Intervention|Withdrawal by Subject|0|||
33457440|NCT04404725|101564278|FG001|First Intervention|Withdrawal by Subject|2|||
33457441|NCT04404725|101564277|FG000|Second Intervention|Adverse Event|1|||
33457442|NCT04404725|101564278|FG001|Second Intervention|Adverse Event|1|||
33457443|NCT04404725|101564277|FG000|Second Intervention|Withdrawal by Subject|0|||
33457444|NCT04404725|101564278|FG001|Second Intervention|Withdrawal by Subject|1|||
33457445|NCT00674128|101564280|FG000|Overall Study|Withdrawal by Subject|25|||
33457446|NCT00674128|101564281|FG001|Overall Study|Withdrawal by Subject|23|||
33457447|NCT01559116|101564282|FG000|Overall Study|Adverse Event|10|||
33457448|NCT01559116|101564282|FG000|Overall Study|Lack of Efficacy|1|||
33457449|NCT01559116|101564282|FG000|Overall Study|Lost to Follow-up|1|||
33457450|NCT01559116|101564282|FG000|Overall Study|Protocol Violation|1|||
33457451|NCT01559116|101564282|FG000|Overall Study|Withdrawal by Subject|4|||
33457452|NCT01559116|101564282|FG000|Overall Study|other than stated above|9|||
33457453|NCT00372996|101564284|FG000|Overall Study|Death|11|||
33457454|NCT00372996|101564285|FG001|Overall Study|Death|4|||
33457455|NCT00372996|101564286|FG002|Overall Study|Death|8|||
33457456|NCT00372996|101564287|FG003|Overall Study|Death|7|||
33457457|NCT00372996|101564284|FG000|Overall Study|Lost to Follow-up|0|||
33457458|NCT00372996|101564285|FG001|Overall Study|Lost to Follow-up|2|||
33457459|NCT00372996|101564286|FG002|Overall Study|Lost to Follow-up|0|||
33457460|NCT00372996|101564287|FG003|Overall Study|Lost to Follow-up|1|||
33457461|NCT00372996|101564284|FG000|Overall Study|Withdrawal by Subject|12|||
33457462|NCT00372996|101564285|FG001|Overall Study|Withdrawal by Subject|6|||
33457463|NCT00372996|101564286|FG002|Overall Study|Withdrawal by Subject|9|||
33457464|NCT00372996|101564287|FG003|Overall Study|Withdrawal by Subject|5|||
33457465|NCT00372996|101564284|FG000|Overall Study|Study Terminated by Sponsor|4|||
33457466|NCT00372996|101564285|FG001|Overall Study|Study Terminated by Sponsor|0|||
33457467|NCT00372996|101564286|FG002|Overall Study|Study Terminated by Sponsor|4|||
33457468|NCT00372996|101564287|FG003|Overall Study|Study Terminated by Sponsor|0|||
33457469|NCT00372996|101564284|FG000|Overall Study|Other|10|||
33457470|NCT00372996|101564285|FG001|Overall Study|Other|2|||
33457471|NCT00372996|101564286|FG002|Overall Study|Other|7|||
33457472|NCT00372996|101564287|FG003|Overall Study|Other|7|||
33457473|NCT00660387|101564288|FG000|Overall Study|Adverse Event|1|||
33457474|NCT00660387|101564289|FG001|Overall Study|Adverse Event|2|||
33457475|NCT00660387|101564288|FG000|Overall Study|Lack of Efficacy|0|||
33457476|NCT00660387|101564289|FG001|Overall Study|Lack of Efficacy|1|||
33457477|NCT00660387|101564288|FG000|Overall Study|Protocol Violation|1|||
33457478|NCT00660387|101564289|FG001|Overall Study|Protocol Violation|0|||
33457479|NCT01721772|101564290|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
33457480|NCT01721772|101564291|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
33457481|NCT01721772|101564290|FG000|Pre-Treatment|Poor/non-compliance|0|||
33457482|NCT01721772|101564291|FG001|Pre-Treatment|Poor/non-compliance|1|||
33457483|NCT01721772|101564290|FG000|Pre-Treatment|Participant withdrew consent|0|||
33457484|NCT01721772|101564291|FG001|Pre-Treatment|Participant withdrew consent|1|||
33457485|NCT01721772|101564290|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
33457486|NCT01721772|101564291|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
33457487|NCT01721772|101564290|FG000|Treatment|Disease progression|119|||
33457488|NCT01721772|101564291|FG001|Treatment|Disease progression|168|||
33457489|NCT01721772|101564290|FG000|Treatment|Study drug toxicity|19|||
33457490|NCT01721772|101564291|FG001|Treatment|Study drug toxicity|10|||
33457491|NCT01721772|101564290|FG000|Treatment|Adverse event unrelated to study drug|7|||
33457492|NCT01721772|101564291|FG001|Treatment|Adverse event unrelated to study drug|7|||
33457493|NCT01721772|101564290|FG000|Treatment|Maximum clinical benefit|16|||
33457494|NCT01721772|101564291|FG001|Treatment|Maximum clinical benefit|4|||
33457495|NCT01721772|101564290|FG000|Treatment|Other|19|||
33457496|NCT01721772|101564291|FG001|Treatment|Other|2|||
33457497|NCT01721772|101564290|FG000|Treatment|Participant withdrew consent|2|||
33457498|NCT01721772|101564291|FG001|Treatment|Participant withdrew consent|5|||
33457499|NCT01721772|101564290|FG000|Treatment|Participant request to discontinue study treatment|21|||
33457500|NCT01721772|101564291|FG001|Treatment|Participant request to discontinue study treatment|8|||
33457501|NCT01721772|101564290|FG000|Treatment|Death|1|||
33457502|NCT01721772|101564291|FG001|Treatment|Death|0|||
33457503|NCT01721772|101564290|FG000|Treatment|Not reported|1|||
33457504|NCT01721772|101564291|FG001|Treatment|Not reported|0|||
33457505|NCT01721772|101564290|FG000|Treatment|Poor/non-compliance|1|||
33457506|NCT01721772|101564291|FG001|Treatment|Poor/non-compliance|0|||
33457507|NCT01721772|101564290|FG000|Treatment|Lost to Follow-up|0|||
33457508|NCT01721772|101564291|FG001|Treatment|Lost to Follow-up|1|||
33457509|NCT04661202|101564296|FG000|Overall Study|Withdrawal by Subject|1|||
33457510|NCT04661202|101564297|FG001|Overall Study|Withdrawal by Subject|1|||
33457511|NCT04661202|101564296|FG000|Overall Study|Lack of Efficacy|2|||
33457512|NCT04661202|101564297|FG001|Overall Study|Lack of Efficacy|0|||
33457513|NCT04049097|101564298|FG000|Overall Study|Adverse Event|18|||
33457514|NCT04049097|101564298|FG000|Overall Study|Death|2|||
33457515|NCT04049097|101564298|FG000|Overall Study|Lost to Follow-up|1|||
33457516|NCT04049097|101564298|FG000|Overall Study|Physician Decision|2|||
33457517|NCT04049097|101564298|FG000|Overall Study|Withdrawal by Subject|9|||
33457518|NCT04049097|101564298|FG000|Overall Study|Protocol Violation|2|||
33457519|NCT04049097|101564298|FG000|Overall Study|Other|1|||
33457520|NCT04049097|101564298|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
33457521|NCT00685334|101564299|FG000|Overall Study|Withdrawal by Subject|5|||
33457522|NCT00685334|101564300|FG001|Overall Study|Withdrawal by Subject|6|||
33457523|NCT00685334|101564299|FG000|Overall Study|Lost to Follow-up|4|||
33457524|NCT00685334|101564300|FG001|Overall Study|Lost to Follow-up|0|||
33457525|NCT00685334|101564299|FG000|Overall Study|Chose to enter hospital|1|||
33457526|NCT00685334|101564300|FG001|Overall Study|Chose to enter hospital|1|||
33457527|NCT00985751|101564302|FG000|Overall Study|Adverse Event|0|||
33457528|NCT00985751|101564303|FG001|Overall Study|Adverse Event|0|||
33457529|NCT00985751|101564304|FG002|Overall Study|Adverse Event|0|||
33457530|NCT00985751|101564305|FG003|Overall Study|Adverse Event|0|||
33457531|NCT00985751|101564306|FG004|Overall Study|Adverse Event|1|||
33457532|NCT05776901|101564313|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
33457533|NCT04320745|101564314|FG000|Overall Study|Adverse Event|26|||
33457534|NCT04320745|101564314|FG000|Overall Study|Withdrawal by Subject|4|||
33457535|NCT04320745|101564314|FG000|Overall Study|Lost to Follow-up|12|||
33457536|NCT04320745|101564314|FG000|Overall Study|Protocol Deviation|2|||
33457537|NCT04320745|101564314|FG000|Overall Study|Non-compliance With Study Drug|2|||
33457538|NCT04320745|101564314|FG000|Overall Study|Reason Not Specified|1|||
33457539|NCT02359864|101564319|FG000|Overall Study|Withdrawal by Subject|1|||
33457540|NCT02359864|101564320|FG001|Overall Study|Withdrawal by Subject|0|||
33457541|NCT01896934|101564321|FG000|Overall Study|Adverse Event|1|||
33457542|NCT01896934|101564321|FG000|Overall Study|Withdrawal by Subject|1|||
33457543|NCT04129944|101564323|FG000|Overall Study|Death|0|||
33457544|NCT04129944|101564324|FG001|Overall Study|Death|0|||
33457545|NCT04129944|101564325|FG002|Overall Study|Death|0|||
33457546|NCT04129944|101564326|FG003|Overall Study|Death|1|||
33457547|NCT04129944|101564323|FG000|Overall Study|Lost to Follow-up|1|||
33457548|NCT04129944|101564324|FG001|Overall Study|Lost to Follow-up|0|||
33457549|NCT04129944|101564325|FG002|Overall Study|Lost to Follow-up|0|||
33457550|NCT04129944|101564326|FG003|Overall Study|Lost to Follow-up|0|||
33457551|NCT04129944|101564323|FG000|Overall Study|Withdrawal by Subject|1|||
33457552|NCT04129944|101564324|FG001|Overall Study|Withdrawal by Subject|0|||
33457553|NCT04129944|101564325|FG002|Overall Study|Withdrawal by Subject|1|||
33457554|NCT04129944|101564326|FG003|Overall Study|Withdrawal by Subject|2|||
33457555|NCT01344018|101564327|FG000|Overall Study|Death|22|||
33457556|NCT01344018|101564328|FG001|Overall Study|Death|25|||
33457557|NCT01344018|101564327|FG000|Overall Study|Lost to Follow-up|4|||
33457558|NCT01344018|101564328|FG001|Overall Study|Lost to Follow-up|7|||
33457559|NCT02676973|101564329|FG000|Overall Study|Withdrawal by Subject|9|||
33457560|NCT02676973|101564330|FG001|Overall Study|Withdrawal by Subject|8|||
33457561|NCT02676973|101564331|FG002|Overall Study|Withdrawal by Subject|11|||
33457562|NCT02676973|101564329|FG000|Overall Study|Lost to Follow-up|8|||
33457563|NCT02676973|101564330|FG001|Overall Study|Lost to Follow-up|12|||
33457564|NCT02676973|101564331|FG002|Overall Study|Lost to Follow-up|8|||
33457565|NCT02676973|101564329|FG000|Overall Study|Death|2|||
33457566|NCT02676973|101564330|FG001|Overall Study|Death|1|||
33457567|NCT02676973|101564331|FG002|Overall Study|Death|5|||
33457568|NCT01547728|101564334|FG000|Overall Study|Change in procedure and equipment|1|||
33457569|NCT01547728|101564334|FG000|Overall Study|Drug not ready for subject|1|||
33457570|NCT01547728|101564334|FG000|Overall Study|Screen failure|39|||
33457571|NCT01992094|101564342|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
33457572|NCT01992094|101564343|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
33457573|NCT01992094|101564344|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
33457574|NCT01992094|101564342|FG000|Overall Study|Adverse Event|1|||
33457575|NCT01992094|101564343|FG001|Overall Study|Adverse Event|0|||
33457576|NCT01992094|101564344|FG002|Overall Study|Adverse Event|0|||
33457577|NCT01992094|101564342|FG000|Overall Study|Death|5|||
33457578|NCT01992094|101564343|FG001|Overall Study|Death|5|||
33457579|NCT01992094|101564344|FG002|Overall Study|Death|2|||
33457580|NCT01992094|101564342|FG000|Overall Study|Lost to Follow-up|26|||
33457581|NCT01992094|101564343|FG001|Overall Study|Lost to Follow-up|9|||
33457582|NCT01992094|101564344|FG002|Overall Study|Lost to Follow-up|13|||
33457583|NCT01992094|101564342|FG000|Overall Study|OTHER|4|||
33457584|NCT01992094|101564343|FG001|Overall Study|OTHER|0|||
33457585|NCT01992094|101564344|FG002|Overall Study|OTHER|0|||
33457586|NCT01992094|101564342|FG000|Overall Study|Protocol Violation|1|||
33457587|NCT01992094|101564343|FG001|Overall Study|Protocol Violation|0|||
33457588|NCT01992094|101564344|FG002|Overall Study|Protocol Violation|1|||
33457589|NCT01992094|101564342|FG000|Overall Study|Withdrawal by Subject|7|||
33457590|NCT01992094|101564343|FG001|Overall Study|Withdrawal by Subject|3|||
33457591|NCT01992094|101564344|FG002|Overall Study|Withdrawal by Subject|4|||
33457592|NCT05511935|101564345|FG000|Overall Study|Lost to Follow-up|9|||
33457593|NCT05511935|101564346|FG001|Overall Study|Lost to Follow-up|27|||
33457594|NCT00695110|101564347|FG000|Treatment Period 1|Adverse Event|1|||
33457595|NCT00695110|101564347|FG000|Treatment Period 1|Withdrawal by Subject|2|||
33457596|NCT00695110|101564347|FG000|Treatment Period 3|Withdrawal by Subject|1|||
33457597|NCT00695110|101564347|FG000|Treatment Period 4|Adverse Event|1|||
33457598|NCT01567527|101564350|FG000|Conversion Phase.|Protocol deviation|3|||
33457599|NCT01567527|101564351|FG001|Conversion Phase.|Protocol deviation|0|||
33457600|NCT01567527|101564352|FG002|Conversion Phase.|Protocol deviation|0|||
33457601|NCT01567527|101564353|FG003|Conversion Phase.|Protocol deviation|0|||
33457602|NCT01567527|101564354|FG004|Conversion Phase.|Protocol deviation|0|||
33457603|NCT01567527|101564350|FG000|Conversion Phase.|Met withdrawal criteria|10|||
33457604|NCT01567527|101564351|FG001|Conversion Phase.|Met withdrawal criteria|0|||
33174292|NCT01414075|100545770|FG002|Overall Study|Death|0|||
33174293|NCT01414075|100545771|FG003|Overall Study|Death|1|||
33457605|NCT01567527|101564352|FG002|Conversion Phase.|Met withdrawal criteria|0|||
33457606|NCT01567527|101564353|FG003|Conversion Phase.|Met withdrawal criteria|0|||
33457607|NCT01567527|101564354|FG004|Conversion Phase.|Met withdrawal criteria|0|||
33457608|NCT01567527|101564350|FG000|Conversion Phase.|Withdrawal by Subject|32|||
33457609|NCT01567527|101564351|FG001|Conversion Phase.|Withdrawal by Subject|0|||
33457610|NCT01567527|101564352|FG002|Conversion Phase.|Withdrawal by Subject|0|||
33457611|NCT01567527|101564353|FG003|Conversion Phase.|Withdrawal by Subject|0|||
33457612|NCT01567527|101564354|FG004|Conversion Phase.|Withdrawal by Subject|0|||
33457613|NCT01567527|101564350|FG000|Conversion Phase.|Lost to Follow-up|16|||
33457614|NCT01567527|101564351|FG001|Conversion Phase.|Lost to Follow-up|0|||
33457615|NCT01567527|101564352|FG002|Conversion Phase.|Lost to Follow-up|0|||
33262563|NCT03611075|100863731|FG000|Overall Study|Physician Decision|0|||
33262564|NCT03611075|100863732|FG001|Overall Study|Physician Decision|1|||
33457616|NCT01567527|101564353|FG003|Conversion Phase.|Lost to Follow-up|0|||
33457617|NCT01567527|101564354|FG004|Conversion Phase.|Lost to Follow-up|0|||
33457618|NCT01567527|101564350|FG000|Conversion Phase.|Lack of Efficacy|2|||
33174294|NCT01414075|100545768|FG000|Overall Study|Withdrawal by Subject|0|||
33174295|NCT01414075|100545769|FG001|Overall Study|Withdrawal by Subject|0|||
33457619|NCT01567527|101564351|FG001|Conversion Phase.|Lack of Efficacy|0|||
33457620|NCT01567527|101564352|FG002|Conversion Phase.|Lack of Efficacy|0|||
33457621|NCT01567527|101564353|FG003|Conversion Phase.|Lack of Efficacy|0|||
33457622|NCT01567527|101564354|FG004|Conversion Phase.|Lack of Efficacy|0|||
33457623|NCT01567527|101564350|FG000|Conversion Phase.|Adverse Event|33|||
33457624|NCT01567527|101564351|FG001|Conversion Phase.|Adverse Event|0|||
33457625|NCT01567527|101564352|FG002|Conversion Phase.|Adverse Event|0|||
33457626|NCT01567527|101564353|FG003|Conversion Phase.|Adverse Event|0|||
33457627|NCT01567527|101564354|FG004|Conversion Phase.|Adverse Event|0|||
33457628|NCT01567527|101564350|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
33457629|NCT01567527|101564351|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
33457630|NCT01567527|101564352|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
33457631|NCT01567527|101564353|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
33457632|NCT01567527|101564354|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
33457633|NCT01567527|101564350|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
33457634|NCT01567527|101564351|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
33457635|NCT01567527|101564352|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
33457636|NCT01567527|101564353|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
33457637|NCT01567527|101564354|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
33457638|NCT01567527|101564350|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
33457639|NCT01567527|101564351|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
33174296|NCT01414075|100545770|FG002|Overall Study|Withdrawal by Subject|0|||
33174297|NCT01414075|100545771|FG003|Overall Study|Withdrawal by Subject|1|||
33174298|NCT01414075|100545768|FG000|Overall Study|Other than specified|1|||
33174299|NCT01414075|100545769|FG001|Overall Study|Other than specified|0|||
33174300|NCT01414075|100545770|FG002|Overall Study|Other than specified|1|||
33174301|NCT01414075|100545771|FG003|Overall Study|Other than specified|0|||
33174302|NCT00533845|100545772|FG000|Overall Study|Physician Decision|1|||
33174303|NCT00533845|100545773|FG001|Overall Study|Physician Decision|0|||
33174304|NCT01286012|100545774|FG000|Overall Study|Adverse Event|3|||
33262565|NCT03611075|100863733|FG002|Overall Study|Physician Decision|1|||
33457640|NCT01567527|101564352|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
33457641|NCT01567527|101564353|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
33457642|NCT01567527|101564354|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
33457643|NCT01567527|101564350|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
33457644|NCT01567527|101564351|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
33457645|NCT01567527|101564352|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
33457646|NCT01567527|101564353|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
33457647|NCT01567527|101564354|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
33457648|NCT01567527|101564350|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
33457649|NCT01567527|101564351|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
33457650|NCT01567527|101564352|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
33457651|NCT01567527|101564353|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
33457652|NCT01567527|101564354|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
33457653|NCT01567527|101564350|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
33457654|NCT01567527|101564351|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
33457655|NCT01567527|101564352|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
33457656|NCT01567527|101564353|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
33457657|NCT01567527|101564354|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
33457658|NCT01567527|101564350|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
33457659|NCT01567527|101564351|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
33457660|NCT01567527|101564352|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
33457661|NCT01567527|101564353|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
33457662|NCT01567527|101564354|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
33457663|NCT01567527|101564350|FG000|IM Depot Stabilization.|Protocol deviation|0|||
33457664|NCT01567527|101564351|FG001|IM Depot Stabilization.|Protocol deviation|0|||
33174305|NCT01286012|100545775|FG001|Overall Study|Adverse Event|3|||
33174306|NCT01286012|100545774|FG000|Overall Study|Death|2|||
33174307|NCT01286012|100545775|FG001|Overall Study|Death|3|||
33174308|NCT01286012|100545774|FG000|Overall Study|Protocol Violation|1|||
33174309|NCT01286012|100545775|FG001|Overall Study|Protocol Violation|1|||
33174310|NCT01286012|100545774|FG000|Overall Study|Withdrawal by Subject|4|||
33174311|NCT01286012|100545775|FG001|Overall Study|Withdrawal by Subject|4|||
33174312|NCT01286012|100545774|FG000|Overall Study|Physician Decision|2|||
33174313|NCT01286012|100545775|FG001|Overall Study|Physician Decision|0|||
33174314|NCT01286012|100545774|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
33174315|NCT01286012|100545775|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
33174316|NCT02425046|100545783|FG000|Overall Study|Lost to Follow-up|52|||
33174317|NCT02425046|100545784|FG001|Overall Study|Lost to Follow-up|50|||
33174318|NCT02425046|100545785|FG002|Overall Study|Lost to Follow-up|56|||
33457665|NCT01567527|101564352|FG002|IM Depot Stabilization.|Protocol deviation|5|||
33262566|NCT03611075|100863734|FG003|Overall Study|Physician Decision|0|||
33262567|NCT03611075|100863735|FG004|Overall Study|Physician Decision|0|||
33262568|NCT03611075|100863736|FG005|Overall Study|Physician Decision|0|||
33262569|NCT03611075|100863737|FG006|Overall Study|Physician Decision|0|||
33262570|NCT03611075|100863738|FG007|Overall Study|Physician Decision|0|||
33262571|NCT03611075|100863739|FG008|Overall Study|Physician Decision|0|||
33262572|NCT03611075|100863731|FG000|Overall Study|Lost to Follow-up|1|||
33262573|NCT03611075|100863732|FG001|Overall Study|Lost to Follow-up|0|||
33262574|NCT03611075|100863733|FG002|Overall Study|Lost to Follow-up|0|||
33262575|NCT03611075|100863734|FG003|Overall Study|Lost to Follow-up|2|||
33262576|NCT03611075|100863735|FG004|Overall Study|Lost to Follow-up|0|||
33262577|NCT03611075|100863736|FG005|Overall Study|Lost to Follow-up|0|||
33262578|NCT03611075|100863737|FG006|Overall Study|Lost to Follow-up|0|||
33262579|NCT03611075|100863738|FG007|Overall Study|Lost to Follow-up|0|||
33262580|NCT03611075|100863739|FG008|Overall Study|Lost to Follow-up|0|||
33262581|NCT03611075|100863731|FG000|Overall Study|Withdrawal by Subject|0|||
33262582|NCT03611075|100863732|FG001|Overall Study|Withdrawal by Subject|1|||
33457666|NCT01567527|101564353|FG003|IM Depot Stabilization.|Protocol deviation|0|||
33457667|NCT01567527|101564354|FG004|IM Depot Stabilization.|Protocol deviation|0|||
33457668|NCT01567527|101564350|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
33457669|NCT01567527|101564351|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
33457670|NCT01567527|101564352|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
33457671|NCT01567527|101564353|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
33457672|NCT01567527|101564354|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
33457673|NCT01567527|101564350|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
33457674|NCT01567527|101564351|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
33457675|NCT01567527|101564352|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
33457676|NCT01567527|101564353|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
33457677|NCT01567527|101564354|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
33457678|NCT01567527|101564350|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
33457679|NCT01567527|101564351|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
33457680|NCT01567527|101564352|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
33457681|NCT01567527|101564353|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
33457682|NCT01567527|101564354|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
33457683|NCT01567527|101564350|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
33457684|NCT01567527|101564351|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
33457685|NCT01567527|101564352|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
33457686|NCT01567527|101564353|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
33457687|NCT01567527|101564354|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
33457688|NCT01567527|101564350|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
33457689|NCT01567527|101564351|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
33174319|NCT02425046|100545783|FG000|Overall Study|Withdrawal by Subject|16|||
33457690|NCT01567527|101564352|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
33174320|NCT02425046|100545784|FG001|Overall Study|Withdrawal by Subject|12|||
33174321|NCT02425046|100545785|FG002|Overall Study|Withdrawal by Subject|0|||
33174322|NCT02326025|100545787|FG000|Overall Study|Adverse Event|3|||
33174323|NCT02326025|100545788|FG001|Overall Study|Adverse Event|0|||
33174324|NCT02326025|100545787|FG000|Overall Study|Physician Decision|1|||
33174325|NCT02326025|100545788|FG001|Overall Study|Physician Decision|2|||
33174326|NCT02326025|100545787|FG000|Overall Study|Physician and Participant Decision|1|||
33174327|NCT02326025|100545788|FG001|Overall Study|Physician and Participant Decision|0|||
33174328|NCT02326025|100545787|FG000|Overall Study|Withdrawal by Subject|0|||
33174329|NCT02326025|100545788|FG001|Overall Study|Withdrawal by Subject|2|||
33174330|NCT02326025|100545787|FG000|Overall Study|Protocol Violation|0|||
33174331|NCT02326025|100545788|FG001|Overall Study|Protocol Violation|1|||
33174332|NCT00040664|100545789|FG000|Overall Study|Adverse Event|12|||
33262583|NCT03611075|100863733|FG002|Overall Study|Withdrawal by Subject|1|||
33262584|NCT03611075|100863734|FG003|Overall Study|Withdrawal by Subject|1|||
33262585|NCT03611075|100863735|FG004|Overall Study|Withdrawal by Subject|0|||
33457691|NCT01567527|101564353|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
33457692|NCT01567527|101564354|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
33457693|NCT01567527|101564350|FG000|IM Depot Stabilization.|Adverse Event|0|||
33457694|NCT01567527|101564351|FG001|IM Depot Stabilization.|Adverse Event|0|||
33457695|NCT01567527|101564352|FG002|IM Depot Stabilization.|Adverse Event|37|||
33457696|NCT01567527|101564353|FG003|IM Depot Stabilization.|Adverse Event|0|||
33457697|NCT01567527|101564354|FG004|IM Depot Stabilization.|Adverse Event|0|||
33457698|NCT01567527|101564350|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
33457699|NCT01567527|101564351|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
33457700|NCT01567527|101564352|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
33457701|NCT01567527|101564353|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
33457702|NCT01567527|101564354|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
33457703|NCT01567527|101564350|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
33457704|NCT01567527|101564351|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
33457705|NCT01567527|101564352|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
33457706|NCT01567527|101564353|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
33457707|NCT01567527|101564354|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
33457708|NCT01567527|101564350|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
33457709|NCT01567527|101564351|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
33457710|NCT01567527|101564352|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
33457711|NCT01567527|101564353|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
33457712|NCT01567527|101564354|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
33457713|NCT01567527|101564350|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
33457714|NCT01567527|101564351|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
33457715|NCT01567527|101564352|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
33457716|NCT01567527|101564353|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
33457717|NCT01567527|101564354|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
33457718|NCT01567527|101564350|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
33457719|NCT01567527|101564351|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
33457720|NCT01567527|101564352|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
33457721|NCT01567527|101564353|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
33457722|NCT01567527|101564354|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
33457723|NCT01567527|101564350|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33457724|NCT01567527|101564351|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33457725|NCT01567527|101564352|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
33457726|NCT01567527|101564353|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
33457727|NCT01567527|101564354|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
33457728|NCT01567527|101564350|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
33457729|NCT01567527|101564351|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
33457730|NCT01567527|101564352|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
33457731|NCT01567527|101564353|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
33457732|NCT01567527|101564354|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
33457733|NCT01567527|101564350|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
33457734|NCT01567527|101564351|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
33457735|NCT01567527|101564352|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
33457736|NCT01567527|101564353|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
33457737|NCT01567527|101564354|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
33457738|NCT01567527|101564350|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33457739|NCT01567527|101564351|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33457740|NCT01567527|101564352|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
33457741|NCT01567527|101564353|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
33457742|NCT01567527|101564354|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
33457743|NCT02943096|101564356|FG000|Overall Study|Lack of Efficacy|0|||
33457744|NCT02943096|101564357|FG001|Overall Study|Lack of Efficacy|1|||
33457745|NCT01073631|101564358|FG000|Overall Study|Death|82|||
33457746|NCT01073631|101564358|FG000|Overall Study|Adverse Event|24|||
33457747|NCT01073631|101564358|FG000|Overall Study|Other|63|||
33457748|NCT01929681|101564359|FG000|Overall Study|Withdrawal by Subject|1|||
33457749|NCT01929681|101564360|FG001|Overall Study|Withdrawal by Subject|0|||
33457750|NCT01929681|101564359|FG000|Overall Study|Physician Decision|1|||
33457751|NCT01929681|101564360|FG001|Overall Study|Physician Decision|1|||
33457752|NCT01664039|101564363|FG000|Overall Study|Adverse Event|3|||
33457753|NCT01664039|101564364|FG001|Overall Study|Adverse Event|4|||
33457754|NCT01664039|101564363|FG000|Overall Study|Lost to Follow-up|1|||
33457755|NCT01664039|101564364|FG001|Overall Study|Lost to Follow-up|1|||
33457756|NCT01664039|101564363|FG000|Overall Study|Withdrawal by Subject|1|||
33457757|NCT01664039|101564364|FG001|Overall Study|Withdrawal by Subject|3|||
33457758|NCT01664039|101564363|FG000|Overall Study|Noncompliance|1|||
33457759|NCT01664039|101564364|FG001|Overall Study|Noncompliance|1|||
33457760|NCT01824498|101564365|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
33457761|NCT01824498|101564366|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
33457762|NCT01824498|101564367|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
33457763|NCT01824498|101564368|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
33457764|NCT01824498|101564369|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
33457765|NCT01824498|101564370|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
33457766|NCT03387462|101564375|FG000|Overall Study|Lost to Follow-up|1|||
33457767|NCT00651183|101564376|FG000|Overall Study|Lack of Efficacy|1|||
33457768|NCT00651183|101564377|FG001|Overall Study|Lack of Efficacy|0|||
33457769|NCT00651183|101564376|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
33457770|NCT00651183|101564377|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
33457771|NCT00651183|101564376|FG000|Overall Study|Tolerability insufficient|5|||
33457772|NCT00651183|101564377|FG001|Overall Study|Tolerability insufficient|2|||
33174333|NCT00040664|100545790|FG001|Overall Study|Adverse Event|3|||
33174334|NCT00040664|100545791|FG002|Overall Study|Adverse Event|2|||
33174335|NCT00040664|100545792|FG003|Overall Study|Adverse Event|7|||
33174336|NCT00040664|100545789|FG000|Overall Study|Lack of Efficacy|9|||
33174337|NCT00040664|100545790|FG001|Overall Study|Lack of Efficacy|2|||
33174338|NCT00040664|100545791|FG002|Overall Study|Lack of Efficacy|3|||
33174339|NCT00040664|100545792|FG003|Overall Study|Lack of Efficacy|4|||
33174340|NCT00040664|100545789|FG000|Overall Study|Insufficient CD4 response|1|||
33174341|NCT00040664|100545790|FG001|Overall Study|Insufficient CD4 response|0|||
33174342|NCT00040664|100545791|FG002|Overall Study|Insufficient CD4 response|1|||
33174343|NCT00040664|100545792|FG003|Overall Study|Insufficient CD4 response|0|||
33174344|NCT00040664|100545789|FG000|Overall Study|Lost to Follow-up|4|||
33174345|NCT00040664|100545790|FG001|Overall Study|Lost to Follow-up|2|||
33174346|NCT00040664|100545791|FG002|Overall Study|Lost to Follow-up|0|||
33174347|NCT00040664|100545792|FG003|Overall Study|Lost to Follow-up|2|||
33174348|NCT00040664|100545789|FG000|Overall Study|Protocol Violation|2|||
33174349|NCT00040664|100545790|FG001|Overall Study|Protocol Violation|1|||
33174350|NCT00040664|100545791|FG002|Overall Study|Protocol Violation|0|||
33174351|NCT00040664|100545792|FG003|Overall Study|Protocol Violation|1|||
33174352|NCT00040664|100545789|FG000|Overall Study|Withdrawal by Subject|7|||
33174353|NCT00040664|100545790|FG001|Overall Study|Withdrawal by Subject|0|||
33457773|NCT00651183|101564376|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
33457774|NCT00651183|101564377|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
33174354|NCT00040664|100545791|FG002|Overall Study|Withdrawal by Subject|3|||
33174355|NCT00040664|100545792|FG003|Overall Study|Withdrawal by Subject|4|||
33174356|NCT00040664|100545789|FG000|Overall Study|Pregnancy|3|||
33174357|NCT00040664|100545790|FG001|Overall Study|Pregnancy|0|||
33174358|NCT00040664|100545791|FG002|Overall Study|Pregnancy|0|||
33174359|NCT00040664|100545792|FG003|Overall Study|Pregnancy|3|||
33174360|NCT00040664|100545789|FG000|Overall Study|Medication adherence/compliance problems|8|||
33174361|NCT00040664|100545790|FG001|Overall Study|Medication adherence/compliance problems|2|||
33174362|NCT00040664|100545791|FG002|Overall Study|Medication adherence/compliance problems|1|||
33174363|NCT00040664|100545792|FG003|Overall Study|Medication adherence/compliance problems|5|||
33174364|NCT00040664|100545789|FG000|Overall Study|Poor taste|2|||
33262586|NCT03611075|100863736|FG005|Overall Study|Withdrawal by Subject|0|||
33262587|NCT03611075|100863737|FG006|Overall Study|Withdrawal by Subject|1|||
33262588|NCT03611075|100863738|FG007|Overall Study|Withdrawal by Subject|0|||
33262589|NCT03611075|100863739|FG008|Overall Study|Withdrawal by Subject|0|||
33262590|NCT03611075|100863731|FG000|Overall Study|Reason unknown|0|||
33262591|NCT03611075|100863732|FG001|Overall Study|Reason unknown|0|||
33262592|NCT03611075|100863733|FG002|Overall Study|Reason unknown|0|||
33262593|NCT03611075|100863734|FG003|Overall Study|Reason unknown|1|||
33262594|NCT03611075|100863735|FG004|Overall Study|Reason unknown|0|||
33262595|NCT03611075|100863736|FG005|Overall Study|Reason unknown|0|||
33262596|NCT03611075|100863737|FG006|Overall Study|Reason unknown|1|||
33262597|NCT03611075|100863738|FG007|Overall Study|Reason unknown|0|||
33262598|NCT03611075|100863739|FG008|Overall Study|Reason unknown|0|||
33262599|NCT00093496|100863742|FG000|Overall Study|Protocol Violation|1|||
33262600|NCT00093496|100863743|FG001|Overall Study|Protocol Violation|3|||
33262601|NCT00811941|100863744|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
33262602|NCT00811941|100863745|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
33262603|NCT00811941|100863744|FG000|All Treated Patients|Adverse Event|2|||
33262604|NCT00811941|100863745|FG001|All Treated Patients|Adverse Event|43|||
33262605|NCT00811941|100863744|FG000|All Treated Patients|Lack of Efficacy|2|||
33262606|NCT00811941|100863745|FG001|All Treated Patients|Lack of Efficacy|3|||
33262607|NCT00811941|100863744|FG000|All Treated Patients|Non-compliance|1|||
33262608|NCT00811941|100863745|FG001|All Treated Patients|Non-compliance|8|||
33262609|NCT00811941|100863744|FG000|All Treated Patients|Protocol Violation|5|||
33262610|NCT00811941|100863745|FG001|All Treated Patients|Protocol Violation|17|||
33262611|NCT00811941|100863744|FG000|All Treated Patients|Withdrawal by Subject|35|||
33262612|NCT00811941|100863745|FG001|All Treated Patients|Withdrawal by Subject|94|||
33262613|NCT00811941|100863744|FG000|All Treated Patients|Lost to Follow-up|3|||
33262614|NCT00811941|100863745|FG001|All Treated Patients|Lost to Follow-up|12|||
33457775|NCT00651183|101564376|FG000|Overall Study|Withdrawal by Subject|6|||
33457776|NCT00651183|101564377|FG001|Overall Study|Withdrawal by Subject|3|||
33457777|NCT00651183|101564376|FG000|Overall Study|Lost to Follow-up|3|||
33457778|NCT00651183|101564377|FG001|Overall Study|Lost to Follow-up|1|||
33457779|NCT00651183|101564376|FG000|Overall Study|Other reasons|4|||
33457780|NCT00651183|101564377|FG001|Overall Study|Other reasons|2|||
33457781|NCT00651183|101564376|FG000|Overall Study|missing|1|||
33457782|NCT00651183|101564377|FG001|Overall Study|missing|0|||
33457783|NCT02107196|101564384|FG000|12-week Treatment Period|Adverse Event|6|||
33457784|NCT02107196|101564385|FG001|12-week Treatment Period|Adverse Event|3|||
33457785|NCT02107196|101564384|FG000|12-week Treatment Period|Lack of Efficacy|2|||
33457786|NCT02107196|101564385|FG001|12-week Treatment Period|Lack of Efficacy|1|||
33457787|NCT02107196|101564384|FG000|12-week Treatment Period|Lost to Follow-up|3|||
33174365|NCT00040664|100545790|FG001|Overall Study|Poor taste|0|||
33174366|NCT00040664|100545791|FG002|Overall Study|Poor taste|2|||
33174367|NCT00040664|100545792|FG003|Overall Study|Poor taste|0|||
33262615|NCT00811941|100863744|FG000|All Treated Patients|Other Reason|4|||
33262616|NCT00811941|100863745|FG001|All Treated Patients|Other Reason|14|||
33262617|NCT02130557|100863746|FG000|Overall Study|Withdrawal by Subject|12|||
33262618|NCT02130557|100863747|FG001|Overall Study|Withdrawal by Subject|12|||
33262619|NCT02130557|100863746|FG000|Overall Study|Investigator Request|0|||
33262620|NCT02130557|100863747|FG001|Overall Study|Investigator Request|2|||
33262621|NCT02130557|100863746|FG000|Overall Study|Deceased|14|||
33262622|NCT02130557|100863747|FG001|Overall Study|Deceased|14|||
33174368|NCT00040664|100545789|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
33174369|NCT00040664|100545790|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
33174370|NCT00040664|100545791|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
33174371|NCT00040664|100545792|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
33174372|NCT00040664|100545789|FG000|Overall Study|Change of formulation|2|||
33174373|NCT00040664|100545790|FG001|Overall Study|Change of formulation|2|||
33174374|NCT00040664|100545791|FG002|Overall Study|Change of formulation|0|||
33174375|NCT00040664|100545792|FG003|Overall Study|Change of formulation|0|||
33174376|NCT00040664|100545789|FG000|Overall Study|Non-viability of oral suspension|1|||
33174377|NCT00040664|100545790|FG001|Overall Study|Non-viability of oral suspension|0|||
33457788|NCT02107196|101564385|FG001|12-week Treatment Period|Lost to Follow-up|6|||
33457789|NCT02107196|101564384|FG000|12-week Treatment Period|Physician Decision|0|||
33457790|NCT02107196|101564385|FG001|12-week Treatment Period|Physician Decision|1|||
33457791|NCT02107196|101564384|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
33457792|NCT02107196|101564385|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
33457793|NCT02107196|101564384|FG000|12-week Treatment Period|Protocol Violation|7|||
33457794|NCT02107196|101564385|FG001|12-week Treatment Period|Protocol Violation|8|||
33457795|NCT02107196|101564384|FG000|12-week Treatment Period|Reason Missing|11|||
33457796|NCT02107196|101564385|FG001|12-week Treatment Period|Reason Missing|8|||
33457797|NCT02107196|101564384|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
33174378|NCT00040664|100545791|FG002|Overall Study|Non-viability of oral suspension|1|||
33174379|NCT00040664|100545792|FG003|Overall Study|Non-viability of oral suspension|0|||
33174380|NCT00450450|100545793|FG000|Overall Study|Death|1|||
33174381|NCT00450450|100545794|FG001|Overall Study|Death|3|||
33174382|NCT00450450|100545793|FG000|Overall Study|Relapse|2|||
33174383|NCT00450450|100545794|FG001|Overall Study|Relapse|0|||
33174384|NCT00450450|100545793|FG000|Overall Study|Missing Data|2|||
33174385|NCT00450450|100545794|FG001|Overall Study|Missing Data|0|||
33174386|NCT01881776|100545795|FG000|Overall Study|Lost to Follow-up|1|||
33174387|NCT01881776|100545796|FG001|Overall Study|Lost to Follow-up|2|||
33174388|NCT01881776|100545797|FG002|Overall Study|Lost to Follow-up|1|||
33174389|NCT01881776|100545795|FG000|Overall Study|Protocol Violation|0|||
33174390|NCT01881776|100545796|FG001|Overall Study|Protocol Violation|2|||
33174391|NCT01881776|100545797|FG002|Overall Study|Protocol Violation|1|||
33174392|NCT00467259|100545798|FG000|Overall Study|Adverse Event|24|||
33174393|NCT00467259|100545799|FG001|Overall Study|Adverse Event|90|||
33174394|NCT00467259|100545798|FG000|Overall Study|Protocol Violation|1|||
33174395|NCT00467259|100545799|FG001|Overall Study|Protocol Violation|7|||
33457798|NCT02107196|101564385|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
33174396|NCT00467259|100545798|FG000|Overall Study|Withdrawal by Subject|34|||
33174397|NCT00467259|100545799|FG001|Overall Study|Withdrawal by Subject|108|||
33174398|NCT00467259|100545798|FG000|Overall Study|Physician Decision|0|||
33174399|NCT00467259|100545799|FG001|Overall Study|Physician Decision|2|||
33174400|NCT00467259|100545798|FG000|Overall Study|Lost to Follow-up|14|||
33457799|NCT02107196|101564384|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
33457800|NCT02107196|101564385|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
33174401|NCT00467259|100545799|FG001|Overall Study|Lost to Follow-up|34|||
33262623|NCT02130557|100863746|FG000|Overall Study|Lost to Follow-up|6|||
33174402|NCT00467259|100545798|FG000|Overall Study|Site Closed|2|||
33174403|NCT00467259|100545799|FG001|Overall Study|Site Closed|1|||
33174404|NCT00372112|100545802|FG000|Overall Study|Adverse Event|0|||
33174405|NCT00372112|100545803|FG001|Overall Study|Adverse Event|1|||
33174406|NCT00372112|100545804|FG002|Overall Study|Adverse Event|1|||
33174407|NCT00372112|100545805|FG003|Overall Study|Adverse Event|1|||
33174408|NCT00372112|100545802|FG000|Overall Study|Withdrawal by Subject|0|||
33174409|NCT00372112|100545803|FG001|Overall Study|Withdrawal by Subject|0|||
33174410|NCT00372112|100545804|FG002|Overall Study|Withdrawal by Subject|2|||
33174411|NCT00372112|100545805|FG003|Overall Study|Withdrawal by Subject|1|||
33174412|NCT00372112|100545802|FG000|Overall Study|Exacerbation|0|||
33174413|NCT00372112|100545803|FG001|Overall Study|Exacerbation|0|||
33174414|NCT00372112|100545804|FG002|Overall Study|Exacerbation|0|||
33174415|NCT00372112|100545805|FG003|Overall Study|Exacerbation|1|||
33174416|NCT00372112|100545802|FG000|Overall Study|PR >240 at Visit 3|0|||
33174417|NCT00372112|100545803|FG001|Overall Study|PR >240 at Visit 3|0|||
33174418|NCT00372112|100545804|FG002|Overall Study|PR >240 at Visit 3|0|||
33174419|NCT00372112|100545805|FG003|Overall Study|PR >240 at Visit 3|1|||
33174420|NCT00372112|100545802|FG000|Overall Study|Hepatitis B|1|||
33174421|NCT00372112|100545803|FG001|Overall Study|Hepatitis B|0|||
33174422|NCT00372112|100545804|FG002|Overall Study|Hepatitis B|0|||
33174423|NCT00372112|100545805|FG003|Overall Study|Hepatitis B|0|||
33174424|NCT00372112|100545802|FG000|Overall Study|Other-protocol violation|0|||
33174425|NCT00372112|100545803|FG001|Overall Study|Other-protocol violation|0|||
33457801|NCT02107196|101564384|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
33457802|NCT02107196|101564385|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
33457803|NCT02107196|101564384|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
33174426|NCT00372112|100545804|FG002|Overall Study|Other-protocol violation|1|||
33174427|NCT00372112|100545805|FG003|Overall Study|Other-protocol violation|0|||
33174428|NCT00555321|100545806|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
33174429|NCT00555321|100545807|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
33174430|NCT00555321|100545808|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
33174431|NCT00555321|100545809|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
33174432|NCT00555321|100545810|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
33174433|NCT00555321|100545806|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
33174434|NCT00555321|100545807|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
33174435|NCT00555321|100545808|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
33262624|NCT02130557|100863747|FG001|Overall Study|Lost to Follow-up|7|||
33262625|NCT02130557|100863746|FG000|Overall Study|Other|2|||
33262626|NCT02130557|100863747|FG001|Overall Study|Other|1|||
33262627|NCT02130557|100863746|FG000|Overall Study|Missing|2|||
33262628|NCT02130557|100863747|FG001|Overall Study|Missing|1|||
33262629|NCT05580003|100863748|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262630|NCT05580003|100863749|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262631|NCT05580003|100863750|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262632|NCT05580003|100863751|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262633|NCT05580003|100863752|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262634|NCT05580003|100863753|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262635|NCT05580003|100863754|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
33262636|NCT05580003|100863755|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262637|NCT05580003|100863756|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262638|NCT05580003|100863757|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262639|NCT05580003|100863758|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262640|NCT05580003|100863759|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262641|NCT05580003|100863760|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262642|NCT05580003|100863761|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262643|NCT05580003|100863762|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262644|NCT05580003|100863763|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262645|NCT05580003|100863764|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262646|NCT05580003|100863765|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262647|NCT05580003|100863766|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262648|NCT05580003|100863767|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262649|NCT05580003|100863768|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262650|NCT05580003|100863769|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262651|NCT05580003|100863770|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262652|NCT05580003|100863771|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262653|NCT05580003|100863772|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262654|NCT05580003|100863773|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262655|NCT05580003|100863774|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262656|NCT05580003|100863775|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
33262657|NCT05580003|100863748|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262658|NCT05580003|100863749|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262659|NCT05580003|100863750|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262660|NCT05580003|100863751|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262661|NCT05580003|100863752|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262662|NCT05580003|100863753|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
33262663|NCT05580003|100863754|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262664|NCT05580003|100863755|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262665|NCT05580003|100863756|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262666|NCT05580003|100863757|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262667|NCT05580003|100863758|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33174436|NCT00555321|100545809|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
33174437|NCT00555321|100545810|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
33174438|NCT00555321|100545806|FG000|Treatment Phase up to 12-months|Death|2|||
33174439|NCT00555321|100545807|FG001|Treatment Phase up to 12-months|Death|1|||
33174440|NCT00555321|100545808|FG002|Treatment Phase up to 12-months|Death|4|||
33174441|NCT00555321|100545809|FG003|Treatment Phase up to 12-months|Death|0|||
33174442|NCT00555321|100545810|FG004|Treatment Phase up to 12-months|Death|0|||
33174443|NCT00555321|100545806|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
33174444|NCT00555321|100545807|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
33174445|NCT00555321|100545808|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
33174446|NCT00555321|100545809|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
33174447|NCT00555321|100545810|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
33174448|NCT00555321|100545806|FG000|Treatment Phase up to 12-months|Other Reason|1|||
33174449|NCT00555321|100545807|FG001|Treatment Phase up to 12-months|Other Reason|3|||
33174450|NCT00555321|100545808|FG002|Treatment Phase up to 12-months|Other Reason|2|||
33174451|NCT00555321|100545809|FG003|Treatment Phase up to 12-months|Other Reason|0|||
33174452|NCT00555321|100545810|FG004|Treatment Phase up to 12-months|Other Reason|0|||
33174453|NCT00555321|100545806|FG000|Treatment Phase up to 12-months|Never treated|2|||
33174454|NCT00555321|100545807|FG001|Treatment Phase up to 12-months|Never treated|3|||
33174455|NCT00555321|100545808|FG002|Treatment Phase up to 12-months|Never treated|1|||
33174456|NCT00555321|100545809|FG003|Treatment Phase up to 12-months|Never treated|0|||
33174457|NCT00555321|100545810|FG004|Treatment Phase up to 12-months|Never treated|4|||
33174458|NCT00555321|100545806|FG000|Long-term Extension Phase|Adverse Event|2|||
33174459|NCT00555321|100545807|FG001|Long-term Extension Phase|Adverse Event|5|||
33174460|NCT00555321|100545808|FG002|Long-term Extension Phase|Adverse Event|2|||
33174461|NCT00555321|100545809|FG003|Long-term Extension Phase|Adverse Event|1|||
33174462|NCT00555321|100545810|FG004|Long-term Extension Phase|Adverse Event|0|||
33174463|NCT00555321|100545806|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
33174464|NCT00555321|100545807|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
33174465|NCT00555321|100545808|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
33174466|NCT00555321|100545809|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
33174467|NCT00555321|100545810|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
33174468|NCT00555321|100545806|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
33174469|NCT00555321|100545807|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
33174470|NCT00555321|100545808|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
33174471|NCT00555321|100545809|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
33174472|NCT00555321|100545810|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
33174473|NCT00555321|100545806|FG000|Long-term Extension Phase|Death|2|||
33174474|NCT00555321|100545807|FG001|Long-term Extension Phase|Death|0|||
33174475|NCT00555321|100545808|FG002|Long-term Extension Phase|Death|0|||
33174476|NCT00555321|100545809|FG003|Long-term Extension Phase|Death|3|||
33174477|NCT00555321|100545810|FG004|Long-term Extension Phase|Death|0|||
33174478|NCT00555321|100545806|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
33174479|NCT00555321|100545807|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
33174480|NCT00555321|100545808|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
33174481|NCT00555321|100545809|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
33174482|NCT00555321|100545810|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
33174483|NCT00555321|100545806|FG000|Long-term Extension Phase|Other Reason|1|||
33174484|NCT00555321|100545807|FG001|Long-term Extension Phase|Other Reason|0|||
33174485|NCT00555321|100545808|FG002|Long-term Extension Phase|Other Reason|2|||
33262668|NCT05580003|100863759|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33174486|NCT00555321|100545809|FG003|Long-term Extension Phase|Other Reason|0|||
33174487|NCT00555321|100545810|FG004|Long-term Extension Phase|Other Reason|0|||
33174488|NCT03804879|100545811|FG000|Overall Study|Adverse Event|3|||
33174489|NCT03804879|100545812|FG001|Overall Study|Adverse Event|0|||
33174490|NCT03804879|100545811|FG000|Overall Study|Study Terminated By Sponsor|10|||
33174491|NCT03804879|100545812|FG001|Overall Study|Study Terminated By Sponsor|12|||
33174492|NCT03804879|100545811|FG000|Overall Study|Withdrawal by Subject|3|||
33174493|NCT03804879|100545812|FG001|Overall Study|Withdrawal by Subject|1|||
33174494|NCT00396591|100545813|FG000|Overall Study|Disease Progression|13|||
33174495|NCT00396591|100545813|FG000|Overall Study|Adverse Event|2|||
33174496|NCT00396591|100545813|FG000|Overall Study|Participant request|1|||
33174497|NCT01349803|100545814|FG000|Overall Study|Adverse Event|0|||
33174498|NCT01349803|100545815|FG001|Overall Study|Adverse Event|0|||
33174499|NCT01349803|100545816|FG002|Overall Study|Adverse Event|0|||
33174500|NCT01349803|100545817|FG003|Overall Study|Adverse Event|2|||
33174501|NCT01349803|100545814|FG000|Overall Study|Withdrawal by Subject|1|||
33174502|NCT01349803|100545815|FG001|Overall Study|Withdrawal by Subject|0|||
33174503|NCT01349803|100545816|FG002|Overall Study|Withdrawal by Subject|0|||
33174504|NCT01349803|100545817|FG003|Overall Study|Withdrawal by Subject|0|||
33174505|NCT01349803|100545814|FG000|Overall Study|Protocol-specified criteria|0|||
33174506|NCT01349803|100545815|FG001|Overall Study|Protocol-specified criteria|1|||
33174507|NCT01349803|100545816|FG002|Overall Study|Protocol-specified criteria|3|||
33174508|NCT01349803|100545817|FG003|Overall Study|Protocol-specified criteria|0|||
33174509|NCT02385045|100545819|FG000|Overall Study|Endoscopy could not be completed|4|||
33457804|NCT02107196|101564385|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
33457805|NCT00640926|101564386|FG000|Overall Study|Adverse Event|2|||
33457806|NCT00640926|101564387|FG001|Overall Study|Adverse Event|3|||
33457807|NCT00640926|101564388|FG002|Overall Study|Adverse Event|2|||
33457808|NCT00640926|101564386|FG000|Overall Study|Lack of Efficacy|0|||
33457809|NCT00640926|101564387|FG001|Overall Study|Lack of Efficacy|2|||
33457810|NCT00640926|101564388|FG002|Overall Study|Lack of Efficacy|1|||
33457811|NCT00640926|101564386|FG000|Overall Study|Protocol Violation|2|||
33457812|NCT00640926|101564387|FG001|Overall Study|Protocol Violation|0|||
33457813|NCT00640926|101564388|FG002|Overall Study|Protocol Violation|2|||
33457814|NCT00640926|101564386|FG000|Overall Study|Lost to Follow-up|3|||
33457815|NCT00640926|101564387|FG001|Overall Study|Lost to Follow-up|1|||
33457816|NCT00640926|101564388|FG002|Overall Study|Lost to Follow-up|2|||
33457817|NCT00640926|101564386|FG000|Overall Study|Withdrawal by Subject|1|||
33457818|NCT00640926|101564387|FG001|Overall Study|Withdrawal by Subject|0|||
33457819|NCT00640926|101564388|FG002|Overall Study|Withdrawal by Subject|1|||
33457820|NCT01663896|101564389|FG000|Overall Study|Various reasons|43|||
33457821|NCT00105157|101564393|FG000|Double-Blind (DB)|Never Treated|1|||
33457822|NCT00105157|101564394|FG001|Double-Blind (DB)|Never Treated|0|||
33457823|NCT00105157|101564395|FG002|Double-Blind (DB)|Never Treated|0|||
33174510|NCT00788151|100545820|FG000|Overall Study|Other adverse event|0|||
33174511|NCT00788151|100545821|FG001|Overall Study|Other adverse event|2|||
33457824|NCT00105157|101564396|FG003|Double-Blind (DB)|Never Treated|0|||
33457825|NCT00105157|101564393|FG000|Double-Blind (DB)|Adverse Event|2|||
33457826|NCT00105157|101564394|FG001|Double-Blind (DB)|Adverse Event|0|||
33457827|NCT00105157|101564395|FG002|Double-Blind (DB)|Adverse Event|1|||
33457828|NCT00105157|101564396|FG003|Double-Blind (DB)|Adverse Event|1|||
33174512|NCT00788151|100545820|FG000|Overall Study|Protocol Violation|0|||
33174513|NCT00788151|100545821|FG001|Overall Study|Protocol Violation|1|||
33174514|NCT00788151|100545820|FG000|Overall Study|Withdrawal by Subject|13|||
33174515|NCT00788151|100545821|FG001|Overall Study|Withdrawal by Subject|6|||
33457829|NCT00105157|101564393|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
33457830|NCT00105157|101564394|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
33174516|NCT00788151|100545820|FG000|Overall Study|Enrolled but not treated|1|||
33457831|NCT00105157|101564395|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
33174517|NCT00788151|100545821|FG001|Overall Study|Enrolled but not treated|1|||
33174518|NCT01905657|100545822|FG000|Overall Study|Adverse Event|23|||
33174519|NCT01905657|100545823|FG001|Overall Study|Adverse Event|17|||
33174520|NCT01905657|100545824|FG002|Overall Study|Adverse Event|18|||
33262669|NCT05580003|100863760|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262670|NCT05580003|100863761|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262671|NCT05580003|100863762|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262672|NCT05580003|100863763|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33174521|NCT01905657|100545822|FG000|Overall Study|Clinical Progression|103|||
33174522|NCT01905657|100545823|FG001|Overall Study|Clinical Progression|78|||
33174523|NCT01905657|100545824|FG002|Overall Study|Clinical Progression|59|||
33174524|NCT01905657|100545822|FG000|Overall Study|Death|40|||
33174525|NCT01905657|100545823|FG001|Overall Study|Death|43|||
33174526|NCT01905657|100545824|FG002|Overall Study|Death|47|||
33174527|NCT01905657|100545822|FG000|Overall Study|Excluded Medication|13|||
33174528|NCT01905657|100545823|FG001|Overall Study|Excluded Medication|16|||
33174529|NCT01905657|100545824|FG002|Overall Study|Excluded Medication|9|||
33174530|NCT01905657|100545822|FG000|Overall Study|Lost to Follow-up|1|||
33174531|NCT01905657|100545823|FG001|Overall Study|Lost to Follow-up|2|||
33174532|NCT01905657|100545824|FG002|Overall Study|Lost to Follow-up|1|||
33174533|NCT01905657|100545822|FG000|Overall Study|Physician Decision|5|||
33174534|NCT01905657|100545823|FG001|Overall Study|Physician Decision|8|||
33174535|NCT01905657|100545824|FG002|Overall Study|Physician Decision|12|||
33174536|NCT01905657|100545822|FG000|Overall Study|Protocol Violation|2|||
33174537|NCT01905657|100545823|FG001|Overall Study|Protocol Violation|1|||
33174538|NCT01905657|100545824|FG002|Overall Study|Protocol Violation|1|||
33174539|NCT01905657|100545822|FG000|Overall Study|Screen Failure|0|||
33174540|NCT01905657|100545823|FG001|Overall Study|Screen Failure|1|||
33174541|NCT01905657|100545824|FG002|Overall Study|Screen Failure|0|||
33174542|NCT01905657|100545822|FG000|Overall Study|Withdrawal by Subject|15|||
33174543|NCT01905657|100545823|FG001|Overall Study|Withdrawal by Subject|21|||
33457832|NCT00105157|101564396|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
33457833|NCT00105157|101564393|FG000|Open-Label Continuation of DB|Adverse Event|3|||
33457834|NCT00105157|101564394|FG001|Open-Label Continuation of DB|Adverse Event|1|||
33457835|NCT00105157|101564395|FG002|Open-Label Continuation of DB|Adverse Event|0|||
33457836|NCT00105157|101564396|FG003|Open-Label Continuation of DB|Adverse Event|0|||
33457837|NCT00105157|101564393|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
33457838|NCT00105157|101564394|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
33457839|NCT00105157|101564395|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
33457840|NCT00105157|101564396|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
33457841|NCT00105157|101564393|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
33457842|NCT00105157|101564394|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
33457843|NCT00105157|101564395|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
33457844|NCT00105157|101564396|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
33457845|NCT00105157|101564393|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
33457846|NCT00105157|101564394|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
33457847|NCT00105157|101564395|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
33457848|NCT00105157|101564396|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
33457849|NCT00105157|101564393|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
33457850|NCT00105157|101564394|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
33457851|NCT00105157|101564395|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
33262673|NCT05580003|100863764|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33457852|NCT00105157|101564396|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
33174544|NCT01905657|100545824|FG002|Overall Study|Withdrawal by Subject|53|||
33174545|NCT01905657|100545822|FG000|Overall Study|Sponsor Decision|1|||
33174546|NCT01905657|100545823|FG001|Overall Study|Sponsor Decision|0|||
33174547|NCT01905657|100545824|FG002|Overall Study|Sponsor Decision|0|||
33174548|NCT01059825|100545825|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
33174549|NCT01059825|100545826|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
33174550|NCT01059825|100545827|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
33174551|NCT01059825|100545828|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
33457853|NCT00105157|101564393|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
33457854|NCT00105157|101564394|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
33457855|NCT00105157|101564395|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
33457856|NCT00105157|101564396|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
33457857|NCT00105157|101564393|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
33457858|NCT00105157|101564394|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
33457859|NCT00105157|101564395|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
33457860|NCT00105157|101564396|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
33457861|NCT00105157|101564393|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
33457862|NCT00105157|101564394|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
33457863|NCT00105157|101564395|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
33457864|NCT00105157|101564396|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
33457865|NCT00105157|101564393|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
33457866|NCT00105157|101564394|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
33457867|NCT00105157|101564395|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
33457868|NCT00105157|101564396|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
33457869|NCT00105157|101564393|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
33457870|NCT00105157|101564394|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
33457871|NCT00105157|101564395|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
33457872|NCT00105157|101564396|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
33457873|NCT00105157|101564393|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
33457874|NCT00105157|101564394|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
33457875|NCT00105157|101564395|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
33457876|NCT00105157|101564396|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
33457877|NCT02448563|101564397|FG000|Overall Study|Lost to Follow-up|16|||
33457878|NCT02448563|101564398|FG001|Overall Study|Lost to Follow-up|10|||
33457879|NCT02448563|101564397|FG000|Overall Study|Withdrawal by Subject|0|||
33457880|NCT02448563|101564398|FG001|Overall Study|Withdrawal by Subject|1|||
33457881|NCT03732833|101564399|FG000|Overall Study|Adverse Event|0|||
33457882|NCT03732833|101564400|FG001|Overall Study|Adverse Event|3|||
33457883|NCT03732833|101564401|FG002|Overall Study|Adverse Event|1|||
33457884|NCT03732833|101564399|FG000|Overall Study|Withdrawal by Subject|11|||
33457885|NCT03732833|101564400|FG001|Overall Study|Withdrawal by Subject|13|||
33457886|NCT03732833|101564401|FG002|Overall Study|Withdrawal by Subject|8|||
33457887|NCT03732833|101564399|FG000|Overall Study|Lost to Follow-up|3|||
33457888|NCT03732833|101564400|FG001|Overall Study|Lost to Follow-up|5|||
33457889|NCT03732833|101564401|FG002|Overall Study|Lost to Follow-up|4|||
33457890|NCT03732833|101564399|FG000|Overall Study|Pregnancy|0|||
33174552|NCT01059825|100545829|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
33174553|NCT01059825|100545830|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
33174554|NCT01059825|100545831|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
33174555|NCT01059825|100545825|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
33174556|NCT01059825|100545826|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
33174557|NCT01059825|100545827|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
33174558|NCT01059825|100545828|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
33174559|NCT01059825|100545829|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
33174560|NCT01059825|100545830|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
33174561|NCT01059825|100545831|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
33174562|NCT01059825|100545825|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
33174563|NCT01059825|100545826|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
33174564|NCT01059825|100545827|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
33174565|NCT01059825|100545828|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
33174566|NCT01059825|100545829|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
33174567|NCT01059825|100545830|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
33174568|NCT01059825|100545831|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
33174569|NCT01059825|100545825|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
33174570|NCT01059825|100545826|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
33174571|NCT01059825|100545827|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
33174572|NCT01059825|100545828|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
33174573|NCT01059825|100545829|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
33174574|NCT01059825|100545830|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
33174575|NCT01059825|100545831|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
33174576|NCT01059825|100545825|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
33174577|NCT01059825|100545826|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
33174578|NCT01059825|100545827|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
33174579|NCT01059825|100545828|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
33174580|NCT01059825|100545829|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
33174581|NCT01059825|100545830|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
33174582|NCT01059825|100545831|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
33174583|NCT01059825|100545825|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
33174584|NCT01059825|100545826|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
33174585|NCT01059825|100545827|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
33174586|NCT01059825|100545828|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
33174587|NCT01059825|100545829|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
33174588|NCT01059825|100545830|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
33174589|NCT01059825|100545831|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
33174590|NCT01059825|100545825|FG000|Treatment Period|Lost to Follow-up|2|||
33174591|NCT01059825|100545826|FG001|Treatment Period|Lost to Follow-up|1|||
33457891|NCT03732833|101564400|FG001|Overall Study|Pregnancy|2|||
33457892|NCT03732833|101564401|FG002|Overall Study|Pregnancy|0|||
33457893|NCT03732833|101564399|FG000|Overall Study|Physician Decision|2|||
33457894|NCT03732833|101564400|FG001|Overall Study|Physician Decision|3|||
33457895|NCT03732833|101564401|FG002|Overall Study|Physician Decision|1|||
33457896|NCT03732833|101564399|FG000|Overall Study|Covid-19 related and other reasons|2|||
33457897|NCT03732833|101564400|FG001|Overall Study|Covid-19 related and other reasons|7|||
33174592|NCT01059825|100545827|FG002|Treatment Period|Lost to Follow-up|0|||
33174593|NCT01059825|100545828|FG003|Treatment Period|Lost to Follow-up|1|||
33174594|NCT01059825|100545829|FG004|Treatment Period|Lost to Follow-up|2|||
33174595|NCT01059825|100545830|FG005|Treatment Period|Lost to Follow-up|0|||
33174596|NCT01059825|100545831|FG006|Treatment Period|Lost to Follow-up|0|||
33262674|NCT05580003|100863765|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262675|NCT05580003|100863766|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33457898|NCT03732833|101564401|FG002|Overall Study|Covid-19 related and other reasons|3|||
33174597|NCT01059825|100545825|FG000|Treatment Period|Withdrawal by Subject|3|||
33174598|NCT01059825|100545826|FG001|Treatment Period|Withdrawal by Subject|0|||
33174599|NCT01059825|100545827|FG002|Treatment Period|Withdrawal by Subject|1|||
33174600|NCT01059825|100545828|FG003|Treatment Period|Withdrawal by Subject|5|||
33174601|NCT01059825|100545829|FG004|Treatment Period|Withdrawal by Subject|4|||
33174602|NCT01059825|100545830|FG005|Treatment Period|Withdrawal by Subject|1|||
33174603|NCT01059825|100545831|FG006|Treatment Period|Withdrawal by Subject|0|||
33174604|NCT01059825|100545825|FG000|Treatment Period|Other reason not specified|1|||
33174605|NCT01059825|100545826|FG001|Treatment Period|Other reason not specified|2|||
33174606|NCT01059825|100545827|FG002|Treatment Period|Other reason not specified|1|||
33174607|NCT01059825|100545828|FG003|Treatment Period|Other reason not specified|2|||
33174608|NCT01059825|100545829|FG004|Treatment Period|Other reason not specified|0|||
33174609|NCT01059825|100545830|FG005|Treatment Period|Other reason not specified|0|||
33174610|NCT01059825|100545831|FG006|Treatment Period|Other reason not specified|0|||
33174611|NCT01059825|100545825|FG000|Treatment Period|Protocol Violation|0|||
33174612|NCT01059825|100545826|FG001|Treatment Period|Protocol Violation|0|||
33174613|NCT01059825|100545827|FG002|Treatment Period|Protocol Violation|1|||
33174614|NCT01059825|100545828|FG003|Treatment Period|Protocol Violation|1|||
33174615|NCT01059825|100545829|FG004|Treatment Period|Protocol Violation|1|||
33174616|NCT01059825|100545830|FG005|Treatment Period|Protocol Violation|1|||
33174617|NCT01059825|100545831|FG006|Treatment Period|Protocol Violation|0|||
33174618|NCT01059825|100545825|FG000|Treatment Period|Adverse event related to study drug|1|||
33174619|NCT01059825|100545826|FG001|Treatment Period|Adverse event related to study drug|0|||
33174620|NCT01059825|100545827|FG002|Treatment Period|Adverse event related to study drug|1|||
33174621|NCT01059825|100545828|FG003|Treatment Period|Adverse event related to study drug|1|||
33174622|NCT01059825|100545829|FG004|Treatment Period|Adverse event related to study drug|0|||
33174623|NCT01059825|100545830|FG005|Treatment Period|Adverse event related to study drug|0|||
33174624|NCT01059825|100545831|FG006|Treatment Period|Adverse event related to study drug|0|||
33174625|NCT01059825|100545825|FG000|Treatment Period|Insufficient clinical response|3|||
33174626|NCT01059825|100545826|FG001|Treatment Period|Insufficient clinical response|0|||
33174627|NCT01059825|100545827|FG002|Treatment Period|Insufficient clinical response|0|||
33174628|NCT01059825|100545828|FG003|Treatment Period|Insufficient clinical response|0|||
33174629|NCT01059825|100545829|FG004|Treatment Period|Insufficient clinical response|0|||
33174630|NCT01059825|100545830|FG005|Treatment Period|Insufficient clinical response|0|||
33174631|NCT01059825|100545831|FG006|Treatment Period|Insufficient clinical response|0|||
33174632|NCT01059825|100545825|FG000|Treatment Period|Adverse event not related to study drug|0|||
33174633|NCT01059825|100545826|FG001|Treatment Period|Adverse event not related to study drug|1|||
33174634|NCT01059825|100545827|FG002|Treatment Period|Adverse event not related to study drug|2|||
33174635|NCT01059825|100545828|FG003|Treatment Period|Adverse event not related to study drug|1|||
33174636|NCT01059825|100545829|FG004|Treatment Period|Adverse event not related to study drug|1|||
33174637|NCT01059825|100545830|FG005|Treatment Period|Adverse event not related to study drug|1|||
33174638|NCT01059825|100545831|FG006|Treatment Period|Adverse event not related to study drug|0|||
33262676|NCT05580003|100863767|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262677|NCT05580003|100863768|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33174639|NCT04271605|100545836|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
33174640|NCT03562481|100545841|FG000|First Intervention|Lost to Follow-up|1|||
33174641|NCT03562481|100545842|FG001|First Intervention|Lost to Follow-up|0|||
33262678|NCT05580003|100863769|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33457899|NCT01962298|101564404|FG000|Overall Study|Protocol Violation|1|||
33457900|NCT01962298|101564405|FG001|Overall Study|Protocol Violation|0|||
33457901|NCT01962298|101564406|FG002|Overall Study|Protocol Violation|1|||
33457902|NCT01962298|101564407|FG003|Overall Study|Protocol Violation|1|||
33457903|NCT01962298|101564408|FG004|Overall Study|Protocol Violation|0|||
33457904|NCT01962298|101564404|FG000|Overall Study|Data quality insufficient|2|||
33457905|NCT01962298|101564405|FG001|Overall Study|Data quality insufficient|0|||
33457906|NCT01962298|101564406|FG002|Overall Study|Data quality insufficient|3|||
33174642|NCT02496533|100545843|FG000|Overall Study|Lack of data on outcome|3|||
33174643|NCT02496533|100545844|FG001|Overall Study|Lack of data on outcome|0|||
33174644|NCT02496533|100545843|FG000|Overall Study|Patient did not complete all measures|0|||
33174645|NCT02496533|100545844|FG001|Overall Study|Patient did not complete all measures|4|||
33174646|NCT02496533|100545843|FG000|Overall Study|Late for radiologic testing|0|||
33174647|NCT02496533|100545844|FG001|Overall Study|Late for radiologic testing|2|||
33174648|NCT02700815|100545845|FG000|Overall Study|Adverse Event|0|||
33174649|NCT02700815|100545846|FG001|Overall Study|Adverse Event|6|||
33174650|NCT02700815|100545847|FG002|Overall Study|Adverse Event|2|||
33174651|NCT02700815|100545848|FG003|Overall Study|Adverse Event|3|||
33174652|NCT02700815|100545845|FG000|Overall Study|Lack of Efficacy|0|||
33174653|NCT02700815|100545846|FG001|Overall Study|Lack of Efficacy|0|||
33174654|NCT02700815|100545847|FG002|Overall Study|Lack of Efficacy|1|||
33174655|NCT02700815|100545848|FG003|Overall Study|Lack of Efficacy|2|||
33457907|NCT01962298|101564407|FG003|Overall Study|Data quality insufficient|1|||
33457908|NCT01962298|101564408|FG004|Overall Study|Data quality insufficient|4|||
33457909|NCT01962298|101564404|FG000|Overall Study|Insufficient data|0|||
33174656|NCT02700815|100545845|FG000|Overall Study|Lost to Follow-up|1|||
33174657|NCT02700815|100545846|FG001|Overall Study|Lost to Follow-up|0|||
33174658|NCT02700815|100545847|FG002|Overall Study|Lost to Follow-up|0|||
33262679|NCT05580003|100863770|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33174659|NCT02700815|100545848|FG003|Overall Study|Lost to Follow-up|1|||
33174660|NCT02700815|100545845|FG000|Overall Study|Refusal to continue medication|0|||
33262680|NCT05580003|100863771|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262681|NCT05580003|100863772|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262682|NCT05580003|100863773|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33457910|NCT01962298|101564405|FG001|Overall Study|Insufficient data|2|||
33457911|NCT01962298|101564406|FG002|Overall Study|Insufficient data|1|||
33457912|NCT01962298|101564407|FG003|Overall Study|Insufficient data|0|||
33457913|NCT01962298|101564408|FG004|Overall Study|Insufficient data|1|||
33457914|NCT01962298|101564404|FG000|Overall Study|Incorrect data recorded|0|||
33457915|NCT01962298|101564405|FG001|Overall Study|Incorrect data recorded|1|||
33457916|NCT01962298|101564406|FG002|Overall Study|Incorrect data recorded|0|||
33457917|NCT01962298|101564407|FG003|Overall Study|Incorrect data recorded|0|||
33457918|NCT01962298|101564408|FG004|Overall Study|Incorrect data recorded|0|||
33457919|NCT01962298|101564404|FG000|Overall Study|Physician Decision|0|||
33457920|NCT01962298|101564405|FG001|Overall Study|Physician Decision|1|||
33457921|NCT01962298|101564406|FG002|Overall Study|Physician Decision|0|||
33457922|NCT01962298|101564407|FG003|Overall Study|Physician Decision|0|||
33457923|NCT01962298|101564408|FG004|Overall Study|Physician Decision|1|||
33457924|NCT03370510|101564409|FG000|Overall Study|COVID-19|2|||
33457925|NCT03370510|101564410|FG001|Overall Study|COVID-19|0|||
33457926|NCT04994431|101564412|FG000|Overall Study|Adverse Event|1|||
33457927|NCT04994431|101564413|FG001|Overall Study|Adverse Event|0|||
33457928|NCT01091363|101564414|FG000|Overall Study|Withdrawal by Subject|11|||
33457929|NCT01091363|101564415|FG001|Overall Study|Withdrawal by Subject|15|||
33457930|NCT01091363|101564414|FG000|Overall Study|Lost to Follow-up|2|||
33457931|NCT01091363|101564415|FG001|Overall Study|Lost to Follow-up|2|||
33457932|NCT01277510|101564416|FG000|Double-blind Phase|Non-compliance|0|||
33457933|NCT01277510|101564417|FG001|Double-blind Phase|Non-compliance|1|||
33457934|NCT01277510|101564416|FG000|Double-blind Phase|Adverse Event|1|||
33457935|NCT01277510|101564417|FG001|Double-blind Phase|Adverse Event|0|||
33457936|NCT01277510|101564416|FG000|Double-blind Phase|Withdrawal by Subject|2|||
33457937|NCT01277510|101564417|FG001|Double-blind Phase|Withdrawal by Subject|0|||
33457938|NCT01277510|101564416|FG000|Double-blind Phase|Administrative decision|7|||
33457939|NCT01277510|101564417|FG001|Double-blind Phase|Administrative decision|9|||
33457940|NCT01277510|101564416|FG000|Double-blind Phase|Death|0|||
33457941|NCT01277510|101564417|FG001|Double-blind Phase|Death|1|||
33457942|NCT01277510|101564416|FG000|Double-blind Phase|Protocol-specified criteria|2|||
33457943|NCT01277510|101564417|FG001|Double-blind Phase|Protocol-specified criteria|6|||
33457944|NCT01277510|101564416|FG000|Double-blind Phase|Other|1|||
33457945|NCT01277510|101564417|FG001|Double-blind Phase|Other|1|||
33457946|NCT01277510|101564416|FG000|Open-label Phase|Administrative decision|4|||
33457947|NCT01277510|101564417|FG001|Open-label Phase|Administrative decision|3|||
33457948|NCT01277510|101564416|FG000|Open-label Phase|Protocol-specified criteria|1|||
33457949|NCT01277510|101564417|FG001|Open-label Phase|Protocol-specified criteria|0|||
33457950|NCT01277510|101564416|FG000|Open-label Phase|Never received investigational product|2|||
33457951|NCT01277510|101564417|FG001|Open-label Phase|Never received investigational product|0|||
33457952|NCT02174276|101564419|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
33457953|NCT02174276|101564420|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
33457954|NCT02174276|101564421|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
33457955|NCT02174276|101564422|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
33457956|NCT02174276|101564419|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
33457957|NCT02174276|101564420|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
33457958|NCT02174276|101564421|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
33457959|NCT02174276|101564422|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
33457960|NCT02174276|101564419|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
33457961|NCT02174276|101564420|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
33457962|NCT02174276|101564421|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
33457963|NCT02174276|101564422|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
33457964|NCT02174276|101564419|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
33457965|NCT02174276|101564420|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
33457966|NCT02174276|101564421|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
33457967|NCT02174276|101564422|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
33457968|NCT02174276|101564419|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
33457969|NCT02174276|101564420|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
33457970|NCT02174276|101564421|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
33457971|NCT02174276|101564422|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
33457972|NCT02174276|101564419|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
33174661|NCT02700815|100545846|FG001|Overall Study|Refusal to continue medication|1|||
33174662|NCT02700815|100545847|FG002|Overall Study|Refusal to continue medication|0|||
33457973|NCT02174276|101564420|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
33457974|NCT02174276|101564421|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
33457975|NCT02174276|101564422|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
33457976|NCT02490800|101564423|FG000|Overall Study|Adverse Event|0|||
33457977|NCT02490800|101564424|FG001|Overall Study|Adverse Event|0|||
33457978|NCT02490800|101564425|FG002|Overall Study|Adverse Event|0|||
33457979|NCT02490800|101564426|FG003|Overall Study|Adverse Event|2|||
33457980|NCT02490800|101564427|FG004|Overall Study|Adverse Event|3|||
33457981|NCT02490800|101564428|FG005|Overall Study|Adverse Event|2|||
33457982|NCT02490800|101564429|FG006|Overall Study|Adverse Event|0|||
33457983|NCT02490800|101564430|FG007|Overall Study|Adverse Event|0|||
33457984|NCT02490800|101564431|FG008|Overall Study|Adverse Event|0|||
33457985|NCT02490800|101564432|FG009|Overall Study|Adverse Event|0|||
33457986|NCT02490800|101564433|FG010|Overall Study|Adverse Event|0|||
33457987|NCT02490800|101564434|FG011|Overall Study|Adverse Event|2|||
33457988|NCT02490800|101564435|FG012|Overall Study|Adverse Event|2|||
33457989|NCT02490800|101564423|FG000|Overall Study|Withdrawal by Subject|0|||
33457990|NCT02490800|101564424|FG001|Overall Study|Withdrawal by Subject|0|||
33457991|NCT02490800|101564425|FG002|Overall Study|Withdrawal by Subject|0|||
33262683|NCT05580003|100863774|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262684|NCT05580003|100863775|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
33262685|NCT05580003|100863748|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262686|NCT05580003|100863749|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262687|NCT05580003|100863750|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262688|NCT05580003|100863751|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
33457992|NCT02490800|101564426|FG003|Overall Study|Withdrawal by Subject|1|||
33457993|NCT02490800|101564427|FG004|Overall Study|Withdrawal by Subject|0|||
33457994|NCT02490800|101564428|FG005|Overall Study|Withdrawal by Subject|0|||
33457995|NCT02490800|101564429|FG006|Overall Study|Withdrawal by Subject|0|||
33457996|NCT02490800|101564430|FG007|Overall Study|Withdrawal by Subject|0|||
33457997|NCT02490800|101564431|FG008|Overall Study|Withdrawal by Subject|1|||
33457998|NCT02490800|101564432|FG009|Overall Study|Withdrawal by Subject|0|||
33457999|NCT02490800|101564433|FG010|Overall Study|Withdrawal by Subject|0|||
33458000|NCT02490800|101564434|FG011|Overall Study|Withdrawal by Subject|0|||
33458001|NCT02490800|101564435|FG012|Overall Study|Withdrawal by Subject|0|||
33458002|NCT02490800|101564423|FG000|Overall Study|Progressive disease|3|||
33458003|NCT02490800|101564424|FG001|Overall Study|Progressive disease|3|||
33458004|NCT02490800|101564425|FG002|Overall Study|Progressive disease|3|||
33458005|NCT02490800|101564426|FG003|Overall Study|Progressive disease|4|||
33458006|NCT02490800|101564427|FG004|Overall Study|Progressive disease|4|||
33458007|NCT02490800|101564428|FG005|Overall Study|Progressive disease|1|||
33458008|NCT02490800|101564429|FG006|Overall Study|Progressive disease|4|||
33458009|NCT02490800|101564430|FG007|Overall Study|Progressive disease|3|||
33458010|NCT02490800|101564431|FG008|Overall Study|Progressive disease|6|||
33458011|NCT02490800|101564432|FG009|Overall Study|Progressive disease|2|||
33458012|NCT02490800|101564433|FG010|Overall Study|Progressive disease|7|||
33458013|NCT02490800|101564434|FG011|Overall Study|Progressive disease|1|||
33458014|NCT02490800|101564435|FG012|Overall Study|Progressive disease|10|||
33458015|NCT02490800|101564423|FG000|Overall Study|Patient enrolled in post-trial access|0|||
33458016|NCT02490800|101564424|FG001|Overall Study|Patient enrolled in post-trial access|0|||
33458017|NCT02490800|101564425|FG002|Overall Study|Patient enrolled in post-trial access|0|||
33458018|NCT02490800|101564426|FG003|Overall Study|Patient enrolled in post-trial access|0|||
33458019|NCT02490800|101564427|FG004|Overall Study|Patient enrolled in post-trial access|0|||
33458020|NCT02490800|101564428|FG005|Overall Study|Patient enrolled in post-trial access|0|||
33458021|NCT02490800|101564429|FG006|Overall Study|Patient enrolled in post-trial access|0|||
33458022|NCT02490800|101564430|FG007|Overall Study|Patient enrolled in post-trial access|0|||
33458023|NCT02490800|101564431|FG008|Overall Study|Patient enrolled in post-trial access|0|||
33458024|NCT02490800|101564432|FG009|Overall Study|Patient enrolled in post-trial access|1|||
33458025|NCT02490800|101564433|FG010|Overall Study|Patient enrolled in post-trial access|1|||
33458026|NCT02490800|101564434|FG011|Overall Study|Patient enrolled in post-trial access|0|||
33458027|NCT02490800|101564435|FG012|Overall Study|Patient enrolled in post-trial access|6|||
33458028|NCT00772148|101564436|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
33458029|NCT00772148|101564437|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
33458030|NCT00772148|101564436|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
33458031|NCT00772148|101564437|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
33458032|NCT00772148|101564436|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
33458033|NCT00772148|101564437|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
33458034|NCT00772148|101564436|FG000|Maintenance Phase (Week 52)|Death|2|||
33458035|NCT00772148|101564437|FG001|Maintenance Phase (Week 52)|Death|2|||
33458036|NCT00772148|101564436|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
33458037|NCT00772148|101564437|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
33458038|NCT00772148|101564436|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
33458039|NCT00772148|101564437|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
33458040|NCT00772148|101564436|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
33458041|NCT00772148|101564437|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
33458042|NCT02212457|101564438|FG000|Overall Study|Adverse Event|1|||
33458043|NCT02212457|101564439|FG001|Overall Study|Adverse Event|2|||
33458044|NCT02212457|101564440|FG002|Overall Study|Adverse Event|2|||
33458045|NCT02212457|101564441|FG003|Overall Study|Adverse Event|2|||
33458046|NCT02212457|101564442|FG004|Overall Study|Adverse Event|0|||
33458047|NCT02212457|101564443|FG005|Overall Study|Adverse Event|1|||
33458048|NCT02212457|101564438|FG000|Overall Study|Withdrawal by Subject|8|||
33458049|NCT02212457|101564439|FG001|Overall Study|Withdrawal by Subject|10|||
33458050|NCT02212457|101564440|FG002|Overall Study|Withdrawal by Subject|8|||
33458051|NCT02212457|101564441|FG003|Overall Study|Withdrawal by Subject|6|||
33458052|NCT02212457|101564442|FG004|Overall Study|Withdrawal by Subject|5|||
33458053|NCT02212457|101564443|FG005|Overall Study|Withdrawal by Subject|4|||
33458054|NCT02212457|101564438|FG000|Overall Study|Lost to Follow-up|6|||
33458055|NCT02212457|101564439|FG001|Overall Study|Lost to Follow-up|7|||
33458056|NCT02212457|101564440|FG002|Overall Study|Lost to Follow-up|4|||
33458057|NCT02212457|101564441|FG003|Overall Study|Lost to Follow-up|1|||
33458058|NCT02212457|101564442|FG004|Overall Study|Lost to Follow-up|8|||
33458059|NCT02212457|101564443|FG005|Overall Study|Lost to Follow-up|4|||
33458060|NCT02212457|101564438|FG000|Overall Study|Protocol Violation|2|||
33458061|NCT02212457|101564439|FG001|Overall Study|Protocol Violation|1|||
33458062|NCT02212457|101564440|FG002|Overall Study|Protocol Violation|0|||
33458063|NCT02212457|101564441|FG003|Overall Study|Protocol Violation|1|||
33458064|NCT02212457|101564442|FG004|Overall Study|Protocol Violation|2|||
33458065|NCT02212457|101564443|FG005|Overall Study|Protocol Violation|3|||
33458066|NCT02212457|101564438|FG000|Overall Study|Other|2|||
33458067|NCT02212457|101564439|FG001|Overall Study|Other|1|||
33174663|NCT02700815|100545848|FG003|Overall Study|Refusal to continue medication|1|||
33174664|NCT02700815|100545845|FG000|Overall Study|Withdrawal by Subject|0|||
33174665|NCT02700815|100545846|FG001|Overall Study|Withdrawal by Subject|0|||
33458068|NCT02212457|101564440|FG002|Overall Study|Other|2|||
33458069|NCT02212457|101564441|FG003|Overall Study|Other|1|||
33174666|NCT02700815|100545847|FG002|Overall Study|Withdrawal by Subject|1|||
33174667|NCT02700815|100545848|FG003|Overall Study|Withdrawal by Subject|0|||
33174668|NCT01752907|100545852|FG000|Overall Study|Withdrawal by Subject|4|||
33174669|NCT01752907|100545853|FG001|Overall Study|Withdrawal by Subject|10|||
33174670|NCT01752907|100545852|FG000|Overall Study|Lost to Follow-up|2|||
33174671|NCT01752907|100545853|FG001|Overall Study|Lost to Follow-up|1|||
33174672|NCT01752907|100545852|FG000|Overall Study|Decision by Sponsor|6|||
33174673|NCT01752907|100545853|FG001|Overall Study|Decision by Sponsor|9|||
33174674|NCT01721330|100545859|FG000|Overall Study|Withdrawal by Subject|0|||
33174675|NCT01721330|100545860|FG001|Overall Study|Withdrawal by Subject|1|||
33174676|NCT02041286|100545862|FG000|Overall Study|Adverse Event|1|||
33174677|NCT04326231|100545871|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
33174678|NCT00927784|100545872|FG000|Overall Study|Death|1|||
33174679|NCT00927784|100545873|FG001|Overall Study|Death|0|||
33174680|NCT00927784|100545872|FG000|Overall Study|Withdrawal by Subject|1|||
33174681|NCT00927784|100545873|FG001|Overall Study|Withdrawal by Subject|0|||
33174682|NCT01991067|100545874|FG000|Overall Study|Lost to Follow-up|6|||
33174683|NCT01991067|100545875|FG001|Overall Study|Lost to Follow-up|5|||
33262689|NCT05580003|100863752|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262690|NCT05580003|100863753|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262691|NCT05580003|100863754|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262692|NCT05580003|100863755|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262693|NCT05580003|100863756|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262694|NCT05580003|100863757|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262695|NCT05580003|100863758|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262696|NCT05580003|100863759|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262697|NCT05580003|100863760|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262698|NCT05580003|100863761|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262699|NCT05580003|100863762|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262700|NCT05580003|100863763|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262701|NCT05580003|100863764|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262702|NCT05580003|100863765|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262703|NCT05580003|100863766|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262704|NCT05580003|100863767|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262705|NCT05580003|100863768|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262706|NCT05580003|100863769|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262707|NCT05580003|100863770|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262708|NCT05580003|100863771|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262709|NCT05580003|100863772|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262710|NCT05580003|100863773|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262711|NCT05580003|100863774|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262712|NCT05580003|100863775|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
33262713|NCT05580003|100863748|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262714|NCT05580003|100863749|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
33262715|NCT05580003|100863750|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262716|NCT05580003|100863751|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262717|NCT05580003|100863752|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262718|NCT05580003|100863753|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262719|NCT05580003|100863754|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33458070|NCT02212457|101564442|FG004|Overall Study|Other|0|||
33174684|NCT00638378|100545876|FG000|Overall Study|Death|2|||
33174685|NCT00638378|100545876|FG000|Overall Study|Adverse Event|1|||
33174686|NCT00638378|100545876|FG000|Overall Study|Disease progression|15|||
33174687|NCT00638378|100545876|FG000|Overall Study|Physician Decision|4|||
33174688|NCT03489720|100545877|FG000|Overall Study|Withdrawal by Subject|2|||
33174689|NCT03489720|100545878|FG001|Overall Study|Withdrawal by Subject|0|||
33174690|NCT00166114|100545882|FG000|Overall Study|Protocol Violation|2|||
33174691|NCT00166114|100545883|FG001|Overall Study|Protocol Violation|1|||
33262720|NCT05580003|100863755|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262721|NCT05580003|100863756|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262722|NCT05580003|100863757|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262723|NCT05580003|100863758|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262724|NCT05580003|100863759|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262725|NCT05580003|100863760|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262726|NCT05580003|100863761|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33458071|NCT02212457|101564443|FG005|Overall Study|Other|1|||
33174692|NCT00166114|100545882|FG000|Overall Study|Withdrawal by Subject|10|||
33174693|NCT00166114|100545883|FG001|Overall Study|Withdrawal by Subject|4|||
33174694|NCT00166114|100545882|FG000|Overall Study|Adverse Event|2|||
33174695|NCT00166114|100545883|FG001|Overall Study|Adverse Event|1|||
33458072|NCT00960154|101564444|FG000|Overall Study|Study termination|25|||
33458073|NCT00960154|101564445|FG001|Overall Study|Study termination|25|||
33458074|NCT00292227|101564446|FG000|Patch Period|Adverse Event|1|||
33458075|NCT00292227|101564447|FG001|Patch Period|Adverse Event|0|||
33458076|NCT00292227|101564448|FG002|Patch Period|Adverse Event|2|||
33458077|NCT00292227|101564446|FG000|Patch Period|Withdrawal by Subject|0|||
33458078|NCT00292227|101564447|FG001|Patch Period|Withdrawal by Subject|0|||
33458079|NCT00292227|101564448|FG002|Patch Period|Withdrawal by Subject|1|||
33458080|NCT01119625|101564449|FG000|Overall Study|Lost to Follow-up|1|||
33458081|NCT01119625|101564450|FG001|Overall Study|Lost to Follow-up|2|||
33458082|NCT01119625|101564449|FG000|Overall Study|Withdrawal by Subject|2|||
33458083|NCT01119625|101564450|FG001|Overall Study|Withdrawal by Subject|1|||
33458084|NCT01119625|101564449|FG000|Overall Study|Other|0|||
33458085|NCT01119625|101564450|FG001|Overall Study|Other|1|||
33458086|NCT02786953|101564451|FG000|Overall Study|Withdrawal by Subject|3|||
33458087|NCT02786953|101564452|FG001|Overall Study|Withdrawal by Subject|0|||
33458088|NCT02786953|101564451|FG000|Overall Study|Physician Decision|0|||
33458089|NCT02786953|101564452|FG001|Overall Study|Physician Decision|1|||
33458090|NCT03277248|101564460|FG000|Overall Study|Adverse Event|3|||
33458091|NCT03277248|101564461|FG001|Overall Study|Adverse Event|1|||
33458092|NCT03277248|101564460|FG000|Overall Study|Subject Withdrawal of Consent|6|||
33458093|NCT03277248|101564461|FG001|Overall Study|Subject Withdrawal of Consent|23|||
33458094|NCT03277248|101564460|FG000|Overall Study|Investigator/Sponsor Decision|2|||
33458095|NCT03277248|101564461|FG001|Overall Study|Investigator/Sponsor Decision|2|||
33458096|NCT03277248|101564460|FG000|Overall Study|Pregnancy|4|||
33458097|NCT03277248|101564461|FG001|Overall Study|Pregnancy|1|||
33458098|NCT03277248|101564460|FG000|Overall Study|Lost to Follow-up|0|||
33458099|NCT03277248|101564461|FG001|Overall Study|Lost to Follow-up|2|||
33458100|NCT03277248|101564460|FG000|Overall Study|Lack of Efficacy|0|||
33458101|NCT03277248|101564461|FG001|Overall Study|Lack of Efficacy|2|||
33458102|NCT03277248|101564460|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
33458103|NCT03277248|101564461|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
33458104|NCT03203642|101564462|FG000|Overall Study|Adverse Event|3|||
33458105|NCT03203642|101564463|FG001|Overall Study|Adverse Event|1|||
33458106|NCT03203642|101564462|FG000|Overall Study|Withdrawal by Subject|6|||
33458107|NCT03203642|101564463|FG001|Overall Study|Withdrawal by Subject|6|||
33458108|NCT03203642|101564462|FG000|Overall Study|Lost to Follow-up|2|||
33458109|NCT03203642|101564463|FG001|Overall Study|Lost to Follow-up|1|||
33458110|NCT03203642|101564462|FG000|Overall Study|Termination of the study by sponsor|1|||
33458111|NCT03203642|101564463|FG001|Overall Study|Termination of the study by sponsor|1|||
33458112|NCT03203642|101564462|FG000|Overall Study|Participant moved|0|||
33458113|NCT03203642|101564463|FG001|Overall Study|Participant moved|1|||
33458114|NCT03203642|101564462|FG000|Overall Study|Investigator's decision|3|||
33458115|NCT03203642|101564463|FG001|Overall Study|Investigator's decision|0|||
33458116|NCT03203642|101564462|FG000|Overall Study|Other than above specified|0|||
33458117|NCT03203642|101564463|FG001|Overall Study|Other than above specified|1|||
33458118|NCT00160524|101564464|FG000|Overall Study|Adverse Event|119|||
33458119|NCT00160524|101564464|FG000|Overall Study|Adverse Event and Other|94|||
33458120|NCT00160524|101564464|FG000|Overall Study|Protocol Violation|16|||
33458121|NCT00160524|101564464|FG000|Overall Study|Protocol Violation and Other|2|||
33458122|NCT00160524|101564464|FG000|Overall Study|Withdrawal by Subject|141|||
33458123|NCT00160524|101564464|FG000|Overall Study|Withdrawal by Subject and Other|17|||
33458124|NCT00160524|101564464|FG000|Overall Study|Physician Decision|27|||
33458125|NCT00160524|101564464|FG000|Overall Study|Physician Decision and Other|6|||
33458126|NCT00160524|101564464|FG000|Overall Study|Lost to Follow-up|13|||
33458127|NCT00160524|101564464|FG000|Overall Study|Lost to Follow-up and Other|1|||
33458128|NCT00160524|101564464|FG000|Overall Study|Lack of Efficacy|21|||
33458129|NCT00160524|101564464|FG000|Overall Study|Lack of Efficacy and Other|1|||
33458130|NCT00160524|101564464|FG000|Overall Study|Other|20|||
33458131|NCT00210639|101564465|FG000|Overall Study|Lost to Follow-up|37|||
33458132|NCT00210639|101564466|FG001|Overall Study|Lost to Follow-up|29|||
33458133|NCT00210639|101564465|FG000|Overall Study|Withdrawal by Subject|8|||
33458134|NCT00210639|101564466|FG001|Overall Study|Withdrawal by Subject|1|||
33458135|NCT00210639|101564465|FG000|Overall Study|Other|18|||
33458136|NCT00210639|101564466|FG001|Overall Study|Other|12|||
33458137|NCT00396630|101564467|FG000|Overall Study|Lost to Follow-up|1|||
33458138|NCT00396630|101564468|FG001|Overall Study|Lost to Follow-up|1|||
33458139|NCT00396630|101564467|FG000|Overall Study|Withdrawal by Subject|1|||
33458140|NCT00396630|101564468|FG001|Overall Study|Withdrawal by Subject|1|||
33458141|NCT00396630|101564467|FG000|Overall Study|Not vaccinated at Visit 3|3|||
33458142|NCT00396630|101564468|FG001|Overall Study|Not vaccinated at Visit 3|3|||
33458143|NCT00274625|101564475|FG000|Overall Study|Lost to Follow-up|46|||
33458144|NCT00274625|101564476|FG001|Overall Study|Lost to Follow-up|54|||
33458145|NCT00274625|101564475|FG000|Overall Study|Excluded from analysis|14|||
33458146|NCT00274625|101564476|FG001|Overall Study|Excluded from analysis|8|||
33458147|NCT00766493|101564479|FG000|30 Days Post-Procedure|Discontinued|7|||
33458148|NCT00766493|101564479|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
33458149|NCT00766493|101564479|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
33458150|NCT05497557|101564489|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
33458151|NCT05497557|101564490|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
33458152|NCT05497557|101564491|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
33458153|NCT01726803|101564492|FG000|Overall Study|Lost to Follow-up|6|||
33458154|NCT01726803|101564493|FG001|Overall Study|Lost to Follow-up|1|||
33458155|NCT01726803|101564492|FG000|Overall Study|Withdrawal by Subject|1|||
33458156|NCT01726803|101564493|FG001|Overall Study|Withdrawal by Subject|0|||
33458157|NCT02260258|101567934|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
33458158|NCT02260258|101567935|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
33458159|NCT01398787|101567939|FG000|Overall Study|Adverse Event|1|||
33458160|NCT01341405|101567940|FG000|Overall Study|Adverse Event|0|||
33458161|NCT01341405|101567941|FG001|Overall Study|Adverse Event|1|||
33458162|NCT01341405|101567942|FG002|Overall Study|Adverse Event|1|||
33458163|NCT01341405|101567940|FG000|Overall Study|Withdrawal by Subject|3|||
33458164|NCT01341405|101567941|FG001|Overall Study|Withdrawal by Subject|2|||
33458165|NCT01341405|101567942|FG002|Overall Study|Withdrawal by Subject|1|||
33458166|NCT00716625|101567943|FG000|Overall Study|Safety was not Assessable|1|||
33458167|NCT02340962|101567944|FG000|Overall Study|Lost to Follow-up|1|||
33458168|NCT02340962|101567945|FG001|Overall Study|Lost to Follow-up|0|||
33458169|NCT04553406|101567946|FG000|Overall Study|Study Discontinuation|0|||
33458170|NCT04553406|101567947|FG001|Overall Study|Study Discontinuation|1|||
33458171|NCT03250117|101567948|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
33458172|NCT03250117|101567949|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
33458173|NCT03250117|101567950|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
33458174|NCT03250117|101567951|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
33458175|NCT02034513|101567952|FG000|Overall Study|Adverse Event|11|||
33458176|NCT02034513|101567953|FG001|Overall Study|Adverse Event|10|||
33458177|NCT02034513|101567952|FG000|Overall Study|Lack of Efficacy|0|||
33458178|NCT02034513|101567953|FG001|Overall Study|Lack of Efficacy|1|||
33458179|NCT02034513|101567952|FG000|Overall Study|Lost to Follow-up|6|||
33458180|NCT02034513|101567953|FG001|Overall Study|Lost to Follow-up|7|||
33458181|NCT02034513|101567952|FG000|Overall Study|Pregnancy|0|||
33458182|NCT02034513|101567953|FG001|Overall Study|Pregnancy|3|||
33458183|NCT02034513|101567952|FG000|Overall Study|Protocol Violation|7|||
33458184|NCT02034513|101567953|FG001|Overall Study|Protocol Violation|10|||
33458185|NCT02034513|101567952|FG000|Overall Study|Withdrawal by Subject|25|||
33458186|NCT02034513|101567953|FG001|Overall Study|Withdrawal by Subject|25|||
33458187|NCT02034513|101567952|FG000|Overall Study|Unclassified|0|||
33458188|NCT02034513|101567953|FG001|Overall Study|Unclassified|1|||
33458189|NCT02583048|101567954|FG000|Overall Study|Withdrawal by Subject|0|||
33458190|NCT02583048|101567955|FG001|Overall Study|Withdrawal by Subject|1|||
33458191|NCT02583048|101567956|FG002|Overall Study|Withdrawal by Subject|0|||
33458192|NCT02583048|101567954|FG000|Overall Study|Failed to meet eligibility criterion|0|||
33458193|NCT02583048|101567955|FG001|Overall Study|Failed to meet eligibility criterion|0|||
33458194|NCT02583048|101567956|FG002|Overall Study|Failed to meet eligibility criterion|1|||
33458195|NCT00668395|101567957|FG000|Overall Study|Withdrawal by Subject|4|||
33458196|NCT00668395|101567958|FG001|Overall Study|Withdrawal by Subject|4|||
33458197|NCT00668395|101567959|FG002|Overall Study|Withdrawal by Subject|1|||
33458198|NCT00668395|101567957|FG000|Overall Study|Adverse Event|1|||
33458199|NCT00668395|101567958|FG001|Overall Study|Adverse Event|1|||
33458200|NCT00668395|101567959|FG002|Overall Study|Adverse Event|0|||
33458201|NCT00668395|101567957|FG000|Overall Study|Physician Decision|1|||
33458202|NCT00668395|101567958|FG001|Overall Study|Physician Decision|1|||
33458203|NCT00668395|101567959|FG002|Overall Study|Physician Decision|0|||
33458204|NCT00724958|101567960|FG000|Overall Study|Adverse Event|28|||
33458205|NCT00724958|101567960|FG000|Overall Study|Loss of Response|40|||
33458206|NCT00724958|101567960|FG000|Overall Study|No Response|18|||
33458207|NCT00724958|101567960|FG000|Overall Study|Remission|7|||
33458208|NCT00724958|101567960|FG000|Overall Study|Other Reason|76|||
33458209|NCT00724958|101567960|FG000|Overall Study|No documentation for end of therapy|13|||
33458210|NCT00965731|101567965|FG000|Overall Study|Death|0|||
33458211|NCT00965731|101567966|FG001|Overall Study|Death|4|||
33458212|NCT00965731|101567965|FG000|Overall Study|Withdrawal by Subject|0|||
33458213|NCT00965731|101567966|FG001|Overall Study|Withdrawal by Subject|1|||
33458214|NCT00965731|101567965|FG000|Overall Study|Other|7|||
33458215|NCT00965731|101567966|FG001|Overall Study|Other|15|||
33458216|NCT00697619|101567967|FG000|Overall Study|Lack of Efficacy|2|||
33458217|NCT00697619|101567968|FG001|Overall Study|Lack of Efficacy|2|||
33458218|NCT00697619|101567967|FG000|Overall Study|Adverse Event|4|||
33458219|NCT00697619|101567968|FG001|Overall Study|Adverse Event|6|||
33458220|NCT04473326|101567969|FG000|Overall Study|Death|0|||
33458221|NCT04473326|101567970|FG001|Overall Study|Death|1|||
33458222|NCT04473326|101567969|FG000|Overall Study|Withdrawal by Subject|1|||
33458223|NCT04473326|101567970|FG001|Overall Study|Withdrawal by Subject|2|||
33458224|NCT01451541|101567976|FG000|Overall Study|Adverse Event|4|||
33458225|NCT01451541|101567977|FG001|Overall Study|Adverse Event|3|||
33458226|NCT01451541|101567978|FG002|Overall Study|Adverse Event|6|||
33458227|NCT01451541|101567976|FG000|Overall Study|Lack of Efficacy|2|||
33458228|NCT01451541|101567977|FG001|Overall Study|Lack of Efficacy|0|||
33458229|NCT01451541|101567978|FG002|Overall Study|Lack of Efficacy|0|||
33458230|NCT01451541|101567976|FG000|Overall Study|Lost to Follow-up|4|||
33458231|NCT01451541|101567977|FG001|Overall Study|Lost to Follow-up|4|||
33458232|NCT01451541|101567978|FG002|Overall Study|Lost to Follow-up|7|||
33458233|NCT01451541|101567976|FG000|Overall Study|Withdrawal by Subject|15|||
33458234|NCT01451541|101567977|FG001|Overall Study|Withdrawal by Subject|8|||
33458235|NCT01451541|101567978|FG002|Overall Study|Withdrawal by Subject|6|||
33458236|NCT01451541|101567976|FG000|Overall Study|randomization error, noncompliance|11|||
33458237|NCT01451541|101567977|FG001|Overall Study|randomization error, noncompliance|10|||
33458238|NCT01451541|101567978|FG002|Overall Study|randomization error, noncompliance|8|||
33458239|NCT01541215|101567981|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
33458240|NCT01541215|101567982|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
33458241|NCT01541215|101567981|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
33458242|NCT01541215|101567982|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
33458243|NCT01541215|101567981|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
33458244|NCT01541215|101567982|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
33458245|NCT01541215|101567981|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
33458246|NCT01541215|101567982|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
33458247|NCT01541215|101567981|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
33458248|NCT01541215|101567982|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
33458249|NCT01541215|101567981|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
33458250|NCT01541215|101567982|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
33458251|NCT04364763|101567985|FG000|Overall Study|Death|1|||
33458252|NCT04364763|101567986|FG001|Overall Study|Death|2|||
33458253|NCT04364763|101567985|FG000|Overall Study|Lost to Follow-up|1|||
33458254|NCT04364763|101567986|FG001|Overall Study|Lost to Follow-up|0|||
33458255|NCT00515216|101567987|FG000|Overall Study|Withdrawal by Subject|1|||
33458256|NCT02597049|101567988|FG000|Overall Study|Lost to Follow-up|0|||
33458257|NCT02597049|101567989|FG001|Overall Study|Lost to Follow-up|3|||
33458258|NCT02597049|101567990|FG002|Overall Study|Lost to Follow-up|2|||
33458259|NCT02597049|101567988|FG000|Overall Study|Withdrawal by Subject|2|||
33458260|NCT02597049|101567989|FG001|Overall Study|Withdrawal by Subject|2|||
33458261|NCT02597049|101567990|FG002|Overall Study|Withdrawal by Subject|1|||
33458262|NCT02597049|101567988|FG000|Overall Study|Adverse Event|2|||
33458263|NCT02597049|101567989|FG001|Overall Study|Adverse Event|0|||
33458264|NCT02597049|101567990|FG002|Overall Study|Adverse Event|0|||
33458265|NCT02597049|101567988|FG000|Overall Study|Death|2|||
33458266|NCT02597049|101567989|FG001|Overall Study|Death|0|||
33458267|NCT02597049|101567990|FG002|Overall Study|Death|0|||
33458268|NCT02597049|101567988|FG000|Overall Study|Noncompliant with Study Visits|1|||
33458269|NCT02597049|101567989|FG001|Overall Study|Noncompliant with Study Visits|0|||
33458270|NCT02597049|101567990|FG002|Overall Study|Noncompliant with Study Visits|0|||
33458271|NCT01390948|101567992|FG000|Overall Study|End of Study|1|||
33458272|NCT01390948|101567993|FG001|Overall Study|End of Study|0|||
33458273|NCT01390948|101567994|FG002|Overall Study|End of Study|0|||
33458274|NCT01390948|101567992|FG000|Overall Study|Withdrew consent|2|||
33458275|NCT01390948|101567993|FG001|Overall Study|Withdrew consent|2|||
33458276|NCT01390948|101567994|FG002|Overall Study|Withdrew consent|0|||
33458277|NCT01390948|101567992|FG000|Overall Study|Progressive Disease|2|||
33458278|NCT01390948|101567993|FG001|Overall Study|Progressive Disease|5|||
33458279|NCT01390948|101567994|FG002|Overall Study|Progressive Disease|0|||
33458280|NCT01390948|101567992|FG000|Overall Study|Death during follow-up|10|||
33458281|NCT01390948|101567993|FG001|Overall Study|Death during follow-up|11|||
33458282|NCT01390948|101567994|FG002|Overall Study|Death during follow-up|1|||
33458283|NCT01841060|101567995|FG000|Overall Study|Protocol Violation|10|||
33458284|NCT00474188|101567996|FG000|Overall Study|Withdrawal by Subject|1|||
33458285|NCT00474188|101567996|FG000|Overall Study|Study discontinued by sponsor|5|||
33458286|NCT04795245|101567997|FG000|Overall Study|Unkown reason|7|||
33458287|NCT04795245|101567997|FG000|Overall Study|Death|17|||
33458288|NCT04795245|101567997|FG000|Overall Study|Other than listed|19|||
33458289|NCT04795245|101567997|FG000|Overall Study|Adverse Event|143|||
33458290|NCT04795245|101567997|FG000|Overall Study|Progressive disease|512|||
33458291|NCT04795245|101567997|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
33458292|NCT03255980|101567998|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
33458293|NCT03255980|101567999|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
33458294|NCT03255980|101568000|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
33458295|NCT03255980|101568001|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
33458296|NCT03255980|101567998|FG000|Overall Study|Adverse Event|1|||
33458297|NCT03255980|101567999|FG001|Overall Study|Adverse Event|1|||
33458298|NCT03255980|101568000|FG002|Overall Study|Adverse Event|0|||
33458299|NCT03255980|101568001|FG003|Overall Study|Adverse Event|1|||
33458300|NCT03255980|101567998|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
33458301|NCT03255980|101567999|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
33458302|NCT03255980|101568000|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
33458303|NCT03255980|101568001|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
33458304|NCT03255980|101567998|FG000|Overall Study|Lost to Follow-up|1|||
33458305|NCT03255980|101567999|FG001|Overall Study|Lost to Follow-up|1|||
33458306|NCT03255980|101568000|FG002|Overall Study|Lost to Follow-up|0|||
33458307|NCT03255980|101568001|FG003|Overall Study|Lost to Follow-up|3|||
33458308|NCT03255980|101567998|FG000|Overall Study|Withdrawal by Subject|0|||
33458309|NCT03255980|101567999|FG001|Overall Study|Withdrawal by Subject|1|||
33458310|NCT03255980|101568000|FG002|Overall Study|Withdrawal by Subject|0|||
33458311|NCT03255980|101568001|FG003|Overall Study|Withdrawal by Subject|3|||
33458312|NCT02451696|101568002|FG000|Overall Study|Surgery postponed|1|||
33458313|NCT02451696|101568003|FG001|Overall Study|Surgery postponed|0|||
33458314|NCT00113919|101568004|FG000|Overall Study|Physician Decision|8|||
33458315|NCT00113919|101568004|FG000|Overall Study|Death|6|||
33458316|NCT01450800|101568005|FG000|Overall Study|Protocol Violation|1|||
33458317|NCT01450800|101568006|FG001|Overall Study|Protocol Violation|3|||
33458318|NCT01435928|101568011|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
33458319|NCT01435928|101568012|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
33458320|NCT01435928|101568013|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
33458321|NCT01435928|101568011|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
33458322|NCT01435928|101568012|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
33458323|NCT01435928|101568013|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
33458324|NCT01435928|101568011|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
33458325|NCT01435928|101568012|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
33458326|NCT01435928|101568013|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
33458327|NCT01435928|101568011|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
33458328|NCT01435928|101568012|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
33458329|NCT01435928|101568013|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
33458330|NCT01435928|101568011|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
33458331|NCT01435928|101568012|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
33458332|NCT01435928|101568013|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
33458333|NCT01435928|101568011|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
33458334|NCT01435928|101568012|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
33458335|NCT01435928|101568013|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
33458336|NCT01435928|101568011|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
33458337|NCT01435928|101568012|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
33458338|NCT01435928|101568013|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
33458339|NCT01435928|101568011|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
33458340|NCT01435928|101568012|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
33458341|NCT01435928|101568013|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
33458342|NCT01435928|101568011|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
33458343|NCT01435928|101568012|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
33458344|NCT01435928|101568013|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
33458345|NCT01435928|101568011|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
33458346|NCT01435928|101568012|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
33458347|NCT01435928|101568013|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
33458348|NCT01435928|101568011|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
33174696|NCT04814433|100548872|FG000|Overall Study|Survey not returned|4|||
33174697|NCT04814433|100548873|FG001|Overall Study|Survey not returned|8|||
33174698|NCT04814433|100548874|FG002|Overall Study|Survey not returned|4|||
33174699|NCT04814433|100548875|FG003|Overall Study|Survey not returned|5|||
33458349|NCT01435928|101568012|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
33458350|NCT01435928|101568013|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
33174700|NCT03021265|100548877|FG000|Overall Study|Adverse Event|29|||
33174701|NCT03021265|100548877|FG000|Overall Study|Lack of Efficacy|3|||
33174702|NCT03021265|100548877|FG000|Overall Study|Improved|17|||
33458351|NCT01435928|101568011|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
33458352|NCT01435928|101568012|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
33458353|NCT01435928|101568013|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
33458354|NCT01435928|101568011|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
33458355|NCT01435928|101568012|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
33458356|NCT01435928|101568013|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
33458357|NCT01435928|101568011|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
33458358|NCT01435928|101568012|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
33458359|NCT01435928|101568013|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
33458360|NCT01435928|101568011|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
33458361|NCT01435928|101568012|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
33458362|NCT01435928|101568013|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
33458363|NCT01435928|101568011|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
33458364|NCT01435928|101568012|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
33458365|NCT01435928|101568013|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
33458366|NCT03428945|101568021|FG000|Overall Study|Lost to Follow-up|5|||
33458367|NCT03428945|101568022|FG001|Overall Study|Lost to Follow-up|3|||
33458368|NCT03428945|101568021|FG000|Overall Study|Withdrawal by Subject|10|||
33458369|NCT03428945|101568022|FG001|Overall Study|Withdrawal by Subject|10|||
33458370|NCT02751424|101568040|FG000|Part 2|Adverse Event|0|||
33458371|NCT02751424|101568041|FG001|Part 2|Adverse Event|0|||
33174703|NCT03021265|100548877|FG000|Overall Study|Lost to Follow-up|67|||
33174704|NCT03021265|100548877|FG000|Overall Study|No reason given|2|||
33174705|NCT03021265|100548877|FG000|Overall Study|No visit since the first visit|4|||
33174706|NCT01409564|100548883|FG000|Overall Study|low medication compliance|4|||
33174707|NCT01409564|100548884|FG001|Overall Study|low medication compliance|3|||
33262727|NCT05580003|100863762|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33458372|NCT02751424|101568042|FG002|Part 2|Adverse Event|0|||
33458373|NCT02751424|101568043|FG003|Part 2|Adverse Event|0|||
33458374|NCT02751424|101568044|FG004|Part 2|Adverse Event|0|||
33458375|NCT02751424|101568045|FG005|Part 2|Adverse Event|0|||
33458376|NCT02751424|101568046|FG006|Part 2|Adverse Event|0|||
33458377|NCT02751424|101568047|FG007|Part 2|Adverse Event|5|||
33458378|NCT02751424|101568048|FG008|Part 2|Adverse Event|0|||
33458379|NCT02986139|101568049|FG000|Overall Study|Sponsor Decision|1|||
33458380|NCT02986139|101568050|FG001|Overall Study|Sponsor Decision|2|||
33458381|NCT02986139|101568049|FG000|Overall Study|Withdrawal by Subject|0|||
33458382|NCT02986139|101568050|FG001|Overall Study|Withdrawal by Subject|1|||
33458383|NCT02986139|101568049|FG000|Overall Study|Lost to Follow-up|0|||
33458384|NCT02986139|101568050|FG001|Overall Study|Lost to Follow-up|1|||
33458385|NCT00982228|101568051|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
33174708|NCT01409564|100548883|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
33174709|NCT01409564|100548884|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
33174710|NCT01829230|100548885|FG000|Overall Study|Protocol Violation|0|||
33174711|NCT01829230|100548886|FG001|Overall Study|Protocol Violation|2|||
33174712|NCT01829230|100548885|FG000|Overall Study|Withdrawal by Subject|0|||
33174713|NCT01829230|100548886|FG001|Overall Study|Withdrawal by Subject|1|||
33174714|NCT01829230|100548885|FG000|Overall Study|Lost to Follow-up|1|||
33174715|NCT01829230|100548886|FG001|Overall Study|Lost to Follow-up|1|||
33174716|NCT02511184|100548887|FG000|Overall Study|Death|1|||
33174717|NCT02511184|100548888|FG001|Overall Study|Death|0|||
33174718|NCT02511184|100548887|FG000|Overall Study|Lost to Follow-up|0|||
33174719|NCT02511184|100548888|FG001|Overall Study|Lost to Follow-up|1|||
33174720|NCT02511184|100548887|FG000|Overall Study|Study terminated by sponsor|1|||
33174721|NCT02511184|100548888|FG001|Overall Study|Study terminated by sponsor|5|||
33174722|NCT02511184|100548887|FG000|Overall Study|Withdrawal by Subject|0|||
33174723|NCT02511184|100548888|FG001|Overall Study|Withdrawal by Subject|1|||
33174724|NCT03855280|100548891|FG000|Treatment Phase|Adverse Event|1|||
33174725|NCT03855280|100548891|FG000|Treatment Phase|Withdrawal by Subject|1|||
33174726|NCT03855280|100548891|FG000|Continuation Phase|Protocol Violation|1|||
33174727|NCT03855280|100548891|FG000|Continuation Phase|Adverse Event|1|||
33174728|NCT03855280|100548891|FG000|Continuation Phase|Sponsor Concluded Study|1|||
33174729|NCT03559257|100548892|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
33174730|NCT03559257|100548893|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
33174731|NCT03559257|100548892|FG000|Double Blind Treatment Period|Protocol Violation|1|||
33174732|NCT03559257|100548893|FG001|Double Blind Treatment Period|Protocol Violation|4|||
33174733|NCT03559257|100548892|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
33174734|NCT03559257|100548893|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
33174735|NCT03559257|100548892|FG000|Double Blind Treatment Period|Adverse Event|0|||
33174736|NCT03559257|100548893|FG001|Double Blind Treatment Period|Adverse Event|1|||
33174737|NCT03559257|100548892|FG000|Double Blind Treatment Period|Screen Failure|0|||
33174738|NCT03559257|100548893|FG001|Double Blind Treatment Period|Screen Failure|1|||
33174739|NCT03559257|100548892|FG000|Open-label Treatment Period|Adverse Event|1|||
33174740|NCT03559257|100548893|FG001|Open-label Treatment Period|Adverse Event|4|||
33174741|NCT03559257|100548892|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
33174742|NCT03559257|100548893|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
33174743|NCT03559257|100548892|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
33174744|NCT03559257|100548893|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
33174745|NCT03559257|100548892|FG000|Open-label Treatment Period|Protocol Violation|2|||
33174746|NCT03559257|100548893|FG001|Open-label Treatment Period|Protocol Violation|0|||
33174747|NCT03559257|100548892|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
33174748|NCT03559257|100548893|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
33174749|NCT03559257|100548892|FG000|Open-label Treatment Period|Physician Decision|0|||
33174750|NCT03559257|100548893|FG001|Open-label Treatment Period|Physician Decision|1|||
33174751|NCT03447990|100548894|FG000|Overall Study|Withdrawal by Subject|0|||
33174752|NCT03447990|100548895|FG001|Overall Study|Withdrawal by Subject|0|||
33174753|NCT03447990|100548896|FG002|Overall Study|Withdrawal by Subject|0|||
33174754|NCT03447990|100548897|FG003|Overall Study|Withdrawal by Subject|0|||
33174755|NCT03447990|100548898|FG004|Overall Study|Withdrawal by Subject|0|||
33174756|NCT03447990|100548899|FG005|Overall Study|Withdrawal by Subject|0|||
33174757|NCT03447990|100548900|FG006|Overall Study|Withdrawal by Subject|1|||
33174758|NCT05620563|100548901|FG000|Overall Study|Adverse Event|3|||
33174759|NCT05620563|100548902|FG001|Overall Study|Adverse Event|1|||
33174760|NCT05620563|100548901|FG000|Overall Study|Lost to Follow-up|0|||
33174761|NCT05620563|100548902|FG001|Overall Study|Lost to Follow-up|2|||
33174762|NCT05620563|100548901|FG000|Overall Study|Protocol Deviation|1|||
33174763|NCT05620563|100548902|FG001|Overall Study|Protocol Deviation|2|||
33174764|NCT05620563|100548901|FG000|Overall Study|Withdrawal by Subject|3|||
33174765|NCT05620563|100548902|FG001|Overall Study|Withdrawal by Subject|3|||
33174766|NCT05620563|100548901|FG000|Overall Study|Physician Decision|0|||
33174767|NCT05620563|100548902|FG001|Overall Study|Physician Decision|1|||
33174768|NCT00680043|100548908|FG000|Overall Study|Withdrawal by Subject|1|||
33174769|NCT00680043|100548909|FG001|Overall Study|Withdrawal by Subject|0|||
33174770|NCT00680043|100548910|FG002|Overall Study|Withdrawal by Subject|0|||
33174771|NCT00680043|100548908|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
33174772|NCT00680043|100548909|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
33174773|NCT00680043|100548910|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
33174774|NCT00680043|100548908|FG000|Overall Study|Renal Transplant|1|||
33174775|NCT00680043|100548909|FG001|Overall Study|Renal Transplant|0|||
33174776|NCT00680043|100548910|FG002|Overall Study|Renal Transplant|4|||
33174777|NCT03235154|100548911|FG000|Overall Study|Withdrawal by Subject|1|||
33174778|NCT03235154|100548911|FG000|Overall Study|Adverse Event|1|||
33174779|NCT03235154|100548911|FG000|Overall Study|Lost to Follow-up|2|||
33458386|NCT00982228|101568052|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
33458387|NCT00982228|101568051|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
33174780|NCT01751867|100548912|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
33174781|NCT01751867|100548913|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
33458388|NCT00982228|101568052|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
33458389|NCT00982228|101568051|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
33174782|NCT01751867|100548912|FG000|Overall Study|Diease Progression|4|||
33458390|NCT00982228|101568052|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
33458391|NCT00982228|101568051|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
33458392|NCT00982228|101568052|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
33458393|NCT00982228|101568051|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
33458394|NCT00982228|101568052|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
33174783|NCT01751867|100548913|FG001|Overall Study|Diease Progression|18|||
33174784|NCT01751867|100548912|FG000|Overall Study|Adverse Event|8|||
33174785|NCT01751867|100548913|FG001|Overall Study|Adverse Event|15|||
33174786|NCT01751867|100548912|FG000|Overall Study|Poor Compliance|0|||
33174787|NCT01751867|100548913|FG001|Overall Study|Poor Compliance|5|||
33458395|NCT00982228|101568051|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
33458396|NCT00982228|101568052|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
33458397|NCT00982228|101568051|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
33458398|NCT00982228|101568052|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
33174788|NCT01751867|100548912|FG000|Overall Study|Withdrawal by Subject|3|||
33458399|NCT00982228|101568051|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
33174789|NCT01751867|100548913|FG001|Overall Study|Withdrawal by Subject|1|||
33458400|NCT00982228|101568052|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
33458401|NCT00982228|101568051|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
33458402|NCT00982228|101568052|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
33458403|NCT00982228|101568051|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
33458404|NCT00982228|101568052|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
33458405|NCT02229084|101568053|FG000|Overall Study|Adverse Event|1|||
33458406|NCT02229084|101568054|FG001|Overall Study|Adverse Event|0|||
33458407|NCT02229084|101568055|FG002|Overall Study|Adverse Event|0|||
33458408|NCT02229084|101568056|FG003|Overall Study|Adverse Event|0|||
33458409|NCT02229084|101568057|FG004|Overall Study|Adverse Event|0|||
33458410|NCT02229084|101568058|FG005|Overall Study|Adverse Event|0|||
33458411|NCT02229084|101568059|FG006|Overall Study|Adverse Event|0|||
33458412|NCT02229084|101568053|FG000|Overall Study|Lost to Follow-up|0|||
33458413|NCT02229084|101568054|FG001|Overall Study|Lost to Follow-up|0|||
33458414|NCT02229084|101568055|FG002|Overall Study|Lost to Follow-up|1|||
33458415|NCT02229084|101568056|FG003|Overall Study|Lost to Follow-up|1|||
33458416|NCT02229084|101568057|FG004|Overall Study|Lost to Follow-up|0|||
33458417|NCT02229084|101568058|FG005|Overall Study|Lost to Follow-up|0|||
33458418|NCT02229084|101568059|FG006|Overall Study|Lost to Follow-up|1|||
33458419|NCT02229084|101568053|FG000|Overall Study|Physician Decision|0|||
33458420|NCT02229084|101568054|FG001|Overall Study|Physician Decision|0|||
33458421|NCT02229084|101568055|FG002|Overall Study|Physician Decision|0|||
33458422|NCT02229084|101568056|FG003|Overall Study|Physician Decision|1|||
33458423|NCT02229084|101568057|FG004|Overall Study|Physician Decision|3|||
33458424|NCT02229084|101568058|FG005|Overall Study|Physician Decision|0|||
33458425|NCT02229084|101568059|FG006|Overall Study|Physician Decision|1|||
33458426|NCT02229084|101568053|FG000|Overall Study|Withdrawal by Subject|0|||
33458427|NCT02229084|101568054|FG001|Overall Study|Withdrawal by Subject|0|||
33458428|NCT02229084|101568055|FG002|Overall Study|Withdrawal by Subject|1|||
33458429|NCT02229084|101568056|FG003|Overall Study|Withdrawal by Subject|0|||
33458430|NCT02229084|101568057|FG004|Overall Study|Withdrawal by Subject|1|||
33458431|NCT02229084|101568058|FG005|Overall Study|Withdrawal by Subject|1|||
33458432|NCT02229084|101568059|FG006|Overall Study|Withdrawal by Subject|1|||
33458433|NCT02229084|101568053|FG000|Overall Study|Death|0|||
33458434|NCT02229084|101568054|FG001|Overall Study|Death|0|||
33458435|NCT02229084|101568055|FG002|Overall Study|Death|0|||
33458436|NCT02229084|101568056|FG003|Overall Study|Death|0|||
33458437|NCT02229084|101568057|FG004|Overall Study|Death|0|||
33458438|NCT02229084|101568058|FG005|Overall Study|Death|0|||
33458439|NCT02229084|101568059|FG006|Overall Study|Death|1|||
33458440|NCT01717040|101568060|FG000|Overall Study|Lost to Follow-up|2|||
33458441|NCT01717040|101568061|FG001|Overall Study|Lost to Follow-up|3|||
33458442|NCT01717040|101568060|FG000|Overall Study|Lack of Efficacy|1|||
33458443|NCT01717040|101568061|FG001|Overall Study|Lack of Efficacy|1|||
33458444|NCT01717040|101568060|FG000|Overall Study|Adverse Event|1|||
33458445|NCT01717040|101568061|FG001|Overall Study|Adverse Event|0|||
33458446|NCT01717040|101568060|FG000|Overall Study|Required Medication Change|0|||
33458447|NCT01717040|101568061|FG001|Overall Study|Required Medication Change|1|||
33458448|NCT01717040|101568060|FG000|Overall Study|New Substance Use Disorder|1|||
33458449|NCT01717040|101568061|FG001|Overall Study|New Substance Use Disorder|0|||
33458450|NCT04254809|101568062|FG000|Overall Study|Lost to Follow-up|5|||
33458451|NCT04254809|101568063|FG001|Overall Study|Lost to Follow-up|10|||
33458452|NCT00659815|101568065|FG000|Overall Study|Study related symptoms and complaints|2|||
33458453|NCT00659815|101568066|FG001|Overall Study|Study related symptoms and complaints|1|||
33458454|NCT00659815|101568065|FG000|Overall Study|Inability to maintain wearing schedule|1|||
33458455|NCT00659815|101568066|FG001|Overall Study|Inability to maintain wearing schedule|2|||
33458456|NCT00659815|101568065|FG000|Overall Study|Withdrawal by Subject|1|||
33458457|NCT00659815|101568066|FG001|Overall Study|Withdrawal by Subject|1|||
33458458|NCT00089973|101568068|FG000|Overall Study|Adverse Event|3|||
33458459|NCT00089973|101568068|FG000|Overall Study|Withdrawal by Subject|1|||
33458460|NCT00089973|101568068|FG000|Overall Study|Disease progression|45|||
33458461|NCT00089973|101568068|FG000|Overall Study|Death|1|||
33458462|NCT00645944|101568069|FG000|Randomized|Withdrawal by Subject|1|||
33458463|NCT00645944|101568070|FG001|Randomized|Withdrawal by Subject|2|||
33458464|NCT00645944|101568069|FG000|Received Medication|Adverse Event|2|||
33458465|NCT00645944|101568070|FG001|Received Medication|Adverse Event|1|||
33458466|NCT00645944|101568069|FG000|Received Medication|Withdrawal by Subject|1|||
33458467|NCT00645944|101568070|FG001|Received Medication|Withdrawal by Subject|1|||
33458468|NCT00645944|101568069|FG000|Received Medication|Lost to Follow-up|1|||
33458469|NCT00645944|101568070|FG001|Received Medication|Lost to Follow-up|0|||
33458470|NCT00645944|101568069|FG000|Received Medication|Protocol Violation|2|||
33458471|NCT00645944|101568070|FG001|Received Medication|Protocol Violation|1|||
33458472|NCT04194008|101568071|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
33458473|NCT04194008|101568071|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
33458474|NCT04194008|101568071|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
33458475|NCT04194008|101568071|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
33458476|NCT04194008|101568071|FG000|Treatment Phase With Nerivio|Missing data|4|||
33458477|NCT04194008|101568071|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
33174790|NCT01751867|100548912|FG000|Overall Study|Physician Decision|4|||
33174791|NCT01751867|100548913|FG001|Overall Study|Physician Decision|7|||
33174792|NCT01751867|100548912|FG000|Overall Study|Protocol Violation|0|||
33174793|NCT01751867|100548913|FG001|Overall Study|Protocol Violation|2|||
33174794|NCT01751867|100548912|FG000|Overall Study|Death|0|||
33174795|NCT01751867|100548913|FG001|Overall Study|Death|5|||
33174796|NCT01751867|100548912|FG000|Overall Study|Other|11|||
33458478|NCT02418754|101568072|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
33174797|NCT01751867|100548913|FG001|Overall Study|Other|37|||
33174798|NCT01751867|100548912|FG000|Overall Study|Randomized but not treated.|2|||
33174799|NCT01751867|100548913|FG001|Overall Study|Randomized but not treated.|1|||
33174800|NCT02738151|100548914|FG000|Overall Study|Randomized but not treated|4|||
33174801|NCT02738151|100548915|FG001|Overall Study|Randomized but not treated|1|||
33174802|NCT02738151|100548914|FG000|Overall Study|Adverse Event|4|||
33174803|NCT02738151|100548915|FG001|Overall Study|Adverse Event|5|||
33174804|NCT02738151|100548914|FG000|Overall Study|Hypoglycemia|0|||
33174805|NCT02738151|100548915|FG001|Overall Study|Hypoglycemia|1|||
33174806|NCT02738151|100548914|FG000|Overall Study|Poor Compliance to Protocol|4|||
33174807|NCT02738151|100548915|FG001|Overall Study|Poor Compliance to Protocol|3|||
33174808|NCT02738151|100548914|FG000|Overall Study|Other than specified above|11|||
33174809|NCT02738151|100548915|FG001|Overall Study|Other than specified above|21|||
33174810|NCT00529542|100548916|FG000|Overall Study|Withdrawal by Subject|1|||
33174811|NCT00529542|100548917|FG001|Overall Study|Withdrawal by Subject|0|||
33174812|NCT00529542|100548916|FG000|Overall Study|Lost to Follow-up|0|||
33174813|NCT00529542|100548917|FG001|Overall Study|Lost to Follow-up|1|||
33174814|NCT02671422|100548920|FG000|Overall Study|Lost to Follow-up|1|||
33174815|NCT02671422|100548920|FG000|Overall Study|Adverse Event|68|||
33174816|NCT02671422|100548920|FG000|Overall Study|Lack of Efficacy|1|||
33174817|NCT02671422|100548920|FG000|Overall Study|Lost to Follow-up|4|||
33262728|NCT05580003|100863763|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262729|NCT05580003|100863764|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262730|NCT05580003|100863765|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262731|NCT05580003|100863766|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33458479|NCT02418754|101568073|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
33174818|NCT02671422|100548920|FG000|Overall Study|Withdrawal by Subject|7|||
33174819|NCT02671422|100548920|FG000|Overall Study|Progressive Disease|156|||
33262732|NCT05580003|100863767|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33458480|NCT02418754|101568074|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
33458481|NCT02418754|101568075|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
33458482|NCT02418754|101568076|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
33458483|NCT02418754|101568072|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
33458484|NCT02418754|101568073|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
33458485|NCT02418754|101568074|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
33174820|NCT02671422|100548920|FG000|Overall Study|Worsening of Disease|4|||
33174821|NCT02671422|100548920|FG000|Overall Study|Sponsor decision|5|||
33174822|NCT02671422|100548920|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
33174823|NCT02671422|100548920|FG000|Overall Study|Not treated with Vargatef®|3|||
33174824|NCT02671422|100548920|FG000|Overall Study|Other not defined above|3|||
33174825|NCT01506479|100548921|FG000|Overall Study|Lost to Follow-up|1|||
33174826|NCT01506479|100548922|FG001|Overall Study|Lost to Follow-up|2|||
33174827|NCT01506479|100548923|FG002|Overall Study|Lost to Follow-up|2|||
33458486|NCT02418754|101568075|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
33458487|NCT02418754|101568076|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
33458488|NCT02418754|101568072|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
33458489|NCT02418754|101568073|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
33458490|NCT02418754|101568074|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
33458491|NCT02418754|101568075|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
33458492|NCT02418754|101568076|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
33458493|NCT02418754|101568072|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
33458494|NCT02418754|101568073|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
33458495|NCT02418754|101568074|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
33458496|NCT02418754|101568075|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
33458497|NCT02418754|101568076|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
33458498|NCT02418754|101568072|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
33458499|NCT02418754|101568073|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
33458500|NCT02418754|101568074|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
33458501|NCT02418754|101568075|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
33458502|NCT02418754|101568076|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
33458503|NCT02418754|101568072|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
33458504|NCT02418754|101568073|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
33458505|NCT02418754|101568074|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
33458506|NCT02418754|101568075|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
33174828|NCT01506479|100548921|FG000|Overall Study|Withdrawal by Subject|1|||
33174829|NCT01506479|100548922|FG001|Overall Study|Withdrawal by Subject|2|||
33174830|NCT01506479|100548923|FG002|Overall Study|Withdrawal by Subject|1|||
33174831|NCT01506479|100548921|FG000|Overall Study|Missing assessment|1|||
33174832|NCT01506479|100548922|FG001|Overall Study|Missing assessment|0|||
33174833|NCT01506479|100548923|FG002|Overall Study|Missing assessment|0|||
33174834|NCT01506479|100548921|FG000|Overall Study|Adverse Event|0|||
33174835|NCT01506479|100548922|FG001|Overall Study|Adverse Event|1|||
33174836|NCT01506479|100548923|FG002|Overall Study|Adverse Event|0|||
33174837|NCT00909389|100548924|FG000|Overall Study|Adverse Event|6|||
33174838|NCT00909389|100548924|FG000|Overall Study|Death|4|||
33458507|NCT02418754|101568076|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
33458508|NCT02418754|101568072|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
33174839|NCT00909389|100548924|FG000|Overall Study|Poor Compliance|16|||
33174840|NCT00909389|100548924|FG000|Overall Study|Lost to Follow-up|4|||
33458509|NCT02418754|101568073|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
33174841|NCT00909389|100548924|FG000|Overall Study|No Information|103|||
33458510|NCT02418754|101568074|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
33458511|NCT02418754|101568075|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
33458512|NCT02418754|101568076|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
33458513|NCT02418754|101568072|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
33458514|NCT02418754|101568073|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
33458515|NCT02418754|101568074|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
33458516|NCT02418754|101568075|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
33458517|NCT02418754|101568076|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
33458518|NCT02418754|101568072|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
33458519|NCT02418754|101568073|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
33458520|NCT02418754|101568074|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
33458521|NCT02418754|101568075|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
33458522|NCT02418754|101568076|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
33458523|NCT02418754|101568072|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
33458524|NCT02418754|101568073|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
33458525|NCT02418754|101568074|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
33458526|NCT02418754|101568075|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
33458527|NCT02418754|101568076|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
33458528|NCT02418754|101568072|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
33458529|NCT02418754|101568073|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
33458530|NCT02418754|101568074|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
33458531|NCT02418754|101568075|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
33458532|NCT02418754|101568076|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
33458533|NCT05889039|101568077|FG000|Overall Study|error in completing survey|0|||
33458534|NCT05889039|101568078|FG001|Overall Study|error in completing survey|2|||
33458535|NCT05889039|101568079|FG002|Overall Study|error in completing survey|0|||
33458536|NCT05889039|101568080|FG003|Overall Study|error in completing survey|0|||
33458537|NCT05889039|101568077|FG000|Overall Study|Lost to Follow-up|4|||
33458538|NCT05889039|101568078|FG001|Overall Study|Lost to Follow-up|0|||
33458539|NCT05889039|101568079|FG002|Overall Study|Lost to Follow-up|0|||
33458540|NCT05889039|101568080|FG003|Overall Study|Lost to Follow-up|0|||
33458541|NCT00721955|101568085|FG000|Overall Study|Adverse Event|0|||
33458542|NCT00721955|101568086|FG001|Overall Study|Adverse Event|0|||
33458543|NCT00721955|101568087|FG002|Overall Study|Adverse Event|2|||
33458544|NCT01160640|101568088|FG000|Overall Study|Physician Decision|3|||
33458545|NCT01160640|101568089|FG001|Overall Study|Physician Decision|3|||
33458546|NCT01160640|101568088|FG000|Overall Study|Incarceration|1|||
33458547|NCT01160640|101568089|FG001|Overall Study|Incarceration|0|||
33458548|NCT01160640|101568088|FG000|Overall Study|Withdrawal by Subject|0|||
33458549|NCT01160640|101568089|FG001|Overall Study|Withdrawal by Subject|3|||
33458550|NCT01710358|101568090|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
33458551|NCT01710358|101568091|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
33458552|NCT01710358|101568092|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
33458553|NCT01710358|101568090|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
33458554|NCT01710358|101568091|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
33458555|NCT01710358|101568092|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
33458556|NCT01710358|101568090|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
33458557|NCT01710358|101568091|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
33458558|NCT01710358|101568092|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
33458559|NCT01710358|101568090|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
33458560|NCT01710358|101568091|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
33458561|NCT01710358|101568092|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
33458562|NCT01710358|101568090|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
33458563|NCT01710358|101568091|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
33458564|NCT01710358|101568092|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
33458565|NCT01710358|101568090|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
33458566|NCT01710358|101568091|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
33458567|NCT01710358|101568092|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
33458568|NCT01710358|101568090|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
33458569|NCT01710358|101568091|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
33458570|NCT01710358|101568092|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
33458571|NCT01710358|101568090|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
33458572|NCT01710358|101568091|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
33458573|NCT01710358|101568092|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
33458574|NCT01710358|101568090|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
33458575|NCT01710358|101568091|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
33458576|NCT01710358|101568092|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
33458577|NCT01710358|101568090|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
33458578|NCT01710358|101568091|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
33458579|NCT01710358|101568092|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
33458580|NCT01710358|101568090|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
33458581|NCT01710358|101568091|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
33458582|NCT01710358|101568092|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
33458583|NCT01710358|101568090|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
33458584|NCT01710358|101568091|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
33458585|NCT01710358|101568092|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
33458586|NCT01710358|101568090|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
33458587|NCT01710358|101568091|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
33458588|NCT01710358|101568092|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
33458589|NCT01710358|101568090|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
33458590|NCT01710358|101568091|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
33458591|NCT01710358|101568092|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
33458592|NCT01710358|101568090|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
33458593|NCT01710358|101568091|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
33458594|NCT01710358|101568092|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
33458595|NCT01710358|101568090|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
33458596|NCT01710358|101568091|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
33458597|NCT01710358|101568092|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
33458598|NCT01710358|101568090|FG000|Rescue Period|Adverse Event|0|||
33458599|NCT01710358|101568091|FG001|Rescue Period|Adverse Event|15|||
33458600|NCT01710358|101568092|FG002|Rescue Period|Adverse Event|0|||
33458601|NCT01710358|101568090|FG000|Rescue Period|Death|0|||
33458602|NCT01710358|101568091|FG001|Rescue Period|Death|1|||
33458603|NCT01710358|101568092|FG002|Rescue Period|Death|0|||
33458604|NCT01710358|101568090|FG000|Rescue Period|Lack of Efficacy|0|||
33458605|NCT01710358|101568091|FG001|Rescue Period|Lack of Efficacy|7|||
33458606|NCT01710358|101568092|FG002|Rescue Period|Lack of Efficacy|0|||
33458607|NCT01710358|101568090|FG000|Rescue Period|Withdrawal by Subject|0|||
33458608|NCT01710358|101568091|FG001|Rescue Period|Withdrawal by Subject|8|||
33458609|NCT01710358|101568092|FG002|Rescue Period|Withdrawal by Subject|0|||
33458610|NCT00530348|101568094|FG000|Overall Study|Adverse Event|5|||
33458611|NCT00530348|101568095|FG001|Overall Study|Adverse Event|1|||
33458612|NCT00530348|101568094|FG000|Overall Study|Death|0|||
33458613|NCT00530348|101568095|FG001|Overall Study|Death|1|||
33458614|NCT00530348|101568094|FG000|Overall Study|Lack of Efficacy|2|||
33458615|NCT00530348|101568095|FG001|Overall Study|Lack of Efficacy|0|||
33458616|NCT00530348|101568094|FG000|Overall Study|Lost to Follow-up|0|||
33458617|NCT00530348|101568095|FG001|Overall Study|Lost to Follow-up|2|||
33458618|NCT00530348|101568094|FG000|Overall Study|Physician Decision|1|||
33458619|NCT00530348|101568095|FG001|Overall Study|Physician Decision|2|||
33458620|NCT00530348|101568094|FG000|Overall Study|Pregnancy|1|||
33458621|NCT00530348|101568095|FG001|Overall Study|Pregnancy|0|||
33458622|NCT00530348|101568094|FG000|Overall Study|Withdrawal by Subject|12|||
33458623|NCT00530348|101568095|FG001|Overall Study|Withdrawal by Subject|12|||
33458624|NCT00530348|101568094|FG000|Overall Study|Randomised in error|1|||
33458625|NCT00530348|101568095|FG001|Overall Study|Randomised in error|0|||
33458626|NCT00530348|101568094|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
33458627|NCT00530348|101568095|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
33458628|NCT04142658|101568097|FG000|Overall Study|Death|2|||
33458629|NCT04142658|101568098|FG001|Overall Study|Death|1|||
33458630|NCT04142658|101568097|FG000|Overall Study|Lost to Follow-up|4|||
33458631|NCT04142658|101568098|FG001|Overall Study|Lost to Follow-up|13|||
33458632|NCT04142658|101568097|FG000|Overall Study|Withdrawal by Subject|9|||
33458633|NCT04142658|101568098|FG001|Overall Study|Withdrawal by Subject|16|||
33458634|NCT03727139|101568101|FG000|Overall Study|Protocol Violation|60|||
33458635|NCT02435433|101568102|FG000|Overall Study|Withdrawal by Subject|2|||
33458636|NCT02435433|101568103|FG001|Overall Study|Withdrawal by Subject|3|||
33458637|NCT02435433|101568104|FG002|Overall Study|Withdrawal by Subject|1|||
33458638|NCT02435433|101568105|FG003|Overall Study|Withdrawal by Subject|0|||
33458639|NCT02435433|101568106|FG004|Overall Study|Withdrawal by Subject|0|||
33458640|NCT02435433|101568102|FG000|Overall Study|Lost to Follow-up|2|||
33458641|NCT02435433|101568103|FG001|Overall Study|Lost to Follow-up|2|||
33458642|NCT02435433|101568104|FG002|Overall Study|Lost to Follow-up|4|||
33458643|NCT02435433|101568105|FG003|Overall Study|Lost to Follow-up|1|||
33458644|NCT02435433|101568106|FG004|Overall Study|Lost to Follow-up|0|||
33458645|NCT00379353|101568107|FG000|Overall Study|Hospitalization|3|||
33458646|NCT00379353|101568108|FG001|Overall Study|Hospitalization|3|||
33458647|NCT00379353|101568107|FG000|Overall Study|Withdrawal by Subject|5|||
33458648|NCT00379353|101568108|FG001|Overall Study|Withdrawal by Subject|2|||
33458649|NCT00379353|101568107|FG000|Overall Study|Death|1|||
33458650|NCT00379353|101568108|FG001|Overall Study|Death|0|||
33458651|NCT00379353|101568107|FG000|Overall Study|Cardiac Tamponade|1|||
33458652|NCT00379353|101568108|FG001|Overall Study|Cardiac Tamponade|0|||
33458653|NCT00379353|101568107|FG000|Overall Study|Non-compliance|1|||
33458654|NCT00379353|101568108|FG001|Overall Study|Non-compliance|0|||
33458655|NCT00379353|101568107|FG000|Overall Study|Conflicting drug treatment|0|||
33458656|NCT00379353|101568108|FG001|Overall Study|Conflicting drug treatment|1|||
33458657|NCT01899053|101568109|FG000|Overall Study|Progressive Disease|4|||
33458658|NCT01899053|101568110|FG001|Overall Study|Progressive Disease|0|||
33458659|NCT01899053|101568111|FG002|Overall Study|Progressive Disease|3|||
33458660|NCT01899053|101568112|FG003|Overall Study|Progressive Disease|0|||
33458661|NCT01899053|101568113|FG004|Overall Study|Progressive Disease|3|||
33458662|NCT01899053|101568114|FG005|Overall Study|Progressive Disease|1|||
33458663|NCT01899053|101568115|FG006|Overall Study|Progressive Disease|1|||
33458664|NCT01899053|101568116|FG007|Overall Study|Progressive Disease|1|||
33458665|NCT01899053|101568117|FG008|Overall Study|Progressive Disease|4|||
33458666|NCT01899053|101568118|FG009|Overall Study|Progressive Disease|3|||
33458667|NCT01899053|101568119|FG010|Overall Study|Progressive Disease|12|||
33458668|NCT01899053|101568120|FG011|Overall Study|Progressive Disease|5|||
33458669|NCT01899053|101568121|FG012|Overall Study|Progressive Disease|8|||
33458670|NCT01899053|101568122|FG013|Overall Study|Progressive Disease|17|||
33458671|NCT01899053|101568109|FG000|Overall Study|Adverse Event|1|||
33458672|NCT01899053|101568110|FG001|Overall Study|Adverse Event|1|||
33458673|NCT01899053|101568111|FG002|Overall Study|Adverse Event|1|||
33458674|NCT01899053|101568112|FG003|Overall Study|Adverse Event|3|||
33458675|NCT01899053|101568113|FG004|Overall Study|Adverse Event|1|||
33458676|NCT01899053|101568114|FG005|Overall Study|Adverse Event|1|||
33458677|NCT01899053|101568115|FG006|Overall Study|Adverse Event|1|||
33458678|NCT01899053|101568116|FG007|Overall Study|Adverse Event|0|||
33458679|NCT01899053|101568117|FG008|Overall Study|Adverse Event|2|||
33458680|NCT01899053|101568118|FG009|Overall Study|Adverse Event|0|||
33458681|NCT01899053|101568119|FG010|Overall Study|Adverse Event|3|||
33458682|NCT01899053|101568120|FG011|Overall Study|Adverse Event|1|||
33458683|NCT01899053|101568121|FG012|Overall Study|Adverse Event|2|||
33458684|NCT01899053|101568122|FG013|Overall Study|Adverse Event|2|||
33458685|NCT01899053|101568109|FG000|Overall Study|Reason Not Specified|0|||
33458686|NCT01899053|101568110|FG001|Overall Study|Reason Not Specified|0|||
33458687|NCT01899053|101568111|FG002|Overall Study|Reason Not Specified|0|||
33458688|NCT01899053|101568112|FG003|Overall Study|Reason Not Specified|0|||
33458689|NCT01899053|101568113|FG004|Overall Study|Reason Not Specified|0|||
33458690|NCT01899053|101568114|FG005|Overall Study|Reason Not Specified|0|||
33458691|NCT01899053|101568115|FG006|Overall Study|Reason Not Specified|1|||
33458692|NCT01899053|101568116|FG007|Overall Study|Reason Not Specified|0|||
33458693|NCT01899053|101568117|FG008|Overall Study|Reason Not Specified|0|||
33458694|NCT01899053|101568118|FG009|Overall Study|Reason Not Specified|0|||
33458695|NCT01899053|101568119|FG010|Overall Study|Reason Not Specified|0|||
33458696|NCT01899053|101568120|FG011|Overall Study|Reason Not Specified|0|||
33458697|NCT01899053|101568121|FG012|Overall Study|Reason Not Specified|1|||
33458698|NCT01899053|101568122|FG013|Overall Study|Reason Not Specified|0|||
33458699|NCT01899053|101568109|FG000|Overall Study|Withdrawal by Subject|1|||
33174842|NCT01084174|100548925|FG000|Overall Study|gastrointestinal symptoms|1|||
33174843|NCT01084174|100548926|FG001|Overall Study|gastrointestinal symptoms|1|||
33458700|NCT01899053|101568110|FG001|Overall Study|Withdrawal by Subject|1|||
33174844|NCT01084174|100548925|FG000|Overall Study|Eosinophilic esophagitis|0|||
33458701|NCT01899053|101568111|FG002|Overall Study|Withdrawal by Subject|2|||
33458702|NCT01899053|101568112|FG003|Overall Study|Withdrawal by Subject|0|||
33458703|NCT01899053|101568113|FG004|Overall Study|Withdrawal by Subject|2|||
33458704|NCT01899053|101568114|FG005|Overall Study|Withdrawal by Subject|0|||
33458705|NCT01899053|101568115|FG006|Overall Study|Withdrawal by Subject|0|||
33458706|NCT01899053|101568116|FG007|Overall Study|Withdrawal by Subject|1|||
33458707|NCT01899053|101568117|FG008|Overall Study|Withdrawal by Subject|0|||
33174845|NCT01084174|100548926|FG001|Overall Study|Eosinophilic esophagitis|1|||
33174846|NCT01084174|100548925|FG000|Overall Study|Anaphylaxis|0|||
33174847|NCT01084174|100548926|FG001|Overall Study|Anaphylaxis|1|||
33174848|NCT01084174|100548925|FG000|Overall Study|Participant noncompliance|0|||
33174849|NCT01084174|100548926|FG001|Overall Study|Participant noncompliance|1|||
33174850|NCT02738450|100548927|FG000|Overall Study|Withdrawal by Subject|0|||
33174851|NCT02738450|100548928|FG001|Overall Study|Withdrawal by Subject|2|||
33174852|NCT02738450|100548929|FG002|Overall Study|Withdrawal by Subject|0|||
33174853|NCT00661622|100548930|FG000|Overall Study|Protocol Violation|1|||
33174854|NCT00661622|100548931|FG001|Overall Study|Protocol Violation|0|||
33174855|NCT01344161|100548937|FG000|Overall Study|Lost to Follow-up|4|||
33174856|NCT01344161|100548938|FG001|Overall Study|Lost to Follow-up|1|||
33174857|NCT01344161|100548937|FG000|Overall Study|Pregnancy|0|||
33174858|NCT01344161|100548938|FG001|Overall Study|Pregnancy|1|||
33174859|NCT01344161|100548937|FG000|Overall Study|Protocol Violation|1|||
33458708|NCT01899053|101568118|FG009|Overall Study|Withdrawal by Subject|0|||
33174860|NCT01344161|100548938|FG001|Overall Study|Protocol Violation|1|||
33174861|NCT00656474|100548945|FG000|Overall Study|Other Reason|1|||
33174862|NCT02998840|100548956|FG000|Overall Study|Lost to Follow-up|1|||
33458709|NCT01899053|101568119|FG010|Overall Study|Withdrawal by Subject|0|||
33174863|NCT02998840|100548957|FG001|Overall Study|Lost to Follow-up|1|||
33458710|NCT01899053|101568120|FG011|Overall Study|Withdrawal by Subject|0|||
33458711|NCT01899053|101568121|FG012|Overall Study|Withdrawal by Subject|1|||
33458712|NCT01899053|101568122|FG013|Overall Study|Withdrawal by Subject|1|||
33458713|NCT01899053|101568109|FG000|Overall Study|Protocol Violation|0|||
33458714|NCT01899053|101568110|FG001|Overall Study|Protocol Violation|0|||
33458715|NCT01899053|101568111|FG002|Overall Study|Protocol Violation|1|||
33458716|NCT01899053|101568112|FG003|Overall Study|Protocol Violation|0|||
33458717|NCT01899053|101568113|FG004|Overall Study|Protocol Violation|0|||
33458718|NCT01899053|101568114|FG005|Overall Study|Protocol Violation|0|||
33458719|NCT01899053|101568115|FG006|Overall Study|Protocol Violation|0|||
33458720|NCT01899053|101568116|FG007|Overall Study|Protocol Violation|0|||
33458721|NCT01899053|101568117|FG008|Overall Study|Protocol Violation|0|||
33458722|NCT01899053|101568118|FG009|Overall Study|Protocol Violation|0|||
33458723|NCT01899053|101568119|FG010|Overall Study|Protocol Violation|0|||
33458724|NCT01899053|101568120|FG011|Overall Study|Protocol Violation|0|||
33458725|NCT01899053|101568121|FG012|Overall Study|Protocol Violation|0|||
33458726|NCT01899053|101568122|FG013|Overall Study|Protocol Violation|0|||
33458727|NCT01899053|101568109|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
33458728|NCT01899053|101568110|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
33458729|NCT01899053|101568111|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
33458730|NCT01899053|101568112|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
33458731|NCT01899053|101568113|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
33458732|NCT01899053|101568114|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
33458733|NCT01899053|101568115|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
33458734|NCT01899053|101568116|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
33458735|NCT01899053|101568117|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
33458736|NCT01899053|101568118|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
33458737|NCT01899053|101568119|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
33458738|NCT01899053|101568120|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
33458739|NCT01899053|101568121|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
33458740|NCT01899053|101568122|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
33458741|NCT01899053|101568109|FG000|Overall Study|Symptomatic Deterioration|0|||
33458742|NCT01899053|101568110|FG001|Overall Study|Symptomatic Deterioration|0|||
33458743|NCT01899053|101568111|FG002|Overall Study|Symptomatic Deterioration|0|||
33458744|NCT01899053|101568112|FG003|Overall Study|Symptomatic Deterioration|0|||
33458745|NCT01899053|101568113|FG004|Overall Study|Symptomatic Deterioration|0|||
33458746|NCT01899053|101568114|FG005|Overall Study|Symptomatic Deterioration|1|||
33458747|NCT01899053|101568115|FG006|Overall Study|Symptomatic Deterioration|0|||
33458748|NCT01899053|101568116|FG007|Overall Study|Symptomatic Deterioration|1|||
33458749|NCT01899053|101568117|FG008|Overall Study|Symptomatic Deterioration|0|||
33458750|NCT01899053|101568118|FG009|Overall Study|Symptomatic Deterioration|0|||
33458751|NCT01899053|101568119|FG010|Overall Study|Symptomatic Deterioration|0|||
33458752|NCT01899053|101568120|FG011|Overall Study|Symptomatic Deterioration|1|||
33458753|NCT01899053|101568121|FG012|Overall Study|Symptomatic Deterioration|2|||
33458754|NCT01899053|101568122|FG013|Overall Study|Symptomatic Deterioration|0|||
33458755|NCT01532908|101568123|FG000|Overall Study|Not Transplanted|1|||
33458756|NCT01532908|101568124|FG001|Overall Study|Not Transplanted|0|||
33458757|NCT01097694|101568126|FG000|Overall Study|Adverse Event|5|||
33458758|NCT01097694|101568127|FG001|Overall Study|Adverse Event|0|||
33458759|NCT01097694|101568126|FG000|Overall Study|Lost to Follow-up|0|||
33458760|NCT01097694|101568127|FG001|Overall Study|Lost to Follow-up|3|||
33458761|NCT01097694|101568126|FG000|Overall Study|Withdrawal by Subject|3|||
33458762|NCT01097694|101568127|FG001|Overall Study|Withdrawal by Subject|1|||
33458763|NCT03950674|101568128|FG000|Overall Study|Death|16|||
33458764|NCT03950674|101568129|FG001|Overall Study|Death|15|||
33458765|NCT03950674|101568128|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
33458766|NCT03950674|101568129|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
33458767|NCT01120691|101568130|FG000|Overall Study|Adverse Event|59|||
33458768|NCT01120691|101568131|FG001|Overall Study|Adverse Event|67|||
33458769|NCT01120691|101568132|FG002|Overall Study|Adverse Event|47|||
33458770|NCT01120691|101568130|FG000|Overall Study|Subject withdrew consent|33|||
33458771|NCT01120691|101568131|FG001|Overall Study|Subject withdrew consent|50|||
33458772|NCT01120691|101568132|FG002|Overall Study|Subject withdrew consent|44|||
33458773|NCT01120691|101568130|FG000|Overall Study|Death|21|||
33458774|NCT01120691|101568131|FG001|Overall Study|Death|22|||
33458775|NCT01120691|101568132|FG002|Overall Study|Death|24|||
33262733|NCT05580003|100863768|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262734|NCT05580003|100863769|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33458776|NCT01120691|101568130|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
33458777|NCT01120691|101568131|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
33458778|NCT01120691|101568132|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
33458779|NCT01120691|101568130|FG000|Overall Study|Administrative problems|15|||
33458780|NCT01120691|101568131|FG001|Overall Study|Administrative problems|8|||
33458781|NCT01120691|101568132|FG002|Overall Study|Administrative problems|9|||
33458782|NCT01120691|101568130|FG000|Overall Study|Protocol deviation|13|||
33458783|NCT01120691|101568131|FG001|Overall Study|Protocol deviation|12|||
33458784|NCT01120691|101568132|FG002|Overall Study|Protocol deviation|12|||
33174864|NCT02998840|100548958|FG002|Overall Study|Lost to Follow-up|2|||
33174865|NCT02998840|100548959|FG003|Overall Study|Lost to Follow-up|3|||
33174866|NCT02998840|100548956|FG000|Overall Study|Withdrawal by Subject|1|||
33174867|NCT02998840|100548957|FG001|Overall Study|Withdrawal by Subject|1|||
33174868|NCT02998840|100548958|FG002|Overall Study|Withdrawal by Subject|0|||
33174869|NCT02998840|100548959|FG003|Overall Study|Withdrawal by Subject|1|||
33458785|NCT01120691|101568130|FG000|Overall Study|Lost to Follow-up|5|||
33458786|NCT01120691|101568131|FG001|Overall Study|Lost to Follow-up|6|||
33458787|NCT01120691|101568132|FG002|Overall Study|Lost to Follow-up|4|||
33458788|NCT01120691|101568130|FG000|Overall Study|Abnormal test procedure result(s)|3|||
33174870|NCT02998840|100548956|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
33458789|NCT01120691|101568131|FG001|Overall Study|Abnormal test procedure result(s)|2|||
33458790|NCT01120691|101568132|FG002|Overall Study|Abnormal test procedure result(s)|1|||
33458791|NCT01120691|101568130|FG000|Overall Study|Patient's inability to use the device|3|||
33458792|NCT01120691|101568131|FG001|Overall Study|Patient's inability to use the device|1|||
33458793|NCT01120691|101568132|FG002|Overall Study|Patient's inability to use the device|0|||
33458794|NCT01120691|101568130|FG000|Overall Study|Abnormal laboratory value(s)|1|||
33458795|NCT01120691|101568131|FG001|Overall Study|Abnormal laboratory value(s)|3|||
33458796|NCT01120691|101568132|FG002|Overall Study|Abnormal laboratory value(s)|4|||
33458797|NCT03247686|101568133|FG000|Overall Study|Withdrawal by Subject|1|||
33458798|NCT03247686|101568134|FG001|Overall Study|Withdrawal by Subject|2|||
33458799|NCT01632306|101568135|FG000|Overall Study|Protocol Violation|1|||
33458800|NCT01632306|101568136|FG001|Overall Study|Protocol Violation|0|||
33458801|NCT01632306|101568137|FG002|Overall Study|Protocol Violation|0|||
33458802|NCT03419962|101568138|FG000|Overall Study|Change to other medication|1|||
33458803|NCT03419962|101568138|FG000|Overall Study|Refusal of continuing with trial drug|1|||
33458804|NCT03419962|101568138|FG000|Overall Study|Lost to Follow-up|3|||
33458805|NCT03419962|101568138|FG000|Overall Study|Difficulty in inhaling the doses|1|||
33458806|NCT03419962|101568138|FG000|Overall Study|Missing completion data|31|||
33458807|NCT01211262|101568141|FG000|Overall Study|Progressive Disease|18|||
33458808|NCT01211262|101568142|FG001|Overall Study|Progressive Disease|9|||
33458809|NCT01211262|101568141|FG000|Overall Study|Adverse Event|4|||
33458810|NCT01211262|101568142|FG001|Overall Study|Adverse Event|0|||
33458811|NCT01211262|101568141|FG000|Overall Study|Withdrawal of Consent|1|||
33458812|NCT01211262|101568142|FG001|Overall Study|Withdrawal of Consent|0|||
33458813|NCT01211262|101568141|FG000|Overall Study|Other|0|||
33458814|NCT01211262|101568142|FG001|Overall Study|Other|1|||
33458815|NCT00021541|101568143|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
33458816|NCT00021541|101568144|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
33458817|NCT00021541|101568143|FG000|Period 1-First Treatment|Adverse Event|2|||
33458818|NCT00021541|101568144|FG001|Period 1-First Treatment|Adverse Event|1|||
33458819|NCT00021541|101568143|FG000|Period 1-First Treatment|non-adherence|3|||
33458820|NCT00021541|101568144|FG001|Period 1-First Treatment|non-adherence|0|||
33458821|NCT00021541|101568143|FG000|Period 1-First Treatment|Death|1|||
33458822|NCT00021541|101568144|FG001|Period 1-First Treatment|Death|0|||
33458823|NCT00021541|101568143|FG000|Period 1-First Treatment|Pts that did not progress|2|||
33174871|NCT02998840|100548957|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
33458824|NCT00021541|101568144|FG001|Period 1-First Treatment|Pts that did not progress|2|||
33458825|NCT00021541|101568143|FG000|Period 1-First Treatment|Ineligible|0|||
33458826|NCT00021541|101568144|FG001|Period 1-First Treatment|Ineligible|2|||
33458827|NCT00021541|101568143|FG000|Period 2-crossover|refused phase B|2|||
33458828|NCT00021541|101568144|FG001|Period 2-crossover|refused phase B|2|||
33458829|NCT00021541|101568143|FG000|Period 2-crossover|Withdrawal by Subject|3|||
33458830|NCT00021541|101568144|FG001|Period 2-crossover|Withdrawal by Subject|4|||
33458831|NCT00021541|101568143|FG000|Period 2-crossover|Adverse Event|2|||
33458832|NCT00021541|101568144|FG001|Period 2-crossover|Adverse Event|2|||
33458833|NCT00021541|101568143|FG000|Period 2-crossover|non-adherence|1|||
33458834|NCT00021541|101568144|FG001|Period 2-crossover|non-adherence|0|||
33458835|NCT00021541|101568143|FG000|Period 2-crossover|Pts that did not progress|2|||
33458836|NCT00021541|101568144|FG001|Period 2-crossover|Pts that did not progress|3|||
33458837|NCT04531527|101568145|FG000|Overall Study|Found to be Ineligible|3|||
33458838|NCT00046839|101568148|FG000|Overall Study|Ineligible / No protocol treatment|0|||
33458839|NCT00046839|101568149|FG001|Overall Study|Ineligible / No protocol treatment|2|||
33458840|NCT00046839|101568148|FG000|Overall Study|Withdrawal of consent|1|||
33458841|NCT00046839|101568149|FG001|Overall Study|Withdrawal of consent|0|||
33458842|NCT00787605|101568150|FG000|Overall Study|Administrative Problems|3|||
33458843|NCT00787605|101568151|FG001|Overall Study|Administrative Problems|0|||
33458844|NCT00787605|101568150|FG000|Overall Study|Adverse Event|14|||
33458845|NCT00787605|101568151|FG001|Overall Study|Adverse Event|25|||
33458846|NCT00787605|101568150|FG000|Overall Study|Lost to Follow-up|3|||
33458847|NCT00787605|101568151|FG001|Overall Study|Lost to Follow-up|6|||
33458848|NCT00787605|101568150|FG000|Overall Study|Protocol Violation|7|||
33458849|NCT00787605|101568151|FG001|Overall Study|Protocol Violation|3|||
33458850|NCT00787605|101568150|FG000|Overall Study|Withdrawal by Subject|6|||
33458851|NCT00787605|101568151|FG001|Overall Study|Withdrawal by Subject|13|||
33458852|NCT00787605|101568150|FG000|Overall Study|Lack of Efficacy|13|||
33458853|NCT00787605|101568151|FG001|Overall Study|Lack of Efficacy|9|||
33458854|NCT00640341|101568152|FG000|Overall Study|Adverse Event|0|||
33458855|NCT00640341|101568153|FG001|Overall Study|Adverse Event|0|||
33458856|NCT00640341|101568154|FG002|Overall Study|Adverse Event|1|||
33458857|NCT00640341|101568152|FG000|Overall Study|Positive Slit Lamp Findings|0|||
33458858|NCT00640341|101568153|FG001|Overall Study|Positive Slit Lamp Findings|0|||
33458859|NCT00640341|101568154|FG002|Overall Study|Positive Slit Lamp Findings|1|||
33458860|NCT00640341|101568152|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
33458861|NCT00640341|101568153|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
33458862|NCT00640341|101568154|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
33458863|NCT00640341|101568152|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
33458864|NCT00640341|101568153|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
33458865|NCT00640341|101568154|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
33458866|NCT00640341|101568152|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
33458867|NCT00640341|101568153|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
33458868|NCT00640341|101568154|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
33458869|NCT00640341|101568152|FG000|Overall Study|Lost to Follow-up|2|||
33458870|NCT00640341|101568153|FG001|Overall Study|Lost to Follow-up|0|||
33458871|NCT00640341|101568154|FG002|Overall Study|Lost to Follow-up|0|||
33458872|NCT00640341|101568152|FG000|Overall Study|Withdrawal by Subject|4|||
33458873|NCT00640341|101568153|FG001|Overall Study|Withdrawal by Subject|0|||
33458874|NCT00640341|101568154|FG002|Overall Study|Withdrawal by Subject|1|||
33458875|NCT00640341|101568152|FG000|Overall Study|Unacceptable Lens Movement|1|||
33458876|NCT00640341|101568153|FG001|Overall Study|Unacceptable Lens Movement|0|||
33458877|NCT00640341|101568154|FG002|Overall Study|Unacceptable Lens Movement|0|||
33458878|NCT00640341|101568152|FG000|Overall Study|Poor fit/Uncomfortable|4|||
33458879|NCT00640341|101568153|FG001|Overall Study|Poor fit/Uncomfortable|0|||
33458880|NCT00640341|101568154|FG002|Overall Study|Poor fit/Uncomfortable|0|||
33458881|NCT00640341|101568152|FG000|Overall Study|Ineligable at Baseline|5|||
33458882|NCT00640341|101568153|FG001|Overall Study|Ineligable at Baseline|3|||
33458883|NCT00640341|101568154|FG002|Overall Study|Ineligable at Baseline|2|||
33458884|NCT00640341|101568152|FG000|Overall Study|Adverse event and positive slit lamp|1|||
33458885|NCT00640341|101568153|FG001|Overall Study|Adverse event and positive slit lamp|0|||
33458886|NCT00640341|101568154|FG002|Overall Study|Adverse event and positive slit lamp|0|||
33458887|NCT02340780|101568155|FG000|Overall Study|Ineligible|1|||
33458888|NCT02906917|101568156|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
33458889|NCT02906917|101568157|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
33174872|NCT02998840|100548958|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
33458890|NCT02906917|101568156|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
33458891|NCT02906917|101568157|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
33458892|NCT02906917|101568156|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
33458893|NCT02906917|101568157|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
33458894|NCT02906917|101568156|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
33458895|NCT02906917|101568157|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
33458896|NCT02906917|101568156|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
33458897|NCT02906917|101568157|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
33458898|NCT02906917|101568156|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
33458899|NCT02906917|101568157|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
33458900|NCT02906917|101568156|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
33458901|NCT02906917|101568157|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
33458902|NCT02906917|101568156|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
33458903|NCT02906917|101568157|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
33458904|NCT03448692|101568158|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
33458905|NCT03448692|101568159|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
33458906|NCT03448692|101568158|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
33458907|NCT03448692|101568159|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
33458908|NCT03448692|101568158|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
33458909|NCT03448692|101568159|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
33458910|NCT03448692|101568158|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
33458911|NCT03448692|101568159|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
33458912|NCT03448692|101568158|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
33458913|NCT03448692|101568159|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
33458914|NCT00522041|101568160|FG000|Overall Study|Adverse Event|9|||
33458915|NCT00522041|101568161|FG001|Overall Study|Adverse Event|3|||
33458916|NCT00522041|101568160|FG000|Overall Study|Protocol Violation|2|||
33458917|NCT00522041|101568161|FG001|Overall Study|Protocol Violation|0|||
33458918|NCT00522041|101568160|FG000|Overall Study|Lost to Follow-up|1|||
33458919|NCT00522041|101568161|FG001|Overall Study|Lost to Follow-up|4|||
33458920|NCT00522041|101568160|FG000|Overall Study|Voluntary withdrawal|5|||
33458921|NCT00522041|101568161|FG001|Overall Study|Voluntary withdrawal|4|||
33458922|NCT00522041|101568160|FG000|Overall Study|Did not receive treatment|0|||
33458923|NCT00522041|101568161|FG001|Overall Study|Did not receive treatment|1|||
33458924|NCT01206439|101568162|FG000|Overall Study|subject did not meet inclusion criteria|1|||
33458925|NCT01067521|101568166|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
33458926|NCT01067521|101568167|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
33458927|NCT01067521|101568166|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
33458928|NCT01067521|101568167|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
33458929|NCT01067521|101568166|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
33458930|NCT01067521|101568167|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
33458931|NCT01067521|101568166|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
33458932|NCT01067521|101568167|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
33458933|NCT01067521|101568166|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
33458934|NCT01067521|101568167|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
33174873|NCT02998840|100548959|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
33174874|NCT02426892|100548960|FG000|Overall Study|Adverse Event|2|||
33174875|NCT02426892|100548960|FG000|Overall Study|Lack of Efficacy|17|||
33174876|NCT02426892|100548960|FG000|Overall Study|Withdrawal by Subject|1|||
33174877|NCT00323115|100548961|FG000|Vaccine Administration|Adverse Event|1|||
33174878|NCT00323115|100548961|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
33174879|NCT02564042|100548962|FG000|Overall Study|Adverse Event|4|||
33174880|NCT02564042|100548963|FG001|Overall Study|Adverse Event|4|||
33174881|NCT02564042|100548964|FG002|Overall Study|Adverse Event|3|||
33174882|NCT02564042|100548965|FG003|Overall Study|Adverse Event|0|||
33458935|NCT01067521|101568166|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
33489762|NCT02952586|101686779|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
33174883|NCT02564042|100548966|FG004|Overall Study|Adverse Event|0|||
33174884|NCT02564042|100548967|FG005|Overall Study|Adverse Event|1|||
33174885|NCT02564042|100548962|FG000|Overall Study|Lost to Follow-up|1|||
33174886|NCT02564042|100548963|FG001|Overall Study|Lost to Follow-up|1|||
33174887|NCT02564042|100548964|FG002|Overall Study|Lost to Follow-up|1|||
33174888|NCT02564042|100548965|FG003|Overall Study|Lost to Follow-up|0|||
33174889|NCT02564042|100548966|FG004|Overall Study|Lost to Follow-up|1|||
33174890|NCT02564042|100548967|FG005|Overall Study|Lost to Follow-up|1|||
33262735|NCT05580003|100863770|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262736|NCT05580003|100863771|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262737|NCT05580003|100863772|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262738|NCT05580003|100863773|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33458936|NCT01067521|101568167|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
33458937|NCT01067521|101568166|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
33174891|NCT02564042|100548962|FG000|Overall Study|Physician Decision|1|||
33458938|NCT01067521|101568167|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
33458939|NCT01067521|101568166|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
33458940|NCT01067521|101568167|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
33458941|NCT01067521|101568166|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
33458942|NCT01067521|101568167|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
33458943|NCT01067521|101568166|FG000|Open-Label Period|Death|3|||
33458944|NCT01067521|101568167|FG001|Open-Label Period|Death|1|||
33458945|NCT01067521|101568166|FG000|Open-Label Period|Adverse Event|30|||
33262739|NCT05580003|100863774|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262740|NCT05580003|100863775|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
33262741|NCT05580003|100863748|FG000|Part 2 (up to 10 Days)|Other|0|||
33458946|NCT01067521|101568167|FG001|Open-Label Period|Adverse Event|28|||
33458947|NCT01067521|101568166|FG000|Open-Label Period|Withdrawal by Subject|160|||
33458948|NCT01067521|101568167|FG001|Open-Label Period|Withdrawal by Subject|88|||
33458949|NCT01067521|101568166|FG000|Open-Label Period|Physician Decision|13|||
33458950|NCT01067521|101568167|FG001|Open-Label Period|Physician Decision|11|||
33458951|NCT01067521|101568166|FG000|Open-Label Period|Non-compliance with study drug|5|||
33458952|NCT01067521|101568167|FG001|Open-Label Period|Non-compliance with study drug|0|||
33458953|NCT01067521|101568166|FG000|Open-Label Period|Protocol Violation|3|||
33458954|NCT01067521|101568167|FG001|Open-Label Period|Protocol Violation|0|||
33458955|NCT01067521|101568166|FG000|Open-Label Period|Pregnancy|14|||
33458956|NCT01067521|101568167|FG001|Open-Label Period|Pregnancy|8|||
33458957|NCT01067521|101568166|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
33458958|NCT01067521|101568167|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
33458959|NCT01067521|101568166|FG000|Open-Label Period|Lost to Follow-up|21|||
33458960|NCT01067521|101568167|FG001|Open-Label Period|Lost to Follow-up|20|||
33458961|NCT00544167|101568168|FG000|Overall Study|Adverse Event|21|||
33458962|NCT00544167|101568168|FG000|Overall Study|Physician Decision|8|||
33458963|NCT00757705|101568171|FG000|Overall Study|Adverse Event|19|||
33458964|NCT00757705|101568171|FG000|Overall Study|Lost to Follow-up|16|||
33458965|NCT00757705|101568171|FG000|Overall Study|Withdrawal by Subject|25|||
33458966|NCT00757705|101568171|FG000|Overall Study|Insufficient Response|26|||
33458967|NCT00757705|101568171|FG000|Overall Study|Ineligible to continue|8|||
33458968|NCT00757705|101568171|FG000|Overall Study|Non-compliant|9|||
33458969|NCT00757705|101568171|FG000|Overall Study|Other|18|||
33458970|NCT04230876|101568172|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
33458971|NCT04230876|101568173|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
33458972|NCT02832167|101568174|FG000|Treatment Period 1|Disease progression|90|||
33458973|NCT02832167|101568174|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
33458974|NCT02832167|101568174|FG000|Treatment Period 1|Death|2|||
33458975|NCT02832167|101568174|FG000|Treatment Period 1|Study Drug Toxicity|6|||
33458976|NCT02832167|101568174|FG000|Treatment Period 1|Participant request to discontinue|9|||
33458977|NCT02832167|101568174|FG000|Treatment Period 1|No longer meet study criteria|1|||
33458978|NCT02832167|101568174|FG000|Treatment Period 1|Participant withdrew consent|3|||
33458979|NCT02832167|101568174|FG000|Treatment Period 1|Other reasons|6|||
33458980|NCT02832167|101568174|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
33458981|NCT02832167|101568174|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
33458982|NCT02832167|101568174|FG000|Transition From Period 1 to Period 2|Death|2|||
33458983|NCT02832167|101568174|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
33458984|NCT02832167|101568174|FG000|Treatment Period 2|Disease progression|69|||
33458985|NCT02832167|101568174|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
33458986|NCT02832167|101568174|FG000|Treatment Period 2|Maximum clinical benefit|1|||
33458987|NCT02832167|101568174|FG000|Treatment Period 2|Study Drug Toxicity|5|||
33458988|NCT02832167|101568174|FG000|Treatment Period 2|Participant request to discontinue|2|||
33458989|NCT02832167|101568174|FG000|Treatment Period 2|Participant withdrew consent|3|||
33458990|NCT02832167|101568174|FG000|Treatment Period 2|Other reasons|3|||
33458991|NCT05065619|101568175|FG000|Up to Day 42|Lost to Follow-up|1|||
33458992|NCT05065619|101568176|FG001|Up to Day 42|Lost to Follow-up|0|||
33458993|NCT05065619|101568175|FG000|Up to Day 42|Withdrawal by Subject|1|||
33458994|NCT05065619|101568176|FG001|Up to Day 42|Withdrawal by Subject|0|||
33458995|NCT05065619|101568175|FG000|After Day 43|Lost to Follow-up|1|||
33458996|NCT05065619|101568176|FG001|After Day 43|Lost to Follow-up|0|||
33458997|NCT05065619|101568175|FG000|After Day 43|Physician Decision|3|||
33458998|NCT05065619|101568176|FG001|After Day 43|Physician Decision|0|||
33458999|NCT05065619|101568175|FG000|After Day 43|Withdrawal by Subject|1|||
33459000|NCT05065619|101568176|FG001|After Day 43|Withdrawal by Subject|2|||
33459001|NCT05065619|101568175|FG000|After Day 43|Public vaccination|6|||
33459002|NCT05065619|101568176|FG001|After Day 43|Public vaccination|8|||
33459003|NCT05065619|101568175|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
33459004|NCT05065619|101568176|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
33459005|NCT05065619|101568175|FG000|After Day 43|Study Terminated by Sponsor|88|||
33459006|NCT05065619|101568176|FG001|After Day 43|Study Terminated by Sponsor|16|||
33459007|NCT02308696|101568178|FG000|Overall Study|Lost to Follow-up|28|||
33459008|NCT02308696|101568179|FG001|Overall Study|Lost to Follow-up|21|||
33459009|NCT02308696|101568178|FG000|Overall Study|Death|8|||
33459010|NCT02308696|101568179|FG001|Overall Study|Death|4|||
33459011|NCT02308696|101568178|FG000|Overall Study|Moved to a Higher Level of Care|17|||
33459012|NCT02308696|101568179|FG001|Overall Study|Moved to a Higher Level of Care|6|||
33459013|NCT03183141|101568180|FG000|Overall Study|Withdrawal by Subject|2|||
33459014|NCT03183141|101568181|FG001|Overall Study|Withdrawal by Subject|4|||
33459015|NCT03183141|101568180|FG000|Overall Study|Death|0|||
33459016|NCT03183141|101568181|FG001|Overall Study|Death|8|||
33459017|NCT01183884|101568182|FG000|Overall Study|Progressive Disease|26|||
33459018|NCT01183884|101568182|FG000|Overall Study|Adverse Event|3|||
33459019|NCT01183884|101568182|FG000|Overall Study|Withdrawal by Subject|1|||
33459020|NCT01183884|101568182|FG000|Overall Study|Other Complicating Disease|3|||
33459021|NCT01183884|101568182|FG000|Overall Study|Not Treated|1|||
33459022|NCT01183884|101568182|FG000|Overall Study|Other|4|||
33459023|NCT00127166|101568185|FG000|Period I|Protocol Violation|0|||
33459024|NCT00127166|101568186|FG001|Period I|Protocol Violation|2|||
33459025|NCT00127166|101568185|FG000|Period I|Withdrawal by Subject|2|||
33459026|NCT00127166|101568186|FG001|Period I|Withdrawal by Subject|0|||
33459027|NCT00127166|101568185|FG000|Period I|Patient did not meet inclusion criteria|1|||
33459028|NCT00127166|101568186|FG001|Period I|Patient did not meet inclusion criteria|0|||
33459029|NCT00127166|101568185|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
33459030|NCT00127166|101568186|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
33459031|NCT00127166|101568185|FG000|Period II|Withdrawal by Subject|2|||
33459032|NCT00127166|101568186|FG001|Period II|Withdrawal by Subject|0|||
33459033|NCT00127166|101568185|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
33459034|NCT00127166|101568186|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
33459035|NCT03750695|101568187|FG000|Overall Study|Lost to Follow-up|0|||
33459036|NCT03750695|101568188|FG001|Overall Study|Lost to Follow-up|1|||
33459037|NCT01223027|101568195|FG000|Overall Study|Adverse Event|20|||
33459038|NCT01223027|101568196|FG001|Overall Study|Adverse Event|10|||
33459039|NCT01223027|101568195|FG000|Overall Study|Death|42|||
33459040|NCT01223027|101568196|FG001|Overall Study|Death|42|||
33459041|NCT01223027|101568195|FG000|Overall Study|Lost to Follow-up|2|||
33459042|NCT01223027|101568196|FG001|Overall Study|Lost to Follow-up|1|||
33459043|NCT01223027|101568195|FG000|Overall Study|Physician Decision|4|||
33174892|NCT02564042|100548963|FG001|Overall Study|Physician Decision|0|||
33174893|NCT02564042|100548964|FG002|Overall Study|Physician Decision|0|||
33174894|NCT02564042|100548965|FG003|Overall Study|Physician Decision|1|||
33174895|NCT02564042|100548966|FG004|Overall Study|Physician Decision|0|||
33174896|NCT02564042|100548967|FG005|Overall Study|Physician Decision|0|||
33174897|NCT02564042|100548962|FG000|Overall Study|Withdrawal by Subject|5|||
33174898|NCT02564042|100548963|FG001|Overall Study|Withdrawal by Subject|3|||
33459044|NCT01223027|101568196|FG001|Overall Study|Physician Decision|8|||
33459045|NCT01223027|101568195|FG000|Overall Study|Progressive Disease|167|||
33459046|NCT01223027|101568196|FG001|Overall Study|Progressive Disease|183|||
33459047|NCT01223027|101568195|FG000|Overall Study|Protocol Violation|2|||
33459048|NCT01223027|101568196|FG001|Overall Study|Protocol Violation|1|||
33459049|NCT01223027|101568195|FG000|Overall Study|Subject/guardian decicion|18|||
33459050|NCT01223027|101568196|FG001|Overall Study|Subject/guardian decicion|16|||
33459051|NCT01223027|101568195|FG000|Overall Study|New therapy for study indication|17|||
33459052|NCT01223027|101568196|FG001|Overall Study|New therapy for study indication|8|||
33459053|NCT01223027|101568195|FG000|Overall Study|Study terminated by sponsor|2|||
33459054|NCT01223027|101568196|FG001|Overall Study|Study terminated by sponsor|8|||
33459055|NCT00942734|101568199|FG000|Overall Study|Adverse Event|2|||
33459056|NCT00942734|101568199|FG000|Overall Study|Protocol Violation|3|||
33459057|NCT00942734|101568199|FG000|Overall Study|Disease Progression|2|||
33174899|NCT02564042|100548964|FG002|Overall Study|Withdrawal by Subject|2|||
33459058|NCT00942734|101568199|FG000|Overall Study|Physician Decision|1|||
33459059|NCT03573336|101568200|FG000|Overall Study|Study terminated|2|||
33459060|NCT03573336|101568201|FG001|Overall Study|Study terminated|4|||
33459061|NCT03573336|101568202|FG002|Overall Study|Study terminated|2|||
33459062|NCT04640194|101568203|FG000|Overall Study|Adverse Event|3|||
33459063|NCT04640194|101568204|FG001|Overall Study|Adverse Event|7|||
33459064|NCT04640194|101568205|FG002|Overall Study|Adverse Event|0|||
33459065|NCT04640194|101568206|FG003|Overall Study|Adverse Event|5|||
33459066|NCT04640194|101568207|FG004|Overall Study|Adverse Event|0|||
33174900|NCT02564042|100548965|FG003|Overall Study|Withdrawal by Subject|2|||
33459067|NCT04640194|101568208|FG005|Overall Study|Adverse Event|4|||
33262742|NCT05580003|100863749|FG001|Part 2 (up to 10 Days)|Other|0|||
33459068|NCT04640194|101568209|FG006|Overall Study|Adverse Event|0|||
33459069|NCT04640194|101568203|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
33459070|NCT04640194|101568204|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
33459071|NCT04640194|101568205|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
33459072|NCT04640194|101568206|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
33459073|NCT04640194|101568207|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
33459074|NCT04640194|101568208|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
33459075|NCT04640194|101568209|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
33459076|NCT04640194|101568203|FG000|Overall Study|fibrinogen level too low|0|||
33459077|NCT04640194|101568204|FG001|Overall Study|fibrinogen level too low|0|||
33459078|NCT04640194|101568205|FG002|Overall Study|fibrinogen level too low|0|||
33459079|NCT04640194|101568206|FG003|Overall Study|fibrinogen level too low|1|||
33459080|NCT04640194|101568207|FG004|Overall Study|fibrinogen level too low|0|||
33459081|NCT04640194|101568208|FG005|Overall Study|fibrinogen level too low|0|||
33459082|NCT04640194|101568209|FG006|Overall Study|fibrinogen level too low|0|||
33459083|NCT04640194|101568203|FG000|Overall Study|mild bleeding|0|||
33459084|NCT04640194|101568204|FG001|Overall Study|mild bleeding|0|||
33459085|NCT04640194|101568205|FG002|Overall Study|mild bleeding|0|||
33459086|NCT04640194|101568206|FG003|Overall Study|mild bleeding|1|||
33459087|NCT04640194|101568207|FG004|Overall Study|mild bleeding|0|||
33459088|NCT04640194|101568208|FG005|Overall Study|mild bleeding|0|||
33459089|NCT04640194|101568209|FG006|Overall Study|mild bleeding|0|||
33459090|NCT04640194|101568203|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
33459091|NCT04640194|101568204|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
33459092|NCT04640194|101568205|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
33459093|NCT04640194|101568206|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
33459094|NCT04640194|101568207|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
33174901|NCT02564042|100548966|FG004|Overall Study|Withdrawal by Subject|10|||
33174902|NCT02564042|100548967|FG005|Overall Study|Withdrawal by Subject|12|||
33174903|NCT02642614|100548973|FG000|Overall Study|Adverse Event|1|||
33174904|NCT02642614|100548974|FG001|Overall Study|Adverse Event|1|||
33174905|NCT02642614|100548975|FG002|Overall Study|Adverse Event|2|||
33174906|NCT02642614|100548976|FG003|Overall Study|Adverse Event|2|||
33459095|NCT04640194|101568208|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
33459096|NCT04640194|101568209|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
33459097|NCT00380588|101568210|FG000|Overall Study|Unequivocal Disease Progression|25|||
33459098|NCT00380588|101568211|FG001|Overall Study|Unequivocal Disease Progression|34|||
33459099|NCT00380588|101568210|FG000|Overall Study|Next Cycle Not Started|4|||
33459100|NCT00380588|101568211|FG001|Overall Study|Next Cycle Not Started|0|||
33459101|NCT00380588|101568210|FG000|Overall Study|Adverse Event|7|||
33459102|NCT00380588|101568211|FG001|Overall Study|Adverse Event|3|||
33459103|NCT00380588|101568210|FG000|Overall Study|Withdrawal by Subject|1|||
33459104|NCT00380588|101568211|FG001|Overall Study|Withdrawal by Subject|3|||
33459105|NCT00380588|101568210|FG000|Overall Study|Physician Decision|2|||
33459106|NCT00380588|101568211|FG001|Overall Study|Physician Decision|0|||
33459107|NCT00434590|101568214|FG000|Overall Study|Administrative problems|5|||
33459108|NCT00434590|101568215|FG001|Overall Study|Administrative problems|5|||
33459109|NCT01198873|101568221|FG000|Overall Study|Adverse Event|4|||
33459110|NCT01198873|101568222|FG001|Overall Study|Adverse Event|7|||
33459111|NCT01198873|101568221|FG000|Overall Study|Study closure|29|||
33459112|NCT01198873|101568222|FG001|Overall Study|Study closure|23|||
33459113|NCT01198873|101568221|FG000|Overall Study|Other than above|4|||
33459114|NCT01198873|101568222|FG001|Overall Study|Other than above|2|||
33459115|NCT02197416|101568223|FG000|Overall Study|Other reasons|0|||
33459116|NCT02197416|101568224|FG001|Overall Study|Other reasons|2|||
33459117|NCT02197416|101568225|FG002|Overall Study|Other reasons|5|||
33459118|NCT02197416|101568223|FG000|Overall Study|Withdrawal by Subject|0|||
33459119|NCT02197416|101568224|FG001|Overall Study|Withdrawal by Subject|2|||
33459120|NCT02197416|101568225|FG002|Overall Study|Withdrawal by Subject|1|||
33459121|NCT02197416|101568223|FG000|Overall Study|Protocol Violation|1|||
33459122|NCT02197416|101568224|FG001|Overall Study|Protocol Violation|0|||
33459123|NCT02197416|101568225|FG002|Overall Study|Protocol Violation|1|||
33459124|NCT02197416|101568223|FG000|Overall Study|Adverse Event|0|||
33459125|NCT02197416|101568224|FG001|Overall Study|Adverse Event|0|||
33459126|NCT02197416|101568225|FG002|Overall Study|Adverse Event|1|||
33459127|NCT03206749|101568226|FG000|Overall Study|Withdrawal of consent|5|||
33459128|NCT03206749|101568227|FG001|Overall Study|Withdrawal of consent|3|||
33459129|NCT03206749|101568228|FG002|Overall Study|Withdrawal of consent|6|||
33459130|NCT03206749|101568226|FG000|Overall Study|Lost to Follow-up|0|||
33459131|NCT03206749|101568227|FG001|Overall Study|Lost to Follow-up|0|||
33459132|NCT03206749|101568228|FG002|Overall Study|Lost to Follow-up|1|||
33459133|NCT04232540|101568229|FG000|Overall Study|Lost to Follow-up|1|||
33459134|NCT04232540|101568230|FG001|Overall Study|Lost to Follow-up|0|||
33459135|NCT01086969|101568231|FG000|Overall Study|Withdrawal by Subject|1|||
33459136|NCT01086969|101568232|FG001|Overall Study|Withdrawal by Subject|2|||
33459137|NCT01086969|101568233|FG002|Overall Study|Withdrawal by Subject|0|||
33459138|NCT00856349|101568239|FG000|Overall Study|Death|418|||
33459139|NCT00856349|101568239|FG000|Overall Study|Withdrawal by Subject|116|||
33459140|NCT00856349|101568239|FG000|Overall Study|Lost to Follow-up|91|||
33459141|NCT00856349|101568239|FG000|Overall Study|Protocol Violation|38|||
33459142|NCT00856349|101568239|FG000|Overall Study|Physician Decision|13|||
33459143|NCT00856349|101568239|FG000|Overall Study|Subject relocation|104|||
33459144|NCT00856349|101568239|FG000|Overall Study|Device explant|33|||
33459145|NCT00856349|101568239|FG000|Overall Study|Site closure|78|||
33459146|NCT00856349|101568239|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
33459147|NCT03450629|101568240|FG000|Overall Study|Adverse Event|15|||
33459148|NCT03450629|101568241|FG001|Overall Study|Adverse Event|14|||
33459149|NCT03450629|101568240|FG000|Overall Study|Physician Decision|2|||
33459150|NCT03450629|101568241|FG001|Overall Study|Physician Decision|2|||
33459151|NCT03450629|101568240|FG000|Overall Study|Lack of Efficacy|2|||
33459152|NCT03450629|101568241|FG001|Overall Study|Lack of Efficacy|0|||
33459153|NCT03450629|101568240|FG000|Overall Study|Lost to Follow-up|4|||
33459154|NCT03450629|101568241|FG001|Overall Study|Lost to Follow-up|2|||
33459155|NCT03450629|101568240|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
33459156|NCT03450629|101568241|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
33459157|NCT03450629|101568240|FG000|Overall Study|Non-Compliance With Study Drug|2|||
33459158|NCT03450629|101568241|FG001|Overall Study|Non-Compliance With Study Drug|1|||
33459159|NCT03450629|101568240|FG000|Overall Study|Protocol Violation|11|||
33459160|NCT03450629|101568241|FG001|Overall Study|Protocol Violation|8|||
33459161|NCT03450629|101568240|FG000|Overall Study|Withdrawal by Subject|12|||
33459162|NCT03450629|101568241|FG001|Overall Study|Withdrawal by Subject|6|||
33459163|NCT02941523|101568243|FG000|Monotherapy|Withdrawal by Subject|0|||
33459164|NCT02941523|101568244|FG001|Monotherapy|Withdrawal by Subject|1|||
33459165|NCT02941523|101568243|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
33459166|NCT02941523|101568244|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
33459167|NCT02941523|101568243|FG000|Carboplatin Combination Therapy|Death|1|||
33459168|NCT02941523|101568244|FG001|Carboplatin Combination Therapy|Death|2|||
33459169|NCT02941523|101568243|FG000|Carboplatin Combination Therapy|Disease progression|2|||
33459170|NCT02941523|101568244|FG001|Carboplatin Combination Therapy|Disease progression|0|||
33459171|NCT02941523|101568243|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
33459172|NCT02941523|101568244|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
33459173|NCT01332968|101568245|FG000|Induction Period|Adverse Event|23|||
33459174|NCT01332968|101568246|FG001|Induction Period|Adverse Event|26|||
33459175|NCT01332968|101568247|FG002|Induction Period|Adverse Event|0|||
33459176|NCT01332968|101568248|FG003|Induction Period|Adverse Event|0|||
33459177|NCT01332968|101568249|FG004|Induction Period|Adverse Event|0|||
33459178|NCT01332968|101568250|FG005|Induction Period|Adverse Event|0|||
33459179|NCT01332968|101568251|FG006|Induction Period|Adverse Event|0|||
33459180|NCT01332968|101568252|FG007|Induction Period|Adverse Event|0|||
33459181|NCT01332968|101568245|FG000|Induction Period|Death|1|||
33459182|NCT01332968|101568246|FG001|Induction Period|Death|4|||
33459183|NCT01332968|101568247|FG002|Induction Period|Death|0|||
33459184|NCT01332968|101568248|FG003|Induction Period|Death|0|||
33459185|NCT01332968|101568249|FG004|Induction Period|Death|0|||
33459186|NCT01332968|101568250|FG005|Induction Period|Death|0|||
33459187|NCT01332968|101568251|FG006|Induction Period|Death|0|||
33459188|NCT01332968|101568252|FG007|Induction Period|Death|0|||
33459189|NCT01332968|101568245|FG000|Induction Period|Non-compliance|1|||
33459190|NCT01332968|101568246|FG001|Induction Period|Non-compliance|0|||
33459191|NCT01332968|101568247|FG002|Induction Period|Non-compliance|0|||
33459192|NCT01332968|101568248|FG003|Induction Period|Non-compliance|0|||
33459193|NCT01332968|101568249|FG004|Induction Period|Non-compliance|0|||
33459194|NCT01332968|101568250|FG005|Induction Period|Non-compliance|0|||
33459195|NCT01332968|101568251|FG006|Induction Period|Non-compliance|0|||
33459196|NCT01332968|101568252|FG007|Induction Period|Non-compliance|0|||
33459197|NCT01332968|101568245|FG000|Induction Period|Other|2|||
33459198|NCT01332968|101568246|FG001|Induction Period|Other|2|||
33459199|NCT01332968|101568247|FG002|Induction Period|Other|0|||
33459200|NCT01332968|101568248|FG003|Induction Period|Other|0|||
33459201|NCT01332968|101568249|FG004|Induction Period|Other|0|||
33459202|NCT01332968|101568250|FG005|Induction Period|Other|0|||
33459203|NCT01332968|101568251|FG006|Induction Period|Other|0|||
33459204|NCT01332968|101568252|FG007|Induction Period|Other|0|||
33459205|NCT01332968|101568245|FG000|Induction Period|Physician Decision|6|||
33459206|NCT01332968|101568246|FG001|Induction Period|Physician Decision|1|||
33459207|NCT01332968|101568247|FG002|Induction Period|Physician Decision|0|||
33459208|NCT01332968|101568248|FG003|Induction Period|Physician Decision|0|||
33459209|NCT01332968|101568249|FG004|Induction Period|Physician Decision|0|||
33459210|NCT01332968|101568250|FG005|Induction Period|Physician Decision|0|||
33459211|NCT01332968|101568251|FG006|Induction Period|Physician Decision|0|||
33459212|NCT01332968|101568252|FG007|Induction Period|Physician Decision|0|||
33459213|NCT01332968|101568245|FG000|Induction Period|Progressive Disease|15|||
33459214|NCT01332968|101568246|FG001|Induction Period|Progressive Disease|7|||
33459215|NCT01332968|101568247|FG002|Induction Period|Progressive Disease|0|||
33459216|NCT01332968|101568248|FG003|Induction Period|Progressive Disease|0|||
33459217|NCT01332968|101568249|FG004|Induction Period|Progressive Disease|0|||
33459218|NCT01332968|101568250|FG005|Induction Period|Progressive Disease|0|||
33459219|NCT01332968|101568251|FG006|Induction Period|Progressive Disease|0|||
33459220|NCT01332968|101568252|FG007|Induction Period|Progressive Disease|0|||
33459221|NCT01332968|101568245|FG000|Induction Period|Protocol Violation|3|||
33459222|NCT01332968|101568246|FG001|Induction Period|Protocol Violation|4|||
33459223|NCT01332968|101568247|FG002|Induction Period|Protocol Violation|0|||
33459224|NCT01332968|101568248|FG003|Induction Period|Protocol Violation|0|||
33459225|NCT01332968|101568249|FG004|Induction Period|Protocol Violation|0|||
33459226|NCT01332968|101568250|FG005|Induction Period|Protocol Violation|0|||
33459227|NCT01332968|101568251|FG006|Induction Period|Protocol Violation|0|||
33459228|NCT01332968|101568252|FG007|Induction Period|Protocol Violation|0|||
33459229|NCT01332968|101568245|FG000|Induction Period|Withdrawal by Subject|3|||
33459230|NCT01332968|101568246|FG001|Induction Period|Withdrawal by Subject|5|||
33459231|NCT01332968|101568247|FG002|Induction Period|Withdrawal by Subject|0|||
33459232|NCT01332968|101568248|FG003|Induction Period|Withdrawal by Subject|0|||
33459233|NCT01332968|101568249|FG004|Induction Period|Withdrawal by Subject|0|||
33459234|NCT01332968|101568250|FG005|Induction Period|Withdrawal by Subject|0|||
33459235|NCT01332968|101568251|FG006|Induction Period|Withdrawal by Subject|0|||
33459236|NCT01332968|101568252|FG007|Induction Period|Withdrawal by Subject|0|||
33459237|NCT01332968|101568245|FG000|Induction Period|Randomised but not treated|4|||
33459238|NCT01332968|101568246|FG001|Induction Period|Randomised but not treated|7|||
33459239|NCT01332968|101568247|FG002|Induction Period|Randomised but not treated|0|||
33459240|NCT01332968|101568248|FG003|Induction Period|Randomised but not treated|0|||
33459241|NCT01332968|101568249|FG004|Induction Period|Randomised but not treated|0|||
33459242|NCT01332968|101568250|FG005|Induction Period|Randomised but not treated|0|||
33459243|NCT01332968|101568251|FG006|Induction Period|Randomised but not treated|0|||
33459244|NCT01332968|101568252|FG007|Induction Period|Randomised but not treated|0|||
33459245|NCT01332968|101568245|FG000|Maintenance/Observation Period|Adverse Event|0|||
33459246|NCT01332968|101568246|FG001|Maintenance/Observation Period|Adverse Event|0|||
33459247|NCT01332968|101568247|FG002|Maintenance/Observation Period|Adverse Event|53|||
33459248|NCT01332968|101568248|FG003|Maintenance/Observation Period|Adverse Event|66|||
33459249|NCT01332968|101568249|FG004|Maintenance/Observation Period|Adverse Event|0|||
33174907|NCT02642614|100548973|FG000|Overall Study|Lost to Follow-up|1|||
33174908|NCT02642614|100548974|FG001|Overall Study|Lost to Follow-up|0|||
33174909|NCT02642614|100548975|FG002|Overall Study|Lost to Follow-up|0|||
33174910|NCT02642614|100548976|FG003|Overall Study|Lost to Follow-up|0|||
33174911|NCT02642614|100548973|FG000|Overall Study|Withdrawal by Subject|1|||
33174912|NCT02642614|100548974|FG001|Overall Study|Withdrawal by Subject|1|||
33174913|NCT02642614|100548975|FG002|Overall Study|Withdrawal by Subject|0|||
33174914|NCT02642614|100548976|FG003|Overall Study|Withdrawal by Subject|0|||
33174915|NCT04492618|100548979|FG000|Overall Study|Withdrawal by Subject|1|||
33174916|NCT00818662|100548980|FG000|Overall Study|Adverse Event|5|||
33174917|NCT00818662|100548981|FG001|Overall Study|Adverse Event|14|||
33174918|NCT00818662|100548982|FG002|Overall Study|Adverse Event|4|||
33174919|NCT00818662|100548983|FG003|Overall Study|Adverse Event|3|||
33174920|NCT00818662|100548980|FG000|Overall Study|Withdrawal by Subject|5|||
33459250|NCT01332968|101568250|FG005|Maintenance/Observation Period|Adverse Event|0|||
33459251|NCT01332968|101568251|FG006|Maintenance/Observation Period|Adverse Event|0|||
33459252|NCT01332968|101568252|FG007|Maintenance/Observation Period|Adverse Event|0|||
33459253|NCT01332968|101568245|FG000|Maintenance/Observation Period|Death|0|||
33459254|NCT01332968|101568246|FG001|Maintenance/Observation Period|Death|0|||
33459255|NCT01332968|101568247|FG002|Maintenance/Observation Period|Death|5|||
33459256|NCT01332968|101568248|FG003|Maintenance/Observation Period|Death|6|||
33459257|NCT01332968|101568249|FG004|Maintenance/Observation Period|Death|0|||
33459258|NCT01332968|101568250|FG005|Maintenance/Observation Period|Death|0|||
33459259|NCT01332968|101568251|FG006|Maintenance/Observation Period|Death|0|||
33174921|NCT00818662|100548981|FG001|Overall Study|Withdrawal by Subject|4|||
33174922|NCT00818662|100548982|FG002|Overall Study|Withdrawal by Subject|2|||
33262743|NCT05580003|100863750|FG002|Part 2 (up to 10 Days)|Other|0|||
33459260|NCT01332968|101568252|FG007|Maintenance/Observation Period|Death|0|||
33459261|NCT01332968|101568245|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
33459262|NCT01332968|101568246|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
33459263|NCT01332968|101568247|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
33459264|NCT01332968|101568248|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
33459265|NCT01332968|101568249|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
33459266|NCT01332968|101568250|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
33459267|NCT01332968|101568251|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
33459268|NCT01332968|101568252|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
33459269|NCT01332968|101568245|FG000|Maintenance/Observation Period|Non-compliance|0|||
33459270|NCT01332968|101568246|FG001|Maintenance/Observation Period|Non-compliance|0|||
33459271|NCT01332968|101568247|FG002|Maintenance/Observation Period|Non-compliance|4|||
33459272|NCT01332968|101568248|FG003|Maintenance/Observation Period|Non-compliance|3|||
33459273|NCT01332968|101568249|FG004|Maintenance/Observation Period|Non-compliance|0|||
33459274|NCT01332968|101568250|FG005|Maintenance/Observation Period|Non-compliance|0|||
33459275|NCT01332968|101568251|FG006|Maintenance/Observation Period|Non-compliance|0|||
33459276|NCT01332968|101568252|FG007|Maintenance/Observation Period|Non-compliance|0|||
33459277|NCT01332968|101568245|FG000|Maintenance/Observation Period|Other|0|||
33459278|NCT01332968|101568246|FG001|Maintenance/Observation Period|Other|0|||
33459279|NCT01332968|101568247|FG002|Maintenance/Observation Period|Other|4|||
33459280|NCT01332968|101568248|FG003|Maintenance/Observation Period|Other|7|||
33459281|NCT01332968|101568249|FG004|Maintenance/Observation Period|Other|0|||
33459282|NCT01332968|101568250|FG005|Maintenance/Observation Period|Other|0|||
33459283|NCT01332968|101568251|FG006|Maintenance/Observation Period|Other|0|||
33459284|NCT01332968|101568252|FG007|Maintenance/Observation Period|Other|0|||
33459285|NCT01332968|101568245|FG000|Maintenance/Observation Period|Physician Decision|0|||
33459286|NCT01332968|101568246|FG001|Maintenance/Observation Period|Physician Decision|0|||
33459287|NCT01332968|101568247|FG002|Maintenance/Observation Period|Physician Decision|14|||
33459288|NCT01332968|101568248|FG003|Maintenance/Observation Period|Physician Decision|19|||
33459289|NCT01332968|101568249|FG004|Maintenance/Observation Period|Physician Decision|0|||
33459290|NCT01332968|101568250|FG005|Maintenance/Observation Period|Physician Decision|1|||
33459291|NCT01332968|101568251|FG006|Maintenance/Observation Period|Physician Decision|0|||
33459292|NCT01332968|101568252|FG007|Maintenance/Observation Period|Physician Decision|0|||
33459293|NCT01332968|101568245|FG000|Maintenance/Observation Period|Progressive Disease|0|||
33459294|NCT01332968|101568246|FG001|Maintenance/Observation Period|Progressive Disease|0|||
33459295|NCT01332968|101568247|FG002|Maintenance/Observation Period|Progressive Disease|72|||
33459296|NCT01332968|101568248|FG003|Maintenance/Observation Period|Progressive Disease|40|||
33459297|NCT01332968|101568249|FG004|Maintenance/Observation Period|Progressive Disease|0|||
33459298|NCT01332968|101568250|FG005|Maintenance/Observation Period|Progressive Disease|0|||
33459299|NCT01332968|101568251|FG006|Maintenance/Observation Period|Progressive Disease|0|||
33459300|NCT01332968|101568252|FG007|Maintenance/Observation Period|Progressive Disease|0|||
33459301|NCT01332968|101568245|FG000|Maintenance/Observation Period|Protocol Violation|0|||
33459302|NCT01332968|101568246|FG001|Maintenance/Observation Period|Protocol Violation|0|||
33459303|NCT01332968|101568247|FG002|Maintenance/Observation Period|Protocol Violation|1|||
33459304|NCT01332968|101568248|FG003|Maintenance/Observation Period|Protocol Violation|1|||
33459305|NCT01332968|101568249|FG004|Maintenance/Observation Period|Protocol Violation|0|||
33459306|NCT01332968|101568250|FG005|Maintenance/Observation Period|Protocol Violation|0|||
33459307|NCT01332968|101568251|FG006|Maintenance/Observation Period|Protocol Violation|0|||
33459308|NCT01332968|101568252|FG007|Maintenance/Observation Period|Protocol Violation|0|||
33459309|NCT01332968|101568245|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
33459310|NCT01332968|101568246|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
33459311|NCT01332968|101568247|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
33459312|NCT01332968|101568248|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
33459313|NCT01332968|101568249|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
33174923|NCT00818662|100548983|FG003|Overall Study|Withdrawal by Subject|2|||
33174924|NCT00818662|100548980|FG000|Overall Study|Death|1|||
33459314|NCT01332968|101568250|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
33459315|NCT01332968|101568251|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
33459316|NCT01332968|101568252|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
33459317|NCT01332968|101568245|FG000|Follow-Up Period|Adverse Event|0|||
33459318|NCT01332968|101568246|FG001|Follow-Up Period|Adverse Event|0|||
33459319|NCT01332968|101568247|FG002|Follow-Up Period|Adverse Event|0|||
33459320|NCT01332968|101568248|FG003|Follow-Up Period|Adverse Event|0|||
33459321|NCT01332968|101568249|FG004|Follow-Up Period|Adverse Event|0|||
33459322|NCT01332968|101568250|FG005|Follow-Up Period|Adverse Event|0|||
33174925|NCT00818662|100548981|FG001|Overall Study|Death|3|||
33174926|NCT00818662|100548982|FG002|Overall Study|Death|0|||
33174927|NCT00818662|100548983|FG003|Overall Study|Death|0|||
33174928|NCT00818662|100548980|FG000|Overall Study|Physician Decision|1|||
33174929|NCT00818662|100548981|FG001|Overall Study|Physician Decision|0|||
33174930|NCT00818662|100548982|FG002|Overall Study|Physician Decision|0|||
33174931|NCT00818662|100548983|FG003|Overall Study|Physician Decision|0|||
33174932|NCT00818662|100548980|FG000|Overall Study|Lost to Follow-up|0|||
33174933|NCT00818662|100548981|FG001|Overall Study|Lost to Follow-up|0|||
33174934|NCT00818662|100548982|FG002|Overall Study|Lost to Follow-up|0|||
33174935|NCT00818662|100548983|FG003|Overall Study|Lost to Follow-up|1|||
33174936|NCT00818662|100548980|FG000|Overall Study|Unwilling or Unable to Participate|4|||
33174937|NCT00818662|100548981|FG001|Overall Study|Unwilling or Unable to Participate|6|||
33174938|NCT00818662|100548982|FG002|Overall Study|Unwilling or Unable to Participate|2|||
33174939|NCT00818662|100548983|FG003|Overall Study|Unwilling or Unable to Participate|4|||
33174940|NCT00818662|100548980|FG000|Overall Study|Protocol Violation|1|||
33174941|NCT00818662|100548981|FG001|Overall Study|Protocol Violation|1|||
33174942|NCT00818662|100548982|FG002|Overall Study|Protocol Violation|0|||
33174943|NCT00818662|100548983|FG003|Overall Study|Protocol Violation|0|||
33174944|NCT00818662|100548980|FG000|Overall Study|Requires a Prohibited Medication|1|||
33174945|NCT00818662|100548981|FG001|Overall Study|Requires a Prohibited Medication|0|||
33174946|NCT00818662|100548982|FG002|Overall Study|Requires a Prohibited Medication|0|||
33174947|NCT00818662|100548983|FG003|Overall Study|Requires a Prohibited Medication|0|||
33174948|NCT00818662|100548980|FG000|Overall Study|Safety Risk|1|||
33174949|NCT00818662|100548981|FG001|Overall Study|Safety Risk|1|||
33174950|NCT00818662|100548982|FG002|Overall Study|Safety Risk|0|||
33174951|NCT00818662|100548983|FG003|Overall Study|Safety Risk|1|||
33174952|NCT00818662|100548980|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
33174953|NCT00818662|100548981|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
33174954|NCT00818662|100548982|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
33174955|NCT00818662|100548983|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
33174956|NCT00818662|100548980|FG000|Overall Study|Participant's health declined|0|||
33459323|NCT01332968|101568251|FG006|Follow-Up Period|Adverse Event|0|||
33459324|NCT01332968|101568252|FG007|Follow-Up Period|Adverse Event|4|||
33174957|NCT00818662|100548981|FG001|Overall Study|Participant's health declined|0|||
33174958|NCT00818662|100548982|FG002|Overall Study|Participant's health declined|0|||
33459325|NCT01332968|101568245|FG000|Follow-Up Period|Death|0|||
33459326|NCT01332968|101568246|FG001|Follow-Up Period|Death|0|||
33174959|NCT00818662|100548983|FG003|Overall Study|Participant's health declined|1|||
33174960|NCT00818662|100548980|FG000|Overall Study|Caregiver to pursue other treatment|0|||
33459327|NCT01332968|101568247|FG002|Follow-Up Period|Death|0|||
33174961|NCT00818662|100548981|FG001|Overall Study|Caregiver to pursue other treatment|1|||
33174962|NCT00818662|100548982|FG002|Overall Study|Caregiver to pursue other treatment|0|||
33174963|NCT00818662|100548983|FG003|Overall Study|Caregiver to pursue other treatment|0|||
33174964|NCT00818662|100548980|FG000|Overall Study|Moving out of state|0|||
33174965|NCT00818662|100548981|FG001|Overall Study|Moving out of state|0|||
33174966|NCT00818662|100548982|FG002|Overall Study|Moving out of state|0|||
33174967|NCT00818662|100548983|FG003|Overall Study|Moving out of state|1|||
33174968|NCT00818662|100548980|FG000|Overall Study|Declined move to another study site|1|||
33174969|NCT00818662|100548981|FG001|Overall Study|Declined move to another study site|0|||
33174970|NCT00818662|100548982|FG002|Overall Study|Declined move to another study site|0|||
33174971|NCT00818662|100548983|FG003|Overall Study|Declined move to another study site|0|||
33174972|NCT00818662|100548980|FG000|Overall Study|Change in living situation|0|||
33174973|NCT00818662|100548981|FG001|Overall Study|Change in living situation|0|||
33174974|NCT00818662|100548982|FG002|Overall Study|Change in living situation|0|||
33174975|NCT00818662|100548983|FG003|Overall Study|Change in living situation|1|||
33174976|NCT00818662|100548980|FG000|Overall Study|Study partner decision|0|||
33174977|NCT00818662|100548981|FG001|Overall Study|Study partner decision|0|||
33262744|NCT05580003|100863751|FG003|Part 2 (up to 10 Days)|Other|0|||
33262745|NCT05580003|100863752|FG004|Part 2 (up to 10 Days)|Other|0|||
33262746|NCT05580003|100863753|FG005|Part 2 (up to 10 Days)|Other|0|||
33262747|NCT05580003|100863754|FG006|Part 2 (up to 10 Days)|Other|0|||
33262748|NCT05580003|100863755|FG007|Part 2 (up to 10 Days)|Other|0|||
33262749|NCT05580003|100863756|FG008|Part 2 (up to 10 Days)|Other|0|||
33262750|NCT05580003|100863757|FG009|Part 2 (up to 10 Days)|Other|1|||
33262751|NCT05580003|100863758|FG010|Part 2 (up to 10 Days)|Other|0|||
33262752|NCT05580003|100863759|FG011|Part 2 (up to 10 Days)|Other|0|||
33262753|NCT05580003|100863760|FG012|Part 2 (up to 10 Days)|Other|0|||
33174978|NCT00818662|100548982|FG002|Overall Study|Study partner decision|0|||
33174979|NCT00818662|100548983|FG003|Overall Study|Study partner decision|1|||
33262754|NCT05580003|100863761|FG013|Part 2 (up to 10 Days)|Other|0|||
33262755|NCT05580003|100863762|FG014|Part 2 (up to 10 Days)|Other|0|||
33174980|NCT00818662|100548980|FG000|Overall Study|Admitted to long term nursing care|0|||
33262756|NCT05580003|100863763|FG015|Part 2 (up to 10 Days)|Other|0|||
33262757|NCT05580003|100863764|FG016|Part 2 (up to 10 Days)|Other|0|||
33459328|NCT01332968|101568248|FG003|Follow-Up Period|Death|0|||
33459329|NCT01332968|101568249|FG004|Follow-Up Period|Death|0|||
33459330|NCT01332968|101568250|FG005|Follow-Up Period|Death|0|||
33459331|NCT01332968|101568251|FG006|Follow-Up Period|Death|27|||
33174981|NCT00818662|100548981|FG001|Overall Study|Admitted to long term nursing care|1|||
33174982|NCT00818662|100548982|FG002|Overall Study|Admitted to long term nursing care|0|||
33174983|NCT00818662|100548983|FG003|Overall Study|Admitted to long term nursing care|0|||
33174984|NCT03518073|100548985|FG000|Overall Study|Adverse Event|2|||
33174985|NCT03518073|100548986|FG001|Overall Study|Adverse Event|4|||
33174986|NCT03518073|100548987|FG002|Overall Study|Adverse Event|2|||
33174987|NCT03518073|100548985|FG000|Overall Study|Death|2|||
33174988|NCT03518073|100548986|FG001|Overall Study|Death|1|||
33174989|NCT03518073|100548987|FG002|Overall Study|Death|3|||
33174990|NCT03518073|100548985|FG000|Overall Study|Lost to Follow-up|1|||
33174991|NCT03518073|100548986|FG001|Overall Study|Lost to Follow-up|0|||
33174992|NCT03518073|100548987|FG002|Overall Study|Lost to Follow-up|1|||
33174993|NCT03518073|100548985|FG000|Overall Study|Physician Decision|5|||
33174994|NCT03518073|100548986|FG001|Overall Study|Physician Decision|0|||
33174995|NCT03518073|100548987|FG002|Overall Study|Physician Decision|2|||
33174996|NCT03518073|100548985|FG000|Overall Study|Progressive disease|1|||
33174997|NCT03518073|100548986|FG001|Overall Study|Progressive disease|1|||
33174998|NCT03518073|100548987|FG002|Overall Study|Progressive disease|1|||
33174999|NCT03518073|100548985|FG000|Overall Study|Protocol Violation|1|||
33459332|NCT01332968|101568252|FG007|Follow-Up Period|Death|30|||
33459333|NCT01332968|101568245|FG000|Follow-Up Period|Lost to Follow-up|0|||
33175000|NCT03518073|100548986|FG001|Overall Study|Protocol Violation|0|||
33175001|NCT03518073|100548987|FG002|Overall Study|Protocol Violation|0|||
33175002|NCT03518073|100548985|FG000|Overall Study|Withdrawal by Subject|30|||
33175003|NCT03518073|100548986|FG001|Overall Study|Withdrawal by Subject|34|||
33175004|NCT03518073|100548987|FG002|Overall Study|Withdrawal by Subject|29|||
33175005|NCT03518073|100548985|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
33175006|NCT03518073|100548986|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
33175007|NCT03518073|100548987|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
33175008|NCT03518073|100548985|FG000|Overall Study|Covid-19|1|||
33175009|NCT03518073|100548986|FG001|Overall Study|Covid-19|2|||
33175010|NCT03518073|100548987|FG002|Overall Study|Covid-19|1|||
33175011|NCT02733367|100548988|FG000|Overall Study|Withdrawal by Subject|6|||
33175012|NCT00143403|100548989|FG000|Overall Study|Adverse Event|3|||
33175013|NCT00143403|100548990|FG001|Overall Study|Adverse Event|8|||
33175014|NCT00143403|100548989|FG000|Overall Study|Death|1|||
33175015|NCT00143403|100548990|FG001|Overall Study|Death|0|||
33175016|NCT00143403|100548989|FG000|Overall Study|Withdrawal by Subject|3|||
33459334|NCT01332968|101568246|FG001|Follow-Up Period|Lost to Follow-up|0|||
33459335|NCT01332968|101568247|FG002|Follow-Up Period|Lost to Follow-up|0|||
33459336|NCT01332968|101568248|FG003|Follow-Up Period|Lost to Follow-up|0|||
33459337|NCT01332968|101568249|FG004|Follow-Up Period|Lost to Follow-up|0|||
33459338|NCT01332968|101568250|FG005|Follow-Up Period|Lost to Follow-up|0|||
33459339|NCT01332968|101568251|FG006|Follow-Up Period|Lost to Follow-up|11|||
33459340|NCT01332968|101568252|FG007|Follow-Up Period|Lost to Follow-up|15|||
33459341|NCT01332968|101568245|FG000|Follow-Up Period|Non-compliance|0|||
33459342|NCT01332968|101568246|FG001|Follow-Up Period|Non-compliance|0|||
33459343|NCT01332968|101568247|FG002|Follow-Up Period|Non-compliance|0|||
33459344|NCT01332968|101568248|FG003|Follow-Up Period|Non-compliance|0|||
33459345|NCT01332968|101568249|FG004|Follow-Up Period|Non-compliance|0|||
33459346|NCT01332968|101568250|FG005|Follow-Up Period|Non-compliance|0|||
33459347|NCT01332968|101568251|FG006|Follow-Up Period|Non-compliance|4|||
33459348|NCT01332968|101568252|FG007|Follow-Up Period|Non-compliance|9|||
33459349|NCT01332968|101568245|FG000|Follow-Up Period|Other|0|||
33459350|NCT01332968|101568246|FG001|Follow-Up Period|Other|0|||
33459351|NCT01332968|101568247|FG002|Follow-Up Period|Other|0|||
33459352|NCT01332968|101568248|FG003|Follow-Up Period|Other|0|||
33459353|NCT01332968|101568249|FG004|Follow-Up Period|Other|0|||
33459354|NCT01332968|101568250|FG005|Follow-Up Period|Other|0|||
33459355|NCT01332968|101568251|FG006|Follow-Up Period|Other|18|||
33459356|NCT01332968|101568252|FG007|Follow-Up Period|Other|21|||
33459357|NCT01332968|101568245|FG000|Follow-Up Period|Physician Decision|0|||
33459358|NCT01332968|101568246|FG001|Follow-Up Period|Physician Decision|0|||
33459359|NCT01332968|101568247|FG002|Follow-Up Period|Physician Decision|0|||
33459360|NCT01332968|101568248|FG003|Follow-Up Period|Physician Decision|0|||
33459361|NCT01332968|101568249|FG004|Follow-Up Period|Physician Decision|0|||
33459362|NCT01332968|101568250|FG005|Follow-Up Period|Physician Decision|0|||
33459363|NCT01332968|101568251|FG006|Follow-Up Period|Physician Decision|12|||
33459364|NCT01332968|101568252|FG007|Follow-Up Period|Physician Decision|15|||
33459365|NCT01332968|101568245|FG000|Follow-Up Period|Progressive Disease|0|||
33459366|NCT01332968|101568246|FG001|Follow-Up Period|Progressive Disease|0|||
33459367|NCT01332968|101568247|FG002|Follow-Up Period|Progressive Disease|0|||
33459368|NCT01332968|101568248|FG003|Follow-Up Period|Progressive Disease|0|||
33459369|NCT01332968|101568249|FG004|Follow-Up Period|Progressive Disease|0|||
33459370|NCT01332968|101568250|FG005|Follow-Up Period|Progressive Disease|0|||
33459371|NCT01332968|101568251|FG006|Follow-Up Period|Progressive Disease|126|||
33459372|NCT01332968|101568252|FG007|Follow-Up Period|Progressive Disease|106|||
33175017|NCT00143403|100548990|FG001|Overall Study|Withdrawal by Subject|12|||
33459373|NCT01332968|101568245|FG000|Follow-Up Period|Protocol Violation|0|||
33459374|NCT01332968|101568246|FG001|Follow-Up Period|Protocol Violation|0|||
33459375|NCT01332968|101568247|FG002|Follow-Up Period|Protocol Violation|0|||
33459376|NCT01332968|101568248|FG003|Follow-Up Period|Protocol Violation|0|||
33459377|NCT01332968|101568249|FG004|Follow-Up Period|Protocol Violation|0|||
33175018|NCT00143403|100548989|FG000|Overall Study|Relapse|15|||
33175019|NCT00143403|100548990|FG001|Overall Study|Relapse|7|||
33459378|NCT01332968|101568250|FG005|Follow-Up Period|Protocol Violation|0|||
33175020|NCT00143403|100548989|FG000|Overall Study|Protocol Violation|2|||
33175021|NCT00143403|100548990|FG001|Overall Study|Protocol Violation|2|||
33175022|NCT00143403|100548989|FG000|Overall Study|specified by site|4|||
33175023|NCT00143403|100548990|FG001|Overall Study|specified by site|9|||
33175024|NCT00143403|100548989|FG000|Overall Study|Randomized Not Treated|7|||
33175025|NCT00143403|100548990|FG001|Overall Study|Randomized Not Treated|8|||
33175026|NCT02953314|100548991|FG000|Overall Study|Adverse Event|0|||
33175027|NCT02953314|100548992|FG001|Overall Study|Adverse Event|1|||
33175028|NCT02953314|100548991|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
33175029|NCT02953314|100548992|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
33175030|NCT00498602|100548993|FG000|Overall Study|Death|0|||
33175031|NCT00498602|100548994|FG001|Overall Study|Death|0|||
33175032|NCT00498602|100548995|FG002|Overall Study|Death|0|||
33175033|NCT00498602|100548996|FG003|Overall Study|Death|0|||
33175034|NCT00498602|100548997|FG004|Overall Study|Death|0|||
33459379|NCT01332968|101568251|FG006|Follow-Up Period|Protocol Violation|1|||
33459380|NCT01332968|101568252|FG007|Follow-Up Period|Protocol Violation|0|||
33459381|NCT01332968|101568245|FG000|Follow-Up Period|Withdrawal by Subject|0|||
33175035|NCT00498602|100548998|FG005|Overall Study|Death|1|||
33175036|NCT00498602|100548999|FG006|Overall Study|Death|0|||
33459382|NCT01332968|101568246|FG001|Follow-Up Period|Withdrawal by Subject|0|||
33459383|NCT01332968|101568247|FG002|Follow-Up Period|Withdrawal by Subject|0|||
33459384|NCT01332968|101568248|FG003|Follow-Up Period|Withdrawal by Subject|0|||
33459385|NCT01332968|101568249|FG004|Follow-Up Period|Withdrawal by Subject|0|||
33459386|NCT01332968|101568250|FG005|Follow-Up Period|Withdrawal by Subject|0|||
33459387|NCT01332968|101568251|FG006|Follow-Up Period|Withdrawal by Subject|29|||
33459388|NCT01332968|101568252|FG007|Follow-Up Period|Withdrawal by Subject|32|||
33459389|NCT01332968|101568245|FG000|Follow-Up Period|No reason provided|0|||
33459390|NCT01332968|101568246|FG001|Follow-Up Period|No reason provided|0|||
33459391|NCT01332968|101568247|FG002|Follow-Up Period|No reason provided|0|||
33459392|NCT01332968|101568248|FG003|Follow-Up Period|No reason provided|0|||
33459393|NCT01332968|101568249|FG004|Follow-Up Period|No reason provided|0|||
33459394|NCT01332968|101568250|FG005|Follow-Up Period|No reason provided|0|||
33459395|NCT01332968|101568251|FG006|Follow-Up Period|No reason provided|2|||
33459396|NCT01332968|101568252|FG007|Follow-Up Period|No reason provided|3|||
33459397|NCT03868631|101568255|FG000|Baseline to Week 6|Adverse Event|0|||
33459398|NCT03868631|101568256|FG001|Baseline to Week 6|Adverse Event|3|||
33459399|NCT03868631|101568255|FG000|Baseline to Week 6|Protocol Violation|1|||
33459400|NCT03868631|101568256|FG001|Baseline to Week 6|Protocol Violation|1|||
33459401|NCT03868631|101568255|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
33459402|NCT03868631|101568256|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
33459403|NCT03868631|101568255|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
33459404|NCT03868631|101568256|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
33459405|NCT03868631|101568255|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
33459406|NCT03868631|101568256|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
33459407|NCT03868631|101568255|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
33459408|NCT03868631|101568256|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
33459409|NCT01853176|101570575|FG000|Overall Study|Study terminated|4|||
33459410|NCT01853176|101570576|FG001|Overall Study|Study terminated|0|||
33459411|NCT03168906|101570578|FG000|Overall Study|Lack of Efficacy|6|||
33459412|NCT03168906|101570579|FG001|Overall Study|Lack of Efficacy|6|||
33459413|NCT04158687|101570582|FG000|Overall Study|Adverse Event|2|||
33459414|NCT04158687|101570583|FG001|Overall Study|Adverse Event|3|||
33459415|NCT04158687|101570584|FG002|Overall Study|Adverse Event|0|||
33459416|NCT04158687|101570585|FG003|Overall Study|Adverse Event|3|||
33459417|NCT04158687|101570582|FG000|Overall Study|Lost to Follow-up|5|||
33459418|NCT04158687|101570583|FG001|Overall Study|Lost to Follow-up|12|||
33459419|NCT04158687|101570584|FG002|Overall Study|Lost to Follow-up|4|||
33175037|NCT00498602|100548993|FG000|Overall Study|Lack of Efficacy|1|||
33175038|NCT00498602|100548994|FG001|Overall Study|Lack of Efficacy|0|||
33175039|NCT00498602|100548995|FG002|Overall Study|Lack of Efficacy|0|||
33175040|NCT00498602|100548996|FG003|Overall Study|Lack of Efficacy|0|||
33175041|NCT00498602|100548997|FG004|Overall Study|Lack of Efficacy|0|||
33459420|NCT04158687|101570585|FG003|Overall Study|Lost to Follow-up|5|||
33459421|NCT04158687|101570582|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
33459422|NCT04158687|101570583|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
33459423|NCT04158687|101570584|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
33459424|NCT04158687|101570585|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
33459425|NCT04158687|101570582|FG000|Overall Study|Non-Compliance with Study Medication|2|||
33175042|NCT00498602|100548998|FG005|Overall Study|Lack of Efficacy|0|||
33175043|NCT00498602|100548999|FG006|Overall Study|Lack of Efficacy|0|||
33175044|NCT00498602|100548993|FG000|Overall Study|Lost to Follow-up|0|||
33459426|NCT04158687|101570583|FG001|Overall Study|Non-Compliance with Study Medication|2|||
33459427|NCT04158687|101570584|FG002|Overall Study|Non-Compliance with Study Medication|3|||
33459428|NCT04158687|101570585|FG003|Overall Study|Non-Compliance with Study Medication|0|||
33459429|NCT04158687|101570582|FG000|Overall Study|Investigator Decision|0|||
33459430|NCT04158687|101570583|FG001|Overall Study|Investigator Decision|0|||
33459431|NCT04158687|101570584|FG002|Overall Study|Investigator Decision|2|||
33459432|NCT04158687|101570585|FG003|Overall Study|Investigator Decision|0|||
33459433|NCT04158687|101570582|FG000|Overall Study|Protocol Violation|0|||
33459434|NCT04158687|101570583|FG001|Overall Study|Protocol Violation|2|||
33459435|NCT04158687|101570584|FG002|Overall Study|Protocol Violation|1|||
33459436|NCT04158687|101570585|FG003|Overall Study|Protocol Violation|0|||
33459437|NCT04158687|101570582|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
33459438|NCT04158687|101570583|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
33459439|NCT04158687|101570584|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
33459440|NCT04158687|101570585|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
33459441|NCT04158687|101570582|FG000|Overall Study|Reason not Specified|3|||
33459442|NCT04158687|101570583|FG001|Overall Study|Reason not Specified|2|||
33459443|NCT04158687|101570584|FG002|Overall Study|Reason not Specified|4|||
33459444|NCT04158687|101570585|FG003|Overall Study|Reason not Specified|4|||
33459445|NCT00381849|101570586|FG000|Wash Out|Withdrawal by Subject|0|||
33459446|NCT00381849|101570587|FG001|Wash Out|Withdrawal by Subject|1|||
33459447|NCT00398073|101570588|FG000|Overall Study|Withdrawal by Subject|1|||
33459448|NCT00398073|101570589|FG001|Overall Study|Withdrawal by Subject|0|||
33459449|NCT03920280|101570596|FG000|Overall Study|Adverse Event|2|||
33459450|NCT03920280|101570597|FG001|Overall Study|Adverse Event|3|||
33459451|NCT03920280|101570596|FG000|Overall Study|Lost to Follow-up|0|||
33459452|NCT03920280|101570597|FG001|Overall Study|Lost to Follow-up|1|||
33459453|NCT03920280|101570596|FG000|Overall Study|Withdrawal by Subject|1|||
33459454|NCT03920280|101570597|FG001|Overall Study|Withdrawal by Subject|1|||
33459455|NCT03920280|101570596|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
33459456|NCT03920280|101570597|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
33459457|NCT03023137|101570598|FG000|Overall Study|Multiple pregnancy|2|||
33459458|NCT03023137|101570599|FG001|Overall Study|Multiple pregnancy|4|||
33459459|NCT03023137|101570598|FG000|Overall Study|Lost to Follow-up|1|||
33459460|NCT03023137|101570599|FG001|Overall Study|Lost to Follow-up|1|||
33459461|NCT03023137|101570598|FG000|Overall Study|Protocol Violation|0|||
33459462|NCT03023137|101570599|FG001|Overall Study|Protocol Violation|4|||
33459463|NCT03023137|101570598|FG000|Overall Study|Lost the baby in a car accident|1|||
33459464|NCT03023137|101570599|FG001|Overall Study|Lost the baby in a car accident|0|||
33459465|NCT02328040|101570600|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
33459466|NCT02328040|101570601|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
33459467|NCT02834390|101570605|FG000|Induction Phase|Progressive disease|0|||
33459468|NCT02834390|101570606|FG001|Induction Phase|Progressive disease|1|||
33459469|NCT02834390|101570605|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
33459470|NCT02834390|101570606|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
33459471|NCT02834390|101570605|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
33459472|NCT02834390|101570606|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
33459473|NCT02834390|101570605|FG000|Consolidation Phase|Physician Decision|1|||
33459474|NCT02834390|101570606|FG001|Consolidation Phase|Physician Decision|1|||
33459475|NCT04449341|101570610|FG000|Overall Study|Protocol Violation|1|||
33459476|NCT04449341|101570611|FG001|Overall Study|Protocol Violation|0|||
33262758|NCT05580003|100863765|FG017|Part 2 (up to 10 Days)|Other|0|||
33262759|NCT05580003|100863766|FG018|Part 2 (up to 10 Days)|Other|0|||
33262760|NCT05580003|100863767|FG019|Part 2 (up to 10 Days)|Other|0|||
33459477|NCT00654641|101570614|FG000|Overall Study|Lost to Follow-up|2|||
33459478|NCT00654641|101570615|FG001|Overall Study|Lost to Follow-up|3|||
33459479|NCT02786927|101570616|FG000|Overall Study|Adverse Event|1|||
33459480|NCT02786927|101570616|FG000|Overall Study|Protocol Violation|4|||
33459481|NCT04729101|101570620|FG000|Overall Study|Adverse Event|1|||
33459482|NCT04729101|101570621|FG001|Overall Study|Adverse Event|0|||
33459483|NCT04729101|101570620|FG000|Overall Study|Physician Decision|1|||
33459484|NCT04729101|101570621|FG001|Overall Study|Physician Decision|0|||
33459485|NCT04729101|101570620|FG000|Overall Study|Withdrawal by Subject|1|||
33459486|NCT04729101|101570621|FG001|Overall Study|Withdrawal by Subject|0|||
33459487|NCT05263505|101570622|FG000|Overall Study|Adverse Event|0|||
33459488|NCT05263505|101570623|FG001|Overall Study|Adverse Event|1|||
33262761|NCT05580003|100863768|FG020|Part 2 (up to 10 Days)|Other|0|||
33459489|NCT00725764|101570626|FG000|Overall Study|Withdrawal by Subject|2|||
33459490|NCT00725764|101570626|FG000|Overall Study|Physician Decision|1|||
33459491|NCT00725764|101570626|FG000|Overall Study|Progressive Disease|7|||
33459492|NCT00725764|101570626|FG000|Overall Study|Lost to Follow-up|1|||
33459493|NCT00725764|101570626|FG000|Overall Study|Death|1|||
33175045|NCT00498602|100548994|FG001|Overall Study|Lost to Follow-up|2|||
33175046|NCT00498602|100548995|FG002|Overall Study|Lost to Follow-up|0|||
33175047|NCT00498602|100548996|FG003|Overall Study|Lost to Follow-up|2|||
33459494|NCT00725764|101570626|FG000|Overall Study|Participant non compliant with protocol|1|||
33459495|NCT00725764|101570626|FG000|Overall Study|Decline in performance status|1|||
33459496|NCT02888743|101570627|FG000|Overall Study|Withdrawal by Subject|1|||
33459497|NCT02888743|101570628|FG001|Overall Study|Withdrawal by Subject|2|||
33459498|NCT02888743|101570629|FG002|Overall Study|Withdrawal by Subject|2|||
33459499|NCT02888743|101570630|FG003|Overall Study|Withdrawal by Subject|0|||
33459500|NCT02888743|101570631|FG004|Overall Study|Withdrawal by Subject|1|||
33459501|NCT02888743|101570627|FG000|Overall Study|Disease progression before treatment|2|||
33459502|NCT02888743|101570628|FG001|Overall Study|Disease progression before treatment|0|||
33459503|NCT02888743|101570629|FG002|Overall Study|Disease progression before treatment|2|||
33459504|NCT02888743|101570630|FG003|Overall Study|Disease progression before treatment|0|||
33459505|NCT02888743|101570631|FG004|Overall Study|Disease progression before treatment|0|||
33459506|NCT02888743|101570627|FG000|Overall Study|Patient ineligible|1|||
33459507|NCT02888743|101570628|FG001|Overall Study|Patient ineligible|2|||
33459508|NCT02888743|101570629|FG002|Overall Study|Patient ineligible|0|||
33459509|NCT02888743|101570630|FG003|Overall Study|Patient ineligible|0|||
33459510|NCT02888743|101570631|FG004|Overall Study|Patient ineligible|0|||
33459511|NCT01691612|101570632|FG000|Overall Study|deemed ineligible after 1st visit|6|||
33459512|NCT01691612|101570632|FG000|Overall Study|Adverse Event|1|||
33459513|NCT05258630|101570633|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
33459514|NCT05258630|101570634|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
33459515|NCT05258630|101570633|FG000|Overall Study|Lost to Follow-up|0|||
33459516|NCT05258630|101570634|FG001|Overall Study|Lost to Follow-up|2|||
33459517|NCT01044433|101570646|FG000|Overall Study|Lost to Follow-up|3|||
33459518|NCT01044433|101570646|FG000|Overall Study|Withdrawal by Subject|3|||
33459519|NCT03105297|101570649|FG000|Baseline Phase (Day 1)|Other|21|||
33459520|NCT03105297|101570649|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
33459521|NCT03105297|101570649|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
33459522|NCT02697617|101570654|FG000|Overall Study|Withdrawal by Subject|0|||
33459523|NCT02697617|101570655|FG001|Overall Study|Withdrawal by Subject|2|||
33459524|NCT02697617|101570654|FG000|Overall Study|Pregnancy|1|||
33459525|NCT02697617|101570655|FG001|Overall Study|Pregnancy|0|||
33459526|NCT01824576|101570656|FG000|Overall Study|Device deficiency|2|||
33459527|NCT03358147|101570657|FG000|Overall Study|Withdrawal by Subject|13|||
33459528|NCT03358147|101570658|FG001|Overall Study|Withdrawal by Subject|19|||
33175048|NCT00498602|100548997|FG004|Overall Study|Lost to Follow-up|0|||
33175049|NCT00498602|100548998|FG005|Overall Study|Lost to Follow-up|0|||
33262762|NCT05580003|100863769|FG021|Part 2 (up to 10 Days)|Other|0|||
33459529|NCT03358147|101570659|FG002|Overall Study|Withdrawal by Subject|16|||
33459530|NCT03358147|101570660|FG003|Overall Study|Withdrawal by Subject|10|||
33459531|NCT03358147|101570661|FG004|Overall Study|Withdrawal by Subject|5|||
33459532|NCT03358147|101570657|FG000|Overall Study|Adverse Event|3|||
33459533|NCT03358147|101570658|FG001|Overall Study|Adverse Event|9|||
33459534|NCT03358147|101570659|FG002|Overall Study|Adverse Event|7|||
33459535|NCT03358147|101570660|FG003|Overall Study|Adverse Event|5|||
33175050|NCT00498602|100548999|FG006|Overall Study|Lost to Follow-up|0|||
33459536|NCT03358147|101570661|FG004|Overall Study|Adverse Event|2|||
33459537|NCT03358147|101570657|FG000|Overall Study|Lost to Follow-up|4|||
33459538|NCT03358147|101570658|FG001|Overall Study|Lost to Follow-up|3|||
33459539|NCT03358147|101570659|FG002|Overall Study|Lost to Follow-up|7|||
33459540|NCT03358147|101570660|FG003|Overall Study|Lost to Follow-up|6|||
33459541|NCT03358147|101570661|FG004|Overall Study|Lost to Follow-up|4|||
33459542|NCT03358147|101570657|FG000|Overall Study|Major Protocol Deviation|11|||
33459543|NCT03358147|101570658|FG001|Overall Study|Major Protocol Deviation|3|||
33459544|NCT03358147|101570659|FG002|Overall Study|Major Protocol Deviation|2|||
33459545|NCT03358147|101570660|FG003|Overall Study|Major Protocol Deviation|3|||
33459546|NCT03358147|101570661|FG004|Overall Study|Major Protocol Deviation|1|||
33459547|NCT03358147|101570657|FG000|Overall Study|Protocol specified criteria|2|||
33459548|NCT03358147|101570658|FG001|Overall Study|Protocol specified criteria|3|||
33459549|NCT03358147|101570659|FG002|Overall Study|Protocol specified criteria|0|||
33459550|NCT03358147|101570660|FG003|Overall Study|Protocol specified criteria|3|||
33459551|NCT03358147|101570661|FG004|Overall Study|Protocol specified criteria|1|||
33459552|NCT03358147|101570657|FG000|Overall Study|Physician Decision|1|||
33459553|NCT03358147|101570658|FG001|Overall Study|Physician Decision|0|||
33459554|NCT03358147|101570659|FG002|Overall Study|Physician Decision|1|||
33459555|NCT03358147|101570660|FG003|Overall Study|Physician Decision|6|||
33459556|NCT03358147|101570661|FG004|Overall Study|Physician Decision|1|||
33459557|NCT03358147|101570657|FG000|Overall Study|Administrative reasons|0|||
33459558|NCT03358147|101570658|FG001|Overall Study|Administrative reasons|1|||
33459559|NCT03358147|101570659|FG002|Overall Study|Administrative reasons|0|||
33459560|NCT03358147|101570660|FG003|Overall Study|Administrative reasons|3|||
33459561|NCT03358147|101570661|FG004|Overall Study|Administrative reasons|0|||
33459562|NCT03358147|101570657|FG000|Overall Study|Lack of Efficacy|0|||
33459563|NCT03358147|101570658|FG001|Overall Study|Lack of Efficacy|1|||
33459564|NCT03358147|101570659|FG002|Overall Study|Lack of Efficacy|1|||
33459565|NCT03358147|101570660|FG003|Overall Study|Lack of Efficacy|0|||
33459566|NCT03358147|101570661|FG004|Overall Study|Lack of Efficacy|0|||
33459567|NCT00691704|101570662|FG000|Induction Therapy|Disease Progression|1|||
33459568|NCT00691704|101570662|FG000|Induction Therapy|Active Hepatitis|1|||
33459569|NCT00691704|101570662|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
33459570|NCT00691704|101570662|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
33459571|NCT00691704|101570662|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
33459572|NCT01214239|101570663|FG000|Overall Study|Adverse Event|3|||
33459573|NCT01214239|101570664|FG001|Overall Study|Adverse Event|4|||
33459574|NCT01214239|101570663|FG000|Overall Study|Protocol Violation|2|||
33459575|NCT01214239|101570664|FG001|Overall Study|Protocol Violation|1|||
33459576|NCT01214239|101570663|FG000|Overall Study|Lost to Follow-up|1|||
33459577|NCT01214239|101570664|FG001|Overall Study|Lost to Follow-up|1|||
33459578|NCT01214239|101570663|FG000|Overall Study|Withdrawal by Subject|4|||
33459579|NCT01214239|101570664|FG001|Overall Study|Withdrawal by Subject|9|||
33459580|NCT01214239|101570663|FG000|Overall Study|Lack of Efficacy|1|||
33459581|NCT01214239|101570664|FG001|Overall Study|Lack of Efficacy|2|||
33459582|NCT01214239|101570663|FG000|Overall Study|patient's private reason|1|||
33459583|NCT01214239|101570664|FG001|Overall Study|patient's private reason|1|||
33459584|NCT00377156|101570665|FG000|Overall Study|Death|23|||
33459585|NCT00377156|101570666|FG001|Overall Study|Death|19|||
33459586|NCT00377156|101570665|FG000|Overall Study|Withdrawal by Subject|16|||
33459587|NCT00377156|101570666|FG001|Overall Study|Withdrawal by Subject|24|||
33459588|NCT00377156|101570665|FG000|Overall Study|Had follow-up <90 d|3|||
33459589|NCT00377156|101570666|FG001|Overall Study|Had follow-up <90 d|6|||
33459590|NCT00377156|101570665|FG000|Overall Study|Cancellation|1|||
33459591|NCT00377156|101570666|FG001|Overall Study|Cancellation|0|||
33459592|NCT00377156|101570665|FG000|Overall Study|Refused testing|0|||
33459593|NCT00377156|101570666|FG001|Overall Study|Refused testing|1|||
33459594|NCT00377156|101570665|FG000|Overall Study|Ineligible|0|||
33459595|NCT00377156|101570666|FG001|Overall Study|Ineligible|1|||
33459596|NCT00377156|101570665|FG000|Overall Study|Disability or language problem|0|||
33459597|NCT00377156|101570666|FG001|Overall Study|Disability or language problem|1|||
33459598|NCT00377156|101570665|FG000|Overall Study|Other|5|||
33459599|NCT00377156|101570666|FG001|Overall Study|Other|2|||
33459600|NCT00926367|101570667|FG000|Overall Study|Withdrawal by Subject|0|||
33459601|NCT00926367|101570668|FG001|Overall Study|Withdrawal by Subject|1|||
33459602|NCT00926367|101570667|FG000|Overall Study|Lost to Follow-up|1|||
33459603|NCT00926367|101570668|FG001|Overall Study|Lost to Follow-up|0|||
33459604|NCT00926367|101570667|FG000|Overall Study|Skin Irritation|1|||
33459605|NCT00926367|101570668|FG001|Overall Study|Skin Irritation|2|||
33459606|NCT01557751|101570675|FG000|Overall Study|Physician Decision|3|||
33459607|NCT04194151|101570680|FG000|Overall Study|Physician Decision|1|||
33459608|NCT04194151|101570681|FG001|Overall Study|Physician Decision|1|||
33459609|NCT04194151|101570682|FG002|Overall Study|Physician Decision|1|||
33459610|NCT04194151|101570683|FG003|Overall Study|Physician Decision|1|||
33459611|NCT04194151|101570684|FG004|Overall Study|Physician Decision|0|||
33459612|NCT04194151|101570685|FG005|Overall Study|Physician Decision|1|||
33459613|NCT04194151|101570680|FG000|Overall Study|Monitorization problem|0|||
33459614|NCT04194151|101570681|FG001|Overall Study|Monitorization problem|1|||
33459615|NCT04194151|101570682|FG002|Overall Study|Monitorization problem|0|||
33459616|NCT04194151|101570683|FG003|Overall Study|Monitorization problem|0|||
33459617|NCT04194151|101570684|FG004|Overall Study|Monitorization problem|0|||
33459618|NCT04194151|101570685|FG005|Overall Study|Monitorization problem|0|||
33459619|NCT02005562|101570686|FG000|Overall Study|Death|2|||
33459620|NCT02005562|101570687|FG001|Overall Study|Death|2|||
33459621|NCT02005562|101570686|FG000|Overall Study|Graft loss|7|||
33459622|NCT02005562|101570687|FG001|Overall Study|Graft loss|6|||
33459623|NCT02005562|101570686|FG000|Overall Study|Withdrawal by Subject|2|||
33459624|NCT02005562|101570687|FG001|Overall Study|Withdrawal by Subject|2|||
33459625|NCT02005562|101570686|FG000|Overall Study|No transplant|1|||
33459626|NCT02005562|101570687|FG001|Overall Study|No transplant|4|||
33459627|NCT02005562|101570686|FG000|Overall Study|Physician Decision|0|||
33459628|NCT02005562|101570687|FG001|Overall Study|Physician Decision|1|||
33459629|NCT00397254|101570688|FG000|Overall Study|Lost to Follow-up|2|||
33459630|NCT00397254|101570689|FG001|Overall Study|Lost to Follow-up|2|||
33459631|NCT02219009|101570692|FG000|Overall Study|Withdrawal by Subject|5|||
33459632|NCT02219009|101570693|FG001|Overall Study|Withdrawal by Subject|1|||
33459633|NCT02219009|101570692|FG000|Overall Study|Adverse Event|2|||
33459634|NCT02219009|101570693|FG001|Overall Study|Adverse Event|4|||
33459635|NCT02219009|101570692|FG000|Overall Study|Lost to Follow-up|2|||
33459636|NCT02219009|101570693|FG001|Overall Study|Lost to Follow-up|2|||
33459637|NCT02219009|101570692|FG000|Overall Study|Protocol deviation|1|||
33459638|NCT02219009|101570693|FG001|Overall Study|Protocol deviation|0|||
33459639|NCT02219009|101570692|FG000|Overall Study|Physician Decision|0|||
33459640|NCT02219009|101570693|FG001|Overall Study|Physician Decision|1|||
33459641|NCT02166606|101570694|FG000|Overall Study|Adverse Event|3|||
33459642|NCT02166606|101570694|FG000|Overall Study|Death|31|||
33459643|NCT02166606|101570694|FG000|Overall Study|Protocol Violation|7|||
33459644|NCT02166606|101570694|FG000|Overall Study|Lost to Follow-up|30|||
33459645|NCT02166606|101570694|FG000|Overall Study|Withdrawal by Subject|1|||
33459646|NCT02166606|101570694|FG000|Overall Study|Physician Decision|1|||
33459647|NCT02166606|101570694|FG000|Overall Study|Device upgrade|1|||
33459648|NCT02166606|101570694|FG000|Overall Study|Enrolled after End of Enrollment|4|||
33459649|NCT03110380|101570695|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
33459650|NCT03110380|101570696|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
33459651|NCT03110380|101570697|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
33459652|NCT03110380|101570698|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
33459653|NCT03110380|101570695|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
33459654|NCT03110380|101570696|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
33459655|NCT03110380|101570697|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33459656|NCT03110380|101570698|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
33459657|NCT03110380|101570695|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
33459658|NCT03110380|101570696|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
33459659|NCT03110380|101570697|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
33459660|NCT03110380|101570698|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
33459661|NCT03110380|101570695|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
33459662|NCT03110380|101570696|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
33459663|NCT03110380|101570697|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
33459664|NCT03110380|101570698|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
33175051|NCT00498602|100548993|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
33175052|NCT00498602|100548994|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
33175053|NCT00498602|100548995|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
33175054|NCT00498602|100548996|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
33175055|NCT00498602|100548997|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
33175056|NCT00498602|100548998|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
33175057|NCT00498602|100548999|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
33175058|NCT00498602|100548993|FG000|Overall Study|AE not related to Study Drug|1|||
33175059|NCT00498602|100548994|FG001|Overall Study|AE not related to Study Drug|3|||
33175060|NCT00498602|100548995|FG002|Overall Study|AE not related to Study Drug|0|||
33175061|NCT00498602|100548996|FG003|Overall Study|AE not related to Study Drug|0|||
33175062|NCT00498602|100548997|FG004|Overall Study|AE not related to Study Drug|2|||
33175063|NCT00498602|100548998|FG005|Overall Study|AE not related to Study Drug|2|||
33175064|NCT00498602|100548999|FG006|Overall Study|AE not related to Study Drug|1|||
33175065|NCT00498602|100548993|FG000|Overall Study|Caregiver Request|2|||
33175066|NCT00498602|100548994|FG001|Overall Study|Caregiver Request|2|||
33175067|NCT00498602|100548995|FG002|Overall Study|Caregiver Request|2|||
33459665|NCT03110380|101570695|FG000|Double-Blind Treatment Phase|Death|2|||
33175068|NCT00498602|100548996|FG003|Overall Study|Caregiver Request|0|||
33459666|NCT03110380|101570696|FG001|Double-Blind Treatment Phase|Death|1|||
33459667|NCT03110380|101570697|FG002|Double-Blind Treatment Phase|Death|0|||
33459668|NCT03110380|101570698|FG003|Double-Blind Treatment Phase|Death|0|||
33459669|NCT03110380|101570695|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
33459670|NCT03110380|101570696|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
33459671|NCT03110380|101570697|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
33459672|NCT03110380|101570698|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
33459673|NCT03110380|101570695|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
33459674|NCT03110380|101570696|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
33459675|NCT03110380|101570697|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
33459676|NCT03110380|101570698|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
33459677|NCT03110380|101570695|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
33459678|NCT03110380|101570696|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
33459679|NCT03110380|101570697|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
33459680|NCT03110380|101570698|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
33459681|NCT03110380|101570695|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
33459682|NCT03110380|101570696|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
33459683|NCT03110380|101570697|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
33459684|NCT03110380|101570698|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
33459685|NCT03110380|101570695|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
33459686|NCT03110380|101570696|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
33459687|NCT03110380|101570697|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
33459688|NCT03110380|101570698|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
33459689|NCT03110380|101570695|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
33459690|NCT03110380|101570696|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
33459691|NCT03110380|101570697|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
33459692|NCT03110380|101570698|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
33459693|NCT02578641|101570699|FG000|Overall Study|Adverse Event|5|||
33459694|NCT02578641|101570700|FG001|Overall Study|Adverse Event|15|||
33459695|NCT02578641|101570699|FG000|Overall Study|Death|16|||
33459696|NCT02578641|101570700|FG001|Overall Study|Death|8|||
33459697|NCT02578641|101570699|FG000|Overall Study|Lost to Follow-up|0|||
33459698|NCT02578641|101570700|FG001|Overall Study|Lost to Follow-up|1|||
33459699|NCT02578641|101570699|FG000|Overall Study|Withdrawal by Subject|14|||
33459700|NCT02578641|101570700|FG001|Overall Study|Withdrawal by Subject|7|||
33459701|NCT02578641|101570699|FG000|Overall Study|Progressive Disease|69|||
33459702|NCT02578641|101570700|FG001|Overall Study|Progressive Disease|21|||
33459703|NCT02578641|101570699|FG000|Overall Study|No Study Drug|2|||
33459704|NCT02578641|101570700|FG001|Overall Study|No Study Drug|0|||
33459705|NCT02578641|101570699|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
33459706|NCT02578641|101570700|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
33459707|NCT02578641|101570699|FG000|Overall Study|Non-compliance with Study Schedule|1|||
33459708|NCT02578641|101570700|FG001|Overall Study|Non-compliance with Study Schedule|0|||
33459709|NCT02578641|101570699|FG000|Overall Study|Other|1|||
33459710|NCT02578641|101570700|FG001|Overall Study|Other|10|||
33459711|NCT02578641|101570699|FG000|Overall Study|Not treated|1|||
33459712|NCT02578641|101570700|FG001|Overall Study|Not treated|4|||
33459713|NCT05692154|101570707|FG000|Overall Study|Adverse Event|0|||
33459714|NCT05692154|101570708|FG001|Overall Study|Adverse Event|1|||
33459715|NCT03496298|101570709|FG000|Overall Study|Adverse Event|49|||
33459716|NCT03496298|101570710|FG001|Overall Study|Adverse Event|68|||
33459717|NCT03496298|101570711|FG002|Overall Study|Adverse Event|79|||
33459718|NCT03496298|101570709|FG000|Overall Study|Study terminated by Sponsor|1050|||
33459719|NCT03496298|101570710|FG001|Overall Study|Study terminated by Sponsor|1063|||
33459720|NCT03496298|101570711|FG002|Overall Study|Study terminated by Sponsor|1071|||
33459721|NCT03496298|101570709|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
33459722|NCT03496298|101570710|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
33459723|NCT03496298|101570711|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
33459724|NCT03496298|101570709|FG000|Overall Study|Withdrawal by Subject|176|||
33459725|NCT03496298|101570710|FG001|Overall Study|Withdrawal by Subject|154|||
33459726|NCT03496298|101570711|FG002|Overall Study|Withdrawal by Subject|151|||
33175069|NCT00498602|100548997|FG004|Overall Study|Caregiver Request|1|||
33175070|NCT00498602|100548998|FG005|Overall Study|Caregiver Request|2|||
33175071|NCT00498602|100548999|FG006|Overall Study|Caregiver Request|0|||
33175072|NCT00498602|100548993|FG000|Overall Study|Investigator Request|0|||
33175073|NCT00498602|100548994|FG001|Overall Study|Investigator Request|0|||
33175074|NCT00498602|100548995|FG002|Overall Study|Investigator Request|1|||
33175075|NCT00498602|100548996|FG003|Overall Study|Investigator Request|0|||
33459727|NCT03496298|101570709|FG000|Overall Study|Other|29|||
33459728|NCT03496298|101570710|FG001|Overall Study|Other|20|||
33459729|NCT03496298|101570711|FG002|Overall Study|Other|23|||
33459730|NCT03496298|101570709|FG000|Overall Study|Randomized and not treated|1|||
33459731|NCT03496298|101570710|FG001|Overall Study|Randomized and not treated|1|||
33459732|NCT03496298|101570711|FG002|Overall Study|Randomized and not treated|1|||
33459733|NCT01098539|101570714|FG000|Overall Study|Adverse Event|26|||
33459734|NCT01098539|101570715|FG001|Overall Study|Adverse Event|26|||
33459735|NCT01098539|101570714|FG000|Overall Study|Protocol Violation|1|||
33175076|NCT00498602|100548997|FG004|Overall Study|Investigator Request|0|||
33175077|NCT00498602|100548998|FG005|Overall Study|Investigator Request|0|||
33459736|NCT01098539|101570715|FG001|Overall Study|Protocol Violation|4|||
33459737|NCT01098539|101570714|FG000|Overall Study|Noncompliance|3|||
33459738|NCT01098539|101570715|FG001|Overall Study|Noncompliance|5|||
33459739|NCT01098539|101570714|FG000|Overall Study|Lost to Follow-up|4|||
33459740|NCT01098539|101570715|FG001|Overall Study|Lost to Follow-up|4|||
33459741|NCT01098539|101570714|FG000|Overall Study|Withdrawal by Subject|12|||
33459742|NCT01098539|101570715|FG001|Overall Study|Withdrawal by Subject|26|||
33459743|NCT01098539|101570714|FG000|Overall Study|Physician Decision|5|||
33459744|NCT01098539|101570715|FG001|Overall Study|Physician Decision|3|||
33459745|NCT02377349|101570718|FG000|Overall Study|Serious Adverse Event|1|||
33459746|NCT02377349|101570719|FG001|Overall Study|Serious Adverse Event|0|||
33459747|NCT02377349|101570718|FG000|Overall Study|Protocol Violation|3|||
33459748|NCT02377349|101570719|FG001|Overall Study|Protocol Violation|2|||
33175078|NCT00498602|100548999|FG006|Overall Study|Investigator Request|0|||
33262763|NCT05580003|100863770|FG022|Part 2 (up to 10 Days)|Other|0|||
33262764|NCT05580003|100863771|FG023|Part 2 (up to 10 Days)|Other|0|||
33459749|NCT02377349|101570718|FG000|Overall Study|Withdrawal by Subject|5|||
33459750|NCT02377349|101570719|FG001|Overall Study|Withdrawal by Subject|3|||
33459751|NCT02377349|101570718|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
33459752|NCT02377349|101570719|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
33459753|NCT02377349|101570718|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
33175079|NCT00498602|100548993|FG000|Overall Study|Subject Request|3|||
33175080|NCT00498602|100548994|FG001|Overall Study|Subject Request|0|||
33175081|NCT00498602|100548995|FG002|Overall Study|Subject Request|1|||
33262765|NCT05580003|100863772|FG024|Part 2 (up to 10 Days)|Other|0|||
33262766|NCT05580003|100863773|FG025|Part 2 (up to 10 Days)|Other|0|||
33262767|NCT05580003|100863774|FG026|Part 2 (up to 10 Days)|Other|0|||
33459754|NCT02377349|101570719|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
33459755|NCT02377349|101570718|FG000|Overall Study|Other|0|||
33459756|NCT02377349|101570719|FG001|Overall Study|Other|1|||
33459757|NCT01142908|101570724|FG000|Overall Study|Lost to Follow-up|19|||
33175082|NCT00498602|100548996|FG003|Overall Study|Subject Request|1|||
33459758|NCT01142908|101570725|FG001|Overall Study|Lost to Follow-up|13|||
33175083|NCT00498602|100548997|FG004|Overall Study|Subject Request|1|||
33459759|NCT01142908|101570724|FG000|Overall Study|Death|1|||
33459760|NCT01142908|101570725|FG001|Overall Study|Death|4|||
33459761|NCT01142908|101570724|FG000|Overall Study|Excluded - did not meet criteria|9|||
33459762|NCT01142908|101570725|FG001|Overall Study|Excluded - did not meet criteria|5|||
33175084|NCT00498602|100548998|FG005|Overall Study|Subject Request|4|||
33262768|NCT05580003|100863775|FG027|Part 2 (up to 10 Days)|Other|0|||
33262769|NCT05580003|100863748|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262770|NCT05580003|100863749|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262771|NCT05580003|100863750|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262772|NCT05580003|100863751|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262773|NCT05580003|100863752|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262774|NCT05580003|100863753|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262775|NCT05580003|100863754|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262776|NCT05580003|100863755|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262777|NCT05580003|100863756|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262778|NCT05580003|100863757|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262779|NCT05580003|100863758|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262780|NCT05580003|100863759|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262781|NCT05580003|100863760|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262782|NCT05580003|100863761|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262783|NCT05580003|100863762|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262784|NCT05580003|100863763|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262785|NCT05580003|100863764|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262786|NCT05580003|100863765|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262787|NCT05580003|100863766|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262788|NCT05580003|100863767|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
33262789|NCT05580003|100863768|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262790|NCT05580003|100863769|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262791|NCT05580003|100863770|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262792|NCT05580003|100863771|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262793|NCT05580003|100863772|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262794|NCT05580003|100863773|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262795|NCT05580003|100863774|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262796|NCT05580003|100863775|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
33262797|NCT05580003|100863748|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262798|NCT05580003|100863749|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262799|NCT05580003|100863750|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262800|NCT05580003|100863751|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262801|NCT05580003|100863752|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262802|NCT05580003|100863753|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262803|NCT05580003|100863754|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262804|NCT05580003|100863755|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262805|NCT05580003|100863756|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262806|NCT05580003|100863757|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262807|NCT05580003|100863758|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262808|NCT05580003|100863759|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262809|NCT05580003|100863760|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262810|NCT05580003|100863761|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262811|NCT05580003|100863762|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262812|NCT05580003|100863763|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262813|NCT05580003|100863764|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262814|NCT05580003|100863765|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33459763|NCT01142908|101570724|FG000|Overall Study|Withdrawal by Subject|3|||
33459764|NCT01142908|101570725|FG001|Overall Study|Withdrawal by Subject|0|||
33175085|NCT00498602|100548999|FG006|Overall Study|Subject Request|1|||
33175086|NCT00498602|100548993|FG000|Overall Study|Other|2|||
33175087|NCT00498602|100548994|FG001|Overall Study|Other|3|||
33175088|NCT00498602|100548995|FG002|Overall Study|Other|1|||
33175089|NCT00498602|100548996|FG003|Overall Study|Other|0|||
33175090|NCT00498602|100548997|FG004|Overall Study|Other|0|||
33175091|NCT00498602|100548998|FG005|Overall Study|Other|3|||
33175092|NCT00498602|100548999|FG006|Overall Study|Other|0|||
33175093|NCT01705652|100549002|FG000|Overall Study|Adverse Event|1|||
33459765|NCT01833169|101570726|FG000|Overall Study|Disease Progression|99|||
33459766|NCT01833169|101570726|FG000|Overall Study|Adverse Event|33|||
33459767|NCT01833169|101570726|FG000|Overall Study|Withdrawal by Subject|9|||
33459768|NCT01833169|101570726|FG000|Overall Study|Death|3|||
33459769|NCT01833169|101570726|FG000|Overall Study|Physician Decision|2|||
33459770|NCT03366194|101570727|FG000|Overall Study|Lost to Follow-up|2|||
33459771|NCT01952691|101570728|FG000|Overall Study|Lost to Follow-up|2|||
33459772|NCT03234608|101570729|FG000|Overall Study|Lost to Follow-up|23|||
33459773|NCT03234608|101570730|FG001|Overall Study|Lost to Follow-up|21|||
33459774|NCT01109849|101570731|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
33459775|NCT01109849|101570732|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
33459776|NCT01109849|101570733|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
33459777|NCT01109849|101570734|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
33459778|NCT01109849|101570735|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
33262815|NCT05580003|100863766|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262816|NCT05580003|100863767|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33459779|NCT01109849|101570731|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
33262817|NCT05580003|100863768|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
33459780|NCT01109849|101570732|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
33459781|NCT01109849|101570733|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
33459782|NCT01109849|101570734|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
33459783|NCT01109849|101570735|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
33459784|NCT01109849|101570731|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
33459785|NCT01109849|101570732|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
33459786|NCT01109849|101570733|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
33459787|NCT01109849|101570734|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
33459788|NCT01109849|101570735|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
33459789|NCT01109849|101570731|FG000|Initial Randomization: ADHD Treatment|move away|2|||
33459790|NCT01109849|101570732|FG001|Initial Randomization: ADHD Treatment|move away|7|||
33459791|NCT01109849|101570733|FG002|Initial Randomization: ADHD Treatment|move away|0|||
33459792|NCT01109849|101570734|FG003|Initial Randomization: ADHD Treatment|move away|0|||
33459793|NCT01109849|101570735|FG004|Initial Randomization: ADHD Treatment|move away|0|||
33459794|NCT01109849|101570731|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
33459795|NCT01109849|101570732|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
33459796|NCT01109849|101570733|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
33459797|NCT01109849|101570734|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
33459798|NCT01109849|101570735|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
33459799|NCT01109849|101570731|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
33459800|NCT01109849|101570732|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
33459801|NCT01109849|101570733|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
33459802|NCT01109849|101570734|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
33459803|NCT01109849|101570735|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
33175094|NCT01705652|100549003|FG001|Overall Study|Adverse Event|0|||
33175095|NCT01705652|100549002|FG000|Overall Study|Withdrawal by Subject|1|||
33175096|NCT01705652|100549003|FG001|Overall Study|Withdrawal by Subject|2|||
33175097|NCT01705652|100549002|FG000|Overall Study|non-compliance|1|||
33459804|NCT02000115|101570736|FG000|Overall Study|Death|56|||
33175098|NCT01705652|100549003|FG001|Overall Study|non-compliance|1|||
33459805|NCT02000115|101570737|FG001|Overall Study|Death|45|||
33459806|NCT02000115|101570738|FG002|Overall Study|Death|0|||
33459807|NCT02000115|101570739|FG003|Overall Study|Death|0|||
33459808|NCT02000115|101570736|FG000|Overall Study|Missed Visit|6|||
33459809|NCT02000115|101570737|FG001|Overall Study|Missed Visit|8|||
33459810|NCT02000115|101570738|FG002|Overall Study|Missed Visit|1|||
33175099|NCT02865187|100549004|FG000|Overall Study|Lost to Follow-up|12|||
33262818|NCT05580003|100863769|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262819|NCT05580003|100863770|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262820|NCT05580003|100863771|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262821|NCT05580003|100863772|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262822|NCT05580003|100863773|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262823|NCT05580003|100863774|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33459811|NCT02000115|101570739|FG003|Overall Study|Missed Visit|0|||
33459812|NCT02000115|101570736|FG000|Overall Study|Protocol Violation|2|||
33459813|NCT02000115|101570737|FG001|Overall Study|Protocol Violation|1|||
33459814|NCT02000115|101570738|FG002|Overall Study|Protocol Violation|0|||
33459815|NCT02000115|101570739|FG003|Overall Study|Protocol Violation|0|||
33459816|NCT02000115|101570736|FG000|Overall Study|Physician Decision|2|||
33459817|NCT02000115|101570737|FG001|Overall Study|Physician Decision|0|||
33459818|NCT02000115|101570738|FG002|Overall Study|Physician Decision|0|||
33459819|NCT02000115|101570739|FG003|Overall Study|Physician Decision|0|||
33459820|NCT02000115|101570736|FG000|Overall Study|Withdrawal by Subject|11|||
33459821|NCT02000115|101570737|FG001|Overall Study|Withdrawal by Subject|11|||
33459822|NCT02000115|101570738|FG002|Overall Study|Withdrawal by Subject|0|||
33459823|NCT02000115|101570739|FG003|Overall Study|Withdrawal by Subject|0|||
33459824|NCT02000115|101570736|FG000|Overall Study|Lost to Follow-up|0|||
33459825|NCT02000115|101570737|FG001|Overall Study|Lost to Follow-up|1|||
33262824|NCT05580003|100863775|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
33262825|NCT05580003|100863748|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262826|NCT05580003|100863749|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262827|NCT05580003|100863750|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33459826|NCT02000115|101570738|FG002|Overall Study|Lost to Follow-up|0|||
33175100|NCT02865187|100549005|FG001|Overall Study|Lost to Follow-up|7|||
33459827|NCT02000115|101570739|FG003|Overall Study|Lost to Follow-up|0|||
33459828|NCT02000115|101570736|FG000|Overall Study|Non-compliance|2|||
33459829|NCT02000115|101570737|FG001|Overall Study|Non-compliance|1|||
33459830|NCT02000115|101570738|FG002|Overall Study|Non-compliance|0|||
33459831|NCT02000115|101570739|FG003|Overall Study|Non-compliance|0|||
33175101|NCT02865187|100549004|FG000|Overall Study|Adverse Event|1|||
33459832|NCT02000115|101570736|FG000|Overall Study|Withdrawn on day of randomization|0|||
33459833|NCT02000115|101570737|FG001|Overall Study|Withdrawn on day of randomization|1|||
33459834|NCT02000115|101570738|FG002|Overall Study|Withdrawn on day of randomization|0|||
33459835|NCT02000115|101570739|FG003|Overall Study|Withdrawn on day of randomization|0|||
33459836|NCT02000115|101570736|FG000|Overall Study|Still on Study|0|||
33459837|NCT02000115|101570737|FG001|Overall Study|Still on Study|0|||
33459838|NCT02000115|101570738|FG002|Overall Study|Still on Study|0|||
33459839|NCT02000115|101570739|FG003|Overall Study|Still on Study|53|||
33459840|NCT01898598|101570741|FG000|Overall Study|Adverse Event|1|||
33459841|NCT01898598|101570742|FG001|Overall Study|Adverse Event|0|||
33459842|NCT01898598|101570741|FG000|Overall Study|Withdrawal by Subject|3|||
33459843|NCT01898598|101570742|FG001|Overall Study|Withdrawal by Subject|0|||
33459844|NCT01898598|101570741|FG000|Overall Study|Lost to Follow-up|0|||
33459845|NCT01898598|101570742|FG001|Overall Study|Lost to Follow-up|1|||
33459846|NCT01898598|101570741|FG000|Overall Study|Other|0|||
33459847|NCT01898598|101570742|FG001|Overall Study|Other|1|||
33459848|NCT02914457|101570743|FG000|Overall Study|Withdrawal by Subject|1|||
33459849|NCT02914457|101570743|FG000|Overall Study|Physician Decision|1|||
33459850|NCT02914457|101570743|FG000|Overall Study|No veins available for lead placement|1|||
33459851|NCT02914457|101570743|FG000|Overall Study|Electrical instability of patient|1|||
33459852|NCT02914457|101570743|FG000|Overall Study|ECG acquisition error due to sweating|1|||
33459853|NCT02914457|101570743|FG000|Overall Study|Protocol Violation|1|||
33459854|NCT02105701|101570748|FG000|Overall Study|Lost to Follow-up|1|||
33459855|NCT02105701|101570749|FG001|Overall Study|Lost to Follow-up|0|||
33459856|NCT02105701|101570750|FG002|Overall Study|Lost to Follow-up|2|||
33459857|NCT02105701|101570751|FG003|Overall Study|Lost to Follow-up|1|||
33459858|NCT02105701|101570748|FG000|Overall Study|Protocol Violation|0|||
33459859|NCT02105701|101570749|FG001|Overall Study|Protocol Violation|0|||
33459860|NCT02105701|101570750|FG002|Overall Study|Protocol Violation|1|||
33459861|NCT02105701|101570751|FG003|Overall Study|Protocol Violation|0|||
33459862|NCT02105701|101570748|FG000|Overall Study|Withdrawal by Subject|2|||
33459863|NCT02105701|101570749|FG001|Overall Study|Withdrawal by Subject|1|||
33459864|NCT02105701|101570750|FG002|Overall Study|Withdrawal by Subject|0|||
33459865|NCT02105701|101570751|FG003|Overall Study|Withdrawal by Subject|1|||
33459866|NCT02105701|101570748|FG000|Overall Study|Death|1|||
33175102|NCT02865187|100549005|FG001|Overall Study|Adverse Event|0|||
33262828|NCT05580003|100863751|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33459867|NCT02105701|101570749|FG001|Overall Study|Death|0|||
33459868|NCT02105701|101570750|FG002|Overall Study|Death|0|||
33459869|NCT02105701|101570751|FG003|Overall Study|Death|0|||
33459870|NCT01408888|101570757|FG000|First Intervention|Adverse Event|0|||
33459871|NCT01408888|101570758|FG001|First Intervention|Adverse Event|1|||
33459872|NCT01408888|101570757|FG000|First Intervention|Withdrawal by Subject|0|||
33459873|NCT01408888|101570758|FG001|First Intervention|Withdrawal by Subject|2|||
33459874|NCT01408888|101570757|FG000|Second Intervention|Withdrawal by Subject|1|||
33459875|NCT01408888|101570758|FG001|Second Intervention|Withdrawal by Subject|0|||
33459876|NCT01408888|101570757|FG000|Second Intervention|Adverse Event|1|||
33459877|NCT01408888|101570758|FG001|Second Intervention|Adverse Event|0|||
33459878|NCT02169336|101570759|FG000|Overall Study|Lack of Efficacy|1|||
33459879|NCT02169336|101570760|FG001|Overall Study|Lack of Efficacy|1|||
33459880|NCT02169336|101570761|FG002|Overall Study|Lack of Efficacy|0|||
33459881|NCT02169336|101570759|FG000|Overall Study|Adverse Event|2|||
33459882|NCT02169336|101570760|FG001|Overall Study|Adverse Event|3|||
33459883|NCT02169336|101570761|FG002|Overall Study|Adverse Event|1|||
33459884|NCT02169336|101570759|FG000|Overall Study|Withdrawal by Subject|1|||
33459885|NCT02169336|101570760|FG001|Overall Study|Withdrawal by Subject|0|||
33459886|NCT02169336|101570761|FG002|Overall Study|Withdrawal by Subject|0|||
33459887|NCT02169336|101570759|FG000|Overall Study|Physician Decision|0|||
33459888|NCT02169336|101570760|FG001|Overall Study|Physician Decision|0|||
33459889|NCT02169336|101570761|FG002|Overall Study|Physician Decision|1|||
33459890|NCT02169336|101570759|FG000|Overall Study|Subject declined to continue dosing|0|||
33459891|NCT02169336|101570760|FG001|Overall Study|Subject declined to continue dosing|0|||
33262829|NCT05580003|100863752|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262830|NCT05580003|100863753|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33459892|NCT02169336|101570761|FG002|Overall Study|Subject declined to continue dosing|1|||
33459893|NCT00842309|101570763|FG000|Overall Study|Withdrawal by Subject|3|||
33459894|NCT00842309|101570764|FG001|Overall Study|Withdrawal by Subject|1|||
33459895|NCT01634854|101570765|FG000|Overall Study|Cesarean delivery|2|||
33459896|NCT01634854|101570766|FG001|Overall Study|Cesarean delivery|7|||
33459897|NCT00743145|101570767|FG000|Overall Study|Withdrawal by Subject|1|||
33459898|NCT00743145|101570767|FG000|Overall Study|Adverse Event|2|||
33459899|NCT00743145|101570767|FG000|Overall Study|Pregnancy|1|||
33459900|NCT00090753|101570768|FG000|First Treatment Period|Adverse Event|20|||
33459901|NCT00090753|101570769|FG001|First Treatment Period|Adverse Event|8|||
33459902|NCT00090753|101570768|FG000|First Treatment Period|Death|88|||
33459903|NCT00090753|101570769|FG001|First Treatment Period|Death|62|||
33459904|NCT00090753|101570768|FG000|First Treatment Period|Lack of Efficacy|2|||
33459905|NCT00090753|101570769|FG001|First Treatment Period|Lack of Efficacy|1|||
33459906|NCT00090753|101570768|FG000|First Treatment Period|Refused Treatment|32|||
33459907|NCT00090753|101570769|FG001|First Treatment Period|Refused Treatment|25|||
33459908|NCT00090753|101570768|FG000|First Treatment Period|Lost to Follow-up|4|||
33459909|NCT00090753|101570769|FG001|First Treatment Period|Lost to Follow-up|4|||
33459910|NCT00090753|101570768|FG000|First Treatment Period|Renal Transplant|70|||
33459911|NCT00090753|101570769|FG001|First Treatment Period|Renal Transplant|50|||
33459912|NCT00090753|101570768|FG000|First Treatment Period|Mircera Commercialization|1|||
33459913|NCT00090753|101570769|FG001|First Treatment Period|Mircera Commercialization|0|||
33459914|NCT00090753|101570768|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
33459915|NCT00090753|101570769|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
33459916|NCT00090753|101570768|FG000|Extended Treatment Period|Adverse Event|11|||
33459917|NCT00090753|101570769|FG001|Extended Treatment Period|Adverse Event|0|||
33459918|NCT00090753|101570768|FG000|Extended Treatment Period|Death|58|||
33459919|NCT00090753|101570769|FG001|Extended Treatment Period|Death|30|||
33459920|NCT00090753|101570768|FG000|Extended Treatment Period|Lack of Efficacy|1|||
33459921|NCT00090753|101570769|FG001|Extended Treatment Period|Lack of Efficacy|0|||
33459922|NCT00090753|101570768|FG000|Extended Treatment Period|Refused Treatment|18|||
33459923|NCT00090753|101570769|FG001|Extended Treatment Period|Refused Treatment|12|||
33459924|NCT00090753|101570768|FG000|Extended Treatment Period|Lost to Follow-up|3|||
33262831|NCT05580003|100863754|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262832|NCT05580003|100863755|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262833|NCT05580003|100863756|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262834|NCT05580003|100863757|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262835|NCT05580003|100863758|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262836|NCT05580003|100863759|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262837|NCT05580003|100863760|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262838|NCT05580003|100863761|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262839|NCT05580003|100863762|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262840|NCT05580003|100863763|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262841|NCT05580003|100863764|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262842|NCT05580003|100863765|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33459925|NCT00090753|101570769|FG001|Extended Treatment Period|Lost to Follow-up|1|||
33459926|NCT00090753|101570768|FG000|Extended Treatment Period|Renal Transplant|15|||
33459927|NCT00090753|101570769|FG001|Extended Treatment Period|Renal Transplant|12|||
33459928|NCT00090753|101570768|FG000|Extended Treatment Period|Mircera Commercialization|188|||
33459929|NCT00090753|101570769|FG001|Extended Treatment Period|Mircera Commercialization|93|||
33459930|NCT00090753|101570768|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
33459931|NCT00090753|101570769|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
33459932|NCT00762411|101570770|FG000|Initial Treatment|Death|7|||
33459933|NCT00762411|101570771|FG001|Initial Treatment|Death|6|||
33459934|NCT00762411|101570770|FG000|Initial Treatment|Adverse Event|132|||
33459935|NCT00762411|101570771|FG001|Initial Treatment|Adverse Event|40|||
33459936|NCT00762411|101570770|FG000|Initial Treatment|Protocol Violation|4|||
33459937|NCT00762411|101570771|FG001|Initial Treatment|Protocol Violation|1|||
33459938|NCT00762411|101570770|FG000|Initial Treatment|Withdrawal by Subject|65|||
33459939|NCT00762411|101570771|FG001|Initial Treatment|Withdrawal by Subject|52|||
33459940|NCT00762411|101570770|FG000|Initial Treatment|Physician Decision|1|||
33459941|NCT00762411|101570771|FG001|Initial Treatment|Physician Decision|0|||
33459942|NCT00762411|101570770|FG000|Initial Treatment|Sponsor Decision|293|||
33459943|NCT00762411|101570771|FG001|Initial Treatment|Sponsor Decision|401|||
33459944|NCT00762411|101570770|FG000|Initial Treatment|Lost to Follow-up|5|||
33459945|NCT00762411|101570771|FG001|Initial Treatment|Lost to Follow-up|0|||
33459946|NCT00762411|101570770|FG000|Initial Treatment|Caregiver Decision|21|||
33459947|NCT00762411|101570771|FG001|Initial Treatment|Caregiver Decision|16|||
33459948|NCT00762411|101570770|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
33459949|NCT00762411|101570771|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
33459950|NCT00762411|101570770|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
33459951|NCT00762411|101570771|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
33459952|NCT00762411|101570770|FG000|Delayed Start|Adverse Event|0|||
33459953|NCT00762411|101570771|FG001|Delayed Start|Adverse Event|4|||
33459954|NCT00762411|101570770|FG000|Delayed Start|Protocol Violation|0|||
33459955|NCT00762411|101570771|FG001|Delayed Start|Protocol Violation|1|||
33459956|NCT00762411|101570770|FG000|Delayed Start|Sponsor Decision|16|||
33459957|NCT00762411|101570771|FG001|Delayed Start|Sponsor Decision|20|||
33459958|NCT00762411|101570770|FG000|Delayed Start|Caregiver Decision|1|||
33459959|NCT00762411|101570771|FG001|Delayed Start|Caregiver Decision|1|||
33459960|NCT00762411|101570770|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
33459961|NCT00762411|101570771|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
33459962|NCT00762411|101570770|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
33459963|NCT00762411|101570771|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
33459964|NCT00762411|101570770|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
33459965|NCT00762411|101570771|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
33459966|NCT00762411|101570770|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
33459967|NCT00762411|101570771|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
33459968|NCT00762411|101570770|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
33459969|NCT00762411|101570771|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
33459970|NCT00762411|101570770|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
33459971|NCT00762411|101570771|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
33459972|NCT01802216|101570774|FG000|4 Month Visit|Participant did not show to visit|3|||
33459973|NCT01802216|101570775|FG001|4 Month Visit|Participant did not show to visit|4|||
33459974|NCT01802216|101570774|FG000|8 Month Visit|Participant did not show to visit|3|||
33459975|NCT01802216|101570775|FG001|8 Month Visit|Participant did not show to visit|5|||
33459976|NCT01802216|101570774|FG000|12 Month Visit|Participant did not show to visit|3|||
33459977|NCT01802216|101570775|FG001|12 Month Visit|Participant did not show to visit|4|||
33459978|NCT03119662|101570780|FG000|Overall Study|Withdrawal by Subject|0|||
33459979|NCT03119662|101570781|FG001|Overall Study|Withdrawal by Subject|1|||
33459980|NCT00874549|101570782|FG000|Overall Study|Adverse Event|0|||
33459981|NCT00874549|101570783|FG001|Overall Study|Adverse Event|0|||
33459982|NCT00874549|101570784|FG002|Overall Study|Adverse Event|1|||
33459983|NCT00874549|101570785|FG003|Overall Study|Adverse Event|0|||
33459984|NCT00874549|101570782|FG000|Overall Study|Protocol Violation|1|||
33459985|NCT00874549|101570783|FG001|Overall Study|Protocol Violation|0|||
33459986|NCT00874549|101570784|FG002|Overall Study|Protocol Violation|2|||
33459987|NCT00874549|101570785|FG003|Overall Study|Protocol Violation|1|||
33459988|NCT00874549|101570782|FG000|Overall Study|Lost to Follow-up|0|||
33459989|NCT00874549|101570783|FG001|Overall Study|Lost to Follow-up|0|||
33459990|NCT00874549|101570784|FG002|Overall Study|Lost to Follow-up|1|||
33459991|NCT00874549|101570785|FG003|Overall Study|Lost to Follow-up|0|||
33459992|NCT00874549|101570782|FG000|Overall Study|Withdrawal by Subject|0|||
33459993|NCT00874549|101570783|FG001|Overall Study|Withdrawal by Subject|1|||
33459994|NCT00874549|101570784|FG002|Overall Study|Withdrawal by Subject|0|||
33459995|NCT00874549|101570785|FG003|Overall Study|Withdrawal by Subject|1|||
33459996|NCT03108820|101570786|FG000|Overall Study|Lost to Follow-up|30|||
33459997|NCT03108820|101570787|FG001|Overall Study|Lost to Follow-up|28|||
33459998|NCT03108820|101570786|FG000|Overall Study|Withdrawal by Subject|32|||
33459999|NCT03108820|101570787|FG001|Overall Study|Withdrawal by Subject|24|||
33460000|NCT03108820|101570786|FG000|Overall Study|Death|6|||
33460001|NCT03108820|101570787|FG001|Overall Study|Death|11|||
33460002|NCT00928057|101570788|FG000|Overall Study|Adverse Event|1|||
33460003|NCT00928057|101570789|FG001|Overall Study|Adverse Event|2|||
33175103|NCT02289079|100549013|FG000|Overall Study|Physician Decision|2|||
33262843|NCT05580003|100863766|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33460004|NCT00928057|101570788|FG000|Overall Study|Withdrawal by Subject|1|||
33460005|NCT00928057|101570789|FG001|Overall Study|Withdrawal by Subject|0|||
33460006|NCT00928057|101570788|FG000|Overall Study|Lost to Follow-up|0|||
33460007|NCT00928057|101570789|FG001|Overall Study|Lost to Follow-up|1|||
33460008|NCT00928057|101570788|FG000|Overall Study|Protocol Violation|0|||
33460009|NCT00928057|101570789|FG001|Overall Study|Protocol Violation|1|||
33460010|NCT01928615|101570793|FG000|Overall Study|Study Terminated by Sponsor|2|||
33460011|NCT02004691|101570794|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
33460012|NCT02004691|101570795|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
33460013|NCT02004691|101570794|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
33460014|NCT02004691|101570795|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
33460015|NCT02004691|101570794|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
33460016|NCT02004691|101570795|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
33460017|NCT02004691|101570794|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
33460018|NCT02004691|101570795|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
33460019|NCT02004691|101570794|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
33460020|NCT02004691|101570795|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
33460021|NCT02004691|101570794|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
33460022|NCT02004691|101570795|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
33460023|NCT01386125|101570796|FG000|Overall Study|Lost to Follow-up|3|||
33460024|NCT01386125|101570797|FG001|Overall Study|Lost to Follow-up|9|||
33460025|NCT01386125|101570796|FG000|Overall Study|Physician Decision|0|||
33460026|NCT01386125|101570797|FG001|Overall Study|Physician Decision|1|||
33460027|NCT01386125|101570796|FG000|Overall Study|Protocol Violation|5|||
33460028|NCT01386125|101570797|FG001|Overall Study|Protocol Violation|7|||
33460029|NCT01386125|101570796|FG000|Overall Study|Disease Progress|1|||
33460030|NCT01386125|101570797|FG001|Overall Study|Disease Progress|2|||
33460031|NCT01386125|101570796|FG000|Overall Study|Withdrawal by Subject|13|||
33460032|NCT01386125|101570797|FG001|Overall Study|Withdrawal by Subject|12|||
33460033|NCT01386125|101570796|FG000|Overall Study|Adverse Event|2|||
33460034|NCT01386125|101570797|FG001|Overall Study|Adverse Event|5|||
33460035|NCT01386125|101570796|FG000|Overall Study|Lack of Efficacy|0|||
33460036|NCT01386125|101570797|FG001|Overall Study|Lack of Efficacy|1|||
33460037|NCT01386125|101570796|FG000|Overall Study|Participant Leaving Country|1|||
33460038|NCT01386125|101570797|FG001|Overall Study|Participant Leaving Country|0|||
33460039|NCT01362296|101570798|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
33460040|NCT01362296|101570799|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
33460041|NCT01362296|101570800|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
33460042|NCT01362296|101570801|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
33460043|NCT01362296|101570798|FG000|Randomized Phase (RP)|Physician Decision|1|||
33460044|NCT01362296|101570799|FG001|Randomized Phase (RP)|Physician Decision|9|||
33460045|NCT01362296|101570800|FG002|Randomized Phase (RP)|Physician Decision|0|||
33460046|NCT01362296|101570801|FG003|Randomized Phase (RP)|Physician Decision|0|||
33460047|NCT01362296|101570798|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
33460048|NCT01362296|101570799|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
33460049|NCT01362296|101570800|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
33460050|NCT01362296|101570801|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
33460051|NCT01362296|101570798|FG000|Randomized Phase (RP)|Adverse Event|20|||
33460052|NCT01362296|101570799|FG001|Randomized Phase (RP)|Adverse Event|4|||
33460053|NCT01362296|101570800|FG002|Randomized Phase (RP)|Adverse Event|0|||
33460054|NCT01362296|101570801|FG003|Randomized Phase (RP)|Adverse Event|0|||
33460055|NCT01362296|101570798|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
33460056|NCT01362296|101570799|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
33460057|NCT01362296|101570800|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
33460058|NCT01362296|101570801|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
33460059|NCT01362296|101570798|FG000|Crossover Phase|PD including Death due to PD|0|||
33460060|NCT01362296|101570799|FG001|Crossover Phase|PD including Death due to PD|0|||
33460061|NCT01362296|101570800|FG002|Crossover Phase|PD including Death due to PD|16|||
33460062|NCT01362296|101570801|FG003|Crossover Phase|PD including Death due to PD|1|||
33460063|NCT01362296|101570798|FG000|Crossover Phase|Withdrawal by Subject|0|||
33460064|NCT01362296|101570799|FG001|Crossover Phase|Withdrawal by Subject|0|||
33460065|NCT01362296|101570800|FG002|Crossover Phase|Withdrawal by Subject|2|||
33460066|NCT01362296|101570801|FG003|Crossover Phase|Withdrawal by Subject|1|||
33460067|NCT01362296|101570798|FG000|Crossover Phase|Adverse Event|0|||
33460068|NCT01362296|101570799|FG001|Crossover Phase|Adverse Event|0|||
33460069|NCT01362296|101570800|FG002|Crossover Phase|Adverse Event|4|||
33460070|NCT01362296|101570801|FG003|Crossover Phase|Adverse Event|0|||
33460071|NCT01362296|101570798|FG000|Crossover Phase|Study Closed/Terminated|0|||
33460072|NCT01362296|101570799|FG001|Crossover Phase|Study Closed/Terminated|0|||
33460073|NCT01362296|101570800|FG002|Crossover Phase|Study Closed/Terminated|1|||
33460074|NCT01362296|101570801|FG003|Crossover Phase|Study Closed/Terminated|0|||
33460075|NCT01499160|101570802|FG000|Overall Study|Adverse Event|1|||
33460076|NCT01499160|101570802|FG000|Overall Study|Withdrawal by Subject|1|||
33460077|NCT01475487|101570803|FG000|Overall Study|had to leave early for personal reasons|2|||
33460078|NCT01475487|101570804|FG001|Overall Study|had to leave early for personal reasons|1|||
33460079|NCT00640393|101570805|FG000|Part 1|Lost to Follow-up|2|||
33460080|NCT00640393|101570806|FG001|Part 1|Lost to Follow-up|0|||
33460081|NCT00640393|101570807|FG002|Part 1|Lost to Follow-up|0|||
33460082|NCT00640393|101570805|FG000|Part 1|Withdrawal by Subject|3|||
33460083|NCT00640393|101570806|FG001|Part 1|Withdrawal by Subject|0|||
33460084|NCT00640393|101570807|FG002|Part 1|Withdrawal by Subject|0|||
33460085|NCT00640393|101570805|FG000|Randomization|Withdrawn per protocol|17|||
33460086|NCT00640393|101570806|FG001|Randomization|Withdrawn per protocol|0|||
33460087|NCT00640393|101570807|FG002|Randomization|Withdrawn per protocol|0|||
33460088|NCT00640393|101570805|FG000|Randomization|Never randomized by site|2|||
33460089|NCT00640393|101570806|FG001|Randomization|Never randomized by site|0|||
33460090|NCT00640393|101570807|FG002|Randomization|Never randomized by site|0|||
33460091|NCT00640393|101570805|FG000|Part 2|Lost to Follow-up|0|||
33460092|NCT00640393|101570806|FG001|Part 2|Lost to Follow-up|2|||
33460093|NCT00640393|101570807|FG002|Part 2|Lost to Follow-up|2|||
33460094|NCT00640393|101570805|FG000|Part 2|Withdrawal by Subject|0|||
33460095|NCT00640393|101570806|FG001|Part 2|Withdrawal by Subject|6|||
33460096|NCT00640393|101570807|FG002|Part 2|Withdrawal by Subject|1|||
33460097|NCT00640393|101570805|FG000|Part 2|Non-adherence|0|||
33460098|NCT00640393|101570806|FG001|Part 2|Non-adherence|1|||
33460099|NCT00640393|101570807|FG002|Part 2|Non-adherence|0|||
33460100|NCT00640393|101570805|FG000|Part 2|Adverse Event|0|||
33460101|NCT00640393|101570806|FG001|Part 2|Adverse Event|1|||
33460102|NCT00640393|101570807|FG002|Part 2|Adverse Event|0|||
33460103|NCT03843125|101570808|FG000|Overall Study|Adverse Event|17|||
33460104|NCT03843125|101570809|FG001|Overall Study|Adverse Event|13|||
33460105|NCT03843125|101570810|FG002|Overall Study|Adverse Event|5|||
33460106|NCT03843125|101570811|FG003|Overall Study|Adverse Event|9|||
33460107|NCT03843125|101570808|FG000|Overall Study|Death|0|||
33460108|NCT03843125|101570809|FG001|Overall Study|Death|6|||
33460109|NCT03843125|101570810|FG002|Overall Study|Death|2|||
33460110|NCT03843125|101570811|FG003|Overall Study|Death|0|||
33460111|NCT03843125|101570808|FG000|Overall Study|Lack of Efficacy|14|||
33460112|NCT03843125|101570809|FG001|Overall Study|Lack of Efficacy|11|||
33460113|NCT03843125|101570810|FG002|Overall Study|Lack of Efficacy|9|||
33460114|NCT03843125|101570811|FG003|Overall Study|Lack of Efficacy|4|||
33175104|NCT02289079|100549014|FG001|Overall Study|Physician Decision|0|||
33460115|NCT03843125|101570808|FG000|Overall Study|Lost to Follow-up|3|||
33460116|NCT03843125|101570809|FG001|Overall Study|Lost to Follow-up|4|||
33460117|NCT03843125|101570810|FG002|Overall Study|Lost to Follow-up|0|||
33460118|NCT03843125|101570811|FG003|Overall Study|Lost to Follow-up|2|||
33460119|NCT03843125|101570808|FG000|Overall Study|Other|12|||
33460120|NCT03843125|101570809|FG001|Overall Study|Other|14|||
33460121|NCT03843125|101570810|FG002|Overall Study|Other|3|||
33460122|NCT03843125|101570811|FG003|Overall Study|Other|4|||
33460123|NCT03843125|101570808|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
33460124|NCT03843125|101570809|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
33460125|NCT03843125|101570810|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
33460126|NCT03843125|101570811|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
33460127|NCT03843125|101570808|FG000|Overall Study|Study Terminated by Sponsor|318|||
33460128|NCT03843125|101570809|FG001|Overall Study|Study Terminated by Sponsor|318|||
33460129|NCT03843125|101570810|FG002|Overall Study|Study Terminated by Sponsor|163|||
33460130|NCT03843125|101570811|FG003|Overall Study|Study Terminated by Sponsor|163|||
33460131|NCT03843125|101570808|FG000|Overall Study|Withdrawal by Subject|23|||
33460132|NCT03843125|101570809|FG001|Overall Study|Withdrawal by Subject|12|||
33460133|NCT03843125|101570810|FG002|Overall Study|Withdrawal by Subject|6|||
33460134|NCT03843125|101570811|FG003|Overall Study|Withdrawal by Subject|9|||
33460135|NCT03843125|101570808|FG000|Overall Study|Missing data|0|||
33175105|NCT02289079|100549013|FG000|Overall Study|Lost to Follow-up|0|||
33175106|NCT02289079|100549014|FG001|Overall Study|Lost to Follow-up|1|||
33175107|NCT00643682|100549021|FG000|Overall Study|did not keep appointment|522|||
33175108|NCT00643682|100549022|FG001|Overall Study|did not keep appointment|509|||
33175109|NCT02268864|100549025|FG000|Overall Study|Withdrawal by Subject|2|||
33175110|NCT02268864|100549026|FG001|Overall Study|Withdrawal by Subject|0|||
33175111|NCT02268864|100549027|FG002|Overall Study|Withdrawal by Subject|0|||
33175112|NCT02268864|100549025|FG000|Overall Study|Death|0|||
33175113|NCT02268864|100549026|FG001|Overall Study|Death|1|||
33175114|NCT02268864|100549027|FG002|Overall Study|Death|0|||
33175115|NCT01189812|100549028|FG000|Overall Study|Withdrawal by Subject|2|||
33175116|NCT01189812|100549029|FG001|Overall Study|Withdrawal by Subject|3|||
33175117|NCT01189812|100549028|FG000|Overall Study|Adverse Event|1|||
33175118|NCT01189812|100549029|FG001|Overall Study|Adverse Event|0|||
33175119|NCT01189812|100549028|FG000|Overall Study|Out of Window|4|||
33175120|NCT01189812|100549029|FG001|Overall Study|Out of Window|3|||
33175121|NCT01189812|100549028|FG000|Overall Study|Moved out of State|1|||
33262844|NCT05580003|100863767|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33460136|NCT03843125|101570809|FG001|Overall Study|Missing data|1|||
33460137|NCT03843125|101570810|FG002|Overall Study|Missing data|1|||
33460138|NCT03843125|101570811|FG003|Overall Study|Missing data|0|||
33460139|NCT05061992|101570816|FG000|Overall Study|Excess bowel movements|1|||
33460140|NCT05061992|101570817|FG001|Overall Study|Excess bowel movements|0|||
33460141|NCT05061992|101570816|FG000|Overall Study|Complications of Medical Care|1|||
33460142|NCT05061992|101570817|FG001|Overall Study|Complications of Medical Care|0|||
33262845|NCT05580003|100863768|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33460143|NCT05061992|101570816|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
33460144|NCT05061992|101570817|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
33460145|NCT05061992|101570816|FG000|Overall Study|Withdrawal by Subject|0|||
33460146|NCT05061992|101570817|FG001|Overall Study|Withdrawal by Subject|1|||
33460147|NCT01628549|101570818|FG000|Overall Study|Adverse Event|1|||
33460148|NCT01628549|101570819|FG001|Overall Study|Adverse Event|1|||
33460149|NCT01628549|101570820|FG002|Overall Study|Adverse Event|0|||
33460150|NCT01628549|101570821|FG003|Overall Study|Adverse Event|4|||
33460151|NCT01628549|101570818|FG000|Overall Study|Lost to Follow-up|3|||
33460152|NCT01628549|101570819|FG001|Overall Study|Lost to Follow-up|4|||
33460153|NCT01628549|101570820|FG002|Overall Study|Lost to Follow-up|3|||
33460154|NCT01628549|101570821|FG003|Overall Study|Lost to Follow-up|3|||
33460155|NCT01628549|101570818|FG000|Overall Study|Withdrawal by Subject|3|||
33460156|NCT01628549|101570819|FG001|Overall Study|Withdrawal by Subject|4|||
33460157|NCT01628549|101570820|FG002|Overall Study|Withdrawal by Subject|4|||
33460158|NCT01628549|101570821|FG003|Overall Study|Withdrawal by Subject|1|||
33460159|NCT01628549|101570818|FG000|Overall Study|Protocol Violation|2|||
33460160|NCT01628549|101570819|FG001|Overall Study|Protocol Violation|1|||
33460161|NCT01628549|101570820|FG002|Overall Study|Protocol Violation|1|||
33460162|NCT01628549|101570821|FG003|Overall Study|Protocol Violation|0|||
33460163|NCT01628549|101570818|FG000|Overall Study|withdrawn for noncompliance|0|||
33460164|NCT01628549|101570819|FG001|Overall Study|withdrawn for noncompliance|2|||
33460165|NCT01628549|101570820|FG002|Overall Study|withdrawn for noncompliance|1|||
33460166|NCT01628549|101570821|FG003|Overall Study|withdrawn for noncompliance|0|||
33460167|NCT01628549|101570818|FG000|Overall Study|abnormal laboratory test results|0|||
33460168|NCT01628549|101570819|FG001|Overall Study|abnormal laboratory test results|0|||
33460169|NCT01628549|101570820|FG002|Overall Study|abnormal laboratory test results|1|||
33460170|NCT01628549|101570821|FG003|Overall Study|abnormal laboratory test results|0|||
33460171|NCT01628549|101570818|FG000|Overall Study|positive pregnancy test|0|||
33460172|NCT01628549|101570819|FG001|Overall Study|positive pregnancy test|0|||
33460173|NCT01628549|101570820|FG002|Overall Study|positive pregnancy test|0|||
33460174|NCT01628549|101570821|FG003|Overall Study|positive pregnancy test|1|||
33460175|NCT00609154|101570823|FG000|Overall Study|Protocol Violation|1|||
33460176|NCT00609154|101570824|FG001|Overall Study|Protocol Violation|2|||
33460177|NCT00609154|101570823|FG000|Overall Study|Unable to establish IV access|0|||
33460178|NCT00609154|101570824|FG001|Overall Study|Unable to establish IV access|4|||
33460179|NCT00609154|101570823|FG000|Overall Study|Adverse Event|0|||
33460180|NCT00609154|101570824|FG001|Overall Study|Adverse Event|2|||
33460181|NCT04439123|101570825|FG000|Overall Study|Adverse Event|11|||
33460182|NCT04439123|101570825|FG000|Overall Study|Death|1|||
33460183|NCT04439123|101570825|FG000|Overall Study|Disease progression|19|||
33460184|NCT04439123|101570825|FG000|Overall Study|Withdrawal by Subject|2|||
33460185|NCT04439123|101570825|FG000|Overall Study|Still on treatment|2|||
33460186|NCT01924364|101570826|FG000|Overall Study|Physician Decision|3|||
33460187|NCT03693950|101573669|FG000|Overall Study|Withdrawal by Subject|1|||
33460188|NCT03693950|101573670|FG001|Overall Study|Withdrawal by Subject|0|||
33460189|NCT01436643|101573673|FG000|2-week Pre-treatment|Abnormal test result|0|||
33460190|NCT01436643|101573674|FG001|2-week Pre-treatment|Abnormal test result|0|||
33460191|NCT01436643|101573675|FG002|2-week Pre-treatment|Abnormal test result|0|||
33460192|NCT01436643|101573676|FG003|2-week Pre-treatment|Abnormal test result|1|||
33460193|NCT01436643|101573673|FG000|2-week Pre-treatment|Adverse Event|0|||
33460194|NCT01436643|101573674|FG001|2-week Pre-treatment|Adverse Event|0|||
33460195|NCT01436643|101573675|FG002|2-week Pre-treatment|Adverse Event|0|||
33460196|NCT01436643|101573676|FG003|2-week Pre-treatment|Adverse Event|5|||
33460197|NCT01436643|101573673|FG000|2-week Pre-treatment|Protocol Violation|0|||
33460198|NCT01436643|101573674|FG001|2-week Pre-treatment|Protocol Violation|0|||
33460199|NCT01436643|101573675|FG002|2-week Pre-treatment|Protocol Violation|0|||
33460200|NCT01436643|101573676|FG003|2-week Pre-treatment|Protocol Violation|4|||
33460201|NCT01436643|101573673|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
33460202|NCT01436643|101573674|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
33460203|NCT01436643|101573675|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
33460204|NCT01436643|101573676|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
33460205|NCT01436643|101573673|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
33460206|NCT01436643|101573674|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
33460207|NCT01436643|101573675|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
33460208|NCT01436643|101573676|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
33460209|NCT01436643|101573673|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
33460210|NCT01436643|101573674|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
33460211|NCT01436643|101573675|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
33460212|NCT01436643|101573676|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
33460213|NCT01579006|101573679|FG000|Overall Study|Lack of Efficacy|10|||
33460214|NCT01579006|101573679|FG000|Overall Study|Adverse Event|13|||
33460215|NCT01579006|101573679|FG000|Overall Study|Withdrawal by Subject|5|||
33460216|NCT01579006|101573679|FG000|Overall Study|Non-compliance|3|||
33460217|NCT01579006|101573679|FG000|Overall Study|Due to participant's health fund|1|||
33175122|NCT01189812|100549029|FG001|Overall Study|Moved out of State|2|||
33460218|NCT01579006|101573679|FG000|Overall Study|Scheduled surgery|1|||
33460219|NCT03578809|101573681|FG000|Overall Study|Death|0|||
33460220|NCT03578809|101573682|FG001|Overall Study|Death|2|||
33460221|NCT03578809|101573683|FG002|Overall Study|Death|0|||
33460222|NCT03578809|101573684|FG003|Overall Study|Death|1|||
33460223|NCT03578809|101573681|FG000|Overall Study|Lost to Follow-up|0|||
33460224|NCT03578809|101573682|FG001|Overall Study|Lost to Follow-up|1|||
33460225|NCT03578809|101573683|FG002|Overall Study|Lost to Follow-up|0|||
33460226|NCT03578809|101573684|FG003|Overall Study|Lost to Follow-up|0|||
33460227|NCT03578809|101573681|FG000|Overall Study|Withdrawal by Subject|3|||
33460228|NCT03578809|101573682|FG001|Overall Study|Withdrawal by Subject|5|||
33460229|NCT03578809|101573683|FG002|Overall Study|Withdrawal by Subject|2|||
33460230|NCT03578809|101573684|FG003|Overall Study|Withdrawal by Subject|0|||
33460231|NCT03578809|101573681|FG000|Overall Study|Other|3|||
33460232|NCT03578809|101573682|FG001|Overall Study|Other|6|||
33460233|NCT03578809|101573683|FG002|Overall Study|Other|2|||
33460234|NCT03578809|101573684|FG003|Overall Study|Other|8|||
33460235|NCT02250651|101573685|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
33460236|NCT02250651|101573686|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
33460237|NCT02250651|101573687|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
33460238|NCT02250651|101573685|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
33460239|NCT02250651|101573686|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
33460240|NCT02250651|101573687|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
33460241|NCT02250651|101573685|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
33460242|NCT02250651|101573686|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
33460243|NCT02250651|101573687|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
33460244|NCT02250651|101573685|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
33460245|NCT02250651|101573686|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
33460246|NCT02250651|101573687|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
33460247|NCT02250651|101573685|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
33175123|NCT00460408|100549033|FG000|Overall Study|Adverse Event|1|||
33175124|NCT00460408|100549034|FG001|Overall Study|Adverse Event|0|||
33175125|NCT00460408|100549035|FG002|Overall Study|Adverse Event|0|||
33175126|NCT00460408|100549036|FG003|Overall Study|Adverse Event|0|||
33175127|NCT00460408|100549033|FG000|Overall Study|Death|7|||
33175128|NCT00460408|100549034|FG001|Overall Study|Death|0|||
33175129|NCT00460408|100549035|FG002|Overall Study|Death|0|||
33175130|NCT00460408|100549036|FG003|Overall Study|Death|0|||
33175131|NCT00460408|100549033|FG000|Overall Study|Lost to Follow-up|11|||
33175132|NCT00460408|100549034|FG001|Overall Study|Lost to Follow-up|0|||
33175133|NCT00460408|100549035|FG002|Overall Study|Lost to Follow-up|1|||
33175134|NCT00460408|100549036|FG003|Overall Study|Lost to Follow-up|0|||
33175135|NCT00460408|100549033|FG000|Overall Study|Withdrawal by Subject|31|||
33175136|NCT00460408|100549034|FG001|Overall Study|Withdrawal by Subject|0|||
33175137|NCT00460408|100549035|FG002|Overall Study|Withdrawal by Subject|0|||
33175138|NCT00460408|100549036|FG003|Overall Study|Withdrawal by Subject|0|||
33175139|NCT00460408|100549033|FG000|Overall Study|Insufficient clinical response|5|||
33175140|NCT00460408|100549034|FG001|Overall Study|Insufficient clinical response|1|||
33175141|NCT00460408|100549035|FG002|Overall Study|Insufficient clinical response|5|||
33175142|NCT00460408|100549036|FG003|Overall Study|Insufficient clinical response|0|||
33262846|NCT05580003|100863769|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
33460248|NCT02250651|101573686|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
33460249|NCT02250651|101573687|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
33460250|NCT02250651|101573685|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
33460251|NCT02250651|101573686|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
33460252|NCT02250651|101573687|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
33460253|NCT02250651|101573685|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
33175143|NCT00460408|100549033|FG000|Overall Study|Other|12|||
33175144|NCT00460408|100549034|FG001|Overall Study|Other|2|||
33175145|NCT00460408|100549035|FG002|Overall Study|Other|0|||
33175146|NCT00460408|100549036|FG003|Overall Study|Other|0|||
33460254|NCT02250651|101573686|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
33460255|NCT02250651|101573687|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
33460256|NCT02250651|101573685|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
33460257|NCT02250651|101573686|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
33460258|NCT02250651|101573687|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
33460259|NCT02250651|101573685|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
33460260|NCT02250651|101573686|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
33460261|NCT02250651|101573687|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
33460262|NCT02250651|101573685|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
33460263|NCT02250651|101573686|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
33460264|NCT02250651|101573687|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
33175147|NCT01614067|100549037|FG000|Overall Study|Pregnancy|1|||
33460265|NCT02250651|101573685|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
33175148|NCT01614067|100549038|FG001|Overall Study|Pregnancy|0|||
33460266|NCT02250651|101573686|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
33460267|NCT02250651|101573687|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
33460268|NCT02250651|101573685|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
33460269|NCT02250651|101573686|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
33460270|NCT02250651|101573687|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
33460271|NCT02250651|101573685|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
33460272|NCT02250651|101573686|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
33460273|NCT02250651|101573687|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
33460274|NCT02250651|101573685|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
33460275|NCT02250651|101573686|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
33460276|NCT02250651|101573687|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
33460277|NCT02250651|101573685|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
33460278|NCT02250651|101573686|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
33460279|NCT02250651|101573687|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
33460280|NCT01203917|101573690|FG000|Overall Study|Death|29|||
33460281|NCT01203917|101573690|FG000|Overall Study|Lost to Follow-up|2|||
33460282|NCT01203917|101573690|FG000|Overall Study|Withdrawal by Subject|3|||
33460283|NCT01203917|101573690|FG000|Overall Study|Due to objective disease progression|1|||
33460284|NCT01203917|101573690|FG000|Overall Study|Due to EGFR M+I patient|1|||
33460285|NCT01958060|101573697|FG000|Overall Study|Not treated|2|||
33460286|NCT01958060|101573698|FG001|Overall Study|Not treated|0|||
33460287|NCT01958060|101573699|FG002|Overall Study|Not treated|0|||
33460288|NCT01958060|101573700|FG003|Overall Study|Not treated|0|||
33460289|NCT01958060|101573701|FG004|Overall Study|Not treated|1|||
33460290|NCT01958060|101573702|FG005|Overall Study|Not treated|0|||
33460291|NCT02754492|101573703|FG000|Overall Study|Protocol Violation|2|||
33460292|NCT02754492|101573704|FG001|Overall Study|Protocol Violation|2|||
33460293|NCT02754492|101573705|FG002|Overall Study|Protocol Violation|0|||
33460294|NCT02754492|101573706|FG003|Overall Study|Protocol Violation|1|||
33460295|NCT02754492|101573703|FG000|Overall Study|Withdrawal by Subject|2|||
33460296|NCT02754492|101573704|FG001|Overall Study|Withdrawal by Subject|0|||
33460297|NCT02754492|101573705|FG002|Overall Study|Withdrawal by Subject|0|||
33460298|NCT02754492|101573706|FG003|Overall Study|Withdrawal by Subject|0|||
33460299|NCT02754492|101573703|FG000|Overall Study|Equipment malfuntion|0|||
33460300|NCT02754492|101573704|FG001|Overall Study|Equipment malfuntion|0|||
33460301|NCT02754492|101573705|FG002|Overall Study|Equipment malfuntion|2|||
33460302|NCT02754492|101573706|FG003|Overall Study|Equipment malfuntion|5|||
33460303|NCT02754492|101573703|FG000|Overall Study|Adverse Event|0|||
33460304|NCT02754492|101573704|FG001|Overall Study|Adverse Event|0|||
33460305|NCT02754492|101573705|FG002|Overall Study|Adverse Event|0|||
33460306|NCT02754492|101573706|FG003|Overall Study|Adverse Event|13|||
33460307|NCT02754492|101573703|FG000|Overall Study|Venous access issues not resulting in AE|0|||
33460308|NCT02754492|101573704|FG001|Overall Study|Venous access issues not resulting in AE|0|||
33460309|NCT02754492|101573705|FG002|Overall Study|Venous access issues not resulting in AE|0|||
33460310|NCT02754492|101573706|FG003|Overall Study|Venous access issues not resulting in AE|4|||
33460311|NCT00708682|101573707|FG000|Infant Series|Adverse Event|1|||
33460312|NCT00708682|101573707|FG000|Infant Series|Lost to Follow-up|4|||
33460313|NCT00708682|101573707|FG000|Infant Series|Protocol Violation|1|||
33460314|NCT00708682|101573707|FG000|Infant Series|Parent/legal guardian request|6|||
33460315|NCT00708682|101573707|FG000|Infant Series|Failed to return|2|||
33175149|NCT01614067|100549037|FG000|Overall Study|Physician Decision|6|||
33460316|NCT00708682|101573707|FG000|Infant Series|Other|19|||
33460317|NCT00708682|101573707|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
33460318|NCT00708682|101573707|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
33460319|NCT00708682|101573707|FG000|Toddler Dose|Lost to Follow-up|3|||
33460320|NCT00708682|101573707|FG000|Toddler Dose|Failed to Return|4|||
33460321|NCT03942211|101573708|FG000|Overall Study|Death|1|||
33460322|NCT03942211|101573709|FG001|Overall Study|Death|0|||
33460323|NCT03942211|101573708|FG000|Overall Study|Study terminated by sponsor|5|||
33460324|NCT03942211|101573709|FG001|Overall Study|Study terminated by sponsor|3|||
33460325|NCT03942211|101573708|FG000|Overall Study|Adverse Event|0|||
33460326|NCT03942211|101573709|FG001|Overall Study|Adverse Event|1|||
33460327|NCT01337596|101573714|FG000|Overall Study|Withdrawal by Subject|0|||
33460328|NCT01337596|101573715|FG001|Overall Study|Withdrawal by Subject|0|||
33460329|NCT01337596|101573716|FG002|Overall Study|Withdrawal by Subject|0|||
33460330|NCT01337596|101573717|FG003|Overall Study|Withdrawal by Subject|0|||
33460331|NCT01337596|101573718|FG004|Overall Study|Withdrawal by Subject|2|||
33460332|NCT01337596|101573719|FG005|Overall Study|Withdrawal by Subject|0|||
33460333|NCT01337596|101573720|FG006|Overall Study|Withdrawal by Subject|0|||
33460334|NCT01337596|101573721|FG007|Overall Study|Withdrawal by Subject|0|||
33460335|NCT01337596|101573722|FG008|Overall Study|Withdrawal by Subject|0|||
33460336|NCT04610580|101573727|FG000|Two-way Crossover Period|Adverse Event|1|||
33460337|NCT04610580|101573728|FG001|Two-way Crossover Period|Adverse Event|0|||
33460338|NCT04610580|101573729|FG002|Two-way Crossover Period|Adverse Event|0|||
33460339|NCT04610580|101573730|FG003|Two-way Crossover Period|Adverse Event|0|||
33460340|NCT04610580|101573731|FG004|Two-way Crossover Period|Adverse Event|0|||
33460341|NCT04610580|101573732|FG005|Two-way Crossover Period|Adverse Event|0|||
33460342|NCT04610580|101573727|FG000|Two-way Crossover Period|Physician Decision|1|||
33460343|NCT04610580|101573728|FG001|Two-way Crossover Period|Physician Decision|0|||
33460344|NCT04610580|101573729|FG002|Two-way Crossover Period|Physician Decision|0|||
33460345|NCT04610580|101573730|FG003|Two-way Crossover Period|Physician Decision|0|||
33460346|NCT04610580|101573731|FG004|Two-way Crossover Period|Physician Decision|0|||
33460347|NCT04610580|101573732|FG005|Two-way Crossover Period|Physician Decision|0|||
33460348|NCT04610580|101573727|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
33460349|NCT04610580|101573728|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
33460350|NCT04610580|101573729|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
33460351|NCT04610580|101573730|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
33460352|NCT04610580|101573731|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
33460353|NCT04610580|101573732|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
33460354|NCT04610580|101573727|FG000|Two-way Crossover Period|Other than specified|0|||
33460355|NCT04610580|101573728|FG001|Two-way Crossover Period|Other than specified|1|||
33460356|NCT04610580|101573729|FG002|Two-way Crossover Period|Other than specified|0|||
33460357|NCT04610580|101573730|FG003|Two-way Crossover Period|Other than specified|0|||
33460358|NCT04610580|101573731|FG004|Two-way Crossover Period|Other than specified|0|||
33460359|NCT04610580|101573732|FG005|Two-way Crossover Period|Other than specified|0|||
33460360|NCT04610580|101573727|FG000|Washout Before Extension Period|Other than specified|0|||
33460361|NCT04610580|101573728|FG001|Washout Before Extension Period|Other than specified|1|||
33460362|NCT04610580|101573729|FG002|Washout Before Extension Period|Other than specified|0|||
33460363|NCT04610580|101573730|FG003|Washout Before Extension Period|Other than specified|0|||
33460364|NCT04610580|101573731|FG004|Washout Before Extension Period|Other than specified|0|||
33460365|NCT04610580|101573732|FG005|Washout Before Extension Period|Other than specified|0|||
33460366|NCT04610580|101573727|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
33460367|NCT04610580|101573728|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
33460368|NCT04610580|101573729|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
33460369|NCT04610580|101573730|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
33460370|NCT04610580|101573731|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
33460371|NCT04610580|101573732|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
33460372|NCT04610580|101573727|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
33460373|NCT04610580|101573728|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
33460374|NCT04610580|101573729|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
33460375|NCT04610580|101573730|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
33460376|NCT04610580|101573731|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
33460377|NCT04610580|101573732|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
33460378|NCT01376037|101573733|FG000|Overall Study|Lost to Follow-up|0|||
33460379|NCT01376037|101573734|FG001|Overall Study|Lost to Follow-up|2|||
33460380|NCT03433703|101573735|FG000|Overall Study|Study terminated by Sponsor|2|||
33460381|NCT01517867|101573748|FG000|Overall Study|never started treatment|29|||
33460382|NCT01517867|101573749|FG001|Overall Study|never started treatment|32|||
33460383|NCT01517867|101573748|FG000|Overall Study|Withdrawal by Subject|34|||
33460384|NCT01517867|101573749|FG001|Overall Study|Withdrawal by Subject|30|||
33460385|NCT01517867|101573748|FG000|Overall Study|Still in treatment at study end|0|||
33460386|NCT01517867|101573749|FG001|Overall Study|Still in treatment at study end|3|||
33460387|NCT02488109|101573750|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
33460388|NCT02488109|101573751|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
33460389|NCT02488109|101573750|FG000|12-month Follow-Up|Lost to Follow-up|4|||
33460390|NCT02488109|101573751|FG001|12-month Follow-Up|Lost to Follow-up|7|||
33460391|NCT02611323|101573752|FG000|Overall Study|Death|3|||
33460392|NCT02611323|101573753|FG001|Overall Study|Death|1|||
33460393|NCT02611323|101573754|FG002|Overall Study|Death|0|||
33460394|NCT02611323|101573755|FG003|Overall Study|Death|0|||
33460395|NCT02611323|101573756|FG004|Overall Study|Death|1|||
33460396|NCT02611323|101573757|FG005|Overall Study|Death|1|||
33460397|NCT02611323|101573758|FG006|Overall Study|Death|8|||
33460398|NCT02611323|101573759|FG007|Overall Study|Death|0|||
33460399|NCT02611323|101573760|FG008|Overall Study|Death|4|||
33460400|NCT02611323|101573761|FG009|Overall Study|Death|6|||
33460401|NCT02611323|101573762|FG010|Overall Study|Death|26|||
33460402|NCT02611323|101573752|FG000|Overall Study|Lost to Follow-up|1|||
33460403|NCT02611323|101573753|FG001|Overall Study|Lost to Follow-up|0|||
33460404|NCT02611323|101573754|FG002|Overall Study|Lost to Follow-up|0|||
33460405|NCT02611323|101573755|FG003|Overall Study|Lost to Follow-up|0|||
33460406|NCT02611323|101573756|FG004|Overall Study|Lost to Follow-up|0|||
33460407|NCT02611323|101573757|FG005|Overall Study|Lost to Follow-up|0|||
33460408|NCT02611323|101573758|FG006|Overall Study|Lost to Follow-up|3|||
33460409|NCT02611323|101573759|FG007|Overall Study|Lost to Follow-up|0|||
33460410|NCT02611323|101573760|FG008|Overall Study|Lost to Follow-up|0|||
33460411|NCT02611323|101573761|FG009|Overall Study|Lost to Follow-up|0|||
33460412|NCT02611323|101573762|FG010|Overall Study|Lost to Follow-up|2|||
33460413|NCT02611323|101573752|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
33460414|NCT02611323|101573753|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
33460415|NCT02611323|101573754|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
33460416|NCT02611323|101573755|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
33460417|NCT02611323|101573756|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
33460418|NCT02611323|101573757|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
33460419|NCT02611323|101573758|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
33460420|NCT02611323|101573759|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
33460421|NCT02611323|101573760|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
33460422|NCT02611323|101573761|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
33460423|NCT02611323|101573762|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
33460424|NCT02611323|101573752|FG000|Overall Study|Progressive Disease|0|||
33460425|NCT02611323|101573753|FG001|Overall Study|Progressive Disease|0|||
33460426|NCT02611323|101573754|FG002|Overall Study|Progressive Disease|0|||
33460427|NCT02611323|101573755|FG003|Overall Study|Progressive Disease|0|||
33460428|NCT02611323|101573756|FG004|Overall Study|Progressive Disease|0|||
33460429|NCT02611323|101573757|FG005|Overall Study|Progressive Disease|0|||
33460430|NCT02611323|101573758|FG006|Overall Study|Progressive Disease|0|||
33460431|NCT02611323|101573759|FG007|Overall Study|Progressive Disease|0|||
33460432|NCT02611323|101573760|FG008|Overall Study|Progressive Disease|0|||
33460433|NCT02611323|101573761|FG009|Overall Study|Progressive Disease|0|||
33460434|NCT02611323|101573762|FG010|Overall Study|Progressive Disease|1|||
33460435|NCT02611323|101573752|FG000|Overall Study|Withdrawal by Subject|1|||
33460436|NCT02611323|101573753|FG001|Overall Study|Withdrawal by Subject|0|||
33460437|NCT02611323|101573754|FG002|Overall Study|Withdrawal by Subject|0|||
33460438|NCT02611323|101573755|FG003|Overall Study|Withdrawal by Subject|0|||
33460439|NCT02611323|101573756|FG004|Overall Study|Withdrawal by Subject|0|||
33460440|NCT02611323|101573757|FG005|Overall Study|Withdrawal by Subject|0|||
33460441|NCT02611323|101573758|FG006|Overall Study|Withdrawal by Subject|0|||
33460442|NCT02611323|101573759|FG007|Overall Study|Withdrawal by Subject|1|||
33460443|NCT02611323|101573760|FG008|Overall Study|Withdrawal by Subject|0|||
33460444|NCT02611323|101573761|FG009|Overall Study|Withdrawal by Subject|1|||
33460445|NCT02611323|101573762|FG010|Overall Study|Withdrawal by Subject|0|||
33460446|NCT01588548|101573765|FG000|Overall Study|Withdrawal by Subject|0|||
33460447|NCT01588548|101573766|FG001|Overall Study|Withdrawal by Subject|1|||
33460448|NCT01588548|101573767|FG002|Overall Study|Withdrawal by Subject|1|||
33460449|NCT01588548|101573768|FG003|Overall Study|Withdrawal by Subject|1|||
33460450|NCT01588548|101573769|FG004|Overall Study|Withdrawal by Subject|2|||
33460451|NCT01588548|101573770|FG005|Overall Study|Withdrawal by Subject|3|||
33460452|NCT01588548|101573765|FG000|Overall Study|Adverse Event|0|||
33460453|NCT01588548|101573766|FG001|Overall Study|Adverse Event|0|||
33460454|NCT01588548|101573767|FG002|Overall Study|Adverse Event|1|||
33460455|NCT01588548|101573768|FG003|Overall Study|Adverse Event|2|||
33460456|NCT01588548|101573769|FG004|Overall Study|Adverse Event|1|||
33460457|NCT01588548|101573770|FG005|Overall Study|Adverse Event|0|||
33460458|NCT01588548|101573765|FG000|Overall Study|Condition Under Investigation Worsened|3|||
33460459|NCT01588548|101573766|FG001|Overall Study|Condition Under Investigation Worsened|6|||
33460460|NCT01588548|101573767|FG002|Overall Study|Condition Under Investigation Worsened|4|||
33460461|NCT01588548|101573768|FG003|Overall Study|Condition Under Investigation Worsened|4|||
33460462|NCT01588548|101573769|FG004|Overall Study|Condition Under Investigation Worsened|3|||
33460463|NCT01588548|101573770|FG005|Overall Study|Condition Under Investigation Worsened|3|||
33460464|NCT00939523|101573771|FG000|Overall Study|Lack of Efficacy|1|||
33460465|NCT00939523|101573771|FG000|Overall Study|Physician Decision|2|||
33460466|NCT03303417|101573772|FG000|Overall Study|Withdrawal by Subject|1|||
33460467|NCT03303417|101573773|FG001|Overall Study|Withdrawal by Subject|1|||
33460468|NCT01917084|101573774|FG000|Overall Study|Withdrawal by Subject|1|||
33460469|NCT03414034|101573775|FG000|Overall Study|Adverse Event|6|||
33460470|NCT03414034|101573776|FG001|Overall Study|Adverse Event|1|||
33460471|NCT03414034|101573777|FG002|Overall Study|Adverse Event|1|||
33460472|NCT03414034|101573775|FG000|Overall Study|Death|0|||
33460473|NCT03414034|101573776|FG001|Overall Study|Death|0|||
33460474|NCT03414034|101573777|FG002|Overall Study|Death|1|||
33460475|NCT03414034|101573775|FG000|Overall Study|Non-compliance With Study Drug|0|||
33460476|NCT03414034|101573776|FG001|Overall Study|Non-compliance With Study Drug|0|||
33460477|NCT03414034|101573777|FG002|Overall Study|Non-compliance With Study Drug|1|||
33460478|NCT03414034|101573775|FG000|Overall Study|Physician Decision|1|||
33460479|NCT03414034|101573776|FG001|Overall Study|Physician Decision|3|||
33460480|NCT03414034|101573777|FG002|Overall Study|Physician Decision|2|||
33460481|NCT03414034|101573775|FG000|Overall Study|Withdrawal of Informed Consent|2|||
33460482|NCT03414034|101573776|FG001|Overall Study|Withdrawal of Informed Consent|1|||
33460483|NCT03414034|101573777|FG002|Overall Study|Withdrawal of Informed Consent|4|||
33460484|NCT03414034|101573775|FG000|Overall Study|Progressive Disease|15|||
33460485|NCT03414034|101573776|FG001|Overall Study|Progressive Disease|15|||
33460486|NCT03414034|101573777|FG002|Overall Study|Progressive Disease|17|||
33460487|NCT03414034|101573775|FG000|Overall Study|Miscellaneous|0|||
33460488|NCT03414034|101573776|FG001|Overall Study|Miscellaneous|0|||
33460489|NCT03414034|101573777|FG002|Overall Study|Miscellaneous|2|||
33460490|NCT03833427|101573781|FG000|Overall Study|Death|4|||
33460491|NCT03833427|101573782|FG001|Overall Study|Death|2|||
33460492|NCT03833427|101573783|FG002|Overall Study|Death|9|||
33460493|NCT03833427|101573784|FG003|Overall Study|Death|11|||
33460494|NCT03833427|101573785|FG004|Overall Study|Death|0|||
33460495|NCT03833427|101573786|FG005|Overall Study|Death|0|||
33460496|NCT03833427|101573787|FG006|Overall Study|Death|0|||
33460497|NCT03833427|101573781|FG000|Overall Study|Withdrawal by Subject|0|||
33460498|NCT03833427|101573782|FG001|Overall Study|Withdrawal by Subject|1|||
33460499|NCT03833427|101573783|FG002|Overall Study|Withdrawal by Subject|1|||
33460500|NCT03833427|101573784|FG003|Overall Study|Withdrawal by Subject|0|||
33460501|NCT03833427|101573785|FG004|Overall Study|Withdrawal by Subject|0|||
33460502|NCT03833427|101573786|FG005|Overall Study|Withdrawal by Subject|0|||
33460503|NCT03833427|101573787|FG006|Overall Study|Withdrawal by Subject|0|||
33460504|NCT03833427|101573781|FG000|Overall Study|Sponsor Decision|0|||
33460505|NCT03833427|101573782|FG001|Overall Study|Sponsor Decision|0|||
33460506|NCT03833427|101573783|FG002|Overall Study|Sponsor Decision|1|||
33175150|NCT01614067|100549038|FG001|Overall Study|Physician Decision|5|||
33175151|NCT01614067|100549037|FG000|Overall Study|Withdrawal by Subject|0|||
33175152|NCT01614067|100549038|FG001|Overall Study|Withdrawal by Subject|1|||
33175153|NCT01614067|100549037|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
33262847|NCT05580003|100863770|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33175154|NCT01614067|100549038|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
33175155|NCT00416078|100549039|FG000|Overall Study|Death|3|||
33262848|NCT05580003|100863771|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262849|NCT05580003|100863772|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262850|NCT05580003|100863773|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262851|NCT05580003|100863774|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262852|NCT05580003|100863775|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
33262853|NCT05580003|100863748|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262854|NCT05580003|100863749|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262855|NCT05580003|100863750|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262856|NCT05580003|100863751|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262857|NCT05580003|100863752|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262858|NCT05580003|100863753|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262859|NCT05580003|100863754|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262860|NCT05580003|100863755|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262861|NCT05580003|100863756|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262862|NCT05580003|100863757|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262863|NCT05580003|100863758|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33460507|NCT03833427|101573784|FG003|Overall Study|Sponsor Decision|3|||
33460508|NCT03833427|101573785|FG004|Overall Study|Sponsor Decision|0|||
33460509|NCT03833427|101573786|FG005|Overall Study|Sponsor Decision|0|||
33460510|NCT03833427|101573787|FG006|Overall Study|Sponsor Decision|0|||
33460511|NCT02539368|101573788|FG000|Overall Study|Death|4|||
33460512|NCT02539368|101573789|FG001|Overall Study|Death|2|||
33460513|NCT02539368|101573790|FG002|Overall Study|Death|1|||
33262864|NCT05580003|100863759|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262865|NCT05580003|100863760|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33460514|NCT02539368|101573791|FG003|Overall Study|Death|0|||
33460515|NCT02539368|101573792|FG004|Overall Study|Death|0|||
33460516|NCT02539368|101573788|FG000|Overall Study|Withdrawal by Subject|44|||
33460517|NCT02539368|101573789|FG001|Overall Study|Withdrawal by Subject|35|||
33460518|NCT02539368|101573790|FG002|Overall Study|Withdrawal by Subject|9|||
33460519|NCT02539368|101573791|FG003|Overall Study|Withdrawal by Subject|1|||
33460520|NCT02539368|101573792|FG004|Overall Study|Withdrawal by Subject|3|||
33460521|NCT02539368|101573788|FG000|Overall Study|Physician Decision|49|||
33460522|NCT02539368|101573789|FG001|Overall Study|Physician Decision|15|||
33460523|NCT02539368|101573790|FG002|Overall Study|Physician Decision|7|||
33175156|NCT00416078|100549040|FG001|Overall Study|Death|4|||
33175157|NCT00416078|100549039|FG000|Overall Study|Withdrawal by Subject|3|||
33460524|NCT02539368|101573791|FG003|Overall Study|Physician Decision|0|||
33460525|NCT02539368|101573792|FG004|Overall Study|Physician Decision|2|||
33460526|NCT02539368|101573788|FG000|Overall Study|Lost to Follow-up|96|||
33460527|NCT02539368|101573789|FG001|Overall Study|Lost to Follow-up|21|||
33460528|NCT02539368|101573790|FG002|Overall Study|Lost to Follow-up|16|||
33460529|NCT02539368|101573791|FG003|Overall Study|Lost to Follow-up|4|||
33460530|NCT02539368|101573792|FG004|Overall Study|Lost to Follow-up|3|||
33262866|NCT05580003|100863761|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262867|NCT05580003|100863762|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262868|NCT05580003|100863763|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262869|NCT05580003|100863764|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262870|NCT05580003|100863765|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262871|NCT05580003|100863766|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262872|NCT05580003|100863767|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262873|NCT05580003|100863768|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262874|NCT05580003|100863769|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262875|NCT05580003|100863770|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262876|NCT05580003|100863771|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262877|NCT05580003|100863772|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33460531|NCT02539368|101573788|FG000|Overall Study|Adverse Event|44|||
33460532|NCT02539368|101573789|FG001|Overall Study|Adverse Event|5|||
33460533|NCT02539368|101573790|FG002|Overall Study|Adverse Event|9|||
33460534|NCT02539368|101573791|FG003|Overall Study|Adverse Event|0|||
33460535|NCT02539368|101573792|FG004|Overall Study|Adverse Event|3|||
33460536|NCT02539368|101573788|FG000|Overall Study|Participant Non-compliant|13|||
33460537|NCT02539368|101573789|FG001|Overall Study|Participant Non-compliant|2|||
33460538|NCT02539368|101573790|FG002|Overall Study|Participant Non-compliant|1|||
33460539|NCT02539368|101573791|FG003|Overall Study|Participant Non-compliant|1|||
33460540|NCT02539368|101573792|FG004|Overall Study|Participant Non-compliant|0|||
33460541|NCT02539368|101573788|FG000|Overall Study|Other|145|||
33460542|NCT02539368|101573789|FG001|Overall Study|Other|18|||
33460543|NCT02539368|101573790|FG002|Overall Study|Other|24|||
33460544|NCT02539368|101573791|FG003|Overall Study|Other|1|||
33460545|NCT02539368|101573792|FG004|Overall Study|Other|3|||
33460546|NCT02539368|101573788|FG000|Overall Study|Missing|10|||
33460547|NCT02539368|101573789|FG001|Overall Study|Missing|3|||
33460548|NCT02539368|101573790|FG002|Overall Study|Missing|0|||
33460549|NCT02539368|101573791|FG003|Overall Study|Missing|0|||
33460550|NCT02539368|101573792|FG004|Overall Study|Missing|0|||
33460551|NCT00084864|101573794|FG000|Overall Study|Adverse Event|1|||
33460552|NCT00084864|101573795|FG001|Overall Study|Adverse Event|0|||
33460553|NCT00084864|101573796|FG002|Overall Study|Adverse Event|0|||
33460554|NCT00084864|101573797|FG003|Overall Study|Adverse Event|0|||
33460555|NCT04307849|101573800|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
33460556|NCT04307849|101573801|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
33460557|NCT04307849|101573802|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
33460558|NCT04307849|101573803|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
33460559|NCT04307849|101573804|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
33460560|NCT04307849|101573805|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
33460561|NCT04307849|101573800|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
33460562|NCT04307849|101573801|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
33175158|NCT00416078|100549040|FG001|Overall Study|Withdrawal by Subject|2|||
33460563|NCT04307849|101573802|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
33460564|NCT04307849|101573803|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
33460565|NCT04307849|101573804|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
33460566|NCT04307849|101573805|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
33460567|NCT04307849|101573800|FG000|Overall Study|Family member did not want them to continue|0|||
33460568|NCT04307849|101573801|FG001|Overall Study|Family member did not want them to continue|0|||
33460569|NCT04307849|101573802|FG002|Overall Study|Family member did not want them to continue|1|||
33460570|NCT04307849|101573803|FG003|Overall Study|Family member did not want them to continue|0|||
33460571|NCT04307849|101573804|FG004|Overall Study|Family member did not want them to continue|0|||
33460572|NCT04307849|101573805|FG005|Overall Study|Family member did not want them to continue|0|||
33460573|NCT04307849|101573800|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
33460574|NCT04307849|101573801|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
33460575|NCT04307849|101573802|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
33460576|NCT04307849|101573803|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
33460577|NCT04307849|101573804|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
33460578|NCT04307849|101573805|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
33460579|NCT00799708|101573806|FG000|Overall Study|non-compliance|1|||
33460580|NCT00799708|101573807|FG001|Overall Study|non-compliance|0|||
33460581|NCT00799708|101573808|FG002|Overall Study|non-compliance|0|||
33460582|NCT01148225|101573810|FG000|Overall Study|Other|185|||
33460583|NCT02658019|101573811|FG000|Overall Study|Adverse Event|1|||
33460584|NCT04523480|101573815|FG000|Overall Study|Lost to Follow-up|30|||
33460585|NCT04523480|101573816|FG001|Overall Study|Lost to Follow-up|35|||
33460586|NCT04523480|101573817|FG002|Overall Study|Lost to Follow-up|0|||
33460587|NCT04233216|101573818|FG000|Overall Study|Lost to Follow-up|1|||
33460588|NCT04233216|101573819|FG001|Overall Study|Lost to Follow-up|0|||
33460589|NCT04233216|101573820|FG002|Overall Study|Lost to Follow-up|2|||
33460590|NCT04233216|101573821|FG003|Overall Study|Lost to Follow-up|0|||
33460591|NCT04233216|101573818|FG000|Overall Study|Physician Decision|0|||
33460592|NCT04233216|101573819|FG001|Overall Study|Physician Decision|3|||
33460593|NCT04233216|101573820|FG002|Overall Study|Physician Decision|0|||
33460594|NCT04233216|101573821|FG003|Overall Study|Physician Decision|2|||
33175159|NCT00416078|100549039|FG000|Overall Study|Physician Decision|1|||
33262878|NCT05580003|100863773|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33262879|NCT05580003|100863774|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
33460595|NCT04233216|101573818|FG000|Overall Study|Withdrawal by Subject|0|||
33460596|NCT04233216|101573819|FG001|Overall Study|Withdrawal by Subject|2|||
33262880|NCT05580003|100863775|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
33460597|NCT04233216|101573820|FG002|Overall Study|Withdrawal by Subject|1|||
33460598|NCT04233216|101573821|FG003|Overall Study|Withdrawal by Subject|0|||
33460599|NCT00562120|101573822|FG000|First Intervention Period|Adverse Event|1|||
33175160|NCT00416078|100549040|FG001|Overall Study|Physician Decision|0|||
33460600|NCT00562120|101573823|FG001|First Intervention Period|Adverse Event|0|||
33460601|NCT00562120|101573824|FG002|First Intervention Period|Adverse Event|0|||
33262881|NCT05580003|100863748|FG000|Part 6 Period 2 (Day 1)|Other|0|||
33175161|NCT00416078|100549039|FG000|Overall Study|Lost to Follow-up|4|||
33460602|NCT00562120|101573825|FG003|First Intervention Period|Adverse Event|0|||
33460603|NCT00562120|101573822|FG000|First Intervention Period|Randomized but not Treated|1|||
33460604|NCT00562120|101573823|FG001|First Intervention Period|Randomized but not Treated|0|||
33175162|NCT00416078|100549040|FG001|Overall Study|Lost to Follow-up|2|||
33460605|NCT00562120|101573824|FG002|First Intervention Period|Randomized but not Treated|0|||
33175163|NCT00293254|100549041|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
33175164|NCT00293254|100549042|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
33460606|NCT00562120|101573825|FG003|First Intervention Period|Randomized but not Treated|0|||
33460607|NCT01115933|101573826|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
33460608|NCT01785615|101573829|FG000|Dietary Phase|Lost to Follow-up|0|||
33460609|NCT01785615|101573830|FG001|Dietary Phase|Lost to Follow-up|0|||
33460610|NCT01785615|101573831|FG002|Dietary Phase|Lost to Follow-up|0|||
33460611|NCT01785615|101573832|FG003|Dietary Phase|Lost to Follow-up|24|||
33460612|NCT00683592|101573834|FG000|Overall Study|Adverse Event|12|||
33460613|NCT00683592|101573835|FG001|Overall Study|Adverse Event|4|||
33460614|NCT00683592|101573834|FG000|Overall Study|Withdrawal by Subject|11|||
33460615|NCT00683592|101573835|FG001|Overall Study|Withdrawal by Subject|11|||
33460616|NCT00683592|101573834|FG000|Overall Study|Lost to Follow-up|17|||
33460617|NCT00683592|101573835|FG001|Overall Study|Lost to Follow-up|17|||
33460618|NCT00683592|101573834|FG000|Overall Study|Lack of Efficacy|3|||
33460619|NCT00683592|101573835|FG001|Overall Study|Lack of Efficacy|7|||
33460620|NCT00683592|101573834|FG000|Overall Study|Physician Decision|0|||
33460621|NCT00683592|101573835|FG001|Overall Study|Physician Decision|1|||
33460622|NCT00683592|101573834|FG000|Overall Study|Non-compliance|3|||
33262882|NCT05580003|100863749|FG001|Part 6 Period 2 (Day 1)|Other|0|||
33460623|NCT00683592|101573835|FG001|Overall Study|Non-compliance|5|||
33460624|NCT00683592|101573834|FG000|Overall Study|Other|1|||
33460625|NCT00683592|101573835|FG001|Overall Study|Other|1|||
33262883|NCT05580003|100863750|FG002|Part 6 Period 2 (Day 1)|Other|0|||
33460626|NCT04573309|101573838|FG000|Overall Study|Protocol Violation|1|||
33460627|NCT04573309|101573839|FG001|Overall Study|Protocol Violation|0|||
33460628|NCT01688882|101573840|FG000|Overall Study|Adverse Event|1|||
33460629|NCT01688882|101573841|FG001|Overall Study|Adverse Event|0|||
33460630|NCT01688882|101573840|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33460631|NCT01688882|101573841|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33460632|NCT01688882|101573840|FG000|Overall Study|Administrative problems|1|||
33460633|NCT01688882|101573841|FG001|Overall Study|Administrative problems|0|||
33262884|NCT05580003|100863751|FG003|Part 6 Period 2 (Day 1)|Other|0|||
33262885|NCT05580003|100863752|FG004|Part 6 Period 2 (Day 1)|Other|0|||
33262886|NCT05580003|100863753|FG005|Part 6 Period 2 (Day 1)|Other|0|||
33262887|NCT05580003|100863754|FG006|Part 6 Period 2 (Day 1)|Other|0|||
33262888|NCT05580003|100863755|FG007|Part 6 Period 2 (Day 1)|Other|0|||
33262889|NCT05580003|100863756|FG008|Part 6 Period 2 (Day 1)|Other|0|||
33262890|NCT05580003|100863757|FG009|Part 6 Period 2 (Day 1)|Other|0|||
33262891|NCT05580003|100863758|FG010|Part 6 Period 2 (Day 1)|Other|0|||
33262892|NCT05580003|100863759|FG011|Part 6 Period 2 (Day 1)|Other|0|||
33262893|NCT05580003|100863760|FG012|Part 6 Period 2 (Day 1)|Other|0|||
33262894|NCT05580003|100863761|FG013|Part 6 Period 2 (Day 1)|Other|0|||
33262895|NCT05580003|100863762|FG014|Part 6 Period 2 (Day 1)|Other|0|||
33262896|NCT05580003|100863763|FG015|Part 6 Period 2 (Day 1)|Other|0|||
33262897|NCT05580003|100863764|FG016|Part 6 Period 2 (Day 1)|Other|0|||
33262898|NCT05580003|100863765|FG017|Part 6 Period 2 (Day 1)|Other|0|||
33262899|NCT05580003|100863766|FG018|Part 6 Period 2 (Day 1)|Other|0|||
33262900|NCT05580003|100863767|FG019|Part 6 Period 2 (Day 1)|Other|0|||
33262901|NCT05580003|100863768|FG020|Part 6 Period 2 (Day 1)|Other|0|||
33262902|NCT05580003|100863769|FG021|Part 6 Period 2 (Day 1)|Other|0|||
33262903|NCT05580003|100863770|FG022|Part 6 Period 2 (Day 1)|Other|0|||
33262904|NCT05580003|100863771|FG023|Part 6 Period 2 (Day 1)|Other|0|||
33262905|NCT05580003|100863772|FG024|Part 6 Period 2 (Day 1)|Other|1|||
33262906|NCT05580003|100863773|FG025|Part 6 Period 2 (Day 1)|Other|0|||
33262907|NCT05580003|100863774|FG026|Part 6 Period 2 (Day 1)|Other|0|||
33262908|NCT05580003|100863775|FG027|Part 6 Period 2 (Day 1)|Other|0|||
33262909|NCT02633215|100863780|FG000|Overall Study|Lost to Follow-up|2|||
33262910|NCT02633215|100863781|FG001|Overall Study|Lost to Follow-up|3|||
33262911|NCT02866942|100863782|FG000|Overall Study|Invalid consent|1|||
33262912|NCT00795184|100863783|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
33262913|NCT00795184|100863784|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
33262914|NCT01367236|100863789|FG000|Overall Study|Withdrawal by Subject|3|||
33262915|NCT01367236|100863790|FG001|Overall Study|Withdrawal by Subject|1|||
33460634|NCT02058160|101573844|FG000|Overall Study|Randomized but not treated|2|||
33460635|NCT02058160|101573845|FG001|Overall Study|Randomized but not treated|4|||
33460636|NCT02058160|101573844|FG000|Overall Study|Poor compliance to protocol|4|||
33460637|NCT02058160|101573845|FG001|Overall Study|Poor compliance to protocol|1|||
33460638|NCT02058160|101573844|FG000|Overall Study|Adverse Event|12|||
33460639|NCT02058160|101573845|FG001|Overall Study|Adverse Event|3|||
33460640|NCT02058160|101573844|FG000|Overall Study|Lost to Follow-up|1|||
33460641|NCT02058160|101573845|FG001|Overall Study|Lost to Follow-up|0|||
33460642|NCT02058160|101573844|FG000|Overall Study|Other than specified above|12|||
33460643|NCT02058160|101573845|FG001|Overall Study|Other than specified above|6|||
33175165|NCT00293254|100549041|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
33460644|NCT00199901|101573846|FG000|Overall Study|Protocol Violation|2|||
33460645|NCT00199901|101573847|FG001|Overall Study|Protocol Violation|0|||
33460646|NCT00199901|101573846|FG000|Overall Study|Withdrawal by Subject|1|||
33460647|NCT00199901|101573847|FG001|Overall Study|Withdrawal by Subject|0|||
33262916|NCT05171777|100863791|FG000|Treatment Crossover Period|Adverse Event|9|||
33262917|NCT05171777|100863792|FG001|Treatment Crossover Period|Adverse Event|6|||
33262918|NCT05171777|100863793|FG002|Treatment Crossover Period|Adverse Event|0|||
33262919|NCT05171777|100863794|FG003|Treatment Crossover Period|Adverse Event|0|||
33262920|NCT05171777|100863791|FG000|Treatment Crossover Period|Death|5|||
33262921|NCT05171777|100863792|FG001|Treatment Crossover Period|Death|5|||
33262922|NCT05171777|100863793|FG002|Treatment Crossover Period|Death|0|||
33175166|NCT00293254|100549042|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
33175167|NCT00293254|100549041|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
33175168|NCT00293254|100549042|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
33175169|NCT00293254|100549041|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
33175170|NCT00293254|100549042|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
33175171|NCT00293254|100549041|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
33175172|NCT00293254|100549042|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
33175173|NCT00293254|100549041|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
33175174|NCT00293254|100549042|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
33175175|NCT00293254|100549041|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
33175176|NCT00293254|100549042|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
33175177|NCT00293254|100549041|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
33175178|NCT00293254|100549042|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
33175179|NCT00293254|100549041|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
33175180|NCT00293254|100549042|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
33175181|NCT00293254|100549041|FG000|Extension - Double-Blind Week 49-156|Death|4|||
33175182|NCT00293254|100549042|FG001|Extension - Double-Blind Week 49-156|Death|1|||
33175183|NCT00293254|100549041|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
33175184|NCT00293254|100549042|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
33175185|NCT00293254|100549041|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
33175186|NCT00293254|100549042|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
33175187|NCT00293254|100549041|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
33175188|NCT00293254|100549042|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
33175189|NCT00293254|100549041|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
33175190|NCT00293254|100549042|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
33175191|NCT00293254|100549041|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
33175192|NCT00293254|100549042|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
33175193|NCT00293254|100549041|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
33175194|NCT00293254|100549042|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
33175195|NCT00293254|100549041|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
33175196|NCT00293254|100549042|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
33175197|NCT00293254|100549041|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
33175198|NCT00293254|100549042|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
33175199|NCT00293254|100549041|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
33175200|NCT00293254|100549042|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
33175201|NCT00293254|100549041|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
33175202|NCT00293254|100549042|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
33175203|NCT00293254|100549041|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
33175204|NCT00293254|100549042|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
33175205|NCT00293254|100549041|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
33175206|NCT00293254|100549042|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
33175207|NCT00293254|100549041|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
33175208|NCT00293254|100549042|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
33175209|NCT00293254|100549041|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
33175210|NCT00293254|100549042|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
33175211|NCT00293254|100549041|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
33460648|NCT00199901|101573846|FG000|Overall Study|Progressive Disease|24|||
33460649|NCT00199901|101573847|FG001|Overall Study|Progressive Disease|24|||
33460650|NCT04592419|101573850|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
33460651|NCT04592419|101573851|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
33460652|NCT04592419|101573850|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
33460653|NCT04592419|101573851|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
33460654|NCT04592419|101573850|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
33460655|NCT04592419|101573851|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
33460656|NCT04592419|101573850|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
33460657|NCT04592419|101573851|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
33460658|NCT04592419|101573850|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
33460659|NCT04592419|101573851|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
33460660|NCT04592419|101573850|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
33460661|NCT04592419|101573851|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
33460662|NCT04592419|101573850|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
33460663|NCT04592419|101573851|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
33460664|NCT04592419|101573850|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
33460665|NCT04592419|101573851|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
33460666|NCT04592419|101573850|FG000|Open-Label Extension Period|Adverse Event|1|||
33460667|NCT04592419|101573851|FG001|Open-Label Extension Period|Adverse Event|2|||
33460668|NCT04592419|101573850|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
33460669|NCT04592419|101573851|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
33460670|NCT04592419|101573850|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
33460671|NCT04592419|101573851|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
33460672|NCT04592419|101573850|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
33460673|NCT04592419|101573851|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
33460674|NCT04592419|101573850|FG000|Open-Label Extension Period|Sponsor Request|73|||
33460675|NCT04592419|101573851|FG001|Open-Label Extension Period|Sponsor Request|84|||
33460676|NCT03343639|101573860|FG000|Overall Study|Withdrawal by Subject|10|||
33460677|NCT03343639|101573861|FG001|Overall Study|Withdrawal by Subject|6|||
33460678|NCT03343639|101573860|FG000|Overall Study|Lost to Follow-up|4|||
33460679|NCT03343639|101573861|FG001|Overall Study|Lost to Follow-up|5|||
33460680|NCT03343639|101573860|FG000|Overall Study|Protocol Violation|0|||
33460681|NCT03343639|101573861|FG001|Overall Study|Protocol Violation|1|||
33460682|NCT01263561|101573862|FG000|Overall Study|Death|1|||
33460683|NCT01263561|101573863|FG001|Overall Study|Death|2|||
33460684|NCT01256060|101573864|FG000|Overall Study|Lost to Follow-up|0|||
33460685|NCT01256060|101573865|FG001|Overall Study|Lost to Follow-up|1|||
33460686|NCT01256060|101573866|FG002|Overall Study|Lost to Follow-up|0|||
33460687|NCT01256060|101573867|FG003|Overall Study|Lost to Follow-up|0|||
33460688|NCT02875028|101573870|FG000|Washout Period|Withdrawal by Subject|0|||
33460689|NCT02875028|101573871|FG001|Washout Period|Withdrawal by Subject|1|||
33460690|NCT02725411|101573874|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
33460691|NCT02725411|101573875|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
33460692|NCT02725411|101573876|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
33460693|NCT02725411|101573874|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
33460694|NCT02725411|101573875|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
33460695|NCT02725411|101573876|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
33460696|NCT02725411|101573874|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
33460697|NCT02725411|101573875|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
33460698|NCT02725411|101573876|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
33460699|NCT02725411|101573874|FG000|Treatment Period (56 Weeks)|Other|1|||
33460700|NCT02725411|101573875|FG001|Treatment Period (56 Weeks)|Other|4|||
33460701|NCT02725411|101573876|FG002|Treatment Period (56 Weeks)|Other|5|||
33460702|NCT02725411|101573874|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
33460703|NCT02725411|101573875|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
33262923|NCT05171777|100863794|FG003|Treatment Crossover Period|Death|0|||
33460704|NCT02725411|101573876|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
33460705|NCT02725411|101573874|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
33460706|NCT02725411|101573875|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
33460707|NCT02725411|101573876|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
33460708|NCT02725411|101573874|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
33460709|NCT02725411|101573875|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
33460710|NCT02725411|101573876|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
33460711|NCT02725411|101573874|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
33175212|NCT00293254|100549042|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
33175213|NCT00293254|100549041|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
33175214|NCT00293254|100549042|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
33175215|NCT00293254|100549041|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
33175216|NCT00293254|100549042|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
33175217|NCT02557646|100549043|FG000|Overall Study|Adverse Event|40|||
33175218|NCT02557646|100549043|FG000|Overall Study|Death|1|||
33460712|NCT02725411|101573875|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
33460713|NCT02725411|101573876|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
33460714|NCT02725411|101573874|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
33460715|NCT02725411|101573875|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
33460716|NCT02725411|101573876|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
33460717|NCT02725411|101573874|FG000|Follow-up Period (24 Weeks)|Other|1|||
33460718|NCT02725411|101573875|FG001|Follow-up Period (24 Weeks)|Other|4|||
33460719|NCT02725411|101573876|FG002|Follow-up Period (24 Weeks)|Other|2|||
33460720|NCT02725411|101573874|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
33460721|NCT02725411|101573875|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
33460722|NCT02725411|101573876|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
33460723|NCT00676494|101573877|FG000|Overall Study|Missed Visit|8|||
33460724|NCT00676494|101573877|FG000|Overall Study|Withdrawal by Subject|6|||
33460725|NCT04480307|101573879|FG000|Overall Study|Withdrawal by Subject|0|||
33460726|NCT04480307|101573880|FG001|Overall Study|Withdrawal by Subject|1|||
33460727|NCT04480307|101573881|FG002|Overall Study|Withdrawal by Subject|0|||
33460728|NCT04480307|101573882|FG003|Overall Study|Withdrawal by Subject|0|||
33460729|NCT04480307|101573879|FG000|Overall Study|Adverse Event|0|||
33460730|NCT04480307|101573880|FG001|Overall Study|Adverse Event|0|||
33460731|NCT04480307|101573881|FG002|Overall Study|Adverse Event|0|||
33460732|NCT04480307|101573882|FG003|Overall Study|Adverse Event|1|||
33460733|NCT03480022|101573886|FG000|Overall Study|Pregnancy|2|||
33460734|NCT03480022|101573887|FG001|Overall Study|Pregnancy|0|||
33460735|NCT03480022|101573886|FG000|Overall Study|Adverse Event|6|||
33460736|NCT03480022|101573887|FG001|Overall Study|Adverse Event|0|||
33460737|NCT03480022|101573886|FG000|Overall Study|Lack of Efficacy|0|||
33460738|NCT03480022|101573887|FG001|Overall Study|Lack of Efficacy|2|||
33460739|NCT03480022|101573886|FG000|Overall Study|Physician Decision|0|||
33460740|NCT03480022|101573887|FG001|Overall Study|Physician Decision|1|||
33460741|NCT03480022|101573886|FG000|Overall Study|Withdrawal by Subject|2|||
33460742|NCT03480022|101573887|FG001|Overall Study|Withdrawal by Subject|0|||
33460743|NCT03480022|101573886|FG000|Overall Study|Medication concerns|1|||
33460744|NCT03480022|101573887|FG001|Overall Study|Medication concerns|0|||
33460745|NCT03480022|101573886|FG000|Overall Study|Family member COVID exposure|0|||
33175219|NCT02557646|100549043|FG000|Overall Study|Lack of Efficacy|186|||
33175220|NCT02557646|100549043|FG000|Overall Study|Withdrawal by Subject|18|||
33175221|NCT02557646|100549043|FG000|Overall Study|Lost to Follow-up|17|||
33460746|NCT03480022|101573887|FG001|Overall Study|Family member COVID exposure|1|||
33460747|NCT01475786|101573888|FG000|Overall Study|Adverse Event|0|||
33460748|NCT01475786|101573889|FG001|Overall Study|Adverse Event|1|||
33460749|NCT01475786|101573890|FG002|Overall Study|Adverse Event|0|||
33460750|NCT01475786|101573888|FG000|Overall Study|Lost to Follow-up|1|||
33175222|NCT02557646|100549043|FG000|Overall Study|Other|14|||
33460751|NCT01475786|101573889|FG001|Overall Study|Lost to Follow-up|2|||
33460752|NCT01475786|101573890|FG002|Overall Study|Lost to Follow-up|1|||
33460753|NCT01475786|101573888|FG000|Overall Study|Withdrawal by Subject|0|||
33460754|NCT01475786|101573889|FG001|Overall Study|Withdrawal by Subject|1|||
33460755|NCT01475786|101573890|FG002|Overall Study|Withdrawal by Subject|1|||
33460756|NCT01475786|101573888|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
33460757|NCT01475786|101573889|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
33460758|NCT01475786|101573890|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
33460759|NCT03407729|101573891|FG000|Overall Study|Lost to Follow-up|2|||
33460760|NCT03407729|101573892|FG001|Overall Study|Lost to Follow-up|0|||
33460761|NCT03407729|101573891|FG000|Overall Study|Unable to schedule|0|||
33460762|NCT03407729|101573892|FG001|Overall Study|Unable to schedule|3|||
33460763|NCT01266603|101573893|FG000|Overall Study|Adverse Event|1|||
33460764|NCT01266603|101573893|FG000|Overall Study|Lack of Efficacy|14|||
33460765|NCT01266603|101573893|FG000|Overall Study|Withdrawal by Subject|1|||
33460766|NCT01266603|101573893|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
33175223|NCT02659631|100549044|FG000|Overall Study|Lost to Follow-up|0|||
33460767|NCT02327325|101573894|FG000|Overall Study|Withdrawal by Subject|1|||
33460768|NCT02327325|101573895|FG001|Overall Study|Withdrawal by Subject|4|||
33460769|NCT02327325|101573896|FG002|Overall Study|Withdrawal by Subject|4|||
33460770|NCT02327325|101573894|FG000|Overall Study|Excluded by Study Team|0|||
33460771|NCT02327325|101573895|FG001|Overall Study|Excluded by Study Team|0|||
33460772|NCT02327325|101573896|FG002|Overall Study|Excluded by Study Team|1|||
33460773|NCT01685216|101573897|FG000|Overall Study|Did not receive study drug|1|||
33460774|NCT02075840|101573903|FG000|Overall Study|Withdrawal by Subject|13|||
33460775|NCT02075840|101573904|FG001|Overall Study|Withdrawal by Subject|22|||
33460776|NCT02075840|101573903|FG000|Overall Study|Reason not specified|1|||
33460777|NCT02075840|101573904|FG001|Overall Study|Reason not specified|0|||
33460778|NCT02075840|101573903|FG000|Overall Study|Adverse Event|0|||
33460779|NCT02075840|101573904|FG001|Overall Study|Adverse Event|2|||
33460780|NCT02075840|101573903|FG000|Overall Study|Death|35|||
33460781|NCT02075840|101573904|FG001|Overall Study|Death|40|||
33460782|NCT02075840|101573903|FG000|Overall Study|Lost to Follow-up|3|||
33460783|NCT02075840|101573904|FG001|Overall Study|Lost to Follow-up|2|||
33460784|NCT02075840|101573903|FG000|Overall Study|Physician Decision|1|||
33460785|NCT02075840|101573904|FG001|Overall Study|Physician Decision|3|||
33460786|NCT02075840|101573903|FG000|Overall Study|Ongoing at CCOD|99|||
33460787|NCT02075840|101573904|FG001|Overall Study|Ongoing at CCOD|82|||
33460788|NCT04019054|101573912|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
33460789|NCT04019054|101573913|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
33460790|NCT04019054|101573912|FG000|Overall Study|Withdrawal by Subject|3|||
33460791|NCT04019054|101573913|FG001|Overall Study|Withdrawal by Subject|1|||
33460792|NCT01705717|101573923|FG000|Overall Study|Adverse Event|2|||
33460793|NCT01705717|101573924|FG001|Overall Study|Adverse Event|2|||
33460794|NCT01705717|101573923|FG000|Overall Study|Lack of Efficacy|0|||
33460795|NCT01705717|101573924|FG001|Overall Study|Lack of Efficacy|1|||
33460796|NCT01705717|101573923|FG000|Overall Study|Other|0|||
33460797|NCT01705717|101573924|FG001|Overall Study|Other|2|||
33460798|NCT04149535|101573929|FG000|Overall Study|Death|11|||
33460799|NCT04149535|101573930|FG001|Overall Study|Death|7|||
33460800|NCT04149535|101573929|FG000|Overall Study|Physician Decision|10|||
33460801|NCT04149535|101573930|FG001|Overall Study|Physician Decision|4|||
33460802|NCT04149535|101573929|FG000|Overall Study|Withdrawal by Subject|6|||
33460803|NCT04149535|101573930|FG001|Overall Study|Withdrawal by Subject|7|||
33460804|NCT04149535|101573929|FG000|Overall Study|Not described|2|||
33460805|NCT04149535|101573930|FG001|Overall Study|Not described|0|||
33460806|NCT04499482|101573931|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
33460807|NCT04164758|101573932|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
33460808|NCT04164758|101573933|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
33460809|NCT04164758|101573934|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
33460810|NCT04164758|101573932|FG000|Overall Study|Adverse Event|0|||
33460811|NCT04164758|101573933|FG001|Overall Study|Adverse Event|1|||
33460812|NCT04164758|101573934|FG002|Overall Study|Adverse Event|0|||
33460813|NCT01872715|101573936|FG000|Overall Study|Adverse Event|1|||
33460814|NCT01872715|101573936|FG000|Overall Study|Protocol Violation|1|||
33460815|NCT01872715|101573936|FG000|Overall Study|Withdrawal by Subject|2|||
33460816|NCT01207492|101573937|FG000|Overall Study|Still on study|1|||
33460817|NCT01207492|101573937|FG000|Overall Study|Withdrawal by Subject|9|||
33460818|NCT01207492|101573937|FG000|Overall Study|Physician Decision|1|||
33460819|NCT01207492|101573937|FG000|Overall Study|Progressive disease|3|||
33460820|NCT01207492|101573937|FG000|Overall Study|Toxicity|1|||
33460821|NCT01745094|101573940|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
33460822|NCT01745094|101573941|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
33460823|NCT01745094|101573942|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
33460824|NCT01745094|101573943|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
33460825|NCT01745094|101573940|FG000|Overall Study|Adverse Event|0|||
33460826|NCT01745094|101573941|FG001|Overall Study|Adverse Event|0|||
33460827|NCT01745094|101573942|FG002|Overall Study|Adverse Event|3|||
33460828|NCT01745094|101573943|FG003|Overall Study|Adverse Event|0|||
33460829|NCT01745094|101573940|FG000|Overall Study|Withdrawal by Subject|2|||
33460830|NCT01745094|101573941|FG001|Overall Study|Withdrawal by Subject|0|||
33460831|NCT01745094|101573942|FG002|Overall Study|Withdrawal by Subject|1|||
33460832|NCT01745094|101573943|FG003|Overall Study|Withdrawal by Subject|2|||
33460833|NCT01745094|101573940|FG000|Overall Study|Protocol Violation|1|||
33460834|NCT01745094|101573941|FG001|Overall Study|Protocol Violation|0|||
33460835|NCT01745094|101573942|FG002|Overall Study|Protocol Violation|3|||
33460836|NCT01745094|101573943|FG003|Overall Study|Protocol Violation|1|||
33460837|NCT01745094|101573940|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
33460838|NCT01745094|101573941|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
33460839|NCT01745094|101573942|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
33460840|NCT01745094|101573943|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
33460841|NCT01745094|101573940|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
33460842|NCT01745094|101573941|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
33460843|NCT01745094|101573942|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
33460844|NCT01745094|101573943|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
33460845|NCT01745094|101573940|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
33460846|NCT01745094|101573941|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
33460847|NCT01745094|101573942|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
33460848|NCT01745094|101573943|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
33175224|NCT02659631|100549045|FG001|Overall Study|Lost to Follow-up|0|||
33175225|NCT02659631|100549046|FG002|Overall Study|Lost to Follow-up|2|||
33175226|NCT02659631|100549047|FG003|Overall Study|Lost to Follow-up|0|||
33175227|NCT02659631|100549048|FG004|Overall Study|Lost to Follow-up|0|||
33175228|NCT02659631|100549049|FG005|Overall Study|Lost to Follow-up|1|||
33175229|NCT02659631|100549050|FG006|Overall Study|Lost to Follow-up|0|||
33175230|NCT02659631|100549051|FG007|Overall Study|Lost to Follow-up|0|||
33175231|NCT02659631|100549052|FG008|Overall Study|Lost to Follow-up|0|||
33175232|NCT02659631|100549053|FG009|Overall Study|Lost to Follow-up|0|||
33175233|NCT02659631|100549044|FG000|Overall Study|Withdrawal prior to treatment|0|||
33175234|NCT02659631|100549045|FG001|Overall Study|Withdrawal prior to treatment|0|||
33175235|NCT02659631|100549046|FG002|Overall Study|Withdrawal prior to treatment|0|||
33175236|NCT02659631|100549047|FG003|Overall Study|Withdrawal prior to treatment|0|||
33175237|NCT02659631|100549048|FG004|Overall Study|Withdrawal prior to treatment|1|||
33175238|NCT02659631|100549049|FG005|Overall Study|Withdrawal prior to treatment|0|||
33175239|NCT02659631|100549050|FG006|Overall Study|Withdrawal prior to treatment|0|||
33175240|NCT02659631|100549051|FG007|Overall Study|Withdrawal prior to treatment|0|||
33175241|NCT02659631|100549052|FG008|Overall Study|Withdrawal prior to treatment|0|||
33175242|NCT02659631|100549053|FG009|Overall Study|Withdrawal prior to treatment|0|||
33175243|NCT02659631|100549044|FG000|Overall Study|Participant refused further follow-up|0|||
33175244|NCT02659631|100549045|FG001|Overall Study|Participant refused further follow-up|0|||
33175245|NCT02659631|100549046|FG002|Overall Study|Participant refused further follow-up|0|||
33175246|NCT02659631|100549047|FG003|Overall Study|Participant refused further follow-up|1|||
33175247|NCT02659631|100549048|FG004|Overall Study|Participant refused further follow-up|0|||
33175248|NCT02659631|100549049|FG005|Overall Study|Participant refused further follow-up|0|||
33175249|NCT02659631|100549050|FG006|Overall Study|Participant refused further follow-up|0|||
33175250|NCT02659631|100549051|FG007|Overall Study|Participant refused further follow-up|0|||
33175251|NCT02659631|100549052|FG008|Overall Study|Participant refused further follow-up|1|||
33175252|NCT02659631|100549053|FG009|Overall Study|Participant refused further follow-up|0|||
33175253|NCT02659631|100549044|FG000|Overall Study|Death (follow-up phase)|1|||
33175254|NCT02659631|100549045|FG001|Overall Study|Death (follow-up phase)|2|||
33175255|NCT02659631|100549046|FG002|Overall Study|Death (follow-up phase)|1|||
33175256|NCT02659631|100549047|FG003|Overall Study|Death (follow-up phase)|1|||
33175257|NCT02659631|100549048|FG004|Overall Study|Death (follow-up phase)|3|||
33175258|NCT02659631|100549049|FG005|Overall Study|Death (follow-up phase)|2|||
33175259|NCT02659631|100549050|FG006|Overall Study|Death (follow-up phase)|0|||
33175260|NCT02659631|100549051|FG007|Overall Study|Death (follow-up phase)|3|||
33175261|NCT02659631|100549052|FG008|Overall Study|Death (follow-up phase)|1|||
33175262|NCT02659631|100549053|FG009|Overall Study|Death (follow-up phase)|0|||
33175263|NCT02659631|100549044|FG000|Overall Study|Death (treatment phase)|0|||
33175264|NCT02659631|100549045|FG001|Overall Study|Death (treatment phase)|0|||
33175265|NCT02659631|100549046|FG002|Overall Study|Death (treatment phase)|0|||
33175266|NCT02659631|100549047|FG003|Overall Study|Death (treatment phase)|0|||
33175267|NCT02659631|100549048|FG004|Overall Study|Death (treatment phase)|1|||
33175268|NCT02659631|100549049|FG005|Overall Study|Death (treatment phase)|0|||
33175269|NCT02659631|100549050|FG006|Overall Study|Death (treatment phase)|1|||
33175270|NCT02659631|100549051|FG007|Overall Study|Death (treatment phase)|0|||
33175271|NCT02659631|100549052|FG008|Overall Study|Death (treatment phase)|0|||
33175272|NCT02659631|100549053|FG009|Overall Study|Death (treatment phase)|0|||
33175273|NCT00464087|100549054|FG000|Overall Study|No PCI per inclusion criteria|0|||
33175274|NCT00464087|100549055|FG001|Overall Study|No PCI per inclusion criteria|0|||
33262924|NCT05171777|100863791|FG000|Treatment Crossover Period|Disease Relapse|0|||
33262925|NCT05171777|100863792|FG001|Treatment Crossover Period|Disease Relapse|1|||
33262926|NCT05171777|100863793|FG002|Treatment Crossover Period|Disease Relapse|0|||
33262927|NCT05171777|100863794|FG003|Treatment Crossover Period|Disease Relapse|0|||
33262928|NCT05171777|100863791|FG000|Treatment Crossover Period|Reason not Specified|2|||
33262929|NCT05171777|100863792|FG001|Treatment Crossover Period|Reason not Specified|1|||
33262930|NCT05171777|100863793|FG002|Treatment Crossover Period|Reason not Specified|0|||
33262931|NCT05171777|100863794|FG003|Treatment Crossover Period|Reason not Specified|0|||
33262932|NCT05171777|100863791|FG000|Treatment Crossover Period|Physician Decision|0|||
33262933|NCT05171777|100863792|FG001|Treatment Crossover Period|Physician Decision|1|||
33175275|NCT00464087|100549056|FG002|Overall Study|No PCI per inclusion criteria|29|||
33175276|NCT04626297|100549057|FG000|Overall Study|Adverse Event|5|||
33175277|NCT04626297|100549058|FG001|Overall Study|Adverse Event|3|||
33175278|NCT04626297|100549057|FG000|Overall Study|Lost to Follow-up|7|||
33175279|NCT04626297|100549058|FG001|Overall Study|Lost to Follow-up|3|||
33262934|NCT05171777|100863793|FG002|Treatment Crossover Period|Physician Decision|0|||
33175280|NCT04626297|100549057|FG000|Overall Study|Protocol Violation|5|||
33175281|NCT04626297|100549058|FG001|Overall Study|Protocol Violation|1|||
33175282|NCT04626297|100549057|FG000|Overall Study|Withdrawal by Subject|20|||
33175283|NCT04626297|100549058|FG001|Overall Study|Withdrawal by Subject|6|||
33262935|NCT05171777|100863794|FG003|Treatment Crossover Period|Physician Decision|0|||
33460849|NCT02795676|101573944|FG000|Overall Study|Adverse Event|2|||
33175284|NCT04626297|100549057|FG000|Overall Study|Sponsor decision|2|||
33175285|NCT04626297|100549058|FG001|Overall Study|Sponsor decision|1|||
33175286|NCT03315208|100549059|FG000|Overall Study|Lost to Follow-up|11|||
33175287|NCT03315208|100549060|FG001|Overall Study|Lost to Follow-up|6|||
33175288|NCT03315208|100549059|FG000|Overall Study|Withdrawal by Subject|2|||
33175289|NCT03315208|100549060|FG001|Overall Study|Withdrawal by Subject|0|||
33175290|NCT03358290|100549062|FG000|Overall Study|Study discontinued by Sponsor|0|||
33175291|NCT03358290|100549063|FG001|Overall Study|Study discontinued by Sponsor|1|||
33175292|NCT03358290|100549064|FG002|Overall Study|Study discontinued by Sponsor|1|||
33175293|NCT03358290|100549065|FG003|Overall Study|Study discontinued by Sponsor|0|||
33175294|NCT03358290|100549066|FG004|Overall Study|Study discontinued by Sponsor|0|||
33175295|NCT03358290|100549062|FG000|Overall Study|Adverse Event|0|||
33175296|NCT03358290|100549063|FG001|Overall Study|Adverse Event|0|||
33175297|NCT03358290|100549064|FG002|Overall Study|Adverse Event|1|||
33175298|NCT03358290|100549065|FG003|Overall Study|Adverse Event|2|||
33175299|NCT03358290|100549066|FG004|Overall Study|Adverse Event|0|||
33175300|NCT03358290|100549062|FG000|Overall Study|Withdrawal by Subject|0|||
33175301|NCT03358290|100549063|FG001|Overall Study|Withdrawal by Subject|0|||
33175302|NCT03358290|100549064|FG002|Overall Study|Withdrawal by Subject|0|||
33175303|NCT03358290|100549065|FG003|Overall Study|Withdrawal by Subject|0|||
33175304|NCT03358290|100549066|FG004|Overall Study|Withdrawal by Subject|1|||
33175305|NCT01986985|100549067|FG000|Overall Study|Withdrawal by Subject|4|||
33175306|NCT01986985|100549067|FG000|Overall Study|Scan not completed due to malfunction|3|||
33175307|NCT02452398|100549068|FG000|Overall Study|Adverse Event|1|||
33175308|NCT02452398|100549068|FG000|Overall Study|Lost to Follow-up|28|||
33175309|NCT02452398|100549068|FG000|Overall Study|Physician Decision|2|||
33175310|NCT02452398|100549068|FG000|Overall Study|Withdrawal by Subject|6|||
33175311|NCT02452398|100549068|FG000|Overall Study|Moved away|4|||
33175312|NCT01961323|100549073|FG000|Overall Study|Withdrawal by Subject|7|||
33175313|NCT01961323|100549073|FG000|Overall Study|Lost to Follow-up|8|||
33175314|NCT01961323|100549073|FG000|Overall Study|screen failure|34|||
33175315|NCT02107482|100549074|FG000|Overall Study|inconveinence|2|||
33175316|NCT02107482|100549074|FG000|Overall Study|Lost to Follow-up|1|||
33175317|NCT02107482|100549074|FG000|Overall Study|Lack of Efficacy|1|||
33175318|NCT03036072|100549075|FG000|Overall Study|Death|0|||
33175319|NCT03036072|100549076|FG001|Overall Study|Death|1|||
33175320|NCT03036072|100549075|FG000|Overall Study|Withdrawal by Subject|0|||
33175321|NCT03036072|100549076|FG001|Overall Study|Withdrawal by Subject|1|||
33175322|NCT03036072|100549075|FG000|Overall Study|Physician Decision|0|||
33175323|NCT03036072|100549076|FG001|Overall Study|Physician Decision|1|||
33175324|NCT00770289|100549077|FG000|Overall Study|Other|6|||
33175325|NCT04053023|100549078|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
33175326|NCT04053023|100549079|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
33175327|NCT03406104|100549081|FG000|Overall Study|Lost to Follow-up|2|||
33175328|NCT03406104|100549081|FG000|Overall Study|Withdrawal by Subject|2|||
33175329|NCT03406104|100549081|FG000|Overall Study|due to Covid patient did not want to travel|1|||
33175330|NCT03406104|100549081|FG000|Overall Study|Death|2|||
33175331|NCT00558025|100549084|FG000|Overall Study|Adverse Event|1|||
33175332|NCT00558025|100549085|FG001|Overall Study|Adverse Event|1|||
33175333|NCT00558025|100549084|FG000|Overall Study|Withdrawal by Subject|2|||
33175334|NCT00558025|100549085|FG001|Overall Study|Withdrawal by Subject|2|||
33175335|NCT00558025|100549084|FG000|Overall Study|Protocol Violation|1|||
33175336|NCT00558025|100549085|FG001|Overall Study|Protocol Violation|0|||
33175337|NCT00710710|100549091|FG000|Overall Study|Consent withdrawn|2|||
33175338|NCT00710710|100549092|FG001|Overall Study|Consent withdrawn|2|||
33175339|NCT00710710|100549091|FG000|Overall Study|Protocol Violation|0|||
33175340|NCT00710710|100549092|FG001|Overall Study|Protocol Violation|1|||
33175341|NCT00710710|100549091|FG000|Overall Study|Adverse Event|3|||
33175342|NCT00710710|100549092|FG001|Overall Study|Adverse Event|3|||
33175343|NCT00710710|100549091|FG000|Overall Study|Progressive disease|40|||
33175344|NCT00710710|100549092|FG001|Overall Study|Progressive disease|38|||
33175345|NCT02905331|100549093|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
33175346|NCT02905331|100549094|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
33175347|NCT02905331|100549095|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
33175348|NCT02905331|100549093|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
33175349|NCT02905331|100549094|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
33175350|NCT02905331|100549095|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
33175351|NCT02905331|100549093|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
33175352|NCT02905331|100549094|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
33175353|NCT02905331|100549095|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
33175354|NCT02905331|100549093|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
33175355|NCT02905331|100549094|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
33175356|NCT02905331|100549095|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
33175357|NCT02905331|100549093|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
33175358|NCT02905331|100549094|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
33460850|NCT02795676|101573945|FG001|Overall Study|Adverse Event|0|||
33460851|NCT02795676|101573944|FG000|Overall Study|Withdrawal by Subject|3|||
33460852|NCT02795676|101573945|FG001|Overall Study|Withdrawal by Subject|1|||
33460853|NCT00258856|101573946|FG000|Overall Study|Lost to Follow-up|1|||
33460854|NCT00258856|101573947|FG001|Overall Study|Lost to Follow-up|0|||
33460855|NCT00258856|101573948|FG002|Overall Study|Lost to Follow-up|2|||
33460856|NCT00258856|101573949|FG003|Overall Study|Lost to Follow-up|0|||
33460857|NCT00258856|101573946|FG000|Overall Study|Non-compliance|2|||
33460858|NCT00258856|101573947|FG001|Overall Study|Non-compliance|0|||
33460859|NCT00258856|101573948|FG002|Overall Study|Non-compliance|0|||
33460860|NCT00258856|101573949|FG003|Overall Study|Non-compliance|1|||
33460861|NCT04330157|101573952|FG000|Overall Study|Protocol Violation|4|||
33460862|NCT04330157|101573952|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
33460863|NCT00593827|101573960|FG000|Overall Study|On Active Treatment/Pending|0|||
33460864|NCT00593827|101573961|FG001|Overall Study|On Active Treatment/Pending|2|||
33460865|NCT05766787|101573962|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
33460866|NCT05766787|101573963|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
33460867|NCT05766787|101573962|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
33460868|NCT05766787|101573963|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
33460869|NCT05766787|101573962|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
33460870|NCT05766787|101573963|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
33460871|NCT01294449|101576656|FG000|Overall Study|Death|11|||
33460872|NCT01294449|101576657|FG001|Overall Study|Death|12|||
33460873|NCT01294449|101576656|FG000|Overall Study|Withdrawal by Subject|1|||
33460874|NCT01294449|101576657|FG001|Overall Study|Withdrawal by Subject|3|||
33460875|NCT01023061|101576658|FG000|Overall Study|Withdrawal prior to treatment|2|||
33460876|NCT01808248|101576660|FG000|Overall Study|Lack of Efficacy|3|||
33460877|NCT01808248|101576660|FG000|Overall Study|Withdrawal by Subject|1|||
33460878|NCT01808248|101576660|FG000|Overall Study|Lost to Follow-up|1|||
33460879|NCT02129062|101576662|FG000|Overall Study|Death|1|||
33460880|NCT02129062|101576662|FG000|Overall Study|Disease Progression|2|||
33460881|NCT01520987|101576665|FG000|Overall Study|Withdrawal by Subject|1|||
33460882|NCT01520987|101576666|FG001|Overall Study|Withdrawal by Subject|0|||
33460883|NCT01520987|101576667|FG002|Overall Study|Withdrawal by Subject|0|||
33460884|NCT01520987|101576668|FG003|Overall Study|Withdrawal by Subject|0|||
33460885|NCT01520987|101576669|FG004|Overall Study|Withdrawal by Subject|0|||
33460886|NCT01520987|101576670|FG005|Overall Study|Withdrawal by Subject|1|||
33460887|NCT01520987|101576671|FG006|Overall Study|Withdrawal by Subject|0|||
33460888|NCT01520987|101576672|FG007|Overall Study|Withdrawal by Subject|0|||
33460889|NCT00329160|101576673|FG000|Overall Study|Adverse Event|27|||
33460890|NCT00329160|101576673|FG000|Overall Study|Withdrawal by Subject|13|||
33460891|NCT00329160|101576673|FG000|Overall Study|Protocol Violation|2|||
33460892|NCT00329160|101576673|FG000|Overall Study|Did not Receive Study Drug|1|||
33460893|NCT00329160|101576673|FG000|Overall Study|Incomplete IVUS|45|||
33460894|NCT00676650|101576674|FG000|Overall Study|Death|45|||
33460895|NCT00676650|101576675|FG001|Overall Study|Death|14|||
33460896|NCT00676650|101576674|FG000|Overall Study|Adverse Event|159|||
33460897|NCT00676650|101576675|FG001|Overall Study|Adverse Event|21|||
33460898|NCT00676650|101576674|FG000|Overall Study|Global deterioration of health status|66|||
33460899|NCT00676650|101576675|FG001|Overall Study|Global deterioration of health status|31|||
33460900|NCT00676650|101576674|FG000|Overall Study|Lost to Follow-up|0|||
33460901|NCT00676650|101576675|FG001|Overall Study|Lost to Follow-up|1|||
33460902|NCT00676650|101576674|FG000|Overall Study|Objective progression or relapse|189|||
33460903|NCT00676650|101576675|FG001|Overall Study|Objective progression or relapse|140|||
33460904|NCT00676650|101576674|FG000|Overall Study|Other|14|||
33460905|NCT00676650|101576675|FG001|Overall Study|Other|10|||
33460906|NCT00676650|101576674|FG000|Overall Study|Protocol Violation|3|||
33460907|NCT00676650|101576675|FG001|Overall Study|Protocol Violation|1|||
33460908|NCT00676650|101576674|FG000|Overall Study|Study terminated by sponsor|57|||
33460909|NCT00676650|101576675|FG001|Overall Study|Study terminated by sponsor|43|||
33460910|NCT00676650|101576674|FG000|Overall Study|Withdrawal by Subject|48|||
33460911|NCT00676650|101576675|FG001|Overall Study|Withdrawal by Subject|24|||
33460912|NCT00676650|101576674|FG000|Overall Study|Randomized but not treated|3|||
33460913|NCT00676650|101576675|FG001|Overall Study|Randomized but not treated|4|||
33460914|NCT03969641|101576678|FG000|Overall Study|Lost to Follow-up|5|||
33460915|NCT03969641|101576679|FG001|Overall Study|Lost to Follow-up|3|||
33460916|NCT03969641|101576678|FG000|Overall Study|Withdrawal by Subject|1|||
33460917|NCT03969641|101576679|FG001|Overall Study|Withdrawal by Subject|2|||
33460918|NCT03969641|101576678|FG000|Overall Study|Found to be ineligible|1|||
33460919|NCT03969641|101576679|FG001|Overall Study|Found to be ineligible|1|||
33460920|NCT03969641|101576678|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
33460921|NCT03969641|101576679|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
33460922|NCT03969641|101576678|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
33460923|NCT03969641|101576679|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
33460924|NCT03969641|101576678|FG000|Overall Study|Elective termination|0|||
33175359|NCT02905331|100549095|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
33175360|NCT03557151|100549096|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
33175361|NCT03557151|100549097|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
33175362|NCT03557151|100549096|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
33175363|NCT03557151|100549097|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
33175364|NCT03557151|100549096|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
33175365|NCT03557151|100549097|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
33175366|NCT03108027|100549104|FG000|Period 1|Subject/Guardian Decision|0|||
33175367|NCT03108027|100549105|FG001|Period 1|Subject/Guardian Decision|0|||
33175368|NCT03108027|100549106|FG002|Period 1|Subject/Guardian Decision|0|||
33175369|NCT03108027|100549107|FG003|Period 1|Subject/Guardian Decision|2|||
33175370|NCT03108027|100549108|FG004|Period 1|Subject/Guardian Decision|0|||
33175371|NCT03108027|100549109|FG005|Period 1|Subject/Guardian Decision|0|||
33175372|NCT03108027|100549104|FG000|Period 3|Adverse Event|0|||
33175373|NCT03108027|100549105|FG001|Period 3|Adverse Event|1|||
33175374|NCT03108027|100549106|FG002|Period 3|Adverse Event|0|||
33175375|NCT03108027|100549107|FG003|Period 3|Adverse Event|0|||
33175376|NCT03108027|100549108|FG004|Period 3|Adverse Event|0|||
33175377|NCT03108027|100549109|FG005|Period 3|Adverse Event|0|||
33175378|NCT02288559|100549110|FG000|Overall Study|Adverse Event|1|||
33175379|NCT02288559|100549111|FG001|Overall Study|Adverse Event|1|||
33175380|NCT02288559|100549112|FG002|Overall Study|Adverse Event|5|||
33175381|NCT02288559|100549113|FG003|Overall Study|Adverse Event|0|||
33175382|NCT02288559|100549110|FG000|Overall Study|Death|0|||
33175383|NCT02288559|100549111|FG001|Overall Study|Death|0|||
33175384|NCT02288559|100549112|FG002|Overall Study|Death|1|||
33175385|NCT02288559|100549113|FG003|Overall Study|Death|0|||
33175386|NCT02288559|100549110|FG000|Overall Study|Lost to Follow-up|0|||
33175387|NCT02288559|100549111|FG001|Overall Study|Lost to Follow-up|0|||
33175388|NCT02288559|100549112|FG002|Overall Study|Lost to Follow-up|0|||
33175389|NCT02288559|100549113|FG003|Overall Study|Lost to Follow-up|1|||
33175390|NCT02288559|100549110|FG000|Overall Study|Withdrawal by Subject|0|||
33175391|NCT02288559|100549111|FG001|Overall Study|Withdrawal by Subject|0|||
33175392|NCT02288559|100549112|FG002|Overall Study|Withdrawal by Subject|2|||
33175393|NCT02288559|100549113|FG003|Overall Study|Withdrawal by Subject|1|||
33175394|NCT02288559|100549110|FG000|Overall Study|Reason Not Specified|0|||
33460925|NCT03969641|101576679|FG001|Overall Study|Elective termination|1|||
33460926|NCT04106817|101576680|FG000|Overall Study|Lost to Follow-up|1|||
33460927|NCT04106817|101576681|FG001|Overall Study|Lost to Follow-up|0|||
33460928|NCT04106817|101576682|FG002|Overall Study|Lost to Follow-up|0|||
33460929|NCT02412722|101576690|FG000|Overall Study|Adverse Event|0|||
33460930|NCT02412722|101576691|FG001|Overall Study|Adverse Event|2|||
33460931|NCT02412722|101576692|FG002|Overall Study|Adverse Event|0|||
33460932|NCT02412722|101576693|FG003|Overall Study|Adverse Event|3|||
33460933|NCT02412722|101576694|FG004|Overall Study|Adverse Event|0|||
33460934|NCT02412722|101576695|FG005|Overall Study|Adverse Event|3|||
33460935|NCT02412722|101576690|FG000|Overall Study|Progressive Disease|6|||
33460936|NCT02412722|101576691|FG001|Overall Study|Progressive Disease|4|||
33460937|NCT02412722|101576692|FG002|Overall Study|Progressive Disease|4|||
33460938|NCT02412722|101576693|FG003|Overall Study|Progressive Disease|9|||
33460939|NCT02412722|101576694|FG004|Overall Study|Progressive Disease|3|||
33460940|NCT02412722|101576695|FG005|Overall Study|Progressive Disease|3|||
33460941|NCT02412722|101576690|FG000|Overall Study|Withdrawal by Subject|2|||
33460942|NCT02412722|101576691|FG001|Overall Study|Withdrawal by Subject|0|||
33460943|NCT02412722|101576692|FG002|Overall Study|Withdrawal by Subject|1|||
33460944|NCT02412722|101576693|FG003|Overall Study|Withdrawal by Subject|2|||
33460945|NCT02412722|101576694|FG004|Overall Study|Withdrawal by Subject|1|||
33460946|NCT02412722|101576695|FG005|Overall Study|Withdrawal by Subject|1|||
33460947|NCT02412722|101576690|FG000|Overall Study|Lost to Follow-up|0|||
33460948|NCT02412722|101576691|FG001|Overall Study|Lost to Follow-up|0|||
33460949|NCT02412722|101576692|FG002|Overall Study|Lost to Follow-up|0|||
33175395|NCT02288559|100549111|FG001|Overall Study|Reason Not Specified|0|||
33175396|NCT02288559|100549112|FG002|Overall Study|Reason Not Specified|3|||
33262936|NCT05171777|100863791|FG000|Treatment Crossover Period|Progressive Disease|13|||
33262937|NCT05171777|100863792|FG001|Treatment Crossover Period|Progressive Disease|9|||
33460950|NCT02412722|101576693|FG003|Overall Study|Lost to Follow-up|0|||
33460951|NCT02412722|101576694|FG004|Overall Study|Lost to Follow-up|1|||
33460952|NCT02412722|101576695|FG005|Overall Study|Lost to Follow-up|0|||
33175397|NCT02288559|100549113|FG003|Overall Study|Reason Not Specified|0|||
33460953|NCT02412722|101576690|FG000|Overall Study|Received drug in run-in and discontinued|0|||
33460954|NCT02412722|101576691|FG001|Overall Study|Received drug in run-in and discontinued|2|||
33175398|NCT01327885|100549117|FG000|Overall Study|Disease progression-according to RECIST|173|||
33175399|NCT01327885|100549118|FG001|Overall Study|Disease progression-according to RECIST|165|||
33175400|NCT01327885|100549117|FG000|Overall Study|Clinical progression|24|||
33175401|NCT01327885|100549118|FG001|Overall Study|Clinical progression|27|||
33175402|NCT01327885|100549117|FG000|Overall Study|Adverse Event|14|||
33175403|NCT01327885|100549118|FG001|Overall Study|Adverse Event|10|||
33175404|NCT01327885|100549117|FG000|Overall Study|Subject choice|5|||
33175405|NCT01327885|100549118|FG001|Overall Study|Subject choice|10|||
33175406|NCT01327885|100549117|FG000|Overall Study|Other|8|||
33175407|NCT01327885|100549118|FG001|Overall Study|Other|6|||
33175408|NCT01327885|100549117|FG000|Overall Study|Withdrawal of consent from study|3|||
33175409|NCT01327885|100549118|FG001|Overall Study|Withdrawal of consent from study|4|||
33175410|NCT01327885|100549117|FG000|Overall Study|Not treated|1|||
33175411|NCT01327885|100549118|FG001|Overall Study|Not treated|1|||
33175412|NCT01327885|100549117|FG000|Overall Study|Administrative decision|0|||
33175413|NCT01327885|100549118|FG001|Overall Study|Administrative decision|1|||
33175414|NCT02200445|100549119|FG000|Overall Study|Lack of Efficacy|1|||
33175415|NCT02200445|100549120|FG001|Overall Study|Lack of Efficacy|2|||
33175416|NCT02200445|100549121|FG002|Overall Study|Lack of Efficacy|2|||
33175417|NCT02200445|100549119|FG000|Overall Study|Adverse Event|0|||
33175418|NCT02200445|100549120|FG001|Overall Study|Adverse Event|2|||
33175419|NCT02200445|100549121|FG002|Overall Study|Adverse Event|0|||
33175420|NCT02157298|100549124|FG000|Overall Study|Adverse Event|1|||
33175421|NCT02157298|100549125|FG001|Overall Study|Adverse Event|0|||
33175422|NCT02157298|100549124|FG000|Overall Study|Subject no longer meets study criteria|1|||
33175423|NCT02157298|100549125|FG001|Overall Study|Subject no longer meets study criteria|2|||
33175424|NCT02157298|100549124|FG000|Overall Study|Poor/Non-compliance|1|||
33175425|NCT02157298|100549125|FG001|Overall Study|Poor/Non-compliance|0|||
33175426|NCT02157298|100549124|FG000|Overall Study|Withdrawal by Subject|1|||
33175427|NCT02157298|100549125|FG001|Overall Study|Withdrawal by Subject|0|||
33175428|NCT01064401|100549126|FG000|Overall Study|Adverse Event|47|||
33175429|NCT01064401|100549127|FG001|Overall Study|Adverse Event|56|||
33175430|NCT01064401|100549126|FG000|Overall Study|Lack of Efficacy|46|||
33175431|NCT01064401|100549127|FG001|Overall Study|Lack of Efficacy|23|||
33175432|NCT01064401|100549126|FG000|Overall Study|Lost to Follow-up|12|||
33175433|NCT01064401|100549127|FG001|Overall Study|Lost to Follow-up|9|||
33175434|NCT01064401|100549126|FG000|Overall Study|Consent Withdrawn|98|||
33175435|NCT01064401|100549127|FG001|Overall Study|Consent Withdrawn|80|||
33175436|NCT01064401|100549126|FG000|Overall Study|Investigator Decision|4|||
33175437|NCT01064401|100549127|FG001|Overall Study|Investigator Decision|6|||
33175438|NCT01064401|100549126|FG000|Overall Study|Death|4|||
33175439|NCT01064401|100549127|FG001|Overall Study|Death|0|||
33460955|NCT02412722|101576692|FG002|Overall Study|Received drug in run-in and discontinued|0|||
33175440|NCT01064401|100549126|FG000|Overall Study|Pregnancy|4|||
33175441|NCT01064401|100549127|FG001|Overall Study|Pregnancy|7|||
33175442|NCT01064401|100549126|FG000|Overall Study|Noncompliance|7|||
33175443|NCT01064401|100549127|FG001|Overall Study|Noncompliance|8|||
33175444|NCT01064401|100549126|FG000|Overall Study|Site Closure|4|||
33175445|NCT01064401|100549127|FG001|Overall Study|Site Closure|5|||
33175446|NCT01064401|100549126|FG000|Overall Study|Other|2|||
33460956|NCT02412722|101576693|FG003|Overall Study|Received drug in run-in and discontinued|0|||
33460957|NCT02412722|101576694|FG004|Overall Study|Received drug in run-in and discontinued|0|||
33460958|NCT02412722|101576695|FG005|Overall Study|Received drug in run-in and discontinued|0|||
33460959|NCT02412722|101576690|FG000|Overall Study|Reason not Specified|3|||
33460960|NCT02412722|101576691|FG001|Overall Study|Reason not Specified|0|||
33460961|NCT02412722|101576692|FG002|Overall Study|Reason not Specified|2|||
33460962|NCT02412722|101576693|FG003|Overall Study|Reason not Specified|1|||
33460963|NCT02412722|101576694|FG004|Overall Study|Reason not Specified|2|||
33460964|NCT02412722|101576695|FG005|Overall Study|Reason not Specified|6|||
33460965|NCT03253744|101576696|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
33460966|NCT03253744|101576697|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
33460967|NCT03253744|101576698|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
33460968|NCT03253744|101576699|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
33460969|NCT02427399|101576700|FG000|Overall Study|Protocol Violation|14|||
33460970|NCT02427399|101576701|FG001|Overall Study|Protocol Violation|16|||
33460971|NCT02427399|101576702|FG002|Overall Study|Protocol Violation|12|||
33460972|NCT02427399|101576703|FG003|Overall Study|Protocol Violation|18|||
33460973|NCT02427399|101576704|FG004|Overall Study|Protocol Violation|15|||
33460974|NCT01691430|101576705|FG000|Overall Study|Death|17|||
33460975|NCT01691430|101576706|FG001|Overall Study|Death|16|||
33460976|NCT01691430|101576705|FG000|Overall Study|Withdrawal by Subject|5|||
33460977|NCT01691430|101576706|FG001|Overall Study|Withdrawal by Subject|1|||
33460978|NCT01691430|101576705|FG000|Overall Study|Lost to Follow-up|0|||
33175447|NCT01064401|100549127|FG001|Overall Study|Other|1|||
33175448|NCT02730455|100549128|FG000|Overall Study|Death|5|||
33175449|NCT02730455|100549129|FG001|Overall Study|Death|6|||
33175450|NCT02730455|100549130|FG002|Overall Study|Death|4|||
33262938|NCT05171777|100863793|FG002|Treatment Crossover Period|Progressive Disease|0|||
33262939|NCT05171777|100863794|FG003|Treatment Crossover Period|Progressive Disease|0|||
33175451|NCT02730455|100549128|FG000|Overall Study|Consent withdrawn|2|||
33175452|NCT02730455|100549129|FG001|Overall Study|Consent withdrawn|4|||
33175453|NCT02730455|100549130|FG002|Overall Study|Consent withdrawn|1|||
33175454|NCT02730455|100549128|FG000|Overall Study|Lost to Follow-up|3|||
33460979|NCT01691430|101576706|FG001|Overall Study|Lost to Follow-up|3|||
33175455|NCT02730455|100549129|FG001|Overall Study|Lost to Follow-up|1|||
33175456|NCT02730455|100549130|FG002|Overall Study|Lost to Follow-up|4|||
33175457|NCT02730455|100549128|FG000|Overall Study|Other|1|||
33175458|NCT02730455|100549129|FG001|Overall Study|Other|1|||
33175459|NCT02730455|100549130|FG002|Overall Study|Other|2|||
33175460|NCT02730455|100549128|FG000|Overall Study|Other|2|||
33175461|NCT02730455|100549129|FG001|Overall Study|Other|2|||
33175462|NCT02730455|100549130|FG002|Overall Study|Other|0|||
33175463|NCT00006903|100549140|FG000|Overall Study|Still receiving treatment|0|||
33175464|NCT00006903|100549141|FG001|Overall Study|Still receiving treatment|0|||
33175465|NCT00006903|100549142|FG002|Overall Study|Still receiving treatment|1|||
33175466|NCT00006903|100549140|FG000|Overall Study|Refused further treatment|0|||
33175467|NCT00006903|100549141|FG001|Overall Study|Refused further treatment|2|||
33175468|NCT00006903|100549142|FG002|Overall Study|Refused further treatment|1|||
33175469|NCT00006903|100549140|FG000|Overall Study|Adverse Event|0|||
33175470|NCT00006903|100549141|FG001|Overall Study|Adverse Event|0|||
33175471|NCT00006903|100549142|FG002|Overall Study|Adverse Event|1|||
33175472|NCT00006903|100549140|FG000|Overall Study|Death|0|||
33175473|NCT00006903|100549141|FG001|Overall Study|Death|1|||
33175474|NCT00006903|100549142|FG002|Overall Study|Death|0|||
33175475|NCT00006903|100549140|FG000|Overall Study|Patient never treated|0|||
33175476|NCT00006903|100549141|FG001|Overall Study|Patient never treated|0|||
33175477|NCT00006903|100549142|FG002|Overall Study|Patient never treated|1|||
33175478|NCT00006903|100549140|FG000|Overall Study|Ineligible|10|||
33175479|NCT00006903|100549141|FG001|Overall Study|Ineligible|1|||
33175480|NCT00006903|100549142|FG002|Overall Study|Ineligible|2|||
33175481|NCT02736409|100549143|FG000|Overall Study|Withdrawal by Subject|4|||
33175482|NCT02736409|100549144|FG001|Overall Study|Withdrawal by Subject|2|||
33175483|NCT02736409|100549145|FG002|Overall Study|Withdrawal by Subject|17|||
33175484|NCT02736409|100549146|FG003|Overall Study|Withdrawal by Subject|3|||
33175485|NCT02736409|100549143|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33175486|NCT02736409|100549144|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33175487|NCT02736409|100549145|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33175488|NCT02736409|100549146|FG003|Overall Study|Non-Compliance with Study Drug|1|||
33175489|NCT02736409|100549143|FG000|Overall Study|Adverse Event|0|||
33175490|NCT02736409|100549144|FG001|Overall Study|Adverse Event|1|||
33175491|NCT02736409|100549145|FG002|Overall Study|Adverse Event|5|||
33175492|NCT02736409|100549146|FG003|Overall Study|Adverse Event|4|||
33175493|NCT02736409|100549143|FG000|Overall Study|Other|0|||
33175494|NCT02736409|100549144|FG001|Overall Study|Other|0|||
33175495|NCT02736409|100549145|FG002|Overall Study|Other|1|||
33175496|NCT02736409|100549146|FG003|Overall Study|Other|1|||
33175497|NCT02736409|100549143|FG000|Overall Study|Pregnancy|0|||
33175498|NCT02736409|100549144|FG001|Overall Study|Pregnancy|0|||
33175499|NCT02736409|100549145|FG002|Overall Study|Pregnancy|1|||
33175500|NCT02736409|100549146|FG003|Overall Study|Pregnancy|0|||
33175501|NCT02736409|100549143|FG000|Overall Study|Lost to Follow-up|0|||
33175502|NCT02736409|100549144|FG001|Overall Study|Lost to Follow-up|0|||
33175503|NCT02736409|100549145|FG002|Overall Study|Lost to Follow-up|2|||
33175504|NCT02736409|100549146|FG003|Overall Study|Lost to Follow-up|1|||
33175505|NCT02736409|100549143|FG000|Overall Study|Physician Decision|0|||
33175506|NCT02736409|100549144|FG001|Overall Study|Physician Decision|0|||
33175507|NCT02736409|100549145|FG002|Overall Study|Physician Decision|0|||
33175508|NCT02736409|100549146|FG003|Overall Study|Physician Decision|2|||
33175509|NCT00531050|100549147|FG000|Part 1: Period 1|Adverse Event|0|||
33175510|NCT00531050|100549148|FG001|Part 1: Period 1|Adverse Event|1|||
33175511|NCT00531050|100549149|FG002|Part 1: Period 1|Adverse Event|0|||
33175512|NCT00531050|100549150|FG003|Part 1: Period 1|Adverse Event|0|||
33175513|NCT00531050|100549151|FG004|Part 1: Period 1|Adverse Event|0|||
33175514|NCT00531050|100549152|FG005|Part 1: Period 1|Adverse Event|0|||
33175515|NCT00531050|100549147|FG000|Part 1: Period 1|Protocol Deviation|0|||
33175516|NCT00531050|100549148|FG001|Part 1: Period 1|Protocol Deviation|0|||
33175517|NCT00531050|100549149|FG002|Part 1: Period 1|Protocol Deviation|0|||
33175518|NCT00531050|100549150|FG003|Part 1: Period 1|Protocol Deviation|1|||
33175519|NCT00531050|100549151|FG004|Part 1: Period 1|Protocol Deviation|0|||
33175520|NCT00531050|100549152|FG005|Part 1: Period 1|Protocol Deviation|0|||
33175521|NCT00531050|100549147|FG000|Part 1: Period 3|Adverse Event|1|||
33175522|NCT00531050|100549148|FG001|Part 1: Period 3|Adverse Event|0|||
33175523|NCT00531050|100549149|FG002|Part 1: Period 3|Adverse Event|0|||
33175524|NCT00531050|100549150|FG003|Part 1: Period 3|Adverse Event|0|||
33175525|NCT00531050|100549151|FG004|Part 1: Period 3|Adverse Event|0|||
33175526|NCT00531050|100549152|FG005|Part 1: Period 3|Adverse Event|0|||
33175527|NCT00531050|100549147|FG000|Part 2: Period 1|Adverse Event|0|||
33175528|NCT00531050|100549148|FG001|Part 2: Period 1|Adverse Event|0|||
33175529|NCT00531050|100549149|FG002|Part 2: Period 1|Adverse Event|0|||
33175530|NCT00531050|100549150|FG003|Part 2: Period 1|Adverse Event|0|||
33175531|NCT00531050|100549151|FG004|Part 2: Period 1|Adverse Event|0|||
33175532|NCT00531050|100549152|FG005|Part 2: Period 1|Adverse Event|1|||
33175533|NCT00531050|100549147|FG000|Part 2: Period 3|Abnormal test procedure|1|||
33175534|NCT00531050|100549148|FG001|Part 2: Period 3|Abnormal test procedure|0|||
33175535|NCT00531050|100549149|FG002|Part 2: Period 3|Abnormal test procedure|0|||
33175536|NCT00531050|100549150|FG003|Part 2: Period 3|Abnormal test procedure|0|||
33175537|NCT00531050|100549151|FG004|Part 2: Period 3|Abnormal test procedure|0|||
33175538|NCT00531050|100549152|FG005|Part 2: Period 3|Abnormal test procedure|1|||
33175539|NCT00330616|100549156|FG000|Overall Study|Adverse Event|13|||
33175540|NCT00330616|100549156|FG000|Overall Study|Lack of Efficacy|1|||
33175541|NCT00330616|100549156|FG000|Overall Study|Lost to Follow-up|2|||
33175542|NCT00330616|100549156|FG000|Overall Study|Withdrawal by Subject|4|||
33175543|NCT00330616|100549156|FG000|Overall Study|Other|1|||
33175544|NCT00224055|100551951|FG000|Overall Study|Adverse Event|9|||
33175545|NCT00224055|100551952|FG001|Overall Study|Adverse Event|3|||
33175546|NCT00224055|100551951|FG000|Overall Study|Lost to Follow-up|1|||
33175547|NCT00224055|100551952|FG001|Overall Study|Lost to Follow-up|2|||
33175548|NCT00224055|100551951|FG000|Overall Study|Protocol Violation|1|||
33175549|NCT00224055|100551952|FG001|Overall Study|Protocol Violation|1|||
33175550|NCT00224055|100551951|FG000|Overall Study|Inclusion Violation|3|||
33175551|NCT00224055|100551952|FG001|Overall Study|Inclusion Violation|6|||
33175552|NCT00224055|100551951|FG000|Overall Study|Withdrawal by Subject|0|||
33175553|NCT00224055|100551952|FG001|Overall Study|Withdrawal by Subject|2|||
33175554|NCT00224055|100551951|FG000|Overall Study|Other|1|||
33175555|NCT00224055|100551952|FG001|Overall Study|Other|0|||
33175556|NCT00513474|100551956|FG000|Overall Study|Death|6|||
33175557|NCT00513474|100551957|FG001|Overall Study|Death|9|||
33175558|NCT00513474|100551956|FG000|Overall Study|Participant Withdrew Consent|1|||
33175559|NCT00513474|100551957|FG001|Overall Study|Participant Withdrew Consent|0|||
33175560|NCT03251079|100551958|FG000|Overall Study|Withdrawal by Subject|1|||
33175561|NCT00503009|100551959|FG000|Overall Study|Protocol Violation|1|||
33175562|NCT00503009|100551960|FG001|Overall Study|Protocol Violation|0|||
33175563|NCT00503009|100551961|FG002|Overall Study|Protocol Violation|1|||
33175564|NCT00503009|100551959|FG000|Overall Study|Withdrawal by Subject|0|||
33175565|NCT00503009|100551960|FG001|Overall Study|Withdrawal by Subject|1|||
33175566|NCT00503009|100551961|FG002|Overall Study|Withdrawal by Subject|1|||
33175567|NCT00503009|100551959|FG000|Overall Study|Physician Decision|0|||
33175568|NCT00503009|100551960|FG001|Overall Study|Physician Decision|1|||
33175569|NCT00503009|100551961|FG002|Overall Study|Physician Decision|1|||
33175570|NCT04350788|100551962|FG000|Overall Study|Lost to Follow-up|6|||
33175571|NCT04350788|100551963|FG001|Overall Study|Lost to Follow-up|2|||
33175572|NCT04350788|100551962|FG000|Overall Study|Withdrawal by Subject|2|||
33175573|NCT04350788|100551963|FG001|Overall Study|Withdrawal by Subject|4|||
33175574|NCT04350788|100551962|FG000|Overall Study|Protocol Violation|4|||
33175575|NCT04350788|100551963|FG001|Overall Study|Protocol Violation|0|||
33175576|NCT01484873|100551967|FG000|Overall Study|Withdrawal by Subject|2|||
33175577|NCT03226392|100551970|FG000|Overall Study|Protocol Deviation|1|||
33175578|NCT03226392|100551971|FG001|Overall Study|Protocol Deviation|0|||
33175579|NCT03226392|100551970|FG000|Overall Study|Physician Decision|1|||
33175580|NCT03226392|100551971|FG001|Overall Study|Physician Decision|0|||
33175581|NCT03226392|100551970|FG000|Overall Study|Lost to Follow-up|1|||
33175582|NCT03226392|100551971|FG001|Overall Study|Lost to Follow-up|0|||
33175583|NCT03226392|100551970|FG000|Overall Study|Adverse Event|1|||
33175584|NCT03226392|100551971|FG001|Overall Study|Adverse Event|0|||
33175585|NCT03226392|100551970|FG000|Overall Study|Technical Problems|0|||
33175586|NCT03226392|100551971|FG001|Overall Study|Technical Problems|2|||
33175587|NCT03226392|100551970|FG000|Overall Study|Subject/Guardian Decision|7|||
33175588|NCT03226392|100551971|FG001|Overall Study|Subject/Guardian Decision|6|||
33175589|NCT03061331|100551972|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
33175590|NCT03061331|100551973|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
33175591|NCT00232817|100551974|FG000|Overall Study|Protocol Violation|2|||
33175592|NCT00232817|100551975|FG001|Overall Study|Protocol Violation|1|||
33175593|NCT02118012|100551976|FG000|Overall Study|Adverse Event|0|||
33460980|NCT00557245|101576714|FG000|Overall Study|Lost to Follow-up|7|||
33460981|NCT00557245|101576715|FG001|Overall Study|Lost to Follow-up|8|||
33175594|NCT02118012|100551977|FG001|Overall Study|Adverse Event|1|||
33175595|NCT02118012|100551976|FG000|Overall Study|Physician Decision|0|||
33175596|NCT02118012|100551977|FG001|Overall Study|Physician Decision|1|||
33175597|NCT02289690|100551978|FG000|Overall Study|Adverse Event Related to Progression|0|||
33175598|NCT02289690|100551979|FG001|Overall Study|Adverse Event Related to Progression|1|||
33175599|NCT02289690|100551980|FG002|Overall Study|Adverse Event Related to Progression|1|||
33175600|NCT02289690|100551981|FG003|Overall Study|Adverse Event Related to Progression|0|||
33175601|NCT02289690|100551982|FG004|Overall Study|Adverse Event Related to Progression|1|||
33175602|NCT02289690|100551983|FG005|Overall Study|Adverse Event Related to Progression|0|||
33175603|NCT02289690|100551984|FG006|Overall Study|Adverse Event Related to Progression|1|||
33175604|NCT02289690|100551985|FG007|Overall Study|Adverse Event Related to Progression|0|||
33175605|NCT02289690|100551986|FG008|Overall Study|Adverse Event Related to Progression|0|||
33175606|NCT02289690|100551987|FG009|Overall Study|Adverse Event Related to Progression|0|||
33175607|NCT02289690|100551978|FG000|Overall Study|Withdrawal by Subject|1|||
33175608|NCT02289690|100551979|FG001|Overall Study|Withdrawal by Subject|0|||
33460982|NCT00557245|101576716|FG002|Overall Study|Lost to Follow-up|10|||
33175609|NCT02289690|100551980|FG002|Overall Study|Withdrawal by Subject|0|||
33175610|NCT02289690|100551981|FG003|Overall Study|Withdrawal by Subject|0|||
33175611|NCT02289690|100551982|FG004|Overall Study|Withdrawal by Subject|1|||
33175612|NCT02289690|100551983|FG005|Overall Study|Withdrawal by Subject|1|||
33175613|NCT02289690|100551984|FG006|Overall Study|Withdrawal by Subject|0|||
33175614|NCT02289690|100551985|FG007|Overall Study|Withdrawal by Subject|0|||
33175615|NCT02289690|100551986|FG008|Overall Study|Withdrawal by Subject|4|||
33175616|NCT02289690|100551987|FG009|Overall Study|Withdrawal by Subject|2|||
33175617|NCT02289690|100551978|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
33175618|NCT02289690|100551979|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
33175619|NCT02289690|100551980|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
33175620|NCT02289690|100551981|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
33175621|NCT02289690|100551982|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
33175622|NCT02289690|100551983|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
33175623|NCT02289690|100551984|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
33175624|NCT02289690|100551985|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
33175625|NCT02289690|100551986|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
33175626|NCT02289690|100551987|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
33175627|NCT02289690|100551978|FG000|Overall Study|Lost to Follow-up|0|||
33175628|NCT02289690|100551979|FG001|Overall Study|Lost to Follow-up|0|||
33175629|NCT02289690|100551980|FG002|Overall Study|Lost to Follow-up|0|||
33175630|NCT02289690|100551981|FG003|Overall Study|Lost to Follow-up|0|||
33175631|NCT02289690|100551982|FG004|Overall Study|Lost to Follow-up|0|||
33175632|NCT02289690|100551983|FG005|Overall Study|Lost to Follow-up|0|||
33175633|NCT02289690|100551984|FG006|Overall Study|Lost to Follow-up|0|||
33175634|NCT02289690|100551985|FG007|Overall Study|Lost to Follow-up|1|||
33175635|NCT02289690|100551986|FG008|Overall Study|Lost to Follow-up|0|||
33175636|NCT02289690|100551987|FG009|Overall Study|Lost to Follow-up|2|||
33175637|NCT02289690|100551978|FG000|Overall Study|Death|0|||
33175638|NCT02289690|100551979|FG001|Overall Study|Death|0|||
33175639|NCT02289690|100551980|FG002|Overall Study|Death|0|||
33460983|NCT00557245|101576714|FG000|Overall Study|Ineligible|5|||
33460984|NCT00557245|101576715|FG001|Overall Study|Ineligible|4|||
33460985|NCT00557245|101576716|FG002|Overall Study|Ineligible|2|||
33460986|NCT02351167|101576717|FG000|Overall Study|Withdrawal by Subject|19|||
33460987|NCT02351167|101576718|FG001|Overall Study|Withdrawal by Subject|18|||
33460988|NCT02351167|101576719|FG002|Overall Study|Withdrawal by Subject|21|||
33460989|NCT00570128|101576720|FG000|Overall Study|Adverse Event|1|||
33460990|NCT00570128|101576721|FG001|Overall Study|Adverse Event|0|||
33460991|NCT00570128|101576720|FG000|Overall Study|Lost to Follow-up|1|||
33460992|NCT00570128|101576721|FG001|Overall Study|Lost to Follow-up|0|||
33460993|NCT00570128|101576720|FG000|Overall Study|Withdrawal by Subject|2|||
33460994|NCT00570128|101576721|FG001|Overall Study|Withdrawal by Subject|0|||
33460995|NCT01849458|101576733|FG000|Overall Study|Lost to Follow-up|4|||
33460996|NCT00569777|101576734|FG000|Overall Study|Withdrawal by Subject|4|||
33460997|NCT00569777|101576735|FG001|Overall Study|Withdrawal by Subject|0|||
33460998|NCT00569777|101576734|FG000|Overall Study|Adverse Event|3|||
33460999|NCT00569777|101576735|FG001|Overall Study|Adverse Event|0|||
33461000|NCT00569777|101576734|FG000|Overall Study|Lost to Follow-up|1|||
33461001|NCT00569777|101576735|FG001|Overall Study|Lost to Follow-up|0|||
33461002|NCT00569777|101576734|FG000|Overall Study|scheduled eye surgery|0|||
33461003|NCT00569777|101576735|FG001|Overall Study|scheduled eye surgery|1|||
33461004|NCT00569777|101576734|FG000|Overall Study|did not meet exclusion criteria|1|||
33461005|NCT00569777|101576735|FG001|Overall Study|did not meet exclusion criteria|2|||
33461006|NCT00569777|101576734|FG000|Overall Study|pregnant|1|||
33461007|NCT00569777|101576735|FG001|Overall Study|pregnant|0|||
33461008|NCT00250705|101576742|FG000|Overall Study|Lack of Efficacy|2|||
33461009|NCT00566722|101576743|FG000|Overall Study|Adverse Event|0|||
33461010|NCT00566722|101576744|FG001|Overall Study|Adverse Event|1|||
33461011|NCT00566722|101576745|FG002|Overall Study|Adverse Event|0|||
33461012|NCT00566722|101576743|FG000|Overall Study|Withdrawal by Subject|0|||
33461013|NCT00566722|101576744|FG001|Overall Study|Withdrawal by Subject|0|||
33461014|NCT00566722|101576745|FG002|Overall Study|Withdrawal by Subject|1|||
33461015|NCT00566722|101576743|FG000|Overall Study|Lost to Follow-up|1|||
33175640|NCT02289690|100551981|FG003|Overall Study|Death|0|||
33461016|NCT00566722|101576744|FG001|Overall Study|Lost to Follow-up|1|||
33461017|NCT00566722|101576745|FG002|Overall Study|Lost to Follow-up|1|||
33461018|NCT00566722|101576743|FG000|Overall Study|Lack of Efficacy|1|||
33461019|NCT00566722|101576744|FG001|Overall Study|Lack of Efficacy|2|||
33461020|NCT00566722|101576745|FG002|Overall Study|Lack of Efficacy|4|||
33461021|NCT00566722|101576743|FG000|Overall Study|Did not meet exclusion criteria|0|||
33262940|NCT05171777|100863791|FG000|Treatment Crossover Period|Protocol Violation|0|||
33461022|NCT00566722|101576744|FG001|Overall Study|Did not meet exclusion criteria|0|||
33175641|NCT02289690|100551982|FG004|Overall Study|Death|0|||
33175642|NCT02289690|100551983|FG005|Overall Study|Death|0|||
33175643|NCT02289690|100551984|FG006|Overall Study|Death|0|||
33461023|NCT00566722|101576745|FG002|Overall Study|Did not meet exclusion criteria|2|||
33461024|NCT00566722|101576743|FG000|Overall Study|Serious adverse event|0|||
33461025|NCT00566722|101576744|FG001|Overall Study|Serious adverse event|1|||
33461026|NCT00566722|101576745|FG002|Overall Study|Serious adverse event|0|||
33461027|NCT00566722|101576743|FG000|Overall Study|Noncompliant with drug administration|0|||
33461028|NCT00566722|101576744|FG001|Overall Study|Noncompliant with drug administration|0|||
33461029|NCT00566722|101576745|FG002|Overall Study|Noncompliant with drug administration|1|||
33461030|NCT03086135|101576749|FG000|Overall Study|Adverse Event|1|||
33461031|NCT03086135|101576749|FG000|Overall Study|Lost to Follow-up|2|||
33461032|NCT02259348|101576750|FG000|Overall Study|Donors|6|||
33461033|NCT02259348|101576750|FG000|Overall Study|Death|4|||
33461034|NCT04205162|101576751|FG000|Overall Study|Lost to Follow-up|1|||
33461035|NCT04205162|101576752|FG001|Overall Study|Lost to Follow-up|0|||
33461036|NCT04205162|101576751|FG000|Overall Study|Withdrawal by Subject|2|||
33461037|NCT04205162|101576752|FG001|Overall Study|Withdrawal by Subject|0|||
33461038|NCT04205162|101576751|FG000|Overall Study|University closure due to COVID-19|1|||
33461039|NCT04205162|101576752|FG001|Overall Study|University closure due to COVID-19|0|||
33461040|NCT00493792|101576754|FG000|Overall Study|Death|55|||
33461041|NCT00493792|101576755|FG001|Overall Study|Death|50|||
33461042|NCT00493792|101576754|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
33461043|NCT00493792|101576755|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
33461044|NCT04660032|101576758|FG000|Overall Study|Protocol Violation|1|||
33461045|NCT04660032|101576759|FG001|Overall Study|Protocol Violation|1|||
33461046|NCT02940522|101576762|FG000|Overall Study|Lost to Follow-up|1|||
33461047|NCT02940522|101576763|FG001|Overall Study|Lost to Follow-up|2|||
33461048|NCT02940522|101576762|FG000|Overall Study|Withdrawal by Subject|1|||
33461049|NCT02940522|101576763|FG001|Overall Study|Withdrawal by Subject|0|||
33461050|NCT00265785|101576764|FG000|Overall Study|Adverse Event|4|||
33461051|NCT00265785|101576764|FG000|Overall Study|Withdrawal by Subject|3|||
33461052|NCT00265785|101576764|FG000|Overall Study|Progression/Relapse|15|||
33461053|NCT00265785|101576764|FG000|Overall Study|Not protocol specified|2|||
33461054|NCT00265785|101576764|FG000|Overall Study|Ineligible|1|||
33461055|NCT00265785|101576764|FG000|Overall Study|Did not receive protocol treatment|2|||
33461056|NCT01175473|101576770|FG000|Overall Study|Adverse Event|2|||
33461057|NCT01175473|101576771|FG001|Overall Study|Adverse Event|2|||
33461058|NCT01098851|101576775|FG000|Overall Study|Equipment failure|1|||
33461059|NCT01098851|101576776|FG001|Overall Study|Equipment failure|0|||
33461060|NCT04117945|101576777|FG000|Overall Study|Death|1|||
33461061|NCT04117945|101576778|FG001|Overall Study|Death|0|||
33461062|NCT04117945|101576777|FG000|Overall Study|Withdrawal by Subject|3|||
33461063|NCT04117945|101576778|FG001|Overall Study|Withdrawal by Subject|1|||
33461064|NCT04117945|101576777|FG000|Overall Study|Disease Progression|0|||
33461065|NCT04117945|101576778|FG001|Overall Study|Disease Progression|2|||
33461066|NCT04117945|101576777|FG000|Overall Study|Ineligible|8|||
33461067|NCT04117945|101576778|FG001|Overall Study|Ineligible|7|||
33461068|NCT01937117|101576779|FG000|Overall Study|Disease Progression|7|||
33461069|NCT01937117|101576779|FG000|Overall Study|Physician Decision|4|||
33461070|NCT01937117|101576779|FG000|Overall Study|Adverse Event|2|||
33461071|NCT03310619|101576780|FG000|Pre-Treatment Period|Death|1|||
33461072|NCT03310619|101576781|FG001|Pre-Treatment Period|Death|0|||
33461073|NCT03310619|101576782|FG002|Pre-Treatment Period|Death|0|||
33461074|NCT03310619|101576783|FG003|Pre-Treatment Period|Death|0|||
33461075|NCT03310619|101576784|FG004|Pre-Treatment Period|Death|1|||
33461076|NCT03310619|101576785|FG005|Pre-Treatment Period|Death|0|||
33461077|NCT03310619|101576786|FG006|Pre-Treatment Period|Death|0|||
33461078|NCT03310619|101576787|FG007|Pre-Treatment Period|Death|0|||
33461079|NCT03310619|101576780|FG000|Pre-Treatment Period|Other reasons|2|||
33461080|NCT03310619|101576781|FG001|Pre-Treatment Period|Other reasons|1|||
33461081|NCT03310619|101576782|FG002|Pre-Treatment Period|Other reasons|2|||
33461082|NCT03310619|101576783|FG003|Pre-Treatment Period|Other reasons|0|||
33461083|NCT03310619|101576784|FG004|Pre-Treatment Period|Other reasons|0|||
33461084|NCT03310619|101576785|FG005|Pre-Treatment Period|Other reasons|0|||
33461085|NCT03310619|101576786|FG006|Pre-Treatment Period|Other reasons|2|||
33461086|NCT03310619|101576787|FG007|Pre-Treatment Period|Other reasons|0|||
33461087|NCT03310619|101576780|FG000|Treatment Period|Death|1|||
33461088|NCT03310619|101576781|FG001|Treatment Period|Death|2|||
33461089|NCT03310619|101576782|FG002|Treatment Period|Death|0|||
33461090|NCT03310619|101576783|FG003|Treatment Period|Death|0|||
33461091|NCT03310619|101576784|FG004|Treatment Period|Death|1|||
33461092|NCT03310619|101576785|FG005|Treatment Period|Death|0|||
33461093|NCT03310619|101576786|FG006|Treatment Period|Death|2|||
33461094|NCT03310619|101576787|FG007|Treatment Period|Death|0|||
33461095|NCT03310619|101576780|FG000|Treatment Period|Adverse Event|0|||
33461096|NCT03310619|101576781|FG001|Treatment Period|Adverse Event|1|||
33461097|NCT03310619|101576782|FG002|Treatment Period|Adverse Event|4|||
33461098|NCT03310619|101576783|FG003|Treatment Period|Adverse Event|1|||
33461099|NCT03310619|101576784|FG004|Treatment Period|Adverse Event|0|||
33461100|NCT03310619|101576785|FG005|Treatment Period|Adverse Event|0|||
33461101|NCT03310619|101576786|FG006|Treatment Period|Adverse Event|0|||
33461102|NCT03310619|101576787|FG007|Treatment Period|Adverse Event|0|||
33461103|NCT03310619|101576780|FG000|Treatment Period|Withdrawal by participant|0|||
33461104|NCT03310619|101576781|FG001|Treatment Period|Withdrawal by participant|0|||
33461105|NCT03310619|101576782|FG002|Treatment Period|Withdrawal by participant|1|||
33461106|NCT03310619|101576783|FG003|Treatment Period|Withdrawal by participant|0|||
33461107|NCT03310619|101576784|FG004|Treatment Period|Withdrawal by participant|0|||
33461108|NCT03310619|101576785|FG005|Treatment Period|Withdrawal by participant|0|||
33461109|NCT03310619|101576786|FG006|Treatment Period|Withdrawal by participant|0|||
33461110|NCT03310619|101576787|FG007|Treatment Period|Withdrawal by participant|0|||
33461111|NCT03310619|101576780|FG000|Treatment Period|Lost to Follow-up|0|||
33461112|NCT03310619|101576781|FG001|Treatment Period|Lost to Follow-up|0|||
33461113|NCT03310619|101576782|FG002|Treatment Period|Lost to Follow-up|0|||
33461114|NCT03310619|101576783|FG003|Treatment Period|Lost to Follow-up|0|||
33461115|NCT03310619|101576784|FG004|Treatment Period|Lost to Follow-up|0|||
33461116|NCT03310619|101576785|FG005|Treatment Period|Lost to Follow-up|0|||
33461117|NCT03310619|101576786|FG006|Treatment Period|Lost to Follow-up|0|||
33461118|NCT03310619|101576787|FG007|Treatment Period|Lost to Follow-up|1|||
33461119|NCT03310619|101576780|FG000|Treatment Period|Study terminated by sponsor|0|||
33461120|NCT03310619|101576781|FG001|Treatment Period|Study terminated by sponsor|0|||
33461121|NCT03310619|101576782|FG002|Treatment Period|Study terminated by sponsor|0|||
33461122|NCT03310619|101576783|FG003|Treatment Period|Study terminated by sponsor|0|||
33461123|NCT03310619|101576784|FG004|Treatment Period|Study terminated by sponsor|0|||
33461124|NCT03310619|101576785|FG005|Treatment Period|Study terminated by sponsor|0|||
33461125|NCT03310619|101576786|FG006|Treatment Period|Study terminated by sponsor|0|||
33461126|NCT03310619|101576787|FG007|Treatment Period|Study terminated by sponsor|1|||
33461127|NCT03310619|101576780|FG000|Treatment Period|Physician Decision|0|||
33461128|NCT03310619|101576781|FG001|Treatment Period|Physician Decision|0|||
33461129|NCT03310619|101576782|FG002|Treatment Period|Physician Decision|0|||
33461130|NCT03310619|101576783|FG003|Treatment Period|Physician Decision|0|||
33461131|NCT03310619|101576784|FG004|Treatment Period|Physician Decision|3|||
33461132|NCT03310619|101576785|FG005|Treatment Period|Physician Decision|0|||
33461133|NCT03310619|101576786|FG006|Treatment Period|Physician Decision|0|||
33461134|NCT03310619|101576787|FG007|Treatment Period|Physician Decision|0|||
33461135|NCT03310619|101576780|FG000|Treatment Period|Other reasons|1|||
33461136|NCT03310619|101576781|FG001|Treatment Period|Other reasons|0|||
33461137|NCT03310619|101576782|FG002|Treatment Period|Other reasons|2|||
33175644|NCT02289690|100551985|FG007|Overall Study|Death|49|||
33175645|NCT02289690|100551986|FG008|Overall Study|Death|45|||
33175646|NCT02289690|100551987|FG009|Overall Study|Death|41|||
33175647|NCT02289690|100551978|FG000|Overall Study|Sponsor Discontinued Study|0|||
33175648|NCT02289690|100551979|FG001|Overall Study|Sponsor Discontinued Study|0|||
33175649|NCT02289690|100551980|FG002|Overall Study|Sponsor Discontinued Study|0|||
33175650|NCT02289690|100551981|FG003|Overall Study|Sponsor Discontinued Study|0|||
33175651|NCT02289690|100551982|FG004|Overall Study|Sponsor Discontinued Study|0|||
33175652|NCT02289690|100551983|FG005|Overall Study|Sponsor Discontinued Study|0|||
33175653|NCT02289690|100551984|FG006|Overall Study|Sponsor Discontinued Study|0|||
33175654|NCT02289690|100551985|FG007|Overall Study|Sponsor Discontinued Study|9|||
33175655|NCT02289690|100551986|FG008|Overall Study|Sponsor Discontinued Study|7|||
33175656|NCT02289690|100551987|FG009|Overall Study|Sponsor Discontinued Study|15|||
33175657|NCT02289690|100551978|FG000|Overall Study|Other|0|||
33175658|NCT02289690|100551979|FG001|Overall Study|Other|0|||
33175659|NCT02289690|100551980|FG002|Overall Study|Other|0|||
33175660|NCT02289690|100551981|FG003|Overall Study|Other|1|||
33175661|NCT02289690|100551982|FG004|Overall Study|Other|1|||
33175662|NCT02289690|100551983|FG005|Overall Study|Other|0|||
33175663|NCT02289690|100551984|FG006|Overall Study|Other|1|||
33175664|NCT02289690|100551985|FG007|Overall Study|Other|2|||
33175665|NCT02289690|100551986|FG008|Overall Study|Other|3|||
33175666|NCT02289690|100551987|FG009|Overall Study|Other|1|||
33175667|NCT03051607|100551990|FG000|Overall Study|Adverse Event|66|||
33175668|NCT00799487|100551995|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
33461138|NCT03310619|101576783|FG003|Treatment Period|Other reasons|0|||
33461139|NCT03310619|101576784|FG004|Treatment Period|Other reasons|0|||
33461140|NCT03310619|101576785|FG005|Treatment Period|Other reasons|0|||
33461141|NCT03310619|101576786|FG006|Treatment Period|Other reasons|0|||
33461142|NCT03310619|101576787|FG007|Treatment Period|Other reasons|0|||
33461143|NCT01740791|101576803|FG000|Overall Study|Randomized but never treated|5|||
33175669|NCT00799487|100551996|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
33175670|NCT00799487|100551997|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
33175671|NCT00799487|100551995|FG000|Dose Adjustment Period|Adverse Event|2|||
33175672|NCT00799487|100551996|FG001|Dose Adjustment Period|Adverse Event|0|||
33175673|NCT00799487|100551997|FG002|Dose Adjustment Period|Adverse Event|0|||
33175674|NCT00799487|100551995|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
33175675|NCT00799487|100551996|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
33461144|NCT01740791|101576804|FG001|Overall Study|Randomized but never treated|3|||
33461145|NCT01740791|101576805|FG002|Overall Study|Randomized but never treated|2|||
33461146|NCT01740791|101576806|FG003|Overall Study|Randomized but never treated|2|||
33461147|NCT01740791|101576807|FG004|Overall Study|Randomized but never treated|1|||
33461148|NCT01740791|101576808|FG005|Overall Study|Randomized but never treated|3|||
33461149|NCT01740791|101576803|FG000|Overall Study|Lost to Follow-up|2|||
33461150|NCT01740791|101576804|FG001|Overall Study|Lost to Follow-up|0|||
33461151|NCT01740791|101576805|FG002|Overall Study|Lost to Follow-up|2|||
33461152|NCT01740791|101576806|FG003|Overall Study|Lost to Follow-up|3|||
33461153|NCT01740791|101576807|FG004|Overall Study|Lost to Follow-up|2|||
33461154|NCT01740791|101576808|FG005|Overall Study|Lost to Follow-up|3|||
33461155|NCT01740791|101576803|FG000|Overall Study|Withdrew Consent|4|||
33461156|NCT01740791|101576804|FG001|Overall Study|Withdrew Consent|0|||
33461157|NCT01740791|101576805|FG002|Overall Study|Withdrew Consent|1|||
33461158|NCT01740791|101576806|FG003|Overall Study|Withdrew Consent|2|||
33461159|NCT01740791|101576807|FG004|Overall Study|Withdrew Consent|0|||
33461160|NCT01740791|101576808|FG005|Overall Study|Withdrew Consent|3|||
33461161|NCT01740791|101576803|FG000|Overall Study|Investigator's discretion|1|||
33461162|NCT01740791|101576804|FG001|Overall Study|Investigator's discretion|0|||
33461163|NCT01740791|101576805|FG002|Overall Study|Investigator's discretion|1|||
33461164|NCT01740791|101576806|FG003|Overall Study|Investigator's discretion|0|||
33461165|NCT01740791|101576807|FG004|Overall Study|Investigator's discretion|0|||
33461166|NCT01740791|101576808|FG005|Overall Study|Investigator's discretion|1|||
33461167|NCT01740791|101576803|FG000|Overall Study|Adverse Event|0|||
33461168|NCT01740791|101576804|FG001|Overall Study|Adverse Event|0|||
33461169|NCT01740791|101576805|FG002|Overall Study|Adverse Event|0|||
33461170|NCT01740791|101576806|FG003|Overall Study|Adverse Event|0|||
33461171|NCT01740791|101576807|FG004|Overall Study|Adverse Event|0|||
33461172|NCT01740791|101576808|FG005|Overall Study|Adverse Event|1|||
33461173|NCT00438659|101576809|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
33461174|NCT00438659|101576810|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
33461175|NCT00438659|101576809|FG000|Overall Study|Cancel|5|||
33461176|NCT00438659|101576810|FG001|Overall Study|Cancel|2|||
33461177|NCT01235442|101576827|FG000|Overall Study|Lost to Follow-up|12|||
33461178|NCT01235442|101576828|FG001|Overall Study|Lost to Follow-up|10|||
33461179|NCT01235442|101576827|FG000|Overall Study|Death|0|||
33461180|NCT01235442|101576828|FG001|Overall Study|Death|2|||
33461181|NCT01235442|101576827|FG000|Overall Study|Pregnancy|1|||
33461182|NCT01235442|101576828|FG001|Overall Study|Pregnancy|1|||
33461183|NCT01235442|101576827|FG000|Overall Study|Ineligibility determined|5|||
33461184|NCT01235442|101576828|FG001|Overall Study|Ineligibility determined|4|||
33461185|NCT01235442|101576827|FG000|Overall Study|Protocol Violation|3|||
33175676|NCT00799487|100551997|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
33175677|NCT00799487|100551995|FG000|Dose Adjustment Period|Investigator Discretion|2|||
33175678|NCT00799487|100551996|FG001|Dose Adjustment Period|Investigator Discretion|0|||
33175679|NCT00799487|100551997|FG002|Dose Adjustment Period|Investigator Discretion|0|||
33175680|NCT00799487|100551995|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
33175681|NCT00799487|100551996|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
33175682|NCT00799487|100551997|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
33175683|NCT00799487|100551995|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
33175684|NCT00799487|100551996|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
33175685|NCT00799487|100551997|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
33175686|NCT00799487|100551995|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
33175687|NCT00799487|100551996|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
33175688|NCT00799487|100551997|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
33461186|NCT01235442|101576828|FG001|Overall Study|Protocol Violation|3|||
33461187|NCT01235442|101576827|FG000|Overall Study|Adverse Event|4|||
33461188|NCT01235442|101576828|FG001|Overall Study|Adverse Event|6|||
33461189|NCT01235442|101576827|FG000|Overall Study|Withdrawal by Subject|15|||
33461190|NCT01235442|101576828|FG001|Overall Study|Withdrawal by Subject|9|||
33461191|NCT01235442|101576827|FG000|Overall Study|Lack of Efficacy|1|||
33461192|NCT01235442|101576828|FG001|Overall Study|Lack of Efficacy|3|||
33461193|NCT01235442|101576827|FG000|Overall Study|Noncompliance|1|||
33461194|NCT01235442|101576828|FG001|Overall Study|Noncompliance|2|||
33461195|NCT01235442|101576827|FG000|Overall Study|Administrative decision|1|||
33461196|NCT01235442|101576828|FG001|Overall Study|Administrative decision|2|||
33461197|NCT01235442|101576827|FG000|Overall Study|Other unspecified|1|||
33461198|NCT01235442|101576828|FG001|Overall Study|Other unspecified|2|||
33461199|NCT02289820|101576830|FG000|Overall Study|Withdrawal by Subject|2|||
33461200|NCT02289820|101576831|FG001|Overall Study|Withdrawal by Subject|1|||
33461201|NCT02289820|101576832|FG002|Overall Study|Withdrawal by Subject|2|||
33461202|NCT02289820|101576833|FG003|Overall Study|Withdrawal by Subject|1|||
33461203|NCT02289820|101576834|FG004|Overall Study|Withdrawal by Subject|0|||
33461204|NCT02289820|101576835|FG005|Overall Study|Withdrawal by Subject|0|||
33461205|NCT02289820|101576836|FG006|Overall Study|Withdrawal by Subject|1|||
33461206|NCT02289820|101576830|FG000|Overall Study|Death|0|||
33461207|NCT02289820|101576831|FG001|Overall Study|Death|0|||
33461208|NCT02289820|101576832|FG002|Overall Study|Death|1|||
33461209|NCT02289820|101576833|FG003|Overall Study|Death|0|||
33461210|NCT02289820|101576834|FG004|Overall Study|Death|0|||
33461211|NCT02289820|101576835|FG005|Overall Study|Death|0|||
33461212|NCT02289820|101576836|FG006|Overall Study|Death|0|||
33461213|NCT02289820|101576830|FG000|Overall Study|Lost to Follow-up|0|||
33461214|NCT02289820|101576831|FG001|Overall Study|Lost to Follow-up|0|||
33461215|NCT02289820|101576832|FG002|Overall Study|Lost to Follow-up|3|||
33461216|NCT02289820|101576833|FG003|Overall Study|Lost to Follow-up|1|||
33461217|NCT02289820|101576834|FG004|Overall Study|Lost to Follow-up|0|||
33461218|NCT02289820|101576835|FG005|Overall Study|Lost to Follow-up|1|||
33461219|NCT02289820|101576836|FG006|Overall Study|Lost to Follow-up|1|||
33461220|NCT02289820|101576830|FG000|Overall Study|withdrawal of consent|0|||
33461221|NCT02289820|101576831|FG001|Overall Study|withdrawal of consent|1|||
33461222|NCT02289820|101576832|FG002|Overall Study|withdrawal of consent|0|||
33461223|NCT02289820|101576833|FG003|Overall Study|withdrawal of consent|0|||
33461224|NCT02289820|101576834|FG004|Overall Study|withdrawal of consent|0|||
33461225|NCT02289820|101576835|FG005|Overall Study|withdrawal of consent|0|||
33461226|NCT02289820|101576836|FG006|Overall Study|withdrawal of consent|0|||
33461227|NCT04405739|101576840|FG000|Overall Study|Adverse Event|0|||
33461228|NCT04405739|101576841|FG001|Overall Study|Adverse Event|1|||
33461229|NCT04405739|101576842|FG002|Overall Study|Adverse Event|0|||
33461230|NCT04405739|101576843|FG003|Overall Study|Adverse Event|0|||
33461231|NCT04405739|101576840|FG000|Overall Study|Lost to Follow-up|0|||
33461232|NCT04405739|101576841|FG001|Overall Study|Lost to Follow-up|2|||
33461233|NCT04405739|101576842|FG002|Overall Study|Lost to Follow-up|1|||
33461234|NCT04405739|101576843|FG003|Overall Study|Lost to Follow-up|3|||
33175689|NCT00799487|100551995|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
33262941|NCT05171777|100863792|FG001|Treatment Crossover Period|Protocol Violation|2|||
33461235|NCT04405739|101576840|FG000|Overall Study|Withdrawal by Subject|0|||
33461236|NCT04405739|101576841|FG001|Overall Study|Withdrawal by Subject|2|||
33461237|NCT04405739|101576842|FG002|Overall Study|Withdrawal by Subject|1|||
33461238|NCT04405739|101576843|FG003|Overall Study|Withdrawal by Subject|1|||
33461239|NCT04405739|101576840|FG000|Overall Study|Death|0|||
33461240|NCT04405739|101576841|FG001|Overall Study|Death|0|||
33461241|NCT04405739|101576842|FG002|Overall Study|Death|1|||
33461242|NCT04405739|101576843|FG003|Overall Study|Death|0|||
33461243|NCT04405739|101576840|FG000|Overall Study|Transferred to rehab|0|||
33461244|NCT04405739|101576841|FG001|Overall Study|Transferred to rehab|0|||
33461245|NCT04405739|101576842|FG002|Overall Study|Transferred to rehab|0|||
33461246|NCT04405739|101576843|FG003|Overall Study|Transferred to rehab|1|||
33175690|NCT00799487|100551996|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
33175691|NCT00799487|100551997|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
33175692|NCT00799487|100551995|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
33175693|NCT00799487|100551996|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
33175694|NCT00799487|100551997|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
33461247|NCT04405739|101576840|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
33461248|NCT04405739|101576841|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
33175695|NCT00799487|100551995|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
33175696|NCT00799487|100551996|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
33175697|NCT00799487|100551997|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
33175698|NCT00799487|100551995|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
33175699|NCT00799487|100551996|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
33175700|NCT00799487|100551997|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
33175701|NCT00799487|100551995|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
33175702|NCT00799487|100551996|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
33175703|NCT00799487|100551997|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
33175704|NCT03641651|100551998|FG000|Overall Study|organizational issues at one study site|1|||
33175705|NCT02233309|100552001|FG000|Overall Study|Physician Decision|5|||
33175706|NCT01980875|100552002|FG000|Overall Study|Withdrew Consent|1|||
33175707|NCT01980875|100552003|FG001|Overall Study|Withdrew Consent|1|||
33175708|NCT01980875|100552004|FG002|Overall Study|Withdrew Consent|1|||
33175709|NCT01980875|100552002|FG000|Overall Study|Study Terminated by Sponsor|7|||
33175710|NCT01980875|100552003|FG001|Overall Study|Study Terminated by Sponsor|24|||
33175711|NCT01980875|100552004|FG002|Overall Study|Study Terminated by Sponsor|22|||
33175712|NCT01980875|100552002|FG000|Overall Study|Lost to Follow-up|0|||
33175713|NCT01980875|100552003|FG001|Overall Study|Lost to Follow-up|0|||
33175714|NCT01980875|100552004|FG002|Overall Study|Lost to Follow-up|1|||
33175715|NCT03316131|100552005|FG000|Treatment Period 2|Protocol deviation|1|||
33175716|NCT03316131|100552006|FG001|Treatment Period 2|Protocol deviation|0|||
33175717|NCT01922089|100552007|FG000|Overall Study|Adverse Event|18|||
33175718|NCT01922089|100552008|FG001|Overall Study|Adverse Event|13|||
33175719|NCT01922089|100552007|FG000|Overall Study|Protocol Deviation|10|||
33175720|NCT01922089|100552008|FG001|Overall Study|Protocol Deviation|7|||
33175721|NCT01922089|100552007|FG000|Overall Study|Withdrawal by Subject|3|||
33175722|NCT01922089|100552008|FG001|Overall Study|Withdrawal by Subject|4|||
33175723|NCT01922089|100552007|FG000|Overall Study|administrative problems|4|||
33175724|NCT01922089|100552008|FG001|Overall Study|administrative problems|1|||
33175725|NCT01922089|100552007|FG000|Overall Study|Physician Decision|2|||
33175726|NCT01922089|100552008|FG001|Overall Study|Physician Decision|3|||
33175727|NCT01922089|100552007|FG000|Overall Study|Death|2|||
33175728|NCT01922089|100552008|FG001|Overall Study|Death|1|||
33175729|NCT01922089|100552007|FG000|Overall Study|Lost to Follow-up|0|||
33175730|NCT01922089|100552008|FG001|Overall Study|Lost to Follow-up|1|||
33175731|NCT00271609|100552009|FG000|Overall Study|Adverse Event|11|||
33175732|NCT00271609|100552010|FG001|Overall Study|Adverse Event|3|||
33175733|NCT00271609|100552009|FG000|Overall Study|Withdrawal by Subject|2|||
33175734|NCT00271609|100552010|FG001|Overall Study|Withdrawal by Subject|0|||
33175735|NCT00967798|100552011|FG000|Overall Study|Withdrawal by Subject|5|||
33175736|NCT00967798|100552012|FG001|Overall Study|Withdrawal by Subject|2|||
33175737|NCT00967798|100552011|FG000|Overall Study|Lost to Follow-up|4|||
33175738|NCT00967798|100552012|FG001|Overall Study|Lost to Follow-up|1|||
33175739|NCT02769247|100552016|FG000|Overall Study|Withdrawal by Subject|1|||
33175740|NCT02769247|100552017|FG001|Overall Study|Withdrawal by Subject|0|||
33175741|NCT02769247|100552018|FG002|Overall Study|Withdrawal by Subject|0|||
33175742|NCT02769247|100552019|FG003|Overall Study|Withdrawal by Subject|1|||
33461249|NCT04405739|101576842|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
33461250|NCT04405739|101576843|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
33461251|NCT01857206|101576844|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
33175743|NCT02769247|100552016|FG000|Overall Study|Protocol Violation|0|||
33175744|NCT02769247|100552017|FG001|Overall Study|Protocol Violation|0|||
33262942|NCT05171777|100863793|FG002|Treatment Crossover Period|Protocol Violation|0|||
33461252|NCT01857206|101576845|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
33461253|NCT01857206|101576844|FG000|Overall Study|Lost to Follow-up|9|||
33461254|NCT01857206|101576845|FG001|Overall Study|Lost to Follow-up|6|||
33461255|NCT01857206|101576844|FG000|Overall Study|Unclassified|3|||
33461256|NCT01857206|101576845|FG001|Overall Study|Unclassified|3|||
33461257|NCT01857206|101576844|FG000|Overall Study|Withdrawal by Subject|1|||
33461258|NCT01857206|101576845|FG001|Overall Study|Withdrawal by Subject|0|||
33461259|NCT01181531|101576846|FG000|Overall Study|Other|17|||
33461260|NCT01181531|101576847|FG001|Overall Study|Other|12|||
33461261|NCT01181531|101576846|FG000|Overall Study|Partial consent by subject withdrawn|0|||
33461262|NCT01181531|101576847|FG001|Overall Study|Partial consent by subject withdrawn|1|||
33461263|NCT01181531|101576846|FG000|Overall Study|Physician Decision|3|||
33461264|NCT01181531|101576847|FG001|Overall Study|Physician Decision|1|||
33461265|NCT01181531|101576846|FG000|Overall Study|Noncompliance|2|||
33461266|NCT01181531|101576847|FG001|Overall Study|Noncompliance|2|||
33461267|NCT01181531|101576846|FG000|Overall Study|Ineligibility determined|1|||
33461268|NCT01181531|101576847|FG001|Overall Study|Ineligibility determined|2|||
33461269|NCT01181531|101576846|FG000|Overall Study|Protocol Specified Criteria|15|||
33461270|NCT01181531|101576847|FG001|Overall Study|Protocol Specified Criteria|8|||
33461271|NCT01181531|101576846|FG000|Overall Study|Pregnancy|0|||
33461272|NCT01181531|101576847|FG001|Overall Study|Pregnancy|1|||
33461273|NCT01181531|101576846|FG000|Overall Study|Withdrawal by Subject|8|||
33461274|NCT01181531|101576847|FG001|Overall Study|Withdrawal by Subject|7|||
33461275|NCT01181531|101576846|FG000|Overall Study|Protocol Violation|6|||
33461276|NCT01181531|101576847|FG001|Overall Study|Protocol Violation|6|||
33461277|NCT01181531|101576846|FG000|Overall Study|Death|9|||
33461278|NCT01181531|101576847|FG001|Overall Study|Death|12|||
33461279|NCT01181531|101576846|FG000|Overall Study|Adverse Event|0|||
33175745|NCT02769247|100552018|FG002|Overall Study|Protocol Violation|1|||
33175746|NCT02769247|100552019|FG003|Overall Study|Protocol Violation|0|||
33175747|NCT02769247|100552016|FG000|Overall Study|Physician Decision|1|||
33175748|NCT02769247|100552017|FG001|Overall Study|Physician Decision|0|||
33175749|NCT02769247|100552018|FG002|Overall Study|Physician Decision|0|||
33175750|NCT02769247|100552019|FG003|Overall Study|Physician Decision|0|||
33175751|NCT02902965|100552022|FG000|Overall Study|Withdrawal by Subject|10|||
33175752|NCT01338493|100552025|FG000|Enrolled|Withdrawal by Subject|1|||
33175753|NCT01338493|100552025|FG000|Enrolled|Patient not implanted|4|||
33175754|NCT01338493|100552025|FG000|Discharge|Death|1|||
33262943|NCT05171777|100863794|FG003|Treatment Crossover Period|Protocol Violation|0|||
33262944|NCT05171777|100863791|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
33262945|NCT05171777|100863792|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
33262946|NCT05171777|100863793|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
33262947|NCT05171777|100863794|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
33262948|NCT05171777|100863791|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
33262949|NCT05171777|100863792|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
33262950|NCT05171777|100863793|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
33262951|NCT05171777|100863794|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
33262952|NCT05171777|100863791|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
33262953|NCT05171777|100863792|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
33262954|NCT05171777|100863793|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
33262955|NCT05171777|100863794|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
33262956|NCT05171777|100863791|FG000|Treatment Continuation Period|Death|0|||
33262957|NCT05171777|100863792|FG001|Treatment Continuation Period|Death|0|||
33175755|NCT01338493|100552025|FG000|Discharge|Missed visit|1|||
33175756|NCT01338493|100552025|FG000|6 Months Follow up|Lost to Follow-up|11|||
33262958|NCT05171777|100863793|FG002|Treatment Continuation Period|Death|1|||
33262959|NCT05171777|100863794|FG003|Treatment Continuation Period|Death|6|||
33262960|NCT05171777|100863791|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
33262961|NCT05171777|100863792|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
33262962|NCT05171777|100863793|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
33262963|NCT05171777|100863794|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
33461280|NCT01181531|101576847|FG001|Overall Study|Adverse Event|1|||
33262964|NCT02755805|100863800|FG000|Overall Study|Lost to Follow-up|1|||
33461281|NCT00754052|101576848|FG000|Overall Study|Study terminated by Sponsor|5|||
33461282|NCT00754052|101576849|FG001|Overall Study|Study terminated by Sponsor|3|||
33262965|NCT02755805|100863801|FG001|Overall Study|Lost to Follow-up|2|||
33175757|NCT01338493|100552025|FG000|6 Months Follow up|Missed visit|8|||
33175758|NCT01338493|100552025|FG000|12 Months Follow up|Lost to Follow-up|9|||
33175759|NCT04517253|100552028|FG000|Overall Study|Adverse Event|1|||
33175760|NCT04517253|100552029|FG001|Overall Study|Adverse Event|0|||
33262966|NCT02755805|100863800|FG000|Overall Study|Refused assessments|1|||
33262967|NCT02755805|100863801|FG001|Overall Study|Refused assessments|0|||
33262968|NCT02755805|100863800|FG000|Overall Study|Withdrawal by Subject|0|||
33262969|NCT02755805|100863801|FG001|Overall Study|Withdrawal by Subject|2|||
33262970|NCT03624972|100863802|FG000|Overall Study|Lost to Follow-up|2|||
33262971|NCT03624972|100863803|FG001|Overall Study|Lost to Follow-up|0|||
33262972|NCT03624972|100863804|FG002|Overall Study|Lost to Follow-up|0|||
33262973|NCT03624972|100863802|FG000|Overall Study|Withdrawal by Subject|0|||
33262974|NCT03624972|100863803|FG001|Overall Study|Withdrawal by Subject|2|||
33262975|NCT03624972|100863804|FG002|Overall Study|Withdrawal by Subject|0|||
33262976|NCT02161146|100863806|FG000|Overall Study|Adverse Event|1|||
33262977|NCT02161146|100863807|FG001|Overall Study|Adverse Event|1|||
33262978|NCT02161146|100863808|FG002|Overall Study|Adverse Event|0|||
33262979|NCT02161146|100863809|FG003|Overall Study|Adverse Event|1|||
33262980|NCT02161146|100863810|FG004|Overall Study|Adverse Event|0|||
33262981|NCT02161146|100863806|FG000|Overall Study|Lost to Follow-up|0|||
33262982|NCT02161146|100863807|FG001|Overall Study|Lost to Follow-up|1|||
33175761|NCT04517253|100552030|FG002|Overall Study|Adverse Event|0|||
33175762|NCT04517253|100552028|FG000|Overall Study|Death|0|||
33175763|NCT04517253|100552029|FG001|Overall Study|Death|1|||
33175764|NCT04517253|100552030|FG002|Overall Study|Death|0|||
33175765|NCT02066233|100552031|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
33175766|NCT02066233|100552032|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
33175767|NCT01026792|100552033|FG000|Overall Study|Protocol Violation|1|||
33175768|NCT00708162|100552034|FG000|Randomized Phase|Randomized but Not Treated|7|||
33175769|NCT00708162|100552035|FG001|Randomized Phase|Randomized but Not Treated|5|||
33175770|NCT00708162|100552034|FG000|Randomized Phase|Participant Noncompliance|40|||
33175771|NCT00708162|100552035|FG001|Randomized Phase|Participant Noncompliance|32|||
33175772|NCT00708162|100552034|FG000|Randomized Phase|Lost to Follow-up|34|||
33175773|NCT00708162|100552035|FG001|Randomized Phase|Lost to Follow-up|34|||
33175774|NCT00708162|100552034|FG000|Randomized Phase|Withdrew Consent|31|||
33175775|NCT00708162|100552035|FG001|Randomized Phase|Withdrew Consent|22|||
33175776|NCT00708162|100552034|FG000|Randomized Phase|Lack of Efficacy|14|||
33175777|NCT00708162|100552035|FG001|Randomized Phase|Lack of Efficacy|19|||
33175778|NCT00708162|100552034|FG000|Randomized Phase|Protocol Violation|10|||
33175779|NCT00708162|100552035|FG001|Randomized Phase|Protocol Violation|11|||
33175780|NCT00708162|100552034|FG000|Randomized Phase|Adverse Event|8|||
33175781|NCT00708162|100552035|FG001|Randomized Phase|Adverse Event|12|||
33175782|NCT00708162|100552034|FG000|Randomized Phase|Investigator's Discretion|7|||
33175783|NCT00708162|100552035|FG001|Randomized Phase|Investigator's Discretion|10|||
33175784|NCT00708162|100552034|FG000|Randomized Phase|Death|2|||
33175785|NCT00708162|100552035|FG001|Randomized Phase|Death|9|||
33175786|NCT00708162|100552034|FG000|Randomized Phase|Pregnancy|3|||
33175787|NCT00708162|100552035|FG001|Randomized Phase|Pregnancy|0|||
33175788|NCT00708162|100552034|FG000|Open-Label Phase|Lost to Follow-up|10|||
33175789|NCT00708162|100552035|FG001|Open-Label Phase|Lost to Follow-up|8|||
33175790|NCT00708162|100552034|FG000|Open-Label Phase|Withdrew Consent|12|||
33175791|NCT00708162|100552035|FG001|Open-Label Phase|Withdrew Consent|6|||
33175792|NCT00708162|100552034|FG000|Open-Label Phase|Participant Noncompliance|7|||
33175793|NCT00708162|100552035|FG001|Open-Label Phase|Participant Noncompliance|7|||
33175794|NCT00708162|100552034|FG000|Open-Label Phase|Lack of Efficacy|7|||
33175795|NCT00708162|100552035|FG001|Open-Label Phase|Lack of Efficacy|4|||
33175796|NCT00708162|100552034|FG000|Open-Label Phase|Investigator's Discretion|3|||
33175797|NCT00708162|100552035|FG001|Open-Label Phase|Investigator's Discretion|2|||
33175798|NCT00708162|100552034|FG000|Open-Label Phase|Death|3|||
33175799|NCT00708162|100552035|FG001|Open-Label Phase|Death|1|||
33175800|NCT00708162|100552034|FG000|Open-Label Phase|Adverse Event|1|||
33175801|NCT00708162|100552035|FG001|Open-Label Phase|Adverse Event|2|||
33175802|NCT00708162|100552034|FG000|Open-Label Phase|Other|1|||
33262983|NCT02161146|100863808|FG002|Overall Study|Lost to Follow-up|0|||
33262984|NCT02161146|100863809|FG003|Overall Study|Lost to Follow-up|0|||
33262985|NCT02161146|100863810|FG004|Overall Study|Lost to Follow-up|0|||
33262986|NCT02161146|100863806|FG000|Overall Study|Personal Reasons|0|||
33262987|NCT02161146|100863807|FG001|Overall Study|Personal Reasons|1|||
33262988|NCT02161146|100863808|FG002|Overall Study|Personal Reasons|0|||
33175803|NCT00708162|100552035|FG001|Open-Label Phase|Other|0|||
33175804|NCT01252940|100552041|FG000|Main Study Phase|Randomized but not treated|4|||
33175805|NCT01252940|100552042|FG001|Main Study Phase|Randomized but not treated|2|||
33262989|NCT02161146|100863809|FG003|Overall Study|Personal Reasons|2|||
33175806|NCT01252940|100552041|FG000|Main Study Phase|Adverse Event|3|||
33262990|NCT02161146|100863810|FG004|Overall Study|Personal Reasons|1|||
33262991|NCT02161146|100863806|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33262992|NCT02161146|100863807|FG001|Overall Study|Other Miscellaneous Reasons|1|||
33262993|NCT02161146|100863808|FG002|Overall Study|Other Miscellaneous Reasons|0|||
33175807|NCT01252940|100552042|FG001|Main Study Phase|Adverse Event|1|||
33175808|NCT01252940|100552041|FG000|Main Study Phase|Lack of Efficacy|1|||
33262994|NCT02161146|100863809|FG003|Overall Study|Other Miscellaneous Reasons|0|||
33262995|NCT02161146|100863810|FG004|Overall Study|Other Miscellaneous Reasons|0|||
33461283|NCT00889252|101576851|FG000|Overall Study|Adverse Event|2|||
33461284|NCT00889252|101576852|FG001|Overall Study|Adverse Event|4|||
33461285|NCT00889252|101576851|FG000|Overall Study|Withdrawal by Subject|3|||
33461286|NCT00889252|101576852|FG001|Overall Study|Withdrawal by Subject|0|||
33175809|NCT01252940|100552042|FG001|Main Study Phase|Lack of Efficacy|0|||
33175810|NCT01252940|100552041|FG000|Main Study Phase|Lost to Follow-up|6|||
33175811|NCT01252940|100552042|FG001|Main Study Phase|Lost to Follow-up|1|||
33175812|NCT01252940|100552041|FG000|Main Study Phase|Physician Decision|1|||
33175813|NCT01252940|100552042|FG001|Main Study Phase|Physician Decision|0|||
33175814|NCT01252940|100552041|FG000|Main Study Phase|Protocol Violation|4|||
33175815|NCT01252940|100552042|FG001|Main Study Phase|Protocol Violation|2|||
33175816|NCT01252940|100552041|FG000|Main Study Phase|Withdrawal by Subject|6|||
33175817|NCT01252940|100552042|FG001|Main Study Phase|Withdrawal by Subject|5|||
33175818|NCT01252940|100552041|FG000|Main Study Phase|Subject Non-compliance|1|||
33175819|NCT01252940|100552042|FG001|Main Study Phase|Subject Non-compliance|1|||
33175820|NCT01252940|100552041|FG000|Extension Phase|Adverse Event|2|||
33175821|NCT01252940|100552042|FG001|Extension Phase|Adverse Event|1|||
33175822|NCT01252940|100552041|FG000|Extension Phase|Lack of Efficacy|1|||
33175823|NCT01252940|100552042|FG001|Extension Phase|Lack of Efficacy|0|||
33175824|NCT01252940|100552041|FG000|Extension Phase|Lost to Follow-up|5|||
33461287|NCT00889252|101576851|FG000|Overall Study|Protocol Violation|2|||
33461288|NCT00889252|101576852|FG001|Overall Study|Protocol Violation|0|||
33461289|NCT02169791|101576853|FG000|Overall Study|Death|6|||
33461290|NCT02169791|101576853|FG000|Overall Study|patient withdrew consent|1|||
33461291|NCT01630616|101576860|FG000|Overall Study|Adverse Event|0|||
33461292|NCT01630616|101576861|FG001|Overall Study|Adverse Event|0|||
33461293|NCT01630616|101576862|FG002|Overall Study|Adverse Event|0|||
33461294|NCT01630616|101576863|FG003|Overall Study|Adverse Event|1|||
33461295|NCT01630616|101576864|FG004|Overall Study|Adverse Event|0|||
33461296|NCT01630616|101576865|FG005|Overall Study|Adverse Event|0|||
33461297|NCT01630616|101576860|FG000|Overall Study|Withdrawal by Subject|0|||
33461298|NCT01630616|101576861|FG001|Overall Study|Withdrawal by Subject|0|||
33461299|NCT01630616|101576862|FG002|Overall Study|Withdrawal by Subject|0|||
33461300|NCT01630616|101576863|FG003|Overall Study|Withdrawal by Subject|2|||
33461301|NCT01630616|101576864|FG004|Overall Study|Withdrawal by Subject|0|||
33461302|NCT01630616|101576865|FG005|Overall Study|Withdrawal by Subject|0|||
33461303|NCT02224053|101576866|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
33461304|NCT02224053|101576866|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
33461305|NCT02224053|101576866|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
33461306|NCT02224053|101576866|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
33461307|NCT02224053|101576866|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
33461308|NCT01186016|101576867|FG000|Overall Study|Withdrawal by Subject|46|||
33461309|NCT01186016|101576868|FG001|Overall Study|Withdrawal by Subject|29|||
33461310|NCT02522780|101576869|FG000|Overall Study|Consent withdrawn by subject|5|||
33461311|NCT02522780|101576870|FG001|Overall Study|Consent withdrawn by subject|7|||
33461312|NCT02522780|101576869|FG000|Overall Study|Protocol deviation|1|||
33461313|NCT02522780|101576870|FG001|Overall Study|Protocol deviation|3|||
33461314|NCT02522780|101576869|FG000|Overall Study|Subject refused endoscopic procedure|0|||
33461315|NCT02522780|101576870|FG001|Overall Study|Subject refused endoscopic procedure|1|||
33461316|NCT02522780|101576869|FG000|Overall Study|Adverse event, non-fatal|11|||
33461317|NCT02522780|101576870|FG001|Overall Study|Adverse event, non-fatal|16|||
33461318|NCT01264835|101576873|FG000|Overall Study|Lost to Follow-up|1|||
33461319|NCT00526162|101576874|FG000|Overall Study|Device not implanted|3|||
33461320|NCT01863433|101576880|FG000|Overall Study|Protocol Violation|1|||
33461321|NCT02655224|101576882|FG000|Overall Study|Adverse Event|1|||
33461322|NCT02655224|101576883|FG001|Overall Study|Adverse Event|1|||
33461323|NCT05412121|101576884|FG000|Overall Study|Withdrawal by Subject|4|||
33461324|NCT05412121|101576884|FG000|Overall Study|Physician Decision|1|||
33461325|NCT05412121|101576884|FG000|Overall Study|Lost to Follow-up|5|||
33461326|NCT02966340|101576887|FG000|Overall Study|Adverse Event|0|||
33461327|NCT02966340|101576888|FG001|Overall Study|Adverse Event|1|||
33461328|NCT02966340|101576887|FG000|Overall Study|Lost to Follow-up|0|||
33461329|NCT02966340|101576888|FG001|Overall Study|Lost to Follow-up|1|||
33461330|NCT02966340|101576887|FG000|Overall Study|Withdrawal by Subject|1|||
33461331|NCT02966340|101576888|FG001|Overall Study|Withdrawal by Subject|0|||
33461332|NCT02966340|101576887|FG000|Overall Study|data acquisition error|1|||
33461333|NCT02966340|101576888|FG001|Overall Study|data acquisition error|0|||
33461334|NCT02966340|101576887|FG000|Overall Study|startle non-responder|1|||
33461335|NCT02966340|101576888|FG001|Overall Study|startle non-responder|1|||
33461336|NCT00605176|101576889|FG000|Overall Study|Adverse Event|2|||
33461337|NCT00605176|101576890|FG001|Overall Study|Adverse Event|1|||
33461338|NCT00605176|101576891|FG002|Overall Study|Adverse Event|3|||
33461339|NCT00605176|101576889|FG000|Overall Study|Withdrawal by Subject|4|||
33175825|NCT01252940|100552042|FG001|Extension Phase|Lost to Follow-up|0|||
33175826|NCT01252940|100552041|FG000|Extension Phase|Physician Decision|0|||
33175827|NCT01252940|100552042|FG001|Extension Phase|Physician Decision|1|||
33262996|NCT00754065|100863811|FG000|Overall Study|Never received treatment|12|||
33262997|NCT00754065|100863812|FG001|Overall Study|Never received treatment|2|||
33262998|NCT00754065|100863811|FG000|Overall Study|Adverse Event|19|||
33262999|NCT00754065|100863812|FG001|Overall Study|Adverse Event|25|||
33263000|NCT00754065|100863811|FG000|Overall Study|Lost to Follow-up|7|||
33263001|NCT00754065|100863812|FG001|Overall Study|Lost to Follow-up|11|||
33263002|NCT00754065|100863811|FG000|Overall Study|Protocol Violation|12|||
33263003|NCT00754065|100863812|FG001|Overall Study|Protocol Violation|10|||
33263004|NCT00754065|100863811|FG000|Overall Study|Withdrawal by Subject|4|||
33263005|NCT00754065|100863812|FG001|Overall Study|Withdrawal by Subject|5|||
33263006|NCT00754065|100863811|FG000|Overall Study|Pregnancy|6|||
33263007|NCT00754065|100863812|FG001|Overall Study|Pregnancy|0|||
33263008|NCT00754065|100863811|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
33263009|NCT00754065|100863812|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
33263010|NCT00989196|100863813|FG000|Treatment Period|Lost to Follow-up|1|||
33263011|NCT00989196|100863814|FG001|Treatment Period|Lost to Follow-up|0|||
33175828|NCT01252940|100552041|FG000|Extension Phase|Subject Non-compliance|1|||
33175829|NCT01252940|100552042|FG001|Extension Phase|Subject Non-compliance|0|||
33175830|NCT01252940|100552041|FG000|Extension Phase|Withdrawal by Subject|1|||
33175831|NCT01252940|100552042|FG001|Extension Phase|Withdrawal by Subject|1|||
33175832|NCT01156311|100552044|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
33175833|NCT01156311|100552045|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
33175834|NCT01156311|100552046|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
33175835|NCT01156311|100552047|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
33175836|NCT01156311|100552044|FG000|2-Month Monotherapy Period|Physician Decision|0|||
33175837|NCT01156311|100552045|FG001|2-Month Monotherapy Period|Physician Decision|1|||
33175838|NCT01156311|100552046|FG002|2-Month Monotherapy Period|Physician Decision|0|||
33175839|NCT01156311|100552047|FG003|2-Month Monotherapy Period|Physician Decision|0|||
33175840|NCT01156311|100552044|FG000|2-Month Monotherapy Period|Other|1|||
33175841|NCT01156311|100552045|FG001|2-Month Monotherapy Period|Other|0|||
33175842|NCT01156311|100552046|FG002|2-Month Monotherapy Period|Other|0|||
33175843|NCT01156311|100552047|FG003|2-Month Monotherapy Period|Other|0|||
33175844|NCT01156311|100552044|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
33175845|NCT01156311|100552045|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
33175846|NCT01156311|100552046|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
33175847|NCT01156311|100552047|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
33263012|NCT00003222|100863815|FG000|Overall Study|Physician Decision|0|||
33263013|NCT00003222|100863816|FG001|Overall Study|Physician Decision|1|||
33461340|NCT00605176|101576890|FG001|Overall Study|Withdrawal by Subject|2|||
33461341|NCT00605176|101576891|FG002|Overall Study|Withdrawal by Subject|4|||
33461342|NCT00605176|101576889|FG000|Overall Study|Lost to Follow-up|2|||
33461343|NCT00605176|101576890|FG001|Overall Study|Lost to Follow-up|2|||
33461344|NCT00605176|101576891|FG002|Overall Study|Lost to Follow-up|1|||
33461345|NCT00605176|101576889|FG000|Overall Study|Non-complicance with study procedures|1|||
33461346|NCT00605176|101576890|FG001|Overall Study|Non-complicance with study procedures|0|||
33461347|NCT00605176|101576891|FG002|Overall Study|Non-complicance with study procedures|0|||
33461348|NCT00605176|101576889|FG000|Overall Study|Use of concomitant therapy|1|||
33461349|NCT00605176|101576890|FG001|Overall Study|Use of concomitant therapy|0|||
33461350|NCT00605176|101576891|FG002|Overall Study|Use of concomitant therapy|1|||
33461351|NCT00605176|101576889|FG000|Overall Study|Other (not due to AE)|1|||
33461352|NCT00605176|101576890|FG001|Overall Study|Other (not due to AE)|1|||
33175848|NCT01156311|100552044|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
33175849|NCT01156311|100552045|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
33175850|NCT01156311|100552046|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
33263014|NCT02128113|100863817|FG000|Overall Study|Withdrawal by Subject|3|||
33175851|NCT01156311|100552047|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
33263015|NCT02128113|100863818|FG001|Overall Study|Withdrawal by Subject|1|||
33263016|NCT02128113|100863819|FG002|Overall Study|Withdrawal by Subject|0|||
33263017|NCT02128113|100863817|FG000|Overall Study|Protocol Violation|0|||
33461353|NCT00605176|101576891|FG002|Overall Study|Other (not due to AE)|0|||
33461354|NCT01609582|101576893|FG000|Overall Study|Adverse Event|20|||
33461355|NCT01609582|101576894|FG001|Overall Study|Adverse Event|18|||
33461356|NCT01609582|101576893|FG000|Overall Study|Lost to Follow-up|10|||
33461357|NCT01609582|101576894|FG001|Overall Study|Lost to Follow-up|10|||
33461358|NCT01609582|101576893|FG000|Overall Study|Withdrawal by Subject|21|||
33175852|NCT01156311|100552044|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
33175853|NCT01156311|100552045|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
33175854|NCT01156311|100552046|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
33175855|NCT01156311|100552047|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
33175856|NCT01156311|100552044|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
33175857|NCT01156311|100552045|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
33175858|NCT01156311|100552046|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
33263018|NCT02128113|100863818|FG001|Overall Study|Protocol Violation|1|||
33263019|NCT02128113|100863819|FG002|Overall Study|Protocol Violation|0|||
33263020|NCT02128113|100863817|FG000|Overall Study|Surgery cancelled|0|||
33263021|NCT02128113|100863818|FG001|Overall Study|Surgery cancelled|1|||
33263022|NCT02128113|100863819|FG002|Overall Study|Surgery cancelled|0|||
33263023|NCT02128113|100863817|FG000|Overall Study|Adverse Event|0|||
33263024|NCT02128113|100863818|FG001|Overall Study|Adverse Event|0|||
33263025|NCT02128113|100863819|FG002|Overall Study|Adverse Event|1|||
33263026|NCT03488719|100863820|FG000|Overall Study|Adverse Event|0|||
33263027|NCT03488719|100863821|FG001|Overall Study|Adverse Event|4|||
33263028|NCT03488719|100863822|FG002|Overall Study|Adverse Event|2|||
33263029|NCT03488719|100863820|FG000|Overall Study|Other|0|||
33263030|NCT03488719|100863821|FG001|Overall Study|Other|0|||
33263031|NCT03488719|100863822|FG002|Overall Study|Other|5|||
33263032|NCT04337931|100863823|FG000|Overall Study|Death|4|||
33263033|NCT04337931|100863824|FG001|Overall Study|Death|1|||
33263034|NCT04337931|100863825|FG002|Overall Study|Death|7|||
33461359|NCT01609582|101576894|FG001|Overall Study|Withdrawal by Subject|15|||
33263035|NCT04337931|100863823|FG000|Overall Study|Withdrawal by Subject|0|||
33263036|NCT04337931|100863824|FG001|Overall Study|Withdrawal by Subject|1|||
33263037|NCT04337931|100863825|FG002|Overall Study|Withdrawal by Subject|0|||
33263038|NCT04337931|100863823|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
33263039|NCT04337931|100863824|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
33263040|NCT04337931|100863825|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
33263041|NCT04337931|100863823|FG000|Overall Study|Study terminated by sponsor|3|||
33263042|NCT04337931|100863824|FG001|Overall Study|Study terminated by sponsor|6|||
33263043|NCT04337931|100863825|FG002|Overall Study|Study terminated by sponsor|2|||
33263044|NCT04337931|100863823|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
33263045|NCT04337931|100863824|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
33263046|NCT04337931|100863825|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
33263047|NCT04337931|100863823|FG000|Overall Study|Colorectal cancer treatment|1|||
33263048|NCT04337931|100863824|FG001|Overall Study|Colorectal cancer treatment|0|||
33263049|NCT04337931|100863825|FG002|Overall Study|Colorectal cancer treatment|0|||
33461360|NCT01609582|101576893|FG000|Overall Study|Study Terminated by Sponsor|1543|||
33461361|NCT01609582|101576894|FG001|Overall Study|Study Terminated by Sponsor|1548|||
33461362|NCT01609582|101576893|FG000|Overall Study|Other|9|||
33461363|NCT01609582|101576894|FG001|Overall Study|Other|10|||
33461364|NCT01609582|101576893|FG000|Overall Study|Randomized, but not treated|0|||
33461365|NCT01609582|101576894|FG001|Overall Study|Randomized, but not treated|3|||
33461366|NCT02329431|101576895|FG000|Overall Study|Lost to Follow-up|20|||
33461367|NCT02329431|101576896|FG001|Overall Study|Lost to Follow-up|13|||
33461368|NCT02726386|101576897|FG000|Overall Study|Adverse Event|17|||
33461369|NCT02726386|101576898|FG001|Overall Study|Adverse Event|20|||
33461370|NCT02726386|101576897|FG000|Overall Study|Withdrawal by Subject|14|||
33461371|NCT02726386|101576898|FG001|Overall Study|Withdrawal by Subject|28|||
33461372|NCT02726386|101576897|FG000|Overall Study|Other reasons|7|||
33461373|NCT02726386|101576898|FG001|Overall Study|Other reasons|8|||
33461374|NCT02608476|101576899|FG000|Overall Study|Withdrawal by Subject|30|||
33461375|NCT02608476|101576900|FG001|Overall Study|Withdrawal by Subject|37|||
33461376|NCT02608476|101576899|FG000|Overall Study|Lost to Follow-up|24|||
33461377|NCT02608476|101576900|FG001|Overall Study|Lost to Follow-up|24|||
33461378|NCT02608476|101576899|FG000|Overall Study|Adverse Event|2|||
33263050|NCT04337931|100863823|FG000|Overall Study|Participant decision|0|||
33263051|NCT04337931|100863824|FG001|Overall Study|Participant decision|1|||
33263052|NCT04337931|100863825|FG002|Overall Study|Participant decision|0|||
33461379|NCT02608476|101576900|FG001|Overall Study|Adverse Event|8|||
33461380|NCT02608476|101576899|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
33461381|NCT02608476|101576900|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
33263053|NCT02132949|100863827|FG000|Overall Study|Death|7|||
33263054|NCT02132949|100863828|FG001|Overall Study|Death|13|||
33461382|NCT02608476|101576899|FG000|Overall Study|Noncompliance with treatment|1|||
33461383|NCT02608476|101576900|FG001|Overall Study|Noncompliance with treatment|5|||
33461384|NCT02608476|101576899|FG000|Overall Study|Lack of Efficacy|3|||
33263055|NCT02132949|100863827|FG000|Overall Study|Lost to Follow-up|14|||
33263056|NCT02132949|100863828|FG001|Overall Study|Lost to Follow-up|4|||
33461385|NCT02608476|101576900|FG001|Overall Study|Lack of Efficacy|1|||
33461386|NCT02608476|101576899|FG000|Overall Study|Other|0|||
33175859|NCT01156311|100552047|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
33175860|NCT01156311|100552044|FG000|6-month Add-on Therapy Period|Other|0|||
33175861|NCT01156311|100552045|FG001|6-month Add-on Therapy Period|Other|0|||
33175862|NCT01156311|100552046|FG002|6-month Add-on Therapy Period|Other|1|||
33175863|NCT01156311|100552047|FG003|6-month Add-on Therapy Period|Other|2|||
33175864|NCT01313767|100552048|FG000|Overall Study|Adverse Event|1|||
33175865|NCT01313767|100552049|FG001|Overall Study|Adverse Event|0|||
33175866|NCT01313767|100552048|FG000|Overall Study|Lost to Follow-up|1|||
33175867|NCT01313767|100552049|FG001|Overall Study|Lost to Follow-up|0|||
33175868|NCT01313767|100552048|FG000|Overall Study|Withdrawal by Subject|2|||
33263057|NCT02132949|100863827|FG000|Overall Study|Withdrawal by Subject|6|||
33263058|NCT02132949|100863828|FG001|Overall Study|Withdrawal by Subject|5|||
33263059|NCT02132949|100863827|FG000|Overall Study|Noncompliance|5|||
33461387|NCT02608476|101576900|FG001|Overall Study|Other|1|||
33461388|NCT02608476|101576899|FG000|Overall Study|Physician Decision|1|||
33461389|NCT02608476|101576900|FG001|Overall Study|Physician Decision|0|||
33461390|NCT02608476|101576899|FG000|Overall Study|Pregnancy|0|||
33461391|NCT02608476|101576900|FG001|Overall Study|Pregnancy|1|||
33461392|NCT02608476|101576899|FG000|Overall Study|Progressive disease|1|||
33461393|NCT02608476|101576900|FG001|Overall Study|Progressive disease|0|||
33263060|NCT02132949|100863828|FG001|Overall Study|Noncompliance|1|||
33263061|NCT02132949|100863827|FG000|Overall Study|Physician Decision|3|||
33461394|NCT01622660|101576901|FG000|Overall Study|Adverse Event|1|||
33461395|NCT04556734|101576902|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
33461396|NCT04556734|101576903|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
33461397|NCT04556734|101576904|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
33461398|NCT04556734|101576905|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33461399|NCT04556734|101576906|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33461400|NCT04556734|101576907|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33461401|NCT04556734|101576908|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33461402|NCT04556734|101576909|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
33461403|NCT04556734|101576902|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
33461404|NCT04556734|101576903|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
33263062|NCT02132949|100863828|FG001|Overall Study|Physician Decision|1|||
33263063|NCT02132949|100863827|FG000|Overall Study|Disease Progression|3|||
33461405|NCT04556734|101576904|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
33461406|NCT04556734|101576905|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
33461407|NCT04556734|101576906|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
33461408|NCT04556734|101576907|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
33263064|NCT02132949|100863828|FG001|Overall Study|Disease Progression|0|||
33461409|NCT04556734|101576908|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
33461410|NCT04556734|101576909|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
33461411|NCT04556734|101576902|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
33461412|NCT04556734|101576903|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33461413|NCT04556734|101576904|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
33461414|NCT04556734|101576905|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33461415|NCT04556734|101576906|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33461416|NCT04556734|101576907|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33461417|NCT04556734|101576908|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33461418|NCT04556734|101576909|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
33461419|NCT04556734|101576902|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
33461420|NCT04556734|101576903|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
33461421|NCT04556734|101576904|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
33461422|NCT04556734|101576905|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
33461423|NCT04556734|101576906|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
33461424|NCT04556734|101576907|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
33461425|NCT04556734|101576908|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
33461426|NCT04556734|101576909|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
33461427|NCT04556734|101576902|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
33461428|NCT04556734|101576903|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
33461429|NCT04556734|101576904|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
33461430|NCT04556734|101576905|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
33461431|NCT04556734|101576906|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
33461432|NCT04556734|101576907|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
33461433|NCT04556734|101576908|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
33461434|NCT04556734|101576909|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
33461435|NCT04556734|101576902|FG000|OLE Period (28 Weeks)|Not reported|0|||
33461436|NCT04556734|101576903|FG001|OLE Period (28 Weeks)|Not reported|0|||
33461437|NCT04556734|101576904|FG002|OLE Period (28 Weeks)|Not reported|0|||
33461438|NCT04556734|101576905|FG003|OLE Period (28 Weeks)|Not reported|0|||
33461439|NCT04556734|101576906|FG004|OLE Period (28 Weeks)|Not reported|0|||
33461440|NCT04556734|101576907|FG005|OLE Period (28 Weeks)|Not reported|1|||
33461441|NCT04556734|101576908|FG006|OLE Period (28 Weeks)|Not reported|0|||
33461442|NCT04556734|101576909|FG007|OLE Period (28 Weeks)|Not reported|0|||
33461443|NCT04556734|101576902|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
33461444|NCT04556734|101576903|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
33461445|NCT04556734|101576904|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
33461446|NCT04556734|101576905|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
33461447|NCT04556734|101576906|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
33461448|NCT04556734|101576907|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
33461449|NCT04556734|101576908|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
33461450|NCT04556734|101576909|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
33461451|NCT04556734|101576902|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
33461452|NCT04556734|101576903|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
33461453|NCT04556734|101576904|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
33263065|NCT02132949|100863827|FG000|Overall Study|Adverse Event|2|||
33461454|NCT04556734|101576905|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
33461455|NCT04556734|101576906|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
33461456|NCT04556734|101576907|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
33461457|NCT04556734|101576908|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
33461458|NCT04556734|101576909|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
33461459|NCT04556734|101576902|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
33461460|NCT04556734|101576903|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
33461461|NCT04556734|101576904|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
33461462|NCT04556734|101576905|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
33461463|NCT04556734|101576906|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
33461464|NCT04556734|101576907|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
33461465|NCT04556734|101576908|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
33461466|NCT04556734|101576909|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
33461467|NCT02972515|101576910|FG000|Overall Study|Lost to Follow-up|78|||
33461468|NCT01077258|101576915|FG000|Overall Study|Lost to Follow-up|1390|||
33175869|NCT01313767|100552049|FG001|Overall Study|Withdrawal by Subject|1|||
33175870|NCT01313767|100552048|FG000|Overall Study|Protocol Violation|3|||
33175871|NCT01313767|100552049|FG001|Overall Study|Protocol Violation|1|||
33175872|NCT00157950|100552057|FG000|Overall Study|Death|1|||
33175873|NCT00157950|100552058|FG001|Overall Study|Death|0|||
33175874|NCT01119131|100552059|FG000|Overall Study|Adverse Event|1|||
33175875|NCT01119131|100552060|FG001|Overall Study|Adverse Event|1|||
33175876|NCT01119131|100552061|FG002|Overall Study|Adverse Event|1|||
33175877|NCT01119131|100552059|FG000|Overall Study|Non-Compliance|1|||
33461469|NCT01077258|101576915|FG000|Overall Study|Adverse drug reaction|218|||
33175878|NCT01119131|100552060|FG001|Overall Study|Non-Compliance|0|||
33175879|NCT01119131|100552061|FG002|Overall Study|Non-Compliance|4|||
33175880|NCT01119131|100552059|FG000|Overall Study|Physician Decision|0|||
33175881|NCT01119131|100552060|FG001|Overall Study|Physician Decision|0|||
33175882|NCT01119131|100552061|FG002|Overall Study|Physician Decision|1|||
33175883|NCT00561080|100552062|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
33175884|NCT00561080|100552063|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
33175885|NCT00561080|100552064|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
33175886|NCT00561080|100552062|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
33175887|NCT00561080|100552063|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
33175888|NCT00561080|100552064|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
33175889|NCT00561080|100552062|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
33175890|NCT00561080|100552063|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
33175891|NCT00561080|100552064|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
33175892|NCT00561080|100552062|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
33175893|NCT00561080|100552063|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
33175894|NCT00561080|100552064|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
33175895|NCT00561080|100552062|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
33175896|NCT00561080|100552063|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
33175897|NCT00561080|100552064|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
33175898|NCT00561080|100552062|FG000|Vaccination Period (up to Month 4)|Other|0|||
33175899|NCT00561080|100552063|FG001|Vaccination Period (up to Month 4)|Other|2|||
33175900|NCT00561080|100552064|FG002|Vaccination Period (up to Month 4)|Other|1|||
33175901|NCT00561080|100552062|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
33175902|NCT00561080|100552063|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
33175903|NCT00561080|100552064|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
33175904|NCT00561080|100552062|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
33175905|NCT00561080|100552063|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
33175906|NCT00561080|100552064|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
33461470|NCT01077258|101576915|FG000|Overall Study|Lack of Efficacy|663|||
33461471|NCT01077258|101576915|FG000|Overall Study|Clinical remission|37|||
33461472|NCT01077258|101576915|FG000|Overall Study|Other reasons|260|||
33461473|NCT00152516|101576917|FG000|Overall Study|Adverse Event|18|||
33461474|NCT00152516|101576917|FG000|Overall Study|Lack and Loss of Efficacy|30|||
33461475|NCT00152516|101576917|FG000|Overall Study|Lost to Follow-up|5|||
33461476|NCT00152516|101576917|FG000|Overall Study|Withdrawal by Subject|8|||
33461477|NCT00152516|101576917|FG000|Overall Study|Protocol Violation|3|||
33461478|NCT00152516|101576917|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
33461479|NCT00152516|101576917|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
33461480|NCT00152516|101576917|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
33461481|NCT00152516|101576917|FG000|Overall Study|Other: Non-Compliance|2|||
33461482|NCT00152516|101576917|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
33461483|NCT00152516|101576917|FG000|Overall Study|Other: Moved Out Of State|1|||
33175907|NCT00561080|100552062|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
33175908|NCT00561080|100552063|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
33263066|NCT02132949|100863828|FG001|Overall Study|Adverse Event|1|||
33461484|NCT00152516|101576917|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
33175909|NCT00561080|100552064|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
33175910|NCT00561080|100552062|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
33175911|NCT00561080|100552063|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
33175912|NCT00561080|100552064|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
33461485|NCT00152516|101576917|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
33461486|NCT00024258|101576918|FG000|Overall Study|Withdrawal by Subject|1|||
33263067|NCT02132949|100863827|FG000|Overall Study|Withdrew Prior to Treatment|1|||
33263068|NCT02132949|100863828|FG001|Overall Study|Withdrew Prior to Treatment|2|||
33263069|NCT02132949|100863827|FG000|Overall Study|Reason Unspecified|0|||
33263070|NCT02132949|100863828|FG001|Overall Study|Reason Unspecified|1|||
33263071|NCT00274261|100863829|FG000|Overall Study|Adverse Event|19|||
33263072|NCT00274261|100863830|FG001|Overall Study|Adverse Event|11|||
33461487|NCT00024258|101576918|FG000|Overall Study|Disease Progression|8|||
33461488|NCT02260635|101576921|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
33461489|NCT02260635|101576922|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
33461490|NCT02260635|101576921|FG000|Open-Label Extension|Study Termination|25|||
33461491|NCT02260635|101576922|FG001|Open-Label Extension|Study Termination|25|||
33461492|NCT02260635|101576921|FG000|Open-Label Extension|Withdrawal by Subject|1|||
33461493|NCT02260635|101576922|FG001|Open-Label Extension|Withdrawal by Subject|0|||
33461494|NCT00360490|101576923|FG000|Overall Study|Adverse Event|4|||
33461495|NCT00360490|101576924|FG001|Overall Study|Adverse Event|2|||
33461496|NCT00360490|101576923|FG000|Overall Study|Lost to Follow-up|2|||
33461497|NCT00360490|101576924|FG001|Overall Study|Lost to Follow-up|1|||
33461498|NCT00360490|101576923|FG000|Overall Study|Physician Decision|2|||
33461499|NCT00360490|101576924|FG001|Overall Study|Physician Decision|1|||
33461500|NCT00360490|101576923|FG000|Overall Study|Protocol Violation|0|||
33461501|NCT00360490|101576924|FG001|Overall Study|Protocol Violation|4|||
33461502|NCT00360490|101576923|FG000|Overall Study|Withdrawal by Subject|1|||
33461503|NCT00360490|101576924|FG001|Overall Study|Withdrawal by Subject|3|||
33461504|NCT02408120|101576925|FG000|Overall Study|Withdrawal by Subject|0|||
33461505|NCT02408120|101576926|FG001|Overall Study|Withdrawal by Subject|1|||
33461506|NCT02408120|101576925|FG000|Overall Study|Treatment Refusal|1|||
33461507|NCT02408120|101576926|FG001|Overall Study|Treatment Refusal|0|||
33461508|NCT02408120|101576925|FG000|Overall Study|Received Steroids|1|||
33461509|NCT02408120|101576926|FG001|Overall Study|Received Steroids|1|||
33461510|NCT02408120|101576925|FG000|Overall Study|Discharged same day|1|||
33461511|NCT02408120|101576926|FG001|Overall Study|Discharged same day|1|||
33461512|NCT02408120|101576925|FG000|Overall Study|Did not receive insulin|1|||
33461513|NCT02408120|101576926|FG001|Overall Study|Did not receive insulin|2|||
33461514|NCT02300987|101576939|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
33461515|NCT02300987|101576940|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
33461516|NCT02300987|101576939|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
33461517|NCT02300987|101576940|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
33461518|NCT02300987|101576939|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
33461519|NCT02300987|101576940|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
33263073|NCT00274261|100863829|FG000|Overall Study|Pregnancy|114|||
33461520|NCT02300987|101576939|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
33461521|NCT02300987|101576940|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
33461522|NCT02300987|101576939|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
33175913|NCT02255981|100552065|FG000|Overall Study|Lost to Follow-up|3|||
33175914|NCT02255981|100552065|FG000|Overall Study|Withdrawal by Subject|1|||
33175915|NCT01846507|100552068|FG000|Overall Study|Lost to Follow-up|4|||
33175916|NCT01846507|100552068|FG000|Overall Study|Protocol Violation|1|||
33175917|NCT01846507|100552068|FG000|Overall Study|Missing data|2|||
33175918|NCT01594125|100552073|FG000|Overall Study|Withdrawal by Subject|1|||
33175919|NCT01594125|100552074|FG001|Overall Study|Withdrawal by Subject|0|||
33175920|NCT01594125|100552075|FG002|Overall Study|Withdrawal by Subject|0|||
33175921|NCT01594125|100552076|FG003|Overall Study|Withdrawal by Subject|1|||
33175922|NCT01594125|100552077|FG004|Overall Study|Withdrawal by Subject|0|||
33175923|NCT01594125|100552073|FG000|Overall Study|Progressive Disease|3|||
33175924|NCT01594125|100552074|FG001|Overall Study|Progressive Disease|12|||
33175925|NCT01594125|100552075|FG002|Overall Study|Progressive Disease|3|||
33175926|NCT01594125|100552076|FG003|Overall Study|Progressive Disease|3|||
33175927|NCT01594125|100552077|FG004|Overall Study|Progressive Disease|7|||
33175928|NCT01712854|100552080|FG000|Overall Study|Physician Decision|1|||
33175929|NCT00849381|100552082|FG000|Overall Study|Adverse Event|1|||
33175930|NCT00849381|100552082|FG000|Overall Study|Lost to Follow-up|129|||
33175931|NCT00849381|100552082|FG000|Overall Study|Protocol Violation|5|||
33175932|NCT00849381|100552082|FG000|Overall Study|Withdrawal by Subject|6|||
33175933|NCT00849381|100552082|FG000|Overall Study|Other|4|||
33175934|NCT02677987|100552083|FG000|Overall Study|Withdrawal by Subject|3|||
33175935|NCT02677987|100552084|FG001|Overall Study|Withdrawal by Subject|0|||
33175936|NCT02677987|100552083|FG000|Overall Study|Lost to Follow-up|1|||
33175937|NCT02677987|100552084|FG001|Overall Study|Lost to Follow-up|0|||
33175938|NCT00937157|100552085|FG000|Overall Study|Pregnancy|1|||
33175939|NCT00937157|100552085|FG000|Overall Study|Lost to Follow-up|3|||
33175940|NCT05517382|100552086|FG000|Overall Study|Lost to Follow-up|0|||
33175941|NCT05517382|100552087|FG001|Overall Study|Lost to Follow-up|1|||
33175942|NCT00461682|100552088|FG000|Overall Study|Protocol Violation|1|||
33175943|NCT00022633|100552089|FG000|Overall Study|Adverse Event|11|||
33175944|NCT00022633|100552090|FG001|Overall Study|Adverse Event|1|||
33175945|NCT00022633|100552089|FG000|Overall Study|Refusal unrelated to adverse event|1|||
33175946|NCT00022633|100552090|FG001|Overall Study|Refusal unrelated to adverse event|0|||
33175947|NCT00022633|100552089|FG000|Overall Study|Progression/relapse|9|||
33175948|NCT00022633|100552090|FG001|Overall Study|Progression/relapse|2|||
33175949|NCT00022633|100552089|FG000|Overall Study|Death|4|||
33175950|NCT00022633|100552090|FG001|Overall Study|Death|0|||
33175951|NCT00022633|100552089|FG000|Overall Study|Other - not protocol specified|3|||
33175952|NCT00022633|100552090|FG001|Overall Study|Other - not protocol specified|2|||
33175953|NCT00022633|100552089|FG000|Overall Study|Ineligible|4|||
33175954|NCT00022633|100552090|FG001|Overall Study|Ineligible|0|||
33175955|NCT01647282|100552093|FG000|Overall Study|Physician Decision|7|||
33175956|NCT01647282|100552094|FG001|Overall Study|Physician Decision|5|||
33175957|NCT01502423|100552095|FG000|Overall Study|Withdrawal by Subject|0|||
33175958|NCT01502423|100552096|FG001|Overall Study|Withdrawal by Subject|1|||
33175959|NCT00549302|100552097|FG000|Double-Blind|Death|2|||
33175960|NCT00549302|100552098|FG001|Double-Blind|Death|9|||
33175961|NCT00549302|100552099|FG002|Double-Blind|Death|0|||
33175962|NCT00549302|100552097|FG000|Double-Blind|Adverse Event|3|||
33175963|NCT00549302|100552098|FG001|Double-Blind|Adverse Event|16|||
33175964|NCT00549302|100552099|FG002|Double-Blind|Adverse Event|0|||
33175965|NCT00549302|100552097|FG000|Double-Blind|Withdrawal by Subject|3|||
33175966|NCT00549302|100552098|FG001|Double-Blind|Withdrawal by Subject|8|||
33175967|NCT00549302|100552099|FG002|Double-Blind|Withdrawal by Subject|0|||
33175968|NCT00549302|100552097|FG000|Double-Blind|Investigator Decision|1|||
33175969|NCT00549302|100552098|FG001|Double-Blind|Investigator Decision|5|||
33175970|NCT00549302|100552099|FG002|Double-Blind|Investigator Decision|0|||
33175971|NCT00549302|100552097|FG000|Double-Blind|Sponsor Decision|0|||
33175972|NCT00549302|100552098|FG001|Double-Blind|Sponsor Decision|1|||
33175973|NCT00549302|100552099|FG002|Double-Blind|Sponsor Decision|0|||
33461523|NCT02300987|101576940|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
33175974|NCT00549302|100552097|FG000|Double-Blind|Lost to Follow-up|1|||
33175975|NCT00549302|100552098|FG001|Double-Blind|Lost to Follow-up|2|||
33175976|NCT00549302|100552099|FG002|Double-Blind|Lost to Follow-up|0|||
33175977|NCT00549302|100552097|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
33175978|NCT00549302|100552098|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
33175979|NCT00549302|100552099|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
33175980|NCT00549302|100552097|FG000|Double-Blind|New condition or starts new therapy|0|||
33175981|NCT00549302|100552098|FG001|Double-Blind|New condition or starts new therapy|2|||
33175982|NCT00549302|100552099|FG002|Double-Blind|New condition or starts new therapy|0|||
33175983|NCT00549302|100552097|FG000|Open-Label|Adverse Event|0|||
33175984|NCT00549302|100552098|FG001|Open-Label|Adverse Event|0|||
33175985|NCT00549302|100552099|FG002|Open-Label|Adverse Event|11|||
33175986|NCT00549302|100552097|FG000|Open-Label|Death|0|||
33175987|NCT00549302|100552098|FG001|Open-Label|Death|0|||
33175988|NCT00549302|100552099|FG002|Open-Label|Death|40|||
33175989|NCT00549302|100552097|FG000|Open-Label|Investigator Decision|0|||
33175990|NCT00549302|100552098|FG001|Open-Label|Investigator Decision|0|||
33461524|NCT02274558|101576941|FG000|Overall Study|Adverse Event|2|||
33461525|NCT02274558|101576942|FG001|Overall Study|Adverse Event|4|||
33461526|NCT02274558|101576943|FG002|Overall Study|Adverse Event|2|||
33461527|NCT02274558|101576941|FG000|Overall Study|Non-compliance|2|||
33461528|NCT02274558|101576942|FG001|Overall Study|Non-compliance|1|||
33461529|NCT02274558|101576943|FG002|Overall Study|Non-compliance|0|||
33461530|NCT02274558|101576941|FG000|Overall Study|Withdrawal by Subject|1|||
33461531|NCT02274558|101576942|FG001|Overall Study|Withdrawal by Subject|5|||
33461532|NCT02274558|101576943|FG002|Overall Study|Withdrawal by Subject|4|||
33461533|NCT02274558|101576941|FG000|Overall Study|Death|0|||
33461534|NCT02274558|101576942|FG001|Overall Study|Death|0|||
33175991|NCT00549302|100552099|FG002|Open-Label|Investigator Decision|5|||
33175992|NCT00549302|100552097|FG000|Open-Label|Lost to Follow-up|0|||
33175993|NCT00549302|100552098|FG001|Open-Label|Lost to Follow-up|0|||
33175994|NCT00549302|100552099|FG002|Open-Label|Lost to Follow-up|2|||
33175995|NCT00549302|100552097|FG000|Open-Label|Other|0|||
33175996|NCT00549302|100552098|FG001|Open-Label|Other|0|||
33175997|NCT00549302|100552099|FG002|Open-Label|Other|3|||
33175998|NCT00549302|100552097|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
33175999|NCT00549302|100552098|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
33176000|NCT00549302|100552099|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
33176001|NCT00549302|100552097|FG000|Open-Label|Withdrawal by Subject|0|||
33176002|NCT00549302|100552098|FG001|Open-Label|Withdrawal by Subject|0|||
33176003|NCT00549302|100552099|FG002|Open-Label|Withdrawal by Subject|6|||
33176004|NCT04690751|100552100|FG000|Overall Study|Protocol Violation|0|||
33176005|NCT04690751|100552101|FG001|Overall Study|Protocol Violation|1|||
33176006|NCT04690751|100552102|FG002|Overall Study|Protocol Violation|0|||
33176007|NCT04690751|100552103|FG003|Overall Study|Protocol Violation|1|||
33176008|NCT04690751|100552104|FG004|Overall Study|Protocol Violation|2|||
33176009|NCT04690751|100552105|FG005|Overall Study|Protocol Violation|0|||
33176010|NCT04690751|100552100|FG000|Overall Study|Adverse Event|0|||
33176011|NCT04690751|100552101|FG001|Overall Study|Adverse Event|0|||
33176012|NCT04690751|100552102|FG002|Overall Study|Adverse Event|1|||
33176013|NCT04690751|100552103|FG003|Overall Study|Adverse Event|0|||
33176014|NCT04690751|100552104|FG004|Overall Study|Adverse Event|0|||
33176015|NCT04690751|100552105|FG005|Overall Study|Adverse Event|0|||
33176016|NCT04690751|100552100|FG000|Overall Study|Positive urine drug screen test|0|||
33176017|NCT04690751|100552101|FG001|Overall Study|Positive urine drug screen test|0|||
33176018|NCT04690751|100552102|FG002|Overall Study|Positive urine drug screen test|0|||
33176019|NCT04690751|100552103|FG003|Overall Study|Positive urine drug screen test|0|||
33176020|NCT04690751|100552104|FG004|Overall Study|Positive urine drug screen test|1|||
33176021|NCT04690751|100552105|FG005|Overall Study|Positive urine drug screen test|0|||
33176022|NCT00065507|100552106|FG000|Overall Study|Death|16|||
33176023|NCT00065507|100552107|FG001|Overall Study|Death|17|||
33176024|NCT00065507|100552106|FG000|Overall Study|Adverse Event|4|||
33176025|NCT00065507|100552107|FG001|Overall Study|Adverse Event|3|||
33176026|NCT00065507|100552106|FG000|Overall Study|Lack of Efficacy|0|||
33461535|NCT02274558|101576943|FG002|Overall Study|Death|1|||
33461536|NCT02274558|101576941|FG000|Overall Study|Lost to Follow-up|2|||
33461537|NCT02274558|101576942|FG001|Overall Study|Lost to Follow-up|1|||
33461538|NCT02274558|101576943|FG002|Overall Study|Lost to Follow-up|1|||
33461539|NCT02274558|101576941|FG000|Overall Study|Physician Decision|0|||
33461540|NCT02274558|101576942|FG001|Overall Study|Physician Decision|2|||
33461541|NCT02274558|101576943|FG002|Overall Study|Physician Decision|1|||
33461542|NCT01120899|101576950|FG000|Overall Study|Withdrawal by Subject|3|||
33461543|NCT01754376|101576951|FG000|Overall Study|Adverse Event|1|||
33461544|NCT01754376|101576951|FG000|Overall Study|Lack of Efficacy|2|||
33461545|NCT01117987|101580010|FG000|Overall Study|Protocol deviation|0|||
33176027|NCT00065507|100552107|FG001|Overall Study|Lack of Efficacy|6|||
33176028|NCT00065507|100552106|FG000|Overall Study|Poor/Non-compliance|3|||
33176029|NCT00065507|100552107|FG001|Overall Study|Poor/Non-compliance|2|||
33263074|NCT00274261|100863830|FG001|Overall Study|Pregnancy|83|||
33461546|NCT01117987|101580011|FG001|Overall Study|Protocol deviation|1|||
33461547|NCT01117987|101580010|FG000|Overall Study|Subject no longer requires study drug|1|||
33461548|NCT01117987|101580011|FG001|Overall Study|Subject no longer requires study drug|0|||
33176030|NCT00065507|100552106|FG000|Overall Study|Lost to Follow-up|3|||
33176031|NCT00065507|100552107|FG001|Overall Study|Lost to Follow-up|0|||
33176032|NCT00065507|100552106|FG000|Overall Study|Subject Withdrew Consent|2|||
33176033|NCT00065507|100552107|FG001|Overall Study|Subject Withdrew Consent|1|||
33176034|NCT00065507|100552106|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
33176035|NCT00065507|100552107|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
33176036|NCT03342690|100552109|FG000|Overall Study|Missing Information|9|||
33176037|NCT03342690|100552109|FG000|Overall Study|Protocol Violation|16|||
33176038|NCT03045328|100552110|FG000|Overall Study|Withdrawal by Subject|2|||
33176039|NCT01349790|100552111|FG000|Overall Study|Investigator Judgement|3|||
33461549|NCT01117987|101580010|FG000|Overall Study|Lost to Follow-up|1|||
33461550|NCT01117987|101580011|FG001|Overall Study|Lost to Follow-up|1|||
33461551|NCT01117987|101580010|FG000|Overall Study|Abnormal test procedure result|2|||
33461552|NCT01117987|101580011|FG001|Overall Study|Abnormal test procedure result|0|||
33461553|NCT01117987|101580010|FG000|Overall Study|Lack of Efficacy|3|||
33461554|NCT01117987|101580011|FG001|Overall Study|Lack of Efficacy|4|||
33461555|NCT01117987|101580010|FG000|Overall Study|Death|5|||
33461556|NCT01117987|101580011|FG001|Overall Study|Death|10|||
33461557|NCT01117987|101580010|FG000|Overall Study|Withdrawal by Subject|5|||
33461558|NCT01117987|101580011|FG001|Overall Study|Withdrawal by Subject|10|||
33461559|NCT01117987|101580010|FG000|Overall Study|Adverse Event|19|||
33461560|NCT01117987|101580011|FG001|Overall Study|Adverse Event|26|||
33461561|NCT01117987|101580010|FG000|Overall Study|Administrative problems|25|||
33461562|NCT01117987|101580011|FG001|Overall Study|Administrative problems|22|||
33176040|NCT01349790|100552111|FG000|Overall Study|Death|2|||
33176041|NCT01349790|100552111|FG000|Overall Study|Withdrawal by Patient|2|||
33461563|NCT01680016|101580012|FG000|Overall Study|Adverse Event|0|||
33263075|NCT00274261|100863829|FG000|Overall Study|Withdrawal by Subject|179|||
33263076|NCT00274261|100863830|FG001|Overall Study|Withdrawal by Subject|126|||
33461564|NCT01680016|101580013|FG001|Overall Study|Adverse Event|0|||
33461565|NCT01680016|101580014|FG002|Overall Study|Adverse Event|1|||
33461566|NCT01680016|101580015|FG003|Overall Study|Adverse Event|4|||
33176042|NCT01349790|100552111|FG000|Overall Study|Adverse Event|1|||
33176043|NCT01349790|100552111|FG000|Overall Study|Lost to Follow-up|1|||
33461567|NCT01680016|101580012|FG000|Overall Study|The Subject went out of The Trial|1|||
33461568|NCT01680016|101580013|FG001|Overall Study|The Subject went out of The Trial|0|||
33461569|NCT01680016|101580014|FG002|Overall Study|The Subject went out of The Trial|3|||
33461570|NCT01680016|101580015|FG003|Overall Study|The Subject went out of The Trial|0|||
33461571|NCT01680016|101580012|FG000|Overall Study|Protocol Violation|0|||
33461572|NCT01680016|101580013|FG001|Overall Study|Protocol Violation|1|||
33461573|NCT01680016|101580014|FG002|Overall Study|Protocol Violation|0|||
33461574|NCT01680016|101580015|FG003|Overall Study|Protocol Violation|0|||
33461575|NCT01680016|101580012|FG000|Overall Study|Withdrawal by Subject|5|||
33461576|NCT01680016|101580013|FG001|Overall Study|Withdrawal by Subject|7|||
33461577|NCT01680016|101580014|FG002|Overall Study|Withdrawal by Subject|1|||
33461578|NCT01680016|101580015|FG003|Overall Study|Withdrawal by Subject|1|||
33461579|NCT05317195|101580022|FG000|Randomization|Withdrawal by Subject|1|||
33461580|NCT05317195|101580022|FG000|Randomization|Discontinued|6|||
33461581|NCT05317195|101580022|FG000|Admission|Withdrawal by Subject|2|||
33461582|NCT01857973|101580023|FG000|Overall Study|Subject did not meet required BG range|3|||
33461583|NCT01857973|101580023|FG000|Overall Study|drop out after 3 failed attempts|1|||
33461584|NCT01857973|101580023|FG000|Overall Study|Physician Decision|1|||
33461585|NCT00784979|101580024|FG000|Overall Study|incomplete data|6|||
33461586|NCT01157234|101580028|FG000|Overall Study|Withdrawal by Subject|1|||
33461587|NCT01157234|101580029|FG001|Overall Study|Withdrawal by Subject|0|||
33461588|NCT02302716|101580030|FG000|Overall Study|Adverse Event|1|||
33461589|NCT02302716|101580031|FG001|Overall Study|Adverse Event|1|||
33461590|NCT02302716|101580030|FG000|Overall Study|Death|0|||
33461591|NCT02302716|101580031|FG001|Overall Study|Death|1|||
33461592|NCT02302716|101580030|FG000|Overall Study|Lack of Efficacy|0|||
33461593|NCT02302716|101580031|FG001|Overall Study|Lack of Efficacy|1|||
33461594|NCT02302716|101580030|FG000|Overall Study|Lost to Follow-up|2|||
33461595|NCT02302716|101580031|FG001|Overall Study|Lost to Follow-up|4|||
33461596|NCT02302716|101580030|FG000|Overall Study|Physician Decision|3|||
33461597|NCT02302716|101580031|FG001|Overall Study|Physician Decision|4|||
33461598|NCT02302716|101580030|FG000|Overall Study|Withdrawal by Subject|13|||
33461599|NCT02302716|101580031|FG001|Overall Study|Withdrawal by Subject|7|||
33461600|NCT02302716|101580030|FG000|Overall Study|Protocol Violation|0|||
33461601|NCT02302716|101580031|FG001|Overall Study|Protocol Violation|1|||
33461602|NCT04668274|101580032|FG000|Part 1 Study Period 1|Adverse Event|3|||
33461603|NCT04668274|101580033|FG001|Part 1 Study Period 1|Adverse Event|0|||
33461604|NCT04668274|101580034|FG002|Part 1 Study Period 1|Adverse Event|0|||
33461605|NCT04668274|101580035|FG003|Part 1 Study Period 1|Adverse Event|0|||
33461606|NCT04668274|101580032|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
33461607|NCT04668274|101580033|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
33461608|NCT04668274|101580034|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
33461609|NCT04668274|101580035|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
33461610|NCT04668274|101580032|FG000|Part 1 Study Period 2|Other|0|||
33461611|NCT04668274|101580033|FG001|Part 1 Study Period 2|Other|1|||
33461612|NCT04668274|101580034|FG002|Part 1 Study Period 2|Other|0|||
33461613|NCT04668274|101580035|FG003|Part 1 Study Period 2|Other|0|||
33461614|NCT04668274|101580032|FG000|Part 1 Study Period 3|Adverse Event|0|||
33461615|NCT04668274|101580033|FG001|Part 1 Study Period 3|Adverse Event|0|||
33461616|NCT04668274|101580034|FG002|Part 1 Study Period 3|Adverse Event|1|||
33461617|NCT04668274|101580035|FG003|Part 1 Study Period 3|Adverse Event|0|||
33461618|NCT04668274|101580032|FG000|Part 1 Study Period 3|Other|0|||
33461619|NCT04668274|101580033|FG001|Part 1 Study Period 3|Other|0|||
33461620|NCT04668274|101580034|FG002|Part 1 Study Period 3|Other|2|||
33461621|NCT04668274|101580035|FG003|Part 1 Study Period 3|Other|0|||
33176044|NCT00613938|100552117|FG000|Overall Study|Withdrawal by Subject|2|||
33176045|NCT00613938|100552118|FG001|Overall Study|Withdrawal by Subject|4|||
33176046|NCT00613938|100552119|FG002|Overall Study|Withdrawal by Subject|9|||
33176047|NCT00613938|100552120|FG003|Overall Study|Withdrawal by Subject|9|||
33176048|NCT00613938|100552117|FG000|Overall Study|Adverse Event|1|||
33176049|NCT00613938|100552118|FG001|Overall Study|Adverse Event|4|||
33176050|NCT00613938|100552119|FG002|Overall Study|Adverse Event|8|||
33176051|NCT00613938|100552120|FG003|Overall Study|Adverse Event|5|||
33461622|NCT04668274|101580032|FG000|Part 2 Study Period 4|Other|0|||
33461623|NCT04668274|101580033|FG001|Part 2 Study Period 4|Other|0|||
33461624|NCT04668274|101580034|FG002|Part 2 Study Period 4|Other|0|||
33461625|NCT04668274|101580035|FG003|Part 2 Study Period 4|Other|1|||
33461626|NCT00857818|101580036|FG000|Overall Study|Lack of Efficacy|1|||
33461627|NCT00857818|101580037|FG001|Overall Study|Lack of Efficacy|0|||
33461628|NCT00857818|101580036|FG000|Overall Study|Adverse Event|3|||
33461629|NCT00857818|101580037|FG001|Overall Study|Adverse Event|0|||
33461630|NCT00857818|101580036|FG000|Overall Study|Withdrawal by Subject|0|||
33461631|NCT00857818|101580037|FG001|Overall Study|Withdrawal by Subject|4|||
33461632|NCT00857818|101580036|FG000|Overall Study|Sponsor terminated study|6|||
33461633|NCT00857818|101580037|FG001|Overall Study|Sponsor terminated study|4|||
33176052|NCT00613938|100552117|FG000|Overall Study|Lack of Efficacy|16|||
33461634|NCT00857818|101580036|FG000|Overall Study|Investigator decision|1|||
33461635|NCT00857818|101580037|FG001|Overall Study|Investigator decision|0|||
33263077|NCT00274261|100863829|FG000|Overall Study|Protocol Violation|71|||
33263078|NCT00274261|100863830|FG001|Overall Study|Protocol Violation|42|||
33263079|NCT00274261|100863829|FG000|Overall Study|Lost to Follow-up|106|||
33263080|NCT00274261|100863830|FG001|Overall Study|Lost to Follow-up|75|||
33263081|NCT01808534|100863833|FG000|Overall Study|Disease progression|3|||
33263082|NCT01808534|100863833|FG000|Overall Study|Physician Decision|1|||
33263083|NCT01359150|100863834|FG000|Overall Study|Lack of Efficacy|1|||
33263084|NCT01359150|100863835|FG001|Overall Study|Lack of Efficacy|1|||
33263085|NCT01359150|100863834|FG000|Overall Study|Withdrawal by Subject|1|||
33263086|NCT01359150|100863835|FG001|Overall Study|Withdrawal by Subject|1|||
33263087|NCT01359150|100863834|FG000|Overall Study|Adverse Event|4|||
33263088|NCT01359150|100863835|FG001|Overall Study|Adverse Event|3|||
33263089|NCT01359150|100863834|FG000|Overall Study|Other|1|||
33263090|NCT01359150|100863835|FG001|Overall Study|Other|0|||
33263091|NCT00112359|100863836|FG000|Overall Study|Unrelated adverse event|16|||
33263092|NCT00112359|100863837|FG001|Overall Study|Unrelated adverse event|8|||
33263093|NCT00112359|100863836|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
33263094|NCT00112359|100863837|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
33263095|NCT00112359|100863836|FG000|Overall Study|Related adverse event|5|||
33263096|NCT00112359|100863837|FG001|Overall Study|Related adverse event|3|||
33263097|NCT00112359|100863836|FG000|Overall Study|Lost to Follow-up|0|||
33263098|NCT00112359|100863837|FG001|Overall Study|Lost to Follow-up|1|||
33263099|NCT00112359|100863836|FG000|Overall Study|Personal/administrative|1|||
33263100|NCT00112359|100863837|FG001|Overall Study|Personal/administrative|1|||
33263101|NCT00112359|100863836|FG000|Overall Study|Other|3|||
33263102|NCT00112359|100863837|FG001|Overall Study|Other|0|||
33263103|NCT00914966|100863838|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
33263104|NCT00914966|100863838|FG000|Step 1: 1500 Units|Physician Decision|1|||
33263105|NCT00914966|100863838|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
33263106|NCT04448561|100863839|FG000|Overall Study|Noncompliance|1|||
33263107|NCT04448561|100863840|FG001|Overall Study|Noncompliance|0|||
33263108|NCT03351075|100863850|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
33461636|NCT02762994|101580038|FG000|Overall Study|Withdrawal by Subject|0|||
33461637|NCT02762994|101580039|FG001|Overall Study|Withdrawal by Subject|1|||
33461638|NCT02762994|101580040|FG002|Overall Study|Withdrawal by Subject|2|||
33461639|NCT02762994|101580041|FG003|Overall Study|Withdrawal by Subject|0|||
33461640|NCT02762994|101580038|FG000|Overall Study|Protocol Violation|1|||
33461641|NCT02762994|101580039|FG001|Overall Study|Protocol Violation|0|||
33461642|NCT02762994|101580040|FG002|Overall Study|Protocol Violation|0|||
33461643|NCT02762994|101580041|FG003|Overall Study|Protocol Violation|2|||
33461644|NCT02020967|101580046|FG000|Overall Study|Withdrawal by Subject|51|||
33461645|NCT00603512|101580047|FG000|Overall Study|Adverse Event|0|||
33461646|NCT00603512|101580048|FG001|Overall Study|Adverse Event|2|||
33461647|NCT00603512|101580049|FG002|Overall Study|Adverse Event|4|||
33461648|NCT00603512|101580050|FG003|Overall Study|Adverse Event|4|||
33461649|NCT00603512|101580051|FG004|Overall Study|Adverse Event|2|||
33461650|NCT00603512|101580047|FG000|Overall Study|Lack of Efficacy|0|||
33461651|NCT00603512|101580048|FG001|Overall Study|Lack of Efficacy|1|||
33461652|NCT00603512|101580049|FG002|Overall Study|Lack of Efficacy|0|||
33461653|NCT00603512|101580050|FG003|Overall Study|Lack of Efficacy|0|||
33461654|NCT00603512|101580051|FG004|Overall Study|Lack of Efficacy|1|||
33461655|NCT00603512|101580047|FG000|Overall Study|Other|2|||
33461656|NCT00603512|101580048|FG001|Overall Study|Other|1|||
33461657|NCT00603512|101580049|FG002|Overall Study|Other|0|||
33461658|NCT00603512|101580050|FG003|Overall Study|Other|1|||
33263109|NCT03351075|100863851|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
33263110|NCT03351075|100863850|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
33461659|NCT00603512|101580051|FG004|Overall Study|Other|1|||
33461660|NCT00603512|101580047|FG000|Overall Study|Withdrawal by Subject|0|||
33461661|NCT00603512|101580048|FG001|Overall Study|Withdrawal by Subject|0|||
33461662|NCT00603512|101580049|FG002|Overall Study|Withdrawal by Subject|0|||
33461663|NCT00603512|101580050|FG003|Overall Study|Withdrawal by Subject|0|||
33263111|NCT03351075|100863851|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
33263112|NCT03351075|100863850|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
33263113|NCT03351075|100863851|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
33461664|NCT00603512|101580051|FG004|Overall Study|Withdrawal by Subject|1|||
33461665|NCT00603512|101580047|FG000|Overall Study|Randomized but not treated|0|||
33461666|NCT00603512|101580048|FG001|Overall Study|Randomized but not treated|1|||
33461667|NCT00603512|101580049|FG002|Overall Study|Randomized but not treated|1|||
33461668|NCT00603512|101580050|FG003|Overall Study|Randomized but not treated|2|||
33461669|NCT00603512|101580051|FG004|Overall Study|Randomized but not treated|0|||
33461670|NCT02339740|101580052|FG000|Overall Study|Death|1|||
33461671|NCT02339740|101580053|FG001|Overall Study|Death|0|||
33461672|NCT02339740|101580052|FG000|Overall Study|Physician Decision|0|||
33461673|NCT02339740|101580053|FG001|Overall Study|Physician Decision|2|||
33461674|NCT02339740|101580052|FG000|Overall Study|Withdrawal by Subject|5|||
33461675|NCT02339740|101580053|FG001|Overall Study|Withdrawal by Subject|1|||
33461676|NCT02339740|101580052|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
33461677|NCT02339740|101580053|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
33461678|NCT01662024|101580054|FG000|Overall Study|Pregnancy|2|||
33461679|NCT01662024|101580054|FG000|Overall Study|Withdrawal by Subject|3|||
33461680|NCT02460835|101580058|FG000|Overall Study|Disease progression prior to treatment|3|||
33461681|NCT02460835|101580058|FG000|Overall Study|Unable to complete planning scans|2|||
33461682|NCT02460835|101580058|FG000|Overall Study|Decrease in performance status|1|||
33461683|NCT02460835|101580058|FG000|Overall Study|Withdrawal by Subject|3|||
33461684|NCT02460835|101580058|FG000|Overall Study|Underwent fractionated RT|10|||
33461685|NCT02460835|101580058|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
33461686|NCT03429049|101580059|FG000|Overall Study|Adverse Event|2|||
33461687|NCT03429049|101580060|FG001|Overall Study|Adverse Event|3|||
33461688|NCT03429049|101580059|FG000|Overall Study|Death|0|||
33461689|NCT03429049|101580060|FG001|Overall Study|Death|1|||
33461690|NCT03429049|101580059|FG000|Overall Study|Lack of Efficacy|4|||
33461691|NCT03429049|101580060|FG001|Overall Study|Lack of Efficacy|2|||
33461692|NCT03429049|101580059|FG000|Overall Study|Lost to Follow-up|9|||
33461693|NCT03429049|101580060|FG001|Overall Study|Lost to Follow-up|8|||
33461694|NCT03429049|101580059|FG000|Overall Study|Physician Decision|1|||
33176053|NCT00613938|100552118|FG001|Overall Study|Lack of Efficacy|18|||
33176054|NCT00613938|100552119|FG002|Overall Study|Lack of Efficacy|5|||
33176055|NCT00613938|100552120|FG003|Overall Study|Lack of Efficacy|9|||
33176056|NCT00613938|100552117|FG000|Overall Study|Other|1|||
33176057|NCT00613938|100552118|FG001|Overall Study|Other|2|||
33176058|NCT00613938|100552119|FG002|Overall Study|Other|1|||
33176059|NCT00613938|100552120|FG003|Overall Study|Other|3|||
33176060|NCT01348347|100552121|FG000|Overall Study|Withdrawal by Subject|1|||
33176061|NCT01348347|100552122|FG001|Overall Study|Withdrawal by Subject|1|||
33176062|NCT01348347|100552123|FG002|Overall Study|Withdrawal by Subject|1|||
33176063|NCT01348347|100552121|FG000|Overall Study|Progressive disease|2|||
33176064|NCT01348347|100552122|FG001|Overall Study|Progressive disease|5|||
33176065|NCT01348347|100552123|FG002|Overall Study|Progressive disease|5|||
33176066|NCT00391274|100552124|FG000|Overall Study|Death Due to Study Disease|55|||
33176067|NCT00391274|100552125|FG001|Overall Study|Death Due to Study Disease|45|||
33176068|NCT00391274|100552124|FG000|Overall Study|Lost to Follow-up|0|||
33176069|NCT00391274|100552125|FG001|Overall Study|Lost to Follow-up|3|||
33176070|NCT00391274|100552124|FG000|Overall Study|Physician Decision|4|||
33176071|NCT00391274|100552125|FG001|Overall Study|Physician Decision|2|||
33176072|NCT00391274|100552124|FG000|Overall Study|Withdrawal by Subject|0|||
33176073|NCT00391274|100552125|FG001|Overall Study|Withdrawal by Subject|3|||
33176074|NCT00391274|100552124|FG000|Overall Study|Death Due to Adverse Event|1|||
33176075|NCT00391274|100552125|FG001|Overall Study|Death Due to Adverse Event|3|||
33176076|NCT00391274|100552124|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
33176077|NCT00391274|100552125|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
33176078|NCT00391274|100552124|FG000|Overall Study|Death Not Study Related|0|||
33176079|NCT00391274|100552125|FG001|Overall Study|Death Not Study Related|1|||
33176080|NCT00268996|100552126|FG000|Overall Study|Adverse Event|11|||
33176081|NCT00268996|100552127|FG001|Overall Study|Adverse Event|7|||
33263114|NCT03351075|100863850|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
33263115|NCT03351075|100863851|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
33263116|NCT02392234|100863855|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
33263117|NCT02392234|100863856|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
33461695|NCT03429049|101580060|FG001|Overall Study|Physician Decision|0|||
33461696|NCT03429049|101580059|FG000|Overall Study|Protocol Violation|3|||
33461697|NCT03429049|101580060|FG001|Overall Study|Protocol Violation|0|||
33461698|NCT03429049|101580059|FG000|Overall Study|Sponsor Decision|2|||
33461699|NCT03429049|101580060|FG001|Overall Study|Sponsor Decision|0|||
33461700|NCT03429049|101580059|FG000|Overall Study|Withdrawal by Subject|4|||
33461701|NCT03429049|101580060|FG001|Overall Study|Withdrawal by Subject|20|||
33176082|NCT00268996|100552126|FG000|Overall Study|Lost to Follow-up|3|||
33176083|NCT00268996|100552127|FG001|Overall Study|Lost to Follow-up|1|||
33176084|NCT00268996|100552126|FG000|Overall Study|Withdrawal by Subject|5|||
33176085|NCT00268996|100552127|FG001|Overall Study|Withdrawal by Subject|11|||
33176086|NCT00268996|100552126|FG000|Overall Study|Non-compliance|1|||
33176087|NCT00268996|100552127|FG001|Overall Study|Non-compliance|0|||
33176088|NCT00268996|100552126|FG000|Overall Study|Other|1|||
33176089|NCT00268996|100552127|FG001|Overall Study|Other|1|||
33176090|NCT03654651|100552128|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
33176091|NCT03654651|100552129|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
33176092|NCT02335489|100552131|FG000|Overall Study|Sponsor terminated study|4|||
33176093|NCT02335489|100552131|FG000|Overall Study|Lost to Follow-up|1|||
33176094|NCT02335489|100552131|FG000|Overall Study|Withdrawal by Subject|2|||
33176095|NCT02335489|100552131|FG000|Overall Study|Physician Decision|2|||
33176096|NCT02335489|100552131|FG000|Overall Study|Lack of Efficacy|1|||
33176097|NCT01831544|100552132|FG000|Overall Study|Death|1|||
33176098|NCT01831544|100552132|FG000|Overall Study|Still on original MVAD device|2|||
33176099|NCT01110707|100552138|FG000|Overall Study|Protocol Violation|0|||
33176100|NCT01110707|100552139|FG001|Overall Study|Protocol Violation|3|||
33176101|NCT04483011|100552144|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
33176102|NCT04483011|100552145|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
33176103|NCT01059786|100552159|FG000|Overall Study|Did not receive 6 cycles.|0|||
33176104|NCT01059786|100552160|FG001|Overall Study|Did not receive 6 cycles.|0|||
33176105|NCT01059786|100552161|FG002|Overall Study|Did not receive 6 cycles.|4|||
33176106|NCT01059786|100552162|FG003|Overall Study|Did not receive 6 cycles.|1|||
33176107|NCT01059786|100552163|FG004|Overall Study|Did not receive 6 cycles.|0|||
33176108|NCT03761147|100552164|FG000|Overall Study|Withdrawal by Subject|6|||
33176109|NCT03761147|100552165|FG001|Overall Study|Withdrawal by Subject|1|||
33176110|NCT03761147|100552164|FG000|Overall Study|Adverse Event|1|||
33176111|NCT03761147|100552165|FG001|Overall Study|Adverse Event|3|||
33176112|NCT01946425|100552166|FG000|Overall Study|Protocol Violation|1|||
33176113|NCT01946425|100552167|FG001|Overall Study|Protocol Violation|0|||
33461702|NCT03429049|101580059|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
33461703|NCT03429049|101580060|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
33176114|NCT01946425|100552166|FG000|Overall Study|Withdrawal by Subject|1|||
33176115|NCT01946425|100552167|FG001|Overall Study|Withdrawal by Subject|0|||
33176116|NCT00449540|100552169|FG000|Pretreatment Phase|No migraine experienced|66|||
33176117|NCT00449540|100552170|FG001|Pretreatment Phase|No migraine experienced|0|||
33176118|NCT00449540|100552171|FG002|Pretreatment Phase|No migraine experienced|0|||
33176119|NCT00449540|100552169|FG000|Treatment Phase|did not experience or treat migraine|0|||
33461704|NCT00880334|101580062|FG000|Randomized Phase|Physician Decision|1|||
33461705|NCT00880334|101580063|FG001|Randomized Phase|Physician Decision|0|||
33461706|NCT00880334|101580062|FG000|Randomized Phase|Withdrawal by Subject|2|||
33461707|NCT00880334|101580063|FG001|Randomized Phase|Withdrawal by Subject|1|||
33461708|NCT00880334|101580062|FG000|Randomized Phase|Inadequate Labs|1|||
33461709|NCT00880334|101580063|FG001|Randomized Phase|Inadequate Labs|1|||
33461710|NCT00880334|101580062|FG000|Randomized Phase|Brain Metastasis|0|||
33461711|NCT00880334|101580063|FG001|Randomized Phase|Brain Metastasis|1|||
33461712|NCT00880334|101580062|FG000|Randomized Phase|Crossover Participants|0|||
33461713|NCT00880334|101580063|FG001|Randomized Phase|Crossover Participants|37|||
33176120|NCT00449540|100552170|FG001|Treatment Phase|did not experience or treat migraine|20|||
33176121|NCT00449540|100552171|FG002|Treatment Phase|did not experience or treat migraine|17|||
33176122|NCT02743806|100552172|FG000|Overall Study|Adverse Event|9|||
33176123|NCT02743806|100552172|FG000|Overall Study|Lost to Follow-up|8|||
33176124|NCT02743806|100552172|FG000|Overall Study|Voluntary Withdrawal|54|||
33176125|NCT02743806|100552172|FG000|Overall Study|Study Termination|65|||
33176126|NCT02743806|100552172|FG000|Overall Study|Pregnancy|6|||
33176127|NCT02743806|100552172|FG000|Overall Study|No Longer Clinically Benefiting|27|||
33176128|NCT02743806|100552172|FG000|Overall Study|Reason Not Specified|12|||
33263118|NCT02392234|100863857|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
33461714|NCT01937351|101580067|FG000|Overall Study|Withdrawal by Subject|4|||
33461715|NCT01937351|101580068|FG001|Overall Study|Withdrawal by Subject|2|||
33461716|NCT01937351|101580067|FG000|Overall Study|Death|1|||
33461717|NCT01937351|101580068|FG001|Overall Study|Death|0|||
33461718|NCT01937351|101580067|FG000|Overall Study|Not treated w device, per protocol fail|4|||
33461719|NCT01937351|101580068|FG001|Overall Study|Not treated w device, per protocol fail|0|||
33461720|NCT03241745|101580069|FG000|Overall Study|Adverse Event|7|||
33461721|NCT03241745|101580069|FG000|Overall Study|Death|1|||
33461722|NCT03241745|101580069|FG000|Overall Study|Withdrawal by Subject|5|||
33461723|NCT03241745|101580069|FG000|Overall Study|Treatment delay >28 days|2|||
33461724|NCT03241745|101580069|FG000|Overall Study|Lack of Efficacy|14|||
33461725|NCT03438006|101580070|FG000|Overall Study|Adverse Event|1|||
33461726|NCT03438006|101580070|FG000|Overall Study|Lost to Follow-up|67|||
33461727|NCT03438006|101580070|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
33461728|NCT03438006|101580070|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
33461729|NCT03431337|101580071|FG000|Overall Study|Lost to Follow-up|21|||
33461730|NCT03431337|101580072|FG001|Overall Study|Lost to Follow-up|19|||
33461731|NCT03431337|101580071|FG000|Overall Study|Withdrawal by Subject|8|||
33461732|NCT03431337|101580072|FG001|Overall Study|Withdrawal by Subject|3|||
33461733|NCT00517192|101580073|FG000|Overall Study|Adverse Event|1|||
33461734|NCT00517192|101580074|FG001|Overall Study|Adverse Event|1|||
33461735|NCT00517192|101580073|FG000|Overall Study|Lost to Follow-up|1|||
33461736|NCT00517192|101580074|FG001|Overall Study|Lost to Follow-up|1|||
33461737|NCT00517192|101580073|FG000|Overall Study|Withdrawal by Subject|1|||
33461738|NCT00517192|101580074|FG001|Overall Study|Withdrawal by Subject|0|||
33461739|NCT00517192|101580073|FG000|Overall Study|Early termination of the trial|16|||
33461740|NCT00517192|101580074|FG001|Overall Study|Early termination of the trial|18|||
33461741|NCT03840382|101580075|FG000|Overall Study|Lost to Follow-up|11|||
33461742|NCT01261624|101580076|FG000|Week 0 to Week 12|Disease Progression|1|||
33461743|NCT01261624|101580077|FG001|Week 0 to Week 12|Disease Progression|1|||
33461744|NCT01261624|101580076|FG000|Week 0 to Week 12|Insufficient Response|0|||
33461745|NCT01261624|101580077|FG001|Week 0 to Week 12|Insufficient Response|2|||
33461746|NCT01261624|101580076|FG000|Week 13 to Week 24|Insufficient Response|0|||
33461747|NCT01261624|101580077|FG001|Week 13 to Week 24|Insufficient Response|1|||
33461748|NCT00351351|101580078|FG000|Overall Study|surgical access pbs; device issues|9|||
33461749|NCT00351351|101580079|FG001|Overall Study|surgical access pbs; device issues|4|||
33461750|NCT05135273|101580080|FG000|Overall Study|Recruited into the army|0|||
33461751|NCT05135273|101580081|FG001|Overall Study|Recruited into the army|0|||
33461752|NCT05135273|101580082|FG002|Overall Study|Recruited into the army|0|||
33461753|NCT05135273|101580083|FG003|Overall Study|Recruited into the army|0|||
33461754|NCT05135273|101580084|FG004|Overall Study|Recruited into the army|1|||
33461755|NCT05135273|101580085|FG005|Overall Study|Recruited into the army|0|||
33461756|NCT05135273|101580086|FG006|Overall Study|Recruited into the army|0|||
33461757|NCT05135273|101580087|FG007|Overall Study|Recruited into the army|0|||
33461758|NCT05135273|101580080|FG000|Overall Study|Moved away from study site|0|||
33461759|NCT05135273|101580081|FG001|Overall Study|Moved away from study site|0|||
33461760|NCT05135273|101580082|FG002|Overall Study|Moved away from study site|0|||
33461761|NCT05135273|101580083|FG003|Overall Study|Moved away from study site|0|||
33461762|NCT05135273|101580084|FG004|Overall Study|Moved away from study site|0|||
33461763|NCT05135273|101580085|FG005|Overall Study|Moved away from study site|1|||
33461764|NCT05135273|101580086|FG006|Overall Study|Moved away from study site|1|||
33461765|NCT05135273|101580087|FG007|Overall Study|Moved away from study site|0|||
33461766|NCT05135273|101580080|FG000|Overall Study|Travel|0|||
33461767|NCT05135273|101580081|FG001|Overall Study|Travel|0|||
33461768|NCT05135273|101580082|FG002|Overall Study|Travel|0|||
33461769|NCT05135273|101580083|FG003|Overall Study|Travel|0|||
33461770|NCT05135273|101580084|FG004|Overall Study|Travel|0|||
33461771|NCT05135273|101580085|FG005|Overall Study|Travel|0|||
33461772|NCT05135273|101580086|FG006|Overall Study|Travel|0|||
33461773|NCT05135273|101580087|FG007|Overall Study|Travel|1|||
33461774|NCT04214288|101580098|FG000|Overall Study|Ongoing in the study|41|||
33461775|NCT04214288|101580099|FG001|Overall Study|Ongoing in the study|51|||
33461776|NCT04214288|101580100|FG002|Overall Study|Ongoing in the study|12|||
33461777|NCT04214288|101580101|FG003|Overall Study|Ongoing in the study|39|||
33461778|NCT04214288|101580098|FG000|Overall Study|Adverse Event|1|||
33461779|NCT04214288|101580099|FG001|Overall Study|Adverse Event|0|||
33461780|NCT04214288|101580100|FG002|Overall Study|Adverse Event|0|||
33461781|NCT04214288|101580101|FG003|Overall Study|Adverse Event|0|||
33461782|NCT04214288|101580098|FG000|Overall Study|Death|22|||
33176129|NCT02377466|100552173|FG000|Overall Study|Other: Randomized and not treated|0|||
33176130|NCT02377466|100552174|FG001|Overall Study|Other: Randomized and not treated|2|||
33176131|NCT04200456|100552175|FG000|Overall Study|Physician Decision|0|||
33176132|NCT04200456|100552176|FG001|Overall Study|Physician Decision|1|||
33176133|NCT04200456|100552175|FG000|Overall Study|Withdrawal by Subject|2|||
33176134|NCT04200456|100552176|FG001|Overall Study|Withdrawal by Subject|2|||
33176135|NCT04200456|100552175|FG000|Overall Study|Lack of Efficacy|1|||
33176136|NCT04200456|100552176|FG001|Overall Study|Lack of Efficacy|1|||
33176137|NCT04200456|100552175|FG000|Overall Study|Adverse event, non-fatal|0|||
33176138|NCT04200456|100552176|FG001|Overall Study|Adverse event, non-fatal|1|||
33176139|NCT04200456|100552175|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
33176140|NCT04200456|100552176|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
33176141|NCT01529346|100552177|FG000|Overall Study|Lost to Follow-up|2|||
33176142|NCT01529346|100552178|FG001|Overall Study|Lost to Follow-up|0|||
33176143|NCT01529346|100552179|FG002|Overall Study|Lost to Follow-up|1|||
33176144|NCT01529346|100552180|FG003|Overall Study|Lost to Follow-up|0|||
33176145|NCT01529346|100552181|FG004|Overall Study|Lost to Follow-up|0|||
33176146|NCT01529346|100552177|FG000|Overall Study|Other|0|||
33176147|NCT01529346|100552178|FG001|Overall Study|Other|1|||
33176148|NCT01529346|100552179|FG002|Overall Study|Other|1|||
33176149|NCT01529346|100552180|FG003|Overall Study|Other|0|||
33176150|NCT01529346|100552181|FG004|Overall Study|Other|0|||
33176151|NCT02069366|100552184|FG000|Overall Study|Lost to Follow-up|0|||
33176152|NCT02069366|100552185|FG001|Overall Study|Lost to Follow-up|0|||
33176153|NCT02069366|100552186|FG002|Overall Study|Lost to Follow-up|1|||
33461783|NCT04214288|101580099|FG001|Overall Study|Death|13|||
33461784|NCT04214288|101580100|FG002|Overall Study|Death|7|||
33461785|NCT04214288|101580101|FG003|Overall Study|Death|19|||
33461786|NCT04214288|101580098|FG000|Overall Study|Lost to Follow-up|1|||
33461787|NCT04214288|101580099|FG001|Overall Study|Lost to Follow-up|2|||
33461788|NCT04214288|101580100|FG002|Overall Study|Lost to Follow-up|1|||
33461789|NCT04214288|101580101|FG003|Overall Study|Lost to Follow-up|0|||
33461790|NCT04214288|101580098|FG000|Overall Study|Other|1|||
33461791|NCT04214288|101580099|FG001|Overall Study|Other|2|||
33461792|NCT04214288|101580100|FG002|Overall Study|Other|0|||
33461793|NCT04214288|101580101|FG003|Overall Study|Other|6|||
33461794|NCT04214288|101580098|FG000|Overall Study|Protocol Violation|0|||
33461795|NCT04214288|101580099|FG001|Overall Study|Protocol Violation|1|||
33461796|NCT04214288|101580100|FG002|Overall Study|Protocol Violation|0|||
33461797|NCT04214288|101580101|FG003|Overall Study|Protocol Violation|0|||
33461798|NCT04214288|101580098|FG000|Overall Study|Withdrawal by Subject|8|||
33461799|NCT04214288|101580099|FG001|Overall Study|Withdrawal by Subject|4|||
33461800|NCT04214288|101580100|FG002|Overall Study|Withdrawal by Subject|0|||
33461801|NCT04214288|101580101|FG003|Overall Study|Withdrawal by Subject|9|||
33461802|NCT00480324|101580104|FG000|Overall Study|Adverse Event|1|||
33461803|NCT00480324|101580105|FG001|Overall Study|Adverse Event|1|||
33461804|NCT00480324|101580104|FG000|Overall Study|Protocol Violation|0|||
33461805|NCT00480324|101580105|FG001|Overall Study|Protocol Violation|1|||
33461806|NCT00480324|101580104|FG000|Overall Study|Withdrawal by Subject|14|||
33461807|NCT00480324|101580105|FG001|Overall Study|Withdrawal by Subject|5|||
33461808|NCT00480324|101580104|FG000|Overall Study|Lost to Follow-up|17|||
33461809|NCT00480324|101580105|FG001|Overall Study|Lost to Follow-up|8|||
33461810|NCT00480324|101580104|FG000|Overall Study|Subject's mother pregnant|0|||
33461811|NCT00480324|101580105|FG001|Overall Study|Subject's mother pregnant|1|||
33461812|NCT01557920|101580106|FG000|Overall Study|Withdrawal by Subject|2|||
33461813|NCT01557920|101580107|FG001|Overall Study|Withdrawal by Subject|3|||
33176154|NCT02069366|100552187|FG003|Overall Study|Lost to Follow-up|0|||
33176155|NCT02069366|100552188|FG004|Overall Study|Lost to Follow-up|0|||
33176156|NCT02069366|100552189|FG005|Overall Study|Lost to Follow-up|2|||
33176157|NCT02069366|100552184|FG000|Overall Study|Protocol Violation|0|||
33176158|NCT02069366|100552185|FG001|Overall Study|Protocol Violation|0|||
33176159|NCT02069366|100552186|FG002|Overall Study|Protocol Violation|1|||
33461814|NCT01557920|101580106|FG000|Overall Study|Lack of Efficacy|1|||
33461815|NCT01557920|101580107|FG001|Overall Study|Lack of Efficacy|0|||
33461816|NCT01463982|101580108|FG000|Overall Study|Withdrawal by Subject|0|||
33461817|NCT01463982|101580109|FG001|Overall Study|Withdrawal by Subject|1|||
33461818|NCT01463982|101580110|FG002|Overall Study|Withdrawal by Subject|1|||
33263119|NCT02392234|100863858|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
33263120|NCT02392234|100863859|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
33461819|NCT01463982|101580111|FG003|Overall Study|Withdrawal by Subject|0|||
33461820|NCT01463982|101580108|FG000|Overall Study|Treatment delay over 5 week|0|||
33461821|NCT01463982|101580109|FG001|Overall Study|Treatment delay over 5 week|0|||
33461822|NCT01463982|101580110|FG002|Overall Study|Treatment delay over 5 week|1|||
33461823|NCT01463982|101580111|FG003|Overall Study|Treatment delay over 5 week|0|||
33461824|NCT05467982|101580112|FG000|Overall Study|Death|0|||
33461825|NCT05467982|101580113|FG001|Overall Study|Death|1|||
33461826|NCT05467982|101580112|FG000|Overall Study|Lost to Follow-up|3|||
33461827|NCT05467982|101580113|FG001|Overall Study|Lost to Follow-up|1|||
33461828|NCT00585312|101580114|FG000|Overall Study|Adverse Event|3|||
33461829|NCT00585312|101580115|FG001|Overall Study|Adverse Event|0|||
33461830|NCT00585312|101580114|FG000|Overall Study|Lack of Efficacy|6|||
33176160|NCT02069366|100552187|FG003|Overall Study|Protocol Violation|0|||
33176161|NCT02069366|100552188|FG004|Overall Study|Protocol Violation|0|||
33176162|NCT02069366|100552189|FG005|Overall Study|Protocol Violation|0|||
33176163|NCT02069366|100552184|FG000|Overall Study|Withdrawal by Subject|1|||
33461831|NCT00585312|101580115|FG001|Overall Study|Lack of Efficacy|11|||
33461832|NCT00585312|101580114|FG000|Overall Study|Lost to Follow-up|1|||
33461833|NCT00585312|101580115|FG001|Overall Study|Lost to Follow-up|1|||
33461834|NCT00585312|101580114|FG000|Overall Study|Reason not specified|2|||
33461835|NCT00585312|101580115|FG001|Overall Study|Reason not specified|0|||
33461836|NCT00585312|101580114|FG000|Overall Study|Withdrawal by Subject|5|||
33461837|NCT00585312|101580115|FG001|Overall Study|Withdrawal by Subject|1|||
33461838|NCT00585312|101580114|FG000|Overall Study|Study terminated by the sponsor|34|||
33461839|NCT00585312|101580115|FG001|Overall Study|Study terminated by the sponsor|31|||
33461840|NCT00220727|101580116|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
33461841|NCT00220727|101580117|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
33461842|NCT02297841|101580121|FG000|Overall Study|Withdrawal by Subject|1|||
33461843|NCT02297841|101580121|FG000|Overall Study|Protocol Violation|7|||
33461844|NCT02124902|101580125|FG000|Overall Study|Adverse Event|7|||
33461845|NCT02124902|101580126|FG001|Overall Study|Adverse Event|2|||
33461846|NCT02124902|101580125|FG000|Overall Study|Went to alternative treatment|4|||
33461847|NCT02124902|101580126|FG001|Overall Study|Went to alternative treatment|0|||
33461848|NCT02124902|101580125|FG000|Overall Study|Withdrawal by Subject|2|||
33461849|NCT02124902|101580126|FG001|Overall Study|Withdrawal by Subject|1|||
33461850|NCT02124902|101580125|FG000|Overall Study|Physician Decision|2|||
33461851|NCT02124902|101580126|FG001|Overall Study|Physician Decision|0|||
33461852|NCT02124902|101580125|FG000|Overall Study|Not eligible|1|||
33461853|NCT02124902|101580126|FG001|Overall Study|Not eligible|0|||
33461854|NCT02124902|101580125|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
33461855|NCT02124902|101580126|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
33461856|NCT03847974|101580133|FG000|Overall Study|relocated out of region|3|||
33461857|NCT03847974|101580133|FG000|Overall Study|Withdrawal by Subject|2|||
33461858|NCT03847974|101580133|FG000|Overall Study|Adverse Event|1|||
33461859|NCT04439110|101580134|FG000|Overall Study|Ineligible|2|||
33461860|NCT04439110|101580134|FG000|Overall Study|Adverse Event|4|||
33461861|NCT04439110|101580134|FG000|Overall Study|Death|2|||
33461862|NCT04439110|101580134|FG000|Overall Study|Disease proression|25|||
33461863|NCT04439110|101580134|FG000|Overall Study|Withdrawal by Subject|1|||
33461864|NCT04439110|101580134|FG000|Overall Study|Alternative therapy|1|||
33263121|NCT02392234|100863860|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
33461865|NCT04439110|101580134|FG000|Overall Study|Other complicating disease|1|||
33461866|NCT04439110|101580134|FG000|Overall Study|Personal reasons|1|||
33461867|NCT04439110|101580134|FG000|Overall Study|Still on treatment|1|||
33461868|NCT03365791|101580135|FG000|Overall Study|Adverse Event|5|||
33461869|NCT03365791|101580135|FG000|Overall Study|Death|1|||
33461870|NCT03365791|101580135|FG000|Overall Study|Lost to Follow-up|1|||
33461871|NCT03365791|101580135|FG000|Overall Study|Physician Decision|9|||
33176164|NCT02069366|100552185|FG001|Overall Study|Withdrawal by Subject|0|||
33461872|NCT03365791|101580135|FG000|Overall Study|Progressive disease|51|||
33461873|NCT03365791|101580135|FG000|Overall Study|Subject/guardian decision|5|||
33461874|NCT03180528|101580136|FG000|Overall Study|Adverse Event|1|||
33461875|NCT03180528|101580136|FG000|Overall Study|Withdrawal by Subject|1|||
33461876|NCT03180528|101580136|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
33461877|NCT00559364|101580137|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
33461878|NCT00559364|101580138|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
33461879|NCT01341587|101580139|FG000|Overall Study|Lost to Follow-up|2|||
33461880|NCT01341587|101580140|FG001|Overall Study|Lost to Follow-up|0|||
33461881|NCT01341587|101580139|FG000|Overall Study|stopped using the meters|2|||
33176165|NCT02069366|100552186|FG002|Overall Study|Withdrawal by Subject|1|||
33176166|NCT02069366|100552187|FG003|Overall Study|Withdrawal by Subject|2|||
33176167|NCT02069366|100552188|FG004|Overall Study|Withdrawal by Subject|0|||
33176168|NCT02069366|100552189|FG005|Overall Study|Withdrawal by Subject|0|||
33176169|NCT01472081|100552196|FG000|Overall Study|Continuing treatment at time of analysis|1|||
33176170|NCT01472081|100552197|FG001|Overall Study|Continuing treatment at time of analysis|4|||
33461882|NCT01341587|101580140|FG001|Overall Study|stopped using the meters|10|||
33461883|NCT00683787|101580143|FG000|Overall Study|Progression|3|||
33461884|NCT00683787|101580144|FG001|Overall Study|Progression|3|||
33461885|NCT00683787|101580145|FG002|Overall Study|Progression|0|||
33461886|NCT00683787|101580143|FG000|Overall Study|Adverse Event|0|||
33461887|NCT00683787|101580144|FG001|Overall Study|Adverse Event|0|||
33461888|NCT00683787|101580145|FG002|Overall Study|Adverse Event|2|||
33461889|NCT05103657|101580146|FG000|Overall Study|Other reasons than listed|9|||
33461890|NCT05103657|101580147|FG001|Overall Study|Other reasons than listed|8|||
33461891|NCT05103657|101580146|FG000|Overall Study|Protocol deviation|2|||
33461892|NCT05103657|101580147|FG001|Overall Study|Protocol deviation|2|||
33461893|NCT05103657|101580146|FG000|Overall Study|No reason available|5|||
33461894|NCT05103657|101580147|FG001|Overall Study|No reason available|4|||
33461895|NCT05103657|101580146|FG000|Overall Study|Burden of study procedures|3|||
33461896|NCT05103657|101580147|FG001|Overall Study|Burden of study procedures|1|||
33461897|NCT05103657|101580146|FG000|Overall Study|Perceived lack of efficacy|1|||
33461898|NCT05103657|101580147|FG001|Overall Study|Perceived lack of efficacy|1|||
33461899|NCT05103657|101580146|FG000|Overall Study|Adverse Event|6|||
33461900|NCT05103657|101580147|FG001|Overall Study|Adverse Event|14|||
33461901|NCT05103657|101580146|FG000|Overall Study|Not Treated|1|||
33461902|NCT05103657|101580147|FG001|Overall Study|Not Treated|1|||
33461903|NCT02654015|101580148|FG000|Overall Study|Death|12|||
33461904|NCT02654015|101580148|FG000|Overall Study|Lost to Follow-up|3|||
33461905|NCT04220775|101580149|FG000|Overall Study|Adverse Event|1|||
33461906|NCT04220775|101580150|FG001|Overall Study|Adverse Event|0|||
33461907|NCT04220775|101580149|FG000|Overall Study|Disease Progression|1|||
33461908|NCT04220775|101580150|FG001|Overall Study|Disease Progression|0|||
33461909|NCT01755975|101580151|FG000|Overall Study|Adverse Event|0|||
33461910|NCT01755975|101580152|FG001|Overall Study|Adverse Event|0|||
33461911|NCT01755975|101580153|FG002|Overall Study|Adverse Event|1|||
33461912|NCT01755975|101580154|FG003|Overall Study|Adverse Event|0|||
33461913|NCT01755975|101580155|FG004|Overall Study|Adverse Event|2|||
33461914|NCT03686215|101580156|FG000|Overall Study|Adverse Event|0|||
33461915|NCT03686215|101580157|FG001|Overall Study|Adverse Event|0|||
33461916|NCT03686215|101580158|FG002|Overall Study|Adverse Event|7|||
33461917|NCT03686215|101580156|FG000|Overall Study|Physician Decision|0|||
33461918|NCT03686215|101580157|FG001|Overall Study|Physician Decision|0|||
33461919|NCT03686215|101580158|FG002|Overall Study|Physician Decision|1|||
33461920|NCT03686215|101580156|FG000|Overall Study|Protocol Violation|0|||
33461921|NCT03686215|101580157|FG001|Overall Study|Protocol Violation|0|||
33461922|NCT03686215|101580158|FG002|Overall Study|Protocol Violation|4|||
33461923|NCT03686215|101580156|FG000|Overall Study|Device issue|1|||
33461924|NCT03686215|101580157|FG001|Overall Study|Device issue|0|||
33461925|NCT03686215|101580158|FG002|Overall Study|Device issue|2|||
33461926|NCT02093923|101580159|FG000|Overall Study|Lost to Follow-up|0|||
33461927|NCT02093923|101580160|FG001|Overall Study|Lost to Follow-up|0|||
33461928|NCT02093923|101580161|FG002|Overall Study|Lost to Follow-up|0|||
33176171|NCT01472081|100552198|FG002|Overall Study|Continuing treatment at time of analysis|1|||
33176172|NCT01472081|100552199|FG003|Overall Study|Continuing treatment at time of analysis|8|||
33461929|NCT02093923|101580162|FG003|Overall Study|Lost to Follow-up|1|||
33461930|NCT02093923|101580163|FG004|Overall Study|Lost to Follow-up|0|||
33461931|NCT02093923|101580159|FG000|Overall Study|Screen failure after randomization|0|||
33461932|NCT02093923|101580160|FG001|Overall Study|Screen failure after randomization|0|||
33461933|NCT02093923|101580161|FG002|Overall Study|Screen failure after randomization|0|||
33461934|NCT02093923|101580162|FG003|Overall Study|Screen failure after randomization|1|||
33461935|NCT02093923|101580163|FG004|Overall Study|Screen failure after randomization|0|||
33461936|NCT00035555|101580164|FG000|Overall Study|Adverse Event|5|||
33461937|NCT00035555|101580165|FG001|Overall Study|Adverse Event|8|||
33461938|NCT00035555|101580166|FG002|Overall Study|Adverse Event|9|||
33461939|NCT00035555|101580164|FG000|Overall Study|Allograft loss|1|||
33461940|NCT00035555|101580165|FG001|Overall Study|Allograft loss|1|||
33461941|NCT00035555|101580166|FG002|Overall Study|Allograft loss|2|||
33461942|NCT00035555|101580164|FG000|Overall Study|Death|0|||
33461943|NCT00035555|101580165|FG001|Overall Study|Death|0|||
33461944|NCT00035555|101580166|FG002|Overall Study|Death|2|||
33461945|NCT00035555|101580164|FG000|Overall Study|Lost to Follow-up|0|||
33461946|NCT00035555|101580165|FG001|Overall Study|Lost to Follow-up|0|||
33176173|NCT01472081|100552200|FG004|Overall Study|Continuing treatment at time of analysis|9|||
33176174|NCT01472081|100552201|FG005|Overall Study|Continuing treatment at time of analysis|0|||
33176175|NCT01472081|100552196|FG000|Overall Study|Disease Progression|4|||
33176176|NCT01472081|100552197|FG001|Overall Study|Disease Progression|10|||
33176177|NCT01472081|100552198|FG002|Overall Study|Disease Progression|12|||
33176178|NCT01472081|100552199|FG003|Overall Study|Disease Progression|31|||
33176179|NCT01472081|100552200|FG004|Overall Study|Disease Progression|22|||
33176180|NCT01472081|100552201|FG005|Overall Study|Disease Progression|3|||
33176181|NCT01472081|100552196|FG000|Overall Study|Study drug toxicity|2|||
33176182|NCT01472081|100552197|FG001|Overall Study|Study drug toxicity|9|||
33176183|NCT01472081|100552198|FG002|Overall Study|Study drug toxicity|4|||
33176184|NCT01472081|100552199|FG003|Overall Study|Study drug toxicity|6|||
33176185|NCT01472081|100552200|FG004|Overall Study|Study drug toxicity|13|||
33176186|NCT01472081|100552201|FG005|Overall Study|Study drug toxicity|2|||
33176187|NCT01472081|100552196|FG000|Overall Study|Death|0|||
33176188|NCT01472081|100552197|FG001|Overall Study|Death|0|||
33176189|NCT01472081|100552198|FG002|Overall Study|Death|0|||
33176190|NCT01472081|100552199|FG003|Overall Study|Death|0|||
33263122|NCT02392234|100863855|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
33461947|NCT00035555|101580166|FG002|Overall Study|Lost to Follow-up|1|||
33461948|NCT00035555|101580164|FG000|Overall Study|Noncompliance|0|||
33461949|NCT00035555|101580165|FG001|Overall Study|Noncompliance|1|||
33461950|NCT00035555|101580166|FG002|Overall Study|Noncompliance|1|||
33461951|NCT00035555|101580164|FG000|Overall Study|Prohibited medication|1|||
33461952|NCT00035555|101580165|FG001|Overall Study|Prohibited medication|1|||
33461953|NCT00035555|101580166|FG002|Overall Study|Prohibited medication|0|||
33461954|NCT00035555|101580164|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
33461955|NCT00035555|101580165|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
33461956|NCT00035555|101580166|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
33461957|NCT00035555|101580164|FG000|Overall Study|Withdrawal by Subject|2|||
33461958|NCT00035555|101580165|FG001|Overall Study|Withdrawal by Subject|0|||
33461959|NCT00035555|101580166|FG002|Overall Study|Withdrawal by Subject|2|||
33461960|NCT00035555|101580164|FG000|Overall Study|Investigator deemed not a good candidate|0|||
33461961|NCT00035555|101580165|FG001|Overall Study|Investigator deemed not a good candidate|0|||
33461962|NCT00035555|101580166|FG002|Overall Study|Investigator deemed not a good candidate|1|||
33461963|NCT00035555|101580164|FG000|Overall Study|Received cyclosporin in error|0|||
33461964|NCT00035555|101580165|FG001|Overall Study|Received cyclosporin in error|0|||
33461965|NCT00035555|101580166|FG002|Overall Study|Received cyclosporin in error|1|||
33461966|NCT02710214|101580167|FG000|Overall Study|Lost to Follow-up|1|||
33461967|NCT02710214|101580168|FG001|Overall Study|Lost to Follow-up|0|||
33461968|NCT02710214|101580167|FG000|Overall Study|Lack of Efficacy|0|||
33461969|NCT02710214|101580168|FG001|Overall Study|Lack of Efficacy|1|||
33461970|NCT02710214|101580167|FG000|Overall Study|Death|0|||
33461971|NCT02710214|101580168|FG001|Overall Study|Death|1|||
33461972|NCT00756717|101580169|FG000|Overall Study|Withdrawal by Subject|2|||
33461973|NCT03430011|101580170|FG000|Pre-Treatment|Death|1|||
33461974|NCT03430011|101580171|FG001|Pre-Treatment|Death|0|||
33461975|NCT03430011|101580172|FG002|Pre-Treatment|Death|0|||
33461976|NCT03430011|101580173|FG003|Pre-Treatment|Death|0|||
33461977|NCT03430011|101580174|FG004|Pre-Treatment|Death|1|||
33461978|NCT03430011|101580175|FG005|Pre-Treatment|Death|0|||
33461979|NCT03430011|101580176|FG006|Pre-Treatment|Death|1|||
33461980|NCT03430011|101580177|FG007|Pre-Treatment|Death|0|||
33461981|NCT03430011|101580170|FG000|Pre-Treatment|Screen Fail|0|||
33461982|NCT03430011|101580171|FG001|Pre-Treatment|Screen Fail|0|||
33461983|NCT03430011|101580172|FG002|Pre-Treatment|Screen Fail|0|||
33461984|NCT03430011|101580173|FG003|Pre-Treatment|Screen Fail|0|||
33461985|NCT03430011|101580174|FG004|Pre-Treatment|Screen Fail|1|||
33176191|NCT01472081|100552200|FG004|Overall Study|Death|1|||
33176192|NCT01472081|100552201|FG005|Overall Study|Death|0|||
33176193|NCT01472081|100552196|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
33176194|NCT01472081|100552197|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
33176195|NCT01472081|100552198|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
33176196|NCT01472081|100552199|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
33461986|NCT03430011|101580175|FG005|Pre-Treatment|Screen Fail|0|||
33461987|NCT03430011|101580176|FG006|Pre-Treatment|Screen Fail|0|||
33461988|NCT03430011|101580177|FG007|Pre-Treatment|Screen Fail|0|||
33461989|NCT03430011|101580170|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
33461990|NCT03430011|101580171|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
33461991|NCT03430011|101580172|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
33461992|NCT03430011|101580173|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
33461993|NCT03430011|101580174|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
33461994|NCT03430011|101580175|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
33461995|NCT03430011|101580176|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
33461996|NCT03430011|101580177|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
33461997|NCT03430011|101580170|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
33461998|NCT03430011|101580171|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
33461999|NCT03430011|101580172|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
33462000|NCT03430011|101580173|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
33462001|NCT03430011|101580174|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
33462002|NCT03430011|101580175|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
33462003|NCT03430011|101580176|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
33462004|NCT03430011|101580177|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
33462005|NCT03430011|101580170|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
33462006|NCT03430011|101580171|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
33462007|NCT03430011|101580172|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
33462008|NCT03430011|101580173|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
33462009|NCT03430011|101580174|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
33462010|NCT03430011|101580175|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
33462011|NCT03430011|101580176|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
33462012|NCT03430011|101580177|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
33462013|NCT03430011|101580170|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
33462014|NCT03430011|101580171|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
33462015|NCT03430011|101580172|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
33462016|NCT03430011|101580173|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
33462017|NCT03430011|101580174|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
33462018|NCT03430011|101580175|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
33462019|NCT03430011|101580176|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
33462020|NCT03430011|101580177|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
33462021|NCT03430011|101580170|FG000|JCARH125 Treatment|Death|4|||
33462022|NCT03430011|101580171|FG001|JCARH125 Treatment|Death|19|||
33462023|NCT03430011|101580172|FG002|JCARH125 Treatment|Death|10|||
33462024|NCT03430011|101580173|FG003|JCARH125 Treatment|Death|8|||
33462025|NCT03430011|101580174|FG004|JCARH125 Treatment|Death|5|||
33462026|NCT03430011|101580175|FG005|JCARH125 Treatment|Death|3|||
33462027|NCT03430011|101580176|FG006|JCARH125 Treatment|Death|4|||
33462028|NCT03430011|101580177|FG007|JCARH125 Treatment|Death|2|||
33462029|NCT03430011|101580170|FG000|JCARH125 Treatment|Other reasons|1|||
33462030|NCT03430011|101580171|FG001|JCARH125 Treatment|Other reasons|0|||
33462031|NCT03430011|101580172|FG002|JCARH125 Treatment|Other reasons|4|||
33462032|NCT03430011|101580173|FG003|JCARH125 Treatment|Other reasons|2|||
33462033|NCT03430011|101580174|FG004|JCARH125 Treatment|Other reasons|2|||
33462034|NCT03430011|101580175|FG005|JCARH125 Treatment|Other reasons|1|||
33462035|NCT03430011|101580176|FG006|JCARH125 Treatment|Other reasons|3|||
33462036|NCT03430011|101580177|FG007|JCARH125 Treatment|Other reasons|2|||
33462037|NCT02466386|101580178|FG000|Overall Study|Adverse Event|5|||
33462038|NCT02466386|101580178|FG000|Overall Study|Protocol Violation|2|||
33462039|NCT02466386|101580178|FG000|Overall Study|Withdrawal by Subject|14|||
33462040|NCT02466386|101580178|FG000|Overall Study|Lost to Follow-up|5|||
33462041|NCT02466386|101580178|FG000|Overall Study|Lack of Efficacy|8|||
33462042|NCT02466386|101580178|FG000|Overall Study|Other|10|||
33462043|NCT01896505|101580181|FG000|Overall Study|Adverse Event|1|||
33462044|NCT01896505|101580182|FG001|Overall Study|Adverse Event|0|||
33462045|NCT01896505|101580183|FG002|Overall Study|Adverse Event|2|||
33462046|NCT01896505|101580184|FG003|Overall Study|Adverse Event|1|||
33462047|NCT01896505|101580185|FG004|Overall Study|Adverse Event|1|||
33462048|NCT01896505|101580186|FG005|Overall Study|Adverse Event|0|||
33462049|NCT01896505|101580181|FG000|Overall Study|Physician Decision|1|||
33462050|NCT01896505|101580182|FG001|Overall Study|Physician Decision|3|||
33462051|NCT01896505|101580183|FG002|Overall Study|Physician Decision|2|||
33462052|NCT01896505|101580184|FG003|Overall Study|Physician Decision|0|||
33462053|NCT01896505|101580185|FG004|Overall Study|Physician Decision|0|||
33462054|NCT01896505|101580186|FG005|Overall Study|Physician Decision|1|||
33462055|NCT01896505|101580181|FG000|Overall Study|Withdrawal by Subject|1|||
33462056|NCT01896505|101580182|FG001|Overall Study|Withdrawal by Subject|0|||
33462057|NCT01896505|101580183|FG002|Overall Study|Withdrawal by Subject|3|||
33462058|NCT01896505|101580184|FG003|Overall Study|Withdrawal by Subject|1|||
33462059|NCT01896505|101580185|FG004|Overall Study|Withdrawal by Subject|0|||
33462060|NCT01896505|101580186|FG005|Overall Study|Withdrawal by Subject|0|||
33462061|NCT01896505|101580181|FG000|Overall Study|Disease Progression|7|||
33462062|NCT01896505|101580182|FG001|Overall Study|Disease Progression|5|||
33462063|NCT01896505|101580183|FG002|Overall Study|Disease Progression|8|||
33462064|NCT01896505|101580184|FG003|Overall Study|Disease Progression|4|||
33462065|NCT01896505|101580185|FG004|Overall Study|Disease Progression|4|||
33462066|NCT01896505|101580186|FG005|Overall Study|Disease Progression|4|||
33462067|NCT01896505|101580181|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
33462068|NCT01896505|101580182|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
33462069|NCT01896505|101580183|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
33462070|NCT01896505|101580184|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
33462071|NCT01896505|101580185|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
33462072|NCT01896505|101580186|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
33462073|NCT01896505|101580181|FG000|Overall Study|Intercurrent illness|0|||
33462074|NCT01896505|101580182|FG001|Overall Study|Intercurrent illness|1|||
33462075|NCT01896505|101580183|FG002|Overall Study|Intercurrent illness|0|||
33462076|NCT01896505|101580184|FG003|Overall Study|Intercurrent illness|0|||
33462077|NCT01896505|101580185|FG004|Overall Study|Intercurrent illness|0|||
33462078|NCT01896505|101580186|FG005|Overall Study|Intercurrent illness|0|||
33462079|NCT01896505|101580181|FG000|Overall Study|Death|0|||
33462080|NCT01896505|101580182|FG001|Overall Study|Death|0|||
33462081|NCT01896505|101580183|FG002|Overall Study|Death|1|||
33462082|NCT01896505|101580184|FG003|Overall Study|Death|1|||
33462083|NCT01896505|101580185|FG004|Overall Study|Death|0|||
33462084|NCT01896505|101580186|FG005|Overall Study|Death|1|||
33462085|NCT01908205|101580188|FG000|Overall Study|Lost to Follow-up|2|||
33462086|NCT01908205|101580189|FG001|Overall Study|Lost to Follow-up|0|||
33462087|NCT01908205|101580188|FG000|Overall Study|Withdrawal by Subject|3|||
33462088|NCT01908205|101580189|FG001|Overall Study|Withdrawal by Subject|1|||
33462089|NCT00631007|101580190|FG000|Overall Study|Adverse Event|0|||
33462090|NCT00631007|101580191|FG001|Overall Study|Adverse Event|2|||
33462091|NCT00631007|101580192|FG002|Overall Study|Adverse Event|0|||
33462092|NCT00631007|101580193|FG003|Overall Study|Adverse Event|2|||
33462093|NCT00631007|101580194|FG004|Overall Study|Adverse Event|3|||
33462094|NCT00631007|101580195|FG005|Overall Study|Adverse Event|2|||
33462095|NCT00631007|101580190|FG000|Overall Study|Lost to Follow-up|2|||
33462096|NCT00631007|101580191|FG001|Overall Study|Lost to Follow-up|1|||
33462097|NCT00631007|101580192|FG002|Overall Study|Lost to Follow-up|2|||
33462098|NCT00631007|101580193|FG003|Overall Study|Lost to Follow-up|4|||
33462099|NCT00631007|101580194|FG004|Overall Study|Lost to Follow-up|5|||
33462100|NCT00631007|101580195|FG005|Overall Study|Lost to Follow-up|3|||
33462101|NCT00631007|101580190|FG000|Overall Study|Physician Decision|1|||
33462102|NCT00631007|101580191|FG001|Overall Study|Physician Decision|0|||
33462103|NCT00631007|101580192|FG002|Overall Study|Physician Decision|1|||
33462104|NCT00631007|101580193|FG003|Overall Study|Physician Decision|0|||
33462105|NCT00631007|101580194|FG004|Overall Study|Physician Decision|0|||
33462106|NCT00631007|101580195|FG005|Overall Study|Physician Decision|2|||
33462107|NCT00631007|101580190|FG000|Overall Study|Persistent Hyperglycemia|2|||
33462108|NCT00631007|101580191|FG001|Overall Study|Persistent Hyperglycemia|2|||
33462109|NCT00631007|101580192|FG002|Overall Study|Persistent Hyperglycemia|5|||
33462110|NCT00631007|101580193|FG003|Overall Study|Persistent Hyperglycemia|1|||
33462111|NCT00631007|101580194|FG004|Overall Study|Persistent Hyperglycemia|2|||
33462112|NCT00631007|101580195|FG005|Overall Study|Persistent Hyperglycemia|5|||
33462113|NCT00631007|101580190|FG000|Overall Study|Withdrawal by Subject|4|||
33462114|NCT00631007|101580191|FG001|Overall Study|Withdrawal by Subject|5|||
33462115|NCT00631007|101580192|FG002|Overall Study|Withdrawal by Subject|2|||
33462116|NCT00631007|101580193|FG003|Overall Study|Withdrawal by Subject|2|||
33462117|NCT00631007|101580194|FG004|Overall Study|Withdrawal by Subject|1|||
33462118|NCT00631007|101580195|FG005|Overall Study|Withdrawal by Subject|3|||
33462119|NCT00631007|101580190|FG000|Overall Study|Other|2|||
33462120|NCT00631007|101580191|FG001|Overall Study|Other|1|||
33462121|NCT00631007|101580192|FG002|Overall Study|Other|0|||
33462122|NCT00631007|101580193|FG003|Overall Study|Other|0|||
33462123|NCT00631007|101580194|FG004|Overall Study|Other|1|||
33462124|NCT00631007|101580195|FG005|Overall Study|Other|0|||
33462125|NCT01560819|101580196|FG000|Overall Study|Physician Decision|1|||
33462126|NCT01560819|101580197|FG001|Overall Study|Physician Decision|0|||
33462127|NCT00983528|101580200|FG000|Overall Study|Death|4|||
33462128|NCT00983528|101580200|FG000|Overall Study|Lost to Follow-up|1|||
33462129|NCT00983528|101580200|FG000|Overall Study|Study Terminated|1|||
33263123|NCT02392234|100863856|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
33263124|NCT02392234|100863857|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
33462130|NCT00726895|101580201|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
33462131|NCT00726895|101580202|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33462132|NCT01438476|101580212|FG000|Overall Study|Protocol Violation|1|||
33462133|NCT01438476|101580213|FG001|Overall Study|Protocol Violation|0|||
33462134|NCT01438476|101580212|FG000|Overall Study|Withdrawal by Subject|1|||
33462135|NCT01438476|101580213|FG001|Overall Study|Withdrawal by Subject|0|||
33462136|NCT01438476|101580212|FG000|Overall Study|No Surgery- Disease|8|||
33462137|NCT01438476|101580213|FG001|Overall Study|No Surgery- Disease|10|||
33462138|NCT01438476|101580212|FG000|Overall Study|Communication barrier|0|||
33462139|NCT01438476|101580213|FG001|Overall Study|Communication barrier|1|||
33462140|NCT04599166|101580214|FG000|Overall Study|Technological failure connecting to study app|80|||
33462141|NCT01466036|101580218|FG000|Overall Study|Death|1|||
33462142|NCT01466036|101580219|FG001|Overall Study|Death|1|||
33462143|NCT01466036|101580218|FG000|Overall Study|Physician Decision|0|||
33462144|NCT01466036|101580219|FG001|Overall Study|Physician Decision|4|||
33176197|NCT01472081|100552200|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
33176198|NCT01472081|100552201|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
33176199|NCT01472081|100552196|FG000|Overall Study|Withdrawal by Subject|0|||
33176200|NCT01472081|100552197|FG001|Overall Study|Withdrawal by Subject|0|||
33176201|NCT01472081|100552198|FG002|Overall Study|Withdrawal by Subject|0|||
33176202|NCT01472081|100552199|FG003|Overall Study|Withdrawal by Subject|0|||
33176203|NCT01472081|100552200|FG004|Overall Study|Withdrawal by Subject|0|||
33176204|NCT01472081|100552201|FG005|Overall Study|Withdrawal by Subject|1|||
33176205|NCT01472081|100552196|FG000|Overall Study|Poor/non-compliance|0|||
33176206|NCT01472081|100552197|FG001|Overall Study|Poor/non-compliance|0|||
33176207|NCT01472081|100552198|FG002|Overall Study|Poor/non-compliance|1|||
33462145|NCT01466036|101580218|FG000|Overall Study|Adverse Event|2|||
33462146|NCT01466036|101580219|FG001|Overall Study|Adverse Event|6|||
33462147|NCT01466036|101580218|FG000|Overall Study|Withdrawal by Subject|2|||
33462148|NCT01466036|101580219|FG001|Overall Study|Withdrawal by Subject|8|||
33462149|NCT01466036|101580218|FG000|Overall Study|progression/relapse|14|||
33462150|NCT01466036|101580219|FG001|Overall Study|progression/relapse|21|||
33462151|NCT01466036|101580218|FG000|Overall Study|prolonged treatment delay|1|||
33462152|NCT01466036|101580219|FG001|Overall Study|prolonged treatment delay|1|||
33462153|NCT01989676|101580220|FG000|Overall Study|Death|52|||
33462154|NCT01989676|101580221|FG001|Overall Study|Death|60|||
33462155|NCT01989676|101580220|FG000|Overall Study|Protocol Violation|2|||
33462156|NCT01989676|101580221|FG001|Overall Study|Protocol Violation|1|||
33462157|NCT01989676|101580220|FG000|Overall Study|Lost to Follow-up|8|||
33462158|NCT01989676|101580221|FG001|Overall Study|Lost to Follow-up|18|||
33462159|NCT01989676|101580220|FG000|Overall Study|No longer willing to participate in study|26|||
33462160|NCT01989676|101580221|FG001|Overall Study|No longer willing to participate in study|26|||
33462161|NCT01989676|101580220|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
33462162|NCT01989676|101580221|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
33462163|NCT01989676|101580220|FG000|Overall Study|Other|4|||
33462164|NCT01989676|101580221|FG001|Overall Study|Other|3|||
33462165|NCT05444543|101580222|FG000|Overall Study|Withdrawal by Subject|1|||
33462166|NCT05444543|101580223|FG001|Overall Study|Withdrawal by Subject|0|||
33462167|NCT05444543|101580222|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
33462168|NCT05444543|101580223|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
33462169|NCT05444543|101580222|FG000|Overall Study|Adverse Event|0|||
33462170|NCT05444543|101580223|FG001|Overall Study|Adverse Event|1|||
33462171|NCT05444543|101580222|FG000|Overall Study|Family relocating at a distance from study site|0|||
33462172|NCT05444543|101580223|FG001|Overall Study|Family relocating at a distance from study site|1|||
33462173|NCT00820599|101580229|FG000|Overall Study|Death|129|||
33462174|NCT00820599|101580229|FG000|Overall Study|Withdrawal by Subject|2|||
33462175|NCT01801917|101580230|FG000|Period 1 - Randomized|Adverse Event|1|||
33462176|NCT01801917|101580231|FG001|Period 1 - Randomized|Adverse Event|0|||
33462177|NCT01801917|101580232|FG002|Period 1 - Randomized|Adverse Event|1|||
33462178|NCT01801917|101580233|FG003|Period 1 - Randomized|Adverse Event|0|||
33462179|NCT03507686|101580234|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
33462180|NCT03507686|101580235|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
33462181|NCT03507686|101580234|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
33462182|NCT03507686|101580235|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
33462183|NCT03507686|101580234|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
33462184|NCT03507686|101580235|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
33462185|NCT03507686|101580234|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
33462186|NCT03507686|101580235|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
33462187|NCT03507686|101580234|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
33462188|NCT03507686|101580235|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
33176208|NCT01472081|100552199|FG003|Overall Study|Poor/non-compliance|0|||
33176209|NCT01472081|100552200|FG004|Overall Study|Poor/non-compliance|1|||
33176210|NCT01472081|100552201|FG005|Overall Study|Poor/non-compliance|0|||
33462189|NCT03507686|101580234|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
33462190|NCT03507686|101580235|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
33462191|NCT03712124|101580236|FG000|Overall Study|Protocol Violation|1|||
33176211|NCT01472081|100552196|FG000|Overall Study|No longer meets study criteria|0|||
33176212|NCT01472081|100552197|FG001|Overall Study|No longer meets study criteria|0|||
33176213|NCT01472081|100552198|FG002|Overall Study|No longer meets study criteria|1|||
33176214|NCT01472081|100552199|FG003|Overall Study|No longer meets study criteria|0|||
33462192|NCT03712124|101580237|FG001|Overall Study|Protocol Violation|0|||
33462193|NCT00537017|101580238|FG000|Treatment Phase|Adverse Event|19|||
33462194|NCT00537017|101580238|FG000|Treatment Phase|Withdrawal by Subject|13|||
33462195|NCT00537017|101580238|FG000|Treatment Phase|Protocol Violation|2|||
33462196|NCT00537017|101580238|FG000|Follow-up Phase|Withdrawal by Subject|9|||
33462197|NCT03619876|101580239|FG000|Overall Study|Withdrawal by Subject|1|||
33462198|NCT03619876|101580240|FG001|Overall Study|Withdrawal by Subject|2|||
33462199|NCT03619876|101580239|FG000|Overall Study|Withdrawal due to incidental finding|0|||
33462200|NCT03619876|101580240|FG001|Overall Study|Withdrawal due to incidental finding|2|||
33462201|NCT02688387|101580241|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462202|NCT02688387|101580242|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462203|NCT02688387|101580243|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
33462204|NCT02688387|101580244|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462205|NCT02688387|101580245|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462206|NCT02688387|101580246|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462207|NCT02688387|101580247|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462208|NCT02688387|101580248|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462209|NCT02688387|101580249|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462210|NCT02688387|101580250|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462211|NCT02688387|101580251|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462212|NCT02688387|101580252|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462213|NCT02688387|101580253|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462214|NCT02688387|101580254|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462215|NCT02688387|101580255|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462216|NCT02688387|101580256|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462217|NCT02688387|101580257|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462218|NCT02688387|101580258|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462219|NCT02688387|101580259|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462220|NCT02688387|101580260|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462221|NCT02688387|101580261|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462222|NCT02688387|101580262|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
33462223|NCT02688387|101580241|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462224|NCT02688387|101580242|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462225|NCT02688387|101580243|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462226|NCT02688387|101580244|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
33462227|NCT02688387|101580245|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462228|NCT02688387|101580246|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462229|NCT02688387|101580247|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462230|NCT02688387|101580248|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462231|NCT02688387|101580249|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462232|NCT02688387|101580250|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462233|NCT02688387|101580251|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462234|NCT02688387|101580252|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462235|NCT02688387|101580253|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462236|NCT02688387|101580254|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462237|NCT02688387|101580255|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462238|NCT02688387|101580256|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462239|NCT02688387|101580257|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462240|NCT02688387|101580258|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462241|NCT02688387|101580259|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33263125|NCT02392234|100863858|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
33263126|NCT02392234|100863859|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
33263127|NCT02392234|100863860|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
33263128|NCT02392234|100863855|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
33263129|NCT02392234|100863856|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
33462242|NCT02688387|101580260|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462243|NCT02688387|101580261|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462244|NCT02688387|101580262|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462245|NCT02688387|101580241|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462246|NCT02688387|101580242|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
33462247|NCT02688387|101580243|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462248|NCT02688387|101580244|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462249|NCT02688387|101580245|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462250|NCT02688387|101580246|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462251|NCT02688387|101580247|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33263130|NCT02392234|100863857|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
33263131|NCT02392234|100863858|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
33263132|NCT02392234|100863859|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
33263133|NCT02392234|100863860|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
33462252|NCT02688387|101580248|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462253|NCT02688387|101580249|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462254|NCT02688387|101580250|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462255|NCT02688387|101580251|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462256|NCT02688387|101580252|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462257|NCT02688387|101580253|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462258|NCT02688387|101580254|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462259|NCT02688387|101580255|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462260|NCT02688387|101580256|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462261|NCT02688387|101580257|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462262|NCT02688387|101580258|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462263|NCT02688387|101580259|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462264|NCT02688387|101580260|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462265|NCT02688387|101580261|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462266|NCT02688387|101580262|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
33462267|NCT02688387|101580241|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462268|NCT02688387|101580242|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462269|NCT02688387|101580243|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
33462270|NCT02688387|101580244|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462271|NCT02688387|101580245|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
33462272|NCT02688387|101580246|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462273|NCT02688387|101580247|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462274|NCT02688387|101580248|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462275|NCT02688387|101580249|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462276|NCT02688387|101580250|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462277|NCT02688387|101580251|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462278|NCT02688387|101580252|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462279|NCT02688387|101580253|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462280|NCT02688387|101580254|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462281|NCT02688387|101580255|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462282|NCT02688387|101580256|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462283|NCT02688387|101580257|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462284|NCT02688387|101580258|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462285|NCT02688387|101580259|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462286|NCT02688387|101580260|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462287|NCT02688387|101580261|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462288|NCT02688387|101580262|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
33462289|NCT02688387|101580241|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
33462290|NCT02688387|101580242|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462291|NCT02688387|101580243|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462292|NCT02688387|101580244|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462293|NCT02688387|101580245|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462294|NCT02688387|101580246|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462295|NCT02688387|101580247|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462296|NCT02688387|101580248|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462297|NCT02688387|101580249|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462298|NCT02688387|101580250|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462299|NCT02688387|101580251|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33176215|NCT01472081|100552200|FG004|Overall Study|No longer meets study criteria|0|||
33176216|NCT01472081|100552201|FG005|Overall Study|No longer meets study criteria|0|||
33176217|NCT01472081|100552196|FG000|Overall Study|Subject request to discontinue treatment|0|||
33176218|NCT01472081|100552197|FG001|Overall Study|Subject request to discontinue treatment|3|||
33176219|NCT01472081|100552198|FG002|Overall Study|Subject request to discontinue treatment|1|||
33176220|NCT01472081|100552199|FG003|Overall Study|Subject request to discontinue treatment|1|||
33176221|NCT01472081|100552200|FG004|Overall Study|Subject request to discontinue treatment|0|||
33176222|NCT01472081|100552201|FG005|Overall Study|Subject request to discontinue treatment|0|||
33176223|NCT00524368|100552202|FG000|Overall Study|Adverse Event|10|||
33176224|NCT00524368|100552203|FG001|Overall Study|Adverse Event|12|||
33176225|NCT00524368|100552202|FG000|Overall Study|Lost to Follow-up|9|||
33176226|NCT00524368|100552203|FG001|Overall Study|Lost to Follow-up|13|||
33462300|NCT02688387|101580252|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462301|NCT02688387|101580253|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462302|NCT02688387|101580254|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462303|NCT02688387|101580255|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462304|NCT02688387|101580256|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462305|NCT02688387|101580257|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462306|NCT02688387|101580258|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462307|NCT02688387|101580259|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462308|NCT02688387|101580260|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462309|NCT02688387|101580261|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462310|NCT02688387|101580262|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
33462311|NCT02688387|101580241|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462312|NCT02688387|101580242|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462313|NCT02688387|101580243|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462314|NCT02688387|101580244|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462315|NCT02688387|101580245|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462316|NCT02688387|101580246|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462317|NCT02688387|101580247|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462318|NCT02688387|101580248|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462319|NCT02688387|101580249|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462320|NCT02688387|101580250|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462321|NCT02688387|101580251|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
33462322|NCT02688387|101580252|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462323|NCT02688387|101580253|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462324|NCT02688387|101580254|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462325|NCT02688387|101580255|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462326|NCT02688387|101580256|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462327|NCT02688387|101580257|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462328|NCT02688387|101580258|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462329|NCT02688387|101580259|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462330|NCT02688387|101580260|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462331|NCT02688387|101580261|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462332|NCT02688387|101580262|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
33462333|NCT02688387|101580241|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462334|NCT02688387|101580242|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462335|NCT02688387|101580243|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462336|NCT02688387|101580244|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462337|NCT02688387|101580245|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462338|NCT02688387|101580246|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462339|NCT02688387|101580247|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462340|NCT02688387|101580248|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462341|NCT02688387|101580249|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462342|NCT02688387|101580250|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462343|NCT02688387|101580251|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462344|NCT02688387|101580252|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462345|NCT02688387|101580253|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462346|NCT02688387|101580254|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462347|NCT02688387|101580255|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
33462348|NCT02688387|101580256|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462349|NCT02688387|101580257|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462350|NCT02688387|101580258|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462351|NCT02688387|101580259|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462352|NCT02688387|101580260|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462353|NCT02688387|101580261|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462354|NCT02688387|101580262|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
33462355|NCT02688387|101580241|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462356|NCT02688387|101580242|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462357|NCT02688387|101580243|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462358|NCT02688387|101580244|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462359|NCT02688387|101580245|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462360|NCT02688387|101580246|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33263134|NCT02392234|100863855|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
33263135|NCT02392234|100863856|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
33263136|NCT02392234|100863857|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
33263137|NCT02392234|100863858|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
33263138|NCT02392234|100863859|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
33263139|NCT02392234|100863860|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
33462361|NCT02688387|101580247|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462362|NCT02688387|101580248|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462363|NCT02688387|101580249|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462364|NCT02688387|101580250|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462365|NCT02688387|101580251|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462366|NCT02688387|101580252|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462367|NCT02688387|101580253|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462368|NCT02688387|101580254|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462369|NCT02688387|101580255|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462370|NCT02688387|101580256|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462371|NCT02688387|101580257|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462372|NCT02688387|101580258|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462373|NCT02688387|101580259|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462374|NCT02688387|101580260|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462375|NCT02688387|101580261|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
33462376|NCT02688387|101580262|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
33462377|NCT02688387|101580241|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462378|NCT02688387|101580242|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462379|NCT02688387|101580243|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462380|NCT02688387|101580244|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462381|NCT02688387|101580245|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462382|NCT02688387|101580246|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462383|NCT02688387|101580247|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462384|NCT02688387|101580248|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462385|NCT02688387|101580249|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462386|NCT02688387|101580250|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462387|NCT02688387|101580251|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462388|NCT02688387|101580252|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462389|NCT02688387|101580253|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462390|NCT02688387|101580254|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462391|NCT02688387|101580255|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462392|NCT02688387|101580256|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462393|NCT02688387|101580257|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462394|NCT02688387|101580258|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462395|NCT02688387|101580259|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
33462396|NCT02688387|101580260|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462397|NCT02688387|101580261|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
33462398|NCT02688387|101580262|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
33462399|NCT02688387|101580241|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462400|NCT02688387|101580242|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462401|NCT02688387|101580243|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462402|NCT02688387|101580244|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462403|NCT02688387|101580245|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462404|NCT02688387|101580246|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462405|NCT02688387|101580247|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462406|NCT02688387|101580248|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462407|NCT02688387|101580249|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462408|NCT02688387|101580250|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462409|NCT02688387|101580251|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462410|NCT02688387|101580252|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462411|NCT02688387|101580253|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462412|NCT02688387|101580254|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462413|NCT02688387|101580255|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462414|NCT02688387|101580256|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462415|NCT02688387|101580257|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462416|NCT02688387|101580258|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462417|NCT02688387|101580259|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462418|NCT02688387|101580260|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
33462419|NCT02688387|101580261|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33462420|NCT02688387|101580262|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
33176227|NCT00524368|100552202|FG000|Overall Study|Withdrawal by Subject|4|||
33462421|NCT01029392|101580263|FG000|Overall Study|Withdrawal by Subject|18|||
33462422|NCT01029392|101580264|FG001|Overall Study|Withdrawal by Subject|11|||
33462423|NCT01029392|101580263|FG000|Overall Study|Physician Decision|2|||
33462424|NCT01029392|101580264|FG001|Overall Study|Physician Decision|0|||
33462425|NCT04501094|101580267|FG000|Overall Study|Death (unrelated to research)|1|||
33462426|NCT04501094|101580268|FG001|Overall Study|Death (unrelated to research)|0|||
33176228|NCT00524368|100552203|FG001|Overall Study|Withdrawal by Subject|5|||
33462427|NCT01894230|101580269|FG000|Overall Study|Lost to Follow-up|2|||
33462428|NCT01894230|101580270|FG001|Overall Study|Lost to Follow-up|2|||
33462429|NCT01894230|101580269|FG000|Overall Study|Withdrawal by Subject|4|||
33462430|NCT01894230|101580270|FG001|Overall Study|Withdrawal by Subject|4|||
33462431|NCT01894230|101580269|FG000|Overall Study|Non-adherent|0|||
33462432|NCT01894230|101580270|FG001|Overall Study|Non-adherent|1|||
33462433|NCT01894230|101580269|FG000|Overall Study|Death|1|||
33462434|NCT01894230|101580270|FG001|Overall Study|Death|0|||
33462435|NCT00685750|101580272|FG000|Overall Study|Tumor sampling failure|0|||
33462436|NCT00685750|101580273|FG001|Overall Study|Tumor sampling failure|0|||
33462437|NCT00685750|101580274|FG002|Overall Study|Tumor sampling failure|1|||
33462438|NCT00685750|101580275|FG003|Overall Study|Tumor sampling failure|0|||
33462439|NCT00685750|101580276|FG004|Overall Study|Tumor sampling failure|0|||
33462440|NCT00685750|101580277|FG005|Overall Study|Tumor sampling failure|0|||
33462441|NCT00685750|101580278|FG006|Overall Study|Tumor sampling failure|0|||
33462442|NCT00685750|101580272|FG000|Overall Study|Patient didn't receive the treatment|0|||
33462443|NCT00685750|101580273|FG001|Overall Study|Patient didn't receive the treatment|0|||
33462444|NCT00685750|101580274|FG002|Overall Study|Patient didn't receive the treatment|0|||
33462445|NCT00685750|101580275|FG003|Overall Study|Patient didn't receive the treatment|0|||
33462446|NCT00685750|101580276|FG004|Overall Study|Patient didn't receive the treatment|0|||
33462447|NCT00685750|101580277|FG005|Overall Study|Patient didn't receive the treatment|0|||
33462448|NCT00685750|101580278|FG006|Overall Study|Patient didn't receive the treatment|1|||
33462449|NCT00685750|101580272|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33462450|NCT00685750|101580273|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33462451|NCT00685750|101580274|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
33462452|NCT00685750|101580275|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
33462453|NCT00685750|101580276|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
33462454|NCT00685750|101580277|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
33462455|NCT00685750|101580278|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
33462456|NCT01074008|101580279|FG000|Overall Study|Adverse Event|0|||
33462457|NCT01074008|101580280|FG001|Overall Study|Adverse Event|1|||
33462458|NCT01074008|101580281|FG002|Overall Study|Adverse Event|0|||
33462459|NCT01074008|101580282|FG003|Overall Study|Adverse Event|0|||
33462460|NCT01074008|101580283|FG004|Overall Study|Adverse Event|0|||
33462461|NCT01074008|101580284|FG005|Overall Study|Adverse Event|0|||
33462462|NCT01074008|101580285|FG006|Overall Study|Adverse Event|0|||
33462463|NCT01074008|101580286|FG007|Overall Study|Adverse Event|0|||
33462464|NCT01074008|101580287|FG008|Overall Study|Adverse Event|0|||
33462465|NCT01074008|101580279|FG000|Overall Study|Withdrawal by Subject|1|||
33462466|NCT01074008|101580280|FG001|Overall Study|Withdrawal by Subject|1|||
33462467|NCT01074008|101580281|FG002|Overall Study|Withdrawal by Subject|1|||
33462468|NCT01074008|101580282|FG003|Overall Study|Withdrawal by Subject|0|||
33462469|NCT01074008|101580283|FG004|Overall Study|Withdrawal by Subject|1|||
33462470|NCT01074008|101580284|FG005|Overall Study|Withdrawal by Subject|0|||
33462471|NCT01074008|101580285|FG006|Overall Study|Withdrawal by Subject|0|||
33462472|NCT01074008|101580286|FG007|Overall Study|Withdrawal by Subject|0|||
33462473|NCT01074008|101580287|FG008|Overall Study|Withdrawal by Subject|0|||
33462474|NCT01074008|101580279|FG000|Overall Study|Lost to Follow-up|0|||
33462475|NCT01074008|101580280|FG001|Overall Study|Lost to Follow-up|1|||
33462476|NCT01074008|101580281|FG002|Overall Study|Lost to Follow-up|1|||
33462477|NCT01074008|101580282|FG003|Overall Study|Lost to Follow-up|1|||
33462478|NCT01074008|101580283|FG004|Overall Study|Lost to Follow-up|1|||
33462479|NCT01074008|101580284|FG005|Overall Study|Lost to Follow-up|0|||
33462480|NCT01074008|101580285|FG006|Overall Study|Lost to Follow-up|1|||
33462481|NCT01074008|101580286|FG007|Overall Study|Lost to Follow-up|0|||
33462482|NCT01074008|101580287|FG008|Overall Study|Lost to Follow-up|4|||
33462483|NCT00985231|101580288|FG000|Overall Study|ineligible|1|||
33462484|NCT00985231|101580289|FG001|Overall Study|ineligible|0|||
33462485|NCT00985231|101580288|FG000|Overall Study|Protocol Violation|1|||
33462486|NCT00985231|101580289|FG001|Overall Study|Protocol Violation|0|||
33462487|NCT00985231|101580288|FG000|Overall Study|Withdrawal by Subject|1|||
33462488|NCT00985231|101580289|FG001|Overall Study|Withdrawal by Subject|0|||
33462489|NCT00985231|101580288|FG000|Overall Study|Lost to Follow-up|0|||
33462490|NCT00985231|101580289|FG001|Overall Study|Lost to Follow-up|1|||
33462491|NCT00985231|101580288|FG000|Overall Study|Study related symptoms & complaints|0|||
33462492|NCT00985231|101580289|FG001|Overall Study|Study related symptoms & complaints|2|||
33462493|NCT01899326|101580298|FG000|Overall Study|Withdrawal by Subject|1|||
33462494|NCT01899326|101580298|FG000|Overall Study|Adverse Event|2|||
33462495|NCT01899326|101580298|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
33462496|NCT00819767|101580300|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33462497|NCT00819767|101580301|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33462498|NCT03069417|101580302|FG000|Overall Study|Lost to Follow-up|2|||
33462499|NCT03069417|101580303|FG001|Overall Study|Lost to Follow-up|0|||
33462500|NCT03069417|101580302|FG000|Overall Study|Reason Unknown|4|||
33462501|NCT03069417|101580303|FG001|Overall Study|Reason Unknown|7|||
33462502|NCT00559637|101580304|FG000|Overall Study|Adverse Event|22|||
33462503|NCT00559637|101580304|FG000|Overall Study|Withdrawal by Subject|4|||
33462504|NCT00559637|101580304|FG000|Overall Study|Protocol Violation|6|||
33462505|NCT00559637|101580304|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
33176229|NCT00524368|100552202|FG000|Overall Study|Non-compliant|8|||
33176230|NCT00524368|100552203|FG001|Overall Study|Non-compliant|9|||
33176231|NCT00524368|100552202|FG000|Overall Study|Reached a Virologic Endpoint|3|||
33176232|NCT00524368|100552203|FG001|Overall Study|Reached a Virologic Endpoint|2|||
33176233|NCT00524368|100552202|FG000|Overall Study|Sponsor's Decision|2|||
33176234|NCT00524368|100552203|FG001|Overall Study|Sponsor's Decision|0|||
33176235|NCT00524368|100552202|FG000|Overall Study|Ineligible to Continue the study|2|||
33176236|NCT00524368|100552203|FG001|Overall Study|Ineligible to Continue the study|5|||
33176237|NCT00524368|100552202|FG000|Overall Study|Other|3|||
33176238|NCT00524368|100552203|FG001|Overall Study|Other|2|||
33176239|NCT00541034|100552204|FG000|Overall Study|Non-Compliance|3|||
33176240|NCT01585428|100552205|FG000|Overall Study|Death during treatment|1|||
33176241|NCT01585428|100552206|FG001|Overall Study|Death during treatment|0|||
33462506|NCT00559637|101580304|FG000|Overall Study|Failure to return|6|||
33176242|NCT04977583|100552209|FG000|Overall Study|Lost to Follow-up|8|||
33176243|NCT04977583|100552210|FG001|Overall Study|Lost to Follow-up|4|||
33176244|NCT04977583|100552211|FG002|Overall Study|Lost to Follow-up|13|||
33176245|NCT04977583|100552209|FG000|Overall Study|Withdrawal by Subject|3|||
33176246|NCT04977583|100552210|FG001|Overall Study|Withdrawal by Subject|2|||
33176247|NCT04977583|100552211|FG002|Overall Study|Withdrawal by Subject|1|||
33176248|NCT00399360|100552217|FG000|Overall Study|Lost to Follow-up|2|||
33176249|NCT00399360|100552218|FG001|Overall Study|Lost to Follow-up|1|||
33176250|NCT00399360|100552219|FG002|Overall Study|Lost to Follow-up|2|||
33176251|NCT00399360|100552220|FG003|Overall Study|Lost to Follow-up|4|||
33176252|NCT00399360|100552217|FG000|Overall Study|Adverse Event|0|||
33176253|NCT00399360|100552218|FG001|Overall Study|Adverse Event|0|||
33176254|NCT00399360|100552219|FG002|Overall Study|Adverse Event|1|||
33176255|NCT00399360|100552220|FG003|Overall Study|Adverse Event|0|||
33176256|NCT00399360|100552217|FG000|Overall Study|Withdrawal by Subject|0|||
33176257|NCT00399360|100552218|FG001|Overall Study|Withdrawal by Subject|2|||
33176258|NCT00399360|100552219|FG002|Overall Study|Withdrawal by Subject|0|||
33176259|NCT00399360|100552220|FG003|Overall Study|Withdrawal by Subject|2|||
33263140|NCT02392234|100863855|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
33462507|NCT00559637|101580304|FG000|Overall Study|Insufficient response|3|||
33462508|NCT00559637|101580304|FG000|Overall Study|Started requiring dialysis after month 7|2|||
33462509|NCT00559637|101580304|FG000|Overall Study|Suspected lung cancer|1|||
33462510|NCT00559637|101580304|FG000|Overall Study|Participation in another study|1|||
33462511|NCT00559637|101580304|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
33462512|NCT00559637|101580304|FG000|Overall Study|Change of center|1|||
33462513|NCT00559637|101580304|FG000|Overall Study|Change of home|1|||
33462514|NCT00559637|101580304|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
33462515|NCT04590781|101580305|FG000|Overall Study|Death|0|||
33462516|NCT04590781|101580306|FG001|Overall Study|Death|2|||
33462517|NCT04590781|101580305|FG000|Overall Study|Withdrawal by Subject|2|||
33462518|NCT04590781|101580306|FG001|Overall Study|Withdrawal by Subject|0|||
33462519|NCT01719562|101580308|FG000|Overall Study|Lost to Follow-up|1|||
33462520|NCT01719562|101580309|FG001|Overall Study|Lost to Follow-up|0|||
33462521|NCT01719562|101580308|FG000|Overall Study|Death|1|||
33462522|NCT01719562|101580309|FG001|Overall Study|Death|0|||
33462523|NCT01719562|101580308|FG000|Overall Study|New cancer diagnosis|1|||
33462524|NCT01719562|101580309|FG001|Overall Study|New cancer diagnosis|0|||
33462525|NCT02911935|101580310|FG000|Overall Study|Lost to Follow-up|5|||
33462526|NCT02911935|101580311|FG001|Overall Study|Lost to Follow-up|7|||
33462527|NCT00084799|101580320|FG000|Overall Study|Disease Progression|1|||
33462528|NCT00084799|101580321|FG001|Overall Study|Disease Progression|0|||
33462529|NCT04167618|101583268|FG000|Overall Study|Trial terminated by sponsor|1|||
33462530|NCT04167618|101583269|FG001|Overall Study|Trial terminated by sponsor|1|||
33462531|NCT00685035|101583276|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
33462532|NCT00685035|101583277|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
33462533|NCT01188226|101583278|FG000|Overall Study|Withdrawal by Subject|4|||
33462534|NCT03877926|101583279|FG000|Overall Study|Adverse Event|1|||
33462535|NCT03877926|101583280|FG001|Overall Study|Adverse Event|0|||
33462536|NCT03877926|101583281|FG002|Overall Study|Adverse Event|0|||
33462537|NCT03877926|101583282|FG003|Overall Study|Adverse Event|0|||
33176260|NCT00137423|100552223|FG000|Overall Study|Adverse Event|7|||
33176261|NCT00137423|100552224|FG001|Overall Study|Adverse Event|9|||
33176262|NCT00137423|100552223|FG000|Overall Study|consent withdrawn|1|||
33462538|NCT03877926|101583279|FG000|Overall Study|Death|2|||
33462539|NCT03877926|101583280|FG001|Overall Study|Death|2|||
33462540|NCT03877926|101583281|FG002|Overall Study|Death|2|||
33462541|NCT03877926|101583282|FG003|Overall Study|Death|0|||
33462542|NCT03877926|101583279|FG000|Overall Study|Lost to Follow-up|41|||
33176263|NCT00137423|100552224|FG001|Overall Study|consent withdrawn|1|||
33176264|NCT00137423|100552223|FG000|Overall Study|Lack of Efficacy|31|||
33176265|NCT00137423|100552224|FG001|Overall Study|Lack of Efficacy|33|||
33176266|NCT00137423|100552223|FG000|Overall Study|Death|0|||
33176267|NCT00137423|100552224|FG001|Overall Study|Death|1|||
33176268|NCT00103142|100552225|FG000|Overall Study|Adverse Event|1|||
33176269|NCT00103142|100552226|FG001|Overall Study|Adverse Event|0|||
33176270|NCT00103142|100552225|FG000|Overall Study|Progression of disease|2|||
33176271|NCT00103142|100552226|FG001|Overall Study|Progression of disease|1|||
33176272|NCT00180414|100552227|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
33176273|NCT00180414|100552228|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
33176274|NCT01770379|100552229|FG000|Overall Study|Technical issues|1|||
33176275|NCT01770379|100552230|FG001|Overall Study|Technical issues|0|||
33176276|NCT01770379|100552231|FG002|Overall Study|Technical issues|0|||
33176277|NCT01770379|100552229|FG000|Overall Study|Withdrawal by Subject|7|||
33176278|NCT01770379|100552230|FG001|Overall Study|Withdrawal by Subject|10|||
33176279|NCT01770379|100552231|FG002|Overall Study|Withdrawal by Subject|7|||
33176280|NCT01770379|100552229|FG000|Overall Study|study terminated by sponsor|22|||
33176281|NCT01770379|100552230|FG001|Overall Study|study terminated by sponsor|23|||
33176282|NCT01770379|100552231|FG002|Overall Study|study terminated by sponsor|22|||
33176283|NCT01770379|100552229|FG000|Overall Study|Protocol Violation|0|||
33176284|NCT01770379|100552230|FG001|Overall Study|Protocol Violation|1|||
33176285|NCT01770379|100552231|FG002|Overall Study|Protocol Violation|1|||
33176286|NCT01770379|100552229|FG000|Overall Study|Physician Decision|0|||
33176287|NCT01770379|100552230|FG001|Overall Study|Physician Decision|1|||
33176288|NCT01770379|100552231|FG002|Overall Study|Physician Decision|2|||
33263141|NCT02392234|100863856|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
33263142|NCT02392234|100863857|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
33263143|NCT02392234|100863858|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
33462543|NCT03877926|101583280|FG001|Overall Study|Lost to Follow-up|52|||
33462544|NCT03877926|101583281|FG002|Overall Study|Lost to Follow-up|45|||
33462545|NCT03877926|101583282|FG003|Overall Study|Lost to Follow-up|17|||
33462546|NCT03877926|101583279|FG000|Overall Study|Physician Decision|2|||
33462547|NCT03877926|101583280|FG001|Overall Study|Physician Decision|0|||
33462548|NCT03877926|101583281|FG002|Overall Study|Physician Decision|2|||
33462549|NCT03877926|101583282|FG003|Overall Study|Physician Decision|0|||
33462550|NCT03877926|101583279|FG000|Overall Study|Withdrawal by Subject|18|||
33462551|NCT03877926|101583280|FG001|Overall Study|Withdrawal by Subject|21|||
33462552|NCT03877926|101583281|FG002|Overall Study|Withdrawal by Subject|12|||
33462553|NCT03877926|101583282|FG003|Overall Study|Withdrawal by Subject|4|||
33462554|NCT03877926|101583279|FG000|Overall Study|Other - Various|4|||
33462555|NCT03877926|101583280|FG001|Overall Study|Other - Various|1|||
33462556|NCT03877926|101583281|FG002|Overall Study|Other - Various|1|||
33462557|NCT03877926|101583282|FG003|Overall Study|Other - Various|0|||
33176289|NCT01770379|100552229|FG000|Overall Study|Lost to Follow-up|0|||
33176290|NCT01770379|100552230|FG001|Overall Study|Lost to Follow-up|0|||
33176291|NCT01770379|100552231|FG002|Overall Study|Lost to Follow-up|2|||
33176292|NCT01770379|100552229|FG000|Overall Study|Lack of Efficacy|8|||
33176293|NCT01770379|100552230|FG001|Overall Study|Lack of Efficacy|6|||
33176294|NCT01770379|100552231|FG002|Overall Study|Lack of Efficacy|6|||
33462558|NCT03877926|101583279|FG000|Overall Study|Not Treated|3|||
33462559|NCT03877926|101583280|FG001|Overall Study|Not Treated|1|||
33176295|NCT01770379|100552229|FG000|Overall Study|Adverse Event|1|||
33176296|NCT01770379|100552230|FG001|Overall Study|Adverse Event|3|||
33462560|NCT03877926|101583281|FG002|Overall Study|Not Treated|1|||
33462561|NCT03877926|101583282|FG003|Overall Study|Not Treated|0|||
33462562|NCT01213836|101583283|FG000|Period 1, First Intervention|Adverse Event|2|||
33462563|NCT01213836|101583284|FG001|Period 1, First Intervention|Adverse Event|1|||
33462564|NCT01213836|101583283|FG000|Period 1, First Intervention|Protocol Violation|0|||
33462565|NCT01213836|101583284|FG001|Period 1, First Intervention|Protocol Violation|1|||
33462566|NCT01213836|101583283|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
33462567|NCT01213836|101583284|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
33462568|NCT03170869|101583285|FG000|Overall Study|Protocol Violation|5|||
33462569|NCT03170869|101583285|FG000|Overall Study|Early study termination|3|||
33462570|NCT02508116|101583286|FG000|Overall Study|Lost to Follow-up|2|||
33462571|NCT02508116|101583287|FG001|Overall Study|Lost to Follow-up|3|||
33462572|NCT02508116|101583286|FG000|Overall Study|Withdrawal by Subject|3|||
33462573|NCT02508116|101583287|FG001|Overall Study|Withdrawal by Subject|2|||
33462574|NCT02508116|101583286|FG000|Overall Study|Protocol Violation|1|||
33462575|NCT02508116|101583287|FG001|Overall Study|Protocol Violation|2|||
33462576|NCT02508116|101583286|FG000|Overall Study|Physician Decision|2|||
33176297|NCT01770379|100552231|FG002|Overall Study|Adverse Event|2|||
33176298|NCT05286307|100552232|FG000|Overall Study|Incomplete outcome assessments|2|||
33462577|NCT02508116|101583287|FG001|Overall Study|Physician Decision|0|||
33462578|NCT00894933|101583288|FG000|Overall Study|Lost to Follow-up|2|||
33462579|NCT00894933|101583288|FG000|Overall Study|Cancelled Procedure|1|||
33462580|NCT00894933|101583288|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
33462581|NCT04253236|101583289|FG000|Overall Study|Adverse Event|1|||
33462582|NCT04253236|101583290|FG001|Overall Study|Adverse Event|0|||
33462583|NCT04253236|101583289|FG000|Overall Study|Safety Concerns|1|||
33462584|NCT04253236|101583290|FG001|Overall Study|Safety Concerns|0|||
33462585|NCT04253236|101583289|FG000|Overall Study|Study Terminated by Sponsor|1|||
33462586|NCT04253236|101583290|FG001|Overall Study|Study Terminated by Sponsor|0|||
33462587|NCT03558139|101583292|FG000|Overall Study|Consent Withdrawn|1|||
33462588|NCT03558139|101583293|FG001|Overall Study|Consent Withdrawn|1|||
33462589|NCT03558139|101583294|FG002|Overall Study|Consent Withdrawn|4|||
33462590|NCT03558139|101583292|FG000|Overall Study|Death|5|||
33462591|NCT03558139|101583293|FG001|Overall Study|Death|3|||
33462592|NCT03558139|101583294|FG002|Overall Study|Death|8|||
33462593|NCT03558139|101583292|FG000|Overall Study|Lost to Follow-up|0|||
33462594|NCT03558139|101583293|FG001|Overall Study|Lost to Follow-up|0|||
33462595|NCT03558139|101583294|FG002|Overall Study|Lost to Follow-up|3|||
33462596|NCT03558139|101583292|FG000|Overall Study|Study Ended Per Protocol|0|||
33462597|NCT03558139|101583293|FG001|Overall Study|Study Ended Per Protocol|3|||
33462598|NCT03558139|101583294|FG002|Overall Study|Study Ended Per Protocol|6|||
33462599|NCT03078478|101583296|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
33462600|NCT03078478|101583297|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
33462601|NCT03078478|101583296|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
33462602|NCT03078478|101583297|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
33462603|NCT03078478|101583296|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
33462604|NCT03078478|101583297|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
33462605|NCT03078478|101583296|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
33462606|NCT03078478|101583297|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
33462607|NCT03078478|101583296|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
33462608|NCT03078478|101583297|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
33462609|NCT03078478|101583296|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
33462610|NCT03078478|101583297|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
33462611|NCT03078478|101583296|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
33462612|NCT03078478|101583297|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
33176299|NCT05286307|100552233|FG001|Overall Study|Incomplete outcome assessments|1|||
33176300|NCT05286307|100552232|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
33176301|NCT05286307|100552233|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
33176302|NCT05286307|100552232|FG000|Overall Study|Lost to follow up at 6 months|25|||
33176303|NCT05286307|100552233|FG001|Overall Study|Lost to follow up at 6 months|35|||
33176304|NCT05286307|100552232|FG000|Overall Study|Study medication not available|1|||
33176305|NCT05286307|100552233|FG001|Overall Study|Study medication not available|1|||
33176306|NCT02611778|100552238|FG000|Overall Study|Withdrawal by Subject|2|||
33462613|NCT03078478|101583296|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
33462614|NCT03078478|101583297|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
33462615|NCT00399893|101583309|FG000|Overall Study|Withdrawal by Subject|1|||
33462616|NCT00399893|101583310|FG001|Overall Study|Withdrawal by Subject|0|||
33462617|NCT00129116|101583311|FG000|Primary Phase|Lost to Follow-up|1|||
33462618|NCT00129116|101583312|FG001|Primary Phase|Lost to Follow-up|1|||
33462619|NCT00129116|101583313|FG002|Primary Phase|Lost to Follow-up|0|||
33176307|NCT02611778|100552239|FG001|Overall Study|Withdrawal by Subject|8|||
33176308|NCT02611778|100552238|FG000|Overall Study|Adverse Event|1|||
33462620|NCT00129116|101583314|FG003|Primary Phase|Lost to Follow-up|1|||
33462621|NCT00129116|101583315|FG004|Primary Phase|Lost to Follow-up|1|||
33462622|NCT00129116|101583311|FG000|Primary Phase|Protocol Violation|0|||
33462623|NCT00129116|101583312|FG001|Primary Phase|Protocol Violation|1|||
33462624|NCT00129116|101583313|FG002|Primary Phase|Protocol Violation|0|||
33462625|NCT00129116|101583314|FG003|Primary Phase|Protocol Violation|0|||
33462626|NCT00129116|101583315|FG004|Primary Phase|Protocol Violation|0|||
33462627|NCT00129116|101583311|FG000|Primary Phase|Adverse Event|1|||
33462628|NCT00129116|101583312|FG001|Primary Phase|Adverse Event|1|||
33462629|NCT00129116|101583313|FG002|Primary Phase|Adverse Event|0|||
33462630|NCT00129116|101583314|FG003|Primary Phase|Adverse Event|0|||
33462631|NCT00129116|101583315|FG004|Primary Phase|Adverse Event|0|||
33462632|NCT00129116|101583311|FG000|Primary Phase|Withdrawal by Subject|0|||
33462633|NCT00129116|101583312|FG001|Primary Phase|Withdrawal by Subject|1|||
33462634|NCT00129116|101583313|FG002|Primary Phase|Withdrawal by Subject|0|||
33462635|NCT00129116|101583314|FG003|Primary Phase|Withdrawal by Subject|0|||
33462636|NCT00129116|101583315|FG004|Primary Phase|Withdrawal by Subject|0|||
33462637|NCT00129116|101583311|FG000|Primary Phase|Other|0|||
33462638|NCT00129116|101583312|FG001|Primary Phase|Other|0|||
33462639|NCT00129116|101583313|FG002|Primary Phase|Other|1|||
33462640|NCT00129116|101583314|FG003|Primary Phase|Other|0|||
33462641|NCT00129116|101583315|FG004|Primary Phase|Other|0|||
33462642|NCT00129116|101583311|FG000|Booster Phase|Lost to Follow-up|2|||
33462643|NCT00129116|101583312|FG001|Booster Phase|Lost to Follow-up|0|||
33462644|NCT00129116|101583313|FG002|Booster Phase|Lost to Follow-up|0|||
33462645|NCT00129116|101583314|FG003|Booster Phase|Lost to Follow-up|0|||
33462646|NCT00129116|101583315|FG004|Booster Phase|Lost to Follow-up|1|||
33462647|NCT04832971|101583324|FG000|Overall Study|Death|1|||
33462648|NCT04832971|101583325|FG001|Overall Study|Death|0|||
33462649|NCT04832971|101583326|FG002|Overall Study|Death|0|||
33462650|NCT04832971|101583327|FG003|Overall Study|Death|0|||
33462651|NCT04832971|101583324|FG000|Overall Study|Lost to Follow-up|1|||
33462652|NCT04832971|101583325|FG001|Overall Study|Lost to Follow-up|1|||
33462653|NCT04832971|101583326|FG002|Overall Study|Lost to Follow-up|1|||
33462654|NCT04832971|101583327|FG003|Overall Study|Lost to Follow-up|0|||
33462655|NCT04832971|101583324|FG000|Overall Study|Withdrawal by Subject|1|||
33462656|NCT04832971|101583325|FG001|Overall Study|Withdrawal by Subject|3|||
33462657|NCT04832971|101583326|FG002|Overall Study|Withdrawal by Subject|2|||
33462658|NCT04832971|101583327|FG003|Overall Study|Withdrawal by Subject|2|||
33462659|NCT04832971|101583324|FG000|Overall Study|Other, Not Specified|0|||
33462660|NCT04832971|101583325|FG001|Overall Study|Other, Not Specified|0|||
33462661|NCT04832971|101583326|FG002|Overall Study|Other, Not Specified|1|||
33462662|NCT04832971|101583327|FG003|Overall Study|Other, Not Specified|0|||
33462663|NCT00529217|101583328|FG000|Overall Study|Lack of Efficacy|2|||
33462664|NCT00529217|101583328|FG000|Overall Study|Unable to adhere to study schedule|2|||
33462665|NCT01009515|101583329|FG000|Overall Study|Withdrawal by Subject|3|||
33462666|NCT01231373|101583330|FG000|Overall Study|Withdrew consent prior to randomization|2|||
33462667|NCT01231373|101583331|FG001|Overall Study|Withdrew consent prior to randomization|1|||
33462668|NCT01231373|101583332|FG002|Overall Study|Withdrew consent prior to randomization|0|||
33462669|NCT01231373|101583333|FG003|Overall Study|Withdrew consent prior to randomization|0|||
33462670|NCT01231373|101583330|FG000|Overall Study|Lost to Follow-up|0|||
33462671|NCT01231373|101583331|FG001|Overall Study|Lost to Follow-up|0|||
33462672|NCT01231373|101583332|FG002|Overall Study|Lost to Follow-up|0|||
33462673|NCT01231373|101583333|FG003|Overall Study|Lost to Follow-up|1|||
33462674|NCT01231373|101583330|FG000|Overall Study|Withdrew Consent|1|||
33462675|NCT01231373|101583331|FG001|Overall Study|Withdrew Consent|0|||
33462676|NCT01231373|101583332|FG002|Overall Study|Withdrew Consent|0|||
33462677|NCT01231373|101583333|FG003|Overall Study|Withdrew Consent|0|||
33462678|NCT00602537|101583338|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
33462679|NCT00602537|101583339|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
33263144|NCT02392234|100863859|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
33263145|NCT02392234|100863860|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
33263146|NCT02392234|100863855|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
33263147|NCT02392234|100863856|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
33263148|NCT02392234|100863857|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
33263149|NCT02392234|100863858|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
33263150|NCT02392234|100863859|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
33263151|NCT02392234|100863860|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
33263152|NCT02392234|100863855|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
33462680|NCT00602537|101583338|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
33462681|NCT00602537|101583339|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
33462682|NCT00602537|101583338|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
33462683|NCT00602537|101583339|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
33462684|NCT00602537|101583338|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
33263153|NCT02392234|100863856|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
33462685|NCT00602537|101583339|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
33462686|NCT00602537|101583338|FG000|Follow Up Study Comparison|Adverse Event|1|||
33462687|NCT00602537|101583339|FG001|Follow Up Study Comparison|Adverse Event|0|||
33462688|NCT00602537|101583338|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
33462689|NCT00602537|101583339|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
33462690|NCT00602537|101583338|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
33462691|NCT00602537|101583339|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
33462692|NCT00983476|101583340|FG000|Overall Study|Did not receive intervention|17|||
33462693|NCT00983476|101583341|FG001|Overall Study|Did not receive intervention|22|||
33462694|NCT00983476|101583342|FG002|Overall Study|Did not receive intervention|0|||
33462695|NCT00440115|101583343|FG000|Overall Study|Death|7|||
33462696|NCT00440115|101583344|FG001|Overall Study|Death|9|||
33462697|NCT00440115|101583345|FG002|Overall Study|Death|5|||
33462698|NCT00440115|101583343|FG000|Overall Study|Incarceration|0|||
33462699|NCT00440115|101583344|FG001|Overall Study|Incarceration|2|||
33462700|NCT00440115|101583345|FG002|Overall Study|Incarceration|1|||
33462701|NCT04823130|101583346|FG000|Overall Study|Withdrawal by Subject|2|||
33462702|NCT04823130|101583347|FG001|Overall Study|Withdrawal by Subject|3|||
33462703|NCT04823130|101583346|FG000|Overall Study|Failure to meet inclusion criteria|6|||
33462704|NCT04823130|101583347|FG001|Overall Study|Failure to meet inclusion criteria|4|||
33462705|NCT04823130|101583346|FG000|Overall Study|Other-unspecified|1|||
33462706|NCT04823130|101583347|FG001|Overall Study|Other-unspecified|0|||
33462707|NCT01867606|101583348|FG000|Overall Study|Withdrawal by Subject|10|||
33462708|NCT01867606|101583349|FG001|Overall Study|Withdrawal by Subject|14|||
33462709|NCT01867606|101583348|FG000|Overall Study|Protocol Violation|0|||
33462710|NCT01867606|101583349|FG001|Overall Study|Protocol Violation|1|||
33462711|NCT01439724|101583353|FG000|Overall Study|missing consultation|9|||
33462712|NCT01439724|101583354|FG001|Overall Study|missing consultation|8|||
33462713|NCT04211766|101583358|FG000|Overall Study|Withdrawal by Subject|5|||
33462714|NCT04211766|101583359|FG001|Overall Study|Withdrawal by Subject|1|||
33462715|NCT01876368|101583360|FG000|Overall Study|Adverse Event|2|||
33462716|NCT01876368|101583361|FG001|Overall Study|Adverse Event|5|||
33462717|NCT01876368|101583360|FG000|Overall Study|Lack of Efficacy|1|||
33462718|NCT01876368|101583361|FG001|Overall Study|Lack of Efficacy|0|||
33462719|NCT01876368|101583360|FG000|Overall Study|Lost to Follow-up|0|||
33462720|NCT01876368|101583361|FG001|Overall Study|Lost to Follow-up|1|||
33462721|NCT01876368|101583360|FG000|Overall Study|Non-compliance with study treatment|0|||
33462722|NCT01876368|101583361|FG001|Overall Study|Non-compliance with study treatment|1|||
33462723|NCT01876368|101583360|FG000|Overall Study|Physician Decision|0|||
33462724|NCT01876368|101583361|FG001|Overall Study|Physician Decision|2|||
33462725|NCT01876368|101583360|FG000|Overall Study|Protocol deviation|3|||
33462726|NCT01876368|101583361|FG001|Overall Study|Protocol deviation|3|||
33462727|NCT01876368|101583360|FG000|Overall Study|Subject/guardian decision|3|||
33462728|NCT01876368|101583361|FG001|Overall Study|Subject/guardian decision|1|||
33462729|NCT02293460|101583362|FG000|Overall Study|Protocol Violation|1|||
33462730|NCT02293460|101583362|FG000|Overall Study|Lack of Efficacy|2|||
33462731|NCT02293460|101583362|FG000|Overall Study|Adverse Event|2|||
33462732|NCT02293460|101583362|FG000|Overall Study|Withdrawal by Subject|1|||
33462733|NCT01999894|101583363|FG000|Overall Study|Adverse Event|9|||
33462734|NCT01999894|101583363|FG000|Overall Study|Lack of Efficacy|5|||
33462735|NCT01999894|101583363|FG000|Overall Study|Protocol Violation|1|||
33462736|NCT01999894|101583363|FG000|Overall Study|Withdrawal by Subject|7|||
33462737|NCT01999894|101583363|FG000|Overall Study|Lost to Follow-up|10|||
33462738|NCT01999894|101583363|FG000|Overall Study|Other Reason|3|||
33462739|NCT01999894|101583363|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
33462740|NCT00263887|101583374|FG000|Overall Study|Withdrawal by Subject|1|||
33462741|NCT00263887|101583375|FG001|Overall Study|Withdrawal by Subject|1|||
33462742|NCT00263887|101583374|FG000|Overall Study|Lung transplantation|1|||
33462743|NCT00263887|101583375|FG001|Overall Study|Lung transplantation|2|||
33462744|NCT00263887|101583374|FG000|Overall Study|Too ill to attend visit|1|||
33462745|NCT00263887|101583375|FG001|Overall Study|Too ill to attend visit|0|||
33462746|NCT00263887|101583374|FG000|Overall Study|Adverse Event|0|||
33462747|NCT00263887|101583375|FG001|Overall Study|Adverse Event|2|||
33462748|NCT00263887|101583374|FG000|Overall Study|Disease progression|0|||
33462749|NCT00263887|101583375|FG001|Overall Study|Disease progression|1|||
33462750|NCT00263887|101583374|FG000|Overall Study|Lack of Efficacy|0|||
33462751|NCT00263887|101583375|FG001|Overall Study|Lack of Efficacy|1|||
33462752|NCT04406194|101583381|FG000|Period 1|Withdrawal by Subject|0|||
33462753|NCT04406194|101583382|FG001|Period 1|Withdrawal by Subject|1|||
33462754|NCT03635983|101583383|FG000|Pre-Treatment Period|Not yet treated at the time of database lock|1|||
33462755|NCT03635983|101583384|FG001|Pre-Treatment Period|Not yet treated at the time of database lock|0|||
33462756|NCT03635983|101583383|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
33462757|NCT03635983|101583384|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
33462758|NCT03635983|101583383|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
33462759|NCT03635983|101583384|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
33462760|NCT03635983|101583383|FG000|Pre-Treatment Period|Other reasons|1|||
33462761|NCT03635983|101583384|FG001|Pre-Treatment Period|Other reasons|2|||
33462762|NCT03635983|101583383|FG000|Pre-Treatment Period|Disease Progression|0|||
33462763|NCT03635983|101583384|FG001|Pre-Treatment Period|Disease Progression|1|||
33462764|NCT03635983|101583383|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
33462765|NCT03635983|101583384|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|0|||
33462766|NCT03635983|101583383|FG000|Treatment Period|Completed treatment period|13|||
33462767|NCT03635983|101583384|FG001|Treatment Period|Completed treatment period|20|||
33462768|NCT03635983|101583383|FG000|Treatment Period|Participant request to discontinue Study treatment|5|||
33462769|NCT03635983|101583384|FG001|Treatment Period|Participant request to discontinue Study treatment|5|||
33462770|NCT03635983|101583383|FG000|Treatment Period|Withdrawal by Subject|2|||
33462771|NCT03635983|101583384|FG001|Treatment Period|Withdrawal by Subject|4|||
33462772|NCT03635983|101583383|FG000|Treatment Period|Death|3|||
33462773|NCT03635983|101583384|FG001|Treatment Period|Death|4|||
33462774|NCT03635983|101583383|FG000|Treatment Period|Poor/Non-compliance|1|||
33462775|NCT03635983|101583384|FG001|Treatment Period|Poor/Non-compliance|0|||
33462776|NCT03635983|101583383|FG000|Treatment Period|Participant no longer meets Study criteria|0|||
33462777|NCT03635983|101583384|FG001|Treatment Period|Participant no longer meets Study criteria|2|||
33462778|NCT03635983|101583383|FG000|Treatment Period|Other reasons|5|||
33462779|NCT03635983|101583384|FG001|Treatment Period|Other reasons|2|||
33462780|NCT03635983|101583383|FG000|Treatment Period|Disease progression|184|||
33462781|NCT03635983|101583384|FG001|Treatment Period|Disease progression|168|||
33462782|NCT03635983|101583383|FG000|Treatment Period|Study drug toxicity|26|||
33462783|NCT03635983|101583384|FG001|Treatment Period|Study drug toxicity|29|||
33462784|NCT03635983|101583383|FG000|Treatment Period|Adverse event unrelated to Study drug|10|||
33462785|NCT03635983|101583384|FG001|Treatment Period|Adverse event unrelated to Study drug|11|||
33462786|NCT03635983|101583383|FG000|Treatment Period|Maximum clinical benefit|3|||
33462787|NCT03635983|101583384|FG001|Treatment Period|Maximum clinical benefit|2|||
33462788|NCT03941834|101583392|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
33462789|NCT03941834|101583393|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
33462790|NCT03941834|101583394|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
33462791|NCT03941834|101583392|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
33462792|NCT03941834|101583393|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
33462793|NCT03941834|101583394|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
33462794|NCT03941834|101583392|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
33462795|NCT03941834|101583393|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
33462796|NCT03941834|101583394|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
33462797|NCT03941834|101583392|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
33462798|NCT03941834|101583393|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
33462799|NCT03941834|101583394|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
33462800|NCT03941834|101583392|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
33462801|NCT03941834|101583393|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
33462802|NCT03941834|101583394|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
33462803|NCT03941834|101583392|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
33462804|NCT03941834|101583393|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
33462805|NCT03941834|101583394|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
33462806|NCT02148445|101583399|FG000|Overall Study|Death|1|||
33462807|NCT02148445|101583400|FG001|Overall Study|Death|3|||
33462808|NCT00545688|101583401|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
33462809|NCT00545688|101583402|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
33462810|NCT00545688|101583403|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
33462811|NCT00545688|101583404|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
33462812|NCT00545688|101583401|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
33462813|NCT00545688|101583402|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
33462814|NCT00545688|101583403|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
33462815|NCT00545688|101583404|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
33462816|NCT00545688|101583401|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
33462817|NCT00545688|101583402|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
33462818|NCT00545688|101583403|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
33462819|NCT00545688|101583404|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
33462820|NCT00545688|101583401|FG000|Neo-Adjuvant Treatment Period|Death|0|||
33462821|NCT00545688|101583402|FG001|Neo-Adjuvant Treatment Period|Death|1|||
33462822|NCT00545688|101583403|FG002|Neo-Adjuvant Treatment Period|Death|0|||
33462823|NCT00545688|101583404|FG003|Neo-Adjuvant Treatment Period|Death|0|||
33462824|NCT00545688|101583401|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
33462825|NCT00545688|101583402|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
33462826|NCT00545688|101583403|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
33462827|NCT00545688|101583404|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
33462828|NCT00545688|101583401|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
33462829|NCT00545688|101583402|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
33462830|NCT00545688|101583403|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
33462831|NCT00545688|101583404|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
33462832|NCT00545688|101583401|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
33462833|NCT00545688|101583402|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
33462834|NCT00545688|101583403|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
33462835|NCT00545688|101583404|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
33462836|NCT00545688|101583401|FG000|Adjuvant Treatment Period|Disease Progression|3|||
33462837|NCT00545688|101583402|FG001|Adjuvant Treatment Period|Disease Progression|3|||
33462838|NCT00545688|101583403|FG002|Adjuvant Treatment Period|Disease Progression|0|||
33462839|NCT00545688|101583404|FG003|Adjuvant Treatment Period|Disease Progression|7|||
33462840|NCT00545688|101583401|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
33462841|NCT00545688|101583402|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
33462842|NCT00545688|101583403|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
33462843|NCT00545688|101583404|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
33462844|NCT00545688|101583401|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
33462845|NCT00545688|101583402|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
33462846|NCT00545688|101583403|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
33462847|NCT00545688|101583404|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
33462848|NCT00545688|101583401|FG000|Adjuvant Treatment Period|Adverse Event|0|||
33462849|NCT00545688|101583402|FG001|Adjuvant Treatment Period|Adverse Event|3|||
33462850|NCT00545688|101583403|FG002|Adjuvant Treatment Period|Adverse Event|2|||
33462851|NCT00545688|101583404|FG003|Adjuvant Treatment Period|Adverse Event|2|||
33462852|NCT00545688|101583401|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
33462853|NCT00545688|101583402|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
33462854|NCT00545688|101583403|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
33462855|NCT00545688|101583404|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
33462856|NCT00545688|101583401|FG000|Follow-Up Period|Death|4|||
33462857|NCT00545688|101583402|FG001|Follow-Up Period|Death|2|||
33462858|NCT00545688|101583403|FG002|Follow-Up Period|Death|2|||
33462859|NCT00545688|101583404|FG003|Follow-Up Period|Death|6|||
33462860|NCT00545688|101583401|FG000|Follow-Up Period|Disease Progression|6|||
33462861|NCT00545688|101583402|FG001|Follow-Up Period|Disease Progression|5|||
33462862|NCT00545688|101583403|FG002|Follow-Up Period|Disease Progression|9|||
33462863|NCT00545688|101583404|FG003|Follow-Up Period|Disease Progression|9|||
33462864|NCT00545688|101583401|FG000|Follow-Up Period|Refused Treatment|6|||
33462865|NCT00545688|101583402|FG001|Follow-Up Period|Refused Treatment|2|||
33462866|NCT00545688|101583403|FG002|Follow-Up Period|Refused Treatment|0|||
33462867|NCT00545688|101583404|FG003|Follow-Up Period|Refused Treatment|2|||
33462868|NCT00545688|101583401|FG000|Follow-Up Period|Lost to Follow-up|3|||
33462869|NCT00545688|101583402|FG001|Follow-Up Period|Lost to Follow-up|3|||
33462870|NCT00545688|101583403|FG002|Follow-Up Period|Lost to Follow-up|3|||
33462871|NCT00545688|101583404|FG003|Follow-Up Period|Lost to Follow-up|1|||
33462872|NCT00545688|101583401|FG000|Follow-Up Period|Unspecified Reason|2|||
33462873|NCT00545688|101583402|FG001|Follow-Up Period|Unspecified Reason|5|||
33462874|NCT00545688|101583403|FG002|Follow-Up Period|Unspecified Reason|6|||
33462875|NCT00545688|101583404|FG003|Follow-Up Period|Unspecified Reason|8|||
33462876|NCT00545688|101583401|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
33462877|NCT00545688|101583402|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
33462878|NCT00545688|101583403|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
33462879|NCT00545688|101583404|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
33462880|NCT03139240|101583407|FG000|Overall Study|Lost to Follow-up|0|||
33462881|NCT03139240|101583408|FG001|Overall Study|Lost to Follow-up|1|||
33462882|NCT03139240|101583409|FG002|Overall Study|Lost to Follow-up|1|||
33462883|NCT03139240|101583410|FG003|Overall Study|Lost to Follow-up|0|||
33462884|NCT00830167|101583411|FG000|Overall Study|Lack of Efficacy|26|||
33462885|NCT00830167|101583412|FG001|Overall Study|Lack of Efficacy|10|||
33462886|NCT00830167|101583411|FG000|Overall Study|Adverse Event|8|||
33462887|NCT00830167|101583412|FG001|Overall Study|Adverse Event|24|||
33462888|NCT00830167|101583411|FG000|Overall Study|Not meeting entrance criteria|2|||
33462889|NCT00830167|101583412|FG001|Overall Study|Not meeting entrance criteria|5|||
33462890|NCT00830167|101583411|FG000|Overall Study|Withdrawal by Subject|2|||
33462891|NCT00830167|101583412|FG001|Overall Study|Withdrawal by Subject|0|||
33462892|NCT00830167|101583411|FG000|Overall Study|Lost to Follow-up|0|||
33462893|NCT00830167|101583412|FG001|Overall Study|Lost to Follow-up|1|||
33462894|NCT00830167|101583411|FG000|Overall Study|Protocol Violation|0|||
33462895|NCT00830167|101583412|FG001|Overall Study|Protocol Violation|1|||
33462896|NCT00830167|101583411|FG000|Overall Study|Other|2|||
33462897|NCT00830167|101583412|FG001|Overall Study|Other|2|||
33462898|NCT02056652|101583420|FG000|Overall Study|Withdrawal by Subject|1|||
33462899|NCT02056652|101583421|FG001|Overall Study|Withdrawal by Subject|0|||
33462900|NCT02056652|101583420|FG000|Overall Study|Lost to Follow-up|0|||
33462901|NCT02056652|101583421|FG001|Overall Study|Lost to Follow-up|3|||
33462902|NCT02063217|101583422|FG000|Overall Study|Withdrawal by Subject|1|||
33462903|NCT02063217|101583423|FG001|Overall Study|Withdrawal by Subject|0|||
33462904|NCT02063217|101583424|FG002|Overall Study|Withdrawal by Subject|0|||
33462905|NCT02462486|101583425|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
33462906|NCT02462486|101583426|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
33462907|NCT02462486|101583427|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
33462908|NCT02462486|101583425|FG000|Overall Study|Adverse Event|53|||
33462909|NCT02462486|101583426|FG001|Overall Study|Adverse Event|48|||
33462910|NCT02462486|101583427|FG002|Overall Study|Adverse Event|21|||
33462911|NCT02462486|101583425|FG000|Overall Study|Lack of Efficacy|6|||
33462912|NCT02462486|101583426|FG001|Overall Study|Lack of Efficacy|12|||
33462913|NCT02462486|101583427|FG002|Overall Study|Lack of Efficacy|3|||
33462914|NCT02462486|101583425|FG000|Overall Study|Lost to Follow-up|3|||
33462915|NCT02462486|101583426|FG001|Overall Study|Lost to Follow-up|4|||
33462916|NCT02462486|101583427|FG002|Overall Study|Lost to Follow-up|2|||
33462917|NCT02462486|101583425|FG000|Overall Study|Withdrawal by Subject|25|||
33462918|NCT02462486|101583426|FG001|Overall Study|Withdrawal by Subject|22|||
33462919|NCT02462486|101583427|FG002|Overall Study|Withdrawal by Subject|19|||
33462920|NCT02462486|101583425|FG000|Overall Study|Protocol Violation|3|||
33462921|NCT02462486|101583426|FG001|Overall Study|Protocol Violation|1|||
33462922|NCT02462486|101583427|FG002|Overall Study|Protocol Violation|1|||
33462923|NCT02462486|101583425|FG000|Overall Study|Reason not Specified|3|||
33462924|NCT02462486|101583426|FG001|Overall Study|Reason not Specified|4|||
33462925|NCT02462486|101583427|FG002|Overall Study|Reason not Specified|3|||
33462926|NCT02722616|101583432|FG000|Overall Study|Sponsor closed study after one month|2|||
33462927|NCT02722616|101583433|FG001|Overall Study|Sponsor closed study after one month|0|||
33462928|NCT02722616|101583434|FG002|Overall Study|Sponsor closed study after one month|0|||
33462929|NCT02618382|101583441|FG000|Overall Study|Physician Decision|1|||
33462930|NCT02618382|101583441|FG000|Overall Study|Withdrawal by Subject|1|||
33462931|NCT02618382|101583441|FG000|Overall Study|Protocol Violation|1|||
33462932|NCT00109850|101583458|FG000|Overall Study|Adverse Event|1|||
33462933|NCT00109850|101583458|FG000|Overall Study|Death|2|||
33462934|NCT00109850|101583458|FG000|Overall Study|Ineligible|1|||
33462935|NCT00587431|101583459|FG000|Overall Study|Adverse Event|1|||
33462936|NCT00587431|101583460|FG001|Overall Study|Adverse Event|0|||
33462937|NCT00587431|101583459|FG000|Overall Study|Withdrawal by Subject|0|||
33462938|NCT00587431|101583460|FG001|Overall Study|Withdrawal by Subject|1|||
33462939|NCT00732160|101583461|FG000|Overall Study|Adverse Event|1|||
33462940|NCT00732160|101583462|FG001|Overall Study|Adverse Event|0|||
33462941|NCT00732160|101583463|FG002|Overall Study|Adverse Event|1|||
33462942|NCT00732160|101583464|FG003|Overall Study|Adverse Event|1|||
33462943|NCT00732160|101583461|FG000|Overall Study|scheduling|4|||
33462944|NCT00732160|101583462|FG001|Overall Study|scheduling|4|||
33462945|NCT00732160|101583463|FG002|Overall Study|scheduling|2|||
33462946|NCT00732160|101583464|FG003|Overall Study|scheduling|1|||
33462947|NCT02447887|101583467|FG000|Overall Study|Study was terminated|3|||
33462948|NCT00179673|101583476|FG000|Overall Study|Adverse Event|7|||
33462949|NCT00179673|101583476|FG000|Overall Study|Lack of Efficacy|15|||
33462950|NCT00179673|101583476|FG000|Overall Study|Withdrawal by Subject|3|||
33462951|NCT00179673|101583476|FG000|Overall Study|Death|4|||
33462952|NCT00179673|101583476|FG000|Overall Study|Other Observations and options|14|||
33462953|NCT02805309|101583477|FG000|Overall Study|Lost to Follow-up|2|||
33462954|NCT02805309|101583478|FG001|Overall Study|Lost to Follow-up|2|||
33462955|NCT02805309|101583479|FG002|Overall Study|Lost to Follow-up|2|||
33462956|NCT02805309|101583477|FG000|Overall Study|Post-Randomization Exclusion|0|||
33462957|NCT02805309|101583478|FG001|Overall Study|Post-Randomization Exclusion|2|||
33462958|NCT02805309|101583479|FG002|Overall Study|Post-Randomization Exclusion|1|||
33462959|NCT01040793|101583480|FG000|Overall Study|Adverse Event|5|||
33462960|NCT01040793|101583481|FG001|Overall Study|Adverse Event|3|||
33462961|NCT01040793|101583482|FG002|Overall Study|Adverse Event|0|||
33462962|NCT01040793|101583483|FG003|Overall Study|Adverse Event|2|||
33462963|NCT01040793|101583484|FG004|Overall Study|Adverse Event|2|||
33462964|NCT01040793|101583485|FG005|Overall Study|Adverse Event|1|||
33462965|NCT01040793|101583480|FG000|Overall Study|Protocol Violation|1|||
33462966|NCT01040793|101583481|FG001|Overall Study|Protocol Violation|1|||
33462967|NCT01040793|101583482|FG002|Overall Study|Protocol Violation|1|||
33462968|NCT01040793|101583483|FG003|Overall Study|Protocol Violation|0|||
33462969|NCT01040793|101583484|FG004|Overall Study|Protocol Violation|1|||
33462970|NCT01040793|101583485|FG005|Overall Study|Protocol Violation|0|||
33462971|NCT01040793|101583480|FG000|Overall Study|Lost to Follow-up|0|||
33462972|NCT01040793|101583481|FG001|Overall Study|Lost to Follow-up|1|||
33462973|NCT01040793|101583482|FG002|Overall Study|Lost to Follow-up|1|||
33462974|NCT01040793|101583483|FG003|Overall Study|Lost to Follow-up|0|||
33462975|NCT01040793|101583484|FG004|Overall Study|Lost to Follow-up|0|||
33462976|NCT01040793|101583485|FG005|Overall Study|Lost to Follow-up|0|||
33462977|NCT01040793|101583480|FG000|Overall Study|Withdrawal by Subject|0|||
33462978|NCT01040793|101583481|FG001|Overall Study|Withdrawal by Subject|0|||
33462979|NCT01040793|101583482|FG002|Overall Study|Withdrawal by Subject|0|||
33462980|NCT01040793|101583483|FG003|Overall Study|Withdrawal by Subject|2|||
33462981|NCT01040793|101583484|FG004|Overall Study|Withdrawal by Subject|0|||
33176309|NCT02611778|100552239|FG001|Overall Study|Adverse Event|2|||
33462982|NCT01040793|101583485|FG005|Overall Study|Withdrawal by Subject|0|||
33462983|NCT01040793|101583480|FG000|Overall Study|Other reasons not listed above|0|||
33462984|NCT01040793|101583481|FG001|Overall Study|Other reasons not listed above|0|||
33462985|NCT01040793|101583482|FG002|Overall Study|Other reasons not listed above|1|||
33462986|NCT01040793|101583483|FG003|Overall Study|Other reasons not listed above|0|||
33462987|NCT01040793|101583484|FG004|Overall Study|Other reasons not listed above|1|||
33462988|NCT01040793|101583485|FG005|Overall Study|Other reasons not listed above|0|||
33462989|NCT04979858|101583486|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
33462990|NCT04979858|101583487|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
33462991|NCT02310763|101583488|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
33462992|NCT02310763|101583489|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
33462993|NCT02310763|101583490|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
33462994|NCT02310763|101583488|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
33462995|NCT02310763|101583489|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
33462996|NCT02310763|101583490|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
33462997|NCT02310763|101583488|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
33462998|NCT02310763|101583489|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
33462999|NCT02310763|101583490|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
33463000|NCT02310763|101583488|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
33463001|NCT02310763|101583489|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
33463002|NCT02310763|101583490|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
33463003|NCT02310763|101583488|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
33463004|NCT02310763|101583489|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
33463005|NCT02310763|101583490|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
33463006|NCT01142661|101583491|FG000|Overall Study|Adverse Event|2|||
33463007|NCT01142661|101583491|FG000|Overall Study|Withdrawal by Subject|1|||
33463008|NCT01142661|101583491|FG000|Overall Study|Physician Decision|1|||
33463009|NCT02094261|101583495|FG000|Overall Study|Death|24|||
33463010|NCT02094261|101583495|FG000|Overall Study|Lost to Follow-up|1|||
33463011|NCT02094261|101583495|FG000|Overall Study|Withdrawal by Subject|4|||
33463012|NCT02094261|101583495|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
33463013|NCT04100096|101583496|FG000|Overall Study|Adverse Event|19|||
33463014|NCT04100096|101583497|FG001|Overall Study|Adverse Event|7|||
33463015|NCT04100096|101583496|FG000|Overall Study|Lack of Efficacy|0|||
33463016|NCT04100096|101583497|FG001|Overall Study|Lack of Efficacy|1|||
33463017|NCT04100096|101583496|FG000|Overall Study|Lost to Follow-up|13|||
33463018|NCT04100096|101583497|FG001|Overall Study|Lost to Follow-up|11|||
33463019|NCT04100096|101583496|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33463020|NCT04100096|101583497|FG001|Overall Study|Non-Compliance With Study Drug|3|||
33463021|NCT04100096|101583496|FG000|Overall Study|Protocol Deviation|1|||
33463022|NCT04100096|101583497|FG001|Overall Study|Protocol Deviation|1|||
33463023|NCT04100096|101583496|FG000|Overall Study|Withdrawal by Participant|13|||
33463024|NCT04100096|101583497|FG001|Overall Study|Withdrawal by Participant|15|||
33463025|NCT04264819|101583500|FG000|Overall Study|Physician Decision|19|||
33463026|NCT04264819|101583500|FG000|Overall Study|Adverse Event|12|||
33463027|NCT04264819|101583500|FG000|Overall Study|Withdrawal by Subject|11|||
33463028|NCT04264819|101583500|FG000|Overall Study|Lost to Follow-up|2|||
33463029|NCT04264819|101583500|FG000|Overall Study|Death|2|||
33463030|NCT03554317|101583501|FG000|Overall Study|Withdrawal by Subject|1|||
33463031|NCT03554317|101583501|FG000|Overall Study|PSA Progression|3|||
33463032|NCT03554317|101583501|FG000|Overall Study|Radiographic Progression|4|||
33463033|NCT00927251|101583502|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
33463034|NCT00460109|101583503|FG000|Overall Study|Death|1|||
33463035|NCT04980456|101583504|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
33463036|NCT04980456|101583505|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
33463037|NCT04980456|101583504|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
33463038|NCT04980456|101583505|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
33463039|NCT04980456|101583504|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
33463040|NCT04980456|101583505|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
33463041|NCT04980456|101583504|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
33463042|NCT04980456|101583505|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
33463043|NCT00089076|101583506|FG000|Overall Study|Alternate Therapy|1|||
33463044|NCT00089076|101583506|FG000|Overall Study|Withdrawal by Subject|2|||
33176310|NCT02611778|100552238|FG000|Overall Study|Death|2|||
33176311|NCT02611778|100552239|FG001|Overall Study|Death|1|||
33176312|NCT02611778|100552238|FG000|Overall Study|Protocol Violation|1|||
33176313|NCT02611778|100552239|FG001|Overall Study|Protocol Violation|0|||
33463045|NCT00089076|101583506|FG000|Overall Study|Progression|7|||
33463046|NCT00500318|101583516|FG000|Overall Study|Adverse Event|3|||
33463047|NCT00500318|101583517|FG001|Overall Study|Adverse Event|8|||
33463048|NCT00500318|101583516|FG000|Overall Study|Protocol Violation|1|||
33463049|NCT00500318|101583517|FG001|Overall Study|Protocol Violation|3|||
33463050|NCT00500318|101583516|FG000|Overall Study|Withdrawal by Subject|1|||
33176314|NCT02611778|100552238|FG000|Overall Study|Lost to Follow-up|3|||
33176315|NCT02611778|100552239|FG001|Overall Study|Lost to Follow-up|1|||
33463051|NCT00500318|101583517|FG001|Overall Study|Withdrawal by Subject|2|||
33463052|NCT00500318|101583516|FG000|Overall Study|Lack of Efficacy|0|||
33463053|NCT00500318|101583517|FG001|Overall Study|Lack of Efficacy|3|||
33463054|NCT00500318|101583516|FG000|Overall Study|Other Reason|0|||
33463055|NCT00500318|101583517|FG001|Overall Study|Other Reason|1|||
33463056|NCT02998541|101583520|FG000|Overall Study|Adverse Event|4|||
33463057|NCT02998541|101583521|FG001|Overall Study|Adverse Event|5|||
33463058|NCT02998541|101583522|FG002|Overall Study|Adverse Event|1|||
33463059|NCT02998541|101583520|FG000|Overall Study|Protocol Violation|1|||
33463060|NCT02998541|101583521|FG001|Overall Study|Protocol Violation|0|||
33463061|NCT02998541|101583522|FG002|Overall Study|Protocol Violation|0|||
33463062|NCT02998541|101583520|FG000|Overall Study|Withdrawal by Subject|3|||
33463063|NCT02998541|101583521|FG001|Overall Study|Withdrawal by Subject|1|||
33463064|NCT02998541|101583522|FG002|Overall Study|Withdrawal by Subject|0|||
33463065|NCT02998541|101583520|FG000|Overall Study|Lost to Follow-up|0|||
33463066|NCT02998541|101583521|FG001|Overall Study|Lost to Follow-up|3|||
33463067|NCT02998541|101583522|FG002|Overall Study|Lost to Follow-up|1|||
33463068|NCT02998541|101583520|FG000|Overall Study|Physician Decision|0|||
33463069|NCT02998541|101583521|FG001|Overall Study|Physician Decision|0|||
33463070|NCT02998541|101583522|FG002|Overall Study|Physician Decision|3|||
33463071|NCT02998541|101583520|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33463072|NCT02998541|101583521|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
33463073|NCT02998541|101583522|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
33463074|NCT02820740|101583523|FG000|Overall Study|Did not have procedure|2|||
33463075|NCT00183196|101583524|FG000|Overall Study|Withdrawal by Subject|18|||
33463076|NCT00183196|101583525|FG001|Overall Study|Withdrawal by Subject|11|||
33463077|NCT00183196|101583526|FG002|Overall Study|Withdrawal by Subject|13|||
33463078|NCT00183196|101583524|FG000|Overall Study|Adverse Event|1|||
33463079|NCT00183196|101583525|FG001|Overall Study|Adverse Event|2|||
33463080|NCT00183196|101583526|FG002|Overall Study|Adverse Event|2|||
33463081|NCT00183196|101583524|FG000|Overall Study|Legal event|1|||
33463082|NCT00183196|101583525|FG001|Overall Study|Legal event|1|||
33463083|NCT00183196|101583526|FG002|Overall Study|Legal event|1|||
33463084|NCT00183196|101583524|FG000|Overall Study|Required more intensive care|0|||
33463085|NCT00183196|101583525|FG001|Overall Study|Required more intensive care|1|||
33463086|NCT00183196|101583526|FG002|Overall Study|Required more intensive care|2|||
33463087|NCT01848210|101583528|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
33463088|NCT01848210|101583529|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
33463089|NCT01848210|101583528|FG000|Overall Study|Lost to Follow-up|24|||
33463090|NCT01848210|101583529|FG001|Overall Study|Lost to Follow-up|12|||
33463091|NCT01848210|101583528|FG000|Overall Study|Protocol Violation|3|||
33463092|NCT01848210|101583529|FG001|Overall Study|Protocol Violation|5|||
33463093|NCT01848210|101583528|FG000|Overall Study|Use of Forbidden Drugs|9|||
33463094|NCT01848210|101583529|FG001|Overall Study|Use of Forbidden Drugs|10|||
33463095|NCT01848210|101583528|FG000|Overall Study|Impedition Condition|5|||
33463096|NCT01848210|101583529|FG001|Overall Study|Impedition Condition|9|||
33463097|NCT01848210|101583528|FG000|Overall Study|Adverse Event|7|||
33463098|NCT01848210|101583529|FG001|Overall Study|Adverse Event|9|||
33463099|NCT01848210|101583528|FG000|Overall Study|Discontinuation Criterion|5|||
33463100|NCT01848210|101583529|FG001|Overall Study|Discontinuation Criterion|7|||
33463101|NCT01848210|101583528|FG000|Overall Study|Hypesensitivity|1|||
33463102|NCT01848210|101583529|FG001|Overall Study|Hypesensitivity|0|||
33463103|NCT01848210|101583528|FG000|Overall Study|Hepatic Function Alteration|4|||
33463104|NCT01848210|101583529|FG001|Overall Study|Hepatic Function Alteration|0|||
33463105|NCT01848210|101583528|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
33463106|NCT01848210|101583529|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
33463107|NCT01848210|101583528|FG000|Overall Study|Administrative|1|||
33463108|NCT01848210|101583529|FG001|Overall Study|Administrative|0|||
33463109|NCT00575380|101583530|FG000|Overall Study|Withdrawal by Subject|1|||
33463110|NCT00575380|101583531|FG001|Overall Study|Withdrawal by Subject|0|||
33463111|NCT00575380|101583530|FG000|Overall Study|Adverse Event|0|||
33463112|NCT00575380|101583531|FG001|Overall Study|Adverse Event|1|||
33463113|NCT00575380|101583530|FG000|Overall Study|Various|0|||
33463114|NCT00575380|101583531|FG001|Overall Study|Various|2|||
33463115|NCT01923311|101583532|FG000|Overall Study|Pregnancy|1|||
33463116|NCT01923311|101583533|FG001|Overall Study|Pregnancy|0|||
33463117|NCT01923311|101583532|FG000|Overall Study|Investigator's Discretion|1|||
33463118|NCT01923311|101583533|FG001|Overall Study|Investigator's Discretion|0|||
33463119|NCT01923311|101583532|FG000|Overall Study|Non-Compliance with Study Drug|2|||
33463120|NCT01923311|101583533|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33463121|NCT01923311|101583532|FG000|Overall Study|Withdrew Consent|1|||
33463122|NCT01923311|101583533|FG001|Overall Study|Withdrew Consent|0|||
33463123|NCT01923311|101583532|FG000|Overall Study|Study Terminated by Sponsor|12|||
33463124|NCT01923311|101583533|FG001|Overall Study|Study Terminated by Sponsor|0|||
33463125|NCT02426541|101583534|FG000|Overall Study|Protocol Violation|1|||
33463126|NCT02426541|101583535|FG001|Overall Study|Protocol Violation|0|||
33463127|NCT04291508|101583542|FG000|Overall Study|Withdrawal by Subject|1|||
33463128|NCT04291508|101583543|FG001|Overall Study|Withdrawal by Subject|0|||
33176316|NCT02611778|100552238|FG000|Overall Study|Need for alternative treatment|1|||
33176317|NCT02611778|100552239|FG001|Overall Study|Need for alternative treatment|0|||
33176318|NCT02611778|100552238|FG000|Overall Study|Other Reason|2|||
33176319|NCT02611778|100552239|FG001|Overall Study|Other Reason|1|||
33176320|NCT00056407|100552240|FG000|Overall Study|Adverse Event|282|||
33176321|NCT00056407|100552241|FG001|Overall Study|Adverse Event|364|||
33176322|NCT00056407|100552240|FG000|Overall Study|Withdrawal by Subject|377|||
33176323|NCT00056407|100552241|FG001|Overall Study|Withdrawal by Subject|361|||
33176324|NCT00056407|100552240|FG000|Overall Study|Lost to Follow-up|123|||
33176325|NCT00056407|100552241|FG001|Overall Study|Lost to Follow-up|113|||
33263154|NCT02392234|100863857|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
33463129|NCT04291508|101583544|FG002|Overall Study|Withdrawal by Subject|1|||
33463130|NCT04291508|101583545|FG003|Overall Study|Withdrawal by Subject|0|||
33463131|NCT04291508|101583542|FG000|Overall Study|lost to follow up|4|||
33463132|NCT04291508|101583543|FG001|Overall Study|lost to follow up|0|||
33463133|NCT04291508|101583544|FG002|Overall Study|lost to follow up|1|||
33463134|NCT04291508|101583545|FG003|Overall Study|lost to follow up|0|||
33463135|NCT00979212|101583546|FG000|Overall Study|Protocol Violation|1|||
33463136|NCT00979212|101583547|FG001|Overall Study|Protocol Violation|8|||
33463137|NCT00979212|101583546|FG000|Overall Study|No protocol therapy received|1|||
33463138|NCT00979212|101583547|FG001|Overall Study|No protocol therapy received|0|||
33176326|NCT00056407|100552240|FG000|Overall Study|Protocol Violation|104|||
33176327|NCT00056407|100552241|FG001|Overall Study|Protocol Violation|95|||
33176328|NCT00056407|100552240|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
33176329|NCT00056407|100552241|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
33176330|NCT00056407|100552240|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
33176331|NCT00056407|100552241|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
33176332|NCT00056407|100552240|FG000|Overall Study|Missing|25|||
33176333|NCT00056407|100552241|FG001|Overall Study|Missing|34|||
33176334|NCT02485301|100552242|FG000|Overall Study|Serious Adverse Events|2|||
33463139|NCT02756637|101583549|FG000|Overall Study|Not eligible for initial SWOG study|10|||
33463140|NCT02756637|101583550|FG001|Overall Study|Not eligible for initial SWOG study|10|||
33463141|NCT02756637|101583549|FG000|Overall Study|No available NLR value|44|||
33176335|NCT02485301|100552243|FG001|Overall Study|Serious Adverse Events|1|||
33176336|NCT02485301|100552242|FG000|Overall Study|Protocol Violation|0|||
33176337|NCT02485301|100552243|FG001|Overall Study|Protocol Violation|1|||
33176338|NCT02485301|100552242|FG000|Overall Study|Withdrawal by Subject|6|||
33176339|NCT02485301|100552243|FG001|Overall Study|Withdrawal by Subject|7|||
33176340|NCT02485301|100552242|FG000|Overall Study|Migrated/moved from study area|10|||
33176341|NCT02485301|100552243|FG001|Overall Study|Migrated/moved from study area|19|||
33176342|NCT02485301|100552242|FG000|Overall Study|Lost to Follow-up|17|||
33176343|NCT02485301|100552243|FG001|Overall Study|Lost to Follow-up|17|||
33176344|NCT02485301|100552242|FG000|Overall Study|Other|3|||
33176345|NCT02485301|100552243|FG001|Overall Study|Other|4|||
33176346|NCT01361464|100552244|FG000|Overall Study|Death|1|||
33176347|NCT01361464|100552244|FG000|Overall Study|Withdrawal by Subject|2|||
33176348|NCT00969150|100556051|FG000|Overall Study|Adverse Event|4|||
33463142|NCT02756637|101583550|FG001|Overall Study|No available NLR value|44|||
33463143|NCT02756637|101583549|FG000|Overall Study|Did not complete curative therapy|33|||
33463144|NCT02756637|101583550|FG001|Overall Study|Did not complete curative therapy|0|||
33463145|NCT03689894|101583553|FG000|Overall Study|Adverse Event|1|||
33176349|NCT00969150|100556052|FG001|Overall Study|Adverse Event|14|||
33176350|NCT00969150|100556051|FG000|Overall Study|Lack of Efficacy|1|||
33176351|NCT00969150|100556052|FG001|Overall Study|Lack of Efficacy|1|||
33176352|NCT00969150|100556051|FG000|Overall Study|Protocol Violation|9|||
33176353|NCT00969150|100556052|FG001|Overall Study|Protocol Violation|12|||
33176354|NCT00969150|100556051|FG000|Overall Study|Withdrawal by Subject|13|||
33176355|NCT00969150|100556052|FG001|Overall Study|Withdrawal by Subject|9|||
33176356|NCT00969150|100556051|FG000|Overall Study|Lost to Follow-up|5|||
33176357|NCT00969150|100556052|FG001|Overall Study|Lost to Follow-up|4|||
33176358|NCT00969150|100556051|FG000|Overall Study|Other reasons|1|||
33176359|NCT00969150|100556052|FG001|Overall Study|Other reasons|0|||
33176360|NCT01702454|100556053|FG000|Overall Study|Consent withdrawal|0|||
33176361|NCT01702454|100556054|FG001|Overall Study|Consent withdrawal|1|||
33176362|NCT01702454|100556053|FG000|Overall Study|Migrated/moved from study area|0|||
33263155|NCT02392234|100863858|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
33463146|NCT03847194|101585978|FG000|Overall Study|Lost to Follow-up|2|||
33463147|NCT03847194|101585979|FG001|Overall Study|Lost to Follow-up|5|||
33176363|NCT01702454|100556054|FG001|Overall Study|Migrated/moved from study area|1|||
33176364|NCT01702454|100556053|FG000|Overall Study|Lost to Follow-up|3|||
33176365|NCT01702454|100556054|FG001|Overall Study|Lost to Follow-up|6|||
33176366|NCT00362115|100556061|FG000|Overall Study|Adverse Event|0|||
33176367|NCT00362115|100556062|FG001|Overall Study|Adverse Event|1|||
33176368|NCT00362115|100556063|FG002|Overall Study|Adverse Event|1|||
33176369|NCT00362115|100556064|FG003|Overall Study|Adverse Event|1|||
33176370|NCT00362115|100556065|FG004|Overall Study|Adverse Event|2|||
33176371|NCT00362115|100556066|FG005|Overall Study|Adverse Event|2|||
33176372|NCT00362115|100556067|FG006|Overall Study|Adverse Event|1|||
33176373|NCT00362115|100556061|FG000|Overall Study|Protocol Violation|0|||
33176374|NCT00362115|100556062|FG001|Overall Study|Protocol Violation|0|||
33176375|NCT00362115|100556063|FG002|Overall Study|Protocol Violation|0|||
33176376|NCT00362115|100556064|FG003|Overall Study|Protocol Violation|0|||
33176377|NCT00362115|100556065|FG004|Overall Study|Protocol Violation|0|||
33176378|NCT00362115|100556066|FG005|Overall Study|Protocol Violation|1|||
33176379|NCT00362115|100556067|FG006|Overall Study|Protocol Violation|0|||
33176380|NCT00362115|100556061|FG000|Overall Study|Lost to Follow-up|0|||
33176381|NCT00362115|100556062|FG001|Overall Study|Lost to Follow-up|1|||
33176382|NCT00362115|100556063|FG002|Overall Study|Lost to Follow-up|0|||
33176383|NCT00362115|100556064|FG003|Overall Study|Lost to Follow-up|0|||
33176384|NCT00362115|100556065|FG004|Overall Study|Lost to Follow-up|2|||
33176385|NCT00362115|100556066|FG005|Overall Study|Lost to Follow-up|0|||
33176386|NCT00362115|100556067|FG006|Overall Study|Lost to Follow-up|1|||
33176387|NCT00362115|100556061|FG000|Overall Study|Withdrawal by Subject|1|||
33176388|NCT00362115|100556062|FG001|Overall Study|Withdrawal by Subject|3|||
33263156|NCT02392234|100863859|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
33263157|NCT02392234|100863860|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
33263158|NCT02392234|100863855|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
33263159|NCT02392234|100863856|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
33463148|NCT03847194|101585978|FG000|Overall Study|Withdrawal by Subject|1|||
33463149|NCT03847194|101585979|FG001|Overall Study|Withdrawal by Subject|2|||
33463150|NCT03847194|101585978|FG000|Overall Study|Death|0|||
33463151|NCT03847194|101585979|FG001|Overall Study|Death|1|||
33463152|NCT01813435|101585982|FG000|Overall Study|did not finish experimental regimen|1902|||
33463153|NCT01813435|101585983|FG001|Overall Study|did not finish experimental regimen|770|||
33463154|NCT01813435|101585982|FG000|Overall Study|Lost to Follow-up|268|||
33463155|NCT01813435|101585983|FG001|Overall Study|Lost to Follow-up|237|||
33463156|NCT01765270|101585984|FG000|Overall Study|Physician Decision|1|||
33463157|NCT01765270|101585985|FG001|Overall Study|Physician Decision|0|||
33463158|NCT01765270|101585984|FG000|Overall Study|Withdrawal by Subject|0|||
33463159|NCT01765270|101585985|FG001|Overall Study|Withdrawal by Subject|1|||
33463160|NCT02039063|101585986|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
33463161|NCT02039063|101585987|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
33176389|NCT00362115|100556063|FG002|Overall Study|Withdrawal by Subject|1|||
33176390|NCT00362115|100556064|FG003|Overall Study|Withdrawal by Subject|0|||
33463162|NCT02039063|101585988|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
33463163|NCT02039063|101585989|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
33463164|NCT02039063|101585986|FG000|Treatment Phase|Progression of disease|0|||
33463165|NCT02039063|101585987|FG001|Treatment Phase|Progression of disease|0|||
33463166|NCT02039063|101585988|FG002|Treatment Phase|Progression of disease|1|||
33463167|NCT02039063|101585989|FG003|Treatment Phase|Progression of disease|1|||
33463168|NCT02039063|101585986|FG000|Extension Phase|Inadequate therapeutic effect|0|||
33463169|NCT02039063|101585987|FG001|Extension Phase|Inadequate therapeutic effect|1|||
33463170|NCT02039063|101585988|FG002|Extension Phase|Inadequate therapeutic effect|2|||
33463171|NCT02039063|101585989|FG003|Extension Phase|Inadequate therapeutic effect|0|||
33463172|NCT02039063|101585986|FG000|Extension Phase|Progression of disease|0|||
33463173|NCT02039063|101585987|FG001|Extension Phase|Progression of disease|0|||
33463174|NCT02039063|101585988|FG002|Extension Phase|Progression of disease|0|||
33463175|NCT02039063|101585989|FG003|Extension Phase|Progression of disease|1|||
33463176|NCT02039063|101585986|FG000|Extension Phase|Adverse Event|0|||
33463177|NCT02039063|101585987|FG001|Extension Phase|Adverse Event|0|||
33176391|NCT00362115|100556065|FG004|Overall Study|Withdrawal by Subject|1|||
33176392|NCT00362115|100556066|FG005|Overall Study|Withdrawal by Subject|3|||
33176393|NCT00362115|100556067|FG006|Overall Study|Withdrawal by Subject|4|||
33176394|NCT00362115|100556061|FG000|Overall Study|Lack of Efficacy|1|||
33176395|NCT00362115|100556062|FG001|Overall Study|Lack of Efficacy|0|||
33176396|NCT00362115|100556063|FG002|Overall Study|Lack of Efficacy|5|||
33176397|NCT00362115|100556064|FG003|Overall Study|Lack of Efficacy|2|||
33176398|NCT00362115|100556065|FG004|Overall Study|Lack of Efficacy|2|||
33176399|NCT00362115|100556066|FG005|Overall Study|Lack of Efficacy|0|||
33463178|NCT02039063|101585988|FG002|Extension Phase|Adverse Event|1|||
33463179|NCT02039063|101585989|FG003|Extension Phase|Adverse Event|0|||
33463180|NCT00108628|101585990|FG000|Overall Study|Withdrawal by Subject|17|||
33463181|NCT00108628|101585991|FG001|Overall Study|Withdrawal by Subject|9|||
33463182|NCT00108628|101585990|FG000|Overall Study|Lack of Efficacy|2|||
33463183|NCT00108628|101585991|FG001|Overall Study|Lack of Efficacy|1|||
33463184|NCT00108628|101585990|FG000|Overall Study|Death|1|||
33176400|NCT00362115|100556067|FG006|Overall Study|Lack of Efficacy|3|||
33176401|NCT00362115|100556061|FG000|Overall Study|Physician Decision|0|||
33176402|NCT00362115|100556062|FG001|Overall Study|Physician Decision|0|||
33463185|NCT00108628|101585991|FG001|Overall Study|Death|0|||
33463186|NCT00895037|101585992|FG000|Overall Study|Death|0|||
33463187|NCT00895037|101585993|FG001|Overall Study|Death|2|||
33176403|NCT00362115|100556063|FG002|Overall Study|Physician Decision|0|||
33263160|NCT02392234|100863857|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
33176404|NCT00362115|100556064|FG003|Overall Study|Physician Decision|0|||
33176405|NCT00362115|100556065|FG004|Overall Study|Physician Decision|0|||
33176406|NCT00362115|100556066|FG005|Overall Study|Physician Decision|0|||
33176407|NCT00362115|100556067|FG006|Overall Study|Physician Decision|3|||
33176408|NCT00362115|100556061|FG000|Overall Study|Other|0|||
33176409|NCT00362115|100556062|FG001|Overall Study|Other|1|||
33176410|NCT00362115|100556063|FG002|Overall Study|Other|0|||
33176411|NCT00362115|100556064|FG003|Overall Study|Other|1|||
33176412|NCT00362115|100556065|FG004|Overall Study|Other|0|||
33176413|NCT00362115|100556066|FG005|Overall Study|Other|1|||
33176414|NCT00362115|100556067|FG006|Overall Study|Other|0|||
33176415|NCT02904512|100556070|FG000|Overall Study|Withdrawal by Subject|1|||
33176416|NCT02904512|100556071|FG001|Overall Study|Withdrawal by Subject|0|||
33176417|NCT02904512|100556070|FG000|Overall Study|Transferred to ICU|1|||
33176418|NCT02904512|100556071|FG001|Overall Study|Transferred to ICU|0|||
33176419|NCT02904512|100556070|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
33176420|NCT02904512|100556071|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
33463188|NCT00895037|101585994|FG002|Overall Study|Death|1|||
33463189|NCT00251316|101585995|FG000|Overall Study|Physician Decision|2|||
33176421|NCT04210310|100556074|FG000|Overall Study|Lost to Follow-up|32|||
33176422|NCT04210310|100556075|FG001|Overall Study|Lost to Follow-up|1|||
33176423|NCT02057198|100556076|FG000|Overall Study|Death|0|||
33176424|NCT02057198|100556077|FG001|Overall Study|Death|0|||
33176425|NCT02057198|100556078|FG002|Overall Study|Death|1|||
33176426|NCT02057198|100556076|FG000|Overall Study|Discharged early; lost to followup|0|||
33176427|NCT02057198|100556077|FG001|Overall Study|Discharged early; lost to followup|1|||
33176428|NCT02057198|100556078|FG002|Overall Study|Discharged early; lost to followup|0|||
33176429|NCT01166178|100556079|FG000|Overall Study|Withdrawal by Subject|1|||
33176430|NCT01166178|100556080|FG001|Overall Study|Withdrawal by Subject|0|||
33176431|NCT01166178|100556079|FG000|Overall Study|Study was terminated|20|||
33263161|NCT02392234|100863858|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
33263162|NCT02392234|100863859|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
33263163|NCT02392234|100863860|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
33263164|NCT04075396|100863881|FG000|Overall Study|Death|11|||
33463190|NCT00251316|101585996|FG001|Overall Study|Physician Decision|3|||
33463191|NCT01701973|101585997|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
33463192|NCT01701973|101585998|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
33463193|NCT01701973|101585999|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
33463194|NCT01701973|101586000|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
33463195|NCT01701973|101586001|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
33463196|NCT01701973|101586002|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
33463197|NCT01701973|101586003|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
33463198|NCT01701973|101586004|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
33263165|NCT04075396|100863882|FG001|Overall Study|Death|9|||
33263166|NCT04075396|100863881|FG000|Overall Study|Withdrawal by Subject|1|||
33263167|NCT04075396|100863882|FG001|Overall Study|Withdrawal by Subject|2|||
33263168|NCT04075396|100863881|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
33263169|NCT04075396|100863882|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
33263170|NCT04075396|100863881|FG000|Overall Study|Enrolled but not-treated|0|||
33463199|NCT00063258|101586007|FG000|Overall Study|Physician Decision|2|||
33463200|NCT00063258|101586008|FG001|Overall Study|Physician Decision|0|||
33463201|NCT00063258|101586007|FG000|Overall Study|Lack of Efficacy|2|||
33463202|NCT00063258|101586008|FG001|Overall Study|Lack of Efficacy|0|||
33463203|NCT00202839|101586014|FG000|Overall Study|Adverse Event|1|||
33463204|NCT00202839|101586015|FG001|Overall Study|Adverse Event|5|||
33463205|NCT00202839|101586014|FG000|Overall Study|Physician Decision|12|||
33463206|NCT00202839|101586015|FG001|Overall Study|Physician Decision|0|||
33463207|NCT00202839|101586014|FG000|Overall Study|Withdrawal by Subject|6|||
33463208|NCT00202839|101586015|FG001|Overall Study|Withdrawal by Subject|2|||
33463209|NCT00202839|101586014|FG000|Overall Study|Protocol Violation|2|||
33263171|NCT04075396|100863882|FG001|Overall Study|Enrolled but not-treated|1|||
33463210|NCT00202839|101586015|FG001|Overall Study|Protocol Violation|1|||
33463211|NCT00202839|101586014|FG000|Overall Study|Lost to Follow-up|3|||
33463212|NCT00202839|101586015|FG001|Overall Study|Lost to Follow-up|2|||
33463213|NCT01961687|101586016|FG000|Overall Study|Lost to Follow-up|19|||
33463214|NCT01961687|101586016|FG000|Overall Study|Re-operation|17|||
33463215|NCT01961687|101586016|FG000|Overall Study|Death|7|||
33176432|NCT01166178|100556080|FG001|Overall Study|Study was terminated|8|||
33176433|NCT03103919|100556085|FG000|Overall Study|Adverse Event|2|||
33176434|NCT03103919|100556086|FG001|Overall Study|Adverse Event|2|||
33176435|NCT00276159|100556087|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
33176436|NCT02772081|100556090|FG000|Overall Study|Physician Decision|1|||
33176437|NCT02772081|100556091|FG001|Overall Study|Physician Decision|1|||
33176438|NCT02772081|100556090|FG000|Overall Study|Death|1|||
33263172|NCT00229658|100863883|FG000|Overall Study|Administrative|2|||
33263173|NCT00229658|100863884|FG001|Overall Study|Administrative|1|||
33463216|NCT01961687|101586016|FG000|Overall Study|Withdrawal by Subject|6|||
33176439|NCT02772081|100556091|FG001|Overall Study|Death|1|||
33463217|NCT01961687|101586016|FG000|Overall Study|Adverse Event|6|||
33463218|NCT01961687|101586016|FG000|Overall Study|Moved to area without study site|2|||
33463219|NCT01961687|101586016|FG000|Overall Study|Sponsor decision|2|||
33463220|NCT01961687|101586016|FG000|Overall Study|Physician Decision|1|||
33463221|NCT01961687|101586016|FG000|Overall Study|Unable to meet follow-up requirements|1|||
33463222|NCT02510261|101586018|FG000|Overall Study|Adverse Event|5|||
33463223|NCT02510261|101586019|FG001|Overall Study|Adverse Event|8|||
33463224|NCT02510261|101586020|FG002|Overall Study|Adverse Event|0|||
33176440|NCT01164956|100556093|FG000|Overall Study|Side Effects|1|||
33176441|NCT01164956|100556094|FG001|Overall Study|Side Effects|0|||
33176442|NCT01164956|100556095|FG002|Overall Study|Side Effects|1|||
33176443|NCT02320149|100556099|FG000|Overall Study|Adverse Event|3|||
33176444|NCT02320149|100556100|FG001|Overall Study|Adverse Event|7|||
33176445|NCT02320149|100556099|FG000|Overall Study|Withdrawal of Consent|28|||
33176446|NCT02320149|100556100|FG001|Overall Study|Withdrawal of Consent|32|||
33176447|NCT02320149|100556099|FG000|Overall Study|Lost to Follow-up|21|||
33176448|NCT02320149|100556100|FG001|Overall Study|Lost to Follow-up|34|||
33176449|NCT02320149|100556099|FG000|Overall Study|Protocol Violation|2|||
33176450|NCT02320149|100556100|FG001|Overall Study|Protocol Violation|1|||
33176451|NCT02320149|100556099|FG000|Overall Study|Noncompliance with Study Treatment|7|||
33176452|NCT02320149|100556100|FG001|Overall Study|Noncompliance with Study Treatment|2|||
33176453|NCT02320149|100556099|FG000|Overall Study|Lack of Efficacy|0|||
33176454|NCT02320149|100556100|FG001|Overall Study|Lack of Efficacy|1|||
33176455|NCT02320149|100556099|FG000|Overall Study|Other Miscellaneous Reasons|2|||
33176456|NCT02320149|100556100|FG001|Overall Study|Other Miscellaneous Reasons|3|||
33176457|NCT00589914|100556101|FG000|Overall Study|Adverse Event|19|||
33176458|NCT00589914|100556102|FG001|Overall Study|Adverse Event|10|||
33176459|NCT00589914|100556101|FG000|Overall Study|Death|2|||
33176460|NCT00589914|100556102|FG001|Overall Study|Death|0|||
33176461|NCT00589914|100556101|FG000|Overall Study|Lack of Efficacy|40|||
33176462|NCT00589914|100556102|FG001|Overall Study|Lack of Efficacy|43|||
33263174|NCT00229658|100863883|FG000|Overall Study|Investigator decision|13|||
33263175|NCT00229658|100863884|FG001|Overall Study|Investigator decision|10|||
33263176|NCT00229658|100863883|FG000|Overall Study|Other|80|||
33263177|NCT00229658|100863884|FG001|Overall Study|Other|60|||
33263178|NCT00229658|100863883|FG000|Overall Study|Lost to Follow-up|82|||
33263179|NCT00229658|100863884|FG001|Overall Study|Lost to Follow-up|55|||
33263180|NCT00229658|100863883|FG000|Overall Study|Serious Adverse Event|2|||
33263181|NCT00229658|100863884|FG001|Overall Study|Serious Adverse Event|2|||
33263182|NCT00229658|100863883|FG000|Overall Study|Withdrawal of consent|46|||
33263183|NCT00229658|100863884|FG001|Overall Study|Withdrawal of consent|39|||
33263184|NCT02593149|100863885|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
33263185|NCT02593149|100863886|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
33263186|NCT02593149|100863885|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
33263187|NCT02593149|100863886|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
33263188|NCT01700205|100863887|FG000|Overall Study|Withdrawal by Subject|13|||
33263189|NCT01700205|100863888|FG001|Overall Study|Withdrawal by Subject|13|||
33263190|NCT01700205|100863887|FG000|Overall Study|Protocol Violation|2|||
33263191|NCT01700205|100863888|FG001|Overall Study|Protocol Violation|2|||
33263192|NCT01211184|100863896|FG000|Overall Study|Withdrawal by Subject|0|||
33263193|NCT01211184|100863897|FG001|Overall Study|Withdrawal by Subject|2|||
33263194|NCT01211184|100863898|FG002|Overall Study|Withdrawal by Subject|1|||
33263195|NCT00145470|100863900|FG000|Overall Study|Adverse Event|19|||
33463225|NCT02510261|101586018|FG000|Overall Study|Physician Decision|1|||
33463226|NCT02510261|101586019|FG001|Overall Study|Physician Decision|5|||
33463227|NCT02510261|101586020|FG002|Overall Study|Physician Decision|0|||
33463228|NCT02510261|101586018|FG000|Overall Study|Death|19|||
33176463|NCT00589914|100556101|FG000|Overall Study|Lost to Follow-up|11|||
33176464|NCT00589914|100556102|FG001|Overall Study|Lost to Follow-up|18|||
33463229|NCT02510261|101586019|FG001|Overall Study|Death|19|||
33176465|NCT00589914|100556101|FG000|Overall Study|Pregnancy|1|||
33176466|NCT00589914|100556102|FG001|Overall Study|Pregnancy|0|||
33176467|NCT00589914|100556101|FG000|Overall Study|Withdrawal by Subject|55|||
33176468|NCT00589914|100556102|FG001|Overall Study|Withdrawal by Subject|49|||
33176469|NCT00589914|100556101|FG000|Overall Study|Other|22|||
33176470|NCT00589914|100556102|FG001|Overall Study|Other|17|||
33176471|NCT02746874|100556103|FG000|Overall Study|Withdrawal by Subject|0|||
33263196|NCT00145470|100863901|FG001|Overall Study|Adverse Event|25|||
33263197|NCT00145470|100863900|FG000|Overall Study|Lack of Efficacy|27|||
33176472|NCT02746874|100556104|FG001|Overall Study|Withdrawal by Subject|1|||
33176473|NCT02746874|100556103|FG000|Overall Study|Surgery Date Changed|0|||
33176474|NCT02746874|100556104|FG001|Overall Study|Surgery Date Changed|2|||
33263198|NCT00145470|100863901|FG001|Overall Study|Lack of Efficacy|13|||
33263199|NCT00145470|100863900|FG000|Overall Study|Withdrawal by Subject|36|||
33263200|NCT00145470|100863901|FG001|Overall Study|Withdrawal by Subject|34|||
33263201|NCT00145470|100863900|FG000|Overall Study|Lost to Follow-up|21|||
33263202|NCT00145470|100863901|FG001|Overall Study|Lost to Follow-up|17|||
33463230|NCT02510261|101586020|FG002|Overall Study|Death|0|||
33263203|NCT00145470|100863900|FG000|Overall Study|Reason Not Reported|9|||
33263204|NCT00145470|100863901|FG001|Overall Study|Reason Not Reported|9|||
33263205|NCT00968149|100863904|FG000|Overall Study|Adverse Event|5|||
33263206|NCT00968149|100863905|FG001|Overall Study|Adverse Event|1|||
33263207|NCT00968149|100863904|FG000|Overall Study|Lack of Efficacy|0|||
33263208|NCT00968149|100863905|FG001|Overall Study|Lack of Efficacy|4|||
33263209|NCT00968149|100863904|FG000|Overall Study|Lost to Follow-up|0|||
33263210|NCT00968149|100863905|FG001|Overall Study|Lost to Follow-up|1|||
33263211|NCT00968149|100863904|FG000|Overall Study|Protocol Violation|4|||
33263212|NCT00968149|100863905|FG001|Overall Study|Protocol Violation|0|||
33263213|NCT00968149|100863904|FG000|Overall Study|Withdrawal by Subject|2|||
33263214|NCT00968149|100863905|FG001|Overall Study|Withdrawal by Subject|0|||
33263215|NCT01638000|100863906|FG000|Overall Study|Randomized but Never Received Drug|7|||
33263216|NCT01638000|100863907|FG001|Overall Study|Randomized but Never Received Drug|10|||
33263217|NCT01638000|100863906|FG000|Overall Study|Adverse Event|14|||
33263218|NCT01638000|100863907|FG001|Overall Study|Adverse Event|16|||
33263219|NCT01638000|100863906|FG000|Overall Study|Lack of Efficacy|5|||
33263220|NCT01638000|100863907|FG001|Overall Study|Lack of Efficacy|6|||
33263221|NCT01638000|100863906|FG000|Overall Study|Protocol Violation|11|||
33176475|NCT00202644|100556105|FG000|Overall Study|Adverse Event|12|||
33176476|NCT00202644|100556106|FG001|Overall Study|Adverse Event|13|||
33263222|NCT01638000|100863907|FG001|Overall Study|Protocol Violation|13|||
33263223|NCT01638000|100863906|FG000|Overall Study|Withdrawal by Subject|21|||
33263224|NCT01638000|100863907|FG001|Overall Study|Withdrawal by Subject|24|||
33263225|NCT01638000|100863906|FG000|Overall Study|Miscellaneous|2|||
33263226|NCT01638000|100863907|FG001|Overall Study|Miscellaneous|2|||
33263227|NCT01400958|100863908|FG000|Overall Study|Physician Decision|0|||
33263228|NCT01400958|100863909|FG001|Overall Study|Physician Decision|1|||
33263229|NCT01400958|100863908|FG000|Overall Study|Withdrawal by Subject|0|||
33263230|NCT01400958|100863909|FG001|Overall Study|Withdrawal by Subject|1|||
33263231|NCT01400958|100863908|FG000|Overall Study|Adverse Event|1|||
33263232|NCT01400958|100863909|FG001|Overall Study|Adverse Event|0|||
33263233|NCT03613740|100863914|FG000|Overall Study|Lost to Follow-up|1|||
33263234|NCT03613740|100863915|FG001|Overall Study|Lost to Follow-up|1|||
33263235|NCT01288443|100863916|FG000|Overall Study|Adverse Event|0|||
33263236|NCT01288443|100863917|FG001|Overall Study|Adverse Event|0|||
33263237|NCT01288443|100863918|FG002|Overall Study|Adverse Event|1|||
33176477|NCT00202644|100556105|FG000|Overall Study|Withdrawal by Subject|8|||
33176478|NCT00202644|100556106|FG001|Overall Study|Withdrawal by Subject|6|||
33176479|NCT00202644|100556105|FG000|Overall Study|Lack of Efficacy|6|||
33176480|NCT00202644|100556106|FG001|Overall Study|Lack of Efficacy|6|||
33263238|NCT01288443|100863919|FG003|Overall Study|Adverse Event|1|||
33263239|NCT01288443|100863920|FG004|Overall Study|Adverse Event|3|||
33263240|NCT01288443|100863921|FG005|Overall Study|Adverse Event|1|||
33263241|NCT01288443|100863916|FG000|Overall Study|Poor compliance to protocol|0|||
33263242|NCT01288443|100863917|FG001|Overall Study|Poor compliance to protocol|0|||
33263243|NCT01288443|100863918|FG002|Overall Study|Poor compliance to protocol|0|||
33263244|NCT01288443|100863919|FG003|Overall Study|Poor compliance to protocol|0|||
33176481|NCT00202644|100556105|FG000|Overall Study|Lost to Follow-up|0|||
33263245|NCT01288443|100863920|FG004|Overall Study|Poor compliance to protocol|0|||
33263246|NCT01288443|100863921|FG005|Overall Study|Poor compliance to protocol|1|||
33263247|NCT01288443|100863916|FG000|Overall Study|Participant Moved|0|||
33263248|NCT01288443|100863917|FG001|Overall Study|Participant Moved|0|||
33263249|NCT01288443|100863918|FG002|Overall Study|Participant Moved|0|||
33263250|NCT01288443|100863919|FG003|Overall Study|Participant Moved|1|||
33463231|NCT02510261|101586018|FG000|Overall Study|Withdrawal by Subject|3|||
33463232|NCT02510261|101586019|FG001|Overall Study|Withdrawal by Subject|10|||
33463233|NCT02510261|101586020|FG002|Overall Study|Withdrawal by Subject|3|||
33463234|NCT04126343|101586021|FG000|Overall Study|Adverse Event|0|||
33463235|NCT04126343|101586022|FG001|Overall Study|Adverse Event|0|||
33463236|NCT04126343|101586023|FG002|Overall Study|Adverse Event|0|||
33463237|NCT04126343|101586024|FG003|Overall Study|Adverse Event|0|||
33463238|NCT04126343|101586025|FG004|Overall Study|Adverse Event|0|||
33263251|NCT01288443|100863920|FG004|Overall Study|Participant Moved|2|||
33263252|NCT01288443|100863921|FG005|Overall Study|Participant Moved|1|||
33263253|NCT01288443|100863916|FG000|Overall Study|Consent withdrawn by Participant|0|||
33263254|NCT01288443|100863917|FG001|Overall Study|Consent withdrawn by Participant|0|||
33263255|NCT01288443|100863918|FG002|Overall Study|Consent withdrawn by Participant|0|||
33263256|NCT01288443|100863919|FG003|Overall Study|Consent withdrawn by Participant|0|||
33263257|NCT01288443|100863920|FG004|Overall Study|Consent withdrawn by Participant|0|||
33263258|NCT01288443|100863921|FG005|Overall Study|Consent withdrawn by Participant|1|||
33263259|NCT01288443|100863916|FG000|Overall Study|Lost to Follow-up|0|||
33263260|NCT01288443|100863917|FG001|Overall Study|Lost to Follow-up|1|||
33263261|NCT01288443|100863918|FG002|Overall Study|Lost to Follow-up|0|||
33263262|NCT01288443|100863919|FG003|Overall Study|Lost to Follow-up|0|||
33263263|NCT01288443|100863920|FG004|Overall Study|Lost to Follow-up|0|||
33263264|NCT01288443|100863921|FG005|Overall Study|Lost to Follow-up|0|||
33263265|NCT01288443|100863916|FG000|Overall Study|Study drug auto-injector administration|0|||
33263266|NCT01288443|100863917|FG001|Overall Study|Study drug auto-injector administration|0|||
33463239|NCT04126343|101586026|FG005|Overall Study|Adverse Event|1|||
33463240|NCT04126343|101586021|FG000|Overall Study|Withdrawal by Subject|0|||
33463241|NCT04126343|101586022|FG001|Overall Study|Withdrawal by Subject|0|||
33263267|NCT01288443|100863918|FG002|Overall Study|Study drug auto-injector administration|0|||
33263268|NCT01288443|100863919|FG003|Overall Study|Study drug auto-injector administration|0|||
33263269|NCT01288443|100863920|FG004|Overall Study|Study drug auto-injector administration|1|||
33263270|NCT01288443|100863921|FG005|Overall Study|Study drug auto-injector administration|1|||
33263271|NCT01288443|100863916|FG000|Overall Study|Other than above|0|||
33263272|NCT01288443|100863917|FG001|Overall Study|Other than above|0|||
33176482|NCT00202644|100556106|FG001|Overall Study|Lost to Follow-up|1|||
33176483|NCT00202644|100556105|FG000|Overall Study|Other|9|||
33176484|NCT00202644|100556106|FG001|Overall Study|Other|1|||
33176485|NCT03010254|100556107|FG000|Overall Study|Adverse Event|0|||
33176486|NCT03010254|100556108|FG001|Overall Study|Adverse Event|1|||
33176487|NCT03010254|100556107|FG000|Overall Study|Lost to Follow-up|4|||
33176488|NCT03010254|100556108|FG001|Overall Study|Lost to Follow-up|0|||
33176489|NCT03010254|100556107|FG000|Overall Study|Withdrawal by Subject|1|||
33176490|NCT03010254|100556108|FG001|Overall Study|Withdrawal by Subject|1|||
33176491|NCT03010254|100556107|FG000|Overall Study|Other|2|||
33176492|NCT03010254|100556108|FG001|Overall Study|Other|3|||
33176493|NCT03178773|100556109|FG000|Overall Study|Death|0|||
33176494|NCT03178773|100556110|FG001|Overall Study|Death|1|||
33176495|NCT03178773|100556109|FG000|Overall Study|Lost to Follow-up|29|||
33176496|NCT03178773|100556110|FG001|Overall Study|Lost to Follow-up|25|||
33176497|NCT03178773|100556109|FG000|Overall Study|Withdrawal by Subject|10|||
33176498|NCT03178773|100556110|FG001|Overall Study|Withdrawal by Subject|14|||
33176499|NCT03480750|100556113|FG000|Overall Study|Withdrawal by Subject|0|||
33176500|NCT03480750|100556114|FG001|Overall Study|Withdrawal by Subject|1|||
33176501|NCT03480750|100556115|FG002|Overall Study|Withdrawal by Subject|0|||
33176502|NCT03480750|100556116|FG003|Overall Study|Withdrawal by Subject|0|||
33176503|NCT03480750|100556117|FG004|Overall Study|Withdrawal by Subject|0|||
33463242|NCT04126343|101586023|FG002|Overall Study|Withdrawal by Subject|0|||
33463243|NCT04126343|101586024|FG003|Overall Study|Withdrawal by Subject|1|||
33463244|NCT04126343|101586025|FG004|Overall Study|Withdrawal by Subject|0|||
33463245|NCT04126343|101586026|FG005|Overall Study|Withdrawal by Subject|0|||
33463246|NCT04126343|101586021|FG000|Overall Study|Related to COVID-19 pandemic|3|||
33463247|NCT04126343|101586022|FG001|Overall Study|Related to COVID-19 pandemic|4|||
33463248|NCT04126343|101586023|FG002|Overall Study|Related to COVID-19 pandemic|3|||
33463249|NCT04126343|101586024|FG003|Overall Study|Related to COVID-19 pandemic|3|||
33463250|NCT04126343|101586025|FG004|Overall Study|Related to COVID-19 pandemic|3|||
33176504|NCT03480750|100556118|FG005|Overall Study|Withdrawal by Subject|0|||
33176505|NCT03480750|100556113|FG000|Overall Study|The interruption in Trientine shippment|0|||
33176506|NCT03480750|100556114|FG001|Overall Study|The interruption in Trientine shippment|0|||
33176507|NCT03480750|100556115|FG002|Overall Study|The interruption in Trientine shippment|0|||
33176508|NCT03480750|100556116|FG003|Overall Study|The interruption in Trientine shippment|0|||
33176509|NCT03480750|100556117|FG004|Overall Study|The interruption in Trientine shippment|0|||
33176510|NCT03480750|100556118|FG005|Overall Study|The interruption in Trientine shippment|1|||
33463251|NCT04126343|101586026|FG005|Overall Study|Related to COVID-19 pandemic|3|||
33176511|NCT03635957|100556119|FG000|Run-In Period|Lost to Follow-up|1|||
33176512|NCT03635957|100556119|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
33176513|NCT01686633|100556120|FG000|Overall Study|Lack of Efficacy|33|||
33176514|NCT01686633|100556121|FG001|Overall Study|Lack of Efficacy|13|||
33176515|NCT01686633|100556122|FG002|Overall Study|Lack of Efficacy|11|||
33176516|NCT01686633|100556120|FG000|Overall Study|Withdrawal by Subject|8|||
33176517|NCT01686633|100556121|FG001|Overall Study|Withdrawal by Subject|8|||
33176518|NCT01686633|100556122|FG002|Overall Study|Withdrawal by Subject|5|||
33176519|NCT01686633|100556120|FG000|Overall Study|Physician Decision|3|||
33176520|NCT01686633|100556121|FG001|Overall Study|Physician Decision|4|||
33176521|NCT01686633|100556122|FG002|Overall Study|Physician Decision|4|||
33176522|NCT01686633|100556120|FG000|Overall Study|Adverse Event|4|||
33176523|NCT01686633|100556121|FG001|Overall Study|Adverse Event|3|||
33176524|NCT01686633|100556122|FG002|Overall Study|Adverse Event|3|||
33176525|NCT01686633|100556120|FG000|Overall Study|Protocol Violation|2|||
33176526|NCT01686633|100556121|FG001|Overall Study|Protocol Violation|3|||
33176527|NCT01686633|100556122|FG002|Overall Study|Protocol Violation|0|||
33176528|NCT01686633|100556120|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
33176529|NCT01686633|100556121|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
33176530|NCT01686633|100556122|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
33176531|NCT01686633|100556120|FG000|Overall Study|Lost to Follow-up|0|||
33176532|NCT01686633|100556121|FG001|Overall Study|Lost to Follow-up|1|||
33263273|NCT01288443|100863918|FG002|Overall Study|Other than above|0|||
33263274|NCT01288443|100863919|FG003|Overall Study|Other than above|2|||
33263275|NCT01288443|100863920|FG004|Overall Study|Other than above|1|||
33263276|NCT01288443|100863921|FG005|Overall Study|Other than above|0|||
33263277|NCT03092726|100863922|FG000|Overall Study|Adverse Event|3|||
33263278|NCT03092726|100863923|FG001|Overall Study|Adverse Event|10|||
33263279|NCT03092726|100863922|FG000|Overall Study|Lack of Efficacy|0|||
33263280|NCT03092726|100863923|FG001|Overall Study|Lack of Efficacy|1|||
33263281|NCT03092726|100863922|FG000|Overall Study|Lost to Follow-up|1|||
33263282|NCT03092726|100863923|FG001|Overall Study|Lost to Follow-up|0|||
33263283|NCT03092726|100863922|FG000|Overall Study|Withdrawal by Subject|5|||
33263284|NCT03092726|100863923|FG001|Overall Study|Withdrawal by Subject|3|||
33263285|NCT00580866|100863924|FG000|Overall Study|Lost to Follow-up|2|||
33263286|NCT00580866|100863925|FG001|Overall Study|Lost to Follow-up|2|||
33263287|NCT01880736|100863930|FG000|Overall Study|Adverse Event|0|||
33263288|NCT01880736|100863931|FG001|Overall Study|Adverse Event|0|||
33263289|NCT01880736|100863932|FG002|Overall Study|Adverse Event|0|||
33263290|NCT01880736|100863933|FG003|Overall Study|Adverse Event|1|||
33263291|NCT01880736|100863930|FG000|Overall Study|Withdrawal Criteria|1|||
33263292|NCT01880736|100863931|FG001|Overall Study|Withdrawal Criteria|2|||
33263293|NCT01880736|100863932|FG002|Overall Study|Withdrawal Criteria|1|||
33176533|NCT01686633|100556122|FG002|Overall Study|Lost to Follow-up|1|||
33176534|NCT00422591|100556123|FG000|Overall Study|Physician Decision|4|||
33176535|NCT00422591|100556123|FG000|Overall Study|Withdrawal by Subject|2|||
33176536|NCT01408914|100556124|FG000|Overall Study|Could not complete tx in protocol period|5|||
33176537|NCT01408914|100556125|FG001|Overall Study|Could not complete tx in protocol period|5|||
33176538|NCT01408914|100556126|FG002|Overall Study|Could not complete tx in protocol period|6|||
33176539|NCT01408914|100556124|FG000|Overall Study|Lost to Follow-up|4|||
33176540|NCT01408914|100556125|FG001|Overall Study|Lost to Follow-up|1|||
33176541|NCT01408914|100556126|FG002|Overall Study|Lost to Follow-up|2|||
33176542|NCT01408914|100556124|FG000|Overall Study|Physician Decision|1|||
33176543|NCT01408914|100556125|FG001|Overall Study|Physician Decision|1|||
33176544|NCT01408914|100556126|FG002|Overall Study|Physician Decision|0|||
33176545|NCT01408914|100556124|FG000|Overall Study|Withdrawal by Subject|1|||
33176546|NCT01408914|100556125|FG001|Overall Study|Withdrawal by Subject|0|||
33176547|NCT01408914|100556126|FG002|Overall Study|Withdrawal by Subject|1|||
33176548|NCT01408914|100556124|FG000|Overall Study|Moved out of study jurisdiction|1|||
33176549|NCT01408914|100556125|FG001|Overall Study|Moved out of study jurisdiction|1|||
33176550|NCT01408914|100556126|FG002|Overall Study|Moved out of study jurisdiction|0|||
33176551|NCT01408914|100556124|FG000|Overall Study|Late exclusion|0|||
33176552|NCT01408914|100556125|FG001|Overall Study|Late exclusion|3|||
33176553|NCT01408914|100556126|FG002|Overall Study|Late exclusion|3|||
33176554|NCT01408914|100556124|FG000|Overall Study|Change in local TB/HIV norms|0|||
33176555|NCT01408914|100556125|FG001|Overall Study|Change in local TB/HIV norms|1|||
33176556|NCT01408914|100556126|FG002|Overall Study|Change in local TB/HIV norms|1|||
33263294|NCT01880736|100863933|FG003|Overall Study|Withdrawal Criteria|5|||
33263295|NCT03781375|100863934|FG000|Double-blind Phase|Adverse Event|0|||
33263296|NCT03781375|100863935|FG001|Double-blind Phase|Adverse Event|1|||
33263297|NCT03781375|100863934|FG000|Double-blind Phase|Lack of Response|6|||
33263298|NCT03781375|100863935|FG001|Double-blind Phase|Lack of Response|2|||
33263299|NCT03781375|100863934|FG000|Double-blind Phase|Other|1|||
33263300|NCT03781375|100863935|FG001|Double-blind Phase|Other|3|||
33263301|NCT03781375|100863934|FG000|Open-label Phase|Protocol Issues|0|||
33263302|NCT03781375|100863935|FG001|Open-label Phase|Protocol Issues|1|||
33263303|NCT03781375|100863934|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
33263304|NCT03781375|100863935|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
33263305|NCT03781375|100863934|FG000|Open-label Phase|Other|2|||
33263306|NCT03781375|100863935|FG001|Open-label Phase|Other|2|||
33263307|NCT00727909|100863939|FG000|Overall Study|Withdrawal by Subject|5|||
33263308|NCT00727909|100863940|FG001|Overall Study|Withdrawal by Subject|11|||
33263309|NCT00727909|100863941|FG002|Overall Study|Withdrawal by Subject|8|||
33263310|NCT00727909|100863942|FG003|Overall Study|Withdrawal by Subject|5|||
33263311|NCT00727909|100863939|FG000|Overall Study|Death|0|||
33263312|NCT00727909|100863940|FG001|Overall Study|Death|0|||
33263313|NCT00727909|100863941|FG002|Overall Study|Death|1|||
33263314|NCT00727909|100863942|FG003|Overall Study|Death|0|||
33263315|NCT01953224|100863944|FG000|Overall Study|Lost to Follow-up|1|||
33263316|NCT01953224|100863945|FG001|Overall Study|Lost to Follow-up|1|||
33263317|NCT01953224|100863944|FG000|Overall Study|Withdrawal by Subject|1|||
33263318|NCT01953224|100863945|FG001|Overall Study|Withdrawal by Subject|2|||
33263319|NCT04919499|100863947|FG000|Overall Study|Adverse Event|0|||
33263320|NCT04919499|100863948|FG001|Overall Study|Adverse Event|0|||
33263321|NCT04919499|100863949|FG002|Overall Study|Adverse Event|0|||
33263322|NCT04919499|100863950|FG003|Overall Study|Adverse Event|0|||
33263323|NCT04919499|100863951|FG004|Overall Study|Adverse Event|2|||
33263324|NCT04919499|100863947|FG000|Overall Study|Not treated|0|||
33263325|NCT04919499|100863948|FG001|Overall Study|Not treated|0|||
33263326|NCT04919499|100863949|FG002|Overall Study|Not treated|0|||
33263327|NCT04919499|100863950|FG003|Overall Study|Not treated|1|||
33176557|NCT00492115|100556127|FG000|Overall Study|Withdrawal by Subject|3|||
33263328|NCT04919499|100863951|FG004|Overall Study|Not treated|0|||
33263329|NCT06571695|100863952|FG000|Overall Study|Lost to Follow-up|1|||
33176558|NCT00492115|100556128|FG001|Overall Study|Withdrawal by Subject|4|||
33263330|NCT06571695|100863953|FG001|Overall Study|Lost to Follow-up|6|||
33263331|NCT01268306|100863954|FG000|Overall Study|Lost to Follow-up|1|||
33263332|NCT02357966|100863957|FG000|Overall Study|Death|0|||
33263333|NCT02357966|100863958|FG001|Overall Study|Death|0|||
33263334|NCT02357966|100863959|FG002|Overall Study|Death|1|||
33263335|NCT02357966|100863960|FG003|Overall Study|Death|0|||
33263336|NCT02357966|100863961|FG004|Overall Study|Death|2|||
33263337|NCT02357966|100863962|FG005|Overall Study|Death|0|||
33263338|NCT02357966|100863957|FG000|Overall Study|Physician Decision|1|||
33263339|NCT02357966|100863958|FG001|Overall Study|Physician Decision|0|||
33263340|NCT02357966|100863959|FG002|Overall Study|Physician Decision|0|||
33263341|NCT02357966|100863960|FG003|Overall Study|Physician Decision|0|||
33176559|NCT01082965|100556129|FG000|Overall Study|Protocol Violation|0|||
33176560|NCT01082965|100556130|FG001|Overall Study|Protocol Violation|1|||
33263342|NCT02357966|100863961|FG004|Overall Study|Physician Decision|1|||
33263343|NCT02357966|100863962|FG005|Overall Study|Physician Decision|0|||
33176561|NCT01082965|100556129|FG000|Overall Study|Other|1|||
33176562|NCT01082965|100556130|FG001|Overall Study|Other|1|||
33176563|NCT00773292|100556133|FG000|Treatment 48 Weeks|Adverse Event|1|||
33176564|NCT00773292|100556133|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
33176565|NCT02892760|100556134|FG000|Overall Study|Withdrawal by Subject|3|||
33176566|NCT02345811|100556135|FG000|First Intervention|Withdrawal by Subject|1|||
33176567|NCT02345811|100556136|FG001|First Intervention|Withdrawal by Subject|1|||
33176568|NCT00588848|100556137|FG000|Overall Study|Physician Decision|0|||
33176569|NCT00588848|100556138|FG001|Overall Study|Physician Decision|3|||
33176570|NCT02673489|100556139|FG000|Treatment Period|Lost to Follow-up|3|||
33176571|NCT02673489|100556140|FG001|Treatment Period|Lost to Follow-up|0|||
33176572|NCT02673489|100556139|FG000|Treatment Period|Participant request to discontinue|1|||
33463252|NCT04703855|101586027|FG000|Overall Study|Heart Transplant|1|||
33463253|NCT00808509|101586032|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
33176573|NCT02673489|100556140|FG001|Treatment Period|Participant request to discontinue|1|||
33176574|NCT02673489|100556139|FG000|Treatment Period|Participant moved to another province|1|||
33176575|NCT02673489|100556140|FG001|Treatment Period|Participant moved to another province|0|||
33176576|NCT02673489|100556139|FG000|Treatment Period|Participant was incarcerated|0|||
33176577|NCT02673489|100556140|FG001|Treatment Period|Participant was incarcerated|1|||
33176578|NCT02673489|100556139|FG000|Treatment Period|Adverse Event|0|||
33176579|NCT02673489|100556140|FG001|Treatment Period|Adverse Event|1|||
33176580|NCT02673489|100556139|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
33176581|NCT02673489|100556140|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
33176582|NCT02673489|100556139|FG000|Follow Up Period|Unable to return for follow-up|0|||
33176583|NCT02673489|100556140|FG001|Follow Up Period|Unable to return for follow-up|1|||
33176584|NCT00412854|100556141|FG000|Overall Study|Withdrawn due to adverse events|1|||
33176585|NCT00412854|100556142|FG001|Overall Study|Withdrawn due to adverse events|5|||
33176586|NCT00412854|100556141|FG000|Overall Study|Withdrawn for other reasons|13|||
33176587|NCT00412854|100556142|FG001|Overall Study|Withdrawn for other reasons|11|||
33176588|NCT00405587|100556143|FG000|Overall Study|Death|0|||
33176589|NCT00405587|100556144|FG001|Overall Study|Death|0|||
33176590|NCT00405587|100556145|FG002|Overall Study|Death|0|||
33176591|NCT00405587|100556146|FG003|Overall Study|Death|1|||
33176592|NCT00405587|100556143|FG000|Overall Study|Disease Progression|22|||
33176593|NCT00405587|100556144|FG001|Overall Study|Disease Progression|23|||
33176594|NCT00405587|100556145|FG002|Overall Study|Disease Progression|21|||
33176595|NCT00405587|100556146|FG003|Overall Study|Disease Progression|17|||
33176596|NCT00405587|100556143|FG000|Overall Study|Physician Decision|3|||
33176597|NCT00405587|100556144|FG001|Overall Study|Physician Decision|2|||
33176598|NCT00405587|100556145|FG002|Overall Study|Physician Decision|0|||
33176599|NCT00405587|100556146|FG003|Overall Study|Physician Decision|0|||
33176600|NCT00405587|100556143|FG000|Overall Study|Adverse Event|1|||
33176601|NCT00405587|100556144|FG001|Overall Study|Adverse Event|0|||
33176602|NCT00405587|100556145|FG002|Overall Study|Adverse Event|0|||
33176603|NCT00405587|100556146|FG003|Overall Study|Adverse Event|0|||
33176604|NCT00405587|100556143|FG000|Overall Study|Lost to Follow-up|0|||
33176605|NCT00405587|100556144|FG001|Overall Study|Lost to Follow-up|1|||
33176606|NCT00405587|100556145|FG002|Overall Study|Lost to Follow-up|1|||
33176607|NCT00405587|100556146|FG003|Overall Study|Lost to Follow-up|0|||
33176608|NCT00405587|100556143|FG000|Overall Study|Radiation induced necrosis|0|||
33176609|NCT00405587|100556144|FG001|Overall Study|Radiation induced necrosis|1|||
33176610|NCT00405587|100556145|FG002|Overall Study|Radiation induced necrosis|0|||
33176611|NCT00405587|100556146|FG003|Overall Study|Radiation induced necrosis|0|||
33176612|NCT00405587|100556143|FG000|Overall Study|Withdrawal by Subject|0|||
33176613|NCT00405587|100556144|FG001|Overall Study|Withdrawal by Subject|0|||
33176614|NCT00405587|100556145|FG002|Overall Study|Withdrawal by Subject|0|||
33176615|NCT00405587|100556146|FG003|Overall Study|Withdrawal by Subject|2|||
33176616|NCT00405587|100556143|FG000|Overall Study|Participant not dosed|0|||
33176617|NCT00405587|100556144|FG001|Overall Study|Participant not dosed|1|||
33176618|NCT00405587|100556145|FG002|Overall Study|Participant not dosed|0|||
33176619|NCT00405587|100556146|FG003|Overall Study|Participant not dosed|0|||
33176620|NCT02062879|100556147|FG000|Overall Study|Withdrawal by Subject|4|||
33176621|NCT02062879|100556148|FG001|Overall Study|Withdrawal by Subject|1|||
33463254|NCT00808509|101586033|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
33463255|NCT00808509|101586032|FG000|Randomized Phase|Reduced methotrexate dose|1|||
33463256|NCT00808509|101586033|FG001|Randomized Phase|Reduced methotrexate dose|2|||
33176622|NCT00003492|100556153|FG000|Overall Study|Not evaluable|6|||
33176623|NCT02335099|100556154|FG000|Treatment|Withdrawal by Subject|1|||
33176624|NCT02335099|100556155|FG001|Treatment|Withdrawal by Subject|3|||
33176625|NCT02335099|100556154|FG000|Treatment|Lost to Follow-up|2|||
33176626|NCT02335099|100556155|FG001|Treatment|Lost to Follow-up|0|||
33176627|NCT02335099|100556154|FG000|Treatment|Death|1|||
33176628|NCT02335099|100556155|FG001|Treatment|Death|0|||
33176629|NCT02335099|100556154|FG000|Treatment|Adverse Event|1|||
33176630|NCT02335099|100556155|FG001|Treatment|Adverse Event|2|||
33176631|NCT02335099|100556154|FG000|Follow-up|Death|0|||
33176632|NCT02335099|100556155|FG001|Follow-up|Death|1|||
33176633|NCT03649711|100556156|FG000|Overall Study|Adverse Event|0|||
33176634|NCT03649711|100556157|FG001|Overall Study|Adverse Event|1|||
33176635|NCT03649711|100556158|FG002|Overall Study|Adverse Event|0|||
33176636|NCT03649711|100556156|FG000|Overall Study|Kidney Transplant|1|||
33176637|NCT03649711|100556157|FG001|Overall Study|Kidney Transplant|0|||
33176638|NCT03649711|100556158|FG002|Overall Study|Kidney Transplant|0|||
33176639|NCT01111149|100556159|FG000|Overall Study|Protocol Violation|1|||
33176640|NCT01111149|100556160|FG001|Overall Study|Protocol Violation|1|||
33176641|NCT01111149|100556161|FG002|Overall Study|Protocol Violation|2|||
33176642|NCT01111149|100556159|FG000|Overall Study|Withdrawal by Subject|1|||
33176643|NCT01111149|100556160|FG001|Overall Study|Withdrawal by Subject|0|||
33176644|NCT01111149|100556161|FG002|Overall Study|Withdrawal by Subject|2|||
33176645|NCT01603459|100556162|FG000|Overall Study|Adverse Event|5|||
33176646|NCT01603459|100556162|FG000|Overall Study|Withdrawal by Subject|5|||
33176647|NCT01603459|100556162|FG000|Overall Study|Lost to Follow-up|3|||
33176648|NCT01603459|100556162|FG000|Overall Study|Predefined discontinuation criteria|3|||
33176649|NCT01603459|100556162|FG000|Overall Study|Non-compliance|1|||
33463257|NCT00808509|101586032|FG000|Randomized Phase|Patient refused rescue therapy|0|||
33463258|NCT00808509|101586033|FG001|Randomized Phase|Patient refused rescue therapy|3|||
33463259|NCT01020526|101586039|FG000|Overall Study|Withdrawal by Subject|5|||
33463260|NCT01020526|101586039|FG000|Overall Study|Other reasons|3|||
33463261|NCT01020526|101586039|FG000|Overall Study|Insufficient clinical response|3|||
33463262|NCT01020526|101586039|FG000|Overall Study|Lost to Follow-up|1|||
33463263|NCT01020526|101586039|FG000|Overall Study|Adverse Event|2|||
33463264|NCT02246764|101586040|FG000|Overall Study|Adverse Event|15|||
33463265|NCT02246764|101586041|FG001|Overall Study|Adverse Event|29|||
33463266|NCT02246764|101586042|FG002|Overall Study|Adverse Event|1|||
33463267|NCT02246764|101586040|FG000|Overall Study|Withdrawal by Subject|0|||
33463268|NCT02246764|101586041|FG001|Overall Study|Withdrawal by Subject|0|||
33463269|NCT02246764|101586042|FG002|Overall Study|Withdrawal by Subject|1|||
33463270|NCT02246764|101586040|FG000|Overall Study|Disallowed Concomitant Medication|1|||
33463271|NCT02246764|101586041|FG001|Overall Study|Disallowed Concomitant Medication|0|||
33463272|NCT02246764|101586042|FG002|Overall Study|Disallowed Concomitant Medication|0|||
33463273|NCT02246764|101586040|FG000|Overall Study|Physician Decision|0|||
33463274|NCT02246764|101586041|FG001|Overall Study|Physician Decision|2|||
33463275|NCT02246764|101586042|FG002|Overall Study|Physician Decision|1|||
33176650|NCT01603459|100556162|FG000|Overall Study|Administrative reason|1|||
33176651|NCT01996709|100556163|FG000|Overall Study|Withdrawal by Subject|1|||
33463276|NCT02246764|101586040|FG000|Overall Study|Protocol Violation|2|||
33176652|NCT01996709|100556164|FG001|Overall Study|Withdrawal by Subject|0|||
33176653|NCT01996709|100556163|FG000|Overall Study|Lost to Follow-up|3|||
33463277|NCT02246764|101586041|FG001|Overall Study|Protocol Violation|1|||
33463278|NCT02246764|101586042|FG002|Overall Study|Protocol Violation|1|||
33176654|NCT01996709|100556164|FG001|Overall Study|Lost to Follow-up|0|||
33176655|NCT01996709|100556163|FG000|Overall Study|Subject Non-Compliant|1|||
33176656|NCT01996709|100556164|FG001|Overall Study|Subject Non-Compliant|0|||
33463279|NCT01363011|101586049|FG000|Main Study|Adverse Event|2|||
33463280|NCT01363011|101586050|FG001|Main Study|Adverse Event|3|||
33463281|NCT01363011|101586049|FG000|Main Study|Investigator's Discretion|1|||
33463282|NCT01363011|101586050|FG001|Main Study|Investigator's Discretion|1|||
33463283|NCT01363011|101586049|FG000|Main Study|Withdrew Consent|1|||
33463284|NCT01363011|101586050|FG001|Main Study|Withdrew Consent|4|||
33463285|NCT01363011|101586049|FG000|Main Study|Protocol Violation|0|||
33463286|NCT01363011|101586050|FG001|Main Study|Protocol Violation|1|||
33463287|NCT01363011|101586049|FG000|Extension Phase|Adverse Event|1|||
33463288|NCT01363011|101586050|FG001|Extension Phase|Adverse Event|1|||
33463289|NCT01363011|101586049|FG000|Extension Phase|Lack of Efficacy|0|||
33463290|NCT01363011|101586050|FG001|Extension Phase|Lack of Efficacy|1|||
33463291|NCT01363011|101586049|FG000|Extension Phase|Investigator's Discretion|2|||
33463292|NCT01363011|101586050|FG001|Extension Phase|Investigator's Discretion|2|||
33463293|NCT01363011|101586049|FG000|Extension Phase|Withdrew Consent|0|||
33463294|NCT01363011|101586050|FG001|Extension Phase|Withdrew Consent|1|||
33463295|NCT01363011|101586049|FG000|Extension Phase|Lost to Follow-up|0|||
33463296|NCT01363011|101586050|FG001|Extension Phase|Lost to Follow-up|2|||
33463297|NCT01363011|101586049|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
33463298|NCT01363011|101586050|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
33463299|NCT00981799|101586052|FG000|Overall Study|Adverse Event|1|||
33463300|NCT00981799|101586053|FG001|Overall Study|Adverse Event|1|||
33463301|NCT00981799|101586054|FG002|Overall Study|Adverse Event|0|||
33463302|NCT00981799|101586055|FG003|Overall Study|Adverse Event|0|||
33463303|NCT02244424|101586056|FG000|Overall Study|Lost to Follow-up|20|||
33463304|NCT02244424|101586057|FG001|Overall Study|Lost to Follow-up|10|||
33463305|NCT00224484|101586058|FG000|Overall Study|Serious Adverse Event|1|||
33463306|NCT00224484|101586059|FG001|Overall Study|Serious Adverse Event|1|||
33463307|NCT00224484|101586060|FG002|Overall Study|Serious Adverse Event|0|||
33463308|NCT00224484|101586058|FG000|Overall Study|Non-Serious Adverse Event|5|||
33463309|NCT00224484|101586059|FG001|Overall Study|Non-Serious Adverse Event|7|||
33463310|NCT00224484|101586060|FG002|Overall Study|Non-Serious Adverse Event|3|||
33463311|NCT00224484|101586058|FG000|Overall Study|Protocol Violation|2|||
33463312|NCT00224484|101586059|FG001|Overall Study|Protocol Violation|2|||
33463313|NCT00224484|101586060|FG002|Overall Study|Protocol Violation|0|||
33463314|NCT00224484|101586058|FG000|Overall Study|Withdrawal by Subject|49|||
33463315|NCT00224484|101586059|FG001|Overall Study|Withdrawal by Subject|18|||
33463316|NCT00224484|101586060|FG002|Overall Study|Withdrawal by Subject|16|||
33463317|NCT00224484|101586058|FG000|Overall Study|Migrated/moved from study area|18|||
33463318|NCT00224484|101586059|FG001|Overall Study|Migrated/moved from study area|5|||
33463319|NCT00224484|101586060|FG002|Overall Study|Migrated/moved from study area|5|||
33463320|NCT00224484|101586058|FG000|Overall Study|Lost to Follow-up|66|||
33463321|NCT00224484|101586059|FG001|Overall Study|Lost to Follow-up|28|||
33463322|NCT00224484|101586060|FG002|Overall Study|Lost to Follow-up|36|||
33463323|NCT00224484|101586058|FG000|Overall Study|Reason not specified|5|||
33463324|NCT00224484|101586059|FG001|Overall Study|Reason not specified|4|||
33463325|NCT00224484|101586060|FG002|Overall Study|Reason not specified|2|||
33463326|NCT02001051|101586061|FG000|Overall Study|Deemed not eligible following enrollment|0|||
33463327|NCT02001051|101586062|FG001|Overall Study|Deemed not eligible following enrollment|1|||
33463328|NCT03259789|101586065|FG000|Overall Study|Adverse Event|3|||
33463329|NCT03259789|101586066|FG001|Overall Study|Adverse Event|2|||
33463330|NCT03259789|101586067|FG002|Overall Study|Adverse Event|1|||
33463331|NCT03259789|101586065|FG000|Overall Study|Withdrawal by Subject|9|||
33463332|NCT03259789|101586066|FG001|Overall Study|Withdrawal by Subject|5|||
33463333|NCT03259789|101586067|FG002|Overall Study|Withdrawal by Subject|1|||
33463334|NCT03259789|101586065|FG000|Overall Study|Lost to Follow-up|5|||
33463335|NCT03259789|101586066|FG001|Overall Study|Lost to Follow-up|9|||
33463336|NCT03259789|101586067|FG002|Overall Study|Lost to Follow-up|4|||
33463337|NCT03259789|101586065|FG000|Overall Study|Physician Decision|0|||
33463338|NCT03259789|101586066|FG001|Overall Study|Physician Decision|1|||
33463339|NCT03259789|101586067|FG002|Overall Study|Physician Decision|0|||
33463340|NCT02938442|101586068|FG000|Overall Study|Death|0|||
33463341|NCT02938442|101586069|FG001|Overall Study|Death|1|||
33463342|NCT02938442|101586068|FG000|Overall Study|Lost to Follow-up|0|||
33463343|NCT02938442|101586069|FG001|Overall Study|Lost to Follow-up|1|||
33463344|NCT02938442|101586068|FG000|Overall Study|Physician Decision|0|||
33463345|NCT02938442|101586069|FG001|Overall Study|Physician Decision|1|||
33463346|NCT02938442|101586068|FG000|Overall Study|Withdrawal by Subject|2|||
33463347|NCT02938442|101586069|FG001|Overall Study|Withdrawal by Subject|0|||
33463348|NCT02485158|101586072|FG000|Overall Study|Withdrawal by Subject|3|||
33463349|NCT02485158|101586072|FG000|Overall Study|expected drug side effect|1|||
33463350|NCT01011556|101586078|FG000|Overall Study|Adverse Event|1|||
33463351|NCT01011556|101586079|FG001|Overall Study|Adverse Event|3|||
33463352|NCT01011556|101586080|FG002|Overall Study|Adverse Event|2|||
33463353|NCT01011556|101586081|FG003|Overall Study|Adverse Event|1|||
33463354|NCT01011556|101586078|FG000|Overall Study|Lost to Follow-up|1|||
33463355|NCT01011556|101586079|FG001|Overall Study|Lost to Follow-up|0|||
33463356|NCT01011556|101586080|FG002|Overall Study|Lost to Follow-up|0|||
33463357|NCT01011556|101586081|FG003|Overall Study|Lost to Follow-up|0|||
33463358|NCT01011556|101586078|FG000|Overall Study|Physician Decision|1|||
33463359|NCT01011556|101586079|FG001|Overall Study|Physician Decision|0|||
33463360|NCT01011556|101586080|FG002|Overall Study|Physician Decision|0|||
33463361|NCT01011556|101586081|FG003|Overall Study|Physician Decision|1|||
33463362|NCT01011556|101586078|FG000|Overall Study|Protocol Violation|0|||
33463363|NCT01011556|101586079|FG001|Overall Study|Protocol Violation|1|||
33463364|NCT01011556|101586080|FG002|Overall Study|Protocol Violation|0|||
33463365|NCT01011556|101586081|FG003|Overall Study|Protocol Violation|0|||
33463366|NCT01011556|101586078|FG000|Overall Study|Withdrawal by Subject|1|||
33463367|NCT01011556|101586079|FG001|Overall Study|Withdrawal by Subject|2|||
33463368|NCT01011556|101586080|FG002|Overall Study|Withdrawal by Subject|4|||
33463369|NCT01011556|101586081|FG003|Overall Study|Withdrawal by Subject|4|||
33463370|NCT01011556|101586078|FG000|Overall Study|Sponsor decision|0|||
33463371|NCT01011556|101586079|FG001|Overall Study|Sponsor decision|1|||
33463372|NCT01011556|101586080|FG002|Overall Study|Sponsor decision|1|||
33463373|NCT01011556|101586081|FG003|Overall Study|Sponsor decision|2|||
33463374|NCT01011556|101586078|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
33463375|NCT01011556|101586079|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
33463376|NCT01011556|101586080|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
33463377|NCT01011556|101586081|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
33463378|NCT02839798|101586082|FG000|Overall Study|Withdrawal by Subject|2|||
33463379|NCT03087786|101586083|FG000|Overall Study|Withdrawal by Subject|2|||
33463380|NCT03087786|101586084|FG001|Overall Study|Withdrawal by Subject|0|||
33463381|NCT00063882|101586085|FG000|Overall Study|Protocol Violation|3|||
33463382|NCT00063882|101586086|FG001|Overall Study|Protocol Violation|3|||
33463383|NCT00063882|101586085|FG000|Overall Study|Withdrawal by Subject|2|||
33463384|NCT00063882|101586086|FG001|Overall Study|Withdrawal by Subject|1|||
33463385|NCT01957150|101586095|FG000|Overall Study|Adverse Event|23|||
33463386|NCT01957150|101586096|FG001|Overall Study|Adverse Event|20|||
33463387|NCT01957150|101586095|FG000|Overall Study|Withdrawal by Subject|13|||
33463388|NCT01957150|101586096|FG001|Overall Study|Withdrawal by Subject|17|||
33463389|NCT01957150|101586095|FG000|Overall Study|Physician Decision|3|||
33463390|NCT01957150|101586096|FG001|Overall Study|Physician Decision|6|||
33463391|NCT01957150|101586095|FG000|Overall Study|Lost to Follow-up|4|||
33463392|NCT01957150|101586096|FG001|Overall Study|Lost to Follow-up|4|||
33463393|NCT01957150|101586095|FG000|Overall Study|Protocol Violation|1|||
33463394|NCT01957150|101586096|FG001|Overall Study|Protocol Violation|0|||
33463395|NCT01957150|101586095|FG000|Overall Study|Lack of Efficacy|11|||
33463396|NCT01957150|101586096|FG001|Overall Study|Lack of Efficacy|11|||
33463397|NCT02344745|101586104|FG000|Overall Study|Data collection sheets were lost|2|||
33463398|NCT02344745|101586105|FG001|Overall Study|Data collection sheets were lost|0|||
33463399|NCT01301482|101586107|FG000|Overall Study|Withdrawal by Subject|1|||
33463400|NCT00442351|101586112|FG000|Overall Study|Administrative|6|||
33463401|NCT00442351|101586113|FG001|Overall Study|Administrative|5|||
33463402|NCT00442351|101586112|FG000|Overall Study|Did not meet protocol eligibility|1|||
33463403|NCT00442351|101586113|FG001|Overall Study|Did not meet protocol eligibility|0|||
33463404|NCT00442351|101586112|FG000|Overall Study|Other|0|||
33463405|NCT00442351|101586113|FG001|Overall Study|Other|1|||
33463406|NCT02419573|101586114|FG000|Overall Study|Lost to Follow-up|3|||
33463407|NCT02419573|101586115|FG001|Overall Study|Lost to Follow-up|0|||
33463408|NCT02419573|101586114|FG000|Overall Study|Withdrawal by Subject|1|||
33176657|NCT01996709|100556163|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
33463409|NCT02419573|101586115|FG001|Overall Study|Withdrawal by Subject|0|||
33463410|NCT03566238|101586116|FG000|Overall Study|Adverse Event|0|||
33463411|NCT03566238|101586117|FG001|Overall Study|Adverse Event|1|||
33463412|NCT03566238|101586118|FG002|Overall Study|Adverse Event|0|||
33463413|NCT03566238|101586116|FG000|Overall Study|Lack of Efficacy|4|||
33463414|NCT03566238|101586117|FG001|Overall Study|Lack of Efficacy|2|||
33263344|NCT03246724|100863965|FG000|Overall Study|Withdrawal by Subject|5|||
33463415|NCT03566238|101586118|FG002|Overall Study|Lack of Efficacy|5|||
33463416|NCT03566238|101586116|FG000|Overall Study|Other|1|||
33463417|NCT03566238|101586117|FG001|Overall Study|Other|0|||
33263345|NCT03246724|100863966|FG001|Overall Study|Withdrawal by Subject|2|||
33463418|NCT03566238|101586118|FG002|Overall Study|Other|0|||
33463419|NCT04403399|101586119|FG000|Period 2|Physician Decision|0|||
33463420|NCT04403399|101586120|FG001|Period 2|Physician Decision|1|||
33263346|NCT03246724|100863967|FG002|Overall Study|Withdrawal by Subject|4|||
33263347|NCT03246724|100863968|FG003|Overall Study|Withdrawal by Subject|2|||
33263348|NCT03246724|100863965|FG000|Overall Study|Ineligible on day of surgery|7|||
33263349|NCT03246724|100863966|FG001|Overall Study|Ineligible on day of surgery|2|||
33263350|NCT03246724|100863967|FG002|Overall Study|Ineligible on day of surgery|0|||
33263351|NCT03246724|100863968|FG003|Overall Study|Ineligible on day of surgery|3|||
33263352|NCT03246724|100863965|FG000|Overall Study|Study completed before surgical date|2|||
33263353|NCT03246724|100863966|FG001|Overall Study|Study completed before surgical date|1|||
33263354|NCT03246724|100863967|FG002|Overall Study|Study completed before surgical date|8|||
33463421|NCT04099641|101586121|FG000|Overall Study|Death|46|||
33463422|NCT04099641|101586122|FG001|Overall Study|Death|12|||
33463423|NCT04099641|101586121|FG000|Overall Study|Lost to Follow-up|1|||
33463424|NCT04099641|101586122|FG001|Overall Study|Lost to Follow-up|0|||
33463425|NCT04099641|101586121|FG000|Overall Study|Withdrawal by Subject|2|||
33463426|NCT04099641|101586122|FG001|Overall Study|Withdrawal by Subject|0|||
33463427|NCT00802178|101586123|FG000|Overall Study|Lack of Efficacy|36|||
33463428|NCT00802178|101586123|FG000|Overall Study|Insufficient tolerability (IT)|17|||
33463429|NCT00802178|101586123|FG000|Overall Study|Withdrawal by Subject|18|||
33463430|NCT00802178|101586123|FG000|Overall Study|Other|32|||
33463431|NCT00802178|101586123|FG000|Overall Study|Lack of efficacy and patient wish|1|||
33463432|NCT00802178|101586123|FG000|Overall Study|IT and patient wish|8|||
33463433|NCT00802178|101586123|FG000|Overall Study|Patients wish and other reason|1|||
33463434|NCT03381196|101586128|FG000|Overall Study|Withdrawal by Subject|7|||
33463435|NCT03381196|101586129|FG001|Overall Study|Withdrawal by Subject|7|||
33463436|NCT03381196|101586128|FG000|Overall Study|Other|0|||
33463437|NCT03381196|101586129|FG001|Overall Study|Other|1|||
33463438|NCT03381196|101586128|FG000|Overall Study|Lost to Follow-up|5|||
33463439|NCT03381196|101586129|FG001|Overall Study|Lost to Follow-up|4|||
33463440|NCT03381196|101586128|FG000|Overall Study|Death|0|||
33463441|NCT03381196|101586129|FG001|Overall Study|Death|1|||
33463442|NCT03381196|101586128|FG000|Overall Study|Adverse Event|1|||
33463443|NCT03381196|101586129|FG001|Overall Study|Adverse Event|0|||
33463444|NCT03381196|101586128|FG000|Overall Study|Randomized, not treated|3|||
33463445|NCT03381196|101586129|FG001|Overall Study|Randomized, not treated|6|||
33463446|NCT04542694|101586130|FG000|Overall Study|The need for prohibited therapy|2|||
33463447|NCT04542694|101586131|FG001|Overall Study|The need for prohibited therapy|0|||
33463448|NCT04542694|101586130|FG000|Overall Study|Adverse Event|1|||
33463449|NCT04542694|101586131|FG001|Overall Study|Adverse Event|0|||
33463450|NCT04542694|101586130|FG000|Overall Study|Protocol Violation|1|||
33463451|NCT04542694|101586131|FG001|Overall Study|Protocol Violation|0|||
33463452|NCT03546647|101586132|FG000|Overall Study|Adverse Event|1|||
33463453|NCT03546647|101586133|FG001|Overall Study|Adverse Event|0|||
33463454|NCT01115855|101586134|FG000|Overall Study|Adverse Event|16|||
33463455|NCT01115855|101586135|FG001|Overall Study|Adverse Event|18|||
33463456|NCT01115855|101586134|FG000|Overall Study|Death|6|||
33463457|NCT01115855|101586135|FG001|Overall Study|Death|5|||
33463458|NCT01115855|101586134|FG000|Overall Study|Lab Abnormality|1|||
33463459|NCT01115855|101586135|FG001|Overall Study|Lab Abnormality|1|||
33463460|NCT01115855|101586134|FG000|Overall Study|Protocol Violation|0|||
33463461|NCT01115855|101586135|FG001|Overall Study|Protocol Violation|1|||
33463462|NCT01115855|101586134|FG000|Overall Study|Withdrawal by Subject|5|||
33463463|NCT01115855|101586135|FG001|Overall Study|Withdrawal by Subject|5|||
33463464|NCT01115855|101586134|FG000|Overall Study|Other|8|||
33463465|NCT01115855|101586135|FG001|Overall Study|Other|6|||
33463466|NCT01662362|101586136|FG000|Overall Study|Lost to Follow-up|38|||
33463467|NCT01011335|101586137|FG000|Overall Study|Lost to Follow-up|0|||
33463468|NCT01011335|101586138|FG001|Overall Study|Lost to Follow-up|0|||
33463469|NCT01011335|101586139|FG002|Overall Study|Lost to Follow-up|1|||
33463470|NCT01011335|101586140|FG003|Overall Study|Lost to Follow-up|1|||
33463471|NCT01011335|101586141|FG004|Overall Study|Lost to Follow-up|1|||
33463472|NCT01011335|101586142|FG005|Overall Study|Lost to Follow-up|1|||
33463473|NCT01011335|101586143|FG006|Overall Study|Lost to Follow-up|2|||
33463474|NCT01011335|101586144|FG007|Overall Study|Lost to Follow-up|2|||
33463475|NCT01011335|101586145|FG008|Overall Study|Lost to Follow-up|1|||
33463476|NCT01011335|101586146|FG009|Overall Study|Lost to Follow-up|0|||
33463477|NCT01011335|101586147|FG010|Overall Study|Lost to Follow-up|0|||
33463478|NCT01011335|101586148|FG011|Overall Study|Lost to Follow-up|1|||
33463479|NCT01011335|101586149|FG012|Overall Study|Lost to Follow-up|2|||
33463480|NCT01011335|101586137|FG000|Overall Study|Protocol Violation|0|||
33463481|NCT01011335|101586138|FG001|Overall Study|Protocol Violation|1|||
33463482|NCT01011335|101586139|FG002|Overall Study|Protocol Violation|0|||
33463483|NCT01011335|101586140|FG003|Overall Study|Protocol Violation|0|||
33463484|NCT01011335|101586141|FG004|Overall Study|Protocol Violation|0|||
33463485|NCT01011335|101586142|FG005|Overall Study|Protocol Violation|0|||
33463486|NCT01011335|101586143|FG006|Overall Study|Protocol Violation|0|||
33463487|NCT01011335|101586144|FG007|Overall Study|Protocol Violation|0|||
33463488|NCT01011335|101586145|FG008|Overall Study|Protocol Violation|0|||
33463489|NCT01011335|101586146|FG009|Overall Study|Protocol Violation|0|||
33463490|NCT01011335|101586147|FG010|Overall Study|Protocol Violation|0|||
33463491|NCT01011335|101586148|FG011|Overall Study|Protocol Violation|0|||
33463492|NCT01011335|101586149|FG012|Overall Study|Protocol Violation|0|||
33463493|NCT01011335|101586137|FG000|Overall Study|Moved/deployed or no booster|1|||
33463494|NCT01011335|101586138|FG001|Overall Study|Moved/deployed or no booster|0|||
33463495|NCT01011335|101586139|FG002|Overall Study|Moved/deployed or no booster|0|||
33463496|NCT01011335|101586140|FG003|Overall Study|Moved/deployed or no booster|1|||
33463497|NCT01011335|101586141|FG004|Overall Study|Moved/deployed or no booster|0|||
33463498|NCT01011335|101586142|FG005|Overall Study|Moved/deployed or no booster|0|||
33463499|NCT01011335|101586143|FG006|Overall Study|Moved/deployed or no booster|1|||
33463500|NCT01011335|101586144|FG007|Overall Study|Moved/deployed or no booster|0|||
33463501|NCT01011335|101586145|FG008|Overall Study|Moved/deployed or no booster|1|||
33463502|NCT01011335|101586146|FG009|Overall Study|Moved/deployed or no booster|0|||
33463503|NCT01011335|101586147|FG010|Overall Study|Moved/deployed or no booster|2|||
33463504|NCT01011335|101586148|FG011|Overall Study|Moved/deployed or no booster|0|||
33463505|NCT01011335|101586149|FG012|Overall Study|Moved/deployed or no booster|0|||
33463506|NCT01011335|101586137|FG000|Overall Study|Adverse Event|0|||
33463507|NCT01011335|101586138|FG001|Overall Study|Adverse Event|0|||
33463508|NCT01011335|101586139|FG002|Overall Study|Adverse Event|0|||
33463509|NCT01011335|101586140|FG003|Overall Study|Adverse Event|0|||
33463510|NCT01011335|101586141|FG004|Overall Study|Adverse Event|0|||
33463511|NCT01011335|101586142|FG005|Overall Study|Adverse Event|0|||
33463512|NCT01011335|101586143|FG006|Overall Study|Adverse Event|0|||
33463513|NCT01011335|101586144|FG007|Overall Study|Adverse Event|0|||
33463514|NCT01011335|101586145|FG008|Overall Study|Adverse Event|0|||
33463515|NCT01011335|101586146|FG009|Overall Study|Adverse Event|0|||
33463516|NCT01011335|101586147|FG010|Overall Study|Adverse Event|4|||
33463517|NCT01011335|101586148|FG011|Overall Study|Adverse Event|0|||
33463518|NCT01011335|101586149|FG012|Overall Study|Adverse Event|1|||
33463519|NCT02985398|101586152|FG000|Overall Study|Adverse Event|1|||
33463520|NCT02985398|101586152|FG000|Overall Study|Lost to Follow-up|4|||
33463521|NCT02985398|101586152|FG000|Overall Study|Withdrawal by Subject|8|||
33463522|NCT02985398|101586152|FG000|Overall Study|Study Burden|9|||
33263355|NCT03246724|100863968|FG003|Overall Study|Study completed before surgical date|1|||
33463523|NCT01321697|101586155|FG000|Overall Study|Study Terminated|7|||
33463524|NCT01644149|101586159|FG000|Overall Study|Withdrawal by Subject|1|||
33463525|NCT01644149|101586160|FG001|Overall Study|Withdrawal by Subject|0|||
33463526|NCT01644149|101586159|FG000|Overall Study|Lost to Follow-up|3|||
33463527|NCT01644149|101586160|FG001|Overall Study|Lost to Follow-up|1|||
33463528|NCT00996437|101586161|FG000|Overall Study|Death|1|||
33463529|NCT00996437|101586162|FG001|Overall Study|Death|0|||
33463530|NCT00996437|101586161|FG000|Overall Study|Dropped|2|||
33463531|NCT00996437|101586162|FG001|Overall Study|Dropped|2|||
33463532|NCT00996437|101586161|FG000|Overall Study|Missed|2|||
33463533|NCT00996437|101586162|FG001|Overall Study|Missed|5|||
33463534|NCT01355302|101586163|FG000|Phase 1b|Death|4|||
33263356|NCT03246724|100863965|FG000|Overall Study|Transferred to other arm|0|||
33263357|NCT03246724|100863966|FG001|Overall Study|Transferred to other arm|0|||
33263358|NCT03246724|100863967|FG002|Overall Study|Transferred to other arm|1|||
33263359|NCT03246724|100863968|FG003|Overall Study|Transferred to other arm|0|||
33263360|NCT03246724|100863965|FG000|Overall Study|Unable to obtain medication timely|0|||
33463535|NCT01355302|101586164|FG001|Phase 1b|Death|0|||
33463536|NCT01355302|101586165|FG002|Phase 1b|Death|0|||
33463537|NCT01355302|101586163|FG000|Phase 1b|Study terminated by sponsor|2|||
33463538|NCT01355302|101586164|FG001|Phase 1b|Study terminated by sponsor|0|||
33463539|NCT01355302|101586165|FG002|Phase 1b|Study terminated by sponsor|0|||
33463540|NCT02280187|101586166|FG000|Overall Study|Lost to Follow-up|218|||
33463541|NCT00595335|101586171|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
33463542|NCT00595335|101586172|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
33463543|NCT00595335|101586171|FG000|Baseline to Six Months|Disease Progression|1|||
33463544|NCT00595335|101586172|FG001|Baseline to Six Months|Disease Progression|1|||
33263361|NCT03246724|100863966|FG001|Overall Study|Unable to obtain medication timely|2|||
33263362|NCT03246724|100863967|FG002|Overall Study|Unable to obtain medication timely|2|||
33263363|NCT03246724|100863968|FG003|Overall Study|Unable to obtain medication timely|1|||
33463545|NCT00595335|101586171|FG000|Baseline to Six Months|Adverse Event|1|||
33463546|NCT00595335|101586172|FG001|Baseline to Six Months|Adverse Event|0|||
33463547|NCT00595335|101586171|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
33463548|NCT00595335|101586172|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
33463549|NCT00595335|101586171|FG000|Six Months to Twelve Months|Disease Progression|1|||
33463550|NCT00595335|101586172|FG001|Six Months to Twelve Months|Disease Progression|0|||
33463551|NCT04234464|101586176|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
33463552|NCT04234464|101586177|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
33463553|NCT01192399|101586178|FG000|Overall Study|Lack of Efficacy|2|||
33463554|NCT02576717|101586179|FG000|Overall Study|Other Reasons|16|||
33463555|NCT02576717|101586180|FG001|Overall Study|Other Reasons|18|||
33463556|NCT02576717|101586181|FG002|Overall Study|Other Reasons|15|||
33463557|NCT02576717|101586179|FG000|Overall Study|Covid-19 Pandemic|0|||
33263364|NCT03246724|100863965|FG000|Overall Study|Re-consented to participate|0|||
33263365|NCT03246724|100863966|FG001|Overall Study|Re-consented to participate|0|||
33263366|NCT03246724|100863967|FG002|Overall Study|Re-consented to participate|0|||
33263367|NCT03246724|100863968|FG003|Overall Study|Re-consented to participate|1|||
33263368|NCT00116649|100863969|FG000|Overall Study|Adverse Event|20|||
33463558|NCT02576717|101586180|FG001|Overall Study|Covid-19 Pandemic|1|||
33463559|NCT02576717|101586181|FG002|Overall Study|Covid-19 Pandemic|1|||
33463560|NCT02576717|101586179|FG000|Overall Study|Sponsor Decision|0|||
33463561|NCT02576717|101586180|FG001|Overall Study|Sponsor Decision|0|||
33463562|NCT02576717|101586181|FG002|Overall Study|Sponsor Decision|1|||
33463563|NCT02576717|101586179|FG000|Overall Study|Physician Decision|3|||
33463564|NCT02576717|101586180|FG001|Overall Study|Physician Decision|8|||
33463565|NCT02576717|101586181|FG002|Overall Study|Physician Decision|9|||
33463566|NCT02576717|101586179|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
33463567|NCT02576717|101586180|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
33463568|NCT02576717|101586181|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
33463569|NCT02576717|101586179|FG000|Overall Study|Death|3|||
33463570|NCT02576717|101586180|FG001|Overall Study|Death|5|||
33463571|NCT02576717|101586181|FG002|Overall Study|Death|3|||
33463572|NCT02576717|101586179|FG000|Overall Study|Lost to Follow-up|9|||
33463573|NCT02576717|101586180|FG001|Overall Study|Lost to Follow-up|10|||
33463574|NCT02576717|101586181|FG002|Overall Study|Lost to Follow-up|19|||
33463575|NCT02576717|101586179|FG000|Overall Study|Protocol Violation|4|||
33463576|NCT02576717|101586180|FG001|Overall Study|Protocol Violation|0|||
33463577|NCT02576717|101586181|FG002|Overall Study|Protocol Violation|5|||
33463578|NCT02576717|101586179|FG000|Overall Study|Lack of Efficacy|24|||
33176658|NCT01996709|100556164|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
33176659|NCT01729754|100556165|FG000|Part 1|Adverse Event|2|||
33176660|NCT01729754|100556166|FG001|Part 1|Adverse Event|0|||
33263369|NCT00116649|100863969|FG000|Overall Study|Lack of Efficacy|1|||
33263370|NCT00116649|100863969|FG000|Overall Study|Lost to Follow-up|32|||
33263371|NCT00116649|100863969|FG000|Overall Study|Withdrawal by Subject|68|||
33263372|NCT00116649|100863969|FG000|Overall Study|Local Skin Reaction|9|||
33263373|NCT00116649|100863969|FG000|Overall Study|Various Reasons|18|||
33463579|NCT02576717|101586180|FG001|Overall Study|Lack of Efficacy|28|||
33463580|NCT02576717|101586181|FG002|Overall Study|Lack of Efficacy|20|||
33463581|NCT02576717|101586179|FG000|Overall Study|Adverse Event|26|||
33463582|NCT02576717|101586180|FG001|Overall Study|Adverse Event|32|||
33463583|NCT02576717|101586181|FG002|Overall Study|Adverse Event|26|||
33463584|NCT01134627|101586182|FG000|Overall Study|Adverse Event|47|||
33463585|NCT01134627|101586183|FG001|Overall Study|Adverse Event|31|||
33463586|NCT01134627|101586182|FG000|Overall Study|Lost to Follow-up|1|||
33463587|NCT01134627|101586183|FG001|Overall Study|Lost to Follow-up|2|||
33463588|NCT01134627|101586182|FG000|Overall Study|Protocol Violation|3|||
33176661|NCT01729754|100556167|FG002|Part 1|Adverse Event|0|||
33463589|NCT01134627|101586183|FG001|Overall Study|Protocol Violation|5|||
33463590|NCT01134627|101586182|FG000|Overall Study|Lack of Efficacy|2|||
33463591|NCT01134627|101586183|FG001|Overall Study|Lack of Efficacy|12|||
33463592|NCT01134627|101586182|FG000|Overall Study|Withdrawal by Subject|4|||
33463593|NCT01134627|101586183|FG001|Overall Study|Withdrawal by Subject|3|||
33463594|NCT01134627|101586182|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
33463595|NCT01134627|101586183|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
33463596|NCT01134627|101586182|FG000|Overall Study|Other|11|||
33463597|NCT01134627|101586183|FG001|Overall Study|Other|14|||
33463598|NCT00388037|101586186|FG000|Overall Study|Protocol Violation|1|||
33463599|NCT02415387|101586189|FG000|Overall Study|Withdrawal by Subject|6|||
33463600|NCT02415387|101586190|FG001|Overall Study|Withdrawal by Subject|1|||
33463601|NCT02415387|101586189|FG000|Overall Study|blood draw problem|0|||
33463602|NCT02415387|101586190|FG001|Overall Study|blood draw problem|1|||
33463603|NCT02415387|101586189|FG000|Overall Study|Protocol Violation|1|||
33176662|NCT01729754|100556168|FG003|Part 1|Adverse Event|1|||
33176663|NCT01729754|100556169|FG004|Part 1|Adverse Event|0|||
33263374|NCT00116649|100863969|FG000|Overall Study|Protocol Specified|7|||
33263375|NCT00503906|100863970|FG000|Overall Study|Withdrawal by Subject|1|||
33263376|NCT00960141|100866674|FG000|Overall Study|Adverse Event|4|||
33263377|NCT00960141|100866675|FG001|Overall Study|Adverse Event|8|||
33463604|NCT02415387|101586190|FG001|Overall Study|Protocol Violation|0|||
33463605|NCT00348816|101586191|FG000|Overall Study|Noncompliance with radiation treatment|1|||
33463606|NCT00588731|101586192|FG000|Overall Study|Withdrawal by Subject|3|||
33463607|NCT00588731|101586193|FG001|Overall Study|Withdrawal by Subject|2|||
33463608|NCT00346164|101586194|FG000|Overall Study|Adverse Event|0|||
33463609|NCT00346164|101586195|FG001|Overall Study|Adverse Event|0|||
33463610|NCT00346164|101586196|FG002|Overall Study|Adverse Event|0|||
33463611|NCT00346164|101586197|FG003|Overall Study|Adverse Event|1|||
33463612|NCT00346164|101586194|FG000|Overall Study|Lack of Efficacy|0|||
33463613|NCT00346164|101586195|FG001|Overall Study|Lack of Efficacy|1|||
33463614|NCT00346164|101586196|FG002|Overall Study|Lack of Efficacy|7|||
33463615|NCT00346164|101586197|FG003|Overall Study|Lack of Efficacy|25|||
33463616|NCT00346164|101586194|FG000|Overall Study|Physician Decision|0|||
33463617|NCT00346164|101586195|FG001|Overall Study|Physician Decision|1|||
33463618|NCT00346164|101586196|FG002|Overall Study|Physician Decision|2|||
33463619|NCT00346164|101586197|FG003|Overall Study|Physician Decision|27|||
33463620|NCT00346164|101586194|FG000|Overall Study|Protocol Violation|6|||
33463621|NCT00346164|101586195|FG001|Overall Study|Protocol Violation|2|||
33176664|NCT01729754|100556170|FG005|Part 1|Adverse Event|0|||
33463622|NCT00346164|101586196|FG002|Overall Study|Protocol Violation|10|||
33463623|NCT00346164|101586197|FG003|Overall Study|Protocol Violation|4|||
33463624|NCT00346164|101586194|FG000|Overall Study|Withdrawal by Subject|0|||
33176665|NCT01729754|100556171|FG006|Part 1|Adverse Event|2|||
33176666|NCT01729754|100556172|FG007|Part 1|Adverse Event|0|||
33176667|NCT01729754|100556173|FG008|Part 1|Adverse Event|0|||
33176668|NCT01729754|100556174|FG009|Part 1|Adverse Event|5|||
33176669|NCT01729754|100556165|FG000|Part 1|Lack of Efficacy|1|||
33176670|NCT01729754|100556166|FG001|Part 1|Lack of Efficacy|0|||
33176671|NCT01729754|100556167|FG002|Part 1|Lack of Efficacy|0|||
33176672|NCT01729754|100556168|FG003|Part 1|Lack of Efficacy|0|||
33176673|NCT01729754|100556169|FG004|Part 1|Lack of Efficacy|0|||
33176674|NCT01729754|100556170|FG005|Part 1|Lack of Efficacy|0|||
33176675|NCT01729754|100556171|FG006|Part 1|Lack of Efficacy|2|||
33176676|NCT01729754|100556172|FG007|Part 1|Lack of Efficacy|0|||
33176677|NCT01729754|100556173|FG008|Part 1|Lack of Efficacy|0|||
33263378|NCT00960141|100866676|FG002|Overall Study|Adverse Event|2|||
33263379|NCT00960141|100866674|FG000|Overall Study|Lack of Efficacy|3|||
33463625|NCT00346164|101586195|FG001|Overall Study|Withdrawal by Subject|0|||
33463626|NCT00346164|101586196|FG002|Overall Study|Withdrawal by Subject|2|||
33463627|NCT00346164|101586197|FG003|Overall Study|Withdrawal by Subject|0|||
33176678|NCT01729754|100556174|FG009|Part 1|Lack of Efficacy|0|||
33176679|NCT01729754|100556165|FG000|Part 1|Lost to Follow-up|1|||
33176680|NCT01729754|100556166|FG001|Part 1|Lost to Follow-up|0|||
33176681|NCT01729754|100556167|FG002|Part 1|Lost to Follow-up|0|||
33176682|NCT01729754|100556168|FG003|Part 1|Lost to Follow-up|2|||
33176683|NCT01729754|100556169|FG004|Part 1|Lost to Follow-up|0|||
33176684|NCT01729754|100556170|FG005|Part 1|Lost to Follow-up|0|||
33176685|NCT01729754|100556171|FG006|Part 1|Lost to Follow-up|3|||
33176686|NCT01729754|100556172|FG007|Part 1|Lost to Follow-up|0|||
33176687|NCT01729754|100556173|FG008|Part 1|Lost to Follow-up|0|||
33176688|NCT01729754|100556174|FG009|Part 1|Lost to Follow-up|3|||
33176689|NCT01729754|100556165|FG000|Part 1|Non-compliance with Study Drug|1|||
33176690|NCT01729754|100556166|FG001|Part 1|Non-compliance with Study Drug|0|||
33176691|NCT01729754|100556167|FG002|Part 1|Non-compliance with Study Drug|0|||
33176692|NCT01729754|100556168|FG003|Part 1|Non-compliance with Study Drug|0|||
33176693|NCT01729754|100556169|FG004|Part 1|Non-compliance with Study Drug|0|||
33176694|NCT01729754|100556170|FG005|Part 1|Non-compliance with Study Drug|0|||
33176695|NCT01729754|100556171|FG006|Part 1|Non-compliance with Study Drug|0|||
33176696|NCT01729754|100556172|FG007|Part 1|Non-compliance with Study Drug|0|||
33176697|NCT01729754|100556173|FG008|Part 1|Non-compliance with Study Drug|0|||
33263380|NCT00960141|100866675|FG001|Overall Study|Lack of Efficacy|4|||
33176698|NCT01729754|100556174|FG009|Part 1|Non-compliance with Study Drug|0|||
33176699|NCT01729754|100556165|FG000|Part 1|Physician Decision|0|||
33176700|NCT01729754|100556166|FG001|Part 1|Physician Decision|0|||
33263381|NCT00960141|100866676|FG002|Overall Study|Lack of Efficacy|2|||
33263382|NCT00960141|100866674|FG000|Overall Study|Lost to Follow-up|1|||
33263383|NCT00960141|100866675|FG001|Overall Study|Lost to Follow-up|0|||
33263384|NCT00960141|100866676|FG002|Overall Study|Lost to Follow-up|0|||
33263385|NCT00960141|100866674|FG000|Overall Study|Protocol Violation|1|||
33263386|NCT00960141|100866675|FG001|Overall Study|Protocol Violation|3|||
33263387|NCT00960141|100866676|FG002|Overall Study|Protocol Violation|2|||
33463628|NCT00346164|101586194|FG000|Overall Study|Ineligible|11|||
33176701|NCT01729754|100556167|FG002|Part 1|Physician Decision|0|||
33176702|NCT01729754|100556168|FG003|Part 1|Physician Decision|0|||
33176703|NCT01729754|100556169|FG004|Part 1|Physician Decision|0|||
33176704|NCT01729754|100556170|FG005|Part 1|Physician Decision|0|||
33176705|NCT01729754|100556171|FG006|Part 1|Physician Decision|0|||
33176706|NCT01729754|100556172|FG007|Part 1|Physician Decision|0|||
33176707|NCT01729754|100556173|FG008|Part 1|Physician Decision|0|||
33176708|NCT01729754|100556174|FG009|Part 1|Physician Decision|4|||
33176709|NCT01729754|100556165|FG000|Part 1|Pregnancy|0|||
33176710|NCT01729754|100556166|FG001|Part 1|Pregnancy|0|||
33463629|NCT00346164|101586195|FG001|Overall Study|Ineligible|2|||
33463630|NCT00346164|101586196|FG002|Overall Study|Ineligible|2|||
33463631|NCT00346164|101586197|FG003|Overall Study|Ineligible|23|||
33463632|NCT00346164|101586194|FG000|Overall Study|Refusal of further protocol therapy|0|||
33463633|NCT00346164|101586195|FG001|Overall Study|Refusal of further protocol therapy|1|||
33463634|NCT00346164|101586196|FG002|Overall Study|Refusal of further protocol therapy|3|||
33463635|NCT00346164|101586197|FG003|Overall Study|Refusal of further protocol therapy|15|||
33463636|NCT00346164|101586194|FG000|Overall Study|Inability to start week 16 tx on time|0|||
33463637|NCT00346164|101586195|FG001|Overall Study|Inability to start week 16 tx on time|0|||
33463638|NCT00346164|101586196|FG002|Overall Study|Inability to start week 16 tx on time|0|||
33463639|NCT00346164|101586197|FG003|Overall Study|Inability to start week 16 tx on time|11|||
33463640|NCT01392326|101586198|FG000|Overall Study|Death|2|||
33463641|NCT01392326|101586199|FG001|Overall Study|Death|0|||
33463642|NCT01392326|101586200|FG002|Overall Study|Death|0|||
33463643|NCT01392326|101586198|FG000|Overall Study|Withdrawal by Subject|12|||
33463644|NCT01392326|101586199|FG001|Overall Study|Withdrawal by Subject|11|||
33463645|NCT01392326|101586200|FG002|Overall Study|Withdrawal by Subject|15|||
33463646|NCT01392326|101586198|FG000|Overall Study|Protocol Violation|2|||
33463647|NCT01392326|101586199|FG001|Overall Study|Protocol Violation|0|||
33463648|NCT01392326|101586200|FG002|Overall Study|Protocol Violation|0|||
33463649|NCT01392326|101586198|FG000|Overall Study|Pregnancy|0|||
33463650|NCT01392326|101586199|FG001|Overall Study|Pregnancy|0|||
33463651|NCT01392326|101586200|FG002|Overall Study|Pregnancy|1|||
33463652|NCT01392326|101586198|FG000|Overall Study|Physician Decision|7|||
33463653|NCT01392326|101586199|FG001|Overall Study|Physician Decision|5|||
33463654|NCT01392326|101586200|FG002|Overall Study|Physician Decision|2|||
33463655|NCT01392326|101586198|FG000|Overall Study|Lost to Follow-up|1|||
33463656|NCT01392326|101586199|FG001|Overall Study|Lost to Follow-up|3|||
33463657|NCT01392326|101586200|FG002|Overall Study|Lost to Follow-up|4|||
33463658|NCT01392326|101586198|FG000|Overall Study|Lack of Efficacy|14|||
33463659|NCT01392326|101586199|FG001|Overall Study|Lack of Efficacy|10|||
33463660|NCT01392326|101586200|FG002|Overall Study|Lack of Efficacy|15|||
33463661|NCT01392326|101586198|FG000|Overall Study|Adverse Event|9|||
33463662|NCT01392326|101586199|FG001|Overall Study|Adverse Event|6|||
33463663|NCT01392326|101586200|FG002|Overall Study|Adverse Event|11|||
33463664|NCT02147587|101586201|FG000|Overall Study|Adverse Event|9|||
33463665|NCT02147587|101586202|FG001|Overall Study|Adverse Event|4|||
33463666|NCT02147587|101586201|FG000|Overall Study|Lack of Efficacy|2|||
33463667|NCT02147587|101586202|FG001|Overall Study|Lack of Efficacy|1|||
33463668|NCT00739973|101586203|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
33463669|NCT00739973|101586204|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33463670|NCT00739973|101586205|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33463671|NCT00739973|101586206|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33463672|NCT00739973|101586207|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33463673|NCT00739973|101586208|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33463674|NCT00739973|101586209|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33463675|NCT00739973|101586210|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33463676|NCT00739973|101586211|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
33463677|NCT00739973|101586203|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
33463678|NCT00739973|101586204|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33463679|NCT00739973|101586205|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33463680|NCT00739973|101586206|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33463681|NCT00739973|101586207|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33463682|NCT00739973|101586208|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33463683|NCT00739973|101586209|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33463684|NCT00739973|101586210|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33463685|NCT00739973|101586211|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
33463686|NCT00739973|101586203|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
33463687|NCT00739973|101586204|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33463688|NCT00739973|101586205|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33463689|NCT00739973|101586206|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33463690|NCT00739973|101586207|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33463691|NCT00739973|101586208|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33463692|NCT00739973|101586209|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33463693|NCT00739973|101586210|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33463694|NCT00739973|101586211|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
33176711|NCT01729754|100556167|FG002|Part 1|Pregnancy|0|||
33176712|NCT01729754|100556168|FG003|Part 1|Pregnancy|1|||
33176713|NCT01729754|100556169|FG004|Part 1|Pregnancy|0|||
33176714|NCT01729754|100556170|FG005|Part 1|Pregnancy|0|||
33176715|NCT01729754|100556171|FG006|Part 1|Pregnancy|0|||
33176716|NCT01729754|100556172|FG007|Part 1|Pregnancy|0|||
33176717|NCT01729754|100556173|FG008|Part 1|Pregnancy|0|||
33176718|NCT01729754|100556174|FG009|Part 1|Pregnancy|1|||
33176719|NCT01729754|100556165|FG000|Part 1|Progressive Disease|0|||
33176720|NCT01729754|100556166|FG001|Part 1|Progressive Disease|0|||
33176721|NCT01729754|100556167|FG002|Part 1|Progressive Disease|0|||
33176722|NCT01729754|100556168|FG003|Part 1|Progressive Disease|0|||
33176723|NCT01729754|100556169|FG004|Part 1|Progressive Disease|0|||
33176724|NCT01729754|100556170|FG005|Part 1|Progressive Disease|0|||
33176725|NCT01729754|100556171|FG006|Part 1|Progressive Disease|0|||
33176726|NCT01729754|100556172|FG007|Part 1|Progressive Disease|0|||
33176727|NCT01729754|100556173|FG008|Part 1|Progressive Disease|0|||
33176728|NCT01729754|100556174|FG009|Part 1|Progressive Disease|1|||
33176729|NCT01729754|100556165|FG000|Part 1|Protocol Violation|2|||
33176730|NCT01729754|100556166|FG001|Part 1|Protocol Violation|0|||
33176731|NCT01729754|100556167|FG002|Part 1|Protocol Violation|0|||
33176732|NCT01729754|100556168|FG003|Part 1|Protocol Violation|1|||
33176733|NCT01729754|100556169|FG004|Part 1|Protocol Violation|0|||
33176734|NCT01729754|100556170|FG005|Part 1|Protocol Violation|0|||
33176735|NCT01729754|100556171|FG006|Part 1|Protocol Violation|1|||
33176736|NCT01729754|100556172|FG007|Part 1|Protocol Violation|0|||
33176737|NCT01729754|100556173|FG008|Part 1|Protocol Violation|0|||
33176738|NCT01729754|100556174|FG009|Part 1|Protocol Violation|0|||
33176739|NCT01729754|100556165|FG000|Part 1|Withdrawal by Subject|5|||
33176740|NCT01729754|100556166|FG001|Part 1|Withdrawal by Subject|0|||
33176741|NCT01729754|100556167|FG002|Part 1|Withdrawal by Subject|0|||
33463695|NCT00739973|101586203|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
33463696|NCT00739973|101586204|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33463697|NCT00739973|101586205|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33463698|NCT00739973|101586206|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33463699|NCT00739973|101586207|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33463700|NCT00739973|101586208|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33463701|NCT00739973|101586209|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33463702|NCT00739973|101586210|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33463703|NCT00739973|101586211|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
33176742|NCT01729754|100556168|FG003|Part 1|Withdrawal by Subject|7|||
33176743|NCT01729754|100556169|FG004|Part 1|Withdrawal by Subject|0|||
33176744|NCT01729754|100556170|FG005|Part 1|Withdrawal by Subject|0|||
33176745|NCT01729754|100556171|FG006|Part 1|Withdrawal by Subject|5|||
33176746|NCT01729754|100556172|FG007|Part 1|Withdrawal by Subject|0|||
33176747|NCT01729754|100556173|FG008|Part 1|Withdrawal by Subject|0|||
33176748|NCT01729754|100556174|FG009|Part 1|Withdrawal by Subject|6|||
33176749|NCT01729754|100556165|FG000|Part 1|Other Protocol Specified Criteria|2|||
33176750|NCT01729754|100556166|FG001|Part 1|Other Protocol Specified Criteria|0|||
33176751|NCT01729754|100556167|FG002|Part 1|Other Protocol Specified Criteria|0|||
33176752|NCT01729754|100556168|FG003|Part 1|Other Protocol Specified Criteria|0|||
33176753|NCT01729754|100556169|FG004|Part 1|Other Protocol Specified Criteria|0|||
33463704|NCT00739973|101586203|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
33463705|NCT00739973|101586204|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33463706|NCT00739973|101586205|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33463707|NCT00739973|101586206|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33176754|NCT01729754|100556170|FG005|Part 1|Other Protocol Specified Criteria|0|||
33463708|NCT00739973|101586207|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33463709|NCT00739973|101586208|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33463710|NCT00739973|101586209|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33176755|NCT01729754|100556171|FG006|Part 1|Other Protocol Specified Criteria|1|||
33176756|NCT01729754|100556172|FG007|Part 1|Other Protocol Specified Criteria|0|||
33176757|NCT01729754|100556173|FG008|Part 1|Other Protocol Specified Criteria|0|||
33176758|NCT01729754|100556174|FG009|Part 1|Other Protocol Specified Criteria|4|||
33176759|NCT01729754|100556165|FG000|Part 2|Adverse Event|2|||
33176760|NCT01729754|100556166|FG001|Part 2|Adverse Event|0|||
33176761|NCT01729754|100556167|FG002|Part 2|Adverse Event|0|||
33176762|NCT01729754|100556168|FG003|Part 2|Adverse Event|0|||
33176763|NCT01729754|100556169|FG004|Part 2|Adverse Event|0|||
33176764|NCT01729754|100556170|FG005|Part 2|Adverse Event|0|||
33176765|NCT01729754|100556171|FG006|Part 2|Adverse Event|0|||
33176766|NCT01729754|100556172|FG007|Part 2|Adverse Event|0|||
33176767|NCT01729754|100556173|FG008|Part 2|Adverse Event|1|||
33176768|NCT01729754|100556174|FG009|Part 2|Adverse Event|2|||
33176769|NCT01729754|100556165|FG000|Part 2|Lack of Efficacy|0|||
33176770|NCT01729754|100556166|FG001|Part 2|Lack of Efficacy|0|||
33176771|NCT01729754|100556167|FG002|Part 2|Lack of Efficacy|0|||
33176772|NCT01729754|100556168|FG003|Part 2|Lack of Efficacy|0|||
33176773|NCT01729754|100556169|FG004|Part 2|Lack of Efficacy|0|||
33176774|NCT01729754|100556170|FG005|Part 2|Lack of Efficacy|0|||
33176775|NCT01729754|100556171|FG006|Part 2|Lack of Efficacy|0|||
33176776|NCT01729754|100556172|FG007|Part 2|Lack of Efficacy|0|||
33176777|NCT01729754|100556173|FG008|Part 2|Lack of Efficacy|2|||
33176778|NCT01729754|100556174|FG009|Part 2|Lack of Efficacy|2|||
33176779|NCT01729754|100556165|FG000|Part 2|Lost to Follow-up|0|||
33176780|NCT01729754|100556166|FG001|Part 2|Lost to Follow-up|0|||
33176781|NCT01729754|100556167|FG002|Part 2|Lost to Follow-up|0|||
33463711|NCT00739973|101586210|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33463712|NCT00739973|101586211|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
33463713|NCT00739973|101586203|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
33463714|NCT00739973|101586204|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33463715|NCT00739973|101586205|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33463716|NCT00739973|101586206|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33463717|NCT00739973|101586207|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33463718|NCT00739973|101586208|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33463719|NCT00739973|101586209|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33463720|NCT00739973|101586210|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33463721|NCT00739973|101586211|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
33463722|NCT00739973|101586203|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
33463723|NCT00739973|101586204|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33463724|NCT00739973|101586205|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33463725|NCT00739973|101586206|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33463726|NCT00739973|101586207|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33463727|NCT00739973|101586208|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33463728|NCT00739973|101586209|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33463729|NCT00739973|101586210|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33463730|NCT00739973|101586211|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
33463731|NCT00739973|101586203|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
33463732|NCT00739973|101586204|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
33463733|NCT00739973|101586205|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
33463734|NCT00739973|101586206|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
33463735|NCT00739973|101586207|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
33463736|NCT00739973|101586208|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
33463737|NCT00739973|101586209|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
33463738|NCT00739973|101586210|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
33463739|NCT00739973|101586211|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
33463740|NCT00739973|101586203|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
33463741|NCT00739973|101586204|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
33463742|NCT00739973|101586205|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
33463743|NCT00739973|101586206|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
33463744|NCT00739973|101586207|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
33463745|NCT00739973|101586208|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
33463746|NCT00739973|101586209|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
33463747|NCT00739973|101586210|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
33463748|NCT00739973|101586211|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
33463749|NCT00739973|101586203|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
33463750|NCT00739973|101586204|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
33463751|NCT00739973|101586205|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
33463752|NCT00739973|101586206|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
33463753|NCT00739973|101586207|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
33463754|NCT00739973|101586208|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
33463755|NCT00739973|101586209|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
33463756|NCT00739973|101586210|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
33463757|NCT00739973|101586211|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
33463758|NCT00739973|101586203|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
33463759|NCT00739973|101586204|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
33463760|NCT00739973|101586205|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
33463761|NCT00739973|101586206|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
33463762|NCT00739973|101586207|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
33463763|NCT00739973|101586208|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
33463764|NCT00739973|101586209|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
33463765|NCT00739973|101586210|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
33176782|NCT01729754|100556168|FG003|Part 2|Lost to Follow-up|2|||
33176783|NCT01729754|100556169|FG004|Part 2|Lost to Follow-up|0|||
33463766|NCT00739973|101586211|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
33463767|NCT00739973|101586203|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33489763|NCT02952586|101686778|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
33176784|NCT01729754|100556170|FG005|Part 2|Lost to Follow-up|0|||
33176785|NCT01729754|100556171|FG006|Part 2|Lost to Follow-up|0|||
33176786|NCT01729754|100556172|FG007|Part 2|Lost to Follow-up|1|||
33463768|NCT00739973|101586204|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33463769|NCT00739973|101586205|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
33463770|NCT00739973|101586206|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33463771|NCT00739973|101586207|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33463772|NCT00739973|101586208|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33463773|NCT00739973|101586209|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33463774|NCT00739973|101586210|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33463775|NCT00739973|101586211|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
33463776|NCT00739973|101586203|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
33463777|NCT00739973|101586204|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
33463778|NCT00739973|101586205|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
33463779|NCT00739973|101586206|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
33463780|NCT00739973|101586207|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
33463781|NCT00739973|101586208|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
33463782|NCT00739973|101586209|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
33463783|NCT00739973|101586210|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
33463784|NCT00739973|101586211|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
33463785|NCT00739973|101586203|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
33463786|NCT00739973|101586204|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
33463787|NCT00739973|101586205|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
33463788|NCT00739973|101586206|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
33463789|NCT00739973|101586207|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
33463790|NCT00739973|101586208|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
33176787|NCT01729754|100556173|FG008|Part 2|Lost to Follow-up|0|||
33176788|NCT01729754|100556174|FG009|Part 2|Lost to Follow-up|2|||
33176789|NCT01729754|100556165|FG000|Part 2|Non-Compliance with Study Drug|0|||
33176790|NCT01729754|100556166|FG001|Part 2|Non-Compliance with Study Drug|0|||
33176791|NCT01729754|100556167|FG002|Part 2|Non-Compliance with Study Drug|0|||
33176792|NCT01729754|100556168|FG003|Part 2|Non-Compliance with Study Drug|0|||
33176793|NCT01729754|100556169|FG004|Part 2|Non-Compliance with Study Drug|0|||
33176794|NCT01729754|100556170|FG005|Part 2|Non-Compliance with Study Drug|0|||
33176795|NCT01729754|100556171|FG006|Part 2|Non-Compliance with Study Drug|0|||
33176796|NCT01729754|100556172|FG007|Part 2|Non-Compliance with Study Drug|0|||
33176797|NCT01729754|100556173|FG008|Part 2|Non-Compliance with Study Drug|0|||
33176798|NCT01729754|100556174|FG009|Part 2|Non-Compliance with Study Drug|1|||
33176799|NCT01729754|100556165|FG000|Part 2|Pregnancy|0|||
33176800|NCT01729754|100556166|FG001|Part 2|Pregnancy|0|||
33176801|NCT01729754|100556167|FG002|Part 2|Pregnancy|0|||
33176802|NCT01729754|100556168|FG003|Part 2|Pregnancy|1|||
33176803|NCT01729754|100556169|FG004|Part 2|Pregnancy|0|||
33176804|NCT01729754|100556170|FG005|Part 2|Pregnancy|0|||
33176805|NCT01729754|100556171|FG006|Part 2|Pregnancy|0|||
33176806|NCT01729754|100556172|FG007|Part 2|Pregnancy|0|||
33176807|NCT01729754|100556173|FG008|Part 2|Pregnancy|0|||
33176808|NCT01729754|100556174|FG009|Part 2|Pregnancy|1|||
33176809|NCT01729754|100556165|FG000|Part 2|Withdrawal by Subject|3|||
33463791|NCT00739973|101586209|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
33463792|NCT00739973|101586210|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
33463793|NCT00739973|101586211|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
33463794|NCT00739973|101586203|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33463795|NCT00739973|101586204|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33463796|NCT00739973|101586205|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33463797|NCT00739973|101586206|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33463798|NCT00739973|101586207|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33463799|NCT00739973|101586208|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33463800|NCT00739973|101586209|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
33463801|NCT00739973|101586210|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33463802|NCT00739973|101586211|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
33463803|NCT00739973|101586203|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
33463804|NCT00739973|101586204|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
33463805|NCT00739973|101586205|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
33463806|NCT00739973|101586206|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
33463807|NCT00739973|101586207|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
33176810|NCT01729754|100556166|FG001|Part 2|Withdrawal by Subject|0|||
33176811|NCT01729754|100556167|FG002|Part 2|Withdrawal by Subject|0|||
33176812|NCT01729754|100556168|FG003|Part 2|Withdrawal by Subject|2|||
33176813|NCT01729754|100556169|FG004|Part 2|Withdrawal by Subject|0|||
33463808|NCT00739973|101586208|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
33463809|NCT00739973|101586209|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
33176814|NCT01729754|100556170|FG005|Part 2|Withdrawal by Subject|0|||
33463810|NCT00739973|101586210|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
33463811|NCT00739973|101586211|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
33463812|NCT00739973|101586203|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
33463813|NCT00739973|101586204|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
33463814|NCT00739973|101586205|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
33463815|NCT00739973|101586206|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
33463816|NCT00739973|101586207|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
33176815|NCT01729754|100556171|FG006|Part 2|Withdrawal by Subject|0|||
33176816|NCT01729754|100556172|FG007|Part 2|Withdrawal by Subject|1|||
33176817|NCT01729754|100556173|FG008|Part 2|Withdrawal by Subject|1|||
33463817|NCT00739973|101586208|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
33463818|NCT00739973|101586209|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
33463819|NCT00739973|101586210|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
33463820|NCT00739973|101586211|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
33463821|NCT00476593|101586222|FG000|Overall Study|Lost to Follow-up|10|||
33463822|NCT00476593|101586223|FG001|Overall Study|Lost to Follow-up|2|||
33463823|NCT00476593|101586224|FG002|Overall Study|Lost to Follow-up|8|||
33463824|NCT00476593|101586225|FG003|Overall Study|Lost to Follow-up|22|||
33463825|NCT01453153|101586226|FG000|Overall Study|Physician Decision|0|||
33463826|NCT01453153|101586227|FG001|Overall Study|Physician Decision|0|||
33463827|NCT01453153|101586228|FG002|Overall Study|Physician Decision|1|||
33463828|NCT01453153|101586226|FG000|Overall Study|Progressive Disease|3|||
33463829|NCT01453153|101586227|FG001|Overall Study|Progressive Disease|2|||
33463830|NCT01453153|101586228|FG002|Overall Study|Progressive Disease|16|||
33463831|NCT01453153|101586226|FG000|Overall Study|Withdrawal by Subject|0|||
33463832|NCT01453153|101586227|FG001|Overall Study|Withdrawal by Subject|1|||
33463833|NCT01453153|101586228|FG002|Overall Study|Withdrawal by Subject|2|||
33463834|NCT01453153|101586226|FG000|Overall Study|Adverse Event|1|||
33463835|NCT01453153|101586227|FG001|Overall Study|Adverse Event|1|||
33463836|NCT01453153|101586228|FG002|Overall Study|Adverse Event|1|||
33463837|NCT04046549|101586230|FG000|Overall Study|Adverse Event|1|||
33463838|NCT04046549|101586230|FG000|Overall Study|Physician Decision|1|||
33463839|NCT04046549|101586230|FG000|Overall Study|Withdrawal by Subject|3|||
33463840|NCT04046549|101586230|FG000|Overall Study|Other, Not Specified|5|||
33463841|NCT03756883|101586231|FG000|Overall Study|Adverse Event|2|||
33463842|NCT03756883|101586232|FG001|Overall Study|Adverse Event|2|||
33463843|NCT03756883|101586233|FG002|Overall Study|Adverse Event|2|||
33463844|NCT03756883|101586231|FG000|Overall Study|Lack of Efficacy|0|||
33463845|NCT03756883|101586232|FG001|Overall Study|Lack of Efficacy|1|||
33463846|NCT03756883|101586233|FG002|Overall Study|Lack of Efficacy|2|||
33463847|NCT03756883|101586231|FG000|Overall Study|Lost to Follow-up|3|||
33463848|NCT03756883|101586232|FG001|Overall Study|Lost to Follow-up|3|||
33463849|NCT03756883|101586233|FG002|Overall Study|Lost to Follow-up|0|||
33463850|NCT03756883|101586231|FG000|Overall Study|Protocol Violation|2|||
33463851|NCT03756883|101586232|FG001|Overall Study|Protocol Violation|0|||
33463852|NCT03756883|101586233|FG002|Overall Study|Protocol Violation|1|||
33463853|NCT03756883|101586231|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
33463854|NCT03756883|101586232|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
33463855|NCT03756883|101586233|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
33463856|NCT03756883|101586231|FG000|Overall Study|Withdrawal by Subject|4|||
33463857|NCT03756883|101586232|FG001|Overall Study|Withdrawal by Subject|1|||
33463858|NCT03756883|101586233|FG002|Overall Study|Withdrawal by Subject|0|||
33463859|NCT03756883|101586231|FG000|Overall Study|Other Reasons|2|||
33463860|NCT03756883|101586232|FG001|Overall Study|Other Reasons|4|||
33176818|NCT01729754|100556174|FG009|Part 2|Withdrawal by Subject|4|||
33463861|NCT03756883|101586233|FG002|Overall Study|Other Reasons|0|||
33463862|NCT01118117|101586235|FG000|Overall Study|Death|8|||
33463863|NCT01118117|101586236|FG001|Overall Study|Death|0|||
33463864|NCT01118117|101586235|FG000|Overall Study|Lost to Follow-up|6|||
33463865|NCT01118117|101586236|FG001|Overall Study|Lost to Follow-up|0|||
33463866|NCT01118117|101586235|FG000|Overall Study|Missed 12 Month Visit|7|||
33463867|NCT01118117|101586236|FG001|Overall Study|Missed 12 Month Visit|0|||
33463868|NCT00931463|101589514|FG000|Overall Study|Death|8|||
33463869|NCT00931463|101589515|FG001|Overall Study|Death|4|||
33463870|NCT00931463|101589514|FG000|Overall Study|Withdrawal by Subject|5|||
33463871|NCT00931463|101589515|FG001|Overall Study|Withdrawal by Subject|0|||
33463872|NCT00931463|101589514|FG000|Overall Study|Lost to Follow-up|4|||
33463873|NCT00931463|101589515|FG001|Overall Study|Lost to Follow-up|1|||
33463874|NCT00537199|101589516|FG000|Overall Study|Study Terminated|1|||
33176819|NCT01729754|100556165|FG000|Part 2|Other Protocol Specified Criteria|1|||
33463875|NCT02663882|101589517|FG000|Overall Study|Lost to Follow-up|4|||
33463876|NCT02663882|101589518|FG001|Overall Study|Lost to Follow-up|2|||
33463877|NCT01235715|101589519|FG000|Overall Study|Physician Decision|0|||
33463878|NCT01235715|101589520|FG001|Overall Study|Physician Decision|2|||
33463879|NCT02339090|101589523|FG000|Overall Study|Adverse Event|1|||
33463880|NCT02339090|101589524|FG001|Overall Study|Adverse Event|0|||
33463881|NCT02339090|101589523|FG000|Overall Study|Lost to Follow-up|0|||
33463882|NCT02339090|101589524|FG001|Overall Study|Lost to Follow-up|1|||
33463883|NCT02339090|101589523|FG000|Overall Study|Non-compliance With Study Drug|0|||
33463884|NCT02339090|101589524|FG001|Overall Study|Non-compliance With Study Drug|1|||
33463885|NCT02339090|101589523|FG000|Overall Study|Withdrawal by Subject|2|||
33463886|NCT02339090|101589524|FG001|Overall Study|Withdrawal by Subject|1|||
33463887|NCT02339090|101589523|FG000|Overall Study|Poor Growth|3|||
33463888|NCT02339090|101589524|FG001|Overall Study|Poor Growth|0|||
33463889|NCT02339090|101589523|FG000|Overall Study|Randomized but not treated|0|||
33463890|NCT02339090|101589524|FG001|Overall Study|Randomized but not treated|2|||
33463891|NCT02999984|101589527|FG000|Overall Study|Treatment Failure|1|||
33463892|NCT03223909|101589531|FG000|Overall Study|Protocol Violation|48|||
33463893|NCT03223909|101589532|FG001|Overall Study|Protocol Violation|45|||
33463894|NCT03223909|101589533|FG002|Overall Study|Protocol Violation|16|||
33463895|NCT00749411|101589534|FG000|Overall Study|Adverse Event|0|||
33463896|NCT00749411|101589535|FG001|Overall Study|Adverse Event|2|||
33463897|NCT00749411|101589534|FG000|Overall Study|Lack of Efficacy|0|||
33463898|NCT00749411|101589535|FG001|Overall Study|Lack of Efficacy|1|||
33463899|NCT00749411|101589534|FG000|Overall Study|Protocol Violation|1|||
33463900|NCT00749411|101589535|FG001|Overall Study|Protocol Violation|1|||
33463901|NCT00749411|101589534|FG000|Overall Study|Protocol-defined stopping criteria|0|||
33463902|NCT00749411|101589535|FG001|Overall Study|Protocol-defined stopping criteria|1|||
33463903|NCT03417830|101589536|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
33463904|NCT03417830|101589537|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
33463905|NCT00436917|101589538|FG000|Overall Study|Withdrawal by Subject|13|||
33463906|NCT00436917|101589538|FG000|Overall Study|Adverse Event|2|||
33463907|NCT00436917|101589538|FG000|Overall Study|Physician Decision|1|||
33463908|NCT00436917|101589538|FG000|Overall Study|Death|1|||
33463909|NCT00436917|101589538|FG000|Overall Study|Lost to Follow-up|1|||
33463910|NCT00436917|101589538|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
33463911|NCT00436917|101589538|FG000|Overall Study|Increased creatinine|1|||
33463912|NCT00436917|101589538|FG000|Overall Study|Personal conflicts of patient|1|||
33463913|NCT02457819|101589539|FG000|Overall Study|reason not given|8|||
33463914|NCT02457819|101589539|FG000|Overall Study|Withdrawal by Subject|24|||
33463915|NCT02457819|101589539|FG000|Overall Study|Protocol Violation|1|||
33463916|NCT02457819|101589539|FG000|Overall Study|non compliance with study drug|4|||
33463917|NCT02457819|101589539|FG000|Overall Study|Lost to Follow-up|10|||
33463918|NCT02457819|101589539|FG000|Overall Study|Lack of Efficacy|19|||
33463919|NCT02457819|101589539|FG000|Overall Study|Adverse Event|33|||
33463920|NCT00544817|101589544|FG000|Combined Modality|Lack of Efficacy|2|||
33463921|NCT00544817|101589544|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
33463922|NCT00544817|101589544|FG000|Combined Modality|Adverse Event|2|||
33463923|NCT00544817|101589544|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
33463924|NCT00544817|101589544|FG000|No Treatment Interval|Lack of Efficacy|8|||
33463925|NCT00544817|101589544|FG000|No Treatment Interval|Physician Decision|3|||
33463926|NCT00544817|101589544|FG000|No Treatment Interval|Adverse Event|1|||
33463927|NCT00544817|101589544|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
33463928|NCT00544817|101589544|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
33463929|NCT00544817|101589544|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
33463930|NCT00779402|101589545|FG000|Treatment Phase 1|Disease Progression|1|||
33463931|NCT00779402|101589546|FG001|Treatment Phase 1|Disease Progression|0|||
33463932|NCT00779402|101589545|FG000|Treatment Phase 1|Adverse Event|2|||
33463933|NCT00779402|101589546|FG001|Treatment Phase 1|Adverse Event|0|||
33463934|NCT00779402|101589545|FG000|Treatment Phase 1|Protocol Violation|1|||
33463935|NCT00779402|101589546|FG001|Treatment Phase 1|Protocol Violation|0|||
33463936|NCT00779402|101589545|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
33463937|NCT00779402|101589546|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
33463938|NCT00779402|101589545|FG000|Treatment Phase 1|Lost to Follow-up|0|||
33463939|NCT00779402|101589546|FG001|Treatment Phase 1|Lost to Follow-up|1|||
33463940|NCT00779402|101589545|FG000|Treatment Phase 1|Death|0|||
33463941|NCT00779402|101589546|FG001|Treatment Phase 1|Death|1|||
33463942|NCT00779402|101589545|FG000|Treatment Phase 1|Intercurrent Illness|1|||
33463943|NCT00779402|101589546|FG001|Treatment Phase 1|Intercurrent Illness|1|||
33463944|NCT00779402|101589545|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
33463945|NCT00779402|101589546|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
33463946|NCT00779402|101589545|FG000|Treatment Phase 1|Other|4|||
33463947|NCT00779402|101589546|FG001|Treatment Phase 1|Other|2|||
33463948|NCT00779402|101589545|FG000|Treatment Phase 1|Closure of Study|3|||
33463949|NCT00779402|101589546|FG001|Treatment Phase 1|Closure of Study|2|||
33463950|NCT00779402|101589545|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
33463951|NCT00779402|101589546|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
33463952|NCT00779402|101589545|FG000|Surveillance Phase|Protocol Violation|0|||
33463953|NCT00779402|101589546|FG001|Surveillance Phase|Protocol Violation|1|||
33463954|NCT00779402|101589545|FG000|Surveillance Phase|Patient refused to continue|22|||
33463955|NCT00779402|101589546|FG001|Surveillance Phase|Patient refused to continue|14|||
33463956|NCT00779402|101589545|FG000|Surveillance Phase|Lost to Follow-up|2|||
33463957|NCT00779402|101589546|FG001|Surveillance Phase|Lost to Follow-up|1|||
33463958|NCT00779402|101589545|FG000|Surveillance Phase|Death|0|||
33463959|NCT00779402|101589546|FG001|Surveillance Phase|Death|1|||
33463960|NCT00779402|101589545|FG000|Surveillance Phase|Intercurrent Illness|2|||
33463961|NCT00779402|101589546|FG001|Surveillance Phase|Intercurrent Illness|0|||
33463962|NCT00779402|101589545|FG000|Surveillance Phase|Other|5|||
33463963|NCT00779402|101589546|FG001|Surveillance Phase|Other|5|||
33463964|NCT00779402|101589545|FG000|Surveillance Phase|Withdrawal by Subject|4|||
33463965|NCT00779402|101589546|FG001|Surveillance Phase|Withdrawal by Subject|1|||
33463966|NCT00779402|101589545|FG000|Surveillance Phase|Closure of study|5|||
33463967|NCT00779402|101589546|FG001|Surveillance Phase|Closure of study|6|||
33463968|NCT00779402|101589545|FG000|Surveillance Phase|Completed Protocol Visits|3|||
33463969|NCT00779402|101589546|FG001|Surveillance Phase|Completed Protocol Visits|2|||
33463970|NCT00779402|101589545|FG000|Long-term Follow-up|Patient refused to continue|2|||
33463971|NCT00779402|101589546|FG001|Long-term Follow-up|Patient refused to continue|0|||
33463972|NCT00779402|101589545|FG000|Long-term Follow-up|Other|5|||
33463973|NCT00779402|101589546|FG001|Long-term Follow-up|Other|0|||
33463974|NCT00779402|101589545|FG000|Long-term Follow-up|Closure of Study|8|||
33463975|NCT00779402|101589546|FG001|Long-term Follow-up|Closure of Study|4|||
33463976|NCT00779402|101589545|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
33463977|NCT00779402|101589546|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
33463978|NCT04569786|101589548|FG000|Overall Study|Lost to Follow-up|1|||
33463979|NCT04569786|101589549|FG001|Overall Study|Lost to Follow-up|0|||
33463980|NCT04569786|101589550|FG002|Overall Study|Lost to Follow-up|4|||
33463981|NCT04569786|101589551|FG003|Overall Study|Lost to Follow-up|1|||
33463982|NCT04569786|101589552|FG004|Overall Study|Lost to Follow-up|0|||
33463983|NCT04569786|101589548|FG000|Overall Study|Withdrawal by Subject|0|||
33463984|NCT04569786|101589549|FG001|Overall Study|Withdrawal by Subject|0|||
33463985|NCT04569786|101589550|FG002|Overall Study|Withdrawal by Subject|0|||
33463986|NCT04569786|101589551|FG003|Overall Study|Withdrawal by Subject|5|||
33463987|NCT04569786|101589552|FG004|Overall Study|Withdrawal by Subject|1|||
33463988|NCT04569786|101589548|FG000|Overall Study|Physician Decision|0|||
33463989|NCT04569786|101589549|FG001|Overall Study|Physician Decision|0|||
33463990|NCT04569786|101589550|FG002|Overall Study|Physician Decision|0|||
33463991|NCT04569786|101589551|FG003|Overall Study|Physician Decision|1|||
33463992|NCT04569786|101589552|FG004|Overall Study|Physician Decision|0|||
33463993|NCT00268892|101589555|FG000|Overall Study|Adverse Event|14|||
33463994|NCT00268892|101589556|FG001|Overall Study|Adverse Event|17|||
33463995|NCT00268892|101589557|FG002|Overall Study|Adverse Event|20|||
33463996|NCT00268892|101589555|FG000|Overall Study|Lack of Efficacy|1|||
33463997|NCT00268892|101589556|FG001|Overall Study|Lack of Efficacy|3|||
33463998|NCT00268892|101589557|FG002|Overall Study|Lack of Efficacy|0|||
33463999|NCT00268892|101589555|FG000|Overall Study|Withdrawal by Subject|14|||
33464000|NCT00268892|101589556|FG001|Overall Study|Withdrawal by Subject|15|||
33464001|NCT00268892|101589557|FG002|Overall Study|Withdrawal by Subject|13|||
33464002|NCT00268892|101589555|FG000|Overall Study|Physician Decision|0|||
33464003|NCT00268892|101589556|FG001|Overall Study|Physician Decision|1|||
33464004|NCT00268892|101589557|FG002|Overall Study|Physician Decision|0|||
33464005|NCT00268892|101589555|FG000|Overall Study|Lost to Follow-up|5|||
33464006|NCT00268892|101589556|FG001|Overall Study|Lost to Follow-up|2|||
33464007|NCT00268892|101589557|FG002|Overall Study|Lost to Follow-up|4|||
33464008|NCT00268892|101589555|FG000|Overall Study|Protocol Violation|0|||
33464009|NCT00268892|101589556|FG001|Overall Study|Protocol Violation|1|||
33464010|NCT00268892|101589557|FG002|Overall Study|Protocol Violation|0|||
33464011|NCT00268892|101589555|FG000|Overall Study|Disease Progression|1|||
33464012|NCT00268892|101589556|FG001|Overall Study|Disease Progression|1|||
33464013|NCT00268892|101589557|FG002|Overall Study|Disease Progression|0|||
33464014|NCT00268892|101589555|FG000|Overall Study|Trial Site Closed|4|||
33464015|NCT00268892|101589556|FG001|Overall Study|Trial Site Closed|2|||
33464016|NCT00268892|101589557|FG002|Overall Study|Trial Site Closed|2|||
33464017|NCT02413294|101589560|FG000|Overall Study|Withdrawal by Subject|1|||
33464018|NCT02087176|101589565|FG000|Overall Study|Withdrawal by Subject|1|||
33464019|NCT02087176|101589565|FG000|Overall Study|Death|10|||
33464020|NCT02087176|101589565|FG000|Overall Study|Censored|19|||
33464021|NCT02087176|101589565|FG000|Overall Study|Study Terminated by Sponsor|2|||
33464022|NCT02654587|101589566|FG000|Overall Study|patient alive at end of study|22|||
33464023|NCT02654587|101589567|FG001|Overall Study|patient alive at end of study|8|||
33464024|NCT02654587|101589566|FG000|Overall Study|Withdrawal by Subject|1|||
33464025|NCT02654587|101589567|FG001|Overall Study|Withdrawal by Subject|7|||
33464026|NCT00784134|101589572|FG000|Overall Study|Lost to Follow-up|3|||
33464027|NCT00784134|101589573|FG001|Overall Study|Lost to Follow-up|6|||
33464028|NCT04314843|101589574|FG000|Overall Study|Death|2|||
33464029|NCT04314843|101589575|FG001|Overall Study|Death|2|||
33464030|NCT04314843|101589574|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
33464031|NCT04314843|101589575|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
33464032|NCT00831233|101589578|FG000|Overall Study|Adverse Event|0|||
33464033|NCT00831233|101589579|FG001|Overall Study|Adverse Event|1|||
33464034|NCT00831233|101589578|FG000|Overall Study|Protocol Violation|1|||
33464035|NCT00831233|101589579|FG001|Overall Study|Protocol Violation|0|||
33464036|NCT00831233|101589578|FG000|Overall Study|Selection Criteria Not Met|2|||
33464037|NCT00831233|101589579|FG001|Overall Study|Selection Criteria Not Met|0|||
33464038|NCT00508027|101589583|FG000|Dose Level 1|Lost to Follow-up|4|||
33464039|NCT00508027|101589583|FG000|Dose Level 1|Withdrawal by Subject|2|||
33176820|NCT01729754|100556166|FG001|Part 2|Other Protocol Specified Criteria|0|||
33176821|NCT01729754|100556167|FG002|Part 2|Other Protocol Specified Criteria|0|||
33176822|NCT01729754|100556168|FG003|Part 2|Other Protocol Specified Criteria|0|||
33176823|NCT01729754|100556169|FG004|Part 2|Other Protocol Specified Criteria|0|||
33176824|NCT01729754|100556170|FG005|Part 2|Other Protocol Specified Criteria|0|||
33176825|NCT01729754|100556171|FG006|Part 2|Other Protocol Specified Criteria|0|||
33176826|NCT01729754|100556172|FG007|Part 2|Other Protocol Specified Criteria|1|||
33176827|NCT01729754|100556173|FG008|Part 2|Other Protocol Specified Criteria|0|||
33176828|NCT01729754|100556174|FG009|Part 2|Other Protocol Specified Criteria|0|||
33176829|NCT01729754|100556165|FG000|Part 3|Adverse Event|0|||
33176830|NCT01729754|100556166|FG001|Part 3|Adverse Event|0|||
33176831|NCT01729754|100556167|FG002|Part 3|Adverse Event|1|||
33176832|NCT01729754|100556168|FG003|Part 3|Adverse Event|0|||
33176833|NCT01729754|100556169|FG004|Part 3|Adverse Event|0|||
33176834|NCT01729754|100556170|FG005|Part 3|Adverse Event|5|||
33176835|NCT01729754|100556171|FG006|Part 3|Adverse Event|0|||
33176836|NCT01729754|100556172|FG007|Part 3|Adverse Event|0|||
33176837|NCT01729754|100556173|FG008|Part 3|Adverse Event|0|||
33176838|NCT01729754|100556174|FG009|Part 3|Adverse Event|3|||
33176839|NCT01729754|100556165|FG000|Part 3|Death|0|||
33176840|NCT01729754|100556166|FG001|Part 3|Death|0|||
33176841|NCT01729754|100556167|FG002|Part 3|Death|0|||
33176842|NCT01729754|100556168|FG003|Part 3|Death|0|||
33176843|NCT01729754|100556169|FG004|Part 3|Death|0|||
33176844|NCT01729754|100556170|FG005|Part 3|Death|2|||
33176845|NCT01729754|100556171|FG006|Part 3|Death|0|||
33176846|NCT01729754|100556172|FG007|Part 3|Death|0|||
33176847|NCT01729754|100556173|FG008|Part 3|Death|0|||
33176848|NCT01729754|100556174|FG009|Part 3|Death|0|||
33176849|NCT01729754|100556165|FG000|Part 3|Lack of Efficacy|0|||
33176850|NCT01729754|100556166|FG001|Part 3|Lack of Efficacy|0|||
33176851|NCT01729754|100556167|FG002|Part 3|Lack of Efficacy|0|||
33176852|NCT01729754|100556168|FG003|Part 3|Lack of Efficacy|0|||
33464040|NCT00508027|101589583|FG000|Dose Level 1|Physician Decision|2|||
33464041|NCT00508027|101589583|FG000|Dose Level 2|Lost to Follow-up|2|||
33464042|NCT00508027|101589583|FG000|Dose Level 2|Withdrawal by Subject|2|||
33464043|NCT02443324|101589584|FG000|Overall Study|Death|4|||
33464044|NCT02443324|101589585|FG001|Overall Study|Death|1|||
33464045|NCT02443324|101589586|FG002|Overall Study|Death|0|||
33464046|NCT02443324|101589587|FG003|Overall Study|Death|3|||
33464047|NCT02443324|101589588|FG004|Overall Study|Death|1|||
33176853|NCT01729754|100556169|FG004|Part 3|Lack of Efficacy|2|||
33176854|NCT01729754|100556170|FG005|Part 3|Lack of Efficacy|0|||
33176855|NCT01729754|100556171|FG006|Part 3|Lack of Efficacy|0|||
33176856|NCT01729754|100556172|FG007|Part 3|Lack of Efficacy|0|||
33176857|NCT01729754|100556173|FG008|Part 3|Lack of Efficacy|0|||
33176858|NCT01729754|100556174|FG009|Part 3|Lack of Efficacy|4|||
33464048|NCT02443324|101589589|FG005|Overall Study|Death|3|||
33464049|NCT02443324|101589590|FG006|Overall Study|Death|2|||
33176859|NCT01729754|100556165|FG000|Part 3|Lost to Follow-up|0|||
33176860|NCT01729754|100556166|FG001|Part 3|Lost to Follow-up|1|||
33176861|NCT01729754|100556167|FG002|Part 3|Lost to Follow-up|2|||
33176862|NCT01729754|100556168|FG003|Part 3|Lost to Follow-up|0|||
33176863|NCT01729754|100556169|FG004|Part 3|Lost to Follow-up|0|||
33176864|NCT01729754|100556170|FG005|Part 3|Lost to Follow-up|3|||
33176865|NCT01729754|100556171|FG006|Part 3|Lost to Follow-up|0|||
33176866|NCT01729754|100556172|FG007|Part 3|Lost to Follow-up|0|||
33464050|NCT02443324|101589584|FG000|Overall Study|Lost to Follow-up|0|||
33464051|NCT02443324|101589585|FG001|Overall Study|Lost to Follow-up|0|||
33464052|NCT02443324|101589586|FG002|Overall Study|Lost to Follow-up|0|||
33464053|NCT02443324|101589587|FG003|Overall Study|Lost to Follow-up|1|||
33464054|NCT02443324|101589588|FG004|Overall Study|Lost to Follow-up|0|||
33464055|NCT02443324|101589589|FG005|Overall Study|Lost to Follow-up|1|||
33464056|NCT02443324|101589590|FG006|Overall Study|Lost to Follow-up|0|||
33464057|NCT02443324|101589584|FG000|Overall Study|Physician Decision|0|||
33464058|NCT02443324|101589585|FG001|Overall Study|Physician Decision|3|||
33464059|NCT02443324|101589586|FG002|Overall Study|Physician Decision|5|||
33464060|NCT02443324|101589587|FG003|Overall Study|Physician Decision|1|||
33464061|NCT02443324|101589588|FG004|Overall Study|Physician Decision|1|||
33464062|NCT02443324|101589589|FG005|Overall Study|Physician Decision|0|||
33464063|NCT02443324|101589590|FG006|Overall Study|Physician Decision|2|||
33464064|NCT02443324|101589584|FG000|Overall Study|Progressive Disease|20|||
33464065|NCT02443324|101589585|FG001|Overall Study|Progressive Disease|20|||
33464066|NCT02443324|101589586|FG002|Overall Study|Progressive Disease|13|||
33464067|NCT02443324|101589587|FG003|Overall Study|Progressive Disease|10|||
33464068|NCT02443324|101589588|FG004|Overall Study|Progressive Disease|13|||
33464069|NCT02443324|101589589|FG005|Overall Study|Progressive Disease|17|||
33464070|NCT02443324|101589590|FG006|Overall Study|Progressive Disease|10|||
33464071|NCT02443324|101589584|FG000|Overall Study|Withdrawal by Subject|0|||
33464072|NCT02443324|101589585|FG001|Overall Study|Withdrawal by Subject|0|||
33464073|NCT02443324|101589586|FG002|Overall Study|Withdrawal by Subject|3|||
33464074|NCT02443324|101589587|FG003|Overall Study|Withdrawal by Subject|1|||
33464075|NCT02443324|101589588|FG004|Overall Study|Withdrawal by Subject|1|||
33464076|NCT02443324|101589589|FG005|Overall Study|Withdrawal by Subject|0|||
33464077|NCT02443324|101589590|FG006|Overall Study|Withdrawal by Subject|1|||
33464078|NCT02443324|101589584|FG000|Overall Study|Adverse Event|0|||
33464079|NCT02443324|101589585|FG001|Overall Study|Adverse Event|1|||
33464080|NCT02443324|101589586|FG002|Overall Study|Adverse Event|3|||
33464081|NCT02443324|101589587|FG003|Overall Study|Adverse Event|0|||
33464082|NCT02443324|101589588|FG004|Overall Study|Adverse Event|4|||
33464083|NCT02443324|101589589|FG005|Overall Study|Adverse Event|3|||
33464084|NCT02443324|101589590|FG006|Overall Study|Adverse Event|3|||
33464085|NCT02443324|101589584|FG000|Overall Study|Enrolled but Never Treated|0|||
33464086|NCT02443324|101589585|FG001|Overall Study|Enrolled but Never Treated|0|||
33464087|NCT02443324|101589586|FG002|Overall Study|Enrolled but Never Treated|1|||
33464088|NCT02443324|101589587|FG003|Overall Study|Enrolled but Never Treated|0|||
33464089|NCT02443324|101589588|FG004|Overall Study|Enrolled but Never Treated|1|||
33464090|NCT02443324|101589589|FG005|Overall Study|Enrolled but Never Treated|0|||
33464091|NCT02443324|101589590|FG006|Overall Study|Enrolled but Never Treated|1|||
33464092|NCT01501110|101589591|FG000|Overall Study|Death|0|||
33464093|NCT01501110|101589592|FG001|Overall Study|Death|1|||
33464094|NCT00775528|101589593|FG000|Overall Study|Protocol Violation|1|||
33464095|NCT03785145|101589594|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
33464096|NCT03785145|101589595|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
33464097|NCT03785145|101589594|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
33464098|NCT03785145|101589595|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
33464099|NCT03785145|101589594|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
33464100|NCT03785145|101589595|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
33464101|NCT03785145|101589594|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
33464102|NCT03785145|101589595|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
33489764|NCT02952586|101686779|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
33263388|NCT00960141|100866674|FG000|Overall Study|Withdrawal by Subject|1|||
33263389|NCT00960141|100866675|FG001|Overall Study|Withdrawal by Subject|2|||
33263390|NCT00960141|100866676|FG002|Overall Study|Withdrawal by Subject|1|||
33464103|NCT03785145|101589594|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
33464104|NCT03785145|101589595|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
33464105|NCT03785145|101589594|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
33464106|NCT03785145|101589595|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
33464107|NCT03785145|101589594|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
33464108|NCT03785145|101589595|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
33176867|NCT01729754|100556173|FG008|Part 3|Lost to Follow-up|1|||
33176868|NCT01729754|100556174|FG009|Part 3|Lost to Follow-up|0|||
33176869|NCT01729754|100556165|FG000|Part 3|Physician Decision|0|||
33176870|NCT01729754|100556166|FG001|Part 3|Physician Decision|0|||
33176871|NCT01729754|100556167|FG002|Part 3|Physician Decision|1|||
33176872|NCT01729754|100556168|FG003|Part 3|Physician Decision|0|||
33176873|NCT01729754|100556169|FG004|Part 3|Physician Decision|0|||
33176874|NCT01729754|100556170|FG005|Part 3|Physician Decision|0|||
33176875|NCT01729754|100556171|FG006|Part 3|Physician Decision|0|||
33176876|NCT01729754|100556172|FG007|Part 3|Physician Decision|0|||
33176877|NCT01729754|100556173|FG008|Part 3|Physician Decision|0|||
33176878|NCT01729754|100556174|FG009|Part 3|Physician Decision|0|||
33176879|NCT01729754|100556165|FG000|Part 3|Withdrawal by Subject|0|||
33176880|NCT01729754|100556166|FG001|Part 3|Withdrawal by Subject|4|||
33176881|NCT01729754|100556167|FG002|Part 3|Withdrawal by Subject|1|||
33176882|NCT01729754|100556168|FG003|Part 3|Withdrawal by Subject|0|||
33176883|NCT01729754|100556169|FG004|Part 3|Withdrawal by Subject|2|||
33176884|NCT01729754|100556170|FG005|Part 3|Withdrawal by Subject|1|||
33176885|NCT01729754|100556171|FG006|Part 3|Withdrawal by Subject|0|||
33176886|NCT01729754|100556172|FG007|Part 3|Withdrawal by Subject|2|||
33176887|NCT01729754|100556173|FG008|Part 3|Withdrawal by Subject|0|||
33464109|NCT03785145|101589594|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
33464110|NCT03785145|101589595|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
33464111|NCT03785145|101589594|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
33464112|NCT03785145|101589595|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
33464113|NCT03785145|101589594|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
33464114|NCT03785145|101589595|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
33464115|NCT03785145|101589594|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
33464116|NCT03785145|101589595|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
33464117|NCT03573817|101589596|FG000|Overall Study|Adverse Event|0|||
33464118|NCT03573817|101589597|FG001|Overall Study|Adverse Event|2|||
33464119|NCT03573817|101589596|FG000|Overall Study|Protocol Violation|0|||
33464120|NCT03573817|101589597|FG001|Overall Study|Protocol Violation|1|||
33464121|NCT03573817|101589596|FG000|Overall Study|Withdrawal by Subject|1|||
33464122|NCT03573817|101589597|FG001|Overall Study|Withdrawal by Subject|1|||
33464123|NCT01813071|101589598|FG000|Overall Study|Protocol Violation|0|||
33464124|NCT01813071|101589599|FG001|Overall Study|Protocol Violation|0|||
33464125|NCT01813071|101589600|FG002|Overall Study|Protocol Violation|0|||
33464126|NCT01813071|101589601|FG003|Overall Study|Protocol Violation|0|||
33464127|NCT01813071|101589602|FG004|Overall Study|Protocol Violation|1|||
33464128|NCT01813071|101589603|FG005|Overall Study|Protocol Violation|4|||
33464129|NCT01813071|101589604|FG006|Overall Study|Protocol Violation|2|||
33464130|NCT01813071|101589605|FG007|Overall Study|Protocol Violation|4|||
33464131|NCT01813071|101589606|FG008|Overall Study|Protocol Violation|2|||
33464132|NCT01813071|101589598|FG000|Overall Study|Withdrawal by Subject|0|||
33176888|NCT01729754|100556174|FG009|Part 3|Withdrawal by Subject|0|||
33176889|NCT01729754|100556165|FG000|Part 3|Other Protocol Specified Criteria|0|||
33176890|NCT01729754|100556166|FG001|Part 3|Other Protocol Specified Criteria|0|||
33176891|NCT01729754|100556167|FG002|Part 3|Other Protocol Specified Criteria|0|||
33263391|NCT01968967|100866677|FG000|Treatment Period|Other|22|||
33263392|NCT01968967|100866678|FG001|Treatment Period|Other|22|||
33263393|NCT01968967|100866679|FG002|Treatment Period|Other|0|||
33263394|NCT01968967|100866680|FG003|Treatment Period|Other|0|||
33263395|NCT01968967|100866681|FG004|Treatment Period|Other|0|||
33263396|NCT01968967|100866677|FG000|Treatment Period|Withdrawal by Subject|71|||
33263397|NCT01968967|100866678|FG001|Treatment Period|Withdrawal by Subject|61|||
33263398|NCT01968967|100866679|FG002|Treatment Period|Withdrawal by Subject|0|||
33263399|NCT01968967|100866680|FG003|Treatment Period|Withdrawal by Subject|0|||
33263400|NCT01968967|100866681|FG004|Treatment Period|Withdrawal by Subject|0|||
33263401|NCT01968967|100866677|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
33464133|NCT01813071|101589599|FG001|Overall Study|Withdrawal by Subject|0|||
33464134|NCT01813071|101589600|FG002|Overall Study|Withdrawal by Subject|0|||
33464135|NCT01813071|101589601|FG003|Overall Study|Withdrawal by Subject|0|||
33464136|NCT01813071|101589602|FG004|Overall Study|Withdrawal by Subject|0|||
33464137|NCT01813071|101589603|FG005|Overall Study|Withdrawal by Subject|1|||
33464138|NCT01813071|101589604|FG006|Overall Study|Withdrawal by Subject|0|||
33464139|NCT01813071|101589605|FG007|Overall Study|Withdrawal by Subject|0|||
33176892|NCT01729754|100556168|FG003|Part 3|Other Protocol Specified Criteria|0|||
33176893|NCT01729754|100556169|FG004|Part 3|Other Protocol Specified Criteria|0|||
33176894|NCT01729754|100556170|FG005|Part 3|Other Protocol Specified Criteria|2|||
33176895|NCT01729754|100556171|FG006|Part 3|Other Protocol Specified Criteria|0|||
33176896|NCT01729754|100556172|FG007|Part 3|Other Protocol Specified Criteria|1|||
33176897|NCT01729754|100556173|FG008|Part 3|Other Protocol Specified Criteria|0|||
33176898|NCT01729754|100556174|FG009|Part 3|Other Protocol Specified Criteria|0|||
33176899|NCT00195676|100556176|FG000|Period O - Open-label Treatment|Adverse Event|82|||
33176900|NCT00195676|100556176|FG000|Period O - Open-label Treatment|Death|6|||
33176901|NCT00195676|100556176|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
33176902|NCT00195676|100556176|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
33176903|NCT00195676|100556176|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
33176904|NCT00195676|100556176|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
33176905|NCT00195676|100556176|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
33176906|NCT00195676|100556176|FG000|Period O - Open-label Treatment|Other reasons|68|||
33176907|NCT00195676|100556176|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
33176908|NCT00195676|100556176|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
33176909|NCT00195676|100556176|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
33176910|NCT00195676|100556176|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
33176911|NCT00195676|100556176|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
33176912|NCT00195676|100556176|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
33176913|NCT00195676|100556176|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
33176914|NCT00195676|100556176|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
33176915|NCT00195676|100556176|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
33176916|NCT00195676|100556176|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
33263402|NCT01968967|100866678|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
33263403|NCT01968967|100866679|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
33263404|NCT01968967|100866680|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
33263405|NCT01968967|100866681|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
33263406|NCT01968967|100866677|FG000|Treatment Period|Lost to Follow-up|26|||
33263407|NCT01968967|100866678|FG001|Treatment Period|Lost to Follow-up|31|||
33263408|NCT01968967|100866679|FG002|Treatment Period|Lost to Follow-up|0|||
33263409|NCT01968967|100866680|FG003|Treatment Period|Lost to Follow-up|0|||
33263410|NCT01968967|100866681|FG004|Treatment Period|Lost to Follow-up|0|||
33176917|NCT00195676|100556176|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
33176918|NCT00195676|100556176|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
33176919|NCT00195676|100556176|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
33176920|NCT00535223|100556177|FG000|Overall Study|Withdrawal by Subject|4|||
33176921|NCT00535223|100556178|FG001|Overall Study|Withdrawal by Subject|1|||
33176922|NCT00553150|100556181|FG000|Overall Study|Withdrawal by Subject|0|||
33176923|NCT00553150|100556182|FG001|Overall Study|Withdrawal by Subject|0|||
33176924|NCT00553150|100556183|FG002|Overall Study|Withdrawal by Subject|0|||
33176925|NCT00553150|100556184|FG003|Overall Study|Withdrawal by Subject|2|||
33176926|NCT00553150|100556181|FG000|Overall Study|Protocol Violation|0|||
33263411|NCT01968967|100866677|FG000|Treatment Period|Protocol Violation|1|||
33263412|NCT01968967|100866678|FG001|Treatment Period|Protocol Violation|2|||
33263413|NCT01968967|100866679|FG002|Treatment Period|Protocol Violation|0|||
33263414|NCT01968967|100866680|FG003|Treatment Period|Protocol Violation|0|||
33263415|NCT01968967|100866681|FG004|Treatment Period|Protocol Violation|0|||
33263416|NCT01968967|100866677|FG000|Treatment Period|Adverse Event|9|||
33263417|NCT01968967|100866678|FG001|Treatment Period|Adverse Event|8|||
33263418|NCT01968967|100866679|FG002|Treatment Period|Adverse Event|0|||
33263419|NCT01968967|100866680|FG003|Treatment Period|Adverse Event|0|||
33263420|NCT01968967|100866681|FG004|Treatment Period|Adverse Event|0|||
33263421|NCT01968967|100866677|FG000|Treatment Period|Death|9|||
33263422|NCT01968967|100866678|FG001|Treatment Period|Death|2|||
33263423|NCT01968967|100866679|FG002|Treatment Period|Death|0|||
33263424|NCT01968967|100866680|FG003|Treatment Period|Death|0|||
33263425|NCT01968967|100866681|FG004|Treatment Period|Death|0|||
33263426|NCT01968967|100866677|FG000|Treatment Period|Randomized Not Treated|6|||
33263427|NCT01968967|100866678|FG001|Treatment Period|Randomized Not Treated|5|||
33263428|NCT01968967|100866679|FG002|Treatment Period|Randomized Not Treated|0|||
33263429|NCT01968967|100866680|FG003|Treatment Period|Randomized Not Treated|0|||
33263430|NCT01968967|100866681|FG004|Treatment Period|Randomized Not Treated|0|||
33263431|NCT01968967|100866677|FG000|Extension Period|Withdrew Consent|0|||
33263432|NCT01968967|100866678|FG001|Extension Period|Withdrew Consent|0|||
33263433|NCT01968967|100866679|FG002|Extension Period|Withdrew Consent|2|||
33263434|NCT01968967|100866680|FG003|Extension Period|Withdrew Consent|0|||
33263435|NCT01968967|100866681|FG004|Extension Period|Withdrew Consent|5|||
33176927|NCT00553150|100556182|FG001|Overall Study|Protocol Violation|0|||
33176928|NCT00553150|100556183|FG002|Overall Study|Protocol Violation|0|||
33176929|NCT00553150|100556184|FG003|Overall Study|Protocol Violation|1|||
33263436|NCT00090519|100866682|FG000|Overall Study|Adverse Event|5|||
33263437|NCT00090519|100866683|FG001|Overall Study|Adverse Event|4|||
33263438|NCT00090519|100866682|FG000|Overall Study|Death|9|||
33263439|NCT00090519|100866683|FG001|Overall Study|Death|9|||
33263440|NCT00090519|100866682|FG000|Overall Study|Lost to Follow-up|26|||
33263441|NCT00090519|100866683|FG001|Overall Study|Lost to Follow-up|29|||
33263442|NCT00090519|100866682|FG000|Overall Study|Withdrawal by Subject|28|||
33176930|NCT00553150|100556181|FG000|Overall Study|Ineligible|0|||
33263443|NCT00090519|100866683|FG001|Overall Study|Withdrawal by Subject|29|||
33263444|NCT00090519|100866682|FG000|Overall Study|Physician Decision|2|||
33263445|NCT00090519|100866683|FG001|Overall Study|Physician Decision|3|||
33263446|NCT00090519|100866682|FG000|Overall Study|Sponsor Decision|3|||
33263447|NCT00090519|100866683|FG001|Overall Study|Sponsor Decision|1|||
33176931|NCT00553150|100556182|FG001|Overall Study|Ineligible|0|||
33176932|NCT00553150|100556183|FG002|Overall Study|Ineligible|0|||
33176933|NCT00553150|100556184|FG003|Overall Study|Ineligible|1|||
33176934|NCT04446377|100556185|FG000|Overall Study|Withdrawal by Subject|6|||
33176935|NCT04446377|100556186|FG001|Overall Study|Withdrawal by Subject|1|||
33176936|NCT04446377|100556185|FG000|Overall Study|Physician Decision|1|||
33176937|NCT04446377|100556186|FG001|Overall Study|Physician Decision|1|||
33176938|NCT04446377|100556185|FG000|Overall Study|Lost to Follow-up|0|||
33176939|NCT04446377|100556186|FG001|Overall Study|Lost to Follow-up|2|||
33176940|NCT04446377|100556185|FG000|Overall Study|Not eligible|0|||
33176941|NCT04446377|100556186|FG001|Overall Study|Not eligible|1|||
33176942|NCT02188589|100556187|FG000|Overall Study|Withdrawal by Subject|5|||
33176943|NCT00732615|100556188|FG000|Overall Study|Withdrawal by Subject|3|||
33176944|NCT00732615|100556189|FG001|Overall Study|Withdrawal by Subject|1|||
33176945|NCT00732615|100556188|FG000|Overall Study|Lost to Follow-up|0|||
33176946|NCT00732615|100556189|FG001|Overall Study|Lost to Follow-up|1|||
33176947|NCT00732615|100556188|FG000|Overall Study|Adverse Event|0|||
33176948|NCT00732615|100556189|FG001|Overall Study|Adverse Event|2|||
33176949|NCT00732615|100556188|FG000|Overall Study|Physician Decision|3|||
33176950|NCT00732615|100556189|FG001|Overall Study|Physician Decision|0|||
33176951|NCT00732615|100556188|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
33176952|NCT00732615|100556189|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
33176953|NCT00267046|100556196|FG000|Overall Study|Disease progression|4|||
33176954|NCT00267046|100556197|FG001|Overall Study|Disease progression|2|||
33176955|NCT00267046|100556196|FG000|Overall Study|Chemotoxicity|2|||
33176956|NCT00267046|100556197|FG001|Overall Study|Chemotoxicity|0|||
33176957|NCT00267046|100556196|FG000|Overall Study|Open-label palifermin|2|||
33176958|NCT00267046|100556197|FG001|Overall Study|Open-label palifermin|7|||
33176959|NCT00267046|100556196|FG000|Overall Study|Surgery|3|||
33176960|NCT00267046|100556197|FG001|Overall Study|Surgery|1|||
33176961|NCT00267046|100556196|FG000|Overall Study|Withdrawal by Subject|1|||
33176962|NCT00267046|100556197|FG001|Overall Study|Withdrawal by Subject|0|||
33176963|NCT00267046|100556196|FG000|Overall Study|Radiation|0|||
33176964|NCT00267046|100556197|FG001|Overall Study|Radiation|1|||
33176965|NCT02484729|100556200|FG000|Overall Study|Failure of IntelliCap Error|0|||
33176966|NCT02484729|100556201|FG001|Overall Study|Failure of IntelliCap Error|0|||
33176967|NCT02484729|100556202|FG002|Overall Study|Failure of IntelliCap Error|0|||
33176968|NCT02484729|100556203|FG003|Overall Study|Failure of IntelliCap Error|0|||
33176969|NCT02484729|100556204|FG004|Overall Study|Failure of IntelliCap Error|0|||
33176970|NCT02484729|100556205|FG005|Overall Study|Failure of IntelliCap Error|0|||
33176971|NCT02484729|100556206|FG006|Overall Study|Failure of IntelliCap Error|0|||
33176972|NCT02484729|100556207|FG007|Overall Study|Failure of IntelliCap Error|0|||
33176973|NCT02484729|100556208|FG008|Overall Study|Failure of IntelliCap Error|0|||
33176974|NCT02484729|100556209|FG009|Overall Study|Failure of IntelliCap Error|1|||
33176975|NCT01549392|100556210|FG000|Overall Study|Withdrawal by Subject|1|||
33176976|NCT01549392|100556211|FG001|Overall Study|Withdrawal by Subject|0|||
33176977|NCT01499667|100556212|FG000|Overall Study|administrative problems|4|||
33176978|NCT01499667|100556213|FG001|Overall Study|administrative problems|5|||
33176979|NCT01499667|100556214|FG002|Overall Study|administrative problems|5|||
33176980|NCT01499667|100556212|FG000|Overall Study|Protocol Violation|1|||
33176981|NCT01499667|100556213|FG001|Overall Study|Protocol Violation|3|||
33176982|NCT01499667|100556214|FG002|Overall Study|Protocol Violation|2|||
33176983|NCT01499667|100556212|FG000|Overall Study|Adverse Event|0|||
33176984|NCT01499667|100556213|FG001|Overall Study|Adverse Event|2|||
33176985|NCT01499667|100556214|FG002|Overall Study|Adverse Event|2|||
33176986|NCT01499667|100556212|FG000|Overall Study|Withdrawal by Subject|2|||
33464140|NCT01813071|101589606|FG008|Overall Study|Withdrawal by Subject|0|||
33464141|NCT01813071|101589598|FG000|Overall Study|Adverse Event|0|||
33176987|NCT01499667|100556213|FG001|Overall Study|Withdrawal by Subject|1|||
33176988|NCT01499667|100556214|FG002|Overall Study|Withdrawal by Subject|1|||
33176989|NCT01499667|100556212|FG000|Overall Study|Lack of Efficacy|2|||
33176990|NCT01499667|100556213|FG001|Overall Study|Lack of Efficacy|0|||
33176991|NCT01499667|100556214|FG002|Overall Study|Lack of Efficacy|0|||
33176992|NCT03630120|100556215|FG000|Overall Study|Disease progression|0|||
33176993|NCT03630120|100556216|FG001|Overall Study|Disease progression|1|||
33176994|NCT03630120|100556217|FG002|Overall Study|Disease progression|1|||
33176995|NCT03630120|100556218|FG003|Overall Study|Disease progression|1|||
33176996|NCT01928329|100556219|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
33176997|NCT01928329|100556220|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
33176998|NCT01928329|100556219|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
33464142|NCT01813071|101589599|FG001|Overall Study|Adverse Event|0|||
33464143|NCT01813071|101589600|FG002|Overall Study|Adverse Event|0|||
33176999|NCT01928329|100556220|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
33464144|NCT01813071|101589601|FG003|Overall Study|Adverse Event|0|||
33177000|NCT01928329|100556219|FG000|Overall Study|Adverse Event|5|||
33177001|NCT01928329|100556220|FG001|Overall Study|Adverse Event|3|||
33177002|NCT01928329|100556219|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
33177003|NCT01928329|100556220|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
33177004|NCT01928329|100556219|FG000|Overall Study|Withdrawal by Subject|1|||
33177005|NCT01928329|100556220|FG001|Overall Study|Withdrawal by Subject|5|||
33177006|NCT01928329|100556219|FG000|Overall Study|Physician Decision|1|||
33177007|NCT01928329|100556220|FG001|Overall Study|Physician Decision|1|||
33177008|NCT02153112|100556222|FG000|Overall Study|Adverse Event|0|||
33177009|NCT02153112|100556223|FG001|Overall Study|Adverse Event|0|||
33177010|NCT02153112|100556224|FG002|Overall Study|Adverse Event|1|||
33177011|NCT02153112|100556225|FG003|Overall Study|Adverse Event|0|||
33177012|NCT02153112|100556226|FG004|Overall Study|Adverse Event|0|||
33177013|NCT02153112|100556227|FG005|Overall Study|Adverse Event|0|||
33177014|NCT02153112|100556228|FG006|Overall Study|Adverse Event|0|||
33464145|NCT01813071|101589602|FG004|Overall Study|Adverse Event|0|||
33464146|NCT01813071|101589603|FG005|Overall Study|Adverse Event|1|||
33464147|NCT01813071|101589604|FG006|Overall Study|Adverse Event|0|||
33464148|NCT01813071|101589605|FG007|Overall Study|Adverse Event|0|||
33464149|NCT01813071|101589606|FG008|Overall Study|Adverse Event|0|||
33464150|NCT01813071|101589598|FG000|Overall Study|Physician Decision|0|||
33464151|NCT01813071|101589599|FG001|Overall Study|Physician Decision|0|||
33464152|NCT01813071|101589600|FG002|Overall Study|Physician Decision|0|||
33464153|NCT01813071|101589601|FG003|Overall Study|Physician Decision|0|||
33464154|NCT01813071|101589602|FG004|Overall Study|Physician Decision|0|||
33464155|NCT01813071|101589603|FG005|Overall Study|Physician Decision|0|||
33464156|NCT01813071|101589604|FG006|Overall Study|Physician Decision|1|||
33464157|NCT01813071|101589605|FG007|Overall Study|Physician Decision|0|||
33464158|NCT01813071|101589606|FG008|Overall Study|Physician Decision|0|||
33464159|NCT01813071|101589598|FG000|Overall Study|Met inc/exc criteria|0|||
33464160|NCT01813071|101589599|FG001|Overall Study|Met inc/exc criteria|0|||
33464161|NCT01813071|101589600|FG002|Overall Study|Met inc/exc criteria|0|||
33464162|NCT01813071|101589601|FG003|Overall Study|Met inc/exc criteria|0|||
33464163|NCT01813071|101589602|FG004|Overall Study|Met inc/exc criteria|0|||
33464164|NCT01813071|101589603|FG005|Overall Study|Met inc/exc criteria|1|||
33464165|NCT01813071|101589604|FG006|Overall Study|Met inc/exc criteria|0|||
33464166|NCT01813071|101589605|FG007|Overall Study|Met inc/exc criteria|1|||
33464167|NCT01813071|101589606|FG008|Overall Study|Met inc/exc criteria|1|||
33464168|NCT00939627|101589609|FG000|Overall Study|Disease Progression|16|||
33464169|NCT00939627|101589610|FG001|Overall Study|Disease Progression|12|||
33464170|NCT00939627|101589611|FG002|Overall Study|Disease Progression|0|||
33464171|NCT00939627|101589609|FG000|Overall Study|Adverse Event|6|||
33464172|NCT00939627|101589610|FG001|Overall Study|Adverse Event|7|||
33464173|NCT00939627|101589611|FG002|Overall Study|Adverse Event|0|||
33464174|NCT00939627|101589609|FG000|Overall Study|Death|0|||
33464175|NCT00939627|101589610|FG001|Overall Study|Death|2|||
33464176|NCT00939627|101589611|FG002|Overall Study|Death|0|||
33464177|NCT00939627|101589609|FG000|Overall Study|Withdrawal by Subject|2|||
33464178|NCT00939627|101589610|FG001|Overall Study|Withdrawal by Subject|4|||
33464179|NCT00939627|101589611|FG002|Overall Study|Withdrawal by Subject|0|||
33464180|NCT00939627|101589609|FG000|Overall Study|Other complicating disease|1|||
33464181|NCT00939627|101589610|FG001|Overall Study|Other complicating disease|1|||
33464182|NCT00939627|101589611|FG002|Overall Study|Other complicating disease|0|||
33464183|NCT00939627|101589609|FG000|Overall Study|Not compliant|2|||
33464184|NCT00939627|101589610|FG001|Overall Study|Not compliant|0|||
33464185|NCT00939627|101589611|FG002|Overall Study|Not compliant|0|||
33177015|NCT02153112|100556229|FG007|Overall Study|Adverse Event|0|||
33464186|NCT00939627|101589609|FG000|Overall Study|No off-tx reason given|0|||
33464187|NCT00939627|101589610|FG001|Overall Study|No off-tx reason given|2|||
33464188|NCT00939627|101589611|FG002|Overall Study|No off-tx reason given|0|||
33464189|NCT01257581|101589613|FG000|Overall Study|Early Termination|3|||
33464190|NCT01257581|101589614|FG001|Overall Study|Early Termination|1|||
33177016|NCT02153112|100556230|FG008|Overall Study|Adverse Event|0|||
33177017|NCT02153112|100556231|FG009|Overall Study|Adverse Event|0|||
33177018|NCT02153112|100556222|FG000|Overall Study|Lost to Follow-up|1|||
33464191|NCT01257581|101589615|FG002|Overall Study|Early Termination|2|||
33464192|NCT01257581|101589613|FG000|Overall Study|Death|2|||
33464193|NCT01257581|101589614|FG001|Overall Study|Death|2|||
33177019|NCT02153112|100556223|FG001|Overall Study|Lost to Follow-up|1|||
33177020|NCT02153112|100556224|FG002|Overall Study|Lost to Follow-up|0|||
33177021|NCT02153112|100556225|FG003|Overall Study|Lost to Follow-up|0|||
33464194|NCT01257581|101589615|FG002|Overall Study|Death|4|||
33464195|NCT04102345|101589616|FG000|Overall Study|Withdrawal by Subject|1|||
33177022|NCT02153112|100556226|FG004|Overall Study|Lost to Follow-up|2|||
33464196|NCT04102345|101589617|FG001|Overall Study|Withdrawal by Subject|0|||
33464197|NCT02031237|101589620|FG000|Overall Study|Death|1|||
33464198|NCT02031237|101589621|FG001|Overall Study|Death|5|||
33464199|NCT02031237|101589622|FG002|Overall Study|Death|0|||
33464200|NCT02031237|101589620|FG000|Overall Study|Physician Decision|0|||
33177023|NCT02153112|100556227|FG005|Overall Study|Lost to Follow-up|1|||
33177024|NCT02153112|100556228|FG006|Overall Study|Lost to Follow-up|1|||
33464201|NCT02031237|101589621|FG001|Overall Study|Physician Decision|1|||
33464202|NCT02031237|101589622|FG002|Overall Study|Physician Decision|0|||
33464203|NCT02031237|101589620|FG000|Overall Study|Withdrawal by Subject|2|||
33177025|NCT02153112|100556229|FG007|Overall Study|Lost to Follow-up|0|||
33177026|NCT02153112|100556230|FG008|Overall Study|Lost to Follow-up|1|||
33263448|NCT00495677|100866684|FG000|Stage 1 (25 Days)|Adverse Event|0|||
33263449|NCT00495677|100866685|FG001|Stage 1 (25 Days)|Adverse Event|0|||
33263450|NCT00495677|100866686|FG002|Stage 1 (25 Days)|Adverse Event|1|||
33263451|NCT00495677|100866687|FG003|Stage 1 (25 Days)|Adverse Event|0|||
33263452|NCT00495677|100866688|FG004|Stage 1 (25 Days)|Adverse Event|0|||
33263453|NCT00495677|100866689|FG005|Stage 1 (25 Days)|Adverse Event|0|||
33263454|NCT00495677|100866690|FG006|Stage 1 (25 Days)|Adverse Event|0|||
33263455|NCT01046136|100866691|FG000|Overall Study|Withdrawal by Subject|0|||
33263456|NCT01046136|100866692|FG001|Overall Study|Withdrawal by Subject|4|||
33263457|NCT01046136|100866691|FG000|Overall Study|Physician Decision|1|||
33464204|NCT02031237|101589621|FG001|Overall Study|Withdrawal by Subject|2|||
33464205|NCT02031237|101589622|FG002|Overall Study|Withdrawal by Subject|0|||
33464206|NCT02031237|101589620|FG000|Overall Study|Protocol Violation|2|||
33464207|NCT02031237|101589621|FG001|Overall Study|Protocol Violation|6|||
33464208|NCT02031237|101589622|FG002|Overall Study|Protocol Violation|0|||
33464209|NCT02031237|101589620|FG000|Overall Study|Alternate Treatment Given|0|||
33464210|NCT02031237|101589621|FG001|Overall Study|Alternate Treatment Given|0|||
33464211|NCT02031237|101589622|FG002|Overall Study|Alternate Treatment Given|3|||
33464212|NCT05816200|101589632|FG000|Overall Study|Lost to Follow-up|2|||
33464213|NCT05816200|101589633|FG001|Overall Study|Lost to Follow-up|1|||
33464214|NCT03166124|101589634|FG000|Treatment Period 1|Adverse Event|0|||
33464215|NCT03166124|101589635|FG001|Treatment Period 1|Adverse Event|0|||
33464216|NCT03166124|101589636|FG002|Treatment Period 1|Adverse Event|1|||
33464217|NCT03166124|101589637|FG003|Treatment Period 1|Adverse Event|0|||
33464218|NCT03166124|101589634|FG000|Wash-out Period|Withdrawal by Subject|0|||
33464219|NCT03166124|101589635|FG001|Wash-out Period|Withdrawal by Subject|1|||
33464220|NCT03166124|101589636|FG002|Wash-out Period|Withdrawal by Subject|0|||
33464221|NCT03166124|101589637|FG003|Wash-out Period|Withdrawal by Subject|1|||
33464222|NCT03166124|101589634|FG000|Wash-out Period|Adverse Event|0|||
33464223|NCT03166124|101589635|FG001|Wash-out Period|Adverse Event|1|||
33464224|NCT03166124|101589636|FG002|Wash-out Period|Adverse Event|1|||
33464225|NCT03166124|101589637|FG003|Wash-out Period|Adverse Event|0|||
33464226|NCT02846883|101589638|FG000|Overall Study|Death|0|||
33464227|NCT02846883|101589639|FG001|Overall Study|Death|1|||
33464228|NCT02846883|101589640|FG002|Overall Study|Death|1|||
33464229|NCT02846883|101589638|FG000|Overall Study|Lost to Follow-up|0|||
33464230|NCT02846883|101589639|FG001|Overall Study|Lost to Follow-up|0|||
33464231|NCT02846883|101589640|FG002|Overall Study|Lost to Follow-up|1|||
33464232|NCT02846883|101589638|FG000|Overall Study|Withdrawal by Subject|1|||
33464233|NCT02846883|101589639|FG001|Overall Study|Withdrawal by Subject|0|||
33464234|NCT02846883|101589640|FG002|Overall Study|Withdrawal by Subject|0|||
33464235|NCT02846883|101589638|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
33464236|NCT02846883|101589639|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
33464237|NCT02846883|101589640|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
33464238|NCT02846883|101589638|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
33464239|NCT02846883|101589639|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
33464240|NCT02846883|101589640|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
33464241|NCT03442569|101589641|FG000|Overall Study|Subject was ineligible after enrollment|1|||
33464242|NCT03823287|101589642|FG000|Overall Study|Withdrawal by Subject|25|||
33177027|NCT02153112|100556231|FG009|Overall Study|Lost to Follow-up|1|||
33177028|NCT02153112|100556222|FG000|Overall Study|Withdrawal by Subject|3|||
33177029|NCT02153112|100556223|FG001|Overall Study|Withdrawal by Subject|1|||
33177030|NCT02153112|100556224|FG002|Overall Study|Withdrawal by Subject|2|||
33177031|NCT02153112|100556225|FG003|Overall Study|Withdrawal by Subject|2|||
33177032|NCT02153112|100556226|FG004|Overall Study|Withdrawal by Subject|1|||
33177033|NCT02153112|100556227|FG005|Overall Study|Withdrawal by Subject|1|||
33177034|NCT02153112|100556228|FG006|Overall Study|Withdrawal by Subject|7|||
33177035|NCT02153112|100556229|FG007|Overall Study|Withdrawal by Subject|2|||
33177036|NCT02153112|100556230|FG008|Overall Study|Withdrawal by Subject|13|||
33263458|NCT01046136|100866692|FG001|Overall Study|Physician Decision|1|||
33263459|NCT01046136|100866691|FG000|Overall Study|Lost to Follow-up|3|||
33263460|NCT01046136|100866692|FG001|Overall Study|Lost to Follow-up|3|||
33263461|NCT00372775|100866693|FG000|Overall Study|Adverse Event|8|||
33263462|NCT00372775|100866693|FG000|Overall Study|Death|15|||
33464243|NCT03823287|101589643|FG001|Overall Study|Withdrawal by Subject|17|||
33464244|NCT03823287|101589642|FG000|Overall Study|Death|13|||
33464245|NCT03823287|101589643|FG001|Overall Study|Death|7|||
33177037|NCT02153112|100556231|FG009|Overall Study|Withdrawal by Subject|12|||
33177038|NCT02153112|100556222|FG000|Overall Study|Reason not Specified|0|||
33263463|NCT00372775|100866693|FG000|Overall Study|Objective progression or relapse|30|||
33464246|NCT03823287|101589642|FG000|Overall Study|Lost to Follow-up|7|||
33464247|NCT03823287|101589643|FG001|Overall Study|Lost to Follow-up|8|||
33464248|NCT03823287|101589642|FG000|Overall Study|Adverse Event|6|||
33177039|NCT02153112|100556223|FG001|Overall Study|Reason not Specified|0|||
33464249|NCT03823287|101589643|FG001|Overall Study|Adverse Event|8|||
33464250|NCT03823287|101589642|FG000|Overall Study|Physician Decision|5|||
33464251|NCT03823287|101589643|FG001|Overall Study|Physician Decision|2|||
33464252|NCT03823287|101589642|FG000|Overall Study|Lack of Efficacy|2|||
33464253|NCT03823287|101589643|FG001|Overall Study|Lack of Efficacy|0|||
33464254|NCT03823287|101589642|FG000|Overall Study|Other|2|||
33263464|NCT00372775|100866693|FG000|Overall Study|Global deterioration of health status|6|||
33263465|NCT00372775|100866693|FG000|Overall Study|Withdrawal by Subject|1|||
33263466|NCT00372775|100866693|FG000|Overall Study|Other|1|||
33464255|NCT03823287|101589643|FG001|Overall Study|Other|4|||
33464256|NCT00271024|101589644|FG000|Overall Study|Lost Interest|3|||
33464257|NCT00271024|101589645|FG001|Overall Study|Lost Interest|4|||
33464258|NCT00271024|101589646|FG002|Overall Study|Lost Interest|2|||
33464259|NCT00271024|101589647|FG003|Overall Study|Lost Interest|3|||
33464260|NCT00271024|101589644|FG000|Overall Study|Unknown/Unspecified|11|||
33464261|NCT00271024|101589645|FG001|Overall Study|Unknown/Unspecified|11|||
33464262|NCT00271024|101589646|FG002|Overall Study|Unknown/Unspecified|8|||
33464263|NCT00271024|101589647|FG003|Overall Study|Unknown/Unspecified|4|||
33464264|NCT00271024|101589644|FG000|Overall Study|Protocol Violation|1|||
33263467|NCT00372775|100866693|FG000|Overall Study|Not Treated|2|||
33263468|NCT01000805|100866694|FG000|Overall Study|Adverse Event|21|||
33177040|NCT02153112|100556224|FG002|Overall Study|Reason not Specified|0|||
33177041|NCT02153112|100556225|FG003|Overall Study|Reason not Specified|0|||
33177042|NCT02153112|100556226|FG004|Overall Study|Reason not Specified|0|||
33177043|NCT02153112|100556227|FG005|Overall Study|Reason not Specified|0|||
33177044|NCT02153112|100556228|FG006|Overall Study|Reason not Specified|0|||
33177045|NCT02153112|100556229|FG007|Overall Study|Reason not Specified|0|||
33177046|NCT02153112|100556230|FG008|Overall Study|Reason not Specified|1|||
33177047|NCT02153112|100556231|FG009|Overall Study|Reason not Specified|1|||
33177048|NCT02150954|100556232|FG000|Overall Study|Protocol Violation|1|||
33177049|NCT02150954|100556233|FG001|Overall Study|Protocol Violation|0|||
33177050|NCT04273217|100556235|FG000|Overall Study|Lost to Follow-up|0|||
33177051|NCT04273217|100556236|FG001|Overall Study|Lost to Follow-up|0|||
33177052|NCT04273217|100556237|FG002|Overall Study|Lost to Follow-up|0|||
33177053|NCT04273217|100556238|FG003|Overall Study|Lost to Follow-up|0|||
33177054|NCT04273217|100556239|FG004|Overall Study|Lost to Follow-up|0|||
33177055|NCT04273217|100556240|FG005|Overall Study|Lost to Follow-up|1|||
33177056|NCT04273217|100556235|FG000|Overall Study|Participant non-compliance|0|||
33177057|NCT04273217|100556236|FG001|Overall Study|Participant non-compliance|0|||
33177058|NCT04273217|100556237|FG002|Overall Study|Participant non-compliance|0|||
33177059|NCT04273217|100556238|FG003|Overall Study|Participant non-compliance|0|||
33177060|NCT04273217|100556239|FG004|Overall Study|Participant non-compliance|1|||
33177061|NCT04273217|100556240|FG005|Overall Study|Participant non-compliance|0|||
33177062|NCT04273217|100556235|FG000|Overall Study|Positive urine drug screen|1|||
33177063|NCT04273217|100556236|FG001|Overall Study|Positive urine drug screen|0|||
33177064|NCT04273217|100556237|FG002|Overall Study|Positive urine drug screen|1|||
33177065|NCT04273217|100556238|FG003|Overall Study|Positive urine drug screen|0|||
33177066|NCT04273217|100556239|FG004|Overall Study|Positive urine drug screen|0|||
33177067|NCT04273217|100556240|FG005|Overall Study|Positive urine drug screen|1|||
33177068|NCT01892501|100556253|FG000|Overall Study|Protocol Violation|2|||
33464265|NCT00271024|101589645|FG001|Overall Study|Protocol Violation|6|||
33177069|NCT01892501|100556253|FG000|Overall Study|Puncture not carried out|9|||
33177070|NCT01892501|100556253|FG000|Overall Study|Radiological monitoring not carried out|5|||
33177071|NCT01892501|100556253|FG000|Overall Study|Non-contributory histological result|12|||
33177072|NCT01998633|100556254|FG000|Overall Study|Death|1|||
33177073|NCT01572909|100556255|FG000|Overall Study|Adverse Event|7|||
33177074|NCT01572909|100556256|FG001|Overall Study|Adverse Event|2|||
33177075|NCT01572909|100556255|FG000|Overall Study|Death|3|||
33177076|NCT01572909|100556256|FG001|Overall Study|Death|1|||
33177077|NCT01572909|100556255|FG000|Overall Study|Lost to Follow-up|8|||
33177078|NCT01572909|100556256|FG001|Overall Study|Lost to Follow-up|7|||
33464266|NCT00271024|101589646|FG002|Overall Study|Protocol Violation|5|||
33464267|NCT00271024|101589647|FG003|Overall Study|Protocol Violation|11|||
33464268|NCT00271024|101589644|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
33464269|NCT00271024|101589645|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
33464270|NCT00271024|101589646|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
33177079|NCT01572909|100556255|FG000|Overall Study|Physician Decision|1|||
33177080|NCT01572909|100556256|FG001|Overall Study|Physician Decision|1|||
33177081|NCT01572909|100556255|FG000|Overall Study|Technical Issues|1|||
33177082|NCT01572909|100556256|FG001|Overall Study|Technical Issues|0|||
33177083|NCT01572909|100556255|FG000|Overall Study|Withdrawal by Subject|12|||
33177084|NCT01572909|100556256|FG001|Overall Study|Withdrawal by Subject|11|||
33177085|NCT01572909|100556255|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
33177086|NCT01572909|100556256|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
33177087|NCT04741074|100556257|FG000|Overall Study|Withdrawal by Subject|1|||
33177088|NCT04741074|100556258|FG001|Overall Study|Withdrawal by Subject|1|||
33177089|NCT04741074|100556257|FG000|Overall Study|Study terminated prematurely|1|||
33177090|NCT04741074|100556258|FG001|Overall Study|Study terminated prematurely|0|||
33177091|NCT00597766|100556259|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
33464271|NCT00271024|101589647|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
33464272|NCT00271024|101589644|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
33464273|NCT00271024|101589645|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
33464274|NCT00271024|101589646|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
33464275|NCT00271024|101589647|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
33464276|NCT00761176|101589650|FG000|Overall Study|Death|1|||
33464277|NCT00761176|101589651|FG001|Overall Study|Death|0|||
33464278|NCT00761176|101589650|FG000|Overall Study|Withdrawal by Subject|1|||
33464279|NCT00761176|101589651|FG001|Overall Study|Withdrawal by Subject|1|||
33464280|NCT01483625|101589652|FG000|Overall Study|Adverse Event|1|||
33464281|NCT01483625|101589653|FG001|Overall Study|Adverse Event|1|||
33464282|NCT01483625|101589652|FG000|Overall Study|Refused to continue medication|2|||
33464283|NCT01483625|101589653|FG001|Overall Study|Refused to continue medication|1|||
33464284|NCT01483625|101589652|FG000|Overall Study|Due to other reason|1|||
33464285|NCT01483625|101589653|FG001|Overall Study|Due to other reason|0|||
33464286|NCT00402025|101589656|FG000|Overall Study|Adverse Event|0|||
33464287|NCT00402025|101589657|FG001|Overall Study|Adverse Event|0|||
33464288|NCT00402025|101589658|FG002|Overall Study|Adverse Event|2|||
33464289|NCT00402025|101589656|FG000|Overall Study|Death|0|||
33464290|NCT00402025|101589657|FG001|Overall Study|Death|1|||
33464291|NCT00402025|101589658|FG002|Overall Study|Death|5|||
33464292|NCT00402025|101589656|FG000|Overall Study|Disease Progression|1|||
33464293|NCT00402025|101589657|FG001|Overall Study|Disease Progression|1|||
33464294|NCT00402025|101589658|FG002|Overall Study|Disease Progression|2|||
33464295|NCT00402025|101589656|FG000|Overall Study|Physician Decision|1|||
33464296|NCT00402025|101589657|FG001|Overall Study|Physician Decision|1|||
33464297|NCT00402025|101589658|FG002|Overall Study|Physician Decision|0|||
33464298|NCT00402025|101589656|FG000|Overall Study|Participant Decision|0|||
33464299|NCT00402025|101589657|FG001|Overall Study|Participant Decision|0|||
33464300|NCT00402025|101589658|FG002|Overall Study|Participant Decision|1|||
33464301|NCT00551616|101589661|FG000|Overall Study|Lost to Follow-up|48|||
33464302|NCT00551616|101589662|FG001|Overall Study|Lost to Follow-up|40|||
33464303|NCT00124462|101589667|FG000|Overall Study|Lost to Follow-up|3|||
33464304|NCT00124462|101589668|FG001|Overall Study|Lost to Follow-up|3|||
33464305|NCT00124462|101589667|FG000|Overall Study|Physician Decision|3|||
33177092|NCT00597766|100556260|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
33464306|NCT00124462|101589668|FG001|Overall Study|Physician Decision|4|||
33464307|NCT00124462|101589667|FG000|Overall Study|Withdrawal by Subject|4|||
33464308|NCT00124462|101589668|FG001|Overall Study|Withdrawal by Subject|5|||
33464309|NCT00124462|101589667|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
33464310|NCT00124462|101589668|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
33464311|NCT02190279|101589678|FG000|Overall Study|Withdrawal consent|1|||
33464312|NCT02190279|101589679|FG001|Overall Study|Withdrawal consent|0|||
33464313|NCT02190279|101589680|FG002|Overall Study|Withdrawal consent|1|||
33464314|NCT02190279|101589678|FG000|Overall Study|Lost to Follow-up|2|||
33464315|NCT02190279|101589679|FG001|Overall Study|Lost to Follow-up|0|||
33464316|NCT02190279|101589680|FG002|Overall Study|Lost to Follow-up|0|||
33464317|NCT02190279|101589678|FG000|Overall Study|Refused further treatment|0|||
33177093|NCT00597766|100556261|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
33177094|NCT00597766|100556259|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
33177095|NCT00597766|100556260|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
33177096|NCT00597766|100556261|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
33177097|NCT03909295|100556266|FG000|Overall Study|Adverse Event|2|||
33177098|NCT03909295|100556266|FG000|Overall Study|Study terminated by sponsor|50|||
33177099|NCT01641692|100556267|FG000|Treatment Period 1|Adverse Event|1|||
33177100|NCT01641692|100556268|FG001|Treatment Period 1|Adverse Event|0|||
33177101|NCT01641692|100556269|FG002|Treatment Period 1|Adverse Event|0|||
33177102|NCT01641692|100556270|FG003|Treatment Period 1|Adverse Event|0|||
33177103|NCT01641692|100556271|FG004|Treatment Period 1|Adverse Event|0|||
33263469|NCT01000805|100866695|FG001|Overall Study|Adverse Event|9|||
33263470|NCT01000805|100866694|FG000|Overall Study|Lack of Efficacy|5|||
33263471|NCT01000805|100866695|FG001|Overall Study|Lack of Efficacy|16|||
33263472|NCT01000805|100866694|FG000|Overall Study|Lost to Follow-up|16|||
33263473|NCT01000805|100866695|FG001|Overall Study|Lost to Follow-up|21|||
33263474|NCT01000805|100866694|FG000|Overall Study|Physician Decision|0|||
33263475|NCT01000805|100866695|FG001|Overall Study|Physician Decision|1|||
33263476|NCT01000805|100866694|FG000|Overall Study|Protocol Violation|12|||
33263477|NCT01000805|100866695|FG001|Overall Study|Protocol Violation|8|||
33263478|NCT01000805|100866694|FG000|Overall Study|Withdrawal by Subject|16|||
33464318|NCT02190279|101589679|FG001|Overall Study|Refused further treatment|0|||
33464319|NCT02190279|101589680|FG002|Overall Study|Refused further treatment|1|||
33464320|NCT02190279|101589678|FG000|Overall Study|Screening failure|0|||
33464321|NCT02190279|101589679|FG001|Overall Study|Screening failure|0|||
33464322|NCT02190279|101589680|FG002|Overall Study|Screening failure|1|||
33464323|NCT00515034|101589684|FG000|Overall Study|Adverse Event|2|||
33464324|NCT00515034|101589685|FG001|Overall Study|Adverse Event|0|||
33464325|NCT00515034|101589686|FG002|Overall Study|Adverse Event|1|||
33464326|NCT00515034|101589687|FG003|Overall Study|Adverse Event|0|||
33464327|NCT00515034|101589684|FG000|Overall Study|Death|4|||
33464328|NCT00515034|101589685|FG001|Overall Study|Death|2|||
33464329|NCT00515034|101589686|FG002|Overall Study|Death|1|||
33464330|NCT00515034|101589687|FG003|Overall Study|Death|3|||
33464331|NCT00515034|101589684|FG000|Overall Study|Withdrawal by Subject|1|||
33464332|NCT00515034|101589685|FG001|Overall Study|Withdrawal by Subject|0|||
33464333|NCT00515034|101589686|FG002|Overall Study|Withdrawal by Subject|3|||
33464334|NCT00515034|101589687|FG003|Overall Study|Withdrawal by Subject|0|||
33464335|NCT00515034|101589684|FG000|Overall Study|Physician Decision|0|||
33464336|NCT00515034|101589685|FG001|Overall Study|Physician Decision|0|||
33464337|NCT00515034|101589686|FG002|Overall Study|Physician Decision|1|||
33464338|NCT00515034|101589687|FG003|Overall Study|Physician Decision|1|||
33464339|NCT00515034|101589684|FG000|Overall Study|Other|1|||
33464340|NCT00515034|101589685|FG001|Overall Study|Other|0|||
33464341|NCT00515034|101589686|FG002|Overall Study|Other|2|||
33464342|NCT00515034|101589687|FG003|Overall Study|Other|1|||
33464343|NCT01546922|101589689|FG000|First Period of 10 Weeks|Protocol Violation|3|||
33464344|NCT01546922|101589690|FG001|First Period of 10 Weeks|Protocol Violation|1|||
33464345|NCT01546922|101589689|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
33464346|NCT01546922|101589690|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
33464347|NCT01546922|101589689|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
33464348|NCT01546922|101589690|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
33464349|NCT01546922|101589689|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
33464350|NCT01546922|101589690|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
33464351|NCT01546922|101589689|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
33464352|NCT01546922|101589690|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
33177104|NCT01641692|100556272|FG005|Treatment Period 1|Adverse Event|0|||
33464353|NCT01098110|101589691|FG000|Overall Study|Withdrawal by Subject|14|||
33464354|NCT01098110|101589692|FG001|Overall Study|Withdrawal by Subject|24|||
33464355|NCT01098110|101589693|FG002|Overall Study|Withdrawal by Subject|19|||
33464356|NCT01098110|101589691|FG000|Overall Study|Adverse Event|30|||
33177105|NCT01641692|100556273|FG006|Treatment Period 1|Adverse Event|0|||
33263479|NCT01000805|100866695|FG001|Overall Study|Withdrawal by Subject|6|||
33263480|NCT01000805|100866694|FG000|Overall Study|Sponsor Decision|0|||
33263481|NCT01000805|100866695|FG001|Overall Study|Sponsor Decision|1|||
33286474|NCT03918447|100943975|FG000|Overall Study|Study Terminated by Sponsor|195|||
33464357|NCT01098110|101589692|FG001|Overall Study|Adverse Event|32|||
33464358|NCT01098110|101589693|FG002|Overall Study|Adverse Event|43|||
33464359|NCT01098110|101589691|FG000|Overall Study|Lack of Efficacy|13|||
33464360|NCT01098110|101589692|FG001|Overall Study|Lack of Efficacy|9|||
33464361|NCT01098110|101589693|FG002|Overall Study|Lack of Efficacy|27|||
33177106|NCT01641692|100556274|FG007|Treatment Period 1|Adverse Event|0|||
33177107|NCT01641692|100556267|FG000|Treatment Period 1|Lack of Efficacy|0|||
33263482|NCT04679675|100866696|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
33263483|NCT04679675|100866697|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
33263484|NCT04679675|100866698|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
33263485|NCT04679675|100866699|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
33263486|NCT04679675|100866696|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
33263487|NCT04679675|100866697|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
33263488|NCT04679675|100866698|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
33263489|NCT04679675|100866699|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
33263490|NCT02397096|100866704|FG000|Day 1 to Week 24|Adverse Event|7|||
33263491|NCT02397096|100866705|FG001|Day 1 to Week 24|Adverse Event|1|||
33263492|NCT02397096|100866704|FG000|Day 1 to Week 24|Death|1|||
33263493|NCT02397096|100866705|FG001|Day 1 to Week 24|Death|0|||
33263494|NCT02397096|100866704|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
33263495|NCT02397096|100866705|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
33263496|NCT02397096|100866704|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
33263497|NCT02397096|100866705|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
33263498|NCT02397096|100866704|FG000|Day 1 to Week 24|Physician Decision|2|||
33263499|NCT02397096|100866705|FG001|Day 1 to Week 24|Physician Decision|3|||
33263500|NCT02397096|100866704|FG000|Day 1 to Week 24|Protocol Violation|1|||
33263501|NCT02397096|100866705|FG001|Day 1 to Week 24|Protocol Violation|4|||
33263502|NCT02397096|100866704|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
33263503|NCT02397096|100866705|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
33263504|NCT02397096|100866704|FG000|Day 1 to Week 24|Randomized, not treated|3|||
33263505|NCT02397096|100866705|FG001|Day 1 to Week 24|Randomized, not treated|0|||
33263506|NCT02397096|100866704|FG000|Week 24 to Week 48|Adverse Event|6|||
33263507|NCT02397096|100866705|FG001|Week 24 to Week 48|Adverse Event|2|||
33263508|NCT02397096|100866704|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
33263509|NCT02397096|100866705|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
33263510|NCT02397096|100866704|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
33263511|NCT02397096|100866705|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
33263512|NCT02397096|100866704|FG000|Week 24 to Week 48|Physician Decision|2|||
33464362|NCT01098110|101589691|FG000|Overall Study|Other|4|||
33464363|NCT01098110|101589692|FG001|Overall Study|Other|7|||
33464364|NCT01098110|101589693|FG002|Overall Study|Other|5|||
33464365|NCT01098110|101589691|FG000|Overall Study|Untreated|1|||
33464366|NCT01098110|101589692|FG001|Overall Study|Untreated|1|||
33464367|NCT01098110|101589693|FG002|Overall Study|Untreated|0|||
33464368|NCT00104247|101589694|FG000|Overall Study|Withdrawal by Subject|1|||
33177108|NCT01641692|100556268|FG001|Treatment Period 1|Lack of Efficacy|0|||
33177109|NCT01641692|100556269|FG002|Treatment Period 1|Lack of Efficacy|0|||
33177110|NCT01641692|100556270|FG003|Treatment Period 1|Lack of Efficacy|0|||
33177111|NCT01641692|100556271|FG004|Treatment Period 1|Lack of Efficacy|0|||
33177112|NCT01641692|100556272|FG005|Treatment Period 1|Lack of Efficacy|0|||
33177113|NCT01641692|100556273|FG006|Treatment Period 1|Lack of Efficacy|0|||
33177114|NCT01641692|100556274|FG007|Treatment Period 1|Lack of Efficacy|1|||
33177115|NCT01641692|100556267|FG000|Treatment Period 1|Protocol Violation|1|||
33177116|NCT01641692|100556268|FG001|Treatment Period 1|Protocol Violation|0|||
33177117|NCT01641692|100556269|FG002|Treatment Period 1|Protocol Violation|0|||
33177118|NCT01641692|100556270|FG003|Treatment Period 1|Protocol Violation|0|||
33177119|NCT01641692|100556271|FG004|Treatment Period 1|Protocol Violation|2|||
33263513|NCT02397096|100866705|FG001|Week 24 to Week 48|Physician Decision|1|||
33263514|NCT02397096|100866704|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
33263515|NCT02397096|100866705|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
33263516|NCT02397096|100866704|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
33263517|NCT02397096|100866705|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
33464369|NCT00104247|101589695|FG001|Overall Study|Withdrawal by Subject|0|||
33464370|NCT00104247|101589694|FG000|Overall Study|Noncompliant with dosing|0|||
33464371|NCT00104247|101589695|FG001|Overall Study|Noncompliant with dosing|1|||
33464372|NCT03653026|101589699|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
33464373|NCT03653026|101589700|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
33464374|NCT03653026|101589701|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
33464375|NCT03653026|101589702|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
33464376|NCT03653026|101589699|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
33464377|NCT03653026|101589700|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
33263518|NCT02397096|100866704|FG000|Study Extension 1|Adverse Event|7|||
33263519|NCT02397096|100866705|FG001|Study Extension 1|Adverse Event|5|||
33464378|NCT03653026|101589701|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33464379|NCT03653026|101589702|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
33464380|NCT03653026|101589699|FG000|Part 1: Placebo-controlled Period|Other|0|||
33177120|NCT01641692|100556272|FG005|Treatment Period 1|Protocol Violation|0|||
33263520|NCT02397096|100866704|FG000|Study Extension 1|Death|1|||
33464381|NCT03653026|101589700|FG001|Part 1: Placebo-controlled Period|Other|3|||
33177121|NCT01641692|100556273|FG006|Treatment Period 1|Protocol Violation|0|||
33464382|NCT03653026|101589701|FG002|Part 1: Placebo-controlled Period|Other|0|||
33464383|NCT03653026|101589702|FG003|Part 1: Placebo-controlled Period|Other|0|||
33464384|NCT03653026|101589699|FG000|Part 2: Open-label Extension|Adverse Event|0|||
33464385|NCT03653026|101589700|FG001|Part 2: Open-label Extension|Adverse Event|0|||
33464386|NCT03653026|101589701|FG002|Part 2: Open-label Extension|Adverse Event|1|||
33464387|NCT03653026|101589702|FG003|Part 2: Open-label Extension|Adverse Event|1|||
33464388|NCT03653026|101589699|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
33464389|NCT03653026|101589700|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
33464390|NCT03653026|101589701|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
33464391|NCT03653026|101589702|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
33464392|NCT03653026|101589699|FG000|Part 2: Open-label Extension|Other|0|||
33464393|NCT03653026|101589700|FG001|Part 2: Open-label Extension|Other|0|||
33464394|NCT03653026|101589701|FG002|Part 2: Open-label Extension|Other|1|||
33464395|NCT03653026|101589702|FG003|Part 2: Open-label Extension|Other|2|||
33464396|NCT01765751|101589703|FG000|Overall Study|Lost to Follow-up|0|||
33464397|NCT01765751|101589704|FG001|Overall Study|Lost to Follow-up|2|||
33464398|NCT01765751|101589705|FG002|Overall Study|Lost to Follow-up|1|||
33464399|NCT04675775|101589706|FG000|Overall Study|Withdrawal by Subject|7|||
33464400|NCT01955044|101589708|FG000|Overall Study|Death|1|||
33464401|NCT01955044|101589709|FG001|Overall Study|Death|1|||
33464402|NCT01955044|101589710|FG002|Overall Study|Death|0|||
33464403|NCT04252287|101589711|FG000|Overall Study|Death|5|||
33464404|NCT04252287|101589712|FG001|Overall Study|Death|3|||
33263521|NCT02397096|100866705|FG001|Study Extension 1|Death|0|||
33263522|NCT02397096|100866704|FG000|Study Extension 1|Lack of Efficacy|2|||
33263523|NCT02397096|100866705|FG001|Study Extension 1|Lack of Efficacy|5|||
33263524|NCT02397096|100866704|FG000|Study Extension 1|Lost to Follow-up|2|||
33464405|NCT04252287|101589711|FG000|Overall Study|Lost to Follow-up|4|||
33464406|NCT04252287|101589712|FG001|Overall Study|Lost to Follow-up|6|||
33464407|NCT04252287|101589711|FG000|Overall Study|Withdrawal by Subject|19|||
33464408|NCT04252287|101589712|FG001|Overall Study|Withdrawal by Subject|16|||
33464409|NCT04252287|101589711|FG000|Overall Study|Protocol Violation|3|||
33464410|NCT04252287|101589712|FG001|Overall Study|Protocol Violation|4|||
33464411|NCT01731886|101589721|FG000|Overall Study|Death|1|||
33464412|NCT01731886|101589722|FG001|Overall Study|Death|0|||
33464413|NCT01731886|101589721|FG000|Overall Study|Never started treatment|0|||
33464414|NCT01731886|101589722|FG001|Overall Study|Never started treatment|1|||
33464415|NCT01731886|101589721|FG000|Overall Study|Non-compliant|1|||
33464416|NCT01731886|101589722|FG001|Overall Study|Non-compliant|0|||
33464417|NCT00810602|101589727|FG000|Overall Study|Withdrawal by Subject|8|||
33464418|NCT00810602|101589728|FG001|Overall Study|Withdrawal by Subject|3|||
33464419|NCT01636934|101589729|FG000|Overall Study|Withdrawal by Subject|3|||
33464420|NCT01636934|101589730|FG001|Overall Study|Withdrawal by Subject|2|||
33464421|NCT01636934|101589729|FG000|Overall Study|Chemo cancel|1|||
33464422|NCT01636934|101589730|FG001|Overall Study|Chemo cancel|0|||
33464423|NCT01636934|101589729|FG000|Overall Study|Too ill to continue|1|||
33464424|NCT01636934|101589730|FG001|Overall Study|Too ill to continue|0|||
33464425|NCT01636934|101589729|FG000|Overall Study|Never started study medication|1|||
33464426|NCT01636934|101589730|FG001|Overall Study|Never started study medication|1|||
33464427|NCT04403763|101589732|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
33464428|NCT04403763|101589733|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
33464429|NCT04403763|101589734|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
33464430|NCT04403763|101589735|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
33464431|NCT04403763|101589736|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
33464432|NCT04403763|101589737|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
33464433|NCT04403763|101589738|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
33464434|NCT04403763|101589732|FG000|Stage 1|Early termination due to PK tube failure|0|||
33464435|NCT04403763|101589733|FG001|Stage 1|Early termination due to PK tube failure|0|||
33464436|NCT04403763|101589734|FG002|Stage 1|Early termination due to PK tube failure|1|||
33464437|NCT04403763|101589735|FG003|Stage 1|Early termination due to PK tube failure|0|||
33464438|NCT04403763|101589736|FG004|Stage 1|Early termination due to PK tube failure|0|||
33464439|NCT04403763|101589737|FG005|Stage 1|Early termination due to PK tube failure|0|||
33464440|NCT04403763|101589738|FG006|Stage 1|Early termination due to PK tube failure|0|||
33464441|NCT04403763|101589732|FG000|Stage 2A|Adverse Event|0|||
33464442|NCT04403763|101589733|FG001|Stage 2A|Adverse Event|0|||
33263525|NCT02397096|100866705|FG001|Study Extension 1|Lost to Follow-up|3|||
33464443|NCT04403763|101589734|FG002|Stage 2A|Adverse Event|0|||
33464444|NCT04403763|101589735|FG003|Stage 2A|Adverse Event|0|||
33464445|NCT04403763|101589736|FG004|Stage 2A|Adverse Event|0|||
33464446|NCT04403763|101589737|FG005|Stage 2A|Adverse Event|0|||
33464447|NCT04403763|101589738|FG006|Stage 2A|Adverse Event|1|||
33464448|NCT01546519|101589739|FG000|Overall Study|Adverse Event|0|||
33464449|NCT01546519|101589740|FG001|Overall Study|Adverse Event|0|||
33464450|NCT01546519|101589741|FG002|Overall Study|Adverse Event|1|||
33464451|NCT01546519|101589742|FG003|Overall Study|Adverse Event|1|||
33263526|NCT02397096|100866704|FG000|Study Extension 1|Non-compliance with study drug|3|||
33464452|NCT01546519|101589739|FG000|Overall Study|Death|0|||
33464453|NCT01546519|101589740|FG001|Overall Study|Death|1|||
33464454|NCT01546519|101589741|FG002|Overall Study|Death|3|||
33464455|NCT01546519|101589742|FG003|Overall Study|Death|1|||
33464456|NCT01546519|101589739|FG000|Overall Study|related to disease progression|2|||
33464457|NCT01546519|101589740|FG001|Overall Study|related to disease progression|2|||
33464458|NCT01546519|101589741|FG002|Overall Study|related to disease progression|2|||
33464459|NCT01546519|101589742|FG003|Overall Study|related to disease progression|1|||
33464460|NCT01546519|101589739|FG000|Overall Study|Physician Decision|6|||
33464461|NCT01546519|101589740|FG001|Overall Study|Physician Decision|5|||
33464462|NCT01546519|101589741|FG002|Overall Study|Physician Decision|2|||
33464463|NCT01546519|101589742|FG003|Overall Study|Physician Decision|3|||
33464464|NCT01546519|101589739|FG000|Overall Study|Withdrawal by Subject|1|||
33263527|NCT02397096|100866705|FG001|Study Extension 1|Non-compliance with study drug|0|||
33263528|NCT02397096|100866704|FG000|Study Extension 1|Physician Decision|4|||
33263529|NCT02397096|100866705|FG001|Study Extension 1|Physician Decision|2|||
33263530|NCT02397096|100866704|FG000|Study Extension 1|Pregnancy|1|||
33263531|NCT02397096|100866705|FG001|Study Extension 1|Pregnancy|0|||
33263532|NCT02397096|100866704|FG000|Study Extension 1|Protocol Violation|0|||
33263533|NCT02397096|100866705|FG001|Study Extension 1|Protocol Violation|1|||
33263534|NCT02397096|100866704|FG000|Study Extension 1|Withdrawal by Subject|21|||
33263535|NCT02397096|100866705|FG001|Study Extension 1|Withdrawal by Subject|7|||
33263536|NCT02397096|100866704|FG000|Study Extension 2|Adverse Event|3|||
33263537|NCT02397096|100866705|FG001|Study Extension 2|Adverse Event|3|||
33263538|NCT02397096|100866704|FG000|Study Extension 2|Availability of study medication locally|152|||
33263539|NCT02397096|100866705|FG001|Study Extension 2|Availability of study medication locally|64|||
33263540|NCT02397096|100866704|FG000|Study Extension 2|Death|2|||
33263541|NCT02397096|100866705|FG001|Study Extension 2|Death|0|||
33263542|NCT02397096|100866704|FG000|Study Extension 2|Lack of Efficacy|1|||
33263543|NCT02397096|100866705|FG001|Study Extension 2|Lack of Efficacy|0|||
33263544|NCT02397096|100866704|FG000|Study Extension 2|Lost to Follow-up|2|||
33263545|NCT02397096|100866705|FG001|Study Extension 2|Lost to Follow-up|1|||
33263546|NCT02397096|100866704|FG000|Study Extension 2|Non-compliance with study drug|1|||
33263547|NCT02397096|100866705|FG001|Study Extension 2|Non-compliance with study drug|0|||
33263548|NCT02397096|100866704|FG000|Study Extension 2|Physician Decision|2|||
33263549|NCT02397096|100866705|FG001|Study Extension 2|Physician Decision|5|||
33263550|NCT02397096|100866704|FG000|Study Extension 2|Pregnancy|1|||
33263551|NCT02397096|100866705|FG001|Study Extension 2|Pregnancy|0|||
33263552|NCT02397096|100866704|FG000|Study Extension 2|Withdrawal by Subject|10|||
33263553|NCT02397096|100866705|FG001|Study Extension 2|Withdrawal by Subject|3|||
33263554|NCT02397096|100866704|FG000|Study Extension 3|Adverse Event|1|||
33263555|NCT02397096|100866705|FG001|Study Extension 3|Adverse Event|0|||
33464465|NCT01546519|101589740|FG001|Overall Study|Withdrawal by Subject|0|||
33464466|NCT01546519|101589741|FG002|Overall Study|Withdrawal by Subject|0|||
33464467|NCT01546519|101589742|FG003|Overall Study|Withdrawal by Subject|0|||
33464468|NCT00576303|101589748|FG000|Dose Titration Period|Early withdrawal|17|||
33464469|NCT00576303|101589748|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
33464470|NCT00576303|101589748|FG000|Long Term Safety Period|Early withdrawal|16|||
33464471|NCT02363439|101589757|FG000|Overall Study|Lack of Efficacy|4|||
33464472|NCT01470417|101589758|FG000|Overall Study|Disease progression|0|||
33464473|NCT01470417|101589759|FG001|Overall Study|Disease progression|2|||
33464474|NCT02457611|101589760|FG000|Overall Study|Lost to Follow-up|3|||
33464475|NCT01557582|101589761|FG000|Overall Study|Protocol Violation|4|||
33464476|NCT01557582|101589761|FG000|Overall Study|Operator error|2|||
33464477|NCT02488824|101589764|FG000|Overall Study|Adverse Event|1|||
33464478|NCT02488824|101589765|FG001|Overall Study|Adverse Event|1|||
33464479|NCT02953678|101589766|FG000|Overall Study|Adverse Event|20|||
33464480|NCT02953678|101589766|FG000|Overall Study|Death|7|||
33464481|NCT02953678|101589766|FG000|Overall Study|Physician Decision|23|||
33464482|NCT02953678|101589766|FG000|Overall Study|Progressive Disease of GVHD|7|||
33464483|NCT02953678|101589766|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
33263556|NCT02397096|100866704|FG000|Study Extension 3|Availability of study medication locally|11|||
33263557|NCT02397096|100866705|FG001|Study Extension 3|Availability of study medication locally|3|||
33263558|NCT02397096|100866704|FG000|Study Extension 3|Lost to Follow-up|1|||
33263559|NCT02397096|100866705|FG001|Study Extension 3|Lost to Follow-up|0|||
33464484|NCT02953678|101589766|FG000|Overall Study|Withdrawal by participant|3|||
33263560|NCT02397096|100866704|FG000|Study Extension 3|Withdrawal by Subject|2|||
33263561|NCT02397096|100866705|FG001|Study Extension 3|Withdrawal by Subject|1|||
33263562|NCT03220724|100866711|FG000|Overall Study|Lost to Follow-up|2|||
33263563|NCT03220724|100866712|FG001|Overall Study|Lost to Follow-up|2|||
33263564|NCT03220724|100866713|FG002|Overall Study|Lost to Follow-up|0|||
33177122|NCT01641692|100556274|FG007|Treatment Period 1|Protocol Violation|0|||
33177123|NCT01641692|100556267|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
33177124|NCT01641692|100556268|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
33177125|NCT01641692|100556269|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
33177126|NCT01641692|100556270|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
33177127|NCT01641692|100556271|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
33263565|NCT03220724|100866714|FG003|Overall Study|Lost to Follow-up|3|||
33263566|NCT03220724|100866715|FG004|Overall Study|Lost to Follow-up|1|||
33263567|NCT03220724|100866716|FG005|Overall Study|Lost to Follow-up|0|||
33263568|NCT03220724|100866717|FG006|Overall Study|Lost to Follow-up|2|||
33263569|NCT03220724|100866718|FG007|Overall Study|Lost to Follow-up|1|||
33263570|NCT03220724|100866719|FG008|Overall Study|Lost to Follow-up|0|||
33263571|NCT03220724|100866711|FG000|Overall Study|Withdrawal by Subject|1|||
33263572|NCT03220724|100866712|FG001|Overall Study|Withdrawal by Subject|0|||
33263573|NCT03220724|100866713|FG002|Overall Study|Withdrawal by Subject|1|||
33263574|NCT03220724|100866714|FG003|Overall Study|Withdrawal by Subject|0|||
33263575|NCT03220724|100866715|FG004|Overall Study|Withdrawal by Subject|0|||
33464485|NCT02953678|101589766|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
33464486|NCT02953678|101589766|FG000|Overall Study|Participants were transferred to commercial product.|3|||
33464487|NCT02487082|101589767|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
33177128|NCT01641692|100556272|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
33177129|NCT01641692|100556273|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
33177130|NCT01641692|100556274|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
33177131|NCT01641692|100556267|FG000|Treatment Period 1|Lost to Follow-up|0|||
33177132|NCT01641692|100556268|FG001|Treatment Period 1|Lost to Follow-up|0|||
33177133|NCT01641692|100556269|FG002|Treatment Period 1|Lost to Follow-up|1|||
33177134|NCT01641692|100556270|FG003|Treatment Period 1|Lost to Follow-up|0|||
33177135|NCT01641692|100556271|FG004|Treatment Period 1|Lost to Follow-up|0|||
33177136|NCT01641692|100556272|FG005|Treatment Period 1|Lost to Follow-up|0|||
33177137|NCT01641692|100556273|FG006|Treatment Period 1|Lost to Follow-up|0|||
33177138|NCT01641692|100556274|FG007|Treatment Period 1|Lost to Follow-up|0|||
33177139|NCT01641692|100556267|FG000|Treatment Period 1|Physician Decision|0|||
33177140|NCT01641692|100556268|FG001|Treatment Period 1|Physician Decision|0|||
33177141|NCT01641692|100556269|FG002|Treatment Period 1|Physician Decision|0|||
33177142|NCT01641692|100556270|FG003|Treatment Period 1|Physician Decision|0|||
33177143|NCT01641692|100556271|FG004|Treatment Period 1|Physician Decision|1|||
33177144|NCT01641692|100556272|FG005|Treatment Period 1|Physician Decision|0|||
33177145|NCT01641692|100556273|FG006|Treatment Period 1|Physician Decision|0|||
33177146|NCT01641692|100556274|FG007|Treatment Period 1|Physician Decision|0|||
33177147|NCT01641692|100556267|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33177148|NCT01641692|100556268|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33177149|NCT01641692|100556269|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33177150|NCT01641692|100556270|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33177151|NCT01641692|100556271|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33177152|NCT01641692|100556272|FG005|Treatment Period 1|Withdrawal by Subject|2|||
33177153|NCT01641692|100556273|FG006|Treatment Period 1|Withdrawal by Subject|0|||
33177154|NCT01641692|100556274|FG007|Treatment Period 1|Withdrawal by Subject|1|||
33177155|NCT01641692|100556267|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
33177156|NCT01641692|100556268|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
33177157|NCT01641692|100556269|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
33177158|NCT01641692|100556270|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
33177159|NCT01641692|100556271|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
33177160|NCT01641692|100556272|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
33177161|NCT01641692|100556273|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
33177162|NCT01641692|100556274|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
33177163|NCT01641692|100556267|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33177164|NCT01641692|100556268|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33177165|NCT01641692|100556269|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33177166|NCT01641692|100556270|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33177167|NCT01641692|100556271|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33177168|NCT01641692|100556272|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33177169|NCT01641692|100556273|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
33263576|NCT03220724|100866716|FG005|Overall Study|Withdrawal by Subject|0|||
33263577|NCT03220724|100866717|FG006|Overall Study|Withdrawal by Subject|0|||
33263578|NCT03220724|100866718|FG007|Overall Study|Withdrawal by Subject|0|||
33177170|NCT01641692|100556274|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
33177171|NCT01641692|100556267|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
33263579|NCT03220724|100866719|FG008|Overall Study|Withdrawal by Subject|0|||
33263580|NCT01212744|100866728|FG000|Overall Study|Withdrawal by Subject|1|||
33263581|NCT03802994|100866737|FG000|Overall Study|Lost to Follow-up|0|||
33263582|NCT03802994|100866738|FG001|Overall Study|Lost to Follow-up|2|||
33263583|NCT03802994|100866739|FG002|Overall Study|Lost to Follow-up|3|||
33263584|NCT03802994|100866740|FG003|Overall Study|Lost to Follow-up|2|||
33263585|NCT03802994|100866741|FG004|Overall Study|Lost to Follow-up|2|||
33263586|NCT01854385|100866743|FG000|Pre-Treatment|Withdrawal by Subject|4|||
33263587|NCT01854385|100866743|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
33263588|NCT01854385|100866743|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
33263589|NCT01854385|100866743|FG000|Pre-Treatment|Unable to come for study visits|1|||
33263590|NCT01854385|100866743|FG000|Treatment|Lost to Follow-up|1|||
33263591|NCT02409680|100866744|FG000|Overall Study|Lost to Follow-up|15|||
33263592|NCT02409680|100866745|FG001|Overall Study|Lost to Follow-up|30|||
33263593|NCT04503681|100866746|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
33263594|NCT04503681|100866747|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
33263595|NCT03739866|100866748|FG000|Overall Study|Lost to Follow-up|0|||
33263596|NCT03739866|100866749|FG001|Overall Study|Lost to Follow-up|0|||
33263597|NCT03739866|100866750|FG002|Overall Study|Lost to Follow-up|0|||
33263598|NCT03739866|100866751|FG003|Overall Study|Lost to Follow-up|1|||
33263599|NCT03739866|100866752|FG004|Overall Study|Lost to Follow-up|0|||
33263600|NCT03739866|100866753|FG005|Overall Study|Lost to Follow-up|0|||
33263601|NCT03739866|100866754|FG006|Overall Study|Lost to Follow-up|0|||
33263602|NCT03739866|100866755|FG007|Overall Study|Lost to Follow-up|0|||
33263603|NCT03739866|100866748|FG000|Overall Study|Enrolled but not treated|0|||
33263604|NCT03739866|100866749|FG001|Overall Study|Enrolled but not treated|0|||
33263605|NCT03739866|100866750|FG002|Overall Study|Enrolled but not treated|1|||
33263606|NCT03739866|100866751|FG003|Overall Study|Enrolled but not treated|0|||
33263607|NCT03739866|100866752|FG004|Overall Study|Enrolled but not treated|1|||
33263608|NCT03739866|100866753|FG005|Overall Study|Enrolled but not treated|0|||
33263609|NCT03739866|100866754|FG006|Overall Study|Enrolled but not treated|0|||
33263610|NCT03739866|100866755|FG007|Overall Study|Enrolled but not treated|0|||
33263611|NCT03355573|100866760|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
33263612|NCT03355573|100866760|FG000|Overall Study|Sponsor's decision|1|||
33263613|NCT03355573|100866760|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
33263614|NCT03355573|100866760|FG000|Overall Study|PI's decision|2|||
33263615|NCT03355573|100866760|FG000|Overall Study|Withdrawal by Subject|23|||
33263616|NCT03355573|100866760|FG000|Overall Study|Lost to Follow-up|4|||
33263617|NCT03355573|100866760|FG000|Overall Study|Lack of Efficacy|2|||
33263618|NCT03355573|100866760|FG000|Overall Study|Adverse Event, non-fatal|17|||
33263619|NCT03355573|100866760|FG000|Overall Study|Adverse Event, serious fatal|2|||
33263620|NCT02189252|100866767|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
33263621|NCT02189252|100866768|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
33263622|NCT02189252|100866769|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
33263623|NCT02189252|100866770|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
33263624|NCT02189252|100866767|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
33263625|NCT02189252|100866768|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
33263626|NCT02189252|100866769|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
33263627|NCT02189252|100866770|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
33263628|NCT02787005|100866773|FG000|Overall Study|Adverse Event|24|||
33263629|NCT02787005|100866774|FG001|Overall Study|Adverse Event|9|||
33263630|NCT02787005|100866775|FG002|Overall Study|Adverse Event|9|||
33263631|NCT02787005|100866776|FG003|Overall Study|Adverse Event|7|||
33263632|NCT02787005|100866777|FG004|Overall Study|Adverse Event|2|||
33263633|NCT02787005|100866773|FG000|Overall Study|Death|100|||
33263634|NCT02787005|100866774|FG001|Overall Study|Death|53|||
33263635|NCT02787005|100866775|FG002|Overall Study|Death|48|||
33263636|NCT02787005|100866776|FG003|Overall Study|Death|69|||
33263637|NCT02787005|100866777|FG004|Overall Study|Death|38|||
33263638|NCT02787005|100866773|FG000|Overall Study|Sponsor Decision|7|||
33263639|NCT02787005|100866774|FG001|Overall Study|Sponsor Decision|4|||
33263640|NCT02787005|100866775|FG002|Overall Study|Sponsor Decision|0|||
33263641|NCT02787005|100866776|FG003|Overall Study|Sponsor Decision|4|||
33263642|NCT02787005|100866777|FG004|Overall Study|Sponsor Decision|5|||
33263643|NCT02787005|100866773|FG000|Overall Study|Withdrawal by Subject|2|||
33263644|NCT02787005|100866774|FG001|Overall Study|Withdrawal by Subject|1|||
33263645|NCT02787005|100866775|FG002|Overall Study|Withdrawal by Subject|1|||
33263646|NCT02787005|100866776|FG003|Overall Study|Withdrawal by Subject|0|||
33263647|NCT02787005|100866777|FG004|Overall Study|Withdrawal by Subject|1|||
33263648|NCT02787005|100866773|FG000|Overall Study|Screen Failure|0|||
33263649|NCT02787005|100866774|FG001|Overall Study|Screen Failure|2|||
33263650|NCT02787005|100866775|FG002|Overall Study|Screen Failure|0|||
33263651|NCT02787005|100866776|FG003|Overall Study|Screen Failure|0|||
33263652|NCT02787005|100866777|FG004|Overall Study|Screen Failure|1|||
33263653|NCT02787005|100866773|FG000|Overall Study|Lost to Follow-up|0|||
33263654|NCT02787005|100866774|FG001|Overall Study|Lost to Follow-up|0|||
33263655|NCT02787005|100866775|FG002|Overall Study|Lost to Follow-up|0|||
33263656|NCT02787005|100866776|FG003|Overall Study|Lost to Follow-up|1|||
33263657|NCT02787005|100866777|FG004|Overall Study|Lost to Follow-up|0|||
33263658|NCT02844439|100866780|FG000|Overall Study|Withdrawal by Subject|1|||
33263659|NCT02844439|100866780|FG000|Overall Study|Lost to Follow-up|2|||
33263660|NCT02844439|100866780|FG000|Overall Study|Termination by Sponsor|4|||
33263661|NCT02844439|100866780|FG000|Overall Study|Death|28|||
33263662|NCT02844439|100866780|FG000|Overall Study|Other|5|||
33263663|NCT01185600|100866781|FG000|Overall Study|Adverse Event|1|||
33263664|NCT01185600|100866782|FG001|Overall Study|Adverse Event|1|||
33263665|NCT01185600|100866781|FG000|Overall Study|Death|0|||
33263666|NCT01185600|100866782|FG001|Overall Study|Death|1|||
33263667|NCT01185600|100866781|FG000|Overall Study|Lost to Follow-up|0|||
33263668|NCT01185600|100866782|FG001|Overall Study|Lost to Follow-up|5|||
33263669|NCT01185600|100866781|FG000|Overall Study|Physician Decision|29|||
33263670|NCT01185600|100866782|FG001|Overall Study|Physician Decision|35|||
33263671|NCT01185600|100866781|FG000|Overall Study|Withdrawal by Subject|1|||
33263672|NCT01185600|100866782|FG001|Overall Study|Withdrawal by Subject|1|||
33263673|NCT01185600|100866781|FG000|Overall Study|Hold by DSMB|1|||
33263674|NCT01185600|100866782|FG001|Overall Study|Hold by DSMB|2|||
33263675|NCT01970007|100866783|FG000|Overall Study|Death|5|||
33263676|NCT01970007|100866783|FG000|Overall Study|Withdrawal by Subject|23|||
33263677|NCT01970007|100866783|FG000|Overall Study|Lost to Follow-up|24|||
33263678|NCT01970007|100866783|FG000|Overall Study|"Other endpoint"|3|||
33263679|NCT04989816|100866784|FG000|Overall Study|Death|77|||
33263680|NCT04989816|100866784|FG000|Overall Study|Lost to Follow-up|3|||
33263681|NCT01091168|100866785|FG000|Overall Study|Progressive disease|250|||
33263682|NCT01091168|100866786|FG001|Overall Study|Progressive disease|234|||
33263683|NCT01091168|100866785|FG000|Overall Study|Adverse Event|21|||
33263684|NCT01091168|100866786|FG001|Overall Study|Adverse Event|24|||
33263685|NCT01091168|100866785|FG000|Overall Study|Lost to Follow-up|0|||
33263686|NCT01091168|100866786|FG001|Overall Study|Lost to Follow-up|1|||
33263687|NCT01091168|100866785|FG000|Overall Study|Physician, patient's decision, other|27|||
33263688|NCT01091168|100866786|FG001|Overall Study|Physician, patient's decision, other|37|||
33263689|NCT02823574|100866789|FG000|Randomization|Disease Progression|0|||
33263690|NCT02823574|100866790|FG001|Randomization|Disease Progression|0|||
33263691|NCT02823574|100866791|FG002|Randomization|Disease Progression|1|||
33263692|NCT02823574|100866792|FG003|Randomization|Disease Progression|0|||
33263693|NCT02823574|100866789|FG000|Randomization|AE unrelated to Study Drug|1|||
33263694|NCT02823574|100866790|FG001|Randomization|AE unrelated to Study Drug|0|||
33263695|NCT02823574|100866791|FG002|Randomization|AE unrelated to Study Drug|0|||
33263696|NCT02823574|100866792|FG003|Randomization|AE unrelated to Study Drug|0|||
33263697|NCT02823574|100866789|FG000|Treatment Period|Poor/Non Compliance|1|||
33263698|NCT02823574|100866790|FG001|Treatment Period|Poor/Non Compliance|0|||
33263699|NCT02823574|100866791|FG002|Treatment Period|Poor/Non Compliance|0|||
33263700|NCT02823574|100866792|FG003|Treatment Period|Poor/Non Compliance|1|||
33263701|NCT02823574|100866789|FG000|Treatment Period|Maximum Clinical Benefit|8|||
33263702|NCT02823574|100866790|FG001|Treatment Period|Maximum Clinical Benefit|4|||
33263703|NCT02823574|100866791|FG002|Treatment Period|Maximum Clinical Benefit|7|||
33263704|NCT02823574|100866792|FG003|Treatment Period|Maximum Clinical Benefit|1|||
33263705|NCT02823574|100866789|FG000|Treatment Period|Lost to Follow-up|1|||
33263706|NCT02823574|100866790|FG001|Treatment Period|Lost to Follow-up|1|||
33263707|NCT02823574|100866791|FG002|Treatment Period|Lost to Follow-up|0|||
33263708|NCT02823574|100866792|FG003|Treatment Period|Lost to Follow-up|0|||
33263709|NCT02823574|100866789|FG000|Treatment Period|Participant withdrew consent|4|||
33263710|NCT02823574|100866790|FG001|Treatment Period|Participant withdrew consent|0|||
33263711|NCT02823574|100866791|FG002|Treatment Period|Participant withdrew consent|0|||
33263712|NCT02823574|100866792|FG003|Treatment Period|Participant withdrew consent|1|||
33263713|NCT02823574|100866789|FG000|Treatment Period|Participant request to discontinue|5|||
33464488|NCT02487082|101589768|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
33464489|NCT02487082|101589767|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
33464490|NCT02487082|101589768|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
33464491|NCT03297294|101589769|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
33263714|NCT02823574|100866790|FG001|Treatment Period|Participant request to discontinue|0|||
33263715|NCT02823574|100866791|FG002|Treatment Period|Participant request to discontinue|3|||
33464492|NCT03297294|101589770|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
33464493|NCT03297294|101589771|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33464494|NCT03297294|101589772|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33263716|NCT02823574|100866792|FG003|Treatment Period|Participant request to discontinue|2|||
33263717|NCT02823574|100866789|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
33263718|NCT02823574|100866790|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
33263719|NCT02823574|100866791|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
33263720|NCT02823574|100866792|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
33464495|NCT03297294|101589773|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
33263721|NCT02823574|100866789|FG000|Treatment Period|Study Drug Toxicity|11|||
33263722|NCT02823574|100866790|FG001|Treatment Period|Study Drug Toxicity|2|||
33263723|NCT02823574|100866791|FG002|Treatment Period|Study Drug Toxicity|14|||
33263724|NCT02823574|100866792|FG003|Treatment Period|Study Drug Toxicity|4|||
33263725|NCT02823574|100866789|FG000|Treatment Period|Disease Progression|113|||
33263726|NCT02823574|100866790|FG001|Treatment Period|Disease Progression|64|||
33263727|NCT02823574|100866791|FG002|Treatment Period|Disease Progression|82|||
33263728|NCT02823574|100866792|FG003|Treatment Period|Disease Progression|43|||
33263729|NCT02823574|100866789|FG000|Treatment Period|Other reasons|5|||
33263730|NCT02823574|100866790|FG001|Treatment Period|Other reasons|9|||
33263731|NCT02823574|100866791|FG002|Treatment Period|Other reasons|3|||
33263732|NCT02823574|100866792|FG003|Treatment Period|Other reasons|6|||
33263733|NCT02823574|100866789|FG000|Treatment Period|Participant no longer meets study criteria|0|||
33263734|NCT02823574|100866790|FG001|Treatment Period|Participant no longer meets study criteria|0|||
33263735|NCT02823574|100866791|FG002|Treatment Period|Participant no longer meets study criteria|1|||
33464496|NCT03297294|101589769|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
33464497|NCT03297294|101589770|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
33464498|NCT03297294|101589771|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33464499|NCT03297294|101589772|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33464500|NCT03297294|101589773|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
33464501|NCT03297294|101589769|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
33464502|NCT03297294|101589770|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
33464503|NCT03297294|101589771|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33464504|NCT03297294|101589772|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33464505|NCT03297294|101589773|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
33464506|NCT03297294|101589769|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
33464507|NCT03297294|101589770|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
33464508|NCT03297294|101589771|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33464509|NCT03297294|101589772|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33464510|NCT03297294|101589773|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
33464511|NCT03297294|101589769|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
33464512|NCT03297294|101589770|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
33177172|NCT01641692|100556268|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33177173|NCT01641692|100556269|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
33464513|NCT03297294|101589771|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
33464514|NCT03297294|101589772|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
33464515|NCT03297294|101589773|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
33464516|NCT02219308|101589774|FG000|Overall Study|Withdrawal by Subject|1|||
33464517|NCT02219308|101589775|FG001|Overall Study|Withdrawal by Subject|2|||
33464518|NCT00401245|101589779|FG000|Double Blind Titration Phase|Adverse Event|3|||
33464519|NCT00401245|101589780|FG001|Double Blind Titration Phase|Adverse Event|2|||
33464520|NCT00401245|101589781|FG002|Double Blind Titration Phase|Adverse Event|5|||
33464521|NCT00401245|101589782|FG003|Double Blind Titration Phase|Adverse Event|12|||
33464522|NCT00401245|101589783|FG004|Double Blind Titration Phase|Adverse Event|0|||
33464523|NCT00401245|101589784|FG005|Double Blind Titration Phase|Adverse Event|0|||
33464524|NCT00401245|101589785|FG006|Double Blind Titration Phase|Adverse Event|0|||
33464525|NCT00401245|101589786|FG007|Double Blind Titration Phase|Adverse Event|0|||
33464526|NCT00401245|101589779|FG000|Double Blind Titration Phase|Other|0|||
33464527|NCT00401245|101589780|FG001|Double Blind Titration Phase|Other|0|||
33464528|NCT00401245|101589781|FG002|Double Blind Titration Phase|Other|1|||
33464529|NCT00401245|101589782|FG003|Double Blind Titration Phase|Other|0|||
33464530|NCT00401245|101589783|FG004|Double Blind Titration Phase|Other|0|||
33464531|NCT00401245|101589784|FG005|Double Blind Titration Phase|Other|0|||
33464532|NCT00401245|101589785|FG006|Double Blind Titration Phase|Other|0|||
33464533|NCT00401245|101589786|FG007|Double Blind Titration Phase|Other|0|||
33464534|NCT00401245|101589779|FG000|Double Blind Titration Phase|Protocol Violation|0|||
33464535|NCT00401245|101589780|FG001|Double Blind Titration Phase|Protocol Violation|0|||
33177174|NCT01641692|100556270|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
33177175|NCT01641692|100556271|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
33177176|NCT01641692|100556272|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33177177|NCT01641692|100556273|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33177178|NCT01641692|100556274|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
33177179|NCT01641692|100556267|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
33177180|NCT01641692|100556268|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
33177181|NCT01641692|100556269|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33177182|NCT01641692|100556270|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
33263736|NCT02823574|100866792|FG003|Treatment Period|Participant no longer meets study criteria|0|||
33263737|NCT02823574|100866789|FG000|Treatment Period|Death|0|||
33177183|NCT01641692|100556271|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
33177184|NCT01641692|100556272|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33464536|NCT00401245|101589781|FG002|Double Blind Titration Phase|Protocol Violation|0|||
33464537|NCT00401245|101589782|FG003|Double Blind Titration Phase|Protocol Violation|1|||
33464538|NCT00401245|101589783|FG004|Double Blind Titration Phase|Protocol Violation|0|||
33464539|NCT00401245|101589784|FG005|Double Blind Titration Phase|Protocol Violation|0|||
33464540|NCT00401245|101589785|FG006|Double Blind Titration Phase|Protocol Violation|0|||
33464541|NCT00401245|101589786|FG007|Double Blind Titration Phase|Protocol Violation|0|||
33464542|NCT00401245|101589779|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
33464543|NCT00401245|101589780|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
33464544|NCT00401245|101589781|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
33464545|NCT00401245|101589782|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
33464546|NCT00401245|101589783|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
33464547|NCT00401245|101589784|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
33464548|NCT00401245|101589785|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
33464549|NCT00401245|101589786|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
33464550|NCT00401245|101589779|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
33464551|NCT00401245|101589780|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
33464552|NCT00401245|101589781|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
33464553|NCT00401245|101589782|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
33464554|NCT00401245|101589783|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
33464555|NCT00401245|101589784|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
33464556|NCT00401245|101589785|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
33464557|NCT00401245|101589786|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
33464558|NCT00401245|101589779|FG000|Open Label Phase|Adverse Event|5|||
33464559|NCT00401245|101589780|FG001|Open Label Phase|Adverse Event|14|||
33464560|NCT00401245|101589781|FG002|Open Label Phase|Adverse Event|6|||
33464561|NCT00401245|101589782|FG003|Open Label Phase|Adverse Event|7|||
33464562|NCT00401245|101589783|FG004|Open Label Phase|Adverse Event|0|||
33464563|NCT00401245|101589784|FG005|Open Label Phase|Adverse Event|0|||
33464564|NCT00401245|101589785|FG006|Open Label Phase|Adverse Event|0|||
33464565|NCT00401245|101589786|FG007|Open Label Phase|Adverse Event|0|||
33464566|NCT00401245|101589779|FG000|Open Label Phase|Lost to Follow-up|5|||
33464567|NCT00401245|101589780|FG001|Open Label Phase|Lost to Follow-up|7|||
33464568|NCT00401245|101589781|FG002|Open Label Phase|Lost to Follow-up|5|||
33464569|NCT00401245|101589782|FG003|Open Label Phase|Lost to Follow-up|4|||
33464570|NCT00401245|101589783|FG004|Open Label Phase|Lost to Follow-up|0|||
33464571|NCT00401245|101589784|FG005|Open Label Phase|Lost to Follow-up|0|||
33464572|NCT00401245|101589785|FG006|Open Label Phase|Lost to Follow-up|0|||
33464573|NCT00401245|101589786|FG007|Open Label Phase|Lost to Follow-up|0|||
33464574|NCT00401245|101589779|FG000|Open Label Phase|Other|4|||
33464575|NCT00401245|101589780|FG001|Open Label Phase|Other|8|||
33464576|NCT00401245|101589781|FG002|Open Label Phase|Other|7|||
33464577|NCT00401245|101589782|FG003|Open Label Phase|Other|8|||
33464578|NCT00401245|101589783|FG004|Open Label Phase|Other|0|||
33464579|NCT00401245|101589784|FG005|Open Label Phase|Other|0|||
33464580|NCT00401245|101589785|FG006|Open Label Phase|Other|0|||
33464581|NCT00401245|101589786|FG007|Open Label Phase|Other|0|||
33464582|NCT00401245|101589779|FG000|Open Label Phase|Protocol Violation|0|||
33464583|NCT00401245|101589780|FG001|Open Label Phase|Protocol Violation|1|||
33464584|NCT00401245|101589781|FG002|Open Label Phase|Protocol Violation|0|||
33464585|NCT00401245|101589782|FG003|Open Label Phase|Protocol Violation|1|||
33177185|NCT01641692|100556273|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
33177186|NCT01641692|100556274|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
33177187|NCT01641692|100556267|FG000|Treatment Period 2|Lack of Efficacy|1|||
33177188|NCT01641692|100556268|FG001|Treatment Period 2|Lack of Efficacy|0|||
33177189|NCT01641692|100556269|FG002|Treatment Period 2|Lack of Efficacy|0|||
33177190|NCT01641692|100556270|FG003|Treatment Period 2|Lack of Efficacy|0|||
33177191|NCT01641692|100556271|FG004|Treatment Period 2|Lack of Efficacy|0|||
33177192|NCT01641692|100556272|FG005|Treatment Period 2|Lack of Efficacy|0|||
33177193|NCT01641692|100556273|FG006|Treatment Period 2|Lack of Efficacy|0|||
33177194|NCT01641692|100556274|FG007|Treatment Period 2|Lack of Efficacy|0|||
33177195|NCT01641692|100556267|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
33177196|NCT01641692|100556268|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33177197|NCT01641692|100556269|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33177198|NCT01641692|100556270|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33263738|NCT02823574|100866790|FG001|Treatment Period|Death|0|||
33464586|NCT00401245|101589783|FG004|Open Label Phase|Protocol Violation|0|||
33464587|NCT00401245|101589784|FG005|Open Label Phase|Protocol Violation|0|||
33464588|NCT00401245|101589785|FG006|Open Label Phase|Protocol Violation|0|||
33464589|NCT00401245|101589786|FG007|Open Label Phase|Protocol Violation|0|||
33464590|NCT00401245|101589779|FG000|Open Label Phase|Withdrawal by Subject|3|||
33177199|NCT01641692|100556271|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33177200|NCT01641692|100556272|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33464591|NCT00401245|101589780|FG001|Open Label Phase|Withdrawal by Subject|3|||
33464592|NCT00401245|101589781|FG002|Open Label Phase|Withdrawal by Subject|2|||
33464593|NCT00401245|101589782|FG003|Open Label Phase|Withdrawal by Subject|1|||
33464594|NCT00401245|101589783|FG004|Open Label Phase|Withdrawal by Subject|0|||
33464595|NCT00401245|101589784|FG005|Open Label Phase|Withdrawal by Subject|0|||
33464596|NCT00401245|101589785|FG006|Open Label Phase|Withdrawal by Subject|0|||
33464597|NCT00401245|101589786|FG007|Open Label Phase|Withdrawal by Subject|0|||
33464598|NCT00401245|101589779|FG000|Open Label Phase|Lack of Efficacy|4|||
33464599|NCT00401245|101589780|FG001|Open Label Phase|Lack of Efficacy|2|||
33464600|NCT00401245|101589781|FG002|Open Label Phase|Lack of Efficacy|3|||
33464601|NCT00401245|101589782|FG003|Open Label Phase|Lack of Efficacy|0|||
33464602|NCT00401245|101589783|FG004|Open Label Phase|Lack of Efficacy|0|||
33464603|NCT00401245|101589784|FG005|Open Label Phase|Lack of Efficacy|0|||
33464604|NCT00401245|101589785|FG006|Open Label Phase|Lack of Efficacy|0|||
33464605|NCT00401245|101589786|FG007|Open Label Phase|Lack of Efficacy|0|||
33464606|NCT00401245|101589779|FG000|Double Blind Tapering Phase|Adverse Event|0|||
33464607|NCT00401245|101589780|FG001|Double Blind Tapering Phase|Adverse Event|0|||
33464608|NCT00401245|101589781|FG002|Double Blind Tapering Phase|Adverse Event|0|||
33464609|NCT00401245|101589782|FG003|Double Blind Tapering Phase|Adverse Event|0|||
33177201|NCT01641692|100556273|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33177202|NCT01641692|100556274|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
33177203|NCT01641692|100556267|FG000|Treatment Period 2|Lost to Follow-up|0|||
33177204|NCT01641692|100556268|FG001|Treatment Period 2|Lost to Follow-up|0|||
33177205|NCT01641692|100556269|FG002|Treatment Period 2|Lost to Follow-up|0|||
33177206|NCT01641692|100556270|FG003|Treatment Period 2|Lost to Follow-up|0|||
33177207|NCT01641692|100556271|FG004|Treatment Period 2|Lost to Follow-up|0|||
33177208|NCT01641692|100556272|FG005|Treatment Period 2|Lost to Follow-up|1|||
33177209|NCT01641692|100556273|FG006|Treatment Period 2|Lost to Follow-up|0|||
33177210|NCT01641692|100556274|FG007|Treatment Period 2|Lost to Follow-up|0|||
33177211|NCT01641692|100556267|FG000|Treatment Period 2|Withdrawal by Subject|1|||
33177212|NCT01641692|100556268|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33177213|NCT01641692|100556269|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33177214|NCT01641692|100556270|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33177215|NCT01641692|100556271|FG004|Treatment Period 2|Withdrawal by Subject|0|||
33177216|NCT01641692|100556272|FG005|Treatment Period 2|Withdrawal by Subject|1|||
33177217|NCT01641692|100556273|FG006|Treatment Period 2|Withdrawal by Subject|0|||
33177218|NCT01641692|100556274|FG007|Treatment Period 2|Withdrawal by Subject|1|||
33177219|NCT01641692|100556267|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33177220|NCT01641692|100556268|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33177221|NCT01641692|100556269|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33177222|NCT01641692|100556270|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33177223|NCT01641692|100556271|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
33177224|NCT01641692|100556272|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33177225|NCT01641692|100556273|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
33177226|NCT01641692|100556274|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
33177227|NCT01641692|100556267|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33177228|NCT01641692|100556268|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33177229|NCT01641692|100556269|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
33177230|NCT01641692|100556270|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33177231|NCT01641692|100556271|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33177232|NCT01641692|100556272|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
33177233|NCT01641692|100556273|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
33177234|NCT01641692|100556274|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
33177235|NCT01641692|100556267|FG000|Treatment Period 3|Adverse Event|0|||
33177236|NCT01641692|100556268|FG001|Treatment Period 3|Adverse Event|0|||
33177237|NCT01641692|100556269|FG002|Treatment Period 3|Adverse Event|0|||
33177238|NCT01641692|100556270|FG003|Treatment Period 3|Adverse Event|0|||
33464610|NCT00401245|101589783|FG004|Double Blind Tapering Phase|Adverse Event|1|||
33464611|NCT00401245|101589784|FG005|Double Blind Tapering Phase|Adverse Event|1|||
33464612|NCT00401245|101589785|FG006|Double Blind Tapering Phase|Adverse Event|2|||
33464613|NCT00401245|101589786|FG007|Double Blind Tapering Phase|Adverse Event|4|||
33177239|NCT01641692|100556271|FG004|Treatment Period 3|Adverse Event|0|||
33177240|NCT01641692|100556272|FG005|Treatment Period 3|Adverse Event|0|||
33177241|NCT01641692|100556273|FG006|Treatment Period 3|Adverse Event|1|||
33263739|NCT02823574|100866791|FG002|Treatment Period|Death|3|||
33464614|NCT00401245|101589779|FG000|Double Blind Tapering Phase|Investigator request|0|||
33464615|NCT00401245|101589780|FG001|Double Blind Tapering Phase|Investigator request|0|||
33464616|NCT00401245|101589781|FG002|Double Blind Tapering Phase|Investigator request|0|||
33464617|NCT00401245|101589782|FG003|Double Blind Tapering Phase|Investigator request|0|||
33464618|NCT00401245|101589783|FG004|Double Blind Tapering Phase|Investigator request|0|||
33177242|NCT01641692|100556274|FG007|Treatment Period 3|Adverse Event|0|||
33177243|NCT01641692|100556267|FG000|Treatment Period 3|Protocol Violation|0|||
33263740|NCT02823574|100866792|FG003|Treatment Period|Death|1|||
33464619|NCT00401245|101589784|FG005|Double Blind Tapering Phase|Investigator request|0|||
33464620|NCT00401245|101589785|FG006|Double Blind Tapering Phase|Investigator request|0|||
33464621|NCT00401245|101589786|FG007|Double Blind Tapering Phase|Investigator request|1|||
33464622|NCT00401245|101589779|FG000|Double Blind Tapering Phase|Other|0|||
33464623|NCT00401245|101589780|FG001|Double Blind Tapering Phase|Other|0|||
33464624|NCT00401245|101589781|FG002|Double Blind Tapering Phase|Other|0|||
33464625|NCT00401245|101589782|FG003|Double Blind Tapering Phase|Other|0|||
33464626|NCT00401245|101589783|FG004|Double Blind Tapering Phase|Other|1|||
33464627|NCT00401245|101589784|FG005|Double Blind Tapering Phase|Other|0|||
33464628|NCT00401245|101589785|FG006|Double Blind Tapering Phase|Other|2|||
33464629|NCT00401245|101589786|FG007|Double Blind Tapering Phase|Other|2|||
33177244|NCT01641692|100556268|FG001|Treatment Period 3|Protocol Violation|0|||
33177245|NCT01641692|100556269|FG002|Treatment Period 3|Protocol Violation|1|||
33177246|NCT01641692|100556270|FG003|Treatment Period 3|Protocol Violation|0|||
33177247|NCT01641692|100556271|FG004|Treatment Period 3|Protocol Violation|0|||
33177248|NCT01641692|100556272|FG005|Treatment Period 3|Protocol Violation|0|||
33177249|NCT01641692|100556273|FG006|Treatment Period 3|Protocol Violation|0|||
33177250|NCT01641692|100556274|FG007|Treatment Period 3|Protocol Violation|0|||
33177251|NCT01641692|100556267|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33177252|NCT01641692|100556268|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33177253|NCT01641692|100556269|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33177254|NCT01641692|100556270|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33177255|NCT01641692|100556271|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33177256|NCT01641692|100556272|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33177257|NCT01641692|100556273|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
33177258|NCT01641692|100556274|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
33177259|NCT01641692|100556267|FG000|Treatment Period 3|Lost to Follow-up|0|||
33177260|NCT01641692|100556268|FG001|Treatment Period 3|Lost to Follow-up|1|||
33177261|NCT01641692|100556269|FG002|Treatment Period 3|Lost to Follow-up|0|||
33177262|NCT01641692|100556270|FG003|Treatment Period 3|Lost to Follow-up|0|||
33177263|NCT01641692|100556271|FG004|Treatment Period 3|Lost to Follow-up|0|||
33177264|NCT01641692|100556272|FG005|Treatment Period 3|Lost to Follow-up|0|||
33177265|NCT01641692|100556273|FG006|Treatment Period 3|Lost to Follow-up|0|||
33177266|NCT01641692|100556274|FG007|Treatment Period 3|Lost to Follow-up|0|||
33177267|NCT01641692|100556267|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
33177268|NCT01641692|100556268|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
33177269|NCT01641692|100556269|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
33177270|NCT01641692|100556270|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
33177271|NCT01641692|100556271|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
33177272|NCT01641692|100556272|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
33177273|NCT01641692|100556273|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
33177274|NCT01641692|100556274|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
33177275|NCT01641692|100556267|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
33177276|NCT01641692|100556268|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
33177277|NCT01641692|100556269|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
33177278|NCT01641692|100556270|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
33177279|NCT01641692|100556271|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
33177280|NCT01641692|100556272|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
33177281|NCT01641692|100556273|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
33177282|NCT01641692|100556274|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
33177283|NCT01103284|100556275|FG000|Overall Study|Death|2|||
33177284|NCT01103284|100556276|FG001|Overall Study|Death|0|||
33177285|NCT01103284|100556275|FG000|Overall Study|Lost to Follow-up|9|||
33177286|NCT01103284|100556276|FG001|Overall Study|Lost to Follow-up|10|||
33177287|NCT01103284|100556275|FG000|Overall Study|Pregnancy|3|||
33177288|NCT01103284|100556276|FG001|Overall Study|Pregnancy|1|||
33177289|NCT01103284|100556275|FG000|Overall Study|Protocol Violation|12|||
33177290|NCT01103284|100556276|FG001|Overall Study|Protocol Violation|5|||
33177291|NCT01103284|100556275|FG000|Overall Study|Adverse Event|0|||
33177292|NCT01103284|100556276|FG001|Overall Study|Adverse Event|5|||
33177293|NCT01103284|100556275|FG000|Overall Study|Withdrawal by Subject|14|||
33177294|NCT01103284|100556276|FG001|Overall Study|Withdrawal by Subject|18|||
33464630|NCT00401245|101589779|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
33177295|NCT01103284|100556275|FG000|Overall Study|Dermal Hypersensitivity|0|||
33177296|NCT01103284|100556276|FG001|Overall Study|Dermal Hypersensitivity|1|||
33177297|NCT01103284|100556275|FG000|Overall Study|Termination by the Sponsor|0|||
33177298|NCT01103284|100556276|FG001|Overall Study|Termination by the Sponsor|1|||
33177299|NCT01103284|100556275|FG000|Overall Study|Not described|2|||
33464631|NCT00401245|101589780|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
33464632|NCT00401245|101589781|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
33177300|NCT01103284|100556276|FG001|Overall Study|Not described|1|||
33177301|NCT01103284|100556275|FG000|Overall Study|Missing CRF entries for study completion|0|||
33177302|NCT01103284|100556276|FG001|Overall Study|Missing CRF entries for study completion|2|||
33177303|NCT03721276|100556277|FG000|Overall Study|Lost to Follow-up|5|||
33177304|NCT03721276|100556278|FG001|Overall Study|Lost to Follow-up|3|||
33177305|NCT03721276|100556277|FG000|Overall Study|Adverse Event|0|||
33177306|NCT03721276|100556278|FG001|Overall Study|Adverse Event|1|||
33177307|NCT04577118|100556279|FG000|Overall Study|Withdrawal by Subject|4|||
33177308|NCT02278263|100556280|FG000|Overall Study|Protocol Violation|7|||
33177309|NCT02278263|100556281|FG001|Overall Study|Protocol Violation|0|||
33177310|NCT02278263|100556282|FG002|Overall Study|Protocol Violation|9|||
33177311|NCT00488345|100556284|FG000|Overall Study|Adverse Event|0|||
33177312|NCT00488345|100556285|FG001|Overall Study|Adverse Event|1|||
33177313|NCT00488345|100556286|FG002|Overall Study|Adverse Event|1|||
33177314|NCT00488345|100556284|FG000|Overall Study|Unable to administer antibiotics at home|0|||
33177315|NCT00488345|100556285|FG001|Overall Study|Unable to administer antibiotics at home|1|||
33177316|NCT00488345|100556286|FG002|Overall Study|Unable to administer antibiotics at home|0|||
33177317|NCT00488345|100556284|FG000|Overall Study|Institutional Review Board review|0|||
33177318|NCT00488345|100556285|FG001|Overall Study|Institutional Review Board review|0|||
33177319|NCT00488345|100556286|FG002|Overall Study|Institutional Review Board review|1|||
33177320|NCT00488345|100556284|FG000|Overall Study|Surgical team recommendation|0|||
33177321|NCT00488345|100556285|FG001|Overall Study|Surgical team recommendation|1|||
33177322|NCT00488345|100556286|FG002|Overall Study|Surgical team recommendation|0|||
33177323|NCT00488345|100556284|FG000|Overall Study|Parent/legal guardian request|0|||
33177324|NCT00488345|100556285|FG001|Overall Study|Parent/legal guardian request|1|||
33177325|NCT00488345|100556286|FG002|Overall Study|Parent/legal guardian request|1|||
33263741|NCT03459846|100866795|FG000|Overall Study|Death|52|||
33263742|NCT03459846|100866796|FG001|Overall Study|Death|46|||
33464633|NCT00401245|101589782|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
33464634|NCT00401245|101589783|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
33464635|NCT00401245|101589784|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
33464636|NCT00401245|101589785|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
33464637|NCT00401245|101589786|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
33464638|NCT00401245|101589779|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
33464639|NCT00401245|101589780|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
33464640|NCT00401245|101589781|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
33464641|NCT00401245|101589782|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
33464642|NCT00401245|101589783|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
33464643|NCT00401245|101589784|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
33464644|NCT00401245|101589785|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
33464645|NCT00401245|101589786|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
33464646|NCT03253094|101589788|FG000|Overall Study|Adverse Event|2|||
33464647|NCT03253094|101589789|FG001|Overall Study|Adverse Event|0|||
33464648|NCT03253094|101589790|FG002|Overall Study|Adverse Event|0|||
33464649|NCT03253094|101589791|FG003|Overall Study|Adverse Event|0|||
33464650|NCT03253094|101589792|FG004|Overall Study|Adverse Event|0|||
33464651|NCT03253094|101589793|FG005|Overall Study|Adverse Event|0|||
33464652|NCT03253094|101589788|FG000|Overall Study|Lack of Efficacy|0|||
33464653|NCT03253094|101589789|FG001|Overall Study|Lack of Efficacy|0|||
33464654|NCT03253094|101589790|FG002|Overall Study|Lack of Efficacy|2|||
33464655|NCT03253094|101589791|FG003|Overall Study|Lack of Efficacy|1|||
33263743|NCT03459846|100866795|FG000|Overall Study|Study terminated by sponsor|24|||
33464656|NCT03253094|101589792|FG004|Overall Study|Lack of Efficacy|2|||
33464657|NCT03253094|101589793|FG005|Overall Study|Lack of Efficacy|1|||
33464658|NCT03253094|101589788|FG000|Overall Study|Lost to Follow-up|0|||
33464659|NCT03253094|101589789|FG001|Overall Study|Lost to Follow-up|0|||
33464660|NCT03253094|101589790|FG002|Overall Study|Lost to Follow-up|1|||
33464661|NCT03253094|101589791|FG003|Overall Study|Lost to Follow-up|1|||
33464662|NCT03253094|101589792|FG004|Overall Study|Lost to Follow-up|0|||
33464663|NCT03253094|101589793|FG005|Overall Study|Lost to Follow-up|1|||
33464664|NCT03253094|101589788|FG000|Overall Study|Physician Decision|1|||
33464665|NCT03253094|101589789|FG001|Overall Study|Physician Decision|0|||
33464666|NCT03253094|101589790|FG002|Overall Study|Physician Decision|0|||
33464667|NCT03253094|101589791|FG003|Overall Study|Physician Decision|1|||
33464668|NCT03253094|101589792|FG004|Overall Study|Physician Decision|0|||
33464669|NCT03253094|101589793|FG005|Overall Study|Physician Decision|2|||
33464670|NCT03253094|101589788|FG000|Overall Study|Withdrawal by Subject|1|||
33464671|NCT03253094|101589789|FG001|Overall Study|Withdrawal by Subject|2|||
33464672|NCT03253094|101589790|FG002|Overall Study|Withdrawal by Subject|1|||
33464673|NCT03253094|101589791|FG003|Overall Study|Withdrawal by Subject|0|||
33464674|NCT03253094|101589792|FG004|Overall Study|Withdrawal by Subject|3|||
33464675|NCT03253094|101589793|FG005|Overall Study|Withdrawal by Subject|0|||
33464676|NCT03253094|101589788|FG000|Overall Study|Other|0|||
33464677|NCT03253094|101589789|FG001|Overall Study|Other|1|||
33464678|NCT03253094|101589790|FG002|Overall Study|Other|2|||
33464679|NCT03253094|101589791|FG003|Overall Study|Other|1|||
33464680|NCT03253094|101589792|FG004|Overall Study|Other|0|||
33464681|NCT03253094|101589793|FG005|Overall Study|Other|0|||
33464682|NCT01144403|101589794|FG000|Overall Study|Lost to Follow-up|3|||
33464683|NCT01144403|101589794|FG000|Overall Study|Death|1|||
33464684|NCT01144403|101589794|FG000|Overall Study|Adverse Event|1|||
33464685|NCT01790113|101589803|FG000|Overall Study|Adverse Event|2|||
33464686|NCT01790113|101589804|FG001|Overall Study|Adverse Event|7|||
33464687|NCT01790113|101589803|FG000|Overall Study|Study ended due to FDA clearance|1|||
33464688|NCT01790113|101589804|FG001|Overall Study|Study ended due to FDA clearance|68|||
33464689|NCT00869440|101589805|FG000|Overall Study|Withdrawal by Subject|1|||
33464690|NCT00869440|101589806|FG001|Overall Study|Withdrawal by Subject|0|||
33464691|NCT00869440|101589807|FG002|Overall Study|Withdrawal by Subject|0|||
33464692|NCT00869440|101589808|FG003|Overall Study|Withdrawal by Subject|0|||
33464693|NCT00869440|101589805|FG000|Overall Study|Physician Decision|1|||
33464694|NCT00869440|101589806|FG001|Overall Study|Physician Decision|1|||
33464695|NCT00869440|101589807|FG002|Overall Study|Physician Decision|0|||
33464696|NCT00869440|101589808|FG003|Overall Study|Physician Decision|0|||
33464697|NCT04034355|101589809|FG000|Overall Study|Study terminated by Sponsor|10|||
33464698|NCT04034355|101589810|FG001|Overall Study|Study terminated by Sponsor|17|||
33464699|NCT04034355|101589809|FG000|Overall Study|Withdrawal by Subject|12|||
33464700|NCT04034355|101589810|FG001|Overall Study|Withdrawal by Subject|11|||
33464701|NCT04034355|101589809|FG000|Overall Study|Site terminated by Sponsor|4|||
33464702|NCT04034355|101589810|FG001|Overall Study|Site terminated by Sponsor|5|||
33464703|NCT04034355|101589809|FG000|Overall Study|Adverse Event|2|||
33464704|NCT04034355|101589810|FG001|Overall Study|Adverse Event|0|||
33464705|NCT04034355|101589809|FG000|Overall Study|Death|1|||
33464706|NCT04034355|101589810|FG001|Overall Study|Death|1|||
33464707|NCT04034355|101589809|FG000|Overall Study|Not reported|2|||
33464708|NCT04034355|101589810|FG001|Overall Study|Not reported|0|||
33464709|NCT04034355|101589809|FG000|Overall Study|Lost to Follow-up|1|||
33464710|NCT04034355|101589810|FG001|Overall Study|Lost to Follow-up|0|||
33464711|NCT04034355|101589809|FG000|Overall Study|Physician Decision|1|||
33464712|NCT04034355|101589810|FG001|Overall Study|Physician Decision|0|||
33464713|NCT04034355|101589809|FG000|Overall Study|Protocol Violation|0|||
33464714|NCT04034355|101589810|FG001|Overall Study|Protocol Violation|1|||
33464715|NCT04034355|101589809|FG000|Overall Study|Progressive disease|1|||
33464716|NCT04034355|101589810|FG001|Overall Study|Progressive disease|0|||
33464717|NCT02733627|101589811|FG000|Overall Study|Adverse Event|0|||
33464718|NCT02733627|101589812|FG001|Overall Study|Adverse Event|1|||
33464719|NCT02733627|101589813|FG002|Overall Study|Adverse Event|1|||
33464720|NCT02733627|101589814|FG003|Overall Study|Adverse Event|0|||
33464721|NCT02733627|101589811|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
33464722|NCT02733627|101589812|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
33464723|NCT02733627|101589813|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
33464724|NCT02733627|101589814|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
33464725|NCT02776553|101589817|FG000|Overall Study|Lost to Follow-up|1|||
33464726|NCT02776553|101589818|FG001|Overall Study|Lost to Follow-up|0|||
33464727|NCT02776553|101589817|FG000|Overall Study|got liver transplant|1|||
33464728|NCT02776553|101589818|FG001|Overall Study|got liver transplant|2|||
33464729|NCT02776553|101589817|FG000|Overall Study|had other surgery|1|||
33464730|NCT02776553|101589818|FG001|Overall Study|had other surgery|0|||
33464731|NCT02776553|101589817|FG000|Overall Study|Protocol Violation|0|||
33464732|NCT02776553|101589818|FG001|Overall Study|Protocol Violation|1|||
33464733|NCT01396421|101589819|FG000|Overall Study|Lost to Follow-up|0|||
33464734|NCT01396421|101589820|FG001|Overall Study|Lost to Follow-up|0|||
33464735|NCT01396421|101589821|FG002|Overall Study|Lost to Follow-up|0|||
33464736|NCT01396421|101589822|FG003|Overall Study|Lost to Follow-up|1|||
33464737|NCT01396421|101589819|FG000|Overall Study|Adverse Event|17|||
33464738|NCT01396421|101589820|FG001|Overall Study|Adverse Event|15|||
33464739|NCT01396421|101589821|FG002|Overall Study|Adverse Event|12|||
33464740|NCT01396421|101589822|FG003|Overall Study|Adverse Event|32|||
33464741|NCT01396421|101589819|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
33263744|NCT03459846|100866796|FG001|Overall Study|Study terminated by sponsor|28|||
33464742|NCT01396421|101589820|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
33464743|NCT01396421|101589821|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
33464744|NCT01396421|101589822|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
33464745|NCT01396421|101589819|FG000|Overall Study|Physician Decision|1|||
33464746|NCT01396421|101589820|FG001|Overall Study|Physician Decision|1|||
33464747|NCT01396421|101589821|FG002|Overall Study|Physician Decision|0|||
33464748|NCT01396421|101589822|FG003|Overall Study|Physician Decision|3|||
33464749|NCT01396421|101589819|FG000|Overall Study|Withdrawal by Subject|31|||
33464750|NCT01396421|101589820|FG001|Overall Study|Withdrawal by Subject|24|||
33464751|NCT01396421|101589821|FG002|Overall Study|Withdrawal by Subject|13|||
33464752|NCT01396421|101589822|FG003|Overall Study|Withdrawal by Subject|21|||
33464753|NCT01396421|101589819|FG000|Overall Study|Protocol Deviation|2|||
33464754|NCT01396421|101589820|FG001|Overall Study|Protocol Deviation|1|||
33464755|NCT01396421|101589821|FG002|Overall Study|Protocol Deviation|1|||
33464756|NCT01396421|101589822|FG003|Overall Study|Protocol Deviation|0|||
33464757|NCT01396421|101589819|FG000|Overall Study|Lack of Efficacy|7|||
33464758|NCT01396421|101589820|FG001|Overall Study|Lack of Efficacy|17|||
33464759|NCT01396421|101589821|FG002|Overall Study|Lack of Efficacy|7|||
33464760|NCT01396421|101589822|FG003|Overall Study|Lack of Efficacy|18|||
33464761|NCT02400476|101589823|FG000|Overall Study|Adverse Event|57|||
33464762|NCT02400476|101589824|FG001|Overall Study|Adverse Event|10|||
33464763|NCT02400476|101589825|FG002|Overall Study|Adverse Event|22|||
33464764|NCT02400476|101589826|FG003|Overall Study|Adverse Event|19|||
33263745|NCT03459846|100866795|FG000|Overall Study|Withdrawal by Subject|2|||
33263746|NCT03459846|100866796|FG001|Overall Study|Withdrawal by Subject|2|||
33263747|NCT00943917|100866797|FG000|Stage I|Adverse Event|1|||
33263748|NCT00943917|100866798|FG001|Stage I|Adverse Event|2|||
33263749|NCT00943917|100866799|FG002|Stage I|Adverse Event|2|||
33263750|NCT00943917|100866800|FG003|Stage I|Adverse Event|0|||
33263751|NCT00943917|100866801|FG004|Stage I|Adverse Event|0|||
33263752|NCT00943917|100866802|FG005|Stage I|Adverse Event|0|||
33263753|NCT00943917|100866803|FG006|Stage I|Adverse Event|0|||
33263754|NCT00943917|100866804|FG007|Stage I|Adverse Event|0|||
33263755|NCT00943917|100866805|FG008|Stage I|Adverse Event|0|||
33263756|NCT00943917|100866806|FG009|Stage I|Adverse Event|0|||
33263757|NCT00943917|100866807|FG010|Stage I|Adverse Event|0|||
33263758|NCT00943917|100866808|FG011|Stage I|Adverse Event|0|||
33263759|NCT00943917|100866809|FG012|Stage I|Adverse Event|0|||
33263760|NCT00943917|100866810|FG013|Stage I|Adverse Event|0|||
33263761|NCT00943917|100866811|FG014|Stage I|Adverse Event|0|||
33263762|NCT00943917|100866797|FG000|Stage I|Lost to Follow-up|0|||
33263763|NCT00943917|100866798|FG001|Stage I|Lost to Follow-up|0|||
33263764|NCT00943917|100866799|FG002|Stage I|Lost to Follow-up|1|||
33263765|NCT00943917|100866800|FG003|Stage I|Lost to Follow-up|0|||
33263766|NCT00943917|100866801|FG004|Stage I|Lost to Follow-up|0|||
33263767|NCT00943917|100866802|FG005|Stage I|Lost to Follow-up|0|||
33464765|NCT02400476|101589827|FG004|Overall Study|Adverse Event|5|||
33464766|NCT02400476|101589828|FG005|Overall Study|Adverse Event|8|||
33263768|NCT00943917|100866803|FG006|Stage I|Lost to Follow-up|0|||
33464767|NCT02400476|101589823|FG000|Overall Study|Withdrawal by Subject|4|||
33464768|NCT02400476|101589824|FG001|Overall Study|Withdrawal by Subject|1|||
33263769|NCT00943917|100866804|FG007|Stage I|Lost to Follow-up|0|||
33263770|NCT00943917|100866805|FG008|Stage I|Lost to Follow-up|0|||
33263771|NCT00943917|100866806|FG009|Stage I|Lost to Follow-up|0|||
33263772|NCT00943917|100866807|FG010|Stage I|Lost to Follow-up|0|||
33263773|NCT00943917|100866808|FG011|Stage I|Lost to Follow-up|0|||
33263774|NCT00943917|100866809|FG012|Stage I|Lost to Follow-up|0|||
33464769|NCT02400476|101589825|FG002|Overall Study|Withdrawal by Subject|12|||
33464770|NCT02400476|101589826|FG003|Overall Study|Withdrawal by Subject|7|||
33464771|NCT02400476|101589827|FG004|Overall Study|Withdrawal by Subject|5|||
33464772|NCT02400476|101589828|FG005|Overall Study|Withdrawal by Subject|5|||
33464773|NCT02400476|101589823|FG000|Overall Study|Lost to Follow-up|0|||
33464774|NCT02400476|101589824|FG001|Overall Study|Lost to Follow-up|0|||
33464775|NCT02400476|101589825|FG002|Overall Study|Lost to Follow-up|0|||
33464776|NCT02400476|101589826|FG003|Overall Study|Lost to Follow-up|1|||
33464777|NCT02400476|101589827|FG004|Overall Study|Lost to Follow-up|3|||
33464778|NCT02400476|101589828|FG005|Overall Study|Lost to Follow-up|1|||
33464779|NCT02400476|101589823|FG000|Overall Study|Physician Decision|0|||
33464780|NCT02400476|101589824|FG001|Overall Study|Physician Decision|0|||
33464781|NCT02400476|101589825|FG002|Overall Study|Physician Decision|1|||
33464782|NCT02400476|101589826|FG003|Overall Study|Physician Decision|1|||
33464783|NCT02400476|101589827|FG004|Overall Study|Physician Decision|0|||
33464784|NCT02400476|101589828|FG005|Overall Study|Physician Decision|1|||
33464785|NCT02400476|101589823|FG000|Overall Study|Other, Disease Progression|0|||
33464786|NCT02400476|101589824|FG001|Overall Study|Other, Disease Progression|1|||
33464787|NCT02400476|101589825|FG002|Overall Study|Other, Disease Progression|2|||
33464788|NCT02400476|101589826|FG003|Overall Study|Other, Disease Progression|1|||
33464789|NCT02400476|101589827|FG004|Overall Study|Other, Disease Progression|2|||
33464790|NCT02400476|101589828|FG005|Overall Study|Other, Disease Progression|1|||
33464791|NCT02400476|101589823|FG000|Overall Study|Other, Decreased Quality of Life|0|||
33464792|NCT02400476|101589824|FG001|Overall Study|Other, Decreased Quality of Life|0|||
33464793|NCT02400476|101589825|FG002|Overall Study|Other, Decreased Quality of Life|2|||
33464794|NCT02400476|101589826|FG003|Overall Study|Other, Decreased Quality of Life|0|||
33464795|NCT02400476|101589827|FG004|Overall Study|Other, Decreased Quality of Life|0|||
33464796|NCT02400476|101589828|FG005|Overall Study|Other, Decreased Quality of Life|0|||
33464797|NCT02400476|101589823|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
33464798|NCT02400476|101589824|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
33464799|NCT02400476|101589825|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
33464800|NCT02400476|101589826|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
33464801|NCT02400476|101589827|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
33464802|NCT02400476|101589828|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
33464803|NCT00955721|101589829|FG000|Overall Study|Physician Decision|1|||
33464804|NCT00955721|101589830|FG001|Overall Study|Physician Decision|0|||
33464805|NCT00955721|101589829|FG000|Overall Study|Death|1|||
33464806|NCT00955721|101589830|FG001|Overall Study|Death|0|||
33464807|NCT00955721|101589829|FG000|Overall Study|Withdrawal by Subject|1|||
33464808|NCT00955721|101589830|FG001|Overall Study|Withdrawal by Subject|0|||
33464809|NCT00330460|101589831|FG000|Overall Study|Physician Decision|1|||
33464810|NCT00330460|101589832|FG001|Overall Study|Physician Decision|0|||
33464811|NCT00330460|101589831|FG000|Overall Study|Adverse Event|10|||
33464812|NCT00330460|101589832|FG001|Overall Study|Adverse Event|8|||
33464813|NCT00330460|101589831|FG000|Overall Study|Withdrawal by Subject|18|||
33464814|NCT00330460|101589832|FG001|Overall Study|Withdrawal by Subject|17|||
33464815|NCT00330460|101589831|FG000|Overall Study|Death|1|||
33464816|NCT00330460|101589832|FG001|Overall Study|Death|1|||
33464817|NCT00330460|101589831|FG000|Overall Study|Ineligibility determined|1|||
33464818|NCT00330460|101589832|FG001|Overall Study|Ineligibility determined|3|||
33464819|NCT00330460|101589831|FG000|Overall Study|Lost to Follow-up|8|||
33464820|NCT00330460|101589832|FG001|Overall Study|Lost to Follow-up|3|||
33464821|NCT00330460|101589831|FG000|Overall Study|Noncompliance|2|||
33464822|NCT00330460|101589832|FG001|Overall Study|Noncompliance|1|||
33263775|NCT00943917|100866810|FG013|Stage I|Lost to Follow-up|0|||
33263776|NCT00943917|100866811|FG014|Stage I|Lost to Follow-up|0|||
33464823|NCT00330460|101589831|FG000|Overall Study|Other|1|||
33464824|NCT00330460|101589832|FG001|Overall Study|Other|0|||
33464825|NCT02013531|101589834|FG000|Overall Study|Lost to Follow-up|3|||
33464826|NCT02013531|101589834|FG000|Overall Study|Met Withdrawal Criteria|1|||
33263777|NCT00943917|100866797|FG000|Stage I|hyperglycemia|0|||
33263778|NCT00943917|100866798|FG001|Stage I|hyperglycemia|0|||
33464827|NCT02013531|101589834|FG000|Overall Study|Withdrawal by Subject|1|||
33464828|NCT01010750|101589841|FG000|Second Intervention|Adverse Event|0|||
33464829|NCT01010750|101589842|FG001|Second Intervention|Adverse Event|1|||
33263779|NCT00943917|100866799|FG002|Stage I|hyperglycemia|1|||
33464830|NCT01010750|101589843|FG002|Second Intervention|Adverse Event|0|||
33464831|NCT01010750|101589844|FG003|Second Intervention|Adverse Event|0|||
33464832|NCT01010750|101589845|FG004|Second Intervention|Adverse Event|0|||
33464833|NCT01010750|101589846|FG005|Second Intervention|Adverse Event|0|||
33263780|NCT00943917|100866800|FG003|Stage I|hyperglycemia|0|||
33263781|NCT00943917|100866801|FG004|Stage I|hyperglycemia|0|||
33263782|NCT00943917|100866802|FG005|Stage I|hyperglycemia|0|||
33263783|NCT00943917|100866803|FG006|Stage I|hyperglycemia|0|||
33464834|NCT02274948|101589847|FG000|Overall Study|Lost to Follow-up|28|||
33464835|NCT02274948|101589848|FG001|Overall Study|Lost to Follow-up|25|||
33464836|NCT02274948|101589847|FG000|Overall Study|Withdrawal by Subject|64|||
33464837|NCT02274948|101589848|FG001|Overall Study|Withdrawal by Subject|58|||
33464838|NCT02274948|101589847|FG000|Overall Study|Stopped on family Practitioner advice|2|||
33464839|NCT02274948|101589848|FG001|Overall Study|Stopped on family Practitioner advice|5|||
33464840|NCT02274948|101589847|FG000|Overall Study|Left the area|4|||
33464841|NCT02274948|101589848|FG001|Overall Study|Left the area|3|||
33464842|NCT01714739|101589849|FG000|Overall Study|Disease progression|3|||
33464843|NCT01714739|101589850|FG001|Overall Study|Disease progression|5|||
33464844|NCT01714739|101589851|FG002|Overall Study|Disease progression|5|||
33464845|NCT01714739|101589852|FG003|Overall Study|Disease progression|204|||
33464846|NCT01714739|101589853|FG004|Overall Study|Disease progression|1|||
33464847|NCT01714739|101589854|FG005|Overall Study|Disease progression|3|||
33464848|NCT01714739|101589855|FG006|Overall Study|Disease progression|5|||
33464849|NCT01714739|101589849|FG000|Overall Study|Study drug toxicity|1|||
33464850|NCT01714739|101589850|FG001|Overall Study|Study drug toxicity|1|||
33177326|NCT03263442|100556289|FG000|Inpatient Phase|Death|1|||
33263784|NCT00943917|100866804|FG007|Stage I|hyperglycemia|0|||
33263785|NCT00943917|100866805|FG008|Stage I|hyperglycemia|0|||
33263786|NCT00943917|100866806|FG009|Stage I|hyperglycemia|0|||
33263787|NCT00943917|100866807|FG010|Stage I|hyperglycemia|0|||
33263788|NCT00943917|100866808|FG011|Stage I|hyperglycemia|0|||
33263789|NCT00943917|100866809|FG012|Stage I|hyperglycemia|0|||
33263790|NCT00943917|100866810|FG013|Stage I|hyperglycemia|0|||
33263791|NCT00943917|100866811|FG014|Stage I|hyperglycemia|0|||
33263792|NCT00943917|100866797|FG000|Stage I|A1C elevation|1|||
33263793|NCT00943917|100866798|FG001|Stage I|A1C elevation|0|||
33263794|NCT00943917|100866799|FG002|Stage I|A1C elevation|0|||
33263795|NCT00943917|100866800|FG003|Stage I|A1C elevation|0|||
33263796|NCT00943917|100866801|FG004|Stage I|A1C elevation|0|||
33263797|NCT00943917|100866802|FG005|Stage I|A1C elevation|0|||
33263798|NCT00943917|100866803|FG006|Stage I|A1C elevation|0|||
33263799|NCT00943917|100866804|FG007|Stage I|A1C elevation|0|||
33263800|NCT00943917|100866805|FG008|Stage I|A1C elevation|0|||
33263801|NCT00943917|100866806|FG009|Stage I|A1C elevation|0|||
33263802|NCT00943917|100866807|FG010|Stage I|A1C elevation|0|||
33263803|NCT00943917|100866808|FG011|Stage I|A1C elevation|0|||
33263804|NCT00943917|100866809|FG012|Stage I|A1C elevation|0|||
33263805|NCT00943917|100866810|FG013|Stage I|A1C elevation|0|||
33263806|NCT00943917|100866811|FG014|Stage I|A1C elevation|0|||
33263807|NCT00943917|100866797|FG000|Stage I|Withdrawal by Subject|2|||
33263808|NCT00943917|100866798|FG001|Stage I|Withdrawal by Subject|1|||
33263809|NCT00943917|100866799|FG002|Stage I|Withdrawal by Subject|2|||
33263810|NCT00943917|100866800|FG003|Stage I|Withdrawal by Subject|0|||
33263811|NCT00943917|100866801|FG004|Stage I|Withdrawal by Subject|0|||
33263812|NCT00943917|100866802|FG005|Stage I|Withdrawal by Subject|0|||
33263813|NCT00943917|100866803|FG006|Stage I|Withdrawal by Subject|0|||
33263814|NCT00943917|100866804|FG007|Stage I|Withdrawal by Subject|0|||
33263815|NCT00943917|100866805|FG008|Stage I|Withdrawal by Subject|0|||
33263816|NCT00943917|100866806|FG009|Stage I|Withdrawal by Subject|0|||
33263817|NCT00943917|100866807|FG010|Stage I|Withdrawal by Subject|0|||
33263818|NCT00943917|100866808|FG011|Stage I|Withdrawal by Subject|0|||
33263819|NCT00943917|100866809|FG012|Stage I|Withdrawal by Subject|0|||
33263820|NCT00943917|100866810|FG013|Stage I|Withdrawal by Subject|0|||
33263821|NCT00943917|100866811|FG014|Stage I|Withdrawal by Subject|0|||
33263822|NCT00943917|100866797|FG000|Stage II|Adverse Event|0|||
33263823|NCT00943917|100866798|FG001|Stage II|Adverse Event|0|||
33263824|NCT00943917|100866799|FG002|Stage II|Adverse Event|0|||
33263825|NCT00943917|100866800|FG003|Stage II|Adverse Event|0|||
33263826|NCT00943917|100866801|FG004|Stage II|Adverse Event|0|||
33263827|NCT00943917|100866802|FG005|Stage II|Adverse Event|1|||
33263828|NCT00943917|100866803|FG006|Stage II|Adverse Event|3|||
33263829|NCT00943917|100866804|FG007|Stage II|Adverse Event|0|||
33263830|NCT00943917|100866805|FG008|Stage II|Adverse Event|1|||
33263831|NCT00943917|100866806|FG009|Stage II|Adverse Event|0|||
33263832|NCT00943917|100866807|FG010|Stage II|Adverse Event|0|||
33263833|NCT00943917|100866808|FG011|Stage II|Adverse Event|0|||
33464851|NCT01714739|101589851|FG002|Overall Study|Study drug toxicity|1|||
33464852|NCT01714739|101589852|FG003|Overall Study|Study drug toxicity|15|||
33464853|NCT01714739|101589853|FG004|Overall Study|Study drug toxicity|0|||
33464854|NCT01714739|101589854|FG005|Overall Study|Study drug toxicity|0|||
33464855|NCT01714739|101589855|FG006|Overall Study|Study drug toxicity|5|||
33177327|NCT03263442|100556290|FG001|Inpatient Phase|Death|0|||
33177328|NCT03263442|100556289|FG000|Inpatient Phase|Withdrawal by Subject|1|||
33177329|NCT03263442|100556290|FG001|Inpatient Phase|Withdrawal by Subject|0|||
33177330|NCT03263442|100556289|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
33177331|NCT03263442|100556290|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
33177332|NCT03263442|100556289|FG000|1-month Follow-Up|Lost to Follow-up|1|||
33177333|NCT03263442|100556290|FG001|1-month Follow-Up|Lost to Follow-up|0|||
33177334|NCT03263442|100556289|FG000|3-month Follow-Up|Lost to Follow-up|1|||
33177335|NCT03263442|100556290|FG001|3-month Follow-Up|Lost to Follow-up|3|||
33177336|NCT03263442|100556289|FG000|6-month Follow-Up|Lost to Follow-up|2|||
33177337|NCT03263442|100556290|FG001|6-month Follow-Up|Lost to Follow-up|2|||
33177338|NCT03527966|100556292|FG000|Overall Study|Lost to Follow-up|3|||
33177339|NCT03527966|100556293|FG001|Overall Study|Lost to Follow-up|0|||
33177340|NCT00411645|100556294|FG000|Overall Study|Consent Withdrawn|13|||
33464856|NCT01714739|101589849|FG000|Overall Study|Death|0|||
33464857|NCT01714739|101589850|FG001|Overall Study|Death|0|||
33464858|NCT01714739|101589851|FG002|Overall Study|Death|0|||
33464859|NCT01714739|101589852|FG003|Overall Study|Death|1|||
33464860|NCT01714739|101589853|FG004|Overall Study|Death|0|||
33464861|NCT01714739|101589854|FG005|Overall Study|Death|0|||
33464862|NCT01714739|101589855|FG006|Overall Study|Death|0|||
33464863|NCT01714739|101589849|FG000|Overall Study|Adverse Event unrelated to drug|0|||
33464864|NCT01714739|101589850|FG001|Overall Study|Adverse Event unrelated to drug|0|||
33464865|NCT01714739|101589851|FG002|Overall Study|Adverse Event unrelated to drug|3|||
33464866|NCT01714739|101589852|FG003|Overall Study|Adverse Event unrelated to drug|21|||
33464867|NCT01714739|101589853|FG004|Overall Study|Adverse Event unrelated to drug|0|||
33464868|NCT01714739|101589854|FG005|Overall Study|Adverse Event unrelated to drug|0|||
33464869|NCT01714739|101589855|FG006|Overall Study|Adverse Event unrelated to drug|0|||
33464870|NCT01714739|101589849|FG000|Overall Study|Participant request to stop therapy|0|||
33464871|NCT01714739|101589850|FG001|Overall Study|Participant request to stop therapy|1|||
33464872|NCT01714739|101589851|FG002|Overall Study|Participant request to stop therapy|0|||
33464873|NCT01714739|101589852|FG003|Overall Study|Participant request to stop therapy|6|||
33464874|NCT01714739|101589853|FG004|Overall Study|Participant request to stop therapy|0|||
33464875|NCT01714739|101589854|FG005|Overall Study|Participant request to stop therapy|0|||
33464876|NCT01714739|101589855|FG006|Overall Study|Participant request to stop therapy|0|||
33464877|NCT01714739|101589849|FG000|Overall Study|Participant withdrew consent|0|||
33464878|NCT01714739|101589850|FG001|Overall Study|Participant withdrew consent|1|||
33464879|NCT01714739|101589851|FG002|Overall Study|Participant withdrew consent|0|||
33464880|NCT01714739|101589852|FG003|Overall Study|Participant withdrew consent|8|||
33464881|NCT01714739|101589853|FG004|Overall Study|Participant withdrew consent|0|||
33464882|NCT01714739|101589854|FG005|Overall Study|Participant withdrew consent|0|||
33464883|NCT01714739|101589855|FG006|Overall Study|Participant withdrew consent|0|||
33464884|NCT01714739|101589849|FG000|Overall Study|Lost to Follow-up|0|||
33464885|NCT01714739|101589850|FG001|Overall Study|Lost to Follow-up|0|||
33464886|NCT01714739|101589851|FG002|Overall Study|Lost to Follow-up|0|||
33464887|NCT01714739|101589852|FG003|Overall Study|Lost to Follow-up|1|||
33464888|NCT01714739|101589853|FG004|Overall Study|Lost to Follow-up|0|||
33464889|NCT01714739|101589854|FG005|Overall Study|Lost to Follow-up|0|||
33464890|NCT01714739|101589855|FG006|Overall Study|Lost to Follow-up|0|||
33464891|NCT01714739|101589849|FG000|Overall Study|Maximum clinical benefit|0|||
33464892|NCT01714739|101589850|FG001|Overall Study|Maximum clinical benefit|1|||
33464893|NCT01714739|101589851|FG002|Overall Study|Maximum clinical benefit|1|||
33464894|NCT01714739|101589852|FG003|Overall Study|Maximum clinical benefit|3|||
33464895|NCT01714739|101589853|FG004|Overall Study|Maximum clinical benefit|0|||
33464896|NCT01714739|101589854|FG005|Overall Study|Maximum clinical benefit|0|||
33464897|NCT01714739|101589855|FG006|Overall Study|Maximum clinical benefit|0|||
33464898|NCT01714739|101589849|FG000|Overall Study|Poor/non-comliance|0|||
33464899|NCT01714739|101589850|FG001|Overall Study|Poor/non-comliance|1|||
33464900|NCT01714739|101589851|FG002|Overall Study|Poor/non-comliance|0|||
33464901|NCT01714739|101589852|FG003|Overall Study|Poor/non-comliance|1|||
33464902|NCT01714739|101589853|FG004|Overall Study|Poor/non-comliance|0|||
33464903|NCT01714739|101589854|FG005|Overall Study|Poor/non-comliance|0|||
33464904|NCT01714739|101589855|FG006|Overall Study|Poor/non-comliance|0|||
33464905|NCT01714739|101589849|FG000|Overall Study|No longer meets study criteria|0|||
33464906|NCT01714739|101589850|FG001|Overall Study|No longer meets study criteria|0|||
33464907|NCT01714739|101589851|FG002|Overall Study|No longer meets study criteria|0|||
33464908|NCT01714739|101589852|FG003|Overall Study|No longer meets study criteria|1|||
33464909|NCT01714739|101589853|FG004|Overall Study|No longer meets study criteria|0|||
33464910|NCT01714739|101589854|FG005|Overall Study|No longer meets study criteria|0|||
33464911|NCT01714739|101589855|FG006|Overall Study|No longer meets study criteria|0|||
33464912|NCT01714739|101589849|FG000|Overall Study|Other reason|0|||
33464913|NCT01714739|101589850|FG001|Overall Study|Other reason|0|||
33464914|NCT01714739|101589851|FG002|Overall Study|Other reason|0|||
33464915|NCT01714739|101589852|FG003|Overall Study|Other reason|3|||
33464916|NCT01714739|101589853|FG004|Overall Study|Other reason|1|||
33464917|NCT01714739|101589854|FG005|Overall Study|Other reason|0|||
33464918|NCT01714739|101589855|FG006|Overall Study|Other reason|0|||
33464919|NCT00991510|101589856|FG000|Period I (Days 1-14)|Adverse Event|1|||
33464920|NCT00991510|101589857|FG001|Period I (Days 1-14)|Adverse Event|0|||
33464921|NCT00991510|101589856|FG000|Period III (Days 29-112)|Adverse Event|1|||
33464922|NCT00991510|101589857|FG001|Period III (Days 29-112)|Adverse Event|1|||
33464923|NCT00611884|101593418|FG000|Overall Study|Adverse Event|1|||
33464924|NCT00611884|101593419|FG001|Overall Study|Adverse Event|0|||
33464925|NCT00611884|101593420|FG002|Overall Study|Adverse Event|0|||
33464926|NCT00611884|101593421|FG003|Overall Study|Adverse Event|1|||
33464927|NCT00611884|101593418|FG000|Overall Study|Non-Compliance|1|||
33464928|NCT00611884|101593419|FG001|Overall Study|Non-Compliance|4|||
33464929|NCT00611884|101593420|FG002|Overall Study|Non-Compliance|2|||
33464930|NCT00611884|101593421|FG003|Overall Study|Non-Compliance|2|||
33464931|NCT00611884|101593418|FG000|Overall Study|Lack of Efficacy|0|||
33464932|NCT00611884|101593419|FG001|Overall Study|Lack of Efficacy|1|||
33464933|NCT00611884|101593420|FG002|Overall Study|Lack of Efficacy|0|||
33464934|NCT00611884|101593421|FG003|Overall Study|Lack of Efficacy|0|||
33464935|NCT00611884|101593418|FG000|Overall Study|Unclassified|7|||
33464936|NCT00611884|101593419|FG001|Overall Study|Unclassified|4|||
33464937|NCT00611884|101593420|FG002|Overall Study|Unclassified|2|||
33464938|NCT00611884|101593421|FG003|Overall Study|Unclassified|3|||
33464939|NCT02563769|101593422|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
33464940|NCT02563769|101593423|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
33464941|NCT02563769|101593424|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
33464942|NCT01998243|101593425|FG000|Overall Study|Pregnancy|0|||
33464943|NCT01998243|101593426|FG001|Overall Study|Pregnancy|1|||
33464944|NCT01998243|101593425|FG000|Overall Study|Protocol Violation|5|||
33464945|NCT01998243|101593426|FG001|Overall Study|Protocol Violation|2|||
33464946|NCT01998243|101593425|FG000|Overall Study|Withdrawal by Subject|3|||
33464947|NCT01998243|101593426|FG001|Overall Study|Withdrawal by Subject|4|||
33464948|NCT00860743|101593431|FG000|Overall Study|Withdrawal by Subject|3|||
33464949|NCT00860743|101593432|FG001|Overall Study|Withdrawal by Subject|0|||
33464950|NCT00094094|101593433|FG000|Overall Study|Death|2|||
33464951|NCT00094094|101593433|FG000|Overall Study|Lack of Efficacy|23|||
33464952|NCT00094094|101593433|FG000|Overall Study|Adverse Event|7|||
33177341|NCT00411645|100556295|FG001|Overall Study|Consent Withdrawn|22|||
33177342|NCT00411645|100556294|FG000|Overall Study|Death|56|||
33177343|NCT00411645|100556295|FG001|Overall Study|Death|135|||
33177344|NCT00411645|100556294|FG000|Overall Study|Investigator/Sponsor Decision|10|||
33177345|NCT00411645|100556295|FG001|Overall Study|Investigator/Sponsor Decision|7|||
33177346|NCT00411645|100556294|FG000|Overall Study|Lost to Follow-up|2|||
33177347|NCT00411645|100556295|FG001|Overall Study|Lost to Follow-up|0|||
33177348|NCT03182829|100556296|FG000|Overall Study|Protocol Violation|12|||
33177349|NCT03182829|100556297|FG001|Overall Study|Protocol Violation|12|||
33177350|NCT03182829|100556296|FG000|Overall Study|Other|4|||
33177351|NCT03182829|100556297|FG001|Overall Study|Other|3|||
33177352|NCT00810407|100556298|FG000|Overall Study|Protocol Violation|3|||
33177353|NCT00810407|100556298|FG000|Overall Study|No Visit After First Day of Treatment|3|||
33177354|NCT02810392|100556303|FG000|Overall Study|Subject too ill to continue|1|||
33177355|NCT02810392|100556304|FG001|Overall Study|Subject too ill to continue|0|||
33464953|NCT00483548|101593436|FG000|Overall Study|Randomized; not treated with study drug|1|||
33464954|NCT00483548|101593437|FG001|Overall Study|Randomized; not treated with study drug|3|||
33464955|NCT00483548|101593436|FG000|Overall Study|Adverse Event|25|||
33464956|NCT00483548|101593437|FG001|Overall Study|Adverse Event|14|||
33464957|NCT00483548|101593436|FG000|Overall Study|Laboratory abnormality|1|||
33464958|NCT00483548|101593437|FG001|Overall Study|Laboratory abnormality|2|||
33177356|NCT02810392|100556303|FG000|Overall Study|COVID 19 research restrictions|0|||
33177357|NCT02810392|100556304|FG001|Overall Study|COVID 19 research restrictions|1|||
33464959|NCT00483548|101593436|FG000|Overall Study|Lack of Efficacy|4|||
33464960|NCT00483548|101593437|FG001|Overall Study|Lack of Efficacy|8|||
33464961|NCT00483548|101593436|FG000|Overall Study|Protocol Violation|11|||
33464962|NCT00483548|101593437|FG001|Overall Study|Protocol Violation|7|||
33464963|NCT00483548|101593436|FG000|Overall Study|Pregnancy|1|||
33464964|NCT00483548|101593437|FG001|Overall Study|Pregnancy|0|||
33464965|NCT00483548|101593436|FG000|Overall Study|Protocol required discontinuation|6|||
33464966|NCT00483548|101593437|FG001|Overall Study|Protocol required discontinuation|6|||
33464967|NCT00483548|101593436|FG000|Overall Study|Unable to comply with protocol schedule|1|||
33464968|NCT00483548|101593437|FG001|Overall Study|Unable to comply with protocol schedule|0|||
33464969|NCT00483548|101593436|FG000|Overall Study|Non-compliance with medication|2|||
33464970|NCT00483548|101593437|FG001|Overall Study|Non-compliance with medication|0|||
33464971|NCT00483548|101593436|FG000|Overall Study|Lost to Follow-up|3|||
33464972|NCT00483548|101593437|FG001|Overall Study|Lost to Follow-up|4|||
33464973|NCT00483548|101593436|FG000|Overall Study|Withdrawal by Subject|5|||
33464974|NCT00483548|101593437|FG001|Overall Study|Withdrawal by Subject|2|||
33464975|NCT02752802|101593438|FG000|Overall Study|Contrast Volume Not Collected|1|||
33464976|NCT02752802|101593439|FG001|Overall Study|Contrast Volume Not Collected|0|||
33464977|NCT00003531|101593440|FG000|Overall Study|Not evaluable|10|||
33464978|NCT00700817|101593441|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
33464979|NCT00700817|101593442|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
33464980|NCT00700817|101593443|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
33464981|NCT00700817|101593444|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
33464982|NCT00700817|101593445|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
33464983|NCT00700817|101593441|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
33464984|NCT00700817|101593442|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
33464985|NCT00700817|101593443|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
33464986|NCT00700817|101593444|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
33464987|NCT00700817|101593445|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
33464988|NCT00700817|101593441|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
33464989|NCT00700817|101593442|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
33464990|NCT00700817|101593443|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
33464991|NCT00700817|101593444|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
33464992|NCT00700817|101593445|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
33464993|NCT00700817|101593441|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
33464994|NCT00700817|101593442|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
33464995|NCT00700817|101593443|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
33464996|NCT00700817|101593444|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
33464997|NCT00700817|101593445|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
33464998|NCT00700817|101593441|FG000|Week 0-26 (Main Period)|Unclassified|14|||
33464999|NCT00700817|101593442|FG001|Week 0-26 (Main Period)|Unclassified|4|||
33465000|NCT00700817|101593443|FG002|Week 0-26 (Main Period)|Unclassified|8|||
33465001|NCT00700817|101593444|FG003|Week 0-26 (Main Period)|Unclassified|0|||
33465002|NCT00700817|101593445|FG004|Week 0-26 (Main Period)|Unclassified|0|||
33465003|NCT00700817|101593441|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
33465004|NCT00700817|101593442|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
33465005|NCT00700817|101593443|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
33465006|NCT00700817|101593444|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
33465007|NCT00700817|101593445|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
33465008|NCT00700817|101593441|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
33465009|NCT00700817|101593442|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
33177358|NCT00453544|100556305|FG000|Overall Study|Withdrawal by Subject|1|||
33177359|NCT00453544|100556306|FG001|Overall Study|Withdrawal by Subject|0|||
33465010|NCT00700817|101593443|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
33465011|NCT00700817|101593444|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
33465012|NCT00700817|101593445|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
33465013|NCT00700817|101593441|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
33465014|NCT00700817|101593442|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
33465015|NCT00700817|101593443|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
33465016|NCT00700817|101593444|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
33465017|NCT00700817|101593445|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
33465018|NCT00700817|101593441|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
33465019|NCT00700817|101593442|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
33465020|NCT00700817|101593443|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
33465021|NCT00700817|101593444|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
33465022|NCT00700817|101593445|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
33465023|NCT00700817|101593441|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
33465024|NCT00700817|101593442|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
33465025|NCT00700817|101593443|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
33465026|NCT00700817|101593444|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
33465027|NCT00700817|101593445|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
33465028|NCT00700817|101593441|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
33177360|NCT00453544|100556307|FG002|Overall Study|Withdrawal by Subject|0|||
33465029|NCT00700817|101593442|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
33465030|NCT00700817|101593443|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
33465031|NCT00700817|101593444|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
33465032|NCT00700817|101593445|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
33465033|NCT00700817|101593441|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
33465034|NCT00700817|101593442|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
33465035|NCT00700817|101593443|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
33465036|NCT00700817|101593444|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
33465037|NCT00700817|101593445|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
33465038|NCT00700817|101593441|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
33465039|NCT00700817|101593442|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
33465040|NCT00700817|101593443|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
33465041|NCT00700817|101593444|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
33465042|NCT00700817|101593445|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
33465043|NCT00700817|101593441|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
33465044|NCT00700817|101593442|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
33465045|NCT00700817|101593443|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
33465046|NCT00700817|101593444|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
33465047|NCT00700817|101593445|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
33465048|NCT00700817|101593441|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
33465049|NCT00700817|101593442|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
33465050|NCT00700817|101593443|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
33465051|NCT00700817|101593444|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
33465052|NCT00700817|101593445|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
33465053|NCT01297322|101593461|FG000|Overall Study|Lost to Follow-up|1|||
33465054|NCT01297322|101593462|FG001|Overall Study|Lost to Follow-up|0|||
33465055|NCT01297322|101593461|FG000|Overall Study|Withdrawal by Subject|0|||
33465056|NCT01297322|101593462|FG001|Overall Study|Withdrawal by Subject|1|||
33465057|NCT01297322|101593461|FG000|Overall Study|Protocol Violation|0|||
33465058|NCT01297322|101593462|FG001|Overall Study|Protocol Violation|3|||
33465059|NCT00885677|101593470|FG000|Overall Study|Death|40|||
33465060|NCT00885677|101593471|FG001|Overall Study|Death|34|||
33465061|NCT00885677|101593470|FG000|Overall Study|Lost to Follow-up|15|||
33465062|NCT00885677|101593471|FG001|Overall Study|Lost to Follow-up|13|||
33465063|NCT00885677|101593470|FG000|Overall Study|Protocol Violation|54|||
33465064|NCT00885677|101593471|FG001|Overall Study|Protocol Violation|54|||
33465065|NCT00885677|101593470|FG000|Overall Study|premature study closure|41|||
33465066|NCT00885677|101593471|FG001|Overall Study|premature study closure|44|||
33465067|NCT00885677|101593470|FG000|Overall Study|device/lead revision or replacement|7|||
33465068|NCT00885677|101593471|FG001|Overall Study|device/lead revision or replacement|6|||
33465069|NCT00885677|101593470|FG000|Overall Study|Heart transplantation|1|||
33465070|NCT00885677|101593471|FG001|Overall Study|Heart transplantation|0|||
33465071|NCT00885677|101593470|FG000|Overall Study|Inclusion/exclusion not met|25|||
33465072|NCT00885677|101593471|FG001|Overall Study|Inclusion/exclusion not met|27|||
33465073|NCT01619579|101593478|FG000|Overall Study|Withdrawal by Subject|0|||
33465074|NCT01619579|101593479|FG001|Overall Study|Withdrawal by Subject|3|||
33465075|NCT02284347|101593483|FG000|Overall Study|Lost to Follow-up|2|||
33465076|NCT02284347|101593483|FG000|Overall Study|Withdrawn prior to treatment|1|||
33465077|NCT03321526|101593486|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
33465078|NCT03321526|101593487|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
33465079|NCT03321526|101593486|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
33465080|NCT03321526|101593487|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
33465081|NCT03321526|101593486|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
33465082|NCT03321526|101593487|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
33465083|NCT03321526|101593486|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
33465084|NCT03321526|101593487|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
33465085|NCT03321526|101593486|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
33465086|NCT03321526|101593487|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
33465087|NCT03321526|101593486|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
33465088|NCT03321526|101593487|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
33465089|NCT03321526|101593486|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
33465090|NCT03321526|101593487|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
33465091|NCT03321526|101593486|FG000|Follow-up Phase (2 Weeks)|Other|24|||
33465092|NCT03321526|101593487|FG001|Follow-up Phase (2 Weeks)|Other|24|||
33465093|NCT00114231|101593488|FG000|Overall Study|No consent|2|||
33465094|NCT00114231|101593489|FG001|Overall Study|No consent|0|||
33465095|NCT00114231|101593488|FG000|Overall Study|QARC requirement not met|1|||
33465096|NCT00114231|101593489|FG001|Overall Study|QARC requirement not met|0|||
33465097|NCT00114231|101593488|FG000|Overall Study|Suspected metastatic disease|1|||
33465098|NCT00114231|101593489|FG001|Overall Study|Suspected metastatic disease|0|||
33465099|NCT00114231|101593488|FG000|Overall Study|No adenocarcinoma|1|||
33465100|NCT00114231|101593489|FG001|Overall Study|No adenocarcinoma|0|||
33465101|NCT00114231|101593488|FG000|Overall Study|Low creatinine clearance|0|||
33465102|NCT00114231|101593489|FG001|Overall Study|Low creatinine clearance|1|||
33465103|NCT00114231|101593488|FG000|Overall Study|Tumor size > 4cm|1|||
33263834|NCT00943917|100866809|FG012|Stage II|Adverse Event|0|||
33263835|NCT00943917|100866810|FG013|Stage II|Adverse Event|0|||
33263836|NCT00943917|100866811|FG014|Stage II|Adverse Event|0|||
33263837|NCT00943917|100866797|FG000|Stage II|Withdrawal by Subject|0|||
33263838|NCT00943917|100866798|FG001|Stage II|Withdrawal by Subject|0|||
33263839|NCT00943917|100866799|FG002|Stage II|Withdrawal by Subject|0|||
33263840|NCT00943917|100866800|FG003|Stage II|Withdrawal by Subject|0|||
33263841|NCT00943917|100866801|FG004|Stage II|Withdrawal by Subject|0|||
33263842|NCT00943917|100866802|FG005|Stage II|Withdrawal by Subject|1|||
33263843|NCT00943917|100866803|FG006|Stage II|Withdrawal by Subject|0|||
33263844|NCT00943917|100866804|FG007|Stage II|Withdrawal by Subject|0|||
33263845|NCT00943917|100866805|FG008|Stage II|Withdrawal by Subject|0|||
33465104|NCT00114231|101593489|FG001|Overall Study|Tumor size > 4cm|0|||
33465105|NCT00114231|101593488|FG000|Overall Study|Tumor fixed on digital exam|0|||
33465106|NCT00114231|101593489|FG001|Overall Study|Tumor fixed on digital exam|1|||
33465107|NCT00114231|101593488|FG000|Overall Study|No Absolute Neutrophil Count|2|||
33465108|NCT00114231|101593489|FG001|Overall Study|No Absolute Neutrophil Count|0|||
33465109|NCT00114231|101593488|FG000|Overall Study|Biopsy done after registration|1|||
33465110|NCT00114231|101593489|FG001|Overall Study|Biopsy done after registration|0|||
33465111|NCT02788513|101593492|FG000|Overall Study|Withdrawal by Subject|3|||
33465112|NCT02788513|101593493|FG001|Overall Study|Withdrawal by Subject|0|||
33465113|NCT02788513|101593494|FG002|Overall Study|Withdrawal by Subject|2|||
33465114|NCT02788513|101593495|FG003|Overall Study|Withdrawal by Subject|3|||
33465115|NCT02788513|101593496|FG004|Overall Study|Withdrawal by Subject|1|||
33465116|NCT02788513|101593492|FG000|Overall Study|Lost to Follow-up|1|||
33465117|NCT02788513|101593493|FG001|Overall Study|Lost to Follow-up|0|||
33465118|NCT02788513|101593494|FG002|Overall Study|Lost to Follow-up|0|||
33465119|NCT02788513|101593495|FG003|Overall Study|Lost to Follow-up|0|||
33465120|NCT02788513|101593496|FG004|Overall Study|Lost to Follow-up|1|||
33465121|NCT02788513|101593492|FG000|Overall Study|Adverse Event|5|||
33465122|NCT02788513|101593493|FG001|Overall Study|Adverse Event|8|||
33465123|NCT02788513|101593494|FG002|Overall Study|Adverse Event|4|||
33465124|NCT02788513|101593495|FG003|Overall Study|Adverse Event|2|||
33465125|NCT02788513|101593496|FG004|Overall Study|Adverse Event|2|||
33465126|NCT02788513|101593492|FG000|Overall Study|Protocol Violation|0|||
33465127|NCT02788513|101593493|FG001|Overall Study|Protocol Violation|0|||
33465128|NCT02788513|101593494|FG002|Overall Study|Protocol Violation|1|||
33465129|NCT02788513|101593495|FG003|Overall Study|Protocol Violation|1|||
33465130|NCT02788513|101593496|FG004|Overall Study|Protocol Violation|0|||
33465131|NCT02788513|101593492|FG000|Overall Study|Subject decided to stop taking treatment|0|||
33465132|NCT02788513|101593493|FG001|Overall Study|Subject decided to stop taking treatment|0|||
33465133|NCT02788513|101593494|FG002|Overall Study|Subject decided to stop taking treatment|1|||
33465134|NCT02788513|101593495|FG003|Overall Study|Subject decided to stop taking treatment|0|||
33465135|NCT02788513|101593496|FG004|Overall Study|Subject decided to stop taking treatment|0|||
33465136|NCT02788513|101593492|FG000|Overall Study|Decision by the study team|0|||
33465137|NCT02788513|101593493|FG001|Overall Study|Decision by the study team|0|||
33465138|NCT02788513|101593494|FG002|Overall Study|Decision by the study team|0|||
33465139|NCT02788513|101593495|FG003|Overall Study|Decision by the study team|0|||
33465140|NCT02788513|101593496|FG004|Overall Study|Decision by the study team|1|||
33177361|NCT00453544|100556308|FG003|Overall Study|Withdrawal by Subject|0|||
33177362|NCT00453544|100556305|FG000|Overall Study|Primary outcome measure not completed|1|||
33177363|NCT00453544|100556306|FG001|Overall Study|Primary outcome measure not completed|1|||
33177364|NCT00453544|100556307|FG002|Overall Study|Primary outcome measure not completed|0|||
33177365|NCT00453544|100556308|FG003|Overall Study|Primary outcome measure not completed|1|||
33177366|NCT01867021|100556310|FG000|Overall Study|Adverse Event|0|||
33465141|NCT00255151|101593497|FG000|Overall Study|Adverse Event|10|||
33465142|NCT00255151|101593498|FG001|Overall Study|Adverse Event|6|||
33465143|NCT00255151|101593499|FG002|Overall Study|Adverse Event|9|||
33465144|NCT00255151|101593497|FG000|Overall Study|Lost to Follow-up|4|||
33177367|NCT01867021|100556311|FG001|Overall Study|Adverse Event|1|||
33177368|NCT01867021|100556310|FG000|Overall Study|Not Eligible|0|||
33177369|NCT01867021|100556311|FG001|Overall Study|Not Eligible|1|||
33263846|NCT00943917|100866806|FG009|Stage II|Withdrawal by Subject|0|||
33263847|NCT00943917|100866807|FG010|Stage II|Withdrawal by Subject|0|||
33465145|NCT00255151|101593498|FG001|Overall Study|Lost to Follow-up|3|||
33465146|NCT00255151|101593499|FG002|Overall Study|Lost to Follow-up|4|||
33465147|NCT00255151|101593497|FG000|Overall Study|Withdrawal by Subject|18|||
33465148|NCT00255151|101593498|FG001|Overall Study|Withdrawal by Subject|17|||
33465149|NCT00255151|101593499|FG002|Overall Study|Withdrawal by Subject|8|||
33465150|NCT00255151|101593497|FG000|Overall Study|Noncompliance|0|||
33465151|NCT00255151|101593498|FG001|Overall Study|Noncompliance|1|||
33465152|NCT00255151|101593499|FG002|Overall Study|Noncompliance|2|||
33263848|NCT00943917|100866808|FG011|Stage II|Withdrawal by Subject|0|||
33465153|NCT00255151|101593497|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
33465154|NCT00255151|101593498|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
33465155|NCT00255151|101593499|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
33465156|NCT00255151|101593497|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
33465157|NCT00255151|101593498|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
33465158|NCT00255151|101593499|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
33465159|NCT00255151|101593497|FG000|Overall Study|Possible Barrett's Esophagus|1|||
33465160|NCT00255151|101593498|FG001|Overall Study|Possible Barrett's Esophagus|3|||
33465161|NCT00255151|101593499|FG002|Overall Study|Possible Barrett's Esophagus|8|||
33465162|NCT00255151|101593497|FG000|Overall Study|Esophageal Stricture|0|||
33465163|NCT00255151|101593498|FG001|Overall Study|Esophageal Stricture|0|||
33465164|NCT00255151|101593499|FG002|Overall Study|Esophageal Stricture|1|||
33465165|NCT00255151|101593497|FG000|Overall Study|Therapeutic Failure|11|||
33465166|NCT00255151|101593498|FG001|Overall Study|Therapeutic Failure|2|||
33465167|NCT00255151|101593499|FG002|Overall Study|Therapeutic Failure|3|||
33465168|NCT02104817|101593505|FG000|Overall Study|Death|363|||
33465169|NCT02104817|101593506|FG001|Overall Study|Death|330|||
33465170|NCT02104817|101593505|FG000|Overall Study|Lost to Follow-up|3|||
33465171|NCT02104817|101593506|FG001|Overall Study|Lost to Follow-up|2|||
33465172|NCT02104817|101593505|FG000|Overall Study|Protocol Violation|0|||
33465173|NCT02104817|101593506|FG001|Overall Study|Protocol Violation|1|||
33465174|NCT02104817|101593505|FG000|Overall Study|Study terminated by sponsor|5854|||
33465175|NCT02104817|101593506|FG001|Overall Study|Study terminated by sponsor|5901|||
33465176|NCT02104817|101593505|FG000|Overall Study|Withdrawal by Subject|111|||
33465177|NCT02104817|101593506|FG001|Overall Study|Withdrawal by Subject|78|||
33465178|NCT02104817|101593505|FG000|Overall Study|Other reasons|128|||
33465179|NCT02104817|101593506|FG001|Overall Study|Other reasons|135|||
33465180|NCT00988208|101593507|FG000|Overall Study|Adverse Event|71|||
33465181|NCT00988208|101593508|FG001|Overall Study|Adverse Event|122|||
33465182|NCT00988208|101593507|FG000|Overall Study|Disease Progression|103|||
33177370|NCT01867021|100556310|FG000|Overall Study|Death|1|||
33177371|NCT01867021|100556311|FG001|Overall Study|Death|0|||
33177372|NCT01867021|100556310|FG000|Overall Study|Lost to Follow-up|0|||
33177373|NCT01867021|100556311|FG001|Overall Study|Lost to Follow-up|2|||
33177374|NCT01867021|100556310|FG000|Overall Study|Withdrawal by Subject|1|||
33177375|NCT01867021|100556311|FG001|Overall Study|Withdrawal by Subject|6|||
33177376|NCT00475176|100556312|FG000|Overall Study|Adverse Event|2|||
33177377|NCT00475176|100556312|FG000|Overall Study|Withdrawal by Subject|1|||
33177378|NCT00475176|100556312|FG000|Overall Study|Protocol Violation|1|||
33177379|NCT03564145|100556315|FG000|Overall Study|Adverse Event|4|||
33263849|NCT00943917|100866809|FG012|Stage II|Withdrawal by Subject|0|||
33263850|NCT00943917|100866810|FG013|Stage II|Withdrawal by Subject|0|||
33263851|NCT00943917|100866811|FG014|Stage II|Withdrawal by Subject|0|||
33263852|NCT00943917|100866797|FG000|Stage II|Pregnancy|0|||
33263853|NCT00943917|100866798|FG001|Stage II|Pregnancy|0|||
33263854|NCT00943917|100866799|FG002|Stage II|Pregnancy|0|||
33263855|NCT00943917|100866800|FG003|Stage II|Pregnancy|0|||
33263856|NCT00943917|100866801|FG004|Stage II|Pregnancy|0|||
33263857|NCT00943917|100866802|FG005|Stage II|Pregnancy|1|||
33263858|NCT00943917|100866803|FG006|Stage II|Pregnancy|0|||
33263859|NCT00943917|100866804|FG007|Stage II|Pregnancy|0|||
33263860|NCT00943917|100866805|FG008|Stage II|Pregnancy|0|||
33263861|NCT00943917|100866806|FG009|Stage II|Pregnancy|0|||
33263862|NCT00943917|100866807|FG010|Stage II|Pregnancy|0|||
33263863|NCT00943917|100866808|FG011|Stage II|Pregnancy|0|||
33263864|NCT00943917|100866809|FG012|Stage II|Pregnancy|0|||
33263865|NCT00943917|100866810|FG013|Stage II|Pregnancy|0|||
33177380|NCT03564145|100556315|FG000|Overall Study|Lost to Follow-up|21|||
33177381|NCT03564145|100556315|FG000|Overall Study|Protocol Violation|2|||
33177382|NCT03564145|100556315|FG000|Overall Study|Withdrawal by Subject|48|||
33177383|NCT03564145|100556315|FG000|Overall Study|Study Terminated by Sponsor|146|||
33263866|NCT00943917|100866811|FG014|Stage II|Pregnancy|0|||
33177384|NCT03564145|100556315|FG000|Overall Study|Physician Decision|1|||
33177385|NCT03564145|100556315|FG000|Overall Study|Other Than Specified|1|||
33177386|NCT03564145|100556315|FG000|Overall Study|Pregnancy|1|||
33263867|NCT00943917|100866797|FG000|Stage II Continuation|Adverse Event|0|||
33263868|NCT00943917|100866798|FG001|Stage II Continuation|Adverse Event|0|||
33263869|NCT00943917|100866799|FG002|Stage II Continuation|Adverse Event|0|||
33263870|NCT00943917|100866800|FG003|Stage II Continuation|Adverse Event|0|||
33263871|NCT00943917|100866801|FG004|Stage II Continuation|Adverse Event|0|||
33465183|NCT00988208|101593508|FG001|Overall Study|Disease Progression|89|||
33465184|NCT00988208|101593507|FG000|Overall Study|Withdrawal by Subject|50|||
33465185|NCT00988208|101593508|FG001|Overall Study|Withdrawal by Subject|57|||
33465186|NCT00988208|101593507|FG000|Overall Study|Death|9|||
33465187|NCT00988208|101593508|FG001|Overall Study|Death|15|||
33177387|NCT01413191|100556316|FG000|Overall Study|Lost to Follow-up|5|||
33263872|NCT00943917|100866802|FG005|Stage II Continuation|Adverse Event|0|||
33263873|NCT00943917|100866803|FG006|Stage II Continuation|Adverse Event|0|||
33465188|NCT00988208|101593507|FG000|Overall Study|Lost to Follow-up|2|||
33465189|NCT00988208|101593508|FG001|Overall Study|Lost to Follow-up|3|||
33465190|NCT00988208|101593507|FG000|Overall Study|Protocol Violation|9|||
33263874|NCT00943917|100866804|FG007|Stage II Continuation|Adverse Event|0|||
33263875|NCT00943917|100866805|FG008|Stage II Continuation|Adverse Event|0|||
33263876|NCT00943917|100866806|FG009|Stage II Continuation|Adverse Event|0|||
33263877|NCT00943917|100866807|FG010|Stage II Continuation|Adverse Event|0|||
33263878|NCT00943917|100866808|FG011|Stage II Continuation|Adverse Event|1|||
33263879|NCT00943917|100866809|FG012|Stage II Continuation|Adverse Event|2|||
33263880|NCT00943917|100866810|FG013|Stage II Continuation|Adverse Event|1|||
33465191|NCT00988208|101593508|FG001|Overall Study|Protocol Violation|2|||
33465192|NCT00988208|101593507|FG000|Overall Study|Sponsor Decision|102|||
33465193|NCT00988208|101593508|FG001|Overall Study|Sponsor Decision|78|||
33465194|NCT00988208|101593507|FG000|Overall Study|Clinical Progression|17|||
33465195|NCT00988208|101593508|FG001|Overall Study|Clinical Progression|16|||
33465196|NCT00988208|101593507|FG000|Overall Study|Biochemical Progression|21|||
33465197|NCT00988208|101593508|FG001|Overall Study|Biochemical Progression|7|||
33465198|NCT00988208|101593507|FG000|Overall Study|Clinical Deterioration|7|||
33465199|NCT00988208|101593508|FG001|Overall Study|Clinical Deterioration|14|||
33465200|NCT00988208|101593507|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
33465201|NCT00988208|101593508|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
33465202|NCT00988208|101593507|FG000|Overall Study|Other|8|||
33465203|NCT00988208|101593508|FG001|Overall Study|Other|3|||
33465204|NCT01220609|101593510|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
33465205|NCT01220609|101593510|FG000|Overall Study|Ineligible- Wrong cell type|1|||
33465206|NCT01220609|101593510|FG000|Overall Study|Ineligible-Never treated|1|||
33465207|NCT02674386|101593517|FG000|Overall Study|Lost to Follow-up|0|||
33465208|NCT02674386|101593518|FG001|Overall Study|Lost to Follow-up|1|||
33465209|NCT02674386|101593519|FG002|Overall Study|Lost to Follow-up|1|||
33465210|NCT02674386|101593517|FG000|Overall Study|Withdrawal by Subject|0|||
33465211|NCT02674386|101593518|FG001|Overall Study|Withdrawal by Subject|4|||
33465212|NCT02674386|101593519|FG002|Overall Study|Withdrawal by Subject|0|||
33263881|NCT00943917|100866811|FG014|Stage II Continuation|Adverse Event|1|||
33263882|NCT00943917|100866797|FG000|Stage II Continuation|Withdrawal by Subject|0|||
33465213|NCT02674386|101593517|FG000|Overall Study|Other|0|||
33465214|NCT02674386|101593518|FG001|Overall Study|Other|1|||
33465215|NCT02674386|101593519|FG002|Overall Study|Other|0|||
33465216|NCT02674386|101593517|FG000|Overall Study|Enrolled but not evaluated|0|||
33465217|NCT02674386|101593518|FG001|Overall Study|Enrolled but not evaluated|4|||
33465218|NCT02674386|101593519|FG002|Overall Study|Enrolled but not evaluated|0|||
33465219|NCT01230892|101593520|FG000|Overall Study|Withdrawal by Subject|1|||
33465220|NCT01230892|101593521|FG001|Overall Study|Withdrawal by Subject|1|||
33465221|NCT01230892|101593520|FG000|Overall Study|Lost to Follow-up|2|||
33465222|NCT01230892|101593521|FG001|Overall Study|Lost to Follow-up|0|||
33465223|NCT00605917|101593524|FG000|Overall Study|Protocol Violation|79|||
33465224|NCT02990806|101593525|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
33465225|NCT02990806|101593526|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
33465226|NCT02990806|101593527|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
33465227|NCT02990806|101593528|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
33177388|NCT01413191|100556316|FG000|Overall Study|Disease Progression|5|||
33177389|NCT01413191|100556316|FG000|Overall Study|Death|1|||
33177390|NCT02551731|100556317|FG000|Overall Study|Withdrawal by Subject|2|||
33177391|NCT00708643|100556320|FG000|Overall Study|Adverse Event|0|||
33177392|NCT00708643|100556321|FG001|Overall Study|Adverse Event|1|||
33177393|NCT03414424|100556322|FG000|Overall Study|Screened out after consent|0|||
33177394|NCT03414424|100556323|FG001|Overall Study|Screened out after consent|2|||
33177395|NCT03414424|100556322|FG000|Overall Study|Lost to Follow-up|0|||
33177396|NCT03414424|100556323|FG001|Overall Study|Lost to Follow-up|1|||
33177397|NCT02393547|100556327|FG000|Overall Study|Adverse Event|2|||
33177398|NCT02393547|100556327|FG000|Overall Study|Withdrawal by Subject|3|||
33177399|NCT02393547|100556327|FG000|Overall Study|Lost to Follow-up|1|||
33177400|NCT02221284|100556330|FG000|Overall Study|Case Report Forms Uncollected|56|||
33177401|NCT02221284|100556330|FG000|Overall Study|Protocol Deviation|5|||
33177402|NCT04461015|100556332|FG000|Overall Study|IV access lost during the study|0|||
33177403|NCT04461015|100556333|FG001|Overall Study|IV access lost during the study|1|||
33177404|NCT04461015|100556332|FG000|Overall Study|Withdrawal by Subject|0|||
33177405|NCT04461015|100556333|FG001|Overall Study|Withdrawal by Subject|1|||
33177406|NCT00723892|100556334|FG000|Overall Study|Participant not tracked|33|||
33263883|NCT00943917|100866798|FG001|Stage II Continuation|Withdrawal by Subject|0|||
33263884|NCT00943917|100866799|FG002|Stage II Continuation|Withdrawal by Subject|0|||
33263885|NCT00943917|100866800|FG003|Stage II Continuation|Withdrawal by Subject|0|||
33263886|NCT00943917|100866801|FG004|Stage II Continuation|Withdrawal by Subject|0|||
33263887|NCT00943917|100866802|FG005|Stage II Continuation|Withdrawal by Subject|0|||
33263888|NCT00943917|100866803|FG006|Stage II Continuation|Withdrawal by Subject|0|||
33263889|NCT00943917|100866804|FG007|Stage II Continuation|Withdrawal by Subject|0|||
33263890|NCT00943917|100866805|FG008|Stage II Continuation|Withdrawal by Subject|0|||
33263891|NCT00943917|100866806|FG009|Stage II Continuation|Withdrawal by Subject|0|||
33263892|NCT00943917|100866807|FG010|Stage II Continuation|Withdrawal by Subject|0|||
33263893|NCT00943917|100866808|FG011|Stage II Continuation|Withdrawal by Subject|0|||
33263894|NCT00943917|100866809|FG012|Stage II Continuation|Withdrawal by Subject|0|||
33263895|NCT00943917|100866810|FG013|Stage II Continuation|Withdrawal by Subject|1|||
33263896|NCT00943917|100866811|FG014|Stage II Continuation|Withdrawal by Subject|3|||
33263897|NCT00943917|100866797|FG000|Stage II Continuation|Protocol Violation|0|||
33465228|NCT02990806|101593525|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
33465229|NCT02990806|101593526|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
33177407|NCT00723892|100556335|FG001|Overall Study|Participant not tracked|35|||
33177408|NCT00723892|100556334|FG000|Overall Study|Virological criterion|24|||
33177409|NCT00723892|100556335|FG001|Overall Study|Virological criterion|9|||
33177410|NCT00723892|100556334|FG000|Overall Study|Withdrawal by Subject|6|||
33177411|NCT00723892|100556335|FG001|Overall Study|Withdrawal by Subject|9|||
33177412|NCT00723892|100556334|FG000|Overall Study|End planned|11|||
33177413|NCT00723892|100556335|FG001|Overall Study|End planned|7|||
33177414|NCT00723892|100556334|FG000|Overall Study|Bad tolerance|5|||
33177415|NCT00723892|100556335|FG001|Overall Study|Bad tolerance|5|||
33177416|NCT00723892|100556334|FG000|Overall Study|Multiple reasons|17|||
33177417|NCT00723892|100556335|FG001|Overall Study|Multiple reasons|12|||
33177418|NCT00723892|100556334|FG000|Overall Study|Other|6|||
33177419|NCT00723892|100556335|FG001|Overall Study|Other|3|||
33177420|NCT00723892|100556334|FG000|Overall Study|Study end|1|||
33177421|NCT00723892|100556335|FG001|Overall Study|Study end|3|||
33177422|NCT00723892|100556334|FG000|Overall Study|Weight loss|1|||
33177423|NCT00723892|100556335|FG001|Overall Study|Weight loss|3|||
33177424|NCT00723892|100556334|FG000|Overall Study|Alcohol abuse|0|||
33177425|NCT00723892|100556335|FG001|Overall Study|Alcohol abuse|1|||
33177426|NCT00723892|100556334|FG000|Overall Study|Intercurrent infection|2|||
33177427|NCT00723892|100556335|FG001|Overall Study|Intercurrent infection|0|||
33177428|NCT00723892|100556334|FG000|Overall Study|Drug addiction|1|||
33177429|NCT00723892|100556335|FG001|Overall Study|Drug addiction|0|||
33177430|NCT01166763|100556336|FG000|Overall Study|Withdrawal by Subject|3|||
33177431|NCT03473808|100556339|FG000|Overall Study|Withdrawal by Subject|1|||
33263898|NCT00943917|100866798|FG001|Stage II Continuation|Protocol Violation|0|||
33177432|NCT00356369|100556342|FG000|Active Phase|Withdrawal by Subject|2|||
33177433|NCT00356369|100556343|FG001|Active Phase|Withdrawal by Subject|1|||
33177434|NCT02457910|100556346|FG000|Overall Study|Withdrawal by Subject|0|||
33177435|NCT02457910|100556347|FG001|Overall Study|Withdrawal by Subject|0|||
33177436|NCT02457910|100556348|FG002|Overall Study|Withdrawal by Subject|0|||
33177437|NCT02457910|100556349|FG003|Overall Study|Withdrawal by Subject|0|||
33177438|NCT02457910|100556350|FG004|Overall Study|Withdrawal by Subject|0|||
33177439|NCT02457910|100556351|FG005|Overall Study|Withdrawal by Subject|1|||
33177440|NCT02457910|100556346|FG000|Overall Study|Adverse Event|0|||
33177441|NCT02457910|100556347|FG001|Overall Study|Adverse Event|2|||
33263899|NCT00943917|100866799|FG002|Stage II Continuation|Protocol Violation|0|||
33263900|NCT00943917|100866800|FG003|Stage II Continuation|Protocol Violation|0|||
33177442|NCT02457910|100556348|FG002|Overall Study|Adverse Event|1|||
33177443|NCT02457910|100556349|FG003|Overall Study|Adverse Event|1|||
33177444|NCT02457910|100556350|FG004|Overall Study|Adverse Event|1|||
33177445|NCT02457910|100556351|FG005|Overall Study|Adverse Event|3|||
33177446|NCT02457910|100556346|FG000|Overall Study|Disease progression|3|||
33177447|NCT02457910|100556347|FG001|Overall Study|Disease progression|3|||
33177448|NCT02457910|100556348|FG002|Overall Study|Disease progression|1|||
33177449|NCT02457910|100556349|FG003|Overall Study|Disease progression|1|||
33177450|NCT02457910|100556350|FG004|Overall Study|Disease progression|4|||
33177451|NCT02457910|100556351|FG005|Overall Study|Disease progression|6|||
33177452|NCT02457910|100556346|FG000|Overall Study|Other complicating illness|0|||
33177453|NCT02457910|100556347|FG001|Overall Study|Other complicating illness|0|||
33177454|NCT02457910|100556348|FG002|Overall Study|Other complicating illness|0|||
33177455|NCT02457910|100556349|FG003|Overall Study|Other complicating illness|0|||
33465230|NCT02990806|101593527|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
33465231|NCT02990806|101593528|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
33465232|NCT02990806|101593525|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
33465233|NCT02990806|101593526|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
33465234|NCT02990806|101593527|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
33465235|NCT02990806|101593528|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
33465236|NCT02990806|101593525|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
33465237|NCT02990806|101593526|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
33465238|NCT02990806|101593527|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
33465239|NCT02990806|101593528|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
33465240|NCT02990806|101593525|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
33465241|NCT02990806|101593526|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
33465242|NCT02990806|101593527|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
33465243|NCT02990806|101593528|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
33465244|NCT02990806|101593525|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
33465245|NCT02990806|101593526|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
33465246|NCT02990806|101593527|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
33465247|NCT02990806|101593528|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
33465248|NCT02990806|101593525|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
33465249|NCT02990806|101593526|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
33465250|NCT02990806|101593527|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
33465251|NCT02990806|101593528|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
33465252|NCT02990806|101593525|FG000|Stage 1 (22 Weeks)|Death|0|||
33465253|NCT02990806|101593526|FG001|Stage 1 (22 Weeks)|Death|1|||
33465254|NCT02990806|101593527|FG002|Stage 1 (22 Weeks)|Death|0|||
33465255|NCT02990806|101593528|FG003|Stage 1 (22 Weeks)|Death|0|||
33465256|NCT02990806|101593525|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
33465257|NCT02990806|101593526|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
33465258|NCT02990806|101593527|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
33465259|NCT02990806|101593528|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
33465260|NCT02990806|101593525|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
33465261|NCT02990806|101593526|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
33465262|NCT02990806|101593527|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
33465263|NCT02990806|101593528|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
33465264|NCT02990806|101593525|FG000|Stage 1 (22 Weeks)|Other|1|||
33465265|NCT02990806|101593526|FG001|Stage 1 (22 Weeks)|Other|3|||
33177456|NCT02457910|100556350|FG004|Overall Study|Other complicating illness|0|||
33465266|NCT02990806|101593527|FG002|Stage 1 (22 Weeks)|Other|0|||
33465267|NCT02990806|101593528|FG003|Stage 1 (22 Weeks)|Other|0|||
33465268|NCT02990806|101593525|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
33465269|NCT02990806|101593526|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
33465270|NCT02990806|101593527|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
33465271|NCT02990806|101593528|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
33465272|NCT02990806|101593525|FG000|Stage 2 (32 Weeks)|Death|1|||
33177457|NCT02457910|100556351|FG005|Overall Study|Other complicating illness|1|||
33177458|NCT02457910|100556346|FG000|Overall Study|Death|0|||
33177459|NCT02457910|100556347|FG001|Overall Study|Death|0|||
33177460|NCT02457910|100556348|FG002|Overall Study|Death|1|||
33177461|NCT02457910|100556349|FG003|Overall Study|Death|0|||
33465273|NCT02990806|101593526|FG001|Stage 2 (32 Weeks)|Death|0|||
33465274|NCT02990806|101593527|FG002|Stage 2 (32 Weeks)|Death|0|||
33465275|NCT02990806|101593528|FG003|Stage 2 (32 Weeks)|Death|0|||
33465276|NCT02990806|101593525|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
33465277|NCT02990806|101593526|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
33465278|NCT02990806|101593527|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
33465279|NCT02990806|101593528|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
33465280|NCT02990806|101593525|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
33465281|NCT02990806|101593526|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
33465282|NCT02990806|101593527|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
33465283|NCT02990806|101593528|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
33465284|NCT02990806|101593525|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
33465285|NCT02990806|101593526|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
33465286|NCT02990806|101593527|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
33465287|NCT02990806|101593528|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
33177462|NCT02457910|100556350|FG004|Overall Study|Death|0|||
33177463|NCT02457910|100556351|FG005|Overall Study|Death|0|||
33177464|NCT03341533|100556352|FG000|Overall Study|Withdrawal by Subject|1|||
33177465|NCT03341533|100556353|FG001|Overall Study|Withdrawal by Subject|1|||
33177466|NCT03341533|100556352|FG000|Overall Study|Not eligible after randomization|2|||
33177467|NCT03341533|100556353|FG001|Overall Study|Not eligible after randomization|1|||
33177468|NCT00514540|100556358|FG000|First-Line Chemo|Withdrawal by Subject|1|||
33177469|NCT00514540|100556358|FG000|First-Line Chemo|Protocol Violation|7|||
33177470|NCT00514540|100556358|FG000|Second-Line|Physician/Patient Decision|31|||
33177471|NCT00665847|100556359|FG000|Overall Study|Adverse Event|8|||
33177472|NCT00665847|100556359|FG000|Overall Study|Withdrawal by Subject|2|||
33177473|NCT00665847|100556359|FG000|Overall Study|Subject non-compliant|8|||
33177474|NCT00665847|100556359|FG000|Overall Study|Subject reached a virologic endpoint|4|||
33177475|NCT00665847|100556359|FG000|Overall Study|Resistance to TMC125|1|||
33263901|NCT00943917|100866801|FG004|Stage II Continuation|Protocol Violation|0|||
33263902|NCT00943917|100866802|FG005|Stage II Continuation|Protocol Violation|0|||
33263903|NCT00943917|100866803|FG006|Stage II Continuation|Protocol Violation|0|||
33263904|NCT00943917|100866804|FG007|Stage II Continuation|Protocol Violation|0|||
33263905|NCT00943917|100866805|FG008|Stage II Continuation|Protocol Violation|0|||
33263906|NCT00943917|100866806|FG009|Stage II Continuation|Protocol Violation|1|||
33263907|NCT00943917|100866807|FG010|Stage II Continuation|Protocol Violation|0|||
33263908|NCT00943917|100866808|FG011|Stage II Continuation|Protocol Violation|1|||
33263909|NCT00943917|100866809|FG012|Stage II Continuation|Protocol Violation|0|||
33263910|NCT00943917|100866810|FG013|Stage II Continuation|Protocol Violation|0|||
33263911|NCT00943917|100866811|FG014|Stage II Continuation|Protocol Violation|0|||
33263912|NCT00943917|100866797|FG000|Stage II Continuation|hypoglycemia|0|||
33263913|NCT00943917|100866798|FG001|Stage II Continuation|hypoglycemia|0|||
33263914|NCT00943917|100866799|FG002|Stage II Continuation|hypoglycemia|0|||
33263915|NCT00943917|100866800|FG003|Stage II Continuation|hypoglycemia|0|||
33263916|NCT00943917|100866801|FG004|Stage II Continuation|hypoglycemia|0|||
33263917|NCT00943917|100866802|FG005|Stage II Continuation|hypoglycemia|0|||
33263918|NCT00943917|100866803|FG006|Stage II Continuation|hypoglycemia|0|||
33263919|NCT00943917|100866804|FG007|Stage II Continuation|hypoglycemia|0|||
33263920|NCT00943917|100866805|FG008|Stage II Continuation|hypoglycemia|0|||
33263921|NCT00943917|100866806|FG009|Stage II Continuation|hypoglycemia|0|||
33263922|NCT00943917|100866807|FG010|Stage II Continuation|hypoglycemia|0|||
33465288|NCT02990806|101593525|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
33465289|NCT02990806|101593526|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
33465290|NCT02990806|101593527|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
33465291|NCT02990806|101593528|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
33177476|NCT00665847|100556359|FG000|Overall Study|Subject ineligible to continue the trial|1|||
33177477|NCT00665847|100556359|FG000|Overall Study|Switch to Commercial Medication|1|||
33177478|NCT00744627|100560207|FG000|Overall Study|Adverse Event|6|||
33177479|NCT00744627|100560208|FG001|Overall Study|Adverse Event|9|||
33177480|NCT00744627|100560207|FG000|Overall Study|Lack of Efficacy|7|||
33177481|NCT00744627|100560208|FG001|Overall Study|Lack of Efficacy|3|||
33177482|NCT00744627|100560207|FG000|Overall Study|Noncompliance|0|||
33177483|NCT00744627|100560208|FG001|Overall Study|Noncompliance|1|||
33177484|NCT00744627|100560207|FG000|Overall Study|Protocol Deviations|0|||
33177485|NCT00744627|100560208|FG001|Overall Study|Protocol Deviations|2|||
33263923|NCT00943917|100866808|FG011|Stage II Continuation|hypoglycemia|0|||
33263924|NCT00943917|100866809|FG012|Stage II Continuation|hypoglycemia|1|||
33263925|NCT00943917|100866810|FG013|Stage II Continuation|hypoglycemia|0|||
33263926|NCT00943917|100866811|FG014|Stage II Continuation|hypoglycemia|0|||
33263927|NCT00943917|100866797|FG000|Stage II Continuation|A1C elevation|0|||
33177486|NCT00744627|100560207|FG000|Overall Study|Voluntary Withdrawal|9|||
33177487|NCT00744627|100560208|FG001|Overall Study|Voluntary Withdrawal|6|||
33263928|NCT00943917|100866798|FG001|Stage II Continuation|A1C elevation|0|||
33465292|NCT02990806|101593525|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
33465293|NCT02990806|101593526|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
33465294|NCT02990806|101593527|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
33465295|NCT02990806|101593528|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
33465296|NCT02990806|101593525|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
33465297|NCT02990806|101593526|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
33465298|NCT02990806|101593527|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
33465299|NCT02990806|101593528|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
33465300|NCT02990806|101593525|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
33465301|NCT02990806|101593526|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
33465302|NCT02990806|101593527|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
33465303|NCT02990806|101593528|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
33465304|NCT02990806|101593525|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
33465305|NCT02990806|101593526|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
33465306|NCT02990806|101593527|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
33465307|NCT02990806|101593528|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
33465308|NCT02990806|101593525|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
33465309|NCT02990806|101593526|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
33465310|NCT02990806|101593527|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
33465311|NCT02990806|101593528|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
33465312|NCT02990806|101593525|FG000|Stage 2 (32 Weeks)|Other|3|||
33465313|NCT02990806|101593526|FG001|Stage 2 (32 Weeks)|Other|0|||
33465314|NCT02990806|101593527|FG002|Stage 2 (32 Weeks)|Other|4|||
33465315|NCT02990806|101593528|FG003|Stage 2 (32 Weeks)|Other|1|||
33465316|NCT02990806|101593525|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
33465317|NCT02990806|101593526|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
33465318|NCT02990806|101593527|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
33465319|NCT02990806|101593528|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
33465320|NCT02990806|101593525|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
33465321|NCT02990806|101593526|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
33465322|NCT02990806|101593527|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
33465323|NCT02990806|101593528|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
33465324|NCT02990806|101593525|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
33465325|NCT02990806|101593526|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
33465326|NCT02990806|101593527|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
33465327|NCT02990806|101593528|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
33465328|NCT02990806|101593525|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
33465329|NCT02990806|101593526|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
33465330|NCT02990806|101593527|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
33465331|NCT02990806|101593528|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
33465332|NCT02990806|101593525|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
33465333|NCT02990806|101593526|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
33465334|NCT02990806|101593527|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
33465335|NCT02990806|101593528|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
33465336|NCT02990806|101593525|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
33465337|NCT02990806|101593526|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
33465338|NCT02990806|101593527|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
33465339|NCT02990806|101593528|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
33177488|NCT00744627|100560207|FG000|Overall Study|Lost to Follow-up|2|||
33177489|NCT00744627|100560208|FG001|Overall Study|Lost to Follow-up|1|||
33177490|NCT00744627|100560207|FG000|Overall Study|Other|1|||
33177491|NCT00744627|100560208|FG001|Overall Study|Other|0|||
33177492|NCT00156533|100560210|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
33177493|NCT00156533|100560211|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
33177494|NCT00156533|100560212|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
33177495|NCT00156533|100560213|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
33177496|NCT00156533|100560210|FG000|Overall Study|Withdrawal by Subject|1|||
33177497|NCT00156533|100560211|FG001|Overall Study|Withdrawal by Subject|0|||
33177498|NCT00156533|100560212|FG002|Overall Study|Withdrawal by Subject|0|||
33177499|NCT00156533|100560213|FG003|Overall Study|Withdrawal by Subject|1|||
33177500|NCT00156533|100560210|FG000|Overall Study|Failed Screening|1|||
33177501|NCT00156533|100560211|FG001|Overall Study|Failed Screening|0|||
33177502|NCT00156533|100560212|FG002|Overall Study|Failed Screening|1|||
33177503|NCT00156533|100560213|FG003|Overall Study|Failed Screening|1|||
33177504|NCT01525550|100560214|FG000|Overall Study|Lost to Follow-up|8|||
33177505|NCT01525550|100560215|FG001|Overall Study|Lost to Follow-up|2|||
33177506|NCT01525550|100560214|FG000|Overall Study|Death|19|||
33263929|NCT00943917|100866799|FG002|Stage II Continuation|A1C elevation|0|||
33465340|NCT02990806|101593525|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
33465341|NCT02990806|101593526|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
33465342|NCT02990806|101593527|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
33465343|NCT02990806|101593528|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
33465344|NCT02990806|101593525|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
33465345|NCT02990806|101593526|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
33465346|NCT02990806|101593527|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
33465347|NCT02990806|101593528|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
33465348|NCT02990806|101593525|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
33465349|NCT02990806|101593526|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
33465350|NCT02990806|101593527|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
33465351|NCT02990806|101593528|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
33465352|NCT00108082|101593537|FG000|Overall Study|Adverse Event|14|||
33465353|NCT00108082|101593538|FG001|Overall Study|Adverse Event|12|||
33465354|NCT00108082|101593539|FG002|Overall Study|Adverse Event|17|||
33465355|NCT00108082|101593537|FG000|Overall Study|Lost to Follow-up|6|||
33465356|NCT00108082|101593538|FG001|Overall Study|Lost to Follow-up|3|||
33465357|NCT00108082|101593539|FG002|Overall Study|Lost to Follow-up|7|||
33465358|NCT00108082|101593537|FG000|Overall Study|Consent Withdrawn|3|||
33465359|NCT00108082|101593538|FG001|Overall Study|Consent Withdrawn|3|||
33465360|NCT00108082|101593539|FG002|Overall Study|Consent Withdrawn|5|||
33465361|NCT00108082|101593537|FG000|Overall Study|Protocol Violation|1|||
33465362|NCT00108082|101593538|FG001|Overall Study|Protocol Violation|2|||
33465363|NCT00108082|101593539|FG002|Overall Study|Protocol Violation|0|||
33465364|NCT00108082|101593537|FG000|Overall Study|Lack of Efficacy|3|||
33465365|NCT00108082|101593538|FG001|Overall Study|Lack of Efficacy|1|||
33465366|NCT00108082|101593539|FG002|Overall Study|Lack of Efficacy|2|||
33465367|NCT00108082|101593537|FG000|Overall Study|Amendment 4: > Month 12|5|||
33465368|NCT00108082|101593538|FG001|Overall Study|Amendment 4: > Month 12|7|||
33465369|NCT00108082|101593539|FG002|Overall Study|Amendment 4: > Month 12|5|||
33465370|NCT00108082|101593537|FG000|Overall Study|Woman of Child-bearing Potential|2|||
33465371|NCT00108082|101593538|FG001|Overall Study|Woman of Child-bearing Potential|0|||
33465372|NCT00108082|101593539|FG002|Overall Study|Woman of Child-bearing Potential|2|||
33465373|NCT00108082|101593537|FG000|Overall Study|Incorrectly Randomized|0|||
33465374|NCT00108082|101593538|FG001|Overall Study|Incorrectly Randomized|0|||
33465375|NCT00108082|101593539|FG002|Overall Study|Incorrectly Randomized|2|||
33465376|NCT00108082|101593537|FG000|Overall Study|Non-compliance|1|||
33465377|NCT00108082|101593538|FG001|Overall Study|Non-compliance|0|||
33465378|NCT00108082|101593539|FG002|Overall Study|Non-compliance|2|||
33465379|NCT00108082|101593537|FG000|Overall Study|Stopped Study Medication|0|||
33465380|NCT00108082|101593538|FG001|Overall Study|Stopped Study Medication|0|||
33465381|NCT00108082|101593539|FG002|Overall Study|Stopped Study Medication|1|||
33465382|NCT00108082|101593537|FG000|Overall Study|Site Closed Study|0|||
33465383|NCT00108082|101593538|FG001|Overall Study|Site Closed Study|2|||
33465384|NCT00108082|101593539|FG002|Overall Study|Site Closed Study|0|||
33465385|NCT00108082|101593537|FG000|Overall Study|Protocol Amendment|0|||
33465386|NCT00108082|101593538|FG001|Overall Study|Protocol Amendment|1|||
33465387|NCT00108082|101593539|FG002|Overall Study|Protocol Amendment|0|||
33465388|NCT00108082|101593537|FG000|Overall Study|Study Medication Not Tapered|0|||
33465389|NCT00108082|101593538|FG001|Overall Study|Study Medication Not Tapered|1|||
33465390|NCT00108082|101593539|FG002|Overall Study|Study Medication Not Tapered|0|||
33177507|NCT01525550|100560215|FG001|Overall Study|Death|28|||
33177508|NCT01525550|100560214|FG000|Overall Study|Other|0|||
33465391|NCT00108082|101593537|FG000|Overall Study|Subject Left Site Location|1|||
33465392|NCT00108082|101593538|FG001|Overall Study|Subject Left Site Location|0|||
33465393|NCT00108082|101593539|FG002|Overall Study|Subject Left Site Location|0|||
33465394|NCT00108082|101593537|FG000|Overall Study|Investigator Not at Site|1|||
33465395|NCT00108082|101593538|FG001|Overall Study|Investigator Not at Site|0|||
33465396|NCT00108082|101593539|FG002|Overall Study|Investigator Not at Site|0|||
33465397|NCT00108082|101593537|FG000|Overall Study|Blood Pressure Not Controlled|1|||
33465398|NCT00108082|101593538|FG001|Overall Study|Blood Pressure Not Controlled|0|||
33177509|NCT01525550|100560215|FG001|Overall Study|Other|4|||
33177510|NCT01525550|100560214|FG000|Overall Study|Sponsor's Decision|30|||
33177511|NCT01525550|100560215|FG001|Overall Study|Sponsor's Decision|11|||
33177512|NCT01525550|100560214|FG000|Overall Study|Withdrawal by Subject|4|||
33177513|NCT01525550|100560215|FG001|Overall Study|Withdrawal by Subject|0|||
33465399|NCT00108082|101593539|FG002|Overall Study|Blood Pressure Not Controlled|0|||
33177514|NCT04351087|100560220|FG000|Overall Study|Lost to Follow-up|7|||
33177515|NCT04351087|100560221|FG001|Overall Study|Lost to Follow-up|3|||
33177516|NCT04351087|100560220|FG000|Overall Study|Withdrawal by Subject|3|||
33465400|NCT01832402|101593540|FG000|Overall Study|Lost to Follow-up|2|||
33465401|NCT01832402|101593541|FG001|Overall Study|Lost to Follow-up|0|||
33465402|NCT01832402|101593540|FG000|Overall Study|Withdrawal by Subject|3|||
33465403|NCT01832402|101593541|FG001|Overall Study|Withdrawal by Subject|3|||
33465404|NCT01832402|101593540|FG000|Overall Study|Declining Performance status|2|||
33465405|NCT01832402|101593541|FG001|Overall Study|Declining Performance status|1|||
33465406|NCT04241133|101593544|FG000|Overall Study|COVID19 Precautions|14|||
33465407|NCT04241133|101593545|FG001|Overall Study|COVID19 Precautions|34|||
33465408|NCT02994394|101593546|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
33465409|NCT02994394|101593547|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
33465410|NCT02994394|101593548|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
33465411|NCT02994394|101593549|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
33465412|NCT02994394|101593550|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
33465413|NCT02994394|101593551|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
33465414|NCT02994394|101593546|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
33465415|NCT02994394|101593547|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
33465416|NCT02994394|101593548|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
33465417|NCT02994394|101593549|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
33465418|NCT02994394|101593550|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
33465419|NCT02994394|101593551|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
33465420|NCT02744755|101593552|FG000|Study Period 1|Protocol Violation|2|||
33465421|NCT02744755|101593553|FG001|Study Period 1|Protocol Violation|1|||
33465422|NCT02744755|101593552|FG000|Study Period 1|not defined|0|||
33177517|NCT04351087|100560221|FG001|Overall Study|Withdrawal by Subject|4|||
33177518|NCT04351087|100560220|FG000|Overall Study|Lack of Efficacy|3|||
33177519|NCT04351087|100560221|FG001|Overall Study|Lack of Efficacy|2|||
33177520|NCT01909479|100560226|FG000|From Baseline to Week 26|Adverse Event|3|||
33177521|NCT01909479|100560227|FG001|From Baseline to Week 26|Adverse Event|2|||
33177522|NCT01909479|100560226|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
33177523|NCT01909479|100560227|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
33177524|NCT01909479|100560226|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
33177525|NCT01909479|100560227|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
33177526|NCT01909479|100560226|FG000|26 - 52 Weeks|Adverse Event|0|||
33177527|NCT01909479|100560227|FG001|26 - 52 Weeks|Adverse Event|1|||
33177528|NCT01909479|100560226|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
33177529|NCT01909479|100560227|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
33177530|NCT01909479|100560226|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
33177531|NCT01909479|100560227|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
33177532|NCT01909479|100560226|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
33177533|NCT01909479|100560227|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
33177534|NCT01909479|100560226|FG000|52 Weeks to End of Study|Adverse Event|2|||
33177535|NCT01909479|100560227|FG001|52 Weeks to End of Study|Adverse Event|1|||
33177536|NCT01909479|100560226|FG000|52 Weeks to End of Study|Death|0|||
33177537|NCT01909479|100560227|FG001|52 Weeks to End of Study|Death|1|||
33177538|NCT01909479|100560226|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
33177539|NCT01909479|100560227|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
33263930|NCT00943917|100866800|FG003|Stage II Continuation|A1C elevation|0|||
33263931|NCT00943917|100866801|FG004|Stage II Continuation|A1C elevation|0|||
33263932|NCT00943917|100866802|FG005|Stage II Continuation|A1C elevation|0|||
33263933|NCT00943917|100866803|FG006|Stage II Continuation|A1C elevation|0|||
33263934|NCT00943917|100866804|FG007|Stage II Continuation|A1C elevation|0|||
33263935|NCT00943917|100866805|FG008|Stage II Continuation|A1C elevation|0|||
33263936|NCT00943917|100866806|FG009|Stage II Continuation|A1C elevation|0|||
33263937|NCT00943917|100866807|FG010|Stage II Continuation|A1C elevation|0|||
33263938|NCT00943917|100866808|FG011|Stage II Continuation|A1C elevation|0|||
33263939|NCT00943917|100866809|FG012|Stage II Continuation|A1C elevation|0|||
33263940|NCT00943917|100866810|FG013|Stage II Continuation|A1C elevation|1|||
33263941|NCT00943917|100866811|FG014|Stage II Continuation|A1C elevation|0|||
33263942|NCT03500549|100866812|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
33263943|NCT03500549|100866813|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
33263944|NCT03500549|100866812|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
33263945|NCT03500549|100866813|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
33263946|NCT01177670|100866814|FG000|Overall Study|Study Terminated|115|||
33263947|NCT01177670|100866814|FG000|Overall Study|Physician Decision|50|||
33465423|NCT02744755|101593553|FG001|Study Period 1|not defined|1|||
33465424|NCT02744755|101593552|FG000|Study Period 1|Pregnancy|1|||
33465425|NCT02744755|101593553|FG001|Study Period 1|Pregnancy|0|||
33465426|NCT02744755|101593552|FG000|Study Period 1|Adverse Event|1|||
33177540|NCT01909479|100560226|FG000|52 Weeks to End of Study|Protocol Violation|1|||
33465427|NCT02744755|101593553|FG001|Study Period 1|Adverse Event|1|||
33465428|NCT02744755|101593552|FG000|Study Period 1|Lost to Follow-up|1|||
33465429|NCT02744755|101593553|FG001|Study Period 1|Lost to Follow-up|1|||
33177541|NCT01909479|100560227|FG001|52 Weeks to End of Study|Protocol Violation|0|||
33177542|NCT01909479|100560226|FG000|52 Weeks to End of Study|Progressive disease|1|||
33263948|NCT01177670|100866814|FG000|Overall Study|Withdrawal by Subject|4|||
33263949|NCT01736475|100866815|FG000|Overall Study|Adverse Event|4|||
33465430|NCT02744755|101593552|FG000|Study Period 1|Lack of Efficacy|1|||
33465431|NCT02744755|101593553|FG001|Study Period 1|Lack of Efficacy|0|||
33465432|NCT02744755|101593552|FG000|Study Period 1|Withdrawal by Subject|8|||
33465433|NCT02744755|101593553|FG001|Study Period 1|Withdrawal by Subject|4|||
33465434|NCT02744755|101593552|FG000|Study Period 2|Adverse Event|5|||
33177543|NCT01909479|100560227|FG001|52 Weeks to End of Study|Progressive disease|1|||
33263950|NCT01736475|100866816|FG001|Overall Study|Adverse Event|0|||
33465435|NCT02744755|101593553|FG001|Study Period 2|Adverse Event|0|||
33177544|NCT01909479|100560226|FG000|52 Weeks to End of Study|Personal reasons|2|||
33177545|NCT01909479|100560227|FG001|52 Weeks to End of Study|Personal reasons|1|||
33177546|NCT01909479|100560226|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
33177547|NCT01909479|100560227|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
33177548|NCT01909479|100560226|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
33177549|NCT01909479|100560227|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
33177550|NCT01909479|100560226|FG000|52 Weeks to End of Study|Lack of contact|1|||
33177551|NCT01909479|100560227|FG001|52 Weeks to End of Study|Lack of contact|0|||
33177552|NCT01909479|100560226|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
33177553|NCT01909479|100560227|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
33177554|NCT01909479|100560226|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
33177555|NCT01909479|100560227|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
33177556|NCT02946047|100560235|FG000|Overall Study|Adverse Event|1|||
33177557|NCT02946047|100560236|FG001|Overall Study|Adverse Event|0|||
33177558|NCT02946047|100560237|FG002|Overall Study|Adverse Event|0|||
33177559|NCT02946047|100560238|FG003|Overall Study|Adverse Event|0|||
33177560|NCT02728895|100560239|FG000|Overall Study|Other|1|||
33177561|NCT02728895|100560240|FG001|Overall Study|Other|2|||
33263951|NCT01736475|100866815|FG000|Overall Study|Withdrawal by Subject|2|||
33263952|NCT01736475|100866816|FG001|Overall Study|Withdrawal by Subject|0|||
33263953|NCT01736475|100866815|FG000|Overall Study|Protocol Violation|4|||
33263954|NCT01736475|100866816|FG001|Overall Study|Protocol Violation|0|||
33263955|NCT01736475|100866815|FG000|Overall Study|Other - Screen failure|1|||
33263956|NCT01736475|100866816|FG001|Overall Study|Other - Screen failure|0|||
33263957|NCT01736475|100866815|FG000|Overall Study|Other - Surgical procedure|1|||
33263958|NCT01736475|100866816|FG001|Overall Study|Other - Surgical procedure|0|||
33263959|NCT00945321|100866822|FG000|Period 1|Adverse Event|0|||
33263960|NCT00945321|100866823|FG001|Period 1|Adverse Event|0|||
33263961|NCT00945321|100866824|FG002|Period 1|Adverse Event|0|||
33263962|NCT00945321|100866825|FG003|Period 1|Adverse Event|0|||
33263963|NCT00945321|100866826|FG004|Period 1|Adverse Event|1|||
33263964|NCT00945321|100866827|FG005|Period 1|Adverse Event|0|||
33263965|NCT00945321|100866822|FG000|Period 4|Lost to Follow-up|0|||
33263966|NCT00945321|100866823|FG001|Period 4|Lost to Follow-up|0|||
33263967|NCT00945321|100866824|FG002|Period 4|Lost to Follow-up|0|||
33263968|NCT00945321|100866825|FG003|Period 4|Lost to Follow-up|0|||
33263969|NCT00945321|100866826|FG004|Period 4|Lost to Follow-up|0|||
33263970|NCT00945321|100866827|FG005|Period 4|Lost to Follow-up|1|||
33465436|NCT02744755|101593552|FG000|Study Period 2|Protocol Violation|1|||
33465437|NCT02744755|101593553|FG001|Study Period 2|Protocol Violation|0|||
33465438|NCT02744755|101593552|FG000|Study Period 2|not defined|3|||
33465439|NCT02744755|101593553|FG001|Study Period 2|not defined|2|||
33465440|NCT02744755|101593552|FG000|Study Period 2|Lost to Follow-up|0|||
33465441|NCT02744755|101593553|FG001|Study Period 2|Lost to Follow-up|2|||
33465442|NCT02744755|101593552|FG000|Study Period 2|Withdrawal by Subject|2|||
33465443|NCT02744755|101593553|FG001|Study Period 2|Withdrawal by Subject|2|||
33465444|NCT02744755|101593552|FG000|Study Period 2|Lack of Efficacy|3|||
33465445|NCT02744755|101593553|FG001|Study Period 2|Lack of Efficacy|2|||
33465446|NCT02010255|101593556|FG000|Overall Study|Death|0|||
33465447|NCT02010255|101593557|FG001|Overall Study|Death|1|||
33465448|NCT02010255|101593558|FG002|Overall Study|Death|4|||
33465449|NCT02010255|101593559|FG003|Overall Study|Death|4|||
33465450|NCT02010255|101593560|FG004|Overall Study|Death|2|||
33465451|NCT02010255|101593561|FG005|Overall Study|Death|0|||
33465452|NCT02010255|101593562|FG006|Overall Study|Death|1|||
33465453|NCT02010255|101593563|FG007|Overall Study|Death|1|||
33177562|NCT02728895|100560239|FG000|Overall Study|Withdrawal by Subject|0|||
33177563|NCT02728895|100560240|FG001|Overall Study|Withdrawal by Subject|3|||
33177564|NCT02864251|100560244|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
33177565|NCT02864251|100560245|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
33177566|NCT02864251|100560246|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
33177567|NCT02864251|100560244|FG000|Pre-Treatment|Withdrawal by Participant|0|||
33177568|NCT02864251|100560245|FG001|Pre-Treatment|Withdrawal by Participant|0|||
33177569|NCT02864251|100560246|FG002|Pre-Treatment|Withdrawal by Participant|4|||
33263971|NCT00371345|100866829|FG000|Overall Study|Disease Progression|21|||
33263972|NCT00371345|100866830|FG001|Overall Study|Disease Progression|35|||
33263973|NCT00371345|100866829|FG000|Overall Study|Study Drug Toxicity|1|||
33263974|NCT00371345|100866830|FG001|Overall Study|Study Drug Toxicity|7|||
33263975|NCT00371345|100866829|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
33465454|NCT02010255|101593564|FG008|Overall Study|Death|1|||
33465455|NCT02010255|101593565|FG009|Overall Study|Death|0|||
33465456|NCT02010255|101593566|FG010|Overall Study|Death|1|||
33465457|NCT02010255|101593567|FG011|Overall Study|Death|1|||
33465458|NCT02010255|101593568|FG012|Overall Study|Death|0|||
33465459|NCT02010255|101593569|FG013|Overall Study|Death|0|||
33465460|NCT02010255|101593556|FG000|Overall Study|Lack of Efficacy|4|||
33465461|NCT02010255|101593557|FG001|Overall Study|Lack of Efficacy|1|||
33465462|NCT02010255|101593558|FG002|Overall Study|Lack of Efficacy|2|||
33465463|NCT02010255|101593559|FG003|Overall Study|Lack of Efficacy|1|||
33465464|NCT02010255|101593560|FG004|Overall Study|Lack of Efficacy|1|||
33465465|NCT02010255|101593561|FG005|Overall Study|Lack of Efficacy|0|||
33465466|NCT02010255|101593562|FG006|Overall Study|Lack of Efficacy|0|||
33465467|NCT02010255|101593563|FG007|Overall Study|Lack of Efficacy|0|||
33465468|NCT02010255|101593564|FG008|Overall Study|Lack of Efficacy|0|||
33465469|NCT02010255|101593565|FG009|Overall Study|Lack of Efficacy|0|||
33465470|NCT02010255|101593566|FG010|Overall Study|Lack of Efficacy|1|||
33465471|NCT02010255|101593567|FG011|Overall Study|Lack of Efficacy|0|||
33465472|NCT02010255|101593568|FG012|Overall Study|Lack of Efficacy|0|||
33465473|NCT02010255|101593569|FG013|Overall Study|Lack of Efficacy|0|||
33465474|NCT02010255|101593556|FG000|Overall Study|Withdrew Consent|1|||
33465475|NCT02010255|101593557|FG001|Overall Study|Withdrew Consent|0|||
33465476|NCT02010255|101593558|FG002|Overall Study|Withdrew Consent|0|||
33465477|NCT02010255|101593559|FG003|Overall Study|Withdrew Consent|1|||
33465478|NCT02010255|101593560|FG004|Overall Study|Withdrew Consent|0|||
33465479|NCT02010255|101593561|FG005|Overall Study|Withdrew Consent|0|||
33465480|NCT02010255|101593562|FG006|Overall Study|Withdrew Consent|0|||
33465481|NCT02010255|101593563|FG007|Overall Study|Withdrew Consent|0|||
33465482|NCT02010255|101593564|FG008|Overall Study|Withdrew Consent|0|||
33465483|NCT02010255|101593565|FG009|Overall Study|Withdrew Consent|0|||
33465484|NCT02010255|101593566|FG010|Overall Study|Withdrew Consent|0|||
33465485|NCT02010255|101593567|FG011|Overall Study|Withdrew Consent|0|||
33465486|NCT02010255|101593568|FG012|Overall Study|Withdrew Consent|0|||
33465487|NCT02010255|101593569|FG013|Overall Study|Withdrew Consent|0|||
33465488|NCT02010255|101593556|FG000|Overall Study|Adverse Event|1|||
33465489|NCT02010255|101593557|FG001|Overall Study|Adverse Event|0|||
33465490|NCT02010255|101593558|FG002|Overall Study|Adverse Event|0|||
33465491|NCT02010255|101593559|FG003|Overall Study|Adverse Event|0|||
33465492|NCT02010255|101593560|FG004|Overall Study|Adverse Event|0|||
33465493|NCT02010255|101593561|FG005|Overall Study|Adverse Event|0|||
33465494|NCT02010255|101593562|FG006|Overall Study|Adverse Event|0|||
33465495|NCT02010255|101593563|FG007|Overall Study|Adverse Event|0|||
33465496|NCT02010255|101593564|FG008|Overall Study|Adverse Event|0|||
33465497|NCT02010255|101593565|FG009|Overall Study|Adverse Event|0|||
33465498|NCT02010255|101593566|FG010|Overall Study|Adverse Event|0|||
33465499|NCT02010255|101593567|FG011|Overall Study|Adverse Event|0|||
33465500|NCT02010255|101593568|FG012|Overall Study|Adverse Event|0|||
33465501|NCT02010255|101593569|FG013|Overall Study|Adverse Event|0|||
33465502|NCT02010255|101593556|FG000|Overall Study|Lost to Follow-up|0|||
33465503|NCT02010255|101593557|FG001|Overall Study|Lost to Follow-up|0|||
33465504|NCT02010255|101593558|FG002|Overall Study|Lost to Follow-up|1|||
33465505|NCT02010255|101593559|FG003|Overall Study|Lost to Follow-up|0|||
33465506|NCT02010255|101593560|FG004|Overall Study|Lost to Follow-up|1|||
33465507|NCT02010255|101593561|FG005|Overall Study|Lost to Follow-up|0|||
33465508|NCT02010255|101593562|FG006|Overall Study|Lost to Follow-up|0|||
33465509|NCT02010255|101593563|FG007|Overall Study|Lost to Follow-up|0|||
33465510|NCT02010255|101593564|FG008|Overall Study|Lost to Follow-up|0|||
33465511|NCT02010255|101593565|FG009|Overall Study|Lost to Follow-up|0|||
33465512|NCT02010255|101593566|FG010|Overall Study|Lost to Follow-up|0|||
33465513|NCT02010255|101593567|FG011|Overall Study|Lost to Follow-up|0|||
33465514|NCT02010255|101593568|FG012|Overall Study|Lost to Follow-up|0|||
33465515|NCT02010255|101593569|FG013|Overall Study|Lost to Follow-up|0|||
33465516|NCT02010255|101593556|FG000|Overall Study|Randomized but Not Treated|0|||
33465517|NCT02010255|101593557|FG001|Overall Study|Randomized but Not Treated|0|||
33465518|NCT02010255|101593558|FG002|Overall Study|Randomized but Not Treated|0|||
33465519|NCT02010255|101593559|FG003|Overall Study|Randomized but Not Treated|0|||
33465520|NCT02010255|101593560|FG004|Overall Study|Randomized but Not Treated|0|||
33465521|NCT02010255|101593561|FG005|Overall Study|Randomized but Not Treated|0|||
33465522|NCT02010255|101593562|FG006|Overall Study|Randomized but Not Treated|0|||
33465523|NCT02010255|101593563|FG007|Overall Study|Randomized but Not Treated|0|||
33177570|NCT02864251|100560244|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
33465524|NCT02010255|101593564|FG008|Overall Study|Randomized but Not Treated|0|||
33465525|NCT02010255|101593565|FG009|Overall Study|Randomized but Not Treated|0|||
33465526|NCT02010255|101593566|FG010|Overall Study|Randomized but Not Treated|0|||
33465527|NCT02010255|101593567|FG011|Overall Study|Randomized but Not Treated|0|||
33465528|NCT02010255|101593568|FG012|Overall Study|Randomized but Not Treated|0|||
33465529|NCT02010255|101593569|FG013|Overall Study|Randomized but Not Treated|1|||
33465530|NCT00763555|101593570|FG000|Overall Study|Adverse Event|2|||
33465531|NCT00763555|101593571|FG001|Overall Study|Adverse Event|1|||
33465532|NCT00763555|101593570|FG000|Overall Study|Withdrawal by Subject|2|||
33465533|NCT00763555|101593571|FG001|Overall Study|Withdrawal by Subject|6|||
33465534|NCT00763555|101593570|FG000|Overall Study|Lost to Follow-up|0|||
33465535|NCT00763555|101593571|FG001|Overall Study|Lost to Follow-up|3|||
33465536|NCT00493779|101593584|FG000|Overall Study|Logistical issue at site|1|||
33465537|NCT01315028|101593585|FG000|Overall Study|Lost to Follow-up|1|||
33465538|NCT01315028|101593586|FG001|Overall Study|Lost to Follow-up|0|||
33465539|NCT01315028|101593585|FG000|Overall Study|Death|0|||
33465540|NCT01315028|101593586|FG001|Overall Study|Death|1|||
33465541|NCT02418455|101593587|FG000|48-Week Treatment Period|Other- Not Specified|1|||
33465542|NCT02418455|101593587|FG000|Continuation Period|Sponsor Decision|7|||
33465543|NCT02927834|101593588|FG000|Overall Study|Lost to Follow-up|1|||
33465544|NCT02927834|101593589|FG001|Overall Study|Lost to Follow-up|2|||
33465545|NCT02927834|101593590|FG002|Overall Study|Lost to Follow-up|2|||
33465546|NCT03891329|101593595|FG000|Overall Study|Death|5|||
33465547|NCT03891329|101593595|FG000|Overall Study|Lost to Follow-up|4|||
33465548|NCT03891329|101593595|FG000|Overall Study|Physician Decision|4|||
33465549|NCT03891329|101593595|FG000|Overall Study|Device explanted|3|||
33465550|NCT03891329|101593595|FG000|Overall Study|No study device implanted|3|||
33465551|NCT03136406|101593596|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
33465552|NCT00823199|101593597|FG000|Overall Study|Withdrawal by Subject|2|||
33465553|NCT02792218|101593598|FG000|Overall Study|Patient/guardian decision|15|||
33465554|NCT02792218|101593599|FG001|Overall Study|Patient/guardian decision|42|||
33465555|NCT02792218|101593598|FG000|Overall Study|Adverse Event|15|||
33465556|NCT02792218|101593599|FG001|Overall Study|Adverse Event|14|||
33465557|NCT02792218|101593598|FG000|Overall Study|Lost to Follow-up|10|||
33465558|NCT02792218|101593599|FG001|Overall Study|Lost to Follow-up|5|||
33465559|NCT02792218|101593598|FG000|Overall Study|Lack of Efficacy|1|||
33465560|NCT02792218|101593599|FG001|Overall Study|Lack of Efficacy|12|||
33465561|NCT02792218|101593598|FG000|Overall Study|Physician Decision|4|||
33465562|NCT02792218|101593599|FG001|Overall Study|Physician Decision|4|||
33465563|NCT02792218|101593598|FG000|Overall Study|Protocol deviation|3|||
33465564|NCT02792218|101593599|FG001|Overall Study|Protocol deviation|2|||
33465565|NCT02792218|101593598|FG000|Overall Study|New therapy for study indication|0|||
33465566|NCT02792218|101593599|FG001|Overall Study|New therapy for study indication|1|||
33465567|NCT02792218|101593598|FG000|Overall Study|Non-compliance with study treatment|0|||
33465568|NCT02792218|101593599|FG001|Overall Study|Non-compliance with study treatment|1|||
33465569|NCT02792218|101593598|FG000|Overall Study|Pregnancy|1|||
33465570|NCT02792218|101593599|FG001|Overall Study|Pregnancy|0|||
33465571|NCT00612677|101593600|FG000|Overall Study|study closed before treatment started|1|||
33465572|NCT03176784|101593601|FG000|Overall Study|Lost to Follow-up|77|||
33465573|NCT03176784|101593602|FG001|Overall Study|Lost to Follow-up|79|||
33465574|NCT03176784|101593603|FG002|Overall Study|Lost to Follow-up|79|||
33465575|NCT03176784|101593604|FG003|Overall Study|Lost to Follow-up|49|||
33465576|NCT03176784|101593601|FG000|Overall Study|Withdrawal by Subject|28|||
33465577|NCT03176784|101593602|FG001|Overall Study|Withdrawal by Subject|34|||
33465578|NCT03176784|101593603|FG002|Overall Study|Withdrawal by Subject|34|||
33465579|NCT03176784|101593604|FG003|Overall Study|Withdrawal by Subject|21|||
33465580|NCT00941720|101593607|FG000|Overall Study|Withdrawal by Subject|1|||
33465581|NCT00941720|101593607|FG000|Overall Study|Insurance denied participation|11|||
33465582|NCT00941720|101593607|FG000|Overall Study|ineligible|2|||
33465583|NCT01610063|101593608|FG000|Overall Study|Lost to Follow-up|42|||
33465584|NCT01610063|101593609|FG001|Overall Study|Lost to Follow-up|20|||
33465585|NCT01841073|101593610|FG000|Overall Study|Adverse Event|1|||
33465586|NCT01841073|101593611|FG001|Overall Study|Adverse Event|1|||
33465587|NCT01841073|101593610|FG000|Overall Study|Physician Decision|1|||
33465588|NCT01841073|101593611|FG001|Overall Study|Physician Decision|0|||
33465589|NCT01841073|101593610|FG000|Overall Study|Lost to Follow-up|0|||
33465590|NCT01841073|101593611|FG001|Overall Study|Lost to Follow-up|2|||
33465591|NCT02751827|101593612|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
33465592|NCT02751827|101593613|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
33465593|NCT02751827|101593614|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
33465594|NCT00546910|101593620|FG000|Overall Study|Adverse Event|2|||
33465595|NCT00546910|101593621|FG001|Overall Study|Adverse Event|3|||
33465596|NCT00546910|101593620|FG000|Overall Study|Lack of Efficacy|5|||
33465597|NCT00546910|101593621|FG001|Overall Study|Lack of Efficacy|7|||
33465598|NCT00546910|101593620|FG000|Overall Study|Physician Decision|0|||
33465599|NCT00546910|101593621|FG001|Overall Study|Physician Decision|1|||
33465600|NCT00546910|101593620|FG000|Overall Study|Withdrawal by Subject|2|||
33465601|NCT00546910|101593621|FG001|Overall Study|Withdrawal by Subject|0|||
33465602|NCT02070757|101593622|FG000|Overall Study|Adverse Event|107|||
33465603|NCT02070757|101593623|FG001|Overall Study|Adverse Event|99|||
33465604|NCT02070757|101593622|FG000|Overall Study|Lost to Follow-up|7|||
33465605|NCT02070757|101593623|FG001|Overall Study|Lost to Follow-up|4|||
33465606|NCT02070757|101593622|FG000|Overall Study|Protocol Violation|0|||
33465607|NCT02070757|101593623|FG001|Overall Study|Protocol Violation|4|||
33465608|NCT02070757|101593622|FG000|Overall Study|Withdrawal by Subject|1|||
33465609|NCT02070757|101593623|FG001|Overall Study|Withdrawal by Subject|3|||
33465610|NCT02070757|101593622|FG000|Overall Study|Investigator Decision|0|||
33465611|NCT02070757|101593623|FG001|Overall Study|Investigator Decision|2|||
33465612|NCT02070757|101593622|FG000|Overall Study|Discharged from Study Hospital|2|||
33465613|NCT02070757|101593623|FG001|Overall Study|Discharged from Study Hospital|2|||
33465614|NCT01647958|101593629|FG000|Initial Study|Lost to Follow-up|2|||
33465615|NCT01647958|101593630|FG001|Initial Study|Lost to Follow-up|3|||
33465616|NCT01647958|101593629|FG000|Continuation Phase|treatment received during Overall Study|39|||
33465617|NCT01647958|101593630|FG001|Continuation Phase|treatment received during Overall Study|0|||
33465618|NCT01647958|101593629|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
33465619|NCT01647958|101593630|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
33465620|NCT04974619|101593631|FG000|Overall Study|Lost to Follow-up|0|||
33465621|NCT04974619|101593632|FG001|Overall Study|Lost to Follow-up|0|||
33465622|NCT04974619|101593633|FG002|Overall Study|Lost to Follow-up|1|||
33465623|NCT04974619|101593631|FG000|Overall Study|Withdrawal by Subject|0|||
33465624|NCT04974619|101593632|FG001|Overall Study|Withdrawal by Subject|0|||
33465625|NCT04974619|101593633|FG002|Overall Study|Withdrawal by Subject|1|||
33465626|NCT04974619|101593631|FG000|Overall Study|Protocol Violation|0|||
33465627|NCT04974619|101593632|FG001|Overall Study|Protocol Violation|1|||
33465628|NCT04974619|101593633|FG002|Overall Study|Protocol Violation|0|||
33465629|NCT01825837|101593634|FG000|PART I|Withdrawal by Subject|0|||
33465630|NCT01825837|101593635|FG001|PART I|Withdrawal by Subject|0|||
33465631|NCT01825837|101593636|FG002|PART I|Withdrawal by Subject|0|||
33465632|NCT01825837|101593637|FG003|PART I|Withdrawal by Subject|6|||
33465633|NCT01825837|101593634|FG000|PART I|Patient non-compliance|0|||
33465634|NCT01825837|101593635|FG001|PART I|Patient non-compliance|0|||
33465635|NCT01825837|101593636|FG002|PART I|Patient non-compliance|0|||
33465636|NCT01825837|101593637|FG003|PART I|Patient non-compliance|1|||
33465637|NCT01825837|101593634|FG000|PART I|Treatment failure|0|||
33465638|NCT01825837|101593635|FG001|PART I|Treatment failure|0|||
33465639|NCT01825837|101593636|FG002|PART I|Treatment failure|0|||
33465640|NCT01825837|101593637|FG003|PART I|Treatment failure|7|||
33465641|NCT01825837|101593634|FG000|PART I|reason unspecified|0|||
33465642|NCT01825837|101593635|FG001|PART I|reason unspecified|0|||
33465643|NCT01825837|101593636|FG002|PART I|reason unspecified|0|||
33465644|NCT01825837|101593637|FG003|PART I|reason unspecified|3|||
33465645|NCT01825837|101593634|FG000|PART II|Withdrawal by Subject|3|||
33465646|NCT01825837|101593635|FG001|PART II|Withdrawal by Subject|3|||
33465647|NCT01825837|101593636|FG002|PART II|Withdrawal by Subject|7|||
33465648|NCT01825837|101593637|FG003|PART II|Withdrawal by Subject|0|||
33465649|NCT01825837|101593634|FG000|PART II|Patient non-compliance|5|||
33465650|NCT01825837|101593635|FG001|PART II|Patient non-compliance|2|||
33465651|NCT01825837|101593636|FG002|PART II|Patient non-compliance|4|||
33465652|NCT01825837|101593637|FG003|PART II|Patient non-compliance|0|||
33465653|NCT01825837|101593634|FG000|PART II|Adverse Event|3|||
33465654|NCT01825837|101593635|FG001|PART II|Adverse Event|3|||
33465655|NCT01825837|101593636|FG002|PART II|Adverse Event|1|||
33465656|NCT01825837|101593637|FG003|PART II|Adverse Event|0|||
33465657|NCT01825837|101593634|FG000|PART II|Treatment failure|6|||
33465658|NCT01825837|101593635|FG001|PART II|Treatment failure|4|||
33465659|NCT01825837|101593636|FG002|PART II|Treatment failure|5|||
33465660|NCT01825837|101593637|FG003|PART II|Treatment failure|0|||
33465661|NCT01825837|101593634|FG000|PART II|reason unspecified|2|||
33465662|NCT01825837|101593635|FG001|PART II|reason unspecified|2|||
33465663|NCT01825837|101593636|FG002|PART II|reason unspecified|2|||
33465664|NCT01825837|101593637|FG003|PART II|reason unspecified|0|||
33465665|NCT01933919|101593638|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
33465666|NCT01933919|101593639|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
33465667|NCT01933919|101593638|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
33465668|NCT01933919|101593639|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
33465669|NCT01933919|101593638|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
33465670|NCT01933919|101593639|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
33465671|NCT01933919|101593638|FG000|Open-label Long-term Phase|Adverse Event|2|||
33465672|NCT01933919|101593639|FG001|Open-label Long-term Phase|Adverse Event|0|||
33465673|NCT01933919|101593638|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
33465674|NCT01933919|101593639|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
33465675|NCT01933919|101593638|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
33465676|NCT01933919|101593639|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
33465677|NCT01933919|101593638|FG000|Open-label Long-term Phase|Other|1|||
33465678|NCT01933919|101593639|FG001|Open-label Long-term Phase|Other|2|||
33465679|NCT00442546|101593640|FG000|Overall Study|Adverse Event|11|||
33465680|NCT00442546|101593641|FG001|Overall Study|Adverse Event|17|||
33465681|NCT00442546|101593642|FG002|Overall Study|Adverse Event|13|||
33465682|NCT00442546|101593640|FG000|Overall Study|Lost to Follow-up|1|||
33465683|NCT00442546|101593641|FG001|Overall Study|Lost to Follow-up|2|||
33465684|NCT00442546|101593642|FG002|Overall Study|Lost to Follow-up|1|||
33465685|NCT00442546|101593640|FG000|Overall Study|Other|4|||
33465686|NCT00442546|101593641|FG001|Overall Study|Other|9|||
33465687|NCT00442546|101593642|FG002|Overall Study|Other|6|||
33465688|NCT00442546|101593640|FG000|Overall Study|Withdrawal by Subject|5|||
33465689|NCT00442546|101593641|FG001|Overall Study|Withdrawal by Subject|5|||
33465690|NCT00442546|101593642|FG002|Overall Study|Withdrawal by Subject|7|||
33465691|NCT00442546|101593640|FG000|Overall Study|Randomized But Not Treated|5|||
33465692|NCT00442546|101593641|FG001|Overall Study|Randomized But Not Treated|4|||
33465693|NCT00442546|101593642|FG002|Overall Study|Randomized But Not Treated|6|||
33465694|NCT01592721|101593643|FG000|Long-term Follow-up|Death|1|||
33465695|NCT01909934|101593644|FG000|Overall Study|Ongoing|23|||
33465696|NCT01909934|101593644|FG000|Overall Study|Withdrawal by Subject|3|||
33465697|NCT01909934|101593644|FG000|Overall Study|Lost to Follow-up|1|||
33465698|NCT01909934|101593644|FG000|Overall Study|Withdrawal of Informed Consent|1|||
33465699|NCT01909934|101593644|FG000|Overall Study|Death|22|||
33465700|NCT01350934|101593647|FG000|Base Study|Adverse Event|6|||
33465701|NCT01350934|101593648|FG001|Base Study|Adverse Event|0|||
33465702|NCT01350934|101593647|FG000|Base Study|Lost to Follow-up|1|||
33465703|NCT01350934|101593648|FG001|Base Study|Lost to Follow-up|0|||
33465704|NCT01350934|101593647|FG000|Base Study|Protocol Violation|1|||
33465705|NCT01350934|101593648|FG001|Base Study|Protocol Violation|1|||
33465706|NCT01350934|101593647|FG000|Base Study|Withdrawal by Subject|1|||
33465707|NCT01350934|101593648|FG001|Base Study|Withdrawal by Subject|2|||
33465708|NCT01350934|101593647|FG000|Base Study|Non-Compliance With Study Drug|2|||
33465709|NCT01350934|101593648|FG001|Base Study|Non-Compliance With Study Drug|0|||
33465710|NCT01350934|101593647|FG000|Extension Study|Adverse Event|2|||
33465711|NCT01350934|101593648|FG001|Extension Study|Adverse Event|1|||
33465712|NCT01350934|101593647|FG000|Extension Study|Lost to Follow-up|2|||
33465713|NCT01350934|101593648|FG001|Extension Study|Lost to Follow-up|0|||
33465714|NCT01350934|101593647|FG000|Extension Study|Protocol Violation|1|||
33465715|NCT01350934|101593648|FG001|Extension Study|Protocol Violation|1|||
33465716|NCT01350934|101593647|FG000|Extension Study|Lack of Efficacy|0|||
33465717|NCT01350934|101593648|FG001|Extension Study|Lack of Efficacy|1|||
33465718|NCT01350934|101593647|FG000|Extension Study|Withdrawal by Subject|0|||
33465719|NCT01350934|101593648|FG001|Extension Study|Withdrawal by Subject|1|||
33465720|NCT01559935|101593651|FG000|Car Phase|Toxicity|4|||
33465721|NCT01559935|101593651|FG000|Car Phase|Death|1|||
33465722|NCT01559935|101593651|FG000|Car Phase|Lack of Efficacy|2|||
33465723|NCT01559935|101593651|FG000|Car Phase|Lost to Follow-up|1|||
33465724|NCT01559935|101593651|FG000|Car Phase|Physician Decision|1|||
33465725|NCT01559935|101593651|FG000|Car Phase|Withdrawal by Subject|2|||
33465726|NCT01559935|101593651|FG000|Car Phase|Per protocol|1|||
33465727|NCT01559935|101593651|FG000|Car Phase|Insurance|1|||
33465728|NCT01559935|101593651|FG000|Car Phase|non-compliance|1|||
33465729|NCT01559935|101593651|FG000|BiRD Phase|Toxicity|1|||
33465730|NCT01559935|101593651|FG000|BiRD Phase|Lack of Efficacy|1|||
33465731|NCT01559935|101593651|FG000|BiRD Phase|Withdrawal by Subject|2|||
33465732|NCT01559935|101593651|FG000|Maintenance Phase|Remains on study|28|||
33465733|NCT01559935|101593651|FG000|Maintenance Phase|Toxicity|1|||
33465734|NCT01559935|101593651|FG000|Maintenance Phase|Lack of Efficacy|18|||
33465735|NCT01559935|101593651|FG000|Maintenance Phase|Withdrawal by Subject|5|||
33465736|NCT01559935|101593651|FG000|Maintenance Phase|Non-compliance|2|||
33465737|NCT00319046|101593652|FG000|Overall Study|withdrawal of subject's consent|7|||
33465738|NCT00319046|101593652|FG000|Overall Study|administrative reason|1|||
33465739|NCT03648879|101593659|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
33465740|NCT03135899|101593672|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
33465741|NCT03135899|101593673|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
33465742|NCT03135899|101593674|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
33465743|NCT03135899|101593675|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
33465744|NCT03135899|101593676|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
33465745|NCT03135899|101593677|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
33465746|NCT03135899|101593678|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
33465747|NCT03135899|101593679|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
33465748|NCT03135899|101593672|FG000|Overall Study|Withdrawal by Subject|0|||
33465749|NCT03135899|101593673|FG001|Overall Study|Withdrawal by Subject|0|||
33465750|NCT03135899|101593674|FG002|Overall Study|Withdrawal by Subject|0|||
33465751|NCT03135899|101593675|FG003|Overall Study|Withdrawal by Subject|0|||
33465752|NCT03135899|101593676|FG004|Overall Study|Withdrawal by Subject|0|||
33465753|NCT03135899|101593677|FG005|Overall Study|Withdrawal by Subject|2|||
33465754|NCT03135899|101593678|FG006|Overall Study|Withdrawal by Subject|0|||
33465755|NCT03135899|101593679|FG007|Overall Study|Withdrawal by Subject|0|||
33465756|NCT03401073|101593682|FG000|Overall Study|Lost to Follow-up|1|||
33465757|NCT03401073|101593683|FG001|Overall Study|Lost to Follow-up|2|||
33465758|NCT04287868|101593684|FG000|Overall Study|Screening fail|1|||
33177571|NCT02864251|100560245|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
33177572|NCT02864251|100560246|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
33177573|NCT02864251|100560244|FG000|Pre-Treatment|Other Reasons|0|||
33177574|NCT02864251|100560245|FG001|Pre-Treatment|Other Reasons|1|||
33465759|NCT04287868|101593685|FG001|Overall Study|Screening fail|0|||
33465760|NCT03547635|101593686|FG000|Overall Study|Adverse Event|5|||
33465761|NCT03547635|101593687|FG001|Overall Study|Adverse Event|2|||
33465762|NCT03547635|101593688|FG002|Overall Study|Adverse Event|3|||
33465763|NCT03547635|101593686|FG000|Overall Study|Lost to Follow-up|1|||
33465764|NCT03547635|101593687|FG001|Overall Study|Lost to Follow-up|3|||
33465765|NCT03547635|101593688|FG002|Overall Study|Lost to Follow-up|4|||
33465766|NCT03547635|101593686|FG000|Overall Study|Withdrawal by Subject|1|||
33465767|NCT03547635|101593687|FG001|Overall Study|Withdrawal by Subject|0|||
33465768|NCT03547635|101593688|FG002|Overall Study|Withdrawal by Subject|0|||
33465769|NCT03547635|101593686|FG000|Overall Study|Withdrawal By PI|0|||
33465770|NCT03547635|101593687|FG001|Overall Study|Withdrawal By PI|1|||
33465771|NCT03547635|101593688|FG002|Overall Study|Withdrawal By PI|0|||
33465772|NCT03547635|101593686|FG000|Overall Study|Withdrawal by Sponsor|0|||
33465773|NCT03547635|101593687|FG001|Overall Study|Withdrawal by Sponsor|0|||
33465774|NCT03547635|101593688|FG002|Overall Study|Withdrawal by Sponsor|1|||
33465775|NCT03547635|101593686|FG000|Overall Study|Errant Randomization before Treatment|0|||
33465776|NCT03547635|101593687|FG001|Overall Study|Errant Randomization before Treatment|1|||
33465777|NCT03547635|101593688|FG002|Overall Study|Errant Randomization before Treatment|0|||
33465778|NCT03547635|101593686|FG000|Overall Study|Withdrawal by Subject|1|||
33465779|NCT03547635|101593687|FG001|Overall Study|Withdrawal by Subject|0|||
33465780|NCT03547635|101593688|FG002|Overall Study|Withdrawal by Subject|0|||
33465781|NCT00171340|101593689|FG000|Overall Study|Adverse Event|46|||
33465782|NCT00171340|101593690|FG001|Overall Study|Adverse Event|42|||
33465783|NCT00171340|101593689|FG000|Overall Study|Lack of Efficacy|29|||
33465784|NCT00171340|101593690|FG001|Overall Study|Lack of Efficacy|41|||
33465785|NCT00171340|101593689|FG000|Overall Study|Protocol Violation|7|||
33465786|NCT00171340|101593690|FG001|Overall Study|Protocol Violation|8|||
33465787|NCT00171340|101593689|FG000|Overall Study|Withdrawal by Subject|22|||
33465788|NCT00171340|101593690|FG001|Overall Study|Withdrawal by Subject|19|||
33465789|NCT00171340|101593689|FG000|Overall Study|Lost to Follow-up|0|||
33465790|NCT00171340|101593690|FG001|Overall Study|Lost to Follow-up|5|||
33465791|NCT00171340|101593689|FG000|Overall Study|Abnormal Laboratory Results|2|||
33465792|NCT00171340|101593690|FG001|Overall Study|Abnormal Laboratory Results|0|||
33465793|NCT00171340|101593689|FG000|Overall Study|Abnormal Test Procedure Results|6|||
33465794|NCT00171340|101593690|FG001|Overall Study|Abnormal Test Procedure Results|11|||
33465795|NCT00171340|101593689|FG000|Overall Study|No Longer Required Study Drug|1|||
33465796|NCT00171340|101593690|FG001|Overall Study|No Longer Required Study Drug|1|||
33465797|NCT00171340|101593689|FG000|Overall Study|Administrative Problems|5|||
33465798|NCT00171340|101593690|FG001|Overall Study|Administrative Problems|2|||
33465799|NCT00171340|101593689|FG000|Overall Study|Death|6|||
33465800|NCT00171340|101593690|FG001|Overall Study|Death|6|||
33465801|NCT02808819|101593693|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
33465802|NCT02808819|101593694|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
33465803|NCT02808819|101593693|FG000|Overall Study|Withdrawal by Subject|10|||
33465804|NCT02808819|101593694|FG001|Overall Study|Withdrawal by Subject|13|||
33465805|NCT02808819|101593693|FG000|Overall Study|Site terminated by sponsor|2|||
33465806|NCT02808819|101593694|FG001|Overall Study|Site terminated by sponsor|0|||
33465807|NCT02808819|101593693|FG000|Overall Study|Pregnancy|1|||
33465808|NCT02808819|101593694|FG001|Overall Study|Pregnancy|0|||
33465809|NCT02808819|101593693|FG000|Overall Study|Lost to Follow-up|1|||
33465810|NCT02808819|101593694|FG001|Overall Study|Lost to Follow-up|6|||
33465811|NCT02808819|101593693|FG000|Overall Study|Protocol Violation|0|||
33465812|NCT02808819|101593694|FG001|Overall Study|Protocol Violation|1|||
33465813|NCT02808819|101593693|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
33465814|NCT02808819|101593694|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
33465815|NCT02808819|101593693|FG000|Overall Study|Death|1|||
33465816|NCT02808819|101593694|FG001|Overall Study|Death|0|||
33465817|NCT02808819|101593693|FG000|Overall Study|Adverse Event|3|||
33465818|NCT02808819|101593694|FG001|Overall Study|Adverse Event|4|||
33465819|NCT00384293|101593695|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
33465820|NCT00384293|101593696|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
33465821|NCT00384293|101593697|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
33465822|NCT00384293|101593695|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
33465823|NCT00384293|101593696|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
33465824|NCT00384293|101593697|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
33465825|NCT00384293|101593695|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
33465826|NCT00384293|101593696|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
33465827|NCT00384293|101593697|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
33465828|NCT00384293|101593695|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
33465829|NCT00384293|101593696|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
33465830|NCT00384293|101593697|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
33177575|NCT02864251|100560246|FG002|Pre-Treatment|Other Reasons|1|||
33177576|NCT02864251|100560244|FG000|Treatment|Disease Progression|109|||
33465831|NCT00384293|101593695|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
33465832|NCT00384293|101593696|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
33465833|NCT00384293|101593697|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
33465834|NCT00384293|101593695|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
33465835|NCT00384293|101593696|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
33465836|NCT00384293|101593697|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
33465837|NCT00384293|101593695|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
33465838|NCT00384293|101593696|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
33465839|NCT00384293|101593697|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
33465840|NCT00384293|101593695|FG000|Post-randomization Period|Adverse Event|0|||
33465841|NCT00384293|101593696|FG001|Post-randomization Period|Adverse Event|23|||
33465842|NCT00384293|101593697|FG002|Post-randomization Period|Adverse Event|7|||
33465843|NCT00384293|101593695|FG000|Post-randomization Period|Lost to Follow-up|0|||
33465844|NCT00384293|101593696|FG001|Post-randomization Period|Lost to Follow-up|2|||
33465845|NCT00384293|101593697|FG002|Post-randomization Period|Lost to Follow-up|1|||
33465846|NCT00384293|101593695|FG000|Post-randomization Period|Protocol Violation|0|||
33465847|NCT00384293|101593696|FG001|Post-randomization Period|Protocol Violation|1|||
33465848|NCT00384293|101593697|FG002|Post-randomization Period|Protocol Violation|0|||
33465849|NCT00384293|101593695|FG000|Post-randomization Period|Withdrawal by Subject|0|||
33465850|NCT00384293|101593696|FG001|Post-randomization Period|Withdrawal by Subject|8|||
33465851|NCT00384293|101593697|FG002|Post-randomization Period|Withdrawal by Subject|6|||
33465852|NCT00384293|101593695|FG000|Post-randomization Period|Trial Termination|0|||
33465853|NCT00384293|101593696|FG001|Post-randomization Period|Trial Termination|180|||
33465854|NCT00384293|101593697|FG002|Post-randomization Period|Trial Termination|204|||
33465855|NCT00384293|101593695|FG000|Post-randomization Period|Patient Randomized in Error|0|||
33465856|NCT00384293|101593696|FG001|Post-randomization Period|Patient Randomized in Error|0|||
33465857|NCT00384293|101593697|FG002|Post-randomization Period|Patient Randomized in Error|1|||
33465858|NCT03451006|101593698|FG000|Overall Study|Withdrawal by Subject|2|||
33465859|NCT03451006|101593699|FG001|Overall Study|Withdrawal by Subject|2|||
33465860|NCT01660022|101593700|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
33465861|NCT01660022|101593701|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
33465862|NCT01660022|101593702|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
33465863|NCT01660022|101593703|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
33465864|NCT01660022|101593704|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
33465865|NCT01660022|101593705|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
33465866|NCT01660022|101593700|FG000|First Sequence (7 Days)|Adverse Event|0|||
33465867|NCT01660022|101593701|FG001|First Sequence (7 Days)|Adverse Event|0|||
33465868|NCT01660022|101593702|FG002|First Sequence (7 Days)|Adverse Event|0|||
33465869|NCT01660022|101593703|FG003|First Sequence (7 Days)|Adverse Event|0|||
33465870|NCT01660022|101593704|FG004|First Sequence (7 Days)|Adverse Event|1|||
33465871|NCT01660022|101593705|FG005|First Sequence (7 Days)|Adverse Event|3|||
33465872|NCT01660022|101593700|FG000|First Sequence (7 Days)|Protocol Violation|0|||
33465873|NCT01660022|101593701|FG001|First Sequence (7 Days)|Protocol Violation|0|||
33465874|NCT01660022|101593702|FG002|First Sequence (7 Days)|Protocol Violation|0|||
33465875|NCT01660022|101593703|FG003|First Sequence (7 Days)|Protocol Violation|0|||
33465876|NCT01660022|101593704|FG004|First Sequence (7 Days)|Protocol Violation|0|||
33465877|NCT01660022|101593705|FG005|First Sequence (7 Days)|Protocol Violation|1|||
33465878|NCT04776746|101593708|FG000|Overall Study|Study terminated by sponsor|61|||
33465879|NCT04776746|101593708|FG000|Overall Study|Adverse Event|5|||
33465880|NCT04776746|101593708|FG000|Overall Study|Death|4|||
33465881|NCT04776746|101593708|FG000|Overall Study|Lack of Efficacy|3|||
33465882|NCT04776746|101593708|FG000|Overall Study|Noncompliance with study drug|2|||
33465883|NCT04776746|101593708|FG000|Overall Study|Not related to COVID-19|2|||
33465884|NCT01606228|101593709|FG000|Overall Study|Lost to Follow-up|20|||
33465885|NCT01606228|101593709|FG000|Overall Study|Withdrawal by Subject|3|||
33465886|NCT01606228|101593709|FG000|Overall Study|Non-compliant|3|||
33465887|NCT01606228|101593709|FG000|Overall Study|Lack of Efficacy|2|||
33465888|NCT01606228|101593709|FG000|Overall Study|Adverse Event|1|||
33465889|NCT01223235|101593713|FG000|Overall Study|Withdrawal by Subject|1|||
33465890|NCT00693225|101593714|FG000|Overall Study|Lost to Follow-up|1|||
33465891|NCT00693225|101593715|FG001|Overall Study|Lost to Follow-up|2|||
33465892|NCT00693225|101593714|FG000|Overall Study|Adverse Event|1|||
33465893|NCT00693225|101593715|FG001|Overall Study|Adverse Event|3|||
33465894|NCT00852917|101593716|FG000|Overall Study|Adverse Event|13|||
33465895|NCT00852917|101593717|FG001|Overall Study|Adverse Event|20|||
33465896|NCT00852917|101593718|FG002|Overall Study|Adverse Event|35|||
33465897|NCT00852917|101593719|FG003|Overall Study|Adverse Event|17|||
33263976|NCT00371345|100866830|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
33263977|NCT00371345|100866829|FG000|Overall Study|Participant Request|1|||
33465898|NCT00852917|101593716|FG000|Overall Study|Lack of Efficacy|21|||
33465899|NCT00852917|101593717|FG001|Overall Study|Lack of Efficacy|11|||
33465900|NCT00852917|101593718|FG002|Overall Study|Lack of Efficacy|11|||
33465901|NCT00852917|101593719|FG003|Overall Study|Lack of Efficacy|47|||
33465902|NCT00852917|101593716|FG000|Overall Study|Withdrawal by Subject|4|||
33465903|NCT00852917|101593717|FG001|Overall Study|Withdrawal by Subject|8|||
33465904|NCT00852917|101593718|FG002|Overall Study|Withdrawal by Subject|10|||
33263978|NCT00371345|100866830|FG001|Overall Study|Participant Request|1|||
33465905|NCT00852917|101593719|FG003|Overall Study|Withdrawal by Subject|9|||
33465906|NCT00852917|101593716|FG000|Overall Study|Physician Decision|6|||
33263979|NCT00371345|100866829|FG000|Overall Study|Participant Withdrew Consent|0|||
33263980|NCT00371345|100866830|FG001|Overall Study|Participant Withdrew Consent|1|||
33465907|NCT00852917|101593717|FG001|Overall Study|Physician Decision|7|||
33465908|NCT00852917|101593718|FG002|Overall Study|Physician Decision|2|||
33465909|NCT00852917|101593719|FG003|Overall Study|Physician Decision|19|||
33465910|NCT00852917|101593716|FG000|Overall Study|Death|0|||
33465911|NCT00852917|101593717|FG001|Overall Study|Death|0|||
33465912|NCT00852917|101593718|FG002|Overall Study|Death|0|||
33465913|NCT00852917|101593719|FG003|Overall Study|Death|1|||
33465914|NCT00493454|101593720|FG000|Overall Study|Withdrawal by Subject|1|||
33465915|NCT05158140|101593721|FG000|Overall Study|Death|0|||
33465916|NCT05158140|101593722|FG001|Overall Study|Death|0|||
33465917|NCT05158140|101593723|FG002|Overall Study|Death|0|||
33465918|NCT05158140|101593724|FG003|Overall Study|Death|1|||
33465919|NCT05158140|101593721|FG000|Overall Study|Lost to Follow-up|3|||
33465920|NCT05158140|101593722|FG001|Overall Study|Lost to Follow-up|6|||
33465921|NCT05158140|101593723|FG002|Overall Study|Lost to Follow-up|4|||
33465922|NCT05158140|101593724|FG003|Overall Study|Lost to Follow-up|3|||
33465923|NCT05158140|101593721|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33465924|NCT05158140|101593722|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
33465925|NCT05158140|101593723|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
33465926|NCT05158140|101593724|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
33465927|NCT05158140|101593721|FG000|Overall Study|Withdrawal by Subject|3|||
33465928|NCT05158140|101593722|FG001|Overall Study|Withdrawal by Subject|7|||
33465929|NCT05158140|101593723|FG002|Overall Study|Withdrawal by Subject|3|||
33465930|NCT05158140|101593724|FG003|Overall Study|Withdrawal by Subject|7|||
33465931|NCT04553913|101593725|FG000|Overall Study|patient's block resolved prior to PACU|1|||
33465932|NCT04553913|101593725|FG000|Overall Study|did not use the device properly|5|||
33465933|NCT00097786|101593726|FG000|Overall Study|lost to follow-up for all-cause death|296|||
33465934|NCT00097786|101593727|FG001|Overall Study|lost to follow-up for all-cause death|292|||
33465935|NCT00097786|101593728|FG002|Overall Study|lost to follow-up for all-cause death|313|||
33465936|NCT00097786|101593729|FG003|Overall Study|lost to follow-up for all-cause death|310|||
33465937|NCT03449199|101593730|FG000|Overall Study|Lost to Follow-up|1|||
33465938|NCT03449199|101593731|FG001|Overall Study|Lost to Follow-up|1|||
33465939|NCT03449199|101593732|FG002|Overall Study|Lost to Follow-up|0|||
33465940|NCT03449199|101593730|FG000|Overall Study|Protocol Deviation|0|||
33465941|NCT03449199|101593731|FG001|Overall Study|Protocol Deviation|0|||
33465942|NCT03449199|101593732|FG002|Overall Study|Protocol Deviation|1|||
33465943|NCT03449199|101593730|FG000|Overall Study|Withdrawal by Subject|0|||
33465944|NCT03449199|101593731|FG001|Overall Study|Withdrawal by Subject|0|||
33465945|NCT03449199|101593732|FG002|Overall Study|Withdrawal by Subject|1|||
33465946|NCT04768296|101593734|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
33465947|NCT04768296|101593735|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
33465948|NCT01567826|101597119|FG000|Overall Study|Lost to Follow-up|3|||
33465949|NCT01567826|101597120|FG001|Overall Study|Lost to Follow-up|2|||
33465950|NCT04157517|101597121|FG000|Overall Study|Death|1|||
33465951|NCT04157517|101597122|FG001|Overall Study|Death|2|||
33465952|NCT04157517|101597123|FG002|Overall Study|Death|2|||
33465953|NCT04157517|101597124|FG003|Overall Study|Death|3|||
33465954|NCT04157517|101597125|FG004|Overall Study|Death|3|||
33465955|NCT04157517|101597126|FG005|Overall Study|Death|4|||
33465956|NCT04157517|101597127|FG006|Overall Study|Death|1|||
33465957|NCT04157517|101597128|FG007|Overall Study|Death|2|||
33465958|NCT04157517|101597129|FG008|Overall Study|Death|4|||
33465959|NCT04157517|101597130|FG009|Overall Study|Death|0|||
33465960|NCT04157517|101597121|FG000|Overall Study|Withdrawal by Subject|1|||
33177577|NCT02864251|100560245|FG001|Treatment|Disease Progression|52|||
33177578|NCT02864251|100560246|FG002|Treatment|Disease Progression|101|||
33177579|NCT02864251|100560244|FG000|Treatment|Study Drug Toxicity|9|||
33465961|NCT04157517|101597122|FG001|Overall Study|Withdrawal by Subject|1|||
33465962|NCT04157517|101597123|FG002|Overall Study|Withdrawal by Subject|1|||
33465963|NCT04157517|101597124|FG003|Overall Study|Withdrawal by Subject|0|||
33177580|NCT02864251|100560245|FG001|Treatment|Study Drug Toxicity|4|||
33177581|NCT02864251|100560246|FG002|Treatment|Study Drug Toxicity|10|||
33177582|NCT02864251|100560244|FG000|Treatment|Death|0|||
33177583|NCT02864251|100560245|FG001|Treatment|Death|2|||
33177584|NCT02864251|100560246|FG002|Treatment|Death|3|||
33177585|NCT02864251|100560244|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
33465964|NCT04157517|101597125|FG004|Overall Study|Withdrawal by Subject|0|||
33465965|NCT04157517|101597126|FG005|Overall Study|Withdrawal by Subject|1|||
33465966|NCT04157517|101597127|FG006|Overall Study|Withdrawal by Subject|0|||
33465967|NCT04157517|101597128|FG007|Overall Study|Withdrawal by Subject|0|||
33465968|NCT04157517|101597129|FG008|Overall Study|Withdrawal by Subject|1|||
33177586|NCT02864251|100560245|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
33263981|NCT01340066|100866831|FG000|Placebo Run in Period|Screen Failures|27|||
33465969|NCT04157517|101597130|FG009|Overall Study|Withdrawal by Subject|0|||
33465970|NCT04157517|101597121|FG000|Overall Study|Other|1|||
33465971|NCT04157517|101597122|FG001|Overall Study|Other|0|||
33465972|NCT04157517|101597123|FG002|Overall Study|Other|0|||
33465973|NCT04157517|101597124|FG003|Overall Study|Other|0|||
33465974|NCT04157517|101597125|FG004|Overall Study|Other|0|||
33465975|NCT04157517|101597126|FG005|Overall Study|Other|1|||
33465976|NCT04157517|101597127|FG006|Overall Study|Other|2|||
33465977|NCT04157517|101597128|FG007|Overall Study|Other|7|||
33465978|NCT04157517|101597129|FG008|Overall Study|Other|7|||
33465979|NCT04157517|101597130|FG009|Overall Study|Other|0|||
33465980|NCT01523587|101597131|FG000|Overall Study|Other than listed|5|||
33465981|NCT01523587|101597132|FG001|Overall Study|Other than listed|5|||
33465982|NCT01523587|101597131|FG000|Overall Study|Worsening of underlying cancer disease|19|||
33465983|NCT01523587|101597132|FG001|Overall Study|Worsening of underlying cancer disease|34|||
33465984|NCT01523587|101597131|FG000|Overall Study|Adverse Event|68|||
33465985|NCT01523587|101597132|FG001|Overall Study|Adverse Event|52|||
33465986|NCT01523587|101597131|FG000|Overall Study|Protocol Violation|5|||
33465987|NCT01523587|101597132|FG001|Overall Study|Protocol Violation|3|||
33465988|NCT01523587|101597131|FG000|Overall Study|Lost to Follow-up|2|||
33465989|NCT01523587|101597132|FG001|Overall Study|Lost to Follow-up|2|||
33465990|NCT01523587|101597131|FG000|Overall Study|Withdrawal by Subject|28|||
33465991|NCT01523587|101597132|FG001|Overall Study|Withdrawal by Subject|20|||
33465992|NCT01523587|101597131|FG000|Overall Study|Withdrew due to Progressive disease|265|||
33465993|NCT01523587|101597132|FG001|Overall Study|Withdrew due to Progressive disease|279|||
33465994|NCT01523587|101597131|FG000|Overall Study|Randomised but bot treated|6|||
33465995|NCT01523587|101597132|FG001|Overall Study|Randomised but bot treated|2|||
33465996|NCT01253317|101597133|FG000|Overall Study|Adverse Event|2|||
33465997|NCT00743509|101597134|FG000|Overall Study|Withdrawal by Subject|2|||
33465998|NCT03718117|101597135|FG000|Overall Study|Death|12|||
33465999|NCT03718117|101597136|FG001|Overall Study|Death|11|||
33466000|NCT03718117|101597137|FG002|Overall Study|Death|0|||
33466001|NCT03718117|101597135|FG000|Overall Study|Other|0|||
33466002|NCT03718117|101597136|FG001|Overall Study|Other|1|||
33466003|NCT03718117|101597137|FG002|Overall Study|Other|0|||
33466004|NCT03718117|101597135|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
33466005|NCT03718117|101597136|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
33466006|NCT03718117|101597137|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
33466007|NCT03718117|101597135|FG000|Overall Study|Participant not met eligibility criteria|0|||
33466008|NCT03718117|101597136|FG001|Overall Study|Participant not met eligibility criteria|0|||
33466009|NCT03718117|101597137|FG002|Overall Study|Participant not met eligibility criteria|2|||
33466010|NCT04412057|101597138|FG000|Overall Study|Death|3|||
33466011|NCT04412057|101597139|FG001|Overall Study|Death|7|||
33466012|NCT04412057|101597138|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
33466013|NCT04412057|101597139|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
33466014|NCT00518622|101597140|FG000|Overall Study|Lost to Follow-up|0|||
33466015|NCT00518622|101597141|FG001|Overall Study|Lost to Follow-up|0|||
33466016|NCT00518622|101597142|FG002|Overall Study|Lost to Follow-up|1|||
33466017|NCT00518622|101597143|FG003|Overall Study|Lost to Follow-up|0|||
33466018|NCT00518622|101597144|FG004|Overall Study|Lost to Follow-up|0|||
33466019|NCT00518622|101597145|FG005|Overall Study|Lost to Follow-up|0|||
33466020|NCT00518622|101597146|FG006|Overall Study|Lost to Follow-up|0|||
33466021|NCT00518622|101597147|FG007|Overall Study|Lost to Follow-up|0|||
33466022|NCT00518622|101597140|FG000|Overall Study|Study medication taken incorrectly|0|||
33466023|NCT00518622|101597141|FG001|Overall Study|Study medication taken incorrectly|1|||
33466024|NCT00518622|101597142|FG002|Overall Study|Study medication taken incorrectly|0|||
33466025|NCT00518622|101597143|FG003|Overall Study|Study medication taken incorrectly|0|||
33466026|NCT00518622|101597144|FG004|Overall Study|Study medication taken incorrectly|0|||
33466027|NCT00518622|101597145|FG005|Overall Study|Study medication taken incorrectly|0|||
33466028|NCT00518622|101597146|FG006|Overall Study|Study medication taken incorrectly|0|||
33466029|NCT00518622|101597147|FG007|Overall Study|Study medication taken incorrectly|0|||
33466030|NCT04213209|101597148|FG000|Overall Study|Protocol Violation|1|||
33466031|NCT04213209|101597149|FG001|Overall Study|Protocol Violation|0|||
33466032|NCT04213209|101597150|FG002|Overall Study|Protocol Violation|0|||
33466033|NCT04213209|101597151|FG003|Overall Study|Protocol Violation|0|||
33466034|NCT04213209|101597152|FG004|Overall Study|Protocol Violation|0|||
33466035|NCT04213209|101597153|FG005|Overall Study|Protocol Violation|0|||
33466036|NCT02427984|101597156|FG000|Overall Study|Lost to Follow-up|13|||
33466037|NCT02427984|101597157|FG001|Overall Study|Lost to Follow-up|5|||
33466038|NCT02427984|101597158|FG002|Overall Study|Lost to Follow-up|18|||
33466039|NCT02012452|101597159|FG000|Overall Study|Lost to Follow-up|2|||
33466040|NCT02012452|101597160|FG001|Overall Study|Lost to Follow-up|1|||
33466041|NCT02012452|101597159|FG000|Overall Study|Withdrawal by Subject|4|||
33466042|NCT02012452|101597160|FG001|Overall Study|Withdrawal by Subject|0|||
33466043|NCT03395639|101597162|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
33466044|NCT03395639|101597163|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
33466045|NCT03395639|101597164|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
33466046|NCT03395639|101597162|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
33466047|NCT03395639|101597163|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
33466048|NCT03395639|101597164|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
33466049|NCT03395639|101597162|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
33466050|NCT03395639|101597163|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
33466051|NCT03395639|101597164|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
33466052|NCT03395639|101597162|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
33466053|NCT03395639|101597163|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
33466054|NCT03395639|101597164|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
33466055|NCT03395639|101597162|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
33466056|NCT03395639|101597163|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
33466057|NCT03395639|101597164|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
33466058|NCT02014441|101597172|FG000|Overall Study|Withdrawal by Subject|12|||
33466059|NCT01467479|101597173|FG000|Overall Study|No Study Medication|1|||
33466060|NCT01467479|101597174|FG001|Overall Study|No Study Medication|0|||
33466061|NCT01467479|101597175|FG002|Overall Study|No Study Medication|2|||
33466062|NCT01467479|101597173|FG000|Overall Study|Adverse Event|1|||
33466063|NCT01467479|101597174|FG001|Overall Study|Adverse Event|2|||
33466064|NCT01467479|101597175|FG002|Overall Study|Adverse Event|0|||
33466065|NCT01467479|101597173|FG000|Overall Study|Death|0|||
33466066|NCT01467479|101597174|FG001|Overall Study|Death|0|||
33466067|NCT01467479|101597175|FG002|Overall Study|Death|1|||
33466068|NCT01467479|101597173|FG000|Overall Study|Lost to Follow-up|2|||
33466069|NCT01467479|101597174|FG001|Overall Study|Lost to Follow-up|5|||
33466070|NCT01467479|101597175|FG002|Overall Study|Lost to Follow-up|3|||
33466071|NCT01467479|101597173|FG000|Overall Study|Withdrawal of Consent|3|||
33466072|NCT01467479|101597174|FG001|Overall Study|Withdrawal of Consent|7|||
33466073|NCT01467479|101597175|FG002|Overall Study|Withdrawal of Consent|7|||
33466074|NCT01467479|101597173|FG000|Overall Study|Study Terminated by Sponsor|1|||
33466075|NCT01467479|101597174|FG001|Overall Study|Study Terminated by Sponsor|3|||
33466076|NCT01467479|101597175|FG002|Overall Study|Study Terminated by Sponsor|3|||
33466077|NCT01467479|101597173|FG000|Overall Study|Other|1|||
33466078|NCT01467479|101597174|FG001|Overall Study|Other|0|||
33466079|NCT01467479|101597175|FG002|Overall Study|Other|0|||
33466080|NCT00707434|101597176|FG000|Overall Study|Adverse Event|1|||
33466081|NCT01961882|101597178|FG000|Overall Study|Adverse Event|3|||
33466082|NCT01961882|101597179|FG001|Overall Study|Adverse Event|2|||
33466083|NCT01961882|101597178|FG000|Overall Study|Physician Decision|1|||
33466084|NCT01961882|101597179|FG001|Overall Study|Physician Decision|0|||
33466085|NCT01961882|101597178|FG000|Overall Study|Withdrawal by Subject|4|||
33466086|NCT01961882|101597179|FG001|Overall Study|Withdrawal by Subject|1|||
33466087|NCT01961882|101597178|FG000|Overall Study|Relapse of AML|39|||
33466088|NCT01961882|101597179|FG001|Overall Study|Relapse of AML|37|||
33466089|NCT01961882|101597178|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
33466090|NCT01961882|101597179|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
33466091|NCT01961882|101597178|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
33466092|NCT01961882|101597179|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
33466093|NCT01286558|101597184|FG000|Overall Study|Adverse Event|1|||
33466094|NCT01286558|101597185|FG001|Overall Study|Adverse Event|1|||
33466095|NCT01286558|101597184|FG000|Overall Study|Withdrawal by Subject|0|||
33466096|NCT01286558|101597185|FG001|Overall Study|Withdrawal by Subject|1|||
33466097|NCT01552369|101597186|FG000|Overall Study|Did not consent to extended follow up|8|||
33466098|NCT01552369|101597187|FG001|Overall Study|Did not consent to extended follow up|9|||
33466099|NCT01885182|101597188|FG000|Overall Study|Adverse Event|11|||
33466100|NCT01885182|101597189|FG001|Overall Study|Adverse Event|13|||
33466101|NCT01885182|101597188|FG000|Overall Study|Withdrawal by Subject|13|||
33466102|NCT01885182|101597189|FG001|Overall Study|Withdrawal by Subject|6|||
33466103|NCT01885182|101597188|FG000|Overall Study|Lost to Follow-up|2|||
33466104|NCT01885182|101597189|FG001|Overall Study|Lost to Follow-up|2|||
33466105|NCT01885182|101597188|FG000|Overall Study|Lack of Efficacy|8|||
33466106|NCT01885182|101597189|FG001|Overall Study|Lack of Efficacy|1|||
33466107|NCT01684215|101597190|FG000|Phase 1, Part 1|Adverse Event|1|||
33466108|NCT01684215|101597191|FG001|Phase 1, Part 1|Adverse Event|0|||
33466109|NCT01684215|101597192|FG002|Phase 1, Part 1|Adverse Event|0|||
33466110|NCT01684215|101597193|FG003|Phase 1, Part 1|Adverse Event|0|||
33466111|NCT01684215|101597190|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
33466112|NCT01684215|101597191|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
33466113|NCT01684215|101597192|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
33466114|NCT01684215|101597193|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
33466115|NCT01684215|101597190|FG000|Phase 1, Part 2|Adverse Event|0|||
33177587|NCT02864251|100560246|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
33466116|NCT01684215|101597191|FG001|Phase 1, Part 2|Adverse Event|0|||
33466117|NCT01684215|101597192|FG002|Phase 1, Part 2|Adverse Event|1|||
33466118|NCT01684215|101597193|FG003|Phase 1, Part 2|Adverse Event|0|||
33177588|NCT02864251|100560244|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
33466119|NCT01684215|101597190|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
33466120|NCT01684215|101597191|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
33466121|NCT01684215|101597192|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
33466122|NCT01684215|101597193|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
33466123|NCT01684215|101597190|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
33466124|NCT01684215|101597191|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
33466125|NCT01684215|101597192|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
33466126|NCT01684215|101597193|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
33466127|NCT01684215|101597190|FG000|Phase 2|Death|0|||
33466128|NCT01684215|101597191|FG001|Phase 2|Death|0|||
33466129|NCT01684215|101597192|FG002|Phase 2|Death|0|||
33466130|NCT01684215|101597193|FG003|Phase 2|Death|8|||
33466131|NCT01684215|101597190|FG000|Phase 2|Study terminated by sponsor|0|||
33466132|NCT01684215|101597191|FG001|Phase 2|Study terminated by sponsor|0|||
33466133|NCT01684215|101597192|FG002|Phase 2|Study terminated by sponsor|0|||
33466134|NCT01684215|101597193|FG003|Phase 2|Study terminated by sponsor|30|||
33466135|NCT01684215|101597190|FG000|Phase 2|Enrolled but not treated|0|||
33466136|NCT01684215|101597191|FG001|Phase 2|Enrolled but not treated|0|||
33466137|NCT01684215|101597192|FG002|Phase 2|Enrolled but not treated|0|||
33466138|NCT01684215|101597193|FG003|Phase 2|Enrolled but not treated|1|||
33466139|NCT01684215|101597190|FG000|Phase 2|Lost to Follow-up|0|||
33466140|NCT01684215|101597191|FG001|Phase 2|Lost to Follow-up|0|||
33466141|NCT01684215|101597192|FG002|Phase 2|Lost to Follow-up|0|||
33466142|NCT01684215|101597193|FG003|Phase 2|Lost to Follow-up|4|||
33466143|NCT01132664|101597194|FG000|Phase lb|Adverse Event|0|||
33466144|NCT01132664|101597195|FG001|Phase lb|Adverse Event|1|||
33177589|NCT02864251|100560245|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
33177590|NCT02864251|100560246|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
33177591|NCT02864251|100560244|FG000|Treatment|Withdrawal by Participant|8|||
33177592|NCT02864251|100560245|FG001|Treatment|Withdrawal by Participant|5|||
33177593|NCT02864251|100560246|FG002|Treatment|Withdrawal by Participant|13|||
33177594|NCT02864251|100560244|FG000|Treatment|Maximum Clinical Benefit|1|||
33177595|NCT02864251|100560245|FG001|Treatment|Maximum Clinical Benefit|0|||
33177596|NCT02864251|100560246|FG002|Treatment|Maximum Clinical Benefit|1|||
33177597|NCT02864251|100560244|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
33177598|NCT02864251|100560245|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
33177599|NCT02864251|100560246|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
33177600|NCT02864251|100560244|FG000|Treatment|Other Reasons|1|||
33177601|NCT02864251|100560245|FG001|Treatment|Other Reasons|1|||
33177602|NCT02864251|100560246|FG002|Treatment|Other Reasons|4|||
33177603|NCT02864251|100560244|FG000|Treatment|Administrative Reason by Sponsor|1|||
33177604|NCT02864251|100560245|FG001|Treatment|Administrative Reason by Sponsor|0|||
33177605|NCT02864251|100560246|FG002|Treatment|Administrative Reason by Sponsor|0|||
33177606|NCT02063854|100560247|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
33177607|NCT02063854|100560248|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
33177608|NCT02063854|100560249|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
33177609|NCT02063854|100560250|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
33177610|NCT02063854|100560251|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
33177611|NCT02063854|100560252|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
33177612|NCT02063854|100560253|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
33177613|NCT02063854|100560247|FG000|Overall Study|Major Protocol Deviation|0|||
33177614|NCT02063854|100560248|FG001|Overall Study|Major Protocol Deviation|0|||
33177615|NCT02063854|100560249|FG002|Overall Study|Major Protocol Deviation|3|||
33177616|NCT02063854|100560250|FG003|Overall Study|Major Protocol Deviation|0|||
33177617|NCT02063854|100560251|FG004|Overall Study|Major Protocol Deviation|0|||
33177618|NCT02063854|100560252|FG005|Overall Study|Major Protocol Deviation|0|||
33177619|NCT02063854|100560253|FG006|Overall Study|Major Protocol Deviation|0|||
33177620|NCT02063854|100560247|FG000|Overall Study|Voluntary Withdrawal|2|||
33177621|NCT02063854|100560248|FG001|Overall Study|Voluntary Withdrawal|0|||
33177622|NCT02063854|100560249|FG002|Overall Study|Voluntary Withdrawal|8|||
33177623|NCT02063854|100560250|FG003|Overall Study|Voluntary Withdrawal|1|||
33263982|NCT01340066|100866832|FG001|Placebo Run in Period|Screen Failures|0|||
33263983|NCT01340066|100866833|FG002|Placebo Run in Period|Screen Failures|0|||
33466145|NCT01132664|101597196|FG002|Phase lb|Adverse Event|0|||
33466146|NCT01132664|101597197|FG003|Phase lb|Adverse Event|0|||
33466147|NCT01132664|101597198|FG004|Phase lb|Adverse Event|0|||
33466148|NCT01132664|101597194|FG000|Phase lb|Withdrawal by Subject|1|||
33177624|NCT02063854|100560251|FG004|Overall Study|Voluntary Withdrawal|3|||
33177625|NCT02063854|100560252|FG005|Overall Study|Voluntary Withdrawal|6|||
33177626|NCT02063854|100560253|FG006|Overall Study|Voluntary Withdrawal|1|||
33177627|NCT02063854|100560247|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
33263984|NCT01340066|100866831|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
33466149|NCT01132664|101597195|FG001|Phase lb|Withdrawal by Subject|2|||
33466150|NCT01132664|101597196|FG002|Phase lb|Withdrawal by Subject|0|||
33466151|NCT01132664|101597197|FG003|Phase lb|Withdrawal by Subject|0|||
33466152|NCT01132664|101597198|FG004|Phase lb|Withdrawal by Subject|0|||
33177628|NCT02063854|100560248|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
33177629|NCT02063854|100560249|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
33177630|NCT02063854|100560250|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
33177631|NCT02063854|100560251|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
33177632|NCT02063854|100560252|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
33177633|NCT02063854|100560253|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
33177634|NCT02063854|100560247|FG000|Overall Study|Reason Not Specified|1|||
33177635|NCT02063854|100560248|FG001|Overall Study|Reason Not Specified|0|||
33177636|NCT02063854|100560249|FG002|Overall Study|Reason Not Specified|0|||
33177637|NCT02063854|100560250|FG003|Overall Study|Reason Not Specified|0|||
33177638|NCT02063854|100560251|FG004|Overall Study|Reason Not Specified|0|||
33177639|NCT02063854|100560252|FG005|Overall Study|Reason Not Specified|0|||
33177640|NCT02063854|100560253|FG006|Overall Study|Reason Not Specified|0|||
33177641|NCT02063854|100560247|FG000|Overall Study|Did Not Receive Study Drug|0|||
33177642|NCT02063854|100560248|FG001|Overall Study|Did Not Receive Study Drug|0|||
33177643|NCT02063854|100560249|FG002|Overall Study|Did Not Receive Study Drug|0|||
33177644|NCT02063854|100560250|FG003|Overall Study|Did Not Receive Study Drug|0|||
33177645|NCT02063854|100560251|FG004|Overall Study|Did Not Receive Study Drug|0|||
33466153|NCT01132664|101597194|FG000|Phase lb|Disease Progression|4|||
33466154|NCT01132664|101597195|FG001|Phase lb|Disease Progression|9|||
33466155|NCT01132664|101597196|FG002|Phase lb|Disease Progression|0|||
33466156|NCT01132664|101597197|FG003|Phase lb|Disease Progression|0|||
33466157|NCT01132664|101597198|FG004|Phase lb|Disease Progression|0|||
33466158|NCT01132664|101597194|FG000|Phase ll|Death|0|||
33466159|NCT01132664|101597195|FG001|Phase ll|Death|0|||
33466160|NCT01132664|101597196|FG002|Phase ll|Death|2|||
33466161|NCT01132664|101597197|FG003|Phase ll|Death|0|||
33466162|NCT01132664|101597198|FG004|Phase ll|Death|0|||
33466163|NCT01132664|101597194|FG000|Phase ll|Adverse Event|0|||
33466164|NCT01132664|101597195|FG001|Phase ll|Adverse Event|0|||
33466165|NCT01132664|101597196|FG002|Phase ll|Adverse Event|10|||
33466166|NCT01132664|101597197|FG003|Phase ll|Adverse Event|0|||
33466167|NCT01132664|101597198|FG004|Phase ll|Adverse Event|0|||
33466168|NCT01132664|101597194|FG000|Phase ll|Withdrawal by Subject|0|||
33466169|NCT01132664|101597195|FG001|Phase ll|Withdrawal by Subject|0|||
33466170|NCT01132664|101597196|FG002|Phase ll|Withdrawal by Subject|3|||
33466171|NCT01132664|101597197|FG003|Phase ll|Withdrawal by Subject|0|||
33466172|NCT01132664|101597198|FG004|Phase ll|Withdrawal by Subject|0|||
33466173|NCT01132664|101597194|FG000|Phase ll|Disease progression|0|||
33466174|NCT01132664|101597195|FG001|Phase ll|Disease progression|0|||
33466175|NCT01132664|101597196|FG002|Phase ll|Disease progression|35|||
33466176|NCT01132664|101597197|FG003|Phase ll|Disease progression|0|||
33466177|NCT01132664|101597198|FG004|Phase ll|Disease progression|0|||
33466178|NCT01132664|101597194|FG000|BM Cohort|Disease progression|0|||
33466179|NCT01132664|101597195|FG001|BM Cohort|Disease progression|0|||
33466180|NCT01132664|101597196|FG002|BM Cohort|Disease progression|0|||
33466181|NCT01132664|101597197|FG003|BM Cohort|Disease progression|3|||
33466182|NCT01132664|101597198|FG004|BM Cohort|Disease progression|4|||
33466183|NCT01132664|101597194|FG000|BM Cohort|Adverse Event|0|||
33466184|NCT01132664|101597195|FG001|BM Cohort|Adverse Event|0|||
33466185|NCT01132664|101597196|FG002|BM Cohort|Adverse Event|0|||
33466186|NCT01132664|101597197|FG003|BM Cohort|Adverse Event|0|||
33466187|NCT01132664|101597198|FG004|BM Cohort|Adverse Event|1|||
33466188|NCT01132664|101597194|FG000|BM Cohort|Withdrawal by Subject|0|||
33466189|NCT01132664|101597195|FG001|BM Cohort|Withdrawal by Subject|0|||
33466190|NCT01132664|101597196|FG002|BM Cohort|Withdrawal by Subject|0|||
33466191|NCT01132664|101597197|FG003|BM Cohort|Withdrawal by Subject|0|||
33466192|NCT01132664|101597198|FG004|BM Cohort|Withdrawal by Subject|1|||
33466193|NCT02356211|101597199|FG000|Overall Study|Withdrawal by Subject|2|||
33466194|NCT02356211|101597200|FG001|Overall Study|Withdrawal by Subject|2|||
33466195|NCT02356211|101597199|FG000|Overall Study|ineligible|1|||
33466196|NCT02356211|101597200|FG001|Overall Study|ineligible|8|||
33466197|NCT01640184|101597201|FG000|Overall Study|Death|1|||
33466198|NCT01640184|101597202|FG001|Overall Study|Death|0|||
33466199|NCT01640184|101597203|FG002|Overall Study|Death|0|||
33466200|NCT01640184|101597201|FG000|Overall Study|Lost to Follow-up|4|||
33466201|NCT01640184|101597202|FG001|Overall Study|Lost to Follow-up|1|||
33466202|NCT01640184|101597203|FG002|Overall Study|Lost to Follow-up|0|||
33177646|NCT02063854|100560252|FG005|Overall Study|Did Not Receive Study Drug|1|||
33177647|NCT02063854|100560253|FG006|Overall Study|Did Not Receive Study Drug|0|||
33177648|NCT01408030|100560260|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
33177649|NCT01408030|100560261|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
33466203|NCT01640184|101597201|FG000|Overall Study|Physician Decision|3|||
33466204|NCT01640184|101597202|FG001|Overall Study|Physician Decision|0|||
33466205|NCT01640184|101597203|FG002|Overall Study|Physician Decision|0|||
33466206|NCT01640184|101597201|FG000|Overall Study|Withdrawal by Subject|0|||
33466207|NCT01640184|101597202|FG001|Overall Study|Withdrawal by Subject|1|||
33466208|NCT01640184|101597203|FG002|Overall Study|Withdrawal by Subject|1|||
33466209|NCT01640184|101597201|FG000|Overall Study|Protocol Violation|0|||
33466210|NCT01640184|101597202|FG001|Overall Study|Protocol Violation|0|||
33466211|NCT01640184|101597203|FG002|Overall Study|Protocol Violation|1|||
33466212|NCT00407745|101597204|FG000|Overall Study|Lack of Efficacy|1|||
33466213|NCT00407745|101597205|FG001|Overall Study|Lack of Efficacy|2|||
33466214|NCT00407745|101597204|FG000|Overall Study|Withdrawal by Subject|3|||
33466215|NCT00407745|101597205|FG001|Overall Study|Withdrawal by Subject|3|||
33466216|NCT00407745|101597204|FG000|Overall Study|Protocol Violation|5|||
33466217|NCT00407745|101597205|FG001|Overall Study|Protocol Violation|3|||
33466218|NCT00407745|101597204|FG000|Overall Study|Adverse Event|8|||
33466219|NCT00407745|101597205|FG001|Overall Study|Adverse Event|8|||
33466220|NCT00407745|101597204|FG000|Overall Study|Other|2|||
33466221|NCT00407745|101597205|FG001|Overall Study|Other|0|||
33466222|NCT00407745|101597204|FG000|Overall Study|Randomized, unknown if treated|0|||
33466223|NCT00407745|101597205|FG001|Overall Study|Randomized, unknown if treated|1|||
33466224|NCT01684878|101597210|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
33466225|NCT01684878|101597211|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
33466226|NCT01684878|101597212|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
33466227|NCT01684878|101597213|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
33466228|NCT01684878|101597210|FG000|Part 1: Safety Run in Phase|Death|15|||
33466229|NCT01684878|101597211|FG001|Part 1: Safety Run in Phase|Death|20|||
33466230|NCT01684878|101597212|FG002|Part 1: Safety Run in Phase|Death|0|||
33466231|NCT01684878|101597213|FG003|Part 1: Safety Run in Phase|Death|0|||
33466232|NCT01684878|101597210|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
33466233|NCT01684878|101597211|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
33466234|NCT01684878|101597212|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
33466235|NCT01684878|101597213|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
33466236|NCT01684878|101597210|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
33466237|NCT01684878|101597211|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
33466238|NCT01684878|101597212|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
33466239|NCT01684878|101597213|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
33466240|NCT01684878|101597210|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
33466241|NCT01684878|101597211|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
33466242|NCT01684878|101597212|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
33466243|NCT01684878|101597213|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
33466244|NCT01684878|101597210|FG000|Part 2: Randomized Phase|Death|0|||
33466245|NCT01684878|101597211|FG001|Part 2: Randomized Phase|Death|0|||
33466246|NCT01684878|101597212|FG002|Part 2: Randomized Phase|Death|62|||
33466247|NCT01684878|101597213|FG003|Part 2: Randomized Phase|Death|68|||
33466248|NCT01684878|101597210|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
33466249|NCT01684878|101597211|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
33466250|NCT01684878|101597212|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
33466251|NCT01684878|101597213|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
33177650|NCT01408030|100560262|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
33177651|NCT01408030|100560263|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
33177652|NCT01408030|100560260|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
33177653|NCT01408030|100560261|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
33177654|NCT01408030|100560262|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
33177655|NCT01408030|100560263|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
33177656|NCT01408030|100560260|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
33177657|NCT01408030|100560261|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
33263985|NCT01340066|100866832|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
33263986|NCT01340066|100866833|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
33263987|NCT01340066|100866831|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
33263988|NCT01340066|100866832|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
33263989|NCT01340066|100866833|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
33263990|NCT01340066|100866831|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
33263991|NCT01340066|100866832|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
33263992|NCT01340066|100866833|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
33263993|NCT01084694|100866834|FG000|Overall Study|Withdrawal by Subject|2|||
33466252|NCT01684878|101597210|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
33466253|NCT01684878|101597211|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
33466254|NCT01684878|101597212|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
33466255|NCT01684878|101597213|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
33466256|NCT00233987|101597214|FG000|Overall Study|Withdrawal by Subject|1|||
33466257|NCT00233987|101597214|FG000|Overall Study|Lack of Efficacy|2|||
33177658|NCT01408030|100560262|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
33177659|NCT01408030|100560263|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
33466258|NCT00233987|101597214|FG000|Overall Study|Reason Under Review|1|||
33466259|NCT00233987|101597214|FG000|Overall Study|Other - Not Protocol Specified|5|||
33466260|NCT00233987|101597214|FG000|Overall Study|Eligible but No Treatment Received|2|||
33177660|NCT01408030|100560260|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
33263994|NCT01084694|100866835|FG001|Overall Study|Withdrawal by Subject|1|||
33263995|NCT01084694|100866834|FG000|Overall Study|Death|2|||
33263996|NCT01084694|100866835|FG001|Overall Study|Death|12|||
33177661|NCT01408030|100560261|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
33177662|NCT01408030|100560262|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
33177663|NCT01408030|100560263|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
33177664|NCT01408030|100560260|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
33177665|NCT01408030|100560261|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
33177666|NCT01408030|100560262|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
33177667|NCT01408030|100560263|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
33177668|NCT01408030|100560260|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
33177669|NCT01408030|100560261|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
33177670|NCT01408030|100560262|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
33263997|NCT01084694|100866834|FG000|Overall Study|eligibility not maintained|2|||
33263998|NCT01084694|100866835|FG001|Overall Study|eligibility not maintained|7|||
33177671|NCT01408030|100560263|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
33177672|NCT01408030|100560260|FG000|Observation Phase (Off Drug)|Other|1|||
33177673|NCT01408030|100560261|FG001|Observation Phase (Off Drug)|Other|1|||
33177674|NCT01408030|100560262|FG002|Observation Phase (Off Drug)|Other|1|||
33177675|NCT01408030|100560263|FG003|Observation Phase (Off Drug)|Other|1|||
33177676|NCT01333059|100560267|FG000|Overall Study|Physician Decision|3|||
33177677|NCT01333059|100560268|FG001|Overall Study|Physician Decision|3|||
33177678|NCT01333059|100560267|FG000|Overall Study|Protocol Violation|3|||
33177679|NCT01333059|100560268|FG001|Overall Study|Protocol Violation|0|||
33177680|NCT03312933|100560269|FG000|Overall Study|Protocol Violation|15|||
33177681|NCT03312933|100560269|FG000|Overall Study|Lost to Follow-up|36|||
33177682|NCT03312933|100560269|FG000|Overall Study|Withdrawal by Subject|3|||
33177683|NCT00759863|100560270|FG000|Overall Study|Death, moved, or lost contact|20|||
33177684|NCT00759863|100560271|FG001|Overall Study|Death, moved, or lost contact|18|||
33177685|NCT01356966|100560276|FG000|Overall Study|Withdrawal by Subject|1|||
33177686|NCT01356966|100560277|FG001|Overall Study|Withdrawal by Subject|2|||
33177687|NCT01356966|100560276|FG000|Overall Study|Physician Decision|1|||
33177688|NCT01356966|100560277|FG001|Overall Study|Physician Decision|0|||
33263999|NCT02406092|100866843|FG000|Overall Study|Screen failure|10|||
33264000|NCT02406092|100866844|FG001|Overall Study|Screen failure|7|||
33264001|NCT02406092|100866843|FG000|Overall Study|Death|22|||
33466261|NCT00233987|101597214|FG000|Overall Study|Ineligible|4|||
33466262|NCT02181296|101597215|FG000|Overall Study|Lost to Follow-up|7|||
33466263|NCT02181296|101597216|FG001|Overall Study|Lost to Follow-up|6|||
33466264|NCT00966381|101597219|FG000|Overall Study|Withdrawal by Subject|2|||
33466265|NCT00966381|101597220|FG001|Overall Study|Withdrawal by Subject|2|||
33466266|NCT01729026|101597226|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
33264002|NCT02406092|100866844|FG001|Overall Study|Death|5|||
33264003|NCT02406092|100866843|FG000|Overall Study|Lost to Follow-up|4|||
33466267|NCT01729026|101597227|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
33466268|NCT01729026|101597226|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
33466269|NCT01729026|101597227|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
33466270|NCT01915940|101597236|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
33466271|NCT01915940|101597237|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
33466272|NCT01915940|101597238|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
33466273|NCT01915940|101597236|FG000|Treatment Period|Decision of Participant|0|||
33466274|NCT01915940|101597237|FG001|Treatment Period|Decision of Participant|1|||
33466275|NCT01915940|101597238|FG002|Treatment Period|Decision of Participant|3|||
33466276|NCT01915940|101597236|FG000|Treatment Period|Adverse Event|0|||
33466277|NCT01915940|101597237|FG001|Treatment Period|Adverse Event|9|||
33466278|NCT01915940|101597238|FG002|Treatment Period|Adverse Event|1|||
33466279|NCT01915940|101597236|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
33466280|NCT01915940|101597237|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
33466281|NCT01915940|101597238|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
33466282|NCT00194792|101597243|FG000|Overall Study|Withdrawal by Subject|1|||
33466283|NCT00702208|101597256|FG000|Overall Study|Lost to Follow-up|28|||
33466284|NCT00702208|101597256|FG000|Overall Study|Did not self-lavage|1|||
33177689|NCT00249444|100560278|FG000|Overall Study|Lost to Follow-up|2|||
33177690|NCT00249444|100560279|FG001|Overall Study|Lost to Follow-up|2|||
33177691|NCT00249444|100560278|FG000|Overall Study|non-compliant|9|||
33177692|NCT00249444|100560279|FG001|Overall Study|non-compliant|11|||
33264004|NCT02406092|100866844|FG001|Overall Study|Lost to Follow-up|1|||
33264005|NCT02406092|100866843|FG000|Overall Study|Adverse Event|1|||
33466285|NCT00702208|101597256|FG000|Overall Study|Unsatisfactory colposcopy|2|||
33466286|NCT02674633|101597257|FG000|Overall Study|Lost to Follow-up|3|||
33466287|NCT02674633|101597258|FG001|Overall Study|Lost to Follow-up|2|||
33264006|NCT02406092|100866844|FG001|Overall Study|Adverse Event|0|||
33264007|NCT02406092|100866843|FG000|Overall Study|Withdrawal by Subject|1|||
33466288|NCT02674633|101597257|FG000|Overall Study|Physician Decision|1|||
33264008|NCT02406092|100866844|FG001|Overall Study|Withdrawal by Subject|0|||
33466289|NCT02674633|101597258|FG001|Overall Study|Physician Decision|0|||
33466290|NCT02674633|101597257|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
33466291|NCT02674633|101597258|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
33466292|NCT01688726|101597259|FG000|Overall Study|Adverse Event|1|||
33466293|NCT01688726|101597260|FG001|Overall Study|Adverse Event|0|||
33466294|NCT01688726|101597259|FG000|Overall Study|Relocated abroad|0|||
33264009|NCT02513667|100866846|FG000|Overall Study|Withdrawal by Subject|0|||
33264010|NCT02513667|100866847|FG001|Overall Study|Withdrawal by Subject|1|||
33264011|NCT03890289|100866848|FG000|Overall Study|Adverse Event|1|||
33264012|NCT03890289|100866848|FG000|Overall Study|Physician Decision|1|||
33264013|NCT03890289|100866848|FG000|Overall Study|Lack of Efficacy|2|||
33264014|NCT01593020|100866849|FG000|Overall Study|Adverse Event|1|||
33264015|NCT01593020|100866850|FG001|Overall Study|Adverse Event|1|||
33264016|NCT01593020|100866849|FG000|Overall Study|Death|0|||
33264017|NCT01593020|100866850|FG001|Overall Study|Death|1|||
33264018|NCT01593020|100866849|FG000|Overall Study|Ineligible|1|||
33264019|NCT01593020|100866850|FG001|Overall Study|Ineligible|0|||
33264020|NCT01759862|100866851|FG000|Overall Study|Physician Decision|3|||
33264021|NCT01759862|100866852|FG001|Overall Study|Physician Decision|1|||
33466295|NCT01688726|101597260|FG001|Overall Study|Relocated abroad|1|||
33466296|NCT00987831|101597261|FG000|Overall Study|Never flared in 12 months|1|||
33466297|NCT00987831|101597262|FG001|Overall Study|Never flared in 12 months|0|||
33466298|NCT00987831|101597263|FG002|Overall Study|Never flared in 12 months|0|||
33466299|NCT00987831|101597261|FG000|Overall Study|Lost to Follow-up|0|||
33466300|NCT00987831|101597262|FG001|Overall Study|Lost to Follow-up|3|||
33466301|NCT00987831|101597263|FG002|Overall Study|Lost to Follow-up|0|||
33466302|NCT00099268|101597264|FG000|Overall Study|Withdrawal by Subject|46|||
33466303|NCT00099268|101597265|FG001|Overall Study|Withdrawal by Subject|28|||
33177693|NCT00249444|100560278|FG000|Overall Study|Adverse Event|1|||
33177694|NCT00249444|100560279|FG001|Overall Study|Adverse Event|1|||
33177695|NCT00249444|100560278|FG000|Overall Study|life event|0|||
33177696|NCT00249444|100560279|FG001|Overall Study|life event|1|||
33177697|NCT01710033|100560280|FG000|Stage 2|Adverse Event|0|||
33177698|NCT01710033|100560281|FG001|Stage 2|Adverse Event|0|||
33177699|NCT01710033|100560282|FG002|Stage 2|Adverse Event|0|||
33177700|NCT01710033|100560283|FG003|Stage 2|Adverse Event|0|||
33177701|NCT01710033|100560284|FG004|Stage 2|Adverse Event|1|||
33177702|NCT00410046|100560291|FG000|Overall Study|Adverse Event|3|||
33177703|NCT00410046|100560291|FG000|Overall Study|Withdrawal by Subject|1|||
33177704|NCT00410046|100560291|FG000|Overall Study|Lost to Follow-up|1|||
33177705|NCT01034462|100560292|FG000|Overall Study|Adverse Event|7|||
33177706|NCT01034462|100560293|FG001|Overall Study|Adverse Event|17|||
33177707|NCT01034462|100560292|FG000|Overall Study|Lack of Efficacy|4|||
33177708|NCT01034462|100560293|FG001|Overall Study|Lack of Efficacy|4|||
33177709|NCT01034462|100560292|FG000|Overall Study|Protocol Violation|10|||
33177710|NCT01034462|100560293|FG001|Overall Study|Protocol Violation|7|||
33177711|NCT01034462|100560292|FG000|Overall Study|Withdrawal by Subject|9|||
33177712|NCT01034462|100560293|FG001|Overall Study|Withdrawal by Subject|8|||
33177713|NCT01034462|100560292|FG000|Overall Study|Lost to Follow-up|14|||
33177714|NCT01034462|100560293|FG001|Overall Study|Lost to Follow-up|16|||
33177715|NCT01034462|100560292|FG000|Overall Study|Other reasons|1|||
33177716|NCT01034462|100560293|FG001|Overall Study|Other reasons|2|||
33177717|NCT02588833|100560296|FG000|Part 1|Withdrawal by Subject|1|||
33177718|NCT02588833|100560297|FG001|Part 1|Withdrawal by Subject|0|||
33177719|NCT02588833|100560296|FG000|Part 2A|Physician Decision|0|||
33177720|NCT02588833|100560297|FG001|Part 2A|Physician Decision|1|||
33177721|NCT02588833|100560296|FG000|Part 2A|Withdrawal by Subject|0|||
33177722|NCT02588833|100560297|FG001|Part 2A|Withdrawal by Subject|1|||
33177723|NCT02588833|100560296|FG000|Part 2B|Adverse Event|0|||
33177724|NCT02588833|100560297|FG001|Part 2B|Adverse Event|1|||
33177725|NCT02588833|100560296|FG000|Part 2C|Adverse Event|0|||
33177726|NCT02588833|100560297|FG001|Part 2C|Adverse Event|1|||
33177727|NCT02588833|100560296|FG000|Part 2C|Withdrawal by Subject|0|||
33264022|NCT01759862|100866851|FG000|Overall Study|Adverse Event|0|||
33466304|NCT00099268|101597264|FG000|Overall Study|Adverse Event|19|||
33466305|NCT00099268|101597265|FG001|Overall Study|Adverse Event|19|||
33466306|NCT00099268|101597264|FG000|Overall Study|Protocol Violation|9|||
33466307|NCT00099268|101597265|FG001|Overall Study|Protocol Violation|8|||
33466308|NCT00099268|101597264|FG000|Overall Study|Lost to Follow-up|6|||
33466309|NCT00099268|101597265|FG001|Overall Study|Lost to Follow-up|4|||
33177728|NCT02588833|100560297|FG001|Part 2C|Withdrawal by Subject|1|||
33177729|NCT02588833|100560296|FG000|Part 3 (Safety Follow-up)|Other|0|||
33177730|NCT02588833|100560297|FG001|Part 3 (Safety Follow-up)|Other|2|||
33177731|NCT00075582|100560300|FG000|Overall Study|Adverse Event|3|||
33177732|NCT00075582|100560301|FG001|Overall Study|Adverse Event|1|||
33177733|NCT00075582|100560300|FG000|Overall Study|Lack of Efficacy|4|||
33177734|NCT00075582|100560301|FG001|Overall Study|Lack of Efficacy|8|||
33264023|NCT01759862|100866852|FG001|Overall Study|Adverse Event|1|||
33264024|NCT05048186|100866854|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
33264025|NCT05048186|100866855|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
33264026|NCT05048186|100866854|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
33264027|NCT05048186|100866855|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
33264028|NCT02717611|100866856|FG000|Overall Study|Death|13|||
33466310|NCT00099268|101597264|FG000|Overall Study|Lack of Efficacy|5|||
33466311|NCT00099268|101597265|FG001|Overall Study|Lack of Efficacy|18|||
33466312|NCT00099268|101597264|FG000|Overall Study|Administrative problems|4|||
33466313|NCT00099268|101597265|FG001|Overall Study|Administrative problems|4|||
33466314|NCT00099268|101597264|FG000|Overall Study|Death|3|||
33466315|NCT00099268|101597265|FG001|Overall Study|Death|1|||
33466316|NCT00058214|101597266|FG000|Overall Study|Adverse Event|1|||
33466317|NCT01083680|101597267|FG000|Overall Study|Lost to Follow-up|2758|||
33466318|NCT01083680|101597267|FG000|Overall Study|Withdrawal by Subject|1086|||
33177735|NCT00075582|100560300|FG000|Overall Study|Physician Decision|5|||
33177736|NCT00075582|100560301|FG001|Overall Study|Physician Decision|8|||
33177737|NCT00075582|100560300|FG000|Overall Study|Withdrawal by Subject|2|||
33177738|NCT00075582|100560301|FG001|Overall Study|Withdrawal by Subject|2|||
33177739|NCT00075582|100560300|FG000|Overall Study|Ineligible for study|36|||
33177740|NCT00075582|100560301|FG001|Overall Study|Ineligible for study|16|||
33177741|NCT03158051|100560307|FG000|Overall Study|Lost to Follow-up|41|||
33177742|NCT03158051|100560308|FG001|Overall Study|Lost to Follow-up|47|||
33177743|NCT03158051|100560307|FG000|Overall Study|Physician Decision|6|||
33177744|NCT03158051|100560308|FG001|Overall Study|Physician Decision|7|||
33177745|NCT03158051|100560307|FG000|Overall Study|Withdrawal by Subject|24|||
33177746|NCT03158051|100560308|FG001|Overall Study|Withdrawal by Subject|15|||
33177747|NCT03158051|100560307|FG000|Overall Study|Death|0|||
33177748|NCT03158051|100560308|FG001|Overall Study|Death|1|||
33177749|NCT02075658|100560311|FG000|Overall Study|Physician Decision|2|||
33177750|NCT02075658|100560312|FG001|Overall Study|Physician Decision|2|||
33177751|NCT03245008|100560313|FG000|Overall Study|Adverse Event|15|||
33177752|NCT03245008|100560314|FG001|Overall Study|Adverse Event|18|||
33177753|NCT03245008|100560315|FG002|Overall Study|Adverse Event|15|||
33177754|NCT03245008|100560316|FG003|Overall Study|Adverse Event|0|||
33177755|NCT03245008|100560317|FG004|Overall Study|Adverse Event|1|||
33177756|NCT03245008|100560313|FG000|Overall Study|Lack of Efficacy|0|||
33177757|NCT03245008|100560314|FG001|Overall Study|Lack of Efficacy|1|||
33177758|NCT03245008|100560315|FG002|Overall Study|Lack of Efficacy|0|||
33177759|NCT03245008|100560316|FG003|Overall Study|Lack of Efficacy|0|||
33177760|NCT03245008|100560317|FG004|Overall Study|Lack of Efficacy|0|||
33177761|NCT03245008|100560313|FG000|Overall Study|Lost to Follow-up|4|||
33177762|NCT03245008|100560314|FG001|Overall Study|Lost to Follow-up|1|||
33177763|NCT03245008|100560315|FG002|Overall Study|Lost to Follow-up|0|||
33177764|NCT03245008|100560316|FG003|Overall Study|Lost to Follow-up|0|||
33177765|NCT03245008|100560317|FG004|Overall Study|Lost to Follow-up|1|||
33177766|NCT03245008|100560313|FG000|Overall Study|Physician Decision|1|||
33177767|NCT03245008|100560314|FG001|Overall Study|Physician Decision|3|||
33177768|NCT03245008|100560315|FG002|Overall Study|Physician Decision|4|||
33177769|NCT03245008|100560316|FG003|Overall Study|Physician Decision|0|||
33177770|NCT03245008|100560317|FG004|Overall Study|Physician Decision|0|||
33177771|NCT03245008|100560313|FG000|Overall Study|Protocol Violation|0|||
33177772|NCT03245008|100560314|FG001|Overall Study|Protocol Violation|1|||
33177773|NCT03245008|100560315|FG002|Overall Study|Protocol Violation|0|||
33177774|NCT03245008|100560316|FG003|Overall Study|Protocol Violation|0|||
33177775|NCT03245008|100560317|FG004|Overall Study|Protocol Violation|0|||
33177776|NCT03245008|100560313|FG000|Overall Study|Withdrawal by Subject|20|||
33264029|NCT02717611|100866856|FG000|Overall Study|Withdrawal by Subject|6|||
33264030|NCT02717611|100866856|FG000|Overall Study|Active, not recruiting|40|||
33466319|NCT00880087|101597268|FG000|Overall Study|Lost to Follow-up|0|||
33466320|NCT00880087|101597269|FG001|Overall Study|Lost to Follow-up|2|||
33466321|NCT00794417|101597270|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
33466322|NCT00794417|101597271|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
33466323|NCT00794417|101597272|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
33466324|NCT00794417|101597273|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
33264031|NCT02717611|100866856|FG000|Overall Study|Complicating disease|1|||
33264032|NCT02964741|100866858|FG000|Overall Study|Protocol Violation|1|||
33466325|NCT00794417|101597270|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
33466326|NCT00794417|101597271|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
33177777|NCT03245008|100560314|FG001|Overall Study|Withdrawal by Subject|19|||
33177778|NCT03245008|100560315|FG002|Overall Study|Withdrawal by Subject|11|||
33177779|NCT03245008|100560316|FG003|Overall Study|Withdrawal by Subject|0|||
33177780|NCT03245008|100560317|FG004|Overall Study|Withdrawal by Subject|0|||
33177781|NCT03245008|100560313|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
33177782|NCT03245008|100560314|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
33466327|NCT00794417|101597272|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
33177783|NCT03245008|100560315|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
33466328|NCT00794417|101597273|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
33177784|NCT03245008|100560316|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
33177785|NCT03245008|100560317|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
33177786|NCT03245008|100560313|FG000|Overall Study|Failure to meet randomization criteria|0|||
33177787|NCT03245008|100560314|FG001|Overall Study|Failure to meet randomization criteria|1|||
33177788|NCT03245008|100560315|FG002|Overall Study|Failure to meet randomization criteria|0|||
33177789|NCT03245008|100560316|FG003|Overall Study|Failure to meet randomization criteria|1|||
33177790|NCT03245008|100560317|FG004|Overall Study|Failure to meet randomization criteria|0|||
33177791|NCT01324388|100560319|FG000|Part 1 of Study|Adverse Event|2|||
33177792|NCT01324388|100560320|FG001|Part 1 of Study|Adverse Event|0|||
33177793|NCT01324388|100560321|FG002|Part 1 of Study|Adverse Event|0|||
33177794|NCT01324388|100560322|FG003|Part 1 of Study|Adverse Event|0|||
33177795|NCT01324388|100560319|FG000|Part 1 of Study|Protocol Violation|1|||
33177796|NCT01324388|100560320|FG001|Part 1 of Study|Protocol Violation|2|||
33177797|NCT01324388|100560321|FG002|Part 1 of Study|Protocol Violation|0|||
33177798|NCT01324388|100560322|FG003|Part 1 of Study|Protocol Violation|0|||
33177799|NCT01324388|100560319|FG000|Part 1 of Study|Physician Decision|1|||
33177800|NCT01324388|100560320|FG001|Part 1 of Study|Physician Decision|0|||
33264033|NCT02964741|100866859|FG001|Overall Study|Protocol Violation|0|||
33264034|NCT02964741|100866860|FG002|Overall Study|Protocol Violation|0|||
33466329|NCT00794417|101597270|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
33177801|NCT01324388|100560321|FG002|Part 1 of Study|Physician Decision|0|||
33177802|NCT01324388|100560322|FG003|Part 1 of Study|Physician Decision|0|||
33177803|NCT01324388|100560319|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
33177804|NCT01324388|100560320|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
33177805|NCT01324388|100560321|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
33177806|NCT01324388|100560322|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
33177807|NCT01324388|100560319|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
33177808|NCT01324388|100560320|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
33177809|NCT01324388|100560321|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
33177810|NCT01324388|100560322|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
33177811|NCT01782664|100560323|FG000|Overall Study|Adverse Event|2|||
33177812|NCT01782664|100560324|FG001|Overall Study|Adverse Event|2|||
33177813|NCT01782664|100560325|FG002|Overall Study|Adverse Event|2|||
33177814|NCT01782664|100560326|FG003|Overall Study|Adverse Event|2|||
33177815|NCT01782664|100560327|FG004|Overall Study|Adverse Event|0|||
33177816|NCT01782664|100560328|FG005|Overall Study|Adverse Event|0|||
33177817|NCT01782664|100560323|FG000|Overall Study|Lack of Efficacy|2|||
33177818|NCT01782664|100560324|FG001|Overall Study|Lack of Efficacy|0|||
33264035|NCT02964741|100866858|FG000|Overall Study|Withdrawal by Subject|0|||
33264036|NCT02964741|100866859|FG001|Overall Study|Withdrawal by Subject|1|||
33264037|NCT02964741|100866860|FG002|Overall Study|Withdrawal by Subject|0|||
33264038|NCT02964741|100866858|FG000|Overall Study|claustrophobia|1|||
33264039|NCT02964741|100866859|FG001|Overall Study|claustrophobia|0|||
33264040|NCT02964741|100866860|FG002|Overall Study|claustrophobia|0|||
33264041|NCT01437319|100866861|FG000|Phase I|Lost to Follow-up|2|||
33466330|NCT00794417|101597271|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
33466331|NCT00794417|101597272|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
33466332|NCT00794417|101597273|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
33466333|NCT00794417|101597270|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
33466334|NCT00794417|101597271|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
33466335|NCT00794417|101597272|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
33177819|NCT01782664|100560325|FG002|Overall Study|Lack of Efficacy|2|||
33264042|NCT01437319|100866862|FG001|Phase I|Lost to Follow-up|0|||
33264043|NCT01437319|100866863|FG002|Phase I|Lost to Follow-up|0|||
33264044|NCT01437319|100866861|FG000|Phase I|Protocol Violation|1|||
33264045|NCT01437319|100866862|FG001|Phase I|Protocol Violation|0|||
33264046|NCT01437319|100866863|FG002|Phase I|Protocol Violation|0|||
33264047|NCT01437319|100866861|FG000|Phase I|Study related symptoms/complaints|27|||
33264048|NCT01437319|100866862|FG001|Phase I|Study related symptoms/complaints|0|||
33466336|NCT00794417|101597273|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
33177820|NCT01782664|100560326|FG003|Overall Study|Lack of Efficacy|2|||
33177821|NCT01782664|100560327|FG004|Overall Study|Lack of Efficacy|0|||
33177822|NCT01782664|100560328|FG005|Overall Study|Lack of Efficacy|0|||
33177823|NCT01782664|100560323|FG000|Overall Study|Protocol Violation|0|||
33177824|NCT01782664|100560324|FG001|Overall Study|Protocol Violation|1|||
33177825|NCT01782664|100560325|FG002|Overall Study|Protocol Violation|0|||
33177826|NCT01782664|100560326|FG003|Overall Study|Protocol Violation|1|||
33264049|NCT01437319|100866863|FG002|Phase I|Study related symptoms/complaints|0|||
33264050|NCT01437319|100866861|FG000|Phase I|Withdrawal by Subject|25|||
33264051|NCT01437319|100866862|FG001|Phase I|Withdrawal by Subject|0|||
33264052|NCT01437319|100866863|FG002|Phase I|Withdrawal by Subject|0|||
33264053|NCT01437319|100866861|FG000|Phase II|Withdrawal by Subject|0|||
33264054|NCT01437319|100866862|FG001|Phase II|Withdrawal by Subject|8|||
33264055|NCT01437319|100866863|FG002|Phase II|Withdrawal by Subject|16|||
33466337|NCT00794417|101597270|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
33466338|NCT00794417|101597271|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
33466339|NCT00794417|101597272|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
33466340|NCT00794417|101597273|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
33177827|NCT01782664|100560327|FG004|Overall Study|Protocol Violation|0|||
33177828|NCT01782664|100560328|FG005|Overall Study|Protocol Violation|0|||
33177829|NCT01782664|100560323|FG000|Overall Study|Withdrawal by Subject|2|||
33177830|NCT01782664|100560324|FG001|Overall Study|Withdrawal by Subject|2|||
33177831|NCT01782664|100560325|FG002|Overall Study|Withdrawal by Subject|0|||
33177832|NCT01782664|100560326|FG003|Overall Study|Withdrawal by Subject|0|||
33177833|NCT01782664|100560327|FG004|Overall Study|Withdrawal by Subject|0|||
33177834|NCT01782664|100560328|FG005|Overall Study|Withdrawal by Subject|0|||
33466341|NCT00794417|101597270|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
33466342|NCT00794417|101597271|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
33466343|NCT00794417|101597272|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
33466344|NCT00794417|101597273|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
33466345|NCT00115934|101597274|FG000|Overall Study|Lost to Follow-up|1|||
33466346|NCT00115934|101597275|FG001|Overall Study|Lost to Follow-up|0|||
33466347|NCT00115934|101597274|FG000|Overall Study|Did not receive intervention|3|||
33466348|NCT00115934|101597275|FG001|Overall Study|Did not receive intervention|2|||
33466349|NCT04025684|101597276|FG000|Overall Study|Withdrawal by Subject|1|||
33466350|NCT04025684|101597277|FG001|Overall Study|Withdrawal by Subject|1|||
33466351|NCT04025684|101597278|FG002|Overall Study|Withdrawal by Subject|0|||
33466352|NCT04025684|101597279|FG003|Overall Study|Withdrawal by Subject|0|||
33466353|NCT04025684|101597276|FG000|Overall Study|Multiple reasons|1|||
33466354|NCT04025684|101597277|FG001|Overall Study|Multiple reasons|3|||
33466355|NCT04025684|101597278|FG002|Overall Study|Multiple reasons|0|||
33466356|NCT04025684|101597279|FG003|Overall Study|Multiple reasons|1|||
33466357|NCT01270620|101597286|FG000|Overall Study|Withdrawal by Subject|1|||
33466358|NCT01270620|101597287|FG001|Overall Study|Withdrawal by Subject|3|||
33466359|NCT03212794|101597290|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
33466360|NCT03212794|101597291|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
33466361|NCT03212794|101597290|FG000|Overall Study|Lost to Follow-up|5|||
33466362|NCT03212794|101597291|FG001|Overall Study|Lost to Follow-up|6|||
33466363|NCT03212794|101597290|FG000|Overall Study|Incarcerated; unable to participate|2|||
33466364|NCT03212794|101597291|FG001|Overall Study|Incarcerated; unable to participate|0|||
33466365|NCT03212794|101597290|FG000|Overall Study|Withdrawal by Subject|1|||
33466366|NCT03212794|101597291|FG001|Overall Study|Withdrawal by Subject|0|||
33466367|NCT03212794|101597290|FG000|Overall Study|Death|0|||
33466368|NCT03212794|101597291|FG001|Overall Study|Death|1|||
33466369|NCT03212794|101597290|FG000|Overall Study|Found to be ineligible after allocation|0|||
33466370|NCT03212794|101597291|FG001|Overall Study|Found to be ineligible after allocation|1|||
33466371|NCT03212794|101597290|FG000|Overall Study|Relocated out of area|2|||
33466372|NCT03212794|101597291|FG001|Overall Study|Relocated out of area|0|||
33466373|NCT02310789|101597292|FG000|Overall Study|Adverse Event|1|||
33466374|NCT00942331|101597293|FG000|Overall Study|Did not start treatment|15|||
33466375|NCT00942331|101597294|FG001|Overall Study|Did not start treatment|22|||
33466376|NCT00949988|101597295|FG000|Overall Study|Withdrawal by Subject|3|||
33466377|NCT02858726|101597296|FG000|Overall Study|Adverse Event|4|||
33466378|NCT02858726|101597297|FG001|Overall Study|Adverse Event|4|||
33466379|NCT02858726|101597298|FG002|Overall Study|Adverse Event|9|||
33466380|NCT02858726|101597299|FG003|Overall Study|Adverse Event|1|||
33466381|NCT02858726|101597296|FG000|Overall Study|Physician Decision|0|||
33177835|NCT03261947|100560331|FG000|Overall Study|Death|10|||
33177836|NCT03261947|100560332|FG001|Overall Study|Death|13|||
33177837|NCT03261947|100560333|FG002|Overall Study|Death|17|||
33177838|NCT03261947|100560334|FG003|Overall Study|Death|12|||
33177839|NCT03261947|100560335|FG004|Overall Study|Death|8|||
33177840|NCT03261947|100560331|FG000|Overall Study|Lost to Follow-up|0|||
33177841|NCT03261947|100560332|FG001|Overall Study|Lost to Follow-up|0|||
33177842|NCT03261947|100560333|FG002|Overall Study|Lost to Follow-up|2|||
33177843|NCT03261947|100560334|FG003|Overall Study|Lost to Follow-up|1|||
33177844|NCT03261947|100560335|FG004|Overall Study|Lost to Follow-up|0|||
33466382|NCT02858726|101597297|FG001|Overall Study|Physician Decision|0|||
33177845|NCT03261947|100560331|FG000|Overall Study|Withdrawal by Subject|0|||
33177846|NCT03261947|100560332|FG001|Overall Study|Withdrawal by Subject|0|||
33177847|NCT03261947|100560333|FG002|Overall Study|Withdrawal by Subject|3|||
33177848|NCT03261947|100560334|FG003|Overall Study|Withdrawal by Subject|0|||
33177849|NCT03261947|100560335|FG004|Overall Study|Withdrawal by Subject|1|||
33177850|NCT03261947|100560331|FG000|Overall Study|Site Terminated by Sponsor|0|||
33466383|NCT02858726|101597298|FG002|Overall Study|Physician Decision|1|||
33466384|NCT02858726|101597299|FG003|Overall Study|Physician Decision|0|||
33466385|NCT02858726|101597296|FG000|Overall Study|Protocol Violation|0|||
33466386|NCT02858726|101597297|FG001|Overall Study|Protocol Violation|0|||
33466387|NCT02858726|101597298|FG002|Overall Study|Protocol Violation|0|||
33177851|NCT03261947|100560332|FG001|Overall Study|Site Terminated by Sponsor|0|||
33177852|NCT03261947|100560333|FG002|Overall Study|Site Terminated by Sponsor|4|||
33177853|NCT03261947|100560334|FG003|Overall Study|Site Terminated by Sponsor|7|||
33177854|NCT03261947|100560335|FG004|Overall Study|Site Terminated by Sponsor|5|||
33177855|NCT03261947|100560331|FG000|Overall Study|Reason not Specified|2|||
33177856|NCT03261947|100560332|FG001|Overall Study|Reason not Specified|0|||
33177857|NCT03261947|100560333|FG002|Overall Study|Reason not Specified|4|||
33177858|NCT03261947|100560334|FG003|Overall Study|Reason not Specified|1|||
33177859|NCT03261947|100560335|FG004|Overall Study|Reason not Specified|3|||
33177860|NCT04779489|100560336|FG000|Overall Study|Physician Decision|1|||
33177861|NCT01881230|100560345|FG000|Overall Study|Death|2|||
33177862|NCT01881230|100560346|FG001|Overall Study|Death|0|||
33177863|NCT01881230|100560347|FG002|Overall Study|Death|1|||
33177864|NCT01881230|100560345|FG000|Overall Study|Adverse Event|9|||
33177865|NCT01881230|100560346|FG001|Overall Study|Adverse Event|13|||
33177866|NCT01881230|100560347|FG002|Overall Study|Adverse Event|12|||
33177867|NCT01881230|100560345|FG000|Overall Study|Progressive Disease|31|||
33177868|NCT01881230|100560346|FG001|Overall Study|Progressive Disease|35|||
33177869|NCT01881230|100560347|FG002|Overall Study|Progressive Disease|36|||
33177870|NCT01881230|100560345|FG000|Overall Study|Symptomatic Deterioration|3|||
33177871|NCT01881230|100560346|FG001|Overall Study|Symptomatic Deterioration|3|||
33177872|NCT01881230|100560347|FG002|Overall Study|Symptomatic Deterioration|1|||
33177873|NCT01881230|100560345|FG000|Overall Study|Withdrawal by Subject|6|||
33177874|NCT01881230|100560346|FG001|Overall Study|Withdrawal by Subject|4|||
33177875|NCT01881230|100560347|FG002|Overall Study|Withdrawal by Subject|6|||
33177876|NCT01881230|100560345|FG000|Overall Study|Physician Decision|4|||
33177877|NCT01881230|100560346|FG001|Overall Study|Physician Decision|3|||
33177878|NCT01881230|100560347|FG002|Overall Study|Physician Decision|6|||
33177879|NCT01881230|100560345|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33177880|NCT01881230|100560346|FG001|Overall Study|Non-Compliance with Study Drug|2|||
33177881|NCT01881230|100560347|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33177882|NCT01881230|100560345|FG000|Overall Study|Given Commercially Available Drug|0|||
33177883|NCT01881230|100560346|FG001|Overall Study|Given Commercially Available Drug|0|||
33177884|NCT01881230|100560347|FG002|Overall Study|Given Commercially Available Drug|2|||
33466388|NCT02858726|101597299|FG003|Overall Study|Protocol Violation|1|||
33466389|NCT02858726|101597296|FG000|Overall Study|Study Terminated by Sponsor|0|||
33466390|NCT02858726|101597297|FG001|Overall Study|Study Terminated by Sponsor|0|||
33466391|NCT02858726|101597298|FG002|Overall Study|Study Terminated by Sponsor|0|||
33466392|NCT02858726|101597299|FG003|Overall Study|Study Terminated by Sponsor|1|||
33466393|NCT02858726|101597296|FG000|Overall Study|Withdrawal by Subject|1|||
33466394|NCT02858726|101597297|FG001|Overall Study|Withdrawal by Subject|2|||
33466395|NCT02858726|101597298|FG002|Overall Study|Withdrawal by Subject|1|||
33466396|NCT02858726|101597299|FG003|Overall Study|Withdrawal by Subject|0|||
33466397|NCT02858726|101597296|FG000|Overall Study|Noncompliance|0|||
33466398|NCT02858726|101597297|FG001|Overall Study|Noncompliance|1|||
33466399|NCT02858726|101597298|FG002|Overall Study|Noncompliance|0|||
33466400|NCT02858726|101597299|FG003|Overall Study|Noncompliance|0|||
33466401|NCT01730040|101597300|FG000|Overall Study|Randomized but not treated|0|||
33466402|NCT01730040|101597301|FG001|Overall Study|Randomized but not treated|0|||
33466403|NCT01730040|101597302|FG002|Overall Study|Randomized but not treated|0|||
33466404|NCT01730040|101597303|FG003|Overall Study|Randomized but not treated|0|||
33466405|NCT01730040|101597304|FG004|Overall Study|Randomized but not treated|0|||
33466406|NCT01730040|101597305|FG005|Overall Study|Randomized but not treated|1|||
33466407|NCT01730040|101597306|FG006|Overall Study|Randomized but not treated|0|||
33466408|NCT01730040|101597300|FG000|Overall Study|Subject moved|0|||
33466409|NCT01730040|101597301|FG001|Overall Study|Subject moved|0|||
33466410|NCT01730040|101597302|FG002|Overall Study|Subject moved|1|||
33466411|NCT01730040|101597303|FG003|Overall Study|Subject moved|0|||
33466412|NCT01730040|101597304|FG004|Overall Study|Subject moved|0|||
33466413|NCT01730040|101597305|FG005|Overall Study|Subject moved|0|||
33466414|NCT01730040|101597306|FG006|Overall Study|Subject moved|1|||
33466415|NCT01730040|101597300|FG000|Overall Study|Physician Decision|0|||
33466416|NCT01730040|101597301|FG001|Overall Study|Physician Decision|0|||
33177885|NCT01881230|100560345|FG000|Overall Study|Protocol Violation|1|||
33177886|NCT01881230|100560346|FG001|Overall Study|Protocol Violation|1|||
33177887|NCT01881230|100560347|FG002|Overall Study|Protocol Violation|0|||
33177888|NCT01881230|100560345|FG000|Overall Study|Miscellaneous|3|||
33177889|NCT01881230|100560346|FG001|Overall Study|Miscellaneous|3|||
33177890|NCT01881230|100560347|FG002|Overall Study|Miscellaneous|0|||
33177891|NCT01881230|100560345|FG000|Overall Study|Untreated: Other|0|||
33177892|NCT01881230|100560346|FG001|Overall Study|Untreated: Other|0|||
33177893|NCT01881230|100560347|FG002|Overall Study|Untreated: Other|1|||
33177894|NCT01881230|100560345|FG000|Overall Study|Untreated: Death|0|||
33177895|NCT01881230|100560346|FG001|Overall Study|Untreated: Death|0|||
33177896|NCT01881230|100560347|FG002|Overall Study|Untreated: Death|1|||
33466417|NCT01730040|101597302|FG002|Overall Study|Physician Decision|0|||
33466418|NCT01730040|101597303|FG003|Overall Study|Physician Decision|0|||
33466419|NCT01730040|101597304|FG004|Overall Study|Physician Decision|0|||
33177897|NCT01881230|100560345|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
33177898|NCT01881230|100560346|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
33177899|NCT01881230|100560347|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
33177900|NCT02154581|100560348|FG000|Overall Study|Lost to Follow-up|7|||
33177901|NCT02154581|100560349|FG001|Overall Study|Lost to Follow-up|8|||
33177902|NCT00842712|100560350|FG000|Safety Run-in Part|Adverse Event|0|||
33177903|NCT00842712|100560351|FG001|Safety Run-in Part|Adverse Event|1|||
33177904|NCT00842712|100560352|FG002|Safety Run-in Part|Adverse Event|0|||
33177905|NCT00842712|100560353|FG003|Safety Run-in Part|Adverse Event|0|||
33177906|NCT00842712|100560354|FG004|Safety Run-in Part|Adverse Event|0|||
33177907|NCT00842712|100560355|FG005|Safety Run-in Part|Adverse Event|0|||
33177908|NCT00842712|100560356|FG006|Safety Run-in Part|Adverse Event|0|||
33177909|NCT00842712|100560350|FG000|Safety Run-in Part|Progressive disease|3|||
33177910|NCT00842712|100560351|FG001|Safety Run-in Part|Progressive disease|1|||
33177911|NCT00842712|100560352|FG002|Safety Run-in Part|Progressive disease|0|||
33177912|NCT00842712|100560353|FG003|Safety Run-in Part|Progressive disease|1|||
33177913|NCT00842712|100560354|FG004|Safety Run-in Part|Progressive disease|0|||
33177914|NCT00842712|100560355|FG005|Safety Run-in Part|Progressive disease|0|||
33177915|NCT00842712|100560356|FG006|Safety Run-in Part|Progressive disease|0|||
33177916|NCT00842712|100560350|FG000|Randomized Part|Randomized but not treated|0|||
33177917|NCT00842712|100560351|FG001|Randomized Part|Randomized but not treated|0|||
33177918|NCT00842712|100560352|FG002|Randomized Part|Randomized but not treated|0|||
33177919|NCT00842712|100560353|FG003|Randomized Part|Randomized but not treated|0|||
33177920|NCT00842712|100560354|FG004|Randomized Part|Randomized but not treated|0|||
33466420|NCT01730040|101597305|FG005|Overall Study|Physician Decision|1|||
33466421|NCT01730040|101597306|FG006|Overall Study|Physician Decision|1|||
33466422|NCT01730040|101597300|FG000|Overall Study|Other than specified|7|||
33466423|NCT01730040|101597301|FG001|Overall Study|Other than specified|8|||
33466424|NCT01730040|101597302|FG002|Overall Study|Other than specified|5|||
33466425|NCT01730040|101597303|FG003|Overall Study|Other than specified|5|||
33466426|NCT01730040|101597304|FG004|Overall Study|Other than specified|5|||
33466427|NCT01730040|101597305|FG005|Overall Study|Other than specified|4|||
33466428|NCT01730040|101597306|FG006|Overall Study|Other than specified|4|||
33466429|NCT01730040|101597300|FG000|Overall Study|Adverse Event|4|||
33466430|NCT01730040|101597301|FG001|Overall Study|Adverse Event|3|||
33466431|NCT01730040|101597302|FG002|Overall Study|Adverse Event|5|||
33466432|NCT01730040|101597303|FG003|Overall Study|Adverse Event|3|||
33466433|NCT01730040|101597304|FG004|Overall Study|Adverse Event|1|||
33466434|NCT01730040|101597305|FG005|Overall Study|Adverse Event|1|||
33466435|NCT01730040|101597306|FG006|Overall Study|Adverse Event|2|||
33466436|NCT01730040|101597300|FG000|Overall Study|Poor compliance to protocol|2|||
33466437|NCT01730040|101597301|FG001|Overall Study|Poor compliance to protocol|4|||
33466438|NCT01730040|101597302|FG002|Overall Study|Poor compliance to protocol|0|||
33466439|NCT01730040|101597303|FG003|Overall Study|Poor compliance to protocol|0|||
33466440|NCT01730040|101597304|FG004|Overall Study|Poor compliance to protocol|0|||
33466441|NCT01730040|101597305|FG005|Overall Study|Poor compliance to protocol|0|||
33466442|NCT01730040|101597306|FG006|Overall Study|Poor compliance to protocol|1|||
33466443|NCT03276676|101597307|FG000|Overall Study|Withdrawal by Subject|2|||
33466444|NCT03276676|101597308|FG001|Overall Study|Withdrawal by Subject|1|||
33466445|NCT02746627|101597309|FG000|Overall Study|Withdrawal by Subject|1|||
33466446|NCT02746627|101597310|FG001|Overall Study|Withdrawal by Subject|1|||
33466447|NCT02746627|101597311|FG002|Overall Study|Withdrawal by Subject|1|||
33466448|NCT05132569|101597318|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
33466449|NCT05132569|101597319|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
33466450|NCT05132569|101597318|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
33466451|NCT05132569|101597319|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
33466452|NCT05132569|101597318|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
33177921|NCT00842712|100560355|FG005|Randomized Part|Randomized but not treated|1|||
33177922|NCT00842712|100560356|FG006|Randomized Part|Randomized but not treated|4|||
33177923|NCT00842712|100560350|FG000|Randomized Part|Ongoing at cut-off date|0|||
33177924|NCT00842712|100560351|FG001|Randomized Part|Ongoing at cut-off date|0|||
33177925|NCT00842712|100560352|FG002|Randomized Part|Ongoing at cut-off date|0|||
33177926|NCT00842712|100560353|FG003|Randomized Part|Ongoing at cut-off date|0|||
33177927|NCT00842712|100560354|FG004|Randomized Part|Ongoing at cut-off date|0|||
33177928|NCT00842712|100560355|FG005|Randomized Part|Ongoing at cut-off date|0|||
33177929|NCT00842712|100560356|FG006|Randomized Part|Ongoing at cut-off date|2|||
33177930|NCT00840294|100560357|FG000|Overall Study|Withdrawal by Subject|2|||
33177931|NCT00840294|100560358|FG001|Overall Study|Withdrawal by Subject|1|||
33177932|NCT00840294|100560357|FG000|Overall Study|Protocol Violation|1|||
33177933|NCT00840294|100560358|FG001|Overall Study|Protocol Violation|3|||
33177934|NCT00840294|100560357|FG000|Overall Study|Illness|0|||
33177935|NCT00840294|100560358|FG001|Overall Study|Illness|1|||
33177936|NCT00423150|100560359|FG000|Overall Study|Adverse Event|11|||
33177937|NCT00423150|100560359|FG000|Overall Study|Progression of disease being studied|69|||
33466453|NCT05132569|101597319|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
33466454|NCT02000531|101597322|FG000|Overall Study|Lost to Follow-up|1|||
33466455|NCT02000531|101597323|FG001|Overall Study|Lost to Follow-up|0|||
33466456|NCT02000531|101597322|FG000|Overall Study|Discontinued due to data cut-off|3|||
33177938|NCT00423150|100560359|FG000|Overall Study|Withdrawal by Subject|1|||
33177939|NCT00423150|100560359|FG000|Overall Study|Non-compliance with protocol|1|||
33177940|NCT00423150|100560359|FG000|Overall Study|Administrative|4|||
33177941|NCT03060447|100560360|FG000|Overall Study|Withdrawal by Subject|2|||
33264056|NCT01437319|100866861|FG000|Phase II|Lost to Follow-up|0|||
33466457|NCT02000531|101597323|FG001|Overall Study|Discontinued due to data cut-off|8|||
33466458|NCT02278718|101597324|FG000|Overall Study|Adverse Event|1|||
33466459|NCT02278718|101597325|FG001|Overall Study|Adverse Event|0|||
33466460|NCT02278718|101597324|FG000|Overall Study|Lost to Follow-up|2|||
33466461|NCT02278718|101597325|FG001|Overall Study|Lost to Follow-up|4|||
33466462|NCT02278718|101597324|FG000|Overall Study|Withdrawal by Subject|1|||
33466463|NCT02278718|101597325|FG001|Overall Study|Withdrawal by Subject|4|||
33466464|NCT02278718|101597324|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
33466465|NCT02278718|101597325|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
33466466|NCT02278718|101597324|FG000|Overall Study|Missing|0|||
33466467|NCT02278718|101597325|FG001|Overall Study|Missing|1|||
33466468|NCT02676284|101597327|FG000|Overall Study|Withdrawal by Subject|1|||
33466469|NCT01796964|101597328|FG000|Overall Study|Adverse Event|1|||
33466470|NCT01796964|101597329|FG001|Overall Study|Adverse Event|1|||
33466471|NCT01796964|101597328|FG000|Overall Study|Death|1|||
33466472|NCT01796964|101597329|FG001|Overall Study|Death|0|||
33466473|NCT01796964|101597328|FG000|Overall Study|Protocol Violation|0|||
33466474|NCT01796964|101597329|FG001|Overall Study|Protocol Violation|1|||
33466475|NCT01796964|101597328|FG000|Overall Study|Withdrawal by Subject|1|||
33466476|NCT01796964|101597329|FG001|Overall Study|Withdrawal by Subject|1|||
33466477|NCT02220725|101597330|FG000|Overall Study|Lost to Follow-up|0|||
33466478|NCT02220725|101597331|FG001|Overall Study|Lost to Follow-up|0|||
33466479|NCT02220725|101597332|FG002|Overall Study|Lost to Follow-up|0|||
33466480|NCT02220725|101597333|FG003|Overall Study|Lost to Follow-up|1|||
33466481|NCT02220725|101597330|FG000|Overall Study|Withdrawal by Subject|0|||
33466482|NCT02220725|101597331|FG001|Overall Study|Withdrawal by Subject|0|||
33466483|NCT02220725|101597332|FG002|Overall Study|Withdrawal by Subject|0|||
33466484|NCT02220725|101597333|FG003|Overall Study|Withdrawal by Subject|1|||
33466485|NCT00977431|101597336|FG000|Overall Study|Other than listed|1|||
33466486|NCT00977431|101597337|FG001|Overall Study|Other than listed|0|||
33466487|NCT00977431|101597338|FG002|Overall Study|Other than listed|0|||
33466488|NCT00977431|101597339|FG003|Overall Study|Other than listed|0|||
33466489|NCT00977431|101597340|FG004|Overall Study|Other than listed|2|||
33466490|NCT00977431|101597336|FG000|Overall Study|Protocol Violation|0|||
33466491|NCT00977431|101597337|FG001|Overall Study|Protocol Violation|0|||
33466492|NCT00977431|101597338|FG002|Overall Study|Protocol Violation|1|||
33466493|NCT00977431|101597339|FG003|Overall Study|Protocol Violation|0|||
33466494|NCT00977431|101597340|FG004|Overall Study|Protocol Violation|0|||
33466495|NCT00977431|101597336|FG000|Overall Study|Adverse Event|3|||
33466496|NCT00977431|101597337|FG001|Overall Study|Adverse Event|0|||
33177942|NCT03060447|100560361|FG001|Overall Study|Withdrawal by Subject|0|||
33466497|NCT00977431|101597338|FG002|Overall Study|Adverse Event|4|||
33466498|NCT00977431|101597339|FG003|Overall Study|Adverse Event|0|||
33466499|NCT00977431|101597340|FG004|Overall Study|Adverse Event|6|||
33466500|NCT00977431|101597336|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
33177943|NCT03325075|100560364|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
33177944|NCT03325075|100560365|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
33177945|NCT03325075|100560366|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
33177946|NCT03325075|100560367|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
33177947|NCT03325075|100560364|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
33177948|NCT03325075|100560365|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
33177949|NCT03325075|100560366|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
33177950|NCT03325075|100560367|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
33177951|NCT03325075|100560364|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
33177952|NCT03325075|100560365|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
33177953|NCT03325075|100560366|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
33177954|NCT03325075|100560367|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
33177955|NCT01988103|100560368|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
33177956|NCT01988103|100560369|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
33177957|NCT01988103|100560370|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
33264057|NCT01437319|100866862|FG001|Phase II|Lost to Follow-up|7|||
33264058|NCT01437319|100866863|FG002|Phase II|Lost to Follow-up|2|||
33466501|NCT00977431|101597337|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
33466502|NCT00977431|101597338|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
33466503|NCT00977431|101597339|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
33466504|NCT00977431|101597340|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
33466505|NCT00977431|101597336|FG000|Overall Study|Progressive disease|2|||
33177958|NCT01988103|100560371|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
33177959|NCT01988103|100560372|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
33177960|NCT01988103|100560368|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
33177961|NCT01988103|100560369|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
33177962|NCT01988103|100560370|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
33177963|NCT01988103|100560371|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
33264059|NCT01437319|100866861|FG000|Phase II|Study related symptoms/complaints|0|||
33466506|NCT00977431|101597337|FG001|Overall Study|Progressive disease|6|||
33466507|NCT00977431|101597338|FG002|Overall Study|Progressive disease|1|||
33466508|NCT00977431|101597339|FG003|Overall Study|Progressive disease|3|||
33466509|NCT00977431|101597340|FG004|Overall Study|Progressive disease|5|||
33466510|NCT01901848|101597341|FG000|Randomized and Treated|Lost to Follow-up|3|||
33466511|NCT01901848|101597342|FG001|Randomized and Treated|Lost to Follow-up|6|||
33466512|NCT01901848|101597341|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
33466513|NCT01901848|101597342|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
33466514|NCT01546142|101597343|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
33466515|NCT01546142|101597344|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
33466516|NCT01546142|101597343|FG000|Overall Study|Subject Noncompliance|1|||
33466517|NCT01546142|101597344|FG001|Overall Study|Subject Noncompliance|1|||
33466518|NCT01546142|101597343|FG000|Overall Study|Adverse Event|6|||
33466519|NCT01546142|101597344|FG001|Overall Study|Adverse Event|3|||
33466520|NCT01546142|101597343|FG000|Overall Study|Lost to Follow-up|20|||
33466521|NCT01546142|101597344|FG001|Overall Study|Lost to Follow-up|15|||
33466522|NCT01546142|101597343|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
33466523|NCT01546142|101597344|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
33466524|NCT01546142|101597343|FG000|Overall Study|Subject Randomized but Not Treated|1|||
33466525|NCT01546142|101597344|FG001|Overall Study|Subject Randomized but Not Treated|0|||
33466526|NCT01647711|101597345|FG000|Overall Study|Progressive disease|6|||
33466527|NCT01647711|101597346|FG001|Overall Study|Progressive disease|2|||
33466528|NCT01647711|101597347|FG002|Overall Study|Progressive disease|6|||
33466529|NCT01647711|101597348|FG003|Overall Study|Progressive disease|8|||
33466530|NCT01647711|101597349|FG004|Overall Study|Progressive disease|2|||
33466531|NCT01647711|101597345|FG000|Overall Study|Other adverse event|0|||
33466532|NCT01647711|101597346|FG001|Overall Study|Other adverse event|0|||
33466533|NCT01647711|101597347|FG002|Overall Study|Other adverse event|2|||
33466534|NCT01647711|101597348|FG003|Overall Study|Other adverse event|0|||
33466535|NCT01647711|101597349|FG004|Overall Study|Other adverse event|2|||
33466536|NCT01647711|101597345|FG000|Overall Study|Protocol Violation|0|||
33466537|NCT01647711|101597346|FG001|Overall Study|Protocol Violation|0|||
33466538|NCT01647711|101597347|FG002|Overall Study|Protocol Violation|0|||
33466539|NCT01647711|101597348|FG003|Overall Study|Protocol Violation|0|||
33466540|NCT01647711|101597349|FG004|Overall Study|Protocol Violation|1|||
33466541|NCT01647711|101597345|FG000|Overall Study|Refused to continue taking medication|0|||
33466542|NCT01647711|101597346|FG001|Overall Study|Refused to continue taking medication|0|||
33466543|NCT01647711|101597347|FG002|Overall Study|Refused to continue taking medication|0|||
33466544|NCT01647711|101597348|FG003|Overall Study|Refused to continue taking medication|2|||
33466545|NCT01647711|101597349|FG004|Overall Study|Refused to continue taking medication|1|||
33466546|NCT01647711|101597345|FG000|Overall Study|Other reason not defined|0|||
33466547|NCT01647711|101597346|FG001|Overall Study|Other reason not defined|1|||
33466548|NCT01647711|101597347|FG002|Overall Study|Other reason not defined|1|||
33466549|NCT01647711|101597348|FG003|Overall Study|Other reason not defined|1|||
33466550|NCT01647711|101597349|FG004|Overall Study|Other reason not defined|0|||
33466551|NCT00890552|101597350|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
33466552|NCT00890552|101597350|FG000|On-treatment|Early prog disease/ death|10|||
33466553|NCT00766831|101597351|FG000|Overall Study|Withdrawal by Subject|4|||
33466554|NCT00766831|101597351|FG000|Overall Study|Lost to Follow-up|3|||
33466555|NCT00766831|101597351|FG000|Overall Study|Adverse Event|20|||
33466556|NCT00766831|101597351|FG000|Overall Study|Protocol Violation|15|||
33466557|NCT00766831|101597351|FG000|Overall Study|Physician Decision|5|||
33466558|NCT00766831|101597351|FG000|Overall Study|Withdrawal of consent|26|||
33466559|NCT00766831|101597351|FG000|Overall Study|Non cooperation by participants|14|||
33466560|NCT00766831|101597351|FG000|Overall Study|Other|28|||
33466561|NCT00848042|101597355|FG000|Overall Study|Death|1|||
33177964|NCT01988103|100560372|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
33466562|NCT00848042|101597356|FG001|Overall Study|Death|2|||
33264060|NCT01437319|100866862|FG001|Phase II|Study related symptoms/complaints|28|||
33466563|NCT00848042|101597357|FG002|Overall Study|Death|0|||
33466564|NCT00848042|101597355|FG000|Overall Study|Other Therapy|3|||
33466565|NCT00848042|101597356|FG001|Overall Study|Other Therapy|0|||
33466566|NCT00848042|101597357|FG002|Overall Study|Other Therapy|0|||
33466567|NCT00418522|101597358|FG000|Overall Study|Adverse Event|7|||
33466568|NCT00418522|101597359|FG001|Overall Study|Adverse Event|1|||
33466569|NCT00418522|101597358|FG000|Overall Study|Lack of Efficacy|1|||
33466570|NCT00418522|101597359|FG001|Overall Study|Lack of Efficacy|3|||
33466571|NCT00418522|101597358|FG000|Overall Study|Lost to Follow-up|10|||
33466572|NCT00418522|101597359|FG001|Overall Study|Lost to Follow-up|4|||
33466573|NCT00418522|101597358|FG000|Overall Study|Withdrawal by Subject|31|||
33466574|NCT00418522|101597359|FG001|Overall Study|Withdrawal by Subject|7|||
33466575|NCT00418522|101597358|FG000|Overall Study|Other|27|||
33466576|NCT00418522|101597359|FG001|Overall Study|Other|23|||
33466577|NCT00418522|101597358|FG000|Overall Study|Randomized but did not receive treatment|7|||
33466578|NCT00418522|101597359|FG001|Overall Study|Randomized but did not receive treatment|4|||
33466579|NCT01478828|101597360|FG000|Overall Study|Adverse Event|1|||
33466580|NCT00708708|101597361|FG000|Overall Study|Another therapy instead of Enbrel|141|||
33466581|NCT00708708|101597361|FG000|Overall Study|Lost to Follow-up|52|||
33466582|NCT00708708|101597361|FG000|Overall Study|Withdrawal by Subject|51|||
33466583|NCT00708708|101597361|FG000|Overall Study|Intolerance|42|||
33466584|NCT00708708|101597361|FG000|Overall Study|Another therapy along with Enbrel|15|||
33466585|NCT00708708|101597361|FG000|Overall Study|Other unspecified|11|||
33466586|NCT00708708|101597361|FG000|Overall Study|Good effectiveness|9|||
33466587|NCT00708708|101597361|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
33466588|NCT00708708|101597361|FG000|Overall Study|Administrative reasons|7|||
33466589|NCT00708708|101597361|FG000|Overall Study|Lack of effectiveness|4|||
33466590|NCT00708708|101597361|FG000|Overall Study|Lack of compliance|3|||
33466591|NCT00708708|101597361|FG000|Overall Study|Pregnancy|3|||
33466592|NCT00708708|101597361|FG000|Overall Study|Adverse Event|3|||
33466593|NCT00708708|101597361|FG000|Overall Study|Missing values|392|||
33466594|NCT02377921|101597362|FG000|Overall Study|Subject non-compliance|1|||
33466595|NCT02377921|101597363|FG001|Overall Study|Subject non-compliance|1|||
33466596|NCT00653159|101597364|FG000|Overall Study|Adverse Event|4|||
33466597|NCT00653159|101597365|FG001|Overall Study|Adverse Event|1|||
33466598|NCT00653159|101597364|FG000|Overall Study|Lost to Follow-up|1|||
33466599|NCT00653159|101597365|FG001|Overall Study|Lost to Follow-up|2|||
33466600|NCT04276935|101597370|FG000|Overall Study|Lost to Follow-up|3|||
33466601|NCT00373425|101597371|FG000|Overall Study|Relapse of NSCLC|116|||
33466602|NCT00373425|101597372|FG001|Overall Study|Relapse of NSCLC|104|||
33466603|NCT00373425|101597373|FG002|Overall Study|Relapse of NSCLC|19|||
33466604|NCT00373425|101597374|FG003|Overall Study|Relapse of NSCLC|2|||
33466605|NCT00373425|101597375|FG004|Overall Study|Relapse of NSCLC|26|||
33466606|NCT00373425|101597371|FG000|Overall Study|Adverse Event|191|||
33466607|NCT00373425|101597372|FG001|Overall Study|Adverse Event|22|||
33466608|NCT00373425|101597373|FG002|Overall Study|Adverse Event|59|||
33466609|NCT00373425|101597374|FG003|Overall Study|Adverse Event|0|||
33466610|NCT00373425|101597375|FG004|Overall Study|Adverse Event|34|||
33466611|NCT00373425|101597371|FG000|Overall Study|Patient request|35|||
33466612|NCT00373425|101597372|FG001|Overall Study|Patient request|18|||
33466613|NCT00373425|101597373|FG002|Overall Study|Patient request|43|||
33466614|NCT00373425|101597374|FG003|Overall Study|Patient request|6|||
33466615|NCT00373425|101597375|FG004|Overall Study|Patient request|7|||
33466616|NCT00373425|101597371|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
33466617|NCT00373425|101597372|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
33466618|NCT00373425|101597373|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
33466619|NCT00373425|101597374|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
33466620|NCT00373425|101597375|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
33466621|NCT00373425|101597371|FG000|Overall Study|Death|7|||
33466622|NCT00373425|101597372|FG001|Overall Study|Death|0|||
33466623|NCT00373425|101597373|FG002|Overall Study|Death|3|||
33466624|NCT00373425|101597374|FG003|Overall Study|Death|1|||
33466625|NCT00373425|101597375|FG004|Overall Study|Death|0|||
33466626|NCT02096588|101597378|FG000|Overall Study|Lack of Efficacy|2|||
33466627|NCT02096588|101597379|FG001|Overall Study|Lack of Efficacy|0|||
33466628|NCT02096588|101597378|FG000|Overall Study|Withdrawal by Subject|0|||
33466629|NCT02096588|101597379|FG001|Overall Study|Withdrawal by Subject|1|||
33466630|NCT01803269|101597382|FG000|Overall Study|Withdrawal by Subject|3|||
33466631|NCT01803269|101597383|FG001|Overall Study|Withdrawal by Subject|0|||
33466632|NCT01803269|101597384|FG002|Overall Study|Withdrawal by Subject|0|||
33466633|NCT04233879|101597395|FG000|Overall Study|Death|2|||
33466634|NCT04233879|101597396|FG001|Overall Study|Death|0|||
33466635|NCT04233879|101597395|FG000|Overall Study|Lost to Follow-up|3|||
33466636|NCT04233879|101597396|FG001|Overall Study|Lost to Follow-up|8|||
33466637|NCT04233879|101597395|FG000|Overall Study|Physician Decision|4|||
33466638|NCT04233879|101597396|FG001|Overall Study|Physician Decision|4|||
33466639|NCT04233879|101597395|FG000|Overall Study|Withdrawal by Subject|7|||
33177965|NCT01988103|100560368|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
33177966|NCT01988103|100560369|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
33177967|NCT01988103|100560370|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
33466640|NCT04233879|101597396|FG001|Overall Study|Withdrawal by Subject|10|||
33466641|NCT04233879|101597395|FG000|Overall Study|Other|281|||
33466642|NCT04233879|101597396|FG001|Overall Study|Other|279|||
33466643|NCT00467831|101597397|FG000|Overall Study|Death|2|||
33466644|NCT00467831|101597397|FG000|Overall Study|Withdrawal by Subject|1|||
33466645|NCT04633642|101597405|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
33466646|NCT04633642|101597406|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
33466647|NCT01929395|101600325|FG000|Overall Study|Did not complete - non-related toxicity|1|||
33466648|NCT01929395|101600326|FG001|Overall Study|Did not complete - non-related toxicity|0|||
33466649|NCT01929395|101600327|FG002|Overall Study|Did not complete - non-related toxicity|0|||
33466650|NCT01929395|101600325|FG000|Overall Study|Withdrawal by Subject|0|||
33466651|NCT01929395|101600326|FG001|Overall Study|Withdrawal by Subject|1|||
33466652|NCT01929395|101600327|FG002|Overall Study|Withdrawal by Subject|0|||
33466653|NCT01929395|101600325|FG000|Overall Study|Screen Fail|0|||
33466654|NCT01929395|101600326|FG001|Overall Study|Screen Fail|0|||
33466655|NCT01929395|101600327|FG002|Overall Study|Screen Fail|1|||
33466656|NCT00337428|101600328|FG000|Overall Study|Withdrawal by Subject|1|||
33466657|NCT00337428|101600329|FG001|Overall Study|Withdrawal by Subject|2|||
33466658|NCT00337428|101600328|FG000|Overall Study|Lack of Time|1|||
33466659|NCT00337428|101600329|FG001|Overall Study|Lack of Time|1|||
33466660|NCT00337428|101600328|FG000|Overall Study|Unwilling to Continue|1|||
33466661|NCT00337428|101600329|FG001|Overall Study|Unwilling to Continue|0|||
33466662|NCT00337428|101600328|FG000|Overall Study|Anorexia|1|||
33466663|NCT00337428|101600329|FG001|Overall Study|Anorexia|0|||
33466664|NCT01355159|101600330|FG000|Overall Study|Withdrew consent|39|||
33466665|NCT01355159|101600331|FG001|Overall Study|Withdrew consent|47|||
33466666|NCT01355159|101600330|FG000|Overall Study|No primary outcome data|17|||
33466667|NCT01355159|101600331|FG001|Overall Study|No primary outcome data|11|||
33466668|NCT01355159|101600330|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
33466669|NCT01355159|101600331|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
33466670|NCT01355159|101600330|FG000|Overall Study|Early intrauterine fetal death|6|||
33466671|NCT01355159|101600331|FG001|Overall Study|Early intrauterine fetal death|6|||
33466672|NCT01553747|101600332|FG000|Overall Study|Protocol Violation|0|||
33466673|NCT01553747|101600333|FG001|Overall Study|Protocol Violation|2|||
33466674|NCT01553747|101600334|FG002|Overall Study|Protocol Violation|0|||
33466675|NCT01553747|101600332|FG000|Overall Study|Voluntarily withdrew|70|||
33466676|NCT01553747|101600333|FG001|Overall Study|Voluntarily withdrew|66|||
33466677|NCT01553747|101600334|FG002|Overall Study|Voluntarily withdrew|74|||
33466678|NCT01553747|101600332|FG000|Overall Study|Adverse event or SAE|32|||
33466679|NCT01553747|101600333|FG001|Overall Study|Adverse event or SAE|28|||
33466680|NCT01553747|101600334|FG002|Overall Study|Adverse event or SAE|19|||
33466681|NCT01553747|101600332|FG000|Overall Study|Physician decision: other|10|||
33466682|NCT01553747|101600333|FG001|Overall Study|Physician decision: other|8|||
33466683|NCT01553747|101600334|FG002|Overall Study|Physician decision: other|7|||
33466684|NCT01553747|101600332|FG000|Overall Study|Lost to Follow-up|11|||
33466685|NCT01553747|101600333|FG001|Overall Study|Lost to Follow-up|5|||
33466686|NCT01553747|101600334|FG002|Overall Study|Lost to Follow-up|6|||
33466687|NCT01553747|101600332|FG000|Overall Study|Sponsor decision, specify|7|||
33466688|NCT01553747|101600333|FG001|Overall Study|Sponsor decision, specify|5|||
33466689|NCT01553747|101600334|FG002|Overall Study|Sponsor decision, specify|0|||
33466690|NCT01553747|101600332|FG000|Overall Study|Physician decision: lack of efficacy|1|||
33466691|NCT01553747|101600333|FG001|Overall Study|Physician decision: lack of efficacy|5|||
33466692|NCT01553747|101600334|FG002|Overall Study|Physician decision: lack of efficacy|3|||
33466693|NCT00049842|101600335|FG000|Treatment Phase|Adverse Event|47|||
33466694|NCT00049842|101600336|FG001|Treatment Phase|Adverse Event|12|||
33466695|NCT00049842|101600335|FG000|Treatment Phase|Withdrawal by Subject|35|||
33466696|NCT00049842|101600336|FG001|Treatment Phase|Withdrawal by Subject|46|||
33466697|NCT00049842|101600335|FG000|Treatment Phase|Non-compliance with protocol|7|||
33466698|NCT00049842|101600336|FG001|Treatment Phase|Non-compliance with protocol|8|||
33466699|NCT00049842|101600335|FG000|Treatment Phase|Lost to Follow-up|4|||
33466700|NCT00049842|101600336|FG001|Treatment Phase|Lost to Follow-up|8|||
33466701|NCT00049842|101600335|FG000|Treatment Phase|Administrative|0|||
33466702|NCT00049842|101600336|FG001|Treatment Phase|Administrative|3|||
33466703|NCT00049842|101600335|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
33466704|NCT00049842|101600336|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
33466705|NCT00049842|101600335|FG000|Follow-up Phase|Adverse Event|6|||
33466706|NCT00049842|101600336|FG001|Follow-up Phase|Adverse Event|1|||
33466707|NCT00049842|101600335|FG000|Follow-up Phase|Other|1|||
33466708|NCT00049842|101600336|FG001|Follow-up Phase|Other|4|||
33466709|NCT00479388|101600337|FG000|Overall Study|Adverse Event|90|||
33466710|NCT00479388|101600338|FG001|Overall Study|Adverse Event|45|||
33466711|NCT00479388|101600337|FG000|Overall Study|Lost to Follow-up|0|||
33466712|NCT00479388|101600338|FG001|Overall Study|Lost to Follow-up|2|||
33466713|NCT00479388|101600337|FG000|Overall Study|Protocol Violation|10|||
33466714|NCT00479388|101600338|FG001|Overall Study|Protocol Violation|9|||
33466715|NCT00479388|101600337|FG000|Overall Study|Withdrawal by Subject|32|||
33466716|NCT00479388|101600338|FG001|Overall Study|Withdrawal by Subject|17|||
33466717|NCT00824369|101600344|FG000|Overall Study|Nolonger willing to participate in study|1|||
33466718|NCT00824369|101600345|FG001|Overall Study|Nolonger willing to participate in study|0|||
33466719|NCT00824369|101600346|FG002|Overall Study|Nolonger willing to participate in study|1|||
33466720|NCT00824369|101600347|FG003|Overall Study|Nolonger willing to participate in study|2|||
33466721|NCT00824369|101600348|FG004|Overall Study|Nolonger willing to participate in study|0|||
33466722|NCT00824369|101600349|FG005|Overall Study|Nolonger willing to participate in study|1|||
33466723|NCT00824369|101600344|FG000|Overall Study|Lost to Follow-up|0|||
33466724|NCT00824369|101600345|FG001|Overall Study|Lost to Follow-up|0|||
33466725|NCT00824369|101600346|FG002|Overall Study|Lost to Follow-up|0|||
33466726|NCT00824369|101600347|FG003|Overall Study|Lost to Follow-up|0|||
33466727|NCT00824369|101600348|FG004|Overall Study|Lost to Follow-up|1|||
33466728|NCT00824369|101600349|FG005|Overall Study|Lost to Follow-up|0|||
33466729|NCT04059549|101600354|FG000|Overall Study|Withdrawal by Subject|2|||
33466730|NCT04059549|101600355|FG001|Overall Study|Withdrawal by Subject|0|||
33466731|NCT00518882|101600356|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
33466732|NCT00518882|101600357|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
33466733|NCT00518882|101600356|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
33466734|NCT00518882|101600357|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
33466735|NCT00518882|101600356|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
33466736|NCT00518882|101600357|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
33466737|NCT00518882|101600356|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
33466738|NCT00518882|101600357|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
33466739|NCT00518882|101600356|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
33177968|NCT01988103|100560371|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
33177969|NCT01988103|100560372|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
33177970|NCT01988103|100560368|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
33177971|NCT01988103|100560369|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
33177972|NCT01988103|100560370|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
33177973|NCT01988103|100560371|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
33177974|NCT01988103|100560372|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
33177975|NCT01988103|100560368|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
33177976|NCT01988103|100560369|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
33177977|NCT01988103|100560370|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
33177978|NCT01988103|100560371|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
33177979|NCT01988103|100560372|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
33177980|NCT01988103|100560368|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
33177981|NCT01988103|100560369|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
33177982|NCT01988103|100560370|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
33177983|NCT01988103|100560371|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
33466740|NCT00518882|101600357|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
33466741|NCT00518882|101600356|FG000|Double-Blind, Week 0-26|Subject decision|1|||
33466742|NCT00518882|101600357|FG001|Double-Blind, Week 0-26|Subject decision|1|||
33466743|NCT00518882|101600356|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
33466744|NCT00518882|101600357|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
33466745|NCT00518882|101600356|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
33466746|NCT00518882|101600357|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
33466747|NCT00518882|101600356|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
33466748|NCT00518882|101600357|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
33466749|NCT00518882|101600356|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
33466750|NCT00518882|101600357|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
33466751|NCT00518882|101600356|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
33466752|NCT00518882|101600357|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
33466753|NCT00518882|101600356|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
33466754|NCT00518882|101600357|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
33466755|NCT00518882|101600356|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
33466756|NCT00518882|101600357|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
33466757|NCT00518882|101600356|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
33466758|NCT00518882|101600357|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
33466759|NCT00518882|101600356|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
33466760|NCT00518882|101600357|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
33466761|NCT00518882|101600356|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
33466762|NCT00518882|101600357|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
33466763|NCT00518882|101600356|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
33466764|NCT00518882|101600357|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
33466765|NCT00518882|101600356|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
33466766|NCT00518882|101600357|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
33466767|NCT00518882|101600356|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
33466768|NCT00518882|101600357|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
33466769|NCT00518882|101600356|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
33466770|NCT00518882|101600357|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
33466771|NCT00518882|101600356|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
33466772|NCT00518882|101600357|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
33466773|NCT00518882|101600356|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
33466774|NCT00518882|101600357|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
33466775|NCT00518882|101600356|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
33466776|NCT00518882|101600357|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
33466777|NCT00518882|101600356|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
33466778|NCT00518882|101600357|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
33466779|NCT03042468|101600360|FG000|Overall Study|Death|0|||
33466780|NCT03042468|101600361|FG001|Overall Study|Death|1|||
33466781|NCT03042468|101600362|FG002|Overall Study|Death|1|||
33466782|NCT03042468|101600363|FG003|Overall Study|Death|0|||
33466783|NCT03042468|101600364|FG004|Overall Study|Death|0|||
33466784|NCT03042468|101600365|FG005|Overall Study|Death|0|||
33466785|NCT03042468|101600360|FG000|Overall Study|Withdrawal by Subject|0|||
33466786|NCT03042468|101600361|FG001|Overall Study|Withdrawal by Subject|0|||
33466787|NCT03042468|101600362|FG002|Overall Study|Withdrawal by Subject|0|||
33466788|NCT03042468|101600363|FG003|Overall Study|Withdrawal by Subject|0|||
33466789|NCT03042468|101600364|FG004|Overall Study|Withdrawal by Subject|0|||
33466790|NCT03042468|101600365|FG005|Overall Study|Withdrawal by Subject|1|||
33466791|NCT03042468|101600360|FG000|Overall Study|Lost to Follow-up|0|||
33466792|NCT03042468|101600361|FG001|Overall Study|Lost to Follow-up|0|||
33466793|NCT03042468|101600362|FG002|Overall Study|Lost to Follow-up|0|||
33466794|NCT03042468|101600363|FG003|Overall Study|Lost to Follow-up|0|||
33466795|NCT03042468|101600364|FG004|Overall Study|Lost to Follow-up|1|||
33466796|NCT03042468|101600365|FG005|Overall Study|Lost to Follow-up|1|||
33466797|NCT00754442|101600366|FG000|Overall Study|Withdrawal by Subject|5|||
33466798|NCT00754442|101600367|FG001|Overall Study|Withdrawal by Subject|3|||
33466799|NCT01232491|101600370|FG000|Overall Study|Adverse Event|13|||
33466800|NCT01232491|101600371|FG001|Overall Study|Adverse Event|8|||
33466801|NCT01232491|101600370|FG000|Overall Study|Lack of Efficacy|1|||
33466802|NCT01232491|101600371|FG001|Overall Study|Lack of Efficacy|5|||
33466803|NCT01232491|101600370|FG000|Overall Study|Protocol Violation|13|||
33466804|NCT01232491|101600371|FG001|Overall Study|Protocol Violation|11|||
33466805|NCT01232491|101600370|FG000|Overall Study|Withdrawal Criteria|12|||
33466806|NCT01232491|101600371|FG001|Overall Study|Withdrawal Criteria|21|||
33466807|NCT01232491|101600370|FG000|Overall Study|Other|21|||
33466808|NCT01232491|101600371|FG001|Overall Study|Other|18|||
33466809|NCT02940730|101600372|FG000|Intervention 2|Physician Decision|7|||
33466810|NCT02940730|101600373|FG001|Intervention 2|Physician Decision|0|||
33466811|NCT02696031|101600374|FG000|Up to Week 24|Adverse Event|2|||
33466812|NCT02696031|101600375|FG001|Up to Week 24|Adverse Event|4|||
33466813|NCT02696031|101600376|FG002|Up to Week 24|Adverse Event|2|||
33466814|NCT02696031|101600377|FG003|Up to Week 24|Adverse Event|0|||
33466815|NCT02696031|101600378|FG004|Up to Week 24|Adverse Event|0|||
33466816|NCT02696031|101600379|FG005|Up to Week 24|Adverse Event|0|||
33466817|NCT02696031|101600374|FG000|Up to Week 24|Lack of Efficacy|2|||
33466818|NCT02696031|101600375|FG001|Up to Week 24|Lack of Efficacy|1|||
33466819|NCT02696031|101600376|FG002|Up to Week 24|Lack of Efficacy|2|||
33466820|NCT02696031|101600377|FG003|Up to Week 24|Lack of Efficacy|0|||
33466821|NCT02696031|101600378|FG004|Up to Week 24|Lack of Efficacy|0|||
33466822|NCT02696031|101600379|FG005|Up to Week 24|Lack of Efficacy|0|||
33466823|NCT02696031|101600374|FG000|Up to Week 24|Lost to Follow-up|0|||
33466824|NCT02696031|101600375|FG001|Up to Week 24|Lost to Follow-up|1|||
33466825|NCT02696031|101600376|FG002|Up to Week 24|Lost to Follow-up|1|||
33466826|NCT02696031|101600377|FG003|Up to Week 24|Lost to Follow-up|0|||
33466827|NCT02696031|101600378|FG004|Up to Week 24|Lost to Follow-up|0|||
33466828|NCT02696031|101600379|FG005|Up to Week 24|Lost to Follow-up|0|||
33466829|NCT02696031|101600374|FG000|Up to Week 24|Physician Decision|1|||
33466830|NCT02696031|101600375|FG001|Up to Week 24|Physician Decision|0|||
33466831|NCT02696031|101600376|FG002|Up to Week 24|Physician Decision|1|||
33466832|NCT02696031|101600377|FG003|Up to Week 24|Physician Decision|0|||
33466833|NCT02696031|101600378|FG004|Up to Week 24|Physician Decision|0|||
33466834|NCT02696031|101600379|FG005|Up to Week 24|Physician Decision|0|||
33177984|NCT01988103|100560372|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
33177985|NCT01988103|100560368|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
33177986|NCT01988103|100560369|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
33177987|NCT01988103|100560370|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
33177988|NCT01988103|100560371|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
33466835|NCT02696031|101600374|FG000|Up to Week 24|Protocol Violation|1|||
33466836|NCT02696031|101600375|FG001|Up to Week 24|Protocol Violation|0|||
33466837|NCT02696031|101600376|FG002|Up to Week 24|Protocol Violation|0|||
33466838|NCT02696031|101600377|FG003|Up to Week 24|Protocol Violation|0|||
33466839|NCT02696031|101600378|FG004|Up to Week 24|Protocol Violation|0|||
33466840|NCT02696031|101600379|FG005|Up to Week 24|Protocol Violation|0|||
33466841|NCT02696031|101600374|FG000|Up to Week 24|Withdrawal by Subject|4|||
33466842|NCT02696031|101600375|FG001|Up to Week 24|Withdrawal by Subject|1|||
33466843|NCT02696031|101600376|FG002|Up to Week 24|Withdrawal by Subject|5|||
33466844|NCT02696031|101600377|FG003|Up to Week 24|Withdrawal by Subject|0|||
33466845|NCT02696031|101600378|FG004|Up to Week 24|Withdrawal by Subject|0|||
33177989|NCT01988103|100560372|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
33177990|NCT00730912|100560373|FG000|Overall Study|Discontinued|0|||
33177991|NCT00730912|100560374|FG001|Overall Study|Discontinued|0|||
33177992|NCT00730912|100560375|FG002|Overall Study|Discontinued|1|||
33177993|NCT00487747|100560376|FG000|Overall Study|Adverse Event|1|||
33177994|NCT00487747|100560376|FG000|Overall Study|Lost to Follow-up|9|||
33177995|NCT00487747|100560376|FG000|Overall Study|Lack of Efficacy|1|||
33466846|NCT02696031|101600379|FG005|Up to Week 24|Withdrawal by Subject|0|||
33466847|NCT02696031|101600374|FG000|Up to Week 52|Adverse Event|4|||
33466848|NCT02696031|101600375|FG001|Up to Week 52|Adverse Event|5|||
33466849|NCT02696031|101600376|FG002|Up to Week 52|Adverse Event|3|||
33466850|NCT02696031|101600377|FG003|Up to Week 52|Adverse Event|0|||
33466851|NCT02696031|101600378|FG004|Up to Week 52|Adverse Event|0|||
33466852|NCT02696031|101600379|FG005|Up to Week 52|Adverse Event|0|||
33466853|NCT02696031|101600374|FG000|Up to Week 52|Lack of Efficacy|10|||
33466854|NCT02696031|101600375|FG001|Up to Week 52|Lack of Efficacy|7|||
33177996|NCT00082355|100560377|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
33177997|NCT00082355|100560377|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
33177998|NCT00082355|100560377|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
33177999|NCT00350636|100560379|FG000|Overall Study|Adverse Event|19|||
33178000|NCT00350636|100560380|FG001|Overall Study|Adverse Event|13|||
33178001|NCT00350636|100560379|FG000|Overall Study|Protocol Violation|1|||
33178002|NCT00350636|100560380|FG001|Overall Study|Protocol Violation|3|||
33178003|NCT00350636|100560379|FG000|Overall Study|Withdrawal by Subject|13|||
33178004|NCT00350636|100560380|FG001|Overall Study|Withdrawal by Subject|17|||
33178005|NCT00350636|100560379|FG000|Overall Study|Lost to Follow-up|9|||
33178006|NCT00350636|100560380|FG001|Overall Study|Lost to Follow-up|8|||
33178007|NCT00350636|100560379|FG000|Overall Study|Physician Decision|0|||
33178008|NCT00350636|100560380|FG001|Overall Study|Physician Decision|2|||
33178009|NCT00350636|100560379|FG000|Overall Study|Other|1|||
33178010|NCT00350636|100560380|FG001|Overall Study|Other|2|||
33178011|NCT02631850|100560381|FG000|Treatment Period|Lost to Follow-up|0|||
33178012|NCT02631850|100560382|FG001|Treatment Period|Lost to Follow-up|1|||
33178013|NCT02631850|100560383|FG002|Treatment Period|Lost to Follow-up|0|||
33178014|NCT02631850|100560384|FG003|Treatment Period|Lost to Follow-up|0|||
33178015|NCT02631850|100560381|FG000|Treatment Period|Protocol Violation|1|||
33178016|NCT02631850|100560382|FG001|Treatment Period|Protocol Violation|0|||
33178017|NCT02631850|100560383|FG002|Treatment Period|Protocol Violation|0|||
33178018|NCT02631850|100560384|FG003|Treatment Period|Protocol Violation|0|||
33178019|NCT02631850|100560381|FG000|Treatment Period|Withdrawal by Subject|0|||
33178020|NCT02631850|100560382|FG001|Treatment Period|Withdrawal by Subject|5|||
33178021|NCT02631850|100560383|FG002|Treatment Period|Withdrawal by Subject|2|||
33178022|NCT02631850|100560384|FG003|Treatment Period|Withdrawal by Subject|2|||
33178023|NCT02631850|100560381|FG000|Treatment Period|Adverse Event|1|||
33178024|NCT02631850|100560382|FG001|Treatment Period|Adverse Event|0|||
33178025|NCT02631850|100560383|FG002|Treatment Period|Adverse Event|2|||
33178026|NCT02631850|100560384|FG003|Treatment Period|Adverse Event|3|||
33178027|NCT02631850|100560381|FG000|Treatment Period|Family medical issue|1|||
33178028|NCT02631850|100560382|FG001|Treatment Period|Family medical issue|0|||
33178029|NCT02631850|100560383|FG002|Treatment Period|Family medical issue|0|||
33178030|NCT02631850|100560384|FG003|Treatment Period|Family medical issue|0|||
33178031|NCT02631850|100560381|FG000|6 Month Follow up|Lost to Follow-up|5|||
33178032|NCT02631850|100560382|FG001|6 Month Follow up|Lost to Follow-up|8|||
33178033|NCT02631850|100560383|FG002|6 Month Follow up|Lost to Follow-up|3|||
33178034|NCT02631850|100560384|FG003|6 Month Follow up|Lost to Follow-up|5|||
33178035|NCT02631850|100560381|FG000|6 Month Follow up|Withdrawal by Subject|1|||
33178036|NCT02631850|100560382|FG001|6 Month Follow up|Withdrawal by Subject|0|||
33178037|NCT02631850|100560383|FG002|6 Month Follow up|Withdrawal by Subject|0|||
33178038|NCT02631850|100560384|FG003|6 Month Follow up|Withdrawal by Subject|2|||
33178039|NCT02631850|100560381|FG000|6 Month Follow up|Adverse Event|1|||
33178040|NCT02631850|100560382|FG001|6 Month Follow up|Adverse Event|4|||
33178041|NCT02631850|100560383|FG002|6 Month Follow up|Adverse Event|1|||
33178042|NCT02631850|100560384|FG003|6 Month Follow up|Adverse Event|3|||
33178043|NCT02631850|100560381|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
33178044|NCT02631850|100560382|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
33178045|NCT02631850|100560383|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
33178046|NCT02631850|100560384|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
33178047|NCT00768300|100560385|FG000|Overall Study|Randomized but not treated|1|||
33178048|NCT00768300|100560386|FG001|Overall Study|Randomized but not treated|1|||
33178049|NCT00768300|100560385|FG000|Overall Study|Adverse Event|10|||
33466855|NCT02696031|101600376|FG002|Up to Week 52|Lack of Efficacy|11|||
33466856|NCT02696031|101600377|FG003|Up to Week 52|Lack of Efficacy|0|||
33466857|NCT02696031|101600378|FG004|Up to Week 52|Lack of Efficacy|0|||
33466858|NCT02696031|101600379|FG005|Up to Week 52|Lack of Efficacy|0|||
33466859|NCT02696031|101600374|FG000|Up to Week 52|Lost to Follow-up|1|||
33466860|NCT02696031|101600375|FG001|Up to Week 52|Lost to Follow-up|1|||
33466861|NCT02696031|101600376|FG002|Up to Week 52|Lost to Follow-up|1|||
33466862|NCT02696031|101600377|FG003|Up to Week 52|Lost to Follow-up|0|||
33466863|NCT02696031|101600378|FG004|Up to Week 52|Lost to Follow-up|0|||
33466864|NCT02696031|101600379|FG005|Up to Week 52|Lost to Follow-up|0|||
33466865|NCT02696031|101600374|FG000|Up to Week 52|Physician Decision|1|||
33466866|NCT02696031|101600375|FG001|Up to Week 52|Physician Decision|1|||
33466867|NCT02696031|101600376|FG002|Up to Week 52|Physician Decision|2|||
33466868|NCT02696031|101600377|FG003|Up to Week 52|Physician Decision|0|||
33466869|NCT02696031|101600378|FG004|Up to Week 52|Physician Decision|0|||
33466870|NCT02696031|101600379|FG005|Up to Week 52|Physician Decision|0|||
33466871|NCT02696031|101600374|FG000|Up to Week 52|Pregnancy|0|||
33466872|NCT02696031|101600375|FG001|Up to Week 52|Pregnancy|2|||
33466873|NCT02696031|101600376|FG002|Up to Week 52|Pregnancy|0|||
33466874|NCT02696031|101600377|FG003|Up to Week 52|Pregnancy|0|||
33178050|NCT00768300|100560386|FG001|Overall Study|Adverse Event|2|||
33178051|NCT00768300|100560385|FG000|Overall Study|Protocol Violation|6|||
33178052|NCT00768300|100560386|FG001|Overall Study|Protocol Violation|1|||
33466875|NCT02696031|101600378|FG004|Up to Week 52|Pregnancy|0|||
33466876|NCT02696031|101600379|FG005|Up to Week 52|Pregnancy|0|||
33466877|NCT02696031|101600374|FG000|Up to Week 52|Protocol Violation|1|||
33466878|NCT02696031|101600375|FG001|Up to Week 52|Protocol Violation|0|||
33466879|NCT02696031|101600376|FG002|Up to Week 52|Protocol Violation|0|||
33466880|NCT02696031|101600377|FG003|Up to Week 52|Protocol Violation|0|||
33466881|NCT02696031|101600378|FG004|Up to Week 52|Protocol Violation|0|||
33466882|NCT02696031|101600379|FG005|Up to Week 52|Protocol Violation|0|||
33466883|NCT02696031|101600374|FG000|Up to Week 52|Withdrawal by Subject|12|||
33466884|NCT02696031|101600375|FG001|Up to Week 52|Withdrawal by Subject|3|||
33466885|NCT02696031|101600376|FG002|Up to Week 52|Withdrawal by Subject|9|||
33466886|NCT02696031|101600377|FG003|Up to Week 52|Withdrawal by Subject|0|||
33466887|NCT02696031|101600378|FG004|Up to Week 52|Withdrawal by Subject|0|||
33466888|NCT02696031|101600379|FG005|Up to Week 52|Withdrawal by Subject|0|||
33466889|NCT02696031|101600374|FG000|Up to Week 104|Pregnancy|0|||
33466890|NCT02696031|101600375|FG001|Up to Week 104|Pregnancy|2|||
33466891|NCT02696031|101600376|FG002|Up to Week 104|Pregnancy|1|||
33466892|NCT02696031|101600377|FG003|Up to Week 104|Pregnancy|0|||
33466893|NCT02696031|101600378|FG004|Up to Week 104|Pregnancy|0|||
33466894|NCT02696031|101600379|FG005|Up to Week 104|Pregnancy|0|||
33466895|NCT02696031|101600374|FG000|Up to Week 104|Withdrawal by Subject|15|||
33466896|NCT02696031|101600375|FG001|Up to Week 104|Withdrawal by Subject|10|||
33466897|NCT02696031|101600376|FG002|Up to Week 104|Withdrawal by Subject|16|||
33466898|NCT02696031|101600377|FG003|Up to Week 104|Withdrawal by Subject|0|||
33466899|NCT02696031|101600378|FG004|Up to Week 104|Withdrawal by Subject|0|||
33466900|NCT02696031|101600379|FG005|Up to Week 104|Withdrawal by Subject|0|||
33466901|NCT02696031|101600374|FG000|Up to Week 104|Protocol Violation|1|||
33466902|NCT02696031|101600375|FG001|Up to Week 104|Protocol Violation|0|||
33466903|NCT02696031|101600376|FG002|Up to Week 104|Protocol Violation|0|||
33466904|NCT02696031|101600377|FG003|Up to Week 104|Protocol Violation|0|||
33466905|NCT02696031|101600378|FG004|Up to Week 104|Protocol Violation|0|||
33466906|NCT02696031|101600379|FG005|Up to Week 104|Protocol Violation|0|||
33466907|NCT02696031|101600374|FG000|Up to Week 104|Physician Decision|1|||
33466908|NCT02696031|101600375|FG001|Up to Week 104|Physician Decision|2|||
33466909|NCT02696031|101600376|FG002|Up to Week 104|Physician Decision|3|||
33466910|NCT02696031|101600377|FG003|Up to Week 104|Physician Decision|0|||
33466911|NCT02696031|101600378|FG004|Up to Week 104|Physician Decision|0|||
33466912|NCT02696031|101600379|FG005|Up to Week 104|Physician Decision|0|||
33466913|NCT02696031|101600374|FG000|Up to Week 104|Lost to Follow-up|2|||
33466914|NCT02696031|101600375|FG001|Up to Week 104|Lost to Follow-up|3|||
33466915|NCT02696031|101600376|FG002|Up to Week 104|Lost to Follow-up|1|||
33466916|NCT02696031|101600377|FG003|Up to Week 104|Lost to Follow-up|0|||
33466917|NCT02696031|101600378|FG004|Up to Week 104|Lost to Follow-up|0|||
33466918|NCT02696031|101600379|FG005|Up to Week 104|Lost to Follow-up|0|||
33466919|NCT02696031|101600374|FG000|Up to Week 104|Lack of Efficacy|13|||
33466920|NCT02696031|101600375|FG001|Up to Week 104|Lack of Efficacy|12|||
33466921|NCT02696031|101600376|FG002|Up to Week 104|Lack of Efficacy|11|||
33466922|NCT02696031|101600377|FG003|Up to Week 104|Lack of Efficacy|0|||
33466923|NCT02696031|101600378|FG004|Up to Week 104|Lack of Efficacy|0|||
33466924|NCT02696031|101600379|FG005|Up to Week 104|Lack of Efficacy|0|||
33466925|NCT02696031|101600374|FG000|Up to Week 104|Adverse Event|7|||
33466926|NCT02696031|101600375|FG001|Up to Week 104|Adverse Event|11|||
33466927|NCT02696031|101600376|FG002|Up to Week 104|Adverse Event|5|||
33466928|NCT02696031|101600377|FG003|Up to Week 104|Adverse Event|0|||
33466929|NCT02696031|101600378|FG004|Up to Week 104|Adverse Event|0|||
33466930|NCT02696031|101600379|FG005|Up to Week 104|Adverse Event|0|||
33178053|NCT00768300|100560385|FG000|Overall Study|Withdrawal by Subject|13|||
33466931|NCT02696031|101600374|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
33178054|NCT00768300|100560386|FG001|Overall Study|Withdrawal by Subject|7|||
33466932|NCT02696031|101600375|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
33466933|NCT02696031|101600376|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
33466934|NCT02696031|101600377|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
33466935|NCT02696031|101600378|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
33466936|NCT02696031|101600379|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
33466937|NCT02696031|101600374|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
33466938|NCT02696031|101600375|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
33466939|NCT02696031|101600376|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
33466940|NCT02696031|101600377|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
33466941|NCT02696031|101600378|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
33466942|NCT02696031|101600379|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
33466943|NCT02696031|101600374|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
33466944|NCT02696031|101600375|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
33466945|NCT02696031|101600376|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
33466946|NCT02696031|101600377|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
33466947|NCT02696031|101600378|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
33466948|NCT02696031|101600379|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
33466949|NCT02696031|101600374|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
33466950|NCT02696031|101600375|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
33466951|NCT02696031|101600376|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
33466952|NCT02696031|101600377|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
33466953|NCT02696031|101600378|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
33466954|NCT02696031|101600379|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
33466955|NCT02696031|101600374|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
33466956|NCT02696031|101600375|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
33466957|NCT02696031|101600376|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
33466958|NCT02696031|101600377|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
33466959|NCT02696031|101600378|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
33466960|NCT02696031|101600379|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
33466961|NCT02696031|101600374|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
33466962|NCT02696031|101600375|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
33466963|NCT02696031|101600376|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
33466964|NCT02696031|101600377|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
33466965|NCT02696031|101600378|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
33466966|NCT02696031|101600379|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
33466967|NCT02696031|101600374|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
33466968|NCT02696031|101600375|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
33466969|NCT02696031|101600376|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
33466970|NCT02696031|101600377|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
33466971|NCT02696031|101600378|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
33466972|NCT02696031|101600379|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
33466973|NCT01272921|101600380|FG000|Overall Study|Protocol Violation|2|||
33466974|NCT01272921|101600381|FG001|Overall Study|Protocol Violation|1|||
33466975|NCT00285584|101600382|FG000|Month 3|Lost to Follow-up|3|||
33466976|NCT00285584|101600383|FG001|Month 3|Lost to Follow-up|3|||
33466977|NCT00285584|101600382|FG000|Month 3|Withdrawal by Subject|1|||
33466978|NCT00285584|101600383|FG001|Month 3|Withdrawal by Subject|0|||
33466979|NCT00285584|101600382|FG000|Month 6|Lost to Follow-up|0|||
33466980|NCT00285584|101600383|FG001|Month 6|Lost to Follow-up|1|||
33466981|NCT01563237|101600384|FG000|Overall Study|Lost to Follow-up|6|||
33466982|NCT01563237|101600385|FG001|Overall Study|Lost to Follow-up|0|||
33466983|NCT01563237|101600384|FG000|Overall Study|Withdrawal by Subject|1|||
33466984|NCT01563237|101600385|FG001|Overall Study|Withdrawal by Subject|0|||
33466985|NCT01563237|101600384|FG000|Overall Study|Adverse Event|1|||
33466986|NCT01563237|101600385|FG001|Overall Study|Adverse Event|0|||
33466987|NCT01563237|101600384|FG000|Overall Study|Medical Reasons|1|||
33466988|NCT01563237|101600385|FG001|Overall Study|Medical Reasons|0|||
33466989|NCT01563237|101600384|FG000|Overall Study|Death|1|||
33466990|NCT01563237|101600385|FG001|Overall Study|Death|0|||
33466991|NCT03702049|101600387|FG000|Overall Study|Lost to Follow-up|4|||
33466992|NCT03702049|101600387|FG000|Overall Study|Physician Decision|1|||
33466993|NCT00904748|101600388|FG000|Overall Study|Withdrawal by Subject|1|||
33466994|NCT00904748|101600389|FG001|Overall Study|Withdrawal by Subject|1|||
33466995|NCT00904748|101600390|FG002|Overall Study|Withdrawal by Subject|1|||
33466996|NCT00904748|101600391|FG003|Overall Study|Withdrawal by Subject|2|||
33466997|NCT00904748|101600392|FG004|Overall Study|Withdrawal by Subject|0|||
33466998|NCT00904748|101600393|FG005|Overall Study|Withdrawal by Subject|0|||
33466999|NCT00904748|101600388|FG000|Overall Study|Adverse Event|0|||
33467000|NCT00904748|101600389|FG001|Overall Study|Adverse Event|0|||
33467001|NCT00904748|101600390|FG002|Overall Study|Adverse Event|0|||
33467002|NCT00904748|101600391|FG003|Overall Study|Adverse Event|0|||
33467003|NCT00904748|101600392|FG004|Overall Study|Adverse Event|1|||
33467004|NCT00904748|101600393|FG005|Overall Study|Adverse Event|0|||
33467005|NCT01258101|101600397|FG000|Overall Study|Adverse Event|5|||
33467006|NCT01258101|101600398|FG001|Overall Study|Adverse Event|6|||
33467007|NCT01258101|101600399|FG002|Overall Study|Adverse Event|0|||
33467008|NCT01258101|101600400|FG003|Overall Study|Adverse Event|0|||
33467009|NCT01258101|101600397|FG000|Overall Study|Extra exclusion criterion amended|2|||
33467010|NCT01258101|101600398|FG001|Overall Study|Extra exclusion criterion amended|1|||
33467011|NCT01258101|101600399|FG002|Overall Study|Extra exclusion criterion amended|1|||
33467012|NCT01258101|101600400|FG003|Overall Study|Extra exclusion criterion amended|1|||
33467013|NCT01258101|101600397|FG000|Overall Study|Informed consent has been withdrawn|2|||
33467014|NCT01258101|101600398|FG001|Overall Study|Informed consent has been withdrawn|2|||
33467015|NCT01258101|101600399|FG002|Overall Study|Informed consent has been withdrawn|1|||
33467016|NCT01258101|101600400|FG003|Overall Study|Informed consent has been withdrawn|1|||
33467017|NCT01258101|101600397|FG000|Overall Study|Patient is not able to attend visits|8|||
33467018|NCT01258101|101600398|FG001|Overall Study|Patient is not able to attend visits|9|||
33467019|NCT01258101|101600399|FG002|Overall Study|Patient is not able to attend visits|7|||
33467020|NCT01258101|101600400|FG003|Overall Study|Patient is not able to attend visits|6|||
33467021|NCT01258101|101600397|FG000|Overall Study|Patient´s compliance|4|||
33467022|NCT01258101|101600398|FG001|Overall Study|Patient´s compliance|3|||
33467023|NCT01258101|101600399|FG002|Overall Study|Patient´s compliance|1|||
33467024|NCT01258101|101600400|FG003|Overall Study|Patient´s compliance|2|||
33178055|NCT00768300|100560385|FG000|Overall Study|Physician Decision|2|||
33178056|NCT00768300|100560386|FG001|Overall Study|Physician Decision|3|||
33178057|NCT00768300|100560385|FG000|Overall Study|Study discontinued by Sponsor|271|||
33178058|NCT00768300|100560386|FG001|Overall Study|Study discontinued by Sponsor|140|||
33178059|NCT00768300|100560385|FG000|Overall Study|Death|21|||
33178060|NCT00768300|100560386|FG001|Overall Study|Death|5|||
33178061|NCT00768300|100560385|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
33178062|NCT00768300|100560386|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
33264061|NCT01437319|100866863|FG002|Phase II|Study related symptoms/complaints|19|||
33467025|NCT01258101|101600397|FG000|Overall Study|Lost to Follow-up|5|||
33467026|NCT01258101|101600398|FG001|Overall Study|Lost to Follow-up|5|||
33467027|NCT01258101|101600399|FG002|Overall Study|Lost to Follow-up|0|||
33467028|NCT01258101|101600400|FG003|Overall Study|Lost to Follow-up|6|||
33467029|NCT01258101|101600397|FG000|Overall Study|PCR positive at week 24|0|||
33467030|NCT01258101|101600398|FG001|Overall Study|PCR positive at week 24|0|||
33467031|NCT01258101|101600399|FG002|Overall Study|PCR positive at week 24|0|||
33467032|NCT01258101|101600400|FG003|Overall Study|PCR positive at week 24|1|||
33467033|NCT01258101|101600397|FG000|Overall Study|Other reason|7|||
33467034|NCT01258101|101600398|FG001|Overall Study|Other reason|8|||
33467035|NCT01258101|101600399|FG002|Overall Study|Other reason|1|||
33467036|NCT01258101|101600400|FG003|Overall Study|Other reason|8|||
33467037|NCT01884688|101600403|FG000|Overall Study|Screen Failure|2|||
33467038|NCT03581188|101600404|FG000|Overall Study|Inclusion criteria not met|3|||
33467039|NCT03581188|101600405|FG001|Overall Study|Inclusion criteria not met|2|||
33467040|NCT03581188|101600404|FG000|Overall Study|Lost to Follow-up|5|||
33467041|NCT03581188|101600405|FG001|Overall Study|Lost to Follow-up|5|||
33467042|NCT03581188|101600404|FG000|Overall Study|Discontinued intervention|11|||
33467043|NCT03581188|101600405|FG001|Overall Study|Discontinued intervention|8|||
33467044|NCT00206102|101600408|FG000|Overall Study|Adverse Event|119|||
33467045|NCT00206102|101600409|FG001|Overall Study|Adverse Event|82|||
33467046|NCT00206102|101600408|FG000|Overall Study|Protocol Violation|0|||
33467047|NCT00206102|101600409|FG001|Overall Study|Protocol Violation|2|||
33467048|NCT00206102|101600408|FG000|Overall Study|Lack of therapeutic response|16|||
33467049|NCT00206102|101600409|FG001|Overall Study|Lack of therapeutic response|11|||
33467050|NCT00206102|101600408|FG000|Overall Study|Lost to Follow-up|95|||
33178063|NCT00768300|100560385|FG000|Overall Study|Screen failure following randomization|1|||
33178064|NCT00768300|100560386|FG001|Overall Study|Screen failure following randomization|0|||
33178065|NCT00768300|100560385|FG000|Overall Study|Received lung transplant|1|||
33178066|NCT00768300|100560386|FG001|Overall Study|Received lung transplant|1|||
33178067|NCT00768300|100560385|FG000|Overall Study|Lost to Follow-up|0|||
33264062|NCT01437319|100866861|FG000|Phase II|Protocol Violation|0|||
33264063|NCT01437319|100866862|FG001|Phase II|Protocol Violation|1|||
33264064|NCT01437319|100866863|FG002|Phase II|Protocol Violation|0|||
33467051|NCT00206102|101600409|FG001|Overall Study|Lost to Follow-up|66|||
33467052|NCT00206102|101600408|FG000|Overall Study|Withdrawal by Subject|118|||
33467053|NCT00206102|101600409|FG001|Overall Study|Withdrawal by Subject|101|||
33467054|NCT00206102|101600408|FG000|Overall Study|Study-specific discontinuation criteria|18|||
33467055|NCT00206102|101600409|FG001|Overall Study|Study-specific discontinuation criteria|17|||
33178068|NCT00768300|100560386|FG001|Overall Study|Lost to Follow-up|1|||
33264065|NCT01303510|100866864|FG000|Overall Study|Lost to Follow-up|1|||
33178069|NCT00768300|100560385|FG000|Overall Study|Began prohibited concomitant medication|0|||
33178070|NCT00768300|100560386|FG001|Overall Study|Began prohibited concomitant medication|1|||
33264066|NCT01303510|100866865|FG001|Overall Study|Lost to Follow-up|0|||
33467056|NCT00206102|101600408|FG000|Overall Study|None of those categories|42|||
33467057|NCT00206102|101600409|FG001|Overall Study|None of those categories|36|||
33467058|NCT04223778|101600410|FG000|Overall Study|Ongoing|322|||
33467059|NCT04223778|101600411|FG001|Overall Study|Ongoing|326|||
33467060|NCT04223778|101600410|FG000|Overall Study|Death|0|||
33467061|NCT04223778|101600411|FG001|Overall Study|Death|1|||
33467062|NCT04223778|101600410|FG000|Overall Study|Lost to Follow-up|1|||
33467063|NCT04223778|101600411|FG001|Overall Study|Lost to Follow-up|5|||
33467064|NCT04223778|101600410|FG000|Overall Study|Physician Decision|3|||
33467065|NCT04223778|101600411|FG001|Overall Study|Physician Decision|1|||
33467066|NCT04223778|101600410|FG000|Overall Study|Withdrawal by Subject|10|||
33467067|NCT04223778|101600411|FG001|Overall Study|Withdrawal by Subject|1|||
33467068|NCT04223778|101600410|FG000|Overall Study|Lack of Efficacy|0|||
33467069|NCT04223778|101600411|FG001|Overall Study|Lack of Efficacy|2|||
33467070|NCT00690482|101600414|FG000|Overall Study|Adverse Event|2|||
33467071|NCT00690482|101600415|FG001|Overall Study|Adverse Event|1|||
33467072|NCT00690482|101600414|FG000|Overall Study|Incorrect enrolment|0|||
33467073|NCT00690482|101600415|FG001|Overall Study|Incorrect enrolment|1|||
33467074|NCT00690482|101600414|FG000|Overall Study|Study-specific discontinuation criteria|1|||
33467075|NCT00690482|101600415|FG001|Overall Study|Study-specific discontinuation criteria|0|||
33467076|NCT00690482|101600414|FG000|Overall Study|Intake of prohibited medicine|1|||
33178071|NCT00768300|100560385|FG000|Overall Study|Treated but never dosed with Study drug|1|||
33467077|NCT00690482|101600415|FG001|Overall Study|Intake of prohibited medicine|0|||
33467078|NCT00690482|101600414|FG000|Overall Study|withdrew consent at rand.day|0|||
33178072|NCT00768300|100560386|FG001|Overall Study|Treated but never dosed with Study drug|0|||
33178073|NCT00768300|100560385|FG000|Overall Study|Missing data|1|||
33178074|NCT00768300|100560386|FG001|Overall Study|Missing data|0|||
33178075|NCT03566823|100560387|FG000|Overall Study|Lack of Efficacy|0|||
33178076|NCT03566823|100560388|FG001|Overall Study|Lack of Efficacy|1|||
33178077|NCT03566823|100560389|FG002|Overall Study|Lack of Efficacy|0|||
33178078|NCT03566823|100560387|FG000|Overall Study|Withdrawal by Subject|1|||
33178079|NCT03566823|100560388|FG001|Overall Study|Withdrawal by Subject|2|||
33178080|NCT03566823|100560389|FG002|Overall Study|Withdrawal by Subject|0|||
33178081|NCT03566823|100560387|FG000|Overall Study|Adverse Event|1|||
33178082|NCT03566823|100560388|FG001|Overall Study|Adverse Event|0|||
33178083|NCT03566823|100560389|FG002|Overall Study|Adverse Event|2|||
33467079|NCT00690482|101600415|FG001|Overall Study|withdrew consent at rand.day|1|||
33467080|NCT02326974|101600420|FG000|Overall Study|Withdrawal by Subject|2|||
33467081|NCT02326974|101600420|FG000|Overall Study|failed heterogenity evaluation|5|||
33467082|NCT03341000|101600425|FG000|Overall Study|Adverse Event|1|||
33467083|NCT02619682|101600426|FG000|Overall Study|Withdrawal by Subject|3|||
33467084|NCT02619682|101600426|FG000|Overall Study|Lack of Efficacy|8|||
33467085|NCT02619682|101600426|FG000|Overall Study|new secondary cancer|1|||
33467086|NCT02619682|101600426|FG000|Overall Study|post surgery complications|2|||
33467087|NCT01048502|101600427|FG000|Overall Study|Lost to Follow-up|2|||
33467088|NCT01048502|101600428|FG001|Overall Study|Lost to Follow-up|0|||
33467089|NCT01048502|101600429|FG002|Overall Study|Lost to Follow-up|0|||
33467090|NCT01048502|101600430|FG003|Overall Study|Lost to Follow-up|0|||
33467091|NCT01048502|101600427|FG000|Overall Study|Adverse Event|1|||
33467092|NCT01048502|101600428|FG001|Overall Study|Adverse Event|0|||
33467093|NCT01048502|101600429|FG002|Overall Study|Adverse Event|0|||
33467094|NCT01048502|101600430|FG003|Overall Study|Adverse Event|0|||
33178084|NCT02677922|100560390|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
33178085|NCT02677922|100560391|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
33178086|NCT02677922|100560392|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
33178087|NCT02677922|100560393|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
33178088|NCT02677922|100560394|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
33178089|NCT02677922|100560395|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
33178090|NCT02677922|100560390|FG000|Treatment Period|Adverse Event|0|||
33178091|NCT02677922|100560391|FG001|Treatment Period|Adverse Event|0|||
33178092|NCT02677922|100560392|FG002|Treatment Period|Adverse Event|1|||
33178093|NCT02677922|100560393|FG003|Treatment Period|Adverse Event|3|||
33178094|NCT02677922|100560394|FG004|Treatment Period|Adverse Event|5|||
33178095|NCT02677922|100560395|FG005|Treatment Period|Adverse Event|2|||
33178096|NCT02677922|100560390|FG000|Treatment Period|Progressive Disease|1|||
33178097|NCT02677922|100560391|FG001|Treatment Period|Progressive Disease|1|||
33178098|NCT02677922|100560392|FG002|Treatment Period|Progressive Disease|0|||
33178099|NCT02677922|100560393|FG003|Treatment Period|Progressive Disease|0|||
33467095|NCT01048502|101600427|FG000|Overall Study|Withdrawal by Subject|1|||
33467096|NCT01048502|101600428|FG001|Overall Study|Withdrawal by Subject|4|||
33467097|NCT01048502|101600429|FG002|Overall Study|Withdrawal by Subject|5|||
33467098|NCT01048502|101600430|FG003|Overall Study|Withdrawal by Subject|3|||
33467099|NCT01048502|101600427|FG000|Overall Study|Physician Decision|0|||
33467100|NCT01048502|101600428|FG001|Overall Study|Physician Decision|3|||
33467101|NCT01048502|101600429|FG002|Overall Study|Physician Decision|0|||
33467102|NCT01048502|101600430|FG003|Overall Study|Physician Decision|1|||
33178100|NCT02677922|100560394|FG004|Treatment Period|Progressive Disease|8|||
33178101|NCT02677922|100560395|FG005|Treatment Period|Progressive Disease|7|||
33178102|NCT02677922|100560390|FG000|Treatment Period|Lack of Efficacy|0|||
33178103|NCT02677922|100560391|FG001|Treatment Period|Lack of Efficacy|0|||
33178104|NCT02677922|100560392|FG002|Treatment Period|Lack of Efficacy|0|||
33178105|NCT02677922|100560393|FG003|Treatment Period|Lack of Efficacy|1|||
33178106|NCT02677922|100560394|FG004|Treatment Period|Lack of Efficacy|1|||
33178107|NCT02677922|100560395|FG005|Treatment Period|Lack of Efficacy|6|||
33178108|NCT02677922|100560390|FG000|Treatment Period|Withdrawal by Subject|0|||
33467103|NCT02531594|101600433|FG000|Overall Study|Withdrawal by Subject|7|||
33467104|NCT02531594|101600434|FG001|Overall Study|Withdrawal by Subject|8|||
33178109|NCT02677922|100560391|FG001|Treatment Period|Withdrawal by Subject|0|||
33178110|NCT02677922|100560392|FG002|Treatment Period|Withdrawal by Subject|1|||
33178111|NCT02677922|100560393|FG003|Treatment Period|Withdrawal by Subject|3|||
33178112|NCT02677922|100560394|FG004|Treatment Period|Withdrawal by Subject|5|||
33264067|NCT01773993|100866868|FG000|Overall Study|No Visit After Treatment|35|||
33264068|NCT02284113|100866871|FG000|Overall Study|Adverse Event|1|||
33178113|NCT02677922|100560395|FG005|Treatment Period|Withdrawal by Subject|5|||
33178114|NCT02677922|100560390|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
33178115|NCT02677922|100560391|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
33178116|NCT02677922|100560392|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
33178117|NCT02677922|100560393|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
33178118|NCT02677922|100560394|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
33178119|NCT02677922|100560395|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
33178120|NCT02677922|100560390|FG000|Treatment Period|Disease Relapse|0|||
33178121|NCT02677922|100560391|FG001|Treatment Period|Disease Relapse|0|||
33178122|NCT02677922|100560392|FG002|Treatment Period|Disease Relapse|0|||
33178123|NCT02677922|100560393|FG003|Treatment Period|Disease Relapse|3|||
33178124|NCT02677922|100560394|FG004|Treatment Period|Disease Relapse|6|||
33178125|NCT02677922|100560395|FG005|Treatment Period|Disease Relapse|1|||
33178126|NCT02677922|100560390|FG000|Treatment Period|Allogeneic HSCT|1|||
33178127|NCT02677922|100560391|FG001|Treatment Period|Allogeneic HSCT|0|||
33178128|NCT02677922|100560392|FG002|Treatment Period|Allogeneic HSCT|0|||
33178129|NCT02677922|100560393|FG003|Treatment Period|Allogeneic HSCT|1|||
33178130|NCT02677922|100560394|FG004|Treatment Period|Allogeneic HSCT|4|||
33178131|NCT02677922|100560395|FG005|Treatment Period|Allogeneic HSCT|1|||
33178132|NCT02677922|100560390|FG000|Treatment Period|Other Reasons|0|||
33178133|NCT02677922|100560391|FG001|Treatment Period|Other Reasons|0|||
33178134|NCT02677922|100560392|FG002|Treatment Period|Other Reasons|0|||
33178135|NCT02677922|100560393|FG003|Treatment Period|Other Reasons|1|||
33178136|NCT02677922|100560394|FG004|Treatment Period|Other Reasons|3|||
33178137|NCT02677922|100560395|FG005|Treatment Period|Other Reasons|5|||
33178138|NCT02677922|100560390|FG000|Treatment Period|Death|0|||
33178139|NCT02677922|100560391|FG001|Treatment Period|Death|0|||
33178140|NCT02677922|100560392|FG002|Treatment Period|Death|0|||
33178141|NCT02677922|100560393|FG003|Treatment Period|Death|0|||
33178142|NCT02677922|100560394|FG004|Treatment Period|Death|12|||
33264069|NCT02284113|100866872|FG001|Overall Study|Adverse Event|0|||
33264070|NCT02284113|100866871|FG000|Overall Study|non-compliance|0|||
33264071|NCT02284113|100866872|FG001|Overall Study|non-compliance|1|||
33264072|NCT02284113|100866871|FG000|Overall Study|Withdrawal by Subject|0|||
33264073|NCT02284113|100866872|FG001|Overall Study|Withdrawal by Subject|1|||
33264074|NCT02284113|100866871|FG000|Overall Study|not provided|0|||
33264075|NCT02284113|100866872|FG001|Overall Study|not provided|1|||
33264076|NCT02284113|100866871|FG000|Overall Study|surgery cancelled|2|||
33264077|NCT02284113|100866872|FG001|Overall Study|surgery cancelled|0|||
33264078|NCT03709706|100866876|FG000|Overall Study|Adverse Event|0|||
33264079|NCT03709706|100866877|FG001|Overall Study|Adverse Event|1|||
33264080|NCT03709706|100866876|FG000|Overall Study|Physician Decision|14|||
33264081|NCT03709706|100866877|FG001|Overall Study|Physician Decision|8|||
33467105|NCT01239472|101600442|FG000|Overall Study|Withdrawal by Subject|5|||
33467106|NCT01239472|101600443|FG001|Overall Study|Withdrawal by Subject|1|||
33467107|NCT01239472|101600442|FG000|Overall Study|Adverse Event|0|||
33467108|NCT01239472|101600443|FG001|Overall Study|Adverse Event|1|||
33467109|NCT01239472|101600442|FG000|Overall Study|Lack of Efficacy|0|||
33467110|NCT01239472|101600443|FG001|Overall Study|Lack of Efficacy|1|||
33467111|NCT02556307|101600444|FG000|Overall Study|Premature treatment interruption|11|||
33467112|NCT02556307|101600444|FG000|Overall Study|Lost to Follow-up|36|||
33178143|NCT02677922|100560395|FG005|Treatment Period|Death|1|||
33178144|NCT02677922|100560390|FG000|Treatment Period|Non-compliance with Study Drug|0|||
33178145|NCT02677922|100560391|FG001|Treatment Period|Non-compliance with Study Drug|0|||
33178146|NCT02677922|100560392|FG002|Treatment Period|Non-compliance with Study Drug|0|||
33178147|NCT02677922|100560393|FG003|Treatment Period|Non-compliance with Study Drug|0|||
33178148|NCT02677922|100560394|FG004|Treatment Period|Non-compliance with Study Drug|1|||
33178149|NCT02677922|100560395|FG005|Treatment Period|Non-compliance with Study Drug|0|||
33178150|NCT02677922|100560390|FG000|Treatment Period|Physician Decision|0|||
33264082|NCT03709706|100866876|FG000|Overall Study|Withdrawal by Subject|2|||
33178151|NCT02677922|100560391|FG001|Treatment Period|Physician Decision|0|||
33178152|NCT02677922|100560392|FG002|Treatment Period|Physician Decision|0|||
33264083|NCT03709706|100866877|FG001|Overall Study|Withdrawal by Subject|1|||
33467113|NCT02556307|101600444|FG000|Overall Study|Change to triple therapy|4|||
33467114|NCT02556307|101600444|FG000|Overall Study|Enrolled but not treated|2|||
33467115|NCT00857259|101600445|FG000|Overall Study|Protocol Violation|1|||
33467116|NCT00857259|101600446|FG001|Overall Study|Protocol Violation|0|||
33467117|NCT00857259|101600447|FG002|Overall Study|Protocol Violation|1|||
33467118|NCT03629028|101600449|FG000|Overall Study|Lost to Follow-up|26|||
33467119|NCT03629028|101600450|FG001|Overall Study|Lost to Follow-up|23|||
33467120|NCT03629028|101600449|FG000|Overall Study|Pregnancy|4|||
33467121|NCT03629028|101600450|FG001|Overall Study|Pregnancy|2|||
33467122|NCT03629028|101600449|FG000|Overall Study|intolerance to examination|2|||
33467123|NCT03629028|101600450|FG001|Overall Study|intolerance to examination|0|||
33467124|NCT00854373|101600453|FG000|Overall Study|Withdrawal by Subject|1|||
33467125|NCT00854373|101600454|FG001|Overall Study|Withdrawal by Subject|3|||
33467126|NCT00854373|101600453|FG000|Overall Study|Forgot to take study drug|1|||
33467127|NCT00854373|101600454|FG001|Overall Study|Forgot to take study drug|1|||
33467128|NCT02502734|101600455|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
33178153|NCT02677922|100560393|FG003|Treatment Period|Physician Decision|0|||
33178154|NCT02677922|100560394|FG004|Treatment Period|Physician Decision|0|||
33178155|NCT02677922|100560395|FG005|Treatment Period|Physician Decision|1|||
33178156|NCT02677922|100560390|FG000|Treatment Period|Symptomatic Deterioration|0|||
33467129|NCT02502734|101600456|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
33467130|NCT02502734|101600455|FG000|Washout Period|Adverse Event|1|||
33467131|NCT02502734|101600456|FG001|Washout Period|Adverse Event|0|||
33467132|NCT01221090|101600457|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
33467133|NCT01221090|101600458|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
33467134|NCT01221090|101600459|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
33467135|NCT01221090|101600460|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
33467136|NCT01221090|101600457|FG000|Overall Study|Withdrawal by Subject|0|||
33467137|NCT01221090|101600458|FG001|Overall Study|Withdrawal by Subject|22|||
33178157|NCT02677922|100560391|FG001|Treatment Period|Symptomatic Deterioration|0|||
33178158|NCT02677922|100560392|FG002|Treatment Period|Symptomatic Deterioration|0|||
33178159|NCT02677922|100560393|FG003|Treatment Period|Symptomatic Deterioration|0|||
33178160|NCT02677922|100560394|FG004|Treatment Period|Symptomatic Deterioration|1|||
33178161|NCT02677922|100560395|FG005|Treatment Period|Symptomatic Deterioration|0|||
33178162|NCT00811473|100560396|FG000|Overall Study|Adverse Event|3|||
33178163|NCT00811473|100560397|FG001|Overall Study|Adverse Event|12|||
33178164|NCT00811473|100560396|FG000|Overall Study|Lost to Follow-up|5|||
33178165|NCT00811473|100560397|FG001|Overall Study|Lost to Follow-up|1|||
33178166|NCT00811473|100560396|FG000|Overall Study|Withdrawal by Subject|2|||
33178167|NCT00811473|100560397|FG001|Overall Study|Withdrawal by Subject|4|||
33178168|NCT00811473|100560396|FG000|Overall Study|Severe non-compliance to protocol|2|||
33178169|NCT00811473|100560397|FG001|Overall Study|Severe non-compliance to protocol|4|||
33178170|NCT00811473|100560396|FG000|Overall Study|Lack of therapeutic response|4|||
33178171|NCT00811473|100560397|FG001|Overall Study|Lack of therapeutic response|1|||
33178172|NCT00811473|100560396|FG000|Overall Study|Condition under investigation worsened|1|||
33178173|NCT00811473|100560397|FG001|Overall Study|Condition under investigation worsened|3|||
33178174|NCT00811473|100560396|FG000|Overall Study|Other 2|4|||
33178175|NCT00811473|100560397|FG001|Overall Study|Other 2|1|||
33178176|NCT00811473|100560396|FG000|Overall Study|Incorrect Enrollment|1|||
33178177|NCT00811473|100560397|FG001|Overall Study|Incorrect Enrollment|0|||
33178178|NCT00811473|100560396|FG000|Overall Study|Safety Reasons|1|||
33178179|NCT00811473|100560397|FG001|Overall Study|Safety Reasons|0|||
33178180|NCT03303079|100560399|FG000|Overall Study|Adverse Event|0|||
33178181|NCT03303079|100560400|FG001|Overall Study|Adverse Event|1|||
33178182|NCT03303079|100560401|FG002|Overall Study|Adverse Event|3|||
33178183|NCT03303079|100560399|FG000|Overall Study|Protocol Violation|5|||
33178184|NCT03303079|100560400|FG001|Overall Study|Protocol Violation|4|||
33178185|NCT03303079|100560401|FG002|Overall Study|Protocol Violation|7|||
33178186|NCT03303079|100560399|FG000|Overall Study|Withdrawal by Subject|2|||
33178187|NCT03303079|100560400|FG001|Overall Study|Withdrawal by Subject|4|||
33178188|NCT03303079|100560401|FG002|Overall Study|Withdrawal by Subject|2|||
33178189|NCT03303079|100560399|FG000|Overall Study|Other than specified|0|||
33178190|NCT03303079|100560400|FG001|Overall Study|Other than specified|2|||
33178191|NCT03303079|100560401|FG002|Overall Study|Other than specified|0|||
33178192|NCT00680745|100560405|FG000|Overall Study|Withdrawal by Subject|8|||
33178193|NCT00680745|100560406|FG001|Overall Study|Withdrawal by Subject|3|||
33467138|NCT01221090|101600459|FG002|Overall Study|Withdrawal by Subject|27|||
33467139|NCT01221090|101600460|FG003|Overall Study|Withdrawal by Subject|2|||
33178194|NCT00680745|100560407|FG002|Overall Study|Withdrawal by Subject|2|||
33178195|NCT00680745|100560408|FG003|Overall Study|Withdrawal by Subject|8|||
33178196|NCT00680745|100560405|FG000|Overall Study|Lost to Follow-up|0|||
33178197|NCT00680745|100560406|FG001|Overall Study|Lost to Follow-up|1|||
33178198|NCT00680745|100560407|FG002|Overall Study|Lost to Follow-up|1|||
33178199|NCT00680745|100560408|FG003|Overall Study|Lost to Follow-up|0|||
33178200|NCT00680745|100560405|FG000|Overall Study|Death|1|||
33178201|NCT00680745|100560406|FG001|Overall Study|Death|0|||
33178202|NCT00680745|100560407|FG002|Overall Study|Death|1|||
33178203|NCT00680745|100560408|FG003|Overall Study|Death|0|||
33178204|NCT00680745|100560405|FG000|Overall Study|Adverse Event|5|||
33178205|NCT00680745|100560406|FG001|Overall Study|Adverse Event|3|||
33178206|NCT00680745|100560407|FG002|Overall Study|Adverse Event|3|||
33178207|NCT00680745|100560408|FG003|Overall Study|Adverse Event|3|||
33178208|NCT00680745|100560405|FG000|Overall Study|Poor/Non-compliance|0|||
33178209|NCT00680745|100560406|FG001|Overall Study|Poor/Non-compliance|3|||
33178210|NCT00680745|100560407|FG002|Overall Study|Poor/Non-compliance|0|||
33178211|NCT00680745|100560408|FG003|Overall Study|Poor/Non-compliance|0|||
33178212|NCT00680745|100560405|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
33178213|NCT00680745|100560406|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
33178214|NCT00680745|100560407|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
33178215|NCT00680745|100560408|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
33178216|NCT00680745|100560405|FG000|Overall Study|False Treatment|0|||
33178217|NCT00680745|100560406|FG001|Overall Study|False Treatment|1|||
33178218|NCT00680745|100560407|FG002|Overall Study|False Treatment|3|||
33178219|NCT00680745|100560408|FG003|Overall Study|False Treatment|0|||
33178220|NCT02794103|100560411|FG000|Overall Study|Loss to follow up due to high sedation|3|||
33178221|NCT01996826|100560413|FG000|Overall Study|Lost to Follow-up|6|||
33178222|NCT01996826|100560414|FG001|Overall Study|Lost to Follow-up|2|||
33178223|NCT01996826|100560413|FG000|Overall Study|Physician Decision|1|||
33178224|NCT01996826|100560414|FG001|Overall Study|Physician Decision|1|||
33178225|NCT02169739|100560419|FG000|Overall Study|Lost to Follow-up|0|||
33178226|NCT02169739|100560420|FG001|Overall Study|Lost to Follow-up|4|||
33178227|NCT01519960|100560423|FG000|Overall Study|Withdrawal from the study|26|||
33178228|NCT01519960|100560424|FG001|Overall Study|Withdrawal from the study|22|||
33178229|NCT01519960|100560425|FG002|Overall Study|Withdrawal from the study|5|||
33178230|NCT01165554|100560429|FG000|Overall Study|Withdrawal by Subject|23|||
33178231|NCT01963403|100560431|FG000|Overall Study|Lost to Follow-up|2|||
33178232|NCT01963403|100560432|FG001|Overall Study|Lost to Follow-up|3|||
33178233|NCT01963403|100560431|FG000|Overall Study|Implant removal|0|||
33178234|NCT01963403|100560432|FG001|Overall Study|Implant removal|1|||
33178235|NCT01106898|100560433|FG000|Overall Study|Adverse Event|6|||
33178236|NCT02875860|100560435|FG000|Overall Study|Withdrawal by Subject|0|||
33178237|NCT02875860|100560436|FG001|Overall Study|Withdrawal by Subject|1|||
33178238|NCT01372501|100560457|FG000|Overall Study|Adverse Event|4|||
33178239|NCT01372501|100560457|FG000|Overall Study|Device migration|1|||
33178240|NCT00483379|100560458|FG000|Treatment Period|Adverse Event|1|||
33178241|NCT00483379|100560459|FG001|Treatment Period|Adverse Event|0|||
33178242|NCT00483379|100560458|FG000|Treatment Period|Withdrawal by Subject|1|||
33178243|NCT00483379|100560459|FG001|Treatment Period|Withdrawal by Subject|0|||
33178244|NCT00674661|100560460|FG000|Overall Study|Other|5|||
33178245|NCT00674661|100560461|FG001|Overall Study|Other|7|||
33178246|NCT00674661|100560460|FG000|Overall Study|Lost to Follow-up|6|||
33178247|NCT00674661|100560461|FG001|Overall Study|Lost to Follow-up|3|||
33178248|NCT00674661|100560460|FG000|Overall Study|Withdrawal by Subject|0|||
33178249|NCT00674661|100560461|FG001|Overall Study|Withdrawal by Subject|5|||
33178250|NCT01852942|100560462|FG000|Overall Study|Physician Decision|1|||
33178251|NCT01852942|100560463|FG001|Overall Study|Physician Decision|0|||
33178252|NCT01852942|100560462|FG000|Overall Study|Death|1|||
33178253|NCT01852942|100560463|FG001|Overall Study|Death|1|||
33178254|NCT01852942|100560462|FG000|Overall Study|Withdrawal by Subject|2|||
33178255|NCT01852942|100560463|FG001|Overall Study|Withdrawal by Subject|3|||
33178256|NCT01852942|100560462|FG000|Overall Study|Lost to Follow-up|1|||
33178257|NCT01852942|100560463|FG001|Overall Study|Lost to Follow-up|2|||
33178258|NCT01462084|100560464|FG000|Overall Study|Withdrawal by Subject|1|||
33178259|NCT01462084|100560465|FG001|Overall Study|Withdrawal by Subject|0|||
33178260|NCT01462084|100560464|FG000|Overall Study|Protocol Violation|1|||
33178261|NCT01462084|100560465|FG001|Overall Study|Protocol Violation|1|||
33178262|NCT01912287|100560467|FG000|Overall Study|Ineligible|1|||
33178263|NCT01912287|100560468|FG001|Overall Study|Ineligible|0|||
33178264|NCT01912287|100560469|FG002|Overall Study|Ineligible|1|||
33178265|NCT01912287|100560467|FG000|Overall Study|No-show|0|||
33178266|NCT01912287|100560468|FG001|Overall Study|No-show|0|||
33178267|NCT01912287|100560469|FG002|Overall Study|No-show|1|||
33178268|NCT01912287|100560467|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
33178269|NCT01912287|100560468|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
33178270|NCT01912287|100560469|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
33178271|NCT01912287|100560467|FG000|Overall Study|Felt treatment no longer needed|0|||
33178272|NCT01912287|100560468|FG001|Overall Study|Felt treatment no longer needed|1|||
33178273|NCT01912287|100560469|FG002|Overall Study|Felt treatment no longer needed|0|||
33178274|NCT01912287|100560467|FG000|Overall Study|Life circumstances|4|||
33178275|NCT01912287|100560468|FG001|Overall Study|Life circumstances|2|||
33178276|NCT01912287|100560469|FG002|Overall Study|Life circumstances|0|||
33178277|NCT01912287|100560467|FG000|Overall Study|Lost Interest|1|||
33178278|NCT01912287|100560468|FG001|Overall Study|Lost Interest|0|||
33178279|NCT01912287|100560469|FG002|Overall Study|Lost Interest|0|||
33467140|NCT00298740|101600461|FG000|Overall Study|Lack of Efficacy|6|||
33178280|NCT01912287|100560467|FG000|Overall Study|Uknown reason - subject drop out|5|||
33178281|NCT01912287|100560468|FG001|Overall Study|Uknown reason - subject drop out|7|||
33178282|NCT01912287|100560469|FG002|Overall Study|Uknown reason - subject drop out|3|||
33178283|NCT01912287|100560467|FG000|Overall Study|Missed Assesment|1|||
33178284|NCT01912287|100560468|FG001|Overall Study|Missed Assesment|1|||
33178285|NCT01912287|100560469|FG002|Overall Study|Missed Assesment|1|||
33178286|NCT01912287|100560467|FG000|Overall Study|Scheduling/change in availability|17|||
33178287|NCT01912287|100560468|FG001|Overall Study|Scheduling/change in availability|10|||
33178288|NCT01912287|100560469|FG002|Overall Study|Scheduling/change in availability|8|||
33178289|NCT01475331|100560470|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
33178290|NCT01475331|100560471|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
33178291|NCT01475331|100560470|FG000|Overall Study|excessive main duct communication|1|||
33178292|NCT01475331|100560471|FG001|Overall Study|excessive main duct communication|1|||
33178293|NCT01475331|100560470|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
33178294|NCT01475331|100560471|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
33178295|NCT01475331|100560470|FG000|Overall Study|Sign of malignancy during the procedure|2|||
33178296|NCT01475331|100560471|FG001|Overall Study|Sign of malignancy during the procedure|0|||
33178297|NCT01475331|100560470|FG000|Overall Study|cyst found to be prohibitively small|0|||
33178298|NCT01475331|100560471|FG001|Overall Study|cyst found to be prohibitively small|1|||
33178299|NCT00255047|100560472|FG000|Overall Study|Serious Adverse Events|2|||
33178300|NCT00255047|100560473|FG001|Overall Study|Serious Adverse Events|1|||
33178301|NCT00255047|100560474|FG002|Overall Study|Serious Adverse Events|2|||
33178302|NCT00255047|100560475|FG003|Overall Study|Serious Adverse Events|1|||
33178303|NCT00255047|100560472|FG000|Overall Study|Adverse Event|0|||
33178304|NCT00255047|100560473|FG001|Overall Study|Adverse Event|3|||
33178305|NCT00255047|100560474|FG002|Overall Study|Adverse Event|2|||
33178306|NCT00255047|100560475|FG003|Overall Study|Adverse Event|1|||
33178307|NCT00255047|100560472|FG000|Overall Study|Protocol Violation|13|||
33178308|NCT00255047|100560473|FG001|Overall Study|Protocol Violation|13|||
33178309|NCT00255047|100560474|FG002|Overall Study|Protocol Violation|16|||
33178310|NCT00255047|100560475|FG003|Overall Study|Protocol Violation|20|||
33178311|NCT00255047|100560472|FG000|Overall Study|Lost to Follow-up|9|||
33178312|NCT00255047|100560473|FG001|Overall Study|Lost to Follow-up|8|||
33178313|NCT00255047|100560474|FG002|Overall Study|Lost to Follow-up|5|||
33178314|NCT00255047|100560475|FG003|Overall Study|Lost to Follow-up|6|||
33178315|NCT00255047|100560472|FG000|Overall Study|Withdrawal by Subject|24|||
33178316|NCT00255047|100560473|FG001|Overall Study|Withdrawal by Subject|23|||
33178317|NCT00255047|100560474|FG002|Overall Study|Withdrawal by Subject|25|||
33178318|NCT00255047|100560475|FG003|Overall Study|Withdrawal by Subject|18|||
33178319|NCT01077804|100560477|FG000|Overall Study|Unreachable|102|||
33178320|NCT01077804|100560477|FG000|Overall Study|Refused to continue|79|||
33178321|NCT01077804|100560477|FG000|Overall Study|Other|18|||
33178322|NCT01013701|100560481|FG000|Overall Study|study prematurely terminated|7|||
33178323|NCT01404325|100560482|FG000|Overall Study|Lost to Follow-up|1|||
33178324|NCT01404325|100560483|FG001|Overall Study|Lost to Follow-up|0|||
33178325|NCT01404325|100560482|FG000|Overall Study|Death|2|||
33178326|NCT01404325|100560483|FG001|Overall Study|Death|0|||
33178327|NCT01404325|100560482|FG000|Overall Study|Graft loss/Retransplantation|1|||
33178328|NCT01404325|100560483|FG001|Overall Study|Graft loss/Retransplantation|0|||
33178329|NCT01404325|100560482|FG000|Overall Study|non-specified reason|0|||
33178330|NCT01404325|100560483|FG001|Overall Study|non-specified reason|2|||
33178331|NCT02140567|100560484|FG000|Overall Study|Problems with recording equipment|6|||
33178332|NCT01505868|100560491|FG000|Overall Study|Withdrawal by Subject|1|||
33178333|NCT01505868|100560492|FG001|Overall Study|Withdrawal by Subject|0|||
33178334|NCT01505868|100560493|FG002|Overall Study|Withdrawal by Subject|0|||
33178335|NCT01505868|100560494|FG003|Overall Study|Withdrawal by Subject|0|||
33178336|NCT01505868|100560495|FG004|Overall Study|Withdrawal by Subject|0|||
33178337|NCT03045081|100560506|FG000|Overall Study|Withdrawal by Subject|6|||
33178338|NCT03045081|100560507|FG001|Overall Study|Withdrawal by Subject|11|||
33178339|NCT01466348|100560508|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
33178340|NCT01466348|100560509|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
33178341|NCT03089606|100560516|FG000|Overall Study|Progression after Cycle 1|1|||
33178342|NCT02750592|100560517|FG000|Overall Study|Adverse Event|3|||
33178343|NCT02750592|100560517|FG000|Overall Study|Lack of Efficacy|2|||
33178344|NCT00495170|100560521|FG000|Overall Study|Lost to Follow-up|9|||
33178345|NCT00495170|100560521|FG000|Overall Study|Withdrawal by Subject|3|||
33178346|NCT00495170|100560521|FG000|Overall Study|Inappropriate staging|8|||
33178347|NCT04251221|100560522|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
33178348|NCT04251221|100560523|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
33178349|NCT01998737|100560524|FG000|Overall Study|Corrupted database|23|||
33178350|NCT01998737|100560525|FG001|Overall Study|Corrupted database|0|||
33178351|NCT01042236|100560526|FG000|Treatment Period 1|Adverse Event|0|||
33178352|NCT01042236|100560527|FG001|Treatment Period 1|Adverse Event|1|||
33178353|NCT01042236|100560528|FG002|Treatment Period 1|Adverse Event|0|||
33178354|NCT01042236|100560529|FG003|Treatment Period 1|Adverse Event|0|||
33178355|NCT01042236|100560530|FG004|Treatment Period 1|Adverse Event|1|||
33178356|NCT01042236|100560531|FG005|Treatment Period 1|Adverse Event|0|||
33178357|NCT01042236|100560526|FG000|Treatment Period 3|Adverse Event|0|||
33178358|NCT01042236|100560527|FG001|Treatment Period 3|Adverse Event|0|||
33467141|NCT00298740|101600461|FG000|Overall Study|Withdrawal by Subject|3|||
33467142|NCT02450526|101600462|FG000|DB Period (Cycle 1)|Adverse Event|0|||
33467143|NCT02450526|101600463|FG001|DB Period (Cycle 1)|Adverse Event|0|||
33467144|NCT02450526|101600464|FG002|DB Period (Cycle 1)|Adverse Event|2|||
33467145|NCT02450526|101600465|FG003|DB Period (Cycle 1)|Adverse Event|0|||
33467146|NCT02450526|101600466|FG004|DB Period (Cycle 1)|Adverse Event|0|||
33467147|NCT02450526|101600462|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
33467148|NCT02450526|101600463|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
33467149|NCT02450526|101600464|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
33467150|NCT02450526|101600465|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
33467151|NCT02450526|101600466|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
33467152|NCT02450526|101600462|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
33467153|NCT02450526|101600463|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
33467154|NCT02450526|101600464|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
33467155|NCT02450526|101600465|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
33467156|NCT02450526|101600466|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
33467157|NCT02450526|101600462|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
33467158|NCT02450526|101600463|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
33467159|NCT02450526|101600464|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
33467160|NCT02450526|101600465|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
33467161|NCT02450526|101600466|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
33467162|NCT02450526|101600462|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
33467163|NCT02450526|101600463|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
33467164|NCT02450526|101600464|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
33467165|NCT02450526|101600465|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
33467166|NCT02450526|101600466|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
33467167|NCT02450526|101600462|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
33467168|NCT02450526|101600463|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
33467169|NCT02450526|101600464|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
33467170|NCT02450526|101600465|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
33467171|NCT02450526|101600466|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
33467172|NCT02450526|101600462|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
33467173|NCT02450526|101600463|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
33467174|NCT02450526|101600464|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
33178359|NCT01042236|100560528|FG002|Treatment Period 3|Adverse Event|0|||
33467175|NCT02450526|101600465|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
33178360|NCT01042236|100560529|FG003|Treatment Period 3|Adverse Event|1|||
33178361|NCT01042236|100560530|FG004|Treatment Period 3|Adverse Event|0|||
33178362|NCT01042236|100560531|FG005|Treatment Period 3|Adverse Event|0|||
33178363|NCT01042236|100560526|FG000|Treatment Period 3|Protocol Violation|0|||
33178364|NCT01042236|100560527|FG001|Treatment Period 3|Protocol Violation|0|||
33178365|NCT01042236|100560528|FG002|Treatment Period 3|Protocol Violation|0|||
33178366|NCT01042236|100560529|FG003|Treatment Period 3|Protocol Violation|1|||
33178367|NCT01042236|100560530|FG004|Treatment Period 3|Protocol Violation|0|||
33178368|NCT01042236|100560531|FG005|Treatment Period 3|Protocol Violation|0|||
33178369|NCT01428453|100560536|FG000|Overall Study|Adverse Event|2|||
33178370|NCT01428453|100560537|FG001|Overall Study|Adverse Event|7|||
33178371|NCT01428453|100560536|FG000|Overall Study|Protocol Violation|1|||
33178372|NCT01428453|100560537|FG001|Overall Study|Protocol Violation|0|||
33178373|NCT01428453|100560536|FG000|Overall Study|Lost to Follow-up|0|||
33178374|NCT01428453|100560537|FG001|Overall Study|Lost to Follow-up|1|||
33264084|NCT03709706|100866876|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
33467176|NCT02450526|101600466|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
33467177|NCT02450526|101600462|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
33467178|NCT02450526|101600463|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
33467179|NCT02450526|101600464|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
33467180|NCT02450526|101600465|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
33467181|NCT02450526|101600466|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
33467182|NCT00918463|101600468|FG000|Overall Study|Death|1|||
33467183|NCT00918463|101600468|FG000|Overall Study|Lack of Efficacy|1|||
33467184|NCT00103402|101600469|FG000|Overall Study|Adverse Event|3|||
33467185|NCT00103402|101600470|FG001|Overall Study|Adverse Event|4|||
33467186|NCT00103402|101600469|FG000|Overall Study|Lost to Follow-up|8|||
33467187|NCT00103402|101600470|FG001|Overall Study|Lost to Follow-up|7|||
33467188|NCT00103402|101600469|FG000|Overall Study|Dissatisfied/No longer interested|6|||
33467189|NCT00103402|101600470|FG001|Overall Study|Dissatisfied/No longer interested|6|||
33467190|NCT00103402|101600469|FG000|Overall Study|Personal constraints/Other|5|||
33467191|NCT00103402|101600470|FG001|Overall Study|Personal constraints/Other|0|||
33467192|NCT00897949|101600471|FG000|Overall Study|Adverse Event|1|||
33178375|NCT01428453|100560536|FG000|Overall Study|Withdrawal by Subject|3|||
33178376|NCT01428453|100560537|FG001|Overall Study|Withdrawal by Subject|1|||
33467193|NCT00897949|101600472|FG001|Overall Study|Adverse Event|1|||
33467194|NCT00897949|101600473|FG002|Overall Study|Adverse Event|0|||
33467195|NCT00897949|101600471|FG000|Overall Study|Lost to Follow-up|0|||
33467196|NCT00897949|101600472|FG001|Overall Study|Lost to Follow-up|2|||
33467197|NCT00897949|101600473|FG002|Overall Study|Lost to Follow-up|1|||
33467198|NCT00897949|101600471|FG000|Overall Study|Protocol Violation|6|||
33467199|NCT00897949|101600472|FG001|Overall Study|Protocol Violation|3|||
33467200|NCT00897949|101600473|FG002|Overall Study|Protocol Violation|1|||
33467201|NCT00897949|101600471|FG000|Overall Study|Withdrawal by Subject|1|||
33467202|NCT00897949|101600472|FG001|Overall Study|Withdrawal by Subject|2|||
33467203|NCT00897949|101600473|FG002|Overall Study|Withdrawal by Subject|0|||
33467204|NCT00897949|101600471|FG000|Overall Study|Patient Uncoorperative|0|||
33467205|NCT00897949|101600472|FG001|Overall Study|Patient Uncoorperative|2|||
33467206|NCT00897949|101600473|FG002|Overall Study|Patient Uncoorperative|1|||
33467207|NCT00897949|101600471|FG000|Overall Study|Lost to Follow-up|30|||
33467208|NCT00897949|101600472|FG001|Overall Study|Lost to Follow-up|23|||
33467209|NCT00897949|101600473|FG002|Overall Study|Lost to Follow-up|17|||
33467210|NCT00897949|101600471|FG000|Overall Study|Withdrawal by Subject|24|||
33467211|NCT00897949|101600472|FG001|Overall Study|Withdrawal by Subject|31|||
33467212|NCT00897949|101600473|FG002|Overall Study|Withdrawal by Subject|17|||
33467213|NCT00897949|101600471|FG000|Overall Study|Abnormal Prestudy Labs|2|||
33467214|NCT00897949|101600472|FG001|Overall Study|Abnormal Prestudy Labs|3|||
33467215|NCT00897949|101600473|FG002|Overall Study|Abnormal Prestudy Labs|4|||
33467216|NCT00897949|101600471|FG000|Overall Study|Abnormal Baseline ECG|2|||
33467217|NCT00897949|101600472|FG001|Overall Study|Abnormal Baseline ECG|2|||
33467218|NCT00897949|101600473|FG002|Overall Study|Abnormal Baseline ECG|4|||
33467219|NCT00897949|101600471|FG000|Overall Study|Need for Concom. Med.|0|||
33467220|NCT00897949|101600472|FG001|Overall Study|Need for Concom. Med.|1|||
33467221|NCT00897949|101600473|FG002|Overall Study|Need for Concom. Med.|1|||
33467222|NCT00897949|101600471|FG000|Overall Study|Lack of Migraine Attack|29|||
33467223|NCT00897949|101600472|FG001|Overall Study|Lack of Migraine Attack|30|||
33467224|NCT00897949|101600473|FG002|Overall Study|Lack of Migraine Attack|19|||
33264085|NCT03709706|100866877|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
33264086|NCT02157116|100866878|FG000|Overall Study|Withdrawal by Subject|4|||
33264087|NCT02157116|100866878|FG000|Overall Study|Physician Decision|3|||
33264088|NCT02157116|100866878|FG000|Overall Study|Failed Screening|2|||
33264089|NCT00571649|100866879|FG000|Treatment Period|Adverse Event|438|||
33264090|NCT00571649|100866880|FG001|Treatment Period|Adverse Event|385|||
33264091|NCT00571649|100866879|FG000|Treatment Period|Clinical endpoint reached|50|||
33264092|NCT00571649|100866880|FG001|Treatment Period|Clinical endpoint reached|56|||
33264093|NCT00571649|100866879|FG000|Treatment Period|Withdrawal by Subject|285|||
33264094|NCT00571649|100866880|FG001|Treatment Period|Withdrawal by Subject|255|||
33264095|NCT00571649|100866879|FG000|Treatment Period|Death|76|||
33264096|NCT00571649|100866880|FG001|Treatment Period|Death|59|||
33264097|NCT00571649|100866879|FG000|Treatment Period|Physician Decision|8|||
33264098|NCT00571649|100866880|FG001|Treatment Period|Physician Decision|9|||
33264099|NCT00571649|100866879|FG000|Treatment Period|Lost to Follow-up|43|||
33264100|NCT00571649|100866880|FG001|Treatment Period|Lost to Follow-up|41|||
33264101|NCT00571649|100866879|FG000|Treatment Period|Non-compliant with study medication|88|||
33264102|NCT00571649|100866880|FG001|Treatment Period|Non-compliant with study medication|89|||
33264103|NCT00571649|100866879|FG000|Treatment Period|Patient convenience|11|||
33264104|NCT00571649|100866880|FG001|Treatment Period|Patient convenience|13|||
33264105|NCT00571649|100866879|FG000|Treatment Period|Protocol Violation|90|||
33264106|NCT00571649|100866880|FG001|Treatment Period|Protocol Violation|92|||
33264107|NCT00571649|100866879|FG000|Treatment Period|Technical problems|3|||
33467225|NCT00897949|101600471|FG000|Overall Study|Did not take study drug|9|||
33467226|NCT00897949|101600472|FG001|Overall Study|Did not take study drug|3|||
33467227|NCT00897949|101600473|FG002|Overall Study|Did not take study drug|4|||
33467228|NCT02924376|101600474|FG000|Overall Study|Progressive Disease|4|||
33467229|NCT02924376|101600475|FG001|Overall Study|Progressive Disease|0|||
33467230|NCT02924376|101600476|FG002|Overall Study|Progressive Disease|1|||
33467231|NCT02924376|101600477|FG003|Overall Study|Progressive Disease|0|||
33467232|NCT02924376|101600474|FG000|Overall Study|Death|73|||
33467233|NCT02924376|101600475|FG001|Overall Study|Death|18|||
33467234|NCT02924376|101600476|FG002|Overall Study|Death|15|||
33467235|NCT02924376|101600477|FG003|Overall Study|Death|2|||
33467236|NCT02924376|101600474|FG000|Overall Study|Lost to Follow-up|3|||
33467237|NCT02924376|101600475|FG001|Overall Study|Lost to Follow-up|0|||
33467238|NCT02924376|101600476|FG002|Overall Study|Lost to Follow-up|0|||
33467239|NCT02924376|101600477|FG003|Overall Study|Lost to Follow-up|0|||
33467240|NCT02924376|101600474|FG000|Overall Study|Study Terminated by Sponsor|19|||
33467241|NCT02924376|101600475|FG001|Overall Study|Study Terminated by Sponsor|0|||
33467242|NCT02924376|101600476|FG002|Overall Study|Study Terminated by Sponsor|0|||
33178377|NCT01359449|100560538|FG000|Overall Study|Lost to Follow-up|1|||
33264108|NCT00571649|100866880|FG001|Treatment Period|Technical problems|5|||
33264109|NCT00571649|100866879|FG000|Follow-up Period|Adverse Event|46|||
33264110|NCT00571649|100866880|FG001|Follow-up Period|Adverse Event|40|||
33467243|NCT02924376|101600477|FG003|Overall Study|Study Terminated by Sponsor|0|||
33264111|NCT00571649|100866879|FG000|Follow-up Period|Clinical endpoint reached|5|||
33264112|NCT00571649|100866880|FG001|Follow-up Period|Clinical endpoint reached|2|||
33264113|NCT00571649|100866879|FG000|Follow-up Period|Withdrawal by Subject|119|||
33264114|NCT00571649|100866880|FG001|Follow-up Period|Withdrawal by Subject|115|||
33264115|NCT00571649|100866879|FG000|Follow-up Period|Death|132|||
33264116|NCT00571649|100866880|FG001|Follow-up Period|Death|133|||
33264117|NCT00571649|100866879|FG000|Follow-up Period|Physician Decision|7|||
33264118|NCT00571649|100866880|FG001|Follow-up Period|Physician Decision|13|||
33264119|NCT00571649|100866879|FG000|Follow-up Period|Lost to Follow-up|95|||
33264120|NCT00571649|100866880|FG001|Follow-up Period|Lost to Follow-up|92|||
33264121|NCT00571649|100866879|FG000|Follow-up Period|Patient convenience|136|||
33264122|NCT00571649|100866880|FG001|Follow-up Period|Patient convenience|121|||
33264123|NCT00571649|100866879|FG000|Follow-up Period|Protocol Violation|5|||
33264124|NCT00571649|100866880|FG001|Follow-up Period|Protocol Violation|12|||
33264125|NCT01471691|100866883|FG000|Overall Study|Lack of Efficacy|0|||
33264126|NCT01471691|100866884|FG001|Overall Study|Lack of Efficacy|1|||
33264127|NCT04029090|100866885|FG000|Overall Study|Protocol Violation|1|||
33264128|NCT04029090|100866886|FG001|Overall Study|Protocol Violation|0|||
33264129|NCT04029090|100866887|FG002|Overall Study|Protocol Violation|0|||
33264130|NCT04029090|100866885|FG000|Overall Study|Withdrawal by Subject|0|||
33264131|NCT04029090|100866886|FG001|Overall Study|Withdrawal by Subject|1|||
33264132|NCT04029090|100866887|FG002|Overall Study|Withdrawal by Subject|0|||
33264133|NCT02432274|100866888|FG000|Overall Study|Death|2|||
33264134|NCT02432274|100866889|FG001|Overall Study|Death|6|||
33264135|NCT02432274|100866890|FG002|Overall Study|Death|7|||
33264136|NCT02432274|100866891|FG003|Overall Study|Death|0|||
33264137|NCT02432274|100866892|FG004|Overall Study|Death|27|||
33264138|NCT02432274|100866893|FG005|Overall Study|Death|7|||
33264139|NCT02432274|100866894|FG006|Overall Study|Death|9|||
33264140|NCT02432274|100866895|FG007|Overall Study|Death|14|||
33264141|NCT02432274|100866888|FG000|Overall Study|Withdrawal of Consent|0|||
33264142|NCT02432274|100866889|FG001|Overall Study|Withdrawal of Consent|0|||
33264143|NCT02432274|100866890|FG002|Overall Study|Withdrawal of Consent|0|||
33264144|NCT02432274|100866891|FG003|Overall Study|Withdrawal of Consent|0|||
33264145|NCT02432274|100866892|FG004|Overall Study|Withdrawal of Consent|2|||
33264146|NCT02432274|100866893|FG005|Overall Study|Withdrawal of Consent|0|||
33264147|NCT02432274|100866894|FG006|Overall Study|Withdrawal of Consent|1|||
33264148|NCT02432274|100866895|FG007|Overall Study|Withdrawal of Consent|2|||
33264149|NCT03936660|100866896|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
33264150|NCT03936660|100866897|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
33264151|NCT00293397|100866898|FG000|Overall Study|Death|2|||
33264152|NCT01750684|100866902|FG000|Overall Study|Death|1|||
33264153|NCT01750684|100866903|FG001|Overall Study|Death|0|||
33264154|NCT01750684|100866902|FG000|Overall Study|Non-compliance with Study Drug|0|||
33264155|NCT01750684|100866903|FG001|Overall Study|Non-compliance with Study Drug|1|||
33264156|NCT01750684|100866902|FG000|Overall Study|Withdrawn by Sponsor|0|||
33264157|NCT01750684|100866903|FG001|Overall Study|Withdrawn by Sponsor|1|||
33264158|NCT01750684|100866902|FG000|Overall Study|Protocol Violation|1|||
33264159|NCT01750684|100866903|FG001|Overall Study|Protocol Violation|0|||
33264160|NCT02972359|100866904|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
33264161|NCT02972359|100866904|FG000|Overall Study|Lack of Efficacy|1|||
33264162|NCT02972359|100866904|FG000|Overall Study|Adverse Event|4|||
33264163|NCT02972359|100866904|FG000|Overall Study|Death|1|||
33264164|NCT02972359|100866904|FG000|Overall Study|Withdrawal by Subject|30|||
33264165|NCT02972359|100866904|FG000|Overall Study|Protocol Violation|1|||
33264166|NCT02972359|100866904|FG000|Overall Study|Lost to Follow-up|26|||
33264167|NCT02972359|100866904|FG000|Overall Study|Other reasons|5|||
33264168|NCT02972359|100866904|FG000|Overall Study|Missing|1|||
33264169|NCT00309166|100866916|FG000|Overall Study|Adverse event, non-fatal|1|||
33264170|NCT00309166|100866917|FG001|Overall Study|Adverse event, non-fatal|0|||
33264171|NCT00309166|100866916|FG000|Overall Study|Withdrawal by Subject|4|||
33264172|NCT00309166|100866917|FG001|Overall Study|Withdrawal by Subject|3|||
33264173|NCT02285270|100866922|FG000|Overall Study|Lost to Follow-up|1|||
33264174|NCT02285270|100866922|FG000|Overall Study|Physician Decision|3|||
33264175|NCT02285270|100866922|FG000|Overall Study|Determined to be ineligible|1|||
33264176|NCT01860079|100866923|FG000|Overall Study|Physician Decision|14|||
33264177|NCT01860079|100866924|FG001|Overall Study|Physician Decision|22|||
33264178|NCT00912964|100866925|FG000|Overall Study|Eligibility criterion not met|1|||
33264179|NCT00912964|100866926|FG001|Overall Study|Eligibility criterion not met|1|||
33264180|NCT00912964|100866927|FG002|Overall Study|Eligibility criterion not met|0|||
33264181|NCT00912964|100866925|FG000|Overall Study|Adverse Event|15|||
33264182|NCT00912964|100866926|FG001|Overall Study|Adverse Event|18|||
33264183|NCT00912964|100866927|FG002|Overall Study|Adverse Event|12|||
33264184|NCT00912964|100866925|FG000|Overall Study|Lack of Efficacy|11|||
33264185|NCT00912964|100866926|FG001|Overall Study|Lack of Efficacy|4|||
33264186|NCT00912964|100866927|FG002|Overall Study|Lack of Efficacy|3|||
33264187|NCT00912964|100866925|FG000|Overall Study|Withdrawal by Subject|20|||
33264188|NCT00912964|100866926|FG001|Overall Study|Withdrawal by Subject|12|||
33264189|NCT00912964|100866927|FG002|Overall Study|Withdrawal by Subject|18|||
33264190|NCT00912964|100866925|FG000|Overall Study|Lost to Follow-up|4|||
33264191|NCT00912964|100866926|FG001|Overall Study|Lost to Follow-up|3|||
33264192|NCT00912964|100866927|FG002|Overall Study|Lost to Follow-up|3|||
33264193|NCT00912964|100866925|FG000|Overall Study|Protocol Violation|5|||
33264194|NCT00912964|100866926|FG001|Overall Study|Protocol Violation|3|||
33264195|NCT00912964|100866927|FG002|Overall Study|Protocol Violation|8|||
33264196|NCT00912964|100866925|FG000|Overall Study|Taking exclusionary medications|7|||
33264197|NCT00912964|100866926|FG001|Overall Study|Taking exclusionary medications|4|||
33264198|NCT00912964|100866927|FG002|Overall Study|Taking exclusionary medications|8|||
33264199|NCT00912964|100866925|FG000|Overall Study|Medical History|1|||
33264200|NCT00912964|100866926|FG001|Overall Study|Medical History|0|||
33264201|NCT00912964|100866927|FG002|Overall Study|Medical History|0|||
33264202|NCT00912964|100866925|FG000|Overall Study|Non-compliance with study procedures|2|||
33264203|NCT00912964|100866926|FG001|Overall Study|Non-compliance with study procedures|0|||
33264204|NCT00912964|100866927|FG002|Overall Study|Non-compliance with study procedures|0|||
33264205|NCT00912964|100866925|FG000|Overall Study|Violation of exclusion criterion|0|||
33264206|NCT00912964|100866926|FG001|Overall Study|Violation of exclusion criterion|0|||
33264207|NCT00912964|100866927|FG002|Overall Study|Violation of exclusion criterion|2|||
33264208|NCT00912964|100866925|FG000|Overall Study|Randomized but never received study drug|0|||
33264209|NCT00912964|100866926|FG001|Overall Study|Randomized but never received study drug|1|||
33264210|NCT00912964|100866927|FG002|Overall Study|Randomized but never received study drug|0|||
33264211|NCT01160354|100866928|FG000|Overall Study|Death|0|||
33264212|NCT01160354|100866929|FG001|Overall Study|Death|1|||
33264213|NCT01160354|100866930|FG002|Overall Study|Death|1|||
33264214|NCT05484661|100866931|FG000|Overall Study|Withdrawal by Subject|1|||
33264215|NCT05484661|100866932|FG001|Overall Study|Withdrawal by Subject|0|||
33264216|NCT02347332|100866933|FG000|Overall Study|Not treated|5|||
33264217|NCT02347332|100866934|FG001|Overall Study|Not treated|2|||
33264218|NCT02347332|100866933|FG000|Overall Study|Progressive disease|141|||
33264219|NCT02347332|100866934|FG001|Overall Study|Progressive disease|159|||
33264220|NCT02347332|100866933|FG000|Overall Study|Adverse Event|50|||
33264221|NCT02347332|100866934|FG001|Overall Study|Adverse Event|41|||
33264222|NCT02347332|100866933|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
33467244|NCT02924376|101600474|FG000|Overall Study|Physician Decision|1|||
33467245|NCT02924376|101600475|FG001|Overall Study|Physician Decision|0|||
33467246|NCT02924376|101600476|FG002|Overall Study|Physician Decision|0|||
33467247|NCT02924376|101600477|FG003|Overall Study|Physician Decision|0|||
33467248|NCT02924376|101600474|FG000|Overall Study|Withdrawal by Subject|7|||
33467249|NCT02924376|101600475|FG001|Overall Study|Withdrawal by Subject|2|||
33467250|NCT02924376|101600476|FG002|Overall Study|Withdrawal by Subject|1|||
33467251|NCT02924376|101600477|FG003|Overall Study|Withdrawal by Subject|0|||
33467252|NCT02924376|101600474|FG000|Overall Study|Rolled Over to Another Study|1|||
33467253|NCT02924376|101600475|FG001|Overall Study|Rolled Over to Another Study|0|||
33467254|NCT02924376|101600476|FG002|Overall Study|Rolled Over to Another Study|0|||
33467255|NCT02924376|101600477|FG003|Overall Study|Rolled Over to Another Study|0|||
33178378|NCT01359449|100560539|FG001|Overall Study|Lost to Follow-up|0|||
33178379|NCT01359449|100560538|FG000|Overall Study|Protocol Violation|0|||
33178380|NCT01359449|100560539|FG001|Overall Study|Protocol Violation|2|||
33178381|NCT01359449|100560538|FG000|Overall Study|Withdrawal by Subject|3|||
33178382|NCT01359449|100560539|FG001|Overall Study|Withdrawal by Subject|2|||
33178383|NCT02699554|100560542|FG000|Overall Study|Lost to Follow-up|9|||
33178384|NCT00624052|100560544|FG000|Overall Study|Adverse Event|7|||
33178385|NCT00624052|100560545|FG001|Overall Study|Adverse Event|6|||
33178386|NCT00624052|100560546|FG002|Overall Study|Adverse Event|0|||
33264223|NCT02347332|100866934|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
33264224|NCT02347332|100866933|FG000|Overall Study|Protocol Violation|1|||
33264225|NCT02347332|100866934|FG001|Overall Study|Protocol Violation|1|||
33264226|NCT02347332|100866933|FG000|Overall Study|Lost to Follow-up|2|||
33264227|NCT02347332|100866934|FG001|Overall Study|Lost to Follow-up|1|||
33264228|NCT02347332|100866933|FG000|Overall Study|Physician Decision|4|||
33264229|NCT02347332|100866934|FG001|Overall Study|Physician Decision|3|||
33467256|NCT00725621|101600478|FG000|Overall Study|Adverse Event|25|||
33467257|NCT00725621|101600478|FG000|Overall Study|Lack of Efficacy|46|||
33467258|NCT00725621|101600478|FG000|Overall Study|Withdrawal by Subject|57|||
33467259|NCT00725621|101600478|FG000|Overall Study|Physician Decision|19|||
33467260|NCT00725621|101600478|FG000|Overall Study|Lost to Follow-up|52|||
33467261|NCT00725621|101600478|FG000|Overall Study|Non-compliance|8|||
33178387|NCT00624052|100560547|FG003|Overall Study|Adverse Event|3|||
33178388|NCT00624052|100560544|FG000|Overall Study|Lack of Efficacy|1|||
33467262|NCT00725621|101600478|FG000|Overall Study|Continued treatment by other physician|6|||
33467263|NCT00725621|101600478|FG000|Overall Study|Switched to other study|1|||
33178389|NCT00624052|100560545|FG001|Overall Study|Lack of Efficacy|1|||
33264230|NCT02347332|100866933|FG000|Overall Study|Withdrawal by Subject|20|||
33264231|NCT02347332|100866934|FG001|Overall Study|Withdrawal by Subject|14|||
33264232|NCT02347332|100866933|FG000|Overall Study|Protocol requirement|1|||
33264233|NCT02347332|100866934|FG001|Overall Study|Protocol requirement|1|||
33264234|NCT02347332|100866933|FG000|Overall Study|Switch Post-Trial program|0|||
33264235|NCT02347332|100866934|FG001|Overall Study|Switch Post-Trial program|1|||
33264236|NCT03861052|100870025|FG000|Overall Study|Adverse Event|1|||
33264237|NCT03861052|100870026|FG001|Overall Study|Adverse Event|1|||
33264238|NCT03861052|100870027|FG002|Overall Study|Adverse Event|2|||
33264239|NCT03861052|100870028|FG003|Overall Study|Adverse Event|4|||
33264240|NCT03861052|100870025|FG000|Overall Study|Lost to Follow-up|0|||
33264241|NCT03861052|100870026|FG001|Overall Study|Lost to Follow-up|0|||
33264242|NCT03861052|100870027|FG002|Overall Study|Lost to Follow-up|0|||
33264243|NCT03861052|100870028|FG003|Overall Study|Lost to Follow-up|1|||
33264244|NCT03861052|100870025|FG000|Overall Study|Physician Decision|0|||
33264245|NCT03861052|100870026|FG001|Overall Study|Physician Decision|1|||
33264246|NCT03861052|100870027|FG002|Overall Study|Physician Decision|0|||
33264247|NCT03861052|100870028|FG003|Overall Study|Physician Decision|0|||
33264248|NCT03861052|100870025|FG000|Overall Study|Withdrawal by Subject|2|||
33264249|NCT03861052|100870026|FG001|Overall Study|Withdrawal by Subject|5|||
33264250|NCT03861052|100870027|FG002|Overall Study|Withdrawal by Subject|3|||
33264251|NCT03861052|100870028|FG003|Overall Study|Withdrawal by Subject|0|||
33264252|NCT03861052|100870025|FG000|Overall Study|Relocation to other city|1|||
33264253|NCT03861052|100870026|FG001|Overall Study|Relocation to other city|0|||
33264254|NCT03861052|100870027|FG002|Overall Study|Relocation to other city|0|||
33264255|NCT03861052|100870028|FG003|Overall Study|Relocation to other city|0|||
33264256|NCT02148705|100870029|FG000|Overall Study|Death|2|||
33264257|NCT02148705|100870030|FG001|Overall Study|Death|0|||
33264258|NCT02148705|100870031|FG002|Overall Study|Death|0|||
33264259|NCT02148705|100870029|FG000|Overall Study|Lost to Follow-up|13|||
33264260|NCT02148705|100870030|FG001|Overall Study|Lost to Follow-up|4|||
33264261|NCT02148705|100870031|FG002|Overall Study|Lost to Follow-up|10|||
33264262|NCT02148705|100870029|FG000|Overall Study|Withdrawal by Subject|3|||
33264263|NCT02148705|100870030|FG001|Overall Study|Withdrawal by Subject|0|||
33264264|NCT02148705|100870031|FG002|Overall Study|Withdrawal by Subject|2|||
33264265|NCT02148705|100870029|FG000|Overall Study|Not Treated|0|||
33264266|NCT02148705|100870030|FG001|Overall Study|Not Treated|1|||
33264267|NCT02148705|100870031|FG002|Overall Study|Not Treated|5|||
33264268|NCT00918333|100870032|FG000|Overall Study|Drug not taken per protocol|1|||
33264269|NCT00918333|100870033|FG001|Overall Study|Drug not taken per protocol|0|||
33264270|NCT00918333|100870032|FG000|Overall Study|Inadequate amount of drugs provided|1|||
33264271|NCT00918333|100870033|FG001|Overall Study|Inadequate amount of drugs provided|4|||
33264272|NCT00918333|100870032|FG000|Overall Study|Ineligible|1|||
33264273|NCT00918333|100870033|FG001|Overall Study|Ineligible|0|||
33264274|NCT00918333|100870032|FG000|Overall Study|Withdrawal by Subject|0|||
33264275|NCT00918333|100870033|FG001|Overall Study|Withdrawal by Subject|1|||
33264276|NCT00640159|100870034|FG000|Overall Study|Lost to Follow-up|2|||
33264277|NCT00523419|100870035|FG000|Overall Study|Adverse Event|1|||
33264278|NCT00523419|100870035|FG000|Overall Study|Withdrawal by Subject|1|||
33264279|NCT00523419|100870035|FG000|Overall Study|Physician Decision|2|||
33264280|NCT00523419|100870035|FG000|Overall Study|Progressive Disease|22|||
33264281|NCT00523419|100870035|FG000|Overall Study|Death due to Study Disease|4|||
33264282|NCT00523419|100870035|FG000|Overall Study|Death due to Adverse Event|2|||
33264283|NCT02613403|100870040|FG000|Overall Study|Lost to Follow-up|0|||
33264284|NCT02613403|100870041|FG001|Overall Study|Lost to Follow-up|1|||
33264285|NCT02613403|100870042|FG002|Overall Study|Lost to Follow-up|0|||
33264286|NCT02613403|100870043|FG003|Overall Study|Lost to Follow-up|0|||
33264287|NCT02613403|100870044|FG004|Overall Study|Lost to Follow-up|0|||
33264288|NCT02613403|100870040|FG000|Overall Study|Withdrawal by Subject|2|||
33467264|NCT00725621|101600478|FG000|Overall Study|Switched to other drug|1|||
33467265|NCT00725621|101600478|FG000|Overall Study|Prepared for elective surgery|1|||
33467266|NCT00725621|101600478|FG000|Overall Study|Reason not specified|55|||
33178390|NCT00624052|100560546|FG002|Overall Study|Lack of Efficacy|0|||
33178391|NCT00624052|100560547|FG003|Overall Study|Lack of Efficacy|0|||
33178392|NCT00624052|100560544|FG000|Overall Study|Lost to Follow-up|2|||
33178393|NCT00624052|100560545|FG001|Overall Study|Lost to Follow-up|3|||
33178394|NCT00624052|100560546|FG002|Overall Study|Lost to Follow-up|1|||
33178395|NCT00624052|100560547|FG003|Overall Study|Lost to Follow-up|0|||
33178396|NCT00624052|100560544|FG000|Overall Study|Non compliant with the protocol|2|||
33178397|NCT00624052|100560545|FG001|Overall Study|Non compliant with the protocol|1|||
33178398|NCT00624052|100560546|FG002|Overall Study|Non compliant with the protocol|1|||
33264289|NCT02613403|100870041|FG001|Overall Study|Withdrawal by Subject|0|||
33264290|NCT02613403|100870042|FG002|Overall Study|Withdrawal by Subject|0|||
33264291|NCT02613403|100870043|FG003|Overall Study|Withdrawal by Subject|0|||
33264292|NCT02613403|100870044|FG004|Overall Study|Withdrawal by Subject|0|||
33264293|NCT02502526|100870051|FG000|Overall Study|Lost to Follow-up|2|||
33264294|NCT02502526|100870052|FG001|Overall Study|Lost to Follow-up|2|||
33264295|NCT02502526|100870053|FG002|Overall Study|Lost to Follow-up|3|||
33264296|NCT02502526|100870051|FG000|Overall Study|Withdrawal by Subject|0|||
33264297|NCT02502526|100870052|FG001|Overall Study|Withdrawal by Subject|1|||
33264298|NCT02502526|100870053|FG002|Overall Study|Withdrawal by Subject|1|||
33264299|NCT02502526|100870051|FG000|Overall Study|Disqualified due to cataract grading|0|||
33264300|NCT02502526|100870052|FG001|Overall Study|Disqualified due to cataract grading|0|||
33264301|NCT02502526|100870053|FG002|Overall Study|Disqualified due to cataract grading|1|||
33264302|NCT02502526|100870051|FG000|Overall Study|Enrollment suspension|4|||
33264303|NCT02502526|100870052|FG001|Overall Study|Enrollment suspension|1|||
33264304|NCT02502526|100870053|FG002|Overall Study|Enrollment suspension|1|||
33264305|NCT00442104|100870055|FG000|Overall Study|Adverse Event|5|||
33264306|NCT00442104|100870055|FG000|Overall Study|Death|2|||
33178399|NCT00624052|100560547|FG003|Overall Study|Non compliant with the protocol|1|||
33178400|NCT00624052|100560544|FG000|Overall Study|Consent withdrawn|3|||
33178401|NCT00624052|100560545|FG001|Overall Study|Consent withdrawn|1|||
33178402|NCT00624052|100560546|FG002|Overall Study|Consent withdrawn|1|||
33178403|NCT00624052|100560547|FG003|Overall Study|Consent withdrawn|0|||
33178404|NCT00624052|100560544|FG000|Overall Study|Changed job/ran out if meds|0|||
33178405|NCT00624052|100560545|FG001|Overall Study|Changed job/ran out if meds|2|||
33178406|NCT00624052|100560546|FG002|Overall Study|Changed job/ran out if meds|0|||
33178407|NCT00624052|100560547|FG003|Overall Study|Changed job/ran out if meds|0|||
33178408|NCT01826487|100560552|FG000|Overall Study|Adverse Event|1|||
33178409|NCT01826487|100560553|FG001|Overall Study|Adverse Event|1|||
33178410|NCT01826487|100560552|FG000|Overall Study|Lost to Follow-up|1|||
33178411|NCT01826487|100560553|FG001|Overall Study|Lost to Follow-up|0|||
33178412|NCT01826487|100560552|FG000|Overall Study|Withdrawal by Subject|1|||
33178413|NCT01826487|100560553|FG001|Overall Study|Withdrawal by Subject|3|||
33178414|NCT01826487|100560552|FG000|Overall Study|Protocol Violation|1|||
33178415|NCT01826487|100560553|FG001|Overall Study|Protocol Violation|1|||
33178416|NCT01894581|100560554|FG000|Overall Study|Withdrawal by Subject|2|||
33178417|NCT01894581|100560555|FG001|Overall Study|Withdrawal by Subject|3|||
33178418|NCT01894581|100560554|FG000|Overall Study|Screen Failure|3|||
33178419|NCT01894581|100560555|FG001|Overall Study|Screen Failure|4|||
33178420|NCT01394523|100560556|FG000|Overall Study|Unable to place block|1|||
33178421|NCT01394523|100560557|FG001|Overall Study|Unable to place block|0|||
33178422|NCT01394523|100560558|FG002|Overall Study|Unable to place block|0|||
33178423|NCT00378209|100560561|FG000|Overall Study|Progressive disease|11|||
33178424|NCT00378209|100560561|FG000|Overall Study|Adverse Event|3|||
33178425|NCT00378209|100560561|FG000|Overall Study|Initiation of non-protocol therapy|3|||
33178426|NCT00378209|100560561|FG000|Overall Study|Physician Decision|3|||
33178427|NCT00378209|100560561|FG000|Overall Study|Death|1|||
33178428|NCT00378209|100560561|FG000|Overall Study|Treatment delay|1|||
33178429|NCT00463346|100560562|FG000|Overall Study|Withdrawal by Subject|3|||
33178430|NCT00463346|100560563|FG001|Overall Study|Withdrawal by Subject|3|||
33178431|NCT02951156|100560564|FG000|Overall Study|Death|3|||
33178432|NCT02951156|100560565|FG001|Overall Study|Death|8|||
33178433|NCT02951156|100560566|FG002|Overall Study|Death|5|||
33178434|NCT02951156|100560564|FG000|Overall Study|Progressive disease|1|||
33178435|NCT02951156|100560565|FG001|Overall Study|Progressive disease|0|||
33178436|NCT02951156|100560566|FG002|Overall Study|Progressive disease|1|||
33178437|NCT02951156|100560564|FG000|Overall Study|Withdrawal by Subject|0|||
33178438|NCT02951156|100560565|FG001|Overall Study|Withdrawal by Subject|0|||
33178439|NCT02951156|100560566|FG002|Overall Study|Withdrawal by Subject|1|||
33178440|NCT02951156|100560564|FG000|Overall Study|Study terminated by sponsor|0|||
33178441|NCT02951156|100560565|FG001|Overall Study|Study terminated by sponsor|0|||
33178442|NCT02951156|100560566|FG002|Overall Study|Study terminated by sponsor|1|||
33178443|NCT02951156|100560564|FG000|Overall Study|Other|5|||
33178444|NCT02951156|100560565|FG001|Overall Study|Other|1|||
33178445|NCT02951156|100560566|FG002|Overall Study|Other|2|||
33178446|NCT01541969|100560572|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
33178447|NCT01541969|100560573|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
33178448|NCT01541969|100560572|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
33178449|NCT01541969|100560573|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
33178450|NCT01541969|100560572|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
33178451|NCT01541969|100560573|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
33178452|NCT01541969|100560572|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
33264307|NCT00442104|100870055|FG000|Overall Study|Lost to Follow-up|3|||
33264308|NCT00442104|100870055|FG000|Overall Study|Withdrawal by Subject|5|||
33264309|NCT00442104|100870055|FG000|Overall Study|Insufficient Clinical Response|10|||
33264310|NCT00442104|100870055|FG000|Overall Study|Other|21|||
33264311|NCT00442104|100870055|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
33178453|NCT01541969|100560573|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
33178454|NCT01541969|100560572|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
33178455|NCT01541969|100560573|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
33178456|NCT01541969|100560572|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
33178457|NCT01541969|100560573|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
33178458|NCT01541969|100560572|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
33178459|NCT01541969|100560573|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
33264312|NCT00680771|100870056|FG000|Overall Study|Withdrawal by Subject|1|||
33264313|NCT00680771|100870057|FG001|Overall Study|Withdrawal by Subject|0|||
33178460|NCT01541969|100560572|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
33178461|NCT01541969|100560573|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
33178462|NCT01541969|100560572|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
33178463|NCT01541969|100560573|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
33178464|NCT01541969|100560572|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
33178465|NCT01541969|100560573|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
33467267|NCT02575339|101600479|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
33467268|NCT02575339|101600480|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
33467269|NCT02575339|101600481|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
33467270|NCT02575339|101600479|FG000|Study Treatment|Disease Progression|5|||
33467271|NCT02575339|101600480|FG001|Study Treatment|Disease Progression|2|||
33467272|NCT02575339|101600481|FG002|Study Treatment|Disease Progression|0|||
33178466|NCT03538158|100563617|FG000|Overall Study|Lost to Follow-up|13|||
33178467|NCT03538158|100563618|FG001|Overall Study|Lost to Follow-up|7|||
33178468|NCT03538158|100563617|FG000|Overall Study|Withdrawal by Subject|2|||
33178469|NCT03538158|100563618|FG001|Overall Study|Withdrawal by Subject|1|||
33178470|NCT03232281|100563621|FG000|Overall Study|Adverse Event|1|||
33178471|NCT03232281|100563622|FG001|Overall Study|Adverse Event|1|||
33178472|NCT03232281|100563621|FG000|Overall Study|Withdrawal by Subject|5|||
33178473|NCT03232281|100563622|FG001|Overall Study|Withdrawal by Subject|4|||
33178474|NCT03232281|100563621|FG000|Overall Study|Protocol Deviation|1|||
33178475|NCT03232281|100563622|FG001|Overall Study|Protocol Deviation|1|||
33178476|NCT01154218|100563623|FG000|Third Intervention Period|Adverse Event|0|||
33178477|NCT01154218|100563624|FG001|Third Intervention Period|Adverse Event|1|||
33178478|NCT01154218|100563625|FG002|Third Intervention Period|Adverse Event|0|||
33178479|NCT01154218|100563626|FG003|Third Intervention Period|Adverse Event|0|||
33178480|NCT01154218|100563623|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
33178481|NCT01154218|100563624|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
33178482|NCT01154218|100563625|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
33178483|NCT01154218|100563626|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
33178484|NCT01154218|100563623|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
33178485|NCT01154218|100563624|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
33178486|NCT01154218|100563625|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
33178487|NCT01154218|100563626|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
33178488|NCT00380978|100563627|FG000|Overall Study|Refused allocated intervention|0|||
33178489|NCT00380978|100563628|FG001|Overall Study|Refused allocated intervention|6|||
33178490|NCT00380978|100563627|FG000|Overall Study|Wrong study envelope|0|||
33178491|NCT00380978|100563628|FG001|Overall Study|Wrong study envelope|2|||
33178492|NCT00380978|100563627|FG000|Overall Study|Allocation prior to analgesia request|1|||
33178493|NCT00380978|100563628|FG001|Overall Study|Allocation prior to analgesia request|2|||
33178494|NCT00380978|100563627|FG000|Overall Study|Parous patient|1|||
33178495|NCT00380978|100563628|FG001|Overall Study|Parous patient|0|||
33178496|NCT01986855|100563629|FG000|Overall Study|Adverse Event|1|||
33264314|NCT00680771|100870056|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
33264315|NCT00680771|100870057|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
33264316|NCT00680771|100870056|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
33264317|NCT00680771|100870057|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
33178497|NCT01986855|100563630|FG001|Overall Study|Adverse Event|0|||
33178498|NCT01986855|100563631|FG002|Overall Study|Adverse Event|0|||
33178499|NCT01986855|100563629|FG000|Overall Study|Death|3|||
33178500|NCT01986855|100563630|FG001|Overall Study|Death|4|||
33178501|NCT01986855|100563631|FG002|Overall Study|Death|4|||
33178502|NCT01986855|100563629|FG000|Overall Study|Lost to Follow-up|2|||
33178503|NCT01986855|100563630|FG001|Overall Study|Lost to Follow-up|1|||
33178504|NCT01986855|100563631|FG002|Overall Study|Lost to Follow-up|0|||
33178505|NCT01986855|100563629|FG000|Overall Study|Screen Failure|0|||
33178506|NCT01986855|100563630|FG001|Overall Study|Screen Failure|1|||
33178507|NCT01986855|100563631|FG002|Overall Study|Screen Failure|0|||
33264318|NCT02386098|100870062|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
33264319|NCT02386098|100870063|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
33264320|NCT02386098|100870064|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
33264321|NCT02386098|100870065|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
33264322|NCT02386098|100870066|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
33467273|NCT02575339|101600479|FG000|Study Treatment|Adverse Event|1|||
33467274|NCT02575339|101600480|FG001|Study Treatment|Adverse Event|2|||
33467275|NCT02575339|101600481|FG002|Study Treatment|Adverse Event|0|||
33467276|NCT02575339|101600479|FG000|Follow up|Death|6|||
33178508|NCT01986855|100563629|FG000|Overall Study|Participant Moved|0|||
33178509|NCT01986855|100563630|FG001|Overall Study|Participant Moved|0|||
33178510|NCT01986855|100563631|FG002|Overall Study|Participant Moved|2|||
33178511|NCT01986855|100563629|FG000|Overall Study|Withdrawal by Subject|7|||
33178512|NCT01986855|100563630|FG001|Overall Study|Withdrawal by Subject|8|||
33178513|NCT01986855|100563631|FG002|Overall Study|Withdrawal by Subject|5|||
33467277|NCT02575339|101600480|FG001|Follow up|Death|2|||
33264323|NCT02386098|100870062|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
33264324|NCT02386098|100870063|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
33264325|NCT02386098|100870064|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
33264326|NCT02386098|100870065|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
33264327|NCT02386098|100870066|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
33264328|NCT02386098|100870062|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
33264329|NCT02386098|100870063|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
33264330|NCT02386098|100870064|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
33264331|NCT02386098|100870065|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
33264332|NCT02386098|100870066|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
33264333|NCT02386098|100870062|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
33264334|NCT02386098|100870063|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
33264335|NCT02386098|100870064|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
33264336|NCT02386098|100870065|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
33264337|NCT02386098|100870066|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
33264338|NCT02386098|100870062|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
33264339|NCT02386098|100870063|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
33264340|NCT02386098|100870064|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
33264341|NCT02386098|100870065|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
33264342|NCT02386098|100870066|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
33467278|NCT02575339|101600481|FG002|Follow up|Death|0|||
33467279|NCT02575339|101600479|FG000|Follow up|Study Terminated|0|||
33178514|NCT00455429|100563633|FG000|Overall Study|Study Terminated by Sponsor|0|||
33178515|NCT00455429|100563634|FG001|Overall Study|Study Terminated by Sponsor|0|||
33178516|NCT00455429|100563635|FG002|Overall Study|Study Terminated by Sponsor|0|||
33178517|NCT00455429|100563636|FG003|Overall Study|Study Terminated by Sponsor|3|||
33178518|NCT00455429|100563633|FG000|Overall Study|Lost to Follow-up|1|||
33178519|NCT00455429|100563634|FG001|Overall Study|Lost to Follow-up|0|||
33178520|NCT00455429|100563635|FG002|Overall Study|Lost to Follow-up|0|||
33178521|NCT00455429|100563636|FG003|Overall Study|Lost to Follow-up|3|||
33178522|NCT00455429|100563633|FG000|Overall Study|Withdrawal by Subject|0|||
33178523|NCT00455429|100563634|FG001|Overall Study|Withdrawal by Subject|1|||
33178524|NCT00455429|100563635|FG002|Overall Study|Withdrawal by Subject|1|||
33178525|NCT00455429|100563636|FG003|Overall Study|Withdrawal by Subject|0|||
33178526|NCT00455429|100563633|FG000|Overall Study|Lack of Efficacy|0|||
33178527|NCT00455429|100563634|FG001|Overall Study|Lack of Efficacy|1|||
33178528|NCT00455429|100563635|FG002|Overall Study|Lack of Efficacy|0|||
33178529|NCT00455429|100563636|FG003|Overall Study|Lack of Efficacy|1|||
33178530|NCT00455429|100563633|FG000|Overall Study|Adverse Event|0|||
33178531|NCT00455429|100563634|FG001|Overall Study|Adverse Event|1|||
33178532|NCT00455429|100563635|FG002|Overall Study|Adverse Event|0|||
33178533|NCT00455429|100563636|FG003|Overall Study|Adverse Event|3|||
33178534|NCT00455429|100563633|FG000|Overall Study|Randomly assigned but not treated|0|||
33178535|NCT00455429|100563634|FG001|Overall Study|Randomly assigned but not treated|0|||
33178536|NCT00455429|100563635|FG002|Overall Study|Randomly assigned but not treated|0|||
33178537|NCT00455429|100563636|FG003|Overall Study|Randomly assigned but not treated|2|||
33178538|NCT00455429|100563633|FG000|Overall Study|Personal Reason|1|||
33178539|NCT00455429|100563634|FG001|Overall Study|Personal Reason|0|||
33178540|NCT00455429|100563635|FG002|Overall Study|Personal Reason|0|||
33178541|NCT00455429|100563636|FG003|Overall Study|Personal Reason|0|||
33178542|NCT00455429|100563633|FG000|Overall Study|Non-compliance|0|||
33178543|NCT00455429|100563634|FG001|Overall Study|Non-compliance|0|||
33178544|NCT00455429|100563635|FG002|Overall Study|Non-compliance|0|||
33178545|NCT00455429|100563636|FG003|Overall Study|Non-compliance|1|||
33178546|NCT00455429|100563633|FG000|Overall Study|Other|0|||
33178547|NCT00455429|100563634|FG001|Overall Study|Other|2|||
33178548|NCT00455429|100563635|FG002|Overall Study|Other|0|||
33178549|NCT00455429|100563636|FG003|Overall Study|Other|1|||
33178550|NCT02268812|100563644|FG000|Overall Study|Adverse Event|8|||
33178551|NCT02268812|100563645|FG001|Overall Study|Adverse Event|26|||
33178552|NCT02268812|100563646|FG002|Overall Study|Adverse Event|7|||
33178553|NCT02268812|100563647|FG003|Overall Study|Adverse Event|10|||
33178554|NCT02268812|100563644|FG000|Overall Study|Protocol deviation|0|||
33178555|NCT02268812|100563645|FG001|Overall Study|Protocol deviation|0|||
33178556|NCT02268812|100563646|FG002|Overall Study|Protocol deviation|1|||
33178557|NCT02268812|100563647|FG003|Overall Study|Protocol deviation|0|||
33178558|NCT02268812|100563644|FG000|Overall Study|Withdrawal by Subject|0|||
33178559|NCT02268812|100563645|FG001|Overall Study|Withdrawal by Subject|1|||
33178560|NCT02268812|100563646|FG002|Overall Study|Withdrawal by Subject|0|||
33178561|NCT02268812|100563647|FG003|Overall Study|Withdrawal by Subject|0|||
33178562|NCT02268812|100563644|FG000|Overall Study|Physician Decision|3|||
33178563|NCT02268812|100563645|FG001|Overall Study|Physician Decision|1|||
33178564|NCT02268812|100563646|FG002|Overall Study|Physician Decision|0|||
33178565|NCT02268812|100563647|FG003|Overall Study|Physician Decision|1|||
33264343|NCT02386098|100870062|FG000|Stage 1 (96 Weeks)|Other|1|||
33264344|NCT02386098|100870063|FG001|Stage 1 (96 Weeks)|Other|0|||
33264345|NCT02386098|100870064|FG002|Stage 1 (96 Weeks)|Other|0|||
33264346|NCT02386098|100870065|FG003|Stage 1 (96 Weeks)|Other|0|||
33264347|NCT02386098|100870066|FG004|Stage 1 (96 Weeks)|Other|0|||
33264348|NCT02386098|100870062|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
33264349|NCT02386098|100870063|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
33264350|NCT02386098|100870064|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
33264351|NCT02386098|100870065|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
33264352|NCT02386098|100870066|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
33264353|NCT03066609|100870078|FG000|INDUCTION|Pregnancy|0|||
33264354|NCT03066609|100870079|FG001|INDUCTION|Pregnancy|0|||
33264355|NCT03066609|100870080|FG002|INDUCTION|Pregnancy|1|||
33264356|NCT03066609|100870081|FG003|INDUCTION|Pregnancy|0|||
33264357|NCT03066609|100870078|FG000|INDUCTION|Lack of Efficacy|0|||
33264358|NCT03066609|100870079|FG001|INDUCTION|Lack of Efficacy|0|||
33264359|NCT03066609|100870080|FG002|INDUCTION|Lack of Efficacy|1|||
33264360|NCT03066609|100870081|FG003|INDUCTION|Lack of Efficacy|0|||
33264361|NCT03066609|100870078|FG000|INDUCTION|Adverse Event|2|||
33264362|NCT03066609|100870079|FG001|INDUCTION|Adverse Event|2|||
33264363|NCT03066609|100870080|FG002|INDUCTION|Adverse Event|0|||
33264364|NCT03066609|100870081|FG003|INDUCTION|Adverse Event|0|||
33264365|NCT03066609|100870078|FG000|MAINTENANCE|Adverse Event|0|||
33264366|NCT03066609|100870079|FG001|MAINTENANCE|Adverse Event|0|||
33264367|NCT03066609|100870080|FG002|MAINTENANCE|Adverse Event|0|||
33264368|NCT03066609|100870081|FG003|MAINTENANCE|Adverse Event|1|||
33264369|NCT03066609|100870078|FG000|MAINTENANCE|Withdrawal by Subject|4|||
33264370|NCT03066609|100870079|FG001|MAINTENANCE|Withdrawal by Subject|2|||
33264371|NCT03066609|100870080|FG002|MAINTENANCE|Withdrawal by Subject|1|||
33264372|NCT03066609|100870081|FG003|MAINTENANCE|Withdrawal by Subject|1|||
33264373|NCT03066609|100870078|FG000|MAINTENANCE|Lost to Follow-up|0|||
33264374|NCT03066609|100870079|FG001|MAINTENANCE|Lost to Follow-up|1|||
33264375|NCT03066609|100870080|FG002|MAINTENANCE|Lost to Follow-up|1|||
33264376|NCT03066609|100870081|FG003|MAINTENANCE|Lost to Follow-up|0|||
33264377|NCT03066609|100870078|FG000|MAINTENANCE|Pregnancy|1|||
33264378|NCT03066609|100870079|FG001|MAINTENANCE|Pregnancy|0|||
33264379|NCT03066609|100870080|FG002|MAINTENANCE|Pregnancy|0|||
33264380|NCT03066609|100870081|FG003|MAINTENANCE|Pregnancy|0|||
33264381|NCT03066609|100870078|FG000|MAINTENANCE|Lack of Efficacy|2|||
33264382|NCT03066609|100870079|FG001|MAINTENANCE|Lack of Efficacy|1|||
33264383|NCT03066609|100870080|FG002|MAINTENANCE|Lack of Efficacy|0|||
33264384|NCT03066609|100870081|FG003|MAINTENANCE|Lack of Efficacy|1|||
33264385|NCT03066609|100870078|FG000|OVERALL STUDY|Adverse Event|2|||
33264386|NCT03066609|100870079|FG001|OVERALL STUDY|Adverse Event|2|||
33264387|NCT03066609|100870080|FG002|OVERALL STUDY|Adverse Event|0|||
33264388|NCT03066609|100870081|FG003|OVERALL STUDY|Adverse Event|1|||
33264389|NCT03066609|100870078|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
33264390|NCT03066609|100870079|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
33264391|NCT03066609|100870080|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
33264392|NCT03066609|100870081|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
33264393|NCT03066609|100870078|FG000|OVERALL STUDY|Lost to Follow-up|1|||
33264394|NCT03066609|100870079|FG001|OVERALL STUDY|Lost to Follow-up|1|||
33264395|NCT03066609|100870080|FG002|OVERALL STUDY|Lost to Follow-up|1|||
33264396|NCT03066609|100870081|FG003|OVERALL STUDY|Lost to Follow-up|1|||
33264397|NCT03066609|100870078|FG000|OVERALL STUDY|Pregnancy|1|||
33264398|NCT03066609|100870079|FG001|OVERALL STUDY|Pregnancy|0|||
33264399|NCT03066609|100870080|FG002|OVERALL STUDY|Pregnancy|1|||
33178566|NCT02268812|100563644|FG000|Overall Study|Other|5|||
33178567|NCT02268812|100563645|FG001|Overall Study|Other|4|||
33178568|NCT02268812|100563646|FG002|Overall Study|Other|1|||
33178569|NCT02268812|100563647|FG003|Overall Study|Other|3|||
33178570|NCT02632552|100563650|FG000|Overall Study|Lost to Follow-up|14|||
33178571|NCT02632552|100563651|FG001|Overall Study|Lost to Follow-up|8|||
33178572|NCT02632552|100563650|FG000|Overall Study|Withdrawal by Subject|2|||
33178573|NCT02632552|100563651|FG001|Overall Study|Withdrawal by Subject|0|||
33264400|NCT03066609|100870081|FG003|OVERALL STUDY|Pregnancy|0|||
33264401|NCT03066609|100870078|FG000|OVERALL STUDY|Lack of Efficacy|2|||
33264402|NCT03066609|100870079|FG001|OVERALL STUDY|Lack of Efficacy|1|||
33264403|NCT03066609|100870080|FG002|OVERALL STUDY|Lack of Efficacy|1|||
33264404|NCT03066609|100870081|FG003|OVERALL STUDY|Lack of Efficacy|1|||
33467280|NCT02575339|101600480|FG001|Follow up|Study Terminated|2|||
33178574|NCT02632552|100563650|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
33264405|NCT03066609|100870078|FG000|OVERALL STUDY|discontinued follow up|0|||
33264406|NCT03066609|100870079|FG001|OVERALL STUDY|discontinued follow up|2|||
33264407|NCT03066609|100870080|FG002|OVERALL STUDY|discontinued follow up|0|||
33264408|NCT03066609|100870081|FG003|OVERALL STUDY|discontinued follow up|0|||
33264409|NCT02698475|100870086|FG000|Main Study Period|Lack of Efficacy|1|||
33264410|NCT02698475|100870086|FG000|Main Study Period|Protocol Violation|2|||
33264411|NCT02698475|100870086|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
33264412|NCT02698475|100870086|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
33264413|NCT02698475|100870086|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
33264414|NCT02698475|100870086|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
33264415|NCT02698475|100870086|FG000|Long-Term Extension Period|Other|1|||
33264416|NCT01324310|100870087|FG000|Overall Study|Adverse Event|1|||
33264417|NCT01324310|100870087|FG000|Overall Study|Disease Progression|1|||
33264418|NCT00683800|100870088|FG000|Overall Study|Adverse Event|195|||
33264419|NCT00683800|100870089|FG001|Overall Study|Adverse Event|102|||
33264420|NCT00683800|100870088|FG000|Overall Study|Death|0|||
33264421|NCT00683800|100870089|FG001|Overall Study|Death|1|||
33178575|NCT02632552|100563651|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
33178576|NCT02268786|100563652|FG000|Overall Study|No Euploid Embryos available|42|||
33178577|NCT02268786|100563653|FG001|Overall Study|No Euploid Embryos available|0|||
33178578|NCT02268786|100563652|FG000|Overall Study|Withdrawal by Subject|7|||
33178579|NCT02268786|100563653|FG001|Overall Study|Withdrawal by Subject|14|||
33178580|NCT02268786|100563652|FG000|Overall Study|Thaw Failure|6|||
33178581|NCT02268786|100563653|FG001|Overall Study|Thaw Failure|4|||
33178582|NCT02268786|100563652|FG000|Overall Study|Protocol Violation|1|||
33178583|NCT02268786|100563653|FG001|Overall Study|Protocol Violation|0|||
33178584|NCT00560950|100563654|FG000|Overall Study|Lost to Follow-up|1|||
33178585|NCT00560950|100563655|FG001|Overall Study|Lost to Follow-up|0|||
33178586|NCT00254540|100563656|FG000|Overall Study|Adverse Event|6|||
33178587|NCT00254540|100563657|FG001|Overall Study|Adverse Event|7|||
33178588|NCT00254540|100563656|FG000|Overall Study|Lack of Efficacy|13|||
33178589|NCT00254540|100563657|FG001|Overall Study|Lack of Efficacy|13|||
33178590|NCT00254540|100563656|FG000|Overall Study|Death|0|||
33178591|NCT00254540|100563657|FG001|Overall Study|Death|1|||
33178592|NCT00254540|100563656|FG000|Overall Study|Laboratory Test Abnormality|0|||
33178593|NCT00254540|100563657|FG001|Overall Study|Laboratory Test Abnormality|1|||
33178594|NCT01846611|100563658|FG000|Overall Study|Lost to Follow-up|4|||
33178595|NCT01846611|100563659|FG001|Overall Study|Lost to Follow-up|6|||
33178596|NCT01846611|100563658|FG000|Overall Study|Withdrawal by Subject|15|||
33178597|NCT01846611|100563659|FG001|Overall Study|Withdrawal by Subject|19|||
33178598|NCT01846611|100563658|FG000|Overall Study|Other|19|||
33178599|NCT01846611|100563659|FG001|Overall Study|Other|18|||
33178600|NCT01589445|100563662|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
33178601|NCT01589445|100563662|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
33178602|NCT01589445|100563662|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
33178603|NCT01589445|100563662|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
33178604|NCT01589445|100563662|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
33178605|NCT01589445|100563662|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
33178606|NCT01589445|100563662|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
33178607|NCT01589445|100563662|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
33178608|NCT01589445|100563662|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
33178609|NCT01589445|100563662|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
33178610|NCT02436356|100563663|FG000|Overall Study|Excluded by MRI Screening|0|||
33178611|NCT02436356|100563664|FG001|Overall Study|Excluded by MRI Screening|0|||
33178612|NCT02436356|100563665|FG002|Overall Study|Excluded by MRI Screening|2|||
33178613|NCT02436356|100563663|FG000|Overall Study|Lost to Follow-up|0|||
33178614|NCT02436356|100563664|FG001|Overall Study|Lost to Follow-up|1|||
33264422|NCT00683800|100870088|FG000|Overall Study|Lost to Follow-up|57|||
33264423|NCT00683800|100870089|FG001|Overall Study|Lost to Follow-up|44|||
33264424|NCT00683800|100870088|FG000|Overall Study|Other|5|||
33264425|NCT00683800|100870089|FG001|Overall Study|Other|2|||
33264426|NCT00683800|100870088|FG000|Overall Study|Protocol Violation|13|||
33178615|NCT02436356|100563665|FG002|Overall Study|Lost to Follow-up|0|||
33178616|NCT02436356|100563663|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
33178617|NCT02436356|100563664|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
33178618|NCT02436356|100563665|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
33178619|NCT02436356|100563663|FG000|Overall Study|Excluded due to other medical conditions|3|||
33178620|NCT02436356|100563664|FG001|Overall Study|Excluded due to other medical conditions|0|||
33178621|NCT02436356|100563665|FG002|Overall Study|Excluded due to other medical conditions|0|||
33178622|NCT02436356|100563663|FG000|Overall Study|Withdrawal by Subject|1|||
33178623|NCT02436356|100563664|FG001|Overall Study|Withdrawal by Subject|0|||
33178624|NCT02436356|100563665|FG002|Overall Study|Withdrawal by Subject|0|||
33178625|NCT00469092|100563666|FG000|Overall Study|Adverse Event|5|||
33178626|NCT00469092|100563667|FG001|Overall Study|Adverse Event|4|||
33264427|NCT00683800|100870089|FG001|Overall Study|Protocol Violation|16|||
33178627|NCT00469092|100563666|FG000|Overall Study|Lack of Efficacy|1|||
33178628|NCT00469092|100563667|FG001|Overall Study|Lack of Efficacy|0|||
33178629|NCT00469092|100563666|FG000|Overall Study|Lost to Follow-up|1|||
33178630|NCT00469092|100563667|FG001|Overall Study|Lost to Follow-up|2|||
33178631|NCT00469092|100563666|FG000|Overall Study|Protocol Violation|3|||
33178632|NCT00469092|100563667|FG001|Overall Study|Protocol Violation|3|||
33178633|NCT00469092|100563666|FG000|Overall Study|Withdrawal by Subject|4|||
33264428|NCT00683800|100870088|FG000|Overall Study|Withdrawal by Subject|66|||
33264429|NCT00683800|100870089|FG001|Overall Study|Withdrawal by Subject|64|||
33467281|NCT02575339|101600481|FG002|Follow up|Study Terminated|0|||
33264430|NCT00683800|100870088|FG000|Overall Study|Lack of Efficacy|61|||
33264431|NCT00683800|100870089|FG001|Overall Study|Lack of Efficacy|104|||
33178634|NCT00469092|100563667|FG001|Overall Study|Withdrawal by Subject|4|||
33178635|NCT00469092|100563666|FG000|Overall Study|Withdrawal Criteria|3|||
33178636|NCT00469092|100563667|FG001|Overall Study|Withdrawal Criteria|4|||
33178637|NCT00469092|100563666|FG000|Overall Study|Incorrectly Randomised|4|||
33178638|NCT00469092|100563667|FG001|Overall Study|Incorrectly Randomised|3|||
33178639|NCT00469092|100563666|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
33178640|NCT00469092|100563667|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
33178641|NCT00469092|100563666|FG000|Overall Study|Use of lipid lowering drug|1|||
33178642|NCT00469092|100563667|FG001|Overall Study|Use of lipid lowering drug|0|||
33178643|NCT00469092|100563666|FG000|Overall Study|Hypoglycaemic Episodes|1|||
33178644|NCT00469092|100563667|FG001|Overall Study|Hypoglycaemic Episodes|1|||
33178645|NCT00469092|100563666|FG000|Overall Study|Abnormal lab value|1|||
33178646|NCT00469092|100563667|FG001|Overall Study|Abnormal lab value|0|||
33178647|NCT00469092|100563666|FG000|Overall Study|Use of Corticosteroid|1|||
33178648|NCT00469092|100563667|FG001|Overall Study|Use of Corticosteroid|0|||
33178649|NCT02337907|100563668|FG000|Overall Study|Other than listed|1|||
33178650|NCT02337907|100563669|FG001|Overall Study|Other than listed|0|||
33178651|NCT02337907|100563670|FG002|Overall Study|Other than listed|0|||
33178652|NCT02337907|100563671|FG003|Overall Study|Other than listed|1|||
33178653|NCT02337907|100563672|FG004|Overall Study|Other than listed|1|||
33178654|NCT02337907|100563673|FG005|Overall Study|Other than listed|0|||
33178655|NCT02337907|100563668|FG000|Overall Study|Withdrawal by Subject|2|||
33178656|NCT02337907|100563669|FG001|Overall Study|Withdrawal by Subject|3|||
33178657|NCT02337907|100563670|FG002|Overall Study|Withdrawal by Subject|0|||
33178658|NCT02337907|100563671|FG003|Overall Study|Withdrawal by Subject|2|||
33178659|NCT02337907|100563672|FG004|Overall Study|Withdrawal by Subject|5|||
33178660|NCT02337907|100563673|FG005|Overall Study|Withdrawal by Subject|0|||
33178661|NCT02337907|100563668|FG000|Overall Study|Lost to Follow-up|0|||
33178662|NCT02337907|100563669|FG001|Overall Study|Lost to Follow-up|0|||
33178663|NCT02337907|100563670|FG002|Overall Study|Lost to Follow-up|0|||
33178664|NCT02337907|100563671|FG003|Overall Study|Lost to Follow-up|0|||
33178665|NCT02337907|100563672|FG004|Overall Study|Lost to Follow-up|0|||
33178666|NCT02337907|100563673|FG005|Overall Study|Lost to Follow-up|1|||
33178667|NCT02337907|100563668|FG000|Overall Study|Adverse Event|1|||
33178668|NCT02337907|100563669|FG001|Overall Study|Adverse Event|1|||
33178669|NCT02337907|100563670|FG002|Overall Study|Adverse Event|1|||
33178670|NCT02337907|100563671|FG003|Overall Study|Adverse Event|1|||
33178671|NCT02337907|100563672|FG004|Overall Study|Adverse Event|4|||
33178672|NCT02337907|100563673|FG005|Overall Study|Adverse Event|0|||
33178673|NCT00567892|100563674|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
33178674|NCT00567892|100563675|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
33178675|NCT00567892|100563676|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
33178676|NCT00567892|100563677|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
33178677|NCT00567892|100563674|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
33178678|NCT00567892|100563675|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
33178679|NCT00567892|100563676|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
33178680|NCT00567892|100563677|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
33178681|NCT00695396|100563680|FG000|Overall Study|Study Closed Prematurely|5|||
33178682|NCT00695396|100563681|FG001|Overall Study|Study Closed Prematurely|6|||
33178683|NCT00695396|100563682|FG002|Overall Study|Study Closed Prematurely|8|||
33178684|NCT00695396|100563680|FG000|Overall Study|Withdrawal by Subject|2|||
33178685|NCT00695396|100563681|FG001|Overall Study|Withdrawal by Subject|2|||
33178686|NCT00695396|100563682|FG002|Overall Study|Withdrawal by Subject|0|||
33178687|NCT00503308|100563683|FG000|Overall Study|Protocol Violation|2|||
33178688|NCT00503308|100563684|FG001|Overall Study|Protocol Violation|1|||
33178689|NCT01287897|100563685|FG000|Overall Study|Adverse Event|5|||
33178690|NCT01287897|100563686|FG001|Overall Study|Adverse Event|3|||
33178691|NCT01287897|100563687|FG002|Overall Study|Adverse Event|6|||
33178692|NCT01287897|100563688|FG003|Overall Study|Adverse Event|4|||
33178693|NCT01287897|100563685|FG000|Overall Study|Lack of Efficacy|2|||
33467282|NCT02575339|101600479|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
33178694|NCT01287897|100563686|FG001|Overall Study|Lack of Efficacy|0|||
33178695|NCT01287897|100563687|FG002|Overall Study|Lack of Efficacy|0|||
33178696|NCT01287897|100563688|FG003|Overall Study|Lack of Efficacy|0|||
33178697|NCT01287897|100563685|FG000|Overall Study|Protocol Violation|1|||
33178698|NCT01287897|100563686|FG001|Overall Study|Protocol Violation|1|||
33178699|NCT01287897|100563687|FG002|Overall Study|Protocol Violation|0|||
33178700|NCT01287897|100563688|FG003|Overall Study|Protocol Violation|1|||
33178701|NCT01287897|100563685|FG000|Overall Study|Lost to Follow-up|0|||
33178702|NCT01287897|100563686|FG001|Overall Study|Lost to Follow-up|0|||
33178703|NCT01287897|100563687|FG002|Overall Study|Lost to Follow-up|2|||
33178704|NCT01287897|100563688|FG003|Overall Study|Lost to Follow-up|0|||
33178705|NCT01287897|100563685|FG000|Overall Study|Withdrawal by Subject|1|||
33178706|NCT01287897|100563686|FG001|Overall Study|Withdrawal by Subject|5|||
33178707|NCT01287897|100563687|FG002|Overall Study|Withdrawal by Subject|3|||
33178708|NCT01287897|100563688|FG003|Overall Study|Withdrawal by Subject|2|||
33178709|NCT01287897|100563685|FG000|Overall Study|Not consented properly|0|||
33178710|NCT01287897|100563686|FG001|Overall Study|Not consented properly|1|||
33467283|NCT02575339|101600480|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
33467284|NCT02575339|101600481|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
33467285|NCT01345318|101600497|FG000|Overall Study|Adverse Event|16|||
33178711|NCT01287897|100563687|FG002|Overall Study|Not consented properly|0|||
33178712|NCT01287897|100563688|FG003|Overall Study|Not consented properly|0|||
33178713|NCT01287897|100563685|FG000|Overall Study|Not meeting entrance criteria|1|||
33178714|NCT01287897|100563686|FG001|Overall Study|Not meeting entrance criteria|1|||
33178715|NCT01287897|100563687|FG002|Overall Study|Not meeting entrance criteria|0|||
33178716|NCT01287897|100563688|FG003|Overall Study|Not meeting entrance criteria|0|||
33178717|NCT01287897|100563685|FG000|Overall Study|Other|1|||
33178718|NCT01287897|100563686|FG001|Overall Study|Other|0|||
33178719|NCT01287897|100563687|FG002|Overall Study|Other|1|||
33178720|NCT01287897|100563688|FG003|Overall Study|Other|0|||
33178721|NCT02081079|100563689|FG000|Overall Study|Lack of Efficacy|3|||
33178722|NCT02081079|100563690|FG001|Overall Study|Lack of Efficacy|2|||
33178723|NCT02081079|100563689|FG000|Overall Study|Lost to Follow-up|1|||
33178724|NCT02081079|100563690|FG001|Overall Study|Lost to Follow-up|0|||
33178725|NCT00225251|100563691|FG000|Overall Study|Withdrawal by Subject|1|||
33178726|NCT00225251|100563692|FG001|Overall Study|Withdrawal by Subject|1|||
33178727|NCT03065244|100563697|FG000|Overall Study|Lost to Follow-up|1|||
33178728|NCT03065244|100563698|FG001|Overall Study|Lost to Follow-up|1|||
33178729|NCT03065244|100563697|FG000|Overall Study|Diagnosed with a different disease|1|||
33178730|NCT03065244|100563698|FG001|Overall Study|Diagnosed with a different disease|1|||
33178731|NCT03065244|100563697|FG000|Overall Study|Protocol Violation|0|||
33178732|NCT03065244|100563698|FG001|Overall Study|Protocol Violation|1|||
33178733|NCT03065244|100563697|FG000|Overall Study|Withdrawal by Subject|1|||
33178734|NCT03065244|100563698|FG001|Overall Study|Withdrawal by Subject|1|||
33178735|NCT00333866|100563699|FG000|Overall Study|Adverse Event|23|||
33178736|NCT00333866|100563700|FG001|Overall Study|Adverse Event|37|||
33178737|NCT00333866|100563701|FG002|Overall Study|Adverse Event|38|||
33178738|NCT00333866|100563702|FG003|Overall Study|Adverse Event|47|||
33178739|NCT00333866|100563699|FG000|Overall Study|Other|3|||
33178740|NCT00333866|100563700|FG001|Overall Study|Other|2|||
33178741|NCT00333866|100563701|FG002|Overall Study|Other|2|||
33178742|NCT00333866|100563702|FG003|Overall Study|Other|2|||
33178743|NCT00333866|100563699|FG000|Overall Study|Lack of Efficacy|8|||
33178744|NCT00333866|100563700|FG001|Overall Study|Lack of Efficacy|6|||
33178745|NCT00333866|100563701|FG002|Overall Study|Lack of Efficacy|3|||
33178746|NCT00333866|100563702|FG003|Overall Study|Lack of Efficacy|5|||
33178747|NCT00333866|100563699|FG000|Overall Study|Lost to Follow-up|1|||
33178748|NCT00333866|100563700|FG001|Overall Study|Lost to Follow-up|2|||
33178749|NCT00333866|100563701|FG002|Overall Study|Lost to Follow-up|2|||
33178750|NCT00333866|100563702|FG003|Overall Study|Lost to Follow-up|2|||
33178751|NCT00333866|100563699|FG000|Overall Study|Withdrawal by Subject|8|||
33178752|NCT00333866|100563700|FG001|Overall Study|Withdrawal by Subject|14|||
33178753|NCT00333866|100563701|FG002|Overall Study|Withdrawal by Subject|4|||
33178754|NCT00333866|100563702|FG003|Overall Study|Withdrawal by Subject|9|||
33178755|NCT00333866|100563699|FG000|Overall Study|Randomized but not Treated|5|||
33178756|NCT00333866|100563700|FG001|Overall Study|Randomized but not Treated|3|||
33178757|NCT00333866|100563701|FG002|Overall Study|Randomized but not Treated|2|||
33178758|NCT00333866|100563702|FG003|Overall Study|Randomized but not Treated|1|||
33178759|NCT03020407|100563703|FG000|Overall Study|Withdrawal by Subject|2|||
33178760|NCT03020407|100563704|FG001|Overall Study|Withdrawal by Subject|1|||
33178761|NCT03020407|100563703|FG000|Overall Study|Lost to Follow-up|2|||
33178762|NCT03020407|100563704|FG001|Overall Study|Lost to Follow-up|3|||
33178763|NCT03020407|100563703|FG000|Overall Study|Protocol Violation|0|||
33264432|NCT00683800|100870088|FG000|Overall Study|Randomized, not treated|35|||
33264433|NCT00683800|100870089|FG001|Overall Study|Randomized, not treated|33|||
33264434|NCT03345095|100870090|FG000|Overall Study|Lack of Efficacy|184|||
33264435|NCT03345095|100870091|FG001|Overall Study|Lack of Efficacy|156|||
33264436|NCT03345095|100870090|FG000|Overall Study|Adverse Event|36|||
33467286|NCT01345318|101600497|FG000|Overall Study|Lack of Efficacy|17|||
33178764|NCT03020407|100563704|FG001|Overall Study|Protocol Violation|1|||
33178765|NCT00772707|100563706|FG000|Overall Study|Withdrawn|3|||
33467287|NCT01345318|101600497|FG000|Overall Study|Lost to Follow-up|2|||
33467288|NCT01345318|101600497|FG000|Overall Study|Protocol Violation|1|||
33467289|NCT01345318|101600497|FG000|Overall Study|Withdrawal by Subject|41|||
33467290|NCT01345318|101600497|FG000|Overall Study|Other|3|||
33178766|NCT02068443|100563708|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33178767|NCT02068443|100563709|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
33178768|NCT02068443|100563710|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
33178769|NCT02068443|100563708|FG000|Overall Study|Voluntary Withdrawal|4|||
33178770|NCT02068443|100563709|FG001|Overall Study|Voluntary Withdrawal|0|||
33178771|NCT02068443|100563710|FG002|Overall Study|Voluntary Withdrawal|1|||
33264437|NCT03345095|100870091|FG001|Overall Study|Adverse Event|118|||
33264438|NCT03345095|100870090|FG000|Overall Study|Withdrawal by Subject|22|||
33178772|NCT02068443|100563708|FG000|Overall Study|Lack of Efficacy|2|||
33178773|NCT02068443|100563709|FG001|Overall Study|Lack of Efficacy|1|||
33178774|NCT02068443|100563710|FG002|Overall Study|Lack of Efficacy|0|||
33467291|NCT00792623|101600500|FG000|Overall Study|Adverse Event|2|||
33467292|NCT00792623|101600500|FG000|Overall Study|Withdrawal by Subject|5|||
33467293|NCT00094458|101600501|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
33467294|NCT00094458|101600502|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
33467295|NCT00094458|101600503|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
33467296|NCT00094458|101600504|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
33467297|NCT00094458|101600505|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
33467298|NCT00094458|101600506|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
33467299|NCT00094458|101600501|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
33467300|NCT00094458|101600502|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
33467301|NCT00094458|101600503|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
33467302|NCT00094458|101600504|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
33467303|NCT00094458|101600505|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
33467304|NCT00094458|101600506|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
33467305|NCT00094458|101600501|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
33467306|NCT00094458|101600502|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
33467307|NCT00094458|101600503|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
33467308|NCT00094458|101600504|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
33467309|NCT00094458|101600505|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
33467310|NCT00094458|101600506|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
33178775|NCT02068443|100563708|FG000|Overall Study|Other Reason Not Specified|1|||
33178776|NCT02068443|100563709|FG001|Overall Study|Other Reason Not Specified|0|||
33178777|NCT02068443|100563710|FG002|Overall Study|Other Reason Not Specified|0|||
33178778|NCT01382446|100563711|FG000|Overall Study|Withdrawal by Subject|0|||
33178779|NCT01382446|100563712|FG001|Overall Study|Withdrawal by Subject|1|||
33178780|NCT01382446|100563711|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
33264439|NCT03345095|100870091|FG001|Overall Study|Withdrawal by Subject|59|||
33264440|NCT03345095|100870090|FG000|Overall Study|Physician Decision|3|||
33264441|NCT03345095|100870091|FG001|Overall Study|Physician Decision|18|||
33264442|NCT03345095|100870090|FG000|Overall Study|Death|2|||
33264443|NCT03345095|100870091|FG001|Overall Study|Death|4|||
33264444|NCT03345095|100870090|FG000|Overall Study|Other reasons|2|||
33264445|NCT03345095|100870091|FG001|Overall Study|Other reasons|11|||
33264446|NCT03345095|100870090|FG000|Overall Study|Protocol Violation|0|||
33264447|NCT03345095|100870091|FG001|Overall Study|Protocol Violation|1|||
33264448|NCT00756574|100870092|FG000|Overall Study|Withdrawal by Subject|9|||
33264449|NCT00756574|100870093|FG001|Overall Study|Withdrawal by Subject|7|||
33264450|NCT00756574|100870092|FG000|Overall Study|Lost to Follow-up|4|||
33264451|NCT00756574|100870093|FG001|Overall Study|Lost to Follow-up|4|||
33264452|NCT04447287|100870094|FG000|Period 1: Run-in Period|Adverse Event|3|||
33264453|NCT04447287|100870095|FG001|Period 1: Run-in Period|Adverse Event|0|||
33264454|NCT04447287|100870096|FG002|Period 1: Run-in Period|Adverse Event|0|||
33264455|NCT04447287|100870094|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
33264456|NCT04447287|100870095|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
33264457|NCT04447287|100870096|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
33264458|NCT04447287|100870094|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
33264459|NCT04447287|100870095|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
33264460|NCT04447287|100870096|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
33264461|NCT01588951|100870097|FG000|Overall Study|Ineligible in retrospect|0|||
33264462|NCT01588951|100870098|FG001|Overall Study|Ineligible in retrospect|0|||
33264463|NCT01588951|100870099|FG002|Overall Study|Ineligible in retrospect|1|||
33264464|NCT03205566|100870100|FG000|Phase 1|Protocol Violation|1|||
33467311|NCT00094458|101600501|FG000|Main Study: Through Week 30|Adverse Event|38|||
33467312|NCT00094458|101600502|FG001|Main Study: Through Week 30|Adverse Event|20|||
33467313|NCT00094458|101600503|FG002|Main Study: Through Week 30|Adverse Event|28|||
33467314|NCT00094458|101600504|FG003|Main Study: Through Week 30|Adverse Event|0|||
33467315|NCT00094458|101600505|FG004|Main Study: Through Week 30|Adverse Event|0|||
33467316|NCT00094458|101600506|FG005|Main Study: Through Week 30|Adverse Event|0|||
33467317|NCT00094458|101600501|FG000|Main Study: Through Week 30|Death|1|||
33467318|NCT00094458|101600502|FG001|Main Study: Through Week 30|Death|0|||
33467319|NCT00094458|101600503|FG002|Main Study: Through Week 30|Death|0|||
33467320|NCT00094458|101600504|FG003|Main Study: Through Week 30|Death|0|||
33467321|NCT00094458|101600505|FG004|Main Study: Through Week 30|Death|0|||
33178781|NCT01382446|100563712|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
33467322|NCT00094458|101600506|FG005|Main Study: Through Week 30|Death|0|||
33467323|NCT00094458|101600501|FG000|Main Study: Through Week 30|Other|19|||
33264465|NCT03205566|100870101|FG001|Phase 1|Protocol Violation|1|||
33264466|NCT02597920|100870102|FG000|Overall Study|Worsening of other pre-existing disease|0|||
33264467|NCT02597920|100870103|FG001|Overall Study|Worsening of other pre-existing disease|1|||
33178782|NCT01465022|100563717|FG000|Overall Study|Lost to Follow-up|15|||
33178783|NCT01465022|100563718|FG001|Overall Study|Lost to Follow-up|14|||
33178784|NCT01465022|100563719|FG002|Overall Study|Lost to Follow-up|0|||
33178785|NCT01465022|100563717|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
33178786|NCT01465022|100563718|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
33178787|NCT01465022|100563719|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
33178788|NCT01465022|100563717|FG000|Overall Study|Not Randomized|0|||
33178789|NCT01465022|100563718|FG001|Overall Study|Not Randomized|0|||
33178790|NCT01465022|100563719|FG002|Overall Study|Not Randomized|70|||
33178791|NCT00171223|100563721|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
33178792|NCT00171223|100563722|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
33178793|NCT00171223|100563723|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
33467324|NCT00094458|101600502|FG001|Main Study: Through Week 30|Other|16|||
33467325|NCT00094458|101600503|FG002|Main Study: Through Week 30|Other|9|||
33467326|NCT00094458|101600504|FG003|Main Study: Through Week 30|Other|0|||
33467327|NCT00094458|101600505|FG004|Main Study: Through Week 30|Other|0|||
33467328|NCT00094458|101600506|FG005|Main Study: Through Week 30|Other|0|||
33467329|NCT00094458|101600501|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
33467330|NCT00094458|101600502|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
33467331|NCT00094458|101600503|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
33467332|NCT00094458|101600504|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
33467333|NCT00094458|101600505|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
33467334|NCT00094458|101600506|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
33467335|NCT00094458|101600501|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
33467336|NCT00094458|101600502|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
33467337|NCT00094458|101600503|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
33467338|NCT00094458|101600504|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
33467339|NCT00094458|101600505|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
33467340|NCT00094458|101600506|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
33467341|NCT00094458|101600501|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
33178794|NCT00171223|100563721|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
33178795|NCT00171223|100563722|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
33178796|NCT00171223|100563723|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
33178797|NCT00171223|100563721|FG000|Overall Study|Abnormal Procedure|1|||
33178798|NCT00171223|100563722|FG001|Overall Study|Abnormal Procedure|0|||
33178799|NCT00171223|100563723|FG002|Overall Study|Abnormal Procedure|0|||
33178800|NCT00171223|100563721|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
33178801|NCT00171223|100563722|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
33178802|NCT00171223|100563723|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
33178803|NCT00171223|100563721|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
33178804|NCT00171223|100563722|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
33178805|NCT00171223|100563723|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
33178806|NCT00171223|100563721|FG000|Overall Study|Protocol Violation|2|||
33178807|NCT00171223|100563722|FG001|Overall Study|Protocol Violation|2|||
33467342|NCT00094458|101600502|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
33467343|NCT00094458|101600503|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
33467344|NCT00094458|101600504|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
33467345|NCT00094458|101600505|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
33467346|NCT00094458|101600506|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
33467347|NCT00094458|101600501|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
33467348|NCT00094458|101600502|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
33467349|NCT00094458|101600503|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
33178808|NCT00171223|100563723|FG002|Overall Study|Protocol Violation|3|||
33178809|NCT00171223|100563721|FG000|Overall Study|Participant Withdrew Consent|12|||
33178810|NCT00171223|100563722|FG001|Overall Study|Participant Withdrew Consent|21|||
33178811|NCT00171223|100563723|FG002|Overall Study|Participant Withdrew Consent|15|||
33178812|NCT00171223|100563721|FG000|Overall Study|Lost to Follow-up|5|||
33178813|NCT00171223|100563722|FG001|Overall Study|Lost to Follow-up|2|||
33178814|NCT00171223|100563723|FG002|Overall Study|Lost to Follow-up|3|||
33178815|NCT00171223|100563721|FG000|Overall Study|Administrative Problems|4|||
33178816|NCT00171223|100563722|FG001|Overall Study|Administrative Problems|7|||
33178817|NCT00171223|100563723|FG002|Overall Study|Administrative Problems|6|||
33178818|NCT00171223|100563721|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
33178819|NCT00171223|100563722|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
33178820|NCT00171223|100563723|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
33178821|NCT00171223|100563721|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
33467350|NCT00094458|101600504|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
33178822|NCT00171223|100563722|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
33467351|NCT00094458|101600505|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
33467352|NCT00094458|101600506|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
33467353|NCT00094458|101600501|FG000|OLE: Open-Label Extension|Adverse Event|0|||
33467354|NCT00094458|101600502|FG001|OLE: Open-Label Extension|Adverse Event|0|||
33467355|NCT00094458|101600503|FG002|OLE: Open-Label Extension|Adverse Event|0|||
33467356|NCT00094458|101600504|FG003|OLE: Open-Label Extension|Adverse Event|0|||
33467357|NCT00094458|101600505|FG004|OLE: Open-Label Extension|Adverse Event|3|||
33467358|NCT00094458|101600506|FG005|OLE: Open-Label Extension|Adverse Event|4|||
33264468|NCT02597920|100870104|FG002|Overall Study|Worsening of other pre-existing disease|0|||
33264469|NCT02597920|100870102|FG000|Overall Study|Other adverse event|20|||
33264470|NCT02597920|100870103|FG001|Overall Study|Other adverse event|30|||
33264471|NCT02597920|100870104|FG002|Overall Study|Other adverse event|0|||
33264472|NCT02597920|100870102|FG000|Overall Study|Lost to Follow-up|7|||
33264473|NCT02597920|100870103|FG001|Overall Study|Lost to Follow-up|9|||
33264474|NCT02597920|100870104|FG002|Overall Study|Lost to Follow-up|0|||
33264475|NCT02597920|100870102|FG000|Overall Study|Refuse to continue in the study|3|||
33264476|NCT02597920|100870103|FG001|Overall Study|Refuse to continue in the study|13|||
33264477|NCT02597920|100870104|FG002|Overall Study|Refuse to continue in the study|1|||
33264478|NCT02597920|100870102|FG000|Overall Study|Other than specified|10|||
33264479|NCT02597920|100870103|FG001|Overall Study|Other than specified|31|||
33264480|NCT02597920|100870104|FG002|Overall Study|Other than specified|5|||
33264481|NCT02597920|100870102|FG000|Overall Study|Other|1|||
33264482|NCT02597920|100870103|FG001|Overall Study|Other|0|||
33264483|NCT02597920|100870104|FG002|Overall Study|Other|0|||
33264484|NCT02022670|100870105|FG000|Overall Study|Adverse Event|1|||
33467359|NCT00094458|101600501|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
33467360|NCT00094458|101600502|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
33264485|NCT02022670|100870106|FG001|Overall Study|Adverse Event|0|||
33264486|NCT02022670|100870107|FG002|Overall Study|Adverse Event|1|||
33264487|NCT02189759|100870110|FG000|Overall Study|Lost to Follow-up|0|||
33264488|NCT02189759|100870111|FG001|Overall Study|Lost to Follow-up|0|||
33264489|NCT02189759|100870112|FG002|Overall Study|Lost to Follow-up|2|||
33264490|NCT02189759|100870113|FG003|Overall Study|Lost to Follow-up|5|||
33467361|NCT00094458|101600503|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
33467362|NCT00094458|101600504|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
33467363|NCT00094458|101600505|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
33467364|NCT00094458|101600506|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
33467365|NCT00094458|101600501|FG000|OLE: Open-Label Extension|Patient decision|0|||
33467366|NCT00094458|101600502|FG001|OLE: Open-Label Extension|Patient decision|0|||
33467367|NCT00094458|101600503|FG002|OLE: Open-Label Extension|Patient decision|0|||
33467368|NCT00094458|101600504|FG003|OLE: Open-Label Extension|Patient decision|0|||
33467369|NCT00094458|101600505|FG004|OLE: Open-Label Extension|Patient decision|1|||
33467370|NCT00094458|101600506|FG005|OLE: Open-Label Extension|Patient decision|0|||
33467371|NCT00567476|101600507|FG000|Overall Study|Adverse Event|2|||
33467372|NCT00567476|101600508|FG001|Overall Study|Adverse Event|0|||
33467373|NCT00567476|101600507|FG000|Overall Study|Pregnancy|1|||
33467374|NCT00567476|101600508|FG001|Overall Study|Pregnancy|0|||
33467375|NCT00567476|101600507|FG000|Overall Study|Protocol Violation|4|||
33467376|NCT00567476|101600508|FG001|Overall Study|Protocol Violation|1|||
33467377|NCT00567476|101600507|FG000|Overall Study|Lost to Follow-up|0|||
33467378|NCT00567476|101600508|FG001|Overall Study|Lost to Follow-up|1|||
33467379|NCT00567476|101600507|FG000|Overall Study|Administrative issues|1|||
33467380|NCT00567476|101600508|FG001|Overall Study|Administrative issues|0|||
33467381|NCT00567476|101600507|FG000|Overall Study|Medical Decision|0|||
33467382|NCT00567476|101600508|FG001|Overall Study|Medical Decision|1|||
33467383|NCT00567476|101600507|FG000|Overall Study|Non-adherence to protocol|0|||
33467384|NCT00567476|101600508|FG001|Overall Study|Non-adherence to protocol|1|||
33467385|NCT03870477|101600514|FG000|Overall Study|Early Study Termination|1|||
33467386|NCT00873119|101600515|FG000|Overall Study|Patient request|4|||
33467387|NCT00873119|101600516|FG001|Overall Study|Patient request|2|||
33467388|NCT00873119|101600515|FG000|Overall Study|Adverse Event|8|||
33467389|NCT00873119|101600516|FG001|Overall Study|Adverse Event|0|||
33467390|NCT00873119|101600515|FG000|Overall Study|Progressive disease|26|||
33467391|NCT00873119|101600516|FG001|Overall Study|Progressive disease|18|||
33467392|NCT00873119|101600515|FG000|Overall Study|Death|2|||
33467393|NCT00873119|101600516|FG001|Overall Study|Death|1|||
33467394|NCT00873119|101600515|FG000|Overall Study|Other|2|||
33467395|NCT00873119|101600516|FG001|Overall Study|Other|5|||
33467396|NCT00873119|101600515|FG000|Overall Study|Not treated|2|||
33467397|NCT00873119|101600516|FG001|Overall Study|Not treated|0|||
33467398|NCT01045707|101600517|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
33467399|NCT01045707|101600518|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
33264491|NCT01662505|100870114|FG000|Overall Study|Progressive disease|6|||
33264492|NCT01662505|100870115|FG001|Overall Study|Progressive disease|1|||
33264493|NCT01662505|100870116|FG002|Overall Study|Progressive disease|5|||
33264494|NCT01662505|100870114|FG000|Overall Study|Refused cont. medication|0|||
33264495|NCT01662505|100870115|FG001|Overall Study|Refused cont. medication|0|||
33264496|NCT01662505|100870116|FG002|Overall Study|Refused cont. medication|1|||
33264497|NCT01662505|100870114|FG000|Overall Study|Not specified above|1|||
33467400|NCT01045707|101600517|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
33467401|NCT01045707|101600518|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
33467402|NCT01045707|101600517|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
33467403|NCT01045707|101600518|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
33467404|NCT01045707|101600517|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
33467405|NCT01045707|101600518|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
33467406|NCT01045707|101600517|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
33467407|NCT01045707|101600518|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
33467408|NCT01045707|101600517|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
33467409|NCT01045707|101600518|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
33467410|NCT01045707|101600517|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
33467411|NCT01045707|101600518|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
33467412|NCT01045707|101600517|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
33467413|NCT01045707|101600518|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
33467414|NCT01045707|101600517|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
33467415|NCT01045707|101600518|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
33467416|NCT00906373|101600519|FG000|Overall Study|Withdrawal by Subject|0|||
33467417|NCT00906373|101600520|FG001|Overall Study|Withdrawal by Subject|5|||
33467418|NCT00906373|101600519|FG000|Overall Study|Other|0|||
33467419|NCT00906373|101600520|FG001|Overall Study|Other|1|||
33264498|NCT01662505|100870115|FG001|Overall Study|Not specified above|3|||
33467420|NCT00906373|101600519|FG000|Overall Study|Still on treatment at cutoff date|0|||
33467421|NCT00906373|101600520|FG001|Overall Study|Still on treatment at cutoff date|2|||
33467422|NCT03739138|101600521|FG000|Overall Study|Death|0|||
33467423|NCT03739138|101600522|FG001|Overall Study|Death|7|||
33467424|NCT03739138|101600523|FG002|Overall Study|Death|4|||
33467425|NCT03739138|101600524|FG003|Overall Study|Death|13|||
33467426|NCT03739138|101600525|FG004|Overall Study|Death|0|||
33467427|NCT03739138|101600521|FG000|Overall Study|Lost to Follow-up|0|||
33467428|NCT03739138|101600522|FG001|Overall Study|Lost to Follow-up|0|||
33467429|NCT03739138|101600523|FG002|Overall Study|Lost to Follow-up|1|||
33467430|NCT03739138|101600524|FG003|Overall Study|Lost to Follow-up|0|||
33467431|NCT03739138|101600525|FG004|Overall Study|Lost to Follow-up|0|||
33467432|NCT03739138|101600521|FG000|Overall Study|Study Terminated By Sponsor|0|||
33467433|NCT03739138|101600522|FG001|Overall Study|Study Terminated By Sponsor|0|||
33467434|NCT03739138|101600523|FG002|Overall Study|Study Terminated By Sponsor|0|||
33467435|NCT03739138|101600524|FG003|Overall Study|Study Terminated By Sponsor|4|||
33264499|NCT01662505|100870116|FG002|Overall Study|Not specified above|2|||
33264500|NCT01170208|100870122|FG000|Overall Study|Withdrawal by Subject|5|||
33264501|NCT01170208|100870123|FG001|Overall Study|Withdrawal by Subject|0|||
33264502|NCT01170208|100870124|FG002|Overall Study|Withdrawal by Subject|1|||
33264503|NCT01170208|100870122|FG000|Overall Study|Protocol Violation|1|||
33264504|NCT01170208|100870123|FG001|Overall Study|Protocol Violation|0|||
33264505|NCT01170208|100870124|FG002|Overall Study|Protocol Violation|1|||
33264506|NCT00686595|100870125|FG000|Overall Study|Adverse Event|3|||
33264507|NCT00686595|100870125|FG000|Overall Study|Protocol Violation|1|||
33264508|NCT00686595|100870125|FG000|Overall Study|Lost to Follow-up|1|||
33264509|NCT00686595|100870125|FG000|Overall Study|Lack of Efficacy|1|||
33264510|NCT00686595|100870125|FG000|Overall Study|Poor Compliance|1|||
33264511|NCT02972034|100870132|FG000|Overall Study|Death|11|||
33264512|NCT02972034|100870133|FG001|Overall Study|Death|1|||
33264513|NCT02972034|100870134|FG002|Overall Study|Death|3|||
33264514|NCT02972034|100870135|FG003|Overall Study|Death|3|||
33264515|NCT02972034|100870136|FG004|Overall Study|Death|2|||
33264516|NCT02972034|100870137|FG005|Overall Study|Death|2|||
33264517|NCT02972034|100870138|FG006|Overall Study|Death|3|||
33264518|NCT02972034|100870139|FG007|Overall Study|Death|4|||
33264519|NCT02972034|100870140|FG008|Overall Study|Death|8|||
33264520|NCT02972034|100870141|FG009|Overall Study|Death|11|||
33264521|NCT02972034|100870142|FG010|Overall Study|Death|3|||
33264522|NCT02972034|100870143|FG011|Overall Study|Death|2|||
33264523|NCT02972034|100870144|FG012|Overall Study|Death|11|||
33264524|NCT02972034|100870145|FG013|Overall Study|Death|10|||
33264525|NCT02972034|100870146|FG014|Overall Study|Death|9|||
33264526|NCT02972034|100870132|FG000|Overall Study|Lost to Follow-up|0|||
33264527|NCT02972034|100870133|FG001|Overall Study|Lost to Follow-up|0|||
33467436|NCT03739138|101600525|FG004|Overall Study|Study Terminated By Sponsor|0|||
33467437|NCT03739138|101600521|FG000|Overall Study|Withdrawal by Subject|0|||
33467438|NCT03739138|101600522|FG001|Overall Study|Withdrawal by Subject|0|||
33467439|NCT03739138|101600523|FG002|Overall Study|Withdrawal by Subject|0|||
33264528|NCT02972034|100870134|FG002|Overall Study|Lost to Follow-up|0|||
33264529|NCT02972034|100870135|FG003|Overall Study|Lost to Follow-up|0|||
33264530|NCT02972034|100870136|FG004|Overall Study|Lost to Follow-up|1|||
33264531|NCT02972034|100870137|FG005|Overall Study|Lost to Follow-up|0|||
33264532|NCT02972034|100870138|FG006|Overall Study|Lost to Follow-up|0|||
33264533|NCT02972034|100870139|FG007|Overall Study|Lost to Follow-up|1|||
33264534|NCT02972034|100870140|FG008|Overall Study|Lost to Follow-up|0|||
33264535|NCT02972034|100870141|FG009|Overall Study|Lost to Follow-up|0|||
33467440|NCT03739138|101600524|FG003|Overall Study|Withdrawal by Subject|1|||
33467441|NCT03739138|101600525|FG004|Overall Study|Withdrawal by Subject|0|||
33264536|NCT02972034|100870142|FG010|Overall Study|Lost to Follow-up|0|||
33264537|NCT02972034|100870143|FG011|Overall Study|Lost to Follow-up|0|||
33264538|NCT02972034|100870144|FG012|Overall Study|Lost to Follow-up|0|||
33264539|NCT02972034|100870145|FG013|Overall Study|Lost to Follow-up|0|||
33264540|NCT02972034|100870146|FG014|Overall Study|Lost to Follow-up|1|||
33264541|NCT02972034|100870132|FG000|Overall Study|Physician Decision|0|||
33264542|NCT02972034|100870133|FG001|Overall Study|Physician Decision|0|||
33264543|NCT02972034|100870134|FG002|Overall Study|Physician Decision|0|||
33467442|NCT01507090|101600526|FG000|Overall Study|incomplete dataset|18|||
33467443|NCT01014624|101600530|FG000|Overall Study|Adverse Event|0|||
33467444|NCT01014624|101600531|FG001|Overall Study|Adverse Event|1|||
33467445|NCT01014624|101600530|FG000|Overall Study|Protocol Violation|1|||
33467446|NCT01014624|101600531|FG001|Overall Study|Protocol Violation|0|||
33467447|NCT01014624|101600530|FG000|Overall Study|Withdrawal by Subject|1|||
33467448|NCT01014624|101600531|FG001|Overall Study|Withdrawal by Subject|0|||
33467449|NCT01298778|101600532|FG000|Overall Study|Lost to Follow-up|2|||
33467450|NCT01298778|101600533|FG001|Overall Study|Lost to Follow-up|3|||
33467451|NCT01298778|101600532|FG000|Overall Study|Incorrect use of VAS|1|||
33467452|NCT01298778|101600533|FG001|Overall Study|Incorrect use of VAS|0|||
33467453|NCT01298778|101600532|FG000|Overall Study|Withdrawal by Subject|0|||
33467454|NCT01298778|101600533|FG001|Overall Study|Withdrawal by Subject|1|||
33467455|NCT01298778|101600532|FG000|Overall Study|Protocol Violation|0|||
33467456|NCT01298778|101600533|FG001|Overall Study|Protocol Violation|1|||
33467457|NCT01298778|101600532|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
33467458|NCT01298778|101600533|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
33467459|NCT02148913|101600542|FG000|Overall Study|Death|0|||
33467460|NCT02148913|101600543|FG001|Overall Study|Death|1|||
33467461|NCT02148913|101600544|FG002|Overall Study|Death|0|||
33467462|NCT02148913|101600545|FG003|Overall Study|Death|0|||
33467463|NCT01917968|101600546|FG000|Overall Study|Death|3|||
33467464|NCT01917968|101600547|FG001|Overall Study|Death|2|||
33467465|NCT01917968|101600546|FG000|Overall Study|Lost to Follow-up|21|||
33467466|NCT01917968|101600547|FG001|Overall Study|Lost to Follow-up|39|||
33467467|NCT01917968|101600546|FG000|Overall Study|Physician Decision|1|||
33467468|NCT01917968|101600547|FG001|Overall Study|Physician Decision|2|||
33467469|NCT01917968|101600546|FG000|Overall Study|Withdrawal by Subject|20|||
33467470|NCT01917968|101600547|FG001|Overall Study|Withdrawal by Subject|35|||
33467471|NCT01917968|101600546|FG000|Overall Study|Subject Relocation|5|||
33467472|NCT01917968|101600547|FG001|Overall Study|Subject Relocation|1|||
33467473|NCT01917968|101600546|FG000|Overall Study|36M Missed Visit|3|||
33467474|NCT01917968|101600547|FG001|Overall Study|36M Missed Visit|2|||
33467475|NCT01917968|101600546|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
33467476|NCT01917968|101600547|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
33467477|NCT01917968|101600546|FG000|Overall Study|Change in Family Circumstances|0|||
33467478|NCT01917968|101600547|FG001|Overall Study|Change in Family Circumstances|1|||
33467479|NCT01917968|101600546|FG000|Overall Study|No Data Available|0|||
33467480|NCT01917968|101600547|FG001|Overall Study|No Data Available|2|||
33467481|NCT04086641|101600549|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
33467482|NCT04086641|101600550|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
33467483|NCT00303667|101600551|FG000|Overall Study|Death|0|||
33178823|NCT00171223|100563723|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
33178824|NCT03287804|100563724|FG000|Overall Study|Death|1|||
33178825|NCT03287804|100563724|FG000|Overall Study|Physician Decision|2|||
33178826|NCT03287804|100563724|FG000|Overall Study|Progressive disease|8|||
33178827|NCT00311623|100563730|FG000|Overall Study|Physician Decision|0|||
33178828|NCT00311623|100563731|FG001|Overall Study|Physician Decision|0|||
33178829|NCT00311623|100563732|FG002|Overall Study|Physician Decision|2|||
33178830|NCT00894322|100563733|FG000|Overall Study|Withdrawal by Subject|1|||
33178831|NCT00894322|100563734|FG001|Overall Study|Withdrawal by Subject|0|||
33178832|NCT00894322|100563735|FG002|Overall Study|Withdrawal by Subject|0|||
33178833|NCT01275833|100563736|FG000|Overall Study|Study terminated|1|||
33178834|NCT01275833|100563737|FG001|Overall Study|Study terminated|1|||
33264544|NCT02972034|100870135|FG003|Overall Study|Physician Decision|0|||
33264545|NCT02972034|100870136|FG004|Overall Study|Physician Decision|0|||
33264546|NCT02972034|100870137|FG005|Overall Study|Physician Decision|0|||
33467484|NCT00303667|101600552|FG001|Overall Study|Death|4|||
33467485|NCT01534078|101600555|FG000|Overall Study|Death|1|||
33467486|NCT01534078|101600555|FG000|Overall Study|Withdrawal by Subject|1|||
33178835|NCT01266460|100563738|FG000|Overall Study|Adverse Event|3|||
33178836|NCT01266460|100563738|FG000|Overall Study|Withdrawal by Subject|5|||
33264547|NCT02972034|100870138|FG006|Overall Study|Physician Decision|0|||
33467487|NCT00710749|101600558|FG000|First Intervention|Withdrawal by Subject|1|||
33467488|NCT00710749|101600559|FG001|First Intervention|Withdrawal by Subject|0|||
33467489|NCT01976728|101600561|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
33467490|NCT01976728|101600562|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
33467491|NCT01976728|101600563|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
33178837|NCT01266460|100563738|FG000|Overall Study|Disease Progression|18|||
33178838|NCT01266460|100563738|FG000|Overall Study|Not otherwise specified|8|||
33178839|NCT02246673|100563741|FG000|Overall Study|Sponsor Decision|1|||
33178840|NCT02246673|100563742|FG001|Overall Study|Sponsor Decision|0|||
33178841|NCT02246673|100563743|FG002|Overall Study|Sponsor Decision|0|||
33178842|NCT02246673|100563744|FG003|Overall Study|Sponsor Decision|0|||
33178843|NCT02246673|100563745|FG004|Overall Study|Sponsor Decision|0|||
33178844|NCT02246673|100563741|FG000|Overall Study|Withdrawal by Subject|0|||
33467492|NCT01976728|101600564|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
33467493|NCT03827018|101600565|FG000|Overall Study|Adverse Event|1|||
33178845|NCT02246673|100563742|FG001|Overall Study|Withdrawal by Subject|0|||
33264548|NCT02972034|100870139|FG007|Overall Study|Physician Decision|1|||
33264549|NCT02972034|100870140|FG008|Overall Study|Physician Decision|0|||
33264550|NCT02972034|100870141|FG009|Overall Study|Physician Decision|0|||
33264551|NCT02972034|100870142|FG010|Overall Study|Physician Decision|1|||
33264552|NCT02972034|100870143|FG011|Overall Study|Physician Decision|0|||
33264553|NCT02972034|100870144|FG012|Overall Study|Physician Decision|0|||
33264554|NCT02972034|100870145|FG013|Overall Study|Physician Decision|0|||
33264555|NCT02972034|100870146|FG014|Overall Study|Physician Decision|0|||
33264556|NCT02972034|100870132|FG000|Overall Study|Sponsor Decision|0|||
33264557|NCT02972034|100870133|FG001|Overall Study|Sponsor Decision|0|||
33264558|NCT02972034|100870134|FG002|Overall Study|Sponsor Decision|0|||
33264559|NCT02972034|100870135|FG003|Overall Study|Sponsor Decision|1|||
33264560|NCT02972034|100870136|FG004|Overall Study|Sponsor Decision|0|||
33264561|NCT02972034|100870137|FG005|Overall Study|Sponsor Decision|0|||
33264562|NCT02972034|100870138|FG006|Overall Study|Sponsor Decision|1|||
33264563|NCT02972034|100870139|FG007|Overall Study|Sponsor Decision|1|||
33264564|NCT02972034|100870140|FG008|Overall Study|Sponsor Decision|1|||
33264565|NCT02972034|100870141|FG009|Overall Study|Sponsor Decision|2|||
33264566|NCT02972034|100870142|FG010|Overall Study|Sponsor Decision|2|||
33264567|NCT02972034|100870143|FG011|Overall Study|Sponsor Decision|0|||
33264568|NCT02972034|100870144|FG012|Overall Study|Sponsor Decision|1|||
33264569|NCT02972034|100870145|FG013|Overall Study|Sponsor Decision|0|||
33264570|NCT02972034|100870146|FG014|Overall Study|Sponsor Decision|1|||
33264571|NCT02972034|100870132|FG000|Overall Study|Withdrawal by Subject|3|||
33264572|NCT02972034|100870133|FG001|Overall Study|Withdrawal by Subject|0|||
33264573|NCT02972034|100870134|FG002|Overall Study|Withdrawal by Subject|0|||
33264574|NCT02972034|100870135|FG003|Overall Study|Withdrawal by Subject|0|||
33264575|NCT02972034|100870136|FG004|Overall Study|Withdrawal by Subject|1|||
33264576|NCT02972034|100870137|FG005|Overall Study|Withdrawal by Subject|1|||
33264577|NCT02972034|100870138|FG006|Overall Study|Withdrawal by Subject|0|||
33264578|NCT02972034|100870139|FG007|Overall Study|Withdrawal by Subject|0|||
33264579|NCT02972034|100870140|FG008|Overall Study|Withdrawal by Subject|1|||
33264580|NCT02972034|100870141|FG009|Overall Study|Withdrawal by Subject|1|||
33264581|NCT02972034|100870142|FG010|Overall Study|Withdrawal by Subject|2|||
33264582|NCT02972034|100870143|FG011|Overall Study|Withdrawal by Subject|1|||
33264583|NCT02972034|100870144|FG012|Overall Study|Withdrawal by Subject|1|||
33264584|NCT02972034|100870145|FG013|Overall Study|Withdrawal by Subject|1|||
33264585|NCT02972034|100870146|FG014|Overall Study|Withdrawal by Subject|0|||
33264586|NCT02972034|100870132|FG000|Overall Study|Screen Failure|0|||
33264587|NCT02972034|100870133|FG001|Overall Study|Screen Failure|0|||
33264588|NCT02972034|100870134|FG002|Overall Study|Screen Failure|0|||
33264589|NCT02972034|100870135|FG003|Overall Study|Screen Failure|0|||
33264590|NCT02972034|100870136|FG004|Overall Study|Screen Failure|0|||
33264591|NCT02972034|100870137|FG005|Overall Study|Screen Failure|0|||
33264592|NCT02972034|100870138|FG006|Overall Study|Screen Failure|0|||
33264593|NCT02972034|100870139|FG007|Overall Study|Screen Failure|0|||
33264594|NCT02972034|100870140|FG008|Overall Study|Screen Failure|0|||
33467494|NCT03827018|101600566|FG001|Overall Study|Adverse Event|0|||
33178846|NCT02246673|100563743|FG002|Overall Study|Withdrawal by Subject|0|||
33178847|NCT02246673|100563744|FG003|Overall Study|Withdrawal by Subject|0|||
33178848|NCT02246673|100563745|FG004|Overall Study|Withdrawal by Subject|1|||
33178849|NCT02246673|100563741|FG000|Overall Study|Lost to Follow-up|0|||
33264595|NCT02972034|100870141|FG009|Overall Study|Screen Failure|0|||
33264596|NCT02972034|100870142|FG010|Overall Study|Screen Failure|0|||
33264597|NCT02972034|100870143|FG011|Overall Study|Screen Failure|0|||
33264598|NCT02972034|100870144|FG012|Overall Study|Screen Failure|1|||
33264599|NCT02972034|100870145|FG013|Overall Study|Screen Failure|0|||
33264600|NCT02972034|100870146|FG014|Overall Study|Screen Failure|0|||
33264601|NCT04984889|100870147|FG000|Extension Part|Ongoing|5|||
33264602|NCT02052440|100870148|FG000|Overall Study|Withdrawal by Subject|0|||
33264603|NCT02052440|100870149|FG001|Overall Study|Withdrawal by Subject|1|||
33264604|NCT03699163|100870160|FG000|Overall Study|Physician Decision|12|||
33264605|NCT03699163|100870161|FG001|Overall Study|Physician Decision|0|||
33467495|NCT03827018|101600565|FG000|Overall Study|Withdrawal by Subject|2|||
33178850|NCT02246673|100563742|FG001|Overall Study|Lost to Follow-up|0|||
33264606|NCT03699163|100870160|FG000|Overall Study|failed QC measures|205|||
33264607|NCT03699163|100870161|FG001|Overall Study|failed QC measures|206|||
33264608|NCT02408887|100870162|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
33264609|NCT02408887|100870163|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
33264610|NCT02408887|100870162|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
33264611|NCT02408887|100870163|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
33264612|NCT04759833|100870164|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
33264613|NCT04759833|100870165|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
33264614|NCT04759833|100870166|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
33264615|NCT04759833|100870167|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
33264616|NCT04759833|100870168|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
33264617|NCT04759833|100870164|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
33264618|NCT04759833|100870165|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
33264619|NCT04759833|100870166|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
33264620|NCT04759833|100870167|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
33264621|NCT04759833|100870168|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
33264622|NCT04759833|100870164|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
33264623|NCT04759833|100870165|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
33264624|NCT04759833|100870166|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
33264625|NCT04759833|100870167|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
33264626|NCT04759833|100870168|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
33264627|NCT04759833|100870164|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
33264628|NCT04759833|100870165|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
33264629|NCT04759833|100870166|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
33264630|NCT04759833|100870167|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
33264631|NCT04759833|100870168|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
33264632|NCT04759833|100870164|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
33264633|NCT04759833|100870165|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
33264634|NCT04759833|100870166|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
33264635|NCT04759833|100870167|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
33264636|NCT04759833|100870168|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
33264637|NCT04759833|100870164|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
33178851|NCT02246673|100563743|FG002|Overall Study|Lost to Follow-up|0|||
33178852|NCT02246673|100563744|FG003|Overall Study|Lost to Follow-up|1|||
33178853|NCT02246673|100563745|FG004|Overall Study|Lost to Follow-up|0|||
33178854|NCT02246673|100563741|FG000|Overall Study|Protocol Violation|0|||
33178855|NCT02246673|100563742|FG001|Overall Study|Protocol Violation|0|||
33178856|NCT02246673|100563743|FG002|Overall Study|Protocol Violation|0|||
33178857|NCT02246673|100563744|FG003|Overall Study|Protocol Violation|1|||
33178858|NCT02246673|100563745|FG004|Overall Study|Protocol Violation|0|||
33178859|NCT02024867|100563746|FG000|Overall Study|Protocol Violation|3|||
33178860|NCT02024867|100563747|FG001|Overall Study|Protocol Violation|3|||
33264638|NCT04759833|100870165|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
33178861|NCT02024867|100563746|FG000|Overall Study|Lost to Follow-up|6|||
33178862|NCT02024867|100563747|FG001|Overall Study|Lost to Follow-up|4|||
33178863|NCT01675128|100563748|FG000|Overall Study|Disease progression on study|1|||
33178864|NCT01675128|100563749|FG001|Overall Study|Disease progression on study|1|||
33178865|NCT01675128|100563750|FG002|Overall Study|Disease progression on study|1|||
33178866|NCT01675128|100563748|FG000|Overall Study|Refused further treatment|1|||
33178867|NCT01675128|100563749|FG001|Overall Study|Refused further treatment|0|||
33178868|NCT01675128|100563750|FG002|Overall Study|Refused further treatment|0|||
33178869|NCT01675128|100563748|FG000|Overall Study|Pulmonary complication; off study|0|||
33178870|NCT01675128|100563749|FG001|Overall Study|Pulmonary complication; off study|1|||
33178871|NCT01675128|100563750|FG002|Overall Study|Pulmonary complication; off study|0|||
33178872|NCT02877082|100563751|FG000|Overall Study|Trial was closed early|5|||
33178873|NCT01782859|100563752|FG000|Overall Study|Protocol Violation|6|||
33178874|NCT01782859|100563753|FG001|Overall Study|Protocol Violation|6|||
33178875|NCT01782859|100563752|FG000|Overall Study|Withdrawal by Subject|0|||
33178876|NCT01782859|100563753|FG001|Overall Study|Withdrawal by Subject|1|||
33178877|NCT00887354|100563756|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
33178878|NCT00887354|100563757|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
33178879|NCT00887354|100563756|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
33178880|NCT00887354|100563757|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
33178881|NCT00887354|100563756|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
33178882|NCT00887354|100563757|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
33178883|NCT00887354|100563756|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
33178884|NCT00887354|100563757|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
33178885|NCT00887354|100563756|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
33178886|NCT00887354|100563757|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
33178887|NCT00887354|100563756|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
33264639|NCT04759833|100870166|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
33264640|NCT04759833|100870167|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
33264641|NCT04759833|100870168|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
33264642|NCT04759833|100870164|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
33264643|NCT04759833|100870165|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
33264644|NCT04759833|100870166|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
33264645|NCT04759833|100870167|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
33264646|NCT04759833|100870168|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
33264647|NCT04759833|100870164|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
33264648|NCT04759833|100870165|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
33264649|NCT04759833|100870166|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
33264650|NCT04759833|100870167|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
33178888|NCT00887354|100563757|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
33178889|NCT00887354|100563756|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
33178890|NCT00887354|100563757|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
33178891|NCT00887354|100563756|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
33178892|NCT00887354|100563757|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
33178893|NCT00887354|100563756|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
33178894|NCT00887354|100563757|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
33178895|NCT00887354|100563756|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
33178896|NCT00887354|100563757|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
33178897|NCT00887354|100563756|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
33178898|NCT00887354|100563757|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
33178899|NCT00887354|100563756|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
33178900|NCT00887354|100563757|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
33178901|NCT00887354|100563756|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
33178902|NCT00887354|100563757|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
33178903|NCT00887354|100563756|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
33178904|NCT00887354|100563757|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
33178905|NCT00887354|100563756|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
33178906|NCT00887354|100563757|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
33178907|NCT01374087|100563758|FG000|Overall Study|Adverse Event|1|||
33178908|NCT01374087|100563759|FG001|Overall Study|Adverse Event|0|||
33178909|NCT01374087|100563758|FG000|Overall Study|Disease progression|2|||
33178910|NCT01374087|100563759|FG001|Overall Study|Disease progression|2|||
33178911|NCT01374087|100563758|FG000|Overall Study|Study discontinued|13|||
33178912|NCT01374087|100563759|FG001|Overall Study|Study discontinued|13|||
33178913|NCT02532647|100563768|FG000|Overall Study|Did not receive trial medication|1|||
33178914|NCT02532647|100563769|FG001|Overall Study|Did not receive trial medication|0|||
33178915|NCT02532647|100563770|FG002|Overall Study|Did not receive trial medication|1|||
33178916|NCT01528254|100563771|FG000|Overall Study|Administrative problems|96|||
33178917|NCT01528254|100563772|FG001|Overall Study|Administrative problems|94|||
33178918|NCT01528254|100563771|FG000|Overall Study|Adverse Event|28|||
33178919|NCT01528254|100563772|FG001|Overall Study|Adverse Event|44|||
33178920|NCT01528254|100563771|FG000|Overall Study|Lost to Follow-up|17|||
33178921|NCT01528254|100563772|FG001|Overall Study|Lost to Follow-up|24|||
33178922|NCT01528254|100563771|FG000|Overall Study|Death|13|||
33178923|NCT01528254|100563772|FG001|Overall Study|Death|9|||
33178924|NCT01528254|100563771|FG000|Overall Study|Protocol deviation|9|||
33178925|NCT01528254|100563772|FG001|Overall Study|Protocol deviation|19|||
33178926|NCT01528254|100563771|FG000|Overall Study|New therapy for study indication|8|||
33178927|NCT01528254|100563772|FG001|Overall Study|New therapy for study indication|6|||
33178928|NCT01528254|100563771|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
33178929|NCT01528254|100563772|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
33178930|NCT01528254|100563771|FG000|Overall Study|Withdrawal by Subject|5|||
33178931|NCT01528254|100563772|FG001|Overall Study|Withdrawal by Subject|4|||
33178932|NCT01528254|100563771|FG000|Overall Study|Abnormal laboratory value(s)|3|||
33178933|NCT01528254|100563772|FG001|Overall Study|Abnormal laboratory value(s)|7|||
33178934|NCT01528254|100563771|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33178935|NCT01528254|100563772|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33178936|NCT01528254|100563771|FG000|Overall Study|No longer requires study drug|1|||
33178937|NCT01528254|100563772|FG001|Overall Study|No longer requires study drug|1|||
33178938|NCT01365507|100563776|FG000|Overall Study|Withdrawal Criteria|8|||
33264651|NCT04759833|100870168|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
33264652|NCT04759833|100870164|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
33264653|NCT04759833|100870165|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
33178939|NCT01365507|100563777|FG001|Overall Study|Withdrawal Criteria|5|||
33178940|NCT01365507|100563776|FG000|Overall Study|Unclassified|1|||
33178941|NCT01365507|100563777|FG001|Overall Study|Unclassified|4|||
33264654|NCT04759833|100870166|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
33264655|NCT04759833|100870167|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
33264656|NCT04759833|100870168|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
33264657|NCT04759833|100870164|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
33264658|NCT04759833|100870165|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
33264659|NCT04759833|100870166|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
33264660|NCT04759833|100870167|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
33264661|NCT04759833|100870168|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
33264662|NCT04759833|100870164|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
33264663|NCT04759833|100870165|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
33264664|NCT04759833|100870166|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
33264665|NCT04759833|100870167|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
33264666|NCT04759833|100870168|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
33264667|NCT04759833|100870164|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
33264668|NCT04759833|100870165|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
33264669|NCT04759833|100870166|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
33264670|NCT04759833|100870167|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
33264671|NCT04759833|100870168|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
33264672|NCT04759833|100870164|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
33264673|NCT04759833|100870165|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
33264674|NCT04759833|100870166|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
33264675|NCT04759833|100870167|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
33264676|NCT04759833|100870168|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
33264677|NCT04060212|100870169|FG000|Overall Study|Withdrawal by Subject|7|||
33264678|NCT03861234|100870178|FG000|Overall Study|Not treated|0|||
33264679|NCT03861234|100870179|FG001|Overall Study|Not treated|0|||
33264680|NCT03861234|100870180|FG002|Overall Study|Not treated|0|||
33264681|NCT03861234|100870181|FG003|Overall Study|Not treated|0|||
33264682|NCT03861234|100870182|FG004|Overall Study|Not treated|0|||
33264683|NCT03861234|100870183|FG005|Overall Study|Not treated|1|||
33264684|NCT03861234|100870184|FG006|Overall Study|Not treated|0|||
33264685|NCT03861234|100870185|FG007|Overall Study|Not treated|0|||
33264686|NCT03861234|100870178|FG000|Overall Study|Adverse Event|0|||
33264687|NCT03861234|100870179|FG001|Overall Study|Adverse Event|0|||
33264688|NCT03861234|100870180|FG002|Overall Study|Adverse Event|0|||
33264689|NCT03861234|100870181|FG003|Overall Study|Adverse Event|0|||
33264690|NCT03861234|100870182|FG004|Overall Study|Adverse Event|0|||
33264691|NCT03861234|100870183|FG005|Overall Study|Adverse Event|1|||
33264692|NCT03861234|100870184|FG006|Overall Study|Adverse Event|0|||
33467496|NCT03827018|101600566|FG001|Overall Study|Withdrawal by Subject|2|||
33467497|NCT03827018|101600565|FG000|Overall Study|Lack of Efficacy|0|||
33467498|NCT03827018|101600566|FG001|Overall Study|Lack of Efficacy|1|||
33467499|NCT02843659|101600567|FG000|Overall Study|Subject Withdrew Consent|0|||
33467500|NCT02843659|101600568|FG001|Overall Study|Subject Withdrew Consent|0|||
33178942|NCT02489344|100563785|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
33178943|NCT02489344|100563785|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
33178944|NCT02489344|100563785|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
33178945|NCT02489344|100563785|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
33178946|NCT02085785|100563787|FG000|Overall Study|Withdrawal by Subject|2|||
33178947|NCT02085785|100563788|FG001|Overall Study|Withdrawal by Subject|1|||
33178948|NCT02085785|100563787|FG000|Overall Study|Lost to Follow-up|0|||
33178949|NCT02085785|100563788|FG001|Overall Study|Lost to Follow-up|1|||
33178950|NCT01558752|100563789|FG000|Overall Study|Physician Decision|2|||
33178951|NCT01558752|100563790|FG001|Overall Study|Physician Decision|0|||
33178952|NCT02410954|100563792|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
33178953|NCT02410954|100563793|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
33178954|NCT02410954|100563792|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
33178955|NCT02410954|100563793|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
33178956|NCT00227903|100563794|FG000|Overall Study|Withdrawal by Subject|2|||
33178957|NCT00227903|100563795|FG001|Overall Study|Withdrawal by Subject|5|||
33178958|NCT00227903|100563794|FG000|Overall Study|Subject moved out of area|1|||
33178959|NCT00227903|100563795|FG001|Overall Study|Subject moved out of area|2|||
33178960|NCT00227903|100563794|FG000|Overall Study|Lost to Follow-up|1|||
33178961|NCT00227903|100563795|FG001|Overall Study|Lost to Follow-up|3|||
33178962|NCT00227903|100563794|FG000|Overall Study|Miscarriage|1|||
33178963|NCT00227903|100563795|FG001|Overall Study|Miscarriage|0|||
33178964|NCT02406651|100563799|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
33178965|NCT03605303|100563805|FG000|Period 1|Study Terminated|2|||
33178966|NCT03605303|100563806|FG001|Period 1|Study Terminated|1|||
33264693|NCT03861234|100870185|FG007|Overall Study|Adverse Event|0|||
33264694|NCT03861234|100870178|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
33264695|NCT03861234|100870179|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
33264696|NCT03861234|100870180|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
33264697|NCT03861234|100870181|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
33264698|NCT03861234|100870182|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
33264699|NCT03861234|100870183|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
33264700|NCT03861234|100870184|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
33264701|NCT03861234|100870185|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
33264702|NCT03861234|100870178|FG000|Overall Study|As per sponsor decision|0|||
33264703|NCT03861234|100870179|FG001|Overall Study|As per sponsor decision|0|||
33264704|NCT03861234|100870180|FG002|Overall Study|As per sponsor decision|0|||
33264705|NCT03861234|100870181|FG003|Overall Study|As per sponsor decision|0|||
33264706|NCT03861234|100870182|FG004|Overall Study|As per sponsor decision|0|||
33264707|NCT03861234|100870183|FG005|Overall Study|As per sponsor decision|0|||
33178967|NCT01870583|100563810|FG000|Overall Study|Protocol Violation|0|||
33178968|NCT01870583|100563811|FG001|Overall Study|Protocol Violation|5|||
33178969|NCT01870583|100563812|FG002|Overall Study|Protocol Violation|3|||
33178970|NCT01870583|100563810|FG000|Overall Study|Lost to Follow-up|11|||
33264708|NCT03861234|100870184|FG006|Overall Study|As per sponsor decision|1|||
33264709|NCT03861234|100870185|FG007|Overall Study|As per sponsor decision|0|||
33264710|NCT03861234|100870178|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
33264711|NCT03861234|100870179|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
33264712|NCT03861234|100870180|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
33264713|NCT03861234|100870181|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
33264714|NCT03861234|100870182|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
33264715|NCT03861234|100870183|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
33264716|NCT03861234|100870184|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
33264717|NCT03861234|100870185|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
33264718|NCT01034306|100870186|FG000|Overall Study|Adverse Event|1|||
33264719|NCT01034306|100870187|FG001|Overall Study|Adverse Event|0|||
33264720|NCT01034306|100870186|FG000|Overall Study|Lost to Follow-up|0|||
33264721|NCT01034306|100870187|FG001|Overall Study|Lost to Follow-up|1|||
33264722|NCT01034306|100870186|FG000|Overall Study|Withdrawal by Subject|2|||
33264723|NCT01034306|100870187|FG001|Overall Study|Withdrawal by Subject|2|||
33264724|NCT01034306|100870186|FG000|Overall Study|hospitalized and decided to stop|1|||
33264725|NCT01034306|100870187|FG001|Overall Study|hospitalized and decided to stop|0|||
33264726|NCT01034306|100870186|FG000|Overall Study|Noncomplience|1|||
33264727|NCT01034306|100870187|FG001|Overall Study|Noncomplience|0|||
33264728|NCT02063659|100870190|FG000|Double-Blind Treatment Period|Adverse Event|1|||
33264729|NCT02063659|100870191|FG001|Double-Blind Treatment Period|Adverse Event|2|||
33264730|NCT02063659|100870192|FG002|Double-Blind Treatment Period|Adverse Event|0|||
33264731|NCT02063659|100870193|FG003|Double-Blind Treatment Period|Adverse Event|0|||
33264732|NCT02063659|100870190|FG000|Double-Blind Treatment Period|Physician Decision|1|||
33467501|NCT02843659|101600569|FG002|Overall Study|Subject Withdrew Consent|1|||
33467502|NCT02843659|101600567|FG000|Overall Study|Administrative Reason by Sponsor|4|||
33467503|NCT02843659|101600568|FG001|Overall Study|Administrative Reason by Sponsor|5|||
33467504|NCT02843659|101600569|FG002|Overall Study|Administrative Reason by Sponsor|4|||
33467505|NCT02843659|101600567|FG000|Overall Study|Adverse Event|0|||
33467506|NCT02843659|101600568|FG001|Overall Study|Adverse Event|1|||
33467507|NCT02843659|101600569|FG002|Overall Study|Adverse Event|0|||
33467508|NCT04142242|101600570|FG000|Stage I|Non-compliance with the protocol|1|||
33467509|NCT04142242|101600571|FG001|Stage I|Non-compliance with the protocol|0|||
33178971|NCT01870583|100563811|FG001|Overall Study|Lost to Follow-up|13|||
33178972|NCT01870583|100563812|FG002|Overall Study|Lost to Follow-up|5|||
33178973|NCT00227305|100563813|FG000|Overall Study|Adverse Event|40|||
33178974|NCT00227305|100563813|FG000|Overall Study|Withdrawal by Subject|42|||
33178975|NCT00227305|100563813|FG000|Overall Study|Lost to Follow-up|33|||
33178976|NCT00227305|100563813|FG000|Overall Study|Study specific discontinuation|13|||
33178977|NCT00227305|100563813|FG000|Overall Study|MOVED OUT OF AREA|3|||
33178978|NCT00227305|100563813|FG000|Overall Study|Lack of Efficacy|7|||
33178979|NCT00227305|100563813|FG000|Overall Study|Physician Decision|3|||
33178980|NCT00227305|100563813|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
33178981|NCT00227305|100563813|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
33178982|NCT00227305|100563813|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
33178983|NCT00679263|100563814|FG000|Visit 2/Dose 1|Adverse Event|1|||
33178984|NCT00679263|100563815|FG001|Visit 2/Dose 1|Adverse Event|0|||
33178985|NCT00679263|100563816|FG002|Visit 2/Dose 1|Adverse Event|0|||
33178986|NCT00679263|100563814|FG000|Visit 2/Dose 1|subject not compliance|1|||
33467510|NCT04142242|101600572|FG002|Stage I|Non-compliance with the protocol|0|||
33178987|NCT00679263|100563815|FG001|Visit 2/Dose 1|subject not compliance|1|||
33178988|NCT00679263|100563816|FG002|Visit 2/Dose 1|subject not compliance|0|||
33178989|NCT00993291|100563820|FG000|Overall Study|Withdrawal by Subject|1|||
33178990|NCT01199289|100563821|FG000|Overall Study|Ineligibility determined|2|||
33178991|NCT01199289|100563822|FG001|Overall Study|Ineligibility determined|1|||
33178992|NCT01199289|100563823|FG002|Overall Study|Ineligibility determined|0|||
33178993|NCT01199289|100563824|FG003|Overall Study|Ineligibility determined|0|||
33178994|NCT01199289|100563821|FG000|Overall Study|Protocol Violation|1|||
33178995|NCT01199289|100563822|FG001|Overall Study|Protocol Violation|0|||
33178996|NCT01199289|100563823|FG002|Overall Study|Protocol Violation|0|||
33178997|NCT01199289|100563824|FG003|Overall Study|Protocol Violation|1|||
33178998|NCT01199289|100563821|FG000|Overall Study|Noncompliance|1|||
33178999|NCT01199289|100563822|FG001|Overall Study|Noncompliance|0|||
33179000|NCT01199289|100563823|FG002|Overall Study|Noncompliance|2|||
33179001|NCT01199289|100563824|FG003|Overall Study|Noncompliance|0|||
33179002|NCT01199289|100563821|FG000|Overall Study|Adverse Event|0|||
33179003|NCT01199289|100563822|FG001|Overall Study|Adverse Event|3|||
33179004|NCT01199289|100563823|FG002|Overall Study|Adverse Event|1|||
33179005|NCT01199289|100563824|FG003|Overall Study|Adverse Event|4|||
33179006|NCT01199289|100563821|FG000|Overall Study|Full consent withdrawn|2|||
33179007|NCT01199289|100563822|FG001|Overall Study|Full consent withdrawn|2|||
33179008|NCT01199289|100563823|FG002|Overall Study|Full consent withdrawn|2|||
33179009|NCT01199289|100563824|FG003|Overall Study|Full consent withdrawn|3|||
33179010|NCT01199289|100563821|FG000|Overall Study|Administrative decision|0|||
33179011|NCT01199289|100563822|FG001|Overall Study|Administrative decision|0|||
33179012|NCT01199289|100563823|FG002|Overall Study|Administrative decision|0|||
33179013|NCT01199289|100563824|FG003|Overall Study|Administrative decision|1|||
33179014|NCT01199289|100563821|FG000|Overall Study|Lost to Follow-up|0|||
33179015|NCT01199289|100563822|FG001|Overall Study|Lost to Follow-up|0|||
33179016|NCT01199289|100563823|FG002|Overall Study|Lost to Follow-up|0|||
33264733|NCT02063659|100870191|FG001|Double-Blind Treatment Period|Physician Decision|0|||
33264734|NCT02063659|100870192|FG002|Double-Blind Treatment Period|Physician Decision|0|||
33467511|NCT04142242|101600573|FG003|Stage I|Non-compliance with the protocol|0|||
33467512|NCT04142242|101600574|FG004|Stage I|Non-compliance with the protocol|0|||
33467513|NCT04142242|101600575|FG005|Stage I|Non-compliance with the protocol|1|||
33467514|NCT04142242|101600570|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
33467515|NCT04142242|101600571|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
33467516|NCT04142242|101600572|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
33467517|NCT04142242|101600573|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
33467518|NCT04142242|101600574|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
33467519|NCT04142242|101600575|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
33467520|NCT04142242|101600570|FG000|Stage II|Non-compliance with the protocol|0|||
33467521|NCT04142242|101600571|FG001|Stage II|Non-compliance with the protocol|0|||
33467522|NCT04142242|101600572|FG002|Stage II|Non-compliance with the protocol|0|||
33467523|NCT04142242|101600573|FG003|Stage II|Non-compliance with the protocol|2|||
33467524|NCT04142242|101600574|FG004|Stage II|Non-compliance with the protocol|0|||
33467525|NCT04142242|101600575|FG005|Stage II|Non-compliance with the protocol|0|||
33467526|NCT04142242|101600570|FG000|Stage II|Lost to Follow-up|0|||
33467527|NCT04142242|101600571|FG001|Stage II|Lost to Follow-up|0|||
33467528|NCT04142242|101600572|FG002|Stage II|Lost to Follow-up|1|||
33467529|NCT04142242|101600573|FG003|Stage II|Lost to Follow-up|2|||
33467530|NCT04142242|101600574|FG004|Stage II|Lost to Follow-up|0|||
33467531|NCT04142242|101600575|FG005|Stage II|Lost to Follow-up|0|||
33467532|NCT04142242|101600570|FG000|Stage II|Withdrawal by Subject|0|||
33467533|NCT04142242|101600571|FG001|Stage II|Withdrawal by Subject|0|||
33467534|NCT04142242|101600572|FG002|Stage II|Withdrawal by Subject|5|||
33467535|NCT04142242|101600573|FG003|Stage II|Withdrawal by Subject|9|||
33467536|NCT04142242|101600574|FG004|Stage II|Withdrawal by Subject|0|||
33467537|NCT04142242|101600575|FG005|Stage II|Withdrawal by Subject|0|||
33467538|NCT00502801|101600576|FG000|Treatment Period|Withdrawal by Subject|3|||
33467539|NCT00502801|101600576|FG000|Treatment Period|Adverse Event|7|||
33467540|NCT00502801|101600576|FG000|Treatment Period|Death|14|||
33467541|NCT00502801|101600576|FG000|Treatment Period|OTHER|30|||
33467542|NCT00502801|101600576|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
33467543|NCT00502801|101600576|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
33467544|NCT00502801|101600576|FG000|End of Therapy to Test of Cure|Death|3|||
33467545|NCT00502801|101600576|FG000|End of Therapy to Test of Cure|OTHER|2|||
33467546|NCT02954159|101600577|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
33467547|NCT02954159|101600578|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
33179017|NCT01199289|100563824|FG003|Overall Study|Lost to Follow-up|1|||
33467548|NCT02954159|101600577|FG000|Overall Study|Withdrawal by Subject|0|||
33467549|NCT02954159|101600578|FG001|Overall Study|Withdrawal by Subject|1|||
33467550|NCT02737592|101600579|FG000|Overall Study|Withdrawal by Subject|1|||
33467551|NCT01787279|101600587|FG000|Overall Study|Lost to Follow-up|2|||
33179018|NCT01199289|100563821|FG000|Overall Study|Protocol-specified criteria|3|||
33179019|NCT01199289|100563822|FG001|Overall Study|Protocol-specified criteria|0|||
33179020|NCT01199289|100563823|FG002|Overall Study|Protocol-specified criteria|0|||
33179021|NCT01199289|100563824|FG003|Overall Study|Protocol-specified criteria|1|||
33467552|NCT01787279|101600587|FG000|Overall Study|Lack of Efficacy|1|||
33467553|NCT01844531|101600592|FG000|Overall Study|Withdrawal by Subject|0|||
33467554|NCT01844531|101600593|FG001|Overall Study|Withdrawal by Subject|1|||
33467555|NCT01844531|101600594|FG002|Overall Study|Withdrawal by Subject|0|||
33467556|NCT01844531|101600595|FG003|Overall Study|Withdrawal by Subject|0|||
33467557|NCT02492841|101600596|FG000|Overall Study|Lost to Follow-up|34|||
33467558|NCT02492841|101600597|FG001|Overall Study|Lost to Follow-up|31|||
33467559|NCT02492841|101600598|FG002|Overall Study|Lost to Follow-up|35|||
33467560|NCT01682148|101600599|FG000|Overall Study|Withdrawal by Subject|2|||
33467561|NCT01682148|101600600|FG001|Overall Study|Withdrawal by Subject|0|||
33467562|NCT01682148|101600599|FG000|Overall Study|Lost to Follow-up|1|||
33467563|NCT01682148|101600600|FG001|Overall Study|Lost to Follow-up|2|||
33467564|NCT01682148|101600599|FG000|Overall Study|Protocol Violation|1|||
33467565|NCT01682148|101600600|FG001|Overall Study|Protocol Violation|1|||
33467566|NCT00227266|101600601|FG000|Overall Study|Withdrawal by Subject|0|||
33467567|NCT00227266|101600602|FG001|Overall Study|Withdrawal by Subject|0|||
33467568|NCT00227266|101600603|FG002|Overall Study|Withdrawal by Subject|1|||
33467569|NCT00227266|101600601|FG000|Overall Study|Protocol Violation|1|||
33467570|NCT00227266|101600602|FG001|Overall Study|Protocol Violation|0|||
33467571|NCT00227266|101600603|FG002|Overall Study|Protocol Violation|1|||
33467572|NCT00227266|101600601|FG000|Overall Study|Excessive weight gain|0|||
33467573|NCT00227266|101600602|FG001|Overall Study|Excessive weight gain|0|||
33467574|NCT00227266|101600603|FG002|Overall Study|Excessive weight gain|2|||
33467575|NCT00706355|101600604|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
33467576|NCT00706355|101600605|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
33467577|NCT00706355|101600606|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
33467578|NCT00706355|101600607|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
33264735|NCT02063659|100870193|FG003|Double-Blind Treatment Period|Physician Decision|0|||
33467579|NCT00706355|101600604|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
33467580|NCT00706355|101600605|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
33467581|NCT00706355|101600606|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
33467582|NCT00706355|101600607|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
33467583|NCT00706355|101600604|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
33467584|NCT00706355|101600605|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
33467585|NCT00706355|101600606|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
33467586|NCT00706355|101600607|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
33467587|NCT00706355|101600604|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
33467588|NCT00706355|101600605|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
33467589|NCT00706355|101600606|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
33467590|NCT00706355|101600607|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
33467591|NCT00706355|101600604|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
33467592|NCT00706355|101600605|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
33467593|NCT00706355|101600606|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
33467594|NCT00706355|101600607|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
33467595|NCT00706355|101600604|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
33467596|NCT00706355|101600605|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
33467597|NCT00706355|101600606|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
33467598|NCT00706355|101600607|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
33467599|NCT00706355|101600604|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
33467600|NCT00706355|101600605|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
33467601|NCT00706355|101600606|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
33467602|NCT00706355|101600607|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
33467603|NCT00706355|101600604|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
33467604|NCT00706355|101600605|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
33467605|NCT00706355|101600606|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
33467606|NCT00706355|101600607|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
33467607|NCT00706355|101600604|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
33467608|NCT00706355|101600605|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
33467609|NCT00706355|101600606|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
33467610|NCT00706355|101600607|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
33467611|NCT01393730|101600608|FG000|Overall Study|Withdrawal by Subject|3|||
33467612|NCT01393730|101600608|FG000|Overall Study|Other|2|||
33467613|NCT01393730|101600608|FG000|Overall Study|Adverse Event|1|||
33467614|NCT00251641|101600609|FG000|Overall Study|Adverse Event|80|||
33264736|NCT02063659|100870190|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
33467615|NCT00251641|101600610|FG001|Overall Study|Adverse Event|8|||
33467616|NCT00251641|101600609|FG000|Overall Study|Lack of Efficacy|2|||
33467617|NCT00251641|101600610|FG001|Overall Study|Lack of Efficacy|1|||
33467618|NCT00251641|101600609|FG000|Overall Study|Progression of Disease|0|||
33467619|NCT00251641|101600610|FG001|Overall Study|Progression of Disease|2|||
33467620|NCT00251641|101600609|FG000|Overall Study|Lost to Follow-up|3|||
33467621|NCT00251641|101600610|FG001|Overall Study|Lost to Follow-up|3|||
33467622|NCT00251641|101600609|FG000|Overall Study|Withdrawal by Subject|6|||
33467623|NCT00251641|101600610|FG001|Overall Study|Withdrawal by Subject|8|||
33467624|NCT00251641|101600609|FG000|Overall Study|Protocol Violation|10|||
33467625|NCT00251641|101600610|FG001|Overall Study|Protocol Violation|2|||
33467626|NCT00251641|101600609|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
33467627|NCT00251641|101600610|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
33467628|NCT00251641|101600609|FG000|Overall Study|Switched Treatment|9|||
33467629|NCT00251641|101600610|FG001|Overall Study|Switched Treatment|63|||
33467630|NCT03005067|101600611|FG000|Overall Study|Withdrawal by Subject|3|||
33467631|NCT03005067|101600612|FG001|Overall Study|Withdrawal by Subject|2|||
33467632|NCT03005067|101600611|FG000|Overall Study|Adverse Event|4|||
33467633|NCT03005067|101600612|FG001|Overall Study|Adverse Event|3|||
33467634|NCT03005067|101600611|FG000|Overall Study|Other (reason not specified)|3|||
33467635|NCT03005067|101600612|FG001|Overall Study|Other (reason not specified)|1|||
33467636|NCT03005067|101600611|FG000|Overall Study|Protocol Violation|0|||
33467637|NCT03005067|101600612|FG001|Overall Study|Protocol Violation|1|||
33467638|NCT00706992|101603615|FG000|Overall Study|Study termination|5|||
33467639|NCT00706992|101603616|FG001|Overall Study|Study termination|5|||
33467640|NCT00706992|101603617|FG002|Overall Study|Study termination|6|||
33467641|NCT00706992|101603618|FG003|Overall Study|Study termination|2|||
33467642|NCT00706992|101603619|FG004|Overall Study|Study termination|3|||
33467643|NCT00706992|101603620|FG005|Overall Study|Study termination|2|||
33467644|NCT00706992|101603621|FG006|Overall Study|Study termination|3|||
33467645|NCT00706992|101603615|FG000|Overall Study|Disease progression before treatment|0|||
33467646|NCT00706992|101603616|FG001|Overall Study|Disease progression before treatment|0|||
33467647|NCT00706992|101603617|FG002|Overall Study|Disease progression before treatment|0|||
33467648|NCT00706992|101603618|FG003|Overall Study|Disease progression before treatment|0|||
33467649|NCT00706992|101603619|FG004|Overall Study|Disease progression before treatment|1|||
33467650|NCT00706992|101603620|FG005|Overall Study|Disease progression before treatment|0|||
33467651|NCT00706992|101603621|FG006|Overall Study|Disease progression before treatment|0|||
33467652|NCT01597479|101603623|FG000|Overall Study|Protocol Violation|1|||
33467653|NCT01597479|101603624|FG001|Overall Study|Protocol Violation|0|||
33467654|NCT01597479|101603623|FG000|Overall Study|Lost to Follow-up|1|||
33467655|NCT01597479|101603624|FG001|Overall Study|Lost to Follow-up|0|||
33467656|NCT02333487|101603625|FG000|Overall Study|Adverse Event|0|||
33467657|NCT02333487|101603626|FG001|Overall Study|Adverse Event|2|||
33467658|NCT02333487|101603627|FG002|Overall Study|Adverse Event|0|||
33467659|NCT01049412|101603628|FG000|Period I|Withdrawal by Subject|4|||
33467660|NCT01049412|101603629|FG001|Period I|Withdrawal by Subject|6|||
33467661|NCT01049412|101603628|FG000|Period I|Lost to Follow-up|2|||
33467662|NCT01049412|101603629|FG001|Period I|Lost to Follow-up|2|||
33467663|NCT01049412|101603628|FG000|Period I|Physician Decision|0|||
33467664|NCT01049412|101603629|FG001|Period I|Physician Decision|3|||
33467665|NCT01049412|101603628|FG000|Period I|Protocol Violation|1|||
33467666|NCT01049412|101603629|FG001|Period I|Protocol Violation|2|||
33467667|NCT01049412|101603628|FG000|Period I|Adverse Event|1|||
33467668|NCT01049412|101603629|FG001|Period I|Adverse Event|0|||
33467669|NCT01049412|101603628|FG000|Period II|Withdrawal by Subject|2|||
33467670|NCT01049412|101603629|FG001|Period II|Withdrawal by Subject|3|||
33467671|NCT01049412|101603628|FG000|Period II|Adverse Event|1|||
33467672|NCT01049412|101603629|FG001|Period II|Adverse Event|0|||
33467673|NCT01049412|101603628|FG000|Period II|Lost to Follow-up|1|||
33467674|NCT01049412|101603629|FG001|Period II|Lost to Follow-up|0|||
33467675|NCT01663727|101603631|FG000|Overall Study|Death|161|||
33467676|NCT01663727|101603632|FG001|Overall Study|Death|155|||
33467677|NCT01663727|101603631|FG000|Overall Study|Lost to Follow-up|10|||
33467678|NCT01663727|101603632|FG001|Overall Study|Lost to Follow-up|8|||
33467679|NCT01663727|101603631|FG000|Overall Study|Withdrawal by Subject|18|||
33467680|NCT01663727|101603632|FG001|Overall Study|Withdrawal by Subject|25|||
33467681|NCT01663727|101603631|FG000|Overall Study|Study Terminated|51|||
33467682|NCT01663727|101603632|FG001|Overall Study|Study Terminated|50|||
33467683|NCT01663727|101603631|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
33467684|NCT01663727|101603632|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
33467685|NCT01663727|101603631|FG000|Overall Study|Withdrawal prior to dosing.|1|||
33467686|NCT01663727|101603632|FG001|Overall Study|Withdrawal prior to dosing.|0|||
33467687|NCT02075606|101603633|FG000|Overall Study|Adverse Event|5|||
33467688|NCT02075606|101603633|FG000|Overall Study|Withdrawal by Subject|1|||
33467689|NCT02075606|101603633|FG000|Overall Study|Death|1|||
33467690|NCT02075606|101603633|FG000|Overall Study|Investigator's decision|1|||
33467691|NCT02075606|101603633|FG000|Overall Study|Symptom management|1|||
33467692|NCT02075606|101603633|FG000|Overall Study|Increasing Symptoms|1|||
33467693|NCT01613378|101603636|FG000|Overall Study|Lack of Efficacy|13|||
33467694|NCT01613378|101603636|FG000|Overall Study|Adverse Event|11|||
33467695|NCT01613378|101603636|FG000|Overall Study|Withdrawal by Subject|8|||
33467696|NCT01613378|101603636|FG000|Overall Study|Death|2|||
33467697|NCT01613378|101603636|FG000|Overall Study|Lost to Follow-up|1|||
33467698|NCT01613378|101603636|FG000|Overall Study|Other Reason|4|||
33467699|NCT00107042|101603637|FG000|Overall Study|Lost to Follow-up|9|||
33467700|NCT00107042|101603638|FG001|Overall Study|Lost to Follow-up|7|||
33467701|NCT00107042|101603637|FG000|Overall Study|Withdrawal by Subject|6|||
33467702|NCT00107042|101603638|FG001|Overall Study|Withdrawal by Subject|1|||
33467703|NCT00107042|101603637|FG000|Overall Study|Moved out of area|5|||
33467704|NCT00107042|101603638|FG001|Overall Study|Moved out of area|3|||
33467705|NCT00107042|101603637|FG000|Overall Study|Pregnancy|1|||
33467706|NCT00107042|101603638|FG001|Overall Study|Pregnancy|1|||
33467707|NCT00107042|101603637|FG000|Overall Study|Inadvertent enrollment|0|||
33467708|NCT00107042|101603638|FG001|Overall Study|Inadvertent enrollment|1|||
33467709|NCT00107042|101603637|FG000|Overall Study|vaccinated outside window|1|||
33467710|NCT00107042|101603638|FG001|Overall Study|vaccinated outside window|1|||
33467711|NCT00107042|101603637|FG000|Overall Study|Disallowed medications|0|||
33467712|NCT00107042|101603638|FG001|Overall Study|Disallowed medications|2|||
33467713|NCT01506908|101603639|FG000|Overall Study|Adverse Event|1|||
33467714|NCT01506908|101603640|FG001|Overall Study|Adverse Event|0|||
33467715|NCT01652729|101603642|FG000|Overall Study|Withdrawal by Subject|14|||
33467716|NCT01652729|101603643|FG001|Overall Study|Withdrawal by Subject|7|||
33467717|NCT01652729|101603644|FG002|Overall Study|Withdrawal by Subject|7|||
33467718|NCT01652729|101603642|FG000|Overall Study|Adverse Event|4|||
33467719|NCT01652729|101603643|FG001|Overall Study|Adverse Event|0|||
33467720|NCT01652729|101603644|FG002|Overall Study|Adverse Event|3|||
33467721|NCT01652729|101603642|FG000|Overall Study|Physician Decision|1|||
33467722|NCT01652729|101603643|FG001|Overall Study|Physician Decision|0|||
33467723|NCT01652729|101603644|FG002|Overall Study|Physician Decision|1|||
33467724|NCT01652729|101603642|FG000|Overall Study|Protocol Violation|1|||
33467725|NCT01652729|101603643|FG001|Overall Study|Protocol Violation|0|||
33467726|NCT01652729|101603644|FG002|Overall Study|Protocol Violation|0|||
33467727|NCT01652729|101603642|FG000|Overall Study|Lost to Follow-up|6|||
33467728|NCT01652729|101603643|FG001|Overall Study|Lost to Follow-up|6|||
33467729|NCT01652729|101603644|FG002|Overall Study|Lost to Follow-up|3|||
33467730|NCT01652729|101603642|FG000|Overall Study|Administrative|1|||
33467731|NCT01652729|101603643|FG001|Overall Study|Administrative|0|||
33467732|NCT01652729|101603644|FG002|Overall Study|Administrative|0|||
33467733|NCT02698865|101603645|FG000|Overall Study|Other|11|||
33467734|NCT02698865|101603646|FG001|Overall Study|Other|11|||
33467735|NCT02698865|101603645|FG000|Overall Study|Withdrawal by Subject|20|||
33467736|NCT02698865|101603646|FG001|Overall Study|Withdrawal by Subject|16|||
33264737|NCT02063659|100870191|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
33264738|NCT02063659|100870192|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
33264739|NCT02063659|100870193|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
33264740|NCT02063659|100870190|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
33264741|NCT02063659|100870191|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
33264742|NCT02063659|100870192|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
33264743|NCT02063659|100870193|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
33264744|NCT02063659|100870190|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
33264745|NCT02063659|100870191|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
33264746|NCT02063659|100870192|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
33264747|NCT02063659|100870193|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
33264748|NCT02063659|100870190|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
33264749|NCT02063659|100870191|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
33264750|NCT02063659|100870192|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
33264751|NCT02063659|100870193|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
33264752|NCT02063659|100870190|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
33264753|NCT02063659|100870191|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
33264754|NCT02063659|100870192|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
33264755|NCT02063659|100870193|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
33264756|NCT02063659|100870190|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
33264757|NCT02063659|100870191|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
33264758|NCT02063659|100870192|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
33264759|NCT02063659|100870193|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
33264760|NCT02111096|100870194|FG000|Overall Study|Adverse Event|4|||
33264761|NCT02111096|100870195|FG001|Overall Study|Adverse Event|1|||
33264762|NCT02111096|100870196|FG002|Overall Study|Adverse Event|2|||
33467737|NCT02698865|101603645|FG000|Overall Study|Physician Decision|0|||
33467738|NCT02698865|101603646|FG001|Overall Study|Physician Decision|4|||
33467739|NCT02698865|101603645|FG000|Overall Study|Lost to Follow-up|4|||
33467740|NCT02698865|101603646|FG001|Overall Study|Lost to Follow-up|2|||
33467741|NCT00767520|101603649|FG000|Overall Study|Participants still on treatment|11|||
33467742|NCT00767520|101603650|FG001|Overall Study|Participants still on treatment|15|||
33467743|NCT00767520|101603649|FG000|Overall Study|Randomized in error and Never treated|0|||
33467744|NCT00767520|101603650|FG001|Overall Study|Randomized in error and Never treated|2|||
33467745|NCT03919448|101603651|FG000|Overall Study|Withdrawal by Subject|1|||
33264763|NCT02111096|100870194|FG000|Overall Study|Non-Compliance with Study Drug|1|||
33264764|NCT02111096|100870195|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33264765|NCT02111096|100870196|FG002|Overall Study|Non-Compliance with Study Drug|0|||
33264766|NCT02111096|100870194|FG000|Overall Study|Lost to Follow Up|1|||
33264767|NCT02111096|100870195|FG001|Overall Study|Lost to Follow Up|1|||
33264768|NCT02111096|100870196|FG002|Overall Study|Lost to Follow Up|1|||
33264769|NCT02111096|100870194|FG000|Overall Study|Physician Decision|0|||
33264770|NCT02111096|100870195|FG001|Overall Study|Physician Decision|1|||
33264771|NCT02111096|100870196|FG002|Overall Study|Physician Decision|0|||
33264772|NCT02111096|100870194|FG000|Overall Study|Protocol Violation|1|||
33264773|NCT02111096|100870195|FG001|Overall Study|Protocol Violation|0|||
33264774|NCT02111096|100870196|FG002|Overall Study|Protocol Violation|1|||
33264775|NCT02111096|100870194|FG000|Overall Study|Terminated by Sponsor|53|||
33264776|NCT02111096|100870195|FG001|Overall Study|Terminated by Sponsor|35|||
33264777|NCT02111096|100870196|FG002|Overall Study|Terminated by Sponsor|54|||
33264778|NCT02111096|100870194|FG000|Overall Study|Withdrawal by Subject|4|||
33264779|NCT02111096|100870195|FG001|Overall Study|Withdrawal by Subject|2|||
33264780|NCT02111096|100870196|FG002|Overall Study|Withdrawal by Subject|8|||
33264781|NCT02091752|100870197|FG000|Overall Study|Study terminated by Sponsor|2|||
33264782|NCT02091752|100870197|FG000|Overall Study|Adverse Event|1|||
33264783|NCT02235298|100870198|FG000|Overall Study|Lost to Follow-up|6|||
33264784|NCT02235298|100870199|FG001|Overall Study|Lost to Follow-up|5|||
33264785|NCT02235298|100870198|FG000|Overall Study|Adverse Event|2|||
33264786|NCT02235298|100870199|FG001|Overall Study|Adverse Event|2|||
33264787|NCT02235298|100870198|FG000|Overall Study|Withdrawal by Subject|0|||
33264788|NCT02235298|100870199|FG001|Overall Study|Withdrawal by Subject|1|||
33264789|NCT03478969|100870202|FG000|Overall Study|Withdrawal by Subject|4|||
33264790|NCT03478969|100870203|FG001|Overall Study|Withdrawal by Subject|7|||
33264791|NCT03478969|100870204|FG002|Overall Study|Withdrawal by Subject|6|||
33264792|NCT03478969|100870202|FG000|Overall Study|Adverse Event|2|||
33264793|NCT03478969|100870203|FG001|Overall Study|Adverse Event|0|||
33264794|NCT03478969|100870204|FG002|Overall Study|Adverse Event|1|||
33264795|NCT03478969|100870202|FG000|Overall Study|Pregnancy|1|||
33264796|NCT03478969|100870203|FG001|Overall Study|Pregnancy|0|||
33264797|NCT03478969|100870204|FG002|Overall Study|Pregnancy|0|||
33264798|NCT03478969|100870202|FG000|Overall Study|Personal Reasons|1|||
33264799|NCT03478969|100870203|FG001|Overall Study|Personal Reasons|0|||
33264800|NCT03478969|100870204|FG002|Overall Study|Personal Reasons|1|||
33264801|NCT03478969|100870202|FG000|Overall Study|Covid-19|1|||
33264802|NCT03478969|100870203|FG001|Overall Study|Covid-19|4|||
33264803|NCT03478969|100870204|FG002|Overall Study|Covid-19|3|||
33264804|NCT03478969|100870202|FG000|Overall Study|Multiple Reasons|0|||
33264805|NCT03478969|100870203|FG001|Overall Study|Multiple Reasons|1|||
33264806|NCT03478969|100870204|FG002|Overall Study|Multiple Reasons|1|||
33264807|NCT03478969|100870202|FG000|Overall Study|Eligibility Criteria|0|||
33264808|NCT03478969|100870203|FG001|Overall Study|Eligibility Criteria|0|||
33264809|NCT03478969|100870204|FG002|Overall Study|Eligibility Criteria|5|||
33264810|NCT03478969|100870202|FG000|Overall Study|Lost to Follow-up|0|||
33264811|NCT03478969|100870203|FG001|Overall Study|Lost to Follow-up|0|||
33264812|NCT03478969|100870204|FG002|Overall Study|Lost to Follow-up|1|||
33264813|NCT00933270|100870211|FG000|Overall Study|Withdrawal by Subject|26|||
33264814|NCT00933270|100870211|FG000|Overall Study|Insufficient Follow-up|10|||
33264815|NCT00933270|100870211|FG000|Overall Study|Lost to Follow-up|14|||
33264816|NCT00933270|100870211|FG000|Overall Study|Adverse Event|1|||
33264817|NCT00933270|100870211|FG000|Overall Study|Missed Visit|2|||
33264818|NCT00933270|100870211|FG000|Overall Study|Death|24|||
33264819|NCT00933270|100870211|FG000|Overall Study|Moved or would not return|10|||
33264820|NCT03489369|100870212|FG000|Overall Study|Documented Progressive Disease|3|||
33264821|NCT03489369|100870213|FG001|Overall Study|Documented Progressive Disease|2|||
33467746|NCT03919448|101603652|FG001|Overall Study|Withdrawal by Subject|0|||
33467747|NCT03919448|101603653|FG002|Overall Study|Withdrawal by Subject|0|||
33264822|NCT03489369|100870214|FG002|Overall Study|Documented Progressive Disease|3|||
33264823|NCT03489369|100870215|FG003|Overall Study|Documented Progressive Disease|6|||
33264824|NCT03489369|100870212|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
33264825|NCT03489369|100870213|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
33264826|NCT03489369|100870214|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
33264827|NCT03489369|100870215|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
33264828|NCT00210106|100870216|FG000|Overall Study|Death|1|||
33264829|NCT00210106|100870216|FG000|Overall Study|Protocol Violation|13|||
33264830|NCT03683576|100870217|FG000|Overall Study|Withdrawal by Subject|2|||
33264831|NCT03683576|100870218|FG001|Overall Study|Withdrawal by Subject|0|||
33264832|NCT03683576|100870219|FG002|Overall Study|Withdrawal by Subject|8|||
33264833|NCT03683576|100870220|FG003|Overall Study|Withdrawal by Subject|3|||
33264834|NCT03683576|100870217|FG000|Overall Study|Adverse Event|3|||
33264835|NCT03683576|100870218|FG001|Overall Study|Adverse Event|0|||
33264836|NCT03683576|100870219|FG002|Overall Study|Adverse Event|0|||
33264837|NCT03683576|100870220|FG003|Overall Study|Adverse Event|4|||
33264838|NCT03683576|100870217|FG000|Overall Study|Lack of Efficacy|1|||
33264839|NCT03683576|100870218|FG001|Overall Study|Lack of Efficacy|0|||
33264840|NCT03683576|100870219|FG002|Overall Study|Lack of Efficacy|1|||
33264841|NCT03683576|100870220|FG003|Overall Study|Lack of Efficacy|1|||
33264842|NCT03683576|100870217|FG000|Overall Study|Lost to Follow-up|0|||
33264843|NCT03683576|100870218|FG001|Overall Study|Lost to Follow-up|1|||
33264844|NCT03683576|100870219|FG002|Overall Study|Lost to Follow-up|2|||
33264845|NCT03683576|100870220|FG003|Overall Study|Lost to Follow-up|0|||
33264846|NCT03683576|100870217|FG000|Overall Study|Other, Not Specified|0|||
33264847|NCT03683576|100870218|FG001|Overall Study|Other, Not Specified|2|||
33264848|NCT03683576|100870219|FG002|Overall Study|Other, Not Specified|0|||
33264849|NCT03683576|100870220|FG003|Overall Study|Other, Not Specified|0|||
33264850|NCT03683576|100870217|FG000|Overall Study|Protocol Violation|0|||
33264851|NCT03683576|100870218|FG001|Overall Study|Protocol Violation|1|||
33264852|NCT03683576|100870219|FG002|Overall Study|Protocol Violation|1|||
33264853|NCT03683576|100870220|FG003|Overall Study|Protocol Violation|0|||
33264854|NCT01371994|100870221|FG000|Overall Study|Adverse Event|3|||
33264855|NCT01371994|100870222|FG001|Overall Study|Adverse Event|6|||
33264856|NCT01371994|100870221|FG000|Overall Study|Lack of Efficacy|3|||
33264857|NCT01371994|100870222|FG001|Overall Study|Lack of Efficacy|0|||
33264858|NCT01371994|100870221|FG000|Overall Study|Withdrawal by Subject|13|||
33264859|NCT01371994|100870222|FG001|Overall Study|Withdrawal by Subject|7|||
33264860|NCT01371994|100870221|FG000|Overall Study|Lost to Follow-up|1|||
33264861|NCT01371994|100870222|FG001|Overall Study|Lost to Follow-up|1|||
33264862|NCT01371994|100870221|FG000|Overall Study|Protocol Violation|24|||
33264863|NCT01371994|100870222|FG001|Overall Study|Protocol Violation|17|||
33264864|NCT01371994|100870221|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
33264865|NCT01371994|100870222|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
33264866|NCT01371994|100870221|FG000|Overall Study|Physician Decision|1|||
33264867|NCT01371994|100870222|FG001|Overall Study|Physician Decision|1|||
33264868|NCT01371994|100870221|FG000|Overall Study|Miscellaneous Reasons|6|||
33264869|NCT01371994|100870222|FG001|Overall Study|Miscellaneous Reasons|4|||
33264870|NCT03876457|100870223|FG000|Overall Study|Lost to Follow-up|1|||
33264871|NCT03876457|100870224|FG001|Overall Study|Lost to Follow-up|3|||
33264872|NCT00822120|100870228|FG000|Initial Registration|Adverse Event|1|||
33264873|NCT00822120|100870229|FG001|Initial Registration|Adverse Event|0|||
33264874|NCT00822120|100870230|FG002|Initial Registration|Adverse Event|0|||
33264875|NCT00822120|100870231|FG003|Initial Registration|Adverse Event|0|||
33264876|NCT00822120|100870232|FG004|Initial Registration|Adverse Event|0|||
33264877|NCT00822120|100870233|FG005|Initial Registration|Adverse Event|0|||
33264878|NCT00822120|100870228|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
33264879|NCT00822120|100870229|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
33264880|NCT00822120|100870230|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
33264881|NCT00822120|100870231|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
33264882|NCT00822120|100870232|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
33467748|NCT01207440|101603659|FG000|Overall Study|Adverse Event|46|||
33467749|NCT01207440|101603660|FG001|Overall Study|Adverse Event|11|||
33467750|NCT01207440|101603661|FG002|Overall Study|Adverse Event|7|||
33467751|NCT01207440|101603662|FG003|Overall Study|Adverse Event|2|||
33467752|NCT01207440|101603663|FG004|Overall Study|Adverse Event|6|||
33467753|NCT01207440|101603664|FG005|Overall Study|Adverse Event|6|||
33467754|NCT01207440|101603665|FG006|Overall Study|Adverse Event|2|||
33467755|NCT01207440|101603659|FG000|Overall Study|Death|6|||
33467756|NCT01207440|101603660|FG001|Overall Study|Death|3|||
33467757|NCT01207440|101603661|FG002|Overall Study|Death|2|||
33467758|NCT01207440|101603662|FG003|Overall Study|Death|2|||
33467759|NCT01207440|101603663|FG004|Overall Study|Death|7|||
33467760|NCT01207440|101603664|FG005|Overall Study|Death|5|||
33467761|NCT01207440|101603665|FG006|Overall Study|Death|1|||
33467762|NCT01207440|101603659|FG000|Overall Study|Lack of Efficacy|13|||
33467763|NCT01207440|101603660|FG001|Overall Study|Lack of Efficacy|2|||
33467764|NCT01207440|101603661|FG002|Overall Study|Lack of Efficacy|5|||
33467765|NCT01207440|101603662|FG003|Overall Study|Lack of Efficacy|1|||
33467766|NCT01207440|101603663|FG004|Overall Study|Lack of Efficacy|2|||
33467767|NCT01207440|101603664|FG005|Overall Study|Lack of Efficacy|3|||
33264883|NCT00822120|100870233|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
33264884|NCT00822120|100870228|FG000|Initial Registration|Reasons not Protocol Specified|2|||
33264885|NCT00822120|100870229|FG001|Initial Registration|Reasons not Protocol Specified|0|||
33264886|NCT00822120|100870230|FG002|Initial Registration|Reasons not Protocol Specified|0|||
33264887|NCT00822120|100870231|FG003|Initial Registration|Reasons not Protocol Specified|0|||
33264888|NCT00822120|100870232|FG004|Initial Registration|Reasons not Protocol Specified|0|||
33264889|NCT00822120|100870233|FG005|Initial Registration|Reasons not Protocol Specified|0|||
33264890|NCT00822120|100870228|FG000|Initial Registration|Ineligible|22|||
33264891|NCT00822120|100870229|FG001|Initial Registration|Ineligible|1|||
33264892|NCT00822120|100870230|FG002|Initial Registration|Ineligible|0|||
33264893|NCT00822120|100870231|FG003|Initial Registration|Ineligible|0|||
33264894|NCT00822120|100870232|FG004|Initial Registration|Ineligible|0|||
33467768|NCT01207440|101603665|FG006|Overall Study|Lack of Efficacy|0|||
33264895|NCT00822120|100870233|FG005|Initial Registration|Ineligible|0|||
33264896|NCT00822120|100870228|FG000|PET-directed Therapy|Adverse Event|0|||
33264897|NCT00822120|100870229|FG001|PET-directed Therapy|Adverse Event|0|||
33264898|NCT00822120|100870230|FG002|PET-directed Therapy|Adverse Event|0|||
33264899|NCT00822120|100870231|FG003|PET-directed Therapy|Adverse Event|1|||
33264900|NCT00822120|100870232|FG004|PET-directed Therapy|Adverse Event|0|||
33264901|NCT00822120|100870233|FG005|PET-directed Therapy|Adverse Event|0|||
33264902|NCT00822120|100870228|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
33264903|NCT00822120|100870229|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
33264904|NCT00822120|100870230|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
33264905|NCT00822120|100870231|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
33264906|NCT00822120|100870232|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
33264907|NCT00822120|100870233|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
33264908|NCT00822120|100870228|FG000|PET-directed Therapy|Death|0|||
33264909|NCT00822120|100870229|FG001|PET-directed Therapy|Death|0|||
33264910|NCT00822120|100870230|FG002|PET-directed Therapy|Death|0|||
33264911|NCT00822120|100870231|FG003|PET-directed Therapy|Death|2|||
33264912|NCT00822120|100870232|FG004|PET-directed Therapy|Death|0|||
33264913|NCT00822120|100870233|FG005|PET-directed Therapy|Death|0|||
33264914|NCT00822120|100870228|FG000|PET-directed Therapy|Protocol Violation|0|||
33264915|NCT00822120|100870229|FG001|PET-directed Therapy|Protocol Violation|0|||
33264916|NCT00822120|100870230|FG002|PET-directed Therapy|Protocol Violation|0|||
33264917|NCT00822120|100870231|FG003|PET-directed Therapy|Protocol Violation|6|||
33264918|NCT00822120|100870232|FG004|PET-directed Therapy|Protocol Violation|0|||
33264919|NCT00822120|100870233|FG005|PET-directed Therapy|Protocol Violation|0|||
33264920|NCT00345046|100870240|FG000|Overall Study|Protocol Violation|1|||
33264921|NCT00345046|100870241|FG001|Overall Study|Protocol Violation|1|||
33264922|NCT00345046|100870242|FG002|Overall Study|Protocol Violation|2|||
33264923|NCT00070317|100870243|FG000|Overall Study|Inevaluable (Never Treated)|1|||
33264924|NCT00070317|100870243|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
33264925|NCT00070317|100870243|FG000|Overall Study|Ineligible required test not done|1|||
33264926|NCT00070317|100870243|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
33264927|NCT00070317|100870243|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
33264928|NCT04860505|100870244|FG000|Overall Study|Lost to Follow-up|2|||
33264929|NCT01227421|100870245|FG000|Overall Study|Lost to Follow-up|6|||
33264930|NCT01227421|100870246|FG001|Overall Study|Lost to Follow-up|7|||
33264931|NCT01227421|100870247|FG002|Overall Study|Lost to Follow-up|5|||
33264932|NCT01227421|100870245|FG000|Overall Study|Adverse Event|2|||
33264933|NCT01227421|100870246|FG001|Overall Study|Adverse Event|7|||
33264934|NCT01227421|100870247|FG002|Overall Study|Adverse Event|2|||
33264935|NCT01227421|100870245|FG000|Overall Study|Withdrawal by Subject|1|||
33264936|NCT01227421|100870246|FG001|Overall Study|Withdrawal by Subject|2|||
33264937|NCT01227421|100870247|FG002|Overall Study|Withdrawal by Subject|1|||
33264938|NCT01227421|100870245|FG000|Overall Study|Protocol Violation|1|||
33264939|NCT01227421|100870246|FG001|Overall Study|Protocol Violation|1|||
33264940|NCT01227421|100870247|FG002|Overall Study|Protocol Violation|2|||
33264941|NCT01227421|100870245|FG000|Overall Study|Randomized in error|1|||
33264942|NCT01227421|100870246|FG001|Overall Study|Randomized in error|1|||
33264943|NCT01227421|100870247|FG002|Overall Study|Randomized in error|0|||
33264944|NCT00312208|100870248|FG000|Overall Study|Adverse Event|97|||
33264945|NCT00312208|100870249|FG001|Overall Study|Adverse Event|61|||
33264946|NCT00312208|100870248|FG000|Overall Study|Protocol Violation|5|||
33264947|NCT00312208|100870249|FG001|Overall Study|Protocol Violation|3|||
33264948|NCT00312208|100870248|FG000|Overall Study|Death|2|||
33264949|NCT00312208|100870249|FG001|Overall Study|Death|1|||
33264950|NCT00312208|100870248|FG000|Overall Study|Lack of Efficacy|7|||
33264951|NCT00312208|100870249|FG001|Overall Study|Lack of Efficacy|4|||
33264952|NCT00312208|100870248|FG000|Overall Study|Lost to Follow-up|3|||
33264953|NCT00312208|100870249|FG001|Overall Study|Lost to Follow-up|5|||
33264954|NCT00312208|100870248|FG000|Overall Study|Withdrawal by Subject|53|||
33264955|NCT00312208|100870249|FG001|Overall Study|Withdrawal by Subject|42|||
33467769|NCT01207440|101603659|FG000|Overall Study|Lost to Follow-up|0|||
33467770|NCT01207440|101603660|FG001|Overall Study|Lost to Follow-up|0|||
33467771|NCT01207440|101603661|FG002|Overall Study|Lost to Follow-up|2|||
33467772|NCT01207440|101603662|FG003|Overall Study|Lost to Follow-up|1|||
33467773|NCT01207440|101603663|FG004|Overall Study|Lost to Follow-up|0|||
33467774|NCT01207440|101603664|FG005|Overall Study|Lost to Follow-up|0|||
33264956|NCT00312208|100870248|FG000|Overall Study|Other|5|||
33467775|NCT01207440|101603665|FG006|Overall Study|Lost to Follow-up|0|||
33467776|NCT01207440|101603659|FG000|Overall Study|Non-compliance with Study Drug|3|||
33264957|NCT00312208|100870249|FG001|Overall Study|Other|7|||
33264958|NCT01988402|100870250|FG000|Overall Study|Adverse Event|1|||
33264959|NCT01988402|100870251|FG001|Overall Study|Adverse Event|2|||
33264960|NCT01988402|100870250|FG000|Overall Study|Withdrawal by Subject|1|||
33264961|NCT01988402|100870251|FG001|Overall Study|Withdrawal by Subject|0|||
33264962|NCT01898299|100870252|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
33264963|NCT01898299|100870253|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
33467777|NCT01207440|101603660|FG001|Overall Study|Non-compliance with Study Drug|0|||
33467778|NCT01207440|101603661|FG002|Overall Study|Non-compliance with Study Drug|1|||
33467779|NCT01207440|101603662|FG003|Overall Study|Non-compliance with Study Drug|0|||
33467780|NCT01207440|101603663|FG004|Overall Study|Non-compliance with Study Drug|0|||
33467781|NCT01207440|101603664|FG005|Overall Study|Non-compliance with Study Drug|0|||
33467782|NCT01207440|101603665|FG006|Overall Study|Non-compliance with Study Drug|0|||
33467783|NCT01207440|101603659|FG000|Overall Study|Physician Decision|6|||
33467784|NCT01207440|101603660|FG001|Overall Study|Physician Decision|5|||
33467785|NCT01207440|101603661|FG002|Overall Study|Physician Decision|5|||
33467786|NCT01207440|101603662|FG003|Overall Study|Physician Decision|0|||
33467787|NCT01207440|101603663|FG004|Overall Study|Physician Decision|1|||
33467788|NCT01207440|101603664|FG005|Overall Study|Physician Decision|0|||
33467789|NCT01207440|101603665|FG006|Overall Study|Physician Decision|0|||
33467790|NCT01207440|101603659|FG000|Overall Study|Progressive Disease|19|||
33467791|NCT01207440|101603660|FG001|Overall Study|Progressive Disease|10|||
33467792|NCT01207440|101603661|FG002|Overall Study|Progressive Disease|19|||
33467793|NCT01207440|101603662|FG003|Overall Study|Progressive Disease|7|||
33467794|NCT01207440|101603663|FG004|Overall Study|Progressive Disease|23|||
33467795|NCT01207440|101603664|FG005|Overall Study|Progressive Disease|27|||
33467796|NCT01207440|101603665|FG006|Overall Study|Progressive Disease|0|||
33467797|NCT01207440|101603659|FG000|Overall Study|Protocol Violation|2|||
33467798|NCT01207440|101603660|FG001|Overall Study|Protocol Violation|0|||
33467799|NCT01207440|101603661|FG002|Overall Study|Protocol Violation|0|||
33467800|NCT01207440|101603662|FG003|Overall Study|Protocol Violation|0|||
33467801|NCT01207440|101603663|FG004|Overall Study|Protocol Violation|0|||
33467802|NCT01207440|101603664|FG005|Overall Study|Protocol Violation|0|||
33467803|NCT01207440|101603665|FG006|Overall Study|Protocol Violation|0|||
33467804|NCT01207440|101603659|FG000|Overall Study|Site Terminated by Sponsor|69|||
33179022|NCT01199289|100563821|FG000|Overall Study|Pregnancy|0|||
33179023|NCT01199289|100563822|FG001|Overall Study|Pregnancy|1|||
33179024|NCT01199289|100563823|FG002|Overall Study|Pregnancy|0|||
33179025|NCT01199289|100563824|FG003|Overall Study|Pregnancy|1|||
33179026|NCT02802592|100563829|FG000|Overall Study|Study terminated due to loss of funding|4|||
33467805|NCT01207440|101603660|FG001|Overall Study|Site Terminated by Sponsor|19|||
33467806|NCT01207440|101603661|FG002|Overall Study|Site Terminated by Sponsor|12|||
33179027|NCT00728130|100563830|FG000|Overall Study|Withdrawal by Subject|1|||
33179028|NCT00728130|100563830|FG000|Overall Study|Paperwork not completed in time|1|||
33179029|NCT00728130|100563830|FG000|Overall Study|Physician Decision|1|||
33179030|NCT02956486|100563831|FG000|Core Phase|Adverse Event|51|||
33179031|NCT02956486|100563832|FG001|Core Phase|Adverse Event|88|||
33179032|NCT02956486|100563833|FG002|Core Phase|Adverse Event|0|||
33179033|NCT02956486|100563831|FG000|Core Phase|Lost to Follow-up|8|||
33179034|NCT02956486|100563832|FG001|Core Phase|Lost to Follow-up|6|||
33179035|NCT02956486|100563833|FG002|Core Phase|Lost to Follow-up|0|||
33179036|NCT02956486|100563831|FG000|Core Phase|Inadequate therapeutic effect|4|||
33179037|NCT02956486|100563832|FG001|Core Phase|Inadequate therapeutic effect|5|||
33179038|NCT02956486|100563833|FG002|Core Phase|Inadequate therapeutic effect|0|||
33179039|NCT02956486|100563831|FG000|Core Phase|Withdrawal by Subject|101|||
33179040|NCT02956486|100563832|FG001|Core Phase|Withdrawal by Subject|104|||
33179041|NCT02956486|100563833|FG002|Core Phase|Withdrawal by Subject|0|||
33179042|NCT02956486|100563831|FG000|Core Phase|Study terminated by sponsor|888|||
33179043|NCT02956486|100563832|FG001|Core Phase|Study terminated by sponsor|848|||
33179044|NCT02956486|100563833|FG002|Core Phase|Study terminated by sponsor|0|||
33179045|NCT02956486|100563831|FG000|Core Phase|Other|27|||
33179046|NCT02956486|100563832|FG001|Core Phase|Other|18|||
33179047|NCT02956486|100563833|FG002|Core Phase|Other|0|||
33179048|NCT02956486|100563831|FG000|Core Phase|Not treated|0|||
33179049|NCT02956486|100563832|FG001|Core Phase|Not treated|3|||
33179050|NCT02956486|100563833|FG002|Core Phase|Not treated|0|||
33179051|NCT02956486|100563831|FG000|Extension Phase|Adverse Event|0|||
33179052|NCT02956486|100563832|FG001|Extension Phase|Adverse Event|0|||
33179053|NCT02956486|100563833|FG002|Extension Phase|Adverse Event|2|||
33179054|NCT02956486|100563831|FG000|Extension Phase|Study terminated by sponsor|0|||
33179055|NCT02956486|100563832|FG001|Extension Phase|Study terminated by sponsor|0|||
33179056|NCT02956486|100563833|FG002|Extension Phase|Study terminated by sponsor|16|||
33179057|NCT02956486|100563831|FG000|Extension Phase|Not Treated|0|||
33467807|NCT01207440|101603662|FG003|Overall Study|Site Terminated by Sponsor|2|||
33467808|NCT01207440|101603663|FG004|Overall Study|Site Terminated by Sponsor|3|||
33467809|NCT01207440|101603664|FG005|Overall Study|Site Terminated by Sponsor|0|||
33467810|NCT01207440|101603665|FG006|Overall Study|Site Terminated by Sponsor|2|||
33467811|NCT01207440|101603659|FG000|Overall Study|Withdrawal by Subject|29|||
33467812|NCT01207440|101603660|FG001|Overall Study|Withdrawal by Subject|4|||
33467813|NCT01207440|101603661|FG002|Overall Study|Withdrawal by Subject|5|||
33467814|NCT01207440|101603662|FG003|Overall Study|Withdrawal by Subject|3|||
33179058|NCT02956486|100563832|FG001|Extension Phase|Not Treated|0|||
33179059|NCT02956486|100563833|FG002|Extension Phase|Not Treated|1|||
33264964|NCT02147093|100870254|FG000|Period 1|Lost to Follow-up|0|||
33467815|NCT01207440|101603663|FG004|Overall Study|Withdrawal by Subject|2|||
33467816|NCT01207440|101603664|FG005|Overall Study|Withdrawal by Subject|2|||
33264965|NCT02147093|100870255|FG001|Period 1|Lost to Follow-up|1|||
33264966|NCT02147093|100870254|FG000|Period 2|Protocol Violation|2|||
33264967|NCT02147093|100870255|FG001|Period 2|Protocol Violation|0|||
33264968|NCT00452452|100870256|FG000|Overall Study|Protocol Violation|0|||
33264969|NCT00452452|100870257|FG001|Overall Study|Protocol Violation|0|||
33264970|NCT00452452|100870258|FG002|Overall Study|Protocol Violation|1|||
33264971|NCT00452452|100870256|FG000|Overall Study|Withdrawal by Subject|1|||
33467817|NCT01207440|101603665|FG006|Overall Study|Withdrawal by Subject|0|||
33467818|NCT01207440|101603659|FG000|Overall Study|Reason Not Specified|10|||
33467819|NCT01207440|101603660|FG001|Overall Study|Reason Not Specified|10|||
33179060|NCT00664742|100563834|FG000|Overall Study|Withdrawn due to adverse events|3|||
33179061|NCT00664742|100563834|FG000|Overall Study|Withdrawal by Subject|31|||
33179062|NCT00664742|100563834|FG000|Overall Study|Lost to Follow-up|92|||
33179063|NCT04007523|100563836|FG000|Overall Study|Withdrawal by Subject|0|||
33179064|NCT04007523|100563837|FG001|Overall Study|Withdrawal by Subject|1|||
33179065|NCT04007523|100563838|FG002|Overall Study|Withdrawal by Subject|1|||
33179066|NCT04007523|100563839|FG003|Overall Study|Withdrawal by Subject|0|||
33179067|NCT04007523|100563836|FG000|Overall Study|ICU Transfer|0|||
33179068|NCT04007523|100563837|FG001|Overall Study|ICU Transfer|1|||
33179069|NCT04007523|100563838|FG002|Overall Study|ICU Transfer|0|||
33179070|NCT04007523|100563839|FG003|Overall Study|ICU Transfer|0|||
33179071|NCT04007523|100563836|FG000|Overall Study|COVID hospital closure|0|||
33179072|NCT04007523|100563837|FG001|Overall Study|COVID hospital closure|0|||
33179073|NCT04007523|100563838|FG002|Overall Study|COVID hospital closure|1|||
33179074|NCT04007523|100563839|FG003|Overall Study|COVID hospital closure|2|||
33179075|NCT04007523|100563836|FG000|Overall Study|Surgery cancelled|0|||
33179076|NCT04007523|100563837|FG001|Overall Study|Surgery cancelled|0|||
33179077|NCT04007523|100563838|FG002|Overall Study|Surgery cancelled|1|||
33179078|NCT04007523|100563839|FG003|Overall Study|Surgery cancelled|1|||
33179079|NCT02710045|100563840|FG000|Overall Study|Death|1|||
33179080|NCT02710045|100563841|FG001|Overall Study|Death|2|||
33179081|NCT02710045|100563842|FG002|Overall Study|Death|0|||
33179082|NCT02710045|100563840|FG000|Overall Study|Withdrawal by Subject|6|||
33179083|NCT02710045|100563841|FG001|Overall Study|Withdrawal by Subject|6|||
33179084|NCT02710045|100563842|FG002|Overall Study|Withdrawal by Subject|2|||
33179085|NCT02710045|100563840|FG000|Overall Study|Protocol Violation|1|||
33179086|NCT02710045|100563841|FG001|Overall Study|Protocol Violation|2|||
33179087|NCT02710045|100563842|FG002|Overall Study|Protocol Violation|3|||
33179088|NCT02710045|100563840|FG000|Overall Study|Lost to Follow-up|3|||
33179089|NCT02710045|100563841|FG001|Overall Study|Lost to Follow-up|6|||
33179090|NCT02710045|100563842|FG002|Overall Study|Lost to Follow-up|7|||
33179091|NCT02710045|100563840|FG000|Overall Study|Physician Decision|0|||
33179092|NCT02710045|100563841|FG001|Overall Study|Physician Decision|0|||
33179093|NCT02710045|100563842|FG002|Overall Study|Physician Decision|1|||
33179094|NCT02710045|100563840|FG000|Overall Study|Poor Attendance|0|||
33179095|NCT02710045|100563841|FG001|Overall Study|Poor Attendance|1|||
33179096|NCT02710045|100563842|FG002|Overall Study|Poor Attendance|0|||
33179097|NCT00309842|100563843|FG000|Overall Study|Lost to Follow-up|1|||
33179098|NCT03970733|100563844|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
33179099|NCT03970733|100563845|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
33179100|NCT03970733|100563846|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
33179101|NCT03970733|100563847|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
33179102|NCT03970733|100563848|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
33179103|NCT03970733|100563844|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
33179104|NCT03970733|100563845|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
33179105|NCT03970733|100563846|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
33179106|NCT03970733|100563847|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
33179107|NCT03970733|100563848|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
33179108|NCT03970733|100563844|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
33179109|NCT03970733|100563845|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
33179110|NCT03970733|100563846|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
33179111|NCT03970733|100563847|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
33179112|NCT03970733|100563848|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
33179113|NCT03970733|100563844|FG000|Main Study Phase (18 Months)|Other|1|||
33179114|NCT03970733|100563845|FG001|Main Study Phase (18 Months)|Other|1|||
33264972|NCT00452452|100870257|FG001|Overall Study|Withdrawal by Subject|0|||
33467820|NCT01207440|101603661|FG002|Overall Study|Reason Not Specified|7|||
33179115|NCT03970733|100563846|FG002|Main Study Phase (18 Months)|Other|0|||
33179116|NCT03970733|100563847|FG003|Main Study Phase (18 Months)|Other|0|||
33179117|NCT03970733|100563848|FG004|Main Study Phase (18 Months)|Other|0|||
33179118|NCT03970733|100563844|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
33179119|NCT03970733|100563845|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
33179120|NCT03970733|100563846|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
33264973|NCT00452452|100870258|FG002|Overall Study|Withdrawal by Subject|0|||
33264974|NCT00452452|100870256|FG000|Overall Study|Lost to Follow-up|1|||
33264975|NCT00452452|100870257|FG001|Overall Study|Lost to Follow-up|0|||
33264976|NCT00452452|100870258|FG002|Overall Study|Lost to Follow-up|0|||
33264977|NCT00273052|100870259|FG000|Overall Study|Withdrawal by Subject|16|||
33264978|NCT00273052|100870260|FG001|Overall Study|Withdrawal by Subject|19|||
33264979|NCT00273052|100870259|FG000|Overall Study|Adverse Event|21|||
33264980|NCT00273052|100870260|FG001|Overall Study|Adverse Event|19|||
33264981|NCT00273052|100870259|FG000|Overall Study|Protocol Violation|14|||
33264982|NCT00273052|100870260|FG001|Overall Study|Protocol Violation|18|||
33264983|NCT00273052|100870259|FG000|Overall Study|Lost to Follow-up|7|||
33264984|NCT00273052|100870260|FG001|Overall Study|Lost to Follow-up|25|||
33264985|NCT00273052|100870259|FG000|Overall Study|Lack of Efficacy|6|||
33264986|NCT00273052|100870260|FG001|Overall Study|Lack of Efficacy|4|||
33264987|NCT00273052|100870259|FG000|Overall Study|Non-Compliance|3|||
33264988|NCT00273052|100870260|FG001|Overall Study|Non-Compliance|1|||
33264989|NCT00273052|100870259|FG000|Overall Study|Other|2|||
33264990|NCT00273052|100870260|FG001|Overall Study|Other|0|||
33264991|NCT00273052|100870259|FG000|Overall Study|Worsening serum lipid levels|0|||
33264992|NCT00273052|100870260|FG001|Overall Study|Worsening serum lipid levels|2|||
33264993|NCT00734578|100870261|FG000|Overall Study|Adverse Event|4|||
33264994|NCT00734578|100870262|FG001|Overall Study|Adverse Event|6|||
33264995|NCT00734578|100870263|FG002|Overall Study|Adverse Event|1|||
33264996|NCT00734578|100870261|FG000|Overall Study|Protocol Violation|8|||
33264997|NCT00734578|100870262|FG001|Overall Study|Protocol Violation|6|||
33264998|NCT00734578|100870263|FG002|Overall Study|Protocol Violation|3|||
33264999|NCT00734578|100870261|FG000|Overall Study|Withdrawal by Subject|7|||
33265000|NCT00734578|100870262|FG001|Overall Study|Withdrawal by Subject|8|||
33265001|NCT00734578|100870263|FG002|Overall Study|Withdrawal by Subject|11|||
33265002|NCT00734578|100870261|FG000|Overall Study|Lost to Follow-up|9|||
33265003|NCT00734578|100870262|FG001|Overall Study|Lost to Follow-up|3|||
33265004|NCT00734578|100870263|FG002|Overall Study|Lost to Follow-up|5|||
33265005|NCT00734578|100870261|FG000|Overall Study|Lack of Efficacy|3|||
33265006|NCT00734578|100870262|FG001|Overall Study|Lack of Efficacy|2|||
33265007|NCT00734578|100870263|FG002|Overall Study|Lack of Efficacy|5|||
33265008|NCT00734578|100870261|FG000|Overall Study|Randomized in error|1|||
33265009|NCT00734578|100870262|FG001|Overall Study|Randomized in error|0|||
33265010|NCT00734578|100870263|FG002|Overall Study|Randomized in error|0|||
33265011|NCT00734578|100870261|FG000|Overall Study|Exclusion criteria|1|||
33265012|NCT00734578|100870262|FG001|Overall Study|Exclusion criteria|0|||
33265013|NCT00734578|100870263|FG002|Overall Study|Exclusion criteria|0|||
33265014|NCT03274076|100870266|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
33265015|NCT03274076|100870267|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
33265016|NCT03274076|100870268|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
33265017|NCT03274076|100870269|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
33265018|NCT03274076|100870266|FG000|24 Weeks Open Label|Adverse Event|0|||
33179121|NCT03970733|100563847|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
33179122|NCT03970733|100563848|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
33179123|NCT02039674|100563849|FG000|Overall Study|Adverse Event|0|||
33179124|NCT02039674|100563850|FG001|Overall Study|Adverse Event|0|||
33179125|NCT02039674|100563851|FG002|Overall Study|Adverse Event|0|||
33179126|NCT02039674|100563852|FG003|Overall Study|Adverse Event|1|||
33179127|NCT02039674|100563853|FG004|Overall Study|Adverse Event|0|||
33179128|NCT02039674|100563854|FG005|Overall Study|Adverse Event|0|||
33179129|NCT02039674|100563855|FG006|Overall Study|Adverse Event|0|||
33179130|NCT02039674|100563856|FG007|Overall Study|Adverse Event|0|||
33179131|NCT02039674|100563857|FG008|Overall Study|Adverse Event|2|||
33179132|NCT02039674|100563858|FG009|Overall Study|Adverse Event|1|||
33179133|NCT02039674|100563859|FG010|Overall Study|Adverse Event|0|||
33179134|NCT02039674|100563860|FG011|Overall Study|Adverse Event|2|||
33179135|NCT02039674|100563861|FG012|Overall Study|Adverse Event|3|||
33179136|NCT02039674|100563862|FG013|Overall Study|Adverse Event|1|||
33179137|NCT02039674|100563849|FG000|Overall Study|Death|2|||
33179138|NCT02039674|100563850|FG001|Overall Study|Death|0|||
33179139|NCT02039674|100563851|FG002|Overall Study|Death|2|||
33179140|NCT02039674|100563852|FG003|Overall Study|Death|3|||
33179141|NCT02039674|100563853|FG004|Overall Study|Death|0|||
33179142|NCT02039674|100563854|FG005|Overall Study|Death|0|||
33179143|NCT02039674|100563855|FG006|Overall Study|Death|1|||
33179144|NCT02039674|100563856|FG007|Overall Study|Death|0|||
33179145|NCT02039674|100563857|FG008|Overall Study|Death|2|||
33179146|NCT02039674|100563858|FG009|Overall Study|Death|0|||
33179147|NCT02039674|100563859|FG010|Overall Study|Death|1|||
33265019|NCT03274076|100870267|FG001|24 Weeks Open Label|Adverse Event|0|||
33265020|NCT03274076|100870268|FG002|24 Weeks Open Label|Adverse Event|2|||
33265021|NCT03274076|100870269|FG003|24 Weeks Open Label|Adverse Event|0|||
33467821|NCT01207440|101603662|FG003|Overall Study|Reason Not Specified|0|||
33467822|NCT01207440|101603663|FG004|Overall Study|Reason Not Specified|4|||
33467823|NCT01207440|101603664|FG005|Overall Study|Reason Not Specified|3|||
33179148|NCT02039674|100563860|FG011|Overall Study|Death|3|||
33265022|NCT03274076|100870266|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
33265023|NCT03274076|100870267|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
33265024|NCT03274076|100870268|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
33265025|NCT03274076|100870269|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
33265026|NCT01972776|100870273|FG000|Part 1|Withdrawal by Subject|0|||
33265027|NCT01972776|100870274|FG001|Part 1|Withdrawal by Subject|0|||
33265028|NCT01972776|100870275|FG002|Part 1|Withdrawal by Subject|1|||
33265029|NCT01972776|100870276|FG003|Part 1|Withdrawal by Subject|0|||
33265030|NCT01972776|100870277|FG004|Part 1|Withdrawal by Subject|0|||
33265031|NCT01972776|100870278|FG005|Part 1|Withdrawal by Subject|0|||
33265032|NCT01972776|100870273|FG000|Part 1|Adverse Event|0|||
33265033|NCT01972776|100870274|FG001|Part 1|Adverse Event|0|||
33265034|NCT01972776|100870275|FG002|Part 1|Adverse Event|1|||
33467824|NCT01207440|101603665|FG006|Overall Study|Reason Not Specified|0|||
33467825|NCT04349631|101603666|FG000|Overall Study|Lost to Follow-up|3|||
33467826|NCT04349631|101603666|FG000|Overall Study|Withdrawal by Subject|7|||
33467827|NCT01807117|101603667|FG000|Overall Study|Physician Decision|2|||
33467828|NCT01807117|101603667|FG000|Overall Study|Disease diagnosis not a study disease|1|||
33467829|NCT00456495|101603668|FG000|Overall Study|Physician Decision|2|||
33467830|NCT01875471|101603674|FG000|Overall Study|Adverse Event|0|||
33467831|NCT01875471|101603675|FG001|Overall Study|Adverse Event|1|||
33467832|NCT01875471|101603674|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
33467833|NCT01875471|101603675|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
33467834|NCT04798482|101603676|FG000|Overall Study|Physician Decision|1|||
33467835|NCT04798482|101603676|FG000|Overall Study|Lost eligibility|1|||
33467836|NCT01042535|101603677|FG000|Overall Study|disease progression prior to treatment|3|||
33467837|NCT01042535|101603677|FG000|Overall Study|disease progression during treatment|3|||
33467838|NCT01042535|101603677|FG000|Overall Study|complications from other disease|2|||
33467839|NCT00484419|101603681|FG000|Overall Study|Adverse Event|3|||
33467840|NCT00484419|101603682|FG001|Overall Study|Adverse Event|0|||
33467841|NCT00484419|101603683|FG002|Overall Study|Adverse Event|0|||
33467842|NCT00484419|101603681|FG000|Overall Study|Lost to Follow-up|1|||
33467843|NCT00484419|101603682|FG001|Overall Study|Lost to Follow-up|0|||
33467844|NCT00484419|101603683|FG002|Overall Study|Lost to Follow-up|2|||
33467845|NCT00484419|101603681|FG000|Overall Study|Withdrawal by Subject|3|||
33467846|NCT00484419|101603682|FG001|Overall Study|Withdrawal by Subject|1|||
33467847|NCT00484419|101603683|FG002|Overall Study|Withdrawal by Subject|1|||
33467848|NCT00484419|101603681|FG000|Overall Study|subject met discontinuation criteria|2|||
33467849|NCT00484419|101603682|FG001|Overall Study|subject met discontinuation criteria|2|||
33467850|NCT00484419|101603683|FG002|Overall Study|subject met discontinuation criteria|4|||
33467851|NCT00484419|101603681|FG000|Overall Study|required restricted medication|1|||
33467852|NCT00484419|101603682|FG001|Overall Study|required restricted medication|0|||
33467853|NCT00484419|101603683|FG002|Overall Study|required restricted medication|1|||
33467854|NCT00484419|101603681|FG000|Overall Study|Physician Decision|1|||
33467855|NCT00484419|101603682|FG001|Overall Study|Physician Decision|1|||
33467856|NCT00484419|101603683|FG002|Overall Study|Physician Decision|1|||
33467857|NCT00484419|101603681|FG000|Overall Study|subject unable to receive medication|1|||
33467858|NCT00484419|101603682|FG001|Overall Study|subject unable to receive medication|0|||
33467859|NCT00484419|101603683|FG002|Overall Study|subject unable to receive medication|0|||
33467860|NCT00484419|101603681|FG000|Overall Study|subject relocated|0|||
33467861|NCT00484419|101603682|FG001|Overall Study|subject relocated|1|||
33467862|NCT00484419|101603683|FG002|Overall Study|subject relocated|0|||
33467863|NCT00484419|101603681|FG000|Overall Study|sponsor decision, randomized in error|0|||
33467864|NCT00484419|101603682|FG001|Overall Study|sponsor decision, randomized in error|0|||
33179149|NCT02039674|100563861|FG012|Overall Study|Death|2|||
33179150|NCT02039674|100563862|FG013|Overall Study|Death|8|||
33179151|NCT02039674|100563849|FG000|Overall Study|Excluded Medication|1|||
33179152|NCT02039674|100563850|FG001|Overall Study|Excluded Medication|1|||
33179153|NCT02039674|100563851|FG002|Overall Study|Excluded Medication|0|||
33179154|NCT02039674|100563852|FG003|Overall Study|Excluded Medication|1|||
33179155|NCT02039674|100563853|FG004|Overall Study|Excluded Medication|0|||
33179156|NCT02039674|100563854|FG005|Overall Study|Excluded Medication|1|||
33179157|NCT02039674|100563855|FG006|Overall Study|Excluded Medication|0|||
33179158|NCT02039674|100563856|FG007|Overall Study|Excluded Medication|0|||
33179159|NCT02039674|100563857|FG008|Overall Study|Excluded Medication|2|||
33179160|NCT02039674|100563858|FG009|Overall Study|Excluded Medication|3|||
33179161|NCT02039674|100563859|FG010|Overall Study|Excluded Medication|5|||
33179162|NCT02039674|100563860|FG011|Overall Study|Excluded Medication|6|||
33179163|NCT02039674|100563861|FG012|Overall Study|Excluded Medication|8|||
33265035|NCT01972776|100870276|FG003|Part 1|Adverse Event|1|||
33265036|NCT01972776|100870277|FG004|Part 1|Adverse Event|0|||
33467865|NCT00484419|101603683|FG002|Overall Study|sponsor decision, randomized in error|2|||
33467866|NCT02938520|101603688|FG000|Overall Study|On-going at the time of analysis|258|||
33467867|NCT02938520|101603689|FG001|Overall Study|On-going at the time of analysis|261|||
33467868|NCT02938520|101603688|FG000|Overall Study|Physician Decision|2|||
33467869|NCT02938520|101603689|FG001|Overall Study|Physician Decision|5|||
33467870|NCT02938520|101603688|FG000|Overall Study|Lost to Follow-up|2|||
33467871|NCT02938520|101603689|FG001|Overall Study|Lost to Follow-up|2|||
33467872|NCT02938520|101603688|FG000|Overall Study|Withdrawal by Subject|7|||
33467873|NCT02938520|101603689|FG001|Overall Study|Withdrawal by Subject|7|||
33467874|NCT02938520|101603688|FG000|Overall Study|Protocol Violation|0|||
33467875|NCT02938520|101603689|FG001|Overall Study|Protocol Violation|1|||
33467876|NCT02938520|101603688|FG000|Overall Study|Lack of Efficacy|5|||
33467877|NCT02938520|101603689|FG001|Overall Study|Lack of Efficacy|3|||
33467878|NCT02938520|101603688|FG000|Overall Study|Adverse Event|9|||
33467879|NCT02938520|101603689|FG001|Overall Study|Adverse Event|4|||
33467880|NCT01201759|101603690|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
33467881|NCT01201759|101603691|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
33467882|NCT01201759|101603690|FG000|Visit 3 - Washout|Adverse Event|0|||
33467883|NCT01201759|101603691|FG001|Visit 3 - Washout|Adverse Event|3|||
33467884|NCT01201759|101603690|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
33467885|NCT01201759|101603691|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
33467886|NCT01201759|101603690|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
33467887|NCT01201759|101603691|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
33179164|NCT02039674|100563862|FG013|Overall Study|Excluded Medication|3|||
33179165|NCT02039674|100563849|FG000|Overall Study|Lost to Follow-up|0|||
33179166|NCT02039674|100563850|FG001|Overall Study|Lost to Follow-up|0|||
33179167|NCT02039674|100563851|FG002|Overall Study|Lost to Follow-up|0|||
33179168|NCT02039674|100563852|FG003|Overall Study|Lost to Follow-up|0|||
33179169|NCT02039674|100563853|FG004|Overall Study|Lost to Follow-up|1|||
33179170|NCT02039674|100563854|FG005|Overall Study|Lost to Follow-up|1|||
33179171|NCT02039674|100563855|FG006|Overall Study|Lost to Follow-up|0|||
33179172|NCT02039674|100563856|FG007|Overall Study|Lost to Follow-up|0|||
33179173|NCT02039674|100563857|FG008|Overall Study|Lost to Follow-up|0|||
33179174|NCT02039674|100563858|FG009|Overall Study|Lost to Follow-up|0|||
33179175|NCT02039674|100563859|FG010|Overall Study|Lost to Follow-up|0|||
33179176|NCT02039674|100563860|FG011|Overall Study|Lost to Follow-up|2|||
33179177|NCT02039674|100563861|FG012|Overall Study|Lost to Follow-up|2|||
33179178|NCT02039674|100563862|FG013|Overall Study|Lost to Follow-up|1|||
33179179|NCT02039674|100563849|FG000|Overall Study|Physician Decision|0|||
33179180|NCT02039674|100563850|FG001|Overall Study|Physician Decision|0|||
33179181|NCT02039674|100563851|FG002|Overall Study|Physician Decision|0|||
33179182|NCT02039674|100563852|FG003|Overall Study|Physician Decision|0|||
33179183|NCT02039674|100563853|FG004|Overall Study|Physician Decision|0|||
33179184|NCT02039674|100563854|FG005|Overall Study|Physician Decision|0|||
33179185|NCT02039674|100563855|FG006|Overall Study|Physician Decision|0|||
33179186|NCT02039674|100563856|FG007|Overall Study|Physician Decision|0|||
33179187|NCT02039674|100563857|FG008|Overall Study|Physician Decision|0|||
33179188|NCT02039674|100563858|FG009|Overall Study|Physician Decision|0|||
33179189|NCT02039674|100563859|FG010|Overall Study|Physician Decision|0|||
33179190|NCT02039674|100563860|FG011|Overall Study|Physician Decision|1|||
33179191|NCT02039674|100563861|FG012|Overall Study|Physician Decision|1|||
33179192|NCT02039674|100563862|FG013|Overall Study|Physician Decision|0|||
33179193|NCT02039674|100563849|FG000|Overall Study|Progressive Disease|8|||
33179194|NCT02039674|100563850|FG001|Overall Study|Progressive Disease|8|||
33179195|NCT02039674|100563851|FG002|Overall Study|Progressive Disease|6|||
33179196|NCT02039674|100563852|FG003|Overall Study|Progressive Disease|7|||
33179197|NCT02039674|100563853|FG004|Overall Study|Progressive Disease|9|||
33179198|NCT02039674|100563854|FG005|Overall Study|Progressive Disease|10|||
33179199|NCT02039674|100563855|FG006|Overall Study|Progressive Disease|1|||
33179200|NCT02039674|100563856|FG007|Overall Study|Progressive Disease|3|||
33179201|NCT02039674|100563857|FG008|Overall Study|Progressive Disease|6|||
33179202|NCT02039674|100563858|FG009|Overall Study|Progressive Disease|4|||
33179203|NCT02039674|100563859|FG010|Overall Study|Progressive Disease|0|||
33179204|NCT02039674|100563860|FG011|Overall Study|Progressive Disease|34|||
33179205|NCT02039674|100563861|FG012|Overall Study|Progressive Disease|34|||
33179206|NCT02039674|100563862|FG013|Overall Study|Progressive Disease|18|||
33179207|NCT02039674|100563849|FG000|Overall Study|Withdrawal by Subject|1|||
33467888|NCT03336242|101603694|FG000|Overall Study|Adverse Event|0|||
33179208|NCT02039674|100563850|FG001|Overall Study|Withdrawal by Subject|2|||
33179209|NCT02039674|100563851|FG002|Overall Study|Withdrawal by Subject|3|||
33179210|NCT02039674|100563852|FG003|Overall Study|Withdrawal by Subject|0|||
33179211|NCT02039674|100563853|FG004|Overall Study|Withdrawal by Subject|1|||
33179212|NCT02039674|100563854|FG005|Overall Study|Withdrawal by Subject|0|||
33179213|NCT02039674|100563855|FG006|Overall Study|Withdrawal by Subject|0|||
33179214|NCT02039674|100563856|FG007|Overall Study|Withdrawal by Subject|0|||
33179215|NCT02039674|100563857|FG008|Overall Study|Withdrawal by Subject|0|||
33179216|NCT02039674|100563858|FG009|Overall Study|Withdrawal by Subject|1|||
33179217|NCT02039674|100563859|FG010|Overall Study|Withdrawal by Subject|1|||
33179218|NCT02039674|100563860|FG011|Overall Study|Withdrawal by Subject|4|||
33179219|NCT02039674|100563861|FG012|Overall Study|Withdrawal by Subject|6|||
33467889|NCT03336242|101603695|FG001|Overall Study|Adverse Event|1|||
33179220|NCT02039674|100563862|FG013|Overall Study|Withdrawal by Subject|2|||
33179221|NCT02039674|100563849|FG000|Overall Study|Clinical Progression|0|||
33179222|NCT02039674|100563850|FG001|Overall Study|Clinical Progression|0|||
33179223|NCT02039674|100563851|FG002|Overall Study|Clinical Progression|0|||
33467890|NCT01949116|101603696|FG000|Overall Study|Death|2|||
33467891|NCT01949116|101603697|FG001|Overall Study|Death|0|||
33265037|NCT01972776|100870278|FG005|Part 1|Adverse Event|0|||
33265038|NCT01972776|100870273|FG000|Part 2|Adverse Event|0|||
33265039|NCT01972776|100870274|FG001|Part 2|Adverse Event|0|||
33265040|NCT01972776|100870275|FG002|Part 2|Adverse Event|0|||
33265041|NCT01972776|100870276|FG003|Part 2|Adverse Event|0|||
33265042|NCT01972776|100870277|FG004|Part 2|Adverse Event|3|||
33265043|NCT01972776|100870278|FG005|Part 2|Adverse Event|0|||
33265044|NCT01972776|100870273|FG000|Part 2|Administrative problems|0|||
33265045|NCT01972776|100870274|FG001|Part 2|Administrative problems|0|||
33265046|NCT01972776|100870275|FG002|Part 2|Administrative problems|0|||
33265047|NCT01972776|100870276|FG003|Part 2|Administrative problems|0|||
33265048|NCT01972776|100870277|FG004|Part 2|Administrative problems|10|||
33265049|NCT01972776|100870278|FG005|Part 2|Administrative problems|7|||
33265050|NCT01640951|100870283|FG000|Overall Study|Adverse Event|8|||
33265051|NCT01640951|100870284|FG001|Overall Study|Adverse Event|3|||
33265052|NCT01640951|100870285|FG002|Overall Study|Adverse Event|10|||
33265053|NCT01640951|100870286|FG003|Overall Study|Adverse Event|6|||
33265054|NCT01640951|100870287|FG004|Overall Study|Adverse Event|1|||
33265055|NCT01640951|100870288|FG005|Overall Study|Adverse Event|11|||
33265056|NCT01640951|100870289|FG006|Overall Study|Adverse Event|1|||
33265057|NCT01640951|100870290|FG007|Overall Study|Adverse Event|3|||
33265058|NCT01640951|100870283|FG000|Overall Study|Lack of Efficacy|20|||
33265059|NCT01640951|100870284|FG001|Overall Study|Lack of Efficacy|1|||
33265060|NCT01640951|100870285|FG002|Overall Study|Lack of Efficacy|7|||
33265061|NCT01640951|100870286|FG003|Overall Study|Lack of Efficacy|14|||
33265062|NCT01640951|100870287|FG004|Overall Study|Lack of Efficacy|0|||
33265063|NCT01640951|100870288|FG005|Overall Study|Lack of Efficacy|6|||
33265064|NCT01640951|100870289|FG006|Overall Study|Lack of Efficacy|5|||
33265065|NCT01640951|100870290|FG007|Overall Study|Lack of Efficacy|6|||
33265066|NCT01640951|100870283|FG000|Overall Study|Lost to Follow-up|1|||
33265067|NCT01640951|100870284|FG001|Overall Study|Lost to Follow-up|0|||
33265068|NCT01640951|100870285|FG002|Overall Study|Lost to Follow-up|6|||
33265069|NCT01640951|100870286|FG003|Overall Study|Lost to Follow-up|2|||
33467892|NCT01949116|101603696|FG000|Overall Study|Lost to Follow-up|1|||
33467893|NCT01949116|101603697|FG001|Overall Study|Lost to Follow-up|3|||
33467894|NCT01949116|101603696|FG000|Overall Study|Withdrawal by Subject|5|||
33467895|NCT01949116|101603697|FG001|Overall Study|Withdrawal by Subject|3|||
33467896|NCT02340221|101603700|FG000|Overall Study|Death|100|||
33467897|NCT02340221|101603701|FG001|Overall Study|Death|197|||
33467898|NCT02340221|101603700|FG000|Overall Study|Withdrawal by Participant|24|||
33467899|NCT02340221|101603701|FG001|Overall Study|Withdrawal by Participant|37|||
33467900|NCT02340221|101603700|FG000|Overall Study|Lost to Follow-up|4|||
33467901|NCT02340221|101603701|FG001|Overall Study|Lost to Follow-up|15|||
33467902|NCT02340221|101603700|FG000|Overall Study|Reason Not Specified|85|||
33179224|NCT02039674|100563852|FG003|Overall Study|Clinical Progression|0|||
33179225|NCT02039674|100563853|FG004|Overall Study|Clinical Progression|0|||
33179226|NCT02039674|100563854|FG005|Overall Study|Clinical Progression|0|||
33179227|NCT02039674|100563855|FG006|Overall Study|Clinical Progression|1|||
33179228|NCT02039674|100563856|FG007|Overall Study|Clinical Progression|0|||
33179229|NCT02039674|100563857|FG008|Overall Study|Clinical Progression|0|||
33179230|NCT02039674|100563858|FG009|Overall Study|Clinical Progression|0|||
33179231|NCT02039674|100563859|FG010|Overall Study|Clinical Progression|0|||
33179232|NCT02039674|100563860|FG011|Overall Study|Clinical Progression|0|||
33179233|NCT02039674|100563861|FG012|Overall Study|Clinical Progression|1|||
33179234|NCT02039674|100563862|FG013|Overall Study|Clinical Progression|0|||
33179235|NCT02039674|100563849|FG000|Overall Study|Sponsor Decision|1|||
33179236|NCT02039674|100563850|FG001|Overall Study|Sponsor Decision|1|||
33179237|NCT02039674|100563851|FG002|Overall Study|Sponsor Decision|1|||
33179238|NCT02039674|100563852|FG003|Overall Study|Sponsor Decision|1|||
33179239|NCT02039674|100563853|FG004|Overall Study|Sponsor Decision|1|||
33179240|NCT02039674|100563854|FG005|Overall Study|Sponsor Decision|0|||
33179241|NCT02039674|100563855|FG006|Overall Study|Sponsor Decision|0|||
33179242|NCT02039674|100563856|FG007|Overall Study|Sponsor Decision|0|||
33179243|NCT02039674|100563857|FG008|Overall Study|Sponsor Decision|0|||
33179244|NCT02039674|100563858|FG009|Overall Study|Sponsor Decision|3|||
33179245|NCT02039674|100563859|FG010|Overall Study|Sponsor Decision|0|||
33179246|NCT02039674|100563860|FG011|Overall Study|Sponsor Decision|8|||
33179247|NCT02039674|100563861|FG012|Overall Study|Sponsor Decision|5|||
33179248|NCT02039674|100563862|FG013|Overall Study|Sponsor Decision|0|||
33179249|NCT02039674|100563849|FG000|Overall Study|Other|0|||
33467903|NCT02340221|101603701|FG001|Overall Study|Reason Not Specified|165|||
33467904|NCT02340221|101603700|FG000|Overall Study|Study Terminated by Sponsor|1|||
33467905|NCT02340221|101603701|FG001|Overall Study|Study Terminated by Sponsor|3|||
33179250|NCT02039674|100563850|FG001|Overall Study|Other|0|||
33179251|NCT02039674|100563851|FG002|Overall Study|Other|0|||
33265070|NCT01640951|100870287|FG004|Overall Study|Lost to Follow-up|2|||
33265071|NCT01640951|100870288|FG005|Overall Study|Lost to Follow-up|3|||
33265072|NCT01640951|100870289|FG006|Overall Study|Lost to Follow-up|1|||
33265073|NCT01640951|100870290|FG007|Overall Study|Lost to Follow-up|1|||
33265074|NCT01640951|100870283|FG000|Overall Study|Non-compliance with study treatment|0|||
33265075|NCT01640951|100870284|FG001|Overall Study|Non-compliance with study treatment|0|||
33265076|NCT01640951|100870285|FG002|Overall Study|Non-compliance with study treatment|1|||
33265077|NCT01640951|100870286|FG003|Overall Study|Non-compliance with study treatment|1|||
33265078|NCT01640951|100870287|FG004|Overall Study|Non-compliance with study treatment|1|||
33265079|NCT01640951|100870288|FG005|Overall Study|Non-compliance with study treatment|4|||
33265080|NCT01640951|100870289|FG006|Overall Study|Non-compliance with study treatment|1|||
33265081|NCT01640951|100870290|FG007|Overall Study|Non-compliance with study treatment|0|||
33265082|NCT01640951|100870283|FG000|Overall Study|Physician Decision|2|||
33265083|NCT01640951|100870284|FG001|Overall Study|Physician Decision|5|||
33265084|NCT01640951|100870285|FG002|Overall Study|Physician Decision|2|||
33265085|NCT01640951|100870286|FG003|Overall Study|Physician Decision|2|||
33265086|NCT01640951|100870287|FG004|Overall Study|Physician Decision|2|||
33265087|NCT01640951|100870288|FG005|Overall Study|Physician Decision|3|||
33265088|NCT01640951|100870289|FG006|Overall Study|Physician Decision|3|||
33265089|NCT01640951|100870290|FG007|Overall Study|Physician Decision|0|||
33265090|NCT01640951|100870283|FG000|Overall Study|Pregnancy|3|||
33265091|NCT01640951|100870284|FG001|Overall Study|Pregnancy|0|||
33265092|NCT01640951|100870285|FG002|Overall Study|Pregnancy|0|||
33265093|NCT01640951|100870286|FG003|Overall Study|Pregnancy|4|||
33265094|NCT01640951|100870287|FG004|Overall Study|Pregnancy|0|||
33265095|NCT01640951|100870288|FG005|Overall Study|Pregnancy|0|||
33265096|NCT01640951|100870289|FG006|Overall Study|Pregnancy|2|||
33265097|NCT01640951|100870290|FG007|Overall Study|Pregnancy|0|||
33265098|NCT01640951|100870283|FG000|Overall Study|Protocol Deviation|0|||
33265099|NCT01640951|100870284|FG001|Overall Study|Protocol Deviation|1|||
33265100|NCT01640951|100870285|FG002|Overall Study|Protocol Deviation|2|||
33265101|NCT01640951|100870286|FG003|Overall Study|Protocol Deviation|1|||
33265102|NCT01640951|100870287|FG004|Overall Study|Protocol Deviation|0|||
33265103|NCT01640951|100870288|FG005|Overall Study|Protocol Deviation|1|||
33265104|NCT01640951|100870289|FG006|Overall Study|Protocol Deviation|0|||
33265105|NCT01640951|100870290|FG007|Overall Study|Protocol Deviation|0|||
33265106|NCT01640951|100870283|FG000|Overall Study|Subject/Guardian decision|12|||
33265107|NCT01640951|100870284|FG001|Overall Study|Subject/Guardian decision|4|||
33265108|NCT01640951|100870285|FG002|Overall Study|Subject/Guardian decision|13|||
33265109|NCT01640951|100870286|FG003|Overall Study|Subject/Guardian decision|15|||
33265110|NCT01640951|100870287|FG004|Overall Study|Subject/Guardian decision|7|||
33265111|NCT01640951|100870288|FG005|Overall Study|Subject/Guardian decision|19|||
33265112|NCT01640951|100870289|FG006|Overall Study|Subject/Guardian decision|5|||
33265113|NCT01640951|100870290|FG007|Overall Study|Subject/Guardian decision|4|||
33265114|NCT01640951|100870283|FG000|Overall Study|Death|0|||
33265115|NCT01640951|100870284|FG001|Overall Study|Death|1|||
33265116|NCT01640951|100870285|FG002|Overall Study|Death|1|||
33265117|NCT01640951|100870286|FG003|Overall Study|Death|0|||
33265118|NCT01640951|100870287|FG004|Overall Study|Death|0|||
33265119|NCT01640951|100870288|FG005|Overall Study|Death|0|||
33265120|NCT01640951|100870289|FG006|Overall Study|Death|0|||
33265121|NCT01640951|100870290|FG007|Overall Study|Death|2|||
33265122|NCT04492475|100870291|FG000|Overall Study|Enrolled but not treated|8|||
33265123|NCT04492475|100870292|FG001|Overall Study|Enrolled but not treated|8|||
33265124|NCT04492475|100870291|FG000|Overall Study|Withdrawal by Subject|4|||
33265125|NCT04492475|100870292|FG001|Overall Study|Withdrawal by Subject|0|||
33265126|NCT04492475|100870291|FG000|Overall Study|Became ineligible after enrollment|2|||
33265127|NCT04492475|100870292|FG001|Overall Study|Became ineligible after enrollment|0|||
33265128|NCT02180724|100870293|FG000|Overall Study|Death|26|||
33265129|NCT02180724|100870294|FG001|Overall Study|Death|1|||
33265130|NCT02180724|100870293|FG000|Overall Study|Lost to Follow-up|3|||
33265131|NCT02180724|100870294|FG001|Overall Study|Lost to Follow-up|1|||
33265132|NCT02180724|100870293|FG000|Overall Study|Withdrawal by Subject|4|||
33265133|NCT02180724|100870294|FG001|Overall Study|Withdrawal by Subject|2|||
33265134|NCT02180724|100870293|FG000|Overall Study|PI Decision|5|||
33265135|NCT02180724|100870294|FG001|Overall Study|PI Decision|2|||
33265136|NCT02180724|100870293|FG000|Overall Study|Study terminated by sponsor|54|||
33265137|NCT02180724|100870294|FG001|Overall Study|Study terminated by sponsor|8|||
33265138|NCT02824198|100870297|FG000|Overall Study|Non-compliance with the protocol|5|||
33265139|NCT02824198|100870298|FG001|Overall Study|Non-compliance with the protocol|1|||
33265140|NCT02824198|100870297|FG000|Overall Study|Lost to Follow-up|5|||
33265141|NCT02824198|100870298|FG001|Overall Study|Lost to Follow-up|2|||
33265142|NCT02824198|100870297|FG000|Overall Study|Withdrawal by Subject|5|||
33265143|NCT02824198|100870298|FG001|Overall Study|Withdrawal by Subject|0|||
33265144|NCT02404441|100870299|FG000|Phase 1 Part|Adverse Event|1|||
33265145|NCT02404441|100870300|FG001|Phase 1 Part|Adverse Event|0|||
33265146|NCT02404441|100870301|FG002|Phase 1 Part|Adverse Event|0|||
33265147|NCT02404441|100870302|FG003|Phase 1 Part|Adverse Event|0|||
33265148|NCT02404441|100870303|FG004|Phase 1 Part|Adverse Event|0|||
33265149|NCT02404441|100870304|FG005|Phase 1 Part|Adverse Event|0|||
33265150|NCT02404441|100870305|FG006|Phase 1 Part|Adverse Event|0|||
33265151|NCT02404441|100870306|FG007|Phase 1 Part|Adverse Event|0|||
33265152|NCT02404441|100870307|FG008|Phase 1 Part|Adverse Event|0|||
33265153|NCT02404441|100870308|FG009|Phase 1 Part|Adverse Event|0|||
33265154|NCT02404441|100870299|FG000|Phase 1 Part|Physician Decision|0|||
33265155|NCT02404441|100870300|FG001|Phase 1 Part|Physician Decision|1|||
33265156|NCT02404441|100870301|FG002|Phase 1 Part|Physician Decision|0|||
33265157|NCT02404441|100870302|FG003|Phase 1 Part|Physician Decision|0|||
33265158|NCT02404441|100870303|FG004|Phase 1 Part|Physician Decision|0|||
33265159|NCT02404441|100870304|FG005|Phase 1 Part|Physician Decision|0|||
33265160|NCT02404441|100870305|FG006|Phase 1 Part|Physician Decision|0|||
33265161|NCT02404441|100870306|FG007|Phase 1 Part|Physician Decision|0|||
33265162|NCT02404441|100870307|FG008|Phase 1 Part|Physician Decision|0|||
33265163|NCT02404441|100870308|FG009|Phase 1 Part|Physician Decision|0|||
33265164|NCT02404441|100870299|FG000|Phase 1 Part|Progressive Disease|14|||
33265165|NCT02404441|100870300|FG001|Phase 1 Part|Progressive Disease|11|||
33265166|NCT02404441|100870301|FG002|Phase 1 Part|Progressive Disease|7|||
33265167|NCT02404441|100870302|FG003|Phase 1 Part|Progressive Disease|6|||
33265168|NCT02404441|100870303|FG004|Phase 1 Part|Progressive Disease|9|||
33265169|NCT02404441|100870304|FG005|Phase 1 Part|Progressive Disease|0|||
33265170|NCT02404441|100870305|FG006|Phase 1 Part|Progressive Disease|0|||
33265171|NCT02404441|100870306|FG007|Phase 1 Part|Progressive Disease|0|||
33265172|NCT02404441|100870307|FG008|Phase 1 Part|Progressive Disease|0|||
33265173|NCT02404441|100870308|FG009|Phase 1 Part|Progressive Disease|0|||
33265174|NCT02404441|100870299|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
33265175|NCT02404441|100870300|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
33265176|NCT02404441|100870301|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
33265177|NCT02404441|100870302|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
33265178|NCT02404441|100870303|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
33265179|NCT02404441|100870304|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
33265180|NCT02404441|100870305|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
33265181|NCT02404441|100870306|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
33265182|NCT02404441|100870307|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
33265183|NCT02404441|100870308|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
33265184|NCT02404441|100870299|FG000|Phase 1 Part|Death|1|||
33265185|NCT02404441|100870300|FG001|Phase 1 Part|Death|1|||
33265186|NCT02404441|100870301|FG002|Phase 1 Part|Death|1|||
33467906|NCT03438539|101603702|FG000|Overall Study|Lost to Follow-up|8|||
33467907|NCT03438539|101603703|FG001|Overall Study|Lost to Follow-up|4|||
33467908|NCT03438539|101603704|FG002|Overall Study|Lost to Follow-up|10|||
33467909|NCT03438539|101603705|FG003|Overall Study|Lost to Follow-up|9|||
33467910|NCT03438539|101603706|FG004|Overall Study|Lost to Follow-up|3|||
33467911|NCT03438539|101603707|FG005|Overall Study|Lost to Follow-up|8|||
33467912|NCT02458092|101603710|FG000|Overall Study|Withdrawal by Subject|1|||
33467913|NCT02458092|101603711|FG001|Overall Study|Withdrawal by Subject|0|||
33467914|NCT02985879|101603712|FG000|Overall Study|Adverse Event|7|||
33467915|NCT02985879|101603713|FG001|Overall Study|Adverse Event|9|||
33467916|NCT02985879|101603714|FG002|Overall Study|Adverse Event|7|||
33467917|NCT02985879|101603712|FG000|Overall Study|Withdrew consent|6|||
33467918|NCT02985879|101603713|FG001|Overall Study|Withdrew consent|8|||
33467919|NCT02985879|101603714|FG002|Overall Study|Withdrew consent|10|||
33467920|NCT02985879|101603712|FG000|Overall Study|Lost to Follow-up|1|||
33467921|NCT02985879|101603713|FG001|Overall Study|Lost to Follow-up|0|||
33467922|NCT02985879|101603714|FG002|Overall Study|Lost to Follow-up|2|||
33467923|NCT02985879|101603712|FG000|Overall Study|Other, not specified|62|||
33467924|NCT02985879|101603713|FG001|Overall Study|Other, not specified|58|||
33467925|NCT02985879|101603714|FG002|Overall Study|Other, not specified|58|||
33467926|NCT03330236|101603717|FG000|Overall Study|Death|2|||
33467927|NCT03330236|101603718|FG001|Overall Study|Death|1|||
33467928|NCT03330236|101603717|FG000|Overall Study|Withdrawal by Subject|2|||
33467929|NCT03330236|101603718|FG001|Overall Study|Withdrawal by Subject|4|||
33467930|NCT03330236|101603717|FG000|Overall Study|Lost to Follow-up|0|||
33467931|NCT03330236|101603718|FG001|Overall Study|Lost to Follow-up|2|||
33467932|NCT03330236|101603717|FG000|Overall Study|Physician Decision|2|||
33467933|NCT03330236|101603718|FG001|Overall Study|Physician Decision|0|||
33467934|NCT03330236|101603717|FG000|Overall Study|Protocol Violation|4|||
33467935|NCT03330236|101603718|FG001|Overall Study|Protocol Violation|3|||
33265187|NCT02404441|100870302|FG003|Phase 1 Part|Death|0|||
33265188|NCT02404441|100870303|FG004|Phase 1 Part|Death|1|||
33265189|NCT02404441|100870304|FG005|Phase 1 Part|Death|0|||
33467936|NCT03330236|101603717|FG000|Overall Study|SedLine malfunction/blinding|19|||
33467937|NCT03330236|101603718|FG001|Overall Study|SedLine malfunction/blinding|14|||
33467938|NCT03330236|101603717|FG000|Overall Study|Volatile anesthetics used|11|||
33467939|NCT03330236|101603718|FG001|Overall Study|Volatile anesthetics used|8|||
33467940|NCT03330236|101603717|FG000|Overall Study|Surgery aborted/converted to open|60|||
33467941|NCT03330236|101603718|FG001|Overall Study|Surgery aborted/converted to open|52|||
33467942|NCT01640873|101603725|FG000|Overall Study|Protocol Violation|2|||
33467943|NCT01640873|101603726|FG001|Overall Study|Protocol Violation|1|||
33467944|NCT04932941|101603730|FG000|Overall Study|Lost to Follow-up|3|||
33265190|NCT02404441|100870305|FG006|Phase 1 Part|Death|0|||
33265191|NCT02404441|100870306|FG007|Phase 1 Part|Death|0|||
33265192|NCT02404441|100870307|FG008|Phase 1 Part|Death|0|||
33265193|NCT02404441|100870308|FG009|Phase 1 Part|Death|0|||
33265194|NCT02404441|100870299|FG000|Phase 2 Part|Adverse Event|0|||
33265195|NCT02404441|100870300|FG001|Phase 2 Part|Adverse Event|0|||
33467945|NCT04932941|101603731|FG001|Overall Study|Lost to Follow-up|1|||
33467946|NCT04932941|101603730|FG000|Overall Study|Withdrawal by Subject|7|||
33467947|NCT04932941|101603731|FG001|Overall Study|Withdrawal by Subject|4|||
33467948|NCT04932941|101603730|FG000|Overall Study|Other|4|||
33467949|NCT04932941|101603731|FG001|Overall Study|Other|2|||
33467950|NCT03235479|101603732|FG000|Overall Study|Lost to Follow-up|8|||
33467951|NCT03235479|101603733|FG001|Overall Study|Lost to Follow-up|11|||
33467952|NCT03235479|101603732|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
33467953|NCT03235479|101603733|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
33467954|NCT03235479|101603732|FG000|Overall Study|Pregnancy|1|||
33467955|NCT03235479|101603733|FG001|Overall Study|Pregnancy|0|||
33467956|NCT03235479|101603732|FG000|Overall Study|Protocol Deviation|1|||
33467957|NCT03235479|101603733|FG001|Overall Study|Protocol Deviation|3|||
33467958|NCT03235479|101603732|FG000|Overall Study|Technical Problems|3|||
33467959|NCT03235479|101603733|FG001|Overall Study|Technical Problems|2|||
33467960|NCT03235479|101603732|FG000|Overall Study|Withdrawal by Subject|2|||
33467961|NCT03235479|101603733|FG001|Overall Study|Withdrawal by Subject|2|||
33467962|NCT03235479|101603732|FG000|Overall Study|Other Reasons|3|||
33467963|NCT03235479|101603733|FG001|Overall Study|Other Reasons|5|||
33467964|NCT03812991|101603739|FG000|Overall Study|Lost to Follow-up|3|||
33179252|NCT02039674|100563852|FG003|Overall Study|Other|0|||
33467965|NCT03812991|101603740|FG001|Overall Study|Lost to Follow-up|1|||
33467966|NCT03123783|101603741|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
33467967|NCT03123783|101603742|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
33467968|NCT03123783|101603743|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
33467969|NCT03123783|101603744|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
33467970|NCT03123783|101603745|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
33467971|NCT03123783|101603746|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
33467972|NCT03123783|101603747|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
33467973|NCT03123783|101603741|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
33467974|NCT03123783|101603742|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
33467975|NCT03123783|101603743|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
33467976|NCT03123783|101603744|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
33467977|NCT03123783|101603745|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
33467978|NCT03123783|101603746|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
33467979|NCT03123783|101603747|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
33467980|NCT03123783|101603741|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
33467981|NCT03123783|101603742|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
33467982|NCT03123783|101603743|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
33467983|NCT03123783|101603744|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
33467984|NCT03123783|101603745|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
33467985|NCT03123783|101603746|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
33467986|NCT03123783|101603747|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
33467987|NCT03123783|101603741|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
33467988|NCT03123783|101603742|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
33467989|NCT03123783|101603743|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
33467990|NCT03123783|101603744|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
33467991|NCT03123783|101603745|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
33467992|NCT03123783|101603746|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
33179253|NCT02039674|100563853|FG004|Overall Study|Other|0|||
33179254|NCT02039674|100563854|FG005|Overall Study|Other|0|||
33179255|NCT02039674|100563855|FG006|Overall Study|Other|0|||
33179256|NCT02039674|100563856|FG007|Overall Study|Other|0|||
33179257|NCT02039674|100563857|FG008|Overall Study|Other|0|||
33179258|NCT02039674|100563858|FG009|Overall Study|Other|0|||
33179259|NCT02039674|100563859|FG010|Overall Study|Other|0|||
33179260|NCT02039674|100563860|FG011|Overall Study|Other|0|||
33179261|NCT02039674|100563861|FG012|Overall Study|Other|1|||
33179262|NCT02039674|100563862|FG013|Overall Study|Other|0|||
33179263|NCT02189473|100563863|FG000|Overall Study|Death|22|||
33179264|NCT02189473|100563864|FG001|Overall Study|Death|23|||
33179265|NCT02189473|100563863|FG000|Overall Study|Lost to Follow-up|1|||
33179266|NCT02189473|100563864|FG001|Overall Study|Lost to Follow-up|2|||
33467993|NCT03123783|101603747|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
33467994|NCT01522950|101603748|FG000|Overall Study|Withdrawal by Subject|3|||
33467995|NCT01522950|101603749|FG001|Overall Study|Withdrawal by Subject|2|||
33179267|NCT01358357|100563865|FG000|Open Label Phase|Adverse Event|0|||
33179268|NCT01358357|100563866|FG001|Open Label Phase|Adverse Event|0|||
33179269|NCT01358357|100563867|FG002|Open Label Phase|Adverse Event|59|||
33179270|NCT01358357|100563865|FG000|Open Label Phase|Lack of Efficacy|0|||
33179271|NCT01358357|100563866|FG001|Open Label Phase|Lack of Efficacy|0|||
33179272|NCT01358357|100563867|FG002|Open Label Phase|Lack of Efficacy|107|||
33179273|NCT01358357|100563865|FG000|Open Label Phase|Lost to Follow-up|0|||
33179274|NCT01358357|100563866|FG001|Open Label Phase|Lost to Follow-up|0|||
33179275|NCT01358357|100563867|FG002|Open Label Phase|Lost to Follow-up|76|||
33179276|NCT01358357|100563865|FG000|Open Label Phase|Protocol Violation|0|||
33179277|NCT01358357|100563866|FG001|Open Label Phase|Protocol Violation|0|||
33179278|NCT01358357|100563867|FG002|Open Label Phase|Protocol Violation|45|||
33179279|NCT01358357|100563865|FG000|Open Label Phase|Withdrawal by Subject|0|||
33179280|NCT01358357|100563866|FG001|Open Label Phase|Withdrawal by Subject|0|||
33179281|NCT01358357|100563867|FG002|Open Label Phase|Withdrawal by Subject|112|||
33179282|NCT01358357|100563865|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
33179283|NCT01358357|100563866|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
33179284|NCT01358357|100563867|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
33179285|NCT01358357|100563865|FG000|Open Label Phase|Terminated at study completion|0|||
33179286|NCT01358357|100563866|FG001|Open Label Phase|Terminated at study completion|0|||
33179287|NCT01358357|100563867|FG002|Open Label Phase|Terminated at study completion|5|||
33179288|NCT01358357|100563865|FG000|Open Label Phase|Mood episode|0|||
33179289|NCT01358357|100563866|FG001|Open Label Phase|Mood episode|0|||
33179290|NCT01358357|100563867|FG002|Open Label Phase|Mood episode|42|||
33179291|NCT01358357|100563865|FG000|Double-Blind Phase|Adverse Event|8|||
33179292|NCT01358357|100563866|FG001|Double-Blind Phase|Adverse Event|5|||
33179293|NCT01358357|100563867|FG002|Double-Blind Phase|Adverse Event|0|||
33179294|NCT01358357|100563865|FG000|Double-Blind Phase|Lost to Follow-up|5|||
33179295|NCT01358357|100563866|FG001|Double-Blind Phase|Lost to Follow-up|7|||
33179296|NCT01358357|100563867|FG002|Double-Blind Phase|Lost to Follow-up|0|||
33179297|NCT01358357|100563865|FG000|Double-Blind Phase|Protocol Violation|1|||
33467996|NCT01522950|101603750|FG002|Overall Study|Withdrawal by Subject|1|||
33467997|NCT01522950|101603748|FG000|Overall Study|Adverse Event|3|||
33467998|NCT01522950|101603749|FG001|Overall Study|Adverse Event|1|||
33467999|NCT01522950|101603750|FG002|Overall Study|Adverse Event|1|||
33468000|NCT01522950|101603748|FG000|Overall Study|Protocol Violation|0|||
33468001|NCT01522950|101603749|FG001|Overall Study|Protocol Violation|0|||
33468002|NCT01522950|101603750|FG002|Overall Study|Protocol Violation|2|||
33468003|NCT01522950|101603748|FG000|Overall Study|Death|0|||
33468004|NCT01522950|101603749|FG001|Overall Study|Death|1|||
33468005|NCT01522950|101603750|FG002|Overall Study|Death|1|||
33468006|NCT01522950|101603748|FG000|Overall Study|Study Medication Sensitivity|0|||
33468007|NCT01522950|101603749|FG001|Overall Study|Study Medication Sensitivity|1|||
33468008|NCT01522950|101603750|FG002|Overall Study|Study Medication Sensitivity|0|||
33468009|NCT00536484|101603753|FG000|Overall Study|Adverse Event|21|||
33468010|NCT00536484|101603754|FG001|Overall Study|Adverse Event|34|||
33468011|NCT00536484|101603753|FG000|Overall Study|Withdrawal by Subject|11|||
33468012|NCT00536484|101603754|FG001|Overall Study|Withdrawal by Subject|11|||
33468013|NCT00536484|101603753|FG000|Overall Study|Lost to Follow-up|8|||
33468014|NCT00536484|101603754|FG001|Overall Study|Lost to Follow-up|6|||
33468015|NCT00536484|101603753|FG000|Overall Study|Lack of Efficacy|16|||
33468016|NCT00536484|101603754|FG001|Overall Study|Lack of Efficacy|5|||
33468017|NCT00536484|101603753|FG000|Overall Study|Other|4|||
33468018|NCT00536484|101603754|FG001|Overall Study|Other|0|||
33468019|NCT03351231|101603756|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
33468020|NCT03351231|101603756|FG000|Combination Therapy Period|Disease progression|2|||
33468021|NCT03351231|101603756|FG000|Combination Therapy Period|Study drug toxicity|1|||
33468022|NCT03351231|101603756|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
33468023|NCT03351231|101603756|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
33468024|NCT03351231|101603756|FG000|Safety Follow-Up Period|Other reason|2|||
33468025|NCT03585959|101603764|FG000|Overall Study|Physician Decision|1|||
33468026|NCT03585959|101603764|FG000|Overall Study|Unsuccessful Procedure|2|||
33468027|NCT00724373|101603765|FG000|Overall Study|Adverse Event|41|||
33468028|NCT00724373|101603765|FG000|Overall Study|Lack of Efficacy|82|||
33468029|NCT00724373|101603765|FG000|Overall Study|Lost to Follow-up|7|||
33468030|NCT00724373|101603765|FG000|Overall Study|Non-compliance|2|||
33468031|NCT00724373|101603765|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
33468032|NCT00724373|101603765|FG000|Overall Study|Participant moved away|1|||
33468033|NCT00724373|101603765|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
33468034|NCT00724373|101603765|FG000|Overall Study|Only to have 24 week regimen|1|||
33468035|NCT00724373|101603765|FG000|Overall Study|Viral Relapse|1|||
33179298|NCT01358357|100563866|FG001|Double-Blind Phase|Protocol Violation|11|||
33179299|NCT01358357|100563867|FG002|Double-Blind Phase|Protocol Violation|0|||
33179300|NCT01358357|100563865|FG000|Double-Blind Phase|Protocol Violation|16|||
33179301|NCT01358357|100563866|FG001|Double-Blind Phase|Protocol Violation|12|||
33179302|NCT01358357|100563867|FG002|Double-Blind Phase|Protocol Violation|0|||
33179303|NCT01358357|100563865|FG000|Double-Blind Phase|Terminated at study completion|2|||
33468036|NCT00724373|101603765|FG000|Overall Study|Acute HCV infection|1|||
33468037|NCT00724373|101603765|FG000|Overall Study|Drug Relapse|1|||
33468038|NCT00724373|101603765|FG000|Overall Study|Tolerability|23|||
33468039|NCT01005329|101603766|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
33468040|NCT01020799|101603767|FG000|Overall Study|Adverse Event|4|||
33468041|NCT01020799|101603768|FG001|Overall Study|Adverse Event|3|||
33468042|NCT01020799|101603769|FG002|Overall Study|Adverse Event|2|||
33468043|NCT01020799|101603767|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
33468044|NCT01020799|101603768|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
33468045|NCT01020799|101603769|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
33468046|NCT01020799|101603767|FG000|Overall Study|Protocol Violation|3|||
33468047|NCT01020799|101603768|FG001|Overall Study|Protocol Violation|2|||
33468048|NCT01020799|101603769|FG002|Overall Study|Protocol Violation|0|||
33468049|NCT01020799|101603767|FG000|Overall Study|Withdrawal by Subject|2|||
33468050|NCT01020799|101603768|FG001|Overall Study|Withdrawal by Subject|2|||
33468051|NCT01020799|101603769|FG002|Overall Study|Withdrawal by Subject|3|||
33468052|NCT01020799|101603767|FG000|Overall Study|Lost to Follow-up|6|||
33468053|NCT01020799|101603768|FG001|Overall Study|Lost to Follow-up|4|||
33468054|NCT01020799|101603769|FG002|Overall Study|Lost to Follow-up|2|||
33468055|NCT02694549|101603770|FG000|Overall Study|screen failures|2|||
33468056|NCT02747004|101603771|FG000|Overall Study|Withdrawal by Subject|8|||
33468057|NCT02747004|101603772|FG001|Overall Study|Withdrawal by Subject|5|||
33468058|NCT02747004|101603773|FG002|Overall Study|Withdrawal by Subject|4|||
33468059|NCT02747004|101603771|FG000|Overall Study|Lost to Follow-up|1|||
33468060|NCT02747004|101603772|FG001|Overall Study|Lost to Follow-up|2|||
33468061|NCT02747004|101603773|FG002|Overall Study|Lost to Follow-up|2|||
33468062|NCT02747004|101603771|FG000|Overall Study|on study treatment/follow-up|48|||
33468063|NCT02747004|101603772|FG001|Overall Study|on study treatment/follow-up|42|||
33468064|NCT02747004|101603773|FG002|Overall Study|on study treatment/follow-up|41|||
33468065|NCT03710590|101603775|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
33468066|NCT03710590|101603776|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
33468067|NCT00606502|101603777|FG000|Randomization|Randomized but not treated|3|||
33468068|NCT00606502|101603778|FG001|Randomization|Randomized but not treated|0|||
33468069|NCT00606502|101603777|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
33468070|NCT00606502|101603778|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
33468071|NCT01189500|101603780|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
33468072|NCT01189500|101603780|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
33468073|NCT03180801|101603781|FG000|Overall Study|Physician Decision|3|||
33468074|NCT03180801|101603782|FG001|Overall Study|Physician Decision|3|||
33468075|NCT03180801|101603783|FG002|Overall Study|Physician Decision|1|||
33468076|NCT03180801|101603781|FG000|Overall Study|Non-compliance|1|||
33468077|NCT03180801|101603782|FG001|Overall Study|Non-compliance|4|||
33468078|NCT03180801|101603783|FG002|Overall Study|Non-compliance|0|||
33468079|NCT03180801|101603781|FG000|Overall Study|Inoculation Target Reached|1|||
33468080|NCT03180801|101603782|FG001|Overall Study|Inoculation Target Reached|1|||
33468081|NCT03180801|101603783|FG002|Overall Study|Inoculation Target Reached|3|||
33468082|NCT03180801|101603781|FG000|Overall Study|Adverse Event|1|||
33468083|NCT03180801|101603782|FG001|Overall Study|Adverse Event|0|||
33468084|NCT03180801|101603783|FG002|Overall Study|Adverse Event|2|||
33468085|NCT03180801|101603781|FG000|Overall Study|Withdrawal by Subject|2|||
33468086|NCT03180801|101603782|FG001|Overall Study|Withdrawal by Subject|2|||
33468087|NCT03180801|101603783|FG002|Overall Study|Withdrawal by Subject|1|||
33468088|NCT03180801|101603781|FG000|Overall Study|Lost to Follow-up|0|||
33468089|NCT03180801|101603782|FG001|Overall Study|Lost to Follow-up|2|||
33468090|NCT03180801|101603783|FG002|Overall Study|Lost to Follow-up|3|||
33468091|NCT00619359|101603784|FG000|Overall Study|Adverse Event|32|||
33468092|NCT00619359|101603785|FG001|Overall Study|Adverse Event|36|||
33468093|NCT00619359|101603784|FG000|Overall Study|Lost to Follow-up|12|||
33468094|NCT00619359|101603785|FG001|Overall Study|Lost to Follow-up|16|||
33468095|NCT00619359|101603784|FG000|Overall Study|Physician Decision|0|||
33468096|NCT00619359|101603785|FG001|Overall Study|Physician Decision|7|||
33468097|NCT00619359|101603784|FG000|Overall Study|Protocol Violation|1|||
33468098|NCT00619359|101603785|FG001|Overall Study|Protocol Violation|1|||
33468099|NCT00619359|101603784|FG000|Overall Study|Withdrawal by Subject|19|||
33468100|NCT00619359|101603785|FG001|Overall Study|Withdrawal by Subject|20|||
33468101|NCT00619359|101603784|FG000|Overall Study|Progressive Disease|3|||
33468102|NCT00619359|101603785|FG001|Overall Study|Progressive Disease|1|||
33468103|NCT04740931|101603786|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
33468104|NCT04740931|101603787|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
33468105|NCT04740931|101603786|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
33468106|NCT04740931|101603787|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
33468107|NCT04740931|101603786|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
33468108|NCT04740931|101603787|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
33179304|NCT01358357|100563866|FG001|Double-Blind Phase|Terminated at study completion|0|||
33468109|NCT04740931|101603786|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
33468110|NCT04740931|101603787|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
33468111|NCT04740931|101603786|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
33468112|NCT04740931|101603787|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
33468113|NCT04740931|101603786|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
33468114|NCT04740931|101603787|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
33468115|NCT04740931|101603786|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
33468116|NCT04740931|101603787|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
33468117|NCT04740931|101603786|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
33468118|NCT04740931|101603787|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
33468119|NCT04740931|101603786|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
33468120|NCT04740931|101603787|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
33468121|NCT04740931|101603786|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
33468122|NCT04740931|101603787|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
33468123|NCT04740931|101603786|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
33468124|NCT04740931|101603787|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
33468125|NCT04740931|101603786|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
33468126|NCT04740931|101603787|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
33468127|NCT04740931|101603786|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
33468128|NCT04740931|101603787|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
33468129|NCT04740931|101603786|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
33468130|NCT04740931|101603787|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
33468131|NCT04740931|101603786|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
33468132|NCT04740931|101603787|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
33468133|NCT01376310|101603788|FG000|Overall Study|Study closed/terminated|1|||
33468134|NCT01376310|101603789|FG001|Overall Study|Study closed/terminated|2|||
33468135|NCT01376310|101603788|FG000|Overall Study|Withdrawal by Subject|8|||
33468136|NCT01376310|101603789|FG001|Overall Study|Withdrawal by Subject|2|||
33468137|NCT01376310|101603788|FG000|Overall Study|Physician Decision|26|||
33468138|NCT01376310|101603789|FG001|Overall Study|Physician Decision|7|||
33468139|NCT01376310|101603788|FG000|Overall Study|Lost to Follow-up|1|||
33468140|NCT01376310|101603789|FG001|Overall Study|Lost to Follow-up|0|||
33468141|NCT02083926|101603796|FG000|Overall Study|Withdrawal by Subject|1|||
33468142|NCT02083926|101603797|FG001|Overall Study|Withdrawal by Subject|0|||
33468143|NCT02211014|101603798|FG000|Overall Study|Adverse Event|0|||
33468144|NCT02211014|101603799|FG001|Overall Study|Adverse Event|2|||
33468145|NCT02211014|101603798|FG000|Overall Study|Physician Decision|1|||
33468146|NCT02211014|101603799|FG001|Overall Study|Physician Decision|2|||
33468147|NCT02211014|101603798|FG000|Overall Study|Started another cancer therapy|1|||
33468148|NCT02211014|101603799|FG001|Overall Study|Started another cancer therapy|0|||
33468149|NCT02211014|101603798|FG000|Overall Study|Withdrawal by Subject|0|||
33468150|NCT02211014|101603799|FG001|Overall Study|Withdrawal by Subject|1|||
33468151|NCT02211014|101603798|FG000|Overall Study|In agreement with patient, no benefit|0|||
33468152|NCT02211014|101603799|FG001|Overall Study|In agreement with patient, no benefit|1|||
33468153|NCT00573170|101603800|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
33468154|NCT00573170|101603801|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
33468155|NCT00573170|101603802|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
33468156|NCT00573170|101603803|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
33468157|NCT00573170|101603804|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
33468158|NCT00573170|101603805|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
33468159|NCT00573170|101603800|FG000|First Washout Period|Adverse Event|1|||
33468160|NCT00573170|101603801|FG001|First Washout Period|Adverse Event|1|||
33468161|NCT00573170|101603802|FG002|First Washout Period|Adverse Event|0|||
33468162|NCT00573170|101603803|FG003|First Washout Period|Adverse Event|0|||
33468163|NCT00573170|101603804|FG004|First Washout Period|Adverse Event|0|||
33468164|NCT00573170|101603805|FG005|First Washout Period|Adverse Event|1|||
33468165|NCT00573170|101603800|FG000|First Washout Period|Lack of Efficacy|0|||
33468166|NCT00573170|101603801|FG001|First Washout Period|Lack of Efficacy|0|||
33468167|NCT00573170|101603802|FG002|First Washout Period|Lack of Efficacy|0|||
33468168|NCT00573170|101603803|FG003|First Washout Period|Lack of Efficacy|0|||
33468169|NCT00573170|101603804|FG004|First Washout Period|Lack of Efficacy|0|||
33468170|NCT00573170|101603805|FG005|First Washout Period|Lack of Efficacy|1|||
33468171|NCT00573170|101603800|FG000|First Washout Period|Lost to Follow-up|1|||
33468172|NCT00573170|101603801|FG001|First Washout Period|Lost to Follow-up|1|||
33468173|NCT00573170|101603802|FG002|First Washout Period|Lost to Follow-up|0|||
33468174|NCT00573170|101603803|FG003|First Washout Period|Lost to Follow-up|2|||
33468175|NCT00573170|101603804|FG004|First Washout Period|Lost to Follow-up|0|||
33468176|NCT00573170|101603805|FG005|First Washout Period|Lost to Follow-up|2|||
33468177|NCT00573170|101603800|FG000|First Washout Period|Withdrawal by Subject|2|||
33468178|NCT00573170|101603801|FG001|First Washout Period|Withdrawal by Subject|0|||
33468179|NCT00573170|101603802|FG002|First Washout Period|Withdrawal by Subject|0|||
33468180|NCT00573170|101603803|FG003|First Washout Period|Withdrawal by Subject|2|||
33468181|NCT00573170|101603804|FG004|First Washout Period|Withdrawal by Subject|3|||
33468182|NCT00573170|101603805|FG005|First Washout Period|Withdrawal by Subject|3|||
33468183|NCT00573170|101603800|FG000|First Washout Period|Other|4|||
33468184|NCT00573170|101603801|FG001|First Washout Period|Other|0|||
33468185|NCT00573170|101603802|FG002|First Washout Period|Other|1|||
33468186|NCT00573170|101603803|FG003|First Washout Period|Other|1|||
33468187|NCT00573170|101603804|FG004|First Washout Period|Other|0|||
33468188|NCT00573170|101603805|FG005|First Washout Period|Other|0|||
33468189|NCT00573170|101603800|FG000|Second Washout Period|Adverse Event|1|||
33468190|NCT00573170|101603801|FG001|Second Washout Period|Adverse Event|0|||
33179305|NCT01358357|100563867|FG002|Double-Blind Phase|Terminated at study completion|0|||
33179306|NCT01358357|100563865|FG000|Double-Blind Phase|Recurrence of mood event|48|||
33179307|NCT01358357|100563866|FG001|Double-Blind Phase|Recurrence of mood event|64|||
33179308|NCT01358357|100563867|FG002|Double-Blind Phase|Recurrence of mood event|0|||
33265196|NCT02404441|100870301|FG002|Phase 2 Part|Adverse Event|0|||
33265197|NCT02404441|100870302|FG003|Phase 2 Part|Adverse Event|0|||
33265198|NCT02404441|100870303|FG004|Phase 2 Part|Adverse Event|0|||
33265199|NCT02404441|100870304|FG005|Phase 2 Part|Adverse Event|2|||
33265200|NCT02404441|100870305|FG006|Phase 2 Part|Adverse Event|3|||
33265201|NCT02404441|100870306|FG007|Phase 2 Part|Adverse Event|3|||
33265202|NCT02404441|100870307|FG008|Phase 2 Part|Adverse Event|6|||
33265203|NCT02404441|100870308|FG009|Phase 2 Part|Adverse Event|1|||
33265204|NCT02404441|100870299|FG000|Phase 2 Part|Physician Decision|0|||
33265205|NCT02404441|100870300|FG001|Phase 2 Part|Physician Decision|0|||
33265206|NCT02404441|100870301|FG002|Phase 2 Part|Physician Decision|0|||
33265207|NCT02404441|100870302|FG003|Phase 2 Part|Physician Decision|0|||
33265208|NCT02404441|100870303|FG004|Phase 2 Part|Physician Decision|0|||
33265209|NCT02404441|100870304|FG005|Phase 2 Part|Physician Decision|7|||
33265210|NCT02404441|100870305|FG006|Phase 2 Part|Physician Decision|9|||
33265211|NCT02404441|100870306|FG007|Phase 2 Part|Physician Decision|2|||
33265212|NCT02404441|100870307|FG008|Phase 2 Part|Physician Decision|1|||
33265213|NCT02404441|100870308|FG009|Phase 2 Part|Physician Decision|3|||
33265214|NCT02404441|100870299|FG000|Phase 2 Part|Progressive disease|0|||
33265215|NCT02404441|100870300|FG001|Phase 2 Part|Progressive disease|0|||
33265216|NCT02404441|100870301|FG002|Phase 2 Part|Progressive disease|0|||
33265217|NCT02404441|100870302|FG003|Phase 2 Part|Progressive disease|0|||
33179309|NCT01358357|100563865|FG000|Double-Blind Phase|Administrative|0|||
33179310|NCT01358357|100563866|FG001|Double-Blind Phase|Administrative|1|||
33179311|NCT01358357|100563867|FG002|Double-Blind Phase|Administrative|0|||
33179312|NCT02882854|100563868|FG000|Overall Study|Lost to Follow-up|1|||
33179313|NCT02882854|100563869|FG001|Overall Study|Lost to Follow-up|2|||
33179314|NCT02882854|100563868|FG000|Overall Study|Physician Decision|0|||
33179315|NCT02882854|100563869|FG001|Overall Study|Physician Decision|1|||
33179316|NCT00501293|100563872|FG000|Optimization Period|Enrolled in error|1|||
33179317|NCT00501293|100563873|FG001|Optimization Period|Enrolled in error|0|||
33179318|NCT00501293|100563872|FG000|Maintenance Period|Withdrawal by Subject|14|||
33179319|NCT00501293|100563873|FG001|Maintenance Period|Withdrawal by Subject|13|||
33179320|NCT00501293|100563872|FG000|Maintenance Period|Lost to Follow-up|12|||
33179321|NCT00501293|100563873|FG001|Maintenance Period|Lost to Follow-up|7|||
33179322|NCT00501293|100563872|FG000|Maintenance Period|Adverse Event|6|||
33179323|NCT00501293|100563873|FG001|Maintenance Period|Adverse Event|6|||
33179324|NCT00501293|100563872|FG000|Maintenance Period|Protocol Violation|2|||
33179325|NCT00501293|100563873|FG001|Maintenance Period|Protocol Violation|1|||
33179326|NCT00501293|100563872|FG000|Maintenance Period|Lack of Efficacy|4|||
33179327|NCT00501293|100563873|FG001|Maintenance Period|Lack of Efficacy|1|||
33179328|NCT00501293|100563872|FG000|Maintenance Period|Noncompliant with study medication|5|||
33179329|NCT00501293|100563873|FG001|Maintenance Period|Noncompliant with study medication|0|||
33179330|NCT00501293|100563872|FG000|Maintenance Period|Went into rehabilitation|1|||
33179331|NCT00501293|100563873|FG001|Maintenance Period|Went into rehabilitation|0|||
33179332|NCT00501293|100563872|FG000|Maintenance Period|Would not wear patch|1|||
33179333|NCT00501293|100563873|FG001|Maintenance Period|Would not wear patch|0|||
33179334|NCT00501293|100563872|FG000|Maintenance Period|Application site reaction|1|||
33179335|NCT00501293|100563873|FG001|Maintenance Period|Application site reaction|0|||
33179336|NCT02197806|100563874|FG000|Overall Study|Adverse Event|0|||
33179337|NCT02197806|100563875|FG001|Overall Study|Adverse Event|1|||
33179338|NCT02197806|100563876|FG002|Overall Study|Adverse Event|0|||
33179339|NCT02197806|100563877|FG003|Overall Study|Adverse Event|1|||
33265218|NCT02404441|100870303|FG004|Phase 2 Part|Progressive disease|0|||
33265219|NCT02404441|100870304|FG005|Phase 2 Part|Progressive disease|43|||
33468191|NCT00573170|101603802|FG002|Second Washout Period|Adverse Event|0|||
33468192|NCT00573170|101603803|FG003|Second Washout Period|Adverse Event|0|||
33468193|NCT00573170|101603804|FG004|Second Washout Period|Adverse Event|1|||
33468194|NCT00573170|101603805|FG005|Second Washout Period|Adverse Event|0|||
33179340|NCT04256785|100563878|FG000|Overall Study|Adverse Event|8|||
33179341|NCT04256785|100563879|FG001|Overall Study|Adverse Event|6|||
33179342|NCT04256785|100563878|FG000|Overall Study|Lack of Efficacy|3|||
33179343|NCT04256785|100563879|FG001|Overall Study|Lack of Efficacy|4|||
33265220|NCT02404441|100870305|FG006|Phase 2 Part|Progressive disease|32|||
33265221|NCT02404441|100870306|FG007|Phase 2 Part|Progressive disease|31|||
33265222|NCT02404441|100870307|FG008|Phase 2 Part|Progressive disease|39|||
33468195|NCT00573170|101603800|FG000|Second Washout Period|Protocol Violation|2|||
33468196|NCT00573170|101603801|FG001|Second Washout Period|Protocol Violation|1|||
33265223|NCT02404441|100870308|FG009|Phase 2 Part|Progressive disease|27|||
33265224|NCT02404441|100870299|FG000|Phase 2 Part|Subject/guardian decision|0|||
33265225|NCT02404441|100870300|FG001|Phase 2 Part|Subject/guardian decision|0|||
33265226|NCT02404441|100870301|FG002|Phase 2 Part|Subject/guardian decision|0|||
33265227|NCT02404441|100870302|FG003|Phase 2 Part|Subject/guardian decision|0|||
33265228|NCT02404441|100870303|FG004|Phase 2 Part|Subject/guardian decision|0|||
33265229|NCT02404441|100870304|FG005|Phase 2 Part|Subject/guardian decision|3|||
33265230|NCT02404441|100870305|FG006|Phase 2 Part|Subject/guardian decision|9|||
33265231|NCT02404441|100870306|FG007|Phase 2 Part|Subject/guardian decision|0|||
33265232|NCT02404441|100870307|FG008|Phase 2 Part|Subject/guardian decision|3|||
33265233|NCT02404441|100870308|FG009|Phase 2 Part|Subject/guardian decision|2|||
33265234|NCT02404441|100870299|FG000|Phase 2 Part|Death|0|||
33265235|NCT02404441|100870300|FG001|Phase 2 Part|Death|0|||
33265236|NCT02404441|100870301|FG002|Phase 2 Part|Death|0|||
33265237|NCT02404441|100870302|FG003|Phase 2 Part|Death|0|||
33265238|NCT02404441|100870303|FG004|Phase 2 Part|Death|0|||
33265239|NCT02404441|100870304|FG005|Phase 2 Part|Death|4|||
33265240|NCT02404441|100870305|FG006|Phase 2 Part|Death|8|||
33265241|NCT02404441|100870306|FG007|Phase 2 Part|Death|4|||
33265242|NCT02404441|100870307|FG008|Phase 2 Part|Death|10|||
33265243|NCT02404441|100870308|FG009|Phase 2 Part|Death|9|||
33265244|NCT00463229|100870309|FG000|Overall Study|Lost to Follow-up|5|||
33265245|NCT00463229|100870310|FG001|Overall Study|Lost to Follow-up|7|||
33265246|NCT00463229|100870309|FG000|Overall Study|Death|4|||
33179344|NCT04256785|100563878|FG000|Overall Study|Lost to Follow-up|7|||
33179345|NCT04256785|100563879|FG001|Overall Study|Lost to Follow-up|7|||
33179346|NCT04256785|100563878|FG000|Overall Study|Protocol Violation|1|||
33179347|NCT04256785|100563879|FG001|Overall Study|Protocol Violation|0|||
33179348|NCT04256785|100563878|FG000|Overall Study|Withdrawal by Subject|4|||
33179349|NCT04256785|100563879|FG001|Overall Study|Withdrawal by Subject|1|||
33179350|NCT04256785|100563878|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
33179351|NCT04256785|100563879|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
33179352|NCT00100815|100563880|FG000|Overall Study|Progression|24|||
33179353|NCT00100815|100563880|FG000|Overall Study|Adverse Event|18|||
33179354|NCT00100815|100563880|FG000|Overall Study|Death|4|||
33179355|NCT00100815|100563880|FG000|Overall Study|Other|3|||
33179356|NCT02357901|100563881|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
33179357|NCT02357901|100563882|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
33179358|NCT02357901|100563883|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
33179359|NCT02357901|100563884|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
33179360|NCT02357901|100563881|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
33179361|NCT02357901|100563882|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
33179362|NCT02357901|100563883|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
33179363|NCT02357901|100563884|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
33179364|NCT02357901|100563881|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
33179365|NCT02357901|100563882|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
33179366|NCT02357901|100563883|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
33179367|NCT02357901|100563884|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
33179368|NCT02357901|100563881|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
33179369|NCT02357901|100563882|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
33179370|NCT02357901|100563883|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
33179371|NCT02357901|100563884|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
33179372|NCT02357901|100563881|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
33179373|NCT02357901|100563882|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
33179374|NCT02357901|100563883|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
33179375|NCT02357901|100563884|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
33179376|NCT02357901|100563881|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
33179377|NCT02357901|100563882|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
33179378|NCT02357901|100563883|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
33179379|NCT02357901|100563884|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
33179380|NCT02357901|100563881|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
33179381|NCT02357901|100563882|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
33179382|NCT02357901|100563883|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
33179383|NCT02357901|100563884|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
33179384|NCT02357901|100563881|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
33265247|NCT00463229|100870310|FG001|Overall Study|Death|3|||
33265248|NCT04334317|100870312|FG000|Overall Study|Adverse Event|1|||
33265249|NCT04334317|100870313|FG001|Overall Study|Adverse Event|2|||
33265250|NCT04334317|100870314|FG002|Overall Study|Adverse Event|0|||
33265251|NCT04334317|100870315|FG003|Overall Study|Adverse Event|0|||
33265252|NCT04334317|100870312|FG000|Overall Study|Protocol Deviation|0|||
33265253|NCT04334317|100870313|FG001|Overall Study|Protocol Deviation|1|||
33265254|NCT04334317|100870314|FG002|Overall Study|Protocol Deviation|0|||
33265255|NCT04334317|100870315|FG003|Overall Study|Protocol Deviation|0|||
33265256|NCT04334317|100870312|FG000|Overall Study|Withdrawal by Subject|2|||
33265257|NCT04334317|100870313|FG001|Overall Study|Withdrawal by Subject|2|||
33265258|NCT04334317|100870314|FG002|Overall Study|Withdrawal by Subject|0|||
33265259|NCT04334317|100870315|FG003|Overall Study|Withdrawal by Subject|0|||
33265260|NCT03567616|100870316|FG000|Overall Study|Disease progression|4|||
33265261|NCT03567616|100870316|FG000|Overall Study|Withdrawal by Subject|1|||
33265262|NCT03567616|100870316|FG000|Overall Study|Physician Decision|1|||
33265263|NCT03567616|100870316|FG000|Overall Study|Death|1|||
33265264|NCT03567616|100870316|FG000|Overall Study|Adverse Event|1|||
33265265|NCT02628626|100870317|FG000|Overall Study|Withdrawal by Subject|2|||
33265266|NCT02628626|100870318|FG001|Overall Study|Withdrawal by Subject|2|||
33265267|NCT01767467|100870320|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
33265268|NCT01767467|100870321|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
33265269|NCT01767467|100870320|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
33265270|NCT01767467|100870321|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
33265271|NCT01767467|100870320|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
33265272|NCT01767467|100870321|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
33265273|NCT01767467|100870320|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
33265274|NCT01767467|100870321|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
33265275|NCT01767467|100870320|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
33265276|NCT01767467|100870321|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
33265277|NCT01767467|100870320|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
33265278|NCT01767467|100870321|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
33265279|NCT01767467|100870320|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
33265280|NCT01767467|100870321|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
33265281|NCT01767467|100870320|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
33265282|NCT01767467|100870321|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
33265283|NCT01767467|100870320|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
33265284|NCT01767467|100870321|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
33179385|NCT02357901|100563882|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
33179386|NCT02357901|100563883|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
33179387|NCT02357901|100563884|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
33179388|NCT02357901|100563881|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
33179389|NCT02357901|100563882|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
33179390|NCT02357901|100563883|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
33179391|NCT02357901|100563884|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
33179392|NCT02357901|100563881|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
33179393|NCT02357901|100563882|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
33179394|NCT02357901|100563883|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
33179395|NCT02357901|100563884|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
33179396|NCT02357901|100563881|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
33179397|NCT02357901|100563882|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
33179398|NCT02357901|100563883|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
33179399|NCT02357901|100563884|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
33179400|NCT01387347|100563885|FG000|Overall Study|Lost to Follow-up|2|||
33179401|NCT01387347|100563886|FG001|Overall Study|Lost to Follow-up|1|||
33179402|NCT00616655|100563887|FG000|Overall Study|Adverse Event|10|||
33179403|NCT00616655|100563888|FG001|Overall Study|Adverse Event|7|||
33179404|NCT00616655|100563889|FG002|Overall Study|Adverse Event|12|||
33179405|NCT00616655|100563887|FG000|Overall Study|Lack of Efficacy|5|||
33179406|NCT00616655|100563888|FG001|Overall Study|Lack of Efficacy|5|||
33179407|NCT00616655|100563889|FG002|Overall Study|Lack of Efficacy|5|||
33179408|NCT00616655|100563887|FG000|Overall Study|Lost to Follow-up|3|||
33179409|NCT00616655|100563888|FG001|Overall Study|Lost to Follow-up|12|||
33179410|NCT00616655|100563889|FG002|Overall Study|Lost to Follow-up|10|||
33179411|NCT00616655|100563887|FG000|Overall Study|Protocol Violation|2|||
33179412|NCT00616655|100563888|FG001|Overall Study|Protocol Violation|4|||
33179413|NCT00616655|100563889|FG002|Overall Study|Protocol Violation|3|||
33179414|NCT00616655|100563887|FG000|Overall Study|Withdrawal by Subject|9|||
33179415|NCT00616655|100563888|FG001|Overall Study|Withdrawal by Subject|7|||
33179416|NCT00616655|100563889|FG002|Overall Study|Withdrawal by Subject|11|||
33179417|NCT00616655|100563887|FG000|Overall Study|Does not meet in/ex criteria|0|||
33179418|NCT00616655|100563888|FG001|Overall Study|Does not meet in/ex criteria|0|||
33179419|NCT00616655|100563889|FG002|Overall Study|Does not meet in/ex criteria|2|||
33265285|NCT01767467|100870320|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
33179420|NCT00616655|100563887|FG000|Overall Study|Other|6|||
33179421|NCT00616655|100563888|FG001|Overall Study|Other|6|||
33179422|NCT00616655|100563889|FG002|Overall Study|Other|5|||
33265286|NCT01767467|100870321|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
33265287|NCT01767467|100870320|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
33265288|NCT01767467|100870321|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
33265289|NCT01767467|100870320|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
33265290|NCT01767467|100870321|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
33265291|NCT01767467|100870320|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
33265292|NCT01767467|100870321|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
33265293|NCT01767467|100870320|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
33265294|NCT01767467|100870321|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
33265295|NCT02568215|100870322|FG000|Overall Study|Death|1|||
33265296|NCT02568215|100870323|FG001|Overall Study|Death|2|||
33265297|NCT02568215|100870324|FG002|Overall Study|Death|0|||
33265298|NCT02568215|100870322|FG000|Overall Study|Physician Decision|2|||
33265299|NCT02568215|100870323|FG001|Overall Study|Physician Decision|2|||
33265300|NCT02568215|100870324|FG002|Overall Study|Physician Decision|2|||
33265301|NCT02568215|100870322|FG000|Overall Study|Lost to Follow-up|29|||
33265302|NCT02568215|100870323|FG001|Overall Study|Lost to Follow-up|32|||
33265303|NCT02568215|100870324|FG002|Overall Study|Lost to Follow-up|41|||
33265304|NCT02568215|100870322|FG000|Overall Study|Withdrawal by Subject|21|||
33265305|NCT02568215|100870323|FG001|Overall Study|Withdrawal by Subject|19|||
33265306|NCT02568215|100870324|FG002|Overall Study|Withdrawal by Subject|22|||
33265307|NCT02568215|100870322|FG000|Overall Study|Protocol Violation|1|||
33265308|NCT02568215|100870323|FG001|Overall Study|Protocol Violation|1|||
33265309|NCT02568215|100870324|FG002|Overall Study|Protocol Violation|0|||
33265310|NCT02568215|100870322|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
33265311|NCT02568215|100870323|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
33265312|NCT02568215|100870324|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
33265313|NCT02568215|100870322|FG000|Overall Study|Other|0|||
33265314|NCT02568215|100870323|FG001|Overall Study|Other|1|||
33265315|NCT02568215|100870324|FG002|Overall Study|Other|4|||
33265316|NCT01532999|100870332|FG000|Overall Study|Lost to Follow-up|14|||
33265317|NCT01532999|100870333|FG001|Overall Study|Lost to Follow-up|8|||
33265318|NCT01532999|100870332|FG000|Overall Study|Physician Decision|1|||
33265319|NCT01532999|100870333|FG001|Overall Study|Physician Decision|2|||
33265320|NCT01532999|100870332|FG000|Overall Study|Withdrawal by Subject|5|||
33265321|NCT01532999|100870333|FG001|Overall Study|Withdrawal by Subject|0|||
33468197|NCT00573170|101603802|FG002|Second Washout Period|Protocol Violation|1|||
33468198|NCT00573170|101603803|FG003|Second Washout Period|Protocol Violation|0|||
33468199|NCT00573170|101603804|FG004|Second Washout Period|Protocol Violation|0|||
33468200|NCT00573170|101603805|FG005|Second Washout Period|Protocol Violation|0|||
33468201|NCT00573170|101603800|FG000|Second Washout Period|Withdrawal by Subject|1|||
33179423|NCT00946712|100563901|FG000|Overall Study|Adverse Event|118|||
33179424|NCT00946712|100563902|FG001|Overall Study|Adverse Event|124|||
33179425|NCT00946712|100563901|FG000|Overall Study|Disease progression|308|||
33179426|NCT00946712|100563902|FG001|Overall Study|Disease progression|404|||
33179427|NCT00946712|100563901|FG000|Overall Study|Death|21|||
33179428|NCT00946712|100563902|FG001|Overall Study|Death|22|||
33179429|NCT00946712|100563901|FG000|Overall Study|No treatment given|25|||
33179430|NCT00946712|100563902|FG001|Overall Study|No treatment given|29|||
33179431|NCT00946712|100563901|FG000|Overall Study|Other reasons|61|||
33179432|NCT00946712|100563902|FG001|Overall Study|Other reasons|73|||
33179433|NCT00946712|100563901|FG000|Overall Study|On Treatment|0|||
33179434|NCT00946712|100563902|FG001|Overall Study|On Treatment|4|||
33179435|NCT00946712|100563901|FG000|Overall Study|Ineligible|14|||
33179436|NCT00946712|100563902|FG001|Overall Study|Ineligible|6|||
33179437|NCT00303498|100563903|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
33179438|NCT00303498|100563904|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
33179439|NCT00303498|100563903|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
33179440|NCT00303498|100563904|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
33179441|NCT00303498|100563903|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
33179442|NCT00303498|100563904|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
33179443|NCT00303498|100563903|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
33179444|NCT00303498|100563904|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
33265322|NCT01532999|100870332|FG000|Overall Study|Relocated|2|||
33265323|NCT01532999|100870333|FG001|Overall Study|Relocated|0|||
33265324|NCT01532999|100870332|FG000|Overall Study|should not have been randomized|1|||
33265325|NCT01532999|100870333|FG001|Overall Study|should not have been randomized|0|||
33265326|NCT01532999|100870332|FG000|Overall Study|substantial noncompliance|2|||
33468202|NCT00573170|101603801|FG001|Second Washout Period|Withdrawal by Subject|1|||
33265327|NCT01532999|100870333|FG001|Overall Study|substantial noncompliance|0|||
33265328|NCT01532999|100870332|FG000|Overall Study|no show for week 9 assessments|6|||
33265329|NCT01532999|100870333|FG001|Overall Study|no show for week 9 assessments|4|||
33265330|NCT01532999|100870332|FG000|Overall Study|Adverse Event|0|||
33179445|NCT00303498|100563903|FG000|Run-In-Phase (10 Weeks)|Other|4|||
33468203|NCT00573170|101603802|FG002|Second Washout Period|Withdrawal by Subject|2|||
33468204|NCT00573170|101603803|FG003|Second Washout Period|Withdrawal by Subject|0|||
33179446|NCT00303498|100563904|FG001|Run-In-Phase (10 Weeks)|Other|1|||
33179447|NCT00303498|100563903|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
33179448|NCT00303498|100563904|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
33179449|NCT00303498|100563903|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
33179450|NCT00303498|100563904|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
33179451|NCT00303498|100563903|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
33179452|NCT00303498|100563904|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
33179453|NCT00303498|100563903|FG000|Maintenance Phase (24 Weeks)|Death|1|||
33179454|NCT00303498|100563904|FG001|Maintenance Phase (24 Weeks)|Death|0|||
33179455|NCT00303498|100563903|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
33179456|NCT00303498|100563904|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
33179457|NCT00303498|100563903|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
33179458|NCT00303498|100563904|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
33179459|NCT00303498|100563903|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
33179460|NCT00303498|100563904|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
33265331|NCT01532999|100870333|FG001|Overall Study|Adverse Event|1|||
33265332|NCT01532999|100870332|FG000|Overall Study|incarcerated|0|||
33265333|NCT01532999|100870333|FG001|Overall Study|incarcerated|1|||
33265334|NCT01532999|100870332|FG000|Overall Study|New job|0|||
33265335|NCT01532999|100870333|FG001|Overall Study|New job|2|||
33265336|NCT05184062|100873657|FG000|Overall Study|Lost to Follow-up|5|||
33265337|NCT05184062|100873658|FG001|Overall Study|Lost to Follow-up|1|||
33265338|NCT05184062|100873657|FG000|Overall Study|Withdrawal by Subject|1|||
33265339|NCT05184062|100873658|FG001|Overall Study|Withdrawal by Subject|0|||
33265340|NCT01478594|100873659|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
33265341|NCT01478594|100873660|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
33265342|NCT01478594|100873659|FG000|Overall Study|Death|45|||
33265343|NCT01478594|100873660|FG001|Overall Study|Death|18|||
33265344|NCT01478594|100873659|FG000|Overall Study|Lost to Follow-up|3|||
33265345|NCT01478594|100873660|FG001|Overall Study|Lost to Follow-up|1|||
33265346|NCT01478594|100873659|FG000|Overall Study|Withdrawal by Subject|9|||
33265347|NCT01478594|100873660|FG001|Overall Study|Withdrawal by Subject|3|||
33265348|NCT01478594|100873659|FG000|Overall Study|Study Closed by Sponsor|8|||
33265349|NCT01478594|100873660|FG001|Overall Study|Study Closed by Sponsor|5|||
33265350|NCT02561195|100873661|FG000|Vaccination 1 to 3|Adverse Event|4|||
33265351|NCT02561195|100873662|FG001|Vaccination 1 to 3|Adverse Event|5|||
33265352|NCT02561195|100873663|FG002|Vaccination 1 to 3|Adverse Event|0|||
33265353|NCT02561195|100873664|FG003|Vaccination 1 to 3|Adverse Event|3|||
33265354|NCT02561195|100873665|FG004|Vaccination 1 to 3|Adverse Event|4|||
33265355|NCT02561195|100873666|FG005|Vaccination 1 to 3|Adverse Event|0|||
33265356|NCT02561195|100873667|FG006|Vaccination 1 to 3|Adverse Event|0|||
33265357|NCT02561195|100873668|FG007|Vaccination 1 to 3|Adverse Event|0|||
33265358|NCT02561195|100873669|FG008|Vaccination 1 to 3|Adverse Event|0|||
33265359|NCT02561195|100873670|FG009|Vaccination 1 to 3|Adverse Event|0|||
33265360|NCT02561195|100873671|FG010|Vaccination 1 to 3|Adverse Event|0|||
33265361|NCT02561195|100873672|FG011|Vaccination 1 to 3|Adverse Event|0|||
33265362|NCT02561195|100873673|FG012|Vaccination 1 to 3|Adverse Event|0|||
33265363|NCT02561195|100873674|FG013|Vaccination 1 to 3|Adverse Event|0|||
33179461|NCT00303498|100563903|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
33179462|NCT00303498|100563904|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
33179463|NCT00303498|100563903|FG000|Maintenance Phase (24 Weeks)|Other|1|||
33179464|NCT00303498|100563904|FG001|Maintenance Phase (24 Weeks)|Other|0|||
33179465|NCT00303498|100563903|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
33179466|NCT00303498|100563904|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
33179467|NCT00303498|100563903|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
33179468|NCT00303498|100563904|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
33179469|NCT02005250|100563906|FG000|Overall Study|Lost to Follow-up|15|||
33179470|NCT02005250|100563907|FG001|Overall Study|Lost to Follow-up|5|||
33179471|NCT02604212|100563913|FG000|Overall Study|Study Terminated by Sponsor|2|||
33179472|NCT02604212|100563914|FG001|Overall Study|Study Terminated by Sponsor|1|||
33179473|NCT02604212|100563915|FG002|Overall Study|Study Terminated by Sponsor|3|||
33179474|NCT02604212|100563916|FG003|Overall Study|Study Terminated by Sponsor|3|||
33179475|NCT02604212|100563913|FG000|Overall Study|Withdrawal by Subject|0|||
33179476|NCT02604212|100563914|FG001|Overall Study|Withdrawal by Subject|0|||
33179477|NCT02604212|100563915|FG002|Overall Study|Withdrawal by Subject|1|||
33265364|NCT02561195|100873661|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
33265365|NCT02561195|100873662|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
33265366|NCT02561195|100873663|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
33265367|NCT02561195|100873664|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
33265368|NCT02561195|100873665|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
33468205|NCT00573170|101603804|FG004|Second Washout Period|Withdrawal by Subject|1|||
33468206|NCT00573170|101603805|FG005|Second Washout Period|Withdrawal by Subject|0|||
33468207|NCT00573170|101603800|FG000|Second Washout Period|Lost to Follow-up|0|||
33265369|NCT02561195|100873666|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
33468208|NCT00573170|101603801|FG001|Second Washout Period|Lost to Follow-up|0|||
33179478|NCT02604212|100563916|FG003|Overall Study|Withdrawal by Subject|0|||
33179479|NCT00832585|100563919|FG000|Overall Study|Withdrawal by Subject|1|||
33179480|NCT00832585|100563919|FG000|Overall Study|Lost to Follow-up|1|||
33265370|NCT02561195|100873667|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
33265371|NCT02561195|100873668|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
33265372|NCT02561195|100873669|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
33265373|NCT02561195|100873670|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
33265374|NCT02561195|100873671|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
33265375|NCT02561195|100873672|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
33265376|NCT02561195|100873673|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
33265377|NCT02561195|100873674|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
33468209|NCT00573170|101603802|FG002|Second Washout Period|Lost to Follow-up|0|||
33468210|NCT00573170|101603803|FG003|Second Washout Period|Lost to Follow-up|1|||
33468211|NCT00573170|101603804|FG004|Second Washout Period|Lost to Follow-up|0|||
33468212|NCT00573170|101603805|FG005|Second Washout Period|Lost to Follow-up|0|||
33468213|NCT00573170|101603800|FG000|Second Washout Period|Other|1|||
33468214|NCT00573170|101603801|FG001|Second Washout Period|Other|2|||
33468215|NCT00573170|101603802|FG002|Second Washout Period|Other|1|||
33468216|NCT00573170|101603803|FG003|Second Washout Period|Other|4|||
33468217|NCT00573170|101603804|FG004|Second Washout Period|Other|6|||
33468218|NCT00573170|101603805|FG005|Second Washout Period|Other|2|||
33468219|NCT00573170|101603800|FG000|Third Treatment Period|Withdrawal by Subject|1|||
33179481|NCT04166435|100563920|FG000|Overall Study|2 patients ineligible for response|2|||
33179482|NCT01092182|100563921|FG000|Overall Study|Death|0|||
33179483|NCT01092182|100563922|FG001|Overall Study|Death|5|||
33265378|NCT02561195|100873661|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33265379|NCT02561195|100873662|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
33468220|NCT00573170|101603801|FG001|Third Treatment Period|Withdrawal by Subject|0|||
33468221|NCT00573170|101603802|FG002|Third Treatment Period|Withdrawal by Subject|0|||
33179484|NCT01092182|100563923|FG002|Overall Study|Death|3|||
33179485|NCT01092182|100563921|FG000|Overall Study|participant safety|1|||
33179486|NCT01092182|100563922|FG001|Overall Study|participant safety|2|||
33179487|NCT01092182|100563923|FG002|Overall Study|participant safety|0|||
33179488|NCT01092182|100563921|FG000|Overall Study|Physician Decision|0|||
33179489|NCT01092182|100563922|FG001|Overall Study|Physician Decision|6|||
33179490|NCT01092182|100563923|FG002|Overall Study|Physician Decision|0|||
33179491|NCT01092182|100563921|FG000|Overall Study|Did not meet criteria|0|||
33179492|NCT01092182|100563922|FG001|Overall Study|Did not meet criteria|0|||
33179493|NCT01092182|100563923|FG002|Overall Study|Did not meet criteria|25|||
33179494|NCT01092182|100563921|FG000|Overall Study|Non-compliance|0|||
33179495|NCT01092182|100563922|FG001|Overall Study|Non-compliance|3|||
33179496|NCT01092182|100563923|FG002|Overall Study|Non-compliance|0|||
33179497|NCT01092182|100563921|FG000|Overall Study|Participant refused follow-up|0|||
33179498|NCT01092182|100563922|FG001|Overall Study|Participant refused follow-up|2|||
33179499|NCT01092182|100563923|FG002|Overall Study|Participant refused follow-up|0|||
33179500|NCT00450333|100563924|FG000|Overall Study|Study terminated|47|||
33179501|NCT00450333|100563925|FG001|Overall Study|Study terminated|54|||
33179502|NCT00450333|100563926|FG002|Overall Study|Study terminated|16|||
33179503|NCT00450333|100563927|FG003|Overall Study|Study terminated|21|||
33179504|NCT00450333|100563924|FG000|Overall Study|Adverse Event|1|||
33179505|NCT00450333|100563925|FG001|Overall Study|Adverse Event|7|||
33179506|NCT00450333|100563926|FG002|Overall Study|Adverse Event|2|||
33179507|NCT00450333|100563927|FG003|Overall Study|Adverse Event|2|||
33179508|NCT00450333|100563924|FG000|Overall Study|Protocol Violation|1|||
33179509|NCT00450333|100563925|FG001|Overall Study|Protocol Violation|0|||
33179510|NCT00450333|100563926|FG002|Overall Study|Protocol Violation|1|||
33179511|NCT00450333|100563927|FG003|Overall Study|Protocol Violation|0|||
33179512|NCT00450333|100563924|FG000|Overall Study|Withdrawal by Subject|1|||
33179513|NCT00450333|100563925|FG001|Overall Study|Withdrawal by Subject|0|||
33179514|NCT00450333|100563926|FG002|Overall Study|Withdrawal by Subject|3|||
33179515|NCT00450333|100563927|FG003|Overall Study|Withdrawal by Subject|0|||
33179516|NCT00450333|100563924|FG000|Overall Study|Kidney transplant|1|||
33179517|NCT00450333|100563925|FG001|Overall Study|Kidney transplant|0|||
33179518|NCT00450333|100563926|FG002|Overall Study|Kidney transplant|1|||
33179519|NCT00450333|100563927|FG003|Overall Study|Kidney transplant|3|||
33179520|NCT00450333|100563924|FG000|Overall Study|Death|3|||
33179521|NCT00450333|100563925|FG001|Overall Study|Death|2|||
33179522|NCT00450333|100563926|FG002|Overall Study|Death|2|||
33179523|NCT00450333|100563927|FG003|Overall Study|Death|2|||
33179524|NCT00228917|100563928|FG000|Overall Study|Migrated/moved from study area|0|||
33179525|NCT00228917|100563929|FG001|Overall Study|Migrated/moved from study area|0|||
33179526|NCT00228917|100563930|FG002|Overall Study|Migrated/moved from study area|0|||
33179527|NCT00228917|100563931|FG003|Overall Study|Migrated/moved from study area|0|||
33179528|NCT00228917|100563932|FG004|Overall Study|Migrated/moved from study area|0|||
33179529|NCT00228917|100563933|FG005|Overall Study|Migrated/moved from study area|2|||
33468222|NCT00573170|101603803|FG003|Third Treatment Period|Withdrawal by Subject|0|||
33179530|NCT00228917|100563934|FG006|Overall Study|Migrated/moved from study area|0|||
33179531|NCT00228917|100563935|FG007|Overall Study|Migrated/moved from study area|0|||
33179532|NCT02389998|100568037|FG000|Overall Study|car accident|1|||
33179533|NCT02389998|100568038|FG001|Overall Study|car accident|0|||
33179534|NCT03011307|100568041|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
33179535|NCT03011307|100568042|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
33179536|NCT03011307|100568041|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
33179537|NCT03011307|100568042|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
33179538|NCT03011307|100568041|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
33179539|NCT03011307|100568042|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
33179540|NCT02587065|100568047|FG000|Overall Study|Adverse Event|14|||
33179541|NCT02587065|100568047|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
33179542|NCT02587065|100568047|FG000|Overall Study|Non-adherence to the Protocol|3|||
33179543|NCT02587065|100568047|FG000|Overall Study|Discontinuation of Study Medication|2|||
33179544|NCT02587065|100568047|FG000|Overall Study|Reason not Specified|3|||
33179545|NCT02617511|100568051|FG000|Overall Study|Withdrawal by Subject|1|||
33179546|NCT02617511|100568052|FG001|Overall Study|Withdrawal by Subject|0|||
33468223|NCT00573170|101603804|FG004|Third Treatment Period|Withdrawal by Subject|0|||
33468224|NCT00573170|101603805|FG005|Third Treatment Period|Withdrawal by Subject|0|||
33468225|NCT00573170|101603800|FG000|Third Treatment Period|Lost to Follow-up|0|||
33468226|NCT00573170|101603801|FG001|Third Treatment Period|Lost to Follow-up|0|||
33468227|NCT00573170|101603802|FG002|Third Treatment Period|Lost to Follow-up|0|||
33468228|NCT00573170|101603803|FG003|Third Treatment Period|Lost to Follow-up|0|||
33468229|NCT00573170|101603804|FG004|Third Treatment Period|Lost to Follow-up|0|||
33468230|NCT00573170|101603805|FG005|Third Treatment Period|Lost to Follow-up|2|||
33468231|NCT01546649|101603806|FG000|Overall Study|Adverse Event|4|||
33468232|NCT01546649|101603807|FG001|Overall Study|Adverse Event|5|||
33468233|NCT01546649|101603806|FG000|Overall Study|Protocol Violation|1|||
33468234|NCT01546649|101603807|FG001|Overall Study|Protocol Violation|0|||
33468235|NCT01546649|101603806|FG000|Overall Study|Lack of Efficacy|1|||
33468236|NCT01546649|101603807|FG001|Overall Study|Lack of Efficacy|0|||
33468237|NCT01546649|101603806|FG000|Overall Study|Recurrence|1|||
33468238|NCT01546649|101603807|FG001|Overall Study|Recurrence|1|||
33468239|NCT01546649|101603806|FG000|Overall Study|Discovery of secondary cancer|0|||
33468240|NCT01546649|101603807|FG001|Overall Study|Discovery of secondary cancer|1|||
33468241|NCT01546649|101603806|FG000|Overall Study|Withdrawal by Subject|1|||
33468242|NCT01546649|101603807|FG001|Overall Study|Withdrawal by Subject|2|||
33468243|NCT02384850|101603814|FG000|Overall Study|Withdrawal by Subject|2|||
33468244|NCT02384850|101603815|FG001|Overall Study|Withdrawal by Subject|2|||
33468245|NCT01280617|101603816|FG000|Overall Study|Adverse Event|0|||
33468246|NCT01280617|101603817|FG001|Overall Study|Adverse Event|1|||
33468247|NCT03463993|101603818|FG000|Overall Study|Lost to Follow-up|7|||
33265380|NCT02561195|100873663|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33265381|NCT02561195|100873664|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
33265382|NCT02561195|100873665|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
33265383|NCT02561195|100873666|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
33265384|NCT02561195|100873667|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33265385|NCT02561195|100873668|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33265386|NCT02561195|100873669|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33468248|NCT03463993|101603819|FG001|Overall Study|Lost to Follow-up|8|||
33468249|NCT03463993|101603818|FG000|Overall Study|Withdrawal by Subject|2|||
33468250|NCT03463993|101603819|FG001|Overall Study|Withdrawal by Subject|0|||
33468251|NCT03463993|101603818|FG000|Overall Study|Protocol Violation|4|||
33468252|NCT03463993|101603819|FG001|Overall Study|Protocol Violation|1|||
33468253|NCT03463993|101603818|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
33468254|NCT03463993|101603819|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
33468255|NCT03463993|101603818|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
33468256|NCT03463993|101603819|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
33179547|NCT04339296|100568055|FG000|Overall Study|Refuse to participate after allocation|1|||
33179548|NCT04339296|100568056|FG001|Overall Study|Refuse to participate after allocation|1|||
33179549|NCT04339296|100568055|FG000|Overall Study|Withdrew after completion of baseline|2|||
33179550|NCT04339296|100568056|FG001|Overall Study|Withdrew after completion of baseline|1|||
33179551|NCT04339296|100568055|FG000|Overall Study|Lost to Follow-up|0|||
33179552|NCT04339296|100568056|FG001|Overall Study|Lost to Follow-up|4|||
33179553|NCT04339296|100568055|FG000|Overall Study|Discontinued intervention|5|||
33179554|NCT04339296|100568056|FG001|Overall Study|Discontinued intervention|3|||
33179555|NCT00322842|100568064|FG000|Overall Study|Withdrawal by Subject|0|||
33179556|NCT00322842|100568065|FG001|Overall Study|Withdrawal by Subject|1|||
33468257|NCT00685802|101603820|FG000|Washout Period of 7 Days|Protocol Violation|2|||
33179557|NCT00322842|100568064|FG000|Overall Study|Lost to Follow-up|0|||
33468258|NCT00685802|101603821|FG001|Washout Period of 7 Days|Protocol Violation|0|||
33468259|NCT00685802|101603820|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
33468260|NCT00685802|101603821|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
33468261|NCT00977548|101603827|FG000|Overall Study|Ineligible|4|||
33468262|NCT00977548|101603827|FG000|Overall Study|Adverse Event|8|||
33468263|NCT00977548|101603827|FG000|Overall Study|Withdrawal by Subject|1|||
33468264|NCT01131299|101603828|FG000|Overall Study|Withdrawal by Subject|4|||
33468265|NCT01131299|101603829|FG001|Overall Study|Withdrawal by Subject|7|||
33468266|NCT02610816|101603830|FG000|Phase 1|Withdrawal by Subject|2|||
33468267|NCT02610816|101603831|FG001|Phase 1|Withdrawal by Subject|6|||
33468268|NCT02610816|101603832|FG002|Phase 1|Withdrawal by Subject|0|||
33265387|NCT02561195|100873670|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33265388|NCT02561195|100873671|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33265389|NCT02561195|100873672|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33265390|NCT02561195|100873673|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33265391|NCT02561195|100873674|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
33265392|NCT02561195|100873661|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
33265393|NCT02561195|100873662|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
33265394|NCT02561195|100873663|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
33265395|NCT02561195|100873664|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
33265396|NCT02561195|100873665|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
33265397|NCT02561195|100873666|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
33265398|NCT02561195|100873667|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
33265399|NCT02561195|100873668|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
33265400|NCT02561195|100873669|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
33265401|NCT02561195|100873670|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
33265402|NCT02561195|100873671|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
33468269|NCT02610816|101603833|FG003|Phase 1|Withdrawal by Subject|0|||
33468270|NCT02610816|101603830|FG000|Phase 1|Lost to Follow-up|2|||
33468271|NCT02610816|101603831|FG001|Phase 1|Lost to Follow-up|1|||
33468272|NCT02610816|101603832|FG002|Phase 1|Lost to Follow-up|0|||
33468273|NCT02610816|101603833|FG003|Phase 1|Lost to Follow-up|0|||
33179558|NCT00322842|100568065|FG001|Overall Study|Lost to Follow-up|1|||
33179559|NCT00322842|100568064|FG000|Overall Study|Refused transplant|1|||
33179560|NCT00322842|100568065|FG001|Overall Study|Refused transplant|0|||
33179561|NCT00322842|100568064|FG000|Overall Study|Death|1|||
33179562|NCT00322842|100568065|FG001|Overall Study|Death|0|||
33179563|NCT00326950|100568066|FG000|Overall Study|Progressive Disease|1|||
33179564|NCT02016482|100568071|FG000|Period A|Adverse Event|3|||
33179565|NCT02016482|100568072|FG001|Period A|Adverse Event|5|||
33179566|NCT02016482|100568071|FG000|Period A|Withdrawal by Subject|3|||
33179567|NCT02016482|100568072|FG001|Period A|Withdrawal by Subject|4|||
33179568|NCT02016482|100568071|FG000|Period A|Lost to Follow-up|3|||
33179569|NCT02016482|100568072|FG001|Period A|Lost to Follow-up|3|||
33179570|NCT02016482|100568071|FG000|Period A|Lack of Efficacy|2|||
33179571|NCT02016482|100568072|FG001|Period A|Lack of Efficacy|1|||
33179572|NCT02016482|100568071|FG000|Period A|Other|3|||
33179573|NCT02016482|100568072|FG001|Period A|Other|0|||
33179574|NCT02016482|100568071|FG000|Period A|Protocol Violation|0|||
33179575|NCT02016482|100568072|FG001|Period A|Protocol Violation|1|||
33179576|NCT02016482|100568071|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
33179577|NCT02016482|100568072|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
33179578|NCT02016482|100568071|FG000|Period B|Withdrawal by Subject|1|||
33179579|NCT02016482|100568072|FG001|Period B|Withdrawal by Subject|1|||
33179580|NCT02016482|100568071|FG000|Period B|Lost to Follow-up|2|||
33179581|NCT02016482|100568072|FG001|Period B|Lost to Follow-up|0|||
33179582|NCT02016482|100568071|FG000|Period B|Lack of Efficacy|6|||
33179583|NCT02016482|100568072|FG001|Period B|Lack of Efficacy|4|||
33179584|NCT02016482|100568071|FG000|Period B|Other|4|||
33179585|NCT02016482|100568072|FG001|Period B|Other|0|||
33179586|NCT02016482|100568071|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
33179587|NCT02016482|100568072|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
33179588|NCT03739112|100568073|FG000|Overall Study|Adverse Event|2|||
33179589|NCT03739112|100568074|FG001|Overall Study|Adverse Event|2|||
33179590|NCT03739112|100568073|FG000|Overall Study|Withdrawal by Subject|38|||
33179591|NCT03739112|100568074|FG001|Overall Study|Withdrawal by Subject|19|||
33179592|NCT03739112|100568073|FG000|Overall Study|Lost to Follow-up|31|||
33468274|NCT02610816|101603830|FG000|Phase 1|Physician Decision|0|||
33468275|NCT02610816|101603831|FG001|Phase 1|Physician Decision|1|||
33468276|NCT02610816|101603832|FG002|Phase 1|Physician Decision|0|||
33179593|NCT03739112|100568074|FG001|Overall Study|Lost to Follow-up|33|||
33179594|NCT03739112|100568073|FG000|Overall Study|Protocol Deviation|12|||
33179595|NCT03739112|100568074|FG001|Overall Study|Protocol Deviation|9|||
33179596|NCT03739112|100568073|FG000|Overall Study|Physician Decision|1|||
33179597|NCT03739112|100568074|FG001|Overall Study|Physician Decision|0|||
33179598|NCT03739112|100568073|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
33179599|NCT03739112|100568074|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
33265403|NCT02561195|100873672|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
33265404|NCT02561195|100873673|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
33265405|NCT02561195|100873674|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
33265406|NCT02561195|100873661|FG000|Vaccination 1 to 3|Other|7|||
33265407|NCT02561195|100873662|FG001|Vaccination 1 to 3|Other|3|||
33265408|NCT02561195|100873663|FG002|Vaccination 1 to 3|Other|1|||
33265409|NCT02561195|100873664|FG003|Vaccination 1 to 3|Other|7|||
33265410|NCT02561195|100873665|FG004|Vaccination 1 to 3|Other|5|||
33265411|NCT02561195|100873666|FG005|Vaccination 1 to 3|Other|1|||
33179600|NCT03739112|100568073|FG000|Overall Study|Site went on hold|65|||
33179601|NCT03739112|100568074|FG001|Overall Study|Site went on hold|67|||
33179602|NCT03739112|100568073|FG000|Overall Study|Other than specified|8|||
33179603|NCT03739112|100568074|FG001|Overall Study|Other than specified|5|||
33179604|NCT03739112|100568073|FG000|Overall Study|Randomized but not vaccinated|31|||
33179605|NCT03739112|100568074|FG001|Overall Study|Randomized but not vaccinated|25|||
33179606|NCT00949325|100568076|FG000|Overall Study|Adverse Event|0|||
33265412|NCT02561195|100873667|FG006|Vaccination 1 to 3|Other|0|||
33265413|NCT02561195|100873668|FG007|Vaccination 1 to 3|Other|0|||
33265414|NCT02561195|100873669|FG008|Vaccination 1 to 3|Other|0|||
33265415|NCT02561195|100873670|FG009|Vaccination 1 to 3|Other|0|||
33265416|NCT02561195|100873671|FG010|Vaccination 1 to 3|Other|0|||
33265417|NCT02561195|100873672|FG011|Vaccination 1 to 3|Other|0|||
33265418|NCT02561195|100873673|FG012|Vaccination 1 to 3|Other|0|||
33265419|NCT02561195|100873674|FG013|Vaccination 1 to 3|Other|0|||
33265420|NCT02561195|100873661|FG000|Vaccination 1 to 3|Protocol Violation|1|||
33265421|NCT02561195|100873662|FG001|Vaccination 1 to 3|Protocol Violation|0|||
33265422|NCT02561195|100873663|FG002|Vaccination 1 to 3|Protocol Violation|1|||
33265423|NCT02561195|100873664|FG003|Vaccination 1 to 3|Protocol Violation|2|||
33265424|NCT02561195|100873665|FG004|Vaccination 1 to 3|Protocol Violation|5|||
33265425|NCT02561195|100873666|FG005|Vaccination 1 to 3|Protocol Violation|2|||
33265426|NCT02561195|100873667|FG006|Vaccination 1 to 3|Protocol Violation|0|||
33265427|NCT02561195|100873668|FG007|Vaccination 1 to 3|Protocol Violation|0|||
33265428|NCT02561195|100873669|FG008|Vaccination 1 to 3|Protocol Violation|0|||
33265429|NCT02561195|100873670|FG009|Vaccination 1 to 3|Protocol Violation|0|||
33265430|NCT02561195|100873671|FG010|Vaccination 1 to 3|Protocol Violation|0|||
33265431|NCT02561195|100873672|FG011|Vaccination 1 to 3|Protocol Violation|0|||
33265432|NCT02561195|100873673|FG012|Vaccination 1 to 3|Protocol Violation|0|||
33265433|NCT02561195|100873674|FG013|Vaccination 1 to 3|Protocol Violation|0|||
33265434|NCT02561195|100873661|FG000|Vaccination 1 to 3|Death|2|||
33265435|NCT02561195|100873662|FG001|Vaccination 1 to 3|Death|1|||
33265436|NCT02561195|100873663|FG002|Vaccination 1 to 3|Death|0|||
33265437|NCT02561195|100873664|FG003|Vaccination 1 to 3|Death|2|||
33265438|NCT02561195|100873665|FG004|Vaccination 1 to 3|Death|0|||
33265439|NCT02561195|100873666|FG005|Vaccination 1 to 3|Death|0|||
33265440|NCT02561195|100873667|FG006|Vaccination 1 to 3|Death|0|||
33265441|NCT02561195|100873668|FG007|Vaccination 1 to 3|Death|0|||
33265442|NCT02561195|100873669|FG008|Vaccination 1 to 3|Death|0|||
33265443|NCT02561195|100873670|FG009|Vaccination 1 to 3|Death|0|||
33265444|NCT02561195|100873671|FG010|Vaccination 1 to 3|Death|0|||
33265445|NCT02561195|100873672|FG011|Vaccination 1 to 3|Death|0|||
33265446|NCT02561195|100873673|FG012|Vaccination 1 to 3|Death|0|||
33265447|NCT02561195|100873674|FG013|Vaccination 1 to 3|Death|0|||
33265448|NCT02561195|100873661|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
33265449|NCT02561195|100873662|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
33265450|NCT02561195|100873663|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
33265451|NCT02561195|100873664|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
33265452|NCT02561195|100873665|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
33265453|NCT02561195|100873666|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
33265454|NCT02561195|100873667|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
33265455|NCT02561195|100873668|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
33265456|NCT02561195|100873669|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
33265457|NCT02561195|100873670|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
33265458|NCT02561195|100873671|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
33468277|NCT02610816|101603833|FG003|Phase 1|Physician Decision|0|||
33468278|NCT02610816|101603830|FG000|Phase 2|Withdrawal by Subject|0|||
33265459|NCT02561195|100873672|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
33265460|NCT02561195|100873673|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
33265461|NCT02561195|100873674|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
33265462|NCT02561195|100873661|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
33265463|NCT02561195|100873662|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
33468279|NCT02610816|101603831|FG001|Phase 2|Withdrawal by Subject|0|||
33179607|NCT00949325|100568077|FG001|Overall Study|Adverse Event|2|||
33179608|NCT00949325|100568078|FG002|Overall Study|Adverse Event|0|||
33265464|NCT02561195|100873663|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
33265465|NCT02561195|100873664|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
33468280|NCT02610816|101603832|FG002|Phase 2|Withdrawal by Subject|9|||
33265466|NCT02561195|100873665|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
33265467|NCT02561195|100873666|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
33265468|NCT02561195|100873667|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
33265469|NCT02561195|100873668|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
33265470|NCT02561195|100873669|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
33265471|NCT02561195|100873670|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
33265472|NCT02561195|100873671|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
33265473|NCT02561195|100873672|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
33265474|NCT02561195|100873673|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
33265475|NCT02561195|100873674|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
33265476|NCT02561195|100873661|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33265477|NCT02561195|100873662|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33265478|NCT02561195|100873663|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33265479|NCT02561195|100873664|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33265480|NCT02561195|100873665|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33265481|NCT02561195|100873666|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33265482|NCT02561195|100873667|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33265483|NCT02561195|100873668|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33265484|NCT02561195|100873669|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
33265485|NCT02561195|100873670|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
33265486|NCT02561195|100873671|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
33265487|NCT02561195|100873672|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
33265488|NCT02561195|100873673|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
33265489|NCT02561195|100873674|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
33265490|NCT02561195|100873661|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
33265491|NCT02561195|100873662|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
33265492|NCT02561195|100873663|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
33265493|NCT02561195|100873664|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
33265494|NCT02561195|100873665|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
33265495|NCT02561195|100873666|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
33265496|NCT02561195|100873667|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
33265497|NCT02561195|100873668|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
33265498|NCT02561195|100873669|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
33265499|NCT02561195|100873670|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
33265500|NCT02561195|100873671|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
33265501|NCT02561195|100873672|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
33265502|NCT02561195|100873673|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
33265503|NCT02561195|100873674|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
33265504|NCT02561195|100873661|FG000|Extension Stage (Vaccination 4)|Death|0|||
33265505|NCT02561195|100873662|FG001|Extension Stage (Vaccination 4)|Death|0|||
33265506|NCT02561195|100873663|FG002|Extension Stage (Vaccination 4)|Death|0|||
33265507|NCT02561195|100873664|FG003|Extension Stage (Vaccination 4)|Death|0|||
33265508|NCT02561195|100873665|FG004|Extension Stage (Vaccination 4)|Death|0|||
33265509|NCT02561195|100873666|FG005|Extension Stage (Vaccination 4)|Death|0|||
33265510|NCT02561195|100873667|FG006|Extension Stage (Vaccination 4)|Death|0|||
33265511|NCT02561195|100873668|FG007|Extension Stage (Vaccination 4)|Death|0|||
33265512|NCT02561195|100873669|FG008|Extension Stage (Vaccination 4)|Death|0|||
33265513|NCT02561195|100873670|FG009|Extension Stage (Vaccination 4)|Death|1|||
33265514|NCT02561195|100873671|FG010|Extension Stage (Vaccination 4)|Death|0|||
33265515|NCT02561195|100873672|FG011|Extension Stage (Vaccination 4)|Death|0|||
33265516|NCT02561195|100873673|FG012|Extension Stage (Vaccination 4)|Death|0|||
33265517|NCT02561195|100873674|FG013|Extension Stage (Vaccination 4)|Death|0|||
33265518|NCT02561195|100873661|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33265519|NCT02561195|100873662|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33265520|NCT02561195|100873663|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33265521|NCT02561195|100873664|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33265522|NCT02561195|100873665|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33265523|NCT02561195|100873666|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33265524|NCT02561195|100873667|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
33265525|NCT02561195|100873668|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
33265526|NCT02561195|100873669|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33265527|NCT02561195|100873670|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
33265528|NCT02561195|100873671|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
33265529|NCT02561195|100873672|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
33265530|NCT02561195|100873673|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
33265531|NCT02561195|100873674|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
33265532|NCT02561195|100873661|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33265533|NCT02561195|100873662|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33265534|NCT02561195|100873663|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33265535|NCT02561195|100873664|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33265536|NCT02561195|100873665|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33265537|NCT02561195|100873666|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33265538|NCT02561195|100873667|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33265539|NCT02561195|100873668|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33265540|NCT02561195|100873669|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33265541|NCT02561195|100873670|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33265542|NCT02561195|100873671|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
33265543|NCT02561195|100873672|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
33265544|NCT02561195|100873673|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
33179609|NCT01050257|100568081|FG000|Overall Study|Adverse Event|4|||
33179610|NCT01050257|100568082|FG001|Overall Study|Adverse Event|4|||
33179611|NCT01050257|100568083|FG002|Overall Study|Adverse Event|2|||
33179612|NCT01050257|100568081|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
33179613|NCT01050257|100568082|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
33179614|NCT01050257|100568083|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
33179615|NCT01050257|100568081|FG000|Overall Study|Withdrawal by Subject|0|||
33179616|NCT01050257|100568082|FG001|Overall Study|Withdrawal by Subject|3|||
33179617|NCT01050257|100568083|FG002|Overall Study|Withdrawal by Subject|0|||
33179618|NCT01050257|100568081|FG000|Overall Study|No reason specified|0|||
33179619|NCT01050257|100568082|FG001|Overall Study|No reason specified|0|||
33179620|NCT01050257|100568083|FG002|Overall Study|No reason specified|2|||
33179621|NCT01050257|100568081|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
33179622|NCT01050257|100568082|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
33179623|NCT01050257|100568083|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
33179624|NCT01050257|100568081|FG000|Overall Study|Violation criteria|0|||
33179625|NCT01050257|100568082|FG001|Overall Study|Violation criteria|1|||
33265545|NCT02561195|100873674|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
33265546|NCT02561195|100873661|FG000|Extension Stage (Vaccination 4)|Other|0|||
33265547|NCT02561195|100873662|FG001|Extension Stage (Vaccination 4)|Other|0|||
33265548|NCT02561195|100873663|FG002|Extension Stage (Vaccination 4)|Other|0|||
33265549|NCT02561195|100873664|FG003|Extension Stage (Vaccination 4)|Other|0|||
33265550|NCT02561195|100873665|FG004|Extension Stage (Vaccination 4)|Other|0|||
33265551|NCT02561195|100873666|FG005|Extension Stage (Vaccination 4)|Other|0|||
33265552|NCT02561195|100873667|FG006|Extension Stage (Vaccination 4)|Other|0|||
33265553|NCT02561195|100873668|FG007|Extension Stage (Vaccination 4)|Other|0|||
33265554|NCT02561195|100873669|FG008|Extension Stage (Vaccination 4)|Other|0|||
33265555|NCT02561195|100873670|FG009|Extension Stage (Vaccination 4)|Other|0|||
33265556|NCT02561195|100873671|FG010|Extension Stage (Vaccination 4)|Other|2|||
33468281|NCT02610816|101603833|FG003|Phase 2|Withdrawal by Subject|3|||
33468282|NCT02610816|101603830|FG000|Phase 2|Lost to Follow-up|0|||
33468283|NCT02610816|101603831|FG001|Phase 2|Lost to Follow-up|0|||
33468284|NCT02610816|101603832|FG002|Phase 2|Lost to Follow-up|2|||
33468285|NCT02610816|101603833|FG003|Phase 2|Lost to Follow-up|0|||
33468286|NCT02610816|101603830|FG000|Phase 2|Physician Decision|0|||
33468287|NCT02610816|101603831|FG001|Phase 2|Physician Decision|0|||
33179626|NCT01050257|100568083|FG002|Overall Study|Violation criteria|0|||
33179627|NCT01050257|100568081|FG000|Overall Study|Failure to return|0|||
33179628|NCT01050257|100568082|FG001|Overall Study|Failure to return|2|||
33265557|NCT02561195|100873672|FG011|Extension Stage (Vaccination 4)|Other|2|||
33265558|NCT02561195|100873673|FG012|Extension Stage (Vaccination 4)|Other|1|||
33265559|NCT02561195|100873674|FG013|Extension Stage (Vaccination 4)|Other|0|||
33265560|NCT02561195|100873661|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33265561|NCT02561195|100873662|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33265562|NCT02561195|100873663|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33265563|NCT02561195|100873664|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33265564|NCT02561195|100873665|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33265565|NCT02561195|100873666|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33265566|NCT02561195|100873667|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
33265567|NCT02561195|100873668|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33265568|NCT02561195|100873669|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33265569|NCT02561195|100873670|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33265570|NCT02561195|100873671|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
33265571|NCT02561195|100873672|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
33468288|NCT02610816|101603832|FG002|Phase 2|Physician Decision|0|||
33468289|NCT02610816|101603833|FG003|Phase 2|Physician Decision|2|||
33468290|NCT02610816|101603830|FG000|Phase 2|Pregnancy|0|||
33468291|NCT02610816|101603831|FG001|Phase 2|Pregnancy|0|||
33468292|NCT02610816|101603832|FG002|Phase 2|Pregnancy|0|||
33468293|NCT02610816|101603833|FG003|Phase 2|Pregnancy|1|||
33179629|NCT01050257|100568083|FG002|Overall Study|Failure to return|0|||
33179630|NCT01050257|100568081|FG000|Overall Study|Death|0|||
33179631|NCT01050257|100568082|FG001|Overall Study|Death|0|||
33179632|NCT01050257|100568083|FG002|Overall Study|Death|1|||
33179633|NCT02542631|100568084|FG000|Overall Study|Adverse Event|1|||
33265572|NCT02561195|100873673|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
33265573|NCT02561195|100873674|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
33265574|NCT03041233|100873677|FG000|Overall Study|Death|5|||
33265575|NCT03041233|100873677|FG000|Overall Study|Physician Decision|1|||
33265576|NCT03041233|100873677|FG000|Overall Study|Lost to Follow-up|16|||
33265577|NCT03041233|100873677|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
33265578|NCT03041233|100873677|FG000|Overall Study|Sponsor Request|1|||
33265579|NCT03041233|100873677|FG000|Overall Study|Duplicate subject|1|||
33265580|NCT03041233|100873677|FG000|Overall Study|Re-ablation|1|||
33265581|NCT00739934|100873678|FG000|Voriconazole IV|Adverse Event|6|||
33265582|NCT00739934|100873678|FG000|Voriconazole Oral|Other|3|||
33265583|NCT01915914|100873684|FG000|Acute Phase|Withdrawal by Subject|4|||
33265584|NCT01915914|100873685|FG001|Acute Phase|Withdrawal by Subject|0|||
33265585|NCT01915914|100873686|FG002|Acute Phase|Withdrawal by Subject|0|||
33265586|NCT01915914|100873687|FG003|Acute Phase|Withdrawal by Subject|0|||
33265587|NCT01915914|100873684|FG000|Acute Phase|Lost to Follow-up|4|||
33265588|NCT01915914|100873685|FG001|Acute Phase|Lost to Follow-up|0|||
33265589|NCT01915914|100873686|FG002|Acute Phase|Lost to Follow-up|0|||
33265590|NCT01915914|100873687|FG003|Acute Phase|Lost to Follow-up|0|||
33265591|NCT01915914|100873684|FG000|Acute Phase|Physician Decision|1|||
33265592|NCT01915914|100873685|FG001|Acute Phase|Physician Decision|0|||
33265593|NCT01915914|100873686|FG002|Acute Phase|Physician Decision|0|||
33265594|NCT01915914|100873687|FG003|Acute Phase|Physician Decision|0|||
33265595|NCT01915914|100873684|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
33265596|NCT01915914|100873685|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
33265597|NCT01915914|100873686|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
33265598|NCT01915914|100873687|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
33265599|NCT01915914|100873684|FG000|Acute Phase|"Not Achieved treatment success"|1|||
33265600|NCT01915914|100873685|FG001|Acute Phase|"Not Achieved treatment success"|0|||
33265601|NCT01915914|100873686|FG002|Acute Phase|"Not Achieved treatment success"|0|||
33265602|NCT01915914|100873687|FG003|Acute Phase|"Not Achieved treatment success"|0|||
33265603|NCT01915914|100873684|FG000|Acute Phase|Missing|1|||
33265604|NCT01915914|100873685|FG001|Acute Phase|Missing|0|||
33265605|NCT01915914|100873686|FG002|Acute Phase|Missing|0|||
33265606|NCT01915914|100873687|FG003|Acute Phase|Missing|0|||
33265607|NCT01915914|100873684|FG000|Maintenance Phase|Withdrawal by Subject|0|||
33265608|NCT01915914|100873685|FG001|Maintenance Phase|Withdrawal by Subject|1|||
33265609|NCT01915914|100873686|FG002|Maintenance Phase|Withdrawal by Subject|1|||
33265610|NCT01915914|100873687|FG003|Maintenance Phase|Withdrawal by Subject|0|||
33265611|NCT01915914|100873684|FG000|Maintenance Phase|Lost to Follow-up|0|||
33265612|NCT01915914|100873685|FG001|Maintenance Phase|Lost to Follow-up|4|||
33265613|NCT01915914|100873686|FG002|Maintenance Phase|Lost to Follow-up|1|||
33265614|NCT01915914|100873687|FG003|Maintenance Phase|Lost to Follow-up|0|||
33265615|NCT01915914|100873684|FG000|Maintenance Phase|Missing|0|||
33265616|NCT01915914|100873685|FG001|Maintenance Phase|Missing|1|||
33265617|NCT01915914|100873686|FG002|Maintenance Phase|Missing|0|||
33265618|NCT01915914|100873687|FG003|Maintenance Phase|Missing|0|||
33265619|NCT01915914|100873684|FG000|Follow-up Phase|Withdrawal by Subject|0|||
33265620|NCT01915914|100873685|FG001|Follow-up Phase|Withdrawal by Subject|0|||
33265621|NCT01915914|100873686|FG002|Follow-up Phase|Withdrawal by Subject|0|||
33265622|NCT01915914|100873687|FG003|Follow-up Phase|Withdrawal by Subject|1|||
33265623|NCT01915914|100873684|FG000|Follow-up Phase|Physician Decision|0|||
33265624|NCT01915914|100873685|FG001|Follow-up Phase|Physician Decision|0|||
33265625|NCT01915914|100873686|FG002|Follow-up Phase|Physician Decision|0|||
33265626|NCT01915914|100873687|FG003|Follow-up Phase|Physician Decision|1|||
33265627|NCT00753545|100873688|FG000|Overall Study|Death|98|||
33265628|NCT00753545|100873689|FG001|Overall Study|Death|112|||
33265629|NCT00753545|100873688|FG000|Overall Study|Lost to Follow-up|2|||
33265630|NCT00753545|100873689|FG001|Overall Study|Lost to Follow-up|3|||
33265631|NCT00753545|100873688|FG000|Overall Study|Protocol Violation|1|||
33265632|NCT00753545|100873689|FG001|Overall Study|Protocol Violation|0|||
33265633|NCT00753545|100873688|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
33265634|NCT00753545|100873689|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
33468294|NCT00597116|101603834|FG000|Overall Study|Adverse Event|2|||
33468295|NCT00597116|101603835|FG001|Overall Study|Adverse Event|1|||
33265635|NCT04250636|100873693|FG000|Overall Study|Lost to Follow-up|2|||
33265636|NCT04097535|100873694|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
33265637|NCT03451422|100873695|FG000|Overall Study|Lost to Follow-up|0|||
33265638|NCT03451422|100873696|FG001|Overall Study|Lost to Follow-up|0|||
33265639|NCT03451422|100873697|FG002|Overall Study|Lost to Follow-up|0|||
33265640|NCT03451422|100873698|FG003|Overall Study|Lost to Follow-up|0|||
33265641|NCT03451422|100873699|FG004|Overall Study|Lost to Follow-up|0|||
33265642|NCT03451422|100873700|FG005|Overall Study|Lost to Follow-up|1|||
33265643|NCT03451422|100873695|FG000|Overall Study|Decision by sponsor|1|||
33265644|NCT03451422|100873696|FG001|Overall Study|Decision by sponsor|0|||
33468296|NCT00597116|101603834|FG000|Overall Study|Withdrawal by Subject|0|||
33265645|NCT03451422|100873697|FG002|Overall Study|Decision by sponsor|1|||
33468297|NCT00597116|101603835|FG001|Overall Study|Withdrawal by Subject|2|||
33265646|NCT03451422|100873698|FG003|Overall Study|Decision by sponsor|0|||
33265647|NCT03451422|100873699|FG004|Overall Study|Decision by sponsor|0|||
33265648|NCT03451422|100873700|FG005|Overall Study|Decision by sponsor|0|||
33265649|NCT03451422|100873695|FG000|Overall Study|Withdrawal by Subject|0|||
33265650|NCT03451422|100873696|FG001|Overall Study|Withdrawal by Subject|0|||
33265651|NCT03451422|100873697|FG002|Overall Study|Withdrawal by Subject|2|||
33265652|NCT03451422|100873698|FG003|Overall Study|Withdrawal by Subject|3|||
33265653|NCT03451422|100873699|FG004|Overall Study|Withdrawal by Subject|2|||
33265654|NCT03451422|100873700|FG005|Overall Study|Withdrawal by Subject|1|||
33265655|NCT02079649|100873701|FG000|Overall Study|Lost to Follow-up|0|||
33265656|NCT02079649|100873702|FG001|Overall Study|Lost to Follow-up|0|||
33265657|NCT02079649|100873703|FG002|Overall Study|Lost to Follow-up|0|||
33265658|NCT02079649|100873704|FG003|Overall Study|Lost to Follow-up|1|||
33265659|NCT02079649|100873701|FG000|Overall Study|Withdrawal by Subject|0|||
33265660|NCT02079649|100873702|FG001|Overall Study|Withdrawal by Subject|0|||
33265661|NCT02079649|100873703|FG002|Overall Study|Withdrawal by Subject|0|||
33265662|NCT02079649|100873704|FG003|Overall Study|Withdrawal by Subject|1|||
33265663|NCT02079649|100873701|FG000|Overall Study|Randomization error (prior to treatment)|1|||
33265664|NCT02079649|100873702|FG001|Overall Study|Randomization error (prior to treatment)|0|||
33265665|NCT02079649|100873703|FG002|Overall Study|Randomization error (prior to treatment)|1|||
33265666|NCT02079649|100873704|FG003|Overall Study|Randomization error (prior to treatment)|0|||
33265667|NCT03875313|100873705|FG000|Overall Study|Withdrawal by Subject|1|||
33265668|NCT03875313|100873706|FG001|Overall Study|Withdrawal by Subject|3|||
33265669|NCT03875313|100873707|FG002|Overall Study|Withdrawal by Subject|0|||
33265670|NCT03875313|100873708|FG003|Overall Study|Withdrawal by Subject|0|||
33265671|NCT03875313|100873709|FG004|Overall Study|Withdrawal by Subject|0|||
33265672|NCT03875313|100873705|FG000|Overall Study|Death|0|||
33265673|NCT03875313|100873706|FG001|Overall Study|Death|0|||
33265674|NCT03875313|100873707|FG002|Overall Study|Death|0|||
33265675|NCT03875313|100873708|FG003|Overall Study|Death|0|||
33265676|NCT03875313|100873709|FG004|Overall Study|Death|1|||
33265677|NCT03875313|100873705|FG000|Overall Study|Lost to Follow-up|0|||
33265678|NCT03875313|100873706|FG001|Overall Study|Lost to Follow-up|0|||
33265679|NCT03875313|100873707|FG002|Overall Study|Lost to Follow-up|0|||
33265680|NCT03875313|100873708|FG003|Overall Study|Lost to Follow-up|0|||
33265681|NCT03875313|100873709|FG004|Overall Study|Lost to Follow-up|1|||
33265682|NCT03875313|100873705|FG000|Overall Study|Study Termination by Sponsor|0|||
33265683|NCT03875313|100873706|FG001|Overall Study|Study Termination by Sponsor|1|||
33265684|NCT03875313|100873707|FG002|Overall Study|Study Termination by Sponsor|1|||
33265685|NCT03875313|100873708|FG003|Overall Study|Study Termination by Sponsor|0|||
33265686|NCT03875313|100873709|FG004|Overall Study|Study Termination by Sponsor|1|||
33265687|NCT03875313|100873705|FG000|Overall Study|New Anticancer Treatment|0|||
33265688|NCT03875313|100873706|FG001|Overall Study|New Anticancer Treatment|1|||
33265689|NCT03875313|100873707|FG002|Overall Study|New Anticancer Treatment|2|||
33265690|NCT03875313|100873708|FG003|Overall Study|New Anticancer Treatment|1|||
33265691|NCT03875313|100873709|FG004|Overall Study|New Anticancer Treatment|0|||
33265692|NCT03875313|100873705|FG000|Overall Study|Other, Not Specified|2|||
33265693|NCT03875313|100873706|FG001|Overall Study|Other, Not Specified|11|||
33265694|NCT03875313|100873707|FG002|Overall Study|Other, Not Specified|3|||
33265695|NCT03875313|100873708|FG003|Overall Study|Other, Not Specified|3|||
33265696|NCT03875313|100873709|FG004|Overall Study|Other, Not Specified|1|||
33265697|NCT01566890|100873710|FG000|Overall Study|Adverse Event|1|||
33265698|NCT01566890|100873711|FG001|Overall Study|Adverse Event|0|||
33265699|NCT01566890|100873712|FG002|Overall Study|Adverse Event|0|||
33265700|NCT01566890|100873713|FG003|Overall Study|Adverse Event|0|||
33265701|NCT01566890|100873714|FG004|Overall Study|Adverse Event|0|||
33265702|NCT01566890|100873710|FG000|Overall Study|Withdrawal by Subject|3|||
33265703|NCT01566890|100873711|FG001|Overall Study|Withdrawal by Subject|1|||
33265704|NCT01566890|100873712|FG002|Overall Study|Withdrawal by Subject|1|||
33265705|NCT01566890|100873713|FG003|Overall Study|Withdrawal by Subject|1|||
33265706|NCT01566890|100873714|FG004|Overall Study|Withdrawal by Subject|0|||
33265707|NCT01566890|100873710|FG000|Overall Study|Screen failure|6|||
33265708|NCT01566890|100873711|FG001|Overall Study|Screen failure|0|||
33265709|NCT01566890|100873712|FG002|Overall Study|Screen failure|1|||
33265710|NCT01566890|100873713|FG003|Overall Study|Screen failure|1|||
33265711|NCT01566890|100873714|FG004|Overall Study|Screen failure|0|||
33265712|NCT01566890|100873710|FG000|Overall Study|Incomplete CEU data|1|||
33265713|NCT01566890|100873711|FG001|Overall Study|Incomplete CEU data|3|||
33265714|NCT01566890|100873712|FG002|Overall Study|Incomplete CEU data|5|||
33265715|NCT01566890|100873713|FG003|Overall Study|Incomplete CEU data|8|||
33265716|NCT01566890|100873714|FG004|Overall Study|Incomplete CEU data|0|||
33265717|NCT01566890|100873710|FG000|Overall Study|Lost to Follow-up|0|||
33265718|NCT01566890|100873711|FG001|Overall Study|Lost to Follow-up|0|||
33265719|NCT01566890|100873712|FG002|Overall Study|Lost to Follow-up|4|||
33265720|NCT01566890|100873713|FG003|Overall Study|Lost to Follow-up|4|||
33265721|NCT01566890|100873714|FG004|Overall Study|Lost to Follow-up|0|||
33265722|NCT01566890|100873710|FG000|Overall Study|Other|0|||
33265723|NCT01566890|100873711|FG001|Overall Study|Other|0|||
33265724|NCT01566890|100873712|FG002|Overall Study|Other|0|||
33265725|NCT01566890|100873713|FG003|Overall Study|Other|0|||
33265726|NCT01566890|100873714|FG004|Overall Study|Other|7|||
33265727|NCT01500200|100873715|FG000|Stage 1|Adverse Event|1|||
33265728|NCT01500200|100873716|FG001|Stage 1|Adverse Event|4|||
33265729|NCT01500200|100873717|FG002|Stage 1|Adverse Event|5|||
33265730|NCT01500200|100873718|FG003|Stage 1|Adverse Event|0|||
33265731|NCT01500200|100873719|FG004|Stage 1|Adverse Event|0|||
33265732|NCT01500200|100873720|FG005|Stage 1|Adverse Event|0|||
33265733|NCT01500200|100873715|FG000|Stage 1|Lost to Follow-up|2|||
33265734|NCT01500200|100873716|FG001|Stage 1|Lost to Follow-up|2|||
33265735|NCT01500200|100873717|FG002|Stage 1|Lost to Follow-up|1|||
33265736|NCT01500200|100873718|FG003|Stage 1|Lost to Follow-up|0|||
33265737|NCT01500200|100873719|FG004|Stage 1|Lost to Follow-up|0|||
33265738|NCT01500200|100873720|FG005|Stage 1|Lost to Follow-up|0|||
33265739|NCT01500200|100873715|FG000|Stage 1|Withdrawal by Subject|3|||
33265740|NCT01500200|100873716|FG001|Stage 1|Withdrawal by Subject|0|||
33265741|NCT01500200|100873717|FG002|Stage 1|Withdrawal by Subject|0|||
33265742|NCT01500200|100873718|FG003|Stage 1|Withdrawal by Subject|0|||
33265743|NCT01500200|100873719|FG004|Stage 1|Withdrawal by Subject|0|||
33265744|NCT01500200|100873720|FG005|Stage 1|Withdrawal by Subject|0|||
33265745|NCT01500200|100873715|FG000|Stage 1|Noncompliance with Study Drug|1|||
33265746|NCT01500200|100873716|FG001|Stage 1|Noncompliance with Study Drug|0|||
33265747|NCT01500200|100873717|FG002|Stage 1|Noncompliance with Study Drug|0|||
33265748|NCT01500200|100873718|FG003|Stage 1|Noncompliance with Study Drug|0|||
33265749|NCT01500200|100873719|FG004|Stage 1|Noncompliance with Study Drug|0|||
33265750|NCT01500200|100873720|FG005|Stage 1|Noncompliance with Study Drug|0|||
33265751|NCT01500200|100873715|FG000|Stage 1|Physician Decision|1|||
33265752|NCT01500200|100873716|FG001|Stage 1|Physician Decision|0|||
33265753|NCT01500200|100873717|FG002|Stage 1|Physician Decision|0|||
33468298|NCT00597116|101603834|FG000|Overall Study|Physician Decision|0|||
33468299|NCT00597116|101603835|FG001|Overall Study|Physician Decision|1|||
33179634|NCT02542631|100568085|FG001|Overall Study|Adverse Event|1|||
33179635|NCT02542631|100568084|FG000|Overall Study|Sponsor Termination|1|||
33468300|NCT00597116|101603834|FG000|Overall Study|Death|0|||
33468301|NCT00597116|101603835|FG001|Overall Study|Death|1|||
33468302|NCT00597116|101603834|FG000|Overall Study|Lost to Follow-up|1|||
33468303|NCT00597116|101603835|FG001|Overall Study|Lost to Follow-up|0|||
33179636|NCT02542631|100568085|FG001|Overall Study|Sponsor Termination|0|||
33179637|NCT02542631|100568084|FG000|Overall Study|Withdrawal by Subject|11|||
33179638|NCT02542631|100568085|FG001|Overall Study|Withdrawal by Subject|16|||
33179639|NCT02542631|100568084|FG000|Overall Study|Protocol Violation|1|||
33179640|NCT02542631|100568085|FG001|Overall Study|Protocol Violation|1|||
33179641|NCT02542631|100568084|FG000|Overall Study|Physician Decision|6|||
33265754|NCT01500200|100873718|FG003|Stage 1|Physician Decision|0|||
33265755|NCT01500200|100873719|FG004|Stage 1|Physician Decision|0|||
33265756|NCT01500200|100873720|FG005|Stage 1|Physician Decision|0|||
33468304|NCT00597116|101603834|FG000|Overall Study|Progressive disease|11|||
33468305|NCT00597116|101603835|FG001|Overall Study|Progressive disease|6|||
33468306|NCT00248170|101603836|FG000|Overall Study|Withdrawal by Subject|71|||
33468307|NCT00248170|101603837|FG001|Overall Study|Withdrawal by Subject|79|||
33468308|NCT00248170|101603836|FG000|Overall Study|Protocol Violation|35|||
33179642|NCT02542631|100568085|FG001|Overall Study|Physician Decision|4|||
33179643|NCT02542631|100568084|FG000|Overall Study|Lost to Follow-up|6|||
33179644|NCT02542631|100568085|FG001|Overall Study|Lost to Follow-up|5|||
33179645|NCT02542631|100568084|FG000|Overall Study|Death|1|||
33179646|NCT02542631|100568085|FG001|Overall Study|Death|2|||
33179647|NCT02542631|100568084|FG000|Overall Study|Other|2|||
33179648|NCT02542631|100568085|FG001|Overall Study|Other|1|||
33179649|NCT02542631|100568084|FG000|Overall Study|Used Prohibited Medication|2|||
33179650|NCT02542631|100568085|FG001|Overall Study|Used Prohibited Medication|1|||
33179651|NCT01581307|100568086|FG000|Overall Study|Withdrawal by Subject|1|||
33179652|NCT04120974|100568102|FG000|Overall Study|Death|1|||
33179653|NCT04120974|100568102|FG000|Overall Study|Physician Decision|1|||
33179654|NCT04120974|100568102|FG000|Overall Study|Lost to Follow-up|6|||
33179655|NCT01172847|100568103|FG000|Overall Study|Withdrawal by Subject|3|||
33179656|NCT00071760|100568104|FG000|Overall Study|Adverse Event|2|||
33265757|NCT01500200|100873715|FG000|Stage 2|Adverse Event|0|||
33265758|NCT01500200|100873716|FG001|Stage 2|Adverse Event|0|||
33468309|NCT00248170|101603837|FG001|Overall Study|Protocol Violation|30|||
33179657|NCT00071760|100568105|FG001|Overall Study|Adverse Event|1|||
33265759|NCT01500200|100873717|FG002|Stage 2|Adverse Event|0|||
33265760|NCT01500200|100873718|FG003|Stage 2|Adverse Event|0|||
33265761|NCT01500200|100873719|FG004|Stage 2|Adverse Event|5|||
33265762|NCT01500200|100873720|FG005|Stage 2|Adverse Event|4|||
33265763|NCT02310581|100873721|FG000|Overall Study|Adverse Event|1|||
33265764|NCT02310581|100873722|FG001|Overall Study|Adverse Event|1|||
33265765|NCT02310581|100873723|FG002|Overall Study|Adverse Event|1|||
33265766|NCT02310581|100873724|FG003|Overall Study|Adverse Event|0|||
33265767|NCT02310581|100873721|FG000|Overall Study|Withdrawal by Subject|2|||
33265768|NCT02310581|100873722|FG001|Overall Study|Withdrawal by Subject|1|||
33265769|NCT02310581|100873723|FG002|Overall Study|Withdrawal by Subject|0|||
33179658|NCT00071760|100568104|FG000|Overall Study|Lost to Follow-up|0|||
33179659|NCT00071760|100568105|FG001|Overall Study|Lost to Follow-up|3|||
33179660|NCT00071760|100568104|FG000|Overall Study|Protocol Violation|1|||
33265770|NCT02310581|100873724|FG003|Overall Study|Withdrawal by Subject|1|||
33265771|NCT00738400|100873725|FG000|Overall Study|Adverse Event|3|||
33265772|NCT00738400|100873726|FG001|Overall Study|Adverse Event|1|||
33265773|NCT00738400|100873725|FG000|Overall Study|Withdrawal by Subject|0|||
33265774|NCT00738400|100873726|FG001|Overall Study|Withdrawal by Subject|1|||
33265775|NCT00738400|100873725|FG000|Overall Study|Lack of Efficacy|0|||
33179661|NCT00071760|100568105|FG001|Overall Study|Protocol Violation|0|||
33179662|NCT00071760|100568104|FG000|Overall Study|Withdrawal by Subject|0|||
33179663|NCT00071760|100568105|FG001|Overall Study|Withdrawal by Subject|1|||
33179664|NCT00071760|100568104|FG000|Overall Study|Insufficient Viral Load Response|1|||
33179665|NCT00071760|100568105|FG001|Overall Study|Insufficient Viral Load Response|1|||
33265776|NCT00738400|100873726|FG001|Overall Study|Lack of Efficacy|1|||
33265777|NCT00738400|100873725|FG000|Overall Study|Lost to Follow-up|0|||
33265778|NCT00738400|100873726|FG001|Overall Study|Lost to Follow-up|3|||
33265779|NCT00738400|100873725|FG000|Overall Study|Protocol Violation|1|||
33265780|NCT00738400|100873726|FG001|Overall Study|Protocol Violation|0|||
33265781|NCT00738400|100873725|FG000|Overall Study|Non-compliant with study medication|0|||
33265782|NCT00738400|100873726|FG001|Overall Study|Non-compliant with study medication|1|||
33265783|NCT03601715|100873728|FG000|Second Intervention|Lost to Follow-up|1|||
33265784|NCT03601715|100873729|FG001|Second Intervention|Lost to Follow-up|1|||
33265785|NCT03601715|100873730|FG002|Second Intervention|Lost to Follow-up|0|||
33265786|NCT00776009|100873735|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
33265787|NCT00776009|100873736|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
33265788|NCT00776009|100873737|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
33265789|NCT00776009|100873738|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
33265790|NCT00776009|100873739|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
33265791|NCT00776009|100873740|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
33265792|NCT00776009|100873735|FG000|Period 1: First Intervention|Protocol Violation|0|||
33265793|NCT00776009|100873736|FG001|Period 1: First Intervention|Protocol Violation|1|||
33265794|NCT00776009|100873737|FG002|Period 1: First Intervention|Protocol Violation|0|||
33265795|NCT00776009|100873738|FG003|Period 1: First Intervention|Protocol Violation|0|||
33265796|NCT00776009|100873739|FG004|Period 1: First Intervention|Protocol Violation|1|||
33265797|NCT00776009|100873740|FG005|Period 1: First Intervention|Protocol Violation|0|||
33265798|NCT00776009|100873735|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
33265799|NCT00776009|100873736|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
33265800|NCT00776009|100873737|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
33265801|NCT00776009|100873738|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
33265802|NCT00776009|100873739|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
33265803|NCT00776009|100873740|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
33265804|NCT00776009|100873735|FG000|Period 2: Second Intervention|Protocol Violation|1|||
33265805|NCT00776009|100873736|FG001|Period 2: Second Intervention|Protocol Violation|0|||
33265806|NCT00776009|100873737|FG002|Period 2: Second Intervention|Protocol Violation|1|||
33265807|NCT00776009|100873738|FG003|Period 2: Second Intervention|Protocol Violation|0|||
33265808|NCT00776009|100873739|FG004|Period 2: Second Intervention|Protocol Violation|0|||
33265809|NCT00776009|100873740|FG005|Period 2: Second Intervention|Protocol Violation|0|||
33265810|NCT00776009|100873735|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
33265811|NCT00776009|100873736|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
33265812|NCT00776009|100873737|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
33265813|NCT00776009|100873738|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
33265814|NCT00776009|100873739|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
33265815|NCT00776009|100873740|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
33265816|NCT01561300|100873741|FG000|Run in on Placebo|Adverse Event|1|||
33265817|NCT01561300|100873742|FG001|Run in on Placebo|Adverse Event|0|||
33265818|NCT00562094|100873743|FG000|Overall Study|Lost to Follow-up|62|||
33265819|NCT02029443|100873744|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
33265820|NCT02029443|100873745|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
33468310|NCT00248170|101603836|FG000|Overall Study|Lost to Follow-up|28|||
33468311|NCT00248170|101603837|FG001|Overall Study|Lost to Follow-up|35|||
33265821|NCT02029443|100873746|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
33265822|NCT02029443|100873747|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
33179666|NCT00071760|100568104|FG000|Overall Study|Lack of availability of RTV|1|||
33265823|NCT02029443|100873748|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
33265824|NCT02029443|100873744|FG000|Overall Study|Death|13|||
33265825|NCT02029443|100873745|FG001|Overall Study|Death|2|||
33265826|NCT02029443|100873746|FG002|Overall Study|Death|2|||
33265827|NCT02029443|100873747|FG003|Overall Study|Death|11|||
33265828|NCT02029443|100873748|FG004|Overall Study|Death|2|||
33265829|NCT02029443|100873744|FG000|Overall Study|Lost to Follow-up|1|||
33265830|NCT02029443|100873745|FG001|Overall Study|Lost to Follow-up|0|||
33468312|NCT00248170|101603836|FG000|Overall Study|Disease progression|196|||
33468313|NCT00248170|101603837|FG001|Overall Study|Disease progression|216|||
33468314|NCT00248170|101603836|FG000|Overall Study|Death|28|||
33468315|NCT00248170|101603837|FG001|Overall Study|Death|47|||
33468316|NCT00248170|101603836|FG000|Overall Study|Adverse Event|311|||
33468317|NCT00248170|101603837|FG001|Overall Study|Adverse Event|296|||
33468318|NCT00248170|101603836|FG000|Overall Study|Administrative problems|22|||
33468319|NCT00248170|101603837|FG001|Overall Study|Administrative problems|25|||
33468320|NCT00248170|101603836|FG000|Overall Study|Abnormal test procedure(s) result|49|||
33468321|NCT00248170|101603837|FG001|Overall Study|Abnormal test procedure(s) result|61|||
33468322|NCT00248170|101603836|FG000|Overall Study|Abnormal laboratory values|4|||
33468323|NCT00248170|101603837|FG001|Overall Study|Abnormal laboratory values|0|||
33468324|NCT00248170|101603836|FG000|Overall Study|Protocol deviation|17|||
33468325|NCT00248170|101603837|FG001|Overall Study|Protocol deviation|19|||
33468326|NCT00375492|101603838|FG000|Overall Study|Adverse Event|4|||
33468327|NCT00375492|101603839|FG001|Overall Study|Adverse Event|5|||
33179667|NCT00071760|100568105|FG001|Overall Study|Lack of availability of RTV|0|||
33179668|NCT00071760|100568104|FG000|Overall Study|Physician Decision|2|||
33179669|NCT00071760|100568105|FG001|Overall Study|Physician Decision|1|||
33179670|NCT00071760|100568104|FG000|Overall Study|Relocation|0|||
33179671|NCT00071760|100568105|FG001|Overall Study|Relocation|1|||
33179672|NCT00951665|100568106|FG000|Phase 1b|Adverse Event|2|||
33179673|NCT00951665|100568107|FG001|Phase 1b|Adverse Event|1|||
33179674|NCT00951665|100568108|FG002|Phase 1b|Adverse Event|0|||
33179675|NCT00951665|100568109|FG003|Phase 1b|Adverse Event|1|||
33179676|NCT00951665|100568110|FG004|Phase 1b|Adverse Event|0|||
33179677|NCT00951665|100568111|FG005|Phase 1b|Adverse Event|0|||
33179678|NCT00951665|100568106|FG000|Phase 1b|Death|1|||
33179679|NCT00951665|100568107|FG001|Phase 1b|Death|0|||
33179680|NCT00951665|100568108|FG002|Phase 1b|Death|2|||
33179681|NCT00951665|100568109|FG003|Phase 1b|Death|0|||
33265831|NCT02029443|100873746|FG002|Overall Study|Lost to Follow-up|1|||
33265832|NCT02029443|100873747|FG003|Overall Study|Lost to Follow-up|1|||
33265833|NCT02029443|100873748|FG004|Overall Study|Lost to Follow-up|0|||
33265834|NCT02029443|100873744|FG000|Overall Study|Started other anti-cancer therapy|17|||
33179682|NCT00951665|100568110|FG004|Phase 1b|Death|0|||
33179683|NCT00951665|100568111|FG005|Phase 1b|Death|0|||
33179684|NCT00951665|100568106|FG000|Phase 1b|Physician Decision|4|||
33179685|NCT00951665|100568107|FG001|Phase 1b|Physician Decision|0|||
33179686|NCT00951665|100568108|FG002|Phase 1b|Physician Decision|1|||
33179687|NCT00951665|100568109|FG003|Phase 1b|Physician Decision|0|||
33179688|NCT00951665|100568110|FG004|Phase 1b|Physician Decision|0|||
33179689|NCT00951665|100568111|FG005|Phase 1b|Physician Decision|0|||
33179690|NCT00951665|100568106|FG000|Phase 1b|Withdrawal by Subject|0|||
33179691|NCT00951665|100568107|FG001|Phase 1b|Withdrawal by Subject|1|||
33179692|NCT00951665|100568108|FG002|Phase 1b|Withdrawal by Subject|0|||
33179693|NCT00951665|100568109|FG003|Phase 1b|Withdrawal by Subject|0|||
33179694|NCT00951665|100568110|FG004|Phase 1b|Withdrawal by Subject|0|||
33179695|NCT00951665|100568111|FG005|Phase 1b|Withdrawal by Subject|0|||
33179696|NCT00951665|100568106|FG000|Phase 1b|Disease Progression|13|||
33179697|NCT00951665|100568107|FG001|Phase 1b|Disease Progression|2|||
33179698|NCT00951665|100568108|FG002|Phase 1b|Disease Progression|14|||
33179699|NCT00951665|100568109|FG003|Phase 1b|Disease Progression|0|||
33179700|NCT00951665|100568110|FG004|Phase 1b|Disease Progression|0|||
33179701|NCT00951665|100568111|FG005|Phase 1b|Disease Progression|0|||
33179702|NCT00951665|100568106|FG000|Phase 1b|Protocol Violation|2|||
33179703|NCT00951665|100568107|FG001|Phase 1b|Protocol Violation|0|||
33179704|NCT00951665|100568108|FG002|Phase 1b|Protocol Violation|0|||
33179705|NCT00951665|100568109|FG003|Phase 1b|Protocol Violation|0|||
33468328|NCT00375492|101603838|FG000|Overall Study|Entry Criteria Not Met|0|||
33468329|NCT00375492|101603839|FG001|Overall Study|Entry Criteria Not Met|1|||
33468330|NCT00375492|101603838|FG000|Overall Study|Loss of Glucose Control|0|||
33468331|NCT00375492|101603839|FG001|Overall Study|Loss of Glucose Control|1|||
33468332|NCT00375492|101603838|FG000|Overall Study|Lost to Follow-up|10|||
33179706|NCT00951665|100568110|FG004|Phase 1b|Protocol Violation|0|||
33179707|NCT00951665|100568111|FG005|Phase 1b|Protocol Violation|0|||
33179708|NCT00951665|100568106|FG000|Phase 2a|Adverse Event|0|||
33179709|NCT00951665|100568107|FG001|Phase 2a|Adverse Event|0|||
33179710|NCT00951665|100568108|FG002|Phase 2a|Adverse Event|0|||
33179711|NCT00951665|100568109|FG003|Phase 2a|Adverse Event|0|||
33179712|NCT00951665|100568110|FG004|Phase 2a|Adverse Event|2|||
33179713|NCT00951665|100568111|FG005|Phase 2a|Adverse Event|0|||
33179714|NCT00951665|100568106|FG000|Phase 2a|Death|0|||
33179715|NCT00951665|100568107|FG001|Phase 2a|Death|0|||
33179716|NCT00951665|100568108|FG002|Phase 2a|Death|0|||
33179717|NCT00951665|100568109|FG003|Phase 2a|Death|0|||
33179718|NCT00951665|100568110|FG004|Phase 2a|Death|1|||
33179719|NCT00951665|100568111|FG005|Phase 2a|Death|1|||
33179720|NCT00951665|100568106|FG000|Phase 2a|Lost to Follow-up|0|||
33179721|NCT00951665|100568107|FG001|Phase 2a|Lost to Follow-up|0|||
33179722|NCT00951665|100568108|FG002|Phase 2a|Lost to Follow-up|0|||
33265835|NCT02029443|100873745|FG001|Overall Study|Started other anti-cancer therapy|4|||
33468333|NCT00375492|101603839|FG001|Overall Study|Lost to Follow-up|5|||
33468334|NCT00375492|101603838|FG000|Overall Study|Physician Decision|0|||
33468335|NCT00375492|101603839|FG001|Overall Study|Physician Decision|4|||
33468336|NCT00375492|101603838|FG000|Overall Study|Protocol Violation|6|||
33468337|NCT00375492|101603839|FG001|Overall Study|Protocol Violation|3|||
33468338|NCT00375492|101603838|FG000|Overall Study|Sponsor Decision|0|||
33468339|NCT00375492|101603839|FG001|Overall Study|Sponsor Decision|1|||
33468340|NCT00375492|101603838|FG000|Overall Study|Withdrawal by Subject|6|||
33468341|NCT00375492|101603839|FG001|Overall Study|Withdrawal by Subject|6|||
33468342|NCT00290251|101603840|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
33468343|NCT00290251|101603841|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
33468344|NCT00290251|101603842|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
33265836|NCT02029443|100873746|FG002|Overall Study|Started other anti-cancer therapy|7|||
33265837|NCT02029443|100873747|FG003|Overall Study|Started other anti-cancer therapy|9|||
33265838|NCT02029443|100873748|FG004|Overall Study|Started other anti-cancer therapy|3|||
33265839|NCT02029443|100873744|FG000|Overall Study|Withdrawal by Subject|3|||
33265840|NCT02029443|100873745|FG001|Overall Study|Withdrawal by Subject|1|||
33265841|NCT02029443|100873746|FG002|Overall Study|Withdrawal by Subject|1|||
33265842|NCT02029443|100873747|FG003|Overall Study|Withdrawal by Subject|1|||
33265843|NCT02029443|100873748|FG004|Overall Study|Withdrawal by Subject|0|||
33265844|NCT02029443|100873744|FG000|Overall Study|Other|6|||
33265845|NCT02029443|100873745|FG001|Overall Study|Other|6|||
33265846|NCT02029443|100873746|FG002|Overall Study|Other|4|||
33265847|NCT02029443|100873747|FG003|Overall Study|Other|2|||
33265848|NCT02029443|100873748|FG004|Overall Study|Other|0|||
33265849|NCT00745875|100873749|FG000|Overall Study|Continuing study treatment|4|||
33265850|NCT00745875|100873750|FG001|Overall Study|Continuing study treatment|4|||
33265851|NCT00949117|100873752|FG000|Overall Study|Lack of Efficacy|2|||
33468345|NCT00290251|101603843|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
33468346|NCT00290251|101603844|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
33468347|NCT00290251|101603845|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
33468348|NCT00290251|101603840|FG000|Treatment 1 (Months 2-4)|headache|0|||
33468349|NCT00290251|101603841|FG001|Treatment 1 (Months 2-4)|headache|0|||
33468350|NCT00290251|101603842|FG002|Treatment 1 (Months 2-4)|headache|0|||
33468351|NCT00290251|101603843|FG003|Treatment 1 (Months 2-4)|headache|0|||
33468352|NCT00290251|101603844|FG004|Treatment 1 (Months 2-4)|headache|1|||
33468353|NCT00290251|101603845|FG005|Treatment 1 (Months 2-4)|headache|0|||
33468354|NCT00290251|101603840|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
33468355|NCT00290251|101603841|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
33468356|NCT00290251|101603842|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
33468357|NCT00290251|101603843|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
33468358|NCT00290251|101603844|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
33468359|NCT00290251|101603845|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
33468360|NCT02459418|101603846|FG000|Overall Study|Exclusion Criteria|4|||
33468361|NCT02459418|101603847|FG001|Overall Study|Exclusion Criteria|0|||
33468362|NCT02459418|101603846|FG000|Overall Study|Protocol Violation|0|||
33468363|NCT02459418|101603847|FG001|Overall Study|Protocol Violation|2|||
33468364|NCT02459418|101603846|FG000|Overall Study|Physician Decision|0|||
33468365|NCT02459418|101603847|FG001|Overall Study|Physician Decision|2|||
33468366|NCT02459418|101603846|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
33468367|NCT02459418|101603847|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
33468368|NCT02459418|101603846|FG000|Overall Study|Adverse Event|0|||
33265852|NCT00949117|100873753|FG001|Overall Study|Lack of Efficacy|3|||
33265853|NCT00949117|100873752|FG000|Overall Study|Protocol Violation|1|||
33265854|NCT00949117|100873753|FG001|Overall Study|Protocol Violation|1|||
33265855|NCT00949117|100873752|FG000|Overall Study|Adverse Event|0|||
33265856|NCT00949117|100873753|FG001|Overall Study|Adverse Event|1|||
33265857|NCT02816398|100873754|FG000|Overall Study|Death|5|||
33265858|NCT02816398|100873754|FG000|Overall Study|Lack of Efficacy|8|||
33265859|NCT02816398|100873754|FG000|Overall Study|Lost to Follow-up|1|||
33265860|NCT01218659|100873755|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
33265861|NCT01218659|100873756|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
33468369|NCT02459418|101603847|FG001|Overall Study|Adverse Event|1|||
33468370|NCT02459418|101603846|FG000|Overall Study|Withdrawal by Subject|1|||
33468371|NCT02459418|101603847|FG001|Overall Study|Withdrawal by Subject|1|||
33468372|NCT02459418|101603846|FG000|Overall Study|Elevated Creatine Kinase|1|||
33468373|NCT02459418|101603847|FG001|Overall Study|Elevated Creatine Kinase|0|||
33468374|NCT02459418|101603846|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
33468375|NCT02459418|101603847|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
33468376|NCT00809965|101603853|FG000|Overall Study|Death|194|||
33468377|NCT00809965|101603854|FG001|Overall Study|Death|147|||
33265862|NCT01218659|100873757|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
33265863|NCT01218659|100873755|FG000|18-Month Randomized Period|Did not receive study drug|0|||
33179723|NCT00951665|100568109|FG003|Phase 2a|Lost to Follow-up|0|||
33468378|NCT00809965|101603855|FG002|Overall Study|Death|196|||
33265864|NCT01218659|100873756|FG001|18-Month Randomized Period|Did not receive study drug|3|||
33265865|NCT01218659|100873757|FG002|18-Month Randomized Period|Did not receive study drug|0|||
33265866|NCT01218659|100873755|FG000|12-Month OLE|Withdrawal by Subject|0|||
33468379|NCT00809965|101603853|FG000|Overall Study|Lost to Follow-up|17|||
33265867|NCT01218659|100873756|FG001|12-Month OLE|Withdrawal by Subject|0|||
33265868|NCT01218659|100873757|FG002|12-Month OLE|Withdrawal by Subject|2|||
33265869|NCT01218659|100873755|FG000|12-Month OLE|Physician Decision|0|||
33265870|NCT01218659|100873756|FG001|12-Month OLE|Physician Decision|0|||
33265871|NCT01218659|100873757|FG002|12-Month OLE|Physician Decision|1|||
33265872|NCT01218659|100873755|FG000|12-Month OLE|Lost to Follow-up|0|||
33468380|NCT00809965|101603854|FG001|Overall Study|Lost to Follow-up|10|||
33468381|NCT00809965|101603855|FG002|Overall Study|Lost to Follow-up|18|||
33468382|NCT00809965|101603853|FG000|Overall Study|Withdrawal by Subject|405|||
33468383|NCT00809965|101603854|FG001|Overall Study|Withdrawal by Subject|448|||
33468384|NCT00809965|101603855|FG002|Overall Study|Withdrawal by Subject|441|||
33265873|NCT01218659|100873756|FG001|12-Month OLE|Lost to Follow-up|0|||
33265874|NCT01218659|100873757|FG002|12-Month OLE|Lost to Follow-up|1|||
33265875|NCT01218659|100873755|FG000|12-Month OLE|Pregnancy|0|||
33265876|NCT01218659|100873756|FG001|12-Month OLE|Pregnancy|0|||
33265877|NCT01218659|100873757|FG002|12-Month OLE|Pregnancy|1|||
33265878|NCT01218659|100873755|FG000|12-Month OLE|Lack of Efficacy|0|||
33468385|NCT00809965|101603853|FG000|Overall Study|Other Reason|167|||
33468386|NCT00809965|101603854|FG001|Overall Study|Other Reason|170|||
33468387|NCT00809965|101603855|FG002|Overall Study|Other Reason|189|||
33468388|NCT00720226|101603861|FG000|Overall Study|Withdrawal by Subject|7|||
33468389|NCT00720226|101603862|FG001|Overall Study|Withdrawal by Subject|4|||
33468390|NCT00733369|101603863|FG000|Overall Study|Lost to Follow-up|2|||
33468391|NCT00733369|101603864|FG001|Overall Study|Lost to Follow-up|1|||
33468392|NCT00733369|101603863|FG000|Overall Study|Adverse Event|4|||
33468393|NCT00733369|101603864|FG001|Overall Study|Adverse Event|4|||
33468394|NCT00733369|101603863|FG000|Overall Study|Protocol Violation|4|||
33468395|NCT00733369|101603864|FG001|Overall Study|Protocol Violation|4|||
33468396|NCT01103479|101603865|FG000|Overall Study|Up to date with CRC screening|1|||
33468397|NCT01103479|101603866|FG001|Overall Study|Up to date with CRC screening|9|||
33468398|NCT01103479|101603867|FG002|Overall Study|Up to date with CRC screening|12|||
33468399|NCT01103479|101603865|FG000|Overall Study|Family history of CRC|1|||
33468400|NCT01103479|101603866|FG001|Overall Study|Family history of CRC|0|||
33468401|NCT01103479|101603867|FG002|Overall Study|Family history of CRC|2|||
33468402|NCT01103479|101603865|FG000|Overall Study|Active cancer|1|||
33468403|NCT01103479|101603866|FG001|Overall Study|Active cancer|0|||
33468404|NCT01103479|101603867|FG002|Overall Study|Active cancer|0|||
33468405|NCT01103479|101603865|FG000|Overall Study|Saw non-study physician|2|||
33468406|NCT01103479|101603866|FG001|Overall Study|Saw non-study physician|0|||
33468407|NCT01103479|101603867|FG002|Overall Study|Saw non-study physician|0|||
33468408|NCT01316419|101603871|FG000|Overall Study|Not treated|103|||
33468409|NCT01316419|101603871|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
33468410|NCT01316419|101603871|FG000|Overall Study|Lost to Follow-up|19|||
33265879|NCT01218659|100873756|FG001|12-Month OLE|Lack of Efficacy|0|||
33265880|NCT01218659|100873757|FG002|12-Month OLE|Lack of Efficacy|1|||
33265881|NCT01218659|100873755|FG000|12-Month OLE|Declined to participate in the OLE|0|||
33265882|NCT01218659|100873756|FG001|12-Month OLE|Declined to participate in the OLE|0|||
33265883|NCT01218659|100873757|FG002|12-Month OLE|Declined to participate in the OLE|4|||
33265884|NCT03520036|100873758|FG000|Overall Study|Adverse Event|1|||
33265885|NCT03520036|100873759|FG001|Overall Study|Adverse Event|2|||
33265886|NCT03520036|100873760|FG002|Overall Study|Adverse Event|0|||
33265887|NCT03520036|100873758|FG000|Overall Study|Protocol Violation|1|||
33265888|NCT03520036|100873759|FG001|Overall Study|Protocol Violation|0|||
33265889|NCT03520036|100873760|FG002|Overall Study|Protocol Violation|0|||
33265890|NCT03520036|100873758|FG000|Overall Study|Withdrawal by Subject|0|||
33265891|NCT03520036|100873759|FG001|Overall Study|Withdrawal by Subject|1|||
33265892|NCT03520036|100873760|FG002|Overall Study|Withdrawal by Subject|4|||
33265893|NCT03520036|100873758|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
33265894|NCT03520036|100873759|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
33265895|NCT03520036|100873760|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
33265896|NCT02470806|100873763|FG000|Overall Study|Lost to Follow-up|1|||
33265897|NCT02470806|100873764|FG001|Overall Study|Lost to Follow-up|1|||
33265898|NCT02470806|100873763|FG000|Overall Study|Adverse Event|5|||
33265899|NCT02470806|100873764|FG001|Overall Study|Adverse Event|2|||
33265900|NCT02470806|100873763|FG000|Overall Study|Protocol Violation|4|||
33265901|NCT02470806|100873764|FG001|Overall Study|Protocol Violation|11|||
33468411|NCT03686150|101603873|FG000|Overall Study|Withdrawal by Subject|1|||
33468412|NCT03686150|101603874|FG001|Overall Study|Withdrawal by Subject|1|||
33468413|NCT03686150|101603875|FG002|Overall Study|Withdrawal by Subject|1|||
33468414|NCT03686150|101603876|FG003|Overall Study|Withdrawal by Subject|0|||
33468415|NCT03686150|101603877|FG004|Overall Study|Withdrawal by Subject|1|||
33468416|NCT03686150|101603878|FG005|Overall Study|Withdrawal by Subject|2|||
33468417|NCT03686150|101603873|FG000|Overall Study|Physician Decision|1|||
33265902|NCT02470806|100873763|FG000|Overall Study|Physician Decision|0|||
33265903|NCT02470806|100873764|FG001|Overall Study|Physician Decision|3|||
33265904|NCT02470806|100873763|FG000|Overall Study|Withdrawal by Subject|3|||
33265905|NCT02470806|100873764|FG001|Overall Study|Withdrawal by Subject|10|||
33265906|NCT02470806|100873763|FG000|Overall Study|Lack of Efficacy|5|||
33265907|NCT02470806|100873764|FG001|Overall Study|Lack of Efficacy|15|||
33265908|NCT02334215|100873765|FG000|Overall Study|Death|1|||
33265909|NCT02334215|100873766|FG001|Overall Study|Death|1|||
33265910|NCT02334215|100873767|FG002|Overall Study|Death|0|||
33265911|NCT02334215|100873765|FG000|Overall Study|Lost to Follow-up|1|||
33265912|NCT02334215|100873766|FG001|Overall Study|Lost to Follow-up|0|||
33265913|NCT02334215|100873767|FG002|Overall Study|Lost to Follow-up|4|||
33179724|NCT00951665|100568110|FG004|Phase 2a|Lost to Follow-up|1|||
33179725|NCT00951665|100568111|FG005|Phase 2a|Lost to Follow-up|0|||
33179726|NCT00951665|100568106|FG000|Phase 2a|Physician Decision|0|||
33179727|NCT00951665|100568107|FG001|Phase 2a|Physician Decision|0|||
33179728|NCT00951665|100568108|FG002|Phase 2a|Physician Decision|0|||
33179729|NCT00951665|100568109|FG003|Phase 2a|Physician Decision|0|||
33179730|NCT00951665|100568110|FG004|Phase 2a|Physician Decision|0|||
33179731|NCT00951665|100568111|FG005|Phase 2a|Physician Decision|1|||
33179732|NCT00951665|100568106|FG000|Phase 2a|Withdrawal by Subject|0|||
33179733|NCT00951665|100568107|FG001|Phase 2a|Withdrawal by Subject|0|||
33179734|NCT00951665|100568108|FG002|Phase 2a|Withdrawal by Subject|0|||
33179735|NCT00951665|100568109|FG003|Phase 2a|Withdrawal by Subject|0|||
33179736|NCT00951665|100568110|FG004|Phase 2a|Withdrawal by Subject|2|||
33179737|NCT00951665|100568111|FG005|Phase 2a|Withdrawal by Subject|0|||
33179738|NCT00951665|100568106|FG000|Phase 2a|Disease Progression|0|||
33179739|NCT00951665|100568107|FG001|Phase 2a|Disease Progression|0|||
33265914|NCT02334215|100873765|FG000|Overall Study|Withdrawal by Subject|2|||
33265915|NCT02334215|100873766|FG001|Overall Study|Withdrawal by Subject|2|||
33265916|NCT02334215|100873767|FG002|Overall Study|Withdrawal by Subject|1|||
33265917|NCT02334215|100873765|FG000|Overall Study|Not released from incarceration on time|3|||
33265918|NCT02334215|100873766|FG001|Overall Study|Not released from incarceration on time|3|||
33265919|NCT02334215|100873767|FG002|Overall Study|Not released from incarceration on time|3|||
33265920|NCT02334215|100873765|FG000|Overall Study|Incarcerated|0|||
33265921|NCT02334215|100873766|FG001|Overall Study|Incarcerated|0|||
33265922|NCT02334215|100873767|FG002|Overall Study|Incarcerated|7|||
33265923|NCT01307800|100873768|FG000|Overall Study|Adverse Event|9|||
33265924|NCT01307800|100873769|FG001|Overall Study|Adverse Event|8|||
33265925|NCT01307800|100873770|FG002|Overall Study|Adverse Event|10|||
33265926|NCT01307800|100873771|FG003|Overall Study|Adverse Event|14|||
33265927|NCT01307800|100873768|FG000|Overall Study|Entry Criteria Not Met|0|||
33265928|NCT01307800|100873769|FG001|Overall Study|Entry Criteria Not Met|0|||
33265929|NCT01307800|100873770|FG002|Overall Study|Entry Criteria Not Met|0|||
33265930|NCT01307800|100873771|FG003|Overall Study|Entry Criteria Not Met|2|||
33265931|NCT01307800|100873768|FG000|Overall Study|Lost to Follow-up|5|||
33265932|NCT01307800|100873769|FG001|Overall Study|Lost to Follow-up|6|||
33265933|NCT01307800|100873770|FG002|Overall Study|Lost to Follow-up|2|||
33265934|NCT01307800|100873771|FG003|Overall Study|Lost to Follow-up|8|||
33265935|NCT01307800|100873768|FG000|Overall Study|Perceived Lack of Efficacy|24|||
33265936|NCT01307800|100873769|FG001|Overall Study|Perceived Lack of Efficacy|23|||
33265937|NCT01307800|100873770|FG002|Overall Study|Perceived Lack of Efficacy|20|||
33265938|NCT01307800|100873771|FG003|Overall Study|Perceived Lack of Efficacy|33|||
33265939|NCT01307800|100873768|FG000|Overall Study|Protocol Violation|0|||
33265940|NCT01307800|100873769|FG001|Overall Study|Protocol Violation|3|||
33265941|NCT01307800|100873770|FG002|Overall Study|Protocol Violation|4|||
33265942|NCT01307800|100873771|FG003|Overall Study|Protocol Violation|5|||
33265943|NCT01307800|100873768|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
33265944|NCT01307800|100873769|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
33265945|NCT01307800|100873770|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
33265946|NCT01307800|100873771|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
33265947|NCT01307800|100873768|FG000|Overall Study|Sponsor Decision|6|||
33265948|NCT01307800|100873769|FG001|Overall Study|Sponsor Decision|9|||
33265949|NCT01307800|100873770|FG002|Overall Study|Sponsor Decision|12|||
33265950|NCT01307800|100873771|FG003|Overall Study|Sponsor Decision|28|||
33265951|NCT01307800|100873768|FG000|Overall Study|Withdrawal by Subject|10|||
33265952|NCT01307800|100873769|FG001|Overall Study|Withdrawal by Subject|11|||
33265953|NCT01307800|100873770|FG002|Overall Study|Withdrawal by Subject|8|||
33265954|NCT01307800|100873771|FG003|Overall Study|Withdrawal by Subject|15|||
33265955|NCT01307800|100873768|FG000|Overall Study|Participant Moved|0|||
33179740|NCT00951665|100568108|FG002|Phase 2a|Disease Progression|0|||
33179741|NCT00951665|100568109|FG003|Phase 2a|Disease Progression|0|||
33179742|NCT00951665|100568110|FG004|Phase 2a|Disease Progression|6|||
33179743|NCT00951665|100568111|FG005|Phase 2a|Disease Progression|5|||
33179744|NCT04532099|100568115|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
33265956|NCT01307800|100873769|FG001|Overall Study|Participant Moved|2|||
33265957|NCT01307800|100873770|FG002|Overall Study|Participant Moved|1|||
33265958|NCT01307800|100873771|FG003|Overall Study|Participant Moved|3|||
33265959|NCT02892019|100873772|FG000|Overall Study|randomized but not treated|0|||
33265960|NCT02892019|100873773|FG001|Overall Study|randomized but not treated|1|||
33265961|NCT02892019|100873772|FG000|Overall Study|Withdrawal by Subject|0|||
33265962|NCT02892019|100873773|FG001|Overall Study|Withdrawal by Subject|1|||
33265963|NCT02892019|100873772|FG000|Overall Study|Adverse Event|1|||
33265964|NCT02892019|100873773|FG001|Overall Study|Adverse Event|1|||
33265965|NCT03347396|100873774|FG000|Part A (26 Weeks)|Adverse Event|1|||
33265966|NCT03347396|100873775|FG001|Part A (26 Weeks)|Adverse Event|0|||
33265967|NCT03347396|100873774|FG000|Part A (26 Weeks)|Death|0|||
33265968|NCT03347396|100873775|FG001|Part A (26 Weeks)|Death|1|||
33265969|NCT03347396|100873774|FG000|Part B (149 Weeks)|Adverse Event|1|||
33265970|NCT03347396|100873775|FG001|Part B (149 Weeks)|Adverse Event|1|||
33265971|NCT03347396|100873774|FG000|Part B (149 Weeks)|Death|1|||
33265972|NCT03347396|100873775|FG001|Part B (149 Weeks)|Death|0|||
33265973|NCT00887224|100873776|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
33265974|NCT00887224|100873777|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
33265975|NCT00887224|100873778|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
33265976|NCT00887224|100873776|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
33265977|NCT00887224|100873777|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
33265978|NCT00887224|100873778|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
33265979|NCT00887224|100873776|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
33265980|NCT00887224|100873777|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
33265981|NCT00887224|100873778|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
33265982|NCT00887224|100873776|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
33265983|NCT00887224|100873777|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
33265984|NCT00887224|100873778|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
33265985|NCT00887224|100873776|FG000|Open-label Response (OLR) Phase|Other|1|||
33265986|NCT00887224|100873777|FG001|Open-label Response (OLR) Phase|Other|0|||
33265987|NCT00887224|100873778|FG002|Open-label Response (OLR) Phase|Other|0|||
33265988|NCT00887224|100873776|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
33265989|NCT00887224|100873777|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
33265990|NCT00887224|100873778|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
33265991|NCT00887224|100873776|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
33265992|NCT00887224|100873777|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
33265993|NCT00887224|100873778|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
33265994|NCT00887224|100873776|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
33265995|NCT00887224|100873777|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
33179745|NCT04532099|100568116|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
33179746|NCT04532099|100568117|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
33179747|NCT02424383|100568121|FG000|Overall Study|Withdrawal by Subject|32|||
33179748|NCT02424383|100568121|FG000|Overall Study|Death|170|||
33179749|NCT02424383|100568121|FG000|Overall Study|Sponsor's decision|3|||
33179750|NCT02424383|100568121|FG000|Overall Study|Investigator's decision|44|||
33265996|NCT00887224|100873778|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
33265997|NCT00887224|100873776|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
33265998|NCT00887224|100873777|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
33265999|NCT00887224|100873778|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
33266000|NCT00887224|100873776|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
33266001|NCT00887224|100873777|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
33266002|NCT00887224|100873778|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
33266003|NCT00887224|100873776|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
33266004|NCT00887224|100873777|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
33266005|NCT00887224|100873778|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
33468418|NCT03686150|101603874|FG001|Overall Study|Physician Decision|0|||
33468419|NCT03686150|101603875|FG002|Overall Study|Physician Decision|0|||
33468420|NCT03686150|101603876|FG003|Overall Study|Physician Decision|0|||
33468421|NCT03686150|101603877|FG004|Overall Study|Physician Decision|0|||
33468422|NCT03686150|101603878|FG005|Overall Study|Physician Decision|1|||
33468423|NCT03686150|101603873|FG000|Overall Study|Lost to Follow-up|0|||
33468424|NCT03686150|101603874|FG001|Overall Study|Lost to Follow-up|1|||
33468425|NCT03686150|101603875|FG002|Overall Study|Lost to Follow-up|0|||
33266006|NCT00887224|100873776|FG000|Open-label Stability (OLS) Phase|Other|1|||
33266007|NCT00887224|100873777|FG001|Open-label Stability (OLS) Phase|Other|0|||
33266008|NCT00887224|100873778|FG002|Open-label Stability (OLS) Phase|Other|0|||
33266009|NCT00887224|100873776|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
33266010|NCT00887224|100873777|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
33266011|NCT00887224|100873778|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
33266012|NCT00887224|100873776|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
33266013|NCT00887224|100873777|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
33468426|NCT03686150|101603876|FG003|Overall Study|Lost to Follow-up|0|||
33468427|NCT03686150|101603877|FG004|Overall Study|Lost to Follow-up|0|||
33179751|NCT02424383|100568121|FG000|Overall Study|Lost to Follow-up|81|||
33266014|NCT00887224|100873778|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
33266015|NCT00887224|100873776|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
33179752|NCT02424383|100568121|FG000|Overall Study|Other|7|||
33468428|NCT03686150|101603878|FG005|Overall Study|Lost to Follow-up|0|||
33468429|NCT01560507|101603879|FG000|Overall Study|Lost to Follow-up|3|||
33468430|NCT01560507|101603880|FG001|Overall Study|Lost to Follow-up|1|||
33266016|NCT00887224|100873777|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
33266017|NCT00887224|100873778|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
33266018|NCT00887224|100873776|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
33266019|NCT00887224|100873777|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
33266020|NCT00887224|100873778|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
33266021|NCT00887224|100873776|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
33266022|NCT00887224|100873777|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
33266023|NCT00887224|100873778|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
33266024|NCT00887224|100873776|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
33266025|NCT00887224|100873777|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
33266026|NCT00887224|100873778|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
33266027|NCT00887224|100873776|FG000|OL Taper Phase / OL Follow Up|Other|30|||
33266028|NCT00887224|100873777|FG001|OL Taper Phase / OL Follow Up|Other|0|||
33266029|NCT00887224|100873778|FG002|OL Taper Phase / OL Follow Up|Other|0|||
33266030|NCT00887224|100873776|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
33266031|NCT00887224|100873777|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
33266032|NCT00887224|100873778|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
33266033|NCT00887224|100873776|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
33266034|NCT00887224|100873777|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
33266035|NCT00887224|100873778|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
33266036|NCT00887224|100873776|FG000|Double-blind (DB) Phase|Adverse Event|0|||
33468431|NCT01560507|101603881|FG002|Overall Study|Lost to Follow-up|2|||
33179753|NCT02424383|100568121|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
33179754|NCT03054870|100568122|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
33179755|NCT03054870|100568122|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
33179756|NCT00101907|100568123|FG000|Overall Study|Adverse Event|1|||
33179757|NCT00101907|100568124|FG001|Overall Study|Adverse Event|0|||
33179758|NCT00101907|100568125|FG002|Overall Study|Adverse Event|0|||
33179759|NCT00101907|100568126|FG003|Overall Study|Adverse Event|0|||
33179760|NCT00101907|100568127|FG004|Overall Study|Adverse Event|0|||
33179761|NCT00101907|100568128|FG005|Overall Study|Adverse Event|0|||
33179762|NCT00101907|100568123|FG000|Overall Study|Death|0|||
33179763|NCT00101907|100568124|FG001|Overall Study|Death|1|||
33179764|NCT00101907|100568125|FG002|Overall Study|Death|0|||
33179765|NCT00101907|100568126|FG003|Overall Study|Death|0|||
33179766|NCT00101907|100568127|FG004|Overall Study|Death|3|||
33179767|NCT00101907|100568128|FG005|Overall Study|Death|0|||
33179768|NCT00101907|100568123|FG000|Overall Study|Physician Decision|0|||
33179769|NCT00101907|100568124|FG001|Overall Study|Physician Decision|0|||
33179770|NCT00101907|100568125|FG002|Overall Study|Physician Decision|0|||
33179771|NCT00101907|100568126|FG003|Overall Study|Physician Decision|1|||
33179772|NCT00101907|100568127|FG004|Overall Study|Physician Decision|1|||
33179773|NCT00101907|100568128|FG005|Overall Study|Physician Decision|0|||
33179774|NCT00101907|100568123|FG000|Overall Study|Withdrawal by Subject|1|||
33179775|NCT00101907|100568124|FG001|Overall Study|Withdrawal by Subject|0|||
33179776|NCT00101907|100568125|FG002|Overall Study|Withdrawal by Subject|1|||
33179777|NCT00101907|100568126|FG003|Overall Study|Withdrawal by Subject|0|||
33179778|NCT00101907|100568127|FG004|Overall Study|Withdrawal by Subject|1|||
33179779|NCT00101907|100568128|FG005|Overall Study|Withdrawal by Subject|0|||
33179780|NCT02981342|100568129|FG000|Overall Study|Adverse Event|0|||
33179781|NCT02981342|100568130|FG001|Overall Study|Adverse Event|0|||
33179782|NCT02981342|100568131|FG002|Overall Study|Adverse Event|0|||
33179783|NCT02981342|100568132|FG003|Overall Study|Adverse Event|1|||
33179784|NCT02981342|100568129|FG000|Overall Study|Death|0|||
33179785|NCT02981342|100568130|FG001|Overall Study|Death|9|||
33179786|NCT02981342|100568131|FG002|Overall Study|Death|9|||
33179787|NCT02981342|100568132|FG003|Overall Study|Death|4|||
33179788|NCT02981342|100568129|FG000|Overall Study|Withdrawal by Subject|0|||
33179789|NCT02981342|100568130|FG001|Overall Study|Withdrawal by Subject|0|||
33179790|NCT02981342|100568131|FG002|Overall Study|Withdrawal by Subject|3|||
33179791|NCT02981342|100568132|FG003|Overall Study|Withdrawal by Subject|1|||
33179792|NCT02981342|100568129|FG000|Overall Study|Study closed by sponsor|0|||
33179793|NCT02981342|100568130|FG001|Overall Study|Study closed by sponsor|0|||
33179794|NCT02981342|100568131|FG002|Overall Study|Study closed by sponsor|1|||
33179795|NCT02981342|100568132|FG003|Overall Study|Study closed by sponsor|1|||
33179796|NCT02981342|100568129|FG000|Overall Study|Randomized, Never Treated|0|||
33179797|NCT02981342|100568130|FG001|Overall Study|Randomized, Never Treated|1|||
33179798|NCT02981342|100568131|FG002|Overall Study|Randomized, Never Treated|0|||
33179799|NCT02981342|100568132|FG003|Overall Study|Randomized, Never Treated|7|||
33179800|NCT02981342|100568129|FG000|Overall Study|Lost to Follow-up|0|||
33179801|NCT02981342|100568130|FG001|Overall Study|Lost to Follow-up|1|||
33266037|NCT00887224|100873777|FG001|Double-blind (DB) Phase|Adverse Event|7|||
33266038|NCT00887224|100873778|FG002|Double-blind (DB) Phase|Adverse Event|2|||
33179802|NCT02981342|100568131|FG002|Overall Study|Lost to Follow-up|0|||
33179803|NCT02981342|100568132|FG003|Overall Study|Lost to Follow-up|0|||
33179804|NCT03255382|100568135|FG000|Overall Study|Adverse Event|3|||
33266039|NCT00887224|100873776|FG000|Double-blind (DB) Phase|Failed to return|0|||
33468432|NCT01560507|101603879|FG000|Overall Study|Withdrawal by Subject|1|||
33468433|NCT01560507|101603880|FG001|Overall Study|Withdrawal by Subject|1|||
33468434|NCT01560507|101603881|FG002|Overall Study|Withdrawal by Subject|0|||
33468435|NCT00396331|101603882|FG000|Overall Study|Failed to mobilize - no transplant|8|||
33468436|NCT00396331|101603882|FG000|Overall Study|Did not go on to transplant|5|||
33468437|NCT00396331|101603882|FG000|Overall Study|Lost to Follow-up|3|||
33468438|NCT00396331|101603882|FG000|Overall Study|Death|16|||
33468439|NCT04364737|101603883|FG000|Overall Study|Withdrawal by Subject|4|||
33468440|NCT04364737|101603884|FG001|Overall Study|Withdrawal by Subject|9|||
33468441|NCT04364737|101603883|FG000|Overall Study|Lost to Follow-up|1|||
33468442|NCT04364737|101603884|FG001|Overall Study|Lost to Follow-up|1|||
33179805|NCT03255382|100568136|FG001|Overall Study|Adverse Event|0|||
33179806|NCT03255382|100568135|FG000|Overall Study|Lost to Follow-up|2|||
33266040|NCT00887224|100873777|FG001|Double-blind (DB) Phase|Failed to return|2|||
33266041|NCT00887224|100873778|FG002|Double-blind (DB) Phase|Failed to return|2|||
33266042|NCT00887224|100873776|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
33266043|NCT00887224|100873777|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
33266044|NCT00887224|100873778|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
33266045|NCT00887224|100873776|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
33266046|NCT00887224|100873777|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
33266047|NCT00887224|100873778|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
33266048|NCT00887224|100873776|FG000|Double-blind (DB) Phase|Other|0|||
33266049|NCT00887224|100873777|FG001|Double-blind (DB) Phase|Other|2|||
33266050|NCT00887224|100873778|FG002|Double-blind (DB) Phase|Other|0|||
33266051|NCT00887224|100873776|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
33266052|NCT00887224|100873777|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
33266053|NCT00887224|100873778|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
33266054|NCT00887224|100873776|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
33266055|NCT00887224|100873777|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
33266056|NCT00887224|100873778|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
33468443|NCT00307931|101603885|FG000|Overall Study|Adverse Event|1|||
33468444|NCT00865098|101603886|FG000|Overall Study|Progressive disease|1|||
33468445|NCT00296491|101603887|FG000|Overall Study|Low Pollen Counts|18|||
33468446|NCT00296491|101603888|FG001|Overall Study|Low Pollen Counts|26|||
33468447|NCT00296491|101603889|FG002|Overall Study|Low Pollen Counts|25|||
33468448|NCT00296491|101603890|FG003|Overall Study|Low Pollen Counts|16|||
33468449|NCT00296491|101603887|FG000|Overall Study|Protocol Violation|4|||
33468450|NCT00296491|101603888|FG001|Overall Study|Protocol Violation|6|||
33468451|NCT00296491|101603889|FG002|Overall Study|Protocol Violation|2|||
33468452|NCT00296491|101603890|FG003|Overall Study|Protocol Violation|3|||
33468453|NCT00296491|101603887|FG000|Overall Study|Adverse Event|1|||
33468454|NCT00296491|101603888|FG001|Overall Study|Adverse Event|3|||
33468455|NCT00296491|101603889|FG002|Overall Study|Adverse Event|1|||
33468456|NCT00296491|101603890|FG003|Overall Study|Adverse Event|4|||
33468457|NCT00296491|101603887|FG000|Overall Study|Withdrawn due to Asthma|0|||
33468458|NCT00296491|101603888|FG001|Overall Study|Withdrawn due to Asthma|0|||
33468459|NCT00296491|101603889|FG002|Overall Study|Withdrawn due to Asthma|0|||
33468460|NCT00296491|101603890|FG003|Overall Study|Withdrawn due to Asthma|4|||
33468461|NCT00296491|101603887|FG000|Overall Study|Withdrawal by Subject|7|||
33468462|NCT00296491|101603888|FG001|Overall Study|Withdrawal by Subject|3|||
33468463|NCT00296491|101603889|FG002|Overall Study|Withdrawal by Subject|3|||
33468464|NCT00296491|101603890|FG003|Overall Study|Withdrawal by Subject|2|||
33468465|NCT00296491|101603887|FG000|Overall Study|Non-Compliance|12|||
33468466|NCT00296491|101603888|FG001|Overall Study|Non-Compliance|13|||
33468467|NCT00296491|101603889|FG002|Overall Study|Non-Compliance|10|||
33468468|NCT00296491|101603890|FG003|Overall Study|Non-Compliance|14|||
33468469|NCT00296491|101603887|FG000|Overall Study|Lost to Follow-up|0|||
33468470|NCT00296491|101603888|FG001|Overall Study|Lost to Follow-up|2|||
33468471|NCT00296491|101603889|FG002|Overall Study|Lost to Follow-up|2|||
33468472|NCT00296491|101603890|FG003|Overall Study|Lost to Follow-up|0|||
33468473|NCT02695719|101603893|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
33468474|NCT02695719|101603894|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
33468475|NCT02695719|101603893|FG000|Overall Study|Significant Protocol Deviation|0|||
33468476|NCT02695719|101603894|FG001|Overall Study|Significant Protocol Deviation|1|||
33468477|NCT02695719|101603893|FG000|Overall Study|Voluntary Withdrawal|1|||
33468478|NCT02695719|101603894|FG001|Overall Study|Voluntary Withdrawal|0|||
33468479|NCT00614822|101603896|FG000|Overall Study|Adverse Event|3|||
33468480|NCT04039919|101603897|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33468481|NCT04039919|101603898|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33468482|NCT04039919|101603899|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33179807|NCT03255382|100568136|FG001|Overall Study|Lost to Follow-up|0|||
33179808|NCT03255382|100568135|FG000|Overall Study|Withdrawal by Subject|2|||
33179809|NCT03255382|100568136|FG001|Overall Study|Withdrawal by Subject|0|||
33179810|NCT03255382|100568135|FG000|Overall Study|Other|6|||
33179811|NCT03255382|100568136|FG001|Overall Study|Other|0|||
33179812|NCT00484939|100568138|FG000|Overall Study|Death|9|||
33266057|NCT00887224|100873776|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
33266058|NCT00887224|100873777|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
33266059|NCT00887224|100873778|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
33266060|NCT00887224|100873776|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
33266061|NCT00887224|100873777|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
33266062|NCT00887224|100873778|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
33266063|NCT00887224|100873776|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
33266064|NCT00887224|100873777|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
33266065|NCT00887224|100873778|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
33266066|NCT00887224|100873776|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
33266067|NCT00887224|100873777|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
33266068|NCT00887224|100873778|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
33266069|NCT00887224|100873776|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
33266070|NCT00887224|100873777|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
33266071|NCT00887224|100873778|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
33266072|NCT00887224|100873776|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
33266073|NCT00887224|100873777|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
33266074|NCT00887224|100873778|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
33266075|NCT00887224|100873776|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
33266076|NCT00887224|100873777|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
33266077|NCT00887224|100873778|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
33266078|NCT01779050|100873779|FG000|Overall Study|Withdrawal by Subject|1|||
33266079|NCT01779050|100873780|FG001|Overall Study|Withdrawal by Subject|0|||
33266080|NCT00452114|100873781|FG000|Overall Study|Physician Decision|3|||
33266081|NCT00452114|100873782|FG001|Overall Study|Physician Decision|3|||
33266082|NCT02605174|100873786|FG000|Overall Study|Adverse Event|0|||
33266083|NCT02605174|100873787|FG001|Overall Study|Adverse Event|0|||
33266084|NCT02605174|100873788|FG002|Overall Study|Adverse Event|1|||
33266085|NCT02605174|100873789|FG003|Overall Study|Adverse Event|0|||
33266086|NCT02605174|100873790|FG004|Overall Study|Adverse Event|4|||
33266087|NCT02605174|100873791|FG005|Overall Study|Adverse Event|0|||
33468483|NCT04039919|101603900|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33179813|NCT00484939|100568139|FG001|Overall Study|Death|13|||
33468484|NCT04039919|101603901|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33179814|NCT00484939|100568138|FG000|Overall Study|Adverse Event|22|||
33179815|NCT00484939|100568139|FG001|Overall Study|Adverse Event|12|||
33179816|NCT00484939|100568138|FG000|Overall Study|Patient Withdrew Consent|19|||
33179817|NCT00484939|100568139|FG001|Overall Study|Patient Withdrew Consent|10|||
33179818|NCT00484939|100568138|FG000|Overall Study|Protocol Violation|3|||
33179819|NCT00484939|100568139|FG001|Overall Study|Protocol Violation|3|||
33179820|NCT00484939|100568138|FG000|Overall Study|Lost to Follow-up|0|||
33179821|NCT00484939|100568139|FG001|Overall Study|Lost to Follow-up|3|||
33179822|NCT00484939|100568138|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
33179823|NCT00484939|100568139|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
33179824|NCT00484939|100568138|FG000|Overall Study|Disease progression|67|||
33179825|NCT00484939|100568139|FG001|Overall Study|Disease progression|88|||
33179826|NCT00484939|100568138|FG000|Overall Study|Screen Failure|2|||
33179827|NCT00484939|100568139|FG001|Overall Study|Screen Failure|2|||
33179828|NCT00484939|100568138|FG000|Overall Study|Reason Not Specified|11|||
33179829|NCT00484939|100568139|FG001|Overall Study|Reason Not Specified|6|||
33179830|NCT01265849|100568140|FG000|Overall Study|Randomized//Treatment not initiated|1|||
33179831|NCT01265849|100568141|FG001|Overall Study|Randomized//Treatment not initiated|4|||
33179832|NCT01265849|100568142|FG002|Overall Study|Randomized//Treatment not initiated|0|||
33179833|NCT01265849|100568140|FG000|Overall Study|Physician Decision|1|||
33179834|NCT01265849|100568141|FG001|Overall Study|Physician Decision|2|||
33179835|NCT01265849|100568142|FG002|Overall Study|Physician Decision|0|||
33179836|NCT01265849|100568140|FG000|Overall Study|Lost to Follow-up|18|||
33179837|NCT01265849|100568141|FG001|Overall Study|Lost to Follow-up|15|||
33179838|NCT01265849|100568142|FG002|Overall Study|Lost to Follow-up|5|||
33266088|NCT02605174|100873792|FG006|Overall Study|Adverse Event|0|||
33468485|NCT04039919|101603897|FG000|Treatment Period 1|Sponsor's decision|0|||
33468486|NCT04039919|101603898|FG001|Treatment Period 1|Sponsor's decision|0|||
33179839|NCT01265849|100568140|FG000|Overall Study|Not otherwise specified|1|||
33179840|NCT01265849|100568141|FG001|Overall Study|Not otherwise specified|6|||
33179841|NCT01265849|100568142|FG002|Overall Study|Not otherwise specified|1|||
33179842|NCT01265849|100568140|FG000|Overall Study|Withdrawal by Subject|25|||
33179843|NCT01265849|100568141|FG001|Overall Study|Withdrawal by Subject|34|||
33179844|NCT01265849|100568142|FG002|Overall Study|Withdrawal by Subject|13|||
33179845|NCT02921776|100568143|FG000|Overall Study|patient deterioration, fatigue|2|||
33266089|NCT02605174|100873786|FG000|Overall Study|Lost to Follow-up|20|||
33266090|NCT02605174|100873787|FG001|Overall Study|Lost to Follow-up|7|||
33266091|NCT02605174|100873788|FG002|Overall Study|Lost to Follow-up|27|||
33266092|NCT02605174|100873789|FG003|Overall Study|Lost to Follow-up|10|||
33468487|NCT04039919|101603899|FG002|Treatment Period 1|Sponsor's decision|0|||
33179846|NCT02921776|100568144|FG001|Overall Study|patient deterioration, fatigue|6|||
33179847|NCT02921776|100568145|FG002|Overall Study|patient deterioration, fatigue|0|||
33179848|NCT02921776|100568146|FG003|Overall Study|patient deterioration, fatigue|0|||
33179849|NCT02921776|100568147|FG004|Overall Study|patient deterioration, fatigue|0|||
33179850|NCT02921776|100568148|FG005|Overall Study|patient deterioration, fatigue|0|||
33179851|NCT02921776|100568149|FG006|Overall Study|patient deterioration, fatigue|0|||
33179852|NCT02921776|100568150|FG007|Overall Study|patient deterioration, fatigue|0|||
33179853|NCT02921776|100568143|FG000|Overall Study|Withdrawal by Subject|0|||
33179854|NCT02921776|100568144|FG001|Overall Study|Withdrawal by Subject|2|||
33179855|NCT02921776|100568145|FG002|Overall Study|Withdrawal by Subject|0|||
33179856|NCT02921776|100568146|FG003|Overall Study|Withdrawal by Subject|1|||
33179857|NCT02921776|100568147|FG004|Overall Study|Withdrawal by Subject|1|||
33468488|NCT04039919|101603900|FG003|Treatment Period 1|Sponsor's decision|0|||
33468489|NCT04039919|101603901|FG004|Treatment Period 1|Sponsor's decision|16|||
33468490|NCT04039919|101603897|FG000|Treatment Period 5|Withdrawal by Subject|1|||
33179858|NCT02921776|100568148|FG005|Overall Study|Withdrawal by Subject|0|||
33179859|NCT02921776|100568149|FG006|Overall Study|Withdrawal by Subject|8|||
33179860|NCT02921776|100568150|FG007|Overall Study|Withdrawal by Subject|1|||
33179861|NCT02921776|100568143|FG000|Overall Study|Death|0|||
33179862|NCT02921776|100568144|FG001|Overall Study|Death|0|||
33179863|NCT02921776|100568145|FG002|Overall Study|Death|0|||
33179864|NCT02921776|100568146|FG003|Overall Study|Death|2|||
33179865|NCT02921776|100568147|FG004|Overall Study|Death|0|||
33179866|NCT02921776|100568148|FG005|Overall Study|Death|0|||
33179867|NCT02921776|100568149|FG006|Overall Study|Death|0|||
33179868|NCT02921776|100568150|FG007|Overall Study|Death|0|||
33179869|NCT02921776|100568143|FG000|Overall Study|extubation or early discharge|0|||
33179870|NCT02921776|100568144|FG001|Overall Study|extubation or early discharge|0|||
33179871|NCT02921776|100568145|FG002|Overall Study|extubation or early discharge|0|||
33179872|NCT02921776|100568146|FG003|Overall Study|extubation or early discharge|5|||
33266093|NCT02605174|100873790|FG004|Overall Study|Lost to Follow-up|20|||
33266094|NCT02605174|100873791|FG005|Overall Study|Lost to Follow-up|10|||
33266095|NCT02605174|100873792|FG006|Overall Study|Lost to Follow-up|29|||
33266096|NCT02605174|100873786|FG000|Overall Study|Protocol Violation|10|||
33266097|NCT02605174|100873787|FG001|Overall Study|Protocol Violation|4|||
33266098|NCT02605174|100873788|FG002|Overall Study|Protocol Violation|14|||
33266099|NCT02605174|100873789|FG003|Overall Study|Protocol Violation|6|||
33266100|NCT02605174|100873790|FG004|Overall Study|Protocol Violation|7|||
33266101|NCT02605174|100873791|FG005|Overall Study|Protocol Violation|7|||
33179873|NCT02921776|100568147|FG004|Overall Study|extubation or early discharge|5|||
33179874|NCT02921776|100568148|FG005|Overall Study|extubation or early discharge|0|||
33179875|NCT02921776|100568149|FG006|Overall Study|extubation or early discharge|0|||
33179876|NCT02921776|100568150|FG007|Overall Study|extubation or early discharge|0|||
33179877|NCT02921776|100568143|FG000|Overall Study|Lost to Follow-up|0|||
33179878|NCT02921776|100568144|FG001|Overall Study|Lost to Follow-up|0|||
33179879|NCT02921776|100568145|FG002|Overall Study|Lost to Follow-up|0|||
33179880|NCT02921776|100568146|FG003|Overall Study|Lost to Follow-up|0|||
33179881|NCT02921776|100568147|FG004|Overall Study|Lost to Follow-up|0|||
33179882|NCT02921776|100568148|FG005|Overall Study|Lost to Follow-up|2|||
33179883|NCT02921776|100568149|FG006|Overall Study|Lost to Follow-up|3|||
33179884|NCT02921776|100568150|FG007|Overall Study|Lost to Follow-up|6|||
33179885|NCT02385084|100568153|FG000|Period 2|Protocol Violation|0|||
33179886|NCT02385084|100568154|FG001|Period 2|Protocol Violation|0|||
33468491|NCT04039919|101603898|FG001|Treatment Period 5|Withdrawal by Subject|0|||
33468492|NCT04039919|101603899|FG002|Treatment Period 5|Withdrawal by Subject|0|||
33179887|NCT02385084|100568155|FG002|Period 2|Protocol Violation|1|||
33179888|NCT02385084|100568156|FG003|Period 2|Protocol Violation|0|||
33266102|NCT02605174|100873792|FG006|Overall Study|Protocol Violation|12|||
33266103|NCT02605174|100873786|FG000|Overall Study|Pregnancy|1|||
33266104|NCT02605174|100873787|FG001|Overall Study|Pregnancy|0|||
33266105|NCT02605174|100873788|FG002|Overall Study|Pregnancy|0|||
33468493|NCT04039919|101603900|FG003|Treatment Period 5|Withdrawal by Subject|0|||
33468494|NCT04039919|101603901|FG004|Treatment Period 5|Withdrawal by Subject|0|||
33179889|NCT02385084|100568157|FG004|Period 2|Protocol Violation|0|||
33179890|NCT02385084|100568158|FG005|Period 2|Protocol Violation|0|||
33179891|NCT02411292|100568159|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
33179892|NCT02411292|100568159|FG000|Overall Study|Death|2|||
33266106|NCT02605174|100873789|FG003|Overall Study|Pregnancy|2|||
33266107|NCT02605174|100873790|FG004|Overall Study|Pregnancy|0|||
33468495|NCT02631876|101603905|FG000|Overall Study|Death|96|||
33468496|NCT02631876|101603906|FG001|Overall Study|Death|50|||
33179893|NCT02411292|100568159|FG000|Overall Study|Lost to Follow-up|3|||
33179894|NCT00507442|100568160|FG000|Overall Study|Adverse Event|8|||
33179895|NCT00507442|100568161|FG001|Overall Study|Adverse Event|11|||
33179896|NCT00507442|100568162|FG002|Overall Study|Adverse Event|4|||
33179897|NCT00507442|100568163|FG003|Overall Study|Adverse Event|1|||
33179898|NCT00507442|100568160|FG000|Overall Study|Protocol Violation|0|||
33179899|NCT00507442|100568161|FG001|Overall Study|Protocol Violation|1|||
33468497|NCT02631876|101603905|FG000|Overall Study|Investigator's discretion|1|||
33266108|NCT02605174|100873791|FG005|Overall Study|Pregnancy|0|||
33266109|NCT02605174|100873792|FG006|Overall Study|Pregnancy|0|||
33266110|NCT02605174|100873786|FG000|Overall Study|Withdrawal by Subject|9|||
33266111|NCT02605174|100873787|FG001|Overall Study|Withdrawal by Subject|6|||
33468498|NCT02631876|101603906|FG001|Overall Study|Investigator's discretion|0|||
33468499|NCT02631876|101603905|FG000|Overall Study|Lost to Follow-up|2|||
33468500|NCT02631876|101603906|FG001|Overall Study|Lost to Follow-up|0|||
33468501|NCT02631876|101603905|FG000|Overall Study|Withdrawal by Subject|16|||
33468502|NCT02631876|101603906|FG001|Overall Study|Withdrawal by Subject|9|||
33468503|NCT02631876|101603905|FG000|Overall Study|Other than specified|4|||
33468504|NCT02631876|101603906|FG001|Overall Study|Other than specified|4|||
33468505|NCT02668822|101603907|FG000|Overall Study|Protocol Violation|2|||
33468506|NCT02668822|101603908|FG001|Overall Study|Protocol Violation|0|||
33468507|NCT02668822|101603907|FG000|Overall Study|Study Terminated by Sponsor|7|||
33468508|NCT02668822|101603908|FG001|Overall Study|Study Terminated by Sponsor|9|||
33468509|NCT04109313|101603912|FG000|Overall Study|Pregnancy|1|||
33468510|NCT04109313|101603912|FG000|Overall Study|Adverse Event|11|||
33468511|NCT04109313|101603912|FG000|Overall Study|Lack of Efficacy|11|||
33468512|NCT04109313|101603912|FG000|Overall Study|Lost to Follow-up|1|||
33468513|NCT04109313|101603912|FG000|Overall Study|Physician Decision|2|||
33468514|NCT04109313|101603912|FG000|Overall Study|Subject Decision|13|||
33468515|NCT04109313|101603912|FG000|Overall Study|Covid-19 situation|2|||
33468516|NCT02442271|101607834|FG000|Overall Study|Adverse Event|1|||
33468517|NCT02442271|101607834|FG000|Overall Study|Withdrew Consent|1|||
33468518|NCT02442271|101607834|FG000|Overall Study|Lost to Follow-up|1|||
33468519|NCT02442271|101607834|FG000|Overall Study|Other|1|||
33468520|NCT00430950|101607835|FG000|Overall Study|Adverse Event|7|||
33468521|NCT00430950|101607836|FG001|Overall Study|Adverse Event|6|||
33468522|NCT00430950|101607835|FG000|Overall Study|Withdrawal by Subject|1|||
33468523|NCT00430950|101607836|FG001|Overall Study|Withdrawal by Subject|0|||
33468524|NCT00430950|101607835|FG000|Overall Study|concomitant medication,etc.|5|||
33468525|NCT00430950|101607836|FG001|Overall Study|concomitant medication,etc.|7|||
33468526|NCT00350402|101607837|FG000|Overall Study|Lost to Follow-up|1|||
33468527|NCT00350402|101607838|FG001|Overall Study|Lost to Follow-up|1|||
33179900|NCT00507442|100568162|FG002|Overall Study|Protocol Violation|0|||
33179901|NCT00507442|100568163|FG003|Overall Study|Protocol Violation|0|||
33179902|NCT00507442|100568160|FG000|Overall Study|Lost to Follow-up|0|||
33179903|NCT00507442|100568161|FG001|Overall Study|Lost to Follow-up|0|||
33179904|NCT00507442|100568162|FG002|Overall Study|Lost to Follow-up|1|||
33179905|NCT00507442|100568163|FG003|Overall Study|Lost to Follow-up|0|||
33179906|NCT00507442|100568160|FG000|Overall Study|Physician Decision|0|||
33179907|NCT00507442|100568161|FG001|Overall Study|Physician Decision|2|||
33179908|NCT00507442|100568162|FG002|Overall Study|Physician Decision|4|||
33179909|NCT00507442|100568163|FG003|Overall Study|Physician Decision|1|||
33179910|NCT00507442|100568160|FG000|Overall Study|Progressive Disease|2|||
33179911|NCT00507442|100568161|FG001|Overall Study|Progressive Disease|4|||
33179912|NCT00507442|100568162|FG002|Overall Study|Progressive Disease|2|||
33179913|NCT00507442|100568163|FG003|Overall Study|Progressive Disease|0|||
33179914|NCT00507442|100568160|FG000|Overall Study|Withdrawal by Subject|4|||
33179915|NCT00507442|100568161|FG001|Overall Study|Withdrawal by Subject|4|||
33179916|NCT00507442|100568162|FG002|Overall Study|Withdrawal by Subject|2|||
33179917|NCT00507442|100568163|FG003|Overall Study|Withdrawal by Subject|1|||
33179918|NCT00507442|100568160|FG000|Overall Study|Other|2|||
33179919|NCT00507442|100568161|FG001|Overall Study|Other|5|||
33179920|NCT00507442|100568162|FG002|Overall Study|Other|2|||
33266112|NCT02605174|100873788|FG002|Overall Study|Withdrawal by Subject|14|||
33266113|NCT02605174|100873789|FG003|Overall Study|Withdrawal by Subject|11|||
33266114|NCT02605174|100873790|FG004|Overall Study|Withdrawal by Subject|6|||
33266115|NCT02605174|100873791|FG005|Overall Study|Withdrawal by Subject|4|||
33266116|NCT02605174|100873792|FG006|Overall Study|Withdrawal by Subject|15|||
33266117|NCT02605174|100873786|FG000|Overall Study|Physician Decision|2|||
33266118|NCT02605174|100873787|FG001|Overall Study|Physician Decision|0|||
33468528|NCT00788593|101607842|FG000|Placebo Run-in Phase|Adverse Event|2|||
33179921|NCT00507442|100568163|FG003|Overall Study|Other|2|||
33179922|NCT02432846|100568166|FG000|Overall Study (4 Arms/Strata)|Death|3|||
33179923|NCT02432846|100568167|FG001|Overall Study (4 Arms/Strata)|Death|2|||
33179924|NCT02432846|100568168|FG002|Overall Study (4 Arms/Strata)|Death|4|||
33179925|NCT02432846|100568169|FG003|Overall Study (4 Arms/Strata)|Death|3|||
33266119|NCT02605174|100873788|FG002|Overall Study|Physician Decision|0|||
33266120|NCT02605174|100873789|FG003|Overall Study|Physician Decision|0|||
33266121|NCT02605174|100873790|FG004|Overall Study|Physician Decision|0|||
33179926|NCT02432846|100568170|FG004|Overall Study (4 Arms/Strata)|Death|0|||
33179927|NCT02432846|100568171|FG005|Overall Study (4 Arms/Strata)|Death|0|||
33468529|NCT00788593|101607843|FG001|Placebo Run-in Phase|Adverse Event|0|||
33468530|NCT00788593|101607844|FG002|Placebo Run-in Phase|Adverse Event|0|||
33468531|NCT00788593|101607842|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
33468532|NCT00788593|101607843|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
33468533|NCT00788593|101607844|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
33468534|NCT00788593|101607842|FG000|Placebo Run-in Phase|Protocol Violation|2|||
33266122|NCT02605174|100873791|FG005|Overall Study|Physician Decision|0|||
33266123|NCT02605174|100873792|FG006|Overall Study|Physician Decision|3|||
33266124|NCT02605174|100873786|FG000|Overall Study|Randomization Failure|22|||
33266125|NCT02605174|100873787|FG001|Overall Study|Randomization Failure|6|||
33266126|NCT02605174|100873788|FG002|Overall Study|Randomization Failure|20|||
33266127|NCT02605174|100873789|FG003|Overall Study|Randomization Failure|7|||
33266128|NCT02605174|100873790|FG004|Overall Study|Randomization Failure|16|||
33266129|NCT02605174|100873791|FG005|Overall Study|Randomization Failure|11|||
33266130|NCT02605174|100873792|FG006|Overall Study|Randomization Failure|30|||
33266131|NCT01074242|100873793|FG000|Overall Study|Case report before date of contract|40|||
33266132|NCT01074242|100873793|FG000|Overall Study|Lost to Follow-up|1|||
33266133|NCT01074242|100873793|FG000|Overall Study|Case report unclear|6|||
33266134|NCT01074242|100873793|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
33266135|NCT01074242|100873793|FG000|Overall Study|Duplicate Case Report Form|5|||
33266136|NCT01105975|100873794|FG000|Overall Study|Adverse Event|2|||
33266137|NCT01105975|100873795|FG001|Overall Study|Adverse Event|1|||
33266138|NCT01105975|100873796|FG002|Overall Study|Adverse Event|5|||
33266139|NCT01105975|100873797|FG003|Overall Study|Adverse Event|1|||
33266140|NCT01105975|100873798|FG004|Overall Study|Adverse Event|0|||
33266141|NCT01105975|100873799|FG005|Overall Study|Adverse Event|1|||
33266142|NCT01105975|100873800|FG006|Overall Study|Adverse Event|2|||
33266143|NCT01105975|100873801|FG007|Overall Study|Adverse Event|4|||
33266144|NCT01105975|100873802|FG008|Overall Study|Adverse Event|1|||
33266145|NCT01105975|100873803|FG009|Overall Study|Adverse Event|4|||
33266146|NCT01105975|100873794|FG000|Overall Study|Withdrawal by Subject|2|||
33266147|NCT01105975|100873795|FG001|Overall Study|Withdrawal by Subject|2|||
33266148|NCT01105975|100873796|FG002|Overall Study|Withdrawal by Subject|2|||
33266149|NCT01105975|100873797|FG003|Overall Study|Withdrawal by Subject|0|||
33266150|NCT01105975|100873798|FG004|Overall Study|Withdrawal by Subject|4|||
33266151|NCT01105975|100873799|FG005|Overall Study|Withdrawal by Subject|1|||
33266152|NCT01105975|100873800|FG006|Overall Study|Withdrawal by Subject|2|||
33266153|NCT01105975|100873801|FG007|Overall Study|Withdrawal by Subject|1|||
33266154|NCT01105975|100873802|FG008|Overall Study|Withdrawal by Subject|0|||
33266155|NCT01105975|100873803|FG009|Overall Study|Withdrawal by Subject|3|||
33266156|NCT01105975|100873794|FG000|Overall Study|Lost to Follow-up|1|||
33266157|NCT01105975|100873795|FG001|Overall Study|Lost to Follow-up|0|||
33266158|NCT01105975|100873796|FG002|Overall Study|Lost to Follow-up|0|||
33266159|NCT01105975|100873797|FG003|Overall Study|Lost to Follow-up|1|||
33266160|NCT01105975|100873798|FG004|Overall Study|Lost to Follow-up|1|||
33266161|NCT01105975|100873799|FG005|Overall Study|Lost to Follow-up|0|||
33266162|NCT01105975|100873800|FG006|Overall Study|Lost to Follow-up|0|||
33266163|NCT01105975|100873801|FG007|Overall Study|Lost to Follow-up|0|||
33266164|NCT01105975|100873802|FG008|Overall Study|Lost to Follow-up|1|||
33266165|NCT01105975|100873803|FG009|Overall Study|Lost to Follow-up|0|||
33266166|NCT01105975|100873794|FG000|Overall Study|Physician Decision|0|||
33266167|NCT01105975|100873795|FG001|Overall Study|Physician Decision|0|||
33266168|NCT01105975|100873796|FG002|Overall Study|Physician Decision|0|||
33266169|NCT01105975|100873797|FG003|Overall Study|Physician Decision|0|||
33266170|NCT01105975|100873798|FG004|Overall Study|Physician Decision|0|||
33266171|NCT01105975|100873799|FG005|Overall Study|Physician Decision|0|||
33266172|NCT01105975|100873800|FG006|Overall Study|Physician Decision|2|||
33266173|NCT01105975|100873801|FG007|Overall Study|Physician Decision|0|||
33266174|NCT01105975|100873802|FG008|Overall Study|Physician Decision|0|||
33266175|NCT01105975|100873803|FG009|Overall Study|Physician Decision|0|||
33266176|NCT01105975|100873794|FG000|Overall Study|Protocol Violation|0|||
33266177|NCT01105975|100873795|FG001|Overall Study|Protocol Violation|2|||
33266178|NCT01105975|100873796|FG002|Overall Study|Protocol Violation|2|||
33266179|NCT01105975|100873797|FG003|Overall Study|Protocol Violation|0|||
33266180|NCT01105975|100873798|FG004|Overall Study|Protocol Violation|1|||
33266181|NCT01105975|100873799|FG005|Overall Study|Protocol Violation|1|||
33468535|NCT00788593|101607843|FG001|Placebo Run-in Phase|Protocol Violation|0|||
33468536|NCT00788593|101607844|FG002|Placebo Run-in Phase|Protocol Violation|0|||
33266182|NCT01105975|100873800|FG006|Overall Study|Protocol Violation|1|||
33266183|NCT01105975|100873801|FG007|Overall Study|Protocol Violation|1|||
33266184|NCT01105975|100873802|FG008|Overall Study|Protocol Violation|2|||
33266185|NCT01105975|100873803|FG009|Overall Study|Protocol Violation|2|||
33266186|NCT01105975|100873794|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
33266187|NCT01105975|100873795|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
33266188|NCT01105975|100873796|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
33266189|NCT01105975|100873797|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
33266190|NCT01105975|100873798|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
33266191|NCT01105975|100873799|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
33266192|NCT01105975|100873800|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
33266193|NCT01105975|100873801|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
33266194|NCT01105975|100873802|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
33266195|NCT01105975|100873803|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
33266196|NCT01641900|100873810|FG000|Overall Study|Withdrawal by Subject|2|||
33266197|NCT01641900|100873811|FG001|Overall Study|Withdrawal by Subject|2|||
33266198|NCT03113409|100873815|FG000|Overall Study|Withdrawal by Subject|5|||
33266199|NCT03113409|100873816|FG001|Overall Study|Withdrawal by Subject|0|||
33266200|NCT03113409|100873817|FG002|Overall Study|Withdrawal by Subject|0|||
33266201|NCT01766206|100873818|FG000|Overall Study|Withdrawal by Subject|22|||
33266202|NCT01766206|100873818|FG000|Overall Study|Lost to Follow-up|10|||
33266203|NCT01766206|100873818|FG000|Overall Study|Inappropriate enrollment|18|||
33266204|NCT01766206|100873818|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
33266205|NCT00609869|100873819|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
33179928|NCT02432846|100568166|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
33179929|NCT02432846|100568167|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
33179930|NCT02432846|100568168|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
33179931|NCT02432846|100568169|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
33179932|NCT02432846|100568170|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
33179933|NCT02432846|100568171|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
33179934|NCT02432846|100568166|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
33179935|NCT02432846|100568167|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
33179936|NCT02432846|100568168|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
33179937|NCT02432846|100568169|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
33179938|NCT02432846|100568170|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
33179939|NCT02432846|100568171|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
33179940|NCT02432846|100568166|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
33179941|NCT02432846|100568167|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
33179942|NCT02432846|100568168|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
33179943|NCT02432846|100568169|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
33179944|NCT02432846|100568170|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
33179945|NCT02432846|100568171|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
33179946|NCT02432846|100568166|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
33179947|NCT02432846|100568167|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
33179948|NCT02432846|100568168|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
33179949|NCT02432846|100568169|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
33179950|NCT02432846|100568170|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
33179951|NCT02432846|100568171|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
33179952|NCT02432846|100568166|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
33179953|NCT02432846|100568167|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
33179954|NCT02432846|100568168|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
33179955|NCT02432846|100568169|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
33179956|NCT02432846|100568170|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
33179957|NCT02432846|100568171|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
33179958|NCT02432846|100568166|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
33179959|NCT02432846|100568167|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
33179960|NCT02432846|100568168|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
33179961|NCT02432846|100568169|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
33179962|NCT02432846|100568170|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
33179963|NCT02432846|100568171|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
33179964|NCT02432846|100568166|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
33179965|NCT02432846|100568167|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
33179966|NCT02432846|100568168|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
33179967|NCT02432846|100568169|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
33179968|NCT02432846|100568170|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
33179969|NCT02432846|100568171|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
33179970|NCT02432846|100568166|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
33179971|NCT02432846|100568167|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
33179972|NCT02432846|100568168|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
33179973|NCT02432846|100568169|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
33179974|NCT02432846|100568170|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
33266206|NCT00609869|100873819|FG000|Overall Study|Severe hematologic toxicity|1|||
33266207|NCT00609869|100873819|FG000|Overall Study|Withdrawal by Subject|1|||
33179975|NCT02432846|100568171|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
33179976|NCT02432846|100568166|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
33179977|NCT02432846|100568167|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
33266208|NCT00609869|100873819|FG000|Overall Study|Seizures|1|||
33266209|NCT00609869|100873819|FG000|Overall Study|Severe tumor flare reaction|1|||
33266210|NCT00609869|100873819|FG000|Overall Study|Hepatitis B infection|1|||
33266211|NCT00609869|100873819|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
33266212|NCT00609869|100873819|FG000|Overall Study|Mantle cell: not evaluable|4|||
33179978|NCT02432846|100568168|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
33266213|NCT00512252|100873824|FG000|Overall Study|Lost to Follow-up|0|||
33266214|NCT00512252|100873825|FG001|Overall Study|Lost to Follow-up|0|||
33266215|NCT00512252|100873826|FG002|Overall Study|Lost to Follow-up|1|||
33266216|NCT00512252|100873824|FG000|Overall Study|Protocol Violation|0|||
33266217|NCT00512252|100873825|FG001|Overall Study|Protocol Violation|0|||
33266218|NCT00512252|100873826|FG002|Overall Study|Protocol Violation|1|||
33266219|NCT00512252|100873824|FG000|Overall Study|Death|0|||
33266220|NCT00512252|100873825|FG001|Overall Study|Death|0|||
33266221|NCT00512252|100873826|FG002|Overall Study|Death|1|||
33266222|NCT01499849|100873827|FG000|Overall Study|Adverse Event|28|||
33266223|NCT01499849|100873828|FG001|Overall Study|Adverse Event|32|||
33266224|NCT01499849|100873827|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
33266225|NCT01499849|100873828|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
33468537|NCT00788593|101607842|FG000|First Intervention Period|Adverse Event|0|||
33468538|NCT00788593|101607843|FG001|First Intervention Period|Adverse Event|1|||
33468539|NCT00788593|101607844|FG002|First Intervention Period|Adverse Event|0|||
33468540|NCT00788593|101607842|FG000|Second Intervention Period|Lost to Follow-up|0|||
33468541|NCT00788593|101607843|FG001|Second Intervention Period|Lost to Follow-up|1|||
33468542|NCT00788593|101607844|FG002|Second Intervention Period|Lost to Follow-up|0|||
33468543|NCT00788593|101607842|FG000|Second Intervention Period|Other|0|||
33468544|NCT00788593|101607843|FG001|Second Intervention Period|Other|0|||
33468545|NCT00788593|101607844|FG002|Second Intervention Period|Other|1|||
33468546|NCT01564459|101607845|FG000|Run-In|Adverse Event|7|||
33468547|NCT01564459|101607846|FG001|Run-In|Adverse Event|0|||
33179979|NCT02432846|100568169|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
33179980|NCT02432846|100568170|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
33179981|NCT02432846|100568171|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
33179982|NCT02432846|100568166|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
33468548|NCT01564459|101607847|FG002|Run-In|Adverse Event|0|||
33468549|NCT01564459|101607845|FG000|Run-In|Lost to Follow-up|1|||
33468550|NCT01564459|101607846|FG001|Run-In|Lost to Follow-up|0|||
33468551|NCT01564459|101607847|FG002|Run-In|Lost to Follow-up|0|||
33468552|NCT01564459|101607845|FG000|Run-In|Non-compliance with study drug|2|||
33468553|NCT01564459|101607846|FG001|Run-In|Non-compliance with study drug|0|||
33468554|NCT01564459|101607847|FG002|Run-In|Non-compliance with study drug|0|||
33179983|NCT02432846|100568167|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
33179984|NCT02432846|100568168|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
33266226|NCT01499849|100873827|FG000|Overall Study|Withdrawal by Subject|43|||
33468555|NCT01564459|101607845|FG000|Run-In|Protocol Violation|1|||
33179985|NCT02432846|100568169|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
33179986|NCT02432846|100568170|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
33179987|NCT02432846|100568171|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
33179988|NCT02432846|100568166|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
33179989|NCT02432846|100568167|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
33179990|NCT02432846|100568168|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
33179991|NCT02432846|100568169|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
33179992|NCT02432846|100568170|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
33179993|NCT02432846|100568171|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
33179994|NCT02432846|100568166|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
33179995|NCT02432846|100568167|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
33179996|NCT02432846|100568168|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
33179997|NCT02432846|100568169|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
33179998|NCT02432846|100568170|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
33179999|NCT02432846|100568171|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
33180000|NCT02432846|100568166|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
33180001|NCT02432846|100568167|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
33180002|NCT02432846|100568168|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
33180003|NCT02432846|100568169|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
33180004|NCT02432846|100568170|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
33180005|NCT02432846|100568171|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
33180006|NCT03164928|100568172|FG000|Overall Study|Lost to Follow-up|1|||
33180007|NCT03164928|100568173|FG001|Overall Study|Lost to Follow-up|0|||
33180008|NCT01400516|100568174|FG000|Primary Trial|Withdrawal by Subject|0|||
33180009|NCT01400516|100568175|FG001|Primary Trial|Withdrawal by Subject|2|||
33180010|NCT01696994|100568177|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
33180011|NCT01696994|100568178|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
33266227|NCT01499849|100873828|FG001|Overall Study|Withdrawal by Subject|43|||
33266228|NCT01499849|100873827|FG000|Overall Study|Death|5|||
33266229|NCT01499849|100873828|FG001|Overall Study|Death|7|||
33266230|NCT01499849|100873827|FG000|Overall Study|Disease Progression|11|||
33468556|NCT01564459|101607846|FG001|Run-In|Protocol Violation|0|||
33468557|NCT01564459|101607847|FG002|Run-In|Protocol Violation|0|||
33468558|NCT01564459|101607845|FG000|Run-In|Withdrawal by Subject|1|||
33468559|NCT01564459|101607846|FG001|Run-In|Withdrawal by Subject|0|||
33468560|NCT01564459|101607847|FG002|Run-In|Withdrawal by Subject|0|||
33468561|NCT01564459|101607845|FG000|Double-blind Treatment|Adverse Event|0|||
33468562|NCT01564459|101607846|FG001|Double-blind Treatment|Adverse Event|0|||
33468563|NCT01564459|101607847|FG002|Double-blind Treatment|Adverse Event|1|||
33468564|NCT01333072|101607853|FG000|Overall Study|Lost to Follow-up|3|||
33468565|NCT01333072|101607854|FG001|Overall Study|Lost to Follow-up|0|||
33468566|NCT01333072|101607853|FG000|Overall Study|Adverse Event|2|||
33468567|NCT01333072|101607854|FG001|Overall Study|Adverse Event|4|||
33468568|NCT01333072|101607853|FG000|Overall Study|Physician Decision|1|||
33468569|NCT01333072|101607854|FG001|Overall Study|Physician Decision|0|||
33468570|NCT00775606|101607860|FG000|Overall Study|Study sponsor terminated funding|3|||
33468571|NCT00775606|101607861|FG001|Overall Study|Study sponsor terminated funding|0|||
33468572|NCT05069155|101607862|FG000|Overall Study|Withdrawal by Subject|1|||
33468573|NCT05069155|101607863|FG001|Overall Study|Withdrawal by Subject|3|||
33468574|NCT00868296|101607866|FG000|Overall Study|Adverse Event|0|||
33468575|NCT00868296|101607867|FG001|Overall Study|Adverse Event|2|||
33468576|NCT00868296|101607866|FG000|Overall Study|Withdrawal by Subject|0|||
33468577|NCT00868296|101607867|FG001|Overall Study|Withdrawal by Subject|1|||
33468578|NCT03499119|101607868|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
33468579|NCT03499119|101607869|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
33468580|NCT03499119|101607870|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
33468581|NCT03499119|101607871|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
33468582|NCT03499119|101607868|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
33180012|NCT01696994|100568177|FG000|Overall Study|Died Before Randomization|1|||
33180013|NCT01696994|100568178|FG001|Overall Study|Died Before Randomization|2|||
33180014|NCT01696994|100568177|FG000|Overall Study|Died Before ASU (Control)|73|||
33266231|NCT01499849|100873828|FG001|Overall Study|Disease Progression|10|||
33468583|NCT03499119|101607869|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
33468584|NCT03499119|101607870|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
33468585|NCT03499119|101607871|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
33468586|NCT03499119|101607868|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
33468587|NCT03499119|101607869|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
33468588|NCT03499119|101607870|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
33468589|NCT03499119|101607871|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
33468590|NCT03499119|101607868|FG000|Optional Extension Phase|Lost to Follow-up|0|||
33468591|NCT03499119|101607869|FG001|Optional Extension Phase|Lost to Follow-up|0|||
33468592|NCT03499119|101607870|FG002|Optional Extension Phase|Lost to Follow-up|0|||
33468593|NCT03499119|101607871|FG003|Optional Extension Phase|Lost to Follow-up|1|||
33468594|NCT03499119|101607868|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
33468595|NCT03499119|101607869|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
33468596|NCT03499119|101607870|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
33468597|NCT03499119|101607871|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
33468598|NCT03499119|101607868|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
33468599|NCT03499119|101607869|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
33468600|NCT03499119|101607870|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
33468601|NCT03499119|101607871|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
33468602|NCT00140413|101607872|FG000|Overall Study|Lost to Follow-up|1|||
33468603|NCT00140413|101607873|FG001|Overall Study|Lost to Follow-up|0|||
33468604|NCT00140413|101607872|FG000|Overall Study|Withdrawal by Subject|2|||
33468605|NCT00140413|101607873|FG001|Overall Study|Withdrawal by Subject|0|||
33468606|NCT02973321|101607874|FG000|Overall Study|Other than specified|0|||
33468607|NCT02973321|101607875|FG001|Overall Study|Other than specified|5|||
33468608|NCT02973321|101607876|FG002|Overall Study|Other than specified|3|||
33468609|NCT02973321|101607877|FG003|Overall Study|Other than specified|3|||
33468610|NCT02973321|101607878|FG004|Overall Study|Other than specified|1|||
33468611|NCT02973321|101607874|FG000|Overall Study|Lack of Efficacy|0|||
33468612|NCT02973321|101607875|FG001|Overall Study|Lack of Efficacy|0|||
33468613|NCT02973321|101607876|FG002|Overall Study|Lack of Efficacy|0|||
33468614|NCT02973321|101607877|FG003|Overall Study|Lack of Efficacy|0|||
33468615|NCT02973321|101607878|FG004|Overall Study|Lack of Efficacy|1|||
33468616|NCT02973321|101607874|FG000|Overall Study|Adverse Event|1|||
33468617|NCT02973321|101607875|FG001|Overall Study|Adverse Event|10|||
33468618|NCT02973321|101607876|FG002|Overall Study|Adverse Event|11|||
33180015|NCT01696994|100568178|FG001|Overall Study|Died Before ASU (Control)|0|||
33266232|NCT01499849|100873827|FG000|Overall Study|Protocol Violation|11|||
33468619|NCT02973321|101607877|FG003|Overall Study|Adverse Event|13|||
33468620|NCT02973321|101607878|FG004|Overall Study|Adverse Event|3|||
33468621|NCT04965389|101607881|FG000|Overall Study|Other reasons|1|||
33468622|NCT04965389|101607882|FG001|Overall Study|Other reasons|0|||
33180016|NCT01696994|100568177|FG000|Overall Study|No Ovaries at Baseline|4807|||
33180017|NCT01696994|100568178|FG001|Overall Study|No Ovaries at Baseline|4851|||
33468623|NCT04965389|101607883|FG002|Overall Study|Other reasons|0|||
33468624|NCT04965389|101607884|FG003|Overall Study|Other reasons|0|||
33468625|NCT04965389|101607881|FG000|Overall Study|Participant withdrew consent|0|||
33468626|NCT04965389|101607882|FG001|Overall Study|Participant withdrew consent|1|||
33468627|NCT04965389|101607883|FG002|Overall Study|Participant withdrew consent|0|||
33266233|NCT01499849|100873828|FG001|Overall Study|Protocol Violation|11|||
33266234|NCT01499849|100873827|FG000|Overall Study|Physician Decision|20|||
33266235|NCT01499849|100873828|FG001|Overall Study|Physician Decision|19|||
33266236|NCT01499849|100873827|FG000|Overall Study|Lack of Efficacy|3|||
33266237|NCT01499849|100873828|FG001|Overall Study|Lack of Efficacy|4|||
33266238|NCT01499849|100873827|FG000|Overall Study|Lost to Follow-up|6|||
33266239|NCT01499849|100873828|FG001|Overall Study|Lost to Follow-up|3|||
33266240|NCT01499849|100873827|FG000|Overall Study|Other Reasons|27|||
33266241|NCT01499849|100873828|FG001|Overall Study|Other Reasons|30|||
33468628|NCT04965389|101607884|FG003|Overall Study|Participant withdrew consent|0|||
33468629|NCT04965389|101607881|FG000|Overall Study|Poor/Non-compliance|0|||
33468630|NCT04965389|101607882|FG001|Overall Study|Poor/Non-compliance|1|||
33180018|NCT01696994|100568177|FG000|Overall Study|Refused ASU (Control)|311|||
33180019|NCT01696994|100568178|FG001|Overall Study|Refused ASU (Control)|0|||
33180020|NCT01696994|100568177|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
33180021|NCT01696994|100568178|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
33180022|NCT02447081|100568179|FG000|Overall Study|Death|161|||
33180023|NCT02447081|100568179|FG000|Overall Study|Lost to Follow-up|36|||
33180024|NCT02447081|100568179|FG000|Overall Study|Visit not completed|17|||
33180025|NCT02447081|100568179|FG000|Overall Study|unsuccessful implant procedure|10|||
33180026|NCT03082599|100568180|FG000|Overall Study|Lost to Follow-up|1|||
33180027|NCT03082599|100568181|FG001|Overall Study|Lost to Follow-up|0|||
33180028|NCT01179477|100568182|FG000|Overall Study|Death|542|||
33180029|NCT01179477|100568182|FG000|Overall Study|Unsuccessful implant|80|||
33180030|NCT01179477|100568182|FG000|Overall Study|Non-death withdrawal|438|||
33180031|NCT01179477|100568182|FG000|Overall Study|Did not complete final visit|27|||
33180032|NCT01173718|100568183|FG000|Overall Study|Death|17|||
33180033|NCT01173718|100568183|FG000|Overall Study|Abandonment of study graft|27|||
33180034|NCT02738333|100568184|FG000|Overall Study|Death|1|||
33180035|NCT02738333|100568185|FG001|Overall Study|Death|0|||
33180036|NCT02738333|100568186|FG002|Overall Study|Death|0|||
33180037|NCT02738333|100568184|FG000|Overall Study|Lost to Follow-up|1|||
33180038|NCT02738333|100568185|FG001|Overall Study|Lost to Follow-up|0|||
33180039|NCT02738333|100568186|FG002|Overall Study|Lost to Follow-up|0|||
33180040|NCT01288287|100568187|FG000|Overall Study|Lost to Follow-up|8|||
33180041|NCT01288287|100568187|FG000|Overall Study|Withdrawal by Subject|4|||
33180042|NCT01288287|100568187|FG000|Overall Study|Lack of Efficacy|13|||
33180043|NCT01288287|100568187|FG000|Overall Study|Other Reason|13|||
33180044|NCT01288287|100568187|FG000|Overall Study|Unknown Reason|1|||
33180045|NCT01288287|100568187|FG000|Overall Study|Unknown Status|7|||
33180046|NCT00454987|100568188|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
33180047|NCT00454987|100568189|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
33180048|NCT00454987|100568190|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
33180049|NCT00454987|100568188|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
33180050|NCT00454987|100568189|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
33180051|NCT00454987|100568190|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
33180052|NCT00454987|100568188|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
33180053|NCT00454987|100568189|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
33180054|NCT00454987|100568190|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
33180055|NCT00720057|100568191|FG000|Overall Study|Lost to Follow-up|0|||
33180056|NCT00720057|100568192|FG001|Overall Study|Lost to Follow-up|2|||
33180057|NCT00720057|100568191|FG000|Overall Study|Protocol Violation|1|||
33180058|NCT00720057|100568192|FG001|Overall Study|Protocol Violation|0|||
33180059|NCT00720057|100568191|FG000|Overall Study|Withdrawal by Subject|0|||
33180060|NCT00720057|100568192|FG001|Overall Study|Withdrawal by Subject|1|||
33180061|NCT02522286|100568193|FG000|Overall Study|Withdrawal by Subject|3|||
33180062|NCT02522286|100568194|FG001|Overall Study|Withdrawal by Subject|0|||
33180063|NCT02522286|100568195|FG002|Overall Study|Withdrawal by Subject|0|||
33180064|NCT02522286|100568196|FG003|Overall Study|Withdrawal by Subject|3|||
33180065|NCT01574612|100568200|FG000|Overall Study|Adverse Event|3|||
33180066|NCT01574612|100568200|FG000|Overall Study|non compliant with drug|2|||
33180067|NCT01574612|100568200|FG000|Overall Study|Withdrawal by Subject|1|||
33180068|NCT01574612|100568200|FG000|Overall Study|Lost to Follow-up|2|||
33266242|NCT00836498|100873830|FG000|Overall Study|Adverse Event|1|||
33266243|NCT00836498|100873831|FG001|Overall Study|Adverse Event|0|||
33180069|NCT03519347|100568201|FG000|Interventional Crossover Period 1|Death|0|||
33180070|NCT03519347|100568202|FG001|Interventional Crossover Period 1|Death|0|||
33180071|NCT03519347|100568203|FG002|Interventional Crossover Period 1|Death|0|||
33180072|NCT03519347|100568204|FG003|Interventional Crossover Period 1|Death|1|||
33180073|NCT05778786|100568205|FG000|Period 1|COVID-19 Related|3|||
33180074|NCT05778786|100568206|FG001|Period 1|COVID-19 Related|3|||
33180075|NCT05778786|100568205|FG000|Period 1|Withdrew Consent during Study|1|||
33266244|NCT00836498|100873830|FG000|Overall Study|Lost to Follow-up|1|||
33266245|NCT00836498|100873831|FG001|Overall Study|Lost to Follow-up|0|||
33468631|NCT04965389|101607883|FG002|Overall Study|Poor/Non-compliance|0|||
33468632|NCT04965389|101607884|FG003|Overall Study|Poor/Non-compliance|0|||
33468633|NCT01615263|101607885|FG000|Overall Study|Post-randomization exclusion|0|||
33468634|NCT01615263|101607886|FG001|Overall Study|Post-randomization exclusion|2|||
33468635|NCT01000610|101607887|FG000|Overall Study|Adverse Event|1|||
33468636|NCT01000610|101607887|FG000|Overall Study|Lost to Follow-up|4|||
33468637|NCT01000610|101607887|FG000|Overall Study|Treatment failure|1|||
33468638|NCT00876018|101607888|FG000|Overall Study|Lost to Follow-up|0|||
33468639|NCT00876018|101607889|FG001|Overall Study|Lost to Follow-up|1|||
33468640|NCT00876018|101607890|FG002|Overall Study|Lost to Follow-up|1|||
33468641|NCT00876018|101607888|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
33468642|NCT00876018|101607889|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
33468643|NCT00876018|101607890|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
33468644|NCT00983918|101607895|FG000|Overall Study|conversion to open cholecystectomy|0|||
33468645|NCT00983918|101607896|FG001|Overall Study|conversion to open cholecystectomy|2|||
33468646|NCT00983918|101607897|FG002|Overall Study|conversion to open cholecystectomy|2|||
33468647|NCT00983918|101607898|FG003|Overall Study|conversion to open cholecystectomy|2|||
33468648|NCT02206620|101607901|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
33468649|NCT02206620|101607902|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
33468650|NCT02206620|101607901|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
33468651|NCT02206620|101607902|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
33468652|NCT02903238|101607903|FG000|Overall Study|Lost to Follow-up|4|||
33468653|NCT03433755|101607905|FG000|Overall Study|Lost to Follow-up|1|||
33468654|NCT03433755|101607906|FG001|Overall Study|Lost to Follow-up|0|||
33468655|NCT03433755|101607907|FG002|Overall Study|Lost to Follow-up|0|||
33468656|NCT03433755|101607908|FG003|Overall Study|Lost to Follow-up|0|||
33468657|NCT03433755|101607905|FG000|Overall Study|Decision by Sponsor|1|||
33468658|NCT03433755|101607906|FG001|Overall Study|Decision by Sponsor|0|||
33468659|NCT03433755|101607907|FG002|Overall Study|Decision by Sponsor|0|||
33468660|NCT03433755|101607908|FG003|Overall Study|Decision by Sponsor|0|||
33468661|NCT03097588|101607909|FG000|Overall Study|Adverse Event|1|||
33468662|NCT00109837|101607917|FG000|Overall Study|Adverse Event|2|||
33468663|NCT00109837|101607917|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
33468664|NCT00109837|101607917|FG000|Overall Study|Death|1|||
33468665|NCT00109837|101607917|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
33468666|NCT00109837|101607917|FG000|Overall Study|Not treated|1|||
33468667|NCT00109837|101607917|FG000|Overall Study|Ineligible|1|||
33468668|NCT00892281|101607918|FG000|Overall Study|Adverse Event|65|||
33468669|NCT00892281|101607919|FG001|Overall Study|Adverse Event|8|||
33468670|NCT00892281|101607918|FG000|Overall Study|Lost to Follow-up|81|||
33468671|NCT00892281|101607919|FG001|Overall Study|Lost to Follow-up|8|||
33468672|NCT00892281|101607918|FG000|Overall Study|Pregnancy|1|||
33468673|NCT00892281|101607919|FG001|Overall Study|Pregnancy|0|||
33468674|NCT00892281|101607918|FG000|Overall Study|Protocol Violation|7|||
33468675|NCT00892281|101607919|FG001|Overall Study|Protocol Violation|2|||
33468676|NCT00892281|101607918|FG000|Overall Study|Withdrawal by Subject|86|||
33468677|NCT00892281|101607919|FG001|Overall Study|Withdrawal by Subject|14|||
33468678|NCT00892281|101607918|FG000|Overall Study|Subject failed to return for final visit|2|||
33468679|NCT00892281|101607919|FG001|Overall Study|Subject failed to return for final visit|0|||
33468680|NCT00892281|101607918|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
33468681|NCT00892281|101607919|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
33468682|NCT00892281|101607918|FG000|Overall Study|Final visit completed 4 weeks late|0|||
33468683|NCT00892281|101607919|FG001|Overall Study|Final visit completed 4 weeks late|1|||
33468684|NCT00892281|101607918|FG000|Overall Study|Subject completed day after study closed|1|||
33468685|NCT00892281|101607919|FG001|Overall Study|Subject completed day after study closed|0|||
33468686|NCT00892281|101607918|FG000|Overall Study|Family emergency|1|||
33180076|NCT05778786|100568206|FG001|Period 1|Withdrew Consent during Study|0|||
33180077|NCT05778786|100568205|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
33266246|NCT00836498|100873830|FG000|Overall Study|Withdrawal by Subject|2|||
33468687|NCT00892281|101607919|FG001|Overall Study|Family emergency|0|||
33468688|NCT00892281|101607918|FG000|Overall Study|Last visit not done - death in family|1|||
33468689|NCT00892281|101607919|FG001|Overall Study|Last visit not done - death in family|0|||
33468690|NCT00892281|101607918|FG000|Overall Study|Did not meet incl/excl criteria|1|||
33468691|NCT00892281|101607919|FG001|Overall Study|Did not meet incl/excl criteria|0|||
33266247|NCT00836498|100873831|FG001|Overall Study|Withdrawal by Subject|1|||
33266248|NCT01823224|100873832|FG000|Overall Study|Lost to Follow-up|5|||
33468692|NCT00892281|101607918|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
33468693|NCT00892281|101607919|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
33468694|NCT00892281|101607918|FG000|Overall Study|Unable to redeem the drug voucher|1|||
33468695|NCT00892281|101607919|FG001|Overall Study|Unable to redeem the drug voucher|0|||
33468696|NCT00892281|101607918|FG000|Overall Study|Subject not good candidate for study|1|||
33468697|NCT00892281|101607919|FG001|Overall Study|Subject not good candidate for study|0|||
33468698|NCT00892281|101607918|FG000|Overall Study|Subject did not return for any visits|1|||
33468699|NCT00892281|101607919|FG001|Overall Study|Subject did not return for any visits|0|||
33468700|NCT00892281|101607918|FG000|Overall Study|Subject missed several visits/lost meds|1|||
33468701|NCT00892281|101607919|FG001|Overall Study|Subject missed several visits/lost meds|0|||
33468702|NCT00892281|101607918|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
33468703|NCT00892281|101607919|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
33468704|NCT00892281|101607918|FG000|Overall Study|Scheduled for knee replacement|0|||
33468705|NCT00892281|101607919|FG001|Overall Study|Scheduled for knee replacement|1|||
33468706|NCT00892281|101607918|FG000|Overall Study|PI complained of inadequate compensation|3|||
33468707|NCT00892281|101607919|FG001|Overall Study|PI complained of inadequate compensation|0|||
33468708|NCT00892281|101607918|FG000|Overall Study|Subject lost interest in program|0|||
33468709|NCT00892281|101607919|FG001|Overall Study|Subject lost interest in program|1|||
33468710|NCT00892281|101607918|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
33468711|NCT00892281|101607919|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
33468712|NCT00892281|101607918|FG000|Overall Study|Death in family|1|||
33468713|NCT00892281|101607919|FG001|Overall Study|Death in family|0|||
33468714|NCT00892281|101607918|FG000|Overall Study|Lack of efficacy of study product|2|||
33468715|NCT00892281|101607919|FG001|Overall Study|Lack of efficacy of study product|0|||
33468716|NCT00892281|101607918|FG000|Overall Study|Subject not seen by PI at final visit|1|||
33468717|NCT00892281|101607919|FG001|Overall Study|Subject not seen by PI at final visit|0|||
33468718|NCT00892281|101607918|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
33468719|NCT00892281|101607919|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
33468720|NCT00892281|101607918|FG000|Overall Study|Missed multiple visits|1|||
33468721|NCT00892281|101607919|FG001|Overall Study|Missed multiple visits|0|||
33468722|NCT00892281|101607918|FG000|Overall Study|Missed visits rescheduled out of window|1|||
33468723|NCT00892281|101607919|FG001|Overall Study|Missed visits rescheduled out of window|0|||
33468724|NCT00892281|101607918|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
33468725|NCT00892281|101607919|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
33468726|NCT00892281|101607918|FG000|Overall Study|Subject had history of drug abuse|1|||
33468727|NCT00892281|101607919|FG001|Overall Study|Subject had history of drug abuse|0|||
33468728|NCT00892281|101607918|FG000|Overall Study|Rash on hand|1|||
33468729|NCT00892281|101607919|FG001|Overall Study|Rash on hand|0|||
33468730|NCT00892281|101607918|FG000|Overall Study|Visit 4 date out of window|1|||
33468731|NCT00892281|101607919|FG001|Overall Study|Visit 4 date out of window|0|||
33468732|NCT00958126|101607926|FG000|Overall Study|Serious Adverse Event|0|||
33468733|NCT00958126|101607927|FG001|Overall Study|Serious Adverse Event|2|||
33468734|NCT00958126|101607928|FG002|Overall Study|Serious Adverse Event|0|||
33468735|NCT00958126|101607929|FG003|Overall Study|Serious Adverse Event|0|||
33468736|NCT00958126|101607930|FG004|Overall Study|Serious Adverse Event|0|||
33468737|NCT00958126|101607931|FG005|Overall Study|Serious Adverse Event|0|||
33468738|NCT00958126|101607932|FG006|Overall Study|Serious Adverse Event|1|||
33468739|NCT00958126|101607933|FG007|Overall Study|Serious Adverse Event|0|||
33468740|NCT00958126|101607926|FG000|Overall Study|Withdrawal by Subject|0|||
33468741|NCT00958126|101607927|FG001|Overall Study|Withdrawal by Subject|2|||
33468742|NCT00958126|101607928|FG002|Overall Study|Withdrawal by Subject|0|||
33468743|NCT00958126|101607929|FG003|Overall Study|Withdrawal by Subject|0|||
33468744|NCT00958126|101607930|FG004|Overall Study|Withdrawal by Subject|0|||
33468745|NCT00958126|101607931|FG005|Overall Study|Withdrawal by Subject|0|||
33468746|NCT00958126|101607932|FG006|Overall Study|Withdrawal by Subject|0|||
33468747|NCT00958126|101607933|FG007|Overall Study|Withdrawal by Subject|0|||
33468748|NCT00958126|101607926|FG000|Overall Study|Moved away from study area|0|||
33468749|NCT00958126|101607927|FG001|Overall Study|Moved away from study area|0|||
33468750|NCT00958126|101607928|FG002|Overall Study|Moved away from study area|1|||
33468751|NCT00958126|101607929|FG003|Overall Study|Moved away from study area|1|||
33468752|NCT00958126|101607930|FG004|Overall Study|Moved away from study area|0|||
33468753|NCT00958126|101607931|FG005|Overall Study|Moved away from study area|0|||
33468754|NCT00958126|101607932|FG006|Overall Study|Moved away from study area|0|||
33468755|NCT00958126|101607933|FG007|Overall Study|Moved away from study area|0|||
33468756|NCT00958126|101607926|FG000|Overall Study|Lost to Follow-up|1|||
33468757|NCT00958126|101607927|FG001|Overall Study|Lost to Follow-up|5|||
33468758|NCT00958126|101607928|FG002|Overall Study|Lost to Follow-up|9|||
33468759|NCT00958126|101607929|FG003|Overall Study|Lost to Follow-up|8|||
33468760|NCT00958126|101607930|FG004|Overall Study|Lost to Follow-up|0|||
33180078|NCT05778786|100568206|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
33180079|NCT05778786|100568205|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
33266249|NCT01823224|100873833|FG001|Overall Study|Lost to Follow-up|6|||
33468761|NCT00958126|101607931|FG005|Overall Study|Lost to Follow-up|0|||
33468762|NCT00958126|101607932|FG006|Overall Study|Lost to Follow-up|0|||
33468763|NCT00958126|101607933|FG007|Overall Study|Lost to Follow-up|0|||
33468764|NCT00958126|101607926|FG000|Overall Study|Sponsor/Investigator decision|0|||
33468765|NCT00958126|101607927|FG001|Overall Study|Sponsor/Investigator decision|0|||
33468766|NCT00958126|101607928|FG002|Overall Study|Sponsor/Investigator decision|0|||
33468767|NCT00958126|101607929|FG003|Overall Study|Sponsor/Investigator decision|1|||
33468768|NCT00958126|101607930|FG004|Overall Study|Sponsor/Investigator decision|0|||
33468769|NCT00958126|101607931|FG005|Overall Study|Sponsor/Investigator decision|0|||
33468770|NCT00958126|101607932|FG006|Overall Study|Sponsor/Investigator decision|0|||
33468771|NCT00958126|101607933|FG007|Overall Study|Sponsor/Investigator decision|0|||
33468772|NCT00958126|101607926|FG000|Overall Study|Other Reason|0|||
33468773|NCT00958126|101607927|FG001|Overall Study|Other Reason|0|||
33468774|NCT00958126|101607928|FG002|Overall Study|Other Reason|0|||
33468775|NCT00958126|101607929|FG003|Overall Study|Other Reason|1|||
33468776|NCT00958126|101607930|FG004|Overall Study|Other Reason|0|||
33468777|NCT00958126|101607931|FG005|Overall Study|Other Reason|1|||
33468778|NCT00958126|101607932|FG006|Overall Study|Other Reason|0|||
33468779|NCT00958126|101607933|FG007|Overall Study|Other Reason|0|||
33468780|NCT00112294|101607934|FG000|Overall Study|Still on study|5|||
33468781|NCT00112294|101607935|FG001|Overall Study|Still on study|0|||
33468782|NCT03856593|101607938|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
33468783|NCT03856593|101607939|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
33468784|NCT02065713|101607946|FG000|Overall Study|Adverse Event|0|||
33468785|NCT02065713|101607947|FG001|Overall Study|Adverse Event|1|||
33468786|NCT02065713|101607946|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33468787|NCT02065713|101607947|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
33468788|NCT00842530|101607954|FG000|Overall Study|Serious adverse event|0|||
33468789|NCT00842530|101607955|FG001|Overall Study|Serious adverse event|6|||
33468790|NCT00842530|101607954|FG000|Overall Study|Other adverse event|6|||
33468791|NCT00842530|101607955|FG001|Overall Study|Other adverse event|1|||
33468792|NCT00842530|101607954|FG000|Overall Study|Protocol Violation|32|||
33468793|NCT00842530|101607955|FG001|Overall Study|Protocol Violation|14|||
33468794|NCT00842530|101607954|FG000|Overall Study|Lost to Follow-up|6|||
33468795|NCT00842530|101607955|FG001|Overall Study|Lost to Follow-up|8|||
33468796|NCT00842530|101607954|FG000|Overall Study|Withdrawal by Subject|73|||
33468797|NCT00842530|101607955|FG001|Overall Study|Withdrawal by Subject|28|||
33468798|NCT02201290|101607956|FG000|Overall Study|Withdrawal by Subject|2|||
33468799|NCT02201290|101607956|FG000|Overall Study|Lack of Efficacy|2|||
33468800|NCT02201290|101607956|FG000|Overall Study|Adverse Event|1|||
33468801|NCT02129647|101607957|FG000|Overall Study|Adverse Event|2|||
33468802|NCT02129647|101607957|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
33468803|NCT04647383|101607960|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
33468804|NCT04647383|101607961|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
33468805|NCT04647383|101607962|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
33468806|NCT04647383|101607963|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
33468807|NCT02459665|101607972|FG000|Overall Study|Withdrawal by Subject|0|||
33468808|NCT02459665|101607973|FG001|Overall Study|Withdrawal by Subject|1|||
33468809|NCT02459665|101607974|FG002|Overall Study|Withdrawal by Subject|1|||
33468810|NCT02459665|101607975|FG003|Overall Study|Withdrawal by Subject|2|||
33468811|NCT01930175|101607976|FG000|Core Study|Lost to Follow-up|0|||
33468812|NCT01930175|101607977|FG001|Core Study|Lost to Follow-up|1|||
33468813|NCT01930175|101607978|FG002|Core Study|Lost to Follow-up|0|||
33468814|NCT01930175|101607976|FG000|Core Study|Adverse Event|0|||
33468815|NCT01930175|101607977|FG001|Core Study|Adverse Event|0|||
33468816|NCT01930175|101607978|FG002|Core Study|Adverse Event|1|||
33468817|NCT03407118|101607980|FG000|Period 2|Withdrawal by Subject|1|||
33468818|NCT03407118|101607981|FG001|Period 2|Withdrawal by Subject|0|||
33468819|NCT01366443|101607982|FG000|Overall Study|Lost to Follow-up|2|||
33180080|NCT05778786|100568206|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
33180081|NCT02355691|100568215|FG000|Overall Study|Loss of Research Personnel|7|||
33180082|NCT02355691|100568216|FG001|Overall Study|Loss of Research Personnel|9|||
33180083|NCT00665353|100568220|FG000|Study Step 1|Adverse Event|1|||
33180084|NCT00665353|100568220|FG000|Study Step 1|Withdrawal by Subject|2|||
33180085|NCT00665353|100568220|FG000|Study Step 2|Lost to Follow-up|2|||
33180086|NCT00665353|100568220|FG000|Study Step 2|Lack of Efficacy|12|||
33180087|NCT02672423|100568225|FG000|Period 1|Adverse Event|0|||
33180088|NCT02672423|100568226|FG001|Period 1|Adverse Event|0|||
33180089|NCT02672423|100568227|FG002|Period 1|Adverse Event|0|||
33180090|NCT02672423|100568228|FG003|Period 1|Adverse Event|0|||
33180091|NCT02672423|100568229|FG004|Period 1|Adverse Event|1|||
33180092|NCT02672423|100568230|FG005|Period 1|Adverse Event|0|||
33180093|NCT02672423|100568231|FG006|Period 1|Adverse Event|0|||
33180094|NCT02672423|100568232|FG007|Period 1|Adverse Event|0|||
33180095|NCT02672423|100568233|FG008|Period 1|Adverse Event|0|||
33180096|NCT02672423|100568234|FG009|Period 1|Adverse Event|0|||
33180097|NCT02672423|100568225|FG000|Period 2|Withdrawal by Subject|0|||
33180098|NCT02672423|100568226|FG001|Period 2|Withdrawal by Subject|0|||
33180099|NCT02672423|100568227|FG002|Period 2|Withdrawal by Subject|1|||
33180100|NCT02672423|100568228|FG003|Period 2|Withdrawal by Subject|0|||
33468820|NCT01366443|101607982|FG000|Overall Study|Under 18 yo|1|||
33468821|NCT00865514|101607983|FG000|Overall Study|Infusion cost exceeded funding|2|||
33468822|NCT00613834|101607984|FG000|Overall Study|Withdrawal by Subject|0|||
33468823|NCT00613834|101607985|FG001|Overall Study|Withdrawal by Subject|3|||
33468824|NCT01791153|101607988|FG000|Part 1: Blinded Period|Adverse Event|7|||
33468825|NCT01791153|101607989|FG001|Part 1: Blinded Period|Adverse Event|3|||
33468826|NCT01791153|101607990|FG002|Part 1: Blinded Period|Adverse Event|2|||
33180101|NCT02672423|100568229|FG004|Period 2|Withdrawal by Subject|0|||
33180102|NCT02672423|100568230|FG005|Period 2|Withdrawal by Subject|0|||
33180103|NCT02672423|100568231|FG006|Period 2|Withdrawal by Subject|0|||
33180104|NCT02672423|100568232|FG007|Period 2|Withdrawal by Subject|0|||
33180105|NCT02672423|100568233|FG008|Period 2|Withdrawal by Subject|0|||
33180106|NCT02672423|100568234|FG009|Period 2|Withdrawal by Subject|0|||
33180107|NCT02672423|100568225|FG000|Period 3|Withdrawal by Subject|0|||
33180108|NCT02672423|100568226|FG001|Period 3|Withdrawal by Subject|0|||
33180109|NCT02672423|100568227|FG002|Period 3|Withdrawal by Subject|0|||
33180110|NCT02672423|100568228|FG003|Period 3|Withdrawal by Subject|0|||
33180111|NCT02672423|100568229|FG004|Period 3|Withdrawal by Subject|0|||
33180112|NCT02672423|100568230|FG005|Period 3|Withdrawal by Subject|0|||
33180113|NCT02672423|100568231|FG006|Period 3|Withdrawal by Subject|0|||
33180114|NCT02672423|100568232|FG007|Period 3|Withdrawal by Subject|1|||
33180115|NCT02672423|100568233|FG008|Period 3|Withdrawal by Subject|0|||
33180116|NCT02672423|100568234|FG009|Period 3|Withdrawal by Subject|0|||
33180117|NCT02672423|100568225|FG000|Period 3|Physician Decision|0|||
33468827|NCT01791153|101607991|FG003|Part 1: Blinded Period|Adverse Event|0|||
33468828|NCT01791153|101607992|FG004|Part 1: Blinded Period|Adverse Event|0|||
33468829|NCT01791153|101607993|FG005|Part 1: Blinded Period|Adverse Event|0|||
33468830|NCT01791153|101607994|FG006|Part 1: Blinded Period|Adverse Event|0|||
33468831|NCT01791153|101607995|FG007|Part 1: Blinded Period|Adverse Event|0|||
33468832|NCT01791153|101607988|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
33468833|NCT01791153|101607989|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
33468834|NCT01791153|101607990|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
33468835|NCT01791153|101607991|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
33468836|NCT01791153|101607992|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
33468837|NCT01791153|101607993|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
33468838|NCT01791153|101607994|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
33468839|NCT01791153|101607995|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
33468840|NCT01791153|101607988|FG000|Part 1: Blinded Period|Non-Compliance|1|||
33468841|NCT01791153|101607989|FG001|Part 1: Blinded Period|Non-Compliance|0|||
33468842|NCT01791153|101607990|FG002|Part 1: Blinded Period|Non-Compliance|0|||
33468843|NCT01791153|101607991|FG003|Part 1: Blinded Period|Non-Compliance|0|||
33468844|NCT01791153|101607992|FG004|Part 1: Blinded Period|Non-Compliance|0|||
33468845|NCT01791153|101607993|FG005|Part 1: Blinded Period|Non-Compliance|0|||
33468846|NCT01791153|101607994|FG006|Part 1: Blinded Period|Non-Compliance|0|||
33468847|NCT01791153|101607995|FG007|Part 1: Blinded Period|Non-Compliance|0|||
33468848|NCT01791153|101607988|FG000|Part 1: Blinded Period|Physician Decision|0|||
33468849|NCT01791153|101607989|FG001|Part 1: Blinded Period|Physician Decision|0|||
33468850|NCT01791153|101607990|FG002|Part 1: Blinded Period|Physician Decision|0|||
33468851|NCT01791153|101607991|FG003|Part 1: Blinded Period|Physician Decision|1|||
33468852|NCT01791153|101607992|FG004|Part 1: Blinded Period|Physician Decision|0|||
33468853|NCT01791153|101607993|FG005|Part 1: Blinded Period|Physician Decision|0|||
33468854|NCT01791153|101607994|FG006|Part 1: Blinded Period|Physician Decision|0|||
33468855|NCT01791153|101607995|FG007|Part 1: Blinded Period|Physician Decision|0|||
33468856|NCT01791153|101607988|FG000|Part 1: Blinded Period|Protocol Violation|0|||
33468857|NCT01791153|101607989|FG001|Part 1: Blinded Period|Protocol Violation|0|||
33468858|NCT01791153|101607990|FG002|Part 1: Blinded Period|Protocol Violation|0|||
33468859|NCT01791153|101607991|FG003|Part 1: Blinded Period|Protocol Violation|1|||
33468860|NCT01791153|101607992|FG004|Part 1: Blinded Period|Protocol Violation|0|||
33468861|NCT01791153|101607993|FG005|Part 1: Blinded Period|Protocol Violation|0|||
33468862|NCT01791153|101607994|FG006|Part 1: Blinded Period|Protocol Violation|0|||
33468863|NCT01791153|101607995|FG007|Part 1: Blinded Period|Protocol Violation|0|||
33468864|NCT01791153|101607988|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
33468865|NCT01791153|101607989|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
33468866|NCT01791153|101607990|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
33468867|NCT01791153|101607991|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
33468868|NCT01791153|101607992|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
33468869|NCT01791153|101607993|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
33468870|NCT01791153|101607994|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
33468871|NCT01791153|101607995|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
33468872|NCT01791153|101607988|FG000|Part 2: Open-label Period|Adverse Event|0|||
33468873|NCT01791153|101607989|FG001|Part 2: Open-label Period|Adverse Event|0|||
33468874|NCT01791153|101607990|FG002|Part 2: Open-label Period|Adverse Event|0|||
33468875|NCT01791153|101607991|FG003|Part 2: Open-label Period|Adverse Event|0|||
33468876|NCT01791153|101607992|FG004|Part 2: Open-label Period|Adverse Event|0|||
33468877|NCT01791153|101607993|FG005|Part 2: Open-label Period|Adverse Event|1|||
33468878|NCT01791153|101607994|FG006|Part 2: Open-label Period|Adverse Event|1|||
33180118|NCT02672423|100568226|FG001|Period 3|Physician Decision|0|||
33180119|NCT02672423|100568227|FG002|Period 3|Physician Decision|0|||
33180120|NCT02672423|100568228|FG003|Period 3|Physician Decision|0|||
33266250|NCT01823224|100873832|FG000|Overall Study|didn't qualify|1|||
33468879|NCT01791153|101607995|FG007|Part 2: Open-label Period|Adverse Event|2|||
33468880|NCT01791153|101607988|FG000|Part 2: Open-label Period|Death|0|||
33180121|NCT02672423|100568229|FG004|Period 3|Physician Decision|0|||
33468881|NCT01791153|101607989|FG001|Part 2: Open-label Period|Death|0|||
33468882|NCT01791153|101607990|FG002|Part 2: Open-label Period|Death|0|||
33468883|NCT01791153|101607991|FG003|Part 2: Open-label Period|Death|0|||
33468884|NCT01791153|101607992|FG004|Part 2: Open-label Period|Death|0|||
33468885|NCT01791153|101607993|FG005|Part 2: Open-label Period|Death|1|||
33468886|NCT01791153|101607994|FG006|Part 2: Open-label Period|Death|1|||
33468887|NCT01791153|101607995|FG007|Part 2: Open-label Period|Death|1|||
33468888|NCT01791153|101607988|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
33468889|NCT01791153|101607989|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
33468890|NCT01791153|101607990|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
33468891|NCT01791153|101607991|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
33468892|NCT01791153|101607992|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
33468893|NCT01791153|101607993|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
33468894|NCT01791153|101607994|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
33468895|NCT01791153|101607995|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
33468896|NCT01791153|101607988|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
33468897|NCT01791153|101607989|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
33468898|NCT01791153|101607990|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
33468899|NCT01791153|101607991|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
33468900|NCT01791153|101607992|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
33468901|NCT01791153|101607993|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
33468902|NCT01791153|101607994|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
33468903|NCT01791153|101607995|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
33468904|NCT01791153|101607988|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
33468905|NCT01791153|101607989|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
33468906|NCT01791153|101607990|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
33468907|NCT01791153|101607991|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
33468908|NCT01791153|101607992|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
33468909|NCT01791153|101607993|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
33468910|NCT01791153|101607994|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
33468911|NCT01791153|101607995|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
33468912|NCT01791153|101607988|FG000|Part 2: Open-label Period|Physician Decision|0|||
33468913|NCT01791153|101607989|FG001|Part 2: Open-label Period|Physician Decision|0|||
33468914|NCT01791153|101607990|FG002|Part 2: Open-label Period|Physician Decision|0|||
33468915|NCT01791153|101607991|FG003|Part 2: Open-label Period|Physician Decision|0|||
33468916|NCT01791153|101607992|FG004|Part 2: Open-label Period|Physician Decision|1|||
33468917|NCT01791153|101607993|FG005|Part 2: Open-label Period|Physician Decision|1|||
33468918|NCT01791153|101607994|FG006|Part 2: Open-label Period|Physician Decision|0|||
33468919|NCT01791153|101607995|FG007|Part 2: Open-label Period|Physician Decision|0|||
33266251|NCT01823224|100873833|FG001|Overall Study|didn't qualify|2|||
33266252|NCT01823224|100873832|FG000|Overall Study|pharmacy error|0|||
33266253|NCT01823224|100873833|FG001|Overall Study|pharmacy error|1|||
33266254|NCT01823224|100873832|FG000|Overall Study|missed med dose|0|||
33266255|NCT01823224|100873833|FG001|Overall Study|missed med dose|1|||
33266256|NCT01823224|100873832|FG000|Overall Study|Withdrawal by Subject|0|||
33266257|NCT01823224|100873833|FG001|Overall Study|Withdrawal by Subject|1|||
33266258|NCT02722434|100873834|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
33266259|NCT02722434|100873835|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
33266260|NCT02722434|100873834|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
33266261|NCT02722434|100873835|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
33266262|NCT00518206|100873836|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
33266263|NCT00518206|100873837|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
33266264|NCT00518206|100873836|FG000|Overall Study|Withdrawal by Subject|2|||
33266265|NCT00518206|100873837|FG001|Overall Study|Withdrawal by Subject|0|||
33266266|NCT00518206|100873836|FG000|Overall Study|Drug Supply Issue|1|||
33266267|NCT00518206|100873837|FG001|Overall Study|Drug Supply Issue|0|||
33266268|NCT00518206|100873836|FG000|Overall Study|Reason Unknown|1|||
33266269|NCT00518206|100873837|FG001|Overall Study|Reason Unknown|0|||
33266270|NCT00518206|100873836|FG000|Overall Study|Completion Status Unknown|1|||
33266271|NCT00518206|100873837|FG001|Overall Study|Completion Status Unknown|0|||
33266272|NCT00605306|100873838|FG000|Overall Study|Adverse Event|0|||
33266273|NCT00605306|100873839|FG001|Overall Study|Adverse Event|1|||
33266274|NCT03697603|100873844|FG000|Overall Study|Adverse Event|3|||
33266275|NCT03697603|100873845|FG001|Overall Study|Adverse Event|18|||
33266276|NCT03697603|100873846|FG002|Overall Study|Adverse Event|3|||
33266277|NCT03697603|100873844|FG000|Overall Study|Physician Decision|1|||
33266278|NCT03697603|100873845|FG001|Overall Study|Physician Decision|0|||
33468920|NCT03078582|101607996|FG000|Overall Study|Adverse Event|0|||
33468921|NCT03078582|101607997|FG001|Overall Study|Adverse Event|8|||
33468922|NCT01782482|101607998|FG000|Overall Study|Adverse Event|2|||
33468923|NCT01782482|101607999|FG001|Overall Study|Adverse Event|1|||
33468924|NCT01782482|101607998|FG000|Overall Study|Lost to Follow-up|2|||
33468925|NCT01782482|101607999|FG001|Overall Study|Lost to Follow-up|3|||
33468926|NCT01782482|101607998|FG000|Overall Study|Physician Decision|1|||
33468927|NCT01782482|101607999|FG001|Overall Study|Physician Decision|0|||
33468928|NCT01782482|101607998|FG000|Overall Study|Protocol Violation|1|||
33468929|NCT01782482|101607999|FG001|Overall Study|Protocol Violation|0|||
33468930|NCT01782482|101607998|FG000|Overall Study|Withdrawal by Subject|2|||
33468931|NCT01782482|101607999|FG001|Overall Study|Withdrawal by Subject|3|||
33468932|NCT01782482|101607998|FG000|Overall Study|Randomized in Error|2|||
33468933|NCT01782482|101607999|FG001|Overall Study|Randomized in Error|2|||
33468934|NCT01782482|101607998|FG000|Overall Study|Habitually wearing toric lens OS|0|||
33468935|NCT01782482|101607999|FG001|Overall Study|Habitually wearing toric lens OS|1|||
33468936|NCT01557842|101608000|FG000|Overall Study|Lost to Follow-up|0|||
33468937|NCT01557842|101608001|FG001|Overall Study|Lost to Follow-up|1|||
33468938|NCT01557842|101608000|FG000|Overall Study|Death|1|||
33468939|NCT01557842|101608001|FG001|Overall Study|Death|0|||
33468940|NCT01557842|101608000|FG000|Overall Study|Lack of Efficacy|0|||
33468941|NCT01557842|101608001|FG001|Overall Study|Lack of Efficacy|1|||
33468942|NCT01557842|101608000|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
33468943|NCT01557842|101608001|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
33468944|NCT01557842|101608000|FG000|Overall Study|Study Terminated by Sponsor|3|||
33468945|NCT01557842|101608001|FG001|Overall Study|Study Terminated by Sponsor|4|||
33468946|NCT01557842|101608000|FG000|Overall Study|Not Ablated|2|||
33468947|NCT01557842|101608001|FG001|Overall Study|Not Ablated|0|||
33468948|NCT01435031|101608012|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
33468949|NCT01435031|101608012|FG000|ITT at 1 Month|Death|1|||
33468950|NCT01435031|101608012|FG000|ITT at 1 Month|Lost to Follow-up|4|||
33468951|NCT01435031|101608012|FG000|ITT at 6 Months|Death|2|||
33468952|NCT01435031|101608012|FG000|ITT at 6 Months|Lost to Follow-up|3|||
33468953|NCT01435031|101608012|FG000|ITT at 1 Year|Death|1|||
33468954|NCT01435031|101608012|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
33468955|NCT01435031|101608012|FG000|ITT at 1 Year|Lost to Follow-up|6|||
33468956|NCT01435031|101608012|FG000|ITT at 2 Years|Death|7|||
33468957|NCT01435031|101608012|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
33468958|NCT01435031|101608012|FG000|ITT at 2 Years|Lost to Follow-up|4|||
33468959|NCT01435031|101608012|FG000|ITT at 3 Years|Death|5|||
33468960|NCT01435031|101608012|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
33468961|NCT01435031|101608012|FG000|ITT at 3 Years|Lost to Follow-up|4|||
33468962|NCT01435031|101608012|FG000|ITT at 4 Years|Death|4|||
33468963|NCT01435031|101608012|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
33468964|NCT01435031|101608012|FG000|ITT at 4 Years|Lost to Follow-up|1|||
33468965|NCT00359632|101608015|FG000|Overall Study|Death|2|||
33468966|NCT00359632|101608016|FG001|Overall Study|Death|0|||
33468967|NCT00359632|101608015|FG000|Overall Study|Adverse Event|1|||
33468968|NCT00359632|101608016|FG001|Overall Study|Adverse Event|0|||
33468969|NCT00359632|101608015|FG000|Overall Study|Non-compliance with visit schedule|1|||
33468970|NCT00359632|101608016|FG001|Overall Study|Non-compliance with visit schedule|0|||
33468971|NCT00969124|101608017|FG000|Overall Study|Protocol Violation|2|||
33468972|NCT00969124|101608017|FG000|Overall Study|Inadequate bowel preparation|15|||
33468973|NCT00969124|101608017|FG000|Overall Study|Inability to reach cecum|9|||
33468974|NCT00969124|101608017|FG000|Overall Study|Previously unrecognized disease|3|||
33468975|NCT00969124|101608017|FG000|Overall Study|Technical error|1|||
33468976|NCT03978091|101608018|FG000|Overall Study|Lost to Follow-up|0|||
33468977|NCT03978091|101608019|FG001|Overall Study|Lost to Follow-up|0|||
33468978|NCT03978091|101608020|FG002|Overall Study|Lost to Follow-up|1|||
33468979|NCT03978091|101608021|FG003|Overall Study|Lost to Follow-up|0|||
33468980|NCT03978091|101608022|FG004|Overall Study|Lost to Follow-up|0|||
33468981|NCT03978091|101608023|FG005|Overall Study|Lost to Follow-up|0|||
33468982|NCT03978091|101608018|FG000|Overall Study|Withdrawal by Subject|0|||
33468983|NCT03978091|101608019|FG001|Overall Study|Withdrawal by Subject|0|||
33468984|NCT03978091|101608020|FG002|Overall Study|Withdrawal by Subject|0|||
33468985|NCT03978091|101608021|FG003|Overall Study|Withdrawal by Subject|1|||
33468986|NCT03978091|101608022|FG004|Overall Study|Withdrawal by Subject|1|||
33468987|NCT03978091|101608023|FG005|Overall Study|Withdrawal by Subject|0|||
33468988|NCT03903159|101608024|FG000|Overall Study|Discharged with Staff Approval|2|||
33468989|NCT03903159|101608024|FG000|Overall Study|Discharged at Staff Request|2|||
33468990|NCT03903159|101608024|FG000|Overall Study|Discharged Against Staff Advice|1|||
33468991|NCT00252174|101608025|FG000|Overall Study|Withdrawal by Subject|0|||
33468992|NCT00252174|101608026|FG001|Overall Study|Withdrawal by Subject|1|||
33468993|NCT00252174|101608027|FG002|Overall Study|Withdrawal by Subject|0|||
33468994|NCT02960438|101608028|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
33468995|NCT02960438|101608029|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
33468996|NCT02960438|101608030|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
33468997|NCT02960438|101608031|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
33468998|NCT02960438|101608028|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
33468999|NCT02960438|101608029|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
33469000|NCT02960438|101608030|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
33469001|NCT02960438|101608031|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
33469002|NCT02960438|101608028|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
33469003|NCT02960438|101608029|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
33469004|NCT02960438|101608030|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
33469005|NCT02960438|101608031|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
33469006|NCT02960438|101608028|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
33469007|NCT02960438|101608029|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
33469008|NCT02960438|101608030|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
33469009|NCT02960438|101608031|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
33469010|NCT02960438|101608028|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
33469011|NCT02960438|101608029|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
33469012|NCT02960438|101608030|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
33469013|NCT02960438|101608031|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
33469014|NCT02960438|101608028|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
33469015|NCT02960438|101608029|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
33469016|NCT02960438|101608030|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
33469017|NCT02960438|101608031|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
33469018|NCT02960438|101608028|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
33469019|NCT02960438|101608029|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
33469020|NCT02960438|101608030|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
33469021|NCT02960438|101608031|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
33469022|NCT02960438|101608028|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
33469023|NCT02960438|101608029|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
33469024|NCT02960438|101608030|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
33469025|NCT02960438|101608031|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
33469026|NCT02960438|101608028|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
33469027|NCT02960438|101608029|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
33469028|NCT02960438|101608030|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
33180122|NCT02672423|100568230|FG005|Period 3|Physician Decision|1|||
33469029|NCT02960438|101608031|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
33469030|NCT02960438|101608028|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
33469031|NCT02960438|101608029|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
33469032|NCT02960438|101608030|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
33469033|NCT02960438|101608031|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
33469034|NCT02960438|101608028|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
33469035|NCT02960438|101608029|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
33469036|NCT02960438|101608030|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
33180123|NCT02672423|100568231|FG006|Period 3|Physician Decision|0|||
33180124|NCT02672423|100568232|FG007|Period 3|Physician Decision|0|||
33180125|NCT02672423|100568233|FG008|Period 3|Physician Decision|0|||
33180126|NCT02672423|100568234|FG009|Period 3|Physician Decision|0|||
33180127|NCT00383149|100568241|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
33180128|NCT00383149|100568241|FG000|Overall Study|Death|2|||
33180129|NCT00383149|100568241|FG000|Overall Study|Disease Progression|38|||
33180130|NCT00383149|100568241|FG000|Overall Study|Lost to Follow-up|1|||
33180131|NCT00383149|100568241|FG000|Overall Study|Other|1|||
33180132|NCT00383149|100568241|FG000|Overall Study|Study Drug Toxicity|4|||
33180133|NCT00383149|100568241|FG000|Overall Study|Request to Discontinue Treatment|4|||
33180134|NCT00383149|100568241|FG000|Overall Study|Participant Withdrew Consent|1|||
33180135|NCT02045797|100568242|FG000|Overall Study|Adverse Event|3|||
33180136|NCT02045797|100568243|FG001|Overall Study|Adverse Event|1|||
33180137|NCT02045797|100568244|FG002|Overall Study|Adverse Event|0|||
33180138|NCT02045797|100568242|FG000|Overall Study|Lack of Efficacy|1|||
33469037|NCT02960438|101608031|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
33469038|NCT02960438|101608028|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
33180139|NCT02045797|100568243|FG001|Overall Study|Lack of Efficacy|0|||
33180140|NCT02045797|100568244|FG002|Overall Study|Lack of Efficacy|0|||
33469039|NCT02960438|101608029|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
33469040|NCT02960438|101608030|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
33469041|NCT02960438|101608031|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
33469042|NCT02692482|101608032|FG000|Overall Study|Death|2|||
33469043|NCT02692482|101608033|FG001|Overall Study|Death|2|||
33469044|NCT02692482|101608032|FG000|Overall Study|Withdrawal by Subject|1|||
33469045|NCT02692482|101608033|FG001|Overall Study|Withdrawal by Subject|2|||
33180141|NCT02045797|100568242|FG000|Overall Study|Lost to Follow-up|2|||
33180142|NCT02045797|100568243|FG001|Overall Study|Lost to Follow-up|3|||
33180143|NCT02045797|100568244|FG002|Overall Study|Lost to Follow-up|1|||
33266279|NCT03697603|100873846|FG002|Overall Study|Physician Decision|2|||
33180144|NCT02045797|100568242|FG000|Overall Study|Physician Decision|0|||
33180145|NCT02045797|100568243|FG001|Overall Study|Physician Decision|1|||
33266280|NCT03697603|100873844|FG000|Overall Study|Protocol Violation|3|||
33180146|NCT02045797|100568244|FG002|Overall Study|Physician Decision|0|||
33180147|NCT02045797|100568242|FG000|Overall Study|Withdrawal by Subject|1|||
33180148|NCT02045797|100568243|FG001|Overall Study|Withdrawal by Subject|2|||
33180149|NCT02045797|100568244|FG002|Overall Study|Withdrawal by Subject|0|||
33180150|NCT02205333|100568247|FG000|Overall Study|Death|5|||
33180151|NCT02205333|100568248|FG001|Overall Study|Death|6|||
33180152|NCT02205333|100568249|FG002|Overall Study|Death|2|||
33180153|NCT02205333|100568250|FG003|Overall Study|Death|6|||
33180154|NCT02205333|100568251|FG004|Overall Study|Death|5|||
33180155|NCT02205333|100568252|FG005|Overall Study|Death|3|||
33180156|NCT02205333|100568253|FG006|Overall Study|Death|3|||
33180157|NCT02205333|100568254|FG007|Overall Study|Death|2|||
33180158|NCT02205333|100568255|FG008|Overall Study|Death|0|||
33180159|NCT02205333|100568247|FG000|Overall Study|Withdrawal by Subject|1|||
33180160|NCT02205333|100568248|FG001|Overall Study|Withdrawal by Subject|0|||
33180161|NCT02205333|100568249|FG002|Overall Study|Withdrawal by Subject|0|||
33180162|NCT02205333|100568250|FG003|Overall Study|Withdrawal by Subject|1|||
33180163|NCT02205333|100568251|FG004|Overall Study|Withdrawal by Subject|0|||
33180164|NCT02205333|100568252|FG005|Overall Study|Withdrawal by Subject|0|||
33180165|NCT02205333|100568253|FG006|Overall Study|Withdrawal by Subject|2|||
33180166|NCT02205333|100568254|FG007|Overall Study|Withdrawal by Subject|0|||
33180167|NCT02205333|100568255|FG008|Overall Study|Withdrawal by Subject|0|||
33180168|NCT00281684|100568256|FG000|Overall Study|Lost to Follow-up|0|||
33180169|NCT00281684|100568257|FG001|Overall Study|Lost to Follow-up|0|||
33180170|NCT00281684|100568258|FG002|Overall Study|Lost to Follow-up|1|||
33180171|NCT00281684|100568259|FG003|Overall Study|Lost to Follow-up|0|||
33180172|NCT00281684|100568256|FG000|Overall Study|Withdrawal by Subject|1|||
33180173|NCT00281684|100568257|FG001|Overall Study|Withdrawal by Subject|0|||
33180174|NCT00281684|100568258|FG002|Overall Study|Withdrawal by Subject|0|||
33469046|NCT01202877|101608034|FG000|Overall Study|Disease Progression|0|||
33469047|NCT01202877|101608035|FG001|Overall Study|Disease Progression|1|||
33469048|NCT01202877|101608036|FG002|Overall Study|Disease Progression|2|||
33469049|NCT01202877|101608034|FG000|Overall Study|Adverse Event|0|||
33469050|NCT01202877|101608035|FG001|Overall Study|Adverse Event|0|||
33469051|NCT01202877|101608036|FG002|Overall Study|Adverse Event|2|||
33469052|NCT01202877|101608034|FG000|Overall Study|Withdrawal by Subject|0|||
33469053|NCT01202877|101608035|FG001|Overall Study|Withdrawal by Subject|0|||
33469054|NCT01202877|101608036|FG002|Overall Study|Withdrawal by Subject|1|||
33469055|NCT01202877|101608034|FG000|Overall Study|Death|0|||
33469056|NCT01202877|101608035|FG001|Overall Study|Death|0|||
33469057|NCT01202877|101608036|FG002|Overall Study|Death|1|||
33469058|NCT01673698|101608038|FG000|Overall Study|Lost to Follow-up|51|||
33469059|NCT01673698|101608039|FG001|Overall Study|Lost to Follow-up|13|||
33469060|NCT01010126|101608040|FG000|Overall Study|Withdrawal by Subject|1|||
33180175|NCT00281684|100568259|FG003|Overall Study|Withdrawal by Subject|0|||
33180176|NCT03165110|100568260|FG000|Overall Study|Anroid phone software incompatibility|1|||
33180177|NCT01254227|100568261|FG000|Overall Study|Withdrawal by Subject|6|||
33180178|NCT01254227|100568261|FG000|Overall Study|Lost to Follow-up|6|||
33180179|NCT01254227|100568261|FG000|Overall Study|Adverse Event|5|||
33180180|NCT01254227|100568261|FG000|Overall Study|Abnormal test procedure result|5|||
33180181|NCT01254227|100568261|FG000|Overall Study|Administrative problems|2|||
33180182|NCT01254227|100568261|FG000|Overall Study|Death|1|||
33180183|NCT01254227|100568261|FG000|Overall Study|Protocol deviation|1|||
33180184|NCT00994240|100568266|FG000|Overall Study|Lost to Follow-up|3|||
33180185|NCT00994240|100568267|FG001|Overall Study|Lost to Follow-up|2|||
33180186|NCT00994240|100568266|FG000|Overall Study|Withdrawal by Subject|1|||
33180187|NCT00994240|100568267|FG001|Overall Study|Withdrawal by Subject|0|||
33180188|NCT00994240|100568266|FG000|Overall Study|study termination|2|||
33180189|NCT00994240|100568267|FG001|Overall Study|study termination|3|||
33180190|NCT05024058|100568273|FG000|Treatment|Study terminated by sponsor|5|||
33180191|NCT05024058|100568274|FG001|Treatment|Study terminated by sponsor|6|||
33180192|NCT05024058|100568275|FG002|Treatment|Study terminated by sponsor|4|||
33180193|NCT05024058|100568276|FG003|Treatment|Study terminated by sponsor|2|||
33180194|NCT05024058|100568277|FG004|Treatment|Study terminated by sponsor|3|||
33180195|NCT05024058|100568278|FG005|Treatment|Study terminated by sponsor|3|||
33180196|NCT05024058|100568279|FG006|Treatment|Study terminated by sponsor|1|||
33180197|NCT05024058|100568280|FG007|Treatment|Study terminated by sponsor|3|||
33180198|NCT05024058|100568281|FG008|Treatment|Study terminated by sponsor|6|||
33180199|NCT05024058|100568282|FG009|Treatment|Study terminated by sponsor|6|||
33180200|NCT05024058|100568273|FG000|Follow-up|Withdrawal by Subject|1|||
33180201|NCT05024058|100568274|FG001|Follow-up|Withdrawal by Subject|0|||
33469061|NCT01010126|101608041|FG001|Overall Study|Withdrawal by Subject|0|||
33180202|NCT05024058|100568275|FG002|Follow-up|Withdrawal by Subject|1|||
33180203|NCT05024058|100568276|FG003|Follow-up|Withdrawal by Subject|0|||
33180204|NCT05024058|100568277|FG004|Follow-up|Withdrawal by Subject|0|||
33469062|NCT01010126|101608042|FG002|Overall Study|Withdrawal by Subject|1|||
33180205|NCT05024058|100568278|FG005|Follow-up|Withdrawal by Subject|0|||
33180206|NCT05024058|100568279|FG006|Follow-up|Withdrawal by Subject|0|||
33180207|NCT05024058|100568280|FG007|Follow-up|Withdrawal by Subject|1|||
33469063|NCT01010126|101608043|FG003|Overall Study|Withdrawal by Subject|0|||
33180208|NCT05024058|100568281|FG008|Follow-up|Withdrawal by Subject|0|||
33180209|NCT05024058|100568282|FG009|Follow-up|Withdrawal by Subject|1|||
33180210|NCT03683758|100568283|FG000|Overall Study|Non-study commitment conflict|1|||
33180211|NCT03683758|100568284|FG001|Overall Study|Non-study commitment conflict|3|||
33180212|NCT03683758|100568283|FG000|Overall Study|Illness preventing participation|1|||
33180213|NCT03683758|100568284|FG001|Overall Study|Illness preventing participation|0|||
33469064|NCT01010126|101608044|FG004|Overall Study|Withdrawal by Subject|3|||
33469065|NCT01010126|101608045|FG005|Overall Study|Withdrawal by Subject|0|||
33469066|NCT00317642|101608046|FG000|Overall Study|Not Received Either Study Drug|1|||
33469067|NCT00317642|101608047|FG001|Overall Study|Not Received Either Study Drug|3|||
33469068|NCT00317642|101608046|FG000|Overall Study|Physician Decision|15|||
33469069|NCT00317642|101608047|FG001|Overall Study|Physician Decision|7|||
33469070|NCT00317642|101608046|FG000|Overall Study|Participant declined treatment|14|||
33469071|NCT00317642|101608047|FG001|Overall Study|Participant declined treatment|3|||
33469072|NCT00317642|101608046|FG000|Overall Study|Adverse Event|17|||
33469073|NCT00317642|101608047|FG001|Overall Study|Adverse Event|5|||
33469074|NCT00317642|101608046|FG000|Overall Study|Treatment Failure|56|||
33469075|NCT00317642|101608047|FG001|Overall Study|Treatment Failure|102|||
33469076|NCT00317642|101608046|FG000|Overall Study|Disease Recurrence|1|||
33469077|NCT00317642|101608047|FG001|Overall Study|Disease Recurrence|2|||
33469078|NCT00317642|101608046|FG000|Overall Study|Death|14|||
33469079|NCT00317642|101608047|FG001|Overall Study|Death|7|||
33469080|NCT00317642|101608046|FG000|Overall Study|Not Continue to Consolidation|2|||
33469081|NCT00317642|101608047|FG001|Overall Study|Not Continue to Consolidation|0|||
33469082|NCT00317642|101608046|FG000|Overall Study|Withdrawal by Subject|0|||
33469083|NCT00317642|101608047|FG001|Overall Study|Withdrawal by Subject|1|||
33469084|NCT00317642|101608046|FG000|Overall Study|Referred For Transplantation|1|||
33469085|NCT00317642|101608047|FG001|Overall Study|Referred For Transplantation|0|||
33469086|NCT00317642|101608046|FG000|Overall Study|AML Not Centrally Confirmed|1|||
33469087|NCT00317642|101608047|FG001|Overall Study|AML Not Centrally Confirmed|5|||
33469088|NCT00731549|101608048|FG000|Overall Study|Lost to Follow-up|19|||
33469089|NCT00731549|101608048|FG000|Overall Study|Met withdrawal criteria|24|||
33469090|NCT00731549|101608048|FG000|Overall Study|Physician Decision|16|||
33469091|NCT00731549|101608048|FG000|Overall Study|Withdrawal by Subject|89|||
33469092|NCT00731549|101608048|FG000|Overall Study|Protocol deviation|1|||
33469093|NCT00731549|101608048|FG000|Overall Study|Adverse Event|31|||
33469094|NCT00731549|101608048|FG000|Overall Study|Lack of efficacy with AE|37|||
33469095|NCT00731549|101608048|FG000|Overall Study|Lack of efficacy without AE|6|||
33180214|NCT03683758|100568283|FG000|Overall Study|Adverse Event|1|||
33180215|NCT03683758|100568284|FG001|Overall Study|Adverse Event|0|||
33180216|NCT00536107|100568296|FG000|Overall Study|Death|5|||
33180217|NCT00536107|100568297|FG001|Overall Study|Death|1|||
33469096|NCT03832738|101608049|FG000|Overall Study|Withdrawal by Subject|6|||
33469097|NCT03832738|101608050|FG001|Overall Study|Withdrawal by Subject|7|||
33469098|NCT03832738|101608051|FG002|Overall Study|Withdrawal by Subject|16|||
33469099|NCT03832738|101608049|FG000|Overall Study|Physician Decision|0|||
33180218|NCT00536107|100568296|FG000|Overall Study|Incorrect enrolment|1|||
33180219|NCT00536107|100568297|FG001|Overall Study|Incorrect enrolment|0|||
33180220|NCT00536107|100568296|FG000|Overall Study|Withdrawal by Subject|0|||
33180221|NCT00536107|100568297|FG001|Overall Study|Withdrawal by Subject|1|||
33180222|NCT00536107|100568296|FG000|Overall Study|Study Termination|2|||
33180223|NCT00536107|100568297|FG001|Overall Study|Study Termination|4|||
33180224|NCT00464568|100568298|FG000|Overall Study|Adverse Event|2|||
33180225|NCT02255500|100568299|FG000|Overall Study|Withdrawal by Subject|1|||
33180226|NCT02255500|100568300|FG001|Overall Study|Withdrawal by Subject|0|||
33180227|NCT03204305|100568301|FG000|Overall Study|Lost to Follow-up|6|||
33180228|NCT03204305|100568302|FG001|Overall Study|Lost to Follow-up|4|||
33180229|NCT03204305|100568303|FG002|Overall Study|Lost to Follow-up|0|||
33180230|NCT03204305|100568304|FG003|Overall Study|Lost to Follow-up|0|||
33180231|NCT03204305|100568301|FG000|Overall Study|Physician Decision|1|||
33180232|NCT03204305|100568302|FG001|Overall Study|Physician Decision|0|||
33180233|NCT03204305|100568303|FG002|Overall Study|Physician Decision|0|||
33180234|NCT03204305|100568304|FG003|Overall Study|Physician Decision|0|||
33180235|NCT03204305|100568301|FG000|Overall Study|failure to place arterial line|2|||
33180236|NCT03204305|100568302|FG001|Overall Study|failure to place arterial line|1|||
33180237|NCT03204305|100568303|FG002|Overall Study|failure to place arterial line|0|||
33180238|NCT03204305|100568304|FG003|Overall Study|failure to place arterial line|0|||
33180239|NCT03204305|100568301|FG000|Overall Study|Withdrawal by Subject|2|||
33469100|NCT03832738|101608050|FG001|Overall Study|Physician Decision|1|||
33469101|NCT03832738|101608051|FG002|Overall Study|Physician Decision|2|||
33180240|NCT03204305|100568302|FG001|Overall Study|Withdrawal by Subject|0|||
33180241|NCT03204305|100568303|FG002|Overall Study|Withdrawal by Subject|0|||
33180242|NCT03204305|100568304|FG003|Overall Study|Withdrawal by Subject|0|||
33180243|NCT01765153|100568311|FG000|Training Phase 1|Format of intervention differed|1|||
33180244|NCT01765153|100568312|FG001|Training Phase 1|Format of intervention differed|0|||
33180245|NCT01765153|100568311|FG000|Training Phase 1|Poor participation in intervention|0|||
33469102|NCT03832738|101608049|FG000|Overall Study|Adverse Event|2|||
33180246|NCT01765153|100568312|FG001|Training Phase 1|Poor participation in intervention|1|||
33180247|NCT01765153|100568311|FG000|Rest Phase 1|Withdrawal by Subject|0|||
33180248|NCT01765153|100568312|FG001|Rest Phase 1|Withdrawal by Subject|1|||
33180249|NCT01765153|100568311|FG000|Training Phase 2|Withdrawal by Subject|0|||
33180250|NCT01765153|100568312|FG001|Training Phase 2|Withdrawal by Subject|1|||
33180251|NCT01765153|100568311|FG000|Rest Phase 2|Lost to Follow-up|2|||
33180252|NCT01765153|100568312|FG001|Rest Phase 2|Lost to Follow-up|1|||
33180253|NCT00605475|100568314|FG000|Overall Study|Abnormal Laboratory Values|0|||
33180254|NCT00605475|100568315|FG001|Overall Study|Abnormal Laboratory Values|0|||
33469103|NCT03832738|101608050|FG001|Overall Study|Adverse Event|3|||
33469104|NCT03832738|101608051|FG002|Overall Study|Adverse Event|1|||
33469105|NCT03832738|101608049|FG000|Overall Study|Pregnancy|0|||
33180255|NCT00605475|100568316|FG002|Overall Study|Abnormal Laboratory Values|0|||
33180256|NCT00605475|100568317|FG003|Overall Study|Abnormal Laboratory Values|0|||
33180257|NCT00605475|100568318|FG004|Overall Study|Abnormal Laboratory Values|0|||
33180258|NCT00605475|100568319|FG005|Overall Study|Abnormal Laboratory Values|0|||
33180259|NCT00605475|100568320|FG006|Overall Study|Abnormal Laboratory Values|0|||
33266281|NCT03697603|100873845|FG001|Overall Study|Protocol Violation|8|||
33469106|NCT03832738|101608050|FG001|Overall Study|Pregnancy|1|||
33469107|NCT03832738|101608051|FG002|Overall Study|Pregnancy|0|||
33469108|NCT02470091|101608055|FG000|Overall Study|Withdrawal by Subject|1|||
33469109|NCT02470091|101608056|FG001|Overall Study|Withdrawal by Subject|0|||
33469110|NCT02470091|101608055|FG000|Overall Study|Ineligible|0|||
33469111|NCT02470091|101608056|FG001|Overall Study|Ineligible|2|||
33469112|NCT00684567|101608057|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
33469113|NCT00684567|101608057|FG000|Monotherapy Period|Adverse Event|2|||
33469114|NCT00684567|101608057|FG000|Monotherapy Period|Death|1|||
33469115|NCT00684567|101608057|FG000|Monotherapy Period|Progression of primary disease|11|||
33469116|NCT00126126|101608058|FG000|Overall Study|Lost to Follow-up|0|||
33469117|NCT00126126|101608059|FG001|Overall Study|Lost to Follow-up|2|||
33469118|NCT00614926|101608061|FG000|Overall Study|Burden of travel|1|||
33469119|NCT00614926|101608062|FG001|Overall Study|Burden of travel|0|||
33469120|NCT00614926|101608061|FG000|Overall Study|Adverse Event|3|||
33469121|NCT00614926|101608062|FG001|Overall Study|Adverse Event|0|||
33469122|NCT00834899|101608063|FG000|Overall Study|Withdrawal by Subject|1|||
33469123|NCT00834899|101608064|FG001|Overall Study|Withdrawal by Subject|1|||
33469124|NCT00369382|101608073|FG000|Overall Study|Death|0|||
33469125|NCT00369382|101608074|FG001|Overall Study|Death|2|||
33469126|NCT00369382|101608073|FG000|Overall Study|Physician Decision|2|||
33469127|NCT00369382|101608074|FG001|Overall Study|Physician Decision|1|||
33469128|NCT00369382|101608073|FG000|Overall Study|Withdrawal by Subject|5|||
33469129|NCT00369382|101608074|FG001|Overall Study|Withdrawal by Subject|0|||
33469130|NCT00369382|101608073|FG000|Overall Study|Randomized, not treated|2|||
33469131|NCT00369382|101608074|FG001|Overall Study|Randomized, not treated|0|||
33469132|NCT00369382|101608073|FG000|Overall Study|Other|1|||
33469133|NCT00369382|101608074|FG001|Overall Study|Other|0|||
33469134|NCT01763918|101608075|FG000|Overall Study|Withdrawal by Subject|2|||
33469135|NCT01763918|101608076|FG001|Overall Study|Withdrawal by Subject|1|||
33469136|NCT01763918|101608077|FG002|Overall Study|Withdrawal by Subject|1|||
33469137|NCT01763918|101608078|FG003|Overall Study|Withdrawal by Subject|2|||
33469138|NCT01763918|101608075|FG000|Overall Study|Sponsor Decision|4|||
33469139|NCT01763918|101608076|FG001|Overall Study|Sponsor Decision|0|||
33469140|NCT01763918|101608077|FG002|Overall Study|Sponsor Decision|9|||
33469141|NCT01763918|101608078|FG003|Overall Study|Sponsor Decision|0|||
33469142|NCT02777918|101608082|FG000|Overall Study|Medical reasons|1|||
33469143|NCT02777918|101608083|FG001|Overall Study|Medical reasons|2|||
33469144|NCT02777918|101608082|FG000|Overall Study|Too busy / stressed|1|||
33469145|NCT02777918|101608083|FG001|Overall Study|Too busy / stressed|1|||
33469146|NCT02777918|101608082|FG000|Overall Study|Withdrawal by Subject|1|||
33469147|NCT02777918|101608083|FG001|Overall Study|Withdrawal by Subject|1|||
33469148|NCT05855616|101608084|FG000|Overall Study|Lost to Follow-up|1|||
33469149|NCT05855616|101608085|FG001|Overall Study|Lost to Follow-up|2|||
33469150|NCT02315066|101608086|FG000|Overall Study|Lost to Follow-up|0|||
33469151|NCT02315066|101608087|FG001|Overall Study|Lost to Follow-up|1|||
33266282|NCT03697603|100873846|FG002|Overall Study|Protocol Violation|5|||
33266283|NCT03697603|100873844|FG000|Overall Study|Withdrawal by Subject|5|||
33469152|NCT02315066|101608088|FG002|Overall Study|Lost to Follow-up|1|||
33469153|NCT02315066|101608089|FG003|Overall Study|Lost to Follow-up|0|||
33469154|NCT02315066|101608090|FG004|Overall Study|Lost to Follow-up|1|||
33469155|NCT02315066|101608091|FG005|Overall Study|Lost to Follow-up|0|||
33469156|NCT02315066|101608092|FG006|Overall Study|Lost to Follow-up|2|||
33180260|NCT00605475|100568321|FG007|Overall Study|Abnormal Laboratory Values|0|||
33469157|NCT02315066|101608093|FG007|Overall Study|Lost to Follow-up|1|||
33469158|NCT02315066|101608094|FG008|Overall Study|Lost to Follow-up|0|||
33180261|NCT00605475|100568322|FG008|Overall Study|Abnormal Laboratory Values|1|||
33180262|NCT00605475|100568323|FG009|Overall Study|Abnormal Laboratory Values|0|||
33469159|NCT02315066|101608095|FG009|Overall Study|Lost to Follow-up|0|||
33469160|NCT02315066|101608096|FG010|Overall Study|Lost to Follow-up|1|||
33469161|NCT02315066|101608097|FG011|Overall Study|Lost to Follow-up|2|||
33469162|NCT02315066|101608098|FG012|Overall Study|Lost to Follow-up|0|||
33469163|NCT02315066|101608099|FG013|Overall Study|Lost to Follow-up|4|||
33469164|NCT02315066|101608086|FG000|Overall Study|Death|2|||
33469165|NCT02315066|101608087|FG001|Overall Study|Death|7|||
33469166|NCT02315066|101608088|FG002|Overall Study|Death|6|||
33469167|NCT02315066|101608089|FG003|Overall Study|Death|11|||
33469168|NCT02315066|101608090|FG004|Overall Study|Death|10|||
33469169|NCT02315066|101608091|FG005|Overall Study|Death|3|||
33469170|NCT02315066|101608092|FG006|Overall Study|Death|9|||
33180263|NCT00605475|100568314|FG000|Overall Study|Administrative problems|0|||
33180264|NCT00605475|100568315|FG001|Overall Study|Administrative problems|0|||
33180265|NCT00605475|100568316|FG002|Overall Study|Administrative problems|0|||
33180266|NCT00605475|100568317|FG003|Overall Study|Administrative problems|0|||
33180267|NCT00605475|100568318|FG004|Overall Study|Administrative problems|0|||
33180268|NCT00605475|100568319|FG005|Overall Study|Administrative problems|0|||
33469171|NCT02315066|101608093|FG007|Overall Study|Death|9|||
33469172|NCT02315066|101608094|FG008|Overall Study|Death|10|||
33469173|NCT02315066|101608095|FG009|Overall Study|Death|8|||
33469174|NCT02315066|101608096|FG010|Overall Study|Death|10|||
33469175|NCT02315066|101608097|FG011|Overall Study|Death|7|||
33469176|NCT02315066|101608098|FG012|Overall Study|Death|8|||
33469177|NCT02315066|101608099|FG013|Overall Study|Death|21|||
33469178|NCT02315066|101608086|FG000|Overall Study|Other|0|||
33469179|NCT02315066|101608087|FG001|Overall Study|Other|0|||
33469180|NCT02315066|101608088|FG002|Overall Study|Other|0|||
33469181|NCT02315066|101608089|FG003|Overall Study|Other|0|||
33469182|NCT02315066|101608090|FG004|Overall Study|Other|0|||
33469183|NCT02315066|101608091|FG005|Overall Study|Other|0|||
33469184|NCT02315066|101608092|FG006|Overall Study|Other|0|||
33469185|NCT02315066|101608093|FG007|Overall Study|Other|1|||
33469186|NCT02315066|101608094|FG008|Overall Study|Other|1|||
33469187|NCT02315066|101608095|FG009|Overall Study|Other|2|||
33469188|NCT02315066|101608096|FG010|Overall Study|Other|0|||
33469189|NCT02315066|101608097|FG011|Overall Study|Other|0|||
33469190|NCT02315066|101608098|FG012|Overall Study|Other|0|||
33469191|NCT02315066|101608099|FG013|Overall Study|Other|0|||
33469192|NCT02315066|101608086|FG000|Overall Study|Subject refused further follow-up|0|||
33469193|NCT02315066|101608087|FG001|Overall Study|Subject refused further follow-up|2|||
33469194|NCT02315066|101608088|FG002|Overall Study|Subject refused further follow-up|2|||
33469195|NCT02315066|101608089|FG003|Overall Study|Subject refused further follow-up|0|||
33469196|NCT02315066|101608090|FG004|Overall Study|Subject refused further follow-up|0|||
33469197|NCT02315066|101608091|FG005|Overall Study|Subject refused further follow-up|0|||
33469198|NCT02315066|101608092|FG006|Overall Study|Subject refused further follow-up|2|||
33469199|NCT02315066|101608093|FG007|Overall Study|Subject refused further follow-up|3|||
33469200|NCT02315066|101608094|FG008|Overall Study|Subject refused further follow-up|0|||
33469201|NCT02315066|101608095|FG009|Overall Study|Subject refused further follow-up|1|||
33469202|NCT02315066|101608096|FG010|Overall Study|Subject refused further follow-up|1|||
33469203|NCT02315066|101608097|FG011|Overall Study|Subject refused further follow-up|2|||
33469204|NCT02315066|101608098|FG012|Overall Study|Subject refused further follow-up|2|||
33469205|NCT02315066|101608099|FG013|Overall Study|Subject refused further follow-up|4|||
33469206|NCT02315066|101608086|FG000|Overall Study|Study ongoing at date of cut-off|0|||
33469207|NCT02315066|101608087|FG001|Overall Study|Study ongoing at date of cut-off|0|||
33469208|NCT02315066|101608088|FG002|Overall Study|Study ongoing at date of cut-off|0|||
33469209|NCT02315066|101608089|FG003|Overall Study|Study ongoing at date of cut-off|0|||
33469210|NCT02315066|101608090|FG004|Overall Study|Study ongoing at date of cut-off|0|||
33469211|NCT02315066|101608091|FG005|Overall Study|Study ongoing at date of cut-off|0|||
33469212|NCT02315066|101608092|FG006|Overall Study|Study ongoing at date of cut-off|0|||
33469213|NCT02315066|101608093|FG007|Overall Study|Study ongoing at date of cut-off|0|||
33469214|NCT02315066|101608094|FG008|Overall Study|Study ongoing at date of cut-off|0|||
33469215|NCT02315066|101608095|FG009|Overall Study|Study ongoing at date of cut-off|0|||
33469216|NCT02315066|101608096|FG010|Overall Study|Study ongoing at date of cut-off|0|||
33469217|NCT02315066|101608097|FG011|Overall Study|Study ongoing at date of cut-off|0|||
33469218|NCT02315066|101608098|FG012|Overall Study|Study ongoing at date of cut-off|0|||
33469219|NCT02315066|101608099|FG013|Overall Study|Study ongoing at date of cut-off|1|||
33469220|NCT01045421|101608100|FG000|Phase 1|Progressive Disease|0|||
33469221|NCT01045421|101608101|FG001|Phase 1|Progressive Disease|0|||
33469222|NCT01045421|101608102|FG002|Phase 1|Progressive Disease|0|||
33469223|NCT01045421|101608103|FG003|Phase 1|Progressive Disease|0|||
33180269|NCT00605475|100568320|FG006|Overall Study|Administrative problems|1|||
33266284|NCT03697603|100873845|FG001|Overall Study|Withdrawal by Subject|1|||
33469224|NCT01045421|101608104|FG004|Phase 1|Progressive Disease|1|||
33469225|NCT01045421|101608105|FG005|Phase 1|Progressive Disease|0|||
33469226|NCT01045421|101608106|FG006|Phase 1|Progressive Disease|0|||
33469227|NCT01045421|101608107|FG007|Phase 1|Progressive Disease|0|||
33469228|NCT01045421|101608108|FG008|Phase 1|Progressive Disease|0|||
33469229|NCT01045421|101608109|FG009|Phase 1|Progressive Disease|0|||
33469230|NCT01045421|101608110|FG010|Phase 1|Progressive Disease|0|||
33469231|NCT01045421|101608100|FG000|Phase 1|Withdrawal by Subject|0|||
33469232|NCT01045421|101608101|FG001|Phase 1|Withdrawal by Subject|0|||
33469233|NCT01045421|101608102|FG002|Phase 1|Withdrawal by Subject|0|||
33469234|NCT01045421|101608103|FG003|Phase 1|Withdrawal by Subject|1|||
33469235|NCT01045421|101608104|FG004|Phase 1|Withdrawal by Subject|0|||
33469236|NCT01045421|101608105|FG005|Phase 1|Withdrawal by Subject|0|||
33469237|NCT01045421|101608106|FG006|Phase 1|Withdrawal by Subject|0|||
33469238|NCT01045421|101608107|FG007|Phase 1|Withdrawal by Subject|0|||
33469239|NCT01045421|101608108|FG008|Phase 1|Withdrawal by Subject|0|||
33469240|NCT01045421|101608109|FG009|Phase 1|Withdrawal by Subject|0|||
33469241|NCT01045421|101608110|FG010|Phase 1|Withdrawal by Subject|0|||
33469242|NCT01045421|101608100|FG000|Phase 2|Progressive Disease|0|||
33469243|NCT01045421|101608101|FG001|Phase 2|Progressive Disease|0|||
33469244|NCT01045421|101608102|FG002|Phase 2|Progressive Disease|0|||
33469245|NCT01045421|101608103|FG003|Phase 2|Progressive Disease|0|||
33469246|NCT01045421|101608104|FG004|Phase 2|Progressive Disease|0|||
33469247|NCT01045421|101608105|FG005|Phase 2|Progressive Disease|0|||
33469248|NCT01045421|101608106|FG006|Phase 2|Progressive Disease|0|||
33469249|NCT01045421|101608107|FG007|Phase 2|Progressive Disease|1|||
33469250|NCT01045421|101608108|FG008|Phase 2|Progressive Disease|1|||
33469251|NCT01045421|101608109|FG009|Phase 2|Progressive Disease|1|||
33469252|NCT01045421|101608110|FG010|Phase 2|Progressive Disease|1|||
33469253|NCT01045421|101608100|FG000|Phase 2|Death|0|||
33469254|NCT01045421|101608101|FG001|Phase 2|Death|0|||
33469255|NCT01045421|101608102|FG002|Phase 2|Death|0|||
33469256|NCT01045421|101608103|FG003|Phase 2|Death|0|||
33469257|NCT01045421|101608104|FG004|Phase 2|Death|0|||
33469258|NCT01045421|101608105|FG005|Phase 2|Death|0|||
33469259|NCT01045421|101608106|FG006|Phase 2|Death|0|||
33469260|NCT01045421|101608107|FG007|Phase 2|Death|1|||
33469261|NCT01045421|101608108|FG008|Phase 2|Death|1|||
33469262|NCT01045421|101608109|FG009|Phase 2|Death|2|||
33469263|NCT01045421|101608110|FG010|Phase 2|Death|0|||
33469264|NCT01045421|101608100|FG000|Phase 2|Other|0|||
33469265|NCT01045421|101608101|FG001|Phase 2|Other|0|||
33469266|NCT01045421|101608102|FG002|Phase 2|Other|0|||
33469267|NCT01045421|101608103|FG003|Phase 2|Other|0|||
33469268|NCT01045421|101608104|FG004|Phase 2|Other|0|||
33469269|NCT01045421|101608105|FG005|Phase 2|Other|0|||
33469270|NCT01045421|101608106|FG006|Phase 2|Other|0|||
33469271|NCT01045421|101608107|FG007|Phase 2|Other|3|||
33469272|NCT01045421|101608108|FG008|Phase 2|Other|0|||
33469273|NCT01045421|101608109|FG009|Phase 2|Other|0|||
33469274|NCT01045421|101608110|FG010|Phase 2|Other|1|||
33469275|NCT00412737|101608111|FG000|Overall Study|Death|1|||
33469276|NCT00412737|101608112|FG001|Overall Study|Death|0|||
33469277|NCT00412737|101608111|FG000|Overall Study|Adverse Event|3|||
33469278|NCT00412737|101608112|FG001|Overall Study|Adverse Event|2|||
33469279|NCT00412737|101608111|FG000|Overall Study|Refused Treatment|6|||
33469280|NCT00412737|101608112|FG001|Overall Study|Refused Treatment|2|||
33469281|NCT00412737|101608111|FG000|Overall Study|Failure to Return|6|||
33469282|NCT00412737|101608112|FG001|Overall Study|Failure to Return|2|||
33469283|NCT03864042|101608113|FG000|DDI Phase|Adverse Event|2|||
33469284|NCT03864042|101608114|FG001|DDI Phase|Adverse Event|0|||
33469285|NCT03864042|101608115|FG002|DDI Phase|Adverse Event|0|||
33469286|NCT03864042|101608113|FG000|DDI Phase|Physician Decision|1|||
33469287|NCT03864042|101608114|FG001|DDI Phase|Physician Decision|0|||
33469288|NCT03864042|101608115|FG002|DDI Phase|Physician Decision|0|||
33469289|NCT03864042|101608113|FG000|DDI Phase|Progressive Disease|1|||
33469290|NCT03864042|101608114|FG001|DDI Phase|Progressive Disease|0|||
33469291|NCT03864042|101608115|FG002|DDI Phase|Progressive Disease|0|||
33469292|NCT03864042|101608113|FG000|Post-DDI Phase|Adverse Event|5|||
33469293|NCT03864042|101608114|FG001|Post-DDI Phase|Adverse Event|3|||
33469294|NCT03864042|101608115|FG002|Post-DDI Phase|Adverse Event|2|||
33469295|NCT03864042|101608113|FG000|Post-DDI Phase|Progressive Disease|11|||
33180270|NCT00605475|100568321|FG007|Overall Study|Administrative problems|0|||
33469296|NCT03864042|101608114|FG001|Post-DDI Phase|Progressive Disease|6|||
33469297|NCT03864042|101608115|FG002|Post-DDI Phase|Progressive Disease|13|||
33469298|NCT03864042|101608113|FG000|Post-DDI Phase|Discretion of investigator|1|||
33180271|NCT00605475|100568322|FG008|Overall Study|Administrative problems|0|||
33180272|NCT00605475|100568323|FG009|Overall Study|Administrative problems|0|||
33180273|NCT00605475|100568314|FG000|Overall Study|Lost to Follow-up|0|||
33266285|NCT03697603|100873846|FG002|Overall Study|Withdrawal by Subject|1|||
33469299|NCT03864042|101608114|FG001|Post-DDI Phase|Discretion of investigator|1|||
33469300|NCT03864042|101608115|FG002|Post-DDI Phase|Discretion of investigator|0|||
33469301|NCT03864042|101608113|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
33180274|NCT00605475|100568315|FG001|Overall Study|Lost to Follow-up|0|||
33180275|NCT00605475|100568316|FG002|Overall Study|Lost to Follow-up|0|||
33469302|NCT03864042|101608114|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
33469303|NCT03864042|101608115|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
33469304|NCT03864042|101608113|FG000|Post-DDI Phase|Withdrawal of consent|1|||
33469305|NCT03864042|101608114|FG001|Post-DDI Phase|Withdrawal of consent|2|||
33469306|NCT03864042|101608115|FG002|Post-DDI Phase|Withdrawal of consent|0|||
33469307|NCT04440449|101608116|FG000|Overall Study|Lost to Follow-up|2|||
33469308|NCT04440449|101608117|FG001|Overall Study|Lost to Follow-up|0|||
33469309|NCT00655850|101608118|FG000|Overall Study|Death|2|||
33469310|NCT00655850|101608118|FG000|Overall Study|Withdrawal by Subject|1|||
33469311|NCT01091103|101608123|FG000|Overall Study|Adverse Event|1|||
33469312|NCT01091103|101608123|FG000|Overall Study|Progressive Disease|3|||
33469313|NCT01360866|101608124|FG000|Overall Study|Lost to Follow-up|11|||
33469314|NCT01360866|101608125|FG001|Overall Study|Lost to Follow-up|28|||
33469315|NCT01360866|101608126|FG002|Overall Study|Lost to Follow-up|41|||
33469316|NCT01360866|101608127|FG003|Overall Study|Lost to Follow-up|0|||
33469317|NCT01360866|101608124|FG000|Overall Study|Adverse Event|56|||
33469318|NCT01360866|101608125|FG001|Overall Study|Adverse Event|61|||
33469319|NCT01360866|101608126|FG002|Overall Study|Adverse Event|134|||
33469320|NCT01360866|101608127|FG003|Overall Study|Adverse Event|6|||
33469321|NCT01360866|101608124|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
33469322|NCT01360866|101608125|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
33469323|NCT01360866|101608126|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
33469324|NCT01360866|101608127|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
33469325|NCT01360866|101608124|FG000|Overall Study|Withdrawn by Investigator|9|||
33469326|NCT01360866|101608125|FG001|Overall Study|Withdrawn by Investigator|8|||
33469327|NCT01360866|101608126|FG002|Overall Study|Withdrawn by Investigator|31|||
33469328|NCT01360866|101608127|FG003|Overall Study|Withdrawn by Investigator|2|||
33469329|NCT01360866|101608124|FG000|Overall Study|Withdrawal by participant|79|||
33469330|NCT01360866|101608125|FG001|Overall Study|Withdrawal by participant|89|||
33469331|NCT01360866|101608126|FG002|Overall Study|Withdrawal by participant|168|||
33469332|NCT01360866|101608127|FG003|Overall Study|Withdrawal by participant|8|||
33469333|NCT01360866|101608124|FG000|Overall Study|Protocol Deviation|25|||
33469334|NCT01360866|101608125|FG001|Overall Study|Protocol Deviation|33|||
33469335|NCT01360866|101608126|FG002|Overall Study|Protocol Deviation|61|||
33469336|NCT01360866|101608127|FG003|Overall Study|Protocol Deviation|2|||
33469337|NCT01360866|101608124|FG000|Overall Study|Lack of Efficacy|30|||
33469338|NCT01360866|101608125|FG001|Overall Study|Lack of Efficacy|40|||
33469339|NCT01360866|101608126|FG002|Overall Study|Lack of Efficacy|30|||
33469340|NCT01360866|101608127|FG003|Overall Study|Lack of Efficacy|4|||
33469341|NCT01491035|101608128|FG000|Overall Study|Lost to Follow-up|0|||
33469342|NCT01491035|101608129|FG001|Overall Study|Lost to Follow-up|0|||
33469343|NCT01491035|101608130|FG002|Overall Study|Lost to Follow-up|0|||
33469344|NCT01491035|101608131|FG003|Overall Study|Lost to Follow-up|0|||
33469345|NCT01491035|101608132|FG004|Overall Study|Lost to Follow-up|1|||
33469346|NCT01491035|101608133|FG005|Overall Study|Lost to Follow-up|0|||
33469347|NCT01491035|101608134|FG006|Overall Study|Lost to Follow-up|0|||
33469348|NCT01491035|101608135|FG007|Overall Study|Lost to Follow-up|0|||
33469349|NCT01351350|101608138|FG000|Overall Study|Disease Progression|5|||
33469350|NCT01351350|101608139|FG001|Overall Study|Disease Progression|13|||
33469351|NCT01351350|101608140|FG002|Overall Study|Disease Progression|6|||
33469352|NCT01351350|101608141|FG003|Overall Study|Disease Progression|8|||
33469353|NCT01351350|101608142|FG004|Overall Study|Disease Progression|5|||
33469354|NCT01351350|101608138|FG000|Overall Study|Adverse Event|1|||
33469355|NCT01351350|101608139|FG001|Overall Study|Adverse Event|10|||
33469356|NCT01351350|101608140|FG002|Overall Study|Adverse Event|1|||
33469357|NCT01351350|101608141|FG003|Overall Study|Adverse Event|2|||
33469358|NCT01351350|101608142|FG004|Overall Study|Adverse Event|0|||
33469359|NCT01351350|101608138|FG000|Overall Study|Participant Decision|2|||
33469360|NCT01351350|101608139|FG001|Overall Study|Participant Decision|6|||
33469361|NCT01351350|101608140|FG002|Overall Study|Participant Decision|3|||
33469362|NCT01351350|101608141|FG003|Overall Study|Participant Decision|3|||
33469363|NCT01351350|101608142|FG004|Overall Study|Participant Decision|2|||
33469364|NCT01351350|101608138|FG000|Overall Study|Enrolled but not Treated|0|||
33469365|NCT01351350|101608139|FG001|Overall Study|Enrolled but not Treated|0|||
33469366|NCT01351350|101608140|FG002|Overall Study|Enrolled but not Treated|1|||
33469367|NCT01351350|101608141|FG003|Overall Study|Enrolled but not Treated|0|||
33469368|NCT01351350|101608142|FG004|Overall Study|Enrolled but not Treated|0|||
33469369|NCT01490866|101608143|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
33469370|NCT01490866|101608143|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
33469371|NCT01490866|101608143|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
33266286|NCT03697603|100873844|FG000|Overall Study|Protocol Violation|0|||
33469372|NCT01490866|101608143|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
33469373|NCT01490866|101608143|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
33469374|NCT01490866|101608143|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
33469375|NCT01490866|101608143|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
33266287|NCT03697603|100873845|FG001|Overall Study|Protocol Violation|0|||
33469376|NCT01490866|101608143|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
33469377|NCT01490866|101608143|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
33469378|NCT01490866|101608143|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
33469379|NCT01490866|101608143|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
33469380|NCT00062751|101608145|FG000|Overall Study|Disease progression|24|||
33469381|NCT00062751|101608146|FG001|Overall Study|Disease progression|17|||
33469382|NCT00062751|101608147|FG002|Overall Study|Disease progression|24|||
33469383|NCT00062751|101608148|FG003|Overall Study|Disease progression|2|||
33469384|NCT00062751|101608149|FG004|Overall Study|Disease progression|2|||
33469385|NCT00062751|101608145|FG000|Overall Study|Adverse Event|4|||
33469386|NCT00062751|101608146|FG001|Overall Study|Adverse Event|7|||
33469387|NCT00062751|101608147|FG002|Overall Study|Adverse Event|2|||
33469388|NCT00062751|101608148|FG003|Overall Study|Adverse Event|2|||
33469389|NCT00062751|101608149|FG004|Overall Study|Adverse Event|2|||
33469390|NCT00062751|101608145|FG000|Overall Study|Other|2|||
33469391|NCT00062751|101608146|FG001|Overall Study|Other|3|||
33469392|NCT00062751|101608147|FG002|Overall Study|Other|1|||
33469393|NCT00062751|101608148|FG003|Overall Study|Other|0|||
33469394|NCT00062751|101608149|FG004|Overall Study|Other|1|||
33469395|NCT00062751|101608145|FG000|Overall Study|Withdrawal by Subject|1|||
33469396|NCT00062751|101608146|FG001|Overall Study|Withdrawal by Subject|2|||
33469397|NCT00062751|101608147|FG002|Overall Study|Withdrawal by Subject|2|||
33469398|NCT00062751|101608148|FG003|Overall Study|Withdrawal by Subject|1|||
33469399|NCT00062751|101608149|FG004|Overall Study|Withdrawal by Subject|0|||
33469400|NCT00062751|101608145|FG000|Overall Study|Symptomatic deterioration|1|||
33469401|NCT00062751|101608146|FG001|Overall Study|Symptomatic deterioration|1|||
33469402|NCT00062751|101608147|FG002|Overall Study|Symptomatic deterioration|0|||
33469403|NCT00062751|101608148|FG003|Overall Study|Symptomatic deterioration|0|||
33469404|NCT00062751|101608149|FG004|Overall Study|Symptomatic deterioration|1|||
33469405|NCT00062751|101608145|FG000|Overall Study|Death|1|||
33469406|NCT00062751|101608146|FG001|Overall Study|Death|0|||
33469407|NCT00062751|101608147|FG002|Overall Study|Death|1|||
33469408|NCT00062751|101608148|FG003|Overall Study|Death|0|||
33469409|NCT00062751|101608149|FG004|Overall Study|Death|0|||
33469410|NCT02370914|101608150|FG000|Overall Study|Protocol Violation|2|||
33469411|NCT02225665|101608151|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
33469412|NCT02225665|101608152|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
33469413|NCT02225665|101608151|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
33469414|NCT02225665|101608152|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
33469415|NCT02549573|101608155|FG000|Overall Study|Withdrawal by Subject|0|||
33469416|NCT02549573|101608156|FG001|Overall Study|Withdrawal by Subject|2|||
33469417|NCT02549573|101608155|FG000|Overall Study|Protocol Violation|0|||
33469418|NCT02549573|101608156|FG001|Overall Study|Protocol Violation|1|||
33469419|NCT03465436|101608164|FG000|Period 1|Protocol Violation|0|||
33469420|NCT03465436|101608165|FG001|Period 1|Protocol Violation|0|||
33469421|NCT03465436|101608166|FG002|Period 1|Protocol Violation|1|||
33469422|NCT03465436|101608167|FG003|Period 1|Protocol Violation|0|||
33469423|NCT03465436|101608164|FG000|Period 2|Protocol Violation|0|||
33469424|NCT03465436|101608165|FG001|Period 2|Protocol Violation|1|||
33469425|NCT03465436|101608166|FG002|Period 2|Protocol Violation|0|||
33469426|NCT03465436|101608167|FG003|Period 2|Protocol Violation|0|||
33469427|NCT03465436|101608164|FG000|Period 3|Protocol Violation|1|||
33469428|NCT03465436|101608165|FG001|Period 3|Protocol Violation|1|||
33469429|NCT03465436|101608166|FG002|Period 3|Protocol Violation|0|||
33469430|NCT03465436|101608167|FG003|Period 3|Protocol Violation|0|||
33469431|NCT03465436|101608164|FG000|Period 4|Protocol Violation|0|||
33469432|NCT03465436|101608165|FG001|Period 4|Protocol Violation|0|||
33469433|NCT03465436|101608166|FG002|Period 4|Protocol Violation|1|||
33469434|NCT03465436|101608167|FG003|Period 4|Protocol Violation|0|||
33469435|NCT00680186|101608168|FG000|Overall Study|Adverse Event|47|||
33469436|NCT00680186|101608169|FG001|Overall Study|Adverse Event|44|||
33469437|NCT00680186|101608168|FG000|Overall Study|Protocol Violation|31|||
33469438|NCT00680186|101608169|FG001|Overall Study|Protocol Violation|26|||
33469439|NCT00680186|101608168|FG000|Overall Study|Lost to Follow-up|11|||
33469440|NCT00680186|101608169|FG001|Overall Study|Lost to Follow-up|6|||
33469441|NCT00680186|101608168|FG000|Overall Study|Withdrawal by Subject|32|||
33469442|NCT00680186|101608169|FG001|Overall Study|Withdrawal by Subject|39|||
33469443|NCT00680186|101608168|FG000|Overall Study|Other|4|||
33469444|NCT00680186|101608169|FG001|Overall Study|Other|1|||
33469445|NCT01056640|101608171|FG000|Overall Study|Withdrawal by Subject|11|||
33469446|NCT01056640|101608172|FG001|Overall Study|Withdrawal by Subject|8|||
33469447|NCT01056640|101608171|FG000|Overall Study|Death|15|||
33469448|NCT01056640|101608172|FG001|Overall Study|Death|4|||
33469449|NCT01334710|101608173|FG000|Overall Study|Trial was terminated|3|||
33469450|NCT03165955|101608174|FG000|Treatment|Withdrawal by Subject|3|||
33469451|NCT03165955|101608174|FG000|Treatment|Death|1|||
33469452|NCT03165955|101608174|FG000|Treatment|Adverse Event|1|||
33469453|NCT03165955|101608174|FG000|Treatment|Progressive disease|3|||
33469454|NCT01064531|101611634|FG000|Overall Study|Lost to Follow-up|0|||
33469455|NCT01064531|101611635|FG001|Overall Study|Lost to Follow-up|2|||
33469456|NCT01064531|101611634|FG000|Overall Study|Physician Decision|0|||
33469457|NCT01064531|101611635|FG001|Overall Study|Physician Decision|1|||
33469458|NCT01064531|101611634|FG000|Overall Study|Withdrawal by Subject|2|||
33469459|NCT01064531|101611635|FG001|Overall Study|Withdrawal by Subject|2|||
33469460|NCT01064531|101611634|FG000|Overall Study|Revision due to femoral stem loosening|1|||
33469461|NCT01064531|101611635|FG001|Overall Study|Revision due to femoral stem loosening|0|||
33469462|NCT01064531|101611634|FG000|Overall Study|Revision due to dislocation|0|||
33469463|NCT01064531|101611635|FG001|Overall Study|Revision due to dislocation|1|||
33469464|NCT01064531|101611634|FG000|Overall Study|Death|0|||
33469465|NCT01064531|101611635|FG001|Overall Study|Death|1|||
33469466|NCT00493246|101611638|FG000|Overall Study|Withdrawal by Subject|0|||
33469467|NCT00493246|101611639|FG001|Overall Study|Withdrawal by Subject|0|||
33469468|NCT00493246|101611640|FG002|Overall Study|Withdrawal by Subject|0|||
33469469|NCT00493246|101611641|FG003|Overall Study|Withdrawal by Subject|0|||
33469470|NCT00493246|101611642|FG004|Overall Study|Withdrawal by Subject|1|||
33469471|NCT00493246|101611643|FG005|Overall Study|Withdrawal by Subject|0|||
33469472|NCT00493246|101611644|FG006|Overall Study|Withdrawal by Subject|0|||
33469473|NCT00493246|101611645|FG007|Overall Study|Withdrawal by Subject|0|||
33469474|NCT00493246|101611638|FG000|Overall Study|No access to draw blood|0|||
33469475|NCT00493246|101611639|FG001|Overall Study|No access to draw blood|0|||
33469476|NCT00493246|101611640|FG002|Overall Study|No access to draw blood|0|||
33469477|NCT00493246|101611641|FG003|Overall Study|No access to draw blood|0|||
33469478|NCT00493246|101611642|FG004|Overall Study|No access to draw blood|0|||
33469479|NCT00493246|101611643|FG005|Overall Study|No access to draw blood|1|||
33469480|NCT00493246|101611644|FG006|Overall Study|No access to draw blood|0|||
33469481|NCT00493246|101611645|FG007|Overall Study|No access to draw blood|0|||
33469482|NCT00493246|101611638|FG000|Overall Study|Lost to Follow-up|0|||
33469483|NCT00493246|101611639|FG001|Overall Study|Lost to Follow-up|0|||
33469484|NCT00493246|101611640|FG002|Overall Study|Lost to Follow-up|0|||
33469485|NCT00493246|101611641|FG003|Overall Study|Lost to Follow-up|0|||
33469486|NCT00493246|101611642|FG004|Overall Study|Lost to Follow-up|0|||
33469487|NCT00493246|101611643|FG005|Overall Study|Lost to Follow-up|0|||
33469488|NCT00493246|101611644|FG006|Overall Study|Lost to Follow-up|1|||
33469489|NCT00493246|101611645|FG007|Overall Study|Lost to Follow-up|0|||
33469490|NCT00986570|101611649|FG000|Overall Study|Lost to Follow-up|6|||
33469491|NCT00986570|101611649|FG000|Overall Study|Potential bias for objective assessment|1|||
33469492|NCT05020249|101611650|FG000|Overall Study|Protocol Violation|1|||
33469493|NCT05020249|101611651|FG001|Overall Study|Protocol Violation|0|||
33469494|NCT03201211|101611654|FG000|Overall Study|Adverse Event|1|||
33469495|NCT03201211|101611655|FG001|Overall Study|Adverse Event|0|||
33469496|NCT03201211|101611656|FG002|Overall Study|Adverse Event|0|||
33469497|NCT03201211|101611654|FG000|Overall Study|Protocol Violation|1|||
33469498|NCT03201211|101611655|FG001|Overall Study|Protocol Violation|0|||
33469499|NCT03201211|101611656|FG002|Overall Study|Protocol Violation|0|||
33469500|NCT03201211|101611654|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33469501|NCT03201211|101611655|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
33469502|NCT03201211|101611656|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
33469503|NCT03201211|101611654|FG000|Overall Study|OTHER unknown reasons|0|||
33469504|NCT03201211|101611655|FG001|Overall Study|OTHER unknown reasons|1|||
33469505|NCT03201211|101611656|FG002|Overall Study|OTHER unknown reasons|0|||
33469506|NCT04317599|101611657|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
33469507|NCT04317599|101611657|FG000|Overall Study|treatment outside standard of care|4|||
33469508|NCT00770692|101611661|FG000|Overall Study|Withdrawal by Subject|7|||
33469509|NCT00770692|101611662|FG001|Overall Study|Withdrawal by Subject|9|||
33469510|NCT00770692|101611663|FG002|Overall Study|Withdrawal by Subject|9|||
33469511|NCT00770692|101611664|FG003|Overall Study|Withdrawal by Subject|6|||
33469512|NCT00770692|101611661|FG000|Overall Study|Adverse Event|3|||
33469513|NCT00770692|101611662|FG001|Overall Study|Adverse Event|0|||
33469514|NCT00770692|101611663|FG002|Overall Study|Adverse Event|4|||
33469515|NCT00770692|101611664|FG003|Overall Study|Adverse Event|4|||
33469516|NCT00770692|101611661|FG000|Overall Study|Investigator judgment|2|||
33469517|NCT00770692|101611662|FG001|Overall Study|Investigator judgment|0|||
33469518|NCT00770692|101611663|FG002|Overall Study|Investigator judgment|1|||
33469519|NCT00770692|101611664|FG003|Overall Study|Investigator judgment|1|||
33469520|NCT01715896|101611665|FG000|Overall Study|Lost to Follow-up|0|||
33469521|NCT01715896|101611666|FG001|Overall Study|Lost to Follow-up|2|||
33469522|NCT01715896|101611665|FG000|Overall Study|Withdrawal by Subject|1|||
33469523|NCT01715896|101611666|FG001|Overall Study|Withdrawal by Subject|4|||
33469524|NCT01715896|101611665|FG000|Overall Study|Other|2|||
33469525|NCT01715896|101611666|FG001|Overall Study|Other|5|||
33180276|NCT00605475|100568317|FG003|Overall Study|Lost to Follow-up|0|||
33469526|NCT01300923|101611667|FG000|Overall Study|Physician Decision|0|||
33469527|NCT01300923|101611668|FG001|Overall Study|Physician Decision|2|||
33469528|NCT03604341|101611671|FG000|Overall Study|Withdrawal by Subject|1|||
33469529|NCT03604341|101611672|FG001|Overall Study|Withdrawal by Subject|1|||
33469530|NCT03604341|101611671|FG000|Overall Study|Adverse Event|1|||
33469531|NCT03604341|101611672|FG001|Overall Study|Adverse Event|0|||
33469532|NCT03604341|101611671|FG000|Overall Study|Protocol Violation|0|||
33469533|NCT03604341|101611672|FG001|Overall Study|Protocol Violation|1|||
33469534|NCT03921151|101611677|FG000|Overall Study|Withdrawal by Subject|11|||
33469535|NCT03921151|101611678|FG001|Overall Study|Withdrawal by Subject|16|||
33469536|NCT02691741|101611679|FG000|Overall Study|Adverse Event|0|||
33469537|NCT02691741|101611680|FG001|Overall Study|Adverse Event|2|||
33469538|NCT02691741|101611679|FG000|Overall Study|Lost to Follow-up|1|||
33469539|NCT02691741|101611680|FG001|Overall Study|Lost to Follow-up|0|||
33469540|NCT02691741|101611679|FG000|Overall Study|Physician Decision|0|||
33469541|NCT02691741|101611680|FG001|Overall Study|Physician Decision|1|||
33469542|NCT02691741|101611679|FG000|Overall Study|Withdrawal by Subject|0|||
33469543|NCT02691741|101611680|FG001|Overall Study|Withdrawal by Subject|4|||
33469544|NCT02709486|101611683|FG000|Overall Study|Adverse Event|2|||
33469545|NCT02709486|101611684|FG001|Overall Study|Adverse Event|5|||
33469546|NCT02709486|101611685|FG002|Overall Study|Adverse Event|3|||
33469547|NCT02709486|101611683|FG000|Overall Study|Death|0|||
33469548|NCT02709486|101611684|FG001|Overall Study|Death|0|||
33469549|NCT02709486|101611685|FG002|Overall Study|Death|2|||
33469550|NCT02709486|101611683|FG000|Overall Study|Insufficient clinical response|7|||
33469551|NCT02709486|101611684|FG001|Overall Study|Insufficient clinical response|3|||
33469552|NCT02709486|101611685|FG002|Overall Study|Insufficient clinical response|3|||
33469553|NCT02709486|101611683|FG000|Overall Study|Lost to Follow-up|3|||
33469554|NCT02709486|101611684|FG001|Overall Study|Lost to Follow-up|2|||
33469555|NCT02709486|101611685|FG002|Overall Study|Lost to Follow-up|2|||
33469556|NCT02709486|101611683|FG000|Overall Study|Other|0|||
33469557|NCT02709486|101611684|FG001|Overall Study|Other|2|||
33469558|NCT02709486|101611685|FG002|Overall Study|Other|3|||
33469559|NCT02709486|101611683|FG000|Overall Study|Withdrawal by Subject|32|||
33469560|NCT02709486|101611684|FG001|Overall Study|Withdrawal by Subject|22|||
33469561|NCT02709486|101611685|FG002|Overall Study|Withdrawal by Subject|32|||
33469562|NCT00507546|101611686|FG000|Overall Study|Withdrawal by Subject|1|||
33469563|NCT00507546|101611687|FG001|Overall Study|Withdrawal by Subject|0|||
33469564|NCT00507546|101611686|FG000|Overall Study|Protocol Violation|1|||
33469565|NCT00507546|101611687|FG001|Overall Study|Protocol Violation|0|||
33469566|NCT00507546|101611686|FG000|Overall Study|Physician Decision|0|||
33469567|NCT00507546|101611687|FG001|Overall Study|Physician Decision|1|||
33469568|NCT05506358|101611690|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
33469569|NCT05506358|101611691|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
33469570|NCT05506358|101611692|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
33469571|NCT05506358|101611693|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
33469572|NCT05506358|101611694|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
33469573|NCT05506358|101611690|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
33469574|NCT05506358|101611691|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
33469575|NCT05506358|101611692|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
33469576|NCT05506358|101611693|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
33469577|NCT05506358|101611694|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
33469578|NCT05506358|101611690|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
33469579|NCT05506358|101611691|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
33469580|NCT05506358|101611692|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
33469581|NCT05506358|101611693|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
33469582|NCT05506358|101611694|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
33469583|NCT05506358|101611690|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
33469584|NCT05506358|101611691|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
33469585|NCT05506358|101611692|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
33469586|NCT05506358|101611693|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
33469587|NCT05506358|101611694|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
33469588|NCT05506358|101611690|FG000|Overall Study|HbE trait|0|||
33469589|NCT05506358|101611691|FG001|Overall Study|HbE trait|0|||
33469590|NCT05506358|101611692|FG002|Overall Study|HbE trait|0|||
33469591|NCT05506358|101611693|FG003|Overall Study|HbE trait|1|||
33469592|NCT05506358|101611694|FG004|Overall Study|HbE trait|0|||
33469593|NCT00257920|101611695|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
33469594|NCT00257920|101611696|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
33469595|NCT00257920|101611695|FG000|Period: Second Intervention|Other|2|||
33180277|NCT00605475|100568318|FG004|Overall Study|Lost to Follow-up|0|||
33180278|NCT00605475|100568319|FG005|Overall Study|Lost to Follow-up|0|||
33469596|NCT00257920|101611696|FG001|Period: Second Intervention|Other|1|||
33469597|NCT00359788|101611697|FG000|Overall Study|Adverse Event|11|||
33469598|NCT00359788|101611698|FG001|Overall Study|Adverse Event|10|||
33469599|NCT00359788|101611697|FG000|Overall Study|Lack of Efficacy|1|||
33469600|NCT00359788|101611698|FG001|Overall Study|Lack of Efficacy|2|||
33469601|NCT00359788|101611697|FG000|Overall Study|Lost to Follow-up|3|||
33469602|NCT00359788|101611698|FG001|Overall Study|Lost to Follow-up|2|||
33469603|NCT00359788|101611697|FG000|Overall Study|Withdrawal by Subject|4|||
33180279|NCT00605475|100568320|FG006|Overall Study|Lost to Follow-up|0|||
33469604|NCT00359788|101611698|FG001|Overall Study|Withdrawal by Subject|1|||
33469605|NCT00359788|101611697|FG000|Overall Study|Protocol Violation|4|||
33469606|NCT00359788|101611698|FG001|Overall Study|Protocol Violation|2|||
33469607|NCT01674647|101611699|FG000|Treatment Period|Death|4|||
33469608|NCT01674647|101611700|FG001|Treatment Period|Death|1|||
33469609|NCT01674647|101611699|FG000|Treatment Period|Efficacy outcome reached|0|||
33469610|NCT01674647|101611700|FG001|Treatment Period|Efficacy outcome reached|1|||
33469611|NCT01674647|101611699|FG000|Treatment Period|Physician Decision|3|||
33469612|NCT01674647|101611700|FG001|Treatment Period|Physician Decision|1|||
33469613|NCT01674647|101611699|FG000|Treatment Period|Adverse Event|60|||
33469614|NCT01674647|101611700|FG001|Treatment Period|Adverse Event|22|||
33469615|NCT01674647|101611699|FG000|Treatment Period|Non-compliance with study drug|3|||
33469616|NCT01674647|101611700|FG001|Treatment Period|Non-compliance with study drug|0|||
33469617|NCT01674647|101611699|FG000|Treatment Period|Lost to Follow-up|1|||
33469618|NCT01674647|101611700|FG001|Treatment Period|Lost to Follow-up|1|||
33469619|NCT01674647|101611699|FG000|Treatment Period|Withdrawal by Subject|19|||
33469620|NCT01674647|101611700|FG001|Treatment Period|Withdrawal by Subject|16|||
33469621|NCT01674647|101611699|FG000|Treatment Period|Switching to other therapy|5|||
33469622|NCT01674647|101611700|FG001|Treatment Period|Switching to other therapy|2|||
33469623|NCT01674647|101611699|FG000|Treatment Period|Logistical difficulties|5|||
33469624|NCT01674647|101611700|FG001|Treatment Period|Logistical difficulties|8|||
33469625|NCT01674647|101611699|FG000|Treatment Period|Treatment failure|0|||
33469626|NCT01674647|101611700|FG001|Treatment Period|Treatment failure|14|||
33469627|NCT01674647|101611699|FG000|Treatment Period|Protocol Violation|56|||
33469628|NCT01674647|101611700|FG001|Treatment Period|Protocol Violation|36|||
33469629|NCT01674647|101611699|FG000|30-day Safety Follow-up Period|Death|3|||
33469630|NCT01674647|101611700|FG001|30-day Safety Follow-up Period|Death|2|||
33469631|NCT01674647|101611699|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
33469632|NCT01674647|101611700|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
33469633|NCT01674647|101611699|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
33469634|NCT01674647|101611700|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
33469635|NCT01674647|101611699|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
33469636|NCT01674647|101611700|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
33469637|NCT01674647|101611699|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
33469638|NCT01674647|101611700|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
33469639|NCT01674647|101611699|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
33469640|NCT01674647|101611700|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
33469641|NCT00952276|101611701|FG000|Overall Study|Withdrawal by Subject|1|||
33469642|NCT00952276|101611702|FG001|Overall Study|Withdrawal by Subject|0|||
33469643|NCT00952276|101611703|FG002|Overall Study|Withdrawal by Subject|0|||
33469644|NCT00952276|101611704|FG003|Overall Study|Withdrawal by Subject|1|||
33469645|NCT00952276|101611705|FG004|Overall Study|Withdrawal by Subject|0|||
33469646|NCT03250299|101611708|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
33469647|NCT03250299|101611709|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
33469648|NCT03250299|101611710|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
33469649|NCT03250299|101611711|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
33469650|NCT03250299|101611712|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
33469651|NCT03250299|101611708|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
33469652|NCT03250299|101611709|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
33469653|NCT03250299|101611710|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
33469654|NCT03250299|101611711|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
33180280|NCT00605475|100568321|FG007|Overall Study|Lost to Follow-up|0|||
33180281|NCT00605475|100568322|FG008|Overall Study|Lost to Follow-up|1|||
33180282|NCT00605475|100568323|FG009|Overall Study|Lost to Follow-up|1|||
33180283|NCT00605475|100568314|FG000|Overall Study|Protocol Violation|0|||
33180284|NCT00605475|100568315|FG001|Overall Study|Protocol Violation|0|||
33180285|NCT00605475|100568316|FG002|Overall Study|Protocol Violation|0|||
33180286|NCT00605475|100568317|FG003|Overall Study|Protocol Violation|0|||
33180287|NCT00605475|100568318|FG004|Overall Study|Protocol Violation|1|||
33180288|NCT00605475|100568319|FG005|Overall Study|Protocol Violation|0|||
33180289|NCT00605475|100568320|FG006|Overall Study|Protocol Violation|0|||
33180290|NCT00605475|100568321|FG007|Overall Study|Protocol Violation|0|||
33180291|NCT00605475|100568322|FG008|Overall Study|Protocol Violation|0|||
33180292|NCT00605475|100568323|FG009|Overall Study|Protocol Violation|0|||
33469655|NCT03250299|101611712|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
33180293|NCT00605475|100568314|FG000|Overall Study|Withdrawal by Subject|0|||
33180294|NCT00605475|100568315|FG001|Overall Study|Withdrawal by Subject|0|||
33180295|NCT00605475|100568316|FG002|Overall Study|Withdrawal by Subject|0|||
33180296|NCT00605475|100568317|FG003|Overall Study|Withdrawal by Subject|0|||
33180297|NCT00605475|100568318|FG004|Overall Study|Withdrawal by Subject|0|||
33469656|NCT03250299|101611708|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
33469657|NCT03250299|101611709|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
33469658|NCT03250299|101611710|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
33469659|NCT03250299|101611711|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
33469660|NCT03250299|101611712|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
33469661|NCT03250299|101611708|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
33469662|NCT03250299|101611709|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
33180298|NCT00605475|100568319|FG005|Overall Study|Withdrawal by Subject|2|||
33469663|NCT03250299|101611710|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
33469664|NCT03250299|101611711|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
33469665|NCT03250299|101611712|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
33469666|NCT00466726|101611713|FG000|Overall Study|Not evaluable for response|14|||
33469667|NCT02037165|101611714|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
33469668|NCT02037165|101611715|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
33469669|NCT02037165|101611716|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
33469670|NCT02037165|101611717|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
33469671|NCT02037165|101611718|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
33469672|NCT02547766|101611721|FG000|Overall Study|Withdrawal by Subject|1|||
33469673|NCT04032158|101611722|FG000|Overall Study|Study Termination|2|||
33469674|NCT04032158|101611723|FG001|Overall Study|Study Termination|1|||
33469675|NCT02813421|101611724|FG000|Overall Study|Withdrawal by Subject|1|||
33469676|NCT02813421|101611725|FG001|Overall Study|Withdrawal by Subject|2|||
33469677|NCT02813421|101611724|FG000|Overall Study|Lost to Follow-up|1|||
33469678|NCT02813421|101611725|FG001|Overall Study|Lost to Follow-up|1|||
33469679|NCT00804141|101611726|FG000|Overall Study|Adverse Event|157|||
33469680|NCT00804141|101611726|FG000|Overall Study|Death|4|||
33469681|NCT00804141|101611726|FG000|Overall Study|Failed to return|96|||
33469682|NCT00804141|101611726|FG000|Overall Study|Investigator request|8|||
33469683|NCT00804141|101611726|FG000|Overall Study|Protocol Violation|85|||
33469684|NCT00804141|101611726|FG000|Overall Study|Withdrawal by Subject|131|||
33469685|NCT00804141|101611726|FG000|Overall Study|Lack of Efficacy|46|||
33469686|NCT00804141|101611726|FG000|Overall Study|Other than specified|30|||
33469687|NCT00804141|101611726|FG000|Overall Study|Enrolled but not treated|6|||
33469688|NCT03036839|101611733|FG000|Overall Study|Adverse Event|0|||
33469689|NCT03036839|101611734|FG001|Overall Study|Adverse Event|0|||
33469690|NCT03036839|101611735|FG002|Overall Study|Adverse Event|1|||
33180299|NCT00605475|100568320|FG006|Overall Study|Withdrawal by Subject|0|||
33266288|NCT03697603|100873846|FG002|Overall Study|Protocol Violation|1|||
33266289|NCT00960206|100873853|FG000|Overall Study|Death|7|||
33266290|NCT00960206|100873854|FG001|Overall Study|Death|4|||
33266291|NCT00960206|100873855|FG002|Overall Study|Death|1|||
33266292|NCT00960206|100873853|FG000|Overall Study|Unwilling/Unable to return|1|||
33266293|NCT00960206|100873854|FG001|Overall Study|Unwilling/Unable to return|2|||
33266294|NCT00960206|100873855|FG002|Overall Study|Unwilling/Unable to return|0|||
33266295|NCT00960206|100873853|FG000|Overall Study|Lost to Follow-up|8|||
33266296|NCT00960206|100873854|FG001|Overall Study|Lost to Follow-up|14|||
33266297|NCT00960206|100873855|FG002|Overall Study|Lost to Follow-up|8|||
33266298|NCT00960206|100873853|FG000|Overall Study|Withdrawal by Subject|2|||
33266299|NCT00960206|100873854|FG001|Overall Study|Withdrawal by Subject|4|||
33266300|NCT00960206|100873855|FG002|Overall Study|Withdrawal by Subject|0|||
33266301|NCT00960206|100873853|FG000|Overall Study|Revision of study component|2|||
33266302|NCT00960206|100873854|FG001|Overall Study|Revision of study component|2|||
33266303|NCT00960206|100873855|FG002|Overall Study|Revision of study component|2|||
33266304|NCT00960206|100873853|FG000|Overall Study|Missing 10 year data|20|||
33266305|NCT00960206|100873854|FG001|Overall Study|Missing 10 year data|1|||
33180300|NCT00605475|100568321|FG007|Overall Study|Withdrawal by Subject|0|||
33180301|NCT00605475|100568322|FG008|Overall Study|Withdrawal by Subject|0|||
33180302|NCT00605475|100568323|FG009|Overall Study|Withdrawal by Subject|1|||
33180303|NCT01523886|100568325|FG000|Overall Study|surgery cancelled|0|||
33180304|NCT01523886|100568326|FG001|Overall Study|surgery cancelled|1|||
33180305|NCT01994629|100568330|FG000|Overall Study|Withdrawal by Subject|1|||
33180306|NCT01994629|100568331|FG001|Overall Study|Withdrawal by Subject|0|||
33180307|NCT01994629|100568330|FG000|Overall Study|Lost to Follow-up|0|||
33180308|NCT01994629|100568331|FG001|Overall Study|Lost to Follow-up|3|||
33180309|NCT00613015|100568334|FG000|Overall Study|Lost to Follow-up|0|||
33180310|NCT00613015|100568335|FG001|Overall Study|Lost to Follow-up|1|||
33180311|NCT00613015|100568336|FG002|Overall Study|Lost to Follow-up|3|||
33180312|NCT00613015|100568337|FG003|Overall Study|Lost to Follow-up|3|||
33180313|NCT00613015|100568338|FG004|Overall Study|Lost to Follow-up|2|||
33180314|NCT00613015|100568339|FG005|Overall Study|Lost to Follow-up|3|||
33266306|NCT00960206|100873855|FG002|Overall Study|Missing 10 year data|1|||
33266307|NCT01579318|100873858|FG000|Overall Study|Disease Progression|1|||
33266308|NCT00824408|100873869|FG000|Run-in Phase|Progressive disease|4|||
33266309|NCT00824408|100873870|FG001|Run-in Phase|Progressive disease|4|||
33469691|NCT03036839|101611733|FG000|Overall Study|Death|3|||
33469692|NCT03036839|101611734|FG001|Overall Study|Death|0|||
33469693|NCT03036839|101611735|FG002|Overall Study|Death|3|||
33180315|NCT00853723|100568340|FG000|Overall Study|Adverse Event|3|||
33180316|NCT00853723|100568341|FG001|Overall Study|Adverse Event|4|||
33180317|NCT00853723|100568342|FG002|Overall Study|Adverse Event|1|||
33469694|NCT03036839|101611733|FG000|Overall Study|Withdrew Consent|0|||
33469695|NCT03036839|101611734|FG001|Overall Study|Withdrew Consent|0|||
33469696|NCT03036839|101611735|FG002|Overall Study|Withdrew Consent|1|||
33469697|NCT02443545|101611738|FG000|Overall Study|Adverse Event|1|||
33469698|NCT02443545|101611739|FG001|Overall Study|Adverse Event|1|||
33469699|NCT02443545|101611738|FG000|Overall Study|Lost to Follow-up|0|||
33469700|NCT02443545|101611739|FG001|Overall Study|Lost to Follow-up|2|||
33469701|NCT02443545|101611738|FG000|Overall Study|Physician Decision|3|||
33469702|NCT02443545|101611739|FG001|Overall Study|Physician Decision|0|||
33469703|NCT02443545|101611738|FG000|Overall Study|Protocol Violation|8|||
33469704|NCT02443545|101611739|FG001|Overall Study|Protocol Violation|1|||
33469705|NCT02443545|101611738|FG000|Overall Study|Pregnancy|1|||
33469706|NCT02443545|101611739|FG001|Overall Study|Pregnancy|1|||
33469707|NCT02443545|101611738|FG000|Overall Study|Withdrawal by Subject|6|||
33469708|NCT02443545|101611739|FG001|Overall Study|Withdrawal by Subject|3|||
33469709|NCT02443545|101611738|FG000|Overall Study|Termination of study|20|||
33469710|NCT02443545|101611739|FG001|Overall Study|Termination of study|11|||
33469711|NCT02133001|101611744|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
33469712|NCT02133001|101611745|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
33469713|NCT02133001|101611744|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
33469714|NCT02133001|101611745|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
33469715|NCT02133001|101611744|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
33469716|NCT02133001|101611745|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
33469717|NCT02133001|101611744|FG000|Double Blind (Day 1-25)|Other|2|||
33469718|NCT02133001|101611745|FG001|Double Blind (Day 1-25)|Other|2|||
33469719|NCT02133001|101611744|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
33469720|NCT02133001|101611745|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
33469721|NCT02133001|101611744|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
33469722|NCT02133001|101611745|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
33469723|NCT02133001|101611744|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
33469724|NCT02133001|101611745|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
33469725|NCT02133001|101611744|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
33469726|NCT02133001|101611745|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
33469727|NCT05016622|101611746|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
33469728|NCT05016622|101611746|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
33469729|NCT02972502|101611747|FG000|Overall Study|Lost to Follow-up|3|||
33469730|NCT02972502|101611748|FG001|Overall Study|Lost to Follow-up|1|||
33469731|NCT02972502|101611747|FG000|Overall Study|Withdrawal by Subject|1|||
33469732|NCT02972502|101611748|FG001|Overall Study|Withdrawal by Subject|1|||
33469733|NCT00594646|101611757|FG000|Overall Study|Withdrawal by Subject|1|||
33469734|NCT00594646|101611757|FG000|Overall Study|Lost to Follow-up|15|||
33469735|NCT00679913|101611760|FG000|Overall Study|Protocol Violation|18|||
33469736|NCT00679913|101611761|FG001|Overall Study|Protocol Violation|13|||
33469737|NCT01568866|101611762|FG000|Overall Study|Disease Progression|208|||
33469738|NCT01568866|101611763|FG001|Overall Study|Disease Progression|183|||
33469739|NCT01568866|101611762|FG000|Overall Study|Adverse Event|94|||
33469740|NCT01568866|101611763|FG001|Overall Study|Adverse Event|96|||
33469741|NCT01568866|101611762|FG000|Overall Study|Patient Request|55|||
33469742|NCT01568866|101611763|FG001|Overall Study|Patient Request|71|||
33469743|NCT01568866|101611762|FG000|Overall Study|Physician Decision|40|||
33469744|NCT01568866|101611763|FG001|Overall Study|Physician Decision|32|||
33469745|NCT01568866|101611762|FG000|Overall Study|Withdrawal by Subject|19|||
33469746|NCT01568866|101611763|FG001|Overall Study|Withdrawal by Subject|11|||
33469747|NCT01568866|101611762|FG000|Overall Study|Death|10|||
33469748|NCT01568866|101611763|FG001|Overall Study|Death|18|||
33469749|NCT01568866|101611762|FG000|Overall Study|Protocol Non-compliance|2|||
33469750|NCT01568866|101611763|FG001|Overall Study|Protocol Non-compliance|4|||
33469751|NCT01568866|101611762|FG000|Overall Study|Lost to Follow-up|1|||
33469752|NCT01568866|101611763|FG001|Overall Study|Lost to Follow-up|0|||
33469753|NCT01568866|101611762|FG000|Overall Study|Randomized but Not Dosed|9|||
33469754|NCT01568866|101611763|FG001|Overall Study|Randomized but Not Dosed|1|||
33469755|NCT03476343|101611764|FG000|Overall Study|Clinical exam moved to another scanner|7|||
33469756|NCT03476343|101611764|FG000|Overall Study|Clinical order cancelled|4|||
33469757|NCT03476343|101611764|FG000|Overall Study|Neonate did not settle down for the scan|1|||
33469758|NCT01421342|101611765|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
33469759|NCT01421342|101611766|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
33180318|NCT00853723|100568340|FG000|Overall Study|Withdrawal by Subject|2|||
33180319|NCT00853723|100568341|FG001|Overall Study|Withdrawal by Subject|1|||
33180320|NCT00853723|100568342|FG002|Overall Study|Withdrawal by Subject|0|||
33180321|NCT00853723|100568340|FG000|Overall Study|Protocol Violation|1|||
33180322|NCT00853723|100568341|FG001|Overall Study|Protocol Violation|2|||
33469760|NCT01421342|101611767|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
33469761|NCT01421342|101611765|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
33469762|NCT01421342|101611766|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
33469763|NCT01421342|101611767|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
33469764|NCT01421342|101611765|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
33469765|NCT01421342|101611766|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
33469766|NCT01421342|101611767|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
33469767|NCT01421342|101611765|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
33469768|NCT01421342|101611766|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
33469769|NCT01421342|101611767|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
33469770|NCT01421342|101611765|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
33469771|NCT01421342|101611766|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
33469772|NCT01421342|101611767|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
33469773|NCT01421342|101611765|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
33469774|NCT01421342|101611766|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
33469775|NCT01421342|101611767|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
33469776|NCT01421342|101611765|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
33469777|NCT01421342|101611766|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
33469778|NCT01421342|101611767|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
33469779|NCT01421342|101611765|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
33469780|NCT01421342|101611766|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
33469781|NCT01421342|101611767|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
33469782|NCT01421342|101611765|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
33469783|NCT01421342|101611766|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
33469784|NCT01421342|101611767|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
33469785|NCT01421342|101611765|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
33469786|NCT01421342|101611766|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
33469787|NCT01421342|101611767|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
33469788|NCT01421342|101611765|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
33469789|NCT01421342|101611766|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
33469790|NCT01421342|101611767|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
33469791|NCT01421342|101611765|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
33469792|NCT01421342|101611766|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
33469793|NCT01421342|101611767|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
33469794|NCT01421342|101611765|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
33469795|NCT01421342|101611766|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
33469796|NCT01421342|101611767|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
33469797|NCT01421342|101611765|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
33469798|NCT01421342|101611766|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
33469799|NCT01421342|101611767|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
33469800|NCT01421342|101611765|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
33469801|NCT01421342|101611766|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
33469802|NCT01421342|101611767|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
33469803|NCT01421342|101611765|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
33469804|NCT01421342|101611766|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
33469805|NCT01421342|101611767|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
33469806|NCT01421342|101611765|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
33469807|NCT01421342|101611766|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
33469808|NCT01421342|101611767|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
33469809|NCT01421342|101611765|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
33469810|NCT01421342|101611766|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
33469811|NCT01421342|101611767|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
33469812|NCT01421342|101611765|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
33469813|NCT01421342|101611766|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
33469814|NCT01421342|101611767|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
33469815|NCT01421342|101611765|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
33180323|NCT00853723|100568342|FG002|Overall Study|Protocol Violation|1|||
33180324|NCT02141282|100568343|FG000|Overall Study|Adverse event, not related to progression|8|||
33180325|NCT02141282|100568344|FG001|Overall Study|Adverse event, not related to progression|1|||
33180326|NCT02141282|100568345|FG002|Overall Study|Adverse event, not related to progression|3|||
33180327|NCT02141282|100568346|FG003|Overall Study|Adverse event, not related to progression|1|||
33180328|NCT02141282|100568343|FG000|Overall Study|Adverse event, related to progression|1|||
33180329|NCT02141282|100568344|FG001|Overall Study|Adverse event, related to progression|0|||
33180330|NCT02141282|100568345|FG002|Overall Study|Adverse event, related to progression|2|||
33266310|NCT00824408|100873871|FG002|Run-in Phase|Progressive disease|0|||
33469816|NCT01421342|101611766|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
33469817|NCT01421342|101611767|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
33266311|NCT00824408|100873872|FG003|Run-in Phase|Progressive disease|0|||
33469818|NCT01421342|101611765|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
33469819|NCT01421342|101611766|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
33266312|NCT00824408|100873873|FG004|Run-in Phase|Progressive disease|0|||
33469820|NCT01421342|101611767|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
33469821|NCT01421342|101611765|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
33469822|NCT01421342|101611766|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
33266313|NCT00824408|100873869|FG000|Run-in Phase|Adverse Event|1|||
33469823|NCT01421342|101611767|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
33469824|NCT01421342|101611765|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
33469825|NCT01421342|101611766|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
33469826|NCT01421342|101611767|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
33469827|NCT01421342|101611765|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
33469828|NCT01421342|101611766|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
33469829|NCT01421342|101611767|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
33469830|NCT01421342|101611765|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
33180331|NCT02141282|100568346|FG003|Overall Study|Adverse event, related to progression|0|||
33180332|NCT02141282|100568343|FG000|Overall Study|COVID-19 infection|1|||
33180333|NCT02141282|100568344|FG001|Overall Study|COVID-19 infection|0|||
33180334|NCT02141282|100568345|FG002|Overall Study|COVID-19 infection|0|||
33180335|NCT02141282|100568346|FG003|Overall Study|COVID-19 infection|0|||
33180336|NCT02141282|100568343|FG000|Overall Study|Lost to Follow-up|0|||
33180337|NCT02141282|100568344|FG001|Overall Study|Lost to Follow-up|0|||
33180338|NCT02141282|100568345|FG002|Overall Study|Lost to Follow-up|4|||
33180339|NCT02141282|100568346|FG003|Overall Study|Lost to Follow-up|2|||
33180340|NCT02141282|100568343|FG000|Overall Study|Other, not specified|14|||
33180341|NCT02141282|100568344|FG001|Overall Study|Other, not specified|11|||
33180342|NCT02141282|100568345|FG002|Overall Study|Other, not specified|23|||
33180343|NCT02141282|100568346|FG003|Overall Study|Other, not specified|9|||
33180344|NCT02141282|100568343|FG000|Overall Study|Progressive disease, Richter's|4|||
33180345|NCT02141282|100568344|FG001|Overall Study|Progressive disease, Richter's|1|||
33180346|NCT02141282|100568345|FG002|Overall Study|Progressive disease, Richter's|1|||
33180347|NCT02141282|100568346|FG003|Overall Study|Progressive disease, Richter's|1|||
33180348|NCT02141282|100568343|FG000|Overall Study|Progressive disease per protocol|12|||
33180349|NCT02141282|100568344|FG001|Overall Study|Progressive disease per protocol|7|||
33180350|NCT02141282|100568345|FG002|Overall Study|Progressive disease per protocol|9|||
33180351|NCT02141282|100568346|FG003|Overall Study|Progressive disease per protocol|2|||
33180352|NCT02141282|100568343|FG000|Overall Study|Stem cell transplant|1|||
33180353|NCT02141282|100568344|FG001|Overall Study|Stem cell transplant|0|||
33180354|NCT02141282|100568345|FG002|Overall Study|Stem cell transplant|1|||
33180355|NCT02141282|100568346|FG003|Overall Study|Stem cell transplant|0|||
33180356|NCT02141282|100568343|FG000|Overall Study|Study terminated by Sponsor|0|||
33180357|NCT02141282|100568344|FG001|Overall Study|Study terminated by Sponsor|1|||
33180358|NCT02141282|100568345|FG002|Overall Study|Study terminated by Sponsor|0|||
33180359|NCT02141282|100568346|FG003|Overall Study|Study terminated by Sponsor|0|||
33469831|NCT01421342|101611766|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
33469832|NCT01421342|101611767|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
33180360|NCT02141282|100568343|FG000|Overall Study|Subject non-compliance|0|||
33180361|NCT02141282|100568344|FG001|Overall Study|Subject non-compliance|0|||
33180362|NCT02141282|100568345|FG002|Overall Study|Subject non-compliance|1|||
33180363|NCT02141282|100568346|FG003|Overall Study|Subject non-compliance|0|||
33180364|NCT02141282|100568343|FG000|Overall Study|Withdrew consent|2|||
33180365|NCT02141282|100568344|FG001|Overall Study|Withdrew consent|0|||
33180366|NCT02141282|100568345|FG002|Overall Study|Withdrew consent|4|||
33180367|NCT02141282|100568346|FG003|Overall Study|Withdrew consent|0|||
33180368|NCT00982488|100568348|FG000|Overall Study|Administrative reason by sponsor|81|||
33180369|NCT00982488|100568349|FG001|Overall Study|Administrative reason by sponsor|3|||
33180370|NCT00982488|100568350|FG002|Overall Study|Administrative reason by sponsor|11|||
33180371|NCT00982488|100568351|FG003|Overall Study|Administrative reason by sponsor|0|||
33180372|NCT00982488|100568352|FG004|Overall Study|Administrative reason by sponsor|0|||
33180373|NCT00982488|100568348|FG000|Overall Study|Adverse event unrelated to study drug|5|||
33180374|NCT00982488|100568349|FG001|Overall Study|Adverse event unrelated to study drug|1|||
33180375|NCT00982488|100568350|FG002|Overall Study|Adverse event unrelated to study drug|0|||
33180376|NCT00982488|100568351|FG003|Overall Study|Adverse event unrelated to study drug|0|||
33180377|NCT00982488|100568352|FG004|Overall Study|Adverse event unrelated to study drug|0|||
33180378|NCT00982488|100568348|FG000|Overall Study|Death|11|||
33180379|NCT00982488|100568349|FG001|Overall Study|Death|0|||
33180380|NCT00982488|100568350|FG002|Overall Study|Death|2|||
33180381|NCT00982488|100568351|FG003|Overall Study|Death|0|||
33180382|NCT00982488|100568352|FG004|Overall Study|Death|0|||
33180383|NCT00982488|100568348|FG000|Overall Study|Disease progression|30|||
33180384|NCT00982488|100568349|FG001|Overall Study|Disease progression|5|||
33180385|NCT00982488|100568350|FG002|Overall Study|Disease progression|10|||
33180386|NCT00982488|100568351|FG003|Overall Study|Disease progression|1|||
33180387|NCT00982488|100568352|FG004|Overall Study|Disease progression|1|||
33180388|NCT00982488|100568348|FG000|Overall Study|Lost to Follow-up|1|||
33180389|NCT00982488|100568349|FG001|Overall Study|Lost to Follow-up|0|||
33180390|NCT00982488|100568350|FG002|Overall Study|Lost to Follow-up|0|||
33180391|NCT00982488|100568351|FG003|Overall Study|Lost to Follow-up|0|||
33180392|NCT00982488|100568352|FG004|Overall Study|Lost to Follow-up|0|||
33180393|NCT00982488|100568348|FG000|Overall Study|Maximum clinical benefit|1|||
33180394|NCT00982488|100568349|FG001|Overall Study|Maximum clinical benefit|1|||
33180395|NCT00982488|100568350|FG002|Overall Study|Maximum clinical benefit|1|||
33180396|NCT00982488|100568351|FG003|Overall Study|Maximum clinical benefit|0|||
33180397|NCT00982488|100568352|FG004|Overall Study|Maximum clinical benefit|0|||
33180398|NCT00982488|100568348|FG000|Overall Study|Other|15|||
33180399|NCT00982488|100568349|FG001|Overall Study|Other|1|||
33180400|NCT00982488|100568350|FG002|Overall Study|Other|3|||
33180401|NCT00982488|100568351|FG003|Overall Study|Other|1|||
33180402|NCT00982488|100568352|FG004|Overall Study|Other|0|||
33180403|NCT00982488|100568348|FG000|Overall Study|Poor compliance/noncompliance|0|||
33180404|NCT00982488|100568349|FG001|Overall Study|Poor compliance/noncompliance|1|||
33180405|NCT00982488|100568350|FG002|Overall Study|Poor compliance/noncompliance|0|||
33180406|NCT00982488|100568351|FG003|Overall Study|Poor compliance/noncompliance|0|||
33180407|NCT00982488|100568352|FG004|Overall Study|Poor compliance/noncompliance|0|||
33180408|NCT00982488|100568348|FG000|Overall Study|Stem cell transplant|2|||
33180409|NCT00982488|100568349|FG001|Overall Study|Stem cell transplant|0|||
33180410|NCT00982488|100568350|FG002|Overall Study|Stem cell transplant|0|||
33180411|NCT00982488|100568351|FG003|Overall Study|Stem cell transplant|1|||
33469833|NCT01421342|101611765|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
33469834|NCT01421342|101611766|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
33469835|NCT01421342|101611767|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
33469836|NCT01421342|101611765|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
33469837|NCT01421342|101611766|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
33469838|NCT01421342|101611767|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
33469839|NCT01421342|101611765|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
33469840|NCT01421342|101611766|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
33469841|NCT01421342|101611767|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
33469842|NCT02780167|101611768|FG000|Overall Study|Adverse Event|9|||
33469843|NCT02780167|101611769|FG001|Overall Study|Adverse Event|8|||
33469844|NCT02780167|101611770|FG002|Overall Study|Adverse Event|8|||
33469845|NCT02780167|101611771|FG003|Overall Study|Adverse Event|12|||
33469846|NCT02780167|101611772|FG004|Overall Study|Adverse Event|8|||
33469847|NCT02780167|101611768|FG000|Overall Study|Lack of Efficacy|6|||
33469848|NCT02780167|101611769|FG001|Overall Study|Lack of Efficacy|5|||
33469849|NCT02780167|101611770|FG002|Overall Study|Lack of Efficacy|6|||
33469850|NCT02780167|101611771|FG003|Overall Study|Lack of Efficacy|1|||
33469851|NCT02780167|101611772|FG004|Overall Study|Lack of Efficacy|0|||
33469852|NCT02780167|101611768|FG000|Overall Study|Lost to Follow-up|2|||
33469853|NCT02780167|101611769|FG001|Overall Study|Lost to Follow-up|0|||
33469854|NCT02780167|101611770|FG002|Overall Study|Lost to Follow-up|1|||
33469855|NCT02780167|101611771|FG003|Overall Study|Lost to Follow-up|0|||
33469856|NCT02780167|101611772|FG004|Overall Study|Lost to Follow-up|0|||
33469857|NCT02780167|101611768|FG000|Overall Study|Does not meet entrance criteria|0|||
33469858|NCT02780167|101611769|FG001|Overall Study|Does not meet entrance criteria|0|||
33469859|NCT02780167|101611770|FG002|Overall Study|Does not meet entrance criteria|1|||
33469860|NCT02780167|101611771|FG003|Overall Study|Does not meet entrance criteria|0|||
33469861|NCT02780167|101611772|FG004|Overall Study|Does not meet entrance criteria|0|||
33469862|NCT02780167|101611768|FG000|Overall Study|No longer meets eligibility criteria|0|||
33469863|NCT02780167|101611769|FG001|Overall Study|No longer meets eligibility criteria|0|||
33469864|NCT02780167|101611770|FG002|Overall Study|No longer meets eligibility criteria|0|||
33469865|NCT02780167|101611771|FG003|Overall Study|No longer meets eligibility criteria|1|||
33469866|NCT02780167|101611772|FG004|Overall Study|No longer meets eligibility criteria|1|||
33469867|NCT02780167|101611768|FG000|Overall Study|Protocol Violation|5|||
33469868|NCT02780167|101611769|FG001|Overall Study|Protocol Violation|5|||
33469869|NCT02780167|101611770|FG002|Overall Study|Protocol Violation|1|||
33469870|NCT02780167|101611771|FG003|Overall Study|Protocol Violation|1|||
33469871|NCT02780167|101611772|FG004|Overall Study|Protocol Violation|2|||
33469872|NCT02780167|101611768|FG000|Overall Study|Withdrawal by Subject|6|||
33469873|NCT02780167|101611769|FG001|Overall Study|Withdrawal by Subject|4|||
33469874|NCT02780167|101611770|FG002|Overall Study|Withdrawal by Subject|4|||
33469875|NCT02780167|101611771|FG003|Overall Study|Withdrawal by Subject|3|||
33469876|NCT02780167|101611772|FG004|Overall Study|Withdrawal by Subject|4|||
33469877|NCT02780167|101611768|FG000|Overall Study|Other|0|||
33469878|NCT02780167|101611769|FG001|Overall Study|Other|0|||
33469879|NCT02780167|101611770|FG002|Overall Study|Other|3|||
33469880|NCT02780167|101611771|FG003|Overall Study|Other|1|||
33469881|NCT02780167|101611772|FG004|Overall Study|Other|2|||
33469882|NCT03197558|101611774|FG000|Overall Study|Tubes not placed|1|||
33469883|NCT02072824|101611775|FG000|Overall Study|Insufficient clinical response|1|||
33469884|NCT02072824|101611776|FG001|Overall Study|Insufficient clinical response|0|||
33469885|NCT02072824|101611777|FG002|Overall Study|Insufficient clinical response|1|||
33469886|NCT02072824|101611775|FG000|Overall Study|No longer willing to participate|1|||
33469887|NCT02072824|101611776|FG001|Overall Study|No longer willing to participate|0|||
33469888|NCT02072824|101611777|FG002|Overall Study|No longer willing to participate|1|||
33180412|NCT00982488|100568352|FG004|Overall Study|Stem cell transplant|0|||
33469889|NCT02072824|101611775|FG000|Overall Study|Medication error|0|||
33469890|NCT02072824|101611776|FG001|Overall Study|Medication error|1|||
33469891|NCT02072824|101611777|FG002|Overall Study|Medication error|0|||
33469892|NCT02072824|101611775|FG000|Overall Study|Adverse Event|0|||
33469893|NCT02072824|101611776|FG001|Overall Study|Adverse Event|0|||
33469894|NCT02072824|101611777|FG002|Overall Study|Adverse Event|1|||
33469895|NCT01641133|101611780|FG000|Overall Study|Protocol Violation|0|||
33469896|NCT01641133|101611781|FG001|Overall Study|Protocol Violation|1|||
33469897|NCT01641133|101611782|FG002|Overall Study|Protocol Violation|1|||
33469898|NCT01641133|101611780|FG000|Overall Study|Migrated/moved from study area|5|||
33469899|NCT01641133|101611781|FG001|Overall Study|Migrated/moved from study area|3|||
33469900|NCT01641133|101611782|FG002|Overall Study|Migrated/moved from study area|1|||
33469901|NCT01641133|101611780|FG000|Overall Study|Adverse Event|0|||
33469902|NCT01641133|101611781|FG001|Overall Study|Adverse Event|0|||
33469903|NCT01641133|101611782|FG002|Overall Study|Adverse Event|1|||
33469904|NCT01641133|101611780|FG000|Overall Study|Withdrawal by Subject|5|||
33469905|NCT01641133|101611781|FG001|Overall Study|Withdrawal by Subject|3|||
33469906|NCT01641133|101611782|FG002|Overall Study|Withdrawal by Subject|3|||
33469907|NCT01641133|101611780|FG000|Overall Study|Lost to Follow-up|0|||
33469908|NCT01641133|101611781|FG001|Overall Study|Lost to Follow-up|2|||
33469909|NCT01641133|101611782|FG002|Overall Study|Lost to Follow-up|2|||
33266314|NCT00824408|100873870|FG001|Run-in Phase|Adverse Event|1|||
33266315|NCT00824408|100873871|FG002|Run-in Phase|Adverse Event|0|||
33266316|NCT00824408|100873872|FG003|Run-in Phase|Adverse Event|0|||
33266317|NCT00824408|100873873|FG004|Run-in Phase|Adverse Event|0|||
33266318|NCT00824408|100873869|FG000|Run-in Phase|Refused to continue medication|1|||
33266319|NCT00824408|100873870|FG001|Run-in Phase|Refused to continue medication|0|||
33266320|NCT00824408|100873871|FG002|Run-in Phase|Refused to continue medication|0|||
33266321|NCT00824408|100873872|FG003|Run-in Phase|Refused to continue medication|0|||
33266322|NCT00824408|100873873|FG004|Run-in Phase|Refused to continue medication|0|||
33266323|NCT00824408|100873869|FG000|Run-in Phase|Other reason not defined above|0|||
33266324|NCT00824408|100873870|FG001|Run-in Phase|Other reason not defined above|1|||
33266325|NCT00824408|100873871|FG002|Run-in Phase|Other reason not defined above|0|||
33266326|NCT00824408|100873872|FG003|Run-in Phase|Other reason not defined above|0|||
33266327|NCT00824408|100873873|FG004|Run-in Phase|Other reason not defined above|0|||
33266328|NCT00824408|100873869|FG000|Randomized Phase|Not treated|0|||
33266329|NCT00824408|100873870|FG001|Randomized Phase|Not treated|0|||
33266330|NCT00824408|100873871|FG002|Randomized Phase|Not treated|1|||
33266331|NCT00824408|100873872|FG003|Randomized Phase|Not treated|1|||
33266332|NCT00824408|100873873|FG004|Randomized Phase|Not treated|1|||
33266333|NCT00824408|100873869|FG000|Randomized Phase|Progressive disease|0|||
33266334|NCT00824408|100873870|FG001|Randomized Phase|Progressive disease|0|||
33266335|NCT00824408|100873871|FG002|Randomized Phase|Progressive disease|25|||
33266336|NCT00824408|100873872|FG003|Randomized Phase|Progressive disease|36|||
33266337|NCT00824408|100873873|FG004|Randomized Phase|Progressive disease|34|||
33266338|NCT00824408|100873869|FG000|Randomized Phase|Adverse Event|0|||
33266339|NCT00824408|100873870|FG001|Randomized Phase|Adverse Event|0|||
33266340|NCT00824408|100873871|FG002|Randomized Phase|Adverse Event|4|||
33266341|NCT00824408|100873872|FG003|Randomized Phase|Adverse Event|5|||
33469910|NCT00925301|101611785|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
33469911|NCT00925301|101611786|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
33469912|NCT00925301|101611787|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
33469913|NCT00925301|101611788|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
33180413|NCT00982488|100568348|FG000|Overall Study|Study drug toxicity|34|||
33180414|NCT00982488|100568349|FG001|Overall Study|Study drug toxicity|1|||
33180415|NCT00982488|100568350|FG002|Overall Study|Study drug toxicity|6|||
33180416|NCT00982488|100568351|FG003|Overall Study|Study drug toxicity|0|||
33180417|NCT00982488|100568352|FG004|Overall Study|Study drug toxicity|0|||
33180418|NCT00982488|100568348|FG000|Overall Study|Withdrawal by Subject|5|||
33180419|NCT00982488|100568349|FG001|Overall Study|Withdrawal by Subject|1|||
33180420|NCT00982488|100568350|FG002|Overall Study|Withdrawal by Subject|1|||
33180421|NCT00982488|100568351|FG003|Overall Study|Withdrawal by Subject|0|||
33180422|NCT00982488|100568352|FG004|Overall Study|Withdrawal by Subject|0|||
33180423|NCT00768144|100568353|FG000|Overall Study|Adverse Event|13|||
33180424|NCT00768144|100568353|FG000|Overall Study|Progressive Disease|21|||
33180425|NCT00768144|100568353|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
33180426|NCT00768144|100568353|FG000|Overall Study|Pt Withdrew Consent|1|||
33180427|NCT01955161|100568354|FG000|Overall Study|Withdrawal before treatment|2|||
33180428|NCT01955161|100568355|FG001|Overall Study|Withdrawal before treatment|0|||
33180429|NCT01955161|100568356|FG002|Overall Study|Withdrawal before treatment|1|||
33180430|NCT01955161|100568354|FG000|Overall Study|Adverse Event|10|||
33180431|NCT01955161|100568355|FG001|Overall Study|Adverse Event|14|||
33180432|NCT01955161|100568356|FG002|Overall Study|Adverse Event|15|||
33266342|NCT00824408|100873873|FG004|Randomized Phase|Adverse Event|5|||
33469914|NCT00925301|101611785|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
33469915|NCT00925301|101611786|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
33469916|NCT00925301|101611787|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
33469917|NCT00925301|101611788|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
33469918|NCT00925301|101611785|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
33469919|NCT00925301|101611786|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
33469920|NCT00925301|101611787|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
33469921|NCT00925301|101611788|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
33469922|NCT00925301|101611785|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
33469923|NCT00925301|101611786|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
33469924|NCT00925301|101611787|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
33469925|NCT00925301|101611788|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
33469926|NCT00925301|101611785|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
33469927|NCT00925301|101611786|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
33469928|NCT00925301|101611787|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
33469929|NCT00925301|101611788|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
33469930|NCT00925301|101611785|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
33469931|NCT00925301|101611786|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
33469932|NCT00925301|101611787|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
33469933|NCT00925301|101611788|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
33469934|NCT00925301|101611785|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
33469935|NCT00925301|101611786|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
33469936|NCT00925301|101611787|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
33469937|NCT00925301|101611788|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
33469938|NCT01370213|101611792|FG000|Overall Study|Early Death|1|||
33469939|NCT01370213|101611793|FG001|Overall Study|Early Death|0|||
33469940|NCT01370213|101611794|FG002|Overall Study|Early Death|0|||
33469941|NCT01370213|101611792|FG000|Overall Study|Not evaluable|0|||
33469942|NCT01370213|101611793|FG001|Overall Study|Not evaluable|2|||
33469943|NCT01370213|101611794|FG002|Overall Study|Not evaluable|0|||
33469944|NCT00355472|101611797|FG000|Overall Study|Physician Decision|1|||
33469945|NCT03545191|101611798|FG000|Overall Study|Death|1|||
33469946|NCT03545191|101611799|FG001|Overall Study|Death|0|||
33469947|NCT03545191|101611800|FG002|Overall Study|Death|0|||
33469948|NCT03545191|101611798|FG000|Overall Study|Adverse Event|4|||
33469949|NCT03545191|101611799|FG001|Overall Study|Adverse Event|2|||
33469950|NCT03545191|101611800|FG002|Overall Study|Adverse Event|7|||
33469951|NCT03545191|101611798|FG000|Overall Study|Other reasons|3|||
33469952|NCT03545191|101611799|FG001|Overall Study|Other reasons|11|||
33469953|NCT03545191|101611800|FG002|Overall Study|Other reasons|8|||
33469954|NCT03545191|101611798|FG000|Overall Study|Withdrawal by Subject|13|||
33469955|NCT03545191|101611799|FG001|Overall Study|Withdrawal by Subject|10|||
33469956|NCT03545191|101611800|FG002|Overall Study|Withdrawal by Subject|12|||
33469957|NCT03545191|101611798|FG000|Overall Study|Lost to Follow-up|1|||
33469958|NCT03545191|101611799|FG001|Overall Study|Lost to Follow-up|2|||
33469959|NCT03545191|101611800|FG002|Overall Study|Lost to Follow-up|3|||
33469960|NCT00912093|101611803|FG000|The Controlled Phase|Death|0|||
33469961|NCT00912093|101611804|FG001|The Controlled Phase|Death|1|||
33469962|NCT00912093|101611805|FG002|The Controlled Phase|Death|0|||
33469963|NCT00912093|101611806|FG003|The Controlled Phase|Death|0|||
33469964|NCT00912093|101611807|FG004|The Controlled Phase|Death|0|||
33469965|NCT00912093|101611803|FG000|The Controlled Phase|Medical Condition|0|||
33469966|NCT00912093|101611804|FG001|The Controlled Phase|Medical Condition|1|||
33469967|NCT00912093|101611805|FG002|The Controlled Phase|Medical Condition|0|||
33469968|NCT00912093|101611806|FG003|The Controlled Phase|Medical Condition|0|||
33469969|NCT00912093|101611807|FG004|The Controlled Phase|Medical Condition|0|||
33469970|NCT00912093|101611803|FG000|The Controlled Phase|Lost to Follow-up|0|||
33469971|NCT00912093|101611804|FG001|The Controlled Phase|Lost to Follow-up|0|||
33469972|NCT00912093|101611805|FG002|The Controlled Phase|Lost to Follow-up|0|||
33469973|NCT00912093|101611806|FG003|The Controlled Phase|Lost to Follow-up|0|||
33469974|NCT00912093|101611807|FG004|The Controlled Phase|Lost to Follow-up|1|||
33469975|NCT00059787|101611808|FG000|Overall Study|Adverse Event|13|||
33469976|NCT00059787|101611808|FG000|Overall Study|disease progression|2|||
33469977|NCT00059787|101611808|FG000|Overall Study|ineligible|1|||
33469978|NCT00059787|101611808|FG000|Overall Study|Other|4|||
33469979|NCT03656874|101611809|FG000|Overall Study|Lost to Follow-up|3|||
33469980|NCT03656874|101611810|FG001|Overall Study|Lost to Follow-up|17|||
33469981|NCT03487848|101611818|FG000|Overall Study|Lost to Follow-up|1|||
33469982|NCT03438227|101611819|FG000|Overall Study|Withdrawal by Subject|10|||
33469983|NCT03438227|101611820|FG001|Overall Study|Withdrawal by Subject|5|||
33469984|NCT01901874|101611822|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
33469985|NCT01901874|101611822|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
33469986|NCT01901874|101611822|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
33469987|NCT01901874|101611822|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
33180433|NCT01955161|100568354|FG000|Overall Study|Death|1|||
33180434|NCT01955161|100568355|FG001|Overall Study|Death|1|||
33180435|NCT01955161|100568356|FG002|Overall Study|Death|3|||
33469988|NCT01901874|101611822|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
33469989|NCT01901874|101611822|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
33469990|NCT01194973|101611823|FG000|Screening Period|Screen Failure|3|||
33469991|NCT01194973|101611823|FG000|26 Week Treatment Period|Adverse Event|1|||
33469992|NCT01194973|101611823|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
33469993|NCT01194973|101611823|FG000|26 Week Treatment Period|Pregnancy|1|||
33469994|NCT01534637|101611824|FG000|Overall Study|Physician Decision|3|||
33469995|NCT01534637|101611824|FG000|Overall Study|Lack of Efficacy|3|||
33469996|NCT01534637|101611824|FG000|Overall Study|Withdrawal by Subject|1|||
33469997|NCT01534637|101611824|FG000|Overall Study|Adverse Event|1|||
33469998|NCT01534637|101611824|FG000|Overall Study|Liver Mets before treatment|1|||
33469999|NCT02100319|101611825|FG000|Overall Study|Case Report Forms Uncollected|11|||
33470000|NCT02100319|101611825|FG000|Overall Study|Protocol Deviation|5|||
33470001|NCT00446199|101611826|FG000|Overall Study|Adverse Event|7|||
33470002|NCT00446199|101611827|FG001|Overall Study|Adverse Event|4|||
33470003|NCT00446199|101611828|FG002|Overall Study|Adverse Event|6|||
33470004|NCT00446199|101611829|FG003|Overall Study|Adverse Event|4|||
33470005|NCT00446199|101611826|FG000|Overall Study|Lost to Follow-up|4|||
33470006|NCT00446199|101611827|FG001|Overall Study|Lost to Follow-up|5|||
33470007|NCT00446199|101611828|FG002|Overall Study|Lost to Follow-up|2|||
33470008|NCT00446199|101611829|FG003|Overall Study|Lost to Follow-up|6|||
33470009|NCT00446199|101611826|FG000|Overall Study|Protocol Violation|1|||
33470010|NCT00446199|101611827|FG001|Overall Study|Protocol Violation|2|||
33470011|NCT00446199|101611828|FG002|Overall Study|Protocol Violation|1|||
33470012|NCT00446199|101611829|FG003|Overall Study|Protocol Violation|3|||
33470013|NCT00446199|101611826|FG000|Overall Study|Withdrawal by Subject|2|||
33470014|NCT00446199|101611827|FG001|Overall Study|Withdrawal by Subject|5|||
33470015|NCT00446199|101611828|FG002|Overall Study|Withdrawal by Subject|9|||
33470016|NCT00446199|101611829|FG003|Overall Study|Withdrawal by Subject|10|||
33470017|NCT00446199|101611826|FG000|Overall Study|Site termination|2|||
33470018|NCT00446199|101611827|FG001|Overall Study|Site termination|0|||
33470019|NCT00446199|101611828|FG002|Overall Study|Site termination|0|||
33470020|NCT00446199|101611829|FG003|Overall Study|Site termination|1|||
33470021|NCT00446199|101611826|FG000|Overall Study|Randomization in Error|2|||
33470022|NCT00446199|101611827|FG001|Overall Study|Randomization in Error|0|||
33470023|NCT00446199|101611828|FG002|Overall Study|Randomization in Error|1|||
33470024|NCT00446199|101611829|FG003|Overall Study|Randomization in Error|1|||
33470025|NCT00446199|101611826|FG000|Overall Study|Lack of Efficacy|1|||
33470026|NCT00446199|101611827|FG001|Overall Study|Lack of Efficacy|0|||
33470027|NCT00446199|101611828|FG002|Overall Study|Lack of Efficacy|0|||
33470028|NCT00446199|101611829|FG003|Overall Study|Lack of Efficacy|1|||
33470029|NCT00446199|101611826|FG000|Overall Study|Non-compliant with study drug|1|||
33470030|NCT00446199|101611827|FG001|Overall Study|Non-compliant with study drug|0|||
33470031|NCT00446199|101611828|FG002|Overall Study|Non-compliant with study drug|5|||
33470032|NCT00446199|101611829|FG003|Overall Study|Non-compliant with study drug|0|||
33470033|NCT00446199|101611826|FG000|Overall Study|Non-compliant with visit schedule|1|||
33470034|NCT00446199|101611827|FG001|Overall Study|Non-compliant with visit schedule|1|||
33470035|NCT00446199|101611828|FG002|Overall Study|Non-compliant with visit schedule|1|||
33470036|NCT00446199|101611829|FG003|Overall Study|Non-compliant with visit schedule|2|||
33470037|NCT00446199|101611826|FG000|Overall Study|Hormone fear|0|||
33470038|NCT00446199|101611827|FG001|Overall Study|Hormone fear|0|||
33470039|NCT00446199|101611828|FG002|Overall Study|Hormone fear|0|||
33470040|NCT00446199|101611829|FG003|Overall Study|Hormone fear|1|||
33470041|NCT00446199|101611826|FG000|Overall Study|Lost interest in study participation|0|||
33470042|NCT00446199|101611827|FG001|Overall Study|Lost interest in study participation|1|||
33470043|NCT00446199|101611828|FG002|Overall Study|Lost interest in study participation|0|||
33470044|NCT00446199|101611829|FG003|Overall Study|Lost interest in study participation|0|||
33470045|NCT00446199|101611826|FG000|Overall Study|In-/Exclusion criterion violated|2|||
33470046|NCT00446199|101611827|FG001|Overall Study|In-/Exclusion criterion violated|1|||
33470047|NCT00446199|101611828|FG002|Overall Study|In-/Exclusion criterion violated|2|||
33470048|NCT00446199|101611829|FG003|Overall Study|In-/Exclusion criterion violated|1|||
33470049|NCT00446199|101611826|FG000|Overall Study|Move|0|||
33470050|NCT00446199|101611827|FG001|Overall Study|Move|1|||
33470051|NCT00446199|101611828|FG002|Overall Study|Move|0|||
33470052|NCT00446199|101611829|FG003|Overall Study|Move|0|||
33470053|NCT03227224|101611830|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
33470054|NCT03227224|101611831|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
33470055|NCT03227224|101611832|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
33470056|NCT03227224|101611833|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
33470057|NCT03227224|101611830|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
33470058|NCT03227224|101611831|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
33470059|NCT03227224|101611832|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
33470060|NCT03227224|101611833|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
33470061|NCT03227224|101611830|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
33470062|NCT03227224|101611831|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
33470063|NCT03227224|101611832|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
33470064|NCT03227224|101611833|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
33470065|NCT03227224|101611830|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
33470066|NCT03227224|101611831|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33470067|NCT03227224|101611832|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33470068|NCT03227224|101611833|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
33470069|NCT03227224|101611830|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
33470070|NCT03227224|101611831|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
33470071|NCT03227224|101611832|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
33470072|NCT03227224|101611833|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
33470073|NCT03227224|101611830|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
33470074|NCT03227224|101611831|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
33266343|NCT00824408|100873869|FG000|Randomized Phase|Refused to continue medication|0|||
33470075|NCT03227224|101611832|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
33470076|NCT03227224|101611833|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
33470077|NCT03227224|101611830|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
33470078|NCT03227224|101611831|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
33470079|NCT03227224|101611832|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
33470080|NCT03227224|101611833|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
33470081|NCT03227224|101611830|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
33470082|NCT03227224|101611831|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
33470083|NCT03227224|101611832|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
33470084|NCT03227224|101611833|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
33470085|NCT03227224|101611830|FG000|Follow-up Phase (2 Weeks)|Other|4|||
33470086|NCT03227224|101611831|FG001|Follow-up Phase (2 Weeks)|Other|4|||
33470087|NCT03227224|101611832|FG002|Follow-up Phase (2 Weeks)|Other|6|||
33470088|NCT03227224|101611833|FG003|Follow-up Phase (2 Weeks)|Other|3|||
33470089|NCT03064438|101611834|FG000|Overall Study|Lost to Follow-up|1|||
33470090|NCT03064438|101611835|FG001|Overall Study|Lost to Follow-up|0|||
33470091|NCT03064438|101611834|FG000|Overall Study|Withdrawal by Subject|0|||
33470092|NCT03064438|101611835|FG001|Overall Study|Withdrawal by Subject|1|||
33470093|NCT01475253|101611836|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
33470094|NCT01475253|101611837|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
33470095|NCT01475253|101611838|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
33470096|NCT01475253|101611839|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
33470097|NCT01475253|101611836|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
33470098|NCT01475253|101611837|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
33470099|NCT01475253|101611838|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
33470100|NCT01475253|101611839|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
33470101|NCT01843348|101611840|FG000|Overall Study|Withdrawal by Subject|4|||
33470102|NCT01843348|101611841|FG001|Overall Study|Withdrawal by Subject|16|||
33470103|NCT01843348|101611842|FG002|Overall Study|Withdrawal by Subject|18|||
33470104|NCT01843348|101611840|FG000|Overall Study|Lost to Follow-up|5|||
33470105|NCT01843348|101611841|FG001|Overall Study|Lost to Follow-up|4|||
33470106|NCT01843348|101611842|FG002|Overall Study|Lost to Follow-up|2|||
33470107|NCT01843348|101611840|FG000|Overall Study|Death|5|||
33470108|NCT01843348|101611841|FG001|Overall Study|Death|3|||
33470109|NCT01843348|101611842|FG002|Overall Study|Death|4|||
33470110|NCT01843348|101611840|FG000|Overall Study|Graft loss/retransplantation|5|||
33470111|NCT01843348|101611841|FG001|Overall Study|Graft loss/retransplantation|8|||
33470112|NCT01843348|101611842|FG002|Overall Study|Graft loss/retransplantation|11|||
33470113|NCT01843348|101611840|FG000|Overall Study|Various reasons|4|||
33470114|NCT01843348|101611841|FG001|Overall Study|Various reasons|9|||
33470115|NCT01843348|101611842|FG002|Overall Study|Various reasons|6|||
33470116|NCT00293202|101611851|FG000|Overall Study|Withdrawal by Subject|1|||
33470117|NCT00293202|101611852|FG001|Overall Study|Withdrawal by Subject|2|||
33470118|NCT00293202|101611851|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
33470119|NCT00293202|101611852|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
33470120|NCT00293202|101611851|FG000|Overall Study|on-hold due to fistula maturation time|1|||
33266344|NCT00824408|100873870|FG001|Randomized Phase|Refused to continue medication|0|||
33470121|NCT00293202|101611852|FG001|Overall Study|on-hold due to fistula maturation time|0|||
33470122|NCT01079832|101611854|FG000|Overall Study|Withdrawal by Subject|1|||
33470123|NCT01382251|101611861|FG000|Overall Study|Surgeries cancelled or delayed|16|||
33470124|NCT01382251|101611862|FG001|Overall Study|Surgeries cancelled or delayed|16|||
33180436|NCT01955161|100568354|FG000|Overall Study|Withdrawal by Subject|9|||
33470125|NCT01382251|101611861|FG000|Overall Study|Lost to Follow-up|4|||
33470126|NCT01382251|101611862|FG001|Overall Study|Lost to Follow-up|4|||
33470127|NCT01382251|101611861|FG000|Overall Study|Contacted after study closed|1|||
33470128|NCT01382251|101611862|FG001|Overall Study|Contacted after study closed|1|||
33180437|NCT01955161|100568355|FG001|Overall Study|Withdrawal by Subject|8|||
33180438|NCT01955161|100568356|FG002|Overall Study|Withdrawal by Subject|12|||
33180439|NCT01955161|100568354|FG000|Overall Study|Protocol Violation|2|||
33470129|NCT01846273|101611863|FG000|Overall Study|Adverse Event|9|||
33470130|NCT01846273|101611864|FG001|Overall Study|Adverse Event|7|||
33470131|NCT01846273|101611865|FG002|Overall Study|Adverse Event|0|||
33470132|NCT01846273|101611863|FG000|Overall Study|Subject withdrew consent|5|||
33470133|NCT01846273|101611864|FG001|Overall Study|Subject withdrew consent|8|||
33470134|NCT01846273|101611865|FG002|Overall Study|Subject withdrew consent|0|||
33470135|NCT01846273|101611863|FG000|Overall Study|Lost to Follow-up|2|||
33470136|NCT01846273|101611864|FG001|Overall Study|Lost to Follow-up|1|||
33470137|NCT01846273|101611865|FG002|Overall Study|Lost to Follow-up|0|||
33470138|NCT01846273|101611863|FG000|Overall Study|Administrative problems|1|||
33470139|NCT01846273|101611864|FG001|Overall Study|Administrative problems|0|||
33470140|NCT01846273|101611865|FG002|Overall Study|Administrative problems|0|||
33180440|NCT01955161|100568355|FG001|Overall Study|Protocol Violation|0|||
33180441|NCT01955161|100568356|FG002|Overall Study|Protocol Violation|0|||
33180442|NCT01955161|100568354|FG000|Overall Study|Other reason: physician decision|0|||
33180443|NCT01955161|100568355|FG001|Overall Study|Other reason: physician decision|1|||
33180444|NCT01955161|100568356|FG002|Overall Study|Other reason: physician decision|1|||
33180445|NCT01955161|100568354|FG000|Overall Study|Other reason: disallowed medication|1|||
33180446|NCT01955161|100568355|FG001|Overall Study|Other reason: disallowed medication|0|||
33180447|NCT01955161|100568356|FG002|Overall Study|Other reason: disallowed medication|1|||
33180448|NCT01955161|100568354|FG000|Overall Study|Other reason: caregiver unavailable|1|||
33180449|NCT01955161|100568355|FG001|Overall Study|Other reason: caregiver unavailable|0|||
33180450|NCT01955161|100568356|FG002|Overall Study|Other reason: caregiver unavailable|0|||
33180451|NCT01955161|100568354|FG000|Overall Study|Other reason: moved to nursing home|0|||
33180452|NCT01955161|100568355|FG001|Overall Study|Other reason: moved to nursing home|1|||
33180453|NCT01955161|100568356|FG002|Overall Study|Other reason: moved to nursing home|0|||
33180454|NCT01955161|100568354|FG000|Overall Study|Other reason: insufficient compliance|0|||
33180455|NCT01955161|100568355|FG001|Overall Study|Other reason: insufficient compliance|0|||
33180456|NCT01955161|100568356|FG002|Overall Study|Other reason: insufficient compliance|1|||
33180457|NCT01955161|100568354|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
33180458|NCT01955161|100568355|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
33180459|NCT01955161|100568356|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
33180460|NCT01955161|100568354|FG000|Overall Study|Other reason: patient's will|0|||
33180461|NCT01955161|100568355|FG001|Overall Study|Other reason: patient's will|0|||
33180462|NCT01955161|100568356|FG002|Overall Study|Other reason: patient's will|1|||
33180463|NCT04984993|100568364|FG000|Overall Study|Withdrawal by Subject|8|||
33180464|NCT04984993|100568365|FG001|Overall Study|Withdrawal by Subject|2|||
33180465|NCT04984993|100568364|FG000|Overall Study|Lost to Follow-up|2|||
33180466|NCT04984993|100568365|FG001|Overall Study|Lost to Follow-up|2|||
33180467|NCT04984993|100568364|FG000|Overall Study|Both patients moved to another country|4|||
33470141|NCT01846273|101611863|FG000|Overall Study|Death|2|||
33470142|NCT01846273|101611864|FG001|Overall Study|Death|1|||
33470143|NCT01846273|101611865|FG002|Overall Study|Death|0|||
33180468|NCT04984993|100568365|FG001|Overall Study|Both patients moved to another country|0|||
33180469|NCT03724812|100568366|FG000|Overall Study|Missed Visit|1|||
33470144|NCT01846273|101611863|FG000|Overall Study|Disease Progression|0|||
33470145|NCT01846273|101611864|FG001|Overall Study|Disease Progression|4|||
33470146|NCT01846273|101611865|FG002|Overall Study|Disease Progression|0|||
33470147|NCT01846273|101611863|FG000|Overall Study|Protocol Deviation|2|||
33470148|NCT01846273|101611864|FG001|Overall Study|Protocol Deviation|3|||
33470149|NCT01846273|101611865|FG002|Overall Study|Protocol Deviation|0|||
33470150|NCT01846273|101611863|FG000|Overall Study|Physician Decision|1|||
33470151|NCT01846273|101611864|FG001|Overall Study|Physician Decision|2|||
33470152|NCT01846273|101611865|FG002|Overall Study|Physician Decision|0|||
33470153|NCT01157897|101611866|FG000|Overall Study|Lost to Follow-up|2|||
33470154|NCT01157897|101611867|FG001|Overall Study|Lost to Follow-up|0|||
33470155|NCT01157897|101611868|FG002|Overall Study|Lost to Follow-up|0|||
33180470|NCT03724812|100568366|FG000|Overall Study|Death|2|||
33180471|NCT03724812|100568366|FG000|Overall Study|Withdrawal by Subject|1|||
33180472|NCT02009046|100568369|FG000|Overall Study|Lost to Follow-up|256|||
33180473|NCT02009046|100568370|FG001|Overall Study|Lost to Follow-up|206|||
33180474|NCT01466387|100568371|FG000|Overall Study|Adverse Event|0|||
33180475|NCT01466387|100568372|FG001|Overall Study|Adverse Event|0|||
33180476|NCT01466387|100568373|FG002|Overall Study|Adverse Event|1|||
33266345|NCT00824408|100873871|FG002|Randomized Phase|Refused to continue medication|2|||
33470156|NCT01157897|101611869|FG003|Overall Study|Lost to Follow-up|1|||
33470157|NCT01157897|101611866|FG000|Overall Study|Relocated|0|||
33470158|NCT01157897|101611867|FG001|Overall Study|Relocated|2|||
33470159|NCT01157897|101611868|FG002|Overall Study|Relocated|0|||
33470160|NCT01157897|101611869|FG003|Overall Study|Relocated|0|||
33470161|NCT03827564|101611872|FG000|Overall Study|Discontinued due to Study Termination|1|||
33470162|NCT03827564|101611873|FG001|Overall Study|Discontinued due to Study Termination|0|||
33470163|NCT01301508|101611875|FG000|Overall Study|Withdrawal by Subject|1|||
33470164|NCT01301508|101611876|FG001|Overall Study|Withdrawal by Subject|2|||
33470165|NCT01301508|101611875|FG000|Overall Study|Lost to Follow-up|0|||
33470166|NCT01301508|101611876|FG001|Overall Study|Lost to Follow-up|1|||
33470167|NCT02865395|101611879|FG000|Overall Study|Physician Decision|6|||
33470168|NCT02865395|101611880|FG001|Overall Study|Physician Decision|10|||
33470169|NCT02865395|101611881|FG002|Overall Study|Physician Decision|7|||
33470170|NCT02224573|101611884|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
33470171|NCT02224573|101611885|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
33470172|NCT02224573|101611884|FG000|Treatment Phase|Started on Other IMP|1|||
33470173|NCT02224573|101611885|FG001|Treatment Phase|Started on Other IMP|0|||
33470174|NCT02224573|101611884|FG000|Treatment Phase|Participant Discontinued IMP|0|||
33470175|NCT02224573|101611885|FG001|Treatment Phase|Participant Discontinued IMP|1|||
33470176|NCT02224573|101611884|FG000|Treatment Phase|Lack of Efficacy|15|||
33470177|NCT02224573|101611885|FG001|Treatment Phase|Lack of Efficacy|8|||
33470178|NCT02224573|101611884|FG000|Treatment Phase|Began Commercial Product|1|||
33470179|NCT02224573|101611885|FG001|Treatment Phase|Began Commercial Product|0|||
33470180|NCT02224573|101611884|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
33470181|NCT02224573|101611885|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
33470182|NCT02224573|101611884|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
33470183|NCT02224573|101611885|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
33470184|NCT02224573|101611884|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
33470185|NCT02224573|101611885|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
33470186|NCT02224573|101611884|FG000|Treatment Phase|Continued Compassionate Use|1|||
33470187|NCT02224573|101611885|FG001|Treatment Phase|Continued Compassionate Use|0|||
33470188|NCT02224573|101611884|FG000|Treatment Phase|Lack of Efficiency|2|||
33470189|NCT02224573|101611885|FG001|Treatment Phase|Lack of Efficiency|1|||
33470190|NCT02224573|101611884|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
33470191|NCT02224573|101611885|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
33470192|NCT02224573|101611884|FG000|Treatment Phase|Participant Moved|2|||
33470193|NCT02224573|101611885|FG001|Treatment Phase|Participant Moved|0|||
33470194|NCT02224573|101611884|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
33470195|NCT02224573|101611885|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
33470196|NCT02224573|101611884|FG000|Treatment Phase|Refused Medication|1|||
33470197|NCT02224573|101611885|FG001|Treatment Phase|Refused Medication|1|||
33470198|NCT02224573|101611884|FG000|Treatment Phase|Adverse Event|26|||
33470199|NCT02224573|101611885|FG001|Treatment Phase|Adverse Event|38|||
33470200|NCT02224573|101611884|FG000|Treatment Phase|Placed in Group Home|0|||
33470201|NCT02224573|101611885|FG001|Treatment Phase|Placed in Group Home|1|||
33470202|NCT02224573|101611884|FG000|Treatment Phase|Pursued Other Trials|1|||
33470203|NCT02224573|101611885|FG001|Treatment Phase|Pursued Other Trials|0|||
33470204|NCT02224573|101611884|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
33470205|NCT02224573|101611885|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
33470206|NCT02224573|101611884|FG000|Treatment Phase|Lost to Follow-up|2|||
33470207|NCT02224573|101611885|FG001|Treatment Phase|Lost to Follow-up|1|||
33470208|NCT02224573|101611884|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
33470209|NCT02224573|101611885|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
33470210|NCT02224573|101611884|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
33470211|NCT02224573|101611885|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
33470212|NCT02224573|101611884|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
33470213|NCT02224573|101611885|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
33470214|NCT02224573|101611884|FG000|Taper Phase|Adverse Event|1|||
33470215|NCT02224573|101611885|FG001|Taper Phase|Adverse Event|1|||
33470216|NCT01000493|101611886|FG000|Overall Study|Adverse Event|3|||
33470217|NCT01000493|101611887|FG001|Overall Study|Adverse Event|6|||
33470218|NCT01000493|101611886|FG000|Overall Study|Lack of Efficacy|1|||
33470219|NCT01000493|101611887|FG001|Overall Study|Lack of Efficacy|1|||
33470220|NCT01000493|101611886|FG000|Overall Study|Protocol Violation|1|||
33470221|NCT01000493|101611887|FG001|Overall Study|Protocol Violation|8|||
33470222|NCT01000493|101611886|FG000|Overall Study|Study closed/terminated|25|||
33470223|NCT01000493|101611887|FG001|Overall Study|Study closed/terminated|23|||
33470224|NCT01000493|101611886|FG000|Overall Study|Lost to Follow-up|5|||
33470225|NCT01000493|101611887|FG001|Overall Study|Lost to Follow-up|9|||
33470226|NCT01000493|101611886|FG000|Overall Study|Physician Decision|1|||
33470227|NCT01000493|101611887|FG001|Overall Study|Physician Decision|1|||
33470228|NCT01000493|101611886|FG000|Overall Study|Withdrawal by Subject|3|||
33180477|NCT01466387|100568374|FG003|Overall Study|Adverse Event|1|||
33180478|NCT01466387|100568375|FG004|Overall Study|Adverse Event|0|||
33180479|NCT01466387|100568376|FG005|Overall Study|Adverse Event|0|||
33180480|NCT01466387|100568371|FG000|Overall Study|Lost to Follow-up|0|||
33470229|NCT01000493|101611887|FG001|Overall Study|Withdrawal by Subject|7|||
33470230|NCT01299805|101611888|FG000|Overall Study|Adverse Event|2|||
33470231|NCT01299805|101611889|FG001|Overall Study|Adverse Event|0|||
33470232|NCT01117337|101611892|FG000|Overall Study|Lost to Follow-up|4|||
33470233|NCT01117337|101611893|FG001|Overall Study|Lost to Follow-up|0|||
33470234|NCT00995085|101611896|FG000|Overall Study|Withdrawal by Subject|5|||
33470235|NCT00754013|101611903|FG000|Overall Study|Lost to Follow-up|1|||
33470236|NCT00754013|101611904|FG001|Overall Study|Lost to Follow-up|1|||
33470237|NCT00754013|101611903|FG000|Overall Study|didn't return after study termed|3|||
33470238|NCT00754013|101611904|FG001|Overall Study|didn't return after study termed|4|||
33470239|NCT01124695|101611905|FG000|Overall Study|Disease progression|77|||
33470240|NCT01124695|101611905|FG000|Overall Study|Adverse Event|11|||
33470241|NCT01124695|101611905|FG000|Overall Study|Death|1|||
33470242|NCT01124695|101611905|FG000|Overall Study|Withdrawal by Subject|7|||
33470243|NCT01124695|101611905|FG000|Overall Study|Physician Decision|3|||
33470244|NCT01124695|101611905|FG000|Overall Study|Alternative therapy|9|||
33470245|NCT01124695|101611905|FG000|Overall Study|No documentation that patient went off treatment|4|||
33470246|NCT01124695|101611905|FG000|Overall Study|Ineligible|9|||
33470247|NCT01124695|101611905|FG000|Overall Study|Ineligible and never start treatment|2|||
33470248|NCT02039414|101611906|FG000|Overall Study|Delivered|1|||
33470249|NCT02039414|101611907|FG001|Overall Study|Delivered|1|||
33470250|NCT02039414|101611906|FG000|Overall Study|Lost to Follow-up|2|||
33470251|NCT02039414|101611907|FG001|Overall Study|Lost to Follow-up|0|||
33470252|NCT02039414|101611906|FG000|Overall Study|Protocol Violation|3|||
33470253|NCT02039414|101611907|FG001|Overall Study|Protocol Violation|1|||
33470254|NCT00831623|101611908|FG000|Overall Study|Withdrawal by Subject|9|||
33470255|NCT00831623|101611908|FG000|Overall Study|Lost to Follow-up|1|||
33470256|NCT00831623|101611908|FG000|Overall Study|Not 2 years post-treatment|12|||
33470257|NCT01408563|101611910|FG000|Overall Study|Ineligible after consent/ registration|2|||
33470258|NCT04969861|101611913|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
33470259|NCT04969861|101611914|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
33470260|NCT02522403|101611915|FG000|Overall Study|Lost to Follow-up|2|||
33470261|NCT02522403|101611916|FG001|Overall Study|Lost to Follow-up|2|||
33470262|NCT02522403|101611915|FG000|Overall Study|Withdrawal by Subject|2|||
33470263|NCT02522403|101611916|FG001|Overall Study|Withdrawal by Subject|4|||
33470264|NCT02080832|101611919|FG000|Overall Study|Excluded from analysis by MRI|9|||
33470265|NCT02080832|101611920|FG001|Overall Study|Excluded from analysis by MRI|10|||
33470266|NCT02080832|101611921|FG002|Overall Study|Excluded from analysis by MRI|14|||
33470267|NCT02080832|101611919|FG000|Overall Study|Lost to Follow-up|0|||
33470268|NCT02080832|101611920|FG001|Overall Study|Lost to Follow-up|2|||
33470269|NCT02080832|101611921|FG002|Overall Study|Lost to Follow-up|2|||
33470270|NCT02041091|101611922|FG000|Treatment|Adverse Event|3|||
33470271|NCT02041091|101611923|FG001|Treatment|Adverse Event|3|||
33470272|NCT02041091|101611922|FG000|Treatment|Withdrawal by Subject|2|||
33470273|NCT02041091|101611923|FG001|Treatment|Withdrawal by Subject|4|||
33470274|NCT02041091|101611922|FG000|Treatment|Physician Decision|1|||
33470275|NCT02041091|101611923|FG001|Treatment|Physician Decision|0|||
33470276|NCT02041091|101611922|FG000|Treatment|Sponsor Decision|15|||
33470277|NCT02041091|101611923|FG001|Treatment|Sponsor Decision|16|||
33470278|NCT02041091|101611922|FG000|Treatment|Lost to Follow-up|1|||
33470279|NCT02041091|101611923|FG001|Treatment|Lost to Follow-up|0|||
33470280|NCT02041091|101611922|FG000|Optional Safety Extension Period|Adverse Event|4|||
33470281|NCT02041091|101611923|FG001|Optional Safety Extension Period|Adverse Event|2|||
33470282|NCT02041091|101611922|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
33470283|NCT02041091|101611923|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
33470284|NCT02041091|101611922|FG000|Optional Safety Extension Period|Protocol Violation|2|||
33470285|NCT02041091|101611923|FG001|Optional Safety Extension Period|Protocol Violation|0|||
33470286|NCT02041091|101611922|FG000|Optional Safety Extension Period|Physician Decision|2|||
33470287|NCT02041091|101611923|FG001|Optional Safety Extension Period|Physician Decision|1|||
33470288|NCT02041091|101611922|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
33470289|NCT02041091|101611923|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
33470290|NCT02041091|101611922|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
33470291|NCT02041091|101611923|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
33470292|NCT04556552|101611924|FG000|Overall Study|Lost to Follow-up|1|||
33470293|NCT04556552|101611925|FG001|Overall Study|Lost to Follow-up|0|||
33470294|NCT04556552|101611924|FG000|Overall Study|Claustrophobia|0|||
33470295|NCT04556552|101611925|FG001|Overall Study|Claustrophobia|1|||
33470296|NCT04556552|101611924|FG000|Overall Study|Inability to continue|0|||
33470297|NCT04556552|101611925|FG001|Overall Study|Inability to continue|1|||
33470298|NCT00673933|101611930|FG000|Overall Study|Withdrawal by Subject|2|||
33470299|NCT00673933|101611930|FG000|Overall Study|Lost to Follow-up|1|||
33470300|NCT02357342|101611931|FG000|First 6 Months|Death|2|||
33470301|NCT02357342|101611932|FG001|First 6 Months|Death|0|||
33180481|NCT01466387|100568372|FG001|Overall Study|Lost to Follow-up|0|||
33470302|NCT00038649|101616008|FG000|Overall Study|Adverse Event|9|||
33470303|NCT02595008|101616009|FG000|Overall Study|Enrolled In Error|1|||
33470304|NCT02595008|101616010|FG001|Overall Study|Enrolled In Error|0|||
33470305|NCT01425723|101616011|FG000|Overall Study|Lack of Efficacy|0|||
33180482|NCT01466387|100568373|FG002|Overall Study|Lost to Follow-up|0|||
33470306|NCT01425723|101616012|FG001|Overall Study|Lack of Efficacy|1|||
33470307|NCT01425723|101616011|FG000|Overall Study|Withdrawal by Subject|1|||
33470308|NCT01425723|101616012|FG001|Overall Study|Withdrawal by Subject|4|||
33470309|NCT01425723|101616011|FG000|Overall Study|Lost to Follow-up|0|||
33470310|NCT01425723|101616012|FG001|Overall Study|Lost to Follow-up|3|||
33470311|NCT01425723|101616011|FG000|Overall Study|Physician Decision|2|||
33470312|NCT01425723|101616012|FG001|Overall Study|Physician Decision|0|||
33470313|NCT01425723|101616011|FG000|Overall Study|Other|1|||
33470314|NCT01425723|101616012|FG001|Overall Study|Other|10|||
33470315|NCT01524913|101616013|FG000|Overall Study|Lost to Follow-up|4|||
33470316|NCT01524913|101616014|FG001|Overall Study|Lost to Follow-up|0|||
33470317|NCT01524913|101616015|FG002|Overall Study|Lost to Follow-up|0|||
33470318|NCT02939014|101616018|FG000|Overall Study|Lost to Follow-up|1|||
33470319|NCT02939014|101616019|FG001|Overall Study|Lost to Follow-up|0|||
33470320|NCT02939014|101616018|FG000|Overall Study|Death|4|||
33470321|NCT02939014|101616019|FG001|Overall Study|Death|3|||
33470322|NCT02546362|101616020|FG000|4-week Treatment Period|Lost to Follow-up|1|||
33470323|NCT02546362|101616020|FG000|4-week Treatment Period|Change in medication|2|||
33470324|NCT02546362|101616020|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
33470325|NCT02546362|101616020|FG000|12-week Treatment Period|Lost to Follow-up|2|||
33470326|NCT02546362|101616020|FG000|12-week Treatment Period|Change in medication|1|||
33470327|NCT01970865|101616024|FG000|Overall Study|Death|3|||
33470328|NCT01970865|101616025|FG001|Overall Study|Death|2|||
33470329|NCT01970865|101616026|FG002|Overall Study|Death|3|||
33470330|NCT01970865|101616027|FG003|Overall Study|Death|6|||
33470331|NCT01970865|101616028|FG004|Overall Study|Death|9|||
33470332|NCT01970865|101616029|FG005|Overall Study|Death|3|||
33470333|NCT01970865|101616030|FG006|Overall Study|Death|2|||
33470334|NCT01970865|101616031|FG007|Overall Study|Death|3|||
33470335|NCT01970865|101616032|FG008|Overall Study|Death|2|||
33470336|NCT01970865|101616033|FG009|Overall Study|Death|2|||
33470337|NCT01970865|101616034|FG010|Overall Study|Death|8|||
33470338|NCT01970865|101616035|FG011|Overall Study|Death|13|||
33470339|NCT01970865|101616036|FG012|Overall Study|Death|25|||
33470340|NCT01970865|101616037|FG013|Overall Study|Death|46|||
33470341|NCT01970865|101616038|FG014|Overall Study|Death|37|||
33470342|NCT01970865|101616039|FG015|Overall Study|Death|22|||
33470343|NCT01970865|101616040|FG016|Overall Study|Death|1|||
33470344|NCT01970865|101616041|FG017|Overall Study|Death|17|||
33470345|NCT01970865|101616024|FG000|Overall Study|Lost to Follow-up|0|||
33470346|NCT01970865|101616025|FG001|Overall Study|Lost to Follow-up|0|||
33470347|NCT01970865|101616026|FG002|Overall Study|Lost to Follow-up|0|||
33470348|NCT01970865|101616027|FG003|Overall Study|Lost to Follow-up|1|||
33470349|NCT01970865|101616028|FG004|Overall Study|Lost to Follow-up|1|||
33470350|NCT01970865|101616029|FG005|Overall Study|Lost to Follow-up|0|||
33470351|NCT01970865|101616030|FG006|Overall Study|Lost to Follow-up|0|||
33470352|NCT01970865|101616031|FG007|Overall Study|Lost to Follow-up|0|||
33470353|NCT01970865|101616032|FG008|Overall Study|Lost to Follow-up|0|||
33470354|NCT01970865|101616033|FG009|Overall Study|Lost to Follow-up|0|||
33470355|NCT01970865|101616034|FG010|Overall Study|Lost to Follow-up|1|||
33470356|NCT01970865|101616035|FG011|Overall Study|Lost to Follow-up|0|||
33470357|NCT01970865|101616036|FG012|Overall Study|Lost to Follow-up|2|||
33470358|NCT01970865|101616037|FG013|Overall Study|Lost to Follow-up|0|||
33470359|NCT01970865|101616038|FG014|Overall Study|Lost to Follow-up|1|||
33470360|NCT01970865|101616039|FG015|Overall Study|Lost to Follow-up|4|||
33470361|NCT01970865|101616040|FG016|Overall Study|Lost to Follow-up|0|||
33470362|NCT01970865|101616041|FG017|Overall Study|Lost to Follow-up|1|||
33470363|NCT01970865|101616024|FG000|Overall Study|Other|0|||
33470364|NCT01970865|101616025|FG001|Overall Study|Other|1|||
33470365|NCT01970865|101616026|FG002|Overall Study|Other|0|||
33470366|NCT01970865|101616027|FG003|Overall Study|Other|1|||
33470367|NCT01970865|101616028|FG004|Overall Study|Other|1|||
33470368|NCT01970865|101616029|FG005|Overall Study|Other|0|||
33470369|NCT01970865|101616030|FG006|Overall Study|Other|1|||
33470370|NCT01970865|101616031|FG007|Overall Study|Other|0|||
33470371|NCT01970865|101616032|FG008|Overall Study|Other|0|||
33470372|NCT01970865|101616033|FG009|Overall Study|Other|0|||
33470373|NCT01970865|101616034|FG010|Overall Study|Other|2|||
33470374|NCT01970865|101616035|FG011|Overall Study|Other|3|||
33470375|NCT01970865|101616036|FG012|Overall Study|Other|8|||
33470376|NCT01970865|101616037|FG013|Overall Study|Other|3|||
33470377|NCT01970865|101616038|FG014|Overall Study|Other|2|||
33470378|NCT01970865|101616039|FG015|Overall Study|Other|3|||
33470379|NCT01970865|101616040|FG016|Overall Study|Other|0|||
33470380|NCT01970865|101616041|FG017|Overall Study|Other|2|||
33470381|NCT01970865|101616024|FG000|Overall Study|Participant refused further follow-up|0|||
33470382|NCT01970865|101616025|FG001|Overall Study|Participant refused further follow-up|0|||
33470383|NCT01970865|101616026|FG002|Overall Study|Participant refused further follow-up|0|||
33470384|NCT01970865|101616027|FG003|Overall Study|Participant refused further follow-up|2|||
33470385|NCT01970865|101616028|FG004|Overall Study|Participant refused further follow-up|3|||
33470386|NCT01970865|101616029|FG005|Overall Study|Participant refused further follow-up|0|||
33470387|NCT01970865|101616030|FG006|Overall Study|Participant refused further follow-up|0|||
33470388|NCT01970865|101616031|FG007|Overall Study|Participant refused further follow-up|0|||
33470389|NCT01970865|101616032|FG008|Overall Study|Participant refused further follow-up|0|||
33470390|NCT01970865|101616033|FG009|Overall Study|Participant refused further follow-up|0|||
33470391|NCT01970865|101616034|FG010|Overall Study|Participant refused further follow-up|1|||
33470392|NCT01970865|101616035|FG011|Overall Study|Participant refused further follow-up|4|||
33470393|NCT01970865|101616036|FG012|Overall Study|Participant refused further follow-up|7|||
33180483|NCT01466387|100568374|FG003|Overall Study|Lost to Follow-up|0|||
33180484|NCT01466387|100568375|FG004|Overall Study|Lost to Follow-up|0|||
33180485|NCT01466387|100568376|FG005|Overall Study|Lost to Follow-up|1|||
33180486|NCT01466387|100568371|FG000|Overall Study|Protocol Violation|1|||
33470394|NCT01970865|101616037|FG013|Overall Study|Participant refused further follow-up|8|||
33470395|NCT01970865|101616038|FG014|Overall Study|Participant refused further follow-up|3|||
33470396|NCT01970865|101616039|FG015|Overall Study|Participant refused further follow-up|11|||
33470397|NCT01970865|101616040|FG016|Overall Study|Participant refused further follow-up|0|||
33470398|NCT01970865|101616041|FG017|Overall Study|Participant refused further follow-up|6|||
33470399|NCT04700280|101616044|FG000|Overall Study|Adverse Event|4|||
33470400|NCT04700280|101616045|FG001|Overall Study|Adverse Event|0|||
33470401|NCT04700280|101616044|FG000|Overall Study|Lack of Efficacy|1|||
33180487|NCT01466387|100568372|FG001|Overall Study|Protocol Violation|0|||
33180488|NCT01466387|100568373|FG002|Overall Study|Protocol Violation|0|||
33180489|NCT01466387|100568374|FG003|Overall Study|Protocol Violation|1|||
33180490|NCT01466387|100568375|FG004|Overall Study|Protocol Violation|0|||
33180491|NCT01466387|100568376|FG005|Overall Study|Protocol Violation|0|||
33180492|NCT01405963|100568377|FG000|Overall Study|Moved Away|2|||
33180493|NCT01405963|100568378|FG001|Overall Study|Moved Away|0|||
33470402|NCT04700280|101616045|FG001|Overall Study|Lack of Efficacy|0|||
33470403|NCT04700280|101616044|FG000|Overall Study|Study terminated by sponsor|5|||
33470404|NCT04700280|101616045|FG001|Overall Study|Study terminated by sponsor|3|||
33470405|NCT04700280|101616044|FG000|Overall Study|Other than specified|1|||
33470406|NCT04700280|101616045|FG001|Overall Study|Other than specified|0|||
33470407|NCT02562482|101616046|FG000|Overall Study|Enrolled, but did not receive product|4|||
33470408|NCT02562482|101616047|FG001|Overall Study|Enrolled, but did not receive product|0|||
33470409|NCT02562482|101616046|FG000|Overall Study|Lost to Follow-up|9|||
33470410|NCT02562482|101616047|FG001|Overall Study|Lost to Follow-up|6|||
33470411|NCT02562482|101616046|FG000|Overall Study|Moved from area|2|||
33470412|NCT02562482|101616047|FG001|Overall Study|Moved from area|3|||
33470413|NCT02562482|101616046|FG000|Overall Study|Withdrawal by Subject|5|||
33470414|NCT02562482|101616047|FG001|Overall Study|Withdrawal by Subject|3|||
33470415|NCT02562482|101616046|FG000|Overall Study|Physician Decision|1|||
33470416|NCT02562482|101616047|FG001|Overall Study|Physician Decision|3|||
33470417|NCT02562482|101616046|FG000|Overall Study|Illness/Injury unrelated to product|0|||
33470418|NCT02562482|101616047|FG001|Overall Study|Illness/Injury unrelated to product|1|||
33470419|NCT00652028|101616048|FG000|Overall Study|Adverse Event|1|||
33470420|NCT00652028|101616049|FG001|Overall Study|Adverse Event|0|||
33470421|NCT00652028|101616050|FG002|Overall Study|Adverse Event|0|||
33470422|NCT00652028|101616051|FG003|Overall Study|Adverse Event|0|||
33470423|NCT00652028|101616048|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
33470424|NCT00652028|101616049|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
33470425|NCT00652028|101616050|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
33470426|NCT00652028|101616051|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
33470427|NCT00652028|101616048|FG000|Overall Study|Physician Decision|0|||
33470428|NCT00652028|101616049|FG001|Overall Study|Physician Decision|0|||
33470429|NCT00652028|101616050|FG002|Overall Study|Physician Decision|1|||
33470430|NCT00652028|101616051|FG003|Overall Study|Physician Decision|0|||
33470431|NCT00653991|101616053|FG000|3 Month Follow-up|Participant would not respond|150|||
33470432|NCT00653991|101616054|FG001|3 Month Follow-up|Participant would not respond|157|||
33470433|NCT00653991|101616053|FG000|6 Month Follow-up|Participant would not respond|133|||
33470434|NCT00653991|101616054|FG001|6 Month Follow-up|Participant would not respond|141|||
33470435|NCT03401450|101616055|FG000|Overall Study|Lost to Follow-up|4|||
33470436|NCT03401450|101616056|FG001|Overall Study|Lost to Follow-up|6|||
33470437|NCT03401450|101616055|FG000|Overall Study|Anesthesia plan changed|2|||
33470438|NCT03401450|101616056|FG001|Overall Study|Anesthesia plan changed|2|||
33470439|NCT03401450|101616055|FG000|Overall Study|Did not complete medication diary|4|||
33470440|NCT03401450|101616056|FG001|Overall Study|Did not complete medication diary|2|||
33180494|NCT01405963|100568377|FG000|Overall Study|Adverse Event|0|||
33180495|NCT01405963|100568378|FG001|Overall Study|Adverse Event|1|||
33180496|NCT01405963|100568377|FG000|Overall Study|Lost to Follow-up|0|||
33180497|NCT01405963|100568378|FG001|Overall Study|Lost to Follow-up|1|||
33470441|NCT03401450|101616055|FG000|Overall Study|post surgery medication change|2|||
33470442|NCT03401450|101616056|FG001|Overall Study|post surgery medication change|1|||
33470443|NCT03401450|101616055|FG000|Overall Study|Cancelled surgery|0|||
33470444|NCT03401450|101616056|FG001|Overall Study|Cancelled surgery|2|||
33470445|NCT02771795|101616062|FG000|Overall Study|Withdrawal by Subject|47|||
33180498|NCT02232425|100568379|FG000|Overall Study|Lost to Follow-up|6|||
33180499|NCT02232425|100568380|FG001|Overall Study|Lost to Follow-up|2|||
33180500|NCT02232425|100568379|FG000|Overall Study|Adverse Event|2|||
33470446|NCT02771795|101616063|FG001|Overall Study|Withdrawal by Subject|37|||
33470447|NCT02771795|101616062|FG000|Overall Study|Termination by premature discontinuation of study|168|||
33470448|NCT02771795|101616063|FG001|Overall Study|Termination by premature discontinuation of study|185|||
33470449|NCT02221037|101616066|FG000|Overall Study|Physician Decision|0|||
33470450|NCT02221037|101616067|FG001|Overall Study|Physician Decision|0|||
33470451|NCT02221037|101616068|FG002|Overall Study|Physician Decision|1|||
33470452|NCT02221037|101616069|FG003|Overall Study|Physician Decision|0|||
33470453|NCT03334721|101616072|FG000|Overall Study|Withdrawal by Subject|1|||
33470454|NCT03334721|101616073|FG001|Overall Study|Withdrawal by Subject|0|||
33470455|NCT03334721|101616072|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
33470456|NCT03334721|101616073|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
33470457|NCT00292188|101616077|FG000|Single-Blind|Adverse Event|14|||
33470458|NCT00292188|101616078|FG001|Single-Blind|Adverse Event|0|||
33470459|NCT00292188|101616079|FG002|Single-Blind|Adverse Event|0|||
33470460|NCT00292188|101616077|FG000|Single-Blind|Lack of Efficacy|2|||
33470461|NCT00292188|101616078|FG001|Single-Blind|Lack of Efficacy|0|||
33470462|NCT00292188|101616079|FG002|Single-Blind|Lack of Efficacy|0|||
33470463|NCT00292188|101616077|FG000|Single-Blind|Laboratory Abnormality|5|||
33470464|NCT00292188|101616078|FG001|Single-Blind|Laboratory Abnormality|0|||
33470465|NCT00292188|101616079|FG002|Single-Blind|Laboratory Abnormality|0|||
33470466|NCT00292188|101616077|FG000|Single-Blind|Lost to Follow-up|3|||
33470467|NCT00292188|101616078|FG001|Single-Blind|Lost to Follow-up|0|||
33470468|NCT00292188|101616079|FG002|Single-Blind|Lost to Follow-up|0|||
33470469|NCT00292188|101616077|FG000|Single-Blind|Other|77|||
33470470|NCT00292188|101616078|FG001|Single-Blind|Other|0|||
33470471|NCT00292188|101616079|FG002|Single-Blind|Other|0|||
33470472|NCT00292188|101616077|FG000|Single-Blind|Withdrawal by Subject|12|||
33470473|NCT00292188|101616078|FG001|Single-Blind|Withdrawal by Subject|0|||
33470474|NCT00292188|101616079|FG002|Single-Blind|Withdrawal by Subject|0|||
33470475|NCT00292188|101616077|FG000|Single-Blind|Did not receive treatment|1|||
33470476|NCT00292188|101616078|FG001|Single-Blind|Did not receive treatment|0|||
33470477|NCT00292188|101616079|FG002|Single-Blind|Did not receive treatment|0|||
33470478|NCT00292188|101616077|FG000|Double-Blind|Adverse Event|0|||
33470479|NCT00292188|101616078|FG001|Double-Blind|Adverse Event|25|||
33470480|NCT00292188|101616079|FG002|Double-Blind|Adverse Event|9|||
33470481|NCT00292188|101616077|FG000|Double-Blind|Lack of Efficacy|0|||
33470482|NCT00292188|101616078|FG001|Double-Blind|Lack of Efficacy|2|||
33470483|NCT00292188|101616079|FG002|Double-Blind|Lack of Efficacy|12|||
33470484|NCT00292188|101616077|FG000|Double-Blind|Lost to Follow-up|0|||
33470485|NCT00292188|101616078|FG001|Double-Blind|Lost to Follow-up|1|||
33470486|NCT00292188|101616079|FG002|Double-Blind|Lost to Follow-up|0|||
33470487|NCT00292188|101616077|FG000|Double-Blind|Other|0|||
33470488|NCT00292188|101616078|FG001|Double-Blind|Other|3|||
33470489|NCT00292188|101616079|FG002|Double-Blind|Other|4|||
33470490|NCT00292188|101616077|FG000|Double-Blind|Withdrawal by Subject|0|||
33180501|NCT02232425|100568380|FG001|Overall Study|Adverse Event|0|||
33180502|NCT02232425|100568379|FG000|Overall Study|Withdrawal by Subject|5|||
33180503|NCT02232425|100568380|FG001|Overall Study|Withdrawal by Subject|6|||
33470491|NCT00292188|101616078|FG001|Double-Blind|Withdrawal by Subject|0|||
33470492|NCT00292188|101616079|FG002|Double-Blind|Withdrawal by Subject|3|||
33470493|NCT00292188|101616077|FG000|Double-Blind|Laboratory Abnormality|0|||
33470494|NCT00292188|101616078|FG001|Double-Blind|Laboratory Abnormality|0|||
33470495|NCT00292188|101616079|FG002|Double-Blind|Laboratory Abnormality|1|||
33470496|NCT02013375|101616090|FG000|Overall Study|Did not engraft|1|||
33470497|NCT02013375|101616090|FG000|Overall Study|Did not engraft|1|||
33470498|NCT01660334|101616091|FG000|Overall Study|Lost to Follow-up|1|||
33470499|NCT03955471|101616093|FG000|Overall Study|Death|22|||
33470500|NCT03955471|101616093|FG000|Overall Study|Lost to Follow-up|1|||
33470501|NCT03955471|101616093|FG000|Overall Study|Withdrawal by Subject|6|||
33470502|NCT03955471|101616093|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
33470503|NCT01083810|101616094|FG000|Overall Study|Lost to Follow-up|23|||
33470504|NCT01083810|101616095|FG001|Overall Study|Lost to Follow-up|11|||
33470505|NCT01083810|101616096|FG002|Overall Study|Lost to Follow-up|4|||
33470506|NCT01083810|101616094|FG000|Overall Study|Adverse Event|15|||
33470507|NCT01083810|101616095|FG001|Overall Study|Adverse Event|11|||
33470508|NCT01083810|101616096|FG002|Overall Study|Adverse Event|4|||
33470509|NCT01083810|101616094|FG000|Overall Study|Withdrawal by Subject|7|||
33470510|NCT01083810|101616095|FG001|Overall Study|Withdrawal by Subject|2|||
33470511|NCT01083810|101616096|FG002|Overall Study|Withdrawal by Subject|4|||
33470512|NCT01083810|101616094|FG000|Overall Study|Reason not reported|6|||
33470513|NCT01083810|101616095|FG001|Overall Study|Reason not reported|1|||
33470514|NCT01083810|101616096|FG002|Overall Study|Reason not reported|1|||
33470515|NCT01083810|101616094|FG000|Overall Study|Non-compliance|4|||
33470516|NCT01083810|101616095|FG001|Overall Study|Non-compliance|7|||
33470517|NCT01083810|101616096|FG002|Overall Study|Non-compliance|2|||
33470518|NCT01083810|101616094|FG000|Overall Study|Simplification|4|||
33470519|NCT01083810|101616095|FG001|Overall Study|Simplification|1|||
33470520|NCT01083810|101616096|FG002|Overall Study|Simplification|0|||
33470521|NCT01083810|101616094|FG000|Overall Study|Death|2|||
33470522|NCT01083810|101616095|FG001|Overall Study|Death|2|||
33470523|NCT01083810|101616096|FG002|Overall Study|Death|3|||
33470524|NCT01083810|101616094|FG000|Overall Study|Co-morbidities|1|||
33470525|NCT01083810|101616095|FG001|Overall Study|Co-morbidities|0|||
33470526|NCT01083810|101616096|FG002|Overall Study|Co-morbidities|0|||
33470527|NCT01083810|101616094|FG000|Overall Study|Participation in study|1|||
33470528|NCT01083810|101616095|FG001|Overall Study|Participation in study|0|||
33470529|NCT01083810|101616096|FG002|Overall Study|Participation in study|0|||
33470530|NCT01083810|101616094|FG000|Overall Study|Therapy break|1|||
33470531|NCT01083810|101616095|FG001|Overall Study|Therapy break|2|||
33470532|NCT01083810|101616096|FG002|Overall Study|Therapy break|2|||
33470533|NCT01083810|101616094|FG000|Overall Study|Virologic failure|1|||
33470534|NCT01083810|101616095|FG001|Overall Study|Virologic failure|8|||
33470535|NCT01083810|101616096|FG002|Overall Study|Virologic failure|0|||
33470536|NCT01432574|101616097|FG000|Overall Study|Moved|2|||
33470537|NCT01432574|101616097|FG000|Overall Study|Not interested|1|||
33470538|NCT01311557|101616100|FG000|Overall Study|Serious adverse event|0|||
33470539|NCT01311557|101616101|FG001|Overall Study|Serious adverse event|1|||
33470540|NCT01311557|101616100|FG000|Overall Study|Protocol Violation|4|||
33470541|NCT01311557|101616101|FG001|Overall Study|Protocol Violation|2|||
33470542|NCT01311557|101616100|FG000|Overall Study|Lost to Follow-up|0|||
33470543|NCT01311557|101616101|FG001|Overall Study|Lost to Follow-up|1|||
33470544|NCT01311557|101616100|FG000|Overall Study|Withdrawal by Subject|1|||
33180504|NCT02232425|100568379|FG000|Overall Study|Lack of Efficacy|1|||
33470545|NCT01311557|101616101|FG001|Overall Study|Withdrawal by Subject|2|||
33470546|NCT05212883|101616104|FG000|Overall Study|Invalid test result|125|||
33470547|NCT03977701|101616105|FG000|Overall Study|COVID-19 pandemic|0|||
33470548|NCT03977701|101616106|FG001|Overall Study|COVID-19 pandemic|0|||
33470549|NCT03977701|101616107|FG002|Overall Study|COVID-19 pandemic|0|||
33470550|NCT03977701|101616108|FG003|Overall Study|COVID-19 pandemic|0|||
33470551|NCT03977701|101616109|FG004|Overall Study|COVID-19 pandemic|0|||
33470552|NCT03977701|101616110|FG005|Overall Study|COVID-19 pandemic|1|||
33470553|NCT03977701|101616111|FG006|Overall Study|COVID-19 pandemic|0|||
33470554|NCT03977701|101616112|FG007|Overall Study|COVID-19 pandemic|1|||
33470555|NCT03977701|101616113|FG008|Overall Study|COVID-19 pandemic|0|||
33470556|NCT03977701|101616114|FG009|Overall Study|COVID-19 pandemic|0|||
33470557|NCT03575871|101616115|FG000|Overall Study|Adverse Event|5|||
33470558|NCT03575871|101616116|FG001|Overall Study|Adverse Event|5|||
33470559|NCT03575871|101616117|FG002|Overall Study|Adverse Event|8|||
33470560|NCT03575871|101616115|FG000|Overall Study|Death|1|||
33470561|NCT03575871|101616116|FG001|Overall Study|Death|0|||
33470562|NCT03575871|101616117|FG002|Overall Study|Death|0|||
33470563|NCT03575871|101616115|FG000|Overall Study|Lack of Efficacy|5|||
33470564|NCT03575871|101616116|FG001|Overall Study|Lack of Efficacy|4|||
33470565|NCT03575871|101616117|FG002|Overall Study|Lack of Efficacy|7|||
33470566|NCT03575871|101616115|FG000|Overall Study|Lost to Follow-up|1|||
33470567|NCT03575871|101616116|FG001|Overall Study|Lost to Follow-up|1|||
33470568|NCT03575871|101616117|FG002|Overall Study|Lost to Follow-up|1|||
33470569|NCT03575871|101616115|FG000|Overall Study|Protocol Deviation|1|||
33470570|NCT03575871|101616116|FG001|Overall Study|Protocol Deviation|1|||
33470571|NCT03575871|101616117|FG002|Overall Study|Protocol Deviation|1|||
33470572|NCT03575871|101616115|FG000|Overall Study|Withdrawal by Subject|6|||
33470573|NCT03575871|101616116|FG001|Overall Study|Withdrawal by Subject|1|||
33470574|NCT03575871|101616117|FG002|Overall Study|Withdrawal by Subject|9|||
33470575|NCT03575871|101616115|FG000|Overall Study|Other than specified|2|||
33470576|NCT03575871|101616116|FG001|Overall Study|Other than specified|2|||
33470577|NCT03575871|101616117|FG002|Overall Study|Other than specified|0|||
33470578|NCT00855803|101616118|FG000|Overall Study|Death|2|||
33470579|NCT00855803|101616118|FG000|Overall Study|Lost to Follow-up|2|||
33470580|NCT00855803|101616118|FG000|Overall Study|Technical inability to undergo procedure|2|||
33470581|NCT00855803|101616118|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
33470582|NCT00855803|101616118|FG000|Overall Study|Withdrawal by Subject|3|||
33470583|NCT00855803|101616118|FG000|Overall Study|Physician Decision|3|||
33180505|NCT02232425|100568380|FG001|Overall Study|Lack of Efficacy|0|||
33180506|NCT03144674|100568381|FG000|Overall Study|Participants Still Ongoing in the Study|1|||
33470584|NCT02192164|101616119|FG000|Overall Study|Other|8|||
33470585|NCT02192164|101616119|FG000|Overall Study|Withdrawal by Subject|1|||
33470586|NCT02192164|101616119|FG000|Overall Study|Physician Decision|4|||
33470587|NCT02192164|101616119|FG000|Overall Study|Did not meet the exclusion criteria|1|||
33470588|NCT02296684|101616120|FG000|Overall Study|Withdrawal by Subject|0|||
33470589|NCT02296684|101616121|FG001|Overall Study|Withdrawal by Subject|1|||
33470590|NCT02296684|101616122|FG002|Overall Study|Withdrawal by Subject|1|||
33470591|NCT02296684|101616120|FG000|Overall Study|Death|2|||
33470592|NCT02296684|101616121|FG001|Overall Study|Death|0|||
33470593|NCT02296684|101616122|FG002|Overall Study|Death|0|||
33470594|NCT02939950|101616123|FG000|Overall Study|Lost to Follow-up|13|||
33470595|NCT02939950|101616124|FG001|Overall Study|Lost to Follow-up|16|||
33470596|NCT02939950|101616123|FG000|Overall Study|Positive slit lamp findings|0|||
33470597|NCT02939950|101616124|FG001|Overall Study|Positive slit lamp findings|1|||
33470598|NCT02939950|101616123|FG000|Overall Study|Chalazion upper lid|0|||
33470599|NCT02939950|101616124|FG001|Overall Study|Chalazion upper lid|1|||
33470600|NCT02939950|101616123|FG000|Overall Study|Lack of motivation|0|||
33470601|NCT02939950|101616124|FG001|Overall Study|Lack of motivation|2|||
33470602|NCT02939950|101616123|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
33470603|NCT02939950|101616124|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
33470604|NCT02939950|101616123|FG000|Overall Study|Military orders|1|||
33470605|NCT02939950|101616124|FG001|Overall Study|Military orders|0|||
33470606|NCT02939950|101616123|FG000|Overall Study|Participant Relocated|5|||
33470607|NCT02939950|101616124|FG001|Overall Study|Participant Relocated|3|||
33470608|NCT02939950|101616123|FG000|Overall Study|Study related symptoms|8|||
33470609|NCT02939950|101616124|FG001|Overall Study|Study related symptoms|8|||
33470610|NCT02939950|101616123|FG000|Overall Study|Unacceptable lens movement|2|||
33470611|NCT02939950|101616124|FG001|Overall Study|Unacceptable lens movement|0|||
33470612|NCT02939950|101616123|FG000|Overall Study|Protocol Violation|6|||
33470613|NCT02939950|101616124|FG001|Overall Study|Protocol Violation|3|||
33470614|NCT02939950|101616123|FG000|Overall Study|Physician Decision|2|||
33470615|NCT02939950|101616124|FG001|Overall Study|Physician Decision|0|||
33470616|NCT02939950|101616123|FG000|Overall Study|Pregnancy|6|||
33470617|NCT02939950|101616124|FG001|Overall Study|Pregnancy|7|||
33470618|NCT02939950|101616123|FG000|Overall Study|Withdrawal by Subject|12|||
33470619|NCT02939950|101616124|FG001|Overall Study|Withdrawal by Subject|28|||
33470620|NCT02939950|101616123|FG000|Overall Study|Adverse Event|7|||
33470621|NCT02939950|101616124|FG001|Overall Study|Adverse Event|3|||
33470622|NCT02939950|101616123|FG000|Overall Study|Randomized, not dispensed|1|||
33470623|NCT02939950|101616124|FG001|Overall Study|Randomized, not dispensed|0|||
33470624|NCT02939950|101616123|FG000|Overall Study|Ineligible at Baseline|2|||
33470625|NCT02939950|101616124|FG001|Overall Study|Ineligible at Baseline|8|||
33470626|NCT00103038|101616125|FG000|Overall Study|Withdrawal by Subject|8|||
33470627|NCT00103038|101616125|FG000|Overall Study|Screen failure|3|||
33470628|NCT00103038|101616125|FG000|Overall Study|Death|1|||
33470629|NCT00103038|101616125|FG000|Overall Study|Physician Decision|1|||
33470630|NCT02243293|101616126|FG000|Overall Study|Adverse Event|1|||
33470631|NCT02243293|101616127|FG001|Overall Study|Adverse Event|0|||
33470632|NCT02243293|101616128|FG002|Overall Study|Adverse Event|0|||
33470633|NCT02243293|101616129|FG003|Overall Study|Adverse Event|0|||
33470634|NCT02243293|101616130|FG004|Overall Study|Adverse Event|0|||
33470635|NCT02243293|101616131|FG005|Overall Study|Adverse Event|0|||
33470636|NCT02243293|101616132|FG006|Overall Study|Adverse Event|0|||
33470637|NCT02243293|101616133|FG007|Overall Study|Adverse Event|0|||
33470638|NCT02243293|101616134|FG008|Overall Study|Adverse Event|0|||
33470639|NCT02243293|101616135|FG009|Overall Study|Adverse Event|0|||
33470640|NCT02243293|101616136|FG010|Overall Study|Adverse Event|0|||
33470641|NCT02243293|101616137|FG011|Overall Study|Adverse Event|0|||
33470642|NCT02243293|101616138|FG012|Overall Study|Adverse Event|0|||
33470643|NCT02243293|101616139|FG013|Overall Study|Adverse Event|0|||
33470644|NCT02243293|101616140|FG014|Overall Study|Adverse Event|0|||
33470645|NCT02243293|101616141|FG015|Overall Study|Adverse Event|1|||
33470646|NCT02243293|101616142|FG016|Overall Study|Adverse Event|0|||
33470647|NCT02243293|101616143|FG017|Overall Study|Adverse Event|0|||
33470648|NCT02243293|101616144|FG018|Overall Study|Adverse Event|0|||
33470649|NCT02243293|101616145|FG019|Overall Study|Adverse Event|0|||
33470650|NCT02243293|101616146|FG020|Overall Study|Adverse Event|1|||
33470651|NCT02243293|101616147|FG021|Overall Study|Adverse Event|0|||
33470652|NCT02243293|101616126|FG000|Overall Study|Withdrawal by Subject|1|||
33470653|NCT02243293|101616127|FG001|Overall Study|Withdrawal by Subject|0|||
33470654|NCT02243293|101616128|FG002|Overall Study|Withdrawal by Subject|0|||
33470655|NCT02243293|101616129|FG003|Overall Study|Withdrawal by Subject|0|||
33470656|NCT02243293|101616130|FG004|Overall Study|Withdrawal by Subject|0|||
33470657|NCT02243293|101616131|FG005|Overall Study|Withdrawal by Subject|0|||
33470658|NCT02243293|101616132|FG006|Overall Study|Withdrawal by Subject|0|||
33470659|NCT02243293|101616133|FG007|Overall Study|Withdrawal by Subject|0|||
33470660|NCT02243293|101616134|FG008|Overall Study|Withdrawal by Subject|0|||
33470661|NCT02243293|101616135|FG009|Overall Study|Withdrawal by Subject|1|||
33470662|NCT02243293|101616136|FG010|Overall Study|Withdrawal by Subject|0|||
33470663|NCT02243293|101616137|FG011|Overall Study|Withdrawal by Subject|1|||
33470664|NCT02243293|101616138|FG012|Overall Study|Withdrawal by Subject|0|||
33470665|NCT02243293|101616139|FG013|Overall Study|Withdrawal by Subject|0|||
33470666|NCT02243293|101616140|FG014|Overall Study|Withdrawal by Subject|0|||
33470667|NCT02243293|101616141|FG015|Overall Study|Withdrawal by Subject|0|||
33470668|NCT02243293|101616142|FG016|Overall Study|Withdrawal by Subject|0|||
33470669|NCT02243293|101616143|FG017|Overall Study|Withdrawal by Subject|0|||
33470670|NCT02243293|101616144|FG018|Overall Study|Withdrawal by Subject|0|||
33470671|NCT02243293|101616145|FG019|Overall Study|Withdrawal by Subject|0|||
33470672|NCT02243293|101616146|FG020|Overall Study|Withdrawal by Subject|0|||
33470673|NCT02243293|101616147|FG021|Overall Study|Withdrawal by Subject|1|||
33470674|NCT02243293|101616126|FG000|Overall Study|Lost to Follow-up|0|||
33470675|NCT02243293|101616127|FG001|Overall Study|Lost to Follow-up|1|||
33470676|NCT02243293|101616128|FG002|Overall Study|Lost to Follow-up|1|||
33470677|NCT02243293|101616129|FG003|Overall Study|Lost to Follow-up|1|||
33470678|NCT02243293|101616130|FG004|Overall Study|Lost to Follow-up|0|||
33470679|NCT02243293|101616131|FG005|Overall Study|Lost to Follow-up|0|||
33470680|NCT02243293|101616132|FG006|Overall Study|Lost to Follow-up|3|||
33470681|NCT02243293|101616133|FG007|Overall Study|Lost to Follow-up|0|||
33470682|NCT02243293|101616134|FG008|Overall Study|Lost to Follow-up|0|||
33470683|NCT02243293|101616135|FG009|Overall Study|Lost to Follow-up|0|||
33470684|NCT02243293|101616136|FG010|Overall Study|Lost to Follow-up|0|||
33470685|NCT02243293|101616137|FG011|Overall Study|Lost to Follow-up|2|||
33470686|NCT02243293|101616138|FG012|Overall Study|Lost to Follow-up|0|||
33470687|NCT02243293|101616139|FG013|Overall Study|Lost to Follow-up|0|||
33470688|NCT02243293|101616140|FG014|Overall Study|Lost to Follow-up|0|||
33470689|NCT02243293|101616141|FG015|Overall Study|Lost to Follow-up|0|||
33470690|NCT02243293|101616142|FG016|Overall Study|Lost to Follow-up|3|||
33470691|NCT02243293|101616143|FG017|Overall Study|Lost to Follow-up|1|||
33470692|NCT02243293|101616144|FG018|Overall Study|Lost to Follow-up|0|||
33470693|NCT02243293|101616145|FG019|Overall Study|Lost to Follow-up|0|||
33470694|NCT02243293|101616146|FG020|Overall Study|Lost to Follow-up|1|||
33470695|NCT02243293|101616147|FG021|Overall Study|Lost to Follow-up|2|||
33470696|NCT02243293|101616126|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
33470697|NCT02243293|101616127|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
33470698|NCT02243293|101616128|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
33470699|NCT02243293|101616129|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
33470700|NCT02243293|101616130|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
33470701|NCT02243293|101616131|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
33470702|NCT02243293|101616132|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
33470703|NCT02243293|101616133|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
33470704|NCT02243293|101616134|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
33470705|NCT02243293|101616135|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
33470706|NCT02243293|101616136|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
33470707|NCT02243293|101616137|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
33470708|NCT02243293|101616138|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
33470709|NCT02243293|101616139|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
33470710|NCT02243293|101616140|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
33470711|NCT02243293|101616141|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
33470712|NCT02243293|101616142|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
33470713|NCT02243293|101616143|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
33470714|NCT02243293|101616144|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
33470715|NCT02243293|101616145|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
33470716|NCT02243293|101616146|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
33470717|NCT02243293|101616147|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
33470718|NCT02243293|101616126|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
33470719|NCT02243293|101616127|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
33470720|NCT02243293|101616128|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
33470721|NCT02243293|101616129|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
33470722|NCT02243293|101616130|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
33470723|NCT02243293|101616131|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
33470724|NCT02243293|101616132|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
33470725|NCT02243293|101616133|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
33470726|NCT02243293|101616134|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
33470727|NCT02243293|101616135|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
33470728|NCT02243293|101616136|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
33470729|NCT02243293|101616137|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
33470730|NCT02243293|101616138|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
33470731|NCT02243293|101616139|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
33470732|NCT02243293|101616140|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
33470733|NCT02243293|101616141|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
33470734|NCT02243293|101616142|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
33470735|NCT02243293|101616143|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
33470736|NCT02243293|101616144|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
33470737|NCT02243293|101616145|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
33470738|NCT02243293|101616146|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
33470739|NCT02243293|101616147|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
33470740|NCT02749292|101616148|FG000|Overall Study|Physician Decision|1|||
33470741|NCT02749292|101616149|FG001|Overall Study|Physician Decision|0|||
33470742|NCT02749292|101616148|FG000|Overall Study|Withdrawal by Subject|5|||
33470743|NCT02749292|101616149|FG001|Overall Study|Withdrawal by Subject|7|||
33470744|NCT02749292|101616148|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
33470745|NCT02749292|101616149|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
33470746|NCT02749292|101616148|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
33470747|NCT02749292|101616149|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
33470748|NCT02749292|101616148|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
33180507|NCT03144674|100568382|FG001|Overall Study|Participants Still Ongoing in the Study|4|||
33180508|NCT03144674|100568383|FG002|Overall Study|Participants Still Ongoing in the Study|24|||
33180509|NCT03144674|100568384|FG003|Overall Study|Participants Still Ongoing in the Study|54|||
33180510|NCT03144674|100568381|FG000|Overall Study|Death|3|||
33180511|NCT03144674|100568382|FG001|Overall Study|Death|1|||
33180512|NCT03144674|100568383|FG002|Overall Study|Death|1|||
33180513|NCT03144674|100568384|FG003|Overall Study|Death|10|||
33180514|NCT03144674|100568381|FG000|Overall Study|Lost to Follow-up|0|||
33180515|NCT03144674|100568382|FG001|Overall Study|Lost to Follow-up|1|||
33180516|NCT03144674|100568383|FG002|Overall Study|Lost to Follow-up|1|||
33180517|NCT03144674|100568384|FG003|Overall Study|Lost to Follow-up|1|||
33180518|NCT03144674|100568381|FG000|Overall Study|Withdrawal by Participant|0|||
33180519|NCT03144674|100568382|FG001|Overall Study|Withdrawal by Participant|0|||
33180520|NCT03144674|100568383|FG002|Overall Study|Withdrawal by Participant|0|||
33180521|NCT03144674|100568384|FG003|Overall Study|Withdrawal by Participant|3|||
33180522|NCT03144674|100568381|FG000|Overall Study|Reason not Specified|0|||
33180523|NCT03144674|100568382|FG001|Overall Study|Reason not Specified|0|||
33180524|NCT03144674|100568383|FG002|Overall Study|Reason not Specified|2|||
33180525|NCT03144674|100568384|FG003|Overall Study|Reason not Specified|4|||
33180526|NCT04267133|100568385|FG000|Overall Study|Withdrawal by Subject|1|||
33180527|NCT04267133|100568385|FG000|Overall Study|Adverse Event|4|||
33180528|NCT00605813|100568386|FG000|Overall Study|Protocol Violation|25|||
33180529|NCT02064166|100568388|FG000|Overall Study|Adverse Event|1|||
33180530|NCT02064166|100568389|FG001|Overall Study|Adverse Event|0|||
33180531|NCT00741039|100568390|FG000|Overall Study|Patient non-compliance|2|||
33180532|NCT00741039|100568391|FG001|Overall Study|Patient non-compliance|0|||
33180533|NCT00945009|100568393|FG000|Overall Study|Lack of Efficacy|10|||
33180534|NCT00945009|100568394|FG001|Overall Study|Lack of Efficacy|0|||
33180535|NCT00945009|100568395|FG002|Overall Study|Lack of Efficacy|0|||
33180536|NCT00945009|100568393|FG000|Overall Study|Physician Decision|21|||
33180537|NCT00945009|100568394|FG001|Overall Study|Physician Decision|4|||
33180538|NCT00945009|100568395|FG002|Overall Study|Physician Decision|3|||
33180539|NCT00945009|100568393|FG000|Overall Study|Protocol Violation|6|||
33180540|NCT00945009|100568394|FG001|Overall Study|Protocol Violation|1|||
33180541|NCT00945009|100568395|FG002|Overall Study|Protocol Violation|0|||
33180542|NCT00945009|100568393|FG000|Overall Study|Withdrawal by Subject|1|||
33180543|NCT00945009|100568394|FG001|Overall Study|Withdrawal by Subject|0|||
33180544|NCT00945009|100568395|FG002|Overall Study|Withdrawal by Subject|0|||
33180545|NCT00945009|100568393|FG000|Overall Study|Ineligible|6|||
33180546|NCT00945009|100568394|FG001|Overall Study|Ineligible|1|||
33180547|NCT00945009|100568395|FG002|Overall Study|Ineligible|0|||
33180548|NCT00945009|100568393|FG000|Overall Study|Inevaluable|0|||
33180549|NCT00945009|100568394|FG001|Overall Study|Inevaluable|1|||
33180550|NCT00945009|100568395|FG002|Overall Study|Inevaluable|0|||
33180551|NCT00945009|100568393|FG000|Overall Study|Refusal of further protocol|1|||
33180552|NCT00945009|100568394|FG001|Overall Study|Refusal of further protocol|0|||
33180553|NCT00945009|100568395|FG002|Overall Study|Refusal of further protocol|0|||
33180554|NCT00518323|100568396|FG000|Overall Study|Lack of Efficacy|14|||
33180555|NCT00518323|100568397|FG001|Overall Study|Lack of Efficacy|2|||
33180556|NCT00518323|100568398|FG002|Overall Study|Lack of Efficacy|4|||
33180557|NCT00518323|100568399|FG003|Overall Study|Lack of Efficacy|20|||
33180558|NCT00518323|100568396|FG000|Overall Study|Withdrawal by Subject|1|||
33180559|NCT00518323|100568397|FG001|Overall Study|Withdrawal by Subject|2|||
33470749|NCT02749292|101616149|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
33470750|NCT02749292|101616148|FG000|Overall Study|Adverse Event|4|||
33180560|NCT00518323|100568398|FG002|Overall Study|Withdrawal by Subject|4|||
33180561|NCT00518323|100568399|FG003|Overall Study|Withdrawal by Subject|2|||
33180562|NCT00518323|100568396|FG000|Overall Study|Lost to Follow-up|0|||
33180563|NCT00518323|100568397|FG001|Overall Study|Lost to Follow-up|2|||
33180564|NCT00518323|100568398|FG002|Overall Study|Lost to Follow-up|1|||
33470751|NCT02749292|101616149|FG001|Overall Study|Adverse Event|1|||
33470752|NCT02749292|101616148|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
33470753|NCT02749292|101616149|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
33470754|NCT02749292|101616148|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
33470755|NCT02749292|101616149|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
33470756|NCT02749292|101616148|FG000|Overall Study|Requiring glucocorticoids|0|||
33470757|NCT02749292|101616149|FG001|Overall Study|Requiring glucocorticoids|3|||
33180565|NCT00518323|100568399|FG003|Overall Study|Lost to Follow-up|3|||
33180566|NCT00518323|100568396|FG000|Overall Study|Adverse Event|1|||
33180567|NCT00518323|100568397|FG001|Overall Study|Adverse Event|1|||
33180568|NCT00518323|100568398|FG002|Overall Study|Adverse Event|1|||
33180569|NCT00518323|100568399|FG003|Overall Study|Adverse Event|0|||
33180570|NCT00518323|100568396|FG000|Overall Study|Prohibited medication and others|3|||
33180571|NCT00518323|100568397|FG001|Overall Study|Prohibited medication and others|1|||
33180572|NCT00518323|100568398|FG002|Overall Study|Prohibited medication and others|1|||
33470758|NCT02749292|101616148|FG000|Overall Study|Cancer|1|||
33470759|NCT02749292|101616149|FG001|Overall Study|Cancer|0|||
33470760|NCT01277718|101616150|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
33470761|NCT01277718|101616151|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
33470762|NCT01277718|101616150|FG000|Period 2 - Second Intervention|Physician Decision|0|||
33470763|NCT01277718|101616151|FG001|Period 2 - Second Intervention|Physician Decision|2|||
33470764|NCT02916693|101616152|FG000|Overall Study|Lost to Follow-up|7|||
33470765|NCT02621034|101616153|FG000|Overall Study|Lost to Follow-up|3|||
33470766|NCT02621034|101616154|FG001|Overall Study|Lost to Follow-up|2|||
33470767|NCT02621034|101616155|FG002|Overall Study|Lost to Follow-up|5|||
33470768|NCT01138111|101616156|FG000|Overall Study|Withdrawal by Subject|5|||
33470769|NCT01138111|101616156|FG000|Overall Study|Adverse Event|1|||
33470770|NCT01138111|101616156|FG000|Overall Study|Death|1|||
33470771|NCT01138111|101616156|FG000|Overall Study|Lost to Follow-up|2|||
33470772|NCT03176459|101616160|FG000|Overall Study|Lost to Follow-up|5|||
33470773|NCT03176459|101616161|FG001|Overall Study|Lost to Follow-up|7|||
33470774|NCT01583218|101616162|FG000|Overall Study|Withdrawal by Subject|43|||
33470775|NCT01583218|101616163|FG001|Overall Study|Withdrawal by Subject|29|||
33470776|NCT01583218|101616162|FG000|Overall Study|Death|206|||
33470777|NCT01583218|101616163|FG001|Overall Study|Death|211|||
33470778|NCT01583218|101616162|FG000|Overall Study|Lost to Follow-up|11|||
33180573|NCT00518323|100568399|FG003|Overall Study|Prohibited medication and others|0|||
33180574|NCT01046682|100568402|FG000|Overall Study|Adverse Event|2|||
33180575|NCT01046682|100568403|FG001|Overall Study|Adverse Event|0|||
33180576|NCT02867709|100568406|FG000|Treatment Period|Adverse Event|1|||
33470779|NCT01583218|101616163|FG001|Overall Study|Lost to Follow-up|17|||
33470780|NCT01583218|101616162|FG000|Overall Study|Adverse event or serious adverse event|3|||
33470781|NCT01583218|101616163|FG001|Overall Study|Adverse event or serious adverse event|3|||
33470782|NCT01583218|101616162|FG000|Overall Study|Patient /Family decision|3|||
33470783|NCT01583218|101616163|FG001|Overall Study|Patient /Family decision|0|||
33470784|NCT01583218|101616162|FG000|Overall Study|Cannot contact patient directly|1|||
33470785|NCT01583218|101616163|FG001|Overall Study|Cannot contact patient directly|2|||
33470786|NCT01583218|101616162|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
33470787|NCT01583218|101616163|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
33470788|NCT01583218|101616162|FG000|Overall Study|Patient did not wish to attend visits|0|||
33470789|NCT01583218|101616163|FG001|Overall Study|Patient did not wish to attend visits|1|||
33470790|NCT01583218|101616162|FG000|Overall Study|Patient randomized but not dosed|17|||
33470791|NCT01583218|101616163|FG001|Overall Study|Patient randomized but not dosed|16|||
33470792|NCT01583218|101616162|FG000|Overall Study|Patient was assessed via phone in person|1|||
33470793|NCT01583218|101616163|FG001|Overall Study|Patient was assessed via phone in person|0|||
33470794|NCT01583218|101616162|FG000|Overall Study|Patient deemed ineligible after random|2|||
33470795|NCT01583218|101616163|FG001|Overall Study|Patient deemed ineligible after random|0|||
33470796|NCT01583218|101616162|FG000|Overall Study|Patient was early terminated from study|0|||
33470797|NCT01583218|101616163|FG001|Overall Study|Patient was early terminated from study|1|||
33470798|NCT01583218|101616162|FG000|Overall Study|Patient was randomized due to mistake|1|||
33470799|NCT01583218|101616163|FG001|Overall Study|Patient was randomized due to mistake|0|||
33470800|NCT01583218|101616162|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
33470801|NCT01583218|101616163|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
33470802|NCT01583218|101616162|FG000|Overall Study|Withdraw of consent on day of random|1|||
33470803|NCT01583218|101616163|FG001|Overall Study|Withdraw of consent on day of random|0|||
33470804|NCT01030341|101616164|FG000|Overall Study|Withdrawal by Subject|1|||
33470805|NCT01030341|101616164|FG000|Overall Study|Lost to Follow-up|2|||
33470806|NCT01672970|101616165|FG000|Overall Study|Lack of Efficacy|12|||
33470807|NCT01672970|101616165|FG000|Overall Study|Adverse Event|18|||
33470808|NCT01672970|101616165|FG000|Overall Study|Withdrawal by Subject|2|||
33470809|NCT01672970|101616165|FG000|Overall Study|Lost to Follow-up|5|||
33470810|NCT01672970|101616165|FG000|Overall Study|Other|9|||
33470811|NCT01672970|101616165|FG000|Overall Study|Enrolled but not treated|1|||
33470812|NCT02071849|101616167|FG000|6-month Primary Endpoint|Did not receive device|4|||
33470813|NCT02071849|101616167|FG000|6-month Primary Endpoint|Adverse Event|1|||
33470814|NCT02071849|101616167|FG000|2-year Extended Follow-up|Adverse Event|1|||
33470815|NCT02701413|101616168|FG000|Overall Study|Withdrawal by Subject|7|||
33470816|NCT02701413|101616169|FG001|Overall Study|Withdrawal by Subject|11|||
33470817|NCT02149121|101616171|FG000|Main Study Period|Lack of Efficacy|2|||
33470818|NCT02149121|101616172|FG001|Main Study Period|Lack of Efficacy|2|||
33470819|NCT02149121|101616173|FG002|Main Study Period|Lack of Efficacy|1|||
33470820|NCT02149121|101616174|FG003|Main Study Period|Lack of Efficacy|0|||
33470821|NCT02149121|101616175|FG004|Main Study Period|Lack of Efficacy|0|||
33180577|NCT02867709|100568407|FG001|Treatment Period|Adverse Event|1|||
33180578|NCT02867709|100568408|FG002|Treatment Period|Adverse Event|2|||
33470822|NCT02149121|101616176|FG005|Main Study Period|Lack of Efficacy|0|||
33180579|NCT02867709|100568406|FG000|Treatment Period|Withdrawal of Consent|7|||
33470823|NCT02149121|101616177|FG006|Main Study Period|Lack of Efficacy|0|||
33470824|NCT02149121|101616171|FG000|Main Study Period|Withdrawal by Subject|9|||
33180580|NCT02867709|100568407|FG001|Treatment Period|Withdrawal of Consent|9|||
33180581|NCT02867709|100568408|FG002|Treatment Period|Withdrawal of Consent|8|||
33180582|NCT02867709|100568406|FG000|Treatment Period|Lost to Follow-up|17|||
33180583|NCT02867709|100568407|FG001|Treatment Period|Lost to Follow-up|20|||
33180584|NCT02867709|100568408|FG002|Treatment Period|Lost to Follow-up|20|||
33180585|NCT02867709|100568406|FG000|Treatment Period|Lack of Qualifying Event|42|||
33180586|NCT02867709|100568407|FG001|Treatment Period|Lack of Qualifying Event|55|||
33180587|NCT02867709|100568408|FG002|Treatment Period|Lack of Qualifying Event|42|||
33470825|NCT02149121|101616172|FG001|Main Study Period|Withdrawal by Subject|5|||
33470826|NCT02149121|101616173|FG002|Main Study Period|Withdrawal by Subject|1|||
33470827|NCT02149121|101616174|FG003|Main Study Period|Withdrawal by Subject|0|||
33470828|NCT02149121|101616175|FG004|Main Study Period|Withdrawal by Subject|0|||
33470829|NCT02149121|101616176|FG005|Main Study Period|Withdrawal by Subject|0|||
33470830|NCT02149121|101616177|FG006|Main Study Period|Withdrawal by Subject|0|||
33470831|NCT02149121|101616171|FG000|Main Study Period|Adverse Event|2|||
33470832|NCT02149121|101616172|FG001|Main Study Period|Adverse Event|5|||
33470833|NCT02149121|101616173|FG002|Main Study Period|Adverse Event|1|||
33470834|NCT02149121|101616174|FG003|Main Study Period|Adverse Event|0|||
33470835|NCT02149121|101616175|FG004|Main Study Period|Adverse Event|0|||
33470836|NCT02149121|101616176|FG005|Main Study Period|Adverse Event|0|||
33470837|NCT02149121|101616177|FG006|Main Study Period|Adverse Event|0|||
33470838|NCT02149121|101616171|FG000|Main Study Period|Protocol Violation|2|||
33470839|NCT02149121|101616172|FG001|Main Study Period|Protocol Violation|0|||
33470840|NCT02149121|101616173|FG002|Main Study Period|Protocol Violation|0|||
33470841|NCT02149121|101616174|FG003|Main Study Period|Protocol Violation|0|||
33470842|NCT02149121|101616175|FG004|Main Study Period|Protocol Violation|0|||
33470843|NCT02149121|101616176|FG005|Main Study Period|Protocol Violation|0|||
33470844|NCT02149121|101616177|FG006|Main Study Period|Protocol Violation|0|||
33470845|NCT02149121|101616171|FG000|Main Study Period|Lost to Follow-up|2|||
33470846|NCT02149121|101616172|FG001|Main Study Period|Lost to Follow-up|1|||
33470847|NCT02149121|101616173|FG002|Main Study Period|Lost to Follow-up|0|||
33470848|NCT02149121|101616174|FG003|Main Study Period|Lost to Follow-up|0|||
33470849|NCT02149121|101616175|FG004|Main Study Period|Lost to Follow-up|0|||
33470850|NCT02149121|101616176|FG005|Main Study Period|Lost to Follow-up|0|||
33470851|NCT02149121|101616177|FG006|Main Study Period|Lost to Follow-up|0|||
33470852|NCT02149121|101616171|FG000|Main Study Period|Death|1|||
33470853|NCT02149121|101616172|FG001|Main Study Period|Death|0|||
33470854|NCT02149121|101616173|FG002|Main Study Period|Death|0|||
33470855|NCT02149121|101616174|FG003|Main Study Period|Death|0|||
33470856|NCT02149121|101616175|FG004|Main Study Period|Death|0|||
33470857|NCT02149121|101616176|FG005|Main Study Period|Death|0|||
33470858|NCT02149121|101616177|FG006|Main Study Period|Death|0|||
33470859|NCT02149121|101616171|FG000|Main Study Period|Physician Decision|1|||
33470860|NCT02149121|101616172|FG001|Main Study Period|Physician Decision|0|||
33470861|NCT02149121|101616173|FG002|Main Study Period|Physician Decision|0|||
33470862|NCT02149121|101616174|FG003|Main Study Period|Physician Decision|0|||
33470863|NCT02149121|101616175|FG004|Main Study Period|Physician Decision|0|||
33470864|NCT02149121|101616176|FG005|Main Study Period|Physician Decision|0|||
33470865|NCT02149121|101616177|FG006|Main Study Period|Physician Decision|0|||
33470866|NCT02149121|101616171|FG000|Main Study Period|Developed any malignancy|0|||
33470867|NCT02149121|101616172|FG001|Main Study Period|Developed any malignancy|1|||
33470868|NCT02149121|101616173|FG002|Main Study Period|Developed any malignancy|1|||
33470869|NCT02149121|101616174|FG003|Main Study Period|Developed any malignancy|0|||
33470870|NCT02149121|101616175|FG004|Main Study Period|Developed any malignancy|0|||
33470871|NCT02149121|101616176|FG005|Main Study Period|Developed any malignancy|0|||
33470872|NCT02149121|101616177|FG006|Main Study Period|Developed any malignancy|0|||
33470873|NCT02149121|101616171|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
33470874|NCT02149121|101616172|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
33470875|NCT02149121|101616173|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
33470876|NCT02149121|101616174|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
33470877|NCT02149121|101616175|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
33470878|NCT02149121|101616176|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
33470879|NCT02149121|101616177|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
33470880|NCT02149121|101616171|FG000|Main Study Period|Disease progression|0|||
33470881|NCT02149121|101616172|FG001|Main Study Period|Disease progression|1|||
33470882|NCT02149121|101616173|FG002|Main Study Period|Disease progression|0|||
33470883|NCT02149121|101616174|FG003|Main Study Period|Disease progression|0|||
33470884|NCT02149121|101616175|FG004|Main Study Period|Disease progression|0|||
33470885|NCT02149121|101616176|FG005|Main Study Period|Disease progression|0|||
33470886|NCT02149121|101616177|FG006|Main Study Period|Disease progression|0|||
33470887|NCT02149121|101616171|FG000|Extension Study Period|Withdrawal by Subject|0|||
33470888|NCT02149121|101616172|FG001|Extension Study Period|Withdrawal by Subject|0|||
33470889|NCT02149121|101616173|FG002|Extension Study Period|Withdrawal by Subject|0|||
33180588|NCT02867709|100568406|FG000|Treatment Period|Protocol Violation|3|||
33470890|NCT02149121|101616174|FG003|Extension Study Period|Withdrawal by Subject|1|||
33470891|NCT02149121|101616175|FG004|Extension Study Period|Withdrawal by Subject|0|||
33470892|NCT02149121|101616176|FG005|Extension Study Period|Withdrawal by Subject|2|||
33470893|NCT02149121|101616177|FG006|Extension Study Period|Withdrawal by Subject|0|||
33470894|NCT04135196|101616178|FG000|Overall Study|Lost to Follow-up|8|||
33470895|NCT04135196|101616179|FG001|Overall Study|Lost to Follow-up|7|||
33470896|NCT04135196|101616180|FG002|Overall Study|Lost to Follow-up|8|||
33470897|NCT04135196|101616181|FG003|Overall Study|Lost to Follow-up|9|||
33470898|NCT04135196|101616182|FG004|Overall Study|Lost to Follow-up|1|||
33470899|NCT04135196|101616178|FG000|Overall Study|Pregnancy|0|||
33470900|NCT04135196|101616179|FG001|Overall Study|Pregnancy|0|||
33470901|NCT04135196|101616180|FG002|Overall Study|Pregnancy|1|||
33470902|NCT04135196|101616181|FG003|Overall Study|Pregnancy|0|||
33470903|NCT04135196|101616182|FG004|Overall Study|Pregnancy|0|||
33470904|NCT04135196|101616178|FG000|Overall Study|Withdrawal by Subject|0|||
33470905|NCT04135196|101616179|FG001|Overall Study|Withdrawal by Subject|0|||
33470906|NCT04135196|101616180|FG002|Overall Study|Withdrawal by Subject|0|||
33470907|NCT04135196|101616181|FG003|Overall Study|Withdrawal by Subject|0|||
33470908|NCT04135196|101616182|FG004|Overall Study|Withdrawal by Subject|1|||
33470909|NCT02132754|101616183|FG000|Overall Study|Adverse Event|0|||
33470910|NCT02132754|101616184|FG001|Overall Study|Adverse Event|0|||
33470911|NCT02132754|101616185|FG002|Overall Study|Adverse Event|0|||
33470912|NCT02132754|101616186|FG003|Overall Study|Adverse Event|0|||
33470913|NCT02132754|101616187|FG004|Overall Study|Adverse Event|0|||
33470914|NCT02132754|101616188|FG005|Overall Study|Adverse Event|0|||
33470915|NCT02132754|101616189|FG006|Overall Study|Adverse Event|0|||
33470916|NCT02132754|101616190|FG007|Overall Study|Adverse Event|0|||
33470917|NCT02132754|101616191|FG008|Overall Study|Adverse Event|0|||
33470918|NCT02132754|101616192|FG009|Overall Study|Adverse Event|0|||
33470919|NCT02132754|101616193|FG010|Overall Study|Adverse Event|0|||
33470920|NCT02132754|101616194|FG011|Overall Study|Adverse Event|0|||
33470921|NCT02132754|101616195|FG012|Overall Study|Adverse Event|0|||
33470922|NCT02132754|101616196|FG013|Overall Study|Adverse Event|0|||
33470923|NCT02132754|101616197|FG014|Overall Study|Adverse Event|0|||
33470924|NCT02132754|101616198|FG015|Overall Study|Adverse Event|0|||
33470925|NCT02132754|101616199|FG016|Overall Study|Adverse Event|0|||
33470926|NCT02132754|101616200|FG017|Overall Study|Adverse Event|1|||
33470927|NCT02132754|101616201|FG018|Overall Study|Adverse Event|0|||
33470928|NCT02132754|101616202|FG019|Overall Study|Adverse Event|0|||
33470929|NCT02132754|101616203|FG020|Overall Study|Adverse Event|0|||
33470930|NCT02132754|101616204|FG021|Overall Study|Adverse Event|0|||
33470931|NCT02132754|101616205|FG022|Overall Study|Adverse Event|0|||
33470932|NCT02132754|101616206|FG023|Overall Study|Adverse Event|0|||
33470933|NCT02132754|101616207|FG024|Overall Study|Adverse Event|0|||
33470934|NCT02132754|101616208|FG025|Overall Study|Adverse Event|1|||
33470935|NCT02132754|101616209|FG026|Overall Study|Adverse Event|1|||
33470936|NCT02132754|101616210|FG027|Overall Study|Adverse Event|0|||
33470937|NCT02132754|101616211|FG028|Overall Study|Adverse Event|0|||
33470938|NCT02132754|101616212|FG029|Overall Study|Adverse Event|0|||
33470939|NCT02132754|101616213|FG030|Overall Study|Adverse Event|1|||
33470940|NCT02132754|101616214|FG031|Overall Study|Adverse Event|0|||
33470941|NCT02132754|101616215|FG032|Overall Study|Adverse Event|1|||
33470942|NCT02132754|101616216|FG033|Overall Study|Adverse Event|1|||
33470943|NCT02132754|101616183|FG000|Overall Study|Clinical Progression|0|||
33470944|NCT02132754|101616184|FG001|Overall Study|Clinical Progression|0|||
33470945|NCT02132754|101616185|FG002|Overall Study|Clinical Progression|0|||
33470946|NCT02132754|101616186|FG003|Overall Study|Clinical Progression|0|||
33470947|NCT02132754|101616187|FG004|Overall Study|Clinical Progression|0|||
33470948|NCT02132754|101616188|FG005|Overall Study|Clinical Progression|0|||
33470949|NCT02132754|101616189|FG006|Overall Study|Clinical Progression|0|||
33470950|NCT02132754|101616190|FG007|Overall Study|Clinical Progression|0|||
33470951|NCT02132754|101616191|FG008|Overall Study|Clinical Progression|0|||
33470952|NCT02132754|101616192|FG009|Overall Study|Clinical Progression|1|||
33470953|NCT02132754|101616193|FG010|Overall Study|Clinical Progression|0|||
33470954|NCT02132754|101616194|FG011|Overall Study|Clinical Progression|0|||
33470955|NCT02132754|101616195|FG012|Overall Study|Clinical Progression|0|||
33470956|NCT02132754|101616196|FG013|Overall Study|Clinical Progression|0|||
33470957|NCT02132754|101616197|FG014|Overall Study|Clinical Progression|0|||
33470958|NCT02132754|101616198|FG015|Overall Study|Clinical Progression|0|||
33470959|NCT02132754|101616199|FG016|Overall Study|Clinical Progression|1|||
33470960|NCT02132754|101616200|FG017|Overall Study|Clinical Progression|1|||
33470961|NCT02132754|101616201|FG018|Overall Study|Clinical Progression|0|||
33470962|NCT02132754|101616202|FG019|Overall Study|Clinical Progression|1|||
33470963|NCT02132754|101616203|FG020|Overall Study|Clinical Progression|0|||
33470964|NCT02132754|101616204|FG021|Overall Study|Clinical Progression|0|||
33470965|NCT02132754|101616205|FG022|Overall Study|Clinical Progression|1|||
33470966|NCT02132754|101616206|FG023|Overall Study|Clinical Progression|0|||
33470967|NCT02132754|101616207|FG024|Overall Study|Clinical Progression|1|||
33470968|NCT02132754|101616208|FG025|Overall Study|Clinical Progression|1|||
33470969|NCT02132754|101616209|FG026|Overall Study|Clinical Progression|0|||
33470970|NCT02132754|101616210|FG027|Overall Study|Clinical Progression|1|||
33470971|NCT02132754|101616211|FG028|Overall Study|Clinical Progression|1|||
33470972|NCT02132754|101616212|FG029|Overall Study|Clinical Progression|0|||
33470973|NCT02132754|101616213|FG030|Overall Study|Clinical Progression|1|||
33470974|NCT02132754|101616214|FG031|Overall Study|Clinical Progression|0|||
33470975|NCT02132754|101616215|FG032|Overall Study|Clinical Progression|0|||
33470976|NCT02132754|101616216|FG033|Overall Study|Clinical Progression|2|||
33470977|NCT02132754|101616183|FG000|Overall Study|Death|0|||
33470978|NCT02132754|101616184|FG001|Overall Study|Death|0|||
33470979|NCT02132754|101616185|FG002|Overall Study|Death|0|||
33470980|NCT02132754|101616186|FG003|Overall Study|Death|0|||
33470981|NCT02132754|101616187|FG004|Overall Study|Death|0|||
33470982|NCT02132754|101616188|FG005|Overall Study|Death|0|||
33470983|NCT02132754|101616189|FG006|Overall Study|Death|0|||
33470984|NCT02132754|101616190|FG007|Overall Study|Death|0|||
33470985|NCT02132754|101616191|FG008|Overall Study|Death|0|||
33470986|NCT02132754|101616192|FG009|Overall Study|Death|0|||
33470987|NCT02132754|101616193|FG010|Overall Study|Death|0|||
33470988|NCT02132754|101616194|FG011|Overall Study|Death|0|||
33470989|NCT02132754|101616195|FG012|Overall Study|Death|0|||
33470990|NCT02132754|101616196|FG013|Overall Study|Death|0|||
33470991|NCT02132754|101616197|FG014|Overall Study|Death|0|||
33470992|NCT02132754|101616198|FG015|Overall Study|Death|1|||
33470993|NCT02132754|101616199|FG016|Overall Study|Death|0|||
33470994|NCT02132754|101616200|FG017|Overall Study|Death|0|||
33470995|NCT02132754|101616201|FG018|Overall Study|Death|0|||
33470996|NCT02132754|101616202|FG019|Overall Study|Death|1|||
33470997|NCT02132754|101616203|FG020|Overall Study|Death|0|||
33470998|NCT02132754|101616204|FG021|Overall Study|Death|1|||
33470999|NCT02132754|101616205|FG022|Overall Study|Death|0|||
33471000|NCT02132754|101616206|FG023|Overall Study|Death|0|||
33471001|NCT02132754|101616207|FG024|Overall Study|Death|0|||
33471002|NCT02132754|101616208|FG025|Overall Study|Death|0|||
33471003|NCT02132754|101616209|FG026|Overall Study|Death|1|||
33471004|NCT02132754|101616210|FG027|Overall Study|Death|0|||
33471005|NCT02132754|101616211|FG028|Overall Study|Death|0|||
33471006|NCT02132754|101616212|FG029|Overall Study|Death|0|||
33471007|NCT02132754|101616213|FG030|Overall Study|Death|0|||
33471008|NCT02132754|101616214|FG031|Overall Study|Death|0|||
33471009|NCT02132754|101616215|FG032|Overall Study|Death|0|||
33471010|NCT02132754|101616216|FG033|Overall Study|Death|2|||
33180589|NCT02867709|100568407|FG001|Treatment Period|Protocol Violation|2|||
33180590|NCT02867709|100568408|FG002|Treatment Period|Protocol Violation|3|||
33180591|NCT02867709|100568406|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
33180592|NCT02867709|100568407|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
33180593|NCT02867709|100568408|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
33180594|NCT02867709|100568406|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
33180595|NCT02867709|100568407|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
33180596|NCT02867709|100568408|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
33180597|NCT02867709|100568406|FG000|Safety Follow-up Period|Pregnancy|0|||
33180598|NCT02867709|100568407|FG001|Safety Follow-up Period|Pregnancy|1|||
33180599|NCT02867709|100568408|FG002|Safety Follow-up Period|Pregnancy|0|||
33180600|NCT02867709|100568406|FG000|Safety Follow-up Period|Protocol Violation|0|||
33180601|NCT02867709|100568407|FG001|Safety Follow-up Period|Protocol Violation|1|||
33180602|NCT02867709|100568408|FG002|Safety Follow-up Period|Protocol Violation|1|||
33180603|NCT00520975|100572157|FG000|Overall Study|Disease progression|31|||
33180604|NCT00520975|100572158|FG001|Overall Study|Disease progression|23|||
33180605|NCT00520975|100572157|FG000|Overall Study|Adverse Event|7|||
33180606|NCT00520975|100572158|FG001|Overall Study|Adverse Event|10|||
33180607|NCT00520975|100572157|FG000|Overall Study|Death|0|||
33180608|NCT00520975|100572158|FG001|Overall Study|Death|2|||
33471011|NCT02132754|101616183|FG000|Overall Study|Excluded Medication|0|||
33471012|NCT02132754|101616184|FG001|Overall Study|Excluded Medication|0|||
33471013|NCT02132754|101616185|FG002|Overall Study|Excluded Medication|0|||
33471014|NCT02132754|101616186|FG003|Overall Study|Excluded Medication|0|||
33471015|NCT02132754|101616187|FG004|Overall Study|Excluded Medication|0|||
33471016|NCT02132754|101616188|FG005|Overall Study|Excluded Medication|0|||
33471017|NCT02132754|101616189|FG006|Overall Study|Excluded Medication|0|||
33471018|NCT02132754|101616190|FG007|Overall Study|Excluded Medication|0|||
33471019|NCT02132754|101616191|FG008|Overall Study|Excluded Medication|0|||
33180609|NCT00520975|100572157|FG000|Overall Study|Withdrawal by Subject|3|||
33180610|NCT00520975|100572158|FG001|Overall Study|Withdrawal by Subject|5|||
33180611|NCT00520975|100572157|FG000|Overall Study|Other therapy|2|||
33180612|NCT00520975|100572158|FG001|Overall Study|Other therapy|4|||
33471020|NCT02132754|101616192|FG009|Overall Study|Excluded Medication|0|||
33471021|NCT02132754|101616193|FG010|Overall Study|Excluded Medication|0|||
33471022|NCT02132754|101616194|FG011|Overall Study|Excluded Medication|0|||
33471023|NCT02132754|101616195|FG012|Overall Study|Excluded Medication|0|||
33471024|NCT02132754|101616196|FG013|Overall Study|Excluded Medication|0|||
33471025|NCT02132754|101616197|FG014|Overall Study|Excluded Medication|0|||
33471026|NCT02132754|101616198|FG015|Overall Study|Excluded Medication|0|||
33471027|NCT02132754|101616199|FG016|Overall Study|Excluded Medication|0|||
33471028|NCT02132754|101616200|FG017|Overall Study|Excluded Medication|0|||
33471029|NCT02132754|101616201|FG018|Overall Study|Excluded Medication|0|||
33471030|NCT02132754|101616202|FG019|Overall Study|Excluded Medication|0|||
33471031|NCT02132754|101616203|FG020|Overall Study|Excluded Medication|1|||
33471032|NCT02132754|101616204|FG021|Overall Study|Excluded Medication|0|||
33471033|NCT02132754|101616205|FG022|Overall Study|Excluded Medication|0|||
33471034|NCT02132754|101616206|FG023|Overall Study|Excluded Medication|0|||
33471035|NCT02132754|101616207|FG024|Overall Study|Excluded Medication|0|||
33471036|NCT02132754|101616208|FG025|Overall Study|Excluded Medication|0|||
33471037|NCT02132754|101616209|FG026|Overall Study|Excluded Medication|0|||
33471038|NCT02132754|101616210|FG027|Overall Study|Excluded Medication|0|||
33471039|NCT02132754|101616211|FG028|Overall Study|Excluded Medication|0|||
33471040|NCT02132754|101616212|FG029|Overall Study|Excluded Medication|0|||
33471041|NCT02132754|101616213|FG030|Overall Study|Excluded Medication|0|||
33471042|NCT02132754|101616214|FG031|Overall Study|Excluded Medication|0|||
33471043|NCT02132754|101616215|FG032|Overall Study|Excluded Medication|0|||
33471044|NCT02132754|101616216|FG033|Overall Study|Excluded Medication|1|||
33471045|NCT02132754|101616183|FG000|Overall Study|Physician Decision|0|||
33471046|NCT02132754|101616184|FG001|Overall Study|Physician Decision|0|||
33471047|NCT02132754|101616185|FG002|Overall Study|Physician Decision|0|||
33471048|NCT02132754|101616186|FG003|Overall Study|Physician Decision|0|||
33471049|NCT02132754|101616187|FG004|Overall Study|Physician Decision|0|||
33471050|NCT02132754|101616188|FG005|Overall Study|Physician Decision|0|||
33471051|NCT02132754|101616189|FG006|Overall Study|Physician Decision|0|||
33471052|NCT02132754|101616190|FG007|Overall Study|Physician Decision|0|||
33471053|NCT02132754|101616191|FG008|Overall Study|Physician Decision|0|||
33471054|NCT02132754|101616192|FG009|Overall Study|Physician Decision|1|||
33471055|NCT02132754|101616193|FG010|Overall Study|Physician Decision|0|||
33471056|NCT02132754|101616194|FG011|Overall Study|Physician Decision|1|||
33471057|NCT02132754|101616195|FG012|Overall Study|Physician Decision|1|||
33471058|NCT02132754|101616196|FG013|Overall Study|Physician Decision|0|||
33471059|NCT02132754|101616197|FG014|Overall Study|Physician Decision|0|||
33471060|NCT02132754|101616198|FG015|Overall Study|Physician Decision|1|||
33471061|NCT02132754|101616199|FG016|Overall Study|Physician Decision|0|||
33471062|NCT02132754|101616200|FG017|Overall Study|Physician Decision|0|||
33471063|NCT02132754|101616201|FG018|Overall Study|Physician Decision|0|||
33471064|NCT02132754|101616202|FG019|Overall Study|Physician Decision|0|||
33471065|NCT02132754|101616203|FG020|Overall Study|Physician Decision|0|||
33471066|NCT02132754|101616204|FG021|Overall Study|Physician Decision|0|||
33471067|NCT02132754|101616205|FG022|Overall Study|Physician Decision|0|||
33471068|NCT02132754|101616206|FG023|Overall Study|Physician Decision|0|||
33471069|NCT02132754|101616207|FG024|Overall Study|Physician Decision|1|||
33471070|NCT02132754|101616208|FG025|Overall Study|Physician Decision|0|||
33471071|NCT02132754|101616209|FG026|Overall Study|Physician Decision|0|||
33471072|NCT02132754|101616210|FG027|Overall Study|Physician Decision|0|||
33180613|NCT00520975|100572157|FG000|Overall Study|Other reasons|4|||
33180614|NCT00520975|100572158|FG001|Overall Study|Other reasons|2|||
33471073|NCT02132754|101616211|FG028|Overall Study|Physician Decision|0|||
33471074|NCT02132754|101616212|FG029|Overall Study|Physician Decision|0|||
33471075|NCT02132754|101616213|FG030|Overall Study|Physician Decision|0|||
33471076|NCT02132754|101616214|FG031|Overall Study|Physician Decision|1|||
33471077|NCT02132754|101616215|FG032|Overall Study|Physician Decision|0|||
33471078|NCT02132754|101616216|FG033|Overall Study|Physician Decision|3|||
33471079|NCT02132754|101616183|FG000|Overall Study|Progressive Disease|1|||
33471080|NCT02132754|101616184|FG001|Overall Study|Progressive Disease|1|||
33471081|NCT02132754|101616185|FG002|Overall Study|Progressive Disease|1|||
33471082|NCT02132754|101616186|FG003|Overall Study|Progressive Disease|1|||
33471083|NCT02132754|101616187|FG004|Overall Study|Progressive Disease|1|||
33471084|NCT02132754|101616188|FG005|Overall Study|Progressive Disease|1|||
33180615|NCT00520975|100572157|FG000|Overall Study|Not start protocol therapy|1|||
33180616|NCT00520975|100572158|FG001|Overall Study|Not start protocol therapy|2|||
33471085|NCT02132754|101616189|FG006|Overall Study|Progressive Disease|1|||
33471086|NCT02132754|101616190|FG007|Overall Study|Progressive Disease|1|||
33471087|NCT02132754|101616191|FG008|Overall Study|Progressive Disease|1|||
33471088|NCT02132754|101616192|FG009|Overall Study|Progressive Disease|3|||
33471089|NCT02132754|101616193|FG010|Overall Study|Progressive Disease|3|||
33471090|NCT02132754|101616194|FG011|Overall Study|Progressive Disease|2|||
33471091|NCT02132754|101616195|FG012|Overall Study|Progressive Disease|2|||
33471092|NCT02132754|101616196|FG013|Overall Study|Progressive Disease|3|||
33471093|NCT02132754|101616197|FG014|Overall Study|Progressive Disease|2|||
33471094|NCT02132754|101616198|FG015|Overall Study|Progressive Disease|1|||
33471095|NCT02132754|101616199|FG016|Overall Study|Progressive Disease|2|||
33471096|NCT02132754|101616200|FG017|Overall Study|Progressive Disease|1|||
33471097|NCT02132754|101616201|FG018|Overall Study|Progressive Disease|3|||
33471098|NCT02132754|101616202|FG019|Overall Study|Progressive Disease|1|||
33471099|NCT02132754|101616203|FG020|Overall Study|Progressive Disease|1|||
33471100|NCT02132754|101616204|FG021|Overall Study|Progressive Disease|3|||
33471101|NCT02132754|101616205|FG022|Overall Study|Progressive Disease|2|||
33471102|NCT02132754|101616206|FG023|Overall Study|Progressive Disease|3|||
33471103|NCT02132754|101616207|FG024|Overall Study|Progressive Disease|0|||
33471104|NCT02132754|101616208|FG025|Overall Study|Progressive Disease|1|||
33471105|NCT02132754|101616209|FG026|Overall Study|Progressive Disease|2|||
33471106|NCT02132754|101616210|FG027|Overall Study|Progressive Disease|1|||
33471107|NCT02132754|101616211|FG028|Overall Study|Progressive Disease|2|||
33471108|NCT02132754|101616212|FG029|Overall Study|Progressive Disease|3|||
33471109|NCT02132754|101616213|FG030|Overall Study|Progressive Disease|1|||
33471110|NCT02132754|101616214|FG031|Overall Study|Progressive Disease|1|||
33471111|NCT02132754|101616215|FG032|Overall Study|Progressive Disease|3|||
33471112|NCT02132754|101616216|FG033|Overall Study|Progressive Disease|6|||
33471113|NCT02132754|101616183|FG000|Overall Study|Screen Failure|0|||
33471114|NCT02132754|101616184|FG001|Overall Study|Screen Failure|0|||
33471115|NCT02132754|101616185|FG002|Overall Study|Screen Failure|0|||
33471116|NCT02132754|101616186|FG003|Overall Study|Screen Failure|0|||
33471117|NCT02132754|101616187|FG004|Overall Study|Screen Failure|0|||
33471118|NCT02132754|101616188|FG005|Overall Study|Screen Failure|0|||
33471119|NCT02132754|101616189|FG006|Overall Study|Screen Failure|0|||
33471120|NCT02132754|101616190|FG007|Overall Study|Screen Failure|0|||
33471121|NCT02132754|101616191|FG008|Overall Study|Screen Failure|0|||
33471122|NCT02132754|101616192|FG009|Overall Study|Screen Failure|0|||
33471123|NCT02132754|101616193|FG010|Overall Study|Screen Failure|0|||
33471124|NCT02132754|101616194|FG011|Overall Study|Screen Failure|0|||
33471125|NCT02132754|101616195|FG012|Overall Study|Screen Failure|0|||
33471126|NCT02132754|101616196|FG013|Overall Study|Screen Failure|0|||
33471127|NCT02132754|101616197|FG014|Overall Study|Screen Failure|0|||
33471128|NCT02132754|101616198|FG015|Overall Study|Screen Failure|0|||
33471129|NCT02132754|101616199|FG016|Overall Study|Screen Failure|0|||
33471130|NCT02132754|101616200|FG017|Overall Study|Screen Failure|0|||
33471131|NCT02132754|101616201|FG018|Overall Study|Screen Failure|0|||
33471132|NCT02132754|101616202|FG019|Overall Study|Screen Failure|1|||
33471133|NCT02132754|101616203|FG020|Overall Study|Screen Failure|0|||
33471134|NCT02132754|101616204|FG021|Overall Study|Screen Failure|1|||
33471135|NCT02132754|101616205|FG022|Overall Study|Screen Failure|0|||
33471136|NCT02132754|101616206|FG023|Overall Study|Screen Failure|0|||
33471137|NCT02132754|101616207|FG024|Overall Study|Screen Failure|0|||
33471138|NCT02132754|101616208|FG025|Overall Study|Screen Failure|0|||
33471139|NCT02132754|101616209|FG026|Overall Study|Screen Failure|0|||
33471140|NCT02132754|101616210|FG027|Overall Study|Screen Failure|0|||
33471141|NCT02132754|101616211|FG028|Overall Study|Screen Failure|0|||
33471142|NCT02132754|101616212|FG029|Overall Study|Screen Failure|0|||
33180617|NCT02723084|100572161|FG000|Overall Study|Withdrawal by Subject|1|||
33180618|NCT02723084|100572162|FG001|Overall Study|Withdrawal by Subject|1|||
33180619|NCT02723084|100572161|FG000|Overall Study|Lost to Follow-up|3|||
33180620|NCT02723084|100572162|FG001|Overall Study|Lost to Follow-up|0|||
33471143|NCT02132754|101616213|FG030|Overall Study|Screen Failure|0|||
33471144|NCT02132754|101616214|FG031|Overall Study|Screen Failure|0|||
33471145|NCT02132754|101616215|FG032|Overall Study|Screen Failure|0|||
33471146|NCT02132754|101616216|FG033|Overall Study|Screen Failure|0|||
33471147|NCT02132754|101616183|FG000|Overall Study|Transferred to Extension Study|0|||
33471148|NCT02132754|101616184|FG001|Overall Study|Transferred to Extension Study|0|||
33471149|NCT02132754|101616185|FG002|Overall Study|Transferred to Extension Study|0|||
33471150|NCT02132754|101616186|FG003|Overall Study|Transferred to Extension Study|0|||
33471151|NCT02132754|101616187|FG004|Overall Study|Transferred to Extension Study|0|||
33471152|NCT02132754|101616188|FG005|Overall Study|Transferred to Extension Study|0|||
33471153|NCT02132754|101616189|FG006|Overall Study|Transferred to Extension Study|0|||
33471154|NCT02132754|101616190|FG007|Overall Study|Transferred to Extension Study|0|||
33471155|NCT02132754|101616191|FG008|Overall Study|Transferred to Extension Study|0|||
33471156|NCT02132754|101616192|FG009|Overall Study|Transferred to Extension Study|0|||
33471157|NCT02132754|101616193|FG010|Overall Study|Transferred to Extension Study|0|||
33471158|NCT02132754|101616194|FG011|Overall Study|Transferred to Extension Study|0|||
33471159|NCT02132754|101616195|FG012|Overall Study|Transferred to Extension Study|0|||
33471160|NCT02132754|101616196|FG013|Overall Study|Transferred to Extension Study|0|||
33471161|NCT02132754|101616197|FG014|Overall Study|Transferred to Extension Study|0|||
33471162|NCT02132754|101616198|FG015|Overall Study|Transferred to Extension Study|0|||
33471163|NCT02132754|101616199|FG016|Overall Study|Transferred to Extension Study|0|||
33471164|NCT02132754|101616200|FG017|Overall Study|Transferred to Extension Study|0|||
33471165|NCT02132754|101616201|FG018|Overall Study|Transferred to Extension Study|0|||
33471166|NCT02132754|101616202|FG019|Overall Study|Transferred to Extension Study|0|||
33266346|NCT00824408|100873872|FG003|Randomized Phase|Refused to continue medication|2|||
33471167|NCT02132754|101616203|FG020|Overall Study|Transferred to Extension Study|0|||
33471168|NCT02132754|101616204|FG021|Overall Study|Transferred to Extension Study|0|||
33471169|NCT02132754|101616205|FG022|Overall Study|Transferred to Extension Study|0|||
33471170|NCT02132754|101616206|FG023|Overall Study|Transferred to Extension Study|0|||
33266347|NCT00824408|100873873|FG004|Randomized Phase|Refused to continue medication|2|||
33471171|NCT02132754|101616207|FG024|Overall Study|Transferred to Extension Study|0|||
33471172|NCT02132754|101616208|FG025|Overall Study|Transferred to Extension Study|0|||
33471173|NCT02132754|101616209|FG026|Overall Study|Transferred to Extension Study|0|||
33180621|NCT01030523|100572163|FG000|Initial Study (5 Years)|Death|1|||
33180622|NCT01030523|100572164|FG001|Initial Study (5 Years)|Death|0|||
33180623|NCT01030523|100572163|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
33180624|NCT01030523|100572164|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
33180625|NCT01030523|100572163|FG000|Initial Study (5 Years)|Implant failure|1|||
33180626|NCT01030523|100572164|FG001|Initial Study (5 Years)|Implant failure|0|||
33180627|NCT01030523|100572163|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
33180628|NCT01030523|100572164|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
33180629|NCT01030523|100572163|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
33471174|NCT02132754|101616210|FG027|Overall Study|Transferred to Extension Study|0|||
33180630|NCT01030523|100572164|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
33180631|NCT01030523|100572163|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
33180632|NCT01030523|100572164|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
33180633|NCT03839212|100572165|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
33471175|NCT02132754|101616211|FG028|Overall Study|Transferred to Extension Study|0|||
33471176|NCT02132754|101616212|FG029|Overall Study|Transferred to Extension Study|0|||
33471177|NCT02132754|101616213|FG030|Overall Study|Transferred to Extension Study|0|||
33471178|NCT02132754|101616214|FG031|Overall Study|Transferred to Extension Study|0|||
33471179|NCT02132754|101616215|FG032|Overall Study|Transferred to Extension Study|0|||
33471180|NCT02132754|101616216|FG033|Overall Study|Transferred to Extension Study|6|||
33471181|NCT02132754|101616183|FG000|Overall Study|Withdrawal by Subject|0|||
33471182|NCT02132754|101616184|FG001|Overall Study|Withdrawal by Subject|0|||
33471183|NCT02132754|101616185|FG002|Overall Study|Withdrawal by Subject|0|||
33471184|NCT02132754|101616186|FG003|Overall Study|Withdrawal by Subject|0|||
33471185|NCT02132754|101616187|FG004|Overall Study|Withdrawal by Subject|0|||
33471186|NCT02132754|101616188|FG005|Overall Study|Withdrawal by Subject|0|||
33471187|NCT02132754|101616189|FG006|Overall Study|Withdrawal by Subject|0|||
33471188|NCT02132754|101616190|FG007|Overall Study|Withdrawal by Subject|0|||
33471189|NCT02132754|101616191|FG008|Overall Study|Withdrawal by Subject|0|||
33471190|NCT02132754|101616192|FG009|Overall Study|Withdrawal by Subject|1|||
33471191|NCT02132754|101616193|FG010|Overall Study|Withdrawal by Subject|0|||
33471192|NCT02132754|101616194|FG011|Overall Study|Withdrawal by Subject|0|||
33471193|NCT02132754|101616195|FG012|Overall Study|Withdrawal by Subject|1|||
33471194|NCT02132754|101616196|FG013|Overall Study|Withdrawal by Subject|0|||
33471195|NCT02132754|101616197|FG014|Overall Study|Withdrawal by Subject|1|||
33180634|NCT00413192|100572174|FG000|Overall Study|Disease progression|26|||
33471196|NCT02132754|101616198|FG015|Overall Study|Withdrawal by Subject|2|||
33471197|NCT02132754|101616199|FG016|Overall Study|Withdrawal by Subject|1|||
33471198|NCT02132754|101616200|FG017|Overall Study|Withdrawal by Subject|0|||
33471199|NCT02132754|101616201|FG018|Overall Study|Withdrawal by Subject|0|||
33180635|NCT00413192|100572175|FG001|Overall Study|Disease progression|31|||
33180636|NCT00413192|100572176|FG002|Overall Study|Disease progression|16|||
33180637|NCT00413192|100572177|FG003|Overall Study|Disease progression|25|||
33180638|NCT00413192|100572174|FG000|Overall Study|Toxicity|3|||
33180639|NCT00413192|100572175|FG001|Overall Study|Toxicity|2|||
33180640|NCT00413192|100572176|FG002|Overall Study|Toxicity|2|||
33180641|NCT00413192|100572177|FG003|Overall Study|Toxicity|2|||
33180642|NCT00413192|100572174|FG000|Overall Study|Withdrawal by Subject|3|||
33266348|NCT00824408|100873869|FG000|Randomized Phase|Other reason not defined above|0|||
33471200|NCT02132754|101616202|FG019|Overall Study|Withdrawal by Subject|0|||
33471201|NCT02132754|101616203|FG020|Overall Study|Withdrawal by Subject|1|||
33471202|NCT02132754|101616204|FG021|Overall Study|Withdrawal by Subject|0|||
33471203|NCT02132754|101616205|FG022|Overall Study|Withdrawal by Subject|0|||
33471204|NCT02132754|101616206|FG023|Overall Study|Withdrawal by Subject|0|||
33471205|NCT02132754|101616207|FG024|Overall Study|Withdrawal by Subject|1|||
33471206|NCT02132754|101616208|FG025|Overall Study|Withdrawal by Subject|0|||
33471207|NCT02132754|101616209|FG026|Overall Study|Withdrawal by Subject|0|||
33471208|NCT02132754|101616210|FG027|Overall Study|Withdrawal by Subject|1|||
33471209|NCT02132754|101616211|FG028|Overall Study|Withdrawal by Subject|0|||
33471210|NCT02132754|101616212|FG029|Overall Study|Withdrawal by Subject|0|||
33471211|NCT02132754|101616213|FG030|Overall Study|Withdrawal by Subject|0|||
33471212|NCT02132754|101616214|FG031|Overall Study|Withdrawal by Subject|1|||
33180643|NCT00413192|100572175|FG001|Overall Study|Withdrawal by Subject|5|||
33180644|NCT00413192|100572176|FG002|Overall Study|Withdrawal by Subject|0|||
33180645|NCT00413192|100572177|FG003|Overall Study|Withdrawal by Subject|1|||
33180646|NCT00413192|100572174|FG000|Overall Study|Intercurrent illness|0|||
33180647|NCT00413192|100572175|FG001|Overall Study|Intercurrent illness|0|||
33180648|NCT00413192|100572176|FG002|Overall Study|Intercurrent illness|0|||
33180649|NCT00413192|100572177|FG003|Overall Study|Intercurrent illness|1|||
33180650|NCT00413192|100572174|FG000|Overall Study|Intercurrent death|0|||
33266349|NCT00824408|100873870|FG001|Randomized Phase|Other reason not defined above|0|||
33266350|NCT00824408|100873871|FG002|Randomized Phase|Other reason not defined above|4|||
33471213|NCT02132754|101616215|FG032|Overall Study|Withdrawal by Subject|0|||
33471214|NCT02132754|101616216|FG033|Overall Study|Withdrawal by Subject|2|||
33471215|NCT03510182|101616217|FG000|Overall Study|Withdrawal by Subject|2|||
33471216|NCT03852459|101616221|FG000|Overall Study|Adverse Event|2|||
33471217|NCT03852459|101616222|FG001|Overall Study|Adverse Event|2|||
33471218|NCT03852459|101616221|FG000|Overall Study|Withdrawal by Subject|1|||
33471219|NCT03852459|101616222|FG001|Overall Study|Withdrawal by Subject|1|||
33471220|NCT01197417|101616223|FG000|Overall Study|Physician Decision|3|||
33471221|NCT01197417|101616224|FG001|Overall Study|Physician Decision|2|||
33471222|NCT01197417|101616223|FG000|Overall Study|Withdrawal by Subject|2|||
33471223|NCT01197417|101616224|FG001|Overall Study|Withdrawal by Subject|4|||
33471224|NCT01197417|101616223|FG000|Overall Study|Site miscommunication|0|||
33471225|NCT01197417|101616224|FG001|Overall Study|Site miscommunication|1|||
33471226|NCT01197417|101616223|FG000|Overall Study|Subject transferred to intensive care|0|||
33471227|NCT01197417|101616224|FG001|Overall Study|Subject transferred to intensive care|1|||
33471228|NCT01197417|101616223|FG000|Overall Study|Not consented in time to receive drug|0|||
33471229|NCT01197417|101616224|FG001|Overall Study|Not consented in time to receive drug|1|||
33471230|NCT01197417|101616223|FG000|Overall Study|Hypotension|1|||
33471231|NCT01197417|101616224|FG001|Overall Study|Hypotension|2|||
33471232|NCT01197417|101616223|FG000|Overall Study|Found to be ineligible|2|||
33471233|NCT01197417|101616224|FG001|Overall Study|Found to be ineligible|5|||
33471234|NCT01197417|101616223|FG000|Overall Study|No 25-hour magnesium level|0|||
33471235|NCT01197417|101616224|FG001|Overall Study|No 25-hour magnesium level|2|||
33471236|NCT03828448|101616229|FG000|Overall Study|Sponsor's Discretion|34|||
33471237|NCT00560937|101616230|FG000|Overall Study|Withdrawal by Subject|0|||
33471238|NCT00560937|101616231|FG001|Overall Study|Withdrawal by Subject|1|||
33471239|NCT00560937|101616230|FG000|Overall Study|Physician Decision|1|||
33471240|NCT00560937|101616231|FG001|Overall Study|Physician Decision|1|||
33471241|NCT03314662|101616232|FG000|Overall Study|Withdrawal by Subject|1|||
33471242|NCT03314662|101616233|FG001|Overall Study|Withdrawal by Subject|1|||
33471243|NCT03314662|101616234|FG002|Overall Study|Withdrawal by Subject|1|||
33471244|NCT03314662|101616232|FG000|Overall Study|Lost to Follow-up|5|||
33471245|NCT03314662|101616233|FG001|Overall Study|Lost to Follow-up|4|||
33471246|NCT03314662|101616234|FG002|Overall Study|Lost to Follow-up|4|||
33471247|NCT03314662|101616232|FG000|Overall Study|Death|2|||
33471248|NCT03314662|101616233|FG001|Overall Study|Death|0|||
33471249|NCT03314662|101616234|FG002|Overall Study|Death|0|||
33471250|NCT03212521|101616235|FG000|Overall Study|Adverse Event|1|||
33471251|NCT03212521|101616235|FG000|Overall Study|Lost to Follow-up|4|||
33471252|NCT03212521|101616235|FG000|Overall Study|Withdrawal by Subject|1|||
33471253|NCT03212521|101616235|FG000|Overall Study|Other|1|||
33471254|NCT02510014|101616238|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
33471255|NCT02510014|101616239|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
33471256|NCT02510014|101616238|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
33471257|NCT02510014|101616239|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
33471258|NCT02510014|101616238|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
33471259|NCT02510014|101616239|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
33471260|NCT02510014|101616238|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
33471261|NCT02510014|101616239|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
33471262|NCT02510014|101616238|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
33471263|NCT02510014|101616239|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
33471264|NCT02510014|101616238|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
33471265|NCT02510014|101616239|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
33471266|NCT02510014|101616238|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
33471267|NCT02510014|101616239|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
33471268|NCT02510014|101616238|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
33471269|NCT02510014|101616239|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
33471270|NCT02510014|101616238|FG000|Treatment Period|Adverse Event|11|||
33471271|NCT02510014|101616239|FG001|Treatment Period|Adverse Event|4|||
33471272|NCT02510014|101616238|FG000|Treatment Period|Withdrawal symptoms|3|||
33471273|NCT02510014|101616239|FG001|Treatment Period|Withdrawal symptoms|0|||
33471274|NCT02510014|101616238|FG000|Treatment Period|Lost to Follow-up|80|||
33471275|NCT02510014|101616239|FG001|Treatment Period|Lost to Follow-up|19|||
33471276|NCT02510014|101616238|FG000|Treatment Period|Physician Decision|5|||
33471277|NCT02510014|101616239|FG001|Treatment Period|Physician Decision|0|||
33471278|NCT02510014|101616238|FG000|Treatment Period|Withdrawal by Subject|67|||
33471279|NCT02510014|101616239|FG001|Treatment Period|Withdrawal by Subject|24|||
33471280|NCT02510014|101616238|FG000|Treatment Period|Withdrawn by the investigator|7|||
33471281|NCT02510014|101616239|FG001|Treatment Period|Withdrawn by the investigator|1|||
33471282|NCT02510014|101616238|FG000|Treatment Period|Protocol Violation|4|||
33471283|NCT02510014|101616239|FG001|Treatment Period|Protocol Violation|4|||
33471284|NCT02510014|101616238|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
33471285|NCT02510014|101616239|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
33471286|NCT04718194|101616240|FG000|Overall Study|Withdrawal by Subject|3|||
33471287|NCT04718194|101616241|FG001|Overall Study|Withdrawal by Subject|0|||
33471288|NCT04718194|101616240|FG000|Overall Study|Lost to Follow-up|3|||
33471289|NCT04718194|101616241|FG001|Overall Study|Lost to Follow-up|0|||
33471290|NCT00841906|101616242|FG000|Overall Study|Withdrawal by Subject|2|||
33471291|NCT00841906|101616243|FG001|Overall Study|Withdrawal by Subject|0|||
33471292|NCT03276780|101616246|FG000|Overall Study|Withdrawal by Subject|5|||
33471293|NCT03276780|101616247|FG001|Overall Study|Withdrawal by Subject|3|||
33471294|NCT03276780|101616246|FG000|Overall Study|Lost to Follow-up|3|||
33471295|NCT03276780|101616247|FG001|Overall Study|Lost to Follow-up|5|||
33471296|NCT03276780|101616246|FG000|Overall Study|Moved out of state|1|||
33471297|NCT03276780|101616247|FG001|Overall Study|Moved out of state|1|||
33471298|NCT03276780|101616246|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
33471299|NCT03276780|101616247|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
33471300|NCT03276780|101616246|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
33471301|NCT03276780|101616247|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
33471302|NCT01458106|101616250|FG000|Overall Study|Withdrawal by Subject|2|||
33471303|NCT01458106|101616251|FG001|Overall Study|Withdrawal by Subject|0|||
33471304|NCT01458106|101616250|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
33471305|NCT01458106|101616251|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
33471306|NCT01458106|101616250|FG000|Overall Study|Withdrawn Per Protocol|0|||
33471307|NCT01458106|101616251|FG001|Overall Study|Withdrawn Per Protocol|1|||
33471308|NCT01855048|101616252|FG000|Overall Study|Withdrawal by Subject|0|||
33471309|NCT01855048|101616253|FG001|Overall Study|Withdrawal by Subject|1|||
33471310|NCT01855048|101616254|FG002|Overall Study|Withdrawal by Subject|0|||
33471311|NCT01855048|101616255|FG003|Overall Study|Withdrawal by Subject|0|||
33471312|NCT01855048|101616256|FG004|Overall Study|Withdrawal by Subject|1|||
33471313|NCT01855048|101616257|FG005|Overall Study|Withdrawal by Subject|0|||
33471314|NCT03043560|101616258|FG000|Overall Study|Discontinued Intervention|1|||
33471315|NCT03043560|101616259|FG001|Overall Study|Discontinued Intervention|2|||
33471316|NCT03043560|101616258|FG000|Overall Study|Lost to Follow-up|0|||
33471317|NCT03043560|101616259|FG001|Overall Study|Lost to Follow-up|1|||
33471318|NCT04322149|101616262|FG000|Overall Study|Adverse Event|1|||
33471319|NCT04322149|101616263|FG001|Overall Study|Adverse Event|1|||
33471320|NCT04322149|101616264|FG002|Overall Study|Adverse Event|0|||
33471321|NCT04322149|101616265|FG003|Overall Study|Adverse Event|0|||
33471322|NCT04322149|101616262|FG000|Overall Study|Withdrawal by Subject|0|||
33471323|NCT04322149|101616263|FG001|Overall Study|Withdrawal by Subject|0|||
33471324|NCT04322149|101616264|FG002|Overall Study|Withdrawal by Subject|0|||
33471325|NCT04322149|101616265|FG003|Overall Study|Withdrawal by Subject|2|||
33471326|NCT04322149|101616262|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
33471327|NCT04322149|101616263|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
33471328|NCT04322149|101616264|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
33471329|NCT04322149|101616265|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
33471330|NCT04551911|101616266|FG000|Overall Study|Lost to Follow-up|2|||
33471331|NCT04551911|101616267|FG001|Overall Study|Lost to Follow-up|1|||
33471332|NCT04551911|101616266|FG000|Overall Study|Withdrawal by Subject|10|||
33471333|NCT04551911|101616267|FG001|Overall Study|Withdrawal by Subject|10|||
33471334|NCT04551911|101616266|FG000|Overall Study|Did not receive the study drug|3|||
33471335|NCT04551911|101616267|FG001|Overall Study|Did not receive the study drug|4|||
33471336|NCT00922987|101616268|FG000|Overall Study|Insufficient clinical response|1|||
33471337|NCT00922987|101616268|FG000|Overall Study|Protocol Violation|2|||
33180651|NCT00413192|100572175|FG001|Overall Study|Intercurrent death|1|||
33180652|NCT00413192|100572176|FG002|Overall Study|Intercurrent death|0|||
33180653|NCT00413192|100572177|FG003|Overall Study|Intercurrent death|0|||
33180654|NCT00413192|100572174|FG000|Overall Study|Other|5|||
33180655|NCT00413192|100572175|FG001|Overall Study|Other|1|||
33180656|NCT00413192|100572176|FG002|Overall Study|Other|1|||
33180657|NCT00413192|100572177|FG003|Overall Study|Other|2|||
33180658|NCT00413192|100572174|FG000|Overall Study|Not treated|0|||
33180659|NCT00413192|100572175|FG001|Overall Study|Not treated|0|||
33180660|NCT00413192|100572176|FG002|Overall Study|Not treated|0|||
33180661|NCT00413192|100572177|FG003|Overall Study|Not treated|1|||
33266351|NCT00824408|100873872|FG003|Randomized Phase|Other reason not defined above|2|||
33471338|NCT00922987|101616268|FG000|Overall Study|Adverse Event|1|||
33471339|NCT03188718|101616270|FG000|Overall Study|Participant noncompliance|4|||
33471340|NCT03188718|101616270|FG000|Overall Study|Withdrawal by Subject|1|||
33471341|NCT03188718|101616270|FG000|Overall Study|Device failure|3|||
33471342|NCT00869024|101616271|FG000|Overall Study|Death|2|||
33471343|NCT00869024|101616272|FG001|Overall Study|Death|3|||
33471344|NCT00869024|101616271|FG000|Overall Study|Lost to Follow-up|0|||
33471345|NCT00869024|101616272|FG001|Overall Study|Lost to Follow-up|1|||
33180662|NCT02608268|100572178|FG000|Overall Study|Adverse Event|0|||
33266352|NCT00824408|100873873|FG004|Randomized Phase|Other reason not defined above|4|||
33266353|NCT01536093|100873876|FG000|Overall Study|Death|1|||
33180663|NCT02608268|100572179|FG001|Overall Study|Adverse Event|0|||
33471346|NCT00869024|101616271|FG000|Overall Study|Protocol Violation|0|||
33180664|NCT02608268|100572180|FG002|Overall Study|Adverse Event|1|||
33180665|NCT02608268|100572181|FG003|Overall Study|Adverse Event|0|||
33180666|NCT02608268|100572182|FG004|Overall Study|Adverse Event|0|||
33180667|NCT02608268|100572183|FG005|Overall Study|Adverse Event|0|||
33471347|NCT00869024|101616272|FG001|Overall Study|Protocol Violation|1|||
33471348|NCT01698775|101616273|FG000|Phase A|Adverse Event|2|||
33471349|NCT01698775|101616274|FG001|Phase A|Adverse Event|1|||
33471350|NCT01698775|101616273|FG000|Phase A|Death|1|||
33471351|NCT01698775|101616274|FG001|Phase A|Death|1|||
33471352|NCT01698775|101616273|FG000|Phase A|Lack of Efficacy|1|||
33471353|NCT01698775|101616274|FG001|Phase A|Lack of Efficacy|0|||
33471354|NCT01698775|101616273|FG000|Phase A|Lost to Follow-up|1|||
33471355|NCT01698775|101616274|FG001|Phase A|Lost to Follow-up|2|||
33471356|NCT01698775|101616273|FG000|Phase A|Protocol Violation|1|||
33471357|NCT01698775|101616274|FG001|Phase A|Protocol Violation|0|||
33471358|NCT01698775|101616273|FG000|Phase A|Withdrawal by Subject|3|||
33471359|NCT01698775|101616274|FG001|Phase A|Withdrawal by Subject|4|||
33471360|NCT01698775|101616273|FG000|Phase A|Kidney [transplant]|0|||
33471361|NCT01698775|101616274|FG001|Phase A|Kidney [transplant]|1|||
33471362|NCT01698775|101616273|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
33471363|NCT01698775|101616274|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
33471364|NCT01698775|101616273|FG000|Phase B|Adverse Event|6|||
33471365|NCT01698775|101616274|FG001|Phase B|Adverse Event|3|||
33471366|NCT01698775|101616273|FG000|Phase B|Death|0|||
33471367|NCT01698775|101616274|FG001|Phase B|Death|1|||
33471368|NCT01698775|101616273|FG000|Phase B|Lack of Efficacy|0|||
33471369|NCT01698775|101616274|FG001|Phase B|Lack of Efficacy|1|||
33471370|NCT01698775|101616273|FG000|Phase B|Lost to Follow-up|0|||
33471371|NCT01698775|101616274|FG001|Phase B|Lost to Follow-up|1|||
33471372|NCT01698775|101616273|FG000|Phase B|Physician Decision|1|||
33471373|NCT01698775|101616274|FG001|Phase B|Physician Decision|1|||
33471374|NCT01698775|101616273|FG000|Phase B|Protocol Violation|1|||
33471375|NCT01698775|101616274|FG001|Phase B|Protocol Violation|1|||
33471376|NCT01698775|101616273|FG000|Phase B|Withdrawal by Subject|6|||
33471377|NCT01698775|101616274|FG001|Phase B|Withdrawal by Subject|2|||
33471378|NCT00513682|101616277|FG000|Washout Phase|Adverse Event|2|||
33471379|NCT02615171|101616278|FG000|Overall Study|Lost to Follow-up|2|||
33471380|NCT02615171|101616279|FG001|Overall Study|Lost to Follow-up|1|||
33471381|NCT02566993|101616280|FG000|Overall Study|Randomized but not treated|5|||
33180668|NCT02608268|100572184|FG006|Overall Study|Adverse Event|0|||
33180669|NCT02608268|100572185|FG007|Overall Study|Adverse Event|0|||
33180670|NCT02608268|100572186|FG008|Overall Study|Adverse Event|0|||
33471382|NCT02566993|101616281|FG001|Overall Study|Randomized but not treated|16|||
33471383|NCT02566993|101616280|FG000|Overall Study|Progressive disease|213|||
33471384|NCT02566993|101616281|FG001|Overall Study|Progressive disease|152|||
33471385|NCT02566993|101616280|FG000|Overall Study|Withdrawal by Subject|12|||
33471386|NCT02566993|101616281|FG001|Overall Study|Withdrawal by Subject|28|||
33471387|NCT02566993|101616280|FG000|Overall Study|Death|17|||
33471388|NCT02566993|101616281|FG001|Overall Study|Death|23|||
33471389|NCT02566993|101616280|FG000|Overall Study|Physician Decision|10|||
33471390|NCT02566993|101616281|FG001|Overall Study|Physician Decision|17|||
33471391|NCT02566993|101616280|FG000|Overall Study|Study drug-related adverse event|20|||
33471392|NCT02566993|101616281|FG001|Overall Study|Study drug-related adverse event|41|||
33471393|NCT02566993|101616280|FG000|Overall Study|Non study drug-related adverse event|9|||
33471394|NCT02566993|101616281|FG001|Overall Study|Non study drug-related adverse event|9|||
33471395|NCT02566993|101616280|FG000|Overall Study|Symptomatic deterioration|9|||
33471396|NCT02566993|101616281|FG001|Overall Study|Symptomatic deterioration|16|||
33471397|NCT02566993|101616280|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
33471398|NCT02566993|101616281|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
33471399|NCT02566993|101616280|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
33471400|NCT02566993|101616281|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
33471401|NCT02566993|101616280|FG000|Overall Study|Screening failure|2|||
33471402|NCT02566993|101616281|FG001|Overall Study|Screening failure|0|||
33180671|NCT02608268|100572187|FG009|Overall Study|Adverse Event|0|||
33180672|NCT02608268|100572188|FG010|Overall Study|Adverse Event|0|||
33180673|NCT02608268|100572189|FG011|Overall Study|Adverse Event|0|||
33471403|NCT02566993|101616280|FG000|Overall Study|Lost to Follow-up|0|||
33471404|NCT02566993|101616281|FG001|Overall Study|Lost to Follow-up|1|||
33471405|NCT02566993|101616280|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
33471406|NCT02566993|101616281|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
33471407|NCT00444457|101616290|FG000|Infant Series|Other|0|||
33471408|NCT00444457|101616291|FG001|Infant Series|Other|1|||
33471409|NCT00444457|101616292|FG002|Infant Series|Other|0|||
33471410|NCT00444457|101616293|FG003|Infant Series|Other|0|||
33471411|NCT00444457|101616290|FG000|Infant Series|Parent or legal guardian request|18|||
33471412|NCT00444457|101616291|FG001|Infant Series|Parent or legal guardian request|29|||
33471413|NCT00444457|101616292|FG002|Infant Series|Parent or legal guardian request|34|||
33471414|NCT00444457|101616293|FG003|Infant Series|Parent or legal guardian request|14|||
33471415|NCT00444457|101616290|FG000|Infant Series|Lost to Follow-up|10|||
33471416|NCT00444457|101616291|FG001|Infant Series|Lost to Follow-up|11|||
33471417|NCT00444457|101616292|FG002|Infant Series|Lost to Follow-up|7|||
33471418|NCT00444457|101616293|FG003|Infant Series|Lost to Follow-up|6|||
33471419|NCT00444457|101616290|FG000|Infant Series|Protocol Violation|16|||
33471420|NCT00444457|101616291|FG001|Infant Series|Protocol Violation|8|||
33471421|NCT00444457|101616292|FG002|Infant Series|Protocol Violation|6|||
33471422|NCT00444457|101616293|FG003|Infant Series|Protocol Violation|3|||
33471423|NCT00444457|101616290|FG000|Infant Series|Failed to return|5|||
33471424|NCT00444457|101616291|FG001|Infant Series|Failed to return|4|||
33471425|NCT00444457|101616292|FG002|Infant Series|Failed to return|4|||
33471426|NCT00444457|101616293|FG003|Infant Series|Failed to return|2|||
33471427|NCT00444457|101616290|FG000|Infant Series|Investigator request|4|||
33471428|NCT00444457|101616291|FG001|Infant Series|Investigator request|3|||
33471429|NCT00444457|101616292|FG002|Infant Series|Investigator request|3|||
33471430|NCT00444457|101616293|FG003|Infant Series|Investigator request|2|||
33471431|NCT00444457|101616290|FG000|Infant Series|Other|0|||
33471432|NCT00444457|101616291|FG001|Infant Series|Other|2|||
33471433|NCT00444457|101616292|FG002|Infant Series|Other|4|||
33471434|NCT00444457|101616293|FG003|Infant Series|Other|0|||
33471435|NCT00444457|101616290|FG000|Infant Series|Adverse Event|1|||
33471436|NCT00444457|101616291|FG001|Infant Series|Adverse Event|2|||
33471437|NCT00444457|101616292|FG002|Infant Series|Adverse Event|2|||
33471438|NCT00444457|101616293|FG003|Infant Series|Adverse Event|0|||
33471439|NCT00444457|101616290|FG000|Infant Series|Death|0|||
33471440|NCT00444457|101616291|FG001|Infant Series|Death|1|||
33471441|NCT00444457|101616292|FG002|Infant Series|Death|1|||
33471442|NCT00444457|101616293|FG003|Infant Series|Death|1|||
33471443|NCT00444457|101616290|FG000|After Infant Series|Other|0|||
33471444|NCT00444457|101616291|FG001|After Infant Series|Other|1|||
33471445|NCT00444457|101616292|FG002|After Infant Series|Other|1|||
33471446|NCT00444457|101616293|FG003|After Infant Series|Other|1|||
33471447|NCT00444457|101616290|FG000|After Infant Series|Parent or legal guardian request|4|||
33471448|NCT00444457|101616291|FG001|After Infant Series|Parent or legal guardian request|11|||
33471449|NCT00444457|101616292|FG002|After Infant Series|Parent or legal guardian request|6|||
33471450|NCT00444457|101616293|FG003|After Infant Series|Parent or legal guardian request|3|||
33471451|NCT00444457|101616290|FG000|After Infant Series|Failed to return|7|||
33471452|NCT00444457|101616291|FG001|After Infant Series|Failed to return|6|||
33471453|NCT00444457|101616292|FG002|After Infant Series|Failed to return|5|||
33471454|NCT00444457|101616293|FG003|After Infant Series|Failed to return|1|||
33471455|NCT00444457|101616290|FG000|After Infant Series|Lost to Follow-up|5|||
33471456|NCT00444457|101616291|FG001|After Infant Series|Lost to Follow-up|5|||
33471457|NCT00444457|101616292|FG002|After Infant Series|Lost to Follow-up|5|||
33471458|NCT00444457|101616293|FG003|After Infant Series|Lost to Follow-up|2|||
33471459|NCT00444457|101616290|FG000|After Infant Series|Protocol Violation|2|||
33471460|NCT00444457|101616291|FG001|After Infant Series|Protocol Violation|4|||
33471461|NCT00444457|101616292|FG002|After Infant Series|Protocol Violation|2|||
33471462|NCT00444457|101616293|FG003|After Infant Series|Protocol Violation|2|||
33471463|NCT00444457|101616290|FG000|After Infant Series|Adverse Event|2|||
33471464|NCT00444457|101616291|FG001|After Infant Series|Adverse Event|2|||
33471465|NCT00444457|101616292|FG002|After Infant Series|Adverse Event|0|||
33471466|NCT00444457|101616293|FG003|After Infant Series|Adverse Event|0|||
33471467|NCT00444457|101616290|FG000|After Infant Series|Investigator request|0|||
33471468|NCT00444457|101616291|FG001|After Infant Series|Investigator request|0|||
33471469|NCT00444457|101616292|FG002|After Infant Series|Investigator request|0|||
33471470|NCT00444457|101616293|FG003|After Infant Series|Investigator request|1|||
33471471|NCT00444457|101616290|FG000|After Infant Series|Other|0|||
33471472|NCT00444457|101616291|FG001|After Infant Series|Other|1|||
33471473|NCT00444457|101616292|FG002|After Infant Series|Other|0|||
33471474|NCT00444457|101616293|FG003|After Infant Series|Other|0|||
33471475|NCT00444457|101616290|FG000|Toddler Dose|Lost to Follow-up|4|||
33471476|NCT00444457|101616291|FG001|Toddler Dose|Lost to Follow-up|1|||
33471477|NCT00444457|101616292|FG002|Toddler Dose|Lost to Follow-up|1|||
33180674|NCT02608268|100572190|FG012|Overall Study|Adverse Event|2|||
33180675|NCT02608268|100572191|FG013|Overall Study|Adverse Event|0|||
33180676|NCT02608268|100572192|FG014|Overall Study|Adverse Event|0|||
33180677|NCT02608268|100572193|FG015|Overall Study|Adverse Event|0|||
33180678|NCT02608268|100572194|FG016|Overall Study|Adverse Event|0|||
33180679|NCT02608268|100572195|FG017|Overall Study|Adverse Event|0|||
33180680|NCT02608268|100572196|FG018|Overall Study|Adverse Event|0|||
33471478|NCT00444457|101616293|FG003|Toddler Dose|Lost to Follow-up|3|||
33471479|NCT00444457|101616290|FG000|Toddler Dose|Failed to return|2|||
33471480|NCT00444457|101616291|FG001|Toddler Dose|Failed to return|2|||
33471481|NCT00444457|101616292|FG002|Toddler Dose|Failed to return|1|||
33471482|NCT00444457|101616293|FG003|Toddler Dose|Failed to return|3|||
33471483|NCT00444457|101616290|FG000|Toddler Dose|Parent or legal guardian request|0|||
33471484|NCT00444457|101616291|FG001|Toddler Dose|Parent or legal guardian request|3|||
33471485|NCT00444457|101616292|FG002|Toddler Dose|Parent or legal guardian request|2|||
33471486|NCT00444457|101616293|FG003|Toddler Dose|Parent or legal guardian request|1|||
33471487|NCT00444457|101616290|FG000|Toddler Dose|Protocol Violation|1|||
33471488|NCT00444457|101616291|FG001|Toddler Dose|Protocol Violation|0|||
33180681|NCT02608268|100572197|FG019|Overall Study|Adverse Event|0|||
33180682|NCT02608268|100572198|FG020|Overall Study|Adverse Event|1|||
33180683|NCT02608268|100572199|FG021|Overall Study|Adverse Event|1|||
33180684|NCT02608268|100572200|FG022|Overall Study|Adverse Event|0|||
33180685|NCT02608268|100572201|FG023|Overall Study|Adverse Event|0|||
33180686|NCT02608268|100572202|FG024|Overall Study|Adverse Event|1|||
33180687|NCT02608268|100572203|FG025|Overall Study|Adverse Event|0|||
33180688|NCT02608268|100572204|FG026|Overall Study|Adverse Event|0|||
33180689|NCT02608268|100572205|FG027|Overall Study|Adverse Event|0|||
33180690|NCT02608268|100572206|FG028|Overall Study|Adverse Event|1|||
33471489|NCT00444457|101616292|FG002|Toddler Dose|Protocol Violation|0|||
33471490|NCT00444457|101616293|FG003|Toddler Dose|Protocol Violation|1|||
33471491|NCT00073021|101616296|FG000|Overall Study|Protocol Violation|2|||
33471492|NCT00073021|101616297|FG001|Overall Study|Protocol Violation|1|||
33471493|NCT00073021|101616296|FG000|Overall Study|Adverse Event|4|||
33471494|NCT00073021|101616297|FG001|Overall Study|Adverse Event|4|||
33471495|NCT00073021|101616296|FG000|Overall Study|Withdrawal by Subject|6|||
33471496|NCT00073021|101616297|FG001|Overall Study|Withdrawal by Subject|5|||
33471497|NCT00073021|101616296|FG000|Overall Study|Physician Decision|3|||
33471498|NCT00073021|101616297|FG001|Overall Study|Physician Decision|1|||
33471499|NCT00073021|101616296|FG000|Overall Study|Lack of Efficacy|11|||
33471500|NCT00073021|101616297|FG001|Overall Study|Lack of Efficacy|5|||
33471501|NCT01144364|101616298|FG000|Induction Phase|Disease progression|14|||
33471502|NCT01144364|101616299|FG001|Induction Phase|Disease progression|0|||
33471503|NCT01144364|101616300|FG002|Induction Phase|Disease progression|0|||
33471504|NCT01144364|101616298|FG000|Induction Phase|Adverse Event|9|||
33471505|NCT01144364|101616299|FG001|Induction Phase|Adverse Event|0|||
33471506|NCT01144364|101616300|FG002|Induction Phase|Adverse Event|0|||
33471507|NCT01144364|101616298|FG000|Induction Phase|Death|1|||
33471508|NCT01144364|101616299|FG001|Induction Phase|Death|0|||
33471509|NCT01144364|101616300|FG002|Induction Phase|Death|0|||
33471510|NCT01144364|101616298|FG000|Induction Phase|Withdrawal by Subject|1|||
33180691|NCT02608268|100572207|FG029|Overall Study|Adverse Event|0|||
33180692|NCT02608268|100572178|FG000|Overall Study|Death|1|||
33180693|NCT02608268|100572179|FG001|Overall Study|Death|0|||
33180694|NCT02608268|100572180|FG002|Overall Study|Death|0|||
33180695|NCT02608268|100572181|FG003|Overall Study|Death|0|||
33180696|NCT02608268|100572182|FG004|Overall Study|Death|0|||
33180697|NCT02608268|100572183|FG005|Overall Study|Death|0|||
33180698|NCT02608268|100572184|FG006|Overall Study|Death|0|||
33180699|NCT02608268|100572185|FG007|Overall Study|Death|0|||
33180700|NCT02608268|100572186|FG008|Overall Study|Death|1|||
33180701|NCT02608268|100572187|FG009|Overall Study|Death|1|||
33180702|NCT02608268|100572188|FG010|Overall Study|Death|0|||
33180703|NCT02608268|100572189|FG011|Overall Study|Death|0|||
33180704|NCT02608268|100572190|FG012|Overall Study|Death|0|||
33180705|NCT02608268|100572191|FG013|Overall Study|Death|0|||
33180706|NCT02608268|100572192|FG014|Overall Study|Death|0|||
33180707|NCT02608268|100572193|FG015|Overall Study|Death|1|||
33180708|NCT02608268|100572194|FG016|Overall Study|Death|0|||
33180709|NCT02608268|100572195|FG017|Overall Study|Death|1|||
33180710|NCT02608268|100572196|FG018|Overall Study|Death|0|||
33180711|NCT02608268|100572197|FG019|Overall Study|Death|1|||
33180712|NCT02608268|100572198|FG020|Overall Study|Death|1|||
33180713|NCT02608268|100572199|FG021|Overall Study|Death|0|||
33180714|NCT02608268|100572200|FG022|Overall Study|Death|0|||
33180715|NCT02608268|100572201|FG023|Overall Study|Death|0|||
33180716|NCT02608268|100572202|FG024|Overall Study|Death|1|||
33180717|NCT02608268|100572203|FG025|Overall Study|Death|2|||
33180718|NCT02608268|100572204|FG026|Overall Study|Death|0|||
33180719|NCT02608268|100572205|FG027|Overall Study|Death|1|||
33180720|NCT02608268|100572206|FG028|Overall Study|Death|4|||
33266354|NCT01536093|100873877|FG001|Overall Study|Death|2|||
33471511|NCT01144364|101616299|FG001|Induction Phase|Withdrawal by Subject|0|||
33471512|NCT01144364|101616300|FG002|Induction Phase|Withdrawal by Subject|0|||
33471513|NCT01144364|101616298|FG000|Induction Phase|Lost to Follow-up|2|||
33471514|NCT01144364|101616299|FG001|Induction Phase|Lost to Follow-up|0|||
33180721|NCT02608268|100572207|FG029|Overall Study|Death|0|||
33180722|NCT02608268|100572178|FG000|Overall Study|Physician Decision|0|||
33180723|NCT02608268|100572179|FG001|Overall Study|Physician Decision|0|||
33180724|NCT02608268|100572180|FG002|Overall Study|Physician Decision|0|||
33180725|NCT02608268|100572181|FG003|Overall Study|Physician Decision|0|||
33471515|NCT01144364|101616300|FG002|Induction Phase|Lost to Follow-up|0|||
33471516|NCT01144364|101616298|FG000|Induction Phase|Physician Decision|1|||
33180726|NCT02608268|100572182|FG004|Overall Study|Physician Decision|0|||
33180727|NCT02608268|100572183|FG005|Overall Study|Physician Decision|0|||
33180728|NCT02608268|100572184|FG006|Overall Study|Physician Decision|0|||
33180729|NCT02608268|100572185|FG007|Overall Study|Physician Decision|0|||
33180730|NCT02608268|100572186|FG008|Overall Study|Physician Decision|0|||
33180731|NCT02608268|100572187|FG009|Overall Study|Physician Decision|0|||
33471517|NCT01144364|101616299|FG001|Induction Phase|Physician Decision|0|||
33471518|NCT01144364|101616300|FG002|Induction Phase|Physician Decision|0|||
33471519|NCT01144364|101616298|FG000|Induction Phase|Stable disease|2|||
33471520|NCT01144364|101616299|FG001|Induction Phase|Stable disease|0|||
33471521|NCT01144364|101616300|FG002|Induction Phase|Stable disease|0|||
33471522|NCT01144364|101616298|FG000|Induction Phase|Secondary neoplasia|1|||
33471523|NCT01144364|101616299|FG001|Induction Phase|Secondary neoplasia|0|||
33471524|NCT01144364|101616300|FG002|Induction Phase|Secondary neoplasia|0|||
33471525|NCT01144364|101616298|FG000|Induction Phase|Protocol Violation|1|||
33471526|NCT01144364|101616299|FG001|Induction Phase|Protocol Violation|0|||
33471527|NCT01144364|101616300|FG002|Induction Phase|Protocol Violation|0|||
33471528|NCT01144364|101616298|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
33471529|NCT01144364|101616299|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
33471530|NCT01144364|101616300|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
33471531|NCT01144364|101616298|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
33471532|NCT01144364|101616299|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
33471533|NCT01144364|101616300|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
33471534|NCT01144364|101616298|FG000|Follow-Up/Maintenance Phase|Death|0|||
33471535|NCT01144364|101616299|FG001|Follow-Up/Maintenance Phase|Death|2|||
33471536|NCT01144364|101616300|FG002|Follow-Up/Maintenance Phase|Death|0|||
33471537|NCT01144364|101616298|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
33471538|NCT01144364|101616299|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
33471539|NCT01144364|101616300|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
33471540|NCT01144364|101616298|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
33471541|NCT01144364|101616299|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
33471542|NCT01144364|101616300|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
33471543|NCT01144364|101616298|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
33471544|NCT01144364|101616299|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
33471545|NCT01144364|101616300|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
33471546|NCT01144364|101616298|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
33471547|NCT01144364|101616299|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
33471548|NCT01144364|101616300|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
33471549|NCT00809159|101616302|FG000|Part 1|Adverse Event|1|||
33471550|NCT00809159|101616303|FG001|Part 1|Adverse Event|1|||
33471551|NCT00809159|101616304|FG002|Part 1|Adverse Event|0|||
33471552|NCT00809159|101616305|FG003|Part 1|Adverse Event|0|||
33471553|NCT00809159|101616306|FG004|Part 1|Adverse Event|0|||
33471554|NCT00809159|101616307|FG005|Part 1|Adverse Event|0|||
33471555|NCT00809159|101616302|FG000|Part 1|Lost to Follow-up|1|||
33471556|NCT00809159|101616303|FG001|Part 1|Lost to Follow-up|0|||
33471557|NCT00809159|101616304|FG002|Part 1|Lost to Follow-up|0|||
33471558|NCT00809159|101616305|FG003|Part 1|Lost to Follow-up|0|||
33471559|NCT00809159|101616306|FG004|Part 1|Lost to Follow-up|0|||
33471560|NCT00809159|101616307|FG005|Part 1|Lost to Follow-up|0|||
33471561|NCT00809159|101616302|FG000|Part 1|Withdrawal by Subject|3|||
33471562|NCT00809159|101616303|FG001|Part 1|Withdrawal by Subject|1|||
33471563|NCT00809159|101616304|FG002|Part 1|Withdrawal by Subject|0|||
33471564|NCT00809159|101616305|FG003|Part 1|Withdrawal by Subject|0|||
33471565|NCT00809159|101616306|FG004|Part 1|Withdrawal by Subject|0|||
33471566|NCT00809159|101616307|FG005|Part 1|Withdrawal by Subject|0|||
33471567|NCT00809159|101616302|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
33180732|NCT02608268|100572188|FG010|Overall Study|Physician Decision|1|||
33180733|NCT02608268|100572189|FG011|Overall Study|Physician Decision|0|||
33180734|NCT02608268|100572190|FG012|Overall Study|Physician Decision|0|||
33180735|NCT02608268|100572191|FG013|Overall Study|Physician Decision|1|||
33180736|NCT02608268|100572192|FG014|Overall Study|Physician Decision|0|||
33180737|NCT02608268|100572193|FG015|Overall Study|Physician Decision|0|||
33180738|NCT02608268|100572194|FG016|Overall Study|Physician Decision|0|||
33180739|NCT02608268|100572195|FG017|Overall Study|Physician Decision|0|||
33180740|NCT02608268|100572196|FG018|Overall Study|Physician Decision|0|||
33180741|NCT02608268|100572197|FG019|Overall Study|Physician Decision|0|||
33180742|NCT02608268|100572198|FG020|Overall Study|Physician Decision|0|||
33180743|NCT02608268|100572199|FG021|Overall Study|Physician Decision|0|||
33180744|NCT02608268|100572200|FG022|Overall Study|Physician Decision|1|||
33180745|NCT02608268|100572201|FG023|Overall Study|Physician Decision|1|||
33180746|NCT02608268|100572202|FG024|Overall Study|Physician Decision|1|||
33180747|NCT02608268|100572203|FG025|Overall Study|Physician Decision|0|||
33180748|NCT02608268|100572204|FG026|Overall Study|Physician Decision|0|||
33180749|NCT02608268|100572205|FG027|Overall Study|Physician Decision|2|||
33471568|NCT00809159|101616303|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
33180750|NCT02608268|100572206|FG028|Overall Study|Physician Decision|1|||
33471569|NCT00809159|101616304|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
33471570|NCT00809159|101616305|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
33471571|NCT00809159|101616306|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
33471572|NCT00809159|101616307|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
33180751|NCT02608268|100572207|FG029|Overall Study|Physician Decision|1|||
33180752|NCT02608268|100572178|FG000|Overall Study|Progressive disease|12|||
33180753|NCT02608268|100572179|FG001|Overall Study|Progressive disease|8|||
33180754|NCT02608268|100572180|FG002|Overall Study|Progressive disease|13|||
33180755|NCT02608268|100572181|FG003|Overall Study|Progressive disease|5|||
33180756|NCT02608268|100572182|FG004|Overall Study|Progressive disease|2|||
33180757|NCT02608268|100572183|FG005|Overall Study|Progressive disease|4|||
33180758|NCT02608268|100572184|FG006|Overall Study|Progressive disease|6|||
33180759|NCT02608268|100572185|FG007|Overall Study|Progressive disease|2|||
33180760|NCT02608268|100572186|FG008|Overall Study|Progressive disease|5|||
33180761|NCT02608268|100572187|FG009|Overall Study|Progressive disease|6|||
33180762|NCT02608268|100572188|FG010|Overall Study|Progressive disease|5|||
33180763|NCT02608268|100572189|FG011|Overall Study|Progressive disease|5|||
33180764|NCT02608268|100572190|FG012|Overall Study|Progressive disease|4|||
33180765|NCT02608268|100572191|FG013|Overall Study|Progressive disease|11|||
33180766|NCT02608268|100572192|FG014|Overall Study|Progressive disease|6|||
33180767|NCT02608268|100572193|FG015|Overall Study|Progressive disease|3|||
33180768|NCT02608268|100572194|FG016|Overall Study|Progressive disease|5|||
33180769|NCT02608268|100572195|FG017|Overall Study|Progressive disease|5|||
33180770|NCT02608268|100572196|FG018|Overall Study|Progressive disease|5|||
33180771|NCT02608268|100572197|FG019|Overall Study|Progressive disease|2|||
33180772|NCT02608268|100572198|FG020|Overall Study|Progressive disease|10|||
33180773|NCT02608268|100572199|FG021|Overall Study|Progressive disease|4|||
33180774|NCT02608268|100572200|FG022|Overall Study|Progressive disease|5|||
33180775|NCT02608268|100572201|FG023|Overall Study|Progressive disease|5|||
33180776|NCT02608268|100572202|FG024|Overall Study|Progressive disease|3|||
33180777|NCT02608268|100572203|FG025|Overall Study|Progressive disease|11|||
33180778|NCT02608268|100572204|FG026|Overall Study|Progressive disease|16|||
33180779|NCT02608268|100572205|FG027|Overall Study|Progressive disease|11|||
33180780|NCT02608268|100572206|FG028|Overall Study|Progressive disease|10|||
33180781|NCT02608268|100572207|FG029|Overall Study|Progressive disease|15|||
33180782|NCT02608268|100572178|FG000|Overall Study|Subject/guardian decision|1|||
33180783|NCT02608268|100572179|FG001|Overall Study|Subject/guardian decision|1|||
33180784|NCT02608268|100572180|FG002|Overall Study|Subject/guardian decision|2|||
33180785|NCT02608268|100572181|FG003|Overall Study|Subject/guardian decision|0|||
33180786|NCT02608268|100572182|FG004|Overall Study|Subject/guardian decision|0|||
33180787|NCT02608268|100572183|FG005|Overall Study|Subject/guardian decision|0|||
33180788|NCT02608268|100572184|FG006|Overall Study|Subject/guardian decision|0|||
33180789|NCT02608268|100572185|FG007|Overall Study|Subject/guardian decision|0|||
33180790|NCT02608268|100572186|FG008|Overall Study|Subject/guardian decision|2|||
33180791|NCT02608268|100572187|FG009|Overall Study|Subject/guardian decision|2|||
33180792|NCT02608268|100572188|FG010|Overall Study|Subject/guardian decision|0|||
33180793|NCT02608268|100572189|FG011|Overall Study|Subject/guardian decision|1|||
33180794|NCT02608268|100572190|FG012|Overall Study|Subject/guardian decision|0|||
33180795|NCT02608268|100572191|FG013|Overall Study|Subject/guardian decision|1|||
33180796|NCT02608268|100572192|FG014|Overall Study|Subject/guardian decision|0|||
33180797|NCT02608268|100572193|FG015|Overall Study|Subject/guardian decision|1|||
33471573|NCT00809159|101616302|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
33471574|NCT00809159|101616303|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
33471575|NCT00809159|101616304|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
33471576|NCT00809159|101616305|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
33471577|NCT00809159|101616306|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
33471578|NCT00809159|101616307|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
33471579|NCT00809159|101616302|FG000|Part 1 and 2|Administrative problems|0|||
33471580|NCT00809159|101616303|FG001|Part 1 and 2|Administrative problems|0|||
33471581|NCT00809159|101616304|FG002|Part 1 and 2|Administrative problems|0|||
33471582|NCT00809159|101616305|FG003|Part 1 and 2|Administrative problems|1|||
33471583|NCT00809159|101616306|FG004|Part 1 and 2|Administrative problems|0|||
33471584|NCT00809159|101616307|FG005|Part 1 and 2|Administrative problems|0|||
33471585|NCT00809159|101616302|FG000|Part 1 and 2|Adverse Event|0|||
33471586|NCT00809159|101616303|FG001|Part 1 and 2|Adverse Event|0|||
33471587|NCT00809159|101616304|FG002|Part 1 and 2|Adverse Event|1|||
33180798|NCT02608268|100572194|FG016|Overall Study|Subject/guardian decision|0|||
33180799|NCT02608268|100572195|FG017|Overall Study|Subject/guardian decision|0|||
33180800|NCT02608268|100572196|FG018|Overall Study|Subject/guardian decision|1|||
33180801|NCT02608268|100572197|FG019|Overall Study|Subject/guardian decision|0|||
33180802|NCT02608268|100572198|FG020|Overall Study|Subject/guardian decision|0|||
33180803|NCT02608268|100572199|FG021|Overall Study|Subject/guardian decision|0|||
33180804|NCT02608268|100572200|FG022|Overall Study|Subject/guardian decision|1|||
33180805|NCT02608268|100572201|FG023|Overall Study|Subject/guardian decision|0|||
33180806|NCT02608268|100572202|FG024|Overall Study|Subject/guardian decision|0|||
33180807|NCT02608268|100572203|FG025|Overall Study|Subject/guardian decision|1|||
33471588|NCT00809159|101616305|FG003|Part 1 and 2|Adverse Event|0|||
33180808|NCT02608268|100572204|FG026|Overall Study|Subject/guardian decision|1|||
33471589|NCT00809159|101616306|FG004|Part 1 and 2|Adverse Event|1|||
33180809|NCT02608268|100572205|FG027|Overall Study|Subject/guardian decision|1|||
33180810|NCT02608268|100572206|FG028|Overall Study|Subject/guardian decision|1|||
33180811|NCT02608268|100572207|FG029|Overall Study|Subject/guardian decision|0|||
33180812|NCT01536379|100572208|FG000|Overall Study|Adverse Event|1|||
33180813|NCT01536379|100572209|FG001|Overall Study|Adverse Event|2|||
33180814|NCT01536379|100572208|FG000|Overall Study|Withdrawal by Subject|1|||
33180815|NCT01536379|100572209|FG001|Overall Study|Withdrawal by Subject|1|||
33180816|NCT01951157|100572211|FG000|Overall Study|Progressive Disease|12|||
33180817|NCT01951157|100572212|FG001|Overall Study|Progressive Disease|13|||
33180818|NCT01951157|100572213|FG002|Overall Study|Progressive Disease|10|||
33180819|NCT01951157|100572211|FG000|Overall Study|Treatment-unrelated AE|1|||
33180820|NCT01951157|100572212|FG001|Overall Study|Treatment-unrelated AE|0|||
33180821|NCT01951157|100572213|FG002|Overall Study|Treatment-unrelated AE|3|||
33180822|NCT01951157|100572211|FG000|Overall Study|Study Termination|0|||
33180823|NCT01951157|100572212|FG001|Overall Study|Study Termination|0|||
33471590|NCT00809159|101616307|FG005|Part 1 and 2|Adverse Event|1|||
33471591|NCT00809159|101616302|FG000|Part 1 and 2|Lost to Follow-up|0|||
33471592|NCT00809159|101616303|FG001|Part 1 and 2|Lost to Follow-up|0|||
33471593|NCT00809159|101616304|FG002|Part 1 and 2|Lost to Follow-up|1|||
33471594|NCT00809159|101616305|FG003|Part 1 and 2|Lost to Follow-up|1|||
33471595|NCT00809159|101616306|FG004|Part 1 and 2|Lost to Follow-up|0|||
33471596|NCT00809159|101616307|FG005|Part 1 and 2|Lost to Follow-up|0|||
33471597|NCT00809159|101616302|FG000|Part 1 and 2|Withdrawal by Subject|0|||
33471598|NCT00809159|101616303|FG001|Part 1 and 2|Withdrawal by Subject|0|||
33471599|NCT00809159|101616304|FG002|Part 1 and 2|Withdrawal by Subject|4|||
33471600|NCT00809159|101616305|FG003|Part 1 and 2|Withdrawal by Subject|0|||
33471601|NCT00809159|101616306|FG004|Part 1 and 2|Withdrawal by Subject|0|||
33471602|NCT00809159|101616307|FG005|Part 1 and 2|Withdrawal by Subject|1|||
33471603|NCT00911807|101616310|FG000|Overall Study|Adverse Event|2|||
33471604|NCT00911807|101616311|FG001|Overall Study|Adverse Event|1|||
33471605|NCT00911807|101616312|FG002|Overall Study|Adverse Event|5|||
33471606|NCT00911807|101616310|FG000|Overall Study|Death|0|||
33471607|NCT00911807|101616311|FG001|Overall Study|Death|0|||
33471608|NCT00911807|101616312|FG002|Overall Study|Death|1|||
33471609|NCT00911807|101616310|FG000|Overall Study|Protocol Violation|6|||
33471610|NCT00911807|101616311|FG001|Overall Study|Protocol Violation|4|||
33471611|NCT00911807|101616312|FG002|Overall Study|Protocol Violation|9|||
33471612|NCT00911807|101616310|FG000|Overall Study|Withdrawal by Subject|8|||
33471613|NCT00911807|101616311|FG001|Overall Study|Withdrawal by Subject|10|||
33471614|NCT00911807|101616312|FG002|Overall Study|Withdrawal by Subject|7|||
33471615|NCT00911807|101616310|FG000|Overall Study|Organizational reasons|1|||
33471616|NCT00911807|101616311|FG001|Overall Study|Organizational reasons|3|||
33471617|NCT00911807|101616312|FG002|Overall Study|Organizational reasons|1|||
33471618|NCT00389831|101616313|FG000|Overall Study|Lack of Efficacy|0|||
33471619|NCT00389831|101616314|FG001|Overall Study|Lack of Efficacy|2|||
33471620|NCT00389831|101616313|FG000|Overall Study|Did not receive treatment.|0|||
33471621|NCT00389831|101616314|FG001|Overall Study|Did not receive treatment.|2|||
33471622|NCT00389831|101616313|FG000|Overall Study|Other reasons|0|||
33471623|NCT00389831|101616314|FG001|Overall Study|Other reasons|2|||
33471624|NCT00389831|101616313|FG000|Overall Study|Lost to Follow-up|0|||
33471625|NCT00389831|101616314|FG001|Overall Study|Lost to Follow-up|1|||
33471626|NCT02516410|101616318|FG000|Overall Study|Adverse Event|0|||
33471627|NCT02516410|101616319|FG001|Overall Study|Adverse Event|1|||
33471628|NCT02516410|101616318|FG000|Overall Study|Withdrawal by Subject|0|||
33471629|NCT02516410|101616319|FG001|Overall Study|Withdrawal by Subject|1|||
33471630|NCT01138826|101616320|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
33471631|NCT01138826|101616321|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
33471632|NCT01138826|101616322|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
33471633|NCT01138826|101616323|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
33266355|NCT01536093|100873876|FG000|Overall Study|absence of maternal colostrum|2|||
33471634|NCT01138826|101616324|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
33471635|NCT01138826|101616325|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
33471636|NCT01829113|101616326|FG000|Overall Study|Disease Progression|37|||
33471637|NCT01829113|101616327|FG001|Overall Study|Disease Progression|48|||
33471638|NCT01829113|101616326|FG000|Overall Study|Adverse Event|14|||
33471639|NCT01829113|101616327|FG001|Overall Study|Adverse Event|10|||
33471640|NCT01829113|101616326|FG000|Overall Study|Withdrawal by Subject|17|||
33266356|NCT01536093|100873877|FG001|Overall Study|absence of maternal colostrum|0|||
33180824|NCT01951157|100572213|FG002|Overall Study|Study Termination|1|||
33471641|NCT01829113|101616327|FG001|Overall Study|Withdrawal by Subject|10|||
33471642|NCT01829113|101616326|FG000|Overall Study|Death|4|||
33471643|NCT01829113|101616327|FG001|Overall Study|Death|6|||
33471644|NCT01829113|101616326|FG000|Overall Study|Sponsor Decision|1|||
33471645|NCT01829113|101616327|FG001|Overall Study|Sponsor Decision|1|||
33471646|NCT01829113|101616326|FG000|Overall Study|No Study Treatment Received|3|||
33471647|NCT01829113|101616327|FG001|Overall Study|No Study Treatment Received|2|||
33471648|NCT01829113|101616326|FG000|Overall Study|Physician Decision|1|||
33471649|NCT01829113|101616327|FG001|Overall Study|Physician Decision|1|||
33471650|NCT00407758|101616328|FG000|Overall Study|ineligible -improper prior treatment|1|||
33471651|NCT02914236|101616329|FG000|Overall Study|Lost to Follow-up|1|||
33471652|NCT00851643|101616330|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
33471653|NCT00851643|101616331|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
33471654|NCT00851643|101616332|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
33471655|NCT00851643|101616333|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
33471656|NCT00851643|101616334|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
33471657|NCT00851643|101616335|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
33471658|NCT00851643|101616330|FG000|Base Study (Up to 12 Months)|Other|0|||
33471659|NCT00851643|101616331|FG001|Base Study (Up to 12 Months)|Other|0|||
33471660|NCT00851643|101616332|FG002|Base Study (Up to 12 Months)|Other|0|||
33471661|NCT00851643|101616333|FG003|Base Study (Up to 12 Months)|Other|0|||
33471662|NCT00851643|101616334|FG004|Base Study (Up to 12 Months)|Other|0|||
33471663|NCT00851643|101616335|FG005|Base Study (Up to 12 Months)|Other|1|||
33471664|NCT00851643|101616330|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
33471665|NCT00851643|101616331|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
33471666|NCT00851643|101616332|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
33471667|NCT00851643|101616333|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
33471668|NCT00851643|101616334|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
33180825|NCT01951157|100572211|FG000|Overall Study|Physician Decision|5|||
33180826|NCT01951157|100572212|FG001|Overall Study|Physician Decision|3|||
33180827|NCT01951157|100572213|FG002|Overall Study|Physician Decision|2|||
33180828|NCT01951157|100572211|FG000|Overall Study|Non-treatmentrelated death|2|||
33471669|NCT00851643|101616335|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
33471670|NCT00851643|101616330|FG000|Extension Study (Up to 36 Months)|Moved|0|||
33471671|NCT00851643|101616331|FG001|Extension Study (Up to 36 Months)|Moved|2|||
33471672|NCT00851643|101616332|FG002|Extension Study (Up to 36 Months)|Moved|1|||
33471673|NCT00851643|101616333|FG003|Extension Study (Up to 36 Months)|Moved|1|||
33471674|NCT00851643|101616334|FG004|Extension Study (Up to 36 Months)|Moved|0|||
33471675|NCT00851643|101616335|FG005|Extension Study (Up to 36 Months)|Moved|1|||
33471676|NCT01940497|101616336|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
33471677|NCT01940497|101616337|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
33471678|NCT01940497|101616336|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
33471679|NCT01940497|101616337|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
33471680|NCT01940497|101616336|FG000|Overall Study|Violation of Entry Criteria|1|||
33471681|NCT01940497|101616337|FG001|Overall Study|Violation of Entry Criteria|1|||
33471682|NCT01940497|101616336|FG000|Overall Study|Refused Treatment|1|||
33471683|NCT01940497|101616337|FG001|Overall Study|Refused Treatment|3|||
33471684|NCT01940497|101616336|FG000|Overall Study|Withdrew Consent|6|||
33180829|NCT01951157|100572212|FG001|Overall Study|Non-treatmentrelated death|2|||
33180830|NCT01951157|100572213|FG002|Overall Study|Non-treatmentrelated death|2|||
33180831|NCT01951157|100572211|FG000|Overall Study|No treated|0|||
33180832|NCT01951157|100572212|FG001|Overall Study|No treated|1|||
33180833|NCT01951157|100572213|FG002|Overall Study|No treated|0|||
33180834|NCT01951157|100572211|FG000|Overall Study|Treatment-related AE|2|||
33180835|NCT01951157|100572212|FG001|Overall Study|Treatment-related AE|0|||
33180836|NCT01951157|100572213|FG002|Overall Study|Treatment-related AE|4|||
33180837|NCT01951157|100572211|FG000|Overall Study|Consent withdrawn by subject|0|||
33180838|NCT01951157|100572212|FG001|Overall Study|Consent withdrawn by subject|1|||
33180839|NCT01951157|100572213|FG002|Overall Study|Consent withdrawn by subject|3|||
33180840|NCT01951157|100572211|FG000|Overall Study|Treatment-related death|0|||
33180841|NCT01951157|100572212|FG001|Overall Study|Treatment-related death|2|||
33180842|NCT01951157|100572213|FG002|Overall Study|Treatment-related death|0|||
33180843|NCT02420691|100572219|FG000|Overall Study|Adverse Event|3|||
33180844|NCT02420691|100572219|FG000|Overall Study|Withdrawal by Subject|3|||
33180845|NCT02225743|100572222|FG000|Overall Study|Withdrawal by Subject|18|||
33180846|NCT00600938|100572223|FG000|Core Study|Abnormal test procedure result(s)|3|||
33180847|NCT00600938|100572224|FG001|Core Study|Abnormal test procedure result(s)|2|||
33180848|NCT00600938|100572225|FG002|Core Study|Abnormal test procedure result(s)|0|||
33180849|NCT00600938|100572226|FG003|Core Study|Abnormal test procedure result(s)|0|||
33180850|NCT00600938|100572223|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
33180851|NCT00600938|100572224|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
33180852|NCT00600938|100572225|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
33180853|NCT00600938|100572226|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
33180854|NCT00600938|100572223|FG000|Core Study|Patient withdrew consent|7|||
33180855|NCT00600938|100572224|FG001|Core Study|Patient withdrew consent|12|||
33471685|NCT01940497|101616337|FG001|Overall Study|Withdrew Consent|2|||
33471686|NCT01940497|101616336|FG000|Overall Study|Administrative/Other|1|||
33471687|NCT01940497|101616337|FG001|Overall Study|Administrative/Other|1|||
33471688|NCT01929031|101616338|FG000|Overall Study|Adverse Event|3|||
33471689|NCT01929031|101616339|FG001|Overall Study|Adverse Event|1|||
33471690|NCT01929031|101616340|FG002|Overall Study|Adverse Event|1|||
33471691|NCT01929031|101616341|FG003|Overall Study|Adverse Event|0|||
33471692|NCT01929031|101616342|FG004|Overall Study|Adverse Event|0|||
33471693|NCT01929031|101616343|FG005|Overall Study|Adverse Event|0|||
33180856|NCT00600938|100572225|FG002|Core Study|Patient withdrew consent|0|||
33180857|NCT00600938|100572226|FG003|Core Study|Patient withdrew consent|0|||
33471694|NCT01929031|101616338|FG000|Overall Study|Protocol Violation|1|||
33471695|NCT01929031|101616339|FG001|Overall Study|Protocol Violation|0|||
33471696|NCT01929031|101616340|FG002|Overall Study|Protocol Violation|0|||
33471697|NCT01929031|101616341|FG003|Overall Study|Protocol Violation|0|||
33471698|NCT01929031|101616342|FG004|Overall Study|Protocol Violation|0|||
33471699|NCT01929031|101616343|FG005|Overall Study|Protocol Violation|1|||
33471700|NCT01929031|101616338|FG000|Overall Study|Reason other than specified above|0|||
33471701|NCT01929031|101616339|FG001|Overall Study|Reason other than specified above|1|||
33471702|NCT01929031|101616340|FG002|Overall Study|Reason other than specified above|0|||
33471703|NCT01929031|101616341|FG003|Overall Study|Reason other than specified above|0|||
33471704|NCT01929031|101616342|FG004|Overall Study|Reason other than specified above|1|||
33471705|NCT01929031|101616343|FG005|Overall Study|Reason other than specified above|0|||
33471706|NCT02707861|101616347|FG000|Overall Study|Went onto commercial drug|30|||
33471707|NCT02707861|101616348|FG001|Overall Study|Went onto commercial drug|23|||
33471708|NCT02707861|101616347|FG000|Overall Study|Adverse Event|2|||
33471709|NCT02707861|101616348|FG001|Overall Study|Adverse Event|3|||
33471710|NCT02707861|101616347|FG000|Overall Study|Death|5|||
33471711|NCT02707861|101616348|FG001|Overall Study|Death|2|||
33471712|NCT02707861|101616347|FG000|Overall Study|Lack of Efficacy|0|||
33471713|NCT02707861|101616348|FG001|Overall Study|Lack of Efficacy|2|||
33471714|NCT02707861|101616347|FG000|Overall Study|Physician Decision|1|||
33471715|NCT02707861|101616348|FG001|Overall Study|Physician Decision|4|||
33471716|NCT02707861|101616347|FG000|Overall Study|Withdrawal by Subject|2|||
33471717|NCT02707861|101616348|FG001|Overall Study|Withdrawal by Subject|1|||
33471718|NCT02707861|101616347|FG000|Overall Study|Lost to Follow-up|1|||
33471719|NCT02707861|101616348|FG001|Overall Study|Lost to Follow-up|3|||
33471720|NCT02072148|101620745|FG000|Overall Study|withdrew prior to surgery|23|||
33471721|NCT02072148|101620746|FG001|Overall Study|withdrew prior to surgery|0|||
33471722|NCT02072148|101620747|FG002|Overall Study|withdrew prior to surgery|0|||
33471723|NCT02072148|101620745|FG000|Overall Study|Death|0|||
33471724|NCT02072148|101620746|FG001|Overall Study|Death|0|||
33471725|NCT02072148|101620747|FG002|Overall Study|Death|1|||
33471726|NCT02072148|101620745|FG000|Overall Study|Withdrawal by Subject|0|||
33471727|NCT02072148|101620746|FG001|Overall Study|Withdrawal by Subject|13|||
33471728|NCT02072148|101620747|FG002|Overall Study|Withdrawal by Subject|12|||
33471729|NCT00973765|101620757|FG000|Overall Study|Lost to Follow-up|8|||
33471730|NCT00973765|101620758|FG001|Overall Study|Lost to Follow-up|14|||
33471731|NCT02667288|101620761|FG000|Overall Study|Protocol Violation|5|||
33471732|NCT02667288|101620761|FG000|Overall Study|Lost to Follow-up|3|||
33471733|NCT02667288|101620761|FG000|Overall Study|Withdrawal by Subject|5|||
33180858|NCT00600938|100572223|FG000|Core Study|Lost to Follow-up|3|||
33180859|NCT00600938|100572224|FG001|Core Study|Lost to Follow-up|2|||
33180860|NCT00600938|100572225|FG002|Core Study|Lost to Follow-up|0|||
33180861|NCT00600938|100572226|FG003|Core Study|Lost to Follow-up|0|||
33180862|NCT00600938|100572223|FG000|Core Study|Death|1|||
33180863|NCT00600938|100572224|FG001|Core Study|Death|1|||
33180864|NCT00600938|100572225|FG002|Core Study|Death|0|||
33180865|NCT00600938|100572226|FG003|Core Study|Death|0|||
33180866|NCT00600938|100572223|FG000|Core Study|Protocol Violation|1|||
33180867|NCT00600938|100572224|FG001|Core Study|Protocol Violation|2|||
33180868|NCT00600938|100572225|FG002|Core Study|Protocol Violation|0|||
33180869|NCT00600938|100572226|FG003|Core Study|Protocol Violation|0|||
33180870|NCT00600938|100572223|FG000|Extension Study|Adverse Event|1|||
33180871|NCT00600938|100572224|FG001|Extension Study|Adverse Event|0|||
33180872|NCT00600938|100572225|FG002|Extension Study|Adverse Event|2|||
33180873|NCT00600938|100572226|FG003|Extension Study|Adverse Event|0|||
33180874|NCT00600938|100572223|FG000|Extension Study|Abnormal test procedure results|0|||
33471734|NCT02697773|101620762|FG000|Overall Study|Adverse Event|2|||
33471735|NCT02697773|101620763|FG001|Overall Study|Adverse Event|1|||
33471736|NCT02697773|101620764|FG002|Overall Study|Adverse Event|2|||
33471737|NCT02697773|101620762|FG000|Overall Study|Death|0|||
33471738|NCT02697773|101620763|FG001|Overall Study|Death|0|||
33180875|NCT00600938|100572224|FG001|Extension Study|Abnormal test procedure results|1|||
33180876|NCT00600938|100572225|FG002|Extension Study|Abnormal test procedure results|1|||
33180877|NCT00600938|100572226|FG003|Extension Study|Abnormal test procedure results|1|||
33180878|NCT00600938|100572223|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
33180879|NCT00600938|100572224|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
33471739|NCT02697773|101620764|FG002|Overall Study|Death|2|||
33471740|NCT02697773|101620762|FG000|Overall Study|Lack of Efficacy|4|||
33471741|NCT02697773|101620763|FG001|Overall Study|Lack of Efficacy|6|||
33471742|NCT02697773|101620764|FG002|Overall Study|Lack of Efficacy|6|||
33471743|NCT02697773|101620762|FG000|Overall Study|Lost to Follow-up|5|||
33471744|NCT02697773|101620763|FG001|Overall Study|Lost to Follow-up|5|||
33471745|NCT02697773|101620764|FG002|Overall Study|Lost to Follow-up|7|||
33471746|NCT02697773|101620762|FG000|Overall Study|Other|15|||
33471747|NCT02697773|101620763|FG001|Overall Study|Other|11|||
33471748|NCT02697773|101620764|FG002|Overall Study|Other|10|||
33471749|NCT02697773|101620762|FG000|Overall Study|Protocol Violation|1|||
33471750|NCT02697773|101620763|FG001|Overall Study|Protocol Violation|1|||
33471751|NCT02697773|101620764|FG002|Overall Study|Protocol Violation|0|||
33471752|NCT02697773|101620762|FG000|Overall Study|Withdrawal by Subject|10|||
33471753|NCT02697773|101620763|FG001|Overall Study|Withdrawal by Subject|13|||
33471754|NCT02697773|101620764|FG002|Overall Study|Withdrawal by Subject|13|||
33471755|NCT02697773|101620762|FG000|Overall Study|Randomized but not treated|1|||
33471756|NCT02697773|101620763|FG001|Overall Study|Randomized but not treated|1|||
33471757|NCT02697773|101620764|FG002|Overall Study|Randomized but not treated|0|||
33471758|NCT01797835|101620768|FG000|Overall Study|Lost to Follow-up|31|||
33180880|NCT00600938|100572225|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
33180881|NCT00600938|100572226|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
33180882|NCT00600938|100572223|FG000|Extension Study|Withdrawal by Subject|2|||
33180883|NCT00600938|100572224|FG001|Extension Study|Withdrawal by Subject|2|||
33180884|NCT00600938|100572225|FG002|Extension Study|Withdrawal by Subject|3|||
33180885|NCT00600938|100572226|FG003|Extension Study|Withdrawal by Subject|0|||
33180886|NCT00600938|100572223|FG000|Extension Study|Lost to Follow-up|1|||
33180887|NCT00600938|100572224|FG001|Extension Study|Lost to Follow-up|1|||
33180888|NCT00600938|100572225|FG002|Extension Study|Lost to Follow-up|2|||
33471759|NCT01797835|101620769|FG001|Overall Study|Lost to Follow-up|27|||
33471760|NCT02963311|101620770|FG000|Overall Study|Withdrawal by Subject|1|||
33471761|NCT02963311|101620770|FG000|Overall Study|Screen Failure|4|||
33471762|NCT02639052|101620784|FG000|Overall Study|Lost to Follow-up|1|||
33471763|NCT04568031|101620785|FG000|Overall Study|Lost to Follow-up|1|||
33471764|NCT04568031|101620786|FG001|Overall Study|Lost to Follow-up|0|||
33471765|NCT04568031|101620787|FG002|Overall Study|Lost to Follow-up|0|||
33180889|NCT00600938|100572226|FG003|Extension Study|Lost to Follow-up|0|||
33180890|NCT00600938|100572223|FG000|Extension Study|Death|1|||
33180891|NCT00600938|100572224|FG001|Extension Study|Death|0|||
33180892|NCT00600938|100572225|FG002|Extension Study|Death|0|||
33180893|NCT00600938|100572226|FG003|Extension Study|Death|0|||
33180894|NCT02081690|100572228|FG000|Overall Study|Death|3|||
33180895|NCT02081690|100572228|FG000|Overall Study|Physician Decision|3|||
33180896|NCT02081690|100572228|FG000|Overall Study|Withdrawal by Subject|1|||
33180897|NCT05089682|100572230|FG000|Overall Study|Withdrawal by Subject|2|||
33180898|NCT00704535|100572231|FG000|Overall Study|Adverse Event|2|||
33180899|NCT00704535|100572231|FG000|Overall Study|Death|2|||
33180900|NCT00704535|100572231|FG000|Overall Study|Lost to Follow-up|8|||
33471766|NCT04568031|101620788|FG003|Overall Study|Lost to Follow-up|0|||
33471767|NCT04568031|101620785|FG000|Overall Study|Physician Decision|1|||
33471768|NCT04568031|101620786|FG001|Overall Study|Physician Decision|0|||
33471769|NCT04568031|101620787|FG002|Overall Study|Physician Decision|1|||
33471770|NCT04568031|101620788|FG003|Overall Study|Physician Decision|0|||
33471771|NCT04568031|101620785|FG000|Overall Study|Withdrawal by Subject|1|||
33180901|NCT00704535|100572231|FG000|Overall Study|Protocol Violation|10|||
33180902|NCT00704535|100572231|FG000|Overall Study|Completed status not on Case Report Form|124|||
33180903|NCT02636868|100572232|FG000|Overall Study|Death|0|||
33471772|NCT04568031|101620786|FG001|Overall Study|Withdrawal by Subject|0|||
33180904|NCT02636868|100572233|FG001|Overall Study|Death|1|||
33180905|NCT02636868|100572234|FG002|Overall Study|Death|2|||
33180906|NCT01485640|100572235|FG000|Overall Study|Adverse Event|10|||
33180907|NCT01485640|100572235|FG000|Overall Study|Lack of Efficacy|2|||
33180908|NCT01485640|100572235|FG000|Overall Study|Protocol Violation|1|||
33180909|NCT01485640|100572235|FG000|Overall Study|Withdrawal by Subject|14|||
33180910|NCT01485640|100572235|FG000|Overall Study|Terminated by Sponsor|95|||
33180911|NCT03311659|100572238|FG000|Overall Study|Protocol Violation|1|||
33180912|NCT00238121|100572239|FG000|Overall Study|Withdrawal by Subject|1|||
33180913|NCT00238121|100572240|FG001|Overall Study|Withdrawal by Subject|1|||
33180914|NCT00238121|100572239|FG000|Overall Study|Adverse Event|2|||
33180915|NCT00238121|100572240|FG001|Overall Study|Adverse Event|1|||
33180916|NCT03745144|100572241|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
33180917|NCT03745144|100572242|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
33180918|NCT03745144|100572243|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
33180919|NCT03745144|100572241|FG000|Period 1|Other|0|||
33180920|NCT03745144|100572242|FG001|Period 1|Other|0|||
33180921|NCT03745144|100572243|FG002|Period 1|Other|1|||
33180922|NCT01480076|100572244|FG000|Overall Study|Run-in Failure|52|||
33180923|NCT01480076|100572244|FG000|Overall Study|Adverse Event|39|||
33180924|NCT01480076|100572244|FG000|Overall Study|Death|2|||
33180925|NCT01480076|100572244|FG000|Overall Study|Disease Progression|5|||
33180926|NCT01480076|100572244|FG000|Overall Study|Non-compliance With Study Protocol|15|||
33180927|NCT01480076|100572244|FG000|Overall Study|Withdrawal by Subject|105|||
33180928|NCT01480076|100572244|FG000|Overall Study|Lost to Follow-up|7|||
33180929|NCT01480076|100572244|FG000|Overall Study|Investigator Decision|13|||
33471773|NCT04568031|101620787|FG002|Overall Study|Withdrawal by Subject|4|||
33471774|NCT04568031|101620788|FG003|Overall Study|Withdrawal by Subject|1|||
33471775|NCT00532935|101620789|FG000|Overall Study|Adverse Event|11|||
33471776|NCT00532935|101620790|FG001|Overall Study|Adverse Event|12|||
33471777|NCT00532935|101620789|FG000|Overall Study|Lack of Efficacy|0|||
33471778|NCT00532935|101620790|FG001|Overall Study|Lack of Efficacy|3|||
33180930|NCT01480076|100572244|FG000|Overall Study|Other|52|||
33180931|NCT01474876|100572249|FG000|Overall Study|Adverse Event|11|||
33471779|NCT00532935|101620789|FG000|Overall Study|Lost to Follow-up|10|||
33471780|NCT00532935|101620790|FG001|Overall Study|Lost to Follow-up|6|||
33471781|NCT00532935|101620789|FG000|Overall Study|Physician Decision|4|||
33471782|NCT00532935|101620790|FG001|Overall Study|Physician Decision|5|||
33471783|NCT00532935|101620789|FG000|Overall Study|Pregnancy|1|||
33471784|NCT00532935|101620790|FG001|Overall Study|Pregnancy|0|||
33471785|NCT00532935|101620789|FG000|Overall Study|Protocol Violation|4|||
33471786|NCT00532935|101620790|FG001|Overall Study|Protocol Violation|2|||
33471787|NCT00532935|101620789|FG000|Overall Study|Withdrawal by Subject|10|||
33471788|NCT00532935|101620790|FG001|Overall Study|Withdrawal by Subject|9|||
33471789|NCT00532935|101620789|FG000|Overall Study|Protocol Specific Criteria|11|||
33471790|NCT00532935|101620790|FG001|Overall Study|Protocol Specific Criteria|15|||
33471791|NCT01700049|101620791|FG000|Overall Study|Withdrawal by Subject|1|||
33471792|NCT02478320|101620792|FG000|Overall Study|Adverse Event|2|||
33471793|NCT02478320|101620793|FG001|Overall Study|Adverse Event|0|||
33471794|NCT02478320|101620792|FG000|Overall Study|Death|1|||
33471795|NCT02478320|101620793|FG001|Overall Study|Death|0|||
33471796|NCT02478320|101620792|FG000|Overall Study|Lack of Efficacy|4|||
33471797|NCT02478320|101620793|FG001|Overall Study|Lack of Efficacy|0|||
33471798|NCT02478320|101620792|FG000|Overall Study|Withdrawal by Subject|2|||
33471799|NCT02478320|101620793|FG001|Overall Study|Withdrawal by Subject|0|||
33471800|NCT02478320|101620792|FG000|Overall Study|Screen Failure|3|||
33471801|NCT02478320|101620793|FG001|Overall Study|Screen Failure|0|||
33471802|NCT03052322|101620794|FG000|Overall Study|Other un-specified|1|||
33471803|NCT03052322|101620795|FG001|Overall Study|Other un-specified|2|||
33471804|NCT03052322|101620794|FG000|Overall Study|Withdrawal by Subject|10|||
33471805|NCT03052322|101620795|FG001|Overall Study|Withdrawal by Subject|9|||
33471806|NCT03052322|101620794|FG000|Overall Study|Death|0|||
33471807|NCT03052322|101620795|FG001|Overall Study|Death|2|||
33471808|NCT03052322|101620794|FG000|Overall Study|Lack of Efficacy|1|||
33471809|NCT03052322|101620795|FG001|Overall Study|Lack of Efficacy|2|||
33471810|NCT03052322|101620794|FG000|Overall Study|Protocol Violation|1|||
33471811|NCT03052322|101620795|FG001|Overall Study|Protocol Violation|0|||
33471812|NCT03052322|101620794|FG000|Overall Study|Lost to Follow-up|2|||
33471813|NCT03052322|101620795|FG001|Overall Study|Lost to Follow-up|4|||
33471814|NCT03052322|101620794|FG000|Overall Study|Adverse Event|6|||
33471815|NCT03052322|101620795|FG001|Overall Study|Adverse Event|13|||
33471816|NCT02238626|101620796|FG000|Overall Study|Adverse Event|3|||
33471817|NCT02238626|101620797|FG001|Overall Study|Adverse Event|5|||
33471818|NCT02238626|101620798|FG002|Overall Study|Adverse Event|0|||
33471819|NCT02238626|101620799|FG003|Overall Study|Adverse Event|3|||
33471820|NCT02238626|101620796|FG000|Overall Study|Lost to Follow-up|2|||
33471821|NCT02238626|101620797|FG001|Overall Study|Lost to Follow-up|4|||
33471822|NCT02238626|101620798|FG002|Overall Study|Lost to Follow-up|2|||
33471823|NCT02238626|101620799|FG003|Overall Study|Lost to Follow-up|2|||
33180932|NCT01474876|100572250|FG001|Overall Study|Adverse Event|5|||
33180933|NCT01474876|100572251|FG002|Overall Study|Adverse Event|0|||
33180934|NCT01474876|100572249|FG000|Overall Study|Serious Adverse Event|2|||
33180935|NCT01474876|100572250|FG001|Overall Study|Serious Adverse Event|3|||
33180936|NCT01474876|100572251|FG002|Overall Study|Serious Adverse Event|0|||
33180937|NCT01474876|100572249|FG000|Overall Study|Lost to Follow-up|5|||
33180938|NCT01474876|100572250|FG001|Overall Study|Lost to Follow-up|4|||
33180939|NCT01474876|100572251|FG002|Overall Study|Lost to Follow-up|0|||
33180940|NCT01474876|100572249|FG000|Overall Study|Investigator's decision|28|||
33180941|NCT01474876|100572250|FG001|Overall Study|Investigator's decision|6|||
33471824|NCT02238626|101620796|FG000|Overall Study|Withdrawal by Subject|0|||
33471825|NCT02238626|101620797|FG001|Overall Study|Withdrawal by Subject|3|||
33471826|NCT02238626|101620798|FG002|Overall Study|Withdrawal by Subject|0|||
33471827|NCT02238626|101620799|FG003|Overall Study|Withdrawal by Subject|1|||
33471828|NCT02238626|101620796|FG000|Overall Study|Death|0|||
33471829|NCT02238626|101620797|FG001|Overall Study|Death|0|||
33471830|NCT02238626|101620798|FG002|Overall Study|Death|1|||
33471831|NCT02238626|101620799|FG003|Overall Study|Death|1|||
33471832|NCT02238626|101620796|FG000|Overall Study|Other|0|||
33471833|NCT02238626|101620797|FG001|Overall Study|Other|2|||
33471834|NCT02238626|101620798|FG002|Overall Study|Other|0|||
33471835|NCT02238626|101620799|FG003|Overall Study|Other|0|||
33471836|NCT03578237|101620800|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
33471837|NCT03578237|101620801|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
33471838|NCT00629265|101620803|FG000|Overall Study|Lost to Follow-up|4|||
33471839|NCT00629265|101620804|FG001|Overall Study|Lost to Follow-up|5|||
33471840|NCT00629265|101620803|FG000|Overall Study|Withdrawal by Subject|11|||
33180942|NCT01474876|100572251|FG002|Overall Study|Investigator's decision|0|||
33471841|NCT00629265|101620804|FG001|Overall Study|Withdrawal by Subject|8|||
33471842|NCT00629265|101620803|FG000|Overall Study|Death|1|||
33180943|NCT01474876|100572249|FG000|Overall Study|Patient's request|19|||
33180944|NCT01474876|100572250|FG001|Overall Study|Patient's request|5|||
33471843|NCT00629265|101620804|FG001|Overall Study|Death|0|||
33471844|NCT00629265|101620803|FG000|Overall Study|Adverse Event|2|||
33471845|NCT00629265|101620804|FG001|Overall Study|Adverse Event|0|||
33471846|NCT00629265|101620803|FG000|Overall Study|HNC Recurrence|4|||
33471847|NCT00629265|101620804|FG001|Overall Study|HNC Recurrence|0|||
33471848|NCT00629265|101620803|FG000|Overall Study|Other CA Requiring Treatment|1|||
33471849|NCT00629265|101620804|FG001|Overall Study|Other CA Requiring Treatment|3|||
33471850|NCT00629265|101620803|FG000|Overall Study|Needed Esophageal Dilation|4|||
33180945|NCT01474876|100572251|FG002|Overall Study|Patient's request|0|||
33180946|NCT01474876|100572249|FG000|Overall Study|Investigator's decision and pt request|1|||
33471851|NCT00629265|101620804|FG001|Overall Study|Needed Esophageal Dilation|1|||
33471852|NCT00629265|101620803|FG000|Overall Study|Unrelated Medical Complications|3|||
33471853|NCT00629265|101620804|FG001|Overall Study|Unrelated Medical Complications|1|||
33471854|NCT00629265|101620803|FG000|Overall Study|Unknown Reason|2|||
33471855|NCT00629265|101620804|FG001|Overall Study|Unknown Reason|2|||
33180947|NCT01474876|100572250|FG001|Overall Study|Investigator's decision and pt request|0|||
33471856|NCT00975286|101620807|FG000|Overall Study|Adverse Event|9|||
33471857|NCT00975286|101620808|FG001|Overall Study|Adverse Event|19|||
33471858|NCT00975286|101620807|FG000|Overall Study|Protocol Violation|1|||
33471859|NCT00975286|101620808|FG001|Overall Study|Protocol Violation|2|||
33180948|NCT01474876|100572251|FG002|Overall Study|Investigator's decision and pt request|0|||
33180949|NCT02171260|100572252|FG000|Overall Study|Death|0|||
33180950|NCT02171260|100572253|FG001|Overall Study|Death|0|||
33180951|NCT02171260|100572254|FG002|Overall Study|Death|0|||
33180952|NCT02171260|100572255|FG003|Overall Study|Death|1|||
33180953|NCT02171260|100572252|FG000|Overall Study|Physician Decision|1|||
33471860|NCT00975286|101620807|FG000|Overall Study|Withdrawal by Subject|0|||
33471861|NCT00975286|101620808|FG001|Overall Study|Withdrawal by Subject|2|||
33471862|NCT00975286|101620807|FG000|Overall Study|Familial and Personal Reasons|2|||
33471863|NCT00975286|101620808|FG001|Overall Study|Familial and Personal Reasons|2|||
33471864|NCT00975286|101620807|FG000|Overall Study|Poor Compliance to Protocol|0|||
33471865|NCT00975286|101620808|FG001|Overall Study|Poor Compliance to Protocol|2|||
33471866|NCT00975286|101620807|FG000|Overall Study|Sponsor Decision|0|||
33471867|NCT00975286|101620808|FG001|Overall Study|Sponsor Decision|2|||
33471868|NCT01366092|101620809|FG000|Overall Study|Progressive cGVHD|2|||
33471869|NCT01366092|101620809|FG000|Overall Study|Physician Decision|1|||
33471870|NCT01366092|101620809|FG000|Overall Study|Withdrawal by Subject|1|||
33471871|NCT04355663|101620821|FG000|Overall Study|Physician Decision|2|||
33471872|NCT04355663|101620822|FG001|Overall Study|Physician Decision|7|||
33471873|NCT04355663|101620823|FG002|Overall Study|Physician Decision|0|||
33471874|NCT04355663|101620821|FG000|Overall Study|Adverse Event|0|||
33471875|NCT04355663|101620822|FG001|Overall Study|Adverse Event|0|||
33471876|NCT04355663|101620823|FG002|Overall Study|Adverse Event|1|||
33471877|NCT04355663|101620821|FG000|Overall Study|Withdrawal by Subject|0|||
33471878|NCT04355663|101620822|FG001|Overall Study|Withdrawal by Subject|8|||
33471879|NCT04355663|101620823|FG002|Overall Study|Withdrawal by Subject|3|||
33471880|NCT03001219|101620824|FG000|Proof of Concept|Study Termination by Sponsor|0|||
33180954|NCT02171260|100572253|FG001|Overall Study|Physician Decision|0|||
33180955|NCT02171260|100572254|FG002|Overall Study|Physician Decision|1|||
33471881|NCT03001219|101620825|FG001|Proof of Concept|Study Termination by Sponsor|1|||
33471882|NCT03001219|101620824|FG000|Proof of Concept|Withdrawal by Subject|0|||
33471883|NCT03001219|101620825|FG001|Proof of Concept|Withdrawal by Subject|4|||
33471884|NCT03001219|101620824|FG000|Proof of Concept|Protocol Deviation|0|||
33471885|NCT03001219|101620825|FG001|Proof of Concept|Protocol Deviation|1|||
33471886|NCT03001219|101620824|FG000|Proof of Concept|Adverse Event|1|||
33471887|NCT03001219|101620825|FG001|Proof of Concept|Adverse Event|1|||
33471888|NCT03001219|101620824|FG000|Proof of Concept|Physician Decision|1|||
33471889|NCT03001219|101620825|FG001|Proof of Concept|Physician Decision|0|||
33471890|NCT03001219|101620824|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
33471891|NCT03001219|101620825|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
33471892|NCT03001219|101620824|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
33471893|NCT03001219|101620825|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
33471894|NCT03001219|101620824|FG000|Extension Period Analysis|Physician Decision|0|||
33180956|NCT02171260|100572255|FG003|Overall Study|Physician Decision|0|||
33180957|NCT02171260|100572252|FG000|Overall Study|Withdrawal by Subject|1|||
33471895|NCT03001219|101620825|FG001|Extension Period Analysis|Physician Decision|1|||
33471896|NCT03001219|101620824|FG000|Extension Period Analysis|Adverse Event|1|||
33471897|NCT03001219|101620825|FG001|Extension Period Analysis|Adverse Event|1|||
33471898|NCT03001219|101620824|FG000|Extension Period Analysis|Protocol Deviation|0|||
33180958|NCT02171260|100572253|FG001|Overall Study|Withdrawal by Subject|0|||
33471899|NCT03001219|101620825|FG001|Extension Period Analysis|Protocol Deviation|1|||
33471900|NCT03001219|101620824|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
33471901|NCT03001219|101620825|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
33471902|NCT04146363|101620828|FG000|Induction Period|Adverse Event|1|||
33471903|NCT04146363|101620829|FG001|Induction Period|Adverse Event|2|||
33471904|NCT04146363|101620830|FG002|Induction Period|Adverse Event|0|||
33471905|NCT04146363|101620831|FG003|Induction Period|Adverse Event|0|||
33471906|NCT04146363|101620832|FG004|Induction Period|Adverse Event|0|||
33471907|NCT04146363|101620833|FG005|Induction Period|Adverse Event|0|||
33180959|NCT02171260|100572254|FG002|Overall Study|Withdrawal by Subject|0|||
33180960|NCT02171260|100572255|FG003|Overall Study|Withdrawal by Subject|0|||
33180961|NCT02171260|100572252|FG000|Overall Study|Evidence of progressive disease|4|||
33180962|NCT02171260|100572253|FG001|Overall Study|Evidence of progressive disease|6|||
33180963|NCT02171260|100572254|FG002|Overall Study|Evidence of progressive disease|4|||
33180964|NCT02171260|100572255|FG003|Overall Study|Evidence of progressive disease|4|||
33180965|NCT00909779|100572256|FG000|Overall Study|Adverse Event|53|||
33180966|NCT00909779|100572257|FG001|Overall Study|Adverse Event|55|||
33180967|NCT00909779|100572256|FG000|Overall Study|Lack of Efficacy|7|||
33180968|NCT00909779|100572257|FG001|Overall Study|Lack of Efficacy|4|||
33180969|NCT00909779|100572256|FG000|Overall Study|Lost to Follow-up|19|||
33180970|NCT00909779|100572257|FG001|Overall Study|Lost to Follow-up|15|||
33180971|NCT00909779|100572256|FG000|Overall Study|Physician Decision|8|||
33180972|NCT00909779|100572257|FG001|Overall Study|Physician Decision|2|||
33471908|NCT04146363|101620834|FG006|Induction Period|Adverse Event|0|||
33471909|NCT04146363|101620835|FG007|Induction Period|Adverse Event|0|||
33471910|NCT04146363|101620836|FG008|Induction Period|Adverse Event|0|||
33471911|NCT04146363|101620837|FG009|Induction Period|Adverse Event|0|||
33471912|NCT04146363|101620838|FG010|Induction Period|Adverse Event|0|||
33471913|NCT04146363|101620828|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
33471914|NCT04146363|101620829|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
33471915|NCT04146363|101620830|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
33471916|NCT04146363|101620831|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
33471917|NCT04146363|101620832|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
33471918|NCT04146363|101620833|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
33471919|NCT04146363|101620834|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
33471920|NCT04146363|101620835|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
33471921|NCT04146363|101620836|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
33471922|NCT04146363|101620837|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
33471923|NCT04146363|101620838|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
33471924|NCT04146363|101620828|FG000|Induction Period|Lack of Efficacy|7|||
33471925|NCT04146363|101620829|FG001|Induction Period|Lack of Efficacy|2|||
33471926|NCT04146363|101620830|FG002|Induction Period|Lack of Efficacy|0|||
33471927|NCT04146363|101620831|FG003|Induction Period|Lack of Efficacy|0|||
33471928|NCT04146363|101620832|FG004|Induction Period|Lack of Efficacy|0|||
33471929|NCT04146363|101620833|FG005|Induction Period|Lack of Efficacy|0|||
33471930|NCT04146363|101620834|FG006|Induction Period|Lack of Efficacy|0|||
33471931|NCT04146363|101620835|FG007|Induction Period|Lack of Efficacy|0|||
33471932|NCT04146363|101620836|FG008|Induction Period|Lack of Efficacy|0|||
33471933|NCT04146363|101620837|FG009|Induction Period|Lack of Efficacy|0|||
33471934|NCT04146363|101620838|FG010|Induction Period|Lack of Efficacy|0|||
33471935|NCT04146363|101620828|FG000|Induction Period|Lost to Follow-up|1|||
33471936|NCT04146363|101620829|FG001|Induction Period|Lost to Follow-up|4|||
33471937|NCT04146363|101620830|FG002|Induction Period|Lost to Follow-up|0|||
33471938|NCT04146363|101620831|FG003|Induction Period|Lost to Follow-up|0|||
33471939|NCT04146363|101620832|FG004|Induction Period|Lost to Follow-up|0|||
33471940|NCT04146363|101620833|FG005|Induction Period|Lost to Follow-up|0|||
33471941|NCT04146363|101620834|FG006|Induction Period|Lost to Follow-up|0|||
33471942|NCT04146363|101620835|FG007|Induction Period|Lost to Follow-up|0|||
33266357|NCT01536093|100873876|FG000|Overall Study|Withdrawal by Subject|0|||
33266358|NCT01536093|100873877|FG001|Overall Study|Withdrawal by Subject|1|||
33266359|NCT03392194|100873878|FG000|Overall Study|Withdrawal by Subject|1|||
33266360|NCT03392194|100873879|FG001|Overall Study|Withdrawal by Subject|2|||
33266361|NCT03392194|100873878|FG000|Overall Study|Conflicts with personal schedule|1|||
33266362|NCT03392194|100873879|FG001|Overall Study|Conflicts with personal schedule|0|||
33266363|NCT01827839|100873887|FG000|Overall Study|Adverse Event|1|||
33266364|NCT01827839|100873887|FG000|Overall Study|Consent Withdrawal|2|||
33266365|NCT00146172|100873888|FG000|Overall Study|Adverse Event|0|||
33266366|NCT00146172|100873889|FG001|Overall Study|Adverse Event|0|||
33266367|NCT00146172|100873890|FG002|Overall Study|Adverse Event|1|||
33471943|NCT04146363|101620836|FG008|Induction Period|Lost to Follow-up|0|||
33471944|NCT04146363|101620837|FG009|Induction Period|Lost to Follow-up|0|||
33471945|NCT04146363|101620838|FG010|Induction Period|Lost to Follow-up|0|||
33180973|NCT00909779|100572256|FG000|Overall Study|Protocol Violation|2|||
33180974|NCT00909779|100572257|FG001|Overall Study|Protocol Violation|5|||
33180975|NCT00909779|100572256|FG000|Overall Study|Withdrawal by Subject|116|||
33180976|NCT00909779|100572257|FG001|Overall Study|Withdrawal by Subject|80|||
33266368|NCT00146172|100873891|FG003|Overall Study|Adverse Event|1|||
33266369|NCT00146172|100873892|FG004|Overall Study|Adverse Event|0|||
33266370|NCT00146172|100873893|FG005|Overall Study|Adverse Event|2|||
33471946|NCT04146363|101620828|FG000|Induction Period|Positive quantiferon test|0|||
33471947|NCT04146363|101620829|FG001|Induction Period|Positive quantiferon test|1|||
33471948|NCT04146363|101620830|FG002|Induction Period|Positive quantiferon test|0|||
33471949|NCT04146363|101620831|FG003|Induction Period|Positive quantiferon test|0|||
33471950|NCT04146363|101620832|FG004|Induction Period|Positive quantiferon test|0|||
33180977|NCT00909779|100572256|FG000|Overall Study|Site Ceasing Operation|2|||
33471951|NCT04146363|101620833|FG005|Induction Period|Positive quantiferon test|0|||
33471952|NCT04146363|101620834|FG006|Induction Period|Positive quantiferon test|0|||
33471953|NCT04146363|101620835|FG007|Induction Period|Positive quantiferon test|0|||
33471954|NCT04146363|101620836|FG008|Induction Period|Positive quantiferon test|0|||
33471955|NCT04146363|101620837|FG009|Induction Period|Positive quantiferon test|0|||
33471956|NCT04146363|101620838|FG010|Induction Period|Positive quantiferon test|0|||
33471957|NCT04146363|101620828|FG000|Induction Period|Protocol Deviation|5|||
33471958|NCT04146363|101620829|FG001|Induction Period|Protocol Deviation|6|||
33471959|NCT04146363|101620830|FG002|Induction Period|Protocol Deviation|0|||
33471960|NCT04146363|101620831|FG003|Induction Period|Protocol Deviation|0|||
33471961|NCT04146363|101620832|FG004|Induction Period|Protocol Deviation|0|||
33471962|NCT04146363|101620833|FG005|Induction Period|Protocol Deviation|0|||
33471963|NCT04146363|101620834|FG006|Induction Period|Protocol Deviation|0|||
33471964|NCT04146363|101620835|FG007|Induction Period|Protocol Deviation|0|||
33471965|NCT04146363|101620836|FG008|Induction Period|Protocol Deviation|0|||
33471966|NCT04146363|101620837|FG009|Induction Period|Protocol Deviation|0|||
33471967|NCT04146363|101620838|FG010|Induction Period|Protocol Deviation|0|||
33471968|NCT04146363|101620828|FG000|Induction Period|Withdrawal by Subject|6|||
33471969|NCT04146363|101620829|FG001|Induction Period|Withdrawal by Subject|3|||
33471970|NCT04146363|101620830|FG002|Induction Period|Withdrawal by Subject|0|||
33471971|NCT04146363|101620831|FG003|Induction Period|Withdrawal by Subject|0|||
33471972|NCT04146363|101620832|FG004|Induction Period|Withdrawal by Subject|0|||
33471973|NCT04146363|101620833|FG005|Induction Period|Withdrawal by Subject|0|||
33471974|NCT04146363|101620834|FG006|Induction Period|Withdrawal by Subject|0|||
33471975|NCT04146363|101620835|FG007|Induction Period|Withdrawal by Subject|0|||
33471976|NCT04146363|101620836|FG008|Induction Period|Withdrawal by Subject|0|||
33471977|NCT04146363|101620837|FG009|Induction Period|Withdrawal by Subject|0|||
33471978|NCT04146363|101620838|FG010|Induction Period|Withdrawal by Subject|0|||
33471979|NCT04146363|101620828|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
33471980|NCT04146363|101620829|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
33471981|NCT04146363|101620830|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
33471982|NCT04146363|101620831|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
33471983|NCT04146363|101620832|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
33471984|NCT04146363|101620833|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
33471985|NCT04146363|101620834|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
33471986|NCT04146363|101620835|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
33471987|NCT04146363|101620836|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
33471988|NCT04146363|101620837|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
33471989|NCT04146363|101620838|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
33471990|NCT04146363|101620828|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33471991|NCT04146363|101620829|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33471992|NCT04146363|101620830|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33471993|NCT04146363|101620831|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33471994|NCT04146363|101620832|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33471995|NCT04146363|101620833|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33471996|NCT04146363|101620834|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33471997|NCT04146363|101620835|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
33471998|NCT04146363|101620836|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33471999|NCT04146363|101620837|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33472000|NCT04146363|101620838|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
33472001|NCT04146363|101620828|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33472002|NCT04146363|101620829|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33472003|NCT04146363|101620830|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33472004|NCT04146363|101620831|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33472005|NCT04146363|101620832|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33472006|NCT04146363|101620833|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33472007|NCT04146363|101620834|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
33472008|NCT04146363|101620835|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
33472009|NCT04146363|101620836|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33472010|NCT04146363|101620837|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33472011|NCT04146363|101620838|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
33472012|NCT04146363|101620828|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
33472013|NCT04146363|101620829|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
33472014|NCT04146363|101620830|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
33472015|NCT04146363|101620831|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
33472016|NCT04146363|101620832|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
33472017|NCT04146363|101620833|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
33472018|NCT04146363|101620834|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
33472019|NCT04146363|101620835|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
33472020|NCT04146363|101620836|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
33472021|NCT04146363|101620837|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
33472022|NCT04146363|101620838|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
33472023|NCT04146363|101620828|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33472024|NCT04146363|101620829|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33472025|NCT04146363|101620830|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33472026|NCT04146363|101620831|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33472027|NCT04146363|101620832|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
33472028|NCT04146363|101620833|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
33472029|NCT04146363|101620834|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
33472030|NCT04146363|101620835|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
33472031|NCT04146363|101620836|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33472032|NCT04146363|101620837|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33472033|NCT04146363|101620838|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
33472034|NCT04146363|101620828|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33472035|NCT04146363|101620829|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33472036|NCT04146363|101620830|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
33472037|NCT04146363|101620831|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33472038|NCT04146363|101620832|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33472039|NCT04146363|101620833|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
33472040|NCT04146363|101620834|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
33472041|NCT04146363|101620835|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
33472042|NCT04146363|101620836|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33472043|NCT04146363|101620837|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33472044|NCT04146363|101620838|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
33472045|NCT04146363|101620828|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
33472046|NCT04146363|101620829|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
33472047|NCT04146363|101620830|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
33472048|NCT04146363|101620831|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
33472049|NCT04146363|101620832|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
33472050|NCT04146363|101620833|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
33472051|NCT04146363|101620834|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
33472052|NCT04146363|101620835|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
33472053|NCT04146363|101620836|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
33472054|NCT04146363|101620837|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
33180978|NCT00909779|100572257|FG001|Overall Study|Site Ceasing Operation|2|||
33180979|NCT00909779|100572256|FG000|Overall Study|Medical Monitor Decision|1|||
33180980|NCT00909779|100572257|FG001|Overall Study|Medical Monitor Decision|0|||
33180981|NCT00909779|100572256|FG000|Overall Study|Noncompliance|1|||
33180982|NCT00909779|100572257|FG001|Overall Study|Noncompliance|1|||
33180983|NCT00909779|100572256|FG000|Overall Study|Randomized in error|1|||
33180984|NCT00909779|100572257|FG001|Overall Study|Randomized in error|1|||
33180985|NCT00278954|100572258|FG000|Overall Study|Adverse Event|3|||
33472055|NCT04146363|101620838|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
33472056|NCT04146363|101620828|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33472057|NCT04146363|101620829|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33472058|NCT04146363|101620830|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33472059|NCT04146363|101620831|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33472060|NCT04146363|101620832|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33472061|NCT04146363|101620833|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33472062|NCT04146363|101620834|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33472063|NCT04146363|101620835|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
33472064|NCT04146363|101620836|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
33472065|NCT04146363|101620837|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
33472066|NCT04146363|101620838|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
33472067|NCT04146363|101620828|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33472068|NCT04146363|101620829|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33472069|NCT04146363|101620830|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33472070|NCT04146363|101620831|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33472071|NCT04146363|101620832|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33472072|NCT04146363|101620833|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33472073|NCT04146363|101620834|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33472074|NCT04146363|101620835|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33180986|NCT00278954|100572258|FG000|Overall Study|Lost to Follow-up|1|||
33180987|NCT00278954|100572258|FG000|Overall Study|Withdrawal by Subject|1|||
33180988|NCT01086540|100572259|FG000|Overall Study|Death|3|||
33180989|NCT01086540|100572260|FG001|Overall Study|Death|1|||
33180990|NCT01086540|100572259|FG000|Overall Study|Physician Decision|2|||
33180991|NCT01086540|100572260|FG001|Overall Study|Physician Decision|1|||
33472075|NCT04146363|101620836|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
33472076|NCT04146363|101620837|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
33472077|NCT04146363|101620838|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
33472078|NCT04146363|101620828|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
33472079|NCT04146363|101620829|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
33472080|NCT04146363|101620830|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
33180992|NCT01086540|100572259|FG000|Overall Study|Addition of new therapy for PAH|1|||
33180993|NCT01086540|100572260|FG001|Overall Study|Addition of new therapy for PAH|0|||
33180994|NCT04404855|100572261|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
33180995|NCT04404855|100572262|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
33180996|NCT00415909|100572263|FG000|Overall Study|Withdrawal by Subject|2|||
33180997|NCT00415909|100572263|FG000|Overall Study|Death|1|||
33180998|NCT02419742|100572264|FG000|Overall Study|Adverse Event|2|||
33180999|NCT02419742|100572265|FG001|Overall Study|Adverse Event|0|||
33181000|NCT02419742|100572264|FG000|Overall Study|Disease Progression|0|||
33181001|NCT02419742|100572265|FG001|Overall Study|Disease Progression|1|||
33472081|NCT04146363|101620831|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
33472082|NCT04146363|101620832|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
33472083|NCT04146363|101620833|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
33472084|NCT04146363|101620834|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
33472085|NCT04146363|101620835|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
33472086|NCT04146363|101620836|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
33181002|NCT02419742|100572264|FG000|Overall Study|Withdrew Consent|2|||
33181003|NCT02419742|100572265|FG001|Overall Study|Withdrew Consent|1|||
33181004|NCT02419742|100572264|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
33181005|NCT02419742|100572265|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
33181006|NCT02136576|100572266|FG000|Overall Study|Lost to Follow-up|2|||
33181007|NCT02136576|100572267|FG001|Overall Study|Lost to Follow-up|0|||
33181008|NCT02136576|100572268|FG002|Overall Study|Lost to Follow-up|0|||
33181009|NCT00335972|100572274|FG000|Overall Study|not given treatments|0|||
33472087|NCT04146363|101620837|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
33472088|NCT04146363|101620838|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
33472089|NCT04146363|101620828|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33472090|NCT04146363|101620829|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33472091|NCT04146363|101620830|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33472092|NCT04146363|101620831|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33472093|NCT04146363|101620832|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33472094|NCT04146363|101620833|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33472095|NCT04146363|101620834|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33472096|NCT04146363|101620835|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
33472097|NCT04146363|101620836|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
33472098|NCT04146363|101620837|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
33472099|NCT04146363|101620838|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
33472100|NCT04146363|101620828|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
33472101|NCT04146363|101620829|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
33472102|NCT04146363|101620830|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
33472103|NCT04146363|101620831|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
33472104|NCT04146363|101620832|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
33472105|NCT04146363|101620833|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
33472106|NCT04146363|101620834|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
33472107|NCT04146363|101620835|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
33181010|NCT00335972|100572275|FG001|Overall Study|not given treatments|3|||
33181011|NCT03025542|100572276|FG000|Overall Study|Adverse Event|0|||
33181012|NCT03025542|100572277|FG001|Overall Study|Adverse Event|2|||
33181013|NCT03025542|100572276|FG000|Overall Study|Lost to Follow-up|1|||
33181014|NCT03025542|100572277|FG001|Overall Study|Lost to Follow-up|0|||
33181015|NCT03025542|100572276|FG000|Overall Study|Withdrawal by Subject|1|||
33181016|NCT03025542|100572277|FG001|Overall Study|Withdrawal by Subject|0|||
33472108|NCT04146363|101620836|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
33472109|NCT04146363|101620837|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
33472110|NCT04146363|101620838|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
33181017|NCT03571581|100572283|FG000|Overall Study|Death|2|||
33181018|NCT03571581|100572283|FG000|Overall Study|Withdrawal by Subject|2|||
33181019|NCT01367158|100572290|FG000|Overall Study|Withdrew consent|0|||
33181020|NCT01367158|100572291|FG001|Overall Study|Withdrew consent|2|||
33472111|NCT04146363|101620828|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33472112|NCT04146363|101620829|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33181021|NCT01367158|100572292|FG002|Overall Study|Withdrew consent|1|||
33181022|NCT01367158|100572293|FG003|Overall Study|Withdrew consent|0|||
33472113|NCT04146363|101620830|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33472114|NCT04146363|101620831|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33472115|NCT04146363|101620832|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33472116|NCT04146363|101620833|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33472117|NCT04146363|101620834|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33472118|NCT04146363|101620835|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33472119|NCT04146363|101620836|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33472120|NCT04146363|101620837|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
33472121|NCT04146363|101620838|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
33472122|NCT01408628|101620839|FG000|Consented|Withdrawal by Subject|12|||
33472123|NCT01408628|101620839|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
33472124|NCT01408628|101620839|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
33472125|NCT01408628|101620839|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
33472126|NCT00262041|101620840|FG000|Overall Study|Withdrawal by Subject|0|||
33472127|NCT00262041|101620841|FG001|Overall Study|Withdrawal by Subject|3|||
33181023|NCT01367158|100572294|FG004|Overall Study|Withdrew consent|2|||
33181024|NCT01367158|100572295|FG005|Overall Study|Withdrew consent|0|||
33181025|NCT01367158|100572296|FG006|Overall Study|Withdrew consent|0|||
33181026|NCT01367158|100572297|FG007|Overall Study|Withdrew consent|1|||
33181027|NCT01367158|100572298|FG008|Overall Study|Withdrew consent|0|||
33181028|NCT01367158|100572299|FG009|Overall Study|Withdrew consent|0|||
33472128|NCT00262041|101620842|FG002|Overall Study|Withdrawal by Subject|1|||
33472129|NCT00262041|101620840|FG000|Overall Study|Lost to Follow-up|1|||
33472130|NCT00262041|101620841|FG001|Overall Study|Lost to Follow-up|1|||
33472131|NCT00262041|101620842|FG002|Overall Study|Lost to Follow-up|5|||
33472132|NCT00262041|101620840|FG000|Overall Study|Unable to classify|1|||
33472133|NCT00262041|101620841|FG001|Overall Study|Unable to classify|0|||
33472134|NCT00262041|101620842|FG002|Overall Study|Unable to classify|0|||
33472135|NCT03096847|101620853|FG000|Overall Study|Other|2|||
33472136|NCT03096847|101620854|FG001|Overall Study|Other|1|||
33472137|NCT03096847|101620855|FG002|Overall Study|Other|2|||
33472138|NCT03096847|101620853|FG000|Overall Study|Lost to Follow-up|1|||
33472139|NCT03096847|101620854|FG001|Overall Study|Lost to Follow-up|0|||
33472140|NCT03096847|101620855|FG002|Overall Study|Lost to Follow-up|1|||
33472141|NCT03096847|101620853|FG000|Overall Study|Death|6|||
33472142|NCT03096847|101620854|FG001|Overall Study|Death|0|||
33472143|NCT03096847|101620855|FG002|Overall Study|Death|2|||
33472144|NCT03096847|101620853|FG000|Overall Study|Protocol Violation|3|||
33472145|NCT03096847|101620854|FG001|Overall Study|Protocol Violation|0|||
33472146|NCT03096847|101620855|FG002|Overall Study|Protocol Violation|6|||
33472147|NCT03096847|101620853|FG000|Overall Study|Physician Decision|12|||
33472148|NCT03096847|101620854|FG001|Overall Study|Physician Decision|2|||
33472149|NCT03096847|101620855|FG002|Overall Study|Physician Decision|8|||
33472150|NCT03096847|101620853|FG000|Overall Study|Withdrawal by Subject|24|||
33181029|NCT01367158|100572300|FG010|Overall Study|Withdrew consent|0|||
33181030|NCT01367158|100572290|FG000|Overall Study|Lost to Follow-up|0|||
33181031|NCT01367158|100572291|FG001|Overall Study|Lost to Follow-up|0|||
33181032|NCT01367158|100572292|FG002|Overall Study|Lost to Follow-up|0|||
33181033|NCT01367158|100572293|FG003|Overall Study|Lost to Follow-up|1|||
33181034|NCT01367158|100572294|FG004|Overall Study|Lost to Follow-up|0|||
33181035|NCT01367158|100572295|FG005|Overall Study|Lost to Follow-up|2|||
33181036|NCT01367158|100572296|FG006|Overall Study|Lost to Follow-up|0|||
33181037|NCT01367158|100572297|FG007|Overall Study|Lost to Follow-up|1|||
33181038|NCT01367158|100572298|FG008|Overall Study|Lost to Follow-up|0|||
33181039|NCT01367158|100572299|FG009|Overall Study|Lost to Follow-up|0|||
33181040|NCT01367158|100572300|FG010|Overall Study|Lost to Follow-up|1|||
33181041|NCT01367158|100572290|FG000|Overall Study|Protocol Violation|0|||
33181042|NCT01367158|100572291|FG001|Overall Study|Protocol Violation|1|||
33181043|NCT01367158|100572292|FG002|Overall Study|Protocol Violation|0|||
33181044|NCT01367158|100572293|FG003|Overall Study|Protocol Violation|0|||
33181045|NCT01367158|100572294|FG004|Overall Study|Protocol Violation|0|||
33181046|NCT01367158|100572295|FG005|Overall Study|Protocol Violation|0|||
33181047|NCT01367158|100572296|FG006|Overall Study|Protocol Violation|0|||
33181048|NCT01367158|100572297|FG007|Overall Study|Protocol Violation|0|||
33181049|NCT01367158|100572298|FG008|Overall Study|Protocol Violation|0|||
33181050|NCT01367158|100572299|FG009|Overall Study|Protocol Violation|0|||
33266371|NCT00146172|100873894|FG006|Overall Study|Adverse Event|3|||
33266372|NCT00146172|100873895|FG007|Overall Study|Adverse Event|10|||
33472151|NCT03096847|101620854|FG001|Overall Study|Withdrawal by Subject|1|||
33472152|NCT03096847|101620855|FG002|Overall Study|Withdrawal by Subject|12|||
33472153|NCT03096847|101620853|FG000|Overall Study|Adverse Event|72|||
33472154|NCT03096847|101620854|FG001|Overall Study|Adverse Event|6|||
33472155|NCT03096847|101620855|FG002|Overall Study|Adverse Event|28|||
33472156|NCT03096847|101620853|FG000|Overall Study|Progressive disease|97|||
33181051|NCT01367158|100572300|FG010|Overall Study|Protocol Violation|0|||
33181052|NCT02250443|100572303|FG000|Overall Study|Administrative problems|7|||
33181053|NCT02250443|100572303|FG000|Overall Study|Adverse Event|3|||
33181054|NCT01327300|100572304|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
33181055|NCT01327300|100572305|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
33472157|NCT03096847|101620854|FG001|Overall Study|Progressive disease|10|||
33472158|NCT03096847|101620855|FG002|Overall Study|Progressive disease|78|||
33472159|NCT03096847|101620853|FG000|Overall Study|Non-compliance with study medication|1|||
33472160|NCT03096847|101620854|FG001|Overall Study|Non-compliance with study medication|0|||
33472161|NCT03096847|101620855|FG002|Overall Study|Non-compliance with study medication|0|||
33472162|NCT03096847|101620853|FG000|Overall Study|New therapy for study indication|1|||
33472163|NCT03096847|101620854|FG001|Overall Study|New therapy for study indication|0|||
33181056|NCT00930579|100572306|FG000|Overall Study|Withdrawal by Subject|1|||
33181057|NCT00930579|100572306|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
33181058|NCT01012622|100572308|FG000|Overall Study|Withdrawal by Subject|6|||
33181059|NCT01012622|100572308|FG000|Overall Study|Lost to Follow-up|5|||
33181060|NCT01012622|100572308|FG000|Overall Study|Adverse Event|7|||
33181061|NCT01012622|100572308|FG000|Overall Study|non-compliance with the drug|9|||
33181062|NCT01012622|100572308|FG000|Overall Study|Other|1|||
33181063|NCT01012622|100572308|FG000|Overall Study|screening failure|1|||
33181064|NCT01012622|100572308|FG000|Overall Study|withdrawal of consent by a parent|2|||
33181065|NCT00878709|100572311|FG000|Overall Study|Withdrawal by Subject|197|||
33181066|NCT00878709|100572312|FG001|Overall Study|Withdrawal by Subject|120|||
33181067|NCT00878709|100572311|FG000|Overall Study|Lost to Follow-up|35|||
33472164|NCT03096847|101620855|FG002|Overall Study|New therapy for study indication|1|||
33472165|NCT02138136|101620856|FG000|Overall Study|Protocol Violation|4|||
33472166|NCT02138136|101620856|FG000|Overall Study|Physician Decision|7|||
33181068|NCT00878709|100572312|FG001|Overall Study|Lost to Follow-up|33|||
33472167|NCT02138136|101620856|FG000|Overall Study|Lack of Efficacy|35|||
33472168|NCT02138136|101620856|FG000|Overall Study|Pregnancy|2|||
33472169|NCT02138136|101620856|FG000|Overall Study|Adverse Event|18|||
33472170|NCT02138136|101620856|FG000|Overall Study|Withdrawal by Subject|36|||
33472171|NCT02138136|101620856|FG000|Overall Study|Lost to Follow-up|32|||
33472172|NCT02138136|101620856|FG000|Overall Study|Withdrawn by Sponsor|5|||
33472173|NCT02025751|101620858|FG000|Overall Study|Lost to Follow-up|1|||
33181069|NCT00878709|100572311|FG000|Overall Study|Other Reasons|93|||
33181070|NCT00878709|100572312|FG001|Overall Study|Other Reasons|84|||
33181071|NCT02092662|100572315|FG000|Overall Study|Lost to Follow-up|13|||
33181072|NCT02092662|100572316|FG001|Overall Study|Lost to Follow-up|0|||
33181073|NCT02968979|100572317|FG000|Overall Study|Protocol Violation|7|||
33181074|NCT02968979|100572317|FG000|Overall Study|Withdrawal by Subject|1|||
33181075|NCT03045887|100572319|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
33181076|NCT03045887|100572320|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33181077|NCT03045887|100572321|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33181078|NCT03045887|100572322|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33181079|NCT03045887|100572323|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33181080|NCT03045887|100572324|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33181081|NCT03045887|100572325|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33181082|NCT03045887|100572326|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33181083|NCT03045887|100572327|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33181084|NCT03045887|100572328|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
33472174|NCT02025751|101620859|FG001|Overall Study|Lost to Follow-up|0|||
33472175|NCT02025751|101620858|FG000|Overall Study|Adverse Event|0|||
33472176|NCT02025751|101620859|FG001|Overall Study|Adverse Event|1|||
33472177|NCT02025751|101620858|FG000|Overall Study|Physician Decision|0|||
33472178|NCT02025751|101620859|FG001|Overall Study|Physician Decision|1|||
33472179|NCT02025751|101620858|FG000|Overall Study|Withdrawal by Subject|0|||
33472180|NCT02025751|101620859|FG001|Overall Study|Withdrawal by Subject|1|||
33472181|NCT01181271|101620860|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
33472182|NCT01181271|101620860|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
33472183|NCT01181271|101620860|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
33472184|NCT01181271|101620860|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
33181085|NCT03045887|100572319|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33181086|NCT03045887|100572320|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33181087|NCT03045887|100572321|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33181088|NCT03045887|100572322|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
33181089|NCT03045887|100572323|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33181090|NCT03045887|100572324|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33181091|NCT03045887|100572325|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33181092|NCT03045887|100572326|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33472185|NCT02792959|101620863|FG000|Overall Study|Protocol Violation|1|||
33472186|NCT00608517|101620865|FG000|Overall Study|Death|1|||
33472187|NCT00608517|101620866|FG001|Overall Study|Death|0|||
33181093|NCT03045887|100572327|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33181094|NCT03045887|100572328|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
33181095|NCT03045887|100572319|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
33181096|NCT03045887|100572320|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
33181097|NCT03045887|100572321|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
33181098|NCT03045887|100572322|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
33181099|NCT03045887|100572323|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
33181100|NCT03045887|100572324|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
33181101|NCT03045887|100572325|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
33181102|NCT03045887|100572326|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
33181103|NCT03045887|100572327|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
33181104|NCT03045887|100572328|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
33181105|NCT03045887|100572319|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33181106|NCT03045887|100572320|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33181107|NCT03045887|100572321|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
33181108|NCT03045887|100572322|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
33181109|NCT03045887|100572323|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33181110|NCT03045887|100572324|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33181111|NCT03045887|100572325|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33181112|NCT03045887|100572326|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33181113|NCT03045887|100572327|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33181114|NCT03045887|100572328|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
33181115|NCT03045887|100572319|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33181116|NCT03045887|100572320|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33181117|NCT03045887|100572321|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33181118|NCT03045887|100572322|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
33181119|NCT03045887|100572323|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33181120|NCT03045887|100572324|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33181121|NCT03045887|100572325|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33181122|NCT03045887|100572326|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33181123|NCT03045887|100572327|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33472188|NCT00608517|101620867|FG002|Overall Study|Death|0|||
33472189|NCT00321737|101620868|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
33472190|NCT00321737|101620869|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
33472191|NCT00321737|101620870|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
33472192|NCT00321737|101620868|FG000|Overall Study|Adverse Event|11|||
33472193|NCT00321737|101620869|FG001|Overall Study|Adverse Event|3|||
33472194|NCT00321737|101620870|FG002|Overall Study|Adverse Event|6|||
33472195|NCT00321737|101620868|FG000|Overall Study|Lost to Follow-up|5|||
33472196|NCT00321737|101620869|FG001|Overall Study|Lost to Follow-up|5|||
33472197|NCT00321737|101620870|FG002|Overall Study|Lost to Follow-up|6|||
33472198|NCT00321737|101620868|FG000|Overall Study|Withdrawal by Subject|19|||
33472199|NCT00321737|101620869|FG001|Overall Study|Withdrawal by Subject|12|||
33472200|NCT00321737|101620870|FG002|Overall Study|Withdrawal by Subject|17|||
33181124|NCT03045887|100572328|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
33181125|NCT01848756|100572331|FG000|Overall Study|Adverse Event|1|||
33181126|NCT01848756|100572331|FG000|Overall Study|Withdrawal by Subject|1|||
33181127|NCT01848756|100572331|FG000|Overall Study|Enrolled in Error|1|||
33181128|NCT00651755|100572332|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
33181129|NCT00651755|100572333|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
33181130|NCT00651755|100572332|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
33181131|NCT00651755|100572333|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
33181132|NCT03774433|100572337|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
33472201|NCT00321737|101620868|FG000|Overall Study|Protocol Violation|0|||
33472202|NCT00321737|101620869|FG001|Overall Study|Protocol Violation|0|||
33472203|NCT00321737|101620870|FG002|Overall Study|Protocol Violation|1|||
33472204|NCT00321737|101620868|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
33472205|NCT00321737|101620869|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
33472206|NCT00321737|101620870|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
33472207|NCT00321737|101620868|FG000|Overall Study|Possible Barrett's Esophagus|2|||
33472208|NCT00321737|101620869|FG001|Overall Study|Possible Barrett's Esophagus|1|||
33472209|NCT00321737|101620870|FG002|Overall Study|Possible Barrett's Esophagus|1|||
33472210|NCT00321737|101620868|FG000|Overall Study|Therapeutic Failure|6|||
33472211|NCT00321737|101620869|FG001|Overall Study|Therapeutic Failure|0|||
33472212|NCT00321737|101620870|FG002|Overall Study|Therapeutic Failure|2|||
33472213|NCT00321737|101620868|FG000|Overall Study|Pregnancy|0|||
33472214|NCT00321737|101620869|FG001|Overall Study|Pregnancy|2|||
33181133|NCT05045144|100572338|FG000|Overall Study|Lost to Follow-up|3|||
33181134|NCT05045144|100572339|FG001|Overall Study|Lost to Follow-up|2|||
33472215|NCT00321737|101620870|FG002|Overall Study|Pregnancy|0|||
33472216|NCT00321737|101620868|FG000|Overall Study|Noncompliance|2|||
33181135|NCT05045144|100572340|FG002|Overall Study|Lost to Follow-up|3|||
33181136|NCT05045144|100572341|FG003|Overall Study|Lost to Follow-up|5|||
33472217|NCT00321737|101620869|FG001|Overall Study|Noncompliance|0|||
33472218|NCT00321737|101620870|FG002|Overall Study|Noncompliance|0|||
33472219|NCT00321737|101620868|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
33472220|NCT00321737|101620869|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
33472221|NCT00321737|101620870|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
33472222|NCT04397445|101620871|FG000|Overall Study|Withdrawal by Subject|1|||
33472223|NCT04397445|101620872|FG001|Overall Study|Withdrawal by Subject|0|||
33472224|NCT04397445|101620873|FG002|Overall Study|Withdrawal by Subject|0|||
33472225|NCT04397445|101620874|FG003|Overall Study|Withdrawal by Subject|0|||
33472226|NCT03918109|101620875|FG000|Overall Study|Withdrawal by Subject|0|||
33472227|NCT03918109|101620876|FG001|Overall Study|Withdrawal by Subject|0|||
33472228|NCT03918109|101620877|FG002|Overall Study|Withdrawal by Subject|2|||
33472229|NCT03918109|101620878|FG003|Overall Study|Withdrawal by Subject|1|||
33472230|NCT03918109|101620875|FG000|Overall Study|Lost to Follow-up|0|||
33472231|NCT03918109|101620876|FG001|Overall Study|Lost to Follow-up|0|||
33472232|NCT03918109|101620877|FG002|Overall Study|Lost to Follow-up|0|||
33472233|NCT03918109|101620878|FG003|Overall Study|Lost to Follow-up|1|||
33472234|NCT03346070|101620879|FG000|Overall Study|Death|0|||
33472235|NCT03346070|101620880|FG001|Overall Study|Death|0|||
33472236|NCT03346070|101620881|FG002|Overall Study|Death|0|||
33472237|NCT03346070|101620882|FG003|Overall Study|Death|0|||
33472238|NCT03346070|101620883|FG004|Overall Study|Death|1|||
33472239|NCT03346070|101620879|FG000|Overall Study|Lost to Follow-up|0|||
33472240|NCT03346070|101620880|FG001|Overall Study|Lost to Follow-up|1|||
33472241|NCT03346070|101620881|FG002|Overall Study|Lost to Follow-up|2|||
33472242|NCT03346070|101620882|FG003|Overall Study|Lost to Follow-up|0|||
33472243|NCT03346070|101620883|FG004|Overall Study|Lost to Follow-up|0|||
33472244|NCT03346070|101620879|FG000|Overall Study|Physician Decision|0|||
33472245|NCT03346070|101620880|FG001|Overall Study|Physician Decision|0|||
33472246|NCT03346070|101620881|FG002|Overall Study|Physician Decision|0|||
33472247|NCT03346070|101620882|FG003|Overall Study|Physician Decision|1|||
33472248|NCT03346070|101620883|FG004|Overall Study|Physician Decision|1|||
33472249|NCT03346070|101620879|FG000|Overall Study|Withdrawal by Subject|1|||
33472250|NCT03346070|101620880|FG001|Overall Study|Withdrawal by Subject|0|||
33472251|NCT03346070|101620881|FG002|Overall Study|Withdrawal by Subject|0|||
33472252|NCT03346070|101620882|FG003|Overall Study|Withdrawal by Subject|1|||
33472253|NCT03346070|101620883|FG004|Overall Study|Withdrawal by Subject|0|||
33472254|NCT03346070|101620879|FG000|Overall Study|Study medication not received as planned|2|||
33472255|NCT03346070|101620880|FG001|Overall Study|Study medication not received as planned|3|||
33472256|NCT03346070|101620881|FG002|Overall Study|Study medication not received as planned|2|||
33472257|NCT03346070|101620882|FG003|Overall Study|Study medication not received as planned|3|||
33472258|NCT03346070|101620883|FG004|Overall Study|Study medication not received as planned|2|||
33472259|NCT03346070|101620879|FG000|Overall Study|Screen Failure|0|||
33472260|NCT03346070|101620880|FG001|Overall Study|Screen Failure|0|||
33472261|NCT03346070|101620881|FG002|Overall Study|Screen Failure|0|||
33472262|NCT03346070|101620882|FG003|Overall Study|Screen Failure|1|||
33472263|NCT03346070|101620883|FG004|Overall Study|Screen Failure|1|||
33472264|NCT01386684|101620884|FG000|Overall Study|Lost to Follow-up|51|||
33472265|NCT01386684|101620884|FG000|Overall Study|Other|51|||
33472266|NCT01386684|101620884|FG000|Overall Study|Death|47|||
33472267|NCT01386684|101620884|FG000|Overall Study|Withdrawal of Consent|44|||
33472268|NCT01386684|101620884|FG000|Overall Study|Alternative Therapy Required|37|||
33472269|NCT01386684|101620884|FG000|Overall Study|Disease Progression|28|||
33472270|NCT01386684|101620884|FG000|Overall Study|Adverse Event|20|||
33472271|NCT01386684|101620884|FG000|Overall Study|Noncompliance|8|||
33472272|NCT01386684|101620884|FG000|Overall Study|Protocol Violation|4|||
33472273|NCT01386684|101620884|FG000|Overall Study|Missing|3|||
33472274|NCT03118570|101620889|FG000|Overall Study|Adverse Event|2|||
33472275|NCT03118570|101620890|FG001|Overall Study|Adverse Event|0|||
33472276|NCT03118570|101620891|FG002|Overall Study|Adverse Event|0|||
33472277|NCT03118570|101620892|FG003|Overall Study|Adverse Event|0|||
33472278|NCT03118570|101620893|FG004|Overall Study|Adverse Event|3|||
33472279|NCT03118570|101620889|FG000|Overall Study|Withdrawal by Subject|0|||
33472280|NCT03118570|101620890|FG001|Overall Study|Withdrawal by Subject|1|||
33472281|NCT03118570|101620891|FG002|Overall Study|Withdrawal by Subject|4|||
33472282|NCT03118570|101620892|FG003|Overall Study|Withdrawal by Subject|0|||
33472283|NCT03118570|101620893|FG004|Overall Study|Withdrawal by Subject|1|||
33472284|NCT03118570|101620889|FG000|Overall Study|Lost to Follow-up|2|||
33472285|NCT03118570|101620890|FG001|Overall Study|Lost to Follow-up|3|||
33472286|NCT03118570|101620891|FG002|Overall Study|Lost to Follow-up|1|||
33472287|NCT03118570|101620892|FG003|Overall Study|Lost to Follow-up|0|||
33472288|NCT03118570|101620893|FG004|Overall Study|Lost to Follow-up|1|||
33472289|NCT03118570|101620889|FG000|Overall Study|Other, Not Specified|1|||
33472290|NCT03118570|101620890|FG001|Overall Study|Other, Not Specified|3|||
33472291|NCT03118570|101620891|FG002|Overall Study|Other, Not Specified|0|||
33181137|NCT05045144|100572342|FG004|Overall Study|Lost to Follow-up|13|||
33472292|NCT03118570|101620892|FG003|Overall Study|Other, Not Specified|0|||
33472293|NCT03118570|101620893|FG004|Overall Study|Other, Not Specified|0|||
33472294|NCT03649412|101620894|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
33472295|NCT03649412|101620895|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
33472296|NCT03649412|101620894|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
33472297|NCT03649412|101620895|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
33472298|NCT03649412|101620894|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
33472299|NCT03649412|101620895|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
33472300|NCT03649412|101620894|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
33472301|NCT03649412|101620895|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
33472302|NCT03649412|101620894|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
33472303|NCT03649412|101620895|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
33472304|NCT03649412|101620894|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
33472305|NCT03649412|101620895|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
33472306|NCT04209205|101620896|FG000|Overall Study|Adverse Event|2|||
33472307|NCT04209205|101620897|FG001|Overall Study|Adverse Event|3|||
33472308|NCT04209205|101620896|FG000|Overall Study|Lost to Follow-up|3|||
33181138|NCT05045144|100572338|FG000|Overall Study|Withdrawal by Subject|0|||
33472309|NCT04209205|101620897|FG001|Overall Study|Lost to Follow-up|1|||
33472310|NCT04209205|101620896|FG000|Overall Study|Physician Decision|1|||
33472311|NCT04209205|101620897|FG001|Overall Study|Physician Decision|1|||
33472312|NCT04209205|101620896|FG000|Overall Study|Subject decision|10|||
33472313|NCT04209205|101620897|FG001|Overall Study|Subject decision|10|||
33472314|NCT04209205|101620896|FG000|Overall Study|Progressive disease|1|||
33472315|NCT04209205|101620897|FG001|Overall Study|Progressive disease|0|||
33472316|NCT04209205|101620896|FG000|Overall Study|Protocol deviation|0|||
33472317|NCT04209205|101620897|FG001|Overall Study|Protocol deviation|1|||
33472318|NCT04209205|101620896|FG000|Overall Study|New therapy for study indication|1|||
33472319|NCT04209205|101620897|FG001|Overall Study|New therapy for study indication|0|||
33472320|NCT04209205|101620896|FG000|Overall Study|Adverse event - placebo not switched|0|||
33472321|NCT04209205|101620897|FG001|Overall Study|Adverse event - placebo not switched|1|||
33472322|NCT04209205|101620896|FG000|Overall Study|Subject decision - placebo not switched|0|||
33472323|NCT04209205|101620897|FG001|Overall Study|Subject decision - placebo not switched|5|||
33472324|NCT04209205|101620896|FG000|Overall Study|Death - placebo not switched|0|||
33472325|NCT04209205|101620897|FG001|Overall Study|Death - placebo not switched|1|||
33472326|NCT01215513|101620898|FG000|Overall Study|Not completed CS42|9|||
33472327|NCT01215513|101620898|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
33472328|NCT01215513|101620898|FG000|Overall Study|Adverse event (CS42A)|2|||
33472329|NCT01215513|101620898|FG000|Overall Study|Physician decision (CS42A)|6|||
33472330|NCT01215513|101620898|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
33472331|NCT01215513|101620898|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
33472332|NCT03185013|101620901|FG000|Overall Study|Withdrawal by Subject|5|||
33472333|NCT03185013|101620902|FG001|Overall Study|Withdrawal by Subject|3|||
33472334|NCT03185013|101620901|FG000|Overall Study|Adverse Event|1|||
33472335|NCT03185013|101620902|FG001|Overall Study|Adverse Event|0|||
33472336|NCT03185013|101620901|FG000|Overall Study|Progressive Disease|1|||
33472337|NCT03185013|101620902|FG001|Overall Study|Progressive Disease|0|||
33472338|NCT03185013|101620901|FG000|Overall Study|Lost to Follow-up|8|||
33472339|NCT03185013|101620902|FG001|Overall Study|Lost to Follow-up|2|||
33472340|NCT03185013|101620901|FG000|Overall Study|Physician Decision|1|||
33472341|NCT03185013|101620902|FG001|Overall Study|Physician Decision|0|||
33472342|NCT03185013|101620901|FG000|Overall Study|Protocol Deviation|2|||
33472343|NCT03185013|101620902|FG001|Overall Study|Protocol Deviation|0|||
33181139|NCT05045144|100572339|FG001|Overall Study|Withdrawal by Subject|1|||
33472344|NCT03185013|101620901|FG000|Overall Study|Reason not Specified|3|||
33472345|NCT03185013|101620902|FG001|Overall Study|Reason not Specified|2|||
33472346|NCT03185013|101620901|FG000|Overall Study|Death|1|||
33472347|NCT03185013|101620902|FG001|Overall Study|Death|0|||
33472348|NCT00311311|101620905|FG000|Overall Study|Adverse Event|3|||
33472349|NCT00311311|101620906|FG001|Overall Study|Adverse Event|2|||
33472350|NCT00311311|101620905|FG000|Overall Study|Withdrawal by Subject|1|||
33472351|NCT00311311|101620906|FG001|Overall Study|Withdrawal by Subject|1|||
33472352|NCT00311311|101620905|FG000|Overall Study|Noncompliance|0|||
33472353|NCT00311311|101620906|FG001|Overall Study|Noncompliance|1|||
33472354|NCT00311311|101620905|FG000|Overall Study|Study Termination by Sponsor|3|||
33472355|NCT00311311|101620906|FG001|Overall Study|Study Termination by Sponsor|4|||
33472356|NCT00311311|101620905|FG000|Overall Study|Death|1|||
33181140|NCT05045144|100572340|FG002|Overall Study|Withdrawal by Subject|0|||
33181141|NCT05045144|100572341|FG003|Overall Study|Withdrawal by Subject|0|||
33181142|NCT05045144|100572342|FG004|Overall Study|Withdrawal by Subject|0|||
33472357|NCT00311311|101620906|FG001|Overall Study|Death|0|||
33472358|NCT00311311|101620905|FG000|Overall Study|Lack of ancillary assistance|0|||
33472359|NCT00311311|101620906|FG001|Overall Study|Lack of ancillary assistance|1|||
33472360|NCT01616953|101620907|FG000|Overall Study|Lost to Follow-up|1|||
33472361|NCT01616953|101620908|FG001|Overall Study|Lost to Follow-up|0|||
33472362|NCT01616953|101620907|FG000|Overall Study|lack of bone and soft tissue|1|||
33472363|NCT01616953|101620908|FG001|Overall Study|lack of bone and soft tissue|0|||
33472364|NCT01462318|101620909|FG000|Main Study / TP-DI Study|Other|2|||
33472365|NCT01462318|101620910|FG001|Main Study / TP-DI Study|Other|0|||
33472366|NCT01462318|101620911|FG002|Main Study / TP-DI Study|Other|0|||
33472367|NCT01462318|101620909|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
33472368|NCT01462318|101620910|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
33472369|NCT01462318|101620911|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
33472370|NCT01462318|101620909|FG000|Main Study / TP-DI Study|Adverse Event|4|||
33472371|NCT01462318|101620910|FG001|Main Study / TP-DI Study|Adverse Event|0|||
33472372|NCT01462318|101620911|FG002|Main Study / TP-DI Study|Adverse Event|0|||
33472373|NCT01462318|101620909|FG000|Extension Phase|Lost to Follow-up|0|||
33472374|NCT01462318|101620910|FG001|Extension Phase|Lost to Follow-up|0|||
33472375|NCT01462318|101620911|FG002|Extension Phase|Lost to Follow-up|1|||
33472376|NCT01462318|101620909|FG000|Extension Phase|Other|0|||
33472377|NCT01462318|101620910|FG001|Extension Phase|Other|0|||
33472378|NCT01462318|101620911|FG002|Extension Phase|Other|1|||
33472379|NCT01462318|101620909|FG000|Extension Phase|Disease Progression|0|||
33472380|NCT01462318|101620910|FG001|Extension Phase|Disease Progression|0|||
33472381|NCT01462318|101620911|FG002|Extension Phase|Disease Progression|1|||
33472382|NCT01462318|101620909|FG000|Extension Phase|Withdrawal by Subject|0|||
33472383|NCT01462318|101620910|FG001|Extension Phase|Withdrawal by Subject|0|||
33472384|NCT01462318|101620911|FG002|Extension Phase|Withdrawal by Subject|15|||
33472385|NCT01462318|101620909|FG000|Extension Phase|Investigator Decision|0|||
33472386|NCT01462318|101620910|FG001|Extension Phase|Investigator Decision|0|||
33472387|NCT01462318|101620911|FG002|Extension Phase|Investigator Decision|5|||
33472388|NCT01462318|101620909|FG000|Extension Phase|Adverse Event|0|||
33472389|NCT01462318|101620910|FG001|Extension Phase|Adverse Event|0|||
33472390|NCT01462318|101620911|FG002|Extension Phase|Adverse Event|22|||
33472391|NCT03407430|101620917|FG000|Washout|Protocol Violation|1|||
33472392|NCT03407430|101620918|FG001|Washout|Protocol Violation|0|||
33472393|NCT01338987|101620924|FG000|Overall Study|enrolled on new protocol|0|||
33472394|NCT01338987|101620925|FG001|Overall Study|enrolled on new protocol|0|||
33472395|NCT01338987|101620926|FG002|Overall Study|enrolled on new protocol|1|||
33472396|NCT01338987|101620927|FG003|Overall Study|enrolled on new protocol|0|||
33472397|NCT01338987|101620928|FG004|Overall Study|enrolled on new protocol|0|||
33472398|NCT01338987|101620924|FG000|Overall Study|Disease progression on study|2|||
33472399|NCT01338987|101620925|FG001|Overall Study|Disease progression on study|1|||
33472400|NCT01338987|101620926|FG002|Overall Study|Disease progression on study|1|||
33472401|NCT01338987|101620927|FG003|Overall Study|Disease progression on study|0|||
33472402|NCT01338987|101620928|FG004|Overall Study|Disease progression on study|0|||
33472403|NCT01300052|101620938|FG000|Overall Study|Adverse Event|3|||
33472404|NCT01300052|101620939|FG001|Overall Study|Adverse Event|0|||
33472405|NCT01300052|101620938|FG000|Overall Study|Withdrawal by Subject|2|||
33472406|NCT01300052|101620939|FG001|Overall Study|Withdrawal by Subject|2|||
33472407|NCT01300052|101620938|FG000|Overall Study|Protocol Violation|1|||
33472408|NCT01300052|101620939|FG001|Overall Study|Protocol Violation|1|||
33472409|NCT02581163|101620940|FG000|Overall Study|Failure to return|15|||
33472410|NCT02581163|101620940|FG000|Overall Study|Insufficient virological response|3|||
33472411|NCT02581163|101620940|FG000|Overall Study|Withdrew consent|1|||
33472412|NCT02581163|101620940|FG000|Overall Study|Death|1|||
33472413|NCT02581163|101620940|FG000|Overall Study|Other, not specified|9|||
33472414|NCT01621191|101620943|FG000|Overall Study|Adverse Event|9|||
33472415|NCT01621191|101620943|FG000|Overall Study|Withdrawal by Subject|8|||
33472416|NCT01621191|101620943|FG000|Overall Study|Lack of Efficacy|6|||
33472417|NCT01621191|101620943|FG000|Overall Study|Lost to Follow-up|1|||
33472418|NCT01621191|101620943|FG000|Overall Study|Site Removed From Study|1|||
33472419|NCT00857792|101620946|FG000|Overall Study|inadequate image quality for analysis|12|||
33472420|NCT00669071|101620951|FG000|Overall Study|Lost to Follow-up|3|||
33472421|NCT00669071|101620951|FG000|Overall Study|Final visit 40 days out of window|1|||
33472422|NCT01470612|101620952|FG000|Overall Study|Adverse Event|20|||
33472423|NCT01470612|101620953|FG001|Overall Study|Adverse Event|80|||
33472424|NCT01470612|101620952|FG000|Overall Study|Death|0|||
33472425|NCT01470612|101620953|FG001|Overall Study|Death|1|||
33472426|NCT01470612|101620952|FG000|Overall Study|Lack of Efficacy|20|||
33472427|NCT01470612|101620953|FG001|Overall Study|Lack of Efficacy|326|||
33472428|NCT01470612|101620952|FG000|Overall Study|Lost to Follow-up|2|||
33472429|NCT01470612|101620953|FG001|Overall Study|Lost to Follow-up|5|||
33472430|NCT01470612|101620952|FG000|Overall Study|Did not meet entrance criteria|0|||
33472431|NCT01470612|101620953|FG001|Overall Study|Did not meet entrance criteria|1|||
33472432|NCT01470612|101620952|FG000|Overall Study|Pregnancy|2|||
33472433|NCT01470612|101620953|FG001|Overall Study|Pregnancy|10|||
33472434|NCT01470612|101620952|FG000|Overall Study|Protocol Violation|2|||
33266373|NCT00146172|100873888|FG000|Overall Study|Lost to Follow-up|0|||
33266374|NCT00146172|100873889|FG001|Overall Study|Lost to Follow-up|0|||
33472435|NCT01470612|101620953|FG001|Overall Study|Protocol Violation|7|||
33472436|NCT01470612|101620952|FG000|Overall Study|Withdrawal by Subject|24|||
33472437|NCT01470612|101620953|FG001|Overall Study|Withdrawal by Subject|79|||
33472438|NCT01470612|101620952|FG000|Overall Study|Other|14|||
33472439|NCT01470612|101620953|FG001|Overall Study|Other|156|||
33181143|NCT05045144|100572338|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33472440|NCT00102687|101620954|FG000|Initial Period|Withdrawal by Subject|6|||
33472441|NCT00102687|101620955|FG001|Initial Period|Withdrawal by Subject|3|||
33472442|NCT00102687|101620956|FG002|Initial Period|Withdrawal by Subject|5|||
33181144|NCT05045144|100572339|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33181145|NCT05045144|100572340|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33181146|NCT05045144|100572341|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33181147|NCT05045144|100572342|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33181148|NCT01412021|100572343|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
33181149|NCT01412021|100572343|FG000|Overall Study|Treatment Prior to Approval|3|||
33181150|NCT01412021|100572343|FG000|Overall Study|Transferred to Other Hospital|9|||
33181151|NCT00453921|100572344|FG000|Overall Study|Withdrawal by Subject|1|||
33181152|NCT00453921|100572345|FG001|Overall Study|Withdrawal by Subject|1|||
33181153|NCT00453921|100572346|FG002|Overall Study|Withdrawal by Subject|1|||
33181154|NCT00453921|100572347|FG003|Overall Study|Withdrawal by Subject|1|||
33181155|NCT00453921|100572344|FG000|Overall Study|Lost to Follow-up|0|||
33181156|NCT00453921|100572345|FG001|Overall Study|Lost to Follow-up|0|||
33181157|NCT00453921|100572346|FG002|Overall Study|Lost to Follow-up|1|||
33181158|NCT00453921|100572347|FG003|Overall Study|Lost to Follow-up|0|||
33181159|NCT00329407|100572350|FG000|Overall Study|Withdrawal by Subject|1|||
33181160|NCT01454570|100572351|FG000|Overall Study|Withdrawal by Subject|2|||
33181161|NCT01454570|100572351|FG000|Overall Study|Screen Failure|7|||
33181162|NCT01990495|100572358|FG000|Overall Study|Physician Decision|5|||
33181163|NCT01990495|100572359|FG001|Overall Study|Physician Decision|4|||
33181164|NCT00256698|100572364|FG000|Overall Study|Withdrawal by Subject|7|||
33181165|NCT00256698|100572365|FG001|Overall Study|Withdrawal by Subject|7|||
33181166|NCT00256698|100572364|FG000|Overall Study|Adverse Event|13|||
33181167|NCT00256698|100572365|FG001|Overall Study|Adverse Event|6|||
33181168|NCT00256698|100572364|FG000|Overall Study|Protocol Violation|6|||
33181169|NCT00256698|100572365|FG001|Overall Study|Protocol Violation|5|||
33181170|NCT00256698|100572364|FG000|Overall Study|Lost to Follow-up|1|||
33181171|NCT00256698|100572365|FG001|Overall Study|Lost to Follow-up|3|||
33181172|NCT00256698|100572364|FG000|Overall Study|disease progression|97|||
33181173|NCT00256698|100572365|FG001|Overall Study|disease progression|105|||
33181174|NCT00256698|100572364|FG000|Overall Study|still ongoing at data cut-off|41|||
33181175|NCT00256698|100572365|FG001|Overall Study|still ongoing at data cut-off|46|||
33181176|NCT00256698|100572364|FG000|Overall Study|withdrawn due to osteoporosis|1|||
33181177|NCT00256698|100572365|FG001|Overall Study|withdrawn due to osteoporosis|0|||
33181178|NCT00256698|100572364|FG000|Overall Study|Prematurely Discontinued|1|||
33181179|NCT00256698|100572365|FG001|Overall Study|Prematurely Discontinued|0|||
33181180|NCT03717480|100572367|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
33181181|NCT00325754|100572368|FG000|Overall Study|Adverse Event|4|||
33181182|NCT00325754|100572369|FG001|Overall Study|Adverse Event|1|||
33181183|NCT02068222|100572370|FG000|Overall Study|Lost to Follow-up|1|||
33181184|NCT00885755|100572373|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
33181185|NCT00885755|100572374|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
33181186|NCT00885755|100572375|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
33181187|NCT00885755|100572373|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
33181188|NCT00885755|100572374|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
33181189|NCT00885755|100572375|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
33181190|NCT00885755|100572373|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
33181191|NCT00885755|100572374|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
33181192|NCT00885755|100572375|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
33181193|NCT00885755|100572373|FG000|Part I: Trastuzumab+Taxane|Death|0|||
33181194|NCT00885755|100572374|FG001|Part I: Trastuzumab+Taxane|Death|0|||
33181195|NCT00885755|100572375|FG002|Part I: Trastuzumab+Taxane|Death|1|||
33181196|NCT00885755|100572373|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
33181197|NCT00885755|100572374|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
33181198|NCT00885755|100572375|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
33181199|NCT03897179|100572378|FG000|Overall Study|Withdrawal by Subject|1|||
33181200|NCT00451321|100572390|FG000|Overall Study|Lost to Follow-up|3|||
33181201|NCT00451321|100572391|FG001|Overall Study|Lost to Follow-up|3|||
33181202|NCT00451321|100572392|FG002|Overall Study|Lost to Follow-up|1|||
33181203|NCT00451321|100572393|FG003|Overall Study|Lost to Follow-up|3|||
33181204|NCT00451321|100572394|FG004|Overall Study|Lost to Follow-up|0|||
33181205|NCT00451321|100572395|FG005|Overall Study|Lost to Follow-up|1|||
33181206|NCT00451321|100572396|FG006|Overall Study|Lost to Follow-up|0|||
33181207|NCT00451321|100572397|FG007|Overall Study|Lost to Follow-up|0|||
33181208|NCT00451321|100572390|FG000|Overall Study|Withdrawal by Subject|3|||
33181209|NCT00451321|100572391|FG001|Overall Study|Withdrawal by Subject|1|||
33181210|NCT00451321|100572392|FG002|Overall Study|Withdrawal by Subject|0|||
33181211|NCT00451321|100572393|FG003|Overall Study|Withdrawal by Subject|4|||
33181212|NCT00451321|100572394|FG004|Overall Study|Withdrawal by Subject|0|||
33181213|NCT00451321|100572395|FG005|Overall Study|Withdrawal by Subject|0|||
33181214|NCT00451321|100572396|FG006|Overall Study|Withdrawal by Subject|0|||
33181215|NCT00451321|100572397|FG007|Overall Study|Withdrawal by Subject|0|||
33181216|NCT00451321|100572390|FG000|Overall Study|Study closed/terminated|1|||
33181217|NCT00451321|100572391|FG001|Overall Study|Study closed/terminated|1|||
33181218|NCT00451321|100572392|FG002|Overall Study|Study closed/terminated|17|||
33181219|NCT00451321|100572393|FG003|Overall Study|Study closed/terminated|5|||
33181220|NCT00451321|100572394|FG004|Overall Study|Study closed/terminated|7|||
33181221|NCT00451321|100572395|FG005|Overall Study|Study closed/terminated|7|||
33181222|NCT00451321|100572396|FG006|Overall Study|Study closed/terminated|5|||
33181223|NCT00451321|100572397|FG007|Overall Study|Study closed/terminated|3|||
33181224|NCT00451321|100572390|FG000|Overall Study|Sponsor decision to amend protocol|0|||
33181225|NCT00451321|100572391|FG001|Overall Study|Sponsor decision to amend protocol|0|||
33181226|NCT00451321|100572392|FG002|Overall Study|Sponsor decision to amend protocol|0|||
33181227|NCT00451321|100572393|FG003|Overall Study|Sponsor decision to amend protocol|0|||
33181228|NCT00451321|100572394|FG004|Overall Study|Sponsor decision to amend protocol|0|||
33181229|NCT00451321|100572395|FG005|Overall Study|Sponsor decision to amend protocol|1|||
33181230|NCT00451321|100572396|FG006|Overall Study|Sponsor decision to amend protocol|1|||
33181231|NCT00451321|100572397|FG007|Overall Study|Sponsor decision to amend protocol|3|||
33181232|NCT02446236|100572401|FG000|Overall Study|Screen Failure|1|||
33181233|NCT02446236|100572402|FG001|Overall Study|Screen Failure|0|||
33181234|NCT02446236|100572403|FG002|Overall Study|Screen Failure|1|||
33181235|NCT02446236|100572401|FG000|Overall Study|Actively Receiving Therapy|0|||
33181236|NCT02446236|100572402|FG001|Overall Study|Actively Receiving Therapy|0|||
33181237|NCT02446236|100572403|FG002|Overall Study|Actively Receiving Therapy|1|||
33181238|NCT02917031|100572407|FG000|Overall Study|Reason not specified|7|||
33181239|NCT02917031|100572408|FG001|Overall Study|Reason not specified|5|||
33181240|NCT02917031|100572409|FG002|Overall Study|Reason not specified|6|||
33181241|NCT02917031|100572407|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
33181242|NCT02917031|100572408|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
33181243|NCT02917031|100572409|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
33181244|NCT02917031|100572407|FG000|Overall Study|Withdrawal by Subject|3|||
33181245|NCT02917031|100572408|FG001|Overall Study|Withdrawal by Subject|3|||
33181246|NCT02917031|100572409|FG002|Overall Study|Withdrawal by Subject|0|||
33181247|NCT02917031|100572407|FG000|Overall Study|Physician Decision|1|||
33181248|NCT02917031|100572408|FG001|Overall Study|Physician Decision|0|||
33181249|NCT02917031|100572409|FG002|Overall Study|Physician Decision|0|||
33181250|NCT02917031|100572407|FG000|Overall Study|Adverse Event|4|||
33181251|NCT02917031|100572408|FG001|Overall Study|Adverse Event|1|||
33181252|NCT02917031|100572409|FG002|Overall Study|Adverse Event|5|||
33181253|NCT02917031|100572407|FG000|Overall Study|Death|2|||
33181254|NCT02917031|100572408|FG001|Overall Study|Death|3|||
33181255|NCT02917031|100572409|FG002|Overall Study|Death|4|||
33181256|NCT01774786|100572410|FG000|Overall Study|Death|300|||
33181257|NCT01774786|100572411|FG001|Overall Study|Death|319|||
33181258|NCT01774786|100572410|FG000|Overall Study|Lost to Follow-up|6|||
33181259|NCT01774786|100572411|FG001|Overall Study|Lost to Follow-up|7|||
33181260|NCT01774786|100572410|FG000|Overall Study|Withdrawal by Subject|18|||
33181261|NCT01774786|100572411|FG001|Overall Study|Withdrawal by Subject|14|||
33181262|NCT01774786|100572410|FG000|Overall Study|Physician Decision|2|||
33181263|NCT01774786|100572411|FG001|Overall Study|Physician Decision|0|||
33181264|NCT01774786|100572410|FG000|Overall Study|Non-compliance|0|||
33181265|NCT01774786|100572411|FG001|Overall Study|Non-compliance|1|||
33181266|NCT01774786|100572410|FG000|Overall Study|Reason Not Specified|2|||
33181267|NCT01774786|100572411|FG001|Overall Study|Reason Not Specified|5|||
33181268|NCT00302458|100572412|FG000|Overall Study|Lost to Follow-up|1|||
33181269|NCT00302458|100572412|FG000|Overall Study|Ineligible after screening|1|||
33181270|NCT00302458|100572412|FG000|Overall Study|Withdrawal by Subject|1|||
33181271|NCT03720470|100572413|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
33181272|NCT03720470|100572414|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
33181273|NCT03720470|100572415|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
33181274|NCT03720470|100572416|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
33181275|NCT03720470|100572417|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
33181276|NCT03720470|100572418|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
33181277|NCT03720470|100572413|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
33181278|NCT03720470|100572414|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
33181279|NCT03720470|100572415|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
33181280|NCT03720470|100572416|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
33181281|NCT03720470|100572417|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
33181282|NCT03720470|100572418|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
33181283|NCT03720470|100572413|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
33181284|NCT03720470|100572414|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
33181285|NCT03720470|100572415|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
33181286|NCT03720470|100572416|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
33181287|NCT03720470|100572417|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
33181288|NCT03720470|100572418|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
33181289|NCT03720470|100572413|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
33181290|NCT03720470|100572414|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
33181291|NCT03720470|100572415|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
33181292|NCT03720470|100572416|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
33181293|NCT03720470|100572417|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
33181294|NCT03720470|100572418|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
33181295|NCT03720470|100572413|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
33181296|NCT03720470|100572414|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
33181297|NCT03720470|100572415|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
33181298|NCT03720470|100572416|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
33181299|NCT03720470|100572417|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
33181300|NCT03720470|100572418|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
33181301|NCT03720470|100572413|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
33181302|NCT03720470|100572414|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
33181303|NCT03720470|100572415|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
33181304|NCT03720470|100572416|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
33181305|NCT03720470|100572417|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
33181306|NCT03720470|100572418|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
33181307|NCT03720470|100572413|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
33181308|NCT03720470|100572414|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
33181309|NCT03720470|100572415|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
33181310|NCT03720470|100572416|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
33181311|NCT03720470|100572417|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
33181312|NCT03720470|100572418|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
33181313|NCT03720470|100572413|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
33181314|NCT03720470|100572414|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
33181315|NCT03720470|100572415|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
33181316|NCT03720470|100572416|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
33181317|NCT03720470|100572417|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
33181318|NCT03720470|100572418|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
33181319|NCT03720470|100572413|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
33181320|NCT03720470|100572414|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
33181321|NCT03720470|100572415|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
33181322|NCT03720470|100572416|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
33181323|NCT03720470|100572417|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
33181324|NCT03720470|100572418|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
33181325|NCT03720470|100572413|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
33181326|NCT03720470|100572414|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
33181327|NCT03720470|100572415|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
33181328|NCT03720470|100572416|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
33181329|NCT03720470|100572417|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
33181330|NCT03720470|100572418|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
33181331|NCT03720470|100572413|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
33181332|NCT03720470|100572414|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
33181333|NCT03720470|100572415|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
33181334|NCT03720470|100572416|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
33181335|NCT03720470|100572417|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
33181336|NCT03720470|100572418|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
33181337|NCT03720470|100572413|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
33181338|NCT03720470|100572414|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
33181339|NCT03720470|100572415|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
33181340|NCT03720470|100572416|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
33181341|NCT03720470|100572417|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
33181342|NCT03720470|100572418|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
33181343|NCT03720470|100572413|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
33181344|NCT03720470|100572414|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
33181345|NCT03720470|100572415|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
33181346|NCT03720470|100572416|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
33181347|NCT03720470|100572417|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
33181348|NCT03720470|100572418|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
33181349|NCT03720470|100572413|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
33181350|NCT03720470|100572414|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
33181351|NCT03720470|100572415|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
33181352|NCT03720470|100572416|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
33181353|NCT03720470|100572417|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
33181354|NCT03720470|100572418|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
33181355|NCT03720470|100572413|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
33181356|NCT03720470|100572414|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
33181357|NCT03720470|100572415|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
33181358|NCT03720470|100572416|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
33181359|NCT03720470|100572417|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
33181360|NCT03720470|100572418|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
33181361|NCT03720470|100572413|FG000|Treatment Period: Final 4 Weeks|Other|0|||
33181362|NCT03720470|100572414|FG001|Treatment Period: Final 4 Weeks|Other|1|||
33181363|NCT03720470|100572415|FG002|Treatment Period: Final 4 Weeks|Other|0|||
33181364|NCT03720470|100572416|FG003|Treatment Period: Final 4 Weeks|Other|2|||
33181365|NCT03720470|100572417|FG004|Treatment Period: Final 4 Weeks|Other|1|||
33181366|NCT03720470|100572418|FG005|Treatment Period: Final 4 Weeks|Other|0|||
33181367|NCT02747420|100572420|FG000|Overall Study|Lost to Follow-up|4|||
33181368|NCT02747420|100572421|FG001|Overall Study|Lost to Follow-up|2|||
33181369|NCT02747420|100572420|FG000|Overall Study|Withdrawal by Subject|3|||
33181370|NCT02747420|100572421|FG001|Overall Study|Withdrawal by Subject|2|||
33181371|NCT03316885|100572423|FG000|Overall Study|Adverse Event|1|||
33181372|NCT03316885|100572423|FG000|Overall Study|Death|10|||
33181373|NCT03316885|100572423|FG000|Overall Study|Lost to Follow-up|4|||
33181374|NCT03316885|100572423|FG000|Overall Study|Withdrawal by Subject|9|||
33181375|NCT03316885|100572423|FG000|Overall Study|COVID related|8|||
33181376|NCT00149747|100575277|FG000|Overall Study|Death|1|||
33181377|NCT00149747|100575278|FG001|Overall Study|Death|0|||
33181378|NCT00149747|100575277|FG000|Overall Study|Withdrawal by Subject|3|||
33181379|NCT00149747|100575278|FG001|Overall Study|Withdrawal by Subject|3|||
33181380|NCT04964128|100575281|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
33181381|NCT04964128|100575281|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
33181382|NCT01853046|100575282|FG000|Overall Study|Withdrawal by Subject|1|||
33181383|NCT01853046|100575283|FG001|Overall Study|Withdrawal by Subject|1|||
33181384|NCT01853046|100575282|FG000|Overall Study|Adverse Event|4|||
33181385|NCT01853046|100575283|FG001|Overall Study|Adverse Event|2|||
33181386|NCT01853046|100575282|FG000|Overall Study|Disease progression|13|||
33181387|NCT01853046|100575283|FG001|Overall Study|Disease progression|3|||
33181388|NCT01163279|100575286|FG000|Overall Study|Withdrawal by Subject|2|||
33181389|NCT01163279|100575287|FG001|Overall Study|Withdrawal by Subject|0|||
33181390|NCT04809220|100575292|FG000|Overall Study|Adverse Event|4|||
33181391|NCT04809220|100575293|FG001|Overall Study|Adverse Event|0|||
33181392|NCT04809220|100575292|FG000|Overall Study|Death|1|||
33181393|NCT04809220|100575293|FG001|Overall Study|Death|0|||
33181394|NCT04809220|100575292|FG000|Overall Study|Lost to Follow-up|3|||
33181395|NCT04809220|100575293|FG001|Overall Study|Lost to Follow-up|0|||
33181396|NCT04809220|100575292|FG000|Overall Study|Physician Decision|0|||
33181397|NCT04809220|100575293|FG001|Overall Study|Physician Decision|1|||
33181398|NCT04809220|100575292|FG000|Overall Study|Withdrawal by Subject|9|||
33181399|NCT04809220|100575293|FG001|Overall Study|Withdrawal by Subject|5|||
33181400|NCT04809220|100575292|FG000|Overall Study|Due to long-term overseas business trips|1|||
33181401|NCT04809220|100575293|FG001|Overall Study|Due to long-term overseas business trips|0|||
33181402|NCT04127786|100575294|FG000|Primary Series|Adverse Event|1|||
33181403|NCT04127786|100575295|FG001|Primary Series|Adverse Event|0|||
33181404|NCT04127786|100575296|FG002|Primary Series|Adverse Event|0|||
33181405|NCT04127786|100575297|FG003|Primary Series|Adverse Event|1|||
33181406|NCT04127786|100575298|FG004|Primary Series|Adverse Event|0|||
33181407|NCT04127786|100575299|FG005|Primary Series|Adverse Event|1|||
33181408|NCT04127786|100575294|FG000|Primary Series|Protocol Violation|5|||
33181409|NCT04127786|100575295|FG001|Primary Series|Protocol Violation|3|||
33181410|NCT04127786|100575296|FG002|Primary Series|Protocol Violation|4|||
33181411|NCT04127786|100575297|FG003|Primary Series|Protocol Violation|3|||
33181412|NCT04127786|100575298|FG004|Primary Series|Protocol Violation|2|||
33181413|NCT04127786|100575299|FG005|Primary Series|Protocol Violation|0|||
33181414|NCT04127786|100575294|FG000|Primary Series|Withdrawal by Subject|0|||
33181415|NCT04127786|100575295|FG001|Primary Series|Withdrawal by Subject|0|||
33181416|NCT04127786|100575296|FG002|Primary Series|Withdrawal by Subject|0|||
33181417|NCT04127786|100575297|FG003|Primary Series|Withdrawal by Subject|1|||
33181418|NCT04127786|100575298|FG004|Primary Series|Withdrawal by Subject|0|||
33181419|NCT04127786|100575299|FG005|Primary Series|Withdrawal by Subject|0|||
33181420|NCT04127786|100575294|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
33181421|NCT04127786|100575295|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
33181422|NCT04127786|100575296|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
33181423|NCT04127786|100575297|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
33181424|NCT04127786|100575298|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
33181425|NCT04127786|100575299|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
33181426|NCT04127786|100575294|FG000|Booster Phase|Withdrawal by Subject|2|||
33181427|NCT04127786|100575295|FG001|Booster Phase|Withdrawal by Subject|0|||
33181428|NCT04127786|100575296|FG002|Booster Phase|Withdrawal by Subject|0|||
33181429|NCT04127786|100575297|FG003|Booster Phase|Withdrawal by Subject|0|||
33181430|NCT04127786|100575298|FG004|Booster Phase|Withdrawal by Subject|0|||
33181431|NCT04127786|100575299|FG005|Booster Phase|Withdrawal by Subject|0|||
33181432|NCT02275481|100575306|FG000|Overall Study|Death|2|||
33181433|NCT02275481|100575307|FG001|Overall Study|Death|1|||
33181434|NCT02275481|100575306|FG000|Overall Study|Lost to Follow-up|2|||
33181435|NCT02275481|100575307|FG001|Overall Study|Lost to Follow-up|0|||
33181436|NCT02275481|100575306|FG000|Overall Study|Withdrawal by Subject|3|||
33181437|NCT02275481|100575307|FG001|Overall Study|Withdrawal by Subject|0|||
33181438|NCT02275481|100575306|FG000|Overall Study|all other reasons combined|2|||
33181439|NCT02275481|100575307|FG001|Overall Study|all other reasons combined|1|||
33181440|NCT02275481|100575306|FG000|Overall Study|Physician Decision|0|||
33181441|NCT02275481|100575307|FG001|Overall Study|Physician Decision|1|||
33181442|NCT02590939|100575308|FG000|Overall Study|Withdrawal by Subject|3|||
33181443|NCT02590939|100575309|FG001|Overall Study|Withdrawal by Subject|1|||
33181444|NCT02590939|100575308|FG000|Overall Study|Failed the nociceptive test|2|||
33181445|NCT02590939|100575309|FG001|Overall Study|Failed the nociceptive test|1|||
33181446|NCT00923559|100575310|FG000|Overall Study|Lost to Follow-up|2|||
33181447|NCT00923559|100575311|FG001|Overall Study|Lost to Follow-up|3|||
33181448|NCT00192504|100575312|FG000|Overall Study|Lost to Follow-up|1|||
33181449|NCT00192504|100575313|FG001|Overall Study|Lost to Follow-up|0|||
33181450|NCT00192504|100575314|FG002|Overall Study|Lost to Follow-up|0|||
33181451|NCT00192504|100575315|FG003|Overall Study|Lost to Follow-up|0|||
33181452|NCT00192504|100575312|FG000|Overall Study|Dosing window missed|0|||
33181453|NCT00192504|100575313|FG001|Overall Study|Dosing window missed|0|||
33181454|NCT00192504|100575314|FG002|Overall Study|Dosing window missed|1|||
33181455|NCT00192504|100575315|FG003|Overall Study|Dosing window missed|0|||
33181456|NCT01614990|100575318|FG000|Overall Study|Protocol Violation|1|||
33181457|NCT01614990|100575319|FG001|Overall Study|Protocol Violation|1|||
33181458|NCT02784821|100575320|FG000|Overall Study|Death|0|||
33181459|NCT02784821|100575321|FG001|Overall Study|Death|5|||
33181460|NCT02784821|100575322|FG002|Overall Study|Death|4|||
33181461|NCT02784821|100575323|FG003|Overall Study|Death|5|||
33181462|NCT04151290|100575324|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
33181463|NCT02503332|100575325|FG000|Overall Study|Adverse Event|17|||
33181464|NCT02503332|100575326|FG001|Overall Study|Adverse Event|5|||
33181465|NCT02503332|100575327|FG002|Overall Study|Adverse Event|3|||
33181466|NCT02503332|100575328|FG003|Overall Study|Adverse Event|1|||
33181467|NCT02503332|100575325|FG000|Overall Study|Investigator's Decision|5|||
33181468|NCT02503332|100575326|FG001|Overall Study|Investigator's Decision|1|||
33181469|NCT02503332|100575327|FG002|Overall Study|Investigator's Decision|0|||
33181470|NCT02503332|100575328|FG003|Overall Study|Investigator's Decision|0|||
33181471|NCT02503332|100575325|FG000|Overall Study|Sponsor's Decision|1|||
33181472|NCT02503332|100575326|FG001|Overall Study|Sponsor's Decision|0|||
33181473|NCT02503332|100575327|FG002|Overall Study|Sponsor's Decision|0|||
33181474|NCT02503332|100575328|FG003|Overall Study|Sponsor's Decision|1|||
33181475|NCT02503332|100575325|FG000|Overall Study|Subject Request|6|||
33181476|NCT02503332|100575326|FG001|Overall Study|Subject Request|5|||
33181477|NCT02503332|100575327|FG002|Overall Study|Subject Request|2|||
33181478|NCT02503332|100575328|FG003|Overall Study|Subject Request|1|||
33181479|NCT02503332|100575325|FG000|Overall Study|Death|0|||
33181480|NCT02503332|100575326|FG001|Overall Study|Death|2|||
33181481|NCT02503332|100575327|FG002|Overall Study|Death|2|||
33181482|NCT02503332|100575328|FG003|Overall Study|Death|0|||
33181483|NCT02503332|100575325|FG000|Overall Study|Other|5|||
33181484|NCT02503332|100575326|FG001|Overall Study|Other|6|||
33181485|NCT02503332|100575327|FG002|Overall Study|Other|1|||
33181486|NCT02503332|100575328|FG003|Overall Study|Other|1|||
33181487|NCT03340025|100575332|FG000|Overall Study|Lost to Follow-up|2|||
33181488|NCT03340025|100575333|FG001|Overall Study|Lost to Follow-up|2|||
33181489|NCT00462761|100575334|FG000|Overall Study|Adverse Event|6|||
33181490|NCT00462761|100575334|FG000|Overall Study|Withdrawal by Subject|9|||
33181491|NCT00462761|100575334|FG000|Overall Study|Physician Decision|5|||
33181492|NCT00462761|100575334|FG000|Overall Study|Disease progression|43|||
33181493|NCT00462761|100575334|FG000|Overall Study|Death|12|||
33181494|NCT00462761|100575334|FG000|Overall Study|Other|1|||
33181495|NCT00445965|100575335|FG000|Overall Study|Adverse Event|2|||
33181496|NCT00445965|100575335|FG000|Overall Study|Physician Decision|1|||
33181497|NCT00445965|100575335|FG000|Overall Study|Enrolled but not treated|1|||
33181498|NCT00445965|100575335|FG000|Overall Study|Removed due to progressive disease|29|||
33181499|NCT02625090|100575336|FG000|Overall Study|Participant wants to be pregnant|2|||
33181500|NCT02625090|100575336|FG000|Overall Study|For the Promoter|1|||
33181501|NCT02625090|100575336|FG000|Overall Study|Sponsor's Decision|9|||
33181502|NCT02625090|100575336|FG000|Overall Study|Somnolence|1|||
33181503|NCT02625090|100575336|FG000|Overall Study|Study terminated by Sponsor|7|||
33181504|NCT02625090|100575336|FG000|Overall Study|Negative Benefit/Risk|1|||
33181505|NCT02625090|100575336|FG000|Overall Study|Protocol Deviation|2|||
33181506|NCT02625090|100575336|FG000|Overall Study|Lack of Efficacy|16|||
33181507|NCT02625090|100575336|FG000|Overall Study|Adverse Event|3|||
33181508|NCT02369341|100575340|FG000|Overall Study|Migrated/moved from study area|1|||
33181509|NCT02369341|100575341|FG001|Overall Study|Migrated/moved from study area|0|||
33181510|NCT05333900|100575343|FG000|Overall Study|Protocol Violation|0|||
33181511|NCT05333900|100575344|FG001|Overall Study|Protocol Violation|1|||
33181512|NCT05333900|100575343|FG000|Overall Study|Withdrawal by Subject|0|||
33181513|NCT05333900|100575344|FG001|Overall Study|Withdrawal by Subject|1|||
33181514|NCT05333900|100575343|FG000|Overall Study|COVID-19 Pandemic|1|||
33181515|NCT05333900|100575344|FG001|Overall Study|COVID-19 Pandemic|1|||
33181516|NCT00218296|100575345|FG000|Overall Study|Lost to Follow-up|9|||
33181517|NCT00218296|100575346|FG001|Overall Study|Lost to Follow-up|7|||
33181518|NCT00218296|100575345|FG000|Overall Study|Withdrawal by Subject|36|||
33181519|NCT00218296|100575346|FG001|Overall Study|Withdrawal by Subject|47|||
33181520|NCT00218296|100575345|FG000|Overall Study|Randomized but did not enter treatment|66|||
33181521|NCT00218296|100575346|FG001|Overall Study|Randomized but did not enter treatment|67|||
33181522|NCT01522365|100575353|FG000|Overall Study|Withdrawal by Subject|1|||
33181523|NCT01522365|100575354|FG001|Overall Study|Withdrawal by Subject|1|||
33181524|NCT01522365|100575353|FG000|Overall Study|Lost to Follow-up|1|||
33181525|NCT01522365|100575354|FG001|Overall Study|Lost to Follow-up|1|||
33181526|NCT00409617|100575355|FG000|Overall Study|Adverse Event|57|||
33181527|NCT00409617|100575355|FG000|Overall Study|Lack of Efficacy|54|||
33181528|NCT00409617|100575355|FG000|Overall Study|Lost to Follow-up|2|||
33181529|NCT00409617|100575355|FG000|Overall Study|Protocol Violation|24|||
33181530|NCT00409617|100575355|FG000|Overall Study|Withdrawal by Subject|8|||
33181531|NCT00409617|100575355|FG000|Overall Study|Administrative reasons|1|||
33181532|NCT00409617|100575355|FG000|Overall Study|Not described|14|||
33181533|NCT05071183|100575360|FG000|Overall Study|Death|1|||
33181534|NCT05071183|100575361|FG001|Overall Study|Death|2|||
33181535|NCT05071183|100575362|FG002|Overall Study|Death|0|||
33181536|NCT05071183|100575360|FG000|Overall Study|Other Reasons|1|||
33181537|NCT05071183|100575361|FG001|Overall Study|Other Reasons|3|||
33181538|NCT05071183|100575362|FG002|Overall Study|Other Reasons|2|||
33181539|NCT00003901|100575363|FG000|Overall Study|Adverse Event|1|||
33181540|NCT00003901|100575363|FG000|Overall Study|Withdrawal by Subject|1|||
33181541|NCT00003901|100575363|FG000|Overall Study|Ineligible|6|||
33181542|NCT00003901|100575363|FG000|Overall Study|CT Scan not within protocol requirement|2|||
33181543|NCT00003901|100575363|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
33181544|NCT00003901|100575363|FG000|Overall Study|Medical problems|6|||
33181545|NCT00896337|100575366|FG000|Overall Study|Death|7|||
33181546|NCT00896337|100575366|FG000|Overall Study|Withdrawal by Subject|7|||
33181547|NCT00896337|100575366|FG000|Overall Study|Lost to Follow-up|11|||
33181548|NCT00939809|100575367|FG000|Overall Study|Adverse Event|2|||
33181549|NCT00939809|100575367|FG000|Overall Study|Death|1|||
33181550|NCT02385266|100575368|FG000|Overall Study|Withdrawal by Subject|1|||
33181551|NCT02385266|100575369|FG001|Overall Study|Withdrawal by Subject|3|||
33181552|NCT01498458|100575370|FG000|Overall Study|Adverse Event|4|||
33181553|NCT01498458|100575370|FG000|Overall Study|Physician Decision|3|||
33181554|NCT02762266|100575371|FG000|Overall Study|Physician Decision|2|||
33181555|NCT02762266|100575372|FG001|Overall Study|Physician Decision|0|||
33181556|NCT02436759|100575373|FG000|Overall Study|Adverse Event|3|||
33181557|NCT02436759|100575374|FG001|Overall Study|Adverse Event|0|||
33181558|NCT02436759|100575373|FG000|Overall Study|Protocol Violation|1|||
33181559|NCT02436759|100575374|FG001|Overall Study|Protocol Violation|0|||
33181560|NCT02436759|100575373|FG000|Overall Study|Withdrawal by Subject|0|||
33181561|NCT02436759|100575374|FG001|Overall Study|Withdrawal by Subject|1|||
33181562|NCT01359254|100575375|FG000|Overall Study|Death|1|||
33181563|NCT01359254|100575376|FG001|Overall Study|Death|0|||
33181564|NCT01132482|100575378|FG000|Overall Study|Adverse Event|1|||
33181565|NCT01132482|100575379|FG001|Overall Study|Adverse Event|0|||
33181566|NCT01139450|100575385|FG000|Overall Study|Withdrawal by Subject|7|||
33181567|NCT01139450|100575386|FG001|Overall Study|Withdrawal by Subject|10|||
33181568|NCT01139450|100575387|FG002|Overall Study|Withdrawal by Subject|13|||
33181569|NCT01139450|100575385|FG000|Overall Study|Lack of Efficacy|3|||
33181570|NCT01139450|100575386|FG001|Overall Study|Lack of Efficacy|1|||
33181571|NCT01139450|100575387|FG002|Overall Study|Lack of Efficacy|8|||
33181572|NCT01139450|100575385|FG000|Overall Study|Protocol Violation|6|||
33181573|NCT01139450|100575386|FG001|Overall Study|Protocol Violation|5|||
33181574|NCT01139450|100575387|FG002|Overall Study|Protocol Violation|2|||
33181575|NCT01139450|100575385|FG000|Overall Study|Lost to Follow-up|9|||
33181576|NCT01139450|100575386|FG001|Overall Study|Lost to Follow-up|7|||
33181577|NCT01139450|100575387|FG002|Overall Study|Lost to Follow-up|11|||
33181578|NCT01139450|100575385|FG000|Overall Study|Administrative|0|||
33181579|NCT01139450|100575386|FG001|Overall Study|Administrative|0|||
33181580|NCT01139450|100575387|FG002|Overall Study|Administrative|1|||
33181581|NCT01139450|100575385|FG000|Overall Study|Adverse Event|2|||
33181582|NCT01139450|100575386|FG001|Overall Study|Adverse Event|2|||
33181583|NCT01139450|100575387|FG002|Overall Study|Adverse Event|3|||
33181584|NCT02574247|100575388|FG000|Overall Study|Withdrawal by Subject|1|||
33181585|NCT02574247|100575389|FG001|Overall Study|Withdrawal by Subject|0|||
33181586|NCT02574247|100575390|FG002|Overall Study|Withdrawal by Subject|0|||
33181587|NCT02574247|100575388|FG000|Overall Study|Did not meet inclusion criteria|4|||
33181588|NCT02574247|100575389|FG001|Overall Study|Did not meet inclusion criteria|3|||
33181589|NCT02574247|100575390|FG002|Overall Study|Did not meet inclusion criteria|5|||
33181590|NCT03989440|100575397|FG000|Overall Study|COVID-19 travel restrictions|0|||
33181591|NCT03989440|100575398|FG001|Overall Study|COVID-19 travel restrictions|0|||
33266375|NCT00146172|100873890|FG002|Overall Study|Lost to Follow-up|0|||
33181592|NCT03989440|100575399|FG002|Overall Study|COVID-19 travel restrictions|1|||
33181593|NCT03989440|100575400|FG003|Overall Study|COVID-19 travel restrictions|0|||
33181594|NCT03989440|100575401|FG004|Overall Study|COVID-19 travel restrictions|0|||
33181595|NCT03989440|100575402|FG005|Overall Study|COVID-19 travel restrictions|0|||
33181596|NCT03989440|100575397|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
33181597|NCT03989440|100575398|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
33181598|NCT03989440|100575399|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
33181599|NCT03989440|100575400|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
33181600|NCT03989440|100575401|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
33181601|NCT03989440|100575402|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
33181602|NCT04307446|100575403|FG000|Overall Study|Lost to Follow-up|2|||
33181603|NCT04307446|100575404|FG001|Overall Study|Lost to Follow-up|0|||
33181604|NCT02206828|100575405|FG000|Overall Study|Lost to Follow-up|7|||
33181605|NCT03560531|100575406|FG000|Overall Study|Death|4|||
33181606|NCT03560531|100575407|FG001|Overall Study|Death|1|||
33181607|NCT03560531|100575408|FG002|Overall Study|Death|1|||
33181608|NCT03560531|100575409|FG003|Overall Study|Death|2|||
33181609|NCT03560531|100575410|FG004|Overall Study|Death|6|||
33181610|NCT03560531|100575411|FG005|Overall Study|Death|1|||
33181611|NCT03560531|100575412|FG006|Overall Study|Death|4|||
33181612|NCT03560531|100575413|FG007|Overall Study|Death|8|||
33181613|NCT03560531|100575414|FG008|Overall Study|Death|1|||
33181614|NCT03560531|100575415|FG009|Overall Study|Death|3|||
33181615|NCT03560531|100575416|FG010|Overall Study|Death|2|||
33181616|NCT03560531|100575417|FG011|Overall Study|Death|0|||
33181617|NCT03560531|100575418|FG012|Overall Study|Death|4|||
33181618|NCT03560531|100575419|FG013|Overall Study|Death|1|||
33181619|NCT03560531|100575406|FG000|Overall Study|Lost to Follow-up|1|||
33181620|NCT03560531|100575407|FG001|Overall Study|Lost to Follow-up|1|||
33181621|NCT03560531|100575408|FG002|Overall Study|Lost to Follow-up|0|||
33181622|NCT03560531|100575409|FG003|Overall Study|Lost to Follow-up|0|||
33181623|NCT03560531|100575410|FG004|Overall Study|Lost to Follow-up|0|||
33181624|NCT03560531|100575411|FG005|Overall Study|Lost to Follow-up|0|||
33181625|NCT03560531|100575412|FG006|Overall Study|Lost to Follow-up|1|||
33181626|NCT03560531|100575413|FG007|Overall Study|Lost to Follow-up|0|||
33181627|NCT03560531|100575414|FG008|Overall Study|Lost to Follow-up|0|||
33181628|NCT03560531|100575415|FG009|Overall Study|Lost to Follow-up|0|||
33181629|NCT03560531|100575416|FG010|Overall Study|Lost to Follow-up|0|||
33181630|NCT03560531|100575417|FG011|Overall Study|Lost to Follow-up|0|||
33181631|NCT03560531|100575418|FG012|Overall Study|Lost to Follow-up|0|||
33181632|NCT03560531|100575419|FG013|Overall Study|Lost to Follow-up|0|||
33181633|NCT03560531|100575406|FG000|Overall Study|Withdrawal by Subject|1|||
33181634|NCT03560531|100575407|FG001|Overall Study|Withdrawal by Subject|0|||
33181635|NCT03560531|100575408|FG002|Overall Study|Withdrawal by Subject|0|||
33181636|NCT03560531|100575409|FG003|Overall Study|Withdrawal by Subject|0|||
33181637|NCT03560531|100575410|FG004|Overall Study|Withdrawal by Subject|0|||
33181638|NCT03560531|100575411|FG005|Overall Study|Withdrawal by Subject|0|||
33181639|NCT03560531|100575412|FG006|Overall Study|Withdrawal by Subject|0|||
33181640|NCT03560531|100575413|FG007|Overall Study|Withdrawal by Subject|3|||
33181641|NCT03560531|100575414|FG008|Overall Study|Withdrawal by Subject|2|||
33181642|NCT03560531|100575415|FG009|Overall Study|Withdrawal by Subject|0|||
33181643|NCT03560531|100575416|FG010|Overall Study|Withdrawal by Subject|0|||
33181644|NCT03560531|100575417|FG011|Overall Study|Withdrawal by Subject|0|||
33181645|NCT03560531|100575418|FG012|Overall Study|Withdrawal by Subject|2|||
33181646|NCT03560531|100575419|FG013|Overall Study|Withdrawal by Subject|0|||
33181647|NCT03560531|100575406|FG000|Overall Study|Study end per-protocol|1|||
33181648|NCT03560531|100575407|FG001|Overall Study|Study end per-protocol|1|||
33181649|NCT03560531|100575408|FG002|Overall Study|Study end per-protocol|2|||
33181650|NCT03560531|100575409|FG003|Overall Study|Study end per-protocol|0|||
33181651|NCT03560531|100575410|FG004|Overall Study|Study end per-protocol|1|||
33181652|NCT03560531|100575411|FG005|Overall Study|Study end per-protocol|0|||
33181653|NCT03560531|100575412|FG006|Overall Study|Study end per-protocol|0|||
33181654|NCT03560531|100575413|FG007|Overall Study|Study end per-protocol|0|||
33181655|NCT03560531|100575414|FG008|Overall Study|Study end per-protocol|0|||
33181656|NCT03560531|100575415|FG009|Overall Study|Study end per-protocol|0|||
33181657|NCT03560531|100575416|FG010|Overall Study|Study end per-protocol|0|||
33181658|NCT03560531|100575417|FG011|Overall Study|Study end per-protocol|0|||
33181659|NCT03560531|100575418|FG012|Overall Study|Study end per-protocol|0|||
33181660|NCT03560531|100575419|FG013|Overall Study|Study end per-protocol|0|||
33181661|NCT03560531|100575406|FG000|Overall Study|Early study termination by sponsor|9|||
33181662|NCT03560531|100575407|FG001|Overall Study|Early study termination by sponsor|0|||
33181663|NCT03560531|100575408|FG002|Overall Study|Early study termination by sponsor|0|||
33181664|NCT03560531|100575409|FG003|Overall Study|Early study termination by sponsor|4|||
33181665|NCT03560531|100575410|FG004|Overall Study|Early study termination by sponsor|8|||
33181666|NCT03560531|100575411|FG005|Overall Study|Early study termination by sponsor|2|||
33181667|NCT03560531|100575412|FG006|Overall Study|Early study termination by sponsor|5|||
33181668|NCT03560531|100575413|FG007|Overall Study|Early study termination by sponsor|64|||
33181669|NCT03560531|100575414|FG008|Overall Study|Early study termination by sponsor|7|||
33181670|NCT03560531|100575415|FG009|Overall Study|Early study termination by sponsor|2|||
33181671|NCT03560531|100575416|FG010|Overall Study|Early study termination by sponsor|16|||
33181672|NCT03560531|100575417|FG011|Overall Study|Early study termination by sponsor|2|||
33181673|NCT03560531|100575418|FG012|Overall Study|Early study termination by sponsor|6|||
33472443|NCT00102687|101620957|FG003|Initial Period|Withdrawal by Subject|0|||
33472444|NCT00102687|101620958|FG004|Initial Period|Withdrawal by Subject|0|||
33472445|NCT00102687|101620954|FG000|Initial Period|Adverse Event|4|||
33472446|NCT00102687|101620955|FG001|Initial Period|Adverse Event|7|||
33472447|NCT00102687|101620956|FG002|Initial Period|Adverse Event|9|||
33472448|NCT00102687|101620957|FG003|Initial Period|Adverse Event|0|||
33472449|NCT00102687|101620958|FG004|Initial Period|Adverse Event|0|||
33472450|NCT00102687|101620954|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
33472451|NCT00102687|101620955|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
33472452|NCT00102687|101620956|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
33472453|NCT00102687|101620957|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
33472454|NCT00102687|101620958|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
33181674|NCT03560531|100575419|FG013|Overall Study|Early study termination by sponsor|2|||
33181675|NCT02226003|100575421|FG000|Overall Study|Lost to Follow-up|2|||
33181676|NCT02226003|100575422|FG001|Overall Study|Lost to Follow-up|1|||
33181677|NCT02226003|100575423|FG002|Overall Study|Lost to Follow-up|3|||
33181678|NCT02226003|100575421|FG000|Overall Study|Withdrawal by Subject|0|||
33181679|NCT02226003|100575422|FG001|Overall Study|Withdrawal by Subject|0|||
33181680|NCT02226003|100575423|FG002|Overall Study|Withdrawal by Subject|3|||
33181681|NCT00791518|100575424|FG000|Overall Study|Protocol Violation|93|||
33181682|NCT00491387|100575425|FG000|Overall Study|study terminated|20|||
33181683|NCT00460031|100575426|FG000|Overall Study|Adverse Event|5|||
33181684|NCT00460031|100575426|FG000|Overall Study|Withdrawal by Subject|5|||
33181685|NCT00460031|100575426|FG000|Overall Study|Death|1|||
33181686|NCT00278109|100575427|FG000|Overall Study|Adverse Event|3|||
33181687|NCT00278109|100575427|FG000|Overall Study|social circumstances|1|||
33181688|NCT04105998|100575428|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
33181689|NCT04105998|100575429|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
33181690|NCT02726074|100575430|FG000|Overall Study|Withdrawal by Subject|4|||
33181691|NCT02726074|100575430|FG000|Overall Study|Adverse Event|14|||
33181692|NCT02726074|100575430|FG000|Overall Study|Protocol Violation|3|||
33181693|NCT02726074|100575430|FG000|Overall Study|Lost to Follow-up|2|||
33472455|NCT00102687|101620954|FG000|Initial Period|Protocol Violation|0|||
33472456|NCT00102687|101620955|FG001|Initial Period|Protocol Violation|0|||
33181694|NCT02726074|100575430|FG000|Overall Study|Others|3|||
33181695|NCT00851799|100575431|FG000|Overall Study|Death|1|||
33181696|NCT00851799|100575432|FG001|Overall Study|Death|0|||
33181697|NCT00851799|100575433|FG002|Overall Study|Death|1|||
33266376|NCT00146172|100873891|FG003|Overall Study|Lost to Follow-up|0|||
33472457|NCT00102687|101620956|FG002|Initial Period|Protocol Violation|2|||
33472458|NCT00102687|101620957|FG003|Initial Period|Protocol Violation|0|||
33472459|NCT00102687|101620958|FG004|Initial Period|Protocol Violation|0|||
33472460|NCT00102687|101620954|FG000|Initial Period|Physician Decision|2|||
33472461|NCT00102687|101620955|FG001|Initial Period|Physician Decision|9|||
33472462|NCT00102687|101620956|FG002|Initial Period|Physician Decision|6|||
33472463|NCT00102687|101620957|FG003|Initial Period|Physician Decision|0|||
33472464|NCT00102687|101620958|FG004|Initial Period|Physician Decision|0|||
33472465|NCT00102687|101620954|FG000|Initial Period|Sponsor's decision|0|||
33472466|NCT00102687|101620955|FG001|Initial Period|Sponsor's decision|1|||
33472467|NCT00102687|101620956|FG002|Initial Period|Sponsor's decision|1|||
33472468|NCT00102687|101620957|FG003|Initial Period|Sponsor's decision|0|||
33472469|NCT00102687|101620958|FG004|Initial Period|Sponsor's decision|0|||
33472470|NCT00102687|101620954|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
33472471|NCT00102687|101620955|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
33181698|NCT00851799|100575431|FG000|Overall Study|Lost to Follow-up|5|||
33181699|NCT00851799|100575432|FG001|Overall Study|Lost to Follow-up|3|||
33181700|NCT00851799|100575433|FG002|Overall Study|Lost to Follow-up|10|||
33266377|NCT00146172|100873892|FG004|Overall Study|Lost to Follow-up|0|||
33472472|NCT00102687|101620956|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
33472473|NCT00102687|101620957|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
33472474|NCT00102687|101620958|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
33472475|NCT00102687|101620954|FG000|Initial Period|Death|1|||
33472476|NCT00102687|101620955|FG001|Initial Period|Death|1|||
33472477|NCT00102687|101620956|FG002|Initial Period|Death|1|||
33472478|NCT00102687|101620957|FG003|Initial Period|Death|0|||
33472479|NCT00102687|101620958|FG004|Initial Period|Death|0|||
33472480|NCT00102687|101620954|FG000|Maintenance Period|Withdrawal by Subject|4|||
33181701|NCT00851799|100575431|FG000|Overall Study|Not able to get to clinic|8|||
33181702|NCT00851799|100575432|FG001|Overall Study|Not able to get to clinic|5|||
33181703|NCT00851799|100575433|FG002|Overall Study|Not able to get to clinic|9|||
33181704|NCT00851799|100575431|FG000|Overall Study|Not willing to adhere to requirements|1|||
33472481|NCT00102687|101620955|FG001|Maintenance Period|Withdrawal by Subject|0|||
33472482|NCT00102687|101620956|FG002|Maintenance Period|Withdrawal by Subject|2|||
33472483|NCT00102687|101620957|FG003|Maintenance Period|Withdrawal by Subject|3|||
33472484|NCT00102687|101620958|FG004|Maintenance Period|Withdrawal by Subject|1|||
33472485|NCT00102687|101620954|FG000|Maintenance Period|Adverse Event|1|||
33472486|NCT00102687|101620955|FG001|Maintenance Period|Adverse Event|0|||
33472487|NCT00102687|101620956|FG002|Maintenance Period|Adverse Event|0|||
33472488|NCT00102687|101620957|FG003|Maintenance Period|Adverse Event|1|||
33472489|NCT00102687|101620958|FG004|Maintenance Period|Adverse Event|3|||
33472490|NCT00102687|101620954|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
33472491|NCT00102687|101620955|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
33472492|NCT00102687|101620956|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
33472493|NCT00102687|101620957|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
33472494|NCT00102687|101620958|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
33472495|NCT00102687|101620954|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
33472496|NCT00102687|101620955|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
33472497|NCT00102687|101620956|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
33472498|NCT00102687|101620957|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
33181705|NCT00851799|100575432|FG001|Overall Study|Not willing to adhere to requirements|2|||
33181706|NCT00851799|100575433|FG002|Overall Study|Not willing to adhere to requirements|2|||
33181707|NCT00851799|100575431|FG000|Overall Study|Withdrew consent prior study completion|1|||
33181708|NCT00851799|100575432|FG001|Overall Study|Withdrew consent prior study completion|2|||
33181709|NCT00851799|100575433|FG002|Overall Study|Withdrew consent prior study completion|1|||
33181710|NCT00851799|100575431|FG000|Overall Study|Severe Debilitation|0|||
33181711|NCT00851799|100575432|FG001|Overall Study|Severe Debilitation|1|||
33181712|NCT00851799|100575433|FG002|Overall Study|Severe Debilitation|0|||
33181713|NCT00851799|100575431|FG000|Overall Study|Completed protocol due to pregnancy|0|||
33181714|NCT00851799|100575432|FG001|Overall Study|Completed protocol due to pregnancy|0|||
33181715|NCT00851799|100575433|FG002|Overall Study|Completed protocol due to pregnancy|1|||
33181716|NCT00751348|100575435|FG000|Overall Study|Withdrawal by Subject|5|||
33181717|NCT00751348|100575436|FG001|Overall Study|Withdrawal by Subject|2|||
33181718|NCT00751348|100575435|FG000|Overall Study|Migration from study area|1|||
33181719|NCT00751348|100575436|FG001|Overall Study|Migration from study area|0|||
33181720|NCT02036502|100575437|FG000|Part 1:Dose Determination/Escalation|Death|3|||
33181721|NCT02036502|100575438|FG001|Part 1:Dose Determination/Escalation|Death|2|||
33181722|NCT02036502|100575439|FG002|Part 1:Dose Determination/Escalation|Death|0|||
33181723|NCT02036502|100575440|FG003|Part 1:Dose Determination/Escalation|Death|0|||
33181724|NCT02036502|100575441|FG004|Part 1:Dose Determination/Escalation|Death|0|||
33181725|NCT02036502|100575442|FG005|Part 1:Dose Determination/Escalation|Death|0|||
33181726|NCT02036502|100575443|FG006|Part 1:Dose Determination/Escalation|Death|0|||
33181727|NCT02036502|100575444|FG007|Part 1:Dose Determination/Escalation|Death|0|||
33181728|NCT02036502|100575437|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
33181729|NCT02036502|100575438|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
33181730|NCT02036502|100575439|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
33181731|NCT02036502|100575440|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
33181732|NCT02036502|100575441|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
33181733|NCT02036502|100575442|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
33181734|NCT02036502|100575443|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
33181735|NCT02036502|100575444|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
33181736|NCT02036502|100575437|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
33181737|NCT02036502|100575438|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
33181738|NCT02036502|100575439|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
33181739|NCT02036502|100575440|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
33181740|NCT02036502|100575441|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
33181741|NCT02036502|100575442|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
33181742|NCT02036502|100575443|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
33181743|NCT02036502|100575444|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
33181744|NCT02036502|100575437|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
33181745|NCT02036502|100575438|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
33181746|NCT02036502|100575439|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
33181747|NCT02036502|100575440|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
33181748|NCT02036502|100575441|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
33181749|NCT02036502|100575442|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
33181750|NCT02036502|100575443|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
33181751|NCT02036502|100575444|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
33181752|NCT02036502|100575437|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
33472499|NCT00102687|101620958|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
33472500|NCT00102687|101620954|FG000|Maintenance Period|Death|0|||
33472501|NCT00102687|101620955|FG001|Maintenance Period|Death|0|||
33181753|NCT02036502|100575438|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
33181754|NCT02036502|100575439|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
33181755|NCT02036502|100575440|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
33181756|NCT02036502|100575441|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
33181757|NCT02036502|100575442|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
33181758|NCT02036502|100575443|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
33181759|NCT02036502|100575444|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
33181760|NCT02036502|100575437|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
33181761|NCT02036502|100575438|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
33181762|NCT02036502|100575439|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
33181763|NCT02036502|100575440|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
33181764|NCT02036502|100575441|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
33181765|NCT02036502|100575442|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
33181766|NCT02036502|100575443|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
33181767|NCT02036502|100575444|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
33181768|NCT02036502|100575437|FG000|Part 2:Dose Confirmation|Death|0|||
33181769|NCT02036502|100575438|FG001|Part 2:Dose Confirmation|Death|0|||
33181770|NCT02036502|100575439|FG002|Part 2:Dose Confirmation|Death|1|||
33181771|NCT02036502|100575440|FG003|Part 2:Dose Confirmation|Death|0|||
33181772|NCT02036502|100575441|FG004|Part 2:Dose Confirmation|Death|0|||
33181773|NCT02036502|100575442|FG005|Part 2:Dose Confirmation|Death|0|||
33472502|NCT00102687|101620956|FG002|Maintenance Period|Death|0|||
33472503|NCT00102687|101620957|FG003|Maintenance Period|Death|1|||
33472504|NCT00102687|101620958|FG004|Maintenance Period|Death|1|||
33472505|NCT00102687|101620954|FG000|Maintenance Period|Physician Decision|1|||
33472506|NCT00102687|101620955|FG001|Maintenance Period|Physician Decision|2|||
33472507|NCT00102687|101620956|FG002|Maintenance Period|Physician Decision|3|||
33472508|NCT00102687|101620957|FG003|Maintenance Period|Physician Decision|0|||
33472509|NCT00102687|101620958|FG004|Maintenance Period|Physician Decision|4|||
33472510|NCT01304693|101620959|FG000|Overall Study|Adverse Event|0|||
33472511|NCT01304693|101620960|FG001|Overall Study|Adverse Event|0|||
33472512|NCT01304693|101620961|FG002|Overall Study|Adverse Event|0|||
33472513|NCT01304693|101620962|FG003|Overall Study|Adverse Event|0|||
33472514|NCT01304693|101620963|FG004|Overall Study|Adverse Event|1|||
33472515|NCT01304693|101620959|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
33181774|NCT02036502|100575443|FG006|Part 2:Dose Confirmation|Death|0|||
33181775|NCT02036502|100575444|FG007|Part 2:Dose Confirmation|Death|0|||
33181776|NCT02036502|100575437|FG000|Part 2:Dose Confirmation|Not treated|0|||
33181777|NCT02036502|100575438|FG001|Part 2:Dose Confirmation|Not treated|0|||
33181778|NCT02036502|100575439|FG002|Part 2:Dose Confirmation|Not treated|0|||
33181779|NCT02036502|100575440|FG003|Part 2:Dose Confirmation|Not treated|1|||
33181780|NCT02036502|100575441|FG004|Part 2:Dose Confirmation|Not treated|0|||
33266378|NCT00146172|100873893|FG005|Overall Study|Lost to Follow-up|0|||
33266379|NCT00146172|100873894|FG006|Overall Study|Lost to Follow-up|0|||
33472516|NCT01304693|101620960|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
33472517|NCT01304693|101620961|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
33472518|NCT01304693|101620962|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
33472519|NCT01304693|101620963|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
33472520|NCT03970837|101620967|FG000|Overall Study|Adverse Event|23|||
33472521|NCT03970837|101620968|FG001|Overall Study|Adverse Event|20|||
33472522|NCT03970837|101620969|FG002|Overall Study|Adverse Event|16|||
33472523|NCT03970837|101620970|FG003|Overall Study|Adverse Event|6|||
33472524|NCT03970837|101620971|FG004|Overall Study|Adverse Event|4|||
33472525|NCT03970837|101620972|FG005|Overall Study|Adverse Event|5|||
33472526|NCT03970837|101620973|FG006|Overall Study|Adverse Event|1|||
33472527|NCT03970837|101620974|FG007|Overall Study|Adverse Event|5|||
33472528|NCT03970837|101620975|FG008|Overall Study|Adverse Event|0|||
33472529|NCT03970837|101620976|FG009|Overall Study|Adverse Event|0|||
33472530|NCT03970837|101620977|FG010|Overall Study|Adverse Event|1|||
33472531|NCT03970837|101620978|FG011|Overall Study|Adverse Event|1|||
33472532|NCT03970837|101620967|FG000|Overall Study|Lack of Efficacy|14|||
33472533|NCT03970837|101620968|FG001|Overall Study|Lack of Efficacy|12|||
33472534|NCT03970837|101620969|FG002|Overall Study|Lack of Efficacy|1|||
33472535|NCT03970837|101620970|FG003|Overall Study|Lack of Efficacy|2|||
33472536|NCT03970837|101620971|FG004|Overall Study|Lack of Efficacy|3|||
33472537|NCT03970837|101620972|FG005|Overall Study|Lack of Efficacy|4|||
33472538|NCT03970837|101620973|FG006|Overall Study|Lack of Efficacy|6|||
33472539|NCT03970837|101620974|FG007|Overall Study|Lack of Efficacy|1|||
33181781|NCT02036502|100575442|FG005|Part 2:Dose Confirmation|Not treated|0|||
33181782|NCT02036502|100575443|FG006|Part 2:Dose Confirmation|Not treated|0|||
33181783|NCT02036502|100575444|FG007|Part 2:Dose Confirmation|Not treated|0|||
33266380|NCT00146172|100873895|FG007|Overall Study|Lost to Follow-up|1|||
33472540|NCT03970837|101620975|FG008|Overall Study|Lack of Efficacy|1|||
33472541|NCT03970837|101620976|FG009|Overall Study|Lack of Efficacy|0|||
33472542|NCT03970837|101620977|FG010|Overall Study|Lack of Efficacy|0|||
33472543|NCT03970837|101620978|FG011|Overall Study|Lack of Efficacy|0|||
33472544|NCT03970837|101620967|FG000|Overall Study|Lost to Follow-up|6|||
33472545|NCT03970837|101620968|FG001|Overall Study|Lost to Follow-up|5|||
33472546|NCT03970837|101620969|FG002|Overall Study|Lost to Follow-up|5|||
33472547|NCT03970837|101620970|FG003|Overall Study|Lost to Follow-up|1|||
33472548|NCT03970837|101620971|FG004|Overall Study|Lost to Follow-up|0|||
33472549|NCT03970837|101620972|FG005|Overall Study|Lost to Follow-up|2|||
33472550|NCT03970837|101620973|FG006|Overall Study|Lost to Follow-up|0|||
33472551|NCT03970837|101620974|FG007|Overall Study|Lost to Follow-up|0|||
33472552|NCT03970837|101620975|FG008|Overall Study|Lost to Follow-up|0|||
33472553|NCT03970837|101620976|FG009|Overall Study|Lost to Follow-up|0|||
33472554|NCT03970837|101620977|FG010|Overall Study|Lost to Follow-up|0|||
33472555|NCT03970837|101620978|FG011|Overall Study|Lost to Follow-up|0|||
33472556|NCT03970837|101620967|FG000|Overall Study|Protocol Violation|1|||
33472557|NCT03970837|101620968|FG001|Overall Study|Protocol Violation|0|||
33472558|NCT03970837|101620969|FG002|Overall Study|Protocol Violation|0|||
33472559|NCT03970837|101620970|FG003|Overall Study|Protocol Violation|0|||
33472560|NCT03970837|101620971|FG004|Overall Study|Protocol Violation|0|||
33472561|NCT03970837|101620972|FG005|Overall Study|Protocol Violation|0|||
33472562|NCT03970837|101620973|FG006|Overall Study|Protocol Violation|0|||
33472563|NCT03970837|101620974|FG007|Overall Study|Protocol Violation|0|||
33472564|NCT03970837|101620975|FG008|Overall Study|Protocol Violation|0|||
33472565|NCT03970837|101620976|FG009|Overall Study|Protocol Violation|0|||
33472566|NCT03970837|101620977|FG010|Overall Study|Protocol Violation|0|||
33472567|NCT03970837|101620978|FG011|Overall Study|Protocol Violation|0|||
33472568|NCT03970837|101620967|FG000|Overall Study|Physician Decision|5|||
33472569|NCT03970837|101620968|FG001|Overall Study|Physician Decision|8|||
33472570|NCT03970837|101620969|FG002|Overall Study|Physician Decision|4|||
33472571|NCT03970837|101620970|FG003|Overall Study|Physician Decision|1|||
33472572|NCT03970837|101620971|FG004|Overall Study|Physician Decision|5|||
33181784|NCT02036502|100575437|FG000|Part 3:Dose Expansion|Adverse Event|0|||
33181785|NCT02036502|100575438|FG001|Part 3:Dose Expansion|Adverse Event|0|||
33181786|NCT02036502|100575439|FG002|Part 3:Dose Expansion|Adverse Event|0|||
33181787|NCT02036502|100575440|FG003|Part 3:Dose Expansion|Adverse Event|0|||
33181788|NCT02036502|100575441|FG004|Part 3:Dose Expansion|Adverse Event|0|||
33472573|NCT03970837|101620972|FG005|Overall Study|Physician Decision|2|||
33472574|NCT03970837|101620973|FG006|Overall Study|Physician Decision|4|||
33472575|NCT03970837|101620974|FG007|Overall Study|Physician Decision|5|||
33472576|NCT03970837|101620975|FG008|Overall Study|Physician Decision|0|||
33472577|NCT03970837|101620976|FG009|Overall Study|Physician Decision|1|||
33472578|NCT03970837|101620977|FG010|Overall Study|Physician Decision|0|||
33472579|NCT03970837|101620978|FG011|Overall Study|Physician Decision|0|||
33472580|NCT03970837|101620967|FG000|Overall Study|Withdrawal by Subject|32|||
33472581|NCT03970837|101620968|FG001|Overall Study|Withdrawal by Subject|35|||
33472582|NCT03970837|101620969|FG002|Overall Study|Withdrawal by Subject|12|||
33472583|NCT03970837|101620970|FG003|Overall Study|Withdrawal by Subject|8|||
33472584|NCT03970837|101620971|FG004|Overall Study|Withdrawal by Subject|6|||
33472585|NCT03970837|101620972|FG005|Overall Study|Withdrawal by Subject|8|||
33181789|NCT02036502|100575442|FG005|Part 3:Dose Expansion|Adverse Event|4|||
33181790|NCT02036502|100575443|FG006|Part 3:Dose Expansion|Adverse Event|0|||
33181791|NCT02036502|100575444|FG007|Part 3:Dose Expansion|Adverse Event|2|||
33181792|NCT02036502|100575437|FG000|Part 3:Dose Expansion|Death|0|||
33181793|NCT02036502|100575438|FG001|Part 3:Dose Expansion|Death|0|||
33181794|NCT02036502|100575439|FG002|Part 3:Dose Expansion|Death|0|||
33181795|NCT02036502|100575440|FG003|Part 3:Dose Expansion|Death|0|||
33181796|NCT02036502|100575441|FG004|Part 3:Dose Expansion|Death|0|||
33181797|NCT02036502|100575442|FG005|Part 3:Dose Expansion|Death|24|||
33181798|NCT02036502|100575443|FG006|Part 3:Dose Expansion|Death|0|||
33181799|NCT02036502|100575444|FG007|Part 3:Dose Expansion|Death|3|||
33181800|NCT02036502|100575437|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
33181801|NCT02036502|100575438|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
33181802|NCT02036502|100575439|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
33181803|NCT02036502|100575440|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
33181804|NCT02036502|100575441|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
33181805|NCT02036502|100575442|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
33181806|NCT02036502|100575443|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
33181807|NCT02036502|100575444|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
33181808|NCT02036502|100575437|FG000|Part 3:Dose Expansion|Physician Decision|0|||
33181809|NCT02036502|100575438|FG001|Part 3:Dose Expansion|Physician Decision|0|||
33181810|NCT02036502|100575439|FG002|Part 3:Dose Expansion|Physician Decision|0|||
33472586|NCT03970837|101620973|FG006|Overall Study|Withdrawal by Subject|2|||
33472587|NCT03970837|101620974|FG007|Overall Study|Withdrawal by Subject|3|||
33472588|NCT03970837|101620975|FG008|Overall Study|Withdrawal by Subject|0|||
33472589|NCT03970837|101620976|FG009|Overall Study|Withdrawal by Subject|0|||
33472590|NCT03970837|101620977|FG010|Overall Study|Withdrawal by Subject|0|||
33472591|NCT03970837|101620978|FG011|Overall Study|Withdrawal by Subject|1|||
33472592|NCT03970837|101620967|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
33472593|NCT03970837|101620968|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
33472594|NCT03970837|101620969|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
33472595|NCT03970837|101620970|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
33472596|NCT03970837|101620971|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
33472597|NCT03970837|101620972|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
33472598|NCT03970837|101620973|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
33472599|NCT03970837|101620974|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
33472600|NCT03970837|101620975|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
33472601|NCT03970837|101620976|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
33472602|NCT03970837|101620977|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
33472603|NCT03970837|101620978|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
33472604|NCT03970837|101620967|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
33472605|NCT03970837|101620968|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
33472606|NCT03970837|101620969|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
33472607|NCT03970837|101620970|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
33472608|NCT03970837|101620971|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
33472609|NCT03970837|101620972|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
33472610|NCT03970837|101620973|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
33472611|NCT03970837|101620974|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
33472612|NCT03970837|101620975|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
33472613|NCT03970837|101620976|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
33472614|NCT03970837|101620977|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
33472615|NCT03970837|101620978|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
33472616|NCT00384176|101620979|FG000|Overall Study|Death|239|||
33472617|NCT00384176|101620980|FG001|Overall Study|Death|247|||
33472618|NCT00384176|101620981|FG002|Overall Study|Death|105|||
33472619|NCT00384176|101620979|FG000|Overall Study|Withdrawal by Subject|52|||
33472620|NCT00384176|101620980|FG001|Overall Study|Withdrawal by Subject|48|||
33472621|NCT00384176|101620981|FG002|Overall Study|Withdrawal by Subject|22|||
33472622|NCT00384176|101620979|FG000|Overall Study|Lost to Follow-up|16|||
33472623|NCT00384176|101620980|FG001|Overall Study|Lost to Follow-up|18|||
33472624|NCT00384176|101620981|FG002|Overall Study|Lost to Follow-up|4|||
33472625|NCT00384176|101620979|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
33472626|NCT00384176|101620980|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
33472627|NCT00384176|101620981|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
33472628|NCT00384176|101620979|FG000|Overall Study|Longer QTC as Visit 1|1|||
33472629|NCT00384176|101620980|FG001|Overall Study|Longer QTC as Visit 1|0|||
33472630|NCT00384176|101620981|FG002|Overall Study|Longer QTC as Visit 1|0|||
33472631|NCT00384176|101620979|FG000|Overall Study|Toxicity of treatment|1|||
33472632|NCT00384176|101620980|FG001|Overall Study|Toxicity of treatment|0|||
33472633|NCT00384176|101620981|FG002|Overall Study|Toxicity of treatment|0|||
33472634|NCT00384176|101620979|FG000|Overall Study|Did not receive study treatment|0|||
33472635|NCT00384176|101620980|FG001|Overall Study|Did not receive study treatment|1|||
33472636|NCT00384176|101620981|FG002|Overall Study|Did not receive study treatment|1|||
33472637|NCT00384176|101620979|FG000|Overall Study|Physician Decision|0|||
33472638|NCT00384176|101620980|FG001|Overall Study|Physician Decision|2|||
33472639|NCT00384176|101620981|FG002|Overall Study|Physician Decision|0|||
33472640|NCT00384176|101620979|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
33472641|NCT00384176|101620980|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
33472642|NCT00384176|101620981|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
33472643|NCT00307034|101620983|FG000|Overall Study|Adverse Event|1|||
33472644|NCT00307034|101620984|FG001|Overall Study|Adverse Event|2|||
33472645|NCT00307034|101620983|FG000|Overall Study|Withdrawal by Subject|1|||
33472646|NCT00307034|101620984|FG001|Overall Study|Withdrawal by Subject|2|||
33472647|NCT00307034|101620983|FG000|Overall Study|Lost to Follow-up|0|||
33472648|NCT00307034|101620984|FG001|Overall Study|Lost to Follow-up|3|||
33472649|NCT00759902|101620985|FG000|Overall Study|Adverse Event|0|||
33472650|NCT00759902|101620986|FG001|Overall Study|Adverse Event|1|||
33472651|NCT02377063|101620987|FG000|Overall Study|Non-compliance|5|||
33472652|NCT01359644|101620988|FG000|Treatment Period|Lack of Efficacy|0|||
33472653|NCT01359644|101620989|FG001|Treatment Period|Lack of Efficacy|1|||
33472654|NCT01359644|101620990|FG002|Treatment Period|Lack of Efficacy|0|||
33472655|NCT01359644|101620991|FG003|Treatment Period|Lack of Efficacy|0|||
33472656|NCT01359644|101620992|FG004|Treatment Period|Lack of Efficacy|0|||
33472657|NCT01359644|101620993|FG005|Treatment Period|Lack of Efficacy|0|||
33181811|NCT02036502|100575440|FG003|Part 3:Dose Expansion|Physician Decision|0|||
33181812|NCT02036502|100575441|FG004|Part 3:Dose Expansion|Physician Decision|0|||
33181813|NCT02036502|100575442|FG005|Part 3:Dose Expansion|Physician Decision|1|||
33472658|NCT01359644|101620994|FG006|Treatment Period|Lack of Efficacy|0|||
33472659|NCT01359644|101620995|FG007|Treatment Period|Lack of Efficacy|0|||
33472660|NCT01359644|101620996|FG008|Treatment Period|Lack of Efficacy|0|||
33472661|NCT01359644|101620997|FG009|Treatment Period|Lack of Efficacy|0|||
33472662|NCT01359644|101620988|FG000|Treatment Period|Adverse Event|0|||
33472663|NCT01359644|101620989|FG001|Treatment Period|Adverse Event|0|||
33472664|NCT01359644|101620990|FG002|Treatment Period|Adverse Event|1|||
33181814|NCT02036502|100575443|FG006|Part 3:Dose Expansion|Physician Decision|0|||
33472665|NCT01359644|101620991|FG003|Treatment Period|Adverse Event|0|||
33472666|NCT01359644|101620992|FG004|Treatment Period|Adverse Event|0|||
33472667|NCT01359644|101620993|FG005|Treatment Period|Adverse Event|1|||
33472668|NCT01359644|101620994|FG006|Treatment Period|Adverse Event|0|||
33472669|NCT01359644|101620995|FG007|Treatment Period|Adverse Event|0|||
33472670|NCT01359644|101620996|FG008|Treatment Period|Adverse Event|0|||
33181815|NCT02036502|100575444|FG007|Part 3:Dose Expansion|Physician Decision|0|||
33181816|NCT02036502|100575437|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
33181817|NCT02036502|100575438|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
33181818|NCT02036502|100575439|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
33181819|NCT02036502|100575440|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
33181820|NCT02036502|100575441|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
33472671|NCT01359644|101620997|FG009|Treatment Period|Adverse Event|0|||
33472672|NCT01359644|101620988|FG000|Treatment Period|Lost to Follow-up|0|||
33472673|NCT01359644|101620989|FG001|Treatment Period|Lost to Follow-up|0|||
33472674|NCT01359644|101620990|FG002|Treatment Period|Lost to Follow-up|0|||
33472675|NCT01359644|101620991|FG003|Treatment Period|Lost to Follow-up|0|||
33472676|NCT01359644|101620992|FG004|Treatment Period|Lost to Follow-up|0|||
33472677|NCT01359644|101620993|FG005|Treatment Period|Lost to Follow-up|1|||
33472678|NCT01359644|101620994|FG006|Treatment Period|Lost to Follow-up|0|||
33472679|NCT01359644|101620995|FG007|Treatment Period|Lost to Follow-up|0|||
33472680|NCT01359644|101620996|FG008|Treatment Period|Lost to Follow-up|0|||
33472681|NCT01359644|101620997|FG009|Treatment Period|Lost to Follow-up|0|||
33472682|NCT01359644|101620988|FG000|Follow-up Period|Withdrawal by Subject|0|||
33472683|NCT01359644|101620989|FG001|Follow-up Period|Withdrawal by Subject|0|||
33472684|NCT01359644|101620990|FG002|Follow-up Period|Withdrawal by Subject|0|||
33472685|NCT01359644|101620991|FG003|Follow-up Period|Withdrawal by Subject|0|||
33472686|NCT01359644|101620992|FG004|Follow-up Period|Withdrawal by Subject|0|||
33472687|NCT01359644|101620993|FG005|Follow-up Period|Withdrawal by Subject|1|||
33472688|NCT01359644|101620994|FG006|Follow-up Period|Withdrawal by Subject|0|||
33472689|NCT01359644|101620995|FG007|Follow-up Period|Withdrawal by Subject|0|||
33472690|NCT01359644|101620996|FG008|Follow-up Period|Withdrawal by Subject|0|||
33472691|NCT01359644|101620997|FG009|Follow-up Period|Withdrawal by Subject|0|||
33472692|NCT01359644|101620988|FG000|Follow-up Period|Lost to Follow-up|0|||
33472693|NCT01359644|101620989|FG001|Follow-up Period|Lost to Follow-up|0|||
33472694|NCT01359644|101620990|FG002|Follow-up Period|Lost to Follow-up|0|||
33472695|NCT01359644|101620991|FG003|Follow-up Period|Lost to Follow-up|0|||
33472696|NCT01359644|101620992|FG004|Follow-up Period|Lost to Follow-up|0|||
33472697|NCT01359644|101620993|FG005|Follow-up Period|Lost to Follow-up|0|||
33472698|NCT01359644|101620994|FG006|Follow-up Period|Lost to Follow-up|1|||
33472699|NCT01359644|101620995|FG007|Follow-up Period|Lost to Follow-up|2|||
33472700|NCT01359644|101620996|FG008|Follow-up Period|Lost to Follow-up|0|||
33472701|NCT01359644|101620997|FG009|Follow-up Period|Lost to Follow-up|0|||
33472702|NCT02429934|101620998|FG000|Overall Study|Withdrawal by Subject|0|||
33472703|NCT02429934|101620999|FG001|Overall Study|Withdrawal by Subject|2|||
33472704|NCT02429934|101620998|FG000|Overall Study|Adverse Event|2|||
33472705|NCT02429934|101620999|FG001|Overall Study|Adverse Event|0|||
33472706|NCT02429934|101620998|FG000|Overall Study|Lost to Follow-up|1|||
33472707|NCT02429934|101620999|FG001|Overall Study|Lost to Follow-up|1|||
33472708|NCT02429934|101620998|FG000|Overall Study|Physician Decision|1|||
33472709|NCT02429934|101620999|FG001|Overall Study|Physician Decision|0|||
33472710|NCT01946191|101621000|FG000|Allocation|Did not complete orientation|1|||
33472711|NCT01946191|101621001|FG001|Allocation|Did not complete orientation|1|||
33472712|NCT01946191|101621000|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
33181821|NCT02036502|100575442|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
33181822|NCT02036502|100575443|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
33181823|NCT02036502|100575444|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
33181824|NCT02036502|100575437|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
33181825|NCT02036502|100575438|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
33472713|NCT01946191|101621001|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
33472714|NCT01946191|101621000|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
33472715|NCT01946191|101621001|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
33181826|NCT02036502|100575439|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
33181827|NCT02036502|100575440|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
33472716|NCT01946191|101621000|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
33472717|NCT01946191|101621001|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
33472718|NCT04920916|101621006|FG000|Phase IIa 60 Day Study|Death|2|||
33472719|NCT04920916|101621007|FG001|Phase IIa 60 Day Study|Death|5|||
33472720|NCT04920916|101621006|FG000|1 Year Follow up (Phone Call)|Death|1|||
33181828|NCT02036502|100575441|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
33472721|NCT04920916|101621007|FG001|1 Year Follow up (Phone Call)|Death|3|||
33472722|NCT04920916|101621006|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
33472723|NCT04920916|101621007|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
33181829|NCT02036502|100575442|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
33472724|NCT00750308|101621010|FG000|First Treatment|Adverse Event|0|||
33472725|NCT00750308|101621011|FG001|First Treatment|Adverse Event|1|||
33472726|NCT00750308|101621012|FG002|First Treatment|Adverse Event|0|||
33472727|NCT00750308|101621013|FG003|First Treatment|Adverse Event|0|||
33472728|NCT00750308|101621014|FG004|First Treatment|Adverse Event|0|||
33472729|NCT00750308|101621015|FG005|First Treatment|Adverse Event|0|||
33472730|NCT00750308|101621016|FG006|First Treatment|Adverse Event|0|||
33472731|NCT00750308|101621017|FG007|First Treatment|Adverse Event|0|||
33472732|NCT00750308|101621018|FG008|First Treatment|Adverse Event|0|||
33472733|NCT00750308|101621019|FG009|First Treatment|Adverse Event|0|||
33472734|NCT00750308|101621020|FG010|First Treatment|Adverse Event|1|||
33472735|NCT00750308|101621021|FG011|First Treatment|Adverse Event|1|||
33472736|NCT00750308|101621010|FG000|First Treatment|Withdrawal by Subject|0|||
33472737|NCT00750308|101621011|FG001|First Treatment|Withdrawal by Subject|0|||
33472738|NCT00750308|101621012|FG002|First Treatment|Withdrawal by Subject|0|||
33472739|NCT00750308|101621013|FG003|First Treatment|Withdrawal by Subject|1|||
33472740|NCT00750308|101621014|FG004|First Treatment|Withdrawal by Subject|0|||
33472741|NCT00750308|101621015|FG005|First Treatment|Withdrawal by Subject|0|||
33472742|NCT00750308|101621016|FG006|First Treatment|Withdrawal by Subject|0|||
33472743|NCT00750308|101621017|FG007|First Treatment|Withdrawal by Subject|1|||
33472744|NCT00750308|101621018|FG008|First Treatment|Withdrawal by Subject|0|||
33472745|NCT00750308|101621019|FG009|First Treatment|Withdrawal by Subject|0|||
33472746|NCT00750308|101621020|FG010|First Treatment|Withdrawal by Subject|0|||
33472747|NCT00750308|101621021|FG011|First Treatment|Withdrawal by Subject|0|||
33472748|NCT00750308|101621010|FG000|Second Treatment|Adverse Event|0|||
33472749|NCT00750308|101621011|FG001|Second Treatment|Adverse Event|0|||
33472750|NCT00750308|101621012|FG002|Second Treatment|Adverse Event|0|||
33472751|NCT00750308|101621013|FG003|Second Treatment|Adverse Event|0|||
33472752|NCT00750308|101621014|FG004|Second Treatment|Adverse Event|0|||
33472753|NCT00750308|101621015|FG005|Second Treatment|Adverse Event|1|||
33472754|NCT00750308|101621016|FG006|Second Treatment|Adverse Event|0|||
33472755|NCT00750308|101621017|FG007|Second Treatment|Adverse Event|0|||
33472756|NCT00750308|101621018|FG008|Second Treatment|Adverse Event|1|||
33472757|NCT00750308|101621019|FG009|Second Treatment|Adverse Event|0|||
33472758|NCT00750308|101621020|FG010|Second Treatment|Adverse Event|0|||
33472759|NCT00750308|101621021|FG011|Second Treatment|Adverse Event|0|||
33472760|NCT00750308|101621010|FG000|Second Treatment|Withdrawal by Subject|0|||
33472761|NCT00750308|101621011|FG001|Second Treatment|Withdrawal by Subject|0|||
33472762|NCT00750308|101621012|FG002|Second Treatment|Withdrawal by Subject|0|||
33472763|NCT00750308|101621013|FG003|Second Treatment|Withdrawal by Subject|0|||
33472764|NCT00750308|101621014|FG004|Second Treatment|Withdrawal by Subject|1|||
33472765|NCT00750308|101621015|FG005|Second Treatment|Withdrawal by Subject|0|||
33472766|NCT00750308|101621016|FG006|Second Treatment|Withdrawal by Subject|0|||
33472767|NCT00750308|101621017|FG007|Second Treatment|Withdrawal by Subject|0|||
33472768|NCT00750308|101621018|FG008|Second Treatment|Withdrawal by Subject|0|||
33472769|NCT00750308|101621019|FG009|Second Treatment|Withdrawal by Subject|0|||
33472770|NCT00750308|101621020|FG010|Second Treatment|Withdrawal by Subject|0|||
33472771|NCT00750308|101621021|FG011|Second Treatment|Withdrawal by Subject|0|||
33472772|NCT00750308|101621010|FG000|Third Treatment|Withdrawal by Subject|0|||
33472773|NCT00750308|101621011|FG001|Third Treatment|Withdrawal by Subject|1|||
33472774|NCT00750308|101621012|FG002|Third Treatment|Withdrawal by Subject|0|||
33472775|NCT00750308|101621013|FG003|Third Treatment|Withdrawal by Subject|0|||
33472776|NCT00750308|101621014|FG004|Third Treatment|Withdrawal by Subject|0|||
33472777|NCT00750308|101621015|FG005|Third Treatment|Withdrawal by Subject|0|||
33472778|NCT00750308|101621016|FG006|Third Treatment|Withdrawal by Subject|0|||
33472779|NCT00750308|101621017|FG007|Third Treatment|Withdrawal by Subject|0|||
33472780|NCT00750308|101621018|FG008|Third Treatment|Withdrawal by Subject|0|||
33472781|NCT00750308|101621019|FG009|Third Treatment|Withdrawal by Subject|0|||
33472782|NCT00750308|101621020|FG010|Third Treatment|Withdrawal by Subject|0|||
33181830|NCT02036502|100575443|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
33181831|NCT02036502|100575444|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
33181832|NCT02036502|100575437|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
33181833|NCT02036502|100575438|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
33181834|NCT02036502|100575439|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
33181835|NCT02036502|100575440|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
33181836|NCT02036502|100575441|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
33472783|NCT00750308|101621021|FG011|Third Treatment|Withdrawal by Subject|0|||
33472784|NCT03438396|101621022|FG000|Overall Study|Reason Not Specified|9|||
33472785|NCT03438396|101621022|FG000|Overall Study|Withdrawal by Subject|5|||
33472786|NCT03438396|101621022|FG000|Overall Study|Lost to Follow-up|2|||
33472787|NCT03438396|101621022|FG000|Overall Study|Death|85|||
33472788|NCT03438396|101621022|FG000|Overall Study|Not treated|1|||
33472789|NCT01460901|101621027|FG000|Overall Study|Withdrawal by Subject|2|||
33472790|NCT02017860|101621028|FG000|Overall Study|Adverse Event|1|||
33472791|NCT02017860|101621028|FG000|Overall Study|Withdrawal by Subject|1|||
33472792|NCT02932228|101621030|FG000|Overall Study|Death|8|||
33472793|NCT02932228|101621031|FG001|Overall Study|Death|23|||
33472794|NCT02932228|101621030|FG000|Overall Study|not eligible upon chart review|2|||
33472795|NCT02932228|101621031|FG001|Overall Study|not eligible upon chart review|5|||
33181837|NCT02036502|100575442|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
33181838|NCT02036502|100575443|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
33181839|NCT02036502|100575444|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
33181840|NCT02036502|100575437|FG000|Part 3:Dose Expansion|Not Treated|0|||
33181841|NCT02036502|100575438|FG001|Part 3:Dose Expansion|Not Treated|0|||
33181842|NCT02036502|100575439|FG002|Part 3:Dose Expansion|Not Treated|0|||
33181843|NCT02036502|100575440|FG003|Part 3:Dose Expansion|Not Treated|0|||
33181844|NCT02036502|100575441|FG004|Part 3:Dose Expansion|Not Treated|0|||
33181845|NCT02036502|100575442|FG005|Part 3:Dose Expansion|Not Treated|2|||
33181846|NCT02036502|100575443|FG006|Part 3:Dose Expansion|Not Treated|0|||
33181847|NCT02036502|100575444|FG007|Part 3:Dose Expansion|Not Treated|0|||
33181848|NCT00697515|100575451|FG000|Dose Optimization Period|Adverse Event|4|||
33181849|NCT00697515|100575452|FG001|Dose Optimization Period|Adverse Event|0|||
33181850|NCT00697515|100575451|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
33181851|NCT00697515|100575452|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
33181852|NCT00697515|100575451|FG000|Dose Optimization Period|Lost to Follow-up|2|||
33181853|NCT00697515|100575452|FG001|Dose Optimization Period|Lost to Follow-up|0|||
33181854|NCT00697515|100575451|FG000|Dose Optimization Period|sponsor request|2|||
33181855|NCT00697515|100575452|FG001|Dose Optimization Period|sponsor request|0|||
33181856|NCT00697515|100575451|FG000|Dose Optimization Period|called to active duty|1|||
33181857|NCT00697515|100575452|FG001|Dose Optimization Period|called to active duty|0|||
33181858|NCT00697515|100575451|FG000|Dose Optimization Period|elevated QTc|1|||
33181859|NCT00697515|100575452|FG001|Dose Optimization Period|elevated QTc|0|||
33181860|NCT00697515|100575451|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
33181861|NCT00697515|100575452|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
33181862|NCT00697515|100575451|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
33181863|NCT00697515|100575452|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
33181864|NCT00697515|100575451|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
33181865|NCT00697515|100575452|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
33181866|NCT00697515|100575451|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
33181867|NCT00697515|100575452|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
33181868|NCT00108160|100575456|FG000|Overall Study|Lost to Follow-up|25|||
33181869|NCT00108160|100575457|FG001|Overall Study|Lost to Follow-up|12|||
33181870|NCT00108160|100575456|FG000|Overall Study|Death|1|||
33181871|NCT00108160|100575457|FG001|Overall Study|Death|2|||
33181872|NCT00108160|100575456|FG000|Overall Study|Withdrawal by Subject|4|||
33181873|NCT00108160|100575457|FG001|Overall Study|Withdrawal by Subject|2|||
33181874|NCT00108160|100575456|FG000|Overall Study|Protocol Violation|9|||
33181875|NCT00108160|100575457|FG001|Overall Study|Protocol Violation|5|||
33181876|NCT01471379|100575458|FG000|Overall Study|Adverse Event|1|||
33181877|NCT01471379|100575459|FG001|Overall Study|Adverse Event|0|||
33181878|NCT01471379|100575460|FG002|Overall Study|Adverse Event|0|||
33181879|NCT01471379|100575458|FG000|Overall Study|Study terminated|0|||
33181880|NCT01471379|100575459|FG001|Overall Study|Study terminated|1|||
33181881|NCT01471379|100575460|FG002|Overall Study|Study terminated|0|||
33181882|NCT01476696|100575461|FG000|Overall Study|Sponsor decision|2|||
33181883|NCT01476696|100575462|FG001|Overall Study|Sponsor decision|1|||
33181884|NCT01476696|100575463|FG002|Overall Study|Sponsor decision|0|||
33181885|NCT01476696|100575461|FG000|Overall Study|Withdrawal by Subject|1|||
33181886|NCT01476696|100575462|FG001|Overall Study|Withdrawal by Subject|0|||
33181887|NCT01476696|100575463|FG002|Overall Study|Withdrawal by Subject|0|||
33181888|NCT00323492|100575472|FG000|Study Phase 1|Adverse Event|2|||
33181889|NCT00323492|100575473|FG001|Study Phase 1|Adverse Event|0|||
33181890|NCT00323492|100575474|FG002|Study Phase 1|Adverse Event|0|||
33181891|NCT00323492|100575472|FG000|Study Phase 2|Adverse Event|1|||
33181892|NCT00323492|100575473|FG001|Study Phase 2|Adverse Event|0|||
33181893|NCT00323492|100575474|FG002|Study Phase 2|Adverse Event|0|||
33181894|NCT00323492|100575472|FG000|Study Phase 2|Physician Decision|1|||
33181895|NCT00323492|100575473|FG001|Study Phase 2|Physician Decision|0|||
33181896|NCT00323492|100575474|FG002|Study Phase 2|Physician Decision|0|||
33181897|NCT00323492|100575472|FG000|Study Phase 2|Lost to Follow-up|1|||
33181898|NCT00323492|100575473|FG001|Study Phase 2|Lost to Follow-up|0|||
33181899|NCT00323492|100575474|FG002|Study Phase 2|Lost to Follow-up|0|||
33181900|NCT00323492|100575472|FG000|Study Phase 2|Withdrawal by Subject|0|||
33181901|NCT00323492|100575473|FG001|Study Phase 2|Withdrawal by Subject|1|||
33181902|NCT00323492|100575474|FG002|Study Phase 2|Withdrawal by Subject|0|||
33181903|NCT00323492|100575472|FG000|Study Phase 2|Noncompliance with study schedule|0|||
33181904|NCT00323492|100575473|FG001|Study Phase 2|Noncompliance with study schedule|0|||
33472796|NCT01347866|101621032|FG000|Overall Study|Death|0|||
33181905|NCT00323492|100575474|FG002|Study Phase 2|Noncompliance with study schedule|1|||
33181906|NCT00323492|100575472|FG000|Study Phase 2|Protocol Violation|1|||
33181907|NCT00323492|100575473|FG001|Study Phase 2|Protocol Violation|0|||
33181908|NCT00323492|100575474|FG002|Study Phase 2|Protocol Violation|0|||
33181909|NCT03886220|100575475|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
33181910|NCT03886220|100575476|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
33181911|NCT03886220|100575475|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
33266381|NCT00146172|100873888|FG000|Overall Study|Disease Progression|2|||
33472797|NCT01347866|101621033|FG001|Overall Study|Death|0|||
33472798|NCT01347866|101621034|FG002|Overall Study|Death|0|||
33472799|NCT01347866|101621035|FG003|Overall Study|Death|1|||
33472800|NCT01347866|101621036|FG004|Overall Study|Death|2|||
33472801|NCT01347866|101621037|FG005|Overall Study|Death|2|||
33472802|NCT01347866|101621038|FG006|Overall Study|Death|1|||
33472803|NCT01347866|101621039|FG007|Overall Study|Death|0|||
33472804|NCT01347866|101621040|FG008|Overall Study|Death|4|||
33472805|NCT01347866|101621041|FG009|Overall Study|Death|1|||
33472806|NCT01347866|101621042|FG010|Overall Study|Death|3|||
33472807|NCT01347866|101621043|FG011|Overall Study|Death|1|||
33472808|NCT01347866|101621044|FG012|Overall Study|Death|2|||
33472809|NCT01347866|101621045|FG013|Overall Study|Death|0|||
33472810|NCT01347866|101621046|FG014|Overall Study|Death|0|||
33472811|NCT01347866|101621047|FG015|Overall Study|Death|1|||
33472812|NCT01347866|101621048|FG016|Overall Study|Death|0|||
33472813|NCT01347866|101621032|FG000|Overall Study|Lost to Follow-up|0|||
33472814|NCT01347866|101621033|FG001|Overall Study|Lost to Follow-up|0|||
33472815|NCT01347866|101621034|FG002|Overall Study|Lost to Follow-up|0|||
33472816|NCT01347866|101621035|FG003|Overall Study|Lost to Follow-up|0|||
33472817|NCT01347866|101621036|FG004|Overall Study|Lost to Follow-up|0|||
33472818|NCT01347866|101621037|FG005|Overall Study|Lost to Follow-up|0|||
33472819|NCT01347866|101621038|FG006|Overall Study|Lost to Follow-up|0|||
33472820|NCT01347866|101621039|FG007|Overall Study|Lost to Follow-up|1|||
33472821|NCT01347866|101621040|FG008|Overall Study|Lost to Follow-up|1|||
33472822|NCT01347866|101621041|FG009|Overall Study|Lost to Follow-up|0|||
33472823|NCT01347866|101621042|FG010|Overall Study|Lost to Follow-up|0|||
33472824|NCT01347866|101621043|FG011|Overall Study|Lost to Follow-up|0|||
33472825|NCT01347866|101621044|FG012|Overall Study|Lost to Follow-up|0|||
33472826|NCT01347866|101621045|FG013|Overall Study|Lost to Follow-up|0|||
33472827|NCT01347866|101621046|FG014|Overall Study|Lost to Follow-up|0|||
33472828|NCT01347866|101621047|FG015|Overall Study|Lost to Follow-up|0|||
33472829|NCT01347866|101621048|FG016|Overall Study|Lost to Follow-up|0|||
33472830|NCT01347866|101621032|FG000|Overall Study|Other|3|||
33472831|NCT01347866|101621033|FG001|Overall Study|Other|1|||
33181912|NCT03886220|100575476|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
33181913|NCT03886220|100575475|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
33181914|NCT03886220|100575476|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
33181915|NCT02968563|100575479|FG000|Overall Study|Adverse Event|0|||
33181916|NCT02968563|100575480|FG001|Overall Study|Adverse Event|6|||
33181917|NCT02968563|100575479|FG000|Overall Study|Death|1|||
33181918|NCT02968563|100575480|FG001|Overall Study|Death|1|||
33181919|NCT02968563|100575479|FG000|Overall Study|Lost to Follow-up|0|||
33181920|NCT02968563|100575480|FG001|Overall Study|Lost to Follow-up|1|||
33181921|NCT03204981|100575481|FG000|Overall Study|Physician Decision|2|||
33181922|NCT03204981|100575481|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
33181923|NCT00673179|100575482|FG000|Overall Study|Toxicity/Complications|3|||
33181924|NCT00673179|100575483|FG001|Overall Study|Toxicity/Complications|0|||
33181925|NCT03424265|100575484|FG000|Overall Study|screening failure|1|||
33181926|NCT03424265|100575485|FG001|Overall Study|screening failure|0|||
33181927|NCT03424265|100575484|FG000|Overall Study|Withdrawal by Subject|0|||
33181928|NCT03424265|100575485|FG001|Overall Study|Withdrawal by Subject|2|||
33181929|NCT01505608|100575488|FG000|Phase I|Lack of Efficacy|0|||
33181930|NCT01505608|100575489|FG001|Phase I|Lack of Efficacy|4|||
33181931|NCT01505608|100575488|FG000|Phase I|Adverse Event|0|||
33181932|NCT01505608|100575489|FG001|Phase I|Adverse Event|1|||
33181933|NCT01505608|100575488|FG000|Phase I|Withdrawal by Subject|0|||
33181934|NCT01505608|100575489|FG001|Phase I|Withdrawal by Subject|1|||
33181935|NCT01505608|100575488|FG000|Phase II|Lack of Efficacy|2|||
33181936|NCT01505608|100575489|FG001|Phase II|Lack of Efficacy|1|||
33181937|NCT01505608|100575488|FG000|Phase II|Protocol Violation|0|||
33181938|NCT01505608|100575489|FG001|Phase II|Protocol Violation|1|||
33181939|NCT01464346|100575493|FG000|Overall Study|Withdrawal by Subject|0|||
33181940|NCT01464346|100575494|FG001|Overall Study|Withdrawal by Subject|0|||
33181941|NCT01464346|100575495|FG002|Overall Study|Withdrawal by Subject|1|||
33472832|NCT01347866|101621034|FG002|Overall Study|Other|1|||
33472833|NCT01347866|101621035|FG003|Overall Study|Other|4|||
33472834|NCT01347866|101621036|FG004|Overall Study|Other|5|||
33181942|NCT02515045|100575498|FG000|Overall Study|Adverse Event|0|||
33181943|NCT02515045|100575499|FG001|Overall Study|Adverse Event|3|||
33181944|NCT02515045|100575500|FG002|Overall Study|Adverse Event|3|||
33266382|NCT00146172|100873889|FG001|Overall Study|Disease Progression|4|||
33472835|NCT01347866|101621037|FG005|Overall Study|Other|0|||
33472836|NCT01347866|101621038|FG006|Overall Study|Other|5|||
33472837|NCT01347866|101621039|FG007|Overall Study|Other|3|||
33472838|NCT01347866|101621040|FG008|Overall Study|Other|22|||
33181945|NCT02515045|100575498|FG000|Overall Study|Lost to Follow-up|0|||
33472839|NCT01347866|101621041|FG009|Overall Study|Other|5|||
33472840|NCT01347866|101621042|FG010|Overall Study|Other|0|||
33472841|NCT01347866|101621043|FG011|Overall Study|Other|3|||
33472842|NCT01347866|101621044|FG012|Overall Study|Other|4|||
33472843|NCT01347866|101621045|FG013|Overall Study|Other|4|||
33472844|NCT01347866|101621046|FG014|Overall Study|Other|2|||
33472845|NCT01347866|101621047|FG015|Overall Study|Other|3|||
33472846|NCT01347866|101621048|FG016|Overall Study|Other|0|||
33472847|NCT01347866|101621032|FG000|Overall Study|Subject refused further follow-up|2|||
33472848|NCT01347866|101621033|FG001|Overall Study|Subject refused further follow-up|0|||
33472849|NCT01347866|101621034|FG002|Overall Study|Subject refused further follow-up|0|||
33472850|NCT01347866|101621035|FG003|Overall Study|Subject refused further follow-up|2|||
33472851|NCT01347866|101621036|FG004|Overall Study|Subject refused further follow-up|0|||
33472852|NCT01347866|101621037|FG005|Overall Study|Subject refused further follow-up|1|||
33472853|NCT01347866|101621038|FG006|Overall Study|Subject refused further follow-up|0|||
33472854|NCT01347866|101621039|FG007|Overall Study|Subject refused further follow-up|0|||
33472855|NCT01347866|101621040|FG008|Overall Study|Subject refused further follow-up|4|||
33472856|NCT01347866|101621041|FG009|Overall Study|Subject refused further follow-up|1|||
33472857|NCT01347866|101621042|FG010|Overall Study|Subject refused further follow-up|0|||
33472858|NCT01347866|101621043|FG011|Overall Study|Subject refused further follow-up|0|||
33472859|NCT01347866|101621044|FG012|Overall Study|Subject refused further follow-up|1|||
33472860|NCT01347866|101621045|FG013|Overall Study|Subject refused further follow-up|3|||
33472861|NCT01347866|101621046|FG014|Overall Study|Subject refused further follow-up|1|||
33472862|NCT01347866|101621047|FG015|Overall Study|Subject refused further follow-up|0|||
33472863|NCT01347866|101621048|FG016|Overall Study|Subject refused further follow-up|2|||
33472864|NCT01833533|101621049|FG000|Overall Study|Adverse Event|0|||
33472865|NCT01833533|101621050|FG001|Overall Study|Adverse Event|1|||
33181946|NCT02515045|100575499|FG001|Overall Study|Lost to Follow-up|1|||
33181947|NCT02515045|100575500|FG002|Overall Study|Lost to Follow-up|1|||
33181948|NCT00634088|100575501|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
33181949|NCT00634088|100575502|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
33472866|NCT01833533|101621049|FG000|Overall Study|Lost to Follow-up|4|||
33472867|NCT01833533|101621050|FG001|Overall Study|Lost to Follow-up|9|||
33472868|NCT01833533|101621049|FG000|Overall Study|To Enter an Extension Study|0|||
33472869|NCT01833533|101621050|FG001|Overall Study|To Enter an Extension Study|4|||
33472870|NCT01833533|101621049|FG000|Overall Study|Other|2|||
33472871|NCT01833533|101621050|FG001|Overall Study|Other|7|||
33472872|NCT02145026|101621051|FG000|Overall Study|Adverse Event|2|||
33181950|NCT00634088|100575503|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
33472873|NCT02145026|101621051|FG000|Overall Study|Death|4|||
33472874|NCT02145026|101621051|FG000|Overall Study|Withdrawal by Subject|2|||
33472875|NCT02145026|101621051|FG000|Overall Study|Physician Decision|4|||
33472876|NCT01045993|101621052|FG000|Overall Study|Treated-later found eligibility not met|0|||
33181951|NCT00634088|100575504|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
33181952|NCT00634088|100575501|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
33181953|NCT00634088|100575502|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
33472877|NCT01045993|101621053|FG001|Overall Study|Treated-later found eligibility not met|1|||
33472878|NCT01045993|101621054|FG002|Overall Study|Treated-later found eligibility not met|0|||
33472879|NCT01045993|101621055|FG003|Overall Study|Treated-later found eligibility not met|0|||
33472880|NCT01117766|101621056|FG000|First Intervention|Adverse Event|0|||
33472881|NCT01117766|101621057|FG001|First Intervention|Adverse Event|1|||
33472882|NCT01117766|101621056|FG000|First Intervention|Protocol Violation|1|||
33472883|NCT01117766|101621057|FG001|First Intervention|Protocol Violation|0|||
33472884|NCT01117766|101621056|FG000|Washout Period|Protocol Violation|0|||
33472885|NCT01117766|101621057|FG001|Washout Period|Protocol Violation|2|||
33472886|NCT01117766|101621056|FG000|Second Intervention|Lost to Follow-up|1|||
33181954|NCT00634088|100575503|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
33181955|NCT00634088|100575504|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
33472887|NCT01117766|101621057|FG001|Second Intervention|Lost to Follow-up|0|||
33472888|NCT01117766|101621056|FG000|Second Intervention|Other|1|||
33472889|NCT01117766|101621057|FG001|Second Intervention|Other|2|||
33472890|NCT01117766|101621056|FG000|Second Intervention|Adverse Event|0|||
33472891|NCT01117766|101621057|FG001|Second Intervention|Adverse Event|2|||
33472892|NCT01117766|101621056|FG000|Second Intervention|Withdrawal by Subject|0|||
33472893|NCT01117766|101621057|FG001|Second Intervention|Withdrawal by Subject|1|||
33181956|NCT00634088|100575501|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
33181957|NCT00634088|100575502|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
33181958|NCT00634088|100575503|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
33472894|NCT00605865|101621058|FG000|Overall Study|Protocol Violation|115|||
33181959|NCT00634088|100575504|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
33181960|NCT00634088|100575501|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
33472895|NCT00136318|101621060|FG000|Overall Study|Adverse Event|5|||
33472896|NCT00136318|101621061|FG001|Overall Study|Adverse Event|5|||
33472897|NCT00136318|101621060|FG000|Overall Study|Withdrawal by Subject|2|||
33472898|NCT00136318|101621061|FG001|Overall Study|Withdrawal by Subject|2|||
33472899|NCT02310646|101621062|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
33472900|NCT02310646|101621063|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
33472901|NCT02310646|101621062|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
33472902|NCT02310646|101621063|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
33472903|NCT00588640|101621064|FG000|Overall Study|Physician Decision|1|||
33472904|NCT00588640|101621064|FG000|Overall Study|Ineligible Patient|1|||
33472905|NCT01753336|101621067|FG000|Overall Study|Patient decision|12|||
33181961|NCT00634088|100575502|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
33181962|NCT00634088|100575503|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
33181963|NCT00634088|100575504|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
33181964|NCT00634088|100575501|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
33181965|NCT00634088|100575502|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
33181966|NCT00634088|100575503|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
33181967|NCT00634088|100575504|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
33181968|NCT00634088|100575501|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
33472906|NCT01753336|101621067|FG000|Overall Study|Lost to Follow-up|3|||
33472907|NCT01753336|101621067|FG000|Overall Study|Physician Decision|2|||
33472908|NCT01753336|101621067|FG000|Overall Study|Sponsor's decision|2|||
33472909|NCT01753336|101621067|FG000|Overall Study|Withdrawal by Subject|1|||
33472910|NCT04430855|101621068|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
33472911|NCT04430855|101621069|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
33472912|NCT04430855|101621068|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
33472913|NCT04430855|101621069|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
33472914|NCT04430855|101621068|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
33181969|NCT00634088|100575502|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
33472915|NCT04430855|101621069|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
33181970|NCT00634088|100575503|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
33181971|NCT00634088|100575504|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
33181972|NCT01062555|100575505|FG000|Phase 1|Death|10|||
33181973|NCT01062555|100575506|FG001|Phase 1|Death|17|||
33181974|NCT01062555|100575507|FG002|Phase 1|Death|0|||
33181975|NCT01062555|100575508|FG003|Phase 1|Death|0|||
33181976|NCT01062555|100575505|FG000|Phase 1|Graft Failure|12|||
33472916|NCT04430855|101621068|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
33472917|NCT04430855|101621069|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
33472918|NCT04430855|101621068|FG000|Period 1 (Weeks 1-12)|Other|0|||
33472919|NCT04430855|101621069|FG001|Period 1 (Weeks 1-12)|Other|1|||
33472920|NCT04430855|101621068|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
33472921|NCT04430855|101621069|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
33472922|NCT04430855|101621068|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
33472923|NCT04430855|101621069|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
33472924|NCT04430855|101621068|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
33472925|NCT04430855|101621069|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
33472926|NCT02622113|101621073|FG000|Overall Study|Adverse Event|4|||
33472927|NCT02622113|101621074|FG001|Overall Study|Adverse Event|4|||
33472928|NCT02622113|101621073|FG000|Overall Study|Physician Decision|0|||
33472929|NCT02622113|101621074|FG001|Overall Study|Physician Decision|1|||
33472930|NCT02622113|101621073|FG000|Overall Study|Withdrawal by Subject|0|||
33472931|NCT02622113|101621074|FG001|Overall Study|Withdrawal by Subject|2|||
33472932|NCT02622113|101621073|FG000|Overall Study|Stopping Criteria|1|||
33472933|NCT02622113|101621074|FG001|Overall Study|Stopping Criteria|3|||
33472934|NCT00891371|101621075|FG000|Pre-assignment|Inclusion/exclusion|5|||
33472935|NCT00891371|101621075|FG000|Pre-assignment|Consent withdrawal|1|||
33472936|NCT00891371|101621075|FG000|Treatment|Lack of Efficacy|5|||
33472937|NCT00891371|101621075|FG000|Treatment|Adverse Event|2|||
33472938|NCT00891371|101621075|FG000|Treatment|Death|1|||
33472939|NCT00891371|101621075|FG000|Treatment|Lost to Follow-up|1|||
33472940|NCT00546572|101621078|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
33472941|NCT00546572|101621079|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
33472942|NCT00546572|101621078|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
33472943|NCT00546572|101621079|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
33472944|NCT00546572|101621078|FG000|Vax 1 / Year 0|Protocol Violation|3|||
33472945|NCT00546572|101621079|FG001|Vax 1 / Year 0|Protocol Violation|4|||
33472946|NCT00546572|101621078|FG000|Vax 1 / Year 0|Death|2|||
33472947|NCT00546572|101621079|FG001|Vax 1 / Year 0|Death|2|||
33472948|NCT00546572|101621078|FG000|Vax 1 / Year 0|Adverse Event|0|||
33472949|NCT00546572|101621079|FG001|Vax 1 / Year 0|Adverse Event|1|||
33472950|NCT00546572|101621078|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
33472951|NCT00546572|101621079|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
33181977|NCT01062555|100575506|FG001|Phase 1|Graft Failure|8|||
33181978|NCT01062555|100575507|FG002|Phase 1|Graft Failure|0|||
33472952|NCT00546572|101621078|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
33181979|NCT01062555|100575508|FG003|Phase 1|Graft Failure|0|||
33472953|NCT00546572|101621079|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
33472954|NCT00546572|101621078|FG000|Vax 2 / Year 1|Other|1|||
33472955|NCT00546572|101621079|FG001|Vax 2 / Year 1|Other|1|||
33181980|NCT01062555|100575505|FG000|Phase 1|Withdrawal by Subject|1|||
33472956|NCT00546572|101621078|FG000|Vax 2 / Year 1|Adverse Event|1|||
33181981|NCT01062555|100575506|FG001|Phase 1|Withdrawal by Subject|1|||
33472957|NCT00546572|101621079|FG001|Vax 2 / Year 1|Adverse Event|0|||
33472958|NCT00546572|101621078|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
33472959|NCT00546572|101621079|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
33472960|NCT03512262|101621080|FG000|Overall Study|Adverse Event|8|||
33472961|NCT03512262|101621081|FG001|Overall Study|Adverse Event|3|||
33472962|NCT03512262|101621080|FG000|Overall Study|Death (non-treatment emergent)|1|||
33472963|NCT03512262|101621081|FG001|Overall Study|Death (non-treatment emergent)|0|||
33472964|NCT03512262|101621080|FG000|Overall Study|Withdrawal by Subject|17|||
33472965|NCT03512262|101621081|FG001|Overall Study|Withdrawal by Subject|9|||
33472966|NCT03512262|101621080|FG000|Overall Study|Lost to Follow-up|7|||
33472967|NCT03512262|101621081|FG001|Overall Study|Lost to Follow-up|1|||
33472968|NCT03512262|101621080|FG000|Overall Study|Other than Specified|2|||
33472969|NCT03512262|101621081|FG001|Overall Study|Other than Specified|2|||
33472970|NCT03923530|101621087|FG000|Overall Study|Withdrawal by Subject|1|||
33472971|NCT03923530|101621087|FG000|Overall Study|screen failure|3|||
33472972|NCT00871741|101621088|FG000|Overall Study|Premature study termination|9|||
33472973|NCT00871741|101621089|FG001|Overall Study|Premature study termination|7|||
33472974|NCT03734666|101623911|FG000|Overall Study|Other|7|||
33472975|NCT03734666|101623912|FG001|Overall Study|Other|4|||
33472976|NCT03734666|101623911|FG000|Overall Study|Lost to Follow-up|12|||
33472977|NCT03734666|101623912|FG001|Overall Study|Lost to Follow-up|12|||
33472978|NCT00468728|101623913|FG000|Treatment|criteria for mITT population|4|||
33472979|NCT00468728|101623914|FG001|Treatment|criteria for mITT population|11|||
33472980|NCT00468728|101623913|FG000|Follow-up|mITT failure|34|||
33472981|NCT00468728|101623914|FG001|Follow-up|mITT failure|31|||
33472982|NCT03493542|101623915|FG000|Overall Study|Ongoing|2|||
33472983|NCT03493542|101623916|FG001|Overall Study|Ongoing|3|||
33472984|NCT03493542|101623915|FG000|Overall Study|Withdrawal by parent or guardian|3|||
33472985|NCT03493542|101623916|FG001|Overall Study|Withdrawal by parent or guardian|0|||
33472986|NCT03493542|101623915|FG000|Overall Study|Withdrawal by Subject|2|||
33472987|NCT03493542|101623916|FG001|Overall Study|Withdrawal by Subject|6|||
33472988|NCT02304458|101623917|FG000|Overall Study|Adverse Event|0|||
33472989|NCT02304458|101623918|FG001|Overall Study|Adverse Event|0|||
33472990|NCT02304458|101623919|FG002|Overall Study|Adverse Event|7|||
33472991|NCT02304458|101623920|FG003|Overall Study|Adverse Event|0|||
33472992|NCT02304458|101623921|FG004|Overall Study|Adverse Event|0|||
33472993|NCT02304458|101623922|FG005|Overall Study|Adverse Event|0|||
33472994|NCT02304458|101623923|FG006|Overall Study|Adverse Event|3|||
33472995|NCT02304458|101623924|FG007|Overall Study|Adverse Event|4|||
33472996|NCT02304458|101623917|FG000|Overall Study|Death|0|||
33472997|NCT02304458|101623918|FG001|Overall Study|Death|0|||
33472998|NCT02304458|101623919|FG002|Overall Study|Death|2|||
33472999|NCT02304458|101623920|FG003|Overall Study|Death|0|||
33473000|NCT02304458|101623921|FG004|Overall Study|Death|0|||
33473001|NCT02304458|101623922|FG005|Overall Study|Death|0|||
33473002|NCT02304458|101623923|FG006|Overall Study|Death|1|||
33473003|NCT02304458|101623924|FG007|Overall Study|Death|0|||
33473004|NCT02304458|101623917|FG000|Overall Study|Lack of Efficacy|4|||
33473005|NCT02304458|101623918|FG001|Overall Study|Lack of Efficacy|6|||
33473006|NCT02304458|101623919|FG002|Overall Study|Lack of Efficacy|38|||
33473007|NCT02304458|101623920|FG003|Overall Study|Lack of Efficacy|5|||
33473008|NCT02304458|101623921|FG004|Overall Study|Lack of Efficacy|6|||
33473009|NCT02304458|101623922|FG005|Overall Study|Lack of Efficacy|6|||
33473010|NCT02304458|101623923|FG006|Overall Study|Lack of Efficacy|21|||
33473011|NCT02304458|101623924|FG007|Overall Study|Lack of Efficacy|4|||
33473012|NCT02304458|101623917|FG000|Overall Study|Physician Decision|2|||
33473013|NCT02304458|101623918|FG001|Overall Study|Physician Decision|0|||
33473014|NCT02304458|101623919|FG002|Overall Study|Physician Decision|16|||
33473015|NCT02304458|101623920|FG003|Overall Study|Physician Decision|1|||
33473016|NCT02304458|101623921|FG004|Overall Study|Physician Decision|0|||
33473017|NCT02304458|101623922|FG005|Overall Study|Physician Decision|0|||
33473018|NCT02304458|101623923|FG006|Overall Study|Physician Decision|3|||
33473019|NCT02304458|101623924|FG007|Overall Study|Physician Decision|0|||
33473020|NCT02304458|101623917|FG000|Overall Study|Protocol Violation|0|||
33473021|NCT02304458|101623918|FG001|Overall Study|Protocol Violation|0|||
33473022|NCT02304458|101623919|FG002|Overall Study|Protocol Violation|1|||
33473023|NCT02304458|101623920|FG003|Overall Study|Protocol Violation|0|||
33473024|NCT02304458|101623921|FG004|Overall Study|Protocol Violation|0|||
33473025|NCT02304458|101623922|FG005|Overall Study|Protocol Violation|0|||
33473026|NCT02304458|101623923|FG006|Overall Study|Protocol Violation|0|||
33473027|NCT02304458|101623924|FG007|Overall Study|Protocol Violation|0|||
33473028|NCT02304458|101623917|FG000|Overall Study|Withdrawal by Subject|1|||
33473029|NCT02304458|101623918|FG001|Overall Study|Withdrawal by Subject|0|||
33473030|NCT02304458|101623919|FG002|Overall Study|Withdrawal by Subject|7|||
33473031|NCT02304458|101623920|FG003|Overall Study|Withdrawal by Subject|0|||
33473032|NCT02304458|101623921|FG004|Overall Study|Withdrawal by Subject|0|||
33473033|NCT02304458|101623922|FG005|Overall Study|Withdrawal by Subject|0|||
33473034|NCT02304458|101623923|FG006|Overall Study|Withdrawal by Subject|1|||
33473035|NCT02304458|101623924|FG007|Overall Study|Withdrawal by Subject|0|||
33473036|NCT03979820|101623925|FG000|Overall Study|Protocol Violation|1|||
33473037|NCT03979820|101623926|FG001|Overall Study|Protocol Violation|0|||
33473038|NCT03979820|101623927|FG002|Overall Study|Protocol Violation|0|||
33473039|NCT03979820|101623928|FG003|Overall Study|Protocol Violation|0|||
33473040|NCT03979820|101623925|FG000|Overall Study|Withdrawal by Subject|0|||
33473041|NCT03979820|101623926|FG001|Overall Study|Withdrawal by Subject|0|||
33473042|NCT03979820|101623927|FG002|Overall Study|Withdrawal by Subject|1|||
33473043|NCT03979820|101623928|FG003|Overall Study|Withdrawal by Subject|0|||
33473044|NCT03979820|101623925|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
33473045|NCT03979820|101623926|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
33473046|NCT03979820|101623927|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
33473047|NCT03979820|101623928|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
33473048|NCT01859130|101623930|FG000|Overall Study|Death|4|||
33473049|NCT01859130|101623930|FG000|Overall Study|Lost to Follow-up|16|||
33473050|NCT01859130|101623930|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
33473051|NCT01859130|101623930|FG000|Overall Study|Physician Decision|6|||
33473052|NCT01859130|101623930|FG000|Overall Study|Withdrawal by Subject|17|||
33473053|NCT01859130|101623930|FG000|Overall Study|Adverse Event|11|||
33473054|NCT02143583|101623931|FG000|Overall Study|Withdrawal by Subject|1|||
33473055|NCT02143583|101623932|FG001|Overall Study|Withdrawal by Subject|0|||
33473056|NCT02143583|101623933|FG002|Overall Study|Withdrawal by Subject|1|||
33473057|NCT02143583|101623931|FG000|Overall Study|husband illness|0|||
33473058|NCT02143583|101623932|FG001|Overall Study|husband illness|0|||
33473059|NCT02143583|101623933|FG002|Overall Study|husband illness|1|||
33473060|NCT02384941|101623934|FG000|Overall Study|Adverse Event|11|||
33473061|NCT02384941|101623935|FG001|Overall Study|Adverse Event|13|||
33473062|NCT02384941|101623936|FG002|Overall Study|Adverse Event|17|||
33473063|NCT02384941|101623934|FG000|Overall Study|Lost to Follow-up|3|||
33473064|NCT02384941|101623935|FG001|Overall Study|Lost to Follow-up|2|||
33473065|NCT02384941|101623936|FG002|Overall Study|Lost to Follow-up|1|||
33473066|NCT02384941|101623934|FG000|Overall Study|Non-Compliance With Study Drug|2|||
33473067|NCT02384941|101623935|FG001|Overall Study|Non-Compliance With Study Drug|0|||
33473068|NCT02384941|101623936|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33473069|NCT02384941|101623934|FG000|Overall Study|Physician Decision|1|||
33473070|NCT02384941|101623935|FG001|Overall Study|Physician Decision|1|||
33473071|NCT02384941|101623936|FG002|Overall Study|Physician Decision|0|||
33473072|NCT02384941|101623934|FG000|Overall Study|Protocol Violation|3|||
33473073|NCT02384941|101623935|FG001|Overall Study|Protocol Violation|0|||
33473074|NCT02384941|101623936|FG002|Overall Study|Protocol Violation|0|||
33473075|NCT02384941|101623934|FG000|Overall Study|Withdrawal by Subject|26|||
33473076|NCT02384941|101623935|FG001|Overall Study|Withdrawal by Subject|19|||
33473077|NCT02384941|101623936|FG002|Overall Study|Withdrawal by Subject|20|||
33473078|NCT02384941|101623934|FG000|Overall Study|Pregnancy|0|||
33473079|NCT02384941|101623935|FG001|Overall Study|Pregnancy|0|||
33473080|NCT02384941|101623936|FG002|Overall Study|Pregnancy|1|||
33473081|NCT02384941|101623934|FG000|Overall Study|Other than specified above|4|||
33473082|NCT02384941|101623935|FG001|Overall Study|Other than specified above|0|||
33473083|NCT02384941|101623936|FG002|Overall Study|Other than specified above|1|||
33473084|NCT00448136|101623946|FG000|Overall Study|Death|3|||
33473085|NCT00448136|101623947|FG001|Overall Study|Death|8|||
33473086|NCT00448136|101623946|FG000|Overall Study|Investigator's decision (progression)|1|||
33473087|NCT00448136|101623947|FG001|Overall Study|Investigator's decision (progression)|0|||
33473088|NCT00289874|101623948|FG000|Overall Study|Adverse Event|1|||
33473089|NCT00289874|101623949|FG001|Overall Study|Adverse Event|5|||
33473090|NCT00289874|101623948|FG000|Overall Study|Lost to Follow-up|1|||
33473091|NCT00289874|101623949|FG001|Overall Study|Lost to Follow-up|1|||
33473092|NCT00289874|101623948|FG000|Overall Study|Protocol Violation|3|||
33473093|NCT00289874|101623949|FG001|Overall Study|Protocol Violation|2|||
33473094|NCT00289874|101623948|FG000|Overall Study|Did not meet eligibility|1|||
33473095|NCT00289874|101623949|FG001|Overall Study|Did not meet eligibility|0|||
33473096|NCT01481324|101623950|FG000|Overall Study|Missing Data|0|||
33473097|NCT01481324|101623951|FG001|Overall Study|Missing Data|2|||
33473098|NCT01481324|101623952|FG002|Overall Study|Missing Data|2|||
33473099|NCT01769339|101623954|FG000|Overall Study|Lost to Follow-up|42|||
33473100|NCT01769339|101623954|FG000|Overall Study|Adverse Event|1|||
33473101|NCT01941940|101623955|FG000|Overall Study|Adverse Event|11|||
33473102|NCT01941940|101623955|FG000|Overall Study|Lost to Follow-up|2|||
33473103|NCT01941940|101623955|FG000|Overall Study|Physician Decision|2|||
33473104|NCT01941940|101623955|FG000|Overall Study|Withdrawal by Subject|15|||
33473105|NCT01941940|101623955|FG000|Overall Study|Death|1|||
33473106|NCT01941940|101623955|FG000|Overall Study|Other|1|||
33473107|NCT01941940|101623955|FG000|Overall Study|Other|1|||
33473108|NCT01565850|101623956|FG000|Overall Study|Adverse Event|0|||
33473109|NCT01565850|101623957|FG001|Overall Study|Adverse Event|1|||
33473110|NCT01565850|101623956|FG000|Overall Study|Lost to Follow-up|12|||
33473111|NCT01565850|101623957|FG001|Overall Study|Lost to Follow-up|4|||
33473112|NCT01565850|101623956|FG000|Overall Study|Investigator's Discretion|2|||
33473113|NCT01565850|101623957|FG001|Overall Study|Investigator's Discretion|1|||
33473114|NCT01565850|101623956|FG000|Overall Study|Participant noncompliance|2|||
33473115|NCT01565850|101623957|FG001|Overall Study|Participant noncompliance|0|||
33181982|NCT01062555|100575507|FG002|Phase 1|Withdrawal by Subject|0|||
33473116|NCT01565850|101623956|FG000|Overall Study|Withdrew Consent|4|||
33473117|NCT01565850|101623957|FG001|Overall Study|Withdrew Consent|2|||
33473118|NCT00931268|101623958|FG000|Overall Study|Lost to Follow-up|6|||
33473119|NCT01550744|101623959|FG000|Open-Label|Lost to Follow-up|7|||
33473120|NCT01550744|101623960|FG001|Open-Label|Lost to Follow-up|0|||
33473121|NCT01550744|101623961|FG002|Open-Label|Lost to Follow-up|0|||
33473122|NCT01550744|101623959|FG000|Open-Label|Withdrawal by Subject|13|||
33473123|NCT01550744|101623960|FG001|Open-Label|Withdrawal by Subject|0|||
33473124|NCT01550744|101623961|FG002|Open-Label|Withdrawal by Subject|0|||
33473125|NCT01550744|101623959|FG000|Open-Label|Adverse Event|11|||
33473126|NCT01550744|101623960|FG001|Open-Label|Adverse Event|0|||
33473127|NCT01550744|101623961|FG002|Open-Label|Adverse Event|0|||
33473128|NCT01550744|101623959|FG000|Open-Label|Lack of Efficacy|4|||
33473129|NCT01550744|101623960|FG001|Open-Label|Lack of Efficacy|0|||
33473130|NCT01550744|101623961|FG002|Open-Label|Lack of Efficacy|0|||
33473131|NCT01550744|101623959|FG000|Open-Label|Protocol Violation|4|||
33473132|NCT01550744|101623960|FG001|Open-Label|Protocol Violation|0|||
33181983|NCT01062555|100575508|FG003|Phase 1|Withdrawal by Subject|0|||
33181984|NCT01062555|100575505|FG000|Phase 2|Death|0|||
33181985|NCT01062555|100575506|FG001|Phase 2|Death|0|||
33473133|NCT01550744|101623961|FG002|Open-Label|Protocol Violation|0|||
33473134|NCT01550744|101623959|FG000|Open-Label|Not all 3 study drug injections received|2|||
33473135|NCT01550744|101623960|FG001|Open-Label|Not all 3 study drug injections received|0|||
33473136|NCT01550744|101623961|FG002|Open-Label|Not all 3 study drug injections received|0|||
33473137|NCT01550744|101623959|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
33473138|NCT01550744|101623960|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
33473139|NCT01550744|101623961|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
33473140|NCT01550744|101623959|FG000|Open-Label|Other|1|||
33473141|NCT01550744|101623960|FG001|Open-Label|Other|0|||
33473142|NCT01550744|101623961|FG002|Open-Label|Other|0|||
33473143|NCT01550744|101623959|FG000|Double-Blind|Lost to Follow-up|0|||
33473144|NCT01550744|101623960|FG001|Double-Blind|Lost to Follow-up|6|||
33473145|NCT01550744|101623961|FG002|Double-Blind|Lost to Follow-up|12|||
33473146|NCT01550744|101623959|FG000|Double-Blind|Withdrawal by Subject|0|||
33473147|NCT01550744|101623960|FG001|Double-Blind|Withdrawal by Subject|2|||
33473148|NCT01550744|101623961|FG002|Double-Blind|Withdrawal by Subject|15|||
33473149|NCT01550744|101623959|FG000|Double-Blind|Adverse Event|0|||
33473150|NCT01550744|101623960|FG001|Double-Blind|Adverse Event|4|||
33473151|NCT01550744|101623961|FG002|Double-Blind|Adverse Event|15|||
33473152|NCT01550744|101623959|FG000|Double-Blind|Death|0|||
33473153|NCT01550744|101623960|FG001|Double-Blind|Death|1|||
33473154|NCT01550744|101623961|FG002|Double-Blind|Death|0|||
33473155|NCT01550744|101623959|FG000|Double-Blind|Lack of Efficacy|0|||
33473156|NCT01550744|101623960|FG001|Double-Blind|Lack of Efficacy|2|||
33473157|NCT01550744|101623961|FG002|Double-Blind|Lack of Efficacy|8|||
33473158|NCT01550744|101623959|FG000|Double-Blind|Protocol Violation|0|||
33473159|NCT01550744|101623960|FG001|Double-Blind|Protocol Violation|0|||
33473160|NCT01550744|101623961|FG002|Double-Blind|Protocol Violation|4|||
33473161|NCT01550744|101623959|FG000|Double-Blind|Pregnancy|0|||
33473162|NCT01550744|101623960|FG001|Double-Blind|Pregnancy|0|||
33473163|NCT01550744|101623961|FG002|Double-Blind|Pregnancy|3|||
33473164|NCT01550744|101623959|FG000|Double-Blind|Other|0|||
33473165|NCT01550744|101623960|FG001|Double-Blind|Other|2|||
33473166|NCT01550744|101623961|FG002|Double-Blind|Other|10|||
33473167|NCT02246439|101623964|FG000|Overall Study|Adverse Event|3|||
33473168|NCT02246439|101623965|FG001|Overall Study|Adverse Event|0|||
33473169|NCT02246439|101623964|FG000|Overall Study|Lost to Follow-up|7|||
33473170|NCT02246439|101623965|FG001|Overall Study|Lost to Follow-up|5|||
33473171|NCT02246439|101623964|FG000|Overall Study|Protocol Violation|0|||
33181986|NCT01062555|100575507|FG002|Phase 2|Death|8|||
33181987|NCT01062555|100575508|FG003|Phase 2|Death|3|||
33181988|NCT01062555|100575505|FG000|Phase 2|Graft failure|0|||
33181989|NCT01062555|100575506|FG001|Phase 2|Graft failure|0|||
33181990|NCT01062555|100575507|FG002|Phase 2|Graft failure|7|||
33181991|NCT01062555|100575508|FG003|Phase 2|Graft failure|4|||
33181992|NCT01062555|100575505|FG000|Phase 2|Withdrawal by Subject|0|||
33181993|NCT01062555|100575506|FG001|Phase 2|Withdrawal by Subject|0|||
33473172|NCT02246439|101623965|FG001|Overall Study|Protocol Violation|2|||
33473173|NCT02246439|101623964|FG000|Overall Study|Physician Decision|0|||
33473174|NCT02246439|101623965|FG001|Overall Study|Physician Decision|1|||
33473175|NCT02246439|101623964|FG000|Overall Study|Unkonwn|1|||
33473176|NCT02246439|101623965|FG001|Overall Study|Unkonwn|3|||
33473177|NCT02246439|101623964|FG000|Overall Study|Withdrawal by Subject|1|||
33473178|NCT02246439|101623965|FG001|Overall Study|Withdrawal by Subject|0|||
33473179|NCT01892657|101623966|FG000|Overall Study|Withdrawal by Subject|6|||
33473180|NCT01892657|101623966|FG000|Overall Study|Protocol Violation|12|||
33473181|NCT00622466|101623970|FG000|Overall Study|Death|1|||
33473182|NCT00622466|101623970|FG000|Overall Study|Adverse Event|1|||
33473183|NCT00622466|101623970|FG000|Overall Study|Withdrawal by Subject|2|||
33473184|NCT01659736|101623972|FG000|Treatment Period|Adverse Event|1|||
33473185|NCT01659736|101623973|FG001|Treatment Period|Adverse Event|1|||
33473186|NCT01659736|101623972|FG000|Treatment Period|Protocol Violation|3|||
33473187|NCT01659736|101623973|FG001|Treatment Period|Protocol Violation|1|||
33473188|NCT01659736|101623972|FG000|Treatment Period|Withdrawal by Subject|1|||
33473189|NCT01659736|101623973|FG001|Treatment Period|Withdrawal by Subject|0|||
33473190|NCT01659736|101623972|FG000|3-month Follow-up|Lost to Follow-up|0|||
33473191|NCT01659736|101623973|FG001|3-month Follow-up|Lost to Follow-up|1|||
33473192|NCT00557076|101623977|FG000|Overall Study|Unblinding|0|||
33473193|NCT00557076|101623978|FG001|Overall Study|Unblinding|1|||
33473194|NCT00620659|101623979|FG000|Treatment Period 1|Adverse Event|1|||
33473195|NCT00620659|101623980|FG001|Treatment Period 1|Adverse Event|0|||
33473196|NCT00620659|101623981|FG002|Treatment Period 1|Adverse Event|0|||
33473197|NCT00620659|101623982|FG003|Treatment Period 1|Adverse Event|3|||
33473198|NCT00620659|101623983|FG004|Treatment Period 1|Adverse Event|0|||
33473199|NCT00620659|101623984|FG005|Treatment Period 1|Adverse Event|0|||
33473200|NCT00620659|101623979|FG000|Treatment Period 1|Protocol Violation|1|||
33473201|NCT00620659|101623980|FG001|Treatment Period 1|Protocol Violation|0|||
33473202|NCT00620659|101623981|FG002|Treatment Period 1|Protocol Violation|0|||
33473203|NCT00620659|101623982|FG003|Treatment Period 1|Protocol Violation|0|||
33473204|NCT00620659|101623983|FG004|Treatment Period 1|Protocol Violation|0|||
33473205|NCT00620659|101623984|FG005|Treatment Period 1|Protocol Violation|0|||
33473206|NCT00620659|101623979|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33473207|NCT00620659|101623980|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33473208|NCT00620659|101623981|FG002|Treatment Period 1|Withdrawal by Subject|1|||
33473209|NCT00620659|101623982|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33181994|NCT01062555|100575507|FG002|Phase 2|Withdrawal by Subject|0|||
33181995|NCT01062555|100575508|FG003|Phase 2|Withdrawal by Subject|7|||
33181996|NCT01062555|100575505|FG000|Phase 2|Protocol Violation|0|||
33181997|NCT01062555|100575506|FG001|Phase 2|Protocol Violation|0|||
33181998|NCT01062555|100575507|FG002|Phase 2|Protocol Violation|0|||
33181999|NCT01062555|100575508|FG003|Phase 2|Protocol Violation|3|||
33182000|NCT01062555|100575505|FG000|Phase 2|Physician Decision|0|||
33182001|NCT01062555|100575506|FG001|Phase 2|Physician Decision|0|||
33182002|NCT01062555|100575507|FG002|Phase 2|Physician Decision|0|||
33182003|NCT01062555|100575508|FG003|Phase 2|Physician Decision|17|||
33182004|NCT00857220|100575514|FG000|Overall Study|Adverse Event|35|||
33182005|NCT00857220|100575514|FG000|Overall Study|Death|1|||
33182006|NCT00857220|100575514|FG000|Overall Study|Lack of Efficacy|11|||
33182007|NCT00857220|100575514|FG000|Overall Study|Lost to Follow-up|30|||
33182008|NCT00857220|100575514|FG000|Overall Study|Physician Decision|4|||
33182009|NCT00857220|100575514|FG000|Overall Study|Protocol Violation|16|||
33182010|NCT00857220|100575514|FG000|Overall Study|Withdrawal by Subject|67|||
33182011|NCT00857220|100575514|FG000|Overall Study|Clinical Hold|6|||
33182012|NCT00857220|100575514|FG000|Overall Study|Site Closed|5|||
33182013|NCT00857220|100575514|FG000|Overall Study|Miscellaneous|8|||
33182014|NCT01592344|100575518|FG000|Overall Study|Adverse Event|1|||
33182015|NCT01592344|100575519|FG001|Overall Study|Adverse Event|1|||
33182016|NCT01592344|100575518|FG000|Overall Study|Lack of Efficacy|1|||
33182017|NCT01592344|100575519|FG001|Overall Study|Lack of Efficacy|0|||
33182018|NCT01592344|100575518|FG000|Overall Study|not available at primary outcome visit|2|||
33182019|NCT01592344|100575519|FG001|Overall Study|not available at primary outcome visit|4|||
33182020|NCT03406858|100575520|FG000|Overall Study|Failure to receive treatment drug.|1|||
33182021|NCT03406858|100575520|FG000|Overall Study|ineligible|1|||
33182022|NCT02642432|100575521|FG000|Overall Study|Adverse Event|2|||
33182023|NCT02642432|100575521|FG000|Overall Study|Withdrew Consent|1|||
33182024|NCT02642432|100575521|FG000|Overall Study|Lost to Follow-up|2|||
33182025|NCT02642432|100575521|FG000|Overall Study|Other|3|||
33182026|NCT02874742|100575522|FG000|Overall Study|Death|0|||
33182027|NCT02874742|100575523|FG001|Overall Study|Death|1|||
33473210|NCT00620659|101623983|FG004|Treatment Period 1|Withdrawal by Subject|1|||
33182028|NCT02874742|100575524|FG002|Overall Study|Death|0|||
33473211|NCT00620659|101623984|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33473212|NCT00620659|101623979|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
33473213|NCT00620659|101623980|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
33182029|NCT02874742|100575522|FG000|Overall Study|Lost to Follow-up|5|||
33182030|NCT02874742|100575523|FG001|Overall Study|Lost to Follow-up|4|||
33182031|NCT02874742|100575524|FG002|Overall Study|Lost to Follow-up|1|||
33182032|NCT02874742|100575522|FG000|Overall Study|Withdrawal by Subject|17|||
33182033|NCT02874742|100575523|FG001|Overall Study|Withdrawal by Subject|8|||
33182034|NCT02874742|100575524|FG002|Overall Study|Withdrawal by Subject|0|||
33182035|NCT02874742|100575522|FG000|Overall Study|Other|4|||
33182036|NCT02874742|100575523|FG001|Overall Study|Other|1|||
33473214|NCT00620659|101623981|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
33473215|NCT00620659|101623982|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
33182037|NCT02874742|100575524|FG002|Overall Study|Other|0|||
33182038|NCT02874742|100575522|FG000|Overall Study|Progressive Disease|1|||
33473216|NCT00620659|101623983|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
33473217|NCT00620659|101623984|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
33473218|NCT00620659|101623979|FG000|Treatment Period 2|Adverse Event|0|||
33473219|NCT00620659|101623980|FG001|Treatment Period 2|Adverse Event|3|||
33473220|NCT00620659|101623981|FG002|Treatment Period 2|Adverse Event|0|||
33473221|NCT00620659|101623982|FG003|Treatment Period 2|Adverse Event|0|||
33473222|NCT00620659|101623983|FG004|Treatment Period 2|Adverse Event|2|||
33473223|NCT00620659|101623984|FG005|Treatment Period 2|Adverse Event|0|||
33473224|NCT00620659|101623979|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33473225|NCT00620659|101623980|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33473226|NCT00620659|101623981|FG002|Treatment Period 2|Withdrawal by Subject|1|||
33473227|NCT00620659|101623982|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33473228|NCT00620659|101623983|FG004|Treatment Period 2|Withdrawal by Subject|3|||
33473229|NCT00620659|101623984|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33473230|NCT00620659|101623979|FG000|Placebo Washout Period 2|Adverse Event|2|||
33473231|NCT00620659|101623980|FG001|Placebo Washout Period 2|Adverse Event|0|||
33473232|NCT00620659|101623981|FG002|Placebo Washout Period 2|Adverse Event|0|||
33473233|NCT00620659|101623982|FG003|Placebo Washout Period 2|Adverse Event|0|||
33473234|NCT00620659|101623983|FG004|Placebo Washout Period 2|Adverse Event|0|||
33473235|NCT00620659|101623984|FG005|Placebo Washout Period 2|Adverse Event|0|||
33473236|NCT00620659|101623979|FG000|Treatment Period 3|Adverse Event|0|||
33473237|NCT00620659|101623980|FG001|Treatment Period 3|Adverse Event|2|||
33473238|NCT00620659|101623981|FG002|Treatment Period 3|Adverse Event|0|||
33473239|NCT00620659|101623982|FG003|Treatment Period 3|Adverse Event|0|||
33473240|NCT00620659|101623983|FG004|Treatment Period 3|Adverse Event|0|||
33473241|NCT00620659|101623984|FG005|Treatment Period 3|Adverse Event|0|||
33473242|NCT00620659|101623979|FG000|Treatment Period 3|Withdrawal by Subject|0|||
33473243|NCT00620659|101623980|FG001|Treatment Period 3|Withdrawal by Subject|0|||
33473244|NCT00620659|101623981|FG002|Treatment Period 3|Withdrawal by Subject|0|||
33473245|NCT00620659|101623982|FG003|Treatment Period 3|Withdrawal by Subject|1|||
33473246|NCT00620659|101623983|FG004|Treatment Period 3|Withdrawal by Subject|0|||
33473247|NCT00620659|101623984|FG005|Treatment Period 3|Withdrawal by Subject|0|||
33473248|NCT01346774|101623989|FG000|Overall Study|Did not take a single dose|6|||
33182039|NCT02874742|100575523|FG001|Overall Study|Progressive Disease|0|||
33182040|NCT02874742|100575524|FG002|Overall Study|Progressive Disease|0|||
33182041|NCT02874742|100575522|FG000|Overall Study|Screen Failure|0|||
33182042|NCT02874742|100575523|FG001|Overall Study|Screen Failure|2|||
33182043|NCT02874742|100575524|FG002|Overall Study|Screen Failure|0|||
33266383|NCT00146172|100873890|FG002|Overall Study|Disease Progression|2|||
33266384|NCT00146172|100873891|FG003|Overall Study|Disease Progression|5|||
33182044|NCT02211131|100575527|FG000|Overall Study|Death|26|||
33182045|NCT02211131|100575528|FG001|Overall Study|Death|16|||
33182046|NCT02211131|100575527|FG000|Overall Study|Lost to Follow-up|4|||
33182047|NCT02211131|100575528|FG001|Overall Study|Lost to Follow-up|3|||
33182048|NCT02211131|100575527|FG000|Overall Study|Decision by Sponsor|1|||
33182049|NCT02211131|100575528|FG001|Overall Study|Decision by Sponsor|1|||
33182050|NCT02211131|100575527|FG000|Overall Study|Withdrawal by Subject|3|||
33182051|NCT02211131|100575528|FG001|Overall Study|Withdrawal by Subject|8|||
33182052|NCT04668950|100575531|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
33182053|NCT04668950|100575532|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
33182054|NCT04668950|100575531|FG000|Overall Study|Could not confirm started study medication|15|||
33182055|NCT04668950|100575532|FG001|Overall Study|Could not confirm started study medication|15|||
33182056|NCT04668950|100575531|FG000|Overall Study|Could not confirm baseline status|6|||
33182057|NCT04668950|100575532|FG001|Overall Study|Could not confirm baseline status|2|||
33182058|NCT04668950|100575531|FG000|Overall Study|Drop out and did not start medication|15|||
33182059|NCT04668950|100575532|FG001|Overall Study|Drop out and did not start medication|17|||
33182060|NCT04668950|100575531|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
33182061|NCT04668950|100575532|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
33182062|NCT04668950|100575531|FG000|Overall Study|Other|2|||
33182063|NCT04668950|100575532|FG001|Overall Study|Other|4|||
33182064|NCT00026793|100575535|FG000|Overall Study|Death on study due to underlying disease|4|||
33182065|NCT00026793|100575535|FG000|Overall Study|Physician Decision|2|||
33182066|NCT00026793|100575535|FG000|Overall Study|Off study|2|||
33182067|NCT02347189|100575537|FG000|Overall Study|No implant attempted of study device|9|||
33182068|NCT02347189|100575537|FG000|Overall Study|No primary outcome data available|2|||
33182069|NCT01176266|100575538|FG000|Overall Study|Death|6|||
33182070|NCT01176266|100575538|FG000|Overall Study|Withdrawal by Subject|3|||
33182071|NCT01290666|100575539|FG000|Overall Study|Lost to Follow-up|11|||
33182072|NCT01290666|100575539|FG000|Overall Study|Withdrawal by Subject|23|||
33182073|NCT01290666|100575539|FG000|Overall Study|Early Termination of Study|4|||
33182074|NCT01085097|100575540|FG000|Overall Study|Adverse Event|0|||
33182075|NCT01085097|100575541|FG001|Overall Study|Adverse Event|0|||
33266385|NCT00146172|100873892|FG004|Overall Study|Disease Progression|2|||
33473249|NCT01346774|101623990|FG001|Overall Study|Did not take a single dose|4|||
33182076|NCT01085097|100575542|FG002|Overall Study|Adverse Event|2|||
33182077|NCT01085097|100575540|FG000|Overall Study|Treatment failure|2|||
33182078|NCT01085097|100575541|FG001|Overall Study|Treatment failure|0|||
33266386|NCT00146172|100873893|FG005|Overall Study|Disease Progression|2|||
33473250|NCT01346774|101623989|FG000|Overall Study|Lost to Follow-up|3|||
33182079|NCT01085097|100575542|FG002|Overall Study|Treatment failure|0|||
33473251|NCT01346774|101623990|FG001|Overall Study|Lost to Follow-up|4|||
33473252|NCT01346774|101623989|FG000|Overall Study|Withdrawal by Subject|1|||
33473253|NCT01346774|101623990|FG001|Overall Study|Withdrawal by Subject|4|||
33473254|NCT01346774|101623989|FG000|Overall Study|Protocol Violation|2|||
33473255|NCT01346774|101623990|FG001|Overall Study|Protocol Violation|3|||
33473256|NCT01346774|101623989|FG000|Overall Study|Adverse Event|1|||
33473257|NCT01346774|101623990|FG001|Overall Study|Adverse Event|2|||
33473258|NCT04874636|101623991|FG000|Overall Study|Adverse Event|17|||
33473259|NCT04874636|101623992|FG001|Overall Study|Adverse Event|7|||
33473260|NCT04874636|101623991|FG000|Overall Study|Lost to Follow-up|1|||
33473261|NCT04874636|101623992|FG001|Overall Study|Lost to Follow-up|0|||
33473262|NCT04874636|101623991|FG000|Overall Study|Non-Compliance with Study Drug|2|||
33473263|NCT04874636|101623992|FG001|Overall Study|Non-Compliance with Study Drug|0|||
33473264|NCT04874636|101623991|FG000|Overall Study|Physician Decision|1|||
33473265|NCT04874636|101623992|FG001|Overall Study|Physician Decision|0|||
33473266|NCT04874636|101623991|FG000|Overall Study|Withdrawal by Subject|6|||
33473267|NCT04874636|101623992|FG001|Overall Study|Withdrawal by Subject|5|||
33473268|NCT04465630|101623993|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
33473269|NCT04465630|101623993|FG000|Overall Study|Screen failure|8|||
33473270|NCT04465630|101623993|FG000|Overall Study|Baseline failure|16|||
33473271|NCT01173471|101623994|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33473272|NCT01173471|101623995|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33473273|NCT01173471|101623996|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
33473274|NCT01173471|101623997|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
33473275|NCT01173471|101623994|FG000|Overall Study|Condition under investigation worsened|2|||
33473276|NCT01173471|101623995|FG001|Overall Study|Condition under investigation worsened|0|||
33473277|NCT01173471|101623996|FG002|Overall Study|Condition under investigation worsened|0|||
33473278|NCT01173471|101623997|FG003|Overall Study|Condition under investigation worsened|0|||
33473279|NCT01173471|101623994|FG000|Overall Study|Lost to Follow-up|0|||
33473280|NCT01173471|101623995|FG001|Overall Study|Lost to Follow-up|0|||
33473281|NCT01173471|101623996|FG002|Overall Study|Lost to Follow-up|1|||
33473282|NCT01173471|101623997|FG003|Overall Study|Lost to Follow-up|0|||
33473283|NCT01173471|101623994|FG000|Overall Study|Reason given as Other|0|||
33473284|NCT01173471|101623995|FG001|Overall Study|Reason given as Other|0|||
33473285|NCT01173471|101623996|FG002|Overall Study|Reason given as Other|1|||
33473286|NCT01173471|101623997|FG003|Overall Study|Reason given as Other|0|||
33473287|NCT02551666|101623999|FG000|Overall Study|Withdrawal by Subject|1|||
33473288|NCT02551666|101624000|FG001|Overall Study|Withdrawal by Subject|3|||
33473289|NCT00423319|101624001|FG000|Overall Study|Death|2|||
33473290|NCT00423319|101624002|FG001|Overall Study|Death|0|||
33473291|NCT00423319|101624001|FG000|Overall Study|Adverse Event|93|||
33473292|NCT00423319|101624002|FG001|Overall Study|Adverse Event|112|||
33473293|NCT00423319|101624001|FG000|Overall Study|Withdrawal by Subject|86|||
33473294|NCT00423319|101624002|FG001|Overall Study|Withdrawal by Subject|99|||
33473295|NCT00423319|101624001|FG000|Overall Study|Lost to Follow-up|4|||
33473296|NCT00423319|101624002|FG001|Overall Study|Lost to Follow-up|3|||
33473297|NCT00423319|101624001|FG000|Overall Study|Poor compliance or noncompliance|1|||
33473298|NCT00423319|101624002|FG001|Overall Study|Poor compliance or noncompliance|1|||
33473299|NCT00423319|101624001|FG000|Overall Study|No longer meets study criteria|15|||
33473300|NCT00423319|101624002|FG001|Overall Study|No longer meets study criteria|15|||
33473301|NCT00423319|101624001|FG000|Overall Study|Other|23|||
33473302|NCT00423319|101624002|FG001|Overall Study|Other|22|||
33473303|NCT03733210|101624005|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
33182080|NCT02013167|100575546|FG000|Overall Study|Withdrawal by Subject|15|||
33182081|NCT02013167|100575547|FG001|Overall Study|Withdrawal by Subject|14|||
33182082|NCT02013167|100575546|FG000|Overall Study|Sponsor Decision|1|||
33182083|NCT02013167|100575547|FG001|Overall Study|Sponsor Decision|3|||
33182084|NCT02013167|100575546|FG000|Overall Study|Lost to Follow-up|0|||
33182085|NCT02013167|100575547|FG001|Overall Study|Lost to Follow-up|1|||
33182086|NCT02013167|100575546|FG000|Overall Study|Death|85|||
33182087|NCT02013167|100575547|FG001|Overall Study|Death|160|||
33182088|NCT02120950|100575550|FG000|Overall Study|Adverse Event|5|||
33182089|NCT02120950|100575551|FG001|Overall Study|Adverse Event|4|||
33182090|NCT02120950|100575552|FG002|Overall Study|Adverse Event|3|||
33182091|NCT02120950|100575550|FG000|Overall Study|Death|3|||
33473304|NCT03733210|101624006|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
33473305|NCT02312063|101624011|FG000|Overall Study|Withdrawal by Subject|0|||
33473306|NCT02312063|101624012|FG001|Overall Study|Withdrawal by Subject|1|||
33473307|NCT01553279|101624016|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
33473308|NCT01553279|101624017|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
33473309|NCT01553279|101624016|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
33473310|NCT01553279|101624017|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
33473311|NCT01553279|101624016|FG000|Interim Period|Withdrawal by Subject|2|||
33473312|NCT01553279|101624017|FG001|Interim Period|Withdrawal by Subject|2|||
33473313|NCT01553279|101624016|FG000|Interim Period|Lost to Follow-up|1|||
33182092|NCT02120950|100575551|FG001|Overall Study|Death|0|||
33182093|NCT02120950|100575552|FG002|Overall Study|Death|1|||
33182094|NCT02120950|100575550|FG000|Overall Study|Withdrawal by Subject|6|||
33182095|NCT02120950|100575551|FG001|Overall Study|Withdrawal by Subject|3|||
33182096|NCT02120950|100575552|FG002|Overall Study|Withdrawal by Subject|2|||
33182097|NCT02120950|100575550|FG000|Overall Study|Protocol Violation|1|||
33182098|NCT02120950|100575551|FG001|Overall Study|Protocol Violation|1|||
33182099|NCT02120950|100575552|FG002|Overall Study|Protocol Violation|7|||
33182100|NCT02120950|100575550|FG000|Overall Study|Other reasons|5|||
33182101|NCT02120950|100575551|FG001|Overall Study|Other reasons|4|||
33182102|NCT02120950|100575552|FG002|Overall Study|Other reasons|1|||
33182103|NCT02120950|100575550|FG000|Overall Study|Lost to Follow-up|0|||
33182104|NCT02120950|100575551|FG001|Overall Study|Lost to Follow-up|2|||
33182105|NCT02120950|100575552|FG002|Overall Study|Lost to Follow-up|1|||
33182106|NCT01393405|100575555|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
33182107|NCT01393405|100575556|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
33182108|NCT01393405|100575557|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
33182109|NCT01393405|100575555|FG000|Induction Period (week1-16)|Adverse Event|16|||
33182110|NCT01393405|100575556|FG001|Induction Period (week1-16)|Adverse Event|0|||
33182111|NCT01393405|100575557|FG002|Induction Period (week1-16)|Adverse Event|0|||
33182112|NCT01393405|100575555|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
33182113|NCT01393405|100575556|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
33182114|NCT01393405|100575557|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
33182115|NCT01393405|100575555|FG000|Maintenance Period Week|Lack of Efficacy|0|||
33182116|NCT01393405|100575556|FG001|Maintenance Period Week|Lack of Efficacy|22|||
33182117|NCT01393405|100575557|FG002|Maintenance Period Week|Lack of Efficacy|22|||
33182118|NCT01393405|100575555|FG000|Maintenance Period Week|Adverse Event|0|||
33182119|NCT01393405|100575556|FG001|Maintenance Period Week|Adverse Event|5|||
33182120|NCT01393405|100575557|FG002|Maintenance Period Week|Adverse Event|2|||
33182121|NCT01393405|100575555|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
33182122|NCT01393405|100575556|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
33182123|NCT01393405|100575557|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
33182124|NCT01393405|100575555|FG000|Maintenance Period Week|Lost to Follow-up|0|||
33182125|NCT01393405|100575556|FG001|Maintenance Period Week|Lost to Follow-up|1|||
33182126|NCT01393405|100575557|FG002|Maintenance Period Week|Lost to Follow-up|0|||
33182127|NCT02520011|100575558|FG000|Overall Study|Adverse Event|0|||
33182128|NCT02520011|100575559|FG001|Overall Study|Adverse Event|1|||
33182129|NCT02520011|100575560|FG002|Overall Study|Adverse Event|2|||
33182130|NCT02520011|100575558|FG000|Overall Study|Death|0|||
33182131|NCT02520011|100575559|FG001|Overall Study|Death|8|||
33182132|NCT02520011|100575560|FG002|Overall Study|Death|1|||
33182133|NCT02520011|100575558|FG000|Overall Study|Lack of Efficacy|4|||
33182134|NCT02520011|100575559|FG001|Overall Study|Lack of Efficacy|26|||
33182135|NCT02520011|100575560|FG002|Overall Study|Lack of Efficacy|4|||
33182136|NCT02520011|100575558|FG000|Overall Study|Physician Decision|0|||
33182137|NCT02520011|100575559|FG001|Overall Study|Physician Decision|2|||
33182138|NCT02520011|100575560|FG002|Overall Study|Physician Decision|0|||
33182139|NCT02520011|100575558|FG000|Overall Study|Withdrawal by Subject|1|||
33182140|NCT02520011|100575559|FG001|Overall Study|Withdrawal by Subject|3|||
33182141|NCT02520011|100575560|FG002|Overall Study|Withdrawal by Subject|0|||
33182142|NCT02520011|100575558|FG000|Overall Study|Protocol Deviation|0|||
33473314|NCT01553279|101624017|FG001|Interim Period|Lost to Follow-up|0|||
33473315|NCT01553279|101624016|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
33473316|NCT01553279|101624017|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
33473317|NCT01553279|101624016|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
33473318|NCT01553279|101624017|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
33473319|NCT02400671|101624018|FG000|Overall Study|Death|5|||
33473320|NCT02400671|101624019|FG001|Overall Study|Death|3|||
33473321|NCT02400671|101624020|FG002|Overall Study|Death|4|||
33473322|NCT02400671|101624018|FG000|Overall Study|Lost to Follow-up|20|||
33473323|NCT02400671|101624019|FG001|Overall Study|Lost to Follow-up|27|||
33182143|NCT02520011|100575559|FG001|Overall Study|Protocol Deviation|1|||
33182144|NCT02520011|100575560|FG002|Overall Study|Protocol Deviation|0|||
33182145|NCT02520011|100575558|FG000|Overall Study|Patient went to hospice|0|||
33182146|NCT02520011|100575559|FG001|Overall Study|Patient went to hospice|1|||
33182147|NCT02520011|100575560|FG002|Overall Study|Patient went to hospice|0|||
33182148|NCT02520011|100575558|FG000|Overall Study|Progressive disease following response|0|||
33182149|NCT02520011|100575559|FG001|Overall Study|Progressive disease following response|4|||
33182150|NCT02520011|100575560|FG002|Overall Study|Progressive disease following response|2|||
33182151|NCT00481195|100575566|FG000|Overall Study|Adverse Event|16|||
33182152|NCT00481195|100575567|FG001|Overall Study|Adverse Event|11|||
33182153|NCT00481195|100575566|FG000|Overall Study|Lack of Efficacy|1|||
33473324|NCT02400671|101624020|FG002|Overall Study|Lost to Follow-up|24|||
33473325|NCT02400671|101624018|FG000|Overall Study|Withdrawal by Subject|2|||
33473326|NCT02400671|101624019|FG001|Overall Study|Withdrawal by Subject|2|||
33182154|NCT00481195|100575567|FG001|Overall Study|Lack of Efficacy|3|||
33182155|NCT00481195|100575566|FG000|Overall Study|Lost to Follow-up|4|||
33182156|NCT00481195|100575567|FG001|Overall Study|Lost to Follow-up|6|||
33182157|NCT00481195|100575566|FG000|Overall Study|Physician Decision|3|||
33182158|NCT00481195|100575567|FG001|Overall Study|Physician Decision|1|||
33182159|NCT00481195|100575566|FG000|Overall Study|Protocol Violation|10|||
33473327|NCT02400671|101624020|FG002|Overall Study|Withdrawal by Subject|0|||
33473328|NCT01765582|101624021|FG000|Overall Study|Other|3|||
33473329|NCT01765582|101624022|FG001|Overall Study|Other|6|||
33473330|NCT01765582|101624023|FG002|Overall Study|Other|9|||
33473331|NCT01765582|101624021|FG000|Overall Study|Lost to Follow-up|2|||
33473332|NCT01765582|101624022|FG001|Overall Study|Lost to Follow-up|2|||
33473333|NCT01765582|101624023|FG002|Overall Study|Lost to Follow-up|1|||
33473334|NCT01765582|101624021|FG000|Overall Study|Death|31|||
33473335|NCT01765582|101624022|FG001|Overall Study|Death|36|||
33473336|NCT01765582|101624023|FG002|Overall Study|Death|33|||
33182160|NCT00481195|100575567|FG001|Overall Study|Protocol Violation|7|||
33182161|NCT00481195|100575566|FG000|Overall Study|Withdrawal by Subject|3|||
33182162|NCT00481195|100575567|FG001|Overall Study|Withdrawal by Subject|9|||
33182163|NCT00481195|100575566|FG000|Overall Study|Miscellaneous|2|||
33182164|NCT00481195|100575567|FG001|Overall Study|Miscellaneous|2|||
33182165|NCT00549562|100575574|FG000|Overall Study|Adverse Event|1|||
33182166|NCT00549562|100575574|FG000|Overall Study|Lack of Efficacy|1|||
33182167|NCT02319031|100575575|FG000|Treatment Period|Death|1|||
33182168|NCT02319031|100575576|FG001|Treatment Period|Death|0|||
33182169|NCT01324349|100575577|FG000|Overall Study|Death|1|||
33182170|NCT01324349|100575578|FG001|Overall Study|Death|1|||
33182171|NCT01324349|100575577|FG000|Overall Study|Withdrawal by Subject|0|||
33182172|NCT01324349|100575578|FG001|Overall Study|Withdrawal by Subject|1|||
33182173|NCT02066467|100575585|FG000|Overall Study|Did not undergo implant procedure|24|||
33182174|NCT02066467|100575585|FG000|Overall Study|Attempted to implant withoput success|43|||
33182175|NCT02066467|100575585|FG000|Overall Study|Consent ineligible|1|||
33182176|NCT02066467|100575585|FG000|Overall Study|Death|54|||
33182177|NCT02066467|100575585|FG000|Overall Study|Lost to Follow-up|51|||
33182178|NCT02066467|100575585|FG000|Overall Study|Adverse Event|20|||
33182179|NCT02066467|100575585|FG000|Overall Study|Withdrawal by Subject|16|||
33473337|NCT01765582|101624021|FG000|Overall Study|Sponsor Decision|46|||
33473338|NCT01765582|101624022|FG001|Overall Study|Sponsor Decision|42|||
33473339|NCT01765582|101624023|FG002|Overall Study|Sponsor Decision|42|||
33473340|NCT01765582|101624021|FG000|Overall Study|Withdrawal of Consent|11|||
33473341|NCT01765582|101624022|FG001|Overall Study|Withdrawal of Consent|6|||
33473342|NCT01765582|101624023|FG002|Overall Study|Withdrawal of Consent|10|||
33473343|NCT02006628|101624024|FG000|Overall Study|Adverse Event|1|||
33473344|NCT02006628|101624025|FG001|Overall Study|Adverse Event|1|||
33473345|NCT02006628|101624024|FG000|Overall Study|Withdrawal by Subject|2|||
33473346|NCT02006628|101624025|FG001|Overall Study|Withdrawal by Subject|1|||
33473347|NCT01558297|101624026|FG000|Overall Study|Withdrawal by Subject|2|||
33473348|NCT01558297|101624027|FG001|Overall Study|Withdrawal by Subject|2|||
33473349|NCT01558297|101624028|FG002|Overall Study|Withdrawal by Subject|1|||
33473350|NCT05304611|101624031|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
33473351|NCT05304611|101624032|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
33473352|NCT05304611|101624033|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
33473353|NCT05304611|101624034|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
33473354|NCT05304611|101624035|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
33473355|NCT05304611|101624036|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
33182180|NCT02066467|100575585|FG000|Overall Study|Physician Decision|2|||
33182181|NCT02066467|100575585|FG000|Overall Study|Not defined|4|||
33182182|NCT00537381|100578467|FG000|Overall Study|Adverse Event|13|||
33182183|NCT00537381|100578468|FG001|Overall Study|Adverse Event|9|||
33182184|NCT00537381|100578467|FG000|Overall Study|Death|3|||
33182185|NCT00537381|100578468|FG001|Overall Study|Death|3|||
33182186|NCT00537381|100578467|FG000|Overall Study|Withdrawal by Subject|5|||
33182187|NCT00537381|100578468|FG001|Overall Study|Withdrawal by Subject|14|||
33182188|NCT00537381|100578467|FG000|Overall Study|Physician Decision|7|||
33182189|NCT00537381|100578468|FG001|Overall Study|Physician Decision|6|||
33182190|NCT00537381|100578467|FG000|Overall Study|Disease Progression|9|||
33182191|NCT00537381|100578468|FG001|Overall Study|Disease Progression|18|||
33182192|NCT00537381|100578467|FG000|Overall Study|Sponsor decision|14|||
33182193|NCT00537381|100578468|FG001|Overall Study|Sponsor decision|9|||
33182194|NCT00537381|100578467|FG000|Overall Study|Other|5|||
33182195|NCT00537381|100578468|FG001|Overall Study|Other|3|||
33182196|NCT01316276|100578469|FG000|Overall Study|Death|1|||
33182197|NCT01316276|100578469|FG000|Overall Study|Adverse Event|19|||
33182198|NCT01316276|100578469|FG000|Overall Study|Withdrawal of consent|24|||
33182199|NCT01316276|100578469|FG000|Overall Study|Lost to Follow-up|1|||
33473356|NCT05304611|101624037|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
33473357|NCT05304611|101624038|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
33473358|NCT05304611|101624039|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
33473359|NCT05304611|101624031|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
33473360|NCT05304611|101624032|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
33473361|NCT05304611|101624033|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
33182200|NCT01316276|100578469|FG000|Overall Study|Other|22|||
33266387|NCT00146172|100873894|FG006|Overall Study|Disease Progression|1|||
33473362|NCT05304611|101624034|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
33473363|NCT05304611|101624035|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
33473364|NCT05304611|101624036|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
33473365|NCT05304611|101624037|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
33473366|NCT05304611|101624038|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
33473367|NCT05304611|101624039|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
33473368|NCT01951885|101624040|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
33473369|NCT01951885|101624041|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
33473370|NCT01951885|101624040|FG000|Overall Study|Adverse Event|1|||
33473371|NCT01951885|101624041|FG001|Overall Study|Adverse Event|0|||
33473372|NCT01951885|101624040|FG000|Overall Study|Withdrawal by Subject|0|||
33473373|NCT01951885|101624041|FG001|Overall Study|Withdrawal by Subject|1|||
33473374|NCT01951885|101624040|FG000|Overall Study|ineligible due to a change in donor|0|||
33473375|NCT01951885|101624041|FG001|Overall Study|ineligible due to a change in donor|1|||
33473376|NCT01951885|101624040|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
33473377|NCT01951885|101624041|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
33473378|NCT02980874|101624042|FG000|Overall Study|Adverse Event|2|||
33473379|NCT02980874|101624043|FG001|Overall Study|Adverse Event|7|||
33473380|NCT02980874|101624042|FG000|Overall Study|Withdrawal by Subject|7|||
33473381|NCT02980874|101624043|FG001|Overall Study|Withdrawal by Subject|2|||
33473382|NCT02980874|101624042|FG000|Overall Study|Lost to Follow-up|5|||
33473383|NCT02980874|101624043|FG001|Overall Study|Lost to Follow-up|5|||
33473384|NCT02980874|101624042|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
33473385|NCT02980874|101624043|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
33473386|NCT02980874|101624042|FG000|Overall Study|Unknown study completion status|1|||
33473387|NCT02980874|101624043|FG001|Overall Study|Unknown study completion status|0|||
33473388|NCT02685202|101624046|FG000|Overall Study|Lost to Follow-up|9|||
33473389|NCT00704730|101624052|FG000|Overall Study|Adverse Event|35|||
33473390|NCT00704730|101624053|FG001|Overall Study|Adverse Event|9|||
33473391|NCT00704730|101624052|FG000|Overall Study|Death|11|||
33473392|NCT00704730|101624053|FG001|Overall Study|Death|5|||
33473393|NCT00704730|101624052|FG000|Overall Study|Physician Decision|2|||
33473394|NCT00704730|101624053|FG001|Overall Study|Physician Decision|0|||
33473395|NCT00704730|101624052|FG000|Overall Study|Did not receive drug|5|||
33473396|NCT00704730|101624053|FG001|Overall Study|Did not receive drug|2|||
33473397|NCT00704730|101624052|FG000|Overall Study|Disease progression per PI|58|||
33473398|NCT00704730|101624053|FG001|Overall Study|Disease progression per PI|67|||
33473399|NCT00704730|101624052|FG000|Overall Study|data unavailable|1|||
33473400|NCT00704730|101624053|FG001|Overall Study|data unavailable|0|||
33473401|NCT00704730|101624052|FG000|Overall Study|Withdrawal by Subject|9|||
33473402|NCT00704730|101624053|FG001|Overall Study|Withdrawal by Subject|13|||
33473403|NCT00361335|101624054|FG000|IV Period: Baseline to E0|Adverse Event|9|||
33473404|NCT00361335|101624055|FG001|IV Period: Baseline to E0|Adverse Event|4|||
33473405|NCT00361335|101624056|FG002|IV Period: Baseline to E0|Adverse Event|5|||
33473406|NCT00361335|101624057|FG003|IV Period: Baseline to E0|Adverse Event|9|||
33473407|NCT00361335|101624058|FG004|IV Period: Baseline to E0|Adverse Event|8|||
33473408|NCT00361335|101624059|FG005|IV Period: Baseline to E0|Adverse Event|0|||
33473409|NCT00361335|101624060|FG006|IV Period: Baseline to E0|Adverse Event|0|||
33473410|NCT00361335|101624054|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
33473411|NCT00361335|101624055|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
33473412|NCT00361335|101624056|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
33182201|NCT00588822|100578471|FG000|Overall Study|progression of disease|8|||
33182202|NCT00477672|100578472|FG000|Overall Study|Adverse Event|3|||
33182203|NCT00477672|100578473|FG001|Overall Study|Adverse Event|5|||
33182204|NCT00477672|100578474|FG002|Overall Study|Adverse Event|6|||
33182205|NCT00477672|100578472|FG000|Overall Study|Death|0|||
33182206|NCT00477672|100578473|FG001|Overall Study|Death|1|||
33182207|NCT00477672|100578474|FG002|Overall Study|Death|0|||
33182208|NCT00477672|100578472|FG000|Overall Study|Disease progression|0|||
33182209|NCT00477672|100578473|FG001|Overall Study|Disease progression|1|||
33182210|NCT00477672|100578474|FG002|Overall Study|Disease progression|0|||
33182211|NCT00477672|100578472|FG000|Overall Study|Physician Decision|1|||
33182212|NCT00477672|100578473|FG001|Overall Study|Physician Decision|0|||
33182213|NCT00477672|100578474|FG002|Overall Study|Physician Decision|0|||
33473413|NCT00361335|101624057|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
33473414|NCT00361335|101624058|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
33473415|NCT00361335|101624059|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
33473416|NCT00361335|101624060|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
33473417|NCT00361335|101624054|FG000|IV Period: Baseline to E0|Death|1|||
33473418|NCT00361335|101624055|FG001|IV Period: Baseline to E0|Death|1|||
33473419|NCT00361335|101624056|FG002|IV Period: Baseline to E0|Death|1|||
33473420|NCT00361335|101624057|FG003|IV Period: Baseline to E0|Death|1|||
33182214|NCT00477672|100578472|FG000|Overall Study|Protocol noncompliance|0|||
33182215|NCT00477672|100578473|FG001|Overall Study|Protocol noncompliance|2|||
33266388|NCT00146172|100873895|FG007|Overall Study|Disease Progression|22|||
33473421|NCT00361335|101624058|FG004|IV Period: Baseline to E0|Death|0|||
33473422|NCT00361335|101624059|FG005|IV Period: Baseline to E0|Death|0|||
33473423|NCT00361335|101624060|FG006|IV Period: Baseline to E0|Death|0|||
33473424|NCT00361335|101624054|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
33473425|NCT00361335|101624055|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
33473426|NCT00361335|101624056|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
33473427|NCT00361335|101624057|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
33473428|NCT00361335|101624058|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
33473429|NCT00361335|101624059|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
33473430|NCT00361335|101624060|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
33473431|NCT00361335|101624054|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
33473432|NCT00361335|101624055|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
33473433|NCT00361335|101624056|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
33473434|NCT00361335|101624057|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
33473435|NCT00361335|101624058|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
33473436|NCT00361335|101624059|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
33473437|NCT00361335|101624060|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
33473438|NCT00361335|101624054|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
33473439|NCT00361335|101624055|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
33473440|NCT00361335|101624056|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
33473441|NCT00361335|101624057|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
33473442|NCT00361335|101624058|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
33473443|NCT00361335|101624059|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
33473444|NCT00361335|101624060|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
33473445|NCT00361335|101624054|FG000|IV Period: Baseline to E0|Other|2|||
33473446|NCT00361335|101624055|FG001|IV Period: Baseline to E0|Other|9|||
33473447|NCT00361335|101624056|FG002|IV Period: Baseline to E0|Other|9|||
33473448|NCT00361335|101624057|FG003|IV Period: Baseline to E0|Other|3|||
33473449|NCT00361335|101624058|FG004|IV Period: Baseline to E0|Other|2|||
33473450|NCT00361335|101624059|FG005|IV Period: Baseline to E0|Other|0|||
33473451|NCT00361335|101624060|FG006|IV Period: Baseline to E0|Other|0|||
33473452|NCT00361335|101624054|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
33473453|NCT00361335|101624055|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
33473454|NCT00361335|101624056|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
33473455|NCT00361335|101624057|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
33473456|NCT00361335|101624058|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
33473457|NCT00361335|101624059|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
33473458|NCT00361335|101624060|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
33473459|NCT00361335|101624054|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
33473460|NCT00361335|101624055|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
33473461|NCT00361335|101624056|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
33473462|NCT00361335|101624057|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
33473463|NCT00361335|101624058|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
33473464|NCT00361335|101624059|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
33473465|NCT00361335|101624060|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
33473466|NCT00361335|101624054|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
33473467|NCT00361335|101624055|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
33473468|NCT00361335|101624056|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
33473469|NCT00361335|101624057|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
33473470|NCT00361335|101624058|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
33473471|NCT00361335|101624059|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
33473472|NCT00361335|101624060|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
33473473|NCT00361335|101624054|FG000|SC Period: Week E0 to Week E24|Death|0|||
33473474|NCT00361335|101624055|FG001|SC Period: Week E0 to Week E24|Death|0|||
33473475|NCT00361335|101624056|FG002|SC Period: Week E0 to Week E24|Death|0|||
33473476|NCT00361335|101624057|FG003|SC Period: Week E0 to Week E24|Death|0|||
33473477|NCT00361335|101624058|FG004|SC Period: Week E0 to Week E24|Death|0|||
33473478|NCT00361335|101624059|FG005|SC Period: Week E0 to Week E24|Death|0|||
33473479|NCT00361335|101624060|FG006|SC Period: Week E0 to Week E24|Death|1|||
33473480|NCT00361335|101624054|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
33473481|NCT00361335|101624055|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
33473482|NCT00361335|101624056|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
33473483|NCT00361335|101624057|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
33473484|NCT00361335|101624058|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
33473485|NCT00361335|101624059|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
33473486|NCT00361335|101624060|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
33473487|NCT00361335|101624054|FG000|SC Period: Week E0 to Week E24|Other|1|||
33473488|NCT00361335|101624055|FG001|SC Period: Week E0 to Week E24|Other|0|||
33473489|NCT00361335|101624056|FG002|SC Period: Week E0 to Week E24|Other|0|||
33473490|NCT00361335|101624057|FG003|SC Period: Week E0 to Week E24|Other|1|||
33473491|NCT00361335|101624058|FG004|SC Period: Week E0 to Week E24|Other|0|||
33266389|NCT00146172|100873888|FG000|Overall Study|Death|0|||
33182216|NCT00477672|100578474|FG002|Overall Study|Protocol noncompliance|0|||
33182217|NCT00477672|100578472|FG000|Overall Study|Consent withdrawn|2|||
33182218|NCT00477672|100578473|FG001|Overall Study|Consent withdrawn|5|||
33182219|NCT00477672|100578474|FG002|Overall Study|Consent withdrawn|10|||
33182220|NCT00477672|100578472|FG000|Overall Study|Discretion of Sponsor|1|||
33182221|NCT00477672|100578473|FG001|Overall Study|Discretion of Sponsor|2|||
33182222|NCT00477672|100578474|FG002|Overall Study|Discretion of Sponsor|0|||
33182223|NCT03318315|100578478|FG000|Overall Study|Lost to Follow-up|3|||
33182224|NCT03318315|100578479|FG001|Overall Study|Lost to Follow-up|2|||
33182225|NCT03318315|100578480|FG002|Overall Study|Lost to Follow-up|1|||
33182226|NCT03318315|100578478|FG000|Overall Study|Protocol Violation|1|||
33182227|NCT03318315|100578479|FG001|Overall Study|Protocol Violation|1|||
33182228|NCT03318315|100578480|FG002|Overall Study|Protocol Violation|1|||
33182229|NCT03318315|100578478|FG000|Overall Study|Withdrawal by Subject|0|||
33182230|NCT03318315|100578479|FG001|Overall Study|Withdrawal by Subject|0|||
33182231|NCT03318315|100578480|FG002|Overall Study|Withdrawal by Subject|2|||
33182232|NCT02618434|100578481|FG000|Overall Study|Withdrawal by Subject|0|||
33182233|NCT02618434|100578482|FG001|Overall Study|Withdrawal by Subject|2|||
33182234|NCT02618434|100578483|FG002|Overall Study|Withdrawal by Subject|3|||
33182235|NCT02618434|100578481|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
33182236|NCT02618434|100578482|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
33182237|NCT02618434|100578483|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
33473492|NCT00361335|101624059|FG005|SC Period: Week E0 to Week E24|Other|1|||
33473493|NCT00361335|101624060|FG006|SC Period: Week E0 to Week E24|Other|2|||
33473494|NCT00361335|101624054|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
33473495|NCT00361335|101624055|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
33182238|NCT02618434|100578481|FG000|Overall Study|Lost to Follow-up|3|||
33182239|NCT02618434|100578482|FG001|Overall Study|Lost to Follow-up|1|||
33182240|NCT02618434|100578483|FG002|Overall Study|Lost to Follow-up|3|||
33182241|NCT02618434|100578481|FG000|Overall Study|Adverse Event|1|||
33182242|NCT02618434|100578482|FG001|Overall Study|Adverse Event|0|||
33182243|NCT02618434|100578483|FG002|Overall Study|Adverse Event|12|||
33182244|NCT02618434|100578481|FG000|Overall Study|Physician Decision|0|||
33182245|NCT02618434|100578482|FG001|Overall Study|Physician Decision|1|||
33182246|NCT02618434|100578483|FG002|Overall Study|Physician Decision|0|||
33182247|NCT02618434|100578481|FG000|Overall Study|Protocol Violation|0|||
33182248|NCT02618434|100578482|FG001|Overall Study|Protocol Violation|0|||
33182249|NCT02618434|100578483|FG002|Overall Study|Protocol Violation|1|||
33182250|NCT02618434|100578481|FG000|Overall Study|Other, Multiple categories|1|||
33182251|NCT02618434|100578482|FG001|Overall Study|Other, Multiple categories|1|||
33182252|NCT02618434|100578483|FG002|Overall Study|Other, Multiple categories|1|||
33182253|NCT00623727|100578484|FG000|Double Blind (DB)|Adverse Event|1|||
33182254|NCT00623727|100578485|FG001|Double Blind (DB)|Adverse Event|3|||
33182255|NCT00623727|100578484|FG000|Double Blind (DB)|Physician Decision|0|||
33182256|NCT00623727|100578485|FG001|Double Blind (DB)|Physician Decision|1|||
33182257|NCT00623727|100578484|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
33182258|NCT00623727|100578485|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
33182259|NCT00623727|100578484|FG000|Double Blind (DB)|Lack of Efficacy|2|||
33182260|NCT00623727|100578485|FG001|Double Blind (DB)|Lack of Efficacy|2|||
33182261|NCT00623727|100578484|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
33182262|NCT00623727|100578485|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
33182263|NCT00623727|100578484|FG000|Double Blind (DB)|Lost to Follow-up|1|||
33182264|NCT00623727|100578485|FG001|Double Blind (DB)|Lost to Follow-up|1|||
33182265|NCT00623727|100578484|FG000|Double Blind (DB)|Protocol Violation|2|||
33182266|NCT00623727|100578485|FG001|Double Blind (DB)|Protocol Violation|2|||
33182267|NCT00623727|100578484|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
33182268|NCT00623727|100578485|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
33182269|NCT00623727|100578484|FG000|Open Label Follow-up|Study termination|0|||
33182270|NCT00623727|100578485|FG001|Open Label Follow-up|Study termination|6|||
33182271|NCT00623727|100578484|FG000|Open Label Follow-up|Participant convenience|0|||
33182272|NCT00623727|100578485|FG001|Open Label Follow-up|Participant convenience|1|||
33182273|NCT01527682|100578486|FG000|Overall Study|Protocol Violation|8|||
33182274|NCT01132547|100578487|FG000|Overall Study|Withdrawal by Subject|3|||
33182275|NCT01132547|100578488|FG001|Overall Study|Withdrawal by Subject|1|||
33182276|NCT01132547|100578487|FG000|Overall Study|Death|1|||
33266390|NCT00146172|100873889|FG001|Overall Study|Death|0|||
33266391|NCT00146172|100873890|FG002|Overall Study|Death|0|||
33266392|NCT00146172|100873891|FG003|Overall Study|Death|0|||
33266393|NCT00146172|100873892|FG004|Overall Study|Death|0|||
33182277|NCT01132547|100578488|FG001|Overall Study|Death|0|||
33266394|NCT00146172|100873893|FG005|Overall Study|Death|0|||
33182278|NCT02098109|100578489|FG000|Overall Study|Protocol Violation|3|||
33266395|NCT00146172|100873894|FG006|Overall Study|Death|1|||
33182279|NCT02098109|100578490|FG001|Overall Study|Protocol Violation|0|||
33182280|NCT03020823|100578493|FG000|Overall Study|Physician Decision|4|||
33182281|NCT03020823|100578493|FG000|Overall Study|Lack of Efficacy|4|||
33182282|NCT03020823|100578493|FG000|Overall Study|Adverse Event|2|||
33473496|NCT00361335|101624056|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
33473497|NCT00361335|101624057|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
33473498|NCT00361335|101624058|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
33473499|NCT00361335|101624059|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
33473500|NCT00361335|101624060|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
33473501|NCT02989168|101624061|FG000|Overall Study|Withdrawal by Subject|2|||
33473502|NCT02989168|101624062|FG001|Overall Study|Withdrawal by Subject|0|||
33473503|NCT02989168|101624061|FG000|Overall Study|Physician Decision|0|||
33473504|NCT02989168|101624062|FG001|Overall Study|Physician Decision|1|||
33473505|NCT02989168|101624061|FG000|Overall Study|Adverse Event|1|||
33473506|NCT02989168|101624062|FG001|Overall Study|Adverse Event|2|||
33473507|NCT02989168|101624061|FG000|Overall Study|Sponsor stopped study.|1|||
33473508|NCT02989168|101624062|FG001|Overall Study|Sponsor stopped study.|0|||
33473509|NCT01429051|101624064|FG000|Titration Phase|Death|1|||
33473510|NCT01429051|101624064|FG000|Titration Phase|Withdrawal by Subject|7|||
33473511|NCT01429051|101624064|FG000|Titration Phase|Physician Decision|1|||
33473512|NCT01429051|101624064|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
33473513|NCT01429051|101624064|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
33473514|NCT01429051|101624064|FG000|Efficacy Phase|Adverse Event|1|||
33473515|NCT01429051|101624064|FG000|Efficacy Phase|Death|1|||
33473516|NCT01429051|101624064|FG000|Tolerability Phase|Death|5|||
33473517|NCT01429051|101624064|FG000|Tolerability Phase|Adverse Event|2|||
33473518|NCT01429051|101624064|FG000|Tolerability Phase|Withdrawal by Subject|5|||
33473519|NCT01429051|101624064|FG000|Tolerability Phase|Physician Decision|1|||
33473520|NCT01429051|101624064|FG000|Tolerability Phase|Other|2|||
33473521|NCT00251719|101624065|FG000|Overall Study|Adverse Event|14|||
33473522|NCT00251719|101624066|FG001|Overall Study|Adverse Event|8|||
33473523|NCT00251719|101624067|FG002|Overall Study|Adverse Event|7|||
33473524|NCT00251719|101624065|FG000|Overall Study|Protocol Violation|1|||
33473525|NCT00251719|101624066|FG001|Overall Study|Protocol Violation|1|||
33473526|NCT00251719|101624067|FG002|Overall Study|Protocol Violation|1|||
33473527|NCT00251719|101624065|FG000|Overall Study|Lost to Follow-up|5|||
33473528|NCT00251719|101624066|FG001|Overall Study|Lost to Follow-up|11|||
33473529|NCT00251719|101624067|FG002|Overall Study|Lost to Follow-up|8|||
33473530|NCT00251719|101624065|FG000|Overall Study|Withdrawal by Subject|14|||
33473531|NCT00251719|101624066|FG001|Overall Study|Withdrawal by Subject|12|||
33473532|NCT00251719|101624067|FG002|Overall Study|Withdrawal by Subject|11|||
33473533|NCT00251719|101624065|FG000|Overall Study|Lack of Efficacy|2|||
33473534|NCT00251719|101624066|FG001|Overall Study|Lack of Efficacy|1|||
33473535|NCT00251719|101624067|FG002|Overall Study|Lack of Efficacy|0|||
33473536|NCT00251719|101624065|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
33473537|NCT00251719|101624066|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
33473538|NCT00251719|101624067|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
33473539|NCT00251719|101624065|FG000|Overall Study|Investigator decision|1|||
33473540|NCT00251719|101624066|FG001|Overall Study|Investigator decision|1|||
33473541|NCT00251719|101624067|FG002|Overall Study|Investigator decision|0|||
33473542|NCT00251719|101624065|FG000|Overall Study|Noncompliance|2|||
33473543|NCT00251719|101624066|FG001|Overall Study|Noncompliance|3|||
33473544|NCT00251719|101624067|FG002|Overall Study|Noncompliance|1|||
33182283|NCT02612428|100578494|FG000|VTL-308|Death|14|||
33182284|NCT02612428|100578495|FG001|VTL-308|Death|16|||
33182285|NCT02612428|100578494|FG000|VTL-308|Withdrawal by Subject|0|||
33182286|NCT02612428|100578495|FG001|VTL-308|Withdrawal by Subject|1|||
33182287|NCT02612428|100578494|FG000|VTL-308E|Death|9|||
33182288|NCT02612428|100578495|FG001|VTL-308E|Death|7|||
33182289|NCT02612428|100578494|FG000|VTL-308E|Lost to Follow-up|2|||
33182290|NCT02612428|100578495|FG001|VTL-308E|Lost to Follow-up|0|||
33182291|NCT01165138|100578496|FG000|Overall Study|Adverse Event|0|||
33182292|NCT01165138|100578497|FG001|Overall Study|Adverse Event|1|||
33182293|NCT01165138|100578498|FG002|Overall Study|Adverse Event|0|||
33182294|NCT01165138|100578499|FG003|Overall Study|Adverse Event|2|||
33182295|NCT01165138|100578496|FG000|Overall Study|Lack of Efficacy|0|||
33182296|NCT01165138|100578497|FG001|Overall Study|Lack of Efficacy|32|||
33182297|NCT01165138|100578498|FG002|Overall Study|Lack of Efficacy|6|||
33182298|NCT01165138|100578499|FG003|Overall Study|Lack of Efficacy|7|||
33182299|NCT01165138|100578496|FG000|Overall Study|Protocol Violation|0|||
33182300|NCT01165138|100578497|FG001|Overall Study|Protocol Violation|7|||
33473545|NCT00251719|101624065|FG000|Overall Study|Barrett's esophagus|2|||
33473546|NCT00251719|101624066|FG001|Overall Study|Barrett's esophagus|2|||
33473547|NCT00251719|101624067|FG002|Overall Study|Barrett's esophagus|0|||
33473548|NCT02139124|101624071|FG000|Overall Study|Adverse Event|2|||
33473549|NCT02139124|101624072|FG001|Overall Study|Adverse Event|0|||
33473550|NCT02139124|101624073|FG002|Overall Study|Adverse Event|1|||
33182301|NCT01165138|100578498|FG002|Overall Study|Protocol Violation|0|||
33182302|NCT01165138|100578499|FG003|Overall Study|Protocol Violation|2|||
33182303|NCT01165138|100578496|FG000|Overall Study|Lost to Follow-up|0|||
33473551|NCT02139124|101624074|FG003|Overall Study|Adverse Event|2|||
33473552|NCT02139124|101624075|FG004|Overall Study|Adverse Event|5|||
33473553|NCT02139124|101624071|FG000|Overall Study|Withdrawal by Subject|2|||
33473554|NCT02139124|101624072|FG001|Overall Study|Withdrawal by Subject|2|||
33473555|NCT02139124|101624073|FG002|Overall Study|Withdrawal by Subject|2|||
33473556|NCT02139124|101624074|FG003|Overall Study|Withdrawal by Subject|2|||
33473557|NCT02139124|101624075|FG004|Overall Study|Withdrawal by Subject|3|||
33473558|NCT02139124|101624071|FG000|Overall Study|Protocol Violation|0|||
33473559|NCT02139124|101624072|FG001|Overall Study|Protocol Violation|0|||
33473560|NCT02139124|101624073|FG002|Overall Study|Protocol Violation|0|||
33473561|NCT02139124|101624074|FG003|Overall Study|Protocol Violation|1|||
33473562|NCT02139124|101624075|FG004|Overall Study|Protocol Violation|1|||
33473563|NCT02139124|101624071|FG000|Overall Study|non-compliant|1|||
33473564|NCT02139124|101624072|FG001|Overall Study|non-compliant|0|||
33473565|NCT02139124|101624073|FG002|Overall Study|non-compliant|0|||
33473566|NCT02139124|101624074|FG003|Overall Study|non-compliant|2|||
33473567|NCT02139124|101624075|FG004|Overall Study|non-compliant|0|||
33473568|NCT02139124|101624071|FG000|Overall Study|incarceration|0|||
33473569|NCT02139124|101624072|FG001|Overall Study|incarceration|0|||
33473570|NCT02139124|101624073|FG002|Overall Study|incarceration|1|||
33473571|NCT02139124|101624074|FG003|Overall Study|incarceration|0|||
33473572|NCT02139124|101624075|FG004|Overall Study|incarceration|0|||
33473573|NCT02139124|101624071|FG000|Overall Study|subject moved|1|||
33473574|NCT02139124|101624072|FG001|Overall Study|subject moved|0|||
33473575|NCT02139124|101624073|FG002|Overall Study|subject moved|0|||
33473576|NCT02139124|101624074|FG003|Overall Study|subject moved|0|||
33473577|NCT02139124|101624075|FG004|Overall Study|subject moved|0|||
33473578|NCT02139124|101624071|FG000|Overall Study|Lost to Follow-up|3|||
33473579|NCT02139124|101624072|FG001|Overall Study|Lost to Follow-up|2|||
33182304|NCT01165138|100578497|FG001|Overall Study|Lost to Follow-up|0|||
33182305|NCT01165138|100578498|FG002|Overall Study|Lost to Follow-up|1|||
33182306|NCT01165138|100578499|FG003|Overall Study|Lost to Follow-up|2|||
33182307|NCT01165138|100578496|FG000|Overall Study|Physician Decision|0|||
33182308|NCT01165138|100578497|FG001|Overall Study|Physician Decision|6|||
33182309|NCT01165138|100578498|FG002|Overall Study|Physician Decision|7|||
33182310|NCT01165138|100578499|FG003|Overall Study|Physician Decision|6|||
33182311|NCT01165138|100578496|FG000|Overall Study|Withdrawal by Subject|0|||
33182312|NCT01165138|100578497|FG001|Overall Study|Withdrawal by Subject|6|||
33182313|NCT01165138|100578498|FG002|Overall Study|Withdrawal by Subject|6|||
33182314|NCT01165138|100578499|FG003|Overall Study|Withdrawal by Subject|3|||
33182315|NCT00304356|100578500|FG000|Nitazoxanide|Physician Decision|5|||
33182316|NCT00304356|100578500|FG000|Nitazoxanide|Physician Decision|1|||
33182317|NCT00304356|100578500|FG000|Nitazoxanide|number is 0|1|||
33182318|NCT00304356|100578500|FG000|Nitazoxanide|Physician Decision|1|||
33182319|NCT00304356|100578500|FG000|Nitazoxanide|Physician Decision|1|||
33182320|NCT00304356|100578500|FG000|Nitazoxanide|Physician Decision|1|||
33182321|NCT03274986|100578504|FG000|Overall Study|Withdrawal by Subject|0|||
33182322|NCT03274986|100578505|FG001|Overall Study|Withdrawal by Subject|1|||
33182323|NCT03274986|100578504|FG000|Overall Study|Lost to Follow-up|0|||
33182324|NCT03274986|100578505|FG001|Overall Study|Lost to Follow-up|1|||
33182325|NCT00076011|100578508|FG000|Overall Study|Death|1|||
33182326|NCT00076011|100578508|FG000|Overall Study|Adverse Event|10|||
33182327|NCT00076011|100578508|FG000|Overall Study|Lack of Efficacy|25|||
33182328|NCT00076011|100578508|FG000|Overall Study|Withdrawal by Subject|1|||
33182329|NCT00076011|100578508|FG000|Overall Study|Study terminated by sponsor|3|||
33182330|NCT00076011|100578508|FG000|Overall Study|Other|11|||
33182331|NCT00076011|100578508|FG000|Overall Study|Ongoing|1|||
33182332|NCT00271947|100578509|FG000|Overall Study|Lost to Follow-up|1|||
33182333|NCT03200899|100578510|FG000|Overall Study|Lost to Follow-up|10|||
33182334|NCT03200899|100578511|FG001|Overall Study|Lost to Follow-up|23|||
33182335|NCT03320564|100578512|FG000|Overall Study|Protocol Violation|1|||
33182336|NCT01148511|100578513|FG000|Exposed to Study Drug|Protocol Violation|2|||
33182337|NCT01148511|100578514|FG001|Exposed to Study Drug|Protocol Violation|0|||
33182338|NCT01148511|100578515|FG002|Exposed to Study Drug|Protocol Violation|0|||
33182339|NCT01148511|100578513|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
33182340|NCT01148511|100578514|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
33182341|NCT01148511|100578515|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
33266396|NCT00146172|100873895|FG007|Overall Study|Death|0|||
33266397|NCT00146172|100873888|FG000|Overall Study|Physician Decision|0|||
33266398|NCT00146172|100873889|FG001|Overall Study|Physician Decision|0|||
33266399|NCT00146172|100873890|FG002|Overall Study|Physician Decision|0|||
33266400|NCT00146172|100873891|FG003|Overall Study|Physician Decision|0|||
33266401|NCT00146172|100873892|FG004|Overall Study|Physician Decision|0|||
33266402|NCT00146172|100873893|FG005|Overall Study|Physician Decision|0|||
33266403|NCT00146172|100873894|FG006|Overall Study|Physician Decision|0|||
33473580|NCT02139124|101624073|FG002|Overall Study|Lost to Follow-up|0|||
33182342|NCT01148511|100578513|FG000|Randomized|Adverse Event|0|||
33266404|NCT00146172|100873895|FG007|Overall Study|Physician Decision|1|||
33266405|NCT00146172|100873888|FG000|Overall Study|Withdrawal by Subject|0|||
33266406|NCT00146172|100873889|FG001|Overall Study|Withdrawal by Subject|0|||
33182343|NCT01148511|100578514|FG001|Randomized|Adverse Event|1|||
33182344|NCT01148511|100578515|FG002|Randomized|Adverse Event|0|||
33473581|NCT02139124|101624074|FG003|Overall Study|Lost to Follow-up|5|||
33182345|NCT01148511|100578513|FG000|Randomized|Protocol Violation|0|||
33182346|NCT01148511|100578514|FG001|Randomized|Protocol Violation|2|||
33182347|NCT01148511|100578515|FG002|Randomized|Protocol Violation|1|||
33182348|NCT01148511|100578513|FG000|Randomized|Lost to Follow-up|0|||
33182349|NCT01148511|100578514|FG001|Randomized|Lost to Follow-up|1|||
33182350|NCT01148511|100578515|FG002|Randomized|Lost to Follow-up|1|||
33182351|NCT01148511|100578513|FG000|Randomized|Consent withdrawal|0|||
33182352|NCT01148511|100578514|FG001|Randomized|Consent withdrawal|5|||
33182353|NCT01148511|100578515|FG002|Randomized|Consent withdrawal|3|||
33182354|NCT01148511|100578513|FG000|Randomized|Other|0|||
33182355|NCT01148511|100578514|FG001|Randomized|Other|1|||
33182356|NCT01148511|100578515|FG002|Randomized|Other|1|||
33182357|NCT02741700|100578516|FG000|Overall Study|Lost to Follow-up|17|||
33182358|NCT02741700|100578517|FG001|Overall Study|Lost to Follow-up|8|||
33182359|NCT02741700|100578516|FG000|Overall Study|Withdrawal by Subject|2|||
33182360|NCT02741700|100578517|FG001|Overall Study|Withdrawal by Subject|5|||
33182361|NCT02741700|100578516|FG000|Overall Study|Physician Decision|3|||
33182362|NCT02741700|100578517|FG001|Overall Study|Physician Decision|0|||
33182363|NCT02741700|100578516|FG000|Overall Study|Moved out of State|0|||
33182364|NCT02741700|100578517|FG001|Overall Study|Moved out of State|1|||
33182365|NCT02741700|100578516|FG000|Overall Study|Death|4|||
33182366|NCT02741700|100578517|FG001|Overall Study|Death|5|||
33182367|NCT00407563|100578518|FG000|Overall Study|Patient continues on treatment|1|||
33182368|NCT01319877|100578519|FG000|Overall Study|Lost to Follow-up|100|||
33182369|NCT01319877|100578520|FG001|Overall Study|Lost to Follow-up|37|||
33182370|NCT01319877|100578519|FG000|Overall Study|Physician Decision|2|||
33182371|NCT01319877|100578520|FG001|Overall Study|Physician Decision|0|||
33182372|NCT01319877|100578519|FG000|Overall Study|Disease Progression|2|||
33182373|NCT01319877|100578520|FG001|Overall Study|Disease Progression|2|||
33182374|NCT01319877|100578519|FG000|Overall Study|Withdrawal by Subject|0|||
33182375|NCT01319877|100578520|FG001|Overall Study|Withdrawal by Subject|1|||
33182376|NCT01319877|100578519|FG000|Overall Study|Reason Not Specified|4|||
33182377|NCT01319877|100578520|FG001|Overall Study|Reason Not Specified|5|||
33182378|NCT03338062|100578521|FG000|Overall Study|Alternative Therapy|1|||
33182379|NCT03338062|100578522|FG001|Overall Study|Alternative Therapy|0|||
33182380|NCT01706003|100578523|FG000|Overall Study|Withdrawal by Subject|2|||
33182381|NCT01706003|100578524|FG001|Overall Study|Withdrawal by Subject|0|||
33182382|NCT01706003|100578523|FG000|Overall Study|Not scheduled|3|||
33182383|NCT01706003|100578524|FG001|Overall Study|Not scheduled|0|||
33182384|NCT01706003|100578523|FG000|Overall Study|Lost to Follow-up|6|||
33182385|NCT01706003|100578524|FG001|Overall Study|Lost to Follow-up|4|||
33182386|NCT04782856|100578527|FG000|Overall Study|Withdrawal by Subject|0|||
33182387|NCT04782856|100578528|FG001|Overall Study|Withdrawal by Subject|1|||
33182388|NCT01277523|100578529|FG000|Overall Study|Adverse Event|1|||
33182389|NCT01277523|100578530|FG001|Overall Study|Adverse Event|0|||
33182390|NCT01277523|100578531|FG002|Overall Study|Adverse Event|0|||
33182391|NCT01277523|100578529|FG000|Overall Study|Protocol Violation|2|||
33182392|NCT01277523|100578530|FG001|Overall Study|Protocol Violation|0|||
33473582|NCT02139124|101624075|FG004|Overall Study|Lost to Follow-up|4|||
33473583|NCT00186043|101624076|FG000|Overall Study|Lack of Efficacy|1|||
33473584|NCT00186043|101624077|FG001|Overall Study|Lack of Efficacy|3|||
33473585|NCT00186043|101624076|FG000|Overall Study|Lost to Follow-up|4|||
33473586|NCT00186043|101624077|FG001|Overall Study|Lost to Follow-up|6|||
33473587|NCT00186043|101624076|FG000|Overall Study|Withdrawal by Subject|1|||
33182393|NCT01277523|100578531|FG002|Overall Study|Protocol Violation|0|||
33182394|NCT01277523|100578529|FG000|Overall Study|Other Reason not Defined|0|||
33182395|NCT01277523|100578530|FG001|Overall Study|Other Reason not Defined|1|||
33182396|NCT01277523|100578531|FG002|Overall Study|Other Reason not Defined|0|||
33182397|NCT02580357|100578532|FG000|Overall Study|Lost to Follow-up|2|||
33182398|NCT02580357|100578533|FG001|Overall Study|Lost to Follow-up|0|||
33182399|NCT02580357|100578534|FG002|Overall Study|Lost to Follow-up|0|||
33182400|NCT02580357|100578532|FG000|Overall Study|Protocol Violation|1|||
33182401|NCT02580357|100578533|FG001|Overall Study|Protocol Violation|0|||
33182402|NCT02580357|100578534|FG002|Overall Study|Protocol Violation|0|||
33182403|NCT01289847|100578539|FG000|Overall Study|Patient could not comply with visits|1|||
33182404|NCT02486042|100578540|FG000|Overall Study|Physician Decision|1|||
33182405|NCT02486042|100578541|FG001|Overall Study|Physician Decision|7|||
33182406|NCT02486042|100578540|FG000|Overall Study|Hospital transfer|2|||
33182407|NCT02486042|100578541|FG001|Overall Study|Hospital transfer|2|||
33182408|NCT02486042|100578540|FG000|Overall Study|Withdrawal by Subject|0|||
33182409|NCT02486042|100578541|FG001|Overall Study|Withdrawal by Subject|2|||
33182410|NCT01623596|100578542|FG000|Overall Study|Abnormal laboratory values|2|||
33182411|NCT01623596|100578543|FG001|Overall Study|Abnormal laboratory values|0|||
33182412|NCT01623596|100578542|FG000|Overall Study|Administrative problems|9|||
33473588|NCT00186043|101624077|FG001|Overall Study|Withdrawal by Subject|0|||
33473589|NCT00186043|101624076|FG000|Overall Study|Adverse Event|7|||
33182413|NCT01623596|100578543|FG001|Overall Study|Administrative problems|13|||
33182414|NCT01623596|100578542|FG000|Overall Study|Adverse Event|20|||
33182415|NCT01623596|100578543|FG001|Overall Study|Adverse Event|29|||
33182416|NCT01623596|100578542|FG000|Overall Study|Death|0|||
33182417|NCT01623596|100578543|FG001|Overall Study|Death|2|||
33182418|NCT01623596|100578542|FG000|Overall Study|Lost to Follow-up|12|||
33182419|NCT01623596|100578543|FG001|Overall Study|Lost to Follow-up|16|||
33182420|NCT01623596|100578542|FG000|Overall Study|Withdrawal by Subject|13|||
33182421|NCT01623596|100578543|FG001|Overall Study|Withdrawal by Subject|31|||
33182422|NCT01623596|100578542|FG000|Overall Study|Patient no longer requires study drug|1|||
33182423|NCT01623596|100578543|FG001|Overall Study|Patient no longer requires study drug|0|||
33182424|NCT01623596|100578542|FG000|Overall Study|Protocol Violation|0|||
33182425|NCT01623596|100578543|FG001|Overall Study|Protocol Violation|6|||
33182426|NCT01623596|100578542|FG000|Overall Study|Lack of Efficacy|5|||
33182427|NCT01623596|100578543|FG001|Overall Study|Lack of Efficacy|3|||
33182428|NCT01524627|100578546|FG000|Overall Study|Physician Decision|0|||
33182429|NCT01524627|100578547|FG001|Overall Study|Physician Decision|1|||
33182430|NCT01524627|100578546|FG000|Overall Study|Lost to Follow-up|1|||
33182431|NCT01524627|100578547|FG001|Overall Study|Lost to Follow-up|1|||
33182432|NCT02132767|100578549|FG000|Overall Study|Death|3|||
33182433|NCT02132767|100578550|FG001|Overall Study|Death|2|||
33182434|NCT02132767|100578549|FG000|Overall Study|Withdrawal by Subject|10|||
33182435|NCT02132767|100578550|FG001|Overall Study|Withdrawal by Subject|9|||
33182436|NCT02132767|100578549|FG000|Overall Study|Lost to Follow-up|4|||
33182437|NCT02132767|100578550|FG001|Overall Study|Lost to Follow-up|4|||
33182438|NCT01514760|100578553|FG000|Overall Study|Lost to Follow-up|2|||
33182439|NCT01380184|100578554|FG000|Part 1 (19 Days)|Adverse Event|1|||
33182440|NCT01380184|100578554|FG000|Part 2|Adverse Event|5|||
33182441|NCT01380184|100578554|FG000|Part 2|Disease Progression|8|||
33182442|NCT01380184|100578554|FG000|Part 2|Lost to Follow-up|1|||
33182443|NCT00973479|100578557|FG000|Overall Study|Lost to Follow-up|0|||
33182444|NCT00973479|100578558|FG001|Overall Study|Lost to Follow-up|3|||
33182445|NCT00973479|100578557|FG000|Overall Study|Death|2|||
33182446|NCT00973479|100578558|FG001|Overall Study|Death|2|||
33182447|NCT00973479|100578557|FG000|Overall Study|Withdrawal by Subject|15|||
33182448|NCT00973479|100578558|FG001|Overall Study|Withdrawal by Subject|16|||
33182449|NCT00973479|100578557|FG000|Overall Study|Lack of Efficacy|5|||
33182450|NCT00973479|100578558|FG001|Overall Study|Lack of Efficacy|7|||
33182451|NCT00973479|100578557|FG000|Overall Study|Adverse Event|12|||
33182452|NCT00973479|100578558|FG001|Overall Study|Adverse Event|32|||
33182453|NCT00973479|100578557|FG000|Overall Study|Protocol Violation|2|||
33182454|NCT00973479|100578558|FG001|Overall Study|Protocol Violation|2|||
33182455|NCT00973479|100578557|FG000|Overall Study|Other|1|||
33182456|NCT00973479|100578558|FG001|Overall Study|Other|7|||
33182457|NCT03343483|100578559|FG000|Overall Study|Death|0|||
33182458|NCT03343483|100578560|FG001|Overall Study|Death|3|||
33182459|NCT03343483|100578559|FG000|Overall Study|Lost to Follow-up|9|||
33182460|NCT03343483|100578560|FG001|Overall Study|Lost to Follow-up|13|||
33182461|NCT03343483|100578559|FG000|Overall Study|Withdrawal by Subject|8|||
33182462|NCT03343483|100578560|FG001|Overall Study|Withdrawal by Subject|17|||
33182463|NCT00644969|100578562|FG000|Treatment Phase|Randomized, not treated|1|||
33182464|NCT00644969|100578563|FG001|Treatment Phase|Randomized, not treated|0|||
33182465|NCT00644969|100578562|FG000|Treatment Phase|Adverse Event|3|||
33182466|NCT00644969|100578563|FG001|Treatment Phase|Adverse Event|0|||
33182467|NCT00644969|100578562|FG000|Treatment Phase|Withdrawal by Subject|4|||
33182468|NCT00644969|100578563|FG001|Treatment Phase|Withdrawal by Subject|0|||
33182469|NCT00644969|100578562|FG000|Treatment Phase|Lost to Follow-up|2|||
33182470|NCT00644969|100578563|FG001|Treatment Phase|Lost to Follow-up|2|||
33182471|NCT00644969|100578562|FG000|Treatment Phase|Other|4|||
33182472|NCT00644969|100578563|FG001|Treatment Phase|Other|1|||
33182473|NCT00644969|100578562|FG000|Post Treatment Phase|Death|1|||
33473590|NCT00186043|101624077|FG001|Overall Study|Adverse Event|3|||
33473591|NCT00186043|101624076|FG000|Overall Study|Protocol Violation|2|||
33473592|NCT00186043|101624077|FG001|Overall Study|Protocol Violation|1|||
33473593|NCT01691820|101624083|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
33182474|NCT00644969|100578563|FG001|Post Treatment Phase|Death|0|||
33182475|NCT00644969|100578562|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
33182476|NCT00644969|100578563|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
33182477|NCT00644969|100578562|FG000|Post Treatment Phase|Lost to Follow-up|4|||
33182478|NCT00644969|100578563|FG001|Post Treatment Phase|Lost to Follow-up|1|||
33182479|NCT00644969|100578562|FG000|Post Treatment Phase|Other|1|||
33182480|NCT00644969|100578563|FG001|Post Treatment Phase|Other|0|||
33182481|NCT00316199|100578564|FG000|Overall Study|Adverse Event|2|||
33182482|NCT00316199|100578564|FG000|Overall Study|Death|8|||
33182483|NCT00316199|100578564|FG000|Overall Study|Lost to Follow-up|2|||
33182484|NCT01859494|100578569|FG000|Overall Study|Adverse Event|1|||
33182485|NCT04014075|100578570|FG000|Overall Study|Progressive Disease|48|||
33473594|NCT01691820|101624084|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
33473595|NCT01691820|101624083|FG000|Overall Study|Migrated/moved from study area|7|||
33182486|NCT04014075|100578570|FG000|Overall Study|Adverse Event|11|||
33182487|NCT04014075|100578570|FG000|Overall Study|Clinical Progression|4|||
33182488|NCT04014075|100578570|FG000|Overall Study|Death|2|||
33182489|NCT04014075|100578570|FG000|Overall Study|Withdrawal by Subject|2|||
33473596|NCT01691820|101624084|FG001|Overall Study|Migrated/moved from study area|4|||
33473597|NCT01691820|101624083|FG000|Overall Study|Lost to Follow-up|6|||
33473598|NCT01691820|101624084|FG001|Overall Study|Lost to Follow-up|17|||
33473599|NCT01691820|101624083|FG000|Overall Study|Other (unspecified)|4|||
33473600|NCT01691820|101624084|FG001|Overall Study|Other (unspecified)|1|||
33473601|NCT01195272|101624085|FG000|Overall Study|Adverse Event|1|||
33473602|NCT01195272|101624085|FG000|Overall Study|Lack of Efficacy|3|||
33473603|NCT02440568|101624086|FG000|Overall Study|Death|1|||
33473604|NCT02440568|101624087|FG001|Overall Study|Death|3|||
33473605|NCT02440568|101624088|FG002|Overall Study|Death|4|||
33473606|NCT02440568|101624089|FG003|Overall Study|Death|2|||
33473607|NCT02440568|101624086|FG000|Overall Study|Lack of Efficacy|2|||
33473608|NCT02440568|101624087|FG001|Overall Study|Lack of Efficacy|0|||
33473609|NCT02440568|101624088|FG002|Overall Study|Lack of Efficacy|1|||
33473610|NCT02440568|101624089|FG003|Overall Study|Lack of Efficacy|0|||
33473611|NCT02440568|101624086|FG000|Overall Study|Lost to Follow-up|1|||
33473612|NCT02440568|101624087|FG001|Overall Study|Lost to Follow-up|0|||
33473613|NCT02440568|101624088|FG002|Overall Study|Lost to Follow-up|0|||
33473614|NCT02440568|101624089|FG003|Overall Study|Lost to Follow-up|0|||
33473615|NCT01244061|101624090|FG000|Overall Study|Death|1|||
33473616|NCT01244061|101624091|FG001|Overall Study|Death|0|||
33473617|NCT01244061|101624090|FG000|Overall Study|Did not meet entrance criteria|1|||
33473618|NCT01244061|101624091|FG001|Overall Study|Did not meet entrance criteria|0|||
33473619|NCT01244061|101624090|FG000|Overall Study|Lack of Efficacy|1|||
33473620|NCT01244061|101624091|FG001|Overall Study|Lack of Efficacy|3|||
33473621|NCT01244061|101624090|FG000|Overall Study|Lost to Follow-up|34|||
33473622|NCT01244061|101624091|FG001|Overall Study|Lost to Follow-up|30|||
33473623|NCT01244061|101624090|FG000|Overall Study|Withdrawal by Subject|29|||
33473624|NCT01244061|101624091|FG001|Overall Study|Withdrawal by Subject|46|||
33473625|NCT01244061|101624090|FG000|Overall Study|Other|8|||
33473626|NCT01244061|101624091|FG001|Overall Study|Other|19|||
33473627|NCT01244061|101624090|FG000|Overall Study|Protocol Violation|1|||
33473628|NCT01244061|101624091|FG001|Overall Study|Protocol Violation|1|||
33266407|NCT00146172|100873890|FG002|Overall Study|Withdrawal by Subject|0|||
33473629|NCT01244061|101624090|FG000|Overall Study|Adverse Event|5|||
33473630|NCT01244061|101624091|FG001|Overall Study|Adverse Event|2|||
33473631|NCT01244061|101624090|FG000|Overall Study|Randomized but not treated|2|||
33473632|NCT01244061|101624091|FG001|Overall Study|Randomized but not treated|2|||
33473633|NCT03439852|101624092|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
33473634|NCT03439852|101624093|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
33473635|NCT03439852|101624092|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
33473636|NCT03439852|101624093|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
33473637|NCT03439852|101624092|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
33473638|NCT03439852|101624093|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
33473639|NCT00741936|101624097|FG000|Overall Study|Lost to Follow-up|1|||
33473640|NCT00741936|101624098|FG001|Overall Study|Lost to Follow-up|1|||
33473641|NCT00741936|101624097|FG000|Overall Study|Adverse Event|3|||
33473642|NCT00741936|101624098|FG001|Overall Study|Adverse Event|4|||
33473643|NCT00741936|101624097|FG000|Overall Study|Pregnancy|0|||
33473644|NCT00741936|101624098|FG001|Overall Study|Pregnancy|1|||
33473645|NCT00741936|101624097|FG000|Overall Study|Protocol Violation|2|||
33473646|NCT00741936|101624098|FG001|Overall Study|Protocol Violation|0|||
33473647|NCT00741936|101624097|FG000|Overall Study|Lack of Efficacy|0|||
33473648|NCT00741936|101624098|FG001|Overall Study|Lack of Efficacy|2|||
33473649|NCT00741936|101624097|FG000|Overall Study|Low compliance|3|||
33473650|NCT00741936|101624098|FG001|Overall Study|Low compliance|0|||
33473651|NCT00914459|101624099|FG000|Overall Study|Protocol Violation|0|||
33473652|NCT00914459|101624100|FG001|Overall Study|Protocol Violation|1|||
33473653|NCT00914459|101624099|FG000|Overall Study|Parent/Legal guardian request|1|||
33473654|NCT00914459|101624100|FG001|Overall Study|Parent/Legal guardian request|0|||
33473655|NCT02302859|101624101|FG000|Overall Study|Lost Phone|1|||
33473656|NCT02302859|101624102|FG001|Overall Study|Lost Phone|1|||
33473657|NCT02302859|101624101|FG000|Overall Study|Withdrawal by Subject|0|||
33473658|NCT02302859|101624102|FG001|Overall Study|Withdrawal by Subject|1|||
33473659|NCT01959035|101624103|FG000|Overall Study|Adverse Event|5|||
33473660|NCT01959035|101624103|FG000|Overall Study|Withdrawal by Subject|4|||
33182490|NCT04014075|100578570|FG000|Overall Study|Miscellaneous|1|||
33473661|NCT01959035|101624103|FG000|Overall Study|Lost to Follow-up|1|||
33473662|NCT01959035|101624103|FG000|Overall Study|Other (no primary reason given)|1|||
33473663|NCT00856973|101624104|FG000|Overall Study|Adverse Event|5|||
33473664|NCT00856973|101624105|FG001|Overall Study|Adverse Event|5|||
33473665|NCT00856973|101624106|FG002|Overall Study|Adverse Event|3|||
33473666|NCT00856973|101624104|FG000|Overall Study|Lost to Follow-up|6|||
33182491|NCT04014075|100578570|FG000|Overall Study|Physician Decision|1|||
33182492|NCT01455012|100578587|FG000|Overall Study|Adverse Event|0|||
33473667|NCT00856973|101624105|FG001|Overall Study|Lost to Follow-up|3|||
33473668|NCT00856973|101624106|FG002|Overall Study|Lost to Follow-up|5|||
33473669|NCT00856973|101624104|FG000|Overall Study|Physician Decision|0|||
33473670|NCT00856973|101624105|FG001|Overall Study|Physician Decision|3|||
33473671|NCT00856973|101624106|FG002|Overall Study|Physician Decision|1|||
33473672|NCT00856973|101624104|FG000|Overall Study|Protocol Violation|1|||
33473673|NCT00856973|101624105|FG001|Overall Study|Protocol Violation|2|||
33473674|NCT00856973|101624106|FG002|Overall Study|Protocol Violation|1|||
33473675|NCT00856973|101624104|FG000|Overall Study|Withdrawal by Subject|13|||
33473676|NCT00856973|101624105|FG001|Overall Study|Withdrawal by Subject|16|||
33473677|NCT00856973|101624106|FG002|Overall Study|Withdrawal by Subject|15|||
33473678|NCT00856973|101624104|FG000|Overall Study|Other|11|||
33473679|NCT00856973|101624105|FG001|Overall Study|Other|12|||
33473680|NCT00856973|101624106|FG002|Overall Study|Other|13|||
33473681|NCT01732484|101624107|FG000|Overall Study|Death|7|||
33473682|NCT01732484|101624107|FG000|Overall Study|Lost to Follow-up|14|||
33473683|NCT01732484|101624107|FG000|Overall Study|chronical illness|5|||
33473684|NCT02791893|101624108|FG000|Blinded Phase|Lost to Follow-up|2|||
33473685|NCT02791893|101624109|FG001|Blinded Phase|Lost to Follow-up|2|||
33473686|NCT02791893|101624108|FG000|Blinded Phase|Withdrawal by Subject|1|||
33473687|NCT02791893|101624109|FG001|Blinded Phase|Withdrawal by Subject|2|||
33473688|NCT02791893|101624108|FG000|Open Label Phase|Lost to Follow-up|3|||
33473689|NCT02791893|101624109|FG001|Open Label Phase|Lost to Follow-up|0|||
33473690|NCT02791893|101624108|FG000|Open Label Phase|Withdrawal by Subject|0|||
33473691|NCT02791893|101624109|FG001|Open Label Phase|Withdrawal by Subject|2|||
33473692|NCT02093221|101624110|FG000|Overall Study|Adverse Event|1|||
33473693|NCT02093221|101624111|FG001|Overall Study|Adverse Event|0|||
33182493|NCT01455012|100578588|FG001|Overall Study|Adverse Event|2|||
33182494|NCT01455012|100578587|FG000|Overall Study|Lack of Efficacy|6|||
33182495|NCT01455012|100578588|FG001|Overall Study|Lack of Efficacy|1|||
33182496|NCT01455012|100578587|FG000|Overall Study|Withdrawal by Subject|3|||
33473694|NCT02093221|101624112|FG002|Overall Study|Adverse Event|0|||
33473695|NCT02093221|101624113|FG003|Overall Study|Adverse Event|0|||
33473696|NCT02093221|101624114|FG004|Overall Study|Adverse Event|0|||
33473697|NCT02093221|101624110|FG000|Overall Study|Withdrawal by Subject|1|||
33473698|NCT02093221|101624111|FG001|Overall Study|Withdrawal by Subject|1|||
33473699|NCT02093221|101624112|FG002|Overall Study|Withdrawal by Subject|4|||
33473700|NCT02093221|101624113|FG003|Overall Study|Withdrawal by Subject|1|||
33473701|NCT02093221|101624114|FG004|Overall Study|Withdrawal by Subject|1|||
33473702|NCT02093221|101624110|FG000|Overall Study|Lost to Follow-up|2|||
33473703|NCT02093221|101624111|FG001|Overall Study|Lost to Follow-up|0|||
33473704|NCT02093221|101624112|FG002|Overall Study|Lost to Follow-up|1|||
33473705|NCT02093221|101624113|FG003|Overall Study|Lost to Follow-up|1|||
33473706|NCT02093221|101624114|FG004|Overall Study|Lost to Follow-up|0|||
33473707|NCT02093221|101624110|FG000|Overall Study|Death|0|||
33473708|NCT02093221|101624111|FG001|Overall Study|Death|1|||
33473709|NCT02093221|101624112|FG002|Overall Study|Death|0|||
33473710|NCT02093221|101624113|FG003|Overall Study|Death|0|||
33473711|NCT02093221|101624114|FG004|Overall Study|Death|0|||
33473712|NCT02093221|101624110|FG000|Overall Study|Protocol Violation|0|||
33473713|NCT02093221|101624111|FG001|Overall Study|Protocol Violation|1|||
33473714|NCT02093221|101624112|FG002|Overall Study|Protocol Violation|0|||
33473715|NCT02093221|101624113|FG003|Overall Study|Protocol Violation|0|||
33473716|NCT02093221|101624114|FG004|Overall Study|Protocol Violation|0|||
33182497|NCT01455012|100578588|FG001|Overall Study|Withdrawal by Subject|1|||
33182498|NCT01455012|100578587|FG000|Overall Study|Unknown reason|2|||
33182499|NCT01455012|100578588|FG001|Overall Study|Unknown reason|0|||
33182500|NCT01817725|100578589|FG000|Overall Study|Withdrawal by Subject|1|||
33182501|NCT05129488|100578594|FG000|Overall Study|Protocol Violation|3|||
33182502|NCT03131440|100578595|FG000|Overall Study|Withdrawal by Subject|1|||
33182503|NCT03131440|100578596|FG001|Overall Study|Withdrawal by Subject|3|||
33182504|NCT03131440|100578597|FG002|Overall Study|Withdrawal by Subject|0|||
33182505|NCT03131440|100578598|FG003|Overall Study|Withdrawal by Subject|0|||
33182506|NCT03131440|100578599|FG004|Overall Study|Withdrawal by Subject|1|||
33182507|NCT03131440|100578600|FG005|Overall Study|Withdrawal by Subject|0|||
33182508|NCT03131440|100578601|FG006|Overall Study|Withdrawal by Subject|0|||
33182509|NCT03131440|100578602|FG007|Overall Study|Withdrawal by Subject|1|||
33182510|NCT03131440|100578603|FG008|Overall Study|Withdrawal by Subject|1|||
33182511|NCT03131440|100578604|FG009|Overall Study|Withdrawal by Subject|1|||
33266408|NCT00146172|100873891|FG003|Overall Study|Withdrawal by Subject|0|||
33473717|NCT02093221|101624110|FG000|Overall Study|Study termination|6|||
33182512|NCT03131440|100578605|FG010|Overall Study|Withdrawal by Subject|0|||
33473718|NCT02093221|101624111|FG001|Overall Study|Study termination|5|||
33182513|NCT03131440|100578606|FG011|Overall Study|Withdrawal by Subject|1|||
33182514|NCT03131440|100578607|FG012|Overall Study|Withdrawal by Subject|1|||
33473719|NCT02093221|101624112|FG002|Overall Study|Study termination|4|||
33473720|NCT02093221|101624113|FG003|Overall Study|Study termination|6|||
33182515|NCT03131440|100578608|FG013|Overall Study|Withdrawal by Subject|0|||
33473721|NCT02093221|101624114|FG004|Overall Study|Study termination|7|||
33473722|NCT04049617|101624115|FG000|Overall Study|Adverse Event|0|||
33473723|NCT04049617|101624116|FG001|Overall Study|Adverse Event|0|||
33473724|NCT04049617|101624117|FG002|Overall Study|Adverse Event|0|||
33473725|NCT04049617|101624118|FG003|Overall Study|Adverse Event|1|||
33473726|NCT04049617|101624119|FG004|Overall Study|Adverse Event|0|||
33182516|NCT03131440|100578609|FG014|Overall Study|Withdrawal by Subject|1|||
33182517|NCT03131440|100578610|FG015|Overall Study|Withdrawal by Subject|0|||
33182518|NCT03131440|100578611|FG016|Overall Study|Withdrawal by Subject|0|||
33182519|NCT03131440|100578612|FG017|Overall Study|Withdrawal by Subject|0|||
33182520|NCT03131440|100578613|FG018|Overall Study|Withdrawal by Subject|1|||
33182521|NCT03131440|100578614|FG019|Overall Study|Withdrawal by Subject|0|||
33182522|NCT03131440|100578615|FG020|Overall Study|Withdrawal by Subject|1|||
33182523|NCT03131440|100578616|FG021|Overall Study|Withdrawal by Subject|1|||
33182524|NCT03131440|100578617|FG022|Overall Study|Withdrawal by Subject|1|||
33473727|NCT04049617|101624120|FG005|Overall Study|Adverse Event|0|||
33473728|NCT04049617|101624115|FG000|Overall Study|Death|0|||
33473729|NCT04049617|101624116|FG001|Overall Study|Death|0|||
33473730|NCT04049617|101624117|FG002|Overall Study|Death|0|||
33473731|NCT04049617|101624118|FG003|Overall Study|Death|0|||
33473732|NCT04049617|101624119|FG004|Overall Study|Death|0|||
33473733|NCT04049617|101624120|FG005|Overall Study|Death|1|||
33473734|NCT04049617|101624115|FG000|Overall Study|Lost to Follow-up|0|||
33473735|NCT04049617|101624116|FG001|Overall Study|Lost to Follow-up|0|||
33473736|NCT04049617|101624117|FG002|Overall Study|Lost to Follow-up|0|||
33473737|NCT04049617|101624118|FG003|Overall Study|Lost to Follow-up|1|||
33473738|NCT04049617|101624119|FG004|Overall Study|Lost to Follow-up|0|||
33473739|NCT04049617|101624120|FG005|Overall Study|Lost to Follow-up|0|||
33473740|NCT04049617|101624115|FG000|Overall Study|Withdrew consent|0|||
33473741|NCT04049617|101624116|FG001|Overall Study|Withdrew consent|0|||
33473742|NCT04049617|101624117|FG002|Overall Study|Withdrew consent|1|||
33473743|NCT04049617|101624118|FG003|Overall Study|Withdrew consent|0|||
33473744|NCT04049617|101624119|FG004|Overall Study|Withdrew consent|0|||
33473745|NCT04049617|101624120|FG005|Overall Study|Withdrew consent|0|||
33473746|NCT02991430|101624123|FG000|Treatment Period 1|Adverse Event|1|||
33182525|NCT03131440|100578618|FG023|Overall Study|Withdrawal by Subject|0|||
33473747|NCT02991430|101624124|FG001|Treatment Period 1|Adverse Event|0|||
33473748|NCT02991430|101624125|FG002|Treatment Period 1|Adverse Event|2|||
33473749|NCT02991430|101624123|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33473750|NCT02991430|101624124|FG001|Treatment Period 1|Withdrawal by Subject|4|||
33473751|NCT02991430|101624125|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33473752|NCT02991430|101624123|FG000|Treatment Period 2|Study Termination|6|||
33182526|NCT03131440|100578619|FG024|Overall Study|Withdrawal by Subject|0|||
33182527|NCT03131440|100578620|FG025|Overall Study|Withdrawal by Subject|0|||
33473753|NCT02991430|101624124|FG001|Treatment Period 2|Study Termination|3|||
33473754|NCT02991430|101624125|FG002|Treatment Period 2|Study Termination|3|||
33473755|NCT02991430|101624123|FG000|Treatment Period 2|Lost to Follow-up|0|||
33182528|NCT03131440|100578621|FG026|Overall Study|Withdrawal by Subject|0|||
33182529|NCT03131440|100578622|FG027|Overall Study|Withdrawal by Subject|0|||
33182530|NCT03131440|100578623|FG028|Overall Study|Withdrawal by Subject|0|||
33182531|NCT03131440|100578624|FG029|Overall Study|Withdrawal by Subject|0|||
33182532|NCT03131440|100578625|FG030|Overall Study|Withdrawal by Subject|1|||
33182533|NCT03131440|100578626|FG031|Overall Study|Withdrawal by Subject|0|||
33182534|NCT03131440|100578595|FG000|Overall Study|Lost to Follow-up|0|||
33182535|NCT03131440|100578596|FG001|Overall Study|Lost to Follow-up|0|||
33182536|NCT03131440|100578597|FG002|Overall Study|Lost to Follow-up|0|||
33182537|NCT03131440|100578598|FG003|Overall Study|Lost to Follow-up|0|||
33182538|NCT03131440|100578599|FG004|Overall Study|Lost to Follow-up|0|||
33182539|NCT03131440|100578600|FG005|Overall Study|Lost to Follow-up|1|||
33182540|NCT03131440|100578601|FG006|Overall Study|Lost to Follow-up|0|||
33182541|NCT03131440|100578602|FG007|Overall Study|Lost to Follow-up|0|||
33182542|NCT03131440|100578603|FG008|Overall Study|Lost to Follow-up|0|||
33182543|NCT03131440|100578604|FG009|Overall Study|Lost to Follow-up|0|||
33182544|NCT03131440|100578605|FG010|Overall Study|Lost to Follow-up|0|||
33182545|NCT03131440|100578606|FG011|Overall Study|Lost to Follow-up|0|||
33182546|NCT03131440|100578607|FG012|Overall Study|Lost to Follow-up|0|||
33182547|NCT03131440|100578608|FG013|Overall Study|Lost to Follow-up|0|||
33266409|NCT00146172|100873892|FG004|Overall Study|Withdrawal by Subject|0|||
33473756|NCT02991430|101624124|FG001|Treatment Period 2|Lost to Follow-up|0|||
33473757|NCT02991430|101624125|FG002|Treatment Period 2|Lost to Follow-up|1|||
33182548|NCT03131440|100578609|FG014|Overall Study|Lost to Follow-up|0|||
33182549|NCT03131440|100578610|FG015|Overall Study|Lost to Follow-up|0|||
33182550|NCT03131440|100578611|FG016|Overall Study|Lost to Follow-up|0|||
33182551|NCT03131440|100578612|FG017|Overall Study|Lost to Follow-up|0|||
33182552|NCT03131440|100578613|FG018|Overall Study|Lost to Follow-up|0|||
33182553|NCT03131440|100578614|FG019|Overall Study|Lost to Follow-up|2|||
33266410|NCT00146172|100873893|FG005|Overall Study|Withdrawal by Subject|1|||
33182554|NCT03131440|100578615|FG020|Overall Study|Lost to Follow-up|1|||
33182555|NCT03131440|100578616|FG021|Overall Study|Lost to Follow-up|0|||
33473758|NCT02991430|101624123|FG000|Post-treatment Observation Period|Study Termination|3|||
33473759|NCT02991430|101624124|FG001|Post-treatment Observation Period|Study Termination|6|||
33473760|NCT02991430|101624125|FG002|Post-treatment Observation Period|Study Termination|5|||
33473761|NCT04053465|101624130|FG000|Overall Study|Withdrawal by Subject|4|||
33473762|NCT04053465|101624131|FG001|Overall Study|Withdrawal by Subject|4|||
33473763|NCT01629966|101624132|FG000|Overall Study|Pregnancy|0|||
33182556|NCT03131440|100578617|FG022|Overall Study|Lost to Follow-up|1|||
33182557|NCT03131440|100578618|FG023|Overall Study|Lost to Follow-up|0|||
33473764|NCT01629966|101624133|FG001|Overall Study|Pregnancy|1|||
33473765|NCT01629966|101624134|FG002|Overall Study|Pregnancy|0|||
33473766|NCT01629966|101624132|FG000|Overall Study|Lost to Follow-up|10|||
33473767|NCT01629966|101624133|FG001|Overall Study|Lost to Follow-up|13|||
33473768|NCT01629966|101624134|FG002|Overall Study|Lost to Follow-up|9|||
33473769|NCT01629966|101624132|FG000|Overall Study|Withdrawal by Subject|8|||
33473770|NCT01629966|101624133|FG001|Overall Study|Withdrawal by Subject|9|||
33473771|NCT01629966|101624134|FG002|Overall Study|Withdrawal by Subject|16|||
33473772|NCT01629966|101624132|FG000|Overall Study|Protocol Violation|7|||
33473773|NCT01629966|101624133|FG001|Overall Study|Protocol Violation|9|||
33473774|NCT01629966|101624134|FG002|Overall Study|Protocol Violation|7|||
33473775|NCT01629966|101624132|FG000|Overall Study|Lack of Efficacy|5|||
33473776|NCT01629966|101624133|FG001|Overall Study|Lack of Efficacy|2|||
33473777|NCT01629966|101624134|FG002|Overall Study|Lack of Efficacy|4|||
33473778|NCT01629966|101624132|FG000|Overall Study|Adverse Event|11|||
33473779|NCT01629966|101624133|FG001|Overall Study|Adverse Event|18|||
33473780|NCT01629966|101624134|FG002|Overall Study|Adverse Event|30|||
33473781|NCT03095118|101624135|FG000|Overall Study|Adverse Event|1|||
33473782|NCT03095118|101624135|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
33473783|NCT01602965|101624136|FG000|Overall Study|Lost to Follow-up|4|||
33473784|NCT01602965|101624137|FG001|Overall Study|Lost to Follow-up|2|||
33473785|NCT00816361|101624142|FG000|Overall Study|Withdrawal by Subject|0|||
33473786|NCT00816361|101624143|FG001|Overall Study|Withdrawal by Subject|0|||
33473787|NCT00816361|101624144|FG002|Overall Study|Withdrawal by Subject|0|||
33473788|NCT00816361|101624145|FG003|Overall Study|Withdrawal by Subject|0|||
33473789|NCT00816361|101624146|FG004|Overall Study|Withdrawal by Subject|1|||
33473790|NCT00816361|101624147|FG005|Overall Study|Withdrawal by Subject|2|||
33473791|NCT00816361|101624148|FG006|Overall Study|Withdrawal by Subject|0|||
33473792|NCT00816361|101624149|FG007|Overall Study|Withdrawal by Subject|2|||
33473793|NCT00816361|101624150|FG008|Overall Study|Withdrawal by Subject|1|||
33473794|NCT00816361|101624142|FG000|Overall Study|Death|4|||
33473795|NCT00816361|101624143|FG001|Overall Study|Death|3|||
33473796|NCT00816361|101624144|FG002|Overall Study|Death|3|||
33473797|NCT00816361|101624145|FG003|Overall Study|Death|3|||
33473798|NCT00816361|101624146|FG004|Overall Study|Death|1|||
33473799|NCT00816361|101624147|FG005|Overall Study|Death|1|||
33473800|NCT00816361|101624148|FG006|Overall Study|Death|3|||
33473801|NCT00816361|101624149|FG007|Overall Study|Death|7|||
33182558|NCT03131440|100578619|FG024|Overall Study|Lost to Follow-up|1|||
33473802|NCT00816361|101624150|FG008|Overall Study|Death|8|||
33473803|NCT00816361|101624142|FG000|Overall Study|Other|0|||
33473804|NCT00816361|101624143|FG001|Overall Study|Other|0|||
33473805|NCT00816361|101624144|FG002|Overall Study|Other|0|||
33473806|NCT00816361|101624145|FG003|Overall Study|Other|0|||
33473807|NCT00816361|101624146|FG004|Overall Study|Other|0|||
33473808|NCT00816361|101624147|FG005|Overall Study|Other|0|||
33473809|NCT00816361|101624148|FG006|Overall Study|Other|0|||
33473810|NCT00816361|101624149|FG007|Overall Study|Other|0|||
33473811|NCT00816361|101624150|FG008|Overall Study|Other|1|||
33473812|NCT01744093|101624151|FG000|Overall Study|Withdrawal by Subject|6|||
33473813|NCT01744093|101624152|FG001|Overall Study|Withdrawal by Subject|1|||
33473814|NCT03340064|101624160|FG000|First Period|Adverse Event, non-fatal|2|||
33473815|NCT03340064|101624161|FG001|First Period|Adverse Event, non-fatal|0|||
33473816|NCT03340064|101624160|FG000|First Period|Lack of Efficacy|3|||
33473817|NCT03340064|101624161|FG001|First Period|Lack of Efficacy|0|||
33473818|NCT03340064|101624160|FG000|Second Period|Adverse Event, non-fatal|1|||
33473819|NCT03340064|101624161|FG001|Second Period|Adverse Event, non-fatal|1|||
33473820|NCT03340064|101624160|FG000|Second Period|Lack of Efficacy|11|||
33473821|NCT03340064|101624161|FG001|Second Period|Lack of Efficacy|0|||
33473822|NCT03340064|101624160|FG000|Second Period|Physician Decision|3|||
33473823|NCT03340064|101624161|FG001|Second Period|Physician Decision|0|||
33182559|NCT03131440|100578620|FG025|Overall Study|Lost to Follow-up|0|||
33182560|NCT03131440|100578621|FG026|Overall Study|Lost to Follow-up|0|||
33473824|NCT03340064|101624160|FG000|Second Period|Withdrawal by Subject|2|||
33473825|NCT03340064|101624161|FG001|Second Period|Withdrawal by Subject|1|||
33473826|NCT03340064|101624160|FG000|Second Period|Approved Drug Available For Indication|1|||
33473827|NCT03340064|101624161|FG001|Second Period|Approved Drug Available For Indication|0|||
33182561|NCT03131440|100578622|FG027|Overall Study|Lost to Follow-up|2|||
33473828|NCT03340064|101624160|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
33473829|NCT03340064|101624161|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
33473830|NCT01649271|101624163|FG000|Overall Study|Progressive disease|4|||
33182562|NCT03131440|100578623|FG028|Overall Study|Lost to Follow-up|0|||
33473831|NCT01649271|101624164|FG001|Overall Study|Progressive disease|5|||
33473832|NCT01649271|101624163|FG000|Overall Study|Other Adverse Event|0|||
33473833|NCT01649271|101624164|FG001|Overall Study|Other Adverse Event|2|||
33473834|NCT01649271|101624163|FG000|Overall Study|Withdrawal by Subject|1|||
33473835|NCT01649271|101624164|FG001|Overall Study|Withdrawal by Subject|0|||
33473836|NCT01649271|101624163|FG000|Overall Study|Other than stated above|1|||
33473837|NCT01649271|101624164|FG001|Overall Study|Other than stated above|0|||
33473838|NCT01388166|101624165|FG000|Overall Study|Adverse Event|16|||
33473839|NCT01388166|101624165|FG000|Overall Study|Lost to Follow-up|30|||
33473840|NCT01388166|101624165|FG000|Overall Study|Others than specified above|13|||
33473841|NCT00062010|101624166|FG000|Overall Study|Ineligible|3|||
33473842|NCT01902628|101624167|FG000|Overall Study|Withdrawal of participant's consent|7|||
33473843|NCT01902628|101624167|FG000|Overall Study|Adverse Event|41|||
33473844|NCT01902628|101624167|FG000|Overall Study|Lost to Follow-up|35|||
33473845|NCT00430495|101624174|FG000|Overall Study|Adverse Event|2|||
33473846|NCT00430495|101624175|FG001|Overall Study|Adverse Event|3|||
33473847|NCT00430495|101624176|FG002|Overall Study|Adverse Event|2|||
33473848|NCT00430495|101624177|FG003|Overall Study|Adverse Event|0|||
33473849|NCT00430495|101624174|FG000|Overall Study|Death|0|||
33473850|NCT00430495|101624175|FG001|Overall Study|Death|0|||
33473851|NCT00430495|101624176|FG002|Overall Study|Death|1|||
33473852|NCT00430495|101624177|FG003|Overall Study|Death|0|||
33473853|NCT00430495|101624174|FG000|Overall Study|Lost to Follow-up|0|||
33473854|NCT00430495|101624175|FG001|Overall Study|Lost to Follow-up|1|||
33182563|NCT03131440|100578624|FG029|Overall Study|Lost to Follow-up|2|||
33182564|NCT03131440|100578625|FG030|Overall Study|Lost to Follow-up|0|||
33182565|NCT03131440|100578626|FG031|Overall Study|Lost to Follow-up|0|||
33182566|NCT03131440|100578595|FG000|Overall Study|Death|0|||
33182567|NCT03131440|100578596|FG001|Overall Study|Death|0|||
33182568|NCT03131440|100578597|FG002|Overall Study|Death|0|||
33182569|NCT03131440|100578598|FG003|Overall Study|Death|0|||
33182570|NCT03131440|100578599|FG004|Overall Study|Death|0|||
33182571|NCT03131440|100578600|FG005|Overall Study|Death|0|||
33182572|NCT03131440|100578601|FG006|Overall Study|Death|0|||
33182573|NCT03131440|100578602|FG007|Overall Study|Death|0|||
33182574|NCT03131440|100578603|FG008|Overall Study|Death|0|||
33182575|NCT03131440|100578604|FG009|Overall Study|Death|0|||
33473855|NCT00430495|101624176|FG002|Overall Study|Lost to Follow-up|4|||
33473856|NCT00430495|101624177|FG003|Overall Study|Lost to Follow-up|0|||
33473857|NCT00430495|101624174|FG000|Overall Study|Protocol Violation|1|||
33473858|NCT00430495|101624175|FG001|Overall Study|Protocol Violation|0|||
33473859|NCT00430495|101624176|FG002|Overall Study|Protocol Violation|1|||
33473860|NCT00430495|101624177|FG003|Overall Study|Protocol Violation|0|||
33473861|NCT00430495|101624174|FG000|Overall Study|Disease Progression|1|||
33473862|NCT00430495|101624175|FG001|Overall Study|Disease Progression|1|||
33473863|NCT00430495|101624176|FG002|Overall Study|Disease Progression|0|||
33473864|NCT00430495|101624177|FG003|Overall Study|Disease Progression|0|||
33473865|NCT00430495|101624174|FG000|Overall Study|Other|8|||
33473866|NCT00430495|101624175|FG001|Overall Study|Other|2|||
33473867|NCT00430495|101624176|FG002|Overall Study|Other|5|||
33473868|NCT00430495|101624177|FG003|Overall Study|Other|4|||
33473869|NCT00430495|101624174|FG000|Overall Study|Randomized but not Treated|2|||
33473870|NCT00430495|101624175|FG001|Overall Study|Randomized but not Treated|0|||
33473871|NCT00430495|101624176|FG002|Overall Study|Randomized but not Treated|0|||
33473872|NCT00430495|101624177|FG003|Overall Study|Randomized but not Treated|0|||
33473873|NCT03835221|101624178|FG000|Methafilcon A|Withdrawal by Subject|1|||
33473874|NCT04156620|101624179|FG000|Overall Study|Adverse event - TP 1|5|||
33473875|NCT04156620|101624180|FG001|Overall Study|Adverse event - TP 1|2|||
33473876|NCT04156620|101624179|FG000|Overall Study|Lost to follow-up TP 1|1|||
33473877|NCT04156620|101624180|FG001|Overall Study|Lost to follow-up TP 1|1|||
33473878|NCT04156620|101624179|FG000|Overall Study|Progressive disease - TP 1|0|||
33473879|NCT04156620|101624180|FG001|Overall Study|Progressive disease - TP 1|1|||
33473880|NCT04156620|101624179|FG000|Overall Study|Subject decision - TP 1|3|||
33473881|NCT04156620|101624180|FG001|Overall Study|Subject decision - TP 1|5|||
33473882|NCT04156620|101624179|FG000|Overall Study|Adverse event - TP 2|5|||
33473883|NCT04156620|101624180|FG001|Overall Study|Adverse event - TP 2|6|||
33473884|NCT04156620|101624179|FG000|Overall Study|Death - TP 2|1|||
33473885|NCT04156620|101624180|FG001|Overall Study|Death - TP 2|0|||
33473886|NCT04156620|101624179|FG000|Overall Study|Lost to follow-up - TP 2|5|||
33473887|NCT04156620|101624180|FG001|Overall Study|Lost to follow-up - TP 2|2|||
33473888|NCT04156620|101624179|FG000|Overall Study|Physician decision - TP 2|4|||
33473889|NCT04156620|101624180|FG001|Overall Study|Physician decision - TP 2|2|||
33473890|NCT04156620|101624179|FG000|Overall Study|Pregnancy - TP 2|1|||
33473891|NCT04156620|101624180|FG001|Overall Study|Pregnancy - TP 2|1|||
33182576|NCT03131440|100578605|FG010|Overall Study|Death|0|||
33182577|NCT03131440|100578606|FG011|Overall Study|Death|0|||
33182578|NCT03131440|100578607|FG012|Overall Study|Death|0|||
33473892|NCT04156620|101624179|FG000|Overall Study|Subject decision - TP 2|11|||
33473893|NCT04156620|101624180|FG001|Overall Study|Subject decision - TP 2|9|||
33473894|NCT04156620|101624179|FG000|Overall Study|New therapy for study indication - TP 2|1|||
33473895|NCT04156620|101624180|FG001|Overall Study|New therapy for study indication - TP 2|0|||
33473896|NCT02823652|101624181|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
33473897|NCT02823652|101624182|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
33182579|NCT03131440|100578608|FG013|Overall Study|Death|0|||
33473898|NCT02823652|101624183|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
33473899|NCT02823652|101624181|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
33473900|NCT02823652|101624182|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
33473901|NCT02823652|101624183|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
33473902|NCT02823652|101624181|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
33473903|NCT02823652|101624182|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
33473904|NCT02823652|101624183|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
33473905|NCT02823652|101624181|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
33473906|NCT02823652|101624182|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
33473907|NCT02823652|101624183|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
33473908|NCT01055132|101624192|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
33473909|NCT01055132|101624193|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
33473910|NCT01055132|101624192|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
33473911|NCT01055132|101624193|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
33473912|NCT01568320|101624196|FG000|Overall Study|Death|20|||
33473913|NCT01568320|101624196|FG000|Overall Study|Lost to Follow-up|9|||
33473914|NCT01568320|101624196|FG000|Overall Study|Withdrawal by Subject|10|||
33473915|NCT01568320|101624196|FG000|Overall Study|Conversion to open repair|1|||
33473916|NCT01568320|101624196|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
33473917|NCT00861198|101624203|FG000|Overall Study|SpyGlass Failed|5|||
33473918|NCT00127036|101624207|FG000|Overall Study|Insufficient Data for Analysis|6|||
33473919|NCT00127036|101624208|FG001|Overall Study|Insufficient Data for Analysis|11|||
33473920|NCT00127036|101624207|FG000|Overall Study|Screen Failure|2|||
33473921|NCT00127036|101624208|FG001|Overall Study|Screen Failure|0|||
33473922|NCT01121666|101624209|FG000|Overall Study|Protocol Violation|29|||
33473923|NCT01121666|101624210|FG001|Overall Study|Protocol Violation|10|||
33473924|NCT01150890|101628206|FG000|Overall Study|Other|0|||
33473925|NCT01150890|101628207|FG001|Overall Study|Other|1|||
33473926|NCT01150890|101628208|FG002|Overall Study|Other|0|||
33473927|NCT01150890|101628209|FG003|Overall Study|Other|2|||
33182580|NCT03131440|100578609|FG014|Overall Study|Death|0|||
33182581|NCT03131440|100578610|FG015|Overall Study|Death|0|||
33182582|NCT03131440|100578611|FG016|Overall Study|Death|0|||
33182583|NCT03131440|100578612|FG017|Overall Study|Death|0|||
33182584|NCT03131440|100578613|FG018|Overall Study|Death|0|||
33182585|NCT03131440|100578614|FG019|Overall Study|Death|0|||
33182586|NCT03131440|100578615|FG020|Overall Study|Death|0|||
33182587|NCT03131440|100578616|FG021|Overall Study|Death|0|||
33182588|NCT03131440|100578617|FG022|Overall Study|Death|0|||
33182589|NCT03131440|100578618|FG023|Overall Study|Death|0|||
33182590|NCT03131440|100578619|FG024|Overall Study|Death|0|||
33182591|NCT03131440|100578620|FG025|Overall Study|Death|1|||
33182592|NCT03131440|100578621|FG026|Overall Study|Death|0|||
33182593|NCT03131440|100578622|FG027|Overall Study|Death|0|||
33182594|NCT03131440|100578623|FG028|Overall Study|Death|0|||
33182595|NCT03131440|100578624|FG029|Overall Study|Death|0|||
33182596|NCT03131440|100578625|FG030|Overall Study|Death|0|||
33182597|NCT03131440|100578626|FG031|Overall Study|Death|0|||
33182598|NCT01957462|100578629|FG000|Test Period 1|Withdrawal by Subject|1|||
33182599|NCT01957462|100578630|FG001|Test Period 1|Withdrawal by Subject|0|||
33473928|NCT01150890|101628206|FG000|Overall Study|Pregnancy|0|||
33473929|NCT01150890|101628207|FG001|Overall Study|Pregnancy|0|||
33473930|NCT01150890|101628208|FG002|Overall Study|Pregnancy|0|||
33473931|NCT01150890|101628209|FG003|Overall Study|Pregnancy|1|||
33473932|NCT01150890|101628206|FG000|Overall Study|Administrative Decision|4|||
33473933|NCT01150890|101628207|FG001|Overall Study|Administrative Decision|4|||
33473934|NCT01150890|101628208|FG002|Overall Study|Administrative Decision|5|||
33473935|NCT01150890|101628209|FG003|Overall Study|Administrative Decision|6|||
33182600|NCT01957462|100578629|FG000|Test Period 1|Adverse Event|1|||
33182601|NCT01957462|100578630|FG001|Test Period 1|Adverse Event|0|||
33182602|NCT00265343|100578631|FG000|Overall Study|Adverse Event|10|||
33182603|NCT00265343|100578632|FG001|Overall Study|Adverse Event|7|||
33473936|NCT01150890|101628206|FG000|Overall Study|Ineligibility determined|0|||
33473937|NCT01150890|101628207|FG001|Overall Study|Ineligibility determined|1|||
33473938|NCT01150890|101628208|FG002|Overall Study|Ineligibility determined|0|||
33473939|NCT01150890|101628209|FG003|Overall Study|Ineligibility determined|0|||
33473940|NCT01150890|101628206|FG000|Overall Study|Adverse Event|0|||
33182604|NCT00265343|100578631|FG000|Overall Study|Withdrawal by Subject|3|||
33182605|NCT00265343|100578632|FG001|Overall Study|Withdrawal by Subject|9|||
33473941|NCT01150890|101628207|FG001|Overall Study|Adverse Event|0|||
33473942|NCT01150890|101628208|FG002|Overall Study|Adverse Event|2|||
33473943|NCT01150890|101628209|FG003|Overall Study|Adverse Event|0|||
33473944|NCT01150890|101628206|FG000|Overall Study|Withdrawal by Subject|0|||
33182606|NCT00265343|100578631|FG000|Overall Study|Other|8|||
33182607|NCT00265343|100578632|FG001|Overall Study|Other|3|||
33182608|NCT04552587|100578633|FG000|Overall Study|Lost to Follow-up|4|||
33182609|NCT00698581|100578634|FG000|Overall Study|Lack of Efficacy|23|||
33182610|NCT00698581|100578635|FG001|Overall Study|Lack of Efficacy|11|||
33182611|NCT00698581|100578634|FG000|Overall Study|Withdrawal by Subject|6|||
33473945|NCT01150890|101628207|FG001|Overall Study|Withdrawal by Subject|0|||
33473946|NCT01150890|101628208|FG002|Overall Study|Withdrawal by Subject|2|||
33182612|NCT00698581|100578635|FG001|Overall Study|Withdrawal by Subject|0|||
33182613|NCT00698581|100578634|FG000|Overall Study|Other reason|9|||
33182614|NCT00698581|100578635|FG001|Overall Study|Other reason|1|||
33182615|NCT00698581|100578634|FG000|Overall Study|SAE, non-fatal|1|||
33182616|NCT00698581|100578635|FG001|Overall Study|SAE, non-fatal|0|||
33182617|NCT00698581|100578634|FG000|Overall Study|AE, non-serious non-fatal|4|||
33182618|NCT00698581|100578635|FG001|Overall Study|AE, non-serious non-fatal|0|||
33182619|NCT00698581|100578634|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33182620|NCT00698581|100578635|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
33182621|NCT00698581|100578634|FG000|Overall Study|AE of unknown type|1|||
33182622|NCT00698581|100578635|FG001|Overall Study|AE of unknown type|0|||
33182623|NCT02295995|100578637|FG000|Overall Study|Lost to Follow-up|5|||
33182624|NCT02295995|100578638|FG001|Overall Study|Lost to Follow-up|1|||
33182625|NCT03265249|100578640|FG000|Overall Study|Withdrawal by Subject|0|||
33266411|NCT00146172|100873894|FG006|Overall Study|Withdrawal by Subject|1|||
33266412|NCT00146172|100873895|FG007|Overall Study|Withdrawal by Subject|4|||
33266413|NCT00146172|100873888|FG000|Overall Study|Symptomatic Deterioration|1|||
33266414|NCT00146172|100873889|FG001|Overall Study|Symptomatic Deterioration|0|||
33266415|NCT00146172|100873890|FG002|Overall Study|Symptomatic Deterioration|1|||
33266416|NCT00146172|100873891|FG003|Overall Study|Symptomatic Deterioration|0|||
33266417|NCT00146172|100873892|FG004|Overall Study|Symptomatic Deterioration|1|||
33266418|NCT00146172|100873893|FG005|Overall Study|Symptomatic Deterioration|2|||
33266419|NCT00146172|100873894|FG006|Overall Study|Symptomatic Deterioration|0|||
33266420|NCT00146172|100873895|FG007|Overall Study|Symptomatic Deterioration|2|||
33266421|NCT00724126|100873899|FG000|Overall Study|Adverse Event|2|||
33266422|NCT00724126|100873900|FG001|Overall Study|Adverse Event|0|||
33266423|NCT00724126|100873899|FG000|Overall Study|Withdrawal by Subject|8|||
33266424|NCT00724126|100873900|FG001|Overall Study|Withdrawal by Subject|6|||
33266425|NCT00724126|100873899|FG000|Overall Study|Lost to Follow-up|6|||
33266426|NCT00724126|100873900|FG001|Overall Study|Lost to Follow-up|6|||
33266427|NCT00724126|100873899|FG000|Overall Study|Noncompliance|2|||
33266428|NCT00724126|100873900|FG001|Overall Study|Noncompliance|1|||
33266429|NCT00724126|100873899|FG000|Overall Study|Subject randomized although ineligible|1|||
33266430|NCT00724126|100873900|FG001|Overall Study|Subject randomized although ineligible|1|||
33266431|NCT00724126|100873899|FG000|Overall Study|Subject had to leave vicinity of site|0|||
33266432|NCT00724126|100873900|FG001|Overall Study|Subject had to leave vicinity of site|1|||
33266433|NCT00845520|100873905|FG000|Overall Study|Death|1|||
33266434|NCT00845520|100873906|FG001|Overall Study|Death|2|||
33266435|NCT00845520|100873907|FG002|Overall Study|Death|0|||
33266436|NCT00845520|100873905|FG000|Overall Study|Lost to Follow-up|1|||
33266437|NCT00845520|100873906|FG001|Overall Study|Lost to Follow-up|0|||
33266438|NCT00845520|100873907|FG002|Overall Study|Lost to Follow-up|0|||
33266439|NCT00845520|100873905|FG000|Overall Study|Adverse Event|0|||
33266440|NCT00845520|100873906|FG001|Overall Study|Adverse Event|0|||
33266441|NCT00845520|100873907|FG002|Overall Study|Adverse Event|1|||
33473947|NCT01150890|101628209|FG003|Overall Study|Withdrawal by Subject|1|||
33473948|NCT01150890|101628206|FG000|Overall Study|Disease progression|0|||
33473949|NCT01150890|101628207|FG001|Overall Study|Disease progression|7|||
33473950|NCT01150890|101628208|FG002|Overall Study|Disease progression|3|||
33473951|NCT01150890|101628209|FG003|Overall Study|Disease progression|7|||
33473952|NCT00974974|101628212|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
33473953|NCT00974974|101628213|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
33473954|NCT00974974|101628212|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
33473955|NCT00974974|101628213|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
33473956|NCT00974974|101628212|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
33473957|NCT00974974|101628213|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
33182626|NCT03265249|100578641|FG001|Overall Study|Withdrawal by Subject|1|||
33182627|NCT02053753|100578643|FG000|Overall Study|Withdrawal by Subject|2|||
33182628|NCT02053753|100578644|FG001|Overall Study|Withdrawal by Subject|4|||
33266442|NCT02106884|100873910|FG000|Overall Study|Change of diagnosis/exclusion|0|||
33182629|NCT02053753|100578643|FG000|Overall Study|Decision by Sponsor|1|||
33182630|NCT02053753|100578644|FG001|Overall Study|Decision by Sponsor|1|||
33182631|NCT02053753|100578643|FG000|Overall Study|Lost to Follow-up|4|||
33182632|NCT02053753|100578644|FG001|Overall Study|Lost to Follow-up|3|||
33266443|NCT02106884|100873911|FG001|Overall Study|Change of diagnosis/exclusion|1|||
33266444|NCT02159352|100873919|FG000|Overall Study|Adverse Event|3|||
33266445|NCT02159352|100873920|FG001|Overall Study|Adverse Event|1|||
33266446|NCT02159352|100873919|FG000|Overall Study|Withdrawal by Subject|0|||
33182633|NCT01526889|100578647|FG000|Treatment Period|Adverse Event|2|||
33266447|NCT02159352|100873920|FG001|Overall Study|Withdrawal by Subject|1|||
33266448|NCT02807857|100873921|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
33266449|NCT02807857|100873921|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
33473958|NCT00974974|101628212|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
33473959|NCT00974974|101628213|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
33182634|NCT01526889|100578648|FG001|Treatment Period|Adverse Event|0|||
33182635|NCT01526889|100578647|FG000|Treatment Extension Period|Administrative problems|1|||
33182636|NCT01526889|100578648|FG001|Treatment Extension Period|Administrative problems|0|||
33182637|NCT00371254|100578649|FG000|Overall Study|Disease progression|13|||
33182638|NCT00371254|100578650|FG001|Overall Study|Disease progression|13|||
33182639|NCT00371254|100578649|FG000|Overall Study|Study drug toxicity|3|||
33182640|NCT00371254|100578650|FG001|Overall Study|Study drug toxicity|5|||
33182641|NCT00371254|100578649|FG000|Overall Study|Subject request|5|||
33182642|NCT00371254|100578650|FG001|Overall Study|Subject request|0|||
33182643|NCT00371254|100578649|FG000|Overall Study|Investigator Decision|2|||
33182644|NCT00371254|100578650|FG001|Overall Study|Investigator Decision|0|||
33182645|NCT00371254|100578649|FG000|Overall Study|Adverse event unrelated to study drug|0|||
33182646|NCT00371254|100578650|FG001|Overall Study|Adverse event unrelated to study drug|1|||
33182647|NCT00371254|100578649|FG000|Overall Study|Lost to Follow-up|0|||
33182648|NCT00371254|100578650|FG001|Overall Study|Lost to Follow-up|1|||
33182649|NCT00371254|100578649|FG000|Overall Study|Withdrawal by Subject|0|||
33182650|NCT00371254|100578650|FG001|Overall Study|Withdrawal by Subject|1|||
33182651|NCT04254978|100578651|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
33182652|NCT04254978|100578651|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
33182653|NCT04254978|100578651|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
33182654|NCT04254978|100578651|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
33182655|NCT04254978|100578651|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
33182656|NCT04254978|100578651|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
33182657|NCT00174915|100578656|FG000|Overall Study|Lost to Follow-up|19|||
33182658|NCT00174915|100578657|FG001|Overall Study|Lost to Follow-up|17|||
33182659|NCT00174915|100578658|FG002|Overall Study|Lost to Follow-up|9|||
33182660|NCT00174915|100578659|FG003|Overall Study|Lost to Follow-up|17|||
33182661|NCT00174915|100578660|FG004|Overall Study|Lost to Follow-up|10|||
33182662|NCT00174915|100578656|FG000|Overall Study|Adverse Event|18|||
33182663|NCT00174915|100578657|FG001|Overall Study|Adverse Event|16|||
33182664|NCT00174915|100578658|FG002|Overall Study|Adverse Event|11|||
33182665|NCT00174915|100578659|FG003|Overall Study|Adverse Event|18|||
33182666|NCT00174915|100578660|FG004|Overall Study|Adverse Event|5|||
33182667|NCT00174915|100578656|FG000|Overall Study|Personal Reason(s)|16|||
33182668|NCT00174915|100578657|FG001|Overall Study|Personal Reason(s)|16|||
33182669|NCT00174915|100578658|FG002|Overall Study|Personal Reason(s)|9|||
33182670|NCT00174915|100578659|FG003|Overall Study|Personal Reason(s)|9|||
33182671|NCT00174915|100578660|FG004|Overall Study|Personal Reason(s)|9|||
33182672|NCT00174915|100578656|FG000|Overall Study|Other|15|||
33473960|NCT00974974|101628212|FG000|IR CD-LD Dose Adjustment|Various|0|||
33473961|NCT00974974|101628213|FG001|IR CD-LD Dose Adjustment|Various|9|||
33473962|NCT00974974|101628212|FG000|IPX066 Dose Conversion|Adverse Event|23|||
33473963|NCT00974974|101628213|FG001|IPX066 Dose Conversion|Adverse Event|0|||
33473964|NCT00974974|101628212|FG000|IPX066 Dose Conversion|Death|2|||
33473965|NCT00974974|101628213|FG001|IPX066 Dose Conversion|Death|0|||
33473966|NCT00974974|101628212|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
33473967|NCT00974974|101628213|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
33473968|NCT00974974|101628212|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
33473969|NCT00974974|101628213|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
33473970|NCT00974974|101628212|FG000|IPX066 Dose Conversion|Various|3|||
33473971|NCT00974974|101628213|FG001|IPX066 Dose Conversion|Various|0|||
33473972|NCT00974974|101628212|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
33473973|NCT00974974|101628213|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
33473974|NCT00974974|101628212|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
33182673|NCT00174915|100578657|FG001|Overall Study|Other|8|||
33182674|NCT00174915|100578658|FG002|Overall Study|Other|6|||
33182675|NCT00174915|100578659|FG003|Overall Study|Other|5|||
33182676|NCT00174915|100578660|FG004|Overall Study|Other|3|||
33182677|NCT00174915|100578656|FG000|Overall Study|Gout Flare|13|||
33473975|NCT00974974|101628213|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
33473976|NCT00974974|101628212|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
33473977|NCT00974974|101628213|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
33182678|NCT00174915|100578657|FG001|Overall Study|Gout Flare|6|||
33182679|NCT00174915|100578658|FG002|Overall Study|Gout Flare|8|||
33182680|NCT00174915|100578659|FG003|Overall Study|Gout Flare|1|||
33182681|NCT00174915|100578660|FG004|Overall Study|Gout Flare|0|||
33182682|NCT00174915|100578656|FG000|Overall Study|Protocol Violation|6|||
33182683|NCT00174915|100578657|FG001|Overall Study|Protocol Violation|3|||
33182684|NCT00174915|100578658|FG002|Overall Study|Protocol Violation|3|||
33182685|NCT00174915|100578659|FG003|Overall Study|Protocol Violation|6|||
33182686|NCT00174915|100578660|FG004|Overall Study|Protocol Violation|3|||
33182687|NCT00174915|100578656|FG000|Overall Study|Therapeutic Failure|6|||
33182688|NCT00174915|100578657|FG001|Overall Study|Therapeutic Failure|3|||
33182689|NCT00174915|100578658|FG002|Overall Study|Therapeutic Failure|2|||
33473978|NCT00974974|101628212|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
33473979|NCT00974974|101628213|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
33473980|NCT00974974|101628212|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
33182690|NCT00174915|100578659|FG003|Overall Study|Therapeutic Failure|1|||
33182691|NCT00174915|100578660|FG004|Overall Study|Therapeutic Failure|3|||
33182692|NCT02939560|100578661|FG000|Overall Study|Withdrawal by Subject|2|||
33182693|NCT02939560|100578661|FG000|Overall Study|Protocol Violation|1|||
33182694|NCT04898673|100578664|FG000|Overall Study|Screenfail|1|||
33182695|NCT04898673|100578665|FG001|Overall Study|Screenfail|0|||
33182696|NCT01187043|100578666|FG000|Overall Study|Adverse Event|0|||
33182697|NCT01187043|100578667|FG001|Overall Study|Adverse Event|0|||
33182698|NCT01187043|100578668|FG002|Overall Study|Adverse Event|0|||
33182699|NCT01187043|100578669|FG003|Overall Study|Adverse Event|0|||
33182700|NCT01187043|100578670|FG004|Overall Study|Adverse Event|1|||
33182701|NCT01187043|100578666|FG000|Overall Study|Unable to make scheduled visits|1|||
33182702|NCT01187043|100578667|FG001|Overall Study|Unable to make scheduled visits|0|||
33182703|NCT01187043|100578668|FG002|Overall Study|Unable to make scheduled visits|4|||
33182704|NCT01187043|100578669|FG003|Overall Study|Unable to make scheduled visits|0|||
33182705|NCT01187043|100578670|FG004|Overall Study|Unable to make scheduled visits|1|||
33182706|NCT04865354|100578671|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
33182707|NCT04865354|100578672|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
33182708|NCT04865354|100578671|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
33182709|NCT04865354|100578672|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
33182710|NCT04865354|100578671|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
33182711|NCT04865354|100578672|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
33182712|NCT01708174|100578673|FG000|Treatment Period|Withdrawal by Subject|1|||
33182713|NCT01708174|100578674|FG001|Treatment Period|Withdrawal by Subject|0|||
33182714|NCT01708174|100578675|FG002|Treatment Period|Withdrawal by Subject|0|||
33182715|NCT01708174|100578673|FG000|Treatment Period|Progressive disease|0|||
33182716|NCT01708174|100578674|FG001|Treatment Period|Progressive disease|1|||
33182717|NCT01708174|100578675|FG002|Treatment Period|Progressive disease|0|||
33182718|NCT01708174|100578673|FG000|Treatment Period|Death|0|||
33182719|NCT01708174|100578674|FG001|Treatment Period|Death|0|||
33182720|NCT01708174|100578675|FG002|Treatment Period|Death|1|||
33182721|NCT01708174|100578673|FG000|Treatment Period|Adverse Event|0|||
33182722|NCT01708174|100578674|FG001|Treatment Period|Adverse Event|1|||
33182723|NCT01708174|100578675|FG002|Treatment Period|Adverse Event|0|||
33182724|NCT00352846|100578678|FG000|Overall Study|Disease progression|0|||
33182725|NCT00352846|100578679|FG001|Overall Study|Disease progression|2|||
33182726|NCT00352846|100578678|FG000|Overall Study|Withdrawal by Subject|3|||
33182727|NCT00352846|100578679|FG001|Overall Study|Withdrawal by Subject|8|||
33182728|NCT00352846|100578678|FG000|Overall Study|Ineligible|3|||
33182729|NCT00352846|100578679|FG001|Overall Study|Ineligible|2|||
33182730|NCT00352846|100578678|FG000|Overall Study|Non-compliance|2|||
33182731|NCT00352846|100578679|FG001|Overall Study|Non-compliance|0|||
33182732|NCT00352846|100578678|FG000|Overall Study|Death|0|||
33182733|NCT00352846|100578679|FG001|Overall Study|Death|1|||
33182734|NCT03760146|100578680|FG000|Overall Study|Adverse Event|11|||
33182735|NCT03760146|100578681|FG001|Overall Study|Adverse Event|8|||
33182736|NCT03760146|100578682|FG002|Overall Study|Adverse Event|0|||
33182737|NCT03760146|100578683|FG003|Overall Study|Adverse Event|0|||
33182738|NCT03760146|100578684|FG004|Overall Study|Adverse Event|0|||
33182739|NCT03760146|100578685|FG005|Overall Study|Adverse Event|0|||
33182740|NCT03760146|100578680|FG000|Overall Study|Death|1|||
33182741|NCT03760146|100578681|FG001|Overall Study|Death|0|||
33182742|NCT03760146|100578682|FG002|Overall Study|Death|0|||
33182743|NCT03760146|100578683|FG003|Overall Study|Death|0|||
33182744|NCT03760146|100578684|FG004|Overall Study|Death|0|||
33182745|NCT03760146|100578685|FG005|Overall Study|Death|0|||
33182746|NCT03760146|100578680|FG000|Overall Study|Lost to Follow-up|41|||
33182747|NCT03760146|100578681|FG001|Overall Study|Lost to Follow-up|28|||
33182748|NCT03760146|100578682|FG002|Overall Study|Lost to Follow-up|9|||
33182749|NCT03760146|100578683|FG003|Overall Study|Lost to Follow-up|2|||
33182750|NCT03760146|100578684|FG004|Overall Study|Lost to Follow-up|14|||
33182751|NCT03760146|100578685|FG005|Overall Study|Lost to Follow-up|8|||
33182752|NCT03760146|100578680|FG000|Overall Study|No longer met eligibility criteria|3|||
33182753|NCT03760146|100578681|FG001|Overall Study|No longer met eligibility criteria|9|||
33182754|NCT03760146|100578682|FG002|Overall Study|No longer met eligibility criteria|0|||
33182755|NCT03760146|100578683|FG003|Overall Study|No longer met eligibility criteria|0|||
33182756|NCT03760146|100578684|FG004|Overall Study|No longer met eligibility criteria|1|||
33182757|NCT03760146|100578685|FG005|Overall Study|No longer met eligibility criteria|0|||
33182758|NCT03760146|100578680|FG000|Overall Study|Protocol Violation|21|||
33182759|NCT03760146|100578681|FG001|Overall Study|Protocol Violation|13|||
33182760|NCT03760146|100578682|FG002|Overall Study|Protocol Violation|1|||
33182761|NCT03760146|100578683|FG003|Overall Study|Protocol Violation|0|||
33182762|NCT03760146|100578684|FG004|Overall Study|Protocol Violation|1|||
33182763|NCT03760146|100578685|FG005|Overall Study|Protocol Violation|0|||
33182764|NCT03760146|100578680|FG000|Overall Study|Withdrawal by Subject|19|||
33182765|NCT03760146|100578681|FG001|Overall Study|Withdrawal by Subject|20|||
33182766|NCT03760146|100578682|FG002|Overall Study|Withdrawal by Subject|1|||
33182767|NCT03760146|100578683|FG003|Overall Study|Withdrawal by Subject|0|||
33182768|NCT03760146|100578684|FG004|Overall Study|Withdrawal by Subject|1|||
33182769|NCT03760146|100578685|FG005|Overall Study|Withdrawal by Subject|0|||
33182770|NCT00733746|100578690|FG000|Overall Study|Ineligible|5|||
33182771|NCT03745937|100578691|FG000|Overall Study|Withdrawal by Subject|0|||
33182772|NCT03745937|100578692|FG001|Overall Study|Withdrawal by Subject|0|||
33182773|NCT03745937|100578693|FG002|Overall Study|Withdrawal by Subject|0|||
33182774|NCT03745937|100578694|FG003|Overall Study|Withdrawal by Subject|1|||
33473981|NCT00974974|101628213|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
33473982|NCT00974974|101628212|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
33473983|NCT00974974|101628213|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
33473984|NCT00974974|101628212|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
33473985|NCT00974974|101628213|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
33473986|NCT00974974|101628212|FG000|Maintenance - Double Blind Treatment|Various|4|||
33473987|NCT00974974|101628213|FG001|Maintenance - Double Blind Treatment|Various|0|||
33473988|NCT00773734|101628223|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
33473989|NCT00773734|101628224|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
33473990|NCT00773734|101628225|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
33473991|NCT00773734|101628226|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
33473992|NCT00773734|101628227|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
33473993|NCT00773734|101628228|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
33473994|NCT00773734|101628223|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
33473995|NCT00773734|101628224|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
33473996|NCT00773734|101628225|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
33473997|NCT00773734|101628226|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
33473998|NCT00773734|101628227|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
33473999|NCT00773734|101628228|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
33474000|NCT00773734|101628223|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
33474001|NCT00773734|101628224|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
33474002|NCT00773734|101628225|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
33474003|NCT00773734|101628226|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
33474004|NCT00773734|101628227|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
33474005|NCT00773734|101628228|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
33474006|NCT00773734|101628223|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
33474007|NCT00773734|101628224|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
33474008|NCT00773734|101628225|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
33474009|NCT00773734|101628226|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
33474010|NCT00773734|101628227|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
33182775|NCT03745937|100578691|FG000|Overall Study|Not-specifed|0|||
33182776|NCT03745937|100578692|FG001|Overall Study|Not-specifed|1|||
33182777|NCT03745937|100578693|FG002|Overall Study|Not-specifed|0|||
33182778|NCT03745937|100578694|FG003|Overall Study|Not-specifed|1|||
33182779|NCT01852812|100578695|FG000|Overall Study|Adverse Event|0|||
33182780|NCT01852812|100578696|FG001|Overall Study|Adverse Event|0|||
33182781|NCT01852812|100578697|FG002|Overall Study|Adverse Event|1|||
33182782|NCT01852812|100578695|FG000|Overall Study|Non-compliance With Study Drug|0|||
33182783|NCT01852812|100578696|FG001|Overall Study|Non-compliance With Study Drug|1|||
33182784|NCT01852812|100578697|FG002|Overall Study|Non-compliance With Study Drug|0|||
33182785|NCT00729183|100578698|FG000|Overall Study|Adverse Event|11|||
33182786|NCT00729183|100578699|FG001|Overall Study|Adverse Event|5|||
33182787|NCT00729183|100578698|FG000|Overall Study|Lack of Efficacy|0|||
33182788|NCT00729183|100578699|FG001|Overall Study|Lack of Efficacy|1|||
33182789|NCT00729183|100578698|FG000|Overall Study|Lost to Follow-up|3|||
33182790|NCT00729183|100578699|FG001|Overall Study|Lost to Follow-up|1|||
33182791|NCT00729183|100578698|FG000|Overall Study|Physician Decision|1|||
33182792|NCT00729183|100578699|FG001|Overall Study|Physician Decision|1|||
33182793|NCT00729183|100578698|FG000|Overall Study|Protocol Violation|1|||
33182794|NCT00729183|100578699|FG001|Overall Study|Protocol Violation|0|||
33182795|NCT00729183|100578698|FG000|Overall Study|Withdrawal by Subject|9|||
33266450|NCT02807857|100873921|FG000|Follow-Up Set|Withdrawal by Subject|8|||
33182796|NCT00729183|100578699|FG001|Overall Study|Withdrawal by Subject|7|||
33182797|NCT03642717|100578700|FG000|Overall Study|Lost to Follow-up|2|||
33266451|NCT02807857|100873921|FG000|Follow-Up Set|Lost to Follow-up|7|||
33474011|NCT00773734|101628228|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
33474012|NCT00773734|101628223|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
33182798|NCT03642717|100578700|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
33182799|NCT03642717|100578700|FG000|Overall Study|Taken study drug prior to contract date|3|||
33182800|NCT01342510|100578701|FG000|Overall Study|Protocol Violation|12|||
33182801|NCT01342510|100578702|FG001|Overall Study|Protocol Violation|6|||
33182802|NCT01342510|100578703|FG002|Overall Study|Protocol Violation|13|||
33182803|NCT01342510|100578704|FG003|Overall Study|Protocol Violation|11|||
33182804|NCT02291055|100578705|FG000|Overall Study|Death|2|||
33182805|NCT02291055|100578706|FG001|Overall Study|Death|2|||
33182806|NCT02291055|100578707|FG002|Overall Study|Death|5|||
33182807|NCT02291055|100578708|FG003|Overall Study|Death|8|||
33182808|NCT02291055|100578709|FG004|Overall Study|Death|12|||
33182809|NCT02291055|100578705|FG000|Overall Study|Lost to Follow-up|0|||
33182810|NCT02291055|100578706|FG001|Overall Study|Lost to Follow-up|0|||
33182811|NCT02291055|100578707|FG002|Overall Study|Lost to Follow-up|0|||
33182812|NCT02291055|100578708|FG003|Overall Study|Lost to Follow-up|1|||
33182813|NCT02291055|100578709|FG004|Overall Study|Lost to Follow-up|2|||
33182814|NCT02291055|100578705|FG000|Overall Study|Withdrawal by Subject|3|||
33182815|NCT02291055|100578706|FG001|Overall Study|Withdrawal by Subject|1|||
33182816|NCT02291055|100578707|FG002|Overall Study|Withdrawal by Subject|1|||
33182817|NCT02291055|100578708|FG003|Overall Study|Withdrawal by Subject|5|||
33182818|NCT02291055|100578709|FG004|Overall Study|Withdrawal by Subject|10|||
33182819|NCT02291055|100578705|FG000|Overall Study|Progressive Disease|0|||
33182820|NCT02291055|100578706|FG001|Overall Study|Progressive Disease|0|||
33182821|NCT02291055|100578707|FG002|Overall Study|Progressive Disease|1|||
33182822|NCT02291055|100578708|FG003|Overall Study|Progressive Disease|4|||
33182823|NCT02291055|100578709|FG004|Overall Study|Progressive Disease|2|||
33182824|NCT02291055|100578705|FG000|Overall Study|Study Terminated by Sponsor|0|||
33182825|NCT02291055|100578706|FG001|Overall Study|Study Terminated by Sponsor|0|||
33182826|NCT02291055|100578707|FG002|Overall Study|Study Terminated by Sponsor|0|||
33182827|NCT02291055|100578708|FG003|Overall Study|Study Terminated by Sponsor|5|||
33182828|NCT02291055|100578709|FG004|Overall Study|Study Terminated by Sponsor|1|||
33182829|NCT02291055|100578705|FG000|Overall Study|Other|0|||
33182830|NCT02291055|100578706|FG001|Overall Study|Other|2|||
33182831|NCT02291055|100578707|FG002|Overall Study|Other|1|||
33182832|NCT02291055|100578708|FG003|Overall Study|Other|4|||
33182833|NCT02291055|100578709|FG004|Overall Study|Other|0|||
33474013|NCT00773734|101628224|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
33474014|NCT00773734|101628225|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
33474015|NCT00773734|101628226|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
33474016|NCT00773734|101628227|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
33182834|NCT01150123|100578710|FG000|Overall Study|Withdrawal by Subject|1|||
33182835|NCT01150123|100578711|FG001|Overall Study|Withdrawal by Subject|1|||
33182836|NCT01150123|100578712|FG002|Overall Study|Withdrawal by Subject|2|||
33182837|NCT01150123|100578713|FG003|Overall Study|Withdrawal by Subject|1|||
33182838|NCT01150123|100578714|FG004|Overall Study|Withdrawal by Subject|1|||
33182839|NCT01150123|100578715|FG005|Overall Study|Withdrawal by Subject|1|||
33266452|NCT02807857|100873921|FG000|Follow-Up Set|Physician Decision|6|||
33474017|NCT00773734|101628228|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
33474018|NCT00773734|101628223|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
33474019|NCT00773734|101628224|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
33474020|NCT00773734|101628225|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
33474021|NCT00773734|101628226|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
33474022|NCT00773734|101628227|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
33474023|NCT00773734|101628228|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
33474024|NCT00773734|101628223|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
33474025|NCT00773734|101628224|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
33474026|NCT00773734|101628225|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
33474027|NCT00773734|101628226|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
33266453|NCT02807857|100873921|FG000|Follow-Up Set|Adverse Event|3|||
33474028|NCT00773734|101628227|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
33474029|NCT00773734|101628228|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
33474030|NCT00773734|101628223|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
33182840|NCT01150123|100578716|FG006|Overall Study|Withdrawal by Subject|0|||
33182841|NCT01150123|100578717|FG007|Overall Study|Withdrawal by Subject|3|||
33182842|NCT01150123|100578718|FG008|Overall Study|Withdrawal by Subject|2|||
33182843|NCT01150123|100578719|FG009|Overall Study|Withdrawal by Subject|0|||
33182844|NCT01150123|100578720|FG010|Overall Study|Withdrawal by Subject|1|||
33182845|NCT01150123|100578721|FG011|Overall Study|Withdrawal by Subject|0|||
33182846|NCT01150123|100578722|FG012|Overall Study|Withdrawal by Subject|1|||
33182847|NCT01150123|100578723|FG013|Overall Study|Withdrawal by Subject|0|||
33182848|NCT01150123|100578724|FG014|Overall Study|Withdrawal by Subject|0|||
33266454|NCT02807857|100873921|FG000|Follow-Up Set|Death|27|||
33474031|NCT00773734|101628224|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
33474032|NCT00773734|101628225|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
33474033|NCT00773734|101628226|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
33474034|NCT00773734|101628227|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
33474035|NCT00773734|101628228|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
33474036|NCT00773734|101628223|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
33474037|NCT00773734|101628224|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
33474038|NCT00773734|101628225|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
33474039|NCT00773734|101628226|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
33474040|NCT00773734|101628227|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
33474041|NCT00773734|101628228|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
33474042|NCT00773734|101628223|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
33474043|NCT00773734|101628224|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
33474044|NCT00773734|101628225|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
33474045|NCT00773734|101628226|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
33474046|NCT00773734|101628227|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
33474047|NCT00773734|101628228|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
33474048|NCT00773734|101628223|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
33474049|NCT00773734|101628224|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
33474050|NCT00773734|101628225|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
33474051|NCT00773734|101628226|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
33474052|NCT00773734|101628227|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
33474053|NCT00773734|101628228|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
33474054|NCT00773734|101628223|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
33474055|NCT00773734|101628224|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
33474056|NCT00773734|101628225|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
33182849|NCT01150123|100578725|FG015|Overall Study|Withdrawal by Subject|1|||
33182850|NCT01150123|100578726|FG016|Overall Study|Withdrawal by Subject|0|||
33182851|NCT01150123|100578727|FG017|Overall Study|Withdrawal by Subject|1|||
33182852|NCT01150123|100578710|FG000|Overall Study|Lost to Follow-up|2|||
33182853|NCT01150123|100578711|FG001|Overall Study|Lost to Follow-up|1|||
33182854|NCT01150123|100578712|FG002|Overall Study|Lost to Follow-up|2|||
33182855|NCT01150123|100578713|FG003|Overall Study|Lost to Follow-up|2|||
33182856|NCT01150123|100578714|FG004|Overall Study|Lost to Follow-up|2|||
33182857|NCT01150123|100578715|FG005|Overall Study|Lost to Follow-up|5|||
33182858|NCT01150123|100578716|FG006|Overall Study|Lost to Follow-up|0|||
33182859|NCT01150123|100578717|FG007|Overall Study|Lost to Follow-up|0|||
33182860|NCT01150123|100578718|FG008|Overall Study|Lost to Follow-up|3|||
33182861|NCT01150123|100578719|FG009|Overall Study|Lost to Follow-up|1|||
33182862|NCT01150123|100578720|FG010|Overall Study|Lost to Follow-up|1|||
33182863|NCT01150123|100578721|FG011|Overall Study|Lost to Follow-up|1|||
33182864|NCT01150123|100578722|FG012|Overall Study|Lost to Follow-up|2|||
33474057|NCT00773734|101628226|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
33474058|NCT00773734|101628227|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
33474059|NCT00773734|101628228|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
33474060|NCT00773734|101628223|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
33182865|NCT01150123|100578723|FG013|Overall Study|Lost to Follow-up|0|||
33182866|NCT01150123|100578724|FG014|Overall Study|Lost to Follow-up|0|||
33182867|NCT01150123|100578725|FG015|Overall Study|Lost to Follow-up|0|||
33474061|NCT00773734|101628224|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
33182868|NCT01150123|100578726|FG016|Overall Study|Lost to Follow-up|0|||
33474062|NCT00773734|101628225|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
33474063|NCT00773734|101628226|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
33474064|NCT00773734|101628227|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
33474065|NCT00773734|101628228|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
33474066|NCT00773734|101628223|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
33474067|NCT00773734|101628224|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
33474068|NCT00773734|101628225|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
33474069|NCT00773734|101628226|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
33474070|NCT00773734|101628227|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
33474071|NCT00773734|101628228|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
33474072|NCT00773734|101628223|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
33474073|NCT00773734|101628224|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
33474074|NCT00773734|101628225|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
33266455|NCT02807857|100873921|FG000|Follow-Up Set|Relocation|2|||
33182869|NCT01150123|100578727|FG017|Overall Study|Lost to Follow-up|0|||
33182870|NCT01816893|100578728|FG000|Washout Period|Withdrawal by Subject|2|||
33182871|NCT01816893|100578729|FG001|Washout Period|Withdrawal by Subject|0|||
33182872|NCT01586819|100578746|FG000|Overall Study|Withdrawal by Subject|1|||
33474075|NCT00773734|101628226|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
33474076|NCT00773734|101628227|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
33474077|NCT00773734|101628228|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
33474078|NCT00773734|101628223|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
33474079|NCT00773734|101628224|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
33474080|NCT00773734|101628225|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
33474081|NCT00773734|101628226|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
33474082|NCT00773734|101628227|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
33474083|NCT00773734|101628228|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
33474084|NCT00773734|101628223|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
33474085|NCT00773734|101628224|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
33474086|NCT00773734|101628225|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
33474087|NCT00773734|101628226|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
33474088|NCT00773734|101628227|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
33474089|NCT00773734|101628228|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
33474090|NCT00773734|101628223|FG000|Extension: Active Treatment Week 24-52|Other|0|||
33474091|NCT00773734|101628224|FG001|Extension: Active Treatment Week 24-52|Other|0|||
33474092|NCT00773734|101628225|FG002|Extension: Active Treatment Week 24-52|Other|1|||
33474093|NCT00773734|101628226|FG003|Extension: Active Treatment Week 24-52|Other|2|||
33474094|NCT00773734|101628227|FG004|Extension: Active Treatment Week 24-52|Other|0|||
33474095|NCT00773734|101628228|FG005|Extension: Active Treatment Week 24-52|Other|1|||
33474096|NCT00773734|101628223|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
33474097|NCT00773734|101628224|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
33474098|NCT00773734|101628225|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
33474099|NCT00773734|101628226|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
33474100|NCT00773734|101628227|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
33474101|NCT00773734|101628228|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
33474102|NCT00773734|101628223|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
33474103|NCT00773734|101628224|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
33474104|NCT00773734|101628225|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
33474105|NCT00773734|101628226|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
33474106|NCT00773734|101628227|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
33474107|NCT00773734|101628228|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
33474108|NCT00773734|101628223|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
33474109|NCT00773734|101628224|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
33474110|NCT00773734|101628225|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
33474111|NCT00773734|101628226|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
33474112|NCT00773734|101628227|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
33474113|NCT00773734|101628228|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
33474114|NCT00773734|101628223|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
33474115|NCT00773734|101628224|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
33474116|NCT00773734|101628225|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
33474117|NCT00773734|101628226|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
33474118|NCT00773734|101628227|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
33474119|NCT00773734|101628228|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
33474120|NCT02448706|101628229|FG000|Overall Study|Withdrawal by Subject|4|||
33474121|NCT02448706|101628230|FG001|Overall Study|Withdrawal by Subject|3|||
33474122|NCT02448706|101628229|FG000|Overall Study|Protocol Violation|1|||
33474123|NCT02448706|101628230|FG001|Overall Study|Protocol Violation|1|||
33474124|NCT01059539|101628231|FG000|Overall Study|Adverse Event|66|||
33474125|NCT01059539|101628231|FG000|Overall Study|Insufficient Therapeutic Response|26|||
33474126|NCT01059539|101628231|FG000|Overall Study|Protocol Violation|55|||
33474127|NCT01059539|101628231|FG000|Overall Study|Withdrawal of Consent|80|||
33474128|NCT01059539|101628231|FG000|Overall Study|Lost to Follow-up|42|||
33474129|NCT01059539|101628231|FG000|Overall Study|Reason Not Specified|2|||
33474130|NCT02856880|101628232|FG000|Overall Study|Withdrawal of consent|1|||
33474131|NCT04188301|101628240|FG000|Month 3|Lost to Follow-up|0|||
33474132|NCT04188301|101628241|FG001|Month 3|Lost to Follow-up|0|||
33474133|NCT04188301|101628242|FG002|Month 3|Lost to Follow-up|1|||
33474134|NCT04188301|101628240|FG000|Month 12|Lost to Follow-up|0|||
33474135|NCT04188301|101628241|FG001|Month 12|Lost to Follow-up|0|||
33266456|NCT01833455|100873922|FG000|Overall Study|Withdrawal by Subject|1|||
33266457|NCT01833455|100873923|FG001|Overall Study|Withdrawal by Subject|0|||
33266458|NCT02241785|100873924|FG000|Overall Study|Sponsor Termination|43|||
33474136|NCT04188301|101628242|FG002|Month 12|Lost to Follow-up|2|||
33474137|NCT04188301|101628240|FG000|Month 12|Death|1|||
33474138|NCT04188301|101628241|FG001|Month 12|Death|1|||
33266459|NCT02241785|100873924|FG000|Overall Study|Withdrawal by Subject|1|||
33266460|NCT02241785|100873924|FG000|Overall Study|Lost to Follow-up|2|||
33266461|NCT02241785|100873924|FG000|Overall Study|Adverse Event|1|||
33266462|NCT01613417|100873925|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
33474139|NCT04188301|101628242|FG002|Month 12|Death|0|||
33474140|NCT04188301|101628240|FG000|Month 18|Lost to Follow-up|6|||
33474141|NCT04188301|101628241|FG001|Month 18|Lost to Follow-up|0|||
33474142|NCT04188301|101628242|FG002|Month 18|Lost to Follow-up|0|||
33474143|NCT05065983|101628243|FG000|Overall Study|Lost to Follow-up|2|||
33474144|NCT03365011|101628244|FG000|Overall Study|Withdrawal by Subject|1|||
33474145|NCT03365011|101628245|FG001|Overall Study|Withdrawal by Subject|2|||
33474146|NCT04132336|101628246|FG000|Overall Study|Investigator Decision|0|||
33474147|NCT04132336|101628247|FG001|Overall Study|Investigator Decision|1|||
33474148|NCT04132336|101628248|FG002|Overall Study|Investigator Decision|0|||
33474149|NCT04132336|101628249|FG003|Overall Study|Investigator Decision|0|||
33474150|NCT04132336|101628250|FG004|Overall Study|Investigator Decision|0|||
33474151|NCT04132336|101628251|FG005|Overall Study|Investigator Decision|0|||
33474152|NCT04132336|101628252|FG006|Overall Study|Investigator Decision|0|||
33474153|NCT00986180|101628253|FG000|Overall Study|Adverse Event|21|||
33474154|NCT00986180|101628254|FG001|Overall Study|Adverse Event|23|||
33474155|NCT00986180|101628253|FG000|Overall Study|Lack of Efficacy|4|||
33474156|NCT00986180|101628254|FG001|Overall Study|Lack of Efficacy|3|||
33474157|NCT00986180|101628253|FG000|Overall Study|Lost to Follow-up|5|||
33474158|NCT00986180|101628254|FG001|Overall Study|Lost to Follow-up|7|||
33474159|NCT00986180|101628253|FG000|Overall Study|Physician Decision|1|||
33474160|NCT00986180|101628254|FG001|Overall Study|Physician Decision|3|||
33474161|NCT00986180|101628253|FG000|Overall Study|Protocol Violation|2|||
33474162|NCT00986180|101628254|FG001|Overall Study|Protocol Violation|0|||
33474163|NCT00986180|101628253|FG000|Overall Study|Withdrawal by Subject|1|||
33474164|NCT00986180|101628254|FG001|Overall Study|Withdrawal by Subject|9|||
33474165|NCT00986180|101628253|FG000|Overall Study|Miscellanies|10|||
33474166|NCT00986180|101628254|FG001|Overall Study|Miscellanies|11|||
33474167|NCT00573157|101628255|FG000|Overall Study|Adverse Event|3|||
33474168|NCT00573157|101628256|FG001|Overall Study|Adverse Event|1|||
33474169|NCT00573157|101628255|FG000|Overall Study|Other|1|||
33474170|NCT00573157|101628256|FG001|Overall Study|Other|1|||
33474171|NCT00270257|101628257|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
33474172|NCT00270257|101628258|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
33474173|NCT01394952|101628269|FG000|Overall Study|Lost to Follow-up|0|||
33474174|NCT01394952|101628270|FG001|Overall Study|Lost to Follow-up|5|||
33474175|NCT01394952|101628269|FG000|Overall Study|Withdrawal by Subject|10|||
33182873|NCT01586819|100578747|FG001|Overall Study|Withdrawal by Subject|0|||
33474176|NCT01394952|101628270|FG001|Overall Study|Withdrawal by Subject|5|||
33474177|NCT01394952|101628269|FG000|Overall Study|Physician Decision|2|||
33474178|NCT01394952|101628270|FG001|Overall Study|Physician Decision|0|||
33474179|NCT01394952|101628269|FG000|Overall Study|Sponsor Decision|5|||
33474180|NCT01394952|101628270|FG001|Overall Study|Sponsor Decision|7|||
33474181|NCT01570283|101628283|FG000|Cohort 1: Dose Level 1|Death|0|||
33474182|NCT01570283|101628284|FG001|Cohort 1: Dose Level 1|Death|1|||
33474183|NCT01570283|101628285|FG002|Cohort 1: Dose Level 1|Death|0|||
33182874|NCT00735878|100578748|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
33182875|NCT00735878|100578749|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
33182876|NCT00735878|100578750|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
33182877|NCT03329690|100578751|FG000|Overall Study|Progressive disease per RECIST|85|||
33182878|NCT03329690|100578752|FG001|Overall Study|Progressive disease per RECIST|44|||
33182879|NCT03329690|100578753|FG002|Overall Study|Progressive disease per RECIST|6|||
33182880|NCT03329690|100578754|FG003|Overall Study|Progressive disease per RECIST|16|||
33182881|NCT03329690|100578755|FG004|Overall Study|Progressive disease per RECIST|20|||
33182882|NCT03329690|100578751|FG000|Overall Study|Clinical progression|7|||
33182883|NCT03329690|100578752|FG001|Overall Study|Clinical progression|4|||
33182884|NCT03329690|100578753|FG002|Overall Study|Clinical progression|1|||
33182885|NCT03329690|100578754|FG003|Overall Study|Clinical progression|1|||
33182886|NCT03329690|100578755|FG004|Overall Study|Clinical progression|1|||
33182887|NCT03329690|100578751|FG000|Overall Study|Adverse Event|22|||
33182888|NCT03329690|100578752|FG001|Overall Study|Adverse Event|4|||
33182889|NCT03329690|100578753|FG002|Overall Study|Adverse Event|0|||
33182890|NCT03329690|100578754|FG003|Overall Study|Adverse Event|1|||
33182891|NCT03329690|100578755|FG004|Overall Study|Adverse Event|2|||
33182892|NCT03329690|100578751|FG000|Overall Study|Death|2|||
33266463|NCT01613417|100873926|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
33474184|NCT01570283|101628286|FG003|Cohort 1: Dose Level 1|Death|0|||
33474185|NCT01570283|101628287|FG004|Cohort 1: Dose Level 1|Death|0|||
33474186|NCT01570283|101628288|FG005|Cohort 1: Dose Level 1|Death|0|||
33474187|NCT01570283|101628283|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
33182893|NCT03329690|100578752|FG001|Overall Study|Death|0|||
33182894|NCT03329690|100578753|FG002|Overall Study|Death|0|||
33266464|NCT04433091|100873943|FG000|Overall Study|Lost to Follow-up|1|||
33474188|NCT01570283|101628284|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
33474189|NCT01570283|101628285|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
33182895|NCT03329690|100578754|FG003|Overall Study|Death|1|||
33182896|NCT03329690|100578755|FG004|Overall Study|Death|0|||
33474190|NCT01570283|101628286|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
33474191|NCT01570283|101628287|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
33474192|NCT01570283|101628288|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
33474193|NCT01570283|101628283|FG000|Cohort 2: Dose Level 2|Death|0|||
33474194|NCT01570283|101628284|FG001|Cohort 2: Dose Level 2|Death|0|||
33474195|NCT01570283|101628285|FG002|Cohort 2: Dose Level 2|Death|1|||
33474196|NCT01570283|101628286|FG003|Cohort 2: Dose Level 2|Death|0|||
33474197|NCT01570283|101628287|FG004|Cohort 2: Dose Level 2|Death|0|||
33474198|NCT01570283|101628288|FG005|Cohort 2: Dose Level 2|Death|0|||
33474199|NCT01570283|101628283|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
33474200|NCT01570283|101628284|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
33474201|NCT01570283|101628285|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
33474202|NCT01570283|101628286|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
33474203|NCT01570283|101628287|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
33474204|NCT01570283|101628288|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
33474205|NCT01570283|101628283|FG000|Cohort 3: Dose Level 3|Death|0|||
33474206|NCT01570283|101628284|FG001|Cohort 3: Dose Level 3|Death|0|||
33474207|NCT01570283|101628285|FG002|Cohort 3: Dose Level 3|Death|0|||
33474208|NCT01570283|101628286|FG003|Cohort 3: Dose Level 3|Death|0|||
33474209|NCT01570283|101628287|FG004|Cohort 3: Dose Level 3|Death|0|||
33474210|NCT01570283|101628288|FG005|Cohort 3: Dose Level 3|Death|1|||
33474211|NCT01570283|101628283|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
33474212|NCT01570283|101628284|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
33474213|NCT01570283|101628285|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
33474214|NCT01570283|101628286|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
33474215|NCT01570283|101628287|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
33474216|NCT01570283|101628288|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
33474217|NCT00584844|101628291|FG000|Overall Study|Withdrawal by Subject|59|||
33474218|NCT00584844|101628291|FG000|Overall Study|Screen Failure|20|||
33474219|NCT03456960|101628294|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
33474220|NCT03456960|101628295|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
33474221|NCT03456960|101628296|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
33474222|NCT03456960|101628297|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
33474223|NCT03456960|101628298|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
33474224|NCT03456960|101628299|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
33474225|NCT03456960|101628294|FG000|Period 2 (1 Day)|Adverse Event|1|||
33474226|NCT03456960|101628295|FG001|Period 2 (1 Day)|Adverse Event|0|||
33474227|NCT03456960|101628296|FG002|Period 2 (1 Day)|Adverse Event|0|||
33474228|NCT03456960|101628297|FG003|Period 2 (1 Day)|Adverse Event|1|||
33474229|NCT03456960|101628298|FG004|Period 2 (1 Day)|Adverse Event|0|||
33474230|NCT03456960|101628299|FG005|Period 2 (1 Day)|Adverse Event|0|||
33474231|NCT03760250|101628300|FG000|Overall Study|Withdrawal by Subject|1|||
33474232|NCT03760250|101628300|FG000|Overall Study|Physician Decision|1|||
33474233|NCT00712985|101628301|FG000|Overall Study|1 withdrew prior to start of drug|1|||
33474234|NCT00712985|101628301|FG000|Overall Study|1 patient moved out of state|1|||
33182897|NCT03329690|100578751|FG000|Overall Study|Withdrawal by Subject|2|||
33182898|NCT03329690|100578752|FG001|Overall Study|Withdrawal by Subject|3|||
33182899|NCT03329690|100578753|FG002|Overall Study|Withdrawal by Subject|0|||
33182900|NCT03329690|100578754|FG003|Overall Study|Withdrawal by Subject|1|||
33182901|NCT03329690|100578755|FG004|Overall Study|Withdrawal by Subject|0|||
33182902|NCT03329690|100578751|FG000|Overall Study|Physician Decision|1|||
33182903|NCT03329690|100578752|FG001|Overall Study|Physician Decision|0|||
33182904|NCT03329690|100578753|FG002|Overall Study|Physician Decision|0|||
33182905|NCT03329690|100578754|FG003|Overall Study|Physician Decision|0|||
33182906|NCT03329690|100578755|FG004|Overall Study|Physician Decision|1|||
33182907|NCT03329690|100578751|FG000|Overall Study|Miscellaneous|6|||
33182908|NCT03329690|100578752|FG001|Overall Study|Miscellaneous|0|||
33182909|NCT03329690|100578753|FG002|Overall Study|Miscellaneous|0|||
33182910|NCT03329690|100578754|FG003|Overall Study|Miscellaneous|0|||
33182911|NCT03329690|100578755|FG004|Overall Study|Miscellaneous|0|||
33182912|NCT03329690|100578751|FG000|Overall Study|Did not receive treatment|1|||
33182913|NCT03329690|100578752|FG001|Overall Study|Did not receive treatment|0|||
33182914|NCT03329690|100578753|FG002|Overall Study|Did not receive treatment|0|||
33182915|NCT03329690|100578754|FG003|Overall Study|Did not receive treatment|1|||
33182916|NCT03329690|100578755|FG004|Overall Study|Did not receive treatment|0|||
33182917|NCT00127712|100578757|FG000|Overall Study|Adverse Event|3|||
33182918|NCT00127712|100578758|FG001|Overall Study|Adverse Event|0|||
33182919|NCT00127712|100578757|FG000|Overall Study|Lack of GI access to continue|2|||
33182920|NCT00127712|100578758|FG001|Overall Study|Lack of GI access to continue|0|||
33182921|NCT01478321|100578761|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
33182922|NCT01478321|100578761|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
33182923|NCT01478321|100578761|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
33182924|NCT01478321|100578761|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
33182925|NCT01478321|100578761|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
33182926|NCT01478321|100578761|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
33182927|NCT01478321|100578761|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
33182928|NCT01478321|100578761|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
33182929|NCT03608774|100578762|FG000|Overall Study|Lost to Follow-up|5|||
33182930|NCT03608774|100578763|FG001|Overall Study|Lost to Follow-up|5|||
33182931|NCT03608774|100578762|FG000|Overall Study|Withdrawal by Subject|1|||
33182932|NCT03608774|100578763|FG001|Overall Study|Withdrawal by Subject|0|||
33182933|NCT03608774|100578762|FG000|Overall Study|Protocol Violation|1|||
33182934|NCT03608774|100578763|FG001|Overall Study|Protocol Violation|0|||
33182935|NCT03608774|100578762|FG000|Overall Study|Not eligible at enrollment|0|||
33182936|NCT03608774|100578763|FG001|Overall Study|Not eligible at enrollment|1|||
33182937|NCT03608774|100578762|FG000|Overall Study|Health related event|0|||
33182938|NCT03608774|100578763|FG001|Overall Study|Health related event|1|||
33182939|NCT02945410|100578767|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
33182940|NCT02945410|100578768|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
33182941|NCT02945410|100578769|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
33182942|NCT02945410|100578770|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
33182943|NCT02945410|100578771|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
33182944|NCT02945410|100578772|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
33182945|NCT02945410|100578767|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
33474235|NCT00712985|101628301|FG000|Overall Study|Lack of Efficacy|3|||
33474236|NCT00706381|101628305|FG000|Overall Study|Lost to Follow-up|0|||
33474237|NCT00706381|101628306|FG001|Overall Study|Lost to Follow-up|1|||
33474238|NCT00706381|101628307|FG002|Overall Study|Lost to Follow-up|1|||
33474239|NCT00706381|101628308|FG003|Overall Study|Lost to Follow-up|0|||
33474240|NCT02570113|101628310|FG000|Overall Study|Withdrawal by Subject|3|||
33474241|NCT02751359|101628313|FG000|Overall Study|Lost to Follow-up|1|||
33474242|NCT02229539|101628314|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
33474243|NCT02229539|101628315|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
33474244|NCT02229539|101628316|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
33474245|NCT02229539|101628314|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
33474246|NCT02229539|101628315|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
33474247|NCT02229539|101628316|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
33474248|NCT02229539|101628314|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
33474249|NCT02229539|101628315|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
33474250|NCT02229539|101628316|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
33474251|NCT02229539|101628314|FG000|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3|||
33182946|NCT02945410|100578768|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
33182947|NCT02945410|100578769|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
33182948|NCT02945410|100578770|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
33182949|NCT02945410|100578771|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
33182950|NCT02945410|100578772|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
33182951|NCT02945410|100578767|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
33182952|NCT02945410|100578768|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
33182953|NCT02945410|100578769|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
33182954|NCT02945410|100578770|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
33182955|NCT02945410|100578771|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
33182956|NCT02945410|100578772|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
33182957|NCT01806896|100578773|FG000|Overall Study|Adverse Event|2|||
33182958|NCT01806896|100578774|FG001|Overall Study|Adverse Event|0|||
33182959|NCT01806896|100578773|FG000|Overall Study|Other|1|||
33182960|NCT01806896|100578774|FG001|Overall Study|Other|0|||
33182961|NCT01528072|100578775|FG000|Overall Study|Withdrawal by Subject|5|||
33182962|NCT01528072|100578775|FG000|Overall Study|Physician Decision|1|||
33182963|NCT01528072|100578775|FG000|Overall Study|Determined not eligible by AEAC|1|||
33182964|NCT01528072|100578775|FG000|Overall Study|Missed Visit|2|||
33182965|NCT01528072|100578775|FG000|Overall Study|Lost to Follow-up|5|||
33182966|NCT01528072|100578775|FG000|Overall Study|Explanted|2|||
33182967|NCT01528072|100578775|FG000|Overall Study|Site Closure|4|||
33182968|NCT01528072|100578775|FG000|Overall Study|Death|2|||
33182969|NCT01528072|100578775|FG000|Overall Study|Early Termination of Study|52|||
33266465|NCT04433091|100873944|FG001|Overall Study|Lost to Follow-up|0|||
33266466|NCT04433091|100873943|FG000|Overall Study|Withdrawn .|2|||
33266467|NCT04433091|100873944|FG001|Overall Study|Withdrawn .|4|||
33266468|NCT01218009|100873945|FG000|Overall Study|Protocol Violation|2|||
33266469|NCT01218009|100873946|FG001|Overall Study|Protocol Violation|1|||
33266470|NCT01218009|100873945|FG000|Overall Study|Withdrawal by Subject|3|||
33474252|NCT02229539|101628315|FG001|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4|||
33474253|NCT02229539|101628316|FG002|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1|||
33474254|NCT02229539|101628314|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
33474255|NCT02229539|101628315|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
33266471|NCT01218009|100873946|FG001|Overall Study|Withdrawal by Subject|1|||
33266472|NCT01218009|100873945|FG000|Overall Study|Sponsor terminated study|161|||
33266473|NCT01218009|100873946|FG001|Overall Study|Sponsor terminated study|163|||
33474256|NCT02229539|101628316|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
33474257|NCT02229539|101628314|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
33474258|NCT02229539|101628315|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
33474259|NCT02229539|101628316|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
33474260|NCT02229539|101628314|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
33474261|NCT02229539|101628315|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
33474262|NCT02229539|101628316|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
33474263|NCT02229539|101628314|FG000|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
33474264|NCT02229539|101628315|FG001|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0|||
33474265|NCT02229539|101628316|FG002|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3|||
33474266|NCT02229539|101628314|FG000|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2|||
33474267|NCT02229539|101628315|FG001|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1|||
33474268|NCT02229539|101628316|FG002|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0|||
33474269|NCT03254602|101628317|FG000|Overall Study|Lost to Follow-up|4|||
33474270|NCT01403064|101628318|FG000|Overall Study|Death|0|||
33474271|NCT01403064|101628319|FG001|Overall Study|Death|0|||
33474272|NCT01403064|101628320|FG002|Overall Study|Death|1|||
33474273|NCT01403064|101628321|FG003|Overall Study|Death|1|||
33474274|NCT01403064|101628318|FG000|Overall Study|Withdrawal by Subject|0|||
33474275|NCT01403064|101628319|FG001|Overall Study|Withdrawal by Subject|0|||
33474276|NCT01403064|101628320|FG002|Overall Study|Withdrawal by Subject|1|||
33474277|NCT01403064|101628321|FG003|Overall Study|Withdrawal by Subject|1|||
33474278|NCT01403064|101628318|FG000|Overall Study|Other|1|||
33474279|NCT01403064|101628319|FG001|Overall Study|Other|0|||
33474280|NCT01403064|101628320|FG002|Overall Study|Other|2|||
33474281|NCT01403064|101628321|FG003|Overall Study|Other|1|||
33266474|NCT03244800|100873949|FG000|Overall Study|Adverse Event|0|||
33474282|NCT00673387|101628326|FG000|Overall Study|Withdrawal by Subject|15|||
33474283|NCT00673387|101628327|FG001|Overall Study|Withdrawal by Subject|16|||
33474284|NCT00673387|101628328|FG002|Overall Study|Withdrawal by Subject|20|||
33474285|NCT00673387|101628329|FG003|Overall Study|Withdrawal by Subject|16|||
33474286|NCT00673387|101628330|FG004|Overall Study|Withdrawal by Subject|18|||
33474287|NCT00673387|101628331|FG005|Overall Study|Withdrawal by Subject|21|||
33474288|NCT00673387|101628332|FG006|Overall Study|Withdrawal by Subject|15|||
33474289|NCT00673387|101628333|FG007|Overall Study|Withdrawal by Subject|21|||
33266475|NCT03244800|100873950|FG001|Overall Study|Adverse Event|1|||
33266476|NCT03244800|100873951|FG002|Overall Study|Adverse Event|0|||
33266477|NCT03244800|100873952|FG003|Overall Study|Adverse Event|1|||
33266478|NCT03244800|100873949|FG000|Overall Study|Withdrew treatment|0|||
33266479|NCT03244800|100873950|FG001|Overall Study|Withdrew treatment|0|||
33266480|NCT03244800|100873951|FG002|Overall Study|Withdrew treatment|0|||
33266481|NCT03244800|100873952|FG003|Overall Study|Withdrew treatment|1|||
33266482|NCT00526994|100873953|FG000|Overall Study|Lost to Follow-up|98|||
33266483|NCT00526994|100873954|FG001|Overall Study|Lost to Follow-up|108|||
33266484|NCT00526994|100873955|FG002|Overall Study|Lost to Follow-up|96|||
33266485|NCT00526994|100873953|FG000|Overall Study|Death|4|||
33266486|NCT00526994|100873954|FG001|Overall Study|Death|3|||
33266487|NCT00526994|100873955|FG002|Overall Study|Death|3|||
33266488|NCT00526994|100873953|FG000|Overall Study|Withdrawal by Subject|2|||
33266489|NCT00526994|100873954|FG001|Overall Study|Withdrawal by Subject|7|||
33266490|NCT00526994|100873955|FG002|Overall Study|Withdrawal by Subject|5|||
33266491|NCT00526994|100873953|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
33266492|NCT00526994|100873954|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
33266493|NCT00526994|100873955|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
33266494|NCT01530334|100873965|FG000|Overall Study|Adverse Event|3|||
33266495|NCT01530334|100873965|FG000|Overall Study|unknown reason|1|||
33266496|NCT01530334|100873965|FG000|Overall Study|Progressive disease|47|||
33266497|NCT02022657|100873966|FG000|Overall Study|Withdrawal by Subject|2|||
33266498|NCT02022657|100873967|FG001|Overall Study|Withdrawal by Subject|0|||
33266499|NCT02022657|100873968|FG002|Overall Study|Withdrawal by Subject|1|||
33266500|NCT02022657|100873969|FG003|Overall Study|Withdrawal by Subject|0|||
33266501|NCT02022657|100873970|FG004|Overall Study|Withdrawal by Subject|0|||
33266502|NCT02022657|100873971|FG005|Overall Study|Withdrawal by Subject|0|||
33266503|NCT02022657|100873966|FG000|Overall Study|Physician Decision|0|||
33266504|NCT02022657|100873967|FG001|Overall Study|Physician Decision|0|||
33266505|NCT02022657|100873968|FG002|Overall Study|Physician Decision|0|||
33266506|NCT02022657|100873969|FG003|Overall Study|Physician Decision|0|||
33266507|NCT02022657|100873970|FG004|Overall Study|Physician Decision|0|||
33266508|NCT02022657|100873971|FG005|Overall Study|Physician Decision|1|||
33266509|NCT00822900|100873972|FG000|Overall Study|Withdrawal by Subject|14|||
33266510|NCT00822900|100873973|FG001|Overall Study|Withdrawal by Subject|14|||
33266511|NCT00822900|100873972|FG000|Overall Study|Lost to Follow-up|9|||
33266512|NCT00822900|100873973|FG001|Overall Study|Lost to Follow-up|9|||
33266513|NCT00822900|100873972|FG000|Overall Study|Death|83|||
33266514|NCT00822900|100873973|FG001|Overall Study|Death|69|||
33266515|NCT00822900|100873972|FG000|Overall Study|Became a ward of the state|2|||
33474290|NCT00673387|101628326|FG000|Overall Study|Adverse Event|3|||
33474291|NCT00673387|101628327|FG001|Overall Study|Adverse Event|1|||
33474292|NCT00673387|101628328|FG002|Overall Study|Adverse Event|5|||
33474293|NCT00673387|101628329|FG003|Overall Study|Adverse Event|2|||
33474294|NCT00673387|101628330|FG004|Overall Study|Adverse Event|6|||
33474295|NCT00673387|101628331|FG005|Overall Study|Adverse Event|2|||
33474296|NCT00673387|101628332|FG006|Overall Study|Adverse Event|5|||
33266516|NCT00822900|100873973|FG001|Overall Study|Became a ward of the state|1|||
33266517|NCT01128595|100873977|FG000|Treatment Period 3|Withdrawal by Subject|0|||
33474297|NCT00673387|101628333|FG007|Overall Study|Adverse Event|5|||
33474298|NCT00673387|101628326|FG000|Overall Study|Physician Decision|0|||
33474299|NCT00673387|101628327|FG001|Overall Study|Physician Decision|0|||
33474300|NCT00673387|101628328|FG002|Overall Study|Physician Decision|0|||
33474301|NCT00673387|101628329|FG003|Overall Study|Physician Decision|0|||
33474302|NCT00673387|101628330|FG004|Overall Study|Physician Decision|0|||
33474303|NCT00673387|101628331|FG005|Overall Study|Physician Decision|5|||
33474304|NCT00673387|101628332|FG006|Overall Study|Physician Decision|1|||
33474305|NCT00673387|101628333|FG007|Overall Study|Physician Decision|1|||
33474306|NCT00673387|101628326|FG000|Overall Study|Protocol Violation|3|||
33474307|NCT00673387|101628327|FG001|Overall Study|Protocol Violation|0|||
33474308|NCT00673387|101628328|FG002|Overall Study|Protocol Violation|1|||
33474309|NCT00673387|101628329|FG003|Overall Study|Protocol Violation|2|||
33474310|NCT00673387|101628330|FG004|Overall Study|Protocol Violation|0|||
33474311|NCT00673387|101628331|FG005|Overall Study|Protocol Violation|1|||
33474312|NCT00673387|101628332|FG006|Overall Study|Protocol Violation|1|||
33474313|NCT00673387|101628333|FG007|Overall Study|Protocol Violation|3|||
33474314|NCT00673387|101628326|FG000|Overall Study|Lost to Follow-up|8|||
33474315|NCT00673387|101628327|FG001|Overall Study|Lost to Follow-up|6|||
33474316|NCT00673387|101628328|FG002|Overall Study|Lost to Follow-up|5|||
33474317|NCT00673387|101628329|FG003|Overall Study|Lost to Follow-up|6|||
33474318|NCT00673387|101628330|FG004|Overall Study|Lost to Follow-up|6|||
33474319|NCT00673387|101628331|FG005|Overall Study|Lost to Follow-up|5|||
33474320|NCT00673387|101628332|FG006|Overall Study|Lost to Follow-up|8|||
33474321|NCT00673387|101628333|FG007|Overall Study|Lost to Follow-up|5|||
33266518|NCT01128595|100873978|FG001|Treatment Period 3|Withdrawal by Subject|1|||
33266519|NCT01128595|100873979|FG002|Treatment Period 3|Withdrawal by Subject|0|||
33266520|NCT01128595|100873980|FG003|Treatment Period 3|Withdrawal by Subject|0|||
33266521|NCT00705406|100873981|FG000|Overall Study|Lost to Follow-up|3|||
33266522|NCT00705406|100873982|FG001|Overall Study|Lost to Follow-up|3|||
33266523|NCT00705406|100873981|FG000|Overall Study|Did not receive study drug|1|||
33266524|NCT00705406|100873982|FG001|Overall Study|Did not receive study drug|2|||
33266525|NCT00692913|100873988|FG000|Overall Study|Adverse Event|8|||
33266526|NCT00692913|100873989|FG001|Overall Study|Adverse Event|4|||
33266527|NCT00692913|100873988|FG000|Overall Study|Lost to Follow-up|3|||
33266528|NCT00692913|100873989|FG001|Overall Study|Lost to Follow-up|5|||
33266529|NCT00692913|100873988|FG000|Overall Study|Physician Decision|2|||
33266530|NCT00692913|100873989|FG001|Overall Study|Physician Decision|0|||
33266531|NCT00692913|100873988|FG000|Overall Study|Protocol Violation|1|||
33266532|NCT00692913|100873989|FG001|Overall Study|Protocol Violation|1|||
33266533|NCT00692913|100873988|FG000|Overall Study|Withdrawal by Subject|15|||
33266534|NCT00692913|100873989|FG001|Overall Study|Withdrawal by Subject|20|||
33266535|NCT01856569|100873990|FG000|Overall Study|Other|1|||
33266536|NCT01856569|100873990|FG000|Overall Study|Changed Site/Structure|1|||
33266537|NCT01856569|100873990|FG000|Overall Study|Lost to Follow-up|3|||
33266538|NCT01856569|100873990|FG000|Overall Study|Did not met inclusion criteria|8|||
33266539|NCT01683409|100873991|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
33266540|NCT01683409|100873992|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
33266541|NCT01683409|100873993|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
33266542|NCT01683409|100873994|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
33266543|NCT01683409|100873995|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
33266544|NCT01683409|100873991|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
33266545|NCT01683409|100873992|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
33474322|NCT03028740|101628334|FG000|Overall Study|Did not Receive Study Drug|4|||
33474323|NCT03028740|101628335|FG001|Overall Study|Did not Receive Study Drug|5|||
33266546|NCT01683409|100873993|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
33266547|NCT01683409|100873994|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
33474324|NCT03028740|101628334|FG000|Overall Study|Adverse Event|8|||
33474325|NCT03028740|101628335|FG001|Overall Study|Adverse Event|26|||
33474326|NCT03028740|101628334|FG000|Overall Study|Lack of Efficacy|0|||
33474327|NCT03028740|101628335|FG001|Overall Study|Lack of Efficacy|1|||
33266548|NCT01683409|100873995|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
33266549|NCT01683409|100873991|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
33266550|NCT01683409|100873992|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
33474328|NCT03028740|101628334|FG000|Overall Study|Withdrawal by Subject|48|||
33474329|NCT03028740|101628335|FG001|Overall Study|Withdrawal by Subject|101|||
33474330|NCT03028740|101628334|FG000|Overall Study|Lost to Follow-up|30|||
33474331|NCT03028740|101628335|FG001|Overall Study|Lost to Follow-up|54|||
33474332|NCT03028740|101628334|FG000|Overall Study|Physician Decision|4|||
33266551|NCT01683409|100873993|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
33266552|NCT01683409|100873994|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
33266553|NCT01683409|100873995|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
33266554|NCT01683409|100873991|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
33266555|NCT01683409|100873992|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
33266556|NCT01683409|100873993|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
33266557|NCT01683409|100873994|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
33266558|NCT01683409|100873995|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
33266559|NCT01683409|100873991|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
33266560|NCT01683409|100873992|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
33266561|NCT01683409|100873993|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
33266562|NCT01683409|100873994|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
33266563|NCT01683409|100873995|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
33266564|NCT01683409|100873991|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
33266565|NCT01683409|100873992|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
33266566|NCT01683409|100873993|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
33266567|NCT01683409|100873994|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
33266568|NCT01683409|100873995|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
33266569|NCT01683409|100873991|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
33266570|NCT01683409|100873992|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
33266571|NCT01683409|100873993|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
33266572|NCT01683409|100873994|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
33266573|NCT01683409|100873995|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
33266574|NCT01683409|100873991|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
33266575|NCT01683409|100873992|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
33266576|NCT01683409|100873993|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
33266577|NCT01683409|100873994|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
33266578|NCT01683409|100873995|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
33474333|NCT03028740|101628335|FG001|Overall Study|Physician Decision|11|||
33474334|NCT03028740|101628334|FG000|Overall Study|Protocol Violation|4|||
33474335|NCT03028740|101628335|FG001|Overall Study|Protocol Violation|8|||
33474336|NCT03028740|101628334|FG000|Overall Study|Non-compliance with Study Drug|0|||
33474337|NCT03028740|101628335|FG001|Overall Study|Non-compliance with Study Drug|2|||
33474338|NCT03028740|101628334|FG000|Overall Study|Study Terminated by Sponsor|467|||
33474339|NCT03028740|101628335|FG001|Overall Study|Study Terminated by Sponsor|917|||
33474340|NCT03028740|101628334|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
33474341|NCT03028740|101628335|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
33474342|NCT03028740|101628334|FG000|Overall Study|Reason not Specified|1|||
33474343|NCT03028740|101628335|FG001|Overall Study|Reason not Specified|5|||
33474344|NCT00857584|101628337|FG000|Overall Study|Lack of Efficacy|1|||
33474345|NCT00857584|101628338|FG001|Overall Study|Lack of Efficacy|2|||
33474346|NCT00857584|101628337|FG000|Overall Study|Adverse Event|2|||
33266579|NCT01683409|100873991|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
33266580|NCT01683409|100873992|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
33266581|NCT01683409|100873993|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
33266582|NCT01683409|100873994|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
33266583|NCT01683409|100873995|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
33266584|NCT01683409|100873991|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
33266585|NCT01683409|100873992|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
33266586|NCT01683409|100873993|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
33266587|NCT01683409|100873994|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
33266588|NCT01683409|100873995|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
33266589|NCT01683409|100873991|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
33266590|NCT01683409|100873992|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
33266591|NCT01683409|100873993|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
33266592|NCT01683409|100873994|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
33266593|NCT01683409|100873995|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
33266594|NCT02701296|100873996|FG000|Overall Study|Incomplete Data|0|||
33266595|NCT02701296|100873997|FG001|Overall Study|Incomplete Data|2|||
33266596|NCT02203032|100873998|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
33266597|NCT02203032|100873999|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
33266598|NCT02203032|100874000|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
33266599|NCT02203032|100874001|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
33266600|NCT02203032|100873998|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
33266601|NCT02203032|100873999|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
33266602|NCT02203032|100874000|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
33266603|NCT02203032|100874001|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
33266604|NCT02203032|100873998|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
33474347|NCT00857584|101628338|FG001|Overall Study|Adverse Event|2|||
33474348|NCT00857584|101628337|FG000|Overall Study|Physician Decision|1|||
33474349|NCT00857584|101628338|FG001|Overall Study|Physician Decision|1|||
33474350|NCT01169532|101628339|FG000|Overall Study|Withdrawal by Subject|1|||
33474351|NCT02963441|101628340|FG000|Overall Study|Protocol violation or withdrawn|8|||
33474352|NCT02963441|101628340|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
33474353|NCT02963441|101628340|FG000|Overall Study|IDx-DR insufficient quality|33|||
33474354|NCT02435836|101628341|FG000|Overall Study|Lost to Follow-up|21|||
33474355|NCT02435836|101628341|FG000|Overall Study|Lack of Efficacy|1|||
33474356|NCT02435836|101628341|FG000|Overall Study|Withdrawal by Subject|236|||
33474357|NCT02435836|101628341|FG000|Overall Study|Insufficient Clinical Response|26|||
33474358|NCT02435836|101628341|FG000|Overall Study|Adverse Event|44|||
33474359|NCT02435836|101628341|FG000|Overall Study|Sponsor discontinued trial|167|||
33474360|NCT02435836|101628341|FG000|Overall Study|Noncompliance|27|||
33474361|NCT02435836|101628341|FG000|Overall Study|Protocol Violation|6|||
33474362|NCT02435836|101628341|FG000|Overall Study|Met Withdrawal Criteria|7|||
33474363|NCT02435836|101628341|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
33474364|NCT02394730|101628342|FG000|Overall Study|Lost to Follow-up|1|||
33474365|NCT02394730|101628343|FG001|Overall Study|Lost to Follow-up|0|||
33474366|NCT02394730|101628342|FG000|Overall Study|Withdrawal by Subject|0|||
33474367|NCT02394730|101628343|FG001|Overall Study|Withdrawal by Subject|1|||
33474368|NCT00678041|101628346|FG000|Overall Study|Physician Decision|5|||
33474369|NCT00678041|101628347|FG001|Overall Study|Physician Decision|5|||
33474370|NCT03493386|101628351|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33474371|NCT03493386|101628352|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
33474372|NCT03493386|101628353|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33474373|NCT03493386|101628354|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
33474374|NCT01345175|101628355|FG000|Overall Study|Physician Decision|0|||
33474375|NCT01345175|101628356|FG001|Overall Study|Physician Decision|1|||
33474376|NCT01345175|101628355|FG000|Overall Study|Withdrawal by Subject|1|||
33474377|NCT01345175|101628356|FG001|Overall Study|Withdrawal by Subject|1|||
33474378|NCT01345175|101628355|FG000|Overall Study|Failed to complete BFI|3|||
33474379|NCT01345175|101628356|FG001|Overall Study|Failed to complete BFI|2|||
33474380|NCT01345175|101628355|FG000|Overall Study|Stopped taking medication|2|||
33474381|NCT01345175|101628356|FG001|Overall Study|Stopped taking medication|2|||
33474382|NCT00910091|101628360|FG000|Pre-assignment|Withdrawal by Subject|0|||
33474383|NCT00910091|101628361|FG001|Pre-assignment|Withdrawal by Subject|2|||
33474384|NCT00910091|101628360|FG000|Treatment and Survival|Withdrawal by Subject|3|||
33474385|NCT00910091|101628361|FG001|Treatment and Survival|Withdrawal by Subject|4|||
33474386|NCT00910091|101628360|FG000|Treatment and Survival|Adverse Event|1|||
33474387|NCT00910091|101628361|FG001|Treatment and Survival|Adverse Event|0|||
33474388|NCT02372071|101628362|FG000|Overall Study|Protocol Violation|18|||
33474389|NCT01321008|101628363|FG000|Overall Study|Early Study Termination|1|||
33474390|NCT02005887|101628364|FG000|Overall Study|Protocol Violation|0|||
33474391|NCT02005887|101628365|FG001|Overall Study|Protocol Violation|2|||
33474392|NCT01183221|101628367|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
33266605|NCT02203032|100873999|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
33266606|NCT02203032|100874000|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
33266607|NCT02203032|100874001|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
33266608|NCT02203032|100873998|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
33266609|NCT02203032|100873999|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
33266610|NCT02203032|100874000|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
33266611|NCT02203032|100874001|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
33266612|NCT02203032|100873998|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
33266613|NCT02203032|100873999|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
33266614|NCT02203032|100874000|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
33266615|NCT02203032|100874001|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
33266616|NCT02203032|100873998|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
33266617|NCT02203032|100873999|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
33266618|NCT02203032|100874000|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
33266619|NCT02203032|100874001|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
33266620|NCT02203032|100873998|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
33266621|NCT02203032|100873999|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
33266622|NCT02203032|100874000|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
33266623|NCT02203032|100874001|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
33266624|NCT02203032|100873998|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
33266625|NCT02203032|100873999|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
33266626|NCT02203032|100874000|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
33266627|NCT02203032|100874001|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
33474393|NCT01183221|101628368|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
33474394|NCT01661179|101628370|FG000|Overall Study|Death|1|||
33474395|NCT01661179|101628370|FG000|Overall Study|Withdrawal by Subject|1|||
33474396|NCT01661179|101628370|FG000|Overall Study|Other Eligibility criteria|4|||
33266628|NCT02203032|100873998|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
33266629|NCT02203032|100873999|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
33266630|NCT02203032|100874000|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
33266631|NCT02203032|100874001|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
33266632|NCT02203032|100873998|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
33266633|NCT02203032|100873999|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
33266634|NCT02203032|100874000|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
33266635|NCT02203032|100874001|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
33266636|NCT02203032|100873998|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
33474397|NCT00838435|101628386|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
33474398|NCT00838435|101628386|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
33474399|NCT00838435|101628386|FG000|Part 2 (7 Years)|Adverse Event|2|||
33474400|NCT00838435|101628386|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
33474401|NCT00838435|101628386|FG000|Part 2 (7 Years)|Physician Decision|1|||
33474402|NCT00838435|101628386|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
33474403|NCT00838435|101628386|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
33474404|NCT03201250|101628387|FG000|Overall Study|screen failures|3|||
33474405|NCT03201250|101628388|FG001|Overall Study|screen failures|0|||
33474406|NCT03201250|101628389|FG002|Overall Study|screen failures|0|||
33474407|NCT03347422|101628390|FG000|Part A (26 Weeks)|Adverse Event|3|||
33474408|NCT03347422|101628391|FG001|Part A (26 Weeks)|Adverse Event|0|||
33474409|NCT03347422|101628390|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
33474410|NCT03347422|101628391|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
33474411|NCT03347422|101628390|FG000|Part B (149 Weeks)|Adverse Event|0|||
33474412|NCT03347422|101628391|FG001|Part B (149 Weeks)|Adverse Event|1|||
33474413|NCT03347422|101628390|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
33474414|NCT03347422|101628391|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
33474415|NCT03347422|101628390|FG000|Part B (149 Weeks)|Other|1|||
33474416|NCT03347422|101628391|FG001|Part B (149 Weeks)|Other|0|||
33474417|NCT01111019|101628392|FG000|Overall Study|Withdrew Prematurely|2|||
33474418|NCT01111019|101628392|FG000|Overall Study|Other|1|||
33474419|NCT02722148|101628393|FG000|Overall Study|Lost to Follow-up|2|||
33474420|NCT02722148|101628393|FG000|Overall Study|Non compliant with treatment regimen|3|||
33474421|NCT00846521|101628394|FG000|Overall Study|Withdrawal by Subject|5|||
33474422|NCT00846521|101628394|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
33474423|NCT00846521|101628394|FG000|Overall Study|Protocol Violation|1|||
33474424|NCT00112866|101628395|FG000|Overall Study|Protocol Violation|1|||
33474425|NCT00112866|101628396|FG001|Overall Study|Protocol Violation|0|||
33474426|NCT00112866|101628395|FG000|Overall Study|did not start treatment post-op|1|||
33266637|NCT02203032|100873999|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
33266638|NCT02203032|100874000|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
33474427|NCT00112866|101628396|FG001|Overall Study|did not start treatment post-op|2|||
33474428|NCT04619992|101628401|FG000|Overall Study|Withdrawal by Subject|1|||
33474429|NCT04619992|101628402|FG001|Overall Study|Withdrawal by Subject|0|||
33474430|NCT01335997|101628403|FG000|Period I and II|Adverse Event|63|||
33474431|NCT01335997|101628404|FG001|Period I and II|Adverse Event|43|||
33474432|NCT01335997|101628403|FG000|Period I and II|Noncompliance with Study Drug|1|||
33474433|NCT01335997|101628404|FG001|Period I and II|Noncompliance with Study Drug|1|||
33474434|NCT01335997|101628403|FG000|Period I and II|Lost to Follow-up|3|||
33474435|NCT01335997|101628404|FG001|Period I and II|Lost to Follow-up|5|||
33474436|NCT01335997|101628403|FG000|Period I and II|Withdrawal by Subject|9|||
33474437|NCT01335997|101628404|FG001|Period I and II|Withdrawal by Subject|4|||
33474438|NCT01335997|101628403|FG000|Period I and II|Study Terminated by Sponsor|406|||
33474439|NCT01335997|101628404|FG001|Period I and II|Study Terminated by Sponsor|415|||
33474440|NCT01335997|101628403|FG000|Period I and II|Protocol Violation|9|||
33474441|NCT01335997|101628404|FG001|Period I and II|Protocol Violation|10|||
33474442|NCT01335997|101628403|FG000|Period I and II|Physician Decision|2|||
33474443|NCT01335997|101628404|FG001|Period I and II|Physician Decision|1|||
33474444|NCT01335997|101628403|FG000|Period III|Adverse Event|0|||
33474445|NCT01335997|101628404|FG001|Period III|Adverse Event|2|||
33474446|NCT01335997|101628403|FG000|Period III|Study Terminated by Sponsor|77|||
33474447|NCT01335997|101628404|FG001|Period III|Study Terminated by Sponsor|76|||
33474448|NCT01335997|101628403|FG000|Period III|Protocol Violation|0|||
33474449|NCT01335997|101628404|FG001|Period III|Protocol Violation|1|||
33474450|NCT01335997|101628403|FG000|Period III|Lost to Follow-up|1|||
33474451|NCT01335997|101628404|FG001|Period III|Lost to Follow-up|0|||
33474452|NCT02177136|101628405|FG000|DB Phase|Withdrawal by Subject|2|||
33266639|NCT02203032|100874001|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
33474453|NCT02177136|101628406|FG001|DB Phase|Withdrawal by Subject|0|||
33474454|NCT02177136|101628407|FG002|DB Phase|Withdrawal by Subject|0|||
33474455|NCT02177136|101628408|FG003|DB Phase|Withdrawal by Subject|0|||
33474456|NCT02177136|101628405|FG000|DB Phase|Discontinued Due to Pruritus|1|||
33474457|NCT02177136|101628406|FG001|DB Phase|Discontinued Due to Pruritus|3|||
33474458|NCT02177136|101628407|FG002|DB Phase|Discontinued Due to Pruritus|0|||
33474459|NCT02177136|101628408|FG003|DB Phase|Discontinued Due to Pruritus|0|||
33474460|NCT02177136|101628405|FG000|DB Phase|Adverse Event|3|||
33474461|NCT02177136|101628406|FG001|DB Phase|Adverse Event|2|||
33474462|NCT02177136|101628407|FG002|DB Phase|Adverse Event|3|||
33474463|NCT02177136|101628408|FG003|DB Phase|Adverse Event|0|||
33474464|NCT02177136|101628405|FG000|DB Phase|Protocol Violation|0|||
33474465|NCT02177136|101628406|FG001|DB Phase|Protocol Violation|0|||
33474466|NCT02177136|101628407|FG002|DB Phase|Protocol Violation|1|||
33474467|NCT02177136|101628408|FG003|DB Phase|Protocol Violation|0|||
33474468|NCT02177136|101628405|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
33474469|NCT02177136|101628406|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
33474470|NCT02177136|101628407|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
33474471|NCT02177136|101628408|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
33474472|NCT02177136|101628405|FG000|LTSE Phase|Withdrawal by Subject|0|||
33474473|NCT02177136|101628406|FG001|LTSE Phase|Withdrawal by Subject|0|||
33474474|NCT02177136|101628407|FG002|LTSE Phase|Withdrawal by Subject|0|||
33474475|NCT02177136|101628408|FG003|LTSE Phase|Withdrawal by Subject|6|||
33474476|NCT02177136|101628405|FG000|LTSE Phase|Adverse Event|0|||
33474477|NCT02177136|101628406|FG001|LTSE Phase|Adverse Event|0|||
33474478|NCT02177136|101628407|FG002|LTSE Phase|Adverse Event|0|||
33474479|NCT02177136|101628408|FG003|LTSE Phase|Adverse Event|10|||
33474480|NCT02177136|101628405|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
33474481|NCT02177136|101628406|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
33474482|NCT02177136|101628407|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
33474483|NCT02177136|101628408|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
33474484|NCT02177136|101628405|FG000|LTSE Phase|Physician Decision|0|||
33474485|NCT02177136|101628406|FG001|LTSE Phase|Physician Decision|0|||
33474486|NCT02177136|101628407|FG002|LTSE Phase|Physician Decision|0|||
33266640|NCT02203032|100873998|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
33266641|NCT02203032|100873999|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
33266642|NCT02203032|100874000|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
33266643|NCT02203032|100874001|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
33266644|NCT03577106|100874004|FG000|Overall Study|Withdrawal by Subject|3|||
33266645|NCT01673594|100874009|FG000|Overall Study|Adverse Event|3|||
33266646|NCT01673594|100874010|FG001|Overall Study|Adverse Event|1|||
33266647|NCT01673594|100874009|FG000|Overall Study|Lost to Follow-up|1|||
33266648|NCT01673594|100874010|FG001|Overall Study|Lost to Follow-up|0|||
33266649|NCT01673594|100874009|FG000|Overall Study|Physician Decision|2|||
33266650|NCT01673594|100874010|FG001|Overall Study|Physician Decision|4|||
33266651|NCT01673594|100874009|FG000|Overall Study|Withdrawal by Subject|0|||
33266652|NCT01673594|100874010|FG001|Overall Study|Withdrawal by Subject|1|||
33266653|NCT00065182|100874011|FG000|Overall Study|Adverse Event|24|||
33266654|NCT00065182|100874012|FG001|Overall Study|Adverse Event|17|||
33266655|NCT00065182|100874011|FG000|Overall Study|Lost to Follow-up|0|||
33266656|NCT00065182|100874012|FG001|Overall Study|Lost to Follow-up|4|||
33266657|NCT00065182|100874011|FG000|Overall Study|Protocol Violation|3|||
33266658|NCT00065182|100874012|FG001|Overall Study|Protocol Violation|4|||
33266659|NCT00065182|100874011|FG000|Overall Study|Serious adverse events (SAE)|1|||
33266660|NCT00065182|100874012|FG001|Overall Study|Serious adverse events (SAE)|0|||
33266661|NCT00065182|100874011|FG000|Overall Study|Sponsor Decision|11|||
33266662|NCT00065182|100874012|FG001|Overall Study|Sponsor Decision|7|||
33266663|NCT00065182|100874011|FG000|Overall Study|Withdrawal by Subject|8|||
33266664|NCT00065182|100874012|FG001|Overall Study|Withdrawal by Subject|3|||
33266665|NCT00065182|100874011|FG000|Overall Study|No clinical benefit|1|||
33266666|NCT00065182|100874012|FG001|Overall Study|No clinical benefit|0|||
33266667|NCT00065182|100874011|FG000|Overall Study|Death|0|||
33266668|NCT00065182|100874012|FG001|Overall Study|Death|1|||
33266669|NCT00065182|100874011|FG000|Overall Study|Decline in Status|0|||
33266670|NCT00065182|100874012|FG001|Overall Study|Decline in Status|1|||
33266671|NCT01353274|100874013|FG000|Overall Study|No case report form (CRF) collected|28|||
33266672|NCT01822756|100877762|FG000|Overall Study|Adverse Event|0|||
33266673|NCT01822756|100877763|FG001|Overall Study|Adverse Event|0|||
33266674|NCT01822756|100877764|FG002|Overall Study|Adverse Event|0|||
33266675|NCT01822756|100877765|FG003|Overall Study|Adverse Event|2|||
33266676|NCT01822756|100877766|FG004|Overall Study|Adverse Event|0|||
33266677|NCT01822756|100877762|FG000|Overall Study|Disease progression|11|||
33266678|NCT01822756|100877763|FG001|Overall Study|Disease progression|1|||
33266679|NCT01822756|100877764|FG002|Overall Study|Disease progression|7|||
33266680|NCT01822756|100877765|FG003|Overall Study|Disease progression|2|||
33266681|NCT01822756|100877766|FG004|Overall Study|Disease progression|6|||
33266682|NCT01822756|100877762|FG000|Overall Study|Death|2|||
33266683|NCT01822756|100877763|FG001|Overall Study|Death|2|||
33266684|NCT01822756|100877764|FG002|Overall Study|Death|1|||
33266685|NCT01822756|100877765|FG003|Overall Study|Death|0|||
33266686|NCT01822756|100877766|FG004|Overall Study|Death|0|||
33474487|NCT02177136|101628408|FG003|LTSE Phase|Physician Decision|2|||
33474488|NCT02177136|101628405|FG000|LTSE Phase|Lost to Follow-up|0|||
33474489|NCT02177136|101628406|FG001|LTSE Phase|Lost to Follow-up|0|||
33474490|NCT02177136|101628407|FG002|LTSE Phase|Lost to Follow-up|0|||
33474491|NCT02177136|101628408|FG003|LTSE Phase|Lost to Follow-up|1|||
33474492|NCT02177136|101628405|FG000|LTSE Phase|Participant Moved|0|||
33474493|NCT02177136|101628406|FG001|LTSE Phase|Participant Moved|0|||
33474494|NCT02177136|101628407|FG002|LTSE Phase|Participant Moved|0|||
33474495|NCT02177136|101628408|FG003|LTSE Phase|Participant Moved|1|||
33474496|NCT03914950|101628409|FG000|Overall Study|Physician Decision|54|||
33474497|NCT00541970|101628418|FG000|Month 7|Protocol Violation|9|||
33474498|NCT00541970|101628419|FG001|Month 7|Protocol Violation|13|||
33474499|NCT00541970|101628420|FG002|Month 7|Protocol Violation|11|||
33474500|NCT00541970|101628421|FG003|Month 7|Protocol Violation|5|||
33474501|NCT00541970|101628418|FG000|Month 12|Adverse Event|0|||
33474502|NCT00541970|101628419|FG001|Month 12|Adverse Event|1|||
33474503|NCT00541970|101628420|FG002|Month 12|Adverse Event|1|||
33474504|NCT00541970|101628421|FG003|Month 12|Adverse Event|1|||
33474505|NCT00541970|101628418|FG000|Month 12|Protocol Violation|12|||
33474506|NCT00541970|101628419|FG001|Month 12|Protocol Violation|21|||
33474507|NCT00541970|101628420|FG002|Month 12|Protocol Violation|20|||
33474508|NCT00541970|101628421|FG003|Month 12|Protocol Violation|15|||
33474509|NCT00541970|101628418|FG000|Month 18|Adverse Event|0|||
33474510|NCT00541970|101628419|FG001|Month 18|Adverse Event|1|||
33474511|NCT00541970|101628420|FG002|Month 18|Adverse Event|1|||
33474512|NCT00541970|101628421|FG003|Month 18|Adverse Event|1|||
33474513|NCT00541970|101628418|FG000|Month 18|Protocol Violation|14|||
33474514|NCT00541970|101628419|FG001|Month 18|Protocol Violation|23|||
33474515|NCT00541970|101628420|FG002|Month 18|Protocol Violation|24|||
33474516|NCT00541970|101628421|FG003|Month 18|Protocol Violation|16|||
33474517|NCT00541970|101628418|FG000|Month 24|Adverse Event|0|||
33474518|NCT00541970|101628419|FG001|Month 24|Adverse Event|1|||
33474519|NCT00541970|101628420|FG002|Month 24|Adverse Event|1|||
33474520|NCT00541970|101628421|FG003|Month 24|Adverse Event|1|||
33474521|NCT00541970|101628418|FG000|Month 24|Protocol Violation|29|||
33474522|NCT00541970|101628419|FG001|Month 24|Protocol Violation|31|||
33474523|NCT00541970|101628420|FG002|Month 24|Protocol Violation|31|||
33474524|NCT00541970|101628421|FG003|Month 24|Protocol Violation|21|||
33474525|NCT00541970|101628418|FG000|Month 36|Protocol Violation|61|||
33474526|NCT00541970|101628419|FG001|Month 36|Protocol Violation|66|||
33474527|NCT00541970|101628420|FG002|Month 36|Protocol Violation|66|||
33474528|NCT00541970|101628421|FG003|Month 36|Protocol Violation|60|||
33474529|NCT00541970|101628418|FG000|Month 48|Withdrawal by Subject|2|||
33474530|NCT00541970|101628419|FG001|Month 48|Withdrawal by Subject|4|||
33474531|NCT00541970|101628420|FG002|Month 48|Withdrawal by Subject|4|||
33474532|NCT00541970|101628421|FG003|Month 48|Withdrawal by Subject|2|||
33474533|NCT00541970|101628418|FG000|Month 48|Other|3|||
33474534|NCT00541970|101628419|FG001|Month 48|Other|1|||
33474535|NCT00541970|101628420|FG002|Month 48|Other|1|||
33474536|NCT00541970|101628421|FG003|Month 48|Other|0|||
33474537|NCT00541970|101628418|FG000|Month 48|Lost to Follow-up|66|||
33474538|NCT00541970|101628419|FG001|Month 48|Lost to Follow-up|68|||
33474539|NCT00541970|101628420|FG002|Month 48|Lost to Follow-up|68|||
33474540|NCT00541970|101628421|FG003|Month 48|Lost to Follow-up|73|||
33474541|NCT00541970|101628418|FG000|Month 60|Protocol Violation|78|||
33474542|NCT00541970|101628419|FG001|Month 60|Protocol Violation|77|||
33474543|NCT00541970|101628420|FG002|Month 60|Protocol Violation|82|||
33474544|NCT00541970|101628421|FG003|Month 60|Protocol Violation|72|||
33474545|NCT03123861|101628422|FG000|Overall Study|Protocol Violation|1|||
33474546|NCT03123861|101628423|FG001|Overall Study|Protocol Violation|1|||
33474547|NCT03123861|101628422|FG000|Overall Study|Withdrawal by Subject|2|||
33474548|NCT03123861|101628423|FG001|Overall Study|Withdrawal by Subject|2|||
33474549|NCT02906930|101628426|FG000|Overall Study|Withdrawal by Subject|0|||
33474550|NCT02906930|101628427|FG001|Overall Study|Withdrawal by Subject|5|||
33474551|NCT02906930|101628428|FG002|Overall Study|Withdrawal by Subject|5|||
33474552|NCT02906930|101628429|FG003|Overall Study|Withdrawal by Subject|4|||
33474553|NCT02906930|101628426|FG000|Overall Study|Lost to Follow-up|5|||
33474554|NCT02906930|101628427|FG001|Overall Study|Lost to Follow-up|7|||
33474555|NCT02906930|101628428|FG002|Overall Study|Lost to Follow-up|5|||
33474556|NCT02906930|101628429|FG003|Overall Study|Lost to Follow-up|2|||
33474557|NCT02906930|101628426|FG000|Overall Study|Death|0|||
33474558|NCT02906930|101628427|FG001|Overall Study|Death|0|||
33474559|NCT02906930|101628428|FG002|Overall Study|Death|1|||
33474560|NCT02906930|101628429|FG003|Overall Study|Death|0|||
33474561|NCT02906930|101628426|FG000|Overall Study|Other|1|||
33474562|NCT02906930|101628427|FG001|Overall Study|Other|2|||
33474563|NCT02906930|101628428|FG002|Overall Study|Other|1|||
33474564|NCT02906930|101628429|FG003|Overall Study|Other|2|||
33474565|NCT01155024|101628432|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
33474566|NCT01155024|101628433|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
33474567|NCT01155024|101628432|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
33474568|NCT01155024|101628433|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
33474569|NCT01155024|101628432|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
33474570|NCT01155024|101628433|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
33474571|NCT02288182|101628434|FG000|Overall Study|Adverse Event|0|||
33474572|NCT02288182|101628435|FG001|Overall Study|Adverse Event|1|||
33474573|NCT02288182|101628434|FG000|Overall Study|Lost to Follow-up|0|||
33474574|NCT02288182|101628435|FG001|Overall Study|Lost to Follow-up|1|||
33474575|NCT05256134|101628436|FG000|Overall Study|Study Terminated by Sponsor|11|||
33474576|NCT05256134|101628437|FG001|Overall Study|Study Terminated by Sponsor|10|||
33474577|NCT05256134|101628436|FG000|Overall Study|Withdrawal by Subject|1|||
33474578|NCT05256134|101628437|FG001|Overall Study|Withdrawal by Subject|3|||
33474579|NCT01705236|101628438|FG000|Overall Study|Lost to Follow-up|1|||
33474580|NCT01705236|101628438|FG000|Overall Study|Administrative problems|2|||
33474581|NCT01705236|101628438|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
33474582|NCT01705236|101628438|FG000|Overall Study|Protocol Violation|3|||
33474583|NCT01705236|101628438|FG000|Overall Study|Abnormal test procedure result(s)|4|||
33474584|NCT01705236|101628438|FG000|Overall Study|Abnormal laboratory value(s)|4|||
33474585|NCT01705236|101628438|FG000|Overall Study|Withdrawal by Subject|5|||
33474586|NCT01705236|101628438|FG000|Overall Study|Adverse Event|5|||
33474587|NCT02674061|101628439|FG000|Overall Study|Death|229|||
33474588|NCT02674061|101628440|FG001|Overall Study|Death|77|||
33474589|NCT02674061|101628439|FG000|Overall Study|Lost to Follow-up|3|||
33474590|NCT02674061|101628440|FG001|Overall Study|Lost to Follow-up|3|||
33474591|NCT02674061|101628439|FG000|Overall Study|Withdrawal by Subject|9|||
33474592|NCT02674061|101628440|FG001|Overall Study|Withdrawal by Subject|1|||
33474593|NCT02674061|101628439|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
33474594|NCT02674061|101628440|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
33474595|NCT02196701|101628442|FG000|Overall Study|Adverse Event|1|||
33474596|NCT02196701|101628442|FG000|Overall Study|Lost to Follow-up|1|||
33474597|NCT02196701|101628442|FG000|Overall Study|Non-adherence to Protocol|1|||
33474598|NCT00158756|101628445|FG000|Overall Study|Withdrawal by Subject|5|||
33474599|NCT00158756|101628446|FG001|Overall Study|Withdrawal by Subject|0|||
33474600|NCT00158756|101628447|FG002|Overall Study|Withdrawal by Subject|6|||
33474601|NCT00158756|101628448|FG003|Overall Study|Withdrawal by Subject|1|||
33474602|NCT00158756|101628449|FG004|Overall Study|Withdrawal by Subject|3|||
33474603|NCT00158756|101628445|FG000|Overall Study|Adverse Event|0|||
33474604|NCT00158756|101628446|FG001|Overall Study|Adverse Event|0|||
33474605|NCT00158756|101628447|FG002|Overall Study|Adverse Event|1|||
33474606|NCT00158756|101628448|FG003|Overall Study|Adverse Event|0|||
33474607|NCT00158756|101628449|FG004|Overall Study|Adverse Event|0|||
33474608|NCT00158756|101628445|FG000|Overall Study|Serious adverse event|0|||
33474609|NCT00158756|101628446|FG001|Overall Study|Serious adverse event|0|||
33474610|NCT00158756|101628447|FG002|Overall Study|Serious adverse event|1|||
33474611|NCT00158756|101628448|FG003|Overall Study|Serious adverse event|0|||
33474612|NCT00158756|101628449|FG004|Overall Study|Serious adverse event|0|||
33474613|NCT00325195|101628451|FG000|Randomized|Not dosed|5|||
33474614|NCT00325195|101628452|FG001|Randomized|Not dosed|5|||
33474615|NCT00325195|101628453|FG002|Randomized|Not dosed|3|||
33474616|NCT00325195|101628451|FG000|Received Intervention: ITT Population|Adverse Event|15|||
33474617|NCT00325195|101628452|FG001|Received Intervention: ITT Population|Adverse Event|17|||
33474618|NCT00325195|101628453|FG002|Received Intervention: ITT Population|Adverse Event|1|||
33474619|NCT00325195|101628451|FG000|Received Intervention: ITT Population|Death|3|||
33474620|NCT00325195|101628452|FG001|Received Intervention: ITT Population|Death|1|||
33474621|NCT00325195|101628453|FG002|Received Intervention: ITT Population|Death|0|||
33474622|NCT00325195|101628451|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
33474623|NCT00325195|101628452|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
33474624|NCT00325195|101628453|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
33474625|NCT00325195|101628451|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
33474626|NCT00325195|101628452|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
33474627|NCT00325195|101628453|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
33474628|NCT00325195|101628451|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
33474629|NCT00325195|101628452|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
33474630|NCT00325195|101628453|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
33474631|NCT00891839|101628454|FG000|Overall Study|Adverse Event|2|||
33474632|NCT00891839|101628454|FG000|Overall Study|Withdrawal by Subject|2|||
33474633|NCT00891839|101628454|FG000|Overall Study|Disease progression|3|||
33474634|NCT00609466|101628456|FG000|Overall Study|Withdrawal by Subject|0|||
33474635|NCT00609466|101628457|FG001|Overall Study|Withdrawal by Subject|1|||
33474636|NCT00609466|101628458|FG002|Overall Study|Withdrawal by Subject|1|||
33474637|NCT00609466|101628456|FG000|Overall Study|Adverse Event|2|||
33474638|NCT00609466|101628457|FG001|Overall Study|Adverse Event|3|||
33474639|NCT00609466|101628458|FG002|Overall Study|Adverse Event|1|||
33474640|NCT00609466|101628456|FG000|Overall Study|Lack of Efficacy|0|||
33474641|NCT00609466|101628457|FG001|Overall Study|Lack of Efficacy|2|||
33474642|NCT00609466|101628458|FG002|Overall Study|Lack of Efficacy|2|||
33474643|NCT02558231|101628467|FG000|Overall Study|Death|4|||
33474644|NCT02558231|101628468|FG001|Overall Study|Death|12|||
33474645|NCT02558231|101628467|FG000|Overall Study|Lost to Follow-up|7|||
33474646|NCT02558231|101628468|FG001|Overall Study|Lost to Follow-up|4|||
33474647|NCT02558231|101628467|FG000|Overall Study|Withdrawal by Subject|7|||
33474648|NCT02558231|101628468|FG001|Overall Study|Withdrawal by Subject|4|||
33474649|NCT02558231|101628467|FG000|Overall Study|Physician Decision|7|||
33474650|NCT02558231|101628468|FG001|Overall Study|Physician Decision|5|||
33474651|NCT02558231|101628467|FG000|Overall Study|Sponsor Decision|0|||
33474652|NCT02558231|101628468|FG001|Overall Study|Sponsor Decision|1|||
33474653|NCT00003138|101628469|FG000|Step 1|Reasons off treatment not documented|60|||
33474654|NCT00003138|101628470|FG001|Step 1|Reasons off treatment not documented|57|||
33474655|NCT00003138|101628469|FG000|Step 1|Never started treatment|1|||
33474656|NCT00003138|101628470|FG001|Step 1|Never started treatment|0|||
33474657|NCT00003138|101628469|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
33474658|NCT00003138|101628470|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
33474659|NCT00003138|101628469|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
33474660|NCT00003138|101628470|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
33474661|NCT00003138|101628469|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
33474662|NCT00003138|101628470|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
33474663|NCT00003138|101628469|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
33474664|NCT00003138|101628470|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
33474665|NCT00390221|101628473|FG000|Overall Study|Lost to Follow-up|0|||
33474666|NCT00390221|101628474|FG001|Overall Study|Lost to Follow-up|3|||
33474667|NCT00390221|101628475|FG002|Overall Study|Lost to Follow-up|0|||
33474668|NCT00390221|101628473|FG000|Overall Study|Adverse Event|1|||
33474669|NCT00390221|101628474|FG001|Overall Study|Adverse Event|4|||
33474670|NCT00390221|101628475|FG002|Overall Study|Adverse Event|3|||
33474671|NCT00390221|101628473|FG000|Overall Study|Investigator Decision|0|||
33474672|NCT00390221|101628474|FG001|Overall Study|Investigator Decision|0|||
33474673|NCT00390221|101628475|FG002|Overall Study|Investigator Decision|1|||
33474674|NCT00390221|101628473|FG000|Overall Study|Withdrawal by Subject|13|||
33266687|NCT01822756|100877762|FG000|Overall Study|Lost to Follow-up|1|||
33266688|NCT01822756|100877763|FG001|Overall Study|Lost to Follow-up|0|||
33266689|NCT01822756|100877764|FG002|Overall Study|Lost to Follow-up|1|||
33474675|NCT00390221|101628474|FG001|Overall Study|Withdrawal by Subject|9|||
33474676|NCT00390221|101628475|FG002|Overall Study|Withdrawal by Subject|7|||
33474677|NCT00390221|101628473|FG000|Overall Study|Subject Non-compliance|1|||
33474678|NCT00390221|101628474|FG001|Overall Study|Subject Non-compliance|0|||
33474679|NCT00390221|101628475|FG002|Overall Study|Subject Non-compliance|2|||
33474680|NCT00390221|101628473|FG000|Overall Study|Other|3|||
33474681|NCT00390221|101628474|FG001|Overall Study|Other|4|||
33474682|NCT00390221|101628475|FG002|Overall Study|Other|2|||
33474683|NCT03861481|101628476|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
33474684|NCT03861481|101628477|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
33474685|NCT03861481|101628476|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
33474686|NCT03861481|101628477|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
33474687|NCT03861481|101628476|FG000|Overall Study|Relapse|1|||
33474688|NCT03861481|101628477|FG001|Overall Study|Relapse|0|||
33474689|NCT03861481|101628476|FG000|Overall Study|Withdrawal by Subject|0|||
33474690|NCT03861481|101628477|FG001|Overall Study|Withdrawal by Subject|1|||
33474691|NCT03861481|101628476|FG000|Overall Study|Lack of Efficacy|4|||
33474692|NCT03861481|101628477|FG001|Overall Study|Lack of Efficacy|5|||
33474693|NCT00415194|101628478|FG000|Overall Study|Adverse Event|37|||
33474694|NCT00415194|101628479|FG001|Overall Study|Adverse Event|32|||
33474695|NCT00415194|101628478|FG000|Overall Study|Entry Criteria Not Met|4|||
33474696|NCT00415194|101628479|FG001|Overall Study|Entry Criteria Not Met|8|||
33474697|NCT00415194|101628478|FG000|Overall Study|Lost to Follow-up|1|||
33474698|NCT00415194|101628479|FG001|Overall Study|Lost to Follow-up|0|||
33474699|NCT00415194|101628478|FG000|Overall Study|Physician Decision|10|||
33474700|NCT00415194|101628479|FG001|Overall Study|Physician Decision|16|||
33474701|NCT00415194|101628478|FG000|Overall Study|Progressive Disease|180|||
33474702|NCT00415194|101628479|FG001|Overall Study|Progressive Disease|217|||
33474703|NCT00415194|101628478|FG000|Overall Study|Protocol Violation|4|||
33474704|NCT00415194|101628479|FG001|Overall Study|Protocol Violation|2|||
33474705|NCT00415194|101628478|FG000|Overall Study|Withdrawal by Subject|28|||
33474706|NCT00415194|101628479|FG001|Overall Study|Withdrawal by Subject|21|||
33474707|NCT00415194|101628478|FG000|Overall Study|Death Due to Study Disease|26|||
33474708|NCT00415194|101628479|FG001|Overall Study|Death Due to Study Disease|29|||
33474709|NCT00415194|101628478|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
33474710|NCT00415194|101628479|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
33474711|NCT00415194|101628478|FG000|Overall Study|Death Due to Procedural Related AE|0|||
33474712|NCT00415194|101628479|FG001|Overall Study|Death Due to Procedural Related AE|1|||
33474713|NCT00415194|101628478|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
33474714|NCT00415194|101628479|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
33474715|NCT03258853|101628480|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
33474716|NCT03258853|101628481|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
33474717|NCT04853992|101628486|FG000|Treatment Period A|Adverse Event|0|||
33474718|NCT04853992|101628487|FG001|Treatment Period A|Adverse Event|1|||
33474719|NCT04853992|101628486|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
33474720|NCT04853992|101628487|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
33474721|NCT00197496|101628488|FG000|Baseline to Discharge|not interested|1|||
33474722|NCT00197496|101628489|FG001|Baseline to Discharge|not interested|0|||
33474723|NCT00197496|101628488|FG000|Baseline to Discharge|MRSA|1|||
33474724|NCT00197496|101628489|FG001|Baseline to Discharge|MRSA|0|||
33474725|NCT00197496|101628488|FG000|Baseline to Discharge|Physician Decision|0|||
33474726|NCT00197496|101628489|FG001|Baseline to Discharge|Physician Decision|1|||
33474727|NCT00197496|101628488|FG000|Baseline to Discharge|Protocol Violation|0|||
33474728|NCT00197496|101628489|FG001|Baseline to Discharge|Protocol Violation|1|||
33474729|NCT00197496|101628488|FG000|Follow-up|Lost to Follow-up|2|||
33474730|NCT00197496|101628489|FG001|Follow-up|Lost to Follow-up|1|||
33474731|NCT00123955|101628490|FG000|Overall Study|Adverse Event|1|||
33474732|NCT00123955|101628491|FG001|Overall Study|Adverse Event|0|||
33474733|NCT00123955|101628490|FG000|Overall Study|Withdrawal by Subject|4|||
33474734|NCT00123955|101628491|FG001|Overall Study|Withdrawal by Subject|3|||
33474735|NCT00123955|101628490|FG000|Overall Study|Death|0|||
33474736|NCT00123955|101628491|FG001|Overall Study|Death|1|||
33474737|NCT00418821|101628492|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
33474738|NCT02283294|101628493|FG000|Overall Study|Lost to Follow-up|1|||
33474739|NCT02283294|101628494|FG001|Overall Study|Lost to Follow-up|1|||
33474740|NCT02283294|101628493|FG000|Overall Study|Withdrawal by Subject|1|||
33474741|NCT02283294|101628494|FG001|Overall Study|Withdrawal by Subject|6|||
33474742|NCT02283294|101628493|FG000|Overall Study|Protocol Violation|1|||
33266690|NCT01822756|100877765|FG003|Overall Study|Lost to Follow-up|0|||
33266691|NCT01822756|100877766|FG004|Overall Study|Lost to Follow-up|1|||
33266692|NCT01822756|100877762|FG000|Overall Study|Physician Decision|0|||
33266693|NCT01822756|100877763|FG001|Overall Study|Physician Decision|1|||
33266694|NCT01822756|100877764|FG002|Overall Study|Physician Decision|0|||
33266695|NCT01822756|100877765|FG003|Overall Study|Physician Decision|0|||
33266696|NCT01822756|100877766|FG004|Overall Study|Physician Decision|0|||
33266697|NCT01822756|100877762|FG000|Overall Study|disease progression & patient preference|2|||
33266698|NCT01822756|100877763|FG001|Overall Study|disease progression & patient preference|0|||
33266699|NCT01822756|100877764|FG002|Overall Study|disease progression & patient preference|1|||
33266700|NCT01822756|100877765|FG003|Overall Study|disease progression & patient preference|0|||
33266701|NCT01822756|100877766|FG004|Overall Study|disease progression & patient preference|0|||
33266702|NCT00999596|100877767|FG000|Overall Study|Statistical population not required|101|||
33266703|NCT02260154|100877768|FG000|Overall Study|Screening failure|2|||
33266704|NCT03653364|100877769|FG000|Overall Study|Withdrawal by Subject|1|||
33266705|NCT03653364|100877769|FG000|Overall Study|Enrolled in Error|1|||
33266706|NCT03653364|100877769|FG000|Overall Study|Death|1|||
33266707|NCT01920932|100877771|FG000|Overall Study|Death|1|||
33266708|NCT01920932|100877771|FG000|Overall Study|Withdrawal of consent|1|||
33266709|NCT01263496|100877775|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
33266710|NCT01263496|100877776|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33266711|NCT01263496|100877777|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33266712|NCT01263496|100877778|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33266713|NCT01263496|100877779|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33266714|NCT01263496|100877780|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33266715|NCT01263496|100877781|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33266716|NCT01263496|100877782|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33266717|NCT01263496|100877783|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
33266718|NCT01263496|100877775|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33266719|NCT01263496|100877776|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33266720|NCT01263496|100877777|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33266721|NCT01263496|100877778|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
33266722|NCT01263496|100877779|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
33266723|NCT01263496|100877780|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33266724|NCT01263496|100877781|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33266725|NCT01263496|100877782|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33266726|NCT01263496|100877783|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
33266727|NCT01263496|100877775|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
33266728|NCT01263496|100877776|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
33266729|NCT01263496|100877777|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
33474743|NCT02283294|101628494|FG001|Overall Study|Protocol Violation|0|||
33266730|NCT01263496|100877778|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
33266731|NCT01263496|100877779|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
33474744|NCT02283294|101628493|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
33474745|NCT02283294|101628494|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
33474746|NCT02091141|101628495|FG000|Overall Study|Death|280|||
33266732|NCT01263496|100877780|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
33474747|NCT02091141|101628496|FG001|Overall Study|Death|118|||
33474748|NCT02091141|101628497|FG002|Overall Study|Death|46|||
33474749|NCT02091141|101628498|FG003|Overall Study|Death|13|||
33474750|NCT02091141|101628499|FG004|Overall Study|Death|31|||
33474751|NCT02091141|101628500|FG005|Overall Study|Death|16|||
33474752|NCT02091141|101628501|FG006|Overall Study|Death|12|||
33474753|NCT02091141|101628495|FG000|Overall Study|Withdrawal by Subject|21|||
33474754|NCT02091141|101628496|FG001|Overall Study|Withdrawal by Subject|13|||
33474755|NCT02091141|101628497|FG002|Overall Study|Withdrawal by Subject|3|||
33474756|NCT02091141|101628498|FG003|Overall Study|Withdrawal by Subject|2|||
33474757|NCT02091141|101628499|FG004|Overall Study|Withdrawal by Subject|2|||
33474758|NCT02091141|101628500|FG005|Overall Study|Withdrawal by Subject|3|||
33474759|NCT02091141|101628501|FG006|Overall Study|Withdrawal by Subject|0|||
33474760|NCT02091141|101628495|FG000|Overall Study|Lost to Follow-up|21|||
33474761|NCT02091141|101628496|FG001|Overall Study|Lost to Follow-up|5|||
33474762|NCT02091141|101628497|FG002|Overall Study|Lost to Follow-up|1|||
33474763|NCT02091141|101628498|FG003|Overall Study|Lost to Follow-up|0|||
33474764|NCT02091141|101628499|FG004|Overall Study|Lost to Follow-up|1|||
33474765|NCT02091141|101628500|FG005|Overall Study|Lost to Follow-up|2|||
33474766|NCT02091141|101628501|FG006|Overall Study|Lost to Follow-up|0|||
33474767|NCT02091141|101628495|FG000|Overall Study|Reason Not Specified|6|||
33474768|NCT02091141|101628496|FG001|Overall Study|Reason Not Specified|5|||
33474769|NCT02091141|101628497|FG002|Overall Study|Reason Not Specified|2|||
33474770|NCT02091141|101628498|FG003|Overall Study|Reason Not Specified|0|||
33474771|NCT02091141|101628499|FG004|Overall Study|Reason Not Specified|0|||
33474772|NCT02091141|101628500|FG005|Overall Study|Reason Not Specified|0|||
33474773|NCT02091141|101628501|FG006|Overall Study|Reason Not Specified|1|||
33474774|NCT02091141|101628495|FG000|Overall Study|Study Ended by Sponsor|1|||
33474775|NCT02091141|101628496|FG001|Overall Study|Study Ended by Sponsor|9|||
33474776|NCT02091141|101628497|FG002|Overall Study|Study Ended by Sponsor|0|||
33474777|NCT02091141|101628498|FG003|Overall Study|Study Ended by Sponsor|0|||
33474778|NCT02091141|101628499|FG004|Overall Study|Study Ended by Sponsor|0|||
33474779|NCT02091141|101628500|FG005|Overall Study|Study Ended by Sponsor|0|||
33474780|NCT02091141|101628501|FG006|Overall Study|Study Ended by Sponsor|0|||
33474781|NCT02091141|101628495|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
33474782|NCT02091141|101628496|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
33474783|NCT02091141|101628497|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
33266733|NCT01263496|100877781|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
33266734|NCT01263496|100877782|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
33474784|NCT02091141|101628498|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
33474785|NCT02091141|101628499|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
33474786|NCT02091141|101628500|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
33474787|NCT02091141|101628501|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
33474788|NCT01206816|101628502|FG000|Overall Study|Protocol Violation|0|||
33474789|NCT01206816|101628503|FG001|Overall Study|Protocol Violation|0|||
33474790|NCT01206816|101628504|FG002|Overall Study|Protocol Violation|1|||
33474791|NCT01206816|101628505|FG003|Overall Study|Protocol Violation|0|||
33474792|NCT01206816|101628506|FG004|Overall Study|Protocol Violation|0|||
33474793|NCT01206816|101628507|FG005|Overall Study|Protocol Violation|0|||
33266735|NCT01263496|100877783|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
33266736|NCT01263496|100877775|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33266737|NCT01263496|100877776|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
33266738|NCT01263496|100877777|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33266739|NCT01263496|100877778|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33266740|NCT01263496|100877779|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33266741|NCT01263496|100877780|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33266742|NCT01263496|100877781|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33266743|NCT01263496|100877782|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33266744|NCT01263496|100877783|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
33266745|NCT01263496|100877775|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33474794|NCT01206816|101628508|FG006|Overall Study|Protocol Violation|0|||
33474795|NCT01206816|101628502|FG000|Overall Study|Withdrawal by Subject|0|||
33474796|NCT01206816|101628503|FG001|Overall Study|Withdrawal by Subject|0|||
33474797|NCT01206816|101628504|FG002|Overall Study|Withdrawal by Subject|1|||
33474798|NCT01206816|101628505|FG003|Overall Study|Withdrawal by Subject|0|||
33474799|NCT01206816|101628506|FG004|Overall Study|Withdrawal by Subject|0|||
33474800|NCT01206816|101628507|FG005|Overall Study|Withdrawal by Subject|0|||
33474801|NCT01206816|101628508|FG006|Overall Study|Withdrawal by Subject|0|||
33474802|NCT01206816|101628502|FG000|Overall Study|Progressive disease|3|||
33474803|NCT01206816|101628503|FG001|Overall Study|Progressive disease|3|||
33474804|NCT01206816|101628504|FG002|Overall Study|Progressive disease|13|||
33474805|NCT01206816|101628505|FG003|Overall Study|Progressive disease|3|||
33474806|NCT01206816|101628506|FG004|Overall Study|Progressive disease|3|||
33474807|NCT01206816|101628507|FG005|Overall Study|Progressive disease|16|||
33474808|NCT01206816|101628508|FG006|Overall Study|Progressive disease|3|||
33266746|NCT01263496|100877776|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33266747|NCT01263496|100877777|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
33266748|NCT01263496|100877778|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
33266749|NCT01263496|100877779|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
33266750|NCT01263496|100877780|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33266751|NCT01263496|100877781|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33266752|NCT01263496|100877782|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
33266753|NCT01263496|100877783|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
33266754|NCT01263496|100877775|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
33266755|NCT01263496|100877776|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
33266756|NCT01263496|100877777|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
33266757|NCT01263496|100877778|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
33266758|NCT01263496|100877779|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
33266759|NCT01263496|100877780|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
33474809|NCT01206816|101628502|FG000|Overall Study|Other AE|0|||
33474810|NCT01206816|101628503|FG001|Overall Study|Other AE|0|||
33474811|NCT01206816|101628504|FG002|Overall Study|Other AE|4|||
33474812|NCT01206816|101628505|FG003|Overall Study|Other AE|0|||
33474813|NCT01206816|101628506|FG004|Overall Study|Other AE|0|||
33474814|NCT01206816|101628507|FG005|Overall Study|Other AE|3|||
33474815|NCT01206816|101628508|FG006|Overall Study|Other AE|2|||
33474816|NCT01206816|101628502|FG000|Overall Study|other than stated above|0|||
33474817|NCT01206816|101628503|FG001|Overall Study|other than stated above|0|||
33474818|NCT01206816|101628504|FG002|Overall Study|other than stated above|1|||
33474819|NCT01206816|101628505|FG003|Overall Study|other than stated above|0|||
33474820|NCT01206816|101628506|FG004|Overall Study|other than stated above|0|||
33474821|NCT01206816|101628507|FG005|Overall Study|other than stated above|0|||
33474822|NCT01206816|101628508|FG006|Overall Study|other than stated above|1|||
33474823|NCT00667810|101628513|FG000|Overall Study|Adverse Event|13|||
33266760|NCT01263496|100877781|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
33266761|NCT01263496|100877782|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
33266762|NCT01263496|100877783|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
33266763|NCT01263496|100877775|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33266764|NCT01263496|100877776|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33266765|NCT01263496|100877777|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33266766|NCT01263496|100877778|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33266767|NCT01263496|100877779|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33266768|NCT01263496|100877780|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33266769|NCT01263496|100877781|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33266770|NCT01263496|100877782|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
33266771|NCT01263496|100877783|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
33266772|NCT02575365|100877784|FG000|Overall Study|Lost to Follow-up|4|||
33266773|NCT03732807|100877788|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
33266774|NCT03732807|100877789|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
33266775|NCT03732807|100877790|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
33266776|NCT03732807|100877791|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
33266777|NCT03732807|100877792|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
33266778|NCT03732807|100877793|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
33266779|NCT03732807|100877794|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
33266780|NCT03732807|100877788|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
33266781|NCT03732807|100877789|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
33266782|NCT03732807|100877790|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
33266783|NCT03732807|100877791|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
33266784|NCT03732807|100877792|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
33266785|NCT03732807|100877793|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
33266786|NCT03732807|100877794|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
33266787|NCT03732807|100877788|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
33266788|NCT03732807|100877789|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
33266789|NCT03732807|100877790|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
33266790|NCT03732807|100877791|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
33266791|NCT03732807|100877792|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
33266792|NCT03732807|100877793|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
33266793|NCT03732807|100877794|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
33266794|NCT03732807|100877788|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
33266795|NCT03732807|100877789|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
33474824|NCT00667810|101628514|FG001|Overall Study|Adverse Event|14|||
33474825|NCT00667810|101628515|FG002|Overall Study|Adverse Event|19|||
33474826|NCT00667810|101628516|FG003|Overall Study|Adverse Event|1|||
33474827|NCT00667810|101628513|FG000|Overall Study|Death|1|||
33474828|NCT00667810|101628514|FG001|Overall Study|Death|1|||
33474829|NCT00667810|101628515|FG002|Overall Study|Death|3|||
33474830|NCT00667810|101628516|FG003|Overall Study|Death|0|||
33474831|NCT00667810|101628513|FG000|Overall Study|Lack of Efficacy|1|||
33474832|NCT00667810|101628514|FG001|Overall Study|Lack of Efficacy|0|||
33474833|NCT00667810|101628515|FG002|Overall Study|Lack of Efficacy|2|||
33474834|NCT00667810|101628516|FG003|Overall Study|Lack of Efficacy|0|||
33474835|NCT00667810|101628513|FG000|Overall Study|Lost to Follow-up|1|||
33474836|NCT00667810|101628514|FG001|Overall Study|Lost to Follow-up|4|||
33474837|NCT00667810|101628515|FG002|Overall Study|Lost to Follow-up|2|||
33474838|NCT00667810|101628516|FG003|Overall Study|Lost to Follow-up|0|||
33474839|NCT00667810|101628513|FG000|Overall Study|Physician Decision|1|||
33474840|NCT00667810|101628514|FG001|Overall Study|Physician Decision|1|||
33474841|NCT00667810|101628515|FG002|Overall Study|Physician Decision|2|||
33474842|NCT00667810|101628516|FG003|Overall Study|Physician Decision|0|||
33474843|NCT00667810|101628513|FG000|Overall Study|Protocol Violation|0|||
33474844|NCT00667810|101628514|FG001|Overall Study|Protocol Violation|2|||
33474845|NCT00667810|101628515|FG002|Overall Study|Protocol Violation|0|||
33474846|NCT00667810|101628516|FG003|Overall Study|Protocol Violation|0|||
33474847|NCT00667810|101628513|FG000|Overall Study|Withdrawal by Subject|14|||
33474848|NCT00667810|101628514|FG001|Overall Study|Withdrawal by Subject|20|||
33474849|NCT00667810|101628515|FG002|Overall Study|Withdrawal by Subject|29|||
33474850|NCT00667810|101628516|FG003|Overall Study|Withdrawal by Subject|1|||
33474851|NCT00667810|101628513|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
33474852|NCT00667810|101628514|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
33474853|NCT00667810|101628515|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
33474854|NCT00667810|101628516|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
33474855|NCT00667810|101628513|FG000|Overall Study|Failed to Return|0|||
33474856|NCT00667810|101628514|FG001|Overall Study|Failed to Return|0|||
33474857|NCT00667810|101628515|FG002|Overall Study|Failed to Return|2|||
33474858|NCT00667810|101628516|FG003|Overall Study|Failed to Return|0|||
33474859|NCT00667810|101628513|FG000|Overall Study|Loss of Caregiver|0|||
33474860|NCT00667810|101628514|FG001|Overall Study|Loss of Caregiver|1|||
33474861|NCT00667810|101628515|FG002|Overall Study|Loss of Caregiver|3|||
33474862|NCT00667810|101628516|FG003|Overall Study|Loss of Caregiver|0|||
33474863|NCT00667810|101628513|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
33474864|NCT00667810|101628514|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
33474865|NCT00667810|101628515|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
33474866|NCT00667810|101628516|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
33474867|NCT00667810|101628513|FG000|Overall Study|Other|6|||
33474868|NCT00667810|101628514|FG001|Overall Study|Other|6|||
33474869|NCT00667810|101628515|FG002|Overall Study|Other|5|||
33474870|NCT00667810|101628516|FG003|Overall Study|Other|0|||
33474871|NCT01685073|101628517|FG000|Overall Study|Lost to Follow-up|6|||
33474872|NCT01685073|101628518|FG001|Overall Study|Lost to Follow-up|8|||
33474873|NCT01685073|101628517|FG000|Overall Study|Withdrawal by Subject|24|||
33474874|NCT01685073|101628518|FG001|Overall Study|Withdrawal by Subject|24|||
33474875|NCT03071094|101628522|FG000|Overall Study|Death|1|||
33474876|NCT03071094|101628523|FG001|Overall Study|Death|1|||
33474877|NCT03071094|101628522|FG000|Overall Study|Adverse Event|1|||
33474878|NCT03071094|101628523|FG001|Overall Study|Adverse Event|0|||
33474879|NCT01855074|101628525|FG000|Overall Study|Adverse Event|1|||
33474880|NCT01855074|101628525|FG000|Overall Study|Lost to Follow-up|4|||
33474881|NCT01855074|101628525|FG000|Overall Study|Withdrawal by Subject|8|||
33474882|NCT01855074|101628525|FG000|Overall Study|Started but not treated|1|||
33474883|NCT00793780|101628529|FG000|Overall Study|Withdrawal by Subject|2|||
33474884|NCT00793780|101628530|FG001|Overall Study|Withdrawal by Subject|1|||
33474885|NCT00706095|101628531|FG000|Overall Study|Progressive Disease|4|||
33474886|NCT00706095|101628532|FG001|Overall Study|Progressive Disease|5|||
33474887|NCT00706095|101628533|FG002|Overall Study|Progressive Disease|3|||
33474888|NCT00706095|101628531|FG000|Overall Study|Clinical Progression|1|||
33474889|NCT00706095|101628532|FG001|Overall Study|Clinical Progression|2|||
33474890|NCT00706095|101628533|FG002|Overall Study|Clinical Progression|2|||
33474891|NCT00706095|101628531|FG000|Overall Study|Withdrawal by Subject|1|||
33474892|NCT00706095|101628532|FG001|Overall Study|Withdrawal by Subject|0|||
33474893|NCT00706095|101628533|FG002|Overall Study|Withdrawal by Subject|0|||
33474894|NCT00616941|101631694|FG000|Overall Study|Progressive Disease|1|||
33474895|NCT00616941|101631695|FG001|Overall Study|Progressive Disease|2|||
33474896|NCT00616941|101631696|FG002|Overall Study|Progressive Disease|1|||
33474897|NCT00616941|101631694|FG000|Overall Study|Adverse Event|0|||
33474898|NCT00616941|101631695|FG001|Overall Study|Adverse Event|1|||
33474899|NCT00616941|101631696|FG002|Overall Study|Adverse Event|1|||
33474900|NCT00616941|101631694|FG000|Overall Study|Subject Non-compliance|0|||
33474901|NCT00616941|101631695|FG001|Overall Study|Subject Non-compliance|0|||
33474902|NCT00616941|101631696|FG002|Overall Study|Subject Non-compliance|1|||
33474903|NCT00616941|101631694|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
33474904|NCT00616941|101631695|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
33474905|NCT00616941|101631696|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
33474906|NCT00616941|101631694|FG000|Overall Study|Vaccination Suspended|0|||
33474907|NCT00616941|101631695|FG001|Overall Study|Vaccination Suspended|0|||
33474908|NCT00616941|101631696|FG002|Overall Study|Vaccination Suspended|3|||
33474909|NCT00450619|101631700|FG000|Overall Study|refused treatment after randomization|2|||
33474910|NCT00450619|101631701|FG001|Overall Study|refused treatment after randomization|0|||
33474911|NCT00450619|101631700|FG000|Overall Study|did not progress; refused further trmt|1|||
33474912|NCT00450619|101631701|FG001|Overall Study|did not progress; refused further trmt|1|||
33474913|NCT00450619|101631700|FG000|Overall Study|Adverse Event|1|||
33474914|NCT00450619|101631701|FG001|Overall Study|Adverse Event|0|||
33474915|NCT05012163|101631702|FG000|Overall Study|Protocol Violation|0|||
33474916|NCT05012163|101631703|FG001|Overall Study|Protocol Violation|0|||
33474917|NCT05012163|101631704|FG002|Overall Study|Protocol Violation|1|||
33474918|NCT05012163|101631705|FG003|Overall Study|Protocol Violation|1|||
33474919|NCT01196078|101631709|FG000|Overall Study|Withdrawal by Subject|3|||
33474920|NCT01196078|101631710|FG001|Overall Study|Withdrawal by Subject|5|||
33474921|NCT01196078|101631709|FG000|Overall Study|Adverse Event|4|||
33474922|NCT01196078|101631710|FG001|Overall Study|Adverse Event|4|||
33474923|NCT01196078|101631709|FG000|Overall Study|Protocol Violation|2|||
33474924|NCT01196078|101631710|FG001|Overall Study|Protocol Violation|1|||
33474925|NCT01196078|101631709|FG000|Overall Study|Lack of Efficacy|17|||
33474926|NCT01196078|101631710|FG001|Overall Study|Lack of Efficacy|23|||
33474927|NCT01196078|101631709|FG000|Overall Study|Lost to Follow-up|1|||
33474928|NCT01196078|101631710|FG001|Overall Study|Lost to Follow-up|0|||
33474929|NCT01196078|101631709|FG000|Overall Study|Death|6|||
33474930|NCT01196078|101631710|FG001|Overall Study|Death|4|||
33474931|NCT01032018|101631713|FG000|Overall Study|Lost to Follow-up|6|||
33474932|NCT01032018|101631714|FG001|Overall Study|Lost to Follow-up|5|||
33474933|NCT01032018|101631713|FG000|Overall Study|Death|0|||
33474934|NCT01032018|101631714|FG001|Overall Study|Death|1|||
33474935|NCT01584843|101631723|FG000|First Treatment Period|Adverse Event|0|||
33474936|NCT01584843|101631724|FG001|First Treatment Period|Adverse Event|0|||
33474937|NCT01584843|101631725|FG002|First Treatment Period|Adverse Event|1|||
33474938|NCT01584843|101631726|FG003|First Treatment Period|Adverse Event|0|||
33266796|NCT03732807|100877790|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
33266797|NCT03732807|100877791|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
33266798|NCT03732807|100877792|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
33266799|NCT03732807|100877793|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
33266800|NCT03732807|100877794|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
33266801|NCT03732807|100877788|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
33266802|NCT03732807|100877789|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
33266803|NCT03732807|100877790|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
33266804|NCT03732807|100877791|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
33266805|NCT03732807|100877792|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
33266806|NCT03732807|100877793|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
33266807|NCT03732807|100877794|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
33266808|NCT03732807|100877788|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
33266809|NCT03732807|100877789|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
33266810|NCT03732807|100877790|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
33266811|NCT03732807|100877791|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
33266812|NCT03732807|100877792|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
33266813|NCT03732807|100877793|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
33266814|NCT03732807|100877794|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
33266815|NCT03732807|100877788|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
33266816|NCT03732807|100877789|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
33266817|NCT03732807|100877790|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
33266818|NCT03732807|100877791|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
33266819|NCT03732807|100877792|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
33266820|NCT03732807|100877793|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
33266821|NCT03732807|100877794|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
33266822|NCT03732807|100877788|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
33474939|NCT01584843|101631727|FG004|First Treatment Period|Adverse Event|0|||
33474940|NCT01584843|101631728|FG005|First Treatment Period|Adverse Event|0|||
33474941|NCT01584843|101631723|FG000|First Treatment Period|Protocol Violation|0|||
33474942|NCT01584843|101631724|FG001|First Treatment Period|Protocol Violation|0|||
33474943|NCT01584843|101631725|FG002|First Treatment Period|Protocol Violation|0|||
33474944|NCT01584843|101631726|FG003|First Treatment Period|Protocol Violation|0|||
33474945|NCT01584843|101631727|FG004|First Treatment Period|Protocol Violation|0|||
33474946|NCT01584843|101631728|FG005|First Treatment Period|Protocol Violation|1|||
33474947|NCT01584843|101631723|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
33474948|NCT01584843|101631724|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
33266823|NCT03732807|100877789|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
33474949|NCT01584843|101631725|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
33474950|NCT01584843|101631726|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
33266824|NCT03732807|100877790|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
33266825|NCT03732807|100877791|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
33266826|NCT03732807|100877792|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
33266827|NCT03732807|100877793|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
33266828|NCT03732807|100877794|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
33266829|NCT03732807|100877788|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
33266830|NCT03732807|100877789|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
33266831|NCT03732807|100877790|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
33266832|NCT03732807|100877791|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
33266833|NCT03732807|100877792|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
33266834|NCT03732807|100877793|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
33266835|NCT03732807|100877794|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
33266836|NCT03732807|100877788|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
33474951|NCT01584843|101631727|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
33474952|NCT01584843|101631728|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
33474953|NCT01584843|101631723|FG000|Second Treatment Period|Withdrawal by Subject|0|||
33474954|NCT01584843|101631724|FG001|Second Treatment Period|Withdrawal by Subject|0|||
33474955|NCT01584843|101631725|FG002|Second Treatment Period|Withdrawal by Subject|0|||
33474956|NCT01584843|101631726|FG003|Second Treatment Period|Withdrawal by Subject|0|||
33474957|NCT01584843|101631727|FG004|Second Treatment Period|Withdrawal by Subject|0|||
33474958|NCT01584843|101631728|FG005|Second Treatment Period|Withdrawal by Subject|1|||
33474959|NCT02056392|101631734|FG000|Overall Study|Lost to Follow-up|0|||
33474960|NCT02056392|101631735|FG001|Overall Study|Lost to Follow-up|1|||
33474961|NCT02056392|101631736|FG002|Overall Study|Lost to Follow-up|2|||
33474962|NCT02056392|101631737|FG003|Overall Study|Lost to Follow-up|0|||
33474963|NCT02056392|101631738|FG004|Overall Study|Lost to Follow-up|0|||
33474964|NCT02056392|101631739|FG005|Overall Study|Lost to Follow-up|0|||
33474965|NCT02056392|101631734|FG000|Overall Study|Protocol Violation|1|||
33474966|NCT02056392|101631735|FG001|Overall Study|Protocol Violation|0|||
33474967|NCT02056392|101631736|FG002|Overall Study|Protocol Violation|1|||
33474968|NCT02056392|101631737|FG003|Overall Study|Protocol Violation|0|||
33474969|NCT02056392|101631738|FG004|Overall Study|Protocol Violation|0|||
33474970|NCT02056392|101631739|FG005|Overall Study|Protocol Violation|0|||
33474971|NCT02056392|101631734|FG000|Overall Study|Withdrawal by Subject|1|||
33474972|NCT02056392|101631735|FG001|Overall Study|Withdrawal by Subject|0|||
33474973|NCT02056392|101631736|FG002|Overall Study|Withdrawal by Subject|0|||
33474974|NCT02056392|101631737|FG003|Overall Study|Withdrawal by Subject|0|||
33474975|NCT02056392|101631738|FG004|Overall Study|Withdrawal by Subject|1|||
33474976|NCT02056392|101631739|FG005|Overall Study|Withdrawal by Subject|0|||
33474977|NCT02331368|101631748|FG000|Overall Study|Withdrawal by Subject|3|||
33474978|NCT00319982|101631749|FG000|Overall Study|Withdrawal by Subject|1|||
33474979|NCT00319982|101631750|FG001|Overall Study|Withdrawal by Subject|0|||
33474980|NCT03514641|101631751|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
33474981|NCT03514641|101631752|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
33474982|NCT03514641|101631753|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
33474983|NCT03514641|101631754|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
33474984|NCT03514641|101631751|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
33474985|NCT03514641|101631752|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
33474986|NCT03514641|101631753|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
33474987|NCT03514641|101631754|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
33474988|NCT03514641|101631751|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
33474989|NCT03514641|101631752|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
33266837|NCT03732807|100877789|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
33266838|NCT03732807|100877790|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
33266839|NCT03732807|100877791|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
33266840|NCT03732807|100877792|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
33266841|NCT03732807|100877793|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
33266842|NCT03732807|100877794|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
33266843|NCT03732807|100877788|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
33474990|NCT03514641|101631753|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
33474991|NCT03514641|101631754|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
33474992|NCT03514641|101631751|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
33474993|NCT03514641|101631752|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
33474994|NCT03514641|101631753|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
33266844|NCT03732807|100877789|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
33266845|NCT03732807|100877790|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
33266846|NCT03732807|100877791|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
33474995|NCT03514641|101631754|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
33474996|NCT03514641|101631751|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
33474997|NCT03514641|101631752|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
33266847|NCT03732807|100877792|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
33266848|NCT03732807|100877793|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
33474998|NCT03514641|101631753|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
33474999|NCT03514641|101631754|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
33475000|NCT03514641|101631751|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
33475001|NCT03514641|101631752|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
33475002|NCT03514641|101631753|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
33475003|NCT03514641|101631754|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
33475004|NCT03514641|101631751|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
33475005|NCT03514641|101631752|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
33475006|NCT03514641|101631753|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
33475007|NCT03514641|101631754|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
33475008|NCT03514641|101631751|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
33475009|NCT03514641|101631752|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
33475010|NCT03514641|101631753|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
33475011|NCT03514641|101631754|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
33475012|NCT03514641|101631751|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
33475013|NCT03514641|101631752|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
33266849|NCT03732807|100877794|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
33266850|NCT03732807|100877788|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
33266851|NCT03732807|100877789|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
33266852|NCT03732807|100877790|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
33266853|NCT03732807|100877791|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
33266854|NCT03732807|100877792|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
33266855|NCT03732807|100877793|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
33266856|NCT03732807|100877794|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
33475014|NCT03514641|101631753|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
33475015|NCT03514641|101631754|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
33475016|NCT03514641|101631751|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
33475017|NCT03514641|101631752|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
33475018|NCT03514641|101631753|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
33475019|NCT03514641|101631754|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
33475020|NCT03514641|101631751|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
33475021|NCT03514641|101631752|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
33475022|NCT03514641|101631753|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
33475023|NCT03514641|101631754|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
33266857|NCT03732807|100877788|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
33266858|NCT03732807|100877789|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
33266859|NCT03732807|100877790|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
33266860|NCT03732807|100877791|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
33266861|NCT03732807|100877792|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
33266862|NCT03732807|100877793|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
33475024|NCT03514641|101631751|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
33475025|NCT03514641|101631752|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
33475026|NCT03514641|101631753|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
33475027|NCT03514641|101631754|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
33475028|NCT01172821|101631755|FG000|Overall Study|Adverse Event|5|||
33475029|NCT01172821|101631756|FG001|Overall Study|Adverse Event|2|||
33475030|NCT01172821|101631757|FG002|Overall Study|Adverse Event|2|||
33475031|NCT01172821|101631758|FG003|Overall Study|Adverse Event|7|||
33475032|NCT01172821|101631755|FG000|Overall Study|Protocol Violation|0|||
33475033|NCT01172821|101631756|FG001|Overall Study|Protocol Violation|2|||
33475034|NCT01172821|101631757|FG002|Overall Study|Protocol Violation|1|||
33475035|NCT01172821|101631758|FG003|Overall Study|Protocol Violation|2|||
33475036|NCT01172821|101631755|FG000|Overall Study|Lost to Follow-up|4|||
33475037|NCT01172821|101631756|FG001|Overall Study|Lost to Follow-up|1|||
33475038|NCT01172821|101631757|FG002|Overall Study|Lost to Follow-up|2|||
33475039|NCT01172821|101631758|FG003|Overall Study|Lost to Follow-up|2|||
33475040|NCT01172821|101631755|FG000|Overall Study|Withdrawal by Subject|2|||
33475041|NCT01172821|101631756|FG001|Overall Study|Withdrawal by Subject|3|||
33475042|NCT01172821|101631757|FG002|Overall Study|Withdrawal by Subject|3|||
33475043|NCT01172821|101631758|FG003|Overall Study|Withdrawal by Subject|3|||
33266863|NCT03732807|100877794|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
33266864|NCT03732807|100877788|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
33266865|NCT03732807|100877789|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
33475044|NCT01172821|101631755|FG000|Overall Study|Other|3|||
33475045|NCT01172821|101631756|FG001|Overall Study|Other|4|||
33475046|NCT01172821|101631757|FG002|Overall Study|Other|5|||
33475047|NCT01172821|101631758|FG003|Overall Study|Other|3|||
33475048|NCT01175811|101631759|FG000|Overall Study|Adverse Event|1|||
33475049|NCT01175811|101631760|FG001|Overall Study|Adverse Event|1|||
33475050|NCT01175811|101631759|FG000|Overall Study|Entry criteria not met|3|||
33475051|NCT01175811|101631760|FG001|Overall Study|Entry criteria not met|1|||
33475052|NCT01175811|101631759|FG000|Overall Study|Lack of Efficacy|1|||
33475053|NCT01175811|101631760|FG001|Overall Study|Lack of Efficacy|0|||
33475054|NCT01175811|101631759|FG000|Overall Study|Lost to Follow-up|3|||
33475055|NCT01175811|101631760|FG001|Overall Study|Lost to Follow-up|2|||
33475056|NCT01175811|101631759|FG000|Overall Study|Physician Decision|1|||
33475057|NCT01175811|101631760|FG001|Overall Study|Physician Decision|1|||
33475058|NCT01175811|101631759|FG000|Overall Study|Protocol Violation|1|||
33475059|NCT01175811|101631760|FG001|Overall Study|Protocol Violation|2|||
33475060|NCT01175811|101631759|FG000|Overall Study|Withdrawal by Subject|6|||
33475061|NCT01175811|101631760|FG001|Overall Study|Withdrawal by Subject|7|||
33475062|NCT04505293|101631761|FG000|Overall Study|Lost to Follow-up|2|||
33475063|NCT04505293|101631761|FG000|Overall Study|Withdrawal by Subject|6|||
33475064|NCT04505293|101631761|FG000|Overall Study|CT scan unreadable|277|||
33475065|NCT02603393|101631769|FG000|Overall Study|Patient/guardian decision|32|||
33475066|NCT02603393|101631770|FG001|Overall Study|Patient/guardian decision|18|||
33475067|NCT02603393|101631769|FG000|Overall Study|Adverse Event|17|||
33475068|NCT02603393|101631770|FG001|Overall Study|Adverse Event|15|||
33266866|NCT03732807|100877790|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
33266867|NCT03732807|100877791|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
33266868|NCT03732807|100877792|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
33266869|NCT03732807|100877793|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
33266870|NCT03732807|100877794|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
33266871|NCT00263757|100877795|FG000|Overall Study|Withdrawal by Subject|5|||
33266872|NCT00263757|100877796|FG001|Overall Study|Withdrawal by Subject|4|||
33266873|NCT00263757|100877795|FG000|Overall Study|Screen failure|0|||
33266874|NCT00263757|100877796|FG001|Overall Study|Screen failure|1|||
33266875|NCT00263757|100877795|FG000|Overall Study|Adverse Event|3|||
33266876|NCT00263757|100877796|FG001|Overall Study|Adverse Event|3|||
33266877|NCT01394276|100877797|FG000|Overall Study|Related Adverse event (AEs)|15|||
33266878|NCT01394276|100877797|FG000|Overall Study|Not related AEs|9|||
33266879|NCT01394276|100877797|FG000|Overall Study|Remission of disease|2|||
33266880|NCT01394276|100877797|FG000|Overall Study|Insufficient therapeutic effect|17|||
33266881|NCT01394276|100877797|FG000|Overall Study|Insufficient compliance|9|||
33266882|NCT01394276|100877797|FG000|Overall Study|Lost to Follow-up|5|||
33266883|NCT01394276|100877797|FG000|Overall Study|Participant moved to another site|1|||
33266884|NCT01394276|100877797|FG000|Overall Study|Pregnancy|1|||
33266885|NCT01394276|100877797|FG000|Overall Study|unavailability of drug at the Hospital|2|||
33266886|NCT01394276|100877797|FG000|Overall Study|Symptoms of concurrent diseases|1|||
33266887|NCT05445557|100877798|FG000|Double Blind Part|Lost to Follow-up|1|||
33266888|NCT02234141|100877799|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
33266889|NCT02234141|100877800|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
33266890|NCT02234141|100877801|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
33266891|NCT02234141|100877802|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
33266892|NCT02234141|100877803|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
33266893|NCT02234141|100877804|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
33266894|NCT02234141|100877805|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
33266895|NCT02234141|100877799|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
33266896|NCT02234141|100877800|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
33266897|NCT02234141|100877801|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
33266898|NCT02234141|100877802|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
33266899|NCT02234141|100877803|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
33266900|NCT02234141|100877804|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
33266901|NCT02234141|100877805|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
33266902|NCT02234141|100877799|FG000|Treatment Period (24 Weeks)|Death|1|||
33266903|NCT02234141|100877800|FG001|Treatment Period (24 Weeks)|Death|2|||
33266904|NCT02234141|100877801|FG002|Treatment Period (24 Weeks)|Death|0|||
33475069|NCT02603393|101631769|FG000|Overall Study|Technical problems|4|||
33475070|NCT02603393|101631770|FG001|Overall Study|Technical problems|7|||
33475071|NCT02603393|101631769|FG000|Overall Study|Lack of Efficacy|7|||
33266905|NCT02234141|100877802|FG003|Treatment Period (24 Weeks)|Death|1|||
33475072|NCT02603393|101631770|FG001|Overall Study|Lack of Efficacy|2|||
33475073|NCT02603393|101631769|FG000|Overall Study|Death|3|||
33475074|NCT02603393|101631770|FG001|Overall Study|Death|4|||
33475075|NCT02603393|101631769|FG000|Overall Study|Physician Decision|3|||
33475076|NCT02603393|101631770|FG001|Overall Study|Physician Decision|3|||
33475077|NCT02603393|101631769|FG000|Overall Study|Protocol deviation|2|||
33266906|NCT02234141|100877803|FG004|Treatment Period (24 Weeks)|Death|0|||
33266907|NCT02234141|100877804|FG005|Treatment Period (24 Weeks)|Death|0|||
33266908|NCT02234141|100877805|FG006|Treatment Period (24 Weeks)|Death|0|||
33266909|NCT02234141|100877799|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
33475078|NCT02603393|101631770|FG001|Overall Study|Protocol deviation|3|||
33475079|NCT02603393|101631769|FG000|Overall Study|Lost to Follow-up|1|||
33266910|NCT02234141|100877800|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
33266911|NCT02234141|100877801|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
33266912|NCT02234141|100877802|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
33266913|NCT02234141|100877803|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
33266914|NCT02234141|100877804|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
33266915|NCT02234141|100877805|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
33266916|NCT02234141|100877799|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
33266917|NCT02234141|100877800|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
33475080|NCT02603393|101631770|FG001|Overall Study|Lost to Follow-up|2|||
33475081|NCT02603393|101631769|FG000|Overall Study|Non-compliance with study treatment|1|||
33475082|NCT02603393|101631770|FG001|Overall Study|Non-compliance with study treatment|0|||
33475083|NCT02603393|101631769|FG000|Overall Study|Sponsor decision|1|||
33475084|NCT02603393|101631770|FG001|Overall Study|Sponsor decision|0|||
33475085|NCT02528123|101631782|FG000|Overall Study|Lost to Follow-up|1|||
33475086|NCT05142566|101631787|FG000|Overall Study|Protocol Violation|1|||
33475087|NCT00655876|101631788|FG000|Overall Study|Protocol Violation|9|||
33475088|NCT00655876|101631789|FG001|Overall Study|Protocol Violation|7|||
33475089|NCT01177059|101631791|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
33475090|NCT01177059|101631791|FG000|Overall Study|Withdrew consent|2|||
33475091|NCT01177059|101631791|FG000|Overall Study|Lost to Follow-up|18|||
33475092|NCT02923674|101631796|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
33475093|NCT02923674|101631797|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
33475094|NCT02923674|101631798|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
33475095|NCT02923674|101631796|FG000|Overall Study|Lost to Follow-up|7|||
33475096|NCT02923674|101631797|FG001|Overall Study|Lost to Follow-up|12|||
33475097|NCT02923674|101631798|FG002|Overall Study|Lost to Follow-up|7|||
33475098|NCT02923674|101631796|FG000|Overall Study|Problem with intervention|2|||
33475099|NCT02923674|101631797|FG001|Overall Study|Problem with intervention|2|||
33475100|NCT02923674|101631798|FG002|Overall Study|Problem with intervention|1|||
33475101|NCT02923674|101631796|FG000|Overall Study|Adverse Event|3|||
33475102|NCT02923674|101631797|FG001|Overall Study|Adverse Event|1|||
33475103|NCT02923674|101631798|FG002|Overall Study|Adverse Event|1|||
33475104|NCT02923674|101631796|FG000|Overall Study|Withdrawal by Subject|2|||
33475105|NCT02923674|101631797|FG001|Overall Study|Withdrawal by Subject|2|||
33475106|NCT02923674|101631798|FG002|Overall Study|Withdrawal by Subject|2|||
33475107|NCT01732874|101631799|FG000|Overall Study|Withdrawal by Subject|5|||
33475108|NCT01732874|101631800|FG001|Overall Study|Withdrawal by Subject|1|||
33475109|NCT01732874|101631799|FG000|Overall Study|Death of Infant|3|||
33475110|NCT01732874|101631800|FG001|Overall Study|Death of Infant|2|||
33475111|NCT02981303|101631801|FG000|Overall Study|Progressive Disease|17|||
33475112|NCT02981303|101631802|FG001|Overall Study|Progressive Disease|37|||
33475113|NCT02981303|101631801|FG000|Overall Study|Adverse Event|1|||
33475114|NCT02981303|101631802|FG001|Overall Study|Adverse Event|4|||
33475115|NCT02981303|101631801|FG000|Overall Study|Withdrawal by Subject|0|||
33475116|NCT02981303|101631802|FG001|Overall Study|Withdrawal by Subject|1|||
33475117|NCT03285308|101631805|FG000|Overall Study|Adverse Event|3|||
33475118|NCT03285308|101631806|FG001|Overall Study|Adverse Event|7|||
33475119|NCT03285308|101631805|FG000|Overall Study|Withdrawal by Subject|8|||
33475120|NCT03285308|101631806|FG001|Overall Study|Withdrawal by Subject|9|||
33475121|NCT03285308|101631805|FG000|Overall Study|Lost to Follow-up|3|||
33475122|NCT03285308|101631806|FG001|Overall Study|Lost to Follow-up|1|||
33475123|NCT03285308|101631805|FG000|Overall Study|Protocol Deviation|6|||
33475124|NCT03285308|101631806|FG001|Overall Study|Protocol Deviation|5|||
33475125|NCT03285308|101631805|FG000|Overall Study|Reason not Specified|0|||
33475126|NCT03285308|101631806|FG001|Overall Study|Reason not Specified|1|||
33475127|NCT00468650|101631816|FG000|Overall Study|Lost to Follow-up|4|||
33475128|NCT00468650|101631816|FG000|Overall Study|Withdrawal by Subject|2|||
33475129|NCT00468650|101631816|FG000|Overall Study|Protocol Violation|1|||
33475130|NCT02618408|101631817|FG000|Overall Study|Withdrawal by Subject|1|||
33475131|NCT02618408|101631818|FG001|Overall Study|Withdrawal by Subject|0|||
33475132|NCT02618408|101631819|FG002|Overall Study|Withdrawal by Subject|4|||
33475133|NCT02618408|101631817|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
33475134|NCT02618408|101631818|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
33266918|NCT02234141|100877801|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
33475135|NCT02618408|101631819|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
33475136|NCT02618408|101631817|FG000|Overall Study|Lost to Follow-up|4|||
33475137|NCT02618408|101631818|FG001|Overall Study|Lost to Follow-up|2|||
33475138|NCT02618408|101631819|FG002|Overall Study|Lost to Follow-up|6|||
33475139|NCT02618408|101631817|FG000|Overall Study|Adverse Event|4|||
33475140|NCT02618408|101631818|FG001|Overall Study|Adverse Event|0|||
33475141|NCT02618408|101631819|FG002|Overall Study|Adverse Event|10|||
33475142|NCT02618408|101631817|FG000|Overall Study|Physician Decision|1|||
33475143|NCT02618408|101631818|FG001|Overall Study|Physician Decision|1|||
33475144|NCT02618408|101631819|FG002|Overall Study|Physician Decision|2|||
33475145|NCT02618408|101631817|FG000|Overall Study|Protocol Violation|1|||
33475146|NCT02618408|101631818|FG001|Overall Study|Protocol Violation|1|||
33475147|NCT02618408|101631819|FG002|Overall Study|Protocol Violation|2|||
33475148|NCT02618408|101631817|FG000|Overall Study|Other, Multiple Categories|0|||
33475149|NCT02618408|101631818|FG001|Overall Study|Other, Multiple Categories|0|||
33475150|NCT02618408|101631819|FG002|Overall Study|Other, Multiple Categories|4|||
33475151|NCT03233230|101631821|FG000|Overall Study|Adverse Event|6|||
33475152|NCT03233230|101631822|FG001|Overall Study|Adverse Event|3|||
33475153|NCT03233230|101631823|FG002|Overall Study|Adverse Event|6|||
33475154|NCT03233230|101631824|FG003|Overall Study|Adverse Event|3|||
33475155|NCT03233230|101631821|FG000|Overall Study|Protocol Violation|1|||
33475156|NCT03233230|101631822|FG001|Overall Study|Protocol Violation|2|||
33475157|NCT03233230|101631823|FG002|Overall Study|Protocol Violation|1|||
33475158|NCT03233230|101631824|FG003|Overall Study|Protocol Violation|1|||
33475159|NCT03233230|101631821|FG000|Overall Study|Lack of Efficacy|1|||
33475160|NCT03233230|101631822|FG001|Overall Study|Lack of Efficacy|0|||
33475161|NCT03233230|101631823|FG002|Overall Study|Lack of Efficacy|0|||
33475162|NCT03233230|101631824|FG003|Overall Study|Lack of Efficacy|0|||
33475163|NCT03233230|101631821|FG000|Overall Study|Other|5|||
33475164|NCT03233230|101631822|FG001|Overall Study|Other|5|||
33475165|NCT03233230|101631823|FG002|Overall Study|Other|5|||
33475166|NCT03233230|101631824|FG003|Overall Study|Other|3|||
33475167|NCT03233230|101631821|FG000|Overall Study|Withdrawal by Subject|2|||
33475168|NCT03233230|101631822|FG001|Overall Study|Withdrawal by Subject|2|||
33475169|NCT03233230|101631823|FG002|Overall Study|Withdrawal by Subject|0|||
33266919|NCT02234141|100877802|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
33266920|NCT02234141|100877803|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
33266921|NCT02234141|100877804|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
33266922|NCT02234141|100877805|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
33266923|NCT02234141|100877799|FG000|Long-Term Treatment Period|Death|0|||
33266924|NCT02234141|100877800|FG001|Long-Term Treatment Period|Death|0|||
33266925|NCT02234141|100877801|FG002|Long-Term Treatment Period|Death|0|||
33266926|NCT02234141|100877802|FG003|Long-Term Treatment Period|Death|0|||
33266927|NCT02234141|100877803|FG004|Long-Term Treatment Period|Death|0|||
33266928|NCT02234141|100877804|FG005|Long-Term Treatment Period|Death|1|||
33266929|NCT02234141|100877805|FG006|Long-Term Treatment Period|Death|0|||
33266930|NCT02234141|100877799|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
33266931|NCT02234141|100877800|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
33266932|NCT02234141|100877801|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
33266933|NCT02234141|100877802|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
33266934|NCT02234141|100877803|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
33266935|NCT02234141|100877804|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
33266936|NCT02234141|100877805|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
33266937|NCT02234141|100877799|FG000|Long-Term Treatment Period|Adverse Event|4|||
33266938|NCT02234141|100877800|FG001|Long-Term Treatment Period|Adverse Event|0|||
33266939|NCT02234141|100877801|FG002|Long-Term Treatment Period|Adverse Event|5|||
33266940|NCT02234141|100877802|FG003|Long-Term Treatment Period|Adverse Event|0|||
33266941|NCT02234141|100877803|FG004|Long-Term Treatment Period|Adverse Event|1|||
33266942|NCT02234141|100877804|FG005|Long-Term Treatment Period|Adverse Event|1|||
33266943|NCT02234141|100877805|FG006|Long-Term Treatment Period|Adverse Event|1|||
33266944|NCT02234141|100877799|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
33266945|NCT02234141|100877800|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
33266946|NCT02234141|100877801|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
33266947|NCT02234141|100877802|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
33266948|NCT02234141|100877803|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
33266949|NCT02234141|100877804|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
33266950|NCT02234141|100877805|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
33266951|NCT02234141|100877799|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
33266952|NCT02234141|100877800|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
33266953|NCT02234141|100877801|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
33266954|NCT02234141|100877802|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
33266955|NCT02234141|100877803|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
33266956|NCT02234141|100877804|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
33266957|NCT02234141|100877805|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
33475170|NCT03233230|101631824|FG003|Overall Study|Withdrawal by Subject|1|||
33475171|NCT03233230|101631821|FG000|Overall Study|Lost to Follow-up|0|||
33475172|NCT03233230|101631822|FG001|Overall Study|Lost to Follow-up|3|||
33475173|NCT03233230|101631823|FG002|Overall Study|Lost to Follow-up|0|||
33266958|NCT03589768|100877810|FG000|Overall Study|Death|1|||
33266959|NCT03589768|100877811|FG001|Overall Study|Death|0|||
33266960|NCT03589768|100877812|FG002|Overall Study|Death|8|||
33475174|NCT03233230|101631824|FG003|Overall Study|Lost to Follow-up|0|||
33475175|NCT00477295|101631831|FG000|Overall Study|Adverse Event|31|||
33475176|NCT00477295|101631832|FG001|Overall Study|Adverse Event|35|||
33475177|NCT00477295|101631831|FG000|Overall Study|Withdrawal by Subject|35|||
33475178|NCT00477295|101631832|FG001|Overall Study|Withdrawal by Subject|24|||
33475179|NCT00477295|101631831|FG000|Overall Study|Lack of Efficacy|23|||
33475180|NCT00477295|101631832|FG001|Overall Study|Lack of Efficacy|23|||
33475181|NCT00477295|101631831|FG000|Overall Study|Protocol Violation|3|||
33475182|NCT00477295|101631832|FG001|Overall Study|Protocol Violation|8|||
33475183|NCT00477295|101631831|FG000|Overall Study|Physician Decision|4|||
33475184|NCT00477295|101631832|FG001|Overall Study|Physician Decision|5|||
33475185|NCT00477295|101631831|FG000|Overall Study|Lost to Follow-up|21|||
33475186|NCT00477295|101631832|FG001|Overall Study|Lost to Follow-up|11|||
33475187|NCT00477295|101631831|FG000|Overall Study|Other|4|||
33475188|NCT00477295|101631832|FG001|Overall Study|Other|3|||
33475189|NCT00076804|101631833|FG000|Overall Study|Death|9|||
33475190|NCT00076804|101631834|FG001|Overall Study|Death|20|||
33475191|NCT00076804|101631833|FG000|Overall Study|Lost to Follow-up|9|||
33475192|NCT00076804|101631834|FG001|Overall Study|Lost to Follow-up|9|||
33475193|NCT00076804|101631833|FG000|Overall Study|Withdrawal by Subject|10|||
33475194|NCT00076804|101631834|FG001|Overall Study|Withdrawal by Subject|8|||
33475195|NCT00076804|101631833|FG000|Overall Study|Early study Closure|32|||
33475196|NCT00076804|101631834|FG001|Overall Study|Early study Closure|32|||
33475197|NCT00548093|101631835|FG000|Overall Study|Death|33|||
33475198|NCT00548093|101631836|FG001|Overall Study|Death|13|||
33475199|NCT00548093|101631835|FG000|Overall Study|Lost to Follow-up|3|||
33475200|NCT00548093|101631836|FG001|Overall Study|Lost to Follow-up|1|||
33475201|NCT00548093|101631835|FG000|Overall Study|Objective progression or relapse|1|||
33475202|NCT00548093|101631836|FG001|Overall Study|Objective progression or relapse|1|||
33475203|NCT00548093|101631835|FG000|Overall Study|Other|11|||
33475204|NCT00548093|101631836|FG001|Overall Study|Other|1|||
33475205|NCT00548093|101631835|FG000|Overall Study|Withdrawal by Subject|1|||
33475206|NCT00548093|101631836|FG001|Overall Study|Withdrawal by Subject|0|||
33475207|NCT00548093|101631835|FG000|Overall Study|Completed post-treatment follow-up|1|||
33475208|NCT00548093|101631836|FG001|Overall Study|Completed post-treatment follow-up|0|||
33475209|NCT03567382|101631837|FG000|Overall Study|Lost to Follow-up|1|||
33475210|NCT03567382|101631838|FG001|Overall Study|Lost to Follow-up|21|||
33475211|NCT03567382|101631839|FG002|Overall Study|Lost to Follow-up|1|||
33475212|NCT03567382|101631840|FG003|Overall Study|Lost to Follow-up|21|||
33475213|NCT03567382|101631837|FG000|Overall Study|Withdrawal by Subject|2|||
33475214|NCT03567382|101631838|FG001|Overall Study|Withdrawal by Subject|14|||
33475215|NCT03567382|101631839|FG002|Overall Study|Withdrawal by Subject|1|||
33475216|NCT03567382|101631840|FG003|Overall Study|Withdrawal by Subject|12|||
33475217|NCT00158600|101631841|FG000|Overall Study|unable to commit time to study|0|||
33475218|NCT00158600|101631842|FG001|Overall Study|unable to commit time to study|1|||
33475219|NCT00158600|101631841|FG000|Overall Study|Adverse Event|2|||
33475220|NCT00158600|101631842|FG001|Overall Study|Adverse Event|1|||
33475221|NCT00158600|101631841|FG000|Overall Study|Death|1|||
33475222|NCT00158600|101631842|FG001|Overall Study|Death|0|||
33475223|NCT00158600|101631841|FG000|Overall Study|Withdrawal by Subject|2|||
33475224|NCT00158600|101631842|FG001|Overall Study|Withdrawal by Subject|2|||
33475225|NCT00719849|101631843|FG000|Overall Study|Death|0|||
33475226|NCT00719849|101631844|FG001|Overall Study|Death|1|||
33475227|NCT02944383|101631845|FG000|Overall Study|Lost to Follow-up|0|||
33475228|NCT02944383|101631846|FG001|Overall Study|Lost to Follow-up|0|||
33475229|NCT02944383|101631847|FG002|Overall Study|Lost to Follow-up|1|||
33475230|NCT02944383|101631845|FG000|Overall Study|Withdrawal by Subject|1|||
33475231|NCT02944383|101631846|FG001|Overall Study|Withdrawal by Subject|0|||
33475232|NCT02944383|101631847|FG002|Overall Study|Withdrawal by Subject|0|||
33475233|NCT00103311|101631848|FG000|Overall Study|Lost to Follow-up|1|||
33475234|NCT00103311|101631849|FG001|Overall Study|Lost to Follow-up|0|||
33475235|NCT00103311|101631848|FG000|Overall Study|Withdrawal by Subject|2|||
33475236|NCT00103311|101631849|FG001|Overall Study|Withdrawal by Subject|1|||
33475237|NCT00103311|101631848|FG000|Overall Study|Adverse Event|1|||
33475238|NCT00103311|101631849|FG001|Overall Study|Adverse Event|0|||
33475239|NCT00085423|101631857|FG000|Overall Study|Withdrawal by Subject|1|||
33475240|NCT00085423|101631857|FG000|Overall Study|screen failure|1|||
33266961|NCT03589768|100877813|FG003|Overall Study|Death|3|||
33266962|NCT03589768|100877810|FG000|Overall Study|Withdrawal by Subject|2|||
33475241|NCT02054130|101631858|FG000|Overall Study|Withdrawal by Subject|4|||
33475242|NCT02054130|101631859|FG001|Overall Study|Withdrawal by Subject|4|||
33475243|NCT02054130|101631860|FG002|Overall Study|Withdrawal by Subject|7|||
33475244|NCT02054130|101631861|FG003|Overall Study|Withdrawal by Subject|10|||
33475245|NCT02054130|101631858|FG000|Overall Study|Death|0|||
33475246|NCT02054130|101631859|FG001|Overall Study|Death|1|||
33475247|NCT02054130|101631860|FG002|Overall Study|Death|0|||
33475248|NCT02054130|101631861|FG003|Overall Study|Death|0|||
33475249|NCT02054130|101631858|FG000|Overall Study|Lost to Follow-up|0|||
33475250|NCT02054130|101631859|FG001|Overall Study|Lost to Follow-up|0|||
33475251|NCT02054130|101631860|FG002|Overall Study|Lost to Follow-up|1|||
33475252|NCT02054130|101631861|FG003|Overall Study|Lost to Follow-up|2|||
33475253|NCT02054130|101631858|FG000|Overall Study|Missed dose|4|||
33475254|NCT02054130|101631859|FG001|Overall Study|Missed dose|6|||
33475255|NCT02054130|101631860|FG002|Overall Study|Missed dose|7|||
33475256|NCT02054130|101631861|FG003|Overall Study|Missed dose|10|||
33475257|NCT02488330|101631862|FG000|Overall Study|Adverse Event|1|||
33475258|NCT02488330|101631862|FG000|Overall Study|Physician Decision|2|||
33475259|NCT02488330|101631862|FG000|Overall Study|Death|2|||
33475260|NCT02488330|101631862|FG000|Overall Study|Disease Progression|3|||
33475261|NCT02488330|101631862|FG000|Overall Study|Study Termination by Sponsor|4|||
33475262|NCT01763684|101631863|FG000|Overall Study|Study terminated early due to low enrollment|126|||
33475263|NCT01763684|101631864|FG001|Overall Study|Study terminated early due to low enrollment|127|||
33475264|NCT01763684|101631863|FG000|Overall Study|Study surgery not performed|7|||
33475265|NCT01763684|101631864|FG001|Overall Study|Study surgery not performed|6|||
33475266|NCT04442490|101631865|FG000|Overall Study|Withdrawal by Subject|18|||
33475267|NCT04442490|101631866|FG001|Overall Study|Withdrawal by Subject|10|||
33475268|NCT04442490|101631865|FG000|Overall Study|Lost to Follow-up|7|||
33475269|NCT04442490|101631866|FG001|Overall Study|Lost to Follow-up|7|||
33475270|NCT04442490|101631865|FG000|Overall Study|Adverse Event|2|||
33475271|NCT04442490|101631866|FG001|Overall Study|Adverse Event|6|||
33475272|NCT04442490|101631865|FG000|Overall Study|Noncompliance|3|||
33475273|NCT04442490|101631866|FG001|Overall Study|Noncompliance|1|||
33475274|NCT04442490|101631865|FG000|Overall Study|Physician Decision|2|||
33475275|NCT04442490|101631866|FG001|Overall Study|Physician Decision|1|||
33475276|NCT04442490|101631865|FG000|Overall Study|Reason not Specified|2|||
33475277|NCT04442490|101631866|FG001|Overall Study|Reason not Specified|1|||
33475278|NCT04442490|101631865|FG000|Overall Study|Randomized but not Treated|3|||
33475279|NCT04442490|101631866|FG001|Overall Study|Randomized but not Treated|3|||
33475280|NCT03050060|101631867|FG000|Overall Study|Adverse Event|7|||
33475281|NCT03050060|101631867|FG000|Overall Study|Withdrawal by Subject|1|||
33475282|NCT03050060|101631867|FG000|Overall Study|Progression|7|||
33475283|NCT00321828|101631868|FG000|Overall Study|Ineligible|3|||
33475284|NCT00321828|101631868|FG000|Overall Study|No follow up data|1|||
33475285|NCT02533375|101631869|FG000|Overall Study|Lack of Efficacy|3|||
33475286|NCT02533375|101631869|FG000|Overall Study|Adverse Event|2|||
33475287|NCT00506129|101631870|FG000|Overall Study|Disease Progression/Relapse|15|||
33475288|NCT00506129|101631870|FG000|Overall Study|Death|7|||
33475289|NCT04639713|101631875|FG000|Overall Study|Protocol Noncompliance|2|||
33475290|NCT04639713|101631875|FG000|Overall Study|Withdrawal by Subject|1|||
33475291|NCT02119286|101631876|FG000|Overall Study|Adverse Event|9|||
33475292|NCT02119286|101631877|FG001|Overall Study|Adverse Event|7|||
33475293|NCT02119286|101631878|FG002|Overall Study|Adverse Event|2|||
33475294|NCT02119286|101631876|FG000|Overall Study|Lack of Efficacy|11|||
33475295|NCT02119286|101631877|FG001|Overall Study|Lack of Efficacy|3|||
33475296|NCT02119286|101631878|FG002|Overall Study|Lack of Efficacy|4|||
33475297|NCT02119286|101631876|FG000|Overall Study|Lost to Follow-up|2|||
33475298|NCT02119286|101631877|FG001|Overall Study|Lost to Follow-up|0|||
33475299|NCT02119286|101631878|FG002|Overall Study|Lost to Follow-up|1|||
33475300|NCT02119286|101631876|FG000|Overall Study|Withdrawal by Subject|4|||
33475301|NCT02119286|101631877|FG001|Overall Study|Withdrawal by Subject|1|||
33475302|NCT02119286|101631878|FG002|Overall Study|Withdrawal by Subject|0|||
33475303|NCT00499174|101631879|FG000|Overall Study|Physician Decision|78|||
33475304|NCT00499174|101631880|FG001|Overall Study|Physician Decision|9|||
33475305|NCT01986010|101631881|FG000|Overall Study|Adverse Event|0|||
33475306|NCT01986010|101631882|FG001|Overall Study|Adverse Event|1|||
33475307|NCT01986010|101631883|FG002|Overall Study|Adverse Event|0|||
33475308|NCT01986010|101631884|FG003|Overall Study|Adverse Event|0|||
33475309|NCT01986010|101631885|FG004|Overall Study|Adverse Event|0|||
33475310|NCT01986010|101631886|FG005|Overall Study|Adverse Event|0|||
33475311|NCT01986010|101631887|FG006|Overall Study|Adverse Event|0|||
33475312|NCT01986010|101631888|FG007|Overall Study|Adverse Event|0|||
33475313|NCT01986010|101631889|FG008|Overall Study|Adverse Event|0|||
33475314|NCT01986010|101631890|FG009|Overall Study|Adverse Event|0|||
33475315|NCT01986010|101631891|FG010|Overall Study|Adverse Event|0|||
33475316|NCT01986010|101631892|FG011|Overall Study|Adverse Event|0|||
33266963|NCT03589768|100877811|FG001|Overall Study|Withdrawal by Subject|0|||
33266964|NCT03589768|100877812|FG002|Overall Study|Withdrawal by Subject|0|||
33266965|NCT03589768|100877813|FG003|Overall Study|Withdrawal by Subject|0|||
33475317|NCT01986010|101631893|FG012|Overall Study|Adverse Event|0|||
33475318|NCT01986010|101631894|FG013|Overall Study|Adverse Event|0|||
33475319|NCT01986010|101631895|FG014|Overall Study|Adverse Event|0|||
33475320|NCT01986010|101631896|FG015|Overall Study|Adverse Event|1|||
33475321|NCT01986010|101631897|FG016|Overall Study|Adverse Event|0|||
33475322|NCT01986010|101631881|FG000|Overall Study|Lost to Follow-up|2|||
33475323|NCT01986010|101631882|FG001|Overall Study|Lost to Follow-up|1|||
33475324|NCT01986010|101631883|FG002|Overall Study|Lost to Follow-up|2|||
33475325|NCT01986010|101631884|FG003|Overall Study|Lost to Follow-up|2|||
33475326|NCT01986010|101631885|FG004|Overall Study|Lost to Follow-up|2|||
33475327|NCT01986010|101631886|FG005|Overall Study|Lost to Follow-up|2|||
33475328|NCT01986010|101631887|FG006|Overall Study|Lost to Follow-up|0|||
33475329|NCT01986010|101631888|FG007|Overall Study|Lost to Follow-up|0|||
33475330|NCT01986010|101631889|FG008|Overall Study|Lost to Follow-up|4|||
33475331|NCT01986010|101631890|FG009|Overall Study|Lost to Follow-up|2|||
33475332|NCT01986010|101631891|FG010|Overall Study|Lost to Follow-up|0|||
33266966|NCT03589768|100877810|FG000|Overall Study|Protocol Violation|1|||
33266967|NCT03589768|100877811|FG001|Overall Study|Protocol Violation|0|||
33266968|NCT03589768|100877812|FG002|Overall Study|Protocol Violation|0|||
33266969|NCT03589768|100877813|FG003|Overall Study|Protocol Violation|0|||
33266970|NCT03987074|100877814|FG000|Overall Study|Withdrew Consent|1|||
33266971|NCT03987074|100877815|FG001|Overall Study|Withdrew Consent|1|||
33266972|NCT03987074|100877816|FG002|Overall Study|Withdrew Consent|0|||
33266973|NCT03987074|100877817|FG003|Overall Study|Withdrew Consent|2|||
33266974|NCT03987074|100877818|FG004|Overall Study|Withdrew Consent|1|||
33266975|NCT03987074|100877814|FG000|Overall Study|Adverse Event|2|||
33266976|NCT03987074|100877815|FG001|Overall Study|Adverse Event|1|||
33266977|NCT03987074|100877816|FG002|Overall Study|Adverse Event|0|||
33266978|NCT03987074|100877817|FG003|Overall Study|Adverse Event|0|||
33266979|NCT03987074|100877818|FG004|Overall Study|Adverse Event|1|||
33266980|NCT03987074|100877814|FG000|Overall Study|Lost to Follow-up|0|||
33266981|NCT03987074|100877815|FG001|Overall Study|Lost to Follow-up|0|||
33266982|NCT03987074|100877816|FG002|Overall Study|Lost to Follow-up|1|||
33266983|NCT03987074|100877817|FG003|Overall Study|Lost to Follow-up|1|||
33266984|NCT03987074|100877818|FG004|Overall Study|Lost to Follow-up|0|||
33266985|NCT03987074|100877814|FG000|Overall Study|Investigator's Discretion|0|||
33266986|NCT03987074|100877815|FG001|Overall Study|Investigator's Discretion|0|||
33266987|NCT03987074|100877816|FG002|Overall Study|Investigator's Discretion|0|||
33266988|NCT03987074|100877817|FG003|Overall Study|Investigator's Discretion|1|||
33266989|NCT03987074|100877818|FG004|Overall Study|Investigator's Discretion|0|||
33266990|NCT03184987|100877819|FG000|Overall Study|Withdrawal by Subject|0|||
33266991|NCT03184987|100877820|FG001|Overall Study|Withdrawal by Subject|1|||
33266992|NCT03184987|100877821|FG002|Overall Study|Withdrawal by Subject|2|||
33266993|NCT03184987|100877819|FG000|Overall Study|Physician Decision|0|||
33266994|NCT03184987|100877820|FG001|Overall Study|Physician Decision|0|||
33266995|NCT03184987|100877821|FG002|Overall Study|Physician Decision|1|||
33266996|NCT03184987|100877819|FG000|Overall Study|Adverse Event|1|||
33266997|NCT03184987|100877820|FG001|Overall Study|Adverse Event|0|||
33266998|NCT03184987|100877821|FG002|Overall Study|Adverse Event|1|||
33266999|NCT03905642|100877824|FG000|Overall Study|Withdrawal by Subject|3|||
33267000|NCT03905642|100877824|FG000|Overall Study|Pregnancy|1|||
33267001|NCT03905642|100877824|FG000|Overall Study|Adverse Event|1|||
33267002|NCT03905642|100877824|FG000|Overall Study|Lack of Efficacy|1|||
33267003|NCT03905642|100877824|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
33267004|NCT00786864|100877825|FG000|Overall Study|Lost to Follow-up|0|||
33267005|NCT00786864|100877826|FG001|Overall Study|Lost to Follow-up|1|||
33267006|NCT00786864|100877825|FG000|Overall Study|Sustained serious back injury|1|||
33267007|NCT00786864|100877826|FG001|Overall Study|Sustained serious back injury|0|||
33267008|NCT02646618|100877832|FG000|Overall Study|Lost to Follow-up|10|||
33267009|NCT02646618|100877833|FG001|Overall Study|Lost to Follow-up|14|||
33267010|NCT01372085|100877834|FG000|Washout Period 2|Physician Decision|0|||
33267011|NCT01372085|100877835|FG001|Washout Period 2|Physician Decision|0|||
33267012|NCT01372085|100877836|FG002|Washout Period 2|Physician Decision|0|||
33267013|NCT01372085|100877837|FG003|Washout Period 2|Physician Decision|0|||
33267014|NCT01372085|100877838|FG004|Washout Period 2|Physician Decision|1|||
33267015|NCT01372085|100877839|FG005|Washout Period 2|Physician Decision|0|||
33267016|NCT01372085|100877840|FG006|Washout Period 2|Physician Decision|0|||
33267017|NCT01372085|100877841|FG007|Washout Period 2|Physician Decision|0|||
33267018|NCT01372085|100877842|FG008|Washout Period 2|Physician Decision|0|||
33267019|NCT01372085|100877843|FG009|Washout Period 2|Physician Decision|0|||
33267020|NCT01372085|100877834|FG000|Washout Period 3|Withdrawal by Subject|0|||
33267021|NCT01372085|100877835|FG001|Washout Period 3|Withdrawal by Subject|0|||
33267022|NCT01372085|100877836|FG002|Washout Period 3|Withdrawal by Subject|0|||
33267023|NCT01372085|100877837|FG003|Washout Period 3|Withdrawal by Subject|0|||
33267024|NCT01372085|100877838|FG004|Washout Period 3|Withdrawal by Subject|0|||
33267025|NCT01372085|100877839|FG005|Washout Period 3|Withdrawal by Subject|2|||
33267026|NCT01372085|100877840|FG006|Washout Period 3|Withdrawal by Subject|0|||
33267027|NCT01372085|100877841|FG007|Washout Period 3|Withdrawal by Subject|0|||
33267028|NCT01372085|100877842|FG008|Washout Period 3|Withdrawal by Subject|0|||
33267029|NCT01372085|100877843|FG009|Washout Period 3|Withdrawal by Subject|0|||
33267030|NCT03490032|100877848|FG000|Overall Study|family issue (child custody)|1|||
33267031|NCT03490032|100877849|FG001|Overall Study|family issue (child custody)|0|||
33267032|NCT03490032|100877850|FG002|Overall Study|family issue (child custody)|0|||
33267033|NCT01555138|100877853|FG000|Overall Study|Death|0|||
33267034|NCT01555138|100877854|FG001|Overall Study|Death|1|||
33267035|NCT01555138|100877853|FG000|Overall Study|Lost to Follow-up|1|||
33267036|NCT01555138|100877854|FG001|Overall Study|Lost to Follow-up|0|||
33267037|NCT01555138|100877853|FG000|Overall Study|Abnormal Lab reults|1|||
33267038|NCT01555138|100877854|FG001|Overall Study|Abnormal Lab reults|3|||
33267039|NCT01555138|100877853|FG000|Overall Study|Lack of Efficacy|2|||
33267040|NCT01555138|100877854|FG001|Overall Study|Lack of Efficacy|2|||
33267041|NCT01555138|100877853|FG000|Overall Study|Protocol Violation|5|||
33267042|NCT01555138|100877854|FG001|Overall Study|Protocol Violation|3|||
33267043|NCT01555138|100877853|FG000|Overall Study|Administrative problems|8|||
33475333|NCT01986010|101631892|FG011|Overall Study|Lost to Follow-up|1|||
33475334|NCT01986010|101631893|FG012|Overall Study|Lost to Follow-up|1|||
33475335|NCT01986010|101631894|FG013|Overall Study|Lost to Follow-up|1|||
33475336|NCT01986010|101631895|FG014|Overall Study|Lost to Follow-up|2|||
33475337|NCT01986010|101631896|FG015|Overall Study|Lost to Follow-up|0|||
33475338|NCT01986010|101631897|FG016|Overall Study|Lost to Follow-up|0|||
33475339|NCT01986010|101631881|FG000|Overall Study|Physician Decision|0|||
33475340|NCT01986010|101631882|FG001|Overall Study|Physician Decision|0|||
33475341|NCT01986010|101631883|FG002|Overall Study|Physician Decision|0|||
33475342|NCT01986010|101631884|FG003|Overall Study|Physician Decision|0|||
33475343|NCT01986010|101631885|FG004|Overall Study|Physician Decision|0|||
33475344|NCT01986010|101631886|FG005|Overall Study|Physician Decision|0|||
33475345|NCT01986010|101631887|FG006|Overall Study|Physician Decision|0|||
33475346|NCT01986010|101631888|FG007|Overall Study|Physician Decision|0|||
33475347|NCT01986010|101631889|FG008|Overall Study|Physician Decision|0|||
33475348|NCT01986010|101631890|FG009|Overall Study|Physician Decision|0|||
33475349|NCT01986010|101631891|FG010|Overall Study|Physician Decision|0|||
33475350|NCT01986010|101631892|FG011|Overall Study|Physician Decision|0|||
33475351|NCT01986010|101631893|FG012|Overall Study|Physician Decision|0|||
33475352|NCT01986010|101631894|FG013|Overall Study|Physician Decision|0|||
33475353|NCT01986010|101631895|FG014|Overall Study|Physician Decision|1|||
33475354|NCT01986010|101631896|FG015|Overall Study|Physician Decision|0|||
33475355|NCT01986010|101631897|FG016|Overall Study|Physician Decision|0|||
33475356|NCT01986010|101631881|FG000|Overall Study|Withdrawal by Subject|2|||
33475357|NCT01986010|101631882|FG001|Overall Study|Withdrawal by Subject|2|||
33475358|NCT01986010|101631883|FG002|Overall Study|Withdrawal by Subject|3|||
33475359|NCT01986010|101631884|FG003|Overall Study|Withdrawal by Subject|0|||
33475360|NCT01986010|101631885|FG004|Overall Study|Withdrawal by Subject|2|||
33475361|NCT01986010|101631886|FG005|Overall Study|Withdrawal by Subject|4|||
33475362|NCT01986010|101631887|FG006|Overall Study|Withdrawal by Subject|0|||
33475363|NCT01986010|101631888|FG007|Overall Study|Withdrawal by Subject|0|||
33475364|NCT01986010|101631889|FG008|Overall Study|Withdrawal by Subject|0|||
33475365|NCT01986010|101631890|FG009|Overall Study|Withdrawal by Subject|0|||
33475366|NCT01986010|101631891|FG010|Overall Study|Withdrawal by Subject|0|||
33475367|NCT01986010|101631892|FG011|Overall Study|Withdrawal by Subject|2|||
33475368|NCT01986010|101631893|FG012|Overall Study|Withdrawal by Subject|0|||
33475369|NCT01986010|101631894|FG013|Overall Study|Withdrawal by Subject|1|||
33475370|NCT01986010|101631895|FG014|Overall Study|Withdrawal by Subject|2|||
33475371|NCT01986010|101631896|FG015|Overall Study|Withdrawal by Subject|0|||
33475372|NCT01986010|101631897|FG016|Overall Study|Withdrawal by Subject|0|||
33475373|NCT01986010|101631881|FG000|Overall Study|Status Not Recorded|2|||
33475374|NCT01986010|101631882|FG001|Overall Study|Status Not Recorded|4|||
33475375|NCT01986010|101631883|FG002|Overall Study|Status Not Recorded|2|||
33475376|NCT01986010|101631884|FG003|Overall Study|Status Not Recorded|0|||
33475377|NCT01986010|101631885|FG004|Overall Study|Status Not Recorded|1|||
33475378|NCT01986010|101631886|FG005|Overall Study|Status Not Recorded|2|||
33475379|NCT01986010|101631887|FG006|Overall Study|Status Not Recorded|0|||
33475380|NCT01986010|101631888|FG007|Overall Study|Status Not Recorded|0|||
33475381|NCT01986010|101631889|FG008|Overall Study|Status Not Recorded|2|||
33475382|NCT01986010|101631890|FG009|Overall Study|Status Not Recorded|1|||
33475383|NCT01986010|101631891|FG010|Overall Study|Status Not Recorded|7|||
33475384|NCT01986010|101631892|FG011|Overall Study|Status Not Recorded|7|||
33475385|NCT01986010|101631893|FG012|Overall Study|Status Not Recorded|9|||
33475386|NCT01986010|101631894|FG013|Overall Study|Status Not Recorded|9|||
33475387|NCT01986010|101631895|FG014|Overall Study|Status Not Recorded|5|||
33475388|NCT01986010|101631896|FG015|Overall Study|Status Not Recorded|10|||
33475389|NCT01986010|101631897|FG016|Overall Study|Status Not Recorded|4|||
33267044|NCT01555138|100877854|FG001|Overall Study|Administrative problems|0|||
33267045|NCT01555138|100877853|FG000|Overall Study|Withdrawal by Subject|16|||
33267046|NCT01555138|100877854|FG001|Overall Study|Withdrawal by Subject|15|||
33267047|NCT01555138|100877853|FG000|Overall Study|Adverse Event|14|||
33267048|NCT01555138|100877854|FG001|Overall Study|Adverse Event|14|||
33267049|NCT01812759|100877855|FG000|Overall Study|Physician Decision|0|||
33267050|NCT01812759|100877856|FG001|Overall Study|Physician Decision|0|||
33475390|NCT01449279|101631909|FG000|Overall Study|Lack of Efficacy|5|||
33475391|NCT01449279|101631909|FG000|Overall Study|Toxicity|2|||
33475392|NCT00228423|101631910|FG000|Overall Study|Adverse Event|2|||
33475393|NCT00228423|101631911|FG001|Overall Study|Adverse Event|5|||
33475394|NCT00228423|101631910|FG000|Overall Study|Withdrawal by Subject|7|||
33475395|NCT00228423|101631911|FG001|Overall Study|Withdrawal by Subject|3|||
33475396|NCT00228423|101631910|FG000|Overall Study|Protocol Violation|1|||
33475397|NCT00228423|101631911|FG001|Overall Study|Protocol Violation|3|||
33475398|NCT00228423|101631910|FG000|Overall Study|Physician Decision|0|||
33475399|NCT00228423|101631911|FG001|Overall Study|Physician Decision|1|||
33475400|NCT00658658|101631912|FG000|Overall Study|Withdrawal by Subject|0|||
33475401|NCT00658658|101631913|FG001|Overall Study|Withdrawal by Subject|1|||
33475402|NCT00658658|101631914|FG002|Overall Study|Withdrawal by Subject|0|||
33475403|NCT00658658|101631915|FG003|Overall Study|Withdrawal by Subject|0|||
33475404|NCT00658658|101631916|FG004|Overall Study|Withdrawal by Subject|0|||
33267051|NCT01812759|100877857|FG002|Overall Study|Physician Decision|1|||
33267052|NCT03890484|100877858|FG000|Overall Study|Lost to Follow-up|1|||
33267053|NCT03890484|100877859|FG001|Overall Study|Lost to Follow-up|1|||
33267054|NCT03057600|100877862|FG000|Overall Study|Adverse Event|0|||
33267055|NCT03057600|100877863|FG001|Overall Study|Adverse Event|0|||
33267056|NCT03057600|100877864|FG002|Overall Study|Adverse Event|4|||
33267057|NCT03057600|100877865|FG003|Overall Study|Adverse Event|0|||
33267058|NCT03057600|100877862|FG000|Overall Study|Radiologic Disease Progression|8|||
33267059|NCT03057600|100877863|FG001|Overall Study|Radiologic Disease Progression|7|||
33267060|NCT03057600|100877864|FG002|Overall Study|Radiologic Disease Progression|13|||
33267061|NCT03057600|100877865|FG003|Overall Study|Radiologic Disease Progression|10|||
33267062|NCT03057600|100877862|FG000|Overall Study|Symptomatic Deterioration|0|||
33267063|NCT03057600|100877863|FG001|Overall Study|Symptomatic Deterioration|1|||
33475405|NCT00658658|101631912|FG000|Overall Study|Death|4|||
33475406|NCT00658658|101631913|FG001|Overall Study|Death|0|||
33475407|NCT00658658|101631914|FG002|Overall Study|Death|0|||
33475408|NCT00658658|101631915|FG003|Overall Study|Death|1|||
33475409|NCT00658658|101631916|FG004|Overall Study|Death|1|||
33475410|NCT00658658|101631912|FG000|Overall Study|Disease Progression|0|||
33475411|NCT00658658|101631913|FG001|Overall Study|Disease Progression|1|||
33475412|NCT00658658|101631914|FG002|Overall Study|Disease Progression|0|||
33475413|NCT00658658|101631915|FG003|Overall Study|Disease Progression|1|||
33475414|NCT00658658|101631916|FG004|Overall Study|Disease Progression|3|||
33475415|NCT00658658|101631912|FG000|Overall Study|Protocol-specified Criteria|1|||
33475416|NCT00658658|101631913|FG001|Overall Study|Protocol-specified Criteria|0|||
33475417|NCT00658658|101631914|FG002|Overall Study|Protocol-specified Criteria|0|||
33475418|NCT00658658|101631915|FG003|Overall Study|Protocol-specified Criteria|0|||
33475419|NCT00658658|101631916|FG004|Overall Study|Protocol-specified Criteria|0|||
33475420|NCT00658658|101631912|FG000|Overall Study|Other|0|||
33475421|NCT00658658|101631913|FG001|Overall Study|Other|0|||
33475422|NCT00658658|101631914|FG002|Overall Study|Other|0|||
33475423|NCT00658658|101631915|FG003|Overall Study|Other|0|||
33475424|NCT00658658|101631916|FG004|Overall Study|Other|1|||
33475425|NCT02358343|101631917|FG000|Screening Intervention|Death|0|||
33475426|NCT02358343|101631918|FG001|Screening Intervention|Death|2|||
33475427|NCT02358343|101631919|FG002|Screening Intervention|Death|0|||
33475428|NCT02358343|101631920|FG003|Screening Intervention|Death|0|||
33475429|NCT02358343|101631921|FG004|Screening Intervention|Death|0|||
33475430|NCT02358343|101631917|FG000|Screening Intervention|Withdrawal by Subject|1|||
33475431|NCT02358343|101631918|FG001|Screening Intervention|Withdrawal by Subject|0|||
33475432|NCT02358343|101631919|FG002|Screening Intervention|Withdrawal by Subject|0|||
33475433|NCT02358343|101631920|FG003|Screening Intervention|Withdrawal by Subject|0|||
33475434|NCT02358343|101631921|FG004|Screening Intervention|Withdrawal by Subject|0|||
33475435|NCT02358343|101631917|FG000|Screening Intervention|Determined Ineligible|5|||
33475436|NCT02358343|101631918|FG001|Screening Intervention|Determined Ineligible|6|||
33475437|NCT02358343|101631919|FG002|Screening Intervention|Determined Ineligible|0|||
33475438|NCT02358343|101631920|FG003|Screening Intervention|Determined Ineligible|0|||
33475439|NCT02358343|101631921|FG004|Screening Intervention|Determined Ineligible|0|||
33475440|NCT02358343|101631917|FG000|Comparative Efficacy Trial / Observation|Death|0|||
33475441|NCT02358343|101631918|FG001|Comparative Efficacy Trial / Observation|Death|0|||
33475442|NCT02358343|101631919|FG002|Comparative Efficacy Trial / Observation|Death|2|||
33475443|NCT02358343|101631920|FG003|Comparative Efficacy Trial / Observation|Death|0|||
33475444|NCT02358343|101631921|FG004|Comparative Efficacy Trial / Observation|Death|0|||
33475445|NCT02358343|101631917|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
33475446|NCT02358343|101631918|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
33475447|NCT02358343|101631919|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
33267064|NCT03057600|100877864|FG002|Overall Study|Symptomatic Deterioration|1|||
33267065|NCT03057600|100877865|FG003|Overall Study|Symptomatic Deterioration|0|||
33267066|NCT03057600|100877862|FG000|Overall Study|Investigator Decision|0|||
33267067|NCT03057600|100877863|FG001|Overall Study|Investigator Decision|0|||
33267068|NCT03057600|100877864|FG002|Overall Study|Investigator Decision|1|||
33267069|NCT03057600|100877865|FG003|Overall Study|Investigator Decision|0|||
33475448|NCT02358343|101631920|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
33475449|NCT02358343|101631921|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
33475450|NCT02358343|101631917|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
33267070|NCT03057600|100877862|FG000|Overall Study|Study Termination by Sponsor|0|||
33475451|NCT02358343|101631918|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
33475452|NCT02358343|101631919|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
33475453|NCT02358343|101631920|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
33475454|NCT02358343|101631921|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
33267071|NCT03057600|100877863|FG001|Overall Study|Study Termination by Sponsor|0|||
33267072|NCT03057600|100877864|FG002|Overall Study|Study Termination by Sponsor|0|||
33267073|NCT03057600|100877865|FG003|Overall Study|Study Termination by Sponsor|2|||
33267074|NCT03057600|100877862|FG000|Overall Study|Withdrawal by Subject|0|||
33475455|NCT02128217|101631925|FG000|Overall Study|Lost to Follow-up|0|||
33475456|NCT02128217|101631926|FG001|Overall Study|Lost to Follow-up|1|||
33475457|NCT04319159|101631927|FG000|Overall Study|Screening failure|13|||
33475458|NCT04319159|101631927|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
33475459|NCT04319159|101631927|FG000|Overall Study|Withdrawal by Subject|1|||
33475460|NCT00856830|101631928|FG000|Irinotecan & Bendamustine|Death|0|||
33475461|NCT00856830|101631929|FG001|Irinotecan & Bendamustine|Death|0|||
33475462|NCT00856830|101631930|FG002|Irinotecan & Bendamustine|Death|0|||
33475463|NCT00856830|101631931|FG003|Irinotecan & Bendamustine|Death|2|||
33475464|NCT00856830|101631928|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
33267075|NCT03057600|100877863|FG001|Overall Study|Withdrawal by Subject|1|||
33267076|NCT03057600|100877864|FG002|Overall Study|Withdrawal by Subject|0|||
33267077|NCT03057600|100877865|FG003|Overall Study|Withdrawal by Subject|0|||
33267078|NCT03057600|100877862|FG000|Overall Study|Other, Not Specified|1|||
33475465|NCT00856830|101631929|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
33475466|NCT00856830|101631930|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
33475467|NCT00856830|101631931|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
33475468|NCT01995266|101631932|FG000|Overall Study|Death|1|||
33475469|NCT01995266|101631932|FG000|Overall Study|Lack of Efficacy|6|||
33475470|NCT01995266|101631932|FG000|Overall Study|Adverse Event|2|||
33475471|NCT00302081|101631934|FG000|Overall Study|Adverse Event|6|||
33475472|NCT00302081|101631935|FG001|Overall Study|Adverse Event|5|||
33475473|NCT00302081|101631936|FG002|Overall Study|Adverse Event|4|||
33475474|NCT00302081|101631934|FG000|Overall Study|Lost to Follow-up|21|||
33475475|NCT00302081|101631935|FG001|Overall Study|Lost to Follow-up|18|||
33475476|NCT00302081|101631936|FG002|Overall Study|Lost to Follow-up|28|||
33475477|NCT00302081|101631934|FG000|Overall Study|Withdrawal by Subject|8|||
33475478|NCT00302081|101631935|FG001|Overall Study|Withdrawal by Subject|12|||
33475479|NCT00302081|101631936|FG002|Overall Study|Withdrawal by Subject|8|||
33475480|NCT00302081|101631934|FG000|Overall Study|Protocol Violation|5|||
33475481|NCT00302081|101631935|FG001|Overall Study|Protocol Violation|1|||
33475482|NCT00302081|101631936|FG002|Overall Study|Protocol Violation|2|||
33475483|NCT00302081|101631934|FG000|Overall Study|Lack of Efficacy|1|||
33475484|NCT00302081|101631935|FG001|Overall Study|Lack of Efficacy|0|||
33475485|NCT00302081|101631936|FG002|Overall Study|Lack of Efficacy|5|||
33475486|NCT00302081|101631934|FG000|Overall Study|Death|2|||
33475487|NCT00302081|101631935|FG001|Overall Study|Death|1|||
33475488|NCT00302081|101631936|FG002|Overall Study|Death|0|||
33475489|NCT00302081|101631934|FG000|Overall Study|Other|13|||
33475490|NCT00302081|101631935|FG001|Overall Study|Other|6|||
33475491|NCT00302081|101631936|FG002|Overall Study|Other|5|||
33475492|NCT02987959|101631937|FG000|Overall Study|Grantor stopped supply of drugs|6|||
33267079|NCT03057600|100877863|FG001|Overall Study|Other, Not Specified|1|||
33267080|NCT03057600|100877864|FG002|Overall Study|Other, Not Specified|1|||
33267081|NCT03057600|100877865|FG003|Overall Study|Other, Not Specified|1|||
33267082|NCT01957163|100877866|FG000|Overall Study|Adverse Event|5|||
33267083|NCT01957163|100877867|FG001|Overall Study|Adverse Event|2|||
33267084|NCT01957163|100877868|FG002|Overall Study|Adverse Event|4|||
33267085|NCT01957163|100877866|FG000|Overall Study|Lack of Efficacy|5|||
33267086|NCT01957163|100877867|FG001|Overall Study|Lack of Efficacy|4|||
33267087|NCT01957163|100877868|FG002|Overall Study|Lack of Efficacy|9|||
33267088|NCT01957163|100877866|FG000|Overall Study|Protocol Violation|1|||
33267089|NCT01957163|100877867|FG001|Overall Study|Protocol Violation|2|||
33267090|NCT01957163|100877868|FG002|Overall Study|Protocol Violation|0|||
33267091|NCT01957163|100877866|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
33267092|NCT01957163|100877867|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
33267093|NCT01957163|100877868|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
33267094|NCT01957163|100877866|FG000|Overall Study|Lost to Follow-up|0|||
33267095|NCT01957163|100877867|FG001|Overall Study|Lost to Follow-up|1|||
33267096|NCT01957163|100877868|FG002|Overall Study|Lost to Follow-up|0|||
33267097|NCT01957163|100877866|FG000|Overall Study|Withdrawal by Subject|4|||
33267098|NCT01957163|100877867|FG001|Overall Study|Withdrawal by Subject|2|||
33475493|NCT00424775|101631938|FG000|Overall Study|Adverse Event|2|||
33475494|NCT00424775|101631939|FG001|Overall Study|Adverse Event|0|||
33475495|NCT00424775|101631938|FG000|Overall Study|Lack of Efficacy|1|||
33267099|NCT01957163|100877868|FG002|Overall Study|Withdrawal by Subject|4|||
33267100|NCT01989689|100877869|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
33267101|NCT01989689|100877870|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
33267102|NCT01989689|100877869|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
33475496|NCT00424775|101631939|FG001|Overall Study|Lack of Efficacy|0|||
33475497|NCT00757848|101631940|FG000|Overall Study|Voluntary discontinuation|1|||
33475498|NCT00757848|101631941|FG001|Overall Study|Voluntary discontinuation|0|||
33475499|NCT00757848|101631940|FG000|Overall Study|Adverse Event|1|||
33475500|NCT00757848|101631941|FG001|Overall Study|Adverse Event|2|||
33475501|NCT00757848|101631940|FG000|Overall Study|Incorrect enrolment|1|||
33267103|NCT01989689|100877870|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
33267104|NCT04248868|100877872|FG000|Overall Study|Death|1|||
33475502|NCT00757848|101631941|FG001|Overall Study|Incorrect enrolment|0|||
33267105|NCT04248868|100877872|FG000|Overall Study|Lost to Follow-up|3|||
33267106|NCT04248868|100877872|FG000|Overall Study|Protocol Violation|2|||
33267107|NCT02630966|100877874|FG000|Overall Study|Adverse Event|1|||
33267108|NCT02630966|100877875|FG001|Overall Study|Adverse Event|3|||
33475503|NCT04421586|101631942|FG000|Overall Study|Death|0|||
33475504|NCT04421586|101631943|FG001|Overall Study|Death|1|||
33475505|NCT04421586|101631942|FG000|Overall Study|Lost to Follow-up|2|||
33475506|NCT04421586|101631943|FG001|Overall Study|Lost to Follow-up|2|||
33475507|NCT04421586|101631942|FG000|Overall Study|Withdrawn by PI|1|||
33475508|NCT04421586|101631943|FG001|Overall Study|Withdrawn by PI|0|||
33475509|NCT04421586|101631942|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
33475510|NCT04421586|101631943|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
33475511|NCT00714493|101631944|FG000|Overall Study|Adverse Event|11|||
33475512|NCT00714493|101631944|FG000|Overall Study|Death|3|||
33475513|NCT00714493|101631944|FG000|Overall Study|Lack of Efficacy|10|||
33475514|NCT00714493|101631944|FG000|Overall Study|Lost to Follow-up|3|||
33475515|NCT00714493|101631944|FG000|Overall Study|Protocol Violation|12|||
33475516|NCT00714493|101631944|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
33475517|NCT00714493|101631944|FG000|Overall Study|OTHER|2|||
33475518|NCT00761865|101631945|FG000|Overall Study|Lost to Follow-up|8|||
33475519|NCT00761865|101631946|FG001|Overall Study|Lost to Follow-up|7|||
33475520|NCT03052959|101631949|FG000|Overall Study|Lost to Follow-up|4|||
33475521|NCT03052959|101631950|FG001|Overall Study|Lost to Follow-up|5|||
33475522|NCT01249365|101631951|FG000|Overall Study|Lost to Follow-up|1|||
33475523|NCT03582826|101631952|FG000|Overall Study|Lost to Follow-up|39|||
33475524|NCT03582826|101631953|FG001|Overall Study|Lost to Follow-up|0|||
33475525|NCT03582826|101631952|FG000|Overall Study|Withdrawal by Subject|2|||
33475526|NCT03582826|101631953|FG001|Overall Study|Withdrawal by Subject|0|||
33475527|NCT03251963|101631954|FG000|Overall Study|inappropriate Xa level timing|6|||
33475528|NCT03251963|101631955|FG001|Overall Study|inappropriate Xa level timing|3|||
33475529|NCT03251963|101631954|FG000|Overall Study|no peak Xa level drawn|2|||
33475530|NCT03251963|101631955|FG001|Overall Study|no peak Xa level drawn|0|||
33475531|NCT03251963|101631954|FG000|Overall Study|bled prior to Xa level|1|||
33475532|NCT03251963|101631955|FG001|Overall Study|bled prior to Xa level|2|||
33475533|NCT01680497|101631960|FG000|Overall Study|Lost to Follow-up|2|||
33475534|NCT04319718|101631961|FG000|Overall Study|Adverse Event|0|||
33475535|NCT04319718|101631962|FG001|Overall Study|Adverse Event|2|||
33475536|NCT04319718|101631961|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
33475537|NCT04319718|101631962|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
33475538|NCT03247517|101631963|FG000|Overall Study|Adverse Event|0|||
33475539|NCT03247517|101631964|FG001|Overall Study|Adverse Event|4|||
33475540|NCT03247517|101631965|FG002|Overall Study|Adverse Event|2|||
33475541|NCT03247517|101631963|FG000|Overall Study|Lost to Follow-up|2|||
33475542|NCT03247517|101631964|FG001|Overall Study|Lost to Follow-up|6|||
33475543|NCT03247517|101631965|FG002|Overall Study|Lost to Follow-up|4|||
33475544|NCT03247517|101631963|FG000|Overall Study|Consent withdrawn by caregiver|1|||
33475545|NCT03247517|101631964|FG001|Overall Study|Consent withdrawn by caregiver|4|||
33475546|NCT03247517|101631965|FG002|Overall Study|Consent withdrawn by caregiver|7|||
33475547|NCT03247517|101631963|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
33475548|NCT03247517|101631964|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
33475549|NCT03247517|101631965|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
33475550|NCT03247517|101631963|FG000|Overall Study|Protocol Violation|0|||
33475551|NCT03247517|101631964|FG001|Overall Study|Protocol Violation|2|||
33475552|NCT03247517|101631965|FG002|Overall Study|Protocol Violation|0|||
33475553|NCT03247517|101631963|FG000|Overall Study|Multiple reasons|3|||
33475554|NCT03247517|101631964|FG001|Overall Study|Multiple reasons|1|||
33267109|NCT02630966|100877874|FG000|Overall Study|Significant Protocol Deviation|0|||
33267110|NCT02630966|100877875|FG001|Overall Study|Significant Protocol Deviation|2|||
33267111|NCT02630966|100877874|FG000|Overall Study|Voluntary Withdrawal|1|||
33267112|NCT02630966|100877875|FG001|Overall Study|Voluntary Withdrawal|1|||
33267113|NCT02630966|100877874|FG000|Overall Study|Lack of Efficacy|0|||
33267114|NCT02630966|100877875|FG001|Overall Study|Lack of Efficacy|2|||
33267115|NCT01619059|100877876|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
33267116|NCT01619059|100877877|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
33267117|NCT01619059|100877876|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
33267118|NCT01619059|100877877|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
33267119|NCT01619059|100877876|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
33267120|NCT01619059|100877877|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
33267121|NCT01619059|100877876|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
33267122|NCT01619059|100877877|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
33475555|NCT03247517|101631965|FG002|Overall Study|Multiple reasons|0|||
33475556|NCT00380692|101631971|FG000|Study Period II - Double Blind|Adverse Event|1|||
33475557|NCT00380692|101631972|FG001|Study Period II - Double Blind|Adverse Event|0|||
33475558|NCT00380692|101631971|FG000|Study Period II - Double Blind|Protocol Violation|2|||
33475559|NCT00380692|101631972|FG001|Study Period II - Double Blind|Protocol Violation|2|||
33475560|NCT00380692|101631971|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
33475561|NCT00380692|101631972|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
33475562|NCT00380692|101631971|FG000|Study Period II - Double Blind|Physician Decision|0|||
33475563|NCT00380692|101631972|FG001|Study Period II - Double Blind|Physician Decision|1|||
33475564|NCT00380692|101631971|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
33475565|NCT00380692|101631972|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
33267123|NCT01619059|100877876|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
33267124|NCT01619059|100877877|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
33267125|NCT01619059|100877876|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
33267126|NCT01619059|100877877|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
33267127|NCT01619059|100877876|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
33267128|NCT01619059|100877877|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
33267129|NCT01619059|100877876|FG000|Long-Term (LT) Treatment Period|Death|1|||
33267130|NCT01619059|100877877|FG001|Long-Term (LT) Treatment Period|Death|0|||
33267131|NCT01619059|100877876|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
33267132|NCT01619059|100877877|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
33267133|NCT01619059|100877876|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
33267134|NCT01619059|100877877|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
33267135|NCT03418545|100877878|FG000|Overall Study|Withdrawal by Participant|2|||
33267136|NCT03418545|100877879|FG001|Overall Study|Withdrawal by Participant|4|||
33267137|NCT03418545|100877878|FG000|Overall Study|Lost to Follow-up|3|||
33267138|NCT03418545|100877879|FG001|Overall Study|Lost to Follow-up|5|||
33267139|NCT03418545|100877878|FG000|Overall Study|Reason Not Specified|0|||
33267140|NCT03418545|100877879|FG001|Overall Study|Reason Not Specified|1|||
33267141|NCT03418545|100877878|FG000|Overall Study|Missing Completion Status|0|||
33267142|NCT03418545|100877879|FG001|Overall Study|Missing Completion Status|1|||
33267143|NCT01450007|100877880|FG000|Overall Study|Late exclusion before treatment|2|||
33267144|NCT01450007|100877881|FG001|Overall Study|Late exclusion before treatment|3|||
33267145|NCT01450007|100877882|FG002|Overall Study|Late exclusion before treatment|2|||
33267146|NCT01450007|100877880|FG000|Overall Study|Protocol Violation|0|||
33267147|NCT01450007|100877881|FG001|Overall Study|Protocol Violation|1|||
33267148|NCT01450007|100877882|FG002|Overall Study|Protocol Violation|1|||
33267149|NCT01450007|100877880|FG000|Overall Study|Adverse Event|0|||
33267150|NCT01450007|100877881|FG001|Overall Study|Adverse Event|1|||
33267151|NCT01450007|100877882|FG002|Overall Study|Adverse Event|0|||
33267152|NCT02644122|100877885|FG000|Overall Study|Withdrawal by Subject|1|||
33267153|NCT05270460|100877886|FG000|Overall Study|Adverse Event|0|||
33267154|NCT05270460|100877887|FG001|Overall Study|Adverse Event|1|||
33267155|NCT05270460|100877888|FG002|Overall Study|Adverse Event|0|||
33267156|NCT05270460|100877886|FG000|Overall Study|Early Termination|0|||
33267157|NCT05270460|100877887|FG001|Overall Study|Early Termination|1|||
33267158|NCT05270460|100877888|FG002|Overall Study|Early Termination|0|||
33267159|NCT01079806|100877889|FG000|Day 1 to Week 96|Adverse Event|0|||
33267160|NCT01079806|100877890|FG001|Day 1 to Week 96|Adverse Event|3|||
33267161|NCT01079806|100877889|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
33267162|NCT01079806|100877890|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
33267163|NCT01079806|100877889|FG000|Day 1 to Week 96|Pregnancy|0|||
33267164|NCT01079806|100877890|FG001|Day 1 to Week 96|Pregnancy|1|||
33267165|NCT01079806|100877889|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
33267166|NCT01079806|100877890|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
33267167|NCT01079806|100877889|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
33267168|NCT01079806|100877890|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
33267169|NCT01079806|100877889|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
33267170|NCT01079806|100877890|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
33267171|NCT01079806|100877889|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
33267172|NCT01079806|100877890|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
33267173|NCT01079806|100877889|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
33267174|NCT01079806|100877890|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
33267175|NCT01079806|100877889|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
33267176|NCT01079806|100877890|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
33267177|NCT01079806|100877889|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
33267178|NCT01079806|100877890|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
33267179|NCT00890591|100877895|FG000|Overall Study|Lack of Efficacy|20|||
33267180|NCT02760654|100877898|FG000|Overall Study|Lost to Follow-up|3|||
33267181|NCT02760654|100877899|FG001|Overall Study|Lost to Follow-up|3|||
33267182|NCT02760654|100877898|FG000|Overall Study|Withdrawal by Subject|4|||
33267183|NCT02760654|100877899|FG001|Overall Study|Withdrawal by Subject|3|||
33475566|NCT00380692|101631971|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
33267184|NCT02410278|100877900|FG000|Run-in Period|Adverse Event|5|||
33267185|NCT02410278|100877901|FG001|Run-in Period|Adverse Event|0|||
33475567|NCT00380692|101631972|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
33475568|NCT00380692|101631971|FG000|Study Period III - Open Label|Adverse Event|5|||
33475569|NCT00380692|101631972|FG001|Study Period III - Open Label|Adverse Event|3|||
33475570|NCT00380692|101631971|FG000|Study Period III - Open Label|Protocol Violation|0|||
33475571|NCT00380692|101631972|FG001|Study Period III - Open Label|Protocol Violation|0|||
33475572|NCT00380692|101631971|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
33475573|NCT00380692|101631972|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
33475574|NCT00380692|101631971|FG000|Study Period III - Open Label|Physician Decision|0|||
33475575|NCT00380692|101631972|FG001|Study Period III - Open Label|Physician Decision|3|||
33475576|NCT00380692|101631971|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
33475577|NCT00380692|101631972|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
33475578|NCT00380692|101631971|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
33475579|NCT00380692|101631972|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
33475580|NCT04280705|101631975|FG000|Overall Study|Enrolled but not treated|4|||
33475581|NCT04280705|101631976|FG001|Overall Study|Enrolled but not treated|10|||
33475582|NCT04280705|101631975|FG000|Overall Study|Physician Decision|1|||
33475583|NCT04280705|101631976|FG001|Overall Study|Physician Decision|0|||
33475584|NCT04280705|101631975|FG000|Overall Study|Withdrawal by Subject|7|||
33475585|NCT04280705|101631976|FG001|Overall Study|Withdrawal by Subject|9|||
33475586|NCT04280705|101631975|FG000|Overall Study|Adverse Event|0|||
33475587|NCT04280705|101631976|FG001|Overall Study|Adverse Event|4|||
33475588|NCT04280705|101631975|FG000|Overall Study|Transferred to another hospital|1|||
33475589|NCT04280705|101631976|FG001|Overall Study|Transferred to another hospital|1|||
33475590|NCT02307266|101631977|FG000|Overall Study|Adverse Event|3|||
33475591|NCT02307266|101631978|FG001|Overall Study|Adverse Event|1|||
33475592|NCT02307266|101631979|FG002|Overall Study|Adverse Event|5|||
33475593|NCT02307266|101631977|FG000|Overall Study|Withdrawal by Subject|2|||
33475594|NCT02307266|101631978|FG001|Overall Study|Withdrawal by Subject|0|||
33475595|NCT02307266|101631979|FG002|Overall Study|Withdrawal by Subject|1|||
33475596|NCT02307266|101631977|FG000|Overall Study|Lost to Follow-up|3|||
33475597|NCT02307266|101631978|FG001|Overall Study|Lost to Follow-up|0|||
33475598|NCT02307266|101631979|FG002|Overall Study|Lost to Follow-up|0|||
33475599|NCT02582866|101631980|FG000|Overall Study|Death|1|||
33475600|NCT02582866|101631980|FG000|Overall Study|Lack of Efficacy|2|||
33475601|NCT02582866|101631980|FG000|Overall Study|Lost to Follow-up|2|||
33475602|NCT02582866|101631980|FG000|Overall Study|Withdrawal by Subject|7|||
33475603|NCT02582866|101631980|FG000|Overall Study|Investigator decision|5|||
33475604|NCT02582866|101631980|FG000|Overall Study|Participant wants to get pregnant|1|||
33475605|NCT02582866|101631980|FG000|Overall Study|Pregnancy|2|||
33475606|NCT02582866|101631980|FG000|Overall Study|Sponsor decision|1|||
33475607|NCT02582866|101631980|FG000|Overall Study|Withdrawal due to personal reasons|1|||
33475608|NCT04740814|101635733|FG000|Overall Study|Adverse Event|3|||
33475609|NCT04740814|101635733|FG000|Overall Study|Protocol Violation|2|||
33475610|NCT04740814|101635733|FG000|Overall Study|Lost to Follow-up|2|||
33475611|NCT04740814|101635733|FG000|Overall Study|Withdrawal by Subject|3|||
33475612|NCT01102374|101635734|FG000|Overall Study|Death|9|||
33475613|NCT01102374|101635735|FG001|Overall Study|Death|13|||
33475614|NCT01102374|101635734|FG000|Overall Study|Lost to Follow-up|7|||
33475615|NCT01102374|101635735|FG001|Overall Study|Lost to Follow-up|6|||
33475616|NCT00171301|101635742|FG000|Overall Study|Death|1|||
33475617|NCT00171301|101635743|FG001|Overall Study|Death|2|||
33475618|NCT00171301|101635742|FG000|Overall Study|Adverse Event|1|||
33475619|NCT00171301|101635743|FG001|Overall Study|Adverse Event|2|||
33267186|NCT02410278|100877902|FG002|Run-in Period|Adverse Event|0|||
33267187|NCT02410278|100877900|FG000|Run-in Period|GSRS Threshold Not Met|30|||
33267188|NCT02410278|100877901|FG001|Run-in Period|GSRS Threshold Not Met|0|||
33267189|NCT02410278|100877902|FG002|Run-in Period|GSRS Threshold Not Met|0|||
33267190|NCT02410278|100877900|FG000|Run-in Period|Lost to Follow-up|1|||
33267191|NCT02410278|100877901|FG001|Run-in Period|Lost to Follow-up|0|||
33267192|NCT02410278|100877902|FG002|Run-in Period|Lost to Follow-up|0|||
33267193|NCT02410278|100877900|FG000|Run-in Period|Withdrawal by Subject|1|||
33267194|NCT02410278|100877901|FG001|Run-in Period|Withdrawal by Subject|0|||
33267195|NCT02410278|100877902|FG002|Run-in Period|Withdrawal by Subject|0|||
33475620|NCT00171301|101635742|FG000|Overall Study|Lost to Follow-up|6|||
33475621|NCT00171301|101635743|FG001|Overall Study|Lost to Follow-up|2|||
33475622|NCT00171301|101635742|FG000|Overall Study|Protocol Violation|0|||
33267196|NCT02410278|100877900|FG000|Run-in Period|Pregnancy|1|||
33267197|NCT02410278|100877901|FG001|Run-in Period|Pregnancy|0|||
33475623|NCT00171301|101635743|FG001|Overall Study|Protocol Violation|2|||
33267198|NCT02410278|100877902|FG002|Run-in Period|Pregnancy|0|||
33267199|NCT02410278|100877900|FG000|Study Treatment Period|Adverse Event|0|||
33267200|NCT02410278|100877901|FG001|Study Treatment Period|Adverse Event|6|||
33475624|NCT00171301|101635742|FG000|Overall Study|Withdrawal by Subject|0|||
33475625|NCT00171301|101635743|FG001|Overall Study|Withdrawal by Subject|1|||
33475626|NCT02534844|101635744|FG000|Part B|Withdrawal by Subject|0|||
33475627|NCT02534844|101635745|FG001|Part B|Withdrawal by Subject|0|||
33475628|NCT02534844|101635746|FG002|Part B|Withdrawal by Subject|0|||
33475629|NCT02534844|101635747|FG003|Part B|Withdrawal by Subject|0|||
33475630|NCT02534844|101635748|FG004|Part B|Withdrawal by Subject|2|||
33475631|NCT02534844|101635749|FG005|Part B|Withdrawal by Subject|1|||
33267201|NCT02410278|100877902|FG002|Study Treatment Period|Adverse Event|3|||
33267202|NCT02410278|100877900|FG000|Study Treatment Period|Physician Decision|0|||
33267203|NCT02410278|100877901|FG001|Study Treatment Period|Physician Decision|0|||
33267204|NCT02410278|100877902|FG002|Study Treatment Period|Physician Decision|1|||
33267205|NCT02410278|100877900|FG000|Study Treatment Period|Withdrawal by Subject|0|||
33267206|NCT02410278|100877901|FG001|Study Treatment Period|Withdrawal by Subject|1|||
33267207|NCT02410278|100877902|FG002|Study Treatment Period|Withdrawal by Subject|0|||
33267208|NCT02410278|100877900|FG000|Study Treatment Period|Other|0|||
33267209|NCT02410278|100877901|FG001|Study Treatment Period|Other|3|||
33267210|NCT02410278|100877902|FG002|Study Treatment Period|Other|0|||
33267211|NCT02410278|100877900|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
33267212|NCT02410278|100877901|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
33267213|NCT02410278|100877902|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
33267214|NCT00713596|100877905|FG000|Overall Study|Study was terminated|2|||
33267215|NCT00713596|100877906|FG001|Overall Study|Study was terminated|3|||
33267216|NCT00713596|100877907|FG002|Overall Study|Study was terminated|2|||
33267217|NCT00747006|100877908|FG000|Overall Study|Adverse Event|1|||
33267218|NCT00747006|100877909|FG001|Overall Study|Adverse Event|0|||
33267219|NCT00747006|100877910|FG002|Overall Study|Adverse Event|0|||
33267220|NCT00747006|100877908|FG000|Overall Study|Lost to Follow-up|0|||
33267221|NCT00747006|100877909|FG001|Overall Study|Lost to Follow-up|1|||
33267222|NCT00747006|100877910|FG002|Overall Study|Lost to Follow-up|0|||
33475632|NCT01968694|101635750|FG000|Washout (1 Month)|Lost to Follow-up|0|||
33475633|NCT01968694|101635751|FG001|Washout (1 Month)|Lost to Follow-up|1|||
33475634|NCT03822832|101635763|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
33475635|NCT03822832|101635764|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
33475636|NCT03822832|101635763|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
33475637|NCT03822832|101635764|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
33475638|NCT03822832|101635763|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
33475639|NCT03822832|101635764|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
33475640|NCT03822832|101635763|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
33475641|NCT03822832|101635764|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
33475642|NCT03822832|101635763|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
33475643|NCT03822832|101635764|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
33475644|NCT03822832|101635763|FG000|Re-allocation|Not re-allocated to open label period|2|||
33475645|NCT03822832|101635764|FG001|Re-allocation|Not re-allocated to open label period|6|||
33475646|NCT03822832|101635763|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
33475647|NCT03822832|101635764|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
33475648|NCT03822832|101635763|FG000|Period 2 - Open Label Period|Adverse Event|0|||
33475649|NCT03822832|101635764|FG001|Period 2 - Open Label Period|Adverse Event|3|||
33267223|NCT00747006|100877908|FG000|Overall Study|Physician Decision|2|||
33267224|NCT00747006|100877909|FG001|Overall Study|Physician Decision|0|||
33267225|NCT00747006|100877910|FG002|Overall Study|Physician Decision|1|||
33267226|NCT00022672|100877921|FG000|Main Phase: 24 Months|Adverse Event|6|||
33267227|NCT00022672|100877922|FG001|Main Phase: 24 Months|Adverse Event|0|||
33267228|NCT00022672|100877921|FG000|Main Phase: 24 Months|Death|0|||
33267229|NCT00022672|100877922|FG001|Main Phase: 24 Months|Death|3|||
33267230|NCT00022672|100877921|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
33475650|NCT02858492|101635765|FG000|Overall Study|Withdrawal by Subject|0|||
33475651|NCT02858492|101635766|FG001|Overall Study|Withdrawal by Subject|1|||
33475652|NCT02858492|101635767|FG002|Overall Study|Withdrawal by Subject|0|||
33475653|NCT02858492|101635768|FG003|Overall Study|Withdrawal by Subject|1|||
33475654|NCT02858492|101635765|FG000|Overall Study|Adverse Event|0|||
33475655|NCT02858492|101635766|FG001|Overall Study|Adverse Event|0|||
33475656|NCT02858492|101635767|FG002|Overall Study|Adverse Event|0|||
33475657|NCT02858492|101635768|FG003|Overall Study|Adverse Event|3|||
33475658|NCT02858492|101635765|FG000|Overall Study|Lack of Efficacy|0|||
33475659|NCT02858492|101635766|FG001|Overall Study|Lack of Efficacy|0|||
33475660|NCT02858492|101635767|FG002|Overall Study|Lack of Efficacy|0|||
33475661|NCT02858492|101635768|FG003|Overall Study|Lack of Efficacy|1|||
33475662|NCT02858492|101635765|FG000|Overall Study|Protocol defined stopping criteria|0|||
33475663|NCT02858492|101635766|FG001|Overall Study|Protocol defined stopping criteria|0|||
33267231|NCT00022672|100877922|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
33267232|NCT00022672|100877921|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
33475664|NCT02858492|101635767|FG002|Overall Study|Protocol defined stopping criteria|0|||
33267233|NCT00022672|100877922|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
33267234|NCT00022672|100877921|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
33267235|NCT00022672|100877922|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
33267236|NCT00022672|100877921|FG000|Main Phase: 24 Months|Refused Treatment|3|||
33267237|NCT00022672|100877922|FG001|Main Phase: 24 Months|Refused Treatment|4|||
33267238|NCT00022672|100877921|FG000|Main Phase: 24 Months|Failure to Return|1|||
33267239|NCT00022672|100877922|FG001|Main Phase: 24 Months|Failure to Return|1|||
33475665|NCT02858492|101635768|FG003|Overall Study|Protocol defined stopping criteria|1|||
33475666|NCT01939496|101635769|FG000|Overall Study|Adverse Event|2|||
33267240|NCT00022672|100877921|FG000|Main Phase: 24 Months|Other|1|||
33267241|NCT00022672|100877922|FG001|Main Phase: 24 Months|Other|0|||
33267242|NCT00022672|100877921|FG000|Extension Phase|Adverse Event|1|||
33475667|NCT01939496|101635770|FG001|Overall Study|Adverse Event|0|||
33475668|NCT01939496|101635771|FG002|Overall Study|Adverse Event|0|||
33475669|NCT01939496|101635769|FG000|Overall Study|Lost to Follow-up|1|||
33475670|NCT01939496|101635770|FG001|Overall Study|Lost to Follow-up|1|||
33475671|NCT01939496|101635771|FG002|Overall Study|Lost to Follow-up|0|||
33475672|NCT01939496|101635769|FG000|Overall Study|Physician Decision|1|||
33475673|NCT01939496|101635770|FG001|Overall Study|Physician Decision|0|||
33475674|NCT01939496|101635771|FG002|Overall Study|Physician Decision|0|||
33475675|NCT01939496|101635769|FG000|Overall Study|Protocol Violation|3|||
33475676|NCT01939496|101635770|FG001|Overall Study|Protocol Violation|0|||
33475677|NCT01939496|101635771|FG002|Overall Study|Protocol Violation|0|||
33475678|NCT01939496|101635769|FG000|Overall Study|Withdrawal by Subject|0|||
33475679|NCT01939496|101635770|FG001|Overall Study|Withdrawal by Subject|1|||
33475680|NCT01939496|101635771|FG002|Overall Study|Withdrawal by Subject|1|||
33475681|NCT01939496|101635769|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
33475682|NCT01939496|101635770|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
33475683|NCT01939496|101635771|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
33475684|NCT01939496|101635769|FG000|Overall Study|Other|2|||
33475685|NCT01939496|101635770|FG001|Overall Study|Other|0|||
33475686|NCT01939496|101635771|FG002|Overall Study|Other|1|||
33475687|NCT00706511|101635772|FG000|Overall Study|Withdrawal by Subject|1|||
33475688|NCT00706511|101635773|FG001|Overall Study|Withdrawal by Subject|0|||
33475689|NCT00706511|101635774|FG002|Overall Study|Withdrawal by Subject|0|||
33475690|NCT00706511|101635775|FG003|Overall Study|Withdrawal by Subject|0|||
33475691|NCT01593696|101635776|FG000|Dose Escalation|Progressive Disease|2|||
33475692|NCT01593696|101635777|FG001|Dose Escalation|Progressive Disease|0|||
33475693|NCT01593696|101635778|FG002|Dose Escalation|Progressive Disease|0|||
33475694|NCT01593696|101635779|FG003|Dose Escalation|Progressive Disease|0|||
33475695|NCT01593696|101635776|FG000|Dose Expansion|Fungal infection|0|||
33475696|NCT01593696|101635777|FG001|Dose Expansion|Fungal infection|0|||
33475697|NCT01593696|101635778|FG002|Dose Expansion|Fungal infection|1|||
33475698|NCT01593696|101635779|FG003|Dose Expansion|Fungal infection|0|||
33475699|NCT00960115|101635780|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
33475700|NCT00960115|101635781|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
33475701|NCT00893737|101635788|FG000|Overall Study|Adverse Event|4|||
33475702|NCT00893737|101635788|FG000|Overall Study|Withdrawal by Subject|2|||
33475703|NCT00893737|101635788|FG000|Overall Study|Lost to Follow-up|6|||
33475704|NCT02038907|101635794|FG000|Overall Study|Protocol Violation|0|||
33475705|NCT02038907|101635795|FG001|Overall Study|Protocol Violation|0|||
33475706|NCT02038907|101635796|FG002|Overall Study|Protocol Violation|0|||
33475707|NCT02038907|101635797|FG003|Overall Study|Protocol Violation|0|||
33475708|NCT02038907|101635798|FG004|Overall Study|Protocol Violation|0|||
33475709|NCT02038907|101635799|FG005|Overall Study|Protocol Violation|0|||
33475710|NCT02038907|101635800|FG006|Overall Study|Protocol Violation|0|||
33475711|NCT02038907|101635801|FG007|Overall Study|Protocol Violation|0|||
33475712|NCT02038907|101635802|FG008|Overall Study|Protocol Violation|0|||
33475713|NCT02038907|101635803|FG009|Overall Study|Protocol Violation|0|||
33475714|NCT02038907|101635804|FG010|Overall Study|Protocol Violation|1|||
33475715|NCT02038907|101635805|FG011|Overall Study|Protocol Violation|0|||
33475716|NCT02038907|101635806|FG012|Overall Study|Protocol Violation|0|||
33475717|NCT02038907|101635807|FG013|Overall Study|Protocol Violation|0|||
33475718|NCT02038907|101635794|FG000|Overall Study|Withdrawal by Subject|0|||
33267243|NCT00022672|100877922|FG001|Extension Phase|Adverse Event|3|||
33267244|NCT00022672|100877921|FG000|Extension Phase|Death|0|||
33267245|NCT00022672|100877922|FG001|Extension Phase|Death|1|||
33267246|NCT00022672|100877921|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
33267247|NCT00022672|100877922|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
33475719|NCT02038907|101635795|FG001|Overall Study|Withdrawal by Subject|0|||
33475720|NCT02038907|101635796|FG002|Overall Study|Withdrawal by Subject|0|||
33475721|NCT02038907|101635797|FG003|Overall Study|Withdrawal by Subject|0|||
33475722|NCT02038907|101635798|FG004|Overall Study|Withdrawal by Subject|0|||
33475723|NCT02038907|101635799|FG005|Overall Study|Withdrawal by Subject|0|||
33475724|NCT02038907|101635800|FG006|Overall Study|Withdrawal by Subject|0|||
33475725|NCT02038907|101635801|FG007|Overall Study|Withdrawal by Subject|0|||
33475726|NCT02038907|101635802|FG008|Overall Study|Withdrawal by Subject|0|||
33475727|NCT02038907|101635803|FG009|Overall Study|Withdrawal by Subject|0|||
33475728|NCT02038907|101635804|FG010|Overall Study|Withdrawal by Subject|1|||
33475729|NCT02038907|101635805|FG011|Overall Study|Withdrawal by Subject|0|||
33267248|NCT00022672|100877921|FG000|Extension Phase|Refused Treatment|0|||
33475730|NCT02038907|101635806|FG012|Overall Study|Withdrawal by Subject|0|||
33475731|NCT02038907|101635807|FG013|Overall Study|Withdrawal by Subject|0|||
33475732|NCT01642914|101635808|FG000|Overall Study|Adverse Event|11|||
33475733|NCT01642914|101635809|FG001|Overall Study|Adverse Event|7|||
33475734|NCT01642914|101635810|FG002|Overall Study|Adverse Event|15|||
33475735|NCT01642914|101635808|FG000|Overall Study|Lack of Efficacy|9|||
33475736|NCT01642914|101635809|FG001|Overall Study|Lack of Efficacy|4|||
33475737|NCT01642914|101635810|FG002|Overall Study|Lack of Efficacy|2|||
33475738|NCT01642914|101635808|FG000|Overall Study|Protocol Violation|15|||
33475739|NCT01642914|101635809|FG001|Overall Study|Protocol Violation|13|||
33475740|NCT01642914|101635810|FG002|Overall Study|Protocol Violation|6|||
33475741|NCT01642914|101635808|FG000|Overall Study|Withdrawal by Subject|5|||
33475742|NCT01642914|101635809|FG001|Overall Study|Withdrawal by Subject|5|||
33475743|NCT01642914|101635810|FG002|Overall Study|Withdrawal by Subject|10|||
33475744|NCT01642914|101635808|FG000|Overall Study|Lost to Follow-up|5|||
33475745|NCT01642914|101635809|FG001|Overall Study|Lost to Follow-up|3|||
33475746|NCT01642914|101635810|FG002|Overall Study|Lost to Follow-up|7|||
33475747|NCT01642914|101635808|FG000|Overall Study|Other Reason|1|||
33475748|NCT01642914|101635809|FG001|Overall Study|Other Reason|0|||
33475749|NCT01642914|101635810|FG002|Overall Study|Other Reason|0|||
33475750|NCT02269163|101635811|FG000|Overall Study|Lost to Follow-up|1|||
33475751|NCT02269163|101635812|FG001|Overall Study|Lost to Follow-up|0|||
33475752|NCT02269163|101635811|FG000|Overall Study|Major protocol violation|0|||
33475753|NCT02269163|101635812|FG001|Overall Study|Major protocol violation|1|||
33475754|NCT02269163|101635811|FG000|Overall Study|Other|2|||
33475755|NCT02269163|101635812|FG001|Overall Study|Other|2|||
33475756|NCT02269163|101635811|FG000|Overall Study|Withdrawal by Subject|0|||
33475757|NCT02269163|101635812|FG001|Overall Study|Withdrawal by Subject|3|||
33475758|NCT02269163|101635811|FG000|Overall Study|Physician Decision|0|||
33475759|NCT02269163|101635812|FG001|Overall Study|Physician Decision|1|||
33475760|NCT02924727|101635813|FG000|Overall Study|Withdrawal by Subject|2|||
33475761|NCT02924727|101635814|FG001|Overall Study|Withdrawal by Subject|4|||
33475762|NCT02924727|101635813|FG000|Overall Study|Lost to Follow-up|2|||
33475763|NCT02924727|101635814|FG001|Overall Study|Lost to Follow-up|5|||
33475764|NCT02924727|101635813|FG000|Overall Study|Death|221|||
33475765|NCT02924727|101635814|FG001|Overall Study|Death|247|||
33475766|NCT02924727|101635813|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
33475767|NCT02924727|101635814|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
33475768|NCT00536263|101635815|FG000|Overall Study|Adverse Event|5|||
33475769|NCT00536263|101635816|FG001|Overall Study|Adverse Event|5|||
33475770|NCT00536263|101635817|FG002|Overall Study|Adverse Event|7|||
33475771|NCT00536263|101635815|FG000|Overall Study|Lost to Follow-up|3|||
33475772|NCT00536263|101635816|FG001|Overall Study|Lost to Follow-up|4|||
33475773|NCT00536263|101635817|FG002|Overall Study|Lost to Follow-up|4|||
33475774|NCT00536263|101635815|FG000|Overall Study|Subject withdrew - not treatment related|2|||
33475775|NCT00536263|101635816|FG001|Overall Study|Subject withdrew - not treatment related|0|||
33475776|NCT00536263|101635817|FG002|Overall Study|Subject withdrew - not treatment related|5|||
33475777|NCT00536263|101635815|FG000|Overall Study|Subject withdrew - treatment related|0|||
33475778|NCT00536263|101635816|FG001|Overall Study|Subject withdrew - treatment related|3|||
33267249|NCT00022672|100877922|FG001|Extension Phase|Refused Treatment|2|||
33267250|NCT00022672|100877921|FG000|Extension Phase|Other|1|||
33267251|NCT00022672|100877922|FG001|Extension Phase|Other|1|||
33267252|NCT00853580|100877931|FG000|Overall Study|Lost to Follow-up|3|||
33267253|NCT00853580|100877932|FG001|Overall Study|Lost to Follow-up|5|||
33267254|NCT00853580|100877931|FG000|Overall Study|Protocol Violation|2|||
33267255|NCT00853580|100877932|FG001|Overall Study|Protocol Violation|1|||
33267256|NCT00853580|100877931|FG000|Overall Study|Withdrawal by Subject|2|||
33267257|NCT00853580|100877932|FG001|Overall Study|Withdrawal by Subject|8|||
33267258|NCT00853580|100877931|FG000|Overall Study|Commenced contraindicated therapy|0|||
33267259|NCT00853580|100877932|FG001|Overall Study|Commenced contraindicated therapy|2|||
33267260|NCT02797132|100877933|FG000|Part A (15 Days)|Adverse Event|1|||
33267261|NCT02797132|100877933|FG000|Part B (24 Weeks)|Adverse Event|3|||
33267262|NCT01323790|100877934|FG000|Overall Study|Other|3|||
33475779|NCT00536263|101635817|FG002|Overall Study|Subject withdrew - treatment related|2|||
33475780|NCT00536263|101635815|FG000|Overall Study|Noncompliance with protocol|0|||
33475781|NCT00536263|101635816|FG001|Overall Study|Noncompliance with protocol|0|||
33475782|NCT00536263|101635817|FG002|Overall Study|Noncompliance with protocol|1|||
33475783|NCT00536263|101635815|FG000|Overall Study|Did not meet protocol eligibility|1|||
33475784|NCT00536263|101635816|FG001|Overall Study|Did not meet protocol eligibility|2|||
33475785|NCT00536263|101635817|FG002|Overall Study|Did not meet protocol eligibility|2|||
33475786|NCT03310411|101635818|FG000|Period 1|Adverse Event|0|||
33475787|NCT03310411|101635819|FG001|Period 1|Adverse Event|0|||
33475788|NCT03310411|101635820|FG002|Period 1|Adverse Event|0|||
33475789|NCT03310411|101635821|FG003|Period 1|Adverse Event|1|||
33475790|NCT00440466|101635822|FG000|Overall Study|Death|3|||
33267263|NCT01323790|100877935|FG001|Overall Study|Other|2|||
33267264|NCT01323790|100877936|FG002|Overall Study|Other|1|||
33267265|NCT01323790|100877934|FG000|Overall Study|Lost to Follow-up|11|||
33267266|NCT01323790|100877935|FG001|Overall Study|Lost to Follow-up|9|||
33267267|NCT01323790|100877936|FG002|Overall Study|Lost to Follow-up|9|||
33475791|NCT00440466|101635823|FG001|Overall Study|Death|2|||
33475792|NCT00440466|101635824|FG002|Overall Study|Death|9|||
33475793|NCT00440466|101635822|FG000|Overall Study|Adverse Event|3|||
33475794|NCT00440466|101635823|FG001|Overall Study|Adverse Event|4|||
33475795|NCT00440466|101635824|FG002|Overall Study|Adverse Event|11|||
33475796|NCT00440466|101635822|FG000|Overall Study|Lost to Follow-up|1|||
33475797|NCT00440466|101635823|FG001|Overall Study|Lost to Follow-up|0|||
33475798|NCT00440466|101635824|FG002|Overall Study|Lost to Follow-up|2|||
33475799|NCT00440466|101635822|FG000|Overall Study|Physician Decision|2|||
33475800|NCT00440466|101635823|FG001|Overall Study|Physician Decision|0|||
33475801|NCT00440466|101635824|FG002|Overall Study|Physician Decision|1|||
33475802|NCT00440466|101635822|FG000|Overall Study|Protocol Violation|2|||
33475803|NCT00440466|101635823|FG001|Overall Study|Protocol Violation|0|||
33475804|NCT00440466|101635824|FG002|Overall Study|Protocol Violation|4|||
33475805|NCT00440466|101635822|FG000|Overall Study|Withdrawal by Subject|2|||
33475806|NCT00440466|101635823|FG001|Overall Study|Withdrawal by Subject|5|||
33475807|NCT00440466|101635824|FG002|Overall Study|Withdrawal by Subject|9|||
33475808|NCT00440466|101635822|FG000|Overall Study|Began Dialysis|0|||
33475809|NCT00440466|101635823|FG001|Overall Study|Began Dialysis|0|||
33475810|NCT00440466|101635824|FG002|Overall Study|Began Dialysis|1|||
33475811|NCT00440466|101635822|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
33475812|NCT00440466|101635823|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
33475813|NCT00440466|101635824|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
33475814|NCT04688931|101635825|FG000|Overall Study|Adverse Event|4|||
33475815|NCT04688931|101635826|FG001|Overall Study|Adverse Event|1|||
33475816|NCT04688931|101635825|FG000|Overall Study|Withdrawal by Subject|5|||
33475817|NCT04688931|101635826|FG001|Overall Study|Withdrawal by Subject|16|||
33475818|NCT04688931|101635825|FG000|Overall Study|Physician Decision|3|||
33475819|NCT04688931|101635826|FG001|Overall Study|Physician Decision|5|||
33475820|NCT04688931|101635825|FG000|Overall Study|Noncompliance|0|||
33475821|NCT04688931|101635826|FG001|Overall Study|Noncompliance|1|||
33475822|NCT04688931|101635825|FG000|Overall Study|Lost to Follow-up|1|||
33475823|NCT04688931|101635826|FG001|Overall Study|Lost to Follow-up|3|||
33475824|NCT04688931|101635825|FG000|Overall Study|Randomization Error|3|||
33475825|NCT04688931|101635826|FG001|Overall Study|Randomization Error|0|||
33475826|NCT04688931|101635825|FG000|Overall Study|Not Eligible|1|||
33475827|NCT04688931|101635826|FG001|Overall Study|Not Eligible|3|||
33475828|NCT04688931|101635825|FG000|Overall Study|Disease Progression|0|||
33475829|NCT04688931|101635826|FG001|Overall Study|Disease Progression|2|||
33475830|NCT04688931|101635825|FG000|Overall Study|Sponsor Requirement|1|||
33475831|NCT04688931|101635826|FG001|Overall Study|Sponsor Requirement|1|||
33475832|NCT04688931|101635825|FG000|Overall Study|Other Reason|1|||
33475833|NCT04688931|101635826|FG001|Overall Study|Other Reason|2|||
33475834|NCT02669758|101635828|FG000|Overall Study|Withdrawal by Subject|43|||
33475835|NCT02669758|101635828|FG000|Overall Study|Lost to Follow-up|19|||
33475836|NCT02669758|101635828|FG000|Overall Study|Adverse Event|16|||
33475837|NCT02669758|101635828|FG000|Overall Study|Non-Compliance with Study Drug|8|||
33267268|NCT01323790|100877934|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
33267269|NCT01323790|100877935|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
33267270|NCT01323790|100877936|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
33267271|NCT01323790|100877934|FG000|Overall Study|Lack of Efficacy|3|||
33267272|NCT01323790|100877935|FG001|Overall Study|Lack of Efficacy|0|||
33475838|NCT02669758|101635828|FG000|Overall Study|Lack of Efficacy|5|||
33267273|NCT01323790|100877936|FG002|Overall Study|Lack of Efficacy|3|||
33267274|NCT01323790|100877934|FG000|Overall Study|Adverse Event|11|||
33267275|NCT01323790|100877935|FG001|Overall Study|Adverse Event|24|||
33267276|NCT01323790|100877936|FG002|Overall Study|Adverse Event|12|||
33267277|NCT01323790|100877934|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
33267278|NCT01323790|100877935|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
33267279|NCT01323790|100877936|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
33267280|NCT01323790|100877934|FG000|Overall Study|Withdrawal by Subject|23|||
33267281|NCT01323790|100877935|FG001|Overall Study|Withdrawal by Subject|20|||
33267282|NCT01323790|100877936|FG002|Overall Study|Withdrawal by Subject|13|||
33267283|NCT01323790|100877934|FG000|Overall Study|Did Not Receive Treatment|2|||
33267284|NCT01323790|100877935|FG001|Overall Study|Did Not Receive Treatment|0|||
33267285|NCT01323790|100877936|FG002|Overall Study|Did Not Receive Treatment|1|||
33267286|NCT01323790|100877934|FG000|Overall Study|Severe non-compliance with protocol|2|||
33267287|NCT01323790|100877935|FG001|Overall Study|Severe non-compliance with protocol|2|||
33267288|NCT01323790|100877936|FG002|Overall Study|Severe non-compliance with protocol|2|||
33267289|NCT04867382|100877937|FG000|Overall Study|Did not complete the survey|2|||
33267290|NCT04867382|100877938|FG001|Overall Study|Did not complete the survey|1|||
33267291|NCT03374254|100877945|FG000|Overall Study|Death|5|||
33475839|NCT02669758|101635828|FG000|Overall Study|Pregnancy|1|||
33475840|NCT02669758|101635828|FG000|Overall Study|Study noncompliance|1|||
33475841|NCT02669758|101635828|FG000|Overall Study|Protocol Violation|1|||
33475842|NCT02408068|101635831|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
33475843|NCT02408068|101635832|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
33475844|NCT02408068|101635833|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
33475845|NCT02408068|101635834|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
33475846|NCT02408068|101635835|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
33475847|NCT02408068|101635836|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
33475848|NCT00895947|101635837|FG000|Overall Study|Adverse Event|3|||
33267292|NCT03374254|100877946|FG001|Overall Study|Death|16|||
33475849|NCT00895947|101635838|FG001|Overall Study|Adverse Event|4|||
33475850|NCT00895947|101635837|FG000|Overall Study|Lost to Follow-up|3|||
33475851|NCT00895947|101635838|FG001|Overall Study|Lost to Follow-up|4|||
33475852|NCT00895947|101635837|FG000|Overall Study|Protocol Violation|4|||
33475853|NCT00895947|101635838|FG001|Overall Study|Protocol Violation|2|||
33475854|NCT00895947|101635837|FG000|Overall Study|Withdrawal by Subject|2|||
33475855|NCT00895947|101635838|FG001|Overall Study|Withdrawal by Subject|0|||
33475856|NCT00574912|101635839|FG000|Overall Study|Could not place IV lines.|3|||
33475857|NCT00574912|101635839|FG000|Overall Study|scheduling conflicts|3|||
33475858|NCT00574912|101635839|FG000|Overall Study|Physician Decision|2|||
33475859|NCT00278889|101635842|FG000|Overall Study|Withdrawal by Subject|0|||
33475860|NCT00278889|101635843|FG001|Overall Study|Withdrawal by Subject|5|||
33475861|NCT00278889|101635844|FG002|Overall Study|Withdrawal by Subject|3|||
33475862|NCT00278889|101635842|FG000|Overall Study|Lost to Follow-up|1|||
33475863|NCT00278889|101635843|FG001|Overall Study|Lost to Follow-up|1|||
33475864|NCT00278889|101635844|FG002|Overall Study|Lost to Follow-up|0|||
33475865|NCT00278889|101635842|FG000|Overall Study|Death|24|||
33475866|NCT00278889|101635843|FG001|Overall Study|Death|21|||
33475867|NCT00278889|101635844|FG002|Overall Study|Death|17|||
33475868|NCT02032706|101635845|FG000|Overall Study|Did not qualify|5|||
33475869|NCT02032706|101635845|FG000|Overall Study|Protocol Violation|1|||
33475870|NCT02746471|101635846|FG000|Overall Study|Death|43|||
33475871|NCT02746471|101635846|FG000|Overall Study|Exited before 36 months|1119|||
33475872|NCT01884311|101635847|FG000|Overall Study|Withdrawal by Subject|3|||
33475873|NCT01884311|101635847|FG000|Overall Study|withdrew consent due to AEs|1|||
33475874|NCT01884311|101635847|FG000|Overall Study|Precautionary measure|1|||
33475875|NCT00114166|101635849|FG000|Overall Study|Wrong primary|0|||
33475876|NCT00114166|101635850|FG001|Overall Study|Wrong primary|1|||
33475877|NCT01288053|101635851|FG000|Overall Study|Death|1|||
33475878|NCT02500641|101635852|FG000|Overall Study|Adverse Event|0|||
33475879|NCT02500641|101635853|FG001|Overall Study|Adverse Event|2|||
33475880|NCT02500641|101635852|FG000|Overall Study|Withdrawal by Subject|4|||
33475881|NCT02500641|101635853|FG001|Overall Study|Withdrawal by Subject|5|||
33475882|NCT02500641|101635852|FG000|Overall Study|Unable to follow study procedures|3|||
33475883|NCT02500641|101635853|FG001|Overall Study|Unable to follow study procedures|2|||
33475884|NCT02500641|101635852|FG000|Overall Study|Protocol Violation|1|||
33475885|NCT02500641|101635853|FG001|Overall Study|Protocol Violation|2|||
33475886|NCT02500641|101635852|FG000|Overall Study|Lost to Follow-up|1|||
33475887|NCT02500641|101635853|FG001|Overall Study|Lost to Follow-up|0|||
33475888|NCT02500641|101635852|FG000|Overall Study|Sponsor decision|1|||
33475889|NCT02500641|101635853|FG001|Overall Study|Sponsor decision|0|||
33475890|NCT02500641|101635852|FG000|Overall Study|Non compliance to study drug|0|||
33475891|NCT02500641|101635853|FG001|Overall Study|Non compliance to study drug|1|||
33475892|NCT02130882|101635854|FG000|Overall Study|Withdrawal by Subject|0|||
33475893|NCT02130882|101635855|FG001|Overall Study|Withdrawal by Subject|1|||
33475894|NCT00688376|101635856|FG000|Double-Blind Phase|Adverse Event|4|||
33475895|NCT00688376|101635857|FG001|Double-Blind Phase|Adverse Event|4|||
33475896|NCT00688376|101635856|FG000|Double-Blind Phase|Protocol Violation|1|||
33475897|NCT00688376|101635857|FG001|Double-Blind Phase|Protocol Violation|2|||
33475898|NCT00688376|101635856|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
33475899|NCT00688376|101635857|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
33475900|NCT00688376|101635856|FG000|Double-Blind Phase|Not treated|0|||
33475901|NCT00688376|101635857|FG001|Double-Blind Phase|Not treated|1|||
33267293|NCT03374254|100877947|FG002|Overall Study|Death|13|||
33267294|NCT03374254|100877948|FG003|Overall Study|Death|11|||
33267295|NCT03374254|100877949|FG004|Overall Study|Death|9|||
33267296|NCT03374254|100877950|FG005|Overall Study|Death|12|||
33267297|NCT03374254|100877951|FG006|Overall Study|Death|11|||
33267298|NCT03374254|100877952|FG007|Overall Study|Death|6|||
33267299|NCT03374254|100877953|FG008|Overall Study|Death|7|||
33267300|NCT03374254|100877945|FG000|Overall Study|Lost to Follow-up|0|||
33267301|NCT03374254|100877946|FG001|Overall Study|Lost to Follow-up|0|||
33267302|NCT03374254|100877947|FG002|Overall Study|Lost to Follow-up|0|||
33267303|NCT03374254|100877948|FG003|Overall Study|Lost to Follow-up|0|||
33475902|NCT00688376|101635856|FG000|Blinded Extension Phase|Adverse Event|3|||
33475903|NCT00688376|101635857|FG001|Blinded Extension Phase|Adverse Event|4|||
33475904|NCT00688376|101635856|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
33475905|NCT00688376|101635857|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
33475906|NCT00688376|101635856|FG000|Blinded Extension Phase|Physician Decision|1|||
33267304|NCT03374254|100877949|FG004|Overall Study|Lost to Follow-up|0|||
33267305|NCT03374254|100877950|FG005|Overall Study|Lost to Follow-up|0|||
33475907|NCT00688376|101635857|FG001|Blinded Extension Phase|Physician Decision|0|||
33267306|NCT03374254|100877951|FG006|Overall Study|Lost to Follow-up|2|||
33475908|NCT00688376|101635856|FG000|Blinded Extension Phase|Other|1|||
33475909|NCT00688376|101635857|FG001|Blinded Extension Phase|Other|0|||
33475910|NCT02802631|101635859|FG000|Overall Study|Withdrawal by Subject|1|||
33267307|NCT03374254|100877952|FG007|Overall Study|Lost to Follow-up|0|||
33475911|NCT02802631|101635860|FG001|Overall Study|Withdrawal by Subject|0|||
33267308|NCT03374254|100877953|FG008|Overall Study|Lost to Follow-up|0|||
33267309|NCT03374254|100877945|FG000|Overall Study|Sponsor Decision|1|||
33267310|NCT03374254|100877946|FG001|Overall Study|Sponsor Decision|0|||
33267311|NCT03374254|100877947|FG002|Overall Study|Sponsor Decision|2|||
33267312|NCT03374254|100877948|FG003|Overall Study|Sponsor Decision|3|||
33267313|NCT03374254|100877949|FG004|Overall Study|Sponsor Decision|2|||
33267314|NCT03374254|100877950|FG005|Overall Study|Sponsor Decision|3|||
33267315|NCT03374254|100877951|FG006|Overall Study|Sponsor Decision|3|||
33267316|NCT03374254|100877952|FG007|Overall Study|Sponsor Decision|3|||
33267317|NCT03374254|100877953|FG008|Overall Study|Sponsor Decision|4|||
33267318|NCT03374254|100877945|FG000|Overall Study|Withdrawal by Subject|0|||
33267319|NCT03374254|100877946|FG001|Overall Study|Withdrawal by Subject|0|||
33267320|NCT03374254|100877947|FG002|Overall Study|Withdrawal by Subject|0|||
33267321|NCT03374254|100877948|FG003|Overall Study|Withdrawal by Subject|2|||
33267322|NCT03374254|100877949|FG004|Overall Study|Withdrawal by Subject|0|||
33267323|NCT03374254|100877950|FG005|Overall Study|Withdrawal by Subject|1|||
33267324|NCT03374254|100877951|FG006|Overall Study|Withdrawal by Subject|0|||
33267325|NCT03374254|100877952|FG007|Overall Study|Withdrawal by Subject|0|||
33267326|NCT03374254|100877953|FG008|Overall Study|Withdrawal by Subject|0|||
33267327|NCT00390884|100877954|FG000|Overall Study|Withdrawal by Subject|2|||
33267328|NCT00390884|100877955|FG001|Overall Study|Withdrawal by Subject|2|||
33267329|NCT04017611|100877956|FG000|Overall Study|Withdrawn prior to completion|1|||
33267330|NCT00790569|100877962|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
33267331|NCT00790569|100877963|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
33267332|NCT00790569|100877964|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
33267333|NCT00790569|100877962|FG000|End of Treatment (6 Month Interview)|Death|0|||
33267334|NCT00790569|100877963|FG001|End of Treatment (6 Month Interview)|Death|2|||
33267335|NCT00790569|100877964|FG002|End of Treatment (6 Month Interview)|Death|1|||
33267336|NCT00790569|100877962|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
33267337|NCT00790569|100877963|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
33267338|NCT00790569|100877964|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
33267339|NCT00790569|100877962|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
33267340|NCT00790569|100877963|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
33267341|NCT00790569|100877964|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
33267342|NCT00790569|100877962|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
33267343|NCT00790569|100877963|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
33267344|NCT00790569|100877964|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
33267345|NCT00790569|100877962|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
33267346|NCT00790569|100877963|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
33267347|NCT00790569|100877964|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
33267348|NCT00705159|100877965|FG000|Overall Study|Withdrawal by Subject|0|||
33267349|NCT00705159|100877966|FG001|Overall Study|Withdrawal by Subject|1|||
33267350|NCT00705159|100877967|FG002|Overall Study|Withdrawal by Subject|1|||
33267351|NCT00705159|100877968|FG003|Overall Study|Withdrawal by Subject|1|||
33267352|NCT00705159|100877965|FG000|Overall Study|Protocol Violation|0|||
33267353|NCT00705159|100877966|FG001|Overall Study|Protocol Violation|1|||
33267354|NCT00705159|100877967|FG002|Overall Study|Protocol Violation|0|||
33267355|NCT00705159|100877968|FG003|Overall Study|Protocol Violation|0|||
33267356|NCT00705159|100877965|FG000|Overall Study|Adverse Event|0|||
33267357|NCT00705159|100877966|FG001|Overall Study|Adverse Event|0|||
33267358|NCT00705159|100877967|FG002|Overall Study|Adverse Event|1|||
33267359|NCT00705159|100877968|FG003|Overall Study|Adverse Event|0|||
33267360|NCT00705159|100877965|FG000|Overall Study|Lost to Follow-up|0|||
33267361|NCT00705159|100877966|FG001|Overall Study|Lost to Follow-up|0|||
33267362|NCT00705159|100877967|FG002|Overall Study|Lost to Follow-up|3|||
33267363|NCT00705159|100877968|FG003|Overall Study|Lost to Follow-up|2|||
33267364|NCT00705159|100877965|FG000|Overall Study|Screen Failure|0|||
33267365|NCT00705159|100877966|FG001|Overall Study|Screen Failure|0|||
33267366|NCT00705159|100877967|FG002|Overall Study|Screen Failure|0|||
33267367|NCT00705159|100877968|FG003|Overall Study|Screen Failure|1|||
33267368|NCT02157948|100877969|FG000|Overall Study|Withdrawal by Subject|4|||
33267369|NCT02157948|100877970|FG001|Overall Study|Withdrawal by Subject|5|||
33267370|NCT02157948|100877969|FG000|Overall Study|Lost to Follow-up|3|||
33267371|NCT02157948|100877970|FG001|Overall Study|Lost to Follow-up|2|||
33267372|NCT02157948|100877969|FG000|Overall Study|Protocol Specified Criteria|2|||
33267373|NCT02157948|100877970|FG001|Overall Study|Protocol Specified Criteria|1|||
33475912|NCT02802631|101635861|FG002|Overall Study|Withdrawal by Subject|0|||
33475913|NCT02802631|101635862|FG003|Overall Study|Withdrawal by Subject|0|||
33475914|NCT02802631|101635863|FG004|Overall Study|Withdrawal by Subject|0|||
33267374|NCT02157948|100877969|FG000|Overall Study|Decision by Sponsor|0|||
33267375|NCT02157948|100877970|FG001|Overall Study|Decision by Sponsor|1|||
33267376|NCT00326183|100877971|FG000|Overall Study|Lost to Follow-up|104|||
33267377|NCT00326183|100877972|FG001|Overall Study|Lost to Follow-up|56|||
33267378|NCT00326183|100877971|FG000|Overall Study|Protocol Violation|6|||
33267379|NCT00326183|100877972|FG001|Overall Study|Protocol Violation|3|||
33475915|NCT02802631|101635864|FG005|Overall Study|Withdrawal by Subject|0|||
33475916|NCT02802631|101635865|FG006|Overall Study|Withdrawal by Subject|0|||
33475917|NCT02802631|101635866|FG007|Overall Study|Withdrawal by Subject|0|||
33475918|NCT02802631|101635859|FG000|Overall Study|Physician Decision|1|||
33475919|NCT02802631|101635860|FG001|Overall Study|Physician Decision|0|||
33475920|NCT02802631|101635861|FG002|Overall Study|Physician Decision|0|||
33475921|NCT02802631|101635862|FG003|Overall Study|Physician Decision|0|||
33475922|NCT02802631|101635863|FG004|Overall Study|Physician Decision|0|||
33475923|NCT02802631|101635864|FG005|Overall Study|Physician Decision|0|||
33475924|NCT02802631|101635865|FG006|Overall Study|Physician Decision|1|||
33475925|NCT02802631|101635866|FG007|Overall Study|Physician Decision|0|||
33475926|NCT02802631|101635859|FG000|Overall Study|Adverse Event|0|||
33475927|NCT02802631|101635860|FG001|Overall Study|Adverse Event|2|||
33475928|NCT02802631|101635861|FG002|Overall Study|Adverse Event|0|||
33475929|NCT02802631|101635862|FG003|Overall Study|Adverse Event|1|||
33475930|NCT02802631|101635863|FG004|Overall Study|Adverse Event|6|||
33475931|NCT02802631|101635864|FG005|Overall Study|Adverse Event|1|||
33475932|NCT02802631|101635865|FG006|Overall Study|Adverse Event|4|||
33475933|NCT02802631|101635866|FG007|Overall Study|Adverse Event|0|||
33475934|NCT02802631|101635859|FG000|Overall Study|Sponsor Decision|0|||
33475935|NCT02802631|101635860|FG001|Overall Study|Sponsor Decision|0|||
33475936|NCT02802631|101635861|FG002|Overall Study|Sponsor Decision|6|||
33475937|NCT02802631|101635862|FG003|Overall Study|Sponsor Decision|0|||
33475938|NCT02802631|101635863|FG004|Overall Study|Sponsor Decision|2|||
33475939|NCT02802631|101635864|FG005|Overall Study|Sponsor Decision|0|||
33475940|NCT02802631|101635865|FG006|Overall Study|Sponsor Decision|0|||
33475941|NCT02802631|101635866|FG007|Overall Study|Sponsor Decision|4|||
33475942|NCT02132637|101635867|FG000|Study Period 1|Withdrawal by Subject|0|||
33475943|NCT02132637|101635868|FG001|Study Period 1|Withdrawal by Subject|4|||
33475944|NCT02132637|101635867|FG000|Study Period 1|Physician Decision|1|||
33475945|NCT02132637|101635868|FG001|Study Period 1|Physician Decision|0|||
33475946|NCT02132637|101635867|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
33475947|NCT02132637|101635868|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
33475948|NCT02132637|101635867|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
33475949|NCT02132637|101635868|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
33475950|NCT01297465|101635872|FG000|Overall Study|Lack of Ovarian Response|1|||
33475951|NCT01297465|101635873|FG001|Overall Study|Lack of Ovarian Response|1|||
33475952|NCT01297465|101635872|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
33475953|NCT01297465|101635873|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
33475954|NCT01297465|101635872|FG000|Overall Study|No Oocytes Retrieved|1|||
33475955|NCT01297465|101635873|FG001|Overall Study|No Oocytes Retrieved|1|||
33475956|NCT01297465|101635872|FG000|Overall Study|Poor oocyte quality|0|||
33475957|NCT01297465|101635873|FG001|Overall Study|Poor oocyte quality|1|||
33475958|NCT01297465|101635872|FG000|Overall Study|No Fertilization|6|||
33475959|NCT01297465|101635873|FG001|Overall Study|No Fertilization|4|||
33475960|NCT01297465|101635872|FG000|Overall Study|All Embryos Discarded|0|||
33475961|NCT01297465|101635873|FG001|Overall Study|All Embryos Discarded|1|||
33475962|NCT01297465|101635872|FG000|Overall Study|Intention to Freeze all Embryos|0|||
33475963|NCT01297465|101635873|FG001|Overall Study|Intention to Freeze all Embryos|1|||
33475964|NCT01780987|101635878|FG000|Overall Study|Adverse Event|0|||
33475965|NCT01780987|101635879|FG001|Overall Study|Adverse Event|4|||
33475966|NCT01780987|101635878|FG000|Overall Study|Withdrawal by Subject|2|||
33475967|NCT01780987|101635879|FG001|Overall Study|Withdrawal by Subject|0|||
33475968|NCT01780987|101635878|FG000|Overall Study|Request of Changing Hospital|0|||
33475969|NCT01780987|101635879|FG001|Overall Study|Request of Changing Hospital|1|||
33475970|NCT01780987|101635878|FG000|Overall Study|Changing Residence|1|||
33475971|NCT01780987|101635879|FG001|Overall Study|Changing Residence|0|||
33475972|NCT01780987|101635878|FG000|Overall Study|Not Receiving any Study Medication|0|||
33475973|NCT01780987|101635879|FG001|Overall Study|Not Receiving any Study Medication|1|||
33475974|NCT00821873|101635882|FG000|Overall Study|Lost to Follow-up|4|||
33475975|NCT01246011|101635887|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
33475976|NCT01246011|101635888|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
33475977|NCT01246011|101635889|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
33475978|NCT01246011|101635887|FG000|Overall Study|Withdrawal by Subject|0|||
33475979|NCT01246011|101635888|FG001|Overall Study|Withdrawal by Subject|0|||
33475980|NCT01246011|101635889|FG002|Overall Study|Withdrawal by Subject|1|||
33475981|NCT03596151|101635891|FG000|Overall Study|Withdrawal by Subject|1|||
33475982|NCT00121134|101635892|FG000|Overall Study|Progression of Disease|5|||
33475983|NCT00121134|101635893|FG001|Overall Study|Progression of Disease|3|||
33475984|NCT00121134|101635894|FG002|Overall Study|Progression of Disease|4|||
33475985|NCT00121134|101635895|FG003|Overall Study|Progression of Disease|2|||
33475986|NCT00121134|101635892|FG000|Overall Study|Toxicity|4|||
33475987|NCT00121134|101635893|FG001|Overall Study|Toxicity|7|||
33475988|NCT00121134|101635894|FG002|Overall Study|Toxicity|13|||
33475989|NCT00121134|101635895|FG003|Overall Study|Toxicity|5|||
33475990|NCT00121134|101635892|FG000|Overall Study|Physician Decision|6|||
33475991|NCT00121134|101635893|FG001|Overall Study|Physician Decision|4|||
33267380|NCT00326183|100877971|FG000|Overall Study|Withdrawal by Subject|35|||
33267381|NCT00326183|100877972|FG001|Overall Study|Withdrawal by Subject|7|||
33267382|NCT00326183|100877971|FG000|Overall Study|Subject Moved|7|||
33267383|NCT00326183|100877972|FG001|Overall Study|Subject Moved|4|||
33267384|NCT00326183|100877971|FG000|Overall Study|Other|47|||
33267385|NCT00326183|100877972|FG001|Overall Study|Other|13|||
33267386|NCT00326183|100877971|FG000|Overall Study|Adverse Event|1|||
33267387|NCT00326183|100877972|FG001|Overall Study|Adverse Event|0|||
33267388|NCT01436175|100877973|FG000|Overall Study|Adverse Event|111|||
33267389|NCT01436175|100877973|FG000|Overall Study|Protocol Violation|49|||
33267390|NCT01436175|100877973|FG000|Overall Study|Withdrawal by Subject|108|||
33267391|NCT01436175|100877973|FG000|Overall Study|Lost to Follow-up|89|||
33267392|NCT01436175|100877973|FG000|Overall Study|Lack of Efficacy|24|||
33267393|NCT01436175|100877973|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
33267394|NCT01436175|100877973|FG000|Overall Study|Other|826|||
33267395|NCT00866619|100877974|FG000|Overall Study|Adverse Event|112|||
33267396|NCT00866619|100877975|FG001|Overall Study|Adverse Event|106|||
33267397|NCT00866619|100877976|FG002|Overall Study|Adverse Event|47|||
33267398|NCT00866619|100877977|FG003|Overall Study|Adverse Event|44|||
33267399|NCT00866619|100877974|FG000|Overall Study|Protocol Violation|2|||
33267400|NCT00866619|100877975|FG001|Overall Study|Protocol Violation|39|||
33267401|NCT00866619|100877976|FG002|Overall Study|Protocol Violation|2|||
33267402|NCT00866619|100877977|FG003|Overall Study|Protocol Violation|17|||
33267403|NCT00866619|100877974|FG000|Overall Study|Withdrawal by Subject|587|||
33267404|NCT00866619|100877975|FG001|Overall Study|Withdrawal by Subject|295|||
33267405|NCT00866619|100877976|FG002|Overall Study|Withdrawal by Subject|272|||
33267406|NCT00866619|100877977|FG003|Overall Study|Withdrawal by Subject|144|||
33267407|NCT00866619|100877974|FG000|Overall Study|Lost to Follow-up|1145|||
33267408|NCT00866619|100877975|FG001|Overall Study|Lost to Follow-up|830|||
33267409|NCT00866619|100877976|FG002|Overall Study|Lost to Follow-up|568|||
33267410|NCT00866619|100877977|FG003|Overall Study|Lost to Follow-up|425|||
33267411|NCT02988713|100877978|FG000|Overall Study|Withdrawal by Subject|1|||
33267412|NCT02988713|100877978|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
33267413|NCT03259568|100877983|FG000|Overall Study|Participant performance was low|3|||
33267414|NCT00875706|100877984|FG000|Overall Study|Withdrawal by Subject|1|||
33267415|NCT00875706|100877985|FG001|Overall Study|Withdrawal by Subject|0|||
33267416|NCT00875706|100877986|FG002|Overall Study|Withdrawal by Subject|0|||
33267417|NCT01092416|100877987|FG000|Enrollment|Atherectomy device not inserted|3|||
33267418|NCT01092416|100877987|FG000|30-Day Follow-up|Death|2|||
33267419|NCT01092416|100877987|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
33267420|NCT01092416|100877987|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
33267421|NCT01092416|100877987|FG000|12-Month Follow-up|Death|16|||
33267422|NCT01092416|100877987|FG000|12-Month Follow-up|Lost to Follow-up|4|||
33267423|NCT01092416|100877987|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
33267424|NCT01092416|100877987|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
33267425|NCT01092416|100877987|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
33267426|NCT04009291|100877988|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
33267427|NCT04009291|100877989|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
33267428|NCT04009291|100877990|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
33267429|NCT04009291|100877991|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
33267430|NCT04009291|100877992|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
33267431|NCT04009291|100877988|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
33267432|NCT04009291|100877989|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
33267433|NCT04009291|100877990|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
33267434|NCT04009291|100877991|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
33267435|NCT04009291|100877992|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
33267436|NCT02208843|100877993|FG000|Overall Study|Clinical symptoms of progression|2|||
33267437|NCT02208843|100877993|FG000|Overall Study|Progression disease according to RECIST|24|||
33267438|NCT02208843|100877993|FG000|Overall Study|Adverse Event|12|||
33267439|NCT02208843|100877993|FG000|Overall Study|Protocol Violation|1|||
33267440|NCT02208843|100877993|FG000|Overall Study|Withdrawal by Subject|1|||
33267441|NCT02208843|100877993|FG000|Overall Study|Switched to commercial afatinib|20|||
33267442|NCT04748341|100877994|FG000|Overall Study|Lost to Follow-up|1|||
33267443|NCT04748341|100877995|FG001|Overall Study|Lost to Follow-up|1|||
33267444|NCT02185794|100877996|FG000|Overall Study|Enrolled but Never Dosed|1|||
33267445|NCT02185794|100877997|FG001|Overall Study|Enrolled but Never Dosed|6|||
33267446|NCT02185794|100877998|FG002|Overall Study|Enrolled but Never Dosed|3|||
33267447|NCT02185794|100877999|FG003|Overall Study|Enrolled but Never Dosed|1|||
33267448|NCT02185794|100878000|FG004|Overall Study|Enrolled but Never Dosed|1|||
33267449|NCT02185794|100878001|FG005|Overall Study|Enrolled but Never Dosed|0|||
33267450|NCT02185794|100877996|FG000|Overall Study|Investigator's Discretion|1|||
33267451|NCT02185794|100877997|FG001|Overall Study|Investigator's Discretion|0|||
33267452|NCT02185794|100877998|FG002|Overall Study|Investigator's Discretion|1|||
33267453|NCT02185794|100877999|FG003|Overall Study|Investigator's Discretion|2|||
33267454|NCT02185794|100878000|FG004|Overall Study|Investigator's Discretion|2|||
33267455|NCT02185794|100878001|FG005|Overall Study|Investigator's Discretion|15|||
33267456|NCT02185794|100877996|FG000|Overall Study|Withdrew Consent|2|||
33267457|NCT02185794|100877997|FG001|Overall Study|Withdrew Consent|5|||
33267458|NCT02185794|100877998|FG002|Overall Study|Withdrew Consent|10|||
33267459|NCT02185794|100877999|FG003|Overall Study|Withdrew Consent|2|||
33267460|NCT02185794|100878000|FG004|Overall Study|Withdrew Consent|0|||
33267461|NCT02185794|100878001|FG005|Overall Study|Withdrew Consent|0|||
33267462|NCT02185794|100877996|FG000|Overall Study|Lost to Follow-up|1|||
33267463|NCT02185794|100877997|FG001|Overall Study|Lost to Follow-up|2|||
33267464|NCT02185794|100877998|FG002|Overall Study|Lost to Follow-up|2|||
33267465|NCT02185794|100877999|FG003|Overall Study|Lost to Follow-up|3|||
33267466|NCT02185794|100878000|FG004|Overall Study|Lost to Follow-up|0|||
33267467|NCT02185794|100878001|FG005|Overall Study|Lost to Follow-up|1|||
33267468|NCT02915783|100878005|FG000|Overall Study|Death|21|||
33267469|NCT02915783|100878005|FG000|Overall Study|Lost to Follow-up|1|||
33267470|NCT02915783|100878005|FG000|Overall Study|Withdrawal by Subject|2|||
33267471|NCT02158806|100878006|FG000|Overall Study|Death|2|||
33267472|NCT02158806|100878007|FG001|Overall Study|Death|0|||
33267473|NCT02158806|100878006|FG000|Overall Study|Withdrawal by Subject|2|||
33267474|NCT02158806|100878007|FG001|Overall Study|Withdrawal by Subject|0|||
33267475|NCT02158806|100878006|FG000|Overall Study|Lost to Follow-up|0|||
33267476|NCT02158806|100878007|FG001|Overall Study|Lost to Follow-up|3|||
33267477|NCT02158806|100878006|FG000|Overall Study|Moved out of area|0|||
33267478|NCT02158806|100878007|FG001|Overall Study|Moved out of area|1|||
33267479|NCT02158806|100878006|FG000|Overall Study|Transferred to palliative care|0|||
33267480|NCT02158806|100878007|FG001|Overall Study|Transferred to palliative care|1|||
33267481|NCT02634307|100878008|FG000|Overall Study|Adverse Event|50|||
33267482|NCT02634307|100878009|FG001|Overall Study|Adverse Event|24|||
33267483|NCT02634307|100878010|FG002|Overall Study|Adverse Event|14|||
33475992|NCT00121134|101635894|FG002|Overall Study|Physician Decision|4|||
33475993|NCT00121134|101635895|FG003|Overall Study|Physician Decision|1|||
33475994|NCT00121134|101635892|FG000|Overall Study|Treatment Delay|1|||
33475995|NCT00121134|101635893|FG001|Overall Study|Treatment Delay|0|||
33475996|NCT00121134|101635894|FG002|Overall Study|Treatment Delay|0|||
33475997|NCT00121134|101635895|FG003|Overall Study|Treatment Delay|0|||
33475998|NCT00121134|101635892|FG000|Overall Study|Intercurrent Illness|0|||
33475999|NCT00121134|101635893|FG001|Overall Study|Intercurrent Illness|0|||
33476000|NCT00121134|101635894|FG002|Overall Study|Intercurrent Illness|0|||
33476001|NCT00121134|101635895|FG003|Overall Study|Intercurrent Illness|1|||
33267484|NCT02634307|100878008|FG000|Overall Study|Lost to Follow-up|21|||
33267485|NCT02634307|100878009|FG001|Overall Study|Lost to Follow-up|5|||
33267486|NCT02634307|100878010|FG002|Overall Study|Lost to Follow-up|6|||
33267487|NCT02634307|100878008|FG000|Overall Study|Pregnancy|5|||
33267488|NCT02634307|100878009|FG001|Overall Study|Pregnancy|1|||
33267489|NCT02634307|100878010|FG002|Overall Study|Pregnancy|3|||
33267490|NCT02634307|100878008|FG000|Overall Study|Withdrawal by Subject|38|||
33267491|NCT02634307|100878009|FG001|Overall Study|Withdrawal by Subject|24|||
33267492|NCT02634307|100878010|FG002|Overall Study|Withdrawal by Subject|18|||
33267493|NCT02634307|100878008|FG000|Overall Study|Non-Compliance with Study Drug|0|||
33267494|NCT02634307|100878009|FG001|Overall Study|Non-Compliance with Study Drug|2|||
33267495|NCT02634307|100878010|FG002|Overall Study|Non-Compliance with Study Drug|2|||
33267496|NCT02634307|100878008|FG000|Overall Study|Lack of Efficacy|1|||
33267497|NCT02634307|100878009|FG001|Overall Study|Lack of Efficacy|5|||
33267498|NCT02634307|100878010|FG002|Overall Study|Lack of Efficacy|3|||
33267499|NCT02634307|100878008|FG000|Overall Study|Physician Decision|7|||
33267500|NCT02634307|100878009|FG001|Overall Study|Physician Decision|5|||
33267501|NCT02634307|100878010|FG002|Overall Study|Physician Decision|5|||
33267502|NCT02634307|100878008|FG000|Overall Study|Reason not Specified|3|||
33267503|NCT02634307|100878009|FG001|Overall Study|Reason not Specified|5|||
33267504|NCT02634307|100878010|FG002|Overall Study|Reason not Specified|10|||
33267505|NCT03065400|100878011|FG000|Overall Study|Adverse Event|1|||
33267506|NCT03065400|100878011|FG000|Overall Study|Physician Decision|3|||
33267507|NCT03065400|100878011|FG000|Overall Study|Withdrawal by Subject|1|||
33267508|NCT03065400|100878011|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
33267509|NCT02040870|100878012|FG000|Overall Study|Completed treatment phase|6|||
33267510|NCT02040870|100878012|FG000|Overall Study|Adverse Event|7|||
33267511|NCT02040870|100878012|FG000|Overall Study|Progressive disease|58|||
33267512|NCT02040870|100878012|FG000|Overall Study|Physician Decision|6|||
33267513|NCT02040870|100878012|FG000|Overall Study|Subject/guardian decision|10|||
33267514|NCT02040870|100878012|FG000|Overall Study|Lost to Follow-up|3|||
33267515|NCT02040870|100878012|FG000|Overall Study|Death|13|||
33267516|NCT02325466|100878013|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
33267517|NCT02325466|100878014|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
33476002|NCT00121134|101635892|FG000|Overall Study|Patient Personal Reasons|0|||
33476003|NCT00121134|101635893|FG001|Overall Study|Patient Personal Reasons|1|||
33476004|NCT00121134|101635894|FG002|Overall Study|Patient Personal Reasons|0|||
33476005|NCT00121134|101635895|FG003|Overall Study|Patient Personal Reasons|0|||
33476006|NCT02585934|101635896|FG000|Overall Study|Lost to Follow-up|2|||
33476007|NCT02585934|101635897|FG001|Overall Study|Lost to Follow-up|2|||
33476008|NCT02585934|101635896|FG000|Overall Study|Protocol Violation|14|||
33476009|NCT02585934|101635897|FG001|Overall Study|Protocol Violation|11|||
33476010|NCT02585934|101635896|FG000|Overall Study|Adverse Event|21|||
33476011|NCT02585934|101635897|FG001|Overall Study|Adverse Event|22|||
33476012|NCT02585934|101635896|FG000|Overall Study|Physician Decision|3|||
33476013|NCT02585934|101635897|FG001|Overall Study|Physician Decision|2|||
33476014|NCT02585934|101635896|FG000|Overall Study|Withdrawal by Subject|7|||
33476015|NCT02585934|101635897|FG001|Overall Study|Withdrawal by Subject|21|||
33476016|NCT02585934|101635896|FG000|Overall Study|Lack of Efficacy|2|||
33476017|NCT02585934|101635897|FG001|Overall Study|Lack of Efficacy|1|||
33476018|NCT02585934|101635896|FG000|Overall Study|Death|2|||
33476019|NCT02585934|101635897|FG001|Overall Study|Death|0|||
33476020|NCT02585934|101635896|FG000|Overall Study|Caregiver Withdrew Consent|7|||
33476021|NCT02585934|101635897|FG001|Overall Study|Caregiver Withdrew Consent|7|||
33476022|NCT02585934|101635896|FG000|Overall Study|Sponsor Termination|1|||
33476023|NCT02585934|101635897|FG001|Overall Study|Sponsor Termination|2|||
33476024|NCT02585934|101635896|FG000|Overall Study|Another Reason|10|||
33476025|NCT02585934|101635897|FG001|Overall Study|Another Reason|5|||
33476026|NCT03127644|101635898|FG000|Overall Study|Study-specific withdrawal criteria|0|||
33476027|NCT03127644|101635899|FG001|Overall Study|Study-specific withdrawal criteria|0|||
33476028|NCT03127644|101635900|FG002|Overall Study|Study-specific withdrawal criteria|2|||
33476029|NCT02518919|101635901|FG000|Overall Study|Protocol Violation|1|||
33476030|NCT02518919|101635902|FG001|Overall Study|Protocol Violation|1|||
33476031|NCT02518919|101635903|FG002|Overall Study|Protocol Violation|2|||
33476032|NCT04234984|101635904|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
33476033|NCT04234984|101635904|FG000|Follow-up at the Second Time Point|Death|1|||
33476034|NCT04234984|101635904|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
33476035|NCT01259115|101635905|FG000|Period 1|Adverse Event|1|||
33476036|NCT01259115|101635906|FG001|Period 1|Adverse Event|0|||
33476037|NCT01259115|101635905|FG000|Period 1|Protocol Violation|2|||
33476038|NCT01259115|101635906|FG001|Period 1|Protocol Violation|0|||
33476039|NCT01259115|101635905|FG000|Period 1|Lost to Follow-up|0|||
33476040|NCT01259115|101635906|FG001|Period 1|Lost to Follow-up|1|||
33476041|NCT01259115|101635905|FG000|Period 2|Adverse Event|1|||
33476042|NCT01259115|101635906|FG001|Period 2|Adverse Event|0|||
33476043|NCT00742924|101635907|FG000|Overall Study|Adverse Event|0|||
33476044|NCT00742924|101635908|FG001|Overall Study|Adverse Event|0|||
33476045|NCT00742924|101635909|FG002|Overall Study|Adverse Event|1|||
33476046|NCT00742924|101635910|FG003|Overall Study|Adverse Event|1|||
33476047|NCT00742924|101635907|FG000|Overall Study|Lack of Efficacy|5|||
33476048|NCT00742924|101635908|FG001|Overall Study|Lack of Efficacy|1|||
33476049|NCT00742924|101635909|FG002|Overall Study|Lack of Efficacy|2|||
33476050|NCT00742924|101635910|FG003|Overall Study|Lack of Efficacy|4|||
33476051|NCT00742924|101635907|FG000|Overall Study|Physician Decision|0|||
33476052|NCT00742924|101635908|FG001|Overall Study|Physician Decision|0|||
33476053|NCT00742924|101635909|FG002|Overall Study|Physician Decision|0|||
33476054|NCT00742924|101635910|FG003|Overall Study|Physician Decision|1|||
33476055|NCT00742924|101635907|FG000|Overall Study|Withdrawal by Subject|0|||
33476056|NCT00742924|101635908|FG001|Overall Study|Withdrawal by Subject|1|||
33476057|NCT00742924|101635909|FG002|Overall Study|Withdrawal by Subject|1|||
33476058|NCT00742924|101635910|FG003|Overall Study|Withdrawal by Subject|0|||
33476059|NCT04614246|101635913|FG000|Overall Study|Adverse Event|0|||
33476060|NCT04614246|101635914|FG001|Overall Study|Adverse Event|1|||
33476061|NCT04614246|101635915|FG002|Overall Study|Adverse Event|1|||
33476062|NCT04614246|101635916|FG003|Overall Study|Adverse Event|2|||
33476063|NCT04614246|101635917|FG004|Overall Study|Adverse Event|1|||
33476064|NCT04614246|101635913|FG000|Overall Study|Lost to Follow-up|0|||
33476065|NCT04614246|101635914|FG001|Overall Study|Lost to Follow-up|1|||
33476066|NCT04614246|101635915|FG002|Overall Study|Lost to Follow-up|0|||
33476067|NCT04614246|101635916|FG003|Overall Study|Lost to Follow-up|1|||
33476068|NCT04614246|101635917|FG004|Overall Study|Lost to Follow-up|3|||
33476069|NCT04614246|101635913|FG000|Overall Study|Other reason|0|||
33476070|NCT04614246|101635914|FG001|Overall Study|Other reason|1|||
33476071|NCT04614246|101635915|FG002|Overall Study|Other reason|2|||
33476072|NCT04614246|101635916|FG003|Overall Study|Other reason|0|||
33476073|NCT04614246|101635917|FG004|Overall Study|Other reason|0|||
33476074|NCT04614246|101635913|FG000|Overall Study|Withdrawal by Subject|4|||
33267518|NCT02325466|100878015|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
33267519|NCT02325466|100878013|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
33267520|NCT02325466|100878014|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
33476075|NCT04614246|101635914|FG001|Overall Study|Withdrawal by Subject|2|||
33476076|NCT04614246|101635915|FG002|Overall Study|Withdrawal by Subject|4|||
33476077|NCT04614246|101635916|FG003|Overall Study|Withdrawal by Subject|3|||
33476078|NCT04614246|101635917|FG004|Overall Study|Withdrawal by Subject|4|||
33476079|NCT04614246|101635913|FG000|Overall Study|Physician Decision|0|||
33476080|NCT04614246|101635914|FG001|Overall Study|Physician Decision|2|||
33476081|NCT04614246|101635915|FG002|Overall Study|Physician Decision|1|||
33476082|NCT04614246|101635916|FG003|Overall Study|Physician Decision|0|||
33476083|NCT04614246|101635917|FG004|Overall Study|Physician Decision|0|||
33476084|NCT04614246|101635913|FG000|Overall Study|Study terminated by sponsor|10|||
33476085|NCT04614246|101635914|FG001|Overall Study|Study terminated by sponsor|15|||
33476086|NCT04614246|101635915|FG002|Overall Study|Study terminated by sponsor|12|||
33476087|NCT04614246|101635916|FG003|Overall Study|Study terminated by sponsor|13|||
33476088|NCT04614246|101635917|FG004|Overall Study|Study terminated by sponsor|9|||
33476089|NCT04614246|101635913|FG000|Overall Study|Pregnancy|2|||
33476090|NCT04614246|101635914|FG001|Overall Study|Pregnancy|0|||
33476091|NCT04614246|101635915|FG002|Overall Study|Pregnancy|1|||
33476092|NCT04614246|101635916|FG003|Overall Study|Pregnancy|0|||
33476093|NCT04614246|101635917|FG004|Overall Study|Pregnancy|0|||
33476094|NCT03837743|101635923|FG000|Overall Study|Adverse Event|1|||
33476095|NCT03837743|101635923|FG000|Overall Study|Withdrawal by Subject|2|||
33476096|NCT02493777|101635926|FG000|Overall Study|Lost to Follow-up|0|||
33476097|NCT02493777|101635927|FG001|Overall Study|Lost to Follow-up|1|||
33476098|NCT00540293|101635928|FG000|Overall Study|Adverse event related to study drug|10|||
33476099|NCT00540293|101635928|FG000|Overall Study|Adverse event not related to study drug|7|||
33476100|NCT00540293|101635928|FG000|Overall Study|Withdrawal by Subject|6|||
33476101|NCT00540293|101635928|FG000|Overall Study|Protocol violation, & subject schedule|12|||
33476102|NCT00324649|101635929|FG000|Overall Study|Adverse Event|1|||
33476103|NCT00324649|101635930|FG001|Overall Study|Adverse Event|4|||
33476104|NCT00324649|101635929|FG000|Overall Study|Withdrawal by Subject|0|||
33476105|NCT00324649|101635930|FG001|Overall Study|Withdrawal by Subject|1|||
33476106|NCT00324649|101635929|FG000|Overall Study|Noncompliance|1|||
33476107|NCT00324649|101635930|FG001|Overall Study|Noncompliance|0|||
33476108|NCT00117325|101635936|FG000|Overall Study|Adverse Event|3|||
33476109|NCT00117325|101635937|FG001|Overall Study|Adverse Event|3|||
33476110|NCT00117325|101635936|FG000|Overall Study|Lost to Follow-up|1|||
33476111|NCT00117325|101635937|FG001|Overall Study|Lost to Follow-up|1|||
33476112|NCT00117325|101635936|FG000|Overall Study|Protocol Violation|2|||
33476113|NCT00117325|101635937|FG001|Overall Study|Protocol Violation|3|||
33476114|NCT00117325|101635936|FG000|Overall Study|Withdrawal by Subject|3|||
33476115|NCT00117325|101635937|FG001|Overall Study|Withdrawal by Subject|2|||
33476116|NCT00117325|101635936|FG000|Overall Study|Lack of Efficacy|1|||
33476117|NCT00117325|101635937|FG001|Overall Study|Lack of Efficacy|0|||
33476118|NCT00117325|101635936|FG000|Overall Study|Use of prohibited medicine|1|||
33476119|NCT00117325|101635937|FG001|Overall Study|Use of prohibited medicine|2|||
33476120|NCT00117325|101635936|FG000|Overall Study|Early termination|1|||
33476121|NCT00117325|101635937|FG001|Overall Study|Early termination|1|||
33476122|NCT00117325|101635936|FG000|Overall Study|Admisnitrative|1|||
33476123|NCT00117325|101635937|FG001|Overall Study|Admisnitrative|0|||
33476124|NCT01197755|101635938|FG000|Overall Study|Adverse Event|8|||
33476125|NCT01197755|101635939|FG001|Overall Study|Adverse Event|10|||
33476126|NCT01197755|101635940|FG002|Overall Study|Adverse Event|10|||
33476127|NCT01197755|101635938|FG000|Overall Study|Study-specific discontinuation criteria|2|||
33476128|NCT01197755|101635939|FG001|Overall Study|Study-specific discontinuation criteria|1|||
33476129|NCT01197755|101635940|FG002|Overall Study|Study-specific discontinuation criteria|0|||
33476130|NCT01197755|101635938|FG000|Overall Study|Entered the long-term extension study|18|||
33476131|NCT01197755|101635939|FG001|Overall Study|Entered the long-term extension study|21|||
33267521|NCT02325466|100878015|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
33267522|NCT02325466|100878013|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
33267523|NCT02325466|100878014|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
33267524|NCT02325466|100878015|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
33267525|NCT02325466|100878013|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
33267526|NCT02325466|100878014|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
33267527|NCT02325466|100878015|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
33267528|NCT02325466|100878013|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
33267529|NCT02325466|100878014|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
33267530|NCT02325466|100878015|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
33267531|NCT02325466|100878013|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
33267532|NCT02325466|100878014|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
33476132|NCT01197755|101635940|FG002|Overall Study|Entered the long-term extension study|35|||
33476133|NCT01197755|101635938|FG000|Overall Study|Lack of therapeutic response|0|||
33476134|NCT01197755|101635939|FG001|Overall Study|Lack of therapeutic response|7|||
33476135|NCT01197755|101635940|FG002|Overall Study|Lack of therapeutic response|4|||
33476136|NCT01197755|101635938|FG000|Overall Study|Severe non-compliance to the protocol|2|||
33476137|NCT01197755|101635939|FG001|Overall Study|Severe non-compliance to the protocol|1|||
33476138|NCT01197755|101635940|FG002|Overall Study|Severe non-compliance to the protocol|2|||
33476139|NCT01197755|101635938|FG000|Overall Study|Withdrawal by Subject|1|||
33476140|NCT01197755|101635939|FG001|Overall Study|Withdrawal by Subject|0|||
33476141|NCT01197755|101635940|FG002|Overall Study|Withdrawal by Subject|0|||
33476142|NCT01197755|101635938|FG000|Overall Study|Lost to Follow-up|0|||
33476143|NCT01197755|101635939|FG001|Overall Study|Lost to Follow-up|0|||
33267533|NCT02325466|100878015|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
33267534|NCT02325466|100878013|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
33267535|NCT02325466|100878014|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
33267536|NCT02325466|100878015|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
33267537|NCT02325466|100878013|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
33267538|NCT02325466|100878014|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
33267539|NCT02325466|100878015|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
33267540|NCT02325466|100878013|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
33267541|NCT02325466|100878014|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
33267542|NCT02325466|100878015|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
33267543|NCT03032198|100878026|FG000|Overall Study|Screen Fail|1|||
33267544|NCT00689351|100878027|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
33267545|NCT00689351|100878028|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
33267546|NCT00689351|100878027|FG000|Infant Series of Dosing|Adverse Event|1|||
33267547|NCT00689351|100878028|FG001|Infant Series of Dosing|Adverse Event|0|||
33267548|NCT00689351|100878027|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
33267549|NCT00689351|100878028|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
33267550|NCT00689351|100878027|FG000|After Infant Series|Parent/legal guardian request|1|||
33267551|NCT00689351|100878028|FG001|After Infant Series|Parent/legal guardian request|0|||
33267552|NCT03611556|100878029|FG000|Overall Study|Death|7|||
33267553|NCT03611556|100878030|FG001|Overall Study|Death|7|||
33267554|NCT03611556|100878031|FG002|Overall Study|Death|3|||
33476144|NCT01197755|101635940|FG002|Overall Study|Lost to Follow-up|1|||
33476145|NCT01197755|101635938|FG000|Overall Study|eg, change in circumstances|7|||
33476146|NCT01197755|101635939|FG001|Overall Study|eg, change in circumstances|3|||
33476147|NCT01197755|101635940|FG002|Overall Study|eg, change in circumstances|2|||
33476148|NCT02317614|101635941|FG000|Overall Study|Lost to Follow-up|1|||
33476149|NCT02317614|101635942|FG001|Overall Study|Lost to Follow-up|1|||
33476150|NCT02317614|101635941|FG000|Overall Study|Withdrawal by Subject|1|||
33476151|NCT02317614|101635942|FG001|Overall Study|Withdrawal by Subject|0|||
33476152|NCT02317614|101635941|FG000|Overall Study|Death|1|||
33476153|NCT02317614|101635942|FG001|Overall Study|Death|1|||
33476154|NCT01104792|101635949|FG000|Overall Study|Adverse Event|77|||
33476155|NCT01104792|101635949|FG000|Overall Study|Insufficient Therapeutic Response|22|||
33476156|NCT01104792|101635949|FG000|Overall Study|Protocol Violation|45|||
33476157|NCT01104792|101635949|FG000|Overall Study|Withdrawal of Consent|179|||
33476158|NCT01104792|101635949|FG000|Overall Study|Lost to Follow-up|43|||
33476159|NCT01104792|101635949|FG000|Overall Study|Reasons Not Specified|27|||
33476160|NCT01104792|101635949|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
33476161|NCT00160641|101635950|FG000|Overall Study|Adverse Event|102|||
33476162|NCT00160641|101635950|FG000|Overall Study|Withdrawal by Subject|87|||
33476163|NCT00160641|101635950|FG000|Overall Study|Lost to Follow-up|8|||
33476164|NCT00160641|101635950|FG000|Overall Study|Lack of Efficacy|12|||
33476165|NCT00160641|101635950|FG000|Overall Study|Protocol Violation|3|||
33476166|NCT00160641|101635950|FG000|Overall Study|Other|9|||
33476167|NCT00354341|101635952|FG000|Overall Study|Adverse Event|1|||
33476168|NCT00354341|101635953|FG001|Overall Study|Adverse Event|0|||
33476169|NCT00354341|101635952|FG000|Overall Study|Death|0|||
33476170|NCT00354341|101635953|FG001|Overall Study|Death|2|||
33476171|NCT00354341|101635952|FG000|Overall Study|Refused treatment|1|||
33476172|NCT00354341|101635953|FG001|Overall Study|Refused treatment|2|||
33476173|NCT00354341|101635952|FG000|Overall Study|Failure to return|0|||
33476174|NCT00354341|101635953|FG001|Overall Study|Failure to return|1|||
33476175|NCT00354341|101635952|FG000|Overall Study|Other|1|||
33476176|NCT00354341|101635953|FG001|Overall Study|Other|2|||
33476177|NCT03246126|101635954|FG000|Overall Study|Withdrawal by Subject|0|||
33476178|NCT03246126|101635955|FG001|Overall Study|Withdrawal by Subject|1|||
33476179|NCT00852969|101635956|FG000|Overall Study|Adverse Event|0|||
33267555|NCT03611556|100878032|FG003|Overall Study|Death|8|||
33267556|NCT03611556|100878033|FG004|Overall Study|Death|47|||
33267557|NCT03611556|100878034|FG005|Overall Study|Death|32|||
33267558|NCT03611556|100878035|FG006|Overall Study|Death|53|||
33267559|NCT03611556|100878029|FG000|Overall Study|Withdrawal by Subject|0|||
33267560|NCT03611556|100878030|FG001|Overall Study|Withdrawal by Subject|0|||
33267561|NCT03611556|100878031|FG002|Overall Study|Withdrawal by Subject|0|||
33267562|NCT03611556|100878032|FG003|Overall Study|Withdrawal by Subject|0|||
33476180|NCT00852969|101635957|FG001|Overall Study|Adverse Event|1|||
33476181|NCT00852969|101635956|FG000|Overall Study|Lost to Follow-up|0|||
33476182|NCT00852969|101635957|FG001|Overall Study|Lost to Follow-up|1|||
33476183|NCT00758680|101635963|FG000|Overall Study|Adverse Event|0|||
33476184|NCT00758680|101635964|FG001|Overall Study|Adverse Event|0|||
33476185|NCT00758680|101635965|FG002|Overall Study|Adverse Event|0|||
33476186|NCT00758680|101635966|FG003|Overall Study|Adverse Event|0|||
33476187|NCT00758680|101635967|FG004|Overall Study|Adverse Event|0|||
33476188|NCT00758680|101635968|FG005|Overall Study|Adverse Event|0|||
33476189|NCT00758680|101635969|FG006|Overall Study|Adverse Event|0|||
33476190|NCT00758680|101635970|FG007|Overall Study|Adverse Event|1|||
33476191|NCT00758680|101635971|FG008|Overall Study|Adverse Event|0|||
33476192|NCT00758680|101635972|FG009|Overall Study|Adverse Event|1|||
33476193|NCT00758680|101635963|FG000|Overall Study|Laboratory Adverse Event|0|||
33267563|NCT03611556|100878033|FG004|Overall Study|Withdrawal by Subject|4|||
33267564|NCT03611556|100878034|FG005|Overall Study|Withdrawal by Subject|2|||
33267565|NCT03611556|100878035|FG006|Overall Study|Withdrawal by Subject|4|||
33476194|NCT00758680|101635964|FG001|Overall Study|Laboratory Adverse Event|0|||
33476195|NCT00758680|101635965|FG002|Overall Study|Laboratory Adverse Event|0|||
33476196|NCT00758680|101635966|FG003|Overall Study|Laboratory Adverse Event|0|||
33476197|NCT00758680|101635967|FG004|Overall Study|Laboratory Adverse Event|0|||
33476198|NCT00758680|101635968|FG005|Overall Study|Laboratory Adverse Event|0|||
33476199|NCT00758680|101635969|FG006|Overall Study|Laboratory Adverse Event|0|||
33476200|NCT00758680|101635970|FG007|Overall Study|Laboratory Adverse Event|0|||
33476201|NCT00758680|101635971|FG008|Overall Study|Laboratory Adverse Event|1|||
33476202|NCT00758680|101635972|FG009|Overall Study|Laboratory Adverse Event|0|||
33476203|NCT00758680|101635963|FG000|Overall Study|Withdrawal by Subject|0|||
33476204|NCT00758680|101635964|FG001|Overall Study|Withdrawal by Subject|0|||
33267566|NCT03611556|100878029|FG000|Overall Study|Sponsor decision|0|||
33267567|NCT03611556|100878030|FG001|Overall Study|Sponsor decision|0|||
33267568|NCT03611556|100878031|FG002|Overall Study|Sponsor decision|0|||
33267569|NCT03611556|100878032|FG003|Overall Study|Sponsor decision|0|||
33267570|NCT03611556|100878033|FG004|Overall Study|Sponsor decision|9|||
33267571|NCT03611556|100878034|FG005|Overall Study|Sponsor decision|4|||
33267572|NCT03611556|100878035|FG006|Overall Study|Sponsor decision|12|||
33267573|NCT03611556|100878029|FG000|Overall Study|Reasons|0|||
33267574|NCT03611556|100878030|FG001|Overall Study|Reasons|0|||
33267575|NCT03611556|100878031|FG002|Overall Study|Reasons|0|||
33267576|NCT03611556|100878032|FG003|Overall Study|Reasons|0|||
33267577|NCT03611556|100878033|FG004|Overall Study|Reasons|2|||
33267578|NCT03611556|100878034|FG005|Overall Study|Reasons|0|||
33267579|NCT03611556|100878035|FG006|Overall Study|Reasons|1|||
33267580|NCT02399449|100878036|FG000|Overall Study|Withdrawal by Subject|3|||
33267581|NCT02399449|100878037|FG001|Overall Study|Withdrawal by Subject|9|||
33267582|NCT02399449|100878036|FG000|Overall Study|Physician Decision|0|||
33267583|NCT02399449|100878037|FG001|Overall Study|Physician Decision|1|||
33267584|NCT04652869|100878038|FG000|Overall Study|Withdrawal by Subject|0|||
33267585|NCT04652869|100878039|FG001|Overall Study|Withdrawal by Subject|2|||
33267586|NCT04652869|100878040|FG002|Overall Study|Withdrawal by Subject|0|||
33267587|NCT04559698|100878041|FG000|Overall Study|Lost to Follow-up|14|||
33267588|NCT04559698|100878042|FG001|Overall Study|Lost to Follow-up|15|||
33267589|NCT04559698|100878041|FG000|Overall Study|Withdrawal by Subject|0|||
33267590|NCT04559698|100878042|FG001|Overall Study|Withdrawal by Subject|1|||
33267591|NCT00600353|100878043|FG000|Overall Study|history of malignancy within 5 years|1|||
33267592|NCT00600353|100878044|FG001|Overall Study|history of malignancy within 5 years|0|||
33267593|NCT00600353|100878043|FG000|Overall Study|History of prepartive regimen|0|||
33267594|NCT00600353|100878044|FG001|Overall Study|History of prepartive regimen|1|||
33267595|NCT00336505|100878045|FG000|Overall Study|Adverse Event|10|||
33267596|NCT00336505|100878046|FG001|Overall Study|Adverse Event|9|||
33267597|NCT00336505|100878045|FG000|Overall Study|Lack of Efficacy|8|||
33267598|NCT00336505|100878046|FG001|Overall Study|Lack of Efficacy|4|||
33267599|NCT00336505|100878045|FG000|Overall Study|Lost to Follow-up|7|||
33267600|NCT00336505|100878046|FG001|Overall Study|Lost to Follow-up|4|||
33267601|NCT00336505|100878045|FG000|Overall Study|Withdrawal by Subject|5|||
33267602|NCT00336505|100878046|FG001|Overall Study|Withdrawal by Subject|3|||
33267603|NCT00336505|100878045|FG000|Overall Study|Other|7|||
33267604|NCT00336505|100878046|FG001|Overall Study|Other|7|||
33267605|NCT03905512|100878049|FG000|Overall Study|Withdrawal by Subject|9|||
33267606|NCT03905512|100878050|FG001|Overall Study|Withdrawal by Subject|8|||
33267607|NCT03905512|100878049|FG000|Overall Study|Adverse Event|1|||
33267608|NCT03905512|100878050|FG001|Overall Study|Adverse Event|2|||
33267609|NCT03905512|100878049|FG000|Overall Study|Lost to Follow-up|4|||
33267610|NCT03905512|100878050|FG001|Overall Study|Lost to Follow-up|3|||
33267611|NCT03905512|100878049|FG000|Overall Study|Other than Specified|7|||
33267612|NCT03905512|100878050|FG001|Overall Study|Other than Specified|4|||
33267613|NCT02161458|100878051|FG000|Overall Study|Withdrawal by Subject|0|||
33267614|NCT02161458|100878052|FG001|Overall Study|Withdrawal by Subject|4|||
33267615|NCT02161458|100878053|FG002|Overall Study|Withdrawal by Subject|4|||
33267616|NCT02161458|100878054|FG003|Overall Study|Withdrawal by Subject|0|||
33476205|NCT00758680|101635965|FG002|Overall Study|Withdrawal by Subject|0|||
33476206|NCT00758680|101635966|FG003|Overall Study|Withdrawal by Subject|0|||
33476207|NCT00758680|101635967|FG004|Overall Study|Withdrawal by Subject|0|||
33267617|NCT02161458|100878051|FG000|Overall Study|Lost to Follow-up|0|||
33267618|NCT02161458|100878052|FG001|Overall Study|Lost to Follow-up|2|||
33267619|NCT02161458|100878053|FG002|Overall Study|Lost to Follow-up|1|||
33267620|NCT02161458|100878054|FG003|Overall Study|Lost to Follow-up|0|||
33267621|NCT02167451|100878055|FG000|Overall Study|Withdrawal by Subject|1|||
33267622|NCT00570505|100878068|FG000|Overall Study|Adverse Event|7|||
33267623|NCT00570505|100878068|FG000|Overall Study|Withdrawal by Subject|7|||
33267624|NCT00570505|100878068|FG000|Overall Study|Lost to Follow-up|23|||
33267625|NCT00570505|100878068|FG000|Overall Study|Other loss to follow-up|4|||
33267626|NCT03041090|100878069|FG000|Overall Study|technical error|0|||
33476208|NCT00758680|101635968|FG005|Overall Study|Withdrawal by Subject|0|||
33476209|NCT00758680|101635969|FG006|Overall Study|Withdrawal by Subject|1|||
33476210|NCT00758680|101635970|FG007|Overall Study|Withdrawal by Subject|0|||
33476211|NCT00758680|101635971|FG008|Overall Study|Withdrawal by Subject|1|||
33476212|NCT00758680|101635972|FG009|Overall Study|Withdrawal by Subject|0|||
33476213|NCT03709823|101635973|FG000|Overall Study|Adverse Event|0|||
33476214|NCT03709823|101635974|FG001|Overall Study|Adverse Event|0|||
33476215|NCT03709823|101635975|FG002|Overall Study|Adverse Event|1|||
33476216|NCT03709823|101635976|FG003|Overall Study|Adverse Event|0|||
33476217|NCT03709823|101635977|FG004|Overall Study|Adverse Event|0|||
33476218|NCT03709823|101635978|FG005|Overall Study|Adverse Event|0|||
33267627|NCT03041090|100878070|FG001|Overall Study|technical error|3|||
33267628|NCT01278030|100878072|FG000|Overall Study|Withdrawal by Subject|8|||
33267629|NCT01278030|100878073|FG001|Overall Study|Withdrawal by Subject|4|||
33267630|NCT00360269|100878076|FG000|Overall Study|Lost to Follow-up|7|||
33267631|NCT00360269|100878077|FG001|Overall Study|Lost to Follow-up|9|||
33267632|NCT00360269|100878076|FG000|Overall Study|Physician Decision|1|||
33267633|NCT00360269|100878077|FG001|Overall Study|Physician Decision|2|||
33267634|NCT00360269|100878076|FG000|Overall Study|Adverse Event|1|||
33267635|NCT00360269|100878077|FG001|Overall Study|Adverse Event|0|||
33267636|NCT00360269|100878076|FG000|Overall Study|Withdrawal by Subject|1|||
33267637|NCT00360269|100878077|FG001|Overall Study|Withdrawal by Subject|1|||
33267638|NCT01529632|100878078|FG000|Overall Study|Administrative problem|2|||
33267639|NCT01529632|100878079|FG001|Overall Study|Administrative problem|1|||
33267640|NCT01529632|100878078|FG000|Overall Study|Protocol Violation|0|||
33267641|NCT01529632|100878079|FG001|Overall Study|Protocol Violation|1|||
33267642|NCT01529632|100878078|FG000|Overall Study|Adverse Event|1|||
33267643|NCT01529632|100878079|FG001|Overall Study|Adverse Event|1|||
33476219|NCT03709823|101635973|FG000|Overall Study|Lost to Follow-up|2|||
33476220|NCT03709823|101635974|FG001|Overall Study|Lost to Follow-up|2|||
33476221|NCT03709823|101635975|FG002|Overall Study|Lost to Follow-up|2|||
33476222|NCT03709823|101635976|FG003|Overall Study|Lost to Follow-up|1|||
33476223|NCT03709823|101635977|FG004|Overall Study|Lost to Follow-up|1|||
33476224|NCT03709823|101635978|FG005|Overall Study|Lost to Follow-up|0|||
33476225|NCT03709823|101635973|FG000|Overall Study|Withdrawal by Subject|1|||
33476226|NCT03709823|101635974|FG001|Overall Study|Withdrawal by Subject|3|||
33476227|NCT03709823|101635975|FG002|Overall Study|Withdrawal by Subject|0|||
33476228|NCT03709823|101635976|FG003|Overall Study|Withdrawal by Subject|0|||
33476229|NCT03709823|101635977|FG004|Overall Study|Withdrawal by Subject|0|||
33476230|NCT03709823|101635978|FG005|Overall Study|Withdrawal by Subject|0|||
33476231|NCT03709823|101635973|FG000|Overall Study|Other, Not Specified|0|||
33267644|NCT01961609|100878080|FG000|Initiation|Missing|3|||
33267645|NCT01961609|100878081|FG001|Initiation|Missing|2|||
33267646|NCT01961609|100878082|FG002|Initiation|Missing|0|||
33267647|NCT01961609|100878083|FG003|Initiation|Missing|0|||
33267648|NCT01961609|100878080|FG000|Initiation|Protocol deviation|1|||
33267649|NCT01961609|100878081|FG001|Initiation|Protocol deviation|0|||
33267650|NCT01961609|100878082|FG002|Initiation|Protocol deviation|0|||
33267651|NCT01961609|100878083|FG003|Initiation|Protocol deviation|0|||
33267652|NCT01961609|100878080|FG000|Initiation|Death|0|||
33267653|NCT01961609|100878081|FG001|Initiation|Death|1|||
33267654|NCT01961609|100878082|FG002|Initiation|Death|0|||
33267655|NCT01961609|100878083|FG003|Initiation|Death|0|||
33267656|NCT01961609|100878080|FG000|Initiation|Administrative problems|1|||
33476232|NCT03709823|101635974|FG001|Overall Study|Other, Not Specified|0|||
33476233|NCT03709823|101635975|FG002|Overall Study|Other, Not Specified|0|||
33476234|NCT03709823|101635976|FG003|Overall Study|Other, Not Specified|1|||
33476235|NCT03709823|101635977|FG004|Overall Study|Other, Not Specified|0|||
33476236|NCT03709823|101635978|FG005|Overall Study|Other, Not Specified|0|||
33267657|NCT01961609|100878081|FG001|Initiation|Administrative problems|0|||
33267658|NCT01961609|100878082|FG002|Initiation|Administrative problems|0|||
33267659|NCT01961609|100878083|FG003|Initiation|Administrative problems|0|||
33267660|NCT01961609|100878080|FG000|Initiation|Withdrawal by Subject|1|||
33267661|NCT01961609|100878081|FG001|Initiation|Withdrawal by Subject|2|||
33267662|NCT01961609|100878082|FG002|Initiation|Withdrawal by Subject|0|||
33267663|NCT01961609|100878083|FG003|Initiation|Withdrawal by Subject|0|||
33267664|NCT01961609|100878080|FG000|Initiation|Lack of Efficacy|2|||
33267665|NCT01961609|100878081|FG001|Initiation|Lack of Efficacy|1|||
33267666|NCT01961609|100878082|FG002|Initiation|Lack of Efficacy|0|||
33267667|NCT01961609|100878083|FG003|Initiation|Lack of Efficacy|0|||
33267668|NCT01961609|100878080|FG000|Initiation|Abnormal lab values|0|||
33267669|NCT01961609|100878081|FG001|Initiation|Abnormal lab values|1|||
33267670|NCT01961609|100878082|FG002|Initiation|Abnormal lab values|0|||
33267671|NCT01961609|100878083|FG003|Initiation|Abnormal lab values|0|||
33267672|NCT01961609|100878080|FG000|Initiation|Adverse Event|3|||
33267673|NCT01961609|100878081|FG001|Initiation|Adverse Event|5|||
33267674|NCT01961609|100878082|FG002|Initiation|Adverse Event|0|||
33476237|NCT03796039|101635979|FG000|Overall Study|Death|2|||
33267675|NCT01961609|100878083|FG003|Initiation|Adverse Event|0|||
33267676|NCT01961609|100878080|FG000|Initiation|Randomized but not treated|1|||
33267677|NCT01961609|100878081|FG001|Initiation|Randomized but not treated|1|||
33267678|NCT01961609|100878082|FG002|Initiation|Randomized but not treated|0|||
33267679|NCT01961609|100878083|FG003|Initiation|Randomized but not treated|0|||
33267680|NCT01961609|100878080|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
33267681|NCT01961609|100878081|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
33267682|NCT01961609|100878082|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
33267683|NCT01961609|100878083|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
33267684|NCT01961609|100878080|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
33267685|NCT01961609|100878081|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
33267686|NCT01961609|100878082|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
33267687|NCT01961609|100878083|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
33267688|NCT01961609|100878080|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
33267689|NCT01961609|100878081|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
33267690|NCT01961609|100878082|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
33267691|NCT01961609|100878083|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
33267692|NCT01961609|100878080|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
33267693|NCT01961609|100878081|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
33267694|NCT01961609|100878082|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
33267695|NCT01961609|100878083|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
33267696|NCT01961609|100878080|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
33267697|NCT01961609|100878081|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
33267698|NCT01961609|100878082|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
33476238|NCT03796039|101635980|FG001|Overall Study|Death|1|||
33476239|NCT03796039|101635979|FG000|Overall Study|Withdrawal by Subject|7|||
33476240|NCT03796039|101635980|FG001|Overall Study|Withdrawal by Subject|4|||
33476241|NCT03014180|101635981|FG000|Overall Study|Protocol Violation|2|||
33267699|NCT01961609|100878083|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
33267700|NCT01961609|100878080|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
33267701|NCT01961609|100878081|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
33267702|NCT01961609|100878082|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
33267703|NCT01961609|100878083|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
33267704|NCT01961609|100878080|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
33267705|NCT01961609|100878081|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
33267706|NCT01961609|100878082|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
33267707|NCT01961609|100878083|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
33267708|NCT01961609|100878080|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
33476242|NCT02227147|101635982|FG000|Controlled Treatment Period|Adverse Event|4|||
33476243|NCT02227147|101635983|FG001|Controlled Treatment Period|Adverse Event|3|||
33476244|NCT02227147|101635982|FG000|Controlled Treatment Period|Other|2|||
33476245|NCT02227147|101635983|FG001|Controlled Treatment Period|Other|0|||
33476246|NCT02227147|101635982|FG000|Follow-up Period|Other|3|||
33476247|NCT02227147|101635983|FG001|Follow-up Period|Other|5|||
33476248|NCT04168190|101635984|FG000|Overall Study|Lost to Follow-up|0|||
33476249|NCT04168190|101635985|FG001|Overall Study|Lost to Follow-up|1|||
33476250|NCT04168190|101635986|FG002|Overall Study|Lost to Follow-up|0|||
33476251|NCT04168190|101635987|FG003|Overall Study|Lost to Follow-up|7|||
33476252|NCT04168190|101635988|FG004|Overall Study|Lost to Follow-up|5|||
33476253|NCT04168190|101635984|FG000|Overall Study|Withdrawal by Subject|1|||
33476254|NCT04168190|101635985|FG001|Overall Study|Withdrawal by Subject|0|||
33476255|NCT04168190|101635986|FG002|Overall Study|Withdrawal by Subject|0|||
33476256|NCT04168190|101635987|FG003|Overall Study|Withdrawal by Subject|2|||
33476257|NCT04168190|101635988|FG004|Overall Study|Withdrawal by Subject|4|||
33476258|NCT04168190|101635984|FG000|Overall Study|Death|0|||
33476259|NCT04168190|101635985|FG001|Overall Study|Death|0|||
33476260|NCT04168190|101635986|FG002|Overall Study|Death|0|||
33267709|NCT01961609|100878081|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
33267710|NCT01961609|100878082|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
33476261|NCT04168190|101635987|FG003|Overall Study|Death|1|||
33476262|NCT04168190|101635988|FG004|Overall Study|Death|0|||
33476263|NCT04392583|101635990|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
33267711|NCT01961609|100878083|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
33267712|NCT01961609|100878080|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
33267713|NCT01961609|100878081|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
33267714|NCT01961609|100878082|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
33267715|NCT01961609|100878083|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
33267716|NCT01961609|100878080|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
33267717|NCT01961609|100878081|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
33267718|NCT01961609|100878082|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
33267719|NCT01961609|100878083|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
33476264|NCT02351960|101635991|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
33476265|NCT02351960|101635992|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
33476266|NCT02351960|101635991|FG000|Overall Study|Voluntary Withdrawal|5|||
33476267|NCT02351960|101635992|FG001|Overall Study|Voluntary Withdrawal|4|||
33476268|NCT02351960|101635991|FG000|Overall Study|Significant Protocol Deviation|0|||
33476269|NCT02351960|101635992|FG001|Overall Study|Significant Protocol Deviation|5|||
33476270|NCT02699684|101635994|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
33476271|NCT02699684|101635995|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
33476272|NCT01007942|101635996|FG000|Overall Study|Adverse Event|29|||
33476273|NCT01007942|101635997|FG001|Overall Study|Adverse Event|14|||
33476274|NCT01007942|101635996|FG000|Overall Study|Abnormal test procedure|0|||
33476275|NCT01007942|101635997|FG001|Overall Study|Abnormal test procedure|1|||
33476276|NCT01007942|101635996|FG000|Overall Study|Disease progression|217|||
33476277|NCT01007942|101635997|FG001|Overall Study|Disease progression|242|||
33476278|NCT01007942|101635996|FG000|Overall Study|New cancer therapy|5|||
33476279|NCT01007942|101635997|FG001|Overall Study|New cancer therapy|1|||
33476280|NCT01007942|101635996|FG000|Overall Study|Protocol Violation|1|||
33476281|NCT01007942|101635997|FG001|Overall Study|Protocol Violation|1|||
33476282|NCT01007942|101635996|FG000|Overall Study|Withdrawal by Subject|19|||
33476283|NCT01007942|101635997|FG001|Overall Study|Withdrawal by Subject|14|||
33476284|NCT01007942|101635996|FG000|Overall Study|Lost to Follow-up|1|||
33476285|NCT01007942|101635997|FG001|Overall Study|Lost to Follow-up|0|||
33267720|NCT01961609|100878080|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
33267721|NCT01961609|100878081|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
33267722|NCT01961609|100878082|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
33476286|NCT01007942|101635996|FG000|Overall Study|Administrative problems|2|||
33476287|NCT01007942|101635997|FG001|Overall Study|Administrative problems|0|||
33476288|NCT01007942|101635996|FG000|Overall Study|Death|3|||
33476289|NCT01007942|101635997|FG001|Overall Study|Death|2|||
33476290|NCT01007942|101635996|FG000|Overall Study|Patients untreated|4|||
33476291|NCT01007942|101635997|FG001|Overall Study|Patients untreated|3|||
33476292|NCT03397771|101636000|FG000|Overall Study|2 erroneously randomized, never treated|3|||
33476293|NCT03397771|101636001|FG001|Overall Study|2 erroneously randomized, never treated|1|||
33476294|NCT03397771|101636000|FG000|Overall Study|Withdrawal by Subject|1|||
33476295|NCT03397771|101636001|FG001|Overall Study|Withdrawal by Subject|3|||
33476296|NCT03397771|101636000|FG000|Overall Study|Protocol Violation|2|||
33476297|NCT03397771|101636001|FG001|Overall Study|Protocol Violation|2|||
33476298|NCT03397771|101636000|FG000|Overall Study|Adverse Event|2|||
33476299|NCT03397771|101636001|FG001|Overall Study|Adverse Event|1|||
33476300|NCT03484117|101636013|FG000|Overall Study|Lost to Follow-up|1|||
33476301|NCT03484117|101636014|FG001|Overall Study|Lost to Follow-up|3|||
33476302|NCT03484117|101636013|FG000|Overall Study|Declined participation in exit assess|1|||
33476303|NCT03484117|101636014|FG001|Overall Study|Declined participation in exit assess|1|||
33476304|NCT02034058|101636018|FG000|Overall Study|Death|3|||
33267723|NCT01961609|100878083|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
33267724|NCT01961609|100878080|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
33267725|NCT01961609|100878081|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
33267726|NCT01961609|100878082|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
33267727|NCT01961609|100878083|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
33267728|NCT00391170|100878084|FG000|Overall Study|Withdrawal by Subject|1|||
33267729|NCT00391170|100878085|FG001|Overall Study|Withdrawal by Subject|0|||
33267730|NCT00391170|100878084|FG000|Overall Study|Adverse Event|3|||
33267731|NCT00391170|100878085|FG001|Overall Study|Adverse Event|2|||
33267732|NCT00391170|100878084|FG000|Overall Study|Physician Decision|2|||
33267733|NCT00391170|100878085|FG001|Overall Study|Physician Decision|2|||
33267734|NCT01583166|100878086|FG000|Overall Study|Withdrawal by Subject|4|||
33267735|NCT01583166|100878087|FG001|Overall Study|Withdrawal by Subject|6|||
33476305|NCT02516553|101636019|FG000|Overall Study|Progressive disease|2|||
33476306|NCT02516553|101636020|FG001|Overall Study|Progressive disease|2|||
33476307|NCT02516553|101636021|FG002|Overall Study|Progressive disease|3|||
33476308|NCT02516553|101636022|FG003|Overall Study|Progressive disease|5|||
33476309|NCT02516553|101636023|FG004|Overall Study|Progressive disease|3|||
33476310|NCT02516553|101636024|FG005|Overall Study|Progressive disease|0|||
33476311|NCT02516553|101636025|FG006|Overall Study|Progressive disease|5|||
33476312|NCT02516553|101636026|FG007|Overall Study|Progressive disease|5|||
33267736|NCT02542943|100878088|FG000|Overall Study|Lost to Follow-up|1|||
33267737|NCT02542943|100878089|FG001|Overall Study|Lost to Follow-up|0|||
33267738|NCT02542943|100878090|FG002|Overall Study|Lost to Follow-up|0|||
33267739|NCT02542943|100878088|FG000|Overall Study|Withdrawal by Subject|0|||
33267740|NCT02542943|100878089|FG001|Overall Study|Withdrawal by Subject|1|||
33267741|NCT02542943|100878090|FG002|Overall Study|Withdrawal by Subject|0|||
33267742|NCT03170882|100878091|FG000|Overall Study|Death|17|||
33476313|NCT02516553|101636027|FG008|Overall Study|Progressive disease|11|||
33476314|NCT02516553|101636028|FG009|Overall Study|Progressive disease|3|||
33476315|NCT02516553|101636029|FG010|Overall Study|Progressive disease|10|||
33476316|NCT02516553|101636030|FG011|Overall Study|Progressive disease|8|||
33476317|NCT02516553|101636031|FG012|Overall Study|Progressive disease|8|||
33267743|NCT03170882|100878092|FG001|Overall Study|Death|29|||
33267744|NCT03170882|100878091|FG000|Overall Study|Lost to Follow-up|0|||
33267745|NCT03170882|100878092|FG001|Overall Study|Lost to Follow-up|1|||
33476318|NCT02516553|101636032|FG013|Overall Study|Progressive disease|2|||
33476319|NCT02516553|101636033|FG014|Overall Study|Progressive disease|2|||
33476320|NCT02516553|101636034|FG015|Overall Study|Progressive disease|2|||
33476321|NCT02516553|101636035|FG016|Overall Study|Progressive disease|1|||
33476322|NCT02516553|101636036|FG017|Overall Study|Progressive disease|9|||
33476323|NCT02516553|101636037|FG018|Overall Study|Progressive disease|12|||
33476324|NCT02516553|101636038|FG019|Overall Study|Progressive disease|7|||
33476325|NCT02516553|101636039|FG020|Overall Study|Progressive disease|16|||
33476326|NCT02516553|101636040|FG021|Overall Study|Progressive disease|18|||
33476327|NCT02516553|101636019|FG000|Overall Study|Dose limiting toxicity|0|||
33267746|NCT03170882|100878091|FG000|Overall Study|Withdrawal by Subject|4|||
33267747|NCT03170882|100878092|FG001|Overall Study|Withdrawal by Subject|7|||
33267748|NCT03170882|100878091|FG000|Overall Study|Reason not Specified|28|||
33267749|NCT03170882|100878092|FG001|Overall Study|Reason not Specified|36|||
33267750|NCT00895245|100878093|FG000|Overall Study|Lack of Efficacy|6|||
33267751|NCT04809623|100880541|FG000|Overall Study|Study Terminated by Sponsor|1|||
33476328|NCT02516553|101636020|FG001|Overall Study|Dose limiting toxicity|0|||
33476329|NCT02516553|101636021|FG002|Overall Study|Dose limiting toxicity|0|||
33476330|NCT02516553|101636022|FG003|Overall Study|Dose limiting toxicity|0|||
33476331|NCT02516553|101636023|FG004|Overall Study|Dose limiting toxicity|3|||
33476332|NCT02516553|101636024|FG005|Overall Study|Dose limiting toxicity|1|||
33476333|NCT02516553|101636025|FG006|Overall Study|Dose limiting toxicity|1|||
33476334|NCT02516553|101636026|FG007|Overall Study|Dose limiting toxicity|0|||
33476335|NCT02516553|101636027|FG008|Overall Study|Dose limiting toxicity|1|||
33476336|NCT02516553|101636028|FG009|Overall Study|Dose limiting toxicity|0|||
33476337|NCT02516553|101636029|FG010|Overall Study|Dose limiting toxicity|0|||
33476338|NCT02516553|101636030|FG011|Overall Study|Dose limiting toxicity|1|||
33476339|NCT02516553|101636031|FG012|Overall Study|Dose limiting toxicity|0|||
33267752|NCT04809623|100880542|FG001|Overall Study|Study Terminated by Sponsor|0|||
33267753|NCT00595959|100880543|FG000|Overall Study|Withdrawal by Subject|1|||
33267754|NCT00595959|100880543|FG000|Overall Study|Lost to Follow-up|1|||
33267755|NCT00536120|100880544|FG000|Overall Study|Lost to Follow-up|1|||
33267756|NCT00536120|100880545|FG001|Overall Study|Lost to Follow-up|0|||
33267757|NCT00536120|100880544|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
33267758|NCT00536120|100880545|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
33267759|NCT00536120|100880544|FG000|Overall Study|Non-compliance|1|||
33267760|NCT00536120|100880545|FG001|Overall Study|Non-compliance|0|||
33267761|NCT00536120|100880544|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
33267762|NCT00536120|100880545|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
33267763|NCT00536120|100880544|FG000|Overall Study|Steroid Use|0|||
33267764|NCT00536120|100880545|FG001|Overall Study|Steroid Use|2|||
33267765|NCT00536120|100880544|FG000|Overall Study|Missed Study Visit|0|||
33476340|NCT02516553|101636032|FG013|Overall Study|Dose limiting toxicity|1|||
33476341|NCT02516553|101636033|FG014|Overall Study|Dose limiting toxicity|0|||
33476342|NCT02516553|101636034|FG015|Overall Study|Dose limiting toxicity|0|||
33476343|NCT02516553|101636035|FG016|Overall Study|Dose limiting toxicity|1|||
33476344|NCT02516553|101636036|FG017|Overall Study|Dose limiting toxicity|1|||
33476345|NCT02516553|101636037|FG018|Overall Study|Dose limiting toxicity|0|||
33476346|NCT02516553|101636038|FG019|Overall Study|Dose limiting toxicity|2|||
33476347|NCT02516553|101636039|FG020|Overall Study|Dose limiting toxicity|0|||
33267766|NCT00536120|100880545|FG001|Overall Study|Missed Study Visit|1|||
33267767|NCT00089791|100880546|FG000|Overall Study|Physician Decision|6|||
33267768|NCT00089791|100880547|FG001|Overall Study|Physician Decision|3|||
33267769|NCT00089791|100880546|FG000|Overall Study|Adverse Event|81|||
33267770|NCT00089791|100880547|FG001|Overall Study|Adverse Event|93|||
33267771|NCT00089791|100880546|FG000|Overall Study|Withdrawal by Subject|403|||
33476348|NCT02516553|101636040|FG021|Overall Study|Dose limiting toxicity|0|||
33476349|NCT02516553|101636019|FG000|Overall Study|Other Adverse Events|0|||
33476350|NCT02516553|101636020|FG001|Overall Study|Other Adverse Events|0|||
33476351|NCT02516553|101636021|FG002|Overall Study|Other Adverse Events|0|||
33476352|NCT02516553|101636022|FG003|Overall Study|Other Adverse Events|1|||
33476353|NCT02516553|101636023|FG004|Overall Study|Other Adverse Events|0|||
33476354|NCT02516553|101636024|FG005|Overall Study|Other Adverse Events|1|||
33267772|NCT00089791|100880547|FG001|Overall Study|Withdrawal by Subject|344|||
33267773|NCT00089791|100880546|FG000|Overall Study|Death|78|||
33267774|NCT00089791|100880547|FG001|Overall Study|Death|62|||
33267775|NCT00089791|100880546|FG000|Overall Study|Disease progression|7|||
33267776|NCT00089791|100880547|FG001|Overall Study|Disease progression|3|||
33267777|NCT00089791|100880546|FG000|Overall Study|Ineligibility determined|12|||
33267778|NCT00089791|100880547|FG001|Overall Study|Ineligibility determined|9|||
33267779|NCT00089791|100880546|FG000|Overall Study|Lost to Follow-up|57|||
33267780|NCT00089791|100880547|FG001|Overall Study|Lost to Follow-up|57|||
33267781|NCT00089791|100880546|FG000|Overall Study|Noncompliance|17|||
33267782|NCT00089791|100880547|FG001|Overall Study|Noncompliance|13|||
33476355|NCT02516553|101636025|FG006|Overall Study|Other Adverse Events|0|||
33476356|NCT02516553|101636026|FG007|Overall Study|Other Adverse Events|0|||
33476357|NCT02516553|101636027|FG008|Overall Study|Other Adverse Events|0|||
33267783|NCT00089791|100880546|FG000|Overall Study|Other|20|||
33267784|NCT00089791|100880547|FG001|Overall Study|Other|32|||
33476358|NCT02516553|101636028|FG009|Overall Study|Other Adverse Events|1|||
33267785|NCT00089791|100880546|FG000|Overall Study|Protocol deviation|12|||
33267786|NCT00089791|100880547|FG001|Overall Study|Protocol deviation|10|||
33267787|NCT00089791|100880546|FG000|Overall Study|Requirement for alternative therapy|7|||
33267788|NCT00089791|100880547|FG001|Overall Study|Requirement for alternative therapy|4|||
33267789|NCT03035942|100880550|FG000|Overall Study|Adverse Event|8|||
33267790|NCT03035942|100880551|FG001|Overall Study|Adverse Event|4|||
33267791|NCT03035942|100880552|FG002|Overall Study|Adverse Event|5|||
33267792|NCT00266656|100880553|FG000|Overall Study|Death|1|||
33267793|NCT00266656|100880554|FG001|Overall Study|Death|0|||
33267794|NCT00266656|100880553|FG000|Overall Study|Lost to Follow-up|4|||
33267795|NCT00266656|100880554|FG001|Overall Study|Lost to Follow-up|1|||
33267796|NCT00266656|100880553|FG000|Overall Study|Withdrawal by Subject|4|||
33267797|NCT00266656|100880554|FG001|Overall Study|Withdrawal by Subject|2|||
33267798|NCT00266656|100880553|FG000|Overall Study|Did Not Reach Final Height|4|||
33267799|NCT00266656|100880554|FG001|Overall Study|Did Not Reach Final Height|8|||
33267800|NCT00266656|100880553|FG000|Overall Study|Parent/Caregiver Decision|1|||
33267801|NCT00266656|100880554|FG001|Overall Study|Parent/Caregiver Decision|2|||
33267802|NCT03442777|100880562|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
33476359|NCT02516553|101636029|FG010|Overall Study|Other Adverse Events|3|||
33476360|NCT02516553|101636030|FG011|Overall Study|Other Adverse Events|2|||
33476361|NCT02516553|101636031|FG012|Overall Study|Other Adverse Events|0|||
33476362|NCT02516553|101636032|FG013|Overall Study|Other Adverse Events|1|||
33476363|NCT02516553|101636033|FG014|Overall Study|Other Adverse Events|0|||
33476364|NCT02516553|101636034|FG015|Overall Study|Other Adverse Events|0|||
33476365|NCT02516553|101636035|FG016|Overall Study|Other Adverse Events|0|||
33476366|NCT02516553|101636036|FG017|Overall Study|Other Adverse Events|2|||
33476367|NCT02516553|101636037|FG018|Overall Study|Other Adverse Events|1|||
33476368|NCT02516553|101636038|FG019|Overall Study|Other Adverse Events|2|||
33267803|NCT03442777|100880563|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
33267804|NCT03442777|100880564|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
33267805|NCT01779700|100880567|FG000|Overall Study|Adverse Event|4|||
33267806|NCT01779700|100880568|FG001|Overall Study|Adverse Event|3|||
33267807|NCT01779700|100880567|FG000|Overall Study|Withdrawal by Subject|0|||
33267808|NCT01779700|100880568|FG001|Overall Study|Withdrawal by Subject|2|||
33267809|NCT01240785|100880570|FG000|Overall Study|Lost to Follow-up|1|||
33267810|NCT01240785|100880571|FG001|Overall Study|Lost to Follow-up|0|||
33267811|NCT01240785|100880570|FG000|Overall Study|Protocol Violation|0|||
33476369|NCT02516553|101636039|FG020|Overall Study|Other Adverse Events|2|||
33476370|NCT02516553|101636040|FG021|Overall Study|Other Adverse Events|1|||
33476371|NCT02516553|101636019|FG000|Overall Study|Refused to continue trial medication|0|||
33476372|NCT02516553|101636020|FG001|Overall Study|Refused to continue trial medication|0|||
33476373|NCT02516553|101636021|FG002|Overall Study|Refused to continue trial medication|0|||
33476374|NCT02516553|101636022|FG003|Overall Study|Refused to continue trial medication|0|||
33476375|NCT02516553|101636023|FG004|Overall Study|Refused to continue trial medication|0|||
33476376|NCT02516553|101636024|FG005|Overall Study|Refused to continue trial medication|0|||
33476377|NCT02516553|101636025|FG006|Overall Study|Refused to continue trial medication|0|||
33476378|NCT02516553|101636026|FG007|Overall Study|Refused to continue trial medication|0|||
33476379|NCT02516553|101636027|FG008|Overall Study|Refused to continue trial medication|0|||
33476380|NCT02516553|101636028|FG009|Overall Study|Refused to continue trial medication|0|||
33476381|NCT02516553|101636029|FG010|Overall Study|Refused to continue trial medication|1|||
33267812|NCT01240785|100880571|FG001|Overall Study|Protocol Violation|3|||
33267813|NCT00148122|100880575|FG000|Overall Study|Withdrawal by Subject|2|||
33267814|NCT01661972|100880586|FG000|Overall Study|Adverse Event|1|||
33267815|NCT01661972|100880587|FG001|Overall Study|Adverse Event|2|||
33267816|NCT01661972|100880586|FG000|Overall Study|Death during Treatment period|1|||
33267817|NCT01661972|100880587|FG001|Overall Study|Death during Treatment period|1|||
33267818|NCT01661972|100880586|FG000|Overall Study|Withdrawal by Subject|0|||
33267819|NCT01661972|100880587|FG001|Overall Study|Withdrawal by Subject|1|||
33267820|NCT00109031|100880590|FG000|Overall Study|Adverse Event|0|||
33267821|NCT00109031|100880591|FG001|Overall Study|Adverse Event|0|||
33476382|NCT02516553|101636030|FG011|Overall Study|Refused to continue trial medication|0|||
33476383|NCT02516553|101636031|FG012|Overall Study|Refused to continue trial medication|0|||
33476384|NCT02516553|101636032|FG013|Overall Study|Refused to continue trial medication|0|||
33267822|NCT00109031|100880592|FG002|Overall Study|Adverse Event|1|||
33267823|NCT00109031|100880593|FG003|Overall Study|Adverse Event|0|||
33267824|NCT00109031|100880590|FG000|Overall Study|Withdrawal by Subject|0|||
33267825|NCT00109031|100880591|FG001|Overall Study|Withdrawal by Subject|1|||
33476385|NCT02516553|101636033|FG014|Overall Study|Refused to continue trial medication|0|||
33476386|NCT02516553|101636034|FG015|Overall Study|Refused to continue trial medication|0|||
33476387|NCT02516553|101636035|FG016|Overall Study|Refused to continue trial medication|0|||
33476388|NCT02516553|101636036|FG017|Overall Study|Refused to continue trial medication|0|||
33476389|NCT02516553|101636037|FG018|Overall Study|Refused to continue trial medication|1|||
33476390|NCT02516553|101636038|FG019|Overall Study|Refused to continue trial medication|0|||
33476391|NCT02516553|101636039|FG020|Overall Study|Refused to continue trial medication|0|||
33476392|NCT02516553|101636040|FG021|Overall Study|Refused to continue trial medication|1|||
33476393|NCT02516553|101636019|FG000|Overall Study|other reasons than listed|0|||
33476394|NCT02516553|101636020|FG001|Overall Study|other reasons than listed|0|||
33476395|NCT02516553|101636021|FG002|Overall Study|other reasons than listed|0|||
33476396|NCT02516553|101636022|FG003|Overall Study|other reasons than listed|0|||
33476397|NCT02516553|101636023|FG004|Overall Study|other reasons than listed|0|||
33476398|NCT02516553|101636024|FG005|Overall Study|other reasons than listed|0|||
33476399|NCT02516553|101636025|FG006|Overall Study|other reasons than listed|0|||
33476400|NCT02516553|101636026|FG007|Overall Study|other reasons than listed|1|||
33476401|NCT02516553|101636027|FG008|Overall Study|other reasons than listed|1|||
33476402|NCT02516553|101636028|FG009|Overall Study|other reasons than listed|0|||
33476403|NCT02516553|101636029|FG010|Overall Study|other reasons than listed|1|||
33476404|NCT02516553|101636030|FG011|Overall Study|other reasons than listed|1|||
33476405|NCT02516553|101636031|FG012|Overall Study|other reasons than listed|0|||
33476406|NCT02516553|101636032|FG013|Overall Study|other reasons than listed|0|||
33476407|NCT02516553|101636033|FG014|Overall Study|other reasons than listed|0|||
33476408|NCT02516553|101636034|FG015|Overall Study|other reasons than listed|0|||
33476409|NCT02516553|101636035|FG016|Overall Study|other reasons than listed|0|||
33476410|NCT02516553|101636036|FG017|Overall Study|other reasons than listed|0|||
33476411|NCT02516553|101636037|FG018|Overall Study|other reasons than listed|0|||
33476412|NCT02516553|101636038|FG019|Overall Study|other reasons than listed|0|||
33476413|NCT02516553|101636039|FG020|Overall Study|other reasons than listed|2|||
33476414|NCT02516553|101636040|FG021|Overall Study|other reasons than listed|2|||
33476415|NCT01229735|101636041|FG000|Overall Study|Lack of Efficacy|8|||
33476416|NCT01229735|101636042|FG001|Overall Study|Lack of Efficacy|8|||
33476417|NCT01229735|101636041|FG000|Overall Study|Protocol Violation|13|||
33476418|NCT01229735|101636042|FG001|Overall Study|Protocol Violation|8|||
33476419|NCT01229735|101636041|FG000|Overall Study|Lost to Follow-up|0|||
33476420|NCT01229735|101636042|FG001|Overall Study|Lost to Follow-up|2|||
33476421|NCT01229735|101636041|FG000|Overall Study|Withdrawal by Subject|18|||
33476422|NCT01229735|101636042|FG001|Overall Study|Withdrawal by Subject|17|||
33476423|NCT01229735|101636041|FG000|Overall Study|Other Reason|13|||
33476424|NCT01229735|101636042|FG001|Overall Study|Other Reason|10|||
33267826|NCT00109031|100880592|FG002|Overall Study|Withdrawal by Subject|0|||
33267827|NCT00109031|100880593|FG003|Overall Study|Withdrawal by Subject|0|||
33267828|NCT00109031|100880590|FG000|Overall Study|Physician Decision|0|||
33267829|NCT00109031|100880591|FG001|Overall Study|Physician Decision|1|||
33267830|NCT00109031|100880592|FG002|Overall Study|Physician Decision|0|||
33267831|NCT00109031|100880593|FG003|Overall Study|Physician Decision|0|||
33267832|NCT00109031|100880590|FG000|Overall Study|Protocol Violation|0|||
33267833|NCT00109031|100880591|FG001|Overall Study|Protocol Violation|0|||
33267834|NCT00109031|100880592|FG002|Overall Study|Protocol Violation|1|||
33267835|NCT00109031|100880593|FG003|Overall Study|Protocol Violation|0|||
33267836|NCT03352713|100880595|FG000|Overall Study|Lost to Follow-up|8|||
33267837|NCT03352713|100880595|FG000|Overall Study|Withdrawn by investigator|5|||
33267838|NCT03352713|100880595|FG000|Overall Study|Completed 0 EMAs|8|||
33267839|NCT03352713|100880595|FG000|Overall Study|Device incompatible/stolen|5|||
33267840|NCT03140670|100880598|FG000|Overall Study|Withdrawal by Subject|2|||
33267841|NCT03140670|100880598|FG000|Overall Study|Lost to Follow-up|1|||
33267842|NCT03140670|100880598|FG000|Overall Study|Physician Decision|1|||
33267843|NCT01787032|100880599|FG000|Overall Study|Protocol Violation|0|||
33267844|NCT01787032|100880600|FG001|Overall Study|Protocol Violation|0|||
33267845|NCT01787032|100880601|FG002|Overall Study|Protocol Violation|0|||
33267846|NCT01787032|100880602|FG003|Overall Study|Protocol Violation|0|||
33267847|NCT01787032|100880603|FG004|Overall Study|Protocol Violation|1|||
33267848|NCT01787032|100880604|FG005|Overall Study|Protocol Violation|1|||
33267849|NCT03403036|100880607|FG000|Overall Study|Lack of Efficacy|5|||
33476425|NCT01229735|101636041|FG000|Overall Study|SAE, non-fatal|0|||
33476426|NCT01229735|101636042|FG001|Overall Study|SAE, non-fatal|4|||
33476427|NCT01229735|101636041|FG000|Overall Study|AE, non-serious non-fatal|13|||
33267850|NCT02169414|100880613|FG000|Overall Study|Withdrawal by Subject|1|||
33476428|NCT01229735|101636042|FG001|Overall Study|AE, non-serious non-fatal|17|||
33476429|NCT01229735|101636041|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
33476430|NCT01229735|101636042|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
33476431|NCT03255655|101636048|FG000|Overall Study|Lost to Follow-up|7|||
33476432|NCT03255655|101636049|FG001|Overall Study|Lost to Follow-up|4|||
33267851|NCT02169414|100880614|FG001|Overall Study|Withdrawal by Subject|0|||
33267852|NCT02169414|100880615|FG002|Overall Study|Withdrawal by Subject|0|||
33267853|NCT02169414|100880616|FG003|Overall Study|Withdrawal by Subject|0|||
33267854|NCT02169414|100880613|FG000|Overall Study|Adverse Event|0|||
33267855|NCT02169414|100880614|FG001|Overall Study|Adverse Event|1|||
33267856|NCT02169414|100880615|FG002|Overall Study|Adverse Event|0|||
33267857|NCT02169414|100880616|FG003|Overall Study|Adverse Event|0|||
33267858|NCT01989104|100880617|FG000|Overall Study|Withdrawal by Subject|3|||
33267859|NCT01989104|100880618|FG001|Overall Study|Withdrawal by Subject|0|||
33267860|NCT01989104|100880619|FG002|Overall Study|Withdrawal by Subject|0|||
33267861|NCT01989104|100880620|FG003|Overall Study|Withdrawal by Subject|0|||
33267862|NCT01989104|100880621|FG004|Overall Study|Withdrawal by Subject|0|||
33267863|NCT01855399|100880622|FG000|6 Month|Lost to Follow-up|12|||
33267864|NCT01855399|100880623|FG001|6 Month|Lost to Follow-up|9|||
33267865|NCT01855399|100880622|FG000|6 Month|Withdrawal by Subject|8|||
33267866|NCT01855399|100880623|FG001|6 Month|Withdrawal by Subject|6|||
33267867|NCT01855399|100880622|FG000|12 Month|Lost to Follow-up|7|||
33267868|NCT01855399|100880623|FG001|12 Month|Lost to Follow-up|11|||
33267869|NCT03128099|100880624|FG000|Overall Study|High dose task was too long|0|||
33267870|NCT03128099|100880625|FG001|Overall Study|High dose task was too long|4|||
33267871|NCT03128099|100880626|FG002|Overall Study|High dose task was too long|0|||
33267872|NCT03128099|100880624|FG000|Overall Study|Participant got a full time job.|1|||
33267873|NCT03128099|100880625|FG001|Overall Study|Participant got a full time job.|0|||
33267874|NCT03128099|100880626|FG002|Overall Study|Participant got a full time job.|0|||
33267875|NCT03128099|100880624|FG000|Overall Study|Became homeless and lost contact|1|||
33476433|NCT03551496|101636055|FG000|Overall Study|Death|11|||
33476434|NCT03551496|101636056|FG001|Overall Study|Death|7|||
33476435|NCT03551496|101636055|FG000|Overall Study|Withdrawal by Subject|4|||
33476436|NCT03551496|101636056|FG001|Overall Study|Withdrawal by Subject|3|||
33476437|NCT03551496|101636055|FG000|Overall Study|Other Reasons|1|||
33476438|NCT03551496|101636056|FG001|Overall Study|Other Reasons|0|||
33476439|NCT04112173|101636057|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
33476440|NCT03107026|101636058|FG000|Overall Study|Adverse Event|2|||
33476441|NCT03107026|101636059|FG001|Overall Study|Adverse Event|14|||
33476442|NCT03107026|101636060|FG002|Overall Study|Adverse Event|23|||
33476443|NCT03107026|101636058|FG000|Overall Study|Lost to Follow-up|12|||
33476444|NCT03107026|101636059|FG001|Overall Study|Lost to Follow-up|12|||
33476445|NCT03107026|101636060|FG002|Overall Study|Lost to Follow-up|13|||
33476446|NCT03107026|101636058|FG000|Overall Study|Protocol Violation|1|||
33476447|NCT03107026|101636059|FG001|Overall Study|Protocol Violation|2|||
33476448|NCT03107026|101636060|FG002|Overall Study|Protocol Violation|0|||
33476449|NCT03107026|101636058|FG000|Overall Study|Pregnancy|1|||
33476450|NCT03107026|101636059|FG001|Overall Study|Pregnancy|0|||
33476451|NCT03107026|101636060|FG002|Overall Study|Pregnancy|0|||
33476452|NCT03107026|101636058|FG000|Overall Study|Withdrawal by Subject|13|||
33476453|NCT03107026|101636059|FG001|Overall Study|Withdrawal by Subject|5|||
33476454|NCT03107026|101636060|FG002|Overall Study|Withdrawal by Subject|17|||
33476455|NCT03107026|101636058|FG000|Overall Study|non compliance with study visits|1|||
33476456|NCT03107026|101636059|FG001|Overall Study|non compliance with study visits|2|||
33476457|NCT03107026|101636060|FG002|Overall Study|non compliance with study visits|0|||
33476458|NCT03107026|101636058|FG000|Overall Study|non-compliance with study drug|2|||
33476459|NCT03107026|101636059|FG001|Overall Study|non-compliance with study drug|2|||
33476460|NCT03107026|101636060|FG002|Overall Study|non-compliance with study drug|3|||
33476461|NCT03107026|101636058|FG000|Overall Study|Physician Decision|0|||
33476462|NCT03107026|101636059|FG001|Overall Study|Physician Decision|1|||
33476463|NCT03107026|101636060|FG002|Overall Study|Physician Decision|0|||
33476464|NCT00725205|101636061|FG000|Overall Study|Adverse Event|22|||
33476465|NCT00725205|101636061|FG000|Overall Study|Investigator Discontinued|1|||
33476466|NCT00725205|101636061|FG000|Overall Study|Non-compliance With Protocol|14|||
33476467|NCT00725205|101636061|FG000|Overall Study|Other|8|||
33476468|NCT00725205|101636061|FG000|Overall Study|Protocol Defined Clinical Event|1|||
33476469|NCT00725205|101636061|FG000|Overall Study|Treatment Failure|41|||
33476470|NCT00826449|101636062|FG000|Overall Study|Disease Progression|4|||
33476471|NCT00826449|101636062|FG000|Overall Study|Withdrawal by Subject|1|||
33476472|NCT03276221|101636063|FG000|Overall Study|Lost to Follow-up|6|||
33476473|NCT03276221|101636064|FG001|Overall Study|Lost to Follow-up|2|||
33476474|NCT03276221|101636065|FG002|Overall Study|Lost to Follow-up|0|||
33476475|NCT03276221|101636063|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
33476476|NCT03276221|101636064|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
33476477|NCT03276221|101636065|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
33476478|NCT04498403|101636068|FG000|Overall Study|Adverse Event|1|||
33476479|NCT04498403|101636069|FG001|Overall Study|Adverse Event|0|||
33267876|NCT03128099|100880625|FG001|Overall Study|Became homeless and lost contact|0|||
33267877|NCT03128099|100880626|FG002|Overall Study|Became homeless and lost contact|0|||
33267878|NCT03128099|100880624|FG000|Overall Study|Did not complete all the assessments|0|||
33267879|NCT03128099|100880625|FG001|Overall Study|Did not complete all the assessments|0|||
33267880|NCT03128099|100880626|FG002|Overall Study|Did not complete all the assessments|1|||
33267881|NCT03547154|100880627|FG000|Overall Study|Disease Progression/Recurrence|6|||
33267882|NCT03547154|100880628|FG001|Overall Study|Disease Progression/Recurrence|14|||
33267883|NCT03547154|100880627|FG000|Overall Study|Adverse Event|26|||
33267884|NCT03547154|100880628|FG001|Overall Study|Adverse Event|31|||
33267885|NCT03547154|100880627|FG000|Overall Study|Protocol Violation|6|||
33267886|NCT03547154|100880628|FG001|Overall Study|Protocol Violation|1|||
33267887|NCT03547154|100880627|FG000|Overall Study|Physician Decision|4|||
33267888|NCT03547154|100880628|FG001|Overall Study|Physician Decision|3|||
33267889|NCT03547154|100880627|FG000|Overall Study|Insufficient Therapeutic Response|13|||
33267890|NCT03547154|100880628|FG001|Overall Study|Insufficient Therapeutic Response|10|||
33267891|NCT03547154|100880627|FG000|Overall Study|Withdrawal by Subject|10|||
33267892|NCT03547154|100880628|FG001|Overall Study|Withdrawal by Subject|6|||
33267893|NCT03547154|100880627|FG000|Overall Study|Not Selected|0|||
33267894|NCT03547154|100880628|FG001|Overall Study|Not Selected|1|||
33267895|NCT03547154|100880627|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
33267896|NCT03547154|100880628|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
33267897|NCT03735849|100880629|FG000|Overall Study|Lost to Follow-up|1|||
33267898|NCT03735849|100880630|FG001|Overall Study|Lost to Follow-up|0|||
33267899|NCT03735849|100880631|FG002|Overall Study|Lost to Follow-up|0|||
33267900|NCT03735849|100880629|FG000|Overall Study|Participant unable to adhere to visit|1|||
33267901|NCT03735849|100880630|FG001|Overall Study|Participant unable to adhere to visit|0|||
33267902|NCT03735849|100880631|FG002|Overall Study|Participant unable to adhere to visit|0|||
33267903|NCT03735849|100880629|FG000|Overall Study|Not Randomized|0|||
33267904|NCT03735849|100880630|FG001|Overall Study|Not Randomized|0|||
33267905|NCT03735849|100880631|FG002|Overall Study|Not Randomized|4|||
33267906|NCT02114515|100880633|FG000|Overall Study|Lost to Follow-up|52|||
33267907|NCT02114515|100880634|FG001|Overall Study|Lost to Follow-up|55|||
33267908|NCT02114515|100880633|FG000|Overall Study|Death|12|||
33267909|NCT02114515|100880634|FG001|Overall Study|Death|12|||
33267910|NCT02114515|100880633|FG000|Overall Study|Withdrawal by Subject|4|||
33267911|NCT02114515|100880634|FG001|Overall Study|Withdrawal by Subject|22|||
33267912|NCT02114515|100880633|FG000|Overall Study|Other|65|||
33267913|NCT02114515|100880634|FG001|Overall Study|Other|61|||
33267914|NCT02707952|100880635|FG000|Overall Study|Adverse Event|1|||
33267915|NCT02707952|100880636|FG001|Overall Study|Adverse Event|0|||
33267916|NCT02707952|100880637|FG002|Overall Study|Adverse Event|0|||
33267917|NCT02707952|100880638|FG003|Overall Study|Adverse Event|0|||
33267918|NCT02707952|100880635|FG000|Overall Study|Lost to Follow-up|1|||
33267919|NCT02707952|100880636|FG001|Overall Study|Lost to Follow-up|0|||
33267920|NCT02707952|100880637|FG002|Overall Study|Lost to Follow-up|0|||
33267921|NCT02707952|100880638|FG003|Overall Study|Lost to Follow-up|0|||
33267922|NCT02707952|100880635|FG000|Overall Study|Withdrawal by Subject|0|||
33267923|NCT02707952|100880636|FG001|Overall Study|Withdrawal by Subject|1|||
33267924|NCT02707952|100880637|FG002|Overall Study|Withdrawal by Subject|2|||
33267925|NCT02707952|100880638|FG003|Overall Study|Withdrawal by Subject|0|||
33267926|NCT00388726|100880641|FG000|Overall Study|Adverse Event|50|||
33267927|NCT00388726|100880642|FG001|Overall Study|Adverse Event|24|||
33267928|NCT00388726|100880641|FG000|Overall Study|Progressive Disease|336|||
33267929|NCT00388726|100880642|FG001|Overall Study|Progressive Disease|153|||
33267930|NCT00388726|100880641|FG000|Overall Study|Clinical Progression|61|||
33267931|NCT00388726|100880642|FG001|Overall Study|Clinical Progression|36|||
33267932|NCT00388726|100880641|FG000|Overall Study|Withdrawal by Subject|10|||
33476480|NCT04498403|101636068|FG000|Overall Study|Study Terminated By Sponsor|29|||
33476481|NCT04498403|101636069|FG001|Overall Study|Study Terminated By Sponsor|10|||
33476482|NCT04713553|101636074|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
33476483|NCT04713553|101636075|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
33476484|NCT04713553|101636076|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
33476485|NCT04713553|101636077|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
33476486|NCT04713553|101636078|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
33267933|NCT00388726|100880642|FG001|Overall Study|Withdrawal by Subject|7|||
33267934|NCT00388726|100880641|FG000|Overall Study|Administrative|6|||
33267935|NCT00388726|100880642|FG001|Overall Study|Administrative|9|||
33267936|NCT00388726|100880641|FG000|Overall Study|Physician Decision|18|||
33267937|NCT00388726|100880642|FG001|Overall Study|Physician Decision|13|||
33267938|NCT00388726|100880641|FG000|Overall Study|Death|3|||
33267939|NCT00388726|100880642|FG001|Overall Study|Death|2|||
33267940|NCT02699099|100880643|FG000|Overall Study|Adverse Event|1|||
33267941|NCT02699099|100880644|FG001|Overall Study|Adverse Event|0|||
33267942|NCT02699099|100880645|FG002|Overall Study|Adverse Event|2|||
33267943|NCT02699099|100880643|FG000|Overall Study|Lost to Follow-up|0|||
33267944|NCT02699099|100880644|FG001|Overall Study|Lost to Follow-up|1|||
33267945|NCT02699099|100880645|FG002|Overall Study|Lost to Follow-up|0|||
33267946|NCT02699099|100880643|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
33267947|NCT02699099|100880644|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
33267948|NCT02699099|100880645|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
33267949|NCT02113449|100880646|FG000|Overall Study|Adverse Event|4|||
33267950|NCT02326220|100880649|FG000|Double-blind Treatment Period|Adverse Event|1|||
33267951|NCT02326220|100880650|FG001|Double-blind Treatment Period|Adverse Event|2|||
33267952|NCT02326220|100880651|FG002|Double-blind Treatment Period|Adverse Event|0|||
33267953|NCT02326220|100880649|FG000|Double-blind Treatment Period|Protocol Violation|0|||
33267954|NCT02326220|100880650|FG001|Double-blind Treatment Period|Protocol Violation|1|||
33267955|NCT02326220|100880651|FG002|Double-blind Treatment Period|Protocol Violation|0|||
33267956|NCT02326220|100880649|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
33267957|NCT02326220|100880650|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
33267958|NCT02326220|100880651|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33267959|NCT02326220|100880649|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
33267960|NCT02326220|100880650|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
33267961|NCT02326220|100880651|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
33267962|NCT02326220|100880649|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
33267963|NCT02326220|100880650|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
33267964|NCT02326220|100880651|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
33267965|NCT01634165|100880652|FG000|Period 2|Adverse Event|0|||
33267966|NCT01634165|100880653|FG001|Period 2|Adverse Event|1|||
33267967|NCT01634165|100880654|FG002|Period 2|Adverse Event|0|||
33267968|NCT01634165|100880655|FG003|Period 2|Adverse Event|0|||
33267969|NCT02455557|100880656|FG000|Overall Study|Withdrawal by Subject|2|||
33267970|NCT03938272|100880657|FG000|Overall Study|Withdrawal by Subject|1|||
33267971|NCT03938272|100880658|FG001|Overall Study|Withdrawal by Subject|0|||
33267972|NCT03938272|100880657|FG000|Overall Study|Physician Decision|0|||
33267973|NCT03938272|100880658|FG001|Overall Study|Physician Decision|2|||
33267974|NCT03938272|100880657|FG000|Overall Study|Study termination by sponsor|10|||
33267975|NCT03938272|100880658|FG001|Overall Study|Study termination by sponsor|8|||
33267976|NCT03292406|100880661|FG000|Overall Study|Progressive Disease|6|||
33267977|NCT03292406|100880662|FG001|Overall Study|Progressive Disease|3|||
33267978|NCT03292406|100880663|FG002|Overall Study|Progressive Disease|4|||
33267979|NCT03292406|100880661|FG000|Overall Study|Adverse Event|7|||
33267980|NCT03292406|100880662|FG001|Overall Study|Adverse Event|1|||
33267981|NCT03292406|100880663|FG002|Overall Study|Adverse Event|4|||
33267982|NCT03292406|100880661|FG000|Overall Study|Withdrawal by Subject|0|||
33267983|NCT03292406|100880662|FG001|Overall Study|Withdrawal by Subject|7|||
33267984|NCT03292406|100880663|FG002|Overall Study|Withdrawal by Subject|2|||
33267985|NCT03292406|100880661|FG000|Overall Study|Protocol Violation|0|||
33267986|NCT03292406|100880662|FG001|Overall Study|Protocol Violation|1|||
33267987|NCT03292406|100880663|FG002|Overall Study|Protocol Violation|1|||
33476487|NCT04713553|101636079|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
33267988|NCT03292406|100880661|FG000|Overall Study|Other|0|||
33267989|NCT03292406|100880662|FG001|Overall Study|Other|1|||
33476488|NCT04713553|101636080|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
33476489|NCT04713553|101636074|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
33476490|NCT04713553|101636075|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
33476491|NCT04713553|101636076|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
33476492|NCT04713553|101636077|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
33476493|NCT04713553|101636078|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
33476494|NCT04713553|101636079|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
33476495|NCT04713553|101636080|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
33476496|NCT04713553|101636074|FG000|Primary Study (2 Months)|Other|1|||
33476497|NCT04713553|101636075|FG001|Primary Study (2 Months)|Other|2|||
33476498|NCT04713553|101636076|FG002|Primary Study (2 Months)|Other|0|||
33476499|NCT04713553|101636077|FG003|Primary Study (2 Months)|Other|0|||
33476500|NCT04713553|101636078|FG004|Primary Study (2 Months)|Other|1|||
33476501|NCT04713553|101636079|FG005|Primary Study (2 Months)|Other|0|||
33476502|NCT04713553|101636080|FG006|Primary Study (2 Months)|Other|0|||
33267990|NCT03292406|100880663|FG002|Overall Study|Other|2|||
33267991|NCT00553332|100880664|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
33267992|NCT01240590|100880668|FG000|Phase I|Refused further treatment|0|||
33267993|NCT01240590|100880669|FG001|Phase I|Refused further treatment|0|||
33267994|NCT01240590|100880670|FG002|Phase I|Refused further treatment|3|||
33267995|NCT01240590|100880671|FG003|Phase I|Refused further treatment|0|||
33267996|NCT01240590|100880672|FG004|Phase I|Refused further treatment|0|||
33267997|NCT01240590|100880668|FG000|Phase II|Refused further treatment|0|||
33267998|NCT01240590|100880669|FG001|Phase II|Refused further treatment|0|||
33476503|NCT04713553|101636074|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
33476504|NCT04713553|101636075|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
33476505|NCT04713553|101636076|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
33476506|NCT04713553|101636077|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
33267999|NCT01240590|100880670|FG002|Phase II|Refused further treatment|0|||
33268000|NCT01240590|100880671|FG003|Phase II|Refused further treatment|2|||
33268001|NCT01240590|100880672|FG004|Phase II|Refused further treatment|1|||
33268002|NCT00620854|100880673|FG000|Washout 1|Withdrawal by Subject|0|||
33268003|NCT00620854|100880674|FG001|Washout 1|Withdrawal by Subject|0|||
33268004|NCT00620854|100880675|FG002|Washout 1|Withdrawal by Subject|1|||
33268005|NCT00620854|100880676|FG003|Washout 1|Withdrawal by Subject|1|||
33268006|NCT00620854|100880677|FG004|Washout 1|Withdrawal by Subject|0|||
33268007|NCT00620854|100880678|FG005|Washout 1|Withdrawal by Subject|0|||
33268008|NCT01885559|100880679|FG000|Overall Study|Lost to Follow-up|15|||
33268009|NCT01885559|100880680|FG001|Overall Study|Lost to Follow-up|16|||
33268010|NCT01885559|100880679|FG000|Overall Study|Less than full participation|9|||
33476507|NCT04713553|101636078|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
33476508|NCT04713553|101636079|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
33476509|NCT04713553|101636080|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
33476510|NCT04713553|101636074|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
33476511|NCT04713553|101636075|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
33268011|NCT01885559|100880680|FG001|Overall Study|Less than full participation|19|||
33268012|NCT01885559|100880679|FG000|Overall Study|Protocol Violation|0|||
33268013|NCT01885559|100880680|FG001|Overall Study|Protocol Violation|1|||
33268014|NCT00513071|100880681|FG000|Overall Study|Adverse Event|1|||
33268015|NCT00513071|100880681|FG000|Overall Study|Withdrawal by Subject|1|||
33268016|NCT00513071|100880681|FG000|Overall Study|Physician Decision|3|||
33268017|NCT03075878|100880686|FG000|Overall Study|Physician Decision|1|||
33268018|NCT01409837|100880687|FG000|Overall Study|Withdrawal by Subject|2|||
33268019|NCT01409837|100880688|FG001|Overall Study|Withdrawal by Subject|1|||
33268020|NCT01409837|100880687|FG000|Overall Study|Lost to Follow-up|1|||
33268021|NCT01409837|100880688|FG001|Overall Study|Lost to Follow-up|0|||
33268022|NCT01409837|100880687|FG000|Overall Study|Physician Decision|0|||
33268023|NCT01409837|100880688|FG001|Overall Study|Physician Decision|1|||
33268024|NCT03547167|100880689|FG000|Overall Study|Withdrawal by Subject|34|||
33268025|NCT03547167|100880690|FG001|Overall Study|Withdrawal by Subject|12|||
33268026|NCT03547167|100880689|FG000|Overall Study|Screen Failure|0|||
33268027|NCT03547167|100880690|FG001|Overall Study|Screen Failure|1|||
33476512|NCT04713553|101636076|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
33476513|NCT04713553|101636077|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
33476514|NCT04713553|101636078|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
33476515|NCT04713553|101636079|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
33476516|NCT04713553|101636080|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
33476517|NCT00505375|101636081|FG000|Overall Study|Death|1|||
33476518|NCT00505375|101636082|FG001|Overall Study|Death|0|||
33476519|NCT00505375|101636081|FG000|Overall Study|Withdrawal by Subject|2|||
33476520|NCT00505375|101636082|FG001|Overall Study|Withdrawal by Subject|2|||
33476521|NCT00505375|101636081|FG000|Overall Study|Lost to Follow-up|0|||
33476522|NCT00505375|101636082|FG001|Overall Study|Lost to Follow-up|2|||
33476523|NCT00505375|101636081|FG000|Overall Study|Pregnancy|1|||
33476524|NCT00505375|101636082|FG001|Overall Study|Pregnancy|0|||
33476525|NCT00505375|101636081|FG000|Overall Study|Travel issues|0|||
33476526|NCT00505375|101636082|FG001|Overall Study|Travel issues|1|||
33476527|NCT01936623|101636084|FG000|Overall Study|Lost to Follow-up|0|||
33476528|NCT01936623|101636085|FG001|Overall Study|Lost to Follow-up|5|||
33476529|NCT00510289|101636086|FG000|Overall Study|Withdrawal by Subject|7|||
33476530|NCT00510289|101636086|FG000|Overall Study|Refused bone marrow biopsy|2|||
33476531|NCT00510289|101636086|FG000|Overall Study|Lost to Follow-up|1|||
33476532|NCT00510289|101636086|FG000|Overall Study|Progressed prior to starting drug|2|||
33268028|NCT03547167|100880689|FG000|Overall Study|Lost to Follow-up|59|||
33268029|NCT03547167|100880690|FG001|Overall Study|Lost to Follow-up|15|||
33268030|NCT03547167|100880689|FG000|Overall Study|Death|4|||
33268031|NCT03547167|100880690|FG001|Overall Study|Death|2|||
33268032|NCT00403494|100880691|FG000|Overall Study|Adverse Event|10|||
33268033|NCT00403494|100880692|FG001|Overall Study|Adverse Event|8|||
33268034|NCT00403494|100880691|FG000|Overall Study|Withdrew Consent|3|||
33268035|NCT00403494|100880692|FG001|Overall Study|Withdrew Consent|2|||
33268036|NCT00403494|100880691|FG000|Overall Study|Inappropriately enrolled|0|||
33268037|NCT00403494|100880692|FG001|Overall Study|Inappropriately enrolled|1|||
33268038|NCT00403494|100880691|FG000|Overall Study|Lost to Follow-up|0|||
33268039|NCT00403494|100880692|FG001|Overall Study|Lost to Follow-up|2|||
33268040|NCT00403494|100880691|FG000|Overall Study|Protocol noncompliance|0|||
33268041|NCT00403494|100880692|FG001|Overall Study|Protocol noncompliance|1|||
33268042|NCT00403494|100880691|FG000|Overall Study|Death|1|||
33268043|NCT00403494|100880692|FG001|Overall Study|Death|0|||
33268044|NCT00403494|100880691|FG000|Overall Study|Sponsor Request|1|||
33268045|NCT00403494|100880692|FG001|Overall Study|Sponsor Request|0|||
33268046|NCT02384382|100880695|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
33268047|NCT02384382|100880695|FG000|Overall Study|Death|1|||
33268048|NCT02384382|100880695|FG000|Overall Study|Adverse Event|1|||
33268049|NCT02384382|100880695|FG000|Overall Study|Disease progression|16|||
33268050|NCT01604824|100880696|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
33476533|NCT02387983|101636087|FG000|Overall Study|Adverse Event|4|||
33268051|NCT01604824|100880697|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
33268052|NCT01604824|100880698|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
33476534|NCT02387983|101636087|FG000|Overall Study|Protocol Violation|1|||
33476535|NCT02387983|101636087|FG000|Overall Study|Withdrawal by Subject|2|||
33476536|NCT02731326|101636092|FG000|Overall Study|Withdrawal by Subject|4|||
33476537|NCT02731326|101636093|FG001|Overall Study|Withdrawal by Subject|1|||
33268053|NCT01604824|100880699|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
33268054|NCT01604824|100880700|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
33476538|NCT02731326|101636092|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
33476539|NCT02731326|101636093|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
33476540|NCT02731326|101636092|FG000|Overall Study|Discharged without AliveCor|10|||
33476541|NCT02731326|101636093|FG001|Overall Study|Discharged without AliveCor|0|||
33476542|NCT02731326|101636092|FG000|Overall Study|Duplicate Participant|1|||
33476543|NCT02731326|101636093|FG001|Overall Study|Duplicate Participant|1|||
33489765|NCT02952586|101686778|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
33489766|NCT02952586|101686779|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
33489767|NCT02952586|101686778|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
33489768|NCT02952586|101686779|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
33489769|NCT02952586|101686778|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
33489770|NCT02952586|101686779|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
33489771|NCT02952586|101686778|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
33489772|NCT02952586|101686779|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
33489773|NCT02952586|101686778|FG000|CRT for Cisplatin (63 Days)|Death|3|||
33489774|NCT02952586|101686779|FG001|CRT for Cisplatin (63 Days)|Death|8|||
33489775|NCT02952586|101686778|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
33489776|NCT02952586|101686779|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
33489777|NCT02952586|101686778|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
33489778|NCT02952586|101686779|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
33489779|NCT02952586|101686778|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
33489780|NCT02952586|101686779|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
33489781|NCT02952586|101686778|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
33489782|NCT02952586|101686779|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
33489783|NCT02952586|101686778|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
33489784|NCT02952586|101686779|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
33489785|NCT02952586|101686778|FG000|CRT for Cisplatin (63 Days)|Other|1|||
33489786|NCT02952586|101686779|FG001|CRT for Cisplatin (63 Days)|Other|1|||
33489787|NCT02952586|101686778|FG000|CRT for IMRT (63 Days)|Death|5|||
33489788|NCT02952586|101686779|FG001|CRT for IMRT (63 Days)|Death|8|||
33489789|NCT02952586|101686778|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
33489790|NCT02952586|101686779|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
33489791|NCT02952586|101686778|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
33489792|NCT02952586|101686779|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
33489793|NCT02952586|101686778|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
33489794|NCT02952586|101686779|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
33489795|NCT02952586|101686778|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
33489796|NCT02952586|101686779|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
33489797|NCT02952586|101686778|FG000|CRT for IMRT (63 Days)|Other|1|||
33489798|NCT02952586|101686779|FG001|CRT for IMRT (63 Days)|Other|0|||
33489799|NCT02952586|101686778|FG000|Maintenance Phase (12 Months)|Death|17|||
33489800|NCT02952586|101686779|FG001|Maintenance Phase (12 Months)|Death|11|||
33489801|NCT02952586|101686778|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
33489802|NCT02952586|101686779|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
33489803|NCT02952586|101686778|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
33489804|NCT02952586|101686779|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
33489805|NCT02952586|101686778|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
33489806|NCT02952586|101686779|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
33489807|NCT02952586|101686778|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
33489808|NCT02952586|101686779|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
33489809|NCT02952586|101686778|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
33489810|NCT02952586|101686779|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
33489811|NCT02952586|101686778|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
33489812|NCT02952586|101686779|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
33489813|NCT02952586|101686778|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
33489814|NCT02952586|101686779|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
33489815|NCT02952586|101686778|FG000|Maintenance Phase (12 Months)|Other|2|||
33489816|NCT02952586|101686779|FG001|Maintenance Phase (12 Months)|Other|1|||
33489817|NCT02952586|101686778|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
33489818|NCT02952586|101686779|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
33489819|NCT02952586|101686778|FG000|Follow-Up Phase (90 Days)|Death|12|||
33489820|NCT02952586|101686779|FG001|Follow-Up Phase (90 Days)|Death|10|||
33489821|NCT02952586|101686778|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
33489822|NCT02952586|101686779|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
33489823|NCT02952586|101686778|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
33489824|NCT02952586|101686779|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
33489825|NCT02952586|101686778|FG000|Follow-Up Phase (90 Days)|Other|7|||
33489826|NCT02952586|101686779|FG001|Follow-Up Phase (90 Days)|Other|5|||
33489827|NCT02952586|101686778|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
33489828|NCT02952586|101686779|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
33476544|NCT00080938|101639171|FG000|Overall Study|Adverse Event|3|||
33476545|NCT00080938|101639171|FG000|Overall Study|Withdrawal by Subject|6|||
33476546|NCT00080938|101639171|FG000|Overall Study|Death|2|||
33476547|NCT00080938|101639171|FG000|Overall Study|Lack of Efficacy|7|||
33476548|NCT00080938|101639171|FG000|Overall Study|other disease|1|||
33476549|NCT00080938|101639171|FG000|Overall Study|Not started protocol therapy|1|||
33476550|NCT00080938|101639171|FG000|Overall Study|Ineligible|4|||
33476551|NCT00090610|101639172|FG000|Overall Study|Withdrawal by Subject|1|||
33476552|NCT00090610|101639173|FG001|Overall Study|Withdrawal by Subject|1|||
33476553|NCT02524730|101639174|FG000|Overall Study|Lost to Follow-up|5|||
33476554|NCT02524730|101639174|FG000|Overall Study|Withdrawal by Subject|18|||
33476555|NCT02524730|101639174|FG000|Overall Study|Death|10|||
33476556|NCT02524730|101639174|FG000|Overall Study|Adverse Event|8|||
33476557|NCT02524730|101639174|FG000|Overall Study|Protocol Violation|1|||
33476558|NCT02524730|101639174|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
33476559|NCT02836496|101639180|FG000|Overall Study|Adverse Event|2|||
33476560|NCT02836496|101639181|FG001|Overall Study|Adverse Event|1|||
33476561|NCT02836496|101639180|FG000|Overall Study|Withdrawal by Subject|0|||
33476562|NCT02836496|101639181|FG001|Overall Study|Withdrawal by Subject|1|||
33476563|NCT01400919|101639182|FG000|Overall Study|Withdrawal by Subject|4|||
33476564|NCT01400919|101639182|FG000|Overall Study|Lost to Follow-up|2|||
33476565|NCT01400919|101639182|FG000|Overall Study|Missed visit|2|||
33476566|NCT01199471|101639185|FG000|Overall Study|Protocol Violation|4|||
33476567|NCT01199471|101639185|FG000|Overall Study|Withdrawal by Subject|1|||
33476568|NCT01199471|101639185|FG000|Overall Study|Physician Decision|1|||
33476569|NCT03265288|101639188|FG000|Overall Study|Adverse Event|0|||
33476570|NCT03265288|101639189|FG001|Overall Study|Adverse Event|1|||
33476571|NCT03265288|101639188|FG000|Overall Study|Withdrawal by Subject|13|||
33476572|NCT03265288|101639189|FG001|Overall Study|Withdrawal by Subject|5|||
33476573|NCT03265288|101639188|FG000|Overall Study|Drug Withdrawn|3|||
33476574|NCT03265288|101639189|FG001|Overall Study|Drug Withdrawn|3|||
33476575|NCT03265288|101639188|FG000|Overall Study|Any Other Reason|7|||
33476576|NCT03265288|101639189|FG001|Overall Study|Any Other Reason|3|||
33476577|NCT00003875|101639197|FG000|Overall Study|Screen Failed|1|||
33476578|NCT00470067|101639198|FG000|Overall Study|Death|1|||
33268055|NCT01604824|100880701|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
33268056|NCT01604824|100880696|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
33268057|NCT01604824|100880697|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
33268058|NCT01604824|100880698|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
33268059|NCT01604824|100880699|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
33268060|NCT01604824|100880700|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
33268061|NCT01604824|100880701|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
33268062|NCT01262456|100880702|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
33268063|NCT01262456|100880703|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
33268064|NCT01262456|100880704|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
33268065|NCT01262456|100880702|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
33268066|NCT01262456|100880703|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
33268067|NCT01262456|100880704|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
33268068|NCT01262456|100880702|FG000|3-Month Double-Blind Period|Adverse Event|6|||
33268069|NCT01262456|100880703|FG001|3-Month Double-Blind Period|Adverse Event|4|||
33268070|NCT01262456|100880704|FG002|3-Month Double-Blind Period|Adverse Event|8|||
33268071|NCT01262456|100880702|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
33268072|NCT01262456|100880703|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
33268073|NCT01262456|100880704|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
33268074|NCT01262456|100880702|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
33268075|NCT01262456|100880703|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
33268076|NCT01262456|100880704|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
33268077|NCT01262456|100880702|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
33268078|NCT01262456|100880703|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
33268079|NCT01262456|100880704|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
33476579|NCT00470067|101639198|FG000|Overall Study|Disease Progression|6|||
33476580|NCT02669940|101639201|FG000|Overall Study|Failure to return|0|||
33476581|NCT02669940|101639202|FG001|Overall Study|Failure to return|3|||
33476582|NCT02669940|101639201|FG000|Overall Study|Insufficient follow-up data|1|||
33476583|NCT02669940|101639202|FG001|Overall Study|Insufficient follow-up data|0|||
33476584|NCT00515541|101639203|FG000|Overall Study|Physician Decision|0|||
33476585|NCT00515541|101639204|FG001|Overall Study|Physician Decision|2|||
33476586|NCT00515541|101639205|FG002|Overall Study|Physician Decision|0|||
33476587|NCT00515541|101639206|FG003|Overall Study|Physician Decision|1|||
33476588|NCT00515541|101639203|FG000|Overall Study|No show for appointments|0|||
33476589|NCT00515541|101639204|FG001|Overall Study|No show for appointments|1|||
33476590|NCT00515541|101639205|FG002|Overall Study|No show for appointments|0|||
33476591|NCT00515541|101639206|FG003|Overall Study|No show for appointments|2|||
33476592|NCT00515541|101639203|FG000|Overall Study|Withdrawal by Subject|0|||
33476593|NCT00515541|101639204|FG001|Overall Study|Withdrawal by Subject|2|||
33476594|NCT00515541|101639205|FG002|Overall Study|Withdrawal by Subject|0|||
33476595|NCT00515541|101639206|FG003|Overall Study|Withdrawal by Subject|2|||
33476596|NCT01267994|101639207|FG000|Overall Study|Adverse Event|2|||
33476597|NCT01682863|101639208|FG000|Overall Study|Subject/guardian decision|19|||
33476598|NCT01682863|101639209|FG001|Overall Study|Subject/guardian decision|12|||
33476599|NCT01682863|101639210|FG002|Overall Study|Subject/guardian decision|10|||
33268080|NCT01262456|100880702|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
33268081|NCT01262456|100880703|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
33268082|NCT01262456|100880704|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
33268083|NCT01262456|100880702|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
33268084|NCT01262456|100880703|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
33268085|NCT01262456|100880704|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
33268086|NCT01262456|100880702|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
33268087|NCT01262456|100880703|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
33268088|NCT01262456|100880704|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
33268089|NCT02060487|100880705|FG000|Overall Study|Other|1|||
33268090|NCT02060487|100880706|FG001|Overall Study|Other|2|||
33268091|NCT02060487|100880707|FG002|Overall Study|Other|1|||
33268092|NCT02060487|100880705|FG000|Overall Study|Lack of Efficacy|0|||
33476600|NCT01682863|101639208|FG000|Overall Study|Lost to Follow-up|5|||
33476601|NCT01682863|101639209|FG001|Overall Study|Lost to Follow-up|1|||
33476602|NCT01682863|101639210|FG002|Overall Study|Lost to Follow-up|6|||
33476603|NCT01682863|101639208|FG000|Overall Study|Death|1|||
33476604|NCT01682863|101639209|FG001|Overall Study|Death|3|||
33476605|NCT01682863|101639210|FG002|Overall Study|Death|4|||
33476606|NCT01682863|101639208|FG000|Overall Study|Protocol deviation|1|||
33476607|NCT01682863|101639209|FG001|Overall Study|Protocol deviation|0|||
33476608|NCT01682863|101639210|FG002|Overall Study|Protocol deviation|1|||
33476609|NCT01682863|101639208|FG000|Overall Study|Technical problems|1|||
33476610|NCT01682863|101639209|FG001|Overall Study|Technical problems|0|||
33476611|NCT01682863|101639210|FG002|Overall Study|Technical problems|0|||
33476612|NCT01682863|101639208|FG000|Overall Study|Adverse Event|0|||
33476613|NCT01682863|101639209|FG001|Overall Study|Adverse Event|1|||
33268093|NCT02060487|100880706|FG001|Overall Study|Lack of Efficacy|1|||
33268094|NCT02060487|100880707|FG002|Overall Study|Lack of Efficacy|0|||
33268095|NCT02060487|100880705|FG000|Overall Study|Withdrawal by Subject|3|||
33268096|NCT02060487|100880706|FG001|Overall Study|Withdrawal by Subject|10|||
33268097|NCT02060487|100880707|FG002|Overall Study|Withdrawal by Subject|4|||
33268098|NCT02060487|100880705|FG000|Overall Study|Study Terminated By Sponsor|87|||
33268099|NCT02060487|100880706|FG001|Overall Study|Study Terminated By Sponsor|89|||
33268100|NCT02060487|100880707|FG002|Overall Study|Study Terminated By Sponsor|100|||
33268101|NCT02060487|100880705|FG000|Overall Study|Randomized in error|1|||
33268102|NCT02060487|100880706|FG001|Overall Study|Randomized in error|0|||
33268103|NCT02060487|100880707|FG002|Overall Study|Randomized in error|0|||
33268104|NCT02060487|100880705|FG000|Overall Study|Protocol Violation|0|||
33268105|NCT02060487|100880706|FG001|Overall Study|Protocol Violation|1|||
33268106|NCT02060487|100880707|FG002|Overall Study|Protocol Violation|1|||
33268107|NCT02060487|100880705|FG000|Overall Study|Lost to Follow-up|3|||
33268108|NCT02060487|100880706|FG001|Overall Study|Lost to Follow-up|0|||
33268109|NCT02060487|100880707|FG002|Overall Study|Lost to Follow-up|2|||
33268110|NCT02060487|100880705|FG000|Overall Study|Death|34|||
33268111|NCT02060487|100880706|FG001|Overall Study|Death|25|||
33268112|NCT02060487|100880707|FG002|Overall Study|Death|19|||
33268113|NCT02060487|100880705|FG000|Overall Study|Adverse Event|0|||
33268114|NCT02060487|100880706|FG001|Overall Study|Adverse Event|0|||
33268115|NCT02060487|100880707|FG002|Overall Study|Adverse Event|1|||
33268116|NCT05376397|100880708|FG000|Overall Study|Lost to Follow-up|1|||
33268117|NCT01147471|100880712|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
33268118|NCT01147471|100880713|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
33268119|NCT01147471|100880712|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
33268120|NCT01147471|100880713|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
33268121|NCT01147471|100880712|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
33268122|NCT01147471|100880713|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
33268123|NCT01147471|100880712|FG000|3 Month Follow Up|Lost to Follow-up|1|||
33268124|NCT01147471|100880713|FG001|3 Month Follow Up|Lost to Follow-up|1|||
33268125|NCT01147471|100880712|FG000|3 Month Follow Up|Physician Decision|0|||
33268126|NCT01147471|100880713|FG001|3 Month Follow Up|Physician Decision|1|||
33268127|NCT01147471|100880712|FG000|6 Month Follow Up|Lost to Follow-up|4|||
33268128|NCT01147471|100880713|FG001|6 Month Follow Up|Lost to Follow-up|2|||
33476614|NCT01682863|101639210|FG002|Overall Study|Adverse Event|2|||
33268129|NCT00963924|100880716|FG000|Overall Study|Adverse Event|1|||
33268130|NCT00963924|100880717|FG001|Overall Study|Adverse Event|0|||
33268131|NCT00963924|100880716|FG000|Overall Study|Withdrawal by Subject|0|||
33476615|NCT01682863|101639208|FG000|Overall Study|Physician Decision|0|||
33476616|NCT01682863|101639209|FG001|Overall Study|Physician Decision|0|||
33476617|NCT01682863|101639210|FG002|Overall Study|Physician Decision|1|||
33476618|NCT00848107|101639211|FG000|Overall Study|Lost to Follow-up|2|||
33476619|NCT00848107|101639211|FG000|Overall Study|Withdrawal by Subject|8|||
33476620|NCT00848107|101639211|FG000|Overall Study|Adverse Event|9|||
33476621|NCT00848107|101639211|FG000|Overall Study|Death|1|||
33476622|NCT00848107|101639211|FG000|Overall Study|Pregnancy|1|||
33476623|NCT00259272|101639215|FG000|Overall Study|Adverse Event|2|||
33476624|NCT00259272|101639216|FG001|Overall Study|Adverse Event|1|||
33476625|NCT00259272|101639217|FG002|Overall Study|Adverse Event|0|||
33476626|NCT00259272|101639218|FG003|Overall Study|Adverse Event|3|||
33476627|NCT00259272|101639215|FG000|Overall Study|Lack of Efficacy|5|||
33476628|NCT00259272|101639216|FG001|Overall Study|Lack of Efficacy|1|||
33476629|NCT00259272|101639217|FG002|Overall Study|Lack of Efficacy|2|||
33476630|NCT00259272|101639218|FG003|Overall Study|Lack of Efficacy|6|||
33476631|NCT00259272|101639215|FG000|Overall Study|Physician Decision|1|||
33476632|NCT00259272|101639216|FG001|Overall Study|Physician Decision|2|||
33476633|NCT00259272|101639217|FG002|Overall Study|Physician Decision|1|||
33476634|NCT00259272|101639218|FG003|Overall Study|Physician Decision|3|||
33476635|NCT00259272|101639215|FG000|Overall Study|Protocol Violation|2|||
33476636|NCT00259272|101639216|FG001|Overall Study|Protocol Violation|0|||
33476637|NCT00259272|101639217|FG002|Overall Study|Protocol Violation|0|||
33476638|NCT00259272|101639218|FG003|Overall Study|Protocol Violation|1|||
33476639|NCT00259272|101639215|FG000|Overall Study|Sponsor Decision|0|||
33476640|NCT00259272|101639216|FG001|Overall Study|Sponsor Decision|1|||
33476641|NCT00259272|101639217|FG002|Overall Study|Sponsor Decision|0|||
33476642|NCT00259272|101639218|FG003|Overall Study|Sponsor Decision|0|||
33476643|NCT00259272|101639215|FG000|Overall Study|Withdrawal by Subject|4|||
33476644|NCT00259272|101639216|FG001|Overall Study|Withdrawal by Subject|2|||
33476645|NCT00259272|101639217|FG002|Overall Study|Withdrawal by Subject|2|||
33476646|NCT00259272|101639218|FG003|Overall Study|Withdrawal by Subject|7|||
33476647|NCT00259272|101639215|FG000|Overall Study|Lost to Follow-up|1|||
33476648|NCT00259272|101639216|FG001|Overall Study|Lost to Follow-up|0|||
33476649|NCT00259272|101639217|FG002|Overall Study|Lost to Follow-up|0|||
33476650|NCT00259272|101639218|FG003|Overall Study|Lost to Follow-up|1|||
33476651|NCT02011113|101639219|FG000|Overall Study|Adverse Event|4|||
33476652|NCT02011113|101639219|FG000|Overall Study|Disease Progression (DP)|16|||
33476653|NCT02011113|101639219|FG000|Overall Study|Death|1|||
33476654|NCT02011113|101639219|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
33476655|NCT02011113|101639219|FG000|Overall Study|Investigator's judgement- DP|3|||
33476656|NCT02011113|101639219|FG000|Overall Study|Study terminated by sponsor|11|||
33476657|NCT04492020|101639222|FG000|Overall Study|Adverse Event|1|||
33476658|NCT04492020|101639223|FG001|Overall Study|Adverse Event|3|||
33476659|NCT04492020|101639222|FG000|Overall Study|Withdrawal by Subject|4|||
33476660|NCT04492020|101639223|FG001|Overall Study|Withdrawal by Subject|3|||
33476661|NCT04492020|101639222|FG000|Overall Study|Lost to Follow-up|4|||
33476662|NCT04492020|101639223|FG001|Overall Study|Lost to Follow-up|3|||
33476663|NCT04492020|101639222|FG000|Overall Study|Protocol Violation|5|||
33476664|NCT04492020|101639223|FG001|Overall Study|Protocol Violation|2|||
33476665|NCT04492020|101639222|FG000|Overall Study|Lack of Qualifying Event|25|||
33476666|NCT04492020|101639223|FG001|Overall Study|Lack of Qualifying Event|27|||
33476667|NCT04492020|101639222|FG000|Overall Study|Non-compliance with Study Drug|2|||
33476668|NCT04492020|101639223|FG001|Overall Study|Non-compliance with Study Drug|1|||
33476669|NCT01908816|101639224|FG000|Overall Study|Subject's no longer requires study drug|0|||
33476670|NCT01908816|101639225|FG001|Overall Study|Subject's no longer requires study drug|0|||
33476671|NCT01908816|101639226|FG002|Overall Study|Subject's no longer requires study drug|0|||
33476672|NCT01908816|101639227|FG003|Overall Study|Subject's no longer requires study drug|1|||
33476673|NCT01908816|101639224|FG000|Overall Study|Protocol deviation|1|||
33476674|NCT01908816|101639225|FG001|Overall Study|Protocol deviation|2|||
33476675|NCT01908816|101639226|FG002|Overall Study|Protocol deviation|1|||
33476676|NCT01908816|101639227|FG003|Overall Study|Protocol deviation|1|||
33476677|NCT01908816|101639224|FG000|Overall Study|Withdrawal by Subject|0|||
33476678|NCT01908816|101639225|FG001|Overall Study|Withdrawal by Subject|4|||
33476679|NCT01908816|101639226|FG002|Overall Study|Withdrawal by Subject|2|||
33476680|NCT01908816|101639227|FG003|Overall Study|Withdrawal by Subject|2|||
33476681|NCT01908816|101639224|FG000|Overall Study|Lost to Follow-up|3|||
33476682|NCT01908816|101639225|FG001|Overall Study|Lost to Follow-up|5|||
33476683|NCT01908816|101639226|FG002|Overall Study|Lost to Follow-up|4|||
33476684|NCT01908816|101639227|FG003|Overall Study|Lost to Follow-up|2|||
33476685|NCT01908816|101639224|FG000|Overall Study|Death|1|||
33476686|NCT01908816|101639225|FG001|Overall Study|Death|0|||
33476687|NCT01908816|101639226|FG002|Overall Study|Death|7|||
33268132|NCT00963924|100880717|FG001|Overall Study|Withdrawal by Subject|1|||
33476688|NCT01908816|101639227|FG003|Overall Study|Death|1|||
33476689|NCT01908816|101639224|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
33476690|NCT01908816|101639225|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
33476691|NCT01908816|101639226|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
33476692|NCT01908816|101639227|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
33476693|NCT01908816|101639224|FG000|Overall Study|Early termination|87|||
33476694|NCT01908816|101639225|FG001|Overall Study|Early termination|60|||
33476695|NCT01908816|101639226|FG002|Overall Study|Early termination|43|||
33476696|NCT01908816|101639227|FG003|Overall Study|Early termination|28|||
33476697|NCT03400943|101639231|FG000|Treatment Period 1|Adverse Event|0|||
33268133|NCT00963924|100880716|FG000|Overall Study|Changed antipsychotic|0|||
33268134|NCT00963924|100880717|FG001|Overall Study|Changed antipsychotic|1|||
33268135|NCT00963924|100880716|FG000|Overall Study|Lost to Follow-up|0|||
33268136|NCT00963924|100880717|FG001|Overall Study|Lost to Follow-up|1|||
33268137|NCT00622700|100880718|FG000|Core Treatment Period|Randomized but Not Treated|0|||
33268138|NCT00622700|100880719|FG001|Core Treatment Period|Randomized but Not Treated|2|||
33268139|NCT00622700|100880720|FG002|Core Treatment Period|Randomized but Not Treated|2|||
33268140|NCT00622700|100880721|FG003|Core Treatment Period|Randomized but Not Treated|0|||
33476698|NCT03400943|101639232|FG001|Treatment Period 1|Adverse Event|0|||
33476699|NCT03400943|101639233|FG002|Treatment Period 1|Adverse Event|0|||
33476700|NCT03400943|101639234|FG003|Treatment Period 1|Adverse Event|1|||
33476701|NCT03400943|101639231|FG000|Treatment Period 1|Lost to Follow-up|1|||
33476702|NCT03400943|101639232|FG001|Treatment Period 1|Lost to Follow-up|0|||
33476703|NCT03400943|101639233|FG002|Treatment Period 1|Lost to Follow-up|0|||
33476704|NCT03400943|101639234|FG003|Treatment Period 1|Lost to Follow-up|0|||
33476705|NCT03400943|101639231|FG000|Treatment Period 1|Protocol Violation|0|||
33476706|NCT03400943|101639232|FG001|Treatment Period 1|Protocol Violation|1|||
33476707|NCT03400943|101639233|FG002|Treatment Period 1|Protocol Violation|1|||
33476708|NCT03400943|101639234|FG003|Treatment Period 1|Protocol Violation|0|||
33476709|NCT03400943|101639231|FG000|Treatment Period 1|Study terminated by sponsor|2|||
33268141|NCT00622700|100880722|FG004|Core Treatment Period|Randomized but Not Treated|0|||
33268142|NCT00622700|100880723|FG005|Core Treatment Period|Randomized but Not Treated|0|||
33268143|NCT00622700|100880724|FG006|Core Treatment Period|Randomized but Not Treated|0|||
33268144|NCT00622700|100880718|FG000|Core Treatment Period|Adverse Event|18|||
33268145|NCT00622700|100880719|FG001|Core Treatment Period|Adverse Event|25|||
33268146|NCT00622700|100880720|FG002|Core Treatment Period|Adverse Event|18|||
33268147|NCT00622700|100880721|FG003|Core Treatment Period|Adverse Event|0|||
33268148|NCT00622700|100880722|FG004|Core Treatment Period|Adverse Event|0|||
33476710|NCT03400943|101639232|FG001|Treatment Period 1|Study terminated by sponsor|0|||
33476711|NCT03400943|101639233|FG002|Treatment Period 1|Study terminated by sponsor|0|||
33476712|NCT03400943|101639234|FG003|Treatment Period 1|Study terminated by sponsor|1|||
33476713|NCT03400943|101639231|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33476714|NCT03400943|101639232|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33476715|NCT03400943|101639233|FG002|Treatment Period 1|Withdrawal by Subject|3|||
33476716|NCT03400943|101639234|FG003|Treatment Period 1|Withdrawal by Subject|1|||
33476717|NCT03400943|101639231|FG000|Treatment Period 1|Other|2|||
33476718|NCT03400943|101639232|FG001|Treatment Period 1|Other|1|||
33476719|NCT03400943|101639233|FG002|Treatment Period 1|Other|2|||
33476720|NCT03400943|101639234|FG003|Treatment Period 1|Other|2|||
33476721|NCT03400943|101639231|FG000|Post-treatment Period 1|Adverse Event|2|||
33476722|NCT03400943|101639232|FG001|Post-treatment Period 1|Adverse Event|0|||
33476723|NCT03400943|101639233|FG002|Post-treatment Period 1|Adverse Event|0|||
33476724|NCT03400943|101639234|FG003|Post-treatment Period 1|Adverse Event|0|||
33476725|NCT03400943|101639231|FG000|Post-treatment Period 1|Protocol Violation|1|||
33476726|NCT03400943|101639232|FG001|Post-treatment Period 1|Protocol Violation|0|||
33476727|NCT03400943|101639233|FG002|Post-treatment Period 1|Protocol Violation|0|||
33476728|NCT03400943|101639234|FG003|Post-treatment Period 1|Protocol Violation|0|||
33476729|NCT03400943|101639231|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
33476730|NCT03400943|101639232|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
33476731|NCT03400943|101639233|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
33476732|NCT03400943|101639234|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
33476733|NCT03400943|101639231|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
33476734|NCT03400943|101639232|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
33476735|NCT03400943|101639233|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
33476736|NCT03400943|101639234|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
33476737|NCT03400943|101639231|FG000|Post-treatment Period 1|Other|2|||
33476738|NCT03400943|101639232|FG001|Post-treatment Period 1|Other|0|||
33476739|NCT03400943|101639233|FG002|Post-treatment Period 1|Other|4|||
33476740|NCT03400943|101639234|FG003|Post-treatment Period 1|Other|5|||
33476741|NCT03400943|101639231|FG000|Treatment Period 2|Study terminated by sponsor|0|||
33476742|NCT03400943|101639232|FG001|Treatment Period 2|Study terminated by sponsor|1|||
33476743|NCT03400943|101639233|FG002|Treatment Period 2|Study terminated by sponsor|0|||
33476744|NCT03400943|101639234|FG003|Treatment Period 2|Study terminated by sponsor|0|||
33476745|NCT03400943|101639231|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33476746|NCT03400943|101639232|FG001|Treatment Period 2|Withdrawal by Subject|1|||
33476747|NCT03400943|101639233|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33476748|NCT03400943|101639234|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33476749|NCT03400943|101639231|FG000|Treatment Period 2|Other|1|||
33268149|NCT00622700|100880723|FG005|Core Treatment Period|Adverse Event|0|||
33268150|NCT00622700|100880724|FG006|Core Treatment Period|Adverse Event|0|||
33476750|NCT03400943|101639232|FG001|Treatment Period 2|Other|6|||
33476751|NCT03400943|101639233|FG002|Treatment Period 2|Other|0|||
33476752|NCT03400943|101639234|FG003|Treatment Period 2|Other|0|||
33476753|NCT03400943|101639231|FG000|Follow-up Period|Withdrawal by Subject|1|||
33476754|NCT03400943|101639232|FG001|Follow-up Period|Withdrawal by Subject|0|||
33476755|NCT03400943|101639233|FG002|Follow-up Period|Withdrawal by Subject|0|||
33476756|NCT03400943|101639234|FG003|Follow-up Period|Withdrawal by Subject|0|||
33476757|NCT00918138|101639237|FG000|Overall Study|Subject withdrew consent|1|||
33476758|NCT00918138|101639238|FG001|Overall Study|Subject withdrew consent|1|||
33476759|NCT00918138|101639237|FG000|Overall Study|Death|1|||
33476760|NCT00918138|101639238|FG001|Overall Study|Death|0|||
33476761|NCT01070771|101639239|FG000|Overall Study|Adverse Event|2|||
33476762|NCT01070771|101639239|FG000|Overall Study|Protocol Violation|1|||
33476763|NCT01675661|101639240|FG000|Overall Study|Lost to Follow-up|22|||
33476764|NCT01675661|101639241|FG001|Overall Study|Lost to Follow-up|23|||
33476765|NCT01675661|101639240|FG000|Overall Study|Practical problems|9|||
33476766|NCT01675661|101639241|FG001|Overall Study|Practical problems|5|||
33476767|NCT01675661|101639240|FG000|Overall Study|Moved away|5|||
33476768|NCT01675661|101639241|FG001|Overall Study|Moved away|6|||
33476769|NCT01675661|101639240|FG000|Overall Study|Withdrawal by Subject|3|||
33476770|NCT01675661|101639241|FG001|Overall Study|Withdrawal by Subject|7|||
33476771|NCT01675661|101639240|FG000|Overall Study|Physician Decision|0|||
33476772|NCT01675661|101639241|FG001|Overall Study|Physician Decision|2|||
33476773|NCT01675661|101639240|FG000|Overall Study|Death|0|||
33476774|NCT01675661|101639241|FG001|Overall Study|Death|1|||
33476775|NCT01675661|101639240|FG000|Overall Study|Other reason|1|||
33476776|NCT01675661|101639241|FG001|Overall Study|Other reason|2|||
33476777|NCT00658021|101639242|FG000|28-Week Treatment Period|Adverse Event|3|||
33476778|NCT00658021|101639243|FG001|28-Week Treatment Period|Adverse Event|1|||
33476779|NCT00658021|101639244|FG002|28-Week Treatment Period|Adverse Event|0|||
33476780|NCT00658021|101639242|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
33476781|NCT00658021|101639243|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
33476782|NCT00658021|101639244|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
33476783|NCT00658021|101639242|FG000|28-Week Treatment Period|Protocol Violation|0|||
33476784|NCT00658021|101639243|FG001|28-Week Treatment Period|Protocol Violation|2|||
33476785|NCT00658021|101639244|FG002|28-Week Treatment Period|Protocol Violation|1|||
33476786|NCT00658021|101639242|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
33476787|NCT00658021|101639243|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
33476788|NCT00658021|101639244|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
33476789|NCT00658021|101639242|FG000|28-Week Treatment Period|Physician Decision|1|||
33476790|NCT00658021|101639243|FG001|28-Week Treatment Period|Physician Decision|2|||
33476791|NCT00658021|101639244|FG002|28-Week Treatment Period|Physician Decision|1|||
33476792|NCT00658021|101639242|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
33476793|NCT00658021|101639243|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
33476794|NCT00658021|101639244|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
33476795|NCT00658021|101639242|FG000|28-Week Treatment Period|Loss of glucose control|1|||
33476796|NCT00658021|101639243|FG001|28-Week Treatment Period|Loss of glucose control|1|||
33476797|NCT00658021|101639244|FG002|28-Week Treatment Period|Loss of glucose control|10|||
33476798|NCT00658021|101639242|FG000|28-Week Treatment Period|Other|2|||
33476799|NCT00658021|101639243|FG001|28-Week Treatment Period|Other|3|||
33476800|NCT00658021|101639244|FG002|28-Week Treatment Period|Other|1|||
33476801|NCT00658021|101639242|FG000|28-Week Treatment Period|Did not receive treatment|2|||
33476802|NCT00658021|101639243|FG001|28-Week Treatment Period|Did not receive treatment|0|||
33476803|NCT00658021|101639244|FG002|28-Week Treatment Period|Did not receive treatment|0|||
33476804|NCT00658021|101639242|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
33476805|NCT00658021|101639243|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
33476806|NCT00658021|101639244|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
33476807|NCT00658021|101639242|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
33476808|NCT00658021|101639243|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
33476809|NCT00658021|101639244|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
33476810|NCT01193127|101639251|FG000|Randomized|Surgery Cancelled|0|||
33476811|NCT01193127|101639252|FG001|Randomized|Surgery Cancelled|0|||
33476812|NCT01193127|101639253|FG002|Randomized|Surgery Cancelled|0|||
33476813|NCT01193127|101639254|FG003|Randomized|Surgery Cancelled|1|||
33476814|NCT01193127|101639251|FG000|Treated|Withdrawal by Subject|0|||
33476815|NCT01193127|101639252|FG001|Treated|Withdrawal by Subject|0|||
33476816|NCT01193127|101639253|FG002|Treated|Withdrawal by Subject|0|||
33476817|NCT01193127|101639254|FG003|Treated|Withdrawal by Subject|1|||
33476818|NCT04126213|101639257|FG000|Overall Study|Lost to Follow-up|9|||
33476819|NCT04126213|101639258|FG001|Overall Study|Lost to Follow-up|1|||
33476820|NCT04126213|101639259|FG002|Overall Study|Lost to Follow-up|5|||
33476821|NCT04126213|101639260|FG003|Overall Study|Lost to Follow-up|10|||
33476822|NCT04126213|101639261|FG004|Overall Study|Lost to Follow-up|4|||
33476823|NCT04126213|101639262|FG005|Overall Study|Lost to Follow-up|7|||
33476824|NCT04126213|101639257|FG000|Overall Study|Withdrawal by Subject|3|||
33476825|NCT04126213|101639258|FG001|Overall Study|Withdrawal by Subject|2|||
33476826|NCT04126213|101639259|FG002|Overall Study|Withdrawal by Subject|1|||
33476827|NCT04126213|101639260|FG003|Overall Study|Withdrawal by Subject|1|||
33476828|NCT04126213|101639261|FG004|Overall Study|Withdrawal by Subject|1|||
33476829|NCT04126213|101639262|FG005|Overall Study|Withdrawal by Subject|1|||
33476830|NCT04126213|101639257|FG000|Overall Study|Other|0|||
33476831|NCT04126213|101639258|FG001|Overall Study|Other|0|||
33476832|NCT04126213|101639259|FG002|Overall Study|Other|2|||
33476833|NCT04126213|101639260|FG003|Overall Study|Other|2|||
33476834|NCT04126213|101639261|FG004|Overall Study|Other|0|||
33476835|NCT04126213|101639262|FG005|Overall Study|Other|1|||
33476836|NCT04126213|101639257|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33476837|NCT04126213|101639258|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
33476838|NCT04126213|101639259|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33476839|NCT04126213|101639260|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33476840|NCT04126213|101639261|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
33476841|NCT04126213|101639262|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
33476842|NCT02853370|101639269|FG000|Overall Study|Physician Decision|1|||
33476843|NCT02853370|101639269|FG000|Overall Study|Lack of Efficacy|2|||
33476844|NCT02853370|101639269|FG000|Overall Study|Death|1|||
33476845|NCT02853370|101639269|FG000|Overall Study|Adverse Event|4|||
33476846|NCT02853370|101639269|FG000|Overall Study|Withdrawal by Subject|3|||
33476847|NCT02444793|101639276|FG000|Overall Study|Lost to Follow-up|2|||
33476848|NCT02444793|101639277|FG001|Overall Study|Lost to Follow-up|2|||
33476849|NCT02444793|101639278|FG002|Overall Study|Lost to Follow-up|0|||
33476850|NCT02444793|101639279|FG003|Overall Study|Lost to Follow-up|0|||
33476851|NCT02444793|101639276|FG000|Overall Study|Death|0|||
33476852|NCT02444793|101639277|FG001|Overall Study|Death|3|||
33476853|NCT02444793|101639278|FG002|Overall Study|Death|0|||
33476854|NCT02444793|101639279|FG003|Overall Study|Death|0|||
33476855|NCT02444793|101639276|FG000|Overall Study|Other|0|||
33476856|NCT02444793|101639277|FG001|Overall Study|Other|0|||
33476857|NCT02444793|101639278|FG002|Overall Study|Other|2|||
33268151|NCT00622700|100880718|FG000|Core Treatment Period|Lack of Efficacy|19|||
33268152|NCT00622700|100880719|FG001|Core Treatment Period|Lack of Efficacy|6|||
33268153|NCT00622700|100880720|FG002|Core Treatment Period|Lack of Efficacy|12|||
33268154|NCT00622700|100880721|FG003|Core Treatment Period|Lack of Efficacy|0|||
33268155|NCT00622700|100880722|FG004|Core Treatment Period|Lack of Efficacy|0|||
33268156|NCT00622700|100880723|FG005|Core Treatment Period|Lack of Efficacy|0|||
33268157|NCT00622700|100880724|FG006|Core Treatment Period|Lack of Efficacy|0|||
33268158|NCT00622700|100880718|FG000|Core Treatment Period|Lost to Follow-up|1|||
33268159|NCT00622700|100880719|FG001|Core Treatment Period|Lost to Follow-up|1|||
33268160|NCT00622700|100880720|FG002|Core Treatment Period|Lost to Follow-up|1|||
33268161|NCT00622700|100880721|FG003|Core Treatment Period|Lost to Follow-up|0|||
33268162|NCT00622700|100880722|FG004|Core Treatment Period|Lost to Follow-up|0|||
33268163|NCT00622700|100880723|FG005|Core Treatment Period|Lost to Follow-up|0|||
33268164|NCT00622700|100880724|FG006|Core Treatment Period|Lost to Follow-up|0|||
33268165|NCT00622700|100880718|FG000|Core Treatment Period|Death|1|||
33268166|NCT00622700|100880719|FG001|Core Treatment Period|Death|0|||
33268167|NCT00622700|100880720|FG002|Core Treatment Period|Death|0|||
33268168|NCT00622700|100880721|FG003|Core Treatment Period|Death|0|||
33268169|NCT00622700|100880722|FG004|Core Treatment Period|Death|0|||
33268170|NCT00622700|100880723|FG005|Core Treatment Period|Death|0|||
33268171|NCT00622700|100880724|FG006|Core Treatment Period|Death|0|||
33268172|NCT00622700|100880718|FG000|Core Treatment Period|Progressive Disease|3|||
33268173|NCT00622700|100880719|FG001|Core Treatment Period|Progressive Disease|1|||
33268174|NCT00622700|100880720|FG002|Core Treatment Period|Progressive Disease|0|||
33268175|NCT00622700|100880721|FG003|Core Treatment Period|Progressive Disease|0|||
33268176|NCT00622700|100880722|FG004|Core Treatment Period|Progressive Disease|0|||
33268177|NCT00622700|100880723|FG005|Core Treatment Period|Progressive Disease|0|||
33268178|NCT00622700|100880724|FG006|Core Treatment Period|Progressive Disease|0|||
33268179|NCT00622700|100880718|FG000|Core Treatment Period|Withdrawal by Subject|12|||
33268180|NCT00622700|100880719|FG001|Core Treatment Period|Withdrawal by Subject|18|||
33268181|NCT00622700|100880720|FG002|Core Treatment Period|Withdrawal by Subject|15|||
33476858|NCT02444793|101639279|FG003|Overall Study|Other|0|||
33476859|NCT02444793|101639276|FG000|Overall Study|Objective progression or relapse|9|||
33476860|NCT02444793|101639277|FG001|Overall Study|Objective progression or relapse|1|||
33476861|NCT02444793|101639278|FG002|Overall Study|Objective progression or relapse|2|||
33268182|NCT00622700|100880721|FG003|Core Treatment Period|Withdrawal by Subject|0|||
33268183|NCT00622700|100880722|FG004|Core Treatment Period|Withdrawal by Subject|0|||
33268184|NCT00622700|100880723|FG005|Core Treatment Period|Withdrawal by Subject|0|||
33268185|NCT00622700|100880724|FG006|Core Treatment Period|Withdrawal by Subject|0|||
33268186|NCT00622700|100880718|FG000|Core Treatment Period|Other than specified above|2|||
33268187|NCT00622700|100880719|FG001|Core Treatment Period|Other than specified above|2|||
33268188|NCT00622700|100880720|FG002|Core Treatment Period|Other than specified above|5|||
33268189|NCT00622700|100880721|FG003|Core Treatment Period|Other than specified above|0|||
33476862|NCT02444793|101639279|FG003|Overall Study|Objective progression or relapse|3|||
33476863|NCT03573505|101639284|FG000|Overall Study|Adverse Event|1|||
33476864|NCT03573505|101639285|FG001|Overall Study|Adverse Event|1|||
33268190|NCT00622700|100880722|FG004|Core Treatment Period|Other than specified above|0|||
33268191|NCT00622700|100880723|FG005|Core Treatment Period|Other than specified above|0|||
33268192|NCT00622700|100880724|FG006|Core Treatment Period|Other than specified above|0|||
33268193|NCT00622700|100880718|FG000|Extension Treatment Period|Adverse Event|0|||
33268194|NCT00622700|100880719|FG001|Extension Treatment Period|Adverse Event|0|||
33268195|NCT00622700|100880720|FG002|Extension Treatment Period|Adverse Event|0|||
33268196|NCT00622700|100880721|FG003|Extension Treatment Period|Adverse Event|5|||
33268197|NCT00622700|100880722|FG004|Extension Treatment Period|Adverse Event|9|||
33268198|NCT00622700|100880723|FG005|Extension Treatment Period|Adverse Event|6|||
33268199|NCT00622700|100880724|FG006|Extension Treatment Period|Adverse Event|8|||
33268200|NCT00622700|100880718|FG000|Extension Treatment Period|Lack of Efficacy|0|||
33268201|NCT00622700|100880719|FG001|Extension Treatment Period|Lack of Efficacy|0|||
33268202|NCT00622700|100880720|FG002|Extension Treatment Period|Lack of Efficacy|0|||
33268203|NCT00622700|100880721|FG003|Extension Treatment Period|Lack of Efficacy|2|||
33268204|NCT00622700|100880722|FG004|Extension Treatment Period|Lack of Efficacy|8|||
33268205|NCT00622700|100880723|FG005|Extension Treatment Period|Lack of Efficacy|1|||
33268206|NCT00622700|100880724|FG006|Extension Treatment Period|Lack of Efficacy|9|||
33268207|NCT00622700|100880718|FG000|Extension Treatment Period|Protocol Violation|0|||
33268208|NCT00622700|100880719|FG001|Extension Treatment Period|Protocol Violation|0|||
33268209|NCT00622700|100880720|FG002|Extension Treatment Period|Protocol Violation|0|||
33268210|NCT00622700|100880721|FG003|Extension Treatment Period|Protocol Violation|0|||
33268211|NCT00622700|100880722|FG004|Extension Treatment Period|Protocol Violation|0|||
33268212|NCT00622700|100880723|FG005|Extension Treatment Period|Protocol Violation|2|||
33268213|NCT00622700|100880724|FG006|Extension Treatment Period|Protocol Violation|0|||
33268214|NCT00622700|100880718|FG000|Extension Treatment Period|Lost to Follow-up|0|||
33268215|NCT00622700|100880719|FG001|Extension Treatment Period|Lost to Follow-up|0|||
33268216|NCT00622700|100880720|FG002|Extension Treatment Period|Lost to Follow-up|0|||
33268217|NCT00622700|100880721|FG003|Extension Treatment Period|Lost to Follow-up|0|||
33268218|NCT00622700|100880722|FG004|Extension Treatment Period|Lost to Follow-up|1|||
33268219|NCT00622700|100880723|FG005|Extension Treatment Period|Lost to Follow-up|0|||
33268220|NCT00622700|100880724|FG006|Extension Treatment Period|Lost to Follow-up|0|||
33268221|NCT00622700|100880718|FG000|Extension Treatment Period|Progressive Disease|0|||
33476865|NCT03573505|101639284|FG000|Overall Study|Consent withdrawn|0|||
33476866|NCT03573505|101639285|FG001|Overall Study|Consent withdrawn|1|||
33476867|NCT03573505|101639284|FG000|Overall Study|Disease progression|0|||
33476868|NCT03573505|101639285|FG001|Overall Study|Disease progression|1|||
33476869|NCT03573505|101639284|FG000|Overall Study|Site Terminated by Sponsor|1|||
33476870|NCT03573505|101639285|FG001|Overall Study|Site Terminated by Sponsor|1|||
33476871|NCT03573505|101639284|FG000|Overall Study|Study terminated by sponsor|50|||
33476872|NCT03573505|101639285|FG001|Overall Study|Study terminated by sponsor|45|||
33476873|NCT03573505|101639284|FG000|Overall Study|Reason not specified|0|||
33476874|NCT03573505|101639285|FG001|Overall Study|Reason not specified|1|||
33476875|NCT03573505|101639284|FG000|Overall Study|Death|0|||
33476876|NCT03573505|101639285|FG001|Overall Study|Death|4|||
33476877|NCT03579966|101639286|FG000|Overall Study|Adverse Event|6|||
33476878|NCT03579966|101639286|FG000|Overall Study|Lost to Follow-up|4|||
33476879|NCT03579966|101639286|FG000|Overall Study|Physician Decision|10|||
33476880|NCT03579966|101639286|FG000|Overall Study|Pregnancy|1|||
33476881|NCT03579966|101639286|FG000|Overall Study|Withdrawal by Subject|16|||
33476882|NCT03579966|101639286|FG000|Overall Study|Study terminated by Sponsor|22|||
33476883|NCT03579966|101639286|FG000|Overall Study|Protocol Violation|1|||
33476884|NCT01287039|101639289|FG000|Overall Study|Noncompliance with study procedures|0|||
33476885|NCT01287039|101639290|FG001|Overall Study|Noncompliance with study procedures|1|||
33476886|NCT01287039|101639289|FG000|Overall Study|Change of location/residence|0|||
33476887|NCT01287039|101639290|FG001|Overall Study|Change of location/residence|3|||
33476888|NCT01287039|101639289|FG000|Overall Study|Elective surgery|0|||
33476889|NCT01287039|101639290|FG001|Overall Study|Elective surgery|1|||
33476890|NCT01287039|101639289|FG000|Overall Study|Protocol Violation|2|||
33476891|NCT01287039|101639290|FG001|Overall Study|Protocol Violation|3|||
33476892|NCT01287039|101639289|FG000|Overall Study|Excluded medication taken|1|||
33476893|NCT01287039|101639290|FG001|Overall Study|Excluded medication taken|0|||
33476894|NCT01287039|101639289|FG000|Overall Study|Noncompliance with study medication|0|||
33476895|NCT01287039|101639290|FG001|Overall Study|Noncompliance with study medication|1|||
33476896|NCT01287039|101639289|FG000|Overall Study|Problem with travel|0|||
33476897|NCT01287039|101639290|FG001|Overall Study|Problem with travel|1|||
33476898|NCT01287039|101639289|FG000|Overall Study|Death|1|||
33476899|NCT01287039|101639290|FG001|Overall Study|Death|0|||
33476900|NCT01287039|101639289|FG000|Overall Study|Change of residence|1|||
33268222|NCT00622700|100880719|FG001|Extension Treatment Period|Progressive Disease|0|||
33268223|NCT00622700|100880720|FG002|Extension Treatment Period|Progressive Disease|0|||
33268224|NCT00622700|100880721|FG003|Extension Treatment Period|Progressive Disease|1|||
33268225|NCT00622700|100880722|FG004|Extension Treatment Period|Progressive Disease|2|||
33476901|NCT01287039|101639290|FG001|Overall Study|Change of residence|0|||
33476902|NCT01287039|101639289|FG000|Overall Study|Adverse Event|7|||
33476903|NCT01287039|101639290|FG001|Overall Study|Adverse Event|4|||
33476904|NCT01287039|101639289|FG000|Overall Study|Withdrawal by Subject|14|||
33476905|NCT01287039|101639290|FG001|Overall Study|Withdrawal by Subject|11|||
33476906|NCT01287039|101639289|FG000|Overall Study|Lost to Follow-up|3|||
33476907|NCT01287039|101639290|FG001|Overall Study|Lost to Follow-up|2|||
33476908|NCT02365558|101639291|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
33476909|NCT02365558|101639292|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
33476910|NCT02365558|101639291|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
33476911|NCT02365558|101639292|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
33476912|NCT02994940|101639293|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
33476913|NCT02994940|101639294|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
33268226|NCT00622700|100880723|FG005|Extension Treatment Period|Progressive Disease|0|||
33268227|NCT00622700|100880724|FG006|Extension Treatment Period|Progressive Disease|2|||
33268228|NCT00622700|100880718|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
33268229|NCT00622700|100880719|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
33476914|NCT02994940|101639293|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
33476915|NCT02994940|101639294|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
33476916|NCT02994940|101639293|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
33476917|NCT02994940|101639294|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
33476918|NCT01671332|101639299|FG000|Overall Study|Withdrawal by Subject|1|||
33476919|NCT01671332|101639300|FG001|Overall Study|Withdrawal by Subject|1|||
33476920|NCT00587990|101639301|FG000|Overall Study|Death|0|||
33476921|NCT00587990|101639302|FG001|Overall Study|Death|0|||
33476922|NCT00587990|101639303|FG002|Overall Study|Death|1|||
33476923|NCT04268316|101639305|FG000|Overall Study|Withdrawal by Subject|2|||
33476924|NCT04268316|101639306|FG001|Overall Study|Withdrawal by Subject|1|||
33476925|NCT04268316|101639307|FG002|Overall Study|Withdrawal by Subject|0|||
33476926|NCT01777620|101639313|FG000|Overall Study|Subject Withdrawal|1|||
33476927|NCT01777620|101639314|FG001|Overall Study|Subject Withdrawal|0|||
33476928|NCT02588950|101639315|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
33476929|NCT02588950|101639316|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
33476930|NCT02588950|101639317|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
33476931|NCT02588950|101639318|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
33476932|NCT02588950|101639315|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
33476933|NCT02588950|101639316|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
33476934|NCT02588950|101639317|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
33476935|NCT02588950|101639318|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
33476936|NCT01561430|101639321|FG000|Overall Study|Adverse Event|0|||
33476937|NCT01561430|101639322|FG001|Overall Study|Adverse Event|0|||
33476938|NCT01561430|101639323|FG002|Overall Study|Adverse Event|3|||
33476939|NCT01561430|101639324|FG003|Overall Study|Adverse Event|1|||
33476940|NCT01561430|101639321|FG000|Overall Study|Withdrawal by Subject|0|||
33476941|NCT01561430|101639322|FG001|Overall Study|Withdrawal by Subject|0|||
33476942|NCT01561430|101639323|FG002|Overall Study|Withdrawal by Subject|1|||
33476943|NCT01561430|101639324|FG003|Overall Study|Withdrawal by Subject|0|||
33476944|NCT01561430|101639321|FG000|Overall Study|Physician Decision|0|||
33476945|NCT01561430|101639322|FG001|Overall Study|Physician Decision|1|||
33476946|NCT01561430|101639323|FG002|Overall Study|Physician Decision|0|||
33476947|NCT01561430|101639324|FG003|Overall Study|Physician Decision|0|||
33476948|NCT01561430|101639321|FG000|Overall Study|Sponsor Decision|1|||
33476949|NCT01561430|101639322|FG001|Overall Study|Sponsor Decision|14|||
33476950|NCT01561430|101639323|FG002|Overall Study|Sponsor Decision|13|||
33476951|NCT01561430|101639324|FG003|Overall Study|Sponsor Decision|12|||
33476952|NCT01831765|101639325|FG000|Overall Study|Lack of Efficacy|1|||
33476953|NCT01831765|101639326|FG001|Overall Study|Lack of Efficacy|0|||
33476954|NCT01831765|101639327|FG002|Overall Study|Lack of Efficacy|0|||
33476955|NCT01831765|101639325|FG000|Overall Study|Other, sponsor withdrew subject|0|||
33476956|NCT01831765|101639326|FG001|Overall Study|Other, sponsor withdrew subject|1|||
33476957|NCT01831765|101639327|FG002|Overall Study|Other, sponsor withdrew subject|0|||
33476958|NCT01831765|101639325|FG000|Overall Study|Pregnancy|1|||
33476959|NCT01831765|101639326|FG001|Overall Study|Pregnancy|1|||
33476960|NCT01831765|101639327|FG002|Overall Study|Pregnancy|2|||
33476961|NCT01831765|101639325|FG000|Overall Study|Death|0|||
33476962|NCT01831765|101639326|FG001|Overall Study|Death|1|||
33476963|NCT01831765|101639327|FG002|Overall Study|Death|1|||
33476964|NCT01831765|101639325|FG000|Overall Study|Other, site closed|1|||
33476965|NCT01831765|101639326|FG001|Overall Study|Other, site closed|1|||
33476966|NCT01831765|101639327|FG002|Overall Study|Other, site closed|0|||
33476967|NCT01831765|101639325|FG000|Overall Study|Adverse Event|5|||
33476968|NCT01831765|101639326|FG001|Overall Study|Adverse Event|3|||
33476969|NCT01831765|101639327|FG002|Overall Study|Adverse Event|3|||
33476970|NCT01831765|101639325|FG000|Overall Study|Withdrawal by Subject|22|||
33476971|NCT01831765|101639326|FG001|Overall Study|Withdrawal by Subject|7|||
33476972|NCT01831765|101639327|FG002|Overall Study|Withdrawal by Subject|17|||
33476973|NCT01831765|101639325|FG000|Overall Study|Withdrawal criteria|12|||
33268230|NCT00622700|100880720|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
33476974|NCT01831765|101639326|FG001|Overall Study|Withdrawal criteria|10|||
33476975|NCT01831765|101639327|FG002|Overall Study|Withdrawal criteria|16|||
33476976|NCT01831765|101639325|FG000|Overall Study|Lost to Follow-up|2|||
33476977|NCT01831765|101639326|FG001|Overall Study|Lost to Follow-up|3|||
33476978|NCT01831765|101639327|FG002|Overall Study|Lost to Follow-up|3|||
33268231|NCT00622700|100880721|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
33268232|NCT00622700|100880722|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
33268233|NCT00622700|100880723|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
33268234|NCT00622700|100880724|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
33476979|NCT00599521|101639328|FG000|Overall Study|Lack of Efficacy|4|||
33476980|NCT00599521|101639329|FG001|Overall Study|Lack of Efficacy|8|||
33476981|NCT00599521|101639328|FG000|Overall Study|Adverse Event|4|||
33476982|NCT00599521|101639329|FG001|Overall Study|Adverse Event|1|||
33476983|NCT00599521|101639328|FG000|Overall Study|Withdrawal by Subject|28|||
33476984|NCT00599521|101639329|FG001|Overall Study|Withdrawal by Subject|34|||
33476985|NCT00599521|101639328|FG000|Overall Study|Protocol Violation|1|||
33476986|NCT00599521|101639329|FG001|Overall Study|Protocol Violation|1|||
33476987|NCT00599521|101639328|FG000|Overall Study|Lost to Follow-up|23|||
33476988|NCT00599521|101639329|FG001|Overall Study|Lost to Follow-up|23|||
33476989|NCT00599521|101639328|FG000|Overall Study|Pregnancy|0|||
33476990|NCT00599521|101639329|FG001|Overall Study|Pregnancy|2|||
33476991|NCT00923273|101639330|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
33476992|NCT00923273|101639331|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
33476993|NCT00923273|101639332|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
33476994|NCT00923273|101639333|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
33476995|NCT00923273|101639334|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
33476996|NCT00923273|101639330|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
33476997|NCT00923273|101639331|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
33476998|NCT00923273|101639332|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
33476999|NCT00923273|101639333|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
33477000|NCT00923273|101639334|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
33477001|NCT02119819|101639335|FG000|Overall Study|Adverse Event|3|||
33477002|NCT02119819|101639336|FG001|Overall Study|Adverse Event|1|||
33477003|NCT02119819|101639337|FG002|Overall Study|Adverse Event|2|||
33477004|NCT02119819|101639338|FG003|Overall Study|Adverse Event|3|||
33477005|NCT02119819|101639339|FG004|Overall Study|Adverse Event|0|||
33477006|NCT02119819|101639340|FG005|Overall Study|Adverse Event|1|||
33477007|NCT02119819|101639335|FG000|Overall Study|Lack of Efficacy|0|||
33477008|NCT02119819|101639336|FG001|Overall Study|Lack of Efficacy|0|||
33477009|NCT02119819|101639337|FG002|Overall Study|Lack of Efficacy|0|||
33477010|NCT02119819|101639338|FG003|Overall Study|Lack of Efficacy|0|||
33477011|NCT02119819|101639339|FG004|Overall Study|Lack of Efficacy|0|||
33477012|NCT02119819|101639340|FG005|Overall Study|Lack of Efficacy|1|||
33477013|NCT02119819|101639335|FG000|Overall Study|Lost to Follow-up|0|||
33477014|NCT02119819|101639336|FG001|Overall Study|Lost to Follow-up|0|||
33477015|NCT02119819|101639337|FG002|Overall Study|Lost to Follow-up|1|||
33477016|NCT02119819|101639338|FG003|Overall Study|Lost to Follow-up|2|||
33477017|NCT02119819|101639339|FG004|Overall Study|Lost to Follow-up|1|||
33477018|NCT02119819|101639340|FG005|Overall Study|Lost to Follow-up|2|||
33477019|NCT02119819|101639335|FG000|Overall Study|Physician Decision|1|||
33268235|NCT00622700|100880718|FG000|Extension Treatment Period|Missing|0|||
33268236|NCT00622700|100880719|FG001|Extension Treatment Period|Missing|0|||
33268237|NCT00622700|100880720|FG002|Extension Treatment Period|Missing|0|||
33268238|NCT00622700|100880721|FG003|Extension Treatment Period|Missing|2|||
33268239|NCT00622700|100880722|FG004|Extension Treatment Period|Missing|3|||
33268240|NCT00622700|100880723|FG005|Extension Treatment Period|Missing|1|||
33268241|NCT00622700|100880724|FG006|Extension Treatment Period|Missing|0|||
33268242|NCT00622700|100880718|FG000|Extension Treatment Period|Other than specified above|0|||
33268243|NCT00622700|100880719|FG001|Extension Treatment Period|Other than specified above|0|||
33477020|NCT02119819|101639336|FG001|Overall Study|Physician Decision|1|||
33477021|NCT02119819|101639337|FG002|Overall Study|Physician Decision|0|||
33477022|NCT02119819|101639338|FG003|Overall Study|Physician Decision|0|||
33477023|NCT02119819|101639339|FG004|Overall Study|Physician Decision|0|||
33477024|NCT02119819|101639340|FG005|Overall Study|Physician Decision|1|||
33477025|NCT02119819|101639335|FG000|Overall Study|Withdrawal by Subject|5|||
33477026|NCT02119819|101639336|FG001|Overall Study|Withdrawal by Subject|3|||
33477027|NCT02119819|101639337|FG002|Overall Study|Withdrawal by Subject|0|||
33477028|NCT02119819|101639338|FG003|Overall Study|Withdrawal by Subject|0|||
33268244|NCT00622700|100880720|FG002|Extension Treatment Period|Other than specified above|0|||
33268245|NCT00622700|100880721|FG003|Extension Treatment Period|Other than specified above|0|||
33268246|NCT00622700|100880722|FG004|Extension Treatment Period|Other than specified above|0|||
33477029|NCT02119819|101639339|FG004|Overall Study|Withdrawal by Subject|6|||
33477030|NCT02119819|101639340|FG005|Overall Study|Withdrawal by Subject|10|||
33477031|NCT02119819|101639335|FG000|Overall Study|Jury Duty|0|||
33477032|NCT02119819|101639336|FG001|Overall Study|Jury Duty|0|||
33477033|NCT02119819|101639337|FG002|Overall Study|Jury Duty|1|||
33477034|NCT02119819|101639338|FG003|Overall Study|Jury Duty|0|||
33477035|NCT02119819|101639339|FG004|Overall Study|Jury Duty|0|||
33477036|NCT02119819|101639340|FG005|Overall Study|Jury Duty|0|||
33477037|NCT02119819|101639335|FG000|Overall Study|Protocol Violation|0|||
33477038|NCT02119819|101639336|FG001|Overall Study|Protocol Violation|0|||
33477039|NCT02119819|101639337|FG002|Overall Study|Protocol Violation|0|||
33477040|NCT02119819|101639338|FG003|Overall Study|Protocol Violation|1|||
33477041|NCT02119819|101639339|FG004|Overall Study|Protocol Violation|0|||
33268247|NCT00622700|100880723|FG005|Extension Treatment Period|Other than specified above|1|||
33268248|NCT00622700|100880724|FG006|Extension Treatment Period|Other than specified above|1|||
33268249|NCT01828021|100880726|FG000|Overall Study|Adverse Event|5|||
33268250|NCT01828021|100880726|FG000|Overall Study|Lack of Efficacy|17|||
33477042|NCT02119819|101639340|FG005|Overall Study|Protocol Violation|0|||
33477043|NCT02119819|101639335|FG000|Overall Study|Left the city to get a job|0|||
33477044|NCT02119819|101639336|FG001|Overall Study|Left the city to get a job|0|||
33477045|NCT02119819|101639337|FG002|Overall Study|Left the city to get a job|0|||
33477046|NCT02119819|101639338|FG003|Overall Study|Left the city to get a job|1|||
33477047|NCT02119819|101639339|FG004|Overall Study|Left the city to get a job|0|||
33477048|NCT02119819|101639340|FG005|Overall Study|Left the city to get a job|0|||
33477049|NCT02563106|101639341|FG000|Overall Study|Withdrawal by Subject|7|||
33477050|NCT02563106|101639342|FG001|Overall Study|Withdrawal by Subject|8|||
33477051|NCT02563106|101639341|FG000|Overall Study|Adverse Event|17|||
33477052|NCT02563106|101639342|FG001|Overall Study|Adverse Event|15|||
33477053|NCT02563106|101639341|FG000|Overall Study|Protocol Violation|1|||
33477054|NCT02563106|101639342|FG001|Overall Study|Protocol Violation|0|||
33477055|NCT02563106|101639341|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
33477056|NCT02563106|101639342|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
33477057|NCT02563106|101639341|FG000|Overall Study|Lost to Follow-up|3|||
33477058|NCT02563106|101639342|FG001|Overall Study|Lost to Follow-up|2|||
33477059|NCT02563106|101639341|FG000|Overall Study|Physician Decision|3|||
33477060|NCT02563106|101639342|FG001|Overall Study|Physician Decision|1|||
33477061|NCT02563106|101639341|FG000|Overall Study|Other reason - not specified|2|||
33477062|NCT02563106|101639342|FG001|Overall Study|Other reason - not specified|1|||
33477063|NCT00807248|101639343|FG000|Overall Study|Adverse Event|1|||
33477064|NCT00807248|101639344|FG001|Overall Study|Adverse Event|2|||
33477065|NCT00807248|101639345|FG002|Overall Study|Adverse Event|2|||
33477066|NCT00807248|101639346|FG003|Overall Study|Adverse Event|6|||
33477067|NCT00807248|101639343|FG000|Overall Study|Lack of Efficacy|14|||
33477068|NCT00807248|101639344|FG001|Overall Study|Lack of Efficacy|4|||
33477069|NCT00807248|101639345|FG002|Overall Study|Lack of Efficacy|8|||
33477070|NCT00807248|101639346|FG003|Overall Study|Lack of Efficacy|3|||
33477071|NCT00807248|101639343|FG000|Overall Study|Protocol Violation|0|||
33477072|NCT00807248|101639344|FG001|Overall Study|Protocol Violation|1|||
33477073|NCT00807248|101639345|FG002|Overall Study|Protocol Violation|1|||
33477074|NCT00807248|101639346|FG003|Overall Study|Protocol Violation|0|||
33477075|NCT00807248|101639343|FG000|Overall Study|Withdrawal of Consent|5|||
33477076|NCT00807248|101639344|FG001|Overall Study|Withdrawal of Consent|5|||
33477077|NCT00807248|101639345|FG002|Overall Study|Withdrawal of Consent|5|||
33477078|NCT00807248|101639346|FG003|Overall Study|Withdrawal of Consent|5|||
33477079|NCT00807248|101639343|FG000|Overall Study|Lost to Follow-up|1|||
33477080|NCT00807248|101639344|FG001|Overall Study|Lost to Follow-up|0|||
33477081|NCT00807248|101639345|FG002|Overall Study|Lost to Follow-up|0|||
33477082|NCT00807248|101639346|FG003|Overall Study|Lost to Follow-up|0|||
33477083|NCT00807248|101639343|FG000|Overall Study|Other Reason|0|||
33477084|NCT00807248|101639344|FG001|Overall Study|Other Reason|0|||
33268251|NCT01828021|100880726|FG000|Overall Study|Withdrawal by Subject|2|||
33268252|NCT01828021|100880726|FG000|Overall Study|Ileal obstruction, unrelated|1|||
33477085|NCT00807248|101639345|FG002|Overall Study|Other Reason|2|||
33477086|NCT00807248|101639346|FG003|Overall Study|Other Reason|0|||
33477087|NCT03768726|101639347|FG000|Treatment Phase|Adverse Event|2|||
33477088|NCT03768726|101639348|FG001|Treatment Phase|Adverse Event|2|||
33477089|NCT03768726|101639347|FG000|Treatment Phase|Lost to Follow-up|1|||
33477090|NCT03768726|101639348|FG001|Treatment Phase|Lost to Follow-up|0|||
33477091|NCT03768726|101639347|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
33477092|NCT03768726|101639348|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
33477093|NCT03768726|101639347|FG000|Treatment Phase|Withdrawal by Subject|3|||
33477094|NCT03768726|101639348|FG001|Treatment Phase|Withdrawal by Subject|1|||
33477095|NCT03768726|101639347|FG000|Follow-Up|Adverse Event|2|||
33477096|NCT03768726|101639348|FG001|Follow-Up|Adverse Event|2|||
33268253|NCT00666705|100880727|FG000|Overall Study|Withdrawal by Subject|1|||
33477097|NCT03768726|101639347|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
33477098|NCT03768726|101639348|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
33268254|NCT01128959|100880729|FG000|Lead in Period|Adverse Event|3|||
33477099|NCT03768726|101639347|FG000|Follow-Up|Withdrawal by Subject|2|||
33477100|NCT03768726|101639348|FG001|Follow-Up|Withdrawal by Subject|0|||
33477101|NCT03768726|101639347|FG000|Follow-Up|Other|1|||
33477102|NCT03768726|101639348|FG001|Follow-Up|Other|0|||
33477103|NCT00950963|101639349|FG000|Overall Study|Lost to Follow-up|29|||
33477104|NCT00950963|101639350|FG001|Overall Study|Lost to Follow-up|24|||
33477105|NCT01523457|101639355|FG000|Overall Study|Withdrawal by Subject|7|||
33477106|NCT01523457|101639356|FG001|Overall Study|Withdrawal by Subject|2|||
33477107|NCT00128830|101639357|FG000|Overall Study|Adverse Event|10|||
33477108|NCT00128830|101639357|FG000|Overall Study|Withdrawal by Subject|14|||
33477109|NCT00128830|101639357|FG000|Overall Study|Lost to Follow-up|4|||
33477110|NCT00128830|101639357|FG000|Overall Study|Reached a virologic endpoint|29|||
33268255|NCT01128959|100880729|FG000|Treatment Period|Adverse Event|3|||
33268256|NCT01128959|100880729|FG000|Treatment Period|Withdrawal by Subject|1|||
33268257|NCT00454194|100880732|FG000|Overall Study|Adverse Event|7|||
33268258|NCT00454194|100880733|FG001|Overall Study|Adverse Event|2|||
33268259|NCT00454194|100880732|FG000|Overall Study|Withdrawal by Subject|12|||
33477111|NCT00128830|101639357|FG000|Overall Study|Non-compliant|4|||
33477112|NCT00128830|101639357|FG000|Overall Study|Discontinued or ineligible for study|2|||
33477113|NCT00128830|101639357|FG000|Overall Study|Other|9|||
33477114|NCT01220297|101639362|FG000|Overall Study|Death|2|||
33477115|NCT01220297|101639362|FG000|Overall Study|Lost to Follow-up|1|||
33477116|NCT02575911|101639365|FG000|Overall Study|Lost to Follow-up|1|||
33477117|NCT00968799|101639366|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
33477118|NCT01770392|101639369|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
33477119|NCT04647721|101639370|FG000|Overall Study|Withdrawal by Subject|0|||
33477120|NCT04647721|101639371|FG001|Overall Study|Withdrawal by Subject|2|||
33477121|NCT04647721|101639370|FG000|Overall Study|Lost to Follow-up|2|||
33477122|NCT04647721|101639371|FG001|Overall Study|Lost to Follow-up|0|||
33477123|NCT00643565|101639372|FG000|Overall Study|Death|12|||
33477124|NCT00643565|101639373|FG001|Overall Study|Death|11|||
33477125|NCT00643565|101639372|FG000|Overall Study|Withdrawal by Subject|4|||
33477126|NCT00643565|101639373|FG001|Overall Study|Withdrawal by Subject|1|||
33477127|NCT00643565|101639372|FG000|Overall Study|Lost to Follow-up|0|||
33477128|NCT00643565|101639373|FG001|Overall Study|Lost to Follow-up|6|||
33477129|NCT00643565|101639372|FG000|Overall Study|Other|7|||
33477130|NCT00643565|101639373|FG001|Overall Study|Other|8|||
33477131|NCT00643565|101639372|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
33477132|NCT00643565|101639373|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
33477133|NCT00643565|101639372|FG000|Overall Study|Recurrence of Disease|2|||
33477134|NCT00643565|101639373|FG001|Overall Study|Recurrence of Disease|1|||
33477135|NCT00643565|101639372|FG000|Overall Study|Progression of Disease|18|||
33477136|NCT00643565|101639373|FG001|Overall Study|Progression of Disease|14|||
33477137|NCT00643565|101639372|FG000|Overall Study|Protocol Violation|3|||
33477138|NCT00643565|101639373|FG001|Overall Study|Protocol Violation|0|||
33477139|NCT00643565|101639372|FG000|Overall Study|Did Not Cooperate|0|||
33477140|NCT00643565|101639373|FG001|Overall Study|Did Not Cooperate|1|||
33477141|NCT00643565|101639372|FG000|Overall Study|Administrative|22|||
33477142|NCT00643565|101639373|FG001|Overall Study|Administrative|16|||
33477143|NCT00643565|101639372|FG000|Overall Study|Adverse Event|5|||
33477144|NCT00643565|101639373|FG001|Overall Study|Adverse Event|8|||
33477145|NCT01971970|101639374|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
33477146|NCT01971970|101639375|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
33477147|NCT01971970|101639374|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
33477148|NCT01971970|101639375|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
33477149|NCT01971970|101639374|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
33477150|NCT01971970|101639375|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
33477151|NCT01971970|101639374|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
33477152|NCT01971970|101639375|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
33477153|NCT01971970|101639374|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
33477154|NCT01971970|101639375|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
33477155|NCT01971970|101639374|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
33477156|NCT01971970|101639375|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
33477157|NCT01971970|101639374|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
33477158|NCT01971970|101639375|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
33268260|NCT00454194|100880733|FG001|Overall Study|Withdrawal by Subject|8|||
33268261|NCT00454194|100880732|FG000|Overall Study|Other Medical Problems|1|||
33268262|NCT00454194|100880733|FG001|Overall Study|Other Medical Problems|2|||
33268263|NCT00454194|100880732|FG000|Overall Study|Other Unspecified Reason|2|||
33477159|NCT01340768|101639376|FG000|Overall Study|Lost to Follow-up|10|||
33477160|NCT01340768|101639377|FG001|Overall Study|Lost to Follow-up|4|||
33477161|NCT01340768|101639376|FG000|Overall Study|Withdrawal by Subject|5|||
33477162|NCT01340768|101639377|FG001|Overall Study|Withdrawal by Subject|1|||
33477163|NCT01340768|101639376|FG000|Overall Study|Other|2|||
33477164|NCT01340768|101639377|FG001|Overall Study|Other|0|||
33268264|NCT00454194|100880733|FG001|Overall Study|Other Unspecified Reason|2|||
33477165|NCT01195103|101639380|FG000|Overall Study|Withdrawal by Subject|1|||
33477166|NCT01195103|101639381|FG001|Overall Study|Withdrawal by Subject|0|||
33477167|NCT01195103|101639382|FG002|Overall Study|Withdrawal by Subject|0|||
33477168|NCT00988065|101639383|FG000|Overall Study|Adverse Event|4|||
33477169|NCT00988065|101639384|FG001|Overall Study|Adverse Event|10|||
33477170|NCT00988065|101639385|FG002|Overall Study|Adverse Event|2|||
33477171|NCT00988065|101639383|FG000|Overall Study|Lost to Follow-up|1|||
33477172|NCT00988065|101639384|FG001|Overall Study|Lost to Follow-up|2|||
33477173|NCT00988065|101639385|FG002|Overall Study|Lost to Follow-up|2|||
33477174|NCT00988065|101639383|FG000|Overall Study|Subject withdrew consent|3|||
33477175|NCT00988065|101639384|FG001|Overall Study|Subject withdrew consent|5|||
33477176|NCT00988065|101639385|FG002|Overall Study|Subject withdrew consent|2|||
33477177|NCT00988065|101639383|FG000|Overall Study|Noncompliance with protocol|5|||
33477178|NCT00988065|101639384|FG001|Overall Study|Noncompliance with protocol|6|||
33477179|NCT00988065|101639385|FG002|Overall Study|Noncompliance with protocol|9|||
33477180|NCT01103466|101639386|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
33477181|NCT01103466|101639387|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
33477182|NCT01103466|101639388|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
33477183|NCT01103466|101639386|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
33477184|NCT01103466|101639387|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
33477185|NCT01103466|101639388|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
33477186|NCT01103466|101639386|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
33477187|NCT01103466|101639387|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
33477188|NCT01103466|101639388|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
33477189|NCT01103466|101639386|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
33477190|NCT01103466|101639387|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
33477191|NCT01103466|101639388|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
33477192|NCT01103466|101639386|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
33477193|NCT01103466|101639387|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
33477194|NCT01103466|101639388|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
33477195|NCT01103466|101639386|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
33268265|NCT03138499|100880734|FG000|Overall Study|Lost to Follow-up|1|||
33268266|NCT03138499|100880735|FG001|Overall Study|Lost to Follow-up|0|||
33268267|NCT03138499|100880734|FG000|Overall Study|Participants withdrew consent|1|||
33268268|NCT03138499|100880735|FG001|Overall Study|Participants withdrew consent|0|||
33268269|NCT03138499|100880734|FG000|Overall Study|Participant discontinued study before treatment|0|||
33268270|NCT03138499|100880735|FG001|Overall Study|Participant discontinued study before treatment|1|||
33268271|NCT03138499|100880734|FG000|Overall Study|Disease Progression|2|||
33268272|NCT03138499|100880735|FG001|Overall Study|Disease Progression|6|||
33268273|NCT03138499|100880734|FG000|Overall Study|Study drug toxicity|2|||
33268274|NCT03138499|100880735|FG001|Overall Study|Study drug toxicity|2|||
33268275|NCT03138499|100880734|FG000|Overall Study|Participant request to discontinue study treatment|1|||
33268276|NCT03138499|100880735|FG001|Overall Study|Participant request to discontinue study treatment|1|||
33268277|NCT03138499|100880734|FG000|Overall Study|Other reasons|2|||
33268278|NCT03138499|100880735|FG001|Overall Study|Other reasons|0|||
33268279|NCT01719172|100880745|FG000|Overall Study|Lost to Follow-up|1|||
33268280|NCT01719172|100880745|FG000|Overall Study|Death|1|||
33268281|NCT00857766|100880748|FG000|Overall Study|Adverse Event|13|||
33268282|NCT00857766|100880749|FG001|Overall Study|Adverse Event|12|||
33268283|NCT00857766|100880748|FG000|Overall Study|Protocol Violation|11|||
33268284|NCT00857766|100880749|FG001|Overall Study|Protocol Violation|11|||
33268285|NCT00857766|100880748|FG000|Overall Study|Lost to Follow-up|1|||
33268286|NCT00857766|100880749|FG001|Overall Study|Lost to Follow-up|0|||
33268287|NCT00857766|100880748|FG000|Overall Study|Investigator Discretion|2|||
33268288|NCT00857766|100880749|FG001|Overall Study|Investigator Discretion|3|||
33268289|NCT00857766|100880748|FG000|Overall Study|Participant Withdrew Consent|4|||
33268290|NCT00857766|100880749|FG001|Overall Study|Participant Withdrew Consent|4|||
33268291|NCT03883828|100880750|FG000|Overall Study|Did not start radiotherapy|1|||
33268292|NCT03883828|100880751|FG001|Overall Study|Did not start radiotherapy|2|||
33268293|NCT01313884|100880752|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
33268294|NCT04213807|100880753|FG000|Overall Study|Physician Decision|0|||
33268295|NCT04213807|100880754|FG001|Overall Study|Physician Decision|0|||
33268296|NCT04213807|100880755|FG002|Overall Study|Physician Decision|1|||
33268297|NCT01332266|100880756|FG000|Phase 1b|Death|3|||
33268298|NCT01332266|100880757|FG001|Phase 1b|Death|3|||
33268299|NCT01332266|100880758|FG002|Phase 1b|Death|2|||
33268300|NCT01332266|100880759|FG003|Phase 1b|Death|0|||
33477196|NCT01103466|101639387|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
33268301|NCT01332266|100880760|FG004|Phase 1b|Death|0|||
33268302|NCT01332266|100880756|FG000|Phase 1b|Lost to Follow-up|0|||
33268303|NCT01332266|100880757|FG001|Phase 1b|Lost to Follow-up|1|||
33268304|NCT01332266|100880758|FG002|Phase 1b|Lost to Follow-up|0|||
33268305|NCT01332266|100880759|FG003|Phase 1b|Lost to Follow-up|0|||
33268306|NCT01332266|100880760|FG004|Phase 1b|Lost to Follow-up|0|||
33268307|NCT01332266|100880756|FG000|Phase 1b|Withdrawal by Subject|1|||
33268308|NCT01332266|100880757|FG001|Phase 1b|Withdrawal by Subject|1|||
33268309|NCT01332266|100880758|FG002|Phase 1b|Withdrawal by Subject|1|||
33268310|NCT01332266|100880759|FG003|Phase 1b|Withdrawal by Subject|0|||
33268311|NCT01332266|100880760|FG004|Phase 1b|Withdrawal by Subject|0|||
33268312|NCT01332266|100880756|FG000|Phase 2|Death|0|||
33268313|NCT01332266|100880757|FG001|Phase 2|Death|0|||
33268314|NCT01332266|100880758|FG002|Phase 2|Death|0|||
33268315|NCT01332266|100880759|FG003|Phase 2|Death|33|||
33268316|NCT01332266|100880760|FG004|Phase 2|Death|36|||
33268317|NCT01332266|100880756|FG000|Phase 2|Lost to Follow-up|0|||
33268318|NCT01332266|100880757|FG001|Phase 2|Lost to Follow-up|0|||
33268319|NCT01332266|100880758|FG002|Phase 2|Lost to Follow-up|0|||
33268320|NCT01332266|100880759|FG003|Phase 2|Lost to Follow-up|2|||
33268321|NCT01332266|100880760|FG004|Phase 2|Lost to Follow-up|0|||
33477197|NCT01103466|101639388|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
33477198|NCT00686075|101639389|FG000|Overall Study|Withdrawal by Subject|4|||
33477199|NCT00686075|101639390|FG001|Overall Study|Withdrawal by Subject|3|||
33477200|NCT00686075|101639391|FG002|Overall Study|Withdrawal by Subject|3|||
33477201|NCT00686075|101639392|FG003|Overall Study|Withdrawal by Subject|7|||
33477202|NCT00686075|101639393|FG004|Overall Study|Withdrawal by Subject|1|||
33477203|NCT00686075|101639394|FG005|Overall Study|Withdrawal by Subject|0|||
33477204|NCT00686075|101639395|FG006|Overall Study|Withdrawal by Subject|0|||
33477205|NCT00686075|101639396|FG007|Overall Study|Withdrawal by Subject|2|||
33477206|NCT00686075|101639397|FG008|Overall Study|Withdrawal by Subject|4|||
33477207|NCT00686075|101639398|FG009|Overall Study|Withdrawal by Subject|6|||
33477208|NCT00686075|101639389|FG000|Overall Study|Lost to Follow-up|3|||
33477209|NCT00686075|101639390|FG001|Overall Study|Lost to Follow-up|6|||
33477210|NCT00686075|101639391|FG002|Overall Study|Lost to Follow-up|3|||
33477211|NCT00686075|101639392|FG003|Overall Study|Lost to Follow-up|2|||
33477212|NCT00686075|101639393|FG004|Overall Study|Lost to Follow-up|3|||
33477213|NCT00686075|101639394|FG005|Overall Study|Lost to Follow-up|3|||
33477214|NCT00686075|101639395|FG006|Overall Study|Lost to Follow-up|0|||
33477215|NCT00686075|101639396|FG007|Overall Study|Lost to Follow-up|0|||
33477216|NCT00686075|101639397|FG008|Overall Study|Lost to Follow-up|2|||
33477217|NCT00686075|101639398|FG009|Overall Study|Lost to Follow-up|3|||
33477218|NCT00686075|101639389|FG000|Overall Study|Other|1|||
33477219|NCT00686075|101639390|FG001|Overall Study|Other|1|||
33477220|NCT00686075|101639391|FG002|Overall Study|Other|0|||
33477221|NCT00686075|101639392|FG003|Overall Study|Other|0|||
33477222|NCT00686075|101639393|FG004|Overall Study|Other|0|||
33268322|NCT01332266|100880756|FG000|Phase 2|Physician Decision|0|||
33268323|NCT01332266|100880757|FG001|Phase 2|Physician Decision|0|||
33268324|NCT01332266|100880758|FG002|Phase 2|Physician Decision|0|||
33268325|NCT01332266|100880759|FG003|Phase 2|Physician Decision|3|||
33268326|NCT01332266|100880760|FG004|Phase 2|Physician Decision|1|||
33477223|NCT00686075|101639394|FG005|Overall Study|Other|0|||
33477224|NCT00686075|101639395|FG006|Overall Study|Other|0|||
33477225|NCT00686075|101639396|FG007|Overall Study|Other|0|||
33477226|NCT00686075|101639397|FG008|Overall Study|Other|0|||
33477227|NCT00686075|101639398|FG009|Overall Study|Other|1|||
33477228|NCT02348723|101639399|FG000|Overall Study|No ablation|21|||
33477229|NCT02348723|101639400|FG001|Overall Study|No ablation|20|||
33477230|NCT02348723|101639399|FG000|Overall Study|Non-compliant with Protocol|1|||
33477231|NCT02348723|101639400|FG001|Overall Study|Non-compliant with Protocol|0|||
33477232|NCT02348723|101639399|FG000|Overall Study|Lost to Follow-up|1|||
33477233|NCT02348723|101639400|FG001|Overall Study|Lost to Follow-up|1|||
33477234|NCT02348723|101639399|FG000|Overall Study|Consent withdrawn|1|||
33477235|NCT02348723|101639400|FG001|Overall Study|Consent withdrawn|3|||
33477236|NCT02348723|101639399|FG000|Overall Study|Reason other than specified|1|||
33477237|NCT02348723|101639400|FG001|Overall Study|Reason other than specified|1|||
33477238|NCT02348723|101639399|FG000|Overall Study|Adverse Event|3|||
33477239|NCT02348723|101639400|FG001|Overall Study|Adverse Event|1|||
33477240|NCT00289536|101639401|FG000|Period 3|Lost to Follow-up|0|||
33477241|NCT00289536|101639402|FG001|Period 3|Lost to Follow-up|0|||
33477242|NCT00289536|101639403|FG002|Period 3|Lost to Follow-up|1|||
33477243|NCT03321630|101639406|FG000|Overall Study|Adverse Event|1|||
33477244|NCT03321630|101639406|FG000|Overall Study|Investigator Discretion|2|||
33477245|NCT03321630|101639406|FG000|Overall Study|Withdrawal by Subject|1|||
33477246|NCT04594707|101639407|FG000|Overall Study|Adverse Event|0|||
33477247|NCT04594707|101639408|FG001|Overall Study|Adverse Event|0|||
33477248|NCT04594707|101639409|FG002|Overall Study|Adverse Event|1|||
33268327|NCT01332266|100880756|FG000|Phase 2|Symptomatic deterioration|0|||
33268328|NCT01332266|100880757|FG001|Phase 2|Symptomatic deterioration|0|||
33268329|NCT01332266|100880758|FG002|Phase 2|Symptomatic deterioration|0|||
33477249|NCT04594707|101639407|FG000|Overall Study|Death|0|||
33477250|NCT04594707|101639408|FG001|Overall Study|Death|2|||
33268330|NCT01332266|100880759|FG003|Phase 2|Symptomatic deterioration|0|||
33268331|NCT01332266|100880760|FG004|Phase 2|Symptomatic deterioration|1|||
33268332|NCT01332266|100880756|FG000|Phase 2|Progression Disease|0|||
33477251|NCT04594707|101639409|FG002|Overall Study|Death|2|||
33477252|NCT04594707|101639407|FG000|Overall Study|Lung Transplant|0|||
33477253|NCT04594707|101639408|FG001|Overall Study|Lung Transplant|0|||
33477254|NCT04594707|101639409|FG002|Overall Study|Lung Transplant|1|||
33477255|NCT04594707|101639407|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
33268333|NCT01332266|100880757|FG001|Phase 2|Progression Disease|0|||
33268334|NCT01332266|100880758|FG002|Phase 2|Progression Disease|0|||
33477256|NCT04594707|101639408|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
33477257|NCT04594707|101639409|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
33477258|NCT04594707|101639407|FG000|Overall Study|Study Terminated By Sponsor|19|||
33477259|NCT04594707|101639408|FG001|Overall Study|Study Terminated By Sponsor|47|||
33477260|NCT04594707|101639409|FG002|Overall Study|Study Terminated By Sponsor|41|||
33477261|NCT04594707|101639407|FG000|Overall Study|Withdrawal by Subject|1|||
33477262|NCT04594707|101639408|FG001|Overall Study|Withdrawal by Subject|0|||
33477263|NCT04594707|101639409|FG002|Overall Study|Withdrawal by Subject|2|||
33477264|NCT00369317|101639410|FG000|Overall Study|Adverse Event|3|||
33477265|NCT00369317|101639410|FG000|Overall Study|Death|1|||
33477266|NCT00369317|101639410|FG000|Overall Study|Lack of Efficacy|5|||
33477267|NCT00369317|101639410|FG000|Overall Study|Physician Decision|2|||
33477268|NCT00369317|101639410|FG000|Overall Study|Withdrawal by Subject|8|||
33477269|NCT00369317|101639410|FG000|Overall Study|Ineligible|1|||
33477270|NCT01709838|101639411|FG000|Overall Study|Withdrawal by Subject|21|||
33477271|NCT01709838|101639411|FG000|Overall Study|Lost to Follow-up|16|||
33477272|NCT01709838|101639411|FG000|Overall Study|Pregnancy|10|||
33477273|NCT01709838|101639411|FG000|Overall Study|Subject/guardian decision|8|||
33477274|NCT01709838|101639411|FG000|Overall Study|Adverse Event|4|||
33477275|NCT01709838|101639411|FG000|Overall Study|Physician Decision|4|||
33268335|NCT01332266|100880759|FG003|Phase 2|Progression Disease|2|||
33268336|NCT01332266|100880760|FG004|Phase 2|Progression Disease|1|||
33268337|NCT01332266|100880756|FG000|Phase 2|Withdrawal by Subject|0|||
33268338|NCT01332266|100880757|FG001|Phase 2|Withdrawal by Subject|0|||
33268339|NCT01332266|100880758|FG002|Phase 2|Withdrawal by Subject|0|||
33268340|NCT01332266|100880759|FG003|Phase 2|Withdrawal by Subject|2|||
33268341|NCT01332266|100880760|FG004|Phase 2|Withdrawal by Subject|2|||
33268342|NCT01328496|100880761|FG000|Overall Study|Significant Change in Health Status|1|||
33268343|NCT01328496|100880762|FG001|Overall Study|Significant Change in Health Status|0|||
33268344|NCT01801007|100880763|FG000|Overall Study|Adverse Event|2|||
33268345|NCT01801007|100880763|FG000|Overall Study|Lost to Follow-up|4|||
33268346|NCT01801007|100880763|FG000|Overall Study|Withdrawal by Subject|5|||
33268347|NCT00777049|100880764|FG000|Overall Study|Withdrawal by Subject|1|||
33268348|NCT00777049|100880765|FG001|Overall Study|Withdrawal by Subject|0|||
33268349|NCT00777049|100880764|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
33268350|NCT00777049|100880765|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
33268351|NCT01728324|100880766|FG000|Termination of DBV|Adverse Event|14|||
33268352|NCT01728324|100880767|FG001|Termination of DBV|Adverse Event|13|||
33268353|NCT01728324|100880768|FG002|Termination of DBV|Adverse Event|4|||
33268354|NCT01728324|100880766|FG000|Termination of DBV|Lack of Efficacy|14|||
33268355|NCT01728324|100880767|FG001|Termination of DBV|Lack of Efficacy|12|||
33268356|NCT01728324|100880768|FG002|Termination of DBV|Lack of Efficacy|8|||
33268357|NCT01728324|100880766|FG000|Termination of DBV|Withdrawal by Subject|9|||
33268358|NCT01728324|100880767|FG001|Termination of DBV|Withdrawal by Subject|6|||
33268359|NCT01728324|100880768|FG002|Termination of DBV|Withdrawal by Subject|2|||
33268360|NCT01728324|100880766|FG000|Termination of DBV|Other than stated|1|||
33268361|NCT01728324|100880767|FG001|Termination of DBV|Other than stated|3|||
33477276|NCT01709838|101639411|FG000|Overall Study|Death|3|||
33477277|NCT01709838|101639411|FG000|Overall Study|Protocol Violation|1|||
33477278|NCT01524679|101639412|FG000|Overall Study|Lost to Follow-up|1|||
33477279|NCT01524679|101639413|FG001|Overall Study|Lost to Follow-up|4|||
33477280|NCT01524679|101639412|FG000|Overall Study|Withdrawal by Subject|4|||
33477281|NCT01524679|101639413|FG001|Overall Study|Withdrawal by Subject|4|||
33477282|NCT01524679|101639412|FG000|Overall Study|Adverse Event|9|||
33477283|NCT01524679|101639413|FG001|Overall Study|Adverse Event|0|||
33477284|NCT01524679|101639412|FG000|Overall Study|Protocol Violation|1|||
33477285|NCT01524679|101639413|FG001|Overall Study|Protocol Violation|0|||
33477286|NCT01524679|101639412|FG000|Overall Study|Lack of Efficacy|2|||
33477287|NCT01524679|101639413|FG001|Overall Study|Lack of Efficacy|0|||
33477288|NCT01524679|101639412|FG000|Overall Study|e.g.wish for children, relocation|6|||
33477289|NCT01524679|101639413|FG001|Overall Study|e.g.wish for children, relocation|1|||
33477290|NCT01898650|101639414|FG000|Overall Study|the subject would not lie still for imaging|1|||
33477291|NCT01372774|101639417|FG000|Overall Study|Withdrawal prior to treatment|4|||
33268362|NCT01728324|100880768|FG002|Termination of DBV|Other than stated|0|||
33268363|NCT01728324|100880766|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
33268364|NCT01728324|100880767|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
33268365|NCT01728324|100880768|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
33268366|NCT01728324|100880766|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
33477292|NCT01372774|101639418|FG001|Overall Study|Withdrawal prior to treatment|5|||
33477293|NCT01806506|101639419|FG000|Overall Study|Lost to Follow-up|2|||
33477294|NCT01806506|101639420|FG001|Overall Study|Lost to Follow-up|1|||
33268367|NCT01728324|100880767|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
33268368|NCT01728324|100880768|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
33268369|NCT01728324|100880766|FG000|Termination of FDV|Adverse Event|14|||
33268370|NCT01728324|100880767|FG001|Termination of FDV|Adverse Event|13|||
33477295|NCT04620135|101639421|FG000|Study Completion|Adverse Event|2|||
33477296|NCT04620135|101639422|FG001|Study Completion|Adverse Event|3|||
33477297|NCT04620135|101639421|FG000|Study Completion|Withdrawal by Subject|2|||
33477298|NCT04620135|101639422|FG001|Study Completion|Withdrawal by Subject|0|||
33477299|NCT02352779|101639423|FG000|Overall Study|Personal Issues|1|||
33477300|NCT02352779|101639424|FG001|Overall Study|Personal Issues|1|||
33477301|NCT02352779|101639425|FG002|Overall Study|Personal Issues|0|||
33477302|NCT02352779|101639423|FG000|Overall Study|Too Many Forms|2|||
33477303|NCT02352779|101639424|FG001|Overall Study|Too Many Forms|0|||
33477304|NCT02352779|101639425|FG002|Overall Study|Too Many Forms|0|||
33477305|NCT02352779|101639423|FG000|Overall Study|Feeling Overwhelmed|1|||
33477306|NCT02352779|101639424|FG001|Overall Study|Feeling Overwhelmed|0|||
33477307|NCT02352779|101639425|FG002|Overall Study|Feeling Overwhelmed|0|||
33477308|NCT02352779|101639423|FG000|Overall Study|Disliked Intervention|1|||
33477309|NCT02352779|101639424|FG001|Overall Study|Disliked Intervention|0|||
33477310|NCT02352779|101639425|FG002|Overall Study|Disliked Intervention|0|||
33477311|NCT02352779|101639423|FG000|Overall Study|Changed Mind|1|||
33477312|NCT02352779|101639424|FG001|Overall Study|Changed Mind|0|||
33477313|NCT02352779|101639425|FG002|Overall Study|Changed Mind|0|||
33477314|NCT02352779|101639423|FG000|Overall Study|Study Related Symptoms|1|||
33477315|NCT02352779|101639424|FG001|Overall Study|Study Related Symptoms|0|||
33477316|NCT02352779|101639425|FG002|Overall Study|Study Related Symptoms|0|||
33477317|NCT02352779|101639423|FG000|Overall Study|Absence of Symptoms|1|||
33477318|NCT02352779|101639424|FG001|Overall Study|Absence of Symptoms|0|||
33477319|NCT02352779|101639425|FG002|Overall Study|Absence of Symptoms|0|||
33477320|NCT02352779|101639423|FG000|Overall Study|Other Medical Reason|0|||
33477321|NCT02352779|101639424|FG001|Overall Study|Other Medical Reason|0|||
33477322|NCT02352779|101639425|FG002|Overall Study|Other Medical Reason|1|||
33477323|NCT02352779|101639423|FG000|Overall Study|No Reason|0|||
33477324|NCT02352779|101639424|FG001|Overall Study|No Reason|0|||
33477325|NCT02352779|101639425|FG002|Overall Study|No Reason|1|||
33477326|NCT01167257|101639426|FG000|Overall Study|Lost to Follow-up|2|||
33477327|NCT01167257|101639427|FG001|Overall Study|Lost to Follow-up|2|||
33477328|NCT01167257|101639426|FG000|Overall Study|Withdrew consent|1|||
33477329|NCT01167257|101639427|FG001|Overall Study|Withdrew consent|1|||
33477330|NCT00724048|101643115|FG000|Overall Study|Adverse Event|1|||
33477331|NCT00724048|101643116|FG001|Overall Study|Adverse Event|1|||
33477332|NCT00724048|101643117|FG002|Overall Study|Adverse Event|1|||
33477333|NCT00724048|101643118|FG003|Overall Study|Adverse Event|0|||
33477334|NCT00724048|101643115|FG000|Overall Study|Lost to Follow-up|0|||
33477335|NCT00724048|101643116|FG001|Overall Study|Lost to Follow-up|1|||
33477336|NCT00724048|101643117|FG002|Overall Study|Lost to Follow-up|0|||
33477337|NCT00724048|101643118|FG003|Overall Study|Lost to Follow-up|0|||
33477338|NCT00724048|101643115|FG000|Overall Study|Withdrawal by Subject|1|||
33477339|NCT00724048|101643116|FG001|Overall Study|Withdrawal by Subject|2|||
33477340|NCT00724048|101643117|FG002|Overall Study|Withdrawal by Subject|1|||
33477341|NCT00724048|101643118|FG003|Overall Study|Withdrawal by Subject|2|||
33477342|NCT00724048|101643115|FG000|Overall Study|Investigator decision|0|||
33477343|NCT00724048|101643116|FG001|Overall Study|Investigator decision|0|||
33477344|NCT00724048|101643117|FG002|Overall Study|Investigator decision|1|||
33477345|NCT00724048|101643118|FG003|Overall Study|Investigator decision|0|||
33477346|NCT00724048|101643115|FG000|Overall Study|Did not tolerate study drug|0|||
33477347|NCT00724048|101643116|FG001|Overall Study|Did not tolerate study drug|0|||
33477348|NCT00724048|101643117|FG002|Overall Study|Did not tolerate study drug|0|||
33477349|NCT00724048|101643118|FG003|Overall Study|Did not tolerate study drug|1|||
33477350|NCT00724048|101643115|FG000|Overall Study|Other than specified|1|||
33477351|NCT00724048|101643116|FG001|Overall Study|Other than specified|1|||
33477352|NCT00724048|101643117|FG002|Overall Study|Other than specified|0|||
33477353|NCT00724048|101643118|FG003|Overall Study|Other than specified|0|||
33477354|NCT04271735|101643119|FG000|Overall Study|Physician Decision|2|||
33477355|NCT04271735|101643120|FG001|Overall Study|Physician Decision|0|||
33477356|NCT02712333|101643121|FG000|First Period|Withdrawal by Subject|3|||
33477357|NCT02712333|101643122|FG001|First Period|Withdrawal by Subject|2|||
33477358|NCT00326963|101643123|FG000|Overall Study|Adverse Event|2|||
33268371|NCT01728324|100880768|FG002|Termination of FDV|Adverse Event|4|||
33268372|NCT01728324|100880766|FG000|Termination of FDV|Lack of Efficacy|14|||
33477359|NCT00326963|101643123|FG000|Overall Study|Injection site reaction|1|||
33477360|NCT00326963|101643123|FG000|Overall Study|Death|1|||
33477361|NCT00326963|101643123|FG000|Overall Study|Failure to return|10|||
33477362|NCT00326963|101643123|FG000|Overall Study|Withdrawal by Subject|10|||
33477363|NCT00326963|101643123|FG000|Overall Study|Refused treatment / did not cooperate|5|||
33477364|NCT00326963|101643123|FG000|Overall Study|Violation of selection criteria at entry|2|||
33477365|NCT00326963|101643123|FG000|Overall Study|Other protocol violation|1|||
33477366|NCT00326963|101643123|FG000|Overall Study|Administrative / other|1|||
33477367|NCT03084367|101643128|FG000|Overall Study|Lost to Follow-up|32|||
33477368|NCT03084367|101643128|FG000|Overall Study|Withdrawal by Subject|4|||
33477369|NCT03084367|101643128|FG000|Overall Study|Other|1|||
33477370|NCT04663295|101643129|FG000|Run-in Period|Withdrawal by Subject|3|||
33477371|NCT04663295|101643129|FG000|Overall Study Period|Pregnancy|1|||
33477372|NCT04663295|101643129|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
33477373|NCT02605993|101643130|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
33477374|NCT02605993|101643131|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
33477375|NCT02605993|101643132|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
33268373|NCT01728324|100880767|FG001|Termination of FDV|Lack of Efficacy|12|||
33268374|NCT01728324|100880768|FG002|Termination of FDV|Lack of Efficacy|8|||
33268375|NCT01728324|100880766|FG000|Termination of FDV|Withdrawal by Subject|9|||
33268376|NCT01728324|100880767|FG001|Termination of FDV|Withdrawal by Subject|6|||
33268377|NCT01728324|100880768|FG002|Termination of FDV|Withdrawal by Subject|2|||
33268378|NCT01728324|100880766|FG000|Termination of FDV|Other than stated|1|||
33268379|NCT01728324|100880767|FG001|Termination of FDV|Other than stated|3|||
33268380|NCT01728324|100880768|FG002|Termination of FDV|Other than stated|0|||
33268381|NCT01728324|100880766|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
33268382|NCT01728324|100880767|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
33268383|NCT01728324|100880768|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
33268384|NCT01728324|100880766|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
33268385|NCT01728324|100880767|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
33268386|NCT01728324|100880768|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
33268387|NCT01728324|100880766|FG000|Termination of RBV|Adverse Event|15|||
33268388|NCT01728324|100880767|FG001|Termination of RBV|Adverse Event|16|||
33268389|NCT01728324|100880768|FG002|Termination of RBV|Adverse Event|5|||
33477376|NCT02605993|101643133|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
33477377|NCT03188666|101643134|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
33477378|NCT03188666|101643135|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
33477379|NCT03188666|101643136|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
33477380|NCT03188666|101643137|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
33477381|NCT03188666|101643134|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
33477382|NCT03188666|101643135|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
33477383|NCT03188666|101643136|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
33477384|NCT03188666|101643137|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
33477385|NCT03188666|101643134|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
33477386|NCT03188666|101643135|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
33477387|NCT03188666|101643136|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
33477388|NCT03188666|101643137|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
33477389|NCT03188666|101643134|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
33477390|NCT03188666|101643135|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
33477391|NCT03188666|101643136|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
33477392|NCT03188666|101643137|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
33477393|NCT03222583|101643138|FG000|Overall Study|Withdrawal by Subject|3|||
33477394|NCT03222583|101643139|FG001|Overall Study|Withdrawal by Subject|3|||
33477395|NCT03222583|101643138|FG000|Overall Study|Lost to Follow-up|1|||
33477396|NCT03222583|101643139|FG001|Overall Study|Lost to Follow-up|0|||
33477397|NCT03222583|101643138|FG000|Overall Study|Other|1|||
33477398|NCT03222583|101643139|FG001|Overall Study|Other|3|||
33477399|NCT04091659|101643140|FG000|Overall Study|Protocol Violation|3|||
33477400|NCT04091659|101643141|FG001|Overall Study|Protocol Violation|0|||
33477401|NCT04091659|101643140|FG000|Overall Study|Lost to Follow-up|0|||
33477402|NCT04091659|101643141|FG001|Overall Study|Lost to Follow-up|1|||
33477403|NCT00426361|101643144|FG000|Overall Study|Lost to Follow-up|3|||
33477404|NCT00426361|101643145|FG001|Overall Study|Lost to Follow-up|2|||
33477405|NCT00426361|101643146|FG002|Overall Study|Lost to Follow-up|5|||
33477406|NCT00426361|101643144|FG000|Overall Study|Withdrawal by Subject|1|||
33477407|NCT00426361|101643145|FG001|Overall Study|Withdrawal by Subject|3|||
33477408|NCT00426361|101643146|FG002|Overall Study|Withdrawal by Subject|0|||
33477409|NCT00593736|101643147|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
33477410|NCT00593736|101643148|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
33477411|NCT00593736|101643149|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
33477412|NCT00593736|101643150|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
33477413|NCT00593736|101643147|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
33477414|NCT00593736|101643148|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
33477415|NCT00593736|101643149|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
33477416|NCT00593736|101643150|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
33477417|NCT00593736|101643147|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
33477418|NCT00593736|101643148|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
33477419|NCT00593736|101643149|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
33477420|NCT00593736|101643150|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
33477421|NCT00593736|101643147|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
33477422|NCT00593736|101643148|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
33477423|NCT00593736|101643149|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
33268390|NCT01728324|100880766|FG000|Termination of RBV|Lack of Efficacy|14|||
33268391|NCT01728324|100880767|FG001|Termination of RBV|Lack of Efficacy|11|||
33477424|NCT00593736|101643150|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
33477425|NCT00593736|101643147|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
33477426|NCT00593736|101643148|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
33477427|NCT00593736|101643149|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
33477428|NCT00593736|101643150|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
33477429|NCT00593736|101643147|FG000|Screening Period and Placebo Run-in|Various|0|||
33477430|NCT00593736|101643148|FG001|Screening Period and Placebo Run-in|Various|0|||
33477431|NCT00593736|101643149|FG002|Screening Period and Placebo Run-in|Various|0|||
33477432|NCT00593736|101643150|FG003|Screening Period and Placebo Run-in|Various|25|||
33477433|NCT00593736|101643147|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
33477434|NCT00593736|101643148|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
33477435|NCT00593736|101643149|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
33477436|NCT00593736|101643150|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
33477437|NCT00593736|101643147|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
33477438|NCT00593736|101643148|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
33477439|NCT00593736|101643149|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
33477440|NCT00593736|101643150|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
33477441|NCT00593736|101643147|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
33477442|NCT00593736|101643148|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
33477443|NCT00593736|101643149|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
33477444|NCT00593736|101643150|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
33477445|NCT00593736|101643147|FG000|Treatment Period and Placebo Run-out|Various|1|||
33477446|NCT00593736|101643148|FG001|Treatment Period and Placebo Run-out|Various|1|||
33477447|NCT00593736|101643149|FG002|Treatment Period and Placebo Run-out|Various|1|||
33477448|NCT00593736|101643150|FG003|Treatment Period and Placebo Run-out|Various|0|||
33477449|NCT02011386|101643153|FG000|Overall Study|Non-compliance|2|||
33477450|NCT02011386|101643153|FG000|Overall Study|Lack of Efficacy|3|||
33477451|NCT04709835|101643157|FG000|Overall Study|Withdrawal by Subject|0|||
33477452|NCT04709835|101643158|FG001|Overall Study|Withdrawal by Subject|1|||
33477453|NCT04709835|101643159|FG002|Overall Study|Withdrawal by Subject|0|||
33477454|NCT04729309|101643163|FG000|Period 1|Subject unable to return for Period 2|3|||
33477455|NCT04729309|101643164|FG001|Period 1|Subject unable to return for Period 2|0|||
33477456|NCT04729309|101643163|FG000|Period 1|Lost to Follow-up|1|||
33477457|NCT04729309|101643164|FG001|Period 1|Lost to Follow-up|0|||
33477458|NCT04669691|101643165|FG000|Overall Study|Death|0|||
33477459|NCT04669691|101643166|FG001|Overall Study|Death|1|||
33477460|NCT04669691|101643167|FG002|Overall Study|Death|0|||
33477461|NCT04669691|101643168|FG003|Overall Study|Death|0|||
33477462|NCT04669691|101643169|FG004|Overall Study|Death|0|||
33477463|NCT04669691|101643170|FG005|Overall Study|Death|0|||
33477464|NCT03623386|101643171|FG000|Overall Study|Protocol Violation|3|||
33477465|NCT03623386|101643172|FG001|Overall Study|Protocol Violation|2|||
33477466|NCT03623386|101643173|FG002|Overall Study|Protocol Violation|0|||
33477467|NCT03623386|101643171|FG000|Overall Study|Physician Decision|1|||
33477468|NCT03623386|101643172|FG001|Overall Study|Physician Decision|1|||
33477469|NCT03623386|101643173|FG002|Overall Study|Physician Decision|0|||
33477470|NCT03623386|101643171|FG000|Overall Study|Lost to Follow-up|0|||
33477471|NCT03623386|101643172|FG001|Overall Study|Lost to Follow-up|2|||
33477472|NCT03623386|101643173|FG002|Overall Study|Lost to Follow-up|0|||
33477473|NCT03623386|101643171|FG000|Overall Study|COVID-19|0|||
33477474|NCT03623386|101643172|FG001|Overall Study|COVID-19|1|||
33477475|NCT03623386|101643173|FG002|Overall Study|COVID-19|0|||
33477476|NCT00895414|101643174|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
33477477|NCT00895414|101643175|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
33477478|NCT00895414|101643174|FG000|First Intervention (14 Days)|Physician Decision|0|||
33477479|NCT00895414|101643175|FG001|First Intervention (14 Days)|Physician Decision|1|||
33268392|NCT01728324|100880768|FG002|Termination of RBV|Lack of Efficacy|7|||
33268393|NCT01728324|100880766|FG000|Termination of RBV|Withdrawal by Subject|9|||
33268394|NCT01728324|100880767|FG001|Termination of RBV|Withdrawal by Subject|5|||
33268395|NCT01728324|100880768|FG002|Termination of RBV|Withdrawal by Subject|2|||
33268396|NCT01728324|100880766|FG000|Termination of RBV|Other than stated|1|||
33477480|NCT04625725|101643176|FG000|Overall Study|Adverse Event|2|||
33477481|NCT04625725|101643177|FG001|Overall Study|Adverse Event|1|||
33477482|NCT04625725|101643176|FG000|Overall Study|Death|22|||
33477483|NCT04625725|101643177|FG001|Overall Study|Death|10|||
33477484|NCT04625725|101643176|FG000|Overall Study|Lost to Follow-up|357|||
33477485|NCT04625725|101643177|FG001|Overall Study|Lost to Follow-up|200|||
33477486|NCT04625725|101643176|FG000|Overall Study|Dosed in sub-study|310|||
33477487|NCT04625725|101643177|FG001|Overall Study|Dosed in sub-study|193|||
33268397|NCT01728324|100880767|FG001|Termination of RBV|Other than stated|3|||
33477488|NCT04625725|101643176|FG000|Overall Study|Physician Decision|5|||
33477489|NCT04625725|101643177|FG001|Overall Study|Physician Decision|0|||
33477490|NCT04625725|101643176|FG000|Overall Study|Protocol Violation|1|||
33477491|NCT04625725|101643177|FG001|Overall Study|Protocol Violation|0|||
33477492|NCT04625725|101643176|FG000|Overall Study|Withdrawal by Subject|242|||
33477493|NCT04625725|101643177|FG001|Overall Study|Withdrawal by Subject|144|||
33477494|NCT04625725|101643176|FG000|Overall Study|Not specified otherwise|31|||
33477495|NCT04625725|101643177|FG001|Overall Study|Not specified otherwise|9|||
33477496|NCT04625725|101643176|FG000|Overall Study|Missing|0|||
33477497|NCT04625725|101643177|FG001|Overall Study|Missing|1|||
33477498|NCT01214915|101643180|FG000|Overall Study|Adverse Event|8|||
33477499|NCT01214915|101643180|FG000|Overall Study|Lack of Efficacy|3|||
33477500|NCT02338193|101643189|FG000|Overall Study|Withdrawal by Subject|0|||
33477501|NCT02338193|101643190|FG001|Overall Study|Withdrawal by Subject|0|||
33477502|NCT02338193|101643191|FG002|Overall Study|Withdrawal by Subject|2|||
33477503|NCT02338193|101643189|FG000|Overall Study|Pregnancy|0|||
33477504|NCT02338193|101643190|FG001|Overall Study|Pregnancy|1|||
33477505|NCT02338193|101643191|FG002|Overall Study|Pregnancy|1|||
33477506|NCT02338193|101643189|FG000|Overall Study|Noncompliant with visits|2|||
33477507|NCT02338193|101643190|FG001|Overall Study|Noncompliant with visits|2|||
33477508|NCT02338193|101643191|FG002|Overall Study|Noncompliant with visits|7|||
33477509|NCT02338193|101643189|FG000|Overall Study|moved out of state|0|||
33477510|NCT02338193|101643190|FG001|Overall Study|moved out of state|1|||
33477511|NCT02338193|101643191|FG002|Overall Study|moved out of state|0|||
33477512|NCT02338193|101643189|FG000|Overall Study|intolerant of side effects|1|||
33477513|NCT02338193|101643190|FG001|Overall Study|intolerant of side effects|0|||
33477514|NCT02338193|101643191|FG002|Overall Study|intolerant of side effects|0|||
33477515|NCT01315132|101643192|FG000|Overall Study|not treated due to disease progression|1|||
33477516|NCT04645966|101643193|FG000|Vaccination Phase|Adverse Event|1|||
33477517|NCT04645966|101643194|FG001|Vaccination Phase|Adverse Event|0|||
33477518|NCT04645966|101643195|FG002|Vaccination Phase|Adverse Event|0|||
33477519|NCT04645966|101643196|FG003|Vaccination Phase|Adverse Event|0|||
33477520|NCT04645966|101643197|FG004|Vaccination Phase|Adverse Event|0|||
33477521|NCT04645966|101643198|FG005|Vaccination Phase|Adverse Event|0|||
33477522|NCT04645966|101643199|FG006|Vaccination Phase|Adverse Event|1|||
33477523|NCT04645966|101643200|FG007|Vaccination Phase|Adverse Event|0|||
33477524|NCT04645966|101643201|FG008|Vaccination Phase|Adverse Event|0|||
33477525|NCT04645966|101643193|FG000|Vaccination Phase|Death|0|||
33477526|NCT04645966|101643194|FG001|Vaccination Phase|Death|0|||
33477527|NCT04645966|101643195|FG002|Vaccination Phase|Death|0|||
33477528|NCT04645966|101643196|FG003|Vaccination Phase|Death|0|||
33477529|NCT04645966|101643197|FG004|Vaccination Phase|Death|0|||
33477530|NCT04645966|101643198|FG005|Vaccination Phase|Death|1|||
33477531|NCT04645966|101643199|FG006|Vaccination Phase|Death|0|||
33477532|NCT04645966|101643200|FG007|Vaccination Phase|Death|0|||
33268398|NCT01728324|100880768|FG002|Termination of RBV|Other than stated|1|||
33268399|NCT01728324|100880766|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
33268400|NCT01728324|100880767|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
33477533|NCT04645966|101643201|FG008|Vaccination Phase|Death|0|||
33477534|NCT04645966|101643193|FG000|Vaccination Phase|Protocol Violation|0|||
33477535|NCT04645966|101643194|FG001|Vaccination Phase|Protocol Violation|0|||
33477536|NCT04645966|101643195|FG002|Vaccination Phase|Protocol Violation|0|||
33477537|NCT04645966|101643196|FG003|Vaccination Phase|Protocol Violation|0|||
33477538|NCT04645966|101643197|FG004|Vaccination Phase|Protocol Violation|1|||
33477539|NCT04645966|101643198|FG005|Vaccination Phase|Protocol Violation|0|||
33477540|NCT04645966|101643199|FG006|Vaccination Phase|Protocol Violation|0|||
33477541|NCT04645966|101643200|FG007|Vaccination Phase|Protocol Violation|0|||
33477542|NCT04645966|101643201|FG008|Vaccination Phase|Protocol Violation|0|||
33477543|NCT04645966|101643193|FG000|Vaccination Phase|Study terminated by sponsor|0|||
33477544|NCT04645966|101643194|FG001|Vaccination Phase|Study terminated by sponsor|0|||
33268401|NCT01728324|100880768|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
33268402|NCT01728324|100880766|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
33268403|NCT01728324|100880767|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
33268404|NCT01728324|100880768|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
33268405|NCT04660799|100880769|FG000|Overall Study|Progressive Disease|1|||
33268406|NCT04660799|100880770|FG001|Overall Study|Progressive Disease|1|||
33268407|NCT04660799|100880769|FG000|Overall Study|Death|2|||
33268408|NCT04660799|100880770|FG001|Overall Study|Death|1|||
33268409|NCT04660799|100880769|FG000|Overall Study|Adverse Event|2|||
33268410|NCT04660799|100880770|FG001|Overall Study|Adverse Event|1|||
33477545|NCT04645966|101643195|FG002|Vaccination Phase|Study terminated by sponsor|14|||
33268411|NCT04660799|100880769|FG000|Overall Study|Withdrawal by Subject|2|||
33477546|NCT04645966|101643196|FG003|Vaccination Phase|Study terminated by sponsor|15|||
33477547|NCT04645966|101643197|FG004|Vaccination Phase|Study terminated by sponsor|47|||
33477548|NCT04645966|101643198|FG005|Vaccination Phase|Study terminated by sponsor|43|||
33477549|NCT04645966|101643199|FG006|Vaccination Phase|Study terminated by sponsor|29|||
33477550|NCT04645966|101643200|FG007|Vaccination Phase|Study terminated by sponsor|29|||
33477551|NCT04645966|101643201|FG008|Vaccination Phase|Study terminated by sponsor|12|||
33477552|NCT04645966|101643193|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
33477553|NCT04645966|101643194|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
33268412|NCT04660799|100880770|FG001|Overall Study|Withdrawal by Subject|5|||
33268413|NCT03131713|100880783|FG000|Overall Study|Lost to Follow-up|5|||
33268414|NCT03131713|100880784|FG001|Overall Study|Lost to Follow-up|0|||
33268415|NCT00019604|100880785|FG000|Overall Study|Death|1|||
33268416|NCT00019604|100880785|FG000|Overall Study|Progressive disease|23|||
33268417|NCT00019604|100880785|FG000|Overall Study|Refused treatment|1|||
33268418|NCT00019604|100880785|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
33268419|NCT00019604|100880785|FG000|Overall Study|Going to have liver transplant|1|||
33268420|NCT00019604|100880785|FG000|Overall Study|Move to a different study|1|||
33268421|NCT00019604|100880785|FG000|Overall Study|Non compliant on systemic CH|1|||
33268422|NCT00019604|100880785|FG000|Overall Study|Non compliant|1|||
33268423|NCT00019604|100880785|FG000|Overall Study|Resectable disease|1|||
33268424|NCT00019604|100880785|FG000|Overall Study|Started new chemo regimen|1|||
33268425|NCT00019604|100880785|FG000|Overall Study|Pt going to immunotherapy study|1|||
33268426|NCT00019604|100880785|FG000|Overall Study|Too much disease|1|||
33268427|NCT00019604|100880785|FG000|Overall Study|Unable to evaluate|1|||
33268428|NCT00019604|100880785|FG000|Overall Study|Details for other not available|4|||
33268429|NCT02442622|100880795|FG000|Overall Study|Withdrawal by Subject|3|||
33268430|NCT02442622|100880796|FG001|Overall Study|Withdrawal by Subject|1|||
33268431|NCT00667017|100880799|FG000|Overall Study|Withdrawal by Subject|1|||
33268432|NCT02744066|100880802|FG000|Overall Study|Withdrawal by parent|0|||
33268433|NCT02744066|100880803|FG001|Overall Study|Withdrawal by parent|1|||
33268434|NCT02744066|100880802|FG000|Overall Study|Discharged from NICU prior to completion|0|||
33268435|NCT02744066|100880803|FG001|Overall Study|Discharged from NICU prior to completion|4|||
33268436|NCT00597376|100880806|FG000|Overall Study|Withdrawal by Subject|4|||
33268437|NCT00597376|100880807|FG001|Overall Study|Withdrawal by Subject|3|||
33268438|NCT00597376|100880806|FG000|Overall Study|Adverse Event|4|||
33268439|NCT00597376|100880807|FG001|Overall Study|Adverse Event|1|||
33268440|NCT01794299|100880808|FG000|Overall Study|ATIR manufacturing not possible|1|||
33268441|NCT01794299|100880808|FG000|Overall Study|Death|14|||
33268442|NCT01794299|100880808|FG000|Overall Study|Graft failure|1|||
33268443|NCT01794299|100880808|FG000|Overall Study|ATIR batch rejected|2|||
33268444|NCT01794299|100880808|FG000|Overall Study|Relapse|2|||
33268445|NCT01794299|100880808|FG000|Overall Study|Discontinued from active follow-up|1|||
33477554|NCT04645966|101643195|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
33268446|NCT01794299|100880808|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
33268447|NCT02542696|100880812|FG000|Overall Study|Adverse Event|167|||
33268448|NCT02542696|100880812|FG000|Overall Study|Lack of Efficacy|26|||
33268449|NCT02542696|100880812|FG000|Overall Study|Lost to Follow-up|6|||
33268450|NCT02542696|100880812|FG000|Overall Study|Withdrawal by Subject|104|||
33477555|NCT04645966|101643196|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
33477556|NCT04645966|101643197|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
33477557|NCT04645966|101643198|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
33477558|NCT04645966|101643199|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
33477559|NCT04645966|101643200|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
33268451|NCT02542696|100880812|FG000|Overall Study|Protocol Violation|5|||
33268452|NCT02542696|100880812|FG000|Overall Study|Death|8|||
33268453|NCT02542696|100880812|FG000|Overall Study|DECREASED OFF TIME|1|||
33268454|NCT02542696|100880812|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
33268455|NCT02542696|100880812|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
33268456|NCT02542696|100880812|FG000|Overall Study|MEDICAL HISTORY|1|||
33268457|NCT02542696|100880812|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
33268458|NCT02542696|100880812|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
33268459|NCT02542696|100880812|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
33268460|NCT02542696|100880812|FG000|Overall Study|SPONSOR DECISION|3|||
33268461|NCT02542696|100880812|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
33268462|NCT02542696|100880812|FG000|Overall Study|SUBJECT DECISION|2|||
33477560|NCT04645966|101643201|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
33477561|NCT04645966|101643193|FG000|Vaccination Phase|Other|0|||
33477562|NCT04645966|101643194|FG001|Vaccination Phase|Other|0|||
33477563|NCT04645966|101643195|FG002|Vaccination Phase|Other|0|||
33477564|NCT04645966|101643196|FG003|Vaccination Phase|Other|0|||
33477565|NCT04645966|101643197|FG004|Vaccination Phase|Other|0|||
33477566|NCT04645966|101643198|FG005|Vaccination Phase|Other|2|||
33268463|NCT02085941|100880813|FG000|Overall Study|Lack of Efficacy|1|||
33268464|NCT02085941|100880814|FG001|Overall Study|Lack of Efficacy|0|||
33268465|NCT02085941|100880813|FG000|Overall Study|Death|6|||
33477567|NCT04645966|101643199|FG006|Vaccination Phase|Other|0|||
33477568|NCT04645966|101643200|FG007|Vaccination Phase|Other|0|||
33477569|NCT04645966|101643201|FG008|Vaccination Phase|Other|0|||
33477570|NCT04645966|101643193|FG000|Vaccination Phase|Lost to Follow-up|0|||
33268466|NCT02085941|100880814|FG001|Overall Study|Death|1|||
33268467|NCT02085941|100880813|FG000|Overall Study|Lost to Follow-up|1|||
33268468|NCT02085941|100880814|FG001|Overall Study|Lost to Follow-up|0|||
33268469|NCT02085941|100880813|FG000|Overall Study|Physician Decision|0|||
33268470|NCT02085941|100880814|FG001|Overall Study|Physician Decision|2|||
33268471|NCT02736188|100880815|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
33477571|NCT04645966|101643194|FG001|Vaccination Phase|Lost to Follow-up|0|||
33477572|NCT04645966|101643195|FG002|Vaccination Phase|Lost to Follow-up|0|||
33477573|NCT04645966|101643196|FG003|Vaccination Phase|Lost to Follow-up|0|||
33477574|NCT04645966|101643197|FG004|Vaccination Phase|Lost to Follow-up|0|||
33477575|NCT04645966|101643198|FG005|Vaccination Phase|Lost to Follow-up|0|||
33477576|NCT04645966|101643199|FG006|Vaccination Phase|Lost to Follow-up|0|||
33477577|NCT04645966|101643200|FG007|Vaccination Phase|Lost to Follow-up|1|||
33477578|NCT04645966|101643201|FG008|Vaccination Phase|Lost to Follow-up|0|||
33477579|NCT04645966|101643193|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
33477580|NCT04645966|101643194|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
33477581|NCT04645966|101643195|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
33477582|NCT04645966|101643196|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
33477583|NCT04645966|101643197|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
33477584|NCT04645966|101643198|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
33477585|NCT04645966|101643199|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
33477586|NCT04645966|101643200|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
33477587|NCT04645966|101643201|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
33477588|NCT04645966|101643193|FG000|Follow-up Phase|Lost to Follow-up|0|||
33477589|NCT04645966|101643194|FG001|Follow-up Phase|Lost to Follow-up|0|||
33477590|NCT04645966|101643195|FG002|Follow-up Phase|Lost to Follow-up|0|||
33477591|NCT04645966|101643196|FG003|Follow-up Phase|Lost to Follow-up|0|||
33477592|NCT04645966|101643197|FG004|Follow-up Phase|Lost to Follow-up|0|||
33477593|NCT04645966|101643198|FG005|Follow-up Phase|Lost to Follow-up|0|||
33477594|NCT04645966|101643199|FG006|Follow-up Phase|Lost to Follow-up|0|||
33477595|NCT04645966|101643200|FG007|Follow-up Phase|Lost to Follow-up|1|||
33477596|NCT04645966|101643201|FG008|Follow-up Phase|Lost to Follow-up|0|||
33477597|NCT02517463|101643202|FG000|Overall Study|Lost to Follow-up|5|||
33477598|NCT02517463|101643203|FG001|Overall Study|Lost to Follow-up|2|||
33477599|NCT00252239|101643216|FG000|Overall Study|Withdrawal by Subject|1|||
33477600|NCT00252239|101643217|FG001|Overall Study|Withdrawal by Subject|0|||
33477601|NCT00252239|101643218|FG002|Overall Study|Withdrawal by Subject|0|||
33477602|NCT00252239|101643219|FG003|Overall Study|Withdrawal by Subject|1|||
33268472|NCT02736188|100880815|FG000|Overall Study|Adverse Event|1|||
33268473|NCT02736188|100880815|FG000|Overall Study|Withdrawal by Subject|1|||
33268474|NCT02736188|100880815|FG000|Overall Study|Other|6|||
33268475|NCT02659540|100880821|FG000|Overall Study|Adverse Event|3|||
33268476|NCT02659540|100880822|FG001|Overall Study|Adverse Event|2|||
33477603|NCT00252239|101643216|FG000|Overall Study|Lost to Follow-up|0|||
33477604|NCT00252239|101643217|FG001|Overall Study|Lost to Follow-up|0|||
33477605|NCT00252239|101643218|FG002|Overall Study|Lost to Follow-up|2|||
33477606|NCT00252239|101643219|FG003|Overall Study|Lost to Follow-up|0|||
33477607|NCT01996332|101643220|FG000|Overall Study|Adverse Event|117|||
33477608|NCT01996332|101643220|FG000|Overall Study|Lack of Efficacy|1245|||
33477609|NCT01996332|101643220|FG000|Overall Study|Death|264|||
33477610|NCT01996332|101643220|FG000|Overall Study|Protocol Violation|9|||
33477611|NCT01996332|101643220|FG000|Overall Study|Withdrawal by Subject|71|||
33477612|NCT01996332|101643220|FG000|Overall Study|Other|20|||
33477613|NCT01996332|101643220|FG000|Overall Study|Clinical Deterioration|28|||
33477614|NCT01996332|101643220|FG000|Overall Study|Physician Decision|17|||
33477615|NCT01996332|101643220|FG000|Overall Study|Lost to Follow-up|34|||
33477616|NCT00619112|101643221|FG000|Overall Study|Adverse Event|1|||
33268477|NCT02659540|100880821|FG000|Overall Study|Death|1|||
33268478|NCT02659540|100880822|FG001|Overall Study|Death|0|||
33268479|NCT02659540|100880821|FG000|Overall Study|Progressive disease|2|||
33268480|NCT02659540|100880822|FG001|Overall Study|Progressive disease|6|||
33268481|NCT01229176|100880823|FG000|Overall Study|Withdrawal by Subject|0|||
33268482|NCT01229176|100880824|FG001|Overall Study|Withdrawal by Subject|0|||
33268483|NCT01229176|100880825|FG002|Overall Study|Withdrawal by Subject|0|||
33268484|NCT01229176|100880826|FG003|Overall Study|Withdrawal by Subject|1|||
33268485|NCT01229176|100880827|FG004|Overall Study|Withdrawal by Subject|1|||
33268486|NCT01229176|100880828|FG005|Overall Study|Withdrawal by Subject|1|||
33268487|NCT01229176|100880829|FG006|Overall Study|Withdrawal by Subject|0|||
33477617|NCT00619112|101643222|FG001|Overall Study|Adverse Event|2|||
33477618|NCT01268501|101643227|FG000|Overall Study|Lost to Follow-up|1|||
33477619|NCT01268501|101643227|FG000|Overall Study|Withdrawal by Subject|3|||
33477620|NCT01268501|101643227|FG000|Overall Study|Unacceptable Subjective Vision|3|||
33477621|NCT01268501|101643227|FG000|Overall Study|Handling Difficulties|2|||
33477622|NCT03301623|101643228|FG000|Overall Study|Death|3|||
33477623|NCT03301623|101643229|FG001|Overall Study|Death|1|||
33477624|NCT03301623|101643228|FG000|Overall Study|Withdrawal by Subject|11|||
33268488|NCT01229176|100880830|FG007|Overall Study|Withdrawal by Subject|1|||
33268489|NCT01229176|100880823|FG000|Overall Study|Lost to Follow-up|0|||
33268490|NCT01229176|100880824|FG001|Overall Study|Lost to Follow-up|3|||
33268491|NCT01229176|100880825|FG002|Overall Study|Lost to Follow-up|0|||
33477625|NCT03301623|101643229|FG001|Overall Study|Withdrawal by Subject|13|||
33477626|NCT03301623|101643228|FG000|Overall Study|Lost to Follow-up|3|||
33268492|NCT01229176|100880826|FG003|Overall Study|Lost to Follow-up|0|||
33477627|NCT03301623|101643229|FG001|Overall Study|Lost to Follow-up|1|||
33268493|NCT01229176|100880827|FG004|Overall Study|Lost to Follow-up|1|||
33268494|NCT01229176|100880828|FG005|Overall Study|Lost to Follow-up|1|||
33268495|NCT01229176|100880829|FG006|Overall Study|Lost to Follow-up|0|||
33268496|NCT01229176|100880830|FG007|Overall Study|Lost to Follow-up|2|||
33268497|NCT02454959|100880831|FG000|Overall Study|Protocol-Specified Criteria|3|||
33268498|NCT02454959|100880831|FG000|Overall Study|Physician Decision|1|||
33268499|NCT02454959|100880831|FG000|Overall Study|Withdrawal by Subject|3|||
33268500|NCT02454959|100880831|FG000|Overall Study|Adverse Event|2|||
33268501|NCT01228734|100880832|FG000|Overall Study|Randomized, but not treated|0|||
33268502|NCT01228734|100880833|FG001|Overall Study|Randomized, but not treated|4|||
33268503|NCT02165202|100880834|FG000|Oral Phase|Refused further participation|5|||
33268504|NCT02165202|100880835|FG001|Oral Phase|Refused further participation|1|||
33268505|NCT02165202|100880834|FG000|Oral Phase|Study product Related Toxicity|1|||
33268506|NCT02165202|100880835|FG001|Oral Phase|Study product Related Toxicity|0|||
33268507|NCT02165202|100880834|FG000|Oral Phase|Unable to contact Participant|1|||
33268508|NCT02165202|100880835|FG001|Oral Phase|Unable to contact Participant|1|||
33268509|NCT02165202|100880834|FG000|Oral Phase|Clinical reasons|1|||
33268510|NCT02165202|100880835|FG001|Oral Phase|Clinical reasons|0|||
33268511|NCT02165202|100880834|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
33268512|NCT02165202|100880835|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
33268513|NCT02165202|100880834|FG000|Oral Phase|CMC advised termination|1|||
33477628|NCT02885181|101643230|FG000|Overall Study|Investigator's Discretion|0|||
33477629|NCT02885181|101643231|FG001|Overall Study|Investigator's Discretion|1|||
33477630|NCT02885181|101643232|FG002|Overall Study|Investigator's Discretion|0|||
33477631|NCT02885181|101643233|FG003|Overall Study|Investigator's Discretion|1|||
33477632|NCT02885181|101643230|FG000|Overall Study|Adverse Event|0|||
33477633|NCT02885181|101643231|FG001|Overall Study|Adverse Event|0|||
33477634|NCT02885181|101643232|FG002|Overall Study|Adverse Event|0|||
33477635|NCT02885181|101643233|FG003|Overall Study|Adverse Event|1|||
33477636|NCT02885181|101643230|FG000|Overall Study|Withdrawal by Subject|0|||
33477637|NCT02885181|101643231|FG001|Overall Study|Withdrawal by Subject|0|||
33477638|NCT02885181|101643232|FG002|Overall Study|Withdrawal by Subject|0|||
33477639|NCT02885181|101643233|FG003|Overall Study|Withdrawal by Subject|1|||
33477640|NCT02564211|101643234|FG000|Overall Study|Adverse Event|4|||
33477641|NCT03654599|101643235|FG000|Overall Study|Lost to Follow-up|14|||
33477642|NCT03654599|101643236|FG001|Overall Study|Lost to Follow-up|12|||
33477643|NCT03654599|101643235|FG000|Overall Study|Death|8|||
33477644|NCT03654599|101643236|FG001|Overall Study|Death|6|||
33477645|NCT03654599|101643235|FG000|Overall Study|Withdrawal by Subject|6|||
33477646|NCT03654599|101643236|FG001|Overall Study|Withdrawal by Subject|4|||
33477647|NCT03469336|101643237|FG000|Overall Study|Adverse Event|1|||
33477648|NCT04844762|101643238|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
33477649|NCT04844762|101643239|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
33477650|NCT04844762|101643240|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
33477651|NCT04844762|101643241|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
33477652|NCT04844762|101643242|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
33477653|NCT04844762|101643243|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
33477654|NCT04844762|101643238|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
33477655|NCT04844762|101643239|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
33477656|NCT04844762|101643240|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
33477657|NCT04844762|101643241|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
33477658|NCT04844762|101643242|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
33477659|NCT04844762|101643243|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
33477660|NCT04844762|101643238|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
33477661|NCT04844762|101643239|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
33477662|NCT04844762|101643240|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
33477663|NCT04844762|101643241|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
33477664|NCT04844762|101643242|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
33477665|NCT04844762|101643243|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
33477666|NCT04844762|101643238|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
33477667|NCT04844762|101643239|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
33477668|NCT04844762|101643240|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
33268514|NCT02165202|100880835|FG001|Oral Phase|CMC advised termination|0|||
33477669|NCT04844762|101643241|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
33477670|NCT04844762|101643242|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
33477671|NCT04844762|101643243|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
33268515|NCT02165202|100880834|FG000|Oral Phase|Relocated, no follow-up planned|1|||
33268516|NCT02165202|100880835|FG001|Oral Phase|Relocated, no follow-up planned|0|||
33268517|NCT02165202|100880834|FG000|Oral Phase|Abnormal EKG|0|||
33268518|NCT02165202|100880835|FG001|Oral Phase|Abnormal EKG|1|||
33268519|NCT02165202|100880834|FG000|Injection Phase|Abnormal Lab Value|5|||
33268520|NCT02165202|100880835|FG001|Injection Phase|Abnormal Lab Value|1|||
33477672|NCT04844762|101643238|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
33477673|NCT04844762|101643239|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
33477674|NCT04844762|101643240|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
33477675|NCT04844762|101643241|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
33477676|NCT04844762|101643242|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
33477677|NCT04844762|101643243|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
33477678|NCT04844762|101643238|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
33477679|NCT04844762|101643239|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
33477680|NCT04844762|101643240|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
33477681|NCT04844762|101643241|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
33477682|NCT04844762|101643242|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
33477683|NCT04844762|101643243|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
33477684|NCT04844762|101643238|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
33477685|NCT04844762|101643239|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
33477686|NCT04844762|101643240|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
33477687|NCT04844762|101643241|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
33477688|NCT04844762|101643242|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
33477689|NCT04844762|101643243|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
33477690|NCT04844762|101643238|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
33477691|NCT04844762|101643239|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
33477692|NCT04844762|101643240|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
33477693|NCT04844762|101643241|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
33477694|NCT04844762|101643242|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
33477695|NCT04844762|101643243|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
33477696|NCT04844762|101643238|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
33477697|NCT04844762|101643239|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
33477698|NCT04844762|101643240|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
33477699|NCT04844762|101643241|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
33477700|NCT04844762|101643242|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
33477701|NCT04844762|101643243|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
33477702|NCT04844762|101643238|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
33477703|NCT04844762|101643239|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
33477704|NCT04844762|101643240|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
33477705|NCT04844762|101643241|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
33477706|NCT04844762|101643242|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
33477707|NCT04844762|101643243|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
33477708|NCT04844762|101643238|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
33477709|NCT04844762|101643239|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
33477710|NCT04844762|101643240|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
33477711|NCT04844762|101643241|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
33477712|NCT04844762|101643242|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
33477713|NCT04844762|101643243|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
33477714|NCT04428333|101643244|FG000|Overall Study|Physician Decision|5|||
33477715|NCT04428333|101643245|FG001|Overall Study|Physician Decision|6|||
33477716|NCT04428333|101643244|FG000|Overall Study|Withdrawal by Subject|1|||
33477717|NCT04428333|101643245|FG001|Overall Study|Withdrawal by Subject|3|||
33477718|NCT04428333|101643244|FG000|Overall Study|Study Terminated By Sponsor|14|||
33477719|NCT04428333|101643245|FG001|Overall Study|Study Terminated By Sponsor|16|||
33477720|NCT01687478|101643257|FG000|Overall Study|Adverse Event|3|||
33477721|NCT01687478|101643258|FG001|Overall Study|Adverse Event|10|||
33477722|NCT01687478|101643257|FG000|Overall Study|Lost to Follow-up|1|||
33477723|NCT01687478|101643258|FG001|Overall Study|Lost to Follow-up|3|||
33477724|NCT01687478|101643257|FG000|Overall Study|Protocol Violation|0|||
33477725|NCT01687478|101643258|FG001|Overall Study|Protocol Violation|2|||
33477726|NCT01687478|101643257|FG000|Overall Study|Withdrawal by Subject|21|||
33477727|NCT01687478|101643258|FG001|Overall Study|Withdrawal by Subject|19|||
33477728|NCT01687478|101643257|FG000|Overall Study|Physician Decision|1|||
33477729|NCT01687478|101643258|FG001|Overall Study|Physician Decision|3|||
33477730|NCT01687478|101643257|FG000|Overall Study|Entry Criteria Not Met|6|||
33477731|NCT01687478|101643258|FG001|Overall Study|Entry Criteria Not Met|2|||
33477732|NCT04495283|101643259|FG000|Overall Study|Physician Decision|0|||
33477733|NCT04495283|101643260|FG001|Overall Study|Physician Decision|0|||
33477734|NCT04495283|101643261|FG002|Overall Study|Physician Decision|1|||
33477735|NCT04495283|101643259|FG000|Overall Study|Withdrawal by Subject|0|||
33268521|NCT02165202|100880834|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
33268522|NCT02165202|100880835|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
33268523|NCT02165202|100880834|FG000|Injection Phase|Unable to attend within Visit Window|1|||
33268524|NCT02165202|100880835|FG001|Injection Phase|Unable to attend within Visit Window|0|||
33477736|NCT04495283|101643260|FG001|Overall Study|Withdrawal by Subject|1|||
33477737|NCT04495283|101643261|FG002|Overall Study|Withdrawal by Subject|1|||
33477738|NCT04495283|101643259|FG000|Overall Study|Other|1|||
33477739|NCT04495283|101643260|FG001|Overall Study|Other|0|||
33477740|NCT04495283|101643261|FG002|Overall Study|Other|1|||
33477741|NCT01957176|101643262|FG000|Overall Study|Adverse Event|2|||
33477742|NCT01957176|101643263|FG001|Overall Study|Adverse Event|0|||
33477743|NCT01957176|101643262|FG000|Overall Study|Physician Decision|2|||
33477744|NCT01957176|101643263|FG001|Overall Study|Physician Decision|1|||
33477745|NCT01957176|101643262|FG000|Overall Study|Withdrawal by Subject|1|||
33477746|NCT01957176|101643263|FG001|Overall Study|Withdrawal by Subject|0|||
33477747|NCT00616629|101643264|FG000|Overall Study|Protocol Violation|1|||
33477748|NCT00616629|101643265|FG001|Overall Study|Protocol Violation|2|||
33477749|NCT00616629|101643266|FG002|Overall Study|Protocol Violation|1|||
33477750|NCT00616629|101643267|FG003|Overall Study|Protocol Violation|0|||
33477751|NCT00616629|101643268|FG004|Overall Study|Protocol Violation|0|||
33477752|NCT00616629|101643264|FG000|Overall Study|AV-block|1|||
33477753|NCT00616629|101643265|FG001|Overall Study|AV-block|0|||
33477754|NCT00616629|101643266|FG002|Overall Study|AV-block|0|||
33477755|NCT00616629|101643267|FG003|Overall Study|AV-block|0|||
33477756|NCT00616629|101643268|FG004|Overall Study|AV-block|0|||
33477757|NCT02325518|101643269|FG000|Overall Study|Adverse Event|4|||
33477758|NCT02325518|101643270|FG001|Overall Study|Adverse Event|1|||
33477759|NCT02325518|101643269|FG000|Overall Study|Physician Decision|0|||
33477760|NCT02325518|101643270|FG001|Overall Study|Physician Decision|1|||
33477761|NCT02325518|101643269|FG000|Overall Study|Withdrawal by Subject|0|||
33477762|NCT02325518|101643270|FG001|Overall Study|Withdrawal by Subject|1|||
33477763|NCT03052127|101643271|FG000|Overall Study|Withdrawal by Subject|0|||
33477764|NCT03052127|101643272|FG001|Overall Study|Withdrawal by Subject|0|||
33477765|NCT03052127|101643273|FG002|Overall Study|Withdrawal by Subject|0|||
33477766|NCT03052127|101643274|FG003|Overall Study|Withdrawal by Subject|0|||
33477767|NCT03052127|101643275|FG004|Overall Study|Withdrawal by Subject|0|||
33477768|NCT03052127|101643276|FG005|Overall Study|Withdrawal by Subject|0|||
33477769|NCT03052127|101643277|FG006|Overall Study|Withdrawal by Subject|0|||
33477770|NCT03052127|101643278|FG007|Overall Study|Withdrawal by Subject|1|||
33477771|NCT03052127|101643279|FG008|Overall Study|Withdrawal by Subject|1|||
33477772|NCT03052127|101643280|FG009|Overall Study|Withdrawal by Subject|1|||
33477773|NCT03052127|101643281|FG010|Overall Study|Withdrawal by Subject|0|||
33477774|NCT03052127|101643282|FG011|Overall Study|Withdrawal by Subject|0|||
33477775|NCT03052127|101643271|FG000|Overall Study|Discontinuation by Sponsor|0|||
33477776|NCT03052127|101643272|FG001|Overall Study|Discontinuation by Sponsor|0|||
33477777|NCT03052127|101643273|FG002|Overall Study|Discontinuation by Sponsor|0|||
33477778|NCT03052127|101643274|FG003|Overall Study|Discontinuation by Sponsor|0|||
33268525|NCT02165202|100880834|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
33268526|NCT02165202|100880835|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
33268527|NCT02165202|100880834|FG000|Injection Phase|End of Study|2|||
33268528|NCT02165202|100880835|FG001|Injection Phase|End of Study|1|||
33268529|NCT02165202|100880834|FG000|Injection Phase|Study Product related Toxicity|1|||
33268530|NCT02165202|100880835|FG001|Injection Phase|Study Product related Toxicity|0|||
33268531|NCT02165202|100880834|FG000|Injection Phase|No longer interested|0|||
33268532|NCT02165202|100880835|FG001|Injection Phase|No longer interested|1|||
33268533|NCT02165202|100880834|FG000|Injection Phase|Participant unwilling to comply|1|||
33268534|NCT02165202|100880835|FG001|Injection Phase|Participant unwilling to comply|0|||
33268535|NCT01380145|100884226|FG000|Overall Study|Progressive disease|4|||
33268536|NCT03418922|100884227|FG000|Overall Study|Withdrawal by Subject|0|||
33268537|NCT03418922|100884228|FG001|Overall Study|Withdrawal by Subject|2|||
33268538|NCT03418922|100884227|FG000|Overall Study|Adverse Event|2|||
33268539|NCT03418922|100884228|FG001|Overall Study|Adverse Event|2|||
33268540|NCT03418922|100884227|FG000|Overall Study|Death|0|||
33268541|NCT03418922|100884228|FG001|Overall Study|Death|1|||
33268542|NCT03418922|100884227|FG000|Overall Study|Physician Decision|0|||
33268543|NCT03418922|100884228|FG001|Overall Study|Physician Decision|1|||
33268544|NCT00337610|100884230|FG000|Overall Study|Adverse Event|2|||
33268545|NCT00337610|100884231|FG001|Overall Study|Adverse Event|2|||
33268546|NCT00337610|100884230|FG000|Overall Study|Death|0|||
33268547|NCT00337610|100884231|FG001|Overall Study|Death|1|||
33268548|NCT00337610|100884230|FG000|Overall Study|Lack of Efficacy|6|||
33268549|NCT00337610|100884231|FG001|Overall Study|Lack of Efficacy|3|||
33268550|NCT00337610|100884230|FG000|Overall Study|Lost to Follow-up|3|||
33268551|NCT00337610|100884231|FG001|Overall Study|Lost to Follow-up|3|||
33477779|NCT03052127|101643275|FG004|Overall Study|Discontinuation by Sponsor|0|||
33477780|NCT03052127|101643276|FG005|Overall Study|Discontinuation by Sponsor|0|||
33477781|NCT03052127|101643277|FG006|Overall Study|Discontinuation by Sponsor|0|||
33477782|NCT03052127|101643278|FG007|Overall Study|Discontinuation by Sponsor|0|||
33477783|NCT03052127|101643279|FG008|Overall Study|Discontinuation by Sponsor|4|||
33477784|NCT03052127|101643280|FG009|Overall Study|Discontinuation by Sponsor|2|||
33268552|NCT00337610|100884230|FG000|Overall Study|Withdrawal by Subject|6|||
33268553|NCT00337610|100884231|FG001|Overall Study|Withdrawal by Subject|5|||
33477785|NCT03052127|101643281|FG010|Overall Study|Discontinuation by Sponsor|5|||
33477786|NCT03052127|101643282|FG011|Overall Study|Discontinuation by Sponsor|13|||
33477787|NCT03052127|101643271|FG000|Overall Study|Inability to comply with trial requirements|0|||
33477788|NCT03052127|101643272|FG001|Overall Study|Inability to comply with trial requirements|0|||
33477789|NCT03052127|101643273|FG002|Overall Study|Inability to comply with trial requirements|1|||
33477790|NCT03052127|101643274|FG003|Overall Study|Inability to comply with trial requirements|0|||
33477791|NCT03052127|101643275|FG004|Overall Study|Inability to comply with trial requirements|0|||
33477792|NCT03052127|101643276|FG005|Overall Study|Inability to comply with trial requirements|0|||
33477793|NCT03052127|101643277|FG006|Overall Study|Inability to comply with trial requirements|0|||
33477794|NCT03052127|101643278|FG007|Overall Study|Inability to comply with trial requirements|0|||
33477795|NCT03052127|101643279|FG008|Overall Study|Inability to comply with trial requirements|0|||
33477796|NCT03052127|101643280|FG009|Overall Study|Inability to comply with trial requirements|0|||
33477797|NCT03052127|101643281|FG010|Overall Study|Inability to comply with trial requirements|0|||
33477798|NCT03052127|101643282|FG011|Overall Study|Inability to comply with trial requirements|0|||
33477799|NCT03052127|101643271|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
33477800|NCT03052127|101643272|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
33477801|NCT03052127|101643273|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
33477802|NCT03052127|101643274|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
33477803|NCT03052127|101643275|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
33477804|NCT03052127|101643276|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
33477805|NCT03052127|101643277|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
33477806|NCT03052127|101643278|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
33477807|NCT03052127|101643279|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
33268554|NCT03775213|100884237|FG000|Overall Study|Withdrawal by Subject|51|||
33268555|NCT03775213|100884238|FG001|Overall Study|Withdrawal by Subject|53|||
33268556|NCT03775213|100884237|FG000|Overall Study|Incomplete Survey|7|||
33268557|NCT03775213|100884238|FG001|Overall Study|Incomplete Survey|7|||
33268558|NCT00357994|100884241|FG000|Overall Study|Adverse Event|1|||
33268559|NCT00357994|100884242|FG001|Overall Study|Adverse Event|2|||
33268560|NCT00357994|100884241|FG000|Overall Study|Lack of Efficacy|0|||
33268561|NCT00357994|100884242|FG001|Overall Study|Lack of Efficacy|1|||
33268562|NCT00357994|100884241|FG000|Overall Study|Protocol Violation|1|||
33268563|NCT00357994|100884242|FG001|Overall Study|Protocol Violation|0|||
33268564|NCT00220805|100884245|FG000|Overall Study|Adverse Event|1|||
33268565|NCT00220805|100884246|FG001|Overall Study|Adverse Event|3|||
33268566|NCT00220805|100884245|FG000|Overall Study|Withdrawal by Subject|3|||
33268567|NCT00220805|100884246|FG001|Overall Study|Withdrawal by Subject|0|||
33268568|NCT00220805|100884245|FG000|Overall Study|Lack of Efficacy|1|||
33268569|NCT00220805|100884246|FG001|Overall Study|Lack of Efficacy|0|||
33268570|NCT00220805|100884245|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
33268571|NCT00220805|100884246|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
33268572|NCT03005106|100884247|FG000|Overall Study|Lost to Follow-up|16|||
33268573|NCT03005106|100884247|FG000|Overall Study|Adverse Event|1|||
33268574|NCT03005106|100884247|FG000|Overall Study|Physician Decision|1|||
33268575|NCT03005106|100884247|FG000|Overall Study|Death|2|||
33268576|NCT00681109|100884249|FG000|Overall Study|Lost to Follow-up|2|||
33268577|NCT00681109|100884250|FG001|Overall Study|Lost to Follow-up|6|||
33268578|NCT00681109|100884251|FG002|Overall Study|Lost to Follow-up|0|||
33268579|NCT00761267|100884252|FG000|Overall Study|Death|1|||
33268580|NCT00761267|100884253|FG001|Overall Study|Death|2|||
33268581|NCT00761267|100884254|FG002|Overall Study|Death|5|||
33268582|NCT00761267|100884252|FG000|Overall Study|Lost to Follow-up|0|||
33268583|NCT00761267|100884253|FG001|Overall Study|Lost to Follow-up|0|||
33268584|NCT00761267|100884254|FG002|Overall Study|Lost to Follow-up|1|||
33268585|NCT00761267|100884252|FG000|Overall Study|Randomized but not treated|1|||
33268586|NCT00761267|100884253|FG001|Overall Study|Randomized but not treated|1|||
33268587|NCT00761267|100884254|FG002|Overall Study|Randomized but not treated|0|||
33268588|NCT00761267|100884252|FG000|Overall Study|Withdrawal by Subject|0|||
33268589|NCT00761267|100884253|FG001|Overall Study|Withdrawal by Subject|1|||
33268590|NCT00761267|100884254|FG002|Overall Study|Withdrawal by Subject|0|||
33477808|NCT03052127|101643280|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
33477809|NCT03052127|101643281|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
33477810|NCT03052127|101643282|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
33268591|NCT03137784|100884259|FG000|Overall Study|Adverse Event|1|||
33268592|NCT03137784|100884260|FG001|Overall Study|Adverse Event|1|||
33268593|NCT03137784|100884261|FG002|Overall Study|Adverse Event|0|||
33268594|NCT03137784|100884262|FG003|Overall Study|Adverse Event|0|||
33268595|NCT03137784|100884263|FG004|Overall Study|Adverse Event|0|||
33268596|NCT03137784|100884264|FG005|Overall Study|Adverse Event|0|||
33268597|NCT03137784|100884259|FG000|Overall Study|Subject/guardian decision|1|||
33268598|NCT03137784|100884260|FG001|Overall Study|Subject/guardian decision|0|||
33268599|NCT03137784|100884261|FG002|Overall Study|Subject/guardian decision|0|||
33268600|NCT03137784|100884262|FG003|Overall Study|Subject/guardian decision|0|||
33477811|NCT02447744|101643283|FG000|Overall Study|Withdrawal by Subject|3|||
33477812|NCT02447744|101643284|FG001|Overall Study|Withdrawal by Subject|1|||
33477813|NCT02447744|101643283|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
33477814|NCT02447744|101643284|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
33477815|NCT01857271|101643287|FG000|Overall Study|Lost to Follow-up|1|||
33477816|NCT02099682|101643294|FG000|Overall Study|Data Not Available|51|||
33477817|NCT02099682|101643294|FG000|Overall Study|Lost to Follow-up|31|||
33477818|NCT02099682|101643294|FG000|Overall Study|Other|29|||
33477819|NCT02140411|101643298|FG000|Overall Study|Adverse Event|1|||
33477820|NCT00699374|101643299|FG000|Overall Study|Death|93|||
33477821|NCT00699374|101643300|FG001|Overall Study|Death|83|||
33477822|NCT00699374|101643299|FG000|Overall Study|Adverse Event|70|||
33477823|NCT00699374|101643300|FG001|Overall Study|Adverse Event|67|||
33477824|NCT00699374|101643299|FG000|Overall Study|Global deterioration of health status|7|||
33477825|NCT00699374|101643300|FG001|Overall Study|Global deterioration of health status|8|||
33477826|NCT00699374|101643299|FG000|Overall Study|Lost to Follow-up|3|||
33477827|NCT00699374|101643300|FG001|Overall Study|Lost to Follow-up|5|||
33477828|NCT00699374|101643299|FG000|Overall Study|Withdrawal by Subject|34|||
33477829|NCT00699374|101643300|FG001|Overall Study|Withdrawal by Subject|44|||
33477830|NCT00699374|101643299|FG000|Overall Study|Objective progression or relapse|281|||
33477831|NCT00699374|101643300|FG001|Overall Study|Objective progression or relapse|277|||
33477832|NCT00699374|101643299|FG000|Overall Study|Other|18|||
33477833|NCT00699374|101643300|FG001|Overall Study|Other|15|||
33477834|NCT00699374|101643299|FG000|Overall Study|Protocol Violation|2|||
33477835|NCT00699374|101643300|FG001|Overall Study|Protocol Violation|6|||
33477836|NCT00699374|101643299|FG000|Overall Study|Study terminated by sponsor|13|||
33268601|NCT03137784|100884263|FG004|Overall Study|Subject/guardian decision|0|||
33268602|NCT03137784|100884264|FG005|Overall Study|Subject/guardian decision|0|||
33268603|NCT03137784|100884259|FG000|Overall Study|Non-compliance with study treatment|0|||
33268604|NCT03137784|100884260|FG001|Overall Study|Non-compliance with study treatment|0|||
33268605|NCT03137784|100884261|FG002|Overall Study|Non-compliance with study treatment|0|||
33268606|NCT03137784|100884262|FG003|Overall Study|Non-compliance with study treatment|0|||
33268607|NCT03137784|100884263|FG004|Overall Study|Non-compliance with study treatment|1|||
33268608|NCT03137784|100884264|FG005|Overall Study|Non-compliance with study treatment|0|||
33477837|NCT00699374|101643300|FG001|Overall Study|Study terminated by sponsor|28|||
33477838|NCT00699374|101643299|FG000|Overall Study|Randomized but not treated|4|||
33477839|NCT00699374|101643300|FG001|Overall Study|Randomized but not treated|2|||
33477840|NCT00699374|101643299|FG000|Overall Study|Died 28 days after last dose|5|||
33477841|NCT00699374|101643300|FG001|Overall Study|Died 28 days after last dose|9|||
33477842|NCT04305587|101643304|FG000|Overall Study|Withdrawal by Subject|0|||
33477843|NCT04305587|101643305|FG001|Overall Study|Withdrawal by Subject|0|||
33477844|NCT04305587|101643306|FG002|Overall Study|Withdrawal by Subject|0|||
33477845|NCT04305587|101643307|FG003|Overall Study|Withdrawal by Subject|1|||
33268609|NCT00240994|100884266|FG000|Overall Study|Lost to Follow-up|1|||
33268610|NCT00240994|100884266|FG000|Overall Study|Protocol Violation|1|||
33268611|NCT00240994|100884266|FG000|Overall Study|Graft failure|1|||
33268612|NCT03072862|100884267|FG000|Overall Study|Withdrawal by Subject|4|||
33268613|NCT03072862|100884267|FG000|Overall Study|Lost to Follow-up|6|||
33268614|NCT03072862|100884267|FG000|Overall Study|Protocol Violation|4|||
33268615|NCT03072862|100884267|FG000|Overall Study|Physician Decision|2|||
33268616|NCT03072862|100884267|FG000|Overall Study|Death|1|||
33268617|NCT03072862|100884267|FG000|Overall Study|Adverse Event|1|||
33268618|NCT01706159|100884268|FG000|Overall Study|Withdrawal Criteria|2|||
33268619|NCT01706159|100884269|FG001|Overall Study|Withdrawal Criteria|1|||
33268620|NCT01706159|100884268|FG000|Overall Study|Unclassified|6|||
33268621|NCT01706159|100884269|FG001|Overall Study|Unclassified|1|||
33268622|NCT03851094|100884276|FG000|Overall Study|Withdrawal by Subject|0|||
33268623|NCT03851094|100884277|FG001|Overall Study|Withdrawal by Subject|1|||
33268624|NCT03851094|100884276|FG000|Overall Study|Participant lost device|0|||
33268625|NCT03851094|100884277|FG001|Overall Study|Participant lost device|1|||
33268626|NCT03851094|100884276|FG000|Overall Study|Participant returned device|0|||
33268627|NCT03851094|100884277|FG001|Overall Study|Participant returned device|2|||
33268628|NCT01021748|100884286|FG000|Overall Study|Adverse Event|2|||
33268629|NCT01021748|100884287|FG001|Overall Study|Adverse Event|1|||
33268630|NCT01021748|100884288|FG002|Overall Study|Adverse Event|2|||
33477846|NCT04305587|101643308|FG004|Overall Study|Withdrawal by Subject|0|||
33268631|NCT01021748|100884289|FG003|Overall Study|Adverse Event|0|||
33268632|NCT01021748|100884290|FG004|Overall Study|Adverse Event|2|||
33268633|NCT01021748|100884291|FG005|Overall Study|Adverse Event|0|||
33268634|NCT01021748|100884292|FG006|Overall Study|Adverse Event|1|||
33268635|NCT01021748|100884293|FG007|Overall Study|Adverse Event|0|||
33268636|NCT01021748|100884294|FG008|Overall Study|Adverse Event|7|||
33268637|NCT01021748|100884286|FG000|Overall Study|Physician Decision|1|||
33477847|NCT04305587|101643309|FG005|Overall Study|Withdrawal by Subject|0|||
33477848|NCT04305587|101643310|FG006|Overall Study|Withdrawal by Subject|0|||
33477849|NCT04305587|101643311|FG007|Overall Study|Withdrawal by Subject|0|||
33477850|NCT04305587|101643312|FG008|Overall Study|Withdrawal by Subject|0|||
33477851|NCT01447420|101643313|FG000|Overall Study|Adverse Event|2|||
33477852|NCT01447420|101643314|FG001|Overall Study|Adverse Event|4|||
33477853|NCT01447420|101643315|FG002|Overall Study|Adverse Event|2|||
33477854|NCT01447420|101643313|FG000|Overall Study|Protocol Violation|3|||
33477855|NCT01447420|101643314|FG001|Overall Study|Protocol Violation|3|||
33477856|NCT01447420|101643315|FG002|Overall Study|Protocol Violation|0|||
33477857|NCT01447420|101643313|FG000|Overall Study|Withdrawal by Subject|4|||
33477858|NCT01447420|101643314|FG001|Overall Study|Withdrawal by Subject|1|||
33477859|NCT01447420|101643315|FG002|Overall Study|Withdrawal by Subject|0|||
33477860|NCT01447420|101643313|FG000|Overall Study|Lack of Efficacy|1|||
33477861|NCT01447420|101643314|FG001|Overall Study|Lack of Efficacy|19|||
33477862|NCT01447420|101643315|FG002|Overall Study|Lack of Efficacy|8|||
33477863|NCT02266134|101643316|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
33477864|NCT02266134|101643317|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
33477865|NCT02266134|101643318|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
33477866|NCT02266134|101643319|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
33477867|NCT02266134|101643316|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
33477868|NCT02266134|101643317|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
33477869|NCT02266134|101643318|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
33477870|NCT02266134|101643319|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
33477871|NCT02266134|101643316|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
33477872|NCT02266134|101643317|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
33477873|NCT02266134|101643318|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
33477874|NCT02266134|101643319|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
33477875|NCT02266134|101643316|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
33477876|NCT02266134|101643317|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
33477877|NCT02266134|101643318|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
33477878|NCT02266134|101643319|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
33477879|NCT02266134|101643316|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
33477880|NCT02266134|101643317|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
33477881|NCT02266134|101643318|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
33477882|NCT02266134|101643319|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
33477883|NCT02266134|101643316|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
33477884|NCT02266134|101643317|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
33477885|NCT02266134|101643318|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
33477886|NCT02266134|101643319|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
33477887|NCT01433549|101643320|FG000|Phase 2: Second Study Product|Adverse Event|0|||
33477888|NCT01433549|101643321|FG001|Phase 2: Second Study Product|Adverse Event|1|||
33477889|NCT04007991|101643324|FG000|Overall Study|Withdrawal by Subject|1|||
33477890|NCT04007991|101643325|FG001|Overall Study|Withdrawal by Subject|1|||
33477891|NCT04007991|101643324|FG000|Overall Study|Physician Decision|1|||
33477892|NCT04007991|101643325|FG001|Overall Study|Physician Decision|1|||
33477893|NCT04007991|101643324|FG000|Overall Study|Non-compliance with Study Drug|0|||
33477894|NCT04007991|101643325|FG001|Overall Study|Non-compliance with Study Drug|1|||
33477895|NCT04007991|101643324|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
33477896|NCT04007991|101643325|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
33477897|NCT04007991|101643324|FG000|Overall Study|Adverse event, non-fatal|5|||
33477898|NCT04007991|101643325|FG001|Overall Study|Adverse event, non-fatal|0|||
33268638|NCT01021748|100884287|FG001|Overall Study|Physician Decision|0|||
33268639|NCT01021748|100884288|FG002|Overall Study|Physician Decision|1|||
33268640|NCT01021748|100884289|FG003|Overall Study|Physician Decision|1|||
33268641|NCT01021748|100884290|FG004|Overall Study|Physician Decision|0|||
33268642|NCT01021748|100884291|FG005|Overall Study|Physician Decision|0|||
33268643|NCT01021748|100884292|FG006|Overall Study|Physician Decision|1|||
33477899|NCT04007991|101643324|FG000|Overall Study|Lost to Follow-up|2|||
33477900|NCT04007991|101643325|FG001|Overall Study|Lost to Follow-up|1|||
33477901|NCT02655666|101643326|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
33477902|NCT03151408|101643327|FG000|Overall Study|Adverse Event|24|||
33477903|NCT03151408|101643328|FG001|Overall Study|Adverse Event|23|||
33477904|NCT03151408|101643327|FG000|Overall Study|Death|46|||
33477905|NCT03151408|101643328|FG001|Overall Study|Death|26|||
33477906|NCT03151408|101643327|FG000|Overall Study|Physician Decision|13|||
33477907|NCT03151408|101643328|FG001|Overall Study|Physician Decision|19|||
33477908|NCT03151408|101643327|FG000|Overall Study|Withdrawal by Subject|16|||
33477909|NCT03151408|101643328|FG001|Overall Study|Withdrawal by Subject|20|||
33268644|NCT01021748|100884293|FG007|Overall Study|Physician Decision|1|||
33268645|NCT01021748|100884294|FG008|Overall Study|Physician Decision|2|||
33477910|NCT03151408|101643327|FG000|Overall Study|Progressive disease|45|||
33477911|NCT03151408|101643328|FG001|Overall Study|Progressive disease|61|||
33477912|NCT03151408|101643327|FG000|Overall Study|non-compliance by patient|1|||
33477913|NCT03151408|101643328|FG001|Overall Study|non-compliance by patient|0|||
33477914|NCT03151408|101643327|FG000|Overall Study|other reasons|56|||
33268646|NCT01021748|100884286|FG000|Overall Study|Progressive Disease|3|||
33268647|NCT01021748|100884287|FG001|Overall Study|Progressive Disease|3|||
33268648|NCT01021748|100884288|FG002|Overall Study|Progressive Disease|4|||
33268649|NCT01021748|100884289|FG003|Overall Study|Progressive Disease|6|||
33268650|NCT01021748|100884290|FG004|Overall Study|Progressive Disease|7|||
33268651|NCT01021748|100884291|FG005|Overall Study|Progressive Disease|3|||
33268652|NCT01021748|100884292|FG006|Overall Study|Progressive Disease|0|||
33268653|NCT01021748|100884293|FG007|Overall Study|Progressive Disease|5|||
33477915|NCT03151408|101643328|FG001|Overall Study|other reasons|52|||
33477916|NCT03151408|101643327|FG000|Overall Study|randomized and not treated|2|||
33477917|NCT03151408|101643328|FG001|Overall Study|randomized and not treated|2|||
33477918|NCT00369655|101643329|FG000|Overall Study|Refusal of further treatment|2|||
33477919|NCT02932306|101643335|FG000|Overall Study|Withdrawal by Subject|16|||
33477920|NCT02932306|101643336|FG001|Overall Study|Withdrawal by Subject|25|||
33477921|NCT02932306|101643335|FG000|Overall Study|Adverse Event|3|||
33477922|NCT02932306|101643336|FG001|Overall Study|Adverse Event|0|||
33477923|NCT02932306|101643335|FG000|Overall Study|Pregnancy|2|||
33477924|NCT02932306|101643336|FG001|Overall Study|Pregnancy|0|||
33477925|NCT02932306|101643335|FG000|Overall Study|Protocol Violation|1|||
33477926|NCT02932306|101643336|FG001|Overall Study|Protocol Violation|1|||
33477927|NCT02932306|101643335|FG000|Overall Study|Noncompliance with Study Drug|1|||
33477928|NCT02932306|101643336|FG001|Overall Study|Noncompliance with Study Drug|1|||
33477929|NCT02932306|101643335|FG000|Overall Study|Lost to Follow-up|36|||
33477930|NCT02932306|101643336|FG001|Overall Study|Lost to Follow-up|40|||
33477931|NCT02932306|101643335|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
33477932|NCT02932306|101643336|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
33477933|NCT02932306|101643335|FG000|Overall Study|Lack of Efficacy|0|||
33477934|NCT02932306|101643336|FG001|Overall Study|Lack of Efficacy|2|||
33477935|NCT02932306|101643335|FG000|Overall Study|Worsening condition|2|||
33477936|NCT02932306|101643336|FG001|Overall Study|Worsening condition|0|||
33477937|NCT02932306|101643335|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
33477938|NCT02932306|101643336|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
33477939|NCT02730351|101643339|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
33477940|NCT02730351|101643340|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
33477941|NCT02730351|101643339|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
33477942|NCT02730351|101643340|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
33477943|NCT02730351|101643339|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
33477944|NCT02730351|101643340|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
33477945|NCT02730351|101643339|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
33477946|NCT02730351|101643340|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
33477947|NCT02730351|101643339|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
33477948|NCT02730351|101643340|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
33477949|NCT00620555|101643342|FG000|Overall Study|Adverse Event|4|||
33477950|NCT00620555|101643342|FG000|Overall Study|Protocol Violation|2|||
33477951|NCT00620555|101643342|FG000|Overall Study|Lack of Efficacy|12|||
33477952|NCT00620555|101643342|FG000|Overall Study|Withdrawal by Subject|1|||
33477953|NCT00620555|101643342|FG000|Overall Study|Choice of other treatment|1|||
33477954|NCT00620555|101643342|FG000|Overall Study|Visit failure against planned|1|||
33477955|NCT00123474|101643345|FG000|Randomized to Treatment|Randomized, never treated|1|||
33477956|NCT00123474|101643346|FG001|Randomized to Treatment|Randomized, never treated|4|||
33477957|NCT00123474|101643347|FG002|Randomized to Treatment|Randomized, never treated|2|||
33477958|NCT00123474|101643348|FG003|Randomized to Treatment|Randomized, never treated|1|||
33477959|NCT00123474|101643345|FG000|As Treated at Study Closure|not reported when site closed|1|||
33477960|NCT00123474|101643346|FG001|As Treated at Study Closure|not reported when site closed|0|||
33477961|NCT00123474|101643347|FG002|As Treated at Study Closure|not reported when site closed|1|||
33477962|NCT00123474|101643348|FG003|As Treated at Study Closure|not reported when site closed|0|||
33477963|NCT00123474|101643345|FG000|As Treated at Study Closure|Adverse Event|10|||
33477964|NCT00123474|101643346|FG001|As Treated at Study Closure|Adverse Event|4|||
33477965|NCT00123474|101643347|FG002|As Treated at Study Closure|Adverse Event|10|||
33477966|NCT00123474|101643348|FG003|As Treated at Study Closure|Adverse Event|8|||
33477967|NCT00123474|101643345|FG000|As Treated at Study Closure|Disease Progression|35|||
33477968|NCT00123474|101643346|FG001|As Treated at Study Closure|Disease Progression|42|||
33477969|NCT00123474|101643347|FG002|As Treated at Study Closure|Disease Progression|29|||
33477970|NCT00123474|101643348|FG003|As Treated at Study Closure|Disease Progression|27|||
33477971|NCT00123474|101643345|FG000|As Treated at Study Closure|Investigator Request|12|||
33477972|NCT00123474|101643346|FG001|As Treated at Study Closure|Investigator Request|6|||
33477973|NCT00123474|101643347|FG002|As Treated at Study Closure|Investigator Request|7|||
33477974|NCT00123474|101643348|FG003|As Treated at Study Closure|Investigator Request|5|||
33268654|NCT01021748|100884294|FG008|Overall Study|Progressive Disease|6|||
33268655|NCT01021748|100884286|FG000|Overall Study|Withdrawal by Subject|0|||
33268656|NCT01021748|100884287|FG001|Overall Study|Withdrawal by Subject|0|||
33268657|NCT01021748|100884288|FG002|Overall Study|Withdrawal by Subject|0|||
33268658|NCT01021748|100884289|FG003|Overall Study|Withdrawal by Subject|0|||
33268659|NCT01021748|100884290|FG004|Overall Study|Withdrawal by Subject|0|||
33268660|NCT01021748|100884291|FG005|Overall Study|Withdrawal by Subject|0|||
33477975|NCT00123474|101643345|FG000|As Treated at Study Closure|non-specified|54|||
33477976|NCT00123474|101643346|FG001|As Treated at Study Closure|non-specified|47|||
33477977|NCT00123474|101643347|FG002|As Treated at Study Closure|non-specified|57|||
33477978|NCT00123474|101643348|FG003|As Treated at Study Closure|non-specified|60|||
33477979|NCT00123474|101643345|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
33477980|NCT00123474|101643346|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
33477981|NCT00123474|101643347|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
33477982|NCT00123474|101643348|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
33477983|NCT00123474|101643345|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
33477984|NCT00123474|101643346|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
33477985|NCT00123474|101643347|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
33477986|NCT00123474|101643348|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
33477987|NCT00851318|101643349|FG000|Overall Study|Withdrawal by Subject|7|||
33477988|NCT00851318|101643350|FG001|Overall Study|Withdrawal by Subject|1|||
33477989|NCT00851318|101643351|FG002|Overall Study|Withdrawal by Subject|5|||
33477990|NCT00851318|101643352|FG003|Overall Study|Withdrawal by Subject|3|||
33477991|NCT00851318|101643349|FG000|Overall Study|Adverse Event|13|||
33477992|NCT00851318|101643350|FG001|Overall Study|Adverse Event|2|||
33477993|NCT00851318|101643351|FG002|Overall Study|Adverse Event|9|||
33477994|NCT00851318|101643352|FG003|Overall Study|Adverse Event|12|||
33477995|NCT00851318|101643349|FG000|Overall Study|Pregnancy|0|||
33477996|NCT00851318|101643350|FG001|Overall Study|Pregnancy|0|||
33477997|NCT00851318|101643351|FG002|Overall Study|Pregnancy|1|||
33477998|NCT00851318|101643352|FG003|Overall Study|Pregnancy|1|||
33477999|NCT00851318|101643349|FG000|Overall Study|Lack of Efficacy|8|||
33478000|NCT00851318|101643350|FG001|Overall Study|Lack of Efficacy|2|||
33478001|NCT00851318|101643351|FG002|Overall Study|Lack of Efficacy|4|||
33478002|NCT00851318|101643352|FG003|Overall Study|Lack of Efficacy|2|||
33478003|NCT00851318|101643349|FG000|Overall Study|Non-compliance with Study Procedures|2|||
33478004|NCT00851318|101643350|FG001|Overall Study|Non-compliance with Study Procedures|0|||
33478005|NCT00851318|101643351|FG002|Overall Study|Non-compliance with Study Procedures|1|||
33478006|NCT00851318|101643352|FG003|Overall Study|Non-compliance with Study Procedures|0|||
33478007|NCT00851318|101643349|FG000|Overall Study|Physician Decision|0|||
33478008|NCT00851318|101643350|FG001|Overall Study|Physician Decision|0|||
33478009|NCT00851318|101643351|FG002|Overall Study|Physician Decision|1|||
33478010|NCT00851318|101643352|FG003|Overall Study|Physician Decision|1|||
33478011|NCT02677714|101643354|FG000|Overall Study|Withdrawal by Subject|2|||
33478012|NCT02677714|101643355|FG001|Overall Study|Withdrawal by Subject|0|||
33478013|NCT01383135|101643356|FG000|Overall Study|Not Scanned / Imaged|1|||
33478014|NCT01383135|101643357|FG001|Overall Study|Not Scanned / Imaged|0|||
33478015|NCT01383135|101643358|FG002|Overall Study|Not Scanned / Imaged|1|||
33478016|NCT01383135|101643359|FG003|Overall Study|Not Scanned / Imaged|0|||
33478017|NCT00987389|101643360|FG000|Overall Study|Ineligible|0|||
33478018|NCT00987389|101643361|FG001|Overall Study|Ineligible|3|||
33478019|NCT00987389|101643362|FG002|Overall Study|Ineligible|0|||
33478020|NCT00987389|101643363|FG003|Overall Study|Ineligible|0|||
33478021|NCT00987389|101643360|FG000|Overall Study|Lost to Follow-up|4|||
33478022|NCT00987389|101643361|FG001|Overall Study|Lost to Follow-up|1|||
33478023|NCT00987389|101643362|FG002|Overall Study|Lost to Follow-up|3|||
33478024|NCT00987389|101643363|FG003|Overall Study|Lost to Follow-up|1|||
33478025|NCT00987389|101643360|FG000|Overall Study|Withdrawal by Subject|4|||
33478026|NCT00987389|101643361|FG001|Overall Study|Withdrawal by Subject|3|||
33478027|NCT00987389|101643362|FG002|Overall Study|Withdrawal by Subject|2|||
33478028|NCT00987389|101643363|FG003|Overall Study|Withdrawal by Subject|1|||
33478029|NCT00987389|101643360|FG000|Overall Study|Withdrawn from Treatment|0|||
33478030|NCT00987389|101643361|FG001|Overall Study|Withdrawn from Treatment|1|||
33478031|NCT00987389|101643362|FG002|Overall Study|Withdrawn from Treatment|0|||
33478032|NCT00987389|101643363|FG003|Overall Study|Withdrawn from Treatment|0|||
33478033|NCT00987389|101643360|FG000|Overall Study|Multiple different reasons|1|||
33478034|NCT00987389|101643361|FG001|Overall Study|Multiple different reasons|0|||
33478035|NCT00987389|101643362|FG002|Overall Study|Multiple different reasons|3|||
33478036|NCT00987389|101643363|FG003|Overall Study|Multiple different reasons|1|||
33478037|NCT01330459|101643364|FG000|Overall Study|Physician Decision|0|||
33478038|NCT01330459|101643365|FG001|Overall Study|Physician Decision|2|||
33478039|NCT02397408|101643366|FG000|Overall Study|Physician Decision|4|||
33478040|NCT02397408|101643366|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
33478041|NCT03866902|101643373|FG000|Overall Study|Lost to Follow-up|98|||
33478042|NCT03866902|101643374|FG001|Overall Study|Lost to Follow-up|82|||
33478043|NCT03866902|101643373|FG000|Overall Study|Pregnancy|18|||
33478044|NCT03866902|101643374|FG001|Overall Study|Pregnancy|24|||
33478045|NCT03402750|101643375|FG000|Overall Study|Lost to Follow-up|2|||
33478046|NCT03402750|101643376|FG001|Overall Study|Lost to Follow-up|1|||
33478047|NCT00801099|101643378|FG000|Overall Study|Lost to Follow-up|101|||
33478048|NCT00186888|101643385|FG000|Overall Study|Toxicity|0|||
33478049|NCT00186888|101643386|FG001|Overall Study|Toxicity|1|||
33478050|NCT00186888|101643387|FG002|Overall Study|Toxicity|0|||
33478051|NCT00186888|101643385|FG000|Overall Study|Relapse or progression of disease|4|||
33478052|NCT00186888|101643386|FG001|Overall Study|Relapse or progression of disease|2|||
33268661|NCT01021748|100884292|FG006|Overall Study|Withdrawal by Subject|1|||
33268662|NCT01021748|100884293|FG007|Overall Study|Withdrawal by Subject|0|||
33268663|NCT01021748|100884294|FG008|Overall Study|Withdrawal by Subject|1|||
33268664|NCT01021748|100884286|FG000|Overall Study|Not Treated|0|||
33478053|NCT00186888|101643387|FG002|Overall Study|Relapse or progression of disease|0|||
33478054|NCT02149108|101643403|FG000|Overall Study|Not treated|1|||
33478055|NCT02149108|101643404|FG001|Overall Study|Not treated|2|||
33478056|NCT02149108|101643403|FG000|Overall Study|Progressive Disease (PD)|324|||
33478057|NCT02149108|101643404|FG001|Overall Study|Progressive Disease (PD)|318|||
33478058|NCT02149108|101643403|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
33478059|NCT02149108|101643404|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
33478060|NCT02149108|101643403|FG000|Overall Study|Other Adverse Event (AE)|8|||
33478061|NCT02149108|101643404|FG001|Overall Study|Other Adverse Event (AE)|18|||
33478062|NCT02149108|101643403|FG000|Overall Study|Other not defined above|0|||
33478063|NCT02149108|101643404|FG001|Overall Study|Other not defined above|2|||
33478064|NCT02149108|101643403|FG000|Overall Study|Refusal to continue trial medication|15|||
33478065|NCT02149108|101643404|FG001|Overall Study|Refusal to continue trial medication|11|||
33478066|NCT02149108|101643403|FG000|Overall Study|Lost to Follow-up|1|||
33478067|NCT02149108|101643404|FG001|Overall Study|Lost to Follow-up|0|||
33478068|NCT00210249|101643405|FG000|Overall Study|Lost to Follow-up|5|||
33478069|NCT00210249|101643405|FG000|Overall Study|Protocol Violation|11|||
33478070|NCT04295135|101643415|FG000|Overall Study|Withdrawal by Subject|2|||
33478071|NCT04295135|101643416|FG001|Overall Study|Withdrawal by Subject|1|||
33478072|NCT04295135|101643415|FG000|Overall Study|Subject left organization|8|||
33478073|NCT04295135|101643416|FG001|Overall Study|Subject left organization|4|||
33478074|NCT03853148|101643417|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
33478075|NCT03853148|101643418|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
33478076|NCT03853148|101643419|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
33478077|NCT03853148|101643420|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
33478078|NCT02912650|101643421|FG000|Overall Study|Withdrawal by Subject|1|||
33478079|NCT02912650|101643422|FG001|Overall Study|Withdrawal by Subject|0|||
33478080|NCT02912650|101643423|FG002|Overall Study|Withdrawal by Subject|1|||
33478081|NCT02912650|101643424|FG003|Overall Study|Withdrawal by Subject|5|||
33478082|NCT02912650|101643421|FG000|Overall Study|Adverse Event|0|||
33478083|NCT02912650|101643422|FG001|Overall Study|Adverse Event|0|||
33478084|NCT02912650|101643423|FG002|Overall Study|Adverse Event|1|||
33478085|NCT02912650|101643424|FG003|Overall Study|Adverse Event|0|||
33478086|NCT04771403|101643427|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
33478087|NCT04771403|101643428|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
33478088|NCT04771403|101643427|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
33478089|NCT04771403|101643428|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
33478090|NCT04771403|101643427|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
33478091|NCT04771403|101643428|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
33478092|NCT04771403|101643427|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
33478093|NCT04771403|101643428|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
33478094|NCT04771403|101643427|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
33478095|NCT04771403|101643428|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
33478096|NCT04771403|101643427|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
33478097|NCT04771403|101643428|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
33478098|NCT04771403|101643427|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
33478099|NCT04771403|101643428|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
33478100|NCT04771403|101643427|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
33478101|NCT04771403|101643428|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
33478102|NCT03559400|101643429|FG000|Overall Study|Lost to Follow-up|9|||
33478103|NCT03559400|101643430|FG001|Overall Study|Lost to Follow-up|7|||
33478104|NCT03559400|101643429|FG000|Overall Study|Death|0|||
33478105|NCT03559400|101643430|FG001|Overall Study|Death|2|||
33478106|NCT01473524|101643438|FG000|DB Phase|Adverse Event|4|||
33478107|NCT01473524|101643439|FG001|DB Phase|Adverse Event|8|||
33478108|NCT01473524|101643440|FG002|DB Phase|Adverse Event|2|||
33478109|NCT01473524|101643441|FG003|DB Phase|Adverse Event|0|||
33478110|NCT01473524|101643442|FG004|DB Phase|Adverse Event|0|||
33268665|NCT01021748|100884287|FG001|Overall Study|Not Treated|1|||
33268666|NCT01021748|100884288|FG002|Overall Study|Not Treated|0|||
33268667|NCT01021748|100884289|FG003|Overall Study|Not Treated|0|||
33268668|NCT01021748|100884290|FG004|Overall Study|Not Treated|0|||
33268669|NCT01021748|100884291|FG005|Overall Study|Not Treated|0|||
33268670|NCT01021748|100884292|FG006|Overall Study|Not Treated|0|||
33268671|NCT01021748|100884293|FG007|Overall Study|Not Treated|0|||
33268672|NCT01021748|100884294|FG008|Overall Study|Not Treated|0|||
33268673|NCT04497415|100884299|FG000|Overall Study|Lost to Follow-up|43|||
33268674|NCT04497415|100884300|FG001|Overall Study|Lost to Follow-up|27|||
33268675|NCT03335488|100884302|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
33268676|NCT03335488|100884303|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
33268677|NCT03335488|100884302|FG000|Safety Extension Period|Adverse Event|1|||
33268678|NCT03335488|100884303|FG001|Safety Extension Period|Adverse Event|0|||
33268679|NCT03335488|100884302|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
33268680|NCT03335488|100884303|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
33268681|NCT02941549|100884304|FG000|Overall Study|Adverse Event|1|||
33268682|NCT02941549|100884305|FG001|Overall Study|Adverse Event|0|||
33268683|NCT02941549|100884306|FG002|Overall Study|Adverse Event|0|||
33268684|NCT02941549|100884304|FG000|Overall Study|Withdrawal by Subject|2|||
33268685|NCT02941549|100884305|FG001|Overall Study|Withdrawal by Subject|1|||
33268686|NCT02941549|100884306|FG002|Overall Study|Withdrawal by Subject|2|||
33268687|NCT03002194|100884310|FG000|Overall Study|Lost to Follow-up|6|||
33268688|NCT03002194|100884310|FG000|Overall Study|Adverse Event|1|||
33268689|NCT03002194|100884310|FG000|Overall Study|Lack of Efficacy|1|||
33268690|NCT03002194|100884310|FG000|Overall Study|Withdrawal by Subject|2|||
33268691|NCT00614614|100884311|FG000|Primary Vaccination Phase|Adverse Event|6|||
33268692|NCT00614614|100884312|FG001|Primary Vaccination Phase|Adverse Event|0|||
33268693|NCT00614614|100884313|FG002|Primary Vaccination Phase|Adverse Event|0|||
33268694|NCT00614614|100884314|FG003|Primary Vaccination Phase|Adverse Event|0|||
33268695|NCT00614614|100884315|FG004|Primary Vaccination Phase|Adverse Event|0|||
33268696|NCT00614614|100884311|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
33268697|NCT00614614|100884312|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
33268698|NCT00614614|100884313|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
33268699|NCT00614614|100884314|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
33268700|NCT00614614|100884315|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
33268701|NCT00614614|100884311|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
33268702|NCT00614614|100884312|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
33268703|NCT00614614|100884313|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
33268704|NCT00614614|100884314|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
33268705|NCT00614614|100884315|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
33268706|NCT00614614|100884311|FG000|Primary Vaccination Phase|Protocol Violation|9|||
33268707|NCT00614614|100884312|FG001|Primary Vaccination Phase|Protocol Violation|3|||
33268708|NCT00614614|100884313|FG002|Primary Vaccination Phase|Protocol Violation|0|||
33268709|NCT00614614|100884314|FG003|Primary Vaccination Phase|Protocol Violation|0|||
33268710|NCT00614614|100884315|FG004|Primary Vaccination Phase|Protocol Violation|0|||
33268711|NCT00614614|100884311|FG000|Primary Vaccination Phase|Other|4|||
33268712|NCT00614614|100884312|FG001|Primary Vaccination Phase|Other|0|||
33268713|NCT00614614|100884313|FG002|Primary Vaccination Phase|Other|0|||
33268714|NCT00614614|100884314|FG003|Primary Vaccination Phase|Other|0|||
33268715|NCT00614614|100884315|FG004|Primary Vaccination Phase|Other|0|||
33268716|NCT00614614|100884311|FG000|Booster Vaccination Phase|Adverse Event|0|||
33268717|NCT00614614|100884312|FG001|Booster Vaccination Phase|Adverse Event|0|||
33268718|NCT00614614|100884313|FG002|Booster Vaccination Phase|Adverse Event|1|||
33268719|NCT00614614|100884314|FG003|Booster Vaccination Phase|Adverse Event|1|||
33268720|NCT00614614|100884315|FG004|Booster Vaccination Phase|Adverse Event|0|||
33268721|NCT00614614|100884311|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
33268722|NCT00614614|100884312|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
33268723|NCT00614614|100884313|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
33268724|NCT00614614|100884314|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
33268725|NCT00614614|100884315|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
33268726|NCT00614614|100884311|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
33268727|NCT00614614|100884312|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
33268728|NCT00614614|100884313|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
33268729|NCT00614614|100884314|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
33268730|NCT00614614|100884315|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
33268731|NCT00614614|100884311|FG000|Booster Vaccination Phase|Protocol Violation|0|||
33268732|NCT00614614|100884312|FG001|Booster Vaccination Phase|Protocol Violation|0|||
33268733|NCT00614614|100884313|FG002|Booster Vaccination Phase|Protocol Violation|2|||
33268734|NCT00614614|100884314|FG003|Booster Vaccination Phase|Protocol Violation|3|||
33268735|NCT00614614|100884315|FG004|Booster Vaccination Phase|Protocol Violation|0|||
33268736|NCT00614614|100884311|FG000|Booster Vaccination Phase|Other|0|||
33268737|NCT00614614|100884312|FG001|Booster Vaccination Phase|Other|1|||
33478111|NCT01473524|101643443|FG005|DB Phase|Adverse Event|0|||
33268738|NCT00614614|100884313|FG002|Booster Vaccination Phase|Other|3|||
33268739|NCT00614614|100884314|FG003|Booster Vaccination Phase|Other|2|||
33268740|NCT00614614|100884315|FG004|Booster Vaccination Phase|Other|1|||
33268741|NCT05405244|100884316|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
33268742|NCT05405244|100884317|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
33268743|NCT05405244|100884316|FG000|Washout (2 Weeks)|Adverse Event|2|||
33268744|NCT05405244|100884317|FG001|Washout (2 Weeks)|Adverse Event|0|||
33268745|NCT05405244|100884316|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
33268746|NCT05405244|100884317|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
33268747|NCT03009344|100884318|FG000|Overall Study|Lack of Efficacy|5|||
33268748|NCT03009344|100884318|FG000|Overall Study|Withdrawal by Subject|1|||
33268749|NCT03009344|100884318|FG000|Overall Study|Adverse Event|1|||
33268750|NCT00048932|100884319|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
33268751|NCT00048932|100884320|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
33268752|NCT00048932|100884321|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
33268753|NCT00048932|100884319|FG000|Double Blind Period (DB)|Adverse Event|51|||
33268754|NCT00048932|100884320|FG001|Double Blind Period (DB)|Adverse Event|19|||
33268755|NCT00048932|100884321|FG002|Double Blind Period (DB)|Adverse Event|0|||
33268756|NCT00048932|100884319|FG000|Double Blind Period (DB)|Death|5|||
33268757|NCT00048932|100884320|FG001|Double Blind Period (DB)|Death|3|||
33268758|NCT00048932|100884321|FG002|Double Blind Period (DB)|Death|0|||
33268759|NCT00048932|100884319|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
33268760|NCT00048932|100884320|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
33268761|NCT00048932|100884321|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
33268762|NCT00048932|100884319|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
33268763|NCT00048932|100884320|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
33268764|NCT00048932|100884321|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
33268765|NCT00048932|100884319|FG000|Double Blind Period (DB)|Relocation|1|||
33268766|NCT00048932|100884320|FG001|Double Blind Period (DB)|Relocation|0|||
33268767|NCT00048932|100884321|FG002|Double Blind Period (DB)|Relocation|0|||
33268768|NCT00048932|100884319|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
33268769|NCT00048932|100884320|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
33268770|NCT00048932|100884321|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
33268771|NCT00048932|100884319|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
33268772|NCT00048932|100884320|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
33268773|NCT00048932|100884321|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
33268774|NCT00048932|100884319|FG000|Double Blind Period (DB)|Pregnancy|1|||
33268775|NCT00048932|100884320|FG001|Double Blind Period (DB)|Pregnancy|0|||
33268776|NCT00048932|100884321|FG002|Double Blind Period (DB)|Pregnancy|0|||
33268777|NCT00048932|100884319|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
33268778|NCT00048932|100884320|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
33268779|NCT00048932|100884321|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
33268780|NCT00048932|100884319|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
33268781|NCT00048932|100884320|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
33268782|NCT00048932|100884321|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
33268783|NCT00048932|100884319|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
33268784|NCT00048932|100884320|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
33268785|NCT00048932|100884321|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
33268786|NCT00048932|100884319|FG000|Open Label Period (OL)|Death|0|||
33268787|NCT00048932|100884320|FG001|Open Label Period (OL)|Death|0|||
33268788|NCT00048932|100884321|FG002|Open Label Period (OL)|Death|25|||
33268789|NCT00048932|100884319|FG000|Open Label Period (OL)|Adverse Event|0|||
33268790|NCT00048932|100884320|FG001|Open Label Period (OL)|Adverse Event|0|||
33268791|NCT00048932|100884321|FG002|Open Label Period (OL)|Adverse Event|103|||
33268792|NCT00048932|100884319|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
33268793|NCT00048932|100884320|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
33268794|NCT00048932|100884321|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
33268795|NCT00048932|100884319|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
33268796|NCT00048932|100884320|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
33268797|NCT00048932|100884321|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
33268798|NCT00048932|100884319|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
33268799|NCT00048932|100884320|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
33268800|NCT00048932|100884321|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
33268801|NCT00048932|100884319|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
33478112|NCT01473524|101643438|FG000|DB Phase|Death|1|||
33268802|NCT00048932|100884320|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
33268803|NCT00048932|100884321|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
33268804|NCT00048932|100884319|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
33268805|NCT00048932|100884320|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
33268806|NCT00048932|100884321|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
33268807|NCT00048932|100884319|FG000|Open Label Period (OL)|Pregnancy|0|||
33268808|NCT00048932|100884320|FG001|Open Label Period (OL)|Pregnancy|0|||
33268809|NCT00048932|100884321|FG002|Open Label Period (OL)|Pregnancy|6|||
33268810|NCT00048932|100884319|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
33268811|NCT00048932|100884320|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
33268812|NCT00048932|100884321|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
33268813|NCT00048932|100884319|FG000|Open Label Period (OL)|Investigator Retiring|0|||
33268814|NCT00048932|100884320|FG001|Open Label Period (OL)|Investigator Retiring|0|||
33268815|NCT00048932|100884321|FG002|Open Label Period (OL)|Investigator Retiring|2|||
33268816|NCT00048932|100884319|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
33268817|NCT00048932|100884320|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
33268818|NCT00048932|100884321|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
33268819|NCT00048932|100884319|FG000|Open Label Period (OL)|Participant Relocated|0|||
33268820|NCT00048932|100884320|FG001|Open Label Period (OL)|Participant Relocated|0|||
33268821|NCT00048932|100884321|FG002|Open Label Period (OL)|Participant Relocated|6|||
33268822|NCT00048932|100884319|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
33268823|NCT00048932|100884320|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
33268824|NCT00048932|100884321|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
33478113|NCT01473524|101643439|FG001|DB Phase|Death|0|||
33268825|NCT00048932|100884319|FG000|Open Label Period (OL)|Site Closure|0|||
33268826|NCT00048932|100884320|FG001|Open Label Period (OL)|Site Closure|0|||
33268827|NCT00048932|100884321|FG002|Open Label Period (OL)|Site Closure|3|||
33268828|NCT00048932|100884319|FG000|Open Label Period (OL)|Trial Terminated|0|||
33268829|NCT00048932|100884320|FG001|Open Label Period (OL)|Trial Terminated|0|||
33268830|NCT00048932|100884321|FG002|Open Label Period (OL)|Trial Terminated|1|||
33268831|NCT00048932|100884319|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
33268832|NCT00048932|100884320|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
33268833|NCT00048932|100884321|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
33268834|NCT00048932|100884319|FG000|Open Label Period (OL)|Patient Decision|0|||
33268835|NCT00048932|100884320|FG001|Open Label Period (OL)|Patient Decision|0|||
33268836|NCT00048932|100884321|FG002|Open Label Period (OL)|Patient Decision|4|||
33268837|NCT00048932|100884319|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
33268838|NCT00048932|100884320|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
33268839|NCT00048932|100884321|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
33268840|NCT00048932|100884319|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
33268841|NCT00048932|100884320|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
33268842|NCT00048932|100884321|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
33268843|NCT00048932|100884319|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
33268844|NCT00048932|100884320|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
33268845|NCT00048932|100884321|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
33268846|NCT00048932|100884319|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
33268847|NCT00048932|100884320|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
33268848|NCT00048932|100884321|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
33268849|NCT00048932|100884319|FG000|Open Label Period (OL)|Investigator Decision|0|||
33268850|NCT00048932|100884320|FG001|Open Label Period (OL)|Investigator Decision|0|||
33268851|NCT00048932|100884321|FG002|Open Label Period (OL)|Investigator Decision|4|||
33268852|NCT00048932|100884319|FG000|Open Label Period (OL)|Site Staff Issues|0|||
33268853|NCT00048932|100884320|FG001|Open Label Period (OL)|Site Staff Issues|0|||
33268854|NCT00048932|100884321|FG002|Open Label Period (OL)|Site Staff Issues|2|||
33268855|NCT00048932|100884319|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
33268856|NCT00048932|100884320|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
33478114|NCT01473524|101643440|FG002|DB Phase|Death|0|||
33268857|NCT00048932|100884321|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
33268858|NCT00048932|100884319|FG000|Open Label Period (OL)|Participant Surgery|0|||
33478115|NCT01473524|101643441|FG003|DB Phase|Death|0|||
33478116|NCT01473524|101643442|FG004|DB Phase|Death|0|||
33478117|NCT01473524|101643443|FG005|DB Phase|Death|0|||
33478118|NCT01473524|101643438|FG000|DB Phase|Withdrawal by Subject|2|||
33478119|NCT01473524|101643439|FG001|DB Phase|Withdrawal by Subject|1|||
33478120|NCT01473524|101643440|FG002|DB Phase|Withdrawal by Subject|1|||
33478121|NCT01473524|101643441|FG003|DB Phase|Withdrawal by Subject|0|||
33478122|NCT01473524|101643442|FG004|DB Phase|Withdrawal by Subject|0|||
33478123|NCT01473524|101643443|FG005|DB Phase|Withdrawal by Subject|0|||
33478124|NCT01473524|101643438|FG000|LTSE Phase|Withdrawal by Subject|0|||
33268859|NCT00048932|100884320|FG001|Open Label Period (OL)|Participant Surgery|0|||
33268860|NCT00048932|100884321|FG002|Open Label Period (OL)|Participant Surgery|1|||
33478125|NCT01473524|101643439|FG001|LTSE Phase|Withdrawal by Subject|0|||
33478126|NCT01473524|101643440|FG002|LTSE Phase|Withdrawal by Subject|0|||
33478127|NCT01473524|101643441|FG003|LTSE Phase|Withdrawal by Subject|3|||
33268861|NCT02574286|100884322|FG000|Overall Study|Adverse Event|3|||
33478128|NCT01473524|101643442|FG004|LTSE Phase|Withdrawal by Subject|3|||
33268862|NCT02574286|100884322|FG000|Overall Study|Withdrawal by Subject|2|||
33268863|NCT00392197|100884327|FG000|Overall Study|Adverse Event|4|||
33268864|NCT00392197|100884328|FG001|Overall Study|Adverse Event|12|||
33478129|NCT01473524|101643443|FG005|LTSE Phase|Withdrawal by Subject|6|||
33478130|NCT01473524|101643438|FG000|LTSE Phase|Death|0|||
33268865|NCT00392197|100884327|FG000|Overall Study|Lack of Efficacy|3|||
33268866|NCT00392197|100884328|FG001|Overall Study|Lack of Efficacy|4|||
33268867|NCT00392197|100884327|FG000|Overall Study|Lost to Follow-up|0|||
33268868|NCT00392197|100884328|FG001|Overall Study|Lost to Follow-up|1|||
33268869|NCT00392197|100884327|FG000|Overall Study|Physician Decision|3|||
33268870|NCT00392197|100884328|FG001|Overall Study|Physician Decision|2|||
33268871|NCT00392197|100884327|FG000|Overall Study|Protocol Violation|7|||
33268872|NCT00392197|100884328|FG001|Overall Study|Protocol Violation|5|||
33268873|NCT00392197|100884327|FG000|Overall Study|Withdrawal by Subject|4|||
33268874|NCT00392197|100884328|FG001|Overall Study|Withdrawal by Subject|6|||
33478131|NCT01473524|101643439|FG001|LTSE Phase|Death|0|||
33478132|NCT01473524|101643440|FG002|LTSE Phase|Death|0|||
33478133|NCT01473524|101643441|FG003|LTSE Phase|Death|0|||
33478134|NCT01473524|101643442|FG004|LTSE Phase|Death|1|||
33478135|NCT01473524|101643443|FG005|LTSE Phase|Death|0|||
33478136|NCT01473524|101643438|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
33478137|NCT01473524|101643439|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
33478138|NCT01473524|101643440|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
33478139|NCT01473524|101643441|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
33478140|NCT01473524|101643442|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
33478141|NCT01473524|101643443|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
33478142|NCT01473524|101643438|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
33478143|NCT01473524|101643439|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
33478144|NCT01473524|101643440|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
33478145|NCT01473524|101643441|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
33478146|NCT01473524|101643442|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
33478147|NCT01473524|101643443|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
33478148|NCT01473524|101643438|FG000|LTSE Phase|Lost to Follow-up|0|||
33478149|NCT01473524|101643439|FG001|LTSE Phase|Lost to Follow-up|0|||
33478150|NCT01473524|101643440|FG002|LTSE Phase|Lost to Follow-up|0|||
33478151|NCT01473524|101643441|FG003|LTSE Phase|Lost to Follow-up|1|||
33478152|NCT01473524|101643442|FG004|LTSE Phase|Lost to Follow-up|3|||
33478153|NCT01473524|101643443|FG005|LTSE Phase|Lost to Follow-up|2|||
33478154|NCT01473524|101643438|FG000|LTSE Phase|Principal Investigator Decision|0|||
33478155|NCT01473524|101643439|FG001|LTSE Phase|Principal Investigator Decision|0|||
33478156|NCT01473524|101643440|FG002|LTSE Phase|Principal Investigator Decision|0|||
33478157|NCT01473524|101643441|FG003|LTSE Phase|Principal Investigator Decision|1|||
33478158|NCT01473524|101643442|FG004|LTSE Phase|Principal Investigator Decision|1|||
33478159|NCT01473524|101643443|FG005|LTSE Phase|Principal Investigator Decision|3|||
33478160|NCT01473524|101643438|FG000|LTSE Phase|Liver Transplantation|0|||
33268875|NCT03026166|100884329|FG000|Overall Study|Death|22|||
33268876|NCT03026166|100884330|FG001|Overall Study|Death|7|||
33268877|NCT03026166|100884329|FG000|Overall Study|Physician Decision|2|||
33268878|NCT03026166|100884330|FG001|Overall Study|Physician Decision|0|||
33268879|NCT03026166|100884329|FG000|Overall Study|Withdrawal by Subject|1|||
33268880|NCT03026166|100884330|FG001|Overall Study|Withdrawal by Subject|2|||
33268881|NCT03026166|100884329|FG000|Overall Study|Lost to Follow-up|1|||
33268882|NCT03026166|100884330|FG001|Overall Study|Lost to Follow-up|0|||
33268883|NCT03026166|100884329|FG000|Overall Study|Study Terminated by Sponsor|3|||
33268884|NCT03026166|100884330|FG001|Overall Study|Study Terminated by Sponsor|3|||
33268885|NCT03026166|100884329|FG000|Overall Study|Other|1|||
33268886|NCT03026166|100884330|FG001|Overall Study|Other|0|||
33268887|NCT01951703|100884331|FG000|First Intervention|Withdrawal by Subject|1|||
33268888|NCT01951703|100884332|FG001|First Intervention|Withdrawal by Subject|0|||
33268889|NCT01951703|100884331|FG000|First Intervention|Subject was not compliant|1|||
33268890|NCT01951703|100884332|FG001|First Intervention|Subject was not compliant|1|||
33268891|NCT01951703|100884331|FG000|First Intervention|Physician Decision|1|||
33268892|NCT01951703|100884332|FG001|First Intervention|Physician Decision|0|||
33268893|NCT01951703|100884331|FG000|Second Intervention|Protocol Violation|0|||
33268894|NCT01951703|100884332|FG001|Second Intervention|Protocol Violation|1|||
33268895|NCT01951703|100884331|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
33268896|NCT01951703|100884332|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
33478161|NCT01473524|101643439|FG001|LTSE Phase|Liver Transplantation|0|||
33478162|NCT01473524|101643440|FG002|LTSE Phase|Liver Transplantation|0|||
33478163|NCT01473524|101643441|FG003|LTSE Phase|Liver Transplantation|0|||
33478164|NCT01473524|101643442|FG004|LTSE Phase|Liver Transplantation|0|||
33478165|NCT01473524|101643443|FG005|LTSE Phase|Liver Transplantation|1|||
33478166|NCT01473524|101643438|FG000|LTSE Phase|Pregnancy|0|||
33268897|NCT02950961|100884333|FG000|Overall Study|Study had to stop due to COVID.|7|||
33268898|NCT00380250|100884335|FG000|Overall Study|Withdrawal by Subject|39|||
33268899|NCT00380250|100884336|FG001|Overall Study|Withdrawal by Subject|28|||
33268900|NCT00380250|100884335|FG000|Overall Study|Adverse Event|20|||
33268901|NCT00380250|100884336|FG001|Overall Study|Adverse Event|9|||
33268902|NCT00380250|100884335|FG000|Overall Study|Lack of Efficacy|10|||
33268903|NCT00380250|100884336|FG001|Overall Study|Lack of Efficacy|8|||
33268904|NCT00380250|100884335|FG000|Overall Study|Protocol Violation|15|||
33268905|NCT00380250|100884336|FG001|Overall Study|Protocol Violation|5|||
33478167|NCT01473524|101643439|FG001|LTSE Phase|Pregnancy|0|||
33478168|NCT01473524|101643440|FG002|LTSE Phase|Pregnancy|0|||
33478169|NCT01473524|101643441|FG003|LTSE Phase|Pregnancy|1|||
33478170|NCT01473524|101643442|FG004|LTSE Phase|Pregnancy|0|||
33478171|NCT01473524|101643443|FG005|LTSE Phase|Pregnancy|0|||
33268906|NCT00380250|100884335|FG000|Overall Study|Lost to Follow-up|14|||
33268907|NCT00380250|100884336|FG001|Overall Study|Lost to Follow-up|5|||
33268908|NCT00380250|100884335|FG000|Overall Study|Physician Decision|1|||
33268909|NCT00380250|100884336|FG001|Overall Study|Physician Decision|0|||
33268910|NCT01523392|100884340|FG000|Treatment Period 1|Withdrawal by Subject|2|||
33268911|NCT01523392|100884341|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33268912|NCT01523392|100884340|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
33268913|NCT01523392|100884341|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
33268914|NCT01523392|100884340|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
33268915|NCT01523392|100884341|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
33268916|NCT02067663|100884342|FG000|Overall Study|Lost to Follow-up|13|||
33268917|NCT02067663|100884343|FG001|Overall Study|Lost to Follow-up|14|||
33268918|NCT00667732|100884347|FG000|Run -In (8 Weeks)|Adverse Event|4|||
33268919|NCT00667732|100884348|FG001|Run -In (8 Weeks)|Adverse Event|0|||
33268920|NCT00667732|100884349|FG002|Run -In (8 Weeks)|Adverse Event|0|||
33268921|NCT00667732|100884347|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
33268922|NCT00667732|100884348|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
33268923|NCT00667732|100884349|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
33268924|NCT00667732|100884347|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
33268925|NCT00667732|100884348|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
33268926|NCT00667732|100884349|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
33268927|NCT01829711|100884350|FG000|Overall Study|Lost to Follow-up|2|||
33268928|NCT01829711|100884350|FG000|Overall Study|Withdrawal by Subject|3|||
33268929|NCT01829711|100884350|FG000|Overall Study|Death|4|||
33268930|NCT01829711|100884350|FG000|Overall Study|Started new therapies|17|||
33268931|NCT01829711|100884350|FG000|Overall Study|Adverse Event|3|||
33268932|NCT01829711|100884350|FG000|Overall Study|Due to progression of disease|13|||
33268933|NCT01829711|100884350|FG000|Overall Study|Due to lack of response|1|||
33268934|NCT01976507|100884352|FG000|Overall Study|Adverse Event|6|||
33268935|NCT01976507|100884352|FG000|Overall Study|ablation not done, drug not given|1|||
33478172|NCT01473524|101643438|FG000|LTSE Phase|Protocol Violation|0|||
33478173|NCT01473524|101643439|FG001|LTSE Phase|Protocol Violation|0|||
33478174|NCT01473524|101643440|FG002|LTSE Phase|Protocol Violation|0|||
33478175|NCT01473524|101643441|FG003|LTSE Phase|Protocol Violation|0|||
33478176|NCT01473524|101643442|FG004|LTSE Phase|Protocol Violation|0|||
33478177|NCT01473524|101643443|FG005|LTSE Phase|Protocol Violation|1|||
33478178|NCT00311402|101643444|FG000|Overall Study|Adverse Event|118|||
33478179|NCT00311402|101643445|FG001|Overall Study|Adverse Event|105|||
33478180|NCT00311402|101643444|FG000|Overall Study|Lost to Follow-up|0|||
33478181|NCT00311402|101643445|FG001|Overall Study|Lost to Follow-up|3|||
33478182|NCT00311402|101643444|FG000|Overall Study|Withdrawal by Subject|17|||
33478183|NCT00311402|101643445|FG001|Overall Study|Withdrawal by Subject|18|||
33478184|NCT00311402|101643444|FG000|Overall Study|Lack of Efficacy|58|||
33478185|NCT00311402|101643445|FG001|Overall Study|Lack of Efficacy|42|||
33478186|NCT00311402|101643444|FG000|Overall Study|Protocol Violation|7|||
33478187|NCT00311402|101643445|FG001|Overall Study|Protocol Violation|6|||
33478188|NCT00311402|101643444|FG000|Overall Study|IRB's rejection etc.|10|||
33268936|NCT04705051|100884353|FG000|Overall Study|Enrolled but not treated|1|||
33268937|NCT04705051|100884353|FG000|Overall Study|Study terminated by sponsor|23|||
33268938|NCT00701415|100884354|FG000|Overall Study|Adverse Event|0|||
33268939|NCT00701415|100884355|FG001|Overall Study|Adverse Event|1|||
33268940|NCT00701415|100884354|FG000|Overall Study|Social/family issues and needle phobia|1|||
33268941|NCT00701415|100884355|FG001|Overall Study|Social/family issues and needle phobia|0|||
33268942|NCT01536704|100884356|FG000|Washout Period 1|Withdrawal by Subject|1|||
33268943|NCT01536704|100884357|FG001|Washout Period 1|Withdrawal by Subject|2|||
33268944|NCT01536704|100884358|FG002|Washout Period 1|Withdrawal by Subject|0|||
33268945|NCT01536704|100884359|FG003|Washout Period 1|Withdrawal by Subject|0|||
33478189|NCT00311402|101643445|FG001|Overall Study|IRB's rejection etc.|3|||
33478190|NCT00265395|101643446|FG000|Overall Study|Adverse Event|3|||
33478191|NCT00265395|101643447|FG001|Overall Study|Adverse Event|6|||
33478192|NCT00265395|101643446|FG000|Overall Study|Lost to Follow-up|2|||
33478193|NCT00265395|101643447|FG001|Overall Study|Lost to Follow-up|1|||
33268946|NCT01536704|100884356|FG000|Washout Period 2|Adverse Event|1|||
33268947|NCT01536704|100884357|FG001|Washout Period 2|Adverse Event|0|||
33268948|NCT01536704|100884358|FG002|Washout Period 2|Adverse Event|0|||
33268949|NCT01536704|100884359|FG003|Washout Period 2|Adverse Event|0|||
33268950|NCT01536704|100884356|FG000|Washout Period 2|Withdrawal by Subject|0|||
33268951|NCT01536704|100884357|FG001|Washout Period 2|Withdrawal by Subject|0|||
33268952|NCT01536704|100884358|FG002|Washout Period 2|Withdrawal by Subject|0|||
33268953|NCT01536704|100884359|FG003|Washout Period 2|Withdrawal by Subject|1|||
33268954|NCT01536704|100884356|FG000|Period 3|Adverse Event|0|||
33268955|NCT01536704|100884357|FG001|Period 3|Adverse Event|0|||
33268956|NCT01536704|100884358|FG002|Period 3|Adverse Event|0|||
33478194|NCT00265395|101643446|FG000|Overall Study|Withdrawal by Subject|1|||
33268957|NCT01536704|100884359|FG003|Period 3|Adverse Event|1|||
33268958|NCT01536704|100884356|FG000|Washout Period 3|Adverse Event|0|||
33268959|NCT01536704|100884357|FG001|Washout Period 3|Adverse Event|0|||
33268960|NCT01536704|100884358|FG002|Washout Period 3|Adverse Event|1|||
33268961|NCT01536704|100884359|FG003|Washout Period 3|Adverse Event|0|||
33268962|NCT02309892|100884364|FG000|Overall Study|Physician Decision|1|||
33268963|NCT02309892|100884365|FG001|Overall Study|Physician Decision|0|||
33268964|NCT02309892|100884366|FG002|Overall Study|Physician Decision|0|||
33268965|NCT02309892|100884367|FG003|Overall Study|Physician Decision|0|||
33268966|NCT02309892|100884368|FG004|Overall Study|Physician Decision|0|||
33268967|NCT02309892|100884369|FG005|Overall Study|Physician Decision|0|||
33268968|NCT02309892|100884370|FG006|Overall Study|Physician Decision|0|||
33268969|NCT02309892|100884364|FG000|Overall Study|Adverse Event|1|||
33268970|NCT02309892|100884365|FG001|Overall Study|Adverse Event|0|||
33268971|NCT02309892|100884366|FG002|Overall Study|Adverse Event|1|||
33268972|NCT02309892|100884367|FG003|Overall Study|Adverse Event|0|||
33268973|NCT02309892|100884368|FG004|Overall Study|Adverse Event|0|||
33268974|NCT02309892|100884369|FG005|Overall Study|Adverse Event|0|||
33268975|NCT02309892|100884370|FG006|Overall Study|Adverse Event|0|||
33268976|NCT02309892|100884364|FG000|Overall Study|Progressive Disease|0|||
33268977|NCT02309892|100884365|FG001|Overall Study|Progressive Disease|1|||
33268978|NCT02309892|100884366|FG002|Overall Study|Progressive Disease|0|||
33268979|NCT02309892|100884367|FG003|Overall Study|Progressive Disease|0|||
33268980|NCT02309892|100884368|FG004|Overall Study|Progressive Disease|1|||
33268981|NCT02309892|100884369|FG005|Overall Study|Progressive Disease|0|||
33268982|NCT02309892|100884370|FG006|Overall Study|Progressive Disease|0|||
33268983|NCT02309892|100884364|FG000|Overall Study|Death|0|||
33478195|NCT00265395|101643447|FG001|Overall Study|Withdrawal by Subject|6|||
33478196|NCT00265395|101643446|FG000|Overall Study|Protocol Violation|2|||
33478197|NCT00265395|101643447|FG001|Overall Study|Protocol Violation|2|||
33478198|NCT00265395|101643446|FG000|Overall Study|Lack of Efficacy|0|||
33478199|NCT00265395|101643447|FG001|Overall Study|Lack of Efficacy|1|||
33478200|NCT00265395|101643446|FG000|Overall Study|Administrative|0|||
33478201|NCT00265395|101643447|FG001|Overall Study|Administrative|1|||
33478202|NCT03393806|101643448|FG000|Overall Study|Physician Decision|1|||
33478203|NCT03393806|101643449|FG001|Overall Study|Physician Decision|0|||
33478204|NCT04078126|101643453|FG000|Washout|Study put on hold due to COVID-19|0|||
33478205|NCT04078126|101643454|FG001|Washout|Study put on hold due to COVID-19|2|||
33478206|NCT04078126|101643453|FG000|Period 2|Study put on hold due to COVID-19|1|||
33478207|NCT04078126|101643454|FG001|Period 2|Study put on hold due to COVID-19|1|||
33478208|NCT01359969|101643455|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
33478209|NCT00191113|101646983|FG000|Core Study|Withdrawal by Subject|25|||
33478210|NCT00191113|101646984|FG001|Core Study|Withdrawal by Subject|9|||
33478211|NCT00191113|101646983|FG000|Core Study|Protocol Violation|6|||
33478212|NCT00191113|101646984|FG001|Core Study|Protocol Violation|2|||
33478213|NCT00191113|101646983|FG000|Core Study|Lost to Follow-up|3|||
33478214|NCT00191113|101646984|FG001|Core Study|Lost to Follow-up|0|||
33478215|NCT00191113|101646983|FG000|Core Study|Adverse Event|0|||
33478216|NCT00191113|101646984|FG001|Core Study|Adverse Event|2|||
33478217|NCT00191113|101646983|FG000|Core Study|Lack of Efficacy|0|||
33478218|NCT00191113|101646984|FG001|Core Study|Lack of Efficacy|2|||
33478219|NCT00191113|101646983|FG000|Core Study|Death|1|||
33478220|NCT00191113|101646984|FG001|Core Study|Death|0|||
33478221|NCT00721630|101646985|FG000|Overall Study|Participant found to be ineligible|1|||
33478222|NCT02065700|101646986|FG000|Overall Study|Adverse Event|165|||
33478223|NCT02065700|101646987|FG001|Overall Study|Adverse Event|101|||
33478224|NCT02065700|101646986|FG000|Overall Study|Withdrawal by Subject|90|||
33478225|NCT02065700|101646987|FG001|Overall Study|Withdrawal by Subject|29|||
33478226|NCT02065700|101646986|FG000|Overall Study|Lost to Follow-up|12|||
33478227|NCT02065700|101646987|FG001|Overall Study|Lost to Follow-up|9|||
33478228|NCT02065700|101646986|FG000|Overall Study|Physician Decision|2|||
33478229|NCT02065700|101646987|FG001|Overall Study|Physician Decision|0|||
33478230|NCT02065700|101646986|FG000|Overall Study|Sponsor Request|38|||
33478231|NCT02065700|101646987|FG001|Overall Study|Sponsor Request|15|||
33478232|NCT02065700|101646986|FG000|Overall Study|Treatment Failure|3|||
33478233|NCT02065700|101646987|FG001|Overall Study|Treatment Failure|2|||
33478234|NCT02065700|101646986|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
33478235|NCT02065700|101646987|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
33478236|NCT02065700|101646986|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
33478237|NCT02065700|101646987|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
33478238|NCT02065700|101646986|FG000|Overall Study|Non-compliance with Study Procedures|2|||
33268984|NCT02309892|100884365|FG001|Overall Study|Death|0|||
33268985|NCT02309892|100884366|FG002|Overall Study|Death|0|||
33268986|NCT02309892|100884367|FG003|Overall Study|Death|0|||
33268987|NCT02309892|100884368|FG004|Overall Study|Death|0|||
33268988|NCT02309892|100884369|FG005|Overall Study|Death|1|||
33478239|NCT02065700|101646987|FG001|Overall Study|Non-compliance with Study Procedures|0|||
33478240|NCT02065700|101646986|FG000|Overall Study|Not Defined|21|||
33478241|NCT02065700|101646987|FG001|Overall Study|Not Defined|3|||
33478242|NCT00837473|101646990|FG000|Overall Study|Lost to Follow-up|1|||
33478243|NCT00837473|101646990|FG000|Overall Study|Withdrawal by Subject|2|||
33478244|NCT01156142|101646991|FG000|Overall Study|Withdrawal by Subject|8|||
33478245|NCT01156142|101646992|FG001|Overall Study|Withdrawal by Subject|6|||
33478246|NCT01156142|101646991|FG000|Overall Study|Ineligible|0|||
33478247|NCT01156142|101646992|FG001|Overall Study|Ineligible|1|||
33478248|NCT00077857|101646997|FG000|Overall Study|Adverse Event|30|||
33478249|NCT00077857|101646998|FG001|Overall Study|Adverse Event|32|||
33478250|NCT00077857|101646997|FG000|Overall Study|Death|7|||
33478251|NCT00077857|101646998|FG001|Overall Study|Death|3|||
33478252|NCT00077857|101646997|FG000|Overall Study|Insufficient therapeutic response|112|||
33478253|NCT00077857|101646998|FG001|Overall Study|Insufficient therapeutic response|128|||
33478254|NCT00077857|101646997|FG000|Overall Study|Violation of selection criteria at entry|3|||
33478255|NCT00077857|101646998|FG001|Overall Study|Violation of selection criteria at entry|1|||
33478256|NCT00077857|101646997|FG000|Overall Study|Other protocol violation|0|||
33478257|NCT00077857|101646998|FG001|Overall Study|Other protocol violation|1|||
33268989|NCT02309892|100884370|FG006|Overall Study|Death|0|||
33268990|NCT03340961|100884371|FG000|Overall Study|Adverse Event|1|||
33268991|NCT03340961|100884372|FG001|Overall Study|Adverse Event|3|||
33268992|NCT03340961|100884373|FG002|Overall Study|Adverse Event|2|||
33268993|NCT03340961|100884374|FG003|Overall Study|Adverse Event|4|||
33268994|NCT03340961|100884371|FG000|Overall Study|Lost to Follow-up|0|||
33268995|NCT03340961|100884372|FG001|Overall Study|Lost to Follow-up|1|||
33478258|NCT00077857|101646997|FG000|Overall Study|Refused treatment|29|||
33478259|NCT00077857|101646998|FG001|Overall Study|Refused treatment|21|||
33478260|NCT00077857|101646997|FG000|Overall Study|Failure to return|5|||
33478261|NCT00077857|101646998|FG001|Overall Study|Failure to return|5|||
33478262|NCT00077857|101646997|FG000|Overall Study|Other|15|||
33478263|NCT00077857|101646998|FG001|Overall Study|Other|13|||
33478264|NCT01329900|101646999|FG000|Overall Study|Elevated creatinine/renal function|1|||
33478265|NCT02492880|101647000|FG000|Overall Study|Lost to Follow-up|1|||
33478266|NCT02492880|101647000|FG000|Overall Study|Protocol Violation|1|||
33478267|NCT01085734|101647006|FG000|Overall Study|Adverse Event|0|||
33478268|NCT01085734|101647007|FG001|Overall Study|Adverse Event|2|||
33478269|NCT01085734|101647006|FG000|Overall Study|Death|1|||
33478270|NCT01085734|101647007|FG001|Overall Study|Death|0|||
33478271|NCT01085734|101647006|FG000|Overall Study|Lost to Follow-up|0|||
33478272|NCT01085734|101647007|FG001|Overall Study|Lost to Follow-up|1|||
33268996|NCT03340961|100884373|FG002|Overall Study|Lost to Follow-up|0|||
33268997|NCT03340961|100884374|FG003|Overall Study|Lost to Follow-up|1|||
33268998|NCT03340961|100884371|FG000|Overall Study|Withdrawal by Subject|3|||
33268999|NCT03340961|100884372|FG001|Overall Study|Withdrawal by Subject|2|||
33269000|NCT03340961|100884373|FG002|Overall Study|Withdrawal by Subject|4|||
33269001|NCT03340961|100884374|FG003|Overall Study|Withdrawal by Subject|7|||
33269002|NCT03340961|100884371|FG000|Overall Study|Use of prohibited treatment|0|||
33269003|NCT03340961|100884372|FG001|Overall Study|Use of prohibited treatment|3|||
33269004|NCT03340961|100884373|FG002|Overall Study|Use of prohibited treatment|2|||
33269005|NCT03340961|100884374|FG003|Overall Study|Use of prohibited treatment|4|||
33269006|NCT03340961|100884371|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
33269007|NCT03340961|100884372|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
33269008|NCT03340961|100884373|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
33269009|NCT03340961|100884374|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
33269010|NCT03340961|100884371|FG000|Overall Study|Subject developed an exclusion criterion|0|||
33269011|NCT03340961|100884372|FG001|Overall Study|Subject developed an exclusion criterion|1|||
33269012|NCT03340961|100884373|FG002|Overall Study|Subject developed an exclusion criterion|0|||
33269013|NCT03340961|100884374|FG003|Overall Study|Subject developed an exclusion criterion|0|||
33269014|NCT03340961|100884371|FG000|Overall Study|Protocol Violation|1|||
33269015|NCT03340961|100884372|FG001|Overall Study|Protocol Violation|0|||
33269016|NCT03340961|100884373|FG002|Overall Study|Protocol Violation|1|||
33269017|NCT03340961|100884374|FG003|Overall Study|Protocol Violation|0|||
33269018|NCT03340961|100884371|FG000|Overall Study|Adverse Event|1|||
33269019|NCT03340961|100884372|FG001|Overall Study|Adverse Event|1|||
33269020|NCT03340961|100884373|FG002|Overall Study|Adverse Event|0|||
33269021|NCT03340961|100884374|FG003|Overall Study|Adverse Event|0|||
33269022|NCT03340961|100884371|FG000|Overall Study|Lack of Efficacy|0|||
33269023|NCT03340961|100884372|FG001|Overall Study|Lack of Efficacy|0|||
33269024|NCT03340961|100884373|FG002|Overall Study|Lack of Efficacy|0|||
33269025|NCT03340961|100884374|FG003|Overall Study|Lack of Efficacy|1|||
33269026|NCT01698918|100884375|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
33478273|NCT01085734|101647006|FG000|Overall Study|Withdrawal by Subject|0|||
33478274|NCT01085734|101647007|FG001|Overall Study|Withdrawal by Subject|1|||
33478275|NCT02828241|101647008|FG000|Overall Study|Adverse Event|7|||
33478276|NCT02828241|101647009|FG001|Overall Study|Adverse Event|2|||
33478277|NCT02828241|101647008|FG000|Overall Study|Protocol Violation|1|||
33269027|NCT01698918|100884375|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
33269028|NCT01698918|100884375|FG000|First Line Treatment (Core+Extension)|Death|2|||
33478278|NCT02828241|101647009|FG001|Overall Study|Protocol Violation|0|||
33478279|NCT00372411|101647010|FG000|Overall Study|Withdrawal by Subject|3|||
33478280|NCT00372411|101647011|FG001|Overall Study|Withdrawal by Subject|4|||
33478281|NCT00372411|101647012|FG002|Overall Study|Withdrawal by Subject|1|||
33478282|NCT00372411|101647010|FG000|Overall Study|Death|0|||
33478283|NCT00372411|101647011|FG001|Overall Study|Death|2|||
33478284|NCT00372411|101647012|FG002|Overall Study|Death|1|||
33478285|NCT00372411|101647010|FG000|Overall Study|Lost to Follow-up|1|||
33478286|NCT00372411|101647011|FG001|Overall Study|Lost to Follow-up|1|||
33478287|NCT00372411|101647012|FG002|Overall Study|Lost to Follow-up|1|||
33478288|NCT00372411|101647010|FG000|Overall Study|Adverse Event|1|||
33478289|NCT00372411|101647011|FG001|Overall Study|Adverse Event|1|||
33478290|NCT00372411|101647012|FG002|Overall Study|Adverse Event|0|||
33478291|NCT02549027|101647013|FG000|Washout After Period 4|Withdrawal by Subject|0|||
33478292|NCT02549027|101647014|FG001|Washout After Period 4|Withdrawal by Subject|1|||
33478293|NCT02549027|101647015|FG002|Washout After Period 4|Withdrawal by Subject|1|||
33478294|NCT02549027|101647016|FG003|Washout After Period 4|Withdrawal by Subject|1|||
33478295|NCT02549027|101647017|FG004|Washout After Period 4|Withdrawal by Subject|0|||
33478296|NCT02549027|101647018|FG005|Washout After Period 4|Withdrawal by Subject|0|||
33478297|NCT02549027|101647013|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
33478298|NCT02549027|101647014|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
33478299|NCT02549027|101647015|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
33478300|NCT02549027|101647016|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
33478301|NCT02549027|101647017|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
33478302|NCT02549027|101647018|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
33478303|NCT00307437|101647019|FG000|Controlled Period|Adverse Event|7|||
33478304|NCT00307437|101647020|FG001|Controlled Period|Adverse Event|2|||
33478305|NCT00307437|101647021|FG002|Controlled Period|Adverse Event|5|||
33478306|NCT00307437|101647022|FG003|Controlled Period|Adverse Event|0|||
33478307|NCT00307437|101647023|FG004|Controlled Period|Adverse Event|0|||
33478308|NCT00307437|101647024|FG005|Controlled Period|Adverse Event|0|||
33478309|NCT00307437|101647025|FG006|Controlled Period|Adverse Event|0|||
33478310|NCT00307437|101647019|FG000|Controlled Period|Death|0|||
33478311|NCT00307437|101647020|FG001|Controlled Period|Death|0|||
33478312|NCT00307437|101647021|FG002|Controlled Period|Death|1|||
33478313|NCT00307437|101647022|FG003|Controlled Period|Death|0|||
33478314|NCT00307437|101647023|FG004|Controlled Period|Death|0|||
33478315|NCT00307437|101647024|FG005|Controlled Period|Death|0|||
33478316|NCT00307437|101647025|FG006|Controlled Period|Death|0|||
33478317|NCT00307437|101647019|FG000|Controlled Period|Lack of Efficacy|2|||
33478318|NCT00307437|101647020|FG001|Controlled Period|Lack of Efficacy|0|||
33478319|NCT00307437|101647021|FG002|Controlled Period|Lack of Efficacy|0|||
33478320|NCT00307437|101647022|FG003|Controlled Period|Lack of Efficacy|0|||
33478321|NCT00307437|101647023|FG004|Controlled Period|Lack of Efficacy|0|||
33478322|NCT00307437|101647024|FG005|Controlled Period|Lack of Efficacy|0|||
33478323|NCT00307437|101647025|FG006|Controlled Period|Lack of Efficacy|0|||
33478324|NCT00307437|101647019|FG000|Controlled Period|Lost to Follow-up|2|||
33478325|NCT00307437|101647020|FG001|Controlled Period|Lost to Follow-up|3|||
33478326|NCT00307437|101647021|FG002|Controlled Period|Lost to Follow-up|0|||
33478327|NCT00307437|101647022|FG003|Controlled Period|Lost to Follow-up|0|||
33478328|NCT00307437|101647023|FG004|Controlled Period|Lost to Follow-up|0|||
33478329|NCT00307437|101647024|FG005|Controlled Period|Lost to Follow-up|0|||
33478330|NCT00307437|101647025|FG006|Controlled Period|Lost to Follow-up|0|||
33478331|NCT00307437|101647019|FG000|Controlled Period|Other|5|||
33478332|NCT00307437|101647020|FG001|Controlled Period|Other|1|||
33478333|NCT00307437|101647021|FG002|Controlled Period|Other|3|||
33478334|NCT00307437|101647022|FG003|Controlled Period|Other|0|||
33478335|NCT00307437|101647023|FG004|Controlled Period|Other|0|||
33478336|NCT00307437|101647024|FG005|Controlled Period|Other|0|||
33478337|NCT00307437|101647025|FG006|Controlled Period|Other|0|||
33478338|NCT00307437|101647019|FG000|After Controlled Period|Adverse Event|0|||
33478339|NCT00307437|101647020|FG001|After Controlled Period|Adverse Event|0|||
33478340|NCT00307437|101647021|FG002|After Controlled Period|Adverse Event|0|||
33478341|NCT00307437|101647022|FG003|After Controlled Period|Adverse Event|18|||
33478342|NCT00307437|101647023|FG004|After Controlled Period|Adverse Event|16|||
33478343|NCT00307437|101647024|FG005|After Controlled Period|Adverse Event|31|||
33478344|NCT00307437|101647025|FG006|After Controlled Period|Adverse Event|40|||
33478345|NCT00307437|101647019|FG000|After Controlled Period|Death|0|||
33478346|NCT00307437|101647020|FG001|After Controlled Period|Death|0|||
33478347|NCT00307437|101647021|FG002|After Controlled Period|Death|0|||
33478348|NCT00307437|101647022|FG003|After Controlled Period|Death|3|||
33478349|NCT00307437|101647023|FG004|After Controlled Period|Death|1|||
33478350|NCT00307437|101647024|FG005|After Controlled Period|Death|1|||
33478351|NCT00307437|101647025|FG006|After Controlled Period|Death|3|||
33478352|NCT00307437|101647019|FG000|After Controlled Period|Lack of Efficacy|0|||
33478353|NCT00307437|101647020|FG001|After Controlled Period|Lack of Efficacy|0|||
33478354|NCT00307437|101647021|FG002|After Controlled Period|Lack of Efficacy|0|||
33478355|NCT00307437|101647022|FG003|After Controlled Period|Lack of Efficacy|15|||
33478356|NCT00307437|101647023|FG004|After Controlled Period|Lack of Efficacy|17|||
33478357|NCT00307437|101647024|FG005|After Controlled Period|Lack of Efficacy|37|||
33269029|NCT01698918|100884375|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
33478358|NCT00307437|101647025|FG006|After Controlled Period|Lack of Efficacy|24|||
33478359|NCT00307437|101647019|FG000|After Controlled Period|Lost to Follow-up|0|||
33478360|NCT00307437|101647020|FG001|After Controlled Period|Lost to Follow-up|0|||
33478361|NCT00307437|101647021|FG002|After Controlled Period|Lost to Follow-up|0|||
33478362|NCT00307437|101647022|FG003|After Controlled Period|Lost to Follow-up|7|||
33478363|NCT00307437|101647023|FG004|After Controlled Period|Lost to Follow-up|12|||
33478364|NCT00307437|101647024|FG005|After Controlled Period|Lost to Follow-up|13|||
33478365|NCT00307437|101647025|FG006|After Controlled Period|Lost to Follow-up|18|||
33478366|NCT00307437|101647019|FG000|After Controlled Period|Other|0|||
33478367|NCT00307437|101647020|FG001|After Controlled Period|Other|0|||
33478368|NCT00307437|101647021|FG002|After Controlled Period|Other|0|||
33478369|NCT00307437|101647022|FG003|After Controlled Period|Other|15|||
33478370|NCT00307437|101647023|FG004|After Controlled Period|Other|9|||
33478371|NCT00307437|101647024|FG005|After Controlled Period|Other|40|||
33478372|NCT00307437|101647025|FG006|After Controlled Period|Other|28|||
33478373|NCT00936897|101647026|FG000|Overall Study|Withdrawal by Subject|9|||
33478374|NCT00936897|101647027|FG001|Overall Study|Withdrawal by Subject|19|||
33478375|NCT00936897|101647026|FG000|Overall Study|Adverse Event|4|||
33478376|NCT00936897|101647027|FG001|Overall Study|Adverse Event|13|||
33478377|NCT00936897|101647026|FG000|Overall Study|Other|3|||
33478378|NCT00936897|101647027|FG001|Overall Study|Other|9|||
33478379|NCT00936897|101647026|FG000|Overall Study|Lost to Follow-up|1|||
33478380|NCT00936897|101647027|FG001|Overall Study|Lost to Follow-up|10|||
33478381|NCT00936897|101647026|FG000|Overall Study|Administrative Decision|1|||
33478382|NCT00936897|101647027|FG001|Overall Study|Administrative Decision|2|||
33478383|NCT00936897|101647026|FG000|Overall Study|Protocol Violation|1|||
33478384|NCT00936897|101647027|FG001|Overall Study|Protocol Violation|1|||
33478385|NCT00936897|101647026|FG000|Overall Study|Ineligibility Determined|0|||
33478386|NCT00936897|101647027|FG001|Overall Study|Ineligibility Determined|3|||
33478387|NCT00936897|101647026|FG000|Overall Study|Noncompliance|0|||
33478388|NCT00936897|101647027|FG001|Overall Study|Noncompliance|2|||
33478389|NCT00936897|101647026|FG000|Overall Study|Death|0|||
33478390|NCT00936897|101647027|FG001|Overall Study|Death|1|||
33478391|NCT01140503|101647029|FG000|Overall Study|Withdrawal by Subject|1|||
33269030|NCT01698918|100884375|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
33269031|NCT01698918|100884375|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
33269032|NCT01698918|100884375|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
33269033|NCT01698918|100884375|FG000|Second Line Treatment (Core+Extension)|Death|1|||
33478392|NCT03665441|101647030|FG000|Overall Study|survival follow up ongoing|23|||
33478393|NCT03665441|101647031|FG001|Overall Study|survival follow up ongoing|0|||
33478394|NCT03665441|101647030|FG000|Overall Study|Patients ongoing on treatment|9|||
33478395|NCT03665441|101647031|FG001|Overall Study|Patients ongoing on treatment|6|||
33478396|NCT03665441|101647030|FG000|Overall Study|Randomized but not treated|7|||
33478397|NCT03665441|101647031|FG001|Overall Study|Randomized but not treated|11|||
33478398|NCT02303041|101647032|FG000|Overall Study|Adverse Event|1|||
33478399|NCT02303041|101647033|FG001|Overall Study|Adverse Event|2|||
33478400|NCT01087489|101647036|FG000|Overall Study|enrolled in another VA study|0|||
33478401|NCT01087489|101647037|FG001|Overall Study|enrolled in another VA study|1|||
33478402|NCT01087489|101647036|FG000|Overall Study|Death|0|||
33478403|NCT01087489|101647037|FG001|Overall Study|Death|1|||
33478404|NCT01087489|101647036|FG000|Overall Study|unable to survey by telephone|0|||
33478405|NCT01087489|101647037|FG001|Overall Study|unable to survey by telephone|1|||
33478406|NCT03275064|101647038|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
33478407|NCT03275064|101647039|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
33478408|NCT03275064|101647040|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
33478409|NCT03275064|101647041|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
33269034|NCT01698918|100884375|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
33269035|NCT01698918|100884375|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
33269036|NCT01584648|100884376|FG000|Overall Study|Death|136|||
33269037|NCT01584648|100884377|FG001|Overall Study|Death|146|||
33269038|NCT01584648|100884376|FG000|Overall Study|Lost to Follow-up|9|||
33269039|NCT01584648|100884377|FG001|Overall Study|Lost to Follow-up|9|||
33269040|NCT01584648|100884376|FG000|Overall Study|Investigator discretion|3|||
33269041|NCT01584648|100884377|FG001|Overall Study|Investigator discretion|2|||
33269042|NCT01584648|100884376|FG000|Overall Study|Withdrew consent|13|||
33478410|NCT03275064|101647042|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
33478411|NCT03275064|101647038|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
33478412|NCT03275064|101647039|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
33478413|NCT03275064|101647040|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
33478414|NCT03275064|101647041|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
33478415|NCT03275064|101647042|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
33478416|NCT03275064|101647038|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
33478417|NCT03275064|101647039|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
33478418|NCT03275064|101647040|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
33478419|NCT03275064|101647041|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
33269043|NCT01584648|100884377|FG001|Overall Study|Withdrew consent|4|||
33269044|NCT01584648|100884376|FG000|Overall Study|Study closed/terminated|50|||
33478420|NCT03275064|101647042|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
33478421|NCT03275064|101647038|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
33478422|NCT03275064|101647039|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
33478423|NCT03275064|101647040|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
33478424|NCT03275064|101647041|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
33478425|NCT03275064|101647042|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
33478426|NCT03275064|101647038|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
33478427|NCT03275064|101647039|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
33478428|NCT03275064|101647040|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
33478429|NCT03275064|101647041|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
33478430|NCT03275064|101647042|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
33478431|NCT01001988|101647043|FG000|Overall Study|Protocol Violation|84|||
33478432|NCT01001988|101647043|FG000|Overall Study|Withdrawal by Subject|18|||
33478433|NCT01001988|101647043|FG000|Overall Study|Lost to Follow-up|15|||
33478434|NCT03283319|101647046|FG000|Overall Study|Lost to Follow-up|5|||
33478435|NCT03283319|101647047|FG001|Overall Study|Lost to Follow-up|4|||
33478436|NCT03283319|101647048|FG002|Overall Study|Lost to Follow-up|5|||
33478437|NCT03283319|101647049|FG003|Overall Study|Lost to Follow-up|5|||
33478438|NCT03283319|101647050|FG004|Overall Study|Lost to Follow-up|4|||
33478439|NCT03283319|101647051|FG005|Overall Study|Lost to Follow-up|3|||
33478440|NCT03283319|101647046|FG000|Overall Study|Withdrawal by Subject|2|||
33478441|NCT03283319|101647047|FG001|Overall Study|Withdrawal by Subject|2|||
33478442|NCT03283319|101647048|FG002|Overall Study|Withdrawal by Subject|2|||
33478443|NCT03283319|101647049|FG003|Overall Study|Withdrawal by Subject|1|||
33478444|NCT03283319|101647050|FG004|Overall Study|Withdrawal by Subject|0|||
33478445|NCT03283319|101647051|FG005|Overall Study|Withdrawal by Subject|1|||
33478446|NCT03283319|101647046|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
33478447|NCT03283319|101647047|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
33478448|NCT03283319|101647048|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
33478449|NCT03283319|101647049|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
33478450|NCT03283319|101647050|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
33478451|NCT03283319|101647051|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
33478452|NCT01284621|101647052|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
33478453|NCT01284621|101647053|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
33478454|NCT01284621|101647054|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
33478455|NCT01284621|101647055|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
33478456|NCT01284621|101647056|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
33478457|NCT01284621|101647057|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
33478458|NCT03186781|101647058|FG000|Overall Study|Lost to Follow-up|0|||
33478459|NCT03186781|101647059|FG001|Overall Study|Lost to Follow-up|0|||
33478460|NCT03186781|101647060|FG002|Overall Study|Lost to Follow-up|1|||
33478461|NCT03186781|101647061|FG003|Overall Study|Lost to Follow-up|0|||
33478462|NCT03186781|101647062|FG004|Overall Study|Lost to Follow-up|1|||
33478463|NCT03186781|101647063|FG005|Overall Study|Lost to Follow-up|0|||
33478464|NCT03186781|101647058|FG000|Overall Study|Moved from Area|0|||
33478465|NCT03186781|101647059|FG001|Overall Study|Moved from Area|0|||
33478466|NCT03186781|101647060|FG002|Overall Study|Moved from Area|0|||
33478467|NCT03186781|101647061|FG003|Overall Study|Moved from Area|0|||
33478468|NCT03186781|101647062|FG004|Overall Study|Moved from Area|1|||
33478469|NCT03186781|101647063|FG005|Overall Study|Moved from Area|0|||
33478470|NCT03186781|101647058|FG000|Overall Study|Withdrawal by Subject|0|||
33478471|NCT03186781|101647059|FG001|Overall Study|Withdrawal by Subject|0|||
33478472|NCT03186781|101647060|FG002|Overall Study|Withdrawal by Subject|0|||
33478473|NCT03186781|101647061|FG003|Overall Study|Withdrawal by Subject|0|||
33478474|NCT03186781|101647062|FG004|Overall Study|Withdrawal by Subject|1|||
33478475|NCT03186781|101647063|FG005|Overall Study|Withdrawal by Subject|0|||
33478476|NCT00827632|101647064|FG000|Overall Study|Lost to Follow-up|8|||
33269045|NCT01584648|100884377|FG001|Overall Study|Study closed/terminated|23|||
33269046|NCT01584648|100884376|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
33269047|NCT01584648|100884377|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
33269048|NCT02202317|100884378|FG000|Overall Study|Lost to Follow-up|1|||
33269049|NCT03288506|100884382|FG000|Overall Study|Withdrawal by Subject|52|||
33269050|NCT02038049|100884383|FG000|Overall Study|Lost to Follow-up|1|||
33269051|NCT02038049|100884384|FG001|Overall Study|Lost to Follow-up|0|||
33269052|NCT00569166|100884386|FG000|Overall Study|Withdrawal by Subject|7|||
33478477|NCT00827632|101647065|FG001|Overall Study|Lost to Follow-up|12|||
33478478|NCT00827632|101647064|FG000|Overall Study|Early withdrawal|14|||
33478479|NCT00827632|101647065|FG001|Overall Study|Early withdrawal|11|||
33478480|NCT03246646|101647069|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
33478481|NCT03246646|101647070|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
33478482|NCT03246646|101647069|FG000|Overall Study|Withdrawal by Subject|3|||
33478483|NCT03246646|101647070|FG001|Overall Study|Withdrawal by Subject|0|||
33478484|NCT03246646|101647069|FG000|Overall Study|Lost to Follow-up|7|||
33478485|NCT03246646|101647070|FG001|Overall Study|Lost to Follow-up|0|||
33478486|NCT02185053|101647072|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
33478487|NCT02185053|101647073|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
33478488|NCT02185053|101647074|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
33478489|NCT02185053|101647072|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
33478490|NCT02185053|101647073|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
33478491|NCT02185053|101647074|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
33478492|NCT02185053|101647072|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
33478493|NCT02185053|101647073|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
33478494|NCT02185053|101647074|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
33478495|NCT02185053|101647072|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
33478496|NCT02185053|101647073|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
33478497|NCT02185053|101647074|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
33478498|NCT02185053|101647072|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
33269053|NCT00569166|100884387|FG001|Overall Study|Withdrawal by Subject|5|||
33269054|NCT00569166|100884388|FG002|Overall Study|Withdrawal by Subject|3|||
33478499|NCT02185053|101647073|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
33478500|NCT02185053|101647074|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
33478501|NCT02185053|101647072|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
33478502|NCT02185053|101647073|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
33478503|NCT02185053|101647074|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
33478504|NCT02185053|101647072|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
33478505|NCT02185053|101647073|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
33478506|NCT02185053|101647074|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
33478507|NCT02185053|101647072|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
33478508|NCT02185053|101647073|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
33478509|NCT02185053|101647074|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
33478510|NCT04485039|101647082|FG000|TPOXX Only|Adverse Event|2|||
33478511|NCT04485039|101647082|FG000|TPOXX Only|Physician Decision|1|||
33478512|NCT04485039|101647082|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
33478513|NCT04485039|101647082|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
33269055|NCT00569166|100884386|FG000|Overall Study|Lost to Follow-up|2|||
33269056|NCT00569166|100884387|FG001|Overall Study|Lost to Follow-up|1|||
33269057|NCT00569166|100884388|FG002|Overall Study|Lost to Follow-up|1|||
33478514|NCT01982812|101647087|FG000|Overall Study|Death|1|||
33478515|NCT01982812|101647088|FG001|Overall Study|Death|5|||
33478516|NCT01982812|101647087|FG000|Overall Study|Adverse Event|0|||
33478517|NCT01982812|101647088|FG001|Overall Study|Adverse Event|5|||
33478518|NCT00638027|101647089|FG000|Overall Study|Adverse Event|0|||
33478519|NCT00638027|101647090|FG001|Overall Study|Adverse Event|2|||
33478520|NCT00951496|101647092|FG000|Overall Study|Did not initiate study treatment|10|||
33478521|NCT00951496|101647093|FG001|Overall Study|Did not initiate study treatment|8|||
33478522|NCT00951496|101647094|FG002|Overall Study|Did not initiate study treatment|13|||
33478523|NCT03511326|101647095|FG000|Overall Study|Withdrawal by Subject|1|||
33478524|NCT00858143|101647096|FG000|Overall Study|Adverse Event|16|||
33478525|NCT00858143|101647096|FG000|Overall Study|Lack of Efficacy|4|||
33478526|NCT00858143|101647096|FG000|Overall Study|Death|7|||
33478527|NCT00858143|101647096|FG000|Overall Study|Other|23|||
33478528|NCT00565617|101647097|FG000|Overall Study|Withdrawal by Subject|1|||
33478529|NCT00988442|101647102|FG000|Overall Study|Death|1|||
33478530|NCT00988442|101647103|FG001|Overall Study|Death|2|||
33478531|NCT00988442|101647102|FG000|Overall Study|Lost to Follow-up|0|||
33478532|NCT00988442|101647103|FG001|Overall Study|Lost to Follow-up|1|||
33478533|NCT00988442|101647102|FG000|Overall Study|Early Study Closure|29|||
33478534|NCT00988442|101647103|FG001|Overall Study|Early Study Closure|25|||
33478535|NCT00132028|101647106|FG000|Overall Study|Adverse Event|7|||
33478536|NCT00132028|101647106|FG000|Overall Study|Death|2|||
33478537|NCT00132028|101647106|FG000|Overall Study|Lack of Efficacy|11|||
33478538|NCT00132028|101647106|FG000|Overall Study|Withdrawal by Subject|2|||
33269058|NCT03015220|100884389|FG000|Overall Study|Withdrawal by Subject|3|||
33478539|NCT00132028|101647106|FG000|Overall Study|not eligible|2|||
33478540|NCT00132028|101647106|FG000|Overall Study|Physician Decision|3|||
33478541|NCT00977379|101647107|FG000|Overall Study|Withdrawal by Subject|1|||
33478542|NCT00977379|101647108|FG001|Overall Study|Withdrawal by Subject|1|||
33269059|NCT03015220|100884390|FG001|Overall Study|Withdrawal by Subject|2|||
33269060|NCT03015220|100884391|FG002|Overall Study|Withdrawal by Subject|2|||
33269061|NCT03015220|100884392|FG003|Overall Study|Withdrawal by Subject|2|||
33478543|NCT00977379|101647107|FG000|Overall Study|Death|7|||
33478544|NCT00977379|101647108|FG001|Overall Study|Death|9|||
33478545|NCT00977379|101647107|FG000|Overall Study|Premature Study Termination|4|||
33478546|NCT00977379|101647108|FG001|Overall Study|Premature Study Termination|0|||
33478547|NCT00977379|101647107|FG000|Overall Study|Participant Moving House|0|||
33478548|NCT00977379|101647108|FG001|Overall Study|Participant Moving House|1|||
33478549|NCT00977379|101647107|FG000|Overall Study|Randomization Error|0|||
33478550|NCT00977379|101647108|FG001|Overall Study|Randomization Error|1|||
33478551|NCT02049450|101647109|FG000|Overall Study|Adverse Event|2|||
33478552|NCT02049450|101647109|FG000|Overall Study|Withdrawal by Subject|1|||
33478553|NCT02049450|101647109|FG000|Overall Study|Patients/guardian decision|1|||
33478554|NCT02455050|101647110|FG000|Treatment Period 1|Lost to Follow-up|1|||
33478555|NCT02455050|101647111|FG001|Treatment Period 1|Lost to Follow-up|1|||
33478556|NCT02455050|101647112|FG002|Treatment Period 1|Lost to Follow-up|1|||
33478557|NCT02455050|101647113|FG003|Treatment Period 1|Lost to Follow-up|2|||
33478558|NCT02455050|101647110|FG000|Treatment Period 2|Lost to Follow-up|1|||
33478559|NCT02455050|101647111|FG001|Treatment Period 2|Lost to Follow-up|0|||
33478560|NCT02455050|101647112|FG002|Treatment Period 2|Lost to Follow-up|2|||
33478561|NCT02455050|101647113|FG003|Treatment Period 2|Lost to Follow-up|1|||
33478562|NCT00777036|101647114|FG000|On Treatment|Reason Not Specified|4|||
33478563|NCT00777036|101647115|FG001|On Treatment|Reason Not Specified|7|||
33478564|NCT00777036|101647116|FG002|On Treatment|Reason Not Specified|12|||
33478565|NCT00777036|101647114|FG000|On Treatment|Failure to Meet Study Criteria|0|||
33478566|NCT00777036|101647115|FG001|On Treatment|Failure to Meet Study Criteria|1|||
33478567|NCT00777036|101647116|FG002|On Treatment|Failure to Meet Study Criteria|0|||
33478568|NCT00777036|101647114|FG000|On Treatment|Non-compliance with Study Drug|1|||
33478569|NCT00777036|101647115|FG001|On Treatment|Non-compliance with Study Drug|0|||
33478570|NCT00777036|101647116|FG002|On Treatment|Non-compliance with Study Drug|0|||
33478571|NCT00777036|101647114|FG000|On Treatment|Maximum Clinical Benefit|2|||
33478572|NCT00777036|101647115|FG001|On Treatment|Maximum Clinical Benefit|0|||
33478573|NCT00777036|101647116|FG002|On Treatment|Maximum Clinical Benefit|1|||
33478574|NCT00777036|101647114|FG000|On Treatment|Withdrawal by Subject|3|||
33478575|NCT00777036|101647115|FG001|On Treatment|Withdrawal by Subject|2|||
33478576|NCT00777036|101647116|FG002|On Treatment|Withdrawal by Subject|3|||
33478577|NCT00777036|101647114|FG000|On Treatment|Death|0|||
33478578|NCT00777036|101647115|FG001|On Treatment|Death|2|||
33478579|NCT00777036|101647116|FG002|On Treatment|Death|0|||
33478580|NCT00777036|101647114|FG000|On Treatment|Study Drug Toxicity|0|||
33478581|NCT00777036|101647115|FG001|On Treatment|Study Drug Toxicity|0|||
33478582|NCT00777036|101647116|FG002|On Treatment|Study Drug Toxicity|1|||
33478583|NCT00777036|101647114|FG000|On Treatment|Progressive Disease|5|||
33478584|NCT00777036|101647115|FG001|On Treatment|Progressive Disease|4|||
33478585|NCT00777036|101647116|FG002|On Treatment|Progressive Disease|6|||
33478586|NCT00777036|101647114|FG000|Follow-Up|Lost to Follow-up|1|||
33478587|NCT00777036|101647115|FG001|Follow-Up|Lost to Follow-up|0|||
33478588|NCT00777036|101647116|FG002|Follow-Up|Lost to Follow-up|0|||
33478589|NCT00777036|101647114|FG000|Follow-Up|Reason Not Specified|2|||
33478590|NCT00777036|101647115|FG001|Follow-Up|Reason Not Specified|0|||
33478591|NCT00777036|101647116|FG002|Follow-Up|Reason Not Specified|0|||
33478592|NCT00777036|101647114|FG000|Follow-Up|Withdrawal by Subject|1|||
33478593|NCT00777036|101647115|FG001|Follow-Up|Withdrawal by Subject|0|||
33478594|NCT00777036|101647116|FG002|Follow-Up|Withdrawal by Subject|4|||
33478595|NCT00777036|101647114|FG000|Follow-Up|Death|1|||
33478596|NCT00777036|101647115|FG001|Follow-Up|Death|8|||
33478597|NCT00777036|101647116|FG002|Follow-Up|Death|0|||
33478598|NCT01437943|101647118|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
33478599|NCT01437943|101647119|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
33478600|NCT01437943|101647118|FG000|Overall Study|Subject expressed pregnancy plans|1|||
33269062|NCT03015220|100884389|FG000|Overall Study|Lost to Follow-up|0|||
33269063|NCT03015220|100884390|FG001|Overall Study|Lost to Follow-up|0|||
33269064|NCT03015220|100884391|FG002|Overall Study|Lost to Follow-up|1|||
33269065|NCT03015220|100884392|FG003|Overall Study|Lost to Follow-up|0|||
33269066|NCT00089609|100884393|FG000|Overall Study|Withdrawal by Subject|3|||
33269067|NCT00089609|100884394|FG001|Overall Study|Withdrawal by Subject|1|||
33478601|NCT01437943|101647119|FG001|Overall Study|Subject expressed pregnancy plans|0|||
33478602|NCT01437943|101647118|FG000|Overall Study|Adverse Event|2|||
33478603|NCT01437943|101647119|FG001|Overall Study|Adverse Event|0|||
33478604|NCT01844856|101647124|FG000|Overall Study|Lost to Follow-up|15|||
33478605|NCT01844856|101647125|FG001|Overall Study|Lost to Follow-up|3|||
33269068|NCT00736502|100884395|FG000|Overall Study|Adverse Event|22|||
33478606|NCT01844856|101647124|FG000|Overall Study|Adverse Event|3|||
33478607|NCT01844856|101647125|FG001|Overall Study|Adverse Event|6|||
33478608|NCT01844856|101647124|FG000|Overall Study|Withdrawal by Subject|3|||
33478609|NCT01844856|101647125|FG001|Overall Study|Withdrawal by Subject|2|||
33478610|NCT01844856|101647124|FG000|Overall Study|Noncompliance|2|||
33478611|NCT01844856|101647125|FG001|Overall Study|Noncompliance|3|||
33478612|NCT01844856|101647124|FG000|Overall Study|Enterococcus Resistant|0|||
33478613|NCT01844856|101647125|FG001|Overall Study|Enterococcus Resistant|1|||
33478614|NCT01844856|101647124|FG000|Overall Study|Inadvertently Not Scheduled|1|||
33478615|NCT01844856|101647125|FG001|Overall Study|Inadvertently Not Scheduled|0|||
33478616|NCT01844856|101647124|FG000|Overall Study|Randomized but was a Screen Failure|0|||
33478617|NCT01844856|101647125|FG001|Overall Study|Randomized but was a Screen Failure|1|||
33478618|NCT03167723|101647126|FG000|Overall Study|Protocol Violation|4|||
33478619|NCT03167723|101647127|FG001|Overall Study|Protocol Violation|6|||
33478620|NCT03783039|101647134|FG000|Overall Study|Death|2|||
33478621|NCT03783039|101647135|FG001|Overall Study|Death|1|||
33478622|NCT02728843|101647136|FG000|Overall Study|Adverse Event|0|||
33478623|NCT02728843|101647137|FG001|Overall Study|Adverse Event|2|||
33478624|NCT02728843|101647138|FG002|Overall Study|Adverse Event|3|||
33478625|NCT02728843|101647139|FG003|Overall Study|Adverse Event|1|||
33478626|NCT02728843|101647140|FG004|Overall Study|Adverse Event|2|||
33478627|NCT02728843|101647136|FG000|Overall Study|Lack of Efficacy|0|||
33478628|NCT02728843|101647137|FG001|Overall Study|Lack of Efficacy|1|||
33478629|NCT02728843|101647138|FG002|Overall Study|Lack of Efficacy|1|||
33478630|NCT02728843|101647139|FG003|Overall Study|Lack of Efficacy|0|||
33478631|NCT02728843|101647140|FG004|Overall Study|Lack of Efficacy|0|||
33478632|NCT02728843|101647136|FG000|Overall Study|Protocol Violation|2|||
33478633|NCT02728843|101647137|FG001|Overall Study|Protocol Violation|0|||
33478634|NCT02728843|101647138|FG002|Overall Study|Protocol Violation|4|||
33478635|NCT02728843|101647139|FG003|Overall Study|Protocol Violation|2|||
33478636|NCT02728843|101647140|FG004|Overall Study|Protocol Violation|2|||
33478637|NCT02728843|101647136|FG000|Overall Study|Withdrawal by Subject|1|||
33478638|NCT02728843|101647137|FG001|Overall Study|Withdrawal by Subject|0|||
33478639|NCT02728843|101647138|FG002|Overall Study|Withdrawal by Subject|0|||
33478640|NCT02728843|101647139|FG003|Overall Study|Withdrawal by Subject|1|||
33478641|NCT02728843|101647140|FG004|Overall Study|Withdrawal by Subject|0|||
33478642|NCT02728843|101647136|FG000|Overall Study|Use of rescue medication|0|||
33478643|NCT02728843|101647137|FG001|Overall Study|Use of rescue medication|2|||
33478644|NCT02728843|101647138|FG002|Overall Study|Use of rescue medication|0|||
33478645|NCT02728843|101647139|FG003|Overall Study|Use of rescue medication|2|||
33478646|NCT02728843|101647140|FG004|Overall Study|Use of rescue medication|1|||
33478647|NCT00537303|101647143|FG000|Overall Study|Adverse Event|1|||
33478648|NCT00537303|101647144|FG001|Overall Study|Adverse Event|4|||
33478649|NCT00537303|101647143|FG000|Overall Study|Lack of Efficacy|6|||
33478650|NCT00537303|101647144|FG001|Overall Study|Lack of Efficacy|7|||
33478651|NCT00537303|101647143|FG000|Overall Study|Protocol Violation|8|||
33478652|NCT00537303|101647144|FG001|Overall Study|Protocol Violation|4|||
33478653|NCT00537303|101647143|FG000|Overall Study|Withdrawal criteria|3|||
33478654|NCT00537303|101647144|FG001|Overall Study|Withdrawal criteria|3|||
33478655|NCT00537303|101647143|FG000|Overall Study|Unclassified|8|||
33478656|NCT00537303|101647144|FG001|Overall Study|Unclassified|7|||
33478657|NCT02628743|101647145|FG000|Overall Study|Other|3|||
33478658|NCT02628743|101647145|FG000|Overall Study|Withdrawal by Subject|50|||
33478659|NCT02628743|101647145|FG000|Overall Study|Study Terminated by Sponsor|76|||
33478660|NCT02628743|101647145|FG000|Overall Study|Physician Decision|2|||
33478661|NCT02335983|101647150|FG000|Overall Study|Sponsor Decision|0|||
33478662|NCT02335983|101647151|FG001|Overall Study|Sponsor Decision|0|||
33478663|NCT02335983|101647152|FG002|Overall Study|Sponsor Decision|1|||
33478664|NCT02335983|101647153|FG003|Overall Study|Sponsor Decision|1|||
33478665|NCT02335983|101647154|FG004|Overall Study|Sponsor Decision|0|||
33478666|NCT02335983|101647155|FG005|Overall Study|Sponsor Decision|1|||
33478667|NCT02335983|101647150|FG000|Overall Study|Withdrawal by Subject|3|||
33478668|NCT02335983|101647151|FG001|Overall Study|Withdrawal by Subject|2|||
33478669|NCT02335983|101647152|FG002|Overall Study|Withdrawal by Subject|2|||
33478670|NCT02335983|101647153|FG003|Overall Study|Withdrawal by Subject|1|||
33478671|NCT02335983|101647154|FG004|Overall Study|Withdrawal by Subject|3|||
33478672|NCT02335983|101647155|FG005|Overall Study|Withdrawal by Subject|9|||
33478673|NCT02335983|101647150|FG000|Overall Study|Death|0|||
33478674|NCT02335983|101647151|FG001|Overall Study|Death|0|||
33269069|NCT00736502|100884395|FG000|Overall Study|Lack of Efficacy|16|||
33269070|NCT00736502|100884395|FG000|Overall Study|Lost to Follow-up|27|||
33269071|NCT02993926|100884396|FG000|Enantone Treatment Phase|Adverse Event|1|||
33478675|NCT02335983|101647152|FG002|Overall Study|Death|2|||
33478676|NCT02335983|101647153|FG003|Overall Study|Death|0|||
33269072|NCT02993926|100884397|FG001|Enantone Treatment Phase|Adverse Event|0|||
33269073|NCT02993926|100884398|FG002|Enantone Treatment Phase|Adverse Event|0|||
33478677|NCT02335983|101647154|FG004|Overall Study|Death|0|||
33478678|NCT02335983|101647155|FG005|Overall Study|Death|0|||
33478679|NCT02335983|101647150|FG000|Overall Study|Lost to Follow-up|0|||
33478680|NCT02335983|101647151|FG001|Overall Study|Lost to Follow-up|0|||
33478681|NCT02335983|101647152|FG002|Overall Study|Lost to Follow-up|0|||
33478682|NCT02335983|101647153|FG003|Overall Study|Lost to Follow-up|0|||
33478683|NCT02335983|101647154|FG004|Overall Study|Lost to Follow-up|0|||
33478684|NCT02335983|101647155|FG005|Overall Study|Lost to Follow-up|1|||
33478685|NCT02335983|101647150|FG000|Overall Study|Protocol Specified Criteria|5|||
33478686|NCT02335983|101647151|FG001|Overall Study|Protocol Specified Criteria|7|||
33478687|NCT02335983|101647152|FG002|Overall Study|Protocol Specified Criteria|27|||
33478688|NCT02335983|101647153|FG003|Overall Study|Protocol Specified Criteria|7|||
33478689|NCT02335983|101647154|FG004|Overall Study|Protocol Specified Criteria|5|||
33478690|NCT02335983|101647155|FG005|Overall Study|Protocol Specified Criteria|21|||
33478691|NCT01206101|101647156|FG000|Overall Study|Adverse Event|1|||
33478692|NCT01206101|101647157|FG001|Overall Study|Adverse Event|0|||
33478693|NCT01206101|101647156|FG000|Overall Study|Physician Decision|0|||
33478694|NCT01206101|101647157|FG001|Overall Study|Physician Decision|1|||
33478695|NCT01206101|101647156|FG000|Overall Study|Unclassified|1|||
33478696|NCT01206101|101647157|FG001|Overall Study|Unclassified|0|||
33478697|NCT01934335|101647158|FG000|Overall Study|Withdrawal by Subject|1|||
33478698|NCT01934335|101647159|FG001|Overall Study|Withdrawal by Subject|1|||
33478699|NCT00090363|101647160|FG000|Overall Study|Lost to Follow-up|1|||
33478700|NCT00090363|101647161|FG001|Overall Study|Lost to Follow-up|2|||
33478701|NCT00090363|101647162|FG002|Overall Study|Lost to Follow-up|1|||
33478702|NCT00090363|101647160|FG000|Overall Study|Withdrawal by Subject|7|||
33478703|NCT00090363|101647161|FG001|Overall Study|Withdrawal by Subject|7|||
33478704|NCT00090363|101647162|FG002|Overall Study|Withdrawal by Subject|6|||
33478705|NCT00090363|101647160|FG000|Overall Study|Study-specific discontinuation criteria|75|||
33478706|NCT00090363|101647161|FG001|Overall Study|Study-specific discontinuation criteria|74|||
33478707|NCT00090363|101647162|FG002|Overall Study|Study-specific discontinuation criteria|62|||
33478708|NCT00090363|101647160|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33478709|NCT00090363|101647161|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33478710|NCT00090363|101647162|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
33478711|NCT00090363|101647160|FG000|Overall Study|Consent expired|7|||
33478712|NCT00090363|101647161|FG001|Overall Study|Consent expired|10|||
33478713|NCT00090363|101647162|FG002|Overall Study|Consent expired|9|||
33478714|NCT00090363|101647160|FG000|Overall Study|Reasons not specified|2|||
33478715|NCT00090363|101647161|FG001|Overall Study|Reasons not specified|1|||
33478716|NCT00090363|101647162|FG002|Overall Study|Reasons not specified|1|||
33478717|NCT00090363|101647160|FG000|Overall Study|Continuing on study off treatment|14|||
33478718|NCT00090363|101647161|FG001|Overall Study|Continuing on study off treatment|13|||
33478719|NCT00090363|101647162|FG002|Overall Study|Continuing on study off treatment|16|||
33478720|NCT00416884|101647163|FG000|Overall Study|Study terminated due to low accrual|1|||
33478721|NCT02393248|101647166|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478722|NCT02393248|101647167|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
33478723|NCT02393248|101647168|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478724|NCT02393248|101647169|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478725|NCT02393248|101647170|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478726|NCT02393248|101647171|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
33478727|NCT02393248|101647172|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
33478728|NCT02393248|101647173|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478729|NCT02393248|101647174|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478730|NCT02393248|101647175|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478731|NCT02393248|101647176|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478732|NCT02393248|101647177|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478733|NCT02393248|101647178|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478734|NCT02393248|101647179|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478735|NCT02393248|101647180|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478736|NCT02393248|101647181|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478737|NCT02393248|101647182|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478738|NCT02393248|101647183|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478739|NCT02393248|101647184|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478740|NCT02393248|101647185|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478741|NCT02393248|101647186|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478742|NCT02393248|101647187|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478743|NCT02393248|101647188|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478744|NCT02393248|101647189|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478745|NCT02393248|101647190|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
33478746|NCT02393248|101647166|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478747|NCT02393248|101647167|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
33478748|NCT02393248|101647168|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478749|NCT02393248|101647169|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33269074|NCT02993926|100884396|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
33269075|NCT02993926|100884397|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
33478750|NCT02393248|101647170|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478751|NCT02393248|101647171|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478752|NCT02393248|101647172|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478753|NCT02393248|101647173|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478754|NCT02393248|101647174|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478755|NCT02393248|101647175|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478756|NCT02393248|101647176|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478757|NCT02393248|101647177|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478758|NCT02393248|101647178|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478759|NCT02393248|101647179|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478760|NCT02393248|101647180|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478761|NCT02393248|101647181|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478762|NCT02393248|101647182|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478763|NCT02393248|101647183|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478764|NCT02393248|101647184|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478765|NCT02393248|101647185|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478766|NCT02393248|101647186|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478767|NCT02393248|101647187|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478768|NCT02393248|101647188|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478769|NCT02393248|101647189|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478770|NCT02393248|101647190|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
33478771|NCT02393248|101647166|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
33269076|NCT02993926|100884398|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
33269077|NCT02993926|100884396|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
33269078|NCT02993926|100884397|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
33269079|NCT02993926|100884398|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
33269080|NCT02993926|100884396|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
33269081|NCT02993926|100884397|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
33269082|NCT02993926|100884398|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
33269083|NCT02102724|100884399|FG000|Overall Study|Lost to Follow-up|1|||
33269084|NCT02102724|100884400|FG001|Overall Study|Lost to Follow-up|0|||
33269085|NCT02102724|100884399|FG000|Overall Study|surgery for brain aneurysm|1|||
33269086|NCT02102724|100884400|FG001|Overall Study|surgery for brain aneurysm|1|||
33269087|NCT01214200|100884401|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
33269088|NCT01214200|100884401|FG000|Overall Study|Withdrawal by Subject|2|||
33269089|NCT00800176|100884404|FG000|Overall Study|Adverse Event|2|||
33269090|NCT00800176|100884405|FG001|Overall Study|Adverse Event|1|||
33269091|NCT00800176|100884406|FG002|Overall Study|Adverse Event|0|||
33269092|NCT00800176|100884407|FG003|Overall Study|Adverse Event|2|||
33269093|NCT00800176|100884408|FG004|Overall Study|Adverse Event|1|||
33269094|NCT00800176|100884409|FG005|Overall Study|Adverse Event|1|||
33269095|NCT00800176|100884404|FG000|Overall Study|Refused treatment|3|||
33478772|NCT02393248|101647167|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
33478773|NCT02393248|101647168|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
33478774|NCT02393248|101647169|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
33478775|NCT02393248|101647170|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
33478776|NCT02393248|101647171|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
33478777|NCT02393248|101647172|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
33478778|NCT02393248|101647173|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
33478779|NCT02393248|101647174|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
33478780|NCT02393248|101647175|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
33478781|NCT02393248|101647176|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
33478782|NCT02393248|101647177|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
33478783|NCT02393248|101647178|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
33478784|NCT02393248|101647179|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
33478785|NCT02393248|101647180|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
33478786|NCT02393248|101647181|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
33478787|NCT02393248|101647182|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
33478788|NCT02393248|101647183|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
33478789|NCT02393248|101647184|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
33478790|NCT02393248|101647185|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
33478791|NCT02393248|101647186|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
33478792|NCT02393248|101647187|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
33478793|NCT02393248|101647188|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
33478794|NCT02393248|101647189|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
33478795|NCT02393248|101647190|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
33478796|NCT02393248|101647166|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
33478797|NCT02393248|101647167|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478798|NCT02393248|101647168|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478799|NCT02393248|101647169|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33269096|NCT00800176|100884405|FG001|Overall Study|Refused treatment|2|||
33269097|NCT00800176|100884406|FG002|Overall Study|Refused treatment|0|||
33269098|NCT00800176|100884407|FG003|Overall Study|Refused treatment|0|||
33269099|NCT00800176|100884408|FG004|Overall Study|Refused treatment|1|||
33269100|NCT00800176|100884409|FG005|Overall Study|Refused treatment|4|||
33269101|NCT00800176|100884404|FG000|Overall Study|Failure to return|3|||
33478800|NCT02393248|101647170|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478801|NCT02393248|101647171|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478802|NCT02393248|101647172|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478803|NCT02393248|101647173|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478804|NCT02393248|101647174|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478805|NCT02393248|101647175|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478806|NCT02393248|101647176|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478807|NCT02393248|101647177|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478808|NCT02393248|101647178|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478809|NCT02393248|101647179|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478810|NCT02393248|101647180|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478811|NCT02393248|101647181|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478812|NCT02393248|101647182|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478813|NCT02393248|101647183|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478814|NCT02393248|101647184|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478815|NCT02393248|101647185|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478816|NCT02393248|101647186|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478817|NCT02393248|101647187|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33269102|NCT00800176|100884405|FG001|Overall Study|Failure to return|3|||
33269103|NCT00800176|100884406|FG002|Overall Study|Failure to return|0|||
33269104|NCT00800176|100884407|FG003|Overall Study|Failure to return|2|||
33269105|NCT00800176|100884408|FG004|Overall Study|Failure to return|0|||
33269106|NCT00800176|100884409|FG005|Overall Study|Failure to return|0|||
33269107|NCT00800176|100884404|FG000|Overall Study|Other|1|||
33269108|NCT00800176|100884405|FG001|Overall Study|Other|0|||
33269109|NCT00800176|100884406|FG002|Overall Study|Other|0|||
33269110|NCT00800176|100884407|FG003|Overall Study|Other|0|||
33269111|NCT00800176|100884408|FG004|Overall Study|Other|2|||
33269112|NCT00800176|100884409|FG005|Overall Study|Other|0|||
33269113|NCT00886834|100884410|FG000|Overall Study|Protocol Violation|0|||
33269114|NCT00886834|100884411|FG001|Overall Study|Protocol Violation|3|||
33269115|NCT04895085|100884412|FG000|Overall Study|Death|1|||
33269116|NCT04895085|100884412|FG000|Overall Study|Withdrawal by Subject|1|||
33269117|NCT04895085|100884412|FG000|Overall Study|No longer eligible: Moved from area|1|||
33269118|NCT03042767|100884413|FG000|Overall Study|Lost to Follow-up|1|||
33269119|NCT03042767|100884414|FG001|Overall Study|Lost to Follow-up|2|||
33269120|NCT04070105|100884415|FG000|Overall Study|Lost to Follow-up|0|||
33269121|NCT04070105|100884416|FG001|Overall Study|Lost to Follow-up|0|||
33269122|NCT04070105|100884417|FG002|Overall Study|Lost to Follow-up|0|||
33269123|NCT04070105|100884418|FG003|Overall Study|Lost to Follow-up|0|||
33269124|NCT04070105|100884419|FG004|Overall Study|Lost to Follow-up|0|||
33269125|NCT04070105|100884420|FG005|Overall Study|Lost to Follow-up|1|||
33269126|NCT04820491|100884421|FG000|Overall Study|Withdrawal by Subject|1|||
33269127|NCT04820491|100884422|FG001|Overall Study|Withdrawal by Subject|0|||
33269128|NCT03176407|100884423|FG000|Overall Study|Protocol Violation|1|||
33269129|NCT03176407|100884423|FG000|Overall Study|human failure|1|||
33269130|NCT03176407|100884423|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
33269131|NCT02255474|100884424|FG000|Overall Study|Lost to Follow-up|1|||
33269132|NCT02255474|100884425|FG001|Overall Study|Lost to Follow-up|1|||
33269133|NCT02255474|100884426|FG002|Overall Study|Lost to Follow-up|3|||
33269134|NCT02255474|100884424|FG000|Overall Study|Withdrawal by Subject|1|||
33269135|NCT02255474|100884425|FG001|Overall Study|Withdrawal by Subject|1|||
33269136|NCT02255474|100884426|FG002|Overall Study|Withdrawal by Subject|0|||
33269137|NCT02827201|100884427|FG000|Overall Study|Death|1|||
33269138|NCT02827201|100884428|FG001|Overall Study|Death|2|||
33269139|NCT02827201|100884427|FG000|Overall Study|Patients not treated|1|||
33269140|NCT02827201|100884428|FG001|Overall Study|Patients not treated|1|||
33269141|NCT01429285|100884429|FG000|Overall Study|Protocol Violation|9|||
33269142|NCT01429285|100884430|FG001|Overall Study|Protocol Violation|4|||
33269143|NCT01429285|100884429|FG000|Overall Study|Missing Data|5|||
33269144|NCT01429285|100884430|FG001|Overall Study|Missing Data|3|||
33269145|NCT01429285|100884429|FG000|Overall Study|Erroneously Enrolled Twice|8|||
33269146|NCT01429285|100884430|FG001|Overall Study|Erroneously Enrolled Twice|2|||
33269147|NCT04183491|100884431|FG000|Overall Study|Withdrawal by Subject|0|||
33269148|NCT04183491|100884432|FG001|Overall Study|Withdrawal by Subject|0|||
33269149|NCT04183491|100884433|FG002|Overall Study|Withdrawal by Subject|1|||
33269150|NCT04183491|100884434|FG003|Overall Study|Withdrawal by Subject|0|||
33269151|NCT04183491|100884435|FG004|Overall Study|Withdrawal by Subject|0|||
33269152|NCT04183491|100884436|FG005|Overall Study|Withdrawal by Subject|1|||
33269153|NCT04183491|100884437|FG006|Overall Study|Withdrawal by Subject|0|||
33269154|NCT01124045|100884439|FG000|Overall Study|Lost to Follow-up|0|||
33269155|NCT01124045|100884440|FG001|Overall Study|Lost to Follow-up|1|||
33269156|NCT01124045|100884439|FG000|Overall Study|Physician Decision|0|||
33269157|NCT01124045|100884440|FG001|Overall Study|Physician Decision|2|||
33269158|NCT03205488|100884444|FG000|Overall Study|Adverse Event|1|||
33269159|NCT03205488|100884445|FG001|Overall Study|Adverse Event|2|||
33478818|NCT02393248|101647188|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478819|NCT02393248|101647189|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478820|NCT02393248|101647190|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
33478821|NCT02393248|101647166|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478822|NCT02393248|101647167|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478823|NCT02393248|101647168|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478824|NCT02393248|101647169|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478825|NCT02393248|101647170|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33269160|NCT03205488|100884446|FG002|Overall Study|Adverse Event|4|||
33269161|NCT03205488|100884444|FG000|Overall Study|Protocol Violation|0|||
33269162|NCT03205488|100884445|FG001|Overall Study|Protocol Violation|0|||
33269163|NCT03205488|100884446|FG002|Overall Study|Protocol Violation|1|||
33269164|NCT01138657|100884454|FG000|Overall Study|Adverse Event|3|||
33478826|NCT02393248|101647171|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
33478827|NCT02393248|101647172|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
33478828|NCT02393248|101647173|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478829|NCT02393248|101647174|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478830|NCT02393248|101647175|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
33478831|NCT02393248|101647176|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478832|NCT02393248|101647177|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478833|NCT02393248|101647178|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478834|NCT02393248|101647179|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478835|NCT02393248|101647180|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478836|NCT02393248|101647181|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478837|NCT02393248|101647182|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478838|NCT02393248|101647183|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478839|NCT02393248|101647184|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478840|NCT02393248|101647185|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478841|NCT02393248|101647186|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478842|NCT02393248|101647187|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478843|NCT02393248|101647188|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478844|NCT02393248|101647189|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478845|NCT02393248|101647190|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
33478846|NCT02393248|101647166|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478847|NCT02393248|101647167|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478848|NCT02393248|101647168|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478849|NCT02393248|101647169|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478850|NCT02393248|101647170|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478851|NCT02393248|101647171|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478852|NCT02393248|101647172|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
33478853|NCT02393248|101647173|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478854|NCT02393248|101647174|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478855|NCT02393248|101647175|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478856|NCT02393248|101647176|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478857|NCT02393248|101647177|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478858|NCT02393248|101647178|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478859|NCT02393248|101647179|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478860|NCT02393248|101647180|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478861|NCT02393248|101647181|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478862|NCT02393248|101647182|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478863|NCT02393248|101647183|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478864|NCT02393248|101647184|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478865|NCT02393248|101647185|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478866|NCT02393248|101647186|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478867|NCT02393248|101647187|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478868|NCT02393248|101647188|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478869|NCT02393248|101647189|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33269165|NCT01138657|100884455|FG001|Overall Study|Adverse Event|10|||
33269166|NCT01138657|100884454|FG000|Overall Study|Lack of Efficacy|2|||
33269167|NCT01138657|100884455|FG001|Overall Study|Lack of Efficacy|1|||
33478870|NCT02393248|101647190|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
33478871|NCT02393248|101647166|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478872|NCT02393248|101647167|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478873|NCT02393248|101647168|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478874|NCT02393248|101647169|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478875|NCT02393248|101647170|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478876|NCT02393248|101647171|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478877|NCT02393248|101647172|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33269168|NCT01138657|100884454|FG000|Overall Study|Lost to Follow-up|0|||
33269169|NCT01138657|100884455|FG001|Overall Study|Lost to Follow-up|3|||
33269170|NCT01138657|100884454|FG000|Overall Study|Miscellaneous Reasons|3|||
33269171|NCT01138657|100884455|FG001|Overall Study|Miscellaneous Reasons|4|||
33269172|NCT01159600|100884459|FG000|Overall Study|Not treated|0|||
33269173|NCT01159600|100884460|FG001|Overall Study|Not treated|0|||
33269174|NCT01159600|100884461|FG002|Overall Study|Not treated|1|||
33269175|NCT01159600|100884462|FG003|Overall Study|Not treated|0|||
33269176|NCT01159600|100884463|FG004|Overall Study|Not treated|0|||
33269177|NCT01159600|100884464|FG005|Overall Study|Not treated|1|||
33269178|NCT01159600|100884465|FG006|Overall Study|Not treated|2|||
33269179|NCT01159600|100884466|FG007|Overall Study|Not treated|2|||
33269180|NCT01159600|100884459|FG000|Overall Study|Adverse Event|7|||
33269181|NCT01159600|100884460|FG001|Overall Study|Adverse Event|2|||
33269182|NCT01159600|100884461|FG002|Overall Study|Adverse Event|5|||
33269183|NCT01159600|100884462|FG003|Overall Study|Adverse Event|1|||
33269184|NCT01159600|100884463|FG004|Overall Study|Adverse Event|8|||
33269185|NCT01159600|100884464|FG005|Overall Study|Adverse Event|6|||
33269186|NCT01159600|100884465|FG006|Overall Study|Adverse Event|7|||
33269187|NCT01159600|100884466|FG007|Overall Study|Adverse Event|5|||
33269188|NCT01159600|100884459|FG000|Overall Study|Lack of Efficacy|0|||
33269189|NCT01159600|100884460|FG001|Overall Study|Lack of Efficacy|0|||
33269190|NCT01159600|100884461|FG002|Overall Study|Lack of Efficacy|0|||
33269191|NCT01159600|100884462|FG003|Overall Study|Lack of Efficacy|0|||
33269192|NCT01159600|100884463|FG004|Overall Study|Lack of Efficacy|2|||
33269193|NCT01159600|100884464|FG005|Overall Study|Lack of Efficacy|0|||
33269194|NCT01159600|100884465|FG006|Overall Study|Lack of Efficacy|0|||
33269195|NCT01159600|100884466|FG007|Overall Study|Lack of Efficacy|1|||
33478878|NCT02393248|101647173|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478879|NCT02393248|101647174|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478880|NCT02393248|101647175|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478881|NCT02393248|101647176|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478882|NCT02393248|101647177|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
33478883|NCT02393248|101647178|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
33478884|NCT02393248|101647179|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
33478885|NCT02393248|101647180|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
33478886|NCT02393248|101647181|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478887|NCT02393248|101647182|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478888|NCT02393248|101647183|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478889|NCT02393248|101647184|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478890|NCT02393248|101647185|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478891|NCT02393248|101647186|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478892|NCT02393248|101647187|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478893|NCT02393248|101647188|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478894|NCT02393248|101647189|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478895|NCT02393248|101647190|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
33478896|NCT02393248|101647166|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478897|NCT02393248|101647167|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478898|NCT02393248|101647168|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33269196|NCT01159600|100884459|FG000|Overall Study|Non compliant with protocol|2|||
33269197|NCT01159600|100884460|FG001|Overall Study|Non compliant with protocol|1|||
33269198|NCT01159600|100884461|FG002|Overall Study|Non compliant with protocol|0|||
33269199|NCT01159600|100884462|FG003|Overall Study|Non compliant with protocol|0|||
33269200|NCT01159600|100884463|FG004|Overall Study|Non compliant with protocol|2|||
33269201|NCT01159600|100884464|FG005|Overall Study|Non compliant with protocol|0|||
33478899|NCT02393248|101647169|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478900|NCT02393248|101647170|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478901|NCT02393248|101647171|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478902|NCT02393248|101647172|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33269202|NCT01159600|100884465|FG006|Overall Study|Non compliant with protocol|2|||
33269203|NCT01159600|100884466|FG007|Overall Study|Non compliant with protocol|0|||
33269204|NCT01159600|100884459|FG000|Overall Study|Lost to Follow-up|2|||
33269205|NCT01159600|100884460|FG001|Overall Study|Lost to Follow-up|3|||
33269206|NCT01159600|100884461|FG002|Overall Study|Lost to Follow-up|4|||
33478903|NCT02393248|101647173|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478904|NCT02393248|101647174|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478905|NCT02393248|101647175|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478906|NCT02393248|101647176|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
33478907|NCT02393248|101647177|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
33478908|NCT02393248|101647178|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478909|NCT02393248|101647179|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478910|NCT02393248|101647180|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478911|NCT02393248|101647181|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478912|NCT02393248|101647182|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478913|NCT02393248|101647183|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478914|NCT02393248|101647184|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478915|NCT02393248|101647185|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478916|NCT02393248|101647186|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33269207|NCT01159600|100884462|FG003|Overall Study|Lost to Follow-up|3|||
33269208|NCT01159600|100884463|FG004|Overall Study|Lost to Follow-up|3|||
33269209|NCT01159600|100884464|FG005|Overall Study|Lost to Follow-up|0|||
33269210|NCT01159600|100884465|FG006|Overall Study|Lost to Follow-up|3|||
33269211|NCT01159600|100884466|FG007|Overall Study|Lost to Follow-up|2|||
33478917|NCT02393248|101647187|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33269212|NCT01159600|100884459|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
33269213|NCT01159600|100884460|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
33269214|NCT01159600|100884461|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
33478918|NCT02393248|101647188|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478919|NCT02393248|101647189|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478920|NCT02393248|101647190|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
33478921|NCT02393248|101647166|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
33269215|NCT01159600|100884462|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
33269216|NCT01159600|100884463|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
33269217|NCT01159600|100884464|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
33269218|NCT01159600|100884465|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
33269219|NCT01159600|100884466|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
33269220|NCT01159600|100884459|FG000|Overall Study|Other reason not defined above|3|||
33269221|NCT01159600|100884460|FG001|Overall Study|Other reason not defined above|0|||
33269222|NCT01159600|100884461|FG002|Overall Study|Other reason not defined above|4|||
33269223|NCT01159600|100884462|FG003|Overall Study|Other reason not defined above|2|||
33269224|NCT01159600|100884463|FG004|Overall Study|Other reason not defined above|5|||
33269225|NCT01159600|100884464|FG005|Overall Study|Other reason not defined above|7|||
33269226|NCT01159600|100884465|FG006|Overall Study|Other reason not defined above|3|||
33269227|NCT01159600|100884466|FG007|Overall Study|Other reason not defined above|3|||
33269228|NCT01686152|100884467|FG000|Overall Study|Withdrawal by Subject|11|||
33269229|NCT01686152|100884468|FG001|Overall Study|Withdrawal by Subject|11|||
33269230|NCT01686152|100884469|FG002|Overall Study|Withdrawal by Subject|3|||
33269231|NCT01686152|100884467|FG000|Overall Study|Drug Code Unblinded|0|||
33269232|NCT01686152|100884468|FG001|Overall Study|Drug Code Unblinded|1|||
33269233|NCT01686152|100884469|FG002|Overall Study|Drug Code Unblinded|0|||
33269234|NCT01686152|100884467|FG000|Overall Study|Protocol Violation|6|||
33269235|NCT01686152|100884468|FG001|Overall Study|Protocol Violation|1|||
33269236|NCT01686152|100884469|FG002|Overall Study|Protocol Violation|0|||
33269237|NCT01686152|100884467|FG000|Overall Study|Adverse Event|12|||
33269238|NCT01686152|100884468|FG001|Overall Study|Adverse Event|11|||
33269239|NCT01686152|100884469|FG002|Overall Study|Adverse Event|0|||
33269240|NCT01686152|100884467|FG000|Overall Study|Lack of Efficacy|0|||
33269241|NCT01686152|100884468|FG001|Overall Study|Lack of Efficacy|0|||
33269242|NCT01686152|100884469|FG002|Overall Study|Lack of Efficacy|1|||
33269243|NCT01686152|100884467|FG000|Overall Study|IP Non-compliance|5|||
33269244|NCT01686152|100884468|FG001|Overall Study|IP Non-compliance|5|||
33269245|NCT01686152|100884469|FG002|Overall Study|IP Non-compliance|0|||
33269246|NCT01686152|100884467|FG000|Overall Study|Lost to Follow-up|7|||
33269247|NCT01686152|100884468|FG001|Overall Study|Lost to Follow-up|6|||
33269248|NCT01686152|100884469|FG002|Overall Study|Lost to Follow-up|5|||
33269249|NCT03100370|100884473|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33269250|NCT03100370|100884474|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33478922|NCT02393248|101647167|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
33269251|NCT03100370|100884475|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33269252|NCT03100370|100884476|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
33269253|NCT03100370|100884477|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33269254|NCT03100370|100884478|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
33269255|NCT03652610|100884481|FG000|Overall Study|Lost to Follow-up|1|||
33269256|NCT03652610|100884482|FG001|Overall Study|Lost to Follow-up|0|||
33269257|NCT03652610|100884481|FG000|Overall Study|Withdrawal by Subject|3|||
33269258|NCT03652610|100884482|FG001|Overall Study|Withdrawal by Subject|5|||
33269259|NCT02095678|100884483|FG000|Overall Study|Withdrawal by Subject|0|||
33269260|NCT02095678|100884484|FG001|Overall Study|Withdrawal by Subject|1|||
33269261|NCT02095678|100884483|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
33269262|NCT02095678|100884484|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
33269263|NCT02095678|100884483|FG000|Overall Study|lesion impacted by previous treatment|1|||
33269264|NCT02095678|100884484|FG001|Overall Study|lesion impacted by previous treatment|1|||
33269265|NCT02095678|100884483|FG000|Overall Study|No Confirmed Diagnosis|0|||
33269266|NCT02095678|100884484|FG001|Overall Study|No Confirmed Diagnosis|3|||
33269267|NCT02095678|100884483|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
33269268|NCT02095678|100884484|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
33269269|NCT02095678|100884483|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
33269270|NCT02095678|100884484|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
33269271|NCT00310037|100884485|FG000|Overall Study|Adverse Event|7|||
33269272|NCT00310037|100884486|FG001|Overall Study|Adverse Event|14|||
33478923|NCT02393248|101647168|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
33478924|NCT02393248|101647169|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
33478925|NCT02393248|101647170|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
33478926|NCT02393248|101647171|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
33269273|NCT00310037|100884485|FG000|Overall Study|Withdrawal by Subject|4|||
33269274|NCT00310037|100884486|FG001|Overall Study|Withdrawal by Subject|3|||
33269275|NCT00310037|100884485|FG000|Overall Study|Progression|6|||
33269276|NCT00310037|100884486|FG001|Overall Study|Progression|0|||
33269277|NCT00310037|100884485|FG000|Overall Study|Non-protocol treatment|1|||
33269278|NCT00310037|100884486|FG001|Overall Study|Non-protocol treatment|0|||
33269279|NCT00878189|100884487|FG000|Overall Study|Death|0|||
33269280|NCT00878189|100884488|FG001|Overall Study|Death|1|||
33269281|NCT00878189|100884489|FG002|Overall Study|Death|0|||
33269282|NCT00878189|100884490|FG003|Overall Study|Death|1|||
33269283|NCT00878189|100884491|FG004|Overall Study|Death|0|||
33269284|NCT00878189|100884492|FG005|Overall Study|Death|0|||
33269285|NCT00878189|100884493|FG006|Overall Study|Death|0|||
33269286|NCT00878189|100884494|FG007|Overall Study|Death|0|||
33269287|NCT00878189|100884495|FG008|Overall Study|Death|1|||
33478927|NCT02393248|101647172|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
33478928|NCT02393248|101647173|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
33478929|NCT02393248|101647174|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
33478930|NCT02393248|101647175|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
33478931|NCT02393248|101647176|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
33478932|NCT02393248|101647177|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
33478933|NCT02393248|101647178|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
33478934|NCT02393248|101647179|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
33478935|NCT02393248|101647180|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
33478936|NCT02393248|101647181|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
33478937|NCT02393248|101647182|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
33478938|NCT02393248|101647183|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
33478939|NCT02393248|101647184|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
33478940|NCT02393248|101647185|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
33478941|NCT02393248|101647186|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
33478942|NCT02393248|101647187|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
33269288|NCT00878189|100884487|FG000|Overall Study|Participant Refused to Follow-up|0|||
33269289|NCT00878189|100884488|FG001|Overall Study|Participant Refused to Follow-up|0|||
33269290|NCT00878189|100884489|FG002|Overall Study|Participant Refused to Follow-up|0|||
33269291|NCT00878189|100884490|FG003|Overall Study|Participant Refused to Follow-up|0|||
33269292|NCT00878189|100884491|FG004|Overall Study|Participant Refused to Follow-up|0|||
33269293|NCT00878189|100884492|FG005|Overall Study|Participant Refused to Follow-up|4|||
33269294|NCT00878189|100884493|FG006|Overall Study|Participant Refused to Follow-up|0|||
33269295|NCT00878189|100884494|FG007|Overall Study|Participant Refused to Follow-up|0|||
33269296|NCT00878189|100884495|FG008|Overall Study|Participant Refused to Follow-up|0|||
33269297|NCT00878189|100884487|FG000|Overall Study|Other|3|||
33269298|NCT00878189|100884488|FG001|Overall Study|Other|2|||
33269299|NCT00878189|100884489|FG002|Overall Study|Other|4|||
33269300|NCT00878189|100884490|FG003|Overall Study|Other|7|||
33269301|NCT00878189|100884491|FG004|Overall Study|Other|4|||
33269302|NCT00878189|100884492|FG005|Overall Study|Other|18|||
33269303|NCT00878189|100884493|FG006|Overall Study|Other|15|||
33269304|NCT00878189|100884494|FG007|Overall Study|Other|3|||
33269305|NCT00878189|100884495|FG008|Overall Study|Other|4|||
33269306|NCT00878189|100884487|FG000|Overall Study|Lost to Follow-up|0|||
33269307|NCT00878189|100884488|FG001|Overall Study|Lost to Follow-up|0|||
33269308|NCT00878189|100884489|FG002|Overall Study|Lost to Follow-up|0|||
33478943|NCT02393248|101647188|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
33269309|NCT00878189|100884490|FG003|Overall Study|Lost to Follow-up|0|||
33269310|NCT00878189|100884491|FG004|Overall Study|Lost to Follow-up|0|||
33269311|NCT00878189|100884492|FG005|Overall Study|Lost to Follow-up|1|||
33269312|NCT00878189|100884493|FG006|Overall Study|Lost to Follow-up|1|||
33478944|NCT02393248|101647189|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
33478945|NCT02393248|101647190|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
33478946|NCT02393248|101647166|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478947|NCT02393248|101647167|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478948|NCT02393248|101647168|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478949|NCT02393248|101647169|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478950|NCT02393248|101647170|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478951|NCT02393248|101647171|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478952|NCT02393248|101647172|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478953|NCT02393248|101647173|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478954|NCT02393248|101647174|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478955|NCT02393248|101647175|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33269313|NCT00878189|100884494|FG007|Overall Study|Lost to Follow-up|0|||
33269314|NCT00878189|100884495|FG008|Overall Study|Lost to Follow-up|0|||
33269315|NCT00878189|100884487|FG000|Overall Study|Objection Progression or Relapse|0|||
33269316|NCT00878189|100884488|FG001|Overall Study|Objection Progression or Relapse|0|||
33269317|NCT00878189|100884489|FG002|Overall Study|Objection Progression or Relapse|0|||
33269318|NCT00878189|100884490|FG003|Overall Study|Objection Progression or Relapse|0|||
33269319|NCT00878189|100884491|FG004|Overall Study|Objection Progression or Relapse|0|||
33269320|NCT00878189|100884492|FG005|Overall Study|Objection Progression or Relapse|0|||
33269321|NCT00878189|100884493|FG006|Overall Study|Objection Progression or Relapse|0|||
33269322|NCT00878189|100884494|FG007|Overall Study|Objection Progression or Relapse|0|||
33269323|NCT00878189|100884495|FG008|Overall Study|Objection Progression or Relapse|3|||
33269324|NCT03820024|100884496|FG000|Overall Study|Physician Decision|1|||
33269325|NCT03820024|100884497|FG001|Overall Study|Physician Decision|2|||
33269326|NCT00068107|100884498|FG000|Overall Study|end-stage renal disease|6|||
33269327|NCT00068107|100884498|FG000|Overall Study|Death|2|||
33269328|NCT00068107|100884498|FG000|Overall Study|Withdrawal by Subject|1|||
33269329|NCT01852045|100884499|FG000|Overall Study|Adverse Event|1|||
33269330|NCT01852045|100884500|FG001|Overall Study|Adverse Event|0|||
33269331|NCT01852045|100884501|FG002|Overall Study|Adverse Event|0|||
33269332|NCT01852045|100884499|FG000|Overall Study|Lack of Efficacy|3|||
33269333|NCT01852045|100884500|FG001|Overall Study|Lack of Efficacy|0|||
33269334|NCT01852045|100884501|FG002|Overall Study|Lack of Efficacy|0|||
33269335|NCT01852045|100884499|FG000|Overall Study|Lost to Follow-up|0|||
33269336|NCT01852045|100884500|FG001|Overall Study|Lost to Follow-up|1|||
33269337|NCT01852045|100884501|FG002|Overall Study|Lost to Follow-up|1|||
33269338|NCT01852045|100884499|FG000|Overall Study|Withdrawal by Subject|1|||
33269339|NCT01852045|100884500|FG001|Overall Study|Withdrawal by Subject|0|||
33269340|NCT01852045|100884501|FG002|Overall Study|Withdrawal by Subject|1|||
33269341|NCT01852045|100884499|FG000|Overall Study|Other Miscellaneous Reasons|1|||
33269342|NCT01852045|100884500|FG001|Overall Study|Other Miscellaneous Reasons|3|||
33269343|NCT01852045|100884501|FG002|Overall Study|Other Miscellaneous Reasons|2|||
33269344|NCT00853593|100884502|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
33269345|NCT00853593|100884502|FG000|Overall Study|Model 4396 lead not attempted|29|||
33269346|NCT00853593|100884502|FG000|Overall Study|Implant not attempted|4|||
33269347|NCT00645411|100884503|FG000|Overall Study|Adverse Event|0|||
33269348|NCT00645411|100884504|FG001|Overall Study|Adverse Event|0|||
33269349|NCT00645411|100884505|FG002|Overall Study|Adverse Event|0|||
33269350|NCT00645411|100884506|FG003|Overall Study|Adverse Event|2|||
33269351|NCT00645411|100884503|FG000|Overall Study|Withdrawal by Subject|2|||
33269352|NCT00645411|100884504|FG001|Overall Study|Withdrawal by Subject|1|||
33269353|NCT00645411|100884505|FG002|Overall Study|Withdrawal by Subject|19|||
33269354|NCT00645411|100884506|FG003|Overall Study|Withdrawal by Subject|21|||
33269355|NCT00645411|100884503|FG000|Overall Study|Lost to Follow-up|10|||
33269356|NCT00645411|100884504|FG001|Overall Study|Lost to Follow-up|5|||
33269357|NCT00645411|100884505|FG002|Overall Study|Lost to Follow-up|124|||
33269358|NCT00645411|100884506|FG003|Overall Study|Lost to Follow-up|75|||
33269359|NCT00645411|100884503|FG000|Overall Study|Protocol Violation|1|||
33269360|NCT00645411|100884504|FG001|Overall Study|Protocol Violation|0|||
33269361|NCT00645411|100884505|FG002|Overall Study|Protocol Violation|1|||
33269362|NCT00645411|100884506|FG003|Overall Study|Protocol Violation|0|||
33269363|NCT00645411|100884503|FG000|Overall Study|Inappropriate enrollment|0|||
33269364|NCT00645411|100884504|FG001|Overall Study|Inappropriate enrollment|0|||
33269365|NCT00645411|100884505|FG002|Overall Study|Inappropriate enrollment|4|||
33269366|NCT00645411|100884506|FG003|Overall Study|Inappropriate enrollment|1|||
33269367|NCT00645411|100884503|FG000|Overall Study|Unable to classify|0|||
33269368|NCT00645411|100884504|FG001|Overall Study|Unable to classify|0|||
33269369|NCT00645411|100884505|FG002|Overall Study|Unable to classify|3|||
33269370|NCT00645411|100884506|FG003|Overall Study|Unable to classify|4|||
33269371|NCT03675321|100884515|FG000|Overall Study|Lack of Efficacy|2|||
33269372|NCT03675321|100884516|FG001|Overall Study|Lack of Efficacy|2|||
33269373|NCT03675321|100884515|FG000|Overall Study|Withdrawal by Subject|1|||
33269374|NCT03675321|100884516|FG001|Overall Study|Withdrawal by Subject|3|||
33269375|NCT01560429|100884517|FG000|Overall Study|Protocol Violation|3|||
33269376|NCT01560429|100884518|FG001|Overall Study|Protocol Violation|6|||
33269377|NCT01567852|100884519|FG000|Overall Study|Withdrawal by Subject|3|||
33269378|NCT01567852|100884520|FG001|Overall Study|Withdrawal by Subject|6|||
33269379|NCT01567852|100884519|FG000|Overall Study|ECT discontinued|1|||
33269380|NCT01567852|100884520|FG001|Overall Study|ECT discontinued|1|||
33269381|NCT02232737|100884521|FG000|Overall Study|Lost to Follow-up|18|||
33269382|NCT02232737|100884522|FG001|Overall Study|Lost to Follow-up|28|||
33269383|NCT02232737|100884523|FG002|Overall Study|Lost to Follow-up|33|||
33478956|NCT02393248|101647176|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478957|NCT02393248|101647177|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
33478958|NCT02393248|101647178|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478959|NCT02393248|101647179|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
33478960|NCT02393248|101647180|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478961|NCT02393248|101647181|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478962|NCT02393248|101647182|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478963|NCT02393248|101647183|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478964|NCT02393248|101647184|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478965|NCT02393248|101647185|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478966|NCT02393248|101647186|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478967|NCT02393248|101647187|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478968|NCT02393248|101647188|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478969|NCT02393248|101647189|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478970|NCT02393248|101647190|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
33478971|NCT02393248|101647166|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478972|NCT02393248|101647167|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478973|NCT02393248|101647168|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478974|NCT02393248|101647169|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478975|NCT02393248|101647170|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478976|NCT02393248|101647171|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478977|NCT02393248|101647172|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478978|NCT02393248|101647173|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478979|NCT02393248|101647174|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478980|NCT02393248|101647175|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478981|NCT02393248|101647176|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478982|NCT02393248|101647177|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478983|NCT02393248|101647178|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478984|NCT02393248|101647179|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478985|NCT02393248|101647180|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478986|NCT02393248|101647181|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478987|NCT02393248|101647182|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478988|NCT02393248|101647183|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478989|NCT02393248|101647184|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
33478990|NCT02393248|101647185|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478991|NCT02393248|101647186|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
33478992|NCT02393248|101647187|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
33478993|NCT02393248|101647188|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478994|NCT02393248|101647189|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
33478995|NCT02393248|101647190|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
33478996|NCT02393248|101647166|FG000|Part 3: Combination Therapy|Death|0|||
33478997|NCT02393248|101647167|FG001|Part 3: Combination Therapy|Death|0|||
33478998|NCT02393248|101647168|FG002|Part 3: Combination Therapy|Death|0|||
33478999|NCT02393248|101647169|FG003|Part 3: Combination Therapy|Death|0|||
33479000|NCT02393248|101647170|FG004|Part 3: Combination Therapy|Death|0|||
33479001|NCT02393248|101647171|FG005|Part 3: Combination Therapy|Death|0|||
33479002|NCT02393248|101647172|FG006|Part 3: Combination Therapy|Death|0|||
33479003|NCT02393248|101647173|FG007|Part 3: Combination Therapy|Death|0|||
33479004|NCT02393248|101647174|FG008|Part 3: Combination Therapy|Death|0|||
33479005|NCT02393248|101647175|FG009|Part 3: Combination Therapy|Death|0|||
33479006|NCT02393248|101647176|FG010|Part 3: Combination Therapy|Death|0|||
33479007|NCT02393248|101647177|FG011|Part 3: Combination Therapy|Death|0|||
33479008|NCT02393248|101647178|FG012|Part 3: Combination Therapy|Death|0|||
33269384|NCT02232737|100884521|FG000|Overall Study|Personal reasons|7|||
33479009|NCT02393248|101647179|FG013|Part 3: Combination Therapy|Death|0|||
33479010|NCT02393248|101647180|FG014|Part 3: Combination Therapy|Death|0|||
33479011|NCT02393248|101647181|FG015|Part 3: Combination Therapy|Death|1|||
33269385|NCT02232737|100884522|FG001|Overall Study|Personal reasons|8|||
33479012|NCT02393248|101647182|FG016|Part 3: Combination Therapy|Death|7|||
33479013|NCT02393248|101647183|FG017|Part 3: Combination Therapy|Death|5|||
33269386|NCT02232737|100884523|FG002|Overall Study|Personal reasons|14|||
33269387|NCT02232737|100884521|FG000|Overall Study|Adverse Event|6|||
33269388|NCT02232737|100884522|FG001|Overall Study|Adverse Event|3|||
33479014|NCT02393248|101647184|FG018|Part 3: Combination Therapy|Death|5|||
33479015|NCT02393248|101647185|FG019|Part 3: Combination Therapy|Death|3|||
33479016|NCT02393248|101647186|FG020|Part 3: Combination Therapy|Death|7|||
33479017|NCT02393248|101647187|FG021|Part 3: Combination Therapy|Death|5|||
33479018|NCT02393248|101647188|FG022|Part 3: Combination Therapy|Death|6|||
33479019|NCT02393248|101647189|FG023|Part 3: Combination Therapy|Death|3|||
33479020|NCT02393248|101647190|FG024|Part 3: Combination Therapy|Death|0|||
33479021|NCT02393248|101647166|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479022|NCT02393248|101647167|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479023|NCT02393248|101647168|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479024|NCT02393248|101647169|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479025|NCT02393248|101647170|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479026|NCT02393248|101647171|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479027|NCT02393248|101647172|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479028|NCT02393248|101647173|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479029|NCT02393248|101647174|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479030|NCT02393248|101647175|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479031|NCT02393248|101647176|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479032|NCT02393248|101647177|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479033|NCT02393248|101647178|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479034|NCT02393248|101647179|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479035|NCT02393248|101647180|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479036|NCT02393248|101647181|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479037|NCT02393248|101647182|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479038|NCT02393248|101647183|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
33479039|NCT02393248|101647184|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
33479040|NCT02393248|101647185|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
33479041|NCT02393248|101647186|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
33479042|NCT02393248|101647187|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
33479043|NCT02393248|101647188|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
33479044|NCT02393248|101647189|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
33479045|NCT02393248|101647190|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
33479046|NCT02393248|101647166|FG000|Part 3: Combination Therapy|Disease Progression|0|||
33479047|NCT02393248|101647167|FG001|Part 3: Combination Therapy|Disease Progression|0|||
33479048|NCT02393248|101647168|FG002|Part 3: Combination Therapy|Disease Progression|0|||
33479049|NCT02393248|101647169|FG003|Part 3: Combination Therapy|Disease Progression|0|||
33479050|NCT02393248|101647170|FG004|Part 3: Combination Therapy|Disease Progression|0|||
33479051|NCT02393248|101647171|FG005|Part 3: Combination Therapy|Disease Progression|0|||
33479052|NCT02393248|101647172|FG006|Part 3: Combination Therapy|Disease Progression|0|||
33479053|NCT02393248|101647173|FG007|Part 3: Combination Therapy|Disease Progression|0|||
33479054|NCT02393248|101647174|FG008|Part 3: Combination Therapy|Disease Progression|0|||
33479055|NCT02393248|101647175|FG009|Part 3: Combination Therapy|Disease Progression|0|||
33479056|NCT02393248|101647176|FG010|Part 3: Combination Therapy|Disease Progression|0|||
33479057|NCT02393248|101647177|FG011|Part 3: Combination Therapy|Disease Progression|0|||
33479058|NCT02393248|101647178|FG012|Part 3: Combination Therapy|Disease Progression|0|||
33479059|NCT02393248|101647179|FG013|Part 3: Combination Therapy|Disease Progression|0|||
33479060|NCT02393248|101647180|FG014|Part 3: Combination Therapy|Disease Progression|0|||
33479061|NCT02393248|101647181|FG015|Part 3: Combination Therapy|Disease Progression|0|||
33479062|NCT02393248|101647182|FG016|Part 3: Combination Therapy|Disease Progression|0|||
33479063|NCT02393248|101647183|FG017|Part 3: Combination Therapy|Disease Progression|0|||
33479064|NCT02393248|101647184|FG018|Part 3: Combination Therapy|Disease Progression|0|||
33479065|NCT02393248|101647185|FG019|Part 3: Combination Therapy|Disease Progression|0|||
33479066|NCT02393248|101647186|FG020|Part 3: Combination Therapy|Disease Progression|2|||
33479067|NCT02393248|101647187|FG021|Part 3: Combination Therapy|Disease Progression|1|||
33479068|NCT02393248|101647188|FG022|Part 3: Combination Therapy|Disease Progression|0|||
33479069|NCT02393248|101647189|FG023|Part 3: Combination Therapy|Disease Progression|0|||
33479070|NCT02393248|101647190|FG024|Part 3: Combination Therapy|Disease Progression|0|||
33479071|NCT02393248|101647166|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479072|NCT02393248|101647167|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479073|NCT02393248|101647168|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479074|NCT02393248|101647169|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479075|NCT02393248|101647170|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479076|NCT02393248|101647171|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
33269389|NCT02232737|100884523|FG002|Overall Study|Adverse Event|8|||
33269390|NCT02232737|100884521|FG000|Overall Study|Incarcerated|2|||
33479077|NCT02393248|101647172|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479078|NCT02393248|101647173|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479079|NCT02393248|101647174|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479080|NCT02393248|101647175|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479081|NCT02393248|101647176|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479082|NCT02393248|101647177|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479083|NCT02393248|101647178|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479084|NCT02393248|101647179|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479085|NCT02393248|101647180|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479086|NCT02393248|101647181|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479087|NCT02393248|101647182|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479088|NCT02393248|101647183|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479089|NCT02393248|101647184|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479090|NCT02393248|101647185|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479091|NCT02393248|101647186|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
33479092|NCT02393248|101647187|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
33479093|NCT02393248|101647188|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479094|NCT02393248|101647189|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479095|NCT02393248|101647190|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
33479096|NCT02393248|101647166|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479097|NCT02393248|101647167|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479098|NCT02393248|101647168|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479099|NCT02393248|101647169|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479100|NCT02393248|101647170|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479101|NCT02393248|101647171|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479102|NCT02393248|101647172|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479103|NCT02393248|101647173|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479104|NCT02393248|101647174|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479105|NCT02393248|101647175|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479106|NCT02393248|101647176|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479107|NCT02393248|101647177|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479108|NCT02393248|101647178|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479109|NCT02393248|101647179|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479110|NCT02393248|101647180|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479111|NCT02393248|101647181|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479112|NCT02393248|101647182|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479113|NCT02393248|101647183|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479114|NCT02393248|101647184|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479115|NCT02393248|101647185|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479116|NCT02393248|101647186|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
33479117|NCT02393248|101647187|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479118|NCT02393248|101647188|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479119|NCT02393248|101647189|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479120|NCT02393248|101647190|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
33479121|NCT02393248|101647166|FG000|Part 3: Combination Therapy|Adverse Event|0|||
33479122|NCT02393248|101647167|FG001|Part 3: Combination Therapy|Adverse Event|0|||
33479123|NCT02393248|101647168|FG002|Part 3: Combination Therapy|Adverse Event|0|||
33479124|NCT02393248|101647169|FG003|Part 3: Combination Therapy|Adverse Event|0|||
33479125|NCT02393248|101647170|FG004|Part 3: Combination Therapy|Adverse Event|0|||
33479126|NCT02393248|101647171|FG005|Part 3: Combination Therapy|Adverse Event|0|||
33479127|NCT02393248|101647172|FG006|Part 3: Combination Therapy|Adverse Event|0|||
33479128|NCT02393248|101647173|FG007|Part 3: Combination Therapy|Adverse Event|0|||
33479129|NCT02393248|101647174|FG008|Part 3: Combination Therapy|Adverse Event|0|||
33479130|NCT02393248|101647175|FG009|Part 3: Combination Therapy|Adverse Event|0|||
33479131|NCT02393248|101647176|FG010|Part 3: Combination Therapy|Adverse Event|0|||
33479132|NCT02393248|101647177|FG011|Part 3: Combination Therapy|Adverse Event|0|||
33479133|NCT02393248|101647178|FG012|Part 3: Combination Therapy|Adverse Event|0|||
33479134|NCT02393248|101647179|FG013|Part 3: Combination Therapy|Adverse Event|0|||
33479135|NCT02393248|101647180|FG014|Part 3: Combination Therapy|Adverse Event|0|||
33479136|NCT02393248|101647181|FG015|Part 3: Combination Therapy|Adverse Event|0|||
33479137|NCT02393248|101647182|FG016|Part 3: Combination Therapy|Adverse Event|0|||
33479138|NCT02393248|101647183|FG017|Part 3: Combination Therapy|Adverse Event|0|||
33479139|NCT02393248|101647184|FG018|Part 3: Combination Therapy|Adverse Event|0|||
33269391|NCT02232737|100884522|FG001|Overall Study|Incarcerated|1|||
33269392|NCT02232737|100884523|FG002|Overall Study|Incarcerated|2|||
33479140|NCT02393248|101647185|FG019|Part 3: Combination Therapy|Adverse Event|0|||
33479141|NCT02393248|101647186|FG020|Part 3: Combination Therapy|Adverse Event|0|||
33479142|NCT02393248|101647187|FG021|Part 3: Combination Therapy|Adverse Event|0|||
33479143|NCT02393248|101647188|FG022|Part 3: Combination Therapy|Adverse Event|0|||
33269393|NCT02232737|100884521|FG000|Overall Study|Withdrawal by Subject|0|||
33269394|NCT02232737|100884522|FG001|Overall Study|Withdrawal by Subject|1|||
33479144|NCT02393248|101647189|FG023|Part 3: Combination Therapy|Adverse Event|1|||
33479145|NCT02393248|101647190|FG024|Part 3: Combination Therapy|Adverse Event|0|||
33479146|NCT02393248|101647166|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479147|NCT02393248|101647167|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479148|NCT02393248|101647168|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479149|NCT02393248|101647169|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479150|NCT02393248|101647170|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479151|NCT02393248|101647171|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479152|NCT02393248|101647172|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479153|NCT02393248|101647173|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479154|NCT02393248|101647174|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479155|NCT02393248|101647175|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479156|NCT02393248|101647176|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479157|NCT02393248|101647177|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479158|NCT02393248|101647178|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479159|NCT02393248|101647179|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479160|NCT02393248|101647180|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33269395|NCT02232737|100884523|FG002|Overall Study|Withdrawal by Subject|2|||
33269396|NCT02232737|100884521|FG000|Overall Study|Death|0|||
33269397|NCT02232737|100884522|FG001|Overall Study|Death|1|||
33269398|NCT02232737|100884523|FG002|Overall Study|Death|1|||
33269399|NCT02232737|100884521|FG000|Overall Study|Physician Decision|1|||
33269400|NCT02232737|100884522|FG001|Overall Study|Physician Decision|3|||
33269401|NCT02232737|100884523|FG002|Overall Study|Physician Decision|1|||
33269402|NCT02232737|100884521|FG000|Overall Study|Protocol Violation|1|||
33269403|NCT02232737|100884522|FG001|Overall Study|Protocol Violation|0|||
33269404|NCT02232737|100884523|FG002|Overall Study|Protocol Violation|1|||
33269405|NCT02232737|100884521|FG000|Overall Study|Reason unknown|1|||
33269406|NCT02232737|100884522|FG001|Overall Study|Reason unknown|0|||
33269407|NCT02232737|100884523|FG002|Overall Study|Reason unknown|0|||
33269408|NCT01218594|100884527|FG000|Overall Study|Death|1|||
33269409|NCT01218594|100884527|FG000|Overall Study|Withdrawal by Subject|3|||
33269410|NCT01218594|100884527|FG000|Overall Study|Adverse Event|2|||
33269411|NCT01218594|100884527|FG000|Overall Study|Physician Decision|6|||
33269412|NCT00428714|100884530|FG000|Overall Study|Progressive Disease|28|||
33269413|NCT00428714|100884531|FG001|Overall Study|Progressive Disease|36|||
33269414|NCT00428714|100884530|FG000|Overall Study|Withdrawal by Subject|0|||
33269415|NCT00428714|100884531|FG001|Overall Study|Withdrawal by Subject|3|||
33269416|NCT00428714|100884530|FG000|Overall Study|Adverse Event|0|||
33269417|NCT00428714|100884531|FG001|Overall Study|Adverse Event|2|||
33269418|NCT00428714|100884530|FG000|Overall Study|Physician Decision|1|||
33269419|NCT00428714|100884531|FG001|Overall Study|Physician Decision|1|||
33269420|NCT00428714|100884530|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
33269421|NCT00428714|100884531|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
33269422|NCT00428714|100884530|FG000|Overall Study|Death due to other then PD|1|||
33269423|NCT00428714|100884531|FG001|Overall Study|Death due to other then PD|0|||
33269424|NCT03909100|100884532|FG000|Overall Study|Protocol Deviation|2|||
33269425|NCT03909100|100884532|FG000|Overall Study|Technical Problems|4|||
33269426|NCT03909100|100884532|FG000|Overall Study|Withdrawal by Subject|4|||
33269427|NCT03909100|100884532|FG000|Overall Study|Lost to Follow-up|1|||
33269428|NCT03909100|100884532|FG000|Overall Study|Reason not Specified|4|||
33269429|NCT03122548|100884533|FG000|Overall Study|Death|2|||
33269430|NCT03122548|100884533|FG000|Overall Study|Progression - subject went into hospice|1|||
33269431|NCT03122548|100884533|FG000|Overall Study|Study Terminated by Sponsor|2|||
33269432|NCT02367794|100884534|FG000|Overall Study|Death|252|||
33269433|NCT02367794|100884535|FG001|Overall Study|Death|245|||
33269434|NCT02367794|100884536|FG002|Overall Study|Death|243|||
33269435|NCT02367794|100884534|FG000|Overall Study|Lost to Follow-up|1|||
33269436|NCT02367794|100884535|FG001|Overall Study|Lost to Follow-up|2|||
33269437|NCT02367794|100884536|FG002|Overall Study|Lost to Follow-up|2|||
33269438|NCT02367794|100884534|FG000|Overall Study|Physician Decision|0|||
33269439|NCT02367794|100884535|FG001|Overall Study|Physician Decision|5|||
33269440|NCT02367794|100884536|FG002|Overall Study|Physician Decision|3|||
33269441|NCT02367794|100884534|FG000|Overall Study|Protocol Violation|1|||
33269442|NCT02367794|100884535|FG001|Overall Study|Protocol Violation|0|||
33269443|NCT02367794|100884536|FG002|Overall Study|Protocol Violation|1|||
33269444|NCT02367794|100884534|FG000|Overall Study|Withdrawal by Subject|25|||
33269445|NCT02367794|100884535|FG001|Overall Study|Withdrawal by Subject|12|||
33269446|NCT02367794|100884536|FG002|Overall Study|Withdrawal by Subject|20|||
33269447|NCT02367794|100884534|FG000|Overall Study|Brain metastasis|1|||
33269448|NCT02367794|100884535|FG001|Overall Study|Brain metastasis|0|||
33269449|NCT02367794|100884536|FG002|Overall Study|Brain metastasis|0|||
33269450|NCT02367794|100884534|FG000|Overall Study|Randomized in error|0|||
33269451|NCT02367794|100884535|FG001|Overall Study|Randomized in error|0|||
33269452|NCT02367794|100884536|FG002|Overall Study|Randomized in error|1|||
33479161|NCT02393248|101647181|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479162|NCT02393248|101647182|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479163|NCT02393248|101647183|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479164|NCT02393248|101647184|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479165|NCT02393248|101647185|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479166|NCT02393248|101647186|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479167|NCT02393248|101647187|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479168|NCT02393248|101647188|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479169|NCT02393248|101647189|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
33479170|NCT02393248|101647190|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
33479171|NCT01081834|101647192|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
33479172|NCT01081834|101647193|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
33479173|NCT01081834|101647194|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
33479174|NCT01081834|101647195|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
33479175|NCT01081834|101647196|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
33479176|NCT01081834|101647192|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
33479177|NCT01081834|101647193|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
33479178|NCT01081834|101647194|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
33479179|NCT01081834|101647195|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
33479180|NCT01081834|101647196|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
33479181|NCT01081834|101647192|FG000|Core Period: Baseline to Week 26|Death|1|||
33479182|NCT01081834|101647193|FG001|Core Period: Baseline to Week 26|Death|0|||
33479183|NCT01081834|101647194|FG002|Core Period: Baseline to Week 26|Death|0|||
33479184|NCT01081834|101647195|FG003|Core Period: Baseline to Week 26|Death|0|||
33479185|NCT01081834|101647196|FG004|Core Period: Baseline to Week 26|Death|0|||
33479186|NCT01081834|101647192|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
33479187|NCT01081834|101647193|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
33479188|NCT01081834|101647194|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
33479189|NCT01081834|101647195|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
33269453|NCT02367794|100884534|FG000|Overall Study|Patient unable to receive carboplatin|0|||
33269454|NCT02367794|100884535|FG001|Overall Study|Patient unable to receive carboplatin|0|||
33269455|NCT02367794|100884536|FG002|Overall Study|Patient unable to receive carboplatin|1|||
33269456|NCT02367794|100884534|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
33269457|NCT02367794|100884535|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
33269458|NCT02367794|100884536|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
33269459|NCT02367794|100884534|FG000|Overall Study|Adverse Event|0|||
33269460|NCT02367794|100884535|FG001|Overall Study|Adverse Event|0|||
33269461|NCT02367794|100884536|FG002|Overall Study|Adverse Event|2|||
33269462|NCT02367794|100884534|FG000|Overall Study|Study Terminated By Sponsor|0|||
33269463|NCT02367794|100884535|FG001|Overall Study|Study Terminated By Sponsor|1|||
33269464|NCT02367794|100884536|FG002|Overall Study|Study Terminated By Sponsor|1|||
33269465|NCT02367794|100884534|FG000|Overall Study|Moved to Roll-Over Study|0|||
33269466|NCT02367794|100884535|FG001|Overall Study|Moved to Roll-Over Study|15|||
33269467|NCT02367794|100884536|FG002|Overall Study|Moved to Roll-Over Study|13|||
33269468|NCT02367794|100884534|FG000|Overall Study|Sponsor Request|60|||
33269469|NCT02367794|100884535|FG001|Overall Study|Sponsor Request|57|||
33269470|NCT02367794|100884536|FG002|Overall Study|Sponsor Request|45|||
33269471|NCT02367794|100884534|FG000|Overall Study|Moved into PTAP Study|0|||
33269472|NCT02367794|100884535|FG001|Overall Study|Moved into PTAP Study|2|||
33269473|NCT02367794|100884536|FG002|Overall Study|Moved into PTAP Study|3|||
33269474|NCT02367794|100884534|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
33269475|NCT02367794|100884535|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
33479190|NCT01081834|101647196|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
33269476|NCT02367794|100884536|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
33269477|NCT02367794|100884534|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
33269478|NCT02367794|100884535|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
33269479|NCT02367794|100884536|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
33269480|NCT02367794|100884534|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
33269481|NCT02367794|100884535|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
33269482|NCT02367794|100884536|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
33479191|NCT01081834|101647192|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
33479192|NCT01081834|101647193|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
33269483|NCT02367794|100884534|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
33269484|NCT02367794|100884535|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
33269485|NCT02367794|100884536|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
33269486|NCT00655499|100884537|FG000|Overall Study|not eligible|4|||
33479193|NCT01081834|101647194|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
33479194|NCT01081834|101647195|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
33479195|NCT01081834|101647196|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
33479196|NCT01081834|101647192|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
33479197|NCT01081834|101647193|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
33479198|NCT01081834|101647194|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
33479199|NCT01081834|101647195|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
33479200|NCT01081834|101647196|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
33479201|NCT01081834|101647192|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
33479202|NCT01081834|101647193|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
33479203|NCT01081834|101647194|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
33479204|NCT01081834|101647195|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
33479205|NCT01081834|101647196|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
33479206|NCT01081834|101647192|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
33479207|NCT01081834|101647193|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
33479208|NCT01081834|101647194|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
33479209|NCT01081834|101647195|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
33479210|NCT01081834|101647196|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
33479211|NCT01081834|101647192|FG000|Core Period: Baseline to Week 26|Other|4|||
33479212|NCT01081834|101647193|FG001|Core Period: Baseline to Week 26|Other|4|||
33479213|NCT01081834|101647194|FG002|Core Period: Baseline to Week 26|Other|3|||
33479214|NCT01081834|101647195|FG003|Core Period: Baseline to Week 26|Other|1|||
33479215|NCT01081834|101647196|FG004|Core Period: Baseline to Week 26|Other|0|||
33479216|NCT01081834|101647192|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
33479217|NCT01081834|101647193|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
33479218|NCT01081834|101647194|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
33479219|NCT01081834|101647195|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
33479220|NCT01081834|101647196|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
33479221|NCT01081834|101647192|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
33479222|NCT01081834|101647193|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
33479223|NCT01081834|101647194|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
33479224|NCT01081834|101647195|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
33479225|NCT01081834|101647196|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
33479226|NCT01081834|101647192|FG000|Extension Period: Week 26 to Week 52|Death|1|||
33479227|NCT01081834|101647193|FG001|Extension Period: Week 26 to Week 52|Death|0|||
33479228|NCT01081834|101647194|FG002|Extension Period: Week 26 to Week 52|Death|0|||
33479229|NCT01081834|101647195|FG003|Extension Period: Week 26 to Week 52|Death|0|||
33479230|NCT01081834|101647196|FG004|Extension Period: Week 26 to Week 52|Death|0|||
33479231|NCT01081834|101647192|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
33479232|NCT01081834|101647193|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
33479233|NCT01081834|101647194|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33479234|NCT01081834|101647195|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33479235|NCT01081834|101647196|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
33479236|NCT01081834|101647192|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33479237|NCT01081834|101647193|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
33479238|NCT01081834|101647194|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33479239|NCT01081834|101647195|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33479240|NCT01081834|101647196|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
33479241|NCT01081834|101647192|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
33479242|NCT01081834|101647193|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
33479243|NCT01081834|101647194|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
33479244|NCT01081834|101647195|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
33479245|NCT01081834|101647196|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
33479246|NCT01081834|101647192|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
33479247|NCT01081834|101647193|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
33479248|NCT01081834|101647194|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
33479249|NCT01081834|101647195|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
33479250|NCT01081834|101647196|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
33269487|NCT02309294|100884538|FG000|Overall Study|Withdrawal by Subject|2|||
33479251|NCT01081834|101647192|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
33479252|NCT01081834|101647193|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
33479253|NCT01081834|101647194|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
33479254|NCT01081834|101647195|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
33479255|NCT01081834|101647196|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
33479256|NCT01081834|101647192|FG000|Extension Period: Week 26 to Week 52|Other|4|||
33479257|NCT01081834|101647193|FG001|Extension Period: Week 26 to Week 52|Other|5|||
33479258|NCT01081834|101647194|FG002|Extension Period: Week 26 to Week 52|Other|4|||
33479259|NCT01081834|101647195|FG003|Extension Period: Week 26 to Week 52|Other|0|||
33479260|NCT01081834|101647196|FG004|Extension Period: Week 26 to Week 52|Other|0|||
33479261|NCT01081834|101647192|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
33479262|NCT01081834|101647193|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
33479263|NCT01081834|101647194|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
33479264|NCT01081834|101647195|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
33479265|NCT01081834|101647196|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
33479266|NCT01081834|101647192|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33479267|NCT01081834|101647193|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
33479268|NCT01081834|101647194|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33479269|NCT01081834|101647195|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33479270|NCT01081834|101647196|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
33479271|NCT04597632|101647197|FG000|Overall Study|Withdrawal by Subject|10|||
33479272|NCT04597632|101647197|FG000|Overall Study|Lost to Follow-up|1|||
33479273|NCT04597632|101647197|FG000|Overall Study|Death|1|||
33479274|NCT04597632|101647197|FG000|Overall Study|Adverse Event|5|||
33479275|NCT01212588|101647198|FG000|Overall Study|Physician Decision|0|||
33479276|NCT01212588|101647199|FG001|Overall Study|Physician Decision|1|||
33479277|NCT01212588|101647198|FG000|Overall Study|Protocol Violation|1|||
33479278|NCT01212588|101647199|FG001|Overall Study|Protocol Violation|1|||
33479279|NCT03151811|101647201|FG000|Overall Study|Randomized But Not Treated|18|||
33479280|NCT03151811|101647202|FG001|Overall Study|Randomized But Not Treated|3|||
33479281|NCT03151811|101647201|FG000|Overall Study|Progressive Disease|130|||
33479282|NCT03151811|101647202|FG001|Overall Study|Progressive Disease|170|||
33479283|NCT03151811|101647201|FG000|Overall Study|Adverse Event|49|||
33479284|NCT03151811|101647202|FG001|Overall Study|Adverse Event|40|||
33479285|NCT03151811|101647201|FG000|Overall Study|Lack of Efficacy|6|||
33479286|NCT03151811|101647202|FG001|Overall Study|Lack of Efficacy|8|||
33479287|NCT03151811|101647201|FG000|Overall Study|Physician Decision|21|||
33479288|NCT03151811|101647202|FG001|Overall Study|Physician Decision|9|||
33479289|NCT03151811|101647201|FG000|Overall Study|Withdrawal by Subject|17|||
33479290|NCT03151811|101647202|FG001|Overall Study|Withdrawal by Subject|7|||
33479291|NCT03151811|101647201|FG000|Overall Study|Lost to Follow-up|0|||
33479292|NCT03151811|101647202|FG001|Overall Study|Lost to Follow-up|1|||
33479293|NCT03151811|101647201|FG000|Overall Study|Study Terminated by Sponsor|5|||
33479294|NCT03151811|101647202|FG001|Overall Study|Study Terminated by Sponsor|11|||
33479295|NCT00554606|101647203|FG000|Overall Study|Adverse Event|3|||
33479296|NCT00554606|101647203|FG000|Overall Study|Abnormal laboratory values|1|||
33479297|NCT00554606|101647203|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
33479298|NCT00554606|101647203|FG000|Overall Study|Subject withdrew consent|2|||
33479299|NCT00554606|101647203|FG000|Overall Study|Lost to Follow-up|2|||
33479300|NCT00554606|101647203|FG000|Overall Study|Administrative problems|60|||
33479301|NCT00554606|101647203|FG000|Overall Study|Death|1|||
33479302|NCT00554606|101647203|FG000|Overall Study|Protocol deviation|2|||
33479303|NCT00859586|101647204|FG000|Overall Study|Donors|4|||
33479304|NCT01868893|101647205|FG000|Overall Study|Adverse Event|2|||
33479305|NCT01868893|101647205|FG000|Overall Study|Commercial availability of study drug|17|||
33479306|NCT01868893|101647205|FG000|Overall Study|Neutropenia|1|||
33479307|NCT00969540|101647211|FG000|Overall Study|Lost to Follow-up|1|||
33479308|NCT00969540|101647212|FG001|Overall Study|Lost to Follow-up|1|||
33479309|NCT03981419|101647213|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
33479310|NCT03981419|101647214|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
33479311|NCT02752906|101647223|FG000|Overall Study|Protocol Violation|2|||
33479312|NCT02752906|101647224|FG001|Overall Study|Protocol Violation|1|||
33479313|NCT02752906|101647223|FG000|Overall Study|Withdrawal by Subject|2|||
33269488|NCT03055988|100884539|FG000|Period 1|Adverse Event|0|||
33269489|NCT03055988|100884540|FG001|Period 1|Adverse Event|1|||
33479314|NCT02752906|101647224|FG001|Overall Study|Withdrawal by Subject|2|||
33479315|NCT02752906|101647223|FG000|Overall Study|Lost to Follow-up|3|||
33479316|NCT02752906|101647224|FG001|Overall Study|Lost to Follow-up|2|||
33479317|NCT00478426|101647225|FG000|Overall Study|Withdrawal by Subject|1|||
33479318|NCT02992418|101647226|FG000|Overall Study|Withdrawal by Subject|11|||
33479319|NCT02992418|101647227|FG001|Overall Study|Withdrawal by Subject|12|||
33479320|NCT02992418|101647226|FG000|Overall Study|Non-compliance with the protocol|308|||
33479321|NCT02992418|101647227|FG001|Overall Study|Non-compliance with the protocol|308|||
33479322|NCT02992418|101647226|FG000|Overall Study|Lost to Follow-up|27|||
33479323|NCT02992418|101647227|FG001|Overall Study|Lost to Follow-up|22|||
33479324|NCT02105974|101647228|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
33479325|NCT02105974|101647229|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
33479326|NCT02105974|101647230|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
33269490|NCT03055988|100884539|FG000|Period 1|Lost to Follow-up|1|||
33479327|NCT02105974|101647228|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
33479328|NCT02105974|101647229|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
33479329|NCT02105974|101647230|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
33479330|NCT02105974|101647228|FG000|2 Week Run-in Period|Adverse Event|6|||
33479331|NCT02105974|101647229|FG001|2 Week Run-in Period|Adverse Event|0|||
33479332|NCT02105974|101647230|FG002|2 Week Run-in Period|Adverse Event|0|||
33479333|NCT02105974|101647228|FG000|2 Week Run-in Period|Study closed/terminated|1|||
33479334|NCT02105974|101647229|FG001|2 Week Run-in Period|Study closed/terminated|0|||
33479335|NCT02105974|101647230|FG002|2 Week Run-in Period|Study closed/terminated|0|||
33479336|NCT02105974|101647228|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
33479337|NCT02105974|101647229|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
33479338|NCT02105974|101647230|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
33479339|NCT02105974|101647228|FG000|2 Week Run-in Period|Withdrew consent|23|||
33479340|NCT02105974|101647229|FG001|2 Week Run-in Period|Withdrew consent|0|||
33479341|NCT02105974|101647230|FG002|2 Week Run-in Period|Withdrew consent|0|||
33479342|NCT02105974|101647228|FG000|2 Week Run-in Period|Investigator discretion|8|||
33269491|NCT03055988|100884540|FG001|Period 1|Lost to Follow-up|0|||
33269492|NCT03055988|100884539|FG000|Period 1|Withdrawal by Subject|0|||
33269493|NCT03055988|100884540|FG001|Period 1|Withdrawal by Subject|4|||
33479343|NCT02105974|101647229|FG001|2 Week Run-in Period|Investigator discretion|0|||
33479344|NCT02105974|101647230|FG002|2 Week Run-in Period|Investigator discretion|0|||
33479345|NCT02105974|101647228|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
33479346|NCT02105974|101647229|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
33479347|NCT02105974|101647230|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
33479348|NCT02105974|101647228|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
33479349|NCT02105974|101647229|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
33479350|NCT02105974|101647230|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
33479351|NCT02105974|101647228|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
33479352|NCT02105974|101647229|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
33479353|NCT02105974|101647230|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
33479354|NCT02105974|101647228|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
33479355|NCT02105974|101647229|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
33479356|NCT02105974|101647230|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
33479357|NCT02105974|101647228|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
33479358|NCT02105974|101647229|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
33479359|NCT02105974|101647230|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
33479360|NCT02105974|101647228|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
33479361|NCT02105974|101647229|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
33479362|NCT02105974|101647230|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
33479363|NCT02105974|101647228|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
33479364|NCT02105974|101647229|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
33479365|NCT02105974|101647230|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
33479366|NCT00094861|101647233|FG000|Overall Study|Adverse Event|5|||
33479367|NCT00094861|101647234|FG001|Overall Study|Adverse Event|2|||
33479368|NCT00094861|101647233|FG000|Overall Study|Withdrawal by Subject|5|||
33479369|NCT00094861|101647234|FG001|Overall Study|Withdrawal by Subject|3|||
33479370|NCT00094861|101647233|FG000|Overall Study|Physician Decision|1|||
33479371|NCT00094861|101647234|FG001|Overall Study|Physician Decision|1|||
33479372|NCT00094861|101647233|FG000|Overall Study|Lost to Follow-up|0|||
33479373|NCT00094861|101647234|FG001|Overall Study|Lost to Follow-up|1|||
33479374|NCT00094861|101647233|FG000|Overall Study|Death|4|||
33269494|NCT03055988|100884539|FG000|Period 2|Adverse Event|0|||
33269495|NCT03055988|100884540|FG001|Period 2|Adverse Event|1|||
33269496|NCT03055988|100884539|FG000|Period 2|Other than listed|1|||
33269497|NCT03055988|100884540|FG001|Period 2|Other than listed|1|||
33286475|NCT03918447|100943976|FG001|Overall Study|Study Terminated by Sponsor|197|||
33479375|NCT00094861|101647234|FG001|Overall Study|Death|2|||
33479376|NCT00094861|101647233|FG000|Overall Study|Other|3|||
33286476|NCT03918447|100943975|FG000|Overall Study|Reason not Specified|0|||
33286477|NCT03918447|100943976|FG001|Overall Study|Reason not Specified|1|||
33479377|NCT00094861|101647234|FG001|Overall Study|Other|0|||
33479378|NCT04325204|101647238|FG000|Overall Study|Death|0|||
33479379|NCT04325204|101647239|FG001|Overall Study|Death|1|||
33479380|NCT04325204|101647238|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
33479381|NCT04325204|101647239|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
33479382|NCT04325204|101647238|FG000|Overall Study|Lost to Follow-up|8|||
33479383|NCT04325204|101647239|FG001|Overall Study|Lost to Follow-up|8|||
33479384|NCT04325204|101647238|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
33479385|NCT04325204|101647239|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
33479386|NCT00824616|101647241|FG000|Overall Study|Adverse Event|2|||
33479387|NCT00824616|101647242|FG001|Overall Study|Adverse Event|1|||
33479388|NCT00824616|101647241|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
33479389|NCT00824616|101647242|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
33479390|NCT00824616|101647241|FG000|Overall Study|Hyperglycemia|1|||
33479391|NCT00824616|101647242|FG001|Overall Study|Hyperglycemia|1|||
33479392|NCT00824616|101647241|FG000|Overall Study|Lack of Efficacy|2|||
33479393|NCT00824616|101647242|FG001|Overall Study|Lack of Efficacy|1|||
33479394|NCT00824616|101647241|FG000|Overall Study|Lost to Follow-up|0|||
33479395|NCT00824616|101647242|FG001|Overall Study|Lost to Follow-up|1|||
33479396|NCT00824616|101647241|FG000|Overall Study|Withdrawal by Subject|1|||
33479397|NCT00824616|101647242|FG001|Overall Study|Withdrawal by Subject|1|||
33479398|NCT00140426|101647243|FG000|Overall Study|Withdrawal by Subject|0|||
33479399|NCT00140426|101647244|FG001|Overall Study|Withdrawal by Subject|3|||
33479400|NCT01783548|101647245|FG000|Overall Study|Adverse Event|8|||
33479401|NCT01783548|101647246|FG001|Overall Study|Adverse Event|4|||
33479402|NCT01783548|101647245|FG000|Overall Study|Withdrawal by Subject|11|||
33479403|NCT01783548|101647246|FG001|Overall Study|Withdrawal by Subject|8|||
33479404|NCT01783548|101647245|FG000|Overall Study|Non-compliance|4|||
33479405|NCT01783548|101647246|FG001|Overall Study|Non-compliance|0|||
33479406|NCT01783548|101647245|FG000|Overall Study|Protocol Violation|2|||
33269498|NCT02236611|100887309|FG000|Overall Study|Adverse Event|10|||
33269499|NCT02236611|100887310|FG001|Overall Study|Adverse Event|16|||
33269500|NCT02236611|100887309|FG000|Overall Study|Lack of Efficacy|4|||
33269501|NCT02236611|100887310|FG001|Overall Study|Lack of Efficacy|7|||
33269502|NCT02236611|100887309|FG000|Overall Study|Lost to Follow-up|0|||
33269503|NCT02236611|100887310|FG001|Overall Study|Lost to Follow-up|2|||
33269504|NCT02236611|100887309|FG000|Overall Study|Protocol deviation|3|||
33269505|NCT02236611|100887310|FG001|Overall Study|Protocol deviation|5|||
33269506|NCT02236611|100887309|FG000|Overall Study|Withdrew consent|9|||
33269507|NCT02236611|100887310|FG001|Overall Study|Withdrew consent|4|||
33269508|NCT02332889|100887311|FG000|Overall Study|Physician Decision|1|||
33269509|NCT01286311|100887312|FG000|Overall Study|Physician did not want outreach sent|14|||
33479407|NCT01783548|101647246|FG001|Overall Study|Protocol Violation|2|||
33479408|NCT01783548|101647245|FG000|Overall Study|Lost to Follow-up|8|||
33479409|NCT01783548|101647246|FG001|Overall Study|Lost to Follow-up|3|||
33479410|NCT01783548|101647245|FG000|Overall Study|Lack of Efficacy|1|||
33479411|NCT01783548|101647246|FG001|Overall Study|Lack of Efficacy|1|||
33479412|NCT02272634|101647247|FG000|Overall Study|Adverse Event|1|||
33479413|NCT02272634|101647248|FG001|Overall Study|Adverse Event|0|||
33479414|NCT02272634|101647249|FG002|Overall Study|Adverse Event|0|||
33479415|NCT02272634|101647247|FG000|Overall Study|Protocol Violation|0|||
33479416|NCT02272634|101647248|FG001|Overall Study|Protocol Violation|0|||
33479417|NCT02272634|101647249|FG002|Overall Study|Protocol Violation|1|||
33269510|NCT01286311|100887313|FG001|Overall Study|Physician did not want outreach sent|0|||
33269511|NCT00799409|100887314|FG000|Overall Study|Withdrawal by Subject|1|||
33269512|NCT00799409|100887315|FG001|Overall Study|Withdrawal by Subject|0|||
33269513|NCT00799409|100887316|FG002|Overall Study|Withdrawal by Subject|0|||
33269514|NCT00799409|100887314|FG000|Overall Study|Lost to Follow-up|1|||
33269515|NCT00799409|100887315|FG001|Overall Study|Lost to Follow-up|0|||
33269516|NCT00799409|100887316|FG002|Overall Study|Lost to Follow-up|0|||
33479418|NCT02272634|101647247|FG000|Overall Study|Withdrawal by Subject|0|||
33479419|NCT02272634|101647248|FG001|Overall Study|Withdrawal by Subject|1|||
33479420|NCT02272634|101647249|FG002|Overall Study|Withdrawal by Subject|0|||
33479421|NCT01293539|101647250|FG000|Overall Study|Physician Decision|1|||
33479422|NCT00789737|101647251|FG000|Overall Study|Withdrawal by Subject|13|||
33269517|NCT00799409|100887314|FG000|Overall Study|Optimal Dose Not Achieved|2|||
33479423|NCT00789737|101647252|FG001|Overall Study|Withdrawal by Subject|22|||
33479424|NCT00789737|101647251|FG000|Overall Study|Lost to Follow-up|10|||
33479425|NCT00789737|101647252|FG001|Overall Study|Lost to Follow-up|14|||
33479426|NCT00789737|101647251|FG000|Overall Study|Adverse Event|8|||
33479427|NCT00789737|101647252|FG001|Overall Study|Adverse Event|8|||
33479428|NCT00789737|101647251|FG000|Overall Study|Protocol Violation|3|||
33479429|NCT00789737|101647252|FG001|Overall Study|Protocol Violation|0|||
33479430|NCT00789737|101647251|FG000|Overall Study|Lack of Efficacy|3|||
33269518|NCT00799409|100887315|FG001|Overall Study|Optimal Dose Not Achieved|0|||
33269519|NCT00799409|100887316|FG002|Overall Study|Optimal Dose Not Achieved|0|||
33269520|NCT00799409|100887314|FG000|Overall Study|Failure to follow study protocol)|1|||
33479431|NCT00789737|101647252|FG001|Overall Study|Lack of Efficacy|0|||
33479432|NCT00789737|101647251|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
33479433|NCT00789737|101647252|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
33479434|NCT00789737|101647251|FG000|Overall Study|Other|11|||
33479435|NCT00789737|101647252|FG001|Overall Study|Other|7|||
33479436|NCT02315196|101647253|FG000|Overall Study|Withdrew consent|9|||
33479437|NCT02092467|101647258|FG000|Overall Study|Death|49|||
33479438|NCT02092467|101647259|FG001|Overall Study|Death|66|||
33479439|NCT02092467|101647260|FG002|Overall Study|Death|38|||
33479440|NCT02092467|101647258|FG000|Overall Study|Lost to Follow-up|38|||
33479441|NCT02092467|101647259|FG001|Overall Study|Lost to Follow-up|35|||
33479442|NCT02092467|101647260|FG002|Overall Study|Lost to Follow-up|40|||
33479443|NCT02092467|101647258|FG000|Overall Study|Global Deterioration of Health Status|1|||
33479444|NCT02092467|101647259|FG001|Overall Study|Global Deterioration of Health Status|0|||
33479445|NCT02092467|101647260|FG002|Overall Study|Global Deterioration of Health Status|0|||
33479446|NCT02092467|101647258|FG000|Overall Study|Other|32|||
33479447|NCT02092467|101647259|FG001|Overall Study|Other|30|||
33269521|NCT00799409|100887315|FG001|Overall Study|Failure to follow study protocol)|0|||
33269522|NCT00799409|100887316|FG002|Overall Study|Failure to follow study protocol)|0|||
33269523|NCT00799409|100887314|FG000|Overall Study|Did not attend lab school day 1|1|||
33269524|NCT00799409|100887315|FG001|Overall Study|Did not attend lab school day 1|0|||
33269525|NCT00799409|100887316|FG002|Overall Study|Did not attend lab school day 1|0|||
33269526|NCT00799409|100887314|FG000|Overall Study|medication compliance|1|||
33269527|NCT00799409|100887315|FG001|Overall Study|medication compliance|0|||
33269528|NCT00799409|100887316|FG002|Overall Study|medication compliance|0|||
33269529|NCT00491400|100887317|FG000|Overall Study|Withdrawal by Subject|5|||
33269530|NCT00491400|100887318|FG001|Overall Study|Withdrawal by Subject|4|||
33269531|NCT02584257|100887323|FG000|Period 1|Withdrawal by Subject|0|||
33479448|NCT02092467|101647260|FG002|Overall Study|Other|24|||
33479449|NCT02092467|101647258|FG000|Overall Study|Withdrawal by Subject|282|||
33479450|NCT02092467|101647259|FG001|Overall Study|Withdrawal by Subject|327|||
33479451|NCT02092467|101647260|FG002|Overall Study|Withdrawal by Subject|289|||
33479452|NCT02092467|101647258|FG000|Overall Study|Randomized but not treated|2|||
33479453|NCT02092467|101647259|FG001|Overall Study|Randomized but not treated|1|||
33479454|NCT02092467|101647260|FG002|Overall Study|Randomized but not treated|7|||
33479455|NCT02740699|101647261|FG000|Overall Study|Lost to Follow-up|5|||
33479456|NCT02740699|101647261|FG000|Overall Study|Withdrawal by Subject|14|||
33479457|NCT02740699|101647261|FG000|Overall Study|Physician Decision|5|||
33479458|NCT01735955|101647262|FG000|Overall Study|Administrative problems|1|||
33479459|NCT01735955|101647262|FG000|Overall Study|Patient/guardian decision|1|||
33479460|NCT01735955|101647262|FG000|Overall Study|Patient withdrew consent|2|||
33479461|NCT01735955|101647262|FG000|Overall Study|Physician Decision|4|||
33479462|NCT01735955|101647262|FG000|Overall Study|Disease progression|24|||
33479463|NCT01735955|101647262|FG000|Overall Study|Adverse Event|5|||
33479464|NCT00985712|101647264|FG000|Overall Study|Adverse Event|0|||
33479465|NCT00985712|101647265|FG001|Overall Study|Adverse Event|1|||
33479466|NCT00985712|101647264|FG000|Overall Study|Lost to Follow-up|2|||
33479467|NCT00985712|101647265|FG001|Overall Study|Lost to Follow-up|2|||
33479468|NCT00985712|101647264|FG000|Overall Study|Protocol Violation|0|||
33479469|NCT00985712|101647265|FG001|Overall Study|Protocol Violation|1|||
33479470|NCT00985712|101647264|FG000|Overall Study|Withdrawal by Subject|4|||
33479471|NCT00985712|101647265|FG001|Overall Study|Withdrawal by Subject|1|||
33479472|NCT00985712|101647264|FG000|Overall Study|Sponsor decision|0|||
33479473|NCT00985712|101647265|FG001|Overall Study|Sponsor decision|2|||
33479474|NCT02283983|101647266|FG000|Overall Study|Inclusion criteria not met|0|||
33479475|NCT02283983|101647267|FG001|Overall Study|Inclusion criteria not met|1|||
33479476|NCT02283983|101647266|FG000|Overall Study|Withdrawal by Subject|4|||
33479477|NCT02283983|101647267|FG001|Overall Study|Withdrawal by Subject|2|||
33479478|NCT02283983|101647266|FG000|Overall Study|Protocol Violation|0|||
33479479|NCT02283983|101647267|FG001|Overall Study|Protocol Violation|4|||
33479480|NCT02283983|101647266|FG000|Overall Study|Physician Decision|2|||
33479481|NCT02283983|101647267|FG001|Overall Study|Physician Decision|4|||
33479482|NCT02283983|101647266|FG000|Overall Study|Death|1|||
33269532|NCT02584257|100887324|FG001|Period 1|Withdrawal by Subject|0|||
33269533|NCT02584257|100887325|FG002|Period 1|Withdrawal by Subject|0|||
33269534|NCT02584257|100887326|FG003|Period 1|Withdrawal by Subject|0|||
33479483|NCT02283983|101647267|FG001|Overall Study|Death|0|||
33479484|NCT02283983|101647266|FG000|Overall Study|Adverse Event|1|||
33479485|NCT02283983|101647267|FG001|Overall Study|Adverse Event|0|||
33479486|NCT02283983|101647266|FG000|Overall Study|Lost to Follow-up|9|||
33479487|NCT02283983|101647267|FG001|Overall Study|Lost to Follow-up|8|||
33479488|NCT02283983|101647266|FG000|Overall Study|Relapse|1|||
33479489|NCT02283983|101647267|FG001|Overall Study|Relapse|0|||
33479490|NCT00528411|101647268|FG000|Overall Study|Adverse Event|4|||
33269535|NCT02584257|100887327|FG004|Period 1|Withdrawal by Subject|0|||
33269536|NCT02584257|100887328|FG005|Period 1|Withdrawal by Subject|0|||
33269537|NCT02584257|100887329|FG006|Period 1|Withdrawal by Subject|1|||
33479491|NCT00528411|101647269|FG001|Overall Study|Adverse Event|0|||
33479492|NCT00528411|101647270|FG002|Overall Study|Adverse Event|1|||
33479493|NCT00528411|101647268|FG000|Overall Study|Incorrect Enrolment|1|||
33479494|NCT00528411|101647269|FG001|Overall Study|Incorrect Enrolment|1|||
33479495|NCT00528411|101647270|FG002|Overall Study|Incorrect Enrolment|0|||
33479496|NCT00528411|101647268|FG000|Overall Study|Severe non-compliance to protocol|0|||
33479497|NCT00528411|101647269|FG001|Overall Study|Severe non-compliance to protocol|1|||
33479498|NCT00528411|101647270|FG002|Overall Study|Severe non-compliance to protocol|0|||
33479499|NCT00528411|101647268|FG000|Overall Study|Prior commitment medication|0|||
33479500|NCT00528411|101647269|FG001|Overall Study|Prior commitment medication|1|||
33479501|NCT00528411|101647270|FG002|Overall Study|Prior commitment medication|0|||
33479502|NCT05819203|101647271|FG000|Overall Study|Protocol Violation|1|||
33479503|NCT05819203|101647272|FG001|Overall Study|Protocol Violation|2|||
33479504|NCT05819203|101647271|FG000|Overall Study|Withdrawal by Subject|1|||
33479505|NCT05819203|101647272|FG001|Overall Study|Withdrawal by Subject|0|||
33479506|NCT01778686|101647273|FG000|Overall Study|Adverse Event|0|||
33479507|NCT01778686|101647274|FG001|Overall Study|Adverse Event|0|||
33479508|NCT01778686|101647275|FG002|Overall Study|Adverse Event|1|||
33479509|NCT04730349|101647276|FG000|Overall Study|Participant withdrew consent|1|||
33479510|NCT04730349|101647277|FG001|Overall Study|Participant withdrew consent|0|||
33479511|NCT04730349|101647276|FG000|Overall Study|Disease progression|6|||
33479512|NCT04730349|101647277|FG001|Overall Study|Disease progression|4|||
33479513|NCT04730349|101647276|FG000|Overall Study|Study drug toxicity|0|||
33479514|NCT04730349|101647277|FG001|Overall Study|Study drug toxicity|1|||
33479515|NCT01367665|101647278|FG000|Overall Study|Death|102|||
33479516|NCT01367665|101647279|FG001|Overall Study|Death|19|||
33479517|NCT01367665|101647278|FG000|Overall Study|Lost to Follow-up|222|||
33479518|NCT01367665|101647279|FG001|Overall Study|Lost to Follow-up|22|||
33479519|NCT01367665|101647278|FG000|Overall Study|Not Done|118|||
33479520|NCT01367665|101647279|FG001|Overall Study|Not Done|14|||
33479521|NCT01910389|101647280|FG000|Overall Study|Withdrawal by Subject|2|||
33479522|NCT01910389|101647281|FG001|Overall Study|Withdrawal by Subject|0|||
33479523|NCT01910389|101647280|FG000|Overall Study|Study Closed|13|||
33479524|NCT01910389|101647281|FG001|Overall Study|Study Closed|8|||
33479525|NCT04715932|101647284|FG000|Overall Study|Lost to Follow-up|1|||
33479526|NCT04715932|101647285|FG001|Overall Study|Lost to Follow-up|0|||
33479527|NCT01341782|101647286|FG000|Overall Study|Adverse Event|1|||
33479528|NCT01341782|101647287|FG001|Overall Study|Adverse Event|1|||
33479529|NCT01341782|101647286|FG000|Overall Study|Withdrawal by Subject|6|||
33479530|NCT01341782|101647287|FG001|Overall Study|Withdrawal by Subject|5|||
33479531|NCT01341782|101647286|FG000|Overall Study|Missed 3 consecutive doses|0|||
33479532|NCT01341782|101647287|FG001|Overall Study|Missed 3 consecutive doses|4|||
33479533|NCT01341782|101647286|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
33479534|NCT01341782|101647287|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
33479535|NCT01341782|101647286|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
33479536|NCT01341782|101647287|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
33479537|NCT01341782|101647286|FG000|Overall Study|Other|5|||
33479538|NCT01341782|101647287|FG001|Overall Study|Other|0|||
33479539|NCT01136967|101647291|FG000|Overall Study|Adverse Event|9|||
33479540|NCT01136967|101647292|FG001|Overall Study|Adverse Event|12|||
33479541|NCT01136967|101647291|FG000|Overall Study|Participant Choice|8|||
33479542|NCT01136967|101647292|FG001|Overall Study|Participant Choice|3|||
33479543|NCT01136967|101647291|FG000|Overall Study|Lost to Follow-up|0|||
33479544|NCT01136967|101647292|FG001|Overall Study|Lost to Follow-up|1|||
33479545|NCT01136967|101647291|FG000|Overall Study|Withdrawal by Subject|1|||
33479546|NCT01136967|101647292|FG001|Overall Study|Withdrawal by Subject|2|||
33479547|NCT01136967|101647291|FG000|Overall Study|Clinical Progression|3|||
33479548|NCT01136967|101647292|FG001|Overall Study|Clinical Progression|5|||
33479549|NCT01136967|101647291|FG000|Overall Study|Radiation|1|||
33479550|NCT01136967|101647292|FG001|Overall Study|Radiation|0|||
33479551|NCT01136967|101647291|FG000|Overall Study|Non-compliance|1|||
33479552|NCT01136967|101647292|FG001|Overall Study|Non-compliance|0|||
33479553|NCT01136967|101647291|FG000|Overall Study|Investigator's Choice|1|||
33479554|NCT01136967|101647292|FG001|Overall Study|Investigator's Choice|1|||
33479555|NCT01136967|101647291|FG000|Overall Study|Increase in Lesion Size|0|||
33479556|NCT01136967|101647292|FG001|Overall Study|Increase in Lesion Size|2|||
33479557|NCT01136967|101647291|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
33479558|NCT01136967|101647292|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
33479559|NCT02640053|101647293|FG000|Overall Study|Withdrawal by Subject|2|||
33269538|NCT02584257|100887330|FG007|Period 1|Withdrawal by Subject|0|||
33269539|NCT02584257|100887331|FG008|Period 1|Withdrawal by Subject|0|||
33269540|NCT02584257|100887323|FG000|Period 2|Physician Decision|1|||
33269541|NCT02584257|100887324|FG001|Period 2|Physician Decision|0|||
33479560|NCT02640053|101647294|FG001|Overall Study|Withdrawal by Subject|1|||
33479561|NCT02640053|101647293|FG000|Overall Study|Adverse Event|1|||
33479562|NCT02640053|101647294|FG001|Overall Study|Adverse Event|1|||
33479563|NCT02640053|101647293|FG000|Overall Study|Alternative Therapy|1|||
33479564|NCT02640053|101647294|FG001|Overall Study|Alternative Therapy|1|||
33479565|NCT02640053|101647293|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
33479566|NCT02640053|101647294|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
33479567|NCT03753763|101647296|FG000|Overall Study|Adverse Event|2|||
33269542|NCT02584257|100887325|FG002|Period 2|Physician Decision|0|||
33479568|NCT03753763|101647297|FG001|Overall Study|Adverse Event|0|||
33479569|NCT03753763|101647296|FG000|Overall Study|Withdrawal by Subject|3|||
33479570|NCT03753763|101647297|FG001|Overall Study|Withdrawal by Subject|1|||
33269543|NCT02584257|100887326|FG003|Period 2|Physician Decision|0|||
33269544|NCT02584257|100887327|FG004|Period 2|Physician Decision|0|||
33269545|NCT02584257|100887328|FG005|Period 2|Physician Decision|0|||
33269546|NCT02584257|100887329|FG006|Period 2|Physician Decision|0|||
33269547|NCT02584257|100887330|FG007|Period 2|Physician Decision|0|||
33269548|NCT02584257|100887331|FG008|Period 2|Physician Decision|0|||
33479571|NCT03753763|101647296|FG000|Overall Study|clinical deterioration|1|||
33479572|NCT03753763|101647297|FG001|Overall Study|clinical deterioration|0|||
33479573|NCT03560986|101647298|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
33479574|NCT03560986|101647299|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
33479575|NCT03560986|101647298|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
33479576|NCT03560986|101647299|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
33479577|NCT03560986|101647298|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
33479578|NCT03560986|101647299|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
33479579|NCT03560986|101647298|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
33479580|NCT03560986|101647299|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
33479581|NCT03560986|101647298|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
33479582|NCT03560986|101647299|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
33479583|NCT03560986|101647298|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
33479584|NCT03560986|101647299|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
33479585|NCT03560986|101647298|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
33479586|NCT03560986|101647299|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
33479587|NCT03694327|101647301|FG000|Overall Study|Lost to Follow-up|13|||
33479588|NCT03694327|101647302|FG001|Overall Study|Lost to Follow-up|23|||
33479589|NCT02085135|101647303|FG000|Overall Study|Adverse Event|4|||
33479590|NCT02085135|101647304|FG001|Overall Study|Adverse Event|7|||
33479591|NCT02085135|101647303|FG000|Overall Study|Lost to Follow-up|2|||
33479592|NCT02085135|101647304|FG001|Overall Study|Lost to Follow-up|2|||
33479593|NCT02085135|101647303|FG000|Overall Study|Withdrawal by Subject|3|||
33479594|NCT02085135|101647304|FG001|Overall Study|Withdrawal by Subject|0|||
33479595|NCT02085135|101647303|FG000|Overall Study|Lack of Efficacy|2|||
33479596|NCT02085135|101647304|FG001|Overall Study|Lack of Efficacy|0|||
33479597|NCT03247816|101651520|FG000|Overall Study|Adverse Event|12|||
33269549|NCT02584257|100887323|FG000|Period 2|Adverse Event|0|||
33269550|NCT02584257|100887324|FG001|Period 2|Adverse Event|1|||
33479598|NCT03247816|101651520|FG000|Overall Study|Physician Decision|3|||
33479599|NCT03247816|101651520|FG000|Overall Study|Lack of Efficacy|1|||
33479600|NCT03247816|101651520|FG000|Overall Study|Lost to Follow-up|10|||
33269551|NCT02584257|100887325|FG002|Period 2|Adverse Event|0|||
33269552|NCT02584257|100887326|FG003|Period 2|Adverse Event|0|||
33269553|NCT02584257|100887327|FG004|Period 2|Adverse Event|0|||
33269554|NCT02584257|100887328|FG005|Period 2|Adverse Event|0|||
33269555|NCT02584257|100887329|FG006|Period 2|Adverse Event|0|||
33269556|NCT02584257|100887330|FG007|Period 2|Adverse Event|0|||
33479601|NCT03247816|101651520|FG000|Overall Study|Missing Feraccru stop date|3|||
33479602|NCT01822275|101651521|FG000|Overall Study|Withdrawal by Subject|3|||
33479603|NCT01822275|101651521|FG000|Overall Study|Adverse Event|3|||
33479604|NCT01822275|101651521|FG000|Overall Study|Progression|14|||
33479605|NCT01822275|101651521|FG000|Overall Study|Physician Decision|2|||
33479606|NCT02504671|101651522|FG000|Overall Study|Withdrawal by Subject|1|||
33479607|NCT02504671|101651523|FG001|Overall Study|Withdrawal by Subject|5|||
33269557|NCT02584257|100887331|FG008|Period 2|Adverse Event|0|||
33269558|NCT02309515|100887332|FG000|Overall Study|Withdrawal by Subject|0|||
33269559|NCT02309515|100887333|FG001|Overall Study|Withdrawal by Subject|1|||
33269560|NCT03964974|100887336|FG000|Overall Study|Lost to Follow-up|3|||
33269561|NCT03964974|100887337|FG001|Overall Study|Lost to Follow-up|2|||
33269562|NCT03964974|100887336|FG000|Overall Study|Withdrawal by Subject|0|||
33269563|NCT03964974|100887337|FG001|Overall Study|Withdrawal by Subject|3|||
33269564|NCT02188459|100887339|FG000|Overall Study|Lost to Follow-up|3|||
33269565|NCT02188459|100887340|FG001|Overall Study|Lost to Follow-up|4|||
33269566|NCT02188459|100887339|FG000|Overall Study|Early Termination|0|||
33269567|NCT02188459|100887340|FG001|Overall Study|Early Termination|3|||
33269568|NCT00578344|100887341|FG000|Overall Study|Insurance problems|1|||
33479608|NCT02504671|101651524|FG002|Overall Study|Withdrawal by Subject|4|||
33269569|NCT00578344|100887341|FG000|Overall Study|Graft failure|1|||
33269570|NCT01419184|100887342|FG000|Overall Study|Site data not available|3|||
33269571|NCT01419184|100887343|FG001|Overall Study|Site data not available|2|||
33269572|NCT01419184|100887342|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
33269573|NCT01419184|100887343|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
33269574|NCT01419184|100887342|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
33269575|NCT01419184|100887343|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
33479609|NCT02504671|101651525|FG003|Overall Study|Withdrawal by Subject|4|||
33479610|NCT02504671|101651526|FG004|Overall Study|Withdrawal by Subject|5|||
33479611|NCT02504671|101651527|FG005|Overall Study|Withdrawal by Subject|3|||
33269576|NCT01419184|100887342|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
33479612|NCT02504671|101651522|FG000|Overall Study|Lack of Efficacy|1|||
33479613|NCT02504671|101651523|FG001|Overall Study|Lack of Efficacy|3|||
33479614|NCT02504671|101651524|FG002|Overall Study|Lack of Efficacy|1|||
33479615|NCT02504671|101651525|FG003|Overall Study|Lack of Efficacy|0|||
33479616|NCT02504671|101651526|FG004|Overall Study|Lack of Efficacy|4|||
33479617|NCT02504671|101651527|FG005|Overall Study|Lack of Efficacy|4|||
33479618|NCT02504671|101651522|FG000|Overall Study|Adverse Event|1|||
33479619|NCT02504671|101651523|FG001|Overall Study|Adverse Event|1|||
33479620|NCT02504671|101651524|FG002|Overall Study|Adverse Event|0|||
33479621|NCT02504671|101651525|FG003|Overall Study|Adverse Event|1|||
33479622|NCT02504671|101651526|FG004|Overall Study|Adverse Event|0|||
33479623|NCT02504671|101651527|FG005|Overall Study|Adverse Event|2|||
33479624|NCT02504671|101651522|FG000|Overall Study|Protocol Violation|2|||
33479625|NCT02504671|101651523|FG001|Overall Study|Protocol Violation|1|||
33479626|NCT02504671|101651524|FG002|Overall Study|Protocol Violation|0|||
33479627|NCT02504671|101651525|FG003|Overall Study|Protocol Violation|0|||
33479628|NCT02504671|101651526|FG004|Overall Study|Protocol Violation|0|||
33479629|NCT02504671|101651527|FG005|Overall Study|Protocol Violation|1|||
33479630|NCT02504671|101651522|FG000|Overall Study|Lost to Follow-up|0|||
33479631|NCT02504671|101651523|FG001|Overall Study|Lost to Follow-up|0|||
33479632|NCT02504671|101651524|FG002|Overall Study|Lost to Follow-up|2|||
33479633|NCT02504671|101651525|FG003|Overall Study|Lost to Follow-up|0|||
33479634|NCT02504671|101651526|FG004|Overall Study|Lost to Follow-up|0|||
33479635|NCT02504671|101651527|FG005|Overall Study|Lost to Follow-up|1|||
33479636|NCT02504671|101651522|FG000|Overall Study|Protocol defined stopping criteria|7|||
33479637|NCT02504671|101651523|FG001|Overall Study|Protocol defined stopping criteria|4|||
33479638|NCT02504671|101651524|FG002|Overall Study|Protocol defined stopping criteria|3|||
33479639|NCT02504671|101651525|FG003|Overall Study|Protocol defined stopping criteria|5|||
33479640|NCT02504671|101651526|FG004|Overall Study|Protocol defined stopping criteria|3|||
33479641|NCT02504671|101651527|FG005|Overall Study|Protocol defined stopping criteria|3|||
33479642|NCT02679235|101651562|FG000|Overall Study|Withdrawal by Subject|3|||
33479643|NCT02679235|101651562|FG000|Overall Study|Adverse Event|1|||
33479644|NCT02903030|101651568|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
33479645|NCT02903030|101651569|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
33479646|NCT04345601|101651570|FG000|Overall Study|Death|0|||
33479647|NCT04345601|101651571|FG001|Overall Study|Death|3|||
33479648|NCT04345601|101651572|FG002|Overall Study|Death|2|||
33479649|NCT04345601|101651570|FG000|Overall Study|Lost to Follow-up|0|||
33479650|NCT04345601|101651571|FG001|Overall Study|Lost to Follow-up|0|||
33479651|NCT04345601|101651572|FG002|Overall Study|Lost to Follow-up|2|||
33479652|NCT04555720|101651573|FG000|Overall Study|Lost to Follow-up|2|||
33479653|NCT04555720|101651574|FG001|Overall Study|Lost to Follow-up|0|||
33479654|NCT04555720|101651575|FG002|Overall Study|Lost to Follow-up|0|||
33479655|NCT04555720|101651576|FG003|Overall Study|Lost to Follow-up|0|||
33479656|NCT04555720|101651573|FG000|Overall Study|Withdrawal by Subject|4|||
33479657|NCT04555720|101651574|FG001|Overall Study|Withdrawal by Subject|6|||
33479658|NCT04555720|101651575|FG002|Overall Study|Withdrawal by Subject|0|||
33479659|NCT04555720|101651576|FG003|Overall Study|Withdrawal by Subject|0|||
33479660|NCT03136965|101651577|FG000|Overall Study|Lost to Follow-up|0|||
33479661|NCT03136965|101651578|FG001|Overall Study|Lost to Follow-up|1|||
33479662|NCT03136965|101651579|FG002|Overall Study|Lost to Follow-up|0|||
33479663|NCT03210714|101651580|FG000|Overall Study|Adverse Event|6|||
33479664|NCT03210714|101651580|FG000|Overall Study|Physician Decision|1|||
33479665|NCT03210714|101651580|FG000|Overall Study|Progressive disease|11|||
33479666|NCT03210714|101651580|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
33479667|NCT02377427|101651581|FG000|Part A (Up to Week 20)|Physician Decision|1|||
33479668|NCT02377427|101651582|FG001|Part A (Up to Week 20)|Physician Decision|0|||
33479669|NCT02377427|101651583|FG002|Part A (Up to Week 20)|Physician Decision|0|||
33479670|NCT02377427|101651584|FG003|Part A (Up to Week 20)|Physician Decision|0|||
33479671|NCT02377427|101651585|FG004|Part A (Up to Week 20)|Physician Decision|0|||
33479672|NCT02377427|101651581|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
33479673|NCT02377427|101651582|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
33479674|NCT02377427|101651583|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
33479675|NCT02377427|101651584|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
33479676|NCT02377427|101651585|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
33479677|NCT02377427|101651581|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
33479678|NCT02377427|101651582|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
33479679|NCT02377427|101651583|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
33479680|NCT02377427|101651584|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
33479681|NCT02377427|101651585|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
33479682|NCT02377427|101651581|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
33479683|NCT02377427|101651582|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
33479684|NCT02377427|101651583|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
33479685|NCT02377427|101651584|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
33479686|NCT02377427|101651585|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
33269577|NCT01419184|100887343|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
33269578|NCT01419184|100887342|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
33479687|NCT00806286|101651588|FG000|Overall Study|Adverse Event|5|||
33479688|NCT00806286|101651589|FG001|Overall Study|Adverse Event|2|||
33479689|NCT00806286|101651590|FG002|Overall Study|Adverse Event|0|||
33479690|NCT00806286|101651588|FG000|Overall Study|Disease progression|31|||
33479691|NCT00806286|101651589|FG001|Overall Study|Disease progression|38|||
33479692|NCT00806286|101651590|FG002|Overall Study|Disease progression|1|||
33479693|NCT00806286|101651588|FG000|Overall Study|Death|1|||
33479694|NCT00806286|101651589|FG001|Overall Study|Death|6|||
33479695|NCT00806286|101651590|FG002|Overall Study|Death|0|||
33479696|NCT00806286|101651588|FG000|Overall Study|Lost to Follow-up|0|||
33479697|NCT00806286|101651589|FG001|Overall Study|Lost to Follow-up|1|||
33479698|NCT00806286|101651590|FG002|Overall Study|Lost to Follow-up|0|||
33479699|NCT00806286|101651588|FG000|Overall Study|Withdrawal by Subject|8|||
33479700|NCT00806286|101651589|FG001|Overall Study|Withdrawal by Subject|3|||
33479701|NCT00806286|101651590|FG002|Overall Study|Withdrawal by Subject|1|||
33479702|NCT00806286|101651588|FG000|Overall Study|Physician Decision|2|||
33479703|NCT00806286|101651589|FG001|Overall Study|Physician Decision|2|||
33479704|NCT00806286|101651590|FG002|Overall Study|Physician Decision|0|||
33479705|NCT00806286|101651588|FG000|Overall Study|Due to a variety of reasons|7|||
33479706|NCT00806286|101651589|FG001|Overall Study|Due to a variety of reasons|2|||
33479707|NCT00806286|101651590|FG002|Overall Study|Due to a variety of reasons|1|||
33479708|NCT00839254|101651591|FG000|Overall Study|Protocol Violation|0|||
33479709|NCT00839254|101651592|FG001|Overall Study|Protocol Violation|1|||
33479710|NCT00839254|101651593|FG002|Overall Study|Protocol Violation|1|||
33479711|NCT00839254|101651594|FG003|Overall Study|Protocol Violation|1|||
33479712|NCT00839254|101651595|FG004|Overall Study|Protocol Violation|0|||
33479713|NCT00839254|101651596|FG005|Overall Study|Protocol Violation|0|||
33479714|NCT00839254|101651597|FG006|Overall Study|Protocol Violation|1|||
33479715|NCT00839254|101651598|FG007|Overall Study|Protocol Violation|2|||
33269579|NCT01419184|100887343|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
33269580|NCT01419184|100887342|FG000|Overall Study|Participant randomized, not treated|1|||
33269581|NCT01419184|100887343|FG001|Overall Study|Participant randomized, not treated|0|||
33269582|NCT01999335|100887344|FG000|Overall Study|Discontinued before receiving treatment|0|||
33269583|NCT01999335|100887345|FG001|Overall Study|Discontinued before receiving treatment|0|||
33269584|NCT01999335|100887346|FG002|Overall Study|Discontinued before receiving treatment|0|||
33269585|NCT01999335|100887347|FG003|Overall Study|Discontinued before receiving treatment|0|||
33269586|NCT01999335|100887348|FG004|Overall Study|Discontinued before receiving treatment|2|||
33269587|NCT02279732|100887349|FG000|Overall Study|Death|23|||
33269588|NCT02279732|100887350|FG001|Overall Study|Death|20|||
33269589|NCT02279732|100887349|FG000|Overall Study|Disease Progression|13|||
33269590|NCT02279732|100887350|FG001|Overall Study|Disease Progression|3|||
33269591|NCT02279732|100887349|FG000|Overall Study|Withdrawal by Subject|2|||
33269592|NCT02279732|100887350|FG001|Overall Study|Withdrawal by Subject|7|||
33269593|NCT02279732|100887349|FG000|Overall Study|Adverse Event|1|||
33269594|NCT02279732|100887350|FG001|Overall Study|Adverse Event|2|||
33269595|NCT02279732|100887349|FG000|Overall Study|Administrative Reason By Sponsor|0|||
33269596|NCT02279732|100887350|FG001|Overall Study|Administrative Reason By Sponsor|2|||
33269597|NCT02279732|100887349|FG000|Overall Study|Study Drug Toxicity|2|||
33269598|NCT02279732|100887350|FG001|Overall Study|Study Drug Toxicity|0|||
33269599|NCT02279732|100887349|FG000|Overall Study|Lost to Follow-up|0|||
33269600|NCT02279732|100887350|FG001|Overall Study|Lost to Follow-up|1|||
33269601|NCT02279732|100887349|FG000|Overall Study|Maximum Clinical Benefit|1|||
33269602|NCT02279732|100887350|FG001|Overall Study|Maximum Clinical Benefit|0|||
33269603|NCT02279732|100887349|FG000|Overall Study|Subject Requested to Discontinue|0|||
33269604|NCT02279732|100887350|FG001|Overall Study|Subject Requested to Discontinue|1|||
33269605|NCT02279732|100887349|FG000|Overall Study|Other|53|||
33269606|NCT02279732|100887350|FG001|Overall Study|Other|67|||
33269607|NCT02279732|100887349|FG000|Overall Study|Other|3|||
33269608|NCT02279732|100887350|FG001|Overall Study|Other|3|||
33269609|NCT04328467|100887353|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
33479716|NCT00839254|101651591|FG000|Overall Study|Physician Decision|0|||
33269610|NCT04328467|100887354|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
33269611|NCT04328467|100887355|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
33269612|NCT04131556|100887356|FG000|Overall Study|Adverse Event|1|||
33269613|NCT04131556|100887356|FG000|Overall Study|Withdrawal by Subject|1|||
33479717|NCT00839254|101651592|FG001|Overall Study|Physician Decision|1|||
33479718|NCT00839254|101651593|FG002|Overall Study|Physician Decision|0|||
33479719|NCT00839254|101651594|FG003|Overall Study|Physician Decision|0|||
33479720|NCT00839254|101651595|FG004|Overall Study|Physician Decision|0|||
33479721|NCT00839254|101651596|FG005|Overall Study|Physician Decision|0|||
33479722|NCT00839254|101651597|FG006|Overall Study|Physician Decision|0|||
33269614|NCT04237792|100887357|FG000|Treatment (Day 1)|Adverse Event|1|||
33269615|NCT04237792|100887358|FG001|Treatment (Day 1)|Adverse Event|0|||
33269616|NCT04237792|100887359|FG002|Treatment (Day 1)|Adverse Event|0|||
33269617|NCT04237792|100887360|FG003|Treatment (Day 1)|Adverse Event|0|||
33479723|NCT00839254|101651598|FG007|Overall Study|Physician Decision|1|||
33479724|NCT00839254|101651591|FG000|Overall Study|Wrong treatment number allocation|0|||
33479725|NCT00839254|101651592|FG001|Overall Study|Wrong treatment number allocation|1|||
33479726|NCT00839254|101651593|FG002|Overall Study|Wrong treatment number allocation|0|||
33479727|NCT00839254|101651594|FG003|Overall Study|Wrong treatment number allocation|0|||
33479728|NCT00839254|101651595|FG004|Overall Study|Wrong treatment number allocation|0|||
33479729|NCT00839254|101651596|FG005|Overall Study|Wrong treatment number allocation|1|||
33479730|NCT00839254|101651597|FG006|Overall Study|Wrong treatment number allocation|0|||
33479731|NCT00839254|101651598|FG007|Overall Study|Wrong treatment number allocation|0|||
33479732|NCT00839254|101651591|FG000|Overall Study|Adverse Event|12|||
33479733|NCT00839254|101651592|FG001|Overall Study|Adverse Event|6|||
33479734|NCT00839254|101651593|FG002|Overall Study|Adverse Event|3|||
33269618|NCT04237792|100887361|FG004|Treatment (Day 1)|Adverse Event|1|||
33479735|NCT00839254|101651594|FG003|Overall Study|Adverse Event|5|||
33479736|NCT00839254|101651595|FG004|Overall Study|Adverse Event|2|||
33479737|NCT00839254|101651596|FG005|Overall Study|Adverse Event|1|||
33479738|NCT00839254|101651597|FG006|Overall Study|Adverse Event|0|||
33479739|NCT00839254|101651598|FG007|Overall Study|Adverse Event|1|||
33479740|NCT00839254|101651591|FG000|Overall Study|Withdrawal by Subject|87|||
33269619|NCT04237792|100887362|FG005|Treatment (Day 1)|Adverse Event|1|||
33269620|NCT04237792|100887357|FG000|Treatment (Day 1)|Other|0|||
33269621|NCT04237792|100887358|FG001|Treatment (Day 1)|Other|0|||
33269622|NCT04237792|100887359|FG002|Treatment (Day 1)|Other|1|||
33269623|NCT04237792|100887360|FG003|Treatment (Day 1)|Other|0|||
33269624|NCT04237792|100887361|FG004|Treatment (Day 1)|Other|0|||
33269625|NCT04237792|100887362|FG005|Treatment (Day 1)|Other|1|||
33269626|NCT04237792|100887357|FG000|Treatment (Day 1)|Not treated|1|||
33269627|NCT04237792|100887358|FG001|Treatment (Day 1)|Not treated|1|||
33269628|NCT04237792|100887359|FG002|Treatment (Day 1)|Not treated|2|||
33269629|NCT04237792|100887360|FG003|Treatment (Day 1)|Not treated|1|||
33269630|NCT04237792|100887361|FG004|Treatment (Day 1)|Not treated|0|||
33269631|NCT04237792|100887362|FG005|Treatment (Day 1)|Not treated|1|||
33269632|NCT00807599|100887363|FG000|Overall Study|Not treated on protocol study|0|||
33269633|NCT00807599|100887364|FG001|Overall Study|Not treated on protocol study|0|||
33269634|NCT00807599|100887365|FG002|Overall Study|Not treated on protocol study|2|||
33269635|NCT00807599|100887363|FG000|Overall Study|Adverse Event|0|||
33269636|NCT00807599|100887364|FG001|Overall Study|Adverse Event|0|||
33269637|NCT00807599|100887365|FG002|Overall Study|Adverse Event|5|||
33269638|NCT00807599|100887363|FG000|Overall Study|Inadequate response to induction|0|||
33269639|NCT00807599|100887364|FG001|Overall Study|Inadequate response to induction|0|||
33269640|NCT00807599|100887365|FG002|Overall Study|Inadequate response to induction|9|||
33269641|NCT00807599|100887363|FG000|Overall Study|Withdrawal by Subject|0|||
33479741|NCT00839254|101651592|FG001|Overall Study|Withdrawal by Subject|53|||
33479742|NCT00839254|101651593|FG002|Overall Study|Withdrawal by Subject|54|||
33479743|NCT00839254|101651594|FG003|Overall Study|Withdrawal by Subject|32|||
33479744|NCT00839254|101651595|FG004|Overall Study|Withdrawal by Subject|27|||
33479745|NCT00839254|101651596|FG005|Overall Study|Withdrawal by Subject|15|||
33479746|NCT00839254|101651597|FG006|Overall Study|Withdrawal by Subject|22|||
33479747|NCT00839254|101651598|FG007|Overall Study|Withdrawal by Subject|9|||
33479748|NCT00839254|101651591|FG000|Overall Study|Wrong group allocation|0|||
33479749|NCT00839254|101651592|FG001|Overall Study|Wrong group allocation|0|||
33479750|NCT00839254|101651593|FG002|Overall Study|Wrong group allocation|0|||
33479751|NCT00839254|101651594|FG003|Overall Study|Wrong group allocation|0|||
33479752|NCT00839254|101651595|FG004|Overall Study|Wrong group allocation|0|||
33479753|NCT00839254|101651596|FG005|Overall Study|Wrong group allocation|0|||
33479754|NCT00839254|101651597|FG006|Overall Study|Wrong group allocation|1|||
33479755|NCT00839254|101651598|FG007|Overall Study|Wrong group allocation|0|||
33479756|NCT00839254|101651591|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
33269642|NCT00807599|100887364|FG001|Overall Study|Withdrawal by Subject|0|||
33269643|NCT00807599|100887365|FG002|Overall Study|Withdrawal by Subject|1|||
33269644|NCT04693637|100887369|FG000|Overall Study|Death|4|||
33479757|NCT00839254|101651592|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
33479758|NCT00839254|101651593|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
33269645|NCT04693637|100887369|FG000|Overall Study|Withdrawal by Subject|3|||
33479759|NCT00839254|101651594|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
33479760|NCT00839254|101651595|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
33479761|NCT00839254|101651596|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
33479762|NCT00839254|101651597|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
33479763|NCT00839254|101651598|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
33479764|NCT00839254|101651591|FG000|Overall Study|Withdrawn due to non-compliance|2|||
33269646|NCT04693637|100887369|FG000|Overall Study|Physician Decision|2|||
33269647|NCT04693637|100887369|FG000|Overall Study|Lost to Follow-up|1|||
33269648|NCT01186809|100887370|FG000|Overall Study|Death|30|||
33269649|NCT03162614|100887371|FG000|Overall Study|Lost to Follow-up|2|||
33269650|NCT03162614|100887372|FG001|Overall Study|Lost to Follow-up|1|||
33269651|NCT03162614|100887373|FG002|Overall Study|Lost to Follow-up|1|||
33479765|NCT00839254|101651592|FG001|Overall Study|Withdrawn due to non-compliance|0|||
33479766|NCT00839254|101651593|FG002|Overall Study|Withdrawn due to non-compliance|0|||
33479767|NCT00839254|101651594|FG003|Overall Study|Withdrawn due to non-compliance|0|||
33479768|NCT00839254|101651595|FG004|Overall Study|Withdrawn due to non-compliance|0|||
33479769|NCT00839254|101651596|FG005|Overall Study|Withdrawn due to non-compliance|0|||
33479770|NCT00839254|101651597|FG006|Overall Study|Withdrawn due to non-compliance|0|||
33479771|NCT00839254|101651598|FG007|Overall Study|Withdrawn due to non-compliance|0|||
33479772|NCT00839254|101651591|FG000|Overall Study|Lost to Follow-up|51|||
33479773|NCT00839254|101651592|FG001|Overall Study|Lost to Follow-up|30|||
33479774|NCT00839254|101651593|FG002|Overall Study|Lost to Follow-up|32|||
33479775|NCT00839254|101651594|FG003|Overall Study|Lost to Follow-up|24|||
33479776|NCT00839254|101651595|FG004|Overall Study|Lost to Follow-up|8|||
33479777|NCT00839254|101651596|FG005|Overall Study|Lost to Follow-up|8|||
33479778|NCT00839254|101651597|FG006|Overall Study|Lost to Follow-up|4|||
33479779|NCT00839254|101651598|FG007|Overall Study|Lost to Follow-up|2|||
33479780|NCT02752087|101651599|FG000|Washout|Physician Decision|1|||
33479781|NCT02752087|101651600|FG001|Washout|Physician Decision|0|||
33479782|NCT01475097|101651602|FG000|Overall Study|Protocol Violation|1|||
33479783|NCT01475097|101651603|FG001|Overall Study|Protocol Violation|1|||
33479784|NCT03825341|101651604|FG000|Overall Study|Withdrawal by Subject|0|||
33479785|NCT03825341|101651605|FG001|Overall Study|Withdrawal by Subject|1|||
33479786|NCT02113189|101651606|FG000|Overall Study|Lost to follow up|2|||
33479787|NCT02113189|101651607|FG001|Overall Study|Lost to follow up|1|||
33479788|NCT02113189|101651608|FG002|Overall Study|Lost to follow up|3|||
33479789|NCT03713619|101651609|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
33479790|NCT03713619|101651610|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
33479791|NCT03713619|101651611|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
33479792|NCT03713619|101651612|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
33479793|NCT03713619|101651613|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
33479794|NCT03713619|101651609|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
33479795|NCT03713619|101651610|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
33479796|NCT03713619|101651611|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
33479797|NCT03713619|101651612|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
33479798|NCT03713619|101651613|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
33479799|NCT03713619|101651609|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
33479800|NCT03713619|101651610|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
33479801|NCT03713619|101651611|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
33479802|NCT03713619|101651612|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
33479803|NCT03713619|101651613|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
33479804|NCT03713619|101651609|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
33479805|NCT03713619|101651610|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
33479806|NCT03713619|101651611|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
33479807|NCT03713619|101651612|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
33479808|NCT03713619|101651613|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
33479809|NCT03713619|101651609|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
33479810|NCT03713619|101651610|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
33479811|NCT03713619|101651611|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
33479812|NCT03713619|101651612|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
33479813|NCT03713619|101651613|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
33479814|NCT03713619|101651609|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
33479815|NCT03713619|101651610|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
33479816|NCT03713619|101651611|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
33479817|NCT03713619|101651612|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
33479818|NCT03713619|101651613|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
33479819|NCT03713619|101651609|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
33479820|NCT03713619|101651610|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
33479821|NCT03713619|101651611|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
33479822|NCT03713619|101651612|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
33479823|NCT03713619|101651613|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
33479824|NCT03713619|101651609|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
33479825|NCT03713619|101651610|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
33269652|NCT03162614|100887374|FG003|Overall Study|Lost to Follow-up|1|||
33479826|NCT03713619|101651611|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
33479827|NCT03713619|101651612|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
33479828|NCT03713619|101651613|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
33479829|NCT03713619|101651609|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
33479830|NCT03713619|101651610|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
33479831|NCT03713619|101651611|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
33479832|NCT03713619|101651612|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
33479833|NCT03713619|101651613|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
33479834|NCT03713619|101651609|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
33479835|NCT03713619|101651610|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
33479836|NCT03713619|101651611|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
33479837|NCT03713619|101651612|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
33479838|NCT03713619|101651613|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
33479839|NCT03713619|101651609|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
33479840|NCT03713619|101651610|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
33479841|NCT03713619|101651611|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
33479842|NCT03713619|101651612|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
33479843|NCT03713619|101651613|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
33479844|NCT03713619|101651609|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
33479845|NCT03713619|101651610|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
33479846|NCT03713619|101651611|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
33479847|NCT03713619|101651612|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
33479848|NCT03713619|101651613|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
33479849|NCT03713619|101651609|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
33479850|NCT03713619|101651610|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
33479851|NCT03713619|101651611|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
33479852|NCT03713619|101651612|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
33479853|NCT03713619|101651613|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
33479854|NCT02968849|101651614|FG000|Overall Study|Death|8|||
33479855|NCT02968849|101651615|FG001|Overall Study|Death|10|||
33479856|NCT02968849|101651614|FG000|Overall Study|Lost to Follow-up|31|||
33479857|NCT02968849|101651615|FG001|Overall Study|Lost to Follow-up|29|||
33479858|NCT02968849|101651614|FG000|Overall Study|Withdrawal by Subject|73|||
33479859|NCT02968849|101651615|FG001|Overall Study|Withdrawal by Subject|64|||
33479860|NCT02968849|101651614|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
33479861|NCT02968849|101651615|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
33479862|NCT02968849|101651614|FG000|Overall Study|Physician Decision|6|||
33479863|NCT02968849|101651615|FG001|Overall Study|Physician Decision|9|||
33479864|NCT02968849|101651614|FG000|Overall Study|Other|16|||
33479865|NCT02968849|101651615|FG001|Overall Study|Other|10|||
33479866|NCT01646138|101651619|FG000|Overall Study|Lost to Follow-up|0|||
33479867|NCT01646138|101651620|FG001|Overall Study|Lost to Follow-up|0|||
33479868|NCT01646138|101651621|FG002|Overall Study|Lost to Follow-up|0|||
33479869|NCT01646138|101651622|FG003|Overall Study|Lost to Follow-up|0|||
33479870|NCT01646138|101651623|FG004|Overall Study|Lost to Follow-up|2|||
33479871|NCT00509366|101651624|FG000|Overall Study|Not Treated (Screen Failure)|1|||
33479872|NCT00509366|101651625|FG001|Overall Study|Not Treated (Screen Failure)|1|||
33479873|NCT00509366|101651626|FG002|Overall Study|Not Treated (Screen Failure)|1|||
33479874|NCT00509366|101651627|FG003|Overall Study|Not Treated (Screen Failure)|0|||
33479875|NCT00509366|101651628|FG004|Overall Study|Not Treated (Screen Failure)|0|||
33479876|NCT03317834|101651631|FG000|Overall Study|Death|2|||
33479877|NCT03317834|101651631|FG000|Overall Study|Device Revision|5|||
33479878|NCT03317834|101651631|FG000|Overall Study|Withdrawal by Subject|13|||
33479879|NCT03317834|101651631|FG000|Overall Study|Lost to Follow-up|13|||
33479880|NCT04933968|101651632|FG000|Overall Study|Adverse Event|0|||
33479881|NCT04933968|101651633|FG001|Overall Study|Adverse Event|0|||
33479882|NCT04933968|101651634|FG002|Overall Study|Adverse Event|1|||
33479883|NCT04933968|101651635|FG003|Overall Study|Adverse Event|1|||
33479884|NCT04933968|101651636|FG004|Overall Study|Adverse Event|0|||
33479885|NCT04933968|101651637|FG005|Overall Study|Adverse Event|0|||
33479886|NCT04933968|101651632|FG000|Overall Study|Lost to Follow-up|1|||
33269653|NCT03162614|100887375|FG004|Overall Study|Lost to Follow-up|2|||
33269654|NCT03162614|100887376|FG005|Overall Study|Lost to Follow-up|0|||
33269655|NCT03162614|100887371|FG000|Overall Study|Protocol Violation|0|||
33269656|NCT03162614|100887372|FG001|Overall Study|Protocol Violation|1|||
33269657|NCT03162614|100887373|FG002|Overall Study|Protocol Violation|0|||
33269658|NCT03162614|100887374|FG003|Overall Study|Protocol Violation|1|||
33269659|NCT03162614|100887375|FG004|Overall Study|Protocol Violation|0|||
33269660|NCT03162614|100887376|FG005|Overall Study|Protocol Violation|0|||
33269661|NCT03162614|100887371|FG000|Overall Study|Withdrawal by Subject|2|||
33269662|NCT03162614|100887372|FG001|Overall Study|Withdrawal by Subject|1|||
33479887|NCT04933968|101651633|FG001|Overall Study|Lost to Follow-up|0|||
33479888|NCT04933968|101651634|FG002|Overall Study|Lost to Follow-up|1|||
33479889|NCT04933968|101651635|FG003|Overall Study|Lost to Follow-up|0|||
33479890|NCT04933968|101651636|FG004|Overall Study|Lost to Follow-up|0|||
33479891|NCT04933968|101651637|FG005|Overall Study|Lost to Follow-up|0|||
33479892|NCT04933968|101651632|FG000|Overall Study|Randomized not treated|1|||
33479893|NCT04933968|101651633|FG001|Overall Study|Randomized not treated|0|||
33479894|NCT04933968|101651634|FG002|Overall Study|Randomized not treated|0|||
33479895|NCT04933968|101651635|FG003|Overall Study|Randomized not treated|0|||
33269663|NCT03162614|100887373|FG002|Overall Study|Withdrawal by Subject|1|||
33269664|NCT03162614|100887374|FG003|Overall Study|Withdrawal by Subject|1|||
33269665|NCT03162614|100887375|FG004|Overall Study|Withdrawal by Subject|0|||
33269666|NCT03162614|100887376|FG005|Overall Study|Withdrawal by Subject|0|||
33269667|NCT03162614|100887371|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
33269668|NCT03162614|100887372|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
33269669|NCT03162614|100887373|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
33479896|NCT04933968|101651636|FG004|Overall Study|Randomized not treated|0|||
33479897|NCT04933968|101651637|FG005|Overall Study|Randomized not treated|0|||
33479898|NCT04933968|101651632|FG000|Overall Study|Sponsor terminated study|0|||
33479899|NCT04933968|101651633|FG001|Overall Study|Sponsor terminated study|0|||
33479900|NCT04933968|101651634|FG002|Overall Study|Sponsor terminated study|0|||
33479901|NCT04933968|101651635|FG003|Overall Study|Sponsor terminated study|1|||
33479902|NCT04933968|101651636|FG004|Overall Study|Sponsor terminated study|2|||
33479903|NCT04933968|101651637|FG005|Overall Study|Sponsor terminated study|0|||
33479904|NCT04933968|101651632|FG000|Overall Study|Other|0|||
33479905|NCT04933968|101651633|FG001|Overall Study|Other|0|||
33479906|NCT04933968|101651634|FG002|Overall Study|Other|0|||
33479907|NCT04933968|101651635|FG003|Overall Study|Other|1|||
33479908|NCT04933968|101651636|FG004|Overall Study|Other|0|||
33479909|NCT04933968|101651637|FG005|Overall Study|Other|0|||
33479910|NCT04933968|101651632|FG000|Overall Study|Missing|1|||
33479911|NCT04933968|101651633|FG001|Overall Study|Missing|3|||
33479912|NCT04933968|101651634|FG002|Overall Study|Missing|2|||
33479913|NCT04933968|101651635|FG003|Overall Study|Missing|1|||
33479914|NCT04933968|101651636|FG004|Overall Study|Missing|1|||
33479915|NCT04933968|101651637|FG005|Overall Study|Missing|0|||
33479916|NCT00922272|101651646|FG000|Open-label Phase|Adverse Event|5|||
33479917|NCT00922272|101651647|FG001|Open-label Phase|Adverse Event|0|||
33479918|NCT00922272|101651646|FG000|Open-label Phase|Protocol Violation|1|||
33479919|NCT00922272|101651647|FG001|Open-label Phase|Protocol Violation|0|||
33479920|NCT00922272|101651646|FG000|Open-label Phase|Withdrawal by Subject|11|||
33479921|NCT00922272|101651647|FG001|Open-label Phase|Withdrawal by Subject|0|||
33479922|NCT00922272|101651646|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
33479923|NCT00922272|101651647|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
33479924|NCT00922272|101651646|FG000|Open-label Phase|Withdrawal criteria met|5|||
33479925|NCT00922272|101651647|FG001|Open-label Phase|Withdrawal criteria met|0|||
33479926|NCT00922272|101651646|FG000|Double-blind Phase|Adverse Event|1|||
33479927|NCT00922272|101651647|FG001|Double-blind Phase|Adverse Event|1|||
33269670|NCT03162614|100887374|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
33269671|NCT03162614|100887375|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
33269672|NCT03162614|100887376|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
33269673|NCT02637063|100887377|FG000|Overall Study|Lost to Follow-up|3|||
33269674|NCT02637063|100887378|FG001|Overall Study|Lost to Follow-up|2|||
33269675|NCT02637063|100887379|FG002|Overall Study|Lost to Follow-up|3|||
33269676|NCT02637063|100887377|FG000|Overall Study|Withdrawal by Subject|2|||
33269677|NCT02637063|100887378|FG001|Overall Study|Withdrawal by Subject|2|||
33269678|NCT02637063|100887379|FG002|Overall Study|Withdrawal by Subject|3|||
33269679|NCT03692871|100887380|FG000|Overall Study|Death|1|||
33269680|NCT03692871|100887381|FG001|Overall Study|Death|1|||
33269681|NCT03692871|100887380|FG000|Overall Study|Lost to Follow-up|24|||
33269682|NCT03692871|100887381|FG001|Overall Study|Lost to Follow-up|9|||
33269683|NCT03692871|100887380|FG000|Overall Study|Physician Decision|22|||
33269684|NCT03692871|100887381|FG001|Overall Study|Physician Decision|7|||
33269685|NCT03692871|100887380|FG000|Overall Study|Protocol Deviation|1|||
33269686|NCT03692871|100887381|FG001|Overall Study|Protocol Deviation|0|||
33269687|NCT03692871|100887380|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
33269688|NCT03692871|100887381|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
33269689|NCT03142932|100887382|FG000|Overall Study|Lost to Follow-up|2|||
33269690|NCT03142932|100887383|FG001|Overall Study|Lost to Follow-up|11|||
33269691|NCT01947491|100887386|FG000|Overall Study|Lost to Follow-up|5|||
33269692|NCT01947491|100887387|FG001|Overall Study|Lost to Follow-up|3|||
33479928|NCT00922272|101651646|FG000|Double-blind Phase|Withdrawal by Subject|1|||
33479929|NCT00922272|101651647|FG001|Double-blind Phase|Withdrawal by Subject|1|||
33479930|NCT00922272|101651646|FG000|Double-blind Phase|Lost to Follow-up|2|||
33269693|NCT01947491|100887388|FG002|Overall Study|Lost to Follow-up|1|||
33269694|NCT01947491|100887389|FG003|Overall Study|Lost to Follow-up|2|||
33269695|NCT01947491|100887386|FG000|Overall Study|Lack of Efficacy|1|||
33269696|NCT01947491|100887387|FG001|Overall Study|Lack of Efficacy|0|||
33269697|NCT01947491|100887388|FG002|Overall Study|Lack of Efficacy|0|||
33269698|NCT01947491|100887389|FG003|Overall Study|Lack of Efficacy|1|||
33269699|NCT01947491|100887386|FG000|Overall Study|Protocol Violation|1|||
33269700|NCT01947491|100887387|FG001|Overall Study|Protocol Violation|0|||
33479931|NCT00922272|101651647|FG001|Double-blind Phase|Lost to Follow-up|1|||
33479932|NCT00922272|101651646|FG000|Double-blind Phase|Withdrawal criteria met|1|||
33269701|NCT01947491|100887388|FG002|Overall Study|Protocol Violation|0|||
33269702|NCT01947491|100887389|FG003|Overall Study|Protocol Violation|0|||
33269703|NCT01947491|100887386|FG000|Overall Study|Withdrawal by Subject|1|||
33269704|NCT01947491|100887387|FG001|Overall Study|Withdrawal by Subject|1|||
33269705|NCT01947491|100887388|FG002|Overall Study|Withdrawal by Subject|1|||
33479933|NCT00922272|101651647|FG001|Double-blind Phase|Withdrawal criteria met|1|||
33269706|NCT01947491|100887389|FG003|Overall Study|Withdrawal by Subject|0|||
33269707|NCT01947491|100887386|FG000|Overall Study|Worsening of condition|0|||
33269708|NCT01947491|100887387|FG001|Overall Study|Worsening of condition|1|||
33479934|NCT00922272|101651646|FG000|Double-blind Phase|Noncompliance|1|||
33479935|NCT00922272|101651647|FG001|Double-blind Phase|Noncompliance|1|||
33479936|NCT00922272|101651646|FG000|Double-blind Phase|Positive urine drug screen|1|||
33479937|NCT00922272|101651647|FG001|Double-blind Phase|Positive urine drug screen|1|||
33479938|NCT00609518|101651648|FG000|Overall Study|Death from Study Disease|32|||
33479939|NCT00609518|101651649|FG001|Overall Study|Death from Study Disease|32|||
33479940|NCT00609518|101651648|FG000|Overall Study|Withdrawal by Subject|5|||
33479941|NCT00609518|101651649|FG001|Overall Study|Withdrawal by Subject|3|||
33479942|NCT00609518|101651648|FG000|Overall Study|Lost to Follow-up|3|||
33479943|NCT00609518|101651649|FG001|Overall Study|Lost to Follow-up|0|||
33479944|NCT00609518|101651648|FG000|Overall Study|Physician Decision|1|||
33479945|NCT00609518|101651649|FG001|Overall Study|Physician Decision|3|||
33479946|NCT00609518|101651648|FG000|Overall Study|Death from Adverse Event|2|||
33479947|NCT00609518|101651649|FG001|Overall Study|Death from Adverse Event|2|||
33479948|NCT00213135|101651650|FG000|Overall Study|Adverse Event|9|||
33479949|NCT00213135|101651651|FG001|Overall Study|Adverse Event|5|||
33479950|NCT00213135|101651652|FG002|Overall Study|Adverse Event|5|||
33479951|NCT00213135|101651650|FG000|Overall Study|Lost to Follow-up|11|||
33479952|NCT00213135|101651651|FG001|Overall Study|Lost to Follow-up|8|||
33479953|NCT00213135|101651652|FG002|Overall Study|Lost to Follow-up|4|||
33479954|NCT00213135|101651650|FG000|Overall Study|Protocol Violation|4|||
33269709|NCT01947491|100887388|FG002|Overall Study|Worsening of condition|0|||
33269710|NCT01947491|100887389|FG003|Overall Study|Worsening of condition|0|||
33269711|NCT01947491|100887386|FG000|Overall Study|Adverse Event|0|||
33479955|NCT00213135|101651651|FG001|Overall Study|Protocol Violation|4|||
33479956|NCT00213135|101651652|FG002|Overall Study|Protocol Violation|10|||
33479957|NCT00213135|101651650|FG000|Overall Study|Death|1|||
33479958|NCT00213135|101651651|FG001|Overall Study|Death|1|||
33479959|NCT00213135|101651652|FG002|Overall Study|Death|2|||
33479960|NCT00213135|101651650|FG000|Overall Study|Disease progression|4|||
33479961|NCT00213135|101651651|FG001|Overall Study|Disease progression|5|||
33479962|NCT00213135|101651652|FG002|Overall Study|Disease progression|21|||
33479963|NCT00213135|101651650|FG000|Overall Study|Other|21|||
33479964|NCT00213135|101651651|FG001|Overall Study|Other|12|||
33479965|NCT00213135|101651652|FG002|Overall Study|Other|15|||
33479966|NCT02116608|101651658|FG000|Overall Study|Lost to Follow-up|0|||
33479967|NCT02116608|101651659|FG001|Overall Study|Lost to Follow-up|0|||
33479968|NCT02116608|101651660|FG002|Overall Study|Lost to Follow-up|1|||
33479969|NCT02116608|101651658|FG000|Overall Study|Physician Decision|0|||
33479970|NCT02116608|101651659|FG001|Overall Study|Physician Decision|1|||
33479971|NCT02116608|101651660|FG002|Overall Study|Physician Decision|0|||
33479972|NCT02116608|101651658|FG000|Overall Study|Death|0|||
33269712|NCT01947491|100887387|FG001|Overall Study|Adverse Event|1|||
33479973|NCT02116608|101651659|FG001|Overall Study|Death|1|||
33479974|NCT02116608|101651660|FG002|Overall Study|Death|0|||
33479975|NCT02036775|101651661|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
33479976|NCT02036775|101651662|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
33479977|NCT02036775|101651663|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
33479978|NCT02036775|101651664|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
33479979|NCT02036775|101651665|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
33269713|NCT01947491|100887388|FG002|Overall Study|Adverse Event|0|||
33269714|NCT01947491|100887389|FG003|Overall Study|Adverse Event|2|||
33269715|NCT01316913|100887390|FG000|Overall Study|Adverse Event|17|||
33269716|NCT01316913|100887391|FG001|Overall Study|Adverse Event|20|||
33269717|NCT01316913|100887392|FG002|Overall Study|Adverse Event|15|||
33269718|NCT01316913|100887393|FG003|Overall Study|Adverse Event|11|||
33269719|NCT01316913|100887390|FG000|Overall Study|Lack of Efficacy|22|||
33269720|NCT01316913|100887391|FG001|Overall Study|Lack of Efficacy|12|||
33269721|NCT01316913|100887392|FG002|Overall Study|Lack of Efficacy|9|||
33269722|NCT01316913|100887393|FG003|Overall Study|Lack of Efficacy|13|||
33269723|NCT01316913|100887390|FG000|Overall Study|Protocol Violation|1|||
33269724|NCT01316913|100887391|FG001|Overall Study|Protocol Violation|4|||
33269725|NCT01316913|100887392|FG002|Overall Study|Protocol Violation|4|||
33269726|NCT01316913|100887393|FG003|Overall Study|Protocol Violation|1|||
33269727|NCT01316913|100887390|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
33479980|NCT02036775|101651666|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
33479981|NCT03858634|101651667|FG000|Overall Study|Withdrawal by Subject|1|||
33479982|NCT03858634|101651668|FG001|Overall Study|Withdrawal by Subject|0|||
33479983|NCT03858634|101651667|FG000|Overall Study|Adverse Event|1|||
33479984|NCT03858634|101651668|FG001|Overall Study|Adverse Event|0|||
33479985|NCT03858634|101651667|FG000|Overall Study|Lost to Follow-up|0|||
33269728|NCT01316913|100887391|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
33269729|NCT01316913|100887392|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
33479986|NCT03858634|101651668|FG001|Overall Study|Lost to Follow-up|1|||
33479987|NCT03858634|101651667|FG000|Overall Study|Other, Not Specified|1|||
33479988|NCT03858634|101651668|FG001|Overall Study|Other, Not Specified|1|||
33269730|NCT01316913|100887393|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
33269731|NCT01316913|100887390|FG000|Overall Study|Lost to Follow-up|0|||
33269732|NCT01316913|100887391|FG001|Overall Study|Lost to Follow-up|1|||
33269733|NCT01316913|100887392|FG002|Overall Study|Lost to Follow-up|0|||
33269734|NCT01316913|100887393|FG003|Overall Study|Lost to Follow-up|2|||
33269735|NCT01316913|100887390|FG000|Overall Study|Withdrawal by Subject|10|||
33269736|NCT01316913|100887391|FG001|Overall Study|Withdrawal by Subject|9|||
33269737|NCT01316913|100887392|FG002|Overall Study|Withdrawal by Subject|10|||
33269738|NCT01316913|100887393|FG003|Overall Study|Withdrawal by Subject|6|||
33269739|NCT00599196|100887394|FG000|Overall Study|Lack of Efficacy|22|||
33269740|NCT00599196|100887394|FG000|Overall Study|Adverse Event|93|||
33269741|NCT00599196|100887394|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
33269742|NCT00599196|100887394|FG000|Overall Study|Subject withdrew consent|43|||
33269743|NCT00599196|100887394|FG000|Overall Study|Study ended per sponsor|197|||
33479989|NCT04630158|101651669|FG000|Overall Study|Adverse Event|1|||
33479990|NCT04630158|101651670|FG001|Overall Study|Adverse Event|1|||
33479991|NCT04630158|101651671|FG002|Overall Study|Adverse Event|1|||
33479992|NCT04630158|101651669|FG000|Overall Study|Physician Decision|0|||
33479993|NCT04630158|101651670|FG001|Overall Study|Physician Decision|2|||
33479994|NCT04630158|101651671|FG002|Overall Study|Physician Decision|0|||
33479995|NCT04630158|101651669|FG000|Overall Study|Protocol Violation|1|||
33479996|NCT04630158|101651670|FG001|Overall Study|Protocol Violation|0|||
33479997|NCT04630158|101651671|FG002|Overall Study|Protocol Violation|1|||
33479998|NCT04630158|101651669|FG000|Overall Study|Withdrawal by Subject|2|||
33479999|NCT04630158|101651670|FG001|Overall Study|Withdrawal by Subject|1|||
33480000|NCT04630158|101651671|FG002|Overall Study|Withdrawal by Subject|2|||
33480001|NCT01517373|101651673|FG000|Run-in Period|Death|1|||
33480002|NCT01517373|101651674|FG001|Run-in Period|Death|0|||
33480003|NCT01517373|101651675|FG002|Run-in Period|Death|0|||
33480004|NCT01517373|101651676|FG003|Run-in Period|Death|0|||
33480005|NCT01517373|101651677|FG004|Run-in Period|Death|0|||
33480006|NCT01517373|101651678|FG005|Run-in Period|Death|0|||
33480007|NCT01517373|101651673|FG000|Run-in Period|Adverse Event|5|||
33480008|NCT01517373|101651674|FG001|Run-in Period|Adverse Event|0|||
33480009|NCT01517373|101651675|FG002|Run-in Period|Adverse Event|0|||
33480010|NCT01517373|101651676|FG003|Run-in Period|Adverse Event|0|||
33480011|NCT01517373|101651677|FG004|Run-in Period|Adverse Event|0|||
33480012|NCT01517373|101651678|FG005|Run-in Period|Adverse Event|0|||
33480013|NCT01517373|101651673|FG000|Run-in Period|Did not meet eligibility criteria|34|||
33480014|NCT01517373|101651674|FG001|Run-in Period|Did not meet eligibility criteria|0|||
33480015|NCT01517373|101651675|FG002|Run-in Period|Did not meet eligibility criteria|0|||
33480016|NCT01517373|101651676|FG003|Run-in Period|Did not meet eligibility criteria|0|||
33480017|NCT01517373|101651677|FG004|Run-in Period|Did not meet eligibility criteria|0|||
33480018|NCT01517373|101651678|FG005|Run-in Period|Did not meet eligibility criteria|0|||
33480019|NCT01517373|101651673|FG000|Run-in Period|Lost to Follow-up|1|||
33480020|NCT01517373|101651674|FG001|Run-in Period|Lost to Follow-up|0|||
33480021|NCT01517373|101651675|FG002|Run-in Period|Lost to Follow-up|0|||
33480022|NCT01517373|101651676|FG003|Run-in Period|Lost to Follow-up|0|||
33480023|NCT01517373|101651677|FG004|Run-in Period|Lost to Follow-up|0|||
33480024|NCT01517373|101651678|FG005|Run-in Period|Lost to Follow-up|0|||
33480025|NCT01517373|101651673|FG000|Run-in Period|Withdrawal by Subject|12|||
33480026|NCT01517373|101651674|FG001|Run-in Period|Withdrawal by Subject|0|||
33480027|NCT01517373|101651675|FG002|Run-in Period|Withdrawal by Subject|0|||
33480028|NCT01517373|101651676|FG003|Run-in Period|Withdrawal by Subject|0|||
33269744|NCT00599196|100887394|FG000|Overall Study|Lost to Follow-up|17|||
33269745|NCT00599196|100887394|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
33269746|NCT00599196|100887394|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
33269747|NCT00599196|100887394|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
33269748|NCT00599196|100887394|FG000|Overall Study|Other: Pt Moved To Australia|1|||
33269749|NCT00599196|100887394|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
33269750|NCT00599196|100887394|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
33269751|NCT02340806|100887401|FG000|Overall Study|Protocol Violation|2|||
33269752|NCT02340806|100887402|FG001|Overall Study|Protocol Violation|0|||
33269753|NCT02340806|100887401|FG000|Overall Study|epidural catheter replaced|2|||
33269754|NCT02340806|100887402|FG001|Overall Study|epidural catheter replaced|1|||
33269755|NCT02340806|100887401|FG000|Overall Study|history of chronic pain medication|1|||
33269756|NCT02340806|100887402|FG001|Overall Study|history of chronic pain medication|0|||
33269757|NCT02340806|100887401|FG000|Overall Study|re-dose < 90 min of CSE|1|||
33269758|NCT02340806|100887402|FG001|Overall Study|re-dose < 90 min of CSE|3|||
33269759|NCT03150589|100887408|FG000|Overall Study|Withdrawal by Subject|16|||
33269760|NCT03150589|100887409|FG001|Overall Study|Withdrawal by Subject|9|||
33480029|NCT01517373|101651677|FG004|Run-in Period|Withdrawal by Subject|0|||
33269761|NCT03150589|100887408|FG000|Overall Study|Adverse Event|7|||
33480030|NCT01517373|101651678|FG005|Run-in Period|Withdrawal by Subject|0|||
33480031|NCT01517373|101651673|FG000|Run-in Period|Sponsor Decision|3|||
33480032|NCT01517373|101651674|FG001|Run-in Period|Sponsor Decision|0|||
33480033|NCT01517373|101651675|FG002|Run-in Period|Sponsor Decision|0|||
33480034|NCT01517373|101651676|FG003|Run-in Period|Sponsor Decision|0|||
33480035|NCT01517373|101651677|FG004|Run-in Period|Sponsor Decision|0|||
33480036|NCT01517373|101651678|FG005|Run-in Period|Sponsor Decision|0|||
33480037|NCT01517373|101651673|FG000|Run-in Period|Other|1|||
33480038|NCT01517373|101651674|FG001|Run-in Period|Other|0|||
33480039|NCT01517373|101651675|FG002|Run-in Period|Other|0|||
33480040|NCT01517373|101651676|FG003|Run-in Period|Other|0|||
33480041|NCT01517373|101651677|FG004|Run-in Period|Other|0|||
33480042|NCT01517373|101651678|FG005|Run-in Period|Other|0|||
33480043|NCT01517373|101651673|FG000|Treatment Period|Adverse Event|0|||
33480044|NCT01517373|101651674|FG001|Treatment Period|Adverse Event|0|||
33480045|NCT01517373|101651675|FG002|Treatment Period|Adverse Event|0|||
33480046|NCT01517373|101651676|FG003|Treatment Period|Adverse Event|0|||
33480047|NCT01517373|101651677|FG004|Treatment Period|Adverse Event|0|||
33480048|NCT01517373|101651678|FG005|Treatment Period|Adverse Event|2|||
33480049|NCT01517373|101651673|FG000|Treatment Period|Lost to Follow-up|0|||
33480050|NCT01517373|101651674|FG001|Treatment Period|Lost to Follow-up|0|||
33480051|NCT01517373|101651675|FG002|Treatment Period|Lost to Follow-up|1|||
33480052|NCT01517373|101651676|FG003|Treatment Period|Lost to Follow-up|1|||
33480053|NCT01517373|101651677|FG004|Treatment Period|Lost to Follow-up|0|||
33480054|NCT01517373|101651678|FG005|Treatment Period|Lost to Follow-up|0|||
33480055|NCT01517373|101651673|FG000|Treatment Period|Withdrawal by Subject|0|||
33480056|NCT01517373|101651674|FG001|Treatment Period|Withdrawal by Subject|3|||
33269762|NCT03150589|100887409|FG001|Overall Study|Adverse Event|6|||
33269763|NCT03150589|100887408|FG000|Overall Study|Protocol Violation|4|||
33269764|NCT03150589|100887409|FG001|Overall Study|Protocol Violation|3|||
33269765|NCT03150589|100887408|FG000|Overall Study|Lost to Follow-up|3|||
33269766|NCT03150589|100887409|FG001|Overall Study|Lost to Follow-up|3|||
33269767|NCT03150589|100887408|FG000|Overall Study|Death|2|||
33269768|NCT03150589|100887409|FG001|Overall Study|Death|3|||
33269769|NCT03150589|100887408|FG000|Overall Study|IP non-compliance and other reasons|12|||
33269770|NCT03150589|100887409|FG001|Overall Study|IP non-compliance and other reasons|3|||
33269771|NCT03265132|100887410|FG000|Overall Study|Adverse Event|0|||
33269772|NCT03265132|100887411|FG001|Overall Study|Adverse Event|1|||
33269773|NCT03265132|100887410|FG000|Overall Study|Lack of Efficacy|0|||
33269774|NCT03265132|100887411|FG001|Overall Study|Lack of Efficacy|2|||
33269775|NCT03265132|100887410|FG000|Overall Study|Progressive disease|0|||
33269776|NCT03265132|100887411|FG001|Overall Study|Progressive disease|2|||
33269777|NCT03265132|100887410|FG000|Overall Study|Withdrawal by Subject|0|||
33269778|NCT03265132|100887411|FG001|Overall Study|Withdrawal by Subject|1|||
33269779|NCT00378898|100887413|FG000|Overall Study|Withdrawal by Subject|10|||
33269780|NCT00378898|100887414|FG001|Overall Study|Withdrawal by Subject|5|||
33269781|NCT00378898|100887413|FG000|Overall Study|Protocol Violation|1|||
33269782|NCT00378898|100887414|FG001|Overall Study|Protocol Violation|1|||
33480057|NCT01517373|101651675|FG002|Treatment Period|Withdrawal by Subject|2|||
33480058|NCT01517373|101651676|FG003|Treatment Period|Withdrawal by Subject|2|||
33480059|NCT01517373|101651677|FG004|Treatment Period|Withdrawal by Subject|2|||
33480060|NCT01517373|101651678|FG005|Treatment Period|Withdrawal by Subject|3|||
33480061|NCT01517373|101651673|FG000|Treatment Period|Other|0|||
33480062|NCT01517373|101651674|FG001|Treatment Period|Other|0|||
33480063|NCT01517373|101651675|FG002|Treatment Period|Other|0|||
33480064|NCT01517373|101651676|FG003|Treatment Period|Other|0|||
33480065|NCT01517373|101651677|FG004|Treatment Period|Other|1|||
33480066|NCT01517373|101651678|FG005|Treatment Period|Other|0|||
33480067|NCT01517373|101651673|FG000|Treatment Period|Protocol Violation|0|||
33480068|NCT01517373|101651674|FG001|Treatment Period|Protocol Violation|0|||
33480069|NCT01517373|101651675|FG002|Treatment Period|Protocol Violation|0|||
33480070|NCT01517373|101651676|FG003|Treatment Period|Protocol Violation|0|||
33480071|NCT01517373|101651677|FG004|Treatment Period|Protocol Violation|1|||
33480072|NCT01517373|101651678|FG005|Treatment Period|Protocol Violation|0|||
33480073|NCT01517373|101651673|FG000|Treatment Period|Lack of Efficacy|0|||
33480074|NCT01517373|101651674|FG001|Treatment Period|Lack of Efficacy|1|||
33480075|NCT01517373|101651675|FG002|Treatment Period|Lack of Efficacy|1|||
33480076|NCT01517373|101651676|FG003|Treatment Period|Lack of Efficacy|3|||
33480077|NCT01517373|101651677|FG004|Treatment Period|Lack of Efficacy|2|||
33480078|NCT01517373|101651678|FG005|Treatment Period|Lack of Efficacy|0|||
33480079|NCT01517373|101651673|FG000|Treatment Period|Medication error without AEs|0|||
33480080|NCT01517373|101651674|FG001|Treatment Period|Medication error without AEs|0|||
33480081|NCT01517373|101651675|FG002|Treatment Period|Medication error without AEs|2|||
33480082|NCT01517373|101651676|FG003|Treatment Period|Medication error without AEs|1|||
33480083|NCT01517373|101651677|FG004|Treatment Period|Medication error without AEs|0|||
33480084|NCT01517373|101651678|FG005|Treatment Period|Medication error without AEs|2|||
33480085|NCT00507130|101651679|FG000|Overall Study|Lost to Follow-up|0|||
33269783|NCT01853384|100887415|FG000|Randomized|Adverse Event|5|||
33269784|NCT01853384|100887416|FG001|Randomized|Adverse Event|3|||
33269785|NCT01853384|100887415|FG000|Randomized|Death|1|||
33269786|NCT01853384|100887416|FG001|Randomized|Death|2|||
33269787|NCT01853384|100887415|FG000|Randomized|Lost to Follow-up|1|||
33480086|NCT00507130|101651680|FG001|Overall Study|Lost to Follow-up|0|||
33480087|NCT00507130|101651681|FG002|Overall Study|Lost to Follow-up|1|||
33480088|NCT00507130|101651682|FG003|Overall Study|Lost to Follow-up|1|||
33480089|NCT00507130|101651679|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
33480090|NCT00507130|101651680|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
33480091|NCT00507130|101651681|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
33480092|NCT00507130|101651682|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
33480093|NCT00144781|101651683|FG000|Overall Study|Adverse Event|0|||
33480094|NCT00144781|101651684|FG001|Overall Study|Adverse Event|1|||
33480095|NCT00144781|101651685|FG002|Overall Study|Adverse Event|0|||
33480096|NCT00144781|101651686|FG003|Overall Study|Adverse Event|0|||
33480097|NCT00144781|101651683|FG000|Overall Study|Non-compliant|0|||
33480098|NCT00144781|101651684|FG001|Overall Study|Non-compliant|1|||
33480099|NCT00144781|101651685|FG002|Overall Study|Non-compliant|0|||
33480100|NCT00144781|101651686|FG003|Overall Study|Non-compliant|0|||
33480101|NCT01094886|101651687|FG000|Overall Study|Adverse Event|2|||
33480102|NCT01094886|101651687|FG000|Overall Study|Withdrawal by Subject|5|||
33480103|NCT00049530|101651690|FG000|Overall Study|Lack of Efficacy|25|||
33480104|NCT00049530|101651690|FG000|Overall Study|Adverse Event|2|||
33480105|NCT00049530|101651690|FG000|Overall Study|Death|1|||
33480106|NCT00049530|101651690|FG000|Overall Study|symptomatic deterioration|1|||
33480107|NCT00049530|101651690|FG000|Overall Study|ineligible|3|||
33480108|NCT02040779|101651693|FG000|Overall Study|Adverse Event|1|||
33480109|NCT02040779|101651694|FG001|Overall Study|Adverse Event|0|||
33480110|NCT02040779|101651695|FG002|Overall Study|Adverse Event|0|||
33480111|NCT02040779|101651693|FG000|Overall Study|Withdrawal by Subject|4|||
33480112|NCT02040779|101651694|FG001|Overall Study|Withdrawal by Subject|1|||
33480113|NCT02040779|101651695|FG002|Overall Study|Withdrawal by Subject|3|||
33480114|NCT02040779|101651693|FG000|Overall Study|Non-compliance|0|||
33480115|NCT02040779|101651694|FG001|Overall Study|Non-compliance|1|||
33480116|NCT02040779|101651695|FG002|Overall Study|Non-compliance|0|||
33480117|NCT02040779|101651693|FG000|Overall Study|Protocol Violation|2|||
33480118|NCT02040779|101651694|FG001|Overall Study|Protocol Violation|1|||
33480119|NCT02040779|101651695|FG002|Overall Study|Protocol Violation|0|||
33480120|NCT02040779|101651693|FG000|Overall Study|Lost to Follow-up|1|||
33480121|NCT02040779|101651694|FG001|Overall Study|Lost to Follow-up|2|||
33480122|NCT02040779|101651695|FG002|Overall Study|Lost to Follow-up|1|||
33480123|NCT02040779|101651693|FG000|Overall Study|Lack of Efficacy|4|||
33480124|NCT02040779|101651694|FG001|Overall Study|Lack of Efficacy|2|||
33480125|NCT02040779|101651695|FG002|Overall Study|Lack of Efficacy|0|||
33480126|NCT03371459|101651696|FG000|Washout|Lost to Follow-up|0|||
33480127|NCT03371459|101651697|FG001|Washout|Lost to Follow-up|1|||
33480128|NCT01154816|101651698|FG000|Overall Study|Withdrawal by Subject|1|||
33480129|NCT01154816|101651699|FG001|Overall Study|Withdrawal by Subject|0|||
33480130|NCT01154816|101651700|FG002|Overall Study|Withdrawal by Subject|0|||
33480131|NCT01154816|101651701|FG003|Overall Study|Withdrawal by Subject|1|||
33480132|NCT01154816|101651702|FG004|Overall Study|Withdrawal by Subject|0|||
33480133|NCT01154816|101651703|FG005|Overall Study|Withdrawal by Subject|0|||
33480134|NCT01154816|101651704|FG006|Overall Study|Withdrawal by Subject|0|||
33480135|NCT01154816|101651705|FG007|Overall Study|Withdrawal by Subject|0|||
33480136|NCT01154816|101651706|FG008|Overall Study|Withdrawal by Subject|1|||
33480137|NCT01154816|101651707|FG009|Overall Study|Withdrawal by Subject|3|||
33480138|NCT01154816|101651708|FG010|Overall Study|Withdrawal by Subject|0|||
33480139|NCT01154816|101651709|FG011|Overall Study|Withdrawal by Subject|0|||
33480140|NCT01154816|101651698|FG000|Overall Study|Progressive Disease|13|||
33480141|NCT01154816|101651699|FG001|Overall Study|Progressive Disease|8|||
33480142|NCT01154816|101651700|FG002|Overall Study|Progressive Disease|9|||
33480143|NCT01154816|101651701|FG003|Overall Study|Progressive Disease|9|||
33480144|NCT01154816|101651702|FG004|Overall Study|Progressive Disease|8|||
33480145|NCT01154816|101651703|FG005|Overall Study|Progressive Disease|8|||
33480146|NCT01154816|101651704|FG006|Overall Study|Progressive Disease|5|||
33480147|NCT01154816|101651705|FG007|Overall Study|Progressive Disease|6|||
33480148|NCT01154816|101651706|FG008|Overall Study|Progressive Disease|8|||
33480149|NCT01154816|101651707|FG009|Overall Study|Progressive Disease|6|||
33480150|NCT01154816|101651708|FG010|Overall Study|Progressive Disease|10|||
33480151|NCT01154816|101651709|FG011|Overall Study|Progressive Disease|3|||
33480152|NCT01154816|101651698|FG000|Overall Study|Physician Decision|1|||
33480153|NCT01154816|101651699|FG001|Overall Study|Physician Decision|0|||
33480154|NCT01154816|101651700|FG002|Overall Study|Physician Decision|1|||
33269788|NCT01853384|100887416|FG001|Randomized|Lost to Follow-up|1|||
33269789|NCT01853384|100887415|FG000|Randomized|Withdrawal by Subject|5|||
33480155|NCT01154816|101651701|FG003|Overall Study|Physician Decision|0|||
33480156|NCT01154816|101651702|FG004|Overall Study|Physician Decision|2|||
33480157|NCT01154816|101651703|FG005|Overall Study|Physician Decision|0|||
33480158|NCT01154816|101651704|FG006|Overall Study|Physician Decision|0|||
33480159|NCT01154816|101651705|FG007|Overall Study|Physician Decision|0|||
33269790|NCT01853384|100887416|FG001|Randomized|Withdrawal by Subject|3|||
33480160|NCT01154816|101651706|FG008|Overall Study|Physician Decision|0|||
33480161|NCT01154816|101651707|FG009|Overall Study|Physician Decision|1|||
33480162|NCT01154816|101651708|FG010|Overall Study|Physician Decision|1|||
33480163|NCT01154816|101651709|FG011|Overall Study|Physician Decision|1|||
33480164|NCT01154816|101651698|FG000|Overall Study|Adverse Event|5|||
33480165|NCT01154816|101651699|FG001|Overall Study|Adverse Event|2|||
33480166|NCT01154816|101651700|FG002|Overall Study|Adverse Event|0|||
33480167|NCT01154816|101651701|FG003|Overall Study|Adverse Event|0|||
33480168|NCT01154816|101651702|FG004|Overall Study|Adverse Event|0|||
33480169|NCT01154816|101651703|FG005|Overall Study|Adverse Event|0|||
33480170|NCT01154816|101651704|FG006|Overall Study|Adverse Event|1|||
33480171|NCT01154816|101651705|FG007|Overall Study|Adverse Event|1|||
33480172|NCT01154816|101651706|FG008|Overall Study|Adverse Event|0|||
33480173|NCT01154816|101651707|FG009|Overall Study|Adverse Event|0|||
33480174|NCT01154816|101651708|FG010|Overall Study|Adverse Event|0|||
33480175|NCT01154816|101651709|FG011|Overall Study|Adverse Event|0|||
33480176|NCT04497948|101651714|FG000|Overall Study|Death|2|||
33480177|NCT02006693|101651715|FG000|Overall Study|No Reason Specified|6|||
33480178|NCT02006693|101651716|FG001|Overall Study|No Reason Specified|8|||
33480179|NCT02006693|101651715|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
33480180|NCT02006693|101651716|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
33480181|NCT02006693|101651715|FG000|Overall Study|XEN Implant Explantation|0|||
33480182|NCT02006693|101651716|FG001|Overall Study|XEN Implant Explantation|1|||
33480183|NCT02006693|101651715|FG000|Overall Study|Death|2|||
33480184|NCT02006693|101651716|FG001|Overall Study|Death|2|||
33480185|NCT02006693|101651715|FG000|Overall Study|Lost to Follow-up|4|||
33480186|NCT02006693|101651716|FG001|Overall Study|Lost to Follow-up|1|||
33480187|NCT02006693|101651715|FG000|Overall Study|Patient Decision|4|||
33480188|NCT02006693|101651716|FG001|Overall Study|Patient Decision|0|||
33480189|NCT01502410|101651718|FG000|Overall Study|Adverse Event|1|||
33480190|NCT01502410|101651719|FG001|Overall Study|Adverse Event|2|||
33480191|NCT01502410|101651720|FG002|Overall Study|Adverse Event|0|||
33480192|NCT01502410|101651721|FG003|Overall Study|Adverse Event|0|||
33480193|NCT01502410|101651718|FG000|Overall Study|Lack of Efficacy|7|||
33480194|NCT01502410|101651719|FG001|Overall Study|Lack of Efficacy|7|||
33480195|NCT01502410|101651720|FG002|Overall Study|Lack of Efficacy|0|||
33269791|NCT01853384|100887415|FG000|Randomized|Sponsor Decision|47|||
33269792|NCT01853384|100887416|FG001|Randomized|Sponsor Decision|34|||
33269793|NCT01853384|100887415|FG000|Randomized|Other|3|||
33269794|NCT01853384|100887416|FG001|Randomized|Other|3|||
33269795|NCT01853384|100887415|FG000|Completed Follow up Visit 1|Early Termination|13|||
33269796|NCT01853384|100887416|FG001|Completed Follow up Visit 1|Early Termination|9|||
33269797|NCT01853384|100887415|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
33269798|NCT01853384|100887416|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
33269799|NCT01853384|100887415|FG000|Completed Follow up Visit 2|Adverse Event|1|||
33480196|NCT01502410|101651721|FG003|Overall Study|Lack of Efficacy|0|||
33480197|NCT01502410|101651718|FG000|Overall Study|Physician Decision|0|||
33480198|NCT01502410|101651719|FG001|Overall Study|Physician Decision|1|||
33480199|NCT01502410|101651720|FG002|Overall Study|Physician Decision|0|||
33480200|NCT01502410|101651721|FG003|Overall Study|Physician Decision|0|||
33480201|NCT01502410|101651718|FG000|Overall Study|Withdrawal by Subject|2|||
33480202|NCT01502410|101651719|FG001|Overall Study|Withdrawal by Subject|0|||
33480203|NCT01502410|101651720|FG002|Overall Study|Withdrawal by Subject|0|||
33480204|NCT01502410|101651721|FG003|Overall Study|Withdrawal by Subject|0|||
33480205|NCT00106964|101651722|FG000|Overall Study|Lost to Follow-up|8|||
33480206|NCT00106964|101651723|FG001|Overall Study|Lost to Follow-up|6|||
33480207|NCT00106964|101651724|FG002|Overall Study|Lost to Follow-up|2|||
33480208|NCT00106964|101651722|FG000|Overall Study|Pregnancy|2|||
33480209|NCT00106964|101651723|FG001|Overall Study|Pregnancy|3|||
33480210|NCT00106964|101651724|FG002|Overall Study|Pregnancy|2|||
33480211|NCT00106964|101651722|FG000|Overall Study|Death|1|||
33480212|NCT00106964|101651723|FG001|Overall Study|Death|1|||
33480213|NCT00106964|101651724|FG002|Overall Study|Death|0|||
33480214|NCT00106964|101651722|FG000|Overall Study|Incarceration|0|||
33480215|NCT00106964|101651723|FG001|Overall Study|Incarceration|1|||
33480216|NCT00106964|101651724|FG002|Overall Study|Incarceration|0|||
33480217|NCT00106964|101651722|FG000|Overall Study|Site Funding Terminated|0|||
33269800|NCT01853384|100887416|FG001|Completed Follow up Visit 2|Adverse Event|0|||
33480218|NCT00106964|101651723|FG001|Overall Study|Site Funding Terminated|1|||
33480219|NCT00106964|101651724|FG002|Overall Study|Site Funding Terminated|1|||
33480220|NCT00106964|101651722|FG000|Overall Study|Failure to adhere|2|||
33269801|NCT01853384|100887415|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
33480221|NCT00106964|101651723|FG001|Overall Study|Failure to adhere|0|||
33480222|NCT00106964|101651724|FG002|Overall Study|Failure to adhere|0|||
33480223|NCT00106964|101651722|FG000|Overall Study|Did not meet eligibility criteria|0|||
33480224|NCT00106964|101651723|FG001|Overall Study|Did not meet eligibility criteria|2|||
33269802|NCT01853384|100887416|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
33480225|NCT00106964|101651724|FG002|Overall Study|Did not meet eligibility criteria|2|||
33480226|NCT00106964|101651722|FG000|Overall Study|Required disallowed medication|0|||
33480227|NCT00106964|101651723|FG001|Overall Study|Required disallowed medication|1|||
33480228|NCT00106964|101651724|FG002|Overall Study|Required disallowed medication|0|||
33480229|NCT00729248|101651726|FG000|Overall Study|Physician Decision|2|||
33480230|NCT01248013|101651727|FG000|Overall Study|Withdrawal by Subject|14|||
33480231|NCT02458287|101651728|FG000|Overall Study|Adverse Event|0|||
33480232|NCT02458287|101651729|FG001|Overall Study|Adverse Event|0|||
33480233|NCT02458287|101651730|FG002|Overall Study|Adverse Event|0|||
33480234|NCT02458287|101651731|FG003|Overall Study|Adverse Event|1|||
33480235|NCT02458287|101651728|FG000|Overall Study|Lost to Follow-up|0|||
33480236|NCT02458287|101651729|FG001|Overall Study|Lost to Follow-up|1|||
33480237|NCT02458287|101651730|FG002|Overall Study|Lost to Follow-up|1|||
33480238|NCT02458287|101651731|FG003|Overall Study|Lost to Follow-up|0|||
33480239|NCT02458287|101651728|FG000|Overall Study|Protocol Violation|0|||
33480240|NCT02458287|101651729|FG001|Overall Study|Protocol Violation|1|||
33480241|NCT02458287|101651730|FG002|Overall Study|Protocol Violation|0|||
33480242|NCT02458287|101651731|FG003|Overall Study|Protocol Violation|0|||
33480243|NCT02458287|101651728|FG000|Overall Study|Withdrawal by Subject|0|||
33480244|NCT02458287|101651729|FG001|Overall Study|Withdrawal by Subject|2|||
33480245|NCT02458287|101651730|FG002|Overall Study|Withdrawal by Subject|2|||
33480246|NCT02458287|101651731|FG003|Overall Study|Withdrawal by Subject|1|||
33480247|NCT02458287|101651728|FG000|Overall Study|Relocated Out of State|0|||
33480248|NCT02458287|101651729|FG001|Overall Study|Relocated Out of State|0|||
33480249|NCT02458287|101651730|FG002|Overall Study|Relocated Out of State|0|||
33480250|NCT02458287|101651731|FG003|Overall Study|Relocated Out of State|1|||
33480251|NCT00605540|101651732|FG000|Overall Study|Death|15|||
33480252|NCT00605540|101651732|FG000|Overall Study|Lost to Follow-up|23|||
33269803|NCT01853384|100887415|FG000|Completed Follow up Visit 2|Death|1|||
33269804|NCT01853384|100887416|FG001|Completed Follow up Visit 2|Death|0|||
33269805|NCT01853384|100887415|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
33269806|NCT01853384|100887416|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
33269807|NCT01613599|100887418|FG000|Overall Study|Death|9|||
33269808|NCT01613599|100887418|FG000|Overall Study|Lost to Follow-up|5|||
33269809|NCT01613599|100887418|FG000|Overall Study|Withdrawal by Subject|8|||
33269810|NCT01613599|100887418|FG000|Overall Study|Reason not specified|3|||
33269811|NCT03345979|100887419|FG000|Overall Study|Withdrawal by Subject|20|||
33269812|NCT03345979|100887420|FG001|Overall Study|Withdrawal by Subject|31|||
33269813|NCT03345979|100887419|FG000|Overall Study|Adverse Event|10|||
33269814|NCT03345979|100887420|FG001|Overall Study|Adverse Event|11|||
33269815|NCT03345979|100887419|FG000|Overall Study|Lost to Follow-up|8|||
33269816|NCT03345979|100887420|FG001|Overall Study|Lost to Follow-up|9|||
33269817|NCT03345979|100887419|FG000|Overall Study|Lack of Efficacy|4|||
33269818|NCT03345979|100887420|FG001|Overall Study|Lack of Efficacy|2|||
33269819|NCT03345979|100887419|FG000|Overall Study|Protocol Violation|1|||
33269820|NCT03345979|100887420|FG001|Overall Study|Protocol Violation|3|||
33269821|NCT03345979|100887419|FG000|Overall Study|Physician Decision|0|||
33269822|NCT03345979|100887420|FG001|Overall Study|Physician Decision|2|||
33269823|NCT01000649|100887421|FG000|Overall Study|Adverse Event|5|||
33269824|NCT01000649|100887422|FG001|Overall Study|Adverse Event|1|||
33269825|NCT01000649|100887423|FG002|Overall Study|Adverse Event|2|||
33269826|NCT01000649|100887424|FG003|Overall Study|Adverse Event|4|||
33269827|NCT01000649|100887421|FG000|Overall Study|Lost to Follow-up|0|||
33269828|NCT01000649|100887422|FG001|Overall Study|Lost to Follow-up|2|||
33269829|NCT01000649|100887423|FG002|Overall Study|Lost to Follow-up|0|||
33269830|NCT01000649|100887424|FG003|Overall Study|Lost to Follow-up|2|||
33269831|NCT02671266|100887425|FG000|Overall Study|Withdrawal by Subject|1|||
33269832|NCT02671266|100887426|FG001|Overall Study|Withdrawal by Subject|1|||
33269833|NCT00047385|100887427|FG000|Overall Study|Death before any screening|2|||
33269834|NCT00047385|100887428|FG001|Overall Study|Death before any screening|5|||
33269835|NCT00047385|100887427|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
33269836|NCT00047385|100887428|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
33480253|NCT01004003|101651733|FG000|Overall Study|Progressive disease|2|||
33480254|NCT01004003|101651734|FG001|Overall Study|Progressive disease|1|||
33480255|NCT01004003|101651735|FG002|Overall Study|Progressive disease|1|||
33480256|NCT01004003|101651736|FG003|Overall Study|Progressive disease|0|||
33480257|NCT01004003|101651737|FG004|Overall Study|Progressive disease|2|||
33480258|NCT01004003|101651738|FG005|Overall Study|Progressive disease|1|||
33480259|NCT01004003|101651739|FG006|Overall Study|Progressive disease|1|||
33269837|NCT00047385|100887427|FG000|Overall Study|Eligible for screening but had no screen|260|||
33480260|NCT01004003|101651740|FG007|Overall Study|Progressive disease|39|||
33480261|NCT01004003|101651741|FG008|Overall Study|Progressive disease|22|||
33269838|NCT00047385|100887428|FG001|Overall Study|Eligible for screening but had no screen|492|||
33269839|NCT04108858|100887429|FG000|Overall Study|Adverse Event|1|||
33269840|NCT02924051|100887432|FG000|Overall Study|Withdrawal by Subject|1|||
33269841|NCT02924051|100887433|FG001|Overall Study|Withdrawal by Subject|9|||
33269842|NCT03200574|100887439|FG000|Overall Study|Death|4|||
33480262|NCT01004003|101651733|FG000|Overall Study|Adverse Event|4|||
33480263|NCT01004003|101651734|FG001|Overall Study|Adverse Event|2|||
33480264|NCT01004003|101651735|FG002|Overall Study|Adverse Event|3|||
33480265|NCT01004003|101651736|FG003|Overall Study|Adverse Event|3|||
33480266|NCT01004003|101651737|FG004|Overall Study|Adverse Event|2|||
33480267|NCT01004003|101651738|FG005|Overall Study|Adverse Event|2|||
33480268|NCT01004003|101651739|FG006|Overall Study|Adverse Event|7|||
33480269|NCT01004003|101651740|FG007|Overall Study|Adverse Event|21|||
33480270|NCT01004003|101651741|FG008|Overall Study|Adverse Event|6|||
33480271|NCT01004003|101651733|FG000|Overall Study|Refused to continue taking trial med.|0|||
33480272|NCT01004003|101651734|FG001|Overall Study|Refused to continue taking trial med.|0|||
33480273|NCT01004003|101651735|FG002|Overall Study|Refused to continue taking trial med.|0|||
33480274|NCT01004003|101651736|FG003|Overall Study|Refused to continue taking trial med.|0|||
33480275|NCT01004003|101651737|FG004|Overall Study|Refused to continue taking trial med.|0|||
33480276|NCT01004003|101651738|FG005|Overall Study|Refused to continue taking trial med.|0|||
33480277|NCT01004003|101651739|FG006|Overall Study|Refused to continue taking trial med.|0|||
33480278|NCT01004003|101651740|FG007|Overall Study|Refused to continue taking trial med.|0|||
33480279|NCT01004003|101651741|FG008|Overall Study|Refused to continue taking trial med.|2|||
33480280|NCT01004003|101651733|FG000|Overall Study|Other|0|||
33480281|NCT01004003|101651734|FG001|Overall Study|Other|0|||
33480282|NCT01004003|101651735|FG002|Overall Study|Other|0|||
33480283|NCT01004003|101651736|FG003|Overall Study|Other|0|||
33480284|NCT01004003|101651737|FG004|Overall Study|Other|0|||
33480285|NCT01004003|101651738|FG005|Overall Study|Other|1|||
33480286|NCT01004003|101651739|FG006|Overall Study|Other|0|||
33480287|NCT01004003|101651740|FG007|Overall Study|Other|0|||
33480288|NCT01004003|101651741|FG008|Overall Study|Other|0|||
33480289|NCT03786718|101651742|FG000|Overall Study|Lost to Follow-up|3|||
33480290|NCT03786718|101651742|FG000|Overall Study|Withdrawal by Subject|1|||
33480291|NCT03786718|101651742|FG000|Overall Study|Did not use the intervention|2|||
33480292|NCT03786718|101651742|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
33480293|NCT04283500|101651745|FG000|Overall Study|Lost to Follow-up|8|||
33480294|NCT04283500|101651745|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
33480295|NCT02031458|101651746|FG000|May 8, 2015 to January 11, 2019|Death|89|||
33480296|NCT02031458|101651747|FG001|May 8, 2015 to January 11, 2019|Death|193|||
33480297|NCT02031458|101651748|FG002|May 8, 2015 to January 11, 2019|Death|198|||
33480298|NCT02031458|101651746|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
33480299|NCT02031458|101651747|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
33480300|NCT02031458|101651748|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
33480301|NCT02031458|101651746|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
33480302|NCT02031458|101651747|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
33480303|NCT02031458|101651748|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
33480304|NCT02031458|101651746|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
33480305|NCT02031458|101651747|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
33480306|NCT02031458|101651748|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
33480307|NCT02031458|101651746|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
33480308|NCT02031458|101651747|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
33480309|NCT02031458|101651748|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
33480310|NCT02031458|101651746|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
33480311|NCT02031458|101651747|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
33480312|NCT02031458|101651748|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
33480313|NCT02031458|101651746|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
33480314|NCT02031458|101651747|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
33480315|NCT02031458|101651748|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
33480316|NCT02031458|101651746|FG000|Baseline to May 8, 2015|Death|36|||
33480317|NCT02031458|101651747|FG001|Baseline to May 8, 2015|Death|87|||
33480318|NCT02031458|101651748|FG002|Baseline to May 8, 2015|Death|100|||
33480319|NCT02031458|101651746|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
33480320|NCT02031458|101651747|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
33480321|NCT02031458|101651748|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
33269843|NCT03200574|100887439|FG000|Overall Study|Withdrawal by Subject|8|||
33269844|NCT03200574|100887439|FG000|Overall Study|Long-Term need for anticoagulation|1|||
33269845|NCT03200574|100887439|FG000|Overall Study|Relocation|2|||
33269846|NCT03200574|100887439|FG000|Overall Study|Lost to Follow-up|2|||
33269847|NCT03456856|100887440|FG000|Overall Study|Lost to Follow-up|2|||
33269848|NCT03456856|100887440|FG000|Overall Study|Withdrawal by Subject|1|||
33269849|NCT00910962|100887441|FG000|Overall Study|Adverse Event|5|||
33269850|NCT00910962|100887442|FG001|Overall Study|Adverse Event|20|||
33269851|NCT00910962|100887443|FG002|Overall Study|Adverse Event|17|||
33480322|NCT02031458|101651746|FG000|Baseline to May 8, 2015|Physician Decision|0|||
33480323|NCT02031458|101651747|FG001|Baseline to May 8, 2015|Physician Decision|1|||
33480324|NCT02031458|101651748|FG002|Baseline to May 8, 2015|Physician Decision|0|||
33480325|NCT02031458|101651746|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
33480326|NCT02031458|101651747|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
33269852|NCT00910962|100887441|FG000|Overall Study|Protocol Violation|1|||
33269853|NCT00910962|100887442|FG001|Overall Study|Protocol Violation|3|||
33269854|NCT00910962|100887443|FG002|Overall Study|Protocol Violation|3|||
33269855|NCT00910962|100887441|FG000|Overall Study|Lost to Follow-up|0|||
33480327|NCT02031458|101651748|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
33480328|NCT02031458|101651746|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
33480329|NCT02031458|101651747|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
33480330|NCT02031458|101651748|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
33480331|NCT02031458|101651746|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
33480332|NCT02031458|101651747|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
33269856|NCT00910962|100887442|FG001|Overall Study|Lost to Follow-up|3|||
33269857|NCT00910962|100887443|FG002|Overall Study|Lost to Follow-up|1|||
33480333|NCT02031458|101651748|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
33480334|NCT02031458|101651746|FG000|Baseline to May 8, 2015|On Treatment|43|||
33480335|NCT02031458|101651747|FG001|Baseline to May 8, 2015|On Treatment|81|||
33480336|NCT02031458|101651748|FG002|Baseline to May 8, 2015|On Treatment|73|||
33480337|NCT02031458|101651746|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
33480338|NCT02031458|101651747|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
33480339|NCT02031458|101651748|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
33480340|NCT03327792|101651749|FG000|Overall Study|Adverse Event|4|||
33480341|NCT03327792|101651750|FG001|Overall Study|Adverse Event|0|||
33480342|NCT03327792|101651749|FG000|Overall Study|Family/Personal issues|3|||
33269858|NCT00910962|100887441|FG000|Overall Study|Physician Decision|0|||
33269859|NCT00910962|100887442|FG001|Overall Study|Physician Decision|6|||
33269860|NCT00910962|100887443|FG002|Overall Study|Physician Decision|6|||
33269861|NCT00910962|100887441|FG000|Overall Study|Withdrawal by Subject|25|||
33269862|NCT00910962|100887442|FG001|Overall Study|Withdrawal by Subject|32|||
33269863|NCT00910962|100887443|FG002|Overall Study|Withdrawal by Subject|32|||
33269864|NCT00910962|100887441|FG000|Overall Study|Reached defined stopping criteria|12|||
33269865|NCT00910962|100887442|FG001|Overall Study|Reached defined stopping criteria|14|||
33269866|NCT00910962|100887443|FG002|Overall Study|Reached defined stopping criteria|17|||
33269867|NCT00446095|100887445|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
33269868|NCT00446095|100887446|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
33269869|NCT00446095|100887447|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
33269870|NCT00446095|100887448|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
33269871|NCT00446095|100887449|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
33269872|NCT00446095|100887445|FG000|Phase II (8 Weeks)|Adverse Event|0|||
33269873|NCT00446095|100887446|FG001|Phase II (8 Weeks)|Adverse Event|1|||
33269874|NCT00446095|100887447|FG002|Phase II (8 Weeks)|Adverse Event|1|||
33269875|NCT00446095|100887448|FG003|Phase II (8 Weeks)|Adverse Event|0|||
33269876|NCT00446095|100887449|FG004|Phase II (8 Weeks)|Adverse Event|0|||
33269877|NCT00446095|100887445|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
33269878|NCT00446095|100887446|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
33269879|NCT00446095|100887447|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
33269880|NCT00446095|100887448|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
33269881|NCT00446095|100887449|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
33269882|NCT00446095|100887445|FG000|Phase II (8 Weeks)|Physician Decision|1|||
33269883|NCT00446095|100887446|FG001|Phase II (8 Weeks)|Physician Decision|0|||
33269884|NCT00446095|100887447|FG002|Phase II (8 Weeks)|Physician Decision|0|||
33269885|NCT00446095|100887448|FG003|Phase II (8 Weeks)|Physician Decision|0|||
33269886|NCT00446095|100887449|FG004|Phase II (8 Weeks)|Physician Decision|0|||
33269887|NCT00446095|100887445|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
33269888|NCT00446095|100887446|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
33269889|NCT00446095|100887447|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
33269890|NCT00446095|100887448|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
33269891|NCT00446095|100887449|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
33269892|NCT00446095|100887445|FG000|Phase II (8 Weeks)|Ongoing|0|||
33269893|NCT00446095|100887446|FG001|Phase II (8 Weeks)|Ongoing|0|||
33269894|NCT00446095|100887447|FG002|Phase II (8 Weeks)|Ongoing|1|||
33269895|NCT00446095|100887448|FG003|Phase II (8 Weeks)|Ongoing|0|||
33269896|NCT00446095|100887449|FG004|Phase II (8 Weeks)|Ongoing|0|||
33269897|NCT00446095|100887445|FG000|Phase I (28 Days)|Adverse Event|0|||
33269898|NCT00446095|100887446|FG001|Phase I (28 Days)|Adverse Event|0|||
33269899|NCT00446095|100887447|FG002|Phase I (28 Days)|Adverse Event|0|||
33269900|NCT00446095|100887448|FG003|Phase I (28 Days)|Adverse Event|1|||
33269901|NCT00446095|100887449|FG004|Phase I (28 Days)|Adverse Event|0|||
33269902|NCT00446095|100887445|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
33269903|NCT00446095|100887446|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
33269904|NCT00446095|100887447|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
33269905|NCT00446095|100887448|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
33269906|NCT00446095|100887449|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
33269907|NCT02000752|100887451|FG000|Overall Study|Dystocic delivery|19|||
33269908|NCT02000752|100887452|FG001|Overall Study|Dystocic delivery|8|||
33480343|NCT03327792|101651750|FG001|Overall Study|Family/Personal issues|2|||
33480344|NCT03327792|101651749|FG000|Overall Study|Lost to Follow-up|0|||
33480345|NCT03327792|101651750|FG001|Overall Study|Lost to Follow-up|1|||
33269909|NCT02000752|100887451|FG000|Overall Study|Shift Changes|12|||
33269910|NCT02000752|100887452|FG001|Overall Study|Shift Changes|5|||
33269911|NCT03678688|100887453|FG000|Overall Study|Reason not Specified|0|||
33269912|NCT03678688|100887454|FG001|Overall Study|Reason not Specified|0|||
33269913|NCT03678688|100887455|FG002|Overall Study|Reason not Specified|3|||
33269914|NCT03678688|100887456|FG003|Overall Study|Reason not Specified|0|||
33269915|NCT03678688|100887457|FG004|Overall Study|Reason not Specified|1|||
33269916|NCT03678688|100887458|FG005|Overall Study|Reason not Specified|0|||
33269917|NCT03678688|100887459|FG006|Overall Study|Reason not Specified|0|||
33269918|NCT03678688|100887460|FG007|Overall Study|Reason not Specified|0|||
33269919|NCT03678688|100887461|FG008|Overall Study|Reason not Specified|0|||
33269920|NCT03678688|100887453|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
33269921|NCT03678688|100887454|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
33269922|NCT03678688|100887455|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
33269923|NCT03678688|100887456|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
33269924|NCT03678688|100887457|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
33269925|NCT03678688|100887458|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
33269926|NCT03678688|100887459|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
33269927|NCT03678688|100887460|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
33269928|NCT03678688|100887461|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
33269929|NCT03678688|100887453|FG000|Overall Study|Covid Related Adverse Event|0|||
33269930|NCT03678688|100887454|FG001|Overall Study|Covid Related Adverse Event|0|||
33269931|NCT03678688|100887455|FG002|Overall Study|Covid Related Adverse Event|0|||
33269932|NCT03678688|100887456|FG003|Overall Study|Covid Related Adverse Event|0|||
33269933|NCT03678688|100887457|FG004|Overall Study|Covid Related Adverse Event|0|||
33269934|NCT03678688|100887458|FG005|Overall Study|Covid Related Adverse Event|3|||
33269935|NCT03678688|100887459|FG006|Overall Study|Covid Related Adverse Event|1|||
33269936|NCT03678688|100887460|FG007|Overall Study|Covid Related Adverse Event|1|||
33269937|NCT03678688|100887461|FG008|Overall Study|Covid Related Adverse Event|0|||
33269938|NCT03678688|100887453|FG000|Overall Study|Physician Decision|0|||
33269939|NCT03678688|100887454|FG001|Overall Study|Physician Decision|0|||
33269940|NCT03678688|100887455|FG002|Overall Study|Physician Decision|0|||
33269941|NCT03678688|100887456|FG003|Overall Study|Physician Decision|0|||
33269942|NCT03678688|100887457|FG004|Overall Study|Physician Decision|0|||
33269943|NCT03678688|100887458|FG005|Overall Study|Physician Decision|1|||
33269944|NCT03678688|100887459|FG006|Overall Study|Physician Decision|0|||
33269945|NCT03678688|100887460|FG007|Overall Study|Physician Decision|0|||
33269946|NCT03678688|100887461|FG008|Overall Study|Physician Decision|0|||
33269947|NCT03678688|100887453|FG000|Overall Study|Withdrawal by Subject|0|||
33269948|NCT03678688|100887454|FG001|Overall Study|Withdrawal by Subject|0|||
33269949|NCT03678688|100887455|FG002|Overall Study|Withdrawal by Subject|0|||
33269950|NCT03678688|100887456|FG003|Overall Study|Withdrawal by Subject|0|||
33269951|NCT03678688|100887457|FG004|Overall Study|Withdrawal by Subject|0|||
33269952|NCT03678688|100887458|FG005|Overall Study|Withdrawal by Subject|0|||
33269953|NCT03678688|100887459|FG006|Overall Study|Withdrawal by Subject|2|||
33269954|NCT03678688|100887460|FG007|Overall Study|Withdrawal by Subject|1|||
33269955|NCT03678688|100887461|FG008|Overall Study|Withdrawal by Subject|0|||
33269956|NCT03737110|100887462|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
33269957|NCT03737110|100887463|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
33269958|NCT03737110|100887464|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
33269959|NCT03737110|100887465|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
33269960|NCT03737110|100887466|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
33269961|NCT03737110|100887467|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
33269962|NCT03737110|100887462|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
33269963|NCT03737110|100887463|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
33269964|NCT03737110|100887464|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
33269965|NCT03737110|100887465|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
33269966|NCT03737110|100887466|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
33269967|NCT03737110|100887467|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
33269968|NCT03737110|100887462|FG000|Run-in (RI) Period|Adverse Event|4|||
33269969|NCT03737110|100887463|FG001|Run-in (RI) Period|Adverse Event|0|||
33269970|NCT03737110|100887464|FG002|Run-in (RI) Period|Adverse Event|0|||
33269971|NCT03737110|100887465|FG003|Run-in (RI) Period|Adverse Event|0|||
33269972|NCT03737110|100887466|FG004|Run-in (RI) Period|Adverse Event|0|||
33269973|NCT03737110|100887467|FG005|Run-in (RI) Period|Adverse Event|0|||
33269974|NCT03737110|100887462|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
33269975|NCT03737110|100887463|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
33269976|NCT03737110|100887464|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
33269977|NCT03737110|100887465|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
33269978|NCT03737110|100887466|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
33269979|NCT03737110|100887467|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
33269980|NCT03737110|100887462|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
33269981|NCT03737110|100887463|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
33269982|NCT03737110|100887464|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
33269983|NCT03737110|100887465|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
33269984|NCT03737110|100887466|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
33286478|NCT03481556|100943977|FG000|Overall Study|Adverse Event|1|||
33269985|NCT03737110|100887467|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
33269986|NCT03737110|100887462|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
33269987|NCT03737110|100887463|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
33269988|NCT03737110|100887464|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
33269989|NCT03737110|100887465|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
33269990|NCT03737110|100887466|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
33269991|NCT03737110|100887467|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
33269992|NCT03737110|100887462|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
33269993|NCT03737110|100887463|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
33269994|NCT03737110|100887464|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
33269995|NCT03737110|100887465|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
33269996|NCT03737110|100887466|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
33269997|NCT03737110|100887467|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
33269998|NCT03737110|100887462|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
33269999|NCT03737110|100887463|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
33270000|NCT03737110|100887464|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
33270001|NCT03737110|100887465|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
33270002|NCT03737110|100887466|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
33270003|NCT03737110|100887467|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
33270004|NCT01970878|100887468|FG000|Overall Study|Withdrawal by Subject|11|||
33270005|NCT01970878|100887469|FG001|Overall Study|Withdrawal by Subject|10|||
33270006|NCT01970878|100887470|FG002|Overall Study|Withdrawal by Subject|14|||
33270007|NCT01970878|100887471|FG003|Overall Study|Withdrawal by Subject|7|||
33270008|NCT01970878|100887468|FG000|Overall Study|Lost to Follow-up|1|||
33270009|NCT01970878|100887469|FG001|Overall Study|Lost to Follow-up|3|||
33270010|NCT01970878|100887470|FG002|Overall Study|Lost to Follow-up|2|||
33270011|NCT01970878|100887471|FG003|Overall Study|Lost to Follow-up|4|||
33270012|NCT01970878|100887468|FG000|Overall Study|Administrative Reasons|1|||
33270013|NCT01970878|100887469|FG001|Overall Study|Administrative Reasons|0|||
33270014|NCT01970878|100887470|FG002|Overall Study|Administrative Reasons|0|||
33270015|NCT01970878|100887471|FG003|Overall Study|Administrative Reasons|4|||
33270016|NCT01970878|100887468|FG000|Overall Study|Lack of Efficacy|2|||
33270017|NCT01970878|100887469|FG001|Overall Study|Lack of Efficacy|1|||
33270018|NCT01970878|100887470|FG002|Overall Study|Lack of Efficacy|2|||
33270019|NCT01970878|100887471|FG003|Overall Study|Lack of Efficacy|0|||
33270020|NCT01970878|100887468|FG000|Overall Study|Adverse Event|12|||
33270021|NCT01970878|100887469|FG001|Overall Study|Adverse Event|7|||
33270022|NCT01970878|100887470|FG002|Overall Study|Adverse Event|4|||
33270023|NCT01970878|100887471|FG003|Overall Study|Adverse Event|3|||
33270024|NCT01970878|100887468|FG000|Overall Study|Protocol Specified Criteria|10|||
33270025|NCT01970878|100887469|FG001|Overall Study|Protocol Specified Criteria|4|||
33270026|NCT01970878|100887470|FG002|Overall Study|Protocol Specified Criteria|3|||
33270027|NCT01970878|100887471|FG003|Overall Study|Protocol Specified Criteria|6|||
33270028|NCT01970878|100887468|FG000|Overall Study|Physician Decision|0|||
33270029|NCT01970878|100887469|FG001|Overall Study|Physician Decision|1|||
33270030|NCT01970878|100887470|FG002|Overall Study|Physician Decision|1|||
33270031|NCT01970878|100887471|FG003|Overall Study|Physician Decision|0|||
33270032|NCT01970878|100887468|FG000|Overall Study|No Completion Status|0|||
33270033|NCT01970878|100887469|FG001|Overall Study|No Completion Status|1|||
33270034|NCT01970878|100887470|FG002|Overall Study|No Completion Status|0|||
33270035|NCT01970878|100887471|FG003|Overall Study|No Completion Status|0|||
33270036|NCT04938453|100887472|FG000|Washout Period 1|Adverse Event|1|||
33270037|NCT04938453|100887473|FG001|Washout Period 1|Adverse Event|0|||
33270038|NCT04938453|100887472|FG000|Washout Period 1|Physician Decision|0|||
33270039|NCT04938453|100887473|FG001|Washout Period 1|Physician Decision|1|||
33270040|NCT01052272|100887474|FG000|Overall Study|Death|0|||
33270041|NCT01052272|100887475|FG001|Overall Study|Death|0|||
33270042|NCT01052272|100887476|FG002|Overall Study|Death|1|||
33270043|NCT01052272|100887477|FG003|Overall Study|Death|1|||
33270044|NCT01052272|100887474|FG000|Overall Study|Physician Decision|0|||
33270045|NCT01052272|100887475|FG001|Overall Study|Physician Decision|1|||
33270046|NCT01052272|100887476|FG002|Overall Study|Physician Decision|0|||
33270047|NCT01052272|100887477|FG003|Overall Study|Physician Decision|0|||
33270048|NCT01052272|100887474|FG000|Overall Study|patient refuses follow-up|5|||
33270049|NCT01052272|100887475|FG001|Overall Study|patient refuses follow-up|4|||
33270050|NCT01052272|100887476|FG002|Overall Study|patient refuses follow-up|2|||
33270051|NCT01052272|100887477|FG003|Overall Study|patient refuses follow-up|4|||
33270052|NCT01052272|100887474|FG000|Overall Study|Withdrawal by Subject|0|||
33270053|NCT01052272|100887475|FG001|Overall Study|Withdrawal by Subject|2|||
33270054|NCT01052272|100887476|FG002|Overall Study|Withdrawal by Subject|3|||
33480346|NCT03207243|101651751|FG000|Overall Study|Adverse Event|2|||
33270055|NCT01052272|100887477|FG003|Overall Study|Withdrawal by Subject|2|||
33270056|NCT01052272|100887474|FG000|Overall Study|placed in long-term care|0|||
33270057|NCT01052272|100887475|FG001|Overall Study|placed in long-term care|0|||
33270058|NCT01052272|100887476|FG002|Overall Study|placed in long-term care|1|||
33270059|NCT01052272|100887477|FG003|Overall Study|placed in long-term care|0|||
33270060|NCT01052272|100887474|FG000|Overall Study|decline in health|0|||
33270061|NCT01052272|100887475|FG001|Overall Study|decline in health|0|||
33270062|NCT01052272|100887476|FG002|Overall Study|decline in health|1|||
33270063|NCT01052272|100887477|FG003|Overall Study|decline in health|0|||
33270064|NCT01005914|100887478|FG000|Overall Study|Adverse Event|4|||
33270065|NCT01005914|100887478|FG000|Overall Study|Death|4|||
33270066|NCT01005914|100887478|FG000|Overall Study|Lack of Efficacy|1|||
33270067|NCT01005914|100887478|FG000|Overall Study|Withdrawal by Subject|1|||
33270068|NCT00655824|100887479|FG000|Overall Study|Adverse Event|3|||
33270069|NCT00655824|100887479|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
33270070|NCT00655824|100887479|FG000|Overall Study|Protocol Violation|1|||
33270071|NCT00655824|100887479|FG000|Overall Study|Withdrawal by Subject|4|||
33270072|NCT00655824|100887479|FG000|Overall Study|Deterioration of Trial Disease|2|||
33270073|NCT03136159|100887483|FG000|Overall Study|chorioamnionitis|2|||
33270074|NCT03136159|100887484|FG001|Overall Study|chorioamnionitis|0|||
33270075|NCT03136159|100887483|FG000|Overall Study|vertical skin incision|1|||
33270076|NCT03136159|100887484|FG001|Overall Study|vertical skin incision|0|||
33270077|NCT03136159|100887483|FG000|Overall Study|additional dressing|1|||
33270078|NCT03136159|100887484|FG001|Overall Study|additional dressing|0|||
33270079|NCT03136159|100887483|FG000|Overall Study|never got dressing placed|1|||
33270080|NCT03136159|100887484|FG001|Overall Study|never got dressing placed|0|||
33270081|NCT03146845|100887486|FG000|Overall Study|Reference ulcer healed|1|||
33270082|NCT03146845|100887487|FG001|Overall Study|Reference ulcer healed|0|||
33270083|NCT03146845|100887486|FG000|Overall Study|Physician Decision|1|||
33270084|NCT03146845|100887487|FG001|Overall Study|Physician Decision|0|||
33270085|NCT03146845|100887486|FG000|Overall Study|Adverse Event|1|||
33270086|NCT03146845|100887487|FG001|Overall Study|Adverse Event|0|||
33270087|NCT03146845|100887486|FG000|Overall Study|Withdrawal by Subject|2|||
33270088|NCT03146845|100887487|FG001|Overall Study|Withdrawal by Subject|0|||
33270089|NCT03146845|100887486|FG000|Overall Study|Noncompliance|0|||
33270090|NCT03146845|100887487|FG001|Overall Study|Noncompliance|1|||
33270091|NCT03146845|100887486|FG000|Overall Study|Protocol Violation|0|||
33270092|NCT03146845|100887487|FG001|Overall Study|Protocol Violation|2|||
33270093|NCT03146845|100887486|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
33270094|NCT03146845|100887487|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
33270095|NCT00704340|100887490|FG000|Overall Study|Lost to Follow-up|2|||
33270096|NCT00704340|100887491|FG001|Overall Study|Lost to Follow-up|1|||
33270097|NCT00704340|100887490|FG000|Overall Study|Death|0|||
33270098|NCT00704340|100887491|FG001|Overall Study|Death|1|||
33270099|NCT01867307|100887492|FG000|Overall Study|Protocol Violation|2|||
33270100|NCT01867307|100887493|FG001|Overall Study|Protocol Violation|0|||
33270101|NCT01867307|100887492|FG000|Overall Study|Other Adverse Event|1|||
33270102|NCT01867307|100887493|FG001|Overall Study|Other Adverse Event|3|||
33270103|NCT01777932|100887505|FG000|Overall Study|Disease progression|136|||
33270104|NCT01777932|100887505|FG000|Overall Study|Death|3|||
33270105|NCT01777932|100887505|FG000|Overall Study|Adverse Event|34|||
33270106|NCT01777932|100887505|FG000|Overall Study|Lost to Follow-up|3|||
33270107|NCT01777932|100887505|FG000|Overall Study|Investigator decision|10|||
33270108|NCT01777932|100887505|FG000|Overall Study|Reimbursement limit|9|||
33270109|NCT01777932|100887505|FG000|Overall Study|Patient refused further treatment|10|||
33270110|NCT02538094|100887506|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
33270111|NCT02538094|100887507|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
33270112|NCT02538094|100887506|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
33270113|NCT02538094|100887507|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
33270114|NCT00195819|100887508|FG000|Double-Blind|Withdrawal by Subject|1|||
33270115|NCT00195819|100887509|FG001|Double-Blind|Withdrawal by Subject|0|||
33270116|NCT00195819|100887508|FG000|Double-Blind|Moved|1|||
33270117|NCT00195819|100887509|FG001|Double-Blind|Moved|0|||
33270118|NCT00195819|100887508|FG000|Open-label|Adverse Event|0|||
33270119|NCT00195819|100887509|FG001|Open-label|Adverse Event|9|||
33270120|NCT00195819|100887508|FG000|Open-label|Lack of Efficacy|0|||
33270121|NCT00195819|100887509|FG001|Open-label|Lack of Efficacy|2|||
33270122|NCT00195819|100887508|FG000|Open-label|Pregnancy|0|||
33270123|NCT00195819|100887509|FG001|Open-label|Pregnancy|1|||
33270124|NCT00195819|100887508|FG000|Open-label|Protocol Violation|0|||
33270125|NCT00195819|100887509|FG001|Open-label|Protocol Violation|2|||
33270126|NCT00195819|100887508|FG000|Open-label|Moved|0|||
33270127|NCT00195819|100887509|FG001|Open-label|Moved|1|||
33270128|NCT00195819|100887508|FG000|Open-label|Withdrawal by Subject|0|||
33270129|NCT00195819|100887509|FG001|Open-label|Withdrawal by Subject|5|||
33270130|NCT02514824|100887514|FG000|Overall Study|Withdrawal by Subject|1|||
33270131|NCT02514824|100887515|FG001|Overall Study|Withdrawal by Subject|0|||
33270132|NCT02514824|100887516|FG002|Overall Study|Withdrawal by Subject|0|||
33270133|NCT02514824|100887517|FG003|Overall Study|Withdrawal by Subject|0|||
33270134|NCT02514824|100887514|FG000|Overall Study|Dose-Limiting Toxicity|0|||
33270135|NCT02514824|100887515|FG001|Overall Study|Dose-Limiting Toxicity|1|||
33270136|NCT02514824|100887516|FG002|Overall Study|Dose-Limiting Toxicity|0|||
33270137|NCT02514824|100887517|FG003|Overall Study|Dose-Limiting Toxicity|0|||
33270138|NCT03132636|100887518|FG000|Overall Study|Adverse Event|1|||
33270139|NCT03132636|100887519|FG001|Overall Study|Adverse Event|2|||
33270140|NCT03132636|100887518|FG000|Overall Study|Death|4|||
33270141|NCT03132636|100887519|FG001|Overall Study|Death|7|||
33270142|NCT03132636|100887518|FG000|Overall Study|Lost to Follow-up|3|||
33270143|NCT03132636|100887519|FG001|Overall Study|Lost to Follow-up|2|||
33270144|NCT03132636|100887518|FG000|Overall Study|Non compliance with protocol by participant|1|||
33270145|NCT03132636|100887519|FG001|Overall Study|Non compliance with protocol by participant|1|||
33270146|NCT03132636|100887518|FG000|Overall Study|Subject decision|1|||
33270147|NCT03132636|100887519|FG001|Overall Study|Subject decision|9|||
33270148|NCT03132636|100887518|FG000|Overall Study|Sponsor decision|0|||
33270149|NCT03132636|100887519|FG001|Overall Study|Sponsor decision|1|||
33270150|NCT03132636|100887518|FG000|Overall Study|Physician Decision|1|||
33270151|NCT03132636|100887519|FG001|Overall Study|Physician Decision|0|||
33270152|NCT03132636|100887518|FG000|Overall Study|Progressive disease|33|||
33270153|NCT03132636|100887519|FG001|Overall Study|Progressive disease|36|||
33270154|NCT03132636|100887518|FG000|Overall Study|Withdrawal of consent|2|||
33270155|NCT03132636|100887519|FG001|Overall Study|Withdrawal of consent|5|||
33270156|NCT03132636|100887518|FG000|Overall Study|Did not re-consent|1|||
33270157|NCT03132636|100887519|FG001|Overall Study|Did not re-consent|0|||
33270158|NCT03132636|100887518|FG000|Overall Study|Lost insurance coverage|1|||
33270159|NCT03132636|100887519|FG001|Overall Study|Lost insurance coverage|0|||
33270160|NCT03132636|100887518|FG000|Overall Study|Related to radiological outcomes|0|||
33270161|NCT03132636|100887519|FG001|Overall Study|Related to radiological outcomes|1|||
33270162|NCT03132636|100887518|FG000|Overall Study|Unable to come to site for continued visits|0|||
33270163|NCT03132636|100887519|FG001|Overall Study|Unable to come to site for continued visits|1|||
33270164|NCT02137785|100887520|FG000|Overall Study|Lost to Follow-up|1|||
33270165|NCT02137785|100887521|FG001|Overall Study|Lost to Follow-up|0|||
33270166|NCT02137785|100887520|FG000|Overall Study|Withdrawal by Subject|1|||
33270167|NCT02137785|100887521|FG001|Overall Study|Withdrawal by Subject|4|||
33270168|NCT02137785|100887520|FG000|Overall Study|subject moved out of state|1|||
33270169|NCT02137785|100887521|FG001|Overall Study|subject moved out of state|0|||
33270170|NCT04803734|100887522|FG000|Overall Study|Withdrawal by Subject|0|||
33270171|NCT04803734|100887523|FG001|Overall Study|Withdrawal by Subject|1|||
33270172|NCT04803734|100887522|FG000|Overall Study|Protocol Violation|0|||
33270173|NCT04803734|100887523|FG001|Overall Study|Protocol Violation|1|||
33270174|NCT03390166|100887524|FG000|Overall Study|Death|0|||
33270175|NCT03390166|100887525|FG001|Overall Study|Death|1|||
33270176|NCT03390166|100887524|FG000|Overall Study|Lost to Follow-up|6|||
33270177|NCT03390166|100887525|FG001|Overall Study|Lost to Follow-up|4|||
33270178|NCT03390166|100887524|FG000|Overall Study|Physician Decision|2|||
33270179|NCT03390166|100887525|FG001|Overall Study|Physician Decision|1|||
33270180|NCT03390166|100887524|FG000|Overall Study|Move from study area|3|||
33270181|NCT03390166|100887525|FG001|Overall Study|Move from study area|2|||
33270182|NCT03390166|100887524|FG000|Overall Study|To militarycamp for conscript|1|||
33270183|NCT03390166|100887525|FG001|Overall Study|To militarycamp for conscript|0|||
33270184|NCT03390166|100887524|FG000|Overall Study|To drug therapy course|0|||
33270185|NCT03390166|100887525|FG001|Overall Study|To drug therapy course|1|||
33270186|NCT03390166|100887524|FG000|Overall Study|Move to work oversea|0|||
33270187|NCT03390166|100887525|FG001|Overall Study|Move to work oversea|1|||
33270188|NCT01918033|100887530|FG000|Overall Study|Adverse Event|1|||
33270189|NCT01918033|100887531|FG001|Overall Study|Adverse Event|0|||
33270190|NCT01918033|100887532|FG002|Overall Study|Adverse Event|2|||
33270191|NCT01918033|100887530|FG000|Overall Study|Lost to Follow-up|0|||
33270192|NCT01918033|100887531|FG001|Overall Study|Lost to Follow-up|1|||
33270193|NCT01918033|100887532|FG002|Overall Study|Lost to Follow-up|0|||
33270194|NCT01918033|100887530|FG000|Overall Study|Protocol Violation|2|||
33270195|NCT01918033|100887531|FG001|Overall Study|Protocol Violation|0|||
33270196|NCT01918033|100887532|FG002|Overall Study|Protocol Violation|1|||
33270197|NCT01918033|100887530|FG000|Overall Study|Withdrawal by Subject|2|||
33270198|NCT01918033|100887531|FG001|Overall Study|Withdrawal by Subject|1|||
33270199|NCT01918033|100887532|FG002|Overall Study|Withdrawal by Subject|0|||
33270200|NCT00659373|100887536|FG000|Overall Study|Withdrawal by Subject|3|||
33270201|NCT00659373|100887537|FG001|Overall Study|Withdrawal by Subject|5|||
33270202|NCT00659373|100887536|FG000|Overall Study|Assessment Missed|2|||
33270203|NCT00659373|100887537|FG001|Overall Study|Assessment Missed|2|||
33270204|NCT02630186|100887544|FG000|Overall Study|Withdrawal by Subject|1|||
33270205|NCT00590759|100887545|FG000|Overall Study|Death|52|||
33270206|NCT00590759|100887545|FG000|Overall Study|Lost to Follow-up|28|||
33270207|NCT01858688|100887556|FG000|Overall Study|Withdrawal by Subject|8|||
33270208|NCT01858688|100887556|FG000|Overall Study|Participant began another therapy|3|||
33270209|NCT01858688|100887556|FG000|Overall Study|Physician Decision|2|||
33270210|NCT01858688|100887556|FG000|Overall Study|Progressive Disease|2|||
33270211|NCT01858688|100887556|FG000|Overall Study|Reason not reproted|5|||
33270212|NCT01137682|100887557|FG000|Overall Study|Adverse Event-CORE|2|||
33270213|NCT01137682|100887558|FG001|Overall Study|Adverse Event-CORE|4|||
33270214|NCT01137682|100887559|FG002|Overall Study|Adverse Event-CORE|0|||
33270215|NCT01137682|100887557|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
33270216|NCT01137682|100887558|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
33270217|NCT01137682|100887559|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
33270218|NCT01137682|100887557|FG000|Overall Study|Administrative problems-CORE|2|||
33270219|NCT01137682|100887558|FG001|Overall Study|Administrative problems-CORE|1|||
33270220|NCT01137682|100887559|FG002|Overall Study|Administrative problems-CORE|0|||
33270221|NCT01137682|100887557|FG000|Overall Study|Protocol Violation-CORE|0|||
33270222|NCT01137682|100887558|FG001|Overall Study|Protocol Violation-CORE|1|||
33270223|NCT01137682|100887559|FG002|Overall Study|Protocol Violation-CORE|1|||
33270224|NCT01137682|100887557|FG000|Overall Study|Adverse Event-Extension|4|||
33270225|NCT01137682|100887558|FG001|Overall Study|Adverse Event-Extension|8|||
33270226|NCT01137682|100887559|FG002|Overall Study|Adverse Event-Extension|7|||
33270227|NCT01137682|100887557|FG000|Overall Study|Lack of Efficacy-Extension|15|||
33270228|NCT01137682|100887558|FG001|Overall Study|Lack of Efficacy-Extension|9|||
33270229|NCT01137682|100887559|FG002|Overall Study|Lack of Efficacy-Extension|13|||
33270230|NCT01137682|100887557|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
33270231|NCT01137682|100887558|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
33270232|NCT01137682|100887559|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
33270233|NCT01137682|100887557|FG000|Overall Study|Lost to Follow Up-Extension|0|||
33270234|NCT01137682|100887558|FG001|Overall Study|Lost to Follow Up-Extension|1|||
33270235|NCT01137682|100887559|FG002|Overall Study|Lost to Follow Up-Extension|0|||
33270236|NCT01137682|100887557|FG000|Overall Study|Administrative problems-Extension|0|||
33270237|NCT01137682|100887558|FG001|Overall Study|Administrative problems-Extension|2|||
33270238|NCT01137682|100887559|FG002|Overall Study|Administrative problems-Extension|0|||
33270239|NCT01137682|100887557|FG000|Overall Study|Death-Extension|2|||
33270240|NCT01137682|100887558|FG001|Overall Study|Death-Extension|0|||
33270241|NCT01137682|100887559|FG002|Overall Study|Death-Extension|0|||
33270242|NCT01137682|100887557|FG000|Overall Study|Protocol Violation-Extension|2|||
33270243|NCT01137682|100887558|FG001|Overall Study|Protocol Violation-Extension|1|||
33270244|NCT01137682|100887559|FG002|Overall Study|Protocol Violation-Extension|0|||
33270245|NCT01137682|100887557|FG000|Overall Study|Did not enter extension|2|||
33270246|NCT01137682|100887558|FG001|Overall Study|Did not enter extension|3|||
33270247|NCT01137682|100887559|FG002|Overall Study|Did not enter extension|2|||
33270248|NCT01137682|100887557|FG000|Overall Study|Did not receive treatment in extension|0|||
33270249|NCT01137682|100887558|FG001|Overall Study|Did not receive treatment in extension|0|||
33270250|NCT01137682|100887559|FG002|Overall Study|Did not receive treatment in extension|1|||
33270251|NCT00641537|100887560|FG000|96-week Period|Adverse Event|0|||
33270252|NCT00641537|100887561|FG001|96-week Period|Adverse Event|1|||
33270253|NCT00641537|100887562|FG002|96-week Period|Adverse Event|3|||
33270254|NCT00641537|100887563|FG003|96-week Period|Adverse Event|0|||
33270255|NCT00641537|100887564|FG004|96-week Period|Adverse Event|2|||
33270256|NCT00641537|100887565|FG005|96-week Period|Adverse Event|0|||
33270257|NCT00641537|100887566|FG006|96-week Period|Adverse Event|0|||
33270258|NCT00641537|100887567|FG007|96-week Period|Adverse Event|0|||
33270259|NCT00641537|100887560|FG000|96-week Period|Lost to Follow-up|3|||
33270260|NCT00641537|100887561|FG001|96-week Period|Lost to Follow-up|1|||
33270261|NCT00641537|100887562|FG002|96-week Period|Lost to Follow-up|2|||
33270262|NCT00641537|100887563|FG003|96-week Period|Lost to Follow-up|2|||
33270263|NCT00641537|100887564|FG004|96-week Period|Lost to Follow-up|4|||
33270264|NCT00641537|100887565|FG005|96-week Period|Lost to Follow-up|0|||
33270265|NCT00641537|100887566|FG006|96-week Period|Lost to Follow-up|1|||
33270266|NCT00641537|100887567|FG007|96-week Period|Lost to Follow-up|0|||
33270267|NCT00641537|100887560|FG000|96-week Period|Protocol Violation|0|||
33270268|NCT00641537|100887561|FG001|96-week Period|Protocol Violation|1|||
33270269|NCT00641537|100887562|FG002|96-week Period|Protocol Violation|0|||
33270270|NCT00641537|100887563|FG003|96-week Period|Protocol Violation|1|||
33270271|NCT00641537|100887564|FG004|96-week Period|Protocol Violation|0|||
33270272|NCT00641537|100887565|FG005|96-week Period|Protocol Violation|1|||
33270273|NCT00641537|100887566|FG006|96-week Period|Protocol Violation|0|||
33270274|NCT00641537|100887567|FG007|96-week Period|Protocol Violation|0|||
33270275|NCT00641537|100887560|FG000|96-week Period|Death|2|||
33270276|NCT00641537|100887561|FG001|96-week Period|Death|0|||
33270277|NCT00641537|100887562|FG002|96-week Period|Death|1|||
33270278|NCT00641537|100887563|FG003|96-week Period|Death|0|||
33270279|NCT00641537|100887564|FG004|96-week Period|Death|0|||
33270280|NCT00641537|100887565|FG005|96-week Period|Death|0|||
33270281|NCT00641537|100887566|FG006|96-week Period|Death|0|||
33270282|NCT00641537|100887567|FG007|96-week Period|Death|0|||
33270283|NCT00641537|100887560|FG000|96-week Period|Other|4|||
33270284|NCT00641537|100887561|FG001|96-week Period|Other|7|||
33270285|NCT00641537|100887562|FG002|96-week Period|Other|14|||
33270286|NCT00641537|100887563|FG003|96-week Period|Other|9|||
33270287|NCT00641537|100887564|FG004|96-week Period|Other|11|||
33270288|NCT00641537|100887565|FG005|96-week Period|Other|6|||
33270289|NCT00641537|100887566|FG006|96-week Period|Other|4|||
33270290|NCT00641537|100887567|FG007|96-week Period|Other|6|||
33270291|NCT00641537|100887560|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
33270292|NCT00641537|100887561|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
33270293|NCT00641537|100887562|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
33270294|NCT00641537|100887563|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
33270295|NCT00641537|100887564|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
33270296|NCT00641537|100887565|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
33270297|NCT00641537|100887566|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
33270298|NCT00641537|100887567|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
33270299|NCT00641537|100887560|FG000|24-Week Supplemental Follow-up Period|Other|0|||
33270300|NCT00641537|100887561|FG001|24-Week Supplemental Follow-up Period|Other|2|||
33270301|NCT00641537|100887562|FG002|24-Week Supplemental Follow-up Period|Other|2|||
33270302|NCT00641537|100887563|FG003|24-Week Supplemental Follow-up Period|Other|1|||
33270303|NCT00641537|100887564|FG004|24-Week Supplemental Follow-up Period|Other|3|||
33270304|NCT00641537|100887565|FG005|24-Week Supplemental Follow-up Period|Other|0|||
33270305|NCT00641537|100887566|FG006|24-Week Supplemental Follow-up Period|Other|1|||
33270306|NCT00641537|100887567|FG007|24-Week Supplemental Follow-up Period|Other|1|||
33270307|NCT02095145|100891251|FG000|Overall Study|Withdrawal by Subject|1|||
33270308|NCT02095145|100891252|FG001|Overall Study|Withdrawal by Subject|0|||
33270309|NCT01670877|100891253|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
33270310|NCT01670877|100891254|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
33270311|NCT01670877|100891255|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
33270312|NCT01670877|100891256|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
33270313|NCT01670877|100891257|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
33270314|NCT01670877|100891258|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
33270315|NCT01670877|100891253|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
33270316|NCT01670877|100891254|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
33270317|NCT01670877|100891255|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
33270318|NCT01670877|100891256|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
33270319|NCT01670877|100891257|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
33270320|NCT01670877|100891258|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
33270321|NCT01670877|100891253|FG000|Part I and Part 2|Grade 2 vomiting|0|||
33270322|NCT01670877|100891254|FG001|Part I and Part 2|Grade 2 vomiting|0|||
33270323|NCT01670877|100891255|FG002|Part I and Part 2|Grade 2 vomiting|0|||
33270324|NCT01670877|100891256|FG003|Part I and Part 2|Grade 2 vomiting|1|||
33270325|NCT01670877|100891257|FG004|Part I and Part 2|Grade 2 vomiting|0|||
33270326|NCT01670877|100891258|FG005|Part I and Part 2|Grade 2 vomiting|0|||
33270327|NCT01670877|100891253|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
33270328|NCT01670877|100891254|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
33270329|NCT01670877|100891255|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
33270330|NCT01670877|100891256|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
33270331|NCT01670877|100891257|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
33270332|NCT01670877|100891258|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
33270333|NCT01670877|100891253|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
33270334|NCT01670877|100891254|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
33270335|NCT01670877|100891255|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
33270336|NCT01670877|100891256|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
33270337|NCT01670877|100891257|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
33270338|NCT01670877|100891258|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
33270339|NCT02991118|100891266|FG000|Overall Study|Death|3|||
33270340|NCT02991118|100891267|FG001|Overall Study|Death|8|||
33270341|NCT02991118|100891266|FG000|Overall Study|Protocol Violation|0|||
33270342|NCT02991118|100891267|FG001|Overall Study|Protocol Violation|3|||
33270343|NCT02991118|100891266|FG000|Overall Study|Physician Decision|0|||
33270344|NCT02991118|100891267|FG001|Overall Study|Physician Decision|1|||
33270345|NCT02991118|100891266|FG000|Overall Study|Moved out of the country|0|||
33270346|NCT02991118|100891267|FG001|Overall Study|Moved out of the country|1|||
33270347|NCT02991118|100891266|FG000|Overall Study|Adverse Event|2|||
33270348|NCT02991118|100891267|FG001|Overall Study|Adverse Event|2|||
33270349|NCT02991118|100891266|FG000|Overall Study|Withdrawal by Subject|1|||
33270350|NCT02991118|100891267|FG001|Overall Study|Withdrawal by Subject|7|||
33270351|NCT02991118|100891266|FG000|Overall Study|Could not attend study visits|0|||
33270352|NCT02991118|100891267|FG001|Overall Study|Could not attend study visits|1|||
33270353|NCT02991118|100891266|FG000|Overall Study|Lost to Follow-up|1|||
33270354|NCT02991118|100891267|FG001|Overall Study|Lost to Follow-up|9|||
33270355|NCT04658784|100891270|FG000|6-month Follow-up|Lost to Follow-up|2|||
33270356|NCT04658784|100891271|FG001|6-month Follow-up|Lost to Follow-up|5|||
33270357|NCT02958553|100891280|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
33270358|NCT02958553|100891280|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
33270359|NCT00703092|100891281|FG000|Overall Study|Withdrawal by Subject|2|||
33270360|NCT00458783|100891286|FG000|Overall Study|Protocol Violation|1228|||
33270361|NCT00458783|100891287|FG001|Overall Study|Protocol Violation|1220|||
33270362|NCT00486954|100891289|FG000|Pilot Part|Adverse Event|4|||
33270363|NCT00486954|100891290|FG001|Pilot Part|Adverse Event|0|||
33270364|NCT00486954|100891291|FG002|Pilot Part|Adverse Event|5|||
33270365|NCT00486954|100891292|FG003|Pilot Part|Adverse Event|0|||
33270366|NCT00486954|100891293|FG004|Pilot Part|Adverse Event|0|||
33270367|NCT00486954|100891289|FG000|Pilot Part|Disease Progression|2|||
33270368|NCT00486954|100891290|FG001|Pilot Part|Disease Progression|0|||
33270369|NCT00486954|100891291|FG002|Pilot Part|Disease Progression|1|||
33270370|NCT00486954|100891292|FG003|Pilot Part|Disease Progression|0|||
33270371|NCT00486954|100891293|FG004|Pilot Part|Disease Progression|0|||
33270372|NCT00486954|100891289|FG000|Randomized Part|Lost to Follow-up|0|||
33270373|NCT00486954|100891290|FG001|Randomized Part|Lost to Follow-up|0|||
33270374|NCT00486954|100891291|FG002|Randomized Part|Lost to Follow-up|0|||
33270375|NCT00486954|100891292|FG003|Randomized Part|Lost to Follow-up|0|||
33270376|NCT00486954|100891293|FG004|Randomized Part|Lost to Follow-up|1|||
33270377|NCT00486954|100891289|FG000|Randomized Part|Withdrawal by Subject|0|||
33270378|NCT00486954|100891290|FG001|Randomized Part|Withdrawal by Subject|0|||
33270379|NCT00486954|100891291|FG002|Randomized Part|Withdrawal by Subject|0|||
33270380|NCT00486954|100891292|FG003|Randomized Part|Withdrawal by Subject|1|||
33270381|NCT00486954|100891293|FG004|Randomized Part|Withdrawal by Subject|0|||
33270382|NCT00486954|100891289|FG000|Randomized Part|Sponsor Terminated Study|0|||
33270383|NCT00486954|100891290|FG001|Randomized Part|Sponsor Terminated Study|0|||
33270384|NCT00486954|100891291|FG002|Randomized Part|Sponsor Terminated Study|0|||
33270385|NCT00486954|100891292|FG003|Randomized Part|Sponsor Terminated Study|19|||
33270386|NCT00486954|100891293|FG004|Randomized Part|Sponsor Terminated Study|13|||
33270387|NCT00308308|100891294|FG000|Overall Study|Adverse Event|17|||
33270388|NCT00308308|100891295|FG001|Overall Study|Adverse Event|2|||
33270389|NCT00308308|100891294|FG000|Overall Study|Lost to Follow-up|5|||
33270390|NCT00308308|100891295|FG001|Overall Study|Lost to Follow-up|5|||
33270391|NCT00308308|100891294|FG000|Overall Study|Physician Decision|15|||
33270392|NCT00308308|100891295|FG001|Overall Study|Physician Decision|7|||
33270393|NCT00308308|100891294|FG000|Overall Study|Protocol Violation|3|||
33270394|NCT00308308|100891295|FG001|Overall Study|Protocol Violation|14|||
33270395|NCT00308308|100891294|FG000|Overall Study|Withdrawal by Subject|47|||
33270396|NCT00308308|100891295|FG001|Overall Study|Withdrawal by Subject|19|||
33270397|NCT00308308|100891294|FG000|Overall Study|Various|7|||
33270398|NCT00308308|100891295|FG001|Overall Study|Various|5|||
33270399|NCT00308308|100891294|FG000|Overall Study|Randomized but not dosed|8|||
33270400|NCT00308308|100891295|FG001|Overall Study|Randomized but not dosed|16|||
33270401|NCT00308308|100891294|FG000|Overall Study|Other|1|||
33270402|NCT00308308|100891295|FG001|Overall Study|Other|0|||
33270403|NCT00787176|100891296|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
33270404|NCT00787176|100891297|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
33270405|NCT00787176|100891298|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
33270406|NCT00787176|100891299|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
33270407|NCT03960645|100891300|FG000|Overall Study|Protocol Violation|1|||
33270408|NCT03960645|100891301|FG001|Overall Study|Protocol Violation|0|||
33270409|NCT03136861|100891302|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
33270410|NCT03136861|100891303|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
33270411|NCT03136861|100891304|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
33270412|NCT03136861|100891305|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
33270413|NCT03136861|100891306|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
33270414|NCT03136861|100891307|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
33270415|NCT03136861|100891308|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
33270416|NCT03136861|100891302|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
33270417|NCT03136861|100891303|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
33270418|NCT03136861|100891304|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
33270419|NCT03136861|100891305|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
33270420|NCT03136861|100891306|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
33270421|NCT03136861|100891307|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
33480347|NCT03207243|101651752|FG001|Overall Study|Adverse Event|2|||
33480348|NCT03207243|101651751|FG000|Overall Study|Loss of Asthma Control|47|||
33480349|NCT03207243|101651752|FG001|Overall Study|Loss of Asthma Control|31|||
33480350|NCT03207243|101651751|FG000|Overall Study|Withdrawal by Subject|2|||
33270422|NCT03136861|100891308|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
33480351|NCT03207243|101651752|FG001|Overall Study|Withdrawal by Subject|4|||
33270423|NCT03136861|100891302|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
33480352|NCT03207243|101651751|FG000|Overall Study|Physician Decision|1|||
33480353|NCT03207243|101651752|FG001|Overall Study|Physician Decision|1|||
33480354|NCT03207243|101651751|FG000|Overall Study|Lost to Follow-up|0|||
33270424|NCT03136861|100891303|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
33270425|NCT03136861|100891304|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
33270426|NCT03136861|100891305|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
33270427|NCT03136861|100891306|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
33270428|NCT03136861|100891307|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
33270429|NCT03136861|100891308|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
33270430|NCT03136861|100891302|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
33270431|NCT03136861|100891303|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
33270432|NCT03136861|100891304|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
33270433|NCT03136861|100891305|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
33270434|NCT03136861|100891306|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
33270435|NCT03136861|100891307|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
33270436|NCT03136861|100891308|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
33270437|NCT03136861|100891302|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
33270438|NCT03136861|100891303|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
33270439|NCT03136861|100891304|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
33270440|NCT03136861|100891305|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
33270441|NCT03136861|100891306|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
33270442|NCT03136861|100891307|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
33270443|NCT03136861|100891308|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
33270444|NCT03136861|100891302|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
33270445|NCT03136861|100891303|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
33270446|NCT03136861|100891304|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
33270447|NCT03136861|100891305|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
33270448|NCT03136861|100891306|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
33270449|NCT03136861|100891307|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
33270450|NCT03136861|100891308|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
33270451|NCT03136861|100891302|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
33270452|NCT03136861|100891303|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
33270453|NCT03136861|100891304|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
33270454|NCT03136861|100891305|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
33270455|NCT03136861|100891306|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
33270456|NCT03136861|100891307|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
33270457|NCT03136861|100891308|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
33270458|NCT03136861|100891302|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
33270459|NCT03136861|100891303|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
33270460|NCT03136861|100891304|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
33270461|NCT03136861|100891305|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
33270462|NCT03136861|100891306|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
33270463|NCT03136861|100891307|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
33270464|NCT03136861|100891308|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
33270465|NCT00439218|100891309|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
33270466|NCT00983294|100891310|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
33270467|NCT00983294|100891310|FG000|Colchicine With Azithromycin|Adverse Event|1|||
33270468|NCT00813709|100891311|FG000|Double Blind Period|Adverse Event|4|||
33270469|NCT00813709|100891312|FG001|Double Blind Period|Adverse Event|1|||
33270470|NCT00813709|100891313|FG002|Double Blind Period|Adverse Event|4|||
33270471|NCT00813709|100891314|FG003|Double Blind Period|Adverse Event|0|||
33270472|NCT00813709|100891315|FG004|Double Blind Period|Adverse Event|0|||
33270473|NCT00813709|100891316|FG005|Double Blind Period|Adverse Event|0|||
33270474|NCT00813709|100891311|FG000|Double Blind Period|Lost to Follow-up|3|||
33270475|NCT00813709|100891312|FG001|Double Blind Period|Lost to Follow-up|2|||
33270476|NCT00813709|100891313|FG002|Double Blind Period|Lost to Follow-up|2|||
33270477|NCT00813709|100891314|FG003|Double Blind Period|Lost to Follow-up|0|||
33270478|NCT00813709|100891315|FG004|Double Blind Period|Lost to Follow-up|0|||
33270479|NCT00813709|100891316|FG005|Double Blind Period|Lost to Follow-up|0|||
33270480|NCT00813709|100891311|FG000|Double Blind Period|Switched to open label phase|9|||
33270481|NCT00813709|100891312|FG001|Double Blind Period|Switched to open label phase|26|||
33270482|NCT00813709|100891313|FG002|Double Blind Period|Switched to open label phase|18|||
33270483|NCT00813709|100891314|FG003|Double Blind Period|Switched to open label phase|0|||
33270484|NCT00813709|100891315|FG004|Double Blind Period|Switched to open label phase|0|||
33270485|NCT00813709|100891316|FG005|Double Blind Period|Switched to open label phase|0|||
33270486|NCT00813709|100891311|FG000|Double Blind Period|Randomized but not treated|1|||
33270487|NCT00813709|100891312|FG001|Double Blind Period|Randomized but not treated|3|||
33270488|NCT00813709|100891313|FG002|Double Blind Period|Randomized but not treated|1|||
33270489|NCT00813709|100891314|FG003|Double Blind Period|Randomized but not treated|0|||
33270490|NCT00813709|100891315|FG004|Double Blind Period|Randomized but not treated|0|||
33270491|NCT00813709|100891316|FG005|Double Blind Period|Randomized but not treated|0|||
33270492|NCT00813709|100891311|FG000|Double Blind Period|Other|14|||
33270493|NCT00813709|100891312|FG001|Double Blind Period|Other|9|||
33270494|NCT00813709|100891313|FG002|Double Blind Period|Other|6|||
33270495|NCT00813709|100891314|FG003|Double Blind Period|Other|0|||
33270496|NCT00813709|100891315|FG004|Double Blind Period|Other|0|||
33270497|NCT00813709|100891316|FG005|Double Blind Period|Other|0|||
33270498|NCT00813709|100891311|FG000|Open Label Period|Adverse Event|0|||
33270499|NCT00813709|100891312|FG001|Open Label Period|Adverse Event|0|||
33270500|NCT00813709|100891313|FG002|Open Label Period|Adverse Event|0|||
33270501|NCT00813709|100891314|FG003|Open Label Period|Adverse Event|5|||
33270502|NCT00813709|100891315|FG004|Open Label Period|Adverse Event|4|||
33270503|NCT00813709|100891316|FG005|Open Label Period|Adverse Event|3|||
33270504|NCT00813709|100891311|FG000|Open Label Period|Lack of Efficacy|0|||
33270505|NCT00813709|100891312|FG001|Open Label Period|Lack of Efficacy|0|||
33270506|NCT00813709|100891313|FG002|Open Label Period|Lack of Efficacy|0|||
33270507|NCT00813709|100891314|FG003|Open Label Period|Lack of Efficacy|3|||
33270508|NCT00813709|100891315|FG004|Open Label Period|Lack of Efficacy|1|||
33270509|NCT00813709|100891316|FG005|Open Label Period|Lack of Efficacy|1|||
33270510|NCT00813709|100891311|FG000|Open Label Period|Randomized but not treated|0|||
33270511|NCT00813709|100891312|FG001|Open Label Period|Randomized but not treated|0|||
33270512|NCT00813709|100891313|FG002|Open Label Period|Randomized but not treated|0|||
33270513|NCT00813709|100891314|FG003|Open Label Period|Randomized but not treated|1|||
33270514|NCT00813709|100891315|FG004|Open Label Period|Randomized but not treated|0|||
33270515|NCT00813709|100891316|FG005|Open Label Period|Randomized but not treated|1|||
33270516|NCT00813709|100891311|FG000|Open Label Period|Other|0|||
33270517|NCT00813709|100891312|FG001|Open Label Period|Other|0|||
33270518|NCT00813709|100891313|FG002|Open Label Period|Other|0|||
33270519|NCT00813709|100891314|FG003|Open Label Period|Other|11|||
33270520|NCT00813709|100891315|FG004|Open Label Period|Other|5|||
33270521|NCT00813709|100891316|FG005|Open Label Period|Other|6|||
33270522|NCT03823703|100891317|FG000|Overall Study|Sponsor request|0|||
33270523|NCT03823703|100891318|FG001|Overall Study|Sponsor request|3|||
33270524|NCT03823703|100891319|FG002|Overall Study|Sponsor request|4|||
33270525|NCT03823703|100891317|FG000|Overall Study|Adverse Event|3|||
33270526|NCT03823703|100891318|FG001|Overall Study|Adverse Event|1|||
33270527|NCT03823703|100891319|FG002|Overall Study|Adverse Event|0|||
33270528|NCT03823703|100891317|FG000|Overall Study|Withdrawal by Subject|0|||
33270529|NCT03823703|100891318|FG001|Overall Study|Withdrawal by Subject|1|||
33270530|NCT03823703|100891319|FG002|Overall Study|Withdrawal by Subject|0|||
33270531|NCT01737398|100891320|FG000|Overall Study|Adverse event or SAE|16|||
33270532|NCT01737398|100891321|FG001|Overall Study|Adverse event or SAE|1|||
33270533|NCT01737398|100891320|FG000|Overall Study|Stopping rule met|2|||
33270534|NCT01737398|100891321|FG001|Overall Study|Stopping rule met|1|||
33270535|NCT01737398|100891320|FG000|Overall Study|Voluntary withdrawal|2|||
33270536|NCT01737398|100891321|FG001|Overall Study|Voluntary withdrawal|3|||
33270537|NCT01737398|100891320|FG000|Overall Study|Ineligibility|1|||
33270538|NCT01737398|100891321|FG001|Overall Study|Ineligibility|0|||
33270539|NCT01737398|100891320|FG000|Overall Study|Liver transplant|1|||
33270540|NCT01737398|100891321|FG001|Overall Study|Liver transplant|0|||
33270541|NCT01737398|100891320|FG000|Overall Study|Disease progression|2|||
33270542|NCT01737398|100891321|FG001|Overall Study|Disease progression|3|||
33270543|NCT01737398|100891320|FG000|Overall Study|Sponsor's decision|2|||
33270544|NCT01737398|100891321|FG001|Overall Study|Sponsor's decision|0|||
33270545|NCT05260437|100891322|FG000|Overall Study|Lost to Follow-up|5|||
33270546|NCT05260437|100891323|FG001|Overall Study|Lost to Follow-up|2|||
33270547|NCT05260437|100891324|FG002|Overall Study|Lost to Follow-up|1|||
33270548|NCT05260437|100891325|FG003|Overall Study|Lost to Follow-up|2|||
33270549|NCT05260437|100891326|FG004|Overall Study|Lost to Follow-up|2|||
33270550|NCT05260437|100891322|FG000|Overall Study|Withdrawal by Subject|3|||
33270551|NCT05260437|100891323|FG001|Overall Study|Withdrawal by Subject|0|||
33270552|NCT05260437|100891324|FG002|Overall Study|Withdrawal by Subject|4|||
33270553|NCT05260437|100891325|FG003|Overall Study|Withdrawal by Subject|5|||
33480355|NCT03207243|101651752|FG001|Overall Study|Lost to Follow-up|1|||
33480356|NCT03207243|101651751|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
33480357|NCT03207243|101651752|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
33270554|NCT05260437|100891326|FG004|Overall Study|Withdrawal by Subject|0|||
33270555|NCT05260437|100891322|FG000|Overall Study|Vaccine Not Administered|0|||
33270556|NCT05260437|100891323|FG001|Overall Study|Vaccine Not Administered|1|||
33270557|NCT05260437|100891324|FG002|Overall Study|Vaccine Not Administered|0|||
33270558|NCT05260437|100891325|FG003|Overall Study|Vaccine Not Administered|0|||
33270559|NCT05260437|100891326|FG004|Overall Study|Vaccine Not Administered|0|||
33270560|NCT02170207|100891327|FG000|Overall Study|Case report forms unavailable|5|||
33270561|NCT00687297|100891332|FG000|Randomization|Withdrawal by Subject|2|||
33270562|NCT00687297|100891333|FG001|Randomization|Withdrawal by Subject|0|||
33270563|NCT00687297|100891332|FG000|Randomization|Withdrew before treatment, ineligible|1|||
33270564|NCT00687297|100891333|FG001|Randomization|Withdrew before treatment, ineligible|1|||
33270565|NCT00687297|100891332|FG000|Induction|Withdrawal by Subject|4|||
33270566|NCT00687297|100891333|FG001|Induction|Withdrawal by Subject|4|||
33270567|NCT00687297|100891332|FG000|Induction|Adverse Event|16|||
33270568|NCT00687297|100891333|FG001|Induction|Adverse Event|15|||
33270569|NCT00687297|100891332|FG000|Induction|Death|7|||
33270570|NCT00687297|100891333|FG001|Induction|Death|11|||
33270571|NCT00687297|100891332|FG000|Induction|Lack of Efficacy|17|||
33270572|NCT00687297|100891333|FG001|Induction|Lack of Efficacy|21|||
33270573|NCT00687297|100891332|FG000|Induction|Ineligible|0|||
33270574|NCT00687297|100891333|FG001|Induction|Ineligible|1|||
33270575|NCT00687297|100891332|FG000|Induction|Patient Noncompliance|1|||
33270576|NCT00687297|100891333|FG001|Induction|Patient Noncompliance|0|||
33270577|NCT00687297|100891332|FG000|Induction|Physician Decision|0|||
33270578|NCT00687297|100891333|FG001|Induction|Physician Decision|2|||
33270579|NCT00687297|100891332|FG000|Induction|Other|0|||
33270580|NCT00687297|100891333|FG001|Induction|Other|1|||
33270581|NCT02203799|100891334|FG000|Overall Study|Withdrawal by Subject|3|||
33270582|NCT01029704|100891335|FG000|Overall Study|Adverse Event|0|||
33270583|NCT01029704|100891336|FG001|Overall Study|Adverse Event|0|||
33270584|NCT01029704|100891337|FG002|Overall Study|Adverse Event|0|||
33270585|NCT01029704|100891338|FG003|Overall Study|Adverse Event|0|||
33270586|NCT01029704|100891339|FG004|Overall Study|Adverse Event|0|||
33270587|NCT01029704|100891340|FG005|Overall Study|Adverse Event|0|||
33270588|NCT01029704|100891341|FG006|Overall Study|Adverse Event|1|||
33270589|NCT01029704|100891342|FG007|Overall Study|Adverse Event|1|||
33270590|NCT01029704|100891343|FG008|Overall Study|Adverse Event|0|||
33270591|NCT01029704|100891335|FG000|Overall Study|Withdrawal by Subject|0|||
33270592|NCT01029704|100891336|FG001|Overall Study|Withdrawal by Subject|0|||
33270593|NCT01029704|100891337|FG002|Overall Study|Withdrawal by Subject|0|||
33270594|NCT01029704|100891338|FG003|Overall Study|Withdrawal by Subject|0|||
33270595|NCT01029704|100891339|FG004|Overall Study|Withdrawal by Subject|2|||
33270596|NCT01029704|100891340|FG005|Overall Study|Withdrawal by Subject|1|||
33270597|NCT01029704|100891341|FG006|Overall Study|Withdrawal by Subject|1|||
33270598|NCT01029704|100891342|FG007|Overall Study|Withdrawal by Subject|1|||
33270599|NCT01029704|100891343|FG008|Overall Study|Withdrawal by Subject|0|||
33270600|NCT01029704|100891335|FG000|Overall Study|Lost to Follow-up|0|||
33270601|NCT01029704|100891336|FG001|Overall Study|Lost to Follow-up|0|||
33270602|NCT01029704|100891337|FG002|Overall Study|Lost to Follow-up|0|||
33270603|NCT01029704|100891338|FG003|Overall Study|Lost to Follow-up|0|||
33270604|NCT01029704|100891339|FG004|Overall Study|Lost to Follow-up|0|||
33270605|NCT01029704|100891340|FG005|Overall Study|Lost to Follow-up|0|||
33270606|NCT01029704|100891341|FG006|Overall Study|Lost to Follow-up|1|||
33270607|NCT01029704|100891342|FG007|Overall Study|Lost to Follow-up|1|||
33270608|NCT01029704|100891343|FG008|Overall Study|Lost to Follow-up|1|||
33270609|NCT01029704|100891335|FG000|Overall Study|Lack of Efficacy|0|||
33270610|NCT01029704|100891336|FG001|Overall Study|Lack of Efficacy|0|||
33270611|NCT01029704|100891337|FG002|Overall Study|Lack of Efficacy|0|||
33270612|NCT01029704|100891338|FG003|Overall Study|Lack of Efficacy|0|||
33270613|NCT01029704|100891339|FG004|Overall Study|Lack of Efficacy|2|||
33270614|NCT01029704|100891340|FG005|Overall Study|Lack of Efficacy|3|||
33270615|NCT01029704|100891341|FG006|Overall Study|Lack of Efficacy|1|||
33270616|NCT01029704|100891342|FG007|Overall Study|Lack of Efficacy|2|||
33270617|NCT01029704|100891343|FG008|Overall Study|Lack of Efficacy|0|||
33270618|NCT01029704|100891335|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
33270619|NCT01029704|100891336|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
33270620|NCT01029704|100891337|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
33270621|NCT01029704|100891338|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
33270622|NCT01029704|100891339|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
33270623|NCT01029704|100891340|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
33270624|NCT01029704|100891341|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
33270625|NCT01029704|100891342|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
33270626|NCT01029704|100891343|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
33270627|NCT00824850|100891344|FG000|Overall Study|Withdrawal by Subject|0|||
33270628|NCT00824850|100891345|FG001|Overall Study|Withdrawal by Subject|1|||
33270629|NCT01084772|100891346|FG000|Baseline|Withdrawal by Subject|7|||
33270630|NCT01084772|100891347|FG001|Baseline|Withdrawal by Subject|6|||
33270631|NCT01084772|100891346|FG000|3 Months|Death|1|||
33270632|NCT01084772|100891347|FG001|3 Months|Death|0|||
33270633|NCT01084772|100891346|FG000|3 Months|Study Termination|2|||
33270634|NCT01084772|100891347|FG001|3 Months|Study Termination|2|||
33270635|NCT01084772|100891346|FG000|1 Year|Withdrawal by Subject|0|||
33270636|NCT01084772|100891347|FG001|1 Year|Withdrawal by Subject|1|||
33270637|NCT01084772|100891346|FG000|1 Year|Lost to Follow-up|3|||
33270638|NCT01084772|100891347|FG001|1 Year|Lost to Follow-up|0|||
33270639|NCT01084772|100891346|FG000|1 Year|Study Termination|0|||
33270640|NCT01084772|100891347|FG001|1 Year|Study Termination|7|||
33270641|NCT01084772|100891346|FG000|2 Years|Withdrawal by Subject|1|||
33270642|NCT01084772|100891347|FG001|2 Years|Withdrawal by Subject|0|||
33270643|NCT01084772|100891346|FG000|2 Years|Lost to Follow-up|5|||
33270644|NCT01084772|100891347|FG001|2 Years|Lost to Follow-up|2|||
33270645|NCT01084772|100891346|FG000|2 Years|Study Termination|3|||
33270646|NCT01084772|100891347|FG001|2 Years|Study Termination|2|||
33270647|NCT01884571|100891355|FG000|Overall Study|Adverse Event|1|||
33270648|NCT01884571|100891355|FG000|Overall Study|Death|2|||
33270649|NCT01884571|100891355|FG000|Overall Study|Withdrawal by Subject|2|||
33270650|NCT01884571|100891355|FG000|Overall Study|Disease progression|3|||
33270651|NCT01836523|100891356|FG000|Overall Study|Adverse Event|15|||
33270652|NCT01836523|100891357|FG001|Overall Study|Adverse Event|41|||
33270653|NCT01836523|100891358|FG002|Overall Study|Adverse Event|49|||
33270654|NCT01836523|100891359|FG003|Overall Study|Adverse Event|14|||
33270655|NCT01836523|100891356|FG000|Overall Study|Protocol Violation|6|||
33270656|NCT01836523|100891357|FG001|Overall Study|Protocol Violation|3|||
33270657|NCT01836523|100891358|FG002|Overall Study|Protocol Violation|2|||
33270658|NCT01836523|100891359|FG003|Overall Study|Protocol Violation|4|||
33270659|NCT01836523|100891356|FG000|Overall Study|Met Withdrawal Criteria|13|||
33270660|NCT01836523|100891357|FG001|Overall Study|Met Withdrawal Criteria|13|||
33270661|NCT01836523|100891358|FG002|Overall Study|Met Withdrawal Criteria|21|||
33270662|NCT01836523|100891359|FG003|Overall Study|Met Withdrawal Criteria|27|||
33270663|NCT01836523|100891356|FG000|Overall Study|Unclassified|17|||
33270664|NCT01836523|100891357|FG001|Overall Study|Unclassified|28|||
33270665|NCT01836523|100891358|FG002|Overall Study|Unclassified|19|||
33270666|NCT01836523|100891359|FG003|Overall Study|Unclassified|29|||
33270667|NCT00786188|100891360|FG000|Overall Study|Adverse Event|3|||
33270668|NCT00786188|100891361|FG001|Overall Study|Adverse Event|1|||
33270669|NCT00786188|100891360|FG000|Overall Study|Withdrawal by Subject|2|||
33270670|NCT00786188|100891361|FG001|Overall Study|Withdrawal by Subject|0|||
33270671|NCT02372799|100891362|FG000|Treatment Period|Adverse Event|3|||
33270672|NCT02372799|100891363|FG001|Treatment Period|Adverse Event|10|||
33270673|NCT02372799|100891364|FG002|Treatment Period|Adverse Event|6|||
33270674|NCT02372799|100891362|FG000|Treatment Period|Insufficient therapeutic response|2|||
33270675|NCT02372799|100891363|FG001|Treatment Period|Insufficient therapeutic response|2|||
33270676|NCT02372799|100891364|FG002|Treatment Period|Insufficient therapeutic response|0|||
33270677|NCT02372799|100891362|FG000|Treatment Period|Withdrawal by Subject|10|||
33270678|NCT02372799|100891363|FG001|Treatment Period|Withdrawal by Subject|10|||
33270679|NCT02372799|100891364|FG002|Treatment Period|Withdrawal by Subject|2|||
33270680|NCT02372799|100891362|FG000|Treatment Period|Lost to Follow-up|11|||
33270681|NCT02372799|100891363|FG001|Treatment Period|Lost to Follow-up|5|||
33270682|NCT02372799|100891364|FG002|Treatment Period|Lost to Follow-up|3|||
33270683|NCT02372799|100891362|FG000|Treatment Period|Protocol Violation|3|||
33270684|NCT02372799|100891363|FG001|Treatment Period|Protocol Violation|0|||
33270685|NCT02372799|100891364|FG002|Treatment Period|Protocol Violation|0|||
33270686|NCT02372799|100891362|FG000|Treatment Period|Non-compliance with study drug|4|||
33270687|NCT02372799|100891363|FG001|Treatment Period|Non-compliance with study drug|4|||
33270688|NCT02372799|100891364|FG002|Treatment Period|Non-compliance with study drug|4|||
33270689|NCT02372799|100891362|FG000|Treatment Period|Miscellaneous Reasons|1|||
33270690|NCT02372799|100891363|FG001|Treatment Period|Miscellaneous Reasons|1|||
33270691|NCT02372799|100891364|FG002|Treatment Period|Miscellaneous Reasons|0|||
33270692|NCT02372799|100891362|FG000|Down-taper Period|Lost to Follow-up|1|||
33270693|NCT02372799|100891363|FG001|Down-taper Period|Lost to Follow-up|2|||
33270694|NCT02372799|100891364|FG002|Down-taper Period|Lost to Follow-up|2|||
33270695|NCT00551421|100891366|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
33270696|NCT03693989|100891367|FG000|Overall Study|Protocol Violation|3|||
33270697|NCT03693989|100891368|FG001|Overall Study|Protocol Violation|4|||
33270698|NCT03019289|100891370|FG000|Overall Study|Adverse Event|1|||
33270699|NCT03019289|100891371|FG001|Overall Study|Adverse Event|0|||
33270700|NCT03019289|100891372|FG002|Overall Study|Adverse Event|0|||
33270701|NCT03019289|100891373|FG003|Overall Study|Adverse Event|0|||
33270702|NCT03019289|100891374|FG004|Overall Study|Adverse Event|0|||
33270703|NCT03019289|100891375|FG005|Overall Study|Adverse Event|0|||
33270704|NCT03019289|100891376|FG006|Overall Study|Adverse Event|0|||
33270705|NCT03019289|100891377|FG007|Overall Study|Adverse Event|0|||
33270706|NCT03019289|100891378|FG008|Overall Study|Adverse Event|1|||
33270707|NCT03019289|100891370|FG000|Overall Study|Other|1|||
33270708|NCT03019289|100891371|FG001|Overall Study|Other|0|||
33270709|NCT03019289|100891372|FG002|Overall Study|Other|0|||
33270710|NCT03019289|100891373|FG003|Overall Study|Other|0|||
33270711|NCT03019289|100891374|FG004|Overall Study|Other|0|||
33270712|NCT03019289|100891375|FG005|Overall Study|Other|0|||
33270713|NCT03019289|100891376|FG006|Overall Study|Other|0|||
33270714|NCT03019289|100891377|FG007|Overall Study|Other|0|||
33270715|NCT03019289|100891378|FG008|Overall Study|Other|0|||
33270716|NCT03953079|100891379|FG000|Core Study|Withdrawal by Subject|1|||
33270717|NCT03953079|100891380|FG001|Core Study|Withdrawal by Subject|2|||
33270718|NCT03953079|100891381|FG002|Core Study|Withdrawal by Subject|1|||
33270719|NCT03953079|100891379|FG000|Core Study|COVID-19|0|||
33270720|NCT03953079|100891380|FG001|Core Study|COVID-19|1|||
33270721|NCT03953079|100891381|FG002|Core Study|COVID-19|0|||
33270722|NCT03953079|100891379|FG000|Core Study|Difficulties leaving the house|0|||
33270723|NCT03953079|100891380|FG001|Core Study|Difficulties leaving the house|1|||
33270724|NCT03953079|100891381|FG002|Core Study|Difficulties leaving the house|0|||
33270725|NCT03953079|100891379|FG000|Extension Study|Withdrawal by Subject|1|||
33270726|NCT03953079|100891380|FG001|Extension Study|Withdrawal by Subject|0|||
33270727|NCT03953079|100891381|FG002|Extension Study|Withdrawal by Subject|0|||
33270728|NCT03953079|100891379|FG000|Extension Study|Received Rescue Treatment|5|||
33270729|NCT03953079|100891380|FG001|Extension Study|Received Rescue Treatment|6|||
33270730|NCT03953079|100891381|FG002|Extension Study|Received Rescue Treatment|5|||
33270731|NCT00871715|100891383|FG000|Overall Study|Withdrawal by Subject|6|||
33270732|NCT00871715|100891384|FG001|Overall Study|Withdrawal by Subject|10|||
33270733|NCT00871715|100891385|FG002|Overall Study|Withdrawal by Subject|15|||
33270734|NCT00871715|100891383|FG000|Overall Study|Physician Decision|6|||
33270735|NCT00871715|100891384|FG001|Overall Study|Physician Decision|0|||
33270736|NCT00871715|100891385|FG002|Overall Study|Physician Decision|2|||
33270737|NCT00871715|100891383|FG000|Overall Study|Lost to Follow-up|3|||
33270738|NCT00871715|100891384|FG001|Overall Study|Lost to Follow-up|6|||
33270739|NCT00871715|100891385|FG002|Overall Study|Lost to Follow-up|9|||
33270740|NCT00768755|100891388|FG000|Phase 1|Death|6|||
33270741|NCT00768755|100891389|FG001|Phase 1|Death|0|||
33270742|NCT00768755|100891390|FG002|Phase 1|Death|0|||
33270743|NCT00768755|100891391|FG003|Phase 1|Death|0|||
33270744|NCT00768755|100891388|FG000|Phase 1|Other|4|||
33270745|NCT00768755|100891389|FG001|Phase 1|Other|0|||
33270746|NCT00768755|100891390|FG002|Phase 1|Other|0|||
33270747|NCT00768755|100891391|FG003|Phase 1|Other|0|||
33270748|NCT00768755|100891388|FG000|Phase 2|Death|0|||
33270749|NCT00768755|100891389|FG001|Phase 2|Death|37|||
33270750|NCT00768755|100891390|FG002|Phase 2|Death|48|||
33270751|NCT00768755|100891391|FG003|Phase 2|Death|31|||
33270752|NCT00768755|100891388|FG000|Phase 2|Protocol Violation|0|||
33270753|NCT00768755|100891389|FG001|Phase 2|Protocol Violation|2|||
33270754|NCT00768755|100891390|FG002|Phase 2|Protocol Violation|0|||
33270755|NCT00768755|100891391|FG003|Phase 2|Protocol Violation|1|||
33270756|NCT00768755|100891388|FG000|Phase 2|Lost to Follow-up|0|||
33270757|NCT00768755|100891389|FG001|Phase 2|Lost to Follow-up|1|||
33270758|NCT00768755|100891390|FG002|Phase 2|Lost to Follow-up|1|||
33270759|NCT00768755|100891391|FG003|Phase 2|Lost to Follow-up|4|||
33270760|NCT00768755|100891388|FG000|Phase 2|Withdrawal by Subject|0|||
33270761|NCT00768755|100891389|FG001|Phase 2|Withdrawal by Subject|1|||
33270762|NCT00768755|100891390|FG002|Phase 2|Withdrawal by Subject|0|||
33270763|NCT00768755|100891391|FG003|Phase 2|Withdrawal by Subject|1|||
33270764|NCT00768755|100891388|FG000|Phase 2|Other|0|||
33270765|NCT00768755|100891389|FG001|Phase 2|Other|1|||
33270766|NCT00768755|100891390|FG002|Phase 2|Other|2|||
33270767|NCT00768755|100891391|FG003|Phase 2|Other|4|||
33270768|NCT00768755|100891388|FG000|Phase 2|Study Terminated by Sponsor|0|||
33270769|NCT00768755|100891389|FG001|Phase 2|Study Terminated by Sponsor|13|||
33270770|NCT00768755|100891390|FG002|Phase 2|Study Terminated by Sponsor|7|||
33270771|NCT00768755|100891391|FG003|Phase 2|Study Terminated by Sponsor|14|||
33270772|NCT00768755|100891388|FG000|Phase 2|Randomized but not treated|0|||
33270773|NCT00768755|100891389|FG001|Phase 2|Randomized but not treated|0|||
33270774|NCT00768755|100891390|FG002|Phase 2|Randomized but not treated|0|||
33270775|NCT00768755|100891391|FG003|Phase 2|Randomized but not treated|2|||
33270776|NCT00754325|100891392|FG000|Initial Treatment|Continuing Active Treatment|4|||
33270777|NCT00754325|100891393|FG001|Initial Treatment|Continuing Active Treatment|5|||
33270778|NCT00754325|100891392|FG000|Initial Treatment|Adverse Event|7|||
33270779|NCT00754325|100891393|FG001|Initial Treatment|Adverse Event|6|||
33270780|NCT00754325|100891392|FG000|Initial Treatment|Withdrawal by Subject|2|||
33270781|NCT00754325|100891393|FG001|Initial Treatment|Withdrawal by Subject|2|||
33270782|NCT00754325|100891392|FG000|Initial Treatment|Physician Decision|2|||
33270783|NCT00754325|100891393|FG001|Initial Treatment|Physician Decision|0|||
33270784|NCT00754325|100891392|FG000|Initial Treatment|Sponsor Request|0|||
33270785|NCT00754325|100891393|FG001|Initial Treatment|Sponsor Request|1|||
33270786|NCT00754325|100891392|FG000|Initial Treatment|Disease Progression|35|||
33270787|NCT00754325|100891393|FG001|Initial Treatment|Disease Progression|35|||
33270788|NCT00638456|100891394|FG000|Overall Study|Withdrawal by Subject|6|||
33480358|NCT03207243|101651751|FG000|Overall Study|Protocol Violation|0|||
33480359|NCT03207243|101651752|FG001|Overall Study|Protocol Violation|3|||
33480360|NCT04159935|101651753|FG000|Overall Study|Study terminated due to COVID-19|1|||
33480361|NCT04159935|101651754|FG001|Overall Study|Study terminated due to COVID-19|3|||
33480362|NCT01119508|101651758|FG000|Overall Study|Adverse Event|56|||
33480363|NCT01119508|101651758|FG000|Overall Study|Withdrawal by Subject|2|||
33270789|NCT00638456|100891395|FG001|Overall Study|Withdrawal by Subject|2|||
33270790|NCT04633200|100891396|FG000|Overall Study|Lost to Follow-up|3|||
33270791|NCT04633200|100891397|FG001|Overall Study|Lost to Follow-up|5|||
33270792|NCT01549951|100891398|FG000|Overall Study|Adverse Event|15|||
33270793|NCT01549951|100891398|FG000|Overall Study|Withdrawal by Subject|2|||
33270794|NCT01549951|100891398|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
33270795|NCT01549951|100891398|FG000|Overall Study|Progressive disease|29|||
33270796|NCT01549951|100891398|FG000|Overall Study|Symptomatic deterioration|1|||
33270797|NCT01549951|100891398|FG000|Overall Study|Other|2|||
33270798|NCT02833948|100891399|FG000|Overall Study|Death|2|||
33270799|NCT02833948|100891400|FG001|Overall Study|Death|3|||
33270800|NCT02833948|100891399|FG000|Overall Study|were not scanned|8|||
33270801|NCT02833948|100891400|FG001|Overall Study|were not scanned|13|||
33270802|NCT02833948|100891399|FG000|Overall Study|scans could not be evaluated|5|||
33270803|NCT02833948|100891400|FG001|Overall Study|scans could not be evaluated|2|||
33270804|NCT02362789|100891401|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
33270805|NCT02362789|100891402|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
33270806|NCT02362789|100891403|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
33270807|NCT02362789|100891401|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
33270808|NCT02362789|100891402|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
33270809|NCT02362789|100891403|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
33270810|NCT02362789|100891401|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
33270811|NCT02362789|100891402|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
33270812|NCT02362789|100891403|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
33270813|NCT02362789|100891401|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
33270814|NCT02362789|100891402|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
33270815|NCT02362789|100891403|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
33270816|NCT02362789|100891401|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
33270817|NCT02362789|100891402|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
33270818|NCT02362789|100891403|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
33270819|NCT01065779|100891404|FG000|Overall Study|Duplicate Investigation|1|||
33270820|NCT01065779|100891404|FG000|Overall Study|Investigation Before Contract Date|37|||
33270821|NCT01065779|100891404|FG000|Overall Study|Non-enrollment Period Administration|10|||
33270822|NCT01065779|100891404|FG000|Overall Study|Not Administered With Study Drug|17|||
33270823|NCT01065779|100891404|FG000|Overall Study|Failed to Follow-up|10|||
33270824|NCT01065779|100891404|FG000|Overall Study|Inclusion Criteria Violation|7|||
33270825|NCT03695185|100891405|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
33270826|NCT03695185|100891405|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
33270827|NCT03695185|100891405|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
33270828|NCT03695185|100891405|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
33270829|NCT03695185|100891405|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
33270830|NCT03695185|100891405|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
33270831|NCT02002689|100891406|FG000|Overall Study|Disease Progression|7|||
33270832|NCT02002689|100891406|FG000|Overall Study|Adverse Event|3|||
33270833|NCT01109979|100891407|FG000|Overall Study|Physician Decision|2|||
33270834|NCT01109979|100891408|FG001|Overall Study|Physician Decision|0|||
33270835|NCT01109979|100891407|FG000|Overall Study|Withdrawal by Subject|0|||
33270836|NCT01109979|100891408|FG001|Overall Study|Withdrawal by Subject|1|||
33270837|NCT02006641|100891410|FG000|Overall Study|Withdrawal before treatment|2|||
33270838|NCT02006641|100891411|FG001|Overall Study|Withdrawal before treatment|5|||
33270839|NCT02006641|100891412|FG002|Overall Study|Withdrawal before treatment|3|||
33270840|NCT02006641|100891410|FG000|Overall Study|Adverse Event|15|||
33270841|NCT02006641|100891411|FG001|Overall Study|Adverse Event|11|||
33270842|NCT02006641|100891412|FG002|Overall Study|Adverse Event|15|||
33270843|NCT02006641|100891410|FG000|Overall Study|Protocol Violation|0|||
33270844|NCT02006641|100891411|FG001|Overall Study|Protocol Violation|2|||
33270845|NCT02006641|100891412|FG002|Overall Study|Protocol Violation|2|||
33270846|NCT02006641|100891410|FG000|Overall Study|Lost to Follow-up|0|||
33270847|NCT02006641|100891411|FG001|Overall Study|Lost to Follow-up|1|||
33270848|NCT02006641|100891412|FG002|Overall Study|Lost to Follow-up|0|||
33270849|NCT02006641|100891410|FG000|Overall Study|Withdrawal by Subject|7|||
33270850|NCT02006641|100891411|FG001|Overall Study|Withdrawal by Subject|12|||
33270851|NCT02006641|100891412|FG002|Overall Study|Withdrawal by Subject|11|||
33270852|NCT02006641|100891410|FG000|Overall Study|Other reason: patient didn't show up|1|||
33270853|NCT02006641|100891411|FG001|Overall Study|Other reason: patient didn't show up|0|||
33270854|NCT02006641|100891412|FG002|Overall Study|Other reason: patient didn't show up|0|||
33270855|NCT02006641|100891410|FG000|Overall Study|Other reason:patient didn't want to come|0|||
33270856|NCT02006641|100891411|FG001|Overall Study|Other reason:patient didn't want to come|0|||
33270857|NCT02006641|100891412|FG002|Overall Study|Other reason:patient didn't want to come|1|||
33270858|NCT02006641|100891410|FG000|Overall Study|Other reason: patient has moved|1|||
33270859|NCT02006641|100891411|FG001|Overall Study|Other reason: patient has moved|0|||
33270860|NCT02006641|100891412|FG002|Overall Study|Other reason: patient has moved|1|||
33270861|NCT02006641|100891410|FG000|Overall Study|Other reason: caregiver in hospital|0|||
33270862|NCT02006641|100891411|FG001|Overall Study|Other reason: caregiver in hospital|1|||
33270863|NCT02006641|100891412|FG002|Overall Study|Other reason: caregiver in hospital|0|||
33270864|NCT02006641|100891410|FG000|Overall Study|Other reason: patient's wife has died|0|||
33270865|NCT02006641|100891411|FG001|Overall Study|Other reason: patient's wife has died|0|||
33270866|NCT02006641|100891412|FG002|Overall Study|Other reason: patient's wife has died|1|||
33270867|NCT02006641|100891410|FG000|Overall Study|Other reason: hospitalisation|0|||
33270868|NCT02006641|100891411|FG001|Overall Study|Other reason: hospitalisation|1|||
33270869|NCT02006641|100891412|FG002|Overall Study|Other reason: hospitalisation|0|||
33270870|NCT02006641|100891410|FG000|Overall Study|Other reason: caregiver impossibility|0|||
33270871|NCT02006641|100891411|FG001|Overall Study|Other reason: caregiver impossibility|0|||
33270872|NCT02006641|100891412|FG002|Overall Study|Other reason: caregiver impossibility|1|||
33270873|NCT02006641|100891410|FG000|Overall Study|Other reason: protocol non-compliance|0|||
33270874|NCT02006641|100891411|FG001|Overall Study|Other reason: protocol non-compliance|0|||
33270875|NCT02006641|100891412|FG002|Overall Study|Other reason: protocol non-compliance|1|||
33270876|NCT03052517|100891413|FG000|Overall Study|Study Terminated By Sponsor|928|||
33270877|NCT03052517|100891414|FG001|Overall Study|Study Terminated By Sponsor|938|||
33270878|NCT03052517|100891415|FG002|Overall Study|Study Terminated By Sponsor|296|||
33270879|NCT03052517|100891413|FG000|Overall Study|Subject/Guardian Decision|50|||
33270880|NCT03052517|100891414|FG001|Overall Study|Subject/Guardian Decision|45|||
33270881|NCT03052517|100891415|FG002|Overall Study|Subject/Guardian Decision|22|||
33270882|NCT03052517|100891413|FG000|Overall Study|Lack of Efficacy|23|||
33270883|NCT03052517|100891414|FG001|Overall Study|Lack of Efficacy|14|||
33270884|NCT03052517|100891415|FG002|Overall Study|Lack of Efficacy|7|||
33270885|NCT03052517|100891413|FG000|Overall Study|Adverse Event|6|||
33270886|NCT03052517|100891414|FG001|Overall Study|Adverse Event|5|||
33270887|NCT03052517|100891415|FG002|Overall Study|Adverse Event|0|||
33270888|NCT03052517|100891413|FG000|Overall Study|Physician Decision|4|||
33270889|NCT03052517|100891414|FG001|Overall Study|Physician Decision|5|||
33270890|NCT03052517|100891415|FG002|Overall Study|Physician Decision|1|||
33270891|NCT03052517|100891413|FG000|Overall Study|Death|3|||
33270892|NCT03052517|100891414|FG001|Overall Study|Death|0|||
33270893|NCT03052517|100891415|FG002|Overall Study|Death|1|||
33270894|NCT03052517|100891413|FG000|Overall Study|Lost to Follow-up|2|||
33270895|NCT03052517|100891414|FG001|Overall Study|Lost to Follow-up|4|||
33270896|NCT03052517|100891415|FG002|Overall Study|Lost to Follow-up|0|||
33270897|NCT03052517|100891413|FG000|Overall Study|Pregnancy|1|||
33270898|NCT03052517|100891414|FG001|Overall Study|Pregnancy|0|||
33270899|NCT03052517|100891415|FG002|Overall Study|Pregnancy|1|||
33270900|NCT03052517|100891413|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
33270901|NCT03052517|100891414|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
33270902|NCT03052517|100891415|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
33270903|NCT03052517|100891413|FG000|Overall Study|Technical Problems|0|||
33270904|NCT03052517|100891414|FG001|Overall Study|Technical Problems|1|||
33270905|NCT03052517|100891415|FG002|Overall Study|Technical Problems|0|||
33270906|NCT01256359|100891420|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
33270907|NCT01256359|100891421|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
33270908|NCT01256359|100891420|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
33270909|NCT01256359|100891421|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
33270910|NCT00321672|100891422|FG000|Overall Study|Withdrawal by Subject|5|||
33270911|NCT00321672|100891423|FG001|Overall Study|Withdrawal by Subject|1|||
33270912|NCT00321672|100891424|FG002|Overall Study|Withdrawal by Subject|2|||
33270913|NCT00321672|100891425|FG003|Overall Study|Withdrawal by Subject|0|||
33270914|NCT00321672|100891422|FG000|Overall Study|Noncompliance|1|||
33270915|NCT00321672|100891423|FG001|Overall Study|Noncompliance|2|||
33270916|NCT00321672|100891424|FG002|Overall Study|Noncompliance|1|||
33270917|NCT00321672|100891425|FG003|Overall Study|Noncompliance|0|||
33270918|NCT00321672|100891422|FG000|Overall Study|Adverse Event|1|||
33270919|NCT00321672|100891423|FG001|Overall Study|Adverse Event|1|||
33270920|NCT00321672|100891424|FG002|Overall Study|Adverse Event|0|||
33270921|NCT00321672|100891425|FG003|Overall Study|Adverse Event|0|||
33270922|NCT00321672|100891422|FG000|Overall Study|Lack of Efficacy|1|||
33270923|NCT00321672|100891423|FG001|Overall Study|Lack of Efficacy|1|||
33270924|NCT00321672|100891424|FG002|Overall Study|Lack of Efficacy|0|||
33270925|NCT00321672|100891425|FG003|Overall Study|Lack of Efficacy|0|||
33270926|NCT00321672|100891422|FG000|Overall Study|Lost to Follow-up|2|||
33270927|NCT00321672|100891423|FG001|Overall Study|Lost to Follow-up|0|||
33270928|NCT00321672|100891424|FG002|Overall Study|Lost to Follow-up|4|||
33270929|NCT00321672|100891425|FG003|Overall Study|Lost to Follow-up|2|||
33480364|NCT01119508|101651758|FG000|Overall Study|Died before tumor response evaluation|1|||
33480365|NCT00849186|101651762|FG000|Overall Study|Adverse Event|2|||
33480366|NCT00849186|101651762|FG000|Overall Study|Withdrawal by Subject|1|||
33480367|NCT00849186|101651762|FG000|Overall Study|not treated|6|||
33480368|NCT00849186|101651762|FG000|Overall Study|Other|1|||
33270930|NCT00321672|100891422|FG000|Overall Study|Death|1|||
33270931|NCT00321672|100891423|FG001|Overall Study|Death|0|||
33270932|NCT00321672|100891424|FG002|Overall Study|Death|0|||
33270933|NCT00321672|100891425|FG003|Overall Study|Death|0|||
33270934|NCT00321672|100891422|FG000|Overall Study|Too far to travel for visits|1|||
33270935|NCT00321672|100891423|FG001|Overall Study|Too far to travel for visits|0|||
33270936|NCT00321672|100891424|FG002|Overall Study|Too far to travel for visits|0|||
33270937|NCT00321672|100891425|FG003|Overall Study|Too far to travel for visits|0|||
33270938|NCT00321672|100891422|FG000|Overall Study|Incarcerated|0|||
33270939|NCT00321672|100891423|FG001|Overall Study|Incarcerated|0|||
33270940|NCT00321672|100891424|FG002|Overall Study|Incarcerated|2|||
33270941|NCT00321672|100891425|FG003|Overall Study|Incarcerated|0|||
33270942|NCT00321672|100891422|FG000|Overall Study|Moved out of state|0|||
33480369|NCT03839823|101651763|FG000|Overall Study|Adverse Event|8|||
33270943|NCT00321672|100891423|FG001|Overall Study|Moved out of state|1|||
33270944|NCT00321672|100891424|FG002|Overall Study|Moved out of state|1|||
33270945|NCT00321672|100891425|FG003|Overall Study|Moved out of state|0|||
33270946|NCT00321672|100891422|FG000|Overall Study|Protocol Violation|0|||
33270947|NCT00321672|100891423|FG001|Overall Study|Protocol Violation|0|||
33270948|NCT00321672|100891424|FG002|Overall Study|Protocol Violation|1|||
33270949|NCT00321672|100891425|FG003|Overall Study|Protocol Violation|0|||
33270950|NCT00321672|100891422|FG000|Overall Study|Diagnosis of testicular cancer|0|||
33270951|NCT00321672|100891423|FG001|Overall Study|Diagnosis of testicular cancer|1|||
33270952|NCT00321672|100891424|FG002|Overall Study|Diagnosis of testicular cancer|0|||
33270953|NCT00321672|100891425|FG003|Overall Study|Diagnosis of testicular cancer|0|||
33270954|NCT00321672|100891422|FG000|Overall Study|Extensive travel required for new job|0|||
33270955|NCT00321672|100891423|FG001|Overall Study|Extensive travel required for new job|1|||
33270956|NCT00321672|100891424|FG002|Overall Study|Extensive travel required for new job|0|||
33270957|NCT00321672|100891425|FG003|Overall Study|Extensive travel required for new job|0|||
33270958|NCT02138838|100891428|FG000|Overall Study|Study Closure|7|||
33270959|NCT02138838|100891429|FG001|Overall Study|Study Closure|6|||
33270960|NCT02138838|100891428|FG000|Overall Study|Withdrawal by Subject|1|||
33270961|NCT02138838|100891429|FG001|Overall Study|Withdrawal by Subject|5|||
33270962|NCT03006393|100891432|FG000|Overall Study|Withdrawal by Subject|1|||
33270963|NCT03006393|100891433|FG001|Overall Study|Withdrawal by Subject|1|||
33270964|NCT03006393|100891432|FG000|Overall Study|Pregnancy|0|||
33270965|NCT03006393|100891433|FG001|Overall Study|Pregnancy|1|||
33270966|NCT03006393|100891432|FG000|Overall Study|Lost to Follow-up|0|||
33270967|NCT03006393|100891433|FG001|Overall Study|Lost to Follow-up|1|||
33270968|NCT01428583|100891438|FG000|Overall Study|Adverse Event|75|||
33270969|NCT01428583|100891438|FG000|Overall Study|Withdrawal by Subject|51|||
33270970|NCT01428583|100891438|FG000|Overall Study|Lack of Efficacy|37|||
33270971|NCT01428583|100891438|FG000|Overall Study|Lost to Follow-up|17|||
33270972|NCT01428583|100891438|FG000|Overall Study|Death|1|||
33270973|NCT01428583|100891438|FG000|Overall Study|Pregnancy|1|||
33270974|NCT01428583|100891438|FG000|Overall Study|Protocol Violation|1|||
33270975|NCT01428583|100891438|FG000|Overall Study|Physician Decision|12|||
33270976|NCT01428583|100891438|FG000|Overall Study|Non-compliant|25|||
33270977|NCT01428583|100891438|FG000|Overall Study|Confirmed positive urine drug test|8|||
33270978|NCT01428583|100891438|FG000|Overall Study|Sponsor's request|3|||
33270979|NCT01428583|100891438|FG000|Overall Study|Other|6|||
33270980|NCT00929526|100891439|FG000|Overall Study|Withdrawal by Subject|1|||
33270981|NCT00929526|100891440|FG001|Overall Study|Withdrawal by Subject|11|||
33270982|NCT00929526|100891439|FG000|Overall Study|Lost to Follow-up|8|||
33270983|NCT00929526|100891440|FG001|Overall Study|Lost to Follow-up|12|||
33270984|NCT00929526|100891439|FG000|Overall Study|Other|8|||
33270985|NCT00929526|100891440|FG001|Overall Study|Other|6|||
33270986|NCT02077374|100891441|FG000|Overall Study|Withdrawal by Subject|0|||
33270987|NCT02077374|100891442|FG001|Overall Study|Withdrawal by Subject|1|||
33270988|NCT02077374|100891441|FG000|Overall Study|Protocol Violation|0|||
33270989|NCT02077374|100891442|FG001|Overall Study|Protocol Violation|1|||
33270990|NCT00985088|100891445|FG000|Overall Study|Serious Adverse Event|1|||
33270991|NCT00985088|100891446|FG001|Overall Study|Serious Adverse Event|1|||
33270992|NCT00985088|100891447|FG002|Overall Study|Serious Adverse Event|0|||
33270993|NCT00985088|100891448|FG003|Overall Study|Serious Adverse Event|0|||
33270994|NCT00985088|100891449|FG004|Overall Study|Serious Adverse Event|0|||
33270995|NCT00985088|100891450|FG005|Overall Study|Serious Adverse Event|0|||
33270996|NCT00985088|100891451|FG006|Overall Study|Serious Adverse Event|0|||
33270997|NCT00985088|100891452|FG007|Overall Study|Serious Adverse Event|1|||
33270998|NCT00985088|100891445|FG000|Overall Study|Adverse Event|0|||
33270999|NCT00985088|100891446|FG001|Overall Study|Adverse Event|0|||
33271000|NCT00985088|100891447|FG002|Overall Study|Adverse Event|1|||
33271001|NCT00985088|100891448|FG003|Overall Study|Adverse Event|0|||
33271002|NCT00985088|100891449|FG004|Overall Study|Adverse Event|0|||
33271003|NCT00985088|100891450|FG005|Overall Study|Adverse Event|0|||
33271004|NCT00985088|100891451|FG006|Overall Study|Adverse Event|0|||
33271005|NCT00985088|100891452|FG007|Overall Study|Adverse Event|0|||
33271006|NCT00985088|100891445|FG000|Overall Study|Withdrawal by Subject|4|||
33271007|NCT00985088|100891446|FG001|Overall Study|Withdrawal by Subject|0|||
33271008|NCT00985088|100891447|FG002|Overall Study|Withdrawal by Subject|0|||
33271009|NCT00985088|100891448|FG003|Overall Study|Withdrawal by Subject|1|||
33271010|NCT00985088|100891449|FG004|Overall Study|Withdrawal by Subject|3|||
33271011|NCT00985088|100891450|FG005|Overall Study|Withdrawal by Subject|2|||
33271012|NCT00985088|100891451|FG006|Overall Study|Withdrawal by Subject|1|||
33271013|NCT00985088|100891452|FG007|Overall Study|Withdrawal by Subject|2|||
33271014|NCT00985088|100891445|FG000|Overall Study|Migrated/moved from study area|0|||
33271015|NCT00985088|100891446|FG001|Overall Study|Migrated/moved from study area|0|||
33271016|NCT00985088|100891447|FG002|Overall Study|Migrated/moved from study area|1|||
33271017|NCT00985088|100891448|FG003|Overall Study|Migrated/moved from study area|0|||
33271018|NCT00985088|100891449|FG004|Overall Study|Migrated/moved from study area|0|||
33271019|NCT00985088|100891450|FG005|Overall Study|Migrated/moved from study area|0|||
33271020|NCT00985088|100891451|FG006|Overall Study|Migrated/moved from study area|0|||
33271021|NCT00985088|100891452|FG007|Overall Study|Migrated/moved from study area|1|||
33271022|NCT00985088|100891445|FG000|Overall Study|Lost to Follow-up|6|||
33271023|NCT00985088|100891446|FG001|Overall Study|Lost to Follow-up|1|||
33271024|NCT00985088|100891447|FG002|Overall Study|Lost to Follow-up|2|||
33271025|NCT00985088|100891448|FG003|Overall Study|Lost to Follow-up|6|||
33271026|NCT00985088|100891449|FG004|Overall Study|Lost to Follow-up|6|||
33271027|NCT00985088|100891450|FG005|Overall Study|Lost to Follow-up|5|||
33271028|NCT00985088|100891451|FG006|Overall Study|Lost to Follow-up|3|||
33271029|NCT00985088|100891452|FG007|Overall Study|Lost to Follow-up|2|||
33271030|NCT00489554|100891453|FG000|Overall Study|Adverse Event|2|||
33271031|NCT00489554|100891453|FG000|Overall Study|Withdrawal by Subject|1|||
33271032|NCT00489554|100891453|FG000|Overall Study|Lost to Follow-up|1|||
33271033|NCT02009332|100891454|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
33271034|NCT02009332|100891455|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
33271035|NCT02009332|100891456|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
33271036|NCT02009332|100891457|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
33271037|NCT02009332|100891458|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
33271038|NCT02009332|100891459|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
33271039|NCT02009332|100891454|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
33271040|NCT02009332|100891455|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
33271041|NCT02009332|100891456|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
33271042|NCT02009332|100891457|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
33271043|NCT02009332|100891458|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
33271044|NCT02009332|100891459|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
33271045|NCT02009332|100891454|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
33271046|NCT02009332|100891455|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
33271047|NCT02009332|100891456|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
33271048|NCT02009332|100891457|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
33271049|NCT02009332|100891458|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
33271050|NCT02009332|100891459|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
33271051|NCT03541369|100891468|FG000|Overall Study|Death|0|||
33271052|NCT03541369|100891469|FG001|Overall Study|Death|0|||
33271053|NCT03541369|100891470|FG002|Overall Study|Death|0|||
33271054|NCT03541369|100891471|FG003|Overall Study|Death|0|||
33271055|NCT03541369|100891472|FG004|Overall Study|Death|1|||
33271056|NCT03541369|100891473|FG005|Overall Study|Death|1|||
33271057|NCT03541369|100891474|FG006|Overall Study|Death|0|||
33271058|NCT03541369|100891475|FG007|Overall Study|Death|2|||
33271059|NCT03541369|100891476|FG008|Overall Study|Death|1|||
33271060|NCT03541369|100891477|FG009|Overall Study|Death|2|||
33271061|NCT03541369|100891478|FG010|Overall Study|Death|1|||
33271062|NCT03541369|100891479|FG011|Overall Study|Death|0|||
33271063|NCT03541369|100891480|FG012|Overall Study|Death|2|||
33271064|NCT03541369|100891481|FG013|Overall Study|Death|1|||
33271065|NCT03541369|100891482|FG014|Overall Study|Death|1|||
33271066|NCT03541369|100891483|FG015|Overall Study|Death|1|||
33271067|NCT03541369|100891484|FG016|Overall Study|Death|0|||
33271068|NCT03541369|100891485|FG017|Overall Study|Death|1|||
33271069|NCT03541369|100891468|FG000|Overall Study|Decision by sponsor|0|||
33271070|NCT03541369|100891469|FG001|Overall Study|Decision by sponsor|0|||
33271071|NCT03541369|100891470|FG002|Overall Study|Decision by sponsor|0|||
33271072|NCT03541369|100891471|FG003|Overall Study|Decision by sponsor|1|||
33271073|NCT03541369|100891472|FG004|Overall Study|Decision by sponsor|0|||
33271074|NCT03541369|100891473|FG005|Overall Study|Decision by sponsor|2|||
33271075|NCT03541369|100891474|FG006|Overall Study|Decision by sponsor|0|||
33271076|NCT03541369|100891475|FG007|Overall Study|Decision by sponsor|1|||
33271077|NCT03541369|100891476|FG008|Overall Study|Decision by sponsor|2|||
33271078|NCT03541369|100891477|FG009|Overall Study|Decision by sponsor|0|||
33271079|NCT03541369|100891478|FG010|Overall Study|Decision by sponsor|0|||
33271080|NCT03541369|100891479|FG011|Overall Study|Decision by sponsor|0|||
33271081|NCT03541369|100891480|FG012|Overall Study|Decision by sponsor|2|||
33271082|NCT03541369|100891481|FG013|Overall Study|Decision by sponsor|2|||
33271083|NCT03541369|100891482|FG014|Overall Study|Decision by sponsor|0|||
33271084|NCT03541369|100891483|FG015|Overall Study|Decision by sponsor|1|||
33271085|NCT03541369|100891484|FG016|Overall Study|Decision by sponsor|1|||
33271086|NCT03541369|100891485|FG017|Overall Study|Decision by sponsor|1|||
33271087|NCT03541369|100891468|FG000|Overall Study|Withdrawal by Subject|0|||
33271088|NCT03541369|100891469|FG001|Overall Study|Withdrawal by Subject|0|||
33271089|NCT03541369|100891470|FG002|Overall Study|Withdrawal by Subject|0|||
33480370|NCT03839823|101651764|FG001|Overall Study|Adverse Event|4|||
33271090|NCT03541369|100891471|FG003|Overall Study|Withdrawal by Subject|0|||
33271091|NCT03541369|100891472|FG004|Overall Study|Withdrawal by Subject|0|||
33271092|NCT03541369|100891473|FG005|Overall Study|Withdrawal by Subject|0|||
33271093|NCT03541369|100891474|FG006|Overall Study|Withdrawal by Subject|1|||
33271094|NCT03541369|100891475|FG007|Overall Study|Withdrawal by Subject|0|||
33271095|NCT03541369|100891476|FG008|Overall Study|Withdrawal by Subject|0|||
33480371|NCT03839823|101651763|FG000|Overall Study|Death|1|||
33271096|NCT03541369|100891477|FG009|Overall Study|Withdrawal by Subject|0|||
33271097|NCT03541369|100891478|FG010|Overall Study|Withdrawal by Subject|0|||
33271098|NCT03541369|100891479|FG011|Overall Study|Withdrawal by Subject|1|||
33271099|NCT03541369|100891480|FG012|Overall Study|Withdrawal by Subject|0|||
33271100|NCT03541369|100891481|FG013|Overall Study|Withdrawal by Subject|0|||
33271101|NCT03541369|100891482|FG014|Overall Study|Withdrawal by Subject|3|||
33271102|NCT03541369|100891483|FG015|Overall Study|Withdrawal by Subject|0|||
33271103|NCT03541369|100891484|FG016|Overall Study|Withdrawal by Subject|4|||
33271104|NCT03541369|100891485|FG017|Overall Study|Withdrawal by Subject|2|||
33271105|NCT03541369|100891468|FG000|Overall Study|Lost to Follow-up|0|||
33271106|NCT03541369|100891469|FG001|Overall Study|Lost to Follow-up|0|||
33271107|NCT03541369|100891470|FG002|Overall Study|Lost to Follow-up|0|||
33271108|NCT03541369|100891471|FG003|Overall Study|Lost to Follow-up|0|||
33271109|NCT03541369|100891472|FG004|Overall Study|Lost to Follow-up|1|||
33271110|NCT03541369|100891473|FG005|Overall Study|Lost to Follow-up|0|||
33271111|NCT03541369|100891474|FG006|Overall Study|Lost to Follow-up|0|||
33271112|NCT03541369|100891475|FG007|Overall Study|Lost to Follow-up|0|||
33271113|NCT03541369|100891476|FG008|Overall Study|Lost to Follow-up|1|||
33271114|NCT03541369|100891477|FG009|Overall Study|Lost to Follow-up|0|||
33271115|NCT03541369|100891478|FG010|Overall Study|Lost to Follow-up|0|||
33271116|NCT03541369|100891479|FG011|Overall Study|Lost to Follow-up|0|||
33271117|NCT03541369|100891480|FG012|Overall Study|Lost to Follow-up|1|||
33271118|NCT03541369|100891481|FG013|Overall Study|Lost to Follow-up|0|||
33271119|NCT03541369|100891482|FG014|Overall Study|Lost to Follow-up|0|||
33271120|NCT03541369|100891483|FG015|Overall Study|Lost to Follow-up|0|||
33271121|NCT03541369|100891484|FG016|Overall Study|Lost to Follow-up|0|||
33271122|NCT03541369|100891485|FG017|Overall Study|Lost to Follow-up|0|||
33271123|NCT01019135|100891486|FG000|Overall Study|Did not receive allocated intervention|12|||
33271124|NCT01019135|100891487|FG001|Overall Study|Did not receive allocated intervention|6|||
33271125|NCT01019135|100891488|FG002|Overall Study|Did not receive allocated intervention|25|||
33271126|NCT01019135|100891486|FG000|Overall Study|Did not attend CR|8|||
33271127|NCT01019135|100891487|FG001|Overall Study|Did not attend CR|13|||
33271128|NCT01019135|100891488|FG002|Overall Study|Did not attend CR|6|||
33271129|NCT03560206|100891489|FG000|Overall Study|Lost to Follow-up|19|||
33271130|NCT03560206|100891490|FG001|Overall Study|Lost to Follow-up|11|||
33271131|NCT03560206|100891489|FG000|Overall Study|Withdrawal by Subject|2|||
33271132|NCT03560206|100891490|FG001|Overall Study|Withdrawal by Subject|4|||
33271133|NCT03560206|100891489|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
33271134|NCT03560206|100891490|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
33271135|NCT03560206|100891489|FG000|Overall Study|Busy schedule|14|||
33271136|NCT03560206|100891490|FG001|Overall Study|Busy schedule|2|||
33271137|NCT03560206|100891489|FG000|Overall Study|patients' new health condition such as cancer|10|||
33271138|NCT03560206|100891490|FG001|Overall Study|patients' new health condition such as cancer|1|||
33271139|NCT00487240|100891491|FG000|Overall Study|Withdrawal by Subject|12|||
33271140|NCT00487240|100891492|FG001|Overall Study|Withdrawal by Subject|6|||
33271141|NCT00487240|100891491|FG000|Overall Study|Lost to Follow-up|7|||
33271142|NCT00487240|100891492|FG001|Overall Study|Lost to Follow-up|6|||
33271143|NCT00487240|100891491|FG000|Overall Study|Adverse Event|0|||
33271144|NCT00487240|100891492|FG001|Overall Study|Adverse Event|4|||
33271145|NCT00487240|100891491|FG000|Overall Study|Protocol Violation|5|||
33271146|NCT00487240|100891492|FG001|Overall Study|Protocol Violation|5|||
33271147|NCT00487240|100891491|FG000|Overall Study|Entry Criteria Not Met|3|||
33271148|NCT00487240|100891492|FG001|Overall Study|Entry Criteria Not Met|4|||
33271149|NCT00487240|100891491|FG000|Overall Study|Sponsor Decision|2|||
33271150|NCT00487240|100891492|FG001|Overall Study|Sponsor Decision|1|||
33271151|NCT00487240|100891491|FG000|Overall Study|Physician Decision|2|||
33271152|NCT00487240|100891492|FG001|Overall Study|Physician Decision|0|||
33271153|NCT01115309|100891493|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
33271154|NCT01115309|100891493|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
33271155|NCT01115309|100891493|FG000|Long-term Follow-up|Lost to Follow-up|6|||
33271156|NCT01480258|100891494|FG000|Infant Series|Protocol Violation|2|||
33271157|NCT01480258|100891495|FG001|Infant Series|Protocol Violation|0|||
33271158|NCT01480258|100891494|FG000|Infant Series|Physician Decision|0|||
33271159|NCT01480258|100891495|FG001|Infant Series|Physician Decision|1|||
33271160|NCT01480258|100891494|FG000|Infant Series|Not Vaccinated|3|||
33271161|NCT01480258|100891495|FG001|Infant Series|Not Vaccinated|0|||
33271162|NCT01480258|100891494|FG000|Infant Series|Adverse Event|1|||
33271163|NCT01480258|100891495|FG001|Infant Series|Adverse Event|1|||
33271164|NCT01480258|100891494|FG000|Infant Series|Withdrawal by Subject|1|||
33271165|NCT01480258|100891495|FG001|Infant Series|Withdrawal by Subject|6|||
33271166|NCT01480258|100891494|FG000|Interim Period|Lost to Follow-up|0|||
33271167|NCT01480258|100891495|FG001|Interim Period|Lost to Follow-up|2|||
33271168|NCT01480258|100891494|FG000|Interim Period|Physician Decision|1|||
33271169|NCT01480258|100891495|FG001|Interim Period|Physician Decision|0|||
33271170|NCT01480258|100891494|FG000|Interim Period|Protocol Violation|0|||
33271171|NCT01480258|100891495|FG001|Interim Period|Protocol Violation|1|||
33271172|NCT01480258|100891494|FG000|Interim Period|Withdrawal by Subject|9|||
33271173|NCT01480258|100891495|FG001|Interim Period|Withdrawal by Subject|6|||
33271174|NCT02196259|100891496|FG000|Overall Study|Researcher choice|0|||
33271175|NCT02196259|100891497|FG001|Overall Study|Researcher choice|0|||
33271176|NCT02196259|100891498|FG002|Overall Study|Researcher choice|1|||
33271177|NCT02196259|100891496|FG000|Overall Study|Partial data analysis|0|||
33271178|NCT02196259|100891497|FG001|Overall Study|Partial data analysis|3|||
33271179|NCT02196259|100891498|FG002|Overall Study|Partial data analysis|0|||
33271180|NCT02058992|100891500|FG000|Overall Study|Lost to Follow-up|4|||
33271181|NCT02058992|100891500|FG000|Overall Study|Protocol Violation|92|||
33271182|NCT02058992|100891500|FG000|Overall Study|CRF Uncollected|20|||
33271183|NCT02066636|100891501|FG000|Overall Study|Disease progression|51|||
33271184|NCT02066636|100891502|FG001|Overall Study|Disease progression|60|||
33271185|NCT02066636|100891503|FG002|Overall Study|Disease progression|700|||
33271186|NCT02066636|100891501|FG000|Overall Study|Study drug toxicity|13|||
33271187|NCT02066636|100891502|FG001|Overall Study|Study drug toxicity|2|||
33271188|NCT02066636|100891503|FG002|Overall Study|Study drug toxicity|58|||
33271189|NCT02066636|100891501|FG000|Overall Study|Death|4|||
33271190|NCT02066636|100891502|FG001|Overall Study|Death|2|||
33271191|NCT02066636|100891503|FG002|Overall Study|Death|158|||
33271192|NCT02066636|100891501|FG000|Overall Study|Adverse event unrelated to study drug|6|||
33271193|NCT02066636|100891502|FG001|Overall Study|Adverse event unrelated to study drug|4|||
33271194|NCT02066636|100891503|FG002|Overall Study|Adverse event unrelated to study drug|45|||
33271195|NCT02066636|100891501|FG000|Overall Study|Participant request to discontinue treatment|12|||
33271196|NCT02066636|100891502|FG001|Overall Study|Participant request to discontinue treatment|12|||
33271197|NCT02066636|100891503|FG002|Overall Study|Participant request to discontinue treatment|70|||
33271198|NCT02066636|100891501|FG000|Overall Study|Participant withdrew consent|10|||
33271199|NCT02066636|100891502|FG001|Overall Study|Participant withdrew consent|18|||
33271200|NCT02066636|100891503|FG002|Overall Study|Participant withdrew consent|61|||
33271201|NCT02066636|100891501|FG000|Overall Study|Lost to Follow-up|0|||
33271202|NCT02066636|100891502|FG001|Overall Study|Lost to Follow-up|2|||
33271203|NCT02066636|100891503|FG002|Overall Study|Lost to Follow-up|2|||
33271204|NCT02066636|100891501|FG000|Overall Study|Maximum clinical benefit|2|||
33271205|NCT02066636|100891502|FG001|Overall Study|Maximum clinical benefit|2|||
33271206|NCT02066636|100891503|FG002|Overall Study|Maximum clinical benefit|3|||
33271207|NCT02066636|100891501|FG000|Overall Study|Poor/non-compliance|2|||
33271208|NCT02066636|100891502|FG001|Overall Study|Poor/non-compliance|1|||
33271209|NCT02066636|100891503|FG002|Overall Study|Poor/non-compliance|1|||
33271210|NCT02066636|100891501|FG000|Overall Study|Participant no loner meets study criteria|3|||
33271211|NCT02066636|100891502|FG001|Overall Study|Participant no loner meets study criteria|2|||
33271212|NCT02066636|100891503|FG002|Overall Study|Participant no loner meets study criteria|28|||
33271213|NCT02066636|100891501|FG000|Overall Study|Administrative reasons by sponsor|8|||
33271214|NCT02066636|100891502|FG001|Overall Study|Administrative reasons by sponsor|5|||
33271215|NCT02066636|100891503|FG002|Overall Study|Administrative reasons by sponsor|0|||
33271216|NCT02066636|100891501|FG000|Overall Study|Other reasons|16|||
33271217|NCT02066636|100891502|FG001|Overall Study|Other reasons|15|||
33271218|NCT02066636|100891503|FG002|Overall Study|Other reasons|50|||
33271219|NCT00721734|100891508|FG000|Overall Study|Progressive Disease|3|||
33271220|NCT00721734|100891509|FG001|Overall Study|Progressive Disease|10|||
33271221|NCT00721734|100891510|FG002|Overall Study|Progressive Disease|4|||
33271222|NCT00721734|100891511|FG003|Overall Study|Progressive Disease|5|||
33271223|NCT00721734|100891512|FG004|Overall Study|Progressive Disease|2|||
33271224|NCT00721734|100891508|FG000|Overall Study|Adverse Event|3|||
33271225|NCT00721734|100891509|FG001|Overall Study|Adverse Event|1|||
33271226|NCT00721734|100891510|FG002|Overall Study|Adverse Event|4|||
33271227|NCT00721734|100891511|FG003|Overall Study|Adverse Event|0|||
33271228|NCT00721734|100891512|FG004|Overall Study|Adverse Event|3|||
33271229|NCT00721734|100891508|FG000|Overall Study|Withdrawal by Subject|2|||
33271230|NCT00721734|100891509|FG001|Overall Study|Withdrawal by Subject|1|||
33271231|NCT00721734|100891510|FG002|Overall Study|Withdrawal by Subject|0|||
33271232|NCT00721734|100891511|FG003|Overall Study|Withdrawal by Subject|0|||
33271233|NCT00721734|100891512|FG004|Overall Study|Withdrawal by Subject|1|||
33271234|NCT00721734|100891508|FG000|Overall Study|Other|0|||
33271235|NCT00721734|100891509|FG001|Overall Study|Other|0|||
33271236|NCT00721734|100891510|FG002|Overall Study|Other|0|||
33271237|NCT00721734|100891511|FG003|Overall Study|Other|1|||
33271238|NCT00721734|100891512|FG004|Overall Study|Other|0|||
33271239|NCT02706483|100891518|FG000|Overall Study|Adverse Event|97|||
33271240|NCT02706483|100891518|FG000|Overall Study|Death|1|||
33271241|NCT02706483|100891518|FG000|Overall Study|Lack of Efficacy|39|||
33271242|NCT02706483|100891518|FG000|Overall Study|Lost to Follow-up|101|||
33271243|NCT02706483|100891518|FG000|Overall Study|Non-compliance with study drug|15|||
33271244|NCT02706483|100891518|FG000|Overall Study|Physician Decision|6|||
33271245|NCT02706483|100891518|FG000|Overall Study|Pregnancy|6|||
33271246|NCT02706483|100891518|FG000|Overall Study|Protocol Violation|18|||
33271247|NCT02706483|100891518|FG000|Overall Study|Withdrawal by Subject|136|||
33271248|NCT02706483|100891518|FG000|Overall Study|Non-compliance with visits|6|||
33271249|NCT02706483|100891518|FG000|Overall Study|Site closure|4|||
33271250|NCT02706483|100891518|FG000|Overall Study|Subject moved|1|||
33271251|NCT00696241|100891520|FG000|Overall Study|Adverse Event|11|||
33271252|NCT00696241|100891521|FG001|Overall Study|Adverse Event|3|||
33271253|NCT00696241|100891522|FG002|Overall Study|Adverse Event|6|||
33271254|NCT00696241|100891523|FG003|Overall Study|Adverse Event|4|||
33271255|NCT00696241|100891524|FG004|Overall Study|Adverse Event|5|||
33271256|NCT00696241|100891520|FG000|Overall Study|Protocol Violation|1|||
33271257|NCT00696241|100891521|FG001|Overall Study|Protocol Violation|1|||
33271258|NCT00696241|100891522|FG002|Overall Study|Protocol Violation|2|||
33271259|NCT00696241|100891523|FG003|Overall Study|Protocol Violation|0|||
33271260|NCT00696241|100891524|FG004|Overall Study|Protocol Violation|3|||
33271261|NCT00696241|100891520|FG000|Overall Study|Lost to Follow-up|1|||
33271262|NCT00696241|100891521|FG001|Overall Study|Lost to Follow-up|4|||
33271263|NCT00696241|100891522|FG002|Overall Study|Lost to Follow-up|1|||
33271264|NCT00696241|100891523|FG003|Overall Study|Lost to Follow-up|2|||
33271265|NCT00696241|100891524|FG004|Overall Study|Lost to Follow-up|0|||
33271266|NCT00696241|100891520|FG000|Overall Study|Withdrawal by Subject|4|||
33271267|NCT00696241|100891521|FG001|Overall Study|Withdrawal by Subject|8|||
33271268|NCT00696241|100891522|FG002|Overall Study|Withdrawal by Subject|6|||
33271269|NCT00696241|100891523|FG003|Overall Study|Withdrawal by Subject|1|||
33271270|NCT00696241|100891524|FG004|Overall Study|Withdrawal by Subject|0|||
33271271|NCT00696241|100891520|FG000|Overall Study|Lack of Efficacy|1|||
33271272|NCT00696241|100891521|FG001|Overall Study|Lack of Efficacy|5|||
33271273|NCT00696241|100891522|FG002|Overall Study|Lack of Efficacy|4|||
33271274|NCT00696241|100891523|FG003|Overall Study|Lack of Efficacy|5|||
33271275|NCT00696241|100891524|FG004|Overall Study|Lack of Efficacy|3|||
33271276|NCT00696241|100891520|FG000|Overall Study|Other|6|||
33271277|NCT00696241|100891521|FG001|Overall Study|Other|1|||
33271278|NCT00696241|100891522|FG002|Overall Study|Other|5|||
33271279|NCT00696241|100891523|FG003|Overall Study|Other|2|||
33271280|NCT00696241|100891524|FG004|Overall Study|Other|1|||
33271281|NCT04323800|100891525|FG000|Overall Study|Withdrawal by Subject|4|||
33271282|NCT04323800|100891526|FG001|Overall Study|Withdrawal by Subject|4|||
33271283|NCT04323800|100891525|FG000|Overall Study|Incomplete transfusion|1|||
33271284|NCT04323800|100891526|FG001|Overall Study|Incomplete transfusion|0|||
33271285|NCT04323800|100891525|FG000|Overall Study|Other|0|||
33271286|NCT04323800|100891526|FG001|Overall Study|Other|1|||
33271287|NCT04323800|100891525|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
33271288|NCT04323800|100891526|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
33271289|NCT01020435|100891533|FG000|Overall Study|Lost to Follow-up|0|||
33271290|NCT01020435|100891534|FG001|Overall Study|Lost to Follow-up|1|||
33271291|NCT01916109|100891535|FG000|Overall Study|Withdrawal by Subject|1|||
33271292|NCT01670526|100891536|FG000|Overall Study|Withdrawal by Subject|3|||
33271293|NCT01670526|100891537|FG001|Overall Study|Withdrawal by Subject|1|||
33271294|NCT01670526|100891536|FG000|Overall Study|Lost to Follow-up|9|||
33271295|NCT01670526|100891537|FG001|Overall Study|Lost to Follow-up|5|||
33271296|NCT02007070|100891538|FG000|Overall Study|Adverse Event|4|||
33271297|NCT02007070|100891538|FG000|Overall Study|Clinical Progression|4|||
33271298|NCT02007070|100891538|FG000|Overall Study|Death|1|||
33271299|NCT02007070|100891538|FG000|Overall Study|Protocol Violation|2|||
33271300|NCT02007070|100891538|FG000|Overall Study|Physician Decision|1|||
33271301|NCT02007070|100891538|FG000|Overall Study|Progressive Disease|21|||
33271302|NCT02010684|100891539|FG000|Overall Study|Lost to Follow-up|8|||
33271303|NCT02010684|100891540|FG001|Overall Study|Lost to Follow-up|18|||
33271304|NCT02010684|100891539|FG000|Overall Study|Withdrawal by Subject|4|||
33271305|NCT02010684|100891540|FG001|Overall Study|Withdrawal by Subject|5|||
33271306|NCT02039401|100891561|FG000|Overall Study|Adverse Event|0|||
33271307|NCT02039401|100891562|FG001|Overall Study|Adverse Event|1|||
33271308|NCT04749797|100891563|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
33271309|NCT04749797|100891564|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
33271310|NCT04749797|100891565|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
33271311|NCT01313663|100891568|FG000|Overall Study|Study Closed/Terminated|2|||
33271312|NCT01313663|100891569|FG001|Overall Study|Study Closed/Terminated|4|||
33271313|NCT01313663|100891568|FG000|Overall Study|Lost to Follow-up|0|||
33271314|NCT01313663|100891569|FG001|Overall Study|Lost to Follow-up|1|||
33271315|NCT01313663|100891568|FG000|Overall Study|Physician Decision|0|||
33271316|NCT01313663|100891569|FG001|Overall Study|Physician Decision|2|||
33271317|NCT01313663|100891568|FG000|Overall Study|Withdrawal by Subject|2|||
33271318|NCT01313663|100891569|FG001|Overall Study|Withdrawal by Subject|1|||
33271319|NCT00670488|100891571|FG000|Overall Study|Adverse Event|0|||
33271320|NCT00670488|100891572|FG001|Overall Study|Adverse Event|7|||
33271321|NCT00670488|100891573|FG002|Overall Study|Adverse Event|0|||
33271322|NCT00670488|100891574|FG003|Overall Study|Adverse Event|3|||
33271323|NCT00670488|100891575|FG004|Overall Study|Adverse Event|1|||
33271324|NCT00670488|100891576|FG005|Overall Study|Adverse Event|1|||
33271325|NCT00670488|100891577|FG006|Overall Study|Adverse Event|5|||
33271326|NCT00670488|100891578|FG007|Overall Study|Adverse Event|1|||
33271327|NCT00670488|100891579|FG008|Overall Study|Adverse Event|0|||
33271328|NCT00670488|100891580|FG009|Overall Study|Adverse Event|1|||
33271329|NCT00670488|100891571|FG000|Overall Study|Physician Decision|1|||
33271330|NCT00670488|100891572|FG001|Overall Study|Physician Decision|9|||
33271331|NCT00670488|100891573|FG002|Overall Study|Physician Decision|0|||
33271332|NCT00670488|100891574|FG003|Overall Study|Physician Decision|1|||
33271333|NCT00670488|100891575|FG004|Overall Study|Physician Decision|0|||
33271334|NCT00670488|100891576|FG005|Overall Study|Physician Decision|0|||
33271335|NCT00670488|100891577|FG006|Overall Study|Physician Decision|0|||
33271336|NCT00670488|100891578|FG007|Overall Study|Physician Decision|0|||
33271337|NCT00670488|100891579|FG008|Overall Study|Physician Decision|0|||
33271338|NCT00670488|100891580|FG009|Overall Study|Physician Decision|0|||
33271339|NCT00670488|100891571|FG000|Overall Study|Progressive Disease|2|||
33271340|NCT00670488|100891572|FG001|Overall Study|Progressive Disease|41|||
33271341|NCT00670488|100891573|FG002|Overall Study|Progressive Disease|3|||
33271342|NCT00670488|100891574|FG003|Overall Study|Progressive Disease|2|||
33271343|NCT00670488|100891575|FG004|Overall Study|Progressive Disease|2|||
33271344|NCT00670488|100891576|FG005|Overall Study|Progressive Disease|4|||
33271345|NCT00670488|100891577|FG006|Overall Study|Progressive Disease|11|||
33271346|NCT00670488|100891578|FG007|Overall Study|Progressive Disease|2|||
33271347|NCT00670488|100891579|FG008|Overall Study|Progressive Disease|2|||
33271348|NCT00670488|100891580|FG009|Overall Study|Progressive Disease|1|||
33271349|NCT00670488|100891571|FG000|Overall Study|Withdrawal by Subject|0|||
33271350|NCT00670488|100891572|FG001|Overall Study|Withdrawal by Subject|1|||
33271351|NCT00670488|100891573|FG002|Overall Study|Withdrawal by Subject|0|||
33271352|NCT00670488|100891574|FG003|Overall Study|Withdrawal by Subject|1|||
33271353|NCT00670488|100891575|FG004|Overall Study|Withdrawal by Subject|0|||
33271354|NCT00670488|100891576|FG005|Overall Study|Withdrawal by Subject|0|||
33271355|NCT00670488|100891577|FG006|Overall Study|Withdrawal by Subject|1|||
33271356|NCT00670488|100891578|FG007|Overall Study|Withdrawal by Subject|0|||
33271357|NCT00670488|100891579|FG008|Overall Study|Withdrawal by Subject|1|||
33271358|NCT00670488|100891580|FG009|Overall Study|Withdrawal by Subject|0|||
33271359|NCT00952523|100891581|FG000|Overall Study|Withdrawal by Subject|7|||
33271360|NCT04410445|100891582|FG000|Overall Study|Lost to Follow-up|3|||
33271361|NCT04410445|100891583|FG001|Overall Study|Lost to Follow-up|9|||
33271362|NCT04410445|100891582|FG000|Overall Study|Withdrawal by Subject|27|||
33271363|NCT04410445|100891583|FG001|Overall Study|Withdrawal by Subject|15|||
33271364|NCT01930188|100891585|FG000|Overall Study|unclassified|4|||
33271365|NCT01930188|100891586|FG001|Overall Study|unclassified|5|||
33271366|NCT01930188|100891587|FG002|Overall Study|unclassified|3|||
33271367|NCT01930188|100891585|FG000|Overall Study|Missing follow-up information|2|||
33271368|NCT01930188|100891586|FG001|Overall Study|Missing follow-up information|2|||
33271369|NCT01930188|100891587|FG002|Overall Study|Missing follow-up information|3|||
33271370|NCT01930188|100891585|FG000|Overall Study|Lost to Follow-up|5|||
33271371|NCT01930188|100891586|FG001|Overall Study|Lost to Follow-up|2|||
33271372|NCT01930188|100891587|FG002|Overall Study|Lost to Follow-up|2|||
33271373|NCT01930188|100891585|FG000|Overall Study|Death|2|||
33271374|NCT01930188|100891586|FG001|Overall Study|Death|1|||
33271375|NCT01930188|100891587|FG002|Overall Study|Death|3|||
33271376|NCT01930188|100891585|FG000|Overall Study|Withdrawal by Subject|9|||
33271377|NCT01930188|100891586|FG001|Overall Study|Withdrawal by Subject|11|||
33271378|NCT01930188|100891587|FG002|Overall Study|Withdrawal by Subject|8|||
33271379|NCT02338999|100891588|FG000|First Intervention|Withdrawal by Subject|3|||
33271380|NCT02338999|100891589|FG001|First Intervention|Withdrawal by Subject|1|||
33271381|NCT02338999|100891588|FG000|Washout Period|Withdrawal by Subject|0|||
33271382|NCT02338999|100891589|FG001|Washout Period|Withdrawal by Subject|2|||
33271383|NCT02338999|100891588|FG000|Second Intervention|Withdrawal by Subject|0|||
33271384|NCT02338999|100891589|FG001|Second Intervention|Withdrawal by Subject|2|||
33271385|NCT03865732|100891591|FG000|Overall Study|Adverse Event|0|||
33271386|NCT03865732|100891592|FG001|Overall Study|Adverse Event|1|||
33271387|NCT01220999|100891593|FG000|Overall Study|Progressive disease|0|||
33271388|NCT01220999|100891594|FG001|Overall Study|Progressive disease|0|||
33271389|NCT01220999|100891595|FG002|Overall Study|Progressive disease|1|||
33271390|NCT01220999|100891596|FG003|Overall Study|Progressive disease|0|||
33271391|NCT01220999|100891597|FG004|Overall Study|Progressive disease|0|||
33271392|NCT01005602|100891598|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
33271393|NCT01005602|100891599|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
33271394|NCT01071317|100891601|FG000|Overall Study|Lost to Follow-up|2|||
33271395|NCT01071317|100891602|FG001|Overall Study|Lost to Follow-up|2|||
33271396|NCT01681511|100894844|FG000|Overall Study|No Treatment Received|1|||
33271397|NCT01681511|100894845|FG001|Overall Study|No Treatment Received|3|||
33271398|NCT01681511|100894844|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
33271399|NCT01681511|100894845|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
33271400|NCT01681511|100894844|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
33271401|NCT01681511|100894845|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
33271402|NCT01681511|100894844|FG000|Overall Study|No Daily Urine Sample Collected|0|||
33271403|NCT01681511|100894845|FG001|Overall Study|No Daily Urine Sample Collected|1|||
33271404|NCT01681511|100894844|FG000|Overall Study|No post-catheter sample collected|11|||
33271405|NCT01681511|100894845|FG001|Overall Study|No post-catheter sample collected|4|||
33271406|NCT02674399|100894846|FG000|Overall Study|Lost to Follow-up|2|||
33271407|NCT02674399|100894847|FG001|Overall Study|Lost to Follow-up|0|||
33271408|NCT00346398|100894854|FG000|Overall Study|Lost to Follow-up|3|||
33271409|NCT00346398|100894855|FG001|Overall Study|Lost to Follow-up|0|||
33271410|NCT00346398|100894854|FG000|Overall Study|Withdrawal by Subject|0|||
33271411|NCT00346398|100894855|FG001|Overall Study|Withdrawal by Subject|2|||
33271412|NCT01986348|100894856|FG000|Overall Study|Death|8|||
33271413|NCT01986348|100894857|FG001|Overall Study|Death|22|||
33271414|NCT01986348|100894858|FG002|Overall Study|Death|10|||
33271415|NCT01986348|100894859|FG003|Overall Study|Death|21|||
33271416|NCT01986348|100894856|FG000|Overall Study|Lost to Follow-up|0|||
33271417|NCT01986348|100894857|FG001|Overall Study|Lost to Follow-up|0|||
33271418|NCT01986348|100894858|FG002|Overall Study|Lost to Follow-up|0|||
33271419|NCT01986348|100894859|FG003|Overall Study|Lost to Follow-up|2|||
33271420|NCT01986348|100894856|FG000|Overall Study|Physician Decision|0|||
33271421|NCT01986348|100894857|FG001|Overall Study|Physician Decision|0|||
33271422|NCT01986348|100894858|FG002|Overall Study|Physician Decision|0|||
33271423|NCT01986348|100894859|FG003|Overall Study|Physician Decision|1|||
33271424|NCT01986348|100894856|FG000|Overall Study|Progressive Disease|0|||
33271425|NCT01986348|100894857|FG001|Overall Study|Progressive Disease|0|||
33271426|NCT01986348|100894858|FG002|Overall Study|Progressive Disease|2|||
33271427|NCT01986348|100894859|FG003|Overall Study|Progressive Disease|0|||
33271428|NCT01986348|100894856|FG000|Overall Study|Withdrawal by Participant|0|||
33271429|NCT01986348|100894857|FG001|Overall Study|Withdrawal by Participant|1|||
33271430|NCT01986348|100894858|FG002|Overall Study|Withdrawal by Participant|2|||
33271431|NCT01986348|100894859|FG003|Overall Study|Withdrawal by Participant|1|||
33271432|NCT01986348|100894856|FG000|Overall Study|Study Terminated by Sponsor|0|||
33271433|NCT01986348|100894857|FG001|Overall Study|Study Terminated by Sponsor|0|||
33271434|NCT01986348|100894858|FG002|Overall Study|Study Terminated by Sponsor|0|||
33271435|NCT01986348|100894859|FG003|Overall Study|Study Terminated by Sponsor|3|||
33271436|NCT01986348|100894856|FG000|Overall Study|Other-unspecified|0|||
33271437|NCT01986348|100894857|FG001|Overall Study|Other-unspecified|1|||
33271438|NCT01986348|100894858|FG002|Overall Study|Other-unspecified|0|||
33271439|NCT01986348|100894859|FG003|Overall Study|Other-unspecified|2|||
33271440|NCT00632736|100894862|FG000|Overall Study|Adverse Event|104|||
33271441|NCT00632736|100894862|FG000|Overall Study|Lost to Follow-up|15|||
33271442|NCT00632736|100894862|FG000|Overall Study|Protocol Violation|14|||
33271443|NCT00632736|100894862|FG000|Overall Study|Withdrawal by Subject|99|||
33271444|NCT00632736|100894862|FG000|Overall Study|Lack of Efficacy|5|||
33271445|NCT00632736|100894862|FG000|Overall Study|Sponsor terminated study|5|||
33271446|NCT00632736|100894862|FG000|Overall Study|Non-compliance|10|||
33271447|NCT00632736|100894862|FG000|Overall Study|Other|16|||
33271448|NCT00658632|100894867|FG000|Overall Study|Adverse Event|13|||
33271449|NCT00658632|100894868|FG001|Overall Study|Adverse Event|11|||
33271450|NCT00658632|100894867|FG000|Overall Study|Lost to Follow-up|25|||
33271451|NCT00658632|100894868|FG001|Overall Study|Lost to Follow-up|23|||
33271452|NCT00658632|100894867|FG000|Overall Study|Withdrawal by Subject|10|||
33271453|NCT00658632|100894868|FG001|Overall Study|Withdrawal by Subject|7|||
33271454|NCT00658632|100894867|FG000|Overall Study|Lack of Efficacy|0|||
33271455|NCT00658632|100894868|FG001|Overall Study|Lack of Efficacy|1|||
33271456|NCT00658632|100894867|FG000|Overall Study|Withdrawal of consent|8|||
33271457|NCT00658632|100894868|FG001|Overall Study|Withdrawal of consent|14|||
33271458|NCT00658632|100894867|FG000|Overall Study|Pregnancy|1|||
33271459|NCT00658632|100894868|FG001|Overall Study|Pregnancy|1|||
33271460|NCT00658632|100894867|FG000|Overall Study|Other|7|||
33271461|NCT00658632|100894868|FG001|Overall Study|Other|8|||
33271462|NCT01722097|100894872|FG000|Overall Study|Patient sheets not returned|6|||
33271463|NCT01722097|100894873|FG001|Overall Study|Patient sheets not returned|5|||
33271464|NCT00990314|100894877|FG000|Overall Study|Death|2|||
33271465|NCT00990314|100894877|FG000|Overall Study|Adverse Event|2|||
33271466|NCT00990314|100894877|FG000|Overall Study|Withdrawal by Subject|3|||
33271467|NCT00990314|100894877|FG000|Overall Study|Non-Compliance|1|||
33271468|NCT00990314|100894877|FG000|Overall Study|Physician Decision|3|||
33271469|NCT00990314|100894877|FG000|Overall Study|Lack of Efficacy|1|||
33271470|NCT01970527|100894878|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
33271471|NCT01970527|100894879|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
33271472|NCT01970527|100894878|FG000|Treatment|Disease progression|0|||
33271473|NCT01970527|100894879|FG001|Treatment|Disease progression|1|||
33271474|NCT01970527|100894878|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
33271475|NCT01970527|100894879|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
33271476|NCT01970527|100894878|FG000|Treatment|Death|0|||
33271477|NCT01970527|100894879|FG001|Treatment|Death|1|||
33271478|NCT01970527|100894878|FG000|Follow-up Clinic Visit|Disease progression|1|||
33271479|NCT01970527|100894879|FG001|Follow-up Clinic Visit|Disease progression|1|||
33271480|NCT01970527|100894878|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
33271481|NCT01970527|100894879|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
33271482|NCT01970527|100894878|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
33271483|NCT01970527|100894879|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
33271484|NCT00942266|100894880|FG000|Overall Study|Withdrawal by Subject|1|||
33271485|NCT00942266|100894881|FG001|Overall Study|Withdrawal by Subject|0|||
33271486|NCT00942266|100894880|FG000|Overall Study|Adverse Event|2|||
33271487|NCT00942266|100894881|FG001|Overall Study|Adverse Event|1|||
33271488|NCT00942266|100894880|FG000|Overall Study|Disease Progression|38|||
33271489|NCT00942266|100894881|FG001|Overall Study|Disease Progression|11|||
33271490|NCT00942266|100894880|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
33271491|NCT00942266|100894881|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
33271492|NCT00942266|100894880|FG000|Overall Study|Intercurrent illness|0|||
33271493|NCT00942266|100894881|FG001|Overall Study|Intercurrent illness|1|||
33271494|NCT00942266|100894880|FG000|Overall Study|Physician Decision|2|||
33271495|NCT00942266|100894881|FG001|Overall Study|Physician Decision|0|||
33271496|NCT00942266|100894880|FG000|Overall Study|medical deterioration (pneumonia)|0|||
33271497|NCT00942266|100894881|FG001|Overall Study|medical deterioration (pneumonia)|1|||
33271498|NCT00091572|100894882|FG000|Overall Study|Lost to Follow-up|1|||
33271499|NCT00091572|100894883|FG001|Overall Study|Lost to Follow-up|1|||
33271500|NCT00091572|100894882|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
33271501|NCT00091572|100894883|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
33480372|NCT03839823|101651764|FG001|Overall Study|Death|0|||
33480373|NCT03839823|101651763|FG000|Overall Study|Physician Decision|1|||
33271502|NCT00091572|100894882|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
33271503|NCT00091572|100894883|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
33271504|NCT00091572|100894882|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
33271505|NCT00091572|100894883|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
33271506|NCT00091572|100894882|FG000|Overall Study|Other Reason|6|||
33271507|NCT00091572|100894883|FG001|Overall Study|Other Reason|13|||
33271508|NCT00091572|100894882|FG000|Overall Study|Ongoing (still on treatment)|8|||
33271509|NCT00091572|100894883|FG001|Overall Study|Ongoing (still on treatment)|12|||
33271510|NCT00091572|100894882|FG000|Overall Study|Major Protocol Violation|2|||
33271511|NCT00091572|100894883|FG001|Overall Study|Major Protocol Violation|0|||
33271512|NCT00091572|100894882|FG000|Overall Study|Toxicity (Related AE)|53|||
33271513|NCT00091572|100894883|FG001|Overall Study|Toxicity (Related AE)|9|||
33271514|NCT02332824|100894884|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
33271515|NCT02332824|100894885|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
33271516|NCT02332824|100894886|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
33271517|NCT02332824|100894887|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
33271518|NCT02332824|100894888|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
33271519|NCT02332824|100894889|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
33271520|NCT02332824|100894884|FG000|Overall Study|Voluntary Withdrawal|1|||
33271521|NCT02332824|100894885|FG001|Overall Study|Voluntary Withdrawal|0|||
33271522|NCT02332824|100894886|FG002|Overall Study|Voluntary Withdrawal|0|||
33271523|NCT02332824|100894887|FG003|Overall Study|Voluntary Withdrawal|0|||
33271524|NCT02332824|100894888|FG004|Overall Study|Voluntary Withdrawal|0|||
33271525|NCT02332824|100894889|FG005|Overall Study|Voluntary Withdrawal|0|||
33271526|NCT02332824|100894884|FG000|Overall Study|Inconvenient schedule|1|||
33271527|NCT02332824|100894885|FG001|Overall Study|Inconvenient schedule|1|||
33271528|NCT02332824|100894886|FG002|Overall Study|Inconvenient schedule|0|||
33271529|NCT02332824|100894887|FG003|Overall Study|Inconvenient schedule|0|||
33271530|NCT02332824|100894888|FG004|Overall Study|Inconvenient schedule|0|||
33271531|NCT02332824|100894889|FG005|Overall Study|Inconvenient schedule|0|||
33271532|NCT02332824|100894884|FG000|Overall Study|Transfer|0|||
33271533|NCT02332824|100894885|FG001|Overall Study|Transfer|0|||
33271534|NCT02332824|100894886|FG002|Overall Study|Transfer|1|||
33271535|NCT02332824|100894887|FG003|Overall Study|Transfer|1|||
33271536|NCT02332824|100894888|FG004|Overall Study|Transfer|0|||
33271537|NCT02332824|100894889|FG005|Overall Study|Transfer|0|||
33271538|NCT00512902|100894890|FG000|Overall Study|Adverse Event|7|||
33271539|NCT00512902|100894890|FG000|Overall Study|Lost to Follow-up|1|||
33271540|NCT00537914|100894891|FG000|Overall Study|Death|1|||
33271541|NCT00537914|100894891|FG000|Overall Study|Adverse Event|7|||
33271542|NCT00537914|100894891|FG000|Overall Study|Treatment failure|10|||
33271543|NCT00537914|100894891|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
33271544|NCT00537914|100894891|FG000|Overall Study|Lost to Follow-up|19|||
33480374|NCT03839823|101651764|FG001|Overall Study|Physician Decision|5|||
33271545|NCT00537914|100894891|FG000|Overall Study|Withdrawal of informed consent|59|||
33271546|NCT01190124|100894895|FG000|Overall Study|Death|3|||
33271547|NCT01190124|100894896|FG001|Overall Study|Death|0|||
33271548|NCT01190124|100894897|FG002|Overall Study|Death|0|||
33271549|NCT01190124|100894895|FG000|Overall Study|Therapeutic Failure|12|||
33271550|NCT01190124|100894896|FG001|Overall Study|Therapeutic Failure|0|||
33271551|NCT01190124|100894897|FG002|Overall Study|Therapeutic Failure|1|||
33271552|NCT01190124|100894895|FG000|Overall Study|Lost to Follow-up|2|||
33271553|NCT01190124|100894896|FG001|Overall Study|Lost to Follow-up|0|||
33271554|NCT01190124|100894897|FG002|Overall Study|Lost to Follow-up|0|||
33271555|NCT00498797|100894900|FG000|Overall Study|Withdrawal by Subject|4|||
33271556|NCT00498797|100894901|FG001|Overall Study|Withdrawal by Subject|2|||
33480375|NCT03839823|101651763|FG000|Overall Study|Progressive Disease (PD)|65|||
33271557|NCT00498797|100894900|FG000|Overall Study|Adverse Event|12|||
33271558|NCT00498797|100894901|FG001|Overall Study|Adverse Event|5|||
33271559|NCT00498797|100894900|FG000|Overall Study|Condition under investigation worsened|19|||
33271560|NCT00498797|100894901|FG001|Overall Study|Condition under investigation worsened|21|||
33271561|NCT00498797|100894900|FG000|Overall Study|Other|3|||
33271562|NCT00498797|100894901|FG001|Overall Study|Other|1|||
33271563|NCT02245620|100894904|FG000|Overall Study|Physician Decision|1|||
33271564|NCT02245620|100894905|FG001|Overall Study|Physician Decision|1|||
33271565|NCT02764320|100894906|FG000|Overall Study|Withdrawal by Subject|35|||
33271566|NCT02764320|100894907|FG001|Overall Study|Withdrawal by Subject|38|||
33271567|NCT02764320|100894906|FG000|Overall Study|Protocol Violation|11|||
33271568|NCT02764320|100894907|FG001|Overall Study|Protocol Violation|6|||
33271569|NCT02764320|100894906|FG000|Overall Study|Adverse Event|2|||
33271570|NCT02764320|100894907|FG001|Overall Study|Adverse Event|0|||
33271571|NCT02764320|100894906|FG000|Overall Study|Health Issues unable to continue|2|||
33271572|NCT02764320|100894907|FG001|Overall Study|Health Issues unable to continue|0|||
33271573|NCT02764320|100894906|FG000|Overall Study|Did not meet inclusion criteria|1|||
33271574|NCT02764320|100894907|FG001|Overall Study|Did not meet inclusion criteria|0|||
33271575|NCT02764320|100894906|FG000|Overall Study|Subject moved|0|||
33271576|NCT02764320|100894907|FG001|Overall Study|Subject moved|2|||
33271577|NCT02764320|100894906|FG000|Overall Study|Overused medication unavailable|0|||
33271578|NCT02764320|100894907|FG001|Overall Study|Overused medication unavailable|1|||
33271579|NCT02764320|100894906|FG000|Overall Study|Seeking care outside site|0|||
33271580|NCT02764320|100894907|FG001|Overall Study|Seeking care outside site|1|||
33271581|NCT02764320|100894906|FG000|Overall Study|Technology barriers|0|||
33271582|NCT02764320|100894907|FG001|Overall Study|Technology barriers|1|||
33271583|NCT02128269|100894908|FG000|Treatment Period|Adverse Event|1|||
33271584|NCT02128269|100894908|FG000|Treatment Period|Physician Decision|1|||
33271585|NCT05124210|100894909|FG000|Overall Study|Lost to Follow-up|1|||
33271586|NCT05124210|100894910|FG001|Overall Study|Lost to Follow-up|0|||
33271587|NCT05124210|100894909|FG000|Overall Study|Withdrawal by Subject|1|||
33271588|NCT05124210|100894910|FG001|Overall Study|Withdrawal by Subject|0|||
33271589|NCT01381549|100894911|FG000|Overall Study|Ineligible: No organisms isolated|0|||
33271590|NCT01381549|100894912|FG001|Overall Study|Ineligible: No organisms isolated|0|||
33271591|NCT01381549|100894913|FG002|Overall Study|Ineligible: No organisms isolated|1|||
33271592|NCT02923349|100894916|FG000|Overall Study|Other|1|||
33271593|NCT02923349|100894917|FG001|Overall Study|Other|2|||
33271594|NCT02923349|100894918|FG002|Overall Study|Other|4|||
33271595|NCT02923349|100894919|FG003|Overall Study|Other|1|||
33271596|NCT02923349|100894920|FG004|Overall Study|Other|3|||
33271597|NCT02923349|100894921|FG005|Overall Study|Other|0|||
33271598|NCT02923349|100894922|FG006|Overall Study|Other|1|||
33271599|NCT02923349|100894916|FG000|Overall Study|Withdrawal by Subject|2|||
33271600|NCT02923349|100894917|FG001|Overall Study|Withdrawal by Subject|2|||
33271601|NCT02923349|100894918|FG002|Overall Study|Withdrawal by Subject|8|||
33271602|NCT02923349|100894919|FG003|Overall Study|Withdrawal by Subject|10|||
33271603|NCT02923349|100894920|FG004|Overall Study|Withdrawal by Subject|12|||
33271604|NCT02923349|100894921|FG005|Overall Study|Withdrawal by Subject|3|||
33271605|NCT02923349|100894922|FG006|Overall Study|Withdrawal by Subject|0|||
33271606|NCT02923349|100894916|FG000|Overall Study|Physician Decision|0|||
33271607|NCT02923349|100894917|FG001|Overall Study|Physician Decision|0|||
33271608|NCT02923349|100894918|FG002|Overall Study|Physician Decision|0|||
33271609|NCT02923349|100894919|FG003|Overall Study|Physician Decision|1|||
33271610|NCT02923349|100894920|FG004|Overall Study|Physician Decision|1|||
33271611|NCT02923349|100894921|FG005|Overall Study|Physician Decision|0|||
33271612|NCT02923349|100894922|FG006|Overall Study|Physician Decision|2|||
33271613|NCT02923349|100894916|FG000|Overall Study|Lost to Follow-up|0|||
33271614|NCT02923349|100894917|FG001|Overall Study|Lost to Follow-up|0|||
33271615|NCT02923349|100894918|FG002|Overall Study|Lost to Follow-up|3|||
33271616|NCT02923349|100894919|FG003|Overall Study|Lost to Follow-up|0|||
33271617|NCT02923349|100894920|FG004|Overall Study|Lost to Follow-up|1|||
33271618|NCT02923349|100894921|FG005|Overall Study|Lost to Follow-up|1|||
33271619|NCT02923349|100894922|FG006|Overall Study|Lost to Follow-up|0|||
33271620|NCT02923349|100894916|FG000|Overall Study|Death|1|||
33271621|NCT02923349|100894917|FG001|Overall Study|Death|0|||
33271622|NCT02923349|100894918|FG002|Overall Study|Death|2|||
33271623|NCT02923349|100894919|FG003|Overall Study|Death|4|||
33271624|NCT02923349|100894920|FG004|Overall Study|Death|2|||
33271625|NCT02923349|100894921|FG005|Overall Study|Death|3|||
33271626|NCT02923349|100894922|FG006|Overall Study|Death|0|||
33271627|NCT00603798|100894928|FG000|Overall Study|Adverse Event|4|||
33271628|NCT00603798|100894929|FG001|Overall Study|Adverse Event|2|||
33271629|NCT00603798|100894930|FG002|Overall Study|Adverse Event|1|||
33271630|NCT00603798|100894928|FG000|Overall Study|Withdrawal by Subject|4|||
33271631|NCT00603798|100894929|FG001|Overall Study|Withdrawal by Subject|3|||
33271632|NCT00603798|100894930|FG002|Overall Study|Withdrawal by Subject|4|||
33271633|NCT00603798|100894928|FG000|Overall Study|Lost to Follow-up|1|||
33271634|NCT00603798|100894929|FG001|Overall Study|Lost to Follow-up|0|||
33271635|NCT00603798|100894930|FG002|Overall Study|Lost to Follow-up|1|||
33271636|NCT00603798|100894928|FG000|Overall Study|Non-compliance with study procedures|0|||
33271637|NCT00603798|100894929|FG001|Overall Study|Non-compliance with study procedures|1|||
33271638|NCT00603798|100894930|FG002|Overall Study|Non-compliance with study procedures|0|||
33271639|NCT00603798|100894928|FG000|Overall Study|Not due to AE|1|||
33271640|NCT00603798|100894929|FG001|Overall Study|Not due to AE|1|||
33271641|NCT00603798|100894930|FG002|Overall Study|Not due to AE|4|||
33271642|NCT03137459|100894931|FG000|2-month Assessment|Withdrawal by Subject|13|||
33271643|NCT03137459|100894932|FG001|2-month Assessment|Withdrawal by Subject|3|||
33271644|NCT03137459|100894931|FG000|2-month Assessment|Unable to reach|42|||
33271645|NCT03137459|100894932|FG001|2-month Assessment|Unable to reach|32|||
33271646|NCT03137459|100894931|FG000|2-month Assessment|Refused assessment|7|||
33271647|NCT03137459|100894932|FG001|2-month Assessment|Refused assessment|5|||
33271648|NCT03137459|100894931|FG000|2-month Assessment|Acutely ill|6|||
33271649|NCT03137459|100894932|FG001|2-month Assessment|Acutely ill|2|||
33271650|NCT03137459|100894931|FG000|4-month Assessment|Death|4|||
33271651|NCT03137459|100894932|FG001|4-month Assessment|Death|2|||
33271652|NCT03137459|100894931|FG000|4-month Assessment|Withdrawal by Subject|4|||
33271653|NCT03137459|100894932|FG001|4-month Assessment|Withdrawal by Subject|2|||
33271654|NCT03137459|100894931|FG000|4-month Assessment|Unable to reach|44|||
33271655|NCT03137459|100894932|FG001|4-month Assessment|Unable to reach|29|||
33271656|NCT03137459|100894931|FG000|4-month Assessment|Refused assessment|24|||
33271657|NCT03137459|100894932|FG001|4-month Assessment|Refused assessment|10|||
33271658|NCT03137459|100894931|FG000|4-month Assessment|Acutely ill|2|||
33271659|NCT03137459|100894932|FG001|4-month Assessment|Acutely ill|3|||
33271660|NCT03137459|100894931|FG000|6-months|Lost to Follow-up|14|||
33271661|NCT03137459|100894932|FG001|6-months|Lost to Follow-up|11|||
33271662|NCT03137459|100894931|FG000|6-months|Death|0|||
33271663|NCT03137459|100894932|FG001|6-months|Death|2|||
33271664|NCT03137459|100894931|FG000|6-months|Refused assessment|6|||
33271665|NCT03137459|100894932|FG001|6-months|Refused assessment|3|||
33271666|NCT03137459|100894931|FG000|6-months|Acutely ill|1|||
33271667|NCT03137459|100894932|FG001|6-months|Acutely ill|1|||
33271668|NCT01328756|100894933|FG000|Overall Study|Protocol Violation|4|||
33271669|NCT01328756|100894933|FG000|Overall Study|Adverse Event|39|||
33271670|NCT01328756|100894933|FG000|Overall Study|Lack of Efficacy|5|||
33271671|NCT01328756|100894933|FG000|Overall Study|Withdrawal by Subject|41|||
33271672|NCT01328756|100894933|FG000|Overall Study|Lost to Follow-up|5|||
33271673|NCT01328756|100894933|FG000|Overall Study|Other|29|||
33271674|NCT02607956|100894934|FG000|Double-Blinded Phase|Withdrew Consent|17|||
33271675|NCT02607956|100894935|FG001|Double-Blinded Phase|Withdrew Consent|19|||
33271676|NCT02607956|100894936|FG002|Double-Blinded Phase|Withdrew Consent|0|||
33271677|NCT02607956|100894937|FG003|Double-Blinded Phase|Withdrew Consent|0|||
33271678|NCT02607956|100894934|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
33271679|NCT02607956|100894935|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
33271680|NCT02607956|100894936|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
33271681|NCT02607956|100894937|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
33271682|NCT02607956|100894934|FG000|Double-Blinded Phase|Randomized but never treated|7|||
33271683|NCT02607956|100894935|FG001|Double-Blinded Phase|Randomized but never treated|5|||
33271684|NCT02607956|100894936|FG002|Double-Blinded Phase|Randomized but never treated|0|||
33271685|NCT02607956|100894937|FG003|Double-Blinded Phase|Randomized but never treated|0|||
33271686|NCT02607956|100894934|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
33271687|NCT02607956|100894935|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
33271688|NCT02607956|100894936|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
33271689|NCT02607956|100894937|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
33271690|NCT02607956|100894934|FG000|Double-Blinded Phase|Death|4|||
33271691|NCT02607956|100894935|FG001|Double-Blinded Phase|Death|4|||
33271692|NCT02607956|100894936|FG002|Double-Blinded Phase|Death|0|||
33271693|NCT02607956|100894937|FG003|Double-Blinded Phase|Death|0|||
33271694|NCT02607956|100894934|FG000|Double-Blinded Phase|Adverse Event|4|||
33271695|NCT02607956|100894935|FG001|Double-Blinded Phase|Adverse Event|3|||
33271696|NCT02607956|100894936|FG002|Double-Blinded Phase|Adverse Event|0|||
33271697|NCT02607956|100894937|FG003|Double-Blinded Phase|Adverse Event|0|||
33271698|NCT02607956|100894934|FG000|Double-Blinded Phase|Protocol Violation|3|||
33271699|NCT02607956|100894935|FG001|Double-Blinded Phase|Protocol Violation|1|||
33271700|NCT02607956|100894936|FG002|Double-Blinded Phase|Protocol Violation|0|||
33271701|NCT02607956|100894937|FG003|Double-Blinded Phase|Protocol Violation|0|||
33271702|NCT02607956|100894934|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
33271703|NCT02607956|100894935|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
33271704|NCT02607956|100894936|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
33271705|NCT02607956|100894937|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
33271706|NCT02607956|100894934|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
33271707|NCT02607956|100894935|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
33271708|NCT02607956|100894936|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
33271709|NCT02607956|100894937|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
33271710|NCT02607956|100894934|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
33271711|NCT02607956|100894935|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
33271712|NCT02607956|100894936|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
33271713|NCT02607956|100894937|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
33271714|NCT02607956|100894934|FG000|Open-Label Extension Phase|Death|0|||
33271715|NCT02607956|100894935|FG001|Open-Label Extension Phase|Death|0|||
33271716|NCT02607956|100894936|FG002|Open-Label Extension Phase|Death|1|||
33271717|NCT02607956|100894937|FG003|Open-Label Extension Phase|Death|3|||
33271718|NCT02607956|100894934|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
33271719|NCT02607956|100894935|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
33271720|NCT02607956|100894936|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
33271721|NCT02607956|100894937|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
33271722|NCT02607956|100894934|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
33271723|NCT02607956|100894935|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
33271724|NCT02607956|100894936|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
33271725|NCT02607956|100894937|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
33271726|NCT02607956|100894934|FG000|Open-Label Extension Phase|Protocol Violation|0|||
33271727|NCT02607956|100894935|FG001|Open-Label Extension Phase|Protocol Violation|0|||
33271728|NCT02607956|100894936|FG002|Open-Label Extension Phase|Protocol Violation|0|||
33271729|NCT02607956|100894937|FG003|Open-Label Extension Phase|Protocol Violation|2|||
33271730|NCT02607956|100894934|FG000|Open-Label Extension Phase|Pregnancy|0|||
33271731|NCT02607956|100894935|FG001|Open-Label Extension Phase|Pregnancy|0|||
33271732|NCT02607956|100894936|FG002|Open-Label Extension Phase|Pregnancy|0|||
33271733|NCT02607956|100894937|FG003|Open-Label Extension Phase|Pregnancy|1|||
33271734|NCT01945086|100894940|FG000|Overall Study|Withdrawal by Subject|1|||
33271735|NCT01945086|100894941|FG001|Overall Study|Withdrawal by Subject|0|||
33271736|NCT01945086|100894942|FG002|Overall Study|Withdrawal by Subject|1|||
33271737|NCT01945086|100894940|FG000|Overall Study|Adverse Event|0|||
33271738|NCT01945086|100894941|FG001|Overall Study|Adverse Event|0|||
33271739|NCT01945086|100894942|FG002|Overall Study|Adverse Event|1|||
33271740|NCT03746015|100894943|FG000|Overall Study|Withdrawal of Consent|1|||
33271741|NCT03746015|100894944|FG001|Overall Study|Withdrawal of Consent|0|||
33271742|NCT03746015|100894945|FG002|Overall Study|Withdrawal of Consent|0|||
33271743|NCT03345407|100894946|FG000|Overall Study|Withdrawal by Subject|11|||
33271744|NCT03345407|100894947|FG001|Overall Study|Withdrawal by Subject|1|||
33271745|NCT03345407|100894948|FG002|Overall Study|Withdrawal by Subject|5|||
33271746|NCT03345407|100894949|FG003|Overall Study|Withdrawal by Subject|6|||
33271747|NCT03345407|100894950|FG004|Overall Study|Withdrawal by Subject|3|||
33271748|NCT03345407|100894951|FG005|Overall Study|Withdrawal by Subject|6|||
33271749|NCT03345407|100894952|FG006|Overall Study|Withdrawal by Subject|16|||
33271750|NCT03345407|100894946|FG000|Overall Study|Physician Decision|3|||
33271751|NCT03345407|100894947|FG001|Overall Study|Physician Decision|1|||
33271752|NCT03345407|100894948|FG002|Overall Study|Physician Decision|0|||
33271753|NCT03345407|100894949|FG003|Overall Study|Physician Decision|0|||
33271754|NCT03345407|100894950|FG004|Overall Study|Physician Decision|1|||
33271755|NCT03345407|100894951|FG005|Overall Study|Physician Decision|2|||
33271756|NCT03345407|100894952|FG006|Overall Study|Physician Decision|3|||
33271757|NCT03345407|100894946|FG000|Overall Study|Lost to Follow-up|2|||
33271758|NCT03345407|100894947|FG001|Overall Study|Lost to Follow-up|0|||
33271759|NCT03345407|100894948|FG002|Overall Study|Lost to Follow-up|1|||
33271760|NCT03345407|100894949|FG003|Overall Study|Lost to Follow-up|0|||
33271761|NCT03345407|100894950|FG004|Overall Study|Lost to Follow-up|1|||
33271762|NCT03345407|100894951|FG005|Overall Study|Lost to Follow-up|2|||
33271763|NCT03345407|100894952|FG006|Overall Study|Lost to Follow-up|3|||
33271764|NCT03345407|100894946|FG000|Overall Study|Protocol-defined stopping criteria|9|||
33271765|NCT03345407|100894947|FG001|Overall Study|Protocol-defined stopping criteria|0|||
33271766|NCT03345407|100894948|FG002|Overall Study|Protocol-defined stopping criteria|0|||
33271767|NCT03345407|100894949|FG003|Overall Study|Protocol-defined stopping criteria|0|||
33271768|NCT03345407|100894950|FG004|Overall Study|Protocol-defined stopping criteria|2|||
33271769|NCT03345407|100894951|FG005|Overall Study|Protocol-defined stopping criteria|1|||
33271770|NCT03345407|100894952|FG006|Overall Study|Protocol-defined stopping criteria|1|||
33271771|NCT03345407|100894946|FG000|Overall Study|Protocol Violation|2|||
33271772|NCT03345407|100894947|FG001|Overall Study|Protocol Violation|0|||
33271773|NCT03345407|100894948|FG002|Overall Study|Protocol Violation|0|||
33271774|NCT03345407|100894949|FG003|Overall Study|Protocol Violation|0|||
33271775|NCT03345407|100894950|FG004|Overall Study|Protocol Violation|1|||
33271776|NCT03345407|100894951|FG005|Overall Study|Protocol Violation|0|||
33271777|NCT03345407|100894952|FG006|Overall Study|Protocol Violation|3|||
33271778|NCT03345407|100894946|FG000|Overall Study|Lack of Efficacy|1|||
33271779|NCT03345407|100894947|FG001|Overall Study|Lack of Efficacy|1|||
33271780|NCT03345407|100894948|FG002|Overall Study|Lack of Efficacy|1|||
33271781|NCT03345407|100894949|FG003|Overall Study|Lack of Efficacy|1|||
33271782|NCT03345407|100894950|FG004|Overall Study|Lack of Efficacy|1|||
33271783|NCT03345407|100894951|FG005|Overall Study|Lack of Efficacy|0|||
33271784|NCT03345407|100894952|FG006|Overall Study|Lack of Efficacy|3|||
33271785|NCT03345407|100894946|FG000|Overall Study|Adverse Event|4|||
33271786|NCT03345407|100894947|FG001|Overall Study|Adverse Event|0|||
33271787|NCT03345407|100894948|FG002|Overall Study|Adverse Event|5|||
33271788|NCT03345407|100894949|FG003|Overall Study|Adverse Event|4|||
33271789|NCT03345407|100894950|FG004|Overall Study|Adverse Event|6|||
33271790|NCT03345407|100894951|FG005|Overall Study|Adverse Event|5|||
33271791|NCT03345407|100894952|FG006|Overall Study|Adverse Event|16|||
33271792|NCT02446015|100894967|FG000|Overall Study|Adverse Event|0|||
33271793|NCT02446015|100894968|FG001|Overall Study|Adverse Event|1|||
33271794|NCT02446015|100894967|FG000|Overall Study|Withdrawal by Subject|1|||
33271795|NCT02446015|100894968|FG001|Overall Study|Withdrawal by Subject|0|||
33271796|NCT00624377|100894971|FG000|Overall Study|Lost to Follow-up|355|||
33271797|NCT00624377|100894971|FG000|Overall Study|Withdrawal by Subject|100|||
33271798|NCT00624377|100894971|FG000|Overall Study|Adverse Event|14|||
33271799|NCT00624377|100894971|FG000|Overall Study|Other|91|||
33271800|NCT00624377|100894971|FG000|Overall Study|Non-evaluable population|84|||
33271801|NCT00805441|100894974|FG000|Overall Study|Adverse Event|5|||
33271802|NCT00805441|100894975|FG001|Overall Study|Adverse Event|2|||
33271803|NCT00805441|100894974|FG000|Overall Study|Lack of Efficacy|0|||
33271804|NCT00805441|100894975|FG001|Overall Study|Lack of Efficacy|2|||
33271805|NCT00805441|100894974|FG000|Overall Study|Protocol Violation|4|||
33271806|NCT00805441|100894975|FG001|Overall Study|Protocol Violation|8|||
33271807|NCT00805441|100894974|FG000|Overall Study|Lost to Follow-up|10|||
33271808|NCT00805441|100894975|FG001|Overall Study|Lost to Follow-up|13|||
33271809|NCT00805441|100894974|FG000|Overall Study|Withdrawal by Subject|15|||
33271810|NCT00805441|100894975|FG001|Overall Study|Withdrawal by Subject|9|||
33271811|NCT00805441|100894974|FG000|Overall Study|Physician Decision|0|||
33271812|NCT00805441|100894975|FG001|Overall Study|Physician Decision|1|||
33271813|NCT00805441|100894974|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
33271814|NCT00805441|100894975|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
33271815|NCT02392507|100894976|FG000|Induction Regimen|Death|3|||
33271816|NCT02392507|100894976|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
33271817|NCT02392507|100894976|FG000|Induction Regimen|Physician Decision|1|||
33271818|NCT02392507|100894976|FG000|Induction Regimen|Withdrawal by Subject|2|||
33271819|NCT02392507|100894976|FG000|Maintenance Regimen|Death|1|||
33271820|NCT02392507|100894976|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
33271821|NCT04766996|100894977|FG000|Overall Study|Withdrawal by Subject|1|||
33271822|NCT04766996|100894978|FG001|Overall Study|Withdrawal by Subject|0|||
33271823|NCT04766996|100894979|FG002|Overall Study|Withdrawal by Subject|13|||
33271824|NCT02106325|100894980|FG000|Phase 1|Lost to Follow-up|2|||
33271825|NCT02106325|100894981|FG001|Phase 1|Lost to Follow-up|2|||
33271826|NCT02106325|100894980|FG000|Phase 2|Lost to Follow-up|2|||
33271827|NCT02106325|100894981|FG001|Phase 2|Lost to Follow-up|3|||
33271828|NCT02106325|100894980|FG000|Phase 3|Lost to Follow-up|2|||
33271829|NCT02106325|100894981|FG001|Phase 3|Lost to Follow-up|1|||
33271830|NCT02382640|100894982|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
33271831|NCT02382640|100894983|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
33271832|NCT02382640|100894984|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
33271833|NCT02382640|100894985|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
33271834|NCT03875729|100894987|FG000|Overall Study|Adverse Event|0|||
33271835|NCT03875729|100894988|FG001|Overall Study|Adverse Event|5|||
33271836|NCT03875729|100894987|FG000|Overall Study|Withdrawal by Subject|8|||
33271837|NCT03875729|100894988|FG001|Overall Study|Withdrawal by Subject|11|||
33271838|NCT03875729|100894987|FG000|Overall Study|Pregnancy|0|||
33271839|NCT03875729|100894988|FG001|Overall Study|Pregnancy|1|||
33271840|NCT03875729|100894987|FG000|Overall Study|Lost to Follow-up|0|||
33271841|NCT03875729|100894988|FG001|Overall Study|Lost to Follow-up|5|||
33271842|NCT03875729|100894987|FG000|Overall Study|Personal reasons|2|||
33271843|NCT03875729|100894988|FG001|Overall Study|Personal reasons|0|||
33271844|NCT02009865|100894989|FG000|Overall Study|Adverse Event|0|||
33271845|NCT02009865|100894990|FG001|Overall Study|Adverse Event|2|||
33271846|NCT02009865|100894989|FG000|Overall Study|Protocol Violation|0|||
33271847|NCT02009865|100894990|FG001|Overall Study|Protocol Violation|2|||
33271848|NCT02009865|100894989|FG000|Overall Study|Withdrawal by Subject|1|||
33271849|NCT02009865|100894990|FG001|Overall Study|Withdrawal by Subject|1|||
33271850|NCT01205126|100894991|FG000|Titration Phase|Adverse Event|5|||
33271851|NCT01205126|100894992|FG001|Titration Phase|Adverse Event|3|||
33271852|NCT01205126|100894991|FG000|Titration Phase|Withdrawal by Subject|5|||
33271853|NCT01205126|100894992|FG001|Titration Phase|Withdrawal by Subject|5|||
33271854|NCT01205126|100894991|FG000|Titration Phase|Lost to Follow-up|2|||
33271855|NCT01205126|100894992|FG001|Titration Phase|Lost to Follow-up|2|||
33271856|NCT01205126|100894991|FG000|Titration Phase|No stable titration dose|1|||
33271857|NCT01205126|100894992|FG001|Titration Phase|No stable titration dose|0|||
33271858|NCT01205126|100894991|FG000|Titration Phase|More than maximum dosage required|2|||
33271859|NCT01205126|100894992|FG001|Titration Phase|More than maximum dosage required|3|||
33271860|NCT01205126|100894991|FG000|Titration Phase|Other|8|||
33271861|NCT01205126|100894992|FG001|Titration Phase|Other|6|||
33271862|NCT01205126|100894991|FG000|Between Titration & Maintenance Phase|Other|0|||
33271863|NCT01205126|100894992|FG001|Between Titration & Maintenance Phase|Other|4|||
33271864|NCT01205126|100894991|FG000|Maintenance Phase|Adverse Event|3|||
33271865|NCT01205126|100894992|FG001|Maintenance Phase|Adverse Event|7|||
33271866|NCT01205126|100894991|FG000|Maintenance Phase|Death|4|||
33271867|NCT01205126|100894992|FG001|Maintenance Phase|Death|4|||
33271868|NCT01205126|100894991|FG000|Maintenance Phase|More than the maximum dosage required|5|||
33271869|NCT01205126|100894992|FG001|Maintenance Phase|More than the maximum dosage required|5|||
33271870|NCT01205126|100894991|FG000|Maintenance Phase|Prohibited drugs used|1|||
33271871|NCT01205126|100894992|FG001|Maintenance Phase|Prohibited drugs used|0|||
33271872|NCT01205126|100894991|FG000|Maintenance Phase|Other|11|||
33271873|NCT01205126|100894992|FG001|Maintenance Phase|Other|8|||
33271874|NCT01205126|100894991|FG000|Maintenance Phase|Lost to Follow-up|5|||
33271875|NCT01205126|100894992|FG001|Maintenance Phase|Lost to Follow-up|5|||
33271876|NCT01205126|100894991|FG000|Maintenance Phase|Withdrawal by Subject|8|||
33271877|NCT01205126|100894992|FG001|Maintenance Phase|Withdrawal by Subject|11|||
33271878|NCT02889900|100894993|FG000|Overall Study|Adverse Event|11|||
33271879|NCT02889900|100894993|FG000|Overall Study|Condition under investigation worsened|32|||
33271880|NCT02889900|100894993|FG000|Overall Study|Other|5|||
33271881|NCT02889900|100894993|FG000|Overall Study|Withdrawal by Subject|7|||
33271882|NCT02889900|100894993|FG000|Overall Study|Not treated|2|||
33271883|NCT03884478|100894994|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
33271884|NCT03884478|100894995|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
33271885|NCT03884478|100894996|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
33271886|NCT03884478|100894994|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
33271887|NCT03884478|100894995|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
33271888|NCT03884478|100894996|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
33271889|NCT03884478|100894994|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
33271890|NCT03884478|100894995|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
33271891|NCT03884478|100894996|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
33271892|NCT03884478|100894994|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
33271893|NCT03884478|100894995|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
33271894|NCT03884478|100894996|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
33271895|NCT01123200|100894997|FG000|Overall Study|Withdrawal by Subject|1|||
33271896|NCT02981953|100894999|FG000|Overall Study|Death|9|||
33271897|NCT02981953|100894999|FG000|Overall Study|Withdrawal by Subject|1|||
33271898|NCT02981953|100894999|FG000|Overall Study|Withdrawal to non-compliance|1|||
33271899|NCT01190436|100895000|FG000|Overall Study|Lost to Follow-up|35|||
33271900|NCT01190436|100895000|FG000|Overall Study|Other|4|||
33271901|NCT02598388|100895001|FG000|Overall Study|Lost to Follow-up|1|||
33271902|NCT02598388|100895002|FG001|Overall Study|Lost to Follow-up|0|||
33271903|NCT02598388|100895003|FG002|Overall Study|Lost to Follow-up|1|||
33271904|NCT02598388|100895004|FG003|Overall Study|Lost to Follow-up|0|||
33271905|NCT02598388|100895005|FG004|Overall Study|Lost to Follow-up|5|||
33271906|NCT02598388|100895006|FG005|Overall Study|Lost to Follow-up|1|||
33480376|NCT03839823|101651764|FG001|Overall Study|Progressive Disease (PD)|65|||
33480377|NCT03839823|101651763|FG000|Overall Study|Subject Decision|2|||
33480378|NCT03839823|101651764|FG001|Overall Study|Subject Decision|9|||
33271907|NCT02598388|100895007|FG006|Overall Study|Lost to Follow-up|2|||
33271908|NCT02598388|100895008|FG007|Overall Study|Lost to Follow-up|1|||
33271909|NCT02598388|100895009|FG008|Overall Study|Lost to Follow-up|0|||
33271910|NCT02598388|100895010|FG009|Overall Study|Lost to Follow-up|0|||
33271911|NCT02598388|100895011|FG010|Overall Study|Lost to Follow-up|1|||
33271912|NCT02598388|100895012|FG011|Overall Study|Lost to Follow-up|0|||
33271913|NCT02598388|100895001|FG000|Overall Study|Withdrawal by Subject|0|||
33271914|NCT02598388|100895002|FG001|Overall Study|Withdrawal by Subject|0|||
33271915|NCT02598388|100895003|FG002|Overall Study|Withdrawal by Subject|0|||
33271916|NCT02598388|100895004|FG003|Overall Study|Withdrawal by Subject|0|||
33271917|NCT02598388|100895005|FG004|Overall Study|Withdrawal by Subject|2|||
33271918|NCT02598388|100895006|FG005|Overall Study|Withdrawal by Subject|0|||
33271919|NCT02598388|100895007|FG006|Overall Study|Withdrawal by Subject|2|||
33271920|NCT02598388|100895008|FG007|Overall Study|Withdrawal by Subject|0|||
33271921|NCT02598388|100895009|FG008|Overall Study|Withdrawal by Subject|0|||
33271922|NCT02598388|100895010|FG009|Overall Study|Withdrawal by Subject|1|||
33271923|NCT02598388|100895011|FG010|Overall Study|Withdrawal by Subject|0|||
33271924|NCT02598388|100895012|FG011|Overall Study|Withdrawal by Subject|0|||
33271925|NCT02598388|100895001|FG000|Overall Study|Other|0|||
33271926|NCT02598388|100895002|FG001|Overall Study|Other|0|||
33271927|NCT02598388|100895003|FG002|Overall Study|Other|1|||
33271928|NCT02598388|100895004|FG003|Overall Study|Other|0|||
33271929|NCT02598388|100895005|FG004|Overall Study|Other|3|||
33271930|NCT02598388|100895006|FG005|Overall Study|Other|0|||
33271931|NCT02598388|100895007|FG006|Overall Study|Other|1|||
33271932|NCT02598388|100895008|FG007|Overall Study|Other|0|||
33271933|NCT02598388|100895009|FG008|Overall Study|Other|0|||
33271934|NCT02598388|100895010|FG009|Overall Study|Other|0|||
33271935|NCT02598388|100895011|FG010|Overall Study|Other|0|||
33271936|NCT02598388|100895012|FG011|Overall Study|Other|0|||
33480379|NCT03839823|101651763|FG000|Overall Study|Not Treated|0|||
33271937|NCT02037568|100895013|FG000|Overall Study|Withdrawal by Subject|17|||
33480380|NCT03839823|101651764|FG001|Overall Study|Not Treated|10|||
33271938|NCT02037568|100895014|FG001|Overall Study|Withdrawal by Subject|24|||
33271939|NCT02037568|100895013|FG000|Overall Study|Lost to Follow-up|16|||
33271940|NCT02037568|100895014|FG001|Overall Study|Lost to Follow-up|13|||
33271941|NCT02037568|100895013|FG000|Overall Study|Screen Failure|3|||
33271942|NCT02037568|100895014|FG001|Overall Study|Screen Failure|1|||
33271943|NCT02037568|100895013|FG000|Overall Study|Patient did not receive transplant|0|||
33271944|NCT02037568|100895014|FG001|Overall Study|Patient did not receive transplant|1|||
33271945|NCT02291549|100895023|FG000|Overall Study|Lost to Follow-up|1|||
33271946|NCT02291549|100895024|FG001|Overall Study|Lost to Follow-up|0|||
33271947|NCT02291549|100895023|FG000|Overall Study|Withdrawal by Subject|0|||
33271948|NCT02291549|100895024|FG001|Overall Study|Withdrawal by Subject|1|||
33271949|NCT00403845|100895030|FG000|Treatment Period 1|Subject withdrew consent|1|||
33271950|NCT00403845|100895031|FG001|Treatment Period 1|Subject withdrew consent|0|||
33271951|NCT00403845|100895032|FG002|Treatment Period 1|Subject withdrew consent|0|||
33271952|NCT00403845|100895033|FG003|Treatment Period 1|Subject withdrew consent|0|||
33271953|NCT00403845|100895030|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
33271954|NCT00403845|100895031|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
33271955|NCT00403845|100895032|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
33271956|NCT00403845|100895033|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
33271957|NCT00403845|100895030|FG000|Treatment Period 2|Subject withdrew consent|1|||
33271958|NCT00403845|100895031|FG001|Treatment Period 2|Subject withdrew consent|0|||
33271959|NCT00403845|100895032|FG002|Treatment Period 2|Subject withdrew consent|0|||
33271960|NCT00403845|100895033|FG003|Treatment Period 2|Subject withdrew consent|0|||
33271961|NCT00403845|100895030|FG000|Treatment Period 3|Subject withdrew consent|0|||
33271962|NCT00403845|100895031|FG001|Treatment Period 3|Subject withdrew consent|0|||
33271963|NCT00403845|100895032|FG002|Treatment Period 3|Subject withdrew consent|0|||
33271964|NCT00403845|100895033|FG003|Treatment Period 3|Subject withdrew consent|1|||
33271965|NCT00403845|100895030|FG000|Treatment Period 3|Adverse Event|0|||
33271966|NCT00403845|100895031|FG001|Treatment Period 3|Adverse Event|0|||
33271967|NCT00403845|100895032|FG002|Treatment Period 3|Adverse Event|0|||
33271968|NCT00403845|100895033|FG003|Treatment Period 3|Adverse Event|1|||
33271969|NCT00103857|100895035|FG000|54-Week Base Study|Adverse Event|12|||
33271970|NCT00103857|100895036|FG001|54-Week Base Study|Adverse Event|9|||
33271971|NCT00103857|100895037|FG002|54-Week Base Study|Adverse Event|11|||
33271972|NCT00103857|100895038|FG003|54-Week Base Study|Adverse Event|6|||
33271973|NCT00103857|100895039|FG004|54-Week Base Study|Adverse Event|5|||
33271974|NCT00103857|100895040|FG005|54-Week Base Study|Adverse Event|11|||
33271975|NCT00103857|100895041|FG006|54-Week Base Study|Adverse Event|3|||
33271976|NCT00103857|100895035|FG000|54-Week Base Study|Death|0|||
33271977|NCT00103857|100895036|FG001|54-Week Base Study|Death|0|||
33271978|NCT00103857|100895037|FG002|54-Week Base Study|Death|0|||
33271979|NCT00103857|100895038|FG003|54-Week Base Study|Death|0|||
33271980|NCT00103857|100895039|FG004|54-Week Base Study|Death|1|||
33271981|NCT00103857|100895040|FG005|54-Week Base Study|Death|1|||
33271982|NCT00103857|100895041|FG006|54-Week Base Study|Death|0|||
33271983|NCT00103857|100895035|FG000|54-Week Base Study|Lack of Efficacy|11|||
33271984|NCT00103857|100895036|FG001|54-Week Base Study|Lack of Efficacy|14|||
33271985|NCT00103857|100895037|FG002|54-Week Base Study|Lack of Efficacy|8|||
33271986|NCT00103857|100895038|FG003|54-Week Base Study|Lack of Efficacy|4|||
33271987|NCT00103857|100895039|FG004|54-Week Base Study|Lack of Efficacy|3|||
33271988|NCT00103857|100895040|FG005|54-Week Base Study|Lack of Efficacy|14|||
33271989|NCT00103857|100895041|FG006|54-Week Base Study|Lack of Efficacy|19|||
33271990|NCT00103857|100895035|FG000|54-Week Base Study|Lost to Follow-up|5|||
33271991|NCT00103857|100895036|FG001|54-Week Base Study|Lost to Follow-up|4|||
33271992|NCT00103857|100895037|FG002|54-Week Base Study|Lost to Follow-up|7|||
33271993|NCT00103857|100895038|FG003|54-Week Base Study|Lost to Follow-up|5|||
33271994|NCT00103857|100895039|FG004|54-Week Base Study|Lost to Follow-up|10|||
33271995|NCT00103857|100895040|FG005|54-Week Base Study|Lost to Follow-up|9|||
33271996|NCT00103857|100895041|FG006|54-Week Base Study|Lost to Follow-up|3|||
33271997|NCT00103857|100895035|FG000|54-Week Base Study|Physician Decision|1|||
33271998|NCT00103857|100895036|FG001|54-Week Base Study|Physician Decision|1|||
33271999|NCT00103857|100895037|FG002|54-Week Base Study|Physician Decision|0|||
33272000|NCT00103857|100895038|FG003|54-Week Base Study|Physician Decision|0|||
33272001|NCT00103857|100895039|FG004|54-Week Base Study|Physician Decision|1|||
33272002|NCT00103857|100895040|FG005|54-Week Base Study|Physician Decision|0|||
33272003|NCT00103857|100895041|FG006|54-Week Base Study|Physician Decision|0|||
33272004|NCT00103857|100895035|FG000|54-Week Base Study|Pregnancy|1|||
33272005|NCT00103857|100895036|FG001|54-Week Base Study|Pregnancy|0|||
33272006|NCT00103857|100895037|FG002|54-Week Base Study|Pregnancy|0|||
33272007|NCT00103857|100895038|FG003|54-Week Base Study|Pregnancy|0|||
33272008|NCT00103857|100895039|FG004|54-Week Base Study|Pregnancy|1|||
33272009|NCT00103857|100895040|FG005|54-Week Base Study|Pregnancy|0|||
33272010|NCT00103857|100895041|FG006|54-Week Base Study|Pregnancy|1|||
33272011|NCT00103857|100895035|FG000|54-Week Base Study|Protocol Violation|6|||
33272012|NCT00103857|100895036|FG001|54-Week Base Study|Protocol Violation|4|||
33272013|NCT00103857|100895037|FG002|54-Week Base Study|Protocol Violation|2|||
33272014|NCT00103857|100895038|FG003|54-Week Base Study|Protocol Violation|4|||
33272015|NCT00103857|100895039|FG004|54-Week Base Study|Protocol Violation|0|||
33272016|NCT00103857|100895040|FG005|54-Week Base Study|Protocol Violation|3|||
33272017|NCT00103857|100895041|FG006|54-Week Base Study|Protocol Violation|3|||
33272018|NCT00103857|100895035|FG000|54-Week Base Study|Withdrawal by Subject|17|||
33272019|NCT00103857|100895036|FG001|54-Week Base Study|Withdrawal by Subject|16|||
33272020|NCT00103857|100895037|FG002|54-Week Base Study|Withdrawal by Subject|16|||
33272021|NCT00103857|100895038|FG003|54-Week Base Study|Withdrawal by Subject|15|||
33272022|NCT00103857|100895039|FG004|54-Week Base Study|Withdrawal by Subject|10|||
33272023|NCT00103857|100895040|FG005|54-Week Base Study|Withdrawal by Subject|15|||
33272024|NCT00103857|100895041|FG006|54-Week Base Study|Withdrawal by Subject|4|||
33272025|NCT00103857|100895035|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
33272026|NCT00103857|100895036|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
33272027|NCT00103857|100895037|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
33272028|NCT00103857|100895038|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
33272029|NCT00103857|100895039|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
33272030|NCT00103857|100895040|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
33272031|NCT00103857|100895041|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
33272032|NCT00103857|100895035|FG000|54-Week Base Study|patient moved|0|||
33272033|NCT00103857|100895036|FG001|54-Week Base Study|patient moved|1|||
33272034|NCT00103857|100895037|FG002|54-Week Base Study|patient moved|1|||
33272035|NCT00103857|100895038|FG003|54-Week Base Study|patient moved|2|||
33272036|NCT00103857|100895039|FG004|54-Week Base Study|patient moved|3|||
33272037|NCT00103857|100895040|FG005|54-Week Base Study|patient moved|1|||
33272038|NCT00103857|100895041|FG006|54-Week Base Study|patient moved|0|||
33272039|NCT00103857|100895035|FG000|54-Week Base Study|non-compliance with study procedures|1|||
33272040|NCT00103857|100895036|FG001|54-Week Base Study|non-compliance with study procedures|2|||
33272041|NCT00103857|100895037|FG002|54-Week Base Study|non-compliance with study procedures|0|||
33272042|NCT00103857|100895038|FG003|54-Week Base Study|non-compliance with study procedures|0|||
33272043|NCT00103857|100895039|FG004|54-Week Base Study|non-compliance with study procedures|0|||
33272044|NCT00103857|100895040|FG005|54-Week Base Study|non-compliance with study procedures|2|||
33272045|NCT00103857|100895041|FG006|54-Week Base Study|non-compliance with study procedures|0|||
33272046|NCT00103857|100895035|FG000|54-Week Base Study|patient incarcerated|0|||
33272047|NCT00103857|100895036|FG001|54-Week Base Study|patient incarcerated|0|||
33272048|NCT00103857|100895037|FG002|54-Week Base Study|patient incarcerated|0|||
33272049|NCT00103857|100895038|FG003|54-Week Base Study|patient incarcerated|0|||
33272050|NCT00103857|100895039|FG004|54-Week Base Study|patient incarcerated|1|||
33272051|NCT00103857|100895040|FG005|54-Week Base Study|patient incarcerated|1|||
33272052|NCT00103857|100895041|FG006|54-Week Base Study|patient incarcerated|0|||
33272053|NCT00103857|100895035|FG000|54-Week Base Study|laboratory reporting error|0|||
33272054|NCT00103857|100895036|FG001|54-Week Base Study|laboratory reporting error|0|||
33272055|NCT00103857|100895037|FG002|54-Week Base Study|laboratory reporting error|0|||
33272056|NCT00103857|100895038|FG003|54-Week Base Study|laboratory reporting error|0|||
33272057|NCT00103857|100895039|FG004|54-Week Base Study|laboratory reporting error|1|||
33272058|NCT00103857|100895040|FG005|54-Week Base Study|laboratory reporting error|0|||
33272059|NCT00103857|100895041|FG006|54-Week Base Study|laboratory reporting error|0|||
33272060|NCT00103857|100895035|FG000|54-Week Base Study|site error|0|||
33272061|NCT00103857|100895036|FG001|54-Week Base Study|site error|0|||
33272062|NCT00103857|100895037|FG002|54-Week Base Study|site error|0|||
33272063|NCT00103857|100895038|FG003|54-Week Base Study|site error|0|||
33272064|NCT00103857|100895039|FG004|54-Week Base Study|site error|0|||
33272065|NCT00103857|100895040|FG005|54-Week Base Study|site error|1|||
33272066|NCT00103857|100895041|FG006|54-Week Base Study|site error|0|||
33272067|NCT00103857|100895035|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
33272068|NCT00103857|100895036|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
33272069|NCT00103857|100895037|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
33272070|NCT00103857|100895038|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
33272071|NCT00103857|100895039|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
33272072|NCT00103857|100895040|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
33272073|NCT00103857|100895041|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
33272074|NCT00103857|100895035|FG000|50-Week Extension Study|Adverse Event|2|||
33272075|NCT00103857|100895036|FG001|50-Week Extension Study|Adverse Event|3|||
33272076|NCT00103857|100895037|FG002|50-Week Extension Study|Adverse Event|2|||
33272077|NCT00103857|100895038|FG003|50-Week Extension Study|Adverse Event|0|||
33272078|NCT00103857|100895039|FG004|50-Week Extension Study|Adverse Event|1|||
33272079|NCT00103857|100895040|FG005|50-Week Extension Study|Adverse Event|1|||
33272080|NCT00103857|100895041|FG006|50-Week Extension Study|Adverse Event|0|||
33272081|NCT00103857|100895035|FG000|50-Week Extension Study|Death|0|||
33272082|NCT00103857|100895036|FG001|50-Week Extension Study|Death|0|||
33272083|NCT00103857|100895037|FG002|50-Week Extension Study|Death|0|||
33272084|NCT00103857|100895038|FG003|50-Week Extension Study|Death|1|||
33272085|NCT00103857|100895039|FG004|50-Week Extension Study|Death|0|||
33272086|NCT00103857|100895040|FG005|50-Week Extension Study|Death|1|||
33480381|NCT03323437|101651765|FG000|Overall Study|Withdrawal by Subject|0|||
33480382|NCT03323437|101651766|FG001|Overall Study|Withdrawal by Subject|4|||
33480383|NCT01161407|101651767|FG000|Overall Study|Protocol Violation|3|||
33480384|NCT01161407|101651768|FG001|Overall Study|Protocol Violation|1|||
33480385|NCT03207867|101651772|FG000|Overall Study|Adverse Event|1|||
33480386|NCT03207867|101651773|FG001|Overall Study|Adverse Event|0|||
33480387|NCT03207867|101651774|FG002|Overall Study|Adverse Event|1|||
33480388|NCT03207867|101651775|FG003|Overall Study|Adverse Event|0|||
33480389|NCT03207867|101651776|FG004|Overall Study|Adverse Event|0|||
33480390|NCT03207867|101651777|FG005|Overall Study|Adverse Event|2|||
33480391|NCT03207867|101651778|FG006|Overall Study|Adverse Event|1|||
33480392|NCT03207867|101651779|FG007|Overall Study|Adverse Event|1|||
33480393|NCT03207867|101651780|FG008|Overall Study|Adverse Event|2|||
33480394|NCT03207867|101651781|FG009|Overall Study|Adverse Event|2|||
33480395|NCT03207867|101651782|FG010|Overall Study|Adverse Event|0|||
33480396|NCT03207867|101651783|FG011|Overall Study|Adverse Event|0|||
33480397|NCT03207867|101651784|FG012|Overall Study|Adverse Event|0|||
33480398|NCT03207867|101651785|FG013|Overall Study|Adverse Event|0|||
33480399|NCT03207867|101651786|FG014|Overall Study|Adverse Event|0|||
33480400|NCT03207867|101651787|FG015|Overall Study|Adverse Event|0|||
33480401|NCT03207867|101651788|FG016|Overall Study|Adverse Event|3|||
33480402|NCT03207867|101651789|FG017|Overall Study|Adverse Event|1|||
33480403|NCT03207867|101651790|FG018|Overall Study|Adverse Event|2|||
33480404|NCT03207867|101651791|FG019|Overall Study|Adverse Event|1|||
33480405|NCT03207867|101651792|FG020|Overall Study|Adverse Event|0|||
33480406|NCT03207867|101651793|FG021|Overall Study|Adverse Event|0|||
33480407|NCT03207867|101651794|FG022|Overall Study|Adverse Event|0|||
33480408|NCT03207867|101651795|FG023|Overall Study|Adverse Event|0|||
33480409|NCT03207867|101651772|FG000|Overall Study|Death|0|||
33480410|NCT03207867|101651773|FG001|Overall Study|Death|0|||
33480411|NCT03207867|101651774|FG002|Overall Study|Death|0|||
33480412|NCT03207867|101651775|FG003|Overall Study|Death|0|||
33480413|NCT03207867|101651776|FG004|Overall Study|Death|0|||
33480414|NCT03207867|101651777|FG005|Overall Study|Death|1|||
33480415|NCT03207867|101651778|FG006|Overall Study|Death|0|||
33480416|NCT03207867|101651779|FG007|Overall Study|Death|3|||
33480417|NCT03207867|101651780|FG008|Overall Study|Death|1|||
33480418|NCT03207867|101651781|FG009|Overall Study|Death|2|||
33480419|NCT03207867|101651782|FG010|Overall Study|Death|0|||
33480420|NCT03207867|101651783|FG011|Overall Study|Death|1|||
33480421|NCT03207867|101651784|FG012|Overall Study|Death|0|||
33480422|NCT03207867|101651785|FG013|Overall Study|Death|1|||
33480423|NCT03207867|101651786|FG014|Overall Study|Death|0|||
33480424|NCT03207867|101651787|FG015|Overall Study|Death|0|||
33480425|NCT03207867|101651788|FG016|Overall Study|Death|0|||
33480426|NCT03207867|101651789|FG017|Overall Study|Death|2|||
33480427|NCT03207867|101651790|FG018|Overall Study|Death|0|||
33480428|NCT03207867|101651791|FG019|Overall Study|Death|1|||
33480429|NCT03207867|101651792|FG020|Overall Study|Death|0|||
33480430|NCT03207867|101651793|FG021|Overall Study|Death|0|||
33480431|NCT03207867|101651794|FG022|Overall Study|Death|0|||
33480432|NCT03207867|101651795|FG023|Overall Study|Death|0|||
33480433|NCT03207867|101651772|FG000|Overall Study|Physician Decision|3|||
33480434|NCT03207867|101651773|FG001|Overall Study|Physician Decision|5|||
33480435|NCT03207867|101651774|FG002|Overall Study|Physician Decision|0|||
33480436|NCT03207867|101651775|FG003|Overall Study|Physician Decision|3|||
33480437|NCT03207867|101651776|FG004|Overall Study|Physician Decision|2|||
33480438|NCT03207867|101651777|FG005|Overall Study|Physician Decision|0|||
33480439|NCT03207867|101651778|FG006|Overall Study|Physician Decision|0|||
33480440|NCT03207867|101651779|FG007|Overall Study|Physician Decision|0|||
33480441|NCT03207867|101651780|FG008|Overall Study|Physician Decision|4|||
33480442|NCT03207867|101651781|FG009|Overall Study|Physician Decision|2|||
33480443|NCT03207867|101651782|FG010|Overall Study|Physician Decision|0|||
33272087|NCT00103857|100895041|FG006|50-Week Extension Study|Death|0|||
33272088|NCT00103857|100895035|FG000|50-Week Extension Study|Lack of Efficacy|26|||
33480444|NCT03207867|101651783|FG011|Overall Study|Physician Decision|4|||
33480445|NCT03207867|101651784|FG012|Overall Study|Physician Decision|0|||
33480446|NCT03207867|101651785|FG013|Overall Study|Physician Decision|0|||
33480447|NCT03207867|101651786|FG014|Overall Study|Physician Decision|2|||
33480448|NCT03207867|101651787|FG015|Overall Study|Physician Decision|1|||
33480449|NCT03207867|101651788|FG016|Overall Study|Physician Decision|1|||
33480450|NCT03207867|101651789|FG017|Overall Study|Physician Decision|2|||
33480451|NCT03207867|101651790|FG018|Overall Study|Physician Decision|1|||
33480452|NCT03207867|101651791|FG019|Overall Study|Physician Decision|3|||
33480453|NCT03207867|101651792|FG020|Overall Study|Physician Decision|0|||
33480454|NCT03207867|101651793|FG021|Overall Study|Physician Decision|0|||
33480455|NCT03207867|101651794|FG022|Overall Study|Physician Decision|0|||
33480456|NCT03207867|101651795|FG023|Overall Study|Physician Decision|0|||
33480457|NCT03207867|101651772|FG000|Overall Study|Progressive Disease|7|||
33480458|NCT03207867|101651773|FG001|Overall Study|Progressive Disease|7|||
33480459|NCT03207867|101651774|FG002|Overall Study|Progressive Disease|9|||
33480460|NCT03207867|101651775|FG003|Overall Study|Progressive Disease|10|||
33480461|NCT03207867|101651776|FG004|Overall Study|Progressive Disease|11|||
33272089|NCT00103857|100895036|FG001|50-Week Extension Study|Lack of Efficacy|15|||
33272090|NCT00103857|100895037|FG002|50-Week Extension Study|Lack of Efficacy|13|||
33272091|NCT00103857|100895038|FG003|50-Week Extension Study|Lack of Efficacy|16|||
33272092|NCT00103857|100895039|FG004|50-Week Extension Study|Lack of Efficacy|8|||
33272093|NCT00103857|100895040|FG005|50-Week Extension Study|Lack of Efficacy|8|||
33272094|NCT00103857|100895041|FG006|50-Week Extension Study|Lack of Efficacy|0|||
33272095|NCT00103857|100895035|FG000|50-Week Extension Study|Lost to Follow-up|4|||
33272096|NCT00103857|100895036|FG001|50-Week Extension Study|Lost to Follow-up|0|||
33272097|NCT00103857|100895037|FG002|50-Week Extension Study|Lost to Follow-up|1|||
33272098|NCT00103857|100895038|FG003|50-Week Extension Study|Lost to Follow-up|4|||
33272099|NCT00103857|100895039|FG004|50-Week Extension Study|Lost to Follow-up|3|||
33272100|NCT00103857|100895040|FG005|50-Week Extension Study|Lost to Follow-up|3|||
33272101|NCT00103857|100895041|FG006|50-Week Extension Study|Lost to Follow-up|0|||
33272102|NCT00103857|100895035|FG000|50-Week Extension Study|Physician Decision|0|||
33272103|NCT00103857|100895036|FG001|50-Week Extension Study|Physician Decision|1|||
33272104|NCT00103857|100895037|FG002|50-Week Extension Study|Physician Decision|1|||
33272105|NCT00103857|100895038|FG003|50-Week Extension Study|Physician Decision|0|||
33272106|NCT00103857|100895039|FG004|50-Week Extension Study|Physician Decision|0|||
33272107|NCT00103857|100895040|FG005|50-Week Extension Study|Physician Decision|0|||
33272108|NCT00103857|100895041|FG006|50-Week Extension Study|Physician Decision|0|||
33272109|NCT00103857|100895035|FG000|50-Week Extension Study|Pregnancy|0|||
33272110|NCT00103857|100895036|FG001|50-Week Extension Study|Pregnancy|0|||
33272111|NCT00103857|100895037|FG002|50-Week Extension Study|Pregnancy|1|||
33272112|NCT00103857|100895038|FG003|50-Week Extension Study|Pregnancy|0|||
33272113|NCT00103857|100895039|FG004|50-Week Extension Study|Pregnancy|1|||
33272114|NCT00103857|100895040|FG005|50-Week Extension Study|Pregnancy|0|||
33272115|NCT00103857|100895041|FG006|50-Week Extension Study|Pregnancy|0|||
33272116|NCT00103857|100895035|FG000|50-Week Extension Study|Protocol Violation|1|||
33272117|NCT00103857|100895036|FG001|50-Week Extension Study|Protocol Violation|1|||
33272118|NCT00103857|100895037|FG002|50-Week Extension Study|Protocol Violation|1|||
33272119|NCT00103857|100895038|FG003|50-Week Extension Study|Protocol Violation|2|||
33272120|NCT00103857|100895039|FG004|50-Week Extension Study|Protocol Violation|0|||
33272121|NCT00103857|100895040|FG005|50-Week Extension Study|Protocol Violation|1|||
33272122|NCT00103857|100895041|FG006|50-Week Extension Study|Protocol Violation|0|||
33272123|NCT00103857|100895035|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
33272124|NCT00103857|100895036|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
33272125|NCT00103857|100895037|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
33272126|NCT00103857|100895038|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
33272127|NCT00103857|100895039|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
33272128|NCT00103857|100895040|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
33272129|NCT00103857|100895041|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
33272130|NCT00103857|100895035|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
33272131|NCT00103857|100895036|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
33272132|NCT00103857|100895037|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
33272133|NCT00103857|100895038|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
33272134|NCT00103857|100895039|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
33272135|NCT00103857|100895040|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
33272136|NCT00103857|100895041|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
33272137|NCT00103857|100895035|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
33272138|NCT00103857|100895036|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
33272139|NCT00103857|100895037|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
33272140|NCT00103857|100895038|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
33272141|NCT00103857|100895039|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
33272142|NCT00103857|100895040|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
33272143|NCT00103857|100895041|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
33272144|NCT00103857|100895035|FG000|50-Week Extension Study|patient moved|0|||
33272145|NCT00103857|100895036|FG001|50-Week Extension Study|patient moved|0|||
33272146|NCT00103857|100895037|FG002|50-Week Extension Study|patient moved|1|||
33272147|NCT00103857|100895038|FG003|50-Week Extension Study|patient moved|2|||
33272148|NCT00103857|100895039|FG004|50-Week Extension Study|patient moved|0|||
33272149|NCT00103857|100895040|FG005|50-Week Extension Study|patient moved|0|||
33272150|NCT00103857|100895041|FG006|50-Week Extension Study|patient moved|0|||
33272151|NCT00103857|100895035|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
33272152|NCT00103857|100895036|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
33272153|NCT00103857|100895037|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
33272154|NCT00103857|100895038|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
33272155|NCT00103857|100895039|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
33272156|NCT00103857|100895040|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
33272157|NCT00103857|100895041|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
33272158|NCT00103857|100895035|FG000|50-Week Extension Study|reason unspecified|0|||
33272159|NCT00103857|100895036|FG001|50-Week Extension Study|reason unspecified|0|||
33272160|NCT00103857|100895037|FG002|50-Week Extension Study|reason unspecified|0|||
33272161|NCT00103857|100895038|FG003|50-Week Extension Study|reason unspecified|0|||
33272162|NCT00103857|100895039|FG004|50-Week Extension Study|reason unspecified|1|||
33272163|NCT00103857|100895040|FG005|50-Week Extension Study|reason unspecified|0|||
33272164|NCT00103857|100895041|FG006|50-Week Extension Study|reason unspecified|0|||
33272165|NCT00636168|100895042|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
33272166|NCT00636168|100895043|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
33272167|NCT00636168|100895042|FG000|Randomized to Study Drug|Adverse Event|1|||
33272168|NCT00636168|100895043|FG001|Randomized to Study Drug|Adverse Event|0|||
33272169|NCT00636168|100895042|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
33272170|NCT00636168|100895043|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
33272171|NCT00636168|100895042|FG000|Treated With Study Drug|Recurrence of disease|135|||
33272172|NCT00636168|100895043|FG001|Treated With Study Drug|Recurrence of disease|282|||
33272173|NCT00636168|100895042|FG000|Treated With Study Drug|Adverse Event|250|||
33272174|NCT00636168|100895043|FG001|Treated With Study Drug|Adverse Event|22|||
33272175|NCT00636168|100895042|FG000|Treated With Study Drug|Participant withdrew consent|16|||
33272176|NCT00636168|100895043|FG001|Treated With Study Drug|Participant withdrew consent|21|||
33272177|NCT00636168|100895042|FG000|Treated With Study Drug|Poor/non-compliance|1|||
33272178|NCT00636168|100895043|FG001|Treated With Study Drug|Poor/non-compliance|3|||
33272179|NCT00636168|100895042|FG000|Treated With Study Drug|Death|3|||
33272180|NCT00636168|100895043|FG001|Treated With Study Drug|Death|0|||
33272181|NCT00636168|100895042|FG000|Treated With Study Drug|Pregnancy|1|||
33272182|NCT00636168|100895043|FG001|Treated With Study Drug|Pregnancy|0|||
33272183|NCT00636168|100895042|FG000|Treated With Study Drug|No longer meets study criteria|1|||
33272184|NCT00636168|100895043|FG001|Treated With Study Drug|No longer meets study criteria|0|||
33272185|NCT00636168|100895042|FG000|Treated With Study Drug|Other reason|1|||
33272186|NCT00636168|100895043|FG001|Treated With Study Drug|Other reason|3|||
33272187|NCT00636168|100895042|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
33272188|NCT00636168|100895043|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
33272189|NCT00636168|100895042|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
33272190|NCT00636168|100895043|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
33272191|NCT00636168|100895042|FG000|Long Term Follow-Up|Death|8|||
33272192|NCT00636168|100895043|FG001|Long Term Follow-Up|Death|9|||
33272193|NCT00267865|100895044|FG000|Induction Treatment|Died before completing.|2|||
33272194|NCT00267865|100895044|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
33272195|NCT03615404|100895045|FG000|Overall Study|Death|1|||
33272196|NCT03615404|100895045|FG000|Overall Study|vaccine did not pass quality assurance|1|||
33272197|NCT01052714|100895046|FG000|Overall Study|Adverse Event|6|||
33272198|NCT01052714|100895047|FG001|Overall Study|Adverse Event|3|||
33272199|NCT01052714|100895048|FG002|Overall Study|Adverse Event|0|||
33272200|NCT01052714|100895046|FG000|Overall Study|Death|1|||
33272201|NCT01052714|100895047|FG001|Overall Study|Death|2|||
33272202|NCT01052714|100895048|FG002|Overall Study|Death|0|||
33272203|NCT01052714|100895046|FG000|Overall Study|Lost to Follow-up|2|||
33272204|NCT01052714|100895047|FG001|Overall Study|Lost to Follow-up|3|||
33272205|NCT01052714|100895048|FG002|Overall Study|Lost to Follow-up|0|||
33272206|NCT01052714|100895046|FG000|Overall Study|Physician Decision|9|||
33272207|NCT01052714|100895047|FG001|Overall Study|Physician Decision|9|||
33272208|NCT01052714|100895048|FG002|Overall Study|Physician Decision|1|||
33272209|NCT01052714|100895046|FG000|Overall Study|Withdrawal by Subject|7|||
33272210|NCT01052714|100895047|FG001|Overall Study|Withdrawal by Subject|12|||
33272211|NCT01052714|100895048|FG002|Overall Study|Withdrawal by Subject|1|||
33272212|NCT01288729|100895052|FG000|Overall Study|Withdrawal by Subject|1|||
33272213|NCT01288729|100895053|FG001|Overall Study|Withdrawal by Subject|0|||
33272214|NCT02935673|100895054|FG000|Overall Study|Adverse Event|0|||
33272215|NCT02935673|100895055|FG001|Overall Study|Adverse Event|1|||
33272216|NCT02935673|100895056|FG002|Overall Study|Adverse Event|0|||
33272217|NCT02935673|100895054|FG000|Overall Study|Withdrawal by Subject|1|||
33272218|NCT02935673|100895055|FG001|Overall Study|Withdrawal by Subject|2|||
33272219|NCT02935673|100895056|FG002|Overall Study|Withdrawal by Subject|0|||
33272220|NCT02354417|100895057|FG000|Overall Study|Physician Decision|1|||
33272221|NCT00923078|100895058|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
33272222|NCT00923078|100895059|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
33272223|NCT00923078|100895060|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
33272224|NCT00923078|100895058|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
33272225|NCT00923078|100895059|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
33272226|NCT00923078|100895060|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
33272227|NCT00417885|100895061|FG000|Overall Study|Adverse Event|1|||
33272228|NCT00417885|100895061|FG000|Overall Study|Objective Progression or Relapse|3|||
33272229|NCT00417885|100895061|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
33272230|NCT00237809|100895062|FG000|Overall Study|Lost to Follow-up|11|||
33272231|NCT00237809|100895063|FG001|Overall Study|Lost to Follow-up|10|||
33272232|NCT00237809|100895064|FG002|Overall Study|Lost to Follow-up|9|||
33272233|NCT00237809|100895065|FG003|Overall Study|Lost to Follow-up|9|||
33272234|NCT02224755|100895066|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
33272235|NCT02224755|100895067|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
33272236|NCT02224755|100895066|FG000|Two Year Follow up Post-implant|Death|103|||
33272237|NCT02224755|100895067|FG001|Two Year Follow up Post-implant|Death|98|||
33272238|NCT02224755|100895066|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
33272239|NCT02224755|100895067|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
33272240|NCT02224755|100895066|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
33272241|NCT02224755|100895067|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
33272242|NCT02224755|100895066|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
33272243|NCT02224755|100895067|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
33272244|NCT01156675|100895072|FG000|Overall Study|Death|5|||
33272245|NCT01156675|100895073|FG001|Overall Study|Death|3|||
33272246|NCT01156675|100895074|FG002|Overall Study|Death|0|||
33272247|NCT01156675|100895072|FG000|Overall Study|No data|29|||
33272248|NCT01156675|100895073|FG001|Overall Study|No data|22|||
33272249|NCT01156675|100895074|FG002|Overall Study|No data|2|||
33272250|NCT00508144|100895079|FG000|Overall Study|Not eligible|6|||
33272251|NCT00508144|100895079|FG000|Overall Study|Death|5|||
33272252|NCT00749944|100895080|FG000|Overall Study|Lost to Follow-up|2|||
33272253|NCT00749944|100895081|FG001|Overall Study|Lost to Follow-up|1|||
33272254|NCT00749944|100895080|FG000|Overall Study|Other|1|||
33272255|NCT00749944|100895081|FG001|Overall Study|Other|0|||
33272256|NCT00749944|100895080|FG000|Overall Study|Withdrawal by Subject|2|||
33272257|NCT00749944|100895081|FG001|Overall Study|Withdrawal by Subject|0|||
33272258|NCT01322386|100895082|FG000|Overall Study|Protocol Violation|0|||
33272259|NCT01322386|100895083|FG001|Overall Study|Protocol Violation|1|||
33272260|NCT01322386|100895082|FG000|Overall Study|Physician Decision|0|||
33272261|NCT01322386|100895083|FG001|Overall Study|Physician Decision|1|||
33272262|NCT01964547|100895084|FG000|Overall Study|Adverse Event|8|||
33272263|NCT01964547|100895085|FG001|Overall Study|Adverse Event|2|||
33272264|NCT01964547|100895084|FG000|Overall Study|Withdrawal by Subject|4|||
33272265|NCT01964547|100895085|FG001|Overall Study|Withdrawal by Subject|7|||
33272266|NCT01964547|100895084|FG000|Overall Study|Lost to Follow-up|0|||
33272267|NCT01964547|100895085|FG001|Overall Study|Lost to Follow-up|1|||
33272268|NCT01964547|100895084|FG000|Overall Study|Withdrawal by Investigator|0|||
33272269|NCT01964547|100895085|FG001|Overall Study|Withdrawal by Investigator|1|||
33272270|NCT04710576|100895086|FG000|Overall Study|Participants still in the study|73|||
33272271|NCT04710576|100895087|FG001|Overall Study|Participants still in the study|70|||
33272272|NCT04710576|100895088|FG002|Overall Study|Participants still in the study|60|||
33272273|NCT04710576|100895086|FG000|Overall Study|Death|2|||
33272274|NCT04710576|100895087|FG001|Overall Study|Death|7|||
33272275|NCT04710576|100895088|FG002|Overall Study|Death|12|||
33272276|NCT04710576|100895086|FG000|Overall Study|Withdrawal by Subject|4|||
33272277|NCT04710576|100895087|FG001|Overall Study|Withdrawal by Subject|3|||
33272278|NCT04710576|100895088|FG002|Overall Study|Withdrawal by Subject|7|||
33272279|NCT04710576|100895086|FG000|Overall Study|Sponsor decision|1|||
33272280|NCT04710576|100895087|FG001|Overall Study|Sponsor decision|0|||
33272281|NCT04710576|100895088|FG002|Overall Study|Sponsor decision|0|||
33272282|NCT00113529|100895091|FG000|Overall Study|Adverse Event|4|||
33272283|NCT00113529|100895091|FG000|Overall Study|Lack of Efficacy|20|||
33272284|NCT00113529|100895091|FG000|Overall Study|Decision of sponsor|6|||
33272285|NCT00113529|100895091|FG000|Overall Study|Withdrawal by Subject|4|||
33272286|NCT03979040|100895092|FG000|Overall Study|Withdrawal by Subject|24|||
33272287|NCT03979040|100895093|FG001|Overall Study|Withdrawal by Subject|32|||
33272288|NCT03979040|100895092|FG000|Overall Study|randomized but never started treatment|32|||
33272289|NCT03979040|100895093|FG001|Overall Study|randomized but never started treatment|39|||
33272290|NCT03979040|100895092|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
33272291|NCT03979040|100895093|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
33272292|NCT00603278|100895094|FG000|Overall Study|Lack of Efficacy|35|||
33272293|NCT00603278|100895095|FG001|Overall Study|Lack of Efficacy|10|||
33272294|NCT00603278|100895096|FG002|Overall Study|Lack of Efficacy|11|||
33272295|NCT00603278|100895097|FG003|Overall Study|Lack of Efficacy|8|||
33272296|NCT00603278|100895098|FG004|Overall Study|Lack of Efficacy|7|||
33272297|NCT00603278|100895099|FG005|Overall Study|Lack of Efficacy|14|||
33272298|NCT00603278|100895094|FG000|Overall Study|Adverse Event|0|||
33272299|NCT00603278|100895095|FG001|Overall Study|Adverse Event|3|||
33272300|NCT00603278|100895096|FG002|Overall Study|Adverse Event|1|||
33272301|NCT00603278|100895097|FG003|Overall Study|Adverse Event|0|||
33272302|NCT00603278|100895098|FG004|Overall Study|Adverse Event|2|||
33272303|NCT00603278|100895099|FG005|Overall Study|Adverse Event|1|||
33272304|NCT00603278|100895094|FG000|Overall Study|Withdrawal by Subject|2|||
33272305|NCT00603278|100895095|FG001|Overall Study|Withdrawal by Subject|3|||
33272306|NCT00603278|100895096|FG002|Overall Study|Withdrawal by Subject|1|||
33272307|NCT00603278|100895097|FG003|Overall Study|Withdrawal by Subject|2|||
33272308|NCT00603278|100895098|FG004|Overall Study|Withdrawal by Subject|1|||
33272309|NCT00603278|100895099|FG005|Overall Study|Withdrawal by Subject|2|||
33272310|NCT00603278|100895094|FG000|Overall Study|Protocol Violation|3|||
33272311|NCT00603278|100895095|FG001|Overall Study|Protocol Violation|0|||
33272312|NCT00603278|100895096|FG002|Overall Study|Protocol Violation|1|||
33272313|NCT00603278|100895097|FG003|Overall Study|Protocol Violation|1|||
33272314|NCT00603278|100895098|FG004|Overall Study|Protocol Violation|0|||
33272315|NCT00603278|100895099|FG005|Overall Study|Protocol Violation|1|||
33272316|NCT00603278|100895094|FG000|Overall Study|Physician Decision|0|||
33272317|NCT00603278|100895095|FG001|Overall Study|Physician Decision|1|||
33272318|NCT00603278|100895096|FG002|Overall Study|Physician Decision|0|||
33272319|NCT00603278|100895097|FG003|Overall Study|Physician Decision|0|||
33272320|NCT00603278|100895098|FG004|Overall Study|Physician Decision|2|||
33272321|NCT00603278|100895099|FG005|Overall Study|Physician Decision|1|||
33272322|NCT00603278|100895094|FG000|Overall Study|Lost to Follow-up|1|||
33272323|NCT00603278|100895095|FG001|Overall Study|Lost to Follow-up|0|||
33272324|NCT00603278|100895096|FG002|Overall Study|Lost to Follow-up|0|||
33272325|NCT00603278|100895097|FG003|Overall Study|Lost to Follow-up|0|||
33272326|NCT00603278|100895098|FG004|Overall Study|Lost to Follow-up|1|||
33272327|NCT00603278|100895099|FG005|Overall Study|Lost to Follow-up|0|||
33272328|NCT00853957|100895106|FG000|Overall Study|Adverse Event|9|||
33272329|NCT00853957|100895107|FG001|Overall Study|Adverse Event|3|||
33272330|NCT00853957|100895106|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33272331|NCT00853957|100895107|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33272332|NCT00853957|100895106|FG000|Overall Study|Subject withdrew consent|4|||
33272333|NCT00853957|100895107|FG001|Overall Study|Subject withdrew consent|5|||
33272334|NCT00853957|100895106|FG000|Overall Study|Lost to Follow-up|1|||
33272335|NCT00853957|100895107|FG001|Overall Study|Lost to Follow-up|6|||
33272336|NCT00853957|100895106|FG000|Overall Study|Protocol deviation|0|||
33272337|NCT00853957|100895107|FG001|Overall Study|Protocol deviation|3|||
33272338|NCT03493282|100895108|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
33272339|NCT03493282|100895109|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
33272340|NCT03493282|100895110|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
33272341|NCT03493282|100895108|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
33272342|NCT03493282|100895109|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
33272343|NCT03493282|100895110|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
33272344|NCT01543204|100895111|FG000|Overall Study|Non-compliance|1|||
33272345|NCT01543204|100895111|FG000|Overall Study|Adverse Event|1|||
33272346|NCT01543204|100895111|FG000|Overall Study|Withdrawal by Subject|4|||
33272347|NCT01543204|100895111|FG000|Overall Study|Requirement for Alternative Therapy|1|||
33272348|NCT01543204|100895111|FG000|Overall Study|Lost to Follow-up|1|||
33272349|NCT00088166|100895115|FG000|Overall Study|Adverse Event|11|||
33272350|NCT00088166|100895116|FG001|Overall Study|Adverse Event|9|||
33272351|NCT00088166|100895115|FG000|Overall Study|Death|3|||
33272352|NCT00088166|100895116|FG001|Overall Study|Death|1|||
33272353|NCT00088166|100895115|FG000|Overall Study|Lost to Follow-up|0|||
33272354|NCT00088166|100895116|FG001|Overall Study|Lost to Follow-up|1|||
33272355|NCT00088166|100895115|FG000|Overall Study|Physician Decision|4|||
33272356|NCT00088166|100895116|FG001|Overall Study|Physician Decision|1|||
33272357|NCT00088166|100895115|FG000|Overall Study|Protocol Violation|1|||
33272358|NCT00088166|100895116|FG001|Overall Study|Protocol Violation|5|||
33272359|NCT00088166|100895115|FG000|Overall Study|Patient deterioration|29|||
33272360|NCT00088166|100895116|FG001|Overall Study|Patient deterioration|39|||
33272361|NCT00088166|100895115|FG000|Overall Study|Withdrawal by Subject|5|||
33272362|NCT00088166|100895116|FG001|Overall Study|Withdrawal by Subject|5|||
33272363|NCT04739306|100895117|FG000|Main Study Period|Adverse Event|6|||
33272364|NCT04739306|100895118|FG001|Main Study Period|Adverse Event|7|||
33272365|NCT04739306|100895117|FG000|Main Study Period|Lost to Follow-up|4|||
33272366|NCT04739306|100895118|FG001|Main Study Period|Lost to Follow-up|6|||
33272367|NCT04739306|100895117|FG000|Main Study Period|Physician Decision|1|||
33272368|NCT04739306|100895118|FG001|Main Study Period|Physician Decision|1|||
33272369|NCT04739306|100895117|FG000|Main Study Period|Withdrawal by Subject|8|||
33272370|NCT04739306|100895118|FG001|Main Study Period|Withdrawal by Subject|6|||
33272371|NCT04739306|100895117|FG000|Main Study Period|Protocol Violation|0|||
33272372|NCT04739306|100895118|FG001|Main Study Period|Protocol Violation|1|||
33272373|NCT04739306|100895117|FG000|Main Study Period|War in Ukraine|1|||
33272374|NCT04739306|100895118|FG001|Main Study Period|War in Ukraine|1|||
33480462|NCT03207867|101651777|FG005|Overall Study|Progressive Disease|10|||
33272375|NCT04765046|100895119|FG000|Overall Study|Screen Failure|2|||
33272376|NCT04765046|100895119|FG000|Overall Study|Withdrawal by Subject|4|||
33272377|NCT04765046|100895119|FG000|Overall Study|Physician Decision|4|||
33272378|NCT04765046|100895119|FG000|Overall Study|Surgery Cancelled|8|||
33272379|NCT03122860|100895120|FG000|Overall Study|Discontinued Before Treatment|1|||
33272380|NCT03122860|100895121|FG001|Overall Study|Discontinued Before Treatment|1|||
33272381|NCT03122860|100895122|FG002|Overall Study|Discontinued Before Treatment|2|||
33272382|NCT03122860|100895123|FG003|Overall Study|Discontinued Before Treatment|0|||
33272383|NCT03122860|100895124|FG004|Overall Study|Discontinued Before Treatment|1|||
33272384|NCT03122860|100895125|FG005|Overall Study|Discontinued Before Treatment|0|||
33272385|NCT03122860|100895120|FG000|Overall Study|Adverse Event|1|||
33272386|NCT03122860|100895121|FG001|Overall Study|Adverse Event|0|||
33272387|NCT03122860|100895122|FG002|Overall Study|Adverse Event|1|||
33272388|NCT03122860|100895123|FG003|Overall Study|Adverse Event|1|||
33272389|NCT03122860|100895124|FG004|Overall Study|Adverse Event|0|||
33272390|NCT03122860|100895125|FG005|Overall Study|Adverse Event|0|||
33272391|NCT03122860|100895120|FG000|Overall Study|Lost to Follow-up|5|||
33272392|NCT03122860|100895121|FG001|Overall Study|Lost to Follow-up|2|||
33272393|NCT03122860|100895122|FG002|Overall Study|Lost to Follow-up|3|||
33272394|NCT03122860|100895123|FG003|Overall Study|Lost to Follow-up|3|||
33272395|NCT03122860|100895124|FG004|Overall Study|Lost to Follow-up|5|||
33272396|NCT03122860|100895125|FG005|Overall Study|Lost to Follow-up|4|||
33272397|NCT03122860|100895120|FG000|Overall Study|Subject Non-Compliance|0|||
33272398|NCT03122860|100895121|FG001|Overall Study|Subject Non-Compliance|0|||
33272399|NCT03122860|100895122|FG002|Overall Study|Subject Non-Compliance|1|||
33272400|NCT03122860|100895123|FG003|Overall Study|Subject Non-Compliance|0|||
33272401|NCT03122860|100895124|FG004|Overall Study|Subject Non-Compliance|0|||
33272402|NCT03122860|100895125|FG005|Overall Study|Subject Non-Compliance|0|||
33272403|NCT03122860|100895120|FG000|Overall Study|Withdrawal by Subject|3|||
33272404|NCT03122860|100895121|FG001|Overall Study|Withdrawal by Subject|2|||
33272405|NCT03122860|100895122|FG002|Overall Study|Withdrawal by Subject|5|||
33272406|NCT03122860|100895123|FG003|Overall Study|Withdrawal by Subject|7|||
33272407|NCT03122860|100895124|FG004|Overall Study|Withdrawal by Subject|9|||
33272408|NCT03122860|100895125|FG005|Overall Study|Withdrawal by Subject|8|||
33272409|NCT00096278|100895129|FG000|Overall Study|No follow-up data|15|||
33272410|NCT00096278|100895130|FG001|Overall Study|No follow-up data|18|||
33272411|NCT00096278|100895129|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
33272412|NCT00096278|100895130|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
33272413|NCT00648895|100895133|FG000|Overall Study|Lack of Efficacy|0|||
33272414|NCT00648895|100895134|FG001|Overall Study|Lack of Efficacy|1|||
33272415|NCT04222088|100895135|FG000|Overall Study|Lost to Follow-up|5|||
33272416|NCT04222088|100895136|FG001|Overall Study|Lost to Follow-up|1|||
33272417|NCT04222088|100895135|FG000|Overall Study|Withdrawal by Subject|4|||
33272418|NCT04222088|100895136|FG001|Overall Study|Withdrawal by Subject|0|||
33272419|NCT03236779|100895137|FG000|Overall Study|Lost to Follow-up|13|||
33272420|NCT03236779|100895138|FG001|Overall Study|Lost to Follow-up|21|||
33272421|NCT03060525|100895139|FG000|Overall Study|moved out of state|1|||
33272422|NCT03060525|100895140|FG001|Overall Study|moved out of state|1|||
33272423|NCT03060525|100895141|FG002|Overall Study|moved out of state|1|||
33272424|NCT03060525|100895142|FG003|Overall Study|moved out of state|1|||
33272425|NCT03060525|100895139|FG000|Overall Study|unable to meet time commitment required of study|2|||
33272426|NCT03060525|100895140|FG001|Overall Study|unable to meet time commitment required of study|3|||
33272427|NCT03060525|100895141|FG002|Overall Study|unable to meet time commitment required of study|3|||
33272428|NCT03060525|100895142|FG003|Overall Study|unable to meet time commitment required of study|1|||
33272429|NCT03060525|100895139|FG000|Overall Study|no longer interested in doing intervention|0|||
33272430|NCT03060525|100895140|FG001|Overall Study|no longer interested in doing intervention|0|||
33272431|NCT03060525|100895141|FG002|Overall Study|no longer interested in doing intervention|0|||
33272432|NCT03060525|100895142|FG003|Overall Study|no longer interested in doing intervention|1|||
33272433|NCT01802333|100895143|FG000|Overall Study|Ineligible|2|||
33272434|NCT01802333|100895144|FG001|Overall Study|Ineligible|6|||
33272435|NCT01802333|100895145|FG002|Overall Study|Ineligible|8|||
33272436|NCT01802333|100895143|FG000|Overall Study|Adverse Event|1|||
33272437|NCT01802333|100895144|FG001|Overall Study|Adverse Event|8|||
33272438|NCT01802333|100895145|FG002|Overall Study|Adverse Event|8|||
33272439|NCT01802333|100895143|FG000|Overall Study|Withdrawal by Subject|6|||
33272440|NCT01802333|100895144|FG001|Overall Study|Withdrawal by Subject|6|||
33272441|NCT01802333|100895145|FG002|Overall Study|Withdrawal by Subject|5|||
33272442|NCT01802333|100895143|FG000|Overall Study|Progression/relapse|1|||
33272443|NCT01802333|100895144|FG001|Overall Study|Progression/relapse|3|||
33272444|NCT01802333|100895145|FG002|Overall Study|Progression/relapse|0|||
33272445|NCT01802333|100895143|FG000|Overall Study|Death|7|||
33272446|NCT01802333|100895144|FG001|Overall Study|Death|14|||
33272447|NCT01802333|100895145|FG002|Overall Study|Death|13|||
33272448|NCT01802333|100895143|FG000|Overall Study|Other - not protocol specified|32|||
33272449|NCT01802333|100895144|FG001|Overall Study|Other - not protocol specified|22|||
33272450|NCT01802333|100895145|FG002|Overall Study|Other - not protocol specified|24|||
33272451|NCT01802333|100895143|FG000|Overall Study|Did not start treatment|0|||
33272452|NCT01802333|100895144|FG001|Overall Study|Did not start treatment|2|||
33272453|NCT01802333|100895145|FG002|Overall Study|Did not start treatment|5|||
33272454|NCT01416285|100897559|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
33272455|NCT01416285|100897560|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
33272456|NCT02312258|100897561|FG000|Overall Study|Lost to Follow-up|8|||
33272457|NCT02312258|100897562|FG001|Overall Study|Lost to Follow-up|8|||
33272458|NCT02312258|100897561|FG000|Overall Study|Withdrawal by Patient|49|||
33272459|NCT02312258|100897562|FG001|Overall Study|Withdrawal by Patient|76|||
33272460|NCT02312258|100897561|FG000|Overall Study|Reason not Specified|107|||
33272461|NCT02312258|100897562|FG001|Overall Study|Reason not Specified|159|||
33272462|NCT02312258|100897561|FG000|Overall Study|Missing|2|||
33272463|NCT02312258|100897562|FG001|Overall Study|Missing|1|||
33272464|NCT02312258|100897561|FG000|Overall Study|Death|115|||
33272465|NCT02312258|100897562|FG001|Overall Study|Death|181|||
33272466|NCT02727998|100897565|FG000|Overall Study|Lost to Follow-up|3|||
33272467|NCT02727998|100897566|FG001|Overall Study|Lost to Follow-up|3|||
33272468|NCT02727998|100897565|FG000|Overall Study|Withdrawal by Subject|0|||
33272469|NCT02727998|100897566|FG001|Overall Study|Withdrawal by Subject|1|||
33272470|NCT01393600|100897567|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
33272471|NCT01393600|100897568|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
33272472|NCT01393600|100897569|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
33272473|NCT01393600|100897570|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
33272474|NCT01393600|100897567|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
33272475|NCT01393600|100897568|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
33272476|NCT01393600|100897569|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
33272477|NCT01393600|100897570|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
33272478|NCT01393600|100897567|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
33272479|NCT01393600|100897568|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
33272480|NCT01393600|100897569|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
33272481|NCT01393600|100897570|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
33272482|NCT01393600|100897567|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
33272483|NCT01393600|100897568|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
33272484|NCT01393600|100897569|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
33272485|NCT01393600|100897570|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
33272486|NCT01393600|100897567|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
33272487|NCT01393600|100897568|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
33272488|NCT01393600|100897569|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
33272489|NCT01393600|100897570|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
33272490|NCT01393600|100897567|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
33272491|NCT01393600|100897568|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
33272492|NCT01393600|100897569|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
33272493|NCT01393600|100897570|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
33272494|NCT01393600|100897567|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
33272495|NCT01393600|100897568|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
33272496|NCT01393600|100897569|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
33272497|NCT01393600|100897570|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
33272498|NCT03406507|100897571|FG000|Extension Period|Lack of Efficacy|0|||
33272499|NCT03406507|100897572|FG001|Extension Period|Lack of Efficacy|1|||
33272500|NCT02676778|100897573|FG000|Overall Study|Disease Progression|7|||
33272501|NCT02676778|100897574|FG001|Overall Study|Disease Progression|3|||
33272502|NCT02676778|100897575|FG002|Overall Study|Disease Progression|1|||
33272503|NCT02676778|100897573|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
33272504|NCT02676778|100897574|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
33272505|NCT02676778|100897575|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
33272506|NCT02676778|100897573|FG000|Overall Study|Withdrawal by Subject|3|||
33272507|NCT02676778|100897574|FG001|Overall Study|Withdrawal by Subject|2|||
33272508|NCT02676778|100897575|FG002|Overall Study|Withdrawal by Subject|0|||
33272509|NCT02676778|100897573|FG000|Overall Study|Other|4|||
33272510|NCT02676778|100897574|FG001|Overall Study|Other|3|||
33272511|NCT02676778|100897575|FG002|Overall Study|Other|0|||
33272512|NCT02676778|100897573|FG000|Overall Study|Adverse Event|2|||
33272513|NCT02676778|100897574|FG001|Overall Study|Adverse Event|3|||
33272514|NCT02676778|100897575|FG002|Overall Study|Adverse Event|0|||
33272515|NCT02713594|100897578|FG000|Overall Study|Withdrawal by Subject|32|||
33272516|NCT02713594|100897579|FG001|Overall Study|Withdrawal by Subject|22|||
33272517|NCT02713594|100897578|FG000|Overall Study|Lost to Follow-up|358|||
33272518|NCT02713594|100897579|FG001|Overall Study|Lost to Follow-up|374|||
33272519|NCT03316170|100897580|FG000|Overall Study|Death|1|||
33272520|NCT03316170|100897581|FG001|Overall Study|Death|0|||
33272521|NCT03316170|100897580|FG000|Overall Study|Lost to Follow-up|6|||
33272522|NCT03316170|100897581|FG001|Overall Study|Lost to Follow-up|7|||
33272523|NCT02825550|100897583|FG000|Overall Study|Physician Decision|1|||
33272524|NCT01517282|100897584|FG000|Overall Study|Consent withdrawn|0|||
33272525|NCT01517282|100897585|FG001|Overall Study|Consent withdrawn|1|||
33272526|NCT01517282|100897586|FG002|Overall Study|Consent withdrawn|1|||
33272527|NCT01517282|100897587|FG003|Overall Study|Consent withdrawn|1|||
33272528|NCT01517282|100897584|FG000|Overall Study|Physician Decision|1|||
33272529|NCT01517282|100897585|FG001|Overall Study|Physician Decision|0|||
33272530|NCT01517282|100897586|FG002|Overall Study|Physician Decision|0|||
33272531|NCT01517282|100897587|FG003|Overall Study|Physician Decision|0|||
33272532|NCT02152384|100897590|FG000|Period 1|Withdrawal by Subject|0|||
33272533|NCT02152384|100897591|FG001|Period 1|Withdrawal by Subject|1|||
33272534|NCT02152384|100897590|FG000|Period 1|Adverse Event|1|||
33272535|NCT02152384|100897591|FG001|Period 1|Adverse Event|1|||
33272536|NCT05005247|100897592|FG000|Overall Study|Withdrawal by Subject|0|||
33272537|NCT05005247|100897593|FG001|Overall Study|Withdrawal by Subject|1|||
33272538|NCT05005247|100897594|FG002|Overall Study|Withdrawal by Subject|0|||
33272539|NCT02516202|100897595|FG000|Overall Study|Withdrawal by Subject|1|||
33272540|NCT02516202|100897596|FG001|Overall Study|Withdrawal by Subject|0|||
33272541|NCT02516202|100897597|FG002|Overall Study|Withdrawal by Subject|1|||
33272542|NCT02516202|100897595|FG000|Overall Study|Lost to Follow-up|1|||
33272543|NCT02516202|100897596|FG001|Overall Study|Lost to Follow-up|1|||
33272544|NCT02516202|100897597|FG002|Overall Study|Lost to Follow-up|1|||
33272545|NCT02516202|100897595|FG000|Overall Study|Stopped Follow-up|0|||
33272546|NCT02516202|100897596|FG001|Overall Study|Stopped Follow-up|0|||
33272547|NCT02516202|100897597|FG002|Overall Study|Stopped Follow-up|1|||
33272548|NCT04311983|100897598|FG000|Overall Study|Lost to Follow-up|421|||
33272549|NCT04311983|100897599|FG001|Overall Study|Lost to Follow-up|456|||
33272550|NCT04311983|100897598|FG000|Overall Study|Incomplete survey|7|||
33272551|NCT04311983|100897599|FG001|Overall Study|Incomplete survey|9|||
33272552|NCT04311983|100897598|FG000|Overall Study|Death|1|||
33272553|NCT04311983|100897599|FG001|Overall Study|Death|0|||
33272554|NCT00476151|100897600|FG000|Overall Study|Adverse Event|0|||
33272555|NCT00476151|100897601|FG001|Overall Study|Adverse Event|2|||
33272556|NCT00476151|100897600|FG000|Overall Study|Protocol Violation|1|||
33272557|NCT00476151|100897601|FG001|Overall Study|Protocol Violation|3|||
33272558|NCT00476151|100897600|FG000|Overall Study|Withdrawal by Subject|2|||
33272559|NCT00476151|100897601|FG001|Overall Study|Withdrawal by Subject|0|||
33272560|NCT00476151|100897600|FG000|Overall Study|Physician Decision|0|||
33272561|NCT00476151|100897601|FG001|Overall Study|Physician Decision|2|||
33272562|NCT01668355|100897602|FG000|Overall Study|Death|3|||
33272563|NCT01668355|100897603|FG001|Overall Study|Death|1|||
33272564|NCT01668355|100897602|FG000|Overall Study|Withdrawal by Subject|6|||
33272565|NCT01668355|100897603|FG001|Overall Study|Withdrawal by Subject|1|||
33272566|NCT01528605|100897604|FG000|Overall Study|Lost to Follow-up|1|||
33272567|NCT01528605|100897605|FG001|Overall Study|Lost to Follow-up|0|||
33272568|NCT01528605|100897606|FG002|Overall Study|Lost to Follow-up|1|||
33272569|NCT01528605|100897607|FG003|Overall Study|Lost to Follow-up|1|||
33272570|NCT01528605|100897608|FG004|Overall Study|Lost to Follow-up|0|||
33272571|NCT01528605|100897609|FG005|Overall Study|Lost to Follow-up|0|||
33272572|NCT01528605|100897604|FG000|Overall Study|Death|1|||
33272573|NCT01528605|100897605|FG001|Overall Study|Death|0|||
33272574|NCT01528605|100897606|FG002|Overall Study|Death|0|||
33272575|NCT01528605|100897607|FG003|Overall Study|Death|0|||
33272576|NCT01528605|100897608|FG004|Overall Study|Death|0|||
33272577|NCT01528605|100897609|FG005|Overall Study|Death|0|||
33272578|NCT01794689|100897612|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
33272579|NCT01794689|100897613|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
33272580|NCT01794689|100897614|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
33272581|NCT01794689|100897615|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
33272582|NCT01794689|100897612|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
33272583|NCT01794689|100897613|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
33272584|NCT01794689|100897614|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
33272585|NCT01794689|100897615|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
33272586|NCT01794689|100897612|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
33272587|NCT01794689|100897613|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
33272588|NCT01794689|100897614|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
33272589|NCT01794689|100897615|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
33272590|NCT01794689|100897612|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
33272591|NCT01794689|100897613|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
33272592|NCT01794689|100897614|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
33272593|NCT01794689|100897615|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
33272594|NCT01009645|100897616|FG000|Overall Study|Lost to Follow-up|2|||
33272595|NCT01009645|100897617|FG001|Overall Study|Lost to Follow-up|8|||
33272596|NCT01009645|100897618|FG002|Overall Study|Lost to Follow-up|4|||
33272597|NCT01009645|100897619|FG003|Overall Study|Lost to Follow-up|5|||
33272598|NCT01441596|100897621|FG000|Overall Study|Other reason not defined below|0|||
33272599|NCT01441596|100897622|FG001|Overall Study|Other reason not defined below|2|||
33272600|NCT01441596|100897623|FG002|Overall Study|Other reason not defined below|1|||
33272601|NCT01441596|100897621|FG000|Overall Study|Withdrawal by Subject|4|||
33272602|NCT01441596|100897622|FG001|Overall Study|Withdrawal by Subject|0|||
33272603|NCT01441596|100897623|FG002|Overall Study|Withdrawal by Subject|2|||
33272604|NCT01441596|100897621|FG000|Overall Study|Not treated|0|||
33272605|NCT01441596|100897622|FG001|Overall Study|Not treated|1|||
33272606|NCT01441596|100897623|FG002|Overall Study|Not treated|1|||
33272607|NCT01365546|100897624|FG000|Overall Study|Withdrawal by Subject|1|||
33272608|NCT01365546|100897624|FG000|Overall Study|Screen failure|9|||
33272609|NCT01365546|100897624|FG000|Overall Study|Study termination|1|||
33272610|NCT02133131|100897625|FG000|Overall Study|Adverse Event|0|||
33272611|NCT02133131|100897626|FG001|Overall Study|Adverse Event|0|||
33272612|NCT02133131|100897627|FG002|Overall Study|Adverse Event|0|||
33272613|NCT02133131|100897628|FG003|Overall Study|Adverse Event|1|||
33272614|NCT02133131|100897629|FG004|Overall Study|Adverse Event|0|||
33272615|NCT02133131|100897630|FG005|Overall Study|Adverse Event|0|||
33272616|NCT02133131|100897631|FG006|Overall Study|Adverse Event|0|||
33272617|NCT02133131|100897625|FG000|Overall Study|Lost to Follow-up|1|||
33272618|NCT02133131|100897626|FG001|Overall Study|Lost to Follow-up|0|||
33272619|NCT02133131|100897627|FG002|Overall Study|Lost to Follow-up|0|||
33272620|NCT02133131|100897628|FG003|Overall Study|Lost to Follow-up|1|||
33272621|NCT02133131|100897629|FG004|Overall Study|Lost to Follow-up|0|||
33272622|NCT02133131|100897630|FG005|Overall Study|Lost to Follow-up|0|||
33272623|NCT02133131|100897631|FG006|Overall Study|Lost to Follow-up|0|||
33272624|NCT02133131|100897625|FG000|Overall Study|Status not recorded|4|||
33272625|NCT02133131|100897626|FG001|Overall Study|Status not recorded|5|||
33272626|NCT02133131|100897627|FG002|Overall Study|Status not recorded|1|||
33272627|NCT02133131|100897628|FG003|Overall Study|Status not recorded|4|||
33272628|NCT02133131|100897629|FG004|Overall Study|Status not recorded|0|||
33272629|NCT02133131|100897630|FG005|Overall Study|Status not recorded|0|||
33272630|NCT02133131|100897631|FG006|Overall Study|Status not recorded|0|||
33272631|NCT02133131|100897625|FG000|Overall Study|Ongoing in study|0|||
33272632|NCT02133131|100897626|FG001|Overall Study|Ongoing in study|0|||
33272633|NCT02133131|100897627|FG002|Overall Study|Ongoing in study|0|||
33272634|NCT02133131|100897628|FG003|Overall Study|Ongoing in study|0|||
33272635|NCT02133131|100897629|FG004|Overall Study|Ongoing in study|15|||
33272636|NCT02133131|100897630|FG005|Overall Study|Ongoing in study|14|||
33272637|NCT02133131|100897631|FG006|Overall Study|Ongoing in study|11|||
33272638|NCT02133131|100897625|FG000|Overall Study|Protocol Violation|0|||
33272639|NCT02133131|100897626|FG001|Overall Study|Protocol Violation|0|||
33272640|NCT02133131|100897627|FG002|Overall Study|Protocol Violation|0|||
33272641|NCT02133131|100897628|FG003|Overall Study|Protocol Violation|0|||
33272642|NCT02133131|100897629|FG004|Overall Study|Protocol Violation|0|||
33272643|NCT02133131|100897630|FG005|Overall Study|Protocol Violation|0|||
33272644|NCT02133131|100897631|FG006|Overall Study|Protocol Violation|1|||
33272645|NCT00390806|100897632|FG000|Overall Study|Lost to Follow-up|7|||
33272646|NCT00390806|100897633|FG001|Overall Study|Lost to Follow-up|6|||
33272647|NCT00390806|100897632|FG000|Overall Study|Protocol Violation|2|||
33272648|NCT00390806|100897633|FG001|Overall Study|Protocol Violation|2|||
33272649|NCT00390806|100897632|FG000|Overall Study|Withdrawal by Subject|12|||
33272650|NCT00390806|100897633|FG001|Overall Study|Withdrawal by Subject|15|||
33272651|NCT00390806|100897632|FG000|Overall Study|Investigator Decision|4|||
33272652|NCT00390806|100897633|FG001|Overall Study|Investigator Decision|6|||
33272653|NCT00390806|100897632|FG000|Overall Study|Death|1|||
33272654|NCT00390806|100897633|FG001|Overall Study|Death|0|||
33272655|NCT00390806|100897632|FG000|Overall Study|Physician Decision|0|||
33272656|NCT00390806|100897633|FG001|Overall Study|Physician Decision|1|||
33272657|NCT00390806|100897632|FG000|Overall Study|Ongoing|4|||
33272658|NCT00390806|100897633|FG001|Overall Study|Ongoing|2|||
33272659|NCT00529529|100897634|FG000|Overall Study|Adverse Event|12|||
33480463|NCT03207867|101651778|FG006|Overall Study|Progressive Disease|9|||
33480464|NCT03207867|101651779|FG007|Overall Study|Progressive Disease|8|||
33272660|NCT00529529|100897635|FG001|Overall Study|Adverse Event|17|||
33272661|NCT00529529|100897636|FG002|Overall Study|Adverse Event|8|||
33272662|NCT00529529|100897634|FG000|Overall Study|Subject withdrew consent|12|||
33272663|NCT00529529|100897635|FG001|Overall Study|Subject withdrew consent|9|||
33272664|NCT00529529|100897636|FG002|Overall Study|Subject withdrew consent|12|||
33272665|NCT00529529|100897634|FG000|Overall Study|Protocol deviation|8|||
33272666|NCT00529529|100897635|FG001|Overall Study|Protocol deviation|12|||
33272667|NCT00529529|100897636|FG002|Overall Study|Protocol deviation|5|||
33272668|NCT00529529|100897634|FG000|Overall Study|Lost to Follow-up|5|||
33272669|NCT00529529|100897635|FG001|Overall Study|Lost to Follow-up|3|||
33272670|NCT00529529|100897636|FG002|Overall Study|Lost to Follow-up|1|||
33272671|NCT00529529|100897634|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33272672|NCT00529529|100897635|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
33272673|NCT00529529|100897636|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
33272674|NCT00529529|100897634|FG000|Overall Study|Death|2|||
33272675|NCT00529529|100897635|FG001|Overall Study|Death|0|||
33272676|NCT00529529|100897636|FG002|Overall Study|Death|0|||
33272677|NCT00529529|100897634|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33272678|NCT00529529|100897635|FG001|Overall Study|Abnormal test procedure result(s)|0|||
33272679|NCT00529529|100897636|FG002|Overall Study|Abnormal test procedure result(s)|0|||
33272680|NCT00529529|100897634|FG000|Overall Study|Administrative problems|1|||
33272681|NCT00529529|100897635|FG001|Overall Study|Administrative problems|0|||
33272682|NCT00529529|100897636|FG002|Overall Study|Administrative problems|3|||
33272683|NCT03242863|100897653|FG000|Study Week 1|Withdrawal by Subject|0|||
33272684|NCT03242863|100897654|FG001|Study Week 1|Withdrawal by Subject|1|||
33272685|NCT03242863|100897655|FG002|Study Week 1|Withdrawal by Subject|0|||
33480465|NCT03207867|101651780|FG008|Overall Study|Progressive Disease|19|||
33272686|NCT03242863|100897656|FG003|Study Week 1|Withdrawal by Subject|0|||
33272687|NCT03242863|100897657|FG004|Study Week 1|Withdrawal by Subject|3|||
33272688|NCT03242863|100897658|FG005|Study Week 1|Withdrawal by Subject|0|||
33272689|NCT00476957|100897659|FG000|Overall Study|Lost to Follow-up|176|||
33480466|NCT03207867|101651781|FG009|Overall Study|Progressive Disease|23|||
33272690|NCT00476957|100897660|FG001|Overall Study|Lost to Follow-up|193|||
33272691|NCT01334606|100897661|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
33272692|NCT00257556|100897662|FG000|Overall Study|Adverse Event|1|||
33272693|NCT00257556|100897663|FG001|Overall Study|Adverse Event|4|||
33272694|NCT00257556|100897662|FG000|Overall Study|Physician Decision|6|||
33272695|NCT00257556|100897663|FG001|Overall Study|Physician Decision|0|||
33272696|NCT00257556|100897662|FG000|Overall Study|Did not meet hCG criterion|3|||
33272697|NCT00257556|100897663|FG001|Overall Study|Did not meet hCG criterion|0|||
33272698|NCT00257556|100897662|FG000|Overall Study|other reason|4|||
33272699|NCT00257556|100897663|FG001|Overall Study|other reason|6|||
33272700|NCT00413283|100897664|FG000|Overall Study|Withdrawal by Subject|1|||
33272701|NCT00413283|100897665|FG001|Overall Study|Withdrawal by Subject|0|||
33272702|NCT00413283|100897666|FG002|Overall Study|Withdrawal by Subject|0|||
33272703|NCT00413283|100897667|FG003|Overall Study|Withdrawal by Subject|1|||
33272704|NCT00413283|100897664|FG000|Overall Study|Death|0|||
33272705|NCT00413283|100897665|FG001|Overall Study|Death|0|||
33272706|NCT00413283|100897666|FG002|Overall Study|Death|1|||
33272707|NCT00413283|100897667|FG003|Overall Study|Death|1|||
33272708|NCT00413283|100897664|FG000|Overall Study|Adverse Event|0|||
33272709|NCT00413283|100897665|FG001|Overall Study|Adverse Event|0|||
33272710|NCT00413283|100897666|FG002|Overall Study|Adverse Event|0|||
33272711|NCT00413283|100897667|FG003|Overall Study|Adverse Event|1|||
33272712|NCT00413283|100897664|FG000|Overall Study|Ineligibility determined|0|||
33272713|NCT00413283|100897665|FG001|Overall Study|Ineligibility determined|0|||
33272714|NCT00413283|100897666|FG002|Overall Study|Ineligibility determined|0|||
33272715|NCT00413283|100897667|FG003|Overall Study|Ineligibility determined|1|||
33272716|NCT00413283|100897664|FG000|Overall Study|Protocol deviation|0|||
33272717|NCT00413283|100897665|FG001|Overall Study|Protocol deviation|1|||
33272718|NCT00413283|100897666|FG002|Overall Study|Protocol deviation|0|||
33272719|NCT00413283|100897667|FG003|Overall Study|Protocol deviation|0|||
33272720|NCT00413283|100897664|FG000|Overall Study|Requirement for alternative therapy|0|||
33272721|NCT00413283|100897665|FG001|Overall Study|Requirement for alternative therapy|2|||
33272722|NCT00413283|100897666|FG002|Overall Study|Requirement for alternative therapy|0|||
33272723|NCT00413283|100897667|FG003|Overall Study|Requirement for alternative therapy|0|||
33272724|NCT00413283|100897664|FG000|Overall Study|Other|0|||
33272725|NCT00413283|100897665|FG001|Overall Study|Other|0|||
33272726|NCT00413283|100897666|FG002|Overall Study|Other|1|||
33272727|NCT00413283|100897667|FG003|Overall Study|Other|0|||
33272728|NCT01944774|100897668|FG000|Overall Study|Withdrawal by Subject|2|||
33272729|NCT01944774|100897669|FG001|Overall Study|Withdrawal by Subject|3|||
33272730|NCT01944774|100897670|FG002|Overall Study|Withdrawal by Subject|3|||
33272731|NCT01944774|100897668|FG000|Overall Study|Adverse Event|3|||
33272732|NCT01944774|100897669|FG001|Overall Study|Adverse Event|2|||
33272733|NCT01944774|100897670|FG002|Overall Study|Adverse Event|3|||
33272734|NCT01944774|100897668|FG000|Overall Study|Lack of Efficacy|1|||
33272735|NCT01944774|100897669|FG001|Overall Study|Lack of Efficacy|2|||
33272736|NCT01944774|100897670|FG002|Overall Study|Lack of Efficacy|2|||
33272737|NCT01944774|100897668|FG000|Overall Study|Lost to Follow-up|0|||
33272738|NCT01944774|100897669|FG001|Overall Study|Lost to Follow-up|1|||
33272739|NCT01944774|100897670|FG002|Overall Study|Lost to Follow-up|0|||
33272740|NCT03166215|100897671|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
33272741|NCT03166215|100897672|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
33272742|NCT03166215|100897673|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
33272743|NCT03166215|100897671|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
33272744|NCT03166215|100897672|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
33272745|NCT03166215|100897673|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
33272746|NCT02991456|100897674|FG000|Overall Study|Adverse Event|2|||
33272747|NCT02991456|100897675|FG001|Overall Study|Adverse Event|0|||
33272748|NCT02991456|100897674|FG000|Overall Study|Lost to Follow-up|0|||
33272749|NCT02991456|100897675|FG001|Overall Study|Lost to Follow-up|2|||
33272750|NCT02991456|100897674|FG000|Overall Study|Withdrawal by Subject|1|||
33272751|NCT02991456|100897675|FG001|Overall Study|Withdrawal by Subject|0|||
33480467|NCT03207867|101651782|FG010|Overall Study|Progressive Disease|2|||
33272752|NCT01287832|100897676|FG000|Overall Study|Adverse Event|1|||
33272753|NCT01287832|100897677|FG001|Overall Study|Adverse Event|0|||
33272754|NCT01287832|100897676|FG000|Overall Study|Death|0|||
33272755|NCT01287832|100897677|FG001|Overall Study|Death|1|||
33272756|NCT03326856|100897678|FG000|Overall Study|Lost to Follow-up|1|||
33272757|NCT03326856|100897679|FG001|Overall Study|Lost to Follow-up|1|||
33272758|NCT03326856|100897680|FG002|Overall Study|Lost to Follow-up|0|||
33272759|NCT03326856|100897681|FG003|Overall Study|Lost to Follow-up|0|||
33272760|NCT03326856|100897682|FG004|Overall Study|Lost to Follow-up|0|||
33272761|NCT04617847|100897687|FG000|Overall Study|Withdrawal by Subject|1|||
33272762|NCT04617847|100897688|FG001|Overall Study|Withdrawal by Subject|0|||
33272763|NCT04617847|100897687|FG000|Overall Study|Adverse Event|0|||
33272764|NCT04617847|100897688|FG001|Overall Study|Adverse Event|2|||
33272765|NCT04617847|100897687|FG000|Overall Study|Death|0|||
33272766|NCT04617847|100897688|FG001|Overall Study|Death|1|||
33272767|NCT04617847|100897687|FG000|Overall Study|Termination of Study by Sponsor|2|||
33272768|NCT04617847|100897688|FG001|Overall Study|Termination of Study by Sponsor|21|||
33272769|NCT00321555|100897689|FG000|Overall Study|Developed antibodies|1|||
33272770|NCT00321555|100897689|FG000|Overall Study|Switched to alternative treatment|3|||
33272771|NCT00321555|100897689|FG000|Overall Study|Physician Decision|1|||
33272772|NCT00321555|100897689|FG000|Overall Study|Disease progression on study|1|||
33272773|NCT01757288|100897696|FG000|Overall Study|Consent withdrawal|0|||
33272774|NCT01757288|100897697|FG001|Overall Study|Consent withdrawal|4|||
33272775|NCT01757288|100897698|FG002|Overall Study|Consent withdrawal|4|||
33272776|NCT01757288|100897696|FG000|Overall Study|Patient off study, IRB hold.|0|||
33272777|NCT01757288|100897697|FG001|Overall Study|Patient off study, IRB hold.|0|||
33272778|NCT01757288|100897698|FG002|Overall Study|Patient off study, IRB hold.|1|||
33272779|NCT01757288|100897696|FG000|Overall Study|Patient death prior to starting treatment|0|||
33272780|NCT01757288|100897697|FG001|Overall Study|Patient death prior to starting treatment|0|||
33272781|NCT01757288|100897698|FG002|Overall Study|Patient death prior to starting treatment|1|||
33272782|NCT01757288|100897696|FG000|Overall Study|Wrong medication administered|0|||
33272783|NCT01757288|100897697|FG001|Overall Study|Wrong medication administered|1|||
33272784|NCT01757288|100897698|FG002|Overall Study|Wrong medication administered|0|||
33272785|NCT01757288|100897696|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
33272786|NCT01757288|100897697|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
33272787|NCT01757288|100897698|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
33272788|NCT01757288|100897696|FG000|Overall Study|Not meeting protocol constraints|0|||
33272789|NCT01757288|100897697|FG001|Overall Study|Not meeting protocol constraints|1|||
33272790|NCT01757288|100897698|FG002|Overall Study|Not meeting protocol constraints|1|||
33272791|NCT01757288|100897696|FG000|Overall Study|Multiple missed appointments|0|||
33272792|NCT01757288|100897697|FG001|Overall Study|Multiple missed appointments|1|||
33272793|NCT01757288|100897698|FG002|Overall Study|Multiple missed appointments|0|||
33272794|NCT01757288|100897696|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
33272795|NCT01757288|100897697|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
33272796|NCT01757288|100897698|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
33272797|NCT01757288|100897696|FG000|Overall Study|>2 weeks treatment break|0|||
33272798|NCT01757288|100897697|FG001|Overall Study|>2 weeks treatment break|0|||
33272799|NCT01757288|100897698|FG002|Overall Study|>2 weeks treatment break|1|||
33272800|NCT04212299|100897701|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
33272801|NCT00818519|100897702|FG000|Overall Study|Adverse Event|2|||
33272802|NCT00818519|100897703|FG001|Overall Study|Adverse Event|2|||
33272803|NCT00818519|100897702|FG000|Overall Study|Lost to Follow-up|4|||
33272804|NCT00818519|100897703|FG001|Overall Study|Lost to Follow-up|6|||
33272805|NCT00818519|100897702|FG000|Overall Study|Protocol Violation|2|||
33272806|NCT00818519|100897703|FG001|Overall Study|Protocol Violation|1|||
33272807|NCT00818519|100897702|FG000|Overall Study|Pregnancy|0|||
33272808|NCT00818519|100897703|FG001|Overall Study|Pregnancy|1|||
33272809|NCT00818519|100897702|FG000|Overall Study|Withdrawal by Subject|4|||
33272810|NCT00818519|100897703|FG001|Overall Study|Withdrawal by Subject|9|||
33272811|NCT00818519|100897702|FG000|Overall Study|participant recovered completely|1|||
33272812|NCT00818519|100897703|FG001|Overall Study|participant recovered completely|0|||
33272813|NCT00818519|100897702|FG000|Overall Study|participant will leave for long tme|1|||
33272814|NCT00818519|100897703|FG001|Overall Study|participant will leave for long tme|0|||
33272815|NCT00595764|100897704|FG000|Overall Study|Protocol Violation|24|||
33272816|NCT00595764|100897705|FG001|Overall Study|Protocol Violation|19|||
33272817|NCT00595764|100897704|FG000|Overall Study|Missed Medication >1 week|10|||
33272818|NCT00595764|100897705|FG001|Overall Study|Missed Medication >1 week|17|||
33272819|NCT00595764|100897704|FG000|Overall Study|Missed 3 PM visits|1|||
33272820|NCT00595764|100897705|FG001|Overall Study|Missed 3 PM visits|7|||
33272821|NCT00595764|100897704|FG000|Overall Study|Withdrawal by Subject|4|||
33272822|NCT00595764|100897705|FG001|Overall Study|Withdrawal by Subject|0|||
33272823|NCT00589628|100897706|FG000|Overall Study|Lost to Follow-up|0|||
33272824|NCT00589628|100897707|FG001|Overall Study|Lost to Follow-up|1|||
33272825|NCT01280721|100897714|FG000|Overall Study|Adverse Event|4|||
33272826|NCT01280721|100897714|FG000|Overall Study|Physician Decision|3|||
33272827|NCT01280721|100897714|FG000|Overall Study|Withdrawal by Subject|6|||
33272828|NCT01280721|100897714|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
33272829|NCT01280721|100897714|FG000|Overall Study|No tolerability for the lowest dose|2|||
33272830|NCT03769090|100897715|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
33272831|NCT03769090|100897716|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
33272832|NCT03769090|100897717|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
33272833|NCT03769090|100897715|FG000|Overall Study|Withdrawal by Subject|52|||
33272834|NCT03769090|100897716|FG001|Overall Study|Withdrawal by Subject|62|||
33272835|NCT03769090|100897717|FG002|Overall Study|Withdrawal by Subject|74|||
33272836|NCT03769090|100897715|FG000|Overall Study|Death|4|||
33272837|NCT03769090|100897716|FG001|Overall Study|Death|2|||
33272838|NCT03769090|100897717|FG002|Overall Study|Death|2|||
33272839|NCT03769090|100897715|FG000|Overall Study|Adverse Event|7|||
33272840|NCT03769090|100897716|FG001|Overall Study|Adverse Event|7|||
33272841|NCT03769090|100897717|FG002|Overall Study|Adverse Event|8|||
33272842|NCT03769090|100897715|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
33272843|NCT03769090|100897716|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
33272844|NCT03769090|100897717|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
33272845|NCT03769090|100897715|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
33272846|NCT03769090|100897716|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
33272847|NCT03769090|100897717|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
33272848|NCT03769090|100897715|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
33272849|NCT03769090|100897716|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
33272850|NCT03769090|100897717|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
33272851|NCT03769090|100897715|FG000|Overall Study|Protocol Violation|5|||
33272852|NCT03769090|100897716|FG001|Overall Study|Protocol Violation|6|||
33272853|NCT03769090|100897717|FG002|Overall Study|Protocol Violation|8|||
33272854|NCT03769090|100897715|FG000|Overall Study|Pregnancy|1|||
33272855|NCT03769090|100897716|FG001|Overall Study|Pregnancy|0|||
33272856|NCT03769090|100897717|FG002|Overall Study|Pregnancy|3|||
33272857|NCT03769090|100897715|FG000|Overall Study|Lost to Follow-up|19|||
33272858|NCT03769090|100897716|FG001|Overall Study|Lost to Follow-up|25|||
33272859|NCT03769090|100897717|FG002|Overall Study|Lost to Follow-up|21|||
33272860|NCT03769090|100897715|FG000|Overall Study|Condition under investigation worsened|2|||
33272861|NCT03769090|100897716|FG001|Overall Study|Condition under investigation worsened|0|||
33272862|NCT03769090|100897717|FG002|Overall Study|Condition under investigation worsened|1|||
33272863|NCT03769090|100897715|FG000|Overall Study|Lack of Efficacy|1|||
33272864|NCT03769090|100897716|FG001|Overall Study|Lack of Efficacy|2|||
33272865|NCT03769090|100897717|FG002|Overall Study|Lack of Efficacy|2|||
33272866|NCT03769090|100897715|FG000|Overall Study|Other reasons|8|||
33272867|NCT03769090|100897716|FG001|Overall Study|Other reasons|12|||
33272868|NCT03769090|100897717|FG002|Overall Study|Other reasons|15|||
33272869|NCT02555397|100897720|FG000|Overall Study|Withdrawal by Subject|1|||
33272870|NCT02555397|100897721|FG001|Overall Study|Withdrawal by Subject|0|||
33272871|NCT02555397|100897722|FG002|Overall Study|Withdrawal by Subject|0|||
33272872|NCT02555397|100897723|FG003|Overall Study|Withdrawal by Subject|0|||
33272873|NCT02555397|100897724|FG004|Overall Study|Withdrawal by Subject|0|||
33272874|NCT01185340|100897725|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
33272875|NCT01185340|100897726|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33272876|NCT01185340|100897727|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33272877|NCT01185340|100897728|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33272878|NCT01185340|100897725|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
33272879|NCT01185340|100897726|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33272880|NCT01185340|100897727|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33272881|NCT01185340|100897728|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33272882|NCT01185340|100897725|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
33272883|NCT01185340|100897726|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33272884|NCT01185340|100897727|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33272885|NCT01185340|100897728|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33272886|NCT01185340|100897725|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
33272887|NCT01185340|100897726|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33272888|NCT01185340|100897727|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33272889|NCT01185340|100897728|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33272890|NCT01185340|100897725|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
33272891|NCT01185340|100897726|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33272892|NCT01185340|100897727|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33272893|NCT01185340|100897728|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33272894|NCT01185340|100897725|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
33272895|NCT01185340|100897726|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33272896|NCT01185340|100897727|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33272897|NCT01185340|100897728|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33272898|NCT01185340|100897725|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
33272899|NCT01185340|100897726|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33272900|NCT01185340|100897727|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33272901|NCT01185340|100897728|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33272902|NCT01185340|100897725|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
33272903|NCT01185340|100897726|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
33272904|NCT01185340|100897727|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
33272905|NCT01185340|100897728|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
33272906|NCT01185340|100897725|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
33272907|NCT01185340|100897726|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
33272908|NCT01185340|100897727|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
33272909|NCT01185340|100897728|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
33272910|NCT01185340|100897725|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
33272911|NCT01185340|100897726|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
33272912|NCT01185340|100897727|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
33272913|NCT01185340|100897728|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
33272914|NCT01185340|100897725|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
33272915|NCT01185340|100897726|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
33272916|NCT01185340|100897727|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
33272917|NCT01185340|100897728|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
33272918|NCT01185340|100897725|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
33272919|NCT01185340|100897726|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
33272920|NCT01185340|100897727|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
33272921|NCT01185340|100897728|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
33272922|NCT01185340|100897725|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
33272923|NCT01185340|100897726|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
33272924|NCT01185340|100897727|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
33272925|NCT01185340|100897728|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
33272926|NCT01185340|100897725|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
33272927|NCT01185340|100897726|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
33272928|NCT01185340|100897727|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
33272929|NCT01185340|100897728|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
33272930|NCT00409747|100897734|FG000|Overall Study|Withdrawal by Subject|1|||
33272931|NCT03696342|100897735|FG000|Overall Study|Lost to Follow-up|1|||
33272932|NCT03696342|100897736|FG001|Overall Study|Lost to Follow-up|0|||
33272933|NCT00742560|100897737|FG000|Overall Study|Adverse Event|0|||
33272934|NCT00742560|100897738|FG001|Overall Study|Adverse Event|0|||
33272935|NCT00742560|100897739|FG002|Overall Study|Adverse Event|1|||
33272936|NCT00742560|100897740|FG003|Overall Study|Adverse Event|1|||
33272937|NCT00742560|100897741|FG004|Overall Study|Adverse Event|1|||
33272938|NCT00742560|100897737|FG000|Overall Study|Death|0|||
33272939|NCT00742560|100897738|FG001|Overall Study|Death|2|||
33272940|NCT00742560|100897739|FG002|Overall Study|Death|0|||
33272941|NCT00742560|100897740|FG003|Overall Study|Death|2|||
33272942|NCT00742560|100897741|FG004|Overall Study|Death|3|||
33272943|NCT00742560|100897737|FG000|Overall Study|Subject's Decision|1|||
33272944|NCT00742560|100897738|FG001|Overall Study|Subject's Decision|0|||
33272945|NCT00742560|100897739|FG002|Overall Study|Subject's Decision|2|||
33272946|NCT00742560|100897740|FG003|Overall Study|Subject's Decision|3|||
33272947|NCT00742560|100897741|FG004|Overall Study|Subject's Decision|3|||
33272948|NCT00742560|100897737|FG000|Overall Study|Investigator's Decision|0|||
33272949|NCT00742560|100897738|FG001|Overall Study|Investigator's Decision|0|||
33272950|NCT00742560|100897739|FG002|Overall Study|Investigator's Decision|4|||
33272951|NCT00742560|100897740|FG003|Overall Study|Investigator's Decision|1|||
33272952|NCT00742560|100897741|FG004|Overall Study|Investigator's Decision|0|||
33272953|NCT00742560|100897737|FG000|Overall Study|Disease Progression|1|||
33272954|NCT00742560|100897738|FG001|Overall Study|Disease Progression|0|||
33272955|NCT00742560|100897739|FG002|Overall Study|Disease Progression|5|||
33272956|NCT00742560|100897740|FG003|Overall Study|Disease Progression|17|||
33272957|NCT00742560|100897741|FG004|Overall Study|Disease Progression|16|||
33272958|NCT00742560|100897737|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
33272959|NCT00742560|100897738|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
33272960|NCT00742560|100897739|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
33272961|NCT00742560|100897740|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
33272962|NCT00742560|100897741|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
33272963|NCT00742560|100897737|FG000|Overall Study|Other|0|||
33272964|NCT00742560|100897738|FG001|Overall Study|Other|1|||
33272965|NCT00742560|100897739|FG002|Overall Study|Other|8|||
33272966|NCT00742560|100897740|FG003|Overall Study|Other|9|||
33272967|NCT00742560|100897741|FG004|Overall Study|Other|9|||
33272968|NCT00742560|100897737|FG000|Overall Study|MIssing|0|||
33272969|NCT00742560|100897738|FG001|Overall Study|MIssing|0|||
33272970|NCT00742560|100897739|FG002|Overall Study|MIssing|0|||
33272971|NCT00742560|100897740|FG003|Overall Study|MIssing|0|||
33272972|NCT00742560|100897741|FG004|Overall Study|MIssing|1|||
33272973|NCT01437540|100897742|FG000|Overall Study|Not listed below|7|||
33272974|NCT01437540|100897743|FG001|Overall Study|Not listed below|6|||
33272975|NCT01437540|100897742|FG000|Overall Study|COPD exacerbation|13|||
33272976|NCT01437540|100897743|FG001|Overall Study|COPD exacerbation|3|||
33272977|NCT01437540|100897742|FG000|Overall Study|Lost to Follow-up|3|||
33272978|NCT01437540|100897743|FG001|Overall Study|Lost to Follow-up|5|||
33272979|NCT01437540|100897742|FG000|Overall Study|Lack of Efficacy|23|||
33272980|NCT01437540|100897743|FG001|Overall Study|Lack of Efficacy|11|||
33272981|NCT01437540|100897742|FG000|Overall Study|Protocol Violation|24|||
33272982|NCT01437540|100897743|FG001|Overall Study|Protocol Violation|12|||
33272983|NCT01437540|100897742|FG000|Overall Study|Adverse Event|26|||
33272984|NCT01437540|100897743|FG001|Overall Study|Adverse Event|13|||
33272985|NCT01437540|100897742|FG000|Overall Study|Withdrawal by Subject|31|||
33272986|NCT01437540|100897743|FG001|Overall Study|Withdrawal by Subject|15|||
33272987|NCT00670449|100897744|FG000|Overall Study|Adverse Event|6|||
33272988|NCT00670449|100897745|FG001|Overall Study|Adverse Event|2|||
33272989|NCT00670449|100897746|FG002|Overall Study|Adverse Event|8|||
33272990|NCT00670449|100897747|FG003|Overall Study|Adverse Event|5|||
33272991|NCT00670449|100897744|FG000|Overall Study|Protocol Deviation|1|||
33272992|NCT00670449|100897745|FG001|Overall Study|Protocol Deviation|2|||
33272993|NCT00670449|100897746|FG002|Overall Study|Protocol Deviation|0|||
33272994|NCT00670449|100897747|FG003|Overall Study|Protocol Deviation|1|||
33272995|NCT00670449|100897744|FG000|Overall Study|Administrative Problems|0|||
33272996|NCT00670449|100897745|FG001|Overall Study|Administrative Problems|2|||
33272997|NCT00670449|100897746|FG002|Overall Study|Administrative Problems|0|||
33272998|NCT00670449|100897747|FG003|Overall Study|Administrative Problems|1|||
33272999|NCT00670449|100897744|FG000|Overall Study|Subject Withdrew Consent|0|||
33273000|NCT00670449|100897745|FG001|Overall Study|Subject Withdrew Consent|2|||
33273001|NCT00670449|100897746|FG002|Overall Study|Subject Withdrew Consent|0|||
33273002|NCT00670449|100897747|FG003|Overall Study|Subject Withdrew Consent|1|||
33273003|NCT00670449|100897744|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
33273004|NCT00670449|100897745|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33273005|NCT00670449|100897746|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
33273006|NCT00670449|100897747|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
33273007|NCT00670449|100897744|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
33273008|NCT00670449|100897745|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
33273009|NCT00670449|100897746|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
33273010|NCT00670449|100897747|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
33273011|NCT04382053|100897752|FG000|Overall Study|Death|6|||
33273012|NCT04382053|100897753|FG001|Overall Study|Death|8|||
33273013|NCT04382053|100897752|FG000|Overall Study|Lost to Follow-up|0|||
33273014|NCT04382053|100897753|FG001|Overall Study|Lost to Follow-up|2|||
33273015|NCT04382053|100897752|FG000|Overall Study|Protocol Deviation|1|||
33273016|NCT04382053|100897753|FG001|Overall Study|Protocol Deviation|2|||
33273017|NCT04382053|100897752|FG000|Overall Study|Withdrawal by Subject|2|||
33273018|NCT04382053|100897753|FG001|Overall Study|Withdrawal by Subject|1|||
33273019|NCT00274287|100897754|FG000|Overall Study|Withdrawal by Subject|1|||
33273020|NCT00274287|100897754|FG000|Overall Study|subject non-compliance|1|||
33273021|NCT02132195|100897755|FG000|Initial Assignment|Relapsed|14|||
33273022|NCT02132195|100897756|FG001|Initial Assignment|Relapsed|0|||
33273023|NCT02132195|100897757|FG002|Initial Assignment|Relapsed|0|||
33273024|NCT02132195|100897755|FG000|Rescue Therapy|Relapsed|0|||
33273025|NCT02132195|100897756|FG001|Rescue Therapy|Relapsed|0|||
33273026|NCT02132195|100897757|FG002|Rescue Therapy|Relapsed|7|||
33273027|NCT02132195|100897755|FG000|Rescue Therapy|Physician Decision|0|||
33273028|NCT02132195|100897756|FG001|Rescue Therapy|Physician Decision|0|||
33273029|NCT02132195|100897757|FG002|Rescue Therapy|Physician Decision|1|||
33273030|NCT02132195|100897755|FG000|Rescue Therapy|Withdrawal by Subject|0|||
33273031|NCT02132195|100897756|FG001|Rescue Therapy|Withdrawal by Subject|0|||
33273032|NCT02132195|100897757|FG002|Rescue Therapy|Withdrawal by Subject|1|||
33273033|NCT02132195|100897755|FG000|Rescue Therapy|Adverse Event|0|||
33273034|NCT02132195|100897756|FG001|Rescue Therapy|Adverse Event|0|||
33273035|NCT02132195|100897757|FG002|Rescue Therapy|Adverse Event|2|||
33273036|NCT01248715|100897758|FG000|Overall Study|Not influenza positive|501|||
33273037|NCT01248715|100897759|FG001|Overall Study|Not influenza positive|510|||
33273038|NCT02109172|100897764|FG000|Overall Study|Withdrawal by Subject|1|||
33273039|NCT02109172|100897765|FG001|Overall Study|Withdrawal by Subject|0|||
33273040|NCT02109172|100897766|FG002|Overall Study|Withdrawal by Subject|0|||
33273041|NCT02109172|100897767|FG003|Overall Study|Withdrawal by Subject|1|||
33273042|NCT02109172|100897768|FG004|Overall Study|Withdrawal by Subject|0|||
33273043|NCT02109172|100897769|FG005|Overall Study|Withdrawal by Subject|0|||
33273044|NCT02109172|100897764|FG000|Overall Study|Adverse Event|0|||
33273045|NCT02109172|100897765|FG001|Overall Study|Adverse Event|0|||
33273046|NCT02109172|100897766|FG002|Overall Study|Adverse Event|1|||
33273047|NCT02109172|100897767|FG003|Overall Study|Adverse Event|0|||
33273048|NCT02109172|100897768|FG004|Overall Study|Adverse Event|0|||
33273049|NCT02109172|100897769|FG005|Overall Study|Adverse Event|1|||
33273050|NCT02109172|100897764|FG000|Overall Study|Death|0|||
33273051|NCT02109172|100897765|FG001|Overall Study|Death|0|||
33273052|NCT02109172|100897766|FG002|Overall Study|Death|0|||
33273053|NCT02109172|100897767|FG003|Overall Study|Death|0|||
33273054|NCT02109172|100897768|FG004|Overall Study|Death|1|||
33273055|NCT02109172|100897769|FG005|Overall Study|Death|0|||
33273056|NCT00617708|100897771|FG000|Overall Study|Adverse Event|0|||
33273057|NCT00617708|100897772|FG001|Overall Study|Adverse Event|6|||
33273058|NCT00617708|100897773|FG002|Overall Study|Adverse Event|9|||
33273059|NCT00617708|100897771|FG000|Overall Study|Withdrawal by Subject|1|||
33273060|NCT00617708|100897772|FG001|Overall Study|Withdrawal by Subject|1|||
33273061|NCT00617708|100897773|FG002|Overall Study|Withdrawal by Subject|7|||
33273062|NCT00617708|100897771|FG000|Overall Study|Death|0|||
33273063|NCT00617708|100897772|FG001|Overall Study|Death|6|||
33273064|NCT00617708|100897773|FG002|Overall Study|Death|5|||
33273065|NCT00617708|100897771|FG000|Overall Study|Progression/Relapse|7|||
33273066|NCT00617708|100897772|FG001|Overall Study|Progression/Relapse|40|||
33273067|NCT00617708|100897773|FG002|Overall Study|Progression/Relapse|36|||
33273068|NCT00617708|100897771|FG000|Overall Study|Not protocol specified|1|||
33273069|NCT00617708|100897772|FG001|Overall Study|Not protocol specified|4|||
33273070|NCT00617708|100897773|FG002|Overall Study|Not protocol specified|2|||
33273071|NCT00617708|100897771|FG000|Overall Study|Not eligible|1|||
33273072|NCT00617708|100897772|FG001|Overall Study|Not eligible|3|||
33273073|NCT00617708|100897773|FG002|Overall Study|Not eligible|5|||
33273074|NCT01279447|100897774|FG000|Overall Study|Lost to Follow-up|3|||
33273075|NCT01279447|100897775|FG001|Overall Study|Lost to Follow-up|1|||
33273076|NCT02771366|100897776|FG000|Period 1|Withdrawal by Subject|0|||
33273077|NCT02771366|100897777|FG001|Period 1|Withdrawal by Subject|2|||
33273078|NCT02771366|100897776|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
33273079|NCT02771366|100897777|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
33273080|NCT02708498|100897778|FG000|Overall Study|Death|20|||
33273081|NCT02708498|100897779|FG001|Overall Study|Death|19|||
33273082|NCT02708498|100897780|FG002|Overall Study|Death|0|||
33273083|NCT02708498|100897781|FG003|Overall Study|Death|0|||
33273084|NCT02708498|100897782|FG004|Overall Study|Death|1|||
33273085|NCT02708498|100897783|FG005|Overall Study|Death|0|||
33273086|NCT02708498|100897784|FG006|Overall Study|Death|0|||
33273087|NCT02708498|100897785|FG007|Overall Study|Death|0|||
33273088|NCT02708498|100897778|FG000|Overall Study|Unknown reason, missing data|0|||
33273089|NCT02708498|100897779|FG001|Overall Study|Unknown reason, missing data|0|||
33273090|NCT02708498|100897780|FG002|Overall Study|Unknown reason, missing data|62|||
33273091|NCT02708498|100897781|FG003|Overall Study|Unknown reason, missing data|51|||
33273092|NCT02708498|100897782|FG004|Overall Study|Unknown reason, missing data|195|||
33273093|NCT02708498|100897783|FG005|Overall Study|Unknown reason, missing data|132|||
33273094|NCT02708498|100897784|FG006|Overall Study|Unknown reason, missing data|0|||
33273095|NCT02708498|100897785|FG007|Overall Study|Unknown reason, missing data|0|||
33273096|NCT00925548|100897786|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
33273097|NCT00925548|100897787|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
33273098|NCT01697956|100897788|FG000|Overall Study|Protocol Violation|1|||
33273099|NCT01697956|100897789|FG001|Overall Study|Protocol Violation|1|||
33273100|NCT00805792|100897790|FG000|Overall Study|Death|3|||
33273101|NCT00805792|100897790|FG000|Overall Study|Lost to Follow-up|2|||
33273102|NCT00451906|100897801|FG000|Overall Study|Adverse Event|515|||
33273103|NCT00451906|100897801|FG000|Overall Study|Lost to Follow-up|31|||
33273104|NCT00451906|100897801|FG000|Overall Study|Withdrawal by Subject|111|||
33273105|NCT00451906|100897801|FG000|Overall Study|Protocol Violation|21|||
33273106|NCT00451906|100897801|FG000|Overall Study|Progressive disease|1328|||
33273107|NCT00451906|100897801|FG000|Overall Study|Termination of the study|108|||
33273108|NCT00451906|100897801|FG000|Overall Study|Other Reasons|121|||
33273109|NCT00451906|100897801|FG000|Overall Study|Did not complete final visit|4|||
33273110|NCT00141271|100897802|FG000|Overall Study|Adverse Event|31|||
33273111|NCT00141271|100897803|FG001|Overall Study|Adverse Event|19|||
33273112|NCT00141271|100897804|FG002|Overall Study|Adverse Event|17|||
33273113|NCT00141271|100897802|FG000|Overall Study|Laboratory Abnormality|2|||
33273114|NCT00141271|100897803|FG001|Overall Study|Laboratory Abnormality|1|||
33273115|NCT00141271|100897804|FG002|Overall Study|Laboratory Abnormality|1|||
33273116|NCT00141271|100897802|FG000|Overall Study|Lack of Efficacy|7|||
33273117|NCT00141271|100897803|FG001|Overall Study|Lack of Efficacy|7|||
33273118|NCT00141271|100897804|FG002|Overall Study|Lack of Efficacy|3|||
33273119|NCT00141271|100897802|FG000|Overall Study|Lost to Follow-up|15|||
33273120|NCT00141271|100897803|FG001|Overall Study|Lost to Follow-up|15|||
33273121|NCT00141271|100897804|FG002|Overall Study|Lost to Follow-up|21|||
33273122|NCT00141271|100897802|FG000|Overall Study|Withdrawal by Subject|14|||
33273123|NCT00141271|100897803|FG001|Overall Study|Withdrawal by Subject|9|||
33273124|NCT00141271|100897804|FG002|Overall Study|Withdrawal by Subject|10|||
33273125|NCT00141271|100897802|FG000|Overall Study|Other|11|||
33273126|NCT00141271|100897803|FG001|Overall Study|Other|12|||
33273127|NCT00141271|100897804|FG002|Overall Study|Other|5|||
33273128|NCT00671853|100897807|FG000|Overall Study|Lack of Efficacy|3|||
33273129|NCT00671853|100897808|FG001|Overall Study|Lack of Efficacy|7|||
33273130|NCT00671853|100897807|FG000|Overall Study|Adverse Event|7|||
33273131|NCT00671853|100897808|FG001|Overall Study|Adverse Event|1|||
33273132|NCT00671853|100897807|FG000|Overall Study|Withdrawal by Subject|1|||
33273133|NCT00671853|100897808|FG001|Overall Study|Withdrawal by Subject|5|||
33273134|NCT00671853|100897807|FG000|Overall Study|Lost to Follow-up|8|||
33273135|NCT00671853|100897808|FG001|Overall Study|Lost to Follow-up|8|||
33273136|NCT00671853|100897807|FG000|Overall Study|Physician Decision|0|||
33273137|NCT00671853|100897808|FG001|Overall Study|Physician Decision|2|||
33273138|NCT00671853|100897807|FG000|Overall Study|Non-adherence with study procedures|1|||
33273139|NCT00671853|100897808|FG001|Overall Study|Non-adherence with study procedures|4|||
33273140|NCT00753896|100897810|FG000|Overall Study|Adverse Event|4|||
33273141|NCT00753896|100897810|FG000|Overall Study|Death|1|||
33273142|NCT00753896|100897810|FG000|Overall Study|Lost to Follow-up|2|||
33273143|NCT00753896|100897810|FG000|Overall Study|Protocol Violation|1|||
33273144|NCT00753896|100897810|FG000|Overall Study|Withdrawal by Subject|4|||
33273145|NCT00753896|100897810|FG000|Overall Study|Entry Criteria Not Met|4|||
33273146|NCT00316121|100897811|FG000|Overall Study|Death|1|||
33273147|NCT00316121|100897812|FG001|Overall Study|Death|0|||
33273148|NCT00316121|100897811|FG000|Overall Study|Lost to Follow-up|14|||
33273149|NCT00316121|100897812|FG001|Overall Study|Lost to Follow-up|8|||
33273150|NCT00316121|100897811|FG000|Overall Study|Withdrawal by Subject|2|||
33273151|NCT00316121|100897812|FG001|Overall Study|Withdrawal by Subject|0|||
33273152|NCT00316121|100897811|FG000|Overall Study|Reason is missing|1|||
33273153|NCT00316121|100897812|FG001|Overall Study|Reason is missing|0|||
33273154|NCT00316121|100897811|FG000|Overall Study|Subject relocated|1|||
33273155|NCT00316121|100897812|FG001|Overall Study|Subject relocated|1|||
33273156|NCT00316121|100897811|FG000|Overall Study|Subject refused to return|1|||
33273157|NCT00316121|100897812|FG001|Overall Study|Subject refused to return|0|||
33273158|NCT00316121|100897811|FG000|Overall Study|Subject no show for visit x 3|1|||
33273159|NCT00316121|100897812|FG001|Overall Study|Subject no show for visit x 3|0|||
33273160|NCT00316121|100897811|FG000|Overall Study|Subject did not have 24 month visit|1|||
33273161|NCT00316121|100897812|FG001|Overall Study|Subject did not have 24 month visit|0|||
33273162|NCT03840993|100897813|FG000|Overall Study|Adverse Event|1|||
33273163|NCT03840993|100897814|FG001|Overall Study|Adverse Event|0|||
33273164|NCT03840993|100897813|FG000|Overall Study|Lost to Follow-up|4|||
33273165|NCT03840993|100897814|FG001|Overall Study|Lost to Follow-up|0|||
33273166|NCT03840993|100897813|FG000|Overall Study|Physician Decision|0|||
33273167|NCT03840993|100897814|FG001|Overall Study|Physician Decision|1|||
33273168|NCT03840993|100897813|FG000|Overall Study|Pregnancy|0|||
33273169|NCT03840993|100897814|FG001|Overall Study|Pregnancy|1|||
33273170|NCT03840993|100897813|FG000|Overall Study|Withdrawal by Subject|1|||
33480468|NCT03207867|101651783|FG011|Overall Study|Progressive Disease|24|||
33480469|NCT03207867|101651784|FG012|Overall Study|Progressive Disease|3|||
33480470|NCT03207867|101651785|FG013|Overall Study|Progressive Disease|11|||
33480471|NCT03207867|101651786|FG014|Overall Study|Progressive Disease|9|||
33480472|NCT03207867|101651787|FG015|Overall Study|Progressive Disease|5|||
33480473|NCT03207867|101651788|FG016|Overall Study|Progressive Disease|10|||
33480474|NCT03207867|101651789|FG017|Overall Study|Progressive Disease|14|||
33480475|NCT03207867|101651790|FG018|Overall Study|Progressive Disease|13|||
33480476|NCT03207867|101651791|FG019|Overall Study|Progressive Disease|14|||
33480477|NCT03207867|101651792|FG020|Overall Study|Progressive Disease|6|||
33480478|NCT03207867|101651793|FG021|Overall Study|Progressive Disease|3|||
33480479|NCT03207867|101651794|FG022|Overall Study|Progressive Disease|3|||
33480480|NCT03207867|101651795|FG023|Overall Study|Progressive Disease|3|||
33480481|NCT03207867|101651772|FG000|Overall Study|Patient/guardian Decision|0|||
33480482|NCT03207867|101651773|FG001|Overall Study|Patient/guardian Decision|0|||
33480483|NCT03207867|101651774|FG002|Overall Study|Patient/guardian Decision|1|||
33480484|NCT03207867|101651775|FG003|Overall Study|Patient/guardian Decision|1|||
33480485|NCT03207867|101651776|FG004|Overall Study|Patient/guardian Decision|1|||
33480486|NCT03207867|101651777|FG005|Overall Study|Patient/guardian Decision|2|||
33480487|NCT03207867|101651778|FG006|Overall Study|Patient/guardian Decision|1|||
33480488|NCT03207867|101651779|FG007|Overall Study|Patient/guardian Decision|0|||
33480489|NCT03207867|101651780|FG008|Overall Study|Patient/guardian Decision|1|||
33480490|NCT03207867|101651781|FG009|Overall Study|Patient/guardian Decision|0|||
33480491|NCT03207867|101651782|FG010|Overall Study|Patient/guardian Decision|0|||
33480492|NCT03207867|101651783|FG011|Overall Study|Patient/guardian Decision|1|||
33480493|NCT03207867|101651784|FG012|Overall Study|Patient/guardian Decision|0|||
33480494|NCT03207867|101651785|FG013|Overall Study|Patient/guardian Decision|1|||
33480495|NCT03207867|101651786|FG014|Overall Study|Patient/guardian Decision|2|||
33480496|NCT03207867|101651787|FG015|Overall Study|Patient/guardian Decision|0|||
33480497|NCT03207867|101651788|FG016|Overall Study|Patient/guardian Decision|1|||
33480498|NCT03207867|101651789|FG017|Overall Study|Patient/guardian Decision|3|||
33480499|NCT03207867|101651790|FG018|Overall Study|Patient/guardian Decision|4|||
33480500|NCT03207867|101651791|FG019|Overall Study|Patient/guardian Decision|1|||
33273171|NCT03840993|100897814|FG001|Overall Study|Withdrawal by Subject|3|||
33273172|NCT03840993|100897813|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
33273173|NCT03840993|100897814|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
33273174|NCT03349476|100897815|FG000|Overall Study|Physician Decision|3|||
33273175|NCT03070301|100897818|FG000|Overall Study|Progression of disease|16|||
33273176|NCT03070301|100897818|FG000|Overall Study|Physician Decision|3|||
33273177|NCT03070301|100897818|FG000|Overall Study|Withdrawal by Subject|1|||
33273178|NCT02721147|100897821|FG000|Overall Study|Lost to Follow-up|2|||
33273179|NCT02721147|100897822|FG001|Overall Study|Lost to Follow-up|0|||
33480501|NCT03207867|101651792|FG020|Overall Study|Patient/guardian Decision|0|||
33480502|NCT03207867|101651793|FG021|Overall Study|Patient/guardian Decision|0|||
33480503|NCT03207867|101651794|FG022|Overall Study|Patient/guardian Decision|0|||
33480504|NCT03207867|101651795|FG023|Overall Study|Patient/guardian Decision|0|||
33480505|NCT00315731|101651796|FG000|Overall Study|Lost to Follow-up|1|||
33480506|NCT00315731|101651796|FG000|Overall Study|Death|5|||
33480507|NCT04431726|101651797|FG000|Overall Study|Ongoing in the Study|55|||
33480508|NCT00912912|101651811|FG000|Overall Study|Withdrawal by Subject|1|||
33273180|NCT02721147|100897823|FG002|Overall Study|Lost to Follow-up|0|||
33273181|NCT00355784|100897824|FG000|Overall Study|Withdrawal by Subject|0|||
33273182|NCT00355784|100897825|FG001|Overall Study|Withdrawal by Subject|0|||
33273183|NCT00355784|100897826|FG002|Overall Study|Withdrawal by Subject|2|||
33273184|NCT01029925|100897835|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
33273185|NCT01029925|100897835|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
33273186|NCT01029925|100897835|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
33273187|NCT01640288|100897836|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
33273188|NCT01640288|100897837|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
33273189|NCT01640288|100897836|FG000|Overall Study|Screen Failure|20|||
33273190|NCT01640288|100897837|FG001|Overall Study|Screen Failure|18|||
33273191|NCT01640288|100897836|FG000|Overall Study|Withdrawn by PI|5|||
33273192|NCT01640288|100897837|FG001|Overall Study|Withdrawn by PI|0|||
33273193|NCT01640288|100897836|FG000|Overall Study|Withdrawal by Subject|1|||
33273194|NCT01640288|100897837|FG001|Overall Study|Withdrawal by Subject|0|||
33273195|NCT01468597|100897838|FG000|Overall Study|Found ineligible|17|||
33273196|NCT01468597|100897838|FG000|Overall Study|concomitant valves|12|||
33273197|NCT01468597|100897838|FG000|Overall Study|off-pump CABG|1|||
33273198|NCT01468597|100897838|FG000|Overall Study|no platelet function data|5|||
33273199|NCT00936065|100897839|FG000|Overall Study|Adverse Event|1|||
33273200|NCT00936065|100897840|FG001|Overall Study|Adverse Event|0|||
33273201|NCT00936065|100897841|FG002|Overall Study|Adverse Event|1|||
33273202|NCT00936065|100897839|FG000|Overall Study|Lack of Efficacy|1|||
33273203|NCT00936065|100897840|FG001|Overall Study|Lack of Efficacy|0|||
33273204|NCT00936065|100897841|FG002|Overall Study|Lack of Efficacy|1|||
33273205|NCT00936065|100897839|FG000|Overall Study|Lost to Follow-up|1|||
33273206|NCT00936065|100897840|FG001|Overall Study|Lost to Follow-up|0|||
33273207|NCT00936065|100897841|FG002|Overall Study|Lost to Follow-up|0|||
33273208|NCT00936065|100897839|FG000|Overall Study|Protocol Violation|1|||
33273209|NCT00936065|100897840|FG001|Overall Study|Protocol Violation|2|||
33273210|NCT00936065|100897841|FG002|Overall Study|Protocol Violation|1|||
33273211|NCT00936065|100897839|FG000|Overall Study|Withdrawal by Subject|0|||
33273212|NCT00936065|100897840|FG001|Overall Study|Withdrawal by Subject|2|||
33273213|NCT00936065|100897841|FG002|Overall Study|Withdrawal by Subject|4|||
33273214|NCT03928743|100900225|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
33273215|NCT03928743|100900226|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
33273216|NCT03928743|100900227|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
33273217|NCT03928743|100900225|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
33273218|NCT03928743|100900226|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
33273219|NCT03928743|100900227|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
33273220|NCT03928743|100900225|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
33273221|NCT03928743|100900226|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
33273222|NCT03928743|100900227|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
33273223|NCT03928743|100900225|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
33273224|NCT03928743|100900226|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
33273225|NCT03928743|100900227|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
33273226|NCT03928743|100900225|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
33273227|NCT03928743|100900226|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
33273228|NCT03928743|100900227|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
33273229|NCT03928743|100900225|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
33273230|NCT03928743|100900226|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
33273231|NCT03928743|100900227|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
33273232|NCT03928743|100900225|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
33273233|NCT03928743|100900226|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
33273234|NCT03928743|100900227|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
33273235|NCT03928743|100900225|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
33273236|NCT03928743|100900226|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
33273237|NCT03928743|100900227|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
33273238|NCT03928743|100900225|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
33273239|NCT03928743|100900226|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
33273240|NCT03928743|100900227|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
33273241|NCT03928743|100900225|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
33273242|NCT03928743|100900226|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
33273243|NCT03928743|100900227|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
33273244|NCT03928743|100900225|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
33273245|NCT03928743|100900226|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
33273246|NCT03928743|100900227|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
33273247|NCT00264576|100900231|FG000|Overall Study|Lost to Follow-up|1|||
33480509|NCT00912912|101651811|FG000|Overall Study|Disease Progression|3|||
33273248|NCT00264576|100900232|FG001|Overall Study|Lost to Follow-up|1|||
33273249|NCT03989232|100900233|FG000|Overall Study|Lost to Follow-up|3|||
33273250|NCT03989232|100900234|FG001|Overall Study|Lost to Follow-up|10|||
33273251|NCT03989232|100900233|FG000|Overall Study|Withdrawal by Subject|6|||
33273252|NCT03989232|100900234|FG001|Overall Study|Withdrawal by Subject|6|||
33273253|NCT03989232|100900233|FG000|Overall Study|Death|1|||
33273254|NCT03989232|100900234|FG001|Overall Study|Death|2|||
33273255|NCT00882050|100900235|FG000|Overall Study|Physician Decision|1|||
33273256|NCT00882050|100900236|FG001|Overall Study|Physician Decision|0|||
33273257|NCT00882050|100900237|FG002|Overall Study|Physician Decision|0|||
33273258|NCT01494467|100900240|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
33273259|NCT01494467|100900241|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
33273260|NCT01494467|100900240|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
33273261|NCT01494467|100900241|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
33273262|NCT01494467|100900240|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
33273263|NCT01494467|100900241|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
33273264|NCT01494467|100900240|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
33273265|NCT01494467|100900241|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
33273266|NCT01494467|100900240|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
33273267|NCT01494467|100900241|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
33273268|NCT01494467|100900240|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
33273269|NCT01494467|100900241|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
33273270|NCT01494467|100900240|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
33273271|NCT01494467|100900241|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
33273272|NCT01494467|100900240|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
33273273|NCT01494467|100900241|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
33273274|NCT01494467|100900240|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
33273275|NCT01494467|100900241|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
33273276|NCT01494467|100900240|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
33273277|NCT01494467|100900241|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
33273278|NCT01494467|100900240|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
33273279|NCT01494467|100900241|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
33273280|NCT01494467|100900240|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
33273281|NCT01494467|100900241|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
33273282|NCT01494467|100900240|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
33273283|NCT01494467|100900241|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
33273284|NCT01494467|100900240|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
33273285|NCT01494467|100900241|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
33273286|NCT03689452|100900242|FG000|Overall Study|Lost to Follow-up|1|||
33273287|NCT03689452|100900243|FG001|Overall Study|Lost to Follow-up|1|||
33273288|NCT00448344|100900244|FG000|Overall Study|Lost to Follow-up|20|||
33273289|NCT00448344|100900245|FG001|Overall Study|Lost to Follow-up|22|||
33273290|NCT00448344|100900244|FG000|Overall Study|Withdrawal by Subject|6|||
33273291|NCT00448344|100900245|FG001|Overall Study|Withdrawal by Subject|8|||
33273292|NCT00448344|100900244|FG000|Overall Study|Death|3|||
33273293|NCT00448344|100900245|FG001|Overall Study|Death|4|||
33273294|NCT00448344|100900244|FG000|Overall Study|Physician Decision|1|||
33273295|NCT00448344|100900245|FG001|Overall Study|Physician Decision|2|||
33273296|NCT02144285|100900246|FG000|Overall Study|Withdrawal by Subject|0|||
33273297|NCT02144285|100900247|FG001|Overall Study|Withdrawal by Subject|0|||
33273298|NCT02144285|100900248|FG002|Overall Study|Withdrawal by Subject|0|||
33273299|NCT02144285|100900249|FG003|Overall Study|Withdrawal by Subject|0|||
33273300|NCT02144285|100900250|FG004|Overall Study|Withdrawal by Subject|1|||
33273301|NCT02144285|100900251|FG005|Overall Study|Withdrawal by Subject|0|||
33273302|NCT02144285|100900252|FG006|Overall Study|Withdrawal by Subject|0|||
33273303|NCT02144285|100900253|FG007|Overall Study|Withdrawal by Subject|0|||
33273304|NCT02144285|100900254|FG008|Overall Study|Withdrawal by Subject|0|||
33273305|NCT02144285|100900255|FG009|Overall Study|Withdrawal by Subject|0|||
33273306|NCT01294644|100900256|FG000|Overall Study|Adverse Event|2|||
33273307|NCT01294644|100900257|FG001|Overall Study|Adverse Event|0|||
33273308|NCT01294644|100900258|FG002|Overall Study|Adverse Event|1|||
33273309|NCT01294644|100900256|FG000|Overall Study|Withdrawal by Subject|3|||
33273310|NCT01294644|100900257|FG001|Overall Study|Withdrawal by Subject|7|||
33273311|NCT01294644|100900258|FG002|Overall Study|Withdrawal by Subject|4|||
33480510|NCT01716715|101651812|FG000|Overall Study|Never Treated|2|||
33273312|NCT01294644|100900256|FG000|Overall Study|Lost to Follow-up|3|||
33273313|NCT01294644|100900257|FG001|Overall Study|Lost to Follow-up|2|||
33273314|NCT01294644|100900258|FG002|Overall Study|Lost to Follow-up|5|||
33273315|NCT01294644|100900256|FG000|Overall Study|Miscellaneous Reason|2|||
33273316|NCT01294644|100900257|FG001|Overall Study|Miscellaneous Reason|1|||
33480511|NCT01716715|101651813|FG001|Overall Study|Never Treated|4|||
33480512|NCT00886288|101651816|FG000|Overall Study|no respect of the 12 weeks period|657|||
33480513|NCT00886288|101651817|FG001|Overall Study|no respect of the 12 weeks period|227|||
33273317|NCT01294644|100900258|FG002|Overall Study|Miscellaneous Reason|4|||
33273318|NCT02400749|100900261|FG000|Week 0 -16|Withdrawal by Subject|5|||
33273319|NCT02400749|100900262|FG001|Week 0 -16|Withdrawal by Subject|5|||
33273320|NCT02400749|100900261|FG000|Week 0 -16|Adverse Event|3|||
33273321|NCT02400749|100900262|FG001|Week 0 -16|Adverse Event|1|||
33273322|NCT02400749|100900261|FG000|Week 0 -16|Lost to Follow-up|2|||
33273323|NCT02400749|100900262|FG001|Week 0 -16|Lost to Follow-up|0|||
33273324|NCT02400749|100900261|FG000|Week 0 -16|Protocol Violation|1|||
33273325|NCT02400749|100900262|FG001|Week 0 -16|Protocol Violation|0|||
33273326|NCT02400749|100900261|FG000|Week 17 - 32|Withdrawal by Subject|3|||
33273327|NCT02400749|100900262|FG001|Week 17 - 32|Withdrawal by Subject|2|||
33273328|NCT02400749|100900261|FG000|Week 17 - 32|Adverse Event|2|||
33273329|NCT02400749|100900262|FG001|Week 17 - 32|Adverse Event|1|||
33273330|NCT03209492|100900263|FG000|Overall Study|Case Report Forms Uncollected|5|||
33273331|NCT02942771|100900264|FG000|Overall Study|Adverse Event|1|||
33273332|NCT02942771|100900265|FG001|Overall Study|Adverse Event|0|||
33273333|NCT02942771|100900266|FG002|Overall Study|Adverse Event|0|||
33273334|NCT02942771|100900267|FG003|Overall Study|Adverse Event|0|||
33273335|NCT02942771|100900268|FG004|Overall Study|Adverse Event|2|||
33273336|NCT02942771|100900264|FG000|Overall Study|Lost to Follow-up|1|||
33273337|NCT02942771|100900265|FG001|Overall Study|Lost to Follow-up|0|||
33273338|NCT02942771|100900266|FG002|Overall Study|Lost to Follow-up|0|||
33273339|NCT02942771|100900267|FG003|Overall Study|Lost to Follow-up|0|||
33273340|NCT02942771|100900268|FG004|Overall Study|Lost to Follow-up|0|||
33273341|NCT02942771|100900264|FG000|Overall Study|Withdrawal by Subject|1|||
33273342|NCT02942771|100900265|FG001|Overall Study|Withdrawal by Subject|0|||
33273343|NCT02942771|100900266|FG002|Overall Study|Withdrawal by Subject|0|||
33273344|NCT02942771|100900267|FG003|Overall Study|Withdrawal by Subject|0|||
33273345|NCT02942771|100900268|FG004|Overall Study|Withdrawal by Subject|2|||
33273346|NCT01714947|100900269|FG000|Part B|Progressive Disease|3|||
33273347|NCT02691702|100900273|FG000|Overall Study|Adverse Event|1|||
33273348|NCT02691702|100900274|FG001|Overall Study|Adverse Event|0|||
33273349|NCT02691702|100900275|FG002|Overall Study|Adverse Event|0|||
33273350|NCT02691702|100900276|FG003|Overall Study|Adverse Event|0|||
33273351|NCT02691702|100900277|FG004|Overall Study|Adverse Event|0|||
33273352|NCT02691702|100900278|FG005|Overall Study|Adverse Event|0|||
33273353|NCT02691702|100900279|FG006|Overall Study|Adverse Event|0|||
33273354|NCT02691702|100900280|FG007|Overall Study|Adverse Event|0|||
33273355|NCT02691702|100900281|FG008|Overall Study|Adverse Event|1|||
33273356|NCT02691702|100900282|FG009|Overall Study|Adverse Event|0|||
33273357|NCT02691702|100900283|FG010|Overall Study|Adverse Event|1|||
33273358|NCT02691702|100900273|FG000|Overall Study|Lost to Follow-up|0|||
33273359|NCT02691702|100900274|FG001|Overall Study|Lost to Follow-up|0|||
33273360|NCT02691702|100900275|FG002|Overall Study|Lost to Follow-up|1|||
33273361|NCT02691702|100900276|FG003|Overall Study|Lost to Follow-up|0|||
33273362|NCT02691702|100900277|FG004|Overall Study|Lost to Follow-up|0|||
33273363|NCT02691702|100900278|FG005|Overall Study|Lost to Follow-up|2|||
33273364|NCT02691702|100900279|FG006|Overall Study|Lost to Follow-up|0|||
33273365|NCT02691702|100900280|FG007|Overall Study|Lost to Follow-up|0|||
33273366|NCT02691702|100900281|FG008|Overall Study|Lost to Follow-up|0|||
33273367|NCT02691702|100900282|FG009|Overall Study|Lost to Follow-up|0|||
33273368|NCT02691702|100900283|FG010|Overall Study|Lost to Follow-up|1|||
33273369|NCT02691702|100900273|FG000|Overall Study|Withdrawal by Subject|1|||
33273370|NCT02691702|100900274|FG001|Overall Study|Withdrawal by Subject|1|||
33273371|NCT02691702|100900275|FG002|Overall Study|Withdrawal by Subject|0|||
33273372|NCT02691702|100900276|FG003|Overall Study|Withdrawal by Subject|0|||
33273373|NCT02691702|100900277|FG004|Overall Study|Withdrawal by Subject|0|||
33273374|NCT02691702|100900278|FG005|Overall Study|Withdrawal by Subject|1|||
33273375|NCT02691702|100900279|FG006|Overall Study|Withdrawal by Subject|2|||
33273376|NCT02691702|100900280|FG007|Overall Study|Withdrawal by Subject|0|||
33273377|NCT02691702|100900281|FG008|Overall Study|Withdrawal by Subject|0|||
33273378|NCT02691702|100900282|FG009|Overall Study|Withdrawal by Subject|0|||
33273379|NCT02691702|100900283|FG010|Overall Study|Withdrawal by Subject|0|||
33273380|NCT02691702|100900273|FG000|Overall Study|Other|0|||
33273381|NCT02691702|100900274|FG001|Overall Study|Other|0|||
33273382|NCT02691702|100900275|FG002|Overall Study|Other|0|||
33273383|NCT02691702|100900276|FG003|Overall Study|Other|0|||
33480514|NCT00886288|101651816|FG000|Overall Study|Lost to Follow-up|86|||
33273384|NCT02691702|100900277|FG004|Overall Study|Other|0|||
33480515|NCT00886288|101651817|FG001|Overall Study|Lost to Follow-up|0|||
33273385|NCT02691702|100900278|FG005|Overall Study|Other|0|||
33273386|NCT02691702|100900279|FG006|Overall Study|Other|1|||
33273387|NCT02691702|100900280|FG007|Overall Study|Other|0|||
33273388|NCT02691702|100900281|FG008|Overall Study|Other|1|||
33273389|NCT02691702|100900282|FG009|Overall Study|Other|0|||
33273390|NCT02691702|100900283|FG010|Overall Study|Other|0|||
33273391|NCT02691702|100900273|FG000|Overall Study|Protocol Violation|0|||
33273392|NCT02691702|100900274|FG001|Overall Study|Protocol Violation|0|||
33273393|NCT02691702|100900275|FG002|Overall Study|Protocol Violation|0|||
33273394|NCT02691702|100900276|FG003|Overall Study|Protocol Violation|0|||
33273395|NCT02691702|100900277|FG004|Overall Study|Protocol Violation|0|||
33273396|NCT02691702|100900278|FG005|Overall Study|Protocol Violation|0|||
33273397|NCT02691702|100900279|FG006|Overall Study|Protocol Violation|0|||
33273398|NCT02691702|100900280|FG007|Overall Study|Protocol Violation|0|||
33480516|NCT02087189|101651818|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
33480517|NCT01874353|101651819|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
33480518|NCT01874353|101651820|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
33480519|NCT01874353|101651821|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
33480520|NCT01874353|101651822|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
33480521|NCT01874353|101651819|FG000|Overall Study|Lost to Follow-up|2|||
33480522|NCT01874353|101651820|FG001|Overall Study|Lost to Follow-up|2|||
33480523|NCT01874353|101651821|FG002|Overall Study|Lost to Follow-up|2|||
33480524|NCT01874353|101651822|FG003|Overall Study|Lost to Follow-up|0|||
33480525|NCT01874353|101651819|FG000|Overall Study|Death|110|||
33480526|NCT01874353|101651820|FG001|Overall Study|Death|60|||
33480527|NCT01874353|101651821|FG002|Overall Study|Death|13|||
33480528|NCT01874353|101651822|FG003|Overall Study|Death|7|||
33480529|NCT01874353|101651819|FG000|Overall Study|Withdrawal by Subject|13|||
33273399|NCT02691702|100900281|FG008|Overall Study|Protocol Violation|0|||
33273400|NCT02691702|100900282|FG009|Overall Study|Protocol Violation|2|||
33273401|NCT02691702|100900283|FG010|Overall Study|Protocol Violation|0|||
33273402|NCT02753075|100900284|FG000|Overall Study|Adverse Event|2|||
33273403|NCT02753075|100900285|FG001|Overall Study|Adverse Event|1|||
33273404|NCT02753075|100900286|FG002|Overall Study|Adverse Event|0|||
33273405|NCT02753075|100900284|FG000|Overall Study|Lost to Follow-up|2|||
33273406|NCT02753075|100900285|FG001|Overall Study|Lost to Follow-up|0|||
33273407|NCT02753075|100900286|FG002|Overall Study|Lost to Follow-up|0|||
33273408|NCT02753075|100900284|FG000|Overall Study|Withdrawal of Consent|1|||
33273409|NCT02753075|100900285|FG001|Overall Study|Withdrawal of Consent|1|||
33273410|NCT02753075|100900286|FG002|Overall Study|Withdrawal of Consent|3|||
33273411|NCT02753075|100900284|FG000|Overall Study|Physician Decision|3|||
33273412|NCT02753075|100900285|FG001|Overall Study|Physician Decision|1|||
33273413|NCT02753075|100900286|FG002|Overall Study|Physician Decision|0|||
33273414|NCT03219216|100900288|FG000|Overall Study|Lost to Follow-up|0|||
33273415|NCT03219216|100900289|FG001|Overall Study|Lost to Follow-up|1|||
33273416|NCT02203513|100900297|FG000|Overall Study|Refused further treatment|2|||
33273417|NCT02203513|100900298|FG001|Overall Study|Refused further treatment|0|||
33273418|NCT02203513|100900299|FG002|Overall Study|Refused further treatment|1|||
33273419|NCT02203513|100900300|FG003|Overall Study|Refused further treatment|0|||
33273420|NCT02203513|100900301|FG004|Overall Study|Refused further treatment|0|||
33273421|NCT02203513|100900297|FG000|Overall Study|Switched to alternative treatment|3|||
33273422|NCT02203513|100900298|FG001|Overall Study|Switched to alternative treatment|4|||
33273423|NCT02203513|100900299|FG002|Overall Study|Switched to alternative treatment|0|||
33273424|NCT02203513|100900300|FG003|Overall Study|Switched to alternative treatment|0|||
33273425|NCT02203513|100900301|FG004|Overall Study|Switched to alternative treatment|4|||
33273426|NCT02203513|100900297|FG000|Overall Study|Did not receive investigational product (IP)|0|||
33273427|NCT02203513|100900298|FG001|Overall Study|Did not receive investigational product (IP)|1|||
33273428|NCT02203513|100900299|FG002|Overall Study|Did not receive investigational product (IP)|0|||
33273429|NCT02203513|100900300|FG003|Overall Study|Did not receive investigational product (IP)|0|||
33273430|NCT02203513|100900301|FG004|Overall Study|Did not receive investigational product (IP)|0|||
33273431|NCT02203513|100900297|FG000|Overall Study|Death (unrelated to study therapy)|1|||
33273432|NCT02203513|100900298|FG001|Overall Study|Death (unrelated to study therapy)|3|||
33273433|NCT02203513|100900299|FG002|Overall Study|Death (unrelated to study therapy)|1|||
33273434|NCT02203513|100900300|FG003|Overall Study|Death (unrelated to study therapy)|0|||
33273435|NCT02203513|100900301|FG004|Overall Study|Death (unrelated to study therapy)|2|||
33273436|NCT02203513|100900297|FG000|Overall Study|Lost to Follow-up|0|||
33273437|NCT02203513|100900298|FG001|Overall Study|Lost to Follow-up|0|||
33273438|NCT02203513|100900299|FG002|Overall Study|Lost to Follow-up|1|||
33273439|NCT02203513|100900300|FG003|Overall Study|Lost to Follow-up|1|||
33273440|NCT02203513|100900301|FG004|Overall Study|Lost to Follow-up|0|||
33273441|NCT00621842|100900302|FG000|Overall Study|Adverse Event|6|||
33273442|NCT00621842|100900302|FG000|Overall Study|Withdrawal by Subject|7|||
33273443|NCT00621842|100900302|FG000|Overall Study|Protocol Violation|4|||
33480530|NCT01874353|101651820|FG001|Overall Study|Withdrawal by Subject|11|||
33273444|NCT00621842|100900302|FG000|Overall Study|Lack of Efficacy|2|||
33273445|NCT00484198|100900303|FG000|Overall Study|Participant Withdrew Consent|12|||
33273446|NCT00484198|100900304|FG001|Overall Study|Participant Withdrew Consent|21|||
33273447|NCT00484198|100900305|FG002|Overall Study|Participant Withdrew Consent|47|||
33273448|NCT00484198|100900306|FG003|Overall Study|Participant Withdrew Consent|59|||
33273449|NCT00484198|100900303|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
33480531|NCT01874353|101651821|FG002|Overall Study|Withdrawal by Subject|0|||
33480532|NCT01874353|101651822|FG003|Overall Study|Withdrawal by Subject|0|||
33273450|NCT00484198|100900304|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
33286479|NCT03481556|100943978|FG001|Overall Study|Adverse Event|0|||
33480533|NCT03375203|101651823|FG000|Overall Study|Protocol Violation|0|||
33480534|NCT03375203|101651824|FG001|Overall Study|Protocol Violation|0|||
33480535|NCT03375203|101651825|FG002|Overall Study|Protocol Violation|1|||
33480536|NCT03375203|101651826|FG003|Overall Study|Protocol Violation|0|||
33480537|NCT03375203|101651827|FG004|Overall Study|Protocol Violation|0|||
33480538|NCT03375203|101651823|FG000|Overall Study|Adverse Event|2|||
33480539|NCT03375203|101651824|FG001|Overall Study|Adverse Event|3|||
33480540|NCT03375203|101651825|FG002|Overall Study|Adverse Event|0|||
33480541|NCT03375203|101651826|FG003|Overall Study|Adverse Event|2|||
33480542|NCT03375203|101651827|FG004|Overall Study|Adverse Event|2|||
33480543|NCT03375203|101651823|FG000|Overall Study|Withdrawal by Subject|3|||
33480544|NCT03375203|101651824|FG001|Overall Study|Withdrawal by Subject|0|||
33273451|NCT00484198|100900305|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
33273452|NCT00484198|100900306|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
33273453|NCT00484198|100900303|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
33273454|NCT00484198|100900304|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
33273455|NCT00484198|100900305|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
33273456|NCT00484198|100900306|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
33273457|NCT00484198|100900303|FG000|Overall Study|Adverse Event|3|||
33273458|NCT00484198|100900304|FG001|Overall Study|Adverse Event|11|||
33273459|NCT00484198|100900305|FG002|Overall Study|Adverse Event|32|||
33273460|NCT00484198|100900306|FG003|Overall Study|Adverse Event|31|||
33273461|NCT00484198|100900303|FG000|Overall Study|Protocol Violation|0|||
33273462|NCT00484198|100900304|FG001|Overall Study|Protocol Violation|5|||
33273463|NCT00484198|100900305|FG002|Overall Study|Protocol Violation|6|||
33273464|NCT00484198|100900306|FG003|Overall Study|Protocol Violation|8|||
33273465|NCT00484198|100900303|FG000|Overall Study|Other|7|||
33273466|NCT00484198|100900304|FG001|Overall Study|Other|10|||
33480545|NCT03375203|101651825|FG002|Overall Study|Withdrawal by Subject|1|||
33480546|NCT03375203|101651826|FG003|Overall Study|Withdrawal by Subject|0|||
33480547|NCT03375203|101651827|FG004|Overall Study|Withdrawal by Subject|2|||
33480548|NCT03375203|101651823|FG000|Overall Study|Non-compliance with study drug|1|||
33480549|NCT03375203|101651824|FG001|Overall Study|Non-compliance with study drug|0|||
33480550|NCT03375203|101651825|FG002|Overall Study|Non-compliance with study drug|0|||
33480551|NCT03375203|101651826|FG003|Overall Study|Non-compliance with study drug|0|||
33480552|NCT03375203|101651827|FG004|Overall Study|Non-compliance with study drug|0|||
33480553|NCT03375203|101651823|FG000|Overall Study|Randomized, not treated.|0|||
33480554|NCT03375203|101651824|FG001|Overall Study|Randomized, not treated.|1|||
33480555|NCT03375203|101651825|FG002|Overall Study|Randomized, not treated.|0|||
33480556|NCT03375203|101651826|FG003|Overall Study|Randomized, not treated.|0|||
33480557|NCT03375203|101651827|FG004|Overall Study|Randomized, not treated.|0|||
33480558|NCT02425904|101651830|FG000|Overall Study|Lost to Follow-up|1|||
33273467|NCT00484198|100900305|FG002|Overall Study|Other|31|||
33480559|NCT02425904|101651831|FG001|Overall Study|Lost to Follow-up|0|||
33480560|NCT02425904|101651830|FG000|Overall Study|Withdrawal by Subject|2|||
33480561|NCT02425904|101651831|FG001|Overall Study|Withdrawal by Subject|0|||
33480562|NCT02425904|101651830|FG000|Overall Study|Death|0|||
33480563|NCT02425904|101651831|FG001|Overall Study|Death|3|||
33480564|NCT03283761|101651833|FG000|Study Treatment|Patient Non-Compliance|1|||
33480565|NCT03283761|101651833|FG000|Study Treatment|Alternative Cancer Therapy|7|||
33480566|NCT03283761|101651833|FG000|Study Treatment|Disease progression|21|||
33480567|NCT03283761|101651833|FG000|Study Treatment|Adverse Event|3|||
33480568|NCT03283761|101651833|FG000|Study Treatment|Withdrawal by Subject|4|||
33480569|NCT03283761|101651833|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
33480570|NCT03283761|101651833|FG000|Study Treatment|Symptomatic Deterioration|1|||
33480571|NCT03283761|101651833|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
33480572|NCT03283761|101651833|FG000|Follow up|Lost to Follow-up|1|||
33480573|NCT03283761|101651833|FG000|Follow up|Symptomatic Deterioration|1|||
33480574|NCT03283761|101651833|FG000|Follow up|Death|29|||
33480575|NCT03283761|101651833|FG000|Follow up|study terminated|4|||
33480576|NCT03283761|101651833|FG000|Follow up|Primary Investigator Withdrawal|1|||
33480577|NCT03283761|101651833|FG000|Follow up|Switched to alternative therapy|1|||
33480578|NCT03283761|101651833|FG000|Follow up|Subject is now in Hospice|1|||
33480579|NCT02552212|101651834|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
33480580|NCT02552212|101651835|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
33480581|NCT02552212|101651836|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
33273468|NCT00484198|100900306|FG003|Overall Study|Other|28|||
33273469|NCT02964234|100900308|FG000|Overall Study|Lost to Follow-up|22|||
33480582|NCT02552212|101651834|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
33480583|NCT02552212|101651835|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
33480584|NCT02552212|101651836|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
33480585|NCT02552212|101651834|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
33273470|NCT02964234|100900309|FG001|Overall Study|Lost to Follow-up|13|||
33480586|NCT02552212|101651835|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
33480587|NCT02552212|101651836|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
33273471|NCT01732757|100900310|FG000|Overall Study|Lost to Follow-up|1|||
33273472|NCT01732757|100900311|FG001|Overall Study|Lost to Follow-up|0|||
33273473|NCT01732757|100900312|FG002|Overall Study|Lost to Follow-up|0|||
33273474|NCT00042939|100900319|FG000|Overall Study|Adverse Event|6|||
33273475|NCT00042939|100900320|FG001|Overall Study|Adverse Event|7|||
33273476|NCT00042939|100900319|FG000|Overall Study|Death|3|||
33273477|NCT00042939|100900320|FG001|Overall Study|Death|2|||
33273478|NCT00042939|100900319|FG000|Overall Study|Withdrawal by Subject|3|||
33273479|NCT00042939|100900320|FG001|Overall Study|Withdrawal by Subject|4|||
33273480|NCT00042939|100900319|FG000|Overall Study|Other disease|1|||
33273481|NCT00042939|100900320|FG001|Overall Study|Other disease|0|||
33273482|NCT00042939|100900319|FG000|Overall Study|Ineligible|2|||
33273483|NCT00042939|100900320|FG001|Overall Study|Ineligible|2|||
33273484|NCT00042939|100900319|FG000|Overall Study|Deterioration of health|3|||
33273485|NCT00042939|100900320|FG001|Overall Study|Deterioration of health|4|||
33273486|NCT00042939|100900319|FG000|Overall Study|QOL diminished|1|||
33273487|NCT00042939|100900320|FG001|Overall Study|QOL diminished|0|||
33273488|NCT00042939|100900319|FG000|Overall Study|Rising ca 19-9|1|||
33273489|NCT00042939|100900320|FG001|Overall Study|Rising ca 19-9|0|||
33273490|NCT00042939|100900319|FG000|Overall Study|Patient non-compliance|1|||
33273491|NCT00042939|100900320|FG001|Overall Study|Patient non-compliance|0|||
33273492|NCT00042939|100900319|FG000|Overall Study|Still on treatment|1|||
33273493|NCT00042939|100900320|FG001|Overall Study|Still on treatment|0|||
33273494|NCT00042939|100900319|FG000|Overall Study|Treatment break > 4 weeks|0|||
33273495|NCT00042939|100900320|FG001|Overall Study|Treatment break > 4 weeks|1|||
33273496|NCT00042939|100900319|FG000|Overall Study|Did not start treatment|2|||
33273497|NCT00042939|100900320|FG001|Overall Study|Did not start treatment|1|||
33273498|NCT00821093|100900321|FG000|Overall Study|Adverse Event|20|||
33273499|NCT00821093|100900322|FG001|Overall Study|Adverse Event|12|||
33273500|NCT00821093|100900321|FG000|Overall Study|Withdrawal by Subject|9|||
33273501|NCT00821093|100900322|FG001|Overall Study|Withdrawal by Subject|13|||
33273502|NCT00821093|100900321|FG000|Overall Study|Lost to Follow-up|9|||
33273503|NCT00821093|100900322|FG001|Overall Study|Lost to Follow-up|3|||
33273504|NCT00821093|100900321|FG000|Overall Study|Protocol deviation|3|||
33273505|NCT00821093|100900322|FG001|Overall Study|Protocol deviation|6|||
33273506|NCT00821093|100900321|FG000|Overall Study|Abnormal laboratory value(s)|2|||
33273507|NCT00821093|100900322|FG001|Overall Study|Abnormal laboratory value(s)|0|||
33273508|NCT00821093|100900321|FG000|Overall Study|Lack of Efficacy|2|||
33273509|NCT00821093|100900322|FG001|Overall Study|Lack of Efficacy|2|||
33273510|NCT00821093|100900321|FG000|Overall Study|Death|2|||
33273511|NCT00821093|100900322|FG001|Overall Study|Death|1|||
33273512|NCT00821093|100900321|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33273513|NCT00821093|100900322|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33273514|NCT00821093|100900321|FG000|Overall Study|Administrative problems|1|||
33273515|NCT00821093|100900322|FG001|Overall Study|Administrative problems|2|||
33273516|NCT01102426|100900325|FG000|Overall Study|Randomized but not treated|4|||
33273517|NCT01102426|100900326|FG001|Overall Study|Randomized but not treated|1|||
33273518|NCT01102426|100900325|FG000|Overall Study|Adverse Events (treatment-related)|15|||
33273519|NCT01102426|100900326|FG001|Overall Study|Adverse Events (treatment-related)|8|||
33273520|NCT01102426|100900325|FG000|Overall Study|Physician Decision|9|||
33273521|NCT01102426|100900326|FG001|Overall Study|Physician Decision|6|||
33273522|NCT01102426|100900325|FG000|Overall Study|Progressive Disease|85|||
33273523|NCT01102426|100900326|FG001|Overall Study|Progressive Disease|44|||
33273524|NCT01102426|100900325|FG000|Overall Study|Adverse Events (unrelated to|9|||
33273525|NCT01102426|100900326|FG001|Overall Study|Adverse Events (unrelated to|1|||
33480588|NCT02552212|101651834|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
33480589|NCT02552212|101651835|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
33480590|NCT02552212|101651836|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
33480591|NCT02552212|101651834|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
33480592|NCT02552212|101651835|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
33480593|NCT02552212|101651836|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
33480594|NCT02552212|101651834|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
33480595|NCT02552212|101651835|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
33273526|NCT01102426|100900325|FG000|Overall Study|Patient Refusal|24|||
33273527|NCT01102426|100900326|FG001|Overall Study|Patient Refusal|12|||
33273528|NCT01102426|100900325|FG000|Overall Study|Death (due to adverse events|0|||
33273529|NCT01102426|100900326|FG001|Overall Study|Death (due to adverse events|1|||
33273530|NCT01102426|100900325|FG000|Overall Study|Death (non-related to the study|19|||
33273531|NCT01102426|100900326|FG001|Overall Study|Death (non-related to the study|8|||
33273532|NCT00795639|100900331|FG000|Overall Study|Death|1|||
33273533|NCT00795639|100900332|FG001|Overall Study|Death|6|||
33273534|NCT00795639|100900331|FG000|Overall Study|Withdrawal by Subject|1|||
33273535|NCT00795639|100900332|FG001|Overall Study|Withdrawal by Subject|3|||
33273536|NCT00795639|100900331|FG000|Overall Study|Pregnancy|1|||
33273537|NCT00795639|100900332|FG001|Overall Study|Pregnancy|0|||
33273538|NCT00795639|100900331|FG000|Overall Study|Adverse Event|5|||
33273539|NCT00795639|100900332|FG001|Overall Study|Adverse Event|2|||
33480596|NCT02552212|101651836|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
33480597|NCT02552212|101651834|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
33480598|NCT02552212|101651835|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
33480599|NCT02552212|101651836|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
33480600|NCT02552212|101651834|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
33480601|NCT02552212|101651835|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
33480602|NCT02552212|101651836|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
33480603|NCT02552212|101651834|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
33480604|NCT02552212|101651835|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
33480605|NCT02552212|101651836|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
33480606|NCT02552212|101651834|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
33480607|NCT02552212|101651835|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
33480608|NCT02552212|101651836|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
33480609|NCT02552212|101651834|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
33480610|NCT02552212|101651835|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
33480611|NCT02552212|101651836|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
33480612|NCT02552212|101651834|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
33480613|NCT02552212|101651835|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
33480614|NCT02552212|101651836|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
33480615|NCT02552212|101651834|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
33480616|NCT02552212|101651835|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
33480617|NCT02552212|101651836|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
33480618|NCT02552212|101651834|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
33480619|NCT02552212|101651835|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
33480620|NCT02552212|101651836|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
33480621|NCT02552212|101651834|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
33480622|NCT02552212|101651835|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
33480623|NCT02552212|101651836|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
33480624|NCT02552212|101651834|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
33480625|NCT02552212|101651835|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
33480626|NCT02552212|101651836|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
33480627|NCT02552212|101651834|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
33480628|NCT02552212|101651835|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
33480629|NCT02552212|101651836|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
33480630|NCT02552212|101651834|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
33480631|NCT02552212|101651835|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
33480632|NCT02552212|101651836|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
33480633|NCT02552212|101651834|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
33480634|NCT02552212|101651835|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
33480635|NCT02552212|101651836|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
33480636|NCT02552212|101651834|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
33480637|NCT02552212|101651835|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
33480638|NCT02552212|101651836|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
33480639|NCT02552212|101651834|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
33480640|NCT02552212|101651835|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
33480641|NCT02552212|101651836|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
33480642|NCT00371397|101651839|FG000|Session 1|Withdrawal by Subject|1|||
33480643|NCT00371397|101651840|FG001|Session 1|Withdrawal by Subject|0|||
33480644|NCT00371397|101651841|FG002|Session 1|Withdrawal by Subject|0|||
33480645|NCT00371397|101651842|FG003|Session 1|Withdrawal by Subject|0|||
33480646|NCT00371397|101651843|FG004|Session 1|Withdrawal by Subject|0|||
33480647|NCT00371397|101651844|FG005|Session 1|Withdrawal by Subject|0|||
33480648|NCT00371397|101651845|FG006|Session 1|Withdrawal by Subject|0|||
33480649|NCT00371397|101651846|FG007|Session 1|Withdrawal by Subject|1|||
33480650|NCT00371397|101651847|FG008|Session 1|Withdrawal by Subject|0|||
33480651|NCT00371397|101651848|FG009|Session 1|Withdrawal by Subject|0|||
33480652|NCT00371397|101651849|FG010|Session 1|Withdrawal by Subject|0|||
33480653|NCT00371397|101651850|FG011|Session 1|Withdrawal by Subject|0|||
33480654|NCT01292226|101651854|FG000|Overall Study|Adverse Event|5|||
33480655|NCT01292226|101651854|FG000|Overall Study|Death|1|||
33480656|NCT01292226|101651854|FG000|Overall Study|Graft loss|1|||
33480657|NCT01292226|101651854|FG000|Overall Study|Protocol Violation|3|||
33480658|NCT01292226|101651854|FG000|Overall Study|Withdrawal by Subject|1|||
33480659|NCT01292226|101651854|FG000|Overall Study|Other|2|||
33480660|NCT00509795|101651857|FG000|Overall Study|Adverse Event|4|||
33480661|NCT00509795|101651858|FG001|Overall Study|Adverse Event|3|||
33480662|NCT00509795|101651859|FG002|Overall Study|Adverse Event|5|||
33480663|NCT00509795|101651860|FG003|Overall Study|Adverse Event|4|||
33480664|NCT00509795|101651857|FG000|Overall Study|Death|3|||
33480665|NCT00509795|101651858|FG001|Overall Study|Death|1|||
33480666|NCT00509795|101651859|FG002|Overall Study|Death|2|||
33480667|NCT00509795|101651860|FG003|Overall Study|Death|7|||
33480668|NCT00509795|101651857|FG000|Overall Study|Lack of Efficacy|0|||
33480669|NCT00509795|101651858|FG001|Overall Study|Lack of Efficacy|0|||
33480670|NCT00509795|101651859|FG002|Overall Study|Lack of Efficacy|2|||
33480671|NCT00509795|101651860|FG003|Overall Study|Lack of Efficacy|2|||
33480672|NCT00509795|101651857|FG000|Overall Study|Lost to Follow-up|1|||
33480673|NCT00509795|101651858|FG001|Overall Study|Lost to Follow-up|2|||
33480674|NCT00509795|101651859|FG002|Overall Study|Lost to Follow-up|4|||
33480675|NCT00509795|101651860|FG003|Overall Study|Lost to Follow-up|4|||
33480676|NCT00509795|101651857|FG000|Overall Study|OTHER|1|||
33480677|NCT00509795|101651858|FG001|Overall Study|OTHER|0|||
33480678|NCT00509795|101651859|FG002|Overall Study|OTHER|4|||
33480679|NCT00509795|101651860|FG003|Overall Study|OTHER|1|||
33480680|NCT00509795|101651857|FG000|Overall Study|Protocol Violation|3|||
33480681|NCT00509795|101651858|FG001|Overall Study|Protocol Violation|0|||
33480682|NCT00509795|101651859|FG002|Overall Study|Protocol Violation|3|||
33480683|NCT00509795|101651860|FG003|Overall Study|Protocol Violation|1|||
33480684|NCT00509795|101651857|FG000|Overall Study|Withdrawal by Subject|10|||
33480685|NCT00509795|101651858|FG001|Overall Study|Withdrawal by Subject|5|||
33480686|NCT00509795|101651859|FG002|Overall Study|Withdrawal by Subject|7|||
33480687|NCT00509795|101651860|FG003|Overall Study|Withdrawal by Subject|8|||
33480688|NCT00928707|101651863|FG000|Overall Study|Protocol Violation|1|||
33480689|NCT00928707|101651864|FG001|Overall Study|Protocol Violation|0|||
33480690|NCT00866658|101651865|FG000|Overall Study|Adverse Event|5|||
33273540|NCT00795639|100900331|FG000|Overall Study|Other|0|||
33273541|NCT00795639|100900332|FG001|Overall Study|Other|2|||
33273542|NCT00795639|100900331|FG000|Overall Study|Terminated by sponsor|13|||
33273543|NCT00795639|100900332|FG001|Overall Study|Terminated by sponsor|12|||
33273544|NCT00795639|100900331|FG000|Overall Study|Randomized and not treated|0|||
33273545|NCT00795639|100900332|FG001|Overall Study|Randomized and not treated|1|||
33273546|NCT00905255|100900333|FG000|Overall Study|Adverse Event|7|||
33273547|NCT00905255|100900334|FG001|Overall Study|Adverse Event|5|||
33273548|NCT00905255|100900333|FG000|Overall Study|Withdrawal by Subject|5|||
33273549|NCT00905255|100900334|FG001|Overall Study|Withdrawal by Subject|4|||
33273550|NCT00905255|100900333|FG000|Overall Study|Familial and Personal Reasons|1|||
33273551|NCT00905255|100900334|FG001|Overall Study|Familial and Personal Reasons|0|||
33273552|NCT02525744|100900342|FG000|Period 1|Physician Decision|0|||
33273553|NCT02525744|100900343|FG001|Period 1|Physician Decision|0|||
33273554|NCT02525744|100900344|FG002|Period 1|Physician Decision|1|||
33273555|NCT02525744|100900345|FG003|Period 1|Physician Decision|0|||
33273556|NCT02525744|100900342|FG000|Period 3|Adverse Event|0|||
33273557|NCT02525744|100900343|FG001|Period 3|Adverse Event|1|||
33273558|NCT02525744|100900344|FG002|Period 3|Adverse Event|0|||
33273559|NCT02525744|100900345|FG003|Period 3|Adverse Event|0|||
33273560|NCT02525744|100900342|FG000|Period 4|Withdrawal by Subject|1|||
33273561|NCT02525744|100900343|FG001|Period 4|Withdrawal by Subject|0|||
33273562|NCT02525744|100900344|FG002|Period 4|Withdrawal by Subject|0|||
33273563|NCT02525744|100900345|FG003|Period 4|Withdrawal by Subject|0|||
33273564|NCT02525744|100900342|FG000|Period 5|Physician Decision|1|||
33273565|NCT02525744|100900343|FG001|Period 5|Physician Decision|0|||
33273566|NCT02525744|100900344|FG002|Period 5|Physician Decision|0|||
33273567|NCT02525744|100900345|FG003|Period 5|Physician Decision|0|||
33273568|NCT01399905|100900348|FG000|Overall Study|Withdrawal by Subject|1|||
33273569|NCT01399905|100900349|FG001|Overall Study|Withdrawal by Subject|1|||
33273570|NCT00307489|100900350|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
33273571|NCT00307489|100900351|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
33273572|NCT00307489|100900350|FG000|Baseline Through Week 48|Physician Decision|1|||
33273573|NCT00307489|100900351|FG001|Baseline Through Week 48|Physician Decision|0|||
33480691|NCT00866658|101651866|FG001|Overall Study|Adverse Event|14|||
33480692|NCT00866658|101651865|FG000|Overall Study|Lack of Efficacy|2|||
33480693|NCT00866658|101651866|FG001|Overall Study|Lack of Efficacy|1|||
33480694|NCT00866658|101651865|FG000|Overall Study|Withdrawal by Subject|1|||
33480695|NCT00866658|101651866|FG001|Overall Study|Withdrawal by Subject|0|||
33480696|NCT00866658|101651865|FG000|Overall Study|Protocol Violation|1|||
33480697|NCT00866658|101651866|FG001|Overall Study|Protocol Violation|1|||
33480698|NCT00866658|101651865|FG000|Overall Study|Familial and Personal Reasons|4|||
33480699|NCT00866658|101651866|FG001|Overall Study|Familial and Personal Reasons|5|||
33480700|NCT00699283|101651867|FG000|Overall Study|Lack of Efficacy|15|||
33480701|NCT00699283|101651868|FG001|Overall Study|Lack of Efficacy|5|||
33273574|NCT00307489|100900350|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
33273575|NCT00307489|100900351|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
33273576|NCT00307489|100900350|FG000|Week 48 Through Week 168|Adverse Event|1|||
33273577|NCT00307489|100900351|FG001|Week 48 Through Week 168|Adverse Event|0|||
33273578|NCT00307489|100900350|FG000|Week 48 Through Week 168|Physician Decision|1|||
33273579|NCT00307489|100900351|FG001|Week 48 Through Week 168|Physician Decision|0|||
33273580|NCT00307489|100900350|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
33273581|NCT00307489|100900351|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
33273582|NCT00307489|100900350|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
33480702|NCT00699283|101651867|FG000|Overall Study|Lost to Follow-up|2|||
33480703|NCT00699283|101651868|FG001|Overall Study|Lost to Follow-up|0|||
33480704|NCT00699283|101651867|FG000|Overall Study|Withdrawal by Subject|1|||
33480705|NCT00699283|101651868|FG001|Overall Study|Withdrawal by Subject|0|||
33480706|NCT00699283|101651867|FG000|Overall Study|Other Reason|5|||
33480707|NCT00699283|101651868|FG001|Overall Study|Other Reason|1|||
33480708|NCT00699283|101651867|FG000|Overall Study|SAE, non-fatal|1|||
33480709|NCT00699283|101651868|FG001|Overall Study|SAE, non-fatal|1|||
33480710|NCT00699283|101651867|FG000|Overall Study|AE, non-serious non-fatal|8|||
33480711|NCT00699283|101651868|FG001|Overall Study|AE, non-serious non-fatal|1|||
33480712|NCT00699283|101651867|FG000|Overall Study|AE of unknown type|1|||
33480713|NCT00699283|101651868|FG001|Overall Study|AE of unknown type|0|||
33480714|NCT01320150|101651876|FG000|Overall Study|Protocol Violation|15|||
33480715|NCT01320150|101651876|FG000|Overall Study|Withdrawal by Subject|5|||
33480716|NCT01320150|101651876|FG000|Overall Study|Death|2|||
33480717|NCT01320150|101651876|FG000|Overall Study|Lost to Follow-up|44|||
33480718|NCT01468818|101651879|FG000|Overall Study|Death during treatment|2|||
33480719|NCT00174954|101651886|FG000|Overall Study|Adverse Event|2|||
33480720|NCT00174954|101651886|FG000|Overall Study|No tophi found in MRI|1|||
33480721|NCT00174954|101651886|FG000|Overall Study|Physician Decision|1|||
33480722|NCT01724489|101651887|FG000|Overall Study|Adverse Event|8|||
33480723|NCT01724489|101651888|FG001|Overall Study|Adverse Event|3|||
33480724|NCT01724489|101651887|FG000|Overall Study|Surgery, medication|1|||
33480725|NCT01724489|101651888|FG001|Overall Study|Surgery, medication|1|||
33480726|NCT01724489|101651887|FG000|Overall Study|Lost to Follow-up|1|||
33480727|NCT01724489|101651888|FG001|Overall Study|Lost to Follow-up|2|||
33480728|NCT01724489|101651887|FG000|Overall Study|Withdrawal by Subject|6|||
33480729|NCT01724489|101651888|FG001|Overall Study|Withdrawal by Subject|6|||
33480730|NCT03249792|101651889|FG000|Arms 1, 2, and 4|Death|1|||
33480731|NCT03249792|101651890|FG001|Arms 1, 2, and 4|Death|1|||
33480732|NCT03249792|101651891|FG002|Arms 1, 2, and 4|Death|0|||
33480733|NCT03249792|101651892|FG003|Arms 1, 2, and 4|Death|2|||
33480734|NCT03249792|101651893|FG004|Arms 1, 2, and 4|Death|3|||
33480735|NCT03249792|101651894|FG005|Arms 1, 2, and 4|Death|2|||
33480736|NCT03249792|101651895|FG006|Arms 1, 2, and 4|Death|2|||
33480737|NCT03249792|101651896|FG007|Arms 1, 2, and 4|Death|4|||
33480738|NCT03249792|101651897|FG008|Arms 1, 2, and 4|Death|2|||
33480739|NCT03249792|101651898|FG009|Arms 1, 2, and 4|Death|1|||
33480740|NCT03249792|101651899|FG010|Arms 1, 2, and 4|Death|7|||
33480741|NCT03249792|101651900|FG011|Arms 1, 2, and 4|Death|7|||
33480742|NCT03249792|101651901|FG012|Arms 1, 2, and 4|Death|12|||
33480743|NCT03249792|101651902|FG013|Arms 1, 2, and 4|Death|7|||
33480744|NCT03249792|101651903|FG014|Arms 1, 2, and 4|Death|0|||
33480745|NCT03249792|101651904|FG015|Arms 1, 2, and 4|Death|4|||
33480746|NCT03249792|101651905|FG016|Arms 1, 2, and 4|Death|4|||
33480747|NCT03249792|101651906|FG017|Arms 1, 2, and 4|Death|12|||
33480748|NCT03249792|101651907|FG018|Arms 1, 2, and 4|Death|6|||
33480749|NCT03249792|101651908|FG019|Arms 1, 2, and 4|Death|4|||
33480750|NCT03249792|101651909|FG020|Arms 1, 2, and 4|Death|2|||
33480751|NCT03249792|101651910|FG021|Arms 1, 2, and 4|Death|3|||
33480752|NCT03249792|101651911|FG022|Arms 1, 2, and 4|Death|1|||
33480753|NCT03249792|101651912|FG023|Arms 1, 2, and 4|Death|1|||
33480754|NCT03249792|101651913|FG024|Arms 1, 2, and 4|Death|4|||
33480755|NCT03249792|101651914|FG025|Arms 1, 2, and 4|Death|0|||
33480756|NCT03249792|101651915|FG026|Arms 1, 2, and 4|Death|0|||
33480757|NCT03249792|101651916|FG027|Arms 1, 2, and 4|Death|0|||
33480758|NCT03249792|101651917|FG028|Arms 1, 2, and 4|Death|0|||
33480759|NCT03249792|101651918|FG029|Arms 1, 2, and 4|Death|0|||
33480760|NCT03249792|101651919|FG030|Arms 1, 2, and 4|Death|0|||
33480761|NCT03249792|101651920|FG031|Arms 1, 2, and 4|Death|0|||
33480762|NCT03249792|101651921|FG032|Arms 1, 2, and 4|Death|0|||
33480763|NCT03249792|101651889|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480764|NCT03249792|101651890|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480765|NCT03249792|101651891|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
33480766|NCT03249792|101651892|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480767|NCT03249792|101651893|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480768|NCT03249792|101651894|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
33480769|NCT03249792|101651895|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
33480770|NCT03249792|101651896|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480771|NCT03249792|101651897|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
33480772|NCT03249792|101651898|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
33480773|NCT03249792|101651899|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
33480774|NCT03249792|101651900|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
33480775|NCT03249792|101651901|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
33480776|NCT03249792|101651902|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
33480777|NCT03249792|101651903|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480778|NCT03249792|101651904|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480779|NCT03249792|101651905|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
33480780|NCT03249792|101651906|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480781|NCT03249792|101651907|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
33480782|NCT03249792|101651908|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480783|NCT03249792|101651909|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480784|NCT03249792|101651910|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480785|NCT03249792|101651911|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
33480786|NCT03249792|101651912|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
33480787|NCT03249792|101651913|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480788|NCT03249792|101651914|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480789|NCT03249792|101651915|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480790|NCT03249792|101651916|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480791|NCT03249792|101651917|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480792|NCT03249792|101651918|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480793|NCT03249792|101651919|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480794|NCT03249792|101651920|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480795|NCT03249792|101651921|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
33480796|NCT03249792|101651889|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
33480797|NCT03249792|101651890|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
33480798|NCT03249792|101651891|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
33480799|NCT03249792|101651892|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
33480800|NCT03249792|101651893|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
33480801|NCT03249792|101651894|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
33480802|NCT03249792|101651895|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
33480803|NCT03249792|101651896|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
33480804|NCT03249792|101651897|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
33480805|NCT03249792|101651898|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
33480806|NCT03249792|101651899|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
33480807|NCT03249792|101651900|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
33480808|NCT03249792|101651901|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
33480809|NCT03249792|101651902|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
33480810|NCT03249792|101651903|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
33480811|NCT03249792|101651904|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
33480812|NCT03249792|101651905|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
33480813|NCT03249792|101651906|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
33480814|NCT03249792|101651907|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
33480815|NCT03249792|101651908|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
33480816|NCT03249792|101651909|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
33480817|NCT03249792|101651910|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
33480818|NCT03249792|101651911|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
33480819|NCT03249792|101651912|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
33480820|NCT03249792|101651913|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
33480821|NCT03249792|101651914|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
33480822|NCT03249792|101651915|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
33480823|NCT03249792|101651916|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
33480824|NCT03249792|101651917|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
33480825|NCT03249792|101651918|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
33480826|NCT03249792|101651919|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
33480827|NCT03249792|101651920|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
33480828|NCT03249792|101651921|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
33480829|NCT03249792|101651889|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480830|NCT03249792|101651890|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480831|NCT03249792|101651891|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480832|NCT03249792|101651892|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480833|NCT03249792|101651893|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480834|NCT03249792|101651894|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480835|NCT03249792|101651895|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480836|NCT03249792|101651896|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480837|NCT03249792|101651897|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
33480838|NCT03249792|101651898|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480839|NCT03249792|101651899|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480840|NCT03249792|101651900|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480841|NCT03249792|101651901|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480842|NCT03249792|101651902|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480843|NCT03249792|101651903|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480844|NCT03249792|101651904|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480845|NCT03249792|101651905|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
33480846|NCT03249792|101651906|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
33480847|NCT03249792|101651907|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480848|NCT03249792|101651908|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
33480849|NCT03249792|101651909|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480850|NCT03249792|101651910|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480851|NCT03249792|101651911|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480852|NCT03249792|101651912|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480853|NCT03249792|101651913|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480854|NCT03249792|101651914|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480855|NCT03249792|101651915|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480856|NCT03249792|101651916|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480857|NCT03249792|101651917|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480858|NCT03249792|101651918|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480859|NCT03249792|101651919|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480860|NCT03249792|101651920|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480861|NCT03249792|101651921|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
33480862|NCT03249792|101651889|FG000|Switch Over Period|Withdrawal by Subject|0|||
33480863|NCT03249792|101651890|FG001|Switch Over Period|Withdrawal by Subject|0|||
33480864|NCT03249792|101651891|FG002|Switch Over Period|Withdrawal by Subject|0|||
33480865|NCT03249792|101651892|FG003|Switch Over Period|Withdrawal by Subject|0|||
33480866|NCT03249792|101651893|FG004|Switch Over Period|Withdrawal by Subject|0|||
33480867|NCT03249792|101651894|FG005|Switch Over Period|Withdrawal by Subject|0|||
33480868|NCT03249792|101651895|FG006|Switch Over Period|Withdrawal by Subject|0|||
33480869|NCT03249792|101651896|FG007|Switch Over Period|Withdrawal by Subject|0|||
33480870|NCT03249792|101651897|FG008|Switch Over Period|Withdrawal by Subject|0|||
33480871|NCT03249792|101651898|FG009|Switch Over Period|Withdrawal by Subject|0|||
33480872|NCT03249792|101651899|FG010|Switch Over Period|Withdrawal by Subject|0|||
33480873|NCT03249792|101651900|FG011|Switch Over Period|Withdrawal by Subject|0|||
33480874|NCT03249792|101651901|FG012|Switch Over Period|Withdrawal by Subject|0|||
33480875|NCT03249792|101651902|FG013|Switch Over Period|Withdrawal by Subject|0|||
33480876|NCT03249792|101651903|FG014|Switch Over Period|Withdrawal by Subject|0|||
33480877|NCT03249792|101651904|FG015|Switch Over Period|Withdrawal by Subject|0|||
33480878|NCT03249792|101651905|FG016|Switch Over Period|Withdrawal by Subject|0|||
33480879|NCT03249792|101651906|FG017|Switch Over Period|Withdrawal by Subject|0|||
33480880|NCT03249792|101651907|FG018|Switch Over Period|Withdrawal by Subject|0|||
33480881|NCT03249792|101651908|FG019|Switch Over Period|Withdrawal by Subject|0|||
33480882|NCT03249792|101651909|FG020|Switch Over Period|Withdrawal by Subject|0|||
33480883|NCT03249792|101651910|FG021|Switch Over Period|Withdrawal by Subject|0|||
33480884|NCT03249792|101651911|FG022|Switch Over Period|Withdrawal by Subject|0|||
33480885|NCT03249792|101651912|FG023|Switch Over Period|Withdrawal by Subject|0|||
33480886|NCT03249792|101651913|FG024|Switch Over Period|Withdrawal by Subject|0|||
33480887|NCT03249792|101651914|FG025|Switch Over Period|Withdrawal by Subject|0|||
33480888|NCT03249792|101651915|FG026|Switch Over Period|Withdrawal by Subject|0|||
33480889|NCT03249792|101651916|FG027|Switch Over Period|Withdrawal by Subject|0|||
33480890|NCT03249792|101651917|FG028|Switch Over Period|Withdrawal by Subject|0|||
33480891|NCT03249792|101651918|FG029|Switch Over Period|Withdrawal by Subject|0|||
33480892|NCT03249792|101651919|FG030|Switch Over Period|Withdrawal by Subject|0|||
33480893|NCT03249792|101651920|FG031|Switch Over Period|Withdrawal by Subject|1|||
33480894|NCT03249792|101651921|FG032|Switch Over Period|Withdrawal by Subject|0|||
33480895|NCT03249792|101651889|FG000|Switch Over Period|Progressive Disease|0|||
33480896|NCT03249792|101651890|FG001|Switch Over Period|Progressive Disease|0|||
33480897|NCT03249792|101651891|FG002|Switch Over Period|Progressive Disease|0|||
33480898|NCT03249792|101651892|FG003|Switch Over Period|Progressive Disease|0|||
33480899|NCT03249792|101651893|FG004|Switch Over Period|Progressive Disease|0|||
33480900|NCT03249792|101651894|FG005|Switch Over Period|Progressive Disease|0|||
33480901|NCT03249792|101651895|FG006|Switch Over Period|Progressive Disease|0|||
33480902|NCT03249792|101651896|FG007|Switch Over Period|Progressive Disease|0|||
33480903|NCT03249792|101651897|FG008|Switch Over Period|Progressive Disease|0|||
33480904|NCT03249792|101651898|FG009|Switch Over Period|Progressive Disease|0|||
33480905|NCT03249792|101651899|FG010|Switch Over Period|Progressive Disease|0|||
33480906|NCT03249792|101651900|FG011|Switch Over Period|Progressive Disease|0|||
33480907|NCT03249792|101651901|FG012|Switch Over Period|Progressive Disease|0|||
33480908|NCT03249792|101651902|FG013|Switch Over Period|Progressive Disease|0|||
33480909|NCT03249792|101651903|FG014|Switch Over Period|Progressive Disease|0|||
33480910|NCT03249792|101651904|FG015|Switch Over Period|Progressive Disease|0|||
33480911|NCT03249792|101651905|FG016|Switch Over Period|Progressive Disease|0|||
33480912|NCT03249792|101651906|FG017|Switch Over Period|Progressive Disease|0|||
33480913|NCT03249792|101651907|FG018|Switch Over Period|Progressive Disease|0|||
33480914|NCT03249792|101651908|FG019|Switch Over Period|Progressive Disease|0|||
33480915|NCT03249792|101651909|FG020|Switch Over Period|Progressive Disease|0|||
33480916|NCT03249792|101651910|FG021|Switch Over Period|Progressive Disease|0|||
33480917|NCT03249792|101651911|FG022|Switch Over Period|Progressive Disease|0|||
33480918|NCT03249792|101651912|FG023|Switch Over Period|Progressive Disease|0|||
33480919|NCT03249792|101651913|FG024|Switch Over Period|Progressive Disease|0|||
33480920|NCT03249792|101651914|FG025|Switch Over Period|Progressive Disease|0|||
33480921|NCT03249792|101651915|FG026|Switch Over Period|Progressive Disease|1|||
33480922|NCT03249792|101651916|FG027|Switch Over Period|Progressive Disease|0|||
33480923|NCT03249792|101651917|FG028|Switch Over Period|Progressive Disease|1|||
33480924|NCT03249792|101651918|FG029|Switch Over Period|Progressive Disease|2|||
33480925|NCT03249792|101651919|FG030|Switch Over Period|Progressive Disease|1|||
33480926|NCT03249792|101651920|FG031|Switch Over Period|Progressive Disease|0|||
33480927|NCT03249792|101651921|FG032|Switch Over Period|Progressive Disease|1|||
33480928|NCT03249792|101651889|FG000|Switch Over Period|Adverse Event|0|||
33480929|NCT03249792|101651890|FG001|Switch Over Period|Adverse Event|0|||
33480930|NCT03249792|101651891|FG002|Switch Over Period|Adverse Event|0|||
33480931|NCT03249792|101651892|FG003|Switch Over Period|Adverse Event|0|||
33480932|NCT03249792|101651893|FG004|Switch Over Period|Adverse Event|0|||
33480933|NCT03249792|101651894|FG005|Switch Over Period|Adverse Event|0|||
33480934|NCT03249792|101651895|FG006|Switch Over Period|Adverse Event|0|||
33480935|NCT03249792|101651896|FG007|Switch Over Period|Adverse Event|0|||
33480936|NCT03249792|101651897|FG008|Switch Over Period|Adverse Event|0|||
33480937|NCT03249792|101651898|FG009|Switch Over Period|Adverse Event|0|||
33480938|NCT03249792|101651899|FG010|Switch Over Period|Adverse Event|0|||
33480939|NCT03249792|101651900|FG011|Switch Over Period|Adverse Event|0|||
33480940|NCT03249792|101651901|FG012|Switch Over Period|Adverse Event|0|||
33480941|NCT03249792|101651902|FG013|Switch Over Period|Adverse Event|0|||
33480942|NCT03249792|101651903|FG014|Switch Over Period|Adverse Event|0|||
33480943|NCT03249792|101651904|FG015|Switch Over Period|Adverse Event|0|||
33480944|NCT03249792|101651905|FG016|Switch Over Period|Adverse Event|0|||
33480945|NCT03249792|101651906|FG017|Switch Over Period|Adverse Event|0|||
33480946|NCT03249792|101651907|FG018|Switch Over Period|Adverse Event|0|||
33480947|NCT03249792|101651908|FG019|Switch Over Period|Adverse Event|0|||
33480948|NCT03249792|101651909|FG020|Switch Over Period|Adverse Event|0|||
33480949|NCT03249792|101651910|FG021|Switch Over Period|Adverse Event|0|||
33480950|NCT03249792|101651911|FG022|Switch Over Period|Adverse Event|0|||
33480951|NCT03249792|101651912|FG023|Switch Over Period|Adverse Event|0|||
33480952|NCT03249792|101651913|FG024|Switch Over Period|Adverse Event|0|||
33480953|NCT03249792|101651914|FG025|Switch Over Period|Adverse Event|1|||
33480954|NCT03249792|101651915|FG026|Switch Over Period|Adverse Event|0|||
33480955|NCT03249792|101651916|FG027|Switch Over Period|Adverse Event|1|||
33480956|NCT03249792|101651917|FG028|Switch Over Period|Adverse Event|0|||
33480957|NCT03249792|101651918|FG029|Switch Over Period|Adverse Event|0|||
33480958|NCT03249792|101651919|FG030|Switch Over Period|Adverse Event|0|||
33480959|NCT03249792|101651920|FG031|Switch Over Period|Adverse Event|0|||
33480960|NCT03249792|101651921|FG032|Switch Over Period|Adverse Event|0|||
33480961|NCT01739348|101651922|FG000|Part I (Base Study)|Adverse Event|41|||
33480962|NCT01739348|101651923|FG001|Part I (Base Study)|Adverse Event|52|||
33480963|NCT01739348|101651924|FG002|Part I (Base Study)|Adverse Event|8|||
33480964|NCT01739348|101651925|FG003|Part I (Base Study)|Adverse Event|33|||
33480965|NCT01739348|101651922|FG000|Part I (Base Study)|Death|10|||
33480966|NCT01739348|101651923|FG001|Part I (Base Study)|Death|7|||
33480967|NCT01739348|101651924|FG002|Part I (Base Study)|Death|2|||
33480968|NCT01739348|101651925|FG003|Part I (Base Study)|Death|8|||
33480969|NCT01739348|101651922|FG000|Part I (Base Study)|Lack of Efficacy|3|||
33480970|NCT01739348|101651923|FG001|Part I (Base Study)|Lack of Efficacy|8|||
33480971|NCT01739348|101651924|FG002|Part I (Base Study)|Lack of Efficacy|0|||
33480972|NCT01739348|101651925|FG003|Part I (Base Study)|Lack of Efficacy|7|||
33480973|NCT01739348|101651922|FG000|Part I (Base Study)|Lost to Follow-up|4|||
33480974|NCT01739348|101651923|FG001|Part I (Base Study)|Lost to Follow-up|2|||
33480975|NCT01739348|101651924|FG002|Part I (Base Study)|Lost to Follow-up|4|||
33480976|NCT01739348|101651925|FG003|Part I (Base Study)|Lost to Follow-up|4|||
33480977|NCT01739348|101651922|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
33480978|NCT01739348|101651923|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
33480979|NCT01739348|101651924|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
33480980|NCT01739348|101651925|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
33480981|NCT01739348|101651922|FG000|Part I (Base Study)|Physician Decision|10|||
33480982|NCT01739348|101651923|FG001|Part I (Base Study)|Physician Decision|7|||
33480983|NCT01739348|101651924|FG002|Part I (Base Study)|Physician Decision|1|||
33480984|NCT01739348|101651925|FG003|Part I (Base Study)|Physician Decision|4|||
33480985|NCT01739348|101651922|FG000|Part I (Base Study)|Protocol Violation|2|||
33480986|NCT01739348|101651923|FG001|Part I (Base Study)|Protocol Violation|0|||
33480987|NCT01739348|101651924|FG002|Part I (Base Study)|Protocol Violation|1|||
33480988|NCT01739348|101651925|FG003|Part I (Base Study)|Protocol Violation|2|||
33480989|NCT01739348|101651922|FG000|Part I (Base Study)|Screen Failure|2|||
33480990|NCT01739348|101651923|FG001|Part I (Base Study)|Screen Failure|0|||
33480991|NCT01739348|101651924|FG002|Part I (Base Study)|Screen Failure|0|||
33480992|NCT01739348|101651925|FG003|Part I (Base Study)|Screen Failure|0|||
33480993|NCT01739348|101651922|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
33480994|NCT01739348|101651923|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
33480995|NCT01739348|101651924|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
33480996|NCT01739348|101651925|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
33480997|NCT01739348|101651922|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
33480998|NCT01739348|101651923|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
33480999|NCT01739348|101651924|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
33481000|NCT01739348|101651925|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
33481001|NCT01739348|101651922|FG000|Part I (Base Study)|Participant Moved|4|||
33481002|NCT01739348|101651923|FG001|Part I (Base Study)|Participant Moved|3|||
33481003|NCT01739348|101651924|FG002|Part I (Base Study)|Participant Moved|1|||
33481004|NCT01739348|101651925|FG003|Part I (Base Study)|Participant Moved|7|||
33481005|NCT01739348|101651922|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
33481006|NCT01739348|101651923|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
33481007|NCT01739348|101651924|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
33481008|NCT01739348|101651925|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
33481009|NCT01739348|101651922|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
33481010|NCT01739348|101651923|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
33481011|NCT01739348|101651924|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
33481012|NCT01739348|101651925|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
33481013|NCT01739348|101651922|FG000|Part II (Extension Study)|Adverse Event|10|||
33481014|NCT01739348|101651923|FG001|Part II (Extension Study)|Adverse Event|11|||
33481015|NCT01739348|101651924|FG002|Part II (Extension Study)|Adverse Event|7|||
33481016|NCT01739348|101651925|FG003|Part II (Extension Study)|Adverse Event|26|||
33481017|NCT01739348|101651922|FG000|Part II (Extension Study)|Death|3|||
33481018|NCT01739348|101651923|FG001|Part II (Extension Study)|Death|3|||
33481019|NCT01739348|101651924|FG002|Part II (Extension Study)|Death|2|||
33481020|NCT01739348|101651925|FG003|Part II (Extension Study)|Death|6|||
33481021|NCT01739348|101651922|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
33273583|NCT00307489|100900351|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
33273584|NCT00307489|100900350|FG000|Week 48 Through Week 168|Death|0|||
33273585|NCT00307489|100900351|FG001|Week 48 Through Week 168|Death|1|||
33273586|NCT00307489|100900350|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
33273587|NCT00307489|100900351|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
33273588|NCT00307489|100900350|FG000|Week 48 Through Week 168|Seroconversion|1|||
33273589|NCT00307489|100900351|FG001|Week 48 Through Week 168|Seroconversion|0|||
33273590|NCT04361617|100900352|FG000|Overall Study|Withdrawal by Subject|0|||
33273591|NCT04361617|100900353|FG001|Overall Study|Withdrawal by Subject|1|||
33273592|NCT02612285|100900357|FG000|Overall Study|Withdrawal by Subject|1|||
33273593|NCT00731692|100900358|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
33273594|NCT00731692|100900359|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
33273595|NCT00731692|100900360|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
33273596|NCT00731692|100900358|FG000|Core Study (36 Months)|Physician Decision|1|||
33273597|NCT00731692|100900359|FG001|Core Study (36 Months)|Physician Decision|0|||
33273598|NCT00731692|100900360|FG002|Core Study (36 Months)|Physician Decision|2|||
33273599|NCT00731692|100900358|FG000|Core Study (36 Months)|Death|2|||
33273600|NCT00731692|100900359|FG001|Core Study (36 Months)|Death|1|||
33273601|NCT00731692|100900360|FG002|Core Study (36 Months)|Death|2|||
33273602|NCT00731692|100900358|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
33273603|NCT00731692|100900359|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
33273604|NCT00731692|100900360|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
33273605|NCT00731692|100900358|FG000|Core Study (36 Months)|Administrative|2|||
33273606|NCT00731692|100900359|FG001|Core Study (36 Months)|Administrative|2|||
33273607|NCT00731692|100900360|FG002|Core Study (36 Months)|Administrative|6|||
33273608|NCT00731692|100900358|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
33273609|NCT00731692|100900359|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
33273610|NCT00731692|100900360|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
33273611|NCT00731692|100900358|FG000|Core Study (36 Months)|Protocol Violation|4|||
33273612|NCT00731692|100900359|FG001|Core Study (36 Months)|Protocol Violation|5|||
33273613|NCT00731692|100900360|FG002|Core Study (36 Months)|Protocol Violation|8|||
33273614|NCT00731692|100900358|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
33273615|NCT00731692|100900359|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
33273616|NCT00731692|100900360|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
33273617|NCT00731692|100900358|FG000|Core Study (36 Months)|Adverse Event|25|||
33273618|NCT00731692|100900359|FG001|Core Study (36 Months)|Adverse Event|28|||
33273619|NCT00731692|100900360|FG002|Core Study (36 Months)|Adverse Event|29|||
33273620|NCT00731692|100900358|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
33273621|NCT00731692|100900359|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
33273622|NCT00731692|100900360|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
33273623|NCT00731692|100900358|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
33273624|NCT00731692|100900359|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
33273625|NCT00731692|100900360|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
33273626|NCT00731692|100900358|FG000|Extension Phase|Abnormal test procedure|0|||
33273627|NCT00731692|100900359|FG001|Extension Phase|Abnormal test procedure|0|||
33273628|NCT00731692|100900360|FG002|Extension Phase|Abnormal test procedure|1|||
33273629|NCT00731692|100900358|FG000|Extension Phase|Abnormal lab values|0|||
33273630|NCT00731692|100900359|FG001|Extension Phase|Abnormal lab values|0|||
33273631|NCT00731692|100900360|FG002|Extension Phase|Abnormal lab values|1|||
33273632|NCT00731692|100900358|FG000|Extension Phase|Lost to Follow-up|0|||
33273633|NCT00731692|100900359|FG001|Extension Phase|Lost to Follow-up|1|||
33273634|NCT00731692|100900360|FG002|Extension Phase|Lost to Follow-up|4|||
33273635|NCT00731692|100900358|FG000|Extension Phase|Withdrawal by Subject|4|||
33273636|NCT00731692|100900359|FG001|Extension Phase|Withdrawal by Subject|5|||
33273637|NCT00731692|100900360|FG002|Extension Phase|Withdrawal by Subject|3|||
33273638|NCT00731692|100900358|FG000|Extension Phase|Adverse Event|1|||
33273639|NCT00731692|100900359|FG001|Extension Phase|Adverse Event|1|||
33273640|NCT00731692|100900360|FG002|Extension Phase|Adverse Event|15|||
33481022|NCT01739348|101651923|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
33273641|NCT01199302|100900361|FG000|Overall Study|Adverse Event|1|||
33273642|NCT01199302|100900362|FG001|Overall Study|Adverse Event|1|||
33273643|NCT01199302|100900363|FG002|Overall Study|Adverse Event|2|||
33273644|NCT01199302|100900364|FG003|Overall Study|Adverse Event|0|||
33481023|NCT01739348|101651924|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
33481024|NCT01739348|101651925|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
33481025|NCT01739348|101651922|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
33481026|NCT01739348|101651923|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
33481027|NCT01739348|101651924|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
33481028|NCT01739348|101651925|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
33481029|NCT01739348|101651922|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
33481030|NCT01739348|101651923|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
33481031|NCT01739348|101651924|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
33481032|NCT01739348|101651925|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
33481033|NCT01739348|101651922|FG000|Part II (Extension Study)|Physician Decision|7|||
33481034|NCT01739348|101651923|FG001|Part II (Extension Study)|Physician Decision|11|||
33481035|NCT01739348|101651924|FG002|Part II (Extension Study)|Physician Decision|6|||
33481036|NCT01739348|101651925|FG003|Part II (Extension Study)|Physician Decision|12|||
33481037|NCT01739348|101651922|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
33481038|NCT01739348|101651923|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
33481039|NCT01739348|101651924|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
33481040|NCT01739348|101651925|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
33481041|NCT01739348|101651922|FG000|Part II (Extension Study)|Participant Moved|3|||
33481042|NCT01739348|101651923|FG001|Part II (Extension Study)|Participant Moved|3|||
33481043|NCT01739348|101651924|FG002|Part II (Extension Study)|Participant Moved|0|||
33481044|NCT01739348|101651925|FG003|Part II (Extension Study)|Participant Moved|3|||
33481045|NCT01739348|101651922|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
33481046|NCT01739348|101651923|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
33481047|NCT01739348|101651924|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
33481048|NCT01739348|101651925|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
33481049|NCT01739348|101651922|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
33481050|NCT01739348|101651923|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
33481051|NCT01739348|101651924|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
33481052|NCT01739348|101651925|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
33481053|NCT02342639|101651926|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
33481054|NCT02342639|101651927|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
33481055|NCT02342639|101651926|FG000|Overall Study|Protocol Violation|0|||
33481056|NCT02342639|101651927|FG001|Overall Study|Protocol Violation|2|||
33481057|NCT02952898|101651932|FG000|Overall Study|Withdrawal by Subject|10|||
33481058|NCT02952898|101651933|FG001|Overall Study|Withdrawal by Subject|8|||
33481059|NCT02952898|101651934|FG002|Overall Study|Withdrawal by Subject|8|||
33481060|NCT02952898|101651932|FG000|Overall Study|Adverse Event|8|||
33481061|NCT02952898|101651933|FG001|Overall Study|Adverse Event|8|||
33481062|NCT02952898|101651934|FG002|Overall Study|Adverse Event|3|||
33481063|NCT02952898|101651932|FG000|Overall Study|Lost to Follow-up|3|||
33481064|NCT02952898|101651933|FG001|Overall Study|Lost to Follow-up|2|||
33481065|NCT02952898|101651934|FG002|Overall Study|Lost to Follow-up|2|||
33481066|NCT02952898|101651932|FG000|Overall Study|Non-compliance with study drug|1|||
33481067|NCT02952898|101651933|FG001|Overall Study|Non-compliance with study drug|1|||
33481068|NCT02952898|101651934|FG002|Overall Study|Non-compliance with study drug|2|||
33481069|NCT01104779|101651935|FG000|Overall Study|Protocol Violation|1|||
33481070|NCT01104779|101651936|FG001|Overall Study|Protocol Violation|2|||
33481071|NCT01104779|101651937|FG002|Overall Study|Protocol Violation|2|||
33481072|NCT01104779|101651935|FG000|Overall Study|Lack of Efficacy|26|||
33481073|NCT01104779|101651936|FG001|Overall Study|Lack of Efficacy|12|||
33481074|NCT01104779|101651937|FG002|Overall Study|Lack of Efficacy|13|||
33481075|NCT01104779|101651935|FG000|Overall Study|Adverse Event|13|||
33481076|NCT01104779|101651936|FG001|Overall Study|Adverse Event|14|||
33481077|NCT01104779|101651937|FG002|Overall Study|Adverse Event|13|||
33481078|NCT01104779|101651935|FG000|Overall Study|Did not meet inc/exc criteria|1|||
33481079|NCT01104779|101651936|FG001|Overall Study|Did not meet inc/exc criteria|1|||
33481080|NCT01104779|101651937|FG002|Overall Study|Did not meet inc/exc criteria|1|||
33481081|NCT01104779|101651935|FG000|Overall Study|Other reasons|0|||
33481082|NCT01104779|101651936|FG001|Overall Study|Other reasons|1|||
33481083|NCT01104779|101651937|FG002|Overall Study|Other reasons|0|||
33481084|NCT01104779|101651935|FG000|Overall Study|Lost to Follow-up|2|||
33481085|NCT01104779|101651936|FG001|Overall Study|Lost to Follow-up|0|||
33481086|NCT01104779|101651937|FG002|Overall Study|Lost to Follow-up|1|||
33481087|NCT01104779|101651935|FG000|Overall Study|Withdrawal by Subject|16|||
33481088|NCT01104779|101651936|FG001|Overall Study|Withdrawal by Subject|25|||
33481089|NCT01104779|101651937|FG002|Overall Study|Withdrawal by Subject|32|||
33481090|NCT00780910|101655165|FG000|Overall Study|Adverse Event|2|||
33481091|NCT01683838|101655169|FG000|Overall Study|Adverse Event|12|||
33481092|NCT01683838|101655170|FG001|Overall Study|Adverse Event|2|||
33481093|NCT01683838|101655169|FG000|Overall Study|Protocol Violation|3|||
33481094|NCT01683838|101655170|FG001|Overall Study|Protocol Violation|1|||
33481095|NCT01683838|101655169|FG000|Overall Study|Withdrawal by Subject|6|||
33481096|NCT01683838|101655170|FG001|Overall Study|Withdrawal by Subject|5|||
33481097|NCT01683838|101655169|FG000|Overall Study|Lost to Follow-up|1|||
33481098|NCT01683838|101655170|FG001|Overall Study|Lost to Follow-up|1|||
33481099|NCT01683838|101655169|FG000|Overall Study|Other|4|||
33481100|NCT01683838|101655170|FG001|Overall Study|Other|3|||
33481101|NCT02906358|101655171|FG000|Overall Study|Withdrawal by Subject|10|||
33481102|NCT02906358|101655172|FG001|Overall Study|Withdrawal by Subject|7|||
33481103|NCT02906358|101655171|FG000|Overall Study|Lost to Follow-up|12|||
33481104|NCT02906358|101655172|FG001|Overall Study|Lost to Follow-up|15|||
33481105|NCT00552578|101655173|FG000|Overall Study|Lost to Follow-up|1|||
33481106|NCT00552578|101655174|FG001|Overall Study|Lost to Follow-up|1|||
33481107|NCT01439009|101655175|FG000|Overall Study|Physician Decision|5|||
33481108|NCT01439009|101655176|FG001|Overall Study|Physician Decision|3|||
33481109|NCT01439009|101655175|FG000|Overall Study|Protocol Violation|2|||
33481110|NCT01439009|101655176|FG001|Overall Study|Protocol Violation|0|||
33481111|NCT01439009|101655175|FG000|Overall Study|Deviation of exclusion criteria|1|||
33481112|NCT01439009|101655176|FG001|Overall Study|Deviation of exclusion criteria|0|||
33481113|NCT01147107|101655177|FG000|Overall Study|Lack of Efficacy|5|||
33481114|NCT01147107|101655178|FG001|Overall Study|Lack of Efficacy|0|||
33481115|NCT01147107|101655177|FG000|Overall Study|Withdrawal by Subject|1|||
33481116|NCT01147107|101655178|FG001|Overall Study|Withdrawal by Subject|1|||
33481117|NCT00368979|101655185|FG000|Overall Study|Adverse Event|9|||
33481118|NCT00368979|101655186|FG001|Overall Study|Adverse Event|16|||
33481119|NCT00368979|101655185|FG000|Overall Study|Lack of Efficacy|5|||
33481120|NCT00368979|101655186|FG001|Overall Study|Lack of Efficacy|3|||
33481121|NCT00368979|101655185|FG000|Overall Study|Other|3|||
33481122|NCT00368979|101655186|FG001|Overall Study|Other|1|||
33481123|NCT00368979|101655185|FG000|Overall Study|Lost to Follow-up|1|||
33481124|NCT00368979|101655186|FG001|Overall Study|Lost to Follow-up|0|||
33481125|NCT00368979|101655185|FG000|Overall Study|Protocol Violation|2|||
33481126|NCT00368979|101655186|FG001|Overall Study|Protocol Violation|1|||
33481127|NCT00368979|101655185|FG000|Overall Study|Withdrawal by Subject|5|||
33481128|NCT00368979|101655186|FG001|Overall Study|Withdrawal by Subject|9|||
33481129|NCT03262038|101655187|FG000|Overall Study|Withdrawal by Subject|0|||
33481130|NCT03262038|101655188|FG001|Overall Study|Withdrawal by Subject|1|||
33481131|NCT03421730|101655195|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33481132|NCT03421730|101655196|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
33481133|NCT03421730|101655197|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33481134|NCT03421730|101655198|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33481135|NCT03421730|101655199|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33481136|NCT03421730|101655200|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33481137|NCT03421730|101655201|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33481138|NCT03421730|101655202|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33481139|NCT03421730|101655203|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33481140|NCT03421730|101655204|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33481141|NCT03421730|101655205|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33481142|NCT03421730|101655206|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
33481143|NCT03421730|101655195|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33481144|NCT03421730|101655196|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33481145|NCT03421730|101655197|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33481146|NCT03421730|101655198|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33481147|NCT03421730|101655199|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
33481148|NCT03421730|101655200|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33481149|NCT03421730|101655201|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33481150|NCT03421730|101655202|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33481151|NCT03421730|101655203|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33481152|NCT03421730|101655204|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33481153|NCT03421730|101655205|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33481154|NCT03421730|101655206|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
33481155|NCT01210612|101655207|FG000|Overall Study|Withdrawal by Subject|0|||
33481156|NCT01210612|101655208|FG001|Overall Study|Withdrawal by Subject|2|||
33481157|NCT04868968|101655212|FG000|Overall Study|Lost to Follow-up|1|||
33481158|NCT03610516|101655213|FG000|Treatment Epoch|Adverse Event|3|||
33481159|NCT03610516|101655214|FG001|Treatment Epoch|Adverse Event|1|||
33481160|NCT03610516|101655213|FG000|Treatment Epoch|Death|1|||
33481161|NCT03610516|101655214|FG001|Treatment Epoch|Death|0|||
33481162|NCT03610516|101655213|FG000|Treatment Epoch|Lack of Efficacy|0|||
33481163|NCT03610516|101655214|FG001|Treatment Epoch|Lack of Efficacy|1|||
33481164|NCT03610516|101655213|FG000|Treatment Epoch|No longer requires treatment|1|||
33481165|NCT03610516|101655214|FG001|Treatment Epoch|No longer requires treatment|0|||
33481166|NCT03610516|101655213|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
33481167|NCT03610516|101655214|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
33481168|NCT03610516|101655213|FG000|Treatment Epoch|Physician Decision|8|||
33481169|NCT03610516|101655214|FG001|Treatment Epoch|Physician Decision|5|||
33481170|NCT03610516|101655213|FG000|Treatment Epoch|Protocol Deviation|1|||
33481171|NCT03610516|101655214|FG001|Treatment Epoch|Protocol Deviation|0|||
33481172|NCT03610516|101655213|FG000|Treatment Epoch|Withdrawal by Subject|3|||
33481173|NCT03610516|101655214|FG001|Treatment Epoch|Withdrawal by Subject|1|||
33481174|NCT03610516|101655213|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
33481175|NCT03610516|101655214|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
33481176|NCT03610516|101655213|FG000|Post-Treatment Follow-up|Death|1|||
33481177|NCT03610516|101655214|FG001|Post-Treatment Follow-up|Death|0|||
33481178|NCT00554190|101655215|FG000|Overall Study|Termination forms not completed|10|||
33481179|NCT01884337|101655216|FG000|Treatment|Adverse Event|2|||
33481180|NCT01884337|101655217|FG001|Treatment|Adverse Event|2|||
33481181|NCT01884337|101655216|FG000|Treatment|Subj. request to discont. treatment|2|||
33481182|NCT01884337|101655217|FG001|Treatment|Subj. request to discont. treatment|0|||
33481183|NCT01884337|101655216|FG000|Follow-up Period|Lost to Follow-up|1|||
33481184|NCT01884337|101655217|FG001|Follow-up Period|Lost to Follow-up|1|||
33481185|NCT01189487|101655218|FG000|Overall Study|Lack of Efficacy|2|||
33481186|NCT01189487|101655218|FG000|Overall Study|Adverse Event|1|||
33481187|NCT04123561|101655219|FG000|Overall Study|Lost to Follow-up|20|||
33481188|NCT04123561|101655220|FG001|Overall Study|Lost to Follow-up|12|||
33481189|NCT04123561|101655221|FG002|Overall Study|Lost to Follow-up|5|||
33481190|NCT04123561|101655219|FG000|Overall Study|Withdrawal by Subject|9|||
33481191|NCT04123561|101655220|FG001|Overall Study|Withdrawal by Subject|7|||
33481192|NCT04123561|101655221|FG002|Overall Study|Withdrawal by Subject|9|||
33481193|NCT04123561|101655219|FG000|Overall Study|Lack of Efficacy|7|||
33481194|NCT04123561|101655220|FG001|Overall Study|Lack of Efficacy|8|||
33481195|NCT04123561|101655221|FG002|Overall Study|Lack of Efficacy|6|||
33481196|NCT04123561|101655219|FG000|Overall Study|Adverse Event|5|||
33481197|NCT04123561|101655220|FG001|Overall Study|Adverse Event|2|||
33481198|NCT04123561|101655221|FG002|Overall Study|Adverse Event|3|||
33481199|NCT04123561|101655219|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
33481200|NCT04123561|101655220|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
33481201|NCT04123561|101655221|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
33481202|NCT04123561|101655219|FG000|Overall Study|Death|0|||
33481203|NCT04123561|101655220|FG001|Overall Study|Death|0|||
33481204|NCT04123561|101655221|FG002|Overall Study|Death|1|||
33481205|NCT04123561|101655219|FG000|Overall Study|Protocol Violation|0|||
33481206|NCT04123561|101655220|FG001|Overall Study|Protocol Violation|1|||
33481207|NCT04123561|101655221|FG002|Overall Study|Protocol Violation|0|||
33481208|NCT01555671|101655222|FG000|Overall Study|Physician Decision|20|||
33481209|NCT01555671|101655223|FG001|Overall Study|Physician Decision|25|||
33481210|NCT04516759|101655226|FG000|Overall Study|Withdrawal by Subject|1|||
33481211|NCT04516759|101655227|FG001|Overall Study|Withdrawal by Subject|1|||
33481212|NCT04516759|101655226|FG000|Overall Study|Other|0|||
33481213|NCT04516759|101655227|FG001|Overall Study|Other|1|||
33481214|NCT01685840|101655228|FG000|Overall Study|Death|77|||
33481215|NCT01685840|101655229|FG001|Overall Study|Death|66|||
33481216|NCT01685840|101655228|FG000|Overall Study|Lost to Follow-up|27|||
33481217|NCT01685840|101655229|FG001|Overall Study|Lost to Follow-up|25|||
33481218|NCT01685840|101655228|FG000|Overall Study|Physician Decision|3|||
33481219|NCT01685840|101655229|FG001|Overall Study|Physician Decision|7|||
33481220|NCT01685840|101655228|FG000|Overall Study|Withdrawal by Subject|14|||
33481221|NCT01685840|101655229|FG001|Overall Study|Withdrawal by Subject|17|||
33481222|NCT01685840|101655228|FG000|Overall Study|Futility|197|||
33481223|NCT01685840|101655229|FG001|Overall Study|Futility|200|||
33481224|NCT01685840|101655228|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
33481225|NCT01685840|101655229|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
33481226|NCT01635218|101655233|FG000|Overall Study|Lost to Follow-up|3|||
33481227|NCT01635218|101655234|FG001|Overall Study|Lost to Follow-up|7|||
33481228|NCT01635218|101655235|FG002|Overall Study|Lost to Follow-up|6|||
33481229|NCT04988087|101655236|FG000|Overall Study|Adverse Event|4|||
33481230|NCT04988087|101655237|FG001|Overall Study|Adverse Event|0|||
33481231|NCT04988087|101655238|FG002|Overall Study|Adverse Event|0|||
33481232|NCT04988087|101655239|FG003|Overall Study|Adverse Event|0|||
33481233|NCT04988087|101655236|FG000|Overall Study|Withdrawal by Subject|1|||
33481234|NCT04988087|101655237|FG001|Overall Study|Withdrawal by Subject|1|||
33481235|NCT04988087|101655238|FG002|Overall Study|Withdrawal by Subject|0|||
33481236|NCT04988087|101655239|FG003|Overall Study|Withdrawal by Subject|0|||
33481237|NCT04988087|101655236|FG000|Overall Study|Technical problems|7|||
33481238|NCT04988087|101655237|FG001|Overall Study|Technical problems|9|||
33481239|NCT04988087|101655238|FG002|Overall Study|Technical problems|1|||
33481240|NCT04988087|101655239|FG003|Overall Study|Technical problems|2|||
33481241|NCT05297578|101655240|FG000|Overall Study|Lost to Follow-up|1|||
33481242|NCT05297578|101655241|FG001|Overall Study|Lost to Follow-up|1|||
33481243|NCT05297578|101655242|FG002|Overall Study|Lost to Follow-up|2|||
33481244|NCT05297578|101655243|FG003|Overall Study|Lost to Follow-up|1|||
33481245|NCT05297578|101655240|FG000|Overall Study|Death|0|||
33481246|NCT05297578|101655241|FG001|Overall Study|Death|1|||
33481247|NCT05297578|101655242|FG002|Overall Study|Death|0|||
33481248|NCT05297578|101655243|FG003|Overall Study|Death|0|||
33481249|NCT05297578|101655240|FG000|Overall Study|Withdrawal by Subject|0|||
33481250|NCT05297578|101655241|FG001|Overall Study|Withdrawal by Subject|0|||
33481251|NCT05297578|101655242|FG002|Overall Study|Withdrawal by Subject|1|||
33481252|NCT05297578|101655243|FG003|Overall Study|Withdrawal by Subject|0|||
33481253|NCT02754856|101655244|FG000|Overall Study|Withdrawal by Subject|1|||
33481254|NCT00103610|101655245|FG000|Overall Study|Entered Rescue Procedure|10|||
33481255|NCT00103610|101655246|FG001|Overall Study|Entered Rescue Procedure|52|||
33481256|NCT00103610|101655245|FG000|Overall Study|Death|16|||
33481257|NCT00103610|101655246|FG001|Overall Study|Death|12|||
33481258|NCT00103610|101655245|FG000|Overall Study|Elective Withdrawal|4|||
33481259|NCT00103610|101655246|FG001|Overall Study|Elective Withdrawal|0|||
33481260|NCT00103610|101655245|FG000|Overall Study|Lost to Follow-up|3|||
33481261|NCT00103610|101655246|FG001|Overall Study|Lost to Follow-up|1|||
33481262|NCT00103610|101655245|FG000|Overall Study|Adverse Event|2|||
33481263|NCT00103610|101655246|FG001|Overall Study|Adverse Event|2|||
33481264|NCT00103610|101655245|FG000|Overall Study|Other|2|||
33481265|NCT00103610|101655246|FG001|Overall Study|Other|7|||
33481266|NCT00103610|101655245|FG000|Overall Study|Failed mobilization|1|||
33481267|NCT00103610|101655246|FG001|Overall Study|Failed mobilization|5|||
33481268|NCT00103610|101655245|FG000|Overall Study|Noncompliance|0|||
33481269|NCT00103610|101655246|FG001|Overall Study|Noncompliance|1|||
33481270|NCT02521376|101655247|FG000|Overall Study|Enrolled, But Not Treated|1|||
33481271|NCT02521376|101655248|FG001|Overall Study|Enrolled, But Not Treated|0|||
33481272|NCT02521376|101655249|FG002|Overall Study|Enrolled, But Not Treated|0|||
33481273|NCT02521376|101655250|FG003|Overall Study|Enrolled, But Not Treated|0|||
33481274|NCT01814553|101655251|FG000|Overall Study|PD per clinical progression|6|||
33481275|NCT01814553|101655252|FG001|Overall Study|PD per clinical progression|8|||
33481276|NCT01814553|101655251|FG000|Overall Study|Other Adverse Event|4|||
33481277|NCT01814553|101655252|FG001|Overall Study|Other Adverse Event|5|||
33481278|NCT01814553|101655251|FG000|Overall Study|Withdrawal by Subject|1|||
33481279|NCT01814553|101655252|FG001|Overall Study|Withdrawal by Subject|1|||
33481280|NCT01814553|101655251|FG000|Overall Study|Other than stated|7|||
33481281|NCT01814553|101655252|FG001|Overall Study|Other than stated|8|||
33481282|NCT04576923|101655253|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
33481283|NCT00678886|101655256|FG000|Overall Study|Withdrawal by Subject|0|||
33481284|NCT00678886|101655257|FG001|Overall Study|Withdrawal by Subject|0|||
33481285|NCT00678886|101655258|FG002|Overall Study|Withdrawal by Subject|4|||
33481286|NCT00678886|101655259|FG003|Overall Study|Withdrawal by Subject|6|||
33481287|NCT00678886|101655256|FG000|Overall Study|Physician Decision|0|||
33481288|NCT00678886|101655257|FG001|Overall Study|Physician Decision|0|||
33481289|NCT00678886|101655258|FG002|Overall Study|Physician Decision|1|||
33481290|NCT00678886|101655259|FG003|Overall Study|Physician Decision|1|||
33481291|NCT00678886|101655256|FG000|Overall Study|Lost to Follow-up|0|||
33481292|NCT00678886|101655257|FG001|Overall Study|Lost to Follow-up|0|||
33481293|NCT00678886|101655258|FG002|Overall Study|Lost to Follow-up|3|||
33481294|NCT00678886|101655259|FG003|Overall Study|Lost to Follow-up|2|||
33481295|NCT00678886|101655256|FG000|Overall Study|Other|0|||
33481296|NCT00678886|101655257|FG001|Overall Study|Other|0|||
33481297|NCT00678886|101655258|FG002|Overall Study|Other|1|||
33481298|NCT00678886|101655259|FG003|Overall Study|Other|0|||
33481299|NCT00492024|101655260|FG000|Treatment|Adverse Event|3|||
33481300|NCT00492024|101655261|FG001|Treatment|Adverse Event|1|||
33481301|NCT00492024|101655260|FG000|Treatment|Lack of Efficacy|21|||
33481302|NCT00492024|101655261|FG001|Treatment|Lack of Efficacy|20|||
33481303|NCT00492024|101655260|FG000|Treatment|Lost to Follow-up|3|||
33481304|NCT00492024|101655261|FG001|Treatment|Lost to Follow-up|1|||
33481305|NCT00492024|101655260|FG000|Treatment|Withdrawal by Subject|2|||
33481306|NCT00492024|101655261|FG001|Treatment|Withdrawal by Subject|0|||
33481307|NCT00492024|101655260|FG000|Follow up|Lack of Efficacy|0|||
33481308|NCT00492024|101655261|FG001|Follow up|Lack of Efficacy|1|||
33481309|NCT00492024|101655260|FG000|Follow up|Lost to Follow-up|1|||
33481310|NCT00492024|101655261|FG001|Follow up|Lost to Follow-up|1|||
33481311|NCT00469144|101655262|FG000|Overall Study|Death|0|||
33481312|NCT00469144|101655263|FG001|Overall Study|Death|1|||
33481313|NCT00469144|101655262|FG000|Overall Study|No Response|5|||
33481314|NCT00469144|101655263|FG001|Overall Study|No Response|5|||
33481315|NCT00469144|101655262|FG000|Overall Study|Progressive Disease|1|||
33481316|NCT00469144|101655263|FG001|Overall Study|Progressive Disease|0|||
33481317|NCT02212379|101655264|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
33481318|NCT02212379|101655264|FG000|From Baseline to Week 48|Adverse Event|7|||
33481319|NCT02212379|101655264|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
33481320|NCT02212379|101655264|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
33481321|NCT02212379|101655264|FG000|From Week 48 to Week 96|Adverse Event|1|||
33481322|NCT02212379|101655264|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
33481323|NCT01006135|101655265|FG000|Overall Study|Adverse Event|22|||
33481324|NCT01006135|101655265|FG000|Overall Study|Protocol Violation|14|||
33481325|NCT01006135|101655265|FG000|Overall Study|Lost to Follow-up|32|||
33481326|NCT01006135|101655265|FG000|Overall Study|Other|72|||
33481327|NCT02293863|101655266|FG000|Overall Study|Death|4|||
33481328|NCT02293863|101655267|FG001|Overall Study|Death|6|||
33481329|NCT02293863|101655268|FG002|Overall Study|Death|4|||
33481330|NCT02293863|101655266|FG000|Overall Study|Lost to Follow-up|2|||
33481331|NCT02293863|101655267|FG001|Overall Study|Lost to Follow-up|2|||
33481332|NCT02293863|101655268|FG002|Overall Study|Lost to Follow-up|2|||
33481333|NCT02293863|101655266|FG000|Overall Study|Withdrawal by Subject|3|||
33481334|NCT02293863|101655267|FG001|Overall Study|Withdrawal by Subject|3|||
33481335|NCT02293863|101655268|FG002|Overall Study|Withdrawal by Subject|1|||
33481336|NCT02293863|101655266|FG000|Overall Study|Reason Not Specified|0|||
33481337|NCT02293863|101655267|FG001|Overall Study|Reason Not Specified|2|||
33481338|NCT02293863|101655268|FG002|Overall Study|Reason Not Specified|2|||
33481339|NCT01275430|101655269|FG000|Overall Study|Adverse Event|1|||
33481340|NCT01275430|101655269|FG000|Overall Study|No Contrast Injection|6|||
33481341|NCT01275430|101655269|FG000|Overall Study|Device Malfunction|1|||
33481342|NCT01275430|101655269|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
33481343|NCT05384171|101655270|FG000|Overall Study|Lost to Follow-up|9|||
33481344|NCT05384171|101655271|FG001|Overall Study|Lost to Follow-up|9|||
33481345|NCT05384171|101655270|FG000|Overall Study|Withdrawal by Subject|3|||
33481346|NCT05384171|101655271|FG001|Overall Study|Withdrawal by Subject|0|||
33481347|NCT00642278|101655274|FG000|Overall Study|Adverse Event|2|||
33481348|NCT00642278|101655275|FG001|Overall Study|Adverse Event|1|||
33481349|NCT00642278|101655276|FG002|Overall Study|Adverse Event|3|||
33481350|NCT00642278|101655277|FG003|Overall Study|Adverse Event|1|||
33481351|NCT00642278|101655278|FG004|Overall Study|Adverse Event|2|||
33481352|NCT00642278|101655279|FG005|Overall Study|Adverse Event|2|||
33481353|NCT00642278|101655280|FG006|Overall Study|Adverse Event|0|||
33481354|NCT00642278|101655274|FG000|Overall Study|Lack of Efficacy|0|||
33481355|NCT00642278|101655275|FG001|Overall Study|Lack of Efficacy|1|||
33481356|NCT00642278|101655276|FG002|Overall Study|Lack of Efficacy|0|||
33481357|NCT00642278|101655277|FG003|Overall Study|Lack of Efficacy|0|||
33481358|NCT00642278|101655278|FG004|Overall Study|Lack of Efficacy|0|||
33481359|NCT00642278|101655279|FG005|Overall Study|Lack of Efficacy|0|||
33481360|NCT00642278|101655280|FG006|Overall Study|Lack of Efficacy|0|||
33481361|NCT00642278|101655274|FG000|Overall Study|Lost to Follow-up|5|||
33481362|NCT00642278|101655275|FG001|Overall Study|Lost to Follow-up|1|||
33481363|NCT00642278|101655276|FG002|Overall Study|Lost to Follow-up|0|||
33481364|NCT00642278|101655277|FG003|Overall Study|Lost to Follow-up|1|||
33481365|NCT00642278|101655278|FG004|Overall Study|Lost to Follow-up|0|||
33481366|NCT00642278|101655279|FG005|Overall Study|Lost to Follow-up|1|||
33481367|NCT00642278|101655280|FG006|Overall Study|Lost to Follow-up|1|||
33481368|NCT00642278|101655274|FG000|Overall Study|Physician Decision|0|||
33481369|NCT00642278|101655275|FG001|Overall Study|Physician Decision|0|||
33481370|NCT00642278|101655276|FG002|Overall Study|Physician Decision|0|||
33481371|NCT00642278|101655277|FG003|Overall Study|Physician Decision|1|||
33481372|NCT00642278|101655278|FG004|Overall Study|Physician Decision|0|||
33481373|NCT00642278|101655279|FG005|Overall Study|Physician Decision|0|||
33481374|NCT00642278|101655280|FG006|Overall Study|Physician Decision|0|||
33481375|NCT00642278|101655274|FG000|Overall Study|Protocol Violation|0|||
33481376|NCT00642278|101655275|FG001|Overall Study|Protocol Violation|0|||
33481377|NCT00642278|101655276|FG002|Overall Study|Protocol Violation|1|||
33481378|NCT00642278|101655277|FG003|Overall Study|Protocol Violation|1|||
33481379|NCT00642278|101655278|FG004|Overall Study|Protocol Violation|0|||
33481380|NCT00642278|101655279|FG005|Overall Study|Protocol Violation|1|||
33481381|NCT00642278|101655280|FG006|Overall Study|Protocol Violation|2|||
33481382|NCT00642278|101655274|FG000|Overall Study|Withdrawal by Subject|1|||
33481383|NCT00642278|101655275|FG001|Overall Study|Withdrawal by Subject|1|||
33481384|NCT00642278|101655276|FG002|Overall Study|Withdrawal by Subject|1|||
33481385|NCT00642278|101655277|FG003|Overall Study|Withdrawal by Subject|3|||
33481386|NCT00642278|101655278|FG004|Overall Study|Withdrawal by Subject|6|||
33481387|NCT00642278|101655279|FG005|Overall Study|Withdrawal by Subject|2|||
33481388|NCT00642278|101655280|FG006|Overall Study|Withdrawal by Subject|2|||
33481389|NCT00642278|101655274|FG000|Overall Study|Noncompliance with study drug regimen|0|||
33481390|NCT00642278|101655275|FG001|Overall Study|Noncompliance with study drug regimen|0|||
33481391|NCT00642278|101655276|FG002|Overall Study|Noncompliance with study drug regimen|0|||
33481392|NCT00642278|101655277|FG003|Overall Study|Noncompliance with study drug regimen|1|||
33481393|NCT00642278|101655278|FG004|Overall Study|Noncompliance with study drug regimen|0|||
33481394|NCT00642278|101655279|FG005|Overall Study|Noncompliance with study drug regimen|0|||
33481395|NCT00642278|101655280|FG006|Overall Study|Noncompliance with study drug regimen|0|||
33481396|NCT00642278|101655274|FG000|Overall Study|Other|2|||
33481397|NCT00642278|101655275|FG001|Overall Study|Other|1|||
33481398|NCT00642278|101655276|FG002|Overall Study|Other|0|||
33481399|NCT00642278|101655277|FG003|Overall Study|Other|1|||
33481400|NCT00642278|101655278|FG004|Overall Study|Other|0|||
33481401|NCT00642278|101655279|FG005|Overall Study|Other|1|||
33481402|NCT00642278|101655280|FG006|Overall Study|Other|0|||
33481403|NCT04241315|101655288|FG000|Overall Study|Withdrawal by Subject|0|||
33481404|NCT04241315|101655289|FG001|Overall Study|Withdrawal by Subject|1|||
33481405|NCT03480386|101655292|FG000|Overall Study|Did not complete measures at 3-months|17|||
33481406|NCT03480386|101655293|FG001|Overall Study|Did not complete measures at 3-months|14|||
33481407|NCT03480386|101655292|FG000|Overall Study|No baseline measures|11|||
33481408|NCT03480386|101655293|FG001|Overall Study|No baseline measures|14|||
33481409|NCT03480386|101655292|FG000|Overall Study|Death|0|||
33481410|NCT03480386|101655293|FG001|Overall Study|Death|5|||
33481411|NCT03480386|101655292|FG000|Overall Study|Withdrawal by Subject|12|||
33481412|NCT03480386|101655293|FG001|Overall Study|Withdrawal by Subject|8|||
33481413|NCT03480386|101655292|FG000|Overall Study|Lost to Follow-up|2|||
33481414|NCT03480386|101655293|FG001|Overall Study|Lost to Follow-up|1|||
33481415|NCT03480386|101655292|FG000|Overall Study|Complicating disease|0|||
33481416|NCT03480386|101655293|FG001|Overall Study|Complicating disease|1|||
33481417|NCT03480386|101655292|FG000|Overall Study|Disease progression|3|||
33481418|NCT03480386|101655293|FG001|Overall Study|Disease progression|0|||
33481419|NCT03480386|101655292|FG000|Overall Study|Became ineligible|0|||
33481420|NCT03480386|101655293|FG001|Overall Study|Became ineligible|2|||
33481421|NCT01987479|101655294|FG000|Overall Study|Protocol Violation|1|||
33481422|NCT01987479|101655294|FG000|Overall Study|Physician Decision|2|||
33481423|NCT01987479|101655294|FG000|Overall Study|Participant/legal guardian decision|1|||
33481424|NCT01987479|101655294|FG000|Overall Study|Other|5|||
33481425|NCT01987479|101655294|FG000|Overall Study|Lost to Follow-up|1|||
33481426|NCT01987479|101655294|FG000|Overall Study|Adverse Event|7|||
33481427|NCT03760185|101655298|FG000|Overall Study|Lost to Follow-up|1|||
33481428|NCT03760185|101655299|FG001|Overall Study|Lost to Follow-up|1|||
33481429|NCT03276078|101655300|FG000|Overall Study|Adverse Event|1|||
33481430|NCT02227446|101655301|FG000|Overall Study|not eligible post randomization|18|||
33481431|NCT02227446|101655302|FG001|Overall Study|not eligible post randomization|29|||
33481432|NCT02227446|101655301|FG000|Overall Study|Withdrawal by Subject|4|||
33481433|NCT02227446|101655302|FG001|Overall Study|Withdrawal by Subject|5|||
33481434|NCT05314816|101655305|FG000|Overall Study|Lost to Follow-up|5|||
33481435|NCT05314816|101655306|FG001|Overall Study|Lost to Follow-up|0|||
33481436|NCT05314816|101655307|FG002|Overall Study|Lost to Follow-up|1|||
33481437|NCT05314816|101655305|FG000|Overall Study|Protocol Violation|13|||
33481438|NCT05314816|101655306|FG001|Overall Study|Protocol Violation|8|||
33481439|NCT05314816|101655307|FG002|Overall Study|Protocol Violation|0|||
33481440|NCT04058067|101655308|FG000|Overall Study|Adverse Event|2|||
33481441|NCT04058067|101655309|FG001|Overall Study|Adverse Event|0|||
33481442|NCT04058067|101655308|FG000|Overall Study|Death|0|||
33481443|NCT04058067|101655309|FG001|Overall Study|Death|1|||
33481444|NCT04058067|101655308|FG000|Overall Study|Physician Decision|3|||
33481445|NCT04058067|101655309|FG001|Overall Study|Physician Decision|1|||
33481446|NCT04058067|101655308|FG000|Overall Study|Protocol Violation|0|||
33481447|NCT04058067|101655309|FG001|Overall Study|Protocol Violation|1|||
33481448|NCT04058067|101655308|FG000|Overall Study|Withdrawal by Subject|7|||
33481449|NCT04058067|101655309|FG001|Overall Study|Withdrawal by Subject|8|||
33481450|NCT02257385|101655321|FG000|Overall Study|Adverse Event|12|||
33481451|NCT02257385|101655322|FG001|Overall Study|Adverse Event|8|||
33481452|NCT02257385|101655321|FG000|Overall Study|Lack of Efficacy|1|||
33481453|NCT02257385|101655322|FG001|Overall Study|Lack of Efficacy|2|||
33481454|NCT02257385|101655321|FG000|Overall Study|Protocol Violation|5|||
33481455|NCT02257385|101655322|FG001|Overall Study|Protocol Violation|7|||
33481456|NCT02257385|101655321|FG000|Overall Study|Lost to Follow-up|0|||
33481457|NCT02257385|101655322|FG001|Overall Study|Lost to Follow-up|1|||
33481458|NCT02257385|101655321|FG000|Overall Study|Withdrawal by Subject|4|||
33481459|NCT02257385|101655322|FG001|Overall Study|Withdrawal by Subject|4|||
33481460|NCT04784533|101655323|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
33481461|NCT04784533|101655324|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
33481462|NCT04784533|101655325|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
33481463|NCT04784533|101655326|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
33481464|NCT04784533|101655327|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
33481465|NCT04784533|101655328|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
33481466|NCT04784533|101655329|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
33481467|NCT04784533|101655330|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
33481468|NCT04784533|101655331|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
33481469|NCT04784533|101655332|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
33273645|NCT01199302|100900361|FG000|Overall Study|Withdrawal by Subject|2|||
33273646|NCT01199302|100900362|FG001|Overall Study|Withdrawal by Subject|2|||
33481470|NCT04784533|101655323|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
33481471|NCT04784533|101655324|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
33481472|NCT04784533|101655325|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
33481473|NCT04784533|101655326|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
33481474|NCT04784533|101655327|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
33481475|NCT04784533|101655328|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
33481476|NCT04784533|101655329|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
33481477|NCT04784533|101655330|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
33481478|NCT04784533|101655331|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
33481479|NCT04784533|101655332|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
33481480|NCT04784533|101655323|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
33481481|NCT04784533|101655324|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
33481482|NCT04784533|101655325|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
33481483|NCT04784533|101655326|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
33481484|NCT04784533|101655327|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
33481485|NCT04784533|101655328|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
33481486|NCT04784533|101655329|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
33481487|NCT04784533|101655330|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
33481488|NCT04784533|101655331|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
33481489|NCT04784533|101655332|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
33481490|NCT04784533|101655323|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
33481491|NCT04784533|101655324|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
33481492|NCT04784533|101655325|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
33481493|NCT04784533|101655326|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
33481494|NCT04784533|101655327|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
33481495|NCT04784533|101655328|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
33481496|NCT04784533|101655329|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
33481497|NCT04784533|101655330|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
33481498|NCT04784533|101655331|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
33481499|NCT04784533|101655332|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
33481500|NCT04784533|101655323|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
33481501|NCT04784533|101655324|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
33481502|NCT04784533|101655325|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
33481503|NCT04784533|101655326|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
33481504|NCT04784533|101655327|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
33481505|NCT04784533|101655328|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
33481506|NCT04784533|101655329|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
33481507|NCT04784533|101655330|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
33481508|NCT04784533|101655331|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
33481509|NCT04784533|101655332|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
33481510|NCT04784533|101655323|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
33481511|NCT04784533|101655324|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
33481512|NCT04784533|101655325|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
33481513|NCT04784533|101655326|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
33481514|NCT04784533|101655327|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
33481515|NCT04784533|101655328|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
33481516|NCT04784533|101655329|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
33481517|NCT04784533|101655330|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
33481518|NCT04784533|101655331|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
33481519|NCT04784533|101655332|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
33481520|NCT04784533|101655323|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
33481521|NCT04784533|101655324|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
33481522|NCT04784533|101655325|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
33481523|NCT04784533|101655326|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
33481524|NCT04784533|101655327|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
33481525|NCT04784533|101655328|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
33481526|NCT04784533|101655329|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
33481527|NCT04784533|101655330|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
33481528|NCT04784533|101655331|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
33481529|NCT04784533|101655332|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
33481530|NCT04784533|101655323|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
33481531|NCT04784533|101655324|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
33481532|NCT04784533|101655325|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
33481533|NCT04784533|101655326|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
33481534|NCT04784533|101655327|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
33481535|NCT04784533|101655328|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
33481536|NCT04784533|101655329|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
33481537|NCT04784533|101655330|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
33481538|NCT04784533|101655331|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
33273647|NCT01199302|100900363|FG002|Overall Study|Withdrawal by Subject|3|||
33273648|NCT01199302|100900364|FG003|Overall Study|Withdrawal by Subject|0|||
33481539|NCT04784533|101655332|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
33481540|NCT04784533|101655323|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
33481541|NCT04784533|101655324|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
33481542|NCT04784533|101655325|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
33481543|NCT04784533|101655326|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
33481544|NCT04784533|101655327|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
33481545|NCT04784533|101655328|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
33481546|NCT04784533|101655329|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
33481547|NCT04784533|101655330|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
33481548|NCT04784533|101655331|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
33481549|NCT04784533|101655332|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
33481550|NCT00896480|101655333|FG000|Overall Study|Disease progression/recurrence|21|||
33481551|NCT03477903|101655334|FG000|Overall Study|Study Terminated by Sponsor|1|||
33481552|NCT02704403|101655341|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
33481553|NCT02704403|101655342|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
33481554|NCT02704403|101655341|FG000|Overall Study|Administrative reasons by sponsor|1251|||
33481555|NCT02704403|101655342|FG001|Overall Study|Administrative reasons by sponsor|616|||
33481556|NCT02704403|101655341|FG000|Overall Study|Death|4|||
33481557|NCT02704403|101655342|FG001|Overall Study|Death|3|||
33481558|NCT02704403|101655341|FG000|Overall Study|Endpoint event|52|||
33481559|NCT02704403|101655342|FG001|Overall Study|Endpoint event|24|||
33481560|NCT02704403|101655341|FG000|Overall Study|Lost to Follow-up|22|||
33481561|NCT02704403|101655342|FG001|Overall Study|Lost to Follow-up|11|||
33481562|NCT02704403|101655341|FG000|Overall Study|Protocol Violation|15|||
33481563|NCT02704403|101655342|FG001|Overall Study|Protocol Violation|15|||
33481564|NCT02704403|101655341|FG000|Overall Study|Adverse Event|2|||
33481565|NCT02704403|101655342|FG001|Overall Study|Adverse Event|0|||
33481566|NCT02704403|101655341|FG000|Overall Study|Withdrawal by Subject|85|||
33481567|NCT02704403|101655342|FG001|Overall Study|Withdrawal by Subject|45|||
33481568|NCT02704403|101655341|FG000|Overall Study|Investigator decision|1|||
33481569|NCT02704403|101655342|FG001|Overall Study|Investigator decision|1|||
33481570|NCT02704403|101655341|FG000|Overall Study|Follow-up not possible|1|||
33481571|NCT02704403|101655342|FG001|Overall Study|Follow-up not possible|2|||
33481572|NCT05307510|101655349|FG000|Overall Study|Lost to Follow-up|3|||
33481573|NCT05307510|101655350|FG001|Overall Study|Lost to Follow-up|6|||
33481574|NCT05307510|101655349|FG000|Overall Study|Withdrawal by Subject|0|||
33481575|NCT05307510|101655350|FG001|Overall Study|Withdrawal by Subject|1|||
33481576|NCT00394524|101655357|FG000|Overall Study|Protocol Violation|2|||
33481577|NCT00394524|101655358|FG001|Overall Study|Protocol Violation|3|||
33481578|NCT00394524|101655357|FG000|Overall Study|Death|1|||
33481579|NCT00394524|101655358|FG001|Overall Study|Death|0|||
33481580|NCT00394524|101655357|FG000|Overall Study|Withdrawal by Subject|0|||
33481581|NCT00394524|101655358|FG001|Overall Study|Withdrawal by Subject|1|||
33481582|NCT03968978|101655359|FG000|Overall Study|Adverse Event|1|||
33481583|NCT03968978|101655360|FG001|Overall Study|Adverse Event|0|||
33481584|NCT01823835|101655361|FG000|Overall Study|Adverse Event|0|||
33481585|NCT01823835|101655362|FG001|Overall Study|Adverse Event|0|||
33481586|NCT01823835|101655363|FG002|Overall Study|Adverse Event|0|||
33481587|NCT01823835|101655364|FG003|Overall Study|Adverse Event|0|||
33481588|NCT01823835|101655365|FG004|Overall Study|Adverse Event|1|||
33481589|NCT01823835|101655366|FG005|Overall Study|Adverse Event|0|||
33481590|NCT01823835|101655367|FG006|Overall Study|Adverse Event|1|||
33481591|NCT01823835|101655368|FG007|Overall Study|Adverse Event|0|||
33481592|NCT01823835|101655369|FG008|Overall Study|Adverse Event|0|||
33481593|NCT01823835|101655370|FG009|Overall Study|Adverse Event|0|||
33481594|NCT01823835|101655371|FG010|Overall Study|Adverse Event|1|||
33481595|NCT01823835|101655372|FG011|Overall Study|Adverse Event|2|||
33481596|NCT01823835|101655373|FG012|Overall Study|Adverse Event|0|||
33481597|NCT01823835|101655374|FG013|Overall Study|Adverse Event|0|||
33481598|NCT01823835|101655375|FG014|Overall Study|Adverse Event|0|||
33481599|NCT01823835|101655361|FG000|Overall Study|Physician Decision|0|||
33481600|NCT01823835|101655362|FG001|Overall Study|Physician Decision|0|||
33481601|NCT01823835|101655363|FG002|Overall Study|Physician Decision|0|||
33481602|NCT01823835|101655364|FG003|Overall Study|Physician Decision|0|||
33481603|NCT01823835|101655365|FG004|Overall Study|Physician Decision|0|||
33481604|NCT01823835|101655366|FG005|Overall Study|Physician Decision|0|||
33481605|NCT01823835|101655367|FG006|Overall Study|Physician Decision|0|||
33481606|NCT01823835|101655368|FG007|Overall Study|Physician Decision|0|||
33481607|NCT01823835|101655369|FG008|Overall Study|Physician Decision|0|||
33481608|NCT01823835|101655370|FG009|Overall Study|Physician Decision|0|||
33481609|NCT01823835|101655371|FG010|Overall Study|Physician Decision|0|||
33481610|NCT01823835|101655372|FG011|Overall Study|Physician Decision|2|||
33481611|NCT01823835|101655373|FG012|Overall Study|Physician Decision|0|||
33481612|NCT01823835|101655374|FG013|Overall Study|Physician Decision|0|||
33481613|NCT01823835|101655375|FG014|Overall Study|Physician Decision|0|||
33481614|NCT01823835|101655361|FG000|Overall Study|Progressive Disease|3|||
33481615|NCT01823835|101655362|FG001|Overall Study|Progressive Disease|4|||
33481616|NCT01823835|101655363|FG002|Overall Study|Progressive Disease|3|||
33481617|NCT01823835|101655364|FG003|Overall Study|Progressive Disease|6|||
33481618|NCT01823835|101655365|FG004|Overall Study|Progressive Disease|4|||
33481619|NCT01823835|101655366|FG005|Overall Study|Progressive Disease|6|||
33481620|NCT01823835|101655367|FG006|Overall Study|Progressive Disease|5|||
33481621|NCT01823835|101655368|FG007|Overall Study|Progressive Disease|3|||
33481622|NCT01823835|101655369|FG008|Overall Study|Progressive Disease|3|||
33481623|NCT01823835|101655370|FG009|Overall Study|Progressive Disease|18|||
33481624|NCT01823835|101655371|FG010|Overall Study|Progressive Disease|8|||
33481625|NCT01823835|101655372|FG011|Overall Study|Progressive Disease|46|||
33481626|NCT01823835|101655373|FG012|Overall Study|Progressive Disease|18|||
33481627|NCT01823835|101655374|FG013|Overall Study|Progressive Disease|4|||
33481628|NCT01823835|101655375|FG014|Overall Study|Progressive Disease|6|||
33481629|NCT01823835|101655361|FG000|Overall Study|Study Termination|0|||
33481630|NCT01823835|101655362|FG001|Overall Study|Study Termination|0|||
33481631|NCT01823835|101655363|FG002|Overall Study|Study Termination|0|||
33481632|NCT01823835|101655364|FG003|Overall Study|Study Termination|0|||
33481633|NCT01823835|101655365|FG004|Overall Study|Study Termination|1|||
33481634|NCT01823835|101655366|FG005|Overall Study|Study Termination|0|||
33481635|NCT01823835|101655367|FG006|Overall Study|Study Termination|0|||
33481636|NCT01823835|101655368|FG007|Overall Study|Study Termination|0|||
33481637|NCT01823835|101655369|FG008|Overall Study|Study Termination|0|||
33481638|NCT01823835|101655370|FG009|Overall Study|Study Termination|0|||
33481639|NCT01823835|101655371|FG010|Overall Study|Study Termination|0|||
33481640|NCT01823835|101655372|FG011|Overall Study|Study Termination|1|||
33481641|NCT01823835|101655373|FG012|Overall Study|Study Termination|0|||
33481642|NCT01823835|101655374|FG013|Overall Study|Study Termination|0|||
33481643|NCT01823835|101655375|FG014|Overall Study|Study Termination|0|||
33481644|NCT01823835|101655361|FG000|Overall Study|Withdrawal by Subject|0|||
33481645|NCT01823835|101655362|FG001|Overall Study|Withdrawal by Subject|0|||
33481646|NCT01823835|101655363|FG002|Overall Study|Withdrawal by Subject|1|||
33481647|NCT01823835|101655364|FG003|Overall Study|Withdrawal by Subject|0|||
33481648|NCT01823835|101655365|FG004|Overall Study|Withdrawal by Subject|0|||
33481649|NCT01823835|101655366|FG005|Overall Study|Withdrawal by Subject|0|||
33481650|NCT01823835|101655367|FG006|Overall Study|Withdrawal by Subject|0|||
33481651|NCT01823835|101655368|FG007|Overall Study|Withdrawal by Subject|0|||
33481652|NCT01823835|101655369|FG008|Overall Study|Withdrawal by Subject|0|||
33481653|NCT01823835|101655370|FG009|Overall Study|Withdrawal by Subject|1|||
33481654|NCT01823835|101655371|FG010|Overall Study|Withdrawal by Subject|1|||
33481655|NCT01823835|101655372|FG011|Overall Study|Withdrawal by Subject|2|||
33481656|NCT01823835|101655373|FG012|Overall Study|Withdrawal by Subject|1|||
33481657|NCT01823835|101655374|FG013|Overall Study|Withdrawal by Subject|0|||
33481658|NCT01823835|101655375|FG014|Overall Study|Withdrawal by Subject|0|||
33481659|NCT00927394|101655383|FG000|Overall Study|Adverse Event|14|||
33481660|NCT00927394|101655384|FG001|Overall Study|Adverse Event|9|||
33481661|NCT00927394|101655383|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
33481662|NCT00927394|101655384|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
33481663|NCT00927394|101655383|FG000|Overall Study|Withdrawal by Subject|20|||
33481664|NCT00927394|101655384|FG001|Overall Study|Withdrawal by Subject|24|||
33481665|NCT00927394|101655383|FG000|Overall Study|Lost to Follow-up|8|||
33481666|NCT00927394|101655384|FG001|Overall Study|Lost to Follow-up|14|||
33481667|NCT00927394|101655383|FG000|Overall Study|Administrative Problem|1|||
33481668|NCT00927394|101655384|FG001|Overall Study|Administrative Problem|0|||
33481669|NCT00927394|101655383|FG000|Overall Study|Death|1|||
33481670|NCT00927394|101655384|FG001|Overall Study|Death|1|||
33481671|NCT00927394|101655383|FG000|Overall Study|Protocol deviation|16|||
33481672|NCT00927394|101655384|FG001|Overall Study|Protocol deviation|13|||
33481673|NCT00927394|101655383|FG000|Overall Study|Randomized in error|0|||
33481674|NCT00927394|101655384|FG001|Overall Study|Randomized in error|1|||
33481675|NCT02013674|101655387|FG000|Overall Study|Death|0|||
33481676|NCT02013674|101655388|FG001|Overall Study|Death|1|||
33481677|NCT02013674|101655387|FG000|Overall Study|Lost to Follow-up|1|||
33481678|NCT02013674|101655388|FG001|Overall Study|Lost to Follow-up|0|||
33481679|NCT00447993|101655389|FG000|Overall Study|Lost to Follow-up|0|||
33481680|NCT00447993|101655390|FG001|Overall Study|Lost to Follow-up|0|||
33481681|NCT00447993|101655391|FG002|Overall Study|Lost to Follow-up|2|||
33481682|NCT00447993|101655392|FG003|Overall Study|Lost to Follow-up|2|||
33481683|NCT00447993|101655389|FG000|Overall Study|Withdrawal by Subject|0|||
33481684|NCT00447993|101655390|FG001|Overall Study|Withdrawal by Subject|0|||
33481685|NCT00447993|101655391|FG002|Overall Study|Withdrawal by Subject|2|||
33481686|NCT00447993|101655392|FG003|Overall Study|Withdrawal by Subject|2|||
33481687|NCT04581369|101655393|FG000|Overall Study|Death|7|||
33481688|NCT04581369|101655394|FG001|Overall Study|Death|6|||
33481689|NCT04581369|101655395|FG002|Overall Study|Death|0|||
33481690|NCT04581369|101655393|FG000|Overall Study|Lost to Follow-up|7|||
33481691|NCT04581369|101655394|FG001|Overall Study|Lost to Follow-up|3|||
33481692|NCT04581369|101655395|FG002|Overall Study|Lost to Follow-up|0|||
33481693|NCT04581369|101655393|FG000|Overall Study|liver transplant|2|||
33481694|NCT04581369|101655394|FG001|Overall Study|liver transplant|2|||
33481695|NCT04581369|101655395|FG002|Overall Study|liver transplant|0|||
33481696|NCT04581369|101655393|FG000|Overall Study|transitioned to hospice care|0|||
33481697|NCT04581369|101655394|FG001|Overall Study|transitioned to hospice care|5|||
33481698|NCT04581369|101655395|FG002|Overall Study|transitioned to hospice care|0|||
33481699|NCT02910063|101655396|FG000|Phase 2|Withdrawal by Subject|3|||
33481700|NCT02910063|101655397|FG001|Phase 2|Withdrawal by Subject|0|||
33481701|NCT02910063|101655398|FG002|Phase 2|Withdrawal by Subject|0|||
33481702|NCT02910063|101655396|FG000|Phase 2|Lost to Follow-up|1|||
33481703|NCT02910063|101655397|FG001|Phase 2|Lost to Follow-up|0|||
33481704|NCT02910063|101655398|FG002|Phase 2|Lost to Follow-up|0|||
33481705|NCT02910063|101655396|FG000|Phase 2|Death|24|||
33481706|NCT02910063|101655397|FG001|Phase 2|Death|0|||
33481707|NCT02910063|101655398|FG002|Phase 2|Death|0|||
33481708|NCT04839692|101655399|FG000|Overall Study|Withdrawal by Subject|0|||
33481709|NCT04839692|101655400|FG001|Overall Study|Withdrawal by Subject|3|||
33481710|NCT04839692|101655399|FG000|Overall Study|Physician Decision|1|||
33481711|NCT04839692|101655400|FG001|Overall Study|Physician Decision|0|||
33481712|NCT00681590|101655401|FG000|Overall Study|Withdrawal by Subject|2|||
33481713|NCT00681590|101655402|FG001|Overall Study|Withdrawal by Subject|12|||
33481714|NCT02643355|101655403|FG000|Overall Study|Withdrawal by Subject|1|||
33481715|NCT02643355|101655404|FG001|Overall Study|Withdrawal by Subject|3|||
33481716|NCT02643355|101655403|FG000|Overall Study|Protocol Violation|0|||
33481717|NCT02643355|101655404|FG001|Overall Study|Protocol Violation|2|||
33481718|NCT02186834|101655405|FG000|Dose Escalation|Death|0|||
33481719|NCT02186834|101655406|FG001|Dose Escalation|Death|0|||
33481720|NCT02186834|101655407|FG002|Dose Escalation|Death|0|||
33481721|NCT02186834|101655408|FG003|Dose Escalation|Death|1|||
33481722|NCT02186834|101655409|FG004|Dose Escalation|Death|0|||
33481723|NCT02186834|101655410|FG005|Dose Escalation|Death|0|||
33481724|NCT02186834|101655405|FG000|Treatment at RP2D|Died prior to treatment|0|||
33481725|NCT02186834|101655406|FG001|Treatment at RP2D|Died prior to treatment|0|||
33481726|NCT02186834|101655407|FG002|Treatment at RP2D|Died prior to treatment|0|||
33481727|NCT02186834|101655408|FG003|Treatment at RP2D|Died prior to treatment|0|||
33481728|NCT02186834|101655409|FG004|Treatment at RP2D|Died prior to treatment|0|||
33481729|NCT02186834|101655410|FG005|Treatment at RP2D|Died prior to treatment|1|||
33481730|NCT00813800|101655412|FG000|Overall Study|Screen Failure after Consent|2|||
33481731|NCT00813800|101655412|FG000|Overall Study|Adverse Event|1|||
33481732|NCT00813800|101655412|FG000|Overall Study|Worsening of depression|2|||
33481733|NCT00813800|101655412|FG000|Overall Study|Physician Decision|1|||
33481734|NCT00603837|101655414|FG000|Overall Study|Physician Decision|3|||
33481735|NCT00603837|101655415|FG001|Overall Study|Physician Decision|0|||
33481736|NCT03489109|101655416|FG000|Overall Study|Lost to Follow-up|1|||
33481737|NCT03489109|101655417|FG001|Overall Study|Lost to Follow-up|2|||
33481738|NCT02648932|101655418|FG000|Overall Study|No transplant|3|||
33481739|NCT02648932|101655419|FG001|Overall Study|No transplant|1|||
33481740|NCT03597529|101655420|FG000|Overall Study|Lost to Follow-up|10|||
33481741|NCT03597529|101655421|FG001|Overall Study|Lost to Follow-up|12|||
33481742|NCT03597529|101655420|FG000|Overall Study|Physician Decision|3|||
33481743|NCT03597529|101655421|FG001|Overall Study|Physician Decision|1|||
33481744|NCT03597529|101655420|FG000|Overall Study|Withdrawal by Subject|6|||
33481745|NCT03597529|101655421|FG001|Overall Study|Withdrawal by Subject|3|||
33481746|NCT03597529|101655420|FG000|Overall Study|Non-compliant with study activities|1|||
33481747|NCT03597529|101655421|FG001|Overall Study|Non-compliant with study activities|2|||
33481748|NCT03893565|101655422|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
33481749|NCT03893565|101655423|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
33481750|NCT03893565|101655424|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
33481751|NCT03893565|101655425|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
33481752|NCT03893565|101655426|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
33481753|NCT03893565|101655427|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
33481754|NCT03893565|101655428|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
33481755|NCT03893565|101655429|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
33481756|NCT03893565|101655430|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
33481757|NCT03893565|101655422|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33481758|NCT03893565|101655423|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
33481759|NCT03893565|101655424|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33481760|NCT03893565|101655425|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33481761|NCT03893565|101655426|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33481762|NCT03893565|101655427|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33481763|NCT03893565|101655428|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33481764|NCT03893565|101655429|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33481765|NCT03893565|101655430|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
33481766|NCT03893565|101655422|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481767|NCT03893565|101655423|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
33481768|NCT03893565|101655424|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481769|NCT03893565|101655425|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
33481770|NCT03893565|101655426|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481771|NCT03893565|101655427|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481772|NCT03893565|101655428|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481773|NCT03893565|101655429|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481774|NCT03893565|101655430|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481775|NCT03893565|101655422|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
33481776|NCT03893565|101655423|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
33481777|NCT03893565|101655424|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
33481778|NCT03893565|101655425|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
33481779|NCT03893565|101655426|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
33481780|NCT03893565|101655427|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
33481781|NCT03893565|101655428|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
33481782|NCT03893565|101655429|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
33481783|NCT03893565|101655430|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
33481784|NCT03893565|101655422|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
33481785|NCT03893565|101655423|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
33481786|NCT03893565|101655424|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
33481787|NCT03893565|101655425|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33481788|NCT03893565|101655426|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
33481789|NCT03893565|101655427|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33481790|NCT03893565|101655428|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33481791|NCT03893565|101655429|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33481792|NCT03893565|101655430|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33481793|NCT03893565|101655422|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33481794|NCT03893565|101655423|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
33481795|NCT03893565|101655424|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33481796|NCT03893565|101655425|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33481797|NCT03893565|101655426|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33481798|NCT03893565|101655427|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33481799|NCT03893565|101655428|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33481800|NCT03893565|101655429|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33481801|NCT03893565|101655430|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
33481802|NCT03893565|101655422|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481803|NCT03893565|101655423|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481804|NCT03893565|101655424|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481805|NCT03893565|101655425|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
33481806|NCT03893565|101655426|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481807|NCT03893565|101655427|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481808|NCT03893565|101655428|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481809|NCT03893565|101655429|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481810|NCT03893565|101655430|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481811|NCT03893565|101655422|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
33481812|NCT03893565|101655423|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
33481813|NCT03893565|101655424|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
33481814|NCT03893565|101655425|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
33481815|NCT03893565|101655426|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
33481816|NCT03893565|101655427|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
33481817|NCT03893565|101655428|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
33481818|NCT03893565|101655429|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
33481819|NCT03893565|101655430|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
33481820|NCT03893565|101655422|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
33481821|NCT03893565|101655423|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
33481822|NCT03893565|101655424|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
33481823|NCT03893565|101655425|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
33481824|NCT03893565|101655426|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
33481825|NCT03893565|101655427|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
33481826|NCT03893565|101655428|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
33481827|NCT03893565|101655429|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
33481828|NCT03893565|101655430|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
33481829|NCT03893565|101655422|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33273649|NCT01199302|100900361|FG000|Overall Study|Disease Progression|3|||
33273650|NCT01199302|100900362|FG001|Overall Study|Disease Progression|4|||
33481830|NCT03893565|101655423|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33481831|NCT03893565|101655424|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33481832|NCT03893565|101655425|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33481833|NCT03893565|101655426|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33481834|NCT03893565|101655427|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33481835|NCT03893565|101655428|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
33481836|NCT03893565|101655429|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33481837|NCT03893565|101655430|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
33481838|NCT03893565|101655422|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
33481839|NCT03893565|101655423|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
33481840|NCT03893565|101655424|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
33481841|NCT03893565|101655425|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
33481842|NCT03893565|101655426|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
33481843|NCT03893565|101655427|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
33481844|NCT03893565|101655428|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
33481845|NCT03893565|101655429|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
33481846|NCT03893565|101655430|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
33481847|NCT03893565|101655422|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
33481848|NCT03893565|101655423|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
33481849|NCT03893565|101655424|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
33481850|NCT03893565|101655425|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
33481851|NCT03893565|101655426|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
33481852|NCT03893565|101655427|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
33481853|NCT03893565|101655428|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
33481854|NCT03893565|101655429|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
33481855|NCT03893565|101655430|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
33481856|NCT03893565|101655422|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481857|NCT03893565|101655423|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481858|NCT03893565|101655424|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481859|NCT03893565|101655425|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481860|NCT03893565|101655426|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481861|NCT03893565|101655427|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481862|NCT03893565|101655428|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481863|NCT03893565|101655429|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
33481864|NCT03893565|101655430|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
33481865|NCT03893565|101655422|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33481866|NCT03893565|101655423|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33481867|NCT03893565|101655424|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33481868|NCT03893565|101655425|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33481869|NCT03893565|101655426|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33481870|NCT03893565|101655427|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33481871|NCT03893565|101655428|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33481872|NCT03893565|101655429|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
33481873|NCT03893565|101655430|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
33481874|NCT03893565|101655422|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481875|NCT03893565|101655423|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481876|NCT03893565|101655424|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481877|NCT03893565|101655425|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481878|NCT03893565|101655426|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481879|NCT03893565|101655427|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481880|NCT03893565|101655428|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481881|NCT03893565|101655429|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
33481882|NCT03893565|101655430|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
33481883|NCT03893565|101655422|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33481884|NCT03893565|101655423|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33481885|NCT03893565|101655424|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33481886|NCT03893565|101655425|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33481887|NCT03893565|101655426|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33481888|NCT03893565|101655427|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33481889|NCT03893565|101655428|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33273651|NCT01199302|100900363|FG002|Overall Study|Disease Progression|4|||
33273652|NCT01199302|100900364|FG003|Overall Study|Disease Progression|2|||
33481890|NCT03893565|101655429|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
33481891|NCT03893565|101655430|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
33481892|NCT03146962|101655431|FG000|Overall Study|Lost to Follow-up|1|||
33481893|NCT03146962|101655432|FG001|Overall Study|Lost to Follow-up|1|||
33481894|NCT03146962|101655433|FG002|Overall Study|Lost to Follow-up|0|||
33481895|NCT03146962|101655434|FG003|Overall Study|Lost to Follow-up|0|||
33481896|NCT03146962|101655435|FG004|Overall Study|Lost to Follow-up|0|||
33481897|NCT03146962|101655436|FG005|Overall Study|Lost to Follow-up|0|||
33481898|NCT03146962|101655437|FG006|Overall Study|Lost to Follow-up|0|||
33481899|NCT03146962|101655438|FG007|Overall Study|Lost to Follow-up|0|||
33481900|NCT03146962|101655439|FG008|Overall Study|Lost to Follow-up|0|||
33481901|NCT03146962|101655440|FG009|Overall Study|Lost to Follow-up|0|||
33481902|NCT03146962|101655431|FG000|Overall Study|Adverse Event|0|||
33481903|NCT03146962|101655432|FG001|Overall Study|Adverse Event|3|||
33481904|NCT03146962|101655433|FG002|Overall Study|Adverse Event|0|||
33481905|NCT03146962|101655434|FG003|Overall Study|Adverse Event|0|||
33481906|NCT03146962|101655435|FG004|Overall Study|Adverse Event|0|||
33481907|NCT03146962|101655436|FG005|Overall Study|Adverse Event|0|||
33481908|NCT03146962|101655437|FG006|Overall Study|Adverse Event|0|||
33481909|NCT03146962|101655438|FG007|Overall Study|Adverse Event|1|||
33481910|NCT03146962|101655439|FG008|Overall Study|Adverse Event|0|||
33481911|NCT03146962|101655440|FG009|Overall Study|Adverse Event|0|||
33273653|NCT01199302|100900361|FG000|Overall Study|Study Termination|13|||
33273654|NCT01199302|100900362|FG001|Overall Study|Study Termination|8|||
33273655|NCT01199302|100900363|FG002|Overall Study|Study Termination|11|||
33273656|NCT01199302|100900364|FG003|Overall Study|Study Termination|9|||
33273657|NCT01199302|100900361|FG000|Overall Study|Lost to Follow-up|0|||
33273658|NCT01199302|100900362|FG001|Overall Study|Lost to Follow-up|1|||
33273659|NCT01199302|100900363|FG002|Overall Study|Lost to Follow-up|0|||
33273660|NCT01199302|100900364|FG003|Overall Study|Lost to Follow-up|0|||
33273661|NCT01199302|100900361|FG000|Overall Study|Other|1|||
33273662|NCT01199302|100900362|FG001|Overall Study|Other|0|||
33273663|NCT01199302|100900363|FG002|Overall Study|Other|0|||
33273664|NCT01199302|100900364|FG003|Overall Study|Other|0|||
33273665|NCT01207453|100900365|FG000|First Intervention|Adverse Event|2|||
33273666|NCT01207453|100900366|FG001|First Intervention|Adverse Event|1|||
33273667|NCT01207453|100900365|FG000|Washout|Adverse Event|1|||
33273668|NCT01207453|100900366|FG001|Washout|Adverse Event|0|||
33273669|NCT01207453|100900365|FG000|Washout|Lost to Follow-up|1|||
33273670|NCT01207453|100900366|FG001|Washout|Lost to Follow-up|0|||
33273671|NCT01207453|100900365|FG000|2nd Intervention|Adverse Event|1|||
33273672|NCT01207453|100900366|FG001|2nd Intervention|Adverse Event|2|||
33273673|NCT01207453|100900365|FG000|2nd Intervention|Lost to Follow-up|1|||
33273674|NCT01207453|100900366|FG001|2nd Intervention|Lost to Follow-up|0|||
33273675|NCT02784834|100900371|FG000|Overall Study|Lack of Efficacy|1|||
33273676|NCT04930263|100900372|FG000|Overall Study|Withdrawal by Subject|3|||
33273677|NCT04930263|100900373|FG001|Overall Study|Withdrawal by Subject|5|||
33273678|NCT02213094|100900380|FG000|Overall Study|Adverse Event|1|||
33273679|NCT02213094|100900381|FG001|Overall Study|Adverse Event|0|||
33273680|NCT02547974|100900382|FG000|Overall Study|Withdrawal by Subject|1|||
33273681|NCT02547974|100900383|FG001|Overall Study|Withdrawal by Subject|0|||
33273682|NCT02547974|100900384|FG002|Overall Study|Withdrawal by Subject|0|||
33273683|NCT02547974|100900385|FG003|Overall Study|Withdrawal by Subject|0|||
33273684|NCT00901459|100900386|FG000|Overall Study|Withdrawal by Subject|6|||
33273685|NCT00134056|100900389|FG000|Randomization|Not eligible for assigned treatment|22|||
33273686|NCT00134056|100900390|FG001|Randomization|Not eligible for assigned treatment|20|||
33273687|NCT00134056|100900389|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
33273688|NCT00134056|100900390|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
33273689|NCT00134056|100900389|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
33273690|NCT00134056|100900390|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
33273691|NCT00134056|100900389|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
33273692|NCT00134056|100900390|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
33481912|NCT03146962|101655431|FG000|Overall Study|Withdrawal by Subject|0|||
33481913|NCT03146962|101655432|FG001|Overall Study|Withdrawal by Subject|0|||
33481914|NCT03146962|101655433|FG002|Overall Study|Withdrawal by Subject|0|||
33481915|NCT03146962|101655434|FG003|Overall Study|Withdrawal by Subject|0|||
33481916|NCT03146962|101655435|FG004|Overall Study|Withdrawal by Subject|1|||
33481917|NCT03146962|101655436|FG005|Overall Study|Withdrawal by Subject|0|||
33481918|NCT03146962|101655437|FG006|Overall Study|Withdrawal by Subject|0|||
33273693|NCT00134056|100900389|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
33273694|NCT00134056|100900390|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
33273695|NCT00990184|100900391|FG000|Overall Study|Physician Decision|1|||
33273696|NCT00663923|100900392|FG000|Overall Study|Lost to Follow-up|2|||
33273697|NCT02092909|100900398|FG000|Overall Study|Adverse Event|0|||
33273698|NCT02092909|100900399|FG001|Overall Study|Adverse Event|0|||
33273699|NCT02092909|100900400|FG002|Overall Study|Adverse Event|4|||
33273700|NCT02092909|100900401|FG003|Overall Study|Adverse Event|2|||
33273701|NCT02092909|100900398|FG000|Overall Study|Lack of Efficacy|0|||
33273702|NCT02092909|100900399|FG001|Overall Study|Lack of Efficacy|2|||
33273703|NCT02092909|100900400|FG002|Overall Study|Lack of Efficacy|1|||
33273704|NCT02092909|100900401|FG003|Overall Study|Lack of Efficacy|0|||
33273705|NCT02092909|100900398|FG000|Overall Study|Withdrawal by Subject|0|||
33273706|NCT02092909|100900399|FG001|Overall Study|Withdrawal by Subject|0|||
33273707|NCT02092909|100900400|FG002|Overall Study|Withdrawal by Subject|2|||
33273708|NCT02092909|100900401|FG003|Overall Study|Withdrawal by Subject|1|||
33273709|NCT02092909|100900398|FG000|Overall Study|Study terminated by Sponsor|0|||
33273710|NCT02092909|100900399|FG001|Overall Study|Study terminated by Sponsor|0|||
33273711|NCT02092909|100900400|FG002|Overall Study|Study terminated by Sponsor|0|||
33273712|NCT02092909|100900401|FG003|Overall Study|Study terminated by Sponsor|2|||
33273713|NCT02092909|100900398|FG000|Overall Study|Miscellaneous|1|||
33273714|NCT02092909|100900399|FG001|Overall Study|Miscellaneous|1|||
33273715|NCT02092909|100900400|FG002|Overall Study|Miscellaneous|2|||
33273716|NCT02092909|100900401|FG003|Overall Study|Miscellaneous|1|||
33273717|NCT02710669|100900402|FG000|Overall Study|Physician Decision|2|||
33273718|NCT02710669|100900403|FG001|Overall Study|Physician Decision|1|||
33273719|NCT02710669|100900404|FG002|Overall Study|Physician Decision|0|||
33273720|NCT02710669|100900402|FG000|Overall Study|Institutional delays (including COVID)|2|||
33273721|NCT02710669|100900403|FG001|Overall Study|Institutional delays (including COVID)|2|||
33273722|NCT02710669|100900404|FG002|Overall Study|Institutional delays (including COVID)|0|||
33273723|NCT02710669|100900402|FG000|Overall Study|arrived in afib/aflutter|10|||
33273724|NCT02710669|100900403|FG001|Overall Study|arrived in afib/aflutter|8|||
33273725|NCT02710669|100900404|FG002|Overall Study|arrived in afib/aflutter|2|||
33273726|NCT00657709|100900414|FG000|Overall Study|AE or Death|7|||
33273727|NCT00657709|100900415|FG001|Overall Study|AE or Death|7|||
33273728|NCT00657709|100900416|FG002|Overall Study|AE or Death|6|||
33273729|NCT00657709|100900417|FG003|Overall Study|AE or Death|7|||
33273730|NCT00657709|100900418|FG004|Overall Study|AE or Death|1|||
33273731|NCT00657709|100900414|FG000|Overall Study|Withdrawal by Subject|7|||
33273732|NCT00657709|100900415|FG001|Overall Study|Withdrawal by Subject|15|||
33273733|NCT00657709|100900416|FG002|Overall Study|Withdrawal by Subject|15|||
33273734|NCT00657709|100900417|FG003|Overall Study|Withdrawal by Subject|5|||
33273735|NCT00657709|100900418|FG004|Overall Study|Withdrawal by Subject|9|||
33273736|NCT00657709|100900414|FG000|Overall Study|Lost to Follow-up|9|||
33273737|NCT00657709|100900415|FG001|Overall Study|Lost to Follow-up|9|||
33273738|NCT00657709|100900416|FG002|Overall Study|Lost to Follow-up|7|||
33273739|NCT00657709|100900417|FG003|Overall Study|Lost to Follow-up|1|||
33273740|NCT00657709|100900418|FG004|Overall Study|Lost to Follow-up|21|||
33273741|NCT00657709|100900414|FG000|Overall Study|Protocol Violation|0|||
33273742|NCT00657709|100900415|FG001|Overall Study|Protocol Violation|2|||
33273743|NCT00657709|100900416|FG002|Overall Study|Protocol Violation|0|||
33273744|NCT00657709|100900417|FG003|Overall Study|Protocol Violation|1|||
33273745|NCT00657709|100900418|FG004|Overall Study|Protocol Violation|2|||
33273746|NCT03031782|100900420|FG000|Treatment Period 1|Lack of Efficacy|3|||
33273747|NCT03031782|100900421|FG001|Treatment Period 1|Lack of Efficacy|0|||
33273748|NCT03031782|100900422|FG002|Treatment Period 1|Lack of Efficacy|0|||
33273749|NCT03031782|100900423|FG003|Treatment Period 1|Lack of Efficacy|0|||
33273750|NCT03031782|100900424|FG004|Treatment Period 1|Lack of Efficacy|0|||
33273751|NCT03031782|100900420|FG000|Treatment Period 2|Physician Decision|0|||
33273752|NCT03031782|100900421|FG001|Treatment Period 2|Physician Decision|1|||
33273753|NCT03031782|100900422|FG002|Treatment Period 2|Physician Decision|0|||
33273754|NCT03031782|100900423|FG003|Treatment Period 2|Physician Decision|0|||
33273755|NCT03031782|100900424|FG004|Treatment Period 2|Physician Decision|3|||
33273756|NCT03031782|100900420|FG000|Treatment Period 2|Lack of Efficacy|0|||
33273757|NCT03031782|100900421|FG001|Treatment Period 2|Lack of Efficacy|1|||
33273758|NCT03031782|100900422|FG002|Treatment Period 2|Lack of Efficacy|0|||
33273759|NCT03031782|100900423|FG003|Treatment Period 2|Lack of Efficacy|0|||
33273760|NCT03031782|100900424|FG004|Treatment Period 2|Lack of Efficacy|1|||
33273761|NCT03031782|100900420|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33273762|NCT03031782|100900421|FG001|Treatment Period 2|Withdrawal by Subject|3|||
33273763|NCT03031782|100900422|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33273764|NCT03031782|100900423|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33273765|NCT03031782|100900424|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33273766|NCT03031782|100900420|FG000|Treatment Period 2|Adverse Event|0|||
33273767|NCT03031782|100900421|FG001|Treatment Period 2|Adverse Event|1|||
33273768|NCT03031782|100900422|FG002|Treatment Period 2|Adverse Event|2|||
33273769|NCT03031782|100900423|FG003|Treatment Period 2|Adverse Event|0|||
33273770|NCT03031782|100900424|FG004|Treatment Period 2|Adverse Event|0|||
33273771|NCT03031782|100900420|FG000|Treatment Period 3|Withdrawal by Subject|0|||
33273772|NCT03031782|100900421|FG001|Treatment Period 3|Withdrawal by Subject|0|||
33273773|NCT03031782|100900422|FG002|Treatment Period 3|Withdrawal by Subject|0|||
33273774|NCT03031782|100900423|FG003|Treatment Period 3|Withdrawal by Subject|1|||
33273775|NCT03031782|100900424|FG004|Treatment Period 3|Withdrawal by Subject|0|||
33273776|NCT04425252|100900432|FG000|Overall Study|Withdrawal by Subject|2|||
33273777|NCT04425252|100900433|FG001|Overall Study|Withdrawal by Subject|1|||
33273778|NCT04425252|100900432|FG000|Overall Study|Lost to Follow-up|1|||
33273779|NCT04425252|100900433|FG001|Overall Study|Lost to Follow-up|0|||
33273780|NCT04425252|100900432|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
33273781|NCT04425252|100900433|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
33273782|NCT00608959|100900434|FG000|Part 1|Did not meet eligibility criteria|1|||
33273783|NCT02935894|100900435|FG000|Overall Study|Subject dismissed|1|||
33273784|NCT00442559|100900436|FG000|Overall Study|Lost to Follow-up|32|||
33273785|NCT00442559|100900437|FG001|Overall Study|Lost to Follow-up|34|||
33273786|NCT00442559|100900436|FG000|Overall Study|Protocol Violation|1|||
33273787|NCT00442559|100900437|FG001|Overall Study|Protocol Violation|1|||
33273788|NCT00442559|100900436|FG000|Overall Study|Withdrawal by Subject|1|||
33273789|NCT00442559|100900437|FG001|Overall Study|Withdrawal by Subject|0|||
33273790|NCT02449902|100900439|FG000|Overall Study|Adverse Event|0|||
33273791|NCT02449902|100900440|FG001|Overall Study|Adverse Event|1|||
33273792|NCT02449902|100900439|FG000|Overall Study|Withdrawal by Subject|0|||
33273793|NCT02449902|100900440|FG001|Overall Study|Withdrawal by Subject|1|||
33273794|NCT00443820|100900442|FG000|Overall Study|Adverse Event|1|||
33273795|NCT00443820|100900443|FG001|Overall Study|Adverse Event|1|||
33273796|NCT00443820|100900444|FG002|Overall Study|Adverse Event|0|||
33273797|NCT00443820|100900445|FG003|Overall Study|Adverse Event|0|||
33273798|NCT00443820|100900442|FG000|Overall Study|Lack of Efficacy|3|||
33273799|NCT00443820|100900443|FG001|Overall Study|Lack of Efficacy|2|||
33273800|NCT00443820|100900444|FG002|Overall Study|Lack of Efficacy|1|||
33273801|NCT00443820|100900445|FG003|Overall Study|Lack of Efficacy|1|||
33273802|NCT00443820|100900442|FG000|Overall Study|Protocol Violation|2|||
33273803|NCT00443820|100900443|FG001|Overall Study|Protocol Violation|1|||
33273804|NCT00443820|100900444|FG002|Overall Study|Protocol Violation|2|||
33273805|NCT00443820|100900445|FG003|Overall Study|Protocol Violation|1|||
33273806|NCT00443820|100900442|FG000|Overall Study|Withdrawal by Subject|6|||
33273807|NCT00443820|100900443|FG001|Overall Study|Withdrawal by Subject|7|||
33273808|NCT00443820|100900444|FG002|Overall Study|Withdrawal by Subject|8|||
33273809|NCT00443820|100900445|FG003|Overall Study|Withdrawal by Subject|9|||
33273810|NCT00443820|100900442|FG000|Overall Study|Lost to Follow-up|9|||
33273811|NCT00443820|100900443|FG001|Overall Study|Lost to Follow-up|8|||
33273812|NCT00443820|100900444|FG002|Overall Study|Lost to Follow-up|6|||
33273813|NCT00443820|100900445|FG003|Overall Study|Lost to Follow-up|5|||
33273814|NCT00443820|100900442|FG000|Overall Study|Administrative problems|0|||
33273815|NCT00443820|100900443|FG001|Overall Study|Administrative problems|0|||
33273816|NCT00443820|100900444|FG002|Overall Study|Administrative problems|0|||
33273817|NCT00443820|100900445|FG003|Overall Study|Administrative problems|1|||
33273818|NCT00443820|100900442|FG000|Overall Study|Death|0|||
33273819|NCT00443820|100900443|FG001|Overall Study|Death|0|||
33273820|NCT00443820|100900444|FG002|Overall Study|Death|1|||
33273821|NCT00443820|100900445|FG003|Overall Study|Death|0|||
33273822|NCT01919489|100900446|FG000|Overall Study|Rejected the need of injections|4|||
33273823|NCT01919489|100900447|FG001|Overall Study|Rejected the need of injections|7|||
33273824|NCT01919489|100900446|FG000|Overall Study|Adverse Event|10|||
33273825|NCT01919489|100900447|FG001|Overall Study|Adverse Event|0|||
33273826|NCT01919489|100900446|FG000|Overall Study|Hospital readmission|2|||
33273827|NCT01919489|100900447|FG001|Overall Study|Hospital readmission|9|||
33273828|NCT01919489|100900446|FG000|Overall Study|Death|2|||
33273829|NCT01919489|100900447|FG001|Overall Study|Death|1|||
33273830|NCT01919489|100900446|FG000|Overall Study|Lost to Follow-up|38|||
33273831|NCT01919489|100900447|FG001|Overall Study|Lost to Follow-up|27|||
33273832|NCT04085614|100900448|FG000|Overall Study|Protocol Violation|9|||
33273833|NCT04085614|100900449|FG001|Overall Study|Protocol Violation|6|||
33273834|NCT01760876|100900450|FG000|Overall Study|Non-cardiac death (head injury)|1|||
33273835|NCT01760876|100900450|FG000|Overall Study|Carcinoma of prostate|1|||
33273836|NCT01760876|100900450|FG000|Overall Study|Impaired renal function|1|||
33273837|NCT01760876|100900450|FG000|Overall Study|Major depression|1|||
33273838|NCT01760876|100900450|FG000|Overall Study|Very poor baseline OCT quality|2|||
33273839|NCT01405508|100900451|FG000|Overall Study|AE, non-serious non-fatal|1|||
33273840|NCT01405508|100900452|FG001|Overall Study|AE, non-serious non-fatal|1|||
33273841|NCT01405508|100900453|FG002|Overall Study|AE, non-serious non-fatal|0|||
33273842|NCT01405508|100900454|FG003|Overall Study|AE, non-serious non-fatal|0|||
33273843|NCT03395197|100900458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
33273844|NCT03395197|100900459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
33273845|NCT03395197|100900460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
33273846|NCT03395197|100900461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
33273847|NCT03395197|100900462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
33273848|NCT03395197|100900463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
33273849|NCT03395197|100900458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
33273850|NCT03395197|100900459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
33273851|NCT03395197|100900460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
33273852|NCT03395197|100900461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
33273853|NCT03395197|100900462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
33481919|NCT03146962|101655438|FG007|Overall Study|Withdrawal by Subject|0|||
33481920|NCT03146962|101655439|FG008|Overall Study|Withdrawal by Subject|0|||
33481921|NCT03146962|101655440|FG009|Overall Study|Withdrawal by Subject|0|||
33481922|NCT03146962|101655431|FG000|Overall Study|Death|0|||
33481923|NCT03146962|101655432|FG001|Overall Study|Death|1|||
33481924|NCT03146962|101655433|FG002|Overall Study|Death|0|||
33481925|NCT03146962|101655434|FG003|Overall Study|Death|0|||
33481926|NCT03146962|101655435|FG004|Overall Study|Death|0|||
33481927|NCT03146962|101655436|FG005|Overall Study|Death|0|||
33481928|NCT03146962|101655437|FG006|Overall Study|Death|0|||
33481929|NCT03146962|101655438|FG007|Overall Study|Death|0|||
33481930|NCT03146962|101655439|FG008|Overall Study|Death|0|||
33481931|NCT03146962|101655440|FG009|Overall Study|Death|0|||
33481932|NCT03146962|101655431|FG000|Overall Study|COVID Precautions|1|||
33481933|NCT03146962|101655432|FG001|Overall Study|COVID Precautions|0|||
33481934|NCT03146962|101655433|FG002|Overall Study|COVID Precautions|0|||
33481935|NCT03146962|101655434|FG003|Overall Study|COVID Precautions|0|||
33481936|NCT03146962|101655435|FG004|Overall Study|COVID Precautions|0|||
33481937|NCT03146962|101655436|FG005|Overall Study|COVID Precautions|0|||
33481938|NCT03146962|101655437|FG006|Overall Study|COVID Precautions|0|||
33481939|NCT03146962|101655438|FG007|Overall Study|COVID Precautions|0|||
33481940|NCT03146962|101655439|FG008|Overall Study|COVID Precautions|0|||
33481941|NCT03146962|101655440|FG009|Overall Study|COVID Precautions|0|||
33481942|NCT03146962|101655431|FG000|Overall Study|Physician Decision|0|||
33481943|NCT03146962|101655432|FG001|Overall Study|Physician Decision|0|||
33481944|NCT03146962|101655433|FG002|Overall Study|Physician Decision|0|||
33481945|NCT03146962|101655434|FG003|Overall Study|Physician Decision|0|||
33481946|NCT03146962|101655435|FG004|Overall Study|Physician Decision|0|||
33481947|NCT03146962|101655436|FG005|Overall Study|Physician Decision|0|||
33481948|NCT03146962|101655437|FG006|Overall Study|Physician Decision|0|||
33481949|NCT03146962|101655438|FG007|Overall Study|Physician Decision|0|||
33481950|NCT03146962|101655439|FG008|Overall Study|Physician Decision|0|||
33481951|NCT03146962|101655440|FG009|Overall Study|Physician Decision|1|||
33481952|NCT03146962|101655431|FG000|Overall Study|Started New Treatment|0|||
33481953|NCT03146962|101655432|FG001|Overall Study|Started New Treatment|1|||
33481954|NCT03146962|101655433|FG002|Overall Study|Started New Treatment|0|||
33481955|NCT03146962|101655434|FG003|Overall Study|Started New Treatment|0|||
33481956|NCT03146962|101655435|FG004|Overall Study|Started New Treatment|0|||
33481957|NCT03146962|101655436|FG005|Overall Study|Started New Treatment|0|||
33481958|NCT03146962|101655437|FG006|Overall Study|Started New Treatment|0|||
33481959|NCT03146962|101655438|FG007|Overall Study|Started New Treatment|0|||
33481960|NCT03146962|101655439|FG008|Overall Study|Started New Treatment|0|||
33481961|NCT03146962|101655440|FG009|Overall Study|Started New Treatment|0|||
33481962|NCT01221363|101655441|FG000|Overall Study|Pregnancy|1|||
33481963|NCT01221363|101655442|FG001|Overall Study|Pregnancy|0|||
33481964|NCT01221363|101655441|FG000|Overall Study|Withdrawal by Subject|11|||
33481965|NCT01221363|101655442|FG001|Overall Study|Withdrawal by Subject|5|||
33481966|NCT02552732|101655443|FG000|Overall Study|Lost to Follow-up|2|||
33481967|NCT02552732|101655443|FG000|Overall Study|Physician Decision|1|||
33481968|NCT02552732|101655443|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
33481969|NCT02552732|101655443|FG000|Overall Study|Withdrawal by Subject|6|||
33481970|NCT03155945|101655444|FG000|Overall Study|Lost to Follow-up|0|||
33481971|NCT03155945|101655445|FG001|Overall Study|Lost to Follow-up|1|||
33481972|NCT03155945|101655444|FG000|Overall Study|Withdrawal by Subject|0|||
33481973|NCT03155945|101655445|FG001|Overall Study|Withdrawal by Subject|1|||
33481974|NCT03155945|101655444|FG000|Overall Study|Other Reason|0|||
33481975|NCT03155945|101655445|FG001|Overall Study|Other Reason|1|||
33481976|NCT04239027|101655449|FG000|Overall Study|Adverse Event|4|||
33481977|NCT04239027|101655449|FG000|Overall Study|Withdrawal by Subject|9|||
33481978|NCT04239027|101655449|FG000|Overall Study|Death|1|||
33481979|NCT04239027|101655449|FG000|Overall Study|Physician Decision|9|||
33481980|NCT04239027|101655449|FG000|Overall Study|Lost to Follow-up|2|||
33481981|NCT04239027|101655449|FG000|Overall Study|Lack of Efficacy|1|||
33273854|NCT03395197|100900463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
33481982|NCT03696953|101655450|FG000|Overall Study|Withdrawal by Subject|6|||
33481983|NCT03696953|101655451|FG001|Overall Study|Withdrawal by Subject|1|||
33481984|NCT03696953|101655450|FG000|Overall Study|missed GBS swabs|2|||
33481985|NCT03696953|101655451|FG001|Overall Study|missed GBS swabs|2|||
33273855|NCT03395197|100900458|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
33481986|NCT03696953|101655450|FG000|Overall Study|lost study bottle containing capsules|2|||
33481987|NCT03696953|101655451|FG001|Overall Study|lost study bottle containing capsules|0|||
33481988|NCT03696953|101655450|FG000|Overall Study|Premature birth|1|||
33481989|NCT03696953|101655451|FG001|Overall Study|Premature birth|4|||
33481990|NCT03696953|101655450|FG000|Overall Study|Gestational hypertension|1|||
33481991|NCT03696953|101655451|FG001|Overall Study|Gestational hypertension|1|||
33481992|NCT03696953|101655450|FG000|Overall Study|Gestational diabetes|2|||
33481993|NCT03696953|101655451|FG001|Overall Study|Gestational diabetes|1|||
33481994|NCT03696953|101655450|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
33481995|NCT03696953|101655451|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
33481996|NCT03696953|101655450|FG000|Overall Study|Changed prenatal provider|1|||
33481997|NCT03696953|101655451|FG001|Overall Study|Changed prenatal provider|1|||
33481998|NCT02278055|101655452|FG000|Overall Study|Adverse Event|1|||
33481999|NCT02278055|101655452|FG000|Overall Study|Lost to Follow-up|1|||
33482000|NCT02278055|101655452|FG000|Overall Study|Withdrawal by Subject|2|||
33482001|NCT02278055|101655452|FG000|Overall Study|Progressive Disease|4|||
33482002|NCT03017612|101655453|FG000|Overall Study|Adverse Event|2|||
33482003|NCT01664130|101655454|FG000|Overall Study|competing secondary disease|2|||
33482004|NCT00919854|101655455|FG000|Overall Study|Adverse Event|1|||
33482005|NCT00792935|101655458|FG000|Overall Study|Adverse Event|2|||
33482006|NCT00792935|101655459|FG001|Overall Study|Adverse Event|1|||
33482007|NCT00792935|101655458|FG000|Overall Study|Lost to Follow-up|0|||
33482008|NCT00792935|101655459|FG001|Overall Study|Lost to Follow-up|1|||
33482009|NCT00792935|101655458|FG000|Overall Study|Protocol Violation|2|||
33482010|NCT00792935|101655459|FG001|Overall Study|Protocol Violation|0|||
33482011|NCT00792935|101655458|FG000|Overall Study|Withdrawal by Subject|0|||
33482012|NCT00792935|101655459|FG001|Overall Study|Withdrawal by Subject|1|||
33482013|NCT02045147|101655460|FG000|Overall Study|Withdrawal by Subject|2|||
33482014|NCT02045147|101655461|FG001|Overall Study|Withdrawal by Subject|0|||
33482015|NCT02045147|101655462|FG002|Overall Study|Withdrawal by Subject|0|||
33482016|NCT02045147|101655463|FG003|Overall Study|Withdrawal by Subject|0|||
33482017|NCT02045147|101655464|FG004|Overall Study|Withdrawal by Subject|0|||
33482018|NCT02045147|101655465|FG005|Overall Study|Withdrawal by Subject|0|||
33482019|NCT02045147|101655466|FG006|Overall Study|Withdrawal by Subject|0|||
33482020|NCT02045147|101655467|FG007|Overall Study|Withdrawal by Subject|1|||
33482021|NCT02045147|101655460|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
33482022|NCT02045147|101655461|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
33482023|NCT02045147|101655462|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
33482024|NCT02045147|101655463|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
33482025|NCT02045147|101655464|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
33482026|NCT02045147|101655465|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
33482027|NCT02045147|101655466|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
33482028|NCT02045147|101655467|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
33482029|NCT01283035|101655469|FG000|Overall Study|Subject later found ineligible|1|||
33482030|NCT01200992|101655470|FG000|Overall Study|Study terminated early|35|||
33482031|NCT01200992|101655471|FG001|Overall Study|Study terminated early|41|||
33273856|NCT03395197|100900459|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
33273857|NCT03395197|100900460|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
33273858|NCT03395197|100900461|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
33273859|NCT03395197|100900462|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
33273860|NCT03395197|100900463|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
33273861|NCT03395197|100900458|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
33273862|NCT03395197|100900459|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
33273863|NCT03395197|100900460|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
33273864|NCT03395197|100900461|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
33273865|NCT03395197|100900462|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
33273866|NCT03395197|100900463|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
33273867|NCT03395197|100900458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
33273868|NCT03395197|100900459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
33273869|NCT03395197|100900460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
33273870|NCT03395197|100900461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
33273871|NCT03395197|100900462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
33273872|NCT03395197|100900463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
33273873|NCT03395197|100900458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
33273874|NCT03395197|100900459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
33273875|NCT03395197|100900460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
33273876|NCT03395197|100900461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
33273877|NCT03395197|100900462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
33273878|NCT03395197|100900463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
33273879|NCT03395197|100900458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
33273880|NCT03395197|100900459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
33273881|NCT03395197|100900460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
33273882|NCT03395197|100900461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
33482032|NCT01200992|101655470|FG000|Overall Study|Randomized but not treated|2|||
33482033|NCT01200992|101655471|FG001|Overall Study|Randomized but not treated|0|||
33482034|NCT01421511|101655472|FG000|Overall Study|Lost to Follow-up|11|||
33273883|NCT03395197|100900462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
33273884|NCT03395197|100900463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
33273885|NCT03395197|100900458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
33273886|NCT03395197|100900459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
33273887|NCT03395197|100900460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
33273888|NCT03395197|100900461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
33273889|NCT03395197|100900462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
33273890|NCT03395197|100900463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
33273891|NCT03395197|100900458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
33273892|NCT03395197|100900459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
33273893|NCT03395197|100900460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
33273894|NCT03395197|100900461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
33273895|NCT03395197|100900462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
33273896|NCT03395197|100900463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
33273897|NCT03395197|100900458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
33273898|NCT03395197|100900459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
33273899|NCT03395197|100900460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
33273900|NCT03395197|100900461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
33273901|NCT03395197|100900462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
33273902|NCT03395197|100900463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
33273903|NCT03395197|100900458|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
33273904|NCT03395197|100900459|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
33273905|NCT03395197|100900460|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
33273906|NCT03395197|100900461|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
33273907|NCT03395197|100900462|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
33273908|NCT03395197|100900463|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
33273909|NCT03395197|100900458|FG000|Analysis for DDR-Deficient Participants|Death|0|||
33273910|NCT03395197|100900459|FG001|Analysis for DDR-Deficient Participants|Death|0|||
33273911|NCT03395197|100900460|FG002|Analysis for DDR-Deficient Participants|Death|0|||
33273912|NCT03395197|100900461|FG003|Analysis for DDR-Deficient Participants|Death|0|||
33273913|NCT03395197|100900462|FG004|Analysis for DDR-Deficient Participants|Death|1|||
33273914|NCT03395197|100900463|FG005|Analysis for DDR-Deficient Participants|Death|4|||
33273915|NCT03395197|100900458|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
33273916|NCT03395197|100900459|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
33273917|NCT03395197|100900460|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
33273918|NCT03395197|100900461|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
33273919|NCT03395197|100900462|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
33273920|NCT03395197|100900463|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
33273921|NCT03395197|100900458|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
33273922|NCT03395197|100900459|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
33273923|NCT03395197|100900460|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
33273924|NCT03395197|100900461|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
33273925|NCT03395197|100900462|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
33273926|NCT03395197|100900463|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
33273927|NCT03395197|100900458|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
33273928|NCT03395197|100900459|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
33273929|NCT03395197|100900460|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
33273930|NCT03395197|100900461|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
33273931|NCT03395197|100900462|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
33273932|NCT03395197|100900463|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
33273933|NCT03395197|100900458|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
33273934|NCT03395197|100900459|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
33273935|NCT03395197|100900460|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
33273936|NCT03395197|100900461|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
33273937|NCT03395197|100900462|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
33273938|NCT03395197|100900463|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
33273939|NCT03395197|100900458|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
33273940|NCT03395197|100900459|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
33273941|NCT03395197|100900460|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
33273942|NCT03395197|100900461|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
33482035|NCT01421511|101655473|FG001|Overall Study|Lost to Follow-up|14|||
33482036|NCT01421511|101655472|FG000|Overall Study|Randomized but didn't receive study drug|1|||
33482037|NCT01421511|101655473|FG001|Overall Study|Randomized but didn't receive study drug|7|||
33273943|NCT03395197|100900462|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
33273944|NCT03395197|100900463|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
33273945|NCT03395197|100900458|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
33273946|NCT03395197|100900459|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
33273947|NCT03395197|100900460|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
33273948|NCT03395197|100900461|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
33273949|NCT03395197|100900462|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
33273950|NCT03395197|100900463|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
33273951|NCT03395197|100900458|FG000|Analysis for DDR-Deficient Participants|Other|0|||
33273952|NCT03395197|100900459|FG001|Analysis for DDR-Deficient Participants|Other|0|||
33273953|NCT03395197|100900460|FG002|Analysis for DDR-Deficient Participants|Other|0|||
33273954|NCT03395197|100900461|FG003|Analysis for DDR-Deficient Participants|Other|0|||
33273955|NCT03395197|100900462|FG004|Analysis for DDR-Deficient Participants|Other|3|||
33273956|NCT03395197|100900463|FG005|Analysis for DDR-Deficient Participants|Other|3|||
33273957|NCT03395197|100900458|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
33273958|NCT03395197|100900459|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
33273959|NCT03395197|100900460|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
33273960|NCT03395197|100900461|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
33273961|NCT03395197|100900462|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
33273962|NCT03395197|100900463|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
33273963|NCT00584909|100900464|FG000|Overall Study|Adverse Event|4|||
33273964|NCT04421456|100900466|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
33273965|NCT04421456|100900467|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
33273966|NCT04421456|100900468|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
33273967|NCT04421456|100900466|FG000|Randomized Treatment Period|Adverse Event|0|||
33273968|NCT04421456|100900467|FG001|Randomized Treatment Period|Adverse Event|1|||
33273969|NCT04421456|100900468|FG002|Randomized Treatment Period|Adverse Event|0|||
33273970|NCT04421456|100900466|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
33273971|NCT04421456|100900467|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
33273972|NCT04421456|100900468|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
33273973|NCT04421456|100900466|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
33273974|NCT04421456|100900467|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
33273975|NCT04421456|100900468|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
33273976|NCT04421456|100900466|FG000|Randomized Treatment Period|Participant non-compliance|1|||
33273977|NCT04421456|100900467|FG001|Randomized Treatment Period|Participant non-compliance|1|||
33273978|NCT04421456|100900468|FG002|Randomized Treatment Period|Participant non-compliance|2|||
33273979|NCT04421456|100900466|FG000|Randomized Treatment Period|Other|0|||
33273980|NCT04421456|100900467|FG001|Randomized Treatment Period|Other|1|||
33273981|NCT04421456|100900468|FG002|Randomized Treatment Period|Other|3|||
33273982|NCT03262389|100900469|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
33273983|NCT03262389|100900469|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
33273984|NCT03262389|100900469|FG000|Overall Study|opted out of PET/MR|1|||
33273985|NCT01090739|100902844|FG000|Enrollment|Withdrawal by Subject|24|||
33273986|NCT01090739|100902844|FG000|Enrollment|Protocol Violation|14|||
33273987|NCT01090739|100902844|FG000|Enrollment|Lost to Follow-up|5|||
33273988|NCT01090739|100902844|FG000|Enrollment|Physician Decision|5|||
33273989|NCT01090739|100902844|FG000|Enrollment|Sponsor termination of site|4|||
33273990|NCT01090739|100902844|FG000|Enrollment|Study implant limit reached|2|||
33273991|NCT01090739|100902844|FG000|Enrollment|Adverse Event|1|||
33273992|NCT01090739|100902844|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
33273993|NCT01090739|100902844|FG000|12 Month Follow-up|Lost to Follow-up|1|||
33273994|NCT01090739|100902844|FG000|12 Month Follow-up|Physician Decision|1|||
33273995|NCT01090739|100902844|FG000|12 Month Follow-up|Death|1|||
33273996|NCT01090739|100902844|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
33273997|NCT01090739|100902844|FG000|24 Month Follow-up|Lost to Follow-up|1|||
33273998|NCT01090739|100902844|FG000|24 Month Follow-up|Death|1|||
33273999|NCT01090739|100902844|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
33274000|NCT01090739|100902844|FG000|36 Month Follow-up|Visit still pending|17|||
33274001|NCT02660086|100902846|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
33274002|NCT02660086|100902847|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
33274003|NCT02660086|100902846|FG000|Overall Study- 12-month|Left full-time employment|12|||
33274004|NCT02660086|100902847|FG001|Overall Study- 12-month|Left full-time employment|20|||
33274005|NCT02660086|100902846|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
33274006|NCT02660086|100902847|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
33274007|NCT02660086|100902846|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
33274008|NCT02660086|100902847|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
33274009|NCT02660086|100902846|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
33274010|NCT02660086|100902847|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
33286480|NCT03481556|100943979|FG002|Overall Study|Adverse Event|0|||
33274011|NCT02660086|100902846|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
33274012|NCT02660086|100902847|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
33274013|NCT03686176|100902848|FG000|Overall Study|Procedure cancelled|1|||
33274014|NCT03686176|100902849|FG001|Overall Study|Procedure cancelled|0|||
33274015|NCT03686176|100902850|FG002|Overall Study|Procedure cancelled|0|||
33274016|NCT03686176|100902848|FG000|Overall Study|VR Malfunction|1|||
33274017|NCT03686176|100902849|FG001|Overall Study|VR Malfunction|0|||
33274018|NCT03686176|100902850|FG002|Overall Study|VR Malfunction|0|||
33274019|NCT02316171|100902852|FG000|Overall Study|difficulties with urinary catheter|1|||
33274020|NCT02316171|100902853|FG001|Overall Study|difficulties with urinary catheter|0|||
33274021|NCT02316171|100902854|FG002|Overall Study|difficulties with urinary catheter|0|||
33274022|NCT02316171|100902855|FG003|Overall Study|difficulties with urinary catheter|0|||
33274023|NCT01699178|100902856|FG000|Overall Study|Adverse Event|1|||
33274024|NCT01699178|100902857|FG001|Overall Study|Adverse Event|5|||
33274025|NCT01699178|100902856|FG000|Overall Study|Lost to Follow-up|1|||
33274026|NCT01699178|100902857|FG001|Overall Study|Lost to Follow-up|6|||
33274027|NCT01699178|100902856|FG000|Overall Study|Non-compliance with Study Drug|3|||
33274028|NCT01699178|100902857|FG001|Overall Study|Non-compliance with Study Drug|1|||
33274029|NCT01699178|100902856|FG000|Overall Study|Physician Decision|1|||
33274030|NCT01699178|100902857|FG001|Overall Study|Physician Decision|0|||
33274031|NCT01699178|100902856|FG000|Overall Study|Withdrawal by Subject|4|||
33274032|NCT01699178|100902857|FG001|Overall Study|Withdrawal by Subject|12|||
33274033|NCT01699178|100902856|FG000|Overall Study|Hematocrit >54%|1|||
33274034|NCT01699178|100902857|FG001|Overall Study|Hematocrit >54%|1|||
33274035|NCT01699178|100902856|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
33274036|NCT01699178|100902857|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
33274037|NCT01699178|100902856|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
33274038|NCT01699178|100902857|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
33274039|NCT00828139|100902861|FG000|Overall Study|Adverse Event|8|||
33274040|NCT00828139|100902862|FG001|Overall Study|Adverse Event|1|||
33274041|NCT00828139|100902863|FG002|Overall Study|Adverse Event|10|||
33274042|NCT00828139|100902864|FG003|Overall Study|Adverse Event|5|||
33274043|NCT00828139|100902861|FG000|Overall Study|Death|2|||
33274044|NCT00828139|100902862|FG001|Overall Study|Death|1|||
33274045|NCT00828139|100902863|FG002|Overall Study|Death|0|||
33274046|NCT00828139|100902864|FG003|Overall Study|Death|2|||
33274047|NCT00828139|100902861|FG000|Overall Study|Refusal unrelated to toxicity|3|||
33274048|NCT00828139|100902862|FG001|Overall Study|Refusal unrelated to toxicity|4|||
33274049|NCT00828139|100902863|FG002|Overall Study|Refusal unrelated to toxicity|5|||
33274050|NCT00828139|100902864|FG003|Overall Study|Refusal unrelated to toxicity|3|||
33274051|NCT00828139|100902861|FG000|Overall Study|Disease Progression|24|||
33274052|NCT00828139|100902862|FG001|Overall Study|Disease Progression|33|||
33274053|NCT00828139|100902863|FG002|Overall Study|Disease Progression|35|||
33274054|NCT00828139|100902864|FG003|Overall Study|Disease Progression|39|||
33274055|NCT00828139|100902861|FG000|Overall Study|Other|4|||
33274056|NCT00828139|100902862|FG001|Overall Study|Other|2|||
33482038|NCT01421511|101655472|FG000|Overall Study|Physician Decision|0|||
33482039|NCT01421511|101655473|FG001|Overall Study|Physician Decision|1|||
33482040|NCT01421511|101655472|FG000|Overall Study|Withdrawal by Subject|6|||
33482041|NCT01421511|101655473|FG001|Overall Study|Withdrawal by Subject|5|||
33482042|NCT01421511|101655472|FG000|Overall Study|Death|1|||
33482043|NCT01421511|101655473|FG001|Overall Study|Death|1|||
33482044|NCT03190330|101655474|FG000|Overall Study|Adverse Event|2|||
33482045|NCT03190330|101655474|FG000|Overall Study|Death|10|||
33482046|NCT03190330|101655474|FG000|Overall Study|Lost to Follow-up|1|||
33274057|NCT00828139|100902863|FG002|Overall Study|Other|5|||
33274058|NCT00828139|100902864|FG003|Overall Study|Other|2|||
33274059|NCT03622580|100902865|FG000|Overall Study|Death|16|||
33274060|NCT03622580|100902866|FG001|Overall Study|Death|21|||
33274061|NCT03622580|100902867|FG002|Overall Study|Death|13|||
33274062|NCT03622580|100902865|FG000|Overall Study|Adverse Event|6|||
33274063|NCT03622580|100902866|FG001|Overall Study|Adverse Event|6|||
33274064|NCT03622580|100902867|FG002|Overall Study|Adverse Event|5|||
33274065|NCT03622580|100902865|FG000|Overall Study|Withdrawal by Subject|12|||
33274066|NCT03622580|100902866|FG001|Overall Study|Withdrawal by Subject|7|||
33274067|NCT03622580|100902867|FG002|Overall Study|Withdrawal by Subject|19|||
33274068|NCT03622580|100902865|FG000|Overall Study|Lost to Follow-up|12|||
33274069|NCT03622580|100902866|FG001|Overall Study|Lost to Follow-up|9|||
33274070|NCT03622580|100902867|FG002|Overall Study|Lost to Follow-up|9|||
33274071|NCT03622580|100902865|FG000|Overall Study|Protocol Violation|1|||
33274072|NCT03622580|100902866|FG001|Overall Study|Protocol Violation|0|||
33274073|NCT03622580|100902867|FG002|Overall Study|Protocol Violation|1|||
33274074|NCT03622580|100902865|FG000|Overall Study|Physician Decision|3|||
33274075|NCT03622580|100902866|FG001|Overall Study|Physician Decision|0|||
33482047|NCT03190330|101655474|FG000|Overall Study|Withdrawal by Subject|6|||
33482048|NCT03190330|101655474|FG000|Overall Study|Progressive Disease|1|||
33482049|NCT00867503|101655475|FG000|Overall Study|Withdrawal by Subject|1|||
33482050|NCT02552303|101655476|FG000|Allocation|Withdrawal by Subject|2|||
33482051|NCT02552303|101655477|FG001|Allocation|Withdrawal by Subject|1|||
33482052|NCT02552303|101655478|FG002|Allocation|Withdrawal by Subject|1|||
33482053|NCT02552303|101655479|FG003|Allocation|Withdrawal by Subject|1|||
33482054|NCT02552303|101655476|FG000|Allocation|ineligible|1|||
33482055|NCT02552303|101655477|FG001|Allocation|ineligible|1|||
33482056|NCT02552303|101655478|FG002|Allocation|ineligible|0|||
33482057|NCT02552303|101655479|FG003|Allocation|ineligible|0|||
33482058|NCT02552303|101655476|FG000|Follow-Up|Lost to Follow-up|0|||
33482059|NCT02552303|101655477|FG001|Follow-Up|Lost to Follow-up|0|||
33482060|NCT02552303|101655478|FG002|Follow-Up|Lost to Follow-up|1|||
33482061|NCT02552303|101655479|FG003|Follow-Up|Lost to Follow-up|0|||
33482062|NCT02552303|101655476|FG000|Follow-Up|ineligible|0|||
33482063|NCT02552303|101655477|FG001|Follow-Up|ineligible|2|||
33482064|NCT02552303|101655478|FG002|Follow-Up|ineligible|0|||
33482065|NCT02552303|101655479|FG003|Follow-Up|ineligible|0|||
33482066|NCT01329549|101655480|FG000|Overall Study|Withdrawal by Subject|1|||
33482067|NCT01329549|101655480|FG000|Overall Study|Adverse Event|1|||
33482068|NCT03485365|101655485|FG000|Overall Study|Protocol Violation|0|||
33482069|NCT03485365|101655486|FG001|Overall Study|Protocol Violation|0|||
33482070|NCT03485365|101655487|FG002|Overall Study|Protocol Violation|0|||
33482071|NCT03485365|101655488|FG003|Overall Study|Protocol Violation|1|||
33482072|NCT03485365|101655489|FG004|Overall Study|Protocol Violation|0|||
33482073|NCT03485365|101655490|FG005|Overall Study|Protocol Violation|0|||
33482074|NCT03485365|101655491|FG006|Overall Study|Protocol Violation|1|||
33482075|NCT03485365|101655492|FG007|Overall Study|Protocol Violation|0|||
33482076|NCT03485365|101655493|FG008|Overall Study|Protocol Violation|0|||
33482077|NCT02927366|101655496|FG000|Overall Study|Adverse Event|1|||
33482078|NCT02927366|101655497|FG001|Overall Study|Adverse Event|0|||
33482079|NCT02927366|101655496|FG000|Overall Study|Patient schedule|1|||
33482080|NCT02927366|101655497|FG001|Overall Study|Patient schedule|0|||
33482081|NCT00576316|101655499|FG000|Overall Study|Adverse Event|9|||
33482082|NCT00576316|101655499|FG000|Overall Study|Withdrawal by Subject|2|||
33482083|NCT00576316|101655499|FG000|Overall Study|Protocol Violation|9|||
33482084|NCT05199090|101655500|FG000|Overall Study|Adverse Event|1|||
33482085|NCT05199090|101655501|FG001|Overall Study|Adverse Event|4|||
33482086|NCT05199090|101655502|FG002|Overall Study|Adverse Event|0|||
33482087|NCT05199090|101655503|FG003|Overall Study|Adverse Event|0|||
33482088|NCT05199090|101655504|FG004|Overall Study|Adverse Event|0|||
33482089|NCT05199090|101655505|FG005|Overall Study|Adverse Event|0|||
33482090|NCT05199090|101655500|FG000|Overall Study|Lost to Follow-up|1|||
33482091|NCT05199090|101655501|FG001|Overall Study|Lost to Follow-up|0|||
33482092|NCT05199090|101655502|FG002|Overall Study|Lost to Follow-up|1|||
33482093|NCT05199090|101655503|FG003|Overall Study|Lost to Follow-up|4|||
33482094|NCT05199090|101655504|FG004|Overall Study|Lost to Follow-up|0|||
33482095|NCT05199090|101655505|FG005|Overall Study|Lost to Follow-up|5|||
33482096|NCT05199090|101655500|FG000|Overall Study|Physician Decision|0|||
33482097|NCT05199090|101655501|FG001|Overall Study|Physician Decision|0|||
33482098|NCT05199090|101655502|FG002|Overall Study|Physician Decision|0|||
33482099|NCT05199090|101655503|FG003|Overall Study|Physician Decision|0|||
33482100|NCT05199090|101655504|FG004|Overall Study|Physician Decision|0|||
33482101|NCT05199090|101655505|FG005|Overall Study|Physician Decision|1|||
33482102|NCT05199090|101655500|FG000|Overall Study|Study terminated by sponsor|0|||
33482103|NCT05199090|101655501|FG001|Overall Study|Study terminated by sponsor|6|||
33482104|NCT05199090|101655502|FG002|Overall Study|Study terminated by sponsor|0|||
33482105|NCT05199090|101655503|FG003|Overall Study|Study terminated by sponsor|0|||
33482106|NCT05199090|101655504|FG004|Overall Study|Study terminated by sponsor|0|||
33482107|NCT05199090|101655505|FG005|Overall Study|Study terminated by sponsor|5|||
33482108|NCT05199090|101655500|FG000|Overall Study|Subject decision|0|||
33482109|NCT05199090|101655501|FG001|Overall Study|Subject decision|4|||
33482110|NCT05199090|101655502|FG002|Overall Study|Subject decision|0|||
33482111|NCT05199090|101655503|FG003|Overall Study|Subject decision|2|||
33482112|NCT05199090|101655504|FG004|Overall Study|Subject decision|5|||
33482113|NCT05199090|101655505|FG005|Overall Study|Subject decision|2|||
33482114|NCT03047330|101657898|FG000|Sleep Block 1|Withdrawal by Subject|3|||
33482115|NCT02111603|101657904|FG000|Overall Study|Withdrawal by Subject|1|||
33482116|NCT04480021|101657905|FG000|Overall Study|Lost to Follow-up|3|||
33482117|NCT04480021|101657906|FG001|Overall Study|Lost to Follow-up|4|||
33482118|NCT01544179|101657907|FG000|Overall Study|Death|50|||
33482119|NCT01544179|101657908|FG001|Overall Study|Death|37|||
33482120|NCT01544179|101657907|FG000|Overall Study|Lost to Follow-up|0|||
33482121|NCT01544179|101657908|FG001|Overall Study|Lost to Follow-up|1|||
33482122|NCT01544179|101657907|FG000|Overall Study|Adverse Event|0|||
33482123|NCT01544179|101657908|FG001|Overall Study|Adverse Event|1|||
33482124|NCT01544179|101657907|FG000|Overall Study|Withdrawal by Subject|12|||
33482125|NCT01544179|101657908|FG001|Overall Study|Withdrawal by Subject|7|||
33482126|NCT01544179|101657907|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
33482127|NCT01544179|101657908|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
33482128|NCT01860677|101657909|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
33482129|NCT01860677|101657910|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
33482130|NCT00205803|101657915|FG000|Infant Series|Lost to Follow-up|10|||
33482131|NCT00205803|101657916|FG001|Infant Series|Lost to Follow-up|4|||
33482132|NCT00205803|101657915|FG000|Infant Series|Withdrawal by Subject|2|||
33482133|NCT00205803|101657916|FG001|Infant Series|Withdrawal by Subject|5|||
33482134|NCT00205803|101657915|FG000|Infant Series|Physician Decision|3|||
33482135|NCT00205803|101657916|FG001|Infant Series|Physician Decision|1|||
33482136|NCT00205803|101657915|FG000|Infant Series|Protocol Violation|1|||
33482137|NCT00205803|101657916|FG001|Infant Series|Protocol Violation|0|||
33482138|NCT00205803|101657915|FG000|Infant Series|Lost Kaiser coverage|0|||
33482139|NCT00205803|101657916|FG001|Infant Series|Lost Kaiser coverage|1|||
33482140|NCT00205803|101657915|FG000|Infant Series|Non-compliant|1|||
33482141|NCT00205803|101657916|FG001|Infant Series|Non-compliant|0|||
33482142|NCT00205803|101657915|FG000|Infant Series|Sponsor request|1|||
33482143|NCT00205803|101657916|FG001|Infant Series|Sponsor request|0|||
33482144|NCT00205803|101657915|FG000|After Infant Series|Adverse Event|1|||
33482145|NCT00205803|101657916|FG001|After Infant Series|Adverse Event|1|||
33482146|NCT00205803|101657915|FG000|After Infant Series|Protocol Violation|1|||
33482147|NCT00205803|101657916|FG001|After Infant Series|Protocol Violation|1|||
33482148|NCT00205803|101657915|FG000|After Infant Series|Lost to Follow-up|2|||
33482149|NCT00205803|101657916|FG001|After Infant Series|Lost to Follow-up|1|||
33482150|NCT00205803|101657915|FG000|After Infant Series|Physician Decision|3|||
33482151|NCT00205803|101657916|FG001|After Infant Series|Physician Decision|2|||
33482152|NCT00205803|101657915|FG000|After Infant Series|Withdrawal by Subject|1|||
33482153|NCT00205803|101657916|FG001|After Infant Series|Withdrawal by Subject|4|||
33482154|NCT00205803|101657915|FG000|After Infant Series|Other|10|||
33482155|NCT00205803|101657916|FG001|After Infant Series|Other|4|||
33482156|NCT00205803|101657915|FG000|Toddler Dose|Lost to Follow-up|2|||
33482157|NCT00205803|101657916|FG001|Toddler Dose|Lost to Follow-up|3|||
33482158|NCT02473523|101657920|FG000|Overall Study|Death|1|||
33482159|NCT02473523|101657920|FG000|Overall Study|Lost to Follow-up|1|||
33482160|NCT00908310|101657922|FG000|Overall Study|Death|37|||
33482161|NCT00908310|101657922|FG000|Overall Study|Withdrawal by Subject|7|||
33482162|NCT00908310|101657922|FG000|Overall Study|Lost to Follow-up|7|||
33482163|NCT00908310|101657922|FG000|Overall Study|Screening failure|5|||
33482164|NCT00908310|101657922|FG000|Overall Study|Other reasons|4|||
33482165|NCT04138823|101657926|FG000|Overall Study|Clinical disease progression|0|||
33482166|NCT04138823|101657927|FG001|Overall Study|Clinical disease progression|0|||
33482167|NCT04138823|101657928|FG002|Overall Study|Clinical disease progression|1|||
33482168|NCT04138823|101657926|FG000|Overall Study|Objective disease progression|3|||
33482169|NCT04138823|101657927|FG001|Overall Study|Objective disease progression|2|||
33482170|NCT04138823|101657928|FG002|Overall Study|Objective disease progression|5|||
33482171|NCT02787408|101657931|FG000|Overall Study|Death|16|||
33482172|NCT02787408|101657931|FG000|Overall Study|Withdrawal by Subject|1|||
33482173|NCT02787408|101657931|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
33482174|NCT04711902|101657932|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
33482175|NCT04711902|101657933|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
33482176|NCT04711902|101657934|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
33482177|NCT04711902|101657935|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
33482178|NCT04711902|101657936|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
33482179|NCT04711902|101657937|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
33482180|NCT00195338|101657941|FG000|Overall Study|Lost to Follow-up|2|||
33482181|NCT00195338|101657941|FG000|Overall Study|Adverse Event|5|||
33482182|NCT00195338|101657941|FG000|Overall Study|Lack of Efficacy|1|||
33482183|NCT00195338|101657941|FG000|Overall Study|Early closure of the site|4|||
33482184|NCT00168818|101657942|FG000|Overall Study|Adverse Event|23|||
33482185|NCT00168818|101657943|FG001|Overall Study|Adverse Event|29|||
33482186|NCT00168818|101657944|FG002|Overall Study|Adverse Event|31|||
33482187|NCT00168818|101657942|FG000|Overall Study|Protocol Violation|16|||
33482188|NCT00168818|101657943|FG001|Overall Study|Protocol Violation|11|||
33482189|NCT00168818|101657944|FG002|Overall Study|Protocol Violation|11|||
33482190|NCT00168818|101657942|FG000|Overall Study|Lost to Follow-up|13|||
33482191|NCT00168818|101657943|FG001|Overall Study|Lost to Follow-up|4|||
33482192|NCT00168818|101657944|FG002|Overall Study|Lost to Follow-up|15|||
33482193|NCT00168818|101657942|FG000|Overall Study|Withdrawal by Subject|43|||
33482194|NCT00168818|101657943|FG001|Overall Study|Withdrawal by Subject|41|||
33482195|NCT00168818|101657944|FG002|Overall Study|Withdrawal by Subject|37|||
33482196|NCT00168818|101657942|FG000|Overall Study|Other|22|||
33274076|NCT03622580|100902867|FG002|Overall Study|Physician Decision|1|||
33274077|NCT03622580|100902865|FG000|Overall Study|Pregnancy|0|||
33482197|NCT00168818|101657943|FG001|Overall Study|Other|24|||
33482198|NCT00168818|101657944|FG002|Overall Study|Other|30|||
33482199|NCT00168818|101657942|FG000|Treatment|Adverse Event|77|||
33482200|NCT00168818|101657943|FG001|Treatment|Adverse Event|89|||
33482201|NCT00168818|101657944|FG002|Treatment|Adverse Event|68|||
33482202|NCT00168818|101657942|FG000|Treatment|Protocol Violation|8|||
33482203|NCT00168818|101657943|FG001|Treatment|Protocol Violation|11|||
33482204|NCT00168818|101657944|FG002|Treatment|Protocol Violation|11|||
33482205|NCT00168818|101657942|FG000|Treatment|Lost to Follow-up|0|||
33482206|NCT00168818|101657943|FG001|Treatment|Lost to Follow-up|2|||
33482207|NCT00168818|101657944|FG002|Treatment|Lost to Follow-up|1|||
33482208|NCT00168818|101657942|FG000|Treatment|Withdrawal by Subject|25|||
33482209|NCT00168818|101657943|FG001|Treatment|Withdrawal by Subject|20|||
33482210|NCT00168818|101657944|FG002|Treatment|Withdrawal by Subject|22|||
33482211|NCT00168818|101657942|FG000|Treatment|Other|23|||
33482212|NCT00168818|101657943|FG001|Treatment|Other|29|||
33482213|NCT00168818|101657944|FG002|Treatment|Other|31|||
33482214|NCT01059344|101657945|FG000|Overall Study|Adverse Event|12|||
33482215|NCT01059344|101657946|FG001|Overall Study|Adverse Event|30|||
33482216|NCT01059344|101657945|FG000|Overall Study|Withdrawal by Subject|6|||
33482217|NCT01059344|101657946|FG001|Overall Study|Withdrawal by Subject|9|||
33482218|NCT01059344|101657945|FG000|Overall Study|Lost to Follow-up|1|||
33482219|NCT01059344|101657946|FG001|Overall Study|Lost to Follow-up|1|||
33482220|NCT01059344|101657945|FG000|Overall Study|Other|3|||
33482221|NCT01059344|101657946|FG001|Overall Study|Other|6|||
33482222|NCT01085201|101657947|FG000|Overall Study|Scheduling conflict|1|||
33482223|NCT01085201|101657948|FG001|Overall Study|Scheduling conflict|0|||
33482224|NCT01085201|101657949|FG002|Overall Study|Scheduling conflict|1|||
33482225|NCT01085201|101657950|FG003|Overall Study|Scheduling conflict|0|||
33482226|NCT01085201|101657951|FG004|Overall Study|Scheduling conflict|0|||
33482227|NCT01085201|101657947|FG000|Overall Study|Unknown- no study drug|2|||
33482228|NCT01085201|101657948|FG001|Overall Study|Unknown- no study drug|0|||
33482229|NCT01085201|101657949|FG002|Overall Study|Unknown- no study drug|0|||
33482230|NCT01085201|101657950|FG003|Overall Study|Unknown- no study drug|0|||
33482231|NCT01085201|101657951|FG004|Overall Study|Unknown- no study drug|0|||
33482232|NCT01085201|101657947|FG000|Overall Study|Fond ineligible after consent|0|||
33482233|NCT01085201|101657948|FG001|Overall Study|Fond ineligible after consent|1|||
33482234|NCT01085201|101657949|FG002|Overall Study|Fond ineligible after consent|1|||
33482235|NCT01085201|101657950|FG003|Overall Study|Fond ineligible after consent|0|||
33482236|NCT01085201|101657951|FG004|Overall Study|Fond ineligible after consent|0|||
33482237|NCT02954991|101657953|FG000|Overall Study|Death|92|||
33482238|NCT02954991|101657954|FG001|Overall Study|Death|11|||
33482239|NCT02954991|101657955|FG002|Overall Study|Death|2|||
33482240|NCT02954991|101657953|FG000|Overall Study|Lost to Follow-up|3|||
33482241|NCT02954991|101657954|FG001|Overall Study|Lost to Follow-up|2|||
33482242|NCT02954991|101657955|FG002|Overall Study|Lost to Follow-up|0|||
33482243|NCT02954991|101657953|FG000|Overall Study|Withdrawal by Subject|9|||
33482244|NCT02954991|101657954|FG001|Overall Study|Withdrawal by Subject|8|||
33482245|NCT02954991|101657955|FG002|Overall Study|Withdrawal by Subject|1|||
33482246|NCT02954991|101657953|FG000|Overall Study|Study Terminated by Sponsor|18|||
33482247|NCT02954991|101657954|FG001|Overall Study|Study Terminated by Sponsor|10|||
33482248|NCT02954991|101657955|FG002|Overall Study|Study Terminated by Sponsor|1|||
33482249|NCT02954991|101657953|FG000|Overall Study|Miscellaneous|2|||
33482250|NCT02954991|101657954|FG001|Overall Study|Miscellaneous|1|||
33482251|NCT02954991|101657955|FG002|Overall Study|Miscellaneous|1|||
33482252|NCT05005312|101657957|FG000|Overall Study|Enrolled, but not treated|0|||
33482253|NCT05005312|101657958|FG001|Overall Study|Enrolled, but not treated|1|||
33482254|NCT02933255|101657970|FG000|Overall Study|Discontinued due to study closure.|1|||
33482255|NCT02933255|101657971|FG001|Overall Study|Discontinued due to study closure.|0|||
33482256|NCT02542605|101657972|FG000|Part B: Challenge Phase|Sponsor decision|1|||
33482257|NCT02542605|101657973|FG001|Part B: Challenge Phase|Sponsor decision|0|||
33482258|NCT02542605|101657974|FG002|Part B: Challenge Phase|Sponsor decision|0|||
33482259|NCT02542605|101657972|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
33482260|NCT02542605|101657973|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
33482261|NCT02542605|101657974|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
33482262|NCT01145508|101657976|FG000|Overall Study|Adverse Event|1|||
33482263|NCT01145508|101657977|FG001|Overall Study|Adverse Event|0|||
33482264|NCT01145508|101657976|FG000|Overall Study|Death|1|||
33482265|NCT01145508|101657977|FG001|Overall Study|Death|0|||
33482266|NCT01145508|101657976|FG000|Overall Study|Physician Decision|2|||
33482267|NCT01145508|101657977|FG001|Overall Study|Physician Decision|1|||
33482268|NCT01145508|101657976|FG000|Overall Study|Never started treatment|1|||
33482269|NCT01145508|101657977|FG001|Overall Study|Never started treatment|1|||
33482270|NCT00952731|101657978|FG000|Overall Study|Drug supply expired|1|||
33274078|NCT03622580|100902866|FG001|Overall Study|Pregnancy|1|||
33274079|NCT03622580|100902867|FG002|Overall Study|Pregnancy|0|||
33274080|NCT03622580|100902865|FG000|Overall Study|Lack of Efficacy|0|||
33482271|NCT00952731|101657979|FG001|Overall Study|Drug supply expired|0|||
33482272|NCT01893346|101657982|FG000|Overall Study|Lost to Follow-up|0|||
33482273|NCT01893346|101657983|FG001|Overall Study|Lost to Follow-up|1|||
33482274|NCT01893346|101657984|FG002|Overall Study|Lost to Follow-up|0|||
33482275|NCT01893346|101657985|FG003|Overall Study|Lost to Follow-up|0|||
33482276|NCT01893346|101657982|FG000|Overall Study|Protocol Violation|1|||
33482277|NCT01893346|101657983|FG001|Overall Study|Protocol Violation|0|||
33482278|NCT01893346|101657984|FG002|Overall Study|Protocol Violation|0|||
33482279|NCT01893346|101657985|FG003|Overall Study|Protocol Violation|0|||
33482280|NCT01893346|101657982|FG000|Overall Study|Withdrawal by Subject|2|||
33482281|NCT01893346|101657983|FG001|Overall Study|Withdrawal by Subject|0|||
33482282|NCT01893346|101657984|FG002|Overall Study|Withdrawal by Subject|0|||
33482283|NCT01893346|101657985|FG003|Overall Study|Withdrawal by Subject|0|||
33482284|NCT03954834|101657986|FG000|Overall Study|Adverse Event|1|||
33482285|NCT03954834|101657987|FG001|Overall Study|Adverse Event|3|||
33482286|NCT03954834|101657988|FG002|Overall Study|Adverse Event|1|||
33482287|NCT03954834|101657989|FG003|Overall Study|Adverse Event|1|||
33482288|NCT03954834|101657986|FG000|Overall Study|Death|0|||
33482289|NCT03954834|101657987|FG001|Overall Study|Death|0|||
33482290|NCT03954834|101657988|FG002|Overall Study|Death|0|||
33482291|NCT03954834|101657989|FG003|Overall Study|Death|1|||
33482292|NCT03954834|101657986|FG000|Overall Study|Physician Decision|0|||
33482293|NCT03954834|101657987|FG001|Overall Study|Physician Decision|1|||
33482294|NCT03954834|101657988|FG002|Overall Study|Physician Decision|0|||
33482295|NCT03954834|101657989|FG003|Overall Study|Physician Decision|2|||
33482296|NCT03954834|101657986|FG000|Overall Study|Protocol Violation|1|||
33482297|NCT03954834|101657987|FG001|Overall Study|Protocol Violation|0|||
33482298|NCT03954834|101657988|FG002|Overall Study|Protocol Violation|0|||
33482299|NCT03954834|101657989|FG003|Overall Study|Protocol Violation|1|||
33482300|NCT03954834|101657986|FG000|Overall Study|Withdrawal by Subject|2|||
33482301|NCT03954834|101657987|FG001|Overall Study|Withdrawal by Subject|3|||
33482302|NCT03954834|101657988|FG002|Overall Study|Withdrawal by Subject|13|||
33482303|NCT03954834|101657989|FG003|Overall Study|Withdrawal by Subject|6|||
33482304|NCT03954834|101657986|FG000|Overall Study|Participant left the country|0|||
33482305|NCT03954834|101657987|FG001|Overall Study|Participant left the country|0|||
33482306|NCT03954834|101657988|FG002|Overall Study|Participant left the country|1|||
33482307|NCT03954834|101657989|FG003|Overall Study|Participant left the country|0|||
33482308|NCT03954834|101657986|FG000|Overall Study|Lost to Follow-up|3|||
33482309|NCT03954834|101657987|FG001|Overall Study|Lost to Follow-up|2|||
33482310|NCT03954834|101657988|FG002|Overall Study|Lost to Follow-up|3|||
33482311|NCT03954834|101657989|FG003|Overall Study|Lost to Follow-up|5|||
33482312|NCT01307111|101657990|FG000|IUD Insertion|Lost to Follow-up|2|||
33482313|NCT01307111|101657991|FG001|IUD Insertion|Lost to Follow-up|0|||
33482314|NCT01307111|101657990|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
33482315|NCT01307111|101657991|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
33482316|NCT04480710|101657992|FG000|Overall Study|Adverse Event|0|||
33482317|NCT04480710|101657993|FG001|Overall Study|Adverse Event|2|||
33482318|NCT04480710|101657994|FG002|Overall Study|Adverse Event|0|||
33482319|NCT04480710|101657995|FG003|Overall Study|Adverse Event|0|||
33482320|NCT04480710|101657992|FG000|Overall Study|Withdrawal by Subject|0|||
33482321|NCT04480710|101657993|FG001|Overall Study|Withdrawal by Subject|1|||
33482322|NCT04480710|101657994|FG002|Overall Study|Withdrawal by Subject|0|||
33482323|NCT04480710|101657995|FG003|Overall Study|Withdrawal by Subject|0|||
33482324|NCT04480710|101657992|FG000|Overall Study|Physician Decision|0|||
33482325|NCT04480710|101657993|FG001|Overall Study|Physician Decision|0|||
33482326|NCT04480710|101657994|FG002|Overall Study|Physician Decision|1|||
33482327|NCT04480710|101657995|FG003|Overall Study|Physician Decision|0|||
33482328|NCT04628793|101657998|FG000|Overall Study|Study terminated by sponsor|0|||
33482329|NCT04628793|101657999|FG001|Overall Study|Study terminated by sponsor|0|||
33482330|NCT04628793|101658000|FG002|Overall Study|Study terminated by sponsor|8|||
33482331|NCT04628793|101657998|FG000|Overall Study|Withdrawal by Subject|2|||
33482332|NCT04628793|101657999|FG001|Overall Study|Withdrawal by Subject|3|||
33482333|NCT04628793|101658000|FG002|Overall Study|Withdrawal by Subject|0|||
33482334|NCT04628793|101657998|FG000|Overall Study|Lost to Follow-up|0|||
33482335|NCT04628793|101657999|FG001|Overall Study|Lost to Follow-up|1|||
33482336|NCT04628793|101658000|FG002|Overall Study|Lost to Follow-up|0|||
33482337|NCT02121392|101658006|FG000|Prior to Intervention|Protocol Violation|40|||
33482338|NCT02121392|101658007|FG001|Prior to Intervention|Protocol Violation|35|||
33482339|NCT02121392|101658006|FG000|Prior to Intervention|Withdrawal by Subject|8|||
33482340|NCT02121392|101658007|FG001|Prior to Intervention|Withdrawal by Subject|6|||
33482341|NCT02121392|101658006|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
33482342|NCT02121392|101658007|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
33274081|NCT03622580|100902866|FG001|Overall Study|Lack of Efficacy|0|||
33274082|NCT03622580|100902867|FG002|Overall Study|Lack of Efficacy|1|||
33274083|NCT03622580|100902865|FG000|Overall Study|Other|2|||
33274084|NCT03622580|100902866|FG001|Overall Study|Other|0|||
33482343|NCT02121392|101658006|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
33482344|NCT02121392|101658007|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
33482345|NCT01398514|101658008|FG000|Overall Study|Adverse Event|1|||
33482346|NCT01398514|101658009|FG001|Overall Study|Adverse Event|0|||
33482347|NCT01398514|101658008|FG000|Overall Study|Non-compliance with study procedures|2|||
33482348|NCT01398514|101658009|FG001|Overall Study|Non-compliance with study procedures|0|||
33482349|NCT01398514|101658008|FG000|Overall Study|Physiologic non-responsiveness|1|||
33482350|NCT01398514|101658009|FG001|Overall Study|Physiologic non-responsiveness|3|||
33482351|NCT01398514|101658008|FG000|Overall Study|Failure to show a conditioned response|4|||
33482352|NCT01398514|101658009|FG001|Overall Study|Failure to show a conditioned response|3|||
33482353|NCT04746794|101658010|FG000|Overall Study|Did not complete any study assessment|50303|||
33482354|NCT04746794|101658011|FG001|Overall Study|Did not complete any study assessment|44997|||
33274085|NCT03622580|100902867|FG002|Overall Study|Other|3|||
33482355|NCT00338728|101658012|FG000|Overall Study|Screen Failure|14|||
33482356|NCT04400682|101658014|FG000|Period 1|Withdrawal by Subject|1|||
33482357|NCT04400682|101658015|FG001|Period 1|Withdrawal by Subject|4|||
33482358|NCT01755767|101658016|FG000|Overall Study|Progressive Disease|8|||
33482359|NCT01755767|101658017|FG001|Overall Study|Progressive Disease|7|||
33482360|NCT01755767|101658018|FG002|Overall Study|Progressive Disease|91|||
33482361|NCT01755767|101658019|FG003|Overall Study|Progressive Disease|43|||
33482362|NCT01755767|101658016|FG000|Overall Study|Clinical Disease Progression|4|||
33482363|NCT01755767|101658017|FG001|Overall Study|Clinical Disease Progression|2|||
33482364|NCT01755767|101658018|FG002|Overall Study|Clinical Disease Progression|29|||
33482365|NCT01755767|101658019|FG003|Overall Study|Clinical Disease Progression|20|||
33482366|NCT01755767|101658016|FG000|Overall Study|Radiographic Disease Progression|9|||
33482367|NCT01755767|101658017|FG001|Overall Study|Radiographic Disease Progression|4|||
33482368|NCT01755767|101658018|FG002|Overall Study|Radiographic Disease Progression|44|||
33482369|NCT01755767|101658019|FG003|Overall Study|Radiographic Disease Progression|27|||
33482370|NCT01755767|101658016|FG000|Overall Study|Adverse Event|6|||
33482371|NCT01755767|101658017|FG001|Overall Study|Adverse Event|0|||
33482372|NCT01755767|101658018|FG002|Overall Study|Adverse Event|28|||
33482373|NCT01755767|101658019|FG003|Overall Study|Adverse Event|11|||
33482374|NCT01755767|101658016|FG000|Overall Study|Death|1|||
33482375|NCT01755767|101658017|FG001|Overall Study|Death|2|||
33482376|NCT01755767|101658018|FG002|Overall Study|Death|15|||
33482377|NCT01755767|101658019|FG003|Overall Study|Death|4|||
33482378|NCT01755767|101658016|FG000|Overall Study|Subject Decision|0|||
33482379|NCT01755767|101658017|FG001|Overall Study|Subject Decision|0|||
33482380|NCT01755767|101658018|FG002|Overall Study|Subject Decision|10|||
33482381|NCT01755767|101658019|FG003|Overall Study|Subject Decision|3|||
33482382|NCT01755767|101658016|FG000|Overall Study|Withdrawal by Subject|0|||
33482383|NCT01755767|101658017|FG001|Overall Study|Withdrawal by Subject|0|||
33482384|NCT01755767|101658018|FG002|Overall Study|Withdrawal by Subject|2|||
33482385|NCT01755767|101658019|FG003|Overall Study|Withdrawal by Subject|1|||
33482386|NCT01755767|101658016|FG000|Overall Study|Other|0|||
33482387|NCT01755767|101658017|FG001|Overall Study|Other|0|||
33482388|NCT01755767|101658018|FG002|Overall Study|Other|2|||
33482389|NCT01755767|101658019|FG003|Overall Study|Other|3|||
33482390|NCT01755767|101658016|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
33482391|NCT01755767|101658017|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
33482392|NCT01755767|101658018|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
33482393|NCT01755767|101658019|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
33482394|NCT03058289|101658020|FG000|Overall Study|Radiographic Deterioration|0|||
33482395|NCT03058289|101658021|FG001|Overall Study|Radiographic Deterioration|3|||
33274086|NCT02105688|100902869|FG000|Part A: Double-Blind|Adverse Event|1|||
33274087|NCT02105688|100902870|FG001|Part A: Double-Blind|Adverse Event|0|||
33274088|NCT02105688|100902869|FG000|Part A: Double-Blind|Death|0|||
33274089|NCT02105688|100902870|FG001|Part A: Double-Blind|Death|1|||
33274090|NCT02105688|100902869|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
33274091|NCT02105688|100902870|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
33274092|NCT02105688|100902869|FG000|Part A: Double-Blind|Physician Decision|0|||
33274093|NCT02105688|100902870|FG001|Part A: Double-Blind|Physician Decision|1|||
33274094|NCT02105688|100902869|FG000|Part A: Double-Blind|Status Unknown|0|||
33274095|NCT02105688|100902870|FG001|Part A: Double-Blind|Status Unknown|2|||
33274096|NCT02105688|100902869|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
33274097|NCT02105688|100902870|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
33274098|NCT02105688|100902869|FG000|Part B: Observational Follow-up|Death|2|||
33274099|NCT02105688|100902870|FG001|Part B: Observational Follow-up|Death|1|||
33274100|NCT02105688|100902869|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
33274101|NCT02105688|100902870|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
33274102|NCT02105688|100902869|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
33274103|NCT02105688|100902870|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
33274104|NCT02105688|100902869|FG000|Part B: Observational Follow-up|Physician Decision|3|||
33274105|NCT02105688|100902870|FG001|Part B: Observational Follow-up|Physician Decision|1|||
33274106|NCT00409006|100902872|FG000|Overall Study|Death|15|||
33274107|NCT00409006|100902873|FG001|Overall Study|Death|6|||
33274108|NCT00409006|100902872|FG000|Overall Study|Lost to Follow-up|1|||
33274109|NCT00409006|100902873|FG001|Overall Study|Lost to Follow-up|2|||
33274110|NCT00409006|100902872|FG000|Overall Study|Withdrawal by Subject|3|||
33274111|NCT00409006|100902873|FG001|Overall Study|Withdrawal by Subject|2|||
33274112|NCT00409006|100902872|FG000|Overall Study|Physician Decision|1|||
33274113|NCT00409006|100902873|FG001|Overall Study|Physician Decision|2|||
33482396|NCT03058289|101658022|FG002|Overall Study|Radiographic Deterioration|1|||
33482397|NCT03058289|101658023|FG003|Overall Study|Radiographic Deterioration|2|||
33482398|NCT03058289|101658024|FG004|Overall Study|Radiographic Deterioration|6|||
33482399|NCT03058289|101658025|FG005|Overall Study|Radiographic Deterioration|3|||
33274114|NCT02865083|100902880|FG000|Overall Study|Early Termination|3|||
33274115|NCT02865083|100902881|FG001|Overall Study|Early Termination|1|||
33482400|NCT03058289|101658026|FG006|Overall Study|Radiographic Deterioration|0|||
33482401|NCT03058289|101658027|FG007|Overall Study|Radiographic Deterioration|4|||
33482402|NCT03058289|101658028|FG008|Overall Study|Radiographic Deterioration|2|||
33482403|NCT03058289|101658020|FG000|Overall Study|Adverse Event|2|||
33482404|NCT03058289|101658021|FG001|Overall Study|Adverse Event|0|||
33482405|NCT03058289|101658022|FG002|Overall Study|Adverse Event|1|||
33482406|NCT03058289|101658023|FG003|Overall Study|Adverse Event|3|||
33482407|NCT03058289|101658024|FG004|Overall Study|Adverse Event|1|||
33482408|NCT03058289|101658025|FG005|Overall Study|Adverse Event|0|||
33482409|NCT03058289|101658026|FG006|Overall Study|Adverse Event|1|||
33482410|NCT03058289|101658027|FG007|Overall Study|Adverse Event|3|||
33482411|NCT03058289|101658028|FG008|Overall Study|Adverse Event|0|||
33482412|NCT03058289|101658020|FG000|Overall Study|Withdrawal by Subject|0|||
33482413|NCT03058289|101658021|FG001|Overall Study|Withdrawal by Subject|0|||
33482414|NCT03058289|101658022|FG002|Overall Study|Withdrawal by Subject|0|||
33482415|NCT03058289|101658023|FG003|Overall Study|Withdrawal by Subject|2|||
33482416|NCT03058289|101658024|FG004|Overall Study|Withdrawal by Subject|0|||
33482417|NCT03058289|101658025|FG005|Overall Study|Withdrawal by Subject|2|||
33482418|NCT03058289|101658026|FG006|Overall Study|Withdrawal by Subject|0|||
33482419|NCT03058289|101658027|FG007|Overall Study|Withdrawal by Subject|4|||
33482420|NCT03058289|101658028|FG008|Overall Study|Withdrawal by Subject|1|||
33482421|NCT03058289|101658020|FG000|Overall Study|Physician Decision|1|||
33482422|NCT03058289|101658021|FG001|Overall Study|Physician Decision|0|||
33482423|NCT03058289|101658022|FG002|Overall Study|Physician Decision|0|||
33482424|NCT03058289|101658023|FG003|Overall Study|Physician Decision|2|||
33482425|NCT03058289|101658024|FG004|Overall Study|Physician Decision|1|||
33482426|NCT03058289|101658025|FG005|Overall Study|Physician Decision|0|||
33482427|NCT03058289|101658026|FG006|Overall Study|Physician Decision|2|||
33482428|NCT03058289|101658027|FG007|Overall Study|Physician Decision|3|||
33482429|NCT03058289|101658028|FG008|Overall Study|Physician Decision|0|||
33482430|NCT03058289|101658020|FG000|Overall Study|Clinical Deterioration|2|||
33482431|NCT03058289|101658021|FG001|Overall Study|Clinical Deterioration|0|||
33482432|NCT03058289|101658022|FG002|Overall Study|Clinical Deterioration|0|||
33482433|NCT03058289|101658023|FG003|Overall Study|Clinical Deterioration|2|||
33482434|NCT03058289|101658024|FG004|Overall Study|Clinical Deterioration|1|||
33482435|NCT03058289|101658025|FG005|Overall Study|Clinical Deterioration|1|||
33482436|NCT03058289|101658026|FG006|Overall Study|Clinical Deterioration|0|||
33482437|NCT03058289|101658027|FG007|Overall Study|Clinical Deterioration|3|||
33482438|NCT03058289|101658028|FG008|Overall Study|Clinical Deterioration|2|||
33482439|NCT03058289|101658020|FG000|Overall Study|Lost to Follow-up|0|||
33482440|NCT03058289|101658021|FG001|Overall Study|Lost to Follow-up|0|||
33482441|NCT03058289|101658022|FG002|Overall Study|Lost to Follow-up|0|||
33482442|NCT03058289|101658023|FG003|Overall Study|Lost to Follow-up|0|||
33482443|NCT03058289|101658024|FG004|Overall Study|Lost to Follow-up|1|||
33482444|NCT03058289|101658025|FG005|Overall Study|Lost to Follow-up|0|||
33482445|NCT03058289|101658026|FG006|Overall Study|Lost to Follow-up|0|||
33482446|NCT03058289|101658027|FG007|Overall Study|Lost to Follow-up|0|||
33482447|NCT03058289|101658028|FG008|Overall Study|Lost to Follow-up|0|||
33482448|NCT03058289|101658020|FG000|Overall Study|Refused Further Treatment|0|||
33482449|NCT03058289|101658021|FG001|Overall Study|Refused Further Treatment|0|||
33482450|NCT03058289|101658022|FG002|Overall Study|Refused Further Treatment|1|||
33482451|NCT03058289|101658023|FG003|Overall Study|Refused Further Treatment|0|||
33482452|NCT03058289|101658024|FG004|Overall Study|Refused Further Treatment|1|||
33482453|NCT03058289|101658025|FG005|Overall Study|Refused Further Treatment|0|||
33482454|NCT03058289|101658026|FG006|Overall Study|Refused Further Treatment|0|||
33482455|NCT03058289|101658027|FG007|Overall Study|Refused Further Treatment|0|||
33482456|NCT03058289|101658028|FG008|Overall Study|Refused Further Treatment|0|||
33482457|NCT03058289|101658020|FG000|Overall Study|Rapid Progression of Disease|0|||
33482458|NCT03058289|101658021|FG001|Overall Study|Rapid Progression of Disease|0|||
33482459|NCT03058289|101658022|FG002|Overall Study|Rapid Progression of Disease|0|||
33482460|NCT03058289|101658023|FG003|Overall Study|Rapid Progression of Disease|1|||
33482461|NCT03058289|101658024|FG004|Overall Study|Rapid Progression of Disease|0|||
33482462|NCT03058289|101658025|FG005|Overall Study|Rapid Progression of Disease|0|||
33482463|NCT03058289|101658026|FG006|Overall Study|Rapid Progression of Disease|0|||
33482464|NCT03058289|101658027|FG007|Overall Study|Rapid Progression of Disease|0|||
33482465|NCT03058289|101658028|FG008|Overall Study|Rapid Progression of Disease|0|||
33482466|NCT01377987|101658029|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
33482467|NCT01377987|101658030|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
33482468|NCT00741286|101658031|FG000|Overall Study|Lost to Follow-up|15|||
33482469|NCT00741286|101658032|FG001|Overall Study|Lost to Follow-up|10|||
33482470|NCT00741286|101658031|FG000|Overall Study|Adverse Event|1|||
33482471|NCT00741286|101658032|FG001|Overall Study|Adverse Event|6|||
33274116|NCT03386344|100902882|FG000|Overall Study|Adverse Event|6|||
33274117|NCT03386344|100902883|FG001|Overall Study|Adverse Event|3|||
33482472|NCT00741286|101658031|FG000|Overall Study|Protocol Violation|3|||
33482473|NCT00741286|101658032|FG001|Overall Study|Protocol Violation|2|||
33482474|NCT00741286|101658031|FG000|Overall Study|Primary Outcome|1|||
33482475|NCT00741286|101658032|FG001|Overall Study|Primary Outcome|1|||
33482476|NCT00660400|101658033|FG000|Overall Study|Lack of insurance approval|1|||
33482477|NCT00660400|101658033|FG000|Overall Study|Suboptimal organ function|1|||
33482478|NCT00660400|101658033|FG000|Overall Study|Intracranial hemorrhage|1|||
33482479|NCT00660400|101658033|FG000|Overall Study|Withdrawal by Subject|1|||
33482480|NCT02383810|101658034|FG000|Overall Study|Physician Decision|1|||
33482481|NCT02383810|101658035|FG001|Overall Study|Physician Decision|1|||
33482482|NCT02383810|101658036|FG002|Overall Study|Physician Decision|0|||
33482483|NCT02383810|101658037|FG003|Overall Study|Physician Decision|0|||
33482484|NCT02383810|101658038|FG004|Overall Study|Physician Decision|0|||
33482485|NCT02383810|101658039|FG005|Overall Study|Physician Decision|0|||
33482486|NCT02383810|101658040|FG006|Overall Study|Physician Decision|0|||
33482487|NCT02383810|101658041|FG007|Overall Study|Physician Decision|0|||
33482488|NCT02383810|101658034|FG000|Overall Study|Withdrawal by Subject|2|||
33482489|NCT02383810|101658035|FG001|Overall Study|Withdrawal by Subject|3|||
33482490|NCT02383810|101658036|FG002|Overall Study|Withdrawal by Subject|3|||
33482491|NCT02383810|101658037|FG003|Overall Study|Withdrawal by Subject|3|||
33482492|NCT02383810|101658038|FG004|Overall Study|Withdrawal by Subject|0|||
33482493|NCT02383810|101658039|FG005|Overall Study|Withdrawal by Subject|0|||
33482494|NCT02383810|101658040|FG006|Overall Study|Withdrawal by Subject|0|||
33482495|NCT02383810|101658041|FG007|Overall Study|Withdrawal by Subject|0|||
33482496|NCT02383810|101658034|FG000|Overall Study|Adverse Event|0|||
33482497|NCT02383810|101658035|FG001|Overall Study|Adverse Event|2|||
33482498|NCT02383810|101658036|FG002|Overall Study|Adverse Event|4|||
33482499|NCT02383810|101658037|FG003|Overall Study|Adverse Event|5|||
33482500|NCT02383810|101658038|FG004|Overall Study|Adverse Event|0|||
33482501|NCT02383810|101658039|FG005|Overall Study|Adverse Event|1|||
33482502|NCT02383810|101658040|FG006|Overall Study|Adverse Event|1|||
33482503|NCT02383810|101658041|FG007|Overall Study|Adverse Event|0|||
33482504|NCT02383810|101658034|FG000|Overall Study|Lost to Follow-up|0|||
33482505|NCT02383810|101658035|FG001|Overall Study|Lost to Follow-up|1|||
33482506|NCT02383810|101658036|FG002|Overall Study|Lost to Follow-up|0|||
33482507|NCT02383810|101658037|FG003|Overall Study|Lost to Follow-up|1|||
33482508|NCT02383810|101658038|FG004|Overall Study|Lost to Follow-up|0|||
33482509|NCT02383810|101658039|FG005|Overall Study|Lost to Follow-up|0|||
33482510|NCT02383810|101658040|FG006|Overall Study|Lost to Follow-up|0|||
33482511|NCT02383810|101658041|FG007|Overall Study|Lost to Follow-up|0|||
33482512|NCT02383810|101658034|FG000|Overall Study|other|0|||
33482513|NCT02383810|101658035|FG001|Overall Study|other|0|||
33482514|NCT02383810|101658036|FG002|Overall Study|other|0|||
33482515|NCT02383810|101658037|FG003|Overall Study|other|2|||
33482516|NCT02383810|101658038|FG004|Overall Study|other|0|||
33482517|NCT02383810|101658039|FG005|Overall Study|other|0|||
33482518|NCT02383810|101658040|FG006|Overall Study|other|0|||
33482519|NCT02383810|101658041|FG007|Overall Study|other|0|||
33482520|NCT02383810|101658034|FG000|Overall Study|subject did not receive study treatment|0|||
33482521|NCT02383810|101658035|FG001|Overall Study|subject did not receive study treatment|1|||
33482522|NCT02383810|101658036|FG002|Overall Study|subject did not receive study treatment|0|||
33482523|NCT02383810|101658037|FG003|Overall Study|subject did not receive study treatment|0|||
33482524|NCT02383810|101658038|FG004|Overall Study|subject did not receive study treatment|0|||
33482525|NCT02383810|101658039|FG005|Overall Study|subject did not receive study treatment|0|||
33482526|NCT02383810|101658040|FG006|Overall Study|subject did not receive study treatment|0|||
33482527|NCT02383810|101658041|FG007|Overall Study|subject did not receive study treatment|0|||
33482528|NCT01449812|101658043|FG000|Overall Study|Migrated/moved from study area|1|||
33482529|NCT01449812|101658044|FG001|Overall Study|Migrated/moved from study area|0|||
33482530|NCT01449812|101658045|FG002|Overall Study|Migrated/moved from study area|0|||
33482531|NCT01449812|101658043|FG000|Overall Study|Withdrawal by Subject|0|||
33482532|NCT01449812|101658044|FG001|Overall Study|Withdrawal by Subject|0|||
33482533|NCT01449812|101658045|FG002|Overall Study|Withdrawal by Subject|1|||
33482534|NCT01449812|101658043|FG000|Overall Study|Lost to Follow-up|1|||
33482535|NCT01449812|101658044|FG001|Overall Study|Lost to Follow-up|0|||
33482536|NCT01449812|101658045|FG002|Overall Study|Lost to Follow-up|0|||
33482537|NCT04562155|101658051|FG000|Overall Study|COVID-19 pandemic|0|||
33482538|NCT04562155|101658052|FG001|Overall Study|COVID-19 pandemic|0|||
33482539|NCT04562155|101658053|FG002|Overall Study|COVID-19 pandemic|0|||
33482540|NCT04562155|101658054|FG003|Overall Study|COVID-19 pandemic|1|||
33482541|NCT04562155|101658051|FG000|Overall Study|Adverse Event|7|||
33482542|NCT04562155|101658052|FG001|Overall Study|Adverse Event|3|||
33482543|NCT04562155|101658053|FG002|Overall Study|Adverse Event|8|||
33482544|NCT04562155|101658054|FG003|Overall Study|Adverse Event|1|||
33482545|NCT04562155|101658051|FG000|Overall Study|Withdrawal by Subject|3|||
33274118|NCT03386344|100902884|FG002|Overall Study|Adverse Event|1|||
33482546|NCT04562155|101658052|FG001|Overall Study|Withdrawal by Subject|6|||
33482547|NCT04562155|101658053|FG002|Overall Study|Withdrawal by Subject|3|||
33274119|NCT03386344|100902882|FG000|Overall Study|Poor Compliance to Protocol|0|||
33286481|NCT03481556|100943980|FG003|Overall Study|Adverse Event|0|||
33482548|NCT04562155|101658054|FG003|Overall Study|Withdrawal by Subject|3|||
33482549|NCT04562155|101658051|FG000|Overall Study|Participant personal reason|1|||
33482550|NCT04562155|101658052|FG001|Overall Study|Participant personal reason|0|||
33482551|NCT04562155|101658053|FG002|Overall Study|Participant personal reason|2|||
33482552|NCT04562155|101658054|FG003|Overall Study|Participant personal reason|1|||
33482553|NCT02359994|101658055|FG000|Overall Population Study|Adverse Event|1|||
33482554|NCT02359994|101658056|FG001|Overall Population Study|Adverse Event|1|||
33482555|NCT02359994|101658055|FG000|Overall Population Study|Death|1|||
33482556|NCT02359994|101658056|FG001|Overall Population Study|Death|5|||
33482557|NCT02359994|101658055|FG000|Overall Population Study|Lost to Follow-up|1|||
33482558|NCT02359994|101658056|FG001|Overall Population Study|Lost to Follow-up|1|||
33274120|NCT03386344|100902883|FG001|Overall Study|Poor Compliance to Protocol|1|||
33274121|NCT03386344|100902884|FG002|Overall Study|Poor Compliance to Protocol|0|||
33274122|NCT03386344|100902882|FG000|Overall Study|Study Terminated by Sponsor|101|||
33274123|NCT03386344|100902883|FG001|Overall Study|Study Terminated by Sponsor|102|||
33274124|NCT03386344|100902884|FG002|Overall Study|Study Terminated by Sponsor|106|||
33274125|NCT03386344|100902882|FG000|Overall Study|Lost to Follow-up|3|||
33274126|NCT03386344|100902883|FG001|Overall Study|Lost to Follow-up|2|||
33274127|NCT03386344|100902884|FG002|Overall Study|Lost to Follow-up|1|||
33274128|NCT03386344|100902882|FG000|Overall Study|At the Participant's own Request|7|||
33274129|NCT03386344|100902883|FG001|Overall Study|At the Participant's own Request|7|||
33274130|NCT03386344|100902884|FG002|Overall Study|At the Participant's own Request|8|||
33274131|NCT03386344|100902882|FG000|Overall Study|Reason not Specified|0|||
33274132|NCT03386344|100902883|FG001|Overall Study|Reason not Specified|1|||
33274133|NCT03386344|100902884|FG002|Overall Study|Reason not Specified|0|||
33274134|NCT00080119|100902885|FG000|Overall Study|Discontinued because of study closure|0|||
33274135|NCT00080119|100902886|FG001|Overall Study|Discontinued because of study closure|0|||
33274136|NCT00080119|100902887|FG002|Overall Study|Discontinued because of study closure|130|||
33274137|NCT00080119|100902888|FG003|Overall Study|Discontinued because of study closure|141|||
33274138|NCT00080119|100902885|FG000|Overall Study|Unable to get to clinic|24|||
33274139|NCT00080119|100902886|FG001|Overall Study|Unable to get to clinic|24|||
33274140|NCT00080119|100902887|FG002|Overall Study|Unable to get to clinic|7|||
33274141|NCT00080119|100902888|FG003|Overall Study|Unable to get to clinic|1|||
33274142|NCT00080119|100902885|FG000|Overall Study|Consent withdrawn|13|||
33274143|NCT00080119|100902886|FG001|Overall Study|Consent withdrawn|17|||
33274144|NCT00080119|100902887|FG002|Overall Study|Consent withdrawn|4|||
33274145|NCT00080119|100902888|FG003|Overall Study|Consent withdrawn|6|||
33274146|NCT00080119|100902885|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
33274147|NCT00080119|100902886|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
33274148|NCT00080119|100902887|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
33274149|NCT00080119|100902888|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
33274150|NCT00080119|100902885|FG000|Overall Study|Lost to Follow-up|16|||
33274151|NCT00080119|100902886|FG001|Overall Study|Lost to Follow-up|19|||
33274152|NCT00080119|100902887|FG002|Overall Study|Lost to Follow-up|19|||
33482559|NCT02359994|101658055|FG000|Overall Population Study|Withdrawal by Subject|1|||
33482560|NCT02359994|101658056|FG001|Overall Population Study|Withdrawal by Subject|0|||
33482561|NCT02359994|101658055|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
33482562|NCT02359994|101658056|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
33482563|NCT02359994|101658055|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
33482564|NCT02359994|101658056|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
33482565|NCT02359994|101658055|FG000|Extended Oncology 24-Month Survival|Death|19|||
33482566|NCT02359994|101658056|FG001|Extended Oncology 24-Month Survival|Death|21|||
33482567|NCT02359994|101658055|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
33482568|NCT02359994|101658056|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
33482569|NCT01696058|101658057|FG000|Overall Study|Adverse Event|21|||
33482570|NCT01696058|101658058|FG001|Overall Study|Adverse Event|11|||
33482571|NCT01696058|101658057|FG000|Overall Study|Lack of Efficacy|2|||
33482572|NCT01696058|101658058|FG001|Overall Study|Lack of Efficacy|3|||
33482573|NCT01696058|101658057|FG000|Overall Study|Protocol Violation|9|||
33482574|NCT01696058|101658058|FG001|Overall Study|Protocol Violation|3|||
33482575|NCT01696058|101658057|FG000|Overall Study|Lost to Follow-up|2|||
33482576|NCT01696058|101658058|FG001|Overall Study|Lost to Follow-up|5|||
33482577|NCT01696058|101658057|FG000|Overall Study|Withdrawal by Subject|4|||
33482578|NCT01696058|101658058|FG001|Overall Study|Withdrawal by Subject|6|||
33482579|NCT01696058|101658057|FG000|Overall Study|Other reason prematurely discontinued|5|||
33482580|NCT01696058|101658058|FG001|Overall Study|Other reason prematurely discontinued|3|||
33482581|NCT00351533|101658061|FG000|Overall Study|Extubated before first BAL|1|||
33482582|NCT00351533|101658062|FG001|Overall Study|Extubated before first BAL|0|||
33482583|NCT00351533|101658061|FG000|Overall Study|Lost to Follow-up|1|||
33274153|NCT00080119|100902888|FG003|Overall Study|Lost to Follow-up|14|||
33274154|NCT03503188|100902897|FG000|Overall Study|Non eligible in the sub study|0|||
33274155|NCT03503188|100902898|FG001|Overall Study|Non eligible in the sub study|1|||
33274156|NCT02577315|100902899|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
33274157|NCT02577315|100902900|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
33274158|NCT01377844|100902901|FG000|Overall Study|Withdrawal by Subject|25|||
33274159|NCT01377844|100902902|FG001|Overall Study|Withdrawal by Subject|28|||
33482584|NCT00351533|101658062|FG001|Overall Study|Lost to Follow-up|3|||
33482585|NCT00351533|101658061|FG000|Overall Study|Physician Decision|0|||
33482586|NCT00351533|101658062|FG001|Overall Study|Physician Decision|1|||
33482587|NCT00351533|101658061|FG000|Overall Study|Withdrawal by Subject|0|||
33482588|NCT00351533|101658062|FG001|Overall Study|Withdrawal by Subject|1|||
33482589|NCT03678285|101658063|FG000|Overall Study|Adverse Event|2|||
33482590|NCT03678285|101658063|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
33482591|NCT03678285|101658063|FG000|Overall Study|Dehydrated prior to start of workout|1|||
33482592|NCT02114385|101658064|FG000|Overall Study|Withdrawal by Subject|3|||
33482593|NCT02114385|101658065|FG001|Overall Study|Withdrawal by Subject|2|||
33482594|NCT02114385|101658064|FG000|Overall Study|Lost to Follow-up|0|||
33482595|NCT02114385|101658065|FG001|Overall Study|Lost to Follow-up|6|||
33482596|NCT00856375|101658066|FG000|Overall Study|Other|0|||
33482597|NCT00856375|101658067|FG001|Overall Study|Other|1|||
33482598|NCT00856375|101658066|FG000|Overall Study|Death|32|||
33482599|NCT00856375|101658067|FG001|Overall Study|Death|30|||
33482600|NCT00856375|101658066|FG000|Overall Study|Sponsor Terminated Study|7|||
33482601|NCT00856375|101658067|FG001|Overall Study|Sponsor Terminated Study|7|||
33482602|NCT00856375|101658066|FG000|Overall Study|Withdrawal by Subject|2|||
33482603|NCT00856375|101658067|FG001|Overall Study|Withdrawal by Subject|1|||
33482604|NCT00856375|101658066|FG000|Overall Study|Lost to Follow-up|1|||
33482605|NCT00856375|101658067|FG001|Overall Study|Lost to Follow-up|2|||
33482606|NCT00577395|101658068|FG000|Overall Study|Study was terminated early by Sponsor|7|||
33482607|NCT00577395|101658069|FG001|Overall Study|Study was terminated early by Sponsor|6|||
33482608|NCT01822366|101658074|FG000|Overall Study|Lost to Follow-up|5|||
33482609|NCT01822366|101658075|FG001|Overall Study|Lost to Follow-up|1|||
33482610|NCT01822366|101658076|FG002|Overall Study|Lost to Follow-up|5|||
33482611|NCT01822366|101658077|FG003|Overall Study|Lost to Follow-up|1|||
33482612|NCT01822366|101658074|FG000|Overall Study|Withdrawal by Subject|0|||
33482613|NCT01822366|101658075|FG001|Overall Study|Withdrawal by Subject|6|||
33482614|NCT01822366|101658076|FG002|Overall Study|Withdrawal by Subject|0|||
33482615|NCT01822366|101658077|FG003|Overall Study|Withdrawal by Subject|6|||
33482616|NCT01822366|101658074|FG000|Overall Study|Partial Intervention Completion|0|||
33482617|NCT01822366|101658075|FG001|Overall Study|Partial Intervention Completion|15|||
33482618|NCT01822366|101658076|FG002|Overall Study|Partial Intervention Completion|0|||
33482619|NCT01822366|101658077|FG003|Overall Study|Partial Intervention Completion|15|||
33482620|NCT00338455|101658078|FG000|Overall Study|Death|2|||
33482621|NCT00338455|101658079|FG001|Overall Study|Death|1|||
33482622|NCT00338455|101658078|FG000|Overall Study|Physician Decision|1|||
33482623|NCT00338455|101658079|FG001|Overall Study|Physician Decision|0|||
33482624|NCT03279692|101658080|FG000|Overall Study|Withdrawal by Subject|1|||
33482625|NCT03456453|101658081|FG000|Overall Study|Withdrawal by Subject|2|||
33482626|NCT03456453|101658082|FG001|Overall Study|Withdrawal by Subject|0|||
33482627|NCT03456453|101658081|FG000|Overall Study|Not released to community|1|||
33482628|NCT03456453|101658082|FG001|Overall Study|Not released to community|5|||
33482629|NCT03456453|101658081|FG000|Overall Study|Lost to Follow-up|0|||
33482630|NCT03456453|101658082|FG001|Overall Study|Lost to Follow-up|2|||
33482631|NCT01547130|101658083|FG000|Overall Study|Lost to Follow-up|9|||
33482632|NCT01547130|101658084|FG001|Overall Study|Lost to Follow-up|5|||
33482633|NCT00428116|101658088|FG000|Overall Study|Death|1|||
33482634|NCT00428116|101658089|FG001|Overall Study|Death|0|||
33482635|NCT00428116|101658088|FG000|Overall Study|Withdrawal by Subject|1|||
33482636|NCT00428116|101658089|FG001|Overall Study|Withdrawal by Subject|0|||
33482637|NCT00428116|101658088|FG000|Overall Study|Lost to Follow-up|1|||
33482638|NCT00428116|101658089|FG001|Overall Study|Lost to Follow-up|0|||
33482639|NCT03597464|101658093|FG000|Overall Study|Withdrawal by Subject|4|||
33482640|NCT03597464|101658094|FG001|Overall Study|Withdrawal by Subject|5|||
33482641|NCT03597464|101658093|FG000|Overall Study|Lost to Follow-up|3|||
33482642|NCT03597464|101658094|FG001|Overall Study|Lost to Follow-up|1|||
33482643|NCT03597464|101658093|FG000|Overall Study|Pregnancy|3|||
33482644|NCT03597464|101658094|FG001|Overall Study|Pregnancy|1|||
33482645|NCT03597464|101658093|FG000|Overall Study|Lack of Efficacy|2|||
33482646|NCT03597464|101658094|FG001|Overall Study|Lack of Efficacy|0|||
33482647|NCT03597464|101658093|FG000|Overall Study|Physician Decision|2|||
33482648|NCT03597464|101658094|FG001|Overall Study|Physician Decision|2|||
33482649|NCT03597464|101658093|FG000|Overall Study|Protocol Violation|1|||
33482650|NCT03597464|101658094|FG001|Overall Study|Protocol Violation|1|||
33482651|NCT03597464|101658093|FG000|Overall Study|Adverse Event|0|||
33482652|NCT03597464|101658094|FG001|Overall Study|Adverse Event|2|||
33482653|NCT03597464|101658093|FG000|Overall Study|Death|0|||
33482654|NCT03597464|101658094|FG001|Overall Study|Death|3|||
33482655|NCT05422625|101658095|FG000|Overall Study|Withdrawal by Subject|1|||
33482656|NCT05422625|101658096|FG001|Overall Study|Withdrawal by Subject|0|||
33482657|NCT02437903|101658097|FG000|Overall Study|Adverse Event|1|||
33482658|NCT02437903|101658097|FG000|Overall Study|Withdrawal by Subject|1|||
33482659|NCT02437903|101658097|FG000|Overall Study|Lost to Follow-up|3|||
33482660|NCT02996487|101658100|FG000|Overall Study|Lost to Follow-up|1|||
33482661|NCT02996487|101658101|FG001|Overall Study|Lost to Follow-up|1|||
33482662|NCT02996487|101658102|FG002|Overall Study|Lost to Follow-up|0|||
33482663|NCT02996487|101658100|FG000|Overall Study|Death|0|||
33482664|NCT02996487|101658101|FG001|Overall Study|Death|1|||
33482665|NCT02996487|101658102|FG002|Overall Study|Death|0|||
33482666|NCT02996487|101658100|FG000|Overall Study|Withdrawal by Subject|2|||
33482667|NCT02996487|101658101|FG001|Overall Study|Withdrawal by Subject|3|||
33482668|NCT02996487|101658102|FG002|Overall Study|Withdrawal by Subject|0|||
33482669|NCT03200912|101658103|FG000|Overall Study|Adverse Event|3|||
33482670|NCT03200912|101658104|FG001|Overall Study|Adverse Event|0|||
33482671|NCT03200912|101658105|FG002|Overall Study|Adverse Event|0|||
33482672|NCT03200912|101658103|FG000|Overall Study|Withdrawal by Subject|1|||
33482673|NCT03200912|101658104|FG001|Overall Study|Withdrawal by Subject|2|||
33482674|NCT03200912|101658105|FG002|Overall Study|Withdrawal by Subject|4|||
33482675|NCT03200912|101658103|FG000|Overall Study|Non-compliance with study drug|0|||
33482676|NCT03200912|101658104|FG001|Overall Study|Non-compliance with study drug|1|||
33482677|NCT03200912|101658105|FG002|Overall Study|Non-compliance with study drug|0|||
33482678|NCT00000378|101658110|FG000|Overall Study|Lack of Efficacy|16|||
33482679|NCT00000378|101658111|FG001|Overall Study|Lack of Efficacy|14|||
33482680|NCT01422187|101658115|FG000|Overall Study|Personal reason|1|||
33482681|NCT01422187|101658116|FG001|Overall Study|Personal reason|0|||
33482682|NCT01422187|101658117|FG002|Overall Study|Personal reason|0|||
33482683|NCT01422187|101658115|FG000|Overall Study|Lost to Follow-up|0|||
33482684|NCT01422187|101658116|FG001|Overall Study|Lost to Follow-up|1|||
33482685|NCT01422187|101658117|FG002|Overall Study|Lost to Follow-up|0|||
33482686|NCT01635283|101658118|FG000|Overall Study|Tumor Progression|3|||
33482687|NCT01635283|101658118|FG000|Overall Study|Lost to Follow-up|1|||
33482688|NCT00303459|101658119|FG000|Overall Study|Death|33|||
33482689|NCT00303459|101658120|FG001|Overall Study|Death|44|||
33482690|NCT00303459|101658119|FG000|Overall Study|Withdrawal of consent|32|||
33482691|NCT00303459|101658120|FG001|Overall Study|Withdrawal of consent|26|||
33482692|NCT00303459|101658119|FG000|Overall Study|Lost to Follow-up|5|||
33482693|NCT00303459|101658120|FG001|Overall Study|Lost to Follow-up|4|||
33482694|NCT00303459|101658119|FG000|Overall Study|Administrative reason|7|||
33482695|NCT00303459|101658120|FG001|Overall Study|Administrative reason|7|||
33482696|NCT00303459|101658119|FG000|Overall Study|Decision by the investigator|5|||
33482697|NCT00303459|101658120|FG001|Overall Study|Decision by the investigator|7|||
33482698|NCT00303459|101658119|FG000|Overall Study|Lung transplantation|1|||
33482699|NCT00303459|101658120|FG001|Overall Study|Lung transplantation|1|||
33482700|NCT04502212|101658124|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
33482701|NCT04502212|101658124|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
33482702|NCT02640690|101658134|FG000|Overall Study|Lost to Follow-up|7|||
33482703|NCT02640690|101658135|FG001|Overall Study|Lost to Follow-up|7|||
33482704|NCT02640690|101658134|FG000|Overall Study|Withdrawal by Subject|16|||
33482705|NCT02640690|101658135|FG001|Overall Study|Withdrawal by Subject|20|||
33482706|NCT02640690|101658134|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
33482707|NCT02640690|101658135|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
33482708|NCT00926783|101658136|FG000|Overall Study|Incomplete CFAE Procedures|3|||
33482709|NCT00926783|101658137|FG001|Overall Study|Incomplete CFAE Procedures|3|||
33482710|NCT04191499|101658138|FG000|Overall Study|Adverse Event|1|||
33482711|NCT04191499|101658139|FG001|Overall Study|Adverse Event|0|||
33482712|NCT04191499|101658138|FG000|Overall Study|Death|42|||
33482713|NCT04191499|101658139|FG001|Overall Study|Death|55|||
33482714|NCT04191499|101658138|FG000|Overall Study|Lost to Follow-up|4|||
33482715|NCT04191499|101658139|FG001|Overall Study|Lost to Follow-up|1|||
33482716|NCT04191499|101658138|FG000|Overall Study|Physician Decision|1|||
33482717|NCT04191499|101658139|FG001|Overall Study|Physician Decision|0|||
33482718|NCT04191499|101658138|FG000|Overall Study|Progressive Disease|1|||
33482719|NCT04191499|101658139|FG001|Overall Study|Progressive Disease|0|||
33482720|NCT04191499|101658138|FG000|Overall Study|Symptomatic Deterioration|1|||
33482721|NCT04191499|101658139|FG001|Overall Study|Symptomatic Deterioration|0|||
33482722|NCT04191499|101658138|FG000|Overall Study|Withdrawal by Subject|7|||
33482723|NCT04191499|101658139|FG001|Overall Study|Withdrawal by Subject|11|||
33482724|NCT04191499|101658138|FG000|Overall Study|Ongoing in the study|104|||
33482725|NCT04191499|101658139|FG001|Overall Study|Ongoing in the study|97|||
33482726|NCT01982448|101658142|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
33274160|NCT01377844|100902901|FG000|Overall Study|Protocol Violation|2|||
33274161|NCT01377844|100902902|FG001|Overall Study|Protocol Violation|3|||
33274162|NCT01377844|100902901|FG000|Overall Study|Adverse Event|3|||
33482727|NCT01982448|101658143|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
33482728|NCT01982448|101658142|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
33482729|NCT01982448|101658143|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
33482730|NCT01982448|101658142|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
33482731|NCT01982448|101658143|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
33482732|NCT01982448|101658142|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
33274163|NCT01377844|100902902|FG001|Overall Study|Adverse Event|0|||
33482733|NCT01982448|101658143|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
33482734|NCT01438996|101658144|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
33482735|NCT01438996|101658145|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
33482736|NCT01438996|101658146|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
33482737|NCT00626392|101658157|FG000|Run-in Period|Adverse Event|0|||
33482738|NCT00626392|101658158|FG001|Run-in Period|Adverse Event|0|||
33482739|NCT00626392|101658159|FG002|Run-in Period|Adverse Event|1|||
33482740|NCT00626392|101658160|FG003|Run-in Period|Adverse Event|0|||
33482741|NCT00626392|101658161|FG004|Run-in Period|Adverse Event|1|||
33482742|NCT00626392|101658162|FG005|Run-in Period|Adverse Event|0|||
33482743|NCT00626392|101658157|FG000|Run-in Period|Withdrawal by Subject|0|||
33482744|NCT00626392|101658158|FG001|Run-in Period|Withdrawal by Subject|1|||
33482745|NCT00626392|101658159|FG002|Run-in Period|Withdrawal by Subject|1|||
33482746|NCT00626392|101658160|FG003|Run-in Period|Withdrawal by Subject|1|||
33482747|NCT00626392|101658161|FG004|Run-in Period|Withdrawal by Subject|3|||
33482748|NCT00626392|101658162|FG005|Run-in Period|Withdrawal by Subject|1|||
33482749|NCT00626392|101658157|FG000|Run-in Period|Noncompliance|1|||
33482750|NCT00626392|101658158|FG001|Run-in Period|Noncompliance|0|||
33482751|NCT00626392|101658159|FG002|Run-in Period|Noncompliance|1|||
33482752|NCT00626392|101658160|FG003|Run-in Period|Noncompliance|0|||
33482753|NCT00626392|101658161|FG004|Run-in Period|Noncompliance|0|||
33482754|NCT00626392|101658162|FG005|Run-in Period|Noncompliance|0|||
33482755|NCT00626392|101658157|FG000|Coadministration Period|Adverse Event|3|||
33482756|NCT00626392|101658158|FG001|Coadministration Period|Adverse Event|1|||
33482757|NCT00626392|101658159|FG002|Coadministration Period|Adverse Event|7|||
33482758|NCT00626392|101658160|FG003|Coadministration Period|Adverse Event|4|||
33482759|NCT00626392|101658161|FG004|Coadministration Period|Adverse Event|3|||
33482760|NCT00626392|101658162|FG005|Coadministration Period|Adverse Event|4|||
33482761|NCT00626392|101658157|FG000|Coadministration Period|Withdrawal by Subject|1|||
33482762|NCT00626392|101658158|FG001|Coadministration Period|Withdrawal by Subject|1|||
33482763|NCT00626392|101658159|FG002|Coadministration Period|Withdrawal by Subject|0|||
33482764|NCT00626392|101658160|FG003|Coadministration Period|Withdrawal by Subject|1|||
33482765|NCT00626392|101658161|FG004|Coadministration Period|Withdrawal by Subject|0|||
33482766|NCT00626392|101658162|FG005|Coadministration Period|Withdrawal by Subject|1|||
33482767|NCT00626392|101658157|FG000|Coadministration Period|Protocol Violation|0|||
33482768|NCT00626392|101658158|FG001|Coadministration Period|Protocol Violation|1|||
33482769|NCT00626392|101658159|FG002|Coadministration Period|Protocol Violation|0|||
33482770|NCT00626392|101658160|FG003|Coadministration Period|Protocol Violation|1|||
33482771|NCT00626392|101658161|FG004|Coadministration Period|Protocol Violation|1|||
33482772|NCT00626392|101658162|FG005|Coadministration Period|Protocol Violation|0|||
33482773|NCT00626392|101658157|FG000|Coadministration Period|Other|0|||
33482774|NCT00626392|101658158|FG001|Coadministration Period|Other|2|||
33482775|NCT00626392|101658159|FG002|Coadministration Period|Other|3|||
33482776|NCT00626392|101658160|FG003|Coadministration Period|Other|1|||
33482777|NCT00626392|101658161|FG004|Coadministration Period|Other|1|||
33482778|NCT00626392|101658162|FG005|Coadministration Period|Other|1|||
33482779|NCT00206323|101658163|FG000|Overall Study|Lack of Efficacy|4|||
33482780|NCT00206323|101658164|FG001|Overall Study|Lack of Efficacy|1|||
33482781|NCT00206323|101658163|FG000|Overall Study|Adverse Event|1|||
33482782|NCT00206323|101658164|FG001|Overall Study|Adverse Event|1|||
33482783|NCT00206323|101658163|FG000|Overall Study|Lost to Follow-up|1|||
33482784|NCT00206323|101658164|FG001|Overall Study|Lost to Follow-up|1|||
33482785|NCT01464931|101658165|FG000|Overall Study|Withdrawal by Subject|1|||
33482786|NCT01464931|101658166|FG001|Overall Study|Withdrawal by Subject|0|||
33482787|NCT00530218|101658169|FG000|Overall Study|CMV Not Detected|13|||
33482788|NCT00530218|101658169|FG000|Overall Study|Death|12|||
33482789|NCT03196635|101662556|FG000|Overall Study|Withdrawal by Subject|1|||
33482790|NCT02027428|101662558|FG000|Induction|Never treated|7|||
33482791|NCT02027428|101662559|FG001|Induction|Never treated|0|||
33482792|NCT02027428|101662560|FG002|Induction|Never treated|0|||
33482793|NCT02027428|101662558|FG000|Induction|Progressive disease|77|||
33482794|NCT02027428|101662559|FG001|Induction|Progressive disease|0|||
33482795|NCT02027428|101662560|FG002|Induction|Progressive disease|0|||
33482796|NCT02027428|101662558|FG000|Induction|Adverse Event|51|||
33482797|NCT02027428|101662559|FG001|Induction|Adverse Event|0|||
33482798|NCT02027428|101662560|FG002|Induction|Adverse Event|0|||
33482799|NCT02027428|101662558|FG000|Induction|Withdrawal by Subject|22|||
33482800|NCT02027428|101662559|FG001|Induction|Withdrawal by Subject|0|||
33482801|NCT02027428|101662560|FG002|Induction|Withdrawal by Subject|0|||
33482802|NCT02027428|101662558|FG000|Induction|Death|21|||
33482803|NCT02027428|101662559|FG001|Induction|Death|0|||
33482804|NCT02027428|101662560|FG002|Induction|Death|0|||
33482805|NCT02027428|101662558|FG000|Induction|Symptomatic deterioration|16|||
33482806|NCT02027428|101662559|FG001|Induction|Symptomatic deterioration|0|||
33482807|NCT02027428|101662560|FG002|Induction|Symptomatic deterioration|0|||
33482808|NCT02027428|101662558|FG000|Induction|Study terminated by sponsor|12|||
33482809|NCT02027428|101662559|FG001|Induction|Study terminated by sponsor|0|||
33482810|NCT02027428|101662560|FG002|Induction|Study terminated by sponsor|0|||
33482811|NCT02027428|101662558|FG000|Induction|Protocol Violation|1|||
33482812|NCT02027428|101662559|FG001|Induction|Protocol Violation|0|||
33482813|NCT02027428|101662560|FG002|Induction|Protocol Violation|0|||
33482814|NCT02027428|101662558|FG000|Induction|Miscellaneous|14|||
33274164|NCT01377844|100902901|FG000|Overall Study|Physician Decision|6|||
33274165|NCT01377844|100902902|FG001|Overall Study|Physician Decision|3|||
33274166|NCT01377844|100902901|FG000|Overall Study|Study terminated by Sponsor|0|||
33274167|NCT01377844|100902902|FG001|Overall Study|Study terminated by Sponsor|1|||
33274168|NCT02069379|100902903|FG000|Baseline Measurements|Lost to Follow-up|1|||
33274169|NCT02069379|100902904|FG001|Baseline Measurements|Lost to Follow-up|0|||
33274170|NCT02069379|100902905|FG002|Baseline Measurements|Lost to Follow-up|0|||
33274171|NCT02069379|100902906|FG003|Baseline Measurements|Lost to Follow-up|0|||
33274172|NCT02069379|100902903|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
33274173|NCT02069379|100902904|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
33274174|NCT02069379|100902905|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
33274175|NCT02069379|100902906|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
33274176|NCT02069379|100902903|FG000|First Treatment Arm|Lost to Follow-up|0|||
33274177|NCT02069379|100902904|FG001|First Treatment Arm|Lost to Follow-up|1|||
33274178|NCT02069379|100902905|FG002|First Treatment Arm|Lost to Follow-up|1|||
33274179|NCT02069379|100902906|FG003|First Treatment Arm|Lost to Follow-up|0|||
33274180|NCT02069379|100902903|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
33274181|NCT02069379|100902904|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
33274182|NCT02069379|100902905|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
33274183|NCT02069379|100902906|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
33274184|NCT02069379|100902903|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
33274185|NCT02069379|100902904|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
33274186|NCT02069379|100902905|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
33274187|NCT02069379|100902906|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
33274188|NCT02069379|100902903|FG000|Second Treatment Arm|Lost to Follow-up|0|||
33274189|NCT02069379|100902904|FG001|Second Treatment Arm|Lost to Follow-up|0|||
33274190|NCT02069379|100902905|FG002|Second Treatment Arm|Lost to Follow-up|1|||
33274191|NCT02069379|100902906|FG003|Second Treatment Arm|Lost to Follow-up|0|||
33274192|NCT00440037|100902907|FG000|Overall Study|Withdrawal by Subject|6|||
33274193|NCT00440037|100902907|FG000|Overall Study|Administrative decision|3|||
33274194|NCT02489799|100902908|FG000|Overall Study|Lost to Follow-up|4|||
33274195|NCT02489799|100902909|FG001|Overall Study|Lost to Follow-up|1|||
33274196|NCT02489799|100902908|FG000|Overall Study|Failure to Maintain Eligibility|4|||
33274197|NCT02489799|100902909|FG001|Overall Study|Failure to Maintain Eligibility|6|||
33274198|NCT02489799|100902908|FG000|Overall Study|Withdrawal by Subject|1|||
33274199|NCT02489799|100902909|FG001|Overall Study|Withdrawal by Subject|1|||
33274200|NCT02489799|100902908|FG000|Overall Study|Death|0|||
33274201|NCT02489799|100902909|FG001|Overall Study|Death|1|||
33274202|NCT00383500|100902912|FG000|Overall Study|Withdrawal by Subject|8|||
33274203|NCT00383500|100902913|FG001|Overall Study|Withdrawal by Subject|3|||
33274204|NCT00383500|100902914|FG002|Overall Study|Withdrawal by Subject|0|||
33274205|NCT00383500|100902912|FG000|Overall Study|Lost to Follow-up|0|||
33274206|NCT00383500|100902913|FG001|Overall Study|Lost to Follow-up|0|||
33274207|NCT00383500|100902914|FG002|Overall Study|Lost to Follow-up|2|||
33274208|NCT03928821|100902915|FG000|Overall Study|Death|0|||
33274209|NCT03928821|100902916|FG001|Overall Study|Death|1|||
33274210|NCT03928821|100902917|FG002|Overall Study|Death|0|||
33274211|NCT03928821|100902918|FG003|Overall Study|Death|0|||
33274212|NCT03928821|100902915|FG000|Overall Study|Lost to Follow-up|0|||
33274213|NCT03928821|100902916|FG001|Overall Study|Lost to Follow-up|2|||
33274214|NCT03928821|100902917|FG002|Overall Study|Lost to Follow-up|3|||
33274215|NCT03928821|100902918|FG003|Overall Study|Lost to Follow-up|0|||
33274216|NCT03928821|100902915|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
33274217|NCT03928821|100902916|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
33274218|NCT03928821|100902917|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
33274219|NCT03928821|100902918|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
33274220|NCT01768572|100902919|FG000|Overall Study|Adverse Event|7|||
33274221|NCT01768572|100902920|FG001|Overall Study|Adverse Event|8|||
33274222|NCT01768572|100902921|FG002|Overall Study|Adverse Event|4|||
33274223|NCT01768572|100902919|FG000|Overall Study|Lack of Efficacy|1|||
33274224|NCT01768572|100902920|FG001|Overall Study|Lack of Efficacy|3|||
33274225|NCT01768572|100902921|FG002|Overall Study|Lack of Efficacy|1|||
33274226|NCT01768572|100902919|FG000|Overall Study|Other, Not due to an adverse event|1|||
33482815|NCT02027428|101662559|FG001|Induction|Miscellaneous|0|||
33274227|NCT01768572|100902920|FG001|Overall Study|Other, Not due to an adverse event|1|||
33482816|NCT02027428|101662560|FG002|Induction|Miscellaneous|0|||
33274228|NCT01768572|100902921|FG002|Overall Study|Other, Not due to an adverse event|1|||
33274229|NCT02097056|100902922|FG000|Overall Study|Protocol Violation|2|||
33274230|NCT02097056|100902922|FG000|Overall Study|Withdrawal by Subject|15|||
33274231|NCT02097056|100902922|FG000|Overall Study|Lost to Follow-up|2|||
33274232|NCT02097056|100902922|FG000|Overall Study|Adverse Event|37|||
33274233|NCT02097056|100902922|FG000|Overall Study|Other|2|||
33274234|NCT01131325|100902923|FG000|Overall Study|Adverse Event|1|||
33482817|NCT02027428|101662558|FG000|Induction|Induction Treatment Ongoing|4|||
33482818|NCT02027428|101662559|FG001|Induction|Induction Treatment Ongoing|0|||
33482819|NCT02027428|101662560|FG002|Induction|Induction Treatment Ongoing|0|||
33482820|NCT02027428|101662558|FG000|Maintenance|Death|0|||
33482821|NCT02027428|101662559|FG001|Maintenance|Death|3|||
33482822|NCT02027428|101662560|FG002|Maintenance|Death|2|||
33482823|NCT02027428|101662558|FG000|Maintenance|Adverse Event|0|||
33482824|NCT02027428|101662559|FG001|Maintenance|Adverse Event|21|||
33482825|NCT02027428|101662560|FG002|Maintenance|Adverse Event|1|||
33482826|NCT02027428|101662558|FG000|Maintenance|Progressive disease|0|||
33482827|NCT02027428|101662559|FG001|Maintenance|Progressive disease|84|||
33482828|NCT02027428|101662560|FG002|Maintenance|Progressive disease|47|||
33482829|NCT02027428|101662558|FG000|Maintenance|Symptomatic deterioration|0|||
33482830|NCT02027428|101662559|FG001|Maintenance|Symptomatic deterioration|4|||
33482831|NCT02027428|101662560|FG002|Maintenance|Symptomatic deterioration|1|||
33482832|NCT02027428|101662558|FG000|Maintenance|Withdrawal by Subject|0|||
33482833|NCT02027428|101662559|FG001|Maintenance|Withdrawal by Subject|6|||
33482834|NCT02027428|101662560|FG002|Maintenance|Withdrawal by Subject|5|||
33482835|NCT02027428|101662558|FG000|Maintenance|Protocol Violation|0|||
33482836|NCT02027428|101662559|FG001|Maintenance|Protocol Violation|0|||
33482837|NCT02027428|101662560|FG002|Maintenance|Protocol Violation|1|||
33482838|NCT02027428|101662558|FG000|Maintenance|Other|0|||
33482839|NCT02027428|101662559|FG001|Maintenance|Other|6|||
33482840|NCT02027428|101662560|FG002|Maintenance|Other|3|||
33482841|NCT02027428|101662558|FG000|Survival Follow-up|Death|0|||
33482842|NCT02027428|101662559|FG001|Survival Follow-up|Death|78|||
33482843|NCT02027428|101662560|FG002|Survival Follow-up|Death|45|||
33482844|NCT02027428|101662558|FG000|Survival Follow-up|Lost to Follow-up|0|||
33482845|NCT02027428|101662559|FG001|Survival Follow-up|Lost to Follow-up|1|||
33482846|NCT02027428|101662560|FG002|Survival Follow-up|Lost to Follow-up|1|||
33482847|NCT04893018|101662562|FG000|Overall Study|Lost to Follow-up|1|||
33482848|NCT04893018|101662563|FG001|Overall Study|Lost to Follow-up|0|||
33482849|NCT04893018|101662562|FG000|Overall Study|Withdrawal by Subject|2|||
33482850|NCT04893018|101662563|FG001|Overall Study|Withdrawal by Subject|0|||
33482851|NCT04893018|101662562|FG000|Overall Study|Study Terminated|1|||
33482852|NCT04893018|101662563|FG001|Overall Study|Study Terminated|2|||
33482853|NCT00000620|101662568|FG000|Overall Study|Death|86|||
33482854|NCT00000620|101662569|FG001|Overall Study|Death|67|||
33482855|NCT00000620|101662570|FG002|Overall Study|Death|112|||
33482856|NCT00000620|101662571|FG003|Overall Study|Death|126|||
33482857|NCT00000620|101662572|FG004|Overall Study|Death|64|||
33482858|NCT00000620|101662573|FG005|Overall Study|Death|77|||
33482859|NCT00000620|101662574|FG006|Overall Study|Death|91|||
33482860|NCT00000620|101662575|FG007|Overall Study|Death|95|||
33482861|NCT00000620|101662568|FG000|Overall Study|Lost to Follow-up|14|||
33482862|NCT00000620|101662569|FG001|Overall Study|Lost to Follow-up|14|||
33482863|NCT00000620|101662570|FG002|Overall Study|Lost to Follow-up|14|||
33482864|NCT00000620|101662571|FG003|Overall Study|Lost to Follow-up|14|||
33482865|NCT00000620|101662572|FG004|Overall Study|Lost to Follow-up|15|||
33482866|NCT00000620|101662573|FG005|Overall Study|Lost to Follow-up|15|||
33482867|NCT00000620|101662574|FG006|Overall Study|Lost to Follow-up|13|||
33482868|NCT00000620|101662575|FG007|Overall Study|Lost to Follow-up|14|||
33482869|NCT00000620|101662568|FG000|Overall Study|Withdrawal by Subject|40|||
33482870|NCT00000620|101662569|FG001|Overall Study|Withdrawal by Subject|27|||
33482871|NCT00000620|101662570|FG002|Overall Study|Withdrawal by Subject|28|||
33482872|NCT00000620|101662571|FG003|Overall Study|Withdrawal by Subject|27|||
33482873|NCT00000620|101662572|FG004|Overall Study|Withdrawal by Subject|30|||
33482874|NCT00000620|101662573|FG005|Overall Study|Withdrawal by Subject|32|||
33482875|NCT00000620|101662574|FG006|Overall Study|Withdrawal by Subject|32|||
33274235|NCT01131325|100902923|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
33274236|NCT02481934|100902924|FG000|Overall Study|Death|2|||
33274237|NCT03029585|100902925|FG000|Overall Study|Death|1|||
33274238|NCT03029585|100902926|FG001|Overall Study|Death|1|||
33274239|NCT03029585|100902925|FG000|Overall Study|Withdrawal by Subject|1|||
33274240|NCT03029585|100902926|FG001|Overall Study|Withdrawal by Subject|0|||
33274241|NCT00441168|100902927|FG000|Treatment Period|Death|3|||
33274242|NCT00441168|100902928|FG001|Treatment Period|Death|0|||
33482876|NCT00000620|101662575|FG007|Overall Study|Withdrawal by Subject|21|||
33482877|NCT00000620|101662568|FG000|Overall Study|missed closeout visit|22|||
33482878|NCT00000620|101662569|FG001|Overall Study|missed closeout visit|28|||
33482879|NCT00000620|101662570|FG002|Overall Study|missed closeout visit|16|||
33482880|NCT00000620|101662571|FG003|Overall Study|missed closeout visit|11|||
33482881|NCT00000620|101662572|FG004|Overall Study|missed closeout visit|26|||
33274243|NCT00441168|100902927|FG000|Treatment Period|Adverse Event|1|||
33274244|NCT00441168|100902928|FG001|Treatment Period|Adverse Event|2|||
33274245|NCT00441168|100902927|FG000|Treatment Period|Progressive Disease|0|||
33482882|NCT00000620|101662573|FG005|Overall Study|missed closeout visit|28|||
33482883|NCT00000620|101662574|FG006|Overall Study|missed closeout visit|13|||
33482884|NCT00000620|101662575|FG007|Overall Study|missed closeout visit|16|||
33482885|NCT00384930|101662579|FG000|Overall Study|Adverse Event|5|||
33482886|NCT00384930|101662580|FG001|Overall Study|Adverse Event|4|||
33482887|NCT00384930|101662581|FG002|Overall Study|Adverse Event|12|||
33482888|NCT00384930|101662582|FG003|Overall Study|Adverse Event|11|||
33482889|NCT00384930|101662583|FG004|Overall Study|Adverse Event|14|||
33482890|NCT00384930|101662579|FG000|Overall Study|Entry Criteria Not Met|2|||
33482891|NCT00384930|101662580|FG001|Overall Study|Entry Criteria Not Met|6|||
33482892|NCT00384930|101662581|FG002|Overall Study|Entry Criteria Not Met|7|||
33482893|NCT00384930|101662582|FG003|Overall Study|Entry Criteria Not Met|8|||
33482894|NCT00384930|101662583|FG004|Overall Study|Entry Criteria Not Met|4|||
33482895|NCT00384930|101662579|FG000|Overall Study|Lack of Efficacy|1|||
33482896|NCT00384930|101662580|FG001|Overall Study|Lack of Efficacy|1|||
33482897|NCT00384930|101662581|FG002|Overall Study|Lack of Efficacy|2|||
33482898|NCT00384930|101662582|FG003|Overall Study|Lack of Efficacy|1|||
33482899|NCT00384930|101662583|FG004|Overall Study|Lack of Efficacy|2|||
33482900|NCT00384930|101662579|FG000|Overall Study|Lost to Follow-up|5|||
33482901|NCT00384930|101662580|FG001|Overall Study|Lost to Follow-up|3|||
33482902|NCT00384930|101662581|FG002|Overall Study|Lost to Follow-up|0|||
33482903|NCT00384930|101662582|FG003|Overall Study|Lost to Follow-up|4|||
33482904|NCT00384930|101662583|FG004|Overall Study|Lost to Follow-up|6|||
33482905|NCT00384930|101662579|FG000|Overall Study|Physician Decision|0|||
33482906|NCT00384930|101662580|FG001|Overall Study|Physician Decision|1|||
33482907|NCT00384930|101662581|FG002|Overall Study|Physician Decision|1|||
33482908|NCT00384930|101662582|FG003|Overall Study|Physician Decision|0|||
33482909|NCT00384930|101662583|FG004|Overall Study|Physician Decision|1|||
33482910|NCT00384930|101662579|FG000|Overall Study|Protocol Violation|1|||
33482911|NCT00384930|101662580|FG001|Overall Study|Protocol Violation|0|||
33482912|NCT00384930|101662581|FG002|Overall Study|Protocol Violation|1|||
33482913|NCT00384930|101662582|FG003|Overall Study|Protocol Violation|6|||
33482914|NCT00384930|101662583|FG004|Overall Study|Protocol Violation|4|||
33482915|NCT00384930|101662579|FG000|Overall Study|Sponsor Decision|3|||
33482916|NCT00384930|101662580|FG001|Overall Study|Sponsor Decision|4|||
33482917|NCT00384930|101662581|FG002|Overall Study|Sponsor Decision|0|||
33482918|NCT00384930|101662582|FG003|Overall Study|Sponsor Decision|5|||
33482919|NCT00384930|101662583|FG004|Overall Study|Sponsor Decision|0|||
33482920|NCT00384930|101662579|FG000|Overall Study|Withdrawal by Subject|9|||
33482921|NCT00384930|101662580|FG001|Overall Study|Withdrawal by Subject|7|||
33482922|NCT00384930|101662581|FG002|Overall Study|Withdrawal by Subject|7|||
33482923|NCT00384930|101662582|FG003|Overall Study|Withdrawal by Subject|6|||
33482924|NCT00384930|101662583|FG004|Overall Study|Withdrawal by Subject|16|||
33482925|NCT00384930|101662579|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
33482926|NCT00384930|101662580|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
33482927|NCT00384930|101662581|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
33482928|NCT00384930|101662582|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
33482929|NCT00384930|101662583|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
33482930|NCT03496610|101662584|FG000|Overall Study|Lost to Follow-up|3|||
33482931|NCT03496610|101662585|FG001|Overall Study|Lost to Follow-up|2|||
33482932|NCT03496610|101662584|FG000|Overall Study|Physician Decision|1|||
33482933|NCT03496610|101662585|FG001|Overall Study|Physician Decision|0|||
33482934|NCT03496610|101662584|FG000|Overall Study|Withdrawal by Subject|1|||
33482935|NCT03496610|101662585|FG001|Overall Study|Withdrawal by Subject|0|||
33482936|NCT00086281|101662586|FG000|Phase 1|Adverse Event|0|||
33482937|NCT00086281|101662587|FG001|Phase 1|Adverse Event|0|||
33482938|NCT00086281|101662588|FG002|Phase 1|Adverse Event|0|||
33482939|NCT00086281|101662589|FG003|Phase 1|Adverse Event|0|||
33482940|NCT00086281|101662590|FG004|Phase 1|Adverse Event|0|||
33482941|NCT00086281|101662591|FG005|Phase 1|Adverse Event|0|||
33482942|NCT00086281|101662592|FG006|Phase 1|Adverse Event|0|||
33482943|NCT00086281|101662593|FG007|Phase 1|Adverse Event|0|||
33482944|NCT00086281|101662594|FG008|Phase 1|Adverse Event|0|||
33482945|NCT00086281|101662595|FG009|Phase 1|Adverse Event|1|||
33482946|NCT00086281|101662596|FG010|Phase 1|Adverse Event|2|||
33482947|NCT00086281|101662597|FG011|Phase 1|Adverse Event|1|||
33482948|NCT00086281|101662598|FG012|Phase 1|Adverse Event|1|||
33482949|NCT00086281|101662599|FG013|Phase 1|Adverse Event|1|||
33482950|NCT00086281|101662600|FG014|Phase 1|Adverse Event|2|||
33482951|NCT00086281|101662586|FG000|Phase 1|Protocol Violation|0|||
33482952|NCT00086281|101662587|FG001|Phase 1|Protocol Violation|0|||
33482953|NCT00086281|101662588|FG002|Phase 1|Protocol Violation|0|||
33482954|NCT00086281|101662589|FG003|Phase 1|Protocol Violation|0|||
33482955|NCT00086281|101662590|FG004|Phase 1|Protocol Violation|0|||
33482956|NCT00086281|101662591|FG005|Phase 1|Protocol Violation|0|||
33482957|NCT00086281|101662592|FG006|Phase 1|Protocol Violation|0|||
33482958|NCT00086281|101662593|FG007|Phase 1|Protocol Violation|0|||
33482959|NCT00086281|101662594|FG008|Phase 1|Protocol Violation|0|||
33482960|NCT00086281|101662595|FG009|Phase 1|Protocol Violation|0|||
33482961|NCT00086281|101662596|FG010|Phase 1|Protocol Violation|1|||
33482962|NCT00086281|101662597|FG011|Phase 1|Protocol Violation|0|||
33482963|NCT00086281|101662598|FG012|Phase 1|Protocol Violation|0|||
33482964|NCT00086281|101662599|FG013|Phase 1|Protocol Violation|0|||
33482965|NCT00086281|101662600|FG014|Phase 1|Protocol Violation|0|||
33482966|NCT00086281|101662586|FG000|Phase 1|Serious Adverse Event|0|||
33482967|NCT00086281|101662587|FG001|Phase 1|Serious Adverse Event|0|||
33482968|NCT00086281|101662588|FG002|Phase 1|Serious Adverse Event|0|||
33482969|NCT00086281|101662589|FG003|Phase 1|Serious Adverse Event|0|||
33482970|NCT00086281|101662590|FG004|Phase 1|Serious Adverse Event|0|||
33482971|NCT00086281|101662591|FG005|Phase 1|Serious Adverse Event|0|||
33482972|NCT00086281|101662592|FG006|Phase 1|Serious Adverse Event|0|||
33482973|NCT00086281|101662593|FG007|Phase 1|Serious Adverse Event|0|||
33482974|NCT00086281|101662594|FG008|Phase 1|Serious Adverse Event|0|||
33482975|NCT00086281|101662595|FG009|Phase 1|Serious Adverse Event|0|||
33482976|NCT00086281|101662596|FG010|Phase 1|Serious Adverse Event|0|||
33482977|NCT00086281|101662597|FG011|Phase 1|Serious Adverse Event|0|||
33482978|NCT00086281|101662598|FG012|Phase 1|Serious Adverse Event|0|||
33482979|NCT00086281|101662599|FG013|Phase 1|Serious Adverse Event|0|||
33482980|NCT00086281|101662600|FG014|Phase 1|Serious Adverse Event|1|||
33482981|NCT00086281|101662586|FG000|Phase 2|Adverse Event|0|||
33482982|NCT00086281|101662587|FG001|Phase 2|Adverse Event|0|||
33482983|NCT00086281|101662588|FG002|Phase 2|Adverse Event|0|||
33482984|NCT00086281|101662589|FG003|Phase 2|Adverse Event|0|||
33482985|NCT00086281|101662590|FG004|Phase 2|Adverse Event|0|||
33482986|NCT00086281|101662591|FG005|Phase 2|Adverse Event|0|||
33482987|NCT00086281|101662592|FG006|Phase 2|Adverse Event|0|||
33482988|NCT00086281|101662593|FG007|Phase 2|Adverse Event|0|||
33482989|NCT00086281|101662594|FG008|Phase 2|Adverse Event|0|||
33482990|NCT00086281|101662595|FG009|Phase 2|Adverse Event|0|||
33482991|NCT00086281|101662596|FG010|Phase 2|Adverse Event|0|||
33482992|NCT00086281|101662597|FG011|Phase 2|Adverse Event|0|||
33482993|NCT00086281|101662598|FG012|Phase 2|Adverse Event|1|||
33482994|NCT00086281|101662599|FG013|Phase 2|Adverse Event|1|||
33482995|NCT00086281|101662600|FG014|Phase 2|Adverse Event|0|||
33482996|NCT01520870|101662604|FG000|Overall Study|Withdrawal by Subject|2|||
33482997|NCT04646005|101662607|FG000|Overall Study|Adverse Event|1|||
33482998|NCT04646005|101662607|FG000|Overall Study|Progressive Disease|60|||
33482999|NCT04646005|101662607|FG000|Overall Study|Death|19|||
33483000|NCT04646005|101662607|FG000|Overall Study|Withdrawal by Subject|9|||
33483001|NCT04646005|101662607|FG000|Overall Study|Study Ongoing|24|||
33483002|NCT02538965|101662608|FG000|Treatment Period|Other = Death due to disease progression|1|||
33483003|NCT02538965|101662608|FG000|Treatment Period|Adverse Event|2|||
33483004|NCT02538965|101662608|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
33483005|NCT02538965|101662608|FG000|Treatment Period|Treatment Failure|9|||
33483006|NCT02538965|101662608|FG000|Treatment Period|Disease Progression|1|||
33483007|NCT02538965|101662608|FG000|Treatment Period|Physician Decision|2|||
33483008|NCT02538965|101662608|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
33483009|NCT02538965|101662608|FG000|Follow-Up Period|Withdrawal by Parent|4|||
33483010|NCT01582152|101662609|FG000|Overall Study|Disease Progression|4|||
33483011|NCT01582152|101662610|FG001|Overall Study|Disease Progression|5|||
33483012|NCT01582152|101662609|FG000|Overall Study|Adverse Event|2|||
33483013|NCT01582152|101662610|FG001|Overall Study|Adverse Event|1|||
33483014|NCT03257865|101662615|FG000|Overall Study|Adverse Event|4|||
33483015|NCT03257865|101662616|FG001|Overall Study|Adverse Event|8|||
33483016|NCT03257865|101662615|FG000|Overall Study|Lack of Efficacy|1|||
33483017|NCT03257865|101662616|FG001|Overall Study|Lack of Efficacy|2|||
33483018|NCT03257865|101662615|FG000|Overall Study|Non-compliance with Study Drug|0|||
33483019|NCT03257865|101662616|FG001|Overall Study|Non-compliance with Study Drug|2|||
33483020|NCT03257865|101662615|FG000|Overall Study|Withdrawal by Subject|23|||
33483021|NCT03257865|101662616|FG001|Overall Study|Withdrawal by Subject|17|||
33483022|NCT03257865|101662615|FG000|Overall Study|Physician Decision|3|||
33483023|NCT03257865|101662616|FG001|Overall Study|Physician Decision|1|||
33483024|NCT03257865|101662615|FG000|Overall Study|Other|0|||
33483025|NCT03257865|101662616|FG001|Overall Study|Other|1|||
33483026|NCT03257865|101662615|FG000|Overall Study|Lost to Follow-up|4|||
33483027|NCT03257865|101662616|FG001|Overall Study|Lost to Follow-up|4|||
33483028|NCT01199016|101662617|FG000|Overall Study|No longer meets eligibility criteria|4|||
33483029|NCT01199016|101662617|FG000|Overall Study|Entrance criteria|5|||
33483030|NCT01199016|101662617|FG000|Overall Study|Protocol Violation|9|||
33483031|NCT01199016|101662617|FG000|Overall Study|Other|13|||
33483032|NCT01199016|101662617|FG000|Overall Study|Withdrawal by Subject|21|||
33483033|NCT01199016|101662617|FG000|Overall Study|Lost to Follow-up|25|||
33483034|NCT01352416|101662622|FG000|Overall Study|Physician Decision|1|||
33483035|NCT01352416|101662623|FG001|Overall Study|Physician Decision|2|||
33483036|NCT01352416|101662624|FG002|Overall Study|Physician Decision|2|||
33483037|NCT01352416|101662625|FG003|Overall Study|Physician Decision|1|||
33483038|NCT01908907|101662631|FG000|Overall Study|Physician Decision|1|||
33274246|NCT00441168|100902928|FG001|Treatment Period|Progressive Disease|2|||
33483039|NCT01908907|101662632|FG001|Overall Study|Physician Decision|0|||
33483040|NCT01908907|101662631|FG000|Overall Study|Protocol Violation|1|||
33483041|NCT01908907|101662632|FG001|Overall Study|Protocol Violation|0|||
33483042|NCT00721227|101662633|FG000|Overall Study|Lost to Follow-up|3|||
33483043|NCT00721227|101662634|FG001|Overall Study|Lost to Follow-up|0|||
33483044|NCT00721227|101662633|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
33483045|NCT00721227|101662634|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
33483046|NCT00843635|101662635|FG000|Overall Study|Adverse Event|2|||
33483047|NCT00843635|101662636|FG001|Overall Study|Adverse Event|2|||
33483048|NCT00843635|101662637|FG002|Overall Study|Adverse Event|0|||
33483049|NCT04106661|101662638|FG000|Overall Study|Protocol Violation|3|||
33483050|NCT04106661|101662639|FG001|Overall Study|Protocol Violation|0|||
33483051|NCT04106661|101662638|FG000|Overall Study|Scheduling difficulties|1|||
33483052|NCT04106661|101662639|FG001|Overall Study|Scheduling difficulties|1|||
33483053|NCT01130597|101662644|FG000|Overall Study|Protocol-specified (High K+)|1|||
33483054|NCT01130597|101662644|FG000|Overall Study|Adverse Event|4|||
33483055|NCT01130597|101662644|FG000|Overall Study|Death|1|||
33483056|NCT01130597|101662644|FG000|Overall Study|Protocol Violation|1|||
33483057|NCT02695537|101662649|FG000|Overall Study|Adverse Event|3|||
33483058|NCT02695537|101662649|FG000|Overall Study|Lack of Efficacy|28|||
33483059|NCT02695537|101662649|FG000|Overall Study|Withdrawal by Subject|4|||
33483060|NCT02695537|101662649|FG000|Overall Study|Protocol Violation|3|||
33483061|NCT02242045|101662650|FG000|Overall Study|Investigator's Discretion|1|||
33483062|NCT02242045|101662650|FG000|Overall Study|Progressive Disease|2|||
33483063|NCT02242045|101662650|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
33483064|NCT02242045|101662650|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
33483065|NCT03316547|101662654|FG000|Overall Study|Death|3|||
33483066|NCT03316547|101662655|FG001|Overall Study|Death|1|||
33483067|NCT03316547|101662654|FG000|Overall Study|Lost to Follow-up|6|||
33483068|NCT03316547|101662655|FG001|Overall Study|Lost to Follow-up|6|||
33483069|NCT03316547|101662654|FG000|Overall Study|Withdrawal by Subject|3|||
33483070|NCT03316547|101662655|FG001|Overall Study|Withdrawal by Subject|2|||
33483071|NCT03316547|101662654|FG000|Overall Study|Transfer to another hospital|6|||
33274247|NCT00441168|100902927|FG000|Treatment Period|Protocol Violation|0|||
33274248|NCT00441168|100902928|FG001|Treatment Period|Protocol Violation|1|||
33274249|NCT00441168|100902927|FG000|Treatment Period|Lost to Follow-up|0|||
33274250|NCT00441168|100902928|FG001|Treatment Period|Lost to Follow-up|1|||
33274251|NCT00441168|100902927|FG000|Treatment Period|Withdrawal by Subject|3|||
33274252|NCT00441168|100902928|FG001|Treatment Period|Withdrawal by Subject|0|||
33274253|NCT00441168|100902927|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
33274254|NCT00441168|100902928|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
33274255|NCT00441168|100902927|FG000|Treatment Period|refractory disease|1|||
33274256|NCT00441168|100902928|FG001|Treatment Period|refractory disease|0|||
33274257|NCT00441168|100902927|FG000|Follow-up Period|Death|3|||
33483072|NCT03316547|101662655|FG001|Overall Study|Transfer to another hospital|4|||
33483073|NCT01590277|101662658|FG000|Overall Study|Withdrawal by Subject|3|||
33483074|NCT01590277|101662658|FG000|Overall Study|Withdrawal by Subject|2|||
33483075|NCT01590277|101662658|FG000|Overall Study|Withdrawal by Subject|1|||
33483076|NCT01590277|101662658|FG000|Overall Study|Withdrawal by Subject|1|||
33483077|NCT00340678|101662659|FG000|Overall Study|Lost to Follow-up|1|||
33483078|NCT00340678|101662660|FG001|Overall Study|Lost to Follow-up|0|||
33483079|NCT00340678|101662661|FG002|Overall Study|Lost to Follow-up|0|||
33483080|NCT00340678|101662662|FG003|Overall Study|Lost to Follow-up|0|||
33483081|NCT00143247|101662671|FG000|Overall Study|Death|8|||
33483082|NCT00143247|101662671|FG000|Overall Study|Adverse Event|19|||
33483083|NCT00143247|101662671|FG000|Overall Study|Lack of Efficacy|3|||
33483084|NCT00143247|101662671|FG000|Overall Study|Withdrawal by Subject|55|||
33483085|NCT00143247|101662671|FG000|Overall Study|Study terminated by sponsor|31|||
33483086|NCT00143247|101662671|FG000|Overall Study|Protocol Violation|15|||
33483087|NCT00143247|101662671|FG000|Overall Study|Lost to Follow-up|12|||
33483088|NCT00143247|101662671|FG000|Overall Study|following inaccurate lab adverse event|1|||
33483089|NCT00143247|101662671|FG000|Overall Study|Other|12|||
33483090|NCT01068262|101662672|FG000|Overall Study|Adverse Event|2|||
33483091|NCT01068262|101662673|FG001|Overall Study|Adverse Event|0|||
33483092|NCT01068262|101662674|FG002|Overall Study|Adverse Event|1|||
33483093|NCT01068262|101662675|FG003|Overall Study|Adverse Event|0|||
33483094|NCT01068262|101662672|FG000|Overall Study|Protocol Violation|1|||
33483095|NCT01068262|101662673|FG001|Overall Study|Protocol Violation|0|||
33483096|NCT01068262|101662674|FG002|Overall Study|Protocol Violation|0|||
33483097|NCT01068262|101662675|FG003|Overall Study|Protocol Violation|0|||
33483098|NCT01068262|101662672|FG000|Overall Study|Withdrawal by Subject|0|||
33483099|NCT01068262|101662673|FG001|Overall Study|Withdrawal by Subject|1|||
33483100|NCT01068262|101662674|FG002|Overall Study|Withdrawal by Subject|0|||
33483101|NCT01068262|101662675|FG003|Overall Study|Withdrawal by Subject|0|||
33274258|NCT00441168|100902928|FG001|Follow-up Period|Death|0|||
33274259|NCT00441168|100902927|FG000|Follow-up Period|Lost to Follow-up|5|||
33274260|NCT00441168|100902928|FG001|Follow-up Period|Lost to Follow-up|6|||
33274261|NCT00441168|100902927|FG000|Follow-up Period|Withdrawal by Subject|3|||
33483102|NCT04386616|101662676|FG000|Overall Study|Death|22|||
33483103|NCT04386616|101662677|FG001|Overall Study|Death|22|||
33286482|NCT03481556|100943977|FG000|Overall Study|Death|4|||
33483104|NCT04386616|101662678|FG002|Overall Study|Death|21|||
33483105|NCT04386616|101662676|FG000|Overall Study|Lost to Follow-up|5|||
33483106|NCT04386616|101662677|FG001|Overall Study|Lost to Follow-up|8|||
33483107|NCT04386616|101662678|FG002|Overall Study|Lost to Follow-up|6|||
33483108|NCT04386616|101662676|FG000|Overall Study|Withdrawal by Subject|2|||
33483109|NCT04386616|101662677|FG001|Overall Study|Withdrawal by Subject|4|||
33483110|NCT04386616|101662678|FG002|Overall Study|Withdrawal by Subject|1|||
33483111|NCT04386616|101662676|FG000|Overall Study|Adverse Event|1|||
33483112|NCT04386616|101662677|FG001|Overall Study|Adverse Event|1|||
33483113|NCT04386616|101662678|FG002|Overall Study|Adverse Event|0|||
33483114|NCT02068092|101662679|FG000|Overall Study|Physician Decision|2|||
33483115|NCT02068092|101662679|FG000|Overall Study|Adverse Event|2|||
33483116|NCT02068092|101662679|FG000|Overall Study|Lost to Follow-up|4|||
33483117|NCT02068092|101662679|FG000|Overall Study|Withdrawal by Subject|2|||
33483118|NCT00229723|101662680|FG000|Concomitant Phase|Adverse Event|4|||
33483119|NCT00229723|101662681|FG001|Concomitant Phase|Adverse Event|2|||
33483120|NCT00229723|101662682|FG002|Concomitant Phase|Adverse Event|5|||
33483121|NCT00229723|101662683|FG003|Concomitant Phase|Adverse Event|2|||
33483122|NCT00229723|101662684|FG004|Concomitant Phase|Adverse Event|0|||
33483123|NCT00229723|101662685|FG005|Concomitant Phase|Adverse Event|1|||
33483124|NCT00229723|101662686|FG006|Concomitant Phase|Adverse Event|2|||
33483125|NCT00229723|101662680|FG000|Concomitant Phase|Objective disease progression|0|||
33483126|NCT00229723|101662681|FG001|Concomitant Phase|Objective disease progression|0|||
33483127|NCT00229723|101662682|FG002|Concomitant Phase|Objective disease progression|0|||
33483128|NCT00229723|101662683|FG003|Concomitant Phase|Objective disease progression|0|||
33483129|NCT00229723|101662684|FG004|Concomitant Phase|Objective disease progression|0|||
33483130|NCT00229723|101662685|FG005|Concomitant Phase|Objective disease progression|0|||
33483131|NCT00229723|101662686|FG006|Concomitant Phase|Objective disease progression|0|||
33483132|NCT00229723|101662680|FG000|Concomitant Phase|Clinical progression|0|||
33483133|NCT00229723|101662681|FG001|Concomitant Phase|Clinical progression|0|||
33483134|NCT00229723|101662682|FG002|Concomitant Phase|Clinical progression|0|||
33483135|NCT00229723|101662683|FG003|Concomitant Phase|Clinical progression|0|||
33483136|NCT00229723|101662684|FG004|Concomitant Phase|Clinical progression|0|||
33483137|NCT00229723|101662685|FG005|Concomitant Phase|Clinical progression|0|||
33483138|NCT00229723|101662686|FG006|Concomitant Phase|Clinical progression|1|||
33483139|NCT00229723|101662680|FG000|Concomitant Phase|Lost to Follow-up|0|||
33483140|NCT00229723|101662681|FG001|Concomitant Phase|Lost to Follow-up|0|||
33483141|NCT00229723|101662682|FG002|Concomitant Phase|Lost to Follow-up|0|||
33483142|NCT00229723|101662683|FG003|Concomitant Phase|Lost to Follow-up|0|||
33483143|NCT00229723|101662684|FG004|Concomitant Phase|Lost to Follow-up|1|||
33483144|NCT00229723|101662685|FG005|Concomitant Phase|Lost to Follow-up|0|||
33483145|NCT00229723|101662686|FG006|Concomitant Phase|Lost to Follow-up|0|||
33483146|NCT00229723|101662680|FG000|Concomitant Phase|Informed consent withdrawn|3|||
33483147|NCT00229723|101662681|FG001|Concomitant Phase|Informed consent withdrawn|2|||
33483148|NCT00229723|101662682|FG002|Concomitant Phase|Informed consent withdrawn|0|||
33483149|NCT00229723|101662683|FG003|Concomitant Phase|Informed consent withdrawn|2|||
33483150|NCT00229723|101662684|FG004|Concomitant Phase|Informed consent withdrawn|0|||
33483151|NCT00229723|101662685|FG005|Concomitant Phase|Informed consent withdrawn|0|||
33483152|NCT00229723|101662686|FG006|Concomitant Phase|Informed consent withdrawn|0|||
33483153|NCT00229723|101662680|FG000|Concomitant Phase|Severe non-compliance|0|||
33483154|NCT00229723|101662681|FG001|Concomitant Phase|Severe non-compliance|1|||
33483155|NCT00229723|101662682|FG002|Concomitant Phase|Severe non-compliance|0|||
33483156|NCT00229723|101662683|FG003|Concomitant Phase|Severe non-compliance|0|||
33483157|NCT00229723|101662684|FG004|Concomitant Phase|Severe non-compliance|1|||
33483158|NCT00229723|101662685|FG005|Concomitant Phase|Severe non-compliance|0|||
33483159|NCT00229723|101662686|FG006|Concomitant Phase|Severe non-compliance|0|||
33483160|NCT00229723|101662680|FG000|Concomitant Phase|Other|3|||
33483161|NCT00229723|101662681|FG001|Concomitant Phase|Other|0|||
33483162|NCT00229723|101662682|FG002|Concomitant Phase|Other|1|||
33483163|NCT00229723|101662683|FG003|Concomitant Phase|Other|1|||
33483164|NCT00229723|101662684|FG004|Concomitant Phase|Other|0|||
33483165|NCT00229723|101662685|FG005|Concomitant Phase|Other|2|||
33483166|NCT00229723|101662686|FG006|Concomitant Phase|Other|0|||
33483167|NCT00229723|101662680|FG000|Maintenance Phase|Adverse Event|7|||
33483168|NCT00229723|101662681|FG001|Maintenance Phase|Adverse Event|2|||
33483169|NCT00229723|101662682|FG002|Maintenance Phase|Adverse Event|1|||
33483170|NCT00229723|101662683|FG003|Maintenance Phase|Adverse Event|4|||
33483171|NCT00229723|101662684|FG004|Maintenance Phase|Adverse Event|7|||
33483172|NCT00229723|101662685|FG005|Maintenance Phase|Adverse Event|5|||
33483173|NCT00229723|101662686|FG006|Maintenance Phase|Adverse Event|2|||
33483174|NCT00229723|101662680|FG000|Maintenance Phase|Objective disease progression|5|||
33483175|NCT00229723|101662681|FG001|Maintenance Phase|Objective disease progression|5|||
33483176|NCT00229723|101662682|FG002|Maintenance Phase|Objective disease progression|3|||
33483177|NCT00229723|101662683|FG003|Maintenance Phase|Objective disease progression|6|||
33483178|NCT00229723|101662684|FG004|Maintenance Phase|Objective disease progression|2|||
33483179|NCT00229723|101662685|FG005|Maintenance Phase|Objective disease progression|9|||
33483180|NCT00229723|101662686|FG006|Maintenance Phase|Objective disease progression|5|||
33483181|NCT00229723|101662680|FG000|Maintenance Phase|Clinical progression|4|||
33483182|NCT00229723|101662681|FG001|Maintenance Phase|Clinical progression|1|||
33483183|NCT00229723|101662682|FG002|Maintenance Phase|Clinical progression|2|||
33483184|NCT00229723|101662683|FG003|Maintenance Phase|Clinical progression|2|||
33483185|NCT00229723|101662684|FG004|Maintenance Phase|Clinical progression|1|||
33483186|NCT00229723|101662685|FG005|Maintenance Phase|Clinical progression|1|||
33483187|NCT00229723|101662686|FG006|Maintenance Phase|Clinical progression|1|||
33483188|NCT00229723|101662680|FG000|Maintenance Phase|Lost to Follow-up|0|||
33483189|NCT00229723|101662681|FG001|Maintenance Phase|Lost to Follow-up|1|||
33483190|NCT00229723|101662682|FG002|Maintenance Phase|Lost to Follow-up|2|||
33483191|NCT00229723|101662683|FG003|Maintenance Phase|Lost to Follow-up|2|||
33483192|NCT00229723|101662684|FG004|Maintenance Phase|Lost to Follow-up|0|||
33483193|NCT00229723|101662685|FG005|Maintenance Phase|Lost to Follow-up|0|||
33483194|NCT00229723|101662686|FG006|Maintenance Phase|Lost to Follow-up|1|||
33483195|NCT00229723|101662680|FG000|Maintenance Phase|Informed consent withdrawn|1|||
33483196|NCT00229723|101662681|FG001|Maintenance Phase|Informed consent withdrawn|0|||
33483197|NCT00229723|101662682|FG002|Maintenance Phase|Informed consent withdrawn|0|||
33483198|NCT00229723|101662683|FG003|Maintenance Phase|Informed consent withdrawn|1|||
33483199|NCT00229723|101662684|FG004|Maintenance Phase|Informed consent withdrawn|1|||
33483200|NCT00229723|101662685|FG005|Maintenance Phase|Informed consent withdrawn|1|||
33483201|NCT00229723|101662686|FG006|Maintenance Phase|Informed consent withdrawn|0|||
33483202|NCT00229723|101662680|FG000|Maintenance Phase|Severe non-compliance|3|||
33483203|NCT00229723|101662681|FG001|Maintenance Phase|Severe non-compliance|1|||
33483204|NCT00229723|101662682|FG002|Maintenance Phase|Severe non-compliance|0|||
33483205|NCT00229723|101662683|FG003|Maintenance Phase|Severe non-compliance|0|||
33483206|NCT00229723|101662684|FG004|Maintenance Phase|Severe non-compliance|1|||
33483207|NCT00229723|101662685|FG005|Maintenance Phase|Severe non-compliance|0|||
33483208|NCT00229723|101662686|FG006|Maintenance Phase|Severe non-compliance|0|||
33483209|NCT00229723|101662680|FG000|Maintenance Phase|Other|5|||
33483210|NCT00229723|101662681|FG001|Maintenance Phase|Other|4|||
33483211|NCT00229723|101662682|FG002|Maintenance Phase|Other|1|||
33483212|NCT00229723|101662683|FG003|Maintenance Phase|Other|2|||
33483213|NCT00229723|101662684|FG004|Maintenance Phase|Other|3|||
33483214|NCT00229723|101662685|FG005|Maintenance Phase|Other|3|||
33483215|NCT00229723|101662686|FG006|Maintenance Phase|Other|1|||
33483216|NCT01753297|101662687|FG000|Overall Study|Lost to Follow-up|7|||
33483217|NCT01753297|101662688|FG001|Overall Study|Lost to Follow-up|2|||
33483218|NCT01753297|101662687|FG000|Overall Study|Withdrawal by Subject|26|||
33483219|NCT01753297|101662688|FG001|Overall Study|Withdrawal by Subject|23|||
33483220|NCT01753297|101662687|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
33483221|NCT01753297|101662688|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
33483222|NCT01753297|101662687|FG000|Overall Study|Death|0|||
33483223|NCT01753297|101662688|FG001|Overall Study|Death|2|||
33483224|NCT01753297|101662687|FG000|Overall Study|Did not attend end of study visit|7|||
33483225|NCT01753297|101662688|FG001|Overall Study|Did not attend end of study visit|8|||
33483226|NCT00143390|101662689|FG000|Overall Study|Death|2|||
33483227|NCT00143390|101662690|FG001|Overall Study|Death|0|||
33483228|NCT00143390|101662689|FG000|Overall Study|Not meeting entry criteria|2|||
33483229|NCT00143390|101662690|FG001|Overall Study|Not meeting entry criteria|5|||
33483230|NCT00143390|101662689|FG000|Overall Study|Withdrawal by Subject|4|||
33483231|NCT00143390|101662690|FG001|Overall Study|Withdrawal by Subject|4|||
33483232|NCT00143390|101662689|FG000|Overall Study|Progressive disease|119|||
33483233|NCT00143390|101662690|FG001|Overall Study|Progressive disease|115|||
33483234|NCT00143390|101662689|FG000|Overall Study|Protocol Violation|2|||
33483235|NCT00143390|101662690|FG001|Overall Study|Protocol Violation|0|||
33483236|NCT00143390|101662689|FG000|Overall Study|Study termination|10|||
33483237|NCT00143390|101662690|FG001|Overall Study|Study termination|15|||
33483238|NCT00143390|101662689|FG000|Overall Study|Adverse Event|9|||
33483239|NCT00143390|101662690|FG001|Overall Study|Adverse Event|8|||
33483240|NCT00143390|101662689|FG000|Overall Study|Other|1|||
33483241|NCT00143390|101662690|FG001|Overall Study|Other|2|||
33483242|NCT04602546|101662708|FG000|Overall Study|Training|2|||
33483243|NCT04602546|101662709|FG001|Overall Study|Training|2|||
33483244|NCT04602546|101662710|FG002|Overall Study|Training|1|||
33483245|NCT04602546|101662711|FG003|Overall Study|Training|2|||
33483246|NCT04602546|101662712|FG004|Overall Study|Training|0|||
33483247|NCT04602546|101662708|FG000|Overall Study|Randomized with disqualified data|2|||
33483248|NCT04602546|101662709|FG001|Overall Study|Randomized with disqualified data|0|||
33483249|NCT04602546|101662710|FG002|Overall Study|Randomized with disqualified data|2|||
33274262|NCT00441168|100902928|FG001|Follow-up Period|Withdrawal by Subject|0|||
33274263|NCT00441168|100902927|FG000|Follow-up Period|Other|1|||
33274264|NCT00441168|100902928|FG001|Follow-up Period|Other|3|||
33274265|NCT00668746|100902929|FG000|Overall Study|Lost to Follow-up|2|||
33274266|NCT00668746|100902930|FG001|Overall Study|Lost to Follow-up|1|||
33274267|NCT01077284|100902931|FG000|Overall Study|Adverse Event|2|||
33483250|NCT04602546|101662711|FG003|Overall Study|Randomized with disqualified data|5|||
33483251|NCT04602546|101662712|FG004|Overall Study|Randomized with disqualified data|3|||
33483252|NCT00339144|101662773|FG000|Overall Study|Disease progression|5|||
33483253|NCT00339144|101662774|FG001|Overall Study|Disease progression|2|||
33483254|NCT00339144|101662775|FG002|Overall Study|Disease progression|2|||
33483255|NCT00339144|101662773|FG000|Overall Study|Study drug toxicity|3|||
33483256|NCT00339144|101662774|FG001|Overall Study|Study drug toxicity|1|||
33483257|NCT00339144|101662775|FG002|Overall Study|Study drug toxicity|1|||
33483258|NCT00339144|101662773|FG000|Overall Study|Participant's request to discontinuation|1|||
33483259|NCT00339144|101662774|FG001|Overall Study|Participant's request to discontinuation|0|||
33483260|NCT00339144|101662775|FG002|Overall Study|Participant's request to discontinuation|1|||
33483261|NCT04015908|101662776|FG000|Overall Study|Lost to Follow-up|0|||
33483262|NCT04015908|101662777|FG001|Overall Study|Lost to Follow-up|1|||
33483263|NCT02593110|101662779|FG000|Overall Study|Withdrawal by Subject|0|||
33483264|NCT02593110|101662780|FG001|Overall Study|Withdrawal by Subject|3|||
33483265|NCT02593110|101662781|FG002|Overall Study|Withdrawal by Subject|3|||
33483266|NCT02593110|101662782|FG003|Overall Study|Withdrawal by Subject|2|||
33483267|NCT02593110|101662779|FG000|Overall Study|Death|0|||
33483268|NCT02593110|101662780|FG001|Overall Study|Death|0|||
33483269|NCT02593110|101662781|FG002|Overall Study|Death|1|||
33483270|NCT02593110|101662782|FG003|Overall Study|Death|0|||
33483271|NCT01885195|101662785|FG000|Overall Study|Adverse Event|29|||
33483272|NCT01885195|101662785|FG000|Overall Study|Death|1|||
33483273|NCT01885195|101662785|FG000|Overall Study|Disease Progression|67|||
33483274|NCT01885195|101662785|FG000|Overall Study|Protocol Deviation|2|||
33483275|NCT01885195|101662785|FG000|Overall Study|Physician Decision|3|||
33483276|NCT01885195|101662785|FG000|Overall Study|Patient/guardian decision|8|||
33483277|NCT04040192|101662786|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
33483278|NCT04040192|101662787|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
33483279|NCT04040192|101662788|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
33483280|NCT04040192|101662786|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
33483281|NCT04040192|101662787|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
33483282|NCT04040192|101662788|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
33483283|NCT04040192|101662786|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
33483284|NCT04040192|101662787|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
33483285|NCT04040192|101662788|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
33483286|NCT04040192|101662786|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
33483287|NCT04040192|101662787|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
33483288|NCT04040192|101662788|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
33483289|NCT04040192|101662786|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
33483290|NCT04040192|101662787|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
33483291|NCT04040192|101662788|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
33483292|NCT04040192|101662786|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
33483293|NCT04040192|101662787|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
33483294|NCT04040192|101662788|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
33483295|NCT04040192|101662786|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
33483296|NCT04040192|101662787|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
33483297|NCT04040192|101662788|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
33483298|NCT04040192|101662786|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
33483299|NCT04040192|101662787|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
33483300|NCT04040192|101662788|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
33483301|NCT04040192|101662786|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
33483302|NCT04040192|101662787|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
33483303|NCT04040192|101662788|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
33483304|NCT04040192|101662786|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
33483305|NCT04040192|101662787|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
33483306|NCT04040192|101662788|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
33483307|NCT04040192|101662786|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
33483308|NCT04040192|101662787|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
33483309|NCT04040192|101662788|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
33483310|NCT04040192|101662786|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
33483311|NCT04040192|101662787|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
33483312|NCT04040192|101662788|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
33483313|NCT04040192|101662786|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
33274268|NCT01077284|100902932|FG001|Overall Study|Adverse Event|0|||
33274269|NCT01077284|100902933|FG002|Overall Study|Adverse Event|1|||
33483314|NCT04040192|101662787|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
33483315|NCT04040192|101662788|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
33483316|NCT04040192|101662786|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
33483317|NCT04040192|101662787|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
33483318|NCT04040192|101662788|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
33483319|NCT04040192|101662786|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
33483320|NCT04040192|101662787|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
33483321|NCT04040192|101662788|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
33483322|NCT04040192|101662786|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
33483323|NCT04040192|101662787|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
33483324|NCT04040192|101662788|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
33483325|NCT04040192|101662786|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
33483326|NCT04040192|101662787|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
33483327|NCT04040192|101662788|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
33483328|NCT02792699|101662800|FG000|Overall Study|Adverse Event|1|||
33483329|NCT02792699|101662801|FG001|Overall Study|Adverse Event|2|||
33483330|NCT02792699|101662802|FG002|Overall Study|Adverse Event|4|||
33483331|NCT02792699|101662800|FG000|Overall Study|Withdrawal by Subject|4|||
33483332|NCT02792699|101662801|FG001|Overall Study|Withdrawal by Subject|4|||
33483333|NCT02792699|101662802|FG002|Overall Study|Withdrawal by Subject|3|||
33483334|NCT02792699|101662800|FG000|Overall Study|Lost to Follow-up|0|||
33483335|NCT02792699|101662801|FG001|Overall Study|Lost to Follow-up|1|||
33483336|NCT02792699|101662802|FG002|Overall Study|Lost to Follow-up|2|||
33483337|NCT02792699|101662800|FG000|Overall Study|Physician Decision|2|||
33483338|NCT02792699|101662801|FG001|Overall Study|Physician Decision|0|||
33483339|NCT02792699|101662802|FG002|Overall Study|Physician Decision|0|||
33483340|NCT02792699|101662800|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
33483341|NCT02792699|101662801|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
33483342|NCT02792699|101662802|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
33483343|NCT02792699|101662800|FG000|Overall Study|Other|1|||
33483344|NCT02792699|101662801|FG001|Overall Study|Other|0|||
33483345|NCT02792699|101662802|FG002|Overall Study|Other|0|||
33483346|NCT00749892|101662803|FG000|Overall Study|Withdrawal by Subject|3|||
33483347|NCT02794870|101662804|FG000|Overall Study|Withdrawal by Subject|2|||
33483348|NCT02794870|101662805|FG001|Overall Study|Withdrawal by Subject|0|||
33483349|NCT01866098|101662806|FG000|Overall Study|Lost to Follow-up|11|||
33483350|NCT01866098|101662807|FG001|Overall Study|Lost to Follow-up|18|||
33483351|NCT01866098|101662808|FG002|Overall Study|Lost to Follow-up|13|||
33483352|NCT01866098|101662806|FG000|Overall Study|Physician Decision|0|||
33483353|NCT01866098|101662807|FG001|Overall Study|Physician Decision|1|||
33483354|NCT01866098|101662808|FG002|Overall Study|Physician Decision|2|||
33483355|NCT01866098|101662806|FG000|Overall Study|Adverse Event|1|||
33483356|NCT01866098|101662807|FG001|Overall Study|Adverse Event|5|||
33483357|NCT01866098|101662808|FG002|Overall Study|Adverse Event|4|||
33483358|NCT01866098|101662806|FG000|Overall Study|Protocol Violation|1|||
33483359|NCT01866098|101662807|FG001|Overall Study|Protocol Violation|0|||
33483360|NCT01866098|101662808|FG002|Overall Study|Protocol Violation|0|||
33483361|NCT01866098|101662806|FG000|Overall Study|Withdrawal by Subject|1|||
33483362|NCT01866098|101662807|FG001|Overall Study|Withdrawal by Subject|2|||
33483363|NCT01866098|101662808|FG002|Overall Study|Withdrawal by Subject|0|||
33483364|NCT01866098|101662806|FG000|Overall Study|Unrelated Hospitalization|2|||
33483365|NCT01866098|101662807|FG001|Overall Study|Unrelated Hospitalization|0|||
33483366|NCT01866098|101662808|FG002|Overall Study|Unrelated Hospitalization|1|||
33483367|NCT01866098|101662806|FG000|Overall Study|Non-compliance|1|||
33483368|NCT01866098|101662807|FG001|Overall Study|Non-compliance|0|||
33483369|NCT01866098|101662808|FG002|Overall Study|Non-compliance|1|||
33483370|NCT01866098|101662806|FG000|Overall Study|Pregnancy|2|||
33483371|NCT01866098|101662807|FG001|Overall Study|Pregnancy|0|||
33483372|NCT01866098|101662808|FG002|Overall Study|Pregnancy|0|||
33483373|NCT01866098|101662806|FG000|Overall Study|Death|0|||
33483374|NCT01866098|101662807|FG001|Overall Study|Death|1|||
33483375|NCT01866098|101662808|FG002|Overall Study|Death|0|||
33483376|NCT04614948|101662809|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
33483377|NCT04614948|101662810|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
33483378|NCT04614948|101662811|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
33483379|NCT04614948|101662809|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
33483380|NCT04614948|101662810|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
33483381|NCT04614948|101662811|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
33483382|NCT04614948|101662809|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
33483383|NCT04614948|101662810|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
33483384|NCT04614948|101662811|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
33483385|NCT04614948|101662809|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
33483386|NCT04614948|101662810|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
33483387|NCT04614948|101662811|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
33483388|NCT04614948|101662809|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
33483389|NCT04614948|101662810|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
33483390|NCT04614948|101662811|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
33483391|NCT04614948|101662809|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
33483392|NCT04614948|101662810|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
33483393|NCT04614948|101662811|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
33483394|NCT04614948|101662809|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
33483395|NCT04614948|101662810|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
33483396|NCT04614948|101662811|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
33483397|NCT04614948|101662809|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
33483398|NCT04614948|101662810|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
33483399|NCT04614948|101662811|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
33483400|NCT04614948|101662809|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
33483401|NCT04614948|101662810|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
33483402|NCT04614948|101662811|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
33483403|NCT04614948|101662809|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
33483404|NCT04614948|101662810|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
33483405|NCT04614948|101662811|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
33274270|NCT01077284|100902931|FG000|Overall Study|Lost to Follow-up|1|||
33274271|NCT01077284|100902932|FG001|Overall Study|Lost to Follow-up|2|||
33483406|NCT04614948|101662809|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
33483407|NCT04614948|101662810|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
33483408|NCT04614948|101662811|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
33483409|NCT04614948|101662809|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
33483410|NCT04614948|101662810|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
33483411|NCT04614948|101662811|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
33483412|NCT04614948|101662809|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
33483413|NCT04614948|101662810|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
33483414|NCT04614948|101662811|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
33483415|NCT04614948|101662809|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
33483416|NCT04614948|101662810|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
33483417|NCT04614948|101662811|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
33483418|NCT04614948|101662809|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
33483419|NCT04614948|101662810|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
33483420|NCT04614948|101662811|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
33483421|NCT04614948|101662809|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
33483422|NCT04614948|101662810|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
33483423|NCT04614948|101662811|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
33483424|NCT04614948|101662809|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
33483425|NCT04614948|101662810|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
33483426|NCT04614948|101662811|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
33483427|NCT04614948|101662809|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
33483428|NCT04614948|101662810|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
33483429|NCT04614948|101662811|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
33483430|NCT04614948|101662809|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
33483431|NCT04614948|101662810|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
33483432|NCT04614948|101662811|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
33483433|NCT04614948|101662809|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
33483434|NCT04614948|101662810|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
33483435|NCT04614948|101662811|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
33483436|NCT04614948|101662809|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
33483437|NCT04614948|101662810|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
33483438|NCT04614948|101662811|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
33483439|NCT04614948|101662809|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
33483440|NCT04614948|101662810|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
33483441|NCT04614948|101662811|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
33483442|NCT04614948|101662809|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
33483443|NCT04614948|101662810|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
33483444|NCT04614948|101662811|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
33483445|NCT00191165|101662812|FG000|Overall Study|Adverse Event|2|||
33483446|NCT00191165|101662813|FG001|Overall Study|Adverse Event|0|||
33483447|NCT00191165|101662812|FG000|Overall Study|Protocol Violation|0|||
33483448|NCT00191165|101662813|FG001|Overall Study|Protocol Violation|1|||
33483449|NCT00191165|101662812|FG000|Overall Study|Participant Moved Away|0|||
33483450|NCT00191165|101662813|FG001|Overall Study|Participant Moved Away|1|||
33483451|NCT00025259|101662823|FG000|Overall Study|Death|1|||
33483452|NCT00025259|101662824|FG001|Overall Study|Death|3|||
33483453|NCT00025259|101662825|FG002|Overall Study|Death|0|||
33274272|NCT01077284|100902933|FG002|Overall Study|Lost to Follow-up|0|||
33274273|NCT01077284|100902931|FG000|Overall Study|Withdrawal by Subject|2|||
33274274|NCT01077284|100902932|FG001|Overall Study|Withdrawal by Subject|3|||
33274275|NCT01077284|100902933|FG002|Overall Study|Withdrawal by Subject|1|||
33274276|NCT01077284|100902931|FG000|Overall Study|Other|0|||
33274277|NCT01077284|100902932|FG001|Overall Study|Other|0|||
33274278|NCT01077284|100902933|FG002|Overall Study|Other|1|||
33483454|NCT00025259|101662826|FG003|Overall Study|Death|3|||
33483455|NCT00025259|101662827|FG004|Overall Study|Death|0|||
33483456|NCT00025259|101662828|FG005|Overall Study|Death|1|||
33483457|NCT00025259|101662829|FG006|Overall Study|Death|2|||
33274279|NCT03747575|100902938|FG000|Overall Study|Withdrawal by Subject|6|||
33274280|NCT03747575|100902939|FG001|Overall Study|Withdrawal by Subject|3|||
33274281|NCT03747575|100902938|FG000|Overall Study|Lost to Follow-up|3|||
33274282|NCT03747575|100902939|FG001|Overall Study|Lost to Follow-up|3|||
33274283|NCT03747575|100902938|FG000|Overall Study|Adverse Event|0|||
33274284|NCT03747575|100902939|FG001|Overall Study|Adverse Event|1|||
33274285|NCT00547300|100902940|FG000|Overall Study|Study was Administratively Terminated|25|||
33274286|NCT00547300|100902941|FG001|Overall Study|Study was Administratively Terminated|24|||
33274287|NCT00547300|100902940|FG000|Overall Study|Did not Meet Entry Criteria|0|||
33274288|NCT00547300|100902941|FG001|Overall Study|Did not Meet Entry Criteria|2|||
33274289|NCT00848198|100902943|FG000|Overall Study|Incomplete Case Report Forms|15|||
33274290|NCT02256553|100902950|FG000|Period I|Adverse Event|5|||
33274291|NCT02256553|100902950|FG000|Period I|Protocol Violation|1|||
33274292|NCT02256553|100902950|FG000|Period II|Adverse Event|1|||
33274293|NCT02256553|100902950|FG000|Period II|Subject Moved|1|||
33274294|NCT02256553|100902950|FG000|Period III|Adverse Event|3|||
33274295|NCT00472082|100902951|FG000|Overall Study|Study prematurely terminated|5|||
33274296|NCT00535626|100902957|FG000|Overall Study|Death|15|||
33274297|NCT00535626|100902957|FG000|Overall Study|Lost to Follow-up|29|||
33274298|NCT00535626|100902957|FG000|Overall Study|Withdrawal by Subject|20|||
33274299|NCT00535626|100902957|FG000|Overall Study|Removal/revision of study component|8|||
33274300|NCT00535626|100902957|FG000|Overall Study|Subject terminated|31|||
33274301|NCT00535626|100902957|FG000|Overall Study|Unable to return|2|||
33274302|NCT01074229|100902962|FG000|Overall Study|Lost to Follow-up|1|||
33274303|NCT01074229|100902963|FG001|Overall Study|Lost to Follow-up|0|||
33274304|NCT01074229|100902964|FG002|Overall Study|Lost to Follow-up|0|||
33274305|NCT01074229|100902962|FG000|Overall Study|Change to open surgical procedure|1|||
33274306|NCT01074229|100902963|FG001|Overall Study|Change to open surgical procedure|3|||
33274307|NCT01074229|100902964|FG002|Overall Study|Change to open surgical procedure|4|||
33274308|NCT01911819|100902967|FG000|Overall Study|Adverse Event|0|||
33274309|NCT01911819|100902968|FG001|Overall Study|Adverse Event|1|||
33274310|NCT01911819|100902969|FG002|Overall Study|Adverse Event|0|||
33274311|NCT01911819|100902967|FG000|Overall Study|Withdrawal by Subject|1|||
33274312|NCT01911819|100902968|FG001|Overall Study|Withdrawal by Subject|1|||
33274313|NCT01911819|100902969|FG002|Overall Study|Withdrawal by Subject|0|||
33274314|NCT04783389|100902974|FG000|Overall Study|Withdrawal by Subject|2|||
33274315|NCT04783389|100902975|FG001|Overall Study|Withdrawal by Subject|0|||
33274316|NCT04783389|100902976|FG002|Overall Study|Withdrawal by Subject|0|||
33274317|NCT04783389|100902974|FG000|Overall Study|Termination of Study by Sponsor|10|||
33274318|NCT04783389|100902975|FG001|Overall Study|Termination of Study by Sponsor|12|||
33274319|NCT04783389|100902976|FG002|Overall Study|Termination of Study by Sponsor|14|||
33274320|NCT03906240|100902977|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
33274321|NCT03906240|100902978|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
33274322|NCT03906240|100902977|FG000|Overall Study|Lost to Follow-up|1|||
33274323|NCT03906240|100902978|FG001|Overall Study|Lost to Follow-up|0|||
33274324|NCT03906240|100902977|FG000|Overall Study|Withdrawal by Subject|0|||
33274325|NCT03906240|100902978|FG001|Overall Study|Withdrawal by Subject|1|||
33274326|NCT01180400|100902979|FG000|Overall Study|Withdrawal by Subject|5|||
33274327|NCT01180400|100902980|FG001|Overall Study|Withdrawal by Subject|6|||
33274328|NCT01180400|100902979|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
33274329|NCT01180400|100902980|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
33274330|NCT01180400|100902979|FG000|Overall Study|Adverse Event|12|||
33274331|NCT01180400|100902980|FG001|Overall Study|Adverse Event|10|||
33274332|NCT01180400|100902979|FG000|Overall Study|Severe non-compliance to protocol|1|||
33274333|NCT01180400|100902980|FG001|Overall Study|Severe non-compliance to protocol|2|||
33274334|NCT01180400|100902979|FG000|Overall Study|Condition under investigation worsened|2|||
33274335|NCT01180400|100902980|FG001|Overall Study|Condition under investigation worsened|1|||
33274336|NCT01180400|100902979|FG000|Overall Study|Lack of Efficacy|2|||
33274337|NCT01180400|100902980|FG001|Overall Study|Lack of Efficacy|0|||
33274338|NCT01180400|100902979|FG000|Overall Study|Study-specific withdrawal criteria|1|||
33274339|NCT01180400|100902980|FG001|Overall Study|Study-specific withdrawal criteria|2|||
33274340|NCT01180400|100902979|FG000|Overall Study|Lost to Follow-up|2|||
33274341|NCT01180400|100902980|FG001|Overall Study|Lost to Follow-up|3|||
33274342|NCT01180400|100902979|FG000|Overall Study|Other|0|||
33274343|NCT01180400|100902980|FG001|Overall Study|Other|1|||
33274344|NCT01721109|100902983|FG000|Overall Study|Lack of Efficacy|1|||
33274345|NCT01721109|100902983|FG000|Overall Study|Non- Compliance with Study Drug|3|||
33274346|NCT01721109|100902983|FG000|Overall Study|Withdrew Consent|1|||
33274347|NCT01721109|100902983|FG000|Overall Study|Lost to Follow-up|2|||
33274348|NCT02135445|100902984|FG000|Overall Study|Lost to Follow-up|1|||
33483458|NCT00025259|101662823|FG000|Overall Study|Lack of Efficacy|2|||
33274349|NCT02135445|100902985|FG001|Overall Study|Lost to Follow-up|0|||
33274350|NCT02135445|100902984|FG000|Overall Study|Withdrawal by Subject|1|||
33274351|NCT02135445|100902985|FG001|Overall Study|Withdrawal by Subject|0|||
33274352|NCT01426217|100902993|FG000|Overall Study|lost sample|8|||
33274353|NCT01426217|100902994|FG001|Overall Study|lost sample|14|||
33274354|NCT00942188|100902995|FG000|Overall Study|Adverse Event|0|||
33274355|NCT00942188|100902996|FG001|Overall Study|Adverse Event|3|||
33274356|NCT00942188|100902997|FG002|Overall Study|Adverse Event|2|||
33274357|NCT00942188|100902998|FG003|Overall Study|Adverse Event|0|||
33274358|NCT00942188|100902995|FG000|Overall Study|Lack of Efficacy|0|||
33274359|NCT00942188|100902996|FG001|Overall Study|Lack of Efficacy|0|||
33274360|NCT00942188|100902997|FG002|Overall Study|Lack of Efficacy|0|||
33274361|NCT00942188|100902998|FG003|Overall Study|Lack of Efficacy|1|||
33274362|NCT00942188|100902995|FG000|Overall Study|Protocol Violation|1|||
33274363|NCT00942188|100902996|FG001|Overall Study|Protocol Violation|1|||
33274364|NCT00942188|100902997|FG002|Overall Study|Protocol Violation|0|||
33274365|NCT00942188|100902998|FG003|Overall Study|Protocol Violation|0|||
33274366|NCT00942188|100902995|FG000|Overall Study|Lost to Follow-up|2|||
33274367|NCT00942188|100902996|FG001|Overall Study|Lost to Follow-up|1|||
33274368|NCT00942188|100902997|FG002|Overall Study|Lost to Follow-up|2|||
33274369|NCT00942188|100902998|FG003|Overall Study|Lost to Follow-up|0|||
33274370|NCT00942188|100902995|FG000|Overall Study|Withdrawal by Subject|1|||
33274371|NCT00942188|100902996|FG001|Overall Study|Withdrawal by Subject|3|||
33274372|NCT00942188|100902997|FG002|Overall Study|Withdrawal by Subject|4|||
33274373|NCT00942188|100902998|FG003|Overall Study|Withdrawal by Subject|2|||
33274374|NCT00942188|100902995|FG000|Overall Study|Physician Decision|0|||
33274375|NCT00942188|100902996|FG001|Overall Study|Physician Decision|0|||
33274376|NCT00942188|100902997|FG002|Overall Study|Physician Decision|1|||
33274377|NCT00942188|100902998|FG003|Overall Study|Physician Decision|0|||
33274378|NCT00942188|100902995|FG000|Overall Study|Sponsor Decision|0|||
33274379|NCT00942188|100902996|FG001|Overall Study|Sponsor Decision|2|||
33274380|NCT00942188|100902997|FG002|Overall Study|Sponsor Decision|0|||
33274381|NCT00942188|100902998|FG003|Overall Study|Sponsor Decision|1|||
33274382|NCT01280656|100902999|FG000|Overall Study|Adverse Event|1|||
33274383|NCT01280656|100903000|FG001|Overall Study|Adverse Event|14|||
33274384|NCT01280656|100903001|FG002|Overall Study|Adverse Event|13|||
33274385|NCT01280656|100902999|FG000|Overall Study|Lack of Efficacy|1|||
33274386|NCT01280656|100903000|FG001|Overall Study|Lack of Efficacy|22|||
33274387|NCT01280656|100903001|FG002|Overall Study|Lack of Efficacy|38|||
33274388|NCT01280656|100902999|FG000|Overall Study|Treatment shortening (RGT)|0|||
33274389|NCT01280656|100903000|FG001|Overall Study|Treatment shortening (RGT)|4|||
33274390|NCT01280656|100903001|FG002|Overall Study|Treatment shortening (RGT)|5|||
33274391|NCT01280656|100902999|FG000|Overall Study|Other|1|||
33274392|NCT01280656|100903000|FG001|Overall Study|Other|7|||
33274393|NCT01280656|100903001|FG002|Overall Study|Other|7|||
33274394|NCT01755598|100903002|FG000|Overall Study|Other|109|||
33274395|NCT01755598|100903003|FG001|Overall Study|Other|109|||
33274396|NCT01755598|100903002|FG000|Overall Study|Lost to Follow-up|32|||
33274397|NCT01755598|100903003|FG001|Overall Study|Lost to Follow-up|43|||
33274398|NCT01755598|100903002|FG000|Overall Study|Migrated/moved from study area|76|||
33274399|NCT01755598|100903003|FG001|Overall Study|Migrated/moved from study area|65|||
33274400|NCT01755598|100903002|FG000|Overall Study|Withdrawal by Subject|22|||
33274401|NCT01755598|100903003|FG001|Overall Study|Withdrawal by Subject|31|||
33274402|NCT01755598|100903002|FG000|Overall Study|Protocol Violation|7|||
33274403|NCT01755598|100903003|FG001|Overall Study|Protocol Violation|7|||
33274404|NCT01755598|100903002|FG000|Overall Study|Adverse Event|19|||
33274405|NCT01755598|100903003|FG001|Overall Study|Adverse Event|28|||
33274406|NCT01894620|100903004|FG000|Overall Study|Withdrawal by Subject|0|||
33274407|NCT01894620|100903005|FG001|Overall Study|Withdrawal by Subject|1|||
33274408|NCT01261793|100903012|FG000|Overall Study|Lack of Efficacy|44|||
33274409|NCT01261793|100903013|FG001|Overall Study|Lack of Efficacy|37|||
33274410|NCT01261793|100903014|FG002|Overall Study|Lack of Efficacy|32|||
33274411|NCT01261793|100903012|FG000|Overall Study|Protocol Violation|3|||
33274412|NCT01261793|100903013|FG001|Overall Study|Protocol Violation|5|||
33274413|NCT01261793|100903014|FG002|Overall Study|Protocol Violation|6|||
33274414|NCT01261793|100903012|FG000|Overall Study|Lost to Follow-up|10|||
33274415|NCT01261793|100903013|FG001|Overall Study|Lost to Follow-up|3|||
33274416|NCT01261793|100903014|FG002|Overall Study|Lost to Follow-up|7|||
33274417|NCT01261793|100903012|FG000|Overall Study|Withdrawal by Subject|12|||
33274418|NCT01261793|100903013|FG001|Overall Study|Withdrawal by Subject|14|||
33274419|NCT01261793|100903014|FG002|Overall Study|Withdrawal by Subject|14|||
33274420|NCT01261793|100903012|FG000|Overall Study|Death|3|||
33274421|NCT01261793|100903013|FG001|Overall Study|Death|1|||
33274422|NCT01261793|100903014|FG002|Overall Study|Death|0|||
33274423|NCT01261793|100903012|FG000|Overall Study|Adverse Event|9|||
33274424|NCT01261793|100903013|FG001|Overall Study|Adverse Event|24|||
33274425|NCT01261793|100903014|FG002|Overall Study|Adverse Event|19|||
33274426|NCT01261793|100903012|FG000|Overall Study|Patient non-availability|1|||
33274427|NCT01261793|100903013|FG001|Overall Study|Patient non-availability|1|||
33274428|NCT01261793|100903014|FG002|Overall Study|Patient non-availability|1|||
33274429|NCT01261793|100903012|FG000|Overall Study|Suspected pregnancy|1|||
33274430|NCT01261793|100903013|FG001|Overall Study|Suspected pregnancy|1|||
33274431|NCT01261793|100903014|FG002|Overall Study|Suspected pregnancy|0|||
33274432|NCT01261793|100903012|FG000|Overall Study|Patient non-compliance|1|||
33274433|NCT01261793|100903013|FG001|Overall Study|Patient non-compliance|0|||
33274434|NCT01261793|100903014|FG002|Overall Study|Patient non-compliance|1|||
33274435|NCT01261793|100903012|FG000|Overall Study|Patient pregnant|1|||
33274436|NCT01261793|100903013|FG001|Overall Study|Patient pregnant|0|||
33274437|NCT01261793|100903014|FG002|Overall Study|Patient pregnant|0|||
33274438|NCT01261793|100903012|FG000|Overall Study|Outside the study area|0|||
33274439|NCT01261793|100903013|FG001|Overall Study|Outside the study area|2|||
33274440|NCT01261793|100903014|FG002|Overall Study|Outside the study area|1|||
33274441|NCT01261793|100903012|FG000|Overall Study|Lack of efficacy & patient not available|0|||
33274442|NCT01261793|100903013|FG001|Overall Study|Lack of efficacy & patient not available|1|||
33274443|NCT01261793|100903014|FG002|Overall Study|Lack of efficacy & patient not available|0|||
33274444|NCT01261793|100903012|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
33274445|NCT01261793|100903013|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
33274446|NCT01261793|100903014|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
33274447|NCT01261793|100903012|FG000|Overall Study|Randomization error|0|||
33274448|NCT01261793|100903013|FG001|Overall Study|Randomization error|1|||
33274449|NCT01261793|100903014|FG002|Overall Study|Randomization error|0|||
33274450|NCT01261793|100903012|FG000|Overall Study|Patient unable to start IV line|0|||
33274451|NCT01261793|100903013|FG001|Overall Study|Patient unable to start IV line|0|||
33274452|NCT01261793|100903014|FG002|Overall Study|Patient unable to start IV line|1|||
33274453|NCT00215943|100903015|FG000|Overall Study|Disease Progression|3|||
33274454|NCT00215943|100903016|FG001|Overall Study|Disease Progression|5|||
33274455|NCT00215943|100903015|FG000|Overall Study|Alternate therapy|0|||
33274456|NCT00215943|100903016|FG001|Overall Study|Alternate therapy|1|||
33274457|NCT00215943|100903015|FG000|Overall Study|Adverse Event|3|||
33274458|NCT00215943|100903016|FG001|Overall Study|Adverse Event|6|||
33274459|NCT00215943|100903015|FG000|Overall Study|Other disease|0|||
33274460|NCT00215943|100903016|FG001|Overall Study|Other disease|1|||
33274461|NCT00215943|100903015|FG000|Overall Study|Other complications|3|||
33274462|NCT00215943|100903016|FG001|Overall Study|Other complications|1|||
33274463|NCT04743999|100903018|FG000|3-month Questionnaire|Death|1|||
33274464|NCT04743999|100903018|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
33274465|NCT04743999|100903018|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
33274466|NCT04743999|100903018|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
33274467|NCT02465866|100903026|FG000|Period 3|Withdrawal by Subject|0|||
33274468|NCT02465866|100903027|FG001|Period 3|Withdrawal by Subject|1|||
33274469|NCT02465866|100903028|FG002|Period 3|Withdrawal by Subject|0|||
33274470|NCT02465866|100903029|FG003|Period 3|Withdrawal by Subject|0|||
33274471|NCT01215253|100903032|FG000|Overall Study|Withdrawal by Subject|57|||
33274472|NCT01215253|100903033|FG001|Overall Study|Withdrawal by Subject|35|||
33274473|NCT01215253|100903032|FG000|Overall Study|Physician Decision|9|||
33274474|NCT01215253|100903033|FG001|Overall Study|Physician Decision|12|||
33274475|NCT01215253|100903032|FG000|Overall Study|Lost to Follow-up|6|||
33274476|NCT01215253|100903033|FG001|Overall Study|Lost to Follow-up|4|||
33274477|NCT01215253|100903032|FG000|Overall Study|Other|14|||
33274478|NCT01215253|100903033|FG001|Overall Study|Other|12|||
33274479|NCT01133678|100903034|FG000|Overall Study|Death|1|||
33274480|NCT01133678|100903035|FG001|Overall Study|Death|1|||
33274481|NCT00732498|100903038|FG000|Overall Study|Ineligible|1|||
33274482|NCT00732498|100903038|FG000|Overall Study|Adverse Event|2|||
33274483|NCT00732498|100903038|FG000|Overall Study|Physician Decision|3|||
33274484|NCT01804140|100903044|FG000|Overall Study|No sampling or biopsy procedures done|114|||
33274485|NCT02206607|100903045|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
33274486|NCT02206607|100903046|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
33274487|NCT02206607|100903047|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
33274488|NCT02206607|100903048|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
33274489|NCT02206607|100903049|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
33274490|NCT02206607|100903045|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
33483459|NCT00025259|101662824|FG001|Overall Study|Lack of Efficacy|46|||
33274491|NCT02206607|100903046|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
33274492|NCT02206607|100903047|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
33274493|NCT02206607|100903048|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
33274494|NCT02206607|100903049|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
33274495|NCT03694210|100903050|FG000|Overall Study|Death|1|||
33274496|NCT03694210|100903050|FG000|Overall Study|Screen Failure|7|||
33274497|NCT00889863|100903055|FG000|Part I: Open Label|Death|1|||
33274498|NCT00889863|100903056|FG001|Part I: Open Label|Death|0|||
33274499|NCT00889863|100903055|FG000|Part I: Open Label|Adverse Event|4|||
33274500|NCT00889863|100903056|FG001|Part I: Open Label|Adverse Event|0|||
33274501|NCT00889863|100903055|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
33274502|NCT00889863|100903056|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
33274503|NCT00889863|100903055|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
33274504|NCT00889863|100903056|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
33274505|NCT00889863|100903055|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
33274506|NCT00889863|100903056|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
33274507|NCT00889863|100903055|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
33274508|NCT00889863|100903056|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
33274509|NCT00889863|100903055|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
33274510|NCT00889863|100903056|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
33274511|NCT00157209|100903057|FG000|Overall Study|Ongoing at data cut-off|10|||
33274512|NCT00157209|100903058|FG001|Overall Study|Ongoing at data cut-off|0|||
33274513|NCT03557307|100903062|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
33274514|NCT03557307|100903062|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
33274515|NCT03557307|100903062|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
33274516|NCT03557307|100903062|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
33274517|NCT03557307|100903062|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
33274518|NCT03557307|100903062|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
33274519|NCT03557307|100903062|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
33274520|NCT03557307|100903062|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
33274521|NCT03557307|100903062|FG000|Period 2: Maintenance Phase|Death|3|||
33274522|NCT03557307|100903062|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
33274523|NCT03557307|100903062|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
33274524|NCT03557307|100903062|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
33274525|NCT03557307|100903062|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
33274526|NCT03557307|100903062|FG000|Period 2: Maintenance Phase|other|3|||
33274527|NCT03873038|100903065|FG000|Part 2|Withdrawal by Subject|0|||
33274528|NCT03873038|100903066|FG001|Part 2|Withdrawal by Subject|0|||
33274529|NCT03873038|100903067|FG002|Part 2|Withdrawal by Subject|0|||
33274530|NCT03873038|100903068|FG003|Part 2|Withdrawal by Subject|0|||
33274531|NCT03873038|100903069|FG004|Part 2|Withdrawal by Subject|0|||
33274532|NCT03873038|100903070|FG005|Part 2|Withdrawal by Subject|1|||
33274533|NCT03873038|100903065|FG000|Part 2|Unknon|0|||
33274534|NCT03873038|100903066|FG001|Part 2|Unknon|0|||
33274535|NCT03873038|100903067|FG002|Part 2|Unknon|0|||
33274536|NCT03873038|100903068|FG003|Part 2|Unknon|0|||
33274537|NCT03873038|100903069|FG004|Part 2|Unknon|1|||
33274538|NCT03873038|100903070|FG005|Part 2|Unknon|0|||
33274539|NCT00424476|100903071|FG000|Overall Study|Withdrawal by Subject|7|||
33274540|NCT00424476|100903072|FG001|Overall Study|Withdrawal by Subject|6|||
33274541|NCT00424476|100903073|FG002|Overall Study|Withdrawal by Subject|3|||
33274542|NCT00424476|100903071|FG000|Overall Study|Adverse Event|19|||
33274543|NCT00424476|100903072|FG001|Overall Study|Adverse Event|16|||
33274544|NCT00424476|100903073|FG002|Overall Study|Adverse Event|15|||
33274545|NCT00424476|100903071|FG000|Overall Study|Lack of Efficacy|16|||
33274546|NCT00424476|100903072|FG001|Overall Study|Lack of Efficacy|12|||
33274547|NCT00424476|100903073|FG002|Overall Study|Lack of Efficacy|12|||
33274548|NCT00424476|100903071|FG000|Overall Study|Lack of Compliance|1|||
33274549|NCT00424476|100903072|FG001|Overall Study|Lack of Compliance|1|||
33274550|NCT00424476|100903073|FG002|Overall Study|Lack of Compliance|1|||
33274551|NCT00424476|100903071|FG000|Overall Study|Lost to Follow-up|4|||
33274552|NCT00424476|100903072|FG001|Overall Study|Lost to Follow-up|6|||
33274553|NCT00424476|100903073|FG002|Overall Study|Lost to Follow-up|3|||
33274554|NCT00424476|100903071|FG000|Overall Study|Protocol Violation|7|||
33274555|NCT00424476|100903072|FG001|Overall Study|Protocol Violation|2|||
33274556|NCT00424476|100903073|FG002|Overall Study|Protocol Violation|3|||
33274557|NCT00424476|100903071|FG000|Overall Study|Physician Decision|3|||
33274558|NCT00424476|100903072|FG001|Overall Study|Physician Decision|2|||
33274559|NCT00424476|100903073|FG002|Overall Study|Physician Decision|3|||
33274560|NCT00424476|100903071|FG000|Overall Study|Other|4|||
33274561|NCT00424476|100903072|FG001|Overall Study|Other|3|||
33274562|NCT00424476|100903073|FG002|Overall Study|Other|9|||
33274563|NCT04626128|100903074|FG000|Overall Study|Withdrawal by Subject|0|||
33274564|NCT04626128|100903075|FG001|Overall Study|Withdrawal by Subject|1|||
33274565|NCT04626128|100903076|FG002|Overall Study|Withdrawal by Subject|0|||
33274566|NCT04626128|100903077|FG003|Overall Study|Withdrawal by Subject|0|||
33274567|NCT01123356|100903078|FG000|Overall Study|Adverse Event|2|||
33274568|NCT01123356|100903078|FG000|Overall Study|Lack of Efficacy|4|||
33274569|NCT01123356|100903078|FG000|Overall Study|Withdrawal by Subject|1|||
33274570|NCT03602053|100903079|FG000|Overall Study|Withdrawal by Subject|7|||
33483460|NCT00025259|101662825|FG002|Overall Study|Lack of Efficacy|60|||
33274571|NCT03602053|100903080|FG001|Overall Study|Withdrawal by Subject|9|||
33274572|NCT03602053|100903081|FG002|Overall Study|Withdrawal by Subject|7|||
33274573|NCT03602053|100903079|FG000|Overall Study|Lost to Follow-up|5|||
33274574|NCT03602053|100903080|FG001|Overall Study|Lost to Follow-up|6|||
33274575|NCT03602053|100903081|FG002|Overall Study|Lost to Follow-up|0|||
33274576|NCT03602053|100903079|FG000|Overall Study|Protocol Violation|3|||
33274577|NCT03602053|100903080|FG001|Overall Study|Protocol Violation|0|||
33274578|NCT03602053|100903081|FG002|Overall Study|Protocol Violation|4|||
33274579|NCT03602053|100903079|FG000|Overall Study|Physician Decision|1|||
33274580|NCT03602053|100903080|FG001|Overall Study|Physician Decision|0|||
33274581|NCT03602053|100903081|FG002|Overall Study|Physician Decision|0|||
33274582|NCT03602053|100903079|FG000|Overall Study|migration|2|||
33274583|NCT03602053|100903080|FG001|Overall Study|migration|3|||
33274584|NCT03602053|100903081|FG002|Overall Study|migration|0|||
33274585|NCT03602053|100903079|FG000|Overall Study|Other|1|||
33274586|NCT03602053|100903080|FG001|Overall Study|Other|0|||
33274587|NCT03602053|100903081|FG002|Overall Study|Other|0|||
33274588|NCT00379210|100903082|FG000|Overall Study|Withdrawal by Subject|10|||
33274589|NCT00379210|100903083|FG001|Overall Study|Withdrawal by Subject|7|||
33274590|NCT02291861|100903084|FG000|Overall Study|Adverse Event|2|||
33274591|NCT02291861|100903085|FG001|Overall Study|Adverse Event|4|||
33274592|NCT02291861|100903086|FG002|Overall Study|Adverse Event|1|||
33274593|NCT02291861|100903087|FG003|Overall Study|Adverse Event|2|||
33274594|NCT02291861|100903084|FG000|Overall Study|Death|0|||
33274595|NCT02291861|100903085|FG001|Overall Study|Death|0|||
33274596|NCT02291861|100903086|FG002|Overall Study|Death|1|||
33274597|NCT02291861|100903087|FG003|Overall Study|Death|1|||
33274598|NCT02291861|100903084|FG000|Overall Study|Protocol Violation|1|||
33274599|NCT02291861|100903085|FG001|Overall Study|Protocol Violation|0|||
33274600|NCT02291861|100903086|FG002|Overall Study|Protocol Violation|0|||
33274601|NCT02291861|100903087|FG003|Overall Study|Protocol Violation|1|||
33274602|NCT02291861|100903084|FG000|Overall Study|Withdrawal by Subject|1|||
33274603|NCT02291861|100903085|FG001|Overall Study|Withdrawal by Subject|2|||
33274604|NCT02291861|100903086|FG002|Overall Study|Withdrawal by Subject|1|||
33274605|NCT02291861|100903087|FG003|Overall Study|Withdrawal by Subject|4|||
33274606|NCT02291861|100903084|FG000|Overall Study|Noncompliance|1|||
33274607|NCT02291861|100903085|FG001|Overall Study|Noncompliance|1|||
33274608|NCT02291861|100903086|FG002|Overall Study|Noncompliance|2|||
33274609|NCT02291861|100903087|FG003|Overall Study|Noncompliance|1|||
33274610|NCT02291861|100903084|FG000|Overall Study|Lost to Follow-up|2|||
33274611|NCT02291861|100903085|FG001|Overall Study|Lost to Follow-up|1|||
33274612|NCT02291861|100903086|FG002|Overall Study|Lost to Follow-up|4|||
33274613|NCT02291861|100903087|FG003|Overall Study|Lost to Follow-up|0|||
33274614|NCT02291861|100903084|FG000|Overall Study|Other|0|||
33274615|NCT02291861|100903085|FG001|Overall Study|Other|0|||
33274616|NCT02291861|100903086|FG002|Overall Study|Other|0|||
33274617|NCT02291861|100903087|FG003|Overall Study|Other|1|||
33274618|NCT05265247|100906481|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
33274619|NCT05265247|100906482|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
33274620|NCT05265247|100906481|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
33274621|NCT05265247|100906482|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
33274622|NCT05265247|100906481|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
33274623|NCT05265247|100906482|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
33274624|NCT01241448|100906485|FG000|Overall Study|Adverse Event|1|||
33274625|NCT01241448|100906486|FG001|Overall Study|Adverse Event|0|||
33274626|NCT01241448|100906487|FG002|Overall Study|Adverse Event|2|||
33274627|NCT01241448|100906488|FG003|Overall Study|Adverse Event|2|||
33274628|NCT01241448|100906485|FG000|Overall Study|Lost to Follow-up|2|||
33274629|NCT01241448|100906486|FG001|Overall Study|Lost to Follow-up|1|||
33274630|NCT01241448|100906487|FG002|Overall Study|Lost to Follow-up|1|||
33274631|NCT01241448|100906488|FG003|Overall Study|Lost to Follow-up|1|||
33274632|NCT01241448|100906485|FG000|Overall Study|Physician Decision|0|||
33274633|NCT01241448|100906486|FG001|Overall Study|Physician Decision|2|||
33274634|NCT01241448|100906487|FG002|Overall Study|Physician Decision|0|||
33274635|NCT01241448|100906488|FG003|Overall Study|Physician Decision|0|||
33274636|NCT01241448|100906485|FG000|Overall Study|Protocol Violation|10|||
33274637|NCT01241448|100906486|FG001|Overall Study|Protocol Violation|5|||
33274638|NCT01241448|100906487|FG002|Overall Study|Protocol Violation|3|||
33274639|NCT01241448|100906488|FG003|Overall Study|Protocol Violation|6|||
33274640|NCT01241448|100906485|FG000|Overall Study|Sponsor Decision|17|||
33274641|NCT01241448|100906486|FG001|Overall Study|Sponsor Decision|14|||
33274642|NCT01241448|100906487|FG002|Overall Study|Sponsor Decision|12|||
33274643|NCT01241448|100906488|FG003|Overall Study|Sponsor Decision|6|||
33274644|NCT01241448|100906485|FG000|Overall Study|Withdrawal by Subject|4|||
33274645|NCT01241448|100906486|FG001|Overall Study|Withdrawal by Subject|5|||
33274646|NCT01241448|100906487|FG002|Overall Study|Withdrawal by Subject|3|||
33274647|NCT01241448|100906488|FG003|Overall Study|Withdrawal by Subject|6|||
33274648|NCT01241448|100906485|FG000|Overall Study|Excluded due to data integrity issues|3|||
33274649|NCT01241448|100906486|FG001|Overall Study|Excluded due to data integrity issues|2|||
33274650|NCT01241448|100906487|FG002|Overall Study|Excluded due to data integrity issues|2|||
33274651|NCT01241448|100906488|FG003|Overall Study|Excluded due to data integrity issues|2|||
33274652|NCT02830893|100906489|FG000|Overall Study|Relocation to out of the country|1|||
33274653|NCT02830893|100906490|FG001|Overall Study|Relocation to out of the country|0|||
33274654|NCT02830893|100906489|FG000|Overall Study|Lost to Follow-up|0|||
33274655|NCT02830893|100906490|FG001|Overall Study|Lost to Follow-up|2|||
33274656|NCT02830893|100906489|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
33274657|NCT02830893|100906490|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
33274658|NCT03481725|100906492|FG000|Overall Study|Withdrawal by Subject|1|||
33274659|NCT03481725|100906493|FG001|Overall Study|Withdrawal by Subject|0|||
33274660|NCT05072795|100906494|FG000|Overall Study|Lost to Follow-up|5|||
33274661|NCT04271254|100906497|FG000|Overall Study|Withdrawal by Subject|3|||
33274662|NCT04454125|100906499|FG000|Overall Study|Lost to Follow-up|0|||
33274663|NCT04454125|100906500|FG001|Overall Study|Lost to Follow-up|1|||
33274664|NCT00460434|100906501|FG000|Overall Study|Lost to Follow-up|3|||
33274665|NCT00460434|100906502|FG001|Overall Study|Lost to Follow-up|7|||
33274666|NCT02548585|100906503|FG000|Overall Study|Withdrawal by Subject|0|||
33274667|NCT02548585|100906504|FG001|Overall Study|Withdrawal by Subject|0|||
33274668|NCT02548585|100906505|FG002|Overall Study|Withdrawal by Subject|0|||
33274669|NCT02548585|100906506|FG003|Overall Study|Withdrawal by Subject|0|||
33274670|NCT02548585|100906507|FG004|Overall Study|Withdrawal by Subject|0|||
33274671|NCT02548585|100906508|FG005|Overall Study|Withdrawal by Subject|1|||
33274672|NCT02548585|100906509|FG006|Overall Study|Withdrawal by Subject|0|||
33274673|NCT02548585|100906503|FG000|Overall Study|Lost to Follow-up|1|||
33274674|NCT02548585|100906504|FG001|Overall Study|Lost to Follow-up|0|||
33274675|NCT02548585|100906505|FG002|Overall Study|Lost to Follow-up|0|||
33274676|NCT02548585|100906506|FG003|Overall Study|Lost to Follow-up|0|||
33274677|NCT02548585|100906507|FG004|Overall Study|Lost to Follow-up|0|||
33274678|NCT02548585|100906508|FG005|Overall Study|Lost to Follow-up|0|||
33274679|NCT02548585|100906509|FG006|Overall Study|Lost to Follow-up|0|||
33274680|NCT02548585|100906503|FG000|Overall Study|Other|1|||
33274681|NCT02548585|100906504|FG001|Overall Study|Other|0|||
33274682|NCT02548585|100906505|FG002|Overall Study|Other|0|||
33274683|NCT02548585|100906506|FG003|Overall Study|Other|2|||
33274684|NCT02548585|100906507|FG004|Overall Study|Other|3|||
33274685|NCT02548585|100906508|FG005|Overall Study|Other|0|||
33274686|NCT02548585|100906509|FG006|Overall Study|Other|1|||
33274687|NCT02548585|100906503|FG000|Overall Study|Randomized but not treated|0|||
33274688|NCT02548585|100906504|FG001|Overall Study|Randomized but not treated|0|||
33274689|NCT02548585|100906505|FG002|Overall Study|Randomized but not treated|0|||
33274690|NCT02548585|100906506|FG003|Overall Study|Randomized but not treated|0|||
33274691|NCT02548585|100906507|FG004|Overall Study|Randomized but not treated|0|||
33274692|NCT02548585|100906508|FG005|Overall Study|Randomized but not treated|1|||
33274693|NCT02548585|100906509|FG006|Overall Study|Randomized but not treated|0|||
33274694|NCT01922102|100906514|FG000|Overall Study|Withdrawal by Subject|7|||
33274695|NCT01922102|100906515|FG001|Overall Study|Withdrawal by Subject|3|||
33274696|NCT01922102|100906516|FG002|Overall Study|Withdrawal by Subject|7|||
33274697|NCT01922102|100906514|FG000|Overall Study|Physician Decision|0|||
33274698|NCT01922102|100906515|FG001|Overall Study|Physician Decision|2|||
33274699|NCT01922102|100906516|FG002|Overall Study|Physician Decision|1|||
33274700|NCT01922102|100906514|FG000|Overall Study|Adverse Event|1|||
33274701|NCT01922102|100906515|FG001|Overall Study|Adverse Event|2|||
33274702|NCT01922102|100906516|FG002|Overall Study|Adverse Event|0|||
33274703|NCT01922102|100906514|FG000|Overall Study|Lost to Follow-up|1|||
33274704|NCT01922102|100906515|FG001|Overall Study|Lost to Follow-up|0|||
33274705|NCT01922102|100906516|FG002|Overall Study|Lost to Follow-up|0|||
33274706|NCT01922102|100906514|FG000|Overall Study|Administrative problems|0|||
33274707|NCT01922102|100906515|FG001|Overall Study|Administrative problems|2|||
33274708|NCT01922102|100906516|FG002|Overall Study|Administrative problems|0|||
33274709|NCT03562117|100906517|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
33274710|NCT03562117|100906518|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
33274711|NCT03562117|100906519|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
33274712|NCT01277302|100906540|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
33274713|NCT01277302|100906541|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
33274714|NCT01277302|100906542|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
33274715|NCT01277302|100906540|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
33274716|NCT01277302|100906541|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
33274717|NCT01277302|100906542|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
33274718|NCT01277302|100906540|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
33274719|NCT01277302|100906541|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
33274720|NCT01277302|100906542|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
33274721|NCT01277302|100906540|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
33274722|NCT01277302|100906541|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
33274723|NCT01277302|100906542|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
33274724|NCT01277302|100906540|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
33274725|NCT01277302|100906541|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
33274726|NCT01277302|100906542|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
33274727|NCT01277302|100906540|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
33274728|NCT01277302|100906541|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
33274729|NCT01277302|100906542|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
33274730|NCT01277302|100906540|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
33274731|NCT01277302|100906541|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
33483461|NCT00025259|101662826|FG003|Overall Study|Lack of Efficacy|78|||
33274732|NCT01277302|100906542|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
33274733|NCT01277302|100906540|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
33274734|NCT01277302|100906541|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
33274735|NCT01277302|100906542|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
33274736|NCT01277302|100906540|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
33274737|NCT01277302|100906541|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
33274738|NCT01277302|100906542|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
33274739|NCT05810285|100906543|FG000|Overall Study|Death|4|||
33274740|NCT05810285|100906544|FG001|Overall Study|Death|21|||
33274741|NCT05810285|100906543|FG000|Overall Study|Adverse Event|18|||
33274742|NCT05810285|100906544|FG001|Overall Study|Adverse Event|16|||
33274743|NCT02005484|100906550|FG000|Overall Study|Death|1|||
33274744|NCT02005484|100906550|FG000|Overall Study|Disease progression|1|||
33274745|NCT02005484|100906550|FG000|Overall Study|Changed to a Different Study|1|||
33274746|NCT02005484|100906550|FG000|Overall Study|Sponsor decision|1|||
33274747|NCT03839355|100906551|FG000|Overall Study|Withdrawal by Subject|1|||
33274748|NCT03839355|100906552|FG001|Overall Study|Withdrawal by Subject|0|||
33274749|NCT01540474|100906553|FG000|Vaccination Period|Lost to Follow-up|0|||
33274750|NCT01540474|100906554|FG001|Vaccination Period|Lost to Follow-up|1|||
33274751|NCT01540474|100906555|FG002|Vaccination Period|Lost to Follow-up|0|||
33274752|NCT01540474|100906556|FG003|Vaccination Period|Lost to Follow-up|0|||
33274753|NCT01912599|100906559|FG000|Overall Study|Withdrawal by Subject|0|||
33274754|NCT01912599|100906560|FG001|Overall Study|Withdrawal by Subject|1|||
33274755|NCT03529942|100906567|FG000|Overall Study|Withdrawal by Subject|13|||
33274756|NCT03529942|100906567|FG000|Overall Study|Physician Decision|1|||
33274757|NCT03529942|100906567|FG000|Overall Study|Lost to Follow-up|7|||
33274758|NCT03529942|100906567|FG000|Overall Study|Needle inserted but no drug administered|1|||
33274759|NCT03529942|100906567|FG000|Overall Study|Personal reasons|1|||
33274760|NCT04879823|100906568|FG000|Overall Study|Physician Decision|3|||
33274761|NCT04879823|100906569|FG001|Overall Study|Physician Decision|1|||
33274762|NCT04879823|100906568|FG000|Overall Study|Protocol Violation|2|||
33274763|NCT04879823|100906569|FG001|Overall Study|Protocol Violation|3|||
33274764|NCT04879823|100906568|FG000|Overall Study|Lost to Follow-up|43|||
33274765|NCT04879823|100906569|FG001|Overall Study|Lost to Follow-up|35|||
33274766|NCT01393964|100906570|FG000|Overall Study|Disease Progression|4|||
33274767|NCT01393964|100906571|FG001|Overall Study|Disease Progression|3|||
33274768|NCT01393964|100906572|FG002|Overall Study|Disease Progression|5|||
33274769|NCT01393964|100906570|FG000|Overall Study|Study drug toxicity|1|||
33274770|NCT01393964|100906571|FG001|Overall Study|Study drug toxicity|0|||
33274771|NCT01393964|100906572|FG002|Overall Study|Study drug toxicity|0|||
33274772|NCT01393964|100906570|FG000|Overall Study|Withdrawal by Subject|0|||
33274773|NCT01393964|100906571|FG001|Overall Study|Withdrawal by Subject|0|||
33274774|NCT01393964|100906572|FG002|Overall Study|Withdrawal by Subject|1|||
33274775|NCT01393964|100906570|FG000|Overall Study|Adverse event unrelated to study drug|0|||
33274776|NCT01393964|100906571|FG001|Overall Study|Adverse event unrelated to study drug|3|||
33274777|NCT01393964|100906572|FG002|Overall Study|Adverse event unrelated to study drug|0|||
33274778|NCT01393964|100906570|FG000|Overall Study|Subject request stop study treatment|0|||
33274779|NCT01393964|100906571|FG001|Overall Study|Subject request stop study treatment|1|||
33274780|NCT01393964|100906572|FG002|Overall Study|Subject request stop study treatment|0|||
33274781|NCT01393964|100906570|FG000|Overall Study|Subject decided to move to transplant|1|||
33274782|NCT01393964|100906571|FG001|Overall Study|Subject decided to move to transplant|0|||
33274783|NCT01393964|100906572|FG002|Overall Study|Subject decided to move to transplant|0|||
33274784|NCT01393964|100906570|FG000|Overall Study|Subject switched to commercial supply|1|||
33274785|NCT01393964|100906571|FG001|Overall Study|Subject switched to commercial supply|0|||
33274786|NCT01393964|100906572|FG002|Overall Study|Subject switched to commercial supply|2|||
33274787|NCT01393964|100906570|FG000|Overall Study|Subject plateaued in terms of effect|1|||
33274788|NCT01393964|100906571|FG001|Overall Study|Subject plateaued in terms of effect|0|||
33274789|NCT01393964|100906572|FG002|Overall Study|Subject plateaued in terms of effect|0|||
33274790|NCT01393964|100906570|FG000|Overall Study|Investigator removed subject from study|0|||
33274791|NCT01393964|100906571|FG001|Overall Study|Investigator removed subject from study|1|||
33274792|NCT01393964|100906572|FG002|Overall Study|Investigator removed subject from study|0|||
33274793|NCT01393964|100906570|FG000|Overall Study|Subject converted to roll-over study|0|||
33274794|NCT01393964|100906571|FG001|Overall Study|Subject converted to roll-over study|1|||
33274795|NCT01393964|100906572|FG002|Overall Study|Subject converted to roll-over study|0|||
33274796|NCT01393964|100906570|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
33274797|NCT01393964|100906571|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
33274798|NCT01393964|100906572|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
33274799|NCT04050722|100906573|FG000|Overall Study|Withdrawal by Subject|1|||
33274800|NCT04050722|100906574|FG001|Overall Study|Withdrawal by Subject|0|||
33274801|NCT00748098|100906575|FG000|First Treatment Intervention Period|Adverse Event|1|||
33274802|NCT00748098|100906576|FG001|First Treatment Intervention Period|Adverse Event|1|||
33274803|NCT00748098|100906575|FG000|First Treatment Intervention Period|Protocol Violation|1|||
33274804|NCT00748098|100906576|FG001|First Treatment Intervention Period|Protocol Violation|0|||
33274805|NCT00748098|100906575|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
33274806|NCT00748098|100906576|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
33274807|NCT00748098|100906575|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
33274808|NCT00748098|100906576|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
33274809|NCT00748098|100906575|FG000|First Taper Period|Protocol Violation|1|||
33274810|NCT00748098|100906576|FG001|First Taper Period|Protocol Violation|0|||
33274811|NCT00748098|100906575|FG000|First Taper Period|Withdrawal by Subject|2|||
33274812|NCT00748098|100906576|FG001|First Taper Period|Withdrawal by Subject|0|||
33274813|NCT00748098|100906575|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
33274814|NCT00748098|100906576|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
33274815|NCT00748098|100906575|FG000|1-Week Washout Period|Adverse Event|0|||
33274816|NCT00748098|100906576|FG001|1-Week Washout Period|Adverse Event|1|||
33274817|NCT00748098|100906575|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
33274818|NCT00748098|100906576|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
33274819|NCT00748098|100906575|FG000|Second Treatment Intervention Period|Adverse Event|4|||
33274820|NCT00748098|100906576|FG001|Second Treatment Intervention Period|Adverse Event|1|||
33274821|NCT00748098|100906575|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
33274822|NCT00748098|100906576|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
33274823|NCT00748098|100906575|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
33274824|NCT00748098|100906576|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
33274825|NCT02799745|100906577|FG000|Overall Study|Participant moved out of state|1|||
33274826|NCT02799745|100906578|FG001|Overall Study|Participant moved out of state|0|||
33274827|NCT02799745|100906577|FG000|Overall Study|Discontinued due to planned surgery|1|||
33274828|NCT02799745|100906578|FG001|Overall Study|Discontinued due to planned surgery|0|||
33274829|NCT02799745|100906577|FG000|Overall Study|Withdrawal by Subject|16|||
33274830|NCT02799745|100906578|FG001|Overall Study|Withdrawal by Subject|25|||
33274831|NCT02799745|100906577|FG000|Overall Study|Protocol Deviation|4|||
33274832|NCT02799745|100906578|FG001|Overall Study|Protocol Deviation|5|||
33274833|NCT02799745|100906577|FG000|Overall Study|Progressive Disease|28|||
33274834|NCT02799745|100906578|FG001|Overall Study|Progressive Disease|38|||
33274835|NCT02799745|100906577|FG000|Overall Study|Lost to Follow-up|3|||
33274836|NCT02799745|100906578|FG001|Overall Study|Lost to Follow-up|2|||
33274837|NCT02799745|100906577|FG000|Overall Study|Death|3|||
33274838|NCT02799745|100906578|FG001|Overall Study|Death|0|||
33274839|NCT02799745|100906577|FG000|Overall Study|Adverse Event|0|||
33274840|NCT02799745|100906578|FG001|Overall Study|Adverse Event|1|||
33274841|NCT00555620|100906579|FG000|Overall Study|Death|0|||
33274842|NCT00555620|100906580|FG001|Overall Study|Death|1|||
33274843|NCT00555620|100906581|FG002|Overall Study|Death|0|||
33274844|NCT00555620|100906582|FG003|Overall Study|Death|0|||
33274845|NCT00555620|100906583|FG004|Overall Study|Death|0|||
33274846|NCT00555620|100906584|FG005|Overall Study|Death|1|||
33274847|NCT00555620|100906579|FG000|Overall Study|Study terminated by sponsor|0|||
33274848|NCT00555620|100906580|FG001|Overall Study|Study terminated by sponsor|0|||
33274849|NCT00555620|100906581|FG002|Overall Study|Study terminated by sponsor|1|||
33274850|NCT00555620|100906582|FG003|Overall Study|Study terminated by sponsor|0|||
33274851|NCT00555620|100906583|FG004|Overall Study|Study terminated by sponsor|0|||
33274852|NCT00555620|100906584|FG005|Overall Study|Study terminated by sponsor|0|||
33274853|NCT00555620|100906579|FG000|Overall Study|Adverse Event|0|||
33274854|NCT00555620|100906580|FG001|Overall Study|Adverse Event|0|||
33274855|NCT00555620|100906581|FG002|Overall Study|Adverse Event|1|||
33274856|NCT00555620|100906582|FG003|Overall Study|Adverse Event|5|||
33274857|NCT00555620|100906583|FG004|Overall Study|Adverse Event|0|||
33274858|NCT00555620|100906584|FG005|Overall Study|Adverse Event|1|||
33274859|NCT00555620|100906579|FG000|Overall Study|Objective progression or relapse|6|||
33274860|NCT00555620|100906580|FG001|Overall Study|Objective progression or relapse|5|||
33274861|NCT00555620|100906581|FG002|Overall Study|Objective progression or relapse|12|||
33274862|NCT00555620|100906582|FG003|Overall Study|Objective progression or relapse|17|||
33274863|NCT00555620|100906583|FG004|Overall Study|Objective progression or relapse|3|||
33274864|NCT00555620|100906584|FG005|Overall Study|Objective progression or relapse|16|||
33274865|NCT00555620|100906579|FG000|Overall Study|Participant refused treatment|0|||
33274866|NCT00555620|100906580|FG001|Overall Study|Participant refused treatment|1|||
33274867|NCT00555620|100906581|FG002|Overall Study|Participant refused treatment|1|||
33274868|NCT00555620|100906582|FG003|Overall Study|Participant refused treatment|0|||
33274869|NCT00555620|100906583|FG004|Overall Study|Participant refused treatment|0|||
33274870|NCT00555620|100906584|FG005|Overall Study|Participant refused treatment|1|||
33274871|NCT00555620|100906579|FG000|Overall Study|Other|0|||
33274872|NCT00555620|100906580|FG001|Overall Study|Other|0|||
33274873|NCT00555620|100906581|FG002|Overall Study|Other|0|||
33274874|NCT00555620|100906582|FG003|Overall Study|Other|1|||
33274875|NCT00555620|100906583|FG004|Overall Study|Other|0|||
33274876|NCT00555620|100906584|FG005|Overall Study|Other|3|||
33274877|NCT03394508|100906585|FG000|Overall Study|Protocol Violation|0|||
33274878|NCT03394508|100906586|FG001|Overall Study|Protocol Violation|3|||
33274879|NCT03394508|100906585|FG000|Overall Study|Lost to Follow-up|1|||
33274880|NCT03394508|100906586|FG001|Overall Study|Lost to Follow-up|0|||
33274881|NCT02722278|100906587|FG000|Overall Study|Withdrawal by Subject|5|||
33274882|NCT02722278|100906588|FG001|Overall Study|Withdrawal by Subject|3|||
33274883|NCT02722278|100906587|FG000|Overall Study|Adverse Event|4|||
33274884|NCT02722278|100906588|FG001|Overall Study|Adverse Event|1|||
33274885|NCT02722278|100906587|FG000|Overall Study|Lost to Follow-up|2|||
33274886|NCT02722278|100906588|FG001|Overall Study|Lost to Follow-up|0|||
33274887|NCT02722278|100906587|FG000|Overall Study|Protocol Violation|1|||
33274888|NCT02722278|100906588|FG001|Overall Study|Protocol Violation|0|||
33274889|NCT02722278|100906587|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
33274890|NCT02722278|100906588|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
33274891|NCT02722278|100906587|FG000|Overall Study|Subject declined after tx assignment|0|||
33274892|NCT02722278|100906588|FG001|Overall Study|Subject declined after tx assignment|1|||
33274893|NCT02722278|100906587|FG000|Overall Study|Site closure not study related|0|||
33274894|NCT02722278|100906588|FG001|Overall Study|Site closure not study related|1|||
33274895|NCT03020914|100906589|FG000|Overall Study|Surgery Cancelled|1|||
33274896|NCT03020914|100906590|FG001|Overall Study|Surgery Cancelled|0|||
33274897|NCT01018992|100906591|FG000|Overall Study|Adverse Event|8|||
33274898|NCT01018992|100906592|FG001|Overall Study|Adverse Event|3|||
33274899|NCT01018992|100906591|FG000|Overall Study|Withdrawal by Subject|3|||
33274900|NCT01018992|100906592|FG001|Overall Study|Withdrawal by Subject|8|||
33274901|NCT01018992|100906591|FG000|Overall Study|Protocol Violation|0|||
33274902|NCT01018992|100906592|FG001|Overall Study|Protocol Violation|4|||
33274903|NCT01018992|100906591|FG000|Overall Study|Lost to Follow-up|5|||
33274904|NCT01018992|100906592|FG001|Overall Study|Lost to Follow-up|1|||
33274905|NCT01989156|100906597|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
33274906|NCT01989156|100906598|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
33274907|NCT01989156|100906599|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
33274908|NCT01989156|100906597|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
33274909|NCT01989156|100906598|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
33274910|NCT01989156|100906599|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
33274911|NCT01989156|100906597|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
33274912|NCT01989156|100906598|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
33274913|NCT01989156|100906599|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
33274914|NCT01989156|100906597|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
33274915|NCT01989156|100906598|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
33274916|NCT01989156|100906599|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
33274917|NCT01989156|100906597|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
33274918|NCT01989156|100906598|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
33274919|NCT01989156|100906599|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
33274920|NCT01989156|100906597|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
33274921|NCT01989156|100906598|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
33274922|NCT01989156|100906599|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
33274923|NCT01989156|100906597|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
33274924|NCT01989156|100906598|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
33274925|NCT01989156|100906599|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
33274926|NCT01989156|100906597|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
33274927|NCT01989156|100906598|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
33274928|NCT01989156|100906599|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
33274929|NCT03034772|100906601|FG000|Overall Study|Adverse Event|0|||
33274930|NCT03034772|100906602|FG001|Overall Study|Adverse Event|1|||
33274931|NCT03034772|100906601|FG000|Overall Study|Withdrawal by Subject|0|||
33274932|NCT03034772|100906602|FG001|Overall Study|Withdrawal by Subject|1|||
33274933|NCT04853394|100906603|FG000|Follow-up Interviews|Lost to Follow-up|22|||
33274934|NCT04853394|100906604|FG001|Follow-up Interviews|Lost to Follow-up|15|||
33274935|NCT02962076|100906605|FG000|Overall Study|MHED tracer not available|5|||
33274936|NCT02962076|100906605|FG000|Overall Study|Protocol Violation|1|||
33274937|NCT02962076|100906605|FG000|Overall Study|Physician Decision|1|||
33274938|NCT01864200|100906606|FG000|Overall Study|Lost to Follow-up|1|||
33274939|NCT01864200|100906607|FG001|Overall Study|Lost to Follow-up|3|||
33274940|NCT01864200|100906606|FG000|Overall Study|Protocol Violation|1|||
33274941|NCT01864200|100906607|FG001|Overall Study|Protocol Violation|0|||
33274942|NCT01469819|100906609|FG000|Overall Study|Withdrawal by Subject|1|||
33274943|NCT01469819|100906609|FG000|Overall Study|Did not meet inclusionary criteria|2|||
33274944|NCT01469819|100906609|FG000|Overall Study|Could not swallow SmartPill|2|||
33274945|NCT01469819|100906609|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
33274946|NCT04474691|100906610|FG000|Overall Study|Withdrawal by Subject|9|||
33274947|NCT03849300|100906611|FG000|Overall Study|move out to different area|1|||
33274948|NCT03849300|100906612|FG001|Overall Study|move out to different area|3|||
33274949|NCT03849300|100906613|FG002|Overall Study|move out to different area|1|||
33274950|NCT03849300|100906614|FG003|Overall Study|move out to different area|4|||
33274951|NCT03849300|100906611|FG000|Overall Study|scheduling/transportation conflict|4|||
33274952|NCT03849300|100906612|FG001|Overall Study|scheduling/transportation conflict|4|||
33274953|NCT03849300|100906613|FG002|Overall Study|scheduling/transportation conflict|3|||
33274954|NCT03849300|100906614|FG003|Overall Study|scheduling/transportation conflict|2|||
33274955|NCT03344458|100906615|FG000|Overall Study|Physician Decision|1|||
33274956|NCT03344458|100906615|FG000|Overall Study|Withdrawal by Subject|16|||
33274957|NCT03344458|100906615|FG000|Overall Study|Other reasons|10|||
33274958|NCT03344458|100906615|FG000|Overall Study|Lost to Follow-up|9|||
33274959|NCT03344458|100906615|FG000|Overall Study|Protocol Violation|3|||
33274960|NCT01767376|100906616|FG000|Overall Study|Lost to Follow-up|3|||
33274961|NCT01767376|100906617|FG001|Overall Study|Lost to Follow-up|2|||
33274962|NCT01767376|100906618|FG002|Overall Study|Lost to Follow-up|0|||
33274963|NCT01767376|100906616|FG000|Overall Study|Withdrawal by Subject|1|||
33274964|NCT01767376|100906617|FG001|Overall Study|Withdrawal by Subject|1|||
33274965|NCT01767376|100906618|FG002|Overall Study|Withdrawal by Subject|0|||
33274966|NCT02205476|100906619|FG000|Overall Study|Study termination by Sponsor|7|||
33274967|NCT02205476|100906620|FG001|Overall Study|Study termination by Sponsor|3|||
33274968|NCT04184622|100906621|FG000|Overall Study|Adverse Event|7|||
33274969|NCT04184622|100906622|FG001|Overall Study|Adverse Event|7|||
33274970|NCT04184622|100906623|FG002|Overall Study|Adverse Event|11|||
33274971|NCT04184622|100906624|FG003|Overall Study|Adverse Event|8|||
33274972|NCT04184622|100906621|FG000|Overall Study|Death|4|||
33274973|NCT04184622|100906622|FG001|Overall Study|Death|4|||
33274974|NCT04184622|100906623|FG002|Overall Study|Death|2|||
33274975|NCT04184622|100906624|FG003|Overall Study|Death|1|||
33274976|NCT04184622|100906621|FG000|Overall Study|Lost to Follow-up|41|||
33274977|NCT04184622|100906622|FG001|Overall Study|Lost to Follow-up|19|||
33274978|NCT04184622|100906623|FG002|Overall Study|Lost to Follow-up|20|||
33274979|NCT04184622|100906624|FG003|Overall Study|Lost to Follow-up|15|||
33274980|NCT04184622|100906621|FG000|Overall Study|Missing Weight at Week 72|1|||
33274981|NCT04184622|100906622|FG001|Overall Study|Missing Weight at Week 72|0|||
33274982|NCT04184622|100906623|FG002|Overall Study|Missing Weight at Week 72|1|||
33274983|NCT04184622|100906624|FG003|Overall Study|Missing Weight at Week 72|0|||
33274984|NCT04184622|100906621|FG000|Overall Study|Other - as reported by the investigator|22|||
33274985|NCT04184622|100906622|FG001|Overall Study|Other - as reported by the investigator|7|||
33274986|NCT04184622|100906623|FG002|Overall Study|Other - as reported by the investigator|5|||
33274987|NCT04184622|100906624|FG003|Overall Study|Other - as reported by the investigator|12|||
33274988|NCT04184622|100906621|FG000|Overall Study|Physician Decision|0|||
33274989|NCT04184622|100906622|FG001|Overall Study|Physician Decision|0|||
33274990|NCT04184622|100906623|FG002|Overall Study|Physician Decision|3|||
33274991|NCT04184622|100906624|FG003|Overall Study|Physician Decision|1|||
33274992|NCT04184622|100906621|FG000|Overall Study|Pregnancy|4|||
33274993|NCT04184622|100906622|FG001|Overall Study|Pregnancy|4|||
33274994|NCT04184622|100906623|FG002|Overall Study|Pregnancy|3|||
33274995|NCT04184622|100906624|FG003|Overall Study|Pregnancy|5|||
33274996|NCT04184622|100906621|FG000|Overall Study|Protocol Deviation|1|||
33274997|NCT04184622|100906622|FG001|Overall Study|Protocol Deviation|0|||
33274998|NCT04184622|100906623|FG002|Overall Study|Protocol Deviation|0|||
33274999|NCT04184622|100906624|FG003|Overall Study|Protocol Deviation|0|||
33275000|NCT04184622|100906621|FG000|Overall Study|Withdrawal by Subject|68|||
33275001|NCT04184622|100906622|FG001|Overall Study|Withdrawal by Subject|28|||
33275002|NCT04184622|100906623|FG002|Overall Study|Withdrawal by Subject|29|||
33275003|NCT04184622|100906624|FG003|Overall Study|Withdrawal by Subject|22|||
33275004|NCT02374476|100906626|FG000|VT Induced Ablation|Screening Failures|36|||
33275005|NCT02374476|100906627|FG001|VT Induced Ablation|Screening Failures|0|||
33275006|NCT02374476|100906628|FG002|VT Induced Ablation|Screening Failures|0|||
33275007|NCT02374476|100906626|FG000|Arm Assignment|Withdrawal by Subject|0|||
33275008|NCT02374476|100906627|FG001|Arm Assignment|Withdrawal by Subject|0|||
33275009|NCT02374476|100906628|FG002|Arm Assignment|Withdrawal by Subject|1|||
33275010|NCT00472199|100906631|FG000|Overall Study|Adverse Event|19|||
33275011|NCT00472199|100906632|FG001|Overall Study|Adverse Event|23|||
33275012|NCT00472199|100906631|FG000|Overall Study|Lack of Efficacy|4|||
33275013|NCT00472199|100906632|FG001|Overall Study|Lack of Efficacy|25|||
33275014|NCT00472199|100906631|FG000|Overall Study|Lost to Follow-up|2|||
33275015|NCT00472199|100906632|FG001|Overall Study|Lost to Follow-up|4|||
33275016|NCT00472199|100906631|FG000|Overall Study|Protocol Violation|3|||
33275017|NCT00472199|100906632|FG001|Overall Study|Protocol Violation|2|||
33275018|NCT00472199|100906631|FG000|Overall Study|Withdrawal by Subject|6|||
33275019|NCT00472199|100906632|FG001|Overall Study|Withdrawal by Subject|5|||
33275020|NCT00472199|100906631|FG000|Overall Study|personal reason|0|||
33275021|NCT00472199|100906632|FG001|Overall Study|personal reason|1|||
33275022|NCT00472199|100906631|FG000|Overall Study|patient was asymptomatic|1|||
33275023|NCT00472199|100906632|FG001|Overall Study|patient was asymptomatic|0|||
33275024|NCT04025762|100906633|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
33275025|NCT04025762|100906634|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
33275026|NCT02604199|100906652|FG000|Overall Study|Pregnancy|0|||
33275027|NCT02604199|100906653|FG001|Overall Study|Pregnancy|0|||
33275028|NCT02604199|100906654|FG002|Overall Study|Pregnancy|0|||
33275029|NCT02604199|100906655|FG003|Overall Study|Pregnancy|1|||
33275030|NCT02604199|100906652|FG000|Overall Study|Study terminated by sponsor|0|||
33275031|NCT02604199|100906653|FG001|Overall Study|Study terminated by sponsor|2|||
33275032|NCT02604199|100906654|FG002|Overall Study|Study terminated by sponsor|0|||
33275033|NCT02604199|100906655|FG003|Overall Study|Study terminated by sponsor|2|||
33275034|NCT02604199|100906652|FG000|Overall Study|Withdrawal by Subject|0|||
33275035|NCT02604199|100906653|FG001|Overall Study|Withdrawal by Subject|1|||
33275036|NCT02604199|100906654|FG002|Overall Study|Withdrawal by Subject|0|||
33275037|NCT02604199|100906655|FG003|Overall Study|Withdrawal by Subject|0|||
33275038|NCT05431543|100906656|FG000|Overall Study|Medical History|1|||
33275039|NCT05431543|100906657|FG001|Overall Study|Medical History|0|||
33275040|NCT05431543|100906658|FG002|Overall Study|Medical History|0|||
33275041|NCT00267956|100906659|FG000|Controlled Period|Adverse Event|4|||
33275042|NCT00267956|100906660|FG001|Controlled Period|Adverse Event|1|||
33275043|NCT00267956|100906661|FG002|Controlled Period|Adverse Event|0|||
33275044|NCT00267956|100906662|FG003|Controlled Period|Adverse Event|0|||
33275045|NCT00267956|100906659|FG000|Controlled Period|Lack of Efficacy|4|||
33275046|NCT00267956|100906660|FG001|Controlled Period|Lack of Efficacy|2|||
33275047|NCT00267956|100906661|FG002|Controlled Period|Lack of Efficacy|0|||
33275048|NCT00267956|100906662|FG003|Controlled Period|Lack of Efficacy|0|||
33275049|NCT00267956|100906659|FG000|Controlled Period|Lost to Follow-up|2|||
33275050|NCT00267956|100906660|FG001|Controlled Period|Lost to Follow-up|0|||
33275051|NCT00267956|100906661|FG002|Controlled Period|Lost to Follow-up|0|||
33275052|NCT00267956|100906662|FG003|Controlled Period|Lost to Follow-up|0|||
33275053|NCT00267956|100906659|FG000|Controlled Period|Withdrew consent|3|||
33275054|NCT00267956|100906660|FG001|Controlled Period|Withdrew consent|1|||
33275055|NCT00267956|100906661|FG002|Controlled Period|Withdrew consent|0|||
33275056|NCT00267956|100906662|FG003|Controlled Period|Withdrew consent|0|||
33483462|NCT00025259|101662827|FG004|Overall Study|Lack of Efficacy|11|||
33275057|NCT00267956|100906659|FG000|After Controlled Period|Adverse Event|0|||
33275058|NCT00267956|100906660|FG001|After Controlled Period|Adverse Event|0|||
33275059|NCT00267956|100906661|FG002|After Controlled Period|Adverse Event|2|||
33275060|NCT00267956|100906662|FG003|After Controlled Period|Adverse Event|1|||
33275061|NCT00267956|100906659|FG000|After Controlled Period|Lack of Efficacy|0|||
33275062|NCT00267956|100906660|FG001|After Controlled Period|Lack of Efficacy|0|||
33275063|NCT00267956|100906661|FG002|After Controlled Period|Lack of Efficacy|1|||
33275064|NCT00267956|100906662|FG003|After Controlled Period|Lack of Efficacy|1|||
33275065|NCT00267956|100906659|FG000|After Controlled Period|Lost to Follow-up|0|||
33275066|NCT00267956|100906660|FG001|After Controlled Period|Lost to Follow-up|0|||
33275067|NCT00267956|100906661|FG002|After Controlled Period|Lost to Follow-up|1|||
33275068|NCT00267956|100906662|FG003|After Controlled Period|Lost to Follow-up|0|||
33275069|NCT00267956|100906659|FG000|After Controlled Period|Withdrew consent|0|||
33275070|NCT00267956|100906660|FG001|After Controlled Period|Withdrew consent|0|||
33275071|NCT00267956|100906661|FG002|After Controlled Period|Withdrew consent|1|||
33275072|NCT00267956|100906662|FG003|After Controlled Period|Withdrew consent|0|||
33275073|NCT01075815|100906665|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
33275074|NCT01075815|100906666|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
33275075|NCT01075815|100906665|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
33275076|NCT01075815|100906666|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
33275077|NCT01075815|100906665|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
33275078|NCT01075815|100906666|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
33275079|NCT02389894|100906667|FG000|Overall Study|Death|4|||
33275080|NCT02389894|100906668|FG001|Overall Study|Death|5|||
33275081|NCT02389894|100906669|FG002|Overall Study|Death|3|||
33275082|NCT02389894|100906667|FG000|Overall Study|Withdrawal by Subject|2|||
33275083|NCT02389894|100906668|FG001|Overall Study|Withdrawal by Subject|4|||
33275084|NCT02389894|100906669|FG002|Overall Study|Withdrawal by Subject|5|||
33275085|NCT02389894|100906667|FG000|Overall Study|Lost to Follow-up|2|||
33275086|NCT02389894|100906668|FG001|Overall Study|Lost to Follow-up|1|||
33275087|NCT02389894|100906669|FG002|Overall Study|Lost to Follow-up|1|||
33275088|NCT01562275|100906670|FG000|Stage 1|Adverse Event|0|||
33275089|NCT01562275|100906671|FG001|Stage 1|Adverse Event|0|||
33275090|NCT01562275|100906672|FG002|Stage 1|Adverse Event|0|||
33275091|NCT01562275|100906673|FG003|Stage 1|Adverse Event|1|||
33275092|NCT01562275|100906674|FG004|Stage 1|Adverse Event|1|||
33275093|NCT01562275|100906675|FG005|Stage 1|Adverse Event|0|||
33275094|NCT01562275|100906676|FG006|Stage 1|Adverse Event|0|||
33275095|NCT01562275|100906677|FG007|Stage 1|Adverse Event|0|||
33275096|NCT01562275|100906678|FG008|Stage 1|Adverse Event|0|||
33275097|NCT01562275|100906679|FG009|Stage 1|Adverse Event|1|||
33275098|NCT01562275|100906680|FG010|Stage 1|Adverse Event|0|||
33275099|NCT01562275|100906681|FG011|Stage 1|Adverse Event|0|||
33275100|NCT01562275|100906682|FG012|Stage 1|Adverse Event|0|||
33275101|NCT01562275|100906670|FG000|Stage 1|Death|1|||
33275102|NCT01562275|100906671|FG001|Stage 1|Death|0|||
33275103|NCT01562275|100906672|FG002|Stage 1|Death|0|||
33275104|NCT01562275|100906673|FG003|Stage 1|Death|0|||
33275105|NCT01562275|100906674|FG004|Stage 1|Death|0|||
33275106|NCT01562275|100906675|FG005|Stage 1|Death|0|||
33275107|NCT01562275|100906676|FG006|Stage 1|Death|0|||
33275108|NCT01562275|100906677|FG007|Stage 1|Death|0|||
33483463|NCT00025259|101662828|FG005|Overall Study|Lack of Efficacy|30|||
33483464|NCT00025259|101662829|FG006|Overall Study|Lack of Efficacy|38|||
33483465|NCT00025259|101662823|FG000|Overall Study|Lost to Follow-up|2|||
33483466|NCT00025259|101662824|FG001|Overall Study|Lost to Follow-up|9|||
33483467|NCT00025259|101662825|FG002|Overall Study|Lost to Follow-up|13|||
33483468|NCT00025259|101662826|FG003|Overall Study|Lost to Follow-up|13|||
33483469|NCT00025259|101662827|FG004|Overall Study|Lost to Follow-up|1|||
33483470|NCT00025259|101662828|FG005|Overall Study|Lost to Follow-up|3|||
33483471|NCT00025259|101662829|FG006|Overall Study|Lost to Follow-up|1|||
33483472|NCT00025259|101662823|FG000|Overall Study|Physician Decision|12|||
33483473|NCT00025259|101662824|FG001|Overall Study|Physician Decision|1|||
33483474|NCT00025259|101662825|FG002|Overall Study|Physician Decision|0|||
33483475|NCT00025259|101662826|FG003|Overall Study|Physician Decision|5|||
33483476|NCT00025259|101662827|FG004|Overall Study|Physician Decision|4|||
33483477|NCT00025259|101662828|FG005|Overall Study|Physician Decision|2|||
33483478|NCT00025259|101662829|FG006|Overall Study|Physician Decision|1|||
33483479|NCT00025259|101662823|FG000|Overall Study|Protocol Violation|3|||
33483480|NCT00025259|101662824|FG001|Overall Study|Protocol Violation|2|||
33483481|NCT00025259|101662825|FG002|Overall Study|Protocol Violation|2|||
33483482|NCT00025259|101662826|FG003|Overall Study|Protocol Violation|1|||
33483483|NCT00025259|101662827|FG004|Overall Study|Protocol Violation|2|||
33483484|NCT00025259|101662828|FG005|Overall Study|Protocol Violation|1|||
33483485|NCT00025259|101662829|FG006|Overall Study|Protocol Violation|3|||
33483486|NCT00025259|101662823|FG000|Overall Study|Withdrawal by Subject|9|||
33275109|NCT01562275|100906678|FG008|Stage 1|Death|0|||
33275110|NCT01562275|100906679|FG009|Stage 1|Death|0|||
33275111|NCT01562275|100906680|FG010|Stage 1|Death|0|||
33275112|NCT01562275|100906681|FG011|Stage 1|Death|0|||
33275113|NCT01562275|100906682|FG012|Stage 1|Death|0|||
33275114|NCT01562275|100906670|FG000|Stage 1|Non Compliance|0|||
33275115|NCT01562275|100906671|FG001|Stage 1|Non Compliance|0|||
33275116|NCT01562275|100906672|FG002|Stage 1|Non Compliance|1|||
33275117|NCT01562275|100906673|FG003|Stage 1|Non Compliance|0|||
33275118|NCT01562275|100906674|FG004|Stage 1|Non Compliance|0|||
33275119|NCT01562275|100906675|FG005|Stage 1|Non Compliance|0|||
33275120|NCT01562275|100906676|FG006|Stage 1|Non Compliance|0|||
33275121|NCT01562275|100906677|FG007|Stage 1|Non Compliance|0|||
33275122|NCT01562275|100906678|FG008|Stage 1|Non Compliance|0|||
33275123|NCT01562275|100906679|FG009|Stage 1|Non Compliance|0|||
33275124|NCT01562275|100906680|FG010|Stage 1|Non Compliance|0|||
33275125|NCT01562275|100906681|FG011|Stage 1|Non Compliance|0|||
33275126|NCT01562275|100906682|FG012|Stage 1|Non Compliance|0|||
33275127|NCT01562275|100906670|FG000|Stage 1|Physician Decision|0|||
33275128|NCT01562275|100906671|FG001|Stage 1|Physician Decision|0|||
33275129|NCT01562275|100906672|FG002|Stage 1|Physician Decision|0|||
33275130|NCT01562275|100906673|FG003|Stage 1|Physician Decision|0|||
33275131|NCT01562275|100906674|FG004|Stage 1|Physician Decision|1|||
33275132|NCT01562275|100906675|FG005|Stage 1|Physician Decision|0|||
33275133|NCT01562275|100906676|FG006|Stage 1|Physician Decision|1|||
33275134|NCT01562275|100906677|FG007|Stage 1|Physician Decision|0|||
33275135|NCT01562275|100906678|FG008|Stage 1|Physician Decision|1|||
33275136|NCT01562275|100906679|FG009|Stage 1|Physician Decision|0|||
33275137|NCT01562275|100906680|FG010|Stage 1|Physician Decision|0|||
33275138|NCT01562275|100906681|FG011|Stage 1|Physician Decision|0|||
33275139|NCT01562275|100906682|FG012|Stage 1|Physician Decision|0|||
33275140|NCT01562275|100906670|FG000|Stage 1|Progression of Disease|2|||
33275141|NCT01562275|100906671|FG001|Stage 1|Progression of Disease|6|||
33275142|NCT01562275|100906672|FG002|Stage 1|Progression of Disease|2|||
33275143|NCT01562275|100906673|FG003|Stage 1|Progression of Disease|1|||
33275144|NCT01562275|100906674|FG004|Stage 1|Progression of Disease|2|||
33275145|NCT01562275|100906675|FG005|Stage 1|Progression of Disease|4|||
33275146|NCT01562275|100906676|FG006|Stage 1|Progression of Disease|1|||
33275147|NCT01562275|100906677|FG007|Stage 1|Progression of Disease|7|||
33275148|NCT01562275|100906678|FG008|Stage 1|Progression of Disease|2|||
33275149|NCT01562275|100906679|FG009|Stage 1|Progression of Disease|5|||
33275150|NCT01562275|100906680|FG010|Stage 1|Progression of Disease|3|||
33483487|NCT00025259|101662824|FG001|Overall Study|Withdrawal by Subject|27|||
33483488|NCT00025259|101662825|FG002|Overall Study|Withdrawal by Subject|6|||
33483489|NCT00025259|101662826|FG003|Overall Study|Withdrawal by Subject|14|||
33483490|NCT00025259|101662827|FG004|Overall Study|Withdrawal by Subject|11|||
33483491|NCT00025259|101662828|FG005|Overall Study|Withdrawal by Subject|8|||
33275151|NCT01562275|100906681|FG011|Stage 1|Progression of Disease|0|||
33275152|NCT01562275|100906682|FG012|Stage 1|Progression of Disease|0|||
33275153|NCT01562275|100906670|FG000|Stage 1|Withdrawal by Subject|0|||
33275154|NCT01562275|100906671|FG001|Stage 1|Withdrawal by Subject|1|||
33275155|NCT01562275|100906672|FG002|Stage 1|Withdrawal by Subject|0|||
33275156|NCT01562275|100906673|FG003|Stage 1|Withdrawal by Subject|2|||
33275157|NCT01562275|100906674|FG004|Stage 1|Withdrawal by Subject|0|||
33275158|NCT01562275|100906675|FG005|Stage 1|Withdrawal by Subject|0|||
33275159|NCT01562275|100906676|FG006|Stage 1|Withdrawal by Subject|1|||
33275160|NCT01562275|100906677|FG007|Stage 1|Withdrawal by Subject|0|||
33483492|NCT00025259|101662829|FG006|Overall Study|Withdrawal by Subject|3|||
33483493|NCT00025259|101662823|FG000|Overall Study|Ineligible|14|||
33483494|NCT00025259|101662824|FG001|Overall Study|Ineligible|1|||
33483495|NCT00025259|101662825|FG002|Overall Study|Ineligible|0|||
33483496|NCT00025259|101662826|FG003|Overall Study|Ineligible|0|||
33483497|NCT00025259|101662827|FG004|Overall Study|Ineligible|6|||
33483498|NCT00025259|101662828|FG005|Overall Study|Ineligible|0|||
33483499|NCT00025259|101662829|FG006|Overall Study|Ineligible|1|||
33483500|NCT00025259|101662823|FG000|Overall Study|Randomization error|1|||
33483501|NCT00025259|101662824|FG001|Overall Study|Randomization error|0|||
33483502|NCT00025259|101662825|FG002|Overall Study|Randomization error|0|||
33483503|NCT00025259|101662826|FG003|Overall Study|Randomization error|0|||
33483504|NCT00025259|101662827|FG004|Overall Study|Randomization error|1|||
33483505|NCT00025259|101662828|FG005|Overall Study|Randomization error|7|||
33483506|NCT00025259|101662829|FG006|Overall Study|Randomization error|2|||
33483507|NCT00025259|101662823|FG000|Overall Study|Adverse Event|1|||
33483508|NCT00025259|101662824|FG001|Overall Study|Adverse Event|0|||
33483509|NCT00025259|101662825|FG002|Overall Study|Adverse Event|0|||
33483510|NCT00025259|101662826|FG003|Overall Study|Adverse Event|0|||
33483511|NCT00025259|101662827|FG004|Overall Study|Adverse Event|0|||
33483512|NCT00025259|101662828|FG005|Overall Study|Adverse Event|0|||
33483513|NCT00025259|101662829|FG006|Overall Study|Adverse Event|0|||
33483514|NCT03548337|101662830|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
33483515|NCT03548337|101662831|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
33483516|NCT03548337|101662830|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
33483517|NCT03548337|101662831|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
33483518|NCT03548337|101662830|FG000|Infant Series|Lost to Follow-up|2|||
33483519|NCT03548337|101662831|FG001|Infant Series|Lost to Follow-up|1|||
33483520|NCT03548337|101662830|FG000|Infant Series|Adverse Event|0|||
33483521|NCT03548337|101662831|FG001|Infant Series|Adverse Event|2|||
33483522|NCT03548337|101662830|FG000|Infant Series|Randomized but Not Vaccinated|1|||
33483523|NCT03548337|101662831|FG001|Infant Series|Randomized but Not Vaccinated|0|||
33483524|NCT03548337|101662830|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
33483525|NCT03548337|101662831|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
33483526|NCT02901548|101662835|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
33483527|NCT02764151|101662836|FG000|Overall Study|Subject refused further follow-up|0|||
33483528|NCT02764151|101662837|FG001|Overall Study|Subject refused further follow-up|0|||
33483529|NCT02764151|101662838|FG002|Overall Study|Subject refused further follow-up|0|||
33483530|NCT02764151|101662839|FG003|Overall Study|Subject refused further follow-up|1|||
33483531|NCT02764151|101662836|FG000|Overall Study|Other|0|||
33483532|NCT02764151|101662837|FG001|Overall Study|Other|0|||
33483533|NCT02764151|101662838|FG002|Overall Study|Other|0|||
33483534|NCT02764151|101662839|FG003|Overall Study|Other|2|||
33483535|NCT02865460|101662840|FG000|Overall Study|Adverse Event|1|||
33483536|NCT02865460|101662841|FG001|Overall Study|Adverse Event|0|||
33483537|NCT02865460|101662840|FG000|Overall Study|Withdrawal by Subject|1|||
33483538|NCT02865460|101662841|FG001|Overall Study|Withdrawal by Subject|1|||
33483539|NCT02865460|101662840|FG000|Overall Study|Lost to Follow-up|7|||
33483540|NCT02865460|101662841|FG001|Overall Study|Lost to Follow-up|4|||
33483541|NCT02865460|101662840|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
33483542|NCT02865460|101662841|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
33483543|NCT02564887|101662842|FG000|Overall Study|Lost to Follow-up|6|||
33483544|NCT02564887|101662843|FG001|Overall Study|Lost to Follow-up|0|||
33483545|NCT02455518|101662848|FG000|Overall Study|Protocol Violation|0|||
33483546|NCT02455518|101662849|FG001|Overall Study|Protocol Violation|1|||
33483547|NCT02455518|101662850|FG002|Overall Study|Protocol Violation|1|||
33483548|NCT02455518|101662851|FG003|Overall Study|Protocol Violation|3|||
33483549|NCT04435184|101662881|FG000|Overall Study|follow-up blood draws missing|3|||
33483550|NCT04435184|101662882|FG001|Overall Study|follow-up blood draws missing|5|||
33483551|NCT04710979|101662883|FG000|Overall Study|Lost to Follow-up|2|||
33483552|NCT04710979|101662884|FG001|Overall Study|Lost to Follow-up|4|||
33483553|NCT04710979|101662883|FG000|Overall Study|Withdrawal by Subject|1|||
33483554|NCT04710979|101662884|FG001|Overall Study|Withdrawal by Subject|0|||
33483555|NCT00253448|101662885|FG000|Overall Study|Withdrawal by Subject|1|||
33483556|NCT02047734|101662886|FG000|Overall Study|Adverse Event|18|||
33483557|NCT02047734|101662887|FG001|Overall Study|Adverse Event|13|||
33483558|NCT02047734|101662888|FG002|Overall Study|Adverse Event|13|||
33483559|NCT02047734|101662886|FG000|Overall Study|Lack of Efficacy|4|||
33483560|NCT02047734|101662887|FG001|Overall Study|Lack of Efficacy|5|||
33483561|NCT02047734|101662888|FG002|Overall Study|Lack of Efficacy|1|||
33483562|NCT02047734|101662886|FG000|Overall Study|Protocol Violation|3|||
33483563|NCT02047734|101662887|FG001|Overall Study|Protocol Violation|1|||
33483564|NCT02047734|101662888|FG002|Overall Study|Protocol Violation|1|||
33483565|NCT02047734|101662886|FG000|Overall Study|Lost to Follow-up|1|||
33483566|NCT02047734|101662887|FG001|Overall Study|Lost to Follow-up|4|||
33483567|NCT02047734|101662888|FG002|Overall Study|Lost to Follow-up|0|||
33483568|NCT02047734|101662886|FG000|Overall Study|Death|0|||
33483569|NCT02047734|101662887|FG001|Overall Study|Death|1|||
33483570|NCT02047734|101662888|FG002|Overall Study|Death|0|||
33483571|NCT02047734|101662886|FG000|Overall Study|Withdrawal by Subject|30|||
33483572|NCT02047734|101662887|FG001|Overall Study|Withdrawal by Subject|31|||
33483573|NCT02047734|101662888|FG002|Overall Study|Withdrawal by Subject|19|||
33483574|NCT02047734|101662886|FG000|Overall Study|Physician Decision|7|||
33483575|NCT02047734|101662887|FG001|Overall Study|Physician Decision|6|||
33483576|NCT02047734|101662888|FG002|Overall Study|Physician Decision|5|||
33483577|NCT02047734|101662886|FG000|Overall Study|Miscellaneous|2|||
33483578|NCT02047734|101662887|FG001|Overall Study|Miscellaneous|4|||
33483579|NCT02047734|101662888|FG002|Overall Study|Miscellaneous|6|||
33483580|NCT02047734|101662886|FG000|Overall Study|Did Not Receive Study Drug|2|||
33483581|NCT02047734|101662887|FG001|Overall Study|Did Not Receive Study Drug|4|||
33483582|NCT02047734|101662888|FG002|Overall Study|Did Not Receive Study Drug|1|||
33483583|NCT04380961|101662889|FG000|Overall Study|Lost to Follow-up|17|||
33483584|NCT04380961|101662890|FG001|Overall Study|Lost to Follow-up|11|||
33483585|NCT04380961|101662889|FG000|Overall Study|Withdrawal by Subject|3|||
33483586|NCT04380961|101662890|FG001|Overall Study|Withdrawal by Subject|0|||
33483587|NCT04380961|101662889|FG000|Overall Study|Death|22|||
33483588|NCT04380961|101662890|FG001|Overall Study|Death|16|||
33483589|NCT04380961|101662889|FG000|Overall Study|Other|1|||
33483590|NCT04380961|101662890|FG001|Overall Study|Other|0|||
33483591|NCT04380961|101662889|FG000|Overall Study|Randomized but Not Treated|1|||
33483592|NCT04380961|101662890|FG001|Overall Study|Randomized but Not Treated|2|||
33483593|NCT00985491|101662891|FG000|Overall Study|Adverse Event|8|||
33483594|NCT00985491|101662891|FG000|Overall Study|device migration|7|||
33483595|NCT00985491|101662891|FG000|Overall Study|Withdrawal by Subject|1|||
33483596|NCT00985491|101662891|FG000|Overall Study|implant failure|3|||
33483597|NCT01855828|101662892|FG000|Overall Study|Adverse Event|1|||
33483598|NCT01855828|101662892|FG000|Overall Study|Withdrawal by Subject|1|||
33483599|NCT00863772|101662895|FG000|Overall Study|Adverse Event|1|||
33483600|NCT00863772|101662896|FG001|Overall Study|Adverse Event|4|||
33483601|NCT00863772|101662897|FG002|Overall Study|Adverse Event|0|||
33483602|NCT00863772|101662895|FG000|Overall Study|Lack of Efficacy|4|||
33483603|NCT00863772|101662896|FG001|Overall Study|Lack of Efficacy|2|||
33483604|NCT00863772|101662897|FG002|Overall Study|Lack of Efficacy|4|||
33483605|NCT00863772|101662895|FG000|Overall Study|Lost to Follow-up|5|||
33483606|NCT00863772|101662896|FG001|Overall Study|Lost to Follow-up|1|||
33483607|NCT00863772|101662897|FG002|Overall Study|Lost to Follow-up|1|||
33483608|NCT00863772|101662895|FG000|Overall Study|Protocol Violation|2|||
33483609|NCT00863772|101662896|FG001|Overall Study|Protocol Violation|0|||
33483610|NCT00863772|101662897|FG002|Overall Study|Protocol Violation|2|||
33483611|NCT00863772|101662895|FG000|Overall Study|Withdrawal by Subject|4|||
33483612|NCT00863772|101662896|FG001|Overall Study|Withdrawal by Subject|7|||
33483613|NCT00863772|101662897|FG002|Overall Study|Withdrawal by Subject|5|||
33483614|NCT00863772|101662895|FG000|Overall Study|Study terminated by sponsor|44|||
33483615|NCT00863772|101662896|FG001|Overall Study|Study terminated by sponsor|45|||
33483616|NCT00863772|101662897|FG002|Overall Study|Study terminated by sponsor|36|||
33483617|NCT00863772|101662895|FG000|Overall Study|Entered extension study|6|||
33483618|NCT00863772|101662896|FG001|Overall Study|Entered extension study|4|||
33483619|NCT00863772|101662897|FG002|Overall Study|Entered extension study|9|||
33483620|NCT00863772|101662895|FG000|Overall Study|Other|1|||
33483621|NCT00863772|101662896|FG001|Overall Study|Other|2|||
33483622|NCT00863772|101662897|FG002|Overall Study|Other|4|||
33483623|NCT00863772|101662895|FG000|Overall Study|Randomized but not Treated|1|||
33483624|NCT00863772|101662896|FG001|Overall Study|Randomized but not Treated|0|||
33483625|NCT00863772|101662897|FG002|Overall Study|Randomized but not Treated|0|||
33483626|NCT01434810|101662902|FG000|Overall Study|Did not receive treatment|11|||
33483627|NCT01434810|101662903|FG001|Overall Study|Did not receive treatment|3|||
33483628|NCT01434810|101662902|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
33483629|NCT01434810|101662903|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
33483630|NCT00875797|101662906|FG000|Overall Study|Protocol Violation|6|||
33483631|NCT00875797|101662907|FG001|Overall Study|Protocol Violation|3|||
33483632|NCT03086551|101662908|FG000|First Intervention|Failure to meet inclusion criterion|1|||
33483633|NCT03086551|101662909|FG001|First Intervention|Failure to meet inclusion criterion|0|||
33483634|NCT03086551|101662908|FG000|First Intervention|Lost to Follow-up|0|||
33275161|NCT01562275|100906678|FG008|Stage 1|Withdrawal by Subject|0|||
33483635|NCT03086551|101662909|FG001|First Intervention|Lost to Follow-up|1|||
33483636|NCT03086551|101662908|FG000|Washout|Lost to Follow-up|1|||
33275162|NCT01562275|100906679|FG009|Stage 1|Withdrawal by Subject|1|||
33275163|NCT01562275|100906680|FG010|Stage 1|Withdrawal by Subject|0|||
33483637|NCT03086551|101662909|FG001|Washout|Lost to Follow-up|2|||
33275164|NCT01562275|100906681|FG011|Stage 1|Withdrawal by Subject|0|||
33275165|NCT01562275|100906682|FG012|Stage 1|Withdrawal by Subject|0|||
33483638|NCT03086551|101662908|FG000|Washout|Withdrawal by Subject|2|||
33483639|NCT03086551|101662909|FG001|Washout|Withdrawal by Subject|1|||
33483640|NCT02203331|101662912|FG000|Overall Study|Pregnancy|1|||
33483641|NCT02203331|101662913|FG001|Overall Study|Pregnancy|0|||
33483642|NCT02203331|101662914|FG002|Overall Study|Pregnancy|0|||
33483643|NCT02203331|101662915|FG003|Overall Study|Pregnancy|0|||
33483644|NCT02203331|101662916|FG004|Overall Study|Pregnancy|2|||
33483645|NCT02203331|101662917|FG005|Overall Study|Pregnancy|0|||
33483646|NCT02203331|101662912|FG000|Overall Study|Withdrawal by Subject|1|||
33483647|NCT02203331|101662913|FG001|Overall Study|Withdrawal by Subject|0|||
33483648|NCT02203331|101662914|FG002|Overall Study|Withdrawal by Subject|1|||
33483649|NCT02203331|101662915|FG003|Overall Study|Withdrawal by Subject|0|||
33483650|NCT02203331|101662916|FG004|Overall Study|Withdrawal by Subject|0|||
33483651|NCT02203331|101662917|FG005|Overall Study|Withdrawal by Subject|3|||
33483652|NCT02203331|101662912|FG000|Overall Study|Adverse Event|4|||
33483653|NCT02203331|101662913|FG001|Overall Study|Adverse Event|8|||
33483654|NCT02203331|101662914|FG002|Overall Study|Adverse Event|3|||
33483655|NCT02203331|101662915|FG003|Overall Study|Adverse Event|4|||
33483656|NCT02203331|101662916|FG004|Overall Study|Adverse Event|3|||
33483657|NCT02203331|101662917|FG005|Overall Study|Adverse Event|3|||
33483658|NCT02203331|101662912|FG000|Overall Study|Other Reasons|1|||
33483659|NCT02203331|101662913|FG001|Overall Study|Other Reasons|2|||
33483660|NCT02203331|101662914|FG002|Overall Study|Other Reasons|0|||
33483661|NCT02203331|101662915|FG003|Overall Study|Other Reasons|2|||
33483662|NCT02203331|101662916|FG004|Overall Study|Other Reasons|0|||
33483663|NCT02203331|101662917|FG005|Overall Study|Other Reasons|0|||
33483664|NCT02203331|101662912|FG000|Overall Study|Lack of Efficacy|0|||
33483665|NCT02203331|101662913|FG001|Overall Study|Lack of Efficacy|2|||
33483666|NCT02203331|101662914|FG002|Overall Study|Lack of Efficacy|1|||
33483667|NCT02203331|101662915|FG003|Overall Study|Lack of Efficacy|0|||
33483668|NCT02203331|101662916|FG004|Overall Study|Lack of Efficacy|0|||
33483669|NCT02203331|101662917|FG005|Overall Study|Lack of Efficacy|1|||
33483670|NCT02203331|101662912|FG000|Overall Study|Protocol Violation|0|||
33483671|NCT02203331|101662913|FG001|Overall Study|Protocol Violation|2|||
33483672|NCT02203331|101662914|FG002|Overall Study|Protocol Violation|0|||
33483673|NCT02203331|101662915|FG003|Overall Study|Protocol Violation|1|||
33483674|NCT02203331|101662916|FG004|Overall Study|Protocol Violation|1|||
33483675|NCT02203331|101662917|FG005|Overall Study|Protocol Violation|0|||
33483676|NCT02203331|101662912|FG000|Overall Study|Lost to Follow-up|0|||
33483677|NCT02203331|101662913|FG001|Overall Study|Lost to Follow-up|0|||
33483678|NCT02203331|101662914|FG002|Overall Study|Lost to Follow-up|0|||
33483679|NCT02203331|101662915|FG003|Overall Study|Lost to Follow-up|0|||
33483680|NCT02203331|101662916|FG004|Overall Study|Lost to Follow-up|1|||
33483681|NCT02203331|101662917|FG005|Overall Study|Lost to Follow-up|0|||
33483682|NCT01243775|101662918|FG000|Overall Study|Withdrawal by Subject|2|||
33483683|NCT01559389|101662919|FG000|Overall Study|Withdrawal by Subject|20|||
33483684|NCT01559389|101662920|FG001|Overall Study|Withdrawal by Subject|20|||
33483685|NCT03203850|101662921|FG000|Overall Study|Subject/guardian decision|4|||
33483686|NCT03203850|101662922|FG001|Overall Study|Subject/guardian decision|3|||
33483687|NCT03203850|101662921|FG000|Overall Study|Adverse Event|3|||
33483688|NCT03203850|101662922|FG001|Overall Study|Adverse Event|0|||
33483689|NCT03203850|101662921|FG000|Overall Study|Death|1|||
33483690|NCT03203850|101662922|FG001|Overall Study|Death|0|||
33483691|NCT03464630|101662936|FG000|Overall Study|Lost to Follow-up|62|||
33483692|NCT03464630|101662937|FG001|Overall Study|Lost to Follow-up|52|||
33483693|NCT03464630|101662936|FG000|Overall Study|Withdrawal by Subject|16|||
33483694|NCT03464630|101662937|FG001|Overall Study|Withdrawal by Subject|10|||
33483695|NCT03464630|101662936|FG000|Overall Study|Passive Disengagement|8|||
33483696|NCT03464630|101662937|FG001|Overall Study|Passive Disengagement|4|||
33483697|NCT03485352|101662938|FG000|Overall Study|Lost to Follow-up|9|||
33483698|NCT02374346|101662939|FG000|Overall Study|operated or discharged during weekend|48|||
33483699|NCT04693416|101662940|FG000|Overall Study|Lost to Follow-up|13|||
33483700|NCT04693416|101662941|FG001|Overall Study|Lost to Follow-up|0|||
33483701|NCT03700385|101662942|FG000|Overall Study|Lost to Follow-up|1|||
33483702|NCT00282919|101662943|FG000|Overall Study|Lack of Efficacy|4|||
33483703|NCT00282919|101662943|FG000|Overall Study|Withdrawal by Subject|1|||
33483704|NCT00282919|101662943|FG000|Overall Study|Asymptomatic Parasitemia|2|||
33483705|NCT02309138|101662944|FG000|Overall Study|Withdrawal by Subject|44|||
33483706|NCT02309138|101662945|FG001|Overall Study|Withdrawal by Subject|15|||
33483707|NCT02309138|101662944|FG000|Overall Study|Protocol Violation|4|||
33275166|NCT01562275|100906670|FG000|Stage 2|Death|0|||
33275167|NCT01562275|100906671|FG001|Stage 2|Death|0|||
33275168|NCT01562275|100906672|FG002|Stage 2|Death|0|||
33483708|NCT02309138|101662945|FG001|Overall Study|Protocol Violation|2|||
33483709|NCT02309138|101662944|FG000|Overall Study|delivered before visit 2|0|||
33483710|NCT02309138|101662945|FG001|Overall Study|delivered before visit 2|1|||
33483711|NCT01994291|101662946|FG000|Overall Study|Adverse Event|4|||
33483712|NCT01994291|101662947|FG001|Overall Study|Adverse Event|1|||
33483713|NCT01994291|101662948|FG002|Overall Study|Adverse Event|3|||
33483714|NCT01994291|101662946|FG000|Overall Study|Lost to Follow-up|1|||
33483715|NCT01994291|101662947|FG001|Overall Study|Lost to Follow-up|1|||
33483716|NCT01994291|101662948|FG002|Overall Study|Lost to Follow-up|0|||
33483717|NCT01994291|101662946|FG000|Overall Study|Does not meet entrance criteria|1|||
33275169|NCT01562275|100906673|FG003|Stage 2|Death|0|||
33483718|NCT01994291|101662947|FG001|Overall Study|Does not meet entrance criteria|0|||
33483719|NCT01994291|101662948|FG002|Overall Study|Does not meet entrance criteria|0|||
33483720|NCT01994291|101662946|FG000|Overall Study|Medication error without associated AE|1|||
33483721|NCT01994291|101662947|FG001|Overall Study|Medication error without associated AE|0|||
33483722|NCT01994291|101662948|FG002|Overall Study|Medication error without associated AE|1|||
33483723|NCT01994291|101662946|FG000|Overall Study|Protocol Violation|1|||
33483724|NCT01994291|101662947|FG001|Overall Study|Protocol Violation|0|||
33483725|NCT01994291|101662948|FG002|Overall Study|Protocol Violation|0|||
33483726|NCT01994291|101662946|FG000|Overall Study|Withdrawal by Subject|6|||
33483727|NCT01994291|101662947|FG001|Overall Study|Withdrawal by Subject|3|||
33483728|NCT01994291|101662948|FG002|Overall Study|Withdrawal by Subject|5|||
33483729|NCT01994291|101662946|FG000|Overall Study|Other|1|||
33483730|NCT01994291|101662947|FG001|Overall Study|Other|2|||
33483731|NCT01994291|101662948|FG002|Overall Study|Other|0|||
33483732|NCT01862484|101662949|FG000|Overall Study|Lack of Efficacy|1|||
33483733|NCT01862484|101662950|FG001|Overall Study|Lack of Efficacy|1|||
33483734|NCT01862484|101662949|FG000|Overall Study|Lost to Follow-up|1|||
33483735|NCT01862484|101662950|FG001|Overall Study|Lost to Follow-up|2|||
33483736|NCT01862484|101662949|FG000|Overall Study|Protocol Violation|0|||
33483737|NCT01862484|101662950|FG001|Overall Study|Protocol Violation|2|||
33483738|NCT01862484|101662949|FG000|Overall Study|Withdrawal by Subject|0|||
33483739|NCT01862484|101662950|FG001|Overall Study|Withdrawal by Subject|3|||
33483740|NCT02714426|101662953|FG000|Overall Study|Withdrawal by Subject|2|||
33483741|NCT02714426|101662954|FG001|Overall Study|Withdrawal by Subject|2|||
33483742|NCT04762277|101662956|FG000|Overall Study|Withdrawal by Subject|0|||
33483743|NCT04762277|101662957|FG001|Overall Study|Withdrawal by Subject|2|||
33483744|NCT04762277|101662956|FG000|Overall Study|Protocol Violation|0|||
33483745|NCT04762277|101662957|FG001|Overall Study|Protocol Violation|1|||
33483746|NCT04762277|101662956|FG000|Overall Study|Adverse Event|1|||
33483747|NCT04762277|101662957|FG001|Overall Study|Adverse Event|0|||
33483748|NCT00805961|101662960|FG000|Modality Therapy|Withdrawal by Subject|1|||
33483749|NCT00805961|101662960|FG000|Modality Therapy|Adverse Event|1|||
33483750|NCT00805961|101662960|FG000|Modality Therapy|Disease Progression|2|||
33483751|NCT00805961|101662960|FG000|Treatment-Free Interval|Adverse Event|3|||
33483752|NCT00805961|101662960|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
33483753|NCT00805961|101662960|FG000|Treatment-Free Interval|Physician Decision|1|||
33483754|NCT00805961|101662960|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
33483755|NCT00805961|101662960|FG000|Maintenance Treatment|Lack of Efficacy|13|||
33483756|NCT00805961|101662960|FG000|Maintenance Treatment|Intercurrent Illness|7|||
33483757|NCT00805961|101662960|FG000|Maintenance Treatment|Adverse Event|6|||
33483758|NCT00805961|101662960|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
33483759|NCT00805961|101662960|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
33483760|NCT00805961|101662960|FG000|Maintenance Treatment|Withdrawn Consent|1|||
33483761|NCT02201277|101662961|FG000|Overall Study|Death|3|||
33483762|NCT02201277|101662962|FG001|Overall Study|Death|4|||
33483763|NCT02201277|101662961|FG000|Overall Study|Lost to Follow-up|2|||
33483764|NCT02201277|101662962|FG001|Overall Study|Lost to Follow-up|1|||
33483765|NCT02201277|101662961|FG000|Overall Study|Failed retrieval|1|||
33483766|NCT02201277|101662962|FG001|Overall Study|Failed retrieval|0|||
33483767|NCT02201277|101662961|FG000|Overall Study|Physician Decision|1|||
33483768|NCT02201277|101662962|FG001|Overall Study|Physician Decision|0|||
33483769|NCT00264550|101662966|FG000|Overall Study|Death|0|||
33483770|NCT00264550|101662967|FG001|Overall Study|Death|3|||
33483771|NCT00264550|101662968|FG002|Overall Study|Death|0|||
33483772|NCT00264550|101662969|FG003|Overall Study|Death|0|||
33483773|NCT00264550|101662966|FG000|Overall Study|Lost to Follow-up|3|||
33483774|NCT00264550|101662967|FG001|Overall Study|Lost to Follow-up|1|||
33483775|NCT00264550|101662968|FG002|Overall Study|Lost to Follow-up|1|||
33483776|NCT00264550|101662969|FG003|Overall Study|Lost to Follow-up|1|||
33483777|NCT00264550|101662966|FG000|Overall Study|Adverse Event|23|||
33483778|NCT00264550|101662967|FG001|Overall Study|Adverse Event|18|||
33483779|NCT00264550|101662968|FG002|Overall Study|Adverse Event|9|||
33483780|NCT00264550|101662969|FG003|Overall Study|Adverse Event|14|||
33483781|NCT00264550|101662966|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
33483782|NCT00264550|101662967|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
33483783|NCT00264550|101662968|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
33275170|NCT01562275|100906674|FG004|Stage 2|Death|0|||
33483784|NCT00264550|101662969|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
33483785|NCT00264550|101662966|FG000|Overall Study|Discontinued oral study agent|0|||
33483786|NCT00264550|101662967|FG001|Overall Study|Discontinued oral study agent|1|||
33483787|NCT00264550|101662968|FG002|Overall Study|Discontinued oral study agent|0|||
33483788|NCT00264550|101662969|FG003|Overall Study|Discontinued oral study agent|0|||
33483789|NCT00264550|101662966|FG000|Overall Study|Other|13|||
33275171|NCT01562275|100906675|FG005|Stage 2|Death|0|||
33483790|NCT00264550|101662967|FG001|Overall Study|Other|7|||
33483791|NCT00264550|101662968|FG002|Overall Study|Other|3|||
33483792|NCT00264550|101662969|FG003|Overall Study|Other|9|||
33483793|NCT04895982|101662970|FG000|Overall Study|Withdrawal by Subject|0|||
33483794|NCT04895982|101662971|FG001|Overall Study|Withdrawal by Subject|0|||
33483795|NCT04895982|101662972|FG002|Overall Study|Withdrawal by Subject|0|||
33483796|NCT04895982|101662973|FG003|Overall Study|Withdrawal by Subject|0|||
33483797|NCT04895982|101662974|FG004|Overall Study|Withdrawal by Subject|0|||
33483798|NCT04895982|101662975|FG005|Overall Study|Withdrawal by Subject|1|||
33483799|NCT04895982|101662976|FG006|Overall Study|Withdrawal by Subject|1|||
33483800|NCT04895982|101662977|FG007|Overall Study|Withdrawal by Subject|0|||
33483801|NCT04895982|101662978|FG008|Overall Study|Withdrawal by Subject|0|||
33483802|NCT04895982|101662979|FG009|Overall Study|Withdrawal by Subject|1|||
33483803|NCT04895982|101662980|FG010|Overall Study|Withdrawal by Subject|0|||
33483804|NCT04895982|101662981|FG011|Overall Study|Withdrawal by Subject|1|||
33483805|NCT04895982|101662970|FG000|Overall Study|Withdrawal by parent/guardian|2|||
33483806|NCT04895982|101662971|FG001|Overall Study|Withdrawal by parent/guardian|3|||
33483807|NCT04895982|101662972|FG002|Overall Study|Withdrawal by parent/guardian|3|||
33483808|NCT04895982|101662973|FG003|Overall Study|Withdrawal by parent/guardian|1|||
33483809|NCT04895982|101662974|FG004|Overall Study|Withdrawal by parent/guardian|3|||
33483810|NCT04895982|101662975|FG005|Overall Study|Withdrawal by parent/guardian|2|||
33483811|NCT04895982|101662976|FG006|Overall Study|Withdrawal by parent/guardian|1|||
33483812|NCT04895982|101662977|FG007|Overall Study|Withdrawal by parent/guardian|0|||
33483813|NCT04895982|101662978|FG008|Overall Study|Withdrawal by parent/guardian|3|||
33483814|NCT04895982|101662979|FG009|Overall Study|Withdrawal by parent/guardian|0|||
33483815|NCT04895982|101662980|FG010|Overall Study|Withdrawal by parent/guardian|0|||
33483816|NCT04895982|101662981|FG011|Overall Study|Withdrawal by parent/guardian|0|||
33483817|NCT04895982|101662970|FG000|Overall Study|Other|0|||
33483818|NCT04895982|101662971|FG001|Overall Study|Other|0|||
33483819|NCT04895982|101662972|FG002|Overall Study|Other|1|||
33483820|NCT04895982|101662973|FG003|Overall Study|Other|1|||
33483821|NCT04895982|101662974|FG004|Overall Study|Other|0|||
33483822|NCT04895982|101662975|FG005|Overall Study|Other|0|||
33483823|NCT04895982|101662976|FG006|Overall Study|Other|0|||
33483824|NCT04895982|101662977|FG007|Overall Study|Other|0|||
33483825|NCT04895982|101662978|FG008|Overall Study|Other|0|||
33483826|NCT04895982|101662979|FG009|Overall Study|Other|1|||
33483827|NCT04895982|101662980|FG010|Overall Study|Other|0|||
33483828|NCT04895982|101662981|FG011|Overall Study|Other|0|||
33483829|NCT04895982|101662970|FG000|Overall Study|Protocol Violation|0|||
33483830|NCT04895982|101662971|FG001|Overall Study|Protocol Violation|0|||
33483831|NCT04895982|101662972|FG002|Overall Study|Protocol Violation|1|||
33483832|NCT04895982|101662973|FG003|Overall Study|Protocol Violation|1|||
33483833|NCT04895982|101662974|FG004|Overall Study|Protocol Violation|1|||
33483834|NCT04895982|101662975|FG005|Overall Study|Protocol Violation|0|||
33483835|NCT04895982|101662976|FG006|Overall Study|Protocol Violation|0|||
33483836|NCT04895982|101662977|FG007|Overall Study|Protocol Violation|1|||
33483837|NCT04895982|101662978|FG008|Overall Study|Protocol Violation|0|||
33483838|NCT04895982|101662979|FG009|Overall Study|Protocol Violation|0|||
33483839|NCT04895982|101662980|FG010|Overall Study|Protocol Violation|0|||
33483840|NCT04895982|101662981|FG011|Overall Study|Protocol Violation|0|||
33483841|NCT04895982|101662970|FG000|Overall Study|Lost to Follow-up|0|||
33483842|NCT04895982|101662971|FG001|Overall Study|Lost to Follow-up|0|||
33483843|NCT04895982|101662972|FG002|Overall Study|Lost to Follow-up|1|||
33483844|NCT04895982|101662973|FG003|Overall Study|Lost to Follow-up|0|||
33483845|NCT04895982|101662974|FG004|Overall Study|Lost to Follow-up|0|||
33483846|NCT04895982|101662975|FG005|Overall Study|Lost to Follow-up|1|||
33483847|NCT04895982|101662976|FG006|Overall Study|Lost to Follow-up|0|||
33483848|NCT04895982|101662977|FG007|Overall Study|Lost to Follow-up|0|||
33483849|NCT04895982|101662978|FG008|Overall Study|Lost to Follow-up|1|||
33483850|NCT04895982|101662979|FG009|Overall Study|Lost to Follow-up|0|||
33483851|NCT04895982|101662980|FG010|Overall Study|Lost to Follow-up|0|||
33483852|NCT04895982|101662981|FG011|Overall Study|Lost to Follow-up|0|||
33483853|NCT04895982|101662970|FG000|Overall Study|Refused further study procedures|0|||
33483854|NCT04895982|101662971|FG001|Overall Study|Refused further study procedures|0|||
33483855|NCT04895982|101662972|FG002|Overall Study|Refused further study procedures|1|||
33483856|NCT04895982|101662973|FG003|Overall Study|Refused further study procedures|0|||
33483857|NCT04895982|101662974|FG004|Overall Study|Refused further study procedures|0|||
33275172|NCT01562275|100906676|FG006|Stage 2|Death|0|||
33275173|NCT01562275|100906677|FG007|Stage 2|Death|0|||
33483858|NCT04895982|101662975|FG005|Overall Study|Refused further study procedures|0|||
33483859|NCT04895982|101662976|FG006|Overall Study|Refused further study procedures|0|||
33483860|NCT04895982|101662977|FG007|Overall Study|Refused further study procedures|0|||
33483861|NCT04895982|101662978|FG008|Overall Study|Refused further study procedures|0|||
33483862|NCT04895982|101662979|FG009|Overall Study|Refused further study procedures|0|||
33483863|NCT04895982|101662980|FG010|Overall Study|Refused further study procedures|0|||
33483864|NCT04895982|101662981|FG011|Overall Study|Refused further study procedures|0|||
33275174|NCT01562275|100906678|FG008|Stage 2|Death|0|||
33483865|NCT04623086|101662988|FG000|Overall Study|Withdrawal by Subject|0|||
33483866|NCT04623086|101662989|FG001|Overall Study|Withdrawal by Subject|0|||
33483867|NCT04623086|101662990|FG002|Overall Study|Withdrawal by Subject|10|||
33483868|NCT01374269|101662996|FG000|Overall Study|Withdrawal by Subject|4|||
33483869|NCT01374269|101662997|FG001|Overall Study|Withdrawal by Subject|0|||
33483870|NCT01374269|101662996|FG000|Overall Study|Lost to Follow-up|1|||
33483871|NCT01374269|101662997|FG001|Overall Study|Lost to Follow-up|3|||
33483872|NCT01374269|101662996|FG000|Overall Study|closed research|1|||
33483873|NCT01374269|101662997|FG001|Overall Study|closed research|2|||
33483874|NCT00710866|101662998|FG000|Overall Study|Protocol Violation|5|||
33483875|NCT00710866|101662999|FG001|Overall Study|Protocol Violation|4|||
33483876|NCT00710866|101662998|FG000|Overall Study|Withdrawal by Subject|2|||
33483877|NCT00710866|101662999|FG001|Overall Study|Withdrawal by Subject|1|||
33483878|NCT00710866|101662998|FG000|Overall Study|Lost to Follow-up|1|||
33483879|NCT00710866|101662999|FG001|Overall Study|Lost to Follow-up|0|||
33483880|NCT00710866|101662998|FG000|Overall Study|Failed to meet eligibility|1|||
33483881|NCT00710866|101662999|FG001|Overall Study|Failed to meet eligibility|1|||
33483882|NCT01955083|101663001|FG000|Overall Study|Lost to Follow-up|1|||
33483883|NCT01955083|101663002|FG001|Overall Study|Lost to Follow-up|1|||
33483884|NCT01377012|101663003|FG000|Core Study|Study terminated by Sponsor|47|||
33483885|NCT01377012|101663004|FG001|Core Study|Study terminated by Sponsor|54|||
33483886|NCT01377012|101663005|FG002|Core Study|Study terminated by Sponsor|46|||
33483887|NCT01377012|101663003|FG000|Core Study|Technical problems|1|||
33483888|NCT01377012|101663004|FG001|Core Study|Technical problems|0|||
33483889|NCT01377012|101663005|FG002|Core Study|Technical problems|0|||
33483890|NCT01377012|101663003|FG000|Core Study|Withdrawal by Subject|15|||
33483891|NCT01377012|101663004|FG001|Core Study|Withdrawal by Subject|23|||
33483892|NCT01377012|101663005|FG002|Core Study|Withdrawal by Subject|18|||
33483893|NCT01377012|101663003|FG000|Core Study|Protocol Violation|7|||
33483894|NCT01377012|101663004|FG001|Core Study|Protocol Violation|3|||
33483895|NCT01377012|101663005|FG002|Core Study|Protocol Violation|2|||
33483896|NCT01377012|101663003|FG000|Core Study|Pregnancy|0|||
33483897|NCT01377012|101663004|FG001|Core Study|Pregnancy|0|||
33483898|NCT01377012|101663005|FG002|Core Study|Pregnancy|1|||
33483899|NCT01377012|101663003|FG000|Core Study|Physician Decision|5|||
33483900|NCT01377012|101663004|FG001|Core Study|Physician Decision|4|||
33483901|NCT01377012|101663005|FG002|Core Study|Physician Decision|10|||
33483902|NCT01377012|101663003|FG000|Core Study|Non-Compliant with study treatment|0|||
33483903|NCT01377012|101663004|FG001|Core Study|Non-Compliant with study treatment|0|||
33483904|NCT01377012|101663005|FG002|Core Study|Non-Compliant with study treatment|1|||
33483905|NCT01377012|101663003|FG000|Core Study|No Longer require treatment|0|||
33483906|NCT01377012|101663004|FG001|Core Study|No Longer require treatment|0|||
33483907|NCT01377012|101663005|FG002|Core Study|No Longer require treatment|1|||
33483908|NCT01377012|101663003|FG000|Core Study|Lost to Follow-up|7|||
33483909|NCT01377012|101663004|FG001|Core Study|Lost to Follow-up|5|||
33483910|NCT01377012|101663005|FG002|Core Study|Lost to Follow-up|4|||
33483911|NCT01377012|101663003|FG000|Core Study|Lack of Efficacy|41|||
33483912|NCT01377012|101663004|FG001|Core Study|Lack of Efficacy|28|||
33483913|NCT01377012|101663005|FG002|Core Study|Lack of Efficacy|37|||
33483914|NCT01377012|101663003|FG000|Core Study|Death|1|||
33483915|NCT01377012|101663004|FG001|Core Study|Death|1|||
33483916|NCT01377012|101663005|FG002|Core Study|Death|1|||
33483917|NCT01377012|101663003|FG000|Core Study|Adverse Event|10|||
33483918|NCT01377012|101663004|FG001|Core Study|Adverse Event|14|||
33483919|NCT01377012|101663005|FG002|Core Study|Adverse Event|13|||
33483920|NCT01377012|101663003|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
33483921|NCT01377012|101663004|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
33483922|NCT01377012|101663005|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
33483923|NCT01377012|101663003|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
33483924|NCT01377012|101663004|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
33483925|NCT01377012|101663005|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
33483926|NCT01377012|101663003|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
33483927|NCT01377012|101663004|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
33483928|NCT01377012|101663005|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
33483929|NCT01377012|101663003|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
33483930|NCT01377012|101663004|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
33483931|NCT01377012|101663005|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
33483932|NCT01377012|101663003|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
33483933|NCT01377012|101663004|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
33483934|NCT01377012|101663005|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
33275175|NCT01562275|100906679|FG009|Stage 2|Death|0|||
33483935|NCT01377012|101663003|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
33483936|NCT01377012|101663004|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
33483937|NCT01377012|101663005|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
33483938|NCT02759692|101663006|FG000|Period 1|Test article no longer available|1|||
33483939|NCT02759692|101663007|FG001|Period 1|Test article no longer available|1|||
33483940|NCT02759692|101663006|FG000|Period 1|No longer meets eligibility criteria.|1|||
33483941|NCT02759692|101663007|FG001|Period 1|No longer meets eligibility criteria.|0|||
33483942|NCT02759692|101663006|FG000|Period 1|Miss-Randomized|1|||
33483943|NCT02759692|101663007|FG001|Period 1|Miss-Randomized|1|||
33483944|NCT02759692|101663006|FG000|Period 2|Lost to Follow-up|1|||
33483945|NCT02759692|101663007|FG001|Period 2|Lost to Follow-up|0|||
33483946|NCT02759692|101663006|FG000|Period 2|Test article no longer available|0|||
33483947|NCT02759692|101663007|FG001|Period 2|Test article no longer available|1|||
33483948|NCT01191944|101663008|FG000|Overall Study|Adverse Event|11|||
33483949|NCT01191944|101663009|FG001|Overall Study|Adverse Event|12|||
33483950|NCT01191944|101663008|FG000|Overall Study|Protocol Violation|1|||
33483951|NCT01191944|101663009|FG001|Overall Study|Protocol Violation|2|||
33483952|NCT01191944|101663008|FG000|Overall Study|Withdrawal by Subject|4|||
33483953|NCT01191944|101663009|FG001|Overall Study|Withdrawal by Subject|2|||
33483954|NCT01191944|101663008|FG000|Overall Study|Other|1|||
33483955|NCT01191944|101663009|FG001|Overall Study|Other|3|||
33483956|NCT02540850|101663014|FG000|Overall Study|Lost to Follow-up|69|||
33483957|NCT02540850|101663015|FG001|Overall Study|Lost to Follow-up|66|||
33483958|NCT02540850|101663016|FG002|Overall Study|Lost to Follow-up|34|||
33483959|NCT03201445|101666864|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
33483960|NCT03201445|101666865|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
33483961|NCT03201445|101666864|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
33483962|NCT03201445|101666865|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
33483963|NCT03201445|101666864|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
33483964|NCT03201445|101666865|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
33483965|NCT03201445|101666864|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
33483966|NCT03201445|101666865|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
33483967|NCT03201445|101666864|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
33483968|NCT03201445|101666865|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
33483969|NCT03201445|101666864|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
33483970|NCT03201445|101666865|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
33483971|NCT03201445|101666864|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
33483972|NCT03201445|101666865|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
33483973|NCT03201445|101666864|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
33483974|NCT03201445|101666865|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
33483975|NCT03201445|101666864|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
33483976|NCT03201445|101666865|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
33483977|NCT03201445|101666864|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
33483978|NCT03201445|101666865|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
33483979|NCT03201445|101666864|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
33483980|NCT03201445|101666865|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
33483981|NCT03201445|101666864|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
33483982|NCT03201445|101666865|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
33483983|NCT03201445|101666864|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
33483984|NCT03201445|101666865|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
33483985|NCT03201445|101666864|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
33483986|NCT03201445|101666865|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
33483987|NCT03201445|101666864|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
33483988|NCT03201445|101666865|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
33483989|NCT03201445|101666864|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
33483990|NCT03201445|101666865|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
33483991|NCT03201445|101666864|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
33483992|NCT03201445|101666865|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
33483993|NCT03201445|101666864|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
33483994|NCT03201445|101666865|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
33483995|NCT03201445|101666864|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
33483996|NCT03201445|101666865|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
33483997|NCT03201445|101666864|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
33483998|NCT03201445|101666865|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
33483999|NCT03201445|101666864|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
33484000|NCT03201445|101666865|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
33484001|NCT02766283|101666866|FG000|Overall Study|Lost to Follow-up|27|||
33484002|NCT04036110|101666870|FG000|Overall Study|Lost to Follow-up|3|||
33484003|NCT04036110|101666871|FG001|Overall Study|Lost to Follow-up|2|||
33484004|NCT04036110|101666872|FG002|Overall Study|Lost to Follow-up|1|||
33484005|NCT04036110|101666870|FG000|Overall Study|Study Suspended|4|||
33484006|NCT04036110|101666871|FG001|Overall Study|Study Suspended|5|||
33484007|NCT04036110|101666872|FG002|Overall Study|Study Suspended|1|||
33484008|NCT02198963|101666873|FG000|Overall Study|Adverse Event|1|||
33484009|NCT02198963|101666873|FG000|Overall Study|Withdrawal by Subject|6|||
33484010|NCT01959295|101666874|FG000|Overall Study|Adverse Event|2|||
33484011|NCT01959295|101666875|FG001|Overall Study|Adverse Event|0|||
33484012|NCT01959295|101666874|FG000|Overall Study|Lost to Follow-up|0|||
33484013|NCT01959295|101666875|FG001|Overall Study|Lost to Follow-up|2|||
33484014|NCT01959295|101666874|FG000|Overall Study|Physician Decision|2|||
33484015|NCT01959295|101666875|FG001|Overall Study|Physician Decision|3|||
33484016|NCT01959295|101666874|FG000|Overall Study|Protocol Violation|16|||
33484017|NCT01959295|101666875|FG001|Overall Study|Protocol Violation|5|||
33484018|NCT01959295|101666874|FG000|Overall Study|Withdrawal by Subject|3|||
33484019|NCT01959295|101666875|FG001|Overall Study|Withdrawal by Subject|1|||
33484020|NCT01959295|101666874|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
33484021|NCT01959295|101666875|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
33484022|NCT03138655|101666878|FG000|Overall Study|Adverse Event|2|||
33484023|NCT03138655|101666879|FG001|Overall Study|Adverse Event|1|||
33484024|NCT03138655|101666880|FG002|Overall Study|Adverse Event|2|||
33484025|NCT03138655|101666881|FG003|Overall Study|Adverse Event|1|||
33484026|NCT03138655|101666882|FG004|Overall Study|Adverse Event|1|||
33484027|NCT03138655|101666883|FG005|Overall Study|Adverse Event|4|||
33484028|NCT03138655|101666884|FG006|Overall Study|Adverse Event|2|||
33484029|NCT03138655|101666885|FG007|Overall Study|Adverse Event|2|||
33484030|NCT03138655|101666878|FG000|Overall Study|Withdrawal by Subject|0|||
33484031|NCT03138655|101666879|FG001|Overall Study|Withdrawal by Subject|1|||
33484032|NCT03138655|101666880|FG002|Overall Study|Withdrawal by Subject|0|||
33484033|NCT03138655|101666881|FG003|Overall Study|Withdrawal by Subject|0|||
33484034|NCT03138655|101666882|FG004|Overall Study|Withdrawal by Subject|0|||
33484035|NCT03138655|101666883|FG005|Overall Study|Withdrawal by Subject|0|||
33484036|NCT03138655|101666884|FG006|Overall Study|Withdrawal by Subject|1|||
33484037|NCT03138655|101666885|FG007|Overall Study|Withdrawal by Subject|0|||
33484038|NCT03138655|101666878|FG000|Overall Study|Reason not Specified|1|||
33484039|NCT03138655|101666879|FG001|Overall Study|Reason not Specified|0|||
33484040|NCT03138655|101666880|FG002|Overall Study|Reason not Specified|0|||
33484041|NCT03138655|101666881|FG003|Overall Study|Reason not Specified|2|||
33484042|NCT03138655|101666882|FG004|Overall Study|Reason not Specified|1|||
33484043|NCT03138655|101666883|FG005|Overall Study|Reason not Specified|1|||
33484044|NCT03138655|101666884|FG006|Overall Study|Reason not Specified|0|||
33484045|NCT03138655|101666885|FG007|Overall Study|Reason not Specified|0|||
33484046|NCT01338870|101666886|FG000|Overall Study|Lost to Follow-up|0|||
33484047|NCT01338870|101666887|FG001|Overall Study|Lost to Follow-up|0|||
33484048|NCT01338870|101666888|FG002|Overall Study|Lost to Follow-up|1|||
33484049|NCT01338870|101666889|FG003|Overall Study|Lost to Follow-up|0|||
33484050|NCT01338870|101666890|FG004|Overall Study|Lost to Follow-up|1|||
33484051|NCT01338870|101666891|FG005|Overall Study|Lost to Follow-up|0|||
33484052|NCT01338870|101666886|FG000|Overall Study|Withdrawal by Subject|2|||
33484053|NCT01338870|101666887|FG001|Overall Study|Withdrawal by Subject|3|||
33484054|NCT01338870|101666888|FG002|Overall Study|Withdrawal by Subject|4|||
33484055|NCT01338870|101666889|FG003|Overall Study|Withdrawal by Subject|0|||
33484056|NCT01338870|101666890|FG004|Overall Study|Withdrawal by Subject|0|||
33484057|NCT01338870|101666891|FG005|Overall Study|Withdrawal by Subject|2|||
33484058|NCT01338870|101666886|FG000|Overall Study|Other|3|||
33484059|NCT01338870|101666887|FG001|Overall Study|Other|3|||
33484060|NCT01338870|101666888|FG002|Overall Study|Other|3|||
33484061|NCT01338870|101666889|FG003|Overall Study|Other|2|||
33484062|NCT01338870|101666890|FG004|Overall Study|Other|0|||
33484063|NCT01338870|101666891|FG005|Overall Study|Other|2|||
33484064|NCT01338870|101666886|FG000|Overall Study|Protocol Violation|0|||
33484065|NCT01338870|101666887|FG001|Overall Study|Protocol Violation|2|||
33484066|NCT01338870|101666888|FG002|Overall Study|Protocol Violation|2|||
33484067|NCT01338870|101666889|FG003|Overall Study|Protocol Violation|2|||
33484068|NCT01338870|101666890|FG004|Overall Study|Protocol Violation|1|||
33484069|NCT01338870|101666891|FG005|Overall Study|Protocol Violation|1|||
33484070|NCT01338870|101666886|FG000|Overall Study|Adverse Event|4|||
33484071|NCT01338870|101666887|FG001|Overall Study|Adverse Event|4|||
33484072|NCT01338870|101666888|FG002|Overall Study|Adverse Event|1|||
33484073|NCT01338870|101666889|FG003|Overall Study|Adverse Event|5|||
33484074|NCT01338870|101666890|FG004|Overall Study|Adverse Event|4|||
33484075|NCT01338870|101666891|FG005|Overall Study|Adverse Event|1|||
33484076|NCT01442688|101666892|FG000|First Intervention|Withdrawal by Subject|1|||
33484077|NCT01442688|101666893|FG001|First Intervention|Withdrawal by Subject|0|||
33484078|NCT01442688|101666892|FG000|First Intervention|subject incarcerated|1|||
33484079|NCT01442688|101666893|FG001|First Intervention|subject incarcerated|0|||
33484080|NCT01442688|101666892|FG000|Second Intervention|Adverse Event|1|||
33484081|NCT01442688|101666893|FG001|Second Intervention|Adverse Event|0|||
33484082|NCT04604795|101666894|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
33484083|NCT04604795|101666895|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
33484084|NCT04604795|101666896|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33484085|NCT04604795|101666897|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33484086|NCT04604795|101666898|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33484087|NCT04604795|101666899|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33484088|NCT04604795|101666900|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33484089|NCT04604795|101666901|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33484090|NCT04604795|101666902|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33484091|NCT04604795|101666903|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
33484092|NCT04604795|101666894|FG000|Part B: Up to Day 14|Adverse Event|0|||
33484093|NCT04604795|101666895|FG001|Part B: Up to Day 14|Adverse Event|0|||
33484094|NCT04604795|101666896|FG002|Part B: Up to Day 14|Adverse Event|0|||
33484095|NCT04604795|101666897|FG003|Part B: Up to Day 14|Adverse Event|0|||
33484096|NCT04604795|101666898|FG004|Part B: Up to Day 14|Adverse Event|2|||
33484097|NCT04604795|101666899|FG005|Part B: Up to Day 14|Adverse Event|1|||
33484098|NCT04604795|101666900|FG006|Part B: Up to Day 14|Adverse Event|0|||
33484099|NCT04604795|101666901|FG007|Part B: Up to Day 14|Adverse Event|0|||
33484100|NCT04604795|101666902|FG008|Part B: Up to Day 14|Adverse Event|0|||
33484101|NCT04604795|101666903|FG009|Part B: Up to Day 14|Adverse Event|0|||
33484102|NCT04604795|101666894|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33484103|NCT04604795|101666895|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33484104|NCT04604795|101666896|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33484105|NCT04604795|101666897|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33484106|NCT04604795|101666898|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33484107|NCT04604795|101666899|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33484108|NCT04604795|101666900|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33484109|NCT04604795|101666901|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33484110|NCT04604795|101666902|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
33484111|NCT04604795|101666903|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
33484112|NCT04604795|101666894|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33484113|NCT04604795|101666895|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33484114|NCT04604795|101666896|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33484115|NCT04604795|101666897|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33484116|NCT04604795|101666898|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33484117|NCT04604795|101666899|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33484118|NCT04604795|101666900|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33484119|NCT04604795|101666901|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33484120|NCT04604795|101666902|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
33484121|NCT04604795|101666903|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
33484122|NCT04604795|101666894|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33484123|NCT04604795|101666895|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33484124|NCT04604795|101666896|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33484125|NCT04604795|101666897|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33484126|NCT04604795|101666898|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33484127|NCT04604795|101666899|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33484128|NCT04604795|101666900|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33484129|NCT04604795|101666901|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33484130|NCT04604795|101666902|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
33484131|NCT04604795|101666903|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
33484132|NCT04604795|101666894|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
33484133|NCT04604795|101666895|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
33484134|NCT04604795|101666896|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
33484135|NCT04604795|101666897|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
33484136|NCT04604795|101666898|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
33484137|NCT04604795|101666899|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
33484138|NCT04604795|101666900|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
33484139|NCT04604795|101666901|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
33484140|NCT04604795|101666902|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
33484141|NCT04604795|101666903|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
33484142|NCT01111825|101666904|FG000|Overall Study|Withdrawal by Subject|0|||
33484143|NCT01111825|101666905|FG001|Overall Study|Withdrawal by Subject|0|||
33484144|NCT01111825|101666906|FG002|Overall Study|Withdrawal by Subject|1|||
33484145|NCT01111825|101666907|FG003|Overall Study|Withdrawal by Subject|0|||
33484146|NCT01111825|101666904|FG000|Overall Study|Lost to Follow-up|0|||
33484147|NCT01111825|101666905|FG001|Overall Study|Lost to Follow-up|0|||
33484148|NCT01111825|101666906|FG002|Overall Study|Lost to Follow-up|3|||
33484149|NCT01111825|101666907|FG003|Overall Study|Lost to Follow-up|1|||
33484150|NCT01111825|101666904|FG000|Overall Study|Adverse Event|2|||
33484151|NCT01111825|101666905|FG001|Overall Study|Adverse Event|1|||
33484152|NCT01111825|101666906|FG002|Overall Study|Adverse Event|4|||
33484153|NCT01111825|101666907|FG003|Overall Study|Adverse Event|0|||
33484154|NCT01111825|101666904|FG000|Overall Study|Disease Progression|1|||
33484155|NCT01111825|101666905|FG001|Overall Study|Disease Progression|0|||
33484156|NCT01111825|101666906|FG002|Overall Study|Disease Progression|0|||
33484157|NCT01111825|101666907|FG003|Overall Study|Disease Progression|0|||
33484158|NCT01111825|101666904|FG000|Overall Study|Discontinuation by Sponsor|0|||
33484159|NCT01111825|101666905|FG001|Overall Study|Discontinuation by Sponsor|0|||
33484160|NCT01111825|101666906|FG002|Overall Study|Discontinuation by Sponsor|0|||
33484161|NCT01111825|101666907|FG003|Overall Study|Discontinuation by Sponsor|20|||
33484162|NCT01851330|101666921|FG000|Overall Study|Lack of Efficacy|10|||
33484163|NCT01851330|101666922|FG001|Overall Study|Lack of Efficacy|9|||
33484164|NCT01851330|101666923|FG002|Overall Study|Lack of Efficacy|2|||
33484165|NCT01851330|101666921|FG000|Overall Study|Lost to Follow-up|1|||
33484166|NCT01851330|101666922|FG001|Overall Study|Lost to Follow-up|6|||
33484167|NCT01851330|101666923|FG002|Overall Study|Lost to Follow-up|9|||
33484168|NCT01851330|101666921|FG000|Overall Study|Withdrew Consent|2|||
33484169|NCT01851330|101666922|FG001|Overall Study|Withdrew Consent|1|||
33484170|NCT01851330|101666923|FG002|Overall Study|Withdrew Consent|0|||
33484171|NCT01851330|101666921|FG000|Overall Study|Investigator's Discretion|0|||
33484172|NCT01851330|101666922|FG001|Overall Study|Investigator's Discretion|0|||
33484173|NCT01851330|101666923|FG002|Overall Study|Investigator's Discretion|1|||
33484174|NCT04803305|101666924|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
33484175|NCT04803305|101666925|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
33484176|NCT04803305|101666924|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
33484177|NCT04803305|101666925|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
33484178|NCT04803305|101666924|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
33484179|NCT04803305|101666925|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
33484180|NCT04803305|101666924|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
33484181|NCT04803305|101666925|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
33484182|NCT04803305|101666924|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
33484183|NCT04803305|101666925|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
33484184|NCT04803305|101666924|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
33484185|NCT04803305|101666925|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
33484186|NCT04803305|101666924|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
33484187|NCT04803305|101666925|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
33484188|NCT04803305|101666924|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
33484189|NCT04803305|101666925|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
33484190|NCT01141205|101666926|FG000|Overall Study|Physician Decision|1|||
33484191|NCT01141205|101666927|FG001|Overall Study|Physician Decision|1|||
33484192|NCT01141205|101666926|FG000|Overall Study|Lost to Follow-up|1|||
33484193|NCT01141205|101666927|FG001|Overall Study|Lost to Follow-up|0|||
33484194|NCT01141205|101666926|FG000|Overall Study|Withdrawal by Subject|1|||
33484195|NCT01141205|101666927|FG001|Overall Study|Withdrawal by Subject|1|||
33484196|NCT02842073|101666928|FG000|Overall Study|Withdrawal by Subject|1|||
33484197|NCT02252406|101666929|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
33484198|NCT02252406|101666930|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
33484199|NCT02252406|101666929|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
33484200|NCT02252406|101666930|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
33484201|NCT02252406|101666929|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
33484202|NCT02252406|101666930|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
33484203|NCT02252406|101666929|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
33484204|NCT02252406|101666930|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
33484205|NCT02252406|101666929|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
33484206|NCT02252406|101666930|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
33484207|NCT00233402|101666931|FG000|Overall Study|No pathology data|12|||
33484208|NCT00233402|101666932|FG001|Overall Study|No pathology data|9|||
33484209|NCT00233402|101666931|FG000|Overall Study|No Ta/T1|89|||
33484210|NCT00233402|101666932|FG001|Overall Study|No Ta/T1|94|||
33484211|NCT00233402|101666931|FG000|Overall Study|Lost to follow up etc|3|||
33484212|NCT00233402|101666932|FG001|Overall Study|Lost to follow up etc|21|||
33484213|NCT02613182|101666935|FG000|Overall Study|Death|6|||
33484214|NCT02613182|101666935|FG000|Overall Study|Physician Decision|1|||
33484215|NCT02613182|101666935|FG000|Overall Study|Study Terminated by Sponsor|21|||
33484216|NCT02613182|101666935|FG000|Overall Study|Withdrawal by Subject|6|||
33484217|NCT01954745|101666941|FG000|Overall Study|Radiological Progression|11|||
33484218|NCT01954745|101666941|FG000|Overall Study|Clinical Progression|5|||
33484219|NCT01954745|101666941|FG000|Overall Study|Adverse Event|2|||
33484220|NCT01954745|101666941|FG000|Overall Study|Death|1|||
33484221|NCT00477633|101666946|FG000|Overall Study|Did not receive treatment|23|||
33275176|NCT01562275|100906680|FG010|Stage 2|Death|0|||
33275177|NCT01562275|100906681|FG011|Stage 2|Death|2|||
33275178|NCT01562275|100906682|FG012|Stage 2|Death|1|||
33484222|NCT00477633|101666946|FG000|Overall Study|Adverse Event|143|||
33484223|NCT00477633|101666946|FG000|Overall Study|Pregnancy|23|||
33484224|NCT00477633|101666946|FG000|Overall Study|Lost to Follow-up|271|||
33275179|NCT01562275|100906670|FG000|Stage 2|Progression of Disease|0|||
33275180|NCT01562275|100906671|FG001|Stage 2|Progression of Disease|0|||
33484225|NCT00477633|101666946|FG000|Overall Study|Withdrawal by Subject|149|||
33484226|NCT00477633|101666946|FG000|Overall Study|Protocol Violation|25|||
33484227|NCT00477633|101666946|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
33484228|NCT00396812|101666947|FG000|Overall Study|Physician Decision|1|||
33484229|NCT01973595|101666948|FG000|Washout|Withdrawal by Subject|1|||
33484230|NCT01973595|101666949|FG001|Washout|Withdrawal by Subject|0|||
33484231|NCT01973595|101666950|FG002|Washout|Withdrawal by Subject|1|||
33484232|NCT01973595|101666951|FG003|Washout|Withdrawal by Subject|0|||
33484233|NCT00993421|101666952|FG000|Overall Study|Adverse Event|2|||
33484234|NCT00993421|101666953|FG001|Overall Study|Adverse Event|7|||
33484235|NCT00993421|101666954|FG002|Overall Study|Adverse Event|6|||
33484236|NCT00993421|101666955|FG003|Overall Study|Adverse Event|9|||
33484237|NCT00993421|101666956|FG004|Overall Study|Adverse Event|5|||
33484238|NCT00993421|101666957|FG005|Overall Study|Adverse Event|7|||
33484239|NCT00993421|101666958|FG006|Overall Study|Adverse Event|1|||
33484240|NCT00993421|101666952|FG000|Overall Study|Sponsor Decision|36|||
33484241|NCT00993421|101666953|FG001|Overall Study|Sponsor Decision|31|||
33484242|NCT00993421|101666954|FG002|Overall Study|Sponsor Decision|28|||
33484243|NCT00993421|101666955|FG003|Overall Study|Sponsor Decision|30|||
33484244|NCT00993421|101666956|FG004|Overall Study|Sponsor Decision|38|||
33484245|NCT00993421|101666957|FG005|Overall Study|Sponsor Decision|30|||
33484246|NCT00993421|101666958|FG006|Overall Study|Sponsor Decision|29|||
33484247|NCT00993421|101666952|FG000|Overall Study|Lost to Follow-up|3|||
33484248|NCT00993421|101666953|FG001|Overall Study|Lost to Follow-up|5|||
33484249|NCT00993421|101666954|FG002|Overall Study|Lost to Follow-up|5|||
33484250|NCT00993421|101666955|FG003|Overall Study|Lost to Follow-up|0|||
33484251|NCT00993421|101666956|FG004|Overall Study|Lost to Follow-up|0|||
33484252|NCT00993421|101666957|FG005|Overall Study|Lost to Follow-up|0|||
33484253|NCT00993421|101666958|FG006|Overall Study|Lost to Follow-up|6|||
33484254|NCT00993421|101666952|FG000|Overall Study|Withdrawal by Subject|3|||
33484255|NCT00993421|101666953|FG001|Overall Study|Withdrawal by Subject|2|||
33484256|NCT00993421|101666954|FG002|Overall Study|Withdrawal by Subject|3|||
33484257|NCT00993421|101666955|FG003|Overall Study|Withdrawal by Subject|3|||
33484258|NCT00993421|101666956|FG004|Overall Study|Withdrawal by Subject|3|||
33484259|NCT00993421|101666957|FG005|Overall Study|Withdrawal by Subject|5|||
33484260|NCT00993421|101666958|FG006|Overall Study|Withdrawal by Subject|3|||
33484261|NCT00993421|101666952|FG000|Overall Study|Death|0|||
33484262|NCT00993421|101666953|FG001|Overall Study|Death|0|||
33484263|NCT00993421|101666954|FG002|Overall Study|Death|0|||
33484264|NCT00993421|101666955|FG003|Overall Study|Death|0|||
33484265|NCT00993421|101666956|FG004|Overall Study|Death|0|||
33484266|NCT00993421|101666957|FG005|Overall Study|Death|0|||
33484267|NCT00993421|101666958|FG006|Overall Study|Death|1|||
33484268|NCT00993421|101666952|FG000|Overall Study|Entry Criteria Exclusion|0|||
33484269|NCT00993421|101666953|FG001|Overall Study|Entry Criteria Exclusion|0|||
33484270|NCT00993421|101666954|FG002|Overall Study|Entry Criteria Exclusion|1|||
33484271|NCT00993421|101666955|FG003|Overall Study|Entry Criteria Exclusion|3|||
33484272|NCT00993421|101666956|FG004|Overall Study|Entry Criteria Exclusion|0|||
33484273|NCT00993421|101666957|FG005|Overall Study|Entry Criteria Exclusion|1|||
33484274|NCT00993421|101666958|FG006|Overall Study|Entry Criteria Exclusion|0|||
33484275|NCT00993421|101666952|FG000|Overall Study|Physician Decision|0|||
33484276|NCT00993421|101666953|FG001|Overall Study|Physician Decision|0|||
33484277|NCT00993421|101666954|FG002|Overall Study|Physician Decision|0|||
33484278|NCT00993421|101666955|FG003|Overall Study|Physician Decision|0|||
33484279|NCT00993421|101666956|FG004|Overall Study|Physician Decision|0|||
33484280|NCT00993421|101666957|FG005|Overall Study|Physician Decision|1|||
33484281|NCT00993421|101666958|FG006|Overall Study|Physician Decision|1|||
33484282|NCT00993421|101666952|FG000|Overall Study|Protocol Violation|0|||
33484283|NCT00993421|101666953|FG001|Overall Study|Protocol Violation|0|||
33484284|NCT00993421|101666954|FG002|Overall Study|Protocol Violation|0|||
33484285|NCT00993421|101666955|FG003|Overall Study|Protocol Violation|0|||
33484286|NCT00993421|101666956|FG004|Overall Study|Protocol Violation|0|||
33484287|NCT00993421|101666957|FG005|Overall Study|Protocol Violation|2|||
33484288|NCT00993421|101666958|FG006|Overall Study|Protocol Violation|1|||
33484289|NCT00425373|101666960|FG000|Overall Study|Adverse Event|2|||
33484290|NCT00425373|101666961|FG001|Overall Study|Adverse Event|2|||
33484291|NCT00425373|101666962|FG002|Overall Study|Adverse Event|0|||
33484292|NCT00425373|101666963|FG003|Overall Study|Adverse Event|1|||
33484293|NCT00425373|101666964|FG004|Overall Study|Adverse Event|4|||
33484294|NCT00425373|101666965|FG005|Overall Study|Adverse Event|6|||
33484295|NCT00425373|101666966|FG006|Overall Study|Adverse Event|2|||
33484296|NCT00425373|101666967|FG007|Overall Study|Adverse Event|3|||
33484297|NCT00425373|101666968|FG008|Overall Study|Adverse Event|8|||
33484298|NCT00425373|101666960|FG000|Overall Study|Lost to Follow-up|0|||
33484299|NCT00425373|101666961|FG001|Overall Study|Lost to Follow-up|1|||
33484300|NCT00425373|101666962|FG002|Overall Study|Lost to Follow-up|0|||
33484301|NCT00425373|101666963|FG003|Overall Study|Lost to Follow-up|0|||
33484302|NCT00425373|101666964|FG004|Overall Study|Lost to Follow-up|1|||
33484303|NCT00425373|101666965|FG005|Overall Study|Lost to Follow-up|0|||
33484304|NCT00425373|101666966|FG006|Overall Study|Lost to Follow-up|0|||
33484305|NCT00425373|101666967|FG007|Overall Study|Lost to Follow-up|0|||
33484306|NCT00425373|101666968|FG008|Overall Study|Lost to Follow-up|0|||
33484307|NCT00425373|101666960|FG000|Overall Study|Protocol Violation|1|||
33484308|NCT00425373|101666961|FG001|Overall Study|Protocol Violation|0|||
33484309|NCT00425373|101666962|FG002|Overall Study|Protocol Violation|1|||
33484310|NCT00425373|101666963|FG003|Overall Study|Protocol Violation|0|||
33484311|NCT00425373|101666964|FG004|Overall Study|Protocol Violation|0|||
33484312|NCT00425373|101666965|FG005|Overall Study|Protocol Violation|0|||
33484313|NCT00425373|101666966|FG006|Overall Study|Protocol Violation|0|||
33484314|NCT00425373|101666967|FG007|Overall Study|Protocol Violation|5|||
33484315|NCT00425373|101666968|FG008|Overall Study|Protocol Violation|3|||
33484316|NCT00425373|101666960|FG000|Overall Study|Withdrawal by Subject|2|||
33484317|NCT00425373|101666961|FG001|Overall Study|Withdrawal by Subject|0|||
33484318|NCT00425373|101666962|FG002|Overall Study|Withdrawal by Subject|2|||
33484319|NCT00425373|101666963|FG003|Overall Study|Withdrawal by Subject|1|||
33484320|NCT00425373|101666964|FG004|Overall Study|Withdrawal by Subject|4|||
33484321|NCT00425373|101666965|FG005|Overall Study|Withdrawal by Subject|0|||
33484322|NCT00425373|101666966|FG006|Overall Study|Withdrawal by Subject|2|||
33484323|NCT00425373|101666967|FG007|Overall Study|Withdrawal by Subject|2|||
33484324|NCT00425373|101666968|FG008|Overall Study|Withdrawal by Subject|2|||
33484325|NCT00425373|101666960|FG000|Overall Study|Lack of Efficacy|0|||
33484326|NCT00425373|101666961|FG001|Overall Study|Lack of Efficacy|0|||
33484327|NCT00425373|101666962|FG002|Overall Study|Lack of Efficacy|0|||
33484328|NCT00425373|101666963|FG003|Overall Study|Lack of Efficacy|0|||
33484329|NCT00425373|101666964|FG004|Overall Study|Lack of Efficacy|1|||
33484330|NCT00425373|101666965|FG005|Overall Study|Lack of Efficacy|3|||
33484331|NCT00425373|101666966|FG006|Overall Study|Lack of Efficacy|3|||
33484332|NCT00425373|101666967|FG007|Overall Study|Lack of Efficacy|0|||
33484333|NCT00425373|101666968|FG008|Overall Study|Lack of Efficacy|5|||
33484334|NCT03999749|101666969|FG000|Overall Study|Toxicity|16|||
33484335|NCT03999749|101666969|FG000|Overall Study|Withdrawal by Subject|3|||
33484336|NCT03999749|101666969|FG000|Overall Study|Disease progression|26|||
33484337|NCT03999749|101666969|FG000|Overall Study|Physician Decision|4|||
33484338|NCT03999749|101666969|FG000|Overall Study|Death|5|||
33484339|NCT03999749|101666969|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
33484340|NCT00535405|101666970|FG000|Overall Study|Adverse Event|6|||
33484341|NCT00535405|101666971|FG001|Overall Study|Adverse Event|8|||
33484342|NCT00535405|101666972|FG002|Overall Study|Adverse Event|3|||
33484343|NCT00535405|101666973|FG003|Overall Study|Adverse Event|8|||
33484344|NCT00535405|101666974|FG004|Overall Study|Adverse Event|6|||
33484345|NCT00535405|101666970|FG000|Overall Study|Lost to Follow-up|1|||
33484346|NCT00535405|101666971|FG001|Overall Study|Lost to Follow-up|3|||
33484347|NCT00535405|101666972|FG002|Overall Study|Lost to Follow-up|3|||
33484348|NCT00535405|101666973|FG003|Overall Study|Lost to Follow-up|2|||
33484349|NCT00535405|101666974|FG004|Overall Study|Lost to Follow-up|1|||
33484350|NCT00535405|101666970|FG000|Overall Study|Physician Decision|3|||
33484351|NCT00535405|101666971|FG001|Overall Study|Physician Decision|2|||
33484352|NCT00535405|101666972|FG002|Overall Study|Physician Decision|0|||
33484353|NCT00535405|101666973|FG003|Overall Study|Physician Decision|1|||
33484354|NCT00535405|101666974|FG004|Overall Study|Physician Decision|1|||
33484355|NCT00535405|101666970|FG000|Overall Study|Protocol Violation|2|||
33484356|NCT00535405|101666971|FG001|Overall Study|Protocol Violation|2|||
33484357|NCT00535405|101666972|FG002|Overall Study|Protocol Violation|2|||
33484358|NCT00535405|101666973|FG003|Overall Study|Protocol Violation|1|||
33484359|NCT00535405|101666974|FG004|Overall Study|Protocol Violation|0|||
33484360|NCT00535405|101666970|FG000|Overall Study|Withdrawal by Subject|5|||
33484361|NCT00535405|101666971|FG001|Overall Study|Withdrawal by Subject|11|||
33484362|NCT00535405|101666972|FG002|Overall Study|Withdrawal by Subject|10|||
33484363|NCT00535405|101666973|FG003|Overall Study|Withdrawal by Subject|10|||
33484364|NCT00535405|101666974|FG004|Overall Study|Withdrawal by Subject|8|||
33484365|NCT04759768|101666976|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
33484366|NCT04759768|101666977|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
33484367|NCT04759768|101666976|FG000|Washout (7 Days)|Physician Decision|0|||
33484368|NCT04759768|101666977|FG001|Washout (7 Days)|Physician Decision|1|||
33484369|NCT02022748|101666978|FG000|Overall Study|Adverse Event|1|||
33484370|NCT02022748|101666979|FG001|Overall Study|Adverse Event|1|||
33484371|NCT02022748|101666980|FG002|Overall Study|Adverse Event|0|||
33484372|NCT02022748|101666978|FG000|Overall Study|Withdrawal by Subject|0|||
33484373|NCT02022748|101666979|FG001|Overall Study|Withdrawal by Subject|1|||
33484374|NCT02022748|101666980|FG002|Overall Study|Withdrawal by Subject|0|||
33484375|NCT02015065|101666981|FG000|Overall Study|Death on study|1|||
33484376|NCT02015065|101666982|FG001|Overall Study|Death on study|2|||
33484377|NCT02015065|101666983|FG002|Overall Study|Death on study|1|||
33484378|NCT04877457|101666990|FG000|Overall Study|Early termination of study due to low enrollment|2|||
33484379|NCT04877457|101666991|FG001|Overall Study|Early termination of study due to low enrollment|1|||
33484380|NCT01775189|101666993|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33484381|NCT01775189|101666994|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
33484382|NCT01775189|101666995|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33484383|NCT01775189|101666996|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33484384|NCT01775189|101666997|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33484385|NCT01775189|101666998|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33484386|NCT01775189|101666999|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
33484387|NCT01775189|101666993|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33484388|NCT01775189|101666994|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
33484389|NCT01775189|101666995|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33484390|NCT01775189|101666996|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33484391|NCT01775189|101666997|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33484392|NCT01775189|101666998|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33484393|NCT01775189|101666999|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
33484394|NCT01775189|101666993|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
33275181|NCT01562275|100906672|FG002|Stage 2|Progression of Disease|0|||
33275182|NCT01562275|100906673|FG003|Stage 2|Progression of Disease|0|||
33275183|NCT01562275|100906674|FG004|Stage 2|Progression of Disease|0|||
33275184|NCT01562275|100906675|FG005|Stage 2|Progression of Disease|0|||
33484395|NCT01775189|101666994|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
33484396|NCT01775189|101666995|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
33484397|NCT01775189|101666996|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
33484398|NCT01775189|101666997|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
33484399|NCT01775189|101666998|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
33484400|NCT01775189|101666999|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
33484401|NCT01775189|101666993|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
33484402|NCT01775189|101666994|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
33484403|NCT01775189|101666995|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
33484404|NCT01775189|101666996|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
33484405|NCT01775189|101666997|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
33484406|NCT01775189|101666998|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
33484407|NCT01775189|101666999|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
33484408|NCT01775189|101666993|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
33484409|NCT01775189|101666994|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
33484410|NCT01775189|101666995|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
33484411|NCT01775189|101666996|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
33484412|NCT01775189|101666997|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
33484413|NCT01775189|101666998|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
33484414|NCT01775189|101666999|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
33484415|NCT01775189|101666993|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
33484416|NCT01775189|101666994|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
33484417|NCT01775189|101666995|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
33484418|NCT01775189|101666996|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
33484419|NCT01775189|101666997|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
33484420|NCT01775189|101666998|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
33484421|NCT01775189|101666999|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
33484422|NCT01449370|101667002|FG000|Overall Study|Disease Progression|5|||
33484423|NCT01449370|101667003|FG001|Overall Study|Disease Progression|4|||
33484424|NCT01449370|101667004|FG002|Overall Study|Disease Progression|8|||
33484425|NCT01449370|101667005|FG003|Overall Study|Disease Progression|3|||
33484426|NCT01449370|101667006|FG004|Overall Study|Disease Progression|3|||
33484427|NCT01449370|101667007|FG005|Overall Study|Disease Progression|3|||
33484428|NCT01449370|101667008|FG006|Overall Study|Disease Progression|3|||
33484429|NCT01449370|101667009|FG007|Overall Study|Disease Progression|2|||
33484430|NCT01449370|101667010|FG008|Overall Study|Disease Progression|9|||
33484431|NCT01449370|101667011|FG009|Overall Study|Disease Progression|1|||
33484432|NCT01449370|101667012|FG010|Overall Study|Disease Progression|3|||
33484433|NCT01449370|101667013|FG011|Overall Study|Disease Progression|3|||
33484434|NCT01449370|101667014|FG012|Overall Study|Disease Progression|2|||
33484435|NCT01449370|101667015|FG013|Overall Study|Disease Progression|8|||
33484436|NCT01449370|101667016|FG014|Overall Study|Disease Progression|3|||
33484437|NCT01449370|101667017|FG015|Overall Study|Disease Progression|1|||
33484438|NCT01449370|101667018|FG016|Overall Study|Disease Progression|4|||
33484439|NCT01449370|101667019|FG017|Overall Study|Disease Progression|3|||
33484440|NCT01449370|101667020|FG018|Overall Study|Disease Progression|1|||
33484441|NCT01449370|101667021|FG019|Overall Study|Disease Progression|2|||
33484442|NCT01449370|101667022|FG020|Overall Study|Disease Progression|5|||
33484443|NCT01449370|101667023|FG021|Overall Study|Disease Progression|2|||
33484444|NCT01449370|101667024|FG022|Overall Study|Disease Progression|3|||
33484445|NCT01449370|101667025|FG023|Overall Study|Disease Progression|7|||
33484446|NCT01449370|101667026|FG024|Overall Study|Disease Progression|3|||
33484447|NCT01449370|101667002|FG000|Overall Study|Adverse Event|1|||
33484448|NCT01449370|101667003|FG001|Overall Study|Adverse Event|2|||
33484449|NCT01449370|101667004|FG002|Overall Study|Adverse Event|0|||
33484450|NCT01449370|101667005|FG003|Overall Study|Adverse Event|1|||
33484451|NCT01449370|101667006|FG004|Overall Study|Adverse Event|0|||
33484452|NCT01449370|101667007|FG005|Overall Study|Adverse Event|0|||
33275185|NCT01562275|100906676|FG006|Stage 2|Progression of Disease|0|||
33275186|NCT01562275|100906677|FG007|Stage 2|Progression of Disease|0|||
33484453|NCT01449370|101667008|FG006|Overall Study|Adverse Event|0|||
33484454|NCT01449370|101667009|FG007|Overall Study|Adverse Event|0|||
33484455|NCT01449370|101667010|FG008|Overall Study|Adverse Event|1|||
33484456|NCT01449370|101667011|FG009|Overall Study|Adverse Event|1|||
33275187|NCT01562275|100906678|FG008|Stage 2|Progression of Disease|0|||
33275188|NCT01562275|100906679|FG009|Stage 2|Progression of Disease|0|||
33275189|NCT01562275|100906680|FG010|Stage 2|Progression of Disease|0|||
33275190|NCT01562275|100906681|FG011|Stage 2|Progression of Disease|12|||
33275191|NCT01562275|100906682|FG012|Stage 2|Progression of Disease|4|||
33275192|NCT03708744|100906683|FG000|Overall Study|Withdrawal by Subject|0|||
33275193|NCT03708744|100906684|FG001|Overall Study|Withdrawal by Subject|0|||
33275194|NCT03708744|100906685|FG002|Overall Study|Withdrawal by Subject|1|||
33275195|NCT03708744|100906686|FG003|Overall Study|Withdrawal by Subject|0|||
33275196|NCT04676763|100906693|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
33275197|NCT04676763|100906694|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
33275198|NCT04676763|100906695|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
33275199|NCT04676763|100906693|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
33275200|NCT04676763|100906694|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
33275201|NCT04676763|100906695|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
33275202|NCT04676763|100906693|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
33275203|NCT04676763|100906694|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
33275204|NCT04676763|100906695|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
33275205|NCT00587171|100906696|FG000|Overall Study|Lost to Follow-up|1|||
33275206|NCT00587171|100906697|FG001|Overall Study|Lost to Follow-up|1|||
33275207|NCT01848483|100906698|FG000|Overall Study|Death|2|||
33275208|NCT01848483|100906699|FG001|Overall Study|Death|1|||
33275209|NCT01848483|100906698|FG000|Overall Study|Lost to Follow-up|6|||
33275210|NCT01848483|100906699|FG001|Overall Study|Lost to Follow-up|8|||
33275211|NCT01848483|100906698|FG000|Overall Study|Withdrawal by Subject|1|||
33275212|NCT01848483|100906699|FG001|Overall Study|Withdrawal by Subject|0|||
33275213|NCT01848483|100906698|FG000|Overall Study|Incarceration|2|||
33275214|NCT01848483|100906699|FG001|Overall Study|Incarceration|2|||
33275215|NCT00422162|100906702|FG000|Overall Study|Adverse Event|11|||
33275216|NCT00422162|100906703|FG001|Overall Study|Adverse Event|9|||
33275217|NCT00422162|100906702|FG000|Overall Study|Lack of Efficacy|4|||
33275218|NCT00422162|100906703|FG001|Overall Study|Lack of Efficacy|10|||
33275219|NCT00422162|100906702|FG000|Overall Study|Withdrawal by Subject|7|||
33275220|NCT00422162|100906703|FG001|Overall Study|Withdrawal by Subject|6|||
33275221|NCT00422162|100906702|FG000|Overall Study|Lost to Follow-up|1|||
33275222|NCT00422162|100906703|FG001|Overall Study|Lost to Follow-up|2|||
33275223|NCT00422162|100906702|FG000|Overall Study|Non-Compliant with Protocol|1|||
33275224|NCT00422162|100906703|FG001|Overall Study|Non-Compliant with Protocol|1|||
33275225|NCT00422162|100906702|FG000|Overall Study|Other|0|||
33275226|NCT00422162|100906703|FG001|Overall Study|Other|1|||
33275227|NCT00422162|100906702|FG000|Overall Study|Didn't Receive Treatment|0|||
33275228|NCT00422162|100906703|FG001|Overall Study|Didn't Receive Treatment|1|||
33275229|NCT01322347|100906704|FG000|Overall Study|Adverse Event|7|||
33275230|NCT01322347|100906705|FG001|Overall Study|Adverse Event|2|||
33275231|NCT01322347|100906704|FG000|Overall Study|Death|5|||
33275232|NCT01322347|100906705|FG001|Overall Study|Death|3|||
33275233|NCT01322347|100906704|FG000|Overall Study|Physician Decision|2|||
33275234|NCT01322347|100906705|FG001|Overall Study|Physician Decision|1|||
33275235|NCT01322347|100906704|FG000|Overall Study|Protocol Violation|5|||
33275236|NCT01322347|100906705|FG001|Overall Study|Protocol Violation|2|||
33275237|NCT01322347|100906704|FG000|Overall Study|Withdrawal by Subject|1|||
33275238|NCT01322347|100906705|FG001|Overall Study|Withdrawal by Subject|4|||
33275239|NCT01322347|100906704|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
33275240|NCT01322347|100906705|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
33275241|NCT01322347|100906704|FG000|Overall Study|blood transfusion|5|||
33275242|NCT01322347|100906705|FG001|Overall Study|blood transfusion|5|||
33275243|NCT01322347|100906704|FG000|Overall Study|sponsor decision|1|||
33275244|NCT01322347|100906705|FG001|Overall Study|sponsor decision|3|||
33275245|NCT01322347|100906704|FG000|Overall Study|ineligible|6|||
33275246|NCT01322347|100906705|FG001|Overall Study|ineligible|3|||
33275247|NCT01322347|100906704|FG000|Overall Study|kidney transplant|3|||
33275248|NCT01322347|100906705|FG001|Overall Study|kidney transplant|1|||
33275249|NCT01322347|100906704|FG000|Overall Study|study drug withheld > 12 wks|0|||
33275250|NCT01322347|100906705|FG001|Overall Study|study drug withheld > 12 wks|1|||
33275251|NCT01322347|100906704|FG000|Overall Study|moved/changed dialysis|2|||
33275252|NCT01322347|100906705|FG001|Overall Study|moved/changed dialysis|4|||
33275253|NCT01320683|100906709|FG000|Overall Study|Positive antibody response|1|||
33275254|NCT03740919|100906710|FG000|Lead-in Period|Lost to Follow-up|1|||
33275255|NCT03740919|100906711|FG001|Lead-in Period|Lost to Follow-up|0|||
33275256|NCT03740919|100906712|FG002|Lead-in Period|Lost to Follow-up|0|||
33275257|NCT03740919|100906713|FG003|Lead-in Period|Lost to Follow-up|0|||
33275258|NCT03740919|100906710|FG000|Lead-in Period|Physician Decision|2|||
33275259|NCT03740919|100906711|FG001|Lead-in Period|Physician Decision|0|||
33275260|NCT03740919|100906712|FG002|Lead-in Period|Physician Decision|0|||
33275261|NCT03740919|100906713|FG003|Lead-in Period|Physician Decision|0|||
33275262|NCT03740919|100906710|FG000|Lead-in Period|Protocol Violation|1|||
33275263|NCT03740919|100906711|FG001|Lead-in Period|Protocol Violation|0|||
33275264|NCT03740919|100906712|FG002|Lead-in Period|Protocol Violation|0|||
33275265|NCT03740919|100906713|FG003|Lead-in Period|Protocol Violation|0|||
33275266|NCT03740919|100906710|FG000|Lead-in Period|Withdrawal by Subject|10|||
33275267|NCT03740919|100906711|FG001|Lead-in Period|Withdrawal by Subject|0|||
33275268|NCT03740919|100906712|FG002|Lead-in Period|Withdrawal by Subject|0|||
33275269|NCT03740919|100906713|FG003|Lead-in Period|Withdrawal by Subject|0|||
33275270|NCT03740919|100906710|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
33275271|NCT03740919|100906711|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
33275272|NCT03740919|100906712|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
33275273|NCT03740919|100906713|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
33275274|NCT03740919|100906710|FG000|Lead-in Period|Study Task Too Burdensome|1|||
33275275|NCT03740919|100906711|FG001|Lead-in Period|Study Task Too Burdensome|0|||
33275276|NCT03740919|100906712|FG002|Lead-in Period|Study Task Too Burdensome|0|||
33275277|NCT03740919|100906713|FG003|Lead-in Period|Study Task Too Burdensome|0|||
33275278|NCT03740919|100906710|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
33275279|NCT03740919|100906711|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
33275280|NCT03740919|100906712|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
33275281|NCT03740919|100906713|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
33275282|NCT03740919|100906710|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
33275283|NCT03740919|100906711|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
33275284|NCT03740919|100906712|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
33275285|NCT03740919|100906713|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
33275286|NCT03740919|100906710|FG000|Treatment Period|Adverse Event|0|||
33275287|NCT03740919|100906711|FG001|Treatment Period|Adverse Event|0|||
33275288|NCT03740919|100906712|FG002|Treatment Period|Adverse Event|2|||
33275289|NCT03740919|100906713|FG003|Treatment Period|Adverse Event|0|||
33275290|NCT03740919|100906710|FG000|Treatment Period|Protocol Violation|0|||
33275291|NCT03740919|100906711|FG001|Treatment Period|Protocol Violation|1|||
33275292|NCT03740919|100906712|FG002|Treatment Period|Protocol Violation|0|||
33275293|NCT03740919|100906713|FG003|Treatment Period|Protocol Violation|0|||
33275294|NCT03740919|100906710|FG000|Treatment Period|Withdrawal by Subject|0|||
33275295|NCT03740919|100906711|FG001|Treatment Period|Withdrawal by Subject|7|||
33275296|NCT03740919|100906712|FG002|Treatment Period|Withdrawal by Subject|6|||
33275297|NCT03740919|100906713|FG003|Treatment Period|Withdrawal by Subject|2|||
33275298|NCT03740919|100906710|FG000|Treatment Period|Terminated by Sponsor|0|||
33275299|NCT03740919|100906711|FG001|Treatment Period|Terminated by Sponsor|1|||
33275300|NCT03740919|100906712|FG002|Treatment Period|Terminated by Sponsor|0|||
33275301|NCT03740919|100906713|FG003|Treatment Period|Terminated by Sponsor|0|||
33275302|NCT03740919|100906710|FG000|Treatment Period|Issue with Insulin Pump|0|||
33275303|NCT03740919|100906711|FG001|Treatment Period|Issue with Insulin Pump|1|||
33275304|NCT03740919|100906712|FG002|Treatment Period|Issue with Insulin Pump|0|||
33275305|NCT03740919|100906713|FG003|Treatment Period|Issue with Insulin Pump|0|||
33275306|NCT03740919|100906710|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
33275307|NCT03740919|100906711|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
33275308|NCT03740919|100906712|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
33275309|NCT03740919|100906713|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
33275310|NCT03740919|100906710|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
33275311|NCT03740919|100906711|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
33275312|NCT03740919|100906712|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
33275313|NCT03740919|100906713|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
33275314|NCT03740919|100906710|FG000|Treatment Period|Not Completing Diary|0|||
33275315|NCT03740919|100906711|FG001|Treatment Period|Not Completing Diary|0|||
33275316|NCT03740919|100906712|FG002|Treatment Period|Not Completing Diary|1|||
33275317|NCT03740919|100906713|FG003|Treatment Period|Not Completing Diary|0|||
33275318|NCT03740919|100906710|FG000|Treatment Period|Insulin Painful to Participant|0|||
33275319|NCT03740919|100906711|FG001|Treatment Period|Insulin Painful to Participant|0|||
33275320|NCT03740919|100906712|FG002|Treatment Period|Insulin Painful to Participant|1|||
33275321|NCT03740919|100906713|FG003|Treatment Period|Insulin Painful to Participant|0|||
33275322|NCT02143713|100906714|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
33275323|NCT02143713|100906715|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
33275324|NCT02143713|100906716|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
33275325|NCT02143713|100906717|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
33275326|NCT02143713|100906714|FG000|Treatment Period (6 Months)|Adverse Event|7|||
33275327|NCT02143713|100906715|FG001|Treatment Period (6 Months)|Adverse Event|8|||
33275328|NCT02143713|100906716|FG002|Treatment Period (6 Months)|Adverse Event|8|||
33275329|NCT02143713|100906717|FG003|Treatment Period (6 Months)|Adverse Event|9|||
33275330|NCT02143713|100906714|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
33275331|NCT02143713|100906715|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
33275332|NCT02143713|100906716|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
33275333|NCT02143713|100906717|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
33275334|NCT02143713|100906714|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
33275335|NCT02143713|100906715|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
33275336|NCT02143713|100906716|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
33275337|NCT02143713|100906717|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
33275338|NCT02143713|100906714|FG000|Treatment Period (6 Months)|Pregnancy|0|||
33275339|NCT02143713|100906715|FG001|Treatment Period (6 Months)|Pregnancy|2|||
33275340|NCT02143713|100906716|FG002|Treatment Period (6 Months)|Pregnancy|2|||
33275341|NCT02143713|100906717|FG003|Treatment Period (6 Months)|Pregnancy|0|||
33275342|NCT02143713|100906714|FG000|Treatment Period (6 Months)|Non-compliance|1|||
33275343|NCT02143713|100906715|FG001|Treatment Period (6 Months)|Non-compliance|0|||
33275344|NCT02143713|100906716|FG002|Treatment Period (6 Months)|Non-compliance|0|||
33275345|NCT02143713|100906717|FG003|Treatment Period (6 Months)|Non-compliance|3|||
33275346|NCT02143713|100906714|FG000|Treatment Period (6 Months)|Other|3|||
33275347|NCT02143713|100906715|FG001|Treatment Period (6 Months)|Other|0|||
33275348|NCT02143713|100906716|FG002|Treatment Period (6 Months)|Other|3|||
33275349|NCT02143713|100906717|FG003|Treatment Period (6 Months)|Other|2|||
33275350|NCT02143713|100906714|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
33275351|NCT02143713|100906715|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
33275352|NCT02143713|100906716|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
33275353|NCT02143713|100906717|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
33275354|NCT02143713|100906714|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
33275355|NCT02143713|100906715|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
33275356|NCT02143713|100906716|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
33275357|NCT02143713|100906717|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
33275358|NCT02143713|100906714|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
33275359|NCT02143713|100906715|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
33275360|NCT02143713|100906716|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
33275361|NCT02143713|100906717|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
33275362|NCT02143713|100906714|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
33275363|NCT02143713|100906715|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
33275364|NCT02143713|100906716|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
33275365|NCT02143713|100906717|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
33275366|NCT02143713|100906714|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
33275367|NCT02143713|100906715|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
33275368|NCT02143713|100906716|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
33275369|NCT02143713|100906717|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
33275370|NCT02143713|100906714|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
33275371|NCT02143713|100906715|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
33275372|NCT02143713|100906716|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
33275373|NCT02143713|100906717|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
33275374|NCT02143713|100906714|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
33275375|NCT02143713|100906715|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
33275376|NCT02143713|100906716|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
33275377|NCT02143713|100906717|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
33275378|NCT02143713|100906714|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
33275379|NCT02143713|100906715|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
33275380|NCT02143713|100906716|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
33275381|NCT02143713|100906717|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
33275382|NCT02143713|100906714|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
33275383|NCT02143713|100906715|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
33275384|NCT02143713|100906716|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
33275385|NCT02143713|100906717|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
33275386|NCT00700999|100906723|FG000|Overall Study|Lost to Follow-up|7|||
33275387|NCT00700999|100906724|FG001|Overall Study|Lost to Follow-up|7|||
33275388|NCT00700999|100906723|FG000|Overall Study|Excluded - did not meet study criteria|0|||
33275389|NCT00700999|100906724|FG001|Overall Study|Excluded - did not meet study criteria|1|||
33275390|NCT00700999|100906723|FG000|Overall Study|Withdrawal by Subject|8|||
33275391|NCT00700999|100906724|FG001|Overall Study|Withdrawal by Subject|1|||
33275392|NCT01535261|100906727|FG000|Overall Study|Physician Decision|8|||
33275393|NCT01535261|100906727|FG000|Overall Study|Protocol Violation|3|||
33275394|NCT01535261|100906727|FG000|Overall Study|Death|5|||
33275395|NCT01535261|100906727|FG000|Overall Study|Lost to Follow-up|8|||
33275396|NCT01535261|100906727|FG000|Overall Study|Withdrawal by Subject|14|||
33275397|NCT01535261|100906727|FG000|Overall Study|Adverse Event|12|||
33275398|NCT02659059|100906731|FG000|Overall Study|Other reasons|6|||
33275399|NCT02659059|100906732|FG001|Overall Study|Other reasons|1|||
33275400|NCT02659059|100906731|FG000|Overall Study|Disease Progression|143|||
33275401|NCT02659059|100906732|FG001|Overall Study|Disease Progression|16|||
33275402|NCT02659059|100906731|FG000|Overall Study|Study Drug toxicity|56|||
33275403|NCT02659059|100906732|FG001|Overall Study|Study Drug toxicity|9|||
33275404|NCT02659059|100906731|FG000|Overall Study|Death|3|||
33275405|NCT02659059|100906732|FG001|Overall Study|Death|1|||
33275406|NCT02659059|100906731|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
33275407|NCT02659059|100906732|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
33275408|NCT02659059|100906731|FG000|Overall Study|Participant request to discontinue study treatment|5|||
33275409|NCT02659059|100906732|FG001|Overall Study|Participant request to discontinue study treatment|0|||
33275410|NCT02659059|100906731|FG000|Overall Study|Participant withdrew consent|6|||
33275411|NCT02659059|100906732|FG001|Overall Study|Participant withdrew consent|1|||
33275412|NCT00538629|100906733|FG000|Overall Study|At subject's request|1|||
33275413|NCT00538629|100906733|FG000|Overall Study|Adverse Event|2|||
33275414|NCT00538629|100906733|FG000|Overall Study|Lack of Efficacy|12|||
33275415|NCT00538629|100906733|FG000|Overall Study|Lost to Follow-up|6|||
33275416|NCT00538629|100906733|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
33275417|NCT00396409|100906734|FG000|Period 1 - 2007|Adverse Event|0|||
33275418|NCT00396409|100906735|FG001|Period 1 - 2007|Adverse Event|1|||
33275419|NCT00396409|100906734|FG000|Period 1 - 2007|Lack of Efficacy|0|||
33275420|NCT00396409|100906735|FG001|Period 1 - 2007|Lack of Efficacy|1|||
33275421|NCT00396409|100906734|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
33275422|NCT00396409|100906735|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
33275423|NCT00396409|100906734|FG000|Period 1 - 2007|Lost to Follow-up|2|||
33275424|NCT00396409|100906735|FG001|Period 1 - 2007|Lost to Follow-up|3|||
33275425|NCT00396409|100906734|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
33275426|NCT00396409|100906735|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
33275427|NCT00396409|100906734|FG000|Period 2 - 2008|Protocol Violation|1|||
33275428|NCT00396409|100906735|FG001|Period 2 - 2008|Protocol Violation|0|||
33275429|NCT00396409|100906734|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
33275430|NCT00396409|100906735|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
33275431|NCT00396409|100906734|FG000|Period 2 - 2008|Lost to Follow-up|3|||
33275432|NCT00396409|100906735|FG001|Period 2 - 2008|Lost to Follow-up|1|||
33275433|NCT01587703|100906736|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
33275434|NCT01587703|100906737|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275435|NCT01587703|100906738|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275436|NCT01587703|100906739|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275437|NCT01587703|100906740|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275438|NCT01587703|100906741|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275439|NCT01587703|100906742|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275440|NCT01587703|100906743|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275441|NCT01587703|100906744|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275442|NCT01587703|100906745|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275443|NCT01587703|100906746|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275444|NCT01587703|100906747|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275445|NCT01587703|100906748|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275446|NCT01587703|100906749|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275447|NCT01587703|100906750|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275448|NCT01587703|100906751|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275449|NCT01587703|100906752|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275450|NCT01587703|100906753|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275451|NCT01587703|100906754|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
33275452|NCT01587703|100906736|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275453|NCT01587703|100906737|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275454|NCT01587703|100906738|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275455|NCT01587703|100906739|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275456|NCT01587703|100906740|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275457|NCT01587703|100906741|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
33275458|NCT01587703|100906742|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275459|NCT01587703|100906743|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
33275460|NCT01587703|100906744|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275461|NCT01587703|100906745|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275462|NCT01587703|100906746|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275463|NCT01587703|100906747|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275464|NCT01587703|100906748|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275465|NCT01587703|100906749|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275466|NCT01587703|100906750|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275467|NCT01587703|100906751|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275468|NCT01587703|100906752|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275469|NCT01587703|100906753|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275470|NCT01587703|100906754|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
33275471|NCT01587703|100906736|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275472|NCT01587703|100906737|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275473|NCT01587703|100906738|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275474|NCT01587703|100906739|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275475|NCT01587703|100906740|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275476|NCT01587703|100906741|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275477|NCT01587703|100906742|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
33275478|NCT01587703|100906743|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275479|NCT01587703|100906744|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275480|NCT01587703|100906745|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275481|NCT01587703|100906746|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275482|NCT01587703|100906747|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275483|NCT01587703|100906748|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275484|NCT01587703|100906749|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275485|NCT01587703|100906750|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275486|NCT01587703|100906751|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275487|NCT01587703|100906752|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275488|NCT01587703|100906753|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275489|NCT01587703|100906754|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
33275490|NCT01587703|100906736|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
33275491|NCT01587703|100906737|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
33275492|NCT01587703|100906738|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
33275493|NCT01587703|100906739|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
33275494|NCT01587703|100906740|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
33275495|NCT01587703|100906741|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
33275496|NCT01587703|100906742|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
33275497|NCT01587703|100906743|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
33275498|NCT01587703|100906744|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33275499|NCT01587703|100906745|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33275500|NCT01587703|100906746|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33275501|NCT01587703|100906747|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33275502|NCT01587703|100906748|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33275503|NCT01587703|100906749|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33275504|NCT01587703|100906750|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33275505|NCT01587703|100906751|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33275506|NCT01587703|100906752|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33275507|NCT01587703|100906753|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33275508|NCT01587703|100906754|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
33275509|NCT01587703|100906736|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275510|NCT01587703|100906737|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275511|NCT01587703|100906738|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275512|NCT01587703|100906739|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275513|NCT01587703|100906740|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275514|NCT01587703|100906741|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275515|NCT01587703|100906742|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275516|NCT01587703|100906743|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275517|NCT01587703|100906744|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
33275518|NCT01587703|100906745|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
33275519|NCT01587703|100906746|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
33275520|NCT01587703|100906747|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275521|NCT01587703|100906748|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275522|NCT01587703|100906749|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275523|NCT01587703|100906750|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275524|NCT01587703|100906751|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275525|NCT01587703|100906752|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275526|NCT01587703|100906753|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275527|NCT01587703|100906754|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
33275528|NCT01587703|100906736|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275529|NCT01587703|100906737|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275530|NCT01587703|100906738|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275531|NCT01587703|100906739|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275532|NCT01587703|100906740|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275533|NCT01587703|100906741|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275534|NCT01587703|100906742|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275535|NCT01587703|100906743|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275536|NCT01587703|100906744|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
33275537|NCT01587703|100906745|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275538|NCT01587703|100906746|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
33275539|NCT01587703|100906747|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33484457|NCT01449370|101667012|FG010|Overall Study|Adverse Event|0|||
33484458|NCT01449370|101667013|FG011|Overall Study|Adverse Event|0|||
33484459|NCT01449370|101667014|FG012|Overall Study|Adverse Event|0|||
33275540|NCT01587703|100906748|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275541|NCT01587703|100906749|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275542|NCT01587703|100906750|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275543|NCT01587703|100906751|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275544|NCT01587703|100906752|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275545|NCT01587703|100906753|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275546|NCT01587703|100906754|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
33275547|NCT01587703|100906736|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275548|NCT01587703|100906737|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275549|NCT01587703|100906738|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275550|NCT01587703|100906739|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275551|NCT01587703|100906740|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275552|NCT01587703|100906741|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275553|NCT01587703|100906742|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275554|NCT01587703|100906743|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275555|NCT01587703|100906744|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275556|NCT01587703|100906745|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
33275557|NCT01587703|100906746|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
33275558|NCT01587703|100906747|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275559|NCT01587703|100906748|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275560|NCT01587703|100906749|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275561|NCT01587703|100906750|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275562|NCT01587703|100906751|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275563|NCT01587703|100906752|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275564|NCT01587703|100906753|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275565|NCT01587703|100906754|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
33275566|NCT01587703|100906736|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275567|NCT01587703|100906737|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275568|NCT01587703|100906738|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275569|NCT01587703|100906739|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275570|NCT01587703|100906740|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275571|NCT01587703|100906741|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275572|NCT01587703|100906742|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275573|NCT01587703|100906743|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275574|NCT01587703|100906744|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
33275575|NCT01587703|100906745|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275576|NCT01587703|100906746|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275577|NCT01587703|100906747|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275578|NCT01587703|100906748|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275579|NCT01587703|100906749|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275580|NCT01587703|100906750|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275581|NCT01587703|100906751|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275582|NCT01587703|100906752|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275583|NCT01587703|100906753|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275584|NCT01587703|100906754|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
33275585|NCT01587703|100906736|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275586|NCT01587703|100906737|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275587|NCT01587703|100906738|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275588|NCT01587703|100906739|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275589|NCT01587703|100906740|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275590|NCT01587703|100906741|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275591|NCT01587703|100906742|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275592|NCT01587703|100906743|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275593|NCT01587703|100906744|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275594|NCT01587703|100906745|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275595|NCT01587703|100906746|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275596|NCT01587703|100906747|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275597|NCT01587703|100906748|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275598|NCT01587703|100906749|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275599|NCT01587703|100906750|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275600|NCT01587703|100906751|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275601|NCT01587703|100906752|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33484460|NCT01449370|101667015|FG013|Overall Study|Adverse Event|2|||
33275602|NCT01587703|100906753|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
33275603|NCT01587703|100906754|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
33275604|NCT01587703|100906736|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275605|NCT01587703|100906737|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275606|NCT01587703|100906738|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275607|NCT01587703|100906739|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275608|NCT01587703|100906740|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275609|NCT01587703|100906741|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275610|NCT01587703|100906742|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275611|NCT01587703|100906743|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275612|NCT01587703|100906744|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275613|NCT01587703|100906745|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275614|NCT01587703|100906746|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275615|NCT01587703|100906747|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275616|NCT01587703|100906748|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275617|NCT01587703|100906749|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275618|NCT01587703|100906750|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275619|NCT01587703|100906751|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275620|NCT01587703|100906752|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
33275621|NCT01587703|100906753|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
33275622|NCT01587703|100906754|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
33275623|NCT01587703|100906736|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275624|NCT01587703|100906737|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275625|NCT01587703|100906738|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275626|NCT01587703|100906739|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275627|NCT01587703|100906740|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275628|NCT01587703|100906741|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275629|NCT01587703|100906742|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275630|NCT01587703|100906743|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275631|NCT01587703|100906744|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275632|NCT01587703|100906745|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275633|NCT01587703|100906746|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275634|NCT01587703|100906747|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275635|NCT01587703|100906748|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275636|NCT01587703|100906749|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275637|NCT01587703|100906750|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275638|NCT01587703|100906751|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
33275639|NCT01587703|100906752|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275640|NCT01587703|100906753|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275641|NCT01587703|100906754|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
33275642|NCT01587703|100906736|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275643|NCT01587703|100906737|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275644|NCT01587703|100906738|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275645|NCT01587703|100906739|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275646|NCT01587703|100906740|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275647|NCT01587703|100906741|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275648|NCT01587703|100906742|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275649|NCT01587703|100906743|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275650|NCT01587703|100906744|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275651|NCT01587703|100906745|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275652|NCT01587703|100906746|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275653|NCT01587703|100906747|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
33275654|NCT01587703|100906748|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275655|NCT01587703|100906749|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275656|NCT01587703|100906750|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
33275657|NCT01587703|100906751|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275658|NCT01587703|100906752|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275659|NCT01587703|100906753|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275660|NCT01587703|100906754|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
33275661|NCT01587703|100906736|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33275662|NCT01587703|100906737|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33275663|NCT01587703|100906738|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33275664|NCT01587703|100906739|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33275665|NCT01587703|100906740|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33275666|NCT01587703|100906741|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33275667|NCT01587703|100906742|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33275668|NCT01587703|100906743|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33275669|NCT01587703|100906744|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33275670|NCT01587703|100906745|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33275671|NCT01587703|100906746|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33275672|NCT01587703|100906747|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
33275673|NCT01587703|100906748|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
33275674|NCT01587703|100906749|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
33275675|NCT01587703|100906750|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
33275676|NCT01587703|100906751|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
33275677|NCT01587703|100906752|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
33275678|NCT01587703|100906753|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33275679|NCT01587703|100906754|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
33275680|NCT01587703|100906736|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
33275681|NCT01587703|100906737|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
33275682|NCT01587703|100906738|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
33275683|NCT01587703|100906739|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
33275684|NCT01587703|100906740|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
33275685|NCT01587703|100906741|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
33275686|NCT01587703|100906742|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
33275687|NCT01587703|100906743|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
33275688|NCT01587703|100906744|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
33275689|NCT01587703|100906745|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
33275690|NCT01587703|100906746|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
33275691|NCT01587703|100906747|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
33275692|NCT01587703|100906748|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
33275693|NCT01587703|100906749|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
33275694|NCT01587703|100906750|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
33275695|NCT01587703|100906751|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
33275696|NCT01587703|100906752|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
33275697|NCT01587703|100906753|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
33275698|NCT01587703|100906754|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
33275699|NCT01587703|100906736|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275700|NCT01587703|100906737|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275701|NCT01587703|100906738|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275702|NCT01587703|100906739|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275703|NCT01587703|100906740|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275704|NCT01587703|100906741|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275705|NCT01587703|100906742|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275706|NCT01587703|100906743|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275707|NCT01587703|100906744|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275708|NCT01587703|100906745|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275709|NCT01587703|100906746|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275710|NCT01587703|100906747|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
33275711|NCT01587703|100906748|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275712|NCT01587703|100906749|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275713|NCT01587703|100906750|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275714|NCT01587703|100906751|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275715|NCT01587703|100906752|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275716|NCT01587703|100906753|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275717|NCT01587703|100906754|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
33275718|NCT00296504|100906755|FG000|Interim Analysis|Withdrawal by Subject|8|||
33275719|NCT00296504|100906756|FG001|Interim Analysis|Withdrawal by Subject|0|||
33275720|NCT00296504|100906757|FG002|Interim Analysis|Withdrawal by Subject|12|||
33275721|NCT00296504|100906758|FG003|Interim Analysis|Withdrawal by Subject|0|||
33275722|NCT00296504|100906759|FG004|Interim Analysis|Withdrawal by Subject|5|||
33275723|NCT00296504|100906760|FG005|Interim Analysis|Withdrawal by Subject|5|||
33275724|NCT00296504|100906761|FG006|Interim Analysis|Withdrawal by Subject|9|||
33275725|NCT00296504|100906762|FG007|Interim Analysis|Withdrawal by Subject|3|||
33275726|NCT00296504|100906763|FG008|Interim Analysis|Withdrawal by Subject|0|||
33275727|NCT00296504|100906755|FG000|Interim Analysis|Lost to Follow-up|13|||
33275728|NCT00296504|100906756|FG001|Interim Analysis|Lost to Follow-up|3|||
33275729|NCT00296504|100906757|FG002|Interim Analysis|Lost to Follow-up|26|||
33275730|NCT00296504|100906758|FG003|Interim Analysis|Lost to Follow-up|8|||
33275731|NCT00296504|100906759|FG004|Interim Analysis|Lost to Follow-up|14|||
33275732|NCT00296504|100906760|FG005|Interim Analysis|Lost to Follow-up|4|||
33275733|NCT00296504|100906761|FG006|Interim Analysis|Lost to Follow-up|11|||
33275734|NCT00296504|100906762|FG007|Interim Analysis|Lost to Follow-up|4|||
33275735|NCT00296504|100906763|FG008|Interim Analysis|Lost to Follow-up|0|||
33275736|NCT00296504|100906755|FG000|Interim Analysis|Clinical Progression|1|||
33275737|NCT00296504|100906756|FG001|Interim Analysis|Clinical Progression|0|||
33275738|NCT00296504|100906757|FG002|Interim Analysis|Clinical Progression|1|||
33275739|NCT00296504|100906758|FG003|Interim Analysis|Clinical Progression|1|||
33275740|NCT00296504|100906759|FG004|Interim Analysis|Clinical Progression|0|||
33275741|NCT00296504|100906760|FG005|Interim Analysis|Clinical Progression|2|||
33275742|NCT00296504|100906761|FG006|Interim Analysis|Clinical Progression|1|||
33275743|NCT00296504|100906762|FG007|Interim Analysis|Clinical Progression|2|||
33275744|NCT00296504|100906763|FG008|Interim Analysis|Clinical Progression|0|||
33275745|NCT00296504|100906755|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
33275746|NCT00296504|100906756|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
33275747|NCT00296504|100906757|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
33275748|NCT00296504|100906758|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
33275749|NCT00296504|100906759|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
33275750|NCT00296504|100906760|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
33275751|NCT00296504|100906761|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
33275752|NCT00296504|100906762|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
33275753|NCT00296504|100906763|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
33275754|NCT00296504|100906755|FG000|Interim Analysis|Adverse Event|0|||
33275755|NCT00296504|100906756|FG001|Interim Analysis|Adverse Event|0|||
33275756|NCT00296504|100906757|FG002|Interim Analysis|Adverse Event|13|||
33275757|NCT00296504|100906758|FG003|Interim Analysis|Adverse Event|4|||
33275758|NCT00296504|100906759|FG004|Interim Analysis|Adverse Event|6|||
33275759|NCT00296504|100906760|FG005|Interim Analysis|Adverse Event|3|||
33275760|NCT00296504|100906761|FG006|Interim Analysis|Adverse Event|4|||
33275761|NCT00296504|100906762|FG007|Interim Analysis|Adverse Event|5|||
33275762|NCT00296504|100906763|FG008|Interim Analysis|Adverse Event|0|||
33275763|NCT00296504|100906755|FG000|Interim Analysis|Protocol Violation|0|||
33275764|NCT00296504|100906756|FG001|Interim Analysis|Protocol Violation|0|||
33275765|NCT00296504|100906757|FG002|Interim Analysis|Protocol Violation|2|||
33275766|NCT00296504|100906758|FG003|Interim Analysis|Protocol Violation|0|||
33275767|NCT00296504|100906759|FG004|Interim Analysis|Protocol Violation|1|||
33275768|NCT00296504|100906760|FG005|Interim Analysis|Protocol Violation|0|||
33275769|NCT00296504|100906761|FG006|Interim Analysis|Protocol Violation|0|||
33275770|NCT00296504|100906762|FG007|Interim Analysis|Protocol Violation|1|||
33275771|NCT00296504|100906763|FG008|Interim Analysis|Protocol Violation|0|||
33275772|NCT00296504|100906755|FG000|Interim Analysis|Insufficient CD4 Response|0|||
33275773|NCT00296504|100906756|FG001|Interim Analysis|Insufficient CD4 Response|0|||
33275774|NCT00296504|100906757|FG002|Interim Analysis|Insufficient CD4 Response|0|||
33275775|NCT00296504|100906758|FG003|Interim Analysis|Insufficient CD4 Response|0|||
33275776|NCT00296504|100906759|FG004|Interim Analysis|Insufficient CD4 Response|1|||
33275777|NCT00296504|100906760|FG005|Interim Analysis|Insufficient CD4 Response|1|||
33275778|NCT00296504|100906761|FG006|Interim Analysis|Insufficient CD4 Response|0|||
33275779|NCT00296504|100906762|FG007|Interim Analysis|Insufficient CD4 Response|0|||
33275780|NCT00296504|100906763|FG008|Interim Analysis|Insufficient CD4 Response|0|||
33275781|NCT00296504|100906755|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
33275782|NCT00296504|100906756|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
33275783|NCT00296504|100906757|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
33275784|NCT00296504|100906758|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
33275785|NCT00296504|100906759|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
33275786|NCT00296504|100906760|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
33275787|NCT00296504|100906761|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
33275788|NCT00296504|100906762|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
33275789|NCT00296504|100906763|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
33275790|NCT00296504|100906755|FG000|Interim Analysis|Pregnancy|4|||
33275791|NCT00296504|100906756|FG001|Interim Analysis|Pregnancy|1|||
33275792|NCT00296504|100906757|FG002|Interim Analysis|Pregnancy|4|||
33275793|NCT00296504|100906758|FG003|Interim Analysis|Pregnancy|2|||
33275794|NCT00296504|100906759|FG004|Interim Analysis|Pregnancy|0|||
33275795|NCT00296504|100906760|FG005|Interim Analysis|Pregnancy|1|||
33275796|NCT00296504|100906761|FG006|Interim Analysis|Pregnancy|1|||
33275797|NCT00296504|100906762|FG007|Interim Analysis|Pregnancy|1|||
33275798|NCT00296504|100906763|FG008|Interim Analysis|Pregnancy|0|||
33275799|NCT00296504|100906755|FG000|Interim Analysis|Death|1|||
33275800|NCT00296504|100906756|FG001|Interim Analysis|Death|0|||
33275801|NCT00296504|100906757|FG002|Interim Analysis|Death|3|||
33484461|NCT01449370|101667016|FG014|Overall Study|Adverse Event|0|||
33275802|NCT00296504|100906758|FG003|Interim Analysis|Death|0|||
33275803|NCT00296504|100906759|FG004|Interim Analysis|Death|0|||
33275804|NCT00296504|100906760|FG005|Interim Analysis|Death|0|||
33275805|NCT00296504|100906761|FG006|Interim Analysis|Death|0|||
33275806|NCT00296504|100906762|FG007|Interim Analysis|Death|0|||
33275807|NCT00296504|100906763|FG008|Interim Analysis|Death|0|||
33275808|NCT00296504|100906755|FG000|Interim Analysis|Participant Non-compliant|0|||
33275809|NCT00296504|100906756|FG001|Interim Analysis|Participant Non-compliant|1|||
33275810|NCT00296504|100906757|FG002|Interim Analysis|Participant Non-compliant|2|||
33275811|NCT00296504|100906758|FG003|Interim Analysis|Participant Non-compliant|1|||
33275812|NCT00296504|100906759|FG004|Interim Analysis|Participant Non-compliant|1|||
33275813|NCT00296504|100906760|FG005|Interim Analysis|Participant Non-compliant|3|||
33275814|NCT00296504|100906761|FG006|Interim Analysis|Participant Non-compliant|6|||
33275815|NCT00296504|100906762|FG007|Interim Analysis|Participant Non-compliant|2|||
33275816|NCT00296504|100906763|FG008|Interim Analysis|Participant Non-compliant|0|||
33275817|NCT00296504|100906755|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
33484462|NCT01449370|101667017|FG015|Overall Study|Adverse Event|1|||
33484463|NCT01449370|101667018|FG016|Overall Study|Adverse Event|0|||
33484464|NCT01449370|101667019|FG017|Overall Study|Adverse Event|0|||
33484465|NCT01449370|101667020|FG018|Overall Study|Adverse Event|1|||
33484466|NCT01449370|101667021|FG019|Overall Study|Adverse Event|1|||
33484467|NCT01449370|101667022|FG020|Overall Study|Adverse Event|0|||
33484468|NCT01449370|101667023|FG021|Overall Study|Adverse Event|1|||
33484469|NCT01449370|101667024|FG022|Overall Study|Adverse Event|0|||
33484470|NCT01449370|101667025|FG023|Overall Study|Adverse Event|1|||
33484471|NCT01449370|101667026|FG024|Overall Study|Adverse Event|3|||
33484472|NCT01449370|101667002|FG000|Overall Study|Participant Decision|0|||
33484473|NCT01449370|101667003|FG001|Overall Study|Participant Decision|0|||
33484474|NCT01449370|101667004|FG002|Overall Study|Participant Decision|0|||
33484475|NCT01449370|101667005|FG003|Overall Study|Participant Decision|0|||
33484476|NCT01449370|101667006|FG004|Overall Study|Participant Decision|0|||
33484477|NCT01449370|101667007|FG005|Overall Study|Participant Decision|0|||
33484478|NCT01449370|101667008|FG006|Overall Study|Participant Decision|0|||
33484479|NCT01449370|101667009|FG007|Overall Study|Participant Decision|1|||
33484480|NCT01449370|101667010|FG008|Overall Study|Participant Decision|1|||
33484481|NCT01449370|101667011|FG009|Overall Study|Participant Decision|0|||
33484482|NCT01449370|101667012|FG010|Overall Study|Participant Decision|0|||
33484483|NCT01449370|101667013|FG011|Overall Study|Participant Decision|0|||
33484484|NCT01449370|101667014|FG012|Overall Study|Participant Decision|1|||
33484485|NCT01449370|101667015|FG013|Overall Study|Participant Decision|1|||
33484486|NCT01449370|101667016|FG014|Overall Study|Participant Decision|0|||
33484487|NCT01449370|101667017|FG015|Overall Study|Participant Decision|1|||
33484488|NCT01449370|101667018|FG016|Overall Study|Participant Decision|3|||
33484489|NCT01449370|101667019|FG017|Overall Study|Participant Decision|0|||
33484490|NCT01449370|101667020|FG018|Overall Study|Participant Decision|1|||
33484491|NCT01449370|101667021|FG019|Overall Study|Participant Decision|0|||
33484492|NCT01449370|101667022|FG020|Overall Study|Participant Decision|0|||
33275818|NCT00296504|100906756|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
33275819|NCT00296504|100906757|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
33275820|NCT00296504|100906758|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
33275821|NCT00296504|100906759|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
33275822|NCT00296504|100906760|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
33275823|NCT00296504|100906761|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
33275824|NCT00296504|100906762|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
33275825|NCT00296504|100906763|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
33275826|NCT00296504|100906755|FG000|Interim Analysis|To Simplify Treatment|0|||
33275827|NCT00296504|100906756|FG001|Interim Analysis|To Simplify Treatment|0|||
33275828|NCT00296504|100906757|FG002|Interim Analysis|To Simplify Treatment|1|||
33275829|NCT00296504|100906758|FG003|Interim Analysis|To Simplify Treatment|0|||
33275830|NCT00296504|100906759|FG004|Interim Analysis|To Simplify Treatment|0|||
33275831|NCT00296504|100906760|FG005|Interim Analysis|To Simplify Treatment|0|||
33275832|NCT00296504|100906761|FG006|Interim Analysis|To Simplify Treatment|2|||
33275833|NCT00296504|100906762|FG007|Interim Analysis|To Simplify Treatment|0|||
33275834|NCT00296504|100906763|FG008|Interim Analysis|To Simplify Treatment|0|||
33275835|NCT00296504|100906755|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
33275836|NCT00296504|100906756|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
33275837|NCT00296504|100906757|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
33275838|NCT00296504|100906758|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
33275839|NCT00296504|100906759|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
33275840|NCT00296504|100906760|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
33484493|NCT01449370|101667023|FG021|Overall Study|Participant Decision|1|||
33484494|NCT01449370|101667024|FG022|Overall Study|Participant Decision|0|||
33275841|NCT00296504|100906761|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
33275842|NCT00296504|100906762|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
33275843|NCT00296504|100906763|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
33275844|NCT00296504|100906755|FG000|Interim Analysis|Participant Moved|1|||
33275845|NCT00296504|100906756|FG001|Interim Analysis|Participant Moved|0|||
33286483|NCT03481556|100943978|FG001|Overall Study|Death|2|||
33484495|NCT01449370|101667025|FG023|Overall Study|Participant Decision|0|||
33484496|NCT01449370|101667026|FG024|Overall Study|Participant Decision|1|||
33484497|NCT01449370|101667002|FG000|Overall Study|Lost to Follow-up|0|||
33484498|NCT01449370|101667003|FG001|Overall Study|Lost to Follow-up|0|||
33484499|NCT01449370|101667004|FG002|Overall Study|Lost to Follow-up|0|||
33275846|NCT00296504|100906757|FG002|Interim Analysis|Participant Moved|1|||
33275847|NCT00296504|100906758|FG003|Interim Analysis|Participant Moved|0|||
33275848|NCT00296504|100906759|FG004|Interim Analysis|Participant Moved|0|||
33275849|NCT00296504|100906760|FG005|Interim Analysis|Participant Moved|1|||
33275850|NCT00296504|100906761|FG006|Interim Analysis|Participant Moved|1|||
33275851|NCT00296504|100906762|FG007|Interim Analysis|Participant Moved|0|||
33275852|NCT00296504|100906763|FG008|Interim Analysis|Participant Moved|0|||
33275853|NCT00296504|100906755|FG000|Interim Analysis|Participant Was Incarcerated|2|||
33275854|NCT00296504|100906756|FG001|Interim Analysis|Participant Was Incarcerated|0|||
33275855|NCT00296504|100906757|FG002|Interim Analysis|Participant Was Incarcerated|1|||
33275856|NCT00296504|100906758|FG003|Interim Analysis|Participant Was Incarcerated|0|||
33275857|NCT00296504|100906759|FG004|Interim Analysis|Participant Was Incarcerated|0|||
33275858|NCT00296504|100906760|FG005|Interim Analysis|Participant Was Incarcerated|0|||
33275859|NCT00296504|100906761|FG006|Interim Analysis|Participant Was Incarcerated|0|||
33275860|NCT00296504|100906762|FG007|Interim Analysis|Participant Was Incarcerated|0|||
33275861|NCT00296504|100906763|FG008|Interim Analysis|Participant Was Incarcerated|0|||
33275862|NCT00296504|100906755|FG000|Interim Analysis|Resistance to FPV|0|||
33275863|NCT00296504|100906756|FG001|Interim Analysis|Resistance to FPV|0|||
33275864|NCT00296504|100906757|FG002|Interim Analysis|Resistance to FPV|1|||
33275865|NCT00296504|100906758|FG003|Interim Analysis|Resistance to FPV|0|||
33275866|NCT00296504|100906759|FG004|Interim Analysis|Resistance to FPV|0|||
33275867|NCT00296504|100906760|FG005|Interim Analysis|Resistance to FPV|0|||
33275868|NCT00296504|100906761|FG006|Interim Analysis|Resistance to FPV|0|||
33275869|NCT00296504|100906762|FG007|Interim Analysis|Resistance to FPV|0|||
33275870|NCT00296504|100906763|FG008|Interim Analysis|Resistance to FPV|0|||
33275871|NCT00296504|100906755|FG000|Interim Analysis|Physician Decision|0|||
33275872|NCT00296504|100906756|FG001|Interim Analysis|Physician Decision|0|||
33275873|NCT00296504|100906757|FG002|Interim Analysis|Physician Decision|1|||
33275874|NCT00296504|100906758|FG003|Interim Analysis|Physician Decision|0|||
33275875|NCT00296504|100906759|FG004|Interim Analysis|Physician Decision|0|||
33275876|NCT00296504|100906760|FG005|Interim Analysis|Physician Decision|0|||
33275877|NCT00296504|100906761|FG006|Interim Analysis|Physician Decision|0|||
33275878|NCT00296504|100906762|FG007|Interim Analysis|Physician Decision|0|||
33275879|NCT00296504|100906763|FG008|Interim Analysis|Physician Decision|0|||
33275880|NCT00296504|100906755|FG000|Interim Analysis|Principle Investigator Discretion|2|||
33275881|NCT00296504|100906756|FG001|Interim Analysis|Principle Investigator Discretion|0|||
33275882|NCT00296504|100906757|FG002|Interim Analysis|Principle Investigator Discretion|1|||
33275883|NCT00296504|100906758|FG003|Interim Analysis|Principle Investigator Discretion|1|||
33275884|NCT00296504|100906759|FG004|Interim Analysis|Principle Investigator Discretion|0|||
33275885|NCT00296504|100906760|FG005|Interim Analysis|Principle Investigator Discretion|0|||
33275886|NCT00296504|100906761|FG006|Interim Analysis|Principle Investigator Discretion|0|||
33275887|NCT00296504|100906762|FG007|Interim Analysis|Principle Investigator Discretion|0|||
33275888|NCT00296504|100906763|FG008|Interim Analysis|Principle Investigator Discretion|0|||
33275889|NCT00296504|100906755|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
33275890|NCT00296504|100906756|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
33275891|NCT00296504|100906757|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
33275892|NCT00296504|100906758|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
33275893|NCT00296504|100906759|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
33275894|NCT00296504|100906760|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
33275895|NCT00296504|100906761|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
33275896|NCT00296504|100906762|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
33275897|NCT00296504|100906763|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
33275898|NCT00296504|100906755|FG000|Interim Analysis|Non-adherence|2|||
33275899|NCT00296504|100906756|FG001|Interim Analysis|Non-adherence|0|||
33275900|NCT00296504|100906757|FG002|Interim Analysis|Non-adherence|0|||
33275901|NCT00296504|100906758|FG003|Interim Analysis|Non-adherence|0|||
33275902|NCT00296504|100906759|FG004|Interim Analysis|Non-adherence|1|||
33275903|NCT00296504|100906760|FG005|Interim Analysis|Non-adherence|0|||
33275904|NCT00296504|100906761|FG006|Interim Analysis|Non-adherence|0|||
33275905|NCT00296504|100906762|FG007|Interim Analysis|Non-adherence|1|||
33275906|NCT00296504|100906763|FG008|Interim Analysis|Non-adherence|0|||
33275907|NCT00296504|100906755|FG000|Interim Analysis|Site Closing|1|||
33275908|NCT00296504|100906756|FG001|Interim Analysis|Site Closing|0|||
33275909|NCT00296504|100906757|FG002|Interim Analysis|Site Closing|0|||
33275910|NCT00296504|100906758|FG003|Interim Analysis|Site Closing|0|||
33275911|NCT00296504|100906759|FG004|Interim Analysis|Site Closing|0|||
33275912|NCT00296504|100906760|FG005|Interim Analysis|Site Closing|1|||
33275913|NCT00296504|100906761|FG006|Interim Analysis|Site Closing|2|||
33275914|NCT00296504|100906762|FG007|Interim Analysis|Site Closing|0|||
33275915|NCT00296504|100906763|FG008|Interim Analysis|Site Closing|0|||
33275916|NCT00296504|100906755|FG000|Interim Analysis|Lack of Personnel at Site|1|||
33275917|NCT00296504|100906756|FG001|Interim Analysis|Lack of Personnel at Site|0|||
33275918|NCT00296504|100906757|FG002|Interim Analysis|Lack of Personnel at Site|0|||
33275919|NCT00296504|100906758|FG003|Interim Analysis|Lack of Personnel at Site|0|||
33275920|NCT00296504|100906759|FG004|Interim Analysis|Lack of Personnel at Site|0|||
33275921|NCT00296504|100906760|FG005|Interim Analysis|Lack of Personnel at Site|0|||
33275922|NCT00296504|100906761|FG006|Interim Analysis|Lack of Personnel at Site|0|||
33275923|NCT00296504|100906762|FG007|Interim Analysis|Lack of Personnel at Site|0|||
33275924|NCT00296504|100906763|FG008|Interim Analysis|Lack of Personnel at Site|0|||
33275925|NCT00296504|100906755|FG000|Interim Analysis|Missed Schedule Date|1|||
33275926|NCT00296504|100906756|FG001|Interim Analysis|Missed Schedule Date|0|||
33275927|NCT00296504|100906757|FG002|Interim Analysis|Missed Schedule Date|0|||
33275928|NCT00296504|100906758|FG003|Interim Analysis|Missed Schedule Date|0|||
33275929|NCT00296504|100906759|FG004|Interim Analysis|Missed Schedule Date|0|||
33275930|NCT00296504|100906760|FG005|Interim Analysis|Missed Schedule Date|0|||
33275931|NCT00296504|100906761|FG006|Interim Analysis|Missed Schedule Date|0|||
33275932|NCT00296504|100906762|FG007|Interim Analysis|Missed Schedule Date|0|||
33275933|NCT00296504|100906763|FG008|Interim Analysis|Missed Schedule Date|0|||
33275934|NCT00296504|100906755|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
33275935|NCT00296504|100906756|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
33275936|NCT00296504|100906757|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
33275937|NCT00296504|100906758|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
33275938|NCT00296504|100906759|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
33275939|NCT00296504|100906760|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
33275940|NCT00296504|100906761|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
33275941|NCT00296504|100906762|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
33275942|NCT00296504|100906763|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
33275943|NCT00296504|100906755|FG000|Interim Analysis|Participant Stopped|0|||
33275944|NCT00296504|100906756|FG001|Interim Analysis|Participant Stopped|0|||
33275945|NCT00296504|100906757|FG002|Interim Analysis|Participant Stopped|0|||
33275946|NCT00296504|100906758|FG003|Interim Analysis|Participant Stopped|0|||
33275947|NCT00296504|100906759|FG004|Interim Analysis|Participant Stopped|1|||
33275948|NCT00296504|100906760|FG005|Interim Analysis|Participant Stopped|0|||
33275949|NCT00296504|100906761|FG006|Interim Analysis|Participant Stopped|0|||
33275950|NCT00296504|100906762|FG007|Interim Analysis|Participant Stopped|0|||
33275951|NCT00296504|100906763|FG008|Interim Analysis|Participant Stopped|0|||
33275952|NCT00296504|100906755|FG000|Interim Analysis|Physician and Participant Decision|0|||
33275953|NCT00296504|100906756|FG001|Interim Analysis|Physician and Participant Decision|0|||
33275954|NCT00296504|100906757|FG002|Interim Analysis|Physician and Participant Decision|0|||
33275955|NCT00296504|100906758|FG003|Interim Analysis|Physician and Participant Decision|0|||
33275956|NCT00296504|100906759|FG004|Interim Analysis|Physician and Participant Decision|0|||
33275957|NCT00296504|100906760|FG005|Interim Analysis|Physician and Participant Decision|1|||
33275958|NCT00296504|100906761|FG006|Interim Analysis|Physician and Participant Decision|0|||
33275959|NCT00296504|100906762|FG007|Interim Analysis|Physician and Participant Decision|0|||
33275960|NCT00296504|100906763|FG008|Interim Analysis|Physician and Participant Decision|0|||
33275961|NCT00296504|100906755|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
33275962|NCT00296504|100906756|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
33275963|NCT00296504|100906757|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
33275964|NCT00296504|100906758|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
33275965|NCT00296504|100906759|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
33275966|NCT00296504|100906760|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
33275967|NCT00296504|100906761|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
33275968|NCT00296504|100906762|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
33275969|NCT00296504|100906763|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
33275970|NCT00296504|100906755|FG000|Interim Analysis|Study Ended|0|||
33275971|NCT00296504|100906756|FG001|Interim Analysis|Study Ended|0|||
33275972|NCT00296504|100906757|FG002|Interim Analysis|Study Ended|0|||
33275973|NCT00296504|100906758|FG003|Interim Analysis|Study Ended|0|||
33275974|NCT00296504|100906759|FG004|Interim Analysis|Study Ended|0|||
33275975|NCT00296504|100906760|FG005|Interim Analysis|Study Ended|0|||
33275976|NCT00296504|100906761|FG006|Interim Analysis|Study Ended|1|||
33275977|NCT00296504|100906762|FG007|Interim Analysis|Study Ended|0|||
33275978|NCT00296504|100906763|FG008|Interim Analysis|Study Ended|0|||
33275979|NCT00296504|100906755|FG000|Interim Analysis|Participant Needed Interferon|0|||
33275980|NCT00296504|100906756|FG001|Interim Analysis|Participant Needed Interferon|0|||
33275981|NCT00296504|100906757|FG002|Interim Analysis|Participant Needed Interferon|0|||
33275982|NCT00296504|100906758|FG003|Interim Analysis|Participant Needed Interferon|0|||
33275983|NCT00296504|100906759|FG004|Interim Analysis|Participant Needed Interferon|0|||
33275984|NCT00296504|100906760|FG005|Interim Analysis|Participant Needed Interferon|0|||
33275985|NCT00296504|100906761|FG006|Interim Analysis|Participant Needed Interferon|0|||
33275986|NCT00296504|100906762|FG007|Interim Analysis|Participant Needed Interferon|1|||
33275987|NCT00296504|100906763|FG008|Interim Analysis|Participant Needed Interferon|0|||
33275988|NCT00296504|100906755|FG000|Interim Analysis|Ongoing|32|||
33275989|NCT00296504|100906756|FG001|Interim Analysis|Ongoing|12|||
33275990|NCT00296504|100906757|FG002|Interim Analysis|Ongoing|16|||
33275991|NCT00296504|100906758|FG003|Interim Analysis|Ongoing|22|||
33275992|NCT00296504|100906759|FG004|Interim Analysis|Ongoing|0|||
33275993|NCT00296504|100906760|FG005|Interim Analysis|Ongoing|0|||
33275994|NCT00296504|100906761|FG006|Interim Analysis|Ongoing|30|||
33275995|NCT00296504|100906762|FG007|Interim Analysis|Ongoing|1|||
33275996|NCT00296504|100906763|FG008|Interim Analysis|Ongoing|0|||
33275997|NCT00296504|100906755|FG000|Final Analysis|Withdrawal by Subject|0|||
33275998|NCT00296504|100906756|FG001|Final Analysis|Withdrawal by Subject|0|||
33275999|NCT00296504|100906757|FG002|Final Analysis|Withdrawal by Subject|0|||
33276000|NCT00296504|100906758|FG003|Final Analysis|Withdrawal by Subject|0|||
33276001|NCT00296504|100906759|FG004|Final Analysis|Withdrawal by Subject|0|||
33276002|NCT00296504|100906760|FG005|Final Analysis|Withdrawal by Subject|0|||
33276003|NCT00296504|100906761|FG006|Final Analysis|Withdrawal by Subject|0|||
33276004|NCT00296504|100906762|FG007|Final Analysis|Withdrawal by Subject|0|||
33276005|NCT00296504|100906763|FG008|Final Analysis|Withdrawal by Subject|1|||
33276006|NCT00296504|100906755|FG000|Final Analysis|Lost to Follow-up|0|||
33276007|NCT00296504|100906756|FG001|Final Analysis|Lost to Follow-up|0|||
33276008|NCT00296504|100906757|FG002|Final Analysis|Lost to Follow-up|0|||
33276009|NCT00296504|100906758|FG003|Final Analysis|Lost to Follow-up|0|||
33276010|NCT00296504|100906759|FG004|Final Analysis|Lost to Follow-up|0|||
33276011|NCT00296504|100906760|FG005|Final Analysis|Lost to Follow-up|0|||
33276012|NCT00296504|100906761|FG006|Final Analysis|Lost to Follow-up|0|||
33276013|NCT00296504|100906762|FG007|Final Analysis|Lost to Follow-up|0|||
33276014|NCT00296504|100906763|FG008|Final Analysis|Lost to Follow-up|5|||
33276015|NCT00296504|100906755|FG000|Final Analysis|Insufficient Viral Load Response|0|||
33276016|NCT00296504|100906756|FG001|Final Analysis|Insufficient Viral Load Response|0|||
33276017|NCT00296504|100906757|FG002|Final Analysis|Insufficient Viral Load Response|0|||
33276018|NCT00296504|100906758|FG003|Final Analysis|Insufficient Viral Load Response|0|||
33276019|NCT00296504|100906759|FG004|Final Analysis|Insufficient Viral Load Response|0|||
33276020|NCT00296504|100906760|FG005|Final Analysis|Insufficient Viral Load Response|0|||
33276021|NCT00296504|100906761|FG006|Final Analysis|Insufficient Viral Load Response|0|||
33276022|NCT00296504|100906762|FG007|Final Analysis|Insufficient Viral Load Response|0|||
33276023|NCT00296504|100906763|FG008|Final Analysis|Insufficient Viral Load Response|6|||
33276024|NCT00296504|100906755|FG000|Final Analysis|Adverse Event|0|||
33276025|NCT00296504|100906756|FG001|Final Analysis|Adverse Event|0|||
33276026|NCT00296504|100906757|FG002|Final Analysis|Adverse Event|0|||
33276027|NCT00296504|100906758|FG003|Final Analysis|Adverse Event|0|||
33276028|NCT00296504|100906759|FG004|Final Analysis|Adverse Event|0|||
33276029|NCT00296504|100906760|FG005|Final Analysis|Adverse Event|0|||
33276030|NCT00296504|100906761|FG006|Final Analysis|Adverse Event|0|||
33276031|NCT00296504|100906762|FG007|Final Analysis|Adverse Event|0|||
33276032|NCT00296504|100906763|FG008|Final Analysis|Adverse Event|2|||
33276033|NCT00296504|100906755|FG000|Final Analysis|Pregnancy|0|||
33276034|NCT00296504|100906756|FG001|Final Analysis|Pregnancy|0|||
33276035|NCT00296504|100906757|FG002|Final Analysis|Pregnancy|0|||
33276036|NCT00296504|100906758|FG003|Final Analysis|Pregnancy|0|||
33276037|NCT00296504|100906759|FG004|Final Analysis|Pregnancy|0|||
33276038|NCT00296504|100906760|FG005|Final Analysis|Pregnancy|0|||
33276039|NCT00296504|100906761|FG006|Final Analysis|Pregnancy|0|||
33276040|NCT00296504|100906762|FG007|Final Analysis|Pregnancy|0|||
33276041|NCT00296504|100906763|FG008|Final Analysis|Pregnancy|4|||
33276042|NCT00296504|100906755|FG000|Final Analysis|Tuberculosis|0|||
33276043|NCT00296504|100906756|FG001|Final Analysis|Tuberculosis|0|||
33276044|NCT00296504|100906757|FG002|Final Analysis|Tuberculosis|0|||
33276045|NCT00296504|100906758|FG003|Final Analysis|Tuberculosis|0|||
33276046|NCT00296504|100906759|FG004|Final Analysis|Tuberculosis|0|||
33276047|NCT00296504|100906760|FG005|Final Analysis|Tuberculosis|0|||
33276048|NCT00296504|100906761|FG006|Final Analysis|Tuberculosis|0|||
33276049|NCT00296504|100906762|FG007|Final Analysis|Tuberculosis|0|||
33276050|NCT00296504|100906763|FG008|Final Analysis|Tuberculosis|1|||
33276051|NCT00296504|100906755|FG000|Final Analysis|Participant Moved to Another Country|0|||
33276052|NCT00296504|100906756|FG001|Final Analysis|Participant Moved to Another Country|0|||
33276053|NCT00296504|100906757|FG002|Final Analysis|Participant Moved to Another Country|0|||
33276054|NCT00296504|100906758|FG003|Final Analysis|Participant Moved to Another Country|0|||
33276055|NCT00296504|100906759|FG004|Final Analysis|Participant Moved to Another Country|0|||
33276056|NCT00296504|100906760|FG005|Final Analysis|Participant Moved to Another Country|0|||
33276057|NCT00296504|100906761|FG006|Final Analysis|Participant Moved to Another Country|0|||
33276058|NCT00296504|100906762|FG007|Final Analysis|Participant Moved to Another Country|0|||
33276059|NCT00296504|100906763|FG008|Final Analysis|Participant Moved to Another Country|1|||
33276060|NCT00296504|100906755|FG000|Final Analysis|Poor Adherence|0|||
33276061|NCT00296504|100906756|FG001|Final Analysis|Poor Adherence|0|||
33276062|NCT00296504|100906757|FG002|Final Analysis|Poor Adherence|0|||
33276063|NCT00296504|100906758|FG003|Final Analysis|Poor Adherence|0|||
33276064|NCT00296504|100906759|FG004|Final Analysis|Poor Adherence|0|||
33276065|NCT00296504|100906760|FG005|Final Analysis|Poor Adherence|0|||
33276066|NCT00296504|100906761|FG006|Final Analysis|Poor Adherence|0|||
33276067|NCT00296504|100906762|FG007|Final Analysis|Poor Adherence|0|||
33276068|NCT00296504|100906763|FG008|Final Analysis|Poor Adherence|1|||
33276069|NCT05104242|100906764|FG000|Overall Study|Withdrawal by Subject|1|||
33276070|NCT05104242|100906765|FG001|Overall Study|Withdrawal by Subject|5|||
33276071|NCT05104242|100906764|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
33276072|NCT05104242|100906765|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
33276073|NCT05647304|100906768|FG000|Overall Study|Withdrawal by Subject|1|||
33276074|NCT05647304|100906769|FG001|Overall Study|Withdrawal by Subject|0|||
33276075|NCT01807234|100906770|FG000|Overall Study|Lost to Follow-up|2|||
33276076|NCT01807234|100906771|FG001|Overall Study|Lost to Follow-up|5|||
33276077|NCT01807234|100906772|FG002|Overall Study|Lost to Follow-up|1|||
33276078|NCT01807234|100906773|FG003|Overall Study|Lost to Follow-up|1|||
33276079|NCT01807234|100906774|FG004|Overall Study|Lost to Follow-up|1|||
33276080|NCT01807234|100906775|FG005|Overall Study|Lost to Follow-up|2|||
33276081|NCT01807234|100906770|FG000|Overall Study|Withdrawal by Subject|3|||
33276082|NCT01807234|100906771|FG001|Overall Study|Withdrawal by Subject|1|||
33276083|NCT01807234|100906772|FG002|Overall Study|Withdrawal by Subject|1|||
33276084|NCT01807234|100906773|FG003|Overall Study|Withdrawal by Subject|1|||
33276085|NCT01807234|100906774|FG004|Overall Study|Withdrawal by Subject|2|||
33276086|NCT01807234|100906775|FG005|Overall Study|Withdrawal by Subject|1|||
33276087|NCT01807234|100906770|FG000|Overall Study|Lack of Efficacy|0|||
33276088|NCT01807234|100906771|FG001|Overall Study|Lack of Efficacy|0|||
33276089|NCT01807234|100906772|FG002|Overall Study|Lack of Efficacy|0|||
33276090|NCT01807234|100906773|FG003|Overall Study|Lack of Efficacy|0|||
33276091|NCT01807234|100906774|FG004|Overall Study|Lack of Efficacy|1|||
33276092|NCT01807234|100906775|FG005|Overall Study|Lack of Efficacy|1|||
33276093|NCT00832650|100908900|FG000|Overall Study|Randomized but not treated|0|||
33276094|NCT00832650|100908901|FG001|Overall Study|Randomized but not treated|0|||
33276095|NCT00832650|100908902|FG002|Overall Study|Randomized but not treated|1|||
33276096|NCT04909593|100908903|FG000|Overall Study|Withdrawal by Subject|1|||
33276097|NCT01816165|100908904|FG000|Overall Study|Adverse Event|1|||
33276098|NCT01816165|100908905|FG001|Overall Study|Adverse Event|0|||
33276099|NCT01816165|100908906|FG002|Overall Study|Adverse Event|0|||
33276100|NCT01816165|100908907|FG003|Overall Study|Adverse Event|0|||
33276101|NCT04944784|100908908|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
33276102|NCT04944784|100908909|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
33276103|NCT04944784|100908910|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
33276104|NCT04944784|100908911|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
33276105|NCT04944784|100908908|FG000|Double-blind Period|Adverse Event|20|||
33276106|NCT04944784|100908909|FG001|Double-blind Period|Adverse Event|4|||
33276107|NCT04944784|100908910|FG002|Double-blind Period|Adverse Event|0|||
33276108|NCT04944784|100908911|FG003|Double-blind Period|Adverse Event|0|||
33276109|NCT04944784|100908908|FG000|Double-blind Period|Withdrawal by Subject|15|||
33276110|NCT04944784|100908909|FG001|Double-blind Period|Withdrawal by Subject|4|||
33276111|NCT04944784|100908910|FG002|Double-blind Period|Withdrawal by Subject|0|||
33276112|NCT04944784|100908911|FG003|Double-blind Period|Withdrawal by Subject|0|||
33276113|NCT04944784|100908908|FG000|Double-blind Period|Death|7|||
33276114|NCT04944784|100908909|FG001|Double-blind Period|Death|2|||
33276115|NCT04944784|100908910|FG002|Double-blind Period|Death|0|||
33276116|NCT04944784|100908911|FG003|Double-blind Period|Death|0|||
33276117|NCT04944784|100908908|FG000|Double-blind Period|Physician Decision|2|||
33276118|NCT04944784|100908909|FG001|Double-blind Period|Physician Decision|1|||
33276119|NCT04944784|100908910|FG002|Double-blind Period|Physician Decision|0|||
33276120|NCT04944784|100908911|FG003|Double-blind Period|Physician Decision|0|||
33276121|NCT04944784|100908908|FG000|Double-blind Period|Lack of Efficacy|0|||
33276122|NCT04944784|100908909|FG001|Double-blind Period|Lack of Efficacy|1|||
33276123|NCT04944784|100908910|FG002|Double-blind Period|Lack of Efficacy|0|||
33276124|NCT04944784|100908911|FG003|Double-blind Period|Lack of Efficacy|0|||
33276125|NCT04944784|100908908|FG000|Double-blind Period|Sponsor Request|2|||
33276126|NCT04944784|100908909|FG001|Double-blind Period|Sponsor Request|1|||
33276127|NCT04944784|100908910|FG002|Double-blind Period|Sponsor Request|0|||
33276128|NCT04944784|100908911|FG003|Double-blind Period|Sponsor Request|0|||
33276129|NCT04944784|100908908|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
33276130|NCT04944784|100908909|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
33276131|NCT04944784|100908910|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
33276132|NCT04944784|100908911|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
33276133|NCT04944784|100908908|FG000|Double-blind Period|Participant Choice|1|||
33276134|NCT04944784|100908909|FG001|Double-blind Period|Participant Choice|1|||
33276135|NCT04944784|100908910|FG002|Double-blind Period|Participant Choice|0|||
33276136|NCT04944784|100908911|FG003|Double-blind Period|Participant Choice|0|||
33276137|NCT04944784|100908908|FG000|Double-blind Period|Progressive Disease|2|||
33276138|NCT04944784|100908909|FG001|Double-blind Period|Progressive Disease|2|||
33276139|NCT04944784|100908910|FG002|Double-blind Period|Progressive Disease|0|||
33276140|NCT04944784|100908911|FG003|Double-blind Period|Progressive Disease|0|||
33276141|NCT04944784|100908908|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
33276142|NCT04944784|100908909|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
33276143|NCT04944784|100908910|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
33276144|NCT04944784|100908911|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
33276145|NCT04944784|100908908|FG000|Active Drug Period|Adverse Event|0|||
33276146|NCT04944784|100908909|FG001|Active Drug Period|Adverse Event|0|||
33276147|NCT04944784|100908910|FG002|Active Drug Period|Adverse Event|3|||
33276148|NCT04944784|100908911|FG003|Active Drug Period|Adverse Event|6|||
33276149|NCT04944784|100908908|FG000|Active Drug Period|Withdrawal by Subject|0|||
33276150|NCT04944784|100908909|FG001|Active Drug Period|Withdrawal by Subject|0|||
33276151|NCT04944784|100908910|FG002|Active Drug Period|Withdrawal by Subject|4|||
33276152|NCT04944784|100908911|FG003|Active Drug Period|Withdrawal by Subject|7|||
33276153|NCT04944784|100908908|FG000|Active Drug Period|Death|0|||
33276154|NCT04944784|100908909|FG001|Active Drug Period|Death|0|||
33276155|NCT04944784|100908910|FG002|Active Drug Period|Death|3|||
33276156|NCT04944784|100908911|FG003|Active Drug Period|Death|4|||
33276157|NCT04944784|100908908|FG000|Active Drug Period|Lack of Efficacy|0|||
33276158|NCT04944784|100908909|FG001|Active Drug Period|Lack of Efficacy|0|||
33276159|NCT04944784|100908910|FG002|Active Drug Period|Lack of Efficacy|2|||
33276160|NCT04944784|100908911|FG003|Active Drug Period|Lack of Efficacy|2|||
33276161|NCT04944784|100908908|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
33276162|NCT04944784|100908909|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
33276163|NCT04944784|100908910|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
33276164|NCT04944784|100908911|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
33276165|NCT04944784|100908908|FG000|Active Drug Period|Participant Choice|0|||
33276166|NCT04944784|100908909|FG001|Active Drug Period|Participant Choice|0|||
33276167|NCT04944784|100908910|FG002|Active Drug Period|Participant Choice|0|||
33276168|NCT04944784|100908911|FG003|Active Drug Period|Participant Choice|1|||
33276169|NCT04944784|100908908|FG000|Active Drug Period|Progressive Disease|0|||
33276170|NCT04944784|100908909|FG001|Active Drug Period|Progressive Disease|0|||
33276171|NCT04944784|100908910|FG002|Active Drug Period|Progressive Disease|4|||
33276172|NCT04944784|100908911|FG003|Active Drug Period|Progressive Disease|4|||
33276173|NCT04944784|100908908|FG000|Active Drug Period|Lost to Follow-up|0|||
33276174|NCT04944784|100908909|FG001|Active Drug Period|Lost to Follow-up|0|||
33276175|NCT04944784|100908910|FG002|Active Drug Period|Lost to Follow-up|0|||
33276176|NCT04944784|100908911|FG003|Active Drug Period|Lost to Follow-up|1|||
33276177|NCT00871494|100908912|FG000|Overall Study|Protocol Violation|5|||
33276178|NCT00871494|100908912|FG000|Overall Study|Lack of Efficacy|4|||
33276179|NCT00871494|100908912|FG000|Overall Study|Adverse Event|4|||
33276180|NCT00871494|100908912|FG000|Overall Study|Lost to Follow-up|1|||
33276181|NCT04908488|100908913|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
33276182|NCT04908488|100908914|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
33276183|NCT04908488|100908913|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
33276184|NCT04908488|100908914|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
33276185|NCT01524887|100908919|FG000|Overall Study|Withdrawal by Subject|6|||
33276186|NCT01524887|100908920|FG001|Overall Study|Withdrawal by Subject|2|||
33276187|NCT01524887|100908921|FG002|Overall Study|Withdrawal by Subject|3|||
33276188|NCT01524887|100908919|FG000|Overall Study|Adverse Event|5|||
33276189|NCT01524887|100908920|FG001|Overall Study|Adverse Event|1|||
33276190|NCT01524887|100908921|FG002|Overall Study|Adverse Event|1|||
33276191|NCT01524887|100908919|FG000|Overall Study|Protocol Violation|0|||
33276192|NCT01524887|100908920|FG001|Overall Study|Protocol Violation|0|||
33276193|NCT01524887|100908921|FG002|Overall Study|Protocol Violation|1|||
33484500|NCT01449370|101667005|FG003|Overall Study|Lost to Follow-up|0|||
33484501|NCT01449370|101667006|FG004|Overall Study|Lost to Follow-up|0|||
33484502|NCT01449370|101667007|FG005|Overall Study|Lost to Follow-up|0|||
33484503|NCT01449370|101667008|FG006|Overall Study|Lost to Follow-up|0|||
33484504|NCT01449370|101667009|FG007|Overall Study|Lost to Follow-up|0|||
33484505|NCT01449370|101667010|FG008|Overall Study|Lost to Follow-up|0|||
33484506|NCT01449370|101667011|FG009|Overall Study|Lost to Follow-up|0|||
33484507|NCT01449370|101667012|FG010|Overall Study|Lost to Follow-up|0|||
33484508|NCT01449370|101667013|FG011|Overall Study|Lost to Follow-up|0|||
33484509|NCT01449370|101667014|FG012|Overall Study|Lost to Follow-up|0|||
33484510|NCT01449370|101667015|FG013|Overall Study|Lost to Follow-up|0|||
33484511|NCT01449370|101667016|FG014|Overall Study|Lost to Follow-up|0|||
33484512|NCT01449370|101667017|FG015|Overall Study|Lost to Follow-up|0|||
33484513|NCT01449370|101667018|FG016|Overall Study|Lost to Follow-up|0|||
33484514|NCT01449370|101667019|FG017|Overall Study|Lost to Follow-up|0|||
33276194|NCT01524887|100908919|FG000|Overall Study|Study termination|73|||
33484515|NCT01449370|101667020|FG018|Overall Study|Lost to Follow-up|0|||
33484516|NCT01449370|101667021|FG019|Overall Study|Lost to Follow-up|0|||
33276195|NCT01524887|100908920|FG001|Overall Study|Study termination|87|||
33276196|NCT01524887|100908921|FG002|Overall Study|Study termination|79|||
33276197|NCT01524887|100908919|FG000|Overall Study|Withdrawal by Caregiver|0|||
33276198|NCT01524887|100908920|FG001|Overall Study|Withdrawal by Caregiver|0|||
33276199|NCT01524887|100908921|FG002|Overall Study|Withdrawal by Caregiver|2|||
33276200|NCT01524887|100908919|FG000|Overall Study|Use of prohibited medication|1|||
33276201|NCT01524887|100908920|FG001|Overall Study|Use of prohibited medication|0|||
33276202|NCT01524887|100908921|FG002|Overall Study|Use of prohibited medication|0|||
33484517|NCT01449370|101667022|FG020|Overall Study|Lost to Follow-up|1|||
33484518|NCT01449370|101667023|FG021|Overall Study|Lost to Follow-up|0|||
33484519|NCT01449370|101667024|FG022|Overall Study|Lost to Follow-up|0|||
33484520|NCT01449370|101667025|FG023|Overall Study|Lost to Follow-up|0|||
33484521|NCT01449370|101667026|FG024|Overall Study|Lost to Follow-up|0|||
33484522|NCT01449370|101667002|FG000|Overall Study|Other|0|||
33484523|NCT01449370|101667003|FG001|Overall Study|Other|0|||
33484524|NCT01449370|101667004|FG002|Overall Study|Other|0|||
33484525|NCT01449370|101667005|FG003|Overall Study|Other|0|||
33484526|NCT01449370|101667006|FG004|Overall Study|Other|0|||
33484527|NCT01449370|101667007|FG005|Overall Study|Other|0|||
33484528|NCT01449370|101667008|FG006|Overall Study|Other|0|||
33484529|NCT01449370|101667009|FG007|Overall Study|Other|0|||
33484530|NCT01449370|101667010|FG008|Overall Study|Other|1|||
33484531|NCT01449370|101667011|FG009|Overall Study|Other|1|||
33484532|NCT01449370|101667012|FG010|Overall Study|Other|0|||
33484533|NCT01449370|101667013|FG011|Overall Study|Other|0|||
33484534|NCT01449370|101667014|FG012|Overall Study|Other|0|||
33484535|NCT01449370|101667015|FG013|Overall Study|Other|0|||
33484536|NCT01449370|101667016|FG014|Overall Study|Other|0|||
33484537|NCT01449370|101667017|FG015|Overall Study|Other|0|||
33484538|NCT01449370|101667018|FG016|Overall Study|Other|0|||
33484539|NCT01449370|101667019|FG017|Overall Study|Other|0|||
33484540|NCT01449370|101667020|FG018|Overall Study|Other|0|||
33484541|NCT01449370|101667021|FG019|Overall Study|Other|0|||
33484542|NCT01449370|101667022|FG020|Overall Study|Other|0|||
33484543|NCT01449370|101667023|FG021|Overall Study|Other|0|||
33484544|NCT01449370|101667024|FG022|Overall Study|Other|1|||
33484545|NCT01449370|101667025|FG023|Overall Study|Other|1|||
33484546|NCT01449370|101667026|FG024|Overall Study|Other|0|||
33484547|NCT01449370|101667002|FG000|Overall Study|Medication Prohibited by Protocol|0|||
33484548|NCT01449370|101667003|FG001|Overall Study|Medication Prohibited by Protocol|0|||
33484549|NCT01449370|101667004|FG002|Overall Study|Medication Prohibited by Protocol|0|||
33484550|NCT01449370|101667005|FG003|Overall Study|Medication Prohibited by Protocol|0|||
33484551|NCT01449370|101667006|FG004|Overall Study|Medication Prohibited by Protocol|0|||
33484552|NCT01449370|101667007|FG005|Overall Study|Medication Prohibited by Protocol|0|||
33484553|NCT01449370|101667008|FG006|Overall Study|Medication Prohibited by Protocol|0|||
33484554|NCT01449370|101667009|FG007|Overall Study|Medication Prohibited by Protocol|0|||
33484555|NCT01449370|101667010|FG008|Overall Study|Medication Prohibited by Protocol|0|||
33484556|NCT01449370|101667011|FG009|Overall Study|Medication Prohibited by Protocol|0|||
33484557|NCT01449370|101667012|FG010|Overall Study|Medication Prohibited by Protocol|0|||
33484558|NCT01449370|101667013|FG011|Overall Study|Medication Prohibited by Protocol|0|||
33484559|NCT01449370|101667014|FG012|Overall Study|Medication Prohibited by Protocol|0|||
33484560|NCT01449370|101667015|FG013|Overall Study|Medication Prohibited by Protocol|0|||
33484561|NCT01449370|101667016|FG014|Overall Study|Medication Prohibited by Protocol|0|||
33484562|NCT01449370|101667017|FG015|Overall Study|Medication Prohibited by Protocol|0|||
33484563|NCT01449370|101667018|FG016|Overall Study|Medication Prohibited by Protocol|0|||
33484564|NCT01449370|101667019|FG017|Overall Study|Medication Prohibited by Protocol|0|||
33484565|NCT01449370|101667020|FG018|Overall Study|Medication Prohibited by Protocol|0|||
33484566|NCT01449370|101667021|FG019|Overall Study|Medication Prohibited by Protocol|0|||
33484567|NCT01449370|101667022|FG020|Overall Study|Medication Prohibited by Protocol|0|||
33484568|NCT01449370|101667023|FG021|Overall Study|Medication Prohibited by Protocol|0|||
33484569|NCT01449370|101667024|FG022|Overall Study|Medication Prohibited by Protocol|0|||
33484570|NCT01449370|101667025|FG023|Overall Study|Medication Prohibited by Protocol|1|||
33484571|NCT01449370|101667026|FG024|Overall Study|Medication Prohibited by Protocol|0|||
33484572|NCT01449370|101667002|FG000|Overall Study|Death|0|||
33484573|NCT01449370|101667003|FG001|Overall Study|Death|0|||
33484574|NCT01449370|101667004|FG002|Overall Study|Death|0|||
33484575|NCT01449370|101667005|FG003|Overall Study|Death|0|||
33484576|NCT01449370|101667006|FG004|Overall Study|Death|0|||
33484577|NCT01449370|101667007|FG005|Overall Study|Death|0|||
33484578|NCT01449370|101667008|FG006|Overall Study|Death|0|||
33276203|NCT01786551|100908922|FG000|Overall Study|Participant withdrew consent|2|||
33276204|NCT00914732|100908926|FG000|Overall Study|Lost to Follow-up|6|||
33276205|NCT00914732|100908927|FG001|Overall Study|Lost to Follow-up|7|||
33484579|NCT01449370|101667009|FG007|Overall Study|Death|0|||
33484580|NCT01449370|101667010|FG008|Overall Study|Death|0|||
33484581|NCT01449370|101667011|FG009|Overall Study|Death|0|||
33484582|NCT01449370|101667012|FG010|Overall Study|Death|0|||
33484583|NCT01449370|101667013|FG011|Overall Study|Death|0|||
33484584|NCT01449370|101667014|FG012|Overall Study|Death|0|||
33484585|NCT01449370|101667015|FG013|Overall Study|Death|0|||
33276206|NCT00914732|100908928|FG002|Overall Study|Lost to Follow-up|9|||
33484586|NCT01449370|101667016|FG014|Overall Study|Death|0|||
33484587|NCT01449370|101667017|FG015|Overall Study|Death|0|||
33484588|NCT01449370|101667018|FG016|Overall Study|Death|0|||
33484589|NCT01449370|101667019|FG017|Overall Study|Death|0|||
33484590|NCT01449370|101667020|FG018|Overall Study|Death|0|||
33484591|NCT01449370|101667021|FG019|Overall Study|Death|0|||
33484592|NCT01449370|101667022|FG020|Overall Study|Death|0|||
33484593|NCT01449370|101667023|FG021|Overall Study|Death|0|||
33484594|NCT01449370|101667024|FG022|Overall Study|Death|0|||
33484595|NCT01449370|101667025|FG023|Overall Study|Death|0|||
33484596|NCT01449370|101667026|FG024|Overall Study|Death|1|||
33484597|NCT02296931|101667039|FG000|Overall Study|Protocol Violation|0|||
33484598|NCT02296931|101667040|FG001|Overall Study|Protocol Violation|2|||
33484599|NCT01589497|101667041|FG000|Overall Study|Withdrawal by Subject|0|||
33484600|NCT01589497|101667042|FG001|Overall Study|Withdrawal by Subject|1|||
33484601|NCT01589497|101667043|FG002|Overall Study|Withdrawal by Subject|0|||
33484602|NCT01589497|101667044|FG003|Overall Study|Withdrawal by Subject|1|||
33484603|NCT01589497|101667041|FG000|Overall Study|Death|1|||
33484604|NCT01589497|101667042|FG001|Overall Study|Death|0|||
33484605|NCT01589497|101667043|FG002|Overall Study|Death|0|||
33484606|NCT01589497|101667044|FG003|Overall Study|Death|0|||
33484607|NCT01589497|101667041|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
33484608|NCT01589497|101667042|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
33484609|NCT01589497|101667043|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
33484610|NCT01589497|101667044|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
33484611|NCT02052011|101667049|FG000|Overall Study|Lost to Follow-up|3|||
33484612|NCT02052011|101667050|FG001|Overall Study|Lost to Follow-up|0|||
33484613|NCT02052011|101667049|FG000|Overall Study|Withdrawal by Subject|1|||
33484614|NCT02052011|101667050|FG001|Overall Study|Withdrawal by Subject|2|||
33484615|NCT02466685|101667053|FG000|Overall Study|Adverse Event|5|||
33484616|NCT02466685|101667054|FG001|Overall Study|Adverse Event|2|||
33484617|NCT02466685|101667053|FG000|Overall Study|Lost to Follow-up|1|||
33484618|NCT02466685|101667054|FG001|Overall Study|Lost to Follow-up|1|||
33484619|NCT02466685|101667053|FG000|Overall Study|Withdrawal by Subject|1|||
33484620|NCT02466685|101667054|FG001|Overall Study|Withdrawal by Subject|0|||
33484621|NCT02466685|101667053|FG000|Overall Study|Physician Decision|1|||
33484622|NCT02466685|101667054|FG001|Overall Study|Physician Decision|1|||
33484623|NCT04971187|101667061|FG000|Overall Study|Screen failures|2|||
33484624|NCT04611529|101667062|FG000|2-day Follow up|Lost to Follow-up|5|||
33484625|NCT04611529|101667063|FG001|2-day Follow up|Lost to Follow-up|6|||
33484626|NCT04611529|101667064|FG002|2-day Follow up|Lost to Follow-up|3|||
33484627|NCT00489827|101667065|FG000|Overall Study|Intraoperative exclusion criteria|1|||
33484628|NCT00489827|101667066|FG001|Overall Study|Intraoperative exclusion criteria|1|||
33484629|NCT00489827|101667065|FG000|Overall Study|Intraoperative exclusion criteria|1|||
33484630|NCT00489827|101667066|FG001|Overall Study|Intraoperative exclusion criteria|1|||
33484631|NCT03390426|101667070|FG000|Overall Study|Protocol Violation|0|||
33484632|NCT03390426|101667071|FG001|Overall Study|Protocol Violation|1|||
33484633|NCT01756079|101667072|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
33484634|NCT01756079|101667072|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
33484635|NCT01756079|101667072|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
33484636|NCT01756079|101667072|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
33484637|NCT01756079|101667072|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
33484638|NCT03172494|101667073|FG000|Overall Study|Adverse Event|5|||
33484639|NCT03172494|101667074|FG001|Overall Study|Adverse Event|1|||
33484640|NCT03172494|101667075|FG002|Overall Study|Adverse Event|15|||
33484641|NCT03172494|101667073|FG000|Overall Study|Protocol Violation|3|||
33484642|NCT03172494|101667074|FG001|Overall Study|Protocol Violation|2|||
33484643|NCT03172494|101667075|FG002|Overall Study|Protocol Violation|1|||
33484644|NCT03172494|101667073|FG000|Overall Study|Lack of Efficacy|0|||
33484645|NCT03172494|101667074|FG001|Overall Study|Lack of Efficacy|0|||
33484646|NCT03172494|101667075|FG002|Overall Study|Lack of Efficacy|4|||
33484647|NCT03172494|101667073|FG000|Overall Study|Pregnancy|0|||
33484648|NCT03172494|101667074|FG001|Overall Study|Pregnancy|1|||
33484649|NCT03172494|101667075|FG002|Overall Study|Pregnancy|0|||
33484650|NCT03172494|101667073|FG000|Overall Study|Withdrawal by Subject|10|||
33484651|NCT03172494|101667074|FG001|Overall Study|Withdrawal by Subject|8|||
33484652|NCT03172494|101667075|FG002|Overall Study|Withdrawal by Subject|8|||
33484653|NCT03172494|101667073|FG000|Overall Study|Severe hypoglycaemic episode|0|||
33484654|NCT03172494|101667074|FG001|Overall Study|Severe hypoglycaemic episode|0|||
33484655|NCT03172494|101667075|FG002|Overall Study|Severe hypoglycaemic episode|1|||
33484656|NCT03172494|101667073|FG000|Overall Study|Non-compliance towards treatment|2|||
33484657|NCT03172494|101667074|FG001|Overall Study|Non-compliance towards treatment|0|||
33484658|NCT03172494|101667075|FG002|Overall Study|Non-compliance towards treatment|0|||
33484659|NCT02125877|101667076|FG000|Overall Study|Physician Decision|1|||
33276207|NCT00914732|100908926|FG000|Overall Study|Withdrawal by Subject|3|||
33276208|NCT00914732|100908927|FG001|Overall Study|Withdrawal by Subject|0|||
33276209|NCT00914732|100908928|FG002|Overall Study|Withdrawal by Subject|2|||
33484660|NCT02125877|101667077|FG001|Overall Study|Physician Decision|0|||
33484661|NCT02125877|101667076|FG000|Overall Study|Death|0|||
33484662|NCT02125877|101667077|FG001|Overall Study|Death|1|||
33484663|NCT02125877|101667076|FG000|Overall Study|Administrative problems|0|||
33484664|NCT02125877|101667077|FG001|Overall Study|Administrative problems|1|||
33484665|NCT02125877|101667076|FG000|Overall Study|Participant/guardian decision|0|||
33484666|NCT02125877|101667077|FG001|Overall Study|Participant/guardian decision|2|||
33484667|NCT02125877|101667076|FG000|Overall Study|Withdrawal by Subject|2|||
33484668|NCT02125877|101667077|FG001|Overall Study|Withdrawal by Subject|1|||
33484669|NCT02125877|101667076|FG000|Overall Study|Protocol deviation|4|||
33484670|NCT02125877|101667077|FG001|Overall Study|Protocol deviation|1|||
33484671|NCT02125877|101667076|FG000|Overall Study|Adverse Event|6|||
33484672|NCT02125877|101667077|FG001|Overall Study|Adverse Event|4|||
33484673|NCT01305044|101667084|FG000|Overall Study|Withdrawal by Subject|3|||
33484674|NCT01305044|101667085|FG001|Overall Study|Withdrawal by Subject|6|||
33484675|NCT01831258|101667086|FG000|Overall Study|Withdrawal by Subject|2|||
33484676|NCT01831258|101667087|FG001|Overall Study|Withdrawal by Subject|1|||
33484677|NCT01831258|101667086|FG000|Overall Study|Lost to Follow-up|3|||
33484678|NCT01831258|101667087|FG001|Overall Study|Lost to Follow-up|2|||
33484679|NCT03583086|101667088|FG000|Overall Study|Death|2|||
33484680|NCT03583086|101667089|FG001|Overall Study|Death|6|||
33484681|NCT03583086|101667090|FG002|Overall Study|Death|12|||
33484682|NCT03583086|101667091|FG003|Overall Study|Death|10|||
33484683|NCT03583086|101667092|FG004|Overall Study|Death|14|||
33484684|NCT03583086|101667093|FG005|Overall Study|Death|14|||
33484685|NCT03583086|101667094|FG006|Overall Study|Death|4|||
33484686|NCT03583086|101667088|FG000|Overall Study|Withdrawal by Subject|0|||
33484687|NCT03583086|101667089|FG001|Overall Study|Withdrawal by Subject|0|||
33484688|NCT03583086|101667090|FG002|Overall Study|Withdrawal by Subject|1|||
33484689|NCT03583086|101667091|FG003|Overall Study|Withdrawal by Subject|0|||
33484690|NCT03583086|101667092|FG004|Overall Study|Withdrawal by Subject|0|||
33484691|NCT03583086|101667093|FG005|Overall Study|Withdrawal by Subject|0|||
33484692|NCT03583086|101667094|FG006|Overall Study|Withdrawal by Subject|1|||
33484693|NCT03583086|101667088|FG000|Overall Study|Refused follow-up|0|||
33484694|NCT03583086|101667089|FG001|Overall Study|Refused follow-up|0|||
33484695|NCT03583086|101667090|FG002|Overall Study|Refused follow-up|1|||
33484696|NCT03583086|101667091|FG003|Overall Study|Refused follow-up|0|||
33484697|NCT03583086|101667092|FG004|Overall Study|Refused follow-up|1|||
33484698|NCT03583086|101667093|FG005|Overall Study|Refused follow-up|0|||
33484699|NCT03583086|101667094|FG006|Overall Study|Refused follow-up|0|||
33484700|NCT03583086|101667088|FG000|Overall Study|Declining Performance Status|0|||
33484701|NCT03583086|101667089|FG001|Overall Study|Declining Performance Status|0|||
33484702|NCT03583086|101667090|FG002|Overall Study|Declining Performance Status|1|||
33484703|NCT03583086|101667091|FG003|Overall Study|Declining Performance Status|0|||
33484704|NCT03583086|101667092|FG004|Overall Study|Declining Performance Status|0|||
33484705|NCT03583086|101667093|FG005|Overall Study|Declining Performance Status|0|||
33484706|NCT03583086|101667094|FG006|Overall Study|Declining Performance Status|0|||
33484707|NCT03583086|101667088|FG000|Overall Study|Still on study|0|||
33484708|NCT03583086|101667089|FG001|Overall Study|Still on study|0|||
33484709|NCT03583086|101667090|FG002|Overall Study|Still on study|0|||
33484710|NCT03583086|101667091|FG003|Overall Study|Still on study|1|||
33484711|NCT03583086|101667092|FG004|Overall Study|Still on study|0|||
33484712|NCT03583086|101667093|FG005|Overall Study|Still on study|0|||
33484713|NCT03583086|101667094|FG006|Overall Study|Still on study|1|||
33484714|NCT03583086|101667088|FG000|Overall Study|Disease progression|0|||
33484715|NCT03583086|101667089|FG001|Overall Study|Disease progression|0|||
33484716|NCT03583086|101667090|FG002|Overall Study|Disease progression|0|||
33484717|NCT03583086|101667091|FG003|Overall Study|Disease progression|0|||
33484718|NCT03583086|101667092|FG004|Overall Study|Disease progression|0|||
33484719|NCT03583086|101667093|FG005|Overall Study|Disease progression|0|||
33484720|NCT03583086|101667094|FG006|Overall Study|Disease progression|1|||
33484721|NCT03583086|101667088|FG000|Overall Study|Undergoing radiation therapy|0|||
33484722|NCT03583086|101667089|FG001|Overall Study|Undergoing radiation therapy|0|||
33484723|NCT03583086|101667090|FG002|Overall Study|Undergoing radiation therapy|0|||
33484724|NCT03583086|101667091|FG003|Overall Study|Undergoing radiation therapy|0|||
33484725|NCT03583086|101667092|FG004|Overall Study|Undergoing radiation therapy|0|||
33484726|NCT03583086|101667093|FG005|Overall Study|Undergoing radiation therapy|0|||
33484727|NCT03583086|101667094|FG006|Overall Study|Undergoing radiation therapy|1|||
33276210|NCT00914732|100908926|FG000|Overall Study|Adverse Event|1|||
33484728|NCT03583086|101667088|FG000|Overall Study|Lost to Follow-up|0|||
33484729|NCT03583086|101667089|FG001|Overall Study|Lost to Follow-up|0|||
33484730|NCT03583086|101667090|FG002|Overall Study|Lost to Follow-up|0|||
33484731|NCT03583086|101667091|FG003|Overall Study|Lost to Follow-up|0|||
33484732|NCT03583086|101667092|FG004|Overall Study|Lost to Follow-up|0|||
33484733|NCT03583086|101667093|FG005|Overall Study|Lost to Follow-up|1|||
33276211|NCT00914732|100908927|FG001|Overall Study|Adverse Event|0|||
33484734|NCT03583086|101667094|FG006|Overall Study|Lost to Follow-up|0|||
33484735|NCT03583086|101667088|FG000|Overall Study|Adverse Event|0|||
33484736|NCT03583086|101667089|FG001|Overall Study|Adverse Event|0|||
33484737|NCT03583086|101667090|FG002|Overall Study|Adverse Event|0|||
33484738|NCT03583086|101667091|FG003|Overall Study|Adverse Event|0|||
33484739|NCT03583086|101667092|FG004|Overall Study|Adverse Event|0|||
33484740|NCT03583086|101667093|FG005|Overall Study|Adverse Event|1|||
33484741|NCT03583086|101667094|FG006|Overall Study|Adverse Event|0|||
33484742|NCT02794246|101667095|FG000|Overall Study|Withdrawal by Subject|2|||
33484743|NCT02794246|101667095|FG000|Overall Study|Physician Decision|4|||
33484744|NCT02181790|101667098|FG000|Overall Study|study terminated|2|||
33484745|NCT02181790|101667099|FG001|Overall Study|study terminated|0|||
33484746|NCT04102189|101667104|FG000|Overall Study|Withdrawal by Subject|1|||
33484747|NCT04102189|101667105|FG001|Overall Study|Withdrawal by Subject|2|||
33484748|NCT04102189|101667104|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33484749|NCT04102189|101667105|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33484750|NCT04102189|101667104|FG000|Overall Study|Lost to Follow-up|1|||
33484751|NCT04102189|101667105|FG001|Overall Study|Lost to Follow-up|0|||
33484752|NCT04590040|101667106|FG000|Treatment Period|Lost to Follow-up|2|||
33484753|NCT04590040|101667107|FG001|Treatment Period|Lost to Follow-up|5|||
33484754|NCT04590040|101667108|FG002|Treatment Period|Lost to Follow-up|0|||
33484755|NCT04590040|101667106|FG000|Treatment Period|Physician Decision|0|||
33484756|NCT04590040|101667107|FG001|Treatment Period|Physician Decision|0|||
33484757|NCT04590040|101667108|FG002|Treatment Period|Physician Decision|2|||
33484758|NCT01998841|101667113|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
33484759|NCT01998841|101667114|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
33484760|NCT01998841|101667115|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
33484761|NCT01998841|101667116|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
33484762|NCT01998841|101667117|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
33484763|NCT01998841|101667113|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
33484764|NCT01998841|101667114|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
33484765|NCT01998841|101667115|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
33484766|NCT01998841|101667116|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
33484767|NCT01998841|101667117|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
33484768|NCT00970593|101667125|FG000|Overall Study|Adverse Event|1|||
33484769|NCT00970593|101667126|FG001|Overall Study|Adverse Event|1|||
33484770|NCT00970593|101667127|FG002|Overall Study|Adverse Event|0|||
33484771|NCT00970593|101667128|FG003|Overall Study|Adverse Event|0|||
33484772|NCT00970593|101667129|FG004|Overall Study|Adverse Event|0|||
33484773|NCT00970593|101667130|FG005|Overall Study|Adverse Event|0|||
33484774|NCT00970593|101667131|FG006|Overall Study|Adverse Event|0|||
33484775|NCT00970593|101667125|FG000|Overall Study|Discontinuation of study by sponsor|0|||
33484776|NCT00970593|101667126|FG001|Overall Study|Discontinuation of study by sponsor|0|||
33484777|NCT00970593|101667127|FG002|Overall Study|Discontinuation of study by sponsor|5|||
33484778|NCT00970593|101667128|FG003|Overall Study|Discontinuation of study by sponsor|0|||
33484779|NCT00970593|101667129|FG004|Overall Study|Discontinuation of study by sponsor|0|||
33484780|NCT00970593|101667130|FG005|Overall Study|Discontinuation of study by sponsor|0|||
33484781|NCT00970593|101667131|FG006|Overall Study|Discontinuation of study by sponsor|2|||
33484782|NCT00970593|101667125|FG000|Overall Study|Withdrawal by Subject|0|||
33484783|NCT00970593|101667126|FG001|Overall Study|Withdrawal by Subject|0|||
33484784|NCT00970593|101667127|FG002|Overall Study|Withdrawal by Subject|1|||
33484785|NCT00970593|101667128|FG003|Overall Study|Withdrawal by Subject|0|||
33484786|NCT00970593|101667129|FG004|Overall Study|Withdrawal by Subject|0|||
33484787|NCT00970593|101667130|FG005|Overall Study|Withdrawal by Subject|0|||
33484788|NCT00970593|101667131|FG006|Overall Study|Withdrawal by Subject|0|||
33484789|NCT04974749|101667133|FG000|Overall Study|Withdrawal by Subject|2|||
33484790|NCT04974749|101667133|FG000|Overall Study|Gestation|1|||
33484791|NCT03713632|101667134|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
33484792|NCT03713632|101667135|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
33484793|NCT03713632|101667136|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
33484794|NCT03713632|101667137|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
33484795|NCT03713632|101667138|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
33484796|NCT03713632|101667134|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
33484797|NCT03713632|101667135|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
33484798|NCT03713632|101667136|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
33484799|NCT03713632|101667137|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
33484800|NCT03713632|101667138|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
33484801|NCT03713632|101667134|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
33484802|NCT03713632|101667135|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
33484803|NCT03713632|101667136|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
33484804|NCT03713632|101667137|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
33484805|NCT03713632|101667138|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
33484806|NCT03713632|101667134|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
33484807|NCT03713632|101667135|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
33484808|NCT03713632|101667136|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
33484809|NCT03713632|101667137|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
33484810|NCT03713632|101667138|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
33484811|NCT03713632|101667134|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
33484812|NCT03713632|101667135|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
33484813|NCT03713632|101667136|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
33484814|NCT03713632|101667137|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
33484815|NCT03713632|101667138|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
33484816|NCT03713632|101667134|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
33484817|NCT03713632|101667135|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
33484818|NCT03713632|101667136|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
33484819|NCT03713632|101667137|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
33484820|NCT03713632|101667138|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
33484821|NCT03713632|101667134|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
33484822|NCT03713632|101667135|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
33484823|NCT03713632|101667136|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
33484824|NCT03713632|101667137|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
33484825|NCT03713632|101667138|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
33484826|NCT03713632|101667134|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
33484827|NCT03713632|101667135|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
33484828|NCT03713632|101667136|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
33484829|NCT03713632|101667137|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
33484830|NCT03713632|101667138|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
33484831|NCT03713632|101667134|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
33484832|NCT03713632|101667135|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
33484833|NCT03713632|101667136|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
33484834|NCT03713632|101667137|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
33484835|NCT03713632|101667138|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
33484836|NCT03713632|101667134|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
33484837|NCT03713632|101667135|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
33484838|NCT03713632|101667136|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
33484839|NCT03713632|101667137|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
33484840|NCT03713632|101667138|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
33484841|NCT03713632|101667134|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
33484842|NCT03713632|101667135|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
33484843|NCT03713632|101667136|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
33484844|NCT03713632|101667137|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
33484845|NCT03713632|101667138|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
33484846|NCT03713632|101667134|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
33484847|NCT03713632|101667135|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
33484848|NCT03713632|101667136|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
33484849|NCT03713632|101667137|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
33484850|NCT03713632|101667138|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
33484851|NCT03713632|101667134|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
33484852|NCT03713632|101667135|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
33484853|NCT03713632|101667136|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
33484854|NCT03713632|101667137|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
33484855|NCT03713632|101667138|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
33484856|NCT03713632|101667134|FG000|Treatment Period 2 (After Week 16)|Death|0|||
33484857|NCT03713632|101667135|FG001|Treatment Period 2 (After Week 16)|Death|1|||
33484858|NCT03713632|101667136|FG002|Treatment Period 2 (After Week 16)|Death|0|||
33484859|NCT03713632|101667137|FG003|Treatment Period 2 (After Week 16)|Death|0|||
33484860|NCT03713632|101667138|FG004|Treatment Period 2 (After Week 16)|Death|0|||
33484861|NCT03713632|101667134|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
33484862|NCT03713632|101667135|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
33484863|NCT03713632|101667136|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
33484864|NCT03713632|101667137|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
33484865|NCT03713632|101667138|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
33484866|NCT04975191|101667145|FG000|Overall Study|Protocol Violation|1|||
33484867|NCT04975191|101667146|FG001|Overall Study|Protocol Violation|2|||
33484868|NCT04975191|101667147|FG002|Overall Study|Protocol Violation|2|||
33484869|NCT04975191|101667148|FG003|Overall Study|Protocol Violation|2|||
33484870|NCT04975191|101667145|FG000|Overall Study|Lost to Follow-up|13|||
33484871|NCT04975191|101667146|FG001|Overall Study|Lost to Follow-up|3|||
33484872|NCT04975191|101667147|FG002|Overall Study|Lost to Follow-up|8|||
33484873|NCT04975191|101667148|FG003|Overall Study|Lost to Follow-up|8|||
33484874|NCT00735397|101667156|FG000|Overall Study|Adverse Event|194|||
33484875|NCT00735397|101667156|FG000|Overall Study|Lost to Follow-up|33|||
33484876|NCT00735397|101667156|FG000|Overall Study|Participant choice|252|||
33484877|NCT00735397|101667156|FG000|Overall Study|Inadequate therapeutic effect|202|||
33484878|NCT00735397|101667156|FG000|Overall Study|Administrative/Other|502|||
33276212|NCT00914732|100908928|FG002|Overall Study|Adverse Event|0|||
33276213|NCT04471428|100908929|FG000|Overall Study|Withdrawal by Subject|29|||
33484879|NCT02213510|101667159|FG000|Overall Study|Death|0|||
33484880|NCT02213510|101667160|FG001|Overall Study|Death|1|||
33484881|NCT02213510|101667159|FG000|Overall Study|Lost to Follow-up|1|||
33484882|NCT02213510|101667160|FG001|Overall Study|Lost to Follow-up|0|||
33484883|NCT00631657|101667165|FG000|6-Month Treatment Period|Adverse Event|47|||
33484884|NCT00631657|101667166|FG001|6-Month Treatment Period|Adverse Event|0|||
33484885|NCT00631657|101667167|FG002|6-Month Treatment Period|Adverse Event|7|||
33484886|NCT00631657|101667165|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
33484887|NCT00631657|101667166|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
33484888|NCT00631657|101667167|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
33484889|NCT00631657|101667165|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
33484890|NCT00631657|101667166|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
33276214|NCT04471428|100908930|FG001|Overall Study|Withdrawal by Subject|1|||
33276215|NCT04471428|100908929|FG000|Overall Study|Physician Decision|0|||
33276216|NCT04471428|100908930|FG001|Overall Study|Physician Decision|1|||
33276217|NCT04471428|100908929|FG000|Overall Study|Reason Not Specified|0|||
33276218|NCT04471428|100908930|FG001|Overall Study|Reason Not Specified|2|||
33276219|NCT04471428|100908929|FG000|Overall Study|Death|106|||
33276220|NCT04471428|100908930|FG001|Overall Study|Death|114|||
33276221|NCT04471428|100908929|FG000|Overall Study|Ongoing in the study|45|||
33276222|NCT04471428|100908930|FG001|Overall Study|Ongoing in the study|68|||
33276223|NCT00402298|100908931|FG000|Overall Study|Withdrawal by Subject|1|||
33276224|NCT00402298|100908932|FG001|Overall Study|Withdrawal by Subject|0|||
33276225|NCT01345253|100908933|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
33276226|NCT01345253|100908934|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
33276227|NCT01345253|100908933|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
33276228|NCT01345253|100908934|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
33276229|NCT01345253|100908933|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
33276230|NCT01345253|100908934|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
33276231|NCT01345253|100908933|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
33276232|NCT01345253|100908934|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
33276233|NCT01345253|100908933|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
33276234|NCT01345253|100908934|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
33276235|NCT01345253|100908933|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
33276236|NCT01345253|100908934|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
33276237|NCT01345253|100908933|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
33276238|NCT01345253|100908934|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
33276239|NCT01345253|100908933|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
33276240|NCT01345253|100908934|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
33276241|NCT01345253|100908933|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
33276242|NCT01345253|100908934|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
33276243|NCT01345253|100908933|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
33276244|NCT01345253|100908934|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
33276245|NCT01345253|100908933|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
33276246|NCT01345253|100908934|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
33276247|NCT01345253|100908933|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
33276248|NCT01345253|100908934|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
33276249|NCT01345253|100908933|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
33276250|NCT01345253|100908934|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
33276251|NCT01345253|100908933|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
33276252|NCT01345253|100908934|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
33276253|NCT01345253|100908933|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
33276254|NCT01345253|100908934|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
33276255|NCT02877680|100908935|FG000|Overall Study|Lost to Follow-up|1|||
33276256|NCT02877680|100908936|FG001|Overall Study|Lost to Follow-up|1|||
33276257|NCT03976102|100908937|FG000|Overall Study|Withdrawal by Subject|4|||
33276258|NCT03976102|100908938|FG001|Overall Study|Withdrawal by Subject|4|||
33276259|NCT03976102|100908937|FG000|Overall Study|Adverse Event|2|||
33484891|NCT00631657|101667167|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
33484892|NCT00631657|101667165|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
33484893|NCT00631657|101667166|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
33484894|NCT00631657|101667167|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
33484895|NCT00631657|101667165|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
33484896|NCT00631657|101667166|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
33484897|NCT00631657|101667167|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
33484898|NCT00631657|101667165|FG000|6-Month Treatment Period|Other|16|||
33484899|NCT00631657|101667166|FG001|6-Month Treatment Period|Other|0|||
33276260|NCT03976102|100908938|FG001|Overall Study|Adverse Event|4|||
33276261|NCT03976102|100908937|FG000|Overall Study|Not related to Covid-19|9|||
33276262|NCT03976102|100908938|FG001|Overall Study|Not related to Covid-19|13|||
33276263|NCT03976102|100908937|FG000|Overall Study|Lost to Follow-up|0|||
33276264|NCT03976102|100908938|FG001|Overall Study|Lost to Follow-up|2|||
33484900|NCT00631657|101667167|FG002|6-Month Treatment Period|Other|4|||
33484901|NCT00631657|101667165|FG000|6-Month Treatment Period|Not Treated|2|||
33484902|NCT00631657|101667166|FG001|6-Month Treatment Period|Not Treated|0|||
33484903|NCT00631657|101667167|FG002|6-Month Treatment Period|Not Treated|1|||
33484904|NCT00631657|101667165|FG000|7-Day Discontinuation Period|Not Treated|1|||
33484905|NCT00631657|101667166|FG001|7-Day Discontinuation Period|Not Treated|1|||
33484906|NCT00631657|101667167|FG002|7-Day Discontinuation Period|Not Treated|1|||
33484907|NCT00631657|101667165|FG000|7-Day Discontinuation Period|Other|1|||
33484908|NCT00631657|101667166|FG001|7-Day Discontinuation Period|Other|0|||
33484909|NCT00631657|101667167|FG002|7-Day Discontinuation Period|Other|0|||
33484910|NCT03510598|101667168|FG000|Overall Study|Withdrawal by Subject|1|||
33484911|NCT00141778|101667169|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
33484912|NCT00141778|101667170|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
33484913|NCT00141778|101667171|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
33484914|NCT00141778|101667169|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
33484915|NCT00141778|101667170|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
33484916|NCT00141778|101667171|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
33484917|NCT00141778|101667169|FG000|Started Study Medication|Withdrawal by Subject|0|||
33484918|NCT00141778|101667170|FG001|Started Study Medication|Withdrawal by Subject|2|||
33484919|NCT00141778|101667171|FG002|Started Study Medication|Withdrawal by Subject|0|||
33484920|NCT00141778|101667169|FG000|Started Study Medication|Difficulty Swallowing|0|||
33484921|NCT00141778|101667170|FG001|Started Study Medication|Difficulty Swallowing|1|||
33484922|NCT00141778|101667171|FG002|Started Study Medication|Difficulty Swallowing|0|||
33484923|NCT00141778|101667169|FG000|Started Study Medication|Chest Discomfort|0|||
33484924|NCT00141778|101667170|FG001|Started Study Medication|Chest Discomfort|0|||
33484925|NCT00141778|101667171|FG002|Started Study Medication|Chest Discomfort|1|||
33484926|NCT04874155|101667177|FG000|Overall Study|Lost to Follow-up|1|||
33484927|NCT04874155|101667178|FG001|Overall Study|Lost to Follow-up|1|||
33484928|NCT04874155|101667177|FG000|Overall Study|Withdrawal by Subject|2|||
33484929|NCT04874155|101667178|FG001|Overall Study|Withdrawal by Subject|2|||
33484930|NCT03516513|101667179|FG000|Overall Study|Withdrawal by Subject|2|||
33484931|NCT03516513|101667180|FG001|Overall Study|Withdrawal by Subject|2|||
33484932|NCT03516513|101667181|FG002|Overall Study|Withdrawal by Subject|0|||
33484933|NCT03516513|101667182|FG003|Overall Study|Withdrawal by Subject|0|||
33484934|NCT00660907|101667183|FG000|Overall Study|Incorrect Enrollment|1|||
33484935|NCT00660907|101667184|FG001|Overall Study|Incorrect Enrollment|1|||
33484936|NCT00660907|101667183|FG000|Overall Study|Adverse Event|33|||
33484937|NCT00660907|101667184|FG001|Overall Study|Adverse Event|19|||
33484938|NCT00660907|101667183|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
33484939|NCT00660907|101667184|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
33484940|NCT00660907|101667183|FG000|Overall Study|Withdrawal by Subject|23|||
33484941|NCT00660907|101667184|FG001|Overall Study|Withdrawal by Subject|32|||
33484942|NCT00660907|101667183|FG000|Overall Study|Lost to Follow-up|3|||
33484943|NCT00660907|101667184|FG001|Overall Study|Lost to Follow-up|3|||
33484944|NCT00660907|101667183|FG000|Overall Study|Poor/Non-Compliance|5|||
33484945|NCT00660907|101667184|FG001|Overall Study|Poor/Non-Compliance|1|||
33484946|NCT00660907|101667183|FG000|Overall Study|Safety|1|||
33484947|NCT00660907|101667184|FG001|Overall Study|Safety|0|||
33484948|NCT00660907|101667183|FG000|Overall Study|Death|1|||
33484949|NCT00660907|101667184|FG001|Overall Study|Death|3|||
33484950|NCT00660907|101667183|FG000|Overall Study|Various|11|||
33484951|NCT00660907|101667184|FG001|Overall Study|Various|8|||
33484952|NCT01890434|101667188|FG000|Overall Study|Adverse Event|8|||
33484953|NCT01890434|101667188|FG000|Overall Study|PCI at external hospital|1|||
33484954|NCT01890434|101667188|FG000|Overall Study|Assessment discrepancy|1|||
33484955|NCT01890434|101667188|FG000|Overall Study|CRC didn't contact participant for FU|1|||
33484956|NCT01890434|101667188|FG000|Overall Study|Could not get whole set of images|1|||
33484957|NCT01890434|101667188|FG000|Overall Study|Decline to return for GSPECT|1|||
33484958|NCT01890434|101667188|FG000|Overall Study|GSPECT at rest was not done|1|||
33484959|NCT01890434|101667188|FG000|Overall Study|Participant didn't complete MRI|1|||
33484960|NCT01890434|101667188|FG000|Overall Study|Uncontactable by phone|1|||
33484961|NCT01890434|101667188|FG000|Overall Study|Moved out of position|1|||
33484962|NCT01890434|101667188|FG000|Overall Study|Unable to contact|1|||
33484963|NCT01890434|101667188|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
33484964|NCT04388553|101667189|FG000|Overall Study|Protocol Violation|1|||
33484965|NCT04388553|101667190|FG001|Overall Study|Protocol Violation|0|||
33484966|NCT04208750|101667191|FG000|Overall Study|Lost to Follow-up|16|||
33484967|NCT04208750|101667192|FG001|Overall Study|Lost to Follow-up|15|||
33484968|NCT02682927|101667193|FG000|Overall Study|Adverse Event|0|||
33484969|NCT02682927|101667194|FG001|Overall Study|Adverse Event|0|||
33484970|NCT02682927|101667195|FG002|Overall Study|Adverse Event|5|||
33484971|NCT02682927|101667196|FG003|Overall Study|Adverse Event|1|||
33484972|NCT02682927|101667197|FG004|Overall Study|Adverse Event|0|||
33484973|NCT02682927|101667198|FG005|Overall Study|Adverse Event|2|||
33484974|NCT02682927|101667193|FG000|Overall Study|Death|0|||
33276265|NCT03976102|100908937|FG000|Overall Study|Death|3|||
33484975|NCT02682927|101667194|FG001|Overall Study|Death|0|||
33484976|NCT02682927|101667195|FG002|Overall Study|Death|0|||
33484977|NCT02682927|101667196|FG003|Overall Study|Death|1|||
33484978|NCT02682927|101667197|FG004|Overall Study|Death|0|||
33484979|NCT02682927|101667198|FG005|Overall Study|Death|0|||
33484980|NCT02682927|101667193|FG000|Overall Study|Lack of Efficacy|1|||
33484981|NCT02682927|101667194|FG001|Overall Study|Lack of Efficacy|0|||
33484982|NCT02682927|101667195|FG002|Overall Study|Lack of Efficacy|0|||
33484983|NCT02682927|101667196|FG003|Overall Study|Lack of Efficacy|1|||
33484984|NCT02682927|101667197|FG004|Overall Study|Lack of Efficacy|0|||
33484985|NCT02682927|101667198|FG005|Overall Study|Lack of Efficacy|0|||
33484986|NCT02682927|101667193|FG000|Overall Study|Other|0|||
33484987|NCT02682927|101667194|FG001|Overall Study|Other|0|||
33484988|NCT02682927|101667195|FG002|Overall Study|Other|0|||
33484989|NCT02682927|101667196|FG003|Overall Study|Other|2|||
33484990|NCT02682927|101667197|FG004|Overall Study|Other|0|||
33484991|NCT02682927|101667198|FG005|Overall Study|Other|0|||
33484992|NCT02682927|101667193|FG000|Overall Study|Withdrawal by Subject|2|||
33276266|NCT03976102|100908938|FG001|Overall Study|Death|2|||
33276267|NCT03976102|100908937|FG000|Overall Study|Physician Decision|1|||
33276268|NCT03976102|100908938|FG001|Overall Study|Physician Decision|1|||
33276269|NCT01263223|100908939|FG000|Period 2|Withdrawal by Subject|0|||
33276270|NCT01263223|100908940|FG001|Period 2|Withdrawal by Subject|1|||
33276271|NCT01263223|100908939|FG000|7-day Follow-up|Withdrawal by Subject|0|||
33276272|NCT01263223|100908940|FG001|7-day Follow-up|Withdrawal by Subject|1|||
33276273|NCT01263223|100908939|FG000|7-day Follow-up|Lost to Follow-up|1|||
33276274|NCT01263223|100908940|FG001|7-day Follow-up|Lost to Follow-up|0|||
33276275|NCT05287178|100908943|FG000|Overall Study|Lost to Follow-up|2|||
33276276|NCT05522777|100908944|FG000|Overall Study|Lack of Efficacy|1|||
33276277|NCT05522777|100908944|FG000|Overall Study|Withdrawal by Subject|1|||
33276278|NCT06080438|100908945|FG000|Overall Study|Lost to Follow-up|2|||
33276279|NCT00841321|100908946|FG000|Overall Study|Lost to Follow-up|1|||
33276280|NCT00841321|100908947|FG001|Overall Study|Lost to Follow-up|1|||
33276281|NCT00841321|100908946|FG000|Overall Study|Adverse Event|0|||
33276282|NCT00841321|100908947|FG001|Overall Study|Adverse Event|2|||
33276283|NCT00376259|100908949|FG000|Overall Study|Sponsor request - study termination|21|||
33276284|NCT00376259|100908950|FG001|Overall Study|Sponsor request - study termination|21|||
33276285|NCT00376259|100908949|FG000|Overall Study|Patient request|1|||
33276286|NCT00376259|100908950|FG001|Overall Study|Patient request|0|||
33276287|NCT01072149|100908951|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276288|NCT01072149|100908952|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276289|NCT01072149|100908953|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
33276290|NCT01072149|100908954|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276291|NCT01072149|100908955|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276292|NCT01072149|100908956|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276293|NCT01072149|100908957|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276294|NCT01072149|100908958|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276295|NCT01072149|100908959|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276296|NCT01072149|100908960|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276297|NCT01072149|100908961|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276298|NCT01072149|100908962|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276299|NCT01072149|100908963|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276300|NCT01072149|100908964|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276301|NCT01072149|100908965|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276302|NCT01072149|100908966|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276303|NCT01072149|100908967|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276304|NCT01072149|100908968|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
33276305|NCT01072149|100908951|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276306|NCT01072149|100908952|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276307|NCT01072149|100908953|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276308|NCT01072149|100908954|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276309|NCT01072149|100908955|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276310|NCT01072149|100908956|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276311|NCT01072149|100908957|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276312|NCT01072149|100908958|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33484993|NCT02682927|101667194|FG001|Overall Study|Withdrawal by Subject|0|||
33484994|NCT02682927|101667195|FG002|Overall Study|Withdrawal by Subject|1|||
33276313|NCT01072149|100908959|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276314|NCT01072149|100908960|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276315|NCT01072149|100908961|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276316|NCT01072149|100908962|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276317|NCT01072149|100908963|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33484995|NCT02682927|101667196|FG003|Overall Study|Withdrawal by Subject|0|||
33484996|NCT02682927|101667197|FG004|Overall Study|Withdrawal by Subject|1|||
33484997|NCT02682927|101667198|FG005|Overall Study|Withdrawal by Subject|1|||
33484998|NCT00976911|101667199|FG000|Overall Study|Withdrawal by Subject|4|||
33276318|NCT01072149|100908964|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276319|NCT01072149|100908965|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276320|NCT01072149|100908966|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276321|NCT01072149|100908967|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
33276322|NCT01072149|100908968|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
33276323|NCT01072149|100908951|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276324|NCT01072149|100908952|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276325|NCT01072149|100908953|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276326|NCT01072149|100908954|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276327|NCT01072149|100908955|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276328|NCT01072149|100908956|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276329|NCT01072149|100908957|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276330|NCT01072149|100908958|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276331|NCT01072149|100908959|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276332|NCT01072149|100908960|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276333|NCT01072149|100908961|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
33276334|NCT01072149|100908962|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276335|NCT01072149|100908963|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276336|NCT01072149|100908964|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276337|NCT01072149|100908965|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276338|NCT01072149|100908966|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276339|NCT01072149|100908967|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276340|NCT01072149|100908968|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
33276341|NCT01072149|100908951|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276342|NCT01072149|100908952|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
33276343|NCT01072149|100908953|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276344|NCT01072149|100908954|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276345|NCT01072149|100908955|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276346|NCT01072149|100908956|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276347|NCT01072149|100908957|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276348|NCT01072149|100908958|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276349|NCT01072149|100908959|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276350|NCT01072149|100908960|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276351|NCT01072149|100908961|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276352|NCT01072149|100908962|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276353|NCT01072149|100908963|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276354|NCT01072149|100908964|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276355|NCT01072149|100908965|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276356|NCT01072149|100908966|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276357|NCT01072149|100908967|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33276358|NCT01072149|100908968|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
33484999|NCT00976911|101667200|FG001|Overall Study|Withdrawal by Subject|6|||
33485000|NCT00976911|101667199|FG000|Overall Study|Death|138|||
33485001|NCT00976911|101667200|FG001|Overall Study|Death|126|||
33485002|NCT00976911|101667199|FG000|Overall Study|Adverse Event|0|||
33485003|NCT00976911|101667200|FG001|Overall Study|Adverse Event|1|||
33485004|NCT00976911|101667199|FG000|Overall Study|Protocol Violation|2|||
33485005|NCT00976911|101667200|FG001|Overall Study|Protocol Violation|0|||
33485006|NCT00976911|101667199|FG000|Overall Study|Other|8|||
33485007|NCT00976911|101667200|FG001|Overall Study|Other|9|||
33485008|NCT00976911|101667199|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
33485009|NCT00976911|101667200|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
33485010|NCT00243412|101667201|FG000|Overall Study|Death|0|||
33485011|NCT00243412|101667202|FG001|Overall Study|Death|1|||
33276359|NCT01072149|100908951|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33276360|NCT01072149|100908952|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33276361|NCT01072149|100908953|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
33276362|NCT01072149|100908954|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33276363|NCT01072149|100908955|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33276364|NCT01072149|100908956|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33276365|NCT01072149|100908957|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33276366|NCT01072149|100908958|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33276367|NCT01072149|100908959|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33276368|NCT01072149|100908960|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33276369|NCT01072149|100908961|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33485012|NCT00243412|101667201|FG000|Overall Study|Adverse Event|4|||
33485013|NCT00243412|101667202|FG001|Overall Study|Adverse Event|2|||
33276370|NCT01072149|100908962|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33276371|NCT01072149|100908963|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33276372|NCT01072149|100908964|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33485014|NCT00243412|101667201|FG000|Overall Study|Lost to Follow-up|0|||
33485015|NCT00243412|101667202|FG001|Overall Study|Lost to Follow-up|1|||
33485016|NCT00243412|101667201|FG000|Overall Study|Physician Decision|1|||
33485017|NCT00243412|101667202|FG001|Overall Study|Physician Decision|1|||
33485018|NCT00243412|101667201|FG000|Overall Study|Withdrawal by Subject|4|||
33485019|NCT00243412|101667202|FG001|Overall Study|Withdrawal by Subject|5|||
33485020|NCT00243412|101667201|FG000|Overall Study|Other|1|||
33485021|NCT00243412|101667202|FG001|Overall Study|Other|1|||
33485022|NCT00879411|101667205|FG000|Overall Study|lost to follow-up (non-AE)|162|||
33485023|NCT03151304|101671201|FG000|Overall Study|Termination of study by Sponsor|23|||
33485024|NCT03151304|101671201|FG000|Overall Study|missing|3|||
33485025|NCT03151304|101671201|FG000|Overall Study|Withdrawal by Subject|8|||
33485026|NCT03151304|101671201|FG000|Overall Study|multiple reasons|30|||
33485027|NCT00796107|101671204|FG000|Overall Study|Lack of Efficacy|1|||
33485028|NCT00796107|101671204|FG000|Overall Study|Progressive Disease|5|||
33485029|NCT01121562|101671212|FG000|Overall Study|Objective progression or relapse|8|||
33485030|NCT01121562|101671212|FG000|Overall Study|Withdrawal by Subject|1|||
33485031|NCT01121562|101671212|FG000|Overall Study|Adverse Event|1|||
33485032|NCT01121562|101671212|FG000|Overall Study|Sponsor Decision|1|||
33485033|NCT01121562|101671212|FG000|Overall Study|Met study discontinuation criteria|1|||
33485034|NCT01174043|101671220|FG000|Overall Study|Disease progression|5|||
33485035|NCT01174043|101671220|FG000|Overall Study|Adverse Event|3|||
33485036|NCT01174043|101671220|FG000|Overall Study|Death|1|||
33485037|NCT01174043|101671220|FG000|Overall Study|Withdrawal by Subject|2|||
33485038|NCT01098487|101671223|FG000|Overall Study|Adverse Event|22|||
33485039|NCT01098487|101671223|FG000|Overall Study|Lack of Efficacy|11|||
33485040|NCT01098487|101671223|FG000|Overall Study|Withdrawal by Subject|7|||
33485041|NCT01098487|101671223|FG000|Overall Study|Lost to Follow-up|3|||
33485042|NCT01098487|101671223|FG000|Overall Study|Physician Decision|1|||
33485043|NCT00799825|101671224|FG000|Overall Study|Adverse Event|1|||
33485044|NCT00799825|101671224|FG000|Overall Study|Withdrawal by Subject|6|||
33485045|NCT00799825|101671224|FG000|Overall Study|Lost to Follow-up|38|||
33485046|NCT00799825|101671224|FG000|Overall Study|Pregnancy|3|||
33485047|NCT00810511|101671241|FG000|Overall Study|Protocol Violation|0|||
33485048|NCT00810511|101671242|FG001|Overall Study|Protocol Violation|1|||
33485049|NCT00810511|101671241|FG000|Overall Study|Lack of Efficacy|9|||
33485050|NCT00810511|101671242|FG001|Overall Study|Lack of Efficacy|1|||
33485051|NCT00810511|101671241|FG000|Overall Study|death in the family|0|||
33485052|NCT00810511|101671242|FG001|Overall Study|death in the family|1|||
33485053|NCT00810511|101671241|FG000|Overall Study|Lost to Follow-up|1|||
33485054|NCT00810511|101671242|FG001|Overall Study|Lost to Follow-up|0|||
33485055|NCT00810511|101671241|FG000|Overall Study|deposits on contact lens|0|||
33485056|NCT00810511|101671242|FG001|Overall Study|deposits on contact lens|1|||
33485057|NCT00940316|101671244|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
33485058|NCT00940316|101671245|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
33485059|NCT00940316|101671246|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
33485060|NCT00940316|101671244|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
33485061|NCT00940316|101671245|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
33485062|NCT00940316|101671246|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
33485063|NCT00940316|101671244|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
33485064|NCT00940316|101671245|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
33485065|NCT00940316|101671246|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
33485066|NCT00940316|101671244|FG000|Treated After Cycle 5|Adverse Event|0|||
33485067|NCT00940316|101671245|FG001|Treated After Cycle 5|Adverse Event|0|||
33485068|NCT00940316|101671246|FG002|Treated After Cycle 5|Adverse Event|1|||
33485069|NCT00940316|101671244|FG000|Treated After Cycle 5|Progressive disease|0|||
33485070|NCT00940316|101671245|FG001|Treated After Cycle 5|Progressive disease|1|||
33485071|NCT00940316|101671246|FG002|Treated After Cycle 5|Progressive disease|0|||
33485072|NCT04936035|101671247|FG000|Overall Study|Adverse Event|0|||
33485073|NCT04936035|101671248|FG001|Overall Study|Adverse Event|1|||
33485074|NCT04936035|101671249|FG002|Overall Study|Adverse Event|0|||
33485075|NCT04936035|101671250|FG003|Overall Study|Adverse Event|0|||
33485076|NCT04936035|101671251|FG004|Overall Study|Adverse Event|0|||
33485077|NCT04936035|101671247|FG000|Overall Study|Death|0|||
33485078|NCT04936035|101671248|FG001|Overall Study|Death|0|||
33485079|NCT04936035|101671249|FG002|Overall Study|Death|0|||
33485080|NCT04936035|101671250|FG003|Overall Study|Death|1|||
33276373|NCT01072149|100908965|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33276374|NCT01072149|100908966|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33485081|NCT04936035|101671251|FG004|Overall Study|Death|0|||
33485082|NCT04936035|101671247|FG000|Overall Study|Lost to Follow-up|0|||
33485083|NCT04936035|101671248|FG001|Overall Study|Lost to Follow-up|1|||
33485084|NCT04936035|101671249|FG002|Overall Study|Lost to Follow-up|1|||
33485085|NCT04936035|101671250|FG003|Overall Study|Lost to Follow-up|2|||
33485086|NCT04936035|101671251|FG004|Overall Study|Lost to Follow-up|1|||
33485087|NCT04936035|101671247|FG000|Overall Study|Physician Decision|0|||
33485088|NCT04936035|101671248|FG001|Overall Study|Physician Decision|1|||
33485089|NCT04936035|101671249|FG002|Overall Study|Physician Decision|0|||
33485090|NCT04936035|101671250|FG003|Overall Study|Physician Decision|0|||
33485091|NCT04936035|101671251|FG004|Overall Study|Physician Decision|0|||
33485092|NCT04936035|101671247|FG000|Overall Study|Protocol Deviation|0|||
33485093|NCT04936035|101671248|FG001|Overall Study|Protocol Deviation|0|||
33485094|NCT04936035|101671249|FG002|Overall Study|Protocol Deviation|1|||
33485095|NCT04936035|101671250|FG003|Overall Study|Protocol Deviation|0|||
33485096|NCT04936035|101671251|FG004|Overall Study|Protocol Deviation|0|||
33485097|NCT04936035|101671247|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
33485098|NCT04936035|101671248|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
33485099|NCT04936035|101671249|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
33485100|NCT04936035|101671250|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
33485101|NCT04936035|101671251|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
33485102|NCT04936035|101671247|FG000|Overall Study|Reason Unknown|0|||
33485103|NCT04936035|101671248|FG001|Overall Study|Reason Unknown|0|||
33485104|NCT04936035|101671249|FG002|Overall Study|Reason Unknown|0|||
33485105|NCT04936035|101671250|FG003|Overall Study|Reason Unknown|0|||
33485106|NCT04936035|101671251|FG004|Overall Study|Reason Unknown|1|||
33485107|NCT04936035|101671247|FG000|Overall Study|Withdrawal by Subject|1|||
33485108|NCT04936035|101671248|FG001|Overall Study|Withdrawal by Subject|0|||
33485109|NCT04936035|101671249|FG002|Overall Study|Withdrawal by Subject|0|||
33485110|NCT04936035|101671250|FG003|Overall Study|Withdrawal by Subject|0|||
33485111|NCT04936035|101671251|FG004|Overall Study|Withdrawal by Subject|0|||
33485112|NCT04936035|101671247|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
33485113|NCT04936035|101671248|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
33485114|NCT04936035|101671249|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
33485115|NCT04936035|101671250|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
33485116|NCT04936035|101671251|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
33485117|NCT04936035|101671247|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
33485118|NCT04936035|101671248|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
33485119|NCT04936035|101671249|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
33485120|NCT04936035|101671250|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
33485121|NCT04936035|101671251|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
33276375|NCT01072149|100908967|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33276376|NCT01072149|100908968|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
33276377|NCT01072149|100908951|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276378|NCT01072149|100908952|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276379|NCT01072149|100908953|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276380|NCT01072149|100908954|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276381|NCT01072149|100908955|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276382|NCT01072149|100908956|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276383|NCT01072149|100908957|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276384|NCT01072149|100908958|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
33276385|NCT01072149|100908959|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276386|NCT01072149|100908960|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276387|NCT01072149|100908961|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276388|NCT01072149|100908962|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276389|NCT01072149|100908963|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276390|NCT01072149|100908964|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276391|NCT01072149|100908965|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276392|NCT01072149|100908966|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276393|NCT01072149|100908967|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276394|NCT01072149|100908968|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
33276395|NCT01072149|100908951|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
33276396|NCT01072149|100908952|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
33276397|NCT01072149|100908953|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
33276398|NCT01072149|100908954|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
33276399|NCT01072149|100908955|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
33276400|NCT01072149|100908956|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
33276401|NCT01072149|100908957|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
33276402|NCT01072149|100908958|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
33276403|NCT01072149|100908959|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
33276404|NCT01072149|100908960|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
33276405|NCT01072149|100908961|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
33276406|NCT01072149|100908962|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
33276407|NCT01072149|100908963|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
33276408|NCT01072149|100908964|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
33276409|NCT01072149|100908965|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
33276410|NCT01072149|100908966|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
33276411|NCT01072149|100908967|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
33276412|NCT01072149|100908968|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
33276413|NCT01072149|100908951|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276414|NCT01072149|100908952|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276415|NCT01072149|100908953|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276416|NCT01072149|100908954|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276417|NCT01072149|100908955|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276418|NCT01072149|100908956|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276419|NCT01072149|100908957|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276420|NCT01072149|100908958|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276421|NCT01072149|100908959|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276422|NCT01072149|100908960|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276423|NCT01072149|100908961|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276424|NCT01072149|100908962|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276425|NCT01072149|100908963|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276426|NCT01072149|100908964|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276427|NCT01072149|100908965|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276428|NCT01072149|100908966|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
33276429|NCT01072149|100908967|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276430|NCT01072149|100908968|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
33276431|NCT01072149|100908951|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
33276432|NCT01072149|100908952|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
33276433|NCT01072149|100908953|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
33276434|NCT01072149|100908954|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
33276435|NCT01072149|100908955|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
33276436|NCT01072149|100908956|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
33276437|NCT01072149|100908957|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
33276438|NCT01072149|100908958|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
33276439|NCT01072149|100908959|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
33276440|NCT01072149|100908960|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
33276441|NCT01072149|100908961|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
33276442|NCT01072149|100908962|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
33276443|NCT01072149|100908963|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
33276444|NCT01072149|100908964|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
33276445|NCT01072149|100908965|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
33276446|NCT01072149|100908966|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
33276447|NCT01072149|100908967|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
33276448|NCT01072149|100908968|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
33276449|NCT01072149|100908951|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276450|NCT01072149|100908952|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276451|NCT01072149|100908953|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276452|NCT01072149|100908954|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276453|NCT01072149|100908955|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276454|NCT01072149|100908956|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276455|NCT01072149|100908957|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276456|NCT01072149|100908958|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276457|NCT01072149|100908959|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276458|NCT01072149|100908960|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276459|NCT01072149|100908961|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276460|NCT01072149|100908962|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276461|NCT01072149|100908963|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
33276462|NCT01072149|100908964|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276463|NCT01072149|100908965|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276464|NCT01072149|100908966|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276465|NCT01072149|100908967|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276466|NCT01072149|100908968|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
33276467|NCT01072149|100908951|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276468|NCT01072149|100908952|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276469|NCT01072149|100908953|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
33276470|NCT01072149|100908954|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276471|NCT01072149|100908955|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276472|NCT01072149|100908956|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276473|NCT01072149|100908957|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276474|NCT01072149|100908958|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276475|NCT01072149|100908959|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276476|NCT01072149|100908960|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276477|NCT01072149|100908961|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276478|NCT01072149|100908962|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276479|NCT01072149|100908963|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33286484|NCT03481556|100943979|FG002|Overall Study|Death|3|||
33276480|NCT01072149|100908964|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
33276481|NCT01072149|100908965|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276482|NCT01072149|100908966|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276483|NCT01072149|100908967|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276484|NCT01072149|100908968|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
33276485|NCT04598776|100908969|FG000|Overall Study|Protocol Violation|5|||
33276486|NCT04598776|100908969|FG000|Overall Study|Physician Decision|4|||
33276487|NCT05203822|100908970|FG000|Overall Study|Adverse Event|1|||
33276488|NCT05203822|100908970|FG000|Overall Study|Withdrawal by Subject|1|||
33276489|NCT02267746|100908971|FG000|Overall Study|Adverse Event|0|||
33276490|NCT02267746|100908972|FG001|Overall Study|Adverse Event|2|||
33276491|NCT02267746|100908973|FG002|Overall Study|Adverse Event|1|||
33276492|NCT02267746|100908971|FG000|Overall Study|Protocol Violation|8|||
33276493|NCT02267746|100908972|FG001|Overall Study|Protocol Violation|7|||
33276494|NCT02267746|100908973|FG002|Overall Study|Protocol Violation|3|||
33276495|NCT02267746|100908971|FG000|Overall Study|Lack of Efficacy|11|||
33276496|NCT02267746|100908972|FG001|Overall Study|Lack of Efficacy|11|||
33276497|NCT02267746|100908973|FG002|Overall Study|Lack of Efficacy|15|||
33276498|NCT02267746|100908971|FG000|Overall Study|Protocol Violation|1|||
33276499|NCT02267746|100908972|FG001|Overall Study|Protocol Violation|2|||
33276500|NCT02267746|100908973|FG002|Overall Study|Protocol Violation|1|||
33276501|NCT02267746|100908971|FG000|Overall Study|Miscellaneous|1|||
33276502|NCT02267746|100908972|FG001|Overall Study|Miscellaneous|0|||
33276503|NCT02267746|100908973|FG002|Overall Study|Miscellaneous|1|||
33276504|NCT04242498|100908974|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
33276505|NCT04242498|100908975|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
33276506|NCT04242498|100908976|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
33276507|NCT04242498|100908977|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
33276508|NCT04242498|100908978|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
33276509|NCT04242498|100908979|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
33276510|NCT04242498|100908980|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
33276511|NCT04242498|100908974|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
33276512|NCT04242498|100908975|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
33276513|NCT04242498|100908976|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
33276514|NCT04242498|100908977|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
33276515|NCT04242498|100908978|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
33276516|NCT04242498|100908979|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
33276517|NCT04242498|100908980|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
33276518|NCT04242498|100908974|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
33276519|NCT04242498|100908975|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
33276520|NCT04242498|100908976|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
33276521|NCT04242498|100908977|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
33276522|NCT04242498|100908978|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
33276523|NCT04242498|100908979|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
33276524|NCT04242498|100908980|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
33276525|NCT04242498|100908974|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
33276526|NCT04242498|100908975|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
33276527|NCT04242498|100908976|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
33276528|NCT04242498|100908977|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
33276529|NCT04242498|100908978|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
33276530|NCT04242498|100908979|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
33276531|NCT04242498|100908980|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
33276532|NCT04242498|100908974|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
33276533|NCT04242498|100908975|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
33276534|NCT04242498|100908976|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
33276535|NCT04242498|100908977|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
33276536|NCT04242498|100908978|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
33276537|NCT04242498|100908979|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
33276538|NCT04242498|100908980|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
33276539|NCT04242498|100908974|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
33276540|NCT04242498|100908975|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
33276541|NCT04242498|100908976|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
33276542|NCT04242498|100908977|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
33276543|NCT04242498|100908978|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
33276544|NCT04242498|100908979|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
33276545|NCT04242498|100908980|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
33276546|NCT04242498|100908974|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
33276547|NCT04242498|100908975|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
33276548|NCT04242498|100908976|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
33276549|NCT04242498|100908977|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
33276550|NCT04242498|100908978|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
33276551|NCT04242498|100908979|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
33276552|NCT04242498|100908980|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
33276553|NCT04242498|100908974|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
33276554|NCT04242498|100908975|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
33276555|NCT04242498|100908976|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
33276556|NCT04242498|100908977|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
33276557|NCT04242498|100908978|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
33276558|NCT04242498|100908979|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
33276559|NCT04242498|100908980|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
33276560|NCT04242498|100908974|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
33276561|NCT04242498|100908975|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
33276562|NCT04242498|100908976|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
33276563|NCT04242498|100908977|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
33276564|NCT04242498|100908978|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
33276565|NCT04242498|100908979|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
33276566|NCT04242498|100908980|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
33276567|NCT04242498|100908974|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
33276568|NCT04242498|100908975|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
33276569|NCT04242498|100908976|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
33276570|NCT04242498|100908977|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
33276571|NCT04242498|100908978|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
33276572|NCT04242498|100908979|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
33276573|NCT04242498|100908980|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
33276574|NCT04242498|100908974|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
33276575|NCT04242498|100908975|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
33276576|NCT04242498|100908976|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
33276577|NCT04242498|100908977|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
33276578|NCT04242498|100908978|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
33276579|NCT04242498|100908979|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
33276580|NCT04242498|100908980|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
33276581|NCT04242498|100908974|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
33276582|NCT04242498|100908975|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
33276583|NCT04242498|100908976|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
33276584|NCT04242498|100908977|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
33276585|NCT04242498|100908978|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
33276586|NCT04242498|100908979|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
33276587|NCT04242498|100908980|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
33276588|NCT04242498|100908974|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
33276589|NCT04242498|100908975|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
33276590|NCT04242498|100908976|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
33276591|NCT04242498|100908977|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
33276592|NCT04242498|100908978|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
33276593|NCT04242498|100908979|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
33276594|NCT04242498|100908980|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
33276595|NCT04242498|100908974|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
33276596|NCT04242498|100908975|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
33276597|NCT04242498|100908976|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
33276598|NCT04242498|100908977|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
33276599|NCT04242498|100908978|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
33276600|NCT04242498|100908979|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
33276601|NCT04242498|100908980|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
33276602|NCT04242498|100908974|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
33286485|NCT03481556|100943980|FG003|Overall Study|Death|16|||
33485122|NCT04936035|101671247|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
33276603|NCT04242498|100908975|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
33276604|NCT04242498|100908976|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
33276605|NCT04242498|100908977|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
33276606|NCT04242498|100908978|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
33276607|NCT04242498|100908979|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
33276608|NCT04242498|100908980|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
33276609|NCT04242498|100908974|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
33276610|NCT04242498|100908975|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
33276611|NCT04242498|100908976|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
33276612|NCT04242498|100908977|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
33276613|NCT04242498|100908978|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
33276614|NCT04242498|100908979|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
33276615|NCT04242498|100908980|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
33276616|NCT04295499|100908981|FG000|Overall Study|moving out of state|1|||
33276617|NCT04295499|100908982|FG001|Overall Study|moving out of state|0|||
33276618|NCT04295499|100908981|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
33276619|NCT04295499|100908982|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
33276620|NCT02154516|100908983|FG000|Overall Study|Withdrawal by Subject|0|||
33276621|NCT02154516|100908984|FG001|Overall Study|Withdrawal by Subject|1|||
33276622|NCT02154516|100908983|FG000|Overall Study|Lost to Follow-up|1|||
33276623|NCT02154516|100908984|FG001|Overall Study|Lost to Follow-up|0|||
33276624|NCT02154516|100908983|FG000|Overall Study|Removal/revision of device|1|||
33276625|NCT02154516|100908984|FG001|Overall Study|Removal/revision of device|0|||
33276626|NCT02154516|100908983|FG000|Overall Study|Death|2|||
33276627|NCT02154516|100908984|FG001|Overall Study|Death|1|||
33276628|NCT04189224|100908985|FG000|Period 2|Adverse Event|0|||
33276629|NCT04189224|100908986|FG001|Period 2|Adverse Event|1|||
33276630|NCT01304940|100908989|FG000|Overall Study|not meet symptom severity requirement|3|||
33276631|NCT01304940|100908990|FG001|Overall Study|not meet symptom severity requirement|0|||
33276632|NCT02959866|100908997|FG000|Overall Study|Withdrawal by Subject|1|||
33276633|NCT02312245|100909000|FG000|Overall Study|Death|0|||
33276634|NCT02312245|100909001|FG001|Overall Study|Death|0|||
33276635|NCT02312245|100909002|FG002|Overall Study|Death|0|||
33276636|NCT02312245|100909003|FG003|Overall Study|Death|1|||
33276637|NCT02312245|100909000|FG000|Overall Study|Withdrawal by Subject|1|||
33276638|NCT02312245|100909001|FG001|Overall Study|Withdrawal by Subject|1|||
33276639|NCT02312245|100909002|FG002|Overall Study|Withdrawal by Subject|0|||
33276640|NCT02312245|100909003|FG003|Overall Study|Withdrawal by Subject|2|||
33276641|NCT02312245|100909000|FG000|Overall Study|Alternative Therapy|1|||
33276642|NCT02312245|100909001|FG001|Overall Study|Alternative Therapy|0|||
33276643|NCT02312245|100909002|FG002|Overall Study|Alternative Therapy|0|||
33276644|NCT02312245|100909003|FG003|Overall Study|Alternative Therapy|0|||
33276645|NCT02312245|100909000|FG000|Overall Study|Progression|0|||
33276646|NCT02312245|100909001|FG001|Overall Study|Progression|0|||
33276647|NCT02312245|100909002|FG002|Overall Study|Progression|0|||
33276648|NCT02312245|100909003|FG003|Overall Study|Progression|5|||
33276649|NCT02312245|100909000|FG000|Overall Study|Patient went to hospice|0|||
33276650|NCT02312245|100909001|FG001|Overall Study|Patient went to hospice|0|||
33276651|NCT02312245|100909002|FG002|Overall Study|Patient went to hospice|0|||
33276652|NCT02312245|100909003|FG003|Overall Study|Patient went to hospice|1|||
33276653|NCT02312245|100909000|FG000|Overall Study|Ineligible|1|||
33276654|NCT02312245|100909001|FG001|Overall Study|Ineligible|0|||
33276655|NCT02312245|100909002|FG002|Overall Study|Ineligible|0|||
33276656|NCT02312245|100909003|FG003|Overall Study|Ineligible|0|||
33276657|NCT00596960|100909004|FG000|Overall Study|Death|1|||
33276658|NCT00596960|100909005|FG001|Overall Study|Death|2|||
33276659|NCT00596960|100909004|FG000|Overall Study|Lost to Follow-up|6|||
33276660|NCT00596960|100909005|FG001|Overall Study|Lost to Follow-up|5|||
33276661|NCT00596960|100909004|FG000|Overall Study|Withdrawal by Subject|1|||
33276662|NCT00596960|100909005|FG001|Overall Study|Withdrawal by Subject|0|||
33276663|NCT00596960|100909004|FG000|Overall Study|Incarcerated|2|||
33276664|NCT00596960|100909005|FG001|Overall Study|Incarcerated|0|||
33276665|NCT00596960|100909004|FG000|Overall Study|Physician Decision|1|||
33276666|NCT00596960|100909005|FG001|Overall Study|Physician Decision|0|||
33276667|NCT00596960|100909004|FG000|Overall Study|Protocol Violation|0|||
33276668|NCT00596960|100909005|FG001|Overall Study|Protocol Violation|1|||
33276669|NCT00596960|100909004|FG000|Overall Study|No alcohol use data|0|||
33276670|NCT00596960|100909005|FG001|Overall Study|No alcohol use data|1|||
33276671|NCT01196741|100909006|FG000|Overall Study|Disease progression|34|||
33276672|NCT01196741|100909007|FG001|Overall Study|Disease progression|14|||
33276673|NCT01196741|100909006|FG000|Overall Study|Adverse Event|10|||
33276674|NCT01196741|100909007|FG001|Overall Study|Adverse Event|6|||
33276675|NCT01196741|100909006|FG000|Overall Study|Serious Adverse Event|3|||
33276676|NCT01196741|100909007|FG001|Overall Study|Serious Adverse Event|1|||
33276677|NCT01196741|100909006|FG000|Overall Study|Dose limiting Adverse Event|2|||
33276678|NCT01196741|100909007|FG001|Overall Study|Dose limiting Adverse Event|1|||
33276679|NCT01196741|100909006|FG000|Overall Study|Withdrawal by Subject|3|||
33276680|NCT01196741|100909007|FG001|Overall Study|Withdrawal by Subject|0|||
33276681|NCT01196741|100909006|FG000|Overall Study|Other reason|3|||
33276682|NCT01196741|100909007|FG001|Overall Study|Other reason|3|||
33276683|NCT01196741|100909006|FG000|Overall Study|Other|3|||
33276684|NCT01196741|100909007|FG001|Overall Study|Other|2|||
33276685|NCT01196741|100909006|FG000|Overall Study|Protocol Violation|2|||
33276686|NCT01196741|100909007|FG001|Overall Study|Protocol Violation|1|||
33276687|NCT03030599|100909008|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
33276688|NCT03030599|100909009|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
33276689|NCT03030599|100909010|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
33276690|NCT03030599|100909008|FG000|Open Label Treatment and Titration|Other|1|||
33276691|NCT03030599|100909009|FG001|Open Label Treatment and Titration|Other|0|||
33276692|NCT03030599|100909010|FG002|Open Label Treatment and Titration|Other|0|||
33276693|NCT03030599|100909008|FG000|Open Label Treatment and Titration|Physician Decision|3|||
33276694|NCT03030599|100909009|FG001|Open Label Treatment and Titration|Physician Decision|0|||
33276695|NCT03030599|100909010|FG002|Open Label Treatment and Titration|Physician Decision|0|||
33276696|NCT03030599|100909008|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
33276697|NCT03030599|100909009|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
33276698|NCT03030599|100909010|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
33276699|NCT03030599|100909008|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
33276700|NCT03030599|100909009|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
33276701|NCT03030599|100909010|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
33276702|NCT03030599|100909008|FG000|Open Label Treatment and Titration|Adverse Event|18|||
33276703|NCT03030599|100909009|FG001|Open Label Treatment and Titration|Adverse Event|0|||
33276704|NCT03030599|100909010|FG002|Open Label Treatment and Titration|Adverse Event|0|||
33276705|NCT03030599|100909008|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
33276706|NCT03030599|100909009|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
33276707|NCT03030599|100909010|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
33276708|NCT03030599|100909008|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
33276709|NCT03030599|100909009|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
33276710|NCT03030599|100909010|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
33276711|NCT03030599|100909008|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
33276712|NCT03030599|100909009|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
33276713|NCT03030599|100909010|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
33276714|NCT03030599|100909008|FG000|Stable Dose|Protocol deviation|3|||
33276715|NCT03030599|100909009|FG001|Stable Dose|Protocol deviation|0|||
33276716|NCT03030599|100909010|FG002|Stable Dose|Protocol deviation|0|||
33276717|NCT03030599|100909008|FG000|Stable Dose|Adverse Event|1|||
33276718|NCT03030599|100909009|FG001|Stable Dose|Adverse Event|0|||
33276719|NCT03030599|100909010|FG002|Stable Dose|Adverse Event|0|||
33276720|NCT03030599|100909008|FG000|Stable Dose|Lost to Follow-up|1|||
33276721|NCT03030599|100909009|FG001|Stable Dose|Lost to Follow-up|0|||
33276722|NCT03030599|100909010|FG002|Stable Dose|Lost to Follow-up|0|||
33276723|NCT03030599|100909008|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
33276724|NCT03030599|100909009|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
33276725|NCT03030599|100909010|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
33276726|NCT03030599|100909008|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
33276727|NCT03030599|100909009|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
33276728|NCT03030599|100909010|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
33276729|NCT03030599|100909008|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
33276730|NCT03030599|100909009|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
33276731|NCT03030599|100909010|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
33276732|NCT03030599|100909008|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
33276733|NCT03030599|100909009|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
33276734|NCT03030599|100909010|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
33276735|NCT03030599|100909008|FG000|Open-label Extension|Adverse Event|3|||
33485123|NCT04936035|101671248|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
33485124|NCT04936035|101671249|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
33485125|NCT04936035|101671250|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
33485126|NCT04936035|101671251|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
33485127|NCT02445963|101671252|FG000|Overall Study|Lost to Follow-up|1|||
33485128|NCT02445963|101671253|FG001|Overall Study|Lost to Follow-up|0|||
33485129|NCT02445963|101671254|FG002|Overall Study|Lost to Follow-up|0|||
33276736|NCT03030599|100909009|FG001|Open-label Extension|Adverse Event|0|||
33276737|NCT03030599|100909010|FG002|Open-label Extension|Adverse Event|0|||
33276738|NCT03030599|100909008|FG000|Open-label Extension|Lost to Follow-up|2|||
33276739|NCT03030599|100909009|FG001|Open-label Extension|Lost to Follow-up|0|||
33276740|NCT03030599|100909010|FG002|Open-label Extension|Lost to Follow-up|0|||
33276741|NCT03030599|100909008|FG000|Open-label Extension|Lack of Efficacy|1|||
33276742|NCT03030599|100909009|FG001|Open-label Extension|Lack of Efficacy|0|||
33276743|NCT03030599|100909010|FG002|Open-label Extension|Lack of Efficacy|0|||
33276744|NCT03030599|100909008|FG000|Open-label Extension|Other Reason|1|||
33276745|NCT03030599|100909009|FG001|Open-label Extension|Other Reason|0|||
33276746|NCT03030599|100909010|FG002|Open-label Extension|Other Reason|0|||
33276747|NCT01762345|100909011|FG000|Overall Study|Adverse Event|5|||
33276748|NCT01762345|100909011|FG000|Overall Study|Protocol Violation|2|||
33276749|NCT04999020|100909012|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
33276750|NCT04999020|100909013|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
33276751|NCT04999020|100909014|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
33276752|NCT04999020|100909015|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
33276753|NCT04999020|100909012|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
33276754|NCT04999020|100909013|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
33276755|NCT04999020|100909014|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
33276756|NCT04999020|100909015|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
33276757|NCT04999020|100909012|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
33276758|NCT04999020|100909013|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
33276759|NCT04999020|100909014|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
33276760|NCT04999020|100909015|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
33276761|NCT04999020|100909012|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
33276762|NCT04999020|100909013|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
33276763|NCT04999020|100909014|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
33276764|NCT04999020|100909015|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
33276765|NCT04999020|100909012|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
33276766|NCT04999020|100909013|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
33276767|NCT04999020|100909014|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
33276768|NCT04999020|100909015|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
33276769|NCT04999020|100909012|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
33276770|NCT04999020|100909013|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
33276771|NCT04999020|100909014|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
33276772|NCT04999020|100909015|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
33276773|NCT04999020|100909012|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
33276774|NCT04999020|100909013|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
33276775|NCT04999020|100909014|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
33276776|NCT04999020|100909015|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
33276777|NCT04999020|100909012|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
33276778|NCT04999020|100909013|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
33276779|NCT04999020|100909014|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
33276780|NCT04999020|100909015|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
33276781|NCT03530345|100909016|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
33276782|NCT03530345|100909017|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
33276783|NCT03530345|100909016|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
33276784|NCT03530345|100909017|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
33276785|NCT03530345|100909016|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
33276786|NCT03530345|100909017|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
33276787|NCT03530345|100909016|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
33276788|NCT03530345|100909017|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
33276789|NCT00331799|100909018|FG000|Overall Study|Withdrawal by Subject|2|||
33276790|NCT00331799|100909018|FG000|Overall Study|Sedation|1|||
33276791|NCT03904693|100909019|FG000|Overall Study|Death|0|||
33276792|NCT03904693|100909020|FG001|Overall Study|Death|0|||
33276793|NCT03904693|100909021|FG002|Overall Study|Death|3|||
33276794|NCT03904693|100909019|FG000|Overall Study|Physician Decision|0|||
33276795|NCT03904693|100909020|FG001|Overall Study|Physician Decision|0|||
33276796|NCT03904693|100909021|FG002|Overall Study|Physician Decision|2|||
33276797|NCT03904693|100909019|FG000|Overall Study|Withdrawal by Subject|0|||
33276798|NCT03904693|100909020|FG001|Overall Study|Withdrawal by Subject|1|||
33276799|NCT03904693|100909021|FG002|Overall Study|Withdrawal by Subject|4|||
33276800|NCT05379400|100909022|FG000|Overall Study|Lost to Follow-up|1|||
33276801|NCT05379400|100909023|FG001|Overall Study|Lost to Follow-up|1|||
33276802|NCT02097420|100909024|FG000|Overall Study|Death|6|||
33276803|NCT02097420|100909024|FG000|Overall Study|Valve explanted|13|||
33276804|NCT02097420|100909024|FG000|Overall Study|Other Reason|1|||
33276805|NCT00561678|100909025|FG000|Overall Study|Withdrawal by Subject|4|||
33276806|NCT00561678|100909026|FG001|Overall Study|Withdrawal by Subject|3|||
33276807|NCT00561678|100909025|FG000|Overall Study|surgery cancelled|1|||
33276808|NCT00561678|100909026|FG001|Overall Study|surgery cancelled|1|||
33276809|NCT00561678|100909025|FG000|Overall Study|surgery rescheduled to different site|2|||
33276810|NCT00561678|100909026|FG001|Overall Study|surgery rescheduled to different site|2|||
33276811|NCT00561678|100909025|FG000|Overall Study|anesthesia provider refusal|1|||
33276812|NCT00561678|100909026|FG001|Overall Study|anesthesia provider refusal|0|||
33276813|NCT01348763|100909027|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
33276814|NCT01348763|100909027|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
33276815|NCT03761849|100909033|FG000|Overall Study|transferred to OpenLabelExtension|35|||
33276816|NCT03761849|100909034|FG001|Overall Study|transferred to OpenLabelExtension|34|||
33276817|NCT03761849|100909035|FG002|Overall Study|transferred to OpenLabelExtension|36|||
33276818|NCT03761849|100909036|FG003|Overall Study|transferred to OpenLabelExtension|0|||
33276819|NCT03761849|100909037|FG004|Overall Study|transferred to OpenLabelExtension|0|||
33276820|NCT03761849|100909038|FG005|Overall Study|transferred to OpenLabelExtension|0|||
33276821|NCT03761849|100909033|FG000|Overall Study|Adverse Event|1|||
33276822|NCT03761849|100909034|FG001|Overall Study|Adverse Event|0|||
33276823|NCT03761849|100909035|FG002|Overall Study|Adverse Event|0|||
33276824|NCT03761849|100909036|FG003|Overall Study|Adverse Event|0|||
33276825|NCT03761849|100909037|FG004|Overall Study|Adverse Event|2|||
33276826|NCT03761849|100909038|FG005|Overall Study|Adverse Event|3|||
33276827|NCT03761849|100909033|FG000|Overall Study|Withdrawal by Subject|0|||
33276828|NCT03761849|100909034|FG001|Overall Study|Withdrawal by Subject|0|||
33276829|NCT03761849|100909035|FG002|Overall Study|Withdrawal by Subject|0|||
33276830|NCT03761849|100909036|FG003|Overall Study|Withdrawal by Subject|41|||
33276831|NCT03761849|100909037|FG004|Overall Study|Withdrawal by Subject|43|||
33276832|NCT03761849|100909038|FG005|Overall Study|Withdrawal by Subject|35|||
33276833|NCT03761849|100909033|FG000|Overall Study|Lost to Follow-up|0|||
33276834|NCT03761849|100909034|FG001|Overall Study|Lost to Follow-up|1|||
33276835|NCT03761849|100909035|FG002|Overall Study|Lost to Follow-up|0|||
33276836|NCT03761849|100909036|FG003|Overall Study|Lost to Follow-up|2|||
33276837|NCT03761849|100909037|FG004|Overall Study|Lost to Follow-up|4|||
33276838|NCT03761849|100909038|FG005|Overall Study|Lost to Follow-up|5|||
33276839|NCT03761849|100909033|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
33276840|NCT03761849|100909034|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
33276841|NCT03761849|100909035|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
33276842|NCT03761849|100909036|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
33276843|NCT03761849|100909037|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
33276844|NCT03761849|100909038|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
33276845|NCT03761849|100909033|FG000|Overall Study|Physician Decision|0|||
33276846|NCT03761849|100909034|FG001|Overall Study|Physician Decision|0|||
33276847|NCT03761849|100909035|FG002|Overall Study|Physician Decision|0|||
33276848|NCT03761849|100909036|FG003|Overall Study|Physician Decision|1|||
33276849|NCT03761849|100909037|FG004|Overall Study|Physician Decision|4|||
33276850|NCT03761849|100909038|FG005|Overall Study|Physician Decision|4|||
33276851|NCT03761849|100909033|FG000|Overall Study|Death|0|||
33276852|NCT03761849|100909034|FG001|Overall Study|Death|0|||
33276853|NCT03761849|100909035|FG002|Overall Study|Death|0|||
33276854|NCT03761849|100909036|FG003|Overall Study|Death|1|||
33276855|NCT03761849|100909037|FG004|Overall Study|Death|1|||
33276856|NCT03761849|100909038|FG005|Overall Study|Death|3|||
33276857|NCT03761849|100909033|FG000|Overall Study|Protocol Violation|0|||
33276858|NCT03761849|100909034|FG001|Overall Study|Protocol Violation|0|||
33276859|NCT03761849|100909035|FG002|Overall Study|Protocol Violation|0|||
33276860|NCT03761849|100909036|FG003|Overall Study|Protocol Violation|2|||
33276861|NCT03761849|100909037|FG004|Overall Study|Protocol Violation|2|||
33276862|NCT03761849|100909038|FG005|Overall Study|Protocol Violation|1|||
33276863|NCT03761849|100909033|FG000|Overall Study|Participant could not come to site|0|||
33276864|NCT03761849|100909034|FG001|Overall Study|Participant could not come to site|0|||
33276865|NCT03761849|100909035|FG002|Overall Study|Participant could not come to site|0|||
33276866|NCT03761849|100909036|FG003|Overall Study|Participant could not come to site|0|||
33276867|NCT03761849|100909037|FG004|Overall Study|Participant could not come to site|1|||
33276868|NCT03761849|100909038|FG005|Overall Study|Participant could not come to site|0|||
33276869|NCT03761849|100909033|FG000|Overall Study|SF- safety Finding|0|||
33276870|NCT03761849|100909034|FG001|Overall Study|SF- safety Finding|0|||
33276871|NCT03761849|100909035|FG002|Overall Study|SF- safety Finding|0|||
33276872|NCT03761849|100909036|FG003|Overall Study|SF- safety Finding|0|||
33276873|NCT03761849|100909037|FG004|Overall Study|SF- safety Finding|0|||
33276874|NCT03761849|100909038|FG005|Overall Study|SF- safety Finding|1|||
33276875|NCT03761849|100909033|FG000|Overall Study|Patient did not attend visit|0|||
33276876|NCT03761849|100909034|FG001|Overall Study|Patient did not attend visit|0|||
33276877|NCT03761849|100909035|FG002|Overall Study|Patient did not attend visit|0|||
33276878|NCT03761849|100909036|FG003|Overall Study|Patient did not attend visit|0|||
33276879|NCT03761849|100909037|FG004|Overall Study|Patient did not attend visit|0|||
33276880|NCT03761849|100909038|FG005|Overall Study|Patient did not attend visit|1|||
33276881|NCT04853238|100909040|FG000|Overall Study|Death|4|||
33276882|NCT04853238|100909041|FG001|Overall Study|Death|0|||
33276883|NCT04853238|100909042|FG002|Overall Study|Death|2|||
33276884|NCT04853238|100909040|FG000|Overall Study|Lost to Follow-up|16|||
33276885|NCT04853238|100909041|FG001|Overall Study|Lost to Follow-up|2|||
33276886|NCT04853238|100909042|FG002|Overall Study|Lost to Follow-up|37|||
33276887|NCT04853238|100909040|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
33276888|NCT04853238|100909041|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
33276889|NCT04853238|100909042|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
33276890|NCT04853238|100909040|FG000|Overall Study|Withdrawal by Subject|6|||
33276891|NCT04853238|100909041|FG001|Overall Study|Withdrawal by Subject|0|||
33276892|NCT04853238|100909042|FG002|Overall Study|Withdrawal by Subject|21|||
33276893|NCT04853238|100909040|FG000|Overall Study|Physician Decision|0|||
33276894|NCT04853238|100909041|FG001|Overall Study|Physician Decision|0|||
33276895|NCT04853238|100909042|FG002|Overall Study|Physician Decision|2|||
33276896|NCT04853238|100909040|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
33276897|NCT04853238|100909041|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
33276898|NCT04853238|100909042|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
33276899|NCT02880293|100909043|FG000|Overall Study|Inevaluable|5|||
33276900|NCT04730271|100909044|FG000|Overall Study|Adverse Event|0|||
33276901|NCT04730271|100909045|FG001|Overall Study|Adverse Event|2|||
33276902|NCT04730271|100909044|FG000|Overall Study|Withdrawal by Subject|1|||
33276903|NCT04730271|100909045|FG001|Overall Study|Withdrawal by Subject|1|||
33276904|NCT04730271|100909044|FG000|Overall Study|Protocol Violation|7|||
33276905|NCT04730271|100909045|FG001|Overall Study|Protocol Violation|13|||
33276906|NCT04730271|100909044|FG000|Overall Study|Lost to Follow-up|3|||
33276907|NCT04730271|100909045|FG001|Overall Study|Lost to Follow-up|3|||
33276908|NCT04730271|100909044|FG000|Overall Study|Death|1|||
33276909|NCT04730271|100909045|FG001|Overall Study|Death|0|||
33276910|NCT00139659|100909046|FG000|Overall Study|Adverse Event|12|||
33276911|NCT00139659|100909047|FG001|Overall Study|Adverse Event|1|||
33276912|NCT00139659|100909046|FG000|Overall Study|Lack of Efficacy|1|||
33276913|NCT00139659|100909047|FG001|Overall Study|Lack of Efficacy|1|||
33276914|NCT00139659|100909046|FG000|Overall Study|Lost to Follow-up|7|||
33276915|NCT00139659|100909047|FG001|Overall Study|Lost to Follow-up|3|||
33276916|NCT00139659|100909046|FG000|Overall Study|Reason not Specified|6|||
33276917|NCT00139659|100909047|FG001|Overall Study|Reason not Specified|3|||
33276918|NCT00139659|100909046|FG000|Overall Study|Withdrawal by Subject|14|||
33276919|NCT00139659|100909047|FG001|Overall Study|Withdrawal by Subject|10|||
33276920|NCT04175392|100909048|FG000|Overall Study|Withdrawal by Subject|3|||
33276921|NCT04175392|100909049|FG001|Overall Study|Withdrawal by Subject|2|||
33276922|NCT02812706|100909050|FG000|Phase 1|Adverse Event|0|||
33276923|NCT02812706|100909051|FG001|Phase 1|Adverse Event|2|||
33276924|NCT02812706|100909052|FG002|Phase 1|Adverse Event|0|||
33276925|NCT02812706|100909050|FG000|Phase 1|Progressive disease|3|||
33276926|NCT02812706|100909051|FG001|Phase 1|Progressive disease|3|||
33276927|NCT02812706|100909052|FG002|Phase 1|Progressive disease|0|||
33276928|NCT02812706|100909050|FG000|Phase 2|Adverse Event|0|||
33276929|NCT02812706|100909051|FG001|Phase 2|Adverse Event|0|||
33276930|NCT02812706|100909052|FG002|Phase 2|Adverse Event|2|||
33276931|NCT02812706|100909050|FG000|Phase 2|Progressive disease|0|||
33276932|NCT02812706|100909051|FG001|Phase 2|Progressive disease|0|||
33276933|NCT02812706|100909052|FG002|Phase 2|Progressive disease|22|||
33276934|NCT02812706|100909050|FG000|Phase 2|Other-Unspecified|0|||
33276935|NCT02812706|100909051|FG001|Phase 2|Other-Unspecified|0|||
33276936|NCT02812706|100909052|FG002|Phase 2|Other-Unspecified|4|||
33276937|NCT03508830|100909053|FG000|Overall Study|Withdrawal by Subject|3|||
33276938|NCT03508830|100909054|FG001|Overall Study|Withdrawal by Subject|4|||
33276939|NCT03508830|100909053|FG000|Overall Study|Physician Decision|2|||
33276940|NCT03508830|100909054|FG001|Overall Study|Physician Decision|2|||
33276941|NCT05700851|100909055|FG000|Overall Study|Received a kidney transplant|1|||
33276942|NCT05700851|100909055|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
33276943|NCT05700851|100909055|FG000|Overall Study|Withdrawal by Subject|1|||
33276944|NCT04754594|100909056|FG000|Blinded Period|Withdrawal by Subject|4|||
33276945|NCT04754594|100909057|FG001|Blinded Period|Withdrawal by Subject|9|||
33276946|NCT04754594|100909058|FG002|Blinded Period|Withdrawal by Subject|0|||
33276947|NCT04754594|100909059|FG003|Blinded Period|Withdrawal by Subject|0|||
33276948|NCT04754594|100909056|FG000|Blinded Period|Protocol Violation|2|||
33276949|NCT04754594|100909057|FG001|Blinded Period|Protocol Violation|2|||
33276950|NCT04754594|100909058|FG002|Blinded Period|Protocol Violation|0|||
33276951|NCT04754594|100909059|FG003|Blinded Period|Protocol Violation|0|||
33276952|NCT04754594|100909056|FG000|Blinded Period|Lost to Follow-up|1|||
33276953|NCT04754594|100909057|FG001|Blinded Period|Lost to Follow-up|1|||
33276954|NCT04754594|100909058|FG002|Blinded Period|Lost to Follow-up|0|||
33276955|NCT04754594|100909059|FG003|Blinded Period|Lost to Follow-up|0|||
33276956|NCT04754594|100909056|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
33276957|NCT04754594|100909057|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
33276958|NCT04754594|100909058|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
33276959|NCT04754594|100909059|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
33276960|NCT04754594|100909056|FG000|Unblinded Period|Withdrawal by Subject|6|||
33276961|NCT04754594|100909057|FG001|Unblinded Period|Withdrawal by Subject|8|||
33276962|NCT04754594|100909058|FG002|Unblinded Period|Withdrawal by Subject|0|||
33276963|NCT04754594|100909059|FG003|Unblinded Period|Withdrawal by Subject|0|||
33276964|NCT04754594|100909056|FG000|Unblinded Period|Lost to Follow-up|5|||
33276965|NCT04754594|100909057|FG001|Unblinded Period|Lost to Follow-up|3|||
33276966|NCT04754594|100909058|FG002|Unblinded Period|Lost to Follow-up|0|||
33276967|NCT04754594|100909059|FG003|Unblinded Period|Lost to Follow-up|0|||
33276968|NCT04754594|100909056|FG000|Unblinded Period|Protocol Violation|2|||
33276969|NCT04754594|100909057|FG001|Unblinded Period|Protocol Violation|4|||
33276970|NCT04754594|100909058|FG002|Unblinded Period|Protocol Violation|0|||
33276971|NCT04754594|100909059|FG003|Unblinded Period|Protocol Violation|0|||
33276972|NCT04754594|100909056|FG000|Unblinded Period|Other|3|||
33276973|NCT04754594|100909057|FG001|Unblinded Period|Other|0|||
33276974|NCT04754594|100909058|FG002|Unblinded Period|Other|0|||
33276975|NCT04754594|100909059|FG003|Unblinded Period|Other|0|||
33276976|NCT04754594|100909056|FG000|Infant Participants|Withdrawal by Subject|0|||
33276977|NCT04754594|100909057|FG001|Infant Participants|Withdrawal by Subject|0|||
33276978|NCT04754594|100909058|FG002|Infant Participants|Withdrawal by Subject|9|||
33276979|NCT04754594|100909059|FG003|Infant Participants|Withdrawal by Subject|17|||
33276980|NCT04754594|100909056|FG000|Infant Participants|Lost to Follow-up|0|||
33276981|NCT04754594|100909057|FG001|Infant Participants|Lost to Follow-up|0|||
33276982|NCT04754594|100909058|FG002|Infant Participants|Lost to Follow-up|4|||
33276983|NCT04754594|100909059|FG003|Infant Participants|Lost to Follow-up|10|||
33276984|NCT04754594|100909056|FG000|Infant Participants|Death|0|||
33276985|NCT04754594|100909057|FG001|Infant Participants|Death|0|||
33276986|NCT04754594|100909058|FG002|Infant Participants|Death|1|||
33276987|NCT04754594|100909059|FG003|Infant Participants|Death|1|||
33276988|NCT04754594|100909056|FG000|Infant Participants|Other|0|||
33276989|NCT04754594|100909057|FG001|Infant Participants|Other|0|||
33276990|NCT04754594|100909058|FG002|Infant Participants|Other|1|||
33276991|NCT04754594|100909059|FG003|Infant Participants|Other|1|||
33276992|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
33276993|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
33276994|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
33276995|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
33276996|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
33276997|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
33276998|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
33276999|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
33277000|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
33277001|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
33277002|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
33277003|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
33277004|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
33277005|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
33277006|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
33277007|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
33277008|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
33277009|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
33277010|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
33277011|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
33277012|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
33277013|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
33277014|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
33277015|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
33277016|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
33277017|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
33277018|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
33277019|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
33277020|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
33277021|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
33277022|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
33277023|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
33277024|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
33277025|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
33277026|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
33277027|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
33277028|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
33277029|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
33277030|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
33277031|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
33277032|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
33277033|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
33485130|NCT02445963|101671255|FG003|Overall Study|Lost to Follow-up|0|||
33277034|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
33277035|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
33277036|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
33277037|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
33277038|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
33277039|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
33277040|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
33277041|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
33277042|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
33277043|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
33277044|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
33277045|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
33277046|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277047|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
33277048|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277049|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277050|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277051|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277052|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277053|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277054|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277055|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
33277056|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
33277057|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
33277058|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
33277059|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
33277060|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
33277061|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
33277062|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
33277063|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
33277064|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
33277065|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
33277066|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
33277067|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
33277068|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
33277069|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
33277070|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
33277071|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
33277072|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
33277073|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
33277074|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
33277075|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
33277076|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
33277077|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
33277078|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
33277079|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
33277080|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
33277081|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
33277082|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
33277083|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
33277084|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
33277085|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
33277086|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
33277087|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
33277088|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
33277089|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
33277090|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
33277091|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277092|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
33277093|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
33277094|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277095|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277096|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277097|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277098|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277099|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
33277100|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
33277101|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
33277102|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
33277103|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
33277104|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
33277105|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
33277106|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
33277107|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
33277108|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
33277109|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
33277110|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
33277111|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
33277112|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
33277113|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
33277114|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
33277115|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
33277116|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
33277117|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
33277118|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
33277119|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
33277120|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
33277121|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
33277122|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
33277123|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
33277124|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
33277125|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
33277126|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
33277127|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
33277128|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
33277129|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
33277130|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
33277131|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
33277132|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
33277133|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
33277134|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
33277135|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
33277136|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
33277137|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
33277138|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
33277139|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
33277140|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
33277141|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
33277142|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
33277143|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
33277144|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
33277145|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
33277146|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
33277147|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
33277148|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
33277149|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
33277150|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
33277151|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
33277152|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
33277153|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
33277154|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
33277155|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
33277156|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
33277157|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
33277158|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
33277159|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
33277160|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
33277161|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
33277162|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
33277163|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
33277164|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
33277165|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
33277166|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
33277167|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
33277168|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
33277169|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
33277170|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
33277171|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
33277172|NCT03598790|100909060|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
33277173|NCT03598790|100909061|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
33277174|NCT03598790|100909062|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
33277175|NCT03598790|100909063|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
33277176|NCT03598790|100909064|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
33277177|NCT03598790|100909065|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
33277178|NCT03598790|100909066|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
33277179|NCT03598790|100909067|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
33277180|NCT03598790|100909068|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
33277181|NCT03598790|100909060|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33277182|NCT03598790|100909061|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33277183|NCT03598790|100909062|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33277184|NCT03598790|100909063|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
33277185|NCT03598790|100909064|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
33277186|NCT03598790|100909065|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
33277187|NCT03598790|100909066|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33277188|NCT03598790|100909067|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33277189|NCT03598790|100909068|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33277190|NCT03598790|100909060|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
33277191|NCT03598790|100909061|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
33277192|NCT03598790|100909062|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
33277193|NCT03598790|100909063|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
33277194|NCT03598790|100909064|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
33277195|NCT03598790|100909065|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
33277196|NCT03598790|100909066|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
33277197|NCT03598790|100909067|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
33277198|NCT03598790|100909068|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
33277199|NCT03598790|100909060|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33277200|NCT03598790|100909061|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33277201|NCT03598790|100909062|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33277202|NCT03598790|100909063|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
33277203|NCT03598790|100909064|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33277204|NCT03598790|100909065|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33277205|NCT03598790|100909066|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33277206|NCT03598790|100909067|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33277207|NCT03598790|100909068|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33277208|NCT03598790|100909060|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
33277209|NCT03598790|100909061|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
33277210|NCT03598790|100909062|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
33277211|NCT03598790|100909063|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
33277212|NCT03598790|100909064|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
33277213|NCT03598790|100909065|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
33277214|NCT03598790|100909066|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
33277215|NCT03598790|100909067|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
33277216|NCT03598790|100909068|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
33277217|NCT03598790|100909060|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
33277218|NCT03598790|100909061|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
33277219|NCT03598790|100909062|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
33277220|NCT03598790|100909063|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
33277221|NCT03598790|100909064|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
33277222|NCT03598790|100909065|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
33277223|NCT03598790|100909066|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
33277224|NCT03598790|100909067|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
33277225|NCT03598790|100909068|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
33277226|NCT01014013|100909069|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
33277227|NCT01014013|100909070|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
33277228|NCT01014013|100909069|FG000|Overall Study|Clinical adverse experience|4|||
33277229|NCT01014013|100909070|FG001|Overall Study|Clinical adverse experience|2|||
33277230|NCT01014013|100909069|FG000|Overall Study|Laboratory adverse experience|1|||
33277231|NCT01014013|100909070|FG001|Overall Study|Laboratory adverse experience|1|||
33277232|NCT01014013|100909069|FG000|Overall Study|Protocol Violation|1|||
33277233|NCT01014013|100909070|FG001|Overall Study|Protocol Violation|3|||
33277234|NCT01014013|100909069|FG000|Overall Study|Withdrawal by Subject|7|||
33277235|NCT01014013|100909070|FG001|Overall Study|Withdrawal by Subject|4|||
33277236|NCT01014013|100909069|FG000|Overall Study|Clinical/microbiologic failure|1|||
33277237|NCT01014013|100909070|FG001|Overall Study|Clinical/microbiologic failure|2|||
33277238|NCT01014013|100909069|FG000|Overall Study|Pathogen culture = no growth|26|||
33277239|NCT01014013|100909070|FG001|Overall Study|Pathogen culture = no growth|34|||
33277240|NCT01014013|100909069|FG000|Overall Study|Negative urine culture|2|||
33277241|NCT01014013|100909070|FG001|Overall Study|Negative urine culture|0|||
33277242|NCT01014013|100909069|FG000|Overall Study|Pathogen resistant|7|||
33277243|NCT01014013|100909070|FG001|Overall Study|Pathogen resistant|4|||
33277244|NCT01014013|100909069|FG000|Overall Study|Physician Decision|0|||
33277245|NCT01014013|100909070|FG001|Overall Study|Physician Decision|1|||
33277246|NCT01014013|100909069|FG000|Overall Study|Another antibiotic therapy required|0|||
33277247|NCT01014013|100909070|FG001|Overall Study|Another antibiotic therapy required|1|||
33277248|NCT01014013|100909069|FG000|Overall Study|Appendectomy|1|||
33485131|NCT02445963|101671252|FG000|Overall Study|Change in employment|1|||
33485132|NCT02445963|101671253|FG001|Overall Study|Change in employment|0|||
33485133|NCT02445963|101671254|FG002|Overall Study|Change in employment|0|||
33485134|NCT02445963|101671255|FG003|Overall Study|Change in employment|0|||
33485135|NCT02445963|101671252|FG000|Overall Study|Symptoms post-vaccination|0|||
33485136|NCT02445963|101671253|FG001|Overall Study|Symptoms post-vaccination|0|||
33485137|NCT02445963|101671254|FG002|Overall Study|Symptoms post-vaccination|1|||
33485138|NCT02445963|101671255|FG003|Overall Study|Symptoms post-vaccination|0|||
33485139|NCT00582010|101671256|FG000|Overall Study|Death|0|||
33485140|NCT00582010|101671257|FG001|Overall Study|Death|1|||
33485141|NCT01769456|101671258|FG000|Overall Study|Lost to Follow-up|19|||
33485142|NCT01769456|101671258|FG000|Overall Study|Withdrawal by Subject|3|||
33485143|NCT01769456|101671258|FG000|Overall Study|Did not receive PCC intervention|6|||
33485144|NCT01769456|101671258|FG000|Overall Study|Moved out of the area|3|||
33485145|NCT01769456|101671258|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
33485146|NCT01769456|101671258|FG000|Overall Study|Parental request to youth to withdraw|1|||
33485147|NCT01371539|101671261|FG000|Period One: One Week|Lost to Follow-up|0|||
33485148|NCT01371539|101671262|FG001|Period One: One Week|Lost to Follow-up|1|||
33485149|NCT01371539|101671261|FG000|Period Two: One Week|Lost to Follow-up|0|||
33485150|NCT01371539|101671262|FG001|Period Two: One Week|Lost to Follow-up|1|||
33485151|NCT01371539|101671261|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
33485152|NCT01371539|101671262|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
33485153|NCT01371539|101671261|FG000|Period Two: One Week|Time/job conflict|0|||
33485154|NCT01371539|101671262|FG001|Period Two: One Week|Time/job conflict|1|||
33485155|NCT02806024|101671265|FG000|Overall Study|Night Delivery|1|||
33485156|NCT02806024|101671266|FG001|Overall Study|Night Delivery|1|||
33485157|NCT02806024|101671265|FG000|Overall Study|DVT during antepartum admission|0|||
33485158|NCT02806024|101671266|FG001|Overall Study|DVT during antepartum admission|1|||
33485159|NCT05513391|101671267|FG000|Overall Study|Adverse Event|1|||
33485160|NCT05513391|101671268|FG001|Overall Study|Adverse Event|0|||
33485161|NCT05513391|101671267|FG000|Overall Study|Protocol Deviation|0|||
33485162|NCT05513391|101671268|FG001|Overall Study|Protocol Deviation|1|||
33485163|NCT05513391|101671267|FG000|Overall Study|Withdrawal by Subject|3|||
33485164|NCT05513391|101671268|FG001|Overall Study|Withdrawal by Subject|1|||
33485165|NCT05513391|101671267|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
33485166|NCT05513391|101671268|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
33485167|NCT05513391|101671267|FG000|Overall Study|Lost to Follow-up|0|||
33485168|NCT05513391|101671268|FG001|Overall Study|Lost to Follow-up|2|||
33485169|NCT01118975|101671269|FG000|Overall Study|Adverse Event|0|||
33485170|NCT01118975|101671270|FG001|Overall Study|Adverse Event|1|||
33485171|NCT00380744|101671271|FG000|Overall Study|Death|0|||
33485172|NCT00380744|101671272|FG001|Overall Study|Death|0|||
33485173|NCT00380744|101671273|FG002|Overall Study|Death|0|||
33485174|NCT00380744|101671274|FG003|Overall Study|Death|0|||
33485175|NCT00380744|101671275|FG004|Overall Study|Death|0|||
33485176|NCT00380744|101671276|FG005|Overall Study|Death|0|||
33485177|NCT00380744|101671277|FG006|Overall Study|Death|1|||
33485178|NCT00380744|101671271|FG000|Overall Study|Withdrawal by Subject|1|||
33485179|NCT00380744|101671272|FG001|Overall Study|Withdrawal by Subject|0|||
33485180|NCT00380744|101671273|FG002|Overall Study|Withdrawal by Subject|0|||
33485181|NCT00380744|101671274|FG003|Overall Study|Withdrawal by Subject|0|||
33485182|NCT00380744|101671275|FG004|Overall Study|Withdrawal by Subject|0|||
33485183|NCT00380744|101671276|FG005|Overall Study|Withdrawal by Subject|0|||
33485184|NCT00380744|101671277|FG006|Overall Study|Withdrawal by Subject|0|||
33485185|NCT00786409|101671280|FG000|Overall Study|Withdrawal by Subject|2|||
33485186|NCT00786409|101671280|FG000|Overall Study|Adverse Event|2|||
33485187|NCT00786409|101671280|FG000|Overall Study|Pregnancy|2|||
33485188|NCT00786409|101671280|FG000|Overall Study|Lost to Follow-up|1|||
33485189|NCT00281957|101671281|FG000|Overall Study|Adverse Event|7|||
33485190|NCT00281957|101671282|FG001|Overall Study|Adverse Event|2|||
33485191|NCT00281957|101671281|FG000|Overall Study|Death|1|||
33485192|NCT00281957|101671282|FG001|Overall Study|Death|0|||
33485193|NCT00281957|101671281|FG000|Overall Study|Progression/relapse|47|||
33485194|NCT00281957|101671282|FG001|Overall Study|Progression/relapse|35|||
33485195|NCT00281957|101671281|FG000|Overall Study|Not protocol specified|8|||
33485196|NCT00281957|101671282|FG001|Overall Study|Not protocol specified|1|||
33485197|NCT00281957|101671281|FG000|Overall Study|Not eligible|1|||
33485198|NCT00281957|101671282|FG001|Overall Study|Not eligible|2|||
33485199|NCT00281957|101671281|FG000|Overall Study|Did not start treatment|3|||
33485200|NCT00281957|101671282|FG001|Overall Study|Did not start treatment|1|||
33485201|NCT00281957|101671281|FG000|Overall Study|Refusal unrelated to adverse events|0|||
33485202|NCT00281957|101671282|FG001|Overall Study|Refusal unrelated to adverse events|1|||
33485203|NCT01085357|101671288|FG000|Overall Study|Adverse Event|1|||
33485204|NCT01085357|101671289|FG001|Overall Study|Adverse Event|1|||
33485205|NCT01085357|101671288|FG000|Overall Study|Subject Decision|4|||
33485206|NCT01085357|101671289|FG001|Overall Study|Subject Decision|3|||
33485207|NCT01085357|101671288|FG000|Overall Study|Investigator Decision|1|||
33485208|NCT01085357|101671289|FG001|Overall Study|Investigator Decision|1|||
33485209|NCT01085357|101671288|FG000|Overall Study|Death|11|||
33485210|NCT01085357|101671289|FG001|Overall Study|Death|1|||
33485211|NCT01085357|101671288|FG000|Overall Study|Lost to Follow-up|2|||
33485212|NCT01085357|101671289|FG001|Overall Study|Lost to Follow-up|0|||
33485213|NCT04338269|101671290|FG000|Overall Study|Death|86|||
33485214|NCT04338269|101671291|FG001|Overall Study|Death|89|||
33485215|NCT04338269|101671290|FG000|Overall Study|Lost to Follow-up|1|||
33485216|NCT04338269|101671291|FG001|Overall Study|Lost to Follow-up|2|||
33485217|NCT04338269|101671290|FG000|Overall Study|Physician Decision|1|||
33485218|NCT04338269|101671291|FG001|Overall Study|Physician Decision|0|||
33485219|NCT04338269|101671290|FG000|Overall Study|Withdrawal by Subject|14|||
33485220|NCT04338269|101671291|FG001|Overall Study|Withdrawal by Subject|11|||
33485221|NCT01653912|101671292|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
33485222|NCT01653912|101671293|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
33485223|NCT01653912|101671294|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
33485224|NCT01653912|101671295|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
33485225|NCT01653912|101671296|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
33485226|NCT01653912|101671297|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
33485227|NCT01653912|101671292|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
33485228|NCT01653912|101671293|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
33485229|NCT01653912|101671294|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
33485230|NCT01653912|101671295|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
33485231|NCT01653912|101671296|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
33485232|NCT01653912|101671297|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
33485233|NCT01653912|101671292|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
33485234|NCT01653912|101671293|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
33485235|NCT01653912|101671294|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
33485236|NCT01653912|101671295|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
33485237|NCT01653912|101671296|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
33485238|NCT01653912|101671297|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
33485239|NCT01653912|101671292|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
33485240|NCT01653912|101671293|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
33485241|NCT01653912|101671294|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
33485242|NCT01653912|101671295|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
33485243|NCT01653912|101671296|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
33485244|NCT01653912|101671297|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
33485245|NCT01653912|101671292|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
33485246|NCT01653912|101671293|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
33485247|NCT01653912|101671294|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
33485248|NCT01653912|101671295|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
33485249|NCT01653912|101671296|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
33485250|NCT01653912|101671297|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
33485251|NCT01653912|101671292|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
33485252|NCT01653912|101671293|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
33485253|NCT01653912|101671294|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
33485254|NCT01653912|101671295|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
33485255|NCT01653912|101671296|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
33485256|NCT01653912|101671297|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
33485257|NCT01653912|101671292|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
33485258|NCT01653912|101671293|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
33485259|NCT01653912|101671294|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
33485260|NCT01653912|101671295|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
33485261|NCT01653912|101671296|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
33485262|NCT01653912|101671297|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
33485263|NCT00230178|101671298|FG000|Overall Study|Adverse Event|1|||
33485264|NCT00230178|101671299|FG001|Overall Study|Adverse Event|5|||
33485265|NCT00230178|101671300|FG002|Overall Study|Adverse Event|2|||
33485266|NCT00230178|101671298|FG000|Overall Study|Withdrawal by Subject|0|||
33485267|NCT00230178|101671299|FG001|Overall Study|Withdrawal by Subject|0|||
33485268|NCT00230178|101671300|FG002|Overall Study|Withdrawal by Subject|1|||
33485269|NCT00230178|101671298|FG000|Overall Study|Various other reasons|3|||
33485270|NCT00230178|101671299|FG001|Overall Study|Various other reasons|2|||
33485271|NCT00230178|101671300|FG002|Overall Study|Various other reasons|4|||
33485272|NCT00920790|101671301|FG000|Overall Study|aggravation of general condition|14|||
33485273|NCT02439970|101671302|FG000|Overall Study|Study Terminated|2|||
33485274|NCT02439970|101671303|FG001|Overall Study|Study Terminated|3|||
33485275|NCT03907878|101671306|FG000|Treatment Period|Withdrawal by Subject|5|||
33485276|NCT03907878|101671306|FG000|Treatment Period|Adverse Event|4|||
33485277|NCT03907878|101671306|FG000|Treatment Period|Lack of Efficacy|1|||
33485278|NCT03907878|101671306|FG000|Treatment Period|Protocol Violation|1|||
33485279|NCT03907878|101671306|FG000|Follow-up Period|Adverse Event|3|||
33485280|NCT03907878|101671306|FG000|Follow-up Period|Withdrawal by Subject|3|||
33485281|NCT02886624|101671307|FG000|12-week Post Treatment Follow-up|Death|1|||
33485282|NCT02886624|101671307|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
33485283|NCT00306995|101671310|FG000|Study Part I|Withdrawal by Subject|0|||
33485284|NCT00306995|101671311|FG001|Study Part I|Withdrawal by Subject|0|||
33485285|NCT00306995|101671312|FG002|Study Part I|Withdrawal by Subject|0|||
33485286|NCT00306995|101671313|FG003|Study Part I|Withdrawal by Subject|0|||
33485287|NCT00306995|101671314|FG004|Study Part I|Withdrawal by Subject|0|||
33485288|NCT00306995|101671315|FG005|Study Part I|Withdrawal by Subject|0|||
33485289|NCT00306995|101671316|FG006|Study Part I|Withdrawal by Subject|1|||
33485290|NCT00306995|101671310|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
33485291|NCT00306995|101671311|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
33485292|NCT00306995|101671312|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
33485293|NCT00306995|101671313|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
33485294|NCT00306995|101671314|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
33485295|NCT00306995|101671315|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
33485296|NCT00306995|101671316|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
33485297|NCT00998309|101671322|FG000|Overall Study|Protocol Violation|4|||
33485298|NCT00474266|101671323|FG000|Overall Study|Withdrawal by Subject|7|||
33485299|NCT00474266|101671324|FG001|Overall Study|Withdrawal by Subject|20|||
33485300|NCT00474266|101671325|FG002|Overall Study|Withdrawal by Subject|4|||
33485301|NCT00474266|101671326|FG003|Overall Study|Withdrawal by Subject|7|||
33485302|NCT00901576|101671327|FG000|Second Intervention|Withdrawal by Subject|0|||
33485303|NCT00901576|101671328|FG001|Second Intervention|Withdrawal by Subject|0|||
33485304|NCT00901576|101671329|FG002|Second Intervention|Withdrawal by Subject|0|||
33485305|NCT00901576|101671330|FG003|Second Intervention|Withdrawal by Subject|1|||
33485306|NCT00901576|101671331|FG004|Second Intervention|Withdrawal by Subject|0|||
33485307|NCT00901576|101671332|FG005|Second Intervention|Withdrawal by Subject|1|||
33485308|NCT00901576|101671327|FG000|Second Intervention|Physician Decision|1|||
33485309|NCT00901576|101671328|FG001|Second Intervention|Physician Decision|0|||
33485310|NCT00901576|101671329|FG002|Second Intervention|Physician Decision|0|||
33485311|NCT00901576|101671330|FG003|Second Intervention|Physician Decision|0|||
33485312|NCT00901576|101671331|FG004|Second Intervention|Physician Decision|0|||
33485313|NCT00901576|101671332|FG005|Second Intervention|Physician Decision|0|||
33485314|NCT05478252|101671333|FG000|Overall Study|Withdrawal by Subject|2|||
33485315|NCT05478252|101671334|FG001|Overall Study|Withdrawal by Subject|3|||
33485316|NCT05478252|101671333|FG000|Overall Study|Lost to Follow-up|4|||
33485317|NCT05478252|101671334|FG001|Overall Study|Lost to Follow-up|2|||
33485318|NCT05478252|101671333|FG000|Overall Study|Physician Decision|1|||
33485319|NCT05478252|101671334|FG001|Overall Study|Physician Decision|1|||
33485320|NCT05478252|101671333|FG000|Overall Study|Death|1|||
33485321|NCT05478252|101671334|FG001|Overall Study|Death|0|||
33485322|NCT02290223|101671335|FG000|6 Months|Lost to Follow-up|9|||
33485323|NCT02290223|101671336|FG001|6 Months|Lost to Follow-up|6|||
33485324|NCT02290223|101671335|FG000|6 Months|Withdrawal by Subject|5|||
33485325|NCT02290223|101671336|FG001|6 Months|Withdrawal by Subject|0|||
33485326|NCT02290223|101671335|FG000|6 Months|deceased (not related to study)|2|||
33485327|NCT02290223|101671336|FG001|6 Months|deceased (not related to study)|0|||
33485328|NCT02290223|101671335|FG000|12 Months|Lost to Follow-up|16|||
33485329|NCT02290223|101671336|FG001|12 Months|Lost to Follow-up|10|||
33485330|NCT02290223|101671335|FG000|12 Months|Refusal|0|||
33485331|NCT02290223|101671336|FG001|12 Months|Refusal|1|||
33485332|NCT00478244|101671344|FG000|Overall Study|Did not receive transplant|1|||
33485333|NCT01590797|101671345|FG000|Overall Study|Adverse Event|4|||
33485334|NCT01590797|101671346|FG001|Overall Study|Adverse Event|3|||
33485335|NCT01590797|101671345|FG000|Overall Study|Lack of Efficacy|0|||
33485336|NCT01590797|101671346|FG001|Overall Study|Lack of Efficacy|2|||
33485337|NCT01590797|101671345|FG000|Overall Study|Lost to Follow-up|0|||
33485338|NCT01590797|101671346|FG001|Overall Study|Lost to Follow-up|1|||
33485339|NCT01590797|101671345|FG000|Overall Study|Protocol Violation|4|||
33485340|NCT01590797|101671346|FG001|Overall Study|Protocol Violation|1|||
33485341|NCT01590797|101671345|FG000|Overall Study|Withdrawal by Subject|7|||
33485342|NCT01590797|101671346|FG001|Overall Study|Withdrawal by Subject|5|||
33485343|NCT01590797|101671345|FG000|Overall Study|Other Protocol Specified Criteria|2|||
33485344|NCT01590797|101671346|FG001|Overall Study|Other Protocol Specified Criteria|4|||
33485345|NCT00101283|101671347|FG000|Overall Study|Withdrawal by Subject|0|||
33485346|NCT00101283|101671348|FG001|Overall Study|Withdrawal by Subject|1|||
33485347|NCT00101283|101671347|FG000|Overall Study|Insurance Refusal|0|||
33485348|NCT00101283|101671348|FG001|Overall Study|Insurance Refusal|1|||
33485349|NCT00101283|101671347|FG000|Overall Study|Prostate Cancer Recurrence|0|||
33485350|NCT00101283|101671348|FG001|Overall Study|Prostate Cancer Recurrence|1|||
33485351|NCT03336528|101671349|FG000|Overall Study|Protocol Violation|1|||
33485352|NCT03336528|101671350|FG001|Overall Study|Protocol Violation|1|||
33485353|NCT03336528|101671349|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
33277249|NCT01014013|100909070|FG001|Overall Study|Appendectomy|0|||
33277250|NCT01014013|100909069|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
33277251|NCT01014013|100909070|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
33277252|NCT02163499|100909072|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
33277253|NCT02163499|100909072|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
33277254|NCT02163499|100909072|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
33277255|NCT02163499|100909072|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
33277256|NCT02163499|100909072|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
33277257|NCT02163499|100909072|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
33277258|NCT02163499|100909072|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
33277259|NCT02163499|100909072|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
33277260|NCT02163499|100909072|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
33277261|NCT02163499|100909072|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
33277262|NCT02163499|100909072|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
33277263|NCT02163499|100909072|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
33277264|NCT02163499|100909072|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
33277265|NCT02163499|100909072|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
33277266|NCT02163499|100909072|FG000|Extended Dosing Phase: ZS|Death|8|||
33277267|NCT02163499|100909072|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
33277268|NCT02163499|100909072|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
33277269|NCT02163499|100909072|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
33277270|NCT00170950|100909073|FG000|Overall Study|Death|236|||
33277271|NCT00170950|100909074|FG001|Overall Study|Death|274|||
33277272|NCT00170950|100909073|FG000|Overall Study|Withdrawal by Subject|496|||
33277273|NCT00170950|100909074|FG001|Overall Study|Withdrawal by Subject|498|||
33277274|NCT00170950|100909073|FG000|Overall Study|Lost to Follow-up|134|||
33277275|NCT00170950|100909074|FG001|Overall Study|Lost to Follow-up|115|||
33277276|NCT00170950|100909073|FG000|Overall Study|Missing|2|||
33485354|NCT03336528|101671350|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
33485355|NCT03336528|101671349|FG000|Overall Study|Did not receive study medication|1|||
33485356|NCT03336528|101671350|FG001|Overall Study|Did not receive study medication|2|||
33277277|NCT00170950|100909074|FG001|Overall Study|Missing|1|||
33277278|NCT00170950|100909073|FG000|Overall Study|Termination Data Not Recorded|17|||
33277279|NCT00170950|100909074|FG001|Overall Study|Termination Data Not Recorded|22|||
33277280|NCT04736602|100909075|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
33277281|NCT04736602|100909075|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
33277282|NCT00447499|100909080|FG000|Overall Study|Adverse Event|1|||
33277283|NCT00447499|100909080|FG000|Overall Study|Patient Decision|4|||
33485357|NCT03447743|101671351|FG000|Overall Study|Withdrawal by Subject|2|||
33485358|NCT03447743|101671351|FG000|Overall Study|Lost to Follow-up|3|||
33485359|NCT03447743|101671351|FG000|Overall Study|Adverse Event|1|||
33485360|NCT03447743|101671351|FG000|Overall Study|Did not meet criteria to continue|1|||
33485361|NCT00314951|101671352|FG000|Treatment|Didn't meet criteria for mITT population|16|||
33485362|NCT00314951|101671353|FG001|Treatment|Didn't meet criteria for mITT population|11|||
33485363|NCT00314951|101671352|FG000|Follow-up|mITT failure|44|||
33485364|NCT00314951|101671353|FG001|Follow-up|mITT failure|34|||
33485365|NCT04868500|101671358|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
33485366|NCT04868500|101671359|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
33485367|NCT04868500|101671358|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
33485368|NCT04868500|101671359|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
33485369|NCT04807400|101671363|FG000|Overall Study|Adverse Event|2|||
33485370|NCT04807400|101671364|FG001|Overall Study|Adverse Event|3|||
33277284|NCT00447499|100909080|FG000|Overall Study|Sponsor Decision|1|||
33277285|NCT00447499|100909080|FG000|Overall Study|Physician Decision|1|||
33277286|NCT04908800|100909085|FG000|Overall Study|Adverse Event|0|||
33277287|NCT04908800|100909086|FG001|Overall Study|Adverse Event|0|||
33277288|NCT04908800|100909087|FG002|Overall Study|Adverse Event|0|||
33277289|NCT04908800|100909088|FG003|Overall Study|Adverse Event|0|||
33277290|NCT04908800|100909089|FG004|Overall Study|Adverse Event|0|||
33277291|NCT04908800|100909090|FG005|Overall Study|Adverse Event|0|||
33277292|NCT04908800|100909091|FG006|Overall Study|Adverse Event|0|||
33277293|NCT04908800|100909092|FG007|Overall Study|Adverse Event|0|||
33277294|NCT04908800|100909093|FG008|Overall Study|Adverse Event|0|||
33485371|NCT04807400|101671365|FG002|Overall Study|Adverse Event|3|||
33485372|NCT04807400|101671363|FG000|Overall Study|Death|2|||
33485373|NCT04807400|101671364|FG001|Overall Study|Death|0|||
33485374|NCT04807400|101671365|FG002|Overall Study|Death|0|||
33485375|NCT04807400|101671363|FG000|Overall Study|Lost to Follow-up|8|||
33485376|NCT04807400|101671364|FG001|Overall Study|Lost to Follow-up|6|||
33485377|NCT04807400|101671365|FG002|Overall Study|Lost to Follow-up|6|||
33485378|NCT04807400|101671363|FG000|Overall Study|Non-Compliance With Study Drug|0|||
33485379|NCT04807400|101671364|FG001|Overall Study|Non-Compliance With Study Drug|4|||
33485380|NCT04807400|101671365|FG002|Overall Study|Non-Compliance With Study Drug|1|||
33485381|NCT04807400|101671363|FG000|Overall Study|Participant Decision|20|||
33485382|NCT04807400|101671364|FG001|Overall Study|Participant Decision|19|||
33485383|NCT04807400|101671365|FG002|Overall Study|Participant Decision|26|||
33485384|NCT04807400|101671363|FG000|Overall Study|Physician Decision|0|||
33485385|NCT04807400|101671364|FG001|Overall Study|Physician Decision|1|||
33485386|NCT04807400|101671365|FG002|Overall Study|Physician Decision|0|||
33485387|NCT04807400|101671363|FG000|Overall Study|Protocol Violation|4|||
33485388|NCT04807400|101671364|FG001|Overall Study|Protocol Violation|3|||
33485389|NCT04807400|101671365|FG002|Overall Study|Protocol Violation|7|||
33485390|NCT04807400|101671363|FG000|Overall Study|Withdrawal by Subject|13|||
33485391|NCT04807400|101671364|FG001|Overall Study|Withdrawal by Subject|9|||
33485392|NCT04807400|101671365|FG002|Overall Study|Withdrawal by Subject|20|||
33485393|NCT04807400|101671363|FG000|Overall Study|Mis-randomized|1|||
33485394|NCT04807400|101671364|FG001|Overall Study|Mis-randomized|0|||
33485395|NCT04807400|101671365|FG002|Overall Study|Mis-randomized|0|||
33485396|NCT00633243|101671368|FG000|Overall Study|Withdrawal by Subject|0|||
33485397|NCT00633243|101671369|FG001|Overall Study|Withdrawal by Subject|1|||
33485398|NCT00633243|101671368|FG000|Overall Study|incarceration|0|||
33485399|NCT00633243|101671369|FG001|Overall Study|incarceration|2|||
33485400|NCT00633243|101671368|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
33485401|NCT00633243|101671369|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
33485402|NCT00633243|101671368|FG000|Overall Study|Not comfortable with self-injecting|0|||
33485403|NCT00633243|101671369|FG001|Overall Study|Not comfortable with self-injecting|1|||
33485404|NCT00633243|101671368|FG000|Overall Study|Mental Health--Depression|0|||
33485405|NCT00633243|101671369|FG001|Overall Study|Mental Health--Depression|1|||
33485406|NCT00633243|101671368|FG000|Overall Study|Couldn't tolerate side-effects|1|||
33485407|NCT00633243|101671369|FG001|Overall Study|Couldn't tolerate side-effects|1|||
33485408|NCT01632280|101671371|FG000|Overall Study|Withdrawal by Subject|1|||
33485409|NCT01632280|101671372|FG001|Overall Study|Withdrawal by Subject|0|||
33485410|NCT02862730|101671373|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
33485411|NCT02862730|101671374|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
33485412|NCT02862730|101671375|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
33485413|NCT02862730|101671376|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
33485414|NCT02862730|101671377|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
33485415|NCT02862730|101671378|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
33485416|NCT02862730|101671379|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
33485417|NCT02862730|101671373|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
33485418|NCT02862730|101671374|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
33485419|NCT02862730|101671375|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
33277295|NCT04908800|100909094|FG009|Overall Study|Adverse Event|0|||
33277296|NCT04908800|100909095|FG010|Overall Study|Adverse Event|1|||
33485420|NCT02862730|101671376|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
33485421|NCT02862730|101671377|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
33277297|NCT04908800|100909096|FG011|Overall Study|Adverse Event|0|||
33277298|NCT04908800|100909097|FG012|Overall Study|Adverse Event|0|||
33277299|NCT02511106|100909098|FG000|Overall Study|Lost to Follow-up|6|||
33277300|NCT02511106|100909099|FG001|Overall Study|Lost to Follow-up|4|||
33277301|NCT02511106|100909098|FG000|Overall Study|Withdrawal by Subject|24|||
33277302|NCT02511106|100909099|FG001|Overall Study|Withdrawal by Subject|21|||
33485422|NCT02862730|101671378|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
33485423|NCT02862730|101671379|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
33485424|NCT02862730|101671373|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
33485425|NCT02862730|101671374|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
33485426|NCT02862730|101671375|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
33485427|NCT02862730|101671376|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
33485428|NCT02862730|101671377|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
33485429|NCT02862730|101671378|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
33485430|NCT02862730|101671379|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
33485431|NCT02862730|101671373|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
33485432|NCT02862730|101671374|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
33485433|NCT02862730|101671375|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
33485434|NCT02862730|101671376|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
33485435|NCT02862730|101671377|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
33485436|NCT02862730|101671378|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
33485437|NCT02862730|101671379|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
33485438|NCT04005352|101671380|FG000|Overall Study|Adverse Event|4|||
33485439|NCT04005352|101671381|FG001|Overall Study|Adverse Event|5|||
33485440|NCT04005352|101671380|FG000|Overall Study|Death|4|||
33485441|NCT04005352|101671381|FG001|Overall Study|Death|2|||
33485442|NCT04005352|101671380|FG000|Overall Study|Lost to Follow-up|6|||
33485443|NCT04005352|101671381|FG001|Overall Study|Lost to Follow-up|2|||
33485444|NCT04005352|101671380|FG000|Overall Study|Physician Decision|7|||
33485445|NCT04005352|101671381|FG001|Overall Study|Physician Decision|13|||
33485446|NCT04005352|101671380|FG000|Overall Study|Protocol Violation|0|||
33485447|NCT04005352|101671381|FG001|Overall Study|Protocol Violation|1|||
33485448|NCT04005352|101671380|FG000|Overall Study|Withdrawal by Subject|28|||
33485449|NCT04005352|101671381|FG001|Overall Study|Withdrawal by Subject|38|||
33485450|NCT03016975|101671382|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
33485451|NCT03016975|101671383|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
33485452|NCT03016975|101671384|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
33485453|NCT03016975|101671382|FG000|At 6 Months Follow-up|Death|2|||
33485454|NCT03016975|101671383|FG001|At 6 Months Follow-up|Death|0|||
33485455|NCT03016975|101671384|FG002|At 6 Months Follow-up|Death|0|||
33485456|NCT03016975|101671382|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
33485457|NCT03016975|101671383|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
33485458|NCT03016975|101671384|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
33485459|NCT03016975|101671382|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
33485460|NCT03016975|101671383|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
33485461|NCT03016975|101671384|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
33485462|NCT03016975|101671382|FG000|At 6 Months Follow-up|Aborted implant|1|||
33485463|NCT03016975|101671383|FG001|At 6 Months Follow-up|Aborted implant|0|||
33485464|NCT03016975|101671384|FG002|At 6 Months Follow-up|Aborted implant|0|||
33277303|NCT02511106|100909098|FG000|Overall Study|Death|42|||
33277304|NCT02511106|100909099|FG001|Overall Study|Death|82|||
33277305|NCT02511106|100909098|FG000|Overall Study|Ongoing study at data cut-off|3|||
33277306|NCT02511106|100909099|FG001|Overall Study|Ongoing study at data cut-off|2|||
33277307|NCT02511106|100909098|FG000|Overall Study|Without specified reason|3|||
33277308|NCT02511106|100909099|FG001|Overall Study|Without specified reason|0|||
33277309|NCT02038803|100909102|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
33277310|NCT02038803|100909102|FG000|Overall Study|Lost to Follow-up|1|||
33277311|NCT02522299|100909103|FG000|Overall Study|Adverse Event|2|||
33277312|NCT02522299|100909104|FG001|Overall Study|Adverse Event|0|||
33277313|NCT02522299|100909103|FG000|Overall Study|Physician Decision|0|||
33277314|NCT02522299|100909104|FG001|Overall Study|Physician Decision|1|||
33277315|NCT02522299|100909103|FG000|Overall Study|Withdrawal by Subject|2|||
33277316|NCT02522299|100909104|FG001|Overall Study|Withdrawal by Subject|0|||
33277317|NCT01078571|100909106|FG000|Overall Study|Adverse Event|36|||
33485465|NCT03016975|101671382|FG000|At 2 Year Follow-up|Death|1|||
33485466|NCT03016975|101671383|FG001|At 2 Year Follow-up|Death|0|||
33485467|NCT03016975|101671384|FG002|At 2 Year Follow-up|Death|0|||
33485468|NCT03016975|101671382|FG000|At 3 Year Follow-up|Death|1|||
33485469|NCT03016975|101671383|FG001|At 3 Year Follow-up|Death|0|||
33277318|NCT01078571|100909106|FG000|Overall Study|Lack of effectiveness|36|||
33277319|NCT01078571|100909106|FG000|Overall Study|Reason not reported|21|||
33277320|NCT01078571|100909106|FG000|Overall Study|Withdrawal by Subject|12|||
33277321|NCT01078571|100909106|FG000|Overall Study|Lost to Follow-up|8|||
33277322|NCT01078571|100909106|FG000|Overall Study|Protocol Violation|2|||
33277323|NCT01648699|100909107|FG000|Overall Study|Death|1|||
33277324|NCT01648699|100909107|FG000|Overall Study|Lost to Follow-up|2|||
33277325|NCT01648699|100909107|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
33485470|NCT03016975|101671384|FG002|At 3 Year Follow-up|Death|0|||
33485471|NCT03016975|101671382|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
33485472|NCT03016975|101671383|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
33485473|NCT03016975|101671384|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
33485474|NCT03016975|101671382|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
33485475|NCT03016975|101671383|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
33485476|NCT03016975|101671384|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
33485477|NCT01783886|101671385|FG000|Overall Study|Lost to Follow-up|0|||
33485478|NCT01783886|101671386|FG001|Overall Study|Lost to Follow-up|3|||
33485479|NCT01783886|101671387|FG002|Overall Study|Lost to Follow-up|0|||
33485480|NCT01783886|101671385|FG000|Overall Study|Protocol deviation|0|||
33485481|NCT01783886|101671386|FG001|Overall Study|Protocol deviation|0|||
33485482|NCT01783886|101671387|FG002|Overall Study|Protocol deviation|2|||
33485483|NCT01783886|101671385|FG000|Overall Study|Withdrawal of consent by participant|1|||
33485484|NCT01783886|101671386|FG001|Overall Study|Withdrawal of consent by participant|3|||
33485485|NCT01783886|101671387|FG002|Overall Study|Withdrawal of consent by participant|4|||
33485486|NCT01783886|101671385|FG000|Overall Study|Adverse Event|4|||
33485487|NCT01783886|101671386|FG001|Overall Study|Adverse Event|5|||
33485488|NCT01783886|101671387|FG002|Overall Study|Adverse Event|4|||
33485489|NCT00459043|101671388|FG000|Overall Study|Withdrawal by Subject|1|||
33485490|NCT00459043|101671389|FG001|Overall Study|Withdrawal by Subject|0|||
33485491|NCT01611857|101671392|FG000|Overall Study|Withdrawal by Subject|0|||
33485492|NCT01611857|101671393|FG001|Overall Study|Withdrawal by Subject|2|||
33485493|NCT02676765|101671394|FG000|Overall Study|Lost to Follow-up|0|||
33485494|NCT02676765|101671395|FG001|Overall Study|Lost to Follow-up|1|||
33485495|NCT01661062|101671396|FG000|Overall Study|Completed Treatment Off Study|3|||
33485496|NCT01661062|101671396|FG000|Overall Study|Withdrawal by Subject|2|||
33485497|NCT03765788|101671397|FG000|Overall Study|Subject decision|2|||
33485498|NCT03765788|101671398|FG001|Overall Study|Subject decision|3|||
33485499|NCT03765788|101671397|FG000|Overall Study|Physician Decision|2|||
33485500|NCT03765788|101671398|FG001|Overall Study|Physician Decision|4|||
33485501|NCT03765788|101671397|FG000|Overall Study|Death|0|||
33485502|NCT03765788|101671398|FG001|Overall Study|Death|1|||
33485503|NCT03765788|101671397|FG000|Overall Study|Lost to Follow-up|1|||
33485504|NCT03765788|101671398|FG001|Overall Study|Lost to Follow-up|0|||
33485505|NCT02694328|101671399|FG000|Overall Study|Adverse Event|27|||
33485506|NCT02694328|101671400|FG001|Overall Study|Adverse Event|33|||
33485507|NCT02694328|101671399|FG000|Overall Study|Withdrawal by Subject|27|||
33485508|NCT02694328|101671400|FG001|Overall Study|Withdrawal by Subject|23|||
33485509|NCT02694328|101671399|FG000|Overall Study|Lost to Follow-up|26|||
33485510|NCT02694328|101671400|FG001|Overall Study|Lost to Follow-up|22|||
33485511|NCT02694328|101671399|FG000|Overall Study|Noncompliant with study drug|11|||
33485512|NCT02694328|101671400|FG001|Overall Study|Noncompliant with study drug|8|||
33485513|NCT02694328|101671399|FG000|Overall Study|Incarceration|1|||
33485514|NCT02694328|101671400|FG001|Overall Study|Incarceration|1|||
33485515|NCT02694328|101671399|FG000|Overall Study|Lack of Efficacy|1|||
33485516|NCT02694328|101671400|FG001|Overall Study|Lack of Efficacy|2|||
33485517|NCT02694328|101671399|FG000|Overall Study|Pregnancy|1|||
33277326|NCT05487300|100909110|FG000|Overall Study|Withdrawal by Subject|1|||
33277327|NCT05487300|100909111|FG001|Overall Study|Withdrawal by Subject|0|||
33277328|NCT01525875|100909114|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
33277329|NCT01525875|100909115|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
33277330|NCT01525875|100909114|FG000|Open-label Period|Lost to Follow-up|0|||
33277331|NCT01525875|100909115|FG001|Open-label Period|Lost to Follow-up|2|||
33277332|NCT00087516|100911572|FG000|Overall Study|Adverse Event|10|||
33277333|NCT00087516|100911573|FG001|Overall Study|Adverse Event|10|||
33485518|NCT02694328|101671400|FG001|Overall Study|Pregnancy|1|||
33485519|NCT02694328|101671399|FG000|Overall Study|Protocol Violation|6|||
33485520|NCT02694328|101671400|FG001|Overall Study|Protocol Violation|5|||
33485521|NCT02694328|101671399|FG000|Overall Study|Abnormal Laboratory Value|0|||
33485522|NCT02694328|101671400|FG001|Overall Study|Abnormal Laboratory Value|3|||
33485523|NCT00696787|101671403|FG000|Overall Study|Adverse Event|1|||
33485524|NCT00696787|101671404|FG001|Overall Study|Adverse Event|0|||
33277334|NCT00087516|100911574|FG002|Overall Study|Adverse Event|3|||
33277335|NCT00087516|100911575|FG003|Overall Study|Adverse Event|6|||
33277336|NCT00087516|100911572|FG000|Overall Study|Lack of Efficacy|82|||
33485525|NCT00696787|101671405|FG002|Overall Study|Adverse Event|6|||
33485526|NCT00696787|101671403|FG000|Overall Study|Discontinuation by Sponsor|9|||
33485527|NCT00696787|101671404|FG001|Overall Study|Discontinuation by Sponsor|13|||
33277337|NCT00087516|100911573|FG001|Overall Study|Lack of Efficacy|80|||
33277338|NCT00087516|100911574|FG002|Overall Study|Lack of Efficacy|39|||
33277339|NCT00087516|100911575|FG003|Overall Study|Lack of Efficacy|29|||
33485528|NCT00696787|101671405|FG002|Overall Study|Discontinuation by Sponsor|14|||
33485529|NCT00696787|101671403|FG000|Overall Study|Lack of Efficacy|0|||
33485530|NCT00696787|101671404|FG001|Overall Study|Lack of Efficacy|1|||
33485531|NCT00696787|101671405|FG002|Overall Study|Lack of Efficacy|0|||
33485532|NCT00696787|101671403|FG000|Overall Study|Lost to Follow-up|4|||
33485533|NCT00696787|101671404|FG001|Overall Study|Lost to Follow-up|0|||
33485534|NCT00696787|101671405|FG002|Overall Study|Lost to Follow-up|3|||
33485535|NCT00696787|101671403|FG000|Overall Study|Withdrawal by Subject|0|||
33485536|NCT00696787|101671404|FG001|Overall Study|Withdrawal by Subject|3|||
33485537|NCT00696787|101671405|FG002|Overall Study|Withdrawal by Subject|2|||
33485538|NCT00696787|101671403|FG000|Overall Study|Failed to return|1|||
33485539|NCT00696787|101671404|FG001|Overall Study|Failed to return|3|||
33485540|NCT00696787|101671405|FG002|Overall Study|Failed to return|1|||
33485541|NCT01808573|101671408|FG000|Overall Study|Death|212|||
33485542|NCT01808573|101671409|FG001|Overall Study|Death|240|||
33485543|NCT01808573|101671408|FG000|Overall Study|Withdrawal by Subject|12|||
33485544|NCT01808573|101671409|FG001|Overall Study|Withdrawal by Subject|10|||
33485545|NCT01808573|101671408|FG000|Overall Study|Lost to Follow-up|3|||
33485546|NCT01808573|101671409|FG001|Overall Study|Lost to Follow-up|0|||
33485547|NCT01808573|101671408|FG000|Overall Study|Discontinuation of study by sponsor|79|||
33485548|NCT01808573|101671409|FG001|Overall Study|Discontinuation of study by sponsor|64|||
33485549|NCT01808573|101671408|FG000|Overall Study|Randomized in Error|1|||
33485550|NCT01808573|101671409|FG001|Overall Study|Randomized in Error|0|||
33485551|NCT01696279|101671412|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
33485552|NCT01696279|101671413|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
33485553|NCT01696279|101671414|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
33485554|NCT01696279|101671415|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
33485555|NCT01696279|101671412|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
33485556|NCT01696279|101671413|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
33485557|NCT01696279|101671414|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
33485558|NCT01696279|101671415|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
33485559|NCT01696279|101671412|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
33485560|NCT01696279|101671413|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
33485561|NCT01696279|101671414|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
33485562|NCT01696279|101671415|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
33485563|NCT01696279|101671412|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
33485564|NCT01696279|101671413|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
33485565|NCT01696279|101671414|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
33485566|NCT01696279|101671415|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
33485567|NCT01696279|101671412|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
33485568|NCT01696279|101671413|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
33485569|NCT01696279|101671414|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
33485570|NCT01696279|101671415|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
33485571|NCT01696279|101671412|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
33485572|NCT01696279|101671413|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
33485573|NCT01696279|101671414|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
33485574|NCT01696279|101671415|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
33485575|NCT01696279|101671412|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
33485576|NCT01696279|101671413|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
33485577|NCT01696279|101671414|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
33485578|NCT01696279|101671415|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
33485579|NCT01696279|101671412|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
33485580|NCT01696279|101671413|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
33485581|NCT01696279|101671414|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
33485582|NCT01696279|101671415|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
33485583|NCT01696279|101671412|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
33485584|NCT01696279|101671413|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
33485585|NCT01696279|101671414|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
33485586|NCT01696279|101671415|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
33485587|NCT01696279|101671412|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
33485588|NCT01696279|101671413|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
33485589|NCT01696279|101671414|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
33485590|NCT01696279|101671415|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
33485591|NCT01696279|101671412|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
33485592|NCT01696279|101671413|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
33485593|NCT01696279|101671414|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
33485594|NCT01696279|101671415|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
33485595|NCT05794503|101671417|FG000|Overall Study|Operation Cancelled|2|||
33485596|NCT05794503|101671418|FG001|Overall Study|Operation Cancelled|0|||
33485597|NCT05794503|101671417|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
33485598|NCT05794503|101671418|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
33485599|NCT05794503|101671417|FG000|Overall Study|Protocol Violation|1|||
33485600|NCT05794503|101671418|FG001|Overall Study|Protocol Violation|0|||
33485601|NCT03685344|101671422|FG000|Overall Study|Withdrawal by Subject|1|||
33485602|NCT03685344|101671423|FG001|Overall Study|Withdrawal by Subject|1|||
33485603|NCT03685344|101671424|FG002|Overall Study|Withdrawal by Subject|2|||
33485604|NCT03685344|101671425|FG003|Overall Study|Withdrawal by Subject|0|||
33485605|NCT03685344|101671422|FG000|Overall Study|Physician Decision|1|||
33485606|NCT03685344|101671423|FG001|Overall Study|Physician Decision|1|||
33485607|NCT03685344|101671424|FG002|Overall Study|Physician Decision|5|||
33485608|NCT03685344|101671425|FG003|Overall Study|Physician Decision|0|||
33485609|NCT03685344|101671422|FG000|Overall Study|Death|1|||
33485610|NCT03685344|101671423|FG001|Overall Study|Death|1|||
33485611|NCT03685344|101671424|FG002|Overall Study|Death|0|||
33485612|NCT03685344|101671425|FG003|Overall Study|Death|0|||
33485613|NCT04194645|101671431|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
33485614|NCT04194645|101671432|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
33485615|NCT04194645|101671433|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
33485616|NCT04194645|101671434|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
33485617|NCT04194645|101671435|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
33485618|NCT04194645|101671436|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
33485619|NCT04194645|101671437|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
33485620|NCT04194645|101671438|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
33485621|NCT04194645|101671439|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
33485622|NCT04194645|101671440|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
33485623|NCT04194645|101671441|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
33485624|NCT04194645|101671442|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
33485625|NCT04194645|101671443|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
33485626|NCT04194645|101671444|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
33485627|NCT04194645|101671445|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
33485628|NCT00534404|101671446|FG000|Overall Study|Death|0|||
33485629|NCT00534404|101671447|FG001|Overall Study|Death|0|||
33485630|NCT00534404|101671448|FG002|Overall Study|Death|2|||
33485631|NCT00534404|101671446|FG000|Overall Study|Withdrawal by Subject|8|||
33485632|NCT00534404|101671447|FG001|Overall Study|Withdrawal by Subject|2|||
33485633|NCT00534404|101671448|FG002|Overall Study|Withdrawal by Subject|38|||
33485634|NCT00534404|101671446|FG000|Overall Study|Removed by study staff|2|||
33485635|NCT00534404|101671447|FG001|Overall Study|Removed by study staff|3|||
33485636|NCT00534404|101671448|FG002|Overall Study|Removed by study staff|1|||
33485637|NCT00534404|101671446|FG000|Overall Study|Lost to Follow-up|170|||
33485638|NCT00534404|101671447|FG001|Overall Study|Lost to Follow-up|138|||
33485639|NCT00534404|101671448|FG002|Overall Study|Lost to Follow-up|201|||
33485640|NCT00996892|101671449|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
33485641|NCT00996892|101671450|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
33485642|NCT00996892|101671451|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
33485643|NCT00996892|101671452|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
33485644|NCT00996892|101671453|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
33485645|NCT00996892|101671454|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
33485646|NCT00996892|101671455|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
33485647|NCT00996892|101671456|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
33485648|NCT00996892|101671457|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
33485649|NCT00996892|101671458|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
33485650|NCT00996892|101671459|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
33485651|NCT00996892|101671460|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
33485652|NCT00996892|101671461|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
33485653|NCT00996892|101671462|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
33485654|NCT00996892|101671463|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
33485655|NCT00996892|101671464|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
33485656|NCT00996892|101671465|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
33485657|NCT00996892|101671466|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
33485658|NCT00996892|101671467|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
33485659|NCT00996892|101671468|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
33485660|NCT00996892|101671449|FG000|Dose-Escalation Stage 1|Death|1|||
33485661|NCT00996892|101671450|FG001|Dose-Escalation Stage 1|Death|0|||
33485662|NCT00996892|101671451|FG002|Dose-Escalation Stage 1|Death|0|||
33485663|NCT00996892|101671452|FG003|Dose-Escalation Stage 1|Death|0|||
33485664|NCT00996892|101671453|FG004|Dose-Escalation Stage 1|Death|0|||
33485665|NCT00996892|101671454|FG005|Dose-Escalation Stage 1|Death|1|||
33485666|NCT00996892|101671455|FG006|Dose-Escalation Stage 1|Death|0|||
33485667|NCT00996892|101671456|FG007|Dose-Escalation Stage 1|Death|0|||
33485668|NCT00996892|101671457|FG008|Dose-Escalation Stage 1|Death|0|||
33485669|NCT00996892|101671458|FG009|Dose-Escalation Stage 1|Death|0|||
33485670|NCT00996892|101671459|FG010|Dose-Escalation Stage 1|Death|0|||
33485671|NCT00996892|101671460|FG011|Dose-Escalation Stage 1|Death|0|||
33485672|NCT00996892|101671461|FG012|Dose-Escalation Stage 1|Death|0|||
33485673|NCT00996892|101671462|FG013|Dose-Escalation Stage 1|Death|0|||
33277340|NCT00087516|100911572|FG000|Overall Study|Lost to Follow-up|8|||
33485674|NCT00996892|101671463|FG014|Dose-Escalation Stage 1|Death|0|||
33485675|NCT00996892|101671464|FG015|Dose-Escalation Stage 1|Death|0|||
33485676|NCT00996892|101671465|FG016|Dose-Escalation Stage 1|Death|0|||
33485677|NCT00996892|101671466|FG017|Dose-Escalation Stage 1|Death|0|||
33485678|NCT00996892|101671467|FG018|Dose-Escalation Stage 1|Death|0|||
33485679|NCT00996892|101671468|FG019|Dose-Escalation Stage 1|Death|0|||
33485680|NCT00996892|101671449|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
33485681|NCT00996892|101671450|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
33485682|NCT00996892|101671451|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
33485683|NCT00996892|101671452|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
33485684|NCT00996892|101671453|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
33485685|NCT00996892|101671454|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
33485686|NCT00996892|101671455|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
33485687|NCT00996892|101671456|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
33485688|NCT00996892|101671457|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
33485689|NCT00996892|101671458|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
33485690|NCT00996892|101671459|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
33485691|NCT00996892|101671460|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
33485692|NCT00996892|101671461|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
33485693|NCT00996892|101671462|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
33485694|NCT00996892|101671463|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
33485695|NCT00996892|101671464|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
33485696|NCT00996892|101671465|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
33485697|NCT00996892|101671466|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
33485698|NCT00996892|101671467|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
33485699|NCT00996892|101671468|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
33485700|NCT00996892|101671449|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485701|NCT00996892|101671450|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
33485702|NCT00996892|101671451|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485703|NCT00996892|101671452|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
33485704|NCT00996892|101671453|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
33485705|NCT00996892|101671454|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
33485706|NCT00996892|101671455|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
33485707|NCT00996892|101671456|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485708|NCT00996892|101671457|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485709|NCT00996892|101671458|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485710|NCT00996892|101671459|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485711|NCT00996892|101671460|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485712|NCT00996892|101671461|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485713|NCT00996892|101671462|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485714|NCT00996892|101671463|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485715|NCT00996892|101671464|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485716|NCT00996892|101671465|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485717|NCT00996892|101671466|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485718|NCT00996892|101671467|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485719|NCT00996892|101671468|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
33485720|NCT00996892|101671449|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
33485721|NCT00996892|101671450|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
33485722|NCT00996892|101671451|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
33485723|NCT00996892|101671452|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
33485724|NCT00996892|101671453|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
33485725|NCT00996892|101671454|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
33485726|NCT00996892|101671455|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
33485727|NCT00996892|101671456|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
33485728|NCT00996892|101671457|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
33485729|NCT00996892|101671458|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
33485730|NCT00996892|101671459|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
33485731|NCT00996892|101671460|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
33485732|NCT00996892|101671461|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
33485733|NCT00996892|101671462|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
33277341|NCT00087516|100911573|FG001|Overall Study|Lost to Follow-up|6|||
33277342|NCT00087516|100911574|FG002|Overall Study|Lost to Follow-up|5|||
33277343|NCT00087516|100911575|FG003|Overall Study|Lost to Follow-up|5|||
33277344|NCT00087516|100911572|FG000|Overall Study|Protocol Violation|4|||
33277345|NCT00087516|100911573|FG001|Overall Study|Protocol Violation|8|||
33277346|NCT00087516|100911574|FG002|Overall Study|Protocol Violation|3|||
33277347|NCT00087516|100911575|FG003|Overall Study|Protocol Violation|6|||
33277348|NCT00087516|100911572|FG000|Overall Study|Withdrawal by Subject|16|||
33277349|NCT00087516|100911573|FG001|Overall Study|Withdrawal by Subject|27|||
33485734|NCT00996892|101671463|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
33485735|NCT00996892|101671464|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
33277350|NCT00087516|100911574|FG002|Overall Study|Withdrawal by Subject|11|||
33277351|NCT00087516|100911575|FG003|Overall Study|Withdrawal by Subject|12|||
33277352|NCT00087516|100911572|FG000|Overall Study|Site terminated|0|||
33277353|NCT00087516|100911573|FG001|Overall Study|Site terminated|2|||
33277354|NCT00087516|100911574|FG002|Overall Study|Site terminated|1|||
33277355|NCT00087516|100911575|FG003|Overall Study|Site terminated|0|||
33277356|NCT00087516|100911572|FG000|Overall Study|Protocol specified discontinuation|35|||
33277357|NCT00087516|100911573|FG001|Overall Study|Protocol specified discontinuation|33|||
33277358|NCT00087516|100911574|FG002|Overall Study|Protocol specified discontinuation|33|||
33277359|NCT00087516|100911575|FG003|Overall Study|Protocol specified discontinuation|26|||
33277360|NCT00087516|100911572|FG000|Overall Study|Patient moved|3|||
33277361|NCT00087516|100911573|FG001|Overall Study|Patient moved|2|||
33277362|NCT00087516|100911574|FG002|Overall Study|Patient moved|1|||
33277363|NCT00087516|100911575|FG003|Overall Study|Patient moved|0|||
33277364|NCT00087516|100911572|FG000|Overall Study|Patient was non-compliant|3|||
33277365|NCT00087516|100911573|FG001|Overall Study|Patient was non-compliant|1|||
33277366|NCT00087516|100911574|FG002|Overall Study|Patient was non-compliant|0|||
33277367|NCT00087516|100911575|FG003|Overall Study|Patient was non-compliant|0|||
33277368|NCT00087516|100911572|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
33277369|NCT00087516|100911573|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
33277370|NCT00087516|100911574|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
33277371|NCT00087516|100911575|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
33277372|NCT00087516|100911572|FG000|Overall Study|Other|0|||
33277373|NCT00087516|100911573|FG001|Overall Study|Other|0|||
33277374|NCT00087516|100911574|FG002|Overall Study|Other|1|||
33277375|NCT00087516|100911575|FG003|Overall Study|Other|0|||
33277376|NCT02588027|100911576|FG000|Overall Study|Withdrawal by Subject|1|||
33277377|NCT02588027|100911577|FG001|Overall Study|Withdrawal by Subject|3|||
33277378|NCT02588027|100911576|FG000|Overall Study|Protocol Violation|4|||
33277379|NCT02588027|100911577|FG001|Overall Study|Protocol Violation|1|||
33277380|NCT02011568|100911579|FG000|Overall Study|Withdrawal by Subject|8|||
33277381|NCT02011568|100911580|FG001|Overall Study|Withdrawal by Subject|10|||
33277382|NCT02011568|100911579|FG000|Overall Study|Physician Decision|1|||
33277383|NCT02011568|100911580|FG001|Overall Study|Physician Decision|3|||
33277384|NCT03672188|100911587|FG000|Overall Study|Withdrawal by Subject|0|||
33277385|NCT03672188|100911588|FG001|Overall Study|Withdrawal by Subject|0|||
33277386|NCT03672188|100911589|FG002|Overall Study|Withdrawal by Subject|0|||
33277387|NCT03672188|100911590|FG003|Overall Study|Withdrawal by Subject|3|||
33277388|NCT03672188|100911591|FG004|Overall Study|Withdrawal by Subject|0|||
33277389|NCT03672188|100911592|FG005|Overall Study|Withdrawal by Subject|0|||
33277390|NCT03672188|100911593|FG006|Overall Study|Withdrawal by Subject|0|||
33277391|NCT03672188|100911594|FG007|Overall Study|Withdrawal by Subject|0|||
33277392|NCT03672188|100911595|FG008|Overall Study|Withdrawal by Subject|0|||
33277393|NCT03672188|100911596|FG009|Overall Study|Withdrawal by Subject|0|||
33277394|NCT03672188|100911597|FG010|Overall Study|Withdrawal by Subject|0|||
33277395|NCT03672188|100911598|FG011|Overall Study|Withdrawal by Subject|0|||
33277396|NCT03672188|100911599|FG012|Overall Study|Withdrawal by Subject|0|||
33277397|NCT03672188|100911600|FG013|Overall Study|Withdrawal by Subject|0|||
33277398|NCT03672188|100911601|FG014|Overall Study|Withdrawal by Subject|0|||
33277399|NCT03672188|100911587|FG000|Overall Study|Death|0|||
33277400|NCT03672188|100911588|FG001|Overall Study|Death|0|||
33277401|NCT03672188|100911589|FG002|Overall Study|Death|0|||
33277402|NCT03672188|100911590|FG003|Overall Study|Death|0|||
33277403|NCT03672188|100911591|FG004|Overall Study|Death|0|||
33277404|NCT03672188|100911592|FG005|Overall Study|Death|0|||
33485736|NCT00996892|101671465|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
33485737|NCT00996892|101671466|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
33277405|NCT03672188|100911593|FG006|Overall Study|Death|0|||
33277406|NCT03672188|100911594|FG007|Overall Study|Death|0|||
33277407|NCT03672188|100911595|FG008|Overall Study|Death|0|||
33277408|NCT03672188|100911596|FG009|Overall Study|Death|0|||
33277409|NCT03672188|100911597|FG010|Overall Study|Death|0|||
33277410|NCT03672188|100911598|FG011|Overall Study|Death|0|||
33277411|NCT03672188|100911599|FG012|Overall Study|Death|1|||
33277412|NCT03672188|100911600|FG013|Overall Study|Death|0|||
33277413|NCT03672188|100911601|FG014|Overall Study|Death|0|||
33277414|NCT03672188|100911587|FG000|Overall Study|Lost to Follow-up|0|||
33277415|NCT03672188|100911588|FG001|Overall Study|Lost to Follow-up|0|||
33277416|NCT03672188|100911589|FG002|Overall Study|Lost to Follow-up|1|||
33277417|NCT03672188|100911590|FG003|Overall Study|Lost to Follow-up|0|||
33277418|NCT03672188|100911591|FG004|Overall Study|Lost to Follow-up|0|||
33277419|NCT03672188|100911592|FG005|Overall Study|Lost to Follow-up|0|||
33277420|NCT03672188|100911593|FG006|Overall Study|Lost to Follow-up|0|||
33277421|NCT03672188|100911594|FG007|Overall Study|Lost to Follow-up|0|||
33277422|NCT03672188|100911595|FG008|Overall Study|Lost to Follow-up|0|||
33277423|NCT03672188|100911596|FG009|Overall Study|Lost to Follow-up|0|||
33277424|NCT03672188|100911597|FG010|Overall Study|Lost to Follow-up|0|||
33277425|NCT03672188|100911598|FG011|Overall Study|Lost to Follow-up|0|||
33277426|NCT03672188|100911599|FG012|Overall Study|Lost to Follow-up|0|||
33277427|NCT03672188|100911600|FG013|Overall Study|Lost to Follow-up|0|||
33277428|NCT03672188|100911601|FG014|Overall Study|Lost to Follow-up|0|||
33277429|NCT00730925|100911606|FG000|Overall Study|Progressive Disease|21|||
33277430|NCT00730925|100911606|FG000|Overall Study|Dose reducing Event|2|||
33277431|NCT00730925|100911606|FG000|Overall Study|Other Averse Event|7|||
33277432|NCT00730925|100911606|FG000|Overall Study|Protocol Violation|1|||
33277433|NCT00730925|100911606|FG000|Overall Study|Withdrawal by Subject|1|||
33277434|NCT00730925|100911606|FG000|Overall Study|Switch to combination therapy|8|||
33277435|NCT00730925|100911606|FG000|Overall Study|Other|1|||
33277436|NCT02164578|100911609|FG000|Treatment Period|Withdrawal by Subject|3|||
33277437|NCT02164578|100911610|FG001|Treatment Period|Withdrawal by Subject|3|||
33277438|NCT02164578|100911609|FG000|Treatment Period|Adverse Event|13|||
33277439|NCT02164578|100911610|FG001|Treatment Period|Adverse Event|6|||
33277440|NCT02164578|100911609|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
33277441|NCT02164578|100911610|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
33277442|NCT02164578|100911609|FG000|Treatment Period|Protocol Violation|0|||
33277443|NCT02164578|100911610|FG001|Treatment Period|Protocol Violation|2|||
33277444|NCT02164578|100911609|FG000|Extension Period|Withdrawal by Subject|2|||
33277445|NCT02164578|100911610|FG001|Extension Period|Withdrawal by Subject|0|||
33277446|NCT02164578|100911609|FG000|Extension Period|Adverse Event|4|||
33277447|NCT02164578|100911610|FG001|Extension Period|Adverse Event|0|||
33277448|NCT02164578|100911609|FG000|Extension Period|Expiry of study medication|1|||
33277449|NCT02164578|100911610|FG001|Extension Period|Expiry of study medication|0|||
33277450|NCT02164578|100911609|FG000|Extension Period|Protocol Violation|0|||
33277451|NCT02164578|100911610|FG001|Extension Period|Protocol Violation|1|||
33277452|NCT04130061|100911611|FG000|Overall Study|OR team forgot to request membrane|1|||
33277453|NCT04130061|100911612|FG001|Overall Study|OR team forgot to request membrane|0|||
33277454|NCT03960437|100911613|FG000|Overall Study|Removed by PI|4|||
33277455|NCT03960437|100911613|FG000|Overall Study|Lost to Follow-up|2|||
33277456|NCT03960437|100911613|FG000|Overall Study|Withdrawal by Subject|1|||
33277457|NCT03960437|100911613|FG000|Overall Study|Death|2|||
33277458|NCT03647709|100911615|FG000|Overall Study|Lost to Follow-up|5|||
33277459|NCT03647709|100911615|FG000|Overall Study|Physician Decision|6|||
33277460|NCT03647709|100911615|FG000|Overall Study|Withdrawal by Subject|3|||
33277461|NCT02820298|100911618|FG000|Overall Study|Withdrawal by Subject|0|||
33277462|NCT02820298|100911619|FG001|Overall Study|Withdrawal by Subject|1|||
33277463|NCT02820298|100911618|FG000|Overall Study|Physician Decision|1|||
33277464|NCT02820298|100911619|FG001|Overall Study|Physician Decision|0|||
33277465|NCT02820298|100911618|FG000|Overall Study|Protocol Violation|0|||
33277466|NCT02820298|100911619|FG001|Overall Study|Protocol Violation|1|||
33277467|NCT01021683|100911620|FG000|Overall Study|Lack of Efficacy|12|||
33277468|NCT01021683|100911620|FG000|Overall Study|Recovery of neutrophil count|51|||
33277469|NCT01021683|100911620|FG000|Overall Study|Other|8|||
33277470|NCT00050167|100911621|FG000|Overall Study|not eligible not invasive|1|||
33277471|NCT00050167|100911622|FG001|Overall Study|not eligible not invasive|1|||
33277472|NCT02282917|100911623|FG000|Overall Study|Withdrawal by Subject|1|||
33277473|NCT02282917|100911623|FG000|Overall Study|Screen Failure/Not Eligible|1|||
33277474|NCT02121808|100911626|FG000|Overall Study|Technical problem|3|||
33277475|NCT02152995|100911627|FG000|Overall Study|Withdrawal by Subject|1|||
33277476|NCT02152995|100911628|FG001|Overall Study|Withdrawal by Subject|0|||
33277477|NCT04150250|100911629|FG000|Overall Study|Lost to Follow-up|0|||
33277478|NCT04150250|100911630|FG001|Overall Study|Lost to Follow-up|2|||
33277479|NCT00070707|100911635|FG000|Overall Study|Adverse Event|1|||
33277480|NCT00070707|100911636|FG001|Overall Study|Adverse Event|2|||
33277481|NCT00070707|100911635|FG000|Overall Study|Lack of Efficacy|4|||
33277482|NCT00070707|100911636|FG001|Overall Study|Lack of Efficacy|1|||
33277483|NCT00070707|100911635|FG000|Overall Study|Protocol Violation|8|||
33277484|NCT00070707|100911636|FG001|Overall Study|Protocol Violation|4|||
33277485|NCT00070707|100911635|FG000|Overall Study|Unrelated to Study Medication|1|||
33277486|NCT00070707|100911636|FG001|Overall Study|Unrelated to Study Medication|0|||
33277487|NCT02335242|100911641|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
33277488|NCT02335242|100911642|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
33277489|NCT02335242|100911641|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
33277490|NCT02335242|100911642|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
33277491|NCT02335242|100911641|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
33277492|NCT02335242|100911642|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
33277493|NCT03733899|100911647|FG000|Period 1|Protocol Violation|0|||
33277494|NCT03733899|100911648|FG001|Period 1|Protocol Violation|0|||
33277495|NCT03733899|100911649|FG002|Period 1|Protocol Violation|0|||
33277496|NCT03733899|100911650|FG003|Period 1|Protocol Violation|0|||
33277497|NCT03733899|100911651|FG004|Period 1|Protocol Violation|0|||
33277498|NCT03733899|100911652|FG005|Period 1|Protocol Violation|1|||
33277499|NCT03733899|100911647|FG000|Period 2|Unscuccessful Treatment|0|||
33277500|NCT03733899|100911648|FG001|Period 2|Unscuccessful Treatment|1|||
33277501|NCT03733899|100911649|FG002|Period 2|Unscuccessful Treatment|0|||
33277502|NCT03733899|100911650|FG003|Period 2|Unscuccessful Treatment|0|||
33277503|NCT03733899|100911651|FG004|Period 2|Unscuccessful Treatment|0|||
33277504|NCT03733899|100911652|FG005|Period 2|Unscuccessful Treatment|0|||
33277505|NCT03733899|100911647|FG000|Period 3|Withdrawal by Subject|1|||
33277506|NCT03733899|100911648|FG001|Period 3|Withdrawal by Subject|0|||
33277507|NCT03733899|100911649|FG002|Period 3|Withdrawal by Subject|0|||
33277508|NCT03733899|100911650|FG003|Period 3|Withdrawal by Subject|0|||
33277509|NCT03733899|100911651|FG004|Period 3|Withdrawal by Subject|0|||
33277510|NCT03733899|100911652|FG005|Period 3|Withdrawal by Subject|0|||
33277511|NCT03749616|100911653|FG000|Overall Study|Lost to Follow-up|4|||
33277512|NCT03749616|100911654|FG001|Overall Study|Lost to Follow-up|7|||
33277513|NCT03749616|100911653|FG000|Overall Study|Screen Failure|1|||
33277514|NCT03749616|100911654|FG001|Overall Study|Screen Failure|1|||
33277515|NCT03749616|100911653|FG000|Overall Study|Withdrawal by Subject|2|||
33277516|NCT03749616|100911654|FG001|Overall Study|Withdrawal by Subject|0|||
33277517|NCT01945593|100911657|FG000|Overall Study|Adverse Event|0|||
33277518|NCT01945593|100911658|FG001|Overall Study|Adverse Event|0|||
33277519|NCT01945593|100911659|FG002|Overall Study|Adverse Event|0|||
33277520|NCT01945593|100911660|FG003|Overall Study|Adverse Event|5|||
33277521|NCT01945593|100911657|FG000|Overall Study|Physician Decision|0|||
33277522|NCT01945593|100911658|FG001|Overall Study|Physician Decision|0|||
33277523|NCT01945593|100911659|FG002|Overall Study|Physician Decision|1|||
33277524|NCT01945593|100911660|FG003|Overall Study|Physician Decision|1|||
33277525|NCT01945593|100911657|FG000|Overall Study|Withdrawal by Subject|0|||
33277526|NCT01945593|100911658|FG001|Overall Study|Withdrawal by Subject|2|||
33277527|NCT01945593|100911659|FG002|Overall Study|Withdrawal by Subject|0|||
33277528|NCT01945593|100911660|FG003|Overall Study|Withdrawal by Subject|4|||
33277529|NCT01945593|100911657|FG000|Overall Study|Protocol Violation|0|||
33277530|NCT01945593|100911658|FG001|Overall Study|Protocol Violation|2|||
33277531|NCT01945593|100911659|FG002|Overall Study|Protocol Violation|1|||
33277532|NCT01945593|100911660|FG003|Overall Study|Protocol Violation|3|||
33277533|NCT01945593|100911657|FG000|Overall Study|Death|0|||
33277534|NCT01945593|100911658|FG001|Overall Study|Death|0|||
33277535|NCT01945593|100911659|FG002|Overall Study|Death|1|||
33277536|NCT01945593|100911660|FG003|Overall Study|Death|0|||
33277537|NCT01945593|100911657|FG000|Overall Study|Other: Terminated|0|||
33277538|NCT01945593|100911658|FG001|Overall Study|Other: Terminated|0|||
33277539|NCT01945593|100911659|FG002|Overall Study|Other: Terminated|0|||
33277540|NCT01945593|100911660|FG003|Overall Study|Other: Terminated|1|||
33277541|NCT01945593|100911657|FG000|Overall Study|Other: Surgical Procedure|0|||
33277542|NCT01945593|100911658|FG001|Overall Study|Other: Surgical Procedure|2|||
33277543|NCT01945593|100911659|FG002|Overall Study|Other: Surgical Procedure|0|||
33277544|NCT01945593|100911660|FG003|Overall Study|Other: Surgical Procedure|6|||
33277545|NCT01945593|100911657|FG000|Overall Study|Other: Screen Failure|0|||
33277546|NCT01945593|100911658|FG001|Overall Study|Other: Screen Failure|2|||
33277547|NCT01945593|100911659|FG002|Overall Study|Other: Screen Failure|0|||
33277548|NCT01945593|100911660|FG003|Overall Study|Other: Screen Failure|0|||
33277549|NCT04267393|100911663|FG000|Randomization|Adverse Event|1|||
33277550|NCT04267393|100911664|FG001|Randomization|Adverse Event|0|||
33277551|NCT04267393|100911665|FG002|Randomization|Adverse Event|0|||
33277552|NCT04267393|100911663|FG000|Randomization|Administrative Reasons by Sponsor|0|||
33277553|NCT04267393|100911664|FG001|Randomization|Administrative Reasons by Sponsor|1|||
33277554|NCT04267393|100911665|FG002|Randomization|Administrative Reasons by Sponsor|0|||
33277555|NCT04267393|100911663|FG000|Treatment Period|Adverse Event|0|||
33277556|NCT04267393|100911664|FG001|Treatment Period|Adverse Event|2|||
33277557|NCT04267393|100911665|FG002|Treatment Period|Adverse Event|3|||
33277558|NCT04267393|100911663|FG000|Treatment Period|Participant Withdrew Consent|0|||
33277559|NCT04267393|100911664|FG001|Treatment Period|Participant Withdrew Consent|0|||
33277560|NCT04267393|100911665|FG002|Treatment Period|Participant Withdrew Consent|1|||
33277561|NCT04267393|100911663|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
33277562|NCT04267393|100911664|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
33277563|NCT04267393|100911665|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
33277564|NCT02418819|100911672|FG000|Overall Study|Adverse Event|0|||
33277565|NCT02418819|100911673|FG001|Overall Study|Adverse Event|0|||
33277566|NCT02418819|100911674|FG002|Overall Study|Adverse Event|1|||
33277567|NCT02418819|100911675|FG003|Overall Study|Adverse Event|0|||
33277568|NCT02418819|100911672|FG000|Overall Study|Lost to Follow-up|1|||
33277569|NCT02418819|100911673|FG001|Overall Study|Lost to Follow-up|0|||
33277570|NCT02418819|100911674|FG002|Overall Study|Lost to Follow-up|0|||
33277571|NCT02418819|100911675|FG003|Overall Study|Lost to Follow-up|0|||
33277572|NCT02418819|100911672|FG000|Overall Study|No longer meets eligibility criteria|0|||
33277573|NCT02418819|100911673|FG001|Overall Study|No longer meets eligibility criteria|0|||
33277574|NCT02418819|100911674|FG002|Overall Study|No longer meets eligibility criteria|1|||
33277575|NCT02418819|100911675|FG003|Overall Study|No longer meets eligibility criteria|0|||
33277576|NCT02418819|100911672|FG000|Overall Study|No longer willing to participate|0|||
33277577|NCT02418819|100911673|FG001|Overall Study|No longer willing to participate|0|||
33277578|NCT02418819|100911674|FG002|Overall Study|No longer willing to participate|2|||
33277579|NCT02418819|100911675|FG003|Overall Study|No longer willing to participate|1|||
33277580|NCT00919061|100911676|FG000|Overall Study|Adverse Event|1|||
33277581|NCT00919061|100911676|FG000|Overall Study|Withdrawal by Subject|1|||
33277582|NCT01268488|100911677|FG000|Overall Study|Adverse Event|3|||
33277583|NCT01268488|100911677|FG000|Overall Study|Physician Decision|2|||
33277584|NCT01148017|100911678|FG000|Overall Study|Withdrawal by Subject|31|||
33277585|NCT01148017|100911679|FG001|Overall Study|Withdrawal by Subject|14|||
33277586|NCT01148017|100911680|FG002|Overall Study|Withdrawal by Subject|0|||
33277587|NCT01148017|100911681|FG003|Overall Study|Withdrawal by Subject|0|||
33277588|NCT01148017|100911678|FG000|Overall Study|Lost to Follow-up|23|||
33277589|NCT01148017|100911679|FG001|Overall Study|Lost to Follow-up|10|||
33277590|NCT01148017|100911680|FG002|Overall Study|Lost to Follow-up|0|||
33277591|NCT01148017|100911681|FG003|Overall Study|Lost to Follow-up|0|||
33277592|NCT01148017|100911678|FG000|Overall Study|Inappropriate enrollment|1|||
33277593|NCT01148017|100911679|FG001|Overall Study|Inappropriate enrollment|0|||
33277594|NCT01148017|100911680|FG002|Overall Study|Inappropriate enrollment|0|||
33277595|NCT01148017|100911681|FG003|Overall Study|Inappropriate enrollment|0|||
33277596|NCT01148017|100911678|FG000|Overall Study|Administrative reason|22|||
33277597|NCT01148017|100911679|FG001|Overall Study|Administrative reason|9|||
33277598|NCT01148017|100911680|FG002|Overall Study|Administrative reason|0|||
33277599|NCT01148017|100911681|FG003|Overall Study|Administrative reason|0|||
33277600|NCT01148017|100911678|FG000|Overall Study|Unable to classify|3|||
33277601|NCT01148017|100911679|FG001|Overall Study|Unable to classify|1|||
33277602|NCT01148017|100911680|FG002|Overall Study|Unable to classify|0|||
33277603|NCT01148017|100911681|FG003|Overall Study|Unable to classify|0|||
33277604|NCT00308113|100911684|FG000|Overall Study|Protocol closure|0|||
33277605|NCT00308113|100911685|FG001|Overall Study|Protocol closure|0|||
33277606|NCT00308113|100911686|FG002|Overall Study|Protocol closure|0|||
33277607|NCT00308113|100911687|FG003|Overall Study|Protocol closure|1|||
33277608|NCT04435522|100911690|FG000|Overall Study|Withdrawal by Subject|2|||
33277609|NCT01876823|100911693|FG000|Overall Study|Withdrawal by Subject|5|||
33277610|NCT01876823|100911693|FG000|Overall Study|Physician Decision|2|||
33277611|NCT01876823|100911693|FG000|Overall Study|Patients moved|2|||
33277612|NCT01877720|100911694|FG000|Overall Study|Adverse Event|1|||
33277613|NCT01877720|100911695|FG001|Overall Study|Adverse Event|0|||
33277614|NCT02246647|100911699|FG000|Overall Study|Withdrawal by Subject|1|||
33277615|NCT02246647|100911700|FG001|Overall Study|Withdrawal by Subject|1|||
33277616|NCT04380688|100911701|FG000|Overall Study|Death|2|||
33277617|NCT04380688|100911702|FG001|Overall Study|Death|2|||
33277618|NCT04380688|100911701|FG000|Overall Study|Lost to Follow-up|2|||
33277619|NCT04380688|100911702|FG001|Overall Study|Lost to Follow-up|4|||
33277620|NCT04380688|100911701|FG000|Overall Study|Withdrawal by Subject|3|||
33277621|NCT04380688|100911702|FG001|Overall Study|Withdrawal by Subject|3|||
33277622|NCT04582864|100911703|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
33277623|NCT04582864|100911703|FG000|Overall Study|Death|1|||
33277624|NCT02379078|100911704|FG000|Overall Study|Lost to Follow-up|33|||
33277625|NCT02379078|100911705|FG001|Overall Study|Lost to Follow-up|30|||
33277626|NCT02379078|100911704|FG000|Overall Study|Withdrawal by Subject|6|||
33277627|NCT02379078|100911705|FG001|Overall Study|Withdrawal by Subject|5|||
33277628|NCT05878522|100911706|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
33277629|NCT05878522|100911707|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
33277630|NCT05878522|100911708|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
33277631|NCT05878522|100911709|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
33277632|NCT05878522|100911710|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
33277633|NCT05878522|100911711|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
33277634|NCT05878522|100911712|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
33277635|NCT05878522|100911713|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
33277636|NCT05878522|100911714|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
33277637|NCT05878522|100911715|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
33277638|NCT05878522|100911716|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
33277639|NCT05878522|100911717|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
33277640|NCT05878522|100911706|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
33277641|NCT05878522|100911707|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
33277642|NCT05878522|100911708|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
33277643|NCT05878522|100911709|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
33277644|NCT05878522|100911710|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
33277645|NCT05878522|100911711|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
33277646|NCT05878522|100911712|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
33277647|NCT05878522|100911713|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
33277648|NCT05878522|100911714|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
33277649|NCT05878522|100911715|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
33277650|NCT05878522|100911716|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
33277651|NCT05878522|100911717|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
33277652|NCT05878522|100911706|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
33277653|NCT05878522|100911707|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
33277654|NCT05878522|100911708|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
33277655|NCT05878522|100911709|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
33277656|NCT05878522|100911710|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
33277657|NCT05878522|100911711|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
33277658|NCT05878522|100911712|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
33277659|NCT05878522|100911713|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
33277660|NCT05878522|100911714|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
33277661|NCT05878522|100911715|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
33277662|NCT05878522|100911716|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
33277663|NCT05878522|100911717|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
33277664|NCT05878522|100911706|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
33277665|NCT05878522|100911707|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
33277666|NCT05878522|100911708|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
33277667|NCT05878522|100911709|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
33277668|NCT05878522|100911710|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
33277669|NCT05878522|100911711|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
33277670|NCT05878522|100911712|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
33277671|NCT05878522|100911713|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
33277672|NCT05878522|100911714|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
33277673|NCT05878522|100911715|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
33277674|NCT05878522|100911716|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
33277675|NCT05878522|100911717|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
33277676|NCT01023022|100911718|FG000|Overall Study|Death|5|||
33277677|NCT01023022|100911718|FG000|Overall Study|Lost to Follow-up|7|||
33277678|NCT01023022|100911718|FG000|Overall Study|due to technical issues|2|||
33277679|NCT05274906|100911719|FG000|Overall Study|Withdrawal by Subject|2|||
33277680|NCT05274906|100911720|FG001|Overall Study|Withdrawal by Subject|1|||
33277681|NCT01770509|100911721|FG000|Overall Study|Injury|0|||
33277682|NCT01770509|100911722|FG001|Overall Study|Injury|1|||
33277683|NCT01770509|100911721|FG000|Overall Study|Lost to Follow-up|1|||
33277684|NCT01770509|100911722|FG001|Overall Study|Lost to Follow-up|2|||
33277685|NCT05361304|100911723|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
33277686|NCT05361304|100911724|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
33277687|NCT05361304|100911723|FG000|Overall Study|COVID-19 Related|1|||
33277688|NCT05361304|100911724|FG001|Overall Study|COVID-19 Related|2|||
33277689|NCT05361304|100911723|FG000|Overall Study|Withdrawal by Subject|1|||
33277690|NCT05361304|100911724|FG001|Overall Study|Withdrawal by Subject|0|||
33277691|NCT00755716|100911729|FG000|Overall Study|Adverse Event|1|||
33277692|NCT00755716|100911730|FG001|Overall Study|Adverse Event|4|||
33277693|NCT00755716|100911731|FG002|Overall Study|Adverse Event|1|||
33277694|NCT00755716|100911729|FG000|Overall Study|Lack of Efficacy|2|||
33277695|NCT00755716|100911730|FG001|Overall Study|Lack of Efficacy|0|||
33277696|NCT00755716|100911731|FG002|Overall Study|Lack of Efficacy|0|||
33277697|NCT00755716|100911729|FG000|Overall Study|Lost to Follow-up|5|||
33277698|NCT00755716|100911730|FG001|Overall Study|Lost to Follow-up|3|||
33277699|NCT00755716|100911731|FG002|Overall Study|Lost to Follow-up|1|||
33277700|NCT00755716|100911729|FG000|Overall Study|work schedule issues|0|||
33277701|NCT00755716|100911730|FG001|Overall Study|work schedule issues|1|||
33277702|NCT00755716|100911731|FG002|Overall Study|work schedule issues|1|||
33277703|NCT01975701|100911735|FG000|Overall Study|Lost to Follow-up|1|||
33277704|NCT01975701|100911735|FG000|Overall Study|Death|23|||
33277705|NCT01975701|100911735|FG000|Overall Study|Physician Decision|1|||
33277706|NCT01655498|100911736|FG000|Overall Study|Unrelated health issue|2|||
33277707|NCT01655498|100911736|FG000|Overall Study|Protocol Violation|2|||
33277708|NCT01655498|100911736|FG000|Overall Study|Withdrawal by Subject|1|||
33277709|NCT01544153|100911737|FG000|Overall Study|Under 18|0|||
33277710|NCT01544153|100911738|FG001|Overall Study|Under 18|1|||
33277711|NCT01544153|100911739|FG002|Overall Study|Under 18|0|||
33277712|NCT01544153|100911740|FG003|Overall Study|Under 18|0|||
33277713|NCT01544153|100911737|FG000|Overall Study|Non-smoker|0|||
33277714|NCT01544153|100911738|FG001|Overall Study|Non-smoker|0|||
33277715|NCT01544153|100911739|FG002|Overall Study|Non-smoker|1|||
33277716|NCT01544153|100911740|FG003|Overall Study|Non-smoker|0|||
33277717|NCT03436797|100911741|FG000|Main Study|Withdrawal by Subject|2|||
33277718|NCT03436797|100911741|FG000|Main Study|Adverse Event|4|||
33277719|NCT03436797|100911741|FG000|Main Study|Lost to Follow-up|1|||
33277720|NCT03436797|100911741|FG000|Main Study|Death|1|||
33277721|NCT03436797|100911741|FG000|Main Study|Non-Specific|2|||
33277722|NCT03436797|100911741|FG000|Extended Dosing|Patient decision|1|||
33277723|NCT06016127|100911742|FG000|Overall Study|Withdrawal by Subject|4|||
33277724|NCT06016127|100911743|FG001|Overall Study|Withdrawal by Subject|3|||
33277725|NCT01863368|100911746|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
33277726|NCT01863368|100911747|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
33277727|NCT01863368|100911746|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
33277728|NCT01863368|100911747|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
33277729|NCT01863368|100911746|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
33277730|NCT01863368|100911747|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
33277731|NCT01863368|100911746|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
33277732|NCT01863368|100911747|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
33277733|NCT01863368|100911746|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
33277734|NCT01863368|100911747|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
33277735|NCT01863368|100911746|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
33277736|NCT01863368|100911747|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
33277737|NCT01654289|100911749|FG000|Overall Study|Withdrawal by Subject|10|||
33277738|NCT01654289|100911750|FG001|Overall Study|Withdrawal by Subject|8|||
33277739|NCT01654289|100911751|FG002|Overall Study|Withdrawal by Subject|5|||
33277740|NCT01654289|100911749|FG000|Overall Study|Withdrew from intervention only|17|||
33277741|NCT01654289|100911750|FG001|Overall Study|Withdrew from intervention only|20|||
33277742|NCT01654289|100911751|FG002|Overall Study|Withdrew from intervention only|0|||
33277743|NCT01536795|100911754|FG000|Overall Study|Lost to Follow-up|0|||
33277744|NCT01536795|100911755|FG001|Overall Study|Lost to Follow-up|2|||
33277745|NCT01536795|100911754|FG000|Overall Study|Lack of Efficacy|1|||
33277746|NCT01536795|100911755|FG001|Overall Study|Lack of Efficacy|0|||
33277747|NCT00676663|100911756|FG000|Overall Study|Death|43|||
33277748|NCT00676663|100911757|FG001|Overall Study|Death|27|||
33277749|NCT00676663|100911756|FG000|Overall Study|Withdrew Consent|1|||
33277750|NCT00676663|100911757|FG001|Overall Study|Withdrew Consent|8|||
33277751|NCT00676663|100911756|FG000|Overall Study|Lost to Follow-up|1|||
33277752|NCT00676663|100911757|FG001|Overall Study|Lost to Follow-up|3|||
33277753|NCT00930644|100911758|FG000|Overall Study|Withdrawal by Subject|4|||
33277754|NCT00930644|100911758|FG000|Overall Study|Physician Decision|2|||
33277755|NCT00930644|100911758|FG000|Overall Study|Death|1|||
33277756|NCT00930644|100911758|FG000|Overall Study|Adverse Event|16|||
33277757|NCT03120949|100911762|FG000|Overall Study|randomized in error|1|||
33277758|NCT03120949|100911763|FG001|Overall Study|randomized in error|0|||
33277759|NCT03120949|100911762|FG000|Overall Study|Death|13|||
33277760|NCT03120949|100911763|FG001|Overall Study|Death|13|||
33277761|NCT03120949|100911762|FG000|Overall Study|Lost to Follow-up|23|||
33277762|NCT03120949|100911763|FG001|Overall Study|Lost to Follow-up|13|||
33277763|NCT03120949|100911762|FG000|Overall Study|Withdrawal by Subject|139|||
33277764|NCT03120949|100911763|FG001|Overall Study|Withdrawal by Subject|124|||
33277765|NCT03120949|100911762|FG000|Overall Study|Covid-19|43|||
33277766|NCT03120949|100911763|FG001|Overall Study|Covid-19|34|||
33277767|NCT03120949|100911762|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
33277768|NCT03120949|100911763|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
33277769|NCT03120949|100911762|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
33277770|NCT03120949|100911763|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
33277771|NCT03120949|100911762|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
33277772|NCT03120949|100911763|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
33277773|NCT03120949|100911762|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
33277774|NCT03120949|100911763|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
33277775|NCT03120949|100911762|FG000|Overall Study|Site was closed|2|||
33277776|NCT03120949|100911763|FG001|Overall Study|Site was closed|3|||
33277777|NCT03120949|100911762|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
33277778|NCT03120949|100911763|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
33277779|NCT03120949|100911762|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
33277780|NCT03120949|100911763|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
33277781|NCT03120949|100911762|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
33277782|NCT03120949|100911763|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
33277783|NCT03120949|100911762|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
33277784|NCT03120949|100911763|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
33277785|NCT03120949|100911762|FG000|Overall Study|Other: Adverse Event|0|||
33277786|NCT03120949|100911763|FG001|Overall Study|Other: Adverse Event|1|||
33277787|NCT03120949|100911762|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
33277788|NCT03120949|100911763|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
33277789|NCT03120949|100911762|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
33277790|NCT03120949|100911763|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
33277791|NCT03120949|100911762|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
33277792|NCT03120949|100911763|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
33277793|NCT03120949|100911762|FG000|Overall Study|Personal Reasons|0|||
33277794|NCT03120949|100911763|FG001|Overall Study|Personal Reasons|1|||
33277795|NCT03120949|100911762|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
33277796|NCT03120949|100911763|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
33277797|NCT03120949|100911762|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
33277798|NCT03120949|100911763|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
33277799|NCT03120949|100911762|FG000|Overall Study|Compliance With Medication|0|||
33277800|NCT03120949|100911763|FG001|Overall Study|Compliance With Medication|1|||
33277801|NCT03120949|100911762|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
33277802|NCT03120949|100911763|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
33277803|NCT03120949|100911762|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
33277804|NCT03120949|100911763|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
33277805|NCT03120949|100911762|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
33277806|NCT03120949|100911763|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
33277807|NCT02116582|100911764|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
33277808|NCT02116582|100911764|FG000|Overall Study|Adverse Event|22|||
33277809|NCT02116582|100911764|FG000|Overall Study|Death|9|||
33277810|NCT02116582|100911764|FG000|Overall Study|Progressive Disease|148|||
33277811|NCT02116582|100911764|FG000|Overall Study|Protocol Violation|3|||
33277812|NCT02116582|100911764|FG000|Overall Study|Withdrawal by Subject|8|||
33277813|NCT02116582|100911764|FG000|Overall Study|Other: Miscellaneous|11|||
33277814|NCT02116582|100911764|FG000|Overall Study|Lost to Follow-up|1|||
33277815|NCT02116582|100911764|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
33277816|NCT04543942|100911765|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
33277817|NCT04543942|100911766|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
33277818|NCT04543942|100911765|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
33277819|NCT04543942|100911766|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
33277820|NCT03214198|100911767|FG000|Overall Study|Case Report Forms Uncollected|18|||
33277821|NCT03214198|100911767|FG000|Overall Study|Protocol Deviation|18|||
33277822|NCT02213458|100911768|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
33277823|NCT02213458|100911769|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
33277824|NCT02213458|100911768|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
33277825|NCT02213458|100911769|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
33277826|NCT02213458|100911768|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
33277827|NCT02213458|100911769|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
33277828|NCT02213458|100911768|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
33277829|NCT02213458|100911769|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
33277830|NCT02213458|100911768|FG000|Overall Study|Refused re-consent|6|||
33277831|NCT02213458|100911769|FG001|Overall Study|Refused re-consent|0|||
33277832|NCT02213458|100911768|FG000|Overall Study|Lost to Follow-up|2|||
33277833|NCT02213458|100911769|FG001|Overall Study|Lost to Follow-up|2|||
33277834|NCT02213458|100911768|FG000|Overall Study|Withdrawal by Subject|26|||
33277835|NCT02213458|100911769|FG001|Overall Study|Withdrawal by Subject|8|||
33277836|NCT02543294|100911770|FG000|Overall Study|Lost to Follow-up|3|||
33277837|NCT02543294|100911770|FG000|Overall Study|Physician Decision|2|||
33277838|NCT02543294|100911770|FG000|Overall Study|Withdrawal by Subject|7|||
33277839|NCT02475733|100911771|FG000|Overall Study|Withdrawal by Subject|1|||
33277840|NCT02475733|100911772|FG001|Overall Study|Withdrawal by Subject|0|||
33277841|NCT02475733|100911771|FG000|Overall Study|Physician Decision|1|||
33277842|NCT02475733|100911772|FG001|Overall Study|Physician Decision|0|||
33277843|NCT03449979|100911773|FG000|Overall Study|Technical difficulty|0|||
33277844|NCT03449979|100911774|FG001|Overall Study|Technical difficulty|0|||
33277845|NCT03449979|100911775|FG002|Overall Study|Technical difficulty|0|||
33277846|NCT03449979|100911776|FG003|Overall Study|Technical difficulty|1|||
33277847|NCT02632045|100911777|FG000|Overall Study|Withdrawal by Subject|1|||
33277848|NCT02632045|100911778|FG001|Overall Study|Withdrawal by Subject|2|||
33277849|NCT01113541|100911779|FG000|Overall Study|Withdrawal by Subject|1|||
33277850|NCT01113541|100911779|FG000|Overall Study|Protocol Violation|1|||
33277851|NCT01113541|100911779|FG000|Overall Study|Study Terminated by Sponsor|7|||
33277852|NCT01113541|100911779|FG000|Overall Study|Adverse Event|4|||
33277853|NCT02567435|100911780|FG000|Overall Study|Death|1|||
33277854|NCT02567435|100911781|FG001|Overall Study|Death|1|||
33277855|NCT02567435|100911782|FG002|Overall Study|Death|0|||
33277856|NCT02567435|100911783|FG003|Overall Study|Death|0|||
33277857|NCT02567435|100911780|FG000|Overall Study|Ineligible|1|||
33277858|NCT02567435|100911781|FG001|Overall Study|Ineligible|3|||
33277859|NCT02567435|100911782|FG002|Overall Study|Ineligible|0|||
33277860|NCT02567435|100911783|FG003|Overall Study|Ineligible|0|||
33277861|NCT02567435|100911780|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
33277862|NCT02567435|100911781|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
33277863|NCT02567435|100911782|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
33277864|NCT02567435|100911783|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
33277865|NCT03745651|100911784|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
33277866|NCT03745651|100911785|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
33277867|NCT03745651|100911786|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33277868|NCT03745651|100911787|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33277869|NCT03745651|100911788|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33277870|NCT03745651|100911789|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33277871|NCT03745651|100911790|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
33277872|NCT03745651|100911784|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
33277873|NCT03745651|100911785|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
33277874|NCT03745651|100911786|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
33277875|NCT03745651|100911787|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33277876|NCT03745651|100911788|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33277877|NCT03745651|100911789|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33277878|NCT03745651|100911790|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
33277879|NCT03745651|100911784|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
33277880|NCT03745651|100911785|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33277881|NCT03745651|100911786|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
33277882|NCT03745651|100911787|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33277883|NCT03745651|100911788|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33277884|NCT03745651|100911789|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33277885|NCT03745651|100911790|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
33277886|NCT03745651|100911784|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33277887|NCT03745651|100911785|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
33277888|NCT03745651|100911786|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33277889|NCT03745651|100911787|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33277890|NCT03745651|100911788|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33277891|NCT03745651|100911789|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33277892|NCT03745651|100911790|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
33277893|NCT03745651|100911784|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
33277894|NCT03745651|100911785|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
33277895|NCT03745651|100911786|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
33277896|NCT03745651|100911787|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33277897|NCT03745651|100911788|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33277898|NCT03745651|100911789|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33277899|NCT03745651|100911790|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
33277900|NCT03745651|100911784|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
33277901|NCT03745651|100911785|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
33277902|NCT03745651|100911786|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
33277903|NCT03745651|100911787|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
33277904|NCT03745651|100911788|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
33277905|NCT03745651|100911789|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
33277906|NCT03745651|100911790|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
33277907|NCT03745651|100911784|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33277908|NCT03745651|100911785|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33277909|NCT03745651|100911786|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33277910|NCT03745651|100911787|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33277911|NCT03745651|100911788|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33277912|NCT03745651|100911789|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
33277913|NCT03745651|100911790|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
33277914|NCT03745651|100911784|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33277915|NCT03745651|100911785|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33277916|NCT03745651|100911786|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33277917|NCT03745651|100911787|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
33277918|NCT03745651|100911788|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
33277919|NCT03745651|100911789|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
33277920|NCT03745651|100911790|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
33277921|NCT03745651|100911784|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33277922|NCT03745651|100911785|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33277923|NCT03745651|100911786|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
33277924|NCT03745651|100911787|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
33277925|NCT03745651|100911788|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
33277926|NCT03745651|100911789|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
33277927|NCT03745651|100911790|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
33277928|NCT03745651|100911784|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33277929|NCT03745651|100911785|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33277930|NCT03745651|100911786|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33277931|NCT03745651|100911787|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
33277932|NCT03745651|100911788|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
33277933|NCT03745651|100911789|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
33277934|NCT03745651|100911790|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
33277935|NCT03745651|100911784|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
33277936|NCT03745651|100911785|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
33277937|NCT03745651|100911786|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
33277938|NCT03745651|100911787|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
33277939|NCT03745651|100911788|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
33277940|NCT03745651|100911789|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
33277941|NCT03745651|100911790|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
33277942|NCT03745651|100911784|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33277943|NCT03745651|100911785|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33277944|NCT03745651|100911786|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33277945|NCT03745651|100911787|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33277946|NCT03745651|100911788|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33277947|NCT03745651|100911789|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
33277948|NCT03745651|100911790|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
33277949|NCT03745651|100911784|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33277950|NCT03745651|100911785|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33277951|NCT03745651|100911786|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
33277952|NCT03745651|100911787|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
33277953|NCT03745651|100911788|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
33277954|NCT03745651|100911789|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
33277955|NCT03745651|100911790|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
33277956|NCT03745651|100911784|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
33277957|NCT03745651|100911785|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
33277958|NCT03745651|100911786|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
33277959|NCT03745651|100911787|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
33277960|NCT03745651|100911788|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
33277961|NCT03745651|100911789|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
33277962|NCT03745651|100911790|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
33277963|NCT01695993|100911791|FG000|Overall Study|Lost to Follow-up|2|||
33277964|NCT01695993|100911792|FG001|Overall Study|Lost to Follow-up|1|||
33277965|NCT01695993|100911793|FG002|Overall Study|Lost to Follow-up|3|||
33277966|NCT01695993|100911791|FG000|Overall Study|Withdrawal by Subject|2|||
33277967|NCT01695993|100911792|FG001|Overall Study|Withdrawal by Subject|2|||
33277968|NCT01695993|100911793|FG002|Overall Study|Withdrawal by Subject|2|||
33277969|NCT01695993|100911791|FG000|Overall Study|To ill to continue|1|||
33277970|NCT01695993|100911792|FG001|Overall Study|To ill to continue|2|||
33277971|NCT01695993|100911793|FG002|Overall Study|To ill to continue|0|||
33277972|NCT01695993|100911791|FG000|Overall Study|Changed Medical Facility|0|||
33277973|NCT01695993|100911792|FG001|Overall Study|Changed Medical Facility|0|||
33277974|NCT01695993|100911793|FG002|Overall Study|Changed Medical Facility|1|||
33277975|NCT01247922|100911794|FG000|Overall Study|Disease progression|4|||
33277976|NCT04049578|100911795|FG000|Overall Study|Physician Decision|1|||
33277977|NCT03356145|100911799|FG000|Overall Study|Withdrawal by Subject|2|||
33277978|NCT03356145|100911800|FG001|Overall Study|Withdrawal by Subject|1|||
33277979|NCT03356145|100911799|FG000|Overall Study|Did not meet inclusion criteria|1|||
33277980|NCT03356145|100911800|FG001|Overall Study|Did not meet inclusion criteria|0|||
33277981|NCT03018288|100911801|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
33277982|NCT03018288|100911802|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
33277983|NCT03018288|100911803|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
33277984|NCT03018288|100911804|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
33277985|NCT03018288|100911801|FG000|Overall Study|Participant withdrew consent.|0|||
33277986|NCT03018288|100911802|FG001|Overall Study|Participant withdrew consent.|0|||
33277987|NCT03018288|100911803|FG002|Overall Study|Participant withdrew consent.|1|||
33277988|NCT03018288|100911804|FG003|Overall Study|Participant withdrew consent.|0|||
33277989|NCT03018288|100911801|FG000|Overall Study|Switched to alternative treatment.|0|||
33277990|NCT03018288|100911802|FG001|Overall Study|Switched to alternative treatment.|0|||
33277991|NCT03018288|100911803|FG002|Overall Study|Switched to alternative treatment.|1|||
33277992|NCT03018288|100911804|FG003|Overall Study|Switched to alternative treatment.|0|||
33277993|NCT03018288|100911801|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
33277994|NCT03018288|100911802|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
33277995|NCT03018288|100911803|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
33277996|NCT03018288|100911804|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
33277997|NCT03018288|100911801|FG000|Overall Study|Screen failures|0|||
33277998|NCT03018288|100911802|FG001|Overall Study|Screen failures|0|||
33277999|NCT03018288|100911803|FG002|Overall Study|Screen failures|0|||
33278000|NCT03018288|100911804|FG003|Overall Study|Screen failures|51|||
33278001|NCT03018288|100911801|FG000|Overall Study|Chose treatment outside of UNC|0|||
33278002|NCT03018288|100911802|FG001|Overall Study|Chose treatment outside of UNC|0|||
33278003|NCT03018288|100911803|FG002|Overall Study|Chose treatment outside of UNC|0|||
33278004|NCT03018288|100911804|FG003|Overall Study|Chose treatment outside of UNC|1|||
33278005|NCT03018288|100911801|FG000|Overall Study|Unable to comply with protocol requirements|1|||
33278006|NCT03018288|100911802|FG001|Overall Study|Unable to comply with protocol requirements|1|||
33278007|NCT03018288|100911803|FG002|Overall Study|Unable to comply with protocol requirements|0|||
33278008|NCT03018288|100911804|FG003|Overall Study|Unable to comply with protocol requirements|1|||
33278009|NCT03018288|100911801|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
33278010|NCT03018288|100911802|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
33278011|NCT03018288|100911803|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
33278012|NCT03018288|100911804|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
33278013|NCT03018288|100911801|FG000|Overall Study|Physician Decision|0|||
33278014|NCT03018288|100911802|FG001|Overall Study|Physician Decision|0|||
33278015|NCT03018288|100911803|FG002|Overall Study|Physician Decision|0|||
33278016|NCT03018288|100911804|FG003|Overall Study|Physician Decision|1|||
33278017|NCT01182285|100911805|FG000|First Intervention Week 1-10|Disease progression|1|||
33278018|NCT01182285|100911806|FG001|First Intervention Week 1-10|Disease progression|0|||
33278019|NCT01182285|100911807|FG002|First Intervention Week 1-10|Disease progression|0|||
33278020|NCT01182285|100911805|FG000|First Intervention Week 1-10|Adverse Event|1|||
33278021|NCT01182285|100911806|FG001|First Intervention Week 1-10|Adverse Event|0|||
33278022|NCT01182285|100911807|FG002|First Intervention Week 1-10|Adverse Event|0|||
33278023|NCT01182285|100911805|FG000|First Intervention Week 1-10|Non-compliance|1|||
33278024|NCT01182285|100911806|FG001|First Intervention Week 1-10|Non-compliance|0|||
33278025|NCT01182285|100911807|FG002|First Intervention Week 1-10|Non-compliance|0|||
33278026|NCT01182285|100911805|FG000|Third Intervention Week 11-52|Disease Progression|0|||
33278027|NCT01182285|100911806|FG001|Third Intervention Week 11-52|Disease Progression|0|||
33278028|NCT01182285|100911807|FG002|Third Intervention Week 11-52|Disease Progression|6|||
33278029|NCT01182285|100911805|FG000|Third Intervention Week 11-52|Other|0|||
33278030|NCT01182285|100911806|FG001|Third Intervention Week 11-52|Other|0|||
33278031|NCT01182285|100911807|FG002|Third Intervention Week 11-52|Other|2|||
33278032|NCT02592434|100911808|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
33278033|NCT02592434|100911809|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
33278034|NCT02592434|100911810|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
33278035|NCT02592434|100911808|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
33278036|NCT02592434|100911809|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
33278037|NCT02592434|100911810|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
33278038|NCT02592434|100911808|FG000|Open-Label Phase (18 Weeks)|Other|3|||
33278039|NCT02592434|100911809|FG001|Open-Label Phase (18 Weeks)|Other|0|||
33278040|NCT02592434|100911810|FG002|Open-Label Phase (18 Weeks)|Other|0|||
33278041|NCT02592434|100911808|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
33278042|NCT02592434|100911809|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
33278043|NCT02592434|100911810|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
33278044|NCT02592434|100911808|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
33278045|NCT02592434|100911809|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
33278046|NCT02592434|100911810|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
33278047|NCT02592434|100911808|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
33278048|NCT02592434|100911809|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
33278049|NCT02592434|100911810|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
33278050|NCT02592434|100911808|FG000|Double Blind Phase (26 Weeks)|Other|0|||
33278051|NCT02592434|100911809|FG001|Double Blind Phase (26 Weeks)|Other|1|||
33278052|NCT02592434|100911810|FG002|Double Blind Phase (26 Weeks)|Other|0|||
33278053|NCT02592434|100911808|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
33278054|NCT02592434|100911809|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
33278055|NCT02592434|100911810|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
33278056|NCT02592434|100911808|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
33278057|NCT02592434|100911809|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
33278058|NCT02592434|100911810|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
33278059|NCT02592434|100911808|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
33278060|NCT02592434|100911809|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
33278061|NCT02592434|100911810|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
33278062|NCT01636258|100911817|FG000|Overall Study|Lost to Follow-up|1|||
33278063|NCT01636258|100911818|FG001|Overall Study|Lost to Follow-up|0|||
33278064|NCT00108355|100911841|FG000|Overall Study|Peritonitis at index paracentesis|1|||
33278065|NCT00108355|100911842|FG001|Overall Study|Peritonitis at index paracentesis|1|||
33278066|NCT00108355|100911841|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
33278067|NCT00108355|100911842|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
33278068|NCT00794573|100914395|FG000|Overall Study|Death|3|||
33278069|NCT00794573|100914396|FG001|Overall Study|Death|0|||
33278070|NCT00794573|100914395|FG000|Overall Study|Withdrawal by Subject|9|||
33278071|NCT00794573|100914396|FG001|Overall Study|Withdrawal by Subject|12|||
33278072|NCT00794573|100914395|FG000|Overall Study|Lost to Follow-up|26|||
33278073|NCT00794573|100914396|FG001|Overall Study|Lost to Follow-up|33|||
33278074|NCT02294461|100914399|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
33278075|NCT02294461|100914400|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
33278076|NCT02294461|100914399|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
33278077|NCT02294461|100914400|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
33278078|NCT02294461|100914399|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
33278079|NCT02294461|100914400|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
33278080|NCT02294461|100914399|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
33278081|NCT02294461|100914400|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
33278082|NCT02294461|100914399|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
33278083|NCT02294461|100914400|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
33278084|NCT02294461|100914399|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
33278085|NCT02294461|100914400|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
33278086|NCT02294461|100914399|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
33278087|NCT02294461|100914400|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
33278088|NCT02294461|100914399|FG000|Open-label Period (up to 54.3 Months)|Ongoing|19|||
33278089|NCT02294461|100914400|FG001|Open-label Period (up to 54.3 Months)|Ongoing|9|||
33278090|NCT02294461|100914399|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
33278091|NCT02294461|100914400|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|12|||
33278092|NCT02294461|100914399|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|18|||
33278093|NCT02294461|100914400|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|9|||
33278094|NCT02294461|100914399|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
33278095|NCT02294461|100914400|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
33278096|NCT02294461|100914399|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|3|||
33278097|NCT02294461|100914400|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|1|||
33278098|NCT02294461|100914399|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|15|||
33278099|NCT02294461|100914400|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|9|||
33278100|NCT02294461|100914399|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
33278101|NCT02294461|100914400|FG001|Open-label Period (up to 54.3 Months)|Death|5|||
33278102|NCT02294461|100914399|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
33278103|NCT02294461|100914400|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
33278104|NCT00857311|100914401|FG000|Overall Study|Lost to Follow-up|1|||
33278105|NCT00857311|100914402|FG001|Overall Study|Lost to Follow-up|0|||
33278106|NCT00857311|100914403|FG002|Overall Study|Lost to Follow-up|0|||
33278107|NCT00857311|100914404|FG003|Overall Study|Lost to Follow-up|0|||
33278108|NCT03751280|100914405|FG000|Overall Study|Adverse Event|0|||
33278109|NCT03751280|100914406|FG001|Overall Study|Adverse Event|1|||
33278110|NCT03751280|100914405|FG000|Overall Study|Lost to Follow-up|3|||
33278111|NCT03751280|100914406|FG001|Overall Study|Lost to Follow-up|5|||
33278112|NCT03751280|100914405|FG000|Overall Study|Physician Decision|0|||
33278113|NCT03751280|100914406|FG001|Overall Study|Physician Decision|2|||
33278114|NCT03751280|100914405|FG000|Overall Study|Protocol Violation|0|||
33278115|NCT03751280|100914406|FG001|Overall Study|Protocol Violation|2|||
33278116|NCT03751280|100914405|FG000|Overall Study|Withdrawal by Subject|5|||
33278117|NCT03751280|100914406|FG001|Overall Study|Withdrawal by Subject|2|||
33278118|NCT04206384|100914408|FG000|Overall Study|Withdrawal by Subject|8|||
33278119|NCT04206384|100914408|FG000|Overall Study|Adverse Event|2|||
33278120|NCT02268526|100914412|FG000|Overall Study|Adverse Event|0|||
33278121|NCT02268526|100914413|FG001|Overall Study|Adverse Event|2|||
33278122|NCT02268526|100914414|FG002|Overall Study|Adverse Event|1|||
33278123|NCT02268526|100914412|FG000|Overall Study|Death|1|||
33278124|NCT02268526|100914413|FG001|Overall Study|Death|11|||
33278125|NCT02268526|100914414|FG002|Overall Study|Death|0|||
33278126|NCT02268526|100914412|FG000|Overall Study|protocol deviation|0|||
33278127|NCT02268526|100914413|FG001|Overall Study|protocol deviation|1|||
33278128|NCT02268526|100914414|FG002|Overall Study|protocol deviation|0|||
33278129|NCT02268526|100914412|FG000|Overall Study|Physician Decision|0|||
33278130|NCT02268526|100914413|FG001|Overall Study|Physician Decision|0|||
33278131|NCT02268526|100914414|FG002|Overall Study|Physician Decision|1|||
33278132|NCT02268526|100914412|FG000|Overall Study|Subject/guardian decision|0|||
33278133|NCT02268526|100914413|FG001|Overall Study|Subject/guardian decision|7|||
33278134|NCT02268526|100914414|FG002|Overall Study|Subject/guardian decision|3|||
33278135|NCT01482819|100914418|FG000|Overall Study|Lost to Follow-up|2|||
33278136|NCT02798861|100914419|FG000|Overall Study|Lost to Follow-up|22|||
33278137|NCT02798861|100914419|FG000|Overall Study|Withdrawal by Subject|1|||
33278138|NCT02446912|100914420|FG000|Overall Study|Adverse Event|3|||
33278139|NCT02446912|100914421|FG001|Overall Study|Adverse Event|13|||
33278140|NCT02446912|100914422|FG002|Overall Study|Adverse Event|5|||
33278141|NCT02446912|100914420|FG000|Overall Study|Condition under investigation worsened|0|||
33278142|NCT02446912|100914421|FG001|Overall Study|Condition under investigation worsened|1|||
33278143|NCT02446912|100914422|FG002|Overall Study|Condition under investigation worsened|1|||
33278144|NCT02446912|100914420|FG000|Overall Study|Study-specific withdrawal criteria|1|||
33278145|NCT02446912|100914421|FG001|Overall Study|Study-specific withdrawal criteria|0|||
33278146|NCT02446912|100914422|FG002|Overall Study|Study-specific withdrawal criteria|0|||
33278147|NCT02446912|100914420|FG000|Overall Study|Lack of Efficacy|1|||
33278148|NCT02446912|100914421|FG001|Overall Study|Lack of Efficacy|4|||
33278149|NCT02446912|100914422|FG002|Overall Study|Lack of Efficacy|7|||
33278150|NCT02446912|100914420|FG000|Overall Study|Lost to Follow-up|0|||
33278151|NCT02446912|100914421|FG001|Overall Study|Lost to Follow-up|0|||
33278152|NCT02446912|100914422|FG002|Overall Study|Lost to Follow-up|2|||
33278153|NCT02446912|100914420|FG000|Overall Study|Severe non-compliance to protocol|1|||
33278154|NCT02446912|100914421|FG001|Overall Study|Severe non-compliance to protocol|0|||
33278155|NCT02446912|100914422|FG002|Overall Study|Severe non-compliance to protocol|1|||
33278156|NCT02446912|100914420|FG000|Overall Study|Withdrawal by Subject|10|||
33278157|NCT02446912|100914421|FG001|Overall Study|Withdrawal by Subject|15|||
33278158|NCT02446912|100914422|FG002|Overall Study|Withdrawal by Subject|15|||
33278159|NCT02446912|100914420|FG000|Overall Study|Miscellaneous|2|||
33278160|NCT02446912|100914421|FG001|Overall Study|Miscellaneous|2|||
33278161|NCT02446912|100914422|FG002|Overall Study|Miscellaneous|4|||
33278162|NCT00276016|100914423|FG000|Intervention 1|Withdrawal by Subject|0|||
33278163|NCT00276016|100914424|FG001|Intervention 1|Withdrawal by Subject|1|||
33278164|NCT00276016|100914425|FG002|Intervention 1|Withdrawal by Subject|0|||
33278165|NCT00276016|100914426|FG003|Intervention 1|Withdrawal by Subject|0|||
33278166|NCT00276016|100914427|FG004|Intervention 1|Withdrawal by Subject|0|||
33278167|NCT00276016|100914428|FG005|Intervention 1|Withdrawal by Subject|0|||
33278168|NCT01332318|100914429|FG000|Overall Study|Adverse Event|0|||
33278169|NCT01332318|100914430|FG001|Overall Study|Adverse Event|3|||
33278170|NCT01332318|100914431|FG002|Overall Study|Adverse Event|0|||
33278171|NCT01332318|100914432|FG003|Overall Study|Adverse Event|0|||
33278172|NCT01332318|100914429|FG000|Overall Study|Withdrawal by Subject|1|||
33278173|NCT01332318|100914430|FG001|Overall Study|Withdrawal by Subject|1|||
33278174|NCT01332318|100914431|FG002|Overall Study|Withdrawal by Subject|0|||
33278175|NCT01332318|100914432|FG003|Overall Study|Withdrawal by Subject|1|||
33278176|NCT01332318|100914429|FG000|Overall Study|Protocol Violation|1|||
33278177|NCT01332318|100914430|FG001|Overall Study|Protocol Violation|0|||
33278178|NCT01332318|100914431|FG002|Overall Study|Protocol Violation|1|||
33278179|NCT01332318|100914432|FG003|Overall Study|Protocol Violation|1|||
33278180|NCT00525915|100914433|FG000|Overall Study|Non-Compliance|0|||
33278181|NCT00525915|100914434|FG001|Overall Study|Non-Compliance|1|||
33278182|NCT00525915|100914433|FG000|Overall Study|Disease Progression|5|||
33278183|NCT00525915|100914434|FG001|Overall Study|Disease Progression|6|||
33278184|NCT00525915|100914433|FG000|Overall Study|Withdrawal by Subject|1|||
33278185|NCT00525915|100914434|FG001|Overall Study|Withdrawal by Subject|0|||
33278186|NCT00525915|100914433|FG000|Overall Study|Refused Surgery|1|||
33278187|NCT00525915|100914434|FG001|Overall Study|Refused Surgery|2|||
33278188|NCT00525915|100914433|FG000|Overall Study|Unrelated illness|1|||
33278189|NCT00525915|100914434|FG001|Overall Study|Unrelated illness|0|||
33278190|NCT03023878|100914446|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
33278191|NCT03023878|100914446|FG000|Pre-Study Run-In Period|Death|1|||
33278192|NCT03023878|100914446|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
33278193|NCT03023878|100914446|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
33278194|NCT03023878|100914446|FG000|Treatment Period|Disease Progression|1|||
33278195|NCT03023878|100914446|FG000|Treatment Period|Withdrawal by Subject|1|||
33278196|NCT03023878|100914446|FG000|Treatment Period|Adverse Event|1|||
33278197|NCT03023878|100914446|FG000|Long Term Follow-Up Period|Death|2|||
33278198|NCT00788671|100914447|FG000|Overall Study|Death|2|||
33278199|NCT00788671|100914447|FG000|Overall Study|Unable to biopsy|1|||
33278200|NCT00788671|100914447|FG000|Overall Study|Withdrawal by Subject|4|||
33278201|NCT00788671|100914447|FG000|Overall Study|IUD expulsed|1|||
33278202|NCT00788671|100914447|FG000|Overall Study|Lost to follow up|2|||
33278203|NCT01358175|100914452|FG000|Overall Study|Death|1|||
33278204|NCT01358175|100914453|FG001|Overall Study|Death|0|||
33278205|NCT01358175|100914454|FG002|Overall Study|Death|1|||
33278206|NCT01358175|100914452|FG000|Overall Study|Withdrawal by Subject|9|||
33278207|NCT01358175|100914453|FG001|Overall Study|Withdrawal by Subject|5|||
33278208|NCT01358175|100914454|FG002|Overall Study|Withdrawal by Subject|10|||
33278209|NCT01358175|100914452|FG000|Overall Study|Technical issues|0|||
33278210|NCT01358175|100914453|FG001|Overall Study|Technical issues|1|||
33278211|NCT01358175|100914454|FG002|Overall Study|Technical issues|0|||
33278212|NCT01358175|100914452|FG000|Overall Study|Pregnancy|0|||
33278213|NCT01358175|100914453|FG001|Overall Study|Pregnancy|1|||
33278214|NCT01358175|100914454|FG002|Overall Study|Pregnancy|0|||
33278215|NCT01358175|100914452|FG000|Overall Study|Physician Decision|1|||
33278216|NCT01358175|100914453|FG001|Overall Study|Physician Decision|0|||
33278217|NCT01358175|100914454|FG002|Overall Study|Physician Decision|0|||
33278218|NCT01358175|100914452|FG000|Overall Study|Non Compliance with Study Treatment|0|||
33278219|NCT01358175|100914453|FG001|Overall Study|Non Compliance with Study Treatment|1|||
33278220|NCT01358175|100914454|FG002|Overall Study|Non Compliance with Study Treatment|1|||
33278221|NCT01358175|100914452|FG000|Overall Study|Lost to Follow-up|1|||
33278222|NCT01358175|100914453|FG001|Overall Study|Lost to Follow-up|1|||
33278223|NCT01358175|100914454|FG002|Overall Study|Lost to Follow-up|3|||
33278224|NCT01358175|100914452|FG000|Overall Study|Lack of Efficacy|3|||
33278225|NCT01358175|100914453|FG001|Overall Study|Lack of Efficacy|8|||
33278226|NCT01358175|100914454|FG002|Overall Study|Lack of Efficacy|6|||
33278227|NCT01358175|100914452|FG000|Overall Study|Adverse Event|6|||
33278228|NCT01358175|100914453|FG001|Overall Study|Adverse Event|11|||
33278229|NCT01358175|100914454|FG002|Overall Study|Adverse Event|11|||
33278230|NCT01812707|100914455|FG000|Overall Study|Adverse Event|0|||
33278231|NCT01812707|100914456|FG001|Overall Study|Adverse Event|0|||
33278232|NCT01812707|100914457|FG002|Overall Study|Adverse Event|0|||
33278233|NCT01812707|100914458|FG003|Overall Study|Adverse Event|2|||
33278234|NCT01812707|100914455|FG000|Overall Study|Poor compliance to protocol|1|||
33278235|NCT01812707|100914456|FG001|Overall Study|Poor compliance to protocol|0|||
33278236|NCT01812707|100914457|FG002|Overall Study|Poor compliance to protocol|0|||
33278237|NCT01812707|100914458|FG003|Overall Study|Poor compliance to protocol|0|||
33278238|NCT01812707|100914455|FG000|Overall Study|Consent withdrawn by participant|1|||
33278239|NCT01812707|100914456|FG001|Overall Study|Consent withdrawn by participant|0|||
33278240|NCT01812707|100914457|FG002|Overall Study|Consent withdrawn by participant|0|||
33278241|NCT01812707|100914458|FG003|Overall Study|Consent withdrawn by participant|0|||
33278242|NCT01124916|100914459|FG000|Overall Study|Lost to Follow-up|3|||
33278243|NCT01124916|100914460|FG001|Overall Study|Lost to Follow-up|2|||
33278244|NCT03441789|100914461|FG000|Overall Study|Withdrawal by Subject|1|||
33278245|NCT03441789|100914462|FG001|Overall Study|Withdrawal by Subject|1|||
33278246|NCT03441789|100914461|FG000|Overall Study|Adverse Event|0|||
33278247|NCT03441789|100914462|FG001|Overall Study|Adverse Event|1|||
33278248|NCT03441789|100914461|FG000|Overall Study|Protocol Violation|0|||
33278249|NCT03441789|100914462|FG001|Overall Study|Protocol Violation|1|||
33278250|NCT03441789|100914461|FG000|Overall Study|Lost to Follow-up|0|||
33278251|NCT03441789|100914462|FG001|Overall Study|Lost to Follow-up|1|||
33278252|NCT00278395|100914465|FG000|Overall Study|Adverse Event|2|||
33278253|NCT00278395|100914465|FG000|Overall Study|Nonevaluable|1|||
33278254|NCT01825785|100914468|FG000|Overall Study|Adverse Event|0|||
33278255|NCT01825785|100914469|FG001|Overall Study|Adverse Event|0|||
33278256|NCT01825785|100914470|FG002|Overall Study|Adverse Event|0|||
33278257|NCT01825785|100914471|FG003|Overall Study|Adverse Event|0|||
33278258|NCT01825785|100914472|FG004|Overall Study|Adverse Event|1|||
33278259|NCT01825785|100914473|FG005|Overall Study|Adverse Event|0|||
33278260|NCT01825785|100914474|FG006|Overall Study|Adverse Event|0|||
33278261|NCT01825785|100914468|FG000|Overall Study|Withdrawal by Subject|0|||
33278262|NCT01825785|100914469|FG001|Overall Study|Withdrawal by Subject|0|||
33278263|NCT01825785|100914470|FG002|Overall Study|Withdrawal by Subject|0|||
33278264|NCT01825785|100914471|FG003|Overall Study|Withdrawal by Subject|0|||
33278265|NCT01825785|100914472|FG004|Overall Study|Withdrawal by Subject|1|||
33278266|NCT01825785|100914473|FG005|Overall Study|Withdrawal by Subject|1|||
33278267|NCT01825785|100914474|FG006|Overall Study|Withdrawal by Subject|0|||
33278268|NCT03613454|100914480|FG000|Overall Study|Protocol Violation|1|||
33278269|NCT03613454|100914481|FG001|Overall Study|Protocol Violation|0|||
33278270|NCT03613454|100914480|FG000|Overall Study|Protocol Violation|0|||
33278271|NCT03613454|100914481|FG001|Overall Study|Protocol Violation|1|||
33278272|NCT00511147|100914482|FG000|Overall Study|Withdrawal by Subject|1|||
33278273|NCT00511147|100914482|FG000|Overall Study|Disease progression|5|||
33278274|NCT00511147|100914482|FG000|Overall Study|Required platelet transfusion|1|||
33278275|NCT00005908|100914483|FG000|Overall Study|Withdrawal by Subject|1|||
33278276|NCT00005908|100914484|FG001|Overall Study|Withdrawal by Subject|0|||
33278277|NCT01294358|100914491|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
33278278|NCT01294358|100914492|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
33278279|NCT01294358|100914493|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
33278280|NCT01294358|100914494|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
33278281|NCT01294358|100914495|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
33278282|NCT01294358|100914491|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
33278283|NCT01294358|100914492|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
33278284|NCT01294358|100914493|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
33278285|NCT01294358|100914494|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
33278286|NCT01294358|100914495|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
33278287|NCT01294358|100914491|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
33278288|NCT01294358|100914492|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
33278289|NCT01294358|100914493|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
33278290|NCT01294358|100914494|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
33278291|NCT01294358|100914495|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
33278292|NCT01294358|100914491|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
33278293|NCT01294358|100914492|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
33278294|NCT01294358|100914493|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
33278295|NCT01294358|100914494|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
33278296|NCT01294358|100914495|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
33278297|NCT02066389|100914506|FG000|Overall Study|Adverse Event|1|||
33278298|NCT02066389|100914507|FG001|Overall Study|Adverse Event|1|||
33278299|NCT02066389|100914508|FG002|Overall Study|Adverse Event|1|||
33278300|NCT02066389|100914509|FG003|Overall Study|Adverse Event|1|||
33278301|NCT02066389|100914510|FG004|Overall Study|Adverse Event|5|||
33278302|NCT02066389|100914511|FG005|Overall Study|Adverse Event|1|||
33278303|NCT02066389|100914506|FG000|Overall Study|Withdrawal by Subject|4|||
33278304|NCT02066389|100914507|FG001|Overall Study|Withdrawal by Subject|0|||
33278305|NCT02066389|100914508|FG002|Overall Study|Withdrawal by Subject|5|||
33278306|NCT02066389|100914509|FG003|Overall Study|Withdrawal by Subject|1|||
33278307|NCT02066389|100914510|FG004|Overall Study|Withdrawal by Subject|1|||
33278308|NCT02066389|100914511|FG005|Overall Study|Withdrawal by Subject|2|||
33278309|NCT02066389|100914506|FG000|Overall Study|Lost to Follow-up|0|||
33278310|NCT02066389|100914507|FG001|Overall Study|Lost to Follow-up|0|||
33278311|NCT02066389|100914508|FG002|Overall Study|Lost to Follow-up|0|||
33278312|NCT02066389|100914509|FG003|Overall Study|Lost to Follow-up|1|||
33278313|NCT02066389|100914510|FG004|Overall Study|Lost to Follow-up|1|||
33278314|NCT02066389|100914511|FG005|Overall Study|Lost to Follow-up|1|||
33278315|NCT02066389|100914506|FG000|Overall Study|Randomized in Error|0|||
33278316|NCT02066389|100914507|FG001|Overall Study|Randomized in Error|0|||
33278317|NCT02066389|100914508|FG002|Overall Study|Randomized in Error|0|||
33278318|NCT02066389|100914509|FG003|Overall Study|Randomized in Error|0|||
33278319|NCT02066389|100914510|FG004|Overall Study|Randomized in Error|0|||
33278320|NCT02066389|100914511|FG005|Overall Study|Randomized in Error|1|||
33278321|NCT02305797|100914514|FG000|Overall Study|Adverse Event|11|||
33278322|NCT02305797|100914515|FG001|Overall Study|Adverse Event|2|||
33278323|NCT02305797|100914514|FG000|Overall Study|Withdrawal by Subject|9|||
33278324|NCT02305797|100914515|FG001|Overall Study|Withdrawal by Subject|10|||
33278325|NCT02305797|100914514|FG000|Overall Study|Lack of Efficacy|6|||
33278326|NCT02305797|100914515|FG001|Overall Study|Lack of Efficacy|0|||
33278327|NCT02305797|100914514|FG000|Overall Study|Lost to Follow-up|5|||
33278328|NCT02305797|100914515|FG001|Overall Study|Lost to Follow-up|11|||
33278329|NCT02305797|100914514|FG000|Overall Study|Pregnancy|0|||
33278330|NCT02305797|100914515|FG001|Overall Study|Pregnancy|2|||
33278331|NCT02305797|100914514|FG000|Overall Study|Noncompliance|14|||
33278332|NCT02305797|100914515|FG001|Overall Study|Noncompliance|12|||
33278333|NCT02305797|100914514|FG000|Overall Study|Reason not collected|0|||
33278334|NCT02305797|100914515|FG001|Overall Study|Reason not collected|1|||
33278335|NCT00784277|100914516|FG000|IR Treatment|Adverse Event|4|||
33278336|NCT00784277|100914517|FG001|IR Treatment|Adverse Event|8|||
33278337|NCT00784277|100914518|FG002|IR Treatment|Adverse Event|19|||
33278338|NCT00784277|100914519|FG003|IR Treatment|Adverse Event|35|||
33278339|NCT00784277|100914520|FG004|IR Treatment|Adverse Event|0|||
33278340|NCT00784277|100914521|FG005|IR Treatment|Adverse Event|0|||
33278341|NCT00784277|100914522|FG006|IR Treatment|Adverse Event|0|||
33278342|NCT00784277|100914516|FG000|IR Treatment|Lack of Efficacy|4|||
33278343|NCT00784277|100914517|FG001|IR Treatment|Lack of Efficacy|4|||
33278344|NCT00784277|100914518|FG002|IR Treatment|Lack of Efficacy|1|||
33278345|NCT00784277|100914519|FG003|IR Treatment|Lack of Efficacy|0|||
33278346|NCT00784277|100914520|FG004|IR Treatment|Lack of Efficacy|0|||
33278347|NCT00784277|100914521|FG005|IR Treatment|Lack of Efficacy|0|||
33278348|NCT00784277|100914522|FG006|IR Treatment|Lack of Efficacy|0|||
33278349|NCT00784277|100914516|FG000|IR Treatment|Lost to Follow-up|1|||
33278350|NCT00784277|100914517|FG001|IR Treatment|Lost to Follow-up|0|||
33278351|NCT00784277|100914518|FG002|IR Treatment|Lost to Follow-up|1|||
33278352|NCT00784277|100914519|FG003|IR Treatment|Lost to Follow-up|0|||
33278353|NCT00784277|100914520|FG004|IR Treatment|Lost to Follow-up|0|||
33278354|NCT00784277|100914521|FG005|IR Treatment|Lost to Follow-up|0|||
33278355|NCT00784277|100914522|FG006|IR Treatment|Lost to Follow-up|0|||
33278356|NCT00784277|100914516|FG000|IR Treatment|Withdrawal by Subject|5|||
33278357|NCT00784277|100914517|FG001|IR Treatment|Withdrawal by Subject|1|||
33278358|NCT00784277|100914518|FG002|IR Treatment|Withdrawal by Subject|4|||
33278359|NCT00784277|100914519|FG003|IR Treatment|Withdrawal by Subject|6|||
33278360|NCT00784277|100914520|FG004|IR Treatment|Withdrawal by Subject|0|||
33278361|NCT00784277|100914521|FG005|IR Treatment|Withdrawal by Subject|0|||
33278362|NCT00784277|100914522|FG006|IR Treatment|Withdrawal by Subject|0|||
33278363|NCT00784277|100914516|FG000|IR Treatment|Resolution Of Pain|0|||
33278364|NCT00784277|100914517|FG001|IR Treatment|Resolution Of Pain|1|||
33278365|NCT00784277|100914518|FG002|IR Treatment|Resolution Of Pain|0|||
33278366|NCT00784277|100914519|FG003|IR Treatment|Resolution Of Pain|0|||
33278367|NCT00784277|100914520|FG004|IR Treatment|Resolution Of Pain|0|||
33278368|NCT00784277|100914521|FG005|IR Treatment|Resolution Of Pain|0|||
33278369|NCT00784277|100914522|FG006|IR Treatment|Resolution Of Pain|0|||
33278370|NCT00784277|100914516|FG000|IR Treatment|Other|2|||
33278371|NCT00784277|100914517|FG001|IR Treatment|Other|3|||
33278372|NCT00784277|100914518|FG002|IR Treatment|Other|3|||
33278373|NCT00784277|100914519|FG003|IR Treatment|Other|2|||
33278374|NCT00784277|100914520|FG004|IR Treatment|Other|0|||
33278375|NCT00784277|100914521|FG005|IR Treatment|Other|0|||
33278376|NCT00784277|100914522|FG006|IR Treatment|Other|0|||
33278377|NCT00784277|100914516|FG000|ER Treatment|Adverse Event|0|||
33278378|NCT00784277|100914517|FG001|ER Treatment|Adverse Event|0|||
33278379|NCT00784277|100914518|FG002|ER Treatment|Adverse Event|0|||
33278380|NCT00784277|100914519|FG003|ER Treatment|Adverse Event|0|||
33278381|NCT00784277|100914520|FG004|ER Treatment|Adverse Event|1|||
33278382|NCT00784277|100914521|FG005|ER Treatment|Adverse Event|7|||
33278383|NCT00784277|100914522|FG006|ER Treatment|Adverse Event|7|||
33278384|NCT00784277|100914516|FG000|ER Treatment|Lack of Efficacy|0|||
33278385|NCT00784277|100914517|FG001|ER Treatment|Lack of Efficacy|0|||
33278386|NCT00784277|100914518|FG002|ER Treatment|Lack of Efficacy|0|||
33278387|NCT00784277|100914519|FG003|ER Treatment|Lack of Efficacy|0|||
33278388|NCT00784277|100914520|FG004|ER Treatment|Lack of Efficacy|3|||
33278389|NCT00784277|100914521|FG005|ER Treatment|Lack of Efficacy|4|||
33278390|NCT00784277|100914522|FG006|ER Treatment|Lack of Efficacy|0|||
33278391|NCT00784277|100914516|FG000|ER Treatment|Lost to Follow-up|0|||
33278392|NCT00784277|100914517|FG001|ER Treatment|Lost to Follow-up|0|||
33278393|NCT00784277|100914518|FG002|ER Treatment|Lost to Follow-up|0|||
33278394|NCT00784277|100914519|FG003|ER Treatment|Lost to Follow-up|0|||
33278395|NCT00784277|100914520|FG004|ER Treatment|Lost to Follow-up|0|||
33278396|NCT00784277|100914521|FG005|ER Treatment|Lost to Follow-up|2|||
33278397|NCT00784277|100914522|FG006|ER Treatment|Lost to Follow-up|0|||
33278398|NCT00784277|100914516|FG000|ER Treatment|Withdrawal by Subject|0|||
33278399|NCT00784277|100914517|FG001|ER Treatment|Withdrawal by Subject|0|||
33278400|NCT00784277|100914518|FG002|ER Treatment|Withdrawal by Subject|0|||
33278401|NCT00784277|100914519|FG003|ER Treatment|Withdrawal by Subject|0|||
33278402|NCT00784277|100914520|FG004|ER Treatment|Withdrawal by Subject|2|||
33278403|NCT00784277|100914521|FG005|ER Treatment|Withdrawal by Subject|5|||
33278404|NCT00784277|100914522|FG006|ER Treatment|Withdrawal by Subject|3|||
33278405|NCT00784277|100914516|FG000|ER Treatment|Study Medication Non-Compliant|0|||
33278406|NCT00784277|100914517|FG001|ER Treatment|Study Medication Non-Compliant|0|||
33278407|NCT00784277|100914518|FG002|ER Treatment|Study Medication Non-Compliant|0|||
33278408|NCT00784277|100914519|FG003|ER Treatment|Study Medication Non-Compliant|0|||
33278409|NCT00784277|100914520|FG004|ER Treatment|Study Medication Non-Compliant|2|||
33278410|NCT00784277|100914521|FG005|ER Treatment|Study Medication Non-Compliant|3|||
33278411|NCT00784277|100914522|FG006|ER Treatment|Study Medication Non-Compliant|3|||
33278412|NCT00784277|100914516|FG000|ER Treatment|Other|0|||
33278413|NCT00784277|100914517|FG001|ER Treatment|Other|0|||
33278414|NCT00784277|100914518|FG002|ER Treatment|Other|0|||
33278415|NCT00784277|100914519|FG003|ER Treatment|Other|0|||
33278416|NCT00784277|100914520|FG004|ER Treatment|Other|1|||
33278417|NCT00784277|100914521|FG005|ER Treatment|Other|3|||
33278418|NCT00784277|100914522|FG006|ER Treatment|Other|2|||
33278419|NCT03444155|100914523|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
33278420|NCT03444155|100914524|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
33278421|NCT00607789|100914525|FG000|Overall Study|Adverse Event|3|||
33278422|NCT00607789|100914526|FG001|Overall Study|Adverse Event|0|||
33278423|NCT00607789|100914525|FG000|Overall Study|Lack of Efficacy|0|||
33278424|NCT00607789|100914526|FG001|Overall Study|Lack of Efficacy|1|||
33278425|NCT00607789|100914525|FG000|Overall Study|Inadequate adherence|3|||
33278426|NCT00607789|100914526|FG001|Overall Study|Inadequate adherence|0|||
33278427|NCT00607789|100914525|FG000|Overall Study|Lost to Follow-up|0|||
33278428|NCT00607789|100914526|FG001|Overall Study|Lost to Follow-up|5|||
33278429|NCT00607789|100914525|FG000|Overall Study|Withdrawal by Subject|1|||
33278430|NCT00607789|100914526|FG001|Overall Study|Withdrawal by Subject|0|||
33278431|NCT03151551|100914527|FG000|Open-Label Treatment Period|Adverse Event|0|||
33278432|NCT03151551|100914528|FG001|Open-Label Treatment Period|Adverse Event|2|||
33278433|NCT03151551|100914527|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
33278434|NCT03151551|100914528|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
33278435|NCT03151551|100914527|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
33278436|NCT03151551|100914528|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
33278437|NCT03151551|100914527|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
33485738|NCT00996892|101671467|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
33278438|NCT03151551|100914528|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
33278439|NCT03151551|100914527|FG000|Open-Label Treatment Period|Physician Decision|3|||
33278440|NCT03151551|100914528|FG001|Open-Label Treatment Period|Physician Decision|0|||
33278441|NCT03151551|100914527|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
33278442|NCT03151551|100914528|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
33278443|NCT03151551|100914527|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
33278444|NCT03151551|100914528|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
33278445|NCT03151551|100914527|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
33278446|NCT03151551|100914528|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
33278447|NCT03151551|100914527|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
33278448|NCT03151551|100914528|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
33278449|NCT03151551|100914527|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
33278450|NCT03151551|100914528|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
33278451|NCT00884793|100914529|FG000|Overall Study|Withdrawal by Subject|1|||
33278452|NCT03469258|100914530|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
33278453|NCT00248794|100914531|FG000|Overall Study|Lost to Follow-up|6|||
33278454|NCT00248794|100914532|FG001|Overall Study|Lost to Follow-up|8|||
33278455|NCT00248794|100914533|FG002|Overall Study|Lost to Follow-up|3|||
33278456|NCT00515112|100914534|FG000|Overall Study|Death|0|||
33278457|NCT00515112|100914535|FG001|Overall Study|Death|1|||
33278458|NCT00515112|100914534|FG000|Overall Study|The study was terminated|3|||
33278459|NCT00515112|100914535|FG001|Overall Study|The study was terminated|2|||
33278460|NCT02632747|100914536|FG000|Wash-out Period|Adverse Event|1|||
33278461|NCT02632747|100914537|FG001|Wash-out Period|Adverse Event|0|||
33278462|NCT01636778|100914542|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
33278463|NCT01636778|100914543|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
33278464|NCT01636778|100914544|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
33278465|NCT01636778|100914542|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
33278466|NCT01636778|100914543|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
33278467|NCT01636778|100914544|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
33278468|NCT01636778|100914542|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
33278469|NCT01636778|100914543|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
33278470|NCT01636778|100914544|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
33278471|NCT01636778|100914542|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
33278472|NCT01636778|100914543|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
33278473|NCT01636778|100914544|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
33278474|NCT01636778|100914542|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
33278475|NCT01636778|100914543|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
33278476|NCT01636778|100914544|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
33278477|NCT01636778|100914542|FG000|Follow-up Period After Part 2|Other|0|||
33278478|NCT01636778|100914543|FG001|Follow-up Period After Part 2|Other|0|||
33278479|NCT01636778|100914544|FG002|Follow-up Period After Part 2|Other|1|||
33278480|NCT01636778|100914542|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
33278481|NCT01636778|100914543|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
33278482|NCT01636778|100914544|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
33278483|NCT01636778|100914542|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
33278484|NCT01636778|100914543|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
33278485|NCT01636778|100914544|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
33278486|NCT00938041|100914548|FG000|Overall Study|Lost to Follow-up|6|||
33278487|NCT00938041|100914548|FG000|Overall Study|Received Alternative Therapy|1|||
33278488|NCT00938041|100914548|FG000|Overall Study|Progressive Disease|5|||
33278489|NCT00938041|100914548|FG000|Overall Study|Death|12|||
33278490|NCT00938041|100914548|FG000|Overall Study|Adrenal Insufficiency|3|||
33278491|NCT00304278|100914549|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
33278492|NCT00304278|100914549|FG000|Overall Study|PT had medical condition preventing TX|1|||
33278493|NCT02014402|100914550|FG000|Overall Study|Adverse Event|1|||
33278494|NCT02014402|100914551|FG001|Overall Study|Adverse Event|0|||
33278495|NCT02014402|100914552|FG002|Overall Study|Adverse Event|0|||
33278496|NCT02014402|100914553|FG003|Overall Study|Adverse Event|0|||
33278497|NCT02014402|100914550|FG000|Overall Study|Withdrawal by Subject|1|||
33278498|NCT02014402|100914551|FG001|Overall Study|Withdrawal by Subject|2|||
33278499|NCT02014402|100914552|FG002|Overall Study|Withdrawal by Subject|2|||
33278500|NCT02014402|100914553|FG003|Overall Study|Withdrawal by Subject|1|||
33278501|NCT02014402|100914550|FG000|Overall Study|Subject did not have transportation|0|||
33278502|NCT02014402|100914551|FG001|Overall Study|Subject did not have transportation|1|||
33278503|NCT02014402|100914552|FG002|Overall Study|Subject did not have transportation|0|||
33278504|NCT02014402|100914553|FG003|Overall Study|Subject did not have transportation|0|||
33278505|NCT02014402|100914550|FG000|Overall Study|Lost to Follow-up|0|||
33278506|NCT02014402|100914551|FG001|Overall Study|Lost to Follow-up|0|||
33278507|NCT02014402|100914552|FG002|Overall Study|Lost to Follow-up|1|||
33278508|NCT02014402|100914553|FG003|Overall Study|Lost to Follow-up|2|||
33278509|NCT00850993|100914554|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
33278510|NCT00850993|100914555|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
33278511|NCT00850993|100914556|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
33278512|NCT00850993|100914557|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
33278513|NCT04839289|100914559|FG000|Overall Study|Withdrawal by Subject|1|||
33278514|NCT04839289|100914560|FG001|Overall Study|Withdrawal by Subject|0|||
33278515|NCT02498418|100914562|FG000|Overall Study|Lack of Efficacy|0|||
33278516|NCT02498418|100914563|FG001|Overall Study|Lack of Efficacy|0|||
33278517|NCT02498418|100914564|FG002|Overall Study|Lack of Efficacy|1|||
33278518|NCT02498418|100914562|FG000|Overall Study|Withdrawal by Subject|2|||
33278519|NCT02498418|100914563|FG001|Overall Study|Withdrawal by Subject|0|||
33278520|NCT02498418|100914564|FG002|Overall Study|Withdrawal by Subject|3|||
33278521|NCT02498418|100914562|FG000|Overall Study|Lost to Follow-up|0|||
33278522|NCT02498418|100914563|FG001|Overall Study|Lost to Follow-up|1|||
33278523|NCT02498418|100914564|FG002|Overall Study|Lost to Follow-up|1|||
33278524|NCT02498418|100914562|FG000|Overall Study|Participant taken prohibited medication|0|||
33278525|NCT02498418|100914563|FG001|Overall Study|Participant taken prohibited medication|1|||
33278526|NCT02498418|100914564|FG002|Overall Study|Participant taken prohibited medication|1|||
33278527|NCT03605745|100914565|FG000|Overall Study|Study was terminated for business reasons|47|||
33278528|NCT01257698|100914566|FG000|Overall Study|Protocol Violation|4|||
33278529|NCT01257698|100914567|FG001|Overall Study|Protocol Violation|0|||
33278530|NCT01204775|100914568|FG000|Overall Study|Poor/non-compliance|0|||
33278531|NCT01204775|100914569|FG001|Overall Study|Poor/non-compliance|1|||
33278532|NCT01204775|100914568|FG000|Overall Study|Withdrawal by Subject|1|||
33278533|NCT01204775|100914569|FG001|Overall Study|Withdrawal by Subject|0|||
33278534|NCT03640754|100914570|FG000|Overall Study|Withdrawal by Subject|1|||
33278535|NCT03640754|100914571|FG001|Overall Study|Withdrawal by Subject|0|||
33278536|NCT03640754|100914570|FG000|Overall Study|Lost to Follow-up|0|||
33278537|NCT03640754|100914571|FG001|Overall Study|Lost to Follow-up|1|||
33278538|NCT01323309|100914572|FG000|Overall Study|Death|9|||
33278539|NCT01323309|100914573|FG001|Overall Study|Death|15|||
33278540|NCT01323309|100914574|FG002|Overall Study|Death|5|||
33278541|NCT01323309|100914572|FG000|Overall Study|Lost to Follow-up|11|||
33278542|NCT01323309|100914573|FG001|Overall Study|Lost to Follow-up|14|||
33278543|NCT01323309|100914574|FG002|Overall Study|Lost to Follow-up|24|||
33278544|NCT01323309|100914572|FG000|Overall Study|Withdrawal by Subject|14|||
33278545|NCT01323309|100914573|FG001|Overall Study|Withdrawal by Subject|14|||
33278546|NCT01323309|100914574|FG002|Overall Study|Withdrawal by Subject|18|||
33278547|NCT01323309|100914572|FG000|Overall Study|Disease progression|5|||
33278548|NCT01323309|100914573|FG001|Overall Study|Disease progression|11|||
33278549|NCT01323309|100914574|FG002|Overall Study|Disease progression|4|||
33278550|NCT01601821|100914576|FG000|Overall Study|Death|2|||
33278551|NCT01601821|100914577|FG001|Overall Study|Death|5|||
33278552|NCT01601821|100914576|FG000|Overall Study|Protocol Violation|2|||
33278553|NCT01601821|100914577|FG001|Overall Study|Protocol Violation|2|||
33278554|NCT01601821|100914576|FG000|Overall Study|Lost to Follow-up|6|||
33278555|NCT01601821|100914577|FG001|Overall Study|Lost to Follow-up|14|||
33278556|NCT01601821|100914576|FG000|Overall Study|Withdrawal by Subject|1|||
33278557|NCT01601821|100914577|FG001|Overall Study|Withdrawal by Subject|0|||
33278558|NCT01601821|100914576|FG000|Overall Study|Graft Loss|6|||
33278559|NCT01601821|100914577|FG001|Overall Study|Graft Loss|6|||
33278560|NCT01601821|100914576|FG000|Overall Study|Study Events|7|||
33278561|NCT01601821|100914577|FG001|Overall Study|Study Events|1|||
33278562|NCT01601821|100914576|FG000|Overall Study|Other|5|||
33278563|NCT01601821|100914577|FG001|Overall Study|Other|1|||
33278564|NCT02879448|100914578|FG000|Overall Study|No implant attempt|17|||
33278565|NCT02879448|100914579|FG001|Overall Study|No implant attempt|28|||
33278566|NCT02879448|100914578|FG000|Overall Study|Withdrawal by Subject|20|||
33278567|NCT02879448|100914579|FG001|Overall Study|Withdrawal by Subject|46|||
33278568|NCT02879448|100914578|FG000|Overall Study|Death|63|||
33278569|NCT02879448|100914579|FG001|Overall Study|Death|85|||
33278570|NCT02879448|100914578|FG000|Overall Study|Lost to Follow-up|3|||
33278571|NCT02879448|100914579|FG001|Overall Study|Lost to Follow-up|4|||
33278572|NCT02879448|100914578|FG000|Overall Study|Missing visit|34|||
33278573|NCT02879448|100914579|FG001|Overall Study|Missing visit|39|||
33278574|NCT02879448|100914578|FG000|Overall Study|Pending evaluation|1|||
33278575|NCT02879448|100914579|FG001|Overall Study|Pending evaluation|0|||
33278576|NCT00473512|100914580|FG000|Period 1 (Phase 1)|Adverse Event|0|||
33278577|NCT00473512|100914581|FG001|Period 1 (Phase 1)|Adverse Event|0|||
33278578|NCT00473512|100914582|FG002|Period 1 (Phase 1)|Adverse Event|0|||
33278579|NCT00473512|100914583|FG003|Period 1 (Phase 1)|Adverse Event|5|||
33278580|NCT00473512|100914584|FG004|Period 1 (Phase 1)|Adverse Event|0|||
33278581|NCT00473512|100914580|FG000|Period 1 (Phase 1)|Death|0|||
33278582|NCT00473512|100914581|FG001|Period 1 (Phase 1)|Death|0|||
33278583|NCT00473512|100914582|FG002|Period 1 (Phase 1)|Death|0|||
33485739|NCT00996892|101671468|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
33278584|NCT00473512|100914583|FG003|Period 1 (Phase 1)|Death|1|||
33278585|NCT00473512|100914584|FG004|Period 1 (Phase 1)|Death|0|||
33278586|NCT00473512|100914580|FG000|Period 1 (Phase 1)|Disease Progression|1|||
33485740|NCT00996892|101671449|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
33485741|NCT00996892|101671450|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
33278587|NCT00473512|100914581|FG001|Period 1 (Phase 1)|Disease Progression|1|||
33278588|NCT00473512|100914582|FG002|Period 1 (Phase 1)|Disease Progression|0|||
33278589|NCT00473512|100914583|FG003|Period 1 (Phase 1)|Disease Progression|10|||
33278590|NCT00473512|100914584|FG004|Period 1 (Phase 1)|Disease Progression|1|||
33278591|NCT00473512|100914580|FG000|Period 1 (Phase 1)|Other|0|||
33278592|NCT00473512|100914581|FG001|Period 1 (Phase 1)|Other|0|||
33278593|NCT00473512|100914582|FG002|Period 1 (Phase 1)|Other|0|||
33278594|NCT00473512|100914583|FG003|Period 1 (Phase 1)|Other|1|||
33278595|NCT00473512|100914584|FG004|Period 1 (Phase 1)|Other|0|||
33278596|NCT00473512|100914580|FG000|Period 2 (Phase 2)|Adverse Event|0|||
33278597|NCT00473512|100914581|FG001|Period 2 (Phase 2)|Adverse Event|0|||
33278598|NCT00473512|100914582|FG002|Period 2 (Phase 2)|Adverse Event|0|||
33278599|NCT00473512|100914583|FG003|Period 2 (Phase 2)|Adverse Event|1|||
33278600|NCT00473512|100914584|FG004|Period 2 (Phase 2)|Adverse Event|0|||
33278601|NCT00473512|100914580|FG000|Period 2 (Phase 2)|Death|0|||
33278602|NCT00473512|100914581|FG001|Period 2 (Phase 2)|Death|0|||
33278603|NCT00473512|100914582|FG002|Period 2 (Phase 2)|Death|0|||
33278604|NCT00473512|100914583|FG003|Period 2 (Phase 2)|Death|1|||
33278605|NCT00473512|100914584|FG004|Period 2 (Phase 2)|Death|1|||
33278606|NCT00473512|100914580|FG000|Period 2 (Phase 2)|Disease Progression|0|||
33278607|NCT00473512|100914581|FG001|Period 2 (Phase 2)|Disease Progression|2|||
33278608|NCT00473512|100914582|FG002|Period 2 (Phase 2)|Disease Progression|2|||
33278609|NCT00473512|100914583|FG003|Period 2 (Phase 2)|Disease Progression|17|||
33278610|NCT00473512|100914584|FG004|Period 2 (Phase 2)|Disease Progression|1|||
33278611|NCT00473512|100914580|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
33278612|NCT00473512|100914581|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
33278613|NCT00473512|100914582|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
33278614|NCT00473512|100914583|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
33278615|NCT00473512|100914584|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
33278616|NCT00473512|100914580|FG000|Period 2 (Phase 2)|Other|1|||
33278617|NCT00473512|100914581|FG001|Period 2 (Phase 2)|Other|0|||
33278618|NCT00473512|100914582|FG002|Period 2 (Phase 2)|Other|0|||
33278619|NCT00473512|100914583|FG003|Period 2 (Phase 2)|Other|3|||
33278620|NCT00473512|100914584|FG004|Period 2 (Phase 2)|Other|0|||
33278621|NCT02092285|100914585|FG000|Induction Phase|Adverse Event|7|||
33278622|NCT02092285|100914585|FG000|Induction Phase|Physician Decision|4|||
33278623|NCT02092285|100914585|FG000|Induction Phase|Pregnancy|1|||
33278624|NCT02092285|100914585|FG000|Induction Phase|Relapse/Recurrence|7|||
33278625|NCT02092285|100914585|FG000|Induction Phase|Withdrawal by Subject|2|||
33278626|NCT02092285|100914585|FG000|Induction Phase|Lack of Efficacy|14|||
33278627|NCT02092285|100914585|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
33278628|NCT02092285|100914585|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
33278629|NCT02092285|100914585|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
33278630|NCT02092285|100914585|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
33278631|NCT02092285|100914585|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
33278632|NCT02092285|100914585|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
33278633|NCT02092285|100914585|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
33278634|NCT02092285|100914585|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
33278635|NCT02092285|100914585|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
33278636|NCT00647699|100914586|FG000|Overall Study|Lost to Follow-up|5|||
33278637|NCT00647699|100914587|FG001|Overall Study|Lost to Follow-up|4|||
33278638|NCT00647699|100914586|FG000|Overall Study|Withdrawal by Subject|3|||
33278639|NCT00647699|100914587|FG001|Overall Study|Withdrawal by Subject|8|||
33278640|NCT00609245|100914588|FG000|Overall Study|Adverse Event|1|||
33278641|NCT00246129|100914590|FG000|Overall Study|Lost to Follow-up|1|||
33278642|NCT00246129|100914591|FG001|Overall Study|Lost to Follow-up|0|||
33278643|NCT00246129|100914590|FG000|Overall Study|Death|2|||
33278644|NCT00246129|100914591|FG001|Overall Study|Death|1|||
33278645|NCT00246129|100914590|FG000|Overall Study|suffered primary non-function|1|||
33278646|NCT00246129|100914591|FG001|Overall Study|suffered primary non-function|0|||
33278647|NCT00246129|100914590|FG000|Overall Study|grafts failed|3|||
33278648|NCT00246129|100914591|FG001|Overall Study|grafts failed|1|||
33278649|NCT01774929|100914592|FG000|Overall Study|Adverse Event|3|||
33278650|NCT00002540|100914593|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
33278651|NCT00002540|100914594|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
33278652|NCT00002540|100914593|FG000|Overall Study|Died Before Randomization|2|||
33278653|NCT00002540|100914594|FG001|Overall Study|Died Before Randomization|6|||
33278654|NCT00002540|100914593|FG000|Overall Study|Died Before ASU (Control)|202|||
33278655|NCT00002540|100914594|FG001|Overall Study|Died Before ASU (Control)|0|||
33485742|NCT00996892|101671451|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
33485743|NCT00996892|101671452|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
33278656|NCT00002540|100914593|FG000|Overall Study|Refused ASU (Control)|597|||
33278657|NCT00002540|100914594|FG001|Overall Study|Refused ASU (Control)|0|||
33278658|NCT00002540|100914593|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
33278659|NCT00002540|100914594|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
33278660|NCT00464737|100914602|FG000|Overall Study|Adverse Event|12|||
33278661|NCT00464737|100914603|FG001|Overall Study|Adverse Event|17|||
33278662|NCT00464737|100914604|FG002|Overall Study|Adverse Event|33|||
33278663|NCT00464737|100914602|FG000|Overall Study|Lack of Efficacy|7|||
33278664|NCT00464737|100914603|FG001|Overall Study|Lack of Efficacy|7|||
33278665|NCT00464737|100914604|FG002|Overall Study|Lack of Efficacy|4|||
33278666|NCT00464737|100914602|FG000|Overall Study|Withdrawal by Subject|5|||
33278667|NCT00464737|100914603|FG001|Overall Study|Withdrawal by Subject|3|||
33278668|NCT00464737|100914604|FG002|Overall Study|Withdrawal by Subject|5|||
33278669|NCT00464737|100914602|FG000|Overall Study|Protocol Violation|1|||
33278670|NCT00464737|100914603|FG001|Overall Study|Protocol Violation|1|||
33278671|NCT00464737|100914604|FG002|Overall Study|Protocol Violation|5|||
33278672|NCT00464737|100914602|FG000|Overall Study|Non-compliance|0|||
33278673|NCT00464737|100914603|FG001|Overall Study|Non-compliance|1|||
33278674|NCT00464737|100914604|FG002|Overall Study|Non-compliance|1|||
33278675|NCT00464737|100914602|FG000|Overall Study|Lost to Follow-up|5|||
33278676|NCT00464737|100914603|FG001|Overall Study|Lost to Follow-up|2|||
33278677|NCT00464737|100914604|FG002|Overall Study|Lost to Follow-up|5|||
33278678|NCT00464737|100914602|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
33278679|NCT00464737|100914603|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
33278680|NCT00464737|100914604|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
33278681|NCT00464737|100914602|FG000|Overall Study|Other: Subject left town; family illness|1|||
33278682|NCT00464737|100914603|FG001|Overall Study|Other: Subject left town; family illness|0|||
33278683|NCT00464737|100914604|FG002|Overall Study|Other: Subject left town; family illness|0|||
33278684|NCT00464737|100914602|FG000|Overall Study|Other: Study demands too great|0|||
33278685|NCT00464737|100914603|FG001|Overall Study|Other: Study demands too great|1|||
33278686|NCT00464737|100914604|FG002|Overall Study|Other: Study demands too great|0|||
33278687|NCT00464737|100914602|FG000|Overall Study|Other: Personal family reasons|0|||
33278688|NCT00464737|100914603|FG001|Overall Study|Other: Personal family reasons|0|||
33278689|NCT00464737|100914604|FG002|Overall Study|Other: Personal family reasons|1|||
33278690|NCT00464737|100914602|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
33278691|NCT00464737|100914603|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
33278692|NCT00464737|100914604|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
33278693|NCT01064856|100914607|FG000|Double-blind (DB) Period|Adverse Event|1|||
33278694|NCT01064856|100914608|FG001|Double-blind (DB) Period|Adverse Event|0|||
33278695|NCT01064856|100914609|FG002|Double-blind (DB) Period|Adverse Event|0|||
33278696|NCT01064856|100914610|FG003|Double-blind (DB) Period|Adverse Event|0|||
33278697|NCT01064856|100914607|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
33278698|NCT01064856|100914608|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
33278699|NCT01064856|100914609|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
33278700|NCT01064856|100914610|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
33278701|NCT01064856|100914607|FG000|Open-label (OL) Period|Adverse Event|0|||
33278702|NCT01064856|100914608|FG001|Open-label (OL) Period|Adverse Event|0|||
33278703|NCT01064856|100914609|FG002|Open-label (OL) Period|Adverse Event|12|||
33278704|NCT01064856|100914610|FG003|Open-label (OL) Period|Adverse Event|6|||
33278705|NCT01064856|100914607|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
33278706|NCT01064856|100914608|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
33278707|NCT01064856|100914609|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
33278708|NCT01064856|100914610|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
33278709|NCT01064856|100914607|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
33278710|NCT01064856|100914608|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
33278711|NCT01064856|100914609|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
33278712|NCT01064856|100914610|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
33278713|NCT01064856|100914607|FG000|Open-label (OL) Period|Other|0|||
33278714|NCT01064856|100914608|FG001|Open-label (OL) Period|Other|0|||
33278715|NCT01064856|100914609|FG002|Open-label (OL) Period|Other|7|||
33278716|NCT01064856|100914610|FG003|Open-label (OL) Period|Other|7|||
33278717|NCT02188784|100914611|FG000|Overall Study|Death|3|||
33278718|NCT02188784|100914612|FG001|Overall Study|Death|1|||
33278719|NCT02188784|100914611|FG000|Overall Study|Lost to Follow-up|1|||
33278720|NCT02188784|100914612|FG001|Overall Study|Lost to Follow-up|0|||
33278721|NCT02188784|100914611|FG000|Overall Study|Withdrawal by Subject|3|||
33278722|NCT02188784|100914612|FG001|Overall Study|Withdrawal by Subject|9|||
33278723|NCT02188784|100914611|FG000|Overall Study|Physician Decision|2|||
33278724|NCT02188784|100914612|FG001|Overall Study|Physician Decision|3|||
33278725|NCT01107912|100914614|FG000|Period 1|Adverse Event|0|||
33278726|NCT01107912|100914615|FG001|Period 1|Adverse Event|0|||
33278727|NCT01107912|100914616|FG002|Period 1|Adverse Event|0|||
33278728|NCT01107912|100914617|FG003|Period 1|Adverse Event|0|||
33278729|NCT01107912|100914618|FG004|Period 1|Adverse Event|2|||
33278730|NCT01107912|100914619|FG005|Period 1|Adverse Event|0|||
33278731|NCT01107912|100914614|FG000|Period 1|Physician Decision|0|||
33278732|NCT01107912|100914615|FG001|Period 1|Physician Decision|0|||
33278733|NCT01107912|100914616|FG002|Period 1|Physician Decision|0|||
33278734|NCT01107912|100914617|FG003|Period 1|Physician Decision|0|||
33278735|NCT01107912|100914618|FG004|Period 1|Physician Decision|1|||
33278736|NCT01107912|100914619|FG005|Period 1|Physician Decision|0|||
33278737|NCT01107912|100914614|FG000|Period 1|Withdrawal by Subject|1|||
33278738|NCT01107912|100914615|FG001|Period 1|Withdrawal by Subject|0|||
33278739|NCT01107912|100914616|FG002|Period 1|Withdrawal by Subject|0|||
33278740|NCT01107912|100914617|FG003|Period 1|Withdrawal by Subject|0|||
33278741|NCT01107912|100914618|FG004|Period 1|Withdrawal by Subject|0|||
33278742|NCT01107912|100914619|FG005|Period 1|Withdrawal by Subject|0|||
33278743|NCT01107912|100914614|FG000|Period 2|Physician Decision|0|||
33278744|NCT01107912|100914615|FG001|Period 2|Physician Decision|0|||
33278745|NCT01107912|100914616|FG002|Period 2|Physician Decision|1|||
33278746|NCT01107912|100914617|FG003|Period 2|Physician Decision|0|||
33278747|NCT01107912|100914618|FG004|Period 2|Physician Decision|0|||
33278748|NCT01107912|100914619|FG005|Period 2|Physician Decision|0|||
33278749|NCT01107912|100914614|FG000|Period 3|Adverse Event|0|||
33278750|NCT01107912|100914615|FG001|Period 3|Adverse Event|1|||
33278751|NCT01107912|100914616|FG002|Period 3|Adverse Event|1|||
33278752|NCT01107912|100914617|FG003|Period 3|Adverse Event|0|||
33278753|NCT01107912|100914618|FG004|Period 3|Adverse Event|0|||
33278754|NCT01107912|100914619|FG005|Period 3|Adverse Event|0|||
33278755|NCT01107912|100914614|FG000|Period 3|Withdrawal by Subject|0|||
33278756|NCT01107912|100914615|FG001|Period 3|Withdrawal by Subject|0|||
33278757|NCT01107912|100914616|FG002|Period 3|Withdrawal by Subject|0|||
33278758|NCT01107912|100914617|FG003|Period 3|Withdrawal by Subject|1|||
33278759|NCT01107912|100914618|FG004|Period 3|Withdrawal by Subject|0|||
33278760|NCT01107912|100914619|FG005|Period 3|Withdrawal by Subject|0|||
33278761|NCT02473913|100914620|FG000|Overall Study|Lost to Follow-up|3|||
33278762|NCT02473913|100914621|FG001|Overall Study|Lost to Follow-up|3|||
33278763|NCT01622088|100914622|FG000|Overall Study|Adverse Event|20|||
33278764|NCT01622088|100914622|FG000|Overall Study|Lost to Follow-up|1|||
33278765|NCT01622088|100914622|FG000|Overall Study|Withdrawal by Subject|20|||
33278766|NCT01622088|100914622|FG000|Overall Study|Investigator Decision|1|||
33278767|NCT01622088|100914622|FG000|Overall Study|Death|53|||
33278768|NCT01622088|100914622|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
33278769|NCT02023099|100914624|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
33278770|NCT02023099|100914625|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
33278771|NCT02023099|100914626|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
33278772|NCT02023099|100914624|FG000|Overall Study|Withdrawn Consent|3|||
33278773|NCT02023099|100914625|FG001|Overall Study|Withdrawn Consent|0|||
33278774|NCT02023099|100914626|FG002|Overall Study|Withdrawn Consent|1|||
33278775|NCT02023099|100914624|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
33278776|NCT02023099|100914625|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
33278777|NCT02023099|100914626|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
33278778|NCT03569891|100914629|FG000|Lead-in|Ineligible during lead-in|8|||
33278779|NCT03569891|100914629|FG000|Lead-in|Withdrawal by Subject|3|||
33278780|NCT03569891|100914629|FG000|Lead-in|Risks related to COVID-19|2|||
33278781|NCT03569891|100914629|FG000|AMT-061|Adverse Event|1|||
33278782|NCT02889809|100914630|FG000|Overall Study|Withdrawal by Subject|30|||
33278783|NCT02889809|100914631|FG001|Overall Study|Withdrawal by Subject|21|||
33278784|NCT02889809|100914630|FG000|Overall Study|Lost to Follow-up|1|||
33278785|NCT02889809|100914631|FG001|Overall Study|Lost to Follow-up|1|||
33278786|NCT02889809|100914630|FG000|Overall Study|Site Closed|12|||
33278787|NCT02889809|100914631|FG001|Overall Study|Site Closed|11|||
33278788|NCT02359552|100914633|FG000|Overall Study|Lost to Follow-up|3|||
33278789|NCT02359552|100914634|FG001|Overall Study|Lost to Follow-up|4|||
33278790|NCT00495612|100914635|FG000|Overall Study|Lost to Follow-up|1|||
33278791|NCT00495612|100914636|FG001|Overall Study|Lost to Follow-up|0|||
33278792|NCT00495612|100914635|FG000|Overall Study|Subject's Decision to Withdraw|3|||
33278793|NCT00495612|100914636|FG001|Overall Study|Subject's Decision to Withdraw|0|||
33278794|NCT00839306|100914647|FG000|Overall Study|Adverse Event|3|||
33278795|NCT00839306|100914648|FG001|Overall Study|Adverse Event|5|||
33278796|NCT00839306|100914647|FG000|Overall Study|Lost to Follow-up|6|||
33278797|NCT00839306|100914648|FG001|Overall Study|Lost to Follow-up|9|||
33278798|NCT00839306|100914647|FG000|Overall Study|Withdrawal by Subject|5|||
33278799|NCT00839306|100914648|FG001|Overall Study|Withdrawal by Subject|7|||
33278800|NCT00839306|100914647|FG000|Overall Study|Lack of Efficacy|5|||
33278801|NCT00839306|100914648|FG001|Overall Study|Lack of Efficacy|4|||
33278802|NCT00839306|100914647|FG000|Overall Study|Other|6|||
33278803|NCT00839306|100914648|FG001|Overall Study|Other|18|||
33278804|NCT01375777|100914649|FG000|Overall Study|Withdrawal by Subject|0|||
33278805|NCT01375777|100914650|FG001|Overall Study|Withdrawal by Subject|2|||
33278806|NCT01375777|100914651|FG002|Overall Study|Withdrawal by Subject|1|||
33278807|NCT01375777|100914652|FG003|Overall Study|Withdrawal by Subject|0|||
33278808|NCT01375777|100914653|FG004|Overall Study|Withdrawal by Subject|1|||
33278809|NCT01375777|100914654|FG005|Overall Study|Withdrawal by Subject|1|||
33278810|NCT01375777|100914655|FG006|Overall Study|Withdrawal by Subject|1|||
33278811|NCT01375777|100914656|FG007|Overall Study|Withdrawal by Subject|2|||
33278812|NCT01375777|100914657|FG008|Overall Study|Withdrawal by Subject|1|||
33278813|NCT01375777|100914649|FG000|Overall Study|Lost to Follow-up|1|||
33278814|NCT01375777|100914650|FG001|Overall Study|Lost to Follow-up|0|||
33278815|NCT01375777|100914651|FG002|Overall Study|Lost to Follow-up|0|||
33278816|NCT01375777|100914652|FG003|Overall Study|Lost to Follow-up|0|||
33278817|NCT01375777|100914653|FG004|Overall Study|Lost to Follow-up|0|||
33278818|NCT01375777|100914654|FG005|Overall Study|Lost to Follow-up|0|||
33278819|NCT01375777|100914655|FG006|Overall Study|Lost to Follow-up|1|||
33278820|NCT01375777|100914656|FG007|Overall Study|Lost to Follow-up|0|||
33278821|NCT01375777|100914657|FG008|Overall Study|Lost to Follow-up|0|||
33278822|NCT01375777|100914649|FG000|Overall Study|Other|1|||
33278823|NCT01375777|100914650|FG001|Overall Study|Other|1|||
33278824|NCT01375777|100914651|FG002|Overall Study|Other|0|||
33278825|NCT01375777|100914652|FG003|Overall Study|Other|0|||
33278826|NCT01375777|100914653|FG004|Overall Study|Other|0|||
33278827|NCT01375777|100914654|FG005|Overall Study|Other|0|||
33278828|NCT01375777|100914655|FG006|Overall Study|Other|0|||
33278829|NCT01375777|100914656|FG007|Overall Study|Other|0|||
33278830|NCT01375777|100914657|FG008|Overall Study|Other|1|||
33278831|NCT01061775|100914662|FG000|Overall Study|Physician Decision|2|||
33278832|NCT01061775|100914662|FG000|Overall Study|Lost to Follow-up|1|||
33278833|NCT00714688|100914667|FG000|Overall Study|Lack of Efficacy|14|||
33278834|NCT00714688|100914668|FG001|Overall Study|Lack of Efficacy|1|||
33278835|NCT00714688|100914669|FG002|Overall Study|Lack of Efficacy|4|||
33278836|NCT00714688|100914667|FG000|Overall Study|Withdrawal by Subject|4|||
33278837|NCT00714688|100914668|FG001|Overall Study|Withdrawal by Subject|3|||
33278838|NCT00714688|100914669|FG002|Overall Study|Withdrawal by Subject|3|||
33278839|NCT00714688|100914667|FG000|Overall Study|Lost to Follow-up|5|||
33278840|NCT00714688|100914668|FG001|Overall Study|Lost to Follow-up|2|||
33278841|NCT00714688|100914669|FG002|Overall Study|Lost to Follow-up|0|||
33278842|NCT00714688|100914667|FG000|Overall Study|Adverse Event|2|||
33278843|NCT00714688|100914668|FG001|Overall Study|Adverse Event|15|||
33278844|NCT00714688|100914669|FG002|Overall Study|Adverse Event|19|||
33278845|NCT00714688|100914667|FG000|Overall Study|Subject Non-compliant|3|||
33278846|NCT00714688|100914668|FG001|Overall Study|Subject Non-compliant|5|||
33278847|NCT00714688|100914669|FG002|Overall Study|Subject Non-compliant|5|||
33278848|NCT00714688|100914667|FG000|Overall Study|Ineligible to Continue the Study|0|||
33278849|NCT00714688|100914668|FG001|Overall Study|Ineligible to Continue the Study|1|||
33278850|NCT00714688|100914669|FG002|Overall Study|Ineligible to Continue the Study|1|||
33278851|NCT00714688|100914667|FG000|Overall Study|Sponsor's Decision|0|||
33278852|NCT00714688|100914668|FG001|Overall Study|Sponsor's Decision|2|||
33278853|NCT00714688|100914669|FG002|Overall Study|Sponsor's Decision|0|||
33278854|NCT00714688|100914667|FG000|Overall Study|Other|1|||
33278855|NCT00714688|100914668|FG001|Overall Study|Other|6|||
33278856|NCT00714688|100914669|FG002|Overall Study|Other|5|||
33278857|NCT00702520|100917690|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
33278858|NCT00702520|100917691|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
33278859|NCT00702520|100917692|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
33278860|NCT00702520|100917693|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
33278861|NCT00702520|100917690|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
33278862|NCT00702520|100917691|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
33278863|NCT00702520|100917692|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
33278864|NCT00702520|100917693|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
33278865|NCT00702520|100917690|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
33278866|NCT00702520|100917691|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
33278867|NCT00702520|100917692|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
33278868|NCT00702520|100917693|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
33278869|NCT02339506|100917694|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
33278870|NCT02339506|100917695|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
33278871|NCT02339506|100917694|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
33278872|NCT02339506|100917695|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
33278873|NCT02040532|100917696|FG000|Overall Study|Lost to Follow-up|1|||
33278874|NCT02040532|100917696|FG000|Overall Study|Physician Decision|4|||
33278875|NCT02040532|100917696|FG000|Overall Study|Adverse Event|4|||
33278876|NCT02040532|100917696|FG000|Overall Study|Withdrawal by Subject|3|||
33278877|NCT00417989|100917697|FG000|Overall Study|Withdrawal by Subject|13|||
33278878|NCT00417989|100917698|FG001|Overall Study|Withdrawal by Subject|13|||
33278879|NCT00417989|100917697|FG000|Overall Study|Lost to Follow-up|1|||
33278880|NCT00417989|100917698|FG001|Overall Study|Lost to Follow-up|6|||
33278881|NCT00417989|100917697|FG000|Overall Study|Protocol Violation|1|||
33278882|NCT00417989|100917698|FG001|Overall Study|Protocol Violation|0|||
33278883|NCT00417989|100917697|FG000|Overall Study|Death|0|||
33278884|NCT00417989|100917698|FG001|Overall Study|Death|1|||
33278885|NCT00417989|100917697|FG000|Overall Study|Physician Decision|5|||
33278886|NCT00417989|100917698|FG001|Overall Study|Physician Decision|2|||
33278887|NCT04088500|100917699|FG000|Overall Study|Reason unknown|1|||
33278888|NCT04088500|100917699|FG000|Overall Study|Participant withdrew consent|1|||
33278889|NCT04088500|100917699|FG000|Overall Study|Disease progression|3|||
33278890|NCT02963922|100917700|FG000|Overall Study|Adverse Event|15|||
33278891|NCT02963922|100917701|FG001|Overall Study|Adverse Event|6|||
33278892|NCT02963922|100917700|FG000|Overall Study|Protocol deviation|6|||
33278893|NCT02963922|100917701|FG001|Overall Study|Protocol deviation|6|||
33278894|NCT02963922|100917700|FG000|Overall Study|Lack of Efficacy|1|||
33278895|NCT02963922|100917701|FG001|Overall Study|Lack of Efficacy|1|||
33278896|NCT02963922|100917700|FG000|Overall Study|Lost to Follow-up|2|||
33278897|NCT02963922|100917701|FG001|Overall Study|Lost to Follow-up|3|||
33278898|NCT02963922|100917700|FG000|Overall Study|Other|8|||
33278899|NCT02963922|100917701|FG001|Overall Study|Other|14|||
33278900|NCT03332589|100917702|FG000|Overall Study|Lack of Efficacy|2|||
33278901|NCT03332589|100917703|FG001|Overall Study|Lack of Efficacy|0|||
33278902|NCT03332589|100917704|FG002|Overall Study|Lack of Efficacy|0|||
33278903|NCT03332589|100917702|FG000|Overall Study|Adverse Event|1|||
33278904|NCT03332589|100917703|FG001|Overall Study|Adverse Event|0|||
33278905|NCT03332589|100917704|FG002|Overall Study|Adverse Event|0|||
33278906|NCT03332589|100917702|FG000|Overall Study|Death|1|||
33278907|NCT03332589|100917703|FG001|Overall Study|Death|0|||
33278908|NCT03332589|100917704|FG002|Overall Study|Death|0|||
33278909|NCT03779334|100917705|FG000|Overall Study|Withdrawal by Subject|3|||
33278910|NCT03779334|100917706|FG001|Overall Study|Withdrawal by Subject|0|||
33278911|NCT03779334|100917707|FG002|Overall Study|Withdrawal by Subject|0|||
33278912|NCT03779334|100917705|FG000|Overall Study|Ongoing in Study|5|||
33278913|NCT03779334|100917706|FG001|Overall Study|Ongoing in Study|13|||
33278914|NCT03779334|100917707|FG002|Overall Study|Ongoing in Study|5|||
33278915|NCT01177228|100917710|FG000|Overall Study|Positive tuberculosis test|0|||
33278916|NCT01177228|100917711|FG001|Overall Study|Positive tuberculosis test|1|||
33278917|NCT01177228|100917712|FG002|Overall Study|Positive tuberculosis test|0|||
33278918|NCT01177228|100917713|FG003|Overall Study|Positive tuberculosis test|0|||
33278919|NCT01177228|100917710|FG000|Overall Study|Worsening disease activity|1|||
33278920|NCT01177228|100917711|FG001|Overall Study|Worsening disease activity|0|||
33278921|NCT01177228|100917712|FG002|Overall Study|Worsening disease activity|0|||
33278922|NCT01177228|100917713|FG003|Overall Study|Worsening disease activity|0|||
33278923|NCT01177228|100917710|FG000|Overall Study|Withdrawal by Subject|0|||
33278924|NCT01177228|100917711|FG001|Overall Study|Withdrawal by Subject|1|||
33278925|NCT01177228|100917712|FG002|Overall Study|Withdrawal by Subject|0|||
33278926|NCT01177228|100917713|FG003|Overall Study|Withdrawal by Subject|0|||
33278927|NCT04374253|100917716|FG000|Overall Study|Adverse Event|0|||
33278928|NCT04374253|100917717|FG001|Overall Study|Adverse Event|26|||
33278929|NCT04374253|100917718|FG002|Overall Study|Adverse Event|2|||
33278930|NCT04374253|100917719|FG003|Overall Study|Adverse Event|12|||
33278931|NCT04374253|100917716|FG000|Overall Study|Study terminated by sponsor|13|||
33278932|NCT04374253|100917717|FG001|Overall Study|Study terminated by sponsor|593|||
33278933|NCT04374253|100917718|FG002|Overall Study|Study terminated by sponsor|21|||
33278934|NCT04374253|100917719|FG003|Overall Study|Study terminated by sponsor|567|||
33278935|NCT04374253|100917716|FG000|Overall Study|Withdrawal by Subject|0|||
33278936|NCT04374253|100917717|FG001|Overall Study|Withdrawal by Subject|55|||
33278937|NCT04374253|100917718|FG002|Overall Study|Withdrawal by Subject|3|||
33278938|NCT04374253|100917719|FG003|Overall Study|Withdrawal by Subject|40|||
33278939|NCT04374253|100917716|FG000|Overall Study|Physician Decision|1|||
33278940|NCT04374253|100917717|FG001|Overall Study|Physician Decision|10|||
33278941|NCT04374253|100917718|FG002|Overall Study|Physician Decision|1|||
33278942|NCT04374253|100917719|FG003|Overall Study|Physician Decision|10|||
33278943|NCT04374253|100917716|FG000|Overall Study|Protocol Violation|0|||
33278944|NCT04374253|100917717|FG001|Overall Study|Protocol Violation|0|||
33278945|NCT04374253|100917718|FG002|Overall Study|Protocol Violation|0|||
33278946|NCT04374253|100917719|FG003|Overall Study|Protocol Violation|2|||
33278947|NCT04374253|100917716|FG000|Overall Study|Death|0|||
33278948|NCT04374253|100917717|FG001|Overall Study|Death|3|||
33278949|NCT04374253|100917718|FG002|Overall Study|Death|1|||
33278950|NCT04374253|100917719|FG003|Overall Study|Death|1|||
33278951|NCT04374253|100917716|FG000|Overall Study|Lack of Efficacy|0|||
33278952|NCT04374253|100917717|FG001|Overall Study|Lack of Efficacy|0|||
33278953|NCT04374253|100917718|FG002|Overall Study|Lack of Efficacy|0|||
33278954|NCT04374253|100917719|FG003|Overall Study|Lack of Efficacy|1|||
33278955|NCT04374253|100917716|FG000|Overall Study|Lost to Follow-up|1|||
33278956|NCT04374253|100917717|FG001|Overall Study|Lost to Follow-up|1|||
33278957|NCT04374253|100917718|FG002|Overall Study|Lost to Follow-up|0|||
33278958|NCT04374253|100917719|FG003|Overall Study|Lost to Follow-up|2|||
33278959|NCT04374253|100917716|FG000|Overall Study|Reason Not Specified|0|||
33278960|NCT04374253|100917717|FG001|Overall Study|Reason Not Specified|8|||
33278961|NCT04374253|100917718|FG002|Overall Study|Reason Not Specified|0|||
33278962|NCT04374253|100917719|FG003|Overall Study|Reason Not Specified|8|||
33278963|NCT05041439|100917720|FG000|Overall Study|Withdrawal by Subject|1|||
33278964|NCT05041439|100917721|FG001|Overall Study|Withdrawal by Subject|1|||
33278965|NCT05041439|100917720|FG000|Overall Study|Death|1|||
33278966|NCT05041439|100917721|FG001|Overall Study|Death|0|||
33278967|NCT04057937|100917722|FG000|Placebo-controlled Phase|Adverse Event|3|||
33278968|NCT04057937|100917723|FG001|Placebo-controlled Phase|Adverse Event|0|||
33278969|NCT04057937|100917722|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
33278970|NCT04057937|100917723|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
33278971|NCT04057937|100917722|FG000|Active-treatment Phase|Pregnancy|0|||
33278972|NCT04057937|100917723|FG001|Active-treatment Phase|Pregnancy|1|||
33278973|NCT04057937|100917722|FG000|Active-treatment Phase|Physician Decision|0|||
33278974|NCT04057937|100917723|FG001|Active-treatment Phase|Physician Decision|1|||
33278975|NCT03614923|100917726|FG000|Overall Study|Withdrawal by Subject|2|||
33278976|NCT03614923|100917727|FG001|Overall Study|Withdrawal by Subject|1|||
33278977|NCT03614923|100917728|FG002|Overall Study|Withdrawal by Subject|1|||
33278978|NCT03614923|100917726|FG000|Overall Study|Adverse Event|0|||
33278979|NCT03614923|100917727|FG001|Overall Study|Adverse Event|2|||
33278980|NCT03614923|100917728|FG002|Overall Study|Adverse Event|1|||
33278981|NCT03614923|100917726|FG000|Overall Study|Lost to Follow-up|1|||
33278982|NCT03614923|100917727|FG001|Overall Study|Lost to Follow-up|0|||
33278983|NCT03614923|100917728|FG002|Overall Study|Lost to Follow-up|1|||
33278984|NCT03614923|100917726|FG000|Overall Study|Lack of Efficacy|2|||
33278985|NCT03614923|100917727|FG001|Overall Study|Lack of Efficacy|0|||
33278986|NCT03614923|100917728|FG002|Overall Study|Lack of Efficacy|1|||
33278987|NCT03614923|100917726|FG000|Overall Study|Non-compliance|0|||
33278988|NCT03614923|100917727|FG001|Overall Study|Non-compliance|1|||
33278989|NCT03614923|100917728|FG002|Overall Study|Non-compliance|0|||
33485744|NCT00996892|101671453|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
33485745|NCT00996892|101671454|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
33485746|NCT00996892|101671455|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
33485747|NCT00996892|101671456|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
33485748|NCT00996892|101671457|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
33485749|NCT00996892|101671458|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
33485750|NCT00996892|101671459|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
33485751|NCT00996892|101671460|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
33485752|NCT00996892|101671461|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
33485753|NCT00996892|101671462|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
33485754|NCT00996892|101671463|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
33485755|NCT00996892|101671464|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
33485756|NCT00996892|101671465|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
33485757|NCT00996892|101671466|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
33485758|NCT00996892|101671467|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
33485759|NCT00996892|101671468|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
33485760|NCT00996892|101671449|FG000|Dose-Escalation Stage 1A|Death|0|||
33485761|NCT00996892|101671450|FG001|Dose-Escalation Stage 1A|Death|0|||
33485762|NCT00996892|101671451|FG002|Dose-Escalation Stage 1A|Death|0|||
33485763|NCT00996892|101671452|FG003|Dose-Escalation Stage 1A|Death|0|||
33485764|NCT00996892|101671453|FG004|Dose-Escalation Stage 1A|Death|0|||
33485765|NCT00996892|101671454|FG005|Dose-Escalation Stage 1A|Death|0|||
33485766|NCT00996892|101671455|FG006|Dose-Escalation Stage 1A|Death|0|||
33485767|NCT00996892|101671456|FG007|Dose-Escalation Stage 1A|Death|0|||
33485768|NCT00996892|101671457|FG008|Dose-Escalation Stage 1A|Death|0|||
33485769|NCT00996892|101671458|FG009|Dose-Escalation Stage 1A|Death|2|||
33485770|NCT00996892|101671459|FG010|Dose-Escalation Stage 1A|Death|0|||
33485771|NCT00996892|101671460|FG011|Dose-Escalation Stage 1A|Death|1|||
33485772|NCT00996892|101671461|FG012|Dose-Escalation Stage 1A|Death|1|||
33485773|NCT00996892|101671462|FG013|Dose-Escalation Stage 1A|Death|0|||
33485774|NCT00996892|101671463|FG014|Dose-Escalation Stage 1A|Death|0|||
33485775|NCT00996892|101671464|FG015|Dose-Escalation Stage 1A|Death|0|||
33485776|NCT00996892|101671465|FG016|Dose-Escalation Stage 1A|Death|0|||
33485777|NCT00996892|101671466|FG017|Dose-Escalation Stage 1A|Death|0|||
33485778|NCT00996892|101671467|FG018|Dose-Escalation Stage 1A|Death|0|||
33485779|NCT00996892|101671468|FG019|Dose-Escalation Stage 1A|Death|0|||
33278990|NCT03614923|100917726|FG000|Overall Study|Other|0|||
33278991|NCT03614923|100917727|FG001|Overall Study|Other|1|||
33278992|NCT03614923|100917728|FG002|Overall Study|Other|1|||
33278993|NCT01780584|100917733|FG000|Overall Study|Death|1|||
33278994|NCT01780584|100917734|FG001|Overall Study|Death|0|||
33278995|NCT01780584|100917735|FG002|Overall Study|Death|1|||
33278996|NCT01780584|100917733|FG000|Overall Study|Adverse Event|0|||
33278997|NCT01780584|100917734|FG001|Overall Study|Adverse Event|1|||
33278998|NCT01780584|100917735|FG002|Overall Study|Adverse Event|0|||
33278999|NCT01780584|100917733|FG000|Overall Study|Protocol Violation|0|||
33279000|NCT01780584|100917734|FG001|Overall Study|Protocol Violation|0|||
33279001|NCT01780584|100917735|FG002|Overall Study|Protocol Violation|1|||
33279002|NCT02971683|100917736|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
33279003|NCT02971683|100917737|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
33279004|NCT02971683|100917736|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
33279005|NCT02971683|100917737|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
33279006|NCT02971683|100917736|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
33279007|NCT02971683|100917737|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
33279008|NCT02971683|100917736|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
33279009|NCT02971683|100917737|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
33279010|NCT02971683|100917736|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
33485780|NCT00996892|101671449|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
33485781|NCT00996892|101671450|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
33485782|NCT00996892|101671451|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
33485783|NCT00996892|101671452|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
33485784|NCT00996892|101671453|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
33485785|NCT00996892|101671454|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
33485786|NCT00996892|101671455|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
33485787|NCT00996892|101671456|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
33485788|NCT00996892|101671457|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
33279011|NCT02971683|100917737|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
33279012|NCT02971683|100917736|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
33279013|NCT02971683|100917737|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
33279014|NCT02971683|100917736|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
33279015|NCT02971683|100917737|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
33279016|NCT02971683|100917736|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
33485789|NCT00996892|101671458|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
33485790|NCT00996892|101671459|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
33485791|NCT00996892|101671460|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
33485792|NCT00996892|101671461|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
33485793|NCT00996892|101671462|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
33485794|NCT00996892|101671463|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
33279017|NCT02971683|100917737|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
33279018|NCT02971683|100917736|FG000|Open-Label|Lost to Follow-up|1|||
33279019|NCT02971683|100917737|FG001|Open-Label|Lost to Follow-up|0|||
33279020|NCT02971683|100917736|FG000|Open-Label|Participants withdrew consent|0|||
33279021|NCT02971683|100917737|FG001|Open-Label|Participants withdrew consent|2|||
33279022|NCT02971683|100917736|FG000|Open-Label|Participant request to discontinue study treatment|1|||
33279023|NCT02971683|100917737|FG001|Open-Label|Participant request to discontinue study treatment|0|||
33279024|NCT02971683|100917736|FG000|Open-Label|Lack of Efficacy|2|||
33279025|NCT02971683|100917737|FG001|Open-Label|Lack of Efficacy|0|||
33485795|NCT00996892|101671464|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
33485796|NCT00996892|101671465|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
33485797|NCT00996892|101671466|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
33485798|NCT00996892|101671467|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
33485799|NCT00996892|101671468|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
33485800|NCT00996892|101671449|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485801|NCT00996892|101671450|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485802|NCT00996892|101671451|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485803|NCT00996892|101671452|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485804|NCT00996892|101671453|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485805|NCT00996892|101671454|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485806|NCT00996892|101671455|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485807|NCT00996892|101671456|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485808|NCT00996892|101671457|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485809|NCT00996892|101671458|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
33485810|NCT00996892|101671459|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
33485811|NCT00996892|101671460|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
33485812|NCT00996892|101671461|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
33485813|NCT00996892|101671462|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485814|NCT00996892|101671463|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485815|NCT00996892|101671464|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485816|NCT00996892|101671465|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485817|NCT00996892|101671466|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485818|NCT00996892|101671467|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485819|NCT00996892|101671468|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
33485820|NCT00996892|101671449|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
33485821|NCT00996892|101671450|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
33485822|NCT00996892|101671451|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
33485823|NCT00996892|101671452|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
33485824|NCT00996892|101671453|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
33485825|NCT00996892|101671454|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
33485826|NCT00996892|101671455|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
33485827|NCT00996892|101671456|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
33485828|NCT00996892|101671457|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
33485829|NCT00996892|101671458|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
33485830|NCT00996892|101671459|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
33279026|NCT02971683|100917736|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
33279027|NCT02971683|100917737|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
33279028|NCT02971683|100917736|FG000|Long-Term Open Label|Participant withdrew consent|1|||
33279029|NCT02971683|100917737|FG001|Long-Term Open Label|Participant withdrew consent|0|||
33279030|NCT02971683|100917736|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
33279031|NCT02971683|100917737|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
33279032|NCT02971683|100917736|FG000|Long-Term Open Label|Adverse Event|1|||
33485831|NCT00996892|101671460|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
33485832|NCT00996892|101671461|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
33485833|NCT00996892|101671462|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
33485834|NCT00996892|101671463|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
33485835|NCT00996892|101671464|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
33279033|NCT02971683|100917737|FG001|Long-Term Open Label|Adverse Event|2|||
33279034|NCT02971683|100917736|FG000|Long-Term Open Label|Lack of Efficacy|1|||
33279035|NCT02971683|100917737|FG001|Long-Term Open Label|Lack of Efficacy|1|||
33279036|NCT01901302|100917738|FG000|Overall Study|Adverse Event|2|||
33279037|NCT01901302|100917739|FG001|Overall Study|Adverse Event|1|||
33279038|NCT01901302|100917738|FG000|Overall Study|Lack of Efficacy|0|||
33279039|NCT01901302|100917739|FG001|Overall Study|Lack of Efficacy|2|||
33279040|NCT01901302|100917738|FG000|Overall Study|Study Terminated by Sponsor|23|||
33279041|NCT01901302|100917739|FG001|Overall Study|Study Terminated by Sponsor|20|||
33279042|NCT01901302|100917738|FG000|Overall Study|Withdrawal by Subject|2|||
33279043|NCT01901302|100917739|FG001|Overall Study|Withdrawal by Subject|0|||
33279044|NCT01066897|100917740|FG000|Overall Study|Withdrawal by Subject|1|||
33279045|NCT01066897|100917741|FG001|Overall Study|Withdrawal by Subject|0|||
33279046|NCT01066897|100917740|FG000|Overall Study|stopped study after developing the flu.|1|||
33279047|NCT01066897|100917741|FG001|Overall Study|stopped study after developing the flu.|0|||
33279048|NCT01114217|100917742|FG000|Overall Study|Adverse Event|5|||
33279049|NCT01114217|100917743|FG001|Overall Study|Adverse Event|3|||
33279050|NCT01114217|100917742|FG000|Overall Study|Lost to Follow-up|17|||
33279051|NCT01114217|100917743|FG001|Overall Study|Lost to Follow-up|33|||
33279052|NCT01114217|100917742|FG000|Overall Study|Withdrawal by Subject|21|||
33279053|NCT01114217|100917743|FG001|Overall Study|Withdrawal by Subject|28|||
33279054|NCT01114217|100917742|FG000|Overall Study|Other-Clerical Error|3|||
33279055|NCT01114217|100917743|FG001|Overall Study|Other-Clerical Error|0|||
33279056|NCT01114217|100917742|FG000|Overall Study|Other-Early termination|6|||
33279057|NCT01114217|100917743|FG001|Overall Study|Other-Early termination|10|||
33279058|NCT01114217|100917742|FG000|Overall Study|Other-Procedure|1|||
33279059|NCT01114217|100917743|FG001|Overall Study|Other-Procedure|1|||
33279060|NCT01114217|100917742|FG000|Overall Study|Other-Pregnancy|2|||
33279061|NCT01114217|100917743|FG001|Overall Study|Other-Pregnancy|4|||
33279062|NCT01114217|100917742|FG000|Overall Study|Other-Protocol Violation|1|||
33279063|NCT01114217|100917743|FG001|Overall Study|Other-Protocol Violation|3|||
33279064|NCT01114217|100917742|FG000|Overall Study|Other-Lack of Efficacy|1|||
33279065|NCT01114217|100917743|FG001|Overall Study|Other-Lack of Efficacy|0|||
33279066|NCT01114217|100917742|FG000|Overall Study|Other-Non Compliance|2|||
33279067|NCT01114217|100917743|FG001|Overall Study|Other-Non Compliance|0|||
33279068|NCT01114217|100917742|FG000|Overall Study|Other-Physician Decision|1|||
33279069|NCT01114217|100917743|FG001|Overall Study|Other-Physician Decision|1|||
33279070|NCT01114217|100917742|FG000|Overall Study|Other-Sponsor Decision|10|||
33279071|NCT01114217|100917743|FG001|Overall Study|Other-Sponsor Decision|12|||
33279072|NCT01114217|100917742|FG000|Overall Study|Other-Study Termination|0|||
33279073|NCT01114217|100917743|FG001|Overall Study|Other-Study Termination|1|||
33279074|NCT01114217|100917742|FG000|Overall Study|Other-Study Withdrawn|1|||
33279075|NCT01114217|100917743|FG001|Overall Study|Other-Study Withdrawn|1|||
33279076|NCT01114217|100917742|FG000|Overall Study|Other-Site Stopped Communicating|2|||
33279077|NCT01114217|100917743|FG001|Overall Study|Other-Site Stopped Communicating|0|||
33279078|NCT01114217|100917742|FG000|Overall Study|Other-Lost to Follow-up|1|||
33279079|NCT01114217|100917743|FG001|Overall Study|Other-Lost to Follow-up|0|||
33279080|NCT01114217|100917742|FG000|Overall Study|Other-Withdrawal by Subject|1|||
33279081|NCT01114217|100917743|FG001|Overall Study|Other-Withdrawal by Subject|1|||
33279082|NCT03360071|100917750|FG000|Overall Study|Lost to Follow-up|1|||
33279083|NCT03360071|100917751|FG001|Overall Study|Lost to Follow-up|0|||
33279084|NCT03320941|100917756|FG000|Overall Study|subject/guardian decision|0|||
33279085|NCT03320941|100917757|FG001|Overall Study|subject/guardian decision|0|||
33279086|NCT03320941|100917758|FG002|Overall Study|subject/guardian decision|0|||
33279087|NCT03320941|100917759|FG003|Overall Study|subject/guardian decision|1|||
33279088|NCT03320941|100917760|FG004|Overall Study|subject/guardian decision|0|||
33279089|NCT01038128|100917763|FG000|Overall Study|Lack of Efficacy|1|||
33279090|NCT01038128|100917763|FG000|Overall Study|Lost to Follow-up|1|||
33279091|NCT01038128|100917763|FG000|Overall Study|Withdrawal by Subject|2|||
33279092|NCT00203502|100917764|FG000|Overall Study|Death|1|||
33279093|NCT01129011|100917765|FG000|Overall Study|Adverse Event|20|||
33279094|NCT01129011|100917766|FG001|Overall Study|Adverse Event|30|||
33279095|NCT01129011|100917765|FG000|Overall Study|Withdrawal by Subject|24|||
33279096|NCT01129011|100917766|FG001|Overall Study|Withdrawal by Subject|8|||
33279097|NCT01129011|100917765|FG000|Overall Study|Lost to Follow-up|6|||
33279098|NCT01129011|100917766|FG001|Overall Study|Lost to Follow-up|7|||
33279099|NCT01129011|100917765|FG000|Overall Study|Duodenal Ulcer|2|||
33279100|NCT01129011|100917766|FG001|Overall Study|Duodenal Ulcer|8|||
33279101|NCT01129011|100917765|FG000|Overall Study|misc|7|||
33279102|NCT01129011|100917766|FG001|Overall Study|misc|4|||
33279103|NCT00988429|100917767|FG000|Overall Study|Adverse Event|9|||
33279104|NCT00988429|100917768|FG001|Overall Study|Adverse Event|21|||
33279105|NCT00988429|100917769|FG002|Overall Study|Adverse Event|45|||
33279106|NCT00988429|100917767|FG000|Overall Study|Lack of Efficacy|0|||
33279107|NCT00988429|100917768|FG001|Overall Study|Lack of Efficacy|0|||
33279108|NCT00988429|100917769|FG002|Overall Study|Lack of Efficacy|1|||
33279109|NCT00988429|100917767|FG000|Overall Study|Non-Compliance with Study Drug|5|||
33279110|NCT00988429|100917768|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33279111|NCT00988429|100917769|FG002|Overall Study|Non-Compliance with Study Drug|3|||
33279112|NCT00988429|100917767|FG000|Overall Study|Physician Decision|1|||
33279113|NCT00988429|100917768|FG001|Overall Study|Physician Decision|0|||
33279114|NCT00988429|100917769|FG002|Overall Study|Physician Decision|3|||
33279115|NCT00988429|100917767|FG000|Overall Study|Pregnancy|2|||
33279116|NCT00988429|100917768|FG001|Overall Study|Pregnancy|1|||
33279117|NCT00988429|100917769|FG002|Overall Study|Pregnancy|0|||
33279118|NCT00988429|100917767|FG000|Overall Study|Protocol Violation|4|||
33279119|NCT00988429|100917768|FG001|Overall Study|Protocol Violation|3|||
33279120|NCT00988429|100917769|FG002|Overall Study|Protocol Violation|3|||
33279121|NCT00988429|100917767|FG000|Overall Study|Withdrawal by Subject|7|||
33279122|NCT00988429|100917768|FG001|Overall Study|Withdrawal by Subject|7|||
33279123|NCT00988429|100917769|FG002|Overall Study|Withdrawal by Subject|12|||
33279124|NCT00988429|100917767|FG000|Overall Study|Administrative Reasons|1|||
33279125|NCT00988429|100917768|FG001|Overall Study|Administrative Reasons|2|||
33279126|NCT00988429|100917769|FG002|Overall Study|Administrative Reasons|1|||
33279127|NCT00988429|100917767|FG000|Overall Study|other reasons|8|||
33279128|NCT00988429|100917768|FG001|Overall Study|other reasons|8|||
33279129|NCT00988429|100917769|FG002|Overall Study|other reasons|1|||
33279130|NCT03651271|100917770|FG000|Overall Study|Death|4|||
33279131|NCT03651271|100917771|FG001|Overall Study|Death|37|||
33279132|NCT03651271|100917772|FG002|Overall Study|Death|0|||
33279133|NCT03651271|100917773|FG003|Overall Study|Death|2|||
33279134|NCT03651271|100917774|FG004|Overall Study|Death|6|||
33279135|NCT03651271|100917770|FG000|Overall Study|Lost to Follow-up|1|||
33279136|NCT03651271|100917771|FG001|Overall Study|Lost to Follow-up|5|||
33279137|NCT03651271|100917772|FG002|Overall Study|Lost to Follow-up|0|||
33279138|NCT03651271|100917773|FG003|Overall Study|Lost to Follow-up|1|||
33279139|NCT03651271|100917774|FG004|Overall Study|Lost to Follow-up|0|||
33279140|NCT03651271|100917770|FG000|Overall Study|Physician Decision|0|||
33279141|NCT03651271|100917771|FG001|Overall Study|Physician Decision|2|||
33279142|NCT03651271|100917772|FG002|Overall Study|Physician Decision|0|||
33279143|NCT03651271|100917773|FG003|Overall Study|Physician Decision|0|||
33279144|NCT03651271|100917774|FG004|Overall Study|Physician Decision|0|||
33279145|NCT03651271|100917770|FG000|Overall Study|Withdrawal by Subject|1|||
33279146|NCT03651271|100917771|FG001|Overall Study|Withdrawal by Subject|15|||
33279147|NCT03651271|100917772|FG002|Overall Study|Withdrawal by Subject|0|||
33279148|NCT03651271|100917773|FG003|Overall Study|Withdrawal by Subject|0|||
33279149|NCT03651271|100917774|FG004|Overall Study|Withdrawal by Subject|1|||
33279150|NCT03651271|100917770|FG000|Overall Study|Patient medically unable to continue|0|||
33279151|NCT03651271|100917771|FG001|Overall Study|Patient medically unable to continue|0|||
33279152|NCT03651271|100917772|FG002|Overall Study|Patient medically unable to continue|0|||
33279153|NCT03651271|100917773|FG003|Overall Study|Patient medically unable to continue|1|||
33279154|NCT03651271|100917774|FG004|Overall Study|Patient medically unable to continue|0|||
33279155|NCT02350127|100917777|FG000|4-Month Assessment|Withdrawal by Subject|10|||
33279156|NCT02350127|100917778|FG001|4-Month Assessment|Withdrawal by Subject|9|||
33279157|NCT02350127|100917777|FG000|4-Month Assessment|Death|1|||
33279158|NCT02350127|100917778|FG001|4-Month Assessment|Death|0|||
33279159|NCT02350127|100917777|FG000|8-Month Assessment|Death|1|||
33279160|NCT02350127|100917778|FG001|8-Month Assessment|Death|1|||
33279161|NCT02350127|100917777|FG000|8-Month Assessment|Withdrawal by Subject|5|||
33279162|NCT02350127|100917778|FG001|8-Month Assessment|Withdrawal by Subject|8|||
33279163|NCT02136797|100917784|FG000|Overall Study|Not Treated|8|||
33279164|NCT00145496|100917785|FG000|Overall Study|Adverse Event|42|||
33279165|NCT00145496|100917786|FG001|Overall Study|Adverse Event|30|||
33279166|NCT00145496|100917785|FG000|Overall Study|Lack of Efficacy|12|||
33279167|NCT00145496|100917786|FG001|Overall Study|Lack of Efficacy|7|||
33279168|NCT00145496|100917785|FG000|Overall Study|Withdrawal by Subject|32|||
33279169|NCT00145496|100917786|FG001|Overall Study|Withdrawal by Subject|26|||
33279170|NCT00145496|100917785|FG000|Overall Study|Lost to Follow-up|12|||
33279171|NCT00145496|100917786|FG001|Overall Study|Lost to Follow-up|5|||
33279172|NCT00145496|100917785|FG000|Overall Study|Other|25|||
33279173|NCT00145496|100917786|FG001|Overall Study|Other|13|||
33279174|NCT01721759|100917787|FG000|Treatment Period|Disease Progression|85|||
33279175|NCT01721759|100917787|FG000|Treatment Period|Study drug toxicity|14|||
33279176|NCT01721759|100917787|FG000|Treatment Period|Death|1|||
33279177|NCT01721759|100917787|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
33279178|NCT01721759|100917787|FG000|Treatment Period|Participant request to withdraw|3|||
33279179|NCT01721759|100917787|FG000|Treatment Period|Other Reasons|3|||
33279180|NCT01721759|100917787|FG000|End of Study Period|Participant Withdrew Consent|5|||
33279181|NCT01721759|100917787|FG000|End of Study Period|Death|101|||
33279182|NCT01721759|100917787|FG000|End of Study Period|Lost to Follow-up|1|||
33279183|NCT01721759|100917787|FG000|End of Study Period|Other Reasons|10|||
33279184|NCT04564027|100917788|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
33279185|NCT04564027|100917789|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
33279186|NCT04564027|100917790|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
33279187|NCT04564027|100917791|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
33279188|NCT04393779|100917792|FG000|Overall Study|Death|1|||
33279189|NCT04393779|100917792|FG000|Overall Study|Device reintervention or explant|4|||
33279190|NCT00747149|100917793|FG000|Overall Study|Adverse Event|0|||
33279191|NCT00747149|100917794|FG001|Overall Study|Adverse Event|15|||
33279192|NCT00747149|100917793|FG000|Overall Study|Lost to Follow-up|0|||
33279193|NCT00747149|100917794|FG001|Overall Study|Lost to Follow-up|10|||
33279194|NCT00747149|100917793|FG000|Overall Study|Withdrawal by Subject|0|||
33279195|NCT00747149|100917794|FG001|Overall Study|Withdrawal by Subject|6|||
33279196|NCT00747149|100917793|FG000|Overall Study|Did not receive treatment|0|||
33279197|NCT00747149|100917794|FG001|Overall Study|Did not receive treatment|1|||
33279198|NCT00747149|100917793|FG000|Overall Study|Incorrect enrollment|0|||
33279199|NCT00747149|100917794|FG001|Overall Study|Incorrect enrollment|6|||
33279200|NCT00747149|100917793|FG000|Overall Study|Severe non-compliance to protocol|0|||
33279201|NCT00747149|100917794|FG001|Overall Study|Severe non-compliance to protocol|1|||
33279202|NCT00747149|100917793|FG000|Overall Study|Not reported|1|||
33279203|NCT00747149|100917794|FG001|Overall Study|Not reported|4|||
33279204|NCT00191984|100917795|FG000|Overall Study|Disease Progression|21|||
33279205|NCT00191984|100917795|FG000|Overall Study|Adverse Event|4|||
33279206|NCT00191984|100917795|FG000|Overall Study|Death|2|||
33279207|NCT00191984|100917795|FG000|Overall Study|Entry Criteria Exclusion|1|||
33279208|NCT00191984|100917795|FG000|Overall Study|Withdrawal by Subject|7|||
33279209|NCT00191984|100917795|FG000|Overall Study|Physician Decision|4|||
33279210|NCT01106586|100917796|FG000|Overall Study|Adverse Event|9|||
33279211|NCT01106586|100917797|FG001|Overall Study|Adverse Event|15|||
33279212|NCT01106586|100917796|FG000|Overall Study|Death|1|||
33279213|NCT01106586|100917797|FG001|Overall Study|Death|3|||
33279214|NCT01106586|100917796|FG000|Overall Study|Pregnancy|2|||
33279215|NCT01106586|100917797|FG001|Overall Study|Pregnancy|2|||
33279216|NCT01106586|100917796|FG000|Overall Study|Lack of Efficacy|1|||
33279217|NCT01106586|100917797|FG001|Overall Study|Lack of Efficacy|0|||
33279218|NCT01106586|100917796|FG000|Overall Study|Investigator's Discretion|5|||
33279219|NCT01106586|100917797|FG001|Overall Study|Investigator's Discretion|8|||
33279220|NCT01106586|100917796|FG000|Overall Study|Withdrew Consent|18|||
33279221|NCT01106586|100917797|FG001|Overall Study|Withdrew Consent|30|||
33279222|NCT01106586|100917796|FG000|Overall Study|Lost to Follow-up|24|||
33279223|NCT01106586|100917797|FG001|Overall Study|Lost to Follow-up|20|||
33279224|NCT01106586|100917796|FG000|Overall Study|Participant Noncompliance|12|||
33279225|NCT01106586|100917797|FG001|Overall Study|Participant Noncompliance|10|||
33279226|NCT01106586|100917796|FG000|Overall Study|Protocol Violation|1|||
33279227|NCT01106586|100917797|FG001|Overall Study|Protocol Violation|0|||
33279228|NCT01106586|100917796|FG000|Overall Study|Participant Transferred to Another Study|212|||
33279229|NCT01106586|100917797|FG001|Overall Study|Participant Transferred to Another Study|197|||
33279230|NCT02409732|100917798|FG000|Overall Study|Withdrawal by Subject|4|||
33279231|NCT02409732|100917798|FG000|Overall Study|Lost to Follow-up|2|||
33279232|NCT01446042|100917809|FG000|Overall Study|Withdrawal by Subject|12|||
33279233|NCT01446042|100917810|FG001|Overall Study|Withdrawal by Subject|2|||
33279234|NCT01446042|100917811|FG002|Overall Study|Withdrawal by Subject|4|||
33279235|NCT01446042|100917809|FG000|Overall Study|Adverse Event|1|||
33279236|NCT01446042|100917810|FG001|Overall Study|Adverse Event|0|||
33279237|NCT01446042|100917811|FG002|Overall Study|Adverse Event|4|||
33279238|NCT01446042|100917809|FG000|Overall Study|Lost to Follow-up|5|||
33279239|NCT01446042|100917810|FG001|Overall Study|Lost to Follow-up|0|||
33279240|NCT01446042|100917811|FG002|Overall Study|Lost to Follow-up|0|||
33279241|NCT01446042|100917809|FG000|Overall Study|Other reasons|2|||
33279242|NCT01446042|100917810|FG001|Overall Study|Other reasons|1|||
33279243|NCT01446042|100917811|FG002|Overall Study|Other reasons|1|||
33279244|NCT01283971|100917812|FG000|Overall Study|Adverse Event|3|||
33279245|NCT01283971|100917813|FG001|Overall Study|Adverse Event|5|||
33279246|NCT01283971|100917812|FG000|Overall Study|Insufficient therapeutic responses|3|||
33279247|NCT01283971|100917813|FG001|Overall Study|Insufficient therapeutic responses|3|||
33279248|NCT01283971|100917812|FG000|Overall Study|Protocol Violation|5|||
33279249|NCT01283971|100917813|FG001|Overall Study|Protocol Violation|1|||
33279250|NCT01283971|100917812|FG000|Overall Study|Refused treatment|3|||
33279251|NCT01283971|100917813|FG001|Overall Study|Refused treatment|1|||
33279252|NCT01283971|100917812|FG000|Overall Study|Failure to return|0|||
33279253|NCT01283971|100917813|FG001|Overall Study|Failure to return|1|||
33279254|NCT01283971|100917812|FG000|Overall Study|Administrative reasons|1|||
33279255|NCT01283971|100917813|FG001|Overall Study|Administrative reasons|1|||
33279256|NCT01631825|100917824|FG000|Overall Study|Adverse Event|42|||
33279257|NCT01631825|100917824|FG000|Overall Study|Lack of Efficacy|7|||
33279258|NCT01631825|100917824|FG000|Overall Study|Withdrawal by Subject|9|||
33279259|NCT01631825|100917824|FG000|Overall Study|Protocol Violation|4|||
33279260|NCT01631825|100917824|FG000|Overall Study|Discontinuation criteria|1|||
33279261|NCT01631825|100917824|FG000|Overall Study|Physician Decision|2|||
33279262|NCT05740371|100917827|FG000|Overall Study|Death|1|||
33279263|NCT01870999|100917828|FG000|Overall Study|Adverse Event|0|||
33279264|NCT01870999|100917829|FG001|Overall Study|Adverse Event|4|||
33279265|NCT01870999|100917830|FG002|Overall Study|Adverse Event|1|||
33279266|NCT01870999|100917828|FG000|Overall Study|Subject met withdrawal criteria|3|||
33279267|NCT01870999|100917829|FG001|Overall Study|Subject met withdrawal criteria|2|||
33279268|NCT01870999|100917830|FG002|Overall Study|Subject met withdrawal criteria|0|||
33279269|NCT01870999|100917828|FG000|Overall Study|Subject withdrawn by Investigator|1|||
33279270|NCT01870999|100917829|FG001|Overall Study|Subject withdrawn by Investigator|0|||
33279271|NCT01870999|100917830|FG002|Overall Study|Subject withdrawn by Investigator|0|||
33279272|NCT01870999|100917828|FG000|Overall Study|Withdrawal by Subject|0|||
33279273|NCT01870999|100917829|FG001|Overall Study|Withdrawal by Subject|2|||
33279274|NCT01870999|100917830|FG002|Overall Study|Withdrawal by Subject|5|||
33279275|NCT01870999|100917828|FG000|Overall Study|Protocol Violation|0|||
33279276|NCT01870999|100917829|FG001|Overall Study|Protocol Violation|0|||
33279277|NCT01870999|100917830|FG002|Overall Study|Protocol Violation|1|||
33279278|NCT01882088|100917833|FG000|Overall Study|Intolerance of esophageal manometry|1|||
33279279|NCT01882088|100917833|FG000|Overall Study|no possibility to place the catheter|1|||
33279280|NCT01882088|100917833|FG000|Overall Study|Protocol Violation|1|||
33279281|NCT01882088|100917833|FG000|Overall Study|inadequate pH-impedance tracings|2|||
33279282|NCT02056873|100917834|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
33279283|NCT01951105|100917836|FG000|Overall Study|Adverse Event|0|||
33279284|NCT01951105|100917837|FG001|Overall Study|Adverse Event|5|||
33279285|NCT01951105|100917838|FG002|Overall Study|Adverse Event|0|||
33279286|NCT01951105|100917836|FG000|Overall Study|Lost to Follow-up|0|||
33279287|NCT01951105|100917837|FG001|Overall Study|Lost to Follow-up|1|||
33279288|NCT01951105|100917838|FG002|Overall Study|Lost to Follow-up|0|||
33279289|NCT01951105|100917836|FG000|Overall Study|Protocol Violation|1|||
33279290|NCT01951105|100917837|FG001|Overall Study|Protocol Violation|1|||
33279291|NCT01951105|100917838|FG002|Overall Study|Protocol Violation|1|||
33279292|NCT01951105|100917836|FG000|Overall Study|Withdrawal by Subject|0|||
33279293|NCT01951105|100917837|FG001|Overall Study|Withdrawal by Subject|3|||
33279294|NCT01951105|100917838|FG002|Overall Study|Withdrawal by Subject|1|||
33279295|NCT00449033|100917842|FG000|Treatment Period|Adverse Event|117|||
33279296|NCT00449033|100917843|FG001|Treatment Period|Adverse Event|83|||
33279297|NCT00449033|100917842|FG000|Treatment Period|Death|21|||
33279298|NCT00449033|100917843|FG001|Treatment Period|Death|12|||
33279299|NCT00449033|100917842|FG000|Treatment Period|Lost to Follow-up|0|||
33279300|NCT00449033|100917843|FG001|Treatment Period|Lost to Follow-up|2|||
33279301|NCT00449033|100917842|FG000|Treatment Period|Physician Decision|4|||
33279302|NCT00449033|100917843|FG001|Treatment Period|Physician Decision|5|||
33279303|NCT00449033|100917842|FG000|Treatment Period|Protocol Violation|8|||
33279304|NCT00449033|100917843|FG001|Treatment Period|Protocol Violation|7|||
33279305|NCT00449033|100917842|FG000|Treatment Period|Disease Progression|231|||
33279306|NCT00449033|100917843|FG001|Treatment Period|Disease Progression|288|||
33279307|NCT00449033|100917842|FG000|Treatment Period|Consent Withdrawn|36|||
33279308|NCT00449033|100917843|FG001|Treatment Period|Consent Withdrawn|20|||
33279309|NCT00449033|100917842|FG000|Treatment Period|Amended Protocol Criteria|22|||
33279310|NCT00449033|100917843|FG001|Treatment Period|Amended Protocol Criteria|18|||
33279311|NCT00449033|100917842|FG000|Treatment Period|Non-compliance|7|||
33279312|NCT00449033|100917843|FG001|Treatment Period|Non-compliance|8|||
33279313|NCT00449033|100917842|FG000|Treatment Period|Second Malignancy|0|||
33279314|NCT00449033|100917843|FG001|Treatment Period|Second Malignancy|1|||
33279315|NCT00449033|100917842|FG000|Treatment Period|Reason Missing|0|||
33279316|NCT00449033|100917843|FG001|Treatment Period|Reason Missing|4|||
33279317|NCT00449033|100917842|FG000|Treatment Period|Treatment Ongoing|6|||
33279318|NCT00449033|100917843|FG001|Treatment Period|Treatment Ongoing|4|||
33279319|NCT00449033|100917842|FG000|Follow-up Period|Death|299|||
33279320|NCT00449033|100917843|FG001|Follow-up Period|Death|311|||
33279321|NCT00449033|100917842|FG000|Follow-up Period|Lost to Follow-up|6|||
33279322|NCT00449033|100917843|FG001|Follow-up Period|Lost to Follow-up|10|||
33279323|NCT00449033|100917842|FG000|Follow-up Period|Reason Missing|120|||
33279324|NCT00449033|100917843|FG001|Follow-up Period|Reason Missing|113|||
33279325|NCT02784535|100917844|FG000|Overall Study|Adverse Event|1|||
33279326|NCT02784535|100917845|FG001|Overall Study|Adverse Event|0|||
33279327|NCT02784535|100917844|FG000|Overall Study|Withdrawal by Subject|0|||
33279328|NCT02784535|100917845|FG001|Overall Study|Withdrawal by Subject|1|||
33279329|NCT02784535|100917844|FG000|Overall Study|Physician Decision|0|||
33279330|NCT02784535|100917845|FG001|Overall Study|Physician Decision|1|||
33279331|NCT02854436|100917846|FG000|Overall Study|Adverse Event|1|||
33279332|NCT02854436|100917846|FG000|Overall Study|Death|208|||
33279333|NCT02854436|100917846|FG000|Overall Study|Lost to Follow-up|5|||
33279334|NCT02854436|100917846|FG000|Overall Study|Withdrawal by Subject|24|||
33279335|NCT02854436|100917846|FG000|Overall Study|Other|45|||
33279336|NCT02854436|100917846|FG000|Overall Study|Physician Decision|6|||
33279337|NCT03169530|100917847|FG000|Overall Study|Study ended by NIH|15|||
33279338|NCT03169530|100917848|FG001|Overall Study|Study ended by NIH|17|||
33279339|NCT02101554|100917849|FG000|Overall Study|Protocol Violation|0|||
33279340|NCT02101554|100917850|FG001|Overall Study|Protocol Violation|1|||
33279341|NCT02101554|100917851|FG002|Overall Study|Protocol Violation|0|||
33279342|NCT02101554|100917849|FG000|Overall Study|Insufficient Clinical Response|0|||
33279343|NCT02101554|100917850|FG001|Overall Study|Insufficient Clinical Response|2|||
33279344|NCT02101554|100917851|FG002|Overall Study|Insufficient Clinical Response|0|||
33279345|NCT02101554|100917849|FG000|Overall Study|Adverse Event|2|||
33279346|NCT02101554|100917850|FG001|Overall Study|Adverse Event|1|||
33279347|NCT02101554|100917851|FG002|Overall Study|Adverse Event|1|||
33279348|NCT02101554|100917849|FG000|Overall Study|Lost to Follow-up|0|||
33279349|NCT02101554|100917850|FG001|Overall Study|Lost to Follow-up|1|||
33279350|NCT02101554|100917851|FG002|Overall Study|Lost to Follow-up|0|||
33279351|NCT02101554|100917849|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
33279352|NCT02101554|100917850|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
33279353|NCT02101554|100917851|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
33279354|NCT02065895|100917854|FG000|Overall Study|Protocol Violation|1|||
33279355|NCT02065895|100917855|FG001|Overall Study|Protocol Violation|0|||
33279356|NCT02065895|100917856|FG002|Overall Study|Protocol Violation|0|||
33279357|NCT02065895|100917857|FG003|Overall Study|Protocol Violation|1|||
33279358|NCT02065895|100917858|FG004|Overall Study|Protocol Violation|0|||
33279359|NCT02065895|100917859|FG005|Overall Study|Protocol Violation|0|||
33279360|NCT02065895|100917854|FG000|Overall Study|Scheduling conflicts|0|||
33279361|NCT02065895|100917855|FG001|Overall Study|Scheduling conflicts|1|||
33279362|NCT02065895|100917856|FG002|Overall Study|Scheduling conflicts|0|||
33279363|NCT02065895|100917857|FG003|Overall Study|Scheduling conflicts|0|||
33279364|NCT02065895|100917858|FG004|Overall Study|Scheduling conflicts|0|||
33279365|NCT02065895|100917859|FG005|Overall Study|Scheduling conflicts|0|||
33279366|NCT01745380|100917860|FG000|Overall Study|Lost to Follow-up|1|||
33279367|NCT01745380|100917861|FG001|Overall Study|Lost to Follow-up|0|||
33279368|NCT01745380|100917860|FG000|Overall Study|Lack of Efficacy|0|||
33279369|NCT01745380|100917861|FG001|Overall Study|Lack of Efficacy|1|||
33279370|NCT01838499|100917865|FG000|Overall Study|Protocol Violation|0|||
33279371|NCT01838499|100917866|FG001|Overall Study|Protocol Violation|1|||
33279372|NCT01838499|100917865|FG000|Overall Study|Lost to Follow-up|2|||
33279373|NCT01838499|100917866|FG001|Overall Study|Lost to Follow-up|4|||
33279374|NCT01838499|100917865|FG000|Overall Study|Lack of Efficacy|1|||
33279375|NCT01838499|100917866|FG001|Overall Study|Lack of Efficacy|2|||
33279376|NCT01838499|100917865|FG000|Overall Study|Adverse Event|2|||
33279377|NCT01838499|100917866|FG001|Overall Study|Adverse Event|1|||
33279378|NCT01838499|100917865|FG000|Overall Study|Withdrawal by Subject|19|||
33279379|NCT01838499|100917866|FG001|Overall Study|Withdrawal by Subject|9|||
33279380|NCT03048058|100917867|FG000|Overall Study|Lost to Follow-up|4|||
33279381|NCT03048058|100917868|FG001|Overall Study|Lost to Follow-up|0|||
33279382|NCT03048058|100917867|FG000|Overall Study|Withdrawal by Subject|0|||
33279383|NCT03048058|100917868|FG001|Overall Study|Withdrawal by Subject|4|||
33279384|NCT00665392|100917869|FG000|Overall Study|not treated|1|||
33279385|NCT01190228|100917870|FG000|Overall Study|Protocol Violation|4|||
33279386|NCT01190228|100917871|FG001|Overall Study|Protocol Violation|0|||
33279387|NCT01190228|100917872|FG002|Overall Study|Protocol Violation|0|||
33279388|NCT01190228|100917870|FG000|Overall Study|Withdrawal by Subject|1|||
33279389|NCT01190228|100917871|FG001|Overall Study|Withdrawal by Subject|0|||
33279390|NCT01190228|100917872|FG002|Overall Study|Withdrawal by Subject|0|||
33279391|NCT03997409|100917880|FG000|Overall Study|Protocol Violation|1|||
33279392|NCT03997409|100917881|FG001|Overall Study|Protocol Violation|1|||
33279393|NCT03997409|100917882|FG002|Overall Study|Protocol Violation|0|||
33279394|NCT03997409|100917880|FG000|Overall Study|Withdrawal by Subject|3|||
33279395|NCT03997409|100917881|FG001|Overall Study|Withdrawal by Subject|0|||
33279396|NCT03997409|100917882|FG002|Overall Study|Withdrawal by Subject|0|||
33279397|NCT03997409|100917880|FG000|Overall Study|Lost to Follow-up|0|||
33279398|NCT03997409|100917881|FG001|Overall Study|Lost to Follow-up|0|||
33279399|NCT03997409|100917882|FG002|Overall Study|Lost to Follow-up|1|||
33279400|NCT01527500|100917883|FG000|Part A|Administrative|11|||
33279401|NCT01527500|100917884|FG001|Part A|Administrative|7|||
33279402|NCT01527500|100917883|FG000|Part A|Adverse Event|4|||
33279403|NCT01527500|100917884|FG001|Part A|Adverse Event|2|||
33279404|NCT01527500|100917883|FG000|Part A|Death|4|||
33279405|NCT01527500|100917884|FG001|Part A|Death|1|||
33279406|NCT01527500|100917883|FG000|Part A|Lost to Follow-up|0|||
33279407|NCT01527500|100917884|FG001|Part A|Lost to Follow-up|1|||
33279408|NCT01527500|100917883|FG000|Part A|Protocol Deviation|9|||
33279409|NCT01527500|100917884|FG001|Part A|Protocol Deviation|2|||
33279410|NCT01527500|100917883|FG000|Part A|Withdrawal by Subject|2|||
33279411|NCT01527500|100917884|FG001|Part A|Withdrawal by Subject|0|||
33279412|NCT01527500|100917883|FG000|Part B|Adverse Event|1|||
33279413|NCT01527500|100917884|FG001|Part B|Adverse Event|0|||
33279414|NCT00946088|100917885|FG000|Overall Study|Withdrawal by Subject|0|||
33279415|NCT00946088|100917886|FG001|Overall Study|Withdrawal by Subject|1|||
33279416|NCT01503515|100917887|FG000|Overall Study|Adverse Event|4|||
33279417|NCT01503515|100917888|FG001|Overall Study|Adverse Event|5|||
33279418|NCT01503515|100917887|FG000|Overall Study|Death|0|||
33485836|NCT00996892|101671465|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
33279419|NCT01503515|100917888|FG001|Overall Study|Death|1|||
33279420|NCT01503515|100917887|FG000|Overall Study|Physician Decision|14|||
33279421|NCT01503515|100917888|FG001|Overall Study|Physician Decision|23|||
33279422|NCT01503515|100917887|FG000|Overall Study|Withdrawal by Subject|0|||
33279423|NCT01503515|100917888|FG001|Overall Study|Withdrawal by Subject|1|||
33279424|NCT01503515|100917887|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
33279425|NCT01503515|100917888|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
33279426|NCT01503515|100917887|FG000|Overall Study|Ineligible|1|||
33279427|NCT01503515|100917888|FG001|Overall Study|Ineligible|1|||
33279428|NCT05066230|100917891|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
33279429|NCT05066230|100917892|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
33279430|NCT05066230|100917891|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
33279431|NCT05066230|100917892|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
33279432|NCT05066230|100917891|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
33279433|NCT05066230|100917892|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
33279434|NCT05066230|100917891|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
33279435|NCT05066230|100917892|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
33279436|NCT05066230|100917891|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
33279437|NCT05066230|100917892|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
33279438|NCT05066230|100917891|FG000|After Week 48|Adverse Event|1|||
33279439|NCT05066230|100917892|FG001|After Week 48|Adverse Event|0|||
33279440|NCT05066230|100917891|FG000|After Week 48|Non-compliance with study schedule|1|||
33279441|NCT05066230|100917892|FG001|After Week 48|Non-compliance with study schedule|0|||
33279442|NCT05066230|100917891|FG000|After Week 48|Withdrawal by Subject|0|||
33279443|NCT05066230|100917892|FG001|After Week 48|Withdrawal by Subject|1|||
33279444|NCT05066230|100917891|FG000|After Week 48|Lost to Follow-up|3|||
33279445|NCT05066230|100917892|FG001|After Week 48|Lost to Follow-up|3|||
33279446|NCT05066230|100917891|FG000|After Week 48|Sponsor Request|115|||
33279447|NCT05066230|100917892|FG001|After Week 48|Sponsor Request|111|||
33279448|NCT02542293|100917893|FG000|Overall Study|Death|367|||
33279449|NCT02542293|100917894|FG001|Overall Study|Death|377|||
33279450|NCT02542293|100917893|FG000|Overall Study|Withdrawal by Subject|8|||
33279451|NCT02542293|100917894|FG001|Overall Study|Withdrawal by Subject|19|||
33279452|NCT04288778|100917897|FG000|Overall Study|Withdrawal by Subject|2|||
33279453|NCT04288778|100917897|FG000|Overall Study|Adverse Event|5|||
33279454|NCT04288778|100917897|FG000|Overall Study|Non-Compliance With Study Drug|1|||
33279455|NCT04288778|100917897|FG000|Overall Study|Other|1|||
33279456|NCT04288778|100917897|FG000|Overall Study|Started but not treated|2|||
33279457|NCT02625922|100917898|FG000|Overall Study|Non-availability of IMP|1|||
33279458|NCT02625922|100917899|FG001|Overall Study|Non-availability of IMP|1|||
33279459|NCT02625922|100917898|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
33279460|NCT02625922|100917899|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
33279461|NCT02849509|100917900|FG000|Overall Study|Worsening of disease under study|1|||
33279462|NCT02849509|100917901|FG001|Overall Study|Worsening of disease under study|1|||
33279463|NCT02849509|100917902|FG002|Overall Study|Worsening of disease under study|1|||
33279464|NCT02849509|100917900|FG000|Overall Study|Worsening of other pre-existing disease|0|||
33279465|NCT02849509|100917901|FG001|Overall Study|Worsening of other pre-existing disease|1|||
33279466|NCT02849509|100917902|FG002|Overall Study|Worsening of other pre-existing disease|2|||
33279467|NCT02849509|100917900|FG000|Overall Study|Other adverse event|36|||
33279468|NCT02849509|100917901|FG001|Overall Study|Other adverse event|41|||
33279469|NCT02849509|100917902|FG002|Overall Study|Other adverse event|8|||
33279470|NCT02849509|100917900|FG000|Overall Study|Withdrawal by Subject|6|||
33279471|NCT02849509|100917901|FG001|Overall Study|Withdrawal by Subject|17|||
33279472|NCT02849509|100917902|FG002|Overall Study|Withdrawal by Subject|12|||
33279473|NCT02849509|100917900|FG000|Overall Study|Lost to Follow-up|27|||
33279474|NCT02849509|100917901|FG001|Overall Study|Lost to Follow-up|67|||
33279475|NCT02849509|100917902|FG002|Overall Study|Lost to Follow-up|36|||
33279476|NCT02849509|100917900|FG000|Overall Study|Other, reason not specified|14|||
33279477|NCT02849509|100917901|FG001|Overall Study|Other, reason not specified|29|||
33279478|NCT02849509|100917902|FG002|Overall Study|Other, reason not specified|25|||
33279479|NCT02849509|100917900|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
33279480|NCT02849509|100917901|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
33279481|NCT02849509|100917902|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
33279482|NCT03816332|100917903|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
33279483|NCT03816332|100917903|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
33279484|NCT03050372|100917904|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
33279485|NCT03050372|100917905|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
33279486|NCT03050372|100917904|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
33279487|NCT03050372|100917905|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
33279488|NCT03786783|100917906|FG000|Overall Study|Death|1|||
33279489|NCT03786783|100917906|FG000|Overall Study|Physician Decision|6|||
33279490|NCT03786783|100917906|FG000|Overall Study|Withdrawal by Subject|2|||
33279491|NCT03786783|100917906|FG000|Overall Study|Disease Progression|7|||
33279492|NCT03786783|100917906|FG000|Overall Study|Patient/Parent Refusal|4|||
33279493|NCT04372186|100917908|FG000|Overall Study|Death|24|||
33279494|NCT04372186|100917909|FG001|Overall Study|Death|11|||
33485837|NCT00996892|101671466|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
33279495|NCT04372186|100917908|FG000|Overall Study|Transferred to a different facility for care|0|||
33279496|NCT04372186|100917909|FG001|Overall Study|Transferred to a different facility for care|2|||
33279497|NCT02567227|100917910|FG000|9 Weeks|Adverse Event|5|||
33279498|NCT02567227|100917911|FG001|9 Weeks|Adverse Event|5|||
33279499|NCT02567227|100917910|FG000|9 Weeks|Withdrawal by Subject|18|||
33279500|NCT02567227|100917911|FG001|9 Weeks|Withdrawal by Subject|8|||
33279501|NCT02567227|100917910|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
33279502|NCT02567227|100917911|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
33279503|NCT02567227|100917910|FG000|6 Month|Death|2|||
33279504|NCT02567227|100917911|FG001|6 Month|Death|0|||
33279505|NCT02567227|100917910|FG000|6 Month|Lost to Follow-up|43|||
33279506|NCT02567227|100917911|FG001|6 Month|Lost to Follow-up|40|||
33279507|NCT02567227|100917910|FG000|12 Months|Lost to Follow-up|31|||
33279508|NCT02567227|100917911|FG001|12 Months|Lost to Follow-up|32|||
33279509|NCT02567227|100917910|FG000|12 Months|Death|0|||
33279510|NCT02567227|100917911|FG001|12 Months|Death|2|||
33279511|NCT02176018|100917918|FG000|Overall Study|Adverse Event|0|||
33279512|NCT02176018|100917919|FG001|Overall Study|Adverse Event|2|||
33279513|NCT02176018|100917918|FG000|Overall Study|Lost to Follow-up|3|||
33279514|NCT02176018|100917919|FG001|Overall Study|Lost to Follow-up|1|||
33279515|NCT02176018|100917918|FG000|Overall Study|Protocol Violation|1|||
33279516|NCT02176018|100917919|FG001|Overall Study|Protocol Violation|1|||
33279517|NCT02176018|100917918|FG000|Overall Study|Withdrawal by Subject|1|||
33279518|NCT02176018|100917919|FG001|Overall Study|Withdrawal by Subject|2|||
33279519|NCT00244751|100917921|FG000|Overall Study|Adverse Event|7|||
33279520|NCT00244751|100917922|FG001|Overall Study|Adverse Event|7|||
33279521|NCT00244751|100917923|FG002|Overall Study|Adverse Event|5|||
33279522|NCT00244751|100917921|FG000|Overall Study|Lost to Follow-up|0|||
33279523|NCT00244751|100917922|FG001|Overall Study|Lost to Follow-up|1|||
33279524|NCT00244751|100917923|FG002|Overall Study|Lost to Follow-up|0|||
33279525|NCT00244751|100917921|FG000|Overall Study|Protocol Violation|1|||
33279526|NCT00244751|100917922|FG001|Overall Study|Protocol Violation|0|||
33279527|NCT00244751|100917923|FG002|Overall Study|Protocol Violation|1|||
33279528|NCT00244751|100917921|FG000|Overall Study|Withdrawal by Subject|7|||
33279529|NCT00244751|100917922|FG001|Overall Study|Withdrawal by Subject|5|||
33279530|NCT00244751|100917923|FG002|Overall Study|Withdrawal by Subject|3|||
33279531|NCT00244751|100917921|FG000|Overall Study|Elevated liver enzymes|1|||
33279532|NCT00244751|100917922|FG001|Overall Study|Elevated liver enzymes|0|||
33279533|NCT00244751|100917923|FG002|Overall Study|Elevated liver enzymes|0|||
33279534|NCT00244751|100917921|FG000|Overall Study|Lack of compliance with protocol|0|||
33279535|NCT00244751|100917922|FG001|Overall Study|Lack of compliance with protocol|1|||
33279536|NCT00244751|100917923|FG002|Overall Study|Lack of compliance with protocol|0|||
33279537|NCT00244751|100917921|FG000|Overall Study|Safety reasons|0|||
33279538|NCT00244751|100917922|FG001|Overall Study|Safety reasons|1|||
33279539|NCT00244751|100917923|FG002|Overall Study|Safety reasons|0|||
33279540|NCT00244751|100917921|FG000|Overall Study|Participant randomized by mistake|0|||
33279541|NCT00244751|100917922|FG001|Overall Study|Participant randomized by mistake|0|||
33279542|NCT00244751|100917923|FG002|Overall Study|Participant randomized by mistake|1|||
33279543|NCT01799993|100917924|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
33279544|NCT01799993|100917925|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
33279545|NCT01799993|100917924|FG000|Overall Study|Death|61|||
33279546|NCT01799993|100917925|FG001|Overall Study|Death|45|||
33279547|NCT01799993|100917924|FG000|Overall Study|Withdrawal by Subject|23|||
33279548|NCT01799993|100917925|FG001|Overall Study|Withdrawal by Subject|24|||
33279549|NCT01799993|100917924|FG000|Overall Study|Lost to Follow-up|5|||
33279550|NCT01799993|100917925|FG001|Overall Study|Lost to Follow-up|8|||
33279551|NCT01799993|100917924|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
33279552|NCT01799993|100917925|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
33279553|NCT01799993|100917924|FG000|Overall Study|Protocol driven decision point|0|||
33279554|NCT01799993|100917925|FG001|Overall Study|Protocol driven decision point|3|||
33279555|NCT01799993|100917924|FG000|Overall Study|Protocol Violation|1|||
33279556|NCT01799993|100917925|FG001|Overall Study|Protocol Violation|1|||
33279557|NCT01799993|100917924|FG000|Overall Study|Deterioration of general conditions|2|||
33279558|NCT01799993|100917925|FG001|Overall Study|Deterioration of general conditions|0|||
33279559|NCT01799993|100917924|FG000|Overall Study|Screen failure|0|||
33279560|NCT01799993|100917925|FG001|Overall Study|Screen failure|1|||
33279561|NCT01799993|100917924|FG000|Overall Study|Adverse Event|1|||
33279562|NCT01799993|100917925|FG001|Overall Study|Adverse Event|0|||
33279563|NCT01799993|100917924|FG000|Overall Study|Lack of Efficacy|1|||
33279564|NCT01799993|100917925|FG001|Overall Study|Lack of Efficacy|0|||
33279565|NCT01799993|100917924|FG000|Overall Study|Recovery|0|||
33279566|NCT01799993|100917925|FG001|Overall Study|Recovery|1|||
33279567|NCT01799993|100917924|FG000|Overall Study|Logistical difficulties|1|||
33279568|NCT01799993|100917925|FG001|Overall Study|Logistical difficulties|0|||
33279569|NCT01799993|100917924|FG000|Overall Study|Protocol deviation|1|||
33279570|NCT01799993|100917925|FG001|Overall Study|Protocol deviation|0|||
33279571|NCT01799993|100917924|FG000|Overall Study|Non-compliance with medical device|1|||
33279572|NCT01799993|100917925|FG001|Overall Study|Non-compliance with medical device|0|||
33279573|NCT01799993|100917924|FG000|Overall Study|Withdrawal by parent/guardian|0|||
33279574|NCT01799993|100917925|FG001|Overall Study|Withdrawal by parent/guardian|1|||
33279575|NCT01799993|100917924|FG000|Overall Study|Other|1|||
33279576|NCT01799993|100917925|FG001|Overall Study|Other|0|||
33279577|NCT01799993|100917924|FG000|Overall Study|Subject didn't return for follow-up|0|||
33279578|NCT01799993|100917925|FG001|Overall Study|Subject didn't return for follow-up|1|||
33279579|NCT03794609|100917926|FG000|Overall Study|Other|10|||
33279580|NCT03794609|100917926|FG000|Overall Study|Withdrawal by Subject|66|||
33279581|NCT03794609|100917926|FG000|Overall Study|The child is enrolled in an interventional study|70|||
33279582|NCT03794609|100917926|FG000|Overall Study|Inclusion/exclusion criteria|8|||
33279583|NCT03794609|100917926|FG000|Overall Study|At sponsor's request|151|||
33279584|NCT03794609|100917926|FG000|Overall Study|Physician Decision|1|||
33279585|NCT03794609|100917926|FG000|Overall Study|Lost to Follow-up|5|||
33279586|NCT03302559|100917927|FG000|Overall Study|Adverse Event|2|||
33279587|NCT03302559|100917927|FG000|Overall Study|Lost to Follow-up|1|||
33279588|NCT03302559|100917927|FG000|Overall Study|Withdrew Consent|3|||
33279589|NCT03873714|100917928|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
33279590|NCT04175834|100917929|FG000|Overall Study|Withdrawal by Subject|1|||
33279591|NCT04175834|100917930|FG001|Overall Study|Withdrawal by Subject|0|||
33279592|NCT01136733|100917931|FG000|Phase 1b|Adverse Event|0|||
33279593|NCT01136733|100917932|FG001|Phase 1b|Adverse Event|3|||
33279594|NCT01136733|100917933|FG002|Phase 1b|Adverse Event|1|||
33279595|NCT01136733|100917934|FG003|Phase 1b|Adverse Event|0|||
33279596|NCT01136733|100917935|FG004|Phase 1b|Adverse Event|0|||
33279597|NCT01136733|100917936|FG005|Phase 1b|Adverse Event|0|||
33279598|NCT01136733|100917937|FG006|Phase 1b|Adverse Event|0|||
33279599|NCT01136733|100917931|FG000|Phase 1b|Participant Choice|0|||
33279600|NCT01136733|100917932|FG001|Phase 1b|Participant Choice|0|||
33279601|NCT01136733|100917933|FG002|Phase 1b|Participant Choice|1|||
33279602|NCT01136733|100917934|FG003|Phase 1b|Participant Choice|0|||
33279603|NCT01136733|100917935|FG004|Phase 1b|Participant Choice|0|||
33279604|NCT01136733|100917936|FG005|Phase 1b|Participant Choice|0|||
33279605|NCT01136733|100917937|FG006|Phase 1b|Participant Choice|0|||
33279606|NCT01136733|100917931|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
33279607|NCT01136733|100917932|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
33279608|NCT01136733|100917933|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
33279609|NCT01136733|100917934|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
33279610|NCT01136733|100917935|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
33279611|NCT01136733|100917936|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
33279612|NCT01136733|100917937|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
33279613|NCT01136733|100917931|FG000|Phase 1b|Clinical Progression|1|||
33279614|NCT01136733|100917932|FG001|Phase 1b|Clinical Progression|1|||
33279615|NCT01136733|100917933|FG002|Phase 1b|Clinical Progression|0|||
33279616|NCT01136733|100917934|FG003|Phase 1b|Clinical Progression|0|||
33279617|NCT01136733|100917935|FG004|Phase 1b|Clinical Progression|0|||
33279618|NCT01136733|100917936|FG005|Phase 1b|Clinical Progression|0|||
33279619|NCT01136733|100917937|FG006|Phase 1b|Clinical Progression|0|||
33279620|NCT01136733|100917931|FG000|Phase 2|Disease Progression|0|||
33279621|NCT01136733|100917932|FG001|Phase 2|Disease Progression|0|||
33279622|NCT01136733|100917933|FG002|Phase 2|Disease Progression|0|||
33279623|NCT01136733|100917934|FG003|Phase 2|Disease Progression|0|||
33279624|NCT01136733|100917935|FG004|Phase 2|Disease Progression|30|||
33279625|NCT01136733|100917936|FG005|Phase 2|Disease Progression|32|||
33279626|NCT01136733|100917937|FG006|Phase 2|Disease Progression|38|||
33279627|NCT01136733|100917931|FG000|Phase 2|Adverse Event|0|||
33279628|NCT01136733|100917932|FG001|Phase 2|Adverse Event|0|||
33279629|NCT01136733|100917933|FG002|Phase 2|Adverse Event|0|||
33279630|NCT01136733|100917934|FG003|Phase 2|Adverse Event|0|||
33279631|NCT01136733|100917935|FG004|Phase 2|Adverse Event|11|||
33279632|NCT01136733|100917936|FG005|Phase 2|Adverse Event|13|||
33279633|NCT01136733|100917937|FG006|Phase 2|Adverse Event|5|||
33279634|NCT01136733|100917931|FG000|Phase 2|Participant Choice|0|||
33279635|NCT01136733|100917932|FG001|Phase 2|Participant Choice|0|||
33279636|NCT01136733|100917933|FG002|Phase 2|Participant Choice|0|||
33279637|NCT01136733|100917934|FG003|Phase 2|Participant Choice|0|||
33279638|NCT01136733|100917935|FG004|Phase 2|Participant Choice|3|||
33279639|NCT01136733|100917936|FG005|Phase 2|Participant Choice|0|||
33279640|NCT01136733|100917937|FG006|Phase 2|Participant Choice|1|||
33279641|NCT01136733|100917931|FG000|Phase 2|Administrative-Withdrew Consent|0|||
33279642|NCT01136733|100917932|FG001|Phase 2|Administrative-Withdrew Consent|0|||
33279643|NCT01136733|100917933|FG002|Phase 2|Administrative-Withdrew Consent|0|||
33279644|NCT01136733|100917934|FG003|Phase 2|Administrative-Withdrew Consent|0|||
33279645|NCT01136733|100917935|FG004|Phase 2|Administrative-Withdrew Consent|1|||
33279646|NCT01136733|100917936|FG005|Phase 2|Administrative-Withdrew Consent|0|||
33279647|NCT01136733|100917937|FG006|Phase 2|Administrative-Withdrew Consent|0|||
33279648|NCT01136733|100917931|FG000|Phase 2|Other|0|||
33279649|NCT01136733|100917932|FG001|Phase 2|Other|0|||
33279650|NCT01136733|100917933|FG002|Phase 2|Other|0|||
33279651|NCT01136733|100917934|FG003|Phase 2|Other|0|||
33279652|NCT01136733|100917935|FG004|Phase 2|Other|6|||
33279653|NCT01136733|100917936|FG005|Phase 2|Other|7|||
33279654|NCT01136733|100917937|FG006|Phase 2|Other|6|||
33279655|NCT03915951|100917946|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
33279656|NCT03915951|100917947|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
33279657|NCT03915951|100917946|FG000|Overall Study|Adverse Event|12|||
33279658|NCT03915951|100917947|FG001|Overall Study|Adverse Event|6|||
33279659|NCT03915951|100917946|FG000|Overall Study|Disease progression (radiological)|17|||
33279660|NCT03915951|100917947|FG001|Overall Study|Disease progression (radiological)|15|||
33279661|NCT03915951|100917946|FG000|Overall Study|Disease progression (clinical)|4|||
33279662|NCT03915951|100917947|FG001|Overall Study|Disease progression (clinical)|1|||
33279663|NCT03915951|100917946|FG000|Overall Study|Patient decision|0|||
33279664|NCT03915951|100917947|FG001|Overall Study|Patient decision|4|||
33279665|NCT03915951|100917946|FG000|Overall Study|Investigator decision|0|||
33279666|NCT03915951|100917947|FG001|Overall Study|Investigator decision|1|||
33279667|NCT03915951|100917946|FG000|Overall Study|Consent withdrawn|1|||
33279668|NCT03915951|100917947|FG001|Overall Study|Consent withdrawn|1|||
33279669|NCT03915951|100917946|FG000|Overall Study|Death|0|||
33279670|NCT03915951|100917947|FG001|Overall Study|Death|3|||
33279671|NCT03340766|100917952|FG000|Overall Study|Withdrawal by Subject|2|||
33279672|NCT03340766|100917953|FG001|Overall Study|Withdrawal by Subject|1|||
33279673|NCT03340766|100917954|FG002|Overall Study|Withdrawal by Subject|3|||
33279674|NCT03340766|100917952|FG000|Overall Study|Lost to Follow-up|0|||
33279675|NCT03340766|100917953|FG001|Overall Study|Lost to Follow-up|0|||
33279676|NCT03340766|100917954|FG002|Overall Study|Lost to Follow-up|1|||
33279677|NCT03340766|100917952|FG000|Overall Study|Death|6|||
33279678|NCT03340766|100917953|FG001|Overall Study|Death|7|||
33279679|NCT03340766|100917954|FG002|Overall Study|Death|4|||
33279680|NCT01350102|100917955|FG000|Overall Study|Adverse Event|0|||
33279681|NCT01350102|100917956|FG001|Overall Study|Adverse Event|0|||
33279682|NCT01350102|100917957|FG002|Overall Study|Adverse Event|1|||
33279683|NCT01350102|100917958|FG003|Overall Study|Adverse Event|0|||
33279684|NCT01757171|100917959|FG000|Overall Study|Adverse Event|5|||
33279685|NCT01757171|100917960|FG001|Overall Study|Adverse Event|1|||
33279686|NCT01757171|100917959|FG000|Overall Study|Disease Progression|1|||
33279687|NCT01757171|100917960|FG001|Overall Study|Disease Progression|0|||
33279688|NCT01757171|100917959|FG000|Overall Study|Hospitalization|1|||
33279689|NCT01757171|100917960|FG001|Overall Study|Hospitalization|0|||
33279690|NCT01757171|100917959|FG000|Overall Study|ECOG decline|1|||
33279691|NCT01757171|100917960|FG001|Overall Study|ECOG decline|0|||
33279692|NCT03861078|100917961|FG000|Overall Study|COVID-19 shut down|4|||
33279693|NCT03861078|100917961|FG000|Overall Study|Lost to Follow-up|1|||
33279694|NCT03861078|100917961|FG000|Overall Study|Protocol Violation|2|||
33279695|NCT03861078|100917961|FG000|Overall Study|lack of venous access|1|||
33279696|NCT00975130|100917965|FG000|Study Part 1|Adverse Event|150|||
33279697|NCT00975130|100917966|FG001|Study Part 1|Adverse Event|0|||
33279698|NCT00975130|100917967|FG002|Study Part 1|Adverse Event|0|||
33279699|NCT00975130|100917965|FG000|Study Part 1|Lost to Follow-up|19|||
33279700|NCT00975130|100917966|FG001|Study Part 1|Lost to Follow-up|0|||
33279701|NCT00975130|100917967|FG002|Study Part 1|Lost to Follow-up|0|||
33279702|NCT00975130|100917965|FG000|Study Part 1|Withdrawal by Subject|61|||
33279703|NCT00975130|100917966|FG001|Study Part 1|Withdrawal by Subject|0|||
33279704|NCT00975130|100917967|FG002|Study Part 1|Withdrawal by Subject|0|||
33279705|NCT00975130|100917965|FG000|Study Part 1|Protocol Violation|13|||
33279706|NCT00975130|100917966|FG001|Study Part 1|Protocol Violation|0|||
33279707|NCT00975130|100917967|FG002|Study Part 1|Protocol Violation|0|||
33279708|NCT00975130|100917965|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
33279709|NCT00975130|100917966|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
33279710|NCT00975130|100917967|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
33279711|NCT00975130|100917965|FG000|Study Part 1|Administrative|4|||
33279712|NCT00975130|100917966|FG001|Study Part 1|Administrative|0|||
33279713|NCT00975130|100917967|FG002|Study Part 1|Administrative|0|||
33279714|NCT00975130|100917965|FG000|Study Part 1|Withdrew Consent|24|||
33279715|NCT00975130|100917966|FG001|Study Part 1|Withdrew Consent|0|||
33279716|NCT00975130|100917967|FG002|Study Part 1|Withdrew Consent|0|||
33279717|NCT00975130|100917965|FG000|Study Part 2|Adverse Event|0|||
33279718|NCT00975130|100917966|FG001|Study Part 2|Adverse Event|14|||
33279719|NCT00975130|100917967|FG002|Study Part 2|Adverse Event|7|||
33279720|NCT00975130|100917965|FG000|Study Part 2|Lost to Follow-up|0|||
33279721|NCT00975130|100917966|FG001|Study Part 2|Lost to Follow-up|0|||
33279722|NCT00975130|100917967|FG002|Study Part 2|Lost to Follow-up|1|||
33485838|NCT00996892|101671467|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
33279723|NCT00975130|100917965|FG000|Study Part 2|Withdrawal by Subject|0|||
33279724|NCT00975130|100917966|FG001|Study Part 2|Withdrawal by Subject|13|||
33279725|NCT00975130|100917967|FG002|Study Part 2|Withdrawal by Subject|5|||
33279726|NCT00975130|100917965|FG000|Study Part 2|Withdrew Consent|0|||
33279727|NCT00975130|100917966|FG001|Study Part 2|Withdrew Consent|6|||
33279728|NCT00975130|100917967|FG002|Study Part 2|Withdrew Consent|2|||
33279729|NCT00975130|100917965|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
33279730|NCT00975130|100917966|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
33279731|NCT00975130|100917967|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
33279732|NCT00975130|100917965|FG000|Study Part 2|Administrative|0|||
33279733|NCT00975130|100917966|FG001|Study Part 2|Administrative|1|||
33279734|NCT00975130|100917967|FG002|Study Part 2|Administrative|0|||
33279735|NCT00975130|100917965|FG000|Study Part 2|Protocol Violation|0|||
33279736|NCT00975130|100917966|FG001|Study Part 2|Protocol Violation|0|||
33279737|NCT00975130|100917967|FG002|Study Part 2|Protocol Violation|1|||
33279738|NCT01753323|100917973|FG000|Overall Study|Lack of Efficacy|0|||
33279739|NCT01753323|100917974|FG001|Overall Study|Lack of Efficacy|0|||
33279740|NCT01753323|100917975|FG002|Overall Study|Lack of Efficacy|8|||
33279741|NCT01753323|100917973|FG000|Overall Study|Protocol deviation|1|||
33279742|NCT01753323|100917974|FG001|Overall Study|Protocol deviation|0|||
33279743|NCT01753323|100917975|FG002|Overall Study|Protocol deviation|0|||
33279744|NCT01753323|100917973|FG000|Overall Study|Adverse Event|0|||
33279745|NCT01753323|100917974|FG001|Overall Study|Adverse Event|0|||
33279746|NCT01753323|100917975|FG002|Overall Study|Adverse Event|1|||
33279747|NCT01544309|100920848|FG000|Overall Study|Withdrawal by Subject|12|||
33279748|NCT01544309|100920849|FG001|Overall Study|Withdrawal by Subject|7|||
33279749|NCT01544309|100920848|FG000|Overall Study|Protocol Violation|2|||
33279750|NCT01544309|100920849|FG001|Overall Study|Protocol Violation|1|||
33279751|NCT01544309|100920848|FG000|Overall Study|Physician Decision|4|||
33279752|NCT01544309|100920849|FG001|Overall Study|Physician Decision|1|||
33279753|NCT01544309|100920848|FG000|Overall Study|Not performed pre-dose examination|1|||
33279754|NCT01544309|100920849|FG001|Overall Study|Not performed pre-dose examination|2|||
33279755|NCT01544309|100920848|FG000|Overall Study|Administered prohibit prior medication|1|||
33279756|NCT01544309|100920849|FG001|Overall Study|Administered prohibit prior medication|0|||
33279757|NCT03575572|100920850|FG000|Overall Study|Withdrawal by Subject|2|||
33279758|NCT03575572|100920850|FG000|Overall Study|Physician Decision|2|||
33279759|NCT03802513|100920855|FG000|Overall Study|Lost to Follow-up|1|||
33279760|NCT03722485|100920856|FG000|Overall Study|Withdrawal by Subject|1|||
33279761|NCT03722485|100920857|FG001|Overall Study|Withdrawal by Subject|0|||
33279762|NCT03722485|100920856|FG000|Overall Study|Adverse Event|0|||
33279763|NCT03722485|100920857|FG001|Overall Study|Adverse Event|2|||
33279764|NCT03722485|100920856|FG000|Overall Study|subject discharged prior to study completion|1|||
33279765|NCT03722485|100920857|FG001|Overall Study|subject discharged prior to study completion|5|||
33279766|NCT03722485|100920856|FG000|Overall Study|eligibility criteria not met|2|||
33279767|NCT03722485|100920857|FG001|Overall Study|eligibility criteria not met|0|||
33279768|NCT02131155|100920858|FG000|Overall Study|Adverse Event|1|||
33279769|NCT02131155|100920859|FG001|Overall Study|Adverse Event|0|||
33279770|NCT02131155|100920858|FG000|Overall Study|Treatment completed|1|||
33279771|NCT02131155|100920859|FG001|Overall Study|Treatment completed|0|||
33279772|NCT02131155|100920858|FG000|Overall Study|Primary tumour recurrence|2|||
33279773|NCT02131155|100920859|FG001|Overall Study|Primary tumour recurrence|1|||
33279774|NCT02131155|100920858|FG000|Overall Study|Refused to continue study medication|1|||
33279775|NCT02131155|100920859|FG001|Overall Study|Refused to continue study medication|0|||
33279776|NCT02131155|100920858|FG000|Overall Study|Study early termination|20|||
33279777|NCT02131155|100920859|FG001|Overall Study|Study early termination|10|||
33279778|NCT03409276|100920860|FG000|Overall Study|Withdrawal by Subject|0|||
33279779|NCT03409276|100920861|FG001|Overall Study|Withdrawal by Subject|0|||
33279780|NCT03409276|100920862|FG002|Overall Study|Withdrawal by Subject|0|||
33279781|NCT03409276|100920863|FG003|Overall Study|Withdrawal by Subject|0|||
33279782|NCT03409276|100920864|FG004|Overall Study|Withdrawal by Subject|1|||
33279783|NCT03409276|100920860|FG000|Overall Study|Lost to Follow-up|0|||
33279784|NCT03409276|100920861|FG001|Overall Study|Lost to Follow-up|0|||
33279785|NCT03409276|100920862|FG002|Overall Study|Lost to Follow-up|0|||
33279786|NCT03409276|100920863|FG003|Overall Study|Lost to Follow-up|2|||
33279787|NCT03409276|100920864|FG004|Overall Study|Lost to Follow-up|2|||
33279788|NCT00428441|100920868|FG000|Overall Study|Lost to Follow-up|1|||
33279789|NCT00187135|100920869|FG000|Visit One|Withdrawal by Subject|1|||
33279790|NCT00187135|100920870|FG001|Visit One|Withdrawal by Subject|0|||
33279791|NCT00187135|100920871|FG002|Visit One|Withdrawal by Subject|0|||
33279792|NCT00187135|100920872|FG003|Visit One|Withdrawal by Subject|0|||
33279793|NCT00187135|100920873|FG004|Visit One|Withdrawal by Subject|0|||
33279794|NCT00187135|100920874|FG005|Visit One|Withdrawal by Subject|1|||
33279795|NCT00187135|100920869|FG000|Visit One|Physician Decision|3|||
33279796|NCT00187135|100920870|FG001|Visit One|Physician Decision|1|||
33279797|NCT00187135|100920871|FG002|Visit One|Physician Decision|0|||
33279798|NCT00187135|100920872|FG003|Visit One|Physician Decision|0|||
33279799|NCT00187135|100920873|FG004|Visit One|Physician Decision|0|||
33279800|NCT00187135|100920874|FG005|Visit One|Physician Decision|1|||
33279801|NCT00187135|100920869|FG000|Visit Two|Death|0|||
33279802|NCT00187135|100920870|FG001|Visit Two|Death|0|||
33279803|NCT00187135|100920871|FG002|Visit Two|Death|0|||
33279804|NCT00187135|100920872|FG003|Visit Two|Death|1|||
33279805|NCT00187135|100920873|FG004|Visit Two|Death|0|||
33279806|NCT00187135|100920874|FG005|Visit Two|Death|1|||
33279807|NCT00187135|100920869|FG000|Visit Two|Physician Decision|1|||
33279808|NCT00187135|100920870|FG001|Visit Two|Physician Decision|0|||
33279809|NCT00187135|100920871|FG002|Visit Two|Physician Decision|0|||
33279810|NCT00187135|100920872|FG003|Visit Two|Physician Decision|0|||
33279811|NCT00187135|100920873|FG004|Visit Two|Physician Decision|0|||
33279812|NCT00187135|100920874|FG005|Visit Two|Physician Decision|0|||
33279813|NCT00187135|100920869|FG000|Visit Two|Withdrawal by Subject|1|||
33279814|NCT00187135|100920870|FG001|Visit Two|Withdrawal by Subject|1|||
33279815|NCT00187135|100920871|FG002|Visit Two|Withdrawal by Subject|1|||
33279816|NCT00187135|100920872|FG003|Visit Two|Withdrawal by Subject|0|||
33279817|NCT00187135|100920873|FG004|Visit Two|Withdrawal by Subject|1|||
33279818|NCT00187135|100920874|FG005|Visit Two|Withdrawal by Subject|1|||
33279819|NCT00187135|100920869|FG000|Visit Two|Study Discontinued|3|||
33279820|NCT00187135|100920870|FG001|Visit Two|Study Discontinued|2|||
33279821|NCT00187135|100920871|FG002|Visit Two|Study Discontinued|1|||
33279822|NCT00187135|100920872|FG003|Visit Two|Study Discontinued|7|||
33279823|NCT00187135|100920873|FG004|Visit Two|Study Discontinued|5|||
33279824|NCT00187135|100920874|FG005|Visit Two|Study Discontinued|6|||
33279825|NCT00187135|100920869|FG000|Visit Three|Death|0|||
33279826|NCT00187135|100920870|FG001|Visit Three|Death|0|||
33279827|NCT00187135|100920871|FG002|Visit Three|Death|1|||
33279828|NCT00187135|100920872|FG003|Visit Three|Death|0|||
33279829|NCT00187135|100920873|FG004|Visit Three|Death|1|||
33279830|NCT00187135|100920874|FG005|Visit Three|Death|0|||
33279831|NCT00187135|100920869|FG000|Visit Three|Withdrawal by Subject|0|||
33279832|NCT00187135|100920870|FG001|Visit Three|Withdrawal by Subject|1|||
33279833|NCT00187135|100920871|FG002|Visit Three|Withdrawal by Subject|1|||
33279834|NCT00187135|100920872|FG003|Visit Three|Withdrawal by Subject|2|||
33279835|NCT00187135|100920873|FG004|Visit Three|Withdrawal by Subject|0|||
33279836|NCT00187135|100920874|FG005|Visit Three|Withdrawal by Subject|0|||
33279837|NCT00187135|100920869|FG000|Visit Three|Study Discontinued|7|||
33279838|NCT00187135|100920870|FG001|Visit Three|Study Discontinued|6|||
33279839|NCT00187135|100920871|FG002|Visit Three|Study Discontinued|7|||
33279840|NCT00187135|100920872|FG003|Visit Three|Study Discontinued|7|||
33279841|NCT00187135|100920873|FG004|Visit Three|Study Discontinued|7|||
33279842|NCT00187135|100920874|FG005|Visit Three|Study Discontinued|6|||
33279843|NCT00168805|100920875|FG000|Overall Study|Adverse Event|7|||
33279844|NCT00168805|100920876|FG001|Overall Study|Adverse Event|11|||
33279845|NCT00168805|100920877|FG002|Overall Study|Adverse Event|16|||
33279846|NCT00168805|100920875|FG000|Overall Study|Protocol Violation|12|||
33279847|NCT00168805|100920876|FG001|Overall Study|Protocol Violation|11|||
33279848|NCT00168805|100920877|FG002|Overall Study|Protocol Violation|8|||
33279849|NCT00168805|100920875|FG000|Overall Study|Lost to Follow-up|12|||
33279850|NCT00168805|100920876|FG001|Overall Study|Lost to Follow-up|17|||
33279851|NCT00168805|100920877|FG002|Overall Study|Lost to Follow-up|11|||
33279852|NCT00168805|100920875|FG000|Overall Study|Withdrawal by Subject|16|||
33279853|NCT00168805|100920876|FG001|Overall Study|Withdrawal by Subject|18|||
33279854|NCT00168805|100920877|FG002|Overall Study|Withdrawal by Subject|21|||
33279855|NCT00168805|100920875|FG000|Overall Study|Other|24|||
33279856|NCT00168805|100920876|FG001|Overall Study|Other|21|||
33279857|NCT00168805|100920877|FG002|Overall Study|Other|22|||
33279858|NCT00168805|100920875|FG000|Treatment|Adverse Event|25|||
33279859|NCT00168805|100920876|FG001|Treatment|Adverse Event|26|||
33279860|NCT00168805|100920877|FG002|Treatment|Adverse Event|32|||
33279861|NCT00168805|100920875|FG000|Treatment|Protocol Violation|3|||
33279862|NCT00168805|100920876|FG001|Treatment|Protocol Violation|5|||
33279863|NCT00168805|100920877|FG002|Treatment|Protocol Violation|5|||
33279864|NCT00168805|100920875|FG000|Treatment|Withdrawal by Subject|3|||
33279865|NCT00168805|100920876|FG001|Treatment|Withdrawal by Subject|7|||
33279866|NCT00168805|100920877|FG002|Treatment|Withdrawal by Subject|8|||
33279867|NCT00168805|100920875|FG000|Treatment|Other|18|||
33279868|NCT00168805|100920876|FG001|Treatment|Other|18|||
33279869|NCT00168805|100920877|FG002|Treatment|Other|17|||
33279870|NCT02392429|100920878|FG000|Screening|Screen failure|15|||
33279871|NCT02392429|100920878|FG000|Enrolled Participants|Ineligible due to disease|3|||
33279872|NCT02392429|100920878|FG000|Enrolled Participants|Withdrawal by Subject|4|||
33279873|NCT02392429|100920878|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
33279874|NCT02392429|100920878|FG000|Evaluable|Death|5|||
33279875|NCT02392429|100920878|FG000|Evaluable|Withdrawal by Subject|1|||
33279876|NCT02392429|100920878|FG000|Evaluable|Adverse Event|1|||
33279877|NCT02392429|100920878|FG000|Evaluable|remission bone marrow biopsy|3|||
33279878|NCT02785900|100920879|FG000|Overall Study|Study Termination by Sponsor|64|||
33279879|NCT02785900|100920880|FG001|Overall Study|Study Termination by Sponsor|81|||
33279880|NCT02785900|100920879|FG000|Overall Study|Death|46|||
33279881|NCT02785900|100920880|FG001|Overall Study|Death|32|||
33279882|NCT02785900|100920879|FG000|Overall Study|Withdrawal by Subject|4|||
33279883|NCT02785900|100920880|FG001|Overall Study|Withdrawal by Subject|8|||
33279884|NCT02785900|100920879|FG000|Overall Study|Physician Decision|3|||
33279885|NCT02785900|100920880|FG001|Overall Study|Physician Decision|2|||
33279886|NCT03341312|100920883|FG000|Period 1|Withdrawal by Subject|0|||
33279887|NCT03341312|100920884|FG001|Period 1|Withdrawal by Subject|1|||
33279888|NCT03341312|100920885|FG002|Period 1|Withdrawal by Subject|0|||
33279889|NCT03341312|100920886|FG003|Period 1|Withdrawal by Subject|0|||
33279890|NCT02030847|100920891|FG000|Overall Study|Death|10|||
33279891|NCT02030847|100920891|FG000|Overall Study|Disease Progression|15|||
33279892|NCT02030847|100920891|FG000|Overall Study|New Cancer Therapy|8|||
33279893|NCT02030847|100920891|FG000|Overall Study|Physician Decision|3|||
33279894|NCT02030847|100920891|FG000|Overall Study|Withdrawal by Subject|1|||
33279895|NCT02965599|100920892|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
33279896|NCT02965599|100920893|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
33279897|NCT01374971|100920897|FG000|Overall Study|Withdrawal by Subject|1|||
33279898|NCT04089332|100920909|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
33279899|NCT04089332|100920909|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
33279900|NCT04089332|100920909|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
33279901|NCT02573883|100920911|FG000|Six Month Follow Up|Lost to Follow-up|1|||
33279902|NCT02573883|100920912|FG001|Six Month Follow Up|Lost to Follow-up|0|||
33279903|NCT02573883|100920913|FG002|Six Month Follow Up|Lost to Follow-up|0|||
33279904|NCT02573883|100920914|FG003|Six Month Follow Up|Lost to Follow-up|0|||
33279905|NCT02573883|100920911|FG000|One Year Follow Up|Lost to Follow-up|2|||
33279906|NCT02573883|100920912|FG001|One Year Follow Up|Lost to Follow-up|1|||
33279907|NCT02573883|100920913|FG002|One Year Follow Up|Lost to Follow-up|0|||
33279908|NCT02573883|100920914|FG003|One Year Follow Up|Lost to Follow-up|0|||
33279909|NCT03845517|100920916|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
33279910|NCT03845517|100920917|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
33279911|NCT03845517|100920918|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
33279912|NCT03845517|100920919|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
33279913|NCT03845517|100920916|FG000|Treatment Period (52 Weeks)|Death|0|||
33279914|NCT03845517|100920917|FG001|Treatment Period (52 Weeks)|Death|0|||
33279915|NCT03845517|100920918|FG002|Treatment Period (52 Weeks)|Death|1|||
33279916|NCT03845517|100920919|FG003|Treatment Period (52 Weeks)|Death|0|||
33279917|NCT03845517|100920916|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
33279918|NCT03845517|100920917|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
33279919|NCT03845517|100920918|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
33279920|NCT03845517|100920919|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
33279921|NCT03845517|100920916|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
33279922|NCT03845517|100920917|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
33279923|NCT03845517|100920918|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
33279924|NCT03845517|100920919|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
33279925|NCT03845517|100920916|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
33279926|NCT03845517|100920917|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
33279927|NCT03845517|100920918|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
33279928|NCT03845517|100920919|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
33279929|NCT03845517|100920916|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
33279930|NCT03845517|100920917|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
33279931|NCT03845517|100920918|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
33279932|NCT03845517|100920919|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
33279933|NCT03845517|100920916|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
33279934|NCT03845517|100920917|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
33279935|NCT03845517|100920918|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
33279936|NCT03845517|100920919|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
33279937|NCT03845517|100920916|FG000|Treatment Period (52 Weeks)|Other|2|||
33279938|NCT03845517|100920917|FG001|Treatment Period (52 Weeks)|Other|0|||
33279939|NCT03845517|100920918|FG002|Treatment Period (52 Weeks)|Other|0|||
33279940|NCT03845517|100920919|FG003|Treatment Period (52 Weeks)|Other|0|||
33279941|NCT03845517|100920916|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
33279942|NCT03845517|100920917|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
33279943|NCT03845517|100920918|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
33279944|NCT03845517|100920919|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
33279945|NCT03845517|100920916|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
33279946|NCT03845517|100920917|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
33279947|NCT03845517|100920918|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
33279948|NCT03845517|100920919|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
33279949|NCT03845517|100920916|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
33279950|NCT03845517|100920917|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
33279951|NCT03845517|100920918|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
33279952|NCT03845517|100920919|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
33279953|NCT03845517|100920916|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
33279954|NCT03845517|100920917|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
33279955|NCT03845517|100920918|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
33279956|NCT03845517|100920919|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
33279957|NCT03845517|100920916|FG000|Follow-up Period (4 Weeks)|Death|0|||
33279958|NCT03845517|100920917|FG001|Follow-up Period (4 Weeks)|Death|0|||
33279959|NCT03845517|100920918|FG002|Follow-up Period (4 Weeks)|Death|1|||
33279960|NCT03845517|100920919|FG003|Follow-up Period (4 Weeks)|Death|1|||
33279961|NCT03845517|100920916|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
33279962|NCT03845517|100920917|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
33279963|NCT03845517|100920918|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
33279964|NCT03845517|100920919|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
33279965|NCT03845517|100920916|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
33279966|NCT03845517|100920917|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
33279967|NCT03845517|100920918|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
33279968|NCT03845517|100920919|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
33279969|NCT03845517|100920916|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
33279970|NCT03845517|100920917|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
33279971|NCT03845517|100920918|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
33279972|NCT03845517|100920919|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
33279973|NCT03845517|100920916|FG000|Follow-up Period (4 Weeks)|Other|1|||
33279974|NCT03845517|100920917|FG001|Follow-up Period (4 Weeks)|Other|0|||
33279975|NCT03845517|100920918|FG002|Follow-up Period (4 Weeks)|Other|1|||
33279976|NCT03845517|100920919|FG003|Follow-up Period (4 Weeks)|Other|0|||
33279977|NCT03845517|100920916|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
33279978|NCT03845517|100920917|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
33279979|NCT03845517|100920918|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
33279980|NCT03845517|100920919|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
33279981|NCT03845517|100920916|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
33279982|NCT03845517|100920917|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
33279983|NCT03845517|100920918|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
33279984|NCT03845517|100920919|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
33279985|NCT03845517|100920916|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
33279986|NCT03845517|100920917|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
33279987|NCT03845517|100920918|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
33279988|NCT03845517|100920919|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
33279989|NCT00274846|100920921|FG000|Overall Study|Did not receive adequate NK cells|1|||
33279990|NCT01379521|100920924|FG000|Overall Study -Treatment Period|Adverse Event|3|||
33279991|NCT01379521|100920925|FG001|Overall Study -Treatment Period|Adverse Event|0|||
33279992|NCT01379521|100920924|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
33279993|NCT01379521|100920925|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
33279994|NCT01379521|100920924|FG000|Overall Study -Treatment Period|Disease Progression|23|||
33279995|NCT01379521|100920925|FG001|Overall Study -Treatment Period|Disease Progression|22|||
33279996|NCT01379521|100920924|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
33279997|NCT01379521|100920925|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
33279998|NCT01379521|100920924|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
33279999|NCT01379521|100920925|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
33280000|NCT01379521|100920924|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
33280001|NCT01379521|100920925|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
33280002|NCT01379521|100920924|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
33280003|NCT01379521|100920925|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
33280004|NCT01379521|100920924|FG000|Overall Study -Treatment Period|Death|2|||
33280005|NCT01379521|100920925|FG001|Overall Study -Treatment Period|Death|1|||
33280006|NCT01379521|100920924|FG000|Post-Treatment Evaluations|Disease Progression|22|||
33280007|NCT01379521|100920925|FG001|Post-Treatment Evaluations|Disease Progression|20|||
33280008|NCT01379521|100920924|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
33280009|NCT01379521|100920925|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
33280010|NCT01379521|100920924|FG000|Post-Treatment Evaluations|Death|1|||
33280011|NCT01379521|100920925|FG001|Post-Treatment Evaluations|Death|0|||
33280012|NCT02490878|100920926|FG000|Overall Study|deemed ineligible|0|||
33280013|NCT02490878|100920927|FG001|Overall Study|deemed ineligible|1|||
33280014|NCT02490878|100920926|FG000|Overall Study|progression prior to treatment|0|||
33280015|NCT02490878|100920927|FG001|Overall Study|progression prior to treatment|1|||
33280016|NCT02490878|100920926|FG000|Overall Study|only submitted baseline QOL|0|||
33280017|NCT02490878|100920927|FG001|Overall Study|only submitted baseline QOL|1|||
33280018|NCT01537120|100920936|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
33280019|NCT01537120|100920936|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
33280020|NCT00946998|100920940|FG000|Overall Study|Exited prior to first outcome assessment|5|||
33280021|NCT00946998|100920941|FG001|Overall Study|Exited prior to first outcome assessment|3|||
33280022|NCT01403805|100920942|FG000|Overall Study|Withdrawal by Subject|0|||
33280023|NCT01403805|100920943|FG001|Overall Study|Withdrawal by Subject|4|||
33280024|NCT01403805|100920942|FG000|Overall Study|Lost to Follow-up|0|||
33280025|NCT01403805|100920943|FG001|Overall Study|Lost to Follow-up|2|||
33280026|NCT01403805|100920942|FG000|Overall Study|Death|0|||
33280027|NCT01403805|100920943|FG001|Overall Study|Death|1|||
33280028|NCT01190449|100920946|FG000|Overall Study|Ineligible|0|||
33280029|NCT01190449|100920947|FG001|Overall Study|Ineligible|4|||
33485839|NCT00996892|101671468|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
33485840|NCT00996892|101671449|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
33280030|NCT00645099|100920948|FG000|Overall Study|Lack of Efficacy|15|||
33280031|NCT00645099|100920949|FG001|Overall Study|Lack of Efficacy|6|||
33280032|NCT00645099|100920948|FG000|Overall Study|Withdrawal by Subject|30|||
33280033|NCT00645099|100920949|FG001|Overall Study|Withdrawal by Subject|22|||
33280034|NCT00645099|100920948|FG000|Overall Study|Lost to Follow-up|6|||
33280035|NCT00645099|100920949|FG001|Overall Study|Lost to Follow-up|4|||
33280036|NCT00645099|100920948|FG000|Overall Study|Adverse Event|11|||
33280037|NCT00645099|100920949|FG001|Overall Study|Adverse Event|5|||
33280038|NCT00645099|100920948|FG000|Overall Study|Other|9|||
33280039|NCT00645099|100920949|FG001|Overall Study|Other|5|||
33280040|NCT04468633|100920952|FG000|Overall Study|Withdrawal by Subject|4|||
33280041|NCT04468633|100920953|FG001|Overall Study|Withdrawal by Subject|0|||
33280042|NCT01536535|100920956|FG000|Overall Study|Withdrawal by Subject|10|||
33280043|NCT01536535|100920957|FG001|Overall Study|Withdrawal by Subject|5|||
33280044|NCT01536535|100920956|FG000|Overall Study|Lost to Follow-up|4|||
33280045|NCT01536535|100920957|FG001|Overall Study|Lost to Follow-up|6|||
33280046|NCT01536535|100920956|FG000|Overall Study|Physician Decision|1|||
33280047|NCT01536535|100920957|FG001|Overall Study|Physician Decision|1|||
33280048|NCT01536535|100920956|FG000|Overall Study|Participant moved|0|||
33280049|NCT01536535|100920957|FG001|Overall Study|Participant moved|1|||
33280050|NCT00774306|100920958|FG000|Overall Study|Adverse Event|3|||
33280051|NCT00774306|100920959|FG001|Overall Study|Adverse Event|0|||
33280052|NCT00774306|100920960|FG002|Overall Study|Adverse Event|0|||
33280053|NCT00774306|100920961|FG003|Overall Study|Adverse Event|0|||
33280054|NCT00774306|100920958|FG000|Overall Study|Protocol Violation|2|||
33280055|NCT00774306|100920959|FG001|Overall Study|Protocol Violation|0|||
33280056|NCT00774306|100920960|FG002|Overall Study|Protocol Violation|3|||
33280057|NCT00774306|100920961|FG003|Overall Study|Protocol Violation|0|||
33280058|NCT00774306|100920958|FG000|Overall Study|Withdrawal by Subject|6|||
33280059|NCT00774306|100920959|FG001|Overall Study|Withdrawal by Subject|1|||
33280060|NCT00774306|100920960|FG002|Overall Study|Withdrawal by Subject|1|||
33280061|NCT00774306|100920961|FG003|Overall Study|Withdrawal by Subject|0|||
33280062|NCT00774306|100920958|FG000|Overall Study|Lost to Follow-up|6|||
33280063|NCT00774306|100920959|FG001|Overall Study|Lost to Follow-up|0|||
33280064|NCT00774306|100920960|FG002|Overall Study|Lost to Follow-up|4|||
33280065|NCT00774306|100920961|FG003|Overall Study|Lost to Follow-up|5|||
33280066|NCT00774306|100920958|FG000|Overall Study|Death|1|||
33280067|NCT00774306|100920959|FG001|Overall Study|Death|1|||
33280068|NCT00774306|100920960|FG002|Overall Study|Death|0|||
33280069|NCT00774306|100920961|FG003|Overall Study|Death|0|||
33280070|NCT01697592|100920962|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
33280071|NCT01697592|100920963|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33280072|NCT01697592|100920964|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33280073|NCT01697592|100920965|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33280074|NCT01697592|100920966|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33280075|NCT01697592|100920967|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33280076|NCT01697592|100920968|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33280077|NCT01697592|100920969|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33280078|NCT01697592|100920970|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33280079|NCT01697592|100920971|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
33280080|NCT01697592|100920962|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33280081|NCT01697592|100920963|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33280082|NCT01697592|100920964|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33280083|NCT01697592|100920965|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33280084|NCT01697592|100920966|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33280085|NCT01697592|100920967|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
33280086|NCT01697592|100920968|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33280087|NCT01697592|100920969|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33280088|NCT01697592|100920970|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33280089|NCT01697592|100920971|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
33280090|NCT01697592|100920962|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
33280091|NCT01697592|100920963|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33280092|NCT01697592|100920964|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33280093|NCT01697592|100920965|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33280094|NCT01697592|100920966|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33280095|NCT01697592|100920967|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33280096|NCT01697592|100920968|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33280097|NCT01697592|100920969|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33280098|NCT01697592|100920970|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33280099|NCT01697592|100920971|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
33280100|NCT01697592|100920962|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
33280101|NCT01697592|100920963|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
33280102|NCT01697592|100920964|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
33280103|NCT01697592|100920965|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
33280104|NCT01697592|100920966|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
33280105|NCT01697592|100920967|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
33280106|NCT01697592|100920968|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
33280107|NCT01697592|100920969|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
33280108|NCT01697592|100920970|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
33280109|NCT01697592|100920971|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
33280110|NCT01697592|100920962|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
33280111|NCT01697592|100920963|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
33280112|NCT01697592|100920964|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
33280113|NCT01697592|100920965|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
33280114|NCT01697592|100920966|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
33280115|NCT01697592|100920967|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
33280116|NCT01697592|100920968|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
33280117|NCT01697592|100920969|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
33280118|NCT01697592|100920970|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
33280119|NCT01697592|100920971|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
33280120|NCT01697592|100920962|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
33280121|NCT01697592|100920963|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33280122|NCT01697592|100920964|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33280123|NCT01697592|100920965|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
33280124|NCT01697592|100920966|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33280125|NCT01697592|100920967|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33280126|NCT01697592|100920968|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33280127|NCT01697592|100920969|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33280128|NCT01697592|100920970|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33280129|NCT01697592|100920971|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
33280130|NCT01697592|100920962|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
33280131|NCT01697592|100920963|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
33280132|NCT01697592|100920964|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
33280133|NCT01697592|100920965|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
33280134|NCT01697592|100920966|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
33485841|NCT00996892|101671450|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
33485842|NCT00996892|101671451|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
33485843|NCT00996892|101671452|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
33485844|NCT00996892|101671453|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
33280135|NCT01697592|100920967|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
33280136|NCT01697592|100920968|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
33485845|NCT00996892|101671454|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
33485846|NCT00996892|101671455|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
33485847|NCT00996892|101671456|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
33485848|NCT00996892|101671457|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
33485849|NCT00996892|101671458|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
33485850|NCT00996892|101671459|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
33485851|NCT00996892|101671460|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
33485852|NCT00996892|101671461|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
33485853|NCT00996892|101671462|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
33485854|NCT00996892|101671463|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
33485855|NCT00996892|101671464|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
33485856|NCT00996892|101671465|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
33485857|NCT00996892|101671466|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
33485858|NCT00996892|101671467|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
33485859|NCT00996892|101671468|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
33485860|NCT00996892|101671449|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
33485861|NCT00996892|101671450|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
33485862|NCT00996892|101671451|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
33485863|NCT00996892|101671452|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
33485864|NCT00996892|101671453|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
33485865|NCT00996892|101671454|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
33485866|NCT00996892|101671455|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
33485867|NCT00996892|101671456|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
33485868|NCT00996892|101671457|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
33485869|NCT00996892|101671458|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
33485870|NCT00996892|101671459|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
33485871|NCT00996892|101671460|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
33485872|NCT00996892|101671461|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
33485873|NCT00996892|101671462|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
33485874|NCT00996892|101671463|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
33485875|NCT00996892|101671464|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
33485876|NCT00996892|101671465|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
33485877|NCT00996892|101671466|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
33485878|NCT00996892|101671467|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
33485879|NCT00996892|101671468|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
33485880|NCT00996892|101671449|FG000|Expansion Stage 2|Adverse Event|0|||
33485881|NCT00996892|101671450|FG001|Expansion Stage 2|Adverse Event|0|||
33485882|NCT00996892|101671451|FG002|Expansion Stage 2|Adverse Event|0|||
33485883|NCT00996892|101671452|FG003|Expansion Stage 2|Adverse Event|0|||
33485884|NCT00996892|101671453|FG004|Expansion Stage 2|Adverse Event|0|||
33485885|NCT00996892|101671454|FG005|Expansion Stage 2|Adverse Event|0|||
33485886|NCT00996892|101671455|FG006|Expansion Stage 2|Adverse Event|0|||
33485887|NCT00996892|101671456|FG007|Expansion Stage 2|Adverse Event|0|||
33485888|NCT00996892|101671457|FG008|Expansion Stage 2|Adverse Event|0|||
33485889|NCT00996892|101671458|FG009|Expansion Stage 2|Adverse Event|0|||
33485890|NCT00996892|101671459|FG010|Expansion Stage 2|Adverse Event|0|||
33485891|NCT00996892|101671460|FG011|Expansion Stage 2|Adverse Event|0|||
33485892|NCT00996892|101671461|FG012|Expansion Stage 2|Adverse Event|0|||
33485893|NCT00996892|101671462|FG013|Expansion Stage 2|Adverse Event|0|||
33485894|NCT00996892|101671463|FG014|Expansion Stage 2|Adverse Event|0|||
33485895|NCT00996892|101671464|FG015|Expansion Stage 2|Adverse Event|0|||
33485896|NCT00996892|101671465|FG016|Expansion Stage 2|Adverse Event|0|||
33485897|NCT00996892|101671466|FG017|Expansion Stage 2|Adverse Event|0|||
33485898|NCT00996892|101671467|FG018|Expansion Stage 2|Adverse Event|3|||
33485899|NCT00996892|101671468|FG019|Expansion Stage 2|Adverse Event|0|||
33485900|NCT00996892|101671449|FG000|Expansion Stage 2|Death|0|||
33485901|NCT00996892|101671450|FG001|Expansion Stage 2|Death|0|||
33485902|NCT00996892|101671451|FG002|Expansion Stage 2|Death|0|||
33485903|NCT00996892|101671452|FG003|Expansion Stage 2|Death|0|||
33485904|NCT00996892|101671453|FG004|Expansion Stage 2|Death|0|||
33485905|NCT00996892|101671454|FG005|Expansion Stage 2|Death|0|||
33485906|NCT00996892|101671455|FG006|Expansion Stage 2|Death|0|||
33485907|NCT00996892|101671456|FG007|Expansion Stage 2|Death|0|||
33485908|NCT00996892|101671457|FG008|Expansion Stage 2|Death|0|||
33485909|NCT00996892|101671458|FG009|Expansion Stage 2|Death|0|||
33485910|NCT00996892|101671459|FG010|Expansion Stage 2|Death|0|||
33485911|NCT00996892|101671460|FG011|Expansion Stage 2|Death|0|||
33485912|NCT00996892|101671461|FG012|Expansion Stage 2|Death|0|||
33485913|NCT00996892|101671462|FG013|Expansion Stage 2|Death|0|||
33485914|NCT00996892|101671463|FG014|Expansion Stage 2|Death|0|||
33485915|NCT00996892|101671464|FG015|Expansion Stage 2|Death|0|||
33485916|NCT00996892|101671465|FG016|Expansion Stage 2|Death|0|||
33485917|NCT00996892|101671466|FG017|Expansion Stage 2|Death|0|||
33485918|NCT00996892|101671467|FG018|Expansion Stage 2|Death|2|||
33485919|NCT00996892|101671468|FG019|Expansion Stage 2|Death|0|||
33485920|NCT00996892|101671449|FG000|Expansion Stage 2|Physician Decision|0|||
33485921|NCT00996892|101671450|FG001|Expansion Stage 2|Physician Decision|0|||
33485922|NCT00996892|101671451|FG002|Expansion Stage 2|Physician Decision|0|||
33485923|NCT00996892|101671452|FG003|Expansion Stage 2|Physician Decision|0|||
33485924|NCT00996892|101671453|FG004|Expansion Stage 2|Physician Decision|0|||
33485925|NCT00996892|101671454|FG005|Expansion Stage 2|Physician Decision|0|||
33485926|NCT00996892|101671455|FG006|Expansion Stage 2|Physician Decision|0|||
33485927|NCT00996892|101671456|FG007|Expansion Stage 2|Physician Decision|0|||
33485928|NCT00996892|101671457|FG008|Expansion Stage 2|Physician Decision|0|||
33485929|NCT00996892|101671458|FG009|Expansion Stage 2|Physician Decision|0|||
33485930|NCT00996892|101671459|FG010|Expansion Stage 2|Physician Decision|0|||
33485931|NCT00996892|101671460|FG011|Expansion Stage 2|Physician Decision|0|||
33485932|NCT00996892|101671461|FG012|Expansion Stage 2|Physician Decision|0|||
33485933|NCT00996892|101671462|FG013|Expansion Stage 2|Physician Decision|0|||
33485934|NCT00996892|101671463|FG014|Expansion Stage 2|Physician Decision|0|||
33485935|NCT00996892|101671464|FG015|Expansion Stage 2|Physician Decision|0|||
33485936|NCT00996892|101671465|FG016|Expansion Stage 2|Physician Decision|0|||
33280137|NCT01697592|100920969|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
33280138|NCT01697592|100920970|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
33280139|NCT01697592|100920971|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
33280140|NCT01697592|100920962|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
33280141|NCT01697592|100920963|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
33280142|NCT01697592|100920964|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
33280143|NCT01697592|100920965|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
33485937|NCT00996892|101671466|FG017|Expansion Stage 2|Physician Decision|0|||
33485938|NCT00996892|101671467|FG018|Expansion Stage 2|Physician Decision|1|||
33485939|NCT00996892|101671468|FG019|Expansion Stage 2|Physician Decision|0|||
33485940|NCT00996892|101671449|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
33485941|NCT00996892|101671450|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
33485942|NCT00996892|101671451|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
33485943|NCT00996892|101671452|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
33485944|NCT00996892|101671453|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
33485945|NCT00996892|101671454|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
33485946|NCT00996892|101671455|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
33485947|NCT00996892|101671456|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
33485948|NCT00996892|101671457|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
33485949|NCT00996892|101671458|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
33485950|NCT00996892|101671459|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
33485951|NCT00996892|101671460|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
33485952|NCT00996892|101671461|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
33485953|NCT00996892|101671462|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
33485954|NCT00996892|101671463|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
33280144|NCT01697592|100920966|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
33280145|NCT01697592|100920967|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
33280146|NCT01697592|100920968|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
33280147|NCT01697592|100920969|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
33280148|NCT01697592|100920970|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
33280149|NCT01697592|100920971|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
33280150|NCT01103141|100920974|FG000|Overall Study|Death|0|||
33280151|NCT01103141|100920975|FG001|Overall Study|Death|1|||
33280152|NCT01103141|100920974|FG000|Overall Study|Lost to Follow-up|2|||
33280153|NCT01103141|100920975|FG001|Overall Study|Lost to Follow-up|1|||
33280154|NCT00443599|100920979|FG000|Overall Study|Physician Decision|2|||
33280155|NCT00443599|100920980|FG001|Overall Study|Physician Decision|1|||
33280156|NCT00443599|100920979|FG000|Overall Study|Death|1|||
33280157|NCT00443599|100920980|FG001|Overall Study|Death|1|||
33280158|NCT00443599|100920979|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
33280159|NCT00443599|100920980|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
33280160|NCT03036124|100920983|FG000|Overall Study|Lost to Follow-up|0|||
33280161|NCT03036124|100920984|FG001|Overall Study|Lost to Follow-up|2|||
33280162|NCT03036124|100920983|FG000|Overall Study|Withdrawal by Subject|5|||
33280163|NCT03036124|100920984|FG001|Overall Study|Withdrawal by Subject|4|||
33280164|NCT00316589|100920986|FG000|Overall Study|Withdrawal by Subject|0|||
33280165|NCT00316589|100920987|FG001|Overall Study|Withdrawal by Subject|5|||
33280166|NCT00316589|100920988|FG002|Overall Study|Withdrawal by Subject|0|||
33280167|NCT00316589|100920989|FG003|Overall Study|Withdrawal by Subject|1|||
33280168|NCT00316589|100920986|FG000|Overall Study|Subject unwilling/unable to comply|0|||
33280169|NCT00316589|100920987|FG001|Overall Study|Subject unwilling/unable to comply|6|||
33280170|NCT00316589|100920988|FG002|Overall Study|Subject unwilling/unable to comply|0|||
33280171|NCT00316589|100920989|FG003|Overall Study|Subject unwilling/unable to comply|2|||
33280172|NCT00316589|100920986|FG000|Overall Study|Adverse Event|1|||
33280173|NCT00316589|100920987|FG001|Overall Study|Adverse Event|0|||
33280174|NCT00316589|100920988|FG002|Overall Study|Adverse Event|0|||
33280175|NCT00316589|100920989|FG003|Overall Study|Adverse Event|1|||
33280176|NCT00316589|100920986|FG000|Overall Study|Physician Decision|0|||
33280177|NCT00316589|100920987|FG001|Overall Study|Physician Decision|1|||
33280178|NCT00316589|100920988|FG002|Overall Study|Physician Decision|0|||
33280179|NCT00316589|100920989|FG003|Overall Study|Physician Decision|0|||
33280180|NCT00316589|100920986|FG000|Overall Study|Other reason|0|||
33280181|NCT00316589|100920987|FG001|Overall Study|Other reason|12|||
33280182|NCT00316589|100920988|FG002|Overall Study|Other reason|1|||
33280183|NCT00316589|100920989|FG003|Overall Study|Other reason|1|||
33280184|NCT04044352|100920990|FG000|Overall Study|Lost to Follow-up|9|||
33280185|NCT04044352|100920990|FG000|Overall Study|Withdrawal by Subject|2|||
33280186|NCT03087851|100920994|FG000|Overall Study|Withdraw on medical grounds|0|||
33280187|NCT03087851|100920995|FG001|Overall Study|Withdraw on medical grounds|1|||
33280188|NCT03087851|100920996|FG002|Overall Study|Withdraw on medical grounds|2|||
33280189|NCT04413149|100920997|FG000|Overall Study|Death|10|||
33280190|NCT04413149|100920998|FG001|Overall Study|Death|5|||
33280191|NCT04413149|100920997|FG000|Overall Study|Lung transplantation|1|||
33280192|NCT04413149|100920998|FG001|Overall Study|Lung transplantation|0|||
33280193|NCT00562484|100921003|FG000|Overall Study|Adverse Event|6|||
33280194|NCT00562484|100921004|FG001|Overall Study|Adverse Event|1|||
33280195|NCT00562484|100921003|FG000|Overall Study|Protocol Violation|11|||
33280196|NCT00562484|100921004|FG001|Overall Study|Protocol Violation|2|||
33280197|NCT00562484|100921003|FG000|Overall Study|Withdrawal by Subject|12|||
33280198|NCT00562484|100921004|FG001|Overall Study|Withdrawal by Subject|9|||
33280199|NCT00562484|100921003|FG000|Overall Study|Moved away from the study area|20|||
33280200|NCT00562484|100921004|FG001|Overall Study|Moved away from the study area|9|||
33280201|NCT00562484|100921003|FG000|Overall Study|Lost to Follow-up|132|||
33280202|NCT00562484|100921004|FG001|Overall Study|Lost to Follow-up|71|||
33280203|NCT00562484|100921003|FG000|Overall Study|Reason not provided or not specified|25|||
33280204|NCT00562484|100921004|FG001|Overall Study|Reason not provided or not specified|12|||
33280205|NCT01568112|100921005|FG000|Overall Study|Randomized But Not Treated|0|||
33280206|NCT01568112|100921006|FG001|Overall Study|Randomized But Not Treated|1|||
33280207|NCT01568112|100921007|FG002|Overall Study|Randomized But Not Treated|0|||
33280208|NCT01568112|100921008|FG003|Overall Study|Randomized But Not Treated|0|||
33280209|NCT01568112|100921005|FG000|Overall Study|Withdrew due to Adverse Event|2|||
33280210|NCT01568112|100921006|FG001|Overall Study|Withdrew due to Adverse Event|4|||
33280211|NCT01568112|100921007|FG002|Overall Study|Withdrew due to Adverse Event|6|||
33280212|NCT01568112|100921008|FG003|Overall Study|Withdrew due to Adverse Event|3|||
33280213|NCT01568112|100921005|FG000|Overall Study|Lost to Follow-up|0|||
33280214|NCT01568112|100921006|FG001|Overall Study|Lost to Follow-up|0|||
33280215|NCT01568112|100921007|FG002|Overall Study|Lost to Follow-up|0|||
33280216|NCT01568112|100921008|FG003|Overall Study|Lost to Follow-up|1|||
33280217|NCT01568112|100921005|FG000|Overall Study|Withdrawal by Subject|2|||
33280218|NCT01568112|100921006|FG001|Overall Study|Withdrawal by Subject|3|||
33280219|NCT01568112|100921007|FG002|Overall Study|Withdrawal by Subject|0|||
33280220|NCT01568112|100921008|FG003|Overall Study|Withdrawal by Subject|7|||
33280221|NCT01568112|100921005|FG000|Overall Study|Withdrawal by Physician|1|||
33280222|NCT01568112|100921006|FG001|Overall Study|Withdrawal by Physician|0|||
33280223|NCT01568112|100921007|FG002|Overall Study|Withdrawal by Physician|1|||
33280224|NCT01568112|100921008|FG003|Overall Study|Withdrawal by Physician|1|||
33280225|NCT00443755|100921009|FG000|Overall Study|Withdrawal by Subject|2|||
33280226|NCT00443755|100921010|FG001|Overall Study|Withdrawal by Subject|1|||
33280227|NCT00147745|100921016|FG000|Overall Study|Withdrawal by Subject|1|||
33280228|NCT00147745|100921017|FG001|Overall Study|Withdrawal by Subject|0|||
33280229|NCT00147745|100921018|FG002|Overall Study|Withdrawal by Subject|0|||
33280230|NCT00092456|100921020|FG000|Overall Study|Adverse Event|0|||
33280231|NCT00092456|100921021|FG001|Overall Study|Adverse Event|0|||
33280232|NCT00092456|100921022|FG002|Overall Study|Adverse Event|1|||
33280233|NCT00092456|100921023|FG003|Overall Study|Adverse Event|1|||
33280234|NCT00092456|100921020|FG000|Overall Study|Lost to Follow-up|2|||
33280235|NCT00092456|100921021|FG001|Overall Study|Lost to Follow-up|2|||
33280236|NCT00092456|100921022|FG002|Overall Study|Lost to Follow-up|1|||
33280237|NCT00092456|100921023|FG003|Overall Study|Lost to Follow-up|2|||
33280238|NCT00092456|100921020|FG000|Overall Study|Protocol Violation|5|||
33280239|NCT00092456|100921021|FG001|Overall Study|Protocol Violation|7|||
33280240|NCT00092456|100921022|FG002|Overall Study|Protocol Violation|8|||
33280241|NCT00092456|100921023|FG003|Overall Study|Protocol Violation|6|||
33280242|NCT00092456|100921020|FG000|Overall Study|Withdrawal by Subject|13|||
33280243|NCT00092456|100921021|FG001|Overall Study|Withdrawal by Subject|5|||
33280244|NCT00092456|100921022|FG002|Overall Study|Withdrawal by Subject|16|||
33280245|NCT00092456|100921023|FG003|Overall Study|Withdrawal by Subject|6|||
33280246|NCT00092456|100921020|FG000|Overall Study|Moved|1|||
33280247|NCT00092456|100921021|FG001|Overall Study|Moved|1|||
33280248|NCT00092456|100921022|FG002|Overall Study|Moved|0|||
33280249|NCT00092456|100921023|FG003|Overall Study|Moved|1|||
33280250|NCT00092456|100921020|FG000|Overall Study|Other|4|||
33280251|NCT00092456|100921021|FG001|Overall Study|Other|2|||
33280252|NCT00092456|100921022|FG002|Overall Study|Other|3|||
33280253|NCT00092456|100921023|FG003|Overall Study|Other|0|||
33280254|NCT03029234|100921024|FG000|Overall Study|Sponsor Decision|1|||
33280255|NCT03029234|100921024|FG000|Overall Study|Withdrawal by Subject|5|||
33280256|NCT03029234|100921024|FG000|Overall Study|Death|91|||
33280257|NCT03029234|100921024|FG000|Overall Study|Lost to Follow-up|2|||
33280258|NCT03326193|100921025|FG000|Overall Study|Treatment ongoing at the time of analysis|26|||
33280259|NCT03326193|100921025|FG000|Overall Study|Death|19|||
33280260|NCT03326193|100921025|FG000|Overall Study|Withdrawal by Subject|8|||
33280261|NCT03785210|100921026|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
33280262|NCT03785210|100921027|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
33280263|NCT02368691|100921028|FG000|Overall Study|Death|13|||
33280264|NCT02368691|100921028|FG000|Overall Study|Lack of Efficacy|15|||
33280265|NCT02368691|100921028|FG000|Overall Study|Physician Decision|4|||
33280266|NCT01193283|100921029|FG000|Overall Study|Death|1|||
33280267|NCT00762502|100921032|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
33280268|NCT00762502|100921033|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
33280269|NCT00762502|100921034|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
33280270|NCT00762502|100921032|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
33280271|NCT00762502|100921033|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
33280272|NCT00762502|100921034|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
33280273|NCT00762502|100921032|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
33280274|NCT00762502|100921033|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
33280275|NCT00762502|100921034|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
33280276|NCT02744898|100921036|FG000|Overall Study|Progressive Disease|2|||
33280277|NCT02744898|100921036|FG000|Overall Study|Physician Decision|1|||
33280278|NCT02744898|100921036|FG000|Overall Study|Toxicity|1|||
33280279|NCT03184519|100921037|FG000|Overall Study|Lost to Follow-up|6|||
33280280|NCT03184519|100921037|FG000|Overall Study|Physician Decision|21|||
33280281|NCT02507297|100921038|FG000|Overall Study|Withdrawal by Subject|1|||
33280282|NCT02507297|100921039|FG001|Overall Study|Withdrawal by Subject|0|||
33280283|NCT02507297|100921038|FG000|Overall Study|Lost to Follow-up|0|||
33280284|NCT02507297|100921039|FG001|Overall Study|Lost to Follow-up|1|||
33280285|NCT00762723|100921041|FG000|Overall Study|Study Terminated slow enrollement|5|||
33280286|NCT00762723|100921042|FG001|Overall Study|Study Terminated slow enrollement|5|||
33280287|NCT00762723|100921043|FG002|Overall Study|Study Terminated slow enrollement|3|||
33280288|NCT04385849|100921044|FG000|Overall Study|Lost to Follow-up|1|||
33280289|NCT04385849|100921045|FG001|Overall Study|Lost to Follow-up|0|||
33280290|NCT01032200|100921048|FG000|Overall Study|Death|1|||
33280291|NCT01032200|100921049|FG001|Overall Study|Death|1|||
33280292|NCT01032200|100921048|FG000|Overall Study|Withdrawal by Subject|1|||
33280293|NCT01032200|100921049|FG001|Overall Study|Withdrawal by Subject|3|||
33280294|NCT01032200|100921048|FG000|Overall Study|Toxicity|0|||
33280295|NCT01032200|100921049|FG001|Overall Study|Toxicity|2|||
33280296|NCT01032200|100921048|FG000|Overall Study|Progression|1|||
33280297|NCT01032200|100921049|FG001|Overall Study|Progression|0|||
33280298|NCT01032200|100921048|FG000|Overall Study|Multiple|1|||
33280299|NCT01032200|100921049|FG001|Overall Study|Multiple|1|||
33280300|NCT02556918|100921050|FG000|Overall Study|Protocol Violation|5|||
33280301|NCT02556918|100921051|FG001|Overall Study|Protocol Violation|6|||
33280302|NCT02556918|100921050|FG000|Overall Study|Withdrawal by Subject|4|||
33280303|NCT02556918|100921051|FG001|Overall Study|Withdrawal by Subject|4|||
33280304|NCT04523571|100921052|FG000|Received 2 Doses|Withdrawal by Subject|0|||
33280305|NCT04523571|100921053|FG001|Received 2 Doses|Withdrawal by Subject|0|||
33280306|NCT04523571|100921054|FG002|Received 2 Doses|Withdrawal by Subject|0|||
33280307|NCT04523571|100921055|FG003|Received 2 Doses|Withdrawal by Subject|1|||
33280308|NCT04523571|100921056|FG004|Received 2 Doses|Withdrawal by Subject|1|||
33280309|NCT04523571|100921057|FG005|Received 2 Doses|Withdrawal by Subject|0|||
33280310|NCT04523571|100921052|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
33280311|NCT04523571|100921053|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
33280312|NCT04523571|100921054|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
33280313|NCT04523571|100921055|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
33280314|NCT04523571|100921056|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
33280315|NCT04523571|100921057|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
33280316|NCT04523571|100921052|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
33280317|NCT04523571|100921053|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
33280318|NCT04523571|100921054|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
33280319|NCT04523571|100921055|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
33280320|NCT04523571|100921056|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
33280321|NCT04523571|100921057|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
33280322|NCT04523571|100921052|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
33280323|NCT04523571|100921053|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
33280324|NCT04523571|100921054|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
33280325|NCT04523571|100921055|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
33280326|NCT04523571|100921056|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
33280327|NCT04523571|100921057|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
33280328|NCT02029521|100921065|FG000|Overall Study|Protocol Violation|1|||
33280329|NCT02029521|100921066|FG001|Overall Study|Protocol Violation|0|||
33280330|NCT02029521|100921065|FG000|Overall Study|Withdrawal by Subject|1|||
33280331|NCT02029521|100921066|FG001|Overall Study|Withdrawal by Subject|1|||
33280332|NCT02711553|100921069|FG000|Overall Study|Withdrawal by Subject|2|||
33280333|NCT02711553|100921070|FG001|Overall Study|Withdrawal by Subject|1|||
33280334|NCT02711553|100921071|FG002|Overall Study|Withdrawal by Subject|1|||
33280335|NCT02711553|100921072|FG003|Overall Study|Withdrawal by Subject|0|||
33280336|NCT02711553|100921069|FG000|Overall Study|Lost to Follow-up|3|||
33280337|NCT02711553|100921070|FG001|Overall Study|Lost to Follow-up|3|||
33280338|NCT02711553|100921071|FG002|Overall Study|Lost to Follow-up|6|||
33280339|NCT02711553|100921072|FG003|Overall Study|Lost to Follow-up|3|||
33280340|NCT02711553|100921069|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
33280341|NCT02711553|100921070|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
33280342|NCT02711553|100921071|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
33280343|NCT02711553|100921072|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
33280344|NCT04783519|100921073|FG000|Overall Study|Withdrawal by Subject|2|||
33280345|NCT04783519|100921074|FG001|Overall Study|Withdrawal by Subject|7|||
33280346|NCT04783519|100921075|FG002|Overall Study|Withdrawal by Subject|3|||
33280347|NCT04783519|100921073|FG000|Overall Study|Lost to Follow-up|9|||
33280348|NCT04783519|100921074|FG001|Overall Study|Lost to Follow-up|7|||
33280349|NCT04783519|100921075|FG002|Overall Study|Lost to Follow-up|6|||
33280350|NCT00734851|100921080|FG000|Overall Study|Withdrawal by Subject|2|||
33280351|NCT00734851|100921080|FG000|Overall Study|Lost to Follow-up|1|||
33280352|NCT00734851|100921080|FG000|Overall Study|Physician Decision|18|||
33280353|NCT01026103|100921082|FG000|Overall Study|Physician Decision|1|||
33280354|NCT01026103|100921082|FG000|Overall Study|did not receive study device bc of error|1|||
33280355|NCT00588341|100921085|FG000|Overall Study|Withdrawal by Subject|3|||
33280356|NCT00588341|100921085|FG000|Overall Study|Not treated due to metastatic disease|1|||
33280357|NCT00588341|100921085|FG000|Overall Study|Patient ineligible|1|||
33280358|NCT00126555|100921086|FG000|Overall Study|Withdrawal by Subject|1|||
33280359|NCT00126555|100921086|FG000|Overall Study|Adverse Event|2|||
33280360|NCT00126555|100921086|FG000|Overall Study|Progressive Disease|3|||
33280361|NCT04194541|100921091|FG000|Day 1 Through 13|Lost to Follow-up|3|||
33280362|NCT04194541|100921091|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
33280363|NCT04194541|100921091|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
33280364|NCT00580047|100921092|FG000|Overall Study|Lost to Follow-up|1|||
33280365|NCT00580047|100921093|FG001|Overall Study|Lost to Follow-up|1|||
33280366|NCT00580047|100921094|FG002|Overall Study|Lost to Follow-up|0|||
33280367|NCT00580047|100921092|FG000|Overall Study|Withdrawal by Subject|1|||
33280368|NCT00580047|100921093|FG001|Overall Study|Withdrawal by Subject|1|||
33280369|NCT00580047|100921094|FG002|Overall Study|Withdrawal by Subject|2|||
33280370|NCT00580047|100921092|FG000|Overall Study|Withdrawal by Subject|1|||
33280371|NCT00580047|100921093|FG001|Overall Study|Withdrawal by Subject|0|||
33280372|NCT00580047|100921094|FG002|Overall Study|Withdrawal by Subject|0|||
33280373|NCT01047306|100921095|FG000|Overall Study|Withdrawal by Subject|2|||
33280374|NCT01047306|100921096|FG001|Overall Study|Withdrawal by Subject|0|||
33280375|NCT01047306|100921095|FG000|Overall Study|Lost to Follow-up|1|||
33280376|NCT01047306|100921096|FG001|Overall Study|Lost to Follow-up|0|||
33280377|NCT03319719|100921099|FG000|Overall Study|Lost to Follow-up|1|||
33280378|NCT02081196|100921100|FG000|Overall Study|Lost to Follow-up|1|||
33280379|NCT03049306|100921103|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
33280380|NCT03049306|100921104|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
33280381|NCT00228813|100921105|FG000|Overall Study|Death|4|||
33280382|NCT01808144|100921108|FG000|Overall Study|Death|1|||
33280383|NCT01808144|100921109|FG001|Overall Study|Death|0|||
33280384|NCT01808144|100921108|FG000|Overall Study|Withdrawal by Subject|16|||
33280385|NCT01808144|100921109|FG001|Overall Study|Withdrawal by Subject|23|||
33280386|NCT01808144|100921108|FG000|Overall Study|Lost to Follow-up|6|||
33280387|NCT01808144|100921109|FG001|Overall Study|Lost to Follow-up|3|||
33280388|NCT01808144|100921108|FG000|Overall Study|Protocol Violation|6|||
33280389|NCT01808144|100921109|FG001|Overall Study|Protocol Violation|6|||
33280390|NCT01808144|100921108|FG000|Overall Study|Gout flare|0|||
33280391|NCT01808144|100921109|FG001|Overall Study|Gout flare|1|||
33280392|NCT01808144|100921108|FG000|Overall Study|Adverse Event|11|||
33280393|NCT01808144|100921109|FG001|Overall Study|Adverse Event|15|||
33280394|NCT01090076|100921110|FG000|Overall Study|Death|1|||
33280395|NCT01090076|100921111|FG001|Overall Study|Death|1|||
33280396|NCT01090076|100921110|FG000|Overall Study|Withdrawal by Subject|0|||
33280397|NCT01090076|100921111|FG001|Overall Study|Withdrawal by Subject|1|||
33280398|NCT01313299|100921112|FG000|Overall Study|Adverse Event|3|||
33280399|NCT01313299|100921113|FG001|Overall Study|Adverse Event|1|||
33280400|NCT01313299|100921114|FG002|Overall Study|Adverse Event|1|||
33280401|NCT01313299|100921112|FG000|Overall Study|Lost to Follow-up|1|||
33280402|NCT01313299|100921113|FG001|Overall Study|Lost to Follow-up|0|||
33280403|NCT01313299|100921114|FG002|Overall Study|Lost to Follow-up|0|||
33280404|NCT01313299|100921112|FG000|Overall Study|Protocol Violation|2|||
33280405|NCT01313299|100921113|FG001|Overall Study|Protocol Violation|0|||
33280406|NCT01313299|100921114|FG002|Overall Study|Protocol Violation|0|||
33280407|NCT01313299|100921112|FG000|Overall Study|Withdrawal by Subject|1|||
33280408|NCT01313299|100921113|FG001|Overall Study|Withdrawal by Subject|0|||
33280409|NCT01313299|100921114|FG002|Overall Study|Withdrawal by Subject|2|||
33280410|NCT01313299|100921112|FG000|Overall Study|Family reason and moved out of state|0|||
33280411|NCT01313299|100921113|FG001|Overall Study|Family reason and moved out of state|2|||
33280412|NCT01313299|100921114|FG002|Overall Study|Family reason and moved out of state|0|||
33280413|NCT01313299|100921112|FG000|Overall Study|Lack of subject compliance|0|||
33280414|NCT01313299|100921113|FG001|Overall Study|Lack of subject compliance|0|||
33280415|NCT01313299|100921114|FG002|Overall Study|Lack of subject compliance|1|||
33280416|NCT03924193|100921115|FG000|Overall Study|Adverse Event|10|||
33280417|NCT03924193|100921116|FG001|Overall Study|Adverse Event|0|||
33280418|NCT03924193|100921117|FG002|Overall Study|Adverse Event|10|||
33280419|NCT03924193|100921115|FG000|Overall Study|Withdrawal by Subject|5|||
33280420|NCT03924193|100921116|FG001|Overall Study|Withdrawal by Subject|10|||
33280421|NCT03924193|100921117|FG002|Overall Study|Withdrawal by Subject|2|||
33280422|NCT00500539|100921118|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
33280423|NCT00500539|100921118|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
33280424|NCT00500539|100921118|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
33280425|NCT00500539|100921118|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
33280426|NCT00500539|100921118|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
33280427|NCT00500539|100921118|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
33280428|NCT00500539|100921118|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
33280429|NCT00500539|100921118|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
33280430|NCT00500539|100921118|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
33280431|NCT00500539|100921118|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
33280432|NCT00500539|100921118|FG000|Follow-up Period (16 Weeks)|Death|1|||
33280433|NCT00500539|100921118|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
33280434|NCT00500539|100921118|FG000|Follow-up Period (16 Weeks)|Missing|3|||
33280435|NCT00382408|100924052|FG000|Overall Study|Did not meet protocol requirement|3|||
33280436|NCT00382408|100924053|FG001|Overall Study|Did not meet protocol requirement|3|||
33280437|NCT00382408|100924052|FG000|Overall Study|Protocol Violation|2|||
33280438|NCT00382408|100924053|FG001|Overall Study|Protocol Violation|2|||
33280439|NCT00382408|100924052|FG000|Overall Study|Physician Decision|1|||
33280440|NCT00382408|100924053|FG001|Overall Study|Physician Decision|0|||
33280441|NCT00382408|100924052|FG000|Overall Study|Withdrawal by Subject|17|||
33280442|NCT00382408|100924053|FG001|Overall Study|Withdrawal by Subject|6|||
33280443|NCT00382408|100924052|FG000|Overall Study|Pregnancy|2|||
33280444|NCT00382408|100924053|FG001|Overall Study|Pregnancy|0|||
33280445|NCT00382408|100924052|FG000|Overall Study|Lost to Follow-up|19|||
33280446|NCT00382408|100924053|FG001|Overall Study|Lost to Follow-up|8|||
33280447|NCT00382408|100924052|FG000|Overall Study|Other|100|||
33280448|NCT00382408|100924053|FG001|Overall Study|Other|35|||
33280449|NCT00910871|100924062|FG000|Overall Study|Adverse Event|5|||
33280450|NCT00910871|100924062|FG000|Overall Study|Death|12|||
33280451|NCT00910871|100924062|FG000|Overall Study|Lost to Follow-up|8|||
33280452|NCT00910871|100924062|FG000|Overall Study|Protocol Violation|11|||
33280453|NCT00910871|100924062|FG000|Overall Study|Withdrawal by Subject|12|||
33280454|NCT00910871|100924062|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
33280455|NCT00910871|100924062|FG000|Overall Study|Undefined|1|||
33280456|NCT02775214|100924063|FG000|Overall Study|Withdrawal by Subject|2|||
33280457|NCT02775214|100924064|FG001|Overall Study|Withdrawal by Subject|0|||
33280458|NCT01475370|100924068|FG000|Overall Study|Exacerbation of primary disease|2|||
33280459|NCT01475370|100924069|FG001|Overall Study|Exacerbation of primary disease|2|||
33280460|NCT01475370|100924070|FG002|Overall Study|Exacerbation of primary disease|2|||
33280461|NCT01475370|100924068|FG000|Overall Study|Study drug administration difficult|0|||
33280462|NCT01475370|100924069|FG001|Overall Study|Study drug administration difficult|1|||
33280463|NCT01475370|100924070|FG002|Overall Study|Study drug administration difficult|1|||
33280464|NCT01475370|100924068|FG000|Overall Study|Other than specified|1|||
33280465|NCT01475370|100924069|FG001|Overall Study|Other than specified|0|||
33280466|NCT01475370|100924070|FG002|Overall Study|Other than specified|0|||
33280467|NCT02762500|100924071|FG000|Overall Study|Lack of Efficacy|1|||
33280468|NCT02762500|100924072|FG001|Overall Study|Lack of Efficacy|0|||
33280469|NCT02762500|100924071|FG000|Overall Study|Withdrawal by Subject|1|||
33280470|NCT02762500|100924072|FG001|Overall Study|Withdrawal by Subject|1|||
33280471|NCT02762500|100924071|FG000|Overall Study|Adverse Event|0|||
33280472|NCT02762500|100924072|FG001|Overall Study|Adverse Event|2|||
33280473|NCT03512288|100924073|FG000|Overall Study|Adverse Event|1|||
33280474|NCT03512288|100924074|FG001|Overall Study|Adverse Event|0|||
33280475|NCT03512288|100924073|FG000|Overall Study|Lost to Follow-up|12|||
33280476|NCT03512288|100924074|FG001|Overall Study|Lost to Follow-up|15|||
33280477|NCT03512288|100924073|FG000|Overall Study|Physician Decision|0|||
33280478|NCT03512288|100924074|FG001|Overall Study|Physician Decision|2|||
33280479|NCT03512288|100924073|FG000|Overall Study|Protocol Violation|6|||
33280480|NCT03512288|100924074|FG001|Overall Study|Protocol Violation|4|||
33280481|NCT03512288|100924073|FG000|Overall Study|Medication error without associated adverse event|1|||
33280482|NCT03512288|100924074|FG001|Overall Study|Medication error without associated adverse event|0|||
33280483|NCT03512288|100924073|FG000|Overall Study|No longer met eligibility criteria|5|||
33280484|NCT03512288|100924074|FG001|Overall Study|No longer met eligibility criteria|2|||
33280485|NCT03512288|100924073|FG000|Overall Study|Withdrawal by parent/guardian|14|||
33280486|NCT03512288|100924074|FG001|Overall Study|Withdrawal by parent/guardian|18|||
33280487|NCT03512288|100924073|FG000|Overall Study|Other|1|||
33280488|NCT03512288|100924074|FG001|Overall Study|Other|1|||
33280489|NCT03512288|100924073|FG000|Overall Study|Randomized but not treated|1|||
33280490|NCT03512288|100924074|FG001|Overall Study|Randomized but not treated|1|||
33280491|NCT05006703|100924075|FG000|Overall Study|Withdrawal by Subject|1|||
33280492|NCT05006703|100924076|FG001|Overall Study|Withdrawal by Subject|0|||
33280493|NCT05006703|100924075|FG000|Overall Study|Lost to Follow-up|13|||
33280494|NCT05006703|100924076|FG001|Overall Study|Lost to Follow-up|5|||
33280495|NCT01329419|100924080|FG000|Overall Study|Protocol Violation|235|||
33280496|NCT01514864|100924083|FG000|Overall Study|Disease progression|7|||
33280497|NCT01514864|100924084|FG001|Overall Study|Disease progression|5|||
33280498|NCT01514864|100924083|FG000|Overall Study|Study drug toxicity|2|||
33280499|NCT01514864|100924084|FG001|Overall Study|Study drug toxicity|0|||
33280500|NCT01072396|100924085|FG000|Period One|Adverse Event|1|||
33280501|NCT01072396|100924086|FG001|Period One|Adverse Event|1|||
33280502|NCT01072396|100924085|FG000|Period One|Protocol Violation|2|||
33280503|NCT01072396|100924086|FG001|Period One|Protocol Violation|1|||
33280504|NCT01072396|100924085|FG000|Period One|Withdrawal by Subject|2|||
33280505|NCT01072396|100924086|FG001|Period One|Withdrawal by Subject|0|||
33280506|NCT01072396|100924085|FG000|Washout Period|Missing termination information|0|||
33280507|NCT01072396|100924086|FG001|Washout Period|Missing termination information|1|||
33280508|NCT01072396|100924085|FG000|Period Two|Adverse Event|0|||
33280509|NCT01072396|100924086|FG001|Period Two|Adverse Event|3|||
33280510|NCT01072396|100924085|FG000|Period Two|Lost to Follow-up|1|||
33280511|NCT01072396|100924086|FG001|Period Two|Lost to Follow-up|0|||
33280512|NCT04620733|100924087|FG000|Overall Study|Adverse Event|4|||
33280513|NCT04620733|100924088|FG001|Overall Study|Adverse Event|3|||
33280514|NCT04620733|100924087|FG000|Overall Study|Withdrawal by Subject|2|||
33280515|NCT04620733|100924088|FG001|Overall Study|Withdrawal by Subject|5|||
33280516|NCT04620733|100924087|FG000|Overall Study|Lost to Follow-up|1|||
33280517|NCT04620733|100924088|FG001|Overall Study|Lost to Follow-up|1|||
33280518|NCT04620733|100924087|FG000|Overall Study|Protocol Deviation|1|||
33280519|NCT04620733|100924088|FG001|Overall Study|Protocol Deviation|1|||
33485955|NCT00996892|101671464|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
33280520|NCT04620733|100924087|FG000|Overall Study|Reason Not Specified|0|||
33280521|NCT04620733|100924088|FG001|Overall Study|Reason Not Specified|1|||
33280522|NCT00312845|100924089|FG000|Overall Study|Adverse Event|19|||
33280523|NCT00312845|100924090|FG001|Overall Study|Adverse Event|5|||
33280524|NCT00312845|100924089|FG000|Overall Study|Death|2|||
33280525|NCT00312845|100924090|FG001|Overall Study|Death|2|||
33280526|NCT00312845|100924089|FG000|Overall Study|Withdrawal by Subject|14|||
33280527|NCT00312845|100924090|FG001|Overall Study|Withdrawal by Subject|6|||
33280528|NCT00312845|100924089|FG000|Overall Study|Disease Progression|56|||
33280529|NCT00312845|100924090|FG001|Overall Study|Disease Progression|77|||
33280530|NCT00312845|100924089|FG000|Overall Study|Lost to Follow-up|2|||
33280531|NCT00312845|100924090|FG001|Overall Study|Lost to Follow-up|0|||
33280532|NCT00312845|100924089|FG000|Overall Study|Other|6|||
33280533|NCT00312845|100924090|FG001|Overall Study|Other|5|||
33280534|NCT04748445|100924091|FG000|Overall Study|No longer met eligibility criteria|12|||
33280535|NCT04748445|100924091|FG000|Overall Study|Other|36|||
33280536|NCT04748445|100924091|FG000|Overall Study|Withdrawal by Subject|553|||
33280537|NCT04748445|100924091|FG000|Overall Study|Lost to Follow-up|30|||
33280538|NCT01012999|100924096|FG000|Overall Study|Protocol Violation|1|||
33280539|NCT00265096|100924099|FG000|Overall Study|Adverse Event|14|||
33280540|NCT00265096|100924100|FG001|Overall Study|Adverse Event|18|||
33280541|NCT00265096|100924101|FG002|Overall Study|Adverse Event|18|||
33280542|NCT00265096|100924099|FG000|Overall Study|Lost to Follow-up|2|||
33280543|NCT00265096|100924100|FG001|Overall Study|Lost to Follow-up|5|||
33280544|NCT00265096|100924101|FG002|Overall Study|Lost to Follow-up|3|||
33280545|NCT00265096|100924099|FG000|Overall Study|Death|0|||
33280546|NCT00265096|100924100|FG001|Overall Study|Death|1|||
33280547|NCT00265096|100924101|FG002|Overall Study|Death|2|||
33280548|NCT00265096|100924099|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
33280549|NCT00265096|100924100|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
33280550|NCT00265096|100924101|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
33280551|NCT00265096|100924099|FG000|Overall Study|Other|11|||
33280552|NCT00265096|100924100|FG001|Overall Study|Other|19|||
33280553|NCT00265096|100924101|FG002|Overall Study|Other|10|||
33280554|NCT01234675|100924105|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
33280555|NCT01234675|100924106|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
33280556|NCT01234675|100924105|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
33280557|NCT01234675|100924106|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
33280558|NCT04054193|100924107|FG000|Cycle 1|Physician Decision|1|||
33280559|NCT04054193|100924107|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
33280560|NCT04054193|100924107|FG000|Cycle 1|Allocated but not treated|3|||
33280561|NCT04054193|100924107|FG000|Cycles 2-3|Physician Decision|2|||
33280562|NCT04054193|100924107|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
33280563|NCT04054193|100924107|FG000|Cycles 2-3|Various reasons|17|||
33280564|NCT02273180|100924122|FG000|Overall Study|Adverse Event|2|||
33280565|NCT02273180|100924123|FG001|Overall Study|Adverse Event|2|||
33280566|NCT02273180|100924122|FG000|Overall Study|Lack of Efficacy|1|||
33280567|NCT02273180|100924123|FG001|Overall Study|Lack of Efficacy|0|||
33280568|NCT02273180|100924122|FG000|Overall Study|Protocol Violation|1|||
33280569|NCT02273180|100924123|FG001|Overall Study|Protocol Violation|7|||
33280570|NCT02273180|100924122|FG000|Overall Study|Randomized but not treated|1|||
33280571|NCT02273180|100924123|FG001|Overall Study|Randomized but not treated|0|||
33280572|NCT02273180|100924122|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
33280573|NCT02273180|100924123|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
33280574|NCT02273180|100924122|FG000|Overall Study|Other than specified above|21|||
33280575|NCT02273180|100924123|FG001|Overall Study|Other than specified above|10|||
33280576|NCT05244226|100924124|FG000|Overall Study|Adverse Event|1|||
33280577|NCT05244226|100924125|FG001|Overall Study|Adverse Event|0|||
33280578|NCT05244226|100924126|FG002|Overall Study|Adverse Event|0|||
33280579|NCT05244226|100924124|FG000|Overall Study|Lost to Follow-up|0|||
33280580|NCT05244226|100924125|FG001|Overall Study|Lost to Follow-up|0|||
33280581|NCT05244226|100924126|FG002|Overall Study|Lost to Follow-up|1|||
33280582|NCT05244226|100924124|FG000|Overall Study|Protocol Violation|0|||
33280583|NCT05244226|100924125|FG001|Overall Study|Protocol Violation|2|||
33280584|NCT05244226|100924126|FG002|Overall Study|Protocol Violation|2|||
33280585|NCT02093897|100924127|FG000|Overall Study|Physician Decision|1|||
33280586|NCT02093897|100924127|FG000|Overall Study|Planned age group closure - no's reached|17|||
33280587|NCT02093897|100924127|FG000|Overall Study|Adverse event, non-fatal|1|||
33280588|NCT01838447|100924130|FG000|Overall Study|Change in surgical plan|1|||
33280589|NCT01838447|100924131|FG001|Overall Study|Change in surgical plan|2|||
33280590|NCT01838447|100924130|FG000|Overall Study|Withdrawal by Subject|1|||
33280591|NCT01838447|100924131|FG001|Overall Study|Withdrawal by Subject|1|||
33280592|NCT02025985|100924132|FG000|Overall Study|Consent withdrawn|0|||
33280593|NCT02025985|100924133|FG001|Overall Study|Consent withdrawn|0|||
33280594|NCT02025985|100924134|FG002|Overall Study|Consent withdrawn|1|||
33280595|NCT02025985|100924135|FG003|Overall Study|Consent withdrawn|0|||
33280596|NCT02025985|100924136|FG004|Overall Study|Consent withdrawn|0|||
33280597|NCT02025985|100924132|FG000|Overall Study|Termination of study by Sponsor|4|||
33280598|NCT02025985|100924133|FG001|Overall Study|Termination of study by Sponsor|3|||
33280599|NCT02025985|100924134|FG002|Overall Study|Termination of study by Sponsor|1|||
33280600|NCT02025985|100924135|FG003|Overall Study|Termination of study by Sponsor|1|||
33280601|NCT02025985|100924136|FG004|Overall Study|Termination of study by Sponsor|3|||
33280602|NCT02025985|100924132|FG000|Overall Study|Death|21|||
33280603|NCT02025985|100924133|FG001|Overall Study|Death|20|||
33280604|NCT02025985|100924134|FG002|Overall Study|Death|23|||
33280605|NCT02025985|100924135|FG003|Overall Study|Death|20|||
33280606|NCT02025985|100924136|FG004|Overall Study|Death|17|||
33280607|NCT00489489|100924138|FG000|Overall Study|Not treated due to protocol violation|0|||
33280608|NCT00489489|100924139|FG001|Overall Study|Not treated due to protocol violation|1|||
33280609|NCT00489489|100924140|FG002|Overall Study|Not treated due to protocol violation|1|||
33280610|NCT00489489|100924138|FG000|Overall Study|Adverse Event|1|||
33280611|NCT00489489|100924139|FG001|Overall Study|Adverse Event|1|||
33280612|NCT00489489|100924140|FG002|Overall Study|Adverse Event|1|||
33280613|NCT00489489|100924138|FG000|Overall Study|Protocol Violation|1|||
33280614|NCT00489489|100924139|FG001|Overall Study|Protocol Violation|0|||
33280615|NCT00489489|100924140|FG002|Overall Study|Protocol Violation|1|||
33280616|NCT00489489|100924138|FG000|Overall Study|Progressive disease|0|||
33280617|NCT00489489|100924139|FG001|Overall Study|Progressive disease|1|||
33280618|NCT00489489|100924140|FG002|Overall Study|Progressive disease|0|||
33280619|NCT00489489|100924138|FG000|Overall Study|Participant did not wish to continue|1|||
33280620|NCT00489489|100924139|FG001|Overall Study|Participant did not wish to continue|1|||
33280621|NCT00489489|100924140|FG002|Overall Study|Participant did not wish to continue|0|||
33280622|NCT00489489|100924138|FG000|Overall Study|Other than above|0|||
33280623|NCT00489489|100924139|FG001|Overall Study|Other than above|1|||
33280624|NCT00489489|100924140|FG002|Overall Study|Other than above|0|||
33280625|NCT00990821|100924143|FG000|Overall Study|Withdrawal by Subject|0|||
33280626|NCT00990821|100924144|FG001|Overall Study|Withdrawal by Subject|2|||
33280627|NCT00990821|100924145|FG002|Overall Study|Withdrawal by Subject|0|||
33280628|NCT00990821|100924146|FG003|Overall Study|Withdrawal by Subject|0|||
33280629|NCT00990821|100924147|FG004|Overall Study|Withdrawal by Subject|3|||
33280630|NCT00990821|100924148|FG005|Overall Study|Withdrawal by Subject|3|||
33280631|NCT00990821|100924149|FG006|Overall Study|Withdrawal by Subject|1|||
33280632|NCT00990821|100924150|FG007|Overall Study|Withdrawal by Subject|0|||
33280633|NCT00990821|100924151|FG008|Overall Study|Withdrawal by Subject|0|||
33280634|NCT00990821|100924152|FG009|Overall Study|Withdrawal by Subject|1|||
33280635|NCT00990821|100924153|FG010|Overall Study|Withdrawal by Subject|3|||
33280636|NCT00990821|100924154|FG011|Overall Study|Withdrawal by Subject|5|||
33280637|NCT00990821|100924155|FG012|Overall Study|Withdrawal by Subject|2|||
33280638|NCT00990821|100924156|FG013|Overall Study|Withdrawal by Subject|1|||
33280639|NCT01732627|100924157|FG000|Overall Study|Withdrawal by Subject|1|||
33280640|NCT01732627|100924158|FG001|Overall Study|Withdrawal by Subject|0|||
33280641|NCT03899259|100924159|FG000|Overall Study|Adverse Event|5|||
33280642|NCT03899259|100924160|FG001|Overall Study|Adverse Event|4|||
33280643|NCT03899259|100924161|FG002|Overall Study|Adverse Event|6|||
33280644|NCT03899259|100924159|FG000|Overall Study|Lack of Efficacy|5|||
33280645|NCT03899259|100924160|FG001|Overall Study|Lack of Efficacy|0|||
33280646|NCT03899259|100924161|FG002|Overall Study|Lack of Efficacy|2|||
33280647|NCT03899259|100924159|FG000|Overall Study|Pregnancy|3|||
33280648|NCT03899259|100924160|FG001|Overall Study|Pregnancy|0|||
33280649|NCT03899259|100924161|FG002|Overall Study|Pregnancy|1|||
33280650|NCT03899259|100924159|FG000|Overall Study|Physician Decision|0|||
33280651|NCT03899259|100924160|FG001|Overall Study|Physician Decision|1|||
33280652|NCT03899259|100924161|FG002|Overall Study|Physician Decision|0|||
33280653|NCT03899259|100924159|FG000|Overall Study|Protocol Deviation|1|||
33280654|NCT03899259|100924160|FG001|Overall Study|Protocol Deviation|1|||
33280655|NCT03899259|100924161|FG002|Overall Study|Protocol Deviation|1|||
33280656|NCT03899259|100924159|FG000|Overall Study|Withdrawal by Subject|8|||
33280657|NCT03899259|100924160|FG001|Overall Study|Withdrawal by Subject|10|||
33280658|NCT03899259|100924161|FG002|Overall Study|Withdrawal by Subject|12|||
33280659|NCT03899259|100924159|FG000|Overall Study|Lost to Follow-up|5|||
33280660|NCT03899259|100924160|FG001|Overall Study|Lost to Follow-up|6|||
33280661|NCT03899259|100924161|FG002|Overall Study|Lost to Follow-up|2|||
33280662|NCT03899259|100924159|FG000|Overall Study|Lack of Adherence|1|||
33280663|NCT03899259|100924160|FG001|Overall Study|Lack of Adherence|0|||
33280664|NCT03899259|100924161|FG002|Overall Study|Lack of Adherence|0|||
33280665|NCT03899259|100924159|FG000|Overall Study|Screen Failure|1|||
33280666|NCT03899259|100924160|FG001|Overall Study|Screen Failure|0|||
33280667|NCT03899259|100924161|FG002|Overall Study|Screen Failure|0|||
33280668|NCT03899259|100924159|FG000|Overall Study|Ongoing Study Participation|127|||
33280669|NCT03899259|100924160|FG001|Overall Study|Ongoing Study Participation|134|||
33280670|NCT03899259|100924161|FG002|Overall Study|Ongoing Study Participation|210|||
33280671|NCT00655668|100924163|FG000|Overall Study|Adverse Event|6|||
33280672|NCT00655668|100924163|FG000|Overall Study|Death|5|||
33280673|NCT00655668|100924163|FG000|Overall Study|Disease Progression|27|||
33280674|NCT00655668|100924163|FG000|Overall Study|Study Terminated|9|||
33280675|NCT00655668|100924163|FG000|Overall Study|Other|1|||
33280676|NCT00655668|100924163|FG000|Overall Study|New Lymphoma Treatment Started|4|||
33280677|NCT00655668|100924163|FG000|Overall Study|Withdrawal by Subject|2|||
33280678|NCT00577096|100924169|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
33280679|NCT00577096|100924170|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
33280680|NCT00577096|100924169|FG000|Short Term Participation|Withdrawal by Subject|3|||
33280681|NCT00577096|100924170|FG001|Short Term Participation|Withdrawal by Subject|5|||
33280682|NCT00577096|100924169|FG000|Short Term Participation|Death|1|||
33280683|NCT00577096|100924170|FG001|Short Term Participation|Death|1|||
33280684|NCT00006436|100924174|FG000|Overall Study|Refused further treatment|2|||
33280685|NCT00006436|100924174|FG000|Overall Study|Declined to participate (before treatment started)|1|||
33280686|NCT02382406|100924175|FG000|Study Treatment|Disease Progression|8|||
33280687|NCT02382406|100924176|FG001|Study Treatment|Disease Progression|0|||
33280688|NCT02382406|100924177|FG002|Study Treatment|Disease Progression|20|||
33280689|NCT02382406|100924175|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
33280690|NCT02382406|100924176|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
33280691|NCT02382406|100924177|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
33280692|NCT02382406|100924175|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
33280693|NCT02382406|100924176|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
33280694|NCT02382406|100924177|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
33280695|NCT02382406|100924175|FG000|Study Treatment|symptomatic deterioration|1|||
33280696|NCT02382406|100924176|FG001|Study Treatment|symptomatic deterioration|0|||
33280697|NCT02382406|100924177|FG002|Study Treatment|symptomatic deterioration|1|||
33280698|NCT02382406|100924175|FG000|Study Treatment|Death|0|||
33280699|NCT02382406|100924176|FG001|Study Treatment|Death|0|||
33280700|NCT02382406|100924177|FG002|Study Treatment|Death|2|||
33280701|NCT02382406|100924175|FG000|Follow up|Death|11|||
33280702|NCT02382406|100924176|FG001|Follow up|Death|0|||
33280703|NCT02382406|100924177|FG002|Follow up|Death|19|||
33280704|NCT02382406|100924175|FG000|Follow up|Symptomatic deterioration|1|||
33280705|NCT02382406|100924176|FG001|Follow up|Symptomatic deterioration|0|||
33280706|NCT02382406|100924177|FG002|Follow up|Symptomatic deterioration|1|||
33280707|NCT02382406|100924175|FG000|Follow up|Patient Refused Follow-up|1|||
33280708|NCT02382406|100924176|FG001|Follow up|Patient Refused Follow-up|0|||
33280709|NCT02382406|100924177|FG002|Follow up|Patient Refused Follow-up|0|||
33280710|NCT02382406|100924175|FG000|Follow up|Study Terminated|1|||
33280711|NCT02382406|100924176|FG001|Follow up|Study Terminated|0|||
33280712|NCT02382406|100924177|FG002|Follow up|Study Terminated|8|||
33485956|NCT00996892|101671465|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
33485957|NCT00996892|101671466|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
33485958|NCT00996892|101671467|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
33485959|NCT00996892|101671468|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
33485960|NCT00996892|101671449|FG000|Expansion Stage 2|Disease Progression|0|||
33485961|NCT00996892|101671450|FG001|Expansion Stage 2|Disease Progression|0|||
33485962|NCT00996892|101671451|FG002|Expansion Stage 2|Disease Progression|0|||
33485963|NCT00996892|101671452|FG003|Expansion Stage 2|Disease Progression|0|||
33485964|NCT00996892|101671453|FG004|Expansion Stage 2|Disease Progression|0|||
33485965|NCT00996892|101671454|FG005|Expansion Stage 2|Disease Progression|0|||
33485966|NCT00996892|101671455|FG006|Expansion Stage 2|Disease Progression|0|||
33485967|NCT00996892|101671456|FG007|Expansion Stage 2|Disease Progression|0|||
33280713|NCT02382406|100924175|FG000|Follow up|Withdrawal by Subject|0|||
33280714|NCT02382406|100924176|FG001|Follow up|Withdrawal by Subject|0|||
33280715|NCT02382406|100924177|FG002|Follow up|Withdrawal by Subject|2|||
33280716|NCT02391545|100924180|FG000|Overall Study|Death|0|||
33280717|NCT02391545|100924181|FG001|Overall Study|Death|2|||
33280718|NCT02391545|100924180|FG000|Overall Study|Lost to Follow-up|0|||
33280719|NCT02391545|100924181|FG001|Overall Study|Lost to Follow-up|1|||
33280720|NCT02391545|100924180|FG000|Overall Study|Termination of study by sponsor|20|||
33280721|NCT02391545|100924181|FG001|Overall Study|Termination of study by sponsor|20|||
33280722|NCT02391545|100924180|FG000|Overall Study|Withdrawal by Subject|0|||
33280723|NCT02391545|100924181|FG001|Overall Study|Withdrawal by Subject|1|||
33280724|NCT02391545|100924180|FG000|Overall Study|Other Reasons|6|||
33280725|NCT02391545|100924181|FG001|Overall Study|Other Reasons|4|||
33280726|NCT00111839|100924184|FG000|Overall Study|Disease Progression|30|||
33280727|NCT00111839|100924185|FG001|Overall Study|Disease Progression|33|||
33280728|NCT00111839|100924186|FG002|Overall Study|Disease Progression|33|||
33280729|NCT00111839|100924184|FG000|Overall Study|Adverse Event|5|||
33280730|NCT00111839|100924185|FG001|Overall Study|Adverse Event|3|||
33280731|NCT00111839|100924186|FG002|Overall Study|Adverse Event|1|||
33280732|NCT00111839|100924184|FG000|Overall Study|Protocol Violation|2|||
33280733|NCT00111839|100924185|FG001|Overall Study|Protocol Violation|4|||
33280734|NCT00111839|100924186|FG002|Overall Study|Protocol Violation|2|||
33280735|NCT00111839|100924184|FG000|Overall Study|Death|1|||
33280736|NCT00111839|100924185|FG001|Overall Study|Death|1|||
33280737|NCT00111839|100924186|FG002|Overall Study|Death|6|||
33280738|NCT00111839|100924184|FG000|Overall Study|Withdrawal by Subject|2|||
33280739|NCT00111839|100924185|FG001|Overall Study|Withdrawal by Subject|2|||
33485968|NCT00996892|101671457|FG008|Expansion Stage 2|Disease Progression|0|||
33485969|NCT00996892|101671458|FG009|Expansion Stage 2|Disease Progression|0|||
33485970|NCT00996892|101671459|FG010|Expansion Stage 2|Disease Progression|0|||
33485971|NCT00996892|101671460|FG011|Expansion Stage 2|Disease Progression|0|||
33280740|NCT00111839|100924186|FG002|Overall Study|Withdrawal by Subject|2|||
33280741|NCT00111839|100924184|FG000|Overall Study|Lost to Follow-up|1|||
33280742|NCT00111839|100924185|FG001|Overall Study|Lost to Follow-up|0|||
33280743|NCT00111839|100924186|FG002|Overall Study|Lost to Follow-up|0|||
33280744|NCT00111839|100924184|FG000|Overall Study|Logistical Constraint|1|||
33280745|NCT00111839|100924185|FG001|Overall Study|Logistical Constraint|0|||
33280746|NCT00111839|100924186|FG002|Overall Study|Logistical Constraint|0|||
33280747|NCT00111839|100924184|FG000|Overall Study|Other|6|||
33280748|NCT00111839|100924185|FG001|Overall Study|Other|3|||
33280749|NCT00111839|100924186|FG002|Overall Study|Other|3|||
33280750|NCT00111839|100924184|FG000|Overall Study|Randomized but Not Treated|0|||
33280751|NCT00111839|100924185|FG001|Overall Study|Randomized but Not Treated|0|||
33280752|NCT00111839|100924186|FG002|Overall Study|Randomized but Not Treated|2|||
33280753|NCT03314233|100924187|FG000|Overall Study|No longer eligible at time of delivery|1|||
33280754|NCT01959607|100924188|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
33280755|NCT01959607|100924189|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
33280756|NCT01959607|100924190|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
33280757|NCT01959607|100924191|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
33280758|NCT04491136|100924192|FG000|Overall Study|Patient withdraw informed consent|9|||
33280759|NCT04491136|100924192|FG000|Overall Study|Adverse Event|2|||
33280760|NCT04491136|100924192|FG000|Overall Study|Death|3|||
33280761|NCT04491136|100924192|FG000|Overall Study|Lost to Follow-up|3|||
33280762|NCT04491136|100924192|FG000|Overall Study|Physician Decision|45|||
33280763|NCT04491136|100924192|FG000|Overall Study|sponsor terminated the study early|16|||
33280764|NCT04491136|100924192|FG000|Overall Study|Patient/guardian's decision|1|||
33280765|NCT01730118|100924195|FG000|Dose Escalation|Death on study|5|||
33280766|NCT01730118|100924196|FG001|Dose Escalation|Death on study|7|||
33280767|NCT01730118|100924197|FG002|Dose Escalation|Death on study|2|||
33280768|NCT01730118|100924198|FG003|Dose Escalation|Death on study|6|||
33280769|NCT01730118|100924199|FG004|Dose Escalation|Death on study|0|||
33280770|NCT01730118|100924200|FG005|Dose Escalation|Death on study|0|||
33280771|NCT01730118|100924201|FG006|Dose Escalation|Death on study|0|||
33280772|NCT01730118|100924195|FG000|Dose Escalation|Died before treatment|0|||
33280773|NCT01730118|100924196|FG001|Dose Escalation|Died before treatment|0|||
33280774|NCT01730118|100924197|FG002|Dose Escalation|Died before treatment|0|||
33280775|NCT01730118|100924198|FG003|Dose Escalation|Died before treatment|0|||
33280776|NCT01730118|100924199|FG004|Dose Escalation|Died before treatment|0|||
33280777|NCT01730118|100924200|FG005|Dose Escalation|Died before treatment|0|||
33280778|NCT01730118|100924201|FG006|Dose Escalation|Died before treatment|1|||
33280779|NCT01730118|100924195|FG000|Dose Escalation|Chose to start a different treatment|1|||
33280780|NCT01730118|100924196|FG001|Dose Escalation|Chose to start a different treatment|0|||
33280781|NCT01730118|100924197|FG002|Dose Escalation|Chose to start a different treatment|0|||
33280782|NCT01730118|100924198|FG003|Dose Escalation|Chose to start a different treatment|0|||
33280783|NCT01730118|100924199|FG004|Dose Escalation|Chose to start a different treatment|0|||
33280784|NCT01730118|100924200|FG005|Dose Escalation|Chose to start a different treatment|0|||
33280785|NCT01730118|100924201|FG006|Dose Escalation|Chose to start a different treatment|0|||
33485972|NCT00996892|101671461|FG012|Expansion Stage 2|Disease Progression|0|||
33485973|NCT00996892|101671462|FG013|Expansion Stage 2|Disease Progression|0|||
33280786|NCT01730118|100924195|FG000|Dose Escalation|Withdrawal by Subject|0|||
33280787|NCT01730118|100924196|FG001|Dose Escalation|Withdrawal by Subject|0|||
33280788|NCT01730118|100924197|FG002|Dose Escalation|Withdrawal by Subject|1|||
33280789|NCT01730118|100924198|FG003|Dose Escalation|Withdrawal by Subject|0|||
33280790|NCT01730118|100924199|FG004|Dose Escalation|Withdrawal by Subject|0|||
33280791|NCT01730118|100924200|FG005|Dose Escalation|Withdrawal by Subject|0|||
33280792|NCT01730118|100924201|FG006|Dose Escalation|Withdrawal by Subject|0|||
33280793|NCT01730118|100924195|FG000|Dose Escalation|Disease progression prior to treatment|0|||
33280794|NCT01730118|100924196|FG001|Dose Escalation|Disease progression prior to treatment|0|||
33280795|NCT01730118|100924197|FG002|Dose Escalation|Disease progression prior to treatment|0|||
33280796|NCT01730118|100924198|FG003|Dose Escalation|Disease progression prior to treatment|0|||
33280797|NCT01730118|100924199|FG004|Dose Escalation|Disease progression prior to treatment|0|||
33280798|NCT01730118|100924200|FG005|Dose Escalation|Disease progression prior to treatment|0|||
33280799|NCT01730118|100924201|FG006|Dose Escalation|Disease progression prior to treatment|1|||
33280800|NCT01730118|100924195|FG000|Dose Expansion|Death|0|||
33280801|NCT01730118|100924196|FG001|Dose Expansion|Death|0|||
33280802|NCT01730118|100924197|FG002|Dose Expansion|Death|0|||
33280803|NCT01730118|100924198|FG003|Dose Expansion|Death|0|||
33280804|NCT01730118|100924199|FG004|Dose Expansion|Death|1|||
33280805|NCT01730118|100924200|FG005|Dose Expansion|Death|0|||
33280806|NCT01730118|100924201|FG006|Dose Expansion|Death|0|||
33280807|NCT01730118|100924195|FG000|Dose Expansion|Other medical condition|0|||
33280808|NCT01730118|100924196|FG001|Dose Expansion|Other medical condition|0|||
33280809|NCT01730118|100924197|FG002|Dose Expansion|Other medical condition|0|||
33485974|NCT00996892|101671463|FG014|Expansion Stage 2|Disease Progression|0|||
33485975|NCT00996892|101671464|FG015|Expansion Stage 2|Disease Progression|0|||
33280810|NCT01730118|100924198|FG003|Dose Expansion|Other medical condition|0|||
33280811|NCT01730118|100924199|FG004|Dose Expansion|Other medical condition|1|||
33485976|NCT00996892|101671465|FG016|Expansion Stage 2|Disease Progression|0|||
33280812|NCT01730118|100924200|FG005|Dose Expansion|Other medical condition|0|||
33280813|NCT01730118|100924201|FG006|Dose Expansion|Other medical condition|0|||
33280814|NCT01730118|100924195|FG000|Dose Expansion|Withdrawal by Subject|0|||
33280815|NCT01730118|100924196|FG001|Dose Expansion|Withdrawal by Subject|0|||
33280816|NCT01730118|100924197|FG002|Dose Expansion|Withdrawal by Subject|0|||
33280817|NCT01730118|100924198|FG003|Dose Expansion|Withdrawal by Subject|0|||
33280818|NCT01730118|100924199|FG004|Dose Expansion|Withdrawal by Subject|1|||
33280819|NCT01730118|100924200|FG005|Dose Expansion|Withdrawal by Subject|0|||
33280820|NCT01730118|100924201|FG006|Dose Expansion|Withdrawal by Subject|0|||
33280821|NCT01730118|100924195|FG000|Dose Expansion|Disease progression|0|||
33280822|NCT01730118|100924196|FG001|Dose Expansion|Disease progression|0|||
33280823|NCT01730118|100924197|FG002|Dose Expansion|Disease progression|0|||
33280824|NCT01730118|100924198|FG003|Dose Expansion|Disease progression|0|||
33280825|NCT01730118|100924199|FG004|Dose Expansion|Disease progression|0|||
33280826|NCT01730118|100924200|FG005|Dose Expansion|Disease progression|1|||
33280827|NCT01730118|100924201|FG006|Dose Expansion|Disease progression|0|||
33280828|NCT01730118|100924195|FG000|Dose Expansion|Inability to return|0|||
33280829|NCT01730118|100924196|FG001|Dose Expansion|Inability to return|0|||
33280830|NCT01730118|100924197|FG002|Dose Expansion|Inability to return|0|||
33280831|NCT01730118|100924198|FG003|Dose Expansion|Inability to return|0|||
33280832|NCT01730118|100924199|FG004|Dose Expansion|Inability to return|0|||
33280833|NCT01730118|100924200|FG005|Dose Expansion|Inability to return|1|||
33280834|NCT01730118|100924201|FG006|Dose Expansion|Inability to return|0|||
33280835|NCT01730118|100924195|FG000|Dose Expansion|Physician Decision|0|||
33280836|NCT01730118|100924196|FG001|Dose Expansion|Physician Decision|0|||
33280837|NCT01730118|100924197|FG002|Dose Expansion|Physician Decision|0|||
33280838|NCT01730118|100924198|FG003|Dose Expansion|Physician Decision|0|||
33280839|NCT01730118|100924199|FG004|Dose Expansion|Physician Decision|0|||
33280840|NCT01730118|100924200|FG005|Dose Expansion|Physician Decision|1|||
33280841|NCT01730118|100924201|FG006|Dose Expansion|Physician Decision|0|||
33280842|NCT04688086|100924202|FG000|Overall Study|Lost to Follow-up|164|||
33280843|NCT04688086|100924202|FG000|Overall Study|Imaging error;|64|||
33280844|NCT01679613|100924203|FG000|Overall Study|other than stated above|0|||
33280845|NCT01679613|100924204|FG001|Overall Study|other than stated above|1|||
33280846|NCT01679613|100924205|FG002|Overall Study|other than stated above|2|||
33280847|NCT01679613|100924206|FG003|Overall Study|other than stated above|2|||
33280848|NCT01287416|100924210|FG000|Pre-post Training|Withdrawal by Subject|17|||
33280849|NCT01287416|100924211|FG001|Pre-post Training|Withdrawal by Subject|24|||
33280850|NCT01287416|100924210|FG000|Pre-post Training|Lost to Follow-up|5|||
33280851|NCT01287416|100924211|FG001|Pre-post Training|Lost to Follow-up|1|||
33280852|NCT01287416|100924210|FG000|6 Month Follow-up|Lost to Follow-up|3|||
33280853|NCT01287416|100924211|FG001|6 Month Follow-up|Lost to Follow-up|2|||
33280854|NCT00705614|100924213|FG000|Initial Intervention|Adverse Event|40|||
33280855|NCT00705614|100924214|FG001|Initial Intervention|Adverse Event|21|||
33280856|NCT00705614|100924213|FG000|Initial Intervention|Lost to Follow-up|310|||
33280857|NCT00705614|100924214|FG001|Initial Intervention|Lost to Follow-up|191|||
33280858|NCT00705614|100924213|FG000|Initial Intervention|Withdrawal by Subject|114|||
33280859|NCT00705614|100924214|FG001|Initial Intervention|Withdrawal by Subject|71|||
33280860|NCT00705614|100924213|FG000|Initial Intervention|Administrative Reason|51|||
33280861|NCT00705614|100924214|FG001|Initial Intervention|Administrative Reason|38|||
33280862|NCT00705614|100924213|FG000|Initial Intervention|Status completion unknown|3|||
33280863|NCT00705614|100924214|FG001|Initial Intervention|Status completion unknown|0|||
33280864|NCT00705614|100924213|FG000|Switch to Remicade|Adverse Event|0|||
33280865|NCT00705614|100924214|FG001|Switch to Remicade|Adverse Event|5|||
33280866|NCT00705614|100924213|FG000|Switch to Remicade|Lost to Follow-up|0|||
33280867|NCT00705614|100924214|FG001|Switch to Remicade|Lost to Follow-up|23|||
33280868|NCT00705614|100924213|FG000|Switch to Remicade|Withdrawal by Subject|0|||
33280869|NCT00705614|100924214|FG001|Switch to Remicade|Withdrawal by Subject|12|||
33280870|NCT00705614|100924213|FG000|Switch to Remicade|Administrative Reason|0|||
33280871|NCT00705614|100924214|FG001|Switch to Remicade|Administrative Reason|9|||
33280872|NCT02391116|100924216|FG000|Treatment|Withdrawal by Subject|1|||
33280873|NCT02391116|100924216|FG000|Treatment|Protocol Violation|1|||
33280874|NCT02391116|100924216|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
33280875|NCT02391116|100924216|FG000|Treatment|AE with Clinical PD|3|||
33280876|NCT02391116|100924216|FG000|Safety Follow-up|Adverse Event|1|||
33280877|NCT02391116|100924216|FG000|Safety Follow-up|Withdrawal by Subject|4|||
33280878|NCT02391116|100924216|FG000|Safety Follow-up|Switching to Other Therapy|4|||
33280879|NCT02391116|100924216|FG000|Safety Follow-up|No Follow Up|1|||
33280880|NCT02391116|100924216|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
33280881|NCT02391116|100924216|FG000|Active Follow-up|Withdrawal by Subject|1|||
33280882|NCT02391116|100924216|FG000|Active Follow-up|Switching to Other Therapy|2|||
33280883|NCT02391116|100924216|FG000|Survival Follow-up|Withdrawal by Subject|3|||
33280884|NCT02391116|100924216|FG000|Survival Follow-up|Switching to Other Therapy|1|||
33280885|NCT04369664|100924217|FG000|Overall Study|Physician Decision|1|||
33280886|NCT04369664|100924218|FG001|Overall Study|Physician Decision|0|||
33280887|NCT00460577|100924224|FG000|Overall Study|Protocol Violation|2|||
33280888|NCT00460577|100924225|FG001|Overall Study|Protocol Violation|6|||
33280889|NCT01924806|100924226|FG000|Overall Study|Physician Decision|2|||
33280890|NCT01924806|100924227|FG001|Overall Study|Physician Decision|1|||
33280891|NCT02679079|100924228|FG000|Overall Study|Adverse Event|2|||
33280892|NCT02679079|100924229|FG001|Overall Study|Adverse Event|0|||
33280893|NCT02679079|100924230|FG002|Overall Study|Adverse Event|2|||
33280894|NCT02679079|100924228|FG000|Overall Study|Protocol Violation|0|||
33280895|NCT02679079|100924229|FG001|Overall Study|Protocol Violation|1|||
33280896|NCT02679079|100924230|FG002|Overall Study|Protocol Violation|0|||
33280897|NCT02679079|100924228|FG000|Overall Study|Withdrawal by Subject|2|||
33280898|NCT02679079|100924229|FG001|Overall Study|Withdrawal by Subject|1|||
33280899|NCT02679079|100924230|FG002|Overall Study|Withdrawal by Subject|0|||
33280900|NCT00759681|100924232|FG000|Overall Study|Death|2|||
33280901|NCT00759681|100924233|FG001|Overall Study|Death|5|||
33280902|NCT00759681|100924232|FG000|Overall Study|Lost to Follow-up|8|||
33280903|NCT00759681|100924233|FG001|Overall Study|Lost to Follow-up|5|||
33280904|NCT04088136|100924234|FG000|Overall Study|Withdrawal by Subject|5|||
33280905|NCT04088136|100924235|FG001|Overall Study|Withdrawal by Subject|0|||
33280906|NCT04088136|100924234|FG000|Overall Study|Lack of Efficacy|0|||
33280907|NCT04088136|100924235|FG001|Overall Study|Lack of Efficacy|1|||
33280908|NCT01678898|100924238|FG000|PB-102-F01|Adverse Event|0|||
33280909|NCT01678898|100924239|FG001|PB-102-F01|Adverse Event|1|||
33280910|NCT01678898|100924240|FG002|PB-102-F01|Adverse Event|0|||
33280911|NCT01678898|100924238|FG000|PB-102-F01|Physician Decision|0|||
33280912|NCT01678898|100924239|FG001|PB-102-F01|Physician Decision|1|||
33280913|NCT01678898|100924240|FG002|PB-102-F01|Physician Decision|0|||
33280914|NCT01075100|100924243|FG000|Overall Study|Adverse Event|15|||
33280915|NCT01075100|100924244|FG001|Overall Study|Adverse Event|18|||
33280916|NCT01075100|100924243|FG000|Overall Study|Patient Request|4|||
33280917|NCT01075100|100924244|FG001|Overall Study|Patient Request|4|||
33280918|NCT01075100|100924243|FG000|Overall Study|Investigator Request|2|||
33280919|NCT01075100|100924244|FG001|Overall Study|Investigator Request|1|||
33280920|NCT01075100|100924243|FG000|Overall Study|Disease Progression|25|||
33280921|NCT01075100|100924244|FG001|Overall Study|Disease Progression|29|||
33280922|NCT01075100|100924243|FG000|Overall Study|Other|3|||
33280923|NCT01075100|100924244|FG001|Overall Study|Other|1|||
33280924|NCT02660034|100924249|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
33280925|NCT02660034|100924250|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
33280926|NCT02660034|100924251|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
33280927|NCT02660034|100924252|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
33280928|NCT02660034|100924253|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
33280929|NCT02660034|100924254|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
33280930|NCT02660034|100924255|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
33280931|NCT02660034|100924256|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
33280932|NCT02660034|100924257|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
33280933|NCT02660034|100924258|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
33280934|NCT02660034|100924259|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
33280935|NCT02660034|100924260|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
33280936|NCT02660034|100924261|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
33280937|NCT02660034|100924262|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
33280938|NCT02660034|100924249|FG000|Overall Study|Progressive Disease (Clinical)|7|||
33280939|NCT02660034|100924250|FG001|Overall Study|Progressive Disease (Clinical)|8|||
33280940|NCT02660034|100924251|FG002|Overall Study|Progressive Disease (Clinical)|3|||
33280941|NCT02660034|100924252|FG003|Overall Study|Progressive Disease (Clinical)|9|||
33280942|NCT02660034|100924253|FG004|Overall Study|Progressive Disease (Clinical)|3|||
33280943|NCT02660034|100924254|FG005|Overall Study|Progressive Disease (Clinical)|0|||
33280944|NCT02660034|100924255|FG006|Overall Study|Progressive Disease (Clinical)|0|||
33280945|NCT02660034|100924256|FG007|Overall Study|Progressive Disease (Clinical)|0|||
33280946|NCT02660034|100924257|FG008|Overall Study|Progressive Disease (Clinical)|0|||
33280947|NCT02660034|100924258|FG009|Overall Study|Progressive Disease (Clinical)|0|||
33280948|NCT02660034|100924259|FG010|Overall Study|Progressive Disease (Clinical)|0|||
33280949|NCT02660034|100924260|FG011|Overall Study|Progressive Disease (Clinical)|0|||
33280950|NCT02660034|100924261|FG012|Overall Study|Progressive Disease (Clinical)|0|||
33280951|NCT02660034|100924262|FG013|Overall Study|Progressive Disease (Clinical)|0|||
33280952|NCT02660034|100924249|FG000|Overall Study|Lost to Follow-up|0|||
33485977|NCT00996892|101671466|FG017|Expansion Stage 2|Disease Progression|0|||
33280953|NCT02660034|100924250|FG001|Overall Study|Lost to Follow-up|0|||
33280954|NCT02660034|100924251|FG002|Overall Study|Lost to Follow-up|1|||
33280955|NCT02660034|100924252|FG003|Overall Study|Lost to Follow-up|1|||
33280956|NCT02660034|100924253|FG004|Overall Study|Lost to Follow-up|0|||
33280957|NCT02660034|100924254|FG005|Overall Study|Lost to Follow-up|0|||
33280958|NCT02660034|100924255|FG006|Overall Study|Lost to Follow-up|0|||
33280959|NCT02660034|100924256|FG007|Overall Study|Lost to Follow-up|0|||
33280960|NCT02660034|100924257|FG008|Overall Study|Lost to Follow-up|0|||
33280961|NCT02660034|100924258|FG009|Overall Study|Lost to Follow-up|1|||
33280962|NCT02660034|100924259|FG010|Overall Study|Lost to Follow-up|1|||
33280963|NCT02660034|100924260|FG011|Overall Study|Lost to Follow-up|1|||
33485978|NCT00996892|101671467|FG018|Expansion Stage 2|Disease Progression|28|||
33280964|NCT02660034|100924261|FG012|Overall Study|Lost to Follow-up|0|||
33280965|NCT02660034|100924262|FG013|Overall Study|Lost to Follow-up|0|||
33280966|NCT02660034|100924249|FG000|Overall Study|Participant moved into special access scheme|1|||
33280967|NCT02660034|100924250|FG001|Overall Study|Participant moved into special access scheme|2|||
33280968|NCT02660034|100924251|FG002|Overall Study|Participant moved into special access scheme|0|||
33280969|NCT02660034|100924252|FG003|Overall Study|Participant moved into special access scheme|0|||
33280970|NCT02660034|100924253|FG004|Overall Study|Participant moved into special access scheme|0|||
33280971|NCT02660034|100924254|FG005|Overall Study|Participant moved into special access scheme|0|||
33280972|NCT02660034|100924255|FG006|Overall Study|Participant moved into special access scheme|0|||
33280973|NCT02660034|100924256|FG007|Overall Study|Participant moved into special access scheme|0|||
33280974|NCT02660034|100924257|FG008|Overall Study|Participant moved into special access scheme|0|||
33280975|NCT02660034|100924258|FG009|Overall Study|Participant moved into special access scheme|0|||
33280976|NCT02660034|100924259|FG010|Overall Study|Participant moved into special access scheme|0|||
33280977|NCT02660034|100924260|FG011|Overall Study|Participant moved into special access scheme|0|||
33280978|NCT02660034|100924261|FG012|Overall Study|Participant moved into special access scheme|0|||
33280979|NCT02660034|100924262|FG013|Overall Study|Participant moved into special access scheme|0|||
33280980|NCT02660034|100924249|FG000|Overall Study|Adverse Event|1|||
33280981|NCT02660034|100924250|FG001|Overall Study|Adverse Event|0|||
33280982|NCT02660034|100924251|FG002|Overall Study|Adverse Event|0|||
33280983|NCT02660034|100924252|FG003|Overall Study|Adverse Event|0|||
33280984|NCT02660034|100924253|FG004|Overall Study|Adverse Event|0|||
33280985|NCT02660034|100924254|FG005|Overall Study|Adverse Event|0|||
33280986|NCT02660034|100924255|FG006|Overall Study|Adverse Event|0|||
33280987|NCT02660034|100924256|FG007|Overall Study|Adverse Event|0|||
33280988|NCT02660034|100924257|FG008|Overall Study|Adverse Event|0|||
33280989|NCT02660034|100924258|FG009|Overall Study|Adverse Event|0|||
33280990|NCT02660034|100924259|FG010|Overall Study|Adverse Event|0|||
33280991|NCT02660034|100924260|FG011|Overall Study|Adverse Event|0|||
33280992|NCT02660034|100924261|FG012|Overall Study|Adverse Event|0|||
33280993|NCT02660034|100924262|FG013|Overall Study|Adverse Event|0|||
33280994|NCT02660034|100924249|FG000|Overall Study|Sponsor Decision|0|||
33280995|NCT02660034|100924250|FG001|Overall Study|Sponsor Decision|1|||
33280996|NCT02660034|100924251|FG002|Overall Study|Sponsor Decision|2|||
33280997|NCT02660034|100924252|FG003|Overall Study|Sponsor Decision|2|||
33280998|NCT02660034|100924253|FG004|Overall Study|Sponsor Decision|3|||
33280999|NCT02660034|100924254|FG005|Overall Study|Sponsor Decision|0|||
33281000|NCT02660034|100924255|FG006|Overall Study|Sponsor Decision|0|||
33281001|NCT02660034|100924256|FG007|Overall Study|Sponsor Decision|0|||
33281002|NCT02660034|100924257|FG008|Overall Study|Sponsor Decision|0|||
33281003|NCT02660034|100924258|FG009|Overall Study|Sponsor Decision|0|||
33281004|NCT02660034|100924259|FG010|Overall Study|Sponsor Decision|0|||
33281005|NCT02660034|100924260|FG011|Overall Study|Sponsor Decision|0|||
33281006|NCT02660034|100924261|FG012|Overall Study|Sponsor Decision|0|||
33281007|NCT02660034|100924262|FG013|Overall Study|Sponsor Decision|1|||
33281008|NCT02660034|100924249|FG000|Overall Study|Withdrawal by Subject|0|||
33281009|NCT02660034|100924250|FG001|Overall Study|Withdrawal by Subject|0|||
33281010|NCT02660034|100924251|FG002|Overall Study|Withdrawal by Subject|0|||
33281011|NCT02660034|100924252|FG003|Overall Study|Withdrawal by Subject|0|||
33281012|NCT02660034|100924253|FG004|Overall Study|Withdrawal by Subject|0|||
33281013|NCT02660034|100924254|FG005|Overall Study|Withdrawal by Subject|0|||
33281014|NCT02660034|100924255|FG006|Overall Study|Withdrawal by Subject|1|||
33281015|NCT02660034|100924256|FG007|Overall Study|Withdrawal by Subject|1|||
33281016|NCT02660034|100924257|FG008|Overall Study|Withdrawal by Subject|1|||
33281017|NCT02660034|100924258|FG009|Overall Study|Withdrawal by Subject|0|||
33281018|NCT02660034|100924259|FG010|Overall Study|Withdrawal by Subject|0|||
33281019|NCT02660034|100924260|FG011|Overall Study|Withdrawal by Subject|1|||
33281020|NCT02660034|100924261|FG012|Overall Study|Withdrawal by Subject|2|||
33281021|NCT02660034|100924262|FG013|Overall Study|Withdrawal by Subject|0|||
33281022|NCT02660034|100924249|FG000|Overall Study|Death|0|||
33281023|NCT02660034|100924250|FG001|Overall Study|Death|0|||
33281024|NCT02660034|100924251|FG002|Overall Study|Death|0|||
33281025|NCT02660034|100924252|FG003|Overall Study|Death|0|||
33281026|NCT02660034|100924253|FG004|Overall Study|Death|0|||
33281027|NCT02660034|100924254|FG005|Overall Study|Death|13|||
33281028|NCT02660034|100924255|FG006|Overall Study|Death|14|||
33281029|NCT02660034|100924256|FG007|Overall Study|Death|10|||
33281030|NCT02660034|100924257|FG008|Overall Study|Death|9|||
33281031|NCT02660034|100924258|FG009|Overall Study|Death|21|||
33281032|NCT02660034|100924259|FG010|Overall Study|Death|17|||
33281033|NCT02660034|100924260|FG011|Overall Study|Death|15|||
33281034|NCT02660034|100924261|FG012|Overall Study|Death|18|||
33281035|NCT02660034|100924262|FG013|Overall Study|Death|7|||
33281036|NCT02660034|100924249|FG000|Overall Study|Physician Decision|0|||
33281037|NCT02660034|100924250|FG001|Overall Study|Physician Decision|0|||
33281038|NCT02660034|100924251|FG002|Overall Study|Physician Decision|0|||
33281039|NCT02660034|100924252|FG003|Overall Study|Physician Decision|0|||
33281040|NCT02660034|100924253|FG004|Overall Study|Physician Decision|0|||
33281041|NCT02660034|100924254|FG005|Overall Study|Physician Decision|0|||
33281042|NCT02660034|100924255|FG006|Overall Study|Physician Decision|0|||
33281043|NCT02660034|100924256|FG007|Overall Study|Physician Decision|0|||
33281044|NCT02660034|100924257|FG008|Overall Study|Physician Decision|0|||
33281045|NCT02660034|100924258|FG009|Overall Study|Physician Decision|0|||
33281046|NCT02660034|100924259|FG010|Overall Study|Physician Decision|0|||
33281047|NCT02660034|100924260|FG011|Overall Study|Physician Decision|0|||
33281048|NCT02660034|100924261|FG012|Overall Study|Physician Decision|0|||
33281049|NCT02660034|100924262|FG013|Overall Study|Physician Decision|1|||
33281050|NCT02660034|100924249|FG000|Overall Study|Participants transferred to LTE|0|||
33281051|NCT02660034|100924250|FG001|Overall Study|Participants transferred to LTE|0|||
33281052|NCT02660034|100924251|FG002|Overall Study|Participants transferred to LTE|0|||
33281053|NCT02660034|100924252|FG003|Overall Study|Participants transferred to LTE|0|||
33281054|NCT02660034|100924253|FG004|Overall Study|Participants transferred to LTE|0|||
33281055|NCT02660034|100924254|FG005|Overall Study|Participants transferred to LTE|10|||
33281056|NCT02660034|100924255|FG006|Overall Study|Participants transferred to LTE|8|||
33281057|NCT02660034|100924256|FG007|Overall Study|Participants transferred to LTE|8|||
33281058|NCT02660034|100924257|FG008|Overall Study|Participants transferred to LTE|10|||
33281059|NCT02660034|100924258|FG009|Overall Study|Participants transferred to LTE|1|||
33281060|NCT02660034|100924259|FG010|Overall Study|Participants transferred to LTE|2|||
33281061|NCT02660034|100924260|FG011|Overall Study|Participants transferred to LTE|4|||
33281062|NCT02660034|100924261|FG012|Overall Study|Participants transferred to LTE|1|||
33281063|NCT02660034|100924262|FG013|Overall Study|Participants transferred to LTE|1|||
33281064|NCT00728884|100924263|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
33281065|NCT00728884|100924263|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
33281066|NCT05335005|100924264|FG000|Overall Study|Lost to Follow-up|1|||
33281067|NCT02005029|100924265|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
33281068|NCT02005029|100924266|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
33281069|NCT00527514|100924267|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
33281070|NCT00527514|100924267|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
33281071|NCT00527514|100924267|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
33281072|NCT00527514|100924267|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
33281073|NCT00527514|100924267|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
33281074|NCT00527514|100924267|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
33281075|NCT00527514|100924267|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
33281076|NCT00348283|100924271|FG000|Induction|Adverse Event|0|||
33281077|NCT00348283|100924272|FG001|Induction|Adverse Event|2|||
33281078|NCT00348283|100924271|FG000|Induction|Protocol Violation|0|||
33281079|NCT00348283|100924272|FG001|Induction|Protocol Violation|4|||
33281080|NCT00348283|100924271|FG000|Double Blind|Adverse Event|2|||
33281081|NCT00348283|100924272|FG001|Double Blind|Adverse Event|5|||
33281082|NCT00348283|100924271|FG000|Double Blind|Withdrawal by Subject|1|||
33281083|NCT00348283|100924272|FG001|Double Blind|Withdrawal by Subject|1|||
33281084|NCT00348283|100924271|FG000|Double Blind|Protocol Violation|0|||
33281085|NCT00348283|100924272|FG001|Double Blind|Protocol Violation|1|||
33281086|NCT00348283|100924271|FG000|Double Blind|Lack of Efficacy|2|||
33281087|NCT00348283|100924272|FG001|Double Blind|Lack of Efficacy|2|||
33281088|NCT00348283|100924271|FG000|Double Blind|Pregnancy|0|||
33281089|NCT00348283|100924272|FG001|Double Blind|Pregnancy|1|||
33281090|NCT00348283|100924271|FG000|Open Label|Adverse Event|0|||
33281091|NCT00348283|100924272|FG001|Open Label|Adverse Event|8|||
33281092|NCT00348283|100924271|FG000|Open Label|Withdrawal by Subject|0|||
33281093|NCT00348283|100924272|FG001|Open Label|Withdrawal by Subject|4|||
33281094|NCT00348283|100924271|FG000|Open Label|Lost to Follow-up|0|||
33281095|NCT00348283|100924272|FG001|Open Label|Lost to Follow-up|1|||
33281096|NCT00348283|100924271|FG000|Open Label|Lack of Efficacy|0|||
33281097|NCT00348283|100924272|FG001|Open Label|Lack of Efficacy|13|||
33281098|NCT00348283|100924271|FG000|Open Label|Administrative reasons|0|||
33281099|NCT00348283|100924272|FG001|Open Label|Administrative reasons|5|||
33281100|NCT00348283|100924271|FG000|Open Label|Subject moved to the United States|0|||
33281101|NCT00348283|100924272|FG001|Open Label|Subject moved to the United States|1|||
33281102|NCT00348283|100924271|FG000|Open Label|Pregnancy|0|||
33281103|NCT00348283|100924272|FG001|Open Label|Pregnancy|1|||
33281104|NCT00348283|100924271|FG000|Open Label|Sponsor decision|0|||
33281105|NCT00348283|100924272|FG001|Open Label|Sponsor decision|1|||
33281106|NCT01502371|100924273|FG000|Overall Study|Withdrawal by Subject|1|||
33281107|NCT01502371|100924274|FG001|Overall Study|Withdrawal by Subject|2|||
33281108|NCT01502371|100924275|FG002|Overall Study|Withdrawal by Subject|1|||
33281109|NCT01502371|100924276|FG003|Overall Study|Withdrawal by Subject|1|||
33281110|NCT01502371|100924277|FG004|Overall Study|Withdrawal by Subject|1|||
33281111|NCT01502371|100924273|FG000|Overall Study|Adverse Event|2|||
33281112|NCT01502371|100924274|FG001|Overall Study|Adverse Event|1|||
33281113|NCT01502371|100924275|FG002|Overall Study|Adverse Event|0|||
33281114|NCT01502371|100924276|FG003|Overall Study|Adverse Event|4|||
33281115|NCT01502371|100924277|FG004|Overall Study|Adverse Event|3|||
33281116|NCT01502371|100924273|FG000|Overall Study|Treatment Failure|22|||
33281117|NCT01502371|100924274|FG001|Overall Study|Treatment Failure|20|||
33281118|NCT01502371|100924275|FG002|Overall Study|Treatment Failure|12|||
33281119|NCT01502371|100924276|FG003|Overall Study|Treatment Failure|19|||
33281120|NCT01502371|100924277|FG004|Overall Study|Treatment Failure|30|||
33281121|NCT01502371|100924273|FG000|Overall Study|Lack of Efficacy|3|||
33281122|NCT01502371|100924274|FG001|Overall Study|Lack of Efficacy|3|||
33281123|NCT01502371|100924275|FG002|Overall Study|Lack of Efficacy|2|||
33281124|NCT01502371|100924276|FG003|Overall Study|Lack of Efficacy|2|||
33281125|NCT01502371|100924277|FG004|Overall Study|Lack of Efficacy|4|||
33281126|NCT01502371|100924273|FG000|Overall Study|Physician Decision|3|||
33281127|NCT01502371|100924274|FG001|Overall Study|Physician Decision|0|||
33281128|NCT01502371|100924275|FG002|Overall Study|Physician Decision|0|||
33281129|NCT01502371|100924276|FG003|Overall Study|Physician Decision|0|||
33281130|NCT01502371|100924277|FG004|Overall Study|Physician Decision|1|||
33281131|NCT01502371|100924273|FG000|Overall Study|Noncompliance with Study Drug|0|||
33281132|NCT01502371|100924274|FG001|Overall Study|Noncompliance with Study Drug|0|||
33281133|NCT01502371|100924275|FG002|Overall Study|Noncompliance with Study Drug|1|||
33281134|NCT01502371|100924276|FG003|Overall Study|Noncompliance with Study Drug|2|||
33281135|NCT01502371|100924277|FG004|Overall Study|Noncompliance with Study Drug|1|||
33281136|NCT01502371|100924273|FG000|Overall Study|Technical Problems|1|||
33281137|NCT01502371|100924274|FG001|Overall Study|Technical Problems|0|||
33281138|NCT01502371|100924275|FG002|Overall Study|Technical Problems|2|||
33281139|NCT01502371|100924276|FG003|Overall Study|Technical Problems|4|||
33281140|NCT01502371|100924277|FG004|Overall Study|Technical Problems|1|||
33281141|NCT01502371|100924273|FG000|Overall Study|Protocol Violation|9|||
33281142|NCT01502371|100924274|FG001|Overall Study|Protocol Violation|5|||
33281143|NCT01502371|100924275|FG002|Overall Study|Protocol Violation|6|||
33281144|NCT01502371|100924276|FG003|Overall Study|Protocol Violation|5|||
33281145|NCT01502371|100924277|FG004|Overall Study|Protocol Violation|10|||
33281146|NCT01502371|100924273|FG000|Overall Study|Excluded Medication|0|||
33281147|NCT01502371|100924274|FG001|Overall Study|Excluded Medication|1|||
33281148|NCT01502371|100924275|FG002|Overall Study|Excluded Medication|1|||
33281149|NCT01502371|100924276|FG003|Overall Study|Excluded Medication|0|||
33281150|NCT01502371|100924277|FG004|Overall Study|Excluded Medication|1|||
33281151|NCT00678899|100924278|FG000|Overall Study|Adverse Event|1|||
33281152|NCT04883541|100924279|FG000|Overall Study|Not attending regular yoga class|16|||
33281153|NCT04883541|100924280|FG001|Overall Study|Not attending regular yoga class|0|||
33281154|NCT04883541|100924279|FG000|Overall Study|Not attending the pregnancy school|0|||
33281155|NCT04883541|100924280|FG001|Overall Study|Not attending the pregnancy school|9|||
33281156|NCT02504502|100924285|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
33281157|NCT02504502|100924286|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
33281158|NCT02504502|100924285|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
33281159|NCT02504502|100924286|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
33281160|NCT01812837|100924287|FG000|Overall Study|Lost to Follow-up|1|||
33281161|NCT01812837|100924288|FG001|Overall Study|Lost to Follow-up|1|||
33281162|NCT01812837|100924289|FG002|Overall Study|Lost to Follow-up|0|||
33281163|NCT01812837|100924287|FG000|Overall Study|Protocol Violation|1|||
33281164|NCT01812837|100924288|FG001|Overall Study|Protocol Violation|0|||
33281165|NCT01812837|100924289|FG002|Overall Study|Protocol Violation|0|||
33281166|NCT01369147|100924290|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
33281167|NCT01369147|100924291|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
33281168|NCT01369147|100924292|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
33281169|NCT00116584|100924293|FG000|Overall Study|Withdrawal by Subject|1|||
33281170|NCT00116584|100924294|FG001|Overall Study|Withdrawal by Subject|0|||
33281171|NCT00116584|100924293|FG000|Overall Study|Protocol Violation|1|||
33281172|NCT00116584|100924294|FG001|Overall Study|Protocol Violation|1|||
33281173|NCT02706834|100924301|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
33281174|NCT02706834|100924302|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
33281175|NCT02706834|100924303|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
33281176|NCT02706834|100924304|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
33281177|NCT02706834|100924305|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
33485979|NCT00996892|101671468|FG019|Expansion Stage 2|Disease Progression|0|||
33485980|NCT00996892|101671449|FG000|Expansion Stage 2A|Adverse Event|0|||
33485981|NCT00996892|101671450|FG001|Expansion Stage 2A|Adverse Event|0|||
33485982|NCT00996892|101671451|FG002|Expansion Stage 2A|Adverse Event|0|||
33485983|NCT00996892|101671452|FG003|Expansion Stage 2A|Adverse Event|0|||
33485984|NCT00996892|101671453|FG004|Expansion Stage 2A|Adverse Event|0|||
33485985|NCT00996892|101671454|FG005|Expansion Stage 2A|Adverse Event|0|||
33485986|NCT00996892|101671455|FG006|Expansion Stage 2A|Adverse Event|0|||
33485987|NCT00996892|101671456|FG007|Expansion Stage 2A|Adverse Event|0|||
33485988|NCT00996892|101671457|FG008|Expansion Stage 2A|Adverse Event|0|||
33281178|NCT02706834|100924306|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
33281179|NCT02706834|100924307|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
33485989|NCT00996892|101671458|FG009|Expansion Stage 2A|Adverse Event|0|||
33485990|NCT00996892|101671459|FG010|Expansion Stage 2A|Adverse Event|0|||
33485991|NCT00996892|101671460|FG011|Expansion Stage 2A|Adverse Event|0|||
33485992|NCT00996892|101671461|FG012|Expansion Stage 2A|Adverse Event|0|||
33485993|NCT00996892|101671462|FG013|Expansion Stage 2A|Adverse Event|0|||
33485994|NCT00996892|101671463|FG014|Expansion Stage 2A|Adverse Event|0|||
33485995|NCT00996892|101671464|FG015|Expansion Stage 2A|Adverse Event|0|||
33485996|NCT00996892|101671465|FG016|Expansion Stage 2A|Adverse Event|0|||
33485997|NCT00996892|101671466|FG017|Expansion Stage 2A|Adverse Event|0|||
33485998|NCT00996892|101671467|FG018|Expansion Stage 2A|Adverse Event|0|||
33485999|NCT00996892|101671468|FG019|Expansion Stage 2A|Adverse Event|8|||
33486000|NCT00996892|101671449|FG000|Expansion Stage 2A|Physician Decision|0|||
33486001|NCT00996892|101671450|FG001|Expansion Stage 2A|Physician Decision|0|||
33486002|NCT00996892|101671451|FG002|Expansion Stage 2A|Physician Decision|0|||
33486003|NCT00996892|101671452|FG003|Expansion Stage 2A|Physician Decision|0|||
33486004|NCT00996892|101671453|FG004|Expansion Stage 2A|Physician Decision|0|||
33486005|NCT00996892|101671454|FG005|Expansion Stage 2A|Physician Decision|0|||
33486006|NCT00996892|101671455|FG006|Expansion Stage 2A|Physician Decision|0|||
33486007|NCT00996892|101671456|FG007|Expansion Stage 2A|Physician Decision|0|||
33486008|NCT00996892|101671457|FG008|Expansion Stage 2A|Physician Decision|0|||
33486009|NCT00996892|101671458|FG009|Expansion Stage 2A|Physician Decision|0|||
33486010|NCT00996892|101671459|FG010|Expansion Stage 2A|Physician Decision|0|||
33486011|NCT00996892|101671460|FG011|Expansion Stage 2A|Physician Decision|0|||
33486012|NCT00996892|101671461|FG012|Expansion Stage 2A|Physician Decision|0|||
33486013|NCT00996892|101671462|FG013|Expansion Stage 2A|Physician Decision|0|||
33281180|NCT02706834|100924308|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
33281181|NCT02706834|100924309|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
33281182|NCT02706834|100924310|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
33281183|NCT02706834|100924311|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
33281184|NCT02706834|100924301|FG000|Overall Study|Lost to Follow-up|0|||
33281185|NCT02706834|100924302|FG001|Overall Study|Lost to Follow-up|0|||
33281186|NCT02706834|100924303|FG002|Overall Study|Lost to Follow-up|1|||
33281187|NCT02706834|100924304|FG003|Overall Study|Lost to Follow-up|0|||
33281188|NCT02706834|100924305|FG004|Overall Study|Lost to Follow-up|0|||
33281189|NCT02706834|100924306|FG005|Overall Study|Lost to Follow-up|0|||
33281190|NCT02706834|100924307|FG006|Overall Study|Lost to Follow-up|0|||
33281191|NCT02706834|100924308|FG007|Overall Study|Lost to Follow-up|0|||
33281192|NCT02706834|100924309|FG008|Overall Study|Lost to Follow-up|0|||
33281193|NCT02706834|100924310|FG009|Overall Study|Lost to Follow-up|0|||
33281194|NCT02706834|100924311|FG010|Overall Study|Lost to Follow-up|0|||
33281195|NCT02706834|100924301|FG000|Overall Study|Voluntary Withdrawal|1|||
33281196|NCT02706834|100924302|FG001|Overall Study|Voluntary Withdrawal|0|||
33281197|NCT02706834|100924303|FG002|Overall Study|Voluntary Withdrawal|0|||
33281198|NCT02706834|100924304|FG003|Overall Study|Voluntary Withdrawal|0|||
33281199|NCT02706834|100924305|FG004|Overall Study|Voluntary Withdrawal|0|||
33281200|NCT02706834|100924306|FG005|Overall Study|Voluntary Withdrawal|0|||
33281201|NCT02706834|100924307|FG006|Overall Study|Voluntary Withdrawal|0|||
33281202|NCT02706834|100924308|FG007|Overall Study|Voluntary Withdrawal|0|||
33281203|NCT02706834|100924309|FG008|Overall Study|Voluntary Withdrawal|0|||
33281204|NCT02706834|100924310|FG009|Overall Study|Voluntary Withdrawal|1|||
33281205|NCT02706834|100924311|FG010|Overall Study|Voluntary Withdrawal|0|||
33281206|NCT02706834|100924301|FG000|Overall Study|Other Reason Not Specified|1|||
33281207|NCT02706834|100924302|FG001|Overall Study|Other Reason Not Specified|0|||
33281208|NCT02706834|100924303|FG002|Overall Study|Other Reason Not Specified|0|||
33281209|NCT02706834|100924304|FG003|Overall Study|Other Reason Not Specified|0|||
33281210|NCT02706834|100924305|FG004|Overall Study|Other Reason Not Specified|1|||
33281211|NCT02706834|100924306|FG005|Overall Study|Other Reason Not Specified|0|||
33281212|NCT02706834|100924307|FG006|Overall Study|Other Reason Not Specified|0|||
33281213|NCT02706834|100924308|FG007|Overall Study|Other Reason Not Specified|0|||
33281214|NCT02706834|100924309|FG008|Overall Study|Other Reason Not Specified|0|||
33281215|NCT02706834|100924310|FG009|Overall Study|Other Reason Not Specified|0|||
33281216|NCT02706834|100924311|FG010|Overall Study|Other Reason Not Specified|0|||
33281217|NCT01020487|100924312|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
33281218|NCT01020487|100924313|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
33281219|NCT01020487|100924314|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
33281220|NCT01020487|100924312|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
33281221|NCT01020487|100924313|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
33281222|NCT01020487|100924314|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
33281223|NCT01020487|100924312|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
33281224|NCT01020487|100924313|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
33281225|NCT01020487|100924314|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
33281226|NCT01020487|100924312|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
33281227|NCT01020487|100924313|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
33281228|NCT01020487|100924314|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
33281229|NCT01020487|100924312|FG000|Part 2 Open-label Period|Adverse Event|0|||
33486014|NCT00996892|101671463|FG014|Expansion Stage 2A|Physician Decision|0|||
33486015|NCT00996892|101671464|FG015|Expansion Stage 2A|Physician Decision|0|||
33486016|NCT00996892|101671465|FG016|Expansion Stage 2A|Physician Decision|0|||
33281230|NCT01020487|100924313|FG001|Part 2 Open-label Period|Adverse Event|4|||
33281231|NCT01020487|100924314|FG002|Part 2 Open-label Period|Adverse Event|1|||
33281232|NCT00776984|100924315|FG000|Overall Study|Adverse Event|8|||
33281233|NCT00776984|100924316|FG001|Overall Study|Adverse Event|2|||
33281234|NCT00776984|100924315|FG000|Overall Study|Protocol Violation|4|||
33281235|NCT00776984|100924316|FG001|Overall Study|Protocol Violation|2|||
33281236|NCT00776984|100924315|FG000|Overall Study|Lost to Follow-up|2|||
33281237|NCT00776984|100924316|FG001|Overall Study|Lost to Follow-up|0|||
33281238|NCT00776984|100924315|FG000|Overall Study|Withdrawal by Subject|12|||
33281239|NCT00776984|100924316|FG001|Overall Study|Withdrawal by Subject|7|||
33281240|NCT00776984|100924315|FG000|Overall Study|Lack of Efficacy|0|||
33281241|NCT00776984|100924316|FG001|Overall Study|Lack of Efficacy|1|||
33281242|NCT00776984|100924315|FG000|Overall Study|Other|5|||
33281243|NCT00776984|100924316|FG001|Overall Study|Other|9|||
33281244|NCT05294328|100924317|FG000|Overall Study|Adverse Event|1|||
33281245|NCT05294328|100924318|FG001|Overall Study|Adverse Event|0|||
33281246|NCT05294328|100924319|FG002|Overall Study|Adverse Event|0|||
33281247|NCT05294328|100924317|FG000|Overall Study|Physician Decision|1|||
33281248|NCT05294328|100924318|FG001|Overall Study|Physician Decision|1|||
33281249|NCT05294328|100924319|FG002|Overall Study|Physician Decision|0|||
33281250|NCT05294328|100924317|FG000|Overall Study|Withdrawal by Subject|0|||
33281251|NCT05294328|100924318|FG001|Overall Study|Withdrawal by Subject|2|||
33281252|NCT05294328|100924319|FG002|Overall Study|Withdrawal by Subject|1|||
33281253|NCT05294328|100924317|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
33281254|NCT05294328|100924318|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
33281255|NCT05294328|100924319|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
33281256|NCT01887418|100924323|FG000|Overall Study|Travelling difficulties|0|||
33281257|NCT01887418|100924324|FG001|Overall Study|Travelling difficulties|0|||
33281258|NCT01887418|100924325|FG002|Overall Study|Travelling difficulties|1|||
33281259|NCT02864342|100924329|FG000|Overall Study|Eligibility Criteria Deviation|2|||
33281260|NCT02864342|100924330|FG001|Overall Study|Eligibility Criteria Deviation|3|||
33281261|NCT02864342|100924329|FG000|Overall Study|Withdrawal by Subject|4|||
33281262|NCT02864342|100924330|FG001|Overall Study|Withdrawal by Subject|2|||
33281263|NCT02864342|100924329|FG000|Overall Study|Device Technology Issue|6|||
33281264|NCT02864342|100924330|FG001|Overall Study|Device Technology Issue|7|||
33281265|NCT02864342|100924329|FG000|Overall Study|Death|0|||
33281266|NCT02864342|100924330|FG001|Overall Study|Death|1|||
33281267|NCT02864342|100924329|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
33281268|NCT02864342|100924330|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
33281269|NCT02864342|100924329|FG000|Overall Study|Lost to Follow-up|1|||
33281270|NCT02864342|100924330|FG001|Overall Study|Lost to Follow-up|5|||
33281271|NCT02864342|100924329|FG000|Overall Study|Lost Device|1|||
33281272|NCT02864342|100924330|FG001|Overall Study|Lost Device|0|||
33281273|NCT02864342|100924329|FG000|Overall Study|Adverse Event|1|||
33281274|NCT02864342|100924330|FG001|Overall Study|Adverse Event|0|||
33281275|NCT03635775|100924333|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
33281276|NCT03635775|100924334|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
33281277|NCT03635775|100924335|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
33281278|NCT03635775|100924336|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
33281279|NCT00240097|100924337|FG000|Part I|Adverse Event|1|||
33281280|NCT00240097|100924337|FG000|Part I|Death|1|||
33281281|NCT00240097|100924337|FG000|Part I|histology|1|||
33486017|NCT00996892|101671466|FG017|Expansion Stage 2A|Physician Decision|0|||
33486018|NCT00996892|101671467|FG018|Expansion Stage 2A|Physician Decision|0|||
33486019|NCT00996892|101671468|FG019|Expansion Stage 2A|Physician Decision|2|||
33486020|NCT00996892|101671449|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
33486021|NCT00996892|101671450|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
33486022|NCT00996892|101671451|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
33486023|NCT00996892|101671452|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
33486024|NCT00996892|101671453|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
33486025|NCT00996892|101671454|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
33486026|NCT00996892|101671455|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
33486027|NCT00996892|101671456|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
33486028|NCT00996892|101671457|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
33486029|NCT00996892|101671458|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
33486030|NCT00996892|101671459|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
33486031|NCT00996892|101671460|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
33281282|NCT00240097|100924337|FG000|Part I|unevaluable|1|||
33281283|NCT00240097|100924337|FG000|Part II|did not continue from Part I|23|||
33281284|NCT04362176|100924339|FG000|Overall Study|Lost to Follow-up|5|||
33281285|NCT04362176|100924340|FG001|Overall Study|Lost to Follow-up|8|||
33486032|NCT00996892|101671461|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
33486033|NCT00996892|101671462|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
33486034|NCT00996892|101671463|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
33486035|NCT00996892|101671464|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
33486036|NCT00996892|101671465|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
33486037|NCT00996892|101671466|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
33486038|NCT00996892|101671467|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
33486039|NCT00996892|101671468|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
33486040|NCT00996892|101671449|FG000|Expansion Stage 2A|Disease Progression|0|||
33486041|NCT00996892|101671450|FG001|Expansion Stage 2A|Disease Progression|0|||
33486042|NCT00996892|101671451|FG002|Expansion Stage 2A|Disease Progression|0|||
33486043|NCT00996892|101671452|FG003|Expansion Stage 2A|Disease Progression|0|||
33486044|NCT00996892|101671453|FG004|Expansion Stage 2A|Disease Progression|0|||
33486045|NCT00996892|101671454|FG005|Expansion Stage 2A|Disease Progression|0|||
33486046|NCT00996892|101671455|FG006|Expansion Stage 2A|Disease Progression|0|||
33486047|NCT00996892|101671456|FG007|Expansion Stage 2A|Disease Progression|0|||
33486048|NCT00996892|101671457|FG008|Expansion Stage 2A|Disease Progression|0|||
33486049|NCT00996892|101671458|FG009|Expansion Stage 2A|Disease Progression|0|||
33486050|NCT00996892|101671459|FG010|Expansion Stage 2A|Disease Progression|0|||
33486051|NCT00996892|101671460|FG011|Expansion Stage 2A|Disease Progression|0|||
33486052|NCT00996892|101671461|FG012|Expansion Stage 2A|Disease Progression|0|||
33486053|NCT00996892|101671462|FG013|Expansion Stage 2A|Disease Progression|0|||
33486054|NCT00996892|101671463|FG014|Expansion Stage 2A|Disease Progression|0|||
33486055|NCT00996892|101671464|FG015|Expansion Stage 2A|Disease Progression|0|||
33486056|NCT00996892|101671465|FG016|Expansion Stage 2A|Disease Progression|0|||
33486057|NCT00996892|101671466|FG017|Expansion Stage 2A|Disease Progression|0|||
33486058|NCT00996892|101671467|FG018|Expansion Stage 2A|Disease Progression|0|||
33486059|NCT00996892|101671468|FG019|Expansion Stage 2A|Disease Progression|31|||
33486060|NCT04003896|101671472|FG000|Overall Study|Withdrawal by Subject|3|||
33486061|NCT04003896|101671472|FG000|Overall Study|Physician Decision|1|||
33486062|NCT01715571|101671478|FG000|Overall Study|Lost to Follow-up|8|||
33486063|NCT01184079|101671479|FG000|Overall Study|Lost to Follow-up|14|||
33486064|NCT01184079|101671480|FG001|Overall Study|Lost to Follow-up|2|||
33486065|NCT03106987|101671481|FG000|Overall Study|Death|37|||
33486066|NCT03106987|101671482|FG001|Overall Study|Death|22|||
33486067|NCT03106987|101671483|FG002|Overall Study|Death|12|||
33486068|NCT03106987|101671484|FG003|Overall Study|Death|8|||
33486069|NCT03106987|101671481|FG000|Overall Study|Lost to Follow-up|2|||
33486070|NCT03106987|101671482|FG001|Overall Study|Lost to Follow-up|0|||
33486071|NCT03106987|101671483|FG002|Overall Study|Lost to Follow-up|2|||
33486072|NCT03106987|101671484|FG003|Overall Study|Lost to Follow-up|2|||
33486073|NCT03106987|101671481|FG000|Overall Study|Withdrawal by Subject|5|||
33486074|NCT03106987|101671482|FG001|Overall Study|Withdrawal by Subject|1|||
33486075|NCT03106987|101671483|FG002|Overall Study|Withdrawal by Subject|4|||
33486076|NCT03106987|101671484|FG003|Overall Study|Withdrawal by Subject|1|||
33486077|NCT01333397|101671486|FG000|Overall Study|Lost to Follow-up|1|||
33486078|NCT01333397|101671487|FG001|Overall Study|Lost to Follow-up|0|||
33486079|NCT01333397|101671488|FG002|Overall Study|Lost to Follow-up|0|||
33486080|NCT01333397|101671489|FG003|Overall Study|Lost to Follow-up|1|||
33486081|NCT01333397|101671490|FG004|Overall Study|Lost to Follow-up|0|||
33486082|NCT02800642|101671491|FG000|Overall Study|Death|3|||
33486083|NCT02800642|101671491|FG000|Overall Study|Other|10|||
33486084|NCT02800642|101671491|FG000|Overall Study|Physician Decision|2|||
33486085|NCT02800642|101671491|FG000|Overall Study|Adverse Event|6|||
33486086|NCT02800642|101671491|FG000|Overall Study|Withdrawal by Subject|3|||
33486087|NCT02800642|101671491|FG000|Overall Study|Lost to Follow-up|1|||
33486088|NCT02774642|101671492|FG000|Overall Study|Lost to Follow-up|9|||
33486089|NCT02774642|101671493|FG001|Overall Study|Lost to Follow-up|7|||
33486090|NCT02461160|101671494|FG000|Overall Study|Lost to Follow-up|0|||
33486091|NCT02461160|101671495|FG001|Overall Study|Lost to Follow-up|0|||
33486092|NCT02461160|101671496|FG002|Overall Study|Lost to Follow-up|0|||
33486093|NCT02461160|101671497|FG003|Overall Study|Lost to Follow-up|0|||
33486094|NCT02461160|101671498|FG004|Overall Study|Lost to Follow-up|0|||
33281286|NCT04362176|100924339|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
33486095|NCT02461160|101671499|FG005|Overall Study|Lost to Follow-up|0|||
33486096|NCT02461160|101671500|FG006|Overall Study|Lost to Follow-up|0|||
33486097|NCT02461160|101671501|FG007|Overall Study|Lost to Follow-up|1|||
33486098|NCT02461160|101671502|FG008|Overall Study|Lost to Follow-up|0|||
33486099|NCT02461160|101671503|FG009|Overall Study|Lost to Follow-up|0|||
33486100|NCT02461160|101671504|FG010|Overall Study|Lost to Follow-up|0|||
33486101|NCT02461160|101671505|FG011|Overall Study|Lost to Follow-up|0|||
33486102|NCT02461160|101671506|FG012|Overall Study|Lost to Follow-up|0|||
33486103|NCT01038297|101671507|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
33486104|NCT01038297|101671508|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
33486105|NCT01038297|101671509|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
33486106|NCT02859142|101671510|FG000|Overall Study|Adverse Event|1|||
33486107|NCT02859142|101671511|FG001|Overall Study|Adverse Event|2|||
33486108|NCT02859142|101671510|FG000|Overall Study|Lost to Follow-up|1|||
33486109|NCT02859142|101671511|FG001|Overall Study|Lost to Follow-up|4|||
33486110|NCT02859142|101671510|FG000|Overall Study|Withdrawal by Subject|2|||
33486111|NCT02859142|101671511|FG001|Overall Study|Withdrawal by Subject|0|||
33486112|NCT02859142|101671510|FG000|Overall Study|Scheduling difficulties|0|||
33486113|NCT02859142|101671511|FG001|Overall Study|Scheduling difficulties|3|||
33486114|NCT02960490|101671512|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
33486115|NCT02960490|101671513|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
33486116|NCT02960490|101671514|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33486117|NCT02960490|101671515|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33486118|NCT02960490|101671516|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33486119|NCT02960490|101671517|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33486120|NCT02960490|101671518|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33486121|NCT02960490|101671519|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33486122|NCT02960490|101671520|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33486123|NCT02960490|101671521|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
33486124|NCT02960490|101671512|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33486125|NCT02960490|101671513|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
33486126|NCT02960490|101671514|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33486127|NCT02960490|101671515|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33486128|NCT02960490|101671516|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33486129|NCT02960490|101671517|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33486130|NCT02960490|101671518|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33486131|NCT02960490|101671519|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33486132|NCT02960490|101671520|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33486133|NCT02960490|101671521|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
33486134|NCT02960490|101671512|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
33486135|NCT02960490|101671513|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
33486136|NCT02960490|101671514|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33486137|NCT02960490|101671515|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33486138|NCT02960490|101671516|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33486139|NCT02960490|101671517|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33486140|NCT02960490|101671518|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33486141|NCT02960490|101671519|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33486142|NCT02960490|101671520|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33486143|NCT02960490|101671521|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
33486144|NCT02960490|101671512|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
33486145|NCT02960490|101671513|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
33486146|NCT02960490|101671514|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33486147|NCT02960490|101671515|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33486148|NCT02960490|101671516|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33486149|NCT02960490|101671517|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33486150|NCT02960490|101671518|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33486151|NCT02960490|101671519|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33486152|NCT02960490|101671520|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33486153|NCT02960490|101671521|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
33486154|NCT02960490|101671512|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
33486155|NCT02960490|101671513|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
33486156|NCT02960490|101671514|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
33486157|NCT02960490|101671515|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
33486158|NCT02960490|101671516|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
33486159|NCT02960490|101671517|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
33486160|NCT02960490|101671518|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
33486161|NCT02960490|101671519|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
33486162|NCT02960490|101671520|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
33486163|NCT02960490|101671521|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
33486164|NCT02960490|101671512|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33486165|NCT02960490|101671513|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33486166|NCT02960490|101671514|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
33486167|NCT02960490|101671515|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33486168|NCT02960490|101671516|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
33486169|NCT02960490|101671517|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33486170|NCT02960490|101671518|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33281287|NCT04362176|100924340|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
33281288|NCT00640042|100924343|FG000|Enrollment|Did not receive study drug|83|||
33281289|NCT01878253|100924344|FG000|Overall Study|Death|1|||
33281290|NCT01878253|100924344|FG000|Overall Study|SIdus System Removal|3|||
33281291|NCT01878253|100924344|FG000|Overall Study|Withdrawal by Subject|1|||
33281292|NCT01878253|100924344|FG000|Overall Study|Lost to Follow-up|2|||
33281293|NCT01878253|100924344|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
33281294|NCT01946529|100924345|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
33281295|NCT01946529|100924346|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
33486171|NCT02960490|101671519|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33486172|NCT02960490|101671520|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33486173|NCT02960490|101671521|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
33486174|NCT02960490|101671512|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
33486175|NCT02960490|101671513|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
33486176|NCT02960490|101671514|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
33486177|NCT02960490|101671515|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
33486178|NCT02960490|101671516|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
33486179|NCT02960490|101671517|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
33486180|NCT02960490|101671518|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
33486181|NCT02960490|101671519|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
33486182|NCT02960490|101671520|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
33486183|NCT02960490|101671521|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
33486184|NCT02960490|101671512|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
33486185|NCT02960490|101671513|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
33486186|NCT02960490|101671514|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
33486187|NCT02960490|101671515|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
33486188|NCT02960490|101671516|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
33486189|NCT02960490|101671517|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
33486190|NCT02960490|101671518|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
33486191|NCT02960490|101671519|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
33486192|NCT02960490|101671520|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
33486193|NCT02960490|101671521|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
33486194|NCT02960490|101671512|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33486195|NCT02960490|101671513|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33486196|NCT02960490|101671514|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33486197|NCT02960490|101671515|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33486198|NCT02960490|101671516|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33486199|NCT02960490|101671517|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33486200|NCT02960490|101671518|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33486201|NCT02960490|101671519|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
33486202|NCT02960490|101671520|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33486203|NCT02960490|101671521|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
33486204|NCT02960490|101671512|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
33486205|NCT02960490|101671513|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
33486206|NCT02960490|101671514|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
33486207|NCT02960490|101671515|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
33486208|NCT02960490|101671516|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
33486209|NCT02960490|101671517|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
33486210|NCT02960490|101671518|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
33486211|NCT02960490|101671519|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
33486212|NCT02960490|101671520|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
33486213|NCT02960490|101671521|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
33486214|NCT02960490|101671512|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33486215|NCT02960490|101671513|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33486216|NCT02960490|101671514|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33486217|NCT02960490|101671515|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33486218|NCT02960490|101671516|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33486219|NCT02960490|101671517|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33486220|NCT02960490|101671518|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
33486221|NCT02960490|101671519|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33486222|NCT02960490|101671520|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33486223|NCT02960490|101671521|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
33486224|NCT02960490|101671512|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
33486225|NCT02960490|101671513|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
33486226|NCT02960490|101671514|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
33486227|NCT02960490|101671515|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
33486228|NCT02960490|101671516|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
33486229|NCT02960490|101671517|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
33486230|NCT02960490|101671518|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
33486231|NCT02960490|101671519|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
33486232|NCT02960490|101671520|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
33486233|NCT02960490|101671521|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
33281296|NCT01946529|100924347|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
33486234|NCT05022212|101671522|FG000|Overall Study|Lost to Follow-up|0|||
33486235|NCT05022212|101671523|FG001|Overall Study|Lost to Follow-up|2|||
33486236|NCT02224157|101671524|FG000|Overall Study|Severe non-compliance to protocol|2|||
33486237|NCT02224157|101671525|FG001|Overall Study|Severe non-compliance to protocol|2|||
33486238|NCT02224157|101671524|FG000|Overall Study|Other|13|||
33486239|NCT02224157|101671525|FG001|Overall Study|Other|10|||
33486240|NCT02224157|101671524|FG000|Overall Study|Subject decision|58|||
33486241|NCT02224157|101671525|FG001|Overall Study|Subject decision|50|||
33486242|NCT02224157|101671524|FG000|Overall Study|Prematurely closed site|4|||
33486243|NCT02224157|101671525|FG001|Overall Study|Prematurely closed site|2|||
33486244|NCT02224157|101671524|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
33486245|NCT02224157|101671525|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
33486246|NCT02224157|101671524|FG000|Overall Study|Lost to Follow-up|27|||
33486247|NCT02224157|101671525|FG001|Overall Study|Lost to Follow-up|35|||
33486248|NCT02224157|101671524|FG000|Overall Study|Death|1|||
33486249|NCT02224157|101671525|FG001|Overall Study|Death|1|||
33486250|NCT02224157|101671524|FG000|Overall Study|Adverse Event|1|||
33486251|NCT02224157|101671525|FG001|Overall Study|Adverse Event|3|||
33486252|NCT03656744|101671535|FG000|Overall Study|Adverse Event|1|||
33486253|NCT03656744|101671536|FG001|Overall Study|Adverse Event|4|||
33486254|NCT03656744|101671537|FG002|Overall Study|Adverse Event|1|||
33486255|NCT03656744|101671535|FG000|Overall Study|Protocol Violation|1|||
33486256|NCT03656744|101671536|FG001|Overall Study|Protocol Violation|0|||
33486257|NCT03656744|101671537|FG002|Overall Study|Protocol Violation|0|||
33486258|NCT03656744|101671535|FG000|Overall Study|Lost to Follow-up|2|||
33486259|NCT03656744|101671536|FG001|Overall Study|Lost to Follow-up|2|||
33486260|NCT03656744|101671537|FG002|Overall Study|Lost to Follow-up|0|||
33486261|NCT03656744|101671535|FG000|Overall Study|Withdrawal by Subject|0|||
33486262|NCT03656744|101671536|FG001|Overall Study|Withdrawal by Subject|1|||
33486263|NCT03656744|101671537|FG002|Overall Study|Withdrawal by Subject|0|||
33486264|NCT03656744|101671535|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
33486265|NCT03656744|101671536|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
33486266|NCT03656744|101671537|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
33486267|NCT04233073|101671538|FG000|Overall Study|Death|5|||
33486268|NCT02256436|101671541|FG000|Overall Study|Adverse Event|9|||
33486269|NCT02256436|101671542|FG001|Overall Study|Adverse Event|14|||
33486270|NCT02256436|101671541|FG000|Overall Study|Death|216|||
33486271|NCT02256436|101671542|FG001|Overall Study|Death|208|||
33486272|NCT02256436|101671541|FG000|Overall Study|Lost to Follow-up|1|||
33486273|NCT02256436|101671542|FG001|Overall Study|Lost to Follow-up|2|||
33486274|NCT02256436|101671541|FG000|Overall Study|Physician Decision|1|||
33486275|NCT02256436|101671542|FG001|Overall Study|Physician Decision|0|||
33486276|NCT02256436|101671541|FG000|Overall Study|Protocol Violation|0|||
33486277|NCT02256436|101671542|FG001|Overall Study|Protocol Violation|1|||
33486278|NCT02256436|101671541|FG000|Overall Study|Withdrawal by Subject|26|||
33486279|NCT02256436|101671542|FG001|Overall Study|Withdrawal by Subject|10|||
33486280|NCT02256436|101671541|FG000|Overall Study|Transferred to Extension Study|11|||
33486281|NCT02256436|101671542|FG001|Overall Study|Transferred to Extension Study|23|||
33486282|NCT02256436|101671541|FG000|Overall Study|Did Not Continue on Extension Study|8|||
33486283|NCT02256436|101671542|FG001|Overall Study|Did Not Continue on Extension Study|12|||
33486284|NCT00041132|101671543|FG000|Overall Study|Adverse Event|19|||
33486285|NCT00041132|101671543|FG000|Overall Study|Death|1|||
33486286|NCT00041132|101671543|FG000|Overall Study|Not Eligible|7|||
33486287|NCT00041132|101671543|FG000|Overall Study|Withdrawal by Subject|1|||
33486288|NCT00041132|101671543|FG000|Overall Study|Physician Decision|2|||
33486289|NCT01128179|101671544|FG000|Overall Study|Death|1|||
33486290|NCT01128179|101671545|FG001|Overall Study|Death|0|||
33486291|NCT01128179|101671544|FG000|Overall Study|Protocol Violation|1|||
33486292|NCT01128179|101671545|FG001|Overall Study|Protocol Violation|0|||
33486293|NCT01266031|101671546|FG000|Overall Study|Not treated|0|||
33486294|NCT01266031|101671547|FG001|Overall Study|Not treated|3|||
33486295|NCT01266031|101671548|FG002|Overall Study|Not treated|2|||
33486296|NCT02129608|101675133|FG000|Overall Study|Lost to Follow-up|0|||
33486297|NCT02129608|101675134|FG001|Overall Study|Lost to Follow-up|1|||
33486298|NCT02129608|101675135|FG002|Overall Study|Lost to Follow-up|1|||
33486299|NCT02129608|101675133|FG000|Overall Study|Withdrawal by Subject|0|||
33486300|NCT02129608|101675134|FG001|Overall Study|Withdrawal by Subject|0|||
33486301|NCT02129608|101675135|FG002|Overall Study|Withdrawal by Subject|2|||
33486302|NCT04411914|101675136|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
33486303|NCT04411914|101675137|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
33486304|NCT04152863|101675140|FG000|Overall Study|Death|13|||
33486305|NCT04152863|101675141|FG001|Overall Study|Death|12|||
33486306|NCT04152863|101675142|FG002|Overall Study|Death|7|||
33486307|NCT04152863|101675140|FG000|Overall Study|Physician Decision|1|||
33486308|NCT04152863|101675141|FG001|Overall Study|Physician Decision|1|||
33486309|NCT04152863|101675142|FG002|Overall Study|Physician Decision|1|||
33486310|NCT04152863|101675140|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
33486311|NCT04152863|101675141|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
33486312|NCT04152863|101675142|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
33486313|NCT04152863|101675140|FG000|Overall Study|Withdrawal by Subject|2|||
33486314|NCT04152863|101675141|FG001|Overall Study|Withdrawal by Subject|1|||
33486315|NCT04152863|101675142|FG002|Overall Study|Withdrawal by Subject|3|||
33486316|NCT04303780|101675143|FG000|Overall Study|Death|104|||
33486317|NCT04303780|101675144|FG001|Overall Study|Death|85|||
33486318|NCT04303780|101675143|FG000|Overall Study|Lost to Follow-up|5|||
33486319|NCT04303780|101675144|FG001|Overall Study|Lost to Follow-up|2|||
33486320|NCT04303780|101675143|FG000|Overall Study|Withdrawal by Subject|12|||
33486321|NCT04303780|101675144|FG001|Overall Study|Withdrawal by Subject|39|||
33486322|NCT04303780|101675143|FG000|Overall Study|Ongoing in study|50|||
33486323|NCT04303780|101675144|FG001|Overall Study|Ongoing in study|45|||
33486324|NCT00761657|101675145|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
33486325|NCT00761657|101675146|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
33486326|NCT00761657|101675147|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
33486327|NCT00761657|101675148|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
33486328|NCT00761657|101675149|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
33486329|NCT00761657|101675150|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
33486330|NCT00761657|101675151|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
33486331|NCT00761657|101675152|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
33486332|NCT00761657|101675153|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
33486333|NCT00761657|101675145|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
33486334|NCT00761657|101675146|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
33486335|NCT00761657|101675147|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
33486336|NCT00761657|101675148|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
33486337|NCT00761657|101675149|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
33486338|NCT00761657|101675150|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
33486339|NCT00761657|101675151|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
33486340|NCT00761657|101675152|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
33486341|NCT00761657|101675153|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
33486342|NCT00761657|101675145|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
33486343|NCT00761657|101675146|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
33486344|NCT00761657|101675147|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
33486345|NCT00761657|101675148|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
33486346|NCT00761657|101675149|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
33486347|NCT00761657|101675150|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
33486348|NCT00761657|101675151|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
33486349|NCT00761657|101675152|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
33486350|NCT00761657|101675153|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
33486351|NCT00761657|101675145|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
33486352|NCT00761657|101675146|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
33486353|NCT00761657|101675147|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
33486354|NCT00761657|101675148|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
33486355|NCT00761657|101675149|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
33486356|NCT00761657|101675150|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
33486357|NCT00761657|101675151|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
33486358|NCT00761657|101675152|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
33486359|NCT00761657|101675153|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
33486360|NCT00811928|101675154|FG000|Overall Study|AEs and SAEs Including Death|7|||
33486361|NCT00811928|101675155|FG001|Overall Study|AEs and SAEs Including Death|11|||
33486362|NCT00811928|101675154|FG000|Overall Study|Withdrawal by Subject|18|||
33486363|NCT00811928|101675155|FG001|Overall Study|Withdrawal by Subject|12|||
33486364|NCT00811928|101675154|FG000|Overall Study|Did Not Take Study Drug|3|||
33486365|NCT00811928|101675155|FG001|Overall Study|Did Not Take Study Drug|0|||
33486366|NCT00811928|101675154|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
33486367|NCT00811928|101675155|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
33486368|NCT00811928|101675154|FG000|Overall Study|Investigator Decision|2|||
33486369|NCT00811928|101675155|FG001|Overall Study|Investigator Decision|1|||
33486370|NCT00811928|101675154|FG000|Overall Study|Poor Compliance|2|||
33486371|NCT00811928|101675155|FG001|Overall Study|Poor Compliance|5|||
33486372|NCT02929056|101675164|FG000|Overall Study|Lost to Follow-up|0|||
33486373|NCT02929056|101675165|FG001|Overall Study|Lost to Follow-up|1|||
33486374|NCT05299528|101675168|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
33486375|NCT05299528|101675169|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
33486376|NCT05299528|101675170|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
33486377|NCT05299528|101675171|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
33486378|NCT05299528|101675172|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
33486379|NCT05299528|101675173|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
33486380|NCT05299528|101675174|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
33486381|NCT05299528|101675168|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
33486382|NCT05299528|101675169|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
33489829|NCT02952586|101686778|FG000|LT Follow-up (up to 45 Months)|Death|51|||
33486383|NCT05299528|101675170|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
33486384|NCT05299528|101675171|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
33486385|NCT05299528|101675172|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
33486386|NCT05299528|101675173|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
33486387|NCT05299528|101675174|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
33486388|NCT05299528|101675168|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
33486389|NCT05299528|101675169|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
33486390|NCT05299528|101675170|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
33486391|NCT05299528|101675171|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
33486392|NCT05299528|101675172|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
33486393|NCT05299528|101675173|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
33486394|NCT05299528|101675174|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
33486395|NCT01107197|101675177|FG000|Overall Study|Death|12|||
33486396|NCT01107197|101675178|FG001|Overall Study|Death|10|||
33486397|NCT01107197|101675177|FG000|Overall Study|Lost to Follow-up|5|||
33486398|NCT01107197|101675178|FG001|Overall Study|Lost to Follow-up|8|||
33486399|NCT01107197|101675177|FG000|Overall Study|Withdrawal by Subject|3|||
33486400|NCT01107197|101675178|FG001|Overall Study|Withdrawal by Subject|5|||
33486401|NCT00625872|101675180|FG000|Overall Study|Withdrawal by Subject|1|||
33486402|NCT00625872|101675181|FG001|Overall Study|Withdrawal by Subject|0|||
33486403|NCT00625872|101675180|FG000|Overall Study|Does not meet inclusion criteria|1|||
33486404|NCT00625872|101675181|FG001|Overall Study|Does not meet inclusion criteria|0|||
33486405|NCT00625872|101675180|FG000|Overall Study|Terminated by sponsor|2|||
33486406|NCT00625872|101675181|FG001|Overall Study|Terminated by sponsor|5|||
33486407|NCT00625872|101675180|FG000|Overall Study|Randomized but not treated|0|||
33486408|NCT00625872|101675181|FG001|Overall Study|Randomized but not treated|1|||
33486409|NCT00359801|101675184|FG000|Overall Study|Lost to Follow-up|72|||
33486410|NCT00359801|101675185|FG001|Overall Study|Lost to Follow-up|58|||
33486411|NCT00359801|101675184|FG000|Overall Study|Withdrawal by Subject|143|||
33486412|NCT00359801|101675185|FG001|Overall Study|Withdrawal by Subject|96|||
33486413|NCT00359801|101675184|FG000|Overall Study|Other|66|||
33486414|NCT00359801|101675185|FG001|Overall Study|Other|46|||
33486415|NCT00359801|101675184|FG000|Overall Study|Final Status Unknown: missing data|7|||
33486416|NCT00359801|101675185|FG001|Overall Study|Final Status Unknown: missing data|4|||
33486417|NCT00359801|101675184|FG000|Overall Study|Sponsor Decision|17|||
33486418|NCT00359801|101675185|FG001|Overall Study|Sponsor Decision|16|||
33486419|NCT02565511|101675186|FG000|Overall Study|Study terminated by Sponsor|35|||
33486420|NCT02565511|101675187|FG001|Overall Study|Study terminated by Sponsor|22|||
33486421|NCT02565511|101675188|FG002|Overall Study|Study terminated by Sponsor|235|||
33486422|NCT02565511|101675189|FG003|Overall Study|Study terminated by Sponsor|156|||
33486423|NCT02565511|101675186|FG000|Overall Study|Withdrawal by Subject|3|||
33486424|NCT02565511|101675187|FG001|Overall Study|Withdrawal by Subject|0|||
33486425|NCT02565511|101675188|FG002|Overall Study|Withdrawal by Subject|12|||
33486426|NCT02565511|101675189|FG003|Overall Study|Withdrawal by Subject|5|||
33486427|NCT02565511|101675186|FG000|Overall Study|Adverse Event|0|||
33486428|NCT02565511|101675187|FG001|Overall Study|Adverse Event|0|||
33486429|NCT02565511|101675188|FG002|Overall Study|Adverse Event|1|||
33486430|NCT02565511|101675189|FG003|Overall Study|Adverse Event|1|||
33486431|NCT02565511|101675186|FG000|Overall Study|Lost to Follow-up|4|||
33486432|NCT02565511|101675187|FG001|Overall Study|Lost to Follow-up|1|||
33486433|NCT02565511|101675188|FG002|Overall Study|Lost to Follow-up|0|||
33486434|NCT02565511|101675189|FG003|Overall Study|Lost to Follow-up|1|||
33486435|NCT02565511|101675186|FG000|Overall Study|Physician Decision|0|||
33486436|NCT02565511|101675187|FG001|Overall Study|Physician Decision|0|||
33486437|NCT02565511|101675188|FG002|Overall Study|Physician Decision|0|||
33486438|NCT02565511|101675189|FG003|Overall Study|Physician Decision|1|||
33486439|NCT02565511|101675186|FG000|Overall Study|Protocol deviation|0|||
33486440|NCT02565511|101675187|FG001|Overall Study|Protocol deviation|0|||
33486441|NCT02565511|101675188|FG002|Overall Study|Protocol deviation|3|||
33486442|NCT02565511|101675189|FG003|Overall Study|Protocol deviation|0|||
33486443|NCT00822692|101675194|FG000|Overall Study|Lost to Follow-up|17|||
33486444|NCT00822692|101675195|FG001|Overall Study|Lost to Follow-up|25|||
33486445|NCT03180645|101675202|FG000|Overall Study|Adverse Event|0|||
33486446|NCT03180645|101675203|FG001|Overall Study|Adverse Event|1|||
33486447|NCT03180645|101675204|FG002|Overall Study|Adverse Event|2|||
33486448|NCT00369486|101675205|FG000|4-Week Visit|Missed visit|2|||
33486449|NCT00369486|101675206|FG001|4-Week Visit|Missed visit|2|||
33486450|NCT00369486|101675207|FG002|4-Week Visit|Missed visit|0|||
33486451|NCT00369486|101675208|FG003|4-Week Visit|Missed visit|2|||
33486452|NCT00369486|101675209|FG004|4-Week Visit|Missed visit|1|||
33486453|NCT00369486|101675205|FG000|4-Week Visit|Dropped|0|||
33486454|NCT00369486|101675206|FG001|4-Week Visit|Dropped|0|||
33486455|NCT00369486|101675207|FG002|4-Week Visit|Dropped|1|||
33486456|NCT00369486|101675208|FG003|4-Week Visit|Dropped|0|||
33486457|NCT00369486|101675209|FG004|4-Week Visit|Dropped|0|||
33486458|NCT00369486|101675205|FG000|8-Week Visit|Missed visit|0|||
33486459|NCT00369486|101675206|FG001|8-Week Visit|Missed visit|1|||
33486460|NCT00369486|101675207|FG002|8-Week Visit|Missed visit|0|||
33486461|NCT00369486|101675208|FG003|8-Week Visit|Missed visit|0|||
33486462|NCT00369486|101675209|FG004|8-Week Visit|Missed visit|1|||
33486463|NCT00369486|101675205|FG000|8-Week Visit|Dropped|0|||
33486464|NCT00369486|101675206|FG001|8-Week Visit|Dropped|0|||
33486465|NCT00369486|101675207|FG002|8-Week Visit|Dropped|0|||
33486466|NCT00369486|101675208|FG003|8-Week Visit|Dropped|1|||
33486467|NCT00369486|101675209|FG004|8-Week Visit|Dropped|0|||
33486468|NCT00369486|101675205|FG000|17-Week Visit|Missed visit|0|||
33486469|NCT00369486|101675206|FG001|17-Week Visit|Missed visit|0|||
33486470|NCT00369486|101675207|FG002|17-Week Visit|Missed visit|1|||
33486471|NCT00369486|101675208|FG003|17-Week Visit|Missed visit|1|||
33486472|NCT00369486|101675209|FG004|17-Week Visit|Missed visit|1|||
33486473|NCT00369486|101675205|FG000|34-Week Visit|Dropped|0|||
33486474|NCT00369486|101675206|FG001|34-Week Visit|Dropped|1|||
33486475|NCT00369486|101675207|FG002|34-Week Visit|Dropped|1|||
33486476|NCT00369486|101675208|FG003|34-Week Visit|Dropped|3|||
33486477|NCT00369486|101675209|FG004|34-Week Visit|Dropped|3|||
33486478|NCT00396565|101675210|FG000|Overall Study|Physician Decision|3|||
33486479|NCT00396565|101675211|FG001|Overall Study|Physician Decision|1|||
33486480|NCT00396565|101675212|FG002|Overall Study|Physician Decision|2|||
33486481|NCT00396565|101675210|FG000|Overall Study|Adverse Event|5|||
33486482|NCT00396565|101675211|FG001|Overall Study|Adverse Event|13|||
33486483|NCT00396565|101675212|FG002|Overall Study|Adverse Event|3|||
33486484|NCT00396565|101675210|FG000|Overall Study|Withdrawal by Subject|8|||
33486485|NCT00396565|101675211|FG001|Overall Study|Withdrawal by Subject|13|||
33486486|NCT00396565|101675212|FG002|Overall Study|Withdrawal by Subject|1|||
33486487|NCT00396565|101675210|FG000|Overall Study|Lack of Efficacy|32|||
33486488|NCT00396565|101675211|FG001|Overall Study|Lack of Efficacy|64|||
33486489|NCT00396565|101675212|FG002|Overall Study|Lack of Efficacy|11|||
33486490|NCT00663026|101675217|FG000|Overall Study|Lost to Follow-up|1|||
33486491|NCT00663026|101675218|FG001|Overall Study|Lost to Follow-up|0|||
33486492|NCT00663026|101675219|FG002|Overall Study|Lost to Follow-up|0|||
33486493|NCT00663026|101675217|FG000|Overall Study|Other|1|||
33486494|NCT00663026|101675218|FG001|Overall Study|Other|2|||
33486495|NCT00663026|101675219|FG002|Overall Study|Other|0|||
33486496|NCT00663026|101675217|FG000|Overall Study|Adverse Event|0|||
33486497|NCT00663026|101675218|FG001|Overall Study|Adverse Event|2|||
33486498|NCT00663026|101675219|FG002|Overall Study|Adverse Event|3|||
33486499|NCT00663026|101675217|FG000|Overall Study|Caregiver Request|0|||
33486500|NCT00663026|101675218|FG001|Overall Study|Caregiver Request|2|||
33486501|NCT00663026|101675219|FG002|Overall Study|Caregiver Request|0|||
33486502|NCT00663026|101675217|FG000|Overall Study|Withdrawal by Subject|0|||
33486503|NCT00663026|101675218|FG001|Overall Study|Withdrawal by Subject|0|||
33486504|NCT00663026|101675219|FG002|Overall Study|Withdrawal by Subject|1|||
33486505|NCT00595309|101675221|FG000|Overall Study|Lost to Follow-up|1|||
33486506|NCT00595309|101675221|FG000|Overall Study|planned vaccination against yellow fever|1|||
33486507|NCT00595309|101675221|FG000|Overall Study|acute infection after V0|1|||
33486508|NCT00595309|101675221|FG000|Overall Study|personal reason|1|||
33486509|NCT04172597|101675224|FG000|Overall Study|Disease Progression|0|||
33486510|NCT04172597|101675225|FG001|Overall Study|Disease Progression|0|||
33486511|NCT04172597|101675226|FG002|Overall Study|Disease Progression|0|||
33486512|NCT04172597|101675227|FG003|Overall Study|Disease Progression|0|||
33486513|NCT04172597|101675228|FG004|Overall Study|Disease Progression|1|||
33486514|NCT01098474|101675233|FG000|Active Phase|Other|0|||
33486515|NCT01098474|101675234|FG001|Active Phase|Other|0|||
33486516|NCT01098474|101675235|FG002|Active Phase|Other|3|||
33486517|NCT01098474|101675236|FG003|Active Phase|Other|0|||
33486518|NCT01098474|101675237|FG004|Active Phase|Other|0|||
33486519|NCT01098474|101675238|FG005|Active Phase|Other|0|||
33486520|NCT01098474|101675233|FG000|Active Phase|Withdrawal by Subject|1|||
33486521|NCT01098474|101675234|FG001|Active Phase|Withdrawal by Subject|1|||
33486522|NCT01098474|101675235|FG002|Active Phase|Withdrawal by Subject|2|||
33486523|NCT01098474|101675236|FG003|Active Phase|Withdrawal by Subject|0|||
33486524|NCT01098474|101675237|FG004|Active Phase|Withdrawal by Subject|0|||
33486525|NCT01098474|101675238|FG005|Active Phase|Withdrawal by Subject|0|||
33486526|NCT01098474|101675233|FG000|Active Phase|Lost to Follow-up|1|||
33486527|NCT01098474|101675234|FG001|Active Phase|Lost to Follow-up|0|||
33486528|NCT01098474|101675235|FG002|Active Phase|Lost to Follow-up|0|||
33486529|NCT01098474|101675236|FG003|Active Phase|Lost to Follow-up|0|||
33486530|NCT01098474|101675237|FG004|Active Phase|Lost to Follow-up|0|||
33486531|NCT01098474|101675238|FG005|Active Phase|Lost to Follow-up|0|||
33486532|NCT01098474|101675233|FG000|Follow Up Phase|Travelled out of study area|0|||
33486533|NCT01098474|101675234|FG001|Follow Up Phase|Travelled out of study area|0|||
33486534|NCT01098474|101675235|FG002|Follow Up Phase|Travelled out of study area|0|||
33486535|NCT01098474|101675236|FG003|Follow Up Phase|Travelled out of study area|0|||
33486536|NCT01098474|101675237|FG004|Follow Up Phase|Travelled out of study area|1|||
33486537|NCT01098474|101675238|FG005|Follow Up Phase|Travelled out of study area|0|||
33486538|NCT01098474|101675233|FG000|Follow Up Phase|Other|0|||
33486539|NCT01098474|101675234|FG001|Follow Up Phase|Other|0|||
33486540|NCT01098474|101675235|FG002|Follow Up Phase|Other|0|||
33486541|NCT01098474|101675236|FG003|Follow Up Phase|Other|0|||
33486542|NCT01098474|101675237|FG004|Follow Up Phase|Other|0|||
33486543|NCT01098474|101675238|FG005|Follow Up Phase|Other|4|||
33486544|NCT01098474|101675233|FG000|Follow Up Phase|Withdrawal by Subject|0|||
33486545|NCT01098474|101675234|FG001|Follow Up Phase|Withdrawal by Subject|0|||
33486546|NCT01098474|101675235|FG002|Follow Up Phase|Withdrawal by Subject|0|||
33486547|NCT01098474|101675236|FG003|Follow Up Phase|Withdrawal by Subject|2|||
33486548|NCT01098474|101675237|FG004|Follow Up Phase|Withdrawal by Subject|0|||
33486549|NCT01098474|101675238|FG005|Follow Up Phase|Withdrawal by Subject|1|||
33486550|NCT01098474|101675233|FG000|Follow Up Phase|Lost to Follow-up|0|||
33486551|NCT01098474|101675234|FG001|Follow Up Phase|Lost to Follow-up|0|||
33486552|NCT01098474|101675235|FG002|Follow Up Phase|Lost to Follow-up|0|||
33486553|NCT01098474|101675236|FG003|Follow Up Phase|Lost to Follow-up|0|||
33486554|NCT01098474|101675237|FG004|Follow Up Phase|Lost to Follow-up|1|||
33486555|NCT01098474|101675238|FG005|Follow Up Phase|Lost to Follow-up|0|||
33486556|NCT01144715|101675240|FG000|Overall Study|Lost to Follow-up|2|||
33486557|NCT01144715|101675241|FG001|Overall Study|Lost to Follow-up|1|||
33486558|NCT01144715|101675240|FG000|Overall Study|Withdrawal by Subject|2|||
33486559|NCT01144715|101675241|FG001|Overall Study|Withdrawal by Subject|1|||
33486560|NCT01144715|101675240|FG000|Overall Study|Adverse Event|0|||
33486561|NCT01144715|101675241|FG001|Overall Study|Adverse Event|1|||
33486562|NCT05093829|101675244|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
33486563|NCT05093829|101675245|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
33486564|NCT05093829|101675246|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
33486565|NCT05093829|101675247|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
33486566|NCT05093829|101675248|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
33486567|NCT01495702|101675249|FG000|Randomized Phase|Randomized But Not Treated|1|||
33486568|NCT01495702|101675250|FG001|Randomized Phase|Randomized But Not Treated|4|||
33486569|NCT01495702|101675249|FG000|Randomized Phase|Adverse Event|2|||
33486570|NCT01495702|101675250|FG001|Randomized Phase|Adverse Event|2|||
33486571|NCT01495702|101675249|FG000|Randomized Phase|Death|1|||
33486572|NCT01495702|101675250|FG001|Randomized Phase|Death|0|||
33486573|NCT01495702|101675249|FG000|Randomized Phase|Lack of Efficacy|2|||
33486574|NCT01495702|101675250|FG001|Randomized Phase|Lack of Efficacy|0|||
33486575|NCT01495702|101675249|FG000|Randomized Phase|Investigators Discretion|2|||
33486576|NCT01495702|101675250|FG001|Randomized Phase|Investigators Discretion|0|||
33486577|NCT01495702|101675249|FG000|Randomized Phase|Withdrew Consent|10|||
33486578|NCT01495702|101675250|FG001|Randomized Phase|Withdrew Consent|18|||
33486579|NCT01495702|101675249|FG000|Randomized Phase|Lost to Follow-up|4|||
33486580|NCT01495702|101675250|FG001|Randomized Phase|Lost to Follow-up|3|||
33486581|NCT01495702|101675249|FG000|Randomized Phase|Participant Noncompliance|1|||
33486582|NCT01495702|101675250|FG001|Randomized Phase|Participant Noncompliance|0|||
33486583|NCT01495702|101675249|FG000|Randomized Phase|Protocol Violation|3|||
33486584|NCT01495702|101675250|FG001|Randomized Phase|Protocol Violation|1|||
33486585|NCT01609023|101675251|FG000|Overall Study|Lack of Efficacy|3|||
33486586|NCT01609023|101675251|FG000|Overall Study|Withdrawal by Subject|4|||
33486587|NCT01609023|101675251|FG000|Overall Study|Lost to Follow-up|8|||
33486588|NCT01609023|101675251|FG000|Overall Study|Toxicity|3|||
33486589|NCT01609023|101675251|FG000|Overall Study|Disease progression|10|||
33486590|NCT01609023|101675251|FG000|Overall Study|Physician Decision|2|||
33486591|NCT01609023|101675251|FG000|Overall Study|Death|2|||
33486592|NCT01609023|101675251|FG000|Overall Study|Personal reasons|1|||
33486593|NCT04096040|101675252|FG000|Overall Study|Protocol Violation|12|||
33486594|NCT04096040|101675252|FG000|Overall Study|Non-compliant site|4|||
33486595|NCT03414684|101675254|FG000|First-course Treatment|Complete response|0|||
33486596|NCT03414684|101675255|FG001|First-course Treatment|Complete response|1|||
33486597|NCT03414684|101675254|FG000|First-course Treatment|Intercurrent illness|1|||
33486598|NCT03414684|101675255|FG001|First-course Treatment|Intercurrent illness|0|||
33486599|NCT03414684|101675254|FG000|First-course Treatment|Progressive Disease|31|||
33486600|NCT03414684|101675255|FG001|First-course Treatment|Progressive Disease|32|||
33486601|NCT03414684|101675254|FG000|First-course Treatment|Adverse Event|1|||
33486602|NCT03414684|101675255|FG001|First-course Treatment|Adverse Event|2|||
33486603|NCT03414684|101675254|FG000|First-course Treatment|Physician Decision|0|||
33486604|NCT03414684|101675255|FG001|First-course Treatment|Physician Decision|1|||
33486605|NCT03414684|101675254|FG000|First-course Treatment|Withdrawal by Subject|0|||
33486606|NCT03414684|101675255|FG001|First-course Treatment|Withdrawal by Subject|1|||
33486607|NCT03414684|101675254|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
33486608|NCT03414684|101675255|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
33486609|NCT03414684|101675254|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
33486610|NCT03414684|101675255|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
33486611|NCT03414684|101675254|FG000|First-course Treatment|Still on treatment|3|||
33486612|NCT03414684|101675255|FG001|First-course Treatment|Still on treatment|0|||
33486613|NCT03414684|101675254|FG000|First-course Treatment|Never started protocol therapy|2|||
33486614|NCT03414684|101675255|FG001|First-course Treatment|Never started protocol therapy|1|||
33486615|NCT03414684|101675254|FG000|Crossover Treatment|Progressive disease|0|||
33486616|NCT03414684|101675255|FG001|Crossover Treatment|Progressive disease|12|||
33486617|NCT03414684|101675254|FG000|Crossover Treatment|Adverse Event|0|||
33486618|NCT03414684|101675255|FG001|Crossover Treatment|Adverse Event|3|||
33486619|NCT03414684|101675254|FG000|Crossover Treatment|Physician Decision|0|||
33486620|NCT03414684|101675255|FG001|Crossover Treatment|Physician Decision|1|||
33486621|NCT03414684|101675254|FG000|Crossover Treatment|Still on treatment|0|||
33486622|NCT03414684|101675255|FG001|Crossover Treatment|Still on treatment|2|||
33486623|NCT02460679|101675258|FG000|Overall Study|Investigator Decision|1|||
33486624|NCT02460679|101675258|FG000|Overall Study|Withdrawal by Subject|4|||
33486625|NCT02290405|101675262|FG000|Overall Study|Withdrawal by Subject|1|||
33486626|NCT02290405|101675263|FG001|Overall Study|Withdrawal by Subject|0|||
33486627|NCT01473407|101675264|FG000|Overall Study|Physician Decision|1|||
33486628|NCT01473407|101675265|FG001|Overall Study|Physician Decision|4|||
33486629|NCT01473407|101675264|FG000|Overall Study|Lost to Follow-up|10|||
33486630|NCT01473407|101675265|FG001|Overall Study|Lost to Follow-up|4|||
33486631|NCT01473407|101675264|FG000|Overall Study|Adverse Event|8|||
33486632|NCT01473407|101675265|FG001|Overall Study|Adverse Event|8|||
33486633|NCT01473407|101675264|FG000|Overall Study|Randomization Error|3|||
33486634|NCT01473407|101675265|FG001|Overall Study|Randomization Error|1|||
33486635|NCT01473407|101675264|FG000|Overall Study|Withdrawal by Subject|4|||
33486636|NCT01473407|101675265|FG001|Overall Study|Withdrawal by Subject|7|||
33486637|NCT01473407|101675264|FG000|Overall Study|Kidney Transplant|7|||
33486638|NCT01473407|101675265|FG001|Overall Study|Kidney Transplant|6|||
33486639|NCT01473407|101675264|FG000|Overall Study|Vacation/Travel|1|||
33486640|NCT01473407|101675265|FG001|Overall Study|Vacation/Travel|1|||
33486641|NCT01473407|101675264|FG000|Overall Study|Elevated Hemoglobin|1|||
33486642|NCT01473407|101675265|FG001|Overall Study|Elevated Hemoglobin|0|||
33486643|NCT01473407|101675264|FG000|Overall Study|Patient Received Aranesp|1|||
33486644|NCT01473407|101675265|FG001|Overall Study|Patient Received Aranesp|0|||
33486645|NCT01473407|101675264|FG000|Overall Study|Patient Lost Green Card Status|1|||
33486646|NCT01473407|101675265|FG001|Overall Study|Patient Lost Green Card Status|0|||
33486647|NCT01473407|101675264|FG000|Overall Study|Temperature Excursion|2|||
33486648|NCT01473407|101675265|FG001|Overall Study|Temperature Excursion|3|||
33486649|NCT01473407|101675264|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
33486650|NCT01473407|101675265|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
33486651|NCT01473407|101675264|FG000|Overall Study|Sponsor's Decision|10|||
33486652|NCT01473407|101675265|FG001|Overall Study|Sponsor's Decision|10|||
33486653|NCT01473407|101675264|FG000|Overall Study|Site Closure|1|||
33486654|NCT01473407|101675265|FG001|Overall Study|Site Closure|0|||
33486655|NCT00397514|101675266|FG000|Overall Study|Withdrawal by Subject|1|||
33486656|NCT00397514|101675266|FG000|Overall Study|Pacing wire malfunction|1|||
33486657|NCT00397514|101675266|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
33486658|NCT00397514|101675266|FG000|Overall Study|early extubation|2|||
33486659|NCT00397514|101675266|FG000|Overall Study|poor echocardiographic windows|1|||
33486660|NCT01450683|101675267|FG000|Overall Study|Adverse Event|2|||
33486661|NCT00450801|101675271|FG000|Overall Study|Death|1|||
33486662|NCT02910011|101675272|FG000|Overall Study|Physician Decision|2|||
33486663|NCT01198132|101675276|FG000|Overall Study|Withdrawal by Subject|4|||
33486664|NCT01198132|101675277|FG001|Overall Study|Withdrawal by Subject|5|||
33486665|NCT01198132|101675276|FG000|Overall Study|Physician Decision|5|||
33486666|NCT01198132|101675277|FG001|Overall Study|Physician Decision|4|||
33486667|NCT01198132|101675276|FG000|Overall Study|Other Unspecified|3|||
33486668|NCT01198132|101675277|FG001|Overall Study|Other Unspecified|6|||
33486669|NCT01198132|101675276|FG000|Overall Study|Lack of Efficacy|2|||
33486670|NCT01198132|101675277|FG001|Overall Study|Lack of Efficacy|3|||
33486671|NCT01198132|101675276|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
33486672|NCT01198132|101675277|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
33486673|NCT01198132|101675276|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
33486674|NCT01198132|101675277|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
33486675|NCT01198132|101675276|FG000|Overall Study|Adverse Event|0|||
33486676|NCT01198132|101675277|FG001|Overall Study|Adverse Event|1|||
33486677|NCT01198132|101675276|FG000|Overall Study|Protocol Violation|1|||
33486678|NCT01198132|101675277|FG001|Overall Study|Protocol Violation|0|||
33486679|NCT03449446|101675280|FG000|Overall Study|Randomized but Never Treated|0|||
33486680|NCT03449446|101675281|FG001|Overall Study|Randomized but Never Treated|0|||
33281297|NCT01946529|100924345|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
33281298|NCT01946529|100924346|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
33281299|NCT01946529|100924347|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
33486681|NCT03449446|101675282|FG002|Overall Study|Randomized but Never Treated|1|||
33486682|NCT03449446|101675283|FG003|Overall Study|Randomized but Never Treated|1|||
33486683|NCT03449446|101675284|FG004|Overall Study|Randomized but Never Treated|1|||
33486684|NCT03449446|101675285|FG005|Overall Study|Randomized but Never Treated|0|||
33486685|NCT03449446|101675286|FG006|Overall Study|Randomized but Never Treated|0|||
33486686|NCT03449446|101675280|FG000|Overall Study|Unknown Reason|33|||
33486687|NCT03449446|101675281|FG001|Overall Study|Unknown Reason|1|||
33486688|NCT03449446|101675282|FG002|Overall Study|Unknown Reason|1|||
33486689|NCT03449446|101675283|FG003|Overall Study|Unknown Reason|1|||
33486690|NCT03449446|101675284|FG004|Overall Study|Unknown Reason|2|||
33486691|NCT03449446|101675285|FG005|Overall Study|Unknown Reason|2|||
33486692|NCT03449446|101675286|FG006|Overall Study|Unknown Reason|0|||
33486693|NCT03449446|101675280|FG000|Overall Study|Withdrew Consent|1|||
33486694|NCT03449446|101675281|FG001|Overall Study|Withdrew Consent|3|||
33486695|NCT03449446|101675282|FG002|Overall Study|Withdrew Consent|1|||
33486696|NCT03449446|101675283|FG003|Overall Study|Withdrew Consent|4|||
33486697|NCT03449446|101675284|FG004|Overall Study|Withdrew Consent|4|||
33486698|NCT03449446|101675285|FG005|Overall Study|Withdrew Consent|4|||
33486699|NCT03449446|101675286|FG006|Overall Study|Withdrew Consent|1|||
33486700|NCT03449446|101675280|FG000|Overall Study|Adverse Event|1|||
33486701|NCT03449446|101675281|FG001|Overall Study|Adverse Event|2|||
33486702|NCT03449446|101675282|FG002|Overall Study|Adverse Event|1|||
33486703|NCT03449446|101675283|FG003|Overall Study|Adverse Event|0|||
33486704|NCT03449446|101675284|FG004|Overall Study|Adverse Event|0|||
33486705|NCT03449446|101675285|FG005|Overall Study|Adverse Event|2|||
33486706|NCT03449446|101675286|FG006|Overall Study|Adverse Event|0|||
33486707|NCT03449446|101675280|FG000|Overall Study|Lost to Follow-up|0|||
33486708|NCT03449446|101675281|FG001|Overall Study|Lost to Follow-up|0|||
33486709|NCT03449446|101675282|FG002|Overall Study|Lost to Follow-up|2|||
33486710|NCT03449446|101675283|FG003|Overall Study|Lost to Follow-up|1|||
33486711|NCT03449446|101675284|FG004|Overall Study|Lost to Follow-up|3|||
33486712|NCT03449446|101675285|FG005|Overall Study|Lost to Follow-up|0|||
33486713|NCT03449446|101675286|FG006|Overall Study|Lost to Follow-up|0|||
33486714|NCT03449446|101675280|FG000|Overall Study|Investigator's Discretion|0|||
33486715|NCT03449446|101675281|FG001|Overall Study|Investigator's Discretion|1|||
33486716|NCT03449446|101675282|FG002|Overall Study|Investigator's Discretion|1|||
33486717|NCT03449446|101675283|FG003|Overall Study|Investigator's Discretion|2|||
33486718|NCT03449446|101675284|FG004|Overall Study|Investigator's Discretion|0|||
33486719|NCT03449446|101675285|FG005|Overall Study|Investigator's Discretion|0|||
33486720|NCT03449446|101675286|FG006|Overall Study|Investigator's Discretion|0|||
33486721|NCT03449446|101675280|FG000|Overall Study|Non Compliance with Study Drug|1|||
33486722|NCT03449446|101675281|FG001|Overall Study|Non Compliance with Study Drug|0|||
33486723|NCT03449446|101675282|FG002|Overall Study|Non Compliance with Study Drug|0|||
33486724|NCT03449446|101675283|FG003|Overall Study|Non Compliance with Study Drug|0|||
33486725|NCT03449446|101675284|FG004|Overall Study|Non Compliance with Study Drug|0|||
33486726|NCT03449446|101675285|FG005|Overall Study|Non Compliance with Study Drug|0|||
33486727|NCT03449446|101675286|FG006|Overall Study|Non Compliance with Study Drug|0|||
33486728|NCT03449446|101675280|FG000|Overall Study|Protocol Violation|0|||
33486729|NCT03449446|101675281|FG001|Overall Study|Protocol Violation|0|||
33486730|NCT03449446|101675282|FG002|Overall Study|Protocol Violation|0|||
33486731|NCT03449446|101675283|FG003|Overall Study|Protocol Violation|0|||
33486732|NCT03449446|101675284|FG004|Overall Study|Protocol Violation|1|||
33486733|NCT03449446|101675285|FG005|Overall Study|Protocol Violation|1|||
33486734|NCT03449446|101675286|FG006|Overall Study|Protocol Violation|0|||
33486735|NCT03449446|101675280|FG000|Overall Study|Death|0|||
33486736|NCT03449446|101675281|FG001|Overall Study|Death|0|||
33486737|NCT03449446|101675282|FG002|Overall Study|Death|0|||
33486738|NCT03449446|101675283|FG003|Overall Study|Death|0|||
33486739|NCT03449446|101675284|FG004|Overall Study|Death|1|||
33486740|NCT03449446|101675285|FG005|Overall Study|Death|0|||
33486741|NCT03449446|101675286|FG006|Overall Study|Death|0|||
33486742|NCT03200717|101675287|FG000|Overall Study|Progressive disease|24|||
33486743|NCT03200717|101675288|FG001|Overall Study|Progressive disease|5|||
33486744|NCT03200717|101675287|FG000|Overall Study|Adverse Event|11|||
33486745|NCT03200717|101675288|FG001|Overall Study|Adverse Event|8|||
33486746|NCT03200717|101675287|FG000|Overall Study|Physician Decision|3|||
33486747|NCT03200717|101675288|FG001|Overall Study|Physician Decision|2|||
33281300|NCT01024036|100924348|FG000|Blinded Treatment|Adverse Event|1|||
33281301|NCT01024036|100924349|FG001|Blinded Treatment|Adverse Event|1|||
33486748|NCT03200717|101675287|FG000|Overall Study|Death|2|||
33486749|NCT03200717|101675288|FG001|Overall Study|Death|0|||
33486750|NCT03200717|101675287|FG000|Overall Study|Subject/Guardian Decision|1|||
33486751|NCT03200717|101675288|FG001|Overall Study|Subject/Guardian Decision|0|||
33486752|NCT05320887|101675295|FG000|Overall Study|Lost to Follow-up|0|||
33486753|NCT05320887|101675296|FG001|Overall Study|Lost to Follow-up|3|||
33486754|NCT05320887|101675297|FG002|Overall Study|Lost to Follow-up|0|||
33486755|NCT05320887|101675298|FG003|Overall Study|Lost to Follow-up|0|||
33486756|NCT02289729|101675299|FG000|Overall Study|Lack of Efficacy|3|||
33486757|NCT02289729|101675299|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
33486758|NCT02289729|101675299|FG000|Overall Study|Withdrawal by Subject|1|||
33486759|NCT02289729|101675299|FG000|Overall Study|Death|1|||
33486760|NCT01106014|101675300|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
33486761|NCT01106014|101675301|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
33486762|NCT01106014|101675300|FG000|Overall Study|Adverse Event|78|||
33486763|NCT01106014|101675301|FG001|Overall Study|Adverse Event|42|||
33486764|NCT01106014|101675300|FG000|Overall Study|Withdrawal by Subject|43|||
33486765|NCT01106014|101675301|FG001|Overall Study|Withdrawal by Subject|37|||
33486766|NCT01106014|101675300|FG000|Overall Study|Administrative reason|7|||
33486767|NCT01106014|101675301|FG001|Overall Study|Administrative reason|6|||
33486768|NCT01106014|101675300|FG000|Overall Study|Lost to Follow-up|2|||
33486769|NCT01106014|101675301|FG001|Overall Study|Lost to Follow-up|3|||
33486770|NCT00715624|101675303|FG000|Overall Study|Adverse Event|12|||
33486771|NCT00715624|101675304|FG001|Overall Study|Adverse Event|37|||
33281302|NCT01024036|100924348|FG000|Blinded Treatment|Lack of Efficacy|16|||
33281303|NCT01024036|100924349|FG001|Blinded Treatment|Lack of Efficacy|14|||
33281304|NCT01024036|100924348|FG000|Blinded Treatment|Physician Decision|1|||
33281305|NCT01024036|100924349|FG001|Blinded Treatment|Physician Decision|0|||
33281306|NCT01024036|100924348|FG000|Blinded Treatment|Death|0|||
33281307|NCT01024036|100924349|FG001|Blinded Treatment|Death|2|||
33281308|NCT01024036|100924348|FG000|Blinded Treatment|Withdrawal by Subject|4|||
33281309|NCT01024036|100924349|FG001|Blinded Treatment|Withdrawal by Subject|3|||
33281310|NCT01024036|100924348|FG000|Unblinded Treatment|Adverse Event|0|||
33281311|NCT01024036|100924349|FG001|Unblinded Treatment|Adverse Event|1|||
33281312|NCT01024036|100924348|FG000|Unblinded Treatment|Lack of Efficacy|0|||
33281313|NCT01024036|100924349|FG001|Unblinded Treatment|Lack of Efficacy|2|||
33281314|NCT01024036|100924348|FG000|Follow-Up Period|Lost to Follow-up|1|||
33281315|NCT01024036|100924349|FG001|Follow-Up Period|Lost to Follow-up|1|||
33281316|NCT01024036|100924348|FG000|Follow-Up Period|Withdrawal by Subject|0|||
33281317|NCT01024036|100924349|FG001|Follow-Up Period|Withdrawal by Subject|1|||
33281318|NCT01024036|100924348|FG000|Follow-Up Period|Adverse Event|4|||
33281319|NCT01024036|100924349|FG001|Follow-Up Period|Adverse Event|1|||
33281320|NCT02538471|100924350|FG000|Overall Study|Progression of disease|2|||
33281321|NCT03740737|100924351|FG000|Overall Study|Protocol deviation|13|||
33281322|NCT03740737|100924352|FG001|Overall Study|Protocol deviation|0|||
33281323|NCT03740737|100924351|FG000|Overall Study|Adverse Event|2|||
33281324|NCT03740737|100924352|FG001|Overall Study|Adverse Event|0|||
33486772|NCT00715624|101675303|FG000|Overall Study|Lack of Efficacy|11|||
33486773|NCT00715624|101675304|FG001|Overall Study|Lack of Efficacy|11|||
33281325|NCT03740737|100924351|FG000|Overall Study|Lost to Follow-up|1|||
33281326|NCT03740737|100924352|FG001|Overall Study|Lost to Follow-up|0|||
33281327|NCT03740737|100924351|FG000|Overall Study|Randomization failure|1|||
33281328|NCT03740737|100924352|FG001|Overall Study|Randomization failure|0|||
33281329|NCT03740737|100924351|FG000|Overall Study|Participant withdrew consent|1|||
33281330|NCT03740737|100924352|FG001|Overall Study|Participant withdrew consent|0|||
33281331|NCT03740737|100924351|FG000|Overall Study|Participant withdrew from trial|2|||
33281332|NCT03740737|100924352|FG001|Overall Study|Participant withdrew from trial|1|||
33281333|NCT00404547|100924359|FG000|Overall Study|Adverse Event|39|||
33281334|NCT00404547|100924360|FG001|Overall Study|Adverse Event|6|||
33281335|NCT00404547|100924359|FG000|Overall Study|Withdrawal by Subject|19|||
33281336|NCT00404547|100924360|FG001|Overall Study|Withdrawal by Subject|2|||
33281337|NCT00404547|100924359|FG000|Overall Study|Protocol Violation|0|||
33281338|NCT00404547|100924360|FG001|Overall Study|Protocol Violation|1|||
33281339|NCT00404547|100924359|FG000|Overall Study|Lost to Follow-up|20|||
33281340|NCT00404547|100924360|FG001|Overall Study|Lost to Follow-up|9|||
33281341|NCT00404547|100924359|FG000|Overall Study|Lack of compliance|5|||
33281342|NCT00404547|100924360|FG001|Overall Study|Lack of compliance|1|||
33281343|NCT00404547|100924359|FG000|Overall Study|Other|4|||
33281344|NCT00404547|100924360|FG001|Overall Study|Other|0|||
33281345|NCT00404547|100924359|FG000|Overall Study|Reason not stated|3|||
33281346|NCT00404547|100924360|FG001|Overall Study|Reason not stated|6|||
33281347|NCT01498445|100924361|FG000|Overall Study|Lack of Efficacy|0|||
33281348|NCT01498445|100924362|FG001|Overall Study|Lack of Efficacy|0|||
33281349|NCT01498445|100924363|FG002|Overall Study|Lack of Efficacy|1|||
33281350|NCT01498445|100924364|FG003|Overall Study|Lack of Efficacy|2|||
33281351|NCT01498445|100924365|FG004|Overall Study|Lack of Efficacy|0|||
33281352|NCT01498445|100924366|FG005|Overall Study|Lack of Efficacy|0|||
33281353|NCT01498445|100924361|FG000|Overall Study|Screen Failure|0|||
33281354|NCT01498445|100924362|FG001|Overall Study|Screen Failure|0|||
33281355|NCT01498445|100924363|FG002|Overall Study|Screen Failure|0|||
33281356|NCT01498445|100924364|FG003|Overall Study|Screen Failure|0|||
33281357|NCT01498445|100924365|FG004|Overall Study|Screen Failure|1|||
33281358|NCT01498445|100924366|FG005|Overall Study|Screen Failure|1|||
33281359|NCT00377312|100924370|FG000|Overall Study|Adverse Event|1|||
33486774|NCT00715624|101675303|FG000|Overall Study|Lost to Follow-up|1|||
33486775|NCT00715624|101675304|FG001|Overall Study|Lost to Follow-up|2|||
33281360|NCT00377312|100924371|FG001|Overall Study|Adverse Event|1|||
33281361|NCT01126879|100927338|FG000|Overall Study|Progressive Disease|3|||
33281362|NCT01126879|100927339|FG001|Overall Study|Progressive Disease|1|||
33281363|NCT01126879|100927338|FG000|Overall Study|Withdrawal by Subject|1|||
33281364|NCT01126879|100927339|FG001|Overall Study|Withdrawal by Subject|0|||
33486776|NCT00715624|101675303|FG000|Overall Study|Protocol Violation|1|||
33486777|NCT00715624|101675304|FG001|Overall Study|Protocol Violation|0|||
33486778|NCT00715624|101675303|FG000|Overall Study|Withdrawal by Subject|11|||
33486779|NCT00715624|101675304|FG001|Overall Study|Withdrawal by Subject|25|||
33281365|NCT01126879|100927338|FG000|Overall Study|Adverse Event|0|||
33281366|NCT01126879|100927339|FG001|Overall Study|Adverse Event|1|||
33486780|NCT00715624|101675303|FG000|Overall Study|Familial and personal reasons|10|||
33486781|NCT00715624|101675304|FG001|Overall Study|Familial and personal reasons|22|||
33486782|NCT00715624|101675303|FG000|Overall Study|Poor compliance|6|||
33486783|NCT00715624|101675304|FG001|Overall Study|Poor compliance|13|||
33486784|NCT00715624|101675303|FG000|Overall Study|Sponsor decision|0|||
33486785|NCT00715624|101675304|FG001|Overall Study|Sponsor decision|4|||
33486786|NCT00715624|101675303|FG000|Overall Study|Incorrect randomization (not treated)|0|||
33486787|NCT00715624|101675304|FG001|Overall Study|Incorrect randomization (not treated)|1|||
33486788|NCT00715624|101675303|FG000|Overall Study|Other|0|||
33486789|NCT00715624|101675304|FG001|Overall Study|Other|1|||
33486790|NCT01137071|101675305|FG000|Overall Study|Disease Progression|11|||
33486791|NCT01137071|101675305|FG000|Overall Study|Withdrawal by Subject|2|||
33486792|NCT01137071|101675305|FG000|Overall Study|Wrongly Included|1|||
33486793|NCT04113018|101675306|FG000|Overall Study|Death|2|||
33486794|NCT04113018|101675306|FG000|Overall Study|Lost to Follow-up|1|||
33486795|NCT04113018|101675306|FG000|Overall Study|Still On Study (on study treatment)|24|||
33486796|NCT04113018|101675306|FG000|Overall Study|Still On Study (in follow up)|12|||
33486797|NCT03132155|101675307|FG000|Overall Study|Lack of Efficacy|6|||
33486798|NCT03132155|101675307|FG000|Overall Study|Lost to Follow-up|1|||
33486799|NCT03132155|101675307|FG000|Overall Study|Withdrawal by Subject|1|||
33486800|NCT01964976|101675308|FG000|Overall Study|Protocol Violation|31|||
33486801|NCT02289456|101675311|FG000|Induction Period|Death|2|||
33486802|NCT02289456|101675311|FG000|Induction Period|Adverse Event|11|||
33486803|NCT02289456|101675311|FG000|Induction Period|Progressive Disease (PD)|4|||
33486804|NCT02289456|101675311|FG000|Induction Period|Symptomatic Deterioration|4|||
33486805|NCT02289456|101675311|FG000|Induction Period|Withdrawal by Subject|2|||
33486806|NCT02289456|101675311|FG000|Induction Period|Miscellaneous|1|||
33486807|NCT02289456|101675311|FG000|Monotherapy Period|Death|1|||
33486808|NCT02289456|101675311|FG000|Monotherapy Period|Adverse Event|1|||
33486809|NCT02289456|101675311|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
33486810|NCT02289456|101675311|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
33486811|NCT02289456|101675311|FG000|Monotherapy Period|Withdrawal by Subject|2|||
33486812|NCT02289456|101675311|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
33486813|NCT02289456|101675311|FG000|Monotherapy Period|Miscellaneous|1|||
33486814|NCT00708227|101675312|FG000|Overall Study|Physician Decision|0|||
33486815|NCT00708227|101675313|FG001|Overall Study|Physician Decision|3|||
33486816|NCT00708227|101675314|FG002|Overall Study|Physician Decision|1|||
33486817|NCT00708227|101675315|FG003|Overall Study|Physician Decision|2|||
33486818|NCT00708227|101675312|FG000|Overall Study|Withdrawal by Subject|1|||
33486819|NCT00708227|101675313|FG001|Overall Study|Withdrawal by Subject|2|||
33486820|NCT00708227|101675314|FG002|Overall Study|Withdrawal by Subject|0|||
33486821|NCT00708227|101675315|FG003|Overall Study|Withdrawal by Subject|1|||
33486822|NCT02552121|101675316|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
33486823|NCT02552121|101675317|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
33486824|NCT02552121|101675318|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
33486825|NCT02552121|101675319|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
33486826|NCT02552121|101675320|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
33486827|NCT02552121|101675321|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
33486828|NCT02552121|101675322|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
33486829|NCT02552121|101675323|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
33486830|NCT02552121|101675316|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
33486831|NCT02552121|101675317|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
33486832|NCT02552121|101675318|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
33486833|NCT02552121|101675319|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
33486834|NCT02552121|101675320|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
33486835|NCT02552121|101675321|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
33486836|NCT02552121|101675322|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
33486837|NCT02552121|101675323|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
33486838|NCT02552121|101675316|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
33486839|NCT02552121|101675317|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
33486840|NCT02552121|101675318|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
33281367|NCT01126879|100927338|FG000|Overall Study|Physician Decision|1|||
33486841|NCT02552121|101675319|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
33486842|NCT02552121|101675320|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
33486843|NCT02552121|101675321|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
33486844|NCT02552121|101675322|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
33486845|NCT02552121|101675323|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
33486846|NCT02552121|101675316|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
33486847|NCT02552121|101675317|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
33486848|NCT02552121|101675318|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
33486849|NCT02552121|101675319|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
33281368|NCT01126879|100927339|FG001|Overall Study|Physician Decision|0|||
33281369|NCT05109117|100927342|FG000|Overall Study|Lost to Follow-up|1|||
33281370|NCT05109117|100927342|FG000|Overall Study|Discontinued for non-compliance|1|||
33281371|NCT02261285|100927343|FG000|Overall Study|Disease progression|0|||
33281372|NCT02261285|100927344|FG001|Overall Study|Disease progression|0|||
33281373|NCT02261285|100927345|FG002|Overall Study|Disease progression|1|||
33281374|NCT04203199|100927346|FG000|First Intervention Period|Lost to Follow-up|0|||
33281375|NCT04203199|100927347|FG001|First Intervention Period|Lost to Follow-up|1|||
33281376|NCT04203199|100927346|FG000|Second Intervention Period|Medication change|1|||
33281377|NCT04203199|100927347|FG001|Second Intervention Period|Medication change|0|||
33281378|NCT02256488|100927348|FG000|Overall Study|Lost to Follow-up|6|||
33281379|NCT02256488|100927349|FG001|Overall Study|Lost to Follow-up|6|||
33281380|NCT02256488|100927350|FG002|Overall Study|Lost to Follow-up|9|||
33281381|NCT02256488|100927351|FG003|Overall Study|Lost to Follow-up|3|||
33281382|NCT02256488|100927348|FG000|Overall Study|OTHER|1|||
33281383|NCT02256488|100927349|FG001|Overall Study|OTHER|0|||
33281384|NCT02256488|100927350|FG002|Overall Study|OTHER|1|||
33281385|NCT02256488|100927351|FG003|Overall Study|OTHER|1|||
33281386|NCT02256488|100927348|FG000|Overall Study|Withdrawal by Subject|1|||
33281387|NCT02256488|100927349|FG001|Overall Study|Withdrawal by Subject|0|||
33281388|NCT02256488|100927350|FG002|Overall Study|Withdrawal by Subject|0|||
33281389|NCT02256488|100927351|FG003|Overall Study|Withdrawal by Subject|2|||
33281390|NCT02499835|100927352|FG000|Overall Study|Withdrawal by Subject|1|||
33281391|NCT02499835|100927353|FG001|Overall Study|Withdrawal by Subject|0|||
33281392|NCT02499835|100927354|FG002|Overall Study|Withdrawal by Subject|0|||
33281393|NCT02499835|100927355|FG003|Overall Study|Withdrawal by Subject|1|||
33281394|NCT02499835|100927352|FG000|Overall Study|Physician Decision|0|||
33281395|NCT02499835|100927353|FG001|Overall Study|Physician Decision|3|||
33281396|NCT02499835|100927354|FG002|Overall Study|Physician Decision|18|||
33281397|NCT02499835|100927355|FG003|Overall Study|Physician Decision|7|||
33281398|NCT02499835|100927352|FG000|Overall Study|Adverse Event|0|||
33281399|NCT02499835|100927353|FG001|Overall Study|Adverse Event|0|||
33281400|NCT02499835|100927354|FG002|Overall Study|Adverse Event|0|||
33281401|NCT02499835|100927355|FG003|Overall Study|Adverse Event|1|||
33281402|NCT02499835|100927352|FG000|Overall Study|Disease progression|2|||
33281403|NCT02499835|100927353|FG001|Overall Study|Disease progression|1|||
33281404|NCT02499835|100927354|FG002|Overall Study|Disease progression|0|||
33281405|NCT02499835|100927355|FG003|Overall Study|Disease progression|7|||
33281406|NCT02604342|100927356|FG000|Overall Study|Death|32|||
33281407|NCT02604342|100927357|FG001|Overall Study|Death|16|||
33281408|NCT02604342|100927356|FG000|Overall Study|Progression of disease|1|||
33281409|NCT02604342|100927357|FG001|Overall Study|Progression of disease|0|||
33281410|NCT02604342|100927356|FG000|Overall Study|Withdrawal by Subject|5|||
33281411|NCT02604342|100927357|FG001|Overall Study|Withdrawal by Subject|6|||
33281412|NCT02604342|100927356|FG000|Overall Study|Other|1|||
33281413|NCT02604342|100927357|FG001|Overall Study|Other|0|||
33281414|NCT02604342|100927356|FG000|Overall Study|Study Termination by Sponsor|1|||
33281415|NCT02604342|100927357|FG001|Overall Study|Study Termination by Sponsor|0|||
33281416|NCT02604342|100927356|FG000|Overall Study|Lost to Follow-up|1|||
33281417|NCT02604342|100927357|FG001|Overall Study|Lost to Follow-up|1|||
33281418|NCT02604342|100927356|FG000|Overall Study|Physician Decision|2|||
33281419|NCT02604342|100927357|FG001|Overall Study|Physician Decision|0|||
33281420|NCT03325608|100927358|FG000|Overall Study|Lost to Follow-up|23|||
33281421|NCT03325608|100927359|FG001|Overall Study|Lost to Follow-up|23|||
33281422|NCT03325608|100927360|FG002|Overall Study|Lost to Follow-up|30|||
33281423|NCT03325608|100927361|FG003|Overall Study|Lost to Follow-up|30|||
33281424|NCT03325608|100927358|FG000|Overall Study|Death of Caregiver|0|||
33281425|NCT03325608|100927359|FG001|Overall Study|Death of Caregiver|0|||
33281426|NCT03325608|100927360|FG002|Overall Study|Death of Caregiver|2|||
33281427|NCT03325608|100927361|FG003|Overall Study|Death of Caregiver|2|||
33281428|NCT03325608|100927358|FG000|Overall Study|Death of Care Recipient|34|||
33281429|NCT03325608|100927359|FG001|Overall Study|Death of Care Recipient|34|||
33281430|NCT03325608|100927360|FG002|Overall Study|Death of Care Recipient|28|||
33281431|NCT03325608|100927361|FG003|Overall Study|Death of Care Recipient|28|||
33281432|NCT03325608|100927358|FG000|Overall Study|Withdrawal by Subject|49|||
33281433|NCT03325608|100927359|FG001|Overall Study|Withdrawal by Subject|49|||
33281434|NCT03325608|100927360|FG002|Overall Study|Withdrawal by Subject|35|||
33281435|NCT03325608|100927361|FG003|Overall Study|Withdrawal by Subject|35|||
33281436|NCT03325608|100927358|FG000|Overall Study|Ineligible|7|||
33281437|NCT03325608|100927359|FG001|Overall Study|Ineligible|7|||
33281438|NCT03325608|100927360|FG002|Overall Study|Ineligible|5|||
33281439|NCT03325608|100927361|FG003|Overall Study|Ineligible|5|||
33281440|NCT01592383|100927362|FG000|Overall Study|Adverse Event|1|||
33281441|NCT01494298|100927363|FG000|Overall Study|Protocol Violation|2|||
33281442|NCT01494298|100927364|FG001|Overall Study|Protocol Violation|8|||
33281443|NCT02642159|100927365|FG000|Overall Study|Randomized but not treated|1|||
33281444|NCT02642159|100927366|FG001|Overall Study|Randomized but not treated|0|||
33281445|NCT02642159|100927365|FG000|Overall Study|Adverse Event|10|||
33281446|NCT02642159|100927366|FG001|Overall Study|Adverse Event|4|||
33281447|NCT02642159|100927365|FG000|Overall Study|Withdrawal by Subject|9|||
33281448|NCT02642159|100927366|FG001|Overall Study|Withdrawal by Subject|1|||
33281449|NCT02642159|100927365|FG000|Overall Study|Poor compliance to study protocol|1|||
33281450|NCT02642159|100927366|FG001|Overall Study|Poor compliance to study protocol|0|||
33281451|NCT02642159|100927365|FG000|Overall Study|Other than specified above|10|||
33281452|NCT02642159|100927366|FG001|Overall Study|Other than specified above|3|||
33281453|NCT00105521|100927367|FG000|Overall Study|Other|1|||
33281454|NCT00105521|100927368|FG001|Overall Study|Other|1|||
33281455|NCT00105521|100927369|FG002|Overall Study|Other|2|||
33281456|NCT00105521|100927370|FG003|Overall Study|Other|0|||
33281457|NCT00105521|100927367|FG000|Overall Study|Adverse Event|10|||
33281458|NCT00105521|100927368|FG001|Overall Study|Adverse Event|4|||
33281459|NCT00105521|100927369|FG002|Overall Study|Adverse Event|10|||
33281460|NCT00105521|100927370|FG003|Overall Study|Adverse Event|8|||
33281461|NCT00105521|100927367|FG000|Overall Study|Withdrawal by Subject|1|||
33281462|NCT00105521|100927368|FG001|Overall Study|Withdrawal by Subject|0|||
33281463|NCT00105521|100927369|FG002|Overall Study|Withdrawal by Subject|1|||
33281464|NCT00105521|100927370|FG003|Overall Study|Withdrawal by Subject|4|||
33281465|NCT00105521|100927367|FG000|Overall Study|Lack of Efficacy|0|||
33281466|NCT00105521|100927368|FG001|Overall Study|Lack of Efficacy|0|||
33281467|NCT00105521|100927369|FG002|Overall Study|Lack of Efficacy|0|||
33281468|NCT00105521|100927370|FG003|Overall Study|Lack of Efficacy|1|||
33281469|NCT00105521|100927367|FG000|Overall Study|Protocol Violation|3|||
33281470|NCT00105521|100927368|FG001|Overall Study|Protocol Violation|5|||
33281471|NCT00105521|100927369|FG002|Overall Study|Protocol Violation|4|||
33281472|NCT00105521|100927370|FG003|Overall Study|Protocol Violation|4|||
33281473|NCT00105521|100927367|FG000|Overall Study|Lost to Follow-up|0|||
33281474|NCT00105521|100927368|FG001|Overall Study|Lost to Follow-up|1|||
33281475|NCT00105521|100927369|FG002|Overall Study|Lost to Follow-up|0|||
33281476|NCT00105521|100927370|FG003|Overall Study|Lost to Follow-up|0|||
33281477|NCT01898442|100927371|FG000|Overall Study|Hemolysis/technical problems|1|||
33281478|NCT01898442|100927372|FG001|Overall Study|Hemolysis/technical problems|2|||
33281479|NCT01898442|100927373|FG002|Overall Study|Hemolysis/technical problems|2|||
33281480|NCT01898442|100927371|FG000|Overall Study|Patient vomited pills|0|||
33281481|NCT01898442|100927372|FG001|Overall Study|Patient vomited pills|0|||
33281482|NCT01898442|100927373|FG002|Overall Study|Patient vomited pills|1|||
33281483|NCT02544113|100927374|FG000|Overall Study|Death|3|||
33281484|NCT02544113|100927375|FG001|Overall Study|Death|4|||
33281485|NCT00907517|100927376|FG000|Overall Study|Progressive Disease|3|||
33281486|NCT00907517|100927377|FG001|Overall Study|Progressive Disease|3|||
33281487|NCT00907517|100927378|FG002|Overall Study|Progressive Disease|4|||
33281488|NCT00907517|100927379|FG003|Overall Study|Progressive Disease|4|||
33281489|NCT00907517|100927380|FG004|Overall Study|Progressive Disease|4|||
33281490|NCT00907517|100927376|FG000|Overall Study|Symptomatic Deterioration|0|||
33281491|NCT00907517|100927377|FG001|Overall Study|Symptomatic Deterioration|0|||
33281492|NCT00907517|100927378|FG002|Overall Study|Symptomatic Deterioration|0|||
33281493|NCT00907517|100927379|FG003|Overall Study|Symptomatic Deterioration|0|||
33281494|NCT00907517|100927380|FG004|Overall Study|Symptomatic Deterioration|1|||
33281495|NCT00744796|100927381|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
33281496|NCT01732926|100927384|FG000|Overall Study|Study Terminated by Sponsor|168|||
33281497|NCT01732926|100927385|FG001|Overall Study|Study Terminated by Sponsor|80|||
33281498|NCT01732926|100927384|FG000|Overall Study|Withdrawal by Subject|46|||
33281499|NCT01732926|100927385|FG001|Overall Study|Withdrawal by Subject|8|||
33281500|NCT01732926|100927384|FG000|Overall Study|Physician Decision|24|||
33281501|NCT01732926|100927385|FG001|Overall Study|Physician Decision|11|||
33281502|NCT01732926|100927384|FG000|Overall Study|Other Reason|21|||
33281503|NCT01732926|100927385|FG001|Overall Study|Other Reason|4|||
33281504|NCT01732926|100927384|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
33281505|NCT01732926|100927385|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
33281506|NCT01732926|100927384|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
33281507|NCT01732926|100927385|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
33281508|NCT01485991|100927386|FG000|Overall Study|Adverse Event|0|||
33281509|NCT01485991|100927387|FG001|Overall Study|Adverse Event|4|||
33281510|NCT01485991|100927386|FG000|Overall Study|Lost to Follow-up|13|||
33281511|NCT01485991|100927387|FG001|Overall Study|Lost to Follow-up|10|||
33281512|NCT01485991|100927386|FG000|Overall Study|Withdrawal by Subject|13|||
33281513|NCT01485991|100927387|FG001|Overall Study|Withdrawal by Subject|20|||
33281514|NCT01485991|100927386|FG000|Overall Study|randomized but not treated|6|||
33281515|NCT01485991|100927387|FG001|Overall Study|randomized but not treated|2|||
33281516|NCT00424177|100927388|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
33281517|NCT00424177|100927388|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
33281518|NCT00424177|100927388|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
33281519|NCT00424177|100927388|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
33281520|NCT00424177|100927388|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
33281521|NCT00424177|100927388|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
33281522|NCT00424177|100927388|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
33281523|NCT00424177|100927388|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
33281524|NCT00424177|100927388|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
33281525|NCT00424177|100927388|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
33281526|NCT00666835|100927390|FG000|Overall Study|Withdrawal by Subject|5|||
33281527|NCT00666835|100927391|FG001|Overall Study|Withdrawal by Subject|2|||
33486850|NCT02552121|101675320|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
33486851|NCT02552121|101675321|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
33486852|NCT02552121|101675322|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
33486853|NCT02552121|101675323|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
33281528|NCT00666835|100927390|FG000|Overall Study|Lack of Efficacy|0|||
33281529|NCT00666835|100927391|FG001|Overall Study|Lack of Efficacy|1|||
33281530|NCT00666835|100927390|FG000|Overall Study|Incl./excl. not fulfilled|7|||
33281531|NCT00666835|100927391|FG001|Overall Study|Incl./excl. not fulfilled|2|||
33281532|NCT00666835|100927390|FG000|Overall Study|Adverse Event|7|||
33281533|NCT00666835|100927391|FG001|Overall Study|Adverse Event|6|||
33486854|NCT02552121|101675316|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
33281534|NCT00666835|100927390|FG000|Overall Study|Protocol Violation|2|||
33281535|NCT00666835|100927391|FG001|Overall Study|Protocol Violation|0|||
33281536|NCT00666835|100927390|FG000|Overall Study|Death|15|||
33281537|NCT00666835|100927391|FG001|Overall Study|Death|4|||
33281538|NCT00666835|100927390|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
33281539|NCT00666835|100927391|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
33281540|NCT00666835|100927390|FG000|Overall Study|Hemoglobulin concentration|4|||
33281541|NCT00666835|100927391|FG001|Overall Study|Hemoglobulin concentration|3|||
33281542|NCT00666835|100927390|FG000|Overall Study|Planned operation|2|||
33281543|NCT00666835|100927391|FG001|Overall Study|Planned operation|0|||
33281544|NCT00666835|100927390|FG000|Overall Study|Physician Decision|1|||
33281545|NCT00666835|100927391|FG001|Overall Study|Physician Decision|2|||
33281546|NCT01116440|100927392|FG000|Treatment|Withdrawal by Subject|2|||
33281547|NCT01116440|100927393|FG001|Treatment|Withdrawal by Subject|2|||
33281548|NCT01116440|100927392|FG000|Treatment|Lost to Follow-up|1|||
33281549|NCT01116440|100927393|FG001|Treatment|Lost to Follow-up|1|||
33281550|NCT01116440|100927392|FG000|Treatment|Protocol Violation|0|||
33281551|NCT01116440|100927393|FG001|Treatment|Protocol Violation|2|||
33281552|NCT01116440|100927392|FG000|Treatment|Lack of Efficacy|0|||
33281553|NCT01116440|100927393|FG001|Treatment|Lack of Efficacy|1|||
33281554|NCT01116440|100927392|FG000|Treatment|Adverse Event|0|||
33281555|NCT01116440|100927393|FG001|Treatment|Adverse Event|1|||
33281556|NCT01116440|100927392|FG000|Withdrawal|Withdrawal by Subject|0|||
33281557|NCT01116440|100927393|FG001|Withdrawal|Withdrawal by Subject|1|||
33281558|NCT01116440|100927392|FG000|Withdrawal|Lost to Follow-up|0|||
33281559|NCT01116440|100927393|FG001|Withdrawal|Lost to Follow-up|1|||
33281560|NCT01116440|100927392|FG000|Follow-up|Lost to Follow-up|0|||
33486855|NCT02552121|101675317|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
33486856|NCT02552121|101675318|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
33486857|NCT02552121|101675319|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
33486858|NCT02552121|101675320|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
33486859|NCT02552121|101675321|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
33486860|NCT02552121|101675322|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
33486861|NCT02552121|101675323|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
33486862|NCT02552121|101675316|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
33486863|NCT02552121|101675317|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
33486864|NCT02552121|101675318|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
33486865|NCT02552121|101675319|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
33281561|NCT01116440|100927393|FG001|Follow-up|Lost to Follow-up|1|||
33281562|NCT01116440|100927392|FG000|Follow-up|Withdrawal by Subject|0|||
33281563|NCT01116440|100927393|FG001|Follow-up|Withdrawal by Subject|1|||
33281564|NCT02878590|100927394|FG000|Overall Study|Withdrawal by Subject|2|||
33281565|NCT05177770|100927395|FG000|Overall Study|Death|4|||
33281566|NCT05177770|100927395|FG000|Overall Study|Withdrawal by Subject|1|||
33281567|NCT05177770|100927395|FG000|Overall Study|Adverse Event prior to dosing|1|||
33281568|NCT03078751|100927396|FG000|Overall Study|Adverse Event|4|||
33281569|NCT03078751|100927397|FG001|Overall Study|Adverse Event|0|||
33281570|NCT03078751|100927396|FG000|Overall Study|Physician Decision|1|||
33281571|NCT03078751|100927397|FG001|Overall Study|Physician Decision|0|||
33281572|NCT03078751|100927396|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
33281573|NCT03078751|100927397|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
33281574|NCT03078751|100927396|FG000|Overall Study|Subject/guardian decision|8|||
33281575|NCT03078751|100927397|FG001|Overall Study|Subject/guardian decision|1|||
33281576|NCT03078751|100927396|FG000|Overall Study|Untreated|0|||
33281577|NCT03078751|100927397|FG001|Overall Study|Untreated|4|||
33281578|NCT05878990|100927398|FG000|Overall Study|Lost to Follow-up|7|||
33486866|NCT02552121|101675320|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
33281579|NCT05878990|100927398|FG000|Overall Study|Withdrawal by Subject|1|||
33281580|NCT02212301|100927399|FG000|Period 1|Lost to Follow-up|0|||
33281581|NCT02212301|100927400|FG001|Period 1|Lost to Follow-up|1|||
33281582|NCT03045302|100927406|FG000|Overall Study|Pre-treatment adverse event|1|||
33281583|NCT02123797|100927409|FG000|Baseline Intervention|Death|9|||
33281584|NCT02123797|100927410|FG001|Baseline Intervention|Death|16|||
33281585|NCT02123797|100927411|FG002|Baseline Intervention|Death|0|||
33281586|NCT02123797|100927412|FG003|Baseline Intervention|Death|0|||
33281587|NCT02123797|100927413|FG004|Baseline Intervention|Death|0|||
33281588|NCT02123797|100927409|FG000|Baseline Intervention|Withdrawal by Subject|2|||
33281589|NCT02123797|100927410|FG001|Baseline Intervention|Withdrawal by Subject|8|||
33281590|NCT02123797|100927411|FG002|Baseline Intervention|Withdrawal by Subject|0|||
33281591|NCT02123797|100927412|FG003|Baseline Intervention|Withdrawal by Subject|0|||
33281592|NCT02123797|100927413|FG004|Baseline Intervention|Withdrawal by Subject|0|||
33281593|NCT02123797|100927409|FG000|Baseline Intervention|Relocation|2|||
33281594|NCT02123797|100927410|FG001|Baseline Intervention|Relocation|0|||
33281595|NCT02123797|100927411|FG002|Baseline Intervention|Relocation|0|||
33281596|NCT02123797|100927412|FG003|Baseline Intervention|Relocation|0|||
33281597|NCT02123797|100927413|FG004|Baseline Intervention|Relocation|0|||
33281598|NCT02123797|100927409|FG000|Baseline Intervention|Out of window for initial survey|6|||
33281599|NCT02123797|100927410|FG001|Baseline Intervention|Out of window for initial survey|13|||
33281600|NCT02123797|100927411|FG002|Baseline Intervention|Out of window for initial survey|0|||
33281601|NCT02123797|100927412|FG003|Baseline Intervention|Out of window for initial survey|0|||
33281602|NCT02123797|100927413|FG004|Baseline Intervention|Out of window for initial survey|0|||
33281603|NCT02123797|100927409|FG000|Baseline Intervention|Lost to Follow-up|0|||
33281604|NCT02123797|100927410|FG001|Baseline Intervention|Lost to Follow-up|5|||
33281605|NCT02123797|100927411|FG002|Baseline Intervention|Lost to Follow-up|0|||
33281606|NCT02123797|100927412|FG003|Baseline Intervention|Lost to Follow-up|0|||
33281607|NCT02123797|100927413|FG004|Baseline Intervention|Lost to Follow-up|0|||
33281608|NCT02123797|100927409|FG000|Baseline Intervention|Other Disease|3|||
33281609|NCT02123797|100927410|FG001|Baseline Intervention|Other Disease|0|||
33281610|NCT02123797|100927411|FG002|Baseline Intervention|Other Disease|0|||
33281611|NCT02123797|100927412|FG003|Baseline Intervention|Other Disease|0|||
33281612|NCT02123797|100927413|FG004|Baseline Intervention|Other Disease|0|||
33281613|NCT02123797|100927409|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
33281614|NCT02123797|100927410|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
33281615|NCT02123797|100927411|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
33281616|NCT02123797|100927412|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
33281617|NCT02123797|100927413|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
33281618|NCT02123797|100927409|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
33281619|NCT02123797|100927410|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
33281620|NCT02123797|100927411|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
33281621|NCT02123797|100927412|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
33281622|NCT02123797|100927413|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
33281623|NCT02123797|100927409|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
33281624|NCT02123797|100927410|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
33281625|NCT02123797|100927411|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
33281626|NCT02123797|100927412|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
33281627|NCT02123797|100927413|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
33281628|NCT02123797|100927409|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
33281629|NCT02123797|100927410|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
33281630|NCT02123797|100927411|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
33281631|NCT02123797|100927412|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
33281632|NCT02123797|100927413|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
33281633|NCT02123797|100927409|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
33281634|NCT02123797|100927410|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
33281635|NCT02123797|100927411|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
33281636|NCT02123797|100927412|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
33281637|NCT02123797|100927413|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
33281638|NCT02123797|100927409|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
33281639|NCT02123797|100927410|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
33281640|NCT02123797|100927411|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
33281641|NCT02123797|100927412|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
33281642|NCT02123797|100927413|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
33281643|NCT02123797|100927409|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
33281644|NCT02123797|100927410|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
33281645|NCT02123797|100927411|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
33281646|NCT02123797|100927412|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
33281647|NCT02123797|100927413|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
33281648|NCT02123797|100927409|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
33281649|NCT02123797|100927410|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
33281650|NCT02123797|100927411|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
33281651|NCT02123797|100927412|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
33281652|NCT02123797|100927413|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
33281653|NCT02123797|100927409|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
33281654|NCT02123797|100927410|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
33281655|NCT02123797|100927411|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
33281656|NCT02123797|100927412|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
33281657|NCT02123797|100927413|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
33281658|NCT03334747|100927414|FG000|Treatment Phase|Technical problems|0|||
33281659|NCT03334747|100927415|FG001|Treatment Phase|Technical problems|0|||
33281660|NCT03334747|100927416|FG002|Treatment Phase|Technical problems|0|||
33281661|NCT03334747|100927417|FG003|Treatment Phase|Technical problems|0|||
33281662|NCT03334747|100927418|FG004|Treatment Phase|Technical problems|1|||
33281663|NCT03334747|100927419|FG005|Treatment Phase|Technical problems|0|||
33281664|NCT03334747|100927420|FG006|Treatment Phase|Technical problems|0|||
33281665|NCT03334747|100927421|FG007|Treatment Phase|Technical problems|0|||
33281666|NCT03334747|100927422|FG008|Treatment Phase|Technical problems|0|||
33281667|NCT03334747|100927414|FG000|Treatment Phase|Subject/guardian decision|1|||
33281668|NCT03334747|100927415|FG001|Treatment Phase|Subject/guardian decision|0|||
33281669|NCT03334747|100927416|FG002|Treatment Phase|Subject/guardian decision|0|||
33281670|NCT03334747|100927417|FG003|Treatment Phase|Subject/guardian decision|0|||
33281671|NCT03334747|100927418|FG004|Treatment Phase|Subject/guardian decision|0|||
33281672|NCT03334747|100927419|FG005|Treatment Phase|Subject/guardian decision|1|||
33281673|NCT03334747|100927420|FG006|Treatment Phase|Subject/guardian decision|0|||
33281674|NCT03334747|100927421|FG007|Treatment Phase|Subject/guardian decision|0|||
33281675|NCT03334747|100927422|FG008|Treatment Phase|Subject/guardian decision|0|||
33281676|NCT03334747|100927414|FG000|Follow-Up Phase|Subject/guardian decision|0|||
33281677|NCT03334747|100927415|FG001|Follow-Up Phase|Subject/guardian decision|0|||
33281678|NCT03334747|100927416|FG002|Follow-Up Phase|Subject/guardian decision|0|||
33281679|NCT03334747|100927417|FG003|Follow-Up Phase|Subject/guardian decision|0|||
33281680|NCT03334747|100927418|FG004|Follow-Up Phase|Subject/guardian decision|0|||
33281681|NCT03334747|100927419|FG005|Follow-Up Phase|Subject/guardian decision|0|||
33281682|NCT03334747|100927420|FG006|Follow-Up Phase|Subject/guardian decision|1|||
33281683|NCT03334747|100927421|FG007|Follow-Up Phase|Subject/guardian decision|0|||
33281684|NCT03334747|100927422|FG008|Follow-Up Phase|Subject/guardian decision|1|||
33281685|NCT02229396|100927425|FG000|Overall Study|Adverse Event|6|||
33281686|NCT02229396|100927426|FG001|Overall Study|Adverse Event|12|||
33281687|NCT02229396|100927427|FG002|Overall Study|Adverse Event|12|||
33281688|NCT02229396|100927425|FG000|Overall Study|Death|2|||
33281689|NCT02229396|100927426|FG001|Overall Study|Death|3|||
33281690|NCT02229396|100927427|FG002|Overall Study|Death|1|||
33281691|NCT02229396|100927425|FG000|Overall Study|Lost to Follow-up|14|||
33281692|NCT02229396|100927426|FG001|Overall Study|Lost to Follow-up|14|||
33281693|NCT02229396|100927427|FG002|Overall Study|Lost to Follow-up|21|||
33281694|NCT02229396|100927425|FG000|Overall Study|Protocol Violation|2|||
33281695|NCT02229396|100927426|FG001|Overall Study|Protocol Violation|1|||
33281696|NCT02229396|100927427|FG002|Overall Study|Protocol Violation|0|||
33281697|NCT02229396|100927425|FG000|Overall Study|Patient Incorrectly Randomized|0|||
33281698|NCT02229396|100927426|FG001|Overall Study|Patient Incorrectly Randomized|0|||
33281699|NCT02229396|100927427|FG002|Overall Study|Patient Incorrectly Randomized|1|||
33281700|NCT02229396|100927425|FG000|Overall Study|Other|10|||
33281701|NCT02229396|100927426|FG001|Overall Study|Other|18|||
33281702|NCT02229396|100927427|FG002|Overall Study|Other|15|||
33281703|NCT02229396|100927425|FG000|Overall Study|Withdrawal by Subject|42|||
33281704|NCT02229396|100927426|FG001|Overall Study|Withdrawal by Subject|28|||
33281705|NCT02229396|100927427|FG002|Overall Study|Withdrawal by Subject|41|||
33281706|NCT02229396|100927425|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
33281707|NCT02229396|100927426|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
33281708|NCT02229396|100927427|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
33281709|NCT02229396|100927425|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
33281710|NCT02229396|100927426|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
33281711|NCT02229396|100927427|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
33281712|NCT01703988|100927428|FG000|Overall Study|Investigator Judgment|0|||
33281713|NCT01703988|100927429|FG001|Overall Study|Investigator Judgment|0|||
33281714|NCT01703988|100927430|FG002|Overall Study|Investigator Judgment|0|||
33281715|NCT01703988|100927431|FG003|Overall Study|Investigator Judgment|1|||
33281716|NCT02661490|100927432|FG000|Overall Study|Lost to Follow-up|0|||
33281717|NCT02661490|100927433|FG001|Overall Study|Lost to Follow-up|1|||
33281718|NCT02661490|100927434|FG002|Overall Study|Lost to Follow-up|0|||
33281719|NCT02661490|100927435|FG003|Overall Study|Lost to Follow-up|0|||
33281720|NCT02661490|100927436|FG004|Overall Study|Lost to Follow-up|2|||
33281721|NCT02661490|100927432|FG000|Overall Study|Withdrawal by Subject|2|||
33281722|NCT02661490|100927433|FG001|Overall Study|Withdrawal by Subject|0|||
33281723|NCT02661490|100927434|FG002|Overall Study|Withdrawal by Subject|2|||
33281724|NCT02661490|100927435|FG003|Overall Study|Withdrawal by Subject|0|||
33281725|NCT02661490|100927436|FG004|Overall Study|Withdrawal by Subject|0|||
33281726|NCT02661490|100927432|FG000|Overall Study|Death|1|||
33281727|NCT02661490|100927433|FG001|Overall Study|Death|1|||
33281728|NCT02661490|100927434|FG002|Overall Study|Death|0|||
33281729|NCT02661490|100927435|FG003|Overall Study|Death|1|||
33281730|NCT02661490|100927436|FG004|Overall Study|Death|0|||
33281731|NCT02661490|100927432|FG000|Overall Study|Reason not Specified|0|||
33281732|NCT02661490|100927433|FG001|Overall Study|Reason not Specified|0|||
33281733|NCT02661490|100927434|FG002|Overall Study|Reason not Specified|0|||
33281734|NCT02661490|100927435|FG003|Overall Study|Reason not Specified|0|||
33281735|NCT02661490|100927436|FG004|Overall Study|Reason not Specified|1|||
33281736|NCT04167085|100927437|FG000|Baseline|Withdrawal by Subject|2|||
33281737|NCT04167085|100927438|FG001|Baseline|Withdrawal by Subject|1|||
33281738|NCT04167085|100927437|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
33281739|NCT04167085|100927438|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
33281740|NCT02515097|100927439|FG000|Overall Study|Lost to Follow-up|4|||
33281741|NCT02515097|100927440|FG001|Overall Study|Lost to Follow-up|2|||
33281742|NCT02515097|100927439|FG000|Overall Study|Withdrawal by Subject|1|||
33281743|NCT02515097|100927440|FG001|Overall Study|Withdrawal by Subject|3|||
33281744|NCT02515097|100927439|FG000|Overall Study|Adverse Event|2|||
33281745|NCT02515097|100927440|FG001|Overall Study|Adverse Event|1|||
33281746|NCT03303521|100927441|FG000|Overall Study|Withdrawal by Subject|2|||
33281747|NCT03303521|100927442|FG001|Overall Study|Withdrawal by Subject|0|||
33281748|NCT03303521|100927441|FG000|Overall Study|Death|1|||
33281749|NCT03303521|100927442|FG001|Overall Study|Death|0|||
33281750|NCT03303521|100927441|FG000|Overall Study|Kidney transplantation|0|||
33281751|NCT03303521|100927442|FG001|Overall Study|Kidney transplantation|1|||
33281752|NCT03303521|100927441|FG000|Overall Study|Investigational product discontinuation|0|||
33281753|NCT03303521|100927442|FG001|Overall Study|Investigational product discontinuation|1|||
33281754|NCT03303521|100927441|FG000|Overall Study|Transferred to non-study dialysis center|1|||
33281755|NCT03303521|100927442|FG001|Overall Study|Transferred to non-study dialysis center|0|||
33281756|NCT03303521|100927441|FG000|Overall Study|Non-comliance to study protocol|0|||
33281757|NCT03303521|100927442|FG001|Overall Study|Non-comliance to study protocol|1|||
33281758|NCT03303521|100927441|FG000|Overall Study|Adverse Event|1|||
33281759|NCT03303521|100927442|FG001|Overall Study|Adverse Event|0|||
33281760|NCT02598934|100927447|FG000|Overall Study|Adverse Event|11|||
33281761|NCT02598934|100927448|FG001|Overall Study|Adverse Event|13|||
33281762|NCT02598934|100927447|FG000|Overall Study|Failure to Return|3|||
33281763|NCT02598934|100927448|FG001|Overall Study|Failure to Return|3|||
33281764|NCT02598934|100927447|FG000|Overall Study|Withdrawal by Subject|2|||
33281765|NCT02598934|100927448|FG001|Overall Study|Withdrawal by Subject|3|||
33281766|NCT02598934|100927447|FG000|Overall Study|Administrative|2|||
33281767|NCT02598934|100927448|FG001|Overall Study|Administrative|1|||
33281768|NCT02598934|100927447|FG000|Overall Study|Protocol Violation|1|||
33281769|NCT02598934|100927448|FG001|Overall Study|Protocol Violation|2|||
33281770|NCT02161185|100927449|FG000|Treatment Phase|Administrative/Other|7|||
33281771|NCT02809677|100927454|FG000|Overall Study|Withdrawal by Subject|8|||
33281772|NCT00230971|100927459|FG000|Randomization|No study drug administered|3|||
33281773|NCT00230971|100927460|FG001|Randomization|No study drug administered|3|||
33281774|NCT00230971|100927459|FG000|Baseline Participants|Lost to Follow-up|5|||
33281775|NCT00230971|100927460|FG001|Baseline Participants|Lost to Follow-up|12|||
33281776|NCT00230971|100927459|FG000|Baseline Participants|Death|6|||
33281777|NCT00230971|100927460|FG001|Baseline Participants|Death|5|||
33281778|NCT00230971|100927459|FG000|Baseline Participants|Withdrawal by Subject|7|||
33281779|NCT00230971|100927460|FG001|Baseline Participants|Withdrawal by Subject|1|||
33281780|NCT00230971|100927459|FG000|Baseline Participants|Adverse Event|1|||
33281781|NCT00230971|100927460|FG001|Baseline Participants|Adverse Event|0|||
33281782|NCT00230971|100927459|FG000|Baseline Participants|No bacteria observed|1|||
33281783|NCT00230971|100927460|FG001|Baseline Participants|No bacteria observed|0|||
33281784|NCT00230971|100927459|FG000|Baseline Participants|Failure to return|1|||
33281785|NCT00230971|100927460|FG001|Baseline Participants|Failure to return|1|||
33281786|NCT00230971|100927459|FG000|Baseline Participants|Reintervention|1|||
33281787|NCT00230971|100927460|FG001|Baseline Participants|Reintervention|0|||
33281788|NCT01954771|100927461|FG000|Overall Study|Missing HbA1c of end-point|1|||
33281789|NCT01954771|100927462|FG001|Overall Study|Missing HbA1c of end-point|1|||
33281790|NCT01954771|100927463|FG002|Overall Study|Missing HbA1c of end-point|0|||
33281791|NCT01954771|100927461|FG000|Overall Study|Missing CGMS of end-point|1|||
33281792|NCT01954771|100927462|FG001|Overall Study|Missing CGMS of end-point|1|||
33281793|NCT01954771|100927463|FG002|Overall Study|Missing CGMS of end-point|0|||
33281794|NCT01954771|100927461|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
33281795|NCT01954771|100927462|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
33281796|NCT01954771|100927463|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
33281797|NCT04572997|100927467|FG000|Overall Study|Adverse Event|1|||
33281798|NCT03738397|100927473|FG000|Overall Study|Adverse Event|3|||
33281799|NCT03738397|100927474|FG001|Overall Study|Adverse Event|7|||
33281800|NCT03738397|100927473|FG000|Overall Study|Withdrawal by Subject|8|||
33281801|NCT03738397|100927474|FG001|Overall Study|Withdrawal by Subject|11|||
33281802|NCT03738397|100927473|FG000|Overall Study|Lost to Follow-up|7|||
33281803|NCT03738397|100927474|FG001|Overall Study|Lost to Follow-up|5|||
33281804|NCT03738397|100927473|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
33281805|NCT03738397|100927474|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
33281806|NCT03738397|100927473|FG000|Overall Study|Other|4|||
33281807|NCT03738397|100927474|FG001|Overall Study|Other|6|||
33281808|NCT01902381|100927477|FG000|Overall Study|Withdrawal by Subject|1|||
33281809|NCT01951261|100927479|FG000|Overall Study|Death|1|||
33281810|NCT01951261|100927480|FG001|Overall Study|Death|0|||
33281811|NCT01951261|100927479|FG000|Overall Study|Lost to Follow-up|4|||
33281812|NCT01951261|100927480|FG001|Overall Study|Lost to Follow-up|3|||
33281813|NCT01951261|100927479|FG000|Overall Study|Protocol Violation|4|||
33281814|NCT01951261|100927480|FG001|Overall Study|Protocol Violation|3|||
33281815|NCT00985621|100927483|FG000|Overall Study|Adverse Event|2|||
33281816|NCT00985621|100927484|FG001|Overall Study|Adverse Event|3|||
33281817|NCT00985621|100927485|FG002|Overall Study|Adverse Event|4|||
33281818|NCT00985621|100927486|FG003|Overall Study|Adverse Event|16|||
33281819|NCT00985621|100927483|FG000|Overall Study|Lack of Efficacy|10|||
33281820|NCT00985621|100927484|FG001|Overall Study|Lack of Efficacy|6|||
33281821|NCT00985621|100927485|FG002|Overall Study|Lack of Efficacy|5|||
33281822|NCT00985621|100927486|FG003|Overall Study|Lack of Efficacy|12|||
33281823|NCT00985621|100927483|FG000|Overall Study|Lost to Follow-up|2|||
33281824|NCT00985621|100927484|FG001|Overall Study|Lost to Follow-up|3|||
33281825|NCT00985621|100927485|FG002|Overall Study|Lost to Follow-up|4|||
33281826|NCT00985621|100927486|FG003|Overall Study|Lost to Follow-up|4|||
33281827|NCT00985621|100927483|FG000|Overall Study|Study Terminated by Sponsor|89|||
33281828|NCT00985621|100927484|FG001|Overall Study|Study Terminated by Sponsor|108|||
33281829|NCT00985621|100927485|FG002|Overall Study|Study Terminated by Sponsor|99|||
33281830|NCT00985621|100927486|FG003|Overall Study|Study Terminated by Sponsor|92|||
33281831|NCT00985621|100927483|FG000|Overall Study|Protocol Violation|1|||
33281832|NCT00985621|100927484|FG001|Overall Study|Protocol Violation|1|||
33281833|NCT00985621|100927485|FG002|Overall Study|Protocol Violation|1|||
33281834|NCT00985621|100927486|FG003|Overall Study|Protocol Violation|0|||
33281835|NCT00985621|100927483|FG000|Overall Study|Withdrawal by Subject|8|||
33281836|NCT00985621|100927484|FG001|Overall Study|Withdrawal by Subject|10|||
33281837|NCT00985621|100927485|FG002|Overall Study|Withdrawal by Subject|8|||
33281838|NCT00985621|100927486|FG003|Overall Study|Withdrawal by Subject|12|||
33281839|NCT00985621|100927483|FG000|Overall Study|Other|1|||
33281840|NCT00985621|100927484|FG001|Overall Study|Other|0|||
33281841|NCT00985621|100927485|FG002|Overall Study|Other|0|||
33281842|NCT00985621|100927486|FG003|Overall Study|Other|0|||
33281843|NCT00985621|100927483|FG000|Overall Study|Randomized but not Treated|1|||
33281844|NCT00985621|100927484|FG001|Overall Study|Randomized but not Treated|0|||
33281845|NCT00985621|100927485|FG002|Overall Study|Randomized but not Treated|2|||
33281846|NCT00985621|100927486|FG003|Overall Study|Randomized but not Treated|1|||
33281847|NCT02998918|100927488|FG000|Overall Study|Withdrawal by Subject|1|||
33281848|NCT02998918|100927489|FG001|Overall Study|Withdrawal by Subject|0|||
33281849|NCT00509925|100927490|FG000|Overall Study|Personal reasons|0|||
33281850|NCT00509925|100927491|FG001|Overall Study|Personal reasons|1|||
33281851|NCT02581189|100927492|FG000|Overall Study|Failure to return|36|||
33281852|NCT02581189|100927492|FG000|Overall Study|Withdrew consent|5|||
33281853|NCT02581189|100927492|FG000|Overall Study|Death|3|||
33281854|NCT02581189|100927492|FG000|Overall Study|Insufficient virological response|2|||
33281855|NCT02581189|100927492|FG000|Overall Study|Other, not specified|7|||
33281856|NCT00317603|100927495|FG000|Overall Study|Progressive Disease|3|||
33281857|NCT02329223|100927496|FG000|Overall Study|Withdrawal by Subject|1|||
33281858|NCT02329223|100927497|FG001|Overall Study|Withdrawal by Subject|2|||
33281859|NCT02329223|100927498|FG002|Overall Study|Withdrawal by Subject|5|||
33281860|NCT02329223|100927496|FG000|Overall Study|Physician Decision|0|||
33281861|NCT02329223|100927497|FG001|Overall Study|Physician Decision|0|||
33281862|NCT02329223|100927498|FG002|Overall Study|Physician Decision|1|||
33281863|NCT02329223|100927496|FG000|Overall Study|Adverse Event|0|||
33281864|NCT02329223|100927497|FG001|Overall Study|Adverse Event|1|||
33281865|NCT02329223|100927498|FG002|Overall Study|Adverse Event|0|||
33281866|NCT03410108|100927499|FG000|Overall Study|Ongoing|41|||
33281867|NCT03410108|100927499|FG000|Overall Study|Adverse Event|4|||
33281868|NCT03410108|100927499|FG000|Overall Study|Progressive Disease|58|||
33281869|NCT03410108|100927499|FG000|Overall Study|Withdrawal by Subject|1|||
33281870|NCT01572493|100927500|FG000|Overall Study|Physician Decision|1|||
33281871|NCT01572493|100927501|FG001|Overall Study|Physician Decision|0|||
33281872|NCT01572493|100927502|FG002|Overall Study|Physician Decision|0|||
33281873|NCT01572493|100927503|FG003|Overall Study|Physician Decision|0|||
33281874|NCT01572493|100927504|FG004|Overall Study|Physician Decision|0|||
33281875|NCT01572493|100927505|FG005|Overall Study|Physician Decision|0|||
33281876|NCT01572493|100927506|FG006|Overall Study|Physician Decision|0|||
33281877|NCT01572493|100927507|FG007|Overall Study|Physician Decision|0|||
33281878|NCT01572493|100927508|FG008|Overall Study|Physician Decision|0|||
33281879|NCT01572493|100927500|FG000|Overall Study|Switched to alternative treatment|0|||
33281880|NCT01572493|100927501|FG001|Overall Study|Switched to alternative treatment|1|||
33281881|NCT01572493|100927502|FG002|Overall Study|Switched to alternative treatment|2|||
33281882|NCT01572493|100927503|FG003|Overall Study|Switched to alternative treatment|1|||
33281883|NCT01572493|100927504|FG004|Overall Study|Switched to alternative treatment|2|||
33281884|NCT01572493|100927505|FG005|Overall Study|Switched to alternative treatment|0|||
33281885|NCT01572493|100927506|FG006|Overall Study|Switched to alternative treatment|2|||
33281886|NCT01572493|100927507|FG007|Overall Study|Switched to alternative treatment|0|||
33281887|NCT01572493|100927508|FG008|Overall Study|Switched to alternative treatment|2|||
33281888|NCT01572493|100927500|FG000|Overall Study|Death|0|||
33281889|NCT01572493|100927501|FG001|Overall Study|Death|0|||
33281890|NCT01572493|100927502|FG002|Overall Study|Death|0|||
33281891|NCT01572493|100927503|FG003|Overall Study|Death|1|||
33281892|NCT01572493|100927504|FG004|Overall Study|Death|0|||
33281893|NCT01572493|100927505|FG005|Overall Study|Death|1|||
33281894|NCT01572493|100927506|FG006|Overall Study|Death|0|||
33281895|NCT01572493|100927507|FG007|Overall Study|Death|0|||
33281896|NCT01572493|100927508|FG008|Overall Study|Death|0|||
33281897|NCT01572493|100927500|FG000|Overall Study|Adverse Event|0|||
33281898|NCT01572493|100927501|FG001|Overall Study|Adverse Event|0|||
33281899|NCT01572493|100927502|FG002|Overall Study|Adverse Event|0|||
33281900|NCT01572493|100927503|FG003|Overall Study|Adverse Event|0|||
33281901|NCT01572493|100927504|FG004|Overall Study|Adverse Event|0|||
33281902|NCT01572493|100927505|FG005|Overall Study|Adverse Event|0|||
33281903|NCT01572493|100927506|FG006|Overall Study|Adverse Event|1|||
33281904|NCT01572493|100927507|FG007|Overall Study|Adverse Event|0|||
33281905|NCT01572493|100927508|FG008|Overall Study|Adverse Event|0|||
33281906|NCT00837096|100927512|FG000|Overall Study|Physician Decision|1|||
33281907|NCT00837096|100927513|FG001|Overall Study|Physician Decision|1|||
33281908|NCT00837096|100927512|FG000|Overall Study|Not reported|9|||
33281909|NCT00837096|100927513|FG001|Overall Study|Not reported|8|||
33281910|NCT03022045|100927514|FG000|Overall Study|Adverse Event|0|||
33281911|NCT03022045|100927515|FG001|Overall Study|Adverse Event|1|||
33281912|NCT03022045|100927514|FG000|Overall Study|Withdrawal by Subject|1|||
33281913|NCT03022045|100927515|FG001|Overall Study|Withdrawal by Subject|1|||
33281914|NCT02186015|100927518|FG000|Overall Study|Physician Decision|1|||
33281915|NCT02186015|100927519|FG001|Overall Study|Physician Decision|0|||
33281916|NCT03721978|100927520|FG000|Overall Study|Withdrawal by Subject|6|||
33281917|NCT03721978|100927521|FG001|Overall Study|Withdrawal by Subject|1|||
33281918|NCT03721978|100927520|FG000|Overall Study|Adverse Event|1|||
33281919|NCT03721978|100927521|FG001|Overall Study|Adverse Event|1|||
33281920|NCT03721978|100927520|FG000|Overall Study|Progressive Disease|1|||
33281921|NCT03721978|100927521|FG001|Overall Study|Progressive Disease|0|||
33281922|NCT03721978|100927520|FG000|Overall Study|Lost to Follow-up|5|||
33281923|NCT03721978|100927521|FG001|Overall Study|Lost to Follow-up|1|||
33281924|NCT03721978|100927520|FG000|Overall Study|Reason not Specified|0|||
33281925|NCT03721978|100927521|FG001|Overall Study|Reason not Specified|2|||
33281926|NCT03746483|100927522|FG000|Overall Study|Adverse Event|0|||
33281927|NCT03746483|100927523|FG001|Overall Study|Adverse Event|1|||
33281928|NCT03746483|100927522|FG000|Overall Study|Lack of Efficacy|3|||
33281929|NCT03746483|100927523|FG001|Overall Study|Lack of Efficacy|2|||
33281930|NCT03746483|100927522|FG000|Overall Study|Lost to Follow-up|1|||
33281931|NCT03746483|100927523|FG001|Overall Study|Lost to Follow-up|0|||
33281932|NCT03746483|100927522|FG000|Overall Study|Protocol Violation|2|||
33281933|NCT03746483|100927523|FG001|Overall Study|Protocol Violation|0|||
33281934|NCT04414397|100927524|FG000|Control Period|Withdrawal by Subject|2|||
33281935|NCT04414397|100927525|FG001|Control Period|Withdrawal by Subject|2|||
33281936|NCT04414397|100927524|FG000|Control Period|Lost to Follow-up|0|||
33281937|NCT04414397|100927525|FG001|Control Period|Lost to Follow-up|4|||
33281938|NCT04414397|100927524|FG000|Control Period|Protocol deviation|0|||
33281939|NCT04414397|100927525|FG001|Control Period|Protocol deviation|1|||
33281940|NCT04414397|100927524|FG000|Post-Control Period|Withdrawal by Subject|3|||
33281941|NCT04414397|100927525|FG001|Post-Control Period|Withdrawal by Subject|6|||
33281942|NCT04414397|100927524|FG000|Post-Control Period|Lost to Follow-up|4|||
33281943|NCT04414397|100927525|FG001|Post-Control Period|Lost to Follow-up|9|||
33281944|NCT04414397|100927524|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
33281945|NCT04414397|100927525|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
33281946|NCT04414397|100927524|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
33281947|NCT04414397|100927525|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
33281948|NCT00550771|100927526|FG000|Overall Study|Adverse Event|11|||
33281949|NCT00550771|100927527|FG001|Overall Study|Adverse Event|3|||
33486867|NCT02552121|101675321|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
33281950|NCT00550771|100927526|FG000|Overall Study|Discontinued for study-related reasons|0|||
33281951|NCT00550771|100927527|FG001|Overall Study|Discontinued for study-related reasons|1|||
33281952|NCT00550771|100927526|FG000|Overall Study|Physician Decision|2|||
33281953|NCT00550771|100927527|FG001|Overall Study|Physician Decision|0|||
33281954|NCT00550771|100927526|FG000|Overall Study|Withdrawal by Subject|0|||
33281955|NCT00550771|100927527|FG001|Overall Study|Withdrawal by Subject|1|||
33281956|NCT00550771|100927526|FG000|Overall Study|Protocol Violation|4|||
33281957|NCT00550771|100927527|FG001|Overall Study|Protocol Violation|5|||
33281958|NCT02864147|100927528|FG000|Overall Study|Withdrawal by Subject|3|||
33281959|NCT02864147|100927529|FG001|Overall Study|Withdrawal by Subject|2|||
33281960|NCT02864147|100927530|FG002|Overall Study|Withdrawal by Subject|1|||
33281961|NCT02864147|100927528|FG000|Overall Study|Lost to Follow-up|0|||
33281962|NCT02864147|100927529|FG001|Overall Study|Lost to Follow-up|4|||
33281963|NCT02864147|100927530|FG002|Overall Study|Lost to Follow-up|0|||
33281964|NCT02864147|100927528|FG000|Overall Study|Adverse Event|0|||
33281965|NCT02864147|100927529|FG001|Overall Study|Adverse Event|1|||
33281966|NCT02864147|100927530|FG002|Overall Study|Adverse Event|0|||
33281967|NCT02864147|100927528|FG000|Overall Study|Pregnancy|4|||
33281968|NCT02864147|100927529|FG001|Overall Study|Pregnancy|0|||
33281969|NCT02864147|100927530|FG002|Overall Study|Pregnancy|0|||
33281970|NCT02864147|100927528|FG000|Overall Study|Physician Decision|0|||
33281971|NCT02864147|100927529|FG001|Overall Study|Physician Decision|0|||
33281972|NCT02864147|100927530|FG002|Overall Study|Physician Decision|1|||
33281973|NCT02864147|100927528|FG000|Overall Study|Opted for excisional procedures|0|||
33281974|NCT02864147|100927529|FG001|Overall Study|Opted for excisional procedures|0|||
33281975|NCT02864147|100927530|FG002|Overall Study|Opted for excisional procedures|3|||
33281976|NCT00130728|100927535|FG000|Overall Study|Death|258|||
33281977|NCT00130728|100927536|FG001|Overall Study|Death|258|||
33281978|NCT00130728|100927535|FG000|Overall Study|Lost to Follow-up|4|||
33281979|NCT00130728|100927536|FG001|Overall Study|Lost to Follow-up|0|||
33281980|NCT00130728|100927535|FG000|Overall Study|Withdrawal by Subject|0|||
33281981|NCT00130728|100927536|FG001|Overall Study|Withdrawal by Subject|2|||
33281982|NCT02250183|100927538|FG000|Overall Study|Withdrawal by Subject|2|||
33281983|NCT02250183|100927538|FG000|Overall Study|Adverse Event|5|||
33281984|NCT02250183|100927538|FG000|Overall Study|Lost to Follow-up|1|||
33281985|NCT06247488|100927539|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
33281986|NCT06247488|100927540|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
33281987|NCT06247488|100927541|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
33281988|NCT06247488|100927542|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
33281989|NCT06247488|100927543|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
33281990|NCT06247488|100927544|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
33281991|NCT06247488|100927539|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
33281992|NCT06247488|100927540|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
33281993|NCT06247488|100927541|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
33281994|NCT06247488|100927542|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
33281995|NCT06247488|100927543|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
33281996|NCT06247488|100927544|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
33281997|NCT06247488|100927539|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
33281998|NCT06247488|100927540|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
33281999|NCT06247488|100927541|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
33282000|NCT06247488|100927542|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
33282001|NCT06247488|100927543|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
33282002|NCT06247488|100927544|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
33282003|NCT06247488|100927539|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
33282004|NCT06247488|100927540|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
33282005|NCT06247488|100927541|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
33282006|NCT06247488|100927542|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
33282007|NCT06247488|100927543|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
33282008|NCT06247488|100927544|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
33282009|NCT06247488|100927539|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
33282010|NCT06247488|100927540|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
33282011|NCT06247488|100927541|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
33282012|NCT06247488|100927542|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
33282013|NCT06247488|100927543|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
33282014|NCT06247488|100927544|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
33282015|NCT06247488|100927539|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
33282016|NCT06247488|100927540|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
33282017|NCT06247488|100927541|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
33282018|NCT06247488|100927542|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
33282019|NCT06247488|100927543|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
33282020|NCT06247488|100927544|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
33282021|NCT06247488|100927539|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
33282022|NCT06247488|100927540|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
33282023|NCT06247488|100927541|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
33282024|NCT06247488|100927542|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
33282025|NCT06247488|100927543|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
33282026|NCT06247488|100927544|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
33282027|NCT05153499|100927545|FG000|Overall Study|Withdrawal by Subject|1|||
33282028|NCT05153499|100927546|FG001|Overall Study|Withdrawal by Subject|0|||
33282029|NCT05153499|100927545|FG000|Overall Study|Clinical Hold|1|||
33282030|NCT05153499|100927546|FG001|Overall Study|Clinical Hold|0|||
33282031|NCT05153499|100927545|FG000|Overall Study|Study Termination|6|||
33282032|NCT05153499|100927546|FG001|Overall Study|Study Termination|5|||
33282033|NCT01040403|100927553|FG000|Overall Study|Adverse Event|10|||
33282034|NCT01040403|100927553|FG000|Overall Study|Protocol Violation|2|||
33282035|NCT01040403|100927553|FG000|Overall Study|Lost to Follow-up|1|||
33282036|NCT01040403|100927553|FG000|Overall Study|Not treated|1|||
33282037|NCT01040403|100927553|FG000|Overall Study|Other reason not defined above|6|||
33282038|NCT00627523|100927556|FG000|Overall Study|Lack of Efficacy|1|||
33282039|NCT00627523|100927557|FG001|Overall Study|Lack of Efficacy|0|||
33282040|NCT00627523|100927556|FG000|Overall Study|Withdrawal by Subject|0|||
33282041|NCT00627523|100927557|FG001|Overall Study|Withdrawal by Subject|2|||
33282042|NCT00627523|100927556|FG000|Overall Study|Other|1|||
33282043|NCT00627523|100927557|FG001|Overall Study|Other|0|||
33282044|NCT03275402|100927560|FG000|Overall Study|Death|17|||
33282045|NCT03275402|100927560|FG000|Overall Study|Study terminated by sponsor|21|||
33282046|NCT03275402|100927560|FG000|Overall Study|Withdrawal by Subject|1|||
33282047|NCT03282799|100927561|FG000|Overall Study|Pregnancy|1|||
33282048|NCT03282799|100927562|FG001|Overall Study|Pregnancy|0|||
33282049|NCT03282799|100927561|FG000|Overall Study|Physician Decision|1|||
33282050|NCT03282799|100927562|FG001|Overall Study|Physician Decision|0|||
33282051|NCT02137239|100927563|FG000|Overall Study|Discontinued Study Treatment|0|||
33282052|NCT02137239|100927564|FG001|Overall Study|Discontinued Study Treatment|3|||
33282053|NCT02137239|100927563|FG000|Overall Study|Withdrew Consent|1|||
33282054|NCT02137239|100927564|FG001|Overall Study|Withdrew Consent|1|||
33282055|NCT02137239|100927563|FG000|Overall Study|Adverse Event|2|||
33282056|NCT02137239|100927564|FG001|Overall Study|Adverse Event|2|||
33282057|NCT02847637|100927567|FG000|Overall Study|Withdrawal by Subject|0|||
33282058|NCT02847637|100927568|FG001|Overall Study|Withdrawal by Subject|1|||
33282059|NCT02847637|100927569|FG002|Overall Study|Withdrawal by Subject|1|||
33282060|NCT02847637|100927570|FG003|Overall Study|Withdrawal by Subject|0|||
33282061|NCT02847637|100927567|FG000|Overall Study|Lost to Follow-up|1|||
33282062|NCT02847637|100927568|FG001|Overall Study|Lost to Follow-up|1|||
33282063|NCT02847637|100927569|FG002|Overall Study|Lost to Follow-up|0|||
33282064|NCT02847637|100927570|FG003|Overall Study|Lost to Follow-up|0|||
33282065|NCT04872101|100927572|FG000|Overall Study|Withdrawal by Subject|10|||
33282066|NCT04872101|100927573|FG001|Overall Study|Withdrawal by Subject|16|||
33282067|NCT04872101|100927572|FG000|Overall Study|Lack of Efficacy|6|||
33282068|NCT04872101|100927573|FG001|Overall Study|Lack of Efficacy|14|||
33282069|NCT04872101|100927572|FG000|Overall Study|Adverse Event|1|||
33282070|NCT04872101|100927573|FG001|Overall Study|Adverse Event|6|||
33282071|NCT04872101|100927572|FG000|Overall Study|Lost to Follow-up|2|||
33282072|NCT04872101|100927573|FG001|Overall Study|Lost to Follow-up|1|||
33282073|NCT04872101|100927572|FG000|Overall Study|Pregnancy|2|||
33282074|NCT04872101|100927573|FG001|Overall Study|Pregnancy|0|||
33282075|NCT04872101|100927572|FG000|Overall Study|Prohibited Medication|1|||
33282076|NCT04872101|100927573|FG001|Overall Study|Prohibited Medication|0|||
33282077|NCT04872101|100927572|FG000|Overall Study|Not dosed|1|||
33282078|NCT04872101|100927573|FG001|Overall Study|Not dosed|0|||
33282079|NCT00809783|100927574|FG000|Overall Study|Death|1|||
33282080|NCT00809783|100927575|FG001|Overall Study|Death|0|||
33282081|NCT00809783|100927576|FG002|Overall Study|Death|0|||
33282082|NCT00809783|100927574|FG000|Overall Study|Adverse Event|34|||
33282083|NCT00809783|100927575|FG001|Overall Study|Adverse Event|52|||
33282084|NCT00809783|100927576|FG002|Overall Study|Adverse Event|71|||
33282085|NCT00809783|100927574|FG000|Overall Study|Lack of Efficacy|39|||
33282086|NCT00809783|100927575|FG001|Overall Study|Lack of Efficacy|52|||
33282087|NCT00809783|100927576|FG002|Overall Study|Lack of Efficacy|63|||
33282088|NCT00809783|100927574|FG000|Overall Study|Lost to Follow-up|0|||
33282089|NCT00809783|100927575|FG001|Overall Study|Lost to Follow-up|3|||
33282090|NCT00809783|100927576|FG002|Overall Study|Lost to Follow-up|4|||
33282091|NCT00809783|100927574|FG000|Overall Study|Withdrawal by Subject|47|||
33282092|NCT00809783|100927575|FG001|Overall Study|Withdrawal by Subject|72|||
33282093|NCT00809783|100927576|FG002|Overall Study|Withdrawal by Subject|64|||
33282094|NCT00809783|100927574|FG000|Overall Study|Protocol Violation|2|||
33282095|NCT00809783|100927575|FG001|Overall Study|Protocol Violation|6|||
33282096|NCT00809783|100927576|FG002|Overall Study|Protocol Violation|5|||
33282097|NCT00809783|100927574|FG000|Overall Study|Randomized, but not treated|3|||
33486868|NCT02552121|101675322|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
33486869|NCT02552121|101675323|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
33282098|NCT00809783|100927575|FG001|Overall Study|Randomized, but not treated|0|||
33282099|NCT00809783|100927576|FG002|Overall Study|Randomized, but not treated|2|||
33282100|NCT00809783|100927574|FG000|Overall Study|Study Terminated by Sponsor|378|||
33282101|NCT00809783|100927575|FG001|Overall Study|Study Terminated by Sponsor|626|||
33282102|NCT00809783|100927576|FG002|Overall Study|Study Terminated by Sponsor|565|||
33282103|NCT00809783|100927574|FG000|Overall Study|Other|21|||
33282104|NCT00809783|100927575|FG001|Overall Study|Other|21|||
33282105|NCT00809783|100927576|FG002|Overall Study|Other|16|||
33282106|NCT04043806|100927577|FG000|Overall Study|Commercial drug is available for participants|13|||
33282107|NCT04043806|100927577|FG000|Overall Study|Physician Decision|2|||
33282108|NCT04043806|100927577|FG000|Overall Study|Other|12|||
33282109|NCT04043806|100927577|FG000|Overall Study|Adverse Event|2|||
33282110|NCT04043806|100927577|FG000|Overall Study|Lost to Follow-up|6|||
33282111|NCT04043806|100927577|FG000|Overall Study|Other non-compliance|2|||
33282112|NCT04043806|100927577|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
33282113|NCT04043806|100927577|FG000|Overall Study|Never Dosed|1|||
33282114|NCT01533181|100927578|FG000|Overall Study|Disease progression pre-active treatment|0|||
33282115|NCT01533181|100927579|FG001|Overall Study|Disease progression pre-active treatment|1|||
33282116|NCT01533181|100927578|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
33282117|NCT01533181|100927579|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
33282118|NCT03972137|100927580|FG000|Overall Study|Lost to Follow-up|2|||
33282119|NCT03972137|100927580|FG000|Overall Study|Withdrawal by Subject|4|||
33282120|NCT05012397|100927581|FG000|Overall Study|Death|10|||
33282121|NCT05012397|100927581|FG000|Overall Study|Physician Decision|9|||
33282122|NCT05012397|100927581|FG000|Overall Study|Withdrawal by Subject|5|||
33282123|NCT05012397|100927581|FG000|Overall Study|Lost to Follow-up|2|||
33282124|NCT01093222|100927582|FG000|Overall Study|Ineligible|6|||
33282125|NCT01093222|100927582|FG000|Overall Study|Adverse Event|7|||
33282126|NCT01093222|100927582|FG000|Overall Study|Progression/relapse|24|||
33282127|NCT01093222|100927582|FG000|Overall Study|Death|2|||
33282128|NCT01093222|100927582|FG000|Overall Study|Not protocol specified|1|||
33282129|NCT02262364|100927585|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
33282130|NCT00981578|100927592|FG000|Overall Study|Death|1|||
33282131|NCT00981578|100927592|FG000|Overall Study|Withdrawal by Subject|2|||
33282132|NCT01837719|100930858|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
33282133|NCT01837719|100930858|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
33282134|NCT01894256|100930859|FG000|Part A|Adverse Event|0|||
33282135|NCT01894256|100930860|FG001|Part A|Adverse Event|1|||
33282136|NCT01894256|100930861|FG002|Part A|Adverse Event|0|||
33282137|NCT01894256|100930859|FG000|Part B|Death|0|||
33282138|NCT01894256|100930860|FG001|Part B|Death|1|||
33282139|NCT01894256|100930861|FG002|Part B|Death|1|||
33282140|NCT01894256|100930859|FG000|Part B|Withdrawal by Subject|0|||
33282141|NCT01894256|100930860|FG001|Part B|Withdrawal by Subject|1|||
33282142|NCT01894256|100930861|FG002|Part B|Withdrawal by Subject|0|||
33282143|NCT01894256|100930859|FG000|Part B|Lack of Efficacy|15|||
33282144|NCT01894256|100930860|FG001|Part B|Lack of Efficacy|12|||
33282145|NCT01894256|100930861|FG002|Part B|Lack of Efficacy|13|||
33282146|NCT00711555|100930862|FG000|Overall Study|Adverse Event|3|||
33282147|NCT05372913|100930863|FG000|Overall Study|Withdrawal by Subject|0|||
33282148|NCT05372913|100930864|FG001|Overall Study|Withdrawal by Subject|2|||
33282149|NCT05372913|100930863|FG000|Overall Study|Protocol Violation|2|||
33282150|NCT05372913|100930864|FG001|Overall Study|Protocol Violation|2|||
33282151|NCT05372913|100930863|FG000|Overall Study|Adverse Event|0|||
33282152|NCT05372913|100930864|FG001|Overall Study|Adverse Event|1|||
33282153|NCT02720198|100930865|FG000|Overall Study|Withdrawal by Subject|0|||
33282154|NCT02720198|100930866|FG001|Overall Study|Withdrawal by Subject|1|||
33282155|NCT01424189|100930867|FG000|Overall Study|Adverse Event|1|||
33282156|NCT01424189|100930868|FG001|Overall Study|Adverse Event|0|||
33282157|NCT01424189|100930867|FG000|Overall Study|Lost to Follow-up|4|||
33282158|NCT01424189|100930868|FG001|Overall Study|Lost to Follow-up|1|||
33282159|NCT01424189|100930867|FG000|Overall Study|Withdrawal by Subject|4|||
33282160|NCT01424189|100930868|FG001|Overall Study|Withdrawal by Subject|4|||
33282161|NCT01424189|100930867|FG000|Overall Study|Subject moved|1|||
33282162|NCT01424189|100930868|FG001|Overall Study|Subject moved|0|||
33282163|NCT01424189|100930867|FG000|Overall Study|Death|3|||
33282164|NCT01424189|100930868|FG001|Overall Study|Death|1|||
33282165|NCT03168425|100930869|FG000|Overall Study|Lost to Follow-up|5|||
33282166|NCT03168425|100930870|FG001|Overall Study|Lost to Follow-up|8|||
33282167|NCT03168425|100930869|FG000|Overall Study|unable to confirm post op opioids|2|||
33282168|NCT03168425|100930870|FG001|Overall Study|unable to confirm post op opioids|3|||
33282169|NCT02996097|100930871|FG000|Overall Study|Lost to Follow-up|11|||
33282170|NCT02996097|100930872|FG001|Overall Study|Lost to Follow-up|11|||
33282171|NCT01129115|100930873|FG000|Overall Study|Adverse Event|1|||
33282172|NCT01129115|100930874|FG001|Overall Study|Adverse Event|2|||
33282173|NCT01129115|100930875|FG002|Overall Study|Adverse Event|3|||
33282174|NCT01129115|100930876|FG003|Overall Study|Adverse Event|3|||
33282175|NCT01129115|100930873|FG000|Overall Study|Withdrawal by Subject|1|||
33282176|NCT01129115|100930874|FG001|Overall Study|Withdrawal by Subject|3|||
33282177|NCT01129115|100930875|FG002|Overall Study|Withdrawal by Subject|1|||
33282178|NCT01129115|100930876|FG003|Overall Study|Withdrawal by Subject|4|||
33282179|NCT01129115|100930873|FG000|Overall Study|Protocol Violation|0|||
33282180|NCT01129115|100930874|FG001|Overall Study|Protocol Violation|2|||
33282181|NCT01129115|100930875|FG002|Overall Study|Protocol Violation|2|||
33282182|NCT01129115|100930876|FG003|Overall Study|Protocol Violation|2|||
33282183|NCT01797705|100930877|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
33282184|NCT01797705|100930877|FG000|Overall Study|Withdrawal by Subject|1|||
33282185|NCT01363297|100930878|FG000|Overall Study|Other|0|||
33282186|NCT01363297|100930879|FG001|Overall Study|Other|0|||
33282187|NCT01363297|100930880|FG002|Overall Study|Other|0|||
33282188|NCT01363297|100930881|FG003|Overall Study|Other|0|||
33282189|NCT01363297|100930882|FG004|Overall Study|Other|1|||
33282190|NCT01363297|100930878|FG000|Overall Study|Death|3|||
33282191|NCT01363297|100930879|FG001|Overall Study|Death|6|||
33282192|NCT01363297|100930880|FG002|Overall Study|Death|6|||
33282193|NCT01363297|100930881|FG003|Overall Study|Death|10|||
33282194|NCT01363297|100930882|FG004|Overall Study|Death|30|||
33282195|NCT01276509|100930884|FG000|Overall Study|Adverse Event|9|||
33282196|NCT01276509|100930885|FG001|Overall Study|Adverse Event|8|||
33282197|NCT01276509|100930886|FG002|Overall Study|Adverse Event|4|||
33282198|NCT01276509|100930887|FG003|Overall Study|Adverse Event|3|||
33282199|NCT01276509|100930884|FG000|Overall Study|Lack of Efficacy|2|||
33282200|NCT01276509|100930885|FG001|Overall Study|Lack of Efficacy|1|||
33282201|NCT01276509|100930886|FG002|Overall Study|Lack of Efficacy|1|||
33282202|NCT01276509|100930887|FG003|Overall Study|Lack of Efficacy|2|||
33282203|NCT01276509|100930884|FG000|Overall Study|Pregnancy|1|||
33282204|NCT01276509|100930885|FG001|Overall Study|Pregnancy|0|||
33282205|NCT01276509|100930886|FG002|Overall Study|Pregnancy|0|||
33282206|NCT01276509|100930887|FG003|Overall Study|Pregnancy|0|||
33282207|NCT01276509|100930884|FG000|Overall Study|Withdrawal by Subject|1|||
33282208|NCT01276509|100930885|FG001|Overall Study|Withdrawal by Subject|2|||
33282209|NCT01276509|100930886|FG002|Overall Study|Withdrawal by Subject|0|||
33282210|NCT01276509|100930887|FG003|Overall Study|Withdrawal by Subject|0|||
33282211|NCT01276509|100930884|FG000|Overall Study|Other|0|||
33282212|NCT01276509|100930885|FG001|Overall Study|Other|1|||
33282213|NCT01276509|100930886|FG002|Overall Study|Other|0|||
33282214|NCT01276509|100930887|FG003|Overall Study|Other|0|||
33282215|NCT01960114|100930888|FG000|Overall Study|Adverse Event|1|||
33282216|NCT01960114|100930889|FG001|Overall Study|Adverse Event|0|||
33282217|NCT01960114|100930888|FG000|Overall Study|Could not swallow study medication|0|||
33282218|NCT01960114|100930889|FG001|Overall Study|Could not swallow study medication|1|||
33282219|NCT01184859|100930890|FG000|Period 1: Single Dose|Insufficient urine production|0|||
33282220|NCT01184859|100930891|FG001|Period 1: Single Dose|Insufficient urine production|1|||
33282221|NCT01184859|100930892|FG002|Period 1: Single Dose|Insufficient urine production|0|||
33282222|NCT01184859|100930893|FG003|Period 1: Single Dose|Insufficient urine production|0|||
33282223|NCT01184859|100930894|FG004|Period 1: Single Dose|Insufficient urine production|0|||
33282224|NCT01184859|100930890|FG000|Period 1: Single Dose|Protocol Violation|0|||
33282225|NCT01184859|100930891|FG001|Period 1: Single Dose|Protocol Violation|1|||
33282226|NCT01184859|100930892|FG002|Period 1: Single Dose|Protocol Violation|0|||
33282227|NCT01184859|100930893|FG003|Period 1: Single Dose|Protocol Violation|0|||
33282228|NCT01184859|100930894|FG004|Period 1: Single Dose|Protocol Violation|0|||
33282229|NCT01184859|100930890|FG000|Period 1: Single Dose|Adverse Event|0|||
33282230|NCT01184859|100930891|FG001|Period 1: Single Dose|Adverse Event|0|||
33282231|NCT01184859|100930892|FG002|Period 1: Single Dose|Adverse Event|0|||
33282232|NCT01184859|100930893|FG003|Period 1: Single Dose|Adverse Event|0|||
33282233|NCT01184859|100930894|FG004|Period 1: Single Dose|Adverse Event|1|||
33282234|NCT01184859|100930890|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
33282235|NCT01184859|100930891|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
33282236|NCT01184859|100930892|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
33282237|NCT01184859|100930893|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
33282238|NCT01184859|100930894|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
33282239|NCT01184859|100930890|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
33282240|NCT01184859|100930891|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
33282241|NCT01184859|100930892|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
33282242|NCT01184859|100930893|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
33282243|NCT01184859|100930894|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
33282244|NCT01393613|100930896|FG000|Overall Study|Adverse Event|11|||
33282245|NCT01393613|100930897|FG001|Overall Study|Adverse Event|11|||
33282246|NCT01393613|100930898|FG002|Overall Study|Adverse Event|13|||
33282247|NCT01393613|100930899|FG003|Overall Study|Adverse Event|22|||
33282248|NCT01393613|100930896|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
33282249|NCT01393613|100930897|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
33282250|NCT01393613|100930898|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
33282251|NCT01393613|100930899|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
33282252|NCT01393613|100930896|FG000|Overall Study|Physician Decision|2|||
33282253|NCT01393613|100930897|FG001|Overall Study|Physician Decision|0|||
33282254|NCT01393613|100930898|FG002|Overall Study|Physician Decision|0|||
33282255|NCT01393613|100930899|FG003|Overall Study|Physician Decision|1|||
33282256|NCT01393613|100930896|FG000|Overall Study|Withdrawal by Subject|15|||
33282257|NCT01393613|100930897|FG001|Overall Study|Withdrawal by Subject|25|||
33282258|NCT01393613|100930898|FG002|Overall Study|Withdrawal by Subject|23|||
33282259|NCT01393613|100930899|FG003|Overall Study|Withdrawal by Subject|21|||
33282260|NCT01393613|100930896|FG000|Overall Study|Protocol Deviation|2|||
33282261|NCT01393613|100930897|FG001|Overall Study|Protocol Deviation|1|||
33282262|NCT01393613|100930898|FG002|Overall Study|Protocol Deviation|0|||
33282263|NCT01393613|100930899|FG003|Overall Study|Protocol Deviation|0|||
33282264|NCT01393613|100930896|FG000|Overall Study|Lack of Efficacy|9|||
33282265|NCT01393613|100930897|FG001|Overall Study|Lack of Efficacy|20|||
33282266|NCT01393613|100930898|FG002|Overall Study|Lack of Efficacy|16|||
33282267|NCT01393613|100930899|FG003|Overall Study|Lack of Efficacy|21|||
33282268|NCT03974100|100930900|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
33282269|NCT03974100|100930901|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
33282270|NCT03974100|100930902|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
33282271|NCT03974100|100930903|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
33282272|NCT03974100|100930904|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
33282273|NCT03974100|100930900|FG000|TP1 - Day 1 to Week 52|Death|1|||
33282274|NCT03974100|100930901|FG001|TP1 - Day 1 to Week 52|Death|0|||
33282275|NCT03974100|100930902|FG002|TP1 - Day 1 to Week 52|Death|0|||
33282276|NCT03974100|100930903|FG003|TP1 - Day 1 to Week 52|Death|0|||
33282277|NCT03974100|100930904|FG004|TP1 - Day 1 to Week 52|Death|0|||
33282278|NCT03974100|100930900|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
33282279|NCT03974100|100930901|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
33282280|NCT03974100|100930902|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
33282281|NCT03974100|100930903|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
33282282|NCT03974100|100930904|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
33282283|NCT03974100|100930900|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
33282284|NCT03974100|100930901|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
33282285|NCT03974100|100930902|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
33282286|NCT03974100|100930903|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
33282287|NCT03974100|100930904|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
33282288|NCT03974100|100930900|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
33282289|NCT03974100|100930901|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
33282290|NCT03974100|100930902|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
33282291|NCT03974100|100930903|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
33282292|NCT03974100|100930904|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
33282293|NCT03974100|100930900|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
33282294|NCT03974100|100930901|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
33282295|NCT03974100|100930902|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
33282296|NCT03974100|100930903|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
33282297|NCT03974100|100930904|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
33282298|NCT03974100|100930900|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
33282299|NCT03974100|100930901|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
33282300|NCT03974100|100930902|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
33282301|NCT03974100|100930903|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
33282302|NCT03974100|100930904|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
33282303|NCT01177137|100930906|FG000|Overall Study|Withdrawal by Subject|10|||
33282304|NCT01177137|100930907|FG001|Overall Study|Withdrawal by Subject|10|||
33282305|NCT01177137|100930908|FG002|Overall Study|Withdrawal by Subject|2|||
33282306|NCT01260142|100930919|FG000|Treatment Period 1|Study on hold|1|||
33282307|NCT01260142|100930920|FG001|Treatment Period 1|Study on hold|1|||
33282308|NCT01260142|100930921|FG002|Treatment Period 1|Study on hold|0|||
33282309|NCT01260142|100930922|FG003|Treatment Period 1|Study on hold|0|||
33282310|NCT01260142|100930923|FG004|Treatment Period 1|Study on hold|1|||
33282311|NCT01260142|100930924|FG005|Treatment Period 1|Study on hold|2|||
33282312|NCT01260142|100930919|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
33282313|NCT01260142|100930920|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
33282314|NCT01260142|100930921|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
33282315|NCT01260142|100930922|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
33282316|NCT01260142|100930923|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
33282317|NCT01260142|100930924|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
33282318|NCT01260142|100930919|FG000|Treatment Period 1|Withdrawal by Subject|0|||
33282319|NCT01260142|100930920|FG001|Treatment Period 1|Withdrawal by Subject|0|||
33282320|NCT01260142|100930921|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33282321|NCT01260142|100930922|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33282322|NCT01260142|100930923|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33282323|NCT01260142|100930924|FG005|Treatment Period 1|Withdrawal by Subject|1|||
33282324|NCT00553605|100930927|FG000|Overall Study|Did not meet entrance criteria|1|||
33282325|NCT00553605|100930928|FG001|Overall Study|Did not meet entrance criteria|3|||
33282326|NCT00553605|100930927|FG000|Overall Study|Did not receive full dose|1|||
33282327|NCT00553605|100930928|FG001|Overall Study|Did not receive full dose|0|||
33282328|NCT00553605|100930927|FG000|Overall Study|Randomized but not treated|2|||
33282329|NCT00553605|100930928|FG001|Overall Study|Randomized but not treated|0|||
33282330|NCT04750577|100930929|FG000|Overall Study|Adverse Event|2|||
33282331|NCT04750577|100930930|FG001|Overall Study|Adverse Event|10|||
33282332|NCT04750577|100930931|FG002|Overall Study|Adverse Event|8|||
33282333|NCT04750577|100930932|FG003|Overall Study|Adverse Event|1|||
33282334|NCT04750577|100930929|FG000|Overall Study|Change of residence|0|||
33282335|NCT04750577|100930930|FG001|Overall Study|Change of residence|0|||
33282336|NCT04750577|100930931|FG002|Overall Study|Change of residence|1|||
33282337|NCT04750577|100930932|FG003|Overall Study|Change of residence|0|||
33282338|NCT04750577|100930929|FG000|Overall Study|Burden of study procedures|0|||
33282339|NCT04750577|100930930|FG001|Overall Study|Burden of study procedures|2|||
33282340|NCT04750577|100930931|FG002|Overall Study|Burden of study procedures|2|||
33282341|NCT04750577|100930932|FG003|Overall Study|Burden of study procedures|0|||
33282342|NCT04750577|100930929|FG000|Overall Study|Prematurely discontinued|0|||
33282343|NCT04750577|100930930|FG001|Overall Study|Prematurely discontinued|0|||
33282344|NCT04750577|100930931|FG002|Overall Study|Prematurely discontinued|0|||
33282345|NCT04750577|100930932|FG003|Overall Study|Prematurely discontinued|2|||
33282346|NCT04750577|100930929|FG000|Overall Study|Protocol deviation|1|||
33282347|NCT04750577|100930930|FG001|Overall Study|Protocol deviation|1|||
33282348|NCT04750577|100930931|FG002|Overall Study|Protocol deviation|1|||
33282349|NCT04750577|100930932|FG003|Overall Study|Protocol deviation|1|||
33282350|NCT04750577|100930929|FG000|Overall Study|Other than listed|3|||
33282351|NCT04750577|100930930|FG001|Overall Study|Other than listed|2|||
33282352|NCT04750577|100930931|FG002|Overall Study|Other than listed|2|||
33282353|NCT04750577|100930932|FG003|Overall Study|Other than listed|1|||
33282354|NCT04750577|100930929|FG000|Overall Study|Not treated|0|||
33282355|NCT04750577|100930930|FG001|Overall Study|Not treated|0|||
33282356|NCT04750577|100930931|FG002|Overall Study|Not treated|0|||
33282357|NCT04750577|100930932|FG003|Overall Study|Not treated|2|||
33282358|NCT02930837|100930933|FG000|Overall Study|Adverse Event|6|||
33282359|NCT02930837|100930933|FG000|Overall Study|Lost to Follow-up|5|||
33282360|NCT02930837|100930933|FG000|Overall Study|Withdrawal by Subject|1|||
33282361|NCT02815735|100930934|FG000|First Intervention (4 Weeks)|Discomfort|1|||
33282362|NCT02815735|100930935|FG001|First Intervention (4 Weeks)|Discomfort|0|||
33282363|NCT02815735|100930934|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
33282364|NCT02815735|100930935|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
33282365|NCT02815735|100930934|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
33282366|NCT02815735|100930935|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
33282367|NCT02815735|100930934|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
33282368|NCT02815735|100930935|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
33282369|NCT00385697|100930938|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
33282370|NCT00385697|100930939|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
33282371|NCT00385697|100930940|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
33282372|NCT00385697|100930941|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
33282373|NCT00385697|100930942|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
33282374|NCT00385697|100930938|FG000|Open-label Segment 1|Lost to Follow-up|1|||
33282375|NCT00385697|100930939|FG001|Open-label Segment 1|Lost to Follow-up|0|||
33282376|NCT00385697|100930940|FG002|Open-label Segment 1|Lost to Follow-up|0|||
33282377|NCT00385697|100930941|FG003|Open-label Segment 1|Lost to Follow-up|0|||
33282378|NCT00385697|100930942|FG004|Open-label Segment 1|Lost to Follow-up|0|||
33282379|NCT00385697|100930938|FG000|Double-blind Segment 2|Adverse Event|0|||
33282380|NCT00385697|100930939|FG001|Double-blind Segment 2|Adverse Event|3|||
33282381|NCT00385697|100930940|FG002|Double-blind Segment 2|Adverse Event|1|||
33282382|NCT00385697|100930941|FG003|Double-blind Segment 2|Adverse Event|0|||
33282383|NCT00385697|100930942|FG004|Double-blind Segment 2|Adverse Event|0|||
33282384|NCT00385697|100930938|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
33282385|NCT00385697|100930939|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
33282386|NCT00385697|100930940|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
33282387|NCT00385697|100930941|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
33282388|NCT00385697|100930942|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
33282389|NCT00385697|100930938|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
33282390|NCT00385697|100930939|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
33282391|NCT00385697|100930940|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
33282392|NCT00385697|100930941|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
33282393|NCT00385697|100930942|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
33282394|NCT00385697|100930938|FG000|Double-blind Segment 2|Other|0|||
33282395|NCT00385697|100930939|FG001|Double-blind Segment 2|Other|2|||
33282396|NCT00385697|100930940|FG002|Double-blind Segment 2|Other|0|||
33282397|NCT00385697|100930941|FG003|Double-blind Segment 2|Other|0|||
33282398|NCT00385697|100930942|FG004|Double-blind Segment 2|Other|0|||
33282399|NCT00760877|100930943|FG000|Overall Study|Protocol Violation|1|||
33282400|NCT00760877|100930944|FG001|Overall Study|Protocol Violation|0|||
33282401|NCT00760877|100930943|FG000|Overall Study|Non-compliance with protocol treatment|2|||
33282402|NCT00760877|100930944|FG001|Overall Study|Non-compliance with protocol treatment|1|||
33282403|NCT00760877|100930943|FG000|Overall Study|Pregnancy|1|||
33282404|NCT00760877|100930944|FG001|Overall Study|Pregnancy|4|||
33282405|NCT00760877|100930943|FG000|Overall Study|Death|2|||
33282406|NCT00760877|100930944|FG001|Overall Study|Death|1|||
33282407|NCT00760877|100930943|FG000|Overall Study|Withdrawal by Subject|7|||
33282408|NCT00760877|100930944|FG001|Overall Study|Withdrawal by Subject|3|||
33282409|NCT00760877|100930943|FG000|Overall Study|Adverse Event|19|||
33282410|NCT00760877|100930944|FG001|Overall Study|Adverse Event|12|||
33282411|NCT00760877|100930943|FG000|Overall Study|Participant diagnosed with AML|0|||
33282412|NCT00760877|100930944|FG001|Overall Study|Participant diagnosed with AML|1|||
33282413|NCT00760877|100930943|FG000|Overall Study|Participant not eligible to cross-over|0|||
33282414|NCT00760877|100930944|FG001|Overall Study|Participant not eligible to cross-over|1|||
33282415|NCT00760877|100930943|FG000|Overall Study|Physician Decision|1|||
33282416|NCT00760877|100930944|FG001|Overall Study|Physician Decision|2|||
33282417|NCT00760877|100930943|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
33282418|NCT00760877|100930944|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
33282419|NCT00760877|100930943|FG000|Overall Study|Treatment failure|1|||
33282420|NCT00760877|100930944|FG001|Overall Study|Treatment failure|0|||
33282421|NCT01284634|100930947|FG000|Overall Study|Adverse Event|1|||
33282422|NCT01284634|100930948|FG001|Overall Study|Adverse Event|0|||
33282423|NCT01284634|100930949|FG002|Overall Study|Adverse Event|2|||
33282424|NCT01284634|100930950|FG003|Overall Study|Adverse Event|1|||
33282425|NCT05135156|100930951|FG000|Overall Study|Lost to Follow-up|0|||
33282426|NCT05135156|100930952|FG001|Overall Study|Lost to Follow-up|0|||
33282427|NCT05135156|100930953|FG002|Overall Study|Lost to Follow-up|2|||
33282428|NCT01203956|100930954|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
33282429|NCT01203956|100930955|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
33282430|NCT01215032|100930956|FG000|Overall Study|Adverse Event|3|||
33282431|NCT01215032|100930956|FG000|Overall Study|Lack of Efficacy|17|||
33282432|NCT01670188|100930957|FG000|Overall Study|Death|0|||
33282433|NCT01670188|100930958|FG001|Overall Study|Death|1|||
33282434|NCT00510783|100930962|FG000|Overall Study|Lost to Follow-up|29|||
33282435|NCT00510783|100930963|FG001|Overall Study|Lost to Follow-up|25|||
33282436|NCT00510783|100930962|FG000|Overall Study|Withdrawal by Subject|2|||
33282437|NCT00510783|100930963|FG001|Overall Study|Withdrawal by Subject|3|||
33282438|NCT00510783|100930962|FG000|Overall Study|Protocol Violation|0|||
33282439|NCT00510783|100930963|FG001|Overall Study|Protocol Violation|1|||
33282440|NCT03042559|100930964|FG000|Overall Study|drop out|1|||
33282441|NCT03042559|100930965|FG001|Overall Study|drop out|1|||
33282442|NCT00802438|100930966|FG000|Overall Study|Screen Failure|20|||
33282443|NCT00802438|100930966|FG000|Overall Study|Withdrawal by Subject|7|||
33282444|NCT00802438|100930966|FG000|Overall Study|Physician Decision|1|||
33282445|NCT03193216|100930967|FG000|Overall Study|Lost to Follow-up|1|||
33282446|NCT03193216|100930968|FG001|Overall Study|Lost to Follow-up|0|||
33282447|NCT03193216|100930967|FG000|Overall Study|Withdrawal by Subject|5|||
33282448|NCT03193216|100930968|FG001|Overall Study|Withdrawal by Subject|0|||
33282449|NCT03193216|100930967|FG000|Overall Study|Physician Decision|4|||
33282450|NCT03193216|100930968|FG001|Overall Study|Physician Decision|0|||
33282451|NCT01675050|100930969|FG000|Period One Treatment|Withdrawal by Subject|1|||
33282452|NCT01675050|100930970|FG001|Period One Treatment|Withdrawal by Subject|0|||
33282453|NCT02162771|100930974|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
33282454|NCT02162771|100930975|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
33282455|NCT02162771|100930974|FG000|Core Study Period (Part 2)|Adverse Event|4|||
33282456|NCT02162771|100930975|FG001|Core Study Period (Part 2)|Adverse Event|1|||
33282457|NCT02162771|100930974|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
33282458|NCT02162771|100930975|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
33282459|NCT02162771|100930974|FG000|Core Study Period (Part 2)|Physician Decision|0|||
33282460|NCT02162771|100930975|FG001|Core Study Period (Part 2)|Physician Decision|2|||
33282461|NCT02162771|100930974|FG000|Core Study Period (Part 2)|Death|1|||
33282462|NCT02162771|100930975|FG001|Core Study Period (Part 2)|Death|0|||
33282463|NCT02162771|100930974|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
33282464|NCT02162771|100930975|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
33282465|NCT02162771|100930974|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
33282466|NCT02162771|100930975|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
33282467|NCT02162771|100930974|FG000|Maintenance Study Period (Part 2)|Death|2|||
33282468|NCT02162771|100930975|FG001|Maintenance Study Period (Part 2)|Death|1|||
33282469|NCT02162771|100930974|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
33282470|NCT02162771|100930975|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
33282471|NCT02162771|100930974|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
33282472|NCT02162771|100930975|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
33282473|NCT02162771|100930974|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
33282474|NCT02162771|100930975|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
33282475|NCT00434577|100930981|FG000|Months 0-3|Serious Adverse Event|0|||
33282476|NCT00434577|100930982|FG001|Months 0-3|Serious Adverse Event|0|||
33282477|NCT00434577|100930983|FG002|Months 0-3|Serious Adverse Event|1|||
33282478|NCT00434577|100930984|FG003|Months 0-3|Serious Adverse Event|0|||
33282479|NCT00434577|100930985|FG004|Months 0-3|Serious Adverse Event|0|||
33282480|NCT00434577|100930981|FG000|Months 0-3|Adverse Event|0|||
33282481|NCT00434577|100930982|FG001|Months 0-3|Adverse Event|1|||
33282482|NCT00434577|100930983|FG002|Months 0-3|Adverse Event|1|||
33282483|NCT00434577|100930984|FG003|Months 0-3|Adverse Event|0|||
33486870|NCT02552121|101675316|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
33486871|NCT02552121|101675317|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
33282484|NCT00434577|100930985|FG004|Months 0-3|Adverse Event|0|||
33282485|NCT00434577|100930981|FG000|Months 0-3|Lost to Follow-up|0|||
33282486|NCT00434577|100930982|FG001|Months 0-3|Lost to Follow-up|0|||
33282487|NCT00434577|100930983|FG002|Months 0-3|Lost to Follow-up|0|||
33282488|NCT00434577|100930984|FG003|Months 0-3|Lost to Follow-up|0|||
33486872|NCT02552121|101675318|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
33486873|NCT02552121|101675319|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
33486874|NCT02552121|101675320|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
33486875|NCT02552121|101675321|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
33486876|NCT02552121|101675322|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
33486877|NCT02552121|101675323|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
33486878|NCT02552121|101675316|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
33486879|NCT02552121|101675317|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
33486880|NCT02552121|101675318|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
33486881|NCT02552121|101675319|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
33486882|NCT02552121|101675320|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
33486883|NCT02552121|101675321|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
33486884|NCT02552121|101675322|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
33486885|NCT02552121|101675323|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
33486886|NCT02552121|101675316|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
33486887|NCT02552121|101675317|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
33486888|NCT02552121|101675318|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
33486889|NCT02552121|101675319|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
33486890|NCT02552121|101675320|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
33486891|NCT02552121|101675321|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
33486892|NCT02552121|101675322|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
33486893|NCT02552121|101675323|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
33486894|NCT02552121|101675316|FG000|Part 2: Cohort Expansion|Death|0|||
33486895|NCT02552121|101675317|FG001|Part 2: Cohort Expansion|Death|0|||
33486896|NCT02552121|101675318|FG002|Part 2: Cohort Expansion|Death|1|||
33486897|NCT02552121|101675319|FG003|Part 2: Cohort Expansion|Death|0|||
33486898|NCT02552121|101675320|FG004|Part 2: Cohort Expansion|Death|0|||
33486899|NCT02552121|101675321|FG005|Part 2: Cohort Expansion|Death|0|||
33486900|NCT02552121|101675322|FG006|Part 2: Cohort Expansion|Death|0|||
33486901|NCT02552121|101675323|FG007|Part 2: Cohort Expansion|Death|0|||
33486902|NCT01399658|101675325|FG000|Overall Study|Ineligible|1|||
33486903|NCT01399658|101675325|FG000|Overall Study|Machine Technical Issue|3|||
33486904|NCT01399658|101675325|FG000|Overall Study|Alternative therapy|1|||
33486905|NCT01399658|101675325|FG000|Overall Study|No reason given|1|||
33486906|NCT01523002|101675330|FG000|Period 1|Withdrawal by Subject|1|||
33486907|NCT01523002|101675331|FG001|Period 1|Withdrawal by Subject|3|||
33486908|NCT01523002|101675330|FG000|Period 1|Lost to Follow-up|1|||
33486909|NCT01523002|101675331|FG001|Period 1|Lost to Follow-up|0|||
33486910|NCT01523002|101675330|FG000|Period 1|Adverse Event|0|||
33486911|NCT01523002|101675331|FG001|Period 1|Adverse Event|8|||
33486912|NCT01523002|101675330|FG000|Period 2|Withdrawal by Subject|4|||
33486913|NCT01523002|101675331|FG001|Period 2|Withdrawal by Subject|1|||
33486914|NCT01523002|101675330|FG000|Period 2|Adverse Event|2|||
33486915|NCT01523002|101675331|FG001|Period 2|Adverse Event|5|||
33486916|NCT01523002|101675330|FG000|Period 3|Withdrawal by Subject|1|||
33486917|NCT01523002|101675331|FG001|Period 3|Withdrawal by Subject|0|||
33486918|NCT01523002|101675330|FG000|Period 3|Adverse Event|3|||
33486919|NCT01523002|101675331|FG001|Period 3|Adverse Event|0|||
33486920|NCT01478373|101675332|FG000|Treatment Phase|Protocol Violation|1|||
33486921|NCT01478373|101675332|FG000|Survival Phase|Adverse Event|8|||
33486922|NCT01478373|101675332|FG000|Survival Phase|Protocol Violation|1|||
33486923|NCT01478373|101675332|FG000|Survival Phase|crossover to another study|2|||
33486924|NCT01478373|101675332|FG000|Survival Phase|Progressive Disease|27|||
33486925|NCT02586155|101675333|FG000|Overall Study|Adverse Event|2|||
33486926|NCT02586155|101675334|FG001|Overall Study|Adverse Event|3|||
33486927|NCT02586155|101675333|FG000|Overall Study|Withdrawal by Subject|31|||
33486928|NCT02586155|101675334|FG001|Overall Study|Withdrawal by Subject|24|||
33486929|NCT02586155|101675333|FG000|Overall Study|Lost to Follow-up|7|||
33486930|NCT02586155|101675334|FG001|Overall Study|Lost to Follow-up|13|||
33486931|NCT02586155|101675333|FG000|Overall Study|Death|61|||
33486932|NCT02586155|101675334|FG001|Overall Study|Death|72|||
33486933|NCT02586155|101675333|FG000|Overall Study|Other reasons|26|||
33486934|NCT02586155|101675334|FG001|Overall Study|Other reasons|15|||
33486935|NCT01876446|101675338|FG000|Overall Study|Death|0|||
33486936|NCT01876446|101675339|FG001|Overall Study|Death|1|||
33486937|NCT01876446|101675338|FG000|Overall Study|Withdrawal by Subject|1|||
33486938|NCT01876446|101675339|FG001|Overall Study|Withdrawal by Subject|2|||
33486939|NCT01876446|101675338|FG000|Overall Study|Physician Decision|1|||
33486940|NCT01876446|101675339|FG001|Overall Study|Physician Decision|3|||
33486941|NCT01308424|101675342|FG000|Baseline Eligibility|Screen Failures|71|||
33486942|NCT01308424|101675343|FG001|Baseline Eligibility|Screen Failures|0|||
33486943|NCT01308424|101675344|FG002|Baseline Eligibility|Screen Failures|0|||
33486944|NCT01308424|101675342|FG000|Randomization|Adverse Event|0|||
33486945|NCT01308424|101675343|FG001|Randomization|Adverse Event|1|||
33486946|NCT01308424|101675344|FG002|Randomization|Adverse Event|1|||
33486947|NCT01308424|101675342|FG000|Randomization|Lost to Follow-up|0|||
33486948|NCT01308424|101675343|FG001|Randomization|Lost to Follow-up|1|||
33486949|NCT01308424|101675344|FG002|Randomization|Lost to Follow-up|0|||
33486950|NCT01308424|101675342|FG000|Randomization|Physician Decision|0|||
33486951|NCT01308424|101675343|FG001|Randomization|Physician Decision|1|||
33486952|NCT01308424|101675344|FG002|Randomization|Physician Decision|1|||
33486953|NCT00699998|101675345|FG000|Overall Study|Withdrawal by Subject|194|||
33486954|NCT00699998|101675346|FG001|Overall Study|Withdrawal by Subject|83|||
33486955|NCT00699998|101675347|FG002|Overall Study|Withdrawal by Subject|202|||
33486956|NCT00699998|101675348|FG003|Overall Study|Withdrawal by Subject|80|||
33486957|NCT00699998|101675345|FG000|Overall Study|Physician Decision|3|||
33486958|NCT00699998|101675346|FG001|Overall Study|Physician Decision|2|||
33486959|NCT00699998|101675347|FG002|Overall Study|Physician Decision|1|||
33486960|NCT00699998|101675348|FG003|Overall Study|Physician Decision|1|||
33486961|NCT00699998|101675345|FG000|Overall Study|Lost to Follow-up|2|||
33486962|NCT00699998|101675346|FG001|Overall Study|Lost to Follow-up|1|||
33486963|NCT00699998|101675347|FG002|Overall Study|Lost to Follow-up|3|||
33486964|NCT00699998|101675348|FG003|Overall Study|Lost to Follow-up|1|||
33486965|NCT04052620|101675352|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
33486966|NCT04052620|101675353|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
33486967|NCT04052620|101675352|FG000|Overall Study|Withdrawal by Subject|1|||
33486968|NCT04052620|101675353|FG001|Overall Study|Withdrawal by Subject|0|||
33486969|NCT04052620|101675352|FG000|Overall Study|Lost to Follow-up|1|||
33486970|NCT04052620|101675353|FG001|Overall Study|Lost to Follow-up|1|||
33486971|NCT04052620|101675352|FG000|Overall Study|Adverse Event|1|||
33486972|NCT04052620|101675353|FG001|Overall Study|Adverse Event|0|||
33486973|NCT04052620|101675352|FG000|Overall Study|Subject did not meet study Criteria|0|||
33486974|NCT04052620|101675353|FG001|Overall Study|Subject did not meet study Criteria|1|||
33486975|NCT04052620|101675352|FG000|Overall Study|Screened failure, randomized by mistake|0|||
33486976|NCT04052620|101675353|FG001|Overall Study|Screened failure, randomized by mistake|1|||
33486977|NCT04052620|101675352|FG000|Overall Study|Personal reasons|2|||
33486978|NCT04052620|101675353|FG001|Overall Study|Personal reasons|4|||
33486979|NCT04052620|101675352|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
33486980|NCT04052620|101675353|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
33486981|NCT03993379|101675354|FG000|Overall Study|The study was terminated early due to business decision.|0|||
33486982|NCT03993379|101675355|FG001|Overall Study|The study was terminated early due to business decision.|2|||
33486983|NCT03993379|101675356|FG002|Overall Study|The study was terminated early due to business decision.|0|||
33486984|NCT03993379|101675357|FG003|Overall Study|The study was terminated early due to business decision.|0|||
33486985|NCT03993379|101675354|FG000|Overall Study|Withdrawal by Subject|0|||
33486986|NCT03993379|101675355|FG001|Overall Study|Withdrawal by Subject|1|||
33486987|NCT03993379|101675356|FG002|Overall Study|Withdrawal by Subject|0|||
33486988|NCT03993379|101675357|FG003|Overall Study|Withdrawal by Subject|0|||
33486989|NCT01941498|101675362|FG000|Overall Study|Relocated out of state|1|||
33486990|NCT00005957|101675363|FG000|Overall Study|No treated|3|||
33486991|NCT00005957|101675364|FG001|Overall Study|No treated|9|||
33486992|NCT00005957|101675363|FG000|Overall Study|Crossover to the other arm|5|||
33486993|NCT00005957|101675364|FG001|Overall Study|Crossover to the other arm|19|||
33486994|NCT02508935|101675365|FG000|Overall Study|Withdrawal by Subject|1|||
33486995|NCT02508935|101675365|FG000|Overall Study|Withdrawal by Caregiver|8|||
33486996|NCT02508935|101675365|FG000|Overall Study|Pain Score <4|1|||
33486997|NCT02508935|101675365|FG000|Overall Study|Emesis|3|||
33486998|NCT02508935|101675365|FG000|Overall Study|Adverse Event|3|||
33486999|NCT02508935|101675365|FG000|Overall Study|Protocol Violation|1|||
33487000|NCT02508935|101675365|FG000|Overall Study|Physician Decision|1|||
33487001|NCT02508935|101675365|FG000|Overall Study|Trial terminated by sponsor|5|||
33487002|NCT03452137|101675367|FG000|Overall Study|Death|67|||
33487003|NCT03452137|101675368|FG001|Overall Study|Death|70|||
33487004|NCT03452137|101675367|FG000|Overall Study|Lost to Follow-up|4|||
33282489|NCT00434577|100930985|FG004|Months 0-3|Lost to Follow-up|2|||
33282490|NCT00434577|100930981|FG000|Months 0-3|Protocol Violation|1|||
33282491|NCT00434577|100930982|FG001|Months 0-3|Protocol Violation|0|||
33282492|NCT00434577|100930983|FG002|Months 0-3|Protocol Violation|1|||
33282493|NCT00434577|100930984|FG003|Months 0-3|Protocol Violation|0|||
33282494|NCT00434577|100930985|FG004|Months 0-3|Protocol Violation|0|||
33282495|NCT00434577|100930981|FG000|Months 0-3|Withdrawal by Subject|2|||
33282496|NCT00434577|100930982|FG001|Months 0-3|Withdrawal by Subject|1|||
33282497|NCT00434577|100930983|FG002|Months 0-3|Withdrawal by Subject|1|||
33282498|NCT00434577|100930984|FG003|Months 0-3|Withdrawal by Subject|1|||
33282499|NCT00434577|100930985|FG004|Months 0-3|Withdrawal by Subject|1|||
33282500|NCT03811834|100930986|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
33282501|NCT04814992|100930989|FG000|Overall Study|Withdrawal by Subject|6|||
33282502|NCT04814992|100930990|FG001|Overall Study|Withdrawal by Subject|3|||
33282503|NCT04814992|100930989|FG000|Overall Study|Lost to Follow-up|1|||
33282504|NCT04814992|100930990|FG001|Overall Study|Lost to Follow-up|4|||
33487005|NCT03452137|101675368|FG001|Overall Study|Lost to Follow-up|2|||
33487006|NCT03452137|101675367|FG000|Overall Study|Physician Decision|0|||
33487007|NCT03452137|101675368|FG001|Overall Study|Physician Decision|1|||
33487008|NCT03452137|101675367|FG000|Overall Study|Study Terminated by Sponsor|120|||
33487009|NCT03452137|101675368|FG001|Overall Study|Study Terminated by Sponsor|121|||
33282505|NCT00396097|100930999|FG000|Overall Study|Withdrawal by Subject|17|||
33487010|NCT03452137|101675367|FG000|Overall Study|Withdrawal by Subject|12|||
33487011|NCT03452137|101675368|FG001|Overall Study|Withdrawal by Subject|9|||
33487012|NCT05445492|101675369|FG000|Overall Study|Physician Decision|1|||
33487013|NCT00352417|101675371|FG000|Overall Study|Adverse Event|1|||
33487014|NCT00352417|101675372|FG001|Overall Study|Adverse Event|0|||
33487015|NCT00352417|101675371|FG000|Overall Study|Protocol Violation|0|||
33487016|NCT00352417|101675372|FG001|Overall Study|Protocol Violation|2|||
33487017|NCT00352417|101675371|FG000|Overall Study|Withdrawal by Subject|1|||
33487018|NCT00352417|101675372|FG001|Overall Study|Withdrawal by Subject|2|||
33487019|NCT00352417|101675371|FG000|Overall Study|Lost to Follow-up|1|||
33487020|NCT00352417|101675372|FG001|Overall Study|Lost to Follow-up|0|||
33487021|NCT00352417|101675371|FG000|Overall Study|Schedule Change|2|||
33487022|NCT00352417|101675372|FG001|Overall Study|Schedule Change|1|||
33487023|NCT02165735|101675373|FG000|Overall Study|Lost to Follow-up|12|||
33487024|NCT02165735|101675374|FG001|Overall Study|Lost to Follow-up|10|||
33487025|NCT02165735|101675373|FG000|Overall Study|Withdrawal by Subject|3|||
33487026|NCT02165735|101675374|FG001|Overall Study|Withdrawal by Subject|0|||
33487027|NCT02165735|101675373|FG000|Overall Study|Participant indicated lack of time|1|||
33487028|NCT02165735|101675374|FG001|Overall Study|Participant indicated lack of time|3|||
33487029|NCT02165735|101675373|FG000|Overall Study|Protocol Violation|0|||
33487030|NCT02165735|101675374|FG001|Overall Study|Protocol Violation|1|||
33487031|NCT00129545|101675390|FG000|Overall Study|Death|5|||
33487032|NCT00129545|101675391|FG001|Overall Study|Death|60|||
33487033|NCT00129545|101675392|FG002|Overall Study|Death|44|||
33487034|NCT00129545|101675390|FG000|Overall Study|Withdrawal by Subject|3|||
33487035|NCT00129545|101675391|FG001|Overall Study|Withdrawal by Subject|18|||
33487036|NCT00129545|101675392|FG002|Overall Study|Withdrawal by Subject|44|||
33487037|NCT00129545|101675390|FG000|Overall Study|Lost to Follow-up|2|||
33487038|NCT00129545|101675391|FG001|Overall Study|Lost to Follow-up|22|||
33487039|NCT00129545|101675392|FG002|Overall Study|Lost to Follow-up|13|||
33487040|NCT00129545|101675390|FG000|Overall Study|Physician Decision|0|||
33487041|NCT00129545|101675391|FG001|Overall Study|Physician Decision|3|||
33487042|NCT00129545|101675392|FG002|Overall Study|Physician Decision|10|||
33487043|NCT00129545|101675390|FG000|Overall Study|Device not implanted|16|||
33487044|NCT00129545|101675391|FG001|Overall Study|Device not implanted|61|||
33487045|NCT00129545|101675392|FG002|Overall Study|Device not implanted|0|||
33487046|NCT00720382|101675393|FG000|Overall Study|Adverse Event|54|||
33487047|NCT00720382|101675394|FG001|Overall Study|Adverse Event|17|||
33487048|NCT00720382|101675393|FG000|Overall Study|Lack of Efficacy|18|||
33487049|NCT00720382|101675394|FG001|Overall Study|Lack of Efficacy|7|||
33487050|NCT00720382|101675393|FG000|Overall Study|Non-Compliance|15|||
33487051|NCT00720382|101675394|FG001|Overall Study|Non-Compliance|5|||
33487052|NCT00720382|101675393|FG000|Overall Study|Withdrawal by Subject|47|||
33487053|NCT00720382|101675394|FG001|Overall Study|Withdrawal by Subject|11|||
33487054|NCT00720382|101675393|FG000|Overall Study|Lost to Follow-up|28|||
33487055|NCT00720382|101675394|FG001|Overall Study|Lost to Follow-up|14|||
33487056|NCT00720382|101675393|FG000|Overall Study|administrative|14|||
33487057|NCT00720382|101675394|FG001|Overall Study|administrative|5|||
33487058|NCT01346293|101675398|FG000|Overall Study|Protocol Violation|30|||
33487059|NCT01346293|101675399|FG001|Overall Study|Protocol Violation|9|||
33487060|NCT01346293|101675398|FG000|Overall Study|Lost to Follow-up|21|||
33487061|NCT01346293|101675399|FG001|Overall Study|Lost to Follow-up|8|||
33487062|NCT01346293|101675398|FG000|Overall Study|Withdrawal by Subject|15|||
33487063|NCT01346293|101675399|FG001|Overall Study|Withdrawal by Subject|4|||
33487064|NCT01346293|101675398|FG000|Overall Study|Other|1|||
33487065|NCT01346293|101675399|FG001|Overall Study|Other|0|||
33487066|NCT02871492|101675400|FG000|Overall Study|Lost to Follow-up|6|||
33487067|NCT02871492|101675401|FG001|Overall Study|Lost to Follow-up|3|||
33487068|NCT02871492|101675402|FG002|Overall Study|Lost to Follow-up|5|||
33487069|NCT02871492|101675400|FG000|Overall Study|Withdrawal by Subject|0|||
33487070|NCT02871492|101675401|FG001|Overall Study|Withdrawal by Subject|0|||
33487071|NCT02871492|101675402|FG002|Overall Study|Withdrawal by Subject|1|||
33487072|NCT02075515|101675408|FG000|Overall Study|Serious Adverse Event|1|||
33487073|NCT02075515|101675409|FG001|Overall Study|Serious Adverse Event|1|||
33487074|NCT02075515|101675410|FG002|Overall Study|Serious Adverse Event|1|||
33487075|NCT02075515|101675408|FG000|Overall Study|Non-Serious Adverse Event|0|||
33487076|NCT02075515|101675409|FG001|Overall Study|Non-Serious Adverse Event|1|||
33487077|NCT02075515|101675410|FG002|Overall Study|Non-Serious Adverse Event|0|||
33487078|NCT02075515|101675408|FG000|Overall Study|Withdrawal by Subject|2|||
33487079|NCT02075515|101675409|FG001|Overall Study|Withdrawal by Subject|0|||
33487080|NCT02075515|101675410|FG002|Overall Study|Withdrawal by Subject|1|||
33487081|NCT02075515|101675408|FG000|Overall Study|Lost to Follow-up|1|||
33487082|NCT02075515|101675409|FG001|Overall Study|Lost to Follow-up|3|||
33487083|NCT02075515|101675410|FG002|Overall Study|Lost to Follow-up|6|||
33487084|NCT00853099|101675412|FG000|Double-blind Period|Adverse Event|7|||
33487085|NCT00853099|101675413|FG001|Double-blind Period|Adverse Event|9|||
33487086|NCT00853099|101675414|FG002|Double-blind Period|Adverse Event|13|||
33487087|NCT00853099|101675415|FG003|Double-blind Period|Adverse Event|0|||
33487088|NCT00853099|101675412|FG000|Double-blind Period|Withdrawal by Subject|2|||
33487089|NCT00853099|101675413|FG001|Double-blind Period|Withdrawal by Subject|3|||
33487090|NCT00853099|101675414|FG002|Double-blind Period|Withdrawal by Subject|0|||
33487091|NCT00853099|101675415|FG003|Double-blind Period|Withdrawal by Subject|0|||
33487092|NCT00853099|101675412|FG000|Double-blind Period|Lack of Efficacy|14|||
33487093|NCT00853099|101675413|FG001|Double-blind Period|Lack of Efficacy|17|||
33487094|NCT00853099|101675414|FG002|Double-blind Period|Lack of Efficacy|16|||
33487095|NCT00853099|101675415|FG003|Double-blind Period|Lack of Efficacy|0|||
33487096|NCT00853099|101675412|FG000|Double-blind Period|Other|0|||
33487097|NCT00853099|101675413|FG001|Double-blind Period|Other|0|||
33487098|NCT00853099|101675414|FG002|Double-blind Period|Other|1|||
33487099|NCT00853099|101675415|FG003|Double-blind Period|Other|0|||
33487100|NCT00853099|101675412|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
33487101|NCT00853099|101675413|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
33487102|NCT00853099|101675414|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
33487103|NCT00853099|101675415|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
33487104|NCT00853099|101675412|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
33487105|NCT00853099|101675413|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
33487106|NCT00853099|101675414|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
33487107|NCT00853099|101675415|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
33487108|NCT00853099|101675412|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
33487109|NCT00853099|101675413|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
33487110|NCT00853099|101675414|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
33487111|NCT00853099|101675415|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
33487112|NCT00853099|101675412|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
33487113|NCT00853099|101675413|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
33487114|NCT00853099|101675414|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
33487115|NCT00853099|101675415|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
33487116|NCT00853099|101675412|FG000|Double-blind + Open-label Periods|Other|0|||
33487117|NCT00853099|101675413|FG001|Double-blind + Open-label Periods|Other|0|||
33487118|NCT00853099|101675414|FG002|Double-blind + Open-label Periods|Other|0|||
33487119|NCT00853099|101675415|FG003|Double-blind + Open-label Periods|Other|6|||
33487120|NCT04546724|101675419|FG000|Overall Study|Withdrawal by Subject|145|||
33487121|NCT04546724|101675420|FG001|Overall Study|Withdrawal by Subject|41|||
33487122|NCT04546724|101675419|FG000|Overall Study|Adverse Event|1|||
33487123|NCT04546724|101675420|FG001|Overall Study|Adverse Event|1|||
33487124|NCT04546724|101675419|FG000|Overall Study|Lost to Follow-up|186|||
33487125|NCT04546724|101675420|FG001|Overall Study|Lost to Follow-up|63|||
33487126|NCT04546724|101675419|FG000|Overall Study|Physician Decision|8|||
33487127|NCT04546724|101675420|FG001|Overall Study|Physician Decision|2|||
33487128|NCT04546724|101675419|FG000|Overall Study|Death|2|||
33487129|NCT04546724|101675420|FG001|Overall Study|Death|1|||
33487130|NCT04546724|101675419|FG000|Overall Study|subject has been out of town|1|||
33487131|NCT04546724|101675420|FG001|Overall Study|subject has been out of town|0|||
33487132|NCT04546724|101675419|FG000|Overall Study|subject is incarcerated|2|||
33487133|NCT04546724|101675420|FG001|Overall Study|subject is incarcerated|0|||
33487134|NCT04546724|101675419|FG000|Overall Study|subject is relocating|12|||
33487135|NCT04546724|101675420|FG001|Overall Study|subject is relocating|4|||
33487136|NCT04546724|101675419|FG000|Overall Study|Subject in another study|1|||
33487137|NCT04546724|101675420|FG001|Overall Study|Subject in another study|1|||
33487138|NCT04439201|101675421|FG000|Overall Study|Ineligible|2|||
33487139|NCT04439201|101675421|FG000|Overall Study|Never start protocol therapy|1|||
33487140|NCT04439201|101675421|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
33487141|NCT04439201|101675421|FG000|Overall Study|Mutation status not confirmed|4|||
33487142|NCT04439201|101675421|FG000|Overall Study|Adverse Event|1|||
33487143|NCT04439201|101675421|FG000|Overall Study|Death|7|||
33487144|NCT04439201|101675421|FG000|Overall Study|Withdrawal by Subject|2|||
33487145|NCT04439201|101675421|FG000|Overall Study|Disease progression|20|||
33487146|NCT04439201|101675421|FG000|Overall Study|Alternative therapy|1|||
33487147|NCT04439201|101675421|FG000|Overall Study|Physician Decision|1|||
33487148|NCT00796757|101675422|FG000|Overall Study|Withdrawal by Subject|14|||
33487149|NCT00796757|101675422|FG000|Overall Study|Death|61|||
33487150|NCT00796757|101675422|FG000|Overall Study|Protocol Violation|1|||
33487151|NCT00796757|101675422|FG000|Overall Study|Participant noncompliance|1|||
33487152|NCT00796757|101675422|FG000|Overall Study|Investigator's decision|2|||
33487153|NCT00796757|101675422|FG000|Overall Study|Other|7|||
33487154|NCT03097991|101675423|FG000|Overall Study|Didn't meet study criteria|8|||
33487155|NCT03097991|101675424|FG001|Overall Study|Didn't meet study criteria|0|||
33487156|NCT03097991|101675423|FG000|Overall Study|Withdrawal by Subject|12|||
33487157|NCT03097991|101675424|FG001|Overall Study|Withdrawal by Subject|6|||
33487158|NCT03097991|101675423|FG000|Overall Study|Death of Baby|3|||
33487159|NCT03097991|101675424|FG001|Overall Study|Death of Baby|1|||
33487160|NCT03097991|101675423|FG000|Overall Study|Lost to Follow-up|24|||
33487161|NCT03097991|101675424|FG001|Overall Study|Lost to Follow-up|38|||
33487162|NCT03097991|101675423|FG000|Overall Study|Adverse Event|3|||
33487163|NCT03097991|101675424|FG001|Overall Study|Adverse Event|5|||
33487164|NCT02503787|101675425|FG000|Enrollment|Withdrawal by Subject|6|||
33487165|NCT02503787|101675425|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
33487166|NCT02503787|101675425|FG000|Enrollment|Physician Decision|2|||
33487167|NCT02503787|101675425|FG000|Enrollment|Insurance issue|2|||
33487168|NCT02503787|101675425|FG000|Enrollment|Lost to Follow-up|1|||
33487169|NCT02503787|101675425|FG000|Enrollment|Study closure|1|||
33487170|NCT02503787|101675425|FG000|Enrollment|Adverse Event|1|||
33487171|NCT02503787|101675425|FG000|Enrollment|Protocol Violation|1|||
33487172|NCT02503787|101675425|FG000|Enrollment|Inability to implant system|1|||
33487173|NCT02503787|101675425|FG000|Enrollment|Unable to be programmed|1|||
33487174|NCT02503787|101675425|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
33487175|NCT02503787|101675425|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
33487176|NCT02503787|101675425|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
33487177|NCT02503787|101675425|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
33487178|NCT02503787|101675425|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
33487179|NCT02503787|101675425|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
33487180|NCT05101343|101675432|FG000|Overall Study|Withdrawal by Subject|2|||
33487181|NCT05101343|101675433|FG001|Overall Study|Withdrawal by Subject|1|||
33487182|NCT02368314|101675434|FG000|Overall Study|Withdrawal by Subject|2|||
33487183|NCT02368314|101675435|FG001|Overall Study|Withdrawal by Subject|1|||
33487184|NCT02368314|101675434|FG000|Overall Study|Adverse Event|1|||
33487185|NCT02368314|101675435|FG001|Overall Study|Adverse Event|2|||
33487186|NCT00616421|101675437|FG000|Overall Study|Withdrawal by Subject|9|||
33487187|NCT00616421|101675438|FG001|Overall Study|Withdrawal by Subject|11|||
33487188|NCT00616421|101675439|FG002|Overall Study|Withdrawal by Subject|8|||
33487189|NCT00616421|101675437|FG000|Overall Study|Lost to Follow-up|12|||
33487190|NCT00616421|101675438|FG001|Overall Study|Lost to Follow-up|26|||
33487191|NCT00616421|101675439|FG002|Overall Study|Lost to Follow-up|30|||
33487192|NCT00616421|101675437|FG000|Overall Study|Inappropriate enrollment|3|||
33487193|NCT00616421|101675438|FG001|Overall Study|Inappropriate enrollment|0|||
33487194|NCT00616421|101675439|FG002|Overall Study|Inappropriate enrollment|1|||
33487195|NCT00616421|101675437|FG000|Overall Study|Administrative reason|1|||
33487196|NCT00616421|101675438|FG001|Overall Study|Administrative reason|0|||
33487197|NCT00616421|101675439|FG002|Overall Study|Administrative reason|0|||
33487198|NCT00616421|101675437|FG000|Overall Study|Protocol Violation|0|||
33487199|NCT00616421|101675438|FG001|Overall Study|Protocol Violation|1|||
33487200|NCT00616421|101675439|FG002|Overall Study|Protocol Violation|2|||
33487201|NCT00616421|101675437|FG000|Overall Study|Unable to classify|1|||
33487202|NCT00616421|101675438|FG001|Overall Study|Unable to classify|0|||
33487203|NCT00616421|101675439|FG002|Overall Study|Unable to classify|0|||
33487204|NCT00805675|101675440|FG000|Overall Study|Adverse Event|0|||
33487205|NCT00805675|101675441|FG001|Overall Study|Adverse Event|0|||
33487206|NCT00805675|101675442|FG002|Overall Study|Adverse Event|1|||
33487207|NCT04660331|101675443|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
33487208|NCT04660331|101675444|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
33487209|NCT04660331|101675445|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
33487210|NCT01721317|101675446|FG000|Overall Study|Study Closed / Terminated|2|||
33487211|NCT01721317|101675447|FG001|Overall Study|Study Closed / Terminated|2|||
33487212|NCT01721317|101675446|FG000|Overall Study|Physician Decision|0|||
33487213|NCT01721317|101675447|FG001|Overall Study|Physician Decision|1|||
33487214|NCT01721317|101675446|FG000|Overall Study|Withdrawal by Subject|0|||
33487215|NCT01721317|101675447|FG001|Overall Study|Withdrawal by Subject|1|||
33487216|NCT02096744|101675448|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
33487217|NCT02096744|101675449|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
33487218|NCT02096744|101675448|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
33487219|NCT02096744|101675449|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
33487220|NCT02096744|101675448|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
33487221|NCT02096744|101675449|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
33487222|NCT01512160|101679436|FG000|Overall Study|Lost to Follow-up|1|||
33487223|NCT01512160|101679437|FG001|Overall Study|Lost to Follow-up|0|||
33487224|NCT01512160|101679438|FG002|Overall Study|Lost to Follow-up|0|||
33487225|NCT01512160|101679439|FG003|Overall Study|Lost to Follow-up|0|||
33487226|NCT01512160|101679436|FG000|Overall Study|Withdrawal by Subject|1|||
33487227|NCT01512160|101679437|FG001|Overall Study|Withdrawal by Subject|0|||
33487228|NCT01512160|101679438|FG002|Overall Study|Withdrawal by Subject|0|||
33487229|NCT01512160|101679439|FG003|Overall Study|Withdrawal by Subject|1|||
33487230|NCT01645787|101679445|FG000|Washout (2 Weeks)|Adverse Event|1|||
33487231|NCT01645787|101679446|FG001|Washout (2 Weeks)|Adverse Event|0|||
33487232|NCT03910673|101679447|FG000|Overall Study|Adverse Event|0|||
33487233|NCT03910673|101679448|FG001|Overall Study|Adverse Event|0|||
33487234|NCT03910673|101679449|FG002|Overall Study|Adverse Event|0|||
33487235|NCT03910673|101679450|FG003|Overall Study|Adverse Event|2|||
33487236|NCT03910673|101679451|FG004|Overall Study|Adverse Event|0|||
33487237|NCT00061932|101679452|FG000|Overall Study|Withdrawal by Subject|13|||
33487238|NCT00061932|101679453|FG001|Overall Study|Withdrawal by Subject|4|||
33487239|NCT00098774|101679463|FG000|Overall Study|Adverse Event|2|||
33487240|NCT00098774|101679463|FG000|Overall Study|Disease Progression|9|||
33487241|NCT00098774|101679463|FG000|Overall Study|Withdrawal by Subject|1|||
33487242|NCT00098774|101679463|FG000|Overall Study|Failed (to respond) during induction|4|||
33487243|NCT00098774|101679463|FG000|Overall Study|Physician Decision|2|||
33487244|NCT01524978|101679466|FG000|Overall Study|Other|16|||
33487245|NCT01524978|101679467|FG001|Overall Study|Other|2|||
33487246|NCT01524978|101679468|FG002|Overall Study|Other|1|||
33487247|NCT01524978|101679469|FG003|Overall Study|Other|2|||
33487248|NCT01524978|101679470|FG004|Overall Study|Other|1|||
33487249|NCT01524978|101679471|FG005|Overall Study|Other|3|||
33487250|NCT01524978|101679472|FG006|Overall Study|Other|17|||
33487251|NCT01524978|101679473|FG007|Overall Study|Other|1|||
33487252|NCT01524978|101679474|FG008|Overall Study|Other|2|||
33487253|NCT01524978|101679475|FG009|Overall Study|Other|2|||
33487254|NCT01524978|101679476|FG010|Overall Study|Other|5|||
33487255|NCT01524978|101679466|FG000|Overall Study|Withdrawal by Subject|12|||
33487256|NCT01524978|101679467|FG001|Overall Study|Withdrawal by Subject|0|||
33487257|NCT01524978|101679468|FG002|Overall Study|Withdrawal by Subject|1|||
33487258|NCT01524978|101679469|FG003|Overall Study|Withdrawal by Subject|1|||
33487259|NCT01524978|101679470|FG004|Overall Study|Withdrawal by Subject|3|||
33487260|NCT01524978|101679471|FG005|Overall Study|Withdrawal by Subject|1|||
33487261|NCT01524978|101679472|FG006|Overall Study|Withdrawal by Subject|6|||
33487262|NCT01524978|101679473|FG007|Overall Study|Withdrawal by Subject|2|||
33487263|NCT01524978|101679474|FG008|Overall Study|Withdrawal by Subject|4|||
33487264|NCT01524978|101679475|FG009|Overall Study|Withdrawal by Subject|0|||
33487265|NCT01524978|101679476|FG010|Overall Study|Withdrawal by Subject|5|||
33487266|NCT01524978|101679466|FG000|Overall Study|Lost to Follow-up|0|||
33487267|NCT01524978|101679467|FG001|Overall Study|Lost to Follow-up|0|||
33487268|NCT01524978|101679468|FG002|Overall Study|Lost to Follow-up|3|||
33487269|NCT01524978|101679469|FG003|Overall Study|Lost to Follow-up|0|||
33487270|NCT01524978|101679470|FG004|Overall Study|Lost to Follow-up|1|||
33487271|NCT01524978|101679471|FG005|Overall Study|Lost to Follow-up|1|||
33487272|NCT01524978|101679472|FG006|Overall Study|Lost to Follow-up|2|||
33487273|NCT01524978|101679473|FG007|Overall Study|Lost to Follow-up|0|||
33487274|NCT01524978|101679474|FG008|Overall Study|Lost to Follow-up|1|||
33487275|NCT01524978|101679475|FG009|Overall Study|Lost to Follow-up|1|||
33487276|NCT01524978|101679476|FG010|Overall Study|Lost to Follow-up|1|||
33487277|NCT01524978|101679466|FG000|Overall Study|Death|34|||
33487278|NCT01524978|101679467|FG001|Overall Study|Death|2|||
33487279|NCT01524978|101679468|FG002|Overall Study|Death|5|||
33487280|NCT01524978|101679469|FG003|Overall Study|Death|24|||
33487281|NCT01524978|101679470|FG004|Overall Study|Death|4|||
33487282|NCT01524978|101679471|FG005|Overall Study|Death|4|||
33487283|NCT01524978|101679472|FG006|Overall Study|Death|1|||
33487284|NCT01524978|101679473|FG007|Overall Study|Death|9|||
33487285|NCT01524978|101679474|FG008|Overall Study|Death|5|||
33487286|NCT01524978|101679475|FG009|Overall Study|Death|6|||
33487287|NCT01524978|101679476|FG010|Overall Study|Death|17|||
33487288|NCT00492778|101679477|FG000|Overall Study|Ineligible by Pathology Review|8|||
33487289|NCT00492778|101679478|FG001|Overall Study|Ineligible by Pathology Review|1|||
33487290|NCT02620579|101679484|FG000|Overall Study|Physician Decision|0|||
33487291|NCT02620579|101679485|FG001|Overall Study|Physician Decision|0|||
33487292|NCT02620579|101679486|FG002|Overall Study|Physician Decision|0|||
33487293|NCT02620579|101679487|FG003|Overall Study|Physician Decision|1|||
33487294|NCT02620579|101679484|FG000|Overall Study|Withdrawal by Subject|0|||
33487295|NCT02620579|101679485|FG001|Overall Study|Withdrawal by Subject|1|||
33487296|NCT02620579|101679486|FG002|Overall Study|Withdrawal by Subject|1|||
33487297|NCT02620579|101679487|FG003|Overall Study|Withdrawal by Subject|0|||
33487298|NCT01228019|101679497|FG000|Overall Study|Dose Violation|70|||
33487299|NCT01228019|101679497|FG000|Overall Study|Duplicate enrollment|1|||
33487300|NCT01228019|101679497|FG000|Overall Study|Missing pre-treatment data|72|||
33487301|NCT01228019|101679497|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
33487302|NCT01228019|101679497|FG000|Overall Study|Violation of Entry Criterion|9|||
33487303|NCT04542057|101679498|FG000|Overall Study|Death|3|||
33487304|NCT04542057|101679499|FG001|Overall Study|Death|1|||
33487305|NCT04542057|101679498|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
33487306|NCT04542057|101679499|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
33487307|NCT04542057|101679498|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
33487308|NCT04542057|101679499|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
33487309|NCT04542057|101679498|FG000|Overall Study|Adverse Event|15|||
33487310|NCT04542057|101679499|FG001|Overall Study|Adverse Event|6|||
33487311|NCT04542057|101679498|FG000|Overall Study|COVID-19 adverse event|6|||
33487312|NCT04542057|101679499|FG001|Overall Study|COVID-19 adverse event|4|||
33487313|NCT04542057|101679498|FG000|Overall Study|Lack of Efficacy|2|||
33487314|NCT04542057|101679499|FG001|Overall Study|Lack of Efficacy|5|||
33487315|NCT04542057|101679498|FG000|Overall Study|Study terminated by sponsor|1|||
33487316|NCT04542057|101679499|FG001|Overall Study|Study terminated by sponsor|0|||
33487317|NCT04542057|101679498|FG000|Overall Study|Investigator discretion|2|||
33487318|NCT04542057|101679499|FG001|Overall Study|Investigator discretion|1|||
33487319|NCT04542057|101679498|FG000|Overall Study|Withdrawal by Subject|52|||
33487320|NCT04542057|101679499|FG001|Overall Study|Withdrawal by Subject|30|||
33487321|NCT04542057|101679498|FG000|Overall Study|Lost to Follow-up|8|||
33487322|NCT04542057|101679499|FG001|Overall Study|Lost to Follow-up|11|||
33487323|NCT04542057|101679498|FG000|Overall Study|Other|2|||
33487324|NCT04542057|101679499|FG001|Overall Study|Other|2|||
33487325|NCT02422797|101679500|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
33487326|NCT02422797|101679501|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
33487327|NCT02422797|101679500|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
33487328|NCT02422797|101679501|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
33487329|NCT02422797|101679500|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
33487330|NCT02422797|101679501|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
33487331|NCT02422797|101679500|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
33487332|NCT02422797|101679501|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
33487333|NCT02422797|101679500|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
33487334|NCT02422797|101679501|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
33487335|NCT02422797|101679500|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
33487336|NCT02422797|101679501|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
33487337|NCT02422797|101679500|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
33487338|NCT02422797|101679501|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
33487339|NCT02422797|101679500|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
33487340|NCT02422797|101679501|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
33487341|NCT02422797|101679500|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
33487342|NCT02422797|101679501|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
33487343|NCT02422797|101679500|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
33487344|NCT02422797|101679501|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
33487345|NCT02422797|101679500|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
33487346|NCT02422797|101679501|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
33487347|NCT02422797|101679500|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
33487348|NCT02422797|101679501|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
33487349|NCT02422797|101679500|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
33487350|NCT02422797|101679501|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
33487351|NCT02422797|101679500|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
33487352|NCT02422797|101679501|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
33487353|NCT02422797|101679500|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
33487354|NCT02422797|101679501|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
33487355|NCT02422797|101679500|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
33487356|NCT02422797|101679501|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
33487357|NCT02422797|101679500|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
33487358|NCT02422797|101679501|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
33487359|NCT02422797|101679500|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
33487360|NCT02422797|101679501|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
33487361|NCT02422797|101679500|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
33487362|NCT02422797|101679501|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
33487363|NCT02422797|101679500|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
33487364|NCT02422797|101679501|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
33487365|NCT02422797|101679500|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
33487366|NCT02422797|101679501|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
33487367|NCT01755091|101679502|FG000|Overall Study|Withdrawal by Subject|6|||
33487368|NCT01755091|101679503|FG001|Overall Study|Withdrawal by Subject|1|||
33487369|NCT01755091|101679504|FG002|Overall Study|Withdrawal by Subject|3|||
33487370|NCT01755091|101679502|FG000|Overall Study|Adverse Event|1|||
33487371|NCT01755091|101679503|FG001|Overall Study|Adverse Event|1|||
33487372|NCT01755091|101679504|FG002|Overall Study|Adverse Event|1|||
33487373|NCT01755091|101679502|FG000|Overall Study|Lost to Follow-up|1|||
33487374|NCT01755091|101679503|FG001|Overall Study|Lost to Follow-up|0|||
33487375|NCT01755091|101679504|FG002|Overall Study|Lost to Follow-up|1|||
33487376|NCT01755091|101679502|FG000|Overall Study|Physician Decision|1|||
33487377|NCT01755091|101679503|FG001|Overall Study|Physician Decision|1|||
33487378|NCT01755091|101679504|FG002|Overall Study|Physician Decision|2|||
33487379|NCT01994850|101679508|FG000|Overall Study|Physician Decision|1|||
33487380|NCT01994850|101679508|FG000|Overall Study|Withdrawal by Subject|1|||
33487381|NCT00362336|101679509|FG000|Overall Study|Serious Adverse Event|1|||
33487382|NCT00362336|101679510|FG001|Overall Study|Serious Adverse Event|0|||
33487383|NCT00362336|101679511|FG002|Overall Study|Serious Adverse Event|1|||
33487384|NCT00362336|101679509|FG000|Overall Study|Protocol Violation|0|||
33487385|NCT00362336|101679510|FG001|Overall Study|Protocol Violation|0|||
33282506|NCT00396097|100931000|FG001|Overall Study|Withdrawal by Subject|17|||
33487386|NCT00362336|101679511|FG002|Overall Study|Protocol Violation|1|||
33487387|NCT00362336|101679509|FG000|Overall Study|Lost to Follow-up|6|||
33487388|NCT00362336|101679510|FG001|Overall Study|Lost to Follow-up|4|||
33487389|NCT00362336|101679511|FG002|Overall Study|Lost to Follow-up|0|||
33487390|NCT00362336|101679509|FG000|Overall Study|Withdrawal by Subject|3|||
33487391|NCT00362336|101679510|FG001|Overall Study|Withdrawal by Subject|3|||
33487392|NCT00362336|101679511|FG002|Overall Study|Withdrawal by Subject|1|||
33487393|NCT01260701|101679514|FG000|Overall Study|Adverse Event|9|||
33487394|NCT01260701|101679514|FG000|Overall Study|Withdrawal by Subject|2|||
33487395|NCT01260701|101679514|FG000|Overall Study|Progression|53|||
33487396|NCT01260701|101679514|FG000|Overall Study|Death|2|||
33487397|NCT01260701|101679514|FG000|Overall Study|Not protocol specified|3|||
33487398|NCT01260701|101679514|FG000|Overall Study|Under review|1|||
33487399|NCT01260701|101679514|FG000|Overall Study|Ineligible|4|||
33487400|NCT01260701|101679514|FG000|Overall Study|Did not begin protocol therapy|1|||
33487401|NCT00996489|101679517|FG000|Overall Study|Device failure|45|||
33487402|NCT00996489|101679517|FG000|Overall Study|Discontinued|116|||
33487403|NCT01659125|101679518|FG000|Overall Study|Withdrawal by Subject|2|||
33487404|NCT01659125|101679518|FG000|Overall Study|Lost to Follow-up|7|||
33487405|NCT01659125|101679518|FG000|Overall Study|Technical Problem|1|||
33487406|NCT01659125|101679518|FG000|Overall Study|Time Constraints|2|||
33487407|NCT01659125|101679518|FG000|Overall Study|Failed to Start Treatment|2|||
33487408|NCT00456300|101679519|FG000|Overall Study|Adverse Event|1|||
33487409|NCT00456300|101679520|FG001|Overall Study|Adverse Event|0|||
33487410|NCT00299130|101679526|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
33487411|NCT00299130|101679527|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
33487412|NCT00299130|101679528|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
33487413|NCT00299130|101679526|FG000|Treatment Period (up to 5 Years)|Death|1|||
33487414|NCT00299130|101679527|FG001|Treatment Period (up to 5 Years)|Death|3|||
33487415|NCT00299130|101679528|FG002|Treatment Period (up to 5 Years)|Death|1|||
33487416|NCT00299130|101679526|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
33487417|NCT00299130|101679527|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
33487418|NCT00299130|101679528|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
33487419|NCT00299130|101679526|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
33487420|NCT00299130|101679527|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
33487421|NCT00299130|101679528|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
33487422|NCT00299130|101679526|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
33487423|NCT00299130|101679527|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
33487424|NCT00299130|101679528|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
33487425|NCT00299130|101679526|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
33487426|NCT00299130|101679527|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
33487427|NCT00299130|101679528|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
33487428|NCT00299130|101679526|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
33487429|NCT00299130|101679527|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
33487430|NCT00299130|101679528|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
33487431|NCT00299130|101679526|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
33487432|NCT00299130|101679527|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
33487433|NCT00299130|101679528|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
33487434|NCT00299130|101679526|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
33487435|NCT00299130|101679527|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
33487436|NCT00299130|101679528|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
33487437|NCT00299130|101679526|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
33487438|NCT00299130|101679527|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
33487439|NCT00299130|101679528|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
33487440|NCT00299130|101679526|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
33487441|NCT00299130|101679527|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
33487442|NCT00299130|101679528|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
33487443|NCT00299130|101679526|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
33487444|NCT00299130|101679527|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
33487445|NCT00299130|101679528|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
33487446|NCT00299130|101679526|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
33487447|NCT00299130|101679527|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
33487448|NCT00299130|101679528|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
33487449|NCT00299130|101679526|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
33487450|NCT00299130|101679527|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
33487451|NCT00299130|101679528|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
33487452|NCT00299130|101679526|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
33487453|NCT00299130|101679527|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
33487454|NCT00299130|101679528|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
33487455|NCT00299130|101679526|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
33487456|NCT00299130|101679527|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
33487457|NCT00299130|101679528|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
33487458|NCT00299130|101679526|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
33487459|NCT00299130|101679527|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
33487460|NCT00299130|101679528|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
33487461|NCT02964312|101679530|FG000|Overall Study|Lost to Follow-up|28|||
33487462|NCT02964312|101679530|FG000|Overall Study|Withdrawal by Subject|11|||
33487463|NCT02964312|101679530|FG000|Overall Study|Lack of Efficacy|10|||
33487464|NCT02964312|101679530|FG000|Overall Study|Did not consent to long-term FU|14|||
33487465|NCT02964312|101679530|FG000|Overall Study|Death|1|||
33487466|NCT00683657|101679535|FG000|Overall Study|Adverse Event|0|||
33487467|NCT00683657|101679536|FG001|Overall Study|Adverse Event|1|||
33487468|NCT00683657|101679535|FG000|Overall Study|Subject Withdrew Consent|1|||
33487469|NCT00683657|101679536|FG001|Overall Study|Subject Withdrew Consent|0|||
33487470|NCT03736031|101679537|FG000|Overall Study|Death|2|||
33487471|NCT03736031|101679538|FG001|Overall Study|Death|4|||
33487472|NCT03736031|101679537|FG000|Overall Study|Lost to Follow-up|21|||
33487473|NCT03736031|101679538|FG001|Overall Study|Lost to Follow-up|2|||
33487474|NCT03736031|101679537|FG000|Overall Study|Withdrawal by Subject|9|||
33487475|NCT03736031|101679538|FG001|Overall Study|Withdrawal by Subject|0|||
33487476|NCT03281876|101679539|FG000|Overall Study|Adverse Event|4|||
33487477|NCT03281876|101679540|FG001|Overall Study|Adverse Event|15|||
33487478|NCT03281876|101679539|FG000|Overall Study|Lost to Follow-up|1|||
33487479|NCT03281876|101679540|FG001|Overall Study|Lost to Follow-up|4|||
33487480|NCT03281876|101679539|FG000|Overall Study|Withdrawal by Subject|11|||
33487481|NCT03281876|101679540|FG001|Overall Study|Withdrawal by Subject|15|||
33487482|NCT03281876|101679539|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
33487483|NCT03281876|101679540|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
33487484|NCT03281876|101679539|FG000|Overall Study|OTHER|5|||
33487485|NCT03281876|101679540|FG001|Overall Study|OTHER|5|||
33487486|NCT03323398|101679545|FG000|Overall Study|Other than Specified|0|||
33487487|NCT03323398|101679546|FG001|Overall Study|Other than Specified|1|||
33487488|NCT03323398|101679547|FG002|Overall Study|Other than Specified|2|||
33487489|NCT03323398|101679548|FG003|Overall Study|Other than Specified|0|||
33487490|NCT03323398|101679549|FG004|Overall Study|Other than Specified|0|||
33487491|NCT03323398|101679550|FG005|Overall Study|Other than Specified|0|||
33487492|NCT03323398|101679551|FG006|Overall Study|Other than Specified|1|||
33487493|NCT03323398|101679552|FG007|Overall Study|Other than Specified|0|||
33487494|NCT03323398|101679553|FG008|Overall Study|Other than Specified|2|||
33487495|NCT03323398|101679545|FG000|Overall Study|Lost to Follow-up|1|||
33487496|NCT03323398|101679546|FG001|Overall Study|Lost to Follow-up|2|||
33487497|NCT03323398|101679547|FG002|Overall Study|Lost to Follow-up|1|||
33487498|NCT03323398|101679548|FG003|Overall Study|Lost to Follow-up|0|||
33487499|NCT03323398|101679549|FG004|Overall Study|Lost to Follow-up|0|||
33487500|NCT03323398|101679550|FG005|Overall Study|Lost to Follow-up|0|||
33487501|NCT03323398|101679551|FG006|Overall Study|Lost to Follow-up|0|||
33487502|NCT03323398|101679552|FG007|Overall Study|Lost to Follow-up|0|||
33487503|NCT03323398|101679553|FG008|Overall Study|Lost to Follow-up|0|||
33487504|NCT03323398|101679545|FG000|Overall Study|Death|4|||
33487505|NCT03323398|101679546|FG001|Overall Study|Death|6|||
33487506|NCT03323398|101679547|FG002|Overall Study|Death|2|||
33487507|NCT03323398|101679548|FG003|Overall Study|Death|2|||
33487508|NCT03323398|101679549|FG004|Overall Study|Death|1|||
33487509|NCT03323398|101679550|FG005|Overall Study|Death|2|||
33487510|NCT03323398|101679551|FG006|Overall Study|Death|0|||
33487511|NCT03323398|101679552|FG007|Overall Study|Death|0|||
33487512|NCT03323398|101679553|FG008|Overall Study|Death|6|||
33487513|NCT03323398|101679545|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
33487514|NCT03323398|101679546|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
33487515|NCT03323398|101679547|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
33487516|NCT03323398|101679548|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
33487517|NCT03323398|101679549|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
33282507|NCT00396097|100930999|FG000|Overall Study|Lost to Follow-up|4|||
33487518|NCT03323398|101679550|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
33487519|NCT03323398|101679551|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
33487520|NCT03323398|101679552|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
33487521|NCT03323398|101679553|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
33487522|NCT03323398|101679545|FG000|Overall Study|Withdrawal by Subject|2|||
33487523|NCT03323398|101679546|FG001|Overall Study|Withdrawal by Subject|1|||
33487524|NCT03323398|101679547|FG002|Overall Study|Withdrawal by Subject|3|||
33487525|NCT03323398|101679548|FG003|Overall Study|Withdrawal by Subject|0|||
33487526|NCT03323398|101679549|FG004|Overall Study|Withdrawal by Subject|0|||
33487527|NCT03323398|101679550|FG005|Overall Study|Withdrawal by Subject|1|||
33487528|NCT03323398|101679551|FG006|Overall Study|Withdrawal by Subject|0|||
33282508|NCT00396097|100931000|FG001|Overall Study|Lost to Follow-up|9|||
33282509|NCT00396097|100930999|FG000|Overall Study|Other|3|||
33487529|NCT03323398|101679552|FG007|Overall Study|Withdrawal by Subject|0|||
33487530|NCT03323398|101679553|FG008|Overall Study|Withdrawal by Subject|0|||
33487531|NCT03323398|101679545|FG000|Overall Study|Participant was Put on Hospice|0|||
33487532|NCT03323398|101679546|FG001|Overall Study|Participant was Put on Hospice|0|||
33487533|NCT03323398|101679547|FG002|Overall Study|Participant was Put on Hospice|0|||
33487534|NCT03323398|101679548|FG003|Overall Study|Participant was Put on Hospice|0|||
33487535|NCT03323398|101679549|FG004|Overall Study|Participant was Put on Hospice|0|||
33487536|NCT03323398|101679550|FG005|Overall Study|Participant was Put on Hospice|0|||
33487537|NCT03323398|101679551|FG006|Overall Study|Participant was Put on Hospice|1|||
33487538|NCT03323398|101679552|FG007|Overall Study|Participant was Put on Hospice|0|||
33487539|NCT03323398|101679553|FG008|Overall Study|Participant was Put on Hospice|0|||
33487540|NCT03323398|101679545|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
33487541|NCT03323398|101679546|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
33487542|NCT03323398|101679547|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
33487543|NCT03323398|101679548|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
33487544|NCT03323398|101679549|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
33487545|NCT03323398|101679550|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
33487546|NCT03323398|101679551|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
33487547|NCT03323398|101679552|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
33487548|NCT03323398|101679553|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
33487549|NCT00345631|101679554|FG000|Overall Study|Withdrawal by Subject|1|||
33487550|NCT00345631|101679555|FG001|Overall Study|Withdrawal by Subject|0|||
33487551|NCT00345631|101679556|FG002|Overall Study|Withdrawal by Subject|1|||
33487552|NCT00345631|101679554|FG000|Overall Study|Adverse Event|0|||
33487553|NCT00345631|101679555|FG001|Overall Study|Adverse Event|1|||
33487554|NCT00345631|101679556|FG002|Overall Study|Adverse Event|0|||
33487555|NCT00345631|101679554|FG000|Overall Study|Lost to Follow-up|3|||
33487556|NCT00345631|101679555|FG001|Overall Study|Lost to Follow-up|7|||
33487557|NCT00345631|101679556|FG002|Overall Study|Lost to Follow-up|4|||
33487558|NCT00345631|101679554|FG000|Overall Study|Other reasons|0|||
33487559|NCT00345631|101679555|FG001|Overall Study|Other reasons|0|||
33487560|NCT00345631|101679556|FG002|Overall Study|Other reasons|1|||
33487561|NCT02652949|101679565|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
33487562|NCT02652949|101679565|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
33487563|NCT02652949|101679565|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
33487564|NCT02652949|101679565|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
33487565|NCT02652949|101679565|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
33487566|NCT02652949|101679565|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
33487567|NCT02652949|101679565|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
33487568|NCT02652949|101679565|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
33487569|NCT02652949|101679565|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
33487570|NCT02652949|101679565|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
33487571|NCT02652949|101679565|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
33487572|NCT02652949|101679565|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
33487573|NCT02652949|101679565|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
33487574|NCT02652949|101679565|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
33487575|NCT02652949|101679565|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
33487576|NCT02652949|101679565|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
33487577|NCT02652949|101679565|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
33487578|NCT02899195|101679569|FG000|Concurrent Durvalumab|Adverse Event|4|||
33487579|NCT02899195|101679569|FG000|Concurrent Durvalumab|Physician Decision|1|||
33487580|NCT02899195|101679569|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
33487581|NCT02899195|101679569|FG000|Concurrent Durvalumab|Progressive Disease|5|||
33487582|NCT02899195|101679569|FG000|Maintenance Durvalumab|Adverse Event|1|||
33487583|NCT02899195|101679569|FG000|Maintenance Durvalumab|Physician Decision|1|||
33487584|NCT02899195|101679569|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
33487585|NCT02899195|101679569|FG000|Maintenance Durvalumab|Progressive Disease|31|||
33487586|NCT00948155|101679570|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
33487587|NCT00948155|101679571|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
33487588|NCT00948155|101679570|FG000|Washout 14 Days|Lost to Follow-up|1|||
33487589|NCT00948155|101679571|FG001|Washout 14 Days|Lost to Follow-up|2|||
33487590|NCT00258960|101679572|FG000|Overall Study|Death|2|||
33487591|NCT00258960|101679572|FG000|Overall Study|Disease Progression|7|||
33487592|NCT00258960|101679572|FG000|Overall Study|Adverse Event|4|||
33487593|NCT00258960|101679572|FG000|Overall Study|Physician Decision|1|||
33487594|NCT00258960|101679572|FG000|Overall Study|Withdrawal by Subject|1|||
33487595|NCT00258960|101679572|FG000|Overall Study|Mistake|2|||
33487596|NCT02215967|101679573|FG000|Overall Study|Patient became ineligible for treatment|0|||
33487597|NCT02215967|101679574|FG001|Overall Study|Patient became ineligible for treatment|0|||
33487598|NCT02215967|101679575|FG002|Overall Study|Patient became ineligible for treatment|0|||
33487599|NCT02215967|101679576|FG003|Overall Study|Patient became ineligible for treatment|3|||
33487600|NCT02215967|101679573|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
33487601|NCT02215967|101679574|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
33487602|NCT02215967|101679575|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
33487603|NCT02215967|101679576|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
33487604|NCT01461538|101679580|FG000|Overall Study|Death|15|||
33487605|NCT01461538|101679581|FG001|Overall Study|Death|6|||
33487606|NCT01461538|101679582|FG002|Overall Study|Death|2|||
33487607|NCT01461538|101679580|FG000|Overall Study|Study Stopped by Sponsor|2|||
33487608|NCT01461538|101679581|FG001|Overall Study|Study Stopped by Sponsor|1|||
33487609|NCT01461538|101679582|FG002|Overall Study|Study Stopped by Sponsor|0|||
33487610|NCT01461538|101679580|FG000|Overall Study|Withdrawal by Subject|1|||
33487611|NCT01461538|101679581|FG001|Overall Study|Withdrawal by Subject|1|||
33487612|NCT01461538|101679582|FG002|Overall Study|Withdrawal by Subject|0|||
33487613|NCT02729909|101679584|FG000|Overall Study|Lost to Follow-up|0|||
33487614|NCT02729909|101679585|FG001|Overall Study|Lost to Follow-up|1|||
33487615|NCT02729909|101679584|FG000|Overall Study|Lack of Efficacy|0|||
33487616|NCT02729909|101679585|FG001|Overall Study|Lack of Efficacy|2|||
33487617|NCT02729909|101679584|FG000|Overall Study|Significant Protocol Deviation|0|||
33487618|NCT02729909|101679585|FG001|Overall Study|Significant Protocol Deviation|2|||
33487619|NCT02729909|101679584|FG000|Overall Study|Voluntary Withdrawal|1|||
33487620|NCT02729909|101679585|FG001|Overall Study|Voluntary Withdrawal|0|||
33487621|NCT01427608|101679586|FG000|Overall Study|Death|1|||
33487622|NCT01427608|101679587|FG001|Overall Study|Death|0|||
33487623|NCT01427608|101679586|FG000|Overall Study|Withdrawal by Subject|7|||
33487624|NCT01427608|101679587|FG001|Overall Study|Withdrawal by Subject|3|||
33487625|NCT01427608|101679586|FG000|Overall Study|Relapsed-all cause|13|||
33487626|NCT01427608|101679587|FG001|Overall Study|Relapsed-all cause|34|||
33487627|NCT01427608|101679586|FG000|Overall Study|Events not attributed to study meds|0|||
33487628|NCT01427608|101679587|FG001|Overall Study|Events not attributed to study meds|1|||
33487629|NCT00852202|101679588|FG000|Overall Study|Adverse Event|2|||
33487630|NCT00852202|101679589|FG001|Overall Study|Adverse Event|3|||
33487631|NCT00852202|101679590|FG002|Overall Study|Adverse Event|7|||
33487632|NCT00852202|101679588|FG000|Overall Study|Lack of Efficacy|4|||
33487633|NCT00852202|101679589|FG001|Overall Study|Lack of Efficacy|1|||
33487634|NCT00852202|101679590|FG002|Overall Study|Lack of Efficacy|2|||
33487635|NCT00852202|101679588|FG000|Overall Study|Protocol Violation|2|||
33487636|NCT00852202|101679589|FG001|Overall Study|Protocol Violation|2|||
33487637|NCT00852202|101679590|FG002|Overall Study|Protocol Violation|7|||
33487638|NCT00852202|101679588|FG000|Overall Study|Withdrawal by Subject|3|||
33487639|NCT00852202|101679589|FG001|Overall Study|Withdrawal by Subject|1|||
33487640|NCT00852202|101679590|FG002|Overall Study|Withdrawal by Subject|2|||
33487641|NCT00852202|101679588|FG000|Overall Study|Lost to Follow-up|5|||
33487642|NCT00852202|101679589|FG001|Overall Study|Lost to Follow-up|5|||
33487643|NCT00852202|101679590|FG002|Overall Study|Lost to Follow-up|6|||
33487644|NCT00852202|101679588|FG000|Overall Study|pregnancy,moving away and surgery|1|||
33487645|NCT00852202|101679589|FG001|Overall Study|pregnancy,moving away and surgery|0|||
33487646|NCT00852202|101679590|FG002|Overall Study|pregnancy,moving away and surgery|2|||
33487647|NCT02201784|101679591|FG000|Overall Study|Failure to achieve adequate block|2|||
33487648|NCT02201784|101679592|FG001|Overall Study|Failure to achieve adequate block|0|||
33487649|NCT01557517|101679594|FG000|Overall Study|Death|1|||
33487650|NCT01557517|101679595|FG001|Overall Study|Death|0|||
33487651|NCT01557517|101679594|FG000|Overall Study|Refused further treatment|0|||
33487652|NCT01557517|101679595|FG001|Overall Study|Refused further treatment|2|||
33487653|NCT01557517|101679594|FG000|Overall Study|Adverse Event|0|||
33487654|NCT01557517|101679595|FG001|Overall Study|Adverse Event|2|||
33487655|NCT01557517|101679594|FG000|Overall Study|Pt declined before treatment started|1|||
33487656|NCT01557517|101679595|FG001|Overall Study|Pt declined before treatment started|0|||
33487657|NCT02861014|101679596|FG000|Primary Analysis|Adverse Event|7|||
33487658|NCT02861014|101679596|FG000|Primary Analysis|Death|1|||
33487659|NCT02861014|101679596|FG000|Primary Analysis|Lack of Efficacy|3|||
33487660|NCT02861014|101679596|FG000|Primary Analysis|Physician Decision|2|||
33487661|NCT02861014|101679596|FG000|Primary Analysis|Pregnancy|4|||
33487662|NCT02861014|101679596|FG000|Primary Analysis|Protocol Violation|2|||
33487663|NCT02861014|101679596|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
33487664|NCT02861014|101679596|FG000|Primary Analysis|Withdrawal by Subject|14|||
33487665|NCT02861014|101679596|FG000|Primary Analysis|Commercial ocrelizumab|3|||
33487666|NCT02861014|101679596|FG000|Safety Follow-up|Adverse Event|1|||
33487667|NCT02861014|101679596|FG000|Safety Follow-up|Pregnancy|1|||
33487668|NCT02861014|101679596|FG000|Safety Follow-up|Withdrawal by Subject|9|||
33487669|NCT02861014|101679596|FG000|Safety Follow-up|Study terminated by sponsor|1|||
33487670|NCT02861014|101679596|FG000|Safety Follow-up|Physician Decision|1|||
33487671|NCT02861014|101679596|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
33487672|NCT02861014|101679596|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
33487673|NCT01284361|101679597|FG000|Overall Study|Withdrawal by Subject|1|||
33487674|NCT01284361|101679597|FG000|Overall Study|Protocol Violation|5|||
33487675|NCT01284361|101679597|FG000|Overall Study|Adverse Event|1|||
33487676|NCT01284361|101679597|FG000|Overall Study|Lost to Follow-up|2|||
33487677|NCT03645863|101679598|FG000|Overall Study|Withdrawal by Subject|1|||
33487678|NCT03645863|101679599|FG001|Overall Study|Withdrawal by Subject|0|||
33487679|NCT03645863|101679600|FG002|Overall Study|Withdrawal by Subject|0|||
33487680|NCT01911273|101679603|FG000|Overall Study|Progression of Disease|1|||
33487681|NCT01911273|101679604|FG001|Overall Study|Progression of Disease|0|||
33487682|NCT01911273|101679603|FG000|Overall Study|Withdrawal by Subject|0|||
33487683|NCT01911273|101679604|FG001|Overall Study|Withdrawal by Subject|2|||
33487684|NCT03142191|101679605|FG000|Placebo Controlled Period|Death|0|||
33487685|NCT03142191|101679606|FG001|Placebo Controlled Period|Death|1|||
33487686|NCT03142191|101679607|FG002|Placebo Controlled Period|Death|1|||
33487687|NCT03142191|101679608|FG003|Placebo Controlled Period|Death|0|||
33487688|NCT03142191|101679609|FG004|Placebo Controlled Period|Death|0|||
33487689|NCT03142191|101679605|FG000|Placebo Controlled Period|Adverse Event|4|||
33487690|NCT03142191|101679606|FG001|Placebo Controlled Period|Adverse Event|5|||
33487691|NCT03142191|101679607|FG002|Placebo Controlled Period|Adverse Event|1|||
33487692|NCT03142191|101679608|FG003|Placebo Controlled Period|Adverse Event|0|||
33487693|NCT03142191|101679609|FG004|Placebo Controlled Period|Adverse Event|0|||
33487694|NCT03142191|101679605|FG000|Placebo Controlled Period|Progressive Disease|1|||
33487695|NCT03142191|101679606|FG001|Placebo Controlled Period|Progressive Disease|0|||
33487696|NCT03142191|101679607|FG002|Placebo Controlled Period|Progressive Disease|1|||
33487697|NCT03142191|101679608|FG003|Placebo Controlled Period|Progressive Disease|0|||
33487698|NCT03142191|101679609|FG004|Placebo Controlled Period|Progressive Disease|0|||
33487699|NCT03142191|101679605|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
33487700|NCT03142191|101679606|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
33487701|NCT03142191|101679607|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
33487702|NCT03142191|101679608|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
33487703|NCT03142191|101679609|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
33487704|NCT03142191|101679605|FG000|Placebo Controlled Period|Other Reasons|1|||
33487705|NCT03142191|101679606|FG001|Placebo Controlled Period|Other Reasons|0|||
33487706|NCT03142191|101679607|FG002|Placebo Controlled Period|Other Reasons|0|||
33487707|NCT03142191|101679608|FG003|Placebo Controlled Period|Other Reasons|0|||
33487708|NCT03142191|101679609|FG004|Placebo Controlled Period|Other Reasons|0|||
33487709|NCT03142191|101679605|FG000|Active Treatment Extension Period|Death|2|||
33487710|NCT03142191|101679606|FG001|Active Treatment Extension Period|Death|1|||
33487711|NCT03142191|101679607|FG002|Active Treatment Extension Period|Death|1|||
33487712|NCT03142191|101679608|FG003|Active Treatment Extension Period|Death|1|||
33487713|NCT03142191|101679609|FG004|Active Treatment Extension Period|Death|0|||
33487714|NCT03142191|101679605|FG000|Active Treatment Extension Period|Adverse Event|6|||
33487715|NCT03142191|101679606|FG001|Active Treatment Extension Period|Adverse Event|5|||
33487716|NCT03142191|101679607|FG002|Active Treatment Extension Period|Adverse Event|4|||
33487717|NCT03142191|101679608|FG003|Active Treatment Extension Period|Adverse Event|1|||
33487718|NCT03142191|101679609|FG004|Active Treatment Extension Period|Adverse Event|0|||
33487719|NCT03142191|101679605|FG000|Active Treatment Extension Period|Progressive Disease|10|||
33487720|NCT03142191|101679606|FG001|Active Treatment Extension Period|Progressive Disease|5|||
33487721|NCT03142191|101679607|FG002|Active Treatment Extension Period|Progressive Disease|4|||
33487722|NCT03142191|101679608|FG003|Active Treatment Extension Period|Progressive Disease|1|||
33487723|NCT03142191|101679609|FG004|Active Treatment Extension Period|Progressive Disease|2|||
33487724|NCT03142191|101679605|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
33487725|NCT03142191|101679606|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
33487726|NCT03142191|101679607|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
33487727|NCT03142191|101679608|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
33487728|NCT03142191|101679609|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
33487729|NCT03142191|101679605|FG000|Active Treatment Extension Period|Physician Decision|2|||
33487730|NCT03142191|101679606|FG001|Active Treatment Extension Period|Physician Decision|0|||
33487731|NCT03142191|101679607|FG002|Active Treatment Extension Period|Physician Decision|0|||
33487732|NCT03142191|101679608|FG003|Active Treatment Extension Period|Physician Decision|0|||
33487733|NCT03142191|101679609|FG004|Active Treatment Extension Period|Physician Decision|0|||
33487734|NCT03142191|101679605|FG000|Active Treatment Extension Period|Other Reasons|3|||
33487735|NCT03142191|101679606|FG001|Active Treatment Extension Period|Other Reasons|3|||
33487736|NCT03142191|101679607|FG002|Active Treatment Extension Period|Other Reasons|3|||
33487737|NCT03142191|101679608|FG003|Active Treatment Extension Period|Other Reasons|8|||
33487738|NCT03142191|101679609|FG004|Active Treatment Extension Period|Other Reasons|3|||
33487739|NCT03142191|101679605|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
33487740|NCT03142191|101679606|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
33487741|NCT03142191|101679607|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
33487742|NCT03142191|101679608|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
33487743|NCT03142191|101679609|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
33487744|NCT00445146|101679611|FG000|Overall Study|Withdrew Consent|29|||
33487745|NCT00445146|101679611|FG000|Overall Study|Lack of Efficacy|28|||
33487746|NCT00445146|101679611|FG000|Overall Study|Investigator's Discretion|22|||
33487747|NCT00445146|101679611|FG000|Overall Study|Adverse Event|13|||
33487748|NCT00445146|101679611|FG000|Overall Study|Lost to Follow-up|13|||
33487749|NCT00445146|101679611|FG000|Overall Study|Death|9|||
33487750|NCT00445146|101679611|FG000|Overall Study|Protocol Violation|4|||
33487751|NCT00445146|101679611|FG000|Overall Study|Pregnancy|1|||
33487752|NCT03717012|101679613|FG000|Overall Study|Due to trial termination|1|||
33487753|NCT03717012|101679614|FG001|Overall Study|Due to trial termination|2|||
33487754|NCT03717012|101679613|FG000|Overall Study|Protocol Violation|0|||
33487755|NCT03717012|101679614|FG001|Overall Study|Protocol Violation|2|||
33487756|NCT03717012|101679613|FG000|Overall Study|Adverse Event|0|||
33487757|NCT03717012|101679614|FG001|Overall Study|Adverse Event|1|||
33487758|NCT03717012|101679613|FG000|Overall Study|Lung transplant|0|||
33487759|NCT03717012|101679614|FG001|Overall Study|Lung transplant|1|||
33487760|NCT02123446|101679615|FG000|Washout Period (1 Day)|Physician Decision|1|||
33487761|NCT02123446|101679616|FG001|Washout Period (1 Day)|Physician Decision|0|||
33487762|NCT01625988|101679617|FG000|Overall Study|Lost to Follow-up|5|||
33487763|NCT01625988|101679618|FG001|Overall Study|Lost to Follow-up|6|||
33487764|NCT01625988|101679617|FG000|Overall Study|Withdrawal by Subject|8|||
33487765|NCT01625988|101679618|FG001|Overall Study|Withdrawal by Subject|3|||
33487766|NCT01625988|101679617|FG000|Overall Study|Adverse Event|0|||
33487767|NCT01625988|101679618|FG001|Overall Study|Adverse Event|1|||
33487768|NCT01625988|101679617|FG000|Overall Study|Lack of Efficacy|0|||
33487769|NCT01625988|101679618|FG001|Overall Study|Lack of Efficacy|1|||
33487770|NCT01625988|101679617|FG000|Overall Study|Randomized Inappropriately|1|||
33487771|NCT01625988|101679618|FG001|Overall Study|Randomized Inappropriately|0|||
33487772|NCT01625988|101679617|FG000|Overall Study|Protocol Violation|0|||
33487773|NCT01625988|101679618|FG001|Overall Study|Protocol Violation|2|||
33487774|NCT00402116|101679620|FG000|Overall Study|Jaw infection after surgery-other|1|||
33487775|NCT00402116|101679621|FG001|Overall Study|Jaw infection after surgery-other|0|||
33487776|NCT00402116|101679622|FG002|Overall Study|Jaw infection after surgery-other|0|||
33487777|NCT00402116|101679620|FG000|Overall Study|Withdrawal by Subject|1|||
33487778|NCT00402116|101679621|FG001|Overall Study|Withdrawal by Subject|0|||
33487779|NCT00402116|101679622|FG002|Overall Study|Withdrawal by Subject|5|||
33487780|NCT00402116|101679620|FG000|Overall Study|Treatment completed per protocol|1|||
33487781|NCT00402116|101679621|FG001|Overall Study|Treatment completed per protocol|1|||
33487782|NCT00402116|101679622|FG002|Overall Study|Treatment completed per protocol|2|||
33487783|NCT00402116|101679620|FG000|Overall Study|other complicating disease|0|||
33487784|NCT00402116|101679621|FG001|Overall Study|other complicating disease|0|||
33487785|NCT00402116|101679622|FG002|Overall Study|other complicating disease|2|||
33487786|NCT00402116|101679620|FG000|Overall Study|Disease Progression|0|||
33487787|NCT00402116|101679621|FG001|Overall Study|Disease Progression|4|||
33487788|NCT00402116|101679622|FG002|Overall Study|Disease Progression|38|||
33487789|NCT00402116|101679620|FG000|Overall Study|mistaken thrombocytopenia|0|||
33487790|NCT00402116|101679621|FG001|Overall Study|mistaken thrombocytopenia|0|||
33487791|NCT00402116|101679622|FG002|Overall Study|mistaken thrombocytopenia|1|||
33487792|NCT00402116|101679620|FG000|Overall Study|decline related hyponatremia/tumor|0|||
33487793|NCT00402116|101679621|FG001|Overall Study|decline related hyponatremia/tumor|0|||
33487794|NCT00402116|101679622|FG002|Overall Study|decline related hyponatremia/tumor|1|||
33487795|NCT00402116|101679620|FG000|Overall Study|Adverse Event|0|||
33487796|NCT00402116|101679621|FG001|Overall Study|Adverse Event|1|||
33487797|NCT00402116|101679622|FG002|Overall Study|Adverse Event|6|||
33487798|NCT01128543|101679635|FG000|Overall Study|Withdrawal by Subject|3|||
33487799|NCT01128543|101679635|FG000|Overall Study|Protocol Violation|1|||
33487800|NCT03076775|101679636|FG000|Overall Study|Lost to Follow-up|1|||
33487801|NCT03076775|101679637|FG001|Overall Study|Lost to Follow-up|0|||
33487802|NCT00972595|101679638|FG000|Period 1|Adverse Event|1|||
33487803|NCT00972595|101679639|FG001|Period 1|Adverse Event|0|||
33487804|NCT03280381|101679645|FG000|Overall Study|Physician Decision|0|||
33487805|NCT03280381|101679646|FG001|Overall Study|Physician Decision|2|||
33487806|NCT03573830|101679647|FG000|Overall Study|Dropped without completing treatment|0|||
33487807|NCT03573830|101679648|FG001|Overall Study|Dropped without completing treatment|7|||
33487808|NCT03573830|101679647|FG000|Overall Study|Lost to Follow-up|4|||
33487809|NCT03573830|101679648|FG001|Overall Study|Lost to Follow-up|0|||
33487810|NCT00489255|101679649|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
33487811|NCT00489255|101679650|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
33487812|NCT00489255|101679649|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
33487813|NCT00489255|101679650|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
33487814|NCT00489255|101679649|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
33487815|NCT00489255|101679650|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
33487816|NCT00489255|101679649|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
33487817|NCT00489255|101679650|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
33487818|NCT00489255|101679649|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
33487819|NCT00489255|101679650|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
33487820|NCT00489255|101679649|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
33487821|NCT00489255|101679650|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
33487822|NCT00489255|101679649|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
33487823|NCT00489255|101679650|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
33487824|NCT00489255|101679649|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
33487825|NCT00489255|101679650|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
33487826|NCT00489255|101679649|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
33487827|NCT00489255|101679650|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
33487828|NCT00489255|101679649|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
33487829|NCT00489255|101679650|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
33487830|NCT02533180|101679653|FG000|Overall Study|Death|0|||
33487831|NCT02533180|101679654|FG001|Overall Study|Death|2|||
33487832|NCT02533180|101679653|FG000|Overall Study|Lost to Follow-up|0|||
33487833|NCT02533180|101679654|FG001|Overall Study|Lost to Follow-up|1|||
33487834|NCT02533180|101679653|FG000|Overall Study|Physician Decision|0|||
33487835|NCT02533180|101679654|FG001|Overall Study|Physician Decision|1|||
33487836|NCT02533180|101679653|FG000|Overall Study|Withdrawal by Subject|2|||
33487837|NCT02533180|101679654|FG001|Overall Study|Withdrawal by Subject|5|||
33487838|NCT02533180|101679653|FG000|Overall Study|Screen Failure|37|||
33487839|NCT02533180|101679654|FG001|Overall Study|Screen Failure|0|||
33487840|NCT02533180|101679653|FG000|Overall Study|Protocol Deviation|0|||
33487841|NCT02533180|101679654|FG001|Overall Study|Protocol Deviation|1|||
33487842|NCT02533180|101679653|FG000|Overall Study|Non-compliance|0|||
33487843|NCT02533180|101679654|FG001|Overall Study|Non-compliance|1|||
33487844|NCT01256502|101679660|FG000|Overall Study|Had scaffold removed|4|||
33487845|NCT01256502|101679660|FG000|Overall Study|Personal reasons|5|||
33487846|NCT01256502|101679660|FG000|Overall Study|Protocol deviation|1|||
33487847|NCT03071276|101679661|FG000|Overall Study|Adverse Event|1|||
33487848|NCT03071276|101679661|FG000|Overall Study|Lack of Efficacy|14|||
33487849|NCT01682811|101679664|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
33487850|NCT01682811|101679665|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
33487851|NCT01682811|101679666|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
33487852|NCT01682811|101679667|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
33487853|NCT01682811|101679668|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
33487854|NCT01682811|101679669|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
33487855|NCT01682811|101679670|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
33487856|NCT01682811|101679664|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
33487857|NCT01682811|101679665|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
33487858|NCT01682811|101679666|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
33487859|NCT01682811|101679667|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
33487860|NCT01682811|101679668|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
33487861|NCT01682811|101679669|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
33487862|NCT01682811|101679670|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
33487863|NCT01682811|101679664|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
33487864|NCT01682811|101679665|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
33487865|NCT01682811|101679666|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
33487866|NCT01682811|101679667|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
33487867|NCT01682811|101679668|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
33487868|NCT01682811|101679669|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
33487869|NCT01682811|101679670|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
33487870|NCT01682811|101679664|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
33487871|NCT01682811|101679665|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
33487872|NCT01682811|101679666|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
33487873|NCT01682811|101679667|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
33487874|NCT01682811|101679668|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
33487875|NCT01682811|101679669|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
33487876|NCT01682811|101679670|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
33487877|NCT04138043|101679671|FG000|Overall Study|Withdrawal by Subject|0|||
33487878|NCT04138043|101679672|FG001|Overall Study|Withdrawal by Subject|1|||
33487879|NCT00658879|101679681|FG000|Overall Study|Protocol Violation|1|||
33487880|NCT01420965|101679682|FG000|Overall Study|Withdrawal by Subject|1|||
33487881|NCT01420965|101679683|FG001|Overall Study|Withdrawal by Subject|0|||
33487882|NCT01420965|101679684|FG002|Overall Study|Withdrawal by Subject|0|||
33487883|NCT01420965|101679682|FG000|Overall Study|Adverse Event|0|||
33487884|NCT01420965|101679683|FG001|Overall Study|Adverse Event|1|||
33487885|NCT01420965|101679684|FG002|Overall Study|Adverse Event|0|||
33487886|NCT02463357|101679685|FG000|Overall Study|Withdrawal by Subject|1|||
33487887|NCT02463357|101679686|FG001|Overall Study|Withdrawal by Subject|0|||
33487888|NCT02463357|101679687|FG002|Overall Study|Withdrawal by Subject|0|||
33487889|NCT02463357|101679688|FG003|Overall Study|Withdrawal by Subject|0|||
33487890|NCT02463357|101679689|FG004|Overall Study|Withdrawal by Subject|0|||
33487891|NCT02463357|101679685|FG000|Overall Study|Withdrawal by Subject|0|||
33487892|NCT02463357|101679686|FG001|Overall Study|Withdrawal by Subject|0|||
33487893|NCT02463357|101679687|FG002|Overall Study|Withdrawal by Subject|0|||
33487894|NCT02463357|101679688|FG003|Overall Study|Withdrawal by Subject|0|||
33487895|NCT02463357|101679689|FG004|Overall Study|Withdrawal by Subject|1|||
33487896|NCT02481869|101679708|FG000|Overall Study|Lost to Follow-up|3|||
33487897|NCT02481869|101679709|FG001|Overall Study|Lost to Follow-up|4|||
33487898|NCT02481869|101679708|FG000|Overall Study|Withdrawal by Subject|2|||
33487899|NCT02481869|101679709|FG001|Overall Study|Withdrawal by Subject|0|||
33487900|NCT00378573|101679711|FG000|Treatment Period|Adverse Event|9|||
33487901|NCT00378573|101679711|FG000|Treatment Period|Physician Decision|1|||
33487902|NCT00378573|101679711|FG000|Treatment Period|Withdrawal by Subject|2|||
33487903|NCT00378573|101679711|FG000|Treatment Period|Disease Progression|4|||
33487904|NCT00378573|101679711|FG000|Treatment Period|Sponsor decision to close study|1|||
33487905|NCT00378573|101679711|FG000|Follow-up|Death|12|||
33487906|NCT00378573|101679711|FG000|Follow-up|Lost to Follow-up|1|||
33487907|NCT00378573|101679711|FG000|Follow-up|Withdrawal by Subject|1|||
33487908|NCT00447876|101679712|FG000|Overall Study|Withdrawal by Subject|1|||
33487909|NCT00447876|101679713|FG001|Overall Study|Withdrawal by Subject|4|||
33487910|NCT00447876|101679712|FG000|Overall Study|Lost to Follow-up|1|||
33487911|NCT00447876|101679713|FG001|Overall Study|Lost to Follow-up|0|||
33487912|NCT00447876|101679712|FG000|Overall Study|Deterioration of symptomology|1|||
33487913|NCT00447876|101679713|FG001|Overall Study|Deterioration of symptomology|0|||
33487914|NCT04778904|101679717|FG000|Overall Study|Protocol Violation|1|||
33487915|NCT04778904|101679718|FG001|Overall Study|Protocol Violation|0|||
33487916|NCT04778904|101679719|FG002|Overall Study|Protocol Violation|0|||
33487917|NCT04778904|101679720|FG003|Overall Study|Protocol Violation|0|||
33487918|NCT04778904|101679717|FG000|Overall Study|Withdrawal by Subject|0|||
33487919|NCT04778904|101679718|FG001|Overall Study|Withdrawal by Subject|0|||
33487920|NCT04778904|101679719|FG002|Overall Study|Withdrawal by Subject|1|||
33487921|NCT04778904|101679720|FG003|Overall Study|Withdrawal by Subject|0|||
33487922|NCT02905032|101679721|FG000|Overall Study|Withdrawal by Subject|2|||
33487923|NCT02905032|101679722|FG001|Overall Study|Withdrawal by Subject|0|||
33487924|NCT02905032|101679723|FG002|Overall Study|Withdrawal by Subject|0|||
33487925|NCT02905032|101679721|FG000|Overall Study|Protocol Violation|6|||
33487926|NCT02905032|101679722|FG001|Overall Study|Protocol Violation|12|||
33487927|NCT02905032|101679723|FG002|Overall Study|Protocol Violation|0|||
33487928|NCT00794339|101679728|FG000|Overall Study|Withdrawal by Subject|3|||
33487929|NCT00794339|101679728|FG000|Overall Study|Ineligible|4|||
33487930|NCT00794339|101679728|FG000|Overall Study|Tx prior to ATSM|3|||
33487931|NCT00794339|101679728|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
33487932|NCT00794339|101679728|FG000|Overall Study|Tx not per protocol|1|||
33487933|NCT03340974|101679729|FG000|Completion of Study -Long Term Follow up|Death|8|||
33487934|NCT03340974|101679730|FG001|Completion of Study -Long Term Follow up|Death|5|||
33487935|NCT03340974|101679731|FG002|Completion of Study -Long Term Follow up|Death|5|||
33487936|NCT03340974|101679732|FG003|Completion of Study -Long Term Follow up|Death|7|||
33487937|NCT03340974|101679729|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
33487938|NCT03340974|101679730|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
33487939|NCT03340974|101679731|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
33487940|NCT03340974|101679732|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
33487941|NCT03340974|101679729|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
33487942|NCT03340974|101679730|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
33487943|NCT03340974|101679731|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
33487944|NCT03340974|101679732|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
33487945|NCT03340974|101679729|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
33487946|NCT03340974|101679730|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
33487947|NCT03340974|101679731|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
33487948|NCT03340974|101679732|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
33487949|NCT03278626|101679735|FG000|Overall Study|Death|2|||
33487950|NCT03278626|101679735|FG000|Overall Study|Toxicity|1|||
33487951|NCT03278626|101679735|FG000|Overall Study|Disease Progression|2|||
33487952|NCT04779879|101679741|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
33487953|NCT04779879|101679742|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
33487954|NCT04779879|101679743|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
33487955|NCT04779879|101679744|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
33487956|NCT04779879|101679745|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
33487957|NCT04779879|101679746|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
33487958|NCT04779879|101679741|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
33487959|NCT04779879|101679742|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
33487960|NCT04779879|101679743|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
33487961|NCT04779879|101679744|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
33487962|NCT04779879|101679745|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
33487963|NCT04779879|101679746|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
33487964|NCT04779879|101679741|FG000|Part C: Up to Week 36|Death|0|||
33487965|NCT04779879|101679742|FG001|Part C: Up to Week 36|Death|0|||
33487966|NCT04779879|101679743|FG002|Part C: Up to Week 36|Death|0|||
33487967|NCT04779879|101679744|FG003|Part C: Up to Week 36|Death|0|||
33487968|NCT04779879|101679745|FG004|Part C: Up to Week 36|Death|0|||
33487969|NCT04779879|101679746|FG005|Part C: Up to Week 36|Death|1|||
33487970|NCT04779879|101679741|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
33487971|NCT04779879|101679742|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
33487972|NCT04779879|101679743|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
33487973|NCT04779879|101679744|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
33487974|NCT04779879|101679745|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
33487975|NCT04779879|101679746|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
33487976|NCT02246114|101679747|FG000|Overall Study|miscarriage|1|||
33487977|NCT02246114|101679748|FG001|Overall Study|miscarriage|0|||
33487978|NCT00270855|101679752|FG000|Overall Study|Withdrawal by Subject|8|||
33487979|NCT00270855|101679753|FG001|Overall Study|Withdrawal by Subject|8|||
33487980|NCT00324987|101679754|FG000|Overall Study|Adverse Event|2|||
33487981|NCT00324987|101679755|FG001|Overall Study|Adverse Event|1|||
33487982|NCT00324987|101679754|FG000|Overall Study|Withdrawal by Subject|1|||
33487983|NCT00324987|101679755|FG001|Overall Study|Withdrawal by Subject|1|||
33487984|NCT00324987|101679754|FG000|Overall Study|Progression|1|||
33487985|NCT00324987|101679755|FG001|Overall Study|Progression|1|||
33487986|NCT00324987|101679754|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
33487987|NCT00324987|101679755|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
33487988|NCT00704132|101679757|FG000|Overall Study|Clinical Adverse Experience|1|||
33487989|NCT00704132|101679758|FG001|Overall Study|Clinical Adverse Experience|0|||
33487990|NCT00704132|101679757|FG000|Overall Study|Lack of Efficacy|0|||
33487991|NCT00704132|101679758|FG001|Overall Study|Lack of Efficacy|1|||
33487992|NCT00704132|101679757|FG000|Overall Study|Withdrawal by Subject|0|||
33487993|NCT00704132|101679758|FG001|Overall Study|Withdrawal by Subject|1|||
33487994|NCT00134901|101679759|FG000|Overall Study|Lost to Follow-up|5|||
33487995|NCT00134901|101679760|FG001|Overall Study|Lost to Follow-up|5|||
33487996|NCT00134901|101679759|FG000|Overall Study|discontinued intervention|12|||
33487997|NCT00134901|101679760|FG001|Overall Study|discontinued intervention|10|||
33487998|NCT01332292|101679761|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
33487999|NCT01332292|101679762|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
33488000|NCT01332292|101679761|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
33488001|NCT01332292|101679762|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
33488002|NCT01332292|101679761|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
33488003|NCT01332292|101679762|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
33488004|NCT00171951|101679763|FG000|Overall Study|Adverse Event|1|||
33488005|NCT00171951|101679763|FG000|Overall Study|Abnormal Laboratory Values|2|||
33488006|NCT00171951|101679763|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
33488007|NCT00171951|101679763|FG000|Overall Study|Participants Withdrew Consent|3|||
33488008|NCT00171951|101679763|FG000|Overall Study|New Cancer Therapy|5|||
33488009|NCT00171951|101679763|FG000|Overall Study|Reason not Specified|2|||
33488010|NCT00741338|101679764|FG000|Overall Study|Adverse Event|0|||
33488011|NCT00741338|101679765|FG001|Overall Study|Adverse Event|1|||
33488012|NCT00104572|101679766|FG000|Overall Study|Withdrawal by Subject|3|||
33488013|NCT00104572|101679767|FG001|Overall Study|Withdrawal by Subject|3|||
33488014|NCT00104572|101679768|FG002|Overall Study|Withdrawal by Subject|0|||
33488015|NCT00911300|101679769|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
33488016|NCT00911300|101679770|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
33488017|NCT00911300|101679769|FG000|Overall Study|Death|1|||
33488018|NCT00911300|101679770|FG001|Overall Study|Death|0|||
33488019|NCT00911300|101679769|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
33488020|NCT00911300|101679770|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
33488021|NCT00911300|101679769|FG000|Overall Study|Adverse Event|14|||
33488022|NCT00911300|101679770|FG001|Overall Study|Adverse Event|6|||
33488023|NCT00911300|101679769|FG000|Overall Study|Protocol Violation|3|||
33488024|NCT00911300|101679770|FG001|Overall Study|Protocol Violation|2|||
33488025|NCT00911300|101679769|FG000|Overall Study|Consent Withdrawn|4|||
33282510|NCT00396097|100931000|FG001|Overall Study|Other|5|||
33282511|NCT00396097|100930999|FG000|Overall Study|Protocol Violation|0|||
33282512|NCT00396097|100931000|FG001|Overall Study|Protocol Violation|6|||
33282513|NCT00396097|100930999|FG000|Overall Study|Adverse Event|1|||
33282514|NCT00396097|100931000|FG001|Overall Study|Adverse Event|5|||
33282515|NCT00396097|100930999|FG000|Overall Study|Insufficient Clinical Response|1|||
33282516|NCT00396097|100931000|FG001|Overall Study|Insufficient Clinical Response|4|||
33488026|NCT00911300|101679770|FG001|Overall Study|Consent Withdrawn|12|||
33488027|NCT00911300|101679769|FG000|Overall Study|Coronary Angiography Performed|1|||
33488028|NCT00911300|101679770|FG001|Overall Study|Coronary Angiography Performed|0|||
33488029|NCT00911300|101679769|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
33488030|NCT00911300|101679770|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
33488031|NCT00911300|101679769|FG000|Overall Study|Received Commercial Treatment|1|||
33488032|NCT00911300|101679770|FG001|Overall Study|Received Commercial Treatment|0|||
33488033|NCT00911300|101679769|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
33488034|NCT00911300|101679770|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
33488035|NCT00911300|101679769|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
33488036|NCT00911300|101679770|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
33488037|NCT00911300|101679769|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
33282517|NCT00651937|100931001|FG000|Overall Study|Withdrawal by Subject|4|||
33282518|NCT00651937|100931002|FG001|Overall Study|Withdrawal by Subject|1|||
33282519|NCT02621047|100931003|FG000|Overall Study|Adverse Event|0|||
33282520|NCT02621047|100931004|FG001|Overall Study|Adverse Event|0|||
33282521|NCT02621047|100931005|FG002|Overall Study|Adverse Event|1|||
33282522|NCT00372255|100931006|FG000|Overall Study|Withdrawn for other reasons|2|||
33282523|NCT00372255|100931007|FG001|Overall Study|Withdrawn for other reasons|1|||
33282524|NCT02435381|100931008|FG000|Overall Study|Lost to Follow-up|2|||
33282525|NCT02435381|100931009|FG001|Overall Study|Lost to Follow-up|1|||
33282526|NCT00514813|100931013|FG000|Overall Study|Study terminated|14|||
33282527|NCT00514813|100931014|FG001|Overall Study|Study terminated|74|||
33282528|NCT00514813|100931015|FG002|Overall Study|Study terminated|40|||
33282529|NCT00514813|100931016|FG003|Overall Study|Study terminated|2|||
33282530|NCT00514813|100931013|FG000|Overall Study|Adverse Event|0|||
33282531|NCT00514813|100931014|FG001|Overall Study|Adverse Event|2|||
33282532|NCT00514813|100931015|FG002|Overall Study|Adverse Event|2|||
33282533|NCT00514813|100931016|FG003|Overall Study|Adverse Event|0|||
33282534|NCT00514813|100931013|FG000|Overall Study|Protocol Violation|1|||
33282535|NCT00514813|100931014|FG001|Overall Study|Protocol Violation|0|||
33282536|NCT00514813|100931015|FG002|Overall Study|Protocol Violation|0|||
33282537|NCT00514813|100931016|FG003|Overall Study|Protocol Violation|0|||
33282538|NCT00514813|100931013|FG000|Overall Study|Withdrawal by Subject|0|||
33282539|NCT00514813|100931014|FG001|Overall Study|Withdrawal by Subject|1|||
33282540|NCT00514813|100931015|FG002|Overall Study|Withdrawal by Subject|0|||
33282541|NCT00514813|100931016|FG003|Overall Study|Withdrawal by Subject|0|||
33282542|NCT00514813|100931013|FG000|Overall Study|Lack of Efficacy|0|||
33282543|NCT00514813|100931014|FG001|Overall Study|Lack of Efficacy|1|||
33282544|NCT00514813|100931015|FG002|Overall Study|Lack of Efficacy|0|||
33282545|NCT00514813|100931016|FG003|Overall Study|Lack of Efficacy|0|||
33282546|NCT00514813|100931013|FG000|Overall Study|Kidney transplant|0|||
33282547|NCT00514813|100931014|FG001|Overall Study|Kidney transplant|6|||
33282548|NCT00514813|100931015|FG002|Overall Study|Kidney transplant|2|||
33282549|NCT00514813|100931016|FG003|Overall Study|Kidney transplant|0|||
33282550|NCT00514813|100931013|FG000|Overall Study|Death|0|||
33282551|NCT00514813|100931014|FG001|Overall Study|Death|2|||
33282552|NCT00514813|100931015|FG002|Overall Study|Death|3|||
33282553|NCT00514813|100931016|FG003|Overall Study|Death|2|||
33282554|NCT02254681|100931017|FG000|Overall Study|Lack of Efficacy|6|||
33282555|NCT00961298|100931018|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
33282556|NCT00961298|100931018|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
33282557|NCT00961298|100931018|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
33282558|NCT02212197|100931021|FG000|Overall Study|Need for radiotherapy|1|||
33282559|NCT02212197|100931022|FG001|Overall Study|Need for radiotherapy|0|||
33282560|NCT02212197|100931023|FG002|Overall Study|Need for radiotherapy|0|||
33282561|NCT01713998|100931024|FG000|Overall Study|Lost to Follow-up|2|||
33282562|NCT01713998|100931025|FG001|Overall Study|Lost to Follow-up|0|||
33282563|NCT01713998|100931026|FG002|Overall Study|Lost to Follow-up|2|||
33282564|NCT01713998|100931024|FG000|Overall Study|Withdrawal by Subject|1|||
33282565|NCT01713998|100931025|FG001|Overall Study|Withdrawal by Subject|0|||
33282566|NCT01713998|100931026|FG002|Overall Study|Withdrawal by Subject|0|||
33282567|NCT00817336|100931032|FG000|Overall Study|Withdrawal by Subject|1|||
33282568|NCT00817336|100931033|FG001|Overall Study|Withdrawal by Subject|1|||
33282569|NCT03840200|100931034|FG000|Overall Study|Death|6|||
33282570|NCT03840200|100931035|FG001|Overall Study|Death|3|||
33282571|NCT03840200|100931036|FG002|Overall Study|Death|6|||
33282572|NCT03840200|100931037|FG003|Overall Study|Death|10|||
33282573|NCT03840200|100931034|FG000|Overall Study|Reason Not Specified|2|||
33282574|NCT03840200|100931035|FG001|Overall Study|Reason Not Specified|2|||
33282575|NCT03840200|100931036|FG002|Overall Study|Reason Not Specified|1|||
33282576|NCT03840200|100931037|FG003|Overall Study|Reason Not Specified|15|||
33282577|NCT03840200|100931034|FG000|Overall Study|Physician Decision|0|||
33282578|NCT03840200|100931035|FG001|Overall Study|Physician Decision|0|||
33282579|NCT03840200|100931036|FG002|Overall Study|Physician Decision|0|||
33282580|NCT03840200|100931037|FG003|Overall Study|Physician Decision|2|||
33282581|NCT03840200|100931034|FG000|Overall Study|Progressive Disease|0|||
33282582|NCT03840200|100931035|FG001|Overall Study|Progressive Disease|0|||
33282583|NCT03840200|100931036|FG002|Overall Study|Progressive Disease|0|||
33282584|NCT03840200|100931037|FG003|Overall Study|Progressive Disease|1|||
33282585|NCT03840200|100931034|FG000|Overall Study|Withdrawal by Subject|0|||
33282586|NCT03840200|100931035|FG001|Overall Study|Withdrawal by Subject|1|||
33282587|NCT03840200|100931036|FG002|Overall Study|Withdrawal by Subject|0|||
33282588|NCT03840200|100931037|FG003|Overall Study|Withdrawal by Subject|2|||
33282589|NCT01990664|100931043|FG000|Overall Study|Lost to Follow-up|2|||
33282590|NCT01990664|100931044|FG001|Overall Study|Lost to Follow-up|6|||
33282591|NCT01990664|100931043|FG000|Overall Study|Withdrawal by Subject|2|||
33282592|NCT01990664|100931044|FG001|Overall Study|Withdrawal by Subject|3|||
33282593|NCT01990664|100931043|FG000|Overall Study|Protocol Violation|1|||
33282594|NCT01990664|100931044|FG001|Overall Study|Protocol Violation|0|||
33282595|NCT01990664|100931043|FG000|Overall Study|Lens Discomfort|1|||
33282596|NCT01990664|100931044|FG001|Overall Study|Lens Discomfort|1|||
33282597|NCT01990664|100931043|FG000|Overall Study|Lens Handling Difficulties|1|||
33282598|NCT01990664|100931044|FG001|Overall Study|Lens Handling Difficulties|0|||
33282599|NCT01990664|100931043|FG000|Overall Study|Unsatisfactory Visual Response|0|||
33282600|NCT01990664|100931044|FG001|Overall Study|Unsatisfactory Visual Response|1|||
33282601|NCT00451555|100931054|FG000|Overall Study|Protocol Violation|2|||
33282602|NCT00451555|100931055|FG001|Overall Study|Protocol Violation|2|||
33282603|NCT00451555|100931054|FG000|Overall Study|Adverse Event|3|||
33282604|NCT00451555|100931055|FG001|Overall Study|Adverse Event|1|||
33282605|NCT00451555|100931054|FG000|Overall Study|Withdrawal by Subject|6|||
33282606|NCT00451555|100931055|FG001|Overall Study|Withdrawal by Subject|0|||
33282607|NCT00451555|100931054|FG000|Overall Study|Physician Decision|2|||
33282608|NCT00451555|100931055|FG001|Overall Study|Physician Decision|1|||
33282609|NCT03322514|100931056|FG000|Overall Study|Withdrawal by Subject|1|||
33282610|NCT03322514|100931057|FG001|Overall Study|Withdrawal by Subject|1|||
33282611|NCT04358068|100931058|FG000|Overall Study|Did not initiate study treatment|2|||
33282612|NCT04358068|100931059|FG001|Overall Study|Did not initiate study treatment|2|||
33282613|NCT01049984|100931062|FG000|Overall Study|Withdrawal by Subject|1|||
33282614|NCT01049984|100931063|FG001|Overall Study|Withdrawal by Subject|5|||
33282615|NCT01049984|100931062|FG000|Overall Study|Protocol Violation|3|||
33282616|NCT01049984|100931063|FG001|Overall Study|Protocol Violation|4|||
33282617|NCT01049984|100931062|FG000|Overall Study|Lost to Follow-up|2|||
33282618|NCT01049984|100931063|FG001|Overall Study|Lost to Follow-up|1|||
33282619|NCT01049984|100931062|FG000|Overall Study|Adverse Event|13|||
33282620|NCT01049984|100931063|FG001|Overall Study|Adverse Event|7|||
33282621|NCT01049984|100931062|FG000|Overall Study|Treatment failure|0|||
33282622|NCT01049984|100931063|FG001|Overall Study|Treatment failure|2|||
33282623|NCT02402465|100931068|FG000|Overall Study|Withdrawal by Subject|0|||
33282624|NCT02402465|100931069|FG001|Overall Study|Withdrawal by Subject|0|||
33282625|NCT02402465|100931070|FG002|Overall Study|Withdrawal by Subject|0|||
33282626|NCT02402465|100931071|FG003|Overall Study|Withdrawal by Subject|0|||
33282627|NCT02402465|100931072|FG004|Overall Study|Withdrawal by Subject|0|||
33282628|NCT02402465|100931073|FG005|Overall Study|Withdrawal by Subject|1|||
33282629|NCT02402465|100931068|FG000|Overall Study|Lost to Follow-up|0|||
33282630|NCT02402465|100931069|FG001|Overall Study|Lost to Follow-up|1|||
33282631|NCT02402465|100931070|FG002|Overall Study|Lost to Follow-up|0|||
33282632|NCT02402465|100931071|FG003|Overall Study|Lost to Follow-up|0|||
33282633|NCT02402465|100931072|FG004|Overall Study|Lost to Follow-up|1|||
33282634|NCT02402465|100931073|FG005|Overall Study|Lost to Follow-up|0|||
33282635|NCT04225039|100931078|FG000|Overall Study|Withdrawal by Subject|1|||
33282636|NCT04225039|100931079|FG001|Overall Study|Withdrawal by Subject|0|||
33282637|NCT04225039|100931080|FG002|Overall Study|Withdrawal by Subject|0|||
33282638|NCT04225039|100931081|FG003|Overall Study|Withdrawal by Subject|1|||
33282639|NCT04225039|100931078|FG000|Overall Study|Currently active on study treatment|0|||
33282640|NCT04225039|100931079|FG001|Overall Study|Currently active on study treatment|1|||
33282641|NCT04225039|100931080|FG002|Overall Study|Currently active on study treatment|0|||
33282642|NCT04225039|100931081|FG003|Overall Study|Currently active on study treatment|0|||
33282643|NCT04225039|100931078|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
33282644|NCT04225039|100931079|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
33282645|NCT04225039|100931080|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
33282646|NCT04225039|100931081|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
33282647|NCT04225039|100931078|FG000|Overall Study|Ineligible for treatment|0|||
33282648|NCT04225039|100931079|FG001|Overall Study|Ineligible for treatment|0|||
33282649|NCT04225039|100931080|FG002|Overall Study|Ineligible for treatment|0|||
33282650|NCT04225039|100931081|FG003|Overall Study|Ineligible for treatment|4|||
33282651|NCT02720081|100931086|FG000|Overall Study|Adverse Event|0|||
33282652|NCT02720081|100931087|FG001|Overall Study|Adverse Event|3|||
33282653|NCT02720081|100931086|FG000|Overall Study|Protocol Violation|4|||
33282654|NCT02720081|100931087|FG001|Overall Study|Protocol Violation|1|||
33282655|NCT02068352|100931088|FG000|Overall Study|Lost to Follow-up|0|||
33282656|NCT02068352|100931089|FG001|Overall Study|Lost to Follow-up|2|||
33282657|NCT02068352|100931090|FG002|Overall Study|Lost to Follow-up|0|||
33282658|NCT02068352|100931088|FG000|Overall Study|Adverse Event|4|||
33282659|NCT02068352|100931089|FG001|Overall Study|Adverse Event|2|||
33282660|NCT02068352|100931090|FG002|Overall Study|Adverse Event|7|||
33282661|NCT02068352|100931088|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
33282662|NCT02068352|100931089|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
33282663|NCT02068352|100931090|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
33282664|NCT02068352|100931088|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
33282665|NCT02068352|100931089|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
33282666|NCT02068352|100931090|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
33282667|NCT02068352|100931088|FG000|Overall Study|Protocol Deviation|0|||
33282668|NCT02068352|100931089|FG001|Overall Study|Protocol Deviation|0|||
33282669|NCT02068352|100931090|FG002|Overall Study|Protocol Deviation|1|||
33282670|NCT01183013|100931091|FG000|Overall Study|Adverse Event|6|||
33282671|NCT01183013|100931092|FG001|Overall Study|Adverse Event|8|||
33282672|NCT01183013|100931093|FG002|Overall Study|Adverse Event|5|||
33282673|NCT01183013|100931094|FG003|Overall Study|Adverse Event|5|||
33282674|NCT01183013|100931095|FG004|Overall Study|Adverse Event|10|||
33282675|NCT01183013|100931096|FG005|Overall Study|Adverse Event|10|||
33282676|NCT01183013|100931097|FG006|Overall Study|Adverse Event|6|||
33282677|NCT01183013|100931091|FG000|Overall Study|Lack of Efficacy|3|||
33282678|NCT01183013|100931092|FG001|Overall Study|Lack of Efficacy|2|||
33282679|NCT01183013|100931093|FG002|Overall Study|Lack of Efficacy|1|||
33282680|NCT01183013|100931094|FG003|Overall Study|Lack of Efficacy|2|||
33282681|NCT01183013|100931095|FG004|Overall Study|Lack of Efficacy|1|||
33282682|NCT01183013|100931096|FG005|Overall Study|Lack of Efficacy|2|||
33282683|NCT01183013|100931097|FG006|Overall Study|Lack of Efficacy|0|||
33282684|NCT01183013|100931091|FG000|Overall Study|Protocol Violation|5|||
33282685|NCT01183013|100931092|FG001|Overall Study|Protocol Violation|2|||
33282686|NCT01183013|100931093|FG002|Overall Study|Protocol Violation|4|||
33282687|NCT01183013|100931094|FG003|Overall Study|Protocol Violation|0|||
33282688|NCT01183013|100931095|FG004|Overall Study|Protocol Violation|4|||
33282689|NCT01183013|100931096|FG005|Overall Study|Protocol Violation|3|||
33282690|NCT01183013|100931097|FG006|Overall Study|Protocol Violation|3|||
33282691|NCT01183013|100931091|FG000|Overall Study|Lost to Follow-up|7|||
33282692|NCT01183013|100931092|FG001|Overall Study|Lost to Follow-up|3|||
33282693|NCT01183013|100931093|FG002|Overall Study|Lost to Follow-up|4|||
33282694|NCT01183013|100931094|FG003|Overall Study|Lost to Follow-up|3|||
33282695|NCT01183013|100931095|FG004|Overall Study|Lost to Follow-up|2|||
33282696|NCT01183013|100931096|FG005|Overall Study|Lost to Follow-up|6|||
33282697|NCT01183013|100931097|FG006|Overall Study|Lost to Follow-up|5|||
33282698|NCT01183013|100931091|FG000|Overall Study|Withdrawal by Subject|9|||
33282699|NCT01183013|100931092|FG001|Overall Study|Withdrawal by Subject|13|||
33282700|NCT01183013|100931093|FG002|Overall Study|Withdrawal by Subject|10|||
33282701|NCT01183013|100931094|FG003|Overall Study|Withdrawal by Subject|8|||
33282702|NCT01183013|100931095|FG004|Overall Study|Withdrawal by Subject|7|||
33282703|NCT01183013|100931096|FG005|Overall Study|Withdrawal by Subject|9|||
33282704|NCT01183013|100931097|FG006|Overall Study|Withdrawal by Subject|10|||
33282705|NCT01183013|100931091|FG000|Overall Study|Reasons other than stated above|15|||
33282706|NCT01183013|100931092|FG001|Overall Study|Reasons other than stated above|11|||
33282707|NCT01183013|100931093|FG002|Overall Study|Reasons other than stated above|17|||
33282708|NCT01183013|100931094|FG003|Overall Study|Reasons other than stated above|12|||
33282709|NCT01183013|100931095|FG004|Overall Study|Reasons other than stated above|12|||
33282710|NCT01183013|100931096|FG005|Overall Study|Reasons other than stated above|15|||
33282711|NCT01183013|100931097|FG006|Overall Study|Reasons other than stated above|13|||
33282712|NCT01560585|100931098|FG000|Overall Study|Physician Decision|3|||
33282713|NCT03132753|100931099|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
33282714|NCT03132753|100931100|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
33282715|NCT03132753|100931099|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
33282716|NCT03132753|100931100|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
33282717|NCT00084747|100931108|FG000|Overall Study|Relapsed|8|||
33282718|NCT00084747|100931108|FG000|Overall Study|Death|3|||
33282719|NCT00084747|100931108|FG000|Overall Study|Withdrawal by Subject|2|||
33282720|NCT01107353|100931109|FG000|Overall Study|Positive Drug Screen|1|||
33282721|NCT01107353|100931110|FG001|Overall Study|Positive Drug Screen|0|||
33282722|NCT02512861|100931112|FG000|Overall Study|Protocol Violation|3|||
33282723|NCT02512861|100931113|FG001|Overall Study|Protocol Violation|7|||
33282724|NCT02512861|100931112|FG000|Overall Study|Physician Decision|3|||
33282725|NCT02512861|100931113|FG001|Overall Study|Physician Decision|1|||
33282726|NCT02512861|100931112|FG000|Overall Study|Withdrawal by Subject|0|||
33282727|NCT02512861|100931113|FG001|Overall Study|Withdrawal by Subject|1|||
33282728|NCT02986659|100931114|FG000|First Intervention Period|Adverse Event|3|||
33282729|NCT02986659|100931115|FG001|First Intervention Period|Adverse Event|1|||
33282730|NCT02986659|100931114|FG000|First Intervention Period|Lost to Follow-up|1|||
33282731|NCT02986659|100931115|FG001|First Intervention Period|Lost to Follow-up|0|||
33282732|NCT02986659|100931114|FG000|First Intervention Period|Withdrawal by Subject|0|||
33282733|NCT02986659|100931115|FG001|First Intervention Period|Withdrawal by Subject|1|||
33282734|NCT02986659|100931114|FG000|Second Intervention Period|Adverse Event|0|||
33282735|NCT02986659|100931115|FG001|Second Intervention Period|Adverse Event|6|||
33282736|NCT02865135|100931118|FG000|Overall Study|Death|0|||
33282737|NCT02865135|100931119|FG001|Overall Study|Death|1|||
33282738|NCT02865135|100931120|FG002|Overall Study|Death|0|||
33282739|NCT02865135|100931118|FG000|Overall Study|Progression|6|||
33282740|NCT02865135|100931119|FG001|Overall Study|Progression|2|||
33282741|NCT02865135|100931120|FG002|Overall Study|Progression|2|||
33282742|NCT01002547|100931121|FG000|Overall Study|Withdrawal by Subject|4|||
33282743|NCT01002547|100931122|FG001|Overall Study|Withdrawal by Subject|0|||
33282744|NCT01002547|100931123|FG002|Overall Study|Withdrawal by Subject|5|||
33282745|NCT01002547|100931121|FG000|Overall Study|Lost to Follow-up|2|||
33282746|NCT01002547|100931122|FG001|Overall Study|Lost to Follow-up|1|||
33282747|NCT01002547|100931123|FG002|Overall Study|Lost to Follow-up|1|||
33282748|NCT01002547|100931121|FG000|Overall Study|Physician Decision|1|||
33282749|NCT01002547|100931122|FG001|Overall Study|Physician Decision|0|||
33282750|NCT01002547|100931123|FG002|Overall Study|Physician Decision|0|||
33282751|NCT01002547|100931121|FG000|Overall Study|Death|0|||
33282752|NCT01002547|100931122|FG001|Overall Study|Death|2|||
33282753|NCT01002547|100931123|FG002|Overall Study|Death|2|||
33282754|NCT01002547|100931121|FG000|Overall Study|Adverse Event|1|||
33282755|NCT01002547|100931122|FG001|Overall Study|Adverse Event|0|||
33282756|NCT01002547|100931123|FG002|Overall Study|Adverse Event|0|||
33282757|NCT02995733|100931124|FG000|Overall Study|Study site closed|9|||
33282758|NCT02995733|100931125|FG001|Overall Study|Study site closed|10|||
33282759|NCT02995733|100931124|FG000|Overall Study|Death|3|||
33282760|NCT02995733|100931125|FG001|Overall Study|Death|4|||
33282761|NCT02995733|100931124|FG000|Overall Study|Withdrawal by Subject|6|||
33282762|NCT02995733|100931125|FG001|Overall Study|Withdrawal by Subject|2|||
33282763|NCT02995733|100931124|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
33282764|NCT02995733|100931125|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
33282765|NCT02995733|100931124|FG000|Overall Study|Lost to Follow-up|48|||
33282766|NCT02995733|100931125|FG001|Overall Study|Lost to Follow-up|37|||
33282767|NCT02995733|100931124|FG000|Overall Study|Other|0|||
33282768|NCT02995733|100931125|FG001|Overall Study|Other|1|||
33282769|NCT04491006|100931138|FG000|Overall Study|Adverse Event|0|||
33282770|NCT04491006|100931139|FG001|Overall Study|Adverse Event|3|||
33282771|NCT04491006|100931140|FG002|Overall Study|Adverse Event|5|||
33282772|NCT04491006|100931138|FG000|Overall Study|Withdrawal by Subject|1|||
33282773|NCT04491006|100931139|FG001|Overall Study|Withdrawal by Subject|0|||
33282774|NCT04491006|100931140|FG002|Overall Study|Withdrawal by Subject|2|||
33282775|NCT00507429|100931145|FG000|Treatment Phase|Disease Progression|12|||
33282776|NCT00507429|100931146|FG001|Treatment Phase|Disease Progression|5|||
33282777|NCT00507429|100931145|FG000|Treatment Phase|Adverse Event|12|||
33282778|NCT00507429|100931146|FG001|Treatment Phase|Adverse Event|5|||
33282779|NCT00507429|100931145|FG000|Treatment Phase|Withdrawal by Subject|3|||
33282780|NCT00507429|100931146|FG001|Treatment Phase|Withdrawal by Subject|3|||
33282781|NCT00507429|100931145|FG000|Treatment Phase|Physician Decision|4|||
33282782|NCT00507429|100931146|FG001|Treatment Phase|Physician Decision|2|||
33282783|NCT00507429|100931145|FG000|Treatment Phase|Other|6|||
33282784|NCT00507429|100931146|FG001|Treatment Phase|Other|3|||
33282785|NCT00507429|100931145|FG000|Maintenance Phase|Progressive Disease|14|||
33282786|NCT00507429|100931146|FG001|Maintenance Phase|Progressive Disease|0|||
33282787|NCT00475735|100931147|FG000|Treatment Period 1|Adverse Event|2|||
33282788|NCT00475735|100931148|FG001|Treatment Period 1|Adverse Event|0|||
33282789|NCT00475735|100931149|FG002|Treatment Period 1|Adverse Event|0|||
33282790|NCT00475735|100931150|FG003|Treatment Period 1|Adverse Event|0|||
33282791|NCT00475735|100931151|FG004|Treatment Period 1|Adverse Event|0|||
33282792|NCT00475735|100931152|FG005|Treatment Period 1|Adverse Event|0|||
33282793|NCT00475735|100931147|FG000|Treatment Period 1|Lack of Efficacy|1|||
33282794|NCT00475735|100931148|FG001|Treatment Period 1|Lack of Efficacy|0|||
33282795|NCT00475735|100931149|FG002|Treatment Period 1|Lack of Efficacy|0|||
33282796|NCT00475735|100931150|FG003|Treatment Period 1|Lack of Efficacy|0|||
33282797|NCT00475735|100931151|FG004|Treatment Period 1|Lack of Efficacy|0|||
33282798|NCT00475735|100931152|FG005|Treatment Period 1|Lack of Efficacy|0|||
33282799|NCT00475735|100931147|FG000|Treatment Period 1|Lost to Follow-up|0|||
33282800|NCT00475735|100931148|FG001|Treatment Period 1|Lost to Follow-up|0|||
33282801|NCT00475735|100931149|FG002|Treatment Period 1|Lost to Follow-up|0|||
33282802|NCT00475735|100931150|FG003|Treatment Period 1|Lost to Follow-up|0|||
33282803|NCT00475735|100931151|FG004|Treatment Period 1|Lost to Follow-up|0|||
33282804|NCT00475735|100931152|FG005|Treatment Period 1|Lost to Follow-up|1|||
33282805|NCT00475735|100931147|FG000|Treatment Period 1|Protocol Violation|0|||
33282806|NCT00475735|100931148|FG001|Treatment Period 1|Protocol Violation|0|||
33282807|NCT00475735|100931149|FG002|Treatment Period 1|Protocol Violation|0|||
33282808|NCT00475735|100931150|FG003|Treatment Period 1|Protocol Violation|1|||
33282809|NCT00475735|100931151|FG004|Treatment Period 1|Protocol Violation|0|||
33282810|NCT00475735|100931152|FG005|Treatment Period 1|Protocol Violation|0|||
33282811|NCT00475735|100931147|FG000|Treatment Period 1|Withdrawal by Subject|1|||
33282812|NCT00475735|100931148|FG001|Treatment Period 1|Withdrawal by Subject|1|||
33282813|NCT00475735|100931149|FG002|Treatment Period 1|Withdrawal by Subject|0|||
33282814|NCT00475735|100931150|FG003|Treatment Period 1|Withdrawal by Subject|0|||
33282815|NCT00475735|100931151|FG004|Treatment Period 1|Withdrawal by Subject|0|||
33282816|NCT00475735|100931152|FG005|Treatment Period 1|Withdrawal by Subject|0|||
33282817|NCT00475735|100931147|FG000|Treatment Period 1|DC due to AE but continuing|0|||
33282818|NCT00475735|100931148|FG001|Treatment Period 1|DC due to AE but continuing|0|||
33282819|NCT00475735|100931149|FG002|Treatment Period 1|DC due to AE but continuing|0|||
33282820|NCT00475735|100931150|FG003|Treatment Period 1|DC due to AE but continuing|1|||
33282821|NCT00475735|100931151|FG004|Treatment Period 1|DC due to AE but continuing|2|||
33282822|NCT00475735|100931152|FG005|Treatment Period 1|DC due to AE but continuing|2|||
33282823|NCT00475735|100931147|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
33282824|NCT00475735|100931148|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
33282825|NCT00475735|100931149|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
33282826|NCT00475735|100931150|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
33282827|NCT00475735|100931151|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
33282828|NCT00475735|100931152|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
33282829|NCT00475735|100931147|FG000|Treatment Washout|Lost to Follow-up|0|||
33282830|NCT00475735|100931148|FG001|Treatment Washout|Lost to Follow-up|1|||
33282831|NCT00475735|100931149|FG002|Treatment Washout|Lost to Follow-up|0|||
33282832|NCT00475735|100931150|FG003|Treatment Washout|Lost to Follow-up|0|||
33282833|NCT00475735|100931151|FG004|Treatment Washout|Lost to Follow-up|0|||
33282834|NCT00475735|100931152|FG005|Treatment Washout|Lost to Follow-up|0|||
33282835|NCT00475735|100931147|FG000|Treatment Washout|Protocol Violation|0|||
33282836|NCT00475735|100931148|FG001|Treatment Washout|Protocol Violation|1|||
33282837|NCT00475735|100931149|FG002|Treatment Washout|Protocol Violation|0|||
33282838|NCT00475735|100931150|FG003|Treatment Washout|Protocol Violation|0|||
33282839|NCT00475735|100931151|FG004|Treatment Washout|Protocol Violation|0|||
33282840|NCT00475735|100931152|FG005|Treatment Washout|Protocol Violation|0|||
33282841|NCT00475735|100931147|FG000|Treatment Period 2|Adverse Event|0|||
33282842|NCT00475735|100931148|FG001|Treatment Period 2|Adverse Event|1|||
33282843|NCT00475735|100931149|FG002|Treatment Period 2|Adverse Event|0|||
33282844|NCT00475735|100931150|FG003|Treatment Period 2|Adverse Event|2|||
33282845|NCT00475735|100931151|FG004|Treatment Period 2|Adverse Event|0|||
33282846|NCT00475735|100931152|FG005|Treatment Period 2|Adverse Event|0|||
33282847|NCT00475735|100931147|FG000|Treatment Period 2|Lack of Efficacy|0|||
33282848|NCT00475735|100931148|FG001|Treatment Period 2|Lack of Efficacy|0|||
33282849|NCT00475735|100931149|FG002|Treatment Period 2|Lack of Efficacy|0|||
33282850|NCT00475735|100931150|FG003|Treatment Period 2|Lack of Efficacy|0|||
33282851|NCT00475735|100931151|FG004|Treatment Period 2|Lack of Efficacy|0|||
33282852|NCT00475735|100931152|FG005|Treatment Period 2|Lack of Efficacy|1|||
33282853|NCT00475735|100931147|FG000|Treatment Period 2|Withdrawal by Subject|0|||
33282854|NCT00475735|100931148|FG001|Treatment Period 2|Withdrawal by Subject|0|||
33282855|NCT00475735|100931149|FG002|Treatment Period 2|Withdrawal by Subject|0|||
33282856|NCT00475735|100931150|FG003|Treatment Period 2|Withdrawal by Subject|0|||
33282857|NCT00475735|100931151|FG004|Treatment Period 2|Withdrawal by Subject|1|||
33282858|NCT00475735|100931152|FG005|Treatment Period 2|Withdrawal by Subject|0|||
33282859|NCT00497198|100931162|FG000|Overall Study|Adverse Event|4|||
33282860|NCT00497198|100931163|FG001|Overall Study|Adverse Event|2|||
33282861|NCT00497198|100931162|FG000|Overall Study|Physician Decision|1|||
33282862|NCT00497198|100931163|FG001|Overall Study|Physician Decision|2|||
33282863|NCT00497198|100931162|FG000|Overall Study|Withdrawal by Subject|0|||
33282864|NCT00497198|100931163|FG001|Overall Study|Withdrawal by Subject|1|||
33282865|NCT03568708|100931164|FG000|Overall Study|Withdrawal by Subject|1|||
33282866|NCT03568708|100931165|FG001|Overall Study|Withdrawal by Subject|1|||
33282867|NCT03568708|100931164|FG000|Overall Study|Lost to Follow-up|0|||
33282868|NCT03568708|100931165|FG001|Overall Study|Lost to Follow-up|1|||
33282869|NCT00727259|100931166|FG000|Overall Study|Not all questionnaires completed|1055|||
33282870|NCT03900715|100931167|FG000|Overall Study|Protocol Deviation|1|||
33282871|NCT03900715|100931167|FG000|Overall Study|Lack of Efficacy|1|||
33282872|NCT03900715|100931167|FG000|Overall Study|Progressive Disease|6|||
33282873|NCT03900715|100931167|FG000|Overall Study|Adverse Event|2|||
33282874|NCT03900715|100931167|FG000|Overall Study|Other reasons|11|||
33282875|NCT01685047|100931168|FG000|Overall Study|Withdrawal by Subject|20|||
33282876|NCT01685047|100931168|FG000|Overall Study|Death|26|||
33282877|NCT01685047|100931168|FG000|Overall Study|Lost to Follow-up|8|||
33282878|NCT01685047|100931168|FG000|Overall Study|Physician Decision|25|||
33282879|NCT01685047|100931168|FG000|Overall Study|Adverse Event|5|||
33282880|NCT01685047|100931168|FG000|Overall Study|patient withdrawn by sponsor|1|||
33282881|NCT04159805|100931169|FG000|Overall Study|Withdrawal by Subject|0|||
33282882|NCT04159805|100931170|FG001|Overall Study|Withdrawal by Subject|2|||
33282883|NCT04159805|100931171|FG002|Overall Study|Withdrawal by Subject|2|||
33282884|NCT02600897|100931174|FG000|Overall Study|Death|1|||
33282885|NCT02600897|100931175|FG001|Overall Study|Death|2|||
33282886|NCT02600897|100931176|FG002|Overall Study|Death|1|||
33282887|NCT02600897|100931177|FG003|Overall Study|Death|2|||
33282888|NCT02600897|100931178|FG004|Overall Study|Death|3|||
33282889|NCT02600897|100931179|FG005|Overall Study|Death|2|||
33488038|NCT00911300|101679770|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
33282890|NCT02600897|100931180|FG006|Overall Study|Death|10|||
33282891|NCT02600897|100931181|FG007|Overall Study|Death|7|||
33282892|NCT02600897|100931182|FG008|Overall Study|Death|20|||
33282893|NCT02600897|100931174|FG000|Overall Study|Lost to Follow-up|1|||
33282894|NCT02600897|100931175|FG001|Overall Study|Lost to Follow-up|0|||
33282895|NCT02600897|100931176|FG002|Overall Study|Lost to Follow-up|0|||
33282896|NCT02600897|100931177|FG003|Overall Study|Lost to Follow-up|0|||
33282897|NCT02600897|100931178|FG004|Overall Study|Lost to Follow-up|0|||
33282898|NCT02600897|100931179|FG005|Overall Study|Lost to Follow-up|0|||
33282899|NCT02600897|100931180|FG006|Overall Study|Lost to Follow-up|0|||
33282900|NCT02600897|100931181|FG007|Overall Study|Lost to Follow-up|1|||
33282901|NCT02600897|100931182|FG008|Overall Study|Lost to Follow-up|0|||
33282902|NCT02600897|100931174|FG000|Overall Study|Withdrawal by Subject|0|||
33282903|NCT02600897|100931175|FG001|Overall Study|Withdrawal by Subject|0|||
33282904|NCT02600897|100931176|FG002|Overall Study|Withdrawal by Subject|0|||
33282905|NCT02600897|100931177|FG003|Overall Study|Withdrawal by Subject|0|||
33282906|NCT02600897|100931178|FG004|Overall Study|Withdrawal by Subject|0|||
33282907|NCT02600897|100931179|FG005|Overall Study|Withdrawal by Subject|0|||
33282908|NCT02600897|100931180|FG006|Overall Study|Withdrawal by Subject|0|||
33282909|NCT02600897|100931181|FG007|Overall Study|Withdrawal by Subject|4|||
33282910|NCT02600897|100931182|FG008|Overall Study|Withdrawal by Subject|2|||
33282911|NCT02600897|100931174|FG000|Overall Study|Reason Not Specified|0|||
33282912|NCT02600897|100931175|FG001|Overall Study|Reason Not Specified|0|||
33282913|NCT02600897|100931176|FG002|Overall Study|Reason Not Specified|0|||
33282914|NCT02600897|100931177|FG003|Overall Study|Reason Not Specified|0|||
33282915|NCT02600897|100931178|FG004|Overall Study|Reason Not Specified|0|||
33282916|NCT02600897|100931179|FG005|Overall Study|Reason Not Specified|0|||
33282917|NCT02600897|100931180|FG006|Overall Study|Reason Not Specified|0|||
33282918|NCT02600897|100931181|FG007|Overall Study|Reason Not Specified|0|||
33282919|NCT02600897|100931182|FG008|Overall Study|Reason Not Specified|1|||
33282920|NCT01747837|100931188|FG000|Overall Study|Lost to Follow-up|5|||
33282921|NCT01747837|100931189|FG001|Overall Study|Lost to Follow-up|2|||
33282922|NCT01747837|100931188|FG000|Overall Study|Death|4|||
33282923|NCT01747837|100931189|FG001|Overall Study|Death|4|||
33282924|NCT02551692|100934151|FG000|Overall Study|Lost to Follow-up|0|||
33282925|NCT02551692|100934152|FG001|Overall Study|Lost to Follow-up|1|||
33282926|NCT02551692|100934153|FG002|Overall Study|Lost to Follow-up|4|||
33282927|NCT02551692|100934151|FG000|Overall Study|Withdrawal by Subject|1|||
33282928|NCT02551692|100934152|FG001|Overall Study|Withdrawal by Subject|0|||
33282929|NCT02551692|100934153|FG002|Overall Study|Withdrawal by Subject|1|||
33282930|NCT03461211|100934154|FG000|Overall Study|Adverse Event|1|||
33282931|NCT03461211|100934155|FG001|Overall Study|Adverse Event|1|||
33282932|NCT03461211|100934154|FG000|Overall Study|Lack of Efficacy|0|||
33282933|NCT03461211|100934155|FG001|Overall Study|Lack of Efficacy|1|||
33282934|NCT03036150|100934160|FG000|Overall Study|Withdrawal by Subject|8|||
33282935|NCT03036150|100934161|FG001|Overall Study|Withdrawal by Subject|3|||
33282936|NCT03036150|100934160|FG000|Overall Study|Lost to Follow-up|2|||
33282937|NCT03036150|100934161|FG001|Overall Study|Lost to Follow-up|2|||
33282938|NCT00509821|100934162|FG000|Study Period 1 (Induction)|Death|0|||
33282939|NCT00509821|100934163|FG001|Study Period 1 (Induction)|Death|1|||
33282940|NCT00509821|100934162|FG000|Study Period 1 (Induction)|Adverse Event|0|||
33282941|NCT00509821|100934163|FG001|Study Period 1 (Induction)|Adverse Event|2|||
33282942|NCT00509821|100934162|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
33282943|NCT00509821|100934163|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
33282944|NCT01078584|100934164|FG000|Overall Study|Final Status Unknown|1073|||
33282945|NCT01078584|100934164|FG000|Overall Study|Lost to Follow-up|670|||
33282946|NCT01078584|100934164|FG000|Overall Study|Non-serious Adverse Event|577|||
33282947|NCT01078584|100934164|FG000|Overall Study|Withdrawal of Consent|244|||
33282948|NCT01078584|100934164|FG000|Overall Study|Physician Withdrew from Study|90|||
33282949|NCT01078584|100934164|FG000|Overall Study|Non-compliance|67|||
33282950|NCT01078584|100934164|FG000|Overall Study|Blood Pressure Controlled|49|||
33282951|NCT01078584|100934164|FG000|Overall Study|Physician Switched Medication|26|||
33282952|NCT01078584|100934164|FG000|Overall Study|Physician Discontinued Patient|12|||
33282953|NCT01078584|100934164|FG000|Overall Study|Lack of Efficacy|98|||
33282954|NCT01078584|100934164|FG000|Overall Study|Protocol Violation|75|||
33282955|NCT01078584|100934164|FG000|Overall Study|Serious Adverse Event|27|||
33282956|NCT01078584|100934164|FG000|Overall Study|Multiple Reasons|2|||
33282957|NCT00255944|100934165|FG000|Overall Study|Lost to Follow-up|797|||
33282958|NCT00255944|100934166|FG001|Overall Study|Lost to Follow-up|834|||
33282959|NCT02166047|100934169|FG000|Overall Study|Withdrawal by Participant|0|||
33282960|NCT02166047|100934170|FG001|Overall Study|Withdrawal by Participant|1|||
33282961|NCT02166047|100934171|FG002|Overall Study|Withdrawal by Participant|2|||
33282962|NCT02166047|100934172|FG003|Overall Study|Withdrawal by Participant|0|||
33282963|NCT02166047|100934173|FG004|Overall Study|Withdrawal by Participant|0|||
33282964|NCT02166047|100934174|FG005|Overall Study|Withdrawal by Participant|0|||
33282965|NCT02166047|100934175|FG006|Overall Study|Withdrawal by Participant|1|||
33282966|NCT02166047|100934176|FG007|Overall Study|Withdrawal by Participant|0|||
33282967|NCT02166047|100934177|FG008|Overall Study|Withdrawal by Participant|0|||
33282968|NCT02166047|100934178|FG009|Overall Study|Withdrawal by Participant|0|||
33282969|NCT02166047|100934179|FG010|Overall Study|Withdrawal by Participant|0|||
33282970|NCT02166047|100934180|FG011|Overall Study|Withdrawal by Participant|0|||
33282971|NCT02166047|100934169|FG000|Overall Study|Adverse Event|0|||
33282972|NCT02166047|100934170|FG001|Overall Study|Adverse Event|0|||
33282973|NCT02166047|100934171|FG002|Overall Study|Adverse Event|0|||
33282974|NCT02166047|100934172|FG003|Overall Study|Adverse Event|0|||
33282975|NCT02166047|100934173|FG004|Overall Study|Adverse Event|1|||
33282976|NCT02166047|100934174|FG005|Overall Study|Adverse Event|0|||
33282977|NCT02166047|100934175|FG006|Overall Study|Adverse Event|1|||
33282978|NCT02166047|100934176|FG007|Overall Study|Adverse Event|0|||
33282979|NCT02166047|100934177|FG008|Overall Study|Adverse Event|0|||
33282980|NCT02166047|100934178|FG009|Overall Study|Adverse Event|0|||
33282981|NCT02166047|100934179|FG010|Overall Study|Adverse Event|2|||
33282982|NCT02166047|100934180|FG011|Overall Study|Adverse Event|0|||
33282983|NCT02236598|100934185|FG000|Overall Study|Adverse Event|0|||
33282984|NCT02236598|100934186|FG001|Overall Study|Adverse Event|1|||
33282985|NCT02236598|100934185|FG000|Overall Study|Withdrawal by Subject|0|||
33282986|NCT02236598|100934186|FG001|Overall Study|Withdrawal by Subject|1|||
33282987|NCT01395914|100934189|FG000|Overall Study|Unrelated to study drug AE|6|||
33282988|NCT01395914|100934190|FG001|Overall Study|Unrelated to study drug AE|1|||
33282989|NCT01395914|100934189|FG000|Overall Study|Death|23|||
33282990|NCT01395914|100934190|FG001|Overall Study|Death|17|||
33282991|NCT01395914|100934189|FG000|Overall Study|Other|9|||
33282992|NCT01395914|100934190|FG001|Overall Study|Other|3|||
33282993|NCT01395914|100934189|FG000|Overall Study|Withdrawal by patient|27|||
33282994|NCT01395914|100934190|FG001|Overall Study|Withdrawal by patient|14|||
33282995|NCT01395914|100934189|FG000|Overall Study|Study drug-related AE|1|||
33282996|NCT01395914|100934190|FG001|Overall Study|Study drug-related AE|0|||
33282997|NCT01395914|100934189|FG000|Overall Study|Lost to Follow-up|6|||
33282998|NCT01395914|100934190|FG001|Overall Study|Lost to Follow-up|2|||
33282999|NCT02388932|100934193|FG000|Overall Study|Death|1|||
33283000|NCT01702519|100934194|FG000|Washout Period|Lost to Follow-up|1|||
33283001|NCT01702519|100934195|FG001|Washout Period|Lost to Follow-up|0|||
33283002|NCT01702519|100934194|FG000|Washout Period|Withdrawal by Subject|0|||
33283003|NCT01702519|100934195|FG001|Washout Period|Withdrawal by Subject|2|||
33283004|NCT03675308|100934196|FG000|Overall Study|Adverse Event|3|||
33283005|NCT03675308|100934197|FG001|Overall Study|Adverse Event|2|||
33283006|NCT03675308|100934196|FG000|Overall Study|Withdrawal by Subject|6|||
33283007|NCT03675308|100934197|FG001|Overall Study|Withdrawal by Subject|4|||
33283008|NCT03675308|100934196|FG000|Overall Study|Lost to Follow-up|3|||
33283009|NCT03675308|100934197|FG001|Overall Study|Lost to Follow-up|0|||
33283010|NCT03675308|100934196|FG000|Overall Study|Lack of Efficacy|1|||
33283011|NCT03675308|100934197|FG001|Overall Study|Lack of Efficacy|1|||
33283012|NCT03675308|100934196|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
33283013|NCT03675308|100934197|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
33283014|NCT03675308|100934196|FG000|Overall Study|Other|0|||
33283015|NCT03675308|100934197|FG001|Overall Study|Other|1|||
33283016|NCT03015181|100934198|FG000|Overall Study|Enrolled, but product never administered|1|||
33283017|NCT03015181|100934199|FG001|Overall Study|Enrolled, but product never administered|0|||
33283018|NCT03015181|100934200|FG002|Overall Study|Enrolled, but product never administered|0|||
33283019|NCT03015181|100934201|FG003|Overall Study|Enrolled, but product never administered|0|||
33283020|NCT03015181|100934202|FG004|Overall Study|Enrolled, but product never administered|0|||
33283021|NCT03015181|100934203|FG005|Overall Study|Enrolled, but product never administered|0|||
33283022|NCT03015181|100934204|FG006|Overall Study|Enrolled, but product never administered|0|||
33283023|NCT03015181|100934198|FG000|Overall Study|Withdrawal by Subject|0|||
33283024|NCT03015181|100934199|FG001|Overall Study|Withdrawal by Subject|0|||
33283025|NCT03015181|100934200|FG002|Overall Study|Withdrawal by Subject|0|||
33283026|NCT03015181|100934201|FG003|Overall Study|Withdrawal by Subject|0|||
33283027|NCT03015181|100934202|FG004|Overall Study|Withdrawal by Subject|0|||
33283028|NCT03015181|100934203|FG005|Overall Study|Withdrawal by Subject|1|||
33283029|NCT03015181|100934204|FG006|Overall Study|Withdrawal by Subject|0|||
33283030|NCT03015181|100934198|FG000|Overall Study|Physician Decision|0|||
33283031|NCT03015181|100934199|FG001|Overall Study|Physician Decision|0|||
33283032|NCT03015181|100934200|FG002|Overall Study|Physician Decision|0|||
33283033|NCT03015181|100934201|FG003|Overall Study|Physician Decision|0|||
33283034|NCT03015181|100934202|FG004|Overall Study|Physician Decision|0|||
33283035|NCT03015181|100934203|FG005|Overall Study|Physician Decision|0|||
33283036|NCT03015181|100934204|FG006|Overall Study|Physician Decision|1|||
33283037|NCT01732588|100934208|FG000|First Intervention (7 Days)|Adverse Event|0|||
33283038|NCT01732588|100934209|FG001|First Intervention (7 Days)|Adverse Event|1|||
33283039|NCT01732588|100934210|FG002|First Intervention (7 Days)|Adverse Event|0|||
33283040|NCT00875615|100934211|FG000|Overall Study|Withdrawal by Subject|1|||
33283041|NCT01772147|100934212|FG000|Overall Study|Adverse Event|13|||
33283042|NCT01772147|100934213|FG001|Overall Study|Adverse Event|10|||
33283043|NCT01772147|100934214|FG002|Overall Study|Adverse Event|6|||
33283044|NCT01772147|100934212|FG000|Overall Study|Withdrew Consent|7|||
33283045|NCT01772147|100934213|FG001|Overall Study|Withdrew Consent|8|||
33283046|NCT01772147|100934214|FG002|Overall Study|Withdrew Consent|4|||
33283047|NCT01772147|100934212|FG000|Overall Study|Lost to Follow-up|1|||
33283048|NCT01772147|100934213|FG001|Overall Study|Lost to Follow-up|0|||
33283049|NCT01772147|100934214|FG002|Overall Study|Lost to Follow-up|1|||
33283050|NCT01772147|100934212|FG000|Overall Study|Protocol Deviation|2|||
33283051|NCT01772147|100934213|FG001|Overall Study|Protocol Deviation|1|||
33283052|NCT01772147|100934214|FG002|Overall Study|Protocol Deviation|1|||
33283053|NCT01772147|100934212|FG000|Overall Study|Lack of Efficacy|8|||
33283054|NCT01772147|100934213|FG001|Overall Study|Lack of Efficacy|6|||
33283055|NCT01772147|100934214|FG002|Overall Study|Lack of Efficacy|6|||
33283056|NCT02394925|100934225|FG000|Overall Study|Adverse Event|1|||
33283057|NCT02394925|100934225|FG000|Overall Study|Lens Discomfort|3|||
33283058|NCT02394925|100934225|FG000|Overall Study|Lens handling difficulities|5|||
33283059|NCT02394925|100934225|FG000|Overall Study|Lost to Follow-up|9|||
33283060|NCT02394925|100934225|FG000|Overall Study|Protocol Violation|5|||
33283061|NCT02394925|100934225|FG000|Overall Study|No longer meet eligibility criteria|1|||
33283062|NCT02394925|100934225|FG000|Overall Study|Unsatisfactory Visual Response|5|||
33283063|NCT01201915|100934226|FG000|Overall Study|Adverse Event|2|||
33283064|NCT01201915|100934227|FG001|Overall Study|Adverse Event|1|||
33283065|NCT01201915|100934228|FG002|Overall Study|Adverse Event|1|||
33283066|NCT01201915|100934226|FG000|Overall Study|Lost to Follow-up|0|||
33283067|NCT01201915|100934227|FG001|Overall Study|Lost to Follow-up|4|||
33283068|NCT01201915|100934228|FG002|Overall Study|Lost to Follow-up|0|||
33283069|NCT01201915|100934226|FG000|Overall Study|Physician Decision|3|||
33283070|NCT01201915|100934227|FG001|Overall Study|Physician Decision|0|||
33283071|NCT01201915|100934228|FG002|Overall Study|Physician Decision|0|||
33283072|NCT01201915|100934226|FG000|Overall Study|Subject Decision|3|||
33283073|NCT01201915|100934227|FG001|Overall Study|Subject Decision|3|||
33283074|NCT01201915|100934228|FG002|Overall Study|Subject Decision|5|||
33283075|NCT01201915|100934226|FG000|Overall Study|Target Lesion Progression|0|||
33283076|NCT01201915|100934227|FG001|Overall Study|Target Lesion Progression|3|||
33283077|NCT01201915|100934228|FG002|Overall Study|Target Lesion Progression|0|||
33283078|NCT00644332|100934232|FG000|Overall Study|Adverse Event|11|||
33283079|NCT00644332|100934232|FG000|Overall Study|Withdrawal by Subject|6|||
33283080|NCT00644332|100934232|FG000|Overall Study|Completion Status Unknown|2|||
33283081|NCT00644332|100934232|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
33283082|NCT00644332|100934232|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
33283083|NCT01157377|100934235|FG000|Overall Study|Lost to Follow-up|0|||
33283084|NCT01157377|100934236|FG001|Overall Study|Lost to Follow-up|0|||
33283085|NCT01157377|100934237|FG002|Overall Study|Lost to Follow-up|1|||
33283086|NCT01157377|100934238|FG003|Overall Study|Lost to Follow-up|0|||
33283087|NCT01157377|100934239|FG004|Overall Study|Lost to Follow-up|1|||
33283088|NCT01157377|100934240|FG005|Overall Study|Lost to Follow-up|1|||
33283089|NCT01157377|100934241|FG006|Overall Study|Lost to Follow-up|0|||
33283090|NCT01157377|100934235|FG000|Overall Study|Personal Reasons|2|||
33283091|NCT01157377|100934236|FG001|Overall Study|Personal Reasons|1|||
33283092|NCT01157377|100934237|FG002|Overall Study|Personal Reasons|0|||
33283093|NCT01157377|100934238|FG003|Overall Study|Personal Reasons|1|||
33283094|NCT01157377|100934239|FG004|Overall Study|Personal Reasons|0|||
33283095|NCT01157377|100934240|FG005|Overall Study|Personal Reasons|0|||
33283096|NCT01157377|100934241|FG006|Overall Study|Personal Reasons|0|||
33283097|NCT01157377|100934235|FG000|Overall Study|Protocol Violation|0|||
33283098|NCT01157377|100934236|FG001|Overall Study|Protocol Violation|0|||
33283099|NCT01157377|100934237|FG002|Overall Study|Protocol Violation|0|||
33283100|NCT01157377|100934238|FG003|Overall Study|Protocol Violation|0|||
33283101|NCT01157377|100934239|FG004|Overall Study|Protocol Violation|0|||
33283102|NCT01157377|100934240|FG005|Overall Study|Protocol Violation|1|||
33283103|NCT01157377|100934241|FG006|Overall Study|Protocol Violation|0|||
33283104|NCT01157377|100934235|FG000|Overall Study|Lack of Efficacy|0|||
33283105|NCT01157377|100934236|FG001|Overall Study|Lack of Efficacy|0|||
33283106|NCT01157377|100934237|FG002|Overall Study|Lack of Efficacy|0|||
33283107|NCT01157377|100934238|FG003|Overall Study|Lack of Efficacy|0|||
33283108|NCT01157377|100934239|FG004|Overall Study|Lack of Efficacy|0|||
33283109|NCT01157377|100934240|FG005|Overall Study|Lack of Efficacy|0|||
33283110|NCT01157377|100934241|FG006|Overall Study|Lack of Efficacy|1|||
33283111|NCT01157377|100934235|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33283112|NCT01157377|100934236|FG001|Overall Study|Other Miscellaneous Reasons|2|||
33283113|NCT01157377|100934237|FG002|Overall Study|Other Miscellaneous Reasons|0|||
33283114|NCT01157377|100934238|FG003|Overall Study|Other Miscellaneous Reasons|0|||
33283115|NCT01157377|100934239|FG004|Overall Study|Other Miscellaneous Reasons|1|||
33283116|NCT01157377|100934240|FG005|Overall Study|Other Miscellaneous Reasons|1|||
33283117|NCT01157377|100934241|FG006|Overall Study|Other Miscellaneous Reasons|1|||
33283118|NCT02675998|100934242|FG000|8-Week Treatment Period|Adverse Event|6|||
33283119|NCT02675998|100934243|FG001|8-Week Treatment Period|Adverse Event|5|||
33283120|NCT02675998|100934244|FG002|8-Week Treatment Period|Adverse Event|6|||
33283121|NCT02675998|100934245|FG003|8-Week Treatment Period|Adverse Event|0|||
33283122|NCT02675998|100934242|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
33283123|NCT02675998|100934243|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
33283124|NCT02675998|100934244|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
33283125|NCT02675998|100934245|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
33283126|NCT02675998|100934242|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
33283127|NCT02675998|100934243|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
33283128|NCT02675998|100934244|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
33283129|NCT02675998|100934245|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
33283130|NCT02675998|100934242|FG000|8-Week Treatment Period|Physician Decision|1|||
33283131|NCT02675998|100934243|FG001|8-Week Treatment Period|Physician Decision|0|||
33283132|NCT02675998|100934244|FG002|8-Week Treatment Period|Physician Decision|2|||
33283133|NCT02675998|100934245|FG003|8-Week Treatment Period|Physician Decision|0|||
33283134|NCT02675998|100934242|FG000|8-Week Treatment Period|GI side Effects|1|||
33283135|NCT02675998|100934243|FG001|8-Week Treatment Period|GI side Effects|4|||
33283136|NCT02675998|100934244|FG002|8-Week Treatment Period|GI side Effects|2|||
33283137|NCT02675998|100934245|FG003|8-Week Treatment Period|GI side Effects|0|||
33283138|NCT02675998|100934242|FG000|8-Week Treatment Period|Protocol Violation|1|||
33283139|NCT02675998|100934243|FG001|8-Week Treatment Period|Protocol Violation|1|||
33283140|NCT02675998|100934244|FG002|8-Week Treatment Period|Protocol Violation|1|||
33283141|NCT02675998|100934245|FG003|8-Week Treatment Period|Protocol Violation|0|||
33283142|NCT02675998|100934242|FG000|8-Week Treatment Period|Other|3|||
33283143|NCT02675998|100934243|FG001|8-Week Treatment Period|Other|1|||
33283144|NCT02675998|100934244|FG002|8-Week Treatment Period|Other|2|||
33283145|NCT02675998|100934245|FG003|8-Week Treatment Period|Other|0|||
33283146|NCT02675998|100934242|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
33283147|NCT02675998|100934243|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
33283148|NCT02675998|100934244|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
33283149|NCT02675998|100934245|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
33283150|NCT02675998|100934242|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
33283151|NCT02675998|100934243|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
33283152|NCT02675998|100934244|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
33283153|NCT02675998|100934245|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
33283154|NCT02675998|100934242|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
33283155|NCT02675998|100934243|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
33283156|NCT02675998|100934244|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
33283157|NCT02675998|100934245|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
33283158|NCT02675998|100934242|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
33283159|NCT02675998|100934243|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
33283160|NCT02675998|100934244|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
33283161|NCT02675998|100934245|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
33283162|NCT02675998|100934242|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
33283163|NCT02675998|100934243|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
33283164|NCT02675998|100934244|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
33283165|NCT02675998|100934245|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
33283166|NCT02110225|100934246|FG000|Overall Study|Lost to Follow-up|0|||
33283167|NCT02110225|100934247|FG001|Overall Study|Lost to Follow-up|1|||
33283168|NCT02110225|100934248|FG002|Overall Study|Lost to Follow-up|0|||
33283169|NCT00578318|100934249|FG000|Overall Study|Lost to Follow-up|2|||
33283170|NCT00578318|100934250|FG001|Overall Study|Lost to Follow-up|0|||
33283171|NCT00578318|100934249|FG000|Overall Study|Physician Decision|1|||
33283172|NCT00578318|100934250|FG001|Overall Study|Physician Decision|0|||
33283173|NCT02201771|100934251|FG000|Overall Study|Death|3|||
33283174|NCT02201771|100934252|FG001|Overall Study|Death|2|||
33283175|NCT02201771|100934253|FG002|Overall Study|Death|0|||
33283176|NCT02201771|100934251|FG000|Overall Study|Protocol Violation|10|||
33283177|NCT02201771|100934252|FG001|Overall Study|Protocol Violation|8|||
33283178|NCT02201771|100934253|FG002|Overall Study|Protocol Violation|10|||
33283179|NCT01059526|100934254|FG000|Overall Study|Patient enrolled but not treated|20|||
33283180|NCT01059526|100934255|FG001|Overall Study|Patient enrolled but not treated|17|||
33283181|NCT01059526|100934254|FG000|Overall Study|Adverse Event|2|||
33283182|NCT01059526|100934255|FG001|Overall Study|Adverse Event|2|||
33283183|NCT01059526|100934254|FG000|Overall Study|Protocol Violation|0|||
33283184|NCT01059526|100934255|FG001|Overall Study|Protocol Violation|1|||
33283185|NCT01059526|100934254|FG000|Overall Study|Withdrawal by Subject|3|||
33283186|NCT01059526|100934255|FG001|Overall Study|Withdrawal by Subject|1|||
33283187|NCT01059526|100934254|FG000|Overall Study|Lost to Follow-up|4|||
33283188|NCT01059526|100934255|FG001|Overall Study|Lost to Follow-up|1|||
33283189|NCT01059526|100934254|FG000|Overall Study|Patient found to be dermatographic|1|||
33283190|NCT01059526|100934255|FG001|Overall Study|Patient found to be dermatographic|0|||
33283191|NCT00745121|100934256|FG000|Overall Study|Death|3|||
33283192|NCT00745121|100934257|FG001|Overall Study|Death|0|||
33283193|NCT00745121|100934256|FG000|Overall Study|Adverse Event|1|||
33283194|NCT00745121|100934257|FG001|Overall Study|Adverse Event|0|||
33283195|NCT00745121|100934256|FG000|Overall Study|Lost to Follow-up|1|||
33283196|NCT00745121|100934257|FG001|Overall Study|Lost to Follow-up|0|||
33283197|NCT00745121|100934256|FG000|Overall Study|Withdrawal by Subject|4|||
33283198|NCT00745121|100934257|FG001|Overall Study|Withdrawal by Subject|2|||
33283199|NCT00520403|100934258|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
33283200|NCT00520403|100934258|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
33283201|NCT00520403|100934258|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
33283202|NCT00520403|100934258|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
33283203|NCT00520403|100934258|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
33283204|NCT00520403|100934258|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
33283205|NCT00520403|100934258|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
33283206|NCT00520403|100934258|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
33283207|NCT02253147|100934260|FG000|Overall Study|Protocol Violation|30|||
33283208|NCT02253147|100934260|FG000|Overall Study|Did not consent to study extension|9|||
33283209|NCT02253147|100934260|FG000|Overall Study|Conditional re-treatment at W52|5|||
33283210|NCT02253147|100934260|FG000|Overall Study|Lost to Follow-up|2|||
33283211|NCT02253147|100934260|FG000|Overall Study|Withdrawal by Subject|1|||
33283212|NCT00352053|100934264|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
33283213|NCT00352053|100934265|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
33283214|NCT00352053|100934264|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
33283215|NCT00352053|100934265|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
33283216|NCT00352053|100934264|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
33283217|NCT00352053|100934265|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
33283218|NCT00352053|100934264|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
33283219|NCT00352053|100934265|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
33283220|NCT00352053|100934264|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
33283221|NCT00352053|100934265|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
33283222|NCT00352053|100934264|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
33283223|NCT00352053|100934265|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
33283224|NCT00352053|100934264|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
33283225|NCT00352053|100934265|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
33283226|NCT00352053|100934264|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
33283227|NCT00352053|100934265|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
33283228|NCT00352053|100934264|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
33283229|NCT00352053|100934265|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
33283230|NCT00352053|100934264|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
33283231|NCT00352053|100934265|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
33283232|NCT00352053|100934264|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
33283233|NCT00352053|100934265|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
33283234|NCT00352053|100934264|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
33283235|NCT00352053|100934265|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
33283236|NCT00352053|100934264|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
33283237|NCT00352053|100934265|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
33283238|NCT02777242|100934266|FG000|Overall Study|Other|2|||
33283239|NCT02777242|100934266|FG000|Overall Study|Lost to Follow-up|1|||
33283240|NCT02777242|100934266|FG000|Overall Study|Multiple|1|||
33283241|NCT02777242|100934266|FG000|Overall Study|Sponsor's request|1|||
33283242|NCT02777242|100934266|FG000|Overall Study|Withdrawal by Subject|1|||
33283243|NCT03723915|100934277|FG000|Screening|Failed to meet screening requirements.|2|||
33283244|NCT03723915|100934277|FG000|On Treatment|Failed to meet treatment requirements|2|||
33283245|NCT01191697|100934278|FG000|Overall Study|Death|1|||
33283246|NCT01191697|100934278|FG000|Overall Study|Physician Decision|2|||
33283247|NCT01191697|100934278|FG000|Overall Study|Pursue chemoradiation|2|||
33283248|NCT01191697|100934278|FG000|Overall Study|Break from chemotherapy|2|||
33283249|NCT01191697|100934278|FG000|Overall Study|Withdrawal by Subject|1|||
33283250|NCT01191697|100934278|FG000|Overall Study|Surveillance|1|||
33283251|NCT01191697|100934278|FG000|Overall Study|Adverse Event|2|||
33283252|NCT01191697|100934278|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
33283253|NCT01191697|100934278|FG000|Overall Study|Not completed but analyzed|25|||
33283254|NCT01874665|100934280|FG000|Overall Study|Adverse Event|6|||
33283255|NCT01874665|100934281|FG001|Overall Study|Adverse Event|2|||
33283256|NCT01874665|100934280|FG000|Overall Study|Withdrawal by Subject|4|||
33283257|NCT01874665|100934281|FG001|Overall Study|Withdrawal by Subject|1|||
33283258|NCT01874665|100934280|FG000|Overall Study|Physician Decision|3|||
33283259|NCT01874665|100934281|FG001|Overall Study|Physician Decision|0|||
33283260|NCT01874665|100934280|FG000|Overall Study|Clinical Progressive Disease|4|||
33283261|NCT01874665|100934281|FG001|Overall Study|Clinical Progressive Disease|3|||
33283262|NCT01874665|100934280|FG000|Overall Study|Study Terminated by Sponsor|0|||
33283263|NCT01874665|100934281|FG001|Overall Study|Study Terminated by Sponsor|2|||
33283264|NCT01874665|100934280|FG000|Overall Study|Documented Progressive Disease|11|||
33283265|NCT01874665|100934281|FG001|Overall Study|Documented Progressive Disease|7|||
33283266|NCT01874665|100934280|FG000|Overall Study|Other|2|||
33283267|NCT01874665|100934281|FG001|Overall Study|Other|0|||
33283268|NCT00853021|100934285|FG000|Overall Study|Adverse Event|2|||
33283269|NCT00853021|100934285|FG000|Overall Study|Withdrawal by Subject|2|||
33488039|NCT00911300|101679769|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
33283270|NCT00853021|100934285|FG000|Overall Study|Death|1|||
33283271|NCT01209286|100934286|FG000|Overall Study|Adverse Event|4|||
33283272|NCT01209286|100934287|FG001|Overall Study|Adverse Event|3|||
33283273|NCT01209286|100934288|FG002|Overall Study|Adverse Event|1|||
33283274|NCT01209286|100934286|FG000|Overall Study|Hematological Relapse After Remission|0|||
33488040|NCT00911300|101679770|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
33283275|NCT01209286|100934287|FG001|Overall Study|Hematological Relapse After Remission|1|||
33283276|NCT01209286|100934288|FG002|Overall Study|Hematological Relapse After Remission|1|||
33283277|NCT01209286|100934286|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
33283278|NCT01209286|100934287|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
33283279|NCT01209286|100934288|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
33283280|NCT01209286|100934286|FG000|Overall Study|Physician Decision|0|||
33283281|NCT01209286|100934287|FG001|Overall Study|Physician Decision|2|||
33283282|NCT01209286|100934288|FG002|Overall Study|Physician Decision|0|||
33283283|NCT01209286|100934286|FG000|Overall Study|Other|0|||
33283284|NCT01209286|100934287|FG001|Overall Study|Other|1|||
33283285|NCT01209286|100934288|FG002|Overall Study|Other|0|||
33283286|NCT01747629|100934290|FG000|Overall Study|Adverse Event|1|||
33283287|NCT01747629|100934291|FG001|Overall Study|Adverse Event|2|||
33283288|NCT01747629|100934290|FG000|Overall Study|Withdrawal by Subject|2|||
33283289|NCT01747629|100934291|FG001|Overall Study|Withdrawal by Subject|2|||
33283290|NCT01747629|100934290|FG000|Overall Study|Noncompliance|1|||
33283291|NCT01747629|100934291|FG001|Overall Study|Noncompliance|1|||
33283292|NCT01747629|100934290|FG000|Overall Study|Inclusion criteria not met|1|||
33283293|NCT01747629|100934291|FG001|Overall Study|Inclusion criteria not met|0|||
33283294|NCT01747629|100934290|FG000|Overall Study|Not treated|1|||
33283295|NCT01747629|100934291|FG001|Overall Study|Not treated|0|||
33283296|NCT01747629|100934290|FG000|Overall Study|Other|2|||
33283297|NCT01747629|100934291|FG001|Overall Study|Other|1|||
33283298|NCT03334695|100934294|FG000|Overall Study|Lost to Follow-up|3|||
33283299|NCT03334695|100934295|FG001|Overall Study|Lost to Follow-up|3|||
33283300|NCT03334695|100934294|FG000|Overall Study|Physician Decision|1|||
33283301|NCT03334695|100934295|FG001|Overall Study|Physician Decision|2|||
33283302|NCT03334695|100934294|FG000|Overall Study|Protocol Violation|0|||
33283303|NCT03334695|100934295|FG001|Overall Study|Protocol Violation|1|||
33283304|NCT03175198|100934296|FG000|Overall Study|Adverse Event|480|||
33283305|NCT03175198|100934296|FG000|Overall Study|No actual visit|120|||
33283306|NCT03175198|100934296|FG000|Overall Study|Registration rule not followed|4|||
33283307|NCT03175198|100934296|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
33283308|NCT03175198|100934296|FG000|Overall Study|Other personal reason|509|||
33283309|NCT03175198|100934296|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
33283310|NCT03175198|100934296|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
33283311|NCT03175198|100934296|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
33283312|NCT03175198|100934296|FG000|Overall Study|To conduct invasive treatment of operation|53|||
33283313|NCT03175198|100934296|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
33283314|NCT03041701|100934297|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
33283315|NCT03041701|100934298|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
33283316|NCT03041701|100934299|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
33283317|NCT03041701|100934297|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
33283318|NCT03041701|100934298|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
33283319|NCT03041701|100934299|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
33283320|NCT03605368|100934300|FG000|Overall Study|Lost to Follow-up|2|||
33283321|NCT03605368|100934301|FG001|Overall Study|Lost to Follow-up|1|||
33283322|NCT03605368|100934302|FG002|Overall Study|Lost to Follow-up|3|||
33283323|NCT03605368|100934303|FG003|Overall Study|Lost to Follow-up|2|||
33283324|NCT03605368|100934300|FG000|Overall Study|Withdrawal by Subject|0|||
33283325|NCT03605368|100934301|FG001|Overall Study|Withdrawal by Subject|0|||
33283326|NCT03605368|100934302|FG002|Overall Study|Withdrawal by Subject|4|||
33283327|NCT03605368|100934303|FG003|Overall Study|Withdrawal by Subject|3|||
33283328|NCT05060237|100934306|FG000|Overall Study|Withdrawal by Subject|4|||
33283329|NCT05060237|100934306|FG000|Overall Study|Screening failure|8|||
33283330|NCT01020747|100934311|FG000|Overall Study|Withdrawal by Subject|1|||
33283331|NCT03220776|100934312|FG000|Overall Study|Claustrophobia|0|||
33283332|NCT03220776|100934313|FG001|Overall Study|Claustrophobia|1|||
33283333|NCT03220776|100934314|FG002|Overall Study|Claustrophobia|1|||
33283334|NCT03220776|100934315|FG003|Overall Study|Claustrophobia|0|||
33283335|NCT03220776|100934316|FG004|Overall Study|Claustrophobia|1|||
33283336|NCT03220776|100934317|FG005|Overall Study|Claustrophobia|0|||
33283337|NCT03220776|100934312|FG000|Overall Study|MRI Equipment Failure|1|||
33283338|NCT03220776|100934313|FG001|Overall Study|MRI Equipment Failure|0|||
33283339|NCT03220776|100934314|FG002|Overall Study|MRI Equipment Failure|0|||
33283340|NCT03220776|100934315|FG003|Overall Study|MRI Equipment Failure|0|||
33283341|NCT03220776|100934316|FG004|Overall Study|MRI Equipment Failure|0|||
33283342|NCT03220776|100934317|FG005|Overall Study|MRI Equipment Failure|0|||
33283343|NCT03220776|100934312|FG000|Overall Study|Inclimate Weather|0|||
33283344|NCT03220776|100934313|FG001|Overall Study|Inclimate Weather|0|||
33283345|NCT03220776|100934314|FG002|Overall Study|Inclimate Weather|0|||
33283346|NCT03220776|100934315|FG003|Overall Study|Inclimate Weather|0|||
33283347|NCT03220776|100934316|FG004|Overall Study|Inclimate Weather|0|||
33283348|NCT03220776|100934317|FG005|Overall Study|Inclimate Weather|1|||
33283349|NCT03220776|100934312|FG000|Overall Study|Physician Decision|0|||
33283350|NCT03220776|100934313|FG001|Overall Study|Physician Decision|0|||
33283351|NCT03220776|100934314|FG002|Overall Study|Physician Decision|0|||
33283352|NCT03220776|100934315|FG003|Overall Study|Physician Decision|1|||
33283353|NCT03220776|100934316|FG004|Overall Study|Physician Decision|0|||
33283354|NCT03220776|100934317|FG005|Overall Study|Physician Decision|0|||
33283355|NCT03220776|100934312|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
33283356|NCT03220776|100934313|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
33283357|NCT03220776|100934314|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
33283358|NCT03220776|100934315|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
33283359|NCT03220776|100934316|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
33283360|NCT03220776|100934317|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
33283361|NCT03220776|100934312|FG000|Overall Study|Protocol Violation|0|||
33283362|NCT03220776|100934313|FG001|Overall Study|Protocol Violation|0|||
33283363|NCT03220776|100934314|FG002|Overall Study|Protocol Violation|0|||
33283364|NCT03220776|100934315|FG003|Overall Study|Protocol Violation|2|||
33283365|NCT03220776|100934316|FG004|Overall Study|Protocol Violation|0|||
33283366|NCT03220776|100934317|FG005|Overall Study|Protocol Violation|1|||
33283367|NCT03220776|100934312|FG000|Overall Study|Withdrawal by Subject|1|||
33283368|NCT03220776|100934313|FG001|Overall Study|Withdrawal by Subject|0|||
33283369|NCT03220776|100934314|FG002|Overall Study|Withdrawal by Subject|0|||
33283370|NCT03220776|100934315|FG003|Overall Study|Withdrawal by Subject|0|||
33283371|NCT03220776|100934316|FG004|Overall Study|Withdrawal by Subject|0|||
33283372|NCT03220776|100934317|FG005|Overall Study|Withdrawal by Subject|0|||
33283373|NCT00570921|100934318|FG000|Overall Study|Protocol Violation|1|||
33283374|NCT00570921|100934318|FG000|Overall Study|Physician Decision|1|||
33283375|NCT02269917|100934319|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
33283376|NCT02269917|100934320|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
33283377|NCT02269917|100934321|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
33283378|NCT02269917|100934319|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
33283379|NCT02269917|100934320|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
33283380|NCT02269917|100934321|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
33283381|NCT02269917|100934319|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
33283382|NCT02269917|100934320|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
33283383|NCT02269917|100934321|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
33283384|NCT02269917|100934319|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
33283385|NCT02269917|100934320|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
33283386|NCT02269917|100934321|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
33283387|NCT02269917|100934319|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
33283388|NCT02269917|100934320|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
33283389|NCT02269917|100934321|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
33283390|NCT02269917|100934319|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
33283391|NCT02269917|100934320|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
33283392|NCT02269917|100934321|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
33283393|NCT02269917|100934319|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
33283394|NCT02269917|100934320|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
33283395|NCT02269917|100934321|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
33283396|NCT02269917|100934319|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
33283397|NCT02269917|100934320|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
33283398|NCT02269917|100934321|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
33283399|NCT02269917|100934319|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
33283400|NCT02269917|100934320|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
33283401|NCT02269917|100934321|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
33283402|NCT02269917|100934319|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
33283403|NCT02269917|100934320|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
33283404|NCT02269917|100934321|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
33283405|NCT02269917|100934319|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
33283406|NCT02269917|100934320|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
33283407|NCT02269917|100934321|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
33283408|NCT02269917|100934319|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
33283409|NCT02269917|100934320|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
33283410|NCT02269917|100934321|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
33283411|NCT02269917|100934319|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
33283412|NCT02269917|100934320|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
33283413|NCT02269917|100934321|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
33283414|NCT02269917|100934319|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
33283415|NCT02269917|100934320|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
33283416|NCT02269917|100934321|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
33283417|NCT02269917|100934319|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
33283418|NCT02269917|100934320|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
33488041|NCT00911300|101679769|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
33283419|NCT02269917|100934321|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
33283420|NCT02269917|100934319|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
33283421|NCT02269917|100934320|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
33283422|NCT02269917|100934321|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
33283423|NCT00931918|100934322|FG000|Overall Study|Adverse Event|4|||
33283424|NCT00931918|100934323|FG001|Overall Study|Adverse Event|6|||
33283425|NCT00931918|100934322|FG000|Overall Study|Progressive Disease|2|||
33283426|NCT00931918|100934323|FG001|Overall Study|Progressive Disease|1|||
33283427|NCT00931918|100934322|FG000|Overall Study|Symptomatic Deterioration|1|||
33283428|NCT00931918|100934323|FG001|Overall Study|Symptomatic Deterioration|0|||
33283429|NCT00931918|100934322|FG000|Overall Study|Withdrawal by Patient|3|||
33283430|NCT00931918|100934323|FG001|Overall Study|Withdrawal by Patient|4|||
33283431|NCT00931918|100934322|FG000|Overall Study|Other Reason not Specified|4|||
33283432|NCT00931918|100934323|FG001|Overall Study|Other Reason not Specified|4|||
33283433|NCT00931918|100934322|FG000|Overall Study|Did not receive study drug|3|||
33283434|NCT00931918|100934323|FG001|Overall Study|Did not receive study drug|2|||
33283435|NCT02469077|100934324|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
33283436|NCT02469077|100934325|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
33283437|NCT02469077|100934324|FG000|Post Randomization/Intervention Period|Relocated|1|||
33283438|NCT02469077|100934325|FG001|Post Randomization/Intervention Period|Relocated|1|||
33283439|NCT02469077|100934324|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
33283440|NCT02469077|100934325|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
33283441|NCT02469077|100934324|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
33283442|NCT02469077|100934325|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
33283443|NCT01011049|100934326|FG000|Overall Study|Protocol Violation|0|||
33283444|NCT01011049|100934327|FG001|Overall Study|Protocol Violation|0|||
33283445|NCT01011049|100934328|FG002|Overall Study|Protocol Violation|2|||
33283446|NCT01011049|100934329|FG003|Overall Study|Protocol Violation|0|||
33283447|NCT01011049|100934326|FG000|Overall Study|Lost to Follow-up|1|||
33283448|NCT01011049|100934327|FG001|Overall Study|Lost to Follow-up|2|||
33283449|NCT01011049|100934328|FG002|Overall Study|Lost to Follow-up|1|||
33283450|NCT01011049|100934329|FG003|Overall Study|Lost to Follow-up|0|||
33283451|NCT01011049|100934326|FG000|Overall Study|Withdrawal by Subject|0|||
33283452|NCT01011049|100934327|FG001|Overall Study|Withdrawal by Subject|0|||
33283453|NCT01011049|100934328|FG002|Overall Study|Withdrawal by Subject|1|||
33283454|NCT01011049|100934329|FG003|Overall Study|Withdrawal by Subject|0|||
33283455|NCT01431950|100934330|FG000|Overall Study|Study Site Closed/Terminated|7|||
33283456|NCT01431950|100934331|FG001|Overall Study|Study Site Closed/Terminated|3|||
33283457|NCT01431950|100934330|FG000|Overall Study|Withdrawal by Subject|4|||
33283458|NCT01431950|100934331|FG001|Overall Study|Withdrawal by Subject|3|||
33283459|NCT01431950|100934330|FG000|Overall Study|Protocol Violation|2|||
33283460|NCT01431950|100934331|FG001|Overall Study|Protocol Violation|3|||
33283461|NCT01431950|100934330|FG000|Overall Study|Adverse Event|2|||
33283462|NCT01431950|100934331|FG001|Overall Study|Adverse Event|2|||
33283463|NCT01431950|100934330|FG000|Overall Study|Physician Decision|2|||
33283464|NCT01431950|100934331|FG001|Overall Study|Physician Decision|1|||
33283465|NCT01431950|100934330|FG000|Overall Study|Lack of Efficacy|2|||
33283466|NCT01431950|100934331|FG001|Overall Study|Lack of Efficacy|1|||
33283467|NCT01431950|100934330|FG000|Overall Study|Lost to Follow-up|0|||
33283468|NCT01431950|100934331|FG001|Overall Study|Lost to Follow-up|1|||
33283469|NCT01431950|100934330|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
33283470|NCT01431950|100934331|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
33283471|NCT03280108|100934345|FG000|Overall Study|Lost to Follow-up|2|||
33283472|NCT03280108|100934346|FG001|Overall Study|Lost to Follow-up|0|||
33283473|NCT02143063|100934347|FG000|Overall Study|Lost to Follow-up|16|||
33283474|NCT02143063|100934348|FG001|Overall Study|Lost to Follow-up|28|||
33283475|NCT02143063|100934349|FG002|Overall Study|Lost to Follow-up|29|||
33283476|NCT02143063|100934347|FG000|Overall Study|Withdrawal by Subject|0|||
33283477|NCT02143063|100934348|FG001|Overall Study|Withdrawal by Subject|1|||
33283478|NCT02143063|100934349|FG002|Overall Study|Withdrawal by Subject|0|||
33283479|NCT02143063|100934347|FG000|Overall Study|Death|0|||
33283480|NCT02143063|100934348|FG001|Overall Study|Death|1|||
33283481|NCT02143063|100934349|FG002|Overall Study|Death|1|||
33283482|NCT01388478|100934352|FG000|Overall Study|Adverse Event|4|||
33283483|NCT01388478|100934352|FG000|Overall Study|Withdrawal by Subject|1|||
33283484|NCT03028012|100934353|FG000|Overall Study|Lost to Follow-up|2|||
33283485|NCT03028012|100934354|FG001|Overall Study|Lost to Follow-up|3|||
33283486|NCT03028012|100934355|FG002|Overall Study|Lost to Follow-up|3|||
33283487|NCT01370018|100934356|FG000|Overall Study|Did not meet criteria for analysis|1|||
33283488|NCT01349036|100934357|FG000|Overall Study|Disease progression|13|||
33283489|NCT01349036|100934358|FG001|Overall Study|Disease progression|22|||
33283490|NCT01349036|100934357|FG000|Overall Study|Other|1|||
33283491|NCT01349036|100934358|FG001|Overall Study|Other|0|||
33283492|NCT01349036|100934357|FG000|Overall Study|Withdrawal by Subject|0|||
33283493|NCT01349036|100934358|FG001|Overall Study|Withdrawal by Subject|2|||
33283494|NCT00819013|100934362|FG000|Overall Study|Not meeting continuing study eligibility|2|||
33283495|NCT00819013|100934363|FG001|Overall Study|Not meeting continuing study eligibility|1|||
33283496|NCT00819013|100934364|FG002|Overall Study|Not meeting continuing study eligibility|2|||
33283497|NCT00819013|100934365|FG003|Overall Study|Not meeting continuing study eligibility|1|||
33283498|NCT00819013|100934362|FG000|Overall Study|Adverse Event|0|||
33283499|NCT00819013|100934363|FG001|Overall Study|Adverse Event|0|||
33283500|NCT00819013|100934364|FG002|Overall Study|Adverse Event|1|||
33283501|NCT00819013|100934365|FG003|Overall Study|Adverse Event|0|||
33283502|NCT00819013|100934362|FG000|Overall Study|Withdrawal by Subject|1|||
33283503|NCT00819013|100934363|FG001|Overall Study|Withdrawal by Subject|0|||
33283504|NCT00819013|100934364|FG002|Overall Study|Withdrawal by Subject|1|||
33283505|NCT00819013|100934365|FG003|Overall Study|Withdrawal by Subject|0|||
33283506|NCT00819013|100934362|FG000|Overall Study|Lost to Follow-up|0|||
33283507|NCT00819013|100934363|FG001|Overall Study|Lost to Follow-up|0|||
33283508|NCT00819013|100934364|FG002|Overall Study|Lost to Follow-up|1|||
33283509|NCT00819013|100934365|FG003|Overall Study|Lost to Follow-up|2|||
33283510|NCT00819013|100934362|FG000|Overall Study|Death|0|||
33283511|NCT00819013|100934363|FG001|Overall Study|Death|0|||
33283512|NCT00819013|100934364|FG002|Overall Study|Death|0|||
33283513|NCT00819013|100934365|FG003|Overall Study|Death|1|||
33283514|NCT01746108|100934371|FG000|Overall Study|Migrated /moved from study area|0|||
33283515|NCT01746108|100934372|FG001|Overall Study|Migrated /moved from study area|1|||
33283516|NCT01746108|100934373|FG002|Overall Study|Migrated /moved from study area|0|||
33283517|NCT01746108|100934371|FG000|Overall Study|Adverse event, non-fatal|0|||
33283518|NCT01746108|100934372|FG001|Overall Study|Adverse event, non-fatal|1|||
33283519|NCT01746108|100934373|FG002|Overall Study|Adverse event, non-fatal|0|||
33283520|NCT01746108|100934371|FG000|Overall Study|Withdrawal by Subject|0|||
33283521|NCT01746108|100934372|FG001|Overall Study|Withdrawal by Subject|1|||
33283522|NCT01746108|100934373|FG002|Overall Study|Withdrawal by Subject|0|||
33283523|NCT01746108|100934371|FG000|Overall Study|Lost to Follow-up|0|||
33283524|NCT01746108|100934372|FG001|Overall Study|Lost to Follow-up|1|||
33283525|NCT01746108|100934373|FG002|Overall Study|Lost to Follow-up|0|||
33283526|NCT01820637|100934374|FG000|Overall Study|Death|2|||
33283527|NCT01820637|100934374|FG000|Overall Study|Withdrawal by Subject|1|||
33283528|NCT00496834|100934375|FG000|Overall Study|Withdrawal by Subject|4|||
33283529|NCT00496834|100934376|FG001|Overall Study|Withdrawal by Subject|6|||
33283530|NCT00496834|100934375|FG000|Overall Study|Contraindicated medication administered|0|||
33283531|NCT00496834|100934376|FG001|Overall Study|Contraindicated medication administered|1|||
33283532|NCT00496834|100934375|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
33283533|NCT00496834|100934376|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
33283534|NCT00496834|100934375|FG000|Overall Study|Adverse Event|5|||
33283535|NCT00496834|100934376|FG001|Overall Study|Adverse Event|3|||
33283536|NCT00496834|100934375|FG000|Overall Study|IP administration violation|2|||
33283537|NCT00496834|100934376|FG001|Overall Study|IP administration violation|0|||
33283538|NCT00496834|100934375|FG000|Overall Study|Lost to Follow-up|2|||
33283539|NCT00496834|100934376|FG001|Overall Study|Lost to Follow-up|0|||
33283540|NCT00496834|100934375|FG000|Overall Study|Blood Pressure control failure|2|||
33283541|NCT00496834|100934376|FG001|Overall Study|Blood Pressure control failure|1|||
33283542|NCT04772313|100934377|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
33283543|NCT04772313|100934377|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
33283544|NCT02287883|100934378|FG000|Overall Study|Death|8|||
33283545|NCT02287883|100934379|FG001|Overall Study|Death|7|||
33283546|NCT02287883|100934378|FG000|Overall Study|No longer eligible|222|||
33283547|NCT02287883|100934379|FG001|Overall Study|No longer eligible|182|||
33283548|NCT02287883|100934378|FG000|Overall Study|Non-response to survey|229|||
33283549|NCT02287883|100934379|FG001|Overall Study|Non-response to survey|237|||
33283550|NCT01123642|100934380|FG000|Overall Study|Lost to Follow-up|23|||
33283551|NCT01123642|100934380|FG000|Overall Study|Withdrawal by Subject|9|||
33283552|NCT01123642|100934380|FG000|Overall Study|ineligible at baseline assessment|36|||
33283553|NCT03503162|100934387|FG000|Overall Study|did not meet eligibility|1|||
33283554|NCT00922441|100934388|FG000|Overall Study|Protocol Violation|0|||
33283555|NCT00922441|100934389|FG001|Overall Study|Protocol Violation|0|||
33283556|NCT00922441|100934390|FG002|Overall Study|Protocol Violation|2|||
33283557|NCT00922441|100934388|FG000|Overall Study|Withdrawal by Subject|0|||
33283558|NCT00922441|100934389|FG001|Overall Study|Withdrawal by Subject|0|||
33283559|NCT00922441|100934390|FG002|Overall Study|Withdrawal by Subject|1|||
33283560|NCT01705145|100934391|FG000|Part B|Adverse Event|1|||
33283561|NCT01978236|100934393|FG000|Overall Study|Discontinued due to study close|2|||
33283562|NCT01251887|100934394|FG000|Overall Study|Scheduling conflict|1|||
33283563|NCT01251887|100934395|FG001|Overall Study|Scheduling conflict|2|||
33283564|NCT01251887|100934396|FG002|Overall Study|Scheduling conflict|2|||
33283565|NCT01251887|100934394|FG000|Overall Study|Physician Decision|0|||
33283566|NCT01251887|100934395|FG001|Overall Study|Physician Decision|1|||
33283567|NCT01251887|100934396|FG002|Overall Study|Physician Decision|0|||
33283568|NCT02383927|100934397|FG000|Overall Study|Disease Progression|8|||
33283569|NCT02383927|100934398|FG001|Overall Study|Disease Progression|8|||
33283570|NCT02383927|100934399|FG002|Overall Study|Disease Progression|15|||
33283571|NCT02383927|100934400|FG003|Overall Study|Disease Progression|4|||
33283572|NCT02383927|100934397|FG000|Overall Study|Physician Decision|0|||
33283573|NCT02383927|100934398|FG001|Overall Study|Physician Decision|0|||
33283574|NCT02383927|100934399|FG002|Overall Study|Physician Decision|2|||
33283575|NCT02383927|100934400|FG003|Overall Study|Physician Decision|0|||
33283576|NCT02383927|100934397|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
33283577|NCT02383927|100934398|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
33283578|NCT02383927|100934399|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
33283579|NCT02383927|100934400|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
33283580|NCT02383927|100934397|FG000|Overall Study|Adverse Event|4|||
33283581|NCT02383927|100934398|FG001|Overall Study|Adverse Event|1|||
33283582|NCT02383927|100934399|FG002|Overall Study|Adverse Event|3|||
33283583|NCT02383927|100934400|FG003|Overall Study|Adverse Event|5|||
33283584|NCT02383927|100934397|FG000|Overall Study|Miscellaneous|1|||
33283585|NCT02383927|100934398|FG001|Overall Study|Miscellaneous|0|||
33283586|NCT02383927|100934399|FG002|Overall Study|Miscellaneous|0|||
33283587|NCT02383927|100934400|FG003|Overall Study|Miscellaneous|1|||
33283588|NCT02383927|100934397|FG000|Overall Study|Withdrawal by Subject|0|||
33283589|NCT02383927|100934398|FG001|Overall Study|Withdrawal by Subject|1|||
33283590|NCT02383927|100934399|FG002|Overall Study|Withdrawal by Subject|4|||
33283591|NCT02383927|100934400|FG003|Overall Study|Withdrawal by Subject|0|||
33283592|NCT00866918|100934403|FG000|Overall Study|Death|1|||
33283593|NCT00866918|100934404|FG001|Overall Study|Death|5|||
33283594|NCT00866918|100934403|FG000|Overall Study|Lack of Efficacy|1|||
33283595|NCT00866918|100934404|FG001|Overall Study|Lack of Efficacy|1|||
33283596|NCT00866918|100934403|FG000|Overall Study|Physician Decision|10|||
33283597|NCT00866918|100934404|FG001|Overall Study|Physician Decision|2|||
33283598|NCT00866918|100934403|FG000|Overall Study|Ineligible|2|||
33283599|NCT00866918|100934404|FG001|Overall Study|Ineligible|4|||
33283600|NCT00866918|100934403|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
33283601|NCT00866918|100934404|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
33283602|NCT00866918|100934403|FG000|Overall Study|Secondary malignancy|1|||
33283603|NCT00866918|100934404|FG001|Overall Study|Secondary malignancy|0|||
33283604|NCT03821064|100934406|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
33283605|NCT04270747|100934409|FG000|Through Week 16|Adverse Event|1|||
33283606|NCT04270747|100934410|FG001|Through Week 16|Adverse Event|2|||
33283607|NCT04270747|100934411|FG002|Through Week 16|Adverse Event|0|||
33488042|NCT00911300|101679770|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
33488043|NCT00911300|101679769|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
33488044|NCT00911300|101679770|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
33488045|NCT00911300|101679769|FG000|Overall Study|International Normalized Ratio Too High|0|||
33488046|NCT00911300|101679770|FG001|Overall Study|International Normalized Ratio Too High|1|||
33488047|NCT00911300|101679769|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
33488048|NCT00911300|101679770|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
33488049|NCT00911300|101679769|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
33488050|NCT00911300|101679770|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
33488051|NCT00911300|101679769|FG000|Overall Study|Physician Decision|0|||
33488052|NCT00911300|101679770|FG001|Overall Study|Physician Decision|1|||
33488053|NCT00911300|101679769|FG000|Overall Study|Treatment Stopped by Mistake|0|||
33488054|NCT00911300|101679770|FG001|Overall Study|Treatment Stopped by Mistake|1|||
33488055|NCT00911300|101679769|FG000|Overall Study|Randomized; No Study Medication Received|0|||
33488056|NCT00911300|101679770|FG001|Overall Study|Randomized; No Study Medication Received|2|||
33488057|NCT02661217|101679772|FG000|Overall Study|Physician Decision|12|||
33488058|NCT02661217|101679773|FG001|Overall Study|Physician Decision|15|||
33488059|NCT02661217|101679772|FG000|Overall Study|Lost to Follow-up|1|||
33488060|NCT02661217|101679773|FG001|Overall Study|Lost to Follow-up|4|||
33488061|NCT02661217|101679772|FG000|Overall Study|Protocol Deviation|0|||
33488062|NCT02661217|101679773|FG001|Overall Study|Protocol Deviation|4|||
33488063|NCT02661217|101679772|FG000|Overall Study|Non-compliance with study treatment|5|||
33488064|NCT02661217|101679773|FG001|Overall Study|Non-compliance with study treatment|5|||
33488065|NCT02661217|101679772|FG000|Overall Study|Death|21|||
33488066|NCT02661217|101679773|FG001|Overall Study|Death|15|||
33488067|NCT02661217|101679772|FG000|Overall Study|Adverse Event|10|||
33488068|NCT02661217|101679773|FG001|Overall Study|Adverse Event|8|||
33488069|NCT02661217|101679772|FG000|Overall Study|Withdrawal by Subject|15|||
33488070|NCT02661217|101679773|FG001|Overall Study|Withdrawal by Subject|19|||
33488071|NCT02661217|101679772|FG000|Overall Study|Did not enter follow-up epoch|7|||
33488072|NCT02661217|101679773|FG001|Overall Study|Did not enter follow-up epoch|10|||
33283608|NCT04270747|100934409|FG000|Through Week 16|Death|0|||
33283609|NCT04270747|100934410|FG001|Through Week 16|Death|2|||
33488073|NCT02661217|101679772|FG000|Overall Study|Death - no study drug received|1|||
33488074|NCT02661217|101679773|FG001|Overall Study|Death - no study drug received|2|||
33283610|NCT04270747|100934411|FG002|Through Week 16|Death|0|||
33283611|NCT04270747|100934409|FG000|Through Week 16|Consent Withdrawn|3|||
33283612|NCT04270747|100934410|FG001|Through Week 16|Consent Withdrawn|3|||
33488075|NCT02661217|101679772|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
33488076|NCT02661217|101679773|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
33488077|NCT02088697|101679784|FG000|Period I|Physician Decision|1|||
33488078|NCT02088697|101679785|FG001|Period I|Physician Decision|4|||
33488079|NCT02088697|101679784|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
33488080|NCT02088697|101679785|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
33488081|NCT04414618|101679794|FG000|Overall Study|Death|3|||
33488082|NCT04414618|101679795|FG001|Overall Study|Death|3|||
33488083|NCT04414618|101679794|FG000|Overall Study|Withdrawal by Subject|2|||
33488084|NCT04414618|101679795|FG001|Overall Study|Withdrawal by Subject|1|||
33488085|NCT04414618|101679794|FG000|Overall Study|Lost to Follow-up|2|||
33488086|NCT04414618|101679795|FG001|Overall Study|Lost to Follow-up|3|||
33488087|NCT04414618|101679794|FG000|Overall Study|Physician Decision|1|||
33488088|NCT04414618|101679795|FG001|Overall Study|Physician Decision|0|||
33488089|NCT02108912|101679796|FG000|Overall Study|Lost to Follow-up|1|||
33488090|NCT02108912|101679797|FG001|Overall Study|Lost to Follow-up|1|||
33488091|NCT02108912|101679796|FG000|Overall Study|lack of transportation|1|||
33488092|NCT02108912|101679797|FG001|Overall Study|lack of transportation|0|||
33488093|NCT02108912|101679796|FG000|Overall Study|high blood pressure|1|||
33488094|NCT02108912|101679797|FG001|Overall Study|high blood pressure|0|||
33488095|NCT00739063|101679798|FG000|Overall Study|Screen failures|8|||
33488096|NCT02536846|101679801|FG000|Overall Study|Withdrawal by Subject|1|||
33488097|NCT01372748|101679802|FG000|Overall Study|Lost to Follow-up|16|||
33488098|NCT01372748|101679803|FG001|Overall Study|Lost to Follow-up|34|||
33488099|NCT01372748|101679802|FG000|Overall Study|Withdrawal by Subject|7|||
33488100|NCT01372748|101679803|FG001|Overall Study|Withdrawal by Subject|5|||
33488101|NCT01408043|101679811|FG000|Overall Study|unable to collect cells|1|||
33488102|NCT01406574|101679812|FG000|Overall Study|Adverse Event|0|||
33488103|NCT01406574|101679813|FG001|Overall Study|Adverse Event|0|||
33488104|NCT01406574|101679814|FG002|Overall Study|Adverse Event|1|||
33488105|NCT01406574|101679815|FG003|Overall Study|Adverse Event|3|||
33488106|NCT01406574|101679812|FG000|Overall Study|Physician Decision|0|||
33488107|NCT01406574|101679813|FG001|Overall Study|Physician Decision|0|||
33488108|NCT01406574|101679814|FG002|Overall Study|Physician Decision|0|||
33488109|NCT01406574|101679815|FG003|Overall Study|Physician Decision|1|||
33488110|NCT01406574|101679812|FG000|Overall Study|Withdrawal by Subject|0|||
33488111|NCT01406574|101679813|FG001|Overall Study|Withdrawal by Subject|1|||
33488112|NCT01406574|101679814|FG002|Overall Study|Withdrawal by Subject|0|||
33488113|NCT01406574|101679815|FG003|Overall Study|Withdrawal by Subject|0|||
33488114|NCT01406574|101679812|FG000|Overall Study|Definite progression of primary disease|1|||
33488115|NCT01406574|101679813|FG001|Overall Study|Definite progression of primary disease|0|||
33488116|NCT01406574|101679814|FG002|Overall Study|Definite progression of primary disease|0|||
33488117|NCT01406574|101679815|FG003|Overall Study|Definite progression of primary disease|0|||
33488118|NCT00640315|101679816|FG000|Overall Study|Withdrawal by Subject|0|||
33488119|NCT00640315|101679817|FG001|Overall Study|Withdrawal by Subject|1|||
33488120|NCT04578535|101679818|FG000|Overall Study|Lost to Follow-up|1|||
33488121|NCT04578535|101679819|FG001|Overall Study|Lost to Follow-up|0|||
33488122|NCT04578535|101679820|FG002|Overall Study|Lost to Follow-up|0|||
33488123|NCT04578535|101679821|FG003|Overall Study|Lost to Follow-up|1|||
33488124|NCT04578535|101679822|FG004|Overall Study|Lost to Follow-up|0|||
33488125|NCT04578535|101679823|FG005|Overall Study|Lost to Follow-up|2|||
33488126|NCT04578535|101679818|FG000|Overall Study|Pregnancy|1|||
33488127|NCT04578535|101679819|FG001|Overall Study|Pregnancy|0|||
33488128|NCT04578535|101679820|FG002|Overall Study|Pregnancy|0|||
33488129|NCT04578535|101679821|FG003|Overall Study|Pregnancy|0|||
33488130|NCT04578535|101679822|FG004|Overall Study|Pregnancy|0|||
33488131|NCT04578535|101679823|FG005|Overall Study|Pregnancy|0|||
33488132|NCT04578535|101679818|FG000|Overall Study|Withdrawal by Subject|0|||
33488133|NCT04578535|101679819|FG001|Overall Study|Withdrawal by Subject|0|||
33488134|NCT04578535|101679820|FG002|Overall Study|Withdrawal by Subject|0|||
33488135|NCT04578535|101679821|FG003|Overall Study|Withdrawal by Subject|1|||
33488136|NCT04578535|101679822|FG004|Overall Study|Withdrawal by Subject|1|||
33488137|NCT04578535|101679823|FG005|Overall Study|Withdrawal by Subject|5|||
33488138|NCT04578535|101679818|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
33488139|NCT04578535|101679819|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
33488140|NCT04578535|101679820|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
33488141|NCT04578535|101679821|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
33488142|NCT04578535|101679822|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
33488143|NCT04578535|101679823|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
33283613|NCT04270747|100934411|FG002|Through Week 16|Consent Withdrawn|0|||
33488144|NCT03280264|101683027|FG000|Overall Study|Adverse Event|1|||
33488145|NCT03280264|101683027|FG000|Overall Study|Physician Decision|1|||
33488146|NCT03280264|101683027|FG000|Overall Study|Withdrawal by Subject|1|||
33488147|NCT00995774|101683030|FG000|Training Period 2|Withdrawal by Subject|2|||
33488148|NCT00995774|101683031|FG001|Training Period 2|Withdrawal by Subject|0|||
33488149|NCT02017015|101683032|FG000|Overall Study|Adverse Event|9|||
33488150|NCT02017015|101683032|FG000|Overall Study|Withdrawal by Subject|21|||
33488151|NCT02017015|101683032|FG000|Overall Study|Death|4|||
33488152|NCT02017015|101683032|FG000|Overall Study|Progressive Disease|31|||
33488153|NCT02017015|101683032|FG000|Overall Study|Non-compliance with study drug|2|||
33488154|NCT02017015|101683032|FG000|Overall Study|Physician Decision|2|||
33488155|NCT02452476|101683033|FG000|Overall Study|Death|4|||
33488156|NCT02452476|101683034|FG001|Overall Study|Death|7|||
33488157|NCT02452476|101683033|FG000|Overall Study|Lost to Follow-up|1|||
33488158|NCT02452476|101683034|FG001|Overall Study|Lost to Follow-up|1|||
33488159|NCT02452476|101683033|FG000|Overall Study|Physician Decision|1|||
33488160|NCT02452476|101683034|FG001|Overall Study|Physician Decision|1|||
33488161|NCT02452476|101683033|FG000|Overall Study|Not treated|5|||
33488162|NCT02452476|101683034|FG001|Overall Study|Not treated|1|||
33488163|NCT03066258|101683037|FG000|Overall Study|Death|1|||
33488164|NCT03066258|101683038|FG001|Overall Study|Death|0|||
33488165|NCT03066258|101683039|FG002|Overall Study|Death|0|||
33488166|NCT03066258|101683040|FG003|Overall Study|Death|0|||
33488167|NCT03066258|101683041|FG004|Overall Study|Death|1|||
33488168|NCT02301390|101683048|FG000|Overall Study|Withdrawal by Subject|3|||
33488169|NCT02301390|101683049|FG001|Overall Study|Withdrawal by Subject|5|||
33488170|NCT02301390|101683048|FG000|Overall Study|Protocol Violation|1|||
33488171|NCT02301390|101683049|FG001|Overall Study|Protocol Violation|0|||
33488172|NCT02301390|101683048|FG000|Overall Study|Physician Decision|1|||
33488173|NCT02301390|101683049|FG001|Overall Study|Physician Decision|0|||
33488174|NCT02301390|101683048|FG000|Overall Study|Lost to Follow-up|0|||
33488175|NCT02301390|101683049|FG001|Overall Study|Lost to Follow-up|1|||
33488176|NCT02301390|101683048|FG000|Overall Study|Death|2|||
33488177|NCT02301390|101683049|FG001|Overall Study|Death|2|||
33488178|NCT02301390|101683048|FG000|Overall Study|Procedure not completed|0|||
33488179|NCT02301390|101683049|FG001|Overall Study|Procedure not completed|4|||
33488180|NCT02301390|101683048|FG000|Overall Study|Missed multiple visits|1|||
33488181|NCT02301390|101683049|FG001|Overall Study|Missed multiple visits|1|||
33488182|NCT02301390|101683048|FG000|Overall Study|study terminated|2|||
33488183|NCT02301390|101683049|FG001|Overall Study|study terminated|0|||
33488184|NCT04315506|101683050|FG000|Overall Study|Lost to Follow-up|74|||
33488185|NCT04315506|101683051|FG001|Overall Study|Lost to Follow-up|82|||
33488186|NCT04315506|101683050|FG000|Overall Study|Withdrawal by Subject|8|||
33488187|NCT04315506|101683051|FG001|Overall Study|Withdrawal by Subject|8|||
33488188|NCT04315506|101683050|FG000|Overall Study|Physician Decision|0|||
33488189|NCT04315506|101683051|FG001|Overall Study|Physician Decision|1|||
33488190|NCT01130493|101683052|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
33488191|NCT01130493|101683053|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
33488192|NCT01130493|101683054|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
33488193|NCT01130493|101683052|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
33488194|NCT01130493|101683053|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
33488195|NCT01130493|101683054|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
33488196|NCT01130493|101683052|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
33488197|NCT01130493|101683053|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
33488198|NCT01130493|101683054|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
33488199|NCT01130493|101683052|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
33488200|NCT01130493|101683053|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
33488201|NCT01130493|101683054|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
33488202|NCT01130493|101683052|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
33488203|NCT01130493|101683053|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
33488204|NCT01130493|101683054|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
33488205|NCT01130493|101683052|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
33488206|NCT01130493|101683053|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
33488207|NCT01130493|101683054|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
33488208|NCT01130493|101683052|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
33488209|NCT01130493|101683053|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
33488210|NCT01130493|101683054|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
33488211|NCT01130493|101683052|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
33488212|NCT01130493|101683053|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
33488213|NCT01130493|101683054|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
33488214|NCT01130493|101683052|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
33488215|NCT01130493|101683053|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
33488216|NCT01130493|101683054|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
33488217|NCT01130493|101683052|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
33488218|NCT01130493|101683053|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
33488219|NCT01130493|101683054|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
33488220|NCT01130493|101683052|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
33488221|NCT01130493|101683053|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
33488222|NCT01130493|101683054|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
33488223|NCT01130493|101683052|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
33488224|NCT01130493|101683053|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
33488225|NCT01130493|101683054|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
33488226|NCT01130493|101683052|FG000|Part 2: OLE|Adverse Event|0|||
33488227|NCT01130493|101683053|FG001|Part 2: OLE|Adverse Event|2|||
33488228|NCT01130493|101683054|FG002|Part 2: OLE|Adverse Event|1|||
33488229|NCT01130493|101683052|FG000|Part 2: OLE|Withdrawal by Subject|0|||
33488230|NCT01130493|101683053|FG001|Part 2: OLE|Withdrawal by Subject|1|||
33488231|NCT01130493|101683054|FG002|Part 2: OLE|Withdrawal by Subject|4|||
33488232|NCT01821807|101683056|FG000|Overall Study|Lost to Follow-up|3|||
33488233|NCT01821807|101683057|FG001|Overall Study|Lost to Follow-up|1|||
33488234|NCT04289363|101683058|FG000|Overall Study|Lost to Follow-up|14|||
33488235|NCT04289363|101683059|FG001|Overall Study|Lost to Follow-up|0|||
33488236|NCT03624192|101683060|FG000|Overall Study|Lost to Follow-up|1|||
33488237|NCT03624192|101683061|FG001|Overall Study|Lost to Follow-up|1|||
33488238|NCT01056289|101683062|FG000|Open-label Phase|Adverse Event|29|||
33488239|NCT01056289|101683063|FG001|Open-label Phase|Adverse Event|0|||
33488240|NCT01056289|101683064|FG002|Open-label Phase|Adverse Event|0|||
33488241|NCT01056289|101683065|FG003|Open-label Phase|Adverse Event|0|||
33488242|NCT01056289|101683062|FG000|Open-label Phase|Lost to Follow-up|30|||
33488243|NCT01056289|101683063|FG001|Open-label Phase|Lost to Follow-up|0|||
33488244|NCT01056289|101683064|FG002|Open-label Phase|Lost to Follow-up|0|||
33488245|NCT01056289|101683065|FG003|Open-label Phase|Lost to Follow-up|0|||
33488246|NCT01056289|101683062|FG000|Open-label Phase|Other|9|||
33488247|NCT01056289|101683063|FG001|Open-label Phase|Other|0|||
33488248|NCT01056289|101683064|FG002|Open-label Phase|Other|0|||
33488249|NCT01056289|101683065|FG003|Open-label Phase|Other|0|||
33488250|NCT01056289|101683062|FG000|Open-label Phase|Protocol Violation|6|||
33488251|NCT01056289|101683063|FG001|Open-label Phase|Protocol Violation|0|||
33488252|NCT01056289|101683064|FG002|Open-label Phase|Protocol Violation|0|||
33488253|NCT01056289|101683065|FG003|Open-label Phase|Protocol Violation|0|||
33488254|NCT01056289|101683062|FG000|Open-label Phase|Withdrawal by Subject|26|||
33488255|NCT01056289|101683063|FG001|Open-label Phase|Withdrawal by Subject|0|||
33488256|NCT01056289|101683064|FG002|Open-label Phase|Withdrawal by Subject|0|||
33488257|NCT01056289|101683065|FG003|Open-label Phase|Withdrawal by Subject|0|||
33488258|NCT01056289|101683062|FG000|Open-label Phase|Lack of Efficacy|18|||
33488259|NCT01056289|101683063|FG001|Open-label Phase|Lack of Efficacy|0|||
33488260|NCT01056289|101683064|FG002|Open-label Phase|Lack of Efficacy|0|||
33488261|NCT01056289|101683065|FG003|Open-label Phase|Lack of Efficacy|0|||
33488262|NCT01056289|101683062|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
33488263|NCT01056289|101683063|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
33488264|NCT01056289|101683064|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
33488265|NCT01056289|101683065|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
33488266|NCT01056289|101683062|FG000|Double-blind Phase|Adverse Event|0|||
33488267|NCT01056289|101683063|FG001|Double-blind Phase|Adverse Event|1|||
33488268|NCT01056289|101683064|FG002|Double-blind Phase|Adverse Event|2|||
33488269|NCT01056289|101683065|FG003|Double-blind Phase|Adverse Event|1|||
33488270|NCT01056289|101683062|FG000|Double-blind Phase|Lost to Follow-up|0|||
33488271|NCT01056289|101683063|FG001|Double-blind Phase|Lost to Follow-up|2|||
33488272|NCT01056289|101683064|FG002|Double-blind Phase|Lost to Follow-up|2|||
33488273|NCT01056289|101683065|FG003|Double-blind Phase|Lost to Follow-up|2|||
33488274|NCT01056289|101683062|FG000|Double-blind Phase|Other|0|||
33488275|NCT01056289|101683063|FG001|Double-blind Phase|Other|0|||
33488276|NCT01056289|101683064|FG002|Double-blind Phase|Other|1|||
33488277|NCT01056289|101683065|FG003|Double-blind Phase|Other|2|||
33488278|NCT01056289|101683062|FG000|Double-blind Phase|Protocol Violation|0|||
33488279|NCT01056289|101683063|FG001|Double-blind Phase|Protocol Violation|0|||
33488280|NCT01056289|101683064|FG002|Double-blind Phase|Protocol Violation|1|||
33488281|NCT01056289|101683065|FG003|Double-blind Phase|Protocol Violation|1|||
33488282|NCT01056289|101683062|FG000|Double-blind Phase|Withdrawal by Subject|0|||
33488283|NCT01056289|101683063|FG001|Double-blind Phase|Withdrawal by Subject|0|||
33488284|NCT01056289|101683064|FG002|Double-blind Phase|Withdrawal by Subject|4|||
33488285|NCT01056289|101683065|FG003|Double-blind Phase|Withdrawal by Subject|2|||
33488286|NCT01056289|101683062|FG000|Double-blind Phase|Discontinuation symptom|0|||
33488287|NCT01056289|101683063|FG001|Double-blind Phase|Discontinuation symptom|1|||
33488288|NCT01056289|101683064|FG002|Double-blind Phase|Discontinuation symptom|2|||
33488289|NCT01056289|101683065|FG003|Double-blind Phase|Discontinuation symptom|2|||
33488290|NCT01056289|101683062|FG000|Double-blind Phase|Physician Decision|0|||
33488291|NCT01056289|101683063|FG001|Double-blind Phase|Physician Decision|0|||
33488292|NCT01056289|101683064|FG002|Double-blind Phase|Physician Decision|1|||
33488293|NCT01056289|101683065|FG003|Double-blind Phase|Physician Decision|0|||
33488294|NCT00550459|101683067|FG000|Overall Study|Adverse Event|0|||
33488295|NCT00550459|101683068|FG001|Overall Study|Adverse Event|2|||
33488296|NCT00550459|101683067|FG000|Overall Study|Withdrawal by Subject|1|||
33488297|NCT00550459|101683068|FG001|Overall Study|Withdrawal by Subject|1|||
33488298|NCT00403585|101683069|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
33488299|NCT00403585|101683069|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
33488300|NCT00403585|101683069|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
33488301|NCT01371747|101683070|FG000|Overall Study|Adverse Event|4|||
33488302|NCT01371747|101683071|FG001|Overall Study|Adverse Event|2|||
33488303|NCT01371747|101683072|FG002|Overall Study|Adverse Event|7|||
33488304|NCT01371747|101683073|FG003|Overall Study|Adverse Event|2|||
33488305|NCT01371747|101683074|FG004|Overall Study|Adverse Event|2|||
33488306|NCT01371747|101683075|FG005|Overall Study|Adverse Event|2|||
33488307|NCT01371747|101683070|FG000|Overall Study|Death|1|||
33488308|NCT01371747|101683071|FG001|Overall Study|Death|0|||
33488309|NCT01371747|101683072|FG002|Overall Study|Death|4|||
33488310|NCT01371747|101683073|FG003|Overall Study|Death|1|||
33488311|NCT01371747|101683074|FG004|Overall Study|Death|2|||
33488312|NCT01371747|101683075|FG005|Overall Study|Death|0|||
33488313|NCT01371747|101683070|FG000|Overall Study|Abnormal Renal Function|0|||
33488314|NCT01371747|101683071|FG001|Overall Study|Abnormal Renal Function|2|||
33488315|NCT01371747|101683072|FG002|Overall Study|Abnormal Renal Function|0|||
33488316|NCT01371747|101683073|FG003|Overall Study|Abnormal Renal Function|1|||
33488317|NCT01371747|101683074|FG004|Overall Study|Abnormal Renal Function|0|||
33488318|NCT01371747|101683075|FG005|Overall Study|Abnormal Renal Function|1|||
33488319|NCT01371747|101683070|FG000|Overall Study|High Serum Potassium Results|1|||
33488320|NCT01371747|101683071|FG001|Overall Study|High Serum Potassium Results|1|||
33488321|NCT01371747|101683072|FG002|Overall Study|High Serum Potassium Results|1|||
33488322|NCT01371747|101683073|FG003|Overall Study|High Serum Potassium Results|2|||
33488323|NCT01371747|101683074|FG004|Overall Study|High Serum Potassium Results|0|||
33488324|NCT01371747|101683075|FG005|Overall Study|High Serum Potassium Results|2|||
33488325|NCT01371747|101683070|FG000|Overall Study|Low Serum Potassium Results|1|||
33488326|NCT01371747|101683071|FG001|Overall Study|Low Serum Potassium Results|1|||
33488327|NCT01371747|101683072|FG002|Overall Study|Low Serum Potassium Results|1|||
33488328|NCT01371747|101683073|FG003|Overall Study|Low Serum Potassium Results|1|||
33488329|NCT01371747|101683074|FG004|Overall Study|Low Serum Potassium Results|0|||
33488330|NCT01371747|101683075|FG005|Overall Study|Low Serum Potassium Results|3|||
33488331|NCT01371747|101683070|FG000|Overall Study|Protocol Violation|0|||
33488332|NCT01371747|101683071|FG001|Overall Study|Protocol Violation|0|||
33488333|NCT01371747|101683072|FG002|Overall Study|Protocol Violation|1|||
33488334|NCT01371747|101683073|FG003|Overall Study|Protocol Violation|0|||
33488335|NCT01371747|101683074|FG004|Overall Study|Protocol Violation|0|||
33488336|NCT01371747|101683075|FG005|Overall Study|Protocol Violation|0|||
33488337|NCT01371747|101683070|FG000|Overall Study|Non-Compliance|3|||
33488338|NCT01371747|101683071|FG001|Overall Study|Non-Compliance|4|||
33488339|NCT01371747|101683072|FG002|Overall Study|Non-Compliance|3|||
33488340|NCT01371747|101683073|FG003|Overall Study|Non-Compliance|0|||
33488341|NCT01371747|101683074|FG004|Overall Study|Non-Compliance|0|||
33488342|NCT01371747|101683075|FG005|Overall Study|Non-Compliance|1|||
33488343|NCT01371747|101683070|FG000|Overall Study|Physician Decision|0|||
33488344|NCT01371747|101683071|FG001|Overall Study|Physician Decision|0|||
33488345|NCT01371747|101683072|FG002|Overall Study|Physician Decision|0|||
33488346|NCT01371747|101683073|FG003|Overall Study|Physician Decision|0|||
33488347|NCT01371747|101683074|FG004|Overall Study|Physician Decision|1|||
33488348|NCT01371747|101683075|FG005|Overall Study|Physician Decision|0|||
33488349|NCT01371747|101683070|FG000|Overall Study|Withdrawal by Subject|6|||
33488350|NCT01371747|101683071|FG001|Overall Study|Withdrawal by Subject|12|||
33488351|NCT01371747|101683072|FG002|Overall Study|Withdrawal by Subject|5|||
33488352|NCT01371747|101683073|FG003|Overall Study|Withdrawal by Subject|2|||
33488353|NCT01371747|101683074|FG004|Overall Study|Withdrawal by Subject|2|||
33488354|NCT01371747|101683075|FG005|Overall Study|Withdrawal by Subject|4|||
33488355|NCT01371747|101683070|FG000|Overall Study|Other Reasons|2|||
33488356|NCT01371747|101683071|FG001|Overall Study|Other Reasons|1|||
33488357|NCT01371747|101683072|FG002|Overall Study|Other Reasons|2|||
33488358|NCT01371747|101683073|FG003|Overall Study|Other Reasons|0|||
33488359|NCT01371747|101683074|FG004|Overall Study|Other Reasons|0|||
33488360|NCT01371747|101683075|FG005|Overall Study|Other Reasons|1|||
33488361|NCT00261950|101683076|FG000|Overall Study|Lost to Follow-up|2|||
33488362|NCT00261950|101683076|FG000|Overall Study|Death|6|||
33488363|NCT00261950|101683076|FG000|Overall Study|Withdrawal by Subject|5|||
33488364|NCT00261950|101683076|FG000|Overall Study|Other|1|||
33488365|NCT00261950|101683076|FG000|Overall Study|Physician Decision|1|||
33488366|NCT00261950|101683076|FG000|Overall Study|Protocol specified Criteria|11|||
33488367|NCT02892149|101683080|FG000|Overall Study|Death|262|||
33488368|NCT02892149|101683081|FG001|Overall Study|Death|278|||
33488369|NCT02892149|101683080|FG000|Overall Study|Withdrawal by Subject|53|||
33488370|NCT02892149|101683081|FG001|Overall Study|Withdrawal by Subject|47|||
33488371|NCT02892149|101683080|FG000|Overall Study|Lost to Follow-up|37|||
33488372|NCT02892149|101683081|FG001|Overall Study|Lost to Follow-up|31|||
33488373|NCT00524420|101683082|FG000|Overall Study|Lack of Efficacy|1|||
33488374|NCT00524420|101683083|FG001|Overall Study|Lack of Efficacy|0|||
33488375|NCT02756208|101683084|FG000|Overall Study|Withdrawal by Subject|1|||
33488376|NCT02756208|101683085|FG001|Overall Study|Withdrawal by Subject|0|||
33488377|NCT02756208|101683086|FG002|Overall Study|Withdrawal by Subject|1|||
33488378|NCT02756208|101683087|FG003|Overall Study|Withdrawal by Subject|3|||
33488379|NCT02756208|101683084|FG000|Overall Study|Lost to Follow-up|3|||
33488380|NCT02756208|101683085|FG001|Overall Study|Lost to Follow-up|1|||
33488381|NCT02756208|101683086|FG002|Overall Study|Lost to Follow-up|1|||
33488382|NCT02756208|101683087|FG003|Overall Study|Lost to Follow-up|1|||
33488383|NCT02756208|101683084|FG000|Overall Study|Physician Decision|1|||
33488384|NCT02756208|101683085|FG001|Overall Study|Physician Decision|0|||
33488385|NCT02756208|101683086|FG002|Overall Study|Physician Decision|0|||
33488386|NCT02756208|101683087|FG003|Overall Study|Physician Decision|0|||
33488387|NCT02756208|101683084|FG000|Overall Study|Protocol Violation|0|||
33488388|NCT02756208|101683085|FG001|Overall Study|Protocol Violation|1|||
33488389|NCT02756208|101683086|FG002|Overall Study|Protocol Violation|0|||
33488390|NCT02756208|101683087|FG003|Overall Study|Protocol Violation|0|||
33488391|NCT01232452|101683088|FG000|Overall Study|Adverse Event|17|||
33488392|NCT01232452|101683089|FG001|Overall Study|Adverse Event|15|||
33488393|NCT01232452|101683088|FG000|Overall Study|Withdrawal by Subject|11|||
33488394|NCT01232452|101683089|FG001|Overall Study|Withdrawal by Subject|8|||
33488395|NCT01232452|101683088|FG000|Overall Study|Physician Decision|8|||
33488396|NCT01232452|101683089|FG001|Overall Study|Physician Decision|12|||
33488397|NCT01232452|101683088|FG000|Overall Study|Protocol entry criterion not met|0|||
33488398|NCT01232452|101683089|FG001|Overall Study|Protocol entry criterion not met|2|||
33488399|NCT01232452|101683088|FG000|Overall Study|Sponsor Decision|3|||
33488400|NCT01232452|101683089|FG001|Overall Study|Sponsor Decision|1|||
33488401|NCT01232452|101683088|FG000|Overall Study|Protocol Violation|0|||
33488402|NCT01232452|101683089|FG001|Overall Study|Protocol Violation|1|||
33488403|NCT00196326|101683090|FG000|Overall Study|Did not meet protocol requirements|64|||
33488404|NCT00196326|101683090|FG000|Overall Study|Non-compliance with the protocol|81|||
33488405|NCT00196326|101683090|FG000|Overall Study|Physician Decision|3|||
33488406|NCT00196326|101683090|FG000|Overall Study|Withdrawal by Subject|225|||
33488407|NCT00196326|101683090|FG000|Overall Study|Adverse Event|253|||
33488408|NCT00196326|101683090|FG000|Overall Study|Pregnancy|34|||
33488409|NCT00196326|101683090|FG000|Overall Study|Lost to Follow-up|304|||
33488410|NCT00196326|101683090|FG000|Overall Study|Other|22|||
33488411|NCT03593395|101683095|FG000|Overall Study|Lost to Follow-up|48|||
33488412|NCT03593395|101683096|FG001|Overall Study|Lost to Follow-up|3|||
33488413|NCT03593395|101683095|FG000|Overall Study|Withdrawal by Subject|5|||
33488414|NCT03593395|101683096|FG001|Overall Study|Withdrawal by Subject|24|||
33488415|NCT03593395|101683095|FG000|Overall Study|Death|2|||
33488416|NCT03593395|101683096|FG001|Overall Study|Death|3|||
33488417|NCT03593395|101683095|FG000|Overall Study|Physician Decision|0|||
33488418|NCT03593395|101683096|FG001|Overall Study|Physician Decision|6|||
33488419|NCT03593395|101683095|FG000|Overall Study|Participant Relocated|19|||
33488420|NCT03593395|101683096|FG001|Overall Study|Participant Relocated|3|||
33488421|NCT03593395|101683095|FG000|Overall Study|No Information|1|||
33488422|NCT03593395|101683096|FG001|Overall Study|No Information|7|||
33488423|NCT01597778|101683100|FG000|Overall Study|Death|7|||
33488424|NCT01597778|101683101|FG001|Overall Study|Death|10|||
33488425|NCT01597778|101683100|FG000|Overall Study|Withdrawal by Subject|3|||
33488426|NCT01597778|101683101|FG001|Overall Study|Withdrawal by Subject|4|||
33488427|NCT01597778|101683100|FG000|Overall Study|Adverse Event|1|||
33488428|NCT01597778|101683101|FG001|Overall Study|Adverse Event|1|||
33488429|NCT01597778|101683100|FG000|Overall Study|Protocol Violation|1|||
33488430|NCT01597778|101683101|FG001|Overall Study|Protocol Violation|11|||
33488431|NCT01597778|101683100|FG000|Overall Study|Transplanted off protocol|2|||
33488432|NCT01597778|101683101|FG001|Overall Study|Transplanted off protocol|3|||
33488433|NCT00111241|101683102|FG000|Overall Study|Lost to Follow-up|1|||
33488434|NCT00111241|101683103|FG001|Overall Study|Lost to Follow-up|0|||
33488435|NCT00111241|101683102|FG000|Overall Study|Withdrawal by Subject|4|||
33488436|NCT00111241|101683103|FG001|Overall Study|Withdrawal by Subject|0|||
33488437|NCT00111241|101683102|FG000|Overall Study|Protocol Violation|9|||
33488438|NCT00111241|101683103|FG001|Overall Study|Protocol Violation|8|||
33488439|NCT00111241|101683102|FG000|Overall Study|Adverse Event|1|||
33488440|NCT00111241|101683103|FG001|Overall Study|Adverse Event|0|||
33488441|NCT01023035|101683108|FG000|Treatment Period|Adverse Event|27|||
33488442|NCT01023035|101683109|FG001|Treatment Period|Adverse Event|32|||
33488443|NCT01023035|101683110|FG002|Treatment Period|Adverse Event|50|||
33488444|NCT01023035|101683108|FG000|Treatment Period|Non-Medical Reasons|19|||
33488445|NCT01023035|101683109|FG001|Treatment Period|Non-Medical Reasons|22|||
33488446|NCT01023035|101683110|FG002|Treatment Period|Non-Medical Reasons|44|||
33488447|NCT01023035|101683108|FG000|Treatment Period|Treatment Failure|26|||
33488448|NCT01023035|101683109|FG001|Treatment Period|Treatment Failure|31|||
33488449|NCT01023035|101683110|FG002|Treatment Period|Treatment Failure|24|||
33488450|NCT01023035|101683108|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
33488451|NCT01023035|101683109|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
33488452|NCT01023035|101683110|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
33488453|NCT01023035|101683108|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
33488454|NCT01023035|101683109|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
33488455|NCT01023035|101683110|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
33488456|NCT03567980|101683111|FG000|Overall Study|Adverse Event|1|||
33488457|NCT01757275|101683112|FG000|Overall Study|Lost to Follow-up|1|||
33488458|NCT01757275|101683113|FG001|Overall Study|Lost to Follow-up|2|||
33488459|NCT01757275|101683112|FG000|Overall Study|Adverse Event|3|||
33488460|NCT01757275|101683113|FG001|Overall Study|Adverse Event|3|||
33488461|NCT01757275|101683112|FG000|Overall Study|Withdrawal by Subject|2|||
33488462|NCT01757275|101683113|FG001|Overall Study|Withdrawal by Subject|4|||
33488463|NCT01757275|101683112|FG000|Overall Study|Not treated|3|||
33488464|NCT01757275|101683113|FG001|Overall Study|Not treated|4|||
33488465|NCT00770328|101683116|FG000|Overall Study|Adverse Event|11|||
33488466|NCT00770328|101683117|FG001|Overall Study|Adverse Event|2|||
33488467|NCT00770328|101683116|FG000|Overall Study|Lost to Follow-up|2|||
33488468|NCT00770328|101683117|FG001|Overall Study|Lost to Follow-up|2|||
33488469|NCT00356525|101683118|FG000|Overall Study|Progressive Disease|8|||
33488470|NCT00356525|101683119|FG001|Overall Study|Progressive Disease|5|||
33488471|NCT00356525|101683120|FG002|Overall Study|Progressive Disease|4|||
33488472|NCT00356525|101683121|FG003|Overall Study|Progressive Disease|2|||
33488473|NCT00356525|101683118|FG000|Overall Study|Adverse Event|1|||
33488474|NCT00356525|101683119|FG001|Overall Study|Adverse Event|3|||
33488475|NCT00356525|101683120|FG002|Overall Study|Adverse Event|1|||
33488476|NCT00356525|101683121|FG003|Overall Study|Adverse Event|1|||
33488477|NCT00356525|101683118|FG000|Overall Study|Lost to Follow-up|1|||
33488478|NCT00356525|101683119|FG001|Overall Study|Lost to Follow-up|0|||
33488479|NCT00356525|101683120|FG002|Overall Study|Lost to Follow-up|0|||
33488480|NCT00356525|101683121|FG003|Overall Study|Lost to Follow-up|0|||
33488481|NCT00356525|101683118|FG000|Overall Study|Physician Decision|2|||
33488482|NCT00356525|101683119|FG001|Overall Study|Physician Decision|2|||
33488483|NCT00356525|101683120|FG002|Overall Study|Physician Decision|2|||
33488484|NCT00356525|101683121|FG003|Overall Study|Physician Decision|1|||
33488485|NCT00356525|101683118|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
33488486|NCT00356525|101683119|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
33488487|NCT00356525|101683120|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
33488488|NCT00356525|101683121|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
33488489|NCT00356525|101683118|FG000|Overall Study|Withdrawal by Subject|1|||
33488490|NCT00356525|101683119|FG001|Overall Study|Withdrawal by Subject|1|||
33488491|NCT00356525|101683120|FG002|Overall Study|Withdrawal by Subject|0|||
33488492|NCT00356525|101683121|FG003|Overall Study|Withdrawal by Subject|3|||
33488493|NCT00356525|101683118|FG000|Overall Study|Death|0|||
33488494|NCT00356525|101683119|FG001|Overall Study|Death|0|||
33488495|NCT00356525|101683120|FG002|Overall Study|Death|0|||
33488496|NCT00356525|101683121|FG003|Overall Study|Death|1|||
33488497|NCT00356525|101683118|FG000|Overall Study|Sponsor Decision|0|||
33488498|NCT00356525|101683119|FG001|Overall Study|Sponsor Decision|0|||
33488499|NCT00356525|101683120|FG002|Overall Study|Sponsor Decision|0|||
33488500|NCT00356525|101683121|FG003|Overall Study|Sponsor Decision|1|||
33488501|NCT02766335|101683122|FG000|Initial Registration|Adverse Event|6|||
33488502|NCT02766335|101683123|FG001|Initial Registration|Adverse Event|3|||
33488503|NCT02766335|101683124|FG002|Initial Registration|Adverse Event|0|||
33488504|NCT02766335|101683122|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
33488505|NCT02766335|101683123|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
33488506|NCT02766335|101683124|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
33488507|NCT02766335|101683122|FG000|Initial Registration|Progression/relapse|49|||
33488508|NCT02766335|101683123|FG001|Initial Registration|Progression/relapse|15|||
33488509|NCT02766335|101683124|FG002|Initial Registration|Progression/relapse|0|||
33488510|NCT02766335|101683122|FG000|Initial Registration|Death|1|||
33488511|NCT02766335|101683123|FG001|Initial Registration|Death|3|||
33488512|NCT02766335|101683124|FG002|Initial Registration|Death|0|||
33488513|NCT02766335|101683122|FG000|Initial Registration|not protocol specified|1|||
33488514|NCT02766335|101683123|FG001|Initial Registration|not protocol specified|9|||
33488515|NCT02766335|101683124|FG002|Initial Registration|not protocol specified|0|||
33488516|NCT02766335|101683122|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
33488517|NCT02766335|101683123|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
33488518|NCT02766335|101683124|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
33488519|NCT02766335|101683122|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
33488520|NCT02766335|101683123|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
33488521|NCT02766335|101683124|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
33488522|NCT02443740|101683125|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
33488523|NCT02443740|101683126|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
33488524|NCT02443740|101683127|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
33488525|NCT02443740|101683128|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
33488526|NCT02443740|101683129|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
33488527|NCT02443740|101683130|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
33488528|NCT02443740|101683131|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
33488529|NCT02443740|101683132|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
33488530|NCT02443740|101683133|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
33488531|NCT02443740|101683134|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
33488532|NCT02443740|101683135|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
33488533|NCT02443740|101683125|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
33488534|NCT02443740|101683126|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33488535|NCT02443740|101683127|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33488536|NCT02443740|101683128|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33488537|NCT02443740|101683129|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33488538|NCT02443740|101683130|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33488539|NCT02443740|101683131|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
33488540|NCT02443740|101683132|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33488541|NCT02443740|101683133|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33488542|NCT02443740|101683134|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33488543|NCT02443740|101683135|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
33488544|NCT02443740|101683125|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33488545|NCT02443740|101683126|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33488546|NCT02443740|101683127|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33488547|NCT02443740|101683128|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33488548|NCT02443740|101683129|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33488549|NCT02443740|101683130|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
33488550|NCT02443740|101683131|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33488551|NCT02443740|101683132|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33488552|NCT02443740|101683133|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33488553|NCT02443740|101683134|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33488554|NCT02443740|101683135|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
33488555|NCT01301729|101683143|FG000|Overall Study|Withdrawal by Subject|2|||
33488556|NCT01301729|101683143|FG000|Overall Study|Participant did not Return for Treatment|1|||
33488557|NCT01301729|101683143|FG000|Overall Study|Violated Selection Criteria|1|||
33488558|NCT02789137|101683144|FG000|Overall Study|Dropped out/Died|58|||
33488559|NCT00866359|101683145|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
33488560|NCT00866359|101683146|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
33488561|NCT00866359|101683147|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
33488562|NCT00866359|101683148|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
33488563|NCT00866359|101683145|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
33488564|NCT00866359|101683146|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
33488565|NCT00866359|101683147|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
33488566|NCT00866359|101683148|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
33488567|NCT00866359|101683145|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
33488568|NCT00866359|101683146|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
33488569|NCT00866359|101683147|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
33488570|NCT00866359|101683148|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
33488571|NCT00866359|101683145|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
33488572|NCT00866359|101683146|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
33488573|NCT00866359|101683147|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
33488574|NCT00866359|101683148|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
33488575|NCT00866359|101683145|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
33488576|NCT00866359|101683146|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
33488577|NCT00866359|101683147|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
33488578|NCT00866359|101683148|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
33488579|NCT00866359|101683145|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
33488580|NCT00866359|101683146|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
33488581|NCT00866359|101683147|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
33488582|NCT00866359|101683148|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
33488583|NCT00711880|101683149|FG000|Overall Study|Adverse Event|11|||
33488584|NCT00711880|101683150|FG001|Overall Study|Adverse Event|2|||
33488585|NCT00711880|101683149|FG000|Overall Study|Patient non-compliance|1|||
33488586|NCT00711880|101683150|FG001|Overall Study|Patient non-compliance|0|||
33488587|NCT00711880|101683149|FG000|Overall Study|Lack of Efficacy|1|||
33488588|NCT00711880|101683150|FG001|Overall Study|Lack of Efficacy|5|||
33488589|NCT00887289|101683151|FG000|Overall Study|Lack of Efficacy|14|||
33488590|NCT00887289|101683151|FG000|Overall Study|Adverse Event|27|||
33488591|NCT00887289|101683151|FG000|Overall Study|Withdrawal by Subject|26|||
33488592|NCT00887289|101683151|FG000|Overall Study|Lost to Follow-up|8|||
33488593|NCT00887289|101683151|FG000|Overall Study|Other|20|||
33488594|NCT00805467|101683154|FG000|Overall Study|Lack of Efficacy|0|||
33488595|NCT00805467|101683155|FG001|Overall Study|Lack of Efficacy|8|||
33488596|NCT00805467|101683156|FG002|Overall Study|Lack of Efficacy|13|||
33488597|NCT00805467|101683157|FG003|Overall Study|Lack of Efficacy|86|||
33488598|NCT00805467|101683154|FG000|Overall Study|Lost to Follow-up|0|||
33488599|NCT00805467|101683155|FG001|Overall Study|Lost to Follow-up|1|||
33488600|NCT00805467|101683156|FG002|Overall Study|Lost to Follow-up|7|||
33488601|NCT00805467|101683157|FG003|Overall Study|Lost to Follow-up|21|||
33488602|NCT00805467|101683154|FG000|Overall Study|Withdrawal by Subject|0|||
33488603|NCT00805467|101683155|FG001|Overall Study|Withdrawal by Subject|6|||
33488604|NCT00805467|101683156|FG002|Overall Study|Withdrawal by Subject|45|||
33488605|NCT00805467|101683157|FG003|Overall Study|Withdrawal by Subject|50|||
33488606|NCT00805467|101683154|FG000|Overall Study|Protocol Violation|0|||
33488607|NCT00805467|101683155|FG001|Overall Study|Protocol Violation|3|||
33488608|NCT00805467|101683156|FG002|Overall Study|Protocol Violation|0|||
33488609|NCT00805467|101683157|FG003|Overall Study|Protocol Violation|5|||
33488610|NCT00805467|101683154|FG000|Overall Study|Adverse Event|0|||
33488611|NCT00805467|101683155|FG001|Overall Study|Adverse Event|13|||
33488612|NCT00805467|101683156|FG002|Overall Study|Adverse Event|26|||
33488613|NCT00805467|101683157|FG003|Overall Study|Adverse Event|57|||
33488614|NCT00805467|101683154|FG000|Overall Study|Death|0|||
33488615|NCT00805467|101683155|FG001|Overall Study|Death|2|||
33488616|NCT00805467|101683156|FG002|Overall Study|Death|7|||
33488617|NCT00805467|101683157|FG003|Overall Study|Death|5|||
33488618|NCT00805467|101683154|FG000|Overall Study|Physician Decision|0|||
33488619|NCT00805467|101683155|FG001|Overall Study|Physician Decision|1|||
33488620|NCT00805467|101683156|FG002|Overall Study|Physician Decision|2|||
33488621|NCT00805467|101683157|FG003|Overall Study|Physician Decision|6|||
33488622|NCT00805467|101683154|FG000|Overall Study|Not reported|0|||
33488623|NCT00805467|101683155|FG001|Overall Study|Not reported|0|||
33488624|NCT00805467|101683156|FG002|Overall Study|Not reported|3|||
33488625|NCT00805467|101683157|FG003|Overall Study|Not reported|7|||
33488626|NCT05013008|101683158|FG000|Overall Study|Exclusion from mBFAS|5|||
33488627|NCT05013008|101683159|FG001|Overall Study|Exclusion from mBFAS|25|||
33488628|NCT01570686|101683160|FG000|Overall Study|Abnormal test procedure result(s)|1|||
33488629|NCT01570686|101683161|FG001|Overall Study|Abnormal test procedure result(s)|1|||
33488630|NCT01570686|101683160|FG000|Overall Study|Administrative problems|0|||
33488631|NCT01570686|101683161|FG001|Overall Study|Administrative problems|1|||
33488632|NCT01570686|101683160|FG000|Overall Study|Adverse Event|8|||
33488633|NCT01570686|101683161|FG001|Overall Study|Adverse Event|6|||
33488634|NCT01570686|101683160|FG000|Overall Study|Lost to Follow-up|4|||
33488635|NCT01570686|101683161|FG001|Overall Study|Lost to Follow-up|3|||
33488636|NCT01570686|101683160|FG000|Overall Study|Protocol Deviation|3|||
33488637|NCT01570686|101683161|FG001|Overall Study|Protocol Deviation|0|||
33488638|NCT01570686|101683160|FG000|Overall Study|Withdrawal by Subject|4|||
33488639|NCT01570686|101683161|FG001|Overall Study|Withdrawal by Subject|4|||
33488640|NCT01570686|101683160|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
33488641|NCT01570686|101683161|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33488642|NCT03908437|101683163|FG000|Overall Study|Death|0|||
33488643|NCT03908437|101683164|FG001|Overall Study|Death|1|||
33488644|NCT03908437|101683163|FG000|Overall Study|Lost to Follow-up|31|||
33488645|NCT03908437|101683164|FG001|Overall Study|Lost to Follow-up|24|||
33488646|NCT02756611|101683166|FG000|Overall Study|Death|70|||
33488647|NCT02756611|101683166|FG000|Overall Study|Withdrawal by Subject|2|||
33488648|NCT02756611|101683166|FG000|Overall Study|Lost to Follow-up|3|||
33488649|NCT02756611|101683166|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
33488650|NCT02756611|101683166|FG000|Overall Study|Other|10|||
33488651|NCT00191191|101683167|FG000|Overall Study|Entry Criteria Exclusion|2|||
33488652|NCT00191191|101683168|FG001|Overall Study|Entry Criteria Exclusion|0|||
33488653|NCT00191191|101683167|FG000|Overall Study|Treated with Another Systemic Agent|1|||
33488654|NCT00191191|101683168|FG001|Overall Study|Treated with Another Systemic Agent|1|||
33488655|NCT00191191|101683167|FG000|Overall Study|Adverse Event|11|||
33488656|NCT00191191|101683168|FG001|Overall Study|Adverse Event|21|||
33488657|NCT00191191|101683167|FG000|Overall Study|Progressive Disease|84|||
33488658|NCT00191191|101683168|FG001|Overall Study|Progressive Disease|72|||
33488659|NCT00191191|101683167|FG000|Overall Study|Toxicity After Dose Reduction|7|||
33488660|NCT00191191|101683168|FG001|Overall Study|Toxicity After Dose Reduction|8|||
33488661|NCT00191191|101683167|FG000|Overall Study|Family/Caregiver Decision|5|||
33488662|NCT00191191|101683168|FG001|Overall Study|Family/Caregiver Decision|7|||
33488663|NCT00191191|101683167|FG000|Overall Study|Lost to Follow-up|1|||
33488664|NCT00191191|101683168|FG001|Overall Study|Lost to Follow-up|0|||
33488665|NCT00191191|101683167|FG000|Overall Study|Physician Decision|3|||
33488666|NCT00191191|101683168|FG001|Overall Study|Physician Decision|2|||
33488667|NCT00191191|101683167|FG000|Overall Study|Good Clinical Practice Violation|0|||
33488668|NCT00191191|101683168|FG001|Overall Study|Good Clinical Practice Violation|1|||
33488669|NCT00182325|101683170|FG000|Overall Study|Lost to Follow-up|7|||
33488670|NCT00182325|101683171|FG001|Overall Study|Lost to Follow-up|7|||
33488671|NCT00182325|101683170|FG000|Overall Study|Miscarriage|5|||
33488672|NCT00182325|101683171|FG001|Overall Study|Miscarriage|3|||
33488673|NCT00182325|101683170|FG000|Overall Study|Did not complete survey|22|||
33488674|NCT00182325|101683171|FG001|Overall Study|Did not complete survey|43|||
33488675|NCT01720225|101683172|FG000|Overall Study|Withdrawal by Subject|0|||
33488676|NCT01720225|101683173|FG001|Overall Study|Withdrawal by Subject|1|||
33283614|NCT04270747|100934409|FG000|Through Week 16|Physician Decision|1|||
33283615|NCT04270747|100934410|FG001|Through Week 16|Physician Decision|1|||
33488677|NCT01720225|101683172|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
33488678|NCT01720225|101683173|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
33488679|NCT00754650|101683174|FG000|Overall Study|Disease Progression|2|||
33488680|NCT03953612|101683175|FG000|Overall Study|Randomized but did not start|1|||
33488681|NCT03953612|101683176|FG001|Overall Study|Randomized but did not start|1|||
33488682|NCT03953612|101683177|FG002|Overall Study|Randomized but did not start|1|||
33488683|NCT03953612|101683175|FG000|Overall Study|Withdrawal by Subject|2|||
33488684|NCT03953612|101683176|FG001|Overall Study|Withdrawal by Subject|1|||
33488685|NCT03953612|101683177|FG002|Overall Study|Withdrawal by Subject|0|||
33488686|NCT01401452|101683178|FG000|Overall Study|Adverse reaction|9|||
33488687|NCT01401452|101683178|FG000|Overall Study|Lost to Follow-up|12|||
33488688|NCT01401452|101683178|FG000|Overall Study|Lack of Efficacy|30|||
33488689|NCT01401452|101683178|FG000|Overall Study|Participant developed breast cancer|1|||
33488690|NCT01401452|101683178|FG000|Overall Study|Tx stopped due to financial reasons|1|||
33488691|NCT01401452|101683178|FG000|Overall Study|Tx stopped by psychiatrist|1|||
33488692|NCT01401452|101683178|FG000|Overall Study|No more visits within the 36 wk followup|4|||
33488693|NCT01401452|101683178|FG000|Overall Study|Subject did not come to follow up visits|2|||
33488694|NCT01401452|101683178|FG000|Overall Study|Subject didn't return for routine visits|1|||
33488695|NCT01401452|101683178|FG000|Overall Study|Subject moved to another city|1|||
33488696|NCT01401452|101683178|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
33488697|NCT01401452|101683178|FG000|Overall Study|Psoriatic arthritis|1|||
33488698|NCT01401452|101683178|FG000|Overall Study|Participant stopped Tx|2|||
33488699|NCT01401452|101683178|FG000|Overall Study|Discontinuation for personal reasons|1|||
33488700|NCT01401452|101683178|FG000|Overall Study|Treatment failure|1|||
33488701|NCT01401452|101683178|FG000|Overall Study|Unsatisfactory output|1|||
33488702|NCT01401452|101683178|FG000|Overall Study|Subject withdrew because of Tx success|1|||
33488703|NCT01401452|101683178|FG000|Overall Study|Subject chose to discontinue treatment|1|||
33488704|NCT01401452|101683178|FG000|Overall Study|Participant withdrew consent|1|||
33488705|NCT01924754|101683179|FG000|Overall Study|Lost to Follow-up|1|||
33488706|NCT01924754|101683180|FG001|Overall Study|Lost to Follow-up|2|||
33488707|NCT01924754|101683181|FG002|Overall Study|Lost to Follow-up|1|||
33488708|NCT01924754|101683179|FG000|Overall Study|Pregnancy|0|||
33488709|NCT01924754|101683180|FG001|Overall Study|Pregnancy|1|||
33488710|NCT01924754|101683181|FG002|Overall Study|Pregnancy|2|||
33488711|NCT00369941|101683182|FG000|Overall Study|Never Treated|1|||
33488712|NCT00369941|101683183|FG001|Overall Study|Never Treated|2|||
33488713|NCT00369941|101683182|FG000|Overall Study|Adverse Event|14|||
33488714|NCT00369941|101683183|FG001|Overall Study|Adverse Event|28|||
33488715|NCT00369941|101683182|FG000|Overall Study|Lack of Efficacy|6|||
33488716|NCT00369941|101683183|FG001|Overall Study|Lack of Efficacy|10|||
33488717|NCT00369941|101683182|FG000|Overall Study|Lost to Follow-up|12|||
33488718|NCT00369941|101683183|FG001|Overall Study|Lost to Follow-up|22|||
33488719|NCT00369941|101683182|FG000|Overall Study|Protocol Violation|5|||
33488720|NCT00369941|101683183|FG001|Overall Study|Protocol Violation|3|||
33488721|NCT00369941|101683182|FG000|Overall Study|Withdrawal by Subject|5|||
33488722|NCT00369941|101683183|FG001|Overall Study|Withdrawal by Subject|18|||
33488723|NCT00369941|101683182|FG000|Overall Study|Pregnancy|4|||
33488724|NCT00369941|101683183|FG001|Overall Study|Pregnancy|2|||
33488725|NCT00369941|101683182|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
33488726|NCT00369941|101683183|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
33488727|NCT00369941|101683182|FG000|Overall Study|Moved|11|||
33488728|NCT00369941|101683183|FG001|Overall Study|Moved|5|||
33488729|NCT00369941|101683182|FG000|Overall Study|Treatment with Prohibited Medication|3|||
33488730|NCT00369941|101683183|FG001|Overall Study|Treatment with Prohibited Medication|1|||
33283616|NCT04270747|100934411|FG002|Through Week 16|Physician Decision|0|||
33283617|NCT04270747|100934409|FG000|Through Week 16|Lost to Follow-up|2|||
33283618|NCT04270747|100934410|FG001|Through Week 16|Lost to Follow-up|0|||
33283619|NCT04270747|100934411|FG002|Through Week 16|Lost to Follow-up|0|||
33283620|NCT04270747|100934409|FG000|Through Week 16|Protocol Violation|1|||
33283621|NCT04270747|100934410|FG001|Through Week 16|Protocol Violation|2|||
33283622|NCT04270747|100934411|FG002|Through Week 16|Protocol Violation|0|||
33283623|NCT04270747|100934409|FG000|Through Week 16|Protocol Specified Criteria|6|||
33283624|NCT04270747|100934410|FG001|Through Week 16|Protocol Specified Criteria|7|||
33283625|NCT04270747|100934411|FG002|Through Week 16|Protocol Specified Criteria|0|||
33283626|NCT04270747|100934409|FG000|Through Week 16|Miscellaneous|1|||
33283627|NCT04270747|100934410|FG001|Through Week 16|Miscellaneous|1|||
33283628|NCT04270747|100934411|FG002|Through Week 16|Miscellaneous|0|||
33283629|NCT04270747|100934409|FG000|Post Week 16|Adverse Event|7|||
33283630|NCT04270747|100934410|FG001|Post Week 16|Adverse Event|5|||
33283631|NCT04270747|100934411|FG002|Post Week 16|Adverse Event|1|||
33283632|NCT04270747|100934409|FG000|Post Week 16|Death|2|||
33283633|NCT04270747|100934410|FG001|Post Week 16|Death|0|||
33283634|NCT04270747|100934411|FG002|Post Week 16|Death|2|||
33488731|NCT00369941|101683182|FG000|Overall Study|Employment Interfered with Study Visits|1|||
33488732|NCT00369941|101683183|FG001|Overall Study|Employment Interfered with Study Visits|0|||
33283635|NCT04270747|100934409|FG000|Post Week 16|Consent Withdrawn|4|||
33488733|NCT00369941|101683182|FG000|Overall Study|Study Site Terminated|2|||
33488734|NCT00369941|101683183|FG001|Overall Study|Study Site Terminated|0|||
33283636|NCT04270747|100934410|FG001|Post Week 16|Consent Withdrawn|3|||
33283637|NCT04270747|100934411|FG002|Post Week 16|Consent Withdrawn|6|||
33488735|NCT00369941|101683182|FG000|Overall Study|Miscellaneous|3|||
33488736|NCT00369941|101683183|FG001|Overall Study|Miscellaneous|3|||
33283638|NCT04270747|100934409|FG000|Post Week 16|Physician Decision|3|||
33283639|NCT04270747|100934410|FG001|Post Week 16|Physician Decision|1|||
33283640|NCT04270747|100934411|FG002|Post Week 16|Physician Decision|1|||
33283641|NCT04270747|100934409|FG000|Post Week 16|Lost to Follow-up|2|||
33283642|NCT04270747|100934410|FG001|Post Week 16|Lost to Follow-up|1|||
33283643|NCT04270747|100934411|FG002|Post Week 16|Lost to Follow-up|0|||
33283644|NCT04270747|100934409|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
33283645|NCT04270747|100934410|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
33283646|NCT04270747|100934411|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
33283647|NCT04270747|100934409|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
33283648|NCT04270747|100934410|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
33283649|NCT04270747|100934411|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
33283650|NCT04270747|100934409|FG000|Post Week 16|Miscellaneous|1|||
33283651|NCT04270747|100934410|FG001|Post Week 16|Miscellaneous|0|||
33283652|NCT04270747|100934411|FG002|Post Week 16|Miscellaneous|1|||
33283653|NCT02973477|100934414|FG000|First Intervention|Lost to Follow-up|0|||
33283654|NCT02973477|100934415|FG001|First Intervention|Lost to Follow-up|2|||
33283655|NCT02973477|100934414|FG000|Washout|Withdrawal by Subject|1|||
33283656|NCT02973477|100934415|FG001|Washout|Withdrawal by Subject|0|||
33283657|NCT02973477|100934414|FG000|Second Intervention|Lost to Follow-up|1|||
33283658|NCT02973477|100934415|FG001|Second Intervention|Lost to Follow-up|0|||
33283659|NCT00857233|100934416|FG000|Overall Study|Adverse Event|24|||
33283660|NCT00857233|100934416|FG000|Overall Study|Lack of Efficacy|1|||
33283661|NCT00857233|100934416|FG000|Overall Study|Non-compliance|1|||
33283662|NCT00857233|100934416|FG000|Overall Study|Withdrawal of Consent|9|||
33283663|NCT00857233|100934416|FG000|Overall Study|Lost to Follow-up|4|||
33283664|NCT00857233|100934416|FG000|Overall Study|Nursing Home Placement|14|||
33283665|NCT00857233|100934416|FG000|Overall Study|Other Reasons|2|||
33283666|NCT03494985|100934419|FG000|Overall Study|Adverse Event|3|||
33283667|NCT03494985|100934420|FG001|Overall Study|Adverse Event|2|||
33283668|NCT03494985|100934421|FG002|Overall Study|Adverse Event|3|||
33283669|NCT03494985|100934422|FG003|Overall Study|Adverse Event|0|||
33283670|NCT03494985|100934419|FG000|Overall Study|Other (Withdrawal of consent)|2|||
33283671|NCT03494985|100934420|FG001|Overall Study|Other (Withdrawal of consent)|3|||
33283672|NCT03494985|100934421|FG002|Overall Study|Other (Withdrawal of consent)|2|||
33283673|NCT03494985|100934422|FG003|Overall Study|Other (Withdrawal of consent)|5|||
33283674|NCT03494985|100934419|FG000|Overall Study|Other (Not specified)|0|||
33283675|NCT03494985|100934420|FG001|Overall Study|Other (Not specified)|1|||
33283676|NCT03494985|100934421|FG002|Overall Study|Other (Not specified)|1|||
33283677|NCT03494985|100934422|FG003|Overall Study|Other (Not specified)|0|||
33283678|NCT01281917|100934423|FG000|Overall Study|Withdrawal by Subject|1|||
33283679|NCT00583115|100934424|FG000|Overall Study|Death|1|||
33283680|NCT02979613|100934429|FG000|Double-Blind Phase|Withdrew Consent|2|||
33283681|NCT02979613|100934430|FG001|Double-Blind Phase|Withdrew Consent|4|||
33283682|NCT02979613|100934429|FG000|Double-Blind Phase|Pregnancy|2|||
33283683|NCT02979613|100934430|FG001|Double-Blind Phase|Pregnancy|2|||
33283684|NCT02979613|100934429|FG000|Double-Blind Phase|Adverse Event|2|||
33283685|NCT02979613|100934430|FG001|Double-Blind Phase|Adverse Event|0|||
33283686|NCT02979613|100934429|FG000|Double-Blind Phase|Lost to Follow-up|1|||
33283687|NCT02979613|100934430|FG001|Double-Blind Phase|Lost to Follow-up|1|||
33283688|NCT02979613|100934429|FG000|Double-Blind Phase|Protocol Violation|1|||
33283689|NCT02979613|100934430|FG001|Double-Blind Phase|Protocol Violation|1|||
33283690|NCT02979613|100934429|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
33283691|NCT02979613|100934430|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
33283692|NCT02979613|100934429|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
33283693|NCT02979613|100934430|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
33283694|NCT02979613|100934429|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
33283695|NCT02979613|100934430|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
33283696|NCT02979613|100934429|FG000|Open-Label Extension (OLE) Phase|Death|0|||
33283697|NCT02979613|100934430|FG001|Open-Label Extension (OLE) Phase|Death|1|||
33283698|NCT02979613|100934429|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
33283699|NCT02979613|100934430|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
33283700|NCT00468858|100934431|FG000|Overall Study|Adverse Event|0|||
33283701|NCT00468858|100934432|FG001|Overall Study|Adverse Event|1|||
33283702|NCT00468858|100934433|FG002|Overall Study|Adverse Event|0|||
33283703|NCT00468858|100934431|FG000|Overall Study|Withdrawal by Subject|7|||
33283704|NCT00468858|100934432|FG001|Overall Study|Withdrawal by Subject|4|||
33283705|NCT00468858|100934433|FG002|Overall Study|Withdrawal by Subject|5|||
33283706|NCT00468858|100934431|FG000|Overall Study|Relocation|1|||
33283707|NCT00468858|100934432|FG001|Overall Study|Relocation|3|||
33283708|NCT00468858|100934433|FG002|Overall Study|Relocation|3|||
33283709|NCT00468858|100934431|FG000|Overall Study|Lost to Follow-up|1|||
33283710|NCT00468858|100934432|FG001|Overall Study|Lost to Follow-up|2|||
33283711|NCT00468858|100934433|FG002|Overall Study|Lost to Follow-up|5|||
33283712|NCT00468858|100934431|FG000|Overall Study|Other|0|||
33283713|NCT00468858|100934432|FG001|Overall Study|Other|0|||
33283714|NCT00468858|100934433|FG002|Overall Study|Other|1|||
33283715|NCT03214250|100934434|FG000|Overall Study|Death|5|||
33283716|NCT03214250|100934435|FG001|Overall Study|Death|5|||
33283717|NCT03214250|100934436|FG002|Overall Study|Death|7|||
33283718|NCT03214250|100934437|FG003|Overall Study|Death|4|||
33283719|NCT03214250|100934438|FG004|Overall Study|Death|23|||
33283720|NCT03214250|100934439|FG005|Overall Study|Death|23|||
33283721|NCT03214250|100934440|FG006|Overall Study|Death|24|||
33283722|NCT03214250|100934434|FG000|Overall Study|Lost to Follow-up|0|||
33283723|NCT03214250|100934435|FG001|Overall Study|Lost to Follow-up|0|||
33283724|NCT03214250|100934436|FG002|Overall Study|Lost to Follow-up|0|||
33283725|NCT03214250|100934437|FG003|Overall Study|Lost to Follow-up|1|||
33283726|NCT03214250|100934438|FG004|Overall Study|Lost to Follow-up|1|||
33283727|NCT03214250|100934439|FG005|Overall Study|Lost to Follow-up|2|||
33283728|NCT03214250|100934440|FG006|Overall Study|Lost to Follow-up|0|||
33283729|NCT03214250|100934434|FG000|Overall Study|Other|0|||
33283730|NCT03214250|100934435|FG001|Overall Study|Other|0|||
33283731|NCT03214250|100934436|FG002|Overall Study|Other|0|||
33283732|NCT03214250|100934437|FG003|Overall Study|Other|0|||
33283733|NCT03214250|100934438|FG004|Overall Study|Other|1|||
33283734|NCT03214250|100934439|FG005|Overall Study|Other|1|||
33283735|NCT03214250|100934440|FG006|Overall Study|Other|2|||
33283736|NCT03214250|100934434|FG000|Overall Study|Remains on Study|2|||
33283737|NCT03214250|100934435|FG001|Overall Study|Remains on Study|2|||
33283738|NCT03214250|100934436|FG002|Overall Study|Remains on Study|0|||
33283739|NCT03214250|100934437|FG003|Overall Study|Remains on Study|1|||
33283740|NCT03214250|100934438|FG004|Overall Study|Remains on Study|7|||
33283741|NCT03214250|100934439|FG005|Overall Study|Remains on Study|5|||
33283742|NCT03214250|100934440|FG006|Overall Study|Remains on Study|3|||
33283743|NCT03214250|100934434|FG000|Overall Study|Withdrawal by Subject|0|||
33283744|NCT03214250|100934435|FG001|Overall Study|Withdrawal by Subject|0|||
33283745|NCT03214250|100934436|FG002|Overall Study|Withdrawal by Subject|1|||
33283746|NCT03214250|100934437|FG003|Overall Study|Withdrawal by Subject|2|||
33283747|NCT03214250|100934438|FG004|Overall Study|Withdrawal by Subject|5|||
33283748|NCT03214250|100934439|FG005|Overall Study|Withdrawal by Subject|0|||
33283749|NCT03214250|100934440|FG006|Overall Study|Withdrawal by Subject|2|||
33283750|NCT00726388|100934444|FG000|Overall Study|Withdrawal by Subject|5|||
33283751|NCT00726388|100934444|FG000|Overall Study|Adverse Event|3|||
33283752|NCT00726388|100934444|FG000|Overall Study|Lost to Follow-up|10|||
33283753|NCT00726388|100934444|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
33283754|NCT00726388|100934444|FG000|Overall Study|Other|5|||
33283755|NCT00726388|100934444|FG000|Overall Study|Enrolled, Not Treated|79|||
33283756|NCT02845375|100934445|FG000|Overall Study|upper airway obstruction|1|||
33283757|NCT02845375|100934446|FG001|Overall Study|upper airway obstruction|2|||
33283758|NCT02845375|100934447|FG002|Overall Study|upper airway obstruction|1|||
33283759|NCT00858247|100936647|FG000|Baseline Assessment|Withdrawal by Subject|1|||
33283760|NCT00858247|100936648|FG001|Baseline Assessment|Withdrawal by Subject|1|||
33283761|NCT00858247|100936647|FG000|Baseline Assessment|Poor IV access|1|||
33283762|NCT00858247|100936648|FG001|Baseline Assessment|Poor IV access|0|||
33283763|NCT00858247|100936647|FG000|Baseline Assessment|Protocol Violation|0|||
33283764|NCT00858247|100936648|FG001|Baseline Assessment|Protocol Violation|1|||
33283765|NCT00858247|100936647|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
33283766|NCT00858247|100936648|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
33283767|NCT00961896|100936649|FG000|Overall Study|Abnormal laboratory value|0|||
33283768|NCT00961896|100936650|FG001|Overall Study|Abnormal laboratory value|0|||
33283769|NCT00961896|100936651|FG002|Overall Study|Abnormal laboratory value|1|||
33283770|NCT02024750|100936654|FG000|Overall Study|Withdrawal by Subject|2|||
33283771|NCT02024750|100936655|FG001|Overall Study|Withdrawal by Subject|1|||
33283772|NCT00001941|100936656|FG000|Overall Study|not treated- rapidly progressing disease|0|||
33283773|NCT00001941|100936657|FG001|Overall Study|not treated- rapidly progressing disease|0|||
33283774|NCT00001941|100936658|FG002|Overall Study|not treated- rapidly progressing disease|0|||
33283775|NCT00001941|100936659|FG003|Overall Study|not treated- rapidly progressing disease|0|||
33283776|NCT00001941|100936660|FG004|Overall Study|not treated- rapidly progressing disease|1|||
33283777|NCT00069277|100936661|FG000|Overall Study|Adverse Event|3|||
33283778|NCT00069277|100936661|FG000|Overall Study|Withdrawal by Subject|1|||
33283779|NCT00069277|100936661|FG000|Overall Study|Progressive Disease|15|||
33283780|NCT00069277|100936661|FG000|Overall Study|Physician Decision|2|||
33283781|NCT03226106|100936662|FG000|Overall Study|Withdrawal by Subject|2|||
33283782|NCT03226106|100936663|FG001|Overall Study|Withdrawal by Subject|0|||
33283783|NCT03226106|100936662|FG000|Overall Study|Adverse Event|1|||
33283784|NCT03226106|100936663|FG001|Overall Study|Adverse Event|0|||
33283785|NCT03226106|100936662|FG000|Overall Study|Lost to Follow-up|2|||
33283786|NCT03226106|100936663|FG001|Overall Study|Lost to Follow-up|0|||
33283787|NCT00125853|100936665|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
33283788|NCT00125853|100936666|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
33283789|NCT04816708|100936667|FG000|Overall Study|Lost to Follow-up|10|||
33283790|NCT04816708|100936668|FG001|Overall Study|Lost to Follow-up|4|||
33283791|NCT01274559|100936669|FG000|Overall Study|Adverse Event|57|||
33283792|NCT01274559|100936670|FG001|Overall Study|Adverse Event|13|||
33283793|NCT01274559|100936669|FG000|Overall Study|Death|1|||
33283794|NCT01274559|100936670|FG001|Overall Study|Death|1|||
33283795|NCT01274559|100936669|FG000|Overall Study|Lost to Follow-up|3|||
33283796|NCT01274559|100936670|FG001|Overall Study|Lost to Follow-up|3|||
33283797|NCT01274559|100936669|FG000|Overall Study|Non-compliance with Study Drug|2|||
33283798|NCT01274559|100936670|FG001|Overall Study|Non-compliance with Study Drug|4|||
33283799|NCT01274559|100936669|FG000|Overall Study|Physician Decision|2|||
33283800|NCT01274559|100936670|FG001|Overall Study|Physician Decision|1|||
33283801|NCT01274559|100936669|FG000|Overall Study|Protocol Violation|28|||
33283802|NCT01274559|100936670|FG001|Overall Study|Protocol Violation|23|||
33283803|NCT01274559|100936669|FG000|Overall Study|Study Terminated by Sponsor|79|||
33283804|NCT01274559|100936670|FG001|Overall Study|Study Terminated by Sponsor|87|||
33283805|NCT01274559|100936669|FG000|Overall Study|Withdrawal by Subject|25|||
33283806|NCT01274559|100936670|FG001|Overall Study|Withdrawal by Subject|13|||
33283807|NCT00635570|100936671|FG000|Overall Study|Lost to Follow-up|8|||
33283808|NCT00635570|100936672|FG001|Overall Study|Lost to Follow-up|8|||
33283809|NCT00635570|100936671|FG000|Overall Study|Withdrawal by Subject|1|||
33283810|NCT00635570|100936672|FG001|Overall Study|Withdrawal by Subject|1|||
33283811|NCT00635570|100936671|FG000|Overall Study|Adverse Event|2|||
33283812|NCT00635570|100936672|FG001|Overall Study|Adverse Event|0|||
33283813|NCT00635570|100936671|FG000|Overall Study|Physician Decision|1|||
33283814|NCT00635570|100936672|FG001|Overall Study|Physician Decision|0|||
33283815|NCT00635570|100936671|FG000|Overall Study|Did not complete survey|2|||
33283816|NCT00635570|100936672|FG001|Overall Study|Did not complete survey|1|||
33283817|NCT00635570|100936671|FG000|Overall Study|Early termination(No sexual activity)|1|||
33283818|NCT00635570|100936672|FG001|Overall Study|Early termination(No sexual activity)|1|||
33283819|NCT01751165|100936677|FG000|Overall Study|Adverse event, serious fatal|1|||
33283820|NCT01751165|100936678|FG001|Overall Study|Adverse event, serious fatal|0|||
33283821|NCT01751165|100936679|FG002|Overall Study|Adverse event, serious fatal|1|||
33283822|NCT01751165|100936677|FG000|Overall Study|Withdrawal by Subject|0|||
33283823|NCT01751165|100936678|FG001|Overall Study|Withdrawal by Subject|0|||
33283824|NCT01751165|100936679|FG002|Overall Study|Withdrawal by Subject|1|||
33283825|NCT01751165|100936677|FG000|Overall Study|Serious adverse event|0|||
33283826|NCT01751165|100936678|FG001|Overall Study|Serious adverse event|2|||
33283827|NCT01751165|100936679|FG002|Overall Study|Serious adverse event|0|||
33283828|NCT01751165|100936677|FG000|Overall Study|Lost to Follow-up|1|||
33283829|NCT01751165|100936678|FG001|Overall Study|Lost to Follow-up|1|||
33283830|NCT01751165|100936679|FG002|Overall Study|Lost to Follow-up|1|||
33283831|NCT00702650|100936681|FG000|Overall Study|Withdrawal by Subject|9|||
33283832|NCT00702650|100936681|FG000|Overall Study|Non-Compliance of Study Drug|3|||
33283833|NCT00702650|100936681|FG000|Overall Study|Lost to Follow-up|2|||
33283834|NCT00702650|100936681|FG000|Overall Study|Non-Compliance with Site Directives|1|||
33283835|NCT00702650|100936681|FG000|Overall Study|Sponsor Request|1|||
33283836|NCT00702650|100936681|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
33283837|NCT00702650|100936681|FG000|Overall Study|Adverse Event|3|||
33283838|NCT00002597|100936682|FG000|Overall Study|Protocol Violation|19|||
33283839|NCT00002597|100936683|FG001|Overall Study|Protocol Violation|17|||
33283840|NCT00002597|100936682|FG000|Overall Study|Withdrawal by Subject|7|||
33283841|NCT00002597|100936683|FG001|Overall Study|Withdrawal by Subject|6|||
33283842|NCT02859558|100936687|FG000|Step 1|Not Eligible|0|||
33283843|NCT02859558|100936688|FG001|Step 1|Not Eligible|0|||
33283844|NCT02859558|100936689|FG002|Step 1|Not Eligible|0|||
33283845|NCT02859558|100936690|FG003|Step 1|Not Eligible|0|||
33283846|NCT02859558|100936691|FG004|Step 1|Not Eligible|3|||
33283847|NCT02859558|100936687|FG000|Step 1|Lost to Follow-up|1|||
33283848|NCT02859558|100936688|FG001|Step 1|Lost to Follow-up|3|||
33283849|NCT02859558|100936689|FG002|Step 1|Lost to Follow-up|3|||
33283850|NCT02859558|100936690|FG003|Step 1|Lost to Follow-up|0|||
33283851|NCT02859558|100936691|FG004|Step 1|Lost to Follow-up|0|||
33283852|NCT02859558|100936687|FG000|Step 1|Did Not Return to Clinic|2|||
33283853|NCT02859558|100936688|FG001|Step 1|Did Not Return to Clinic|3|||
33283854|NCT02859558|100936689|FG002|Step 1|Did Not Return to Clinic|4|||
33283855|NCT02859558|100936690|FG003|Step 1|Did Not Return to Clinic|0|||
33283856|NCT02859558|100936691|FG004|Step 1|Did Not Return to Clinic|0|||
33283857|NCT02859558|100936687|FG000|Step 1|Moved|0|||
33283858|NCT02859558|100936688|FG001|Step 1|Moved|1|||
33283859|NCT02859558|100936689|FG002|Step 1|Moved|1|||
33283860|NCT02859558|100936690|FG003|Step 1|Moved|0|||
33283861|NCT02859558|100936691|FG004|Step 1|Moved|0|||
33283862|NCT02859558|100936687|FG000|Step 1|Withdrawal By Participant|1|||
33283863|NCT02859558|100936688|FG001|Step 1|Withdrawal By Participant|2|||
33283864|NCT02859558|100936689|FG002|Step 1|Withdrawal By Participant|1|||
33283865|NCT02859558|100936690|FG003|Step 1|Withdrawal By Participant|0|||
33283866|NCT02859558|100936691|FG004|Step 1|Withdrawal By Participant|0|||
33283867|NCT02859558|100936687|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
33283868|NCT02859558|100936688|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
33283869|NCT02859558|100936689|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
33283870|NCT02859558|100936690|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
33283871|NCT02859558|100936691|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
33283872|NCT02859558|100936687|FG000|Step 1|Incarceration|0|||
33283873|NCT02859558|100936688|FG001|Step 1|Incarceration|1|||
33283874|NCT02859558|100936689|FG002|Step 1|Incarceration|0|||
33283875|NCT02859558|100936690|FG003|Step 1|Incarceration|0|||
33283876|NCT02859558|100936691|FG004|Step 1|Incarceration|0|||
33283877|NCT02859558|100936687|FG000|Step 1|Non-Adherence to Study Drug|2|||
33283878|NCT02859558|100936688|FG001|Step 1|Non-Adherence to Study Drug|0|||
33283879|NCT02859558|100936689|FG002|Step 1|Non-Adherence to Study Drug|1|||
33283880|NCT02859558|100936690|FG003|Step 1|Non-Adherence to Study Drug|0|||
33283881|NCT02859558|100936691|FG004|Step 1|Non-Adherence to Study Drug|0|||
33283882|NCT02859558|100936687|FG000|Step 1|Non-Adherence to Study Requirements|3|||
33283883|NCT02859558|100936688|FG001|Step 1|Non-Adherence to Study Requirements|1|||
33283884|NCT02859558|100936689|FG002|Step 1|Non-Adherence to Study Requirements|0|||
33283885|NCT02859558|100936690|FG003|Step 1|Non-Adherence to Study Requirements|0|||
33283886|NCT02859558|100936691|FG004|Step 1|Non-Adherence to Study Requirements|0|||
33283887|NCT02859558|100936687|FG000|Step 1|Virologic Failure|2|||
33283888|NCT02859558|100936688|FG001|Step 1|Virologic Failure|1|||
33283889|NCT02859558|100936689|FG002|Step 1|Virologic Failure|1|||
33283890|NCT02859558|100936690|FG003|Step 1|Virologic Failure|0|||
33283891|NCT02859558|100936691|FG004|Step 1|Virologic Failure|0|||
33283892|NCT02859558|100936687|FG000|Step 2|Active On Study|23|||
33283893|NCT02859558|100936688|FG001|Step 2|Active On Study|38|||
33283894|NCT02859558|100936689|FG002|Step 2|Active On Study|20|||
33283895|NCT02859558|100936690|FG003|Step 2|Active On Study|0|||
33283896|NCT02859558|100936691|FG004|Step 2|Active On Study|0|||
33283897|NCT02859558|100936687|FG000|Step 2|Did Not Return to Clinic|2|||
33283898|NCT02859558|100936688|FG001|Step 2|Did Not Return to Clinic|0|||
33283899|NCT02859558|100936689|FG002|Step 2|Did Not Return to Clinic|0|||
33283900|NCT02859558|100936690|FG003|Step 2|Did Not Return to Clinic|0|||
33283901|NCT02859558|100936691|FG004|Step 2|Did Not Return to Clinic|0|||
33283902|NCT02859558|100936687|FG000|Step 2|Unexpected Closure of Site|0|||
33283903|NCT02859558|100936688|FG001|Step 2|Unexpected Closure of Site|1|||
33283904|NCT02859558|100936689|FG002|Step 2|Unexpected Closure of Site|1|||
33283905|NCT02859558|100936690|FG003|Step 2|Unexpected Closure of Site|0|||
33283906|NCT02859558|100936691|FG004|Step 2|Unexpected Closure of Site|0|||
33283907|NCT00439647|100936692|FG000|Overall Study|Withdrawal by Subject|25|||
33283908|NCT00439647|100936693|FG001|Overall Study|Withdrawal by Subject|22|||
33283909|NCT00439647|100936692|FG000|Overall Study|Death|15|||
33283910|NCT00439647|100936693|FG001|Overall Study|Death|18|||
33283911|NCT00439647|100936692|FG000|Overall Study|Adverse Event|11|||
33283912|NCT00439647|100936693|FG001|Overall Study|Adverse Event|11|||
33283913|NCT00439647|100936692|FG000|Overall Study|Lost to Follow-up|4|||
33283914|NCT00439647|100936693|FG001|Overall Study|Lost to Follow-up|12|||
33283915|NCT00439647|100936692|FG000|Overall Study|Protocol Violation|3|||
33283916|NCT00439647|100936693|FG001|Overall Study|Protocol Violation|4|||
33283917|NCT00439647|100936692|FG000|Overall Study|Lack of Efficacy|0|||
33283918|NCT00439647|100936693|FG001|Overall Study|Lack of Efficacy|4|||
33283919|NCT03357471|100936694|FG000|Overall Study|Adverse Event|1|||
33283920|NCT03357471|100936695|FG001|Overall Study|Adverse Event|0|||
33283921|NCT03357471|100936694|FG000|Overall Study|Lost to Follow-up|1|||
33283922|NCT03357471|100936695|FG001|Overall Study|Lost to Follow-up|0|||
33283923|NCT02176356|100936696|FG000|Overall Study|Screen Failure|14|||
33283924|NCT02176356|100936696|FG000|Overall Study|Lost to Follow-up|4|||
33283925|NCT02176356|100936696|FG000|Overall Study|Personal Reasons|3|||
33283926|NCT02176356|100936696|FG000|Overall Study|Other Miscellaneous Reasons|2|||
33283927|NCT05896696|100936697|FG000|Overall Study|Screening Failure|7|||
33283928|NCT05896696|100936697|FG000|Overall Study|Withdrawal by Subject|2|||
33283929|NCT03891641|100936698|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
33283930|NCT03891641|100936699|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
33283931|NCT02396758|100936703|FG000|Overall Study|Withdrawal by Subject|2|||
33283932|NCT02396758|100936704|FG001|Overall Study|Withdrawal by Subject|0|||
33283933|NCT02396758|100936705|FG002|Overall Study|Withdrawal by Subject|0|||
33283934|NCT02396758|100936706|FG003|Overall Study|Withdrawal by Subject|1|||
33283935|NCT02396758|100936703|FG000|Overall Study|Lost to Follow-up|8|||
33283936|NCT02396758|100936704|FG001|Overall Study|Lost to Follow-up|5|||
33283937|NCT02396758|100936705|FG002|Overall Study|Lost to Follow-up|3|||
33283938|NCT02396758|100936706|FG003|Overall Study|Lost to Follow-up|3|||
33283939|NCT02396758|100936703|FG000|Overall Study|Death|1|||
33283940|NCT02396758|100936704|FG001|Overall Study|Death|1|||
33283941|NCT02396758|100936705|FG002|Overall Study|Death|0|||
33283942|NCT02396758|100936706|FG003|Overall Study|Death|1|||
33283943|NCT02396758|100936703|FG000|Overall Study|Randomized but not treated|1|||
33283944|NCT02396758|100936704|FG001|Overall Study|Randomized but not treated|0|||
33283945|NCT02396758|100936705|FG002|Overall Study|Randomized but not treated|1|||
33283946|NCT02396758|100936706|FG003|Overall Study|Randomized but not treated|0|||
33283947|NCT00925288|100936707|FG000|Overall Study|Lost to Follow-up|9|||
33283948|NCT00925288|100936708|FG001|Overall Study|Lost to Follow-up|7|||
33283949|NCT01951378|100936709|FG000|Overall Study|Study Terminated-Not completed|23|||
33283950|NCT01951378|100936710|FG001|Overall Study|Study Terminated-Not completed|17|||
33283951|NCT03681353|100936711|FG000|Overall Study|Lost to Follow-up|2|||
33283952|NCT03681353|100936711|FG000|Overall Study|Withdrawal by Subject|3|||
33283953|NCT03681353|100936711|FG000|Overall Study|withdrawn by PI|2|||
33283954|NCT01780545|100936712|FG000|Overall Study|Withdrawal by Subject|3|||
33283955|NCT01780545|100936713|FG001|Overall Study|Withdrawal by Subject|1|||
33283956|NCT01780545|100936712|FG000|Overall Study|Lost to Follow-up|1|||
33283957|NCT01780545|100936713|FG001|Overall Study|Lost to Follow-up|1|||
33283958|NCT00332488|100936714|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
33283959|NCT00332488|100936715|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
33283960|NCT00332488|100936716|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
33283961|NCT00332488|100936714|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
33283962|NCT00332488|100936715|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
33283963|NCT00332488|100936716|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
33283964|NCT00332488|100936714|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
33283965|NCT00332488|100936715|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
33283966|NCT00332488|100936716|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
33283967|NCT00332488|100936714|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
33283968|NCT00332488|100936715|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
33283969|NCT00332488|100936716|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
33283970|NCT00332488|100936714|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
33283971|NCT00332488|100936715|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
33283972|NCT00332488|100936716|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
33283973|NCT00332488|100936714|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
33283974|NCT00332488|100936715|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
33283975|NCT00332488|100936716|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
33283976|NCT00332488|100936714|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
33283977|NCT00332488|100936715|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
33283978|NCT00332488|100936716|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
33283979|NCT00332488|100936714|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
33283980|NCT00332488|100936715|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
33283981|NCT00332488|100936716|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
33283982|NCT00332488|100936714|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
33283983|NCT00332488|100936715|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
33283984|NCT00332488|100936716|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
33283985|NCT00332488|100936714|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
33283986|NCT00332488|100936715|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
33283987|NCT00332488|100936716|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
33283988|NCT00332488|100936714|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
33283989|NCT00332488|100936715|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
33283990|NCT00332488|100936716|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
33283991|NCT00332488|100936714|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
33283992|NCT00332488|100936715|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
33283993|NCT00332488|100936716|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
33283994|NCT01885936|100936719|FG000|Overall Study|Withdrawal by Subject|1|||
33283995|NCT01885936|100936720|FG001|Overall Study|Withdrawal by Subject|0|||
33283996|NCT01704547|100936721|FG000|Overall Study|Physician Decision|4|||
33283997|NCT01704547|100936721|FG000|Overall Study|Withdrawal by Subject|1|||
33283998|NCT01180790|100936723|FG000|Overall Study|Adverse Event|1|||
33283999|NCT01180790|100936724|FG001|Overall Study|Adverse Event|1|||
33284000|NCT01180790|100936725|FG002|Overall Study|Adverse Event|2|||
33284001|NCT01180790|100936726|FG003|Overall Study|Adverse Event|0|||
33284002|NCT01180790|100936727|FG004|Overall Study|Adverse Event|1|||
33284003|NCT01180790|100936728|FG005|Overall Study|Adverse Event|3|||
33284004|NCT01180790|100936729|FG006|Overall Study|Adverse Event|0|||
33284005|NCT01180790|100936723|FG000|Overall Study|Withdrawal by Subject|3|||
33284006|NCT01180790|100936724|FG001|Overall Study|Withdrawal by Subject|0|||
33284007|NCT01180790|100936725|FG002|Overall Study|Withdrawal by Subject|5|||
33284008|NCT01180790|100936726|FG003|Overall Study|Withdrawal by Subject|0|||
33284009|NCT01180790|100936727|FG004|Overall Study|Withdrawal by Subject|2|||
33284010|NCT01180790|100936728|FG005|Overall Study|Withdrawal by Subject|1|||
33284011|NCT01180790|100936729|FG006|Overall Study|Withdrawal by Subject|0|||
33284012|NCT01180790|100936723|FG000|Overall Study|Lost to Follow-up|3|||
33284013|NCT01180790|100936724|FG001|Overall Study|Lost to Follow-up|1|||
33284014|NCT01180790|100936725|FG002|Overall Study|Lost to Follow-up|0|||
33284015|NCT01180790|100936726|FG003|Overall Study|Lost to Follow-up|2|||
33284016|NCT01180790|100936727|FG004|Overall Study|Lost to Follow-up|1|||
33284017|NCT01180790|100936728|FG005|Overall Study|Lost to Follow-up|0|||
33284018|NCT01180790|100936729|FG006|Overall Study|Lost to Follow-up|1|||
33284019|NCT01180790|100936723|FG000|Overall Study|Physician Decision|1|||
33284020|NCT01180790|100936724|FG001|Overall Study|Physician Decision|0|||
33284021|NCT01180790|100936725|FG002|Overall Study|Physician Decision|0|||
33284022|NCT01180790|100936726|FG003|Overall Study|Physician Decision|1|||
33284023|NCT01180790|100936727|FG004|Overall Study|Physician Decision|0|||
33284024|NCT01180790|100936728|FG005|Overall Study|Physician Decision|0|||
33284025|NCT01180790|100936729|FG006|Overall Study|Physician Decision|0|||
33284026|NCT01180790|100936723|FG000|Overall Study|Lack of Efficacy|1|||
33284027|NCT01180790|100936724|FG001|Overall Study|Lack of Efficacy|2|||
33284028|NCT01180790|100936725|FG002|Overall Study|Lack of Efficacy|5|||
33284029|NCT01180790|100936726|FG003|Overall Study|Lack of Efficacy|6|||
33284030|NCT01180790|100936727|FG004|Overall Study|Lack of Efficacy|1|||
33284031|NCT01180790|100936728|FG005|Overall Study|Lack of Efficacy|3|||
33284032|NCT01180790|100936729|FG006|Overall Study|Lack of Efficacy|0|||
33284033|NCT01180790|100936723|FG000|Overall Study|compliance|0|||
33284034|NCT01180790|100936724|FG001|Overall Study|compliance|1|||
33284035|NCT01180790|100936725|FG002|Overall Study|compliance|0|||
33284036|NCT01180790|100936726|FG003|Overall Study|compliance|0|||
33284037|NCT01180790|100936727|FG004|Overall Study|compliance|0|||
33284038|NCT01180790|100936728|FG005|Overall Study|compliance|0|||
33284039|NCT01180790|100936729|FG006|Overall Study|compliance|0|||
33284040|NCT01180790|100936723|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
33284041|NCT01180790|100936724|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
33284042|NCT01180790|100936725|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
33284043|NCT01180790|100936726|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
33284044|NCT01180790|100936727|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
33284045|NCT01180790|100936728|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
33284046|NCT01180790|100936729|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
33284047|NCT02482935|100936734|FG000|Period 1|Withdrawal by Subject|1|||
33284048|NCT02482935|100936735|FG001|Period 1|Withdrawal by Subject|0|||
33284049|NCT01194271|100936736|FG000|Overall Study|Withdrawal by Subject|1|||
33488737|NCT00444587|101683188|FG000|Overall Study|Death|2|||
33488738|NCT00444587|101683189|FG001|Overall Study|Death|1|||
33488739|NCT00444587|101683188|FG000|Overall Study|Progression of the disease|73|||
33488740|NCT00444587|101683189|FG001|Overall Study|Progression of the disease|8|||
33488741|NCT00444587|101683188|FG000|Overall Study|Refused treatment/did not cooperate|4|||
33488742|NCT00444587|101683189|FG001|Overall Study|Refused treatment/did not cooperate|1|||
33488743|NCT00444587|101683188|FG000|Overall Study|Investigator decision|3|||
33488744|NCT00444587|101683189|FG001|Overall Study|Investigator decision|0|||
33488745|NCT00444587|101683188|FG000|Overall Study|Protocol Violation|1|||
33488746|NCT00444587|101683189|FG001|Overall Study|Protocol Violation|0|||
33488747|NCT00444587|101683188|FG000|Overall Study|Missing|0|||
33488748|NCT00444587|101683189|FG001|Overall Study|Missing|5|||
33488749|NCT00584454|101683190|FG000|Overall Study|Adverse Event|1|||
33488750|NCT00584454|101683190|FG000|Overall Study|Relocation|1|||
33488751|NCT00584454|101683190|FG000|Overall Study|Clinical Hold|2|||
33488752|NCT02797171|101683192|FG000|Overall Study|Lost to Follow-up|2|||
33488753|NCT02797171|101683193|FG001|Overall Study|Lost to Follow-up|0|||
33488754|NCT02797171|101683194|FG002|Overall Study|Lost to Follow-up|2|||
33488755|NCT02797171|101683195|FG003|Overall Study|Lost to Follow-up|1|||
33488756|NCT02797171|101683196|FG004|Overall Study|Lost to Follow-up|2|||
33488757|NCT02797171|101683197|FG005|Overall Study|Lost to Follow-up|0|||
33488758|NCT02797171|101683192|FG000|Overall Study|Withdrawal by Subject|1|||
33488759|NCT02797171|101683193|FG001|Overall Study|Withdrawal by Subject|1|||
33488760|NCT02797171|101683194|FG002|Overall Study|Withdrawal by Subject|0|||
33488761|NCT02797171|101683195|FG003|Overall Study|Withdrawal by Subject|0|||
33488762|NCT02797171|101683196|FG004|Overall Study|Withdrawal by Subject|0|||
33488763|NCT02797171|101683197|FG005|Overall Study|Withdrawal by Subject|0|||
33488764|NCT02797171|101683192|FG000|Overall Study|Protocol Violation|1|||
33488765|NCT02797171|101683193|FG001|Overall Study|Protocol Violation|0|||
33488766|NCT02797171|101683194|FG002|Overall Study|Protocol Violation|0|||
33488767|NCT02797171|101683195|FG003|Overall Study|Protocol Violation|0|||
33488768|NCT02797171|101683196|FG004|Overall Study|Protocol Violation|0|||
33488769|NCT02797171|101683197|FG005|Overall Study|Protocol Violation|0|||
33488770|NCT02797171|101683192|FG000|Overall Study|Participant unable to adhere|0|||
33488771|NCT02797171|101683193|FG001|Overall Study|Participant unable to adhere|1|||
33488772|NCT02797171|101683194|FG002|Overall Study|Participant unable to adhere|0|||
33488773|NCT02797171|101683195|FG003|Overall Study|Participant unable to adhere|0|||
33488774|NCT02797171|101683196|FG004|Overall Study|Participant unable to adhere|0|||
33488775|NCT02797171|101683197|FG005|Overall Study|Participant unable to adhere|0|||
33284050|NCT01194271|100936736|FG000|Overall Study|Ineligible, Screen Failure|1|||
33284051|NCT01194271|100936736|FG000|Overall Study|Death|1|||
33284052|NCT01182181|100936737|FG000|First Intervention|Adverse Event|1|||
33284053|NCT01182181|100936738|FG001|First Intervention|Adverse Event|0|||
33284054|NCT01182181|100936737|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
33284055|NCT01182181|100936738|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
33284056|NCT05600036|100936742|FG000|Overall Study|Adverse Event|0|||
33488776|NCT02797171|101683192|FG000|Overall Study|Not Randomized|0|||
33488777|NCT02797171|101683193|FG001|Overall Study|Not Randomized|0|||
33488778|NCT02797171|101683194|FG002|Overall Study|Not Randomized|0|||
33284057|NCT05600036|100936743|FG001|Overall Study|Adverse Event|2|||
33488779|NCT02797171|101683195|FG003|Overall Study|Not Randomized|0|||
33488780|NCT02797171|101683196|FG004|Overall Study|Not Randomized|0|||
33488781|NCT02797171|101683197|FG005|Overall Study|Not Randomized|1|||
33488782|NCT02856802|101683204|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
33488783|NCT02856802|101683205|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
33488784|NCT02856802|101683204|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
33488785|NCT02856802|101683205|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
33488786|NCT02856802|101683204|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
33488787|NCT02856802|101683205|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
33488788|NCT02856802|101683204|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
33488789|NCT02856802|101683205|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
33488790|NCT02856802|101683204|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
33488791|NCT02856802|101683205|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
33488792|NCT02856802|101683204|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
33488793|NCT02856802|101683205|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
33488794|NCT01245283|101683210|FG000|Overall Study|Lost to Follow-up|14|||
33488795|NCT01245283|101683211|FG001|Overall Study|Lost to Follow-up|11|||
33488796|NCT01245283|101683212|FG002|Overall Study|Lost to Follow-up|11|||
33488797|NCT04238650|101683217|FG000|Overall Study|Withdrawal by Subject|0|||
33488798|NCT04238650|101683218|FG001|Overall Study|Withdrawal by Subject|1|||
33488799|NCT04043455|101683219|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
33488800|NCT04043455|101683220|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
33488801|NCT04043455|101683221|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
33488802|NCT04043455|101683222|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
33488803|NCT04043455|101683223|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
33488804|NCT04043455|101683224|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
33488805|NCT04043455|101683219|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
33488806|NCT04043455|101683220|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
33488807|NCT04043455|101683221|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
33488808|NCT04043455|101683222|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
33488809|NCT04043455|101683223|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
33488810|NCT04043455|101683224|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
33488811|NCT04043455|101683219|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
33488812|NCT04043455|101683220|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
33488813|NCT04043455|101683221|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
33488814|NCT04043455|101683222|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
33488815|NCT04043455|101683223|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
33488816|NCT04043455|101683224|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
33488817|NCT04043455|101683219|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
33488818|NCT04043455|101683220|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
33488819|NCT04043455|101683221|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
33488820|NCT04043455|101683222|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
33488821|NCT04043455|101683223|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
33488822|NCT04043455|101683224|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
33488823|NCT04043455|101683219|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
33488824|NCT04043455|101683220|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
33488825|NCT04043455|101683221|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
33488826|NCT04043455|101683222|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
33488827|NCT04043455|101683223|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
33488828|NCT04043455|101683224|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
33488829|NCT04043455|101683219|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
33488830|NCT04043455|101683220|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
33488831|NCT04043455|101683221|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
33488832|NCT04043455|101683222|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
33488833|NCT04043455|101683223|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
33488834|NCT04043455|101683224|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
33488835|NCT04043455|101683219|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
33488836|NCT04043455|101683220|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
33488837|NCT04043455|101683221|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
33488838|NCT04043455|101683222|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
33488839|NCT04043455|101683223|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
33488840|NCT04043455|101683224|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
33284058|NCT05600036|100936744|FG002|Overall Study|Adverse Event|1|||
33284059|NCT05600036|100936745|FG003|Overall Study|Adverse Event|0|||
33284060|NCT05600036|100936746|FG004|Overall Study|Adverse Event|1|||
33488841|NCT04043455|101683219|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
33488842|NCT04043455|101683220|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
33488843|NCT04043455|101683221|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
33488844|NCT04043455|101683222|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
33488845|NCT04043455|101683223|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
33488846|NCT04043455|101683224|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
33488847|NCT04043455|101683219|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
33488848|NCT04043455|101683220|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
33488849|NCT04043455|101683221|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
33488850|NCT04043455|101683222|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
33488851|NCT04043455|101683223|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
33488852|NCT04043455|101683224|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
33488853|NCT04043455|101683219|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
33488854|NCT04043455|101683220|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
33488855|NCT04043455|101683221|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
33488856|NCT04043455|101683222|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
33488857|NCT04043455|101683223|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
33488858|NCT04043455|101683224|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
33488859|NCT04043455|101683219|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
33488860|NCT04043455|101683220|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
33488861|NCT04043455|101683221|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
33488862|NCT04043455|101683222|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
33488863|NCT04043455|101683223|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
33488864|NCT04043455|101683224|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
33488865|NCT03404674|101683225|FG000|Overall Study|Inability to Attend Future Visits|0|||
33488866|NCT03404674|101683226|FG001|Overall Study|Inability to Attend Future Visits|1|||
33488867|NCT03404674|101683227|FG002|Overall Study|Inability to Attend Future Visits|1|||
33488868|NCT03404674|101683228|FG003|Overall Study|Inability to Attend Future Visits|0|||
33488869|NCT03404674|101683229|FG004|Overall Study|Inability to Attend Future Visits|0|||
33488870|NCT03404674|101683230|FG005|Overall Study|Inability to Attend Future Visits|0|||
33488871|NCT03404674|101683225|FG000|Overall Study|Behavioral Problems|0|||
33488872|NCT03404674|101683226|FG001|Overall Study|Behavioral Problems|0|||
33488873|NCT03404674|101683227|FG002|Overall Study|Behavioral Problems|1|||
33488874|NCT03404674|101683228|FG003|Overall Study|Behavioral Problems|0|||
33488875|NCT03404674|101683229|FG004|Overall Study|Behavioral Problems|0|||
33488876|NCT03404674|101683230|FG005|Overall Study|Behavioral Problems|0|||
33488877|NCT03404674|101683225|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
33488878|NCT03404674|101683226|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
33488879|NCT03404674|101683227|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
33488880|NCT03404674|101683228|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
33488881|NCT03404674|101683229|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
33488882|NCT03404674|101683230|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
33488883|NCT02413229|101683236|FG000|Overall Study|Adverse Event|0|||
33488884|NCT02413229|101683237|FG001|Overall Study|Adverse Event|0|||
33488885|NCT02413229|101683238|FG002|Overall Study|Adverse Event|0|||
33488886|NCT02413229|101683239|FG003|Overall Study|Adverse Event|1|||
33488887|NCT02413229|101683240|FG004|Overall Study|Adverse Event|0|||
33488888|NCT02413229|101683241|FG005|Overall Study|Adverse Event|0|||
33488889|NCT02413229|101683242|FG006|Overall Study|Adverse Event|0|||
33488890|NCT02413229|101683243|FG007|Overall Study|Adverse Event|1|||
33488891|NCT02413229|101683236|FG000|Overall Study|Lost to Follow-up|0|||
33488892|NCT02413229|101683237|FG001|Overall Study|Lost to Follow-up|0|||
33488893|NCT02413229|101683238|FG002|Overall Study|Lost to Follow-up|1|||
33488894|NCT02413229|101683239|FG003|Overall Study|Lost to Follow-up|0|||
33488895|NCT02413229|101683240|FG004|Overall Study|Lost to Follow-up|2|||
33488896|NCT02413229|101683241|FG005|Overall Study|Lost to Follow-up|0|||
33488897|NCT02413229|101683242|FG006|Overall Study|Lost to Follow-up|0|||
33488898|NCT02413229|101683243|FG007|Overall Study|Lost to Follow-up|0|||
33488899|NCT02413229|101683236|FG000|Overall Study|Withdrawal by Subject|1|||
33488900|NCT02413229|101683237|FG001|Overall Study|Withdrawal by Subject|1|||
33488901|NCT02413229|101683238|FG002|Overall Study|Withdrawal by Subject|0|||
33488902|NCT02413229|101683239|FG003|Overall Study|Withdrawal by Subject|0|||
33488903|NCT02413229|101683240|FG004|Overall Study|Withdrawal by Subject|1|||
33488904|NCT02413229|101683241|FG005|Overall Study|Withdrawal by Subject|0|||
33488905|NCT02413229|101683242|FG006|Overall Study|Withdrawal by Subject|0|||
33488906|NCT02413229|101683243|FG007|Overall Study|Withdrawal by Subject|2|||
33488907|NCT02413229|101683236|FG000|Overall Study|Progressive Disease|0|||
33488908|NCT02413229|101683237|FG001|Overall Study|Progressive Disease|0|||
33488909|NCT02413229|101683238|FG002|Overall Study|Progressive Disease|0|||
33284061|NCT05600036|100936747|FG005|Overall Study|Adverse Event|0|||
33488910|NCT02413229|101683239|FG003|Overall Study|Progressive Disease|0|||
33488911|NCT02413229|101683240|FG004|Overall Study|Progressive Disease|0|||
33488912|NCT02413229|101683241|FG005|Overall Study|Progressive Disease|0|||
33488913|NCT02413229|101683242|FG006|Overall Study|Progressive Disease|0|||
33488914|NCT02413229|101683243|FG007|Overall Study|Progressive Disease|1|||
33488915|NCT01108718|101683244|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
33488916|NCT01108718|101683245|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
33488917|NCT02211417|101683246|FG000|Overall Study|Withdrawal by Subject|11|||
33488918|NCT02211417|101683247|FG001|Overall Study|Withdrawal by Subject|8|||
33488919|NCT02211417|101683246|FG000|Overall Study|Protocol Violation|1|||
33488920|NCT02211417|101683247|FG001|Overall Study|Protocol Violation|0|||
33488921|NCT02211417|101683246|FG000|Overall Study|Pregnancy|0|||
33488922|NCT02211417|101683247|FG001|Overall Study|Pregnancy|1|||
33488923|NCT02211417|101683246|FG000|Overall Study|Lost to Follow-up|2|||
33488924|NCT02211417|101683247|FG001|Overall Study|Lost to Follow-up|3|||
33488925|NCT02211417|101683246|FG000|Overall Study|Adverse Event|1|||
33488926|NCT02211417|101683247|FG001|Overall Study|Adverse Event|4|||
33488927|NCT02685735|101683250|FG000|Overall Study|Missing construct or pain data|23|||
33488928|NCT02685735|101683251|FG001|Overall Study|Missing construct or pain data|22|||
33488929|NCT00461253|101683253|FG000|Overall Study|Death|985|||
33488930|NCT00461253|101683254|FG001|Overall Study|Death|0|||
33488931|NCT00461253|101683253|FG000|Overall Study|Protocol Violation|613|||
33488932|NCT00461253|101683254|FG001|Overall Study|Protocol Violation|236|||
33488933|NCT00461253|101683253|FG000|Overall Study|no response|2609|||
33488934|NCT00461253|101683254|FG001|Overall Study|no response|11789|||
33488935|NCT00461253|101683253|FG000|Overall Study|administrative|773|||
33488936|NCT00461253|101683254|FG001|Overall Study|administrative|7773|||
33488937|NCT03629184|101683255|FG000|Overall Study|Withdrawal by Subject|2|||
33488938|NCT03629184|101683256|FG001|Overall Study|Withdrawal by Subject|1|||
33488939|NCT03629184|101683255|FG000|Overall Study|Physician Decision|1|||
33488940|NCT03629184|101683256|FG001|Overall Study|Physician Decision|0|||
33488941|NCT04841577|101683261|FG000|Overall Study|Adverse Event|5|||
33488942|NCT04841577|101683262|FG001|Overall Study|Adverse Event|10|||
33488943|NCT04841577|101683261|FG000|Overall Study|Lost to Follow-up|8|||
33488944|NCT04841577|101683262|FG001|Overall Study|Lost to Follow-up|7|||
33488945|NCT04841577|101683261|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
33488946|NCT04841577|101683262|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
33488947|NCT04841577|101683261|FG000|Overall Study|Other|0|||
33488948|NCT04841577|101683262|FG001|Overall Study|Other|1|||
33488949|NCT02348112|101683264|FG000|Overall Study|Withdrawal by Subject|32|||
33488950|NCT02348112|101683265|FG001|Overall Study|Withdrawal by Subject|29|||
33488951|NCT02348112|101683264|FG000|Overall Study|Lost to Follow-up|24|||
33488952|NCT02348112|101683265|FG001|Overall Study|Lost to Follow-up|20|||
33488953|NCT02348112|101683264|FG000|Overall Study|Physician Decision|17|||
33488954|NCT02348112|101683265|FG001|Overall Study|Physician Decision|15|||
33488955|NCT02348112|101683264|FG000|Overall Study|Site closed due to PI leaving|0|||
33488956|NCT02348112|101683265|FG001|Overall Study|Site closed due to PI leaving|30|||
33488957|NCT02348112|101683264|FG000|Overall Study|Sponsor withdrawal|0|||
33488958|NCT02348112|101683265|FG001|Overall Study|Sponsor withdrawal|7|||
33488959|NCT02348112|101683264|FG000|Overall Study|Death|0|||
33488960|NCT02348112|101683265|FG001|Overall Study|Death|1|||
33488961|NCT02208089|101683266|FG000|Overall Study|Withdrawal by Subject|1|||
33488962|NCT02208089|101683267|FG001|Overall Study|Withdrawal by Subject|0|||
33488963|NCT02208089|101683266|FG000|Overall Study|Lost to Follow-up|6|||
33488964|NCT02208089|101683267|FG001|Overall Study|Lost to Follow-up|0|||
33488965|NCT00193050|101683268|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
33488966|NCT00193050|101683268|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
33488967|NCT00193050|101683268|FG000|Neoadjuvant Treatment|Physician Decision|2|||
33488968|NCT00193050|101683268|FG000|Neoadjuvant Treatment|Adverse Event|2|||
33488969|NCT00193050|101683268|FG000|Adjuvant|Physician Decision|5|||
33488970|NCT00193050|101683268|FG000|Adjuvant|Intercurrent Hospitalization|3|||
33488971|NCT00193050|101683268|FG000|Adjuvant|Lack of Efficacy|2|||
33488972|NCT03156504|101683269|FG000|Overall Study|Withdrawal by Subject|1|||
33488973|NCT00626561|101683276|FG000|Overall Study|Withdrawal by Subject|2|||
33488974|NCT00626561|101683276|FG000|Overall Study|Disease Progression|2|||
33488975|NCT01514461|101683277|FG000|Overall Study|Adverse Event|2|||
33488976|NCT01514461|101683278|FG001|Overall Study|Adverse Event|1|||
33488977|NCT01514461|101683279|FG002|Overall Study|Adverse Event|3|||
33488978|NCT01514461|101683277|FG000|Overall Study|Physician Decision|1|||
33488979|NCT01514461|101683278|FG001|Overall Study|Physician Decision|1|||
33488980|NCT01514461|101683279|FG002|Overall Study|Physician Decision|0|||
33488981|NCT01514461|101683277|FG000|Overall Study|Patient/guardian decision|1|||
33488982|NCT01514461|101683278|FG001|Overall Study|Patient/guardian decision|1|||
33284062|NCT05600036|100936742|FG000|Overall Study|Lost to Follow-up|0|||
33488983|NCT01514461|101683279|FG002|Overall Study|Patient/guardian decision|1|||
33488984|NCT01514461|101683277|FG000|Overall Study|Death|1|||
33488985|NCT01514461|101683278|FG001|Overall Study|Death|0|||
33488986|NCT01514461|101683279|FG002|Overall Study|Death|0|||
33488987|NCT01277211|101683282|FG000|Overall Study|Adverse Event|60|||
33488988|NCT01277211|101683283|FG001|Overall Study|Adverse Event|22|||
33488989|NCT01277211|101683282|FG000|Overall Study|Pregnancy|9|||
33488990|NCT01277211|101683283|FG001|Overall Study|Pregnancy|4|||
33488991|NCT01277211|101683282|FG000|Overall Study|Lost to Follow-up|14|||
33488992|NCT01277211|101683283|FG001|Overall Study|Lost to Follow-up|9|||
33488993|NCT01277211|101683282|FG000|Overall Study|Did not wish to continue|17|||
33488994|NCT01277211|101683283|FG001|Overall Study|Did not wish to continue|0|||
33488995|NCT01277211|101683282|FG000|Overall Study|Withdrew Consent|9|||
33488996|NCT01277211|101683283|FG001|Overall Study|Withdrew Consent|9|||
33488997|NCT01277211|101683282|FG000|Overall Study|Non-compliance with protocol|13|||
33488998|NCT01277211|101683283|FG001|Overall Study|Non-compliance with protocol|4|||
33488999|NCT01277211|101683282|FG000|Overall Study|Did not meet protocol eligibility|1|||
33489000|NCT01277211|101683283|FG001|Overall Study|Did not meet protocol eligibility|0|||
33489001|NCT01277211|101683282|FG000|Overall Study|Administrative|3|||
33489002|NCT01277211|101683283|FG001|Overall Study|Administrative|0|||
33489003|NCT01277211|101683282|FG000|Overall Study|Pregnancy wish|0|||
33489004|NCT01277211|101683283|FG001|Overall Study|Pregnancy wish|2|||
33489005|NCT01277211|101683282|FG000|Overall Study|Discontinued prior to treatment|24|||
33489006|NCT01277211|101683283|FG001|Overall Study|Discontinued prior to treatment|13|||
33489007|NCT02633787|101683284|FG000|Overall Study|Withdrawal by Subject|1|||
33489008|NCT00789035|101683285|FG000|Overall Study|Adverse Event|0|||
33489009|NCT00789035|101683286|FG001|Overall Study|Adverse Event|2|||
33489010|NCT00789035|101683287|FG002|Overall Study|Adverse Event|0|||
33489011|NCT00789035|101683288|FG003|Overall Study|Adverse Event|1|||
33489012|NCT00789035|101683289|FG004|Overall Study|Adverse Event|3|||
33489013|NCT00789035|101683285|FG000|Overall Study|Lack of Efficacy|3|||
33489014|NCT00789035|101683286|FG001|Overall Study|Lack of Efficacy|0|||
33489015|NCT00789035|101683287|FG002|Overall Study|Lack of Efficacy|0|||
33489016|NCT00789035|101683288|FG003|Overall Study|Lack of Efficacy|0|||
33489017|NCT00789035|101683289|FG004|Overall Study|Lack of Efficacy|2|||
33489018|NCT00789035|101683285|FG000|Overall Study|Protocol Violation|1|||
33489019|NCT00789035|101683286|FG001|Overall Study|Protocol Violation|0|||
33489020|NCT00789035|101683287|FG002|Overall Study|Protocol Violation|0|||
33489021|NCT00789035|101683288|FG003|Overall Study|Protocol Violation|0|||
33489022|NCT00789035|101683289|FG004|Overall Study|Protocol Violation|0|||
33489023|NCT00789035|101683285|FG000|Overall Study|Withdrawal by Subject|0|||
33489024|NCT00789035|101683286|FG001|Overall Study|Withdrawal by Subject|2|||
33489025|NCT00789035|101683287|FG002|Overall Study|Withdrawal by Subject|0|||
33489026|NCT00789035|101683288|FG003|Overall Study|Withdrawal by Subject|0|||
33489027|NCT00789035|101683289|FG004|Overall Study|Withdrawal by Subject|0|||
33489028|NCT00789035|101683285|FG000|Overall Study|Other reason not defined above|2|||
33489029|NCT00789035|101683286|FG001|Overall Study|Other reason not defined above|3|||
33489030|NCT00789035|101683287|FG002|Overall Study|Other reason not defined above|1|||
33489031|NCT00789035|101683288|FG003|Overall Study|Other reason not defined above|0|||
33489032|NCT00789035|101683289|FG004|Overall Study|Other reason not defined above|1|||
33489033|NCT02430480|101683290|FG000|Overall Study|Death|1|||
33489034|NCT02430480|101683290|FG000|Overall Study|Anesthesia concerns|1|||
33489035|NCT02430480|101683290|FG000|Overall Study|Progressed on treatment|1|||
33489036|NCT01957397|101683293|FG000|Test Period 1|sudden leakage/small bag|1|||
33489037|NCT01957397|101683294|FG001|Test Period 1|sudden leakage/small bag|1|||
33489038|NCT01957397|101683293|FG000|Test Period 1|Withdrawal by Subject|1|||
33489039|NCT01957397|101683294|FG001|Test Period 1|Withdrawal by Subject|0|||
33489040|NCT01957397|101683293|FG000|Test Period 2|Adverse Event|0|||
33489041|NCT01957397|101683294|FG001|Test Period 2|Adverse Event|1|||
33489042|NCT01957397|101683293|FG000|Test Period 3|Adverse Event|1|||
33489043|NCT01957397|101683294|FG001|Test Period 3|Adverse Event|2|||
33489044|NCT01957397|101683293|FG000|Test Period 3|the adhesive did not work|1|||
33489045|NCT01957397|101683294|FG001|Test Period 3|the adhesive did not work|0|||
33489046|NCT01074944|101683301|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
33489047|NCT01074944|101683302|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
33489048|NCT01074944|101683303|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
33489049|NCT01074944|101683304|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
33489050|NCT01074944|101683305|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
33489051|NCT01074944|101683301|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
33489052|NCT01074944|101683302|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
33489053|NCT01074944|101683303|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
33489054|NCT01074944|101683304|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
33489055|NCT01074944|101683305|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
33489056|NCT01074944|101683301|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
33489057|NCT01074944|101683302|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
33489058|NCT01074944|101683303|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
33489059|NCT01074944|101683304|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
33489060|NCT01074944|101683305|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
33489061|NCT01074944|101683301|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
33489062|NCT01074944|101683302|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
33489063|NCT01074944|101683303|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
33489064|NCT01074944|101683304|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
33489065|NCT01074944|101683305|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
33489066|NCT01074944|101683301|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
33489067|NCT01074944|101683302|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
33489068|NCT01074944|101683303|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
33489069|NCT01074944|101683304|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
33489070|NCT01074944|101683305|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
33489071|NCT01074944|101683301|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
33489072|NCT01074944|101683302|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
33489073|NCT01074944|101683303|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
33489074|NCT01074944|101683304|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
33489075|NCT01074944|101683305|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
33489076|NCT01074944|101683301|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
33489077|NCT01074944|101683302|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
33489078|NCT01074944|101683303|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
33489079|NCT01074944|101683304|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
33489080|NCT01074944|101683305|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
33489081|NCT01074944|101683301|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
33489082|NCT01074944|101683302|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
33489083|NCT01074944|101683303|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
33489084|NCT01074944|101683304|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
33489085|NCT01074944|101683305|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
33489086|NCT01074944|101683301|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
33489087|NCT01074944|101683302|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
33489088|NCT01074944|101683303|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
33489089|NCT01074944|101683304|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
33489090|NCT01074944|101683305|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
33489091|NCT01074944|101683301|FG000|Long Term Treatment|Adverse Event|0|||
33489092|NCT01074944|101683302|FG001|Long Term Treatment|Adverse Event|0|||
33489093|NCT01074944|101683303|FG002|Long Term Treatment|Adverse Event|0|||
33489094|NCT01074944|101683304|FG003|Long Term Treatment|Adverse Event|3|||
33489095|NCT01074944|101683305|FG004|Long Term Treatment|Adverse Event|0|||
33489096|NCT01074944|101683301|FG000|Long Term Treatment|Lost to Follow-up|0|||
33489097|NCT01074944|101683302|FG001|Long Term Treatment|Lost to Follow-up|0|||
33489098|NCT01074944|101683303|FG002|Long Term Treatment|Lost to Follow-up|0|||
33489099|NCT01074944|101683304|FG003|Long Term Treatment|Lost to Follow-up|2|||
33489100|NCT01074944|101683305|FG004|Long Term Treatment|Lost to Follow-up|0|||
33489101|NCT01074944|101683301|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
33489102|NCT01074944|101683302|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
33489103|NCT01074944|101683303|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
33489104|NCT01074944|101683304|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
33489105|NCT01074944|101683305|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
33489106|NCT01074944|101683301|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
33489107|NCT01074944|101683302|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
33489108|NCT01074944|101683303|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
33489109|NCT01074944|101683304|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
33489110|NCT01074944|101683305|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
33489111|NCT01074944|101683301|FG000|Long Term Treatment|Withdrawal by Subject|0|||
33489112|NCT01074944|101683302|FG001|Long Term Treatment|Withdrawal by Subject|0|||
33489113|NCT01074944|101683303|FG002|Long Term Treatment|Withdrawal by Subject|0|||
33489114|NCT01074944|101683304|FG003|Long Term Treatment|Withdrawal by Subject|2|||
33489115|NCT01074944|101683305|FG004|Long Term Treatment|Withdrawal by Subject|0|||
33489116|NCT01074944|101683301|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
33489117|NCT01074944|101683302|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
33489118|NCT01074944|101683303|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
33489119|NCT01074944|101683304|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
33489120|NCT01074944|101683305|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
33489121|NCT01074944|101683301|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
33489122|NCT01074944|101683302|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
33489123|NCT01074944|101683303|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
33489124|NCT01074944|101683304|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
33489125|NCT01074944|101683305|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
33489126|NCT02245412|101683306|FG000|Treatment Period|Death|1|||
33489127|NCT02245412|101683307|FG001|Treatment Period|Death|1|||
33489128|NCT02245412|101683308|FG002|Treatment Period|Death|0|||
33489129|NCT02245412|101683306|FG000|Treatment Period|Physician Decision|1|||
33489130|NCT02245412|101683307|FG001|Treatment Period|Physician Decision|1|||
33489131|NCT02245412|101683308|FG002|Treatment Period|Physician Decision|0|||
33489132|NCT02245412|101683306|FG000|Treatment Period|Withdrawal by Subject|2|||
33489133|NCT02245412|101683307|FG001|Treatment Period|Withdrawal by Subject|1|||
33489134|NCT02245412|101683308|FG002|Treatment Period|Withdrawal by Subject|0|||
33489135|NCT02245412|101683306|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
33489136|NCT02245412|101683307|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
33489137|NCT02245412|101683308|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
33489138|NCT02245412|101683306|FG000|Follow-Up Period|Death|4|||
33489139|NCT02245412|101683307|FG001|Follow-Up Period|Death|2|||
33489140|NCT02245412|101683308|FG002|Follow-Up Period|Death|1|||
33489141|NCT02245412|101683306|FG000|Follow-Up Period|Physician Decision|1|||
33489142|NCT02245412|101683307|FG001|Follow-Up Period|Physician Decision|0|||
33489143|NCT02245412|101683308|FG002|Follow-Up Period|Physician Decision|0|||
33489144|NCT02245412|101683306|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
33489145|NCT02245412|101683307|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
33489146|NCT02245412|101683308|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
33489147|NCT00958893|101683311|FG000|Overall Study|Study prematurely terminated|4|||
33489148|NCT01644617|101683317|FG000|Overall Study|Withdrawal by Subject|3|||
33489149|NCT01644617|101683318|FG001|Overall Study|Withdrawal by Subject|4|||
33489150|NCT01644617|101683319|FG002|Overall Study|Withdrawal by Subject|1|||
33489151|NCT01644617|101683317|FG000|Overall Study|Lost to Follow-up|0|||
33489152|NCT01644617|101683318|FG001|Overall Study|Lost to Follow-up|1|||
33489153|NCT01644617|101683319|FG002|Overall Study|Lost to Follow-up|0|||
33489154|NCT01644617|101683317|FG000|Overall Study|Adverse Event|3|||
33489155|NCT01644617|101683318|FG001|Overall Study|Adverse Event|0|||
33489156|NCT01644617|101683319|FG002|Overall Study|Adverse Event|6|||
33489157|NCT00451178|101683320|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
33489158|NCT00451178|101683321|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
33489159|NCT00451178|101683320|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
33489160|NCT00451178|101683321|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
33489161|NCT00451178|101683320|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
33489162|NCT00451178|101683321|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
33489163|NCT00451178|101683320|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
33489164|NCT00451178|101683321|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
33489165|NCT00451178|101683320|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
33489166|NCT00451178|101683321|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
33489167|NCT00451178|101683320|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
33489168|NCT00451178|101683321|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
33489169|NCT00451178|101683320|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
33489170|NCT00451178|101683321|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
33489171|NCT00451178|101683320|FG000|Prior to Maintenance Therapy|PD|2|||
33489172|NCT00451178|101683321|FG001|Prior to Maintenance Therapy|PD|0|||
33489173|NCT00451178|101683320|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
33489174|NCT00451178|101683321|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
33489175|NCT00451178|101683320|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
33489176|NCT00451178|101683321|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
33489177|NCT00451178|101683320|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
33489178|NCT00451178|101683321|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
33489179|NCT00451178|101683320|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
33489180|NCT00451178|101683321|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
33489181|NCT00451178|101683320|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
33489182|NCT00451178|101683321|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
33489183|NCT00451178|101683320|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
33489184|NCT00451178|101683321|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
33489185|NCT00451178|101683320|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
33489186|NCT00451178|101683321|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
33489187|NCT01275729|101683325|FG000|Overall Study|Death|3|||
33489188|NCT01275729|101683325|FG000|Overall Study|Withdrawal by Subject|1|||
33489189|NCT00442962|101683328|FG000|Overall Study|Pregnancy|1|||
33489190|NCT00442962|101683328|FG000|Overall Study|Lost to Follow-up|7|||
33489191|NCT02755649|101683329|FG000|Overall Study|Transitioned into OLE study|99|||
33489192|NCT02755649|101683330|FG001|Overall Study|Transitioned into OLE study|98|||
33489193|NCT02755649|101683331|FG002|Overall Study|Transitioned into OLE study|100|||
33489194|NCT02755649|101683329|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
33489195|NCT02755649|101683330|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
33489196|NCT02755649|101683331|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
33489197|NCT02755649|101683329|FG000|Overall Study|Physician Decision|0|||
33489198|NCT02755649|101683330|FG001|Overall Study|Physician Decision|0|||
33489199|NCT02755649|101683331|FG002|Overall Study|Physician Decision|2|||
33489200|NCT02755649|101683329|FG000|Overall Study|Withdrawal by Subject|0|||
33489201|NCT02755649|101683330|FG001|Overall Study|Withdrawal by Subject|1|||
33489202|NCT02755649|101683331|FG002|Overall Study|Withdrawal by Subject|0|||
33489203|NCT02755649|101683329|FG000|Overall Study|Undecided|1|||
33489204|NCT02755649|101683330|FG001|Overall Study|Undecided|0|||
33489205|NCT02755649|101683331|FG002|Overall Study|Undecided|0|||
33489206|NCT03536884|101683334|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
33489207|NCT03536884|101683335|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
33489208|NCT03536884|101683336|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
33489209|NCT03536884|101683337|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
33489210|NCT03536884|101683338|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
33489211|NCT03536884|101683339|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
33489212|NCT03536884|101683340|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
33489213|NCT03536884|101683341|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
33489214|NCT03536884|101683342|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
33489215|NCT03536884|101683343|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
33489216|NCT03536884|101683344|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
33489217|NCT03536884|101683345|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
33489218|NCT03536884|101683334|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
33489219|NCT03536884|101683335|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
33489220|NCT03536884|101683336|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
33489221|NCT03536884|101683337|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
33489222|NCT03536884|101683338|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
33489223|NCT03536884|101683339|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
33489224|NCT03536884|101683340|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
33489225|NCT03536884|101683341|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
33489226|NCT03536884|101683342|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
33489227|NCT03536884|101683343|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
33489228|NCT03536884|101683344|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
33489229|NCT03536884|101683345|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
33489230|NCT03536884|101683334|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
33489231|NCT03536884|101683335|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
33489232|NCT03536884|101683336|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
33489233|NCT03536884|101683337|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
33489234|NCT03536884|101683338|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
33489235|NCT03536884|101683339|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
33489236|NCT03536884|101683340|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
33489237|NCT03536884|101683341|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
33489238|NCT03536884|101683342|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
33489239|NCT03536884|101683343|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
33489240|NCT03536884|101683344|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
33489241|NCT03536884|101683345|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
33489242|NCT03536884|101683334|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
33489243|NCT03536884|101683335|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
33489244|NCT03536884|101683336|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
33489245|NCT03536884|101683337|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
33489246|NCT03536884|101683338|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
33489247|NCT03536884|101683339|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
33489248|NCT03536884|101683340|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
33489249|NCT03536884|101683341|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
33489250|NCT03536884|101683342|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
33489251|NCT03536884|101683343|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
33489252|NCT03536884|101683344|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
33489253|NCT03536884|101683345|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
33489254|NCT03536884|101683334|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33489255|NCT03536884|101683335|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
33489256|NCT03536884|101683336|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33489257|NCT03536884|101683337|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33489258|NCT03536884|101683338|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33489259|NCT03536884|101683339|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33489260|NCT03536884|101683340|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33489261|NCT03536884|101683341|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33489262|NCT03536884|101683342|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33489263|NCT03536884|101683343|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33489264|NCT03536884|101683344|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33489265|NCT03536884|101683345|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
33489266|NCT03536884|101683334|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
33489267|NCT03536884|101683335|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
33489268|NCT03536884|101683336|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
33489269|NCT03536884|101683337|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
33489270|NCT03536884|101683338|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
33489271|NCT03536884|101683339|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
33489272|NCT03536884|101683340|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
33489273|NCT03536884|101683341|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
33489274|NCT03536884|101683342|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
33489275|NCT03536884|101683343|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
33489276|NCT03536884|101683344|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
33489277|NCT03536884|101683345|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
33489278|NCT03536884|101683334|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
33489279|NCT03536884|101683335|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
33489280|NCT03536884|101683336|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
33489281|NCT03536884|101683337|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
33489282|NCT03536884|101683338|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
33489283|NCT03536884|101683339|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
33489284|NCT03536884|101683340|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
33489285|NCT03536884|101683341|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
33489286|NCT03536884|101683342|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
33489287|NCT03536884|101683343|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
33489288|NCT03536884|101683344|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
33489289|NCT03536884|101683345|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
33489290|NCT03536884|101683334|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
33489291|NCT03536884|101683335|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
33489292|NCT03536884|101683336|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
33489293|NCT03536884|101683337|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
33489294|NCT03536884|101683338|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
33489295|NCT03536884|101683339|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
33489296|NCT03536884|101683340|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
33489297|NCT03536884|101683341|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
33489298|NCT03536884|101683342|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
33489299|NCT03536884|101683343|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
33489300|NCT03536884|101683344|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
33489301|NCT03536884|101683345|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
33489302|NCT03536884|101683334|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
33489303|NCT03536884|101683335|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
33489304|NCT03536884|101683336|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
33489305|NCT03536884|101683337|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
33489306|NCT03536884|101683338|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
33489307|NCT03536884|101683339|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
33489308|NCT03536884|101683340|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
33489309|NCT03536884|101683341|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
33489310|NCT03536884|101683342|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
33489311|NCT03536884|101683343|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
33489312|NCT03536884|101683344|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
33489313|NCT03536884|101683345|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
33489314|NCT03536884|101683334|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
33489315|NCT03536884|101683335|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
33489316|NCT03536884|101683336|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
33489317|NCT03536884|101683337|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
33489318|NCT03536884|101683338|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
33489319|NCT03536884|101683339|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
33489320|NCT03536884|101683340|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
33489321|NCT03536884|101683341|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
33489322|NCT03536884|101683342|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
33489323|NCT03536884|101683343|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
33489324|NCT03536884|101683344|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
33489325|NCT03536884|101683345|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
33489326|NCT03536884|101683334|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
33489327|NCT03536884|101683335|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
33489328|NCT03536884|101683336|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
33489329|NCT03536884|101683337|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
33489330|NCT03536884|101683338|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
33489331|NCT03536884|101683339|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
33489332|NCT03536884|101683340|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
33489333|NCT03536884|101683341|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
33489334|NCT03536884|101683342|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
33489335|NCT03536884|101683343|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
33489336|NCT03536884|101683344|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
33489337|NCT03536884|101683345|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
33489338|NCT03536884|101683334|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
33489339|NCT03536884|101683335|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
33489340|NCT03536884|101683336|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
33489341|NCT03536884|101683337|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
33489342|NCT03536884|101683338|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
33489343|NCT03536884|101683339|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
33489344|NCT03536884|101683340|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
33489345|NCT03536884|101683341|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
33489346|NCT03536884|101683342|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
33489347|NCT03536884|101683343|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
33489348|NCT03536884|101683344|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
33489349|NCT03536884|101683345|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
33489350|NCT03536884|101683334|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
33489351|NCT03536884|101683335|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
33489352|NCT03536884|101683336|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
33489353|NCT03536884|101683337|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
33489354|NCT03536884|101683338|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
33489355|NCT03536884|101683339|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
33489356|NCT03536884|101683340|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
33489357|NCT03536884|101683341|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
33489358|NCT03536884|101683342|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
33489359|NCT03536884|101683343|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
33489360|NCT03536884|101683344|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
33489361|NCT03536884|101683345|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
33489362|NCT03536884|101683334|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
33489363|NCT03536884|101683335|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
33489364|NCT03536884|101683336|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
33489365|NCT03536884|101683337|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
33489366|NCT03536884|101683338|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
33489367|NCT03536884|101683339|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
33489368|NCT03536884|101683340|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
33489369|NCT03536884|101683341|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
33489370|NCT03536884|101683342|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
33489371|NCT03536884|101683343|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
33489372|NCT03536884|101683344|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
33489373|NCT03536884|101683345|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
33489374|NCT03536884|101683334|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
33489375|NCT03536884|101683335|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
33489376|NCT03536884|101683336|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
33489377|NCT03536884|101683337|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
33489378|NCT03536884|101683338|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
33489379|NCT03536884|101683339|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
33489380|NCT03536884|101683340|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
33489381|NCT03536884|101683341|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
33489382|NCT03536884|101683342|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
33489383|NCT03536884|101683343|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
33489384|NCT03536884|101683344|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
33489385|NCT03536884|101683345|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
33489386|NCT03536884|101683334|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
33489387|NCT03536884|101683335|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
33489388|NCT03536884|101683336|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
33489389|NCT03536884|101683337|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
33489390|NCT03536884|101683338|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
33489391|NCT03536884|101683339|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
33489392|NCT03536884|101683340|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
33489393|NCT03536884|101683341|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
33489394|NCT03536884|101683342|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
33489395|NCT03536884|101683343|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
33489396|NCT03536884|101683344|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
33489397|NCT03536884|101683345|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
33489398|NCT03536884|101683334|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
33489399|NCT03536884|101683335|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
33489400|NCT03536884|101683336|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
33489401|NCT03536884|101683337|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
33489402|NCT03536884|101683338|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
33489403|NCT03536884|101683339|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
33489404|NCT03536884|101683340|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
33489405|NCT03536884|101683341|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
33489406|NCT03536884|101683342|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
33489407|NCT03536884|101683343|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
33489408|NCT03536884|101683344|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
33489409|NCT03536884|101683345|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
33489410|NCT03536884|101683334|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
33489411|NCT03536884|101683335|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
33489412|NCT03536884|101683336|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
33489413|NCT03536884|101683337|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
33489414|NCT03536884|101683338|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
33489415|NCT03536884|101683339|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
33489416|NCT03536884|101683340|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
33489417|NCT03536884|101683341|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
33489418|NCT03536884|101683342|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
33489419|NCT03536884|101683343|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
33489420|NCT03536884|101683344|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
33489421|NCT03536884|101683345|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
33489422|NCT03536884|101683334|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
33489423|NCT03536884|101683335|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
33489424|NCT03536884|101683336|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
33489425|NCT03536884|101683337|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
33489426|NCT03536884|101683338|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
33489427|NCT03536884|101683339|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
33489428|NCT03536884|101683340|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
33489429|NCT03536884|101683341|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
33489430|NCT03536884|101683342|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
33489431|NCT03536884|101683343|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
33489432|NCT03536884|101683344|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
33489433|NCT03536884|101683345|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
33489434|NCT03536884|101683334|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
33489435|NCT03536884|101683335|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
33489436|NCT03536884|101683336|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
33489437|NCT03536884|101683337|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
33489438|NCT03536884|101683338|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
33489439|NCT03536884|101683339|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
33489440|NCT03536884|101683340|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
33489441|NCT03536884|101683341|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
33489442|NCT03536884|101683342|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
33489443|NCT03536884|101683343|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
33489444|NCT03536884|101683344|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
33489445|NCT03536884|101683345|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
33489446|NCT03536884|101683334|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
33489447|NCT03536884|101683335|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
33489448|NCT03536884|101683336|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
33489449|NCT03536884|101683337|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
33284063|NCT05600036|100936743|FG001|Overall Study|Lost to Follow-up|2|||
33284064|NCT05600036|100936744|FG002|Overall Study|Lost to Follow-up|1|||
33284065|NCT05600036|100936745|FG003|Overall Study|Lost to Follow-up|1|||
33284066|NCT05600036|100936746|FG004|Overall Study|Lost to Follow-up|0|||
33284067|NCT05600036|100936747|FG005|Overall Study|Lost to Follow-up|0|||
33284068|NCT05600036|100936742|FG000|Overall Study|Protocol Violation|0|||
33284069|NCT05600036|100936743|FG001|Overall Study|Protocol Violation|0|||
33284070|NCT05600036|100936744|FG002|Overall Study|Protocol Violation|2|||
33284071|NCT05600036|100936745|FG003|Overall Study|Protocol Violation|0|||
33284072|NCT05600036|100936746|FG004|Overall Study|Protocol Violation|0|||
33284073|NCT05600036|100936747|FG005|Overall Study|Protocol Violation|0|||
33284074|NCT05600036|100936742|FG000|Overall Study|Withdrawal by Subject|0|||
33284075|NCT05600036|100936743|FG001|Overall Study|Withdrawal by Subject|1|||
33284076|NCT05600036|100936744|FG002|Overall Study|Withdrawal by Subject|2|||
33284077|NCT05600036|100936745|FG003|Overall Study|Withdrawal by Subject|0|||
33284078|NCT05600036|100936746|FG004|Overall Study|Withdrawal by Subject|3|||
33284079|NCT05600036|100936747|FG005|Overall Study|Withdrawal by Subject|5|||
33284080|NCT05600036|100936742|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
33284081|NCT05600036|100936743|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
33284082|NCT05600036|100936744|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
33284083|NCT05600036|100936745|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
33284084|NCT05600036|100936746|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
33284085|NCT05600036|100936747|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
33284086|NCT05600036|100936742|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
33284087|NCT05600036|100936743|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
33284088|NCT05600036|100936744|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
33284089|NCT05600036|100936745|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
33284090|NCT05600036|100936746|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
33284091|NCT05600036|100936747|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
33284092|NCT05600036|100936742|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
33284093|NCT05600036|100936743|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
33284094|NCT05600036|100936744|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
33284095|NCT05600036|100936745|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
33284096|NCT05600036|100936746|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
33284097|NCT05600036|100936747|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
33284098|NCT03226353|100936748|FG000|Overall Study|Withdrawal by Subject|1|||
33284099|NCT03226353|100936748|FG000|Overall Study|Screen Failure|5|||
33284100|NCT00706914|100936753|FG000|Overall Study|Lack of Efficacy|0|||
33284101|NCT00706914|100936754|FG001|Overall Study|Lack of Efficacy|1|||
33284102|NCT00706914|100936755|FG002|Overall Study|Lack of Efficacy|0|||
33284103|NCT00706914|100936753|FG000|Overall Study|Lost to Follow-up|1|||
33284104|NCT00706914|100936754|FG001|Overall Study|Lost to Follow-up|0|||
33284105|NCT00706914|100936755|FG002|Overall Study|Lost to Follow-up|0|||
33284106|NCT00706914|100936753|FG000|Overall Study|Adverse Event|2|||
33284107|NCT00706914|100936754|FG001|Overall Study|Adverse Event|2|||
33284108|NCT00706914|100936755|FG002|Overall Study|Adverse Event|0|||
33284109|NCT00706914|100936753|FG000|Overall Study|Protocol Violation|3|||
33284110|NCT00706914|100936754|FG001|Overall Study|Protocol Violation|1|||
33284111|NCT00706914|100936755|FG002|Overall Study|Protocol Violation|1|||
33284112|NCT01967719|100936756|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
33284113|NCT01967719|100936757|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
33284114|NCT01967719|100936758|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
33284115|NCT01967719|100936759|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
33284116|NCT01967719|100936756|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
33284117|NCT01967719|100936757|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
33284118|NCT01967719|100936758|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
33284119|NCT01967719|100936759|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
33284120|NCT00361842|100936765|FG000|Overall Study|Withdrawal by Subject|2|||
33284121|NCT00361842|100936766|FG001|Overall Study|Withdrawal by Subject|3|||
33284122|NCT00361842|100936765|FG000|Overall Study|Death|2|||
33284123|NCT00361842|100936766|FG001|Overall Study|Death|1|||
33284124|NCT00361842|100936765|FG000|Overall Study|Disease progression|19|||
33284125|NCT00361842|100936766|FG001|Overall Study|Disease progression|20|||
33284126|NCT00361842|100936765|FG000|Overall Study|Adverse Event|2|||
33284127|NCT00361842|100936766|FG001|Overall Study|Adverse Event|3|||
33284128|NCT00361842|100936765|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
33284129|NCT00361842|100936766|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
33284130|NCT00361842|100936765|FG000|Overall Study|Other|1|||
33284131|NCT00361842|100936766|FG001|Overall Study|Other|0|||
33284132|NCT00361842|100936765|FG000|Overall Study|Other|0|||
33284133|NCT00361842|100936766|FG001|Overall Study|Other|2|||
33284134|NCT00053352|100936767|FG000|Overall Study|Lost to Follow-up|0|||
33284135|NCT00053352|100936768|FG001|Overall Study|Lost to Follow-up|1|||
33284136|NCT00053352|100936767|FG000|Overall Study|Physician Decision|11|||
33284137|NCT00053352|100936768|FG001|Overall Study|Physician Decision|1|||
33284138|NCT00053352|100936767|FG000|Overall Study|Withdrawal by Subject|1|||
33284139|NCT00053352|100936768|FG001|Overall Study|Withdrawal by Subject|0|||
33284140|NCT00053352|100936767|FG000|Overall Study|Ineligible|8|||
33284141|NCT00053352|100936768|FG001|Overall Study|Ineligible|8|||
33284142|NCT00053352|100936767|FG000|Overall Study|Disease at new site|1|||
33284143|NCT00053352|100936768|FG001|Overall Study|Disease at new site|0|||
33284144|NCT01182207|100936769|FG000|First Intervention|Positive Hepatitis Results|0|||
33284145|NCT01182207|100936770|FG001|First Intervention|Positive Hepatitis Results|1|||
33284146|NCT01182207|100936769|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
33284147|NCT01182207|100936770|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
33284148|NCT01831726|100936773|FG000|Overall Study|Adverse Event|16|||
33284149|NCT01831726|100936773|FG000|Overall Study|Death|7|||
33284150|NCT01831726|100936773|FG000|Overall Study|Disease Progression|49|||
33284151|NCT01831726|100936773|FG000|Overall Study|Physician Decision|1|||
33284152|NCT01831726|100936773|FG000|Overall Study|Subject/guardian decision|7|||
33284153|NCT01960348|100936775|FG000|Overall Study|Adverse event, not serious|2|||
33284154|NCT01960348|100936776|FG001|Overall Study|Adverse event, not serious|2|||
33284155|NCT01960348|100936775|FG000|Overall Study|Adverse event, serious fatal|6|||
33284156|NCT01960348|100936776|FG001|Overall Study|Adverse event, serious fatal|5|||
33284157|NCT01960348|100936775|FG000|Overall Study|Adverse event, serious non-fatal|0|||
33284158|NCT01960348|100936776|FG001|Overall Study|Adverse event, serious non-fatal|3|||
33284159|NCT01960348|100936775|FG000|Overall Study|Withdrawal by Subject|1|||
33284160|NCT01960348|100936776|FG001|Overall Study|Withdrawal by Subject|11|||
33284161|NCT01960348|100936775|FG000|Overall Study|Physician Decision|0|||
33284162|NCT01960348|100936776|FG001|Overall Study|Physician Decision|1|||
33284163|NCT01960348|100936775|FG000|Overall Study|Protocol Violation|1|||
33284164|NCT01960348|100936776|FG001|Overall Study|Protocol Violation|0|||
33284165|NCT01726517|100936781|FG000|Overall Study|Withdrawal by Subject|0|||
33284166|NCT01726517|100936782|FG001|Overall Study|Withdrawal by Subject|0|||
33284167|NCT01726517|100936783|FG002|Overall Study|Withdrawal by Subject|1|||
33284168|NCT01726517|100936784|FG003|Overall Study|Withdrawal by Subject|0|||
33284169|NCT01726517|100936785|FG004|Overall Study|Withdrawal by Subject|0|||
33284170|NCT02168478|100936786|FG000|Overall Study|Withdrawal by Subject|1|||
33284171|NCT02168478|100936786|FG000|Overall Study|Did Not Consent to Participation|2|||
33284172|NCT02168478|100936786|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
33284173|NCT01077622|100936787|FG000|Overall Study|Physician Decision|2|||
33284174|NCT01077622|100936787|FG000|Overall Study|Withdrawal by Subject|1|||
33284175|NCT00920699|100936794|FG000|Overall Study|Withdrawal by Subject|2|||
33284176|NCT00920699|100936795|FG001|Overall Study|Withdrawal by Subject|0|||
33284177|NCT00920699|100936796|FG002|Overall Study|Withdrawal by Subject|2|||
33284178|NCT00920699|100936794|FG000|Overall Study|no longer met eligibility|0|||
33284179|NCT00920699|100936795|FG001|Overall Study|no longer met eligibility|1|||
33284180|NCT00920699|100936796|FG002|Overall Study|no longer met eligibility|0|||
33284181|NCT00920699|100936794|FG000|Overall Study|Lost to Follow-up|0|||
33284182|NCT00920699|100936795|FG001|Overall Study|Lost to Follow-up|0|||
33284183|NCT00920699|100936796|FG002|Overall Study|Lost to Follow-up|2|||
33284184|NCT01225159|100936797|FG000|Overall Study|Change operation|1|||
33284185|NCT01225159|100936798|FG001|Overall Study|Change operation|0|||
33284186|NCT04357964|100936799|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
33284187|NCT04357964|100936800|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
33284188|NCT04357964|100936799|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
33284189|NCT04357964|100936800|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
33284190|NCT04357964|100936799|FG000|Overall Study|Adipose sample was insufficient quality|0|||
33284191|NCT04357964|100936800|FG001|Overall Study|Adipose sample was insufficient quality|1|||
33284192|NCT01145417|100936804|FG000|Overall Study|Death|1|||
33284193|NCT01145417|100936805|FG001|Overall Study|Death|0|||
33284194|NCT01145417|100936804|FG000|Overall Study|Lost to Follow-up|2|||
33284195|NCT01145417|100936805|FG001|Overall Study|Lost to Follow-up|1|||
33284196|NCT01145417|100936804|FG000|Overall Study|Withdrawal by Subject|1|||
33284197|NCT01145417|100936805|FG001|Overall Study|Withdrawal by Subject|2|||
33284198|NCT01145417|100936804|FG000|Overall Study|Pregnancy|1|||
33284199|NCT01145417|100936805|FG001|Overall Study|Pregnancy|0|||
33284200|NCT01145417|100936804|FG000|Overall Study|Adverse Event|0|||
33284201|NCT01145417|100936805|FG001|Overall Study|Adverse Event|1|||
33284202|NCT01145417|100936804|FG000|Overall Study|Study terminated by sponsor|35|||
33284203|NCT01145417|100936805|FG001|Overall Study|Study terminated by sponsor|43|||
33284204|NCT01145417|100936804|FG000|Overall Study|Other|1|||
33284205|NCT01145417|100936805|FG001|Overall Study|Other|0|||
33284206|NCT00899379|100936806|FG000|Overall Study|Adverse Event|2|||
33284207|NCT00899379|100936807|FG001|Overall Study|Adverse Event|2|||
33284208|NCT00899379|100936808|FG002|Overall Study|Adverse Event|1|||
33284209|NCT00899379|100936809|FG003|Overall Study|Adverse Event|1|||
33284210|NCT00899379|100936810|FG004|Overall Study|Adverse Event|2|||
33284211|NCT00899379|100936806|FG000|Overall Study|Lack of Efficacy|0|||
33284212|NCT00899379|100936807|FG001|Overall Study|Lack of Efficacy|4|||
33284213|NCT00899379|100936808|FG002|Overall Study|Lack of Efficacy|3|||
33284214|NCT00899379|100936809|FG003|Overall Study|Lack of Efficacy|0|||
33284215|NCT00899379|100936810|FG004|Overall Study|Lack of Efficacy|1|||
33284216|NCT00899379|100936806|FG000|Overall Study|Lost to Follow-up|9|||
33284217|NCT00899379|100936807|FG001|Overall Study|Lost to Follow-up|3|||
33284218|NCT00899379|100936808|FG002|Overall Study|Lost to Follow-up|0|||
33284219|NCT00899379|100936809|FG003|Overall Study|Lost to Follow-up|6|||
33284220|NCT00899379|100936810|FG004|Overall Study|Lost to Follow-up|2|||
33284221|NCT00899379|100936806|FG000|Overall Study|Protocol Violation|0|||
33284222|NCT00899379|100936807|FG001|Overall Study|Protocol Violation|0|||
33284223|NCT00899379|100936808|FG002|Overall Study|Protocol Violation|1|||
33284224|NCT00899379|100936809|FG003|Overall Study|Protocol Violation|1|||
33284225|NCT00899379|100936810|FG004|Overall Study|Protocol Violation|0|||
33284226|NCT00899379|100936806|FG000|Overall Study|Withdrawal by Subject|2|||
33489450|NCT03536884|101683338|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
33284227|NCT00899379|100936807|FG001|Overall Study|Withdrawal by Subject|4|||
33284228|NCT00899379|100936808|FG002|Overall Study|Withdrawal by Subject|2|||
33284229|NCT00899379|100936809|FG003|Overall Study|Withdrawal by Subject|3|||
33284230|NCT00899379|100936810|FG004|Overall Study|Withdrawal by Subject|6|||
33284231|NCT00899379|100936806|FG000|Overall Study|Pregnancy|0|||
33284232|NCT00899379|100936807|FG001|Overall Study|Pregnancy|0|||
33284233|NCT00899379|100936808|FG002|Overall Study|Pregnancy|1|||
33284234|NCT00899379|100936809|FG003|Overall Study|Pregnancy|0|||
33284235|NCT00899379|100936810|FG004|Overall Study|Pregnancy|1|||
33284236|NCT00899379|100936806|FG000|Overall Study|Patient Uncooperative|0|||
33284237|NCT00899379|100936807|FG001|Overall Study|Patient Uncooperative|1|||
33284238|NCT00899379|100936808|FG002|Overall Study|Patient Uncooperative|0|||
33284239|NCT00899379|100936809|FG003|Overall Study|Patient Uncooperative|1|||
33284240|NCT00899379|100936810|FG004|Overall Study|Patient Uncooperative|2|||
33284241|NCT00899379|100936806|FG000|Overall Study|Abnormal Baseline ECG|0|||
33284242|NCT00899379|100936807|FG001|Overall Study|Abnormal Baseline ECG|0|||
33284243|NCT00899379|100936808|FG002|Overall Study|Abnormal Baseline ECG|0|||
33284244|NCT00899379|100936809|FG003|Overall Study|Abnormal Baseline ECG|1|||
33284245|NCT00899379|100936810|FG004|Overall Study|Abnormal Baseline ECG|0|||
33284246|NCT00899379|100936806|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
33284247|NCT00899379|100936807|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
33284248|NCT00899379|100936808|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
33284249|NCT00899379|100936809|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33284250|NCT00899379|100936810|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33284251|NCT00899379|100936806|FG000|Overall Study|Not Completed/Entered Extn|5|||
33284252|NCT00899379|100936807|FG001|Overall Study|Not Completed/Entered Extn|1|||
33284253|NCT00899379|100936808|FG002|Overall Study|Not Completed/Entered Extn|6|||
33284254|NCT00899379|100936809|FG003|Overall Study|Not Completed/Entered Extn|4|||
33284255|NCT00899379|100936810|FG004|Overall Study|Not Completed/Entered Extn|3|||
33284256|NCT00899379|100936806|FG000|Overall Study|Study Terminated|3|||
33284257|NCT00899379|100936807|FG001|Overall Study|Study Terminated|0|||
33284258|NCT00899379|100936808|FG002|Overall Study|Study Terminated|3|||
33284259|NCT00899379|100936809|FG003|Overall Study|Study Terminated|3|||
33284260|NCT00899379|100936810|FG004|Overall Study|Study Terminated|1|||
33284261|NCT00899379|100936806|FG000|Overall Study|Lost to Follow-up|3|||
33284262|NCT00899379|100936807|FG001|Overall Study|Lost to Follow-up|1|||
33284263|NCT00899379|100936808|FG002|Overall Study|Lost to Follow-up|0|||
33284264|NCT00899379|100936809|FG003|Overall Study|Lost to Follow-up|2|||
33284265|NCT00899379|100936810|FG004|Overall Study|Lost to Follow-up|5|||
33284266|NCT00899379|100936806|FG000|Overall Study|Withdrawal by Subject|4|||
33284267|NCT00899379|100936807|FG001|Overall Study|Withdrawal by Subject|7|||
33284268|NCT00899379|100936808|FG002|Overall Study|Withdrawal by Subject|4|||
33284269|NCT00899379|100936809|FG003|Overall Study|Withdrawal by Subject|7|||
33284270|NCT00899379|100936810|FG004|Overall Study|Withdrawal by Subject|2|||
33284271|NCT00899379|100936806|FG000|Overall Study|Pregnancy|1|||
33284272|NCT00899379|100936807|FG001|Overall Study|Pregnancy|0|||
33284273|NCT00899379|100936808|FG002|Overall Study|Pregnancy|0|||
33284274|NCT00899379|100936809|FG003|Overall Study|Pregnancy|0|||
33284275|NCT00899379|100936810|FG004|Overall Study|Pregnancy|0|||
33284276|NCT00899379|100936806|FG000|Overall Study|Patient Uncooperative|0|||
33284277|NCT00899379|100936807|FG001|Overall Study|Patient Uncooperative|0|||
33284278|NCT00899379|100936808|FG002|Overall Study|Patient Uncooperative|0|||
33284279|NCT00899379|100936809|FG003|Overall Study|Patient Uncooperative|1|||
33284280|NCT00899379|100936810|FG004|Overall Study|Patient Uncooperative|0|||
33284281|NCT00899379|100936806|FG000|Overall Study|Abnormal Prestudy Labs|0|||
33284282|NCT00899379|100936807|FG001|Overall Study|Abnormal Prestudy Labs|0|||
33284283|NCT00899379|100936808|FG002|Overall Study|Abnormal Prestudy Labs|0|||
33284284|NCT00899379|100936809|FG003|Overall Study|Abnormal Prestudy Labs|0|||
33284285|NCT00899379|100936810|FG004|Overall Study|Abnormal Prestudy Labs|2|||
33284286|NCT00899379|100936806|FG000|Overall Study|Abnormal Baseline ECG|0|||
33284287|NCT00899379|100936807|FG001|Overall Study|Abnormal Baseline ECG|0|||
33284288|NCT00899379|100936808|FG002|Overall Study|Abnormal Baseline ECG|1|||
33284289|NCT00899379|100936809|FG003|Overall Study|Abnormal Baseline ECG|1|||
33284290|NCT00899379|100936810|FG004|Overall Study|Abnormal Baseline ECG|0|||
33284291|NCT00899379|100936806|FG000|Overall Study|No Attack Pretreatment|3|||
33284292|NCT00899379|100936807|FG001|Overall Study|No Attack Pretreatment|5|||
33284293|NCT00899379|100936808|FG002|Overall Study|No Attack Pretreatment|5|||
33284294|NCT00899379|100936809|FG003|Overall Study|No Attack Pretreatment|6|||
33284295|NCT00899379|100936810|FG004|Overall Study|No Attack Pretreatment|4|||
33284296|NCT00899379|100936806|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
33284297|NCT00899379|100936807|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33284298|NCT00899379|100936808|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33284299|NCT00899379|100936809|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33284300|NCT00899379|100936810|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
33284301|NCT00899379|100936806|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
33284302|NCT00899379|100936807|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
33284303|NCT00899379|100936808|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
33284304|NCT00899379|100936809|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
33284305|NCT00899379|100936810|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
33284306|NCT00506922|100936811|FG000|Overall Study|Physician Decision|0|||
33284307|NCT00506922|100936812|FG001|Overall Study|Physician Decision|0|||
33284308|NCT00506922|100936813|FG002|Overall Study|Physician Decision|0|||
33284309|NCT00506922|100936814|FG003|Overall Study|Physician Decision|2|||
33284310|NCT00506922|100936815|FG004|Overall Study|Physician Decision|0|||
33284311|NCT00506922|100936811|FG000|Overall Study|Withdrawal by Subject|0|||
33284312|NCT00506922|100936812|FG001|Overall Study|Withdrawal by Subject|0|||
33284313|NCT00506922|100936813|FG002|Overall Study|Withdrawal by Subject|0|||
33284314|NCT00506922|100936814|FG003|Overall Study|Withdrawal by Subject|0|||
33284315|NCT00506922|100936815|FG004|Overall Study|Withdrawal by Subject|1|||
33284316|NCT02158247|100936816|FG000|Overall Study|Invisible vocal cords|5|||
33284317|NCT00088452|100936818|FG000|Overall Study|Did not receive intervention|1|||
33284318|NCT00088452|100936819|FG001|Overall Study|Did not receive intervention|0|||
33284319|NCT00088452|100936820|FG002|Overall Study|Did not receive intervention|1|||
33284320|NCT02396953|100936821|FG000|Overall Study|Withdrawal by Subject|0|||
33284321|NCT02396953|100936822|FG001|Overall Study|Withdrawal by Subject|0|||
33284322|NCT02396953|100936823|FG002|Overall Study|Withdrawal by Subject|1|||
33284323|NCT02396953|100936821|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
33284324|NCT02396953|100936822|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
33284325|NCT02396953|100936823|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
33284326|NCT02396953|100936821|FG000|Overall Study|Personal Reasons|1|||
33284327|NCT02396953|100936822|FG001|Overall Study|Personal Reasons|1|||
33284328|NCT02396953|100936823|FG002|Overall Study|Personal Reasons|0|||
33284329|NCT00695136|100936824|FG000|Overall Study|Withdrawal by Subject|1|||
33284330|NCT00695136|100936824|FG000|Overall Study|unrelated adverse event|1|||
33284331|NCT03807700|100936825|FG000|Overall Study|Withdrawal by Subject|2|||
33284332|NCT03807700|100936826|FG001|Overall Study|Withdrawal by Subject|1|||
33284333|NCT00498433|100936827|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
33284334|NCT00498433|100936828|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
33284335|NCT00498433|100936829|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
33284336|NCT00498433|100936827|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
33284337|NCT00498433|100936828|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
33284338|NCT00498433|100936829|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
33284339|NCT00498433|100936827|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
33284340|NCT00498433|100936828|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
33284341|NCT00498433|100936829|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
33284342|NCT00498433|100936827|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
33284343|NCT00498433|100936828|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
33284344|NCT00498433|100936829|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
33284345|NCT01202409|100936830|FG000|Overall Study|Adverse Event|1|||
33284346|NCT01202409|100936830|FG000|Overall Study|Ineligible - KRAS mutants|7|||
33284347|NCT03927222|100936831|FG000|Overall Study|Progression|3|||
33284348|NCT03927222|100936831|FG000|Overall Study|CMV testing results inconclusive|1|||
33284349|NCT03927222|100936831|FG000|Overall Study|Unable to generate enough vaccines|1|||
33284350|NCT03927222|100936831|FG000|Overall Study|Early study termination|1|||
33284351|NCT00797511|100936835|FG000|Overall Study|Withdrawal by Subject|1|||
33284352|NCT04150341|100936838|FG000|Overall Study|Physician Decision|0|||
33284353|NCT04150341|100936839|FG001|Overall Study|Physician Decision|0|||
33284354|NCT04150341|100936840|FG002|Overall Study|Physician Decision|1|||
33284355|NCT04150341|100936841|FG003|Overall Study|Physician Decision|0|||
33284356|NCT04150341|100936842|FG004|Overall Study|Physician Decision|0|||
33284357|NCT04150341|100936843|FG005|Overall Study|Physician Decision|0|||
33284358|NCT04150341|100936838|FG000|Overall Study|Adverse Event|0|||
33284359|NCT04150341|100936839|FG001|Overall Study|Adverse Event|0|||
33284360|NCT04150341|100936840|FG002|Overall Study|Adverse Event|0|||
33284361|NCT04150341|100936841|FG003|Overall Study|Adverse Event|0|||
33284362|NCT04150341|100936842|FG004|Overall Study|Adverse Event|1|||
33284363|NCT04150341|100936843|FG005|Overall Study|Adverse Event|0|||
33284364|NCT03772613|100936844|FG000|Overall Study|Lost to Follow-up|0|||
33284365|NCT03772613|100936845|FG001|Overall Study|Lost to Follow-up|1|||
33284366|NCT03772613|100936846|FG002|Overall Study|Lost to Follow-up|1|||
33284367|NCT03188536|100936847|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
33284368|NCT03188536|100936847|FG000|Overall Study|Not participated/met inclusion criteria|1|||
33284369|NCT00814632|100936848|FG000|Overall Study|Lack of Efficacy|2|||
33284370|NCT01121913|100936849|FG000|First Intervention Period|Adverse Event|0|||
33284371|NCT01121913|100936850|FG001|First Intervention Period|Adverse Event|0|||
33284372|NCT01121913|100936851|FG002|First Intervention Period|Adverse Event|1|||
33284373|NCT01121913|100936852|FG003|First Intervention Period|Adverse Event|0|||
33284374|NCT01121913|100936849|FG000|First Washout Period|Withdrawal by Subject|1|||
33284375|NCT01121913|100936850|FG001|First Washout Period|Withdrawal by Subject|0|||
33284376|NCT01121913|100936851|FG002|First Washout Period|Withdrawal by Subject|0|||
33284377|NCT01121913|100936852|FG003|First Washout Period|Withdrawal by Subject|0|||
33284378|NCT01121913|100936849|FG000|Second Intervention Period|Adverse Event|0|||
33284379|NCT01121913|100936850|FG001|Second Intervention Period|Adverse Event|0|||
33284380|NCT01121913|100936851|FG002|Second Intervention Period|Adverse Event|1|||
33284381|NCT01121913|100936852|FG003|Second Intervention Period|Adverse Event|0|||
33284382|NCT01121913|100936849|FG000|Second Washout Period|Withdrawal by Subject|0|||
33284383|NCT01121913|100936850|FG001|Second Washout Period|Withdrawal by Subject|0|||
33284384|NCT01121913|100936851|FG002|Second Washout Period|Withdrawal by Subject|1|||
33284385|NCT01121913|100936852|FG003|Second Washout Period|Withdrawal by Subject|0|||
33284386|NCT01121913|100936849|FG000|Third Washout Period|Adverse Event|1|||
33284387|NCT01121913|100936850|FG001|Third Washout Period|Adverse Event|0|||
33284388|NCT01121913|100936851|FG002|Third Washout Period|Adverse Event|0|||
33284389|NCT01121913|100936852|FG003|Third Washout Period|Adverse Event|0|||
33284390|NCT05006417|100936854|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
33284391|NCT01208870|100936858|FG000|Overall Study|Lost to Follow-up|2|||
33284392|NCT01208870|100936859|FG001|Overall Study|Lost to Follow-up|8|||
33284393|NCT00815919|100936860|FG000|Overall Study|Unrelated Fungal Infection|1|||
33284394|NCT00815919|100936860|FG000|Overall Study|AML Relapse|1|||
33284395|NCT00815919|100936860|FG000|Overall Study|Lack of Efficacy|2|||
33284396|NCT00988117|100936865|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
33284397|NCT00988117|100936865|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
33284398|NCT00676195|100936867|FG000|Overall Study|Lost to Follow-up|1|||
33284399|NCT00676195|100936867|FG000|Overall Study|Adverse Event|1|||
33284400|NCT00676195|100936867|FG000|Overall Study|Physician Decision|1|||
33284401|NCT00297778|100936870|FG000|Overall Study|Adverse Event|16|||
33284402|NCT00297778|100936871|FG001|Overall Study|Adverse Event|10|||
33284403|NCT00297778|100936870|FG000|Overall Study|Withdrawal by Subject|1|||
33284404|NCT00297778|100936871|FG001|Overall Study|Withdrawal by Subject|5|||
33284405|NCT00297778|100936870|FG000|Overall Study|Lack of Efficacy|2|||
33284406|NCT00297778|100936871|FG001|Overall Study|Lack of Efficacy|1|||
33284407|NCT00297778|100936870|FG000|Overall Study|Non-compliant with trial protocol|0|||
33284408|NCT00297778|100936871|FG001|Overall Study|Non-compliant with trial protocol|3|||
33284409|NCT00297778|100936870|FG000|Overall Study|Other|0|||
33284410|NCT00297778|100936871|FG001|Overall Study|Other|1|||
33284411|NCT01091519|100936874|FG000|Overall Study|Adverse Event|12|||
33284412|NCT01091519|100936875|FG001|Overall Study|Adverse Event|16|||
33284413|NCT01091519|100936874|FG000|Overall Study|Death|1|||
33284414|NCT01091519|100936875|FG001|Overall Study|Death|0|||
33284415|NCT01091519|100936874|FG000|Overall Study|Lack of Efficacy|16|||
33284416|NCT01091519|100936875|FG001|Overall Study|Lack of Efficacy|19|||
33284417|NCT01091519|100936874|FG000|Overall Study|Lost to Follow-up|14|||
33284418|NCT01091519|100936875|FG001|Overall Study|Lost to Follow-up|24|||
33284419|NCT01091519|100936874|FG000|Overall Study|Withdrawal by Subject|2|||
33284420|NCT01091519|100936875|FG001|Overall Study|Withdrawal by Subject|2|||
33284421|NCT01091519|100936874|FG000|Overall Study|Other|6|||
33284422|NCT01091519|100936875|FG001|Overall Study|Other|8|||
33284423|NCT01091519|100936874|FG000|Overall Study|Randomized not treated|4|||
33284424|NCT01091519|100936875|FG001|Overall Study|Randomized not treated|4|||
33284425|NCT03511378|100936876|FG000|Overall Study|Withdrawal by Subject|2|||
33284426|NCT03511378|100936877|FG001|Overall Study|Withdrawal by Subject|2|||
33284427|NCT03511378|100936876|FG000|Overall Study|Patient not coming or schedule visit|1|||
33284428|NCT03511378|100936877|FG001|Overall Study|Patient not coming or schedule visit|0|||
33284429|NCT01649297|100936880|FG000|Overall Study|Adverse Event|5|||
33284430|NCT01649297|100936881|FG001|Overall Study|Adverse Event|5|||
33284431|NCT01649297|100936882|FG002|Overall Study|Adverse Event|4|||
33284432|NCT01649297|100936883|FG003|Overall Study|Adverse Event|13|||
33284433|NCT01649297|100936884|FG004|Overall Study|Adverse Event|1|||
33284434|NCT01649297|100936880|FG000|Overall Study|Lack of Efficacy|0|||
33284435|NCT01649297|100936881|FG001|Overall Study|Lack of Efficacy|0|||
33284436|NCT01649297|100936882|FG002|Overall Study|Lack of Efficacy|0|||
33284437|NCT01649297|100936883|FG003|Overall Study|Lack of Efficacy|0|||
33284438|NCT01649297|100936884|FG004|Overall Study|Lack of Efficacy|1|||
33284439|NCT01649297|100936880|FG000|Overall Study|Non compliant with Protocol|1|||
33284440|NCT01649297|100936881|FG001|Overall Study|Non compliant with Protocol|0|||
33284441|NCT01649297|100936882|FG002|Overall Study|Non compliant with Protocol|3|||
33284442|NCT01649297|100936883|FG003|Overall Study|Non compliant with Protocol|2|||
33284443|NCT01649297|100936884|FG004|Overall Study|Non compliant with Protocol|1|||
33284444|NCT01649297|100936880|FG000|Overall Study|Lost to Follow-up|1|||
33284445|NCT01649297|100936881|FG001|Overall Study|Lost to Follow-up|1|||
33284446|NCT01649297|100936882|FG002|Overall Study|Lost to Follow-up|4|||
33284447|NCT01649297|100936883|FG003|Overall Study|Lost to Follow-up|3|||
33284448|NCT01649297|100936884|FG004|Overall Study|Lost to Follow-up|0|||
33284449|NCT01649297|100936880|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
33284450|NCT01649297|100936881|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
33284451|NCT01649297|100936882|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
33284452|NCT01649297|100936883|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
33284453|NCT01649297|100936884|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
33284454|NCT01649297|100936880|FG000|Overall Study|For other reason|4|||
33284455|NCT01649297|100936881|FG001|Overall Study|For other reason|1|||
33284456|NCT01649297|100936882|FG002|Overall Study|For other reason|2|||
33284457|NCT01649297|100936883|FG003|Overall Study|For other reason|0|||
33284458|NCT01649297|100936884|FG004|Overall Study|For other reason|0|||
33284459|NCT01774019|100936885|FG000|Overall Study|No longer meets protocol criteria|2|||
33284460|NCT01774019|100936886|FG001|Overall Study|No longer meets protocol criteria|0|||
33284461|NCT01774019|100936885|FG000|Overall Study|Withdrawal by Subject|1|||
33284462|NCT01774019|100936886|FG001|Overall Study|Withdrawal by Subject|0|||
33284463|NCT01774019|100936885|FG000|Overall Study|Surgery delayed > 120 days|1|||
33284464|NCT01774019|100936886|FG001|Overall Study|Surgery delayed > 120 days|0|||
33284465|NCT01774019|100936885|FG000|Overall Study|Patient refused surgery|1|||
33284466|NCT01774019|100936886|FG001|Overall Study|Patient refused surgery|1|||
33284467|NCT01774019|100936885|FG000|Overall Study|Unable to implant study device|1|||
33284468|NCT01774019|100936886|FG001|Overall Study|Unable to implant study device|0|||
33284469|NCT01774019|100936885|FG000|Overall Study|Lost to Follow-up|0|||
33284470|NCT01774019|100936886|FG001|Overall Study|Lost to Follow-up|3|||
33284471|NCT00463580|100936890|FG000|Overall Study|Lost to Follow-up|1|||
33284472|NCT00463580|100936891|FG001|Overall Study|Lost to Follow-up|0|||
33284473|NCT00463580|100936890|FG000|Overall Study|Schedule conflict|2|||
33284474|NCT00463580|100936891|FG001|Overall Study|Schedule conflict|0|||
33284475|NCT00463580|100936890|FG000|Overall Study|Medical/psychiatric complications|0|||
33284476|NCT00463580|100936891|FG001|Overall Study|Medical/psychiatric complications|2|||
33284477|NCT02016690|100936892|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
33284478|NCT02016690|100936892|FG000|Overall Study|Excluded from SAS: Duplication|2|||
33284479|NCT02016690|100936892|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
33284480|NCT02016690|100936892|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
33284481|NCT02016690|100936892|FG000|Overall Study|Did not meet inclusion criteria|13|||
33284482|NCT02016690|100936892|FG000|Overall Study|Hospitalized for RSV at study start|3|||
33284483|NCT03371485|100936893|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
33284484|NCT03371485|100936893|FG000|2-year Follow-up|Death|5|||
33284485|NCT02172950|100936894|FG000|Overall Study|Physician Decision|3|||
33284486|NCT02172950|100936895|FG001|Overall Study|Physician Decision|3|||
33284487|NCT02172950|100936894|FG000|Overall Study|Lack of Efficacy|1|||
33284488|NCT02172950|100936895|FG001|Overall Study|Lack of Efficacy|0|||
33284489|NCT02172950|100936894|FG000|Overall Study|Adverse Event|4|||
33284490|NCT02172950|100936895|FG001|Overall Study|Adverse Event|1|||
33284491|NCT02172950|100936894|FG000|Overall Study|Withdrawal by Subject|10|||
33284492|NCT02172950|100936895|FG001|Overall Study|Withdrawal by Subject|0|||
33284493|NCT02172950|100936894|FG000|Overall Study|Protocol Violation|1|||
33284494|NCT02172950|100936895|FG001|Overall Study|Protocol Violation|0|||
33284495|NCT02172950|100936894|FG000|Overall Study|Lost to Follow-up|1|||
33284496|NCT02172950|100936895|FG001|Overall Study|Lost to Follow-up|0|||
33284497|NCT02172950|100936894|FG000|Overall Study|Death|1|||
33284498|NCT02172950|100936895|FG001|Overall Study|Death|0|||
33284499|NCT02172950|100936894|FG000|Overall Study|Patient traveling|1|||
33284500|NCT02172950|100936895|FG001|Overall Study|Patient traveling|0|||
33284501|NCT02172950|100936894|FG000|Overall Study|Patient went to other country|1|||
33284502|NCT02172950|100936895|FG001|Overall Study|Patient went to other country|0|||
33284503|NCT02172950|100936894|FG000|Overall Study|Patient relocated overseas|1|||
33284504|NCT02172950|100936895|FG001|Overall Study|Patient relocated overseas|1|||
33284505|NCT02172950|100936894|FG000|Overall Study|Patient moving|1|||
33284506|NCT02172950|100936895|FG001|Overall Study|Patient moving|0|||
33284507|NCT00225277|100936896|FG000|Overall Study|Adverse Event|30|||
33284508|NCT00225277|100936897|FG001|Overall Study|Adverse Event|34|||
33284509|NCT00225277|100936896|FG000|Overall Study|Lack of Efficacy|4|||
33284510|NCT00225277|100936897|FG001|Overall Study|Lack of Efficacy|1|||
33284511|NCT00225277|100936896|FG000|Overall Study|Lost to Follow-up|4|||
33284512|NCT00225277|100936897|FG001|Overall Study|Lost to Follow-up|6|||
33284513|NCT00225277|100936896|FG000|Overall Study|Physician Decision|6|||
33284514|NCT00225277|100936897|FG001|Overall Study|Physician Decision|8|||
33284515|NCT00225277|100936896|FG000|Overall Study|Protocol Violation|6|||
33284516|NCT00225277|100936897|FG001|Overall Study|Protocol Violation|3|||
33284517|NCT00225277|100936896|FG000|Overall Study|Withdrawal by Subject|40|||
33284518|NCT00225277|100936897|FG001|Overall Study|Withdrawal by Subject|34|||
33284519|NCT00225277|100936896|FG000|Overall Study|Other|7|||
33284520|NCT00225277|100936897|FG001|Overall Study|Other|9|||
33284521|NCT00679549|100936902|FG000|Overall Study|dropout|2|||
33284522|NCT00679549|100936903|FG001|Overall Study|dropout|4|||
33284523|NCT00679549|100936902|FG000|Overall Study|missing outcome echocardiograms|4|||
33284524|NCT00679549|100936903|FG001|Overall Study|missing outcome echocardiograms|5|||
33284525|NCT01904019|100936904|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
33284526|NCT01904019|100936904|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
33284527|NCT01904019|100936904|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
33284528|NCT01904019|100936904|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
33284529|NCT01904019|100936904|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
33284530|NCT01904019|100936904|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
33284531|NCT02564718|100936905|FG000|Overall Study|Withdrew from treatment|0|||
33284532|NCT02564718|100936906|FG001|Overall Study|Withdrew from treatment|1|||
33284533|NCT01920178|100936909|FG000|Overall Study|Lost to Follow-up|2|||
33284534|NCT01920178|100936910|FG001|Overall Study|Lost to Follow-up|1|||
33284535|NCT01435798|100936911|FG000|Overall Study|Withdrawal by Subject|1|||
33284536|NCT00363649|100936912|FG000|Overall Study|Withdrawal by Subject|1|||
33284537|NCT00363649|100936913|FG001|Overall Study|Withdrawal by Subject|1|||
33284538|NCT00363649|100936912|FG000|Overall Study|Adverse Event|6|||
33284539|NCT00363649|100936913|FG001|Overall Study|Adverse Event|0|||
33284540|NCT02299427|100936914|FG000|Overall Study|Withdrawal by Subject|1|||
33284541|NCT02299427|100936915|FG001|Overall Study|Withdrawal by Subject|0|||
33284542|NCT02299427|100936914|FG000|Overall Study|Lost to Follow-up|1|||
33284543|NCT02299427|100936915|FG001|Overall Study|Lost to Follow-up|3|||
33284544|NCT02299427|100936914|FG000|Overall Study|not adherent to dog website use|21|||
33284545|NCT02299427|100936915|FG001|Overall Study|not adherent to dog website use|0|||
33284546|NCT00594178|100936916|FG000|Overall Study|Physician Decision|5|||
33284547|NCT02316847|100936917|FG000|Overall Study|Adverse Event|0|||
33284548|NCT02316847|100936918|FG001|Overall Study|Adverse Event|3|||
33284549|NCT02316847|100936917|FG000|Overall Study|Lost to Follow-up|0|||
33284550|NCT02316847|100936918|FG001|Overall Study|Lost to Follow-up|2|||
33284551|NCT02316847|100936917|FG000|Overall Study|Physician Decision|0|||
33284552|NCT02316847|100936918|FG001|Overall Study|Physician Decision|1|||
33284553|NCT02316847|100936917|FG000|Overall Study|Pregnancy|0|||
33284554|NCT02316847|100936918|FG001|Overall Study|Pregnancy|1|||
33284555|NCT02316847|100936917|FG000|Overall Study|Withdrawal by Subject|2|||
33284556|NCT02316847|100936918|FG001|Overall Study|Withdrawal by Subject|9|||
33284557|NCT02316847|100936917|FG000|Overall Study|Noncompliance with study drug|0|||
33284558|NCT02316847|100936918|FG001|Overall Study|Noncompliance with study drug|3|||
33284559|NCT02316847|100936917|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
33284560|NCT02316847|100936918|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
33284561|NCT00474383|100936919|FG000|Main Study|Adverse Event|11|||
33284562|NCT00474383|100936920|FG001|Main Study|Adverse Event|0|||
33284563|NCT00474383|100936919|FG000|Main Study|Symptomatic Deterioration|1|||
33284564|NCT00474383|100936920|FG001|Main Study|Symptomatic Deterioration|0|||
33284565|NCT00474383|100936919|FG000|Main Study|Progressive Disease|23|||
33284566|NCT00474383|100936920|FG001|Main Study|Progressive Disease|0|||
33284567|NCT00474383|100936919|FG000|Main Study|Other|1|||
33284568|NCT00474383|100936920|FG001|Main Study|Other|0|||
33284569|NCT00474383|100936919|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
33284570|NCT00474383|100936920|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
33284571|NCT00474383|100936919|FG000|Extension|Progressive Disease|0|||
33284572|NCT00474383|100936920|FG001|Extension|Progressive Disease|5|||
33284573|NCT02413593|100936922|FG000|Overall Study|Lost to Follow-up|3|||
33284574|NCT02413593|100936922|FG000|Overall Study|Adverse Event|1|||
33284575|NCT00337285|100939962|FG000|Overall Study|Withdrawal by Subject|42|||
33284576|NCT00337285|100939962|FG000|Overall Study|Lost to Follow-up|41|||
33284577|NCT00337285|100939962|FG000|Overall Study|Adverse Event|28|||
33284578|NCT00337285|100939962|FG000|Overall Study|Protocol Violation|27|||
33284579|NCT00337285|100939962|FG000|Overall Study|Lack of Efficacy|11|||
33284580|NCT00337285|100939962|FG000|Overall Study|Death|1|||
33284581|NCT00337285|100939962|FG000|Overall Study|Physician Decision|1|||
33284582|NCT00337285|100939962|FG000|Overall Study|Lack of protocol compliance|7|||
33284583|NCT03294941|100939963|FG000|Overall Study|Withdrawal by Subject|0|||
33284584|NCT03294941|100939964|FG001|Overall Study|Withdrawal by Subject|2|||
33284585|NCT01085812|100939965|FG000|Open-Label Period|Adverse Event|0|||
33284586|NCT01085812|100939966|FG001|Open-Label Period|Adverse Event|80|||
33284587|NCT01085812|100939965|FG000|Open-Label Period|Lack of Efficacy|0|||
33284588|NCT01085812|100939966|FG001|Open-Label Period|Lack of Efficacy|26|||
33284589|NCT01085812|100939965|FG000|Open-Label Period|Protocol Violation|0|||
33284590|NCT01085812|100939966|FG001|Open-Label Period|Protocol Violation|39|||
33284591|NCT01085812|100939965|FG000|Open-Label Period|Withdrawal by Subject|0|||
33284592|NCT01085812|100939966|FG001|Open-Label Period|Withdrawal by Subject|53|||
33284593|NCT01085812|100939965|FG000|Open-Label Period|Lost to Follow-up|0|||
33284594|NCT01085812|100939966|FG001|Open-Label Period|Lost to Follow-up|42|||
33284595|NCT01085812|100939965|FG000|Double-Blind Period|Adverse Event|3|||
33284596|NCT01085812|100939966|FG001|Double-Blind Period|Adverse Event|8|||
33284597|NCT01085812|100939965|FG000|Double-Blind Period|Protocol Violation|2|||
33284598|NCT01085812|100939966|FG001|Double-Blind Period|Protocol Violation|7|||
33284599|NCT01085812|100939965|FG000|Double-Blind Period|Withdrawal by Subject|11|||
33284600|NCT01085812|100939966|FG001|Double-Blind Period|Withdrawal by Subject|24|||
33284601|NCT01085812|100939965|FG000|Double-Blind Period|Lost to Follow-up|5|||
33284602|NCT01085812|100939966|FG001|Double-Blind Period|Lost to Follow-up|17|||
33284603|NCT01085812|100939965|FG000|Double-Blind Period|Other Reasons|0|||
33284604|NCT01085812|100939966|FG001|Double-Blind Period|Other Reasons|2|||
33284605|NCT01085812|100939965|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
33284606|NCT01085812|100939966|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
33284607|NCT01085812|100939965|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
33284608|NCT01085812|100939966|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
33284609|NCT01085812|100939965|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
33284610|NCT01085812|100939966|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
33284611|NCT01085812|100939965|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
33284612|NCT01085812|100939966|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
33284613|NCT01085812|100939965|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
33284614|NCT01085812|100939966|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
33284615|NCT02246218|100939967|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
33284616|NCT02246218|100939968|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
33284617|NCT02246218|100939967|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
33284618|NCT02246218|100939968|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
33284619|NCT02246218|100939967|FG000|Overall Study|Adverse Event|1|||
33284620|NCT02246218|100939968|FG001|Overall Study|Adverse Event|1|||
33284621|NCT02246218|100939967|FG000|Overall Study|Lost to Follow-up|1|||
33284622|NCT02246218|100939968|FG001|Overall Study|Lost to Follow-up|0|||
33284623|NCT00239681|100939969|FG000|Overall Study|Adverse Event|100|||
33284624|NCT00239681|100939970|FG001|Overall Study|Adverse Event|99|||
33284625|NCT00239681|100939969|FG000|Overall Study|Withdrawal by Subject|458|||
33284626|NCT00239681|100939970|FG001|Overall Study|Withdrawal by Subject|489|||
33284627|NCT00239681|100939969|FG000|Overall Study|Lost to Follow-up|28|||
33284628|NCT00239681|100939970|FG001|Overall Study|Lost to Follow-up|22|||
33284629|NCT00239681|100939969|FG000|Overall Study|Protocol Violation|4|||
33284630|NCT00239681|100939970|FG001|Overall Study|Protocol Violation|4|||
33284631|NCT00239681|100939969|FG000|Overall Study|Physician Decision|13|||
33284632|NCT00239681|100939970|FG001|Overall Study|Physician Decision|17|||
33284633|NCT00239681|100939969|FG000|Overall Study|No information chacked on CaseReportForm|90|||
33284634|NCT00239681|100939970|FG001|Overall Study|No information chacked on CaseReportForm|84|||
33284635|NCT01878383|100939971|FG000|Overall Study|Lost to Follow-up|0|||
33284636|NCT01878383|100939972|FG001|Overall Study|Lost to Follow-up|1499|||
33284637|NCT02412111|100939973|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
33284638|NCT02412111|100939974|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
33284639|NCT02412111|100939975|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
33284640|NCT02412111|100939973|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
33284641|NCT02412111|100939974|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
33284642|NCT02412111|100939975|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
33284643|NCT02412111|100939973|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
33284644|NCT02412111|100939974|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
33284645|NCT02412111|100939975|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
33284646|NCT02412111|100939973|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
33284647|NCT02412111|100939974|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
33284648|NCT02412111|100939975|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
33284649|NCT02412111|100939973|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
33284650|NCT02412111|100939974|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
33284651|NCT02412111|100939975|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
33284652|NCT02412111|100939973|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
33284653|NCT02412111|100939974|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
33284654|NCT02412111|100939975|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
33284655|NCT02412111|100939973|FG000|Active Comparator Period (8 Weeks)|Other|0|||
33284656|NCT02412111|100939974|FG001|Active Comparator Period (8 Weeks)|Other|0|||
33284657|NCT02412111|100939975|FG002|Active Comparator Period (8 Weeks)|Other|2|||
33284658|NCT00582114|100939976|FG000|Overall Study|Death|4|||
33284659|NCT00582114|100939977|FG001|Overall Study|Death|4|||
33284660|NCT00582114|100939976|FG000|Overall Study|Kidney Transplant|3|||
33284661|NCT00582114|100939977|FG001|Overall Study|Kidney Transplant|1|||
33284662|NCT00582114|100939976|FG000|Overall Study|Lost to Follow-up|7|||
33284663|NCT00582114|100939977|FG001|Overall Study|Lost to Follow-up|6|||
33284664|NCT00582114|100939976|FG000|Overall Study|Withdrawal by Subject|8|||
33284665|NCT00582114|100939977|FG001|Overall Study|Withdrawal by Subject|16|||
33284666|NCT00582114|100939976|FG000|Overall Study|Adverse Event|1|||
33284667|NCT00582114|100939977|FG001|Overall Study|Adverse Event|1|||
33284668|NCT00582114|100939976|FG000|Overall Study|Physician Decision|0|||
33284669|NCT00582114|100939977|FG001|Overall Study|Physician Decision|6|||
33284670|NCT00582114|100939976|FG000|Overall Study|Stopped by data safety monitoring board|19|||
33284671|NCT00582114|100939977|FG001|Overall Study|Stopped by data safety monitoring board|20|||
33284672|NCT02725008|100939978|FG000|Overall Study|Lost to Follow-up|7|||
33284673|NCT02725008|100939979|FG001|Overall Study|Lost to Follow-up|9|||
33284674|NCT02725008|100939978|FG000|Overall Study|Withdrawal by Subject|2|||
33284675|NCT02725008|100939979|FG001|Overall Study|Withdrawal by Subject|2|||
33284676|NCT02725008|100939978|FG000|Overall Study|Admitted to hospital|0|||
33284677|NCT02725008|100939979|FG001|Overall Study|Admitted to hospital|1|||
33284678|NCT02427958|100939980|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
33284679|NCT02427958|100939980|FG000|Overall Study|Lost to Follow-up|6|||
33284680|NCT02427958|100939980|FG000|Overall Study|Withdrawal by Subject|14|||
33284681|NCT02427958|100939980|FG000|Overall Study|Lack of Efficacy|1|||
33284682|NCT00690378|100939981|FG000|Overall Study|Adverse Event|1|||
33284683|NCT00690378|100939982|FG001|Overall Study|Adverse Event|0|||
33284684|NCT00690378|100939981|FG000|Overall Study|Withdrawal by Subject|2|||
33284685|NCT00690378|100939982|FG001|Overall Study|Withdrawal by Subject|0|||
33284686|NCT00690378|100939981|FG000|Overall Study|Protocol Violation|1|||
33284687|NCT00690378|100939982|FG001|Overall Study|Protocol Violation|0|||
33284688|NCT00690378|100939981|FG000|Overall Study|Lost to Follow-up|2|||
33284689|NCT00690378|100939982|FG001|Overall Study|Lost to Follow-up|3|||
33284690|NCT00690378|100939981|FG000|Overall Study|Did not meet inc/exc criteria|13|||
33284691|NCT00690378|100939982|FG001|Overall Study|Did not meet inc/exc criteria|11|||
33284692|NCT00690378|100939981|FG000|Overall Study|Social problem|1|||
33284693|NCT00690378|100939982|FG001|Overall Study|Social problem|0|||
33284694|NCT01837797|100939989|FG000|Period 1|Adverse Event|9|||
33284695|NCT01837797|100939990|FG001|Period 1|Adverse Event|0|||
33284696|NCT01837797|100939991|FG002|Period 1|Adverse Event|0|||
33284697|NCT01837797|100939992|FG003|Period 1|Adverse Event|0|||
33284698|NCT01837797|100939993|FG004|Period 1|Adverse Event|0|||
33284699|NCT01837797|100939989|FG000|Period 1|Withdrawal by Subject|6|||
33284700|NCT01837797|100939990|FG001|Period 1|Withdrawal by Subject|0|||
33284701|NCT01837797|100939991|FG002|Period 1|Withdrawal by Subject|0|||
33284702|NCT01837797|100939992|FG003|Period 1|Withdrawal by Subject|0|||
33284703|NCT01837797|100939993|FG004|Period 1|Withdrawal by Subject|0|||
33284704|NCT01837797|100939989|FG000|Period 1|Administrative reasons|76|||
33284705|NCT01837797|100939990|FG001|Period 1|Administrative reasons|0|||
33284706|NCT01837797|100939991|FG002|Period 1|Administrative reasons|0|||
33284707|NCT01837797|100939992|FG003|Period 1|Administrative reasons|0|||
33284708|NCT01837797|100939993|FG004|Period 1|Administrative reasons|0|||
33284709|NCT01837797|100939989|FG000|Period 1|Withdrawal of consent before treatment|1|||
33284710|NCT01837797|100939990|FG001|Period 1|Withdrawal of consent before treatment|0|||
33284711|NCT01837797|100939991|FG002|Period 1|Withdrawal of consent before treatment|0|||
33284712|NCT01837797|100939992|FG003|Period 1|Withdrawal of consent before treatment|0|||
33284713|NCT01837797|100939993|FG004|Period 1|Withdrawal of consent before treatment|0|||
33284714|NCT01837797|100939989|FG000|Period 1|Other|10|||
33284715|NCT01837797|100939990|FG001|Period 1|Other|0|||
33284716|NCT01837797|100939991|FG002|Period 1|Other|0|||
33284717|NCT01837797|100939992|FG003|Period 1|Other|0|||
33284718|NCT01837797|100939993|FG004|Period 1|Other|0|||
33284719|NCT01837797|100939989|FG000|Period 2|Administrative or other reasons|0|||
33284720|NCT01837797|100939990|FG001|Period 2|Administrative or other reasons|5|||
33284721|NCT01837797|100939991|FG002|Period 2|Administrative or other reasons|2|||
33284722|NCT01837797|100939992|FG003|Period 2|Administrative or other reasons|4|||
33284723|NCT01837797|100939993|FG004|Period 2|Administrative or other reasons|0|||
33284724|NCT01837797|100939989|FG000|Period 2|Adverse Event|0|||
33284725|NCT01837797|100939990|FG001|Period 2|Adverse Event|0|||
33284726|NCT01837797|100939991|FG002|Period 2|Adverse Event|0|||
33284727|NCT01837797|100939992|FG003|Period 2|Adverse Event|1|||
33284728|NCT01837797|100939993|FG004|Period 2|Adverse Event|0|||
33284729|NCT01837797|100939989|FG000|Period 3|Adverse Event|0|||
33284730|NCT01837797|100939990|FG001|Period 3|Adverse Event|0|||
33284731|NCT01837797|100939991|FG002|Period 3|Adverse Event|0|||
33284732|NCT01837797|100939992|FG003|Period 3|Adverse Event|0|||
33284733|NCT01837797|100939993|FG004|Period 3|Adverse Event|1|||
33284734|NCT01837797|100939989|FG000|Period 3|Administrative reasons|0|||
33284735|NCT01837797|100939990|FG001|Period 3|Administrative reasons|0|||
33284736|NCT01837797|100939991|FG002|Period 3|Administrative reasons|0|||
33284737|NCT01837797|100939992|FG003|Period 3|Administrative reasons|0|||
33284738|NCT01837797|100939993|FG004|Period 3|Administrative reasons|20|||
33284739|NCT01837797|100939989|FG000|Period 3|Other|0|||
33284740|NCT01837797|100939990|FG001|Period 3|Other|0|||
33284741|NCT01837797|100939991|FG002|Period 3|Other|0|||
33284742|NCT01837797|100939992|FG003|Period 3|Other|0|||
33284743|NCT01837797|100939993|FG004|Period 3|Other|2|||
33284744|NCT00537329|100939994|FG000|Overall Study|Death|10|||
33284745|NCT00537329|100939994|FG000|Overall Study|Adverse Event|3|||
33284746|NCT00537329|100939994|FG000|Overall Study|Lack of Efficacy|2|||
33284747|NCT00537329|100939994|FG000|Overall Study|Lost to Follow-up|6|||
33284748|NCT00537329|100939994|FG000|Overall Study|Withdrawal by Subject|4|||
33284749|NCT00537329|100939994|FG000|Overall Study|Other|1|||
33284750|NCT02853305|100939995|FG000|Overall Study|Death|287|||
33284751|NCT02853305|100939996|FG001|Overall Study|Death|249|||
33284752|NCT02853305|100939997|FG002|Overall Study|Death|300|||
33284753|NCT02853305|100939995|FG000|Overall Study|Withdrawal by Subject|2|||
33284754|NCT02853305|100939996|FG001|Overall Study|Withdrawal by Subject|8|||
33284755|NCT02853305|100939997|FG002|Overall Study|Withdrawal by Subject|3|||
33284756|NCT02853305|100939995|FG000|Overall Study|Transferred to Extension Study|46|||
33284757|NCT02853305|100939996|FG001|Overall Study|Transferred to Extension Study|30|||
33284758|NCT02853305|100939997|FG002|Overall Study|Transferred to Extension Study|25|||
33284759|NCT02853305|100939995|FG000|Overall Study|Did Not Continue on Extension Study|16|||
33284760|NCT02853305|100939996|FG001|Overall Study|Did Not Continue on Extension Study|20|||
33284761|NCT02853305|100939997|FG002|Overall Study|Did Not Continue on Extension Study|24|||
33284762|NCT00427778|100939998|FG000|First Intervention (4 Weeks)|no longer interested|1|||
33284763|NCT00427778|100939999|FG001|First Intervention (4 Weeks)|no longer interested|0|||
33284764|NCT00427778|100939998|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
33284765|NCT00427778|100939999|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
33284766|NCT00427778|100939998|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
33284767|NCT00427778|100939999|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
33284768|NCT00427778|100939998|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
33284769|NCT00427778|100939999|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
33284770|NCT01220856|100940000|FG000|Overall Study|graft loss|3|||
33284771|NCT01220856|100940001|FG001|Overall Study|graft loss|3|||
33284772|NCT01220856|100940000|FG000|Overall Study|Lost to Follow-up|1|||
33284773|NCT01220856|100940001|FG001|Overall Study|Lost to Follow-up|0|||
33284774|NCT00853229|100940010|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
33284775|NCT00853229|100940011|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
33284776|NCT01880437|100940013|FG000|Overall Study|Death|12|||
33284777|NCT01880437|100940014|FG001|Overall Study|Death|4|||
33284778|NCT01880437|100940015|FG002|Overall Study|Death|17|||
33284779|NCT01880437|100940013|FG000|Overall Study|Study terminated by Sponsor|3|||
33284780|NCT01880437|100940014|FG001|Overall Study|Study terminated by Sponsor|0|||
33284781|NCT01880437|100940015|FG002|Overall Study|Study terminated by Sponsor|2|||
33284782|NCT00519285|100940016|FG000|Overall Study|Adverse Event|127|||
33284783|NCT00519285|100940017|FG001|Overall Study|Adverse Event|266|||
33284784|NCT00519285|100940016|FG000|Overall Study|Disease progression|334|||
33284785|NCT00519285|100940017|FG001|Overall Study|Disease progression|186|||
33284786|NCT00519285|100940016|FG000|Overall Study|Physician Decision|75|||
33284787|NCT00519285|100940017|FG001|Overall Study|Physician Decision|47|||
33284788|NCT00519285|100940016|FG000|Overall Study|Participant's request|53|||
33284789|NCT00519285|100940017|FG001|Overall Study|Participant's request|84|||
33284790|NCT00519285|100940016|FG000|Overall Study|Consent withdrawn|4|||
33284791|NCT00519285|100940017|FG001|Overall Study|Consent withdrawn|5|||
33284792|NCT00519285|100940016|FG000|Overall Study|Poor compliance to protocol|5|||
33284793|NCT00519285|100940017|FG001|Overall Study|Poor compliance to protocol|7|||
33284794|NCT00519285|100940016|FG000|Overall Study|Reason unspecified|5|||
33284795|NCT00519285|100940017|FG001|Overall Study|Reason unspecified|8|||
33284796|NCT00519285|100940016|FG000|Overall Study|Not treated|8|||
33284797|NCT00519285|100940017|FG001|Overall Study|Not treated|7|||
33284798|NCT00519285|100940016|FG000|Overall Study|Treatment ongoing|1|||
33284799|NCT00519285|100940017|FG001|Overall Study|Treatment ongoing|2|||
33284800|NCT02514577|100940018|FG000|Overall Study|Lost to Follow-up|6|||
33284801|NCT02514577|100940019|FG001|Overall Study|Lost to Follow-up|6|||
33284802|NCT02514577|100940018|FG000|Overall Study|Protocol Violation|1|||
33284803|NCT02514577|100940019|FG001|Overall Study|Protocol Violation|0|||
33284804|NCT02514577|100940018|FG000|Overall Study|Withdrawal by Subject|6|||
33284805|NCT02514577|100940019|FG001|Overall Study|Withdrawal by Subject|6|||
33284806|NCT02514577|100940018|FG000|Overall Study|Adverse Event|1|||
33284807|NCT02514577|100940019|FG001|Overall Study|Adverse Event|1|||
33284808|NCT01722045|100940020|FG000|Overall Study|Adverse Event|8|||
33284809|NCT01722045|100940020|FG000|Overall Study|Death|3|||
33284810|NCT01722045|100940020|FG000|Overall Study|Withdrawal by Subject|8|||
33284811|NCT01722045|100940020|FG000|Overall Study|Lost to Follow-up|4|||
33284812|NCT01722045|100940020|FG000|Overall Study|Protocol Deviation|1|||
33284813|NCT01722045|100940020|FG000|Overall Study|Physician Decision|3|||
33284814|NCT01722045|100940020|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
33284815|NCT02647645|100940022|FG000|Overall Study|Lost to Follow-up|2|||
33284816|NCT02647645|100940023|FG001|Overall Study|Lost to Follow-up|1|||
33284817|NCT00766142|100940026|FG000|Overall Study|Protocol Violation|4|||
33284818|NCT03187353|100940027|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
33284819|NCT03187353|100940028|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
33284820|NCT03187353|100940027|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
33284821|NCT03187353|100940028|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
33284822|NCT03187353|100940027|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
33284823|NCT03187353|100940028|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
33284824|NCT03187353|100940027|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
33284825|NCT03187353|100940028|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
33284826|NCT03187353|100940027|FG000|Washout (2 Weeks)|Adverse Event|2|||
33284827|NCT03187353|100940028|FG001|Washout (2 Weeks)|Adverse Event|0|||
33284828|NCT03187353|100940027|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
33284829|NCT03187353|100940028|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
33284830|NCT00118703|100940029|FG000|Overall Study|Protocol Violation|1|||
33284831|NCT00118703|100940030|FG001|Overall Study|Protocol Violation|0|||
33284832|NCT00118703|100940029|FG000|Overall Study|Adverse Event|1|||
33284833|NCT00118703|100940030|FG001|Overall Study|Adverse Event|1|||
33284834|NCT00118703|100940029|FG000|Overall Study|Participant took two different treatment|0|||
33284835|NCT00118703|100940030|FG001|Overall Study|Participant took two different treatment|1|||
33284836|NCT00118703|100940029|FG000|Overall Study|Withdrawal by Subject|2|||
33284837|NCT00118703|100940030|FG001|Overall Study|Withdrawal by Subject|5|||
33284838|NCT00118703|100940029|FG000|Overall Study|Lost to Follow-up|1|||
33284839|NCT00118703|100940030|FG001|Overall Study|Lost to Follow-up|2|||
33284840|NCT01121185|100940031|FG000|Overall Study|Not infused|0|||
33284841|NCT01121185|100940032|FG001|Overall Study|Not infused|1|||
33284842|NCT01121185|100940031|FG000|Overall Study|Not transplanted|1|||
33284843|NCT01121185|100940032|FG001|Overall Study|Not transplanted|0|||
33284844|NCT00405912|100940033|FG000|Overall Study|Withdrawal by Subject|12|||
33284845|NCT00405912|100940034|FG001|Overall Study|Withdrawal by Subject|11|||
33284846|NCT00405912|100940035|FG002|Overall Study|Withdrawal by Subject|12|||
33284847|NCT00405912|100940033|FG000|Overall Study|Lost to Follow-up|4|||
33284848|NCT00405912|100940034|FG001|Overall Study|Lost to Follow-up|8|||
33284849|NCT00405912|100940035|FG002|Overall Study|Lost to Follow-up|4|||
33284850|NCT02037256|100940036|FG000|Overall Study|Protocol Violation|0|||
33284851|NCT02037256|100940037|FG001|Overall Study|Protocol Violation|1|||
33284852|NCT02037256|100940036|FG000|Overall Study|Withdrawn prior to Velcade|0|||
33284853|NCT02037256|100940037|FG001|Overall Study|Withdrawn prior to Velcade|2|||
33284854|NCT04052997|100940038|FG000|Overall Study|Withdrawal by Subject|17|||
33284855|NCT04052997|100940038|FG000|Overall Study|Physician Decision|50|||
33284856|NCT04052997|100940038|FG000|Overall Study|Death|43|||
33284857|NCT04052997|100940038|FG000|Overall Study|Lost to Follow-up|5|||
33284858|NCT04052997|100940038|FG000|Overall Study|Progression of Disease|1|||
33284859|NCT04599907|100940039|FG000|Overall Study|Withdrawal by Subject|1|||
33284860|NCT04599907|100940040|FG001|Overall Study|Withdrawal by Subject|7|||
33284861|NCT04599907|100940041|FG002|Overall Study|Withdrawal by Subject|6|||
33284862|NCT04599907|100940039|FG000|Overall Study|Lost to Follow-up|0|||
33284863|NCT04599907|100940040|FG001|Overall Study|Lost to Follow-up|1|||
33284864|NCT04599907|100940041|FG002|Overall Study|Lost to Follow-up|0|||
33284865|NCT00546078|100940043|FG000|Overall Study|Lost to Follow-up|1|||
33284866|NCT00546078|100940044|FG001|Overall Study|Lost to Follow-up|3|||
33284867|NCT00546078|100940043|FG000|Overall Study|Withdrawal by Subject|2|||
33284868|NCT00546078|100940044|FG001|Overall Study|Withdrawal by Subject|3|||
33284869|NCT00546078|100940043|FG000|Overall Study|Other reason|1|||
33284870|NCT00546078|100940044|FG001|Overall Study|Other reason|1|||
33284871|NCT00511797|100940047|FG000|Overall Study|Adverse Event|1|||
33284872|NCT00511797|100940048|FG001|Overall Study|Adverse Event|2|||
33284873|NCT00511797|100940049|FG002|Overall Study|Adverse Event|2|||
33284874|NCT00511797|100940050|FG003|Overall Study|Adverse Event|2|||
33284875|NCT00511797|100940047|FG000|Overall Study|Lost to Follow-up|1|||
33284876|NCT00511797|100940048|FG001|Overall Study|Lost to Follow-up|0|||
33284877|NCT00511797|100940049|FG002|Overall Study|Lost to Follow-up|0|||
33284878|NCT00511797|100940050|FG003|Overall Study|Lost to Follow-up|1|||
33284879|NCT00511797|100940047|FG000|Overall Study|Pregnancy|0|||
33284880|NCT00511797|100940048|FG001|Overall Study|Pregnancy|0|||
33284881|NCT00511797|100940049|FG002|Overall Study|Pregnancy|0|||
33284882|NCT00511797|100940050|FG003|Overall Study|Pregnancy|1|||
33284883|NCT00511797|100940047|FG000|Overall Study|Protocol Violation|0|||
33284884|NCT00511797|100940048|FG001|Overall Study|Protocol Violation|2|||
33284885|NCT00511797|100940049|FG002|Overall Study|Protocol Violation|2|||
33284886|NCT00511797|100940050|FG003|Overall Study|Protocol Violation|3|||
33284887|NCT00511797|100940047|FG000|Overall Study|Withdrawal by Subject|3|||
33284888|NCT00511797|100940048|FG001|Overall Study|Withdrawal by Subject|3|||
33284889|NCT00511797|100940049|FG002|Overall Study|Withdrawal by Subject|4|||
33284890|NCT00511797|100940050|FG003|Overall Study|Withdrawal by Subject|2|||
33284891|NCT00511797|100940047|FG000|Overall Study|Never dispensed|1|||
33284892|NCT00511797|100940048|FG001|Overall Study|Never dispensed|0|||
33284893|NCT00511797|100940049|FG002|Overall Study|Never dispensed|1|||
33284894|NCT00511797|100940050|FG003|Overall Study|Never dispensed|3|||
33284895|NCT00511797|100940047|FG000|Overall Study|Study drug not taken|0|||
33284896|NCT00511797|100940048|FG001|Overall Study|Study drug not taken|1|||
33284897|NCT00511797|100940049|FG002|Overall Study|Study drug not taken|0|||
33284898|NCT00511797|100940050|FG003|Overall Study|Study drug not taken|1|||
33284899|NCT00511797|100940047|FG000|Overall Study|Partially missing diary|0|||
33284900|NCT00511797|100940048|FG001|Overall Study|Partially missing diary|0|||
33284901|NCT00511797|100940049|FG002|Overall Study|Partially missing diary|1|||
33284902|NCT00511797|100940050|FG003|Overall Study|Partially missing diary|0|||
33284903|NCT00511797|100940047|FG000|Overall Study|Other (moving etc)|1|||
33284904|NCT00511797|100940048|FG001|Overall Study|Other (moving etc)|0|||
33284905|NCT00511797|100940049|FG002|Overall Study|Other (moving etc)|1|||
33284906|NCT00511797|100940050|FG003|Overall Study|Other (moving etc)|2|||
33284907|NCT00740597|100940051|FG000|Overall Study|insurance would not cover treatment|1|||
33284908|NCT01525641|100940052|FG000|Overall Study|Case report form not collected|25|||
33284909|NCT01525641|100940052|FG000|Overall Study|No visit since the first visit|16|||
33284910|NCT01525641|100940052|FG000|Overall Study|Adverse Event|73|||
33284911|NCT01525641|100940052|FG000|Overall Study|Lack of Efficacy|24|||
33284912|NCT01525641|100940052|FG000|Overall Study|Improvement|5|||
33284913|NCT01525641|100940052|FG000|Overall Study|Lost to follow-up (relocation)|1|||
33284914|NCT01525641|100940052|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
33284915|NCT01525641|100940052|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
33284916|NCT01525641|100940052|FG000|Overall Study|Other than stated above|7|||
33284917|NCT03772041|100940054|FG000|Overall Study|Adverse Event|8|||
33284918|NCT03772041|100940055|FG001|Overall Study|Adverse Event|3|||
33284919|NCT03772041|100940054|FG000|Overall Study|Withdrawal by Subject|0|||
33284920|NCT03772041|100940055|FG001|Overall Study|Withdrawal by Subject|2|||
33284921|NCT03772041|100940054|FG000|Overall Study|Protocol Violation|4|||
33284922|NCT03772041|100940055|FG001|Overall Study|Protocol Violation|2|||
33284923|NCT03772041|100940054|FG000|Overall Study|Physician Decision|2|||
33284924|NCT03772041|100940055|FG001|Overall Study|Physician Decision|3|||
33284925|NCT00488319|100940056|FG000|Overall Study|Adverse Event|1|||
33284926|NCT00488319|100940057|FG001|Overall Study|Adverse Event|2|||
33284927|NCT00488319|100940058|FG002|Overall Study|Adverse Event|23|||
33284928|NCT00488319|100940056|FG000|Overall Study|Lack of Efficacy|6|||
33284929|NCT00488319|100940057|FG001|Overall Study|Lack of Efficacy|12|||
33284930|NCT00488319|100940058|FG002|Overall Study|Lack of Efficacy|27|||
33284931|NCT00488319|100940056|FG000|Overall Study|Lost to Follow-up|3|||
33284932|NCT00488319|100940057|FG001|Overall Study|Lost to Follow-up|5|||
33284933|NCT00488319|100940058|FG002|Overall Study|Lost to Follow-up|16|||
33284934|NCT00488319|100940056|FG000|Overall Study|Withdrawal by Subject|5|||
33284935|NCT00488319|100940057|FG001|Overall Study|Withdrawal by Subject|20|||
33284936|NCT00488319|100940058|FG002|Overall Study|Withdrawal by Subject|44|||
33284937|NCT00488319|100940056|FG000|Overall Study|Other reasons for withdrawal|0|||
33284938|NCT00488319|100940057|FG001|Overall Study|Other reasons for withdrawal|4|||
33284939|NCT00488319|100940058|FG002|Overall Study|Other reasons for withdrawal|12|||
33284940|NCT00632931|100940067|FG000|Part 1, Period 1|Protocol Violation|1|||
33284941|NCT00632931|100940068|FG001|Part 1, Period 1|Protocol Violation|0|||
33284942|NCT00632931|100940069|FG002|Part 1, Period 1|Protocol Violation|0|||
33284943|NCT00632931|100940067|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
33284944|NCT00632931|100940068|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
33284945|NCT00632931|100940069|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
33284946|NCT00632931|100940067|FG000|Part 2|Adverse Event|0|||
33284947|NCT00632931|100940068|FG001|Part 2|Adverse Event|0|||
33284948|NCT00632931|100940069|FG002|Part 2|Adverse Event|3|||
33284949|NCT00632931|100940067|FG000|Part 2|Death|0|||
33284950|NCT00632931|100940068|FG001|Part 2|Death|0|||
33284951|NCT00632931|100940069|FG002|Part 2|Death|1|||
33284952|NCT00632931|100940067|FG000|Part 2|Lack of Efficacy|0|||
33284953|NCT00632931|100940068|FG001|Part 2|Lack of Efficacy|0|||
33284954|NCT00632931|100940069|FG002|Part 2|Lack of Efficacy|17|||
33284955|NCT00632931|100940067|FG000|Part 2|Withdrawal by Subject|0|||
33284956|NCT00632931|100940068|FG001|Part 2|Withdrawal by Subject|0|||
33284957|NCT00632931|100940069|FG002|Part 2|Withdrawal by Subject|3|||
33284958|NCT02151643|100940070|FG000|Overall Study|Adverse Event|2|||
33284959|NCT02151643|100940071|FG001|Overall Study|Adverse Event|0|||
33284960|NCT02151643|100940072|FG002|Overall Study|Adverse Event|1|||
33284961|NCT02151643|100940073|FG003|Overall Study|Adverse Event|4|||
33284962|NCT02151643|100940074|FG004|Overall Study|Adverse Event|0|||
33284963|NCT02151643|100940070|FG000|Overall Study|Withdrawal by Subject|0|||
33284964|NCT02151643|100940071|FG001|Overall Study|Withdrawal by Subject|1|||
33284965|NCT02151643|100940072|FG002|Overall Study|Withdrawal by Subject|1|||
33284966|NCT02151643|100940073|FG003|Overall Study|Withdrawal by Subject|1|||
33284967|NCT02151643|100940074|FG004|Overall Study|Withdrawal by Subject|1|||
33284968|NCT02151643|100940070|FG000|Overall Study|Hyperphosphataemia|1|||
33284969|NCT02151643|100940071|FG001|Overall Study|Hyperphosphataemia|0|||
33284970|NCT02151643|100940072|FG002|Overall Study|Hyperphosphataemia|0|||
33284971|NCT02151643|100940073|FG003|Overall Study|Hyperphosphataemia|0|||
33284972|NCT02151643|100940074|FG004|Overall Study|Hyperphosphataemia|1|||
33284973|NCT02151643|100940070|FG000|Overall Study|High Ferritin levels|3|||
33284974|NCT02151643|100940071|FG001|Overall Study|High Ferritin levels|3|||
33284975|NCT02151643|100940072|FG002|Overall Study|High Ferritin levels|2|||
33284976|NCT02151643|100940073|FG003|Overall Study|High Ferritin levels|2|||
33284977|NCT02151643|100940074|FG004|Overall Study|High Ferritin levels|1|||
33284978|NCT00496626|100940081|FG000|Overall Study|Lost to Follow-up|0|||
33284979|NCT00496626|100940082|FG001|Overall Study|Lost to Follow-up|1|||
33284980|NCT00496626|100940081|FG000|Overall Study|Protocol Violation|1|||
33284981|NCT00496626|100940082|FG001|Overall Study|Protocol Violation|0|||
33284982|NCT00496626|100940081|FG000|Overall Study|Withdrawal by Subject|5|||
33284983|NCT00496626|100940082|FG001|Overall Study|Withdrawal by Subject|4|||
33284984|NCT00496626|100940081|FG000|Overall Study|Relocated|0|||
33284985|NCT00496626|100940082|FG001|Overall Study|Relocated|1|||
33284986|NCT03463577|100940083|FG000|Overall Study|Lost to Follow-up|238|||
33284987|NCT03463577|100940084|FG001|Overall Study|Lost to Follow-up|435|||
33284988|NCT03463577|100940085|FG002|Overall Study|Lost to Follow-up|0|||
33284989|NCT03463577|100940086|FG003|Overall Study|Lost to Follow-up|0|||
33284990|NCT03463577|100940087|FG004|Overall Study|Lost to Follow-up|0|||
33284991|NCT03463577|100940088|FG005|Overall Study|Lost to Follow-up|0|||
33284992|NCT03463577|100940083|FG000|Overall Study|With unknown pregnancy outcome|0|||
33284993|NCT03463577|100940084|FG001|Overall Study|With unknown pregnancy outcome|5|||
33284994|NCT03463577|100940085|FG002|Overall Study|With unknown pregnancy outcome|0|||
33284995|NCT03463577|100940086|FG003|Overall Study|With unknown pregnancy outcome|0|||
33284996|NCT03463577|100940087|FG004|Overall Study|With unknown pregnancy outcome|0|||
33284997|NCT03463577|100940088|FG005|Overall Study|With unknown pregnancy outcome|0|||
33284998|NCT03463577|100940083|FG000|Overall Study|Maternal death|2|||
33284999|NCT03463577|100940084|FG001|Overall Study|Maternal death|0|||
33285000|NCT03463577|100940085|FG002|Overall Study|Maternal death|0|||
33285001|NCT03463577|100940086|FG003|Overall Study|Maternal death|0|||
33285002|NCT03463577|100940087|FG004|Overall Study|Maternal death|0|||
33285003|NCT03463577|100940088|FG005|Overall Study|Maternal death|0|||
33285004|NCT03463577|100940083|FG000|Overall Study|Neonatal death|0|||
33285005|NCT03463577|100940084|FG001|Overall Study|Neonatal death|0|||
33285006|NCT03463577|100940085|FG002|Overall Study|Neonatal death|0|||
33285007|NCT03463577|100940086|FG003|Overall Study|Neonatal death|15|||
33285008|NCT03463577|100940087|FG004|Overall Study|Neonatal death|17|||
33285009|NCT03463577|100940088|FG005|Overall Study|Neonatal death|0|||
33285010|NCT00523549|100940091|FG000|Overall Study|Adverse Event|6|||
33285011|NCT00523549|100940092|FG001|Overall Study|Adverse Event|3|||
33285012|NCT00523549|100940091|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
33285013|NCT00523549|100940092|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
33285014|NCT00523549|100940091|FG000|Overall Study|Protocol Deviation|3|||
33285015|NCT00523549|100940092|FG001|Overall Study|Protocol Deviation|1|||
33285016|NCT00523549|100940091|FG000|Overall Study|Patient withdrew consent|7|||
33285017|NCT00523549|100940092|FG001|Overall Study|Patient withdrew consent|6|||
33285018|NCT00523549|100940091|FG000|Overall Study|Lost to Follow-up|3|||
33285019|NCT00523549|100940092|FG001|Overall Study|Lost to Follow-up|5|||
33285020|NCT02705625|100940098|FG000|Overall Study|Protocol Violation|1|||
33285021|NCT02705625|100940099|FG001|Overall Study|Protocol Violation|0|||
33285022|NCT02705625|100940100|FG002|Overall Study|Protocol Violation|0|||
33285023|NCT02705625|100940098|FG000|Overall Study|Adverse Event|6|||
33285024|NCT02705625|100940099|FG001|Overall Study|Adverse Event|5|||
33285025|NCT02705625|100940100|FG002|Overall Study|Adverse Event|2|||
33285026|NCT02705625|100940098|FG000|Overall Study|Death|0|||
33285027|NCT02705625|100940099|FG001|Overall Study|Death|0|||
33285028|NCT02705625|100940100|FG002|Overall Study|Death|1|||
33285029|NCT02705625|100940098|FG000|Overall Study|Withdrawal by Subject|1|||
33285030|NCT02705625|100940099|FG001|Overall Study|Withdrawal by Subject|4|||
33285031|NCT02705625|100940100|FG002|Overall Study|Withdrawal by Subject|5|||
33285032|NCT02705625|100940098|FG000|Overall Study|Lost to Follow-up|0|||
33285033|NCT02705625|100940099|FG001|Overall Study|Lost to Follow-up|0|||
33285034|NCT02705625|100940100|FG002|Overall Study|Lost to Follow-up|1|||
33285035|NCT02705625|100940098|FG000|Overall Study|Non-compliance|0|||
33285036|NCT02705625|100940099|FG001|Overall Study|Non-compliance|1|||
33285037|NCT02705625|100940100|FG002|Overall Study|Non-compliance|1|||
33285038|NCT02705625|100940098|FG000|Overall Study|Overdosing|0|||
33285039|NCT02705625|100940099|FG001|Overall Study|Overdosing|0|||
33285040|NCT02705625|100940100|FG002|Overall Study|Overdosing|1|||
33285041|NCT02956278|100940101|FG000|Overall Study|Withdrawal by Subject|6|||
33285042|NCT02956278|100940102|FG001|Overall Study|Withdrawal by Subject|2|||
33285043|NCT02956278|100940103|FG002|Overall Study|Withdrawal by Subject|0|||
33285044|NCT01665599|100940106|FG000|Overall Study|Adverse Event|1|||
33285045|NCT01665599|100940106|FG000|Overall Study|Consent Withdrawn|1|||
33285046|NCT01665599|100940106|FG000|Overall Study|Investigator/Sponsor decision|1|||
33285047|NCT01665599|100940106|FG000|Overall Study|Death|1|||
33285048|NCT01665599|100940106|FG000|Overall Study|Lost to Follow-up|2|||
33285049|NCT01665599|100940106|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
33285050|NCT01665599|100940106|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
33285051|NCT01084239|100940112|FG000|28-Day Follow-up|Lost to Follow-up|4|||
33285052|NCT01084239|100940113|FG001|28-Day Follow-up|Lost to Follow-up|9|||
33285053|NCT01222078|100940114|FG000|Overall Study|Early termination of the study|1|||
33285054|NCT03098797|100940115|FG000|Part 2 Open Label Extension|Adverse Event|2|||
33285055|NCT03098797|100940116|FG001|Part 2 Open Label Extension|Adverse Event|0|||
33285056|NCT04545476|100940119|FG000|Overall Study|Lost to Follow-up|1|||
33285057|NCT04545476|100940120|FG001|Overall Study|Lost to Follow-up|1|||
33285058|NCT04545476|100940121|FG002|Overall Study|Lost to Follow-up|0|||
33285059|NCT04545476|100940122|FG003|Overall Study|Lost to Follow-up|0|||
33285060|NCT01087814|100940123|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
33285061|NCT01087814|100940124|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
33285062|NCT01087814|100940123|FG000|Second Intervention (5 Days)|Physician Decision|1|||
33285063|NCT01087814|100940124|FG001|Second Intervention (5 Days)|Physician Decision|0|||
33285064|NCT00848393|100940127|FG000|Overall Study|Protocol Violation|0|||
33285065|NCT00848393|100940128|FG001|Overall Study|Protocol Violation|0|||
33285066|NCT00848393|100940129|FG002|Overall Study|Protocol Violation|1|||
33285067|NCT00848393|100940127|FG000|Overall Study|surgical complications unrelated to stud|0|||
33285068|NCT00848393|100940128|FG001|Overall Study|surgical complications unrelated to stud|0|||
33285069|NCT00848393|100940129|FG002|Overall Study|surgical complications unrelated to stud|2|||
33285070|NCT01703845|100940135|FG000|Overall Study|Adverse Event|1|||
33285071|NCT01703845|100940136|FG001|Overall Study|Adverse Event|0|||
33285072|NCT01703845|100940135|FG000|Overall Study|Protocol Violation|1|||
33285073|NCT01703845|100940136|FG001|Overall Study|Protocol Violation|0|||
33285074|NCT01703845|100940135|FG000|Overall Study|other than stated above|1|||
33285075|NCT01703845|100940136|FG001|Overall Study|other than stated above|0|||
33285076|NCT02165397|100940137|FG000|Overall Study|Death|7|||
33285077|NCT02165397|100940138|FG001|Overall Study|Death|10|||
33285078|NCT02165397|100940139|FG002|Overall Study|Death|8|||
33285079|NCT02165397|100940137|FG000|Overall Study|Lost to Follow-up|1|||
33285080|NCT02165397|100940138|FG001|Overall Study|Lost to Follow-up|3|||
33285081|NCT02165397|100940139|FG002|Overall Study|Lost to Follow-up|0|||
33285082|NCT02165397|100940137|FG000|Overall Study|Withdrawal by Subject|6|||
33285083|NCT02165397|100940138|FG001|Overall Study|Withdrawal by Subject|6|||
33285084|NCT02165397|100940139|FG002|Overall Study|Withdrawal by Subject|1|||
33285085|NCT02165397|100940137|FG000|Overall Study|Other, Not Specified|0|||
33285086|NCT02165397|100940138|FG001|Overall Study|Other, Not Specified|0|||
33285087|NCT02165397|100940139|FG002|Overall Study|Other, Not Specified|1|||
33285088|NCT02971228|100940143|FG000|Overall Study|Withdrawal by Subject|1|||
33285089|NCT02971228|100940144|FG001|Overall Study|Withdrawal by Subject|1|||
33285090|NCT02971228|100940145|FG002|Overall Study|Withdrawal by Subject|0|||
33285091|NCT02971228|100940146|FG003|Overall Study|Withdrawal by Subject|0|||
33285092|NCT02971228|100940147|FG004|Overall Study|Withdrawal by Subject|0|||
33285093|NCT02971228|100940143|FG000|Overall Study|Logistical challenges|0|||
33285094|NCT02971228|100940144|FG001|Overall Study|Logistical challenges|1|||
33285095|NCT02971228|100940145|FG002|Overall Study|Logistical challenges|0|||
33285096|NCT02971228|100940146|FG003|Overall Study|Logistical challenges|0|||
33285097|NCT02971228|100940147|FG004|Overall Study|Logistical challenges|0|||
33285098|NCT00691678|100940148|FG000|Overall Study|Adverse Event|5|||
33285099|NCT00691678|100940148|FG000|Overall Study|life events, pain|11|||
33285100|NCT03449134|100940149|FG000|52-Week Treatment Period|Death|2|||
33285101|NCT03449134|100940150|FG001|52-Week Treatment Period|Death|1|||
33285102|NCT03449134|100940151|FG002|52-Week Treatment Period|Death|0|||
33285103|NCT03449134|100940149|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
33285104|NCT03449134|100940150|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
33285105|NCT03449134|100940151|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
33285106|NCT03449134|100940149|FG000|52-Week Treatment Period|Physician Decision|2|||
33285107|NCT03449134|100940150|FG001|52-Week Treatment Period|Physician Decision|3|||
33285108|NCT03449134|100940151|FG002|52-Week Treatment Period|Physician Decision|3|||
33285109|NCT03449134|100940149|FG000|52-Week Treatment Period|Screen Failure|1|||
33285110|NCT03449134|100940150|FG001|52-Week Treatment Period|Screen Failure|0|||
33285111|NCT03449134|100940151|FG002|52-Week Treatment Period|Screen Failure|1|||
33285112|NCT03449134|100940149|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
33285113|NCT03449134|100940150|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
33285114|NCT03449134|100940151|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
33285115|NCT03449134|100940149|FG000|52-Week Treatment Period|Site Closure|1|||
33285116|NCT03449134|100940150|FG001|52-Week Treatment Period|Site Closure|0|||
33285117|NCT03449134|100940151|FG002|52-Week Treatment Period|Site Closure|0|||
33285118|NCT01037413|100940152|FG000|Part A: Skin Testing|Adverse Event|1|||
33285119|NCT01037413|100940153|FG001|Part A: Skin Testing|Adverse Event|0|||
33285120|NCT01037413|100940152|FG000|Part A: Skin Testing|Protocol Violation|1|||
33285121|NCT01037413|100940153|FG001|Part A: Skin Testing|Protocol Violation|0|||
33285122|NCT01037413|100940152|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
33285123|NCT01037413|100940153|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
33285124|NCT01037413|100940152|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
33285125|NCT01037413|100940153|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
33285126|NCT00275301|100940154|FG000|Overall Study|Adverse Event|5|||
33285127|NCT00619983|100940155|FG000|Test Drug Alone|Withdrawal by Subject|1|||
33285128|NCT00619983|100940156|FG001|Test Drug Alone|Withdrawal by Subject|0|||
33285129|NCT00619983|100940157|FG002|Test Drug Alone|Withdrawal by Subject|0|||
33285130|NCT00619983|100940158|FG003|Test Drug Alone|Withdrawal by Subject|1|||
33285131|NCT00619983|100940155|FG000|Test Drug Alone|Failure of daily diary device|1|||
33285132|NCT00619983|100940156|FG001|Test Drug Alone|Failure of daily diary device|1|||
33285133|NCT00619983|100940157|FG002|Test Drug Alone|Failure of daily diary device|2|||
33285134|NCT00619983|100940158|FG003|Test Drug Alone|Failure of daily diary device|2|||
33285135|NCT02633397|100940164|FG000|Overall Study|Adverse Event|8|||
33285136|NCT02633397|100940165|FG001|Overall Study|Adverse Event|8|||
33285137|NCT02633397|100940164|FG000|Overall Study|Study Burden|4|||
33285138|NCT02633397|100940165|FG001|Overall Study|Study Burden|1|||
33285139|NCT02633397|100940164|FG000|Overall Study|Treatment interruption|2|||
33285140|NCT02633397|100940165|FG001|Overall Study|Treatment interruption|5|||
33285141|NCT02633397|100940164|FG000|Overall Study|Death|2|||
33285142|NCT02633397|100940165|FG001|Overall Study|Death|2|||
33285143|NCT02633397|100940164|FG000|Overall Study|Physician Decision|0|||
33285144|NCT02633397|100940165|FG001|Overall Study|Physician Decision|1|||
33285145|NCT01891890|100940166|FG000|Overall Study|Lost to Follow-up|0|||
33285146|NCT01891890|100940167|FG001|Overall Study|Lost to Follow-up|0|||
33285147|NCT01891890|100940168|FG002|Overall Study|Lost to Follow-up|1|||
33285148|NCT01891890|100940166|FG000|Overall Study|Study ended before endpoint reached|7|||
33285149|NCT01891890|100940167|FG001|Overall Study|Study ended before endpoint reached|3|||
33285150|NCT01891890|100940168|FG002|Overall Study|Study ended before endpoint reached|6|||
33285151|NCT04124471|100940169|FG000|Overall Study|screen failure|1|||
33285152|NCT00143598|100940172|FG000|Overall Study|Lost to Follow-up|23|||
33285153|NCT00143598|100940173|FG001|Overall Study|Lost to Follow-up|21|||
33285154|NCT00143598|100940172|FG000|Overall Study|Withdrawal by Subject|33|||
33285155|NCT00143598|100940173|FG001|Overall Study|Withdrawal by Subject|37|||
33285156|NCT00143598|100940172|FG000|Overall Study|Death|36|||
33285157|NCT00143598|100940173|FG001|Overall Study|Death|36|||
33285158|NCT00487552|100940175|FG000|Overall Study|Unsuccessful magnet placements|3|||
33285159|NCT00487552|100940175|FG000|Overall Study|Death due to progressive malignancy|2|||
33285160|NCT00487552|100940175|FG000|Overall Study|Stent not placed|1|||
33285161|NCT00460564|100940176|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
33285162|NCT00460564|100940177|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
33285163|NCT00460564|100940178|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33285164|NCT00460564|100940179|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33285165|NCT00460564|100940180|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33285166|NCT00460564|100940181|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33285167|NCT00460564|100940182|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33285168|NCT00460564|100940183|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
33285169|NCT00460564|100940176|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
33285170|NCT00460564|100940177|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33285171|NCT00460564|100940178|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33285172|NCT00460564|100940179|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33285173|NCT00460564|100940180|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33285174|NCT00460564|100940181|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33285175|NCT00460564|100940182|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33285176|NCT00460564|100940183|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
33285177|NCT00460564|100940176|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
33285178|NCT00460564|100940177|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
33285179|NCT00460564|100940178|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
33285180|NCT00460564|100940179|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
33285181|NCT00460564|100940180|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
33285182|NCT00460564|100940181|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
33285183|NCT00460564|100940182|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
33285184|NCT00460564|100940183|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
33285185|NCT00460564|100940176|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33285186|NCT00460564|100940177|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33285187|NCT00460564|100940178|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33285188|NCT00460564|100940179|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33285189|NCT00460564|100940180|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
33285190|NCT00460564|100940181|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
33285191|NCT00460564|100940182|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33285192|NCT00460564|100940183|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
33285193|NCT00460564|100940176|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
33285194|NCT00460564|100940177|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
33285195|NCT00460564|100940178|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
33285196|NCT00460564|100940179|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
33285197|NCT00460564|100940180|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
33285198|NCT00460564|100940181|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
33285199|NCT00460564|100940182|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
33285200|NCT00460564|100940183|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
33285201|NCT02257918|100940184|FG000|Overall Study|Lost to Follow-up|4|||
33285202|NCT02257918|100940185|FG001|Overall Study|Lost to Follow-up|1|||
33285203|NCT02257918|100940186|FG002|Overall Study|Lost to Follow-up|0|||
33285204|NCT02257918|100940184|FG000|Overall Study|Withdrawal by Subject|0|||
33285205|NCT02257918|100940185|FG001|Overall Study|Withdrawal by Subject|0|||
33285206|NCT02257918|100940186|FG002|Overall Study|Withdrawal by Subject|1|||
33285207|NCT02257918|100940184|FG000|Overall Study|Pregnancy|0|||
33285208|NCT02257918|100940185|FG001|Overall Study|Pregnancy|0|||
33285209|NCT02257918|100940186|FG002|Overall Study|Pregnancy|1|||
33285210|NCT01845649|100940187|FG000|Overall Study|Adverse Event|7|||
33285211|NCT01845649|100940188|FG001|Overall Study|Adverse Event|10|||
33285212|NCT01845649|100940187|FG000|Overall Study|Lack of Efficacy|1|||
33285213|NCT01845649|100940188|FG001|Overall Study|Lack of Efficacy|1|||
33285214|NCT01845649|100940187|FG000|Overall Study|Lost to Follow-up|2|||
33285215|NCT01845649|100940188|FG001|Overall Study|Lost to Follow-up|2|||
33285216|NCT01845649|100940187|FG000|Overall Study|Withdrew Consent|12|||
33285217|NCT01845649|100940188|FG001|Overall Study|Withdrew Consent|4|||
33285218|NCT01845649|100940187|FG000|Overall Study|Protocol Deviation|7|||
33285219|NCT01845649|100940188|FG001|Overall Study|Protocol Deviation|4|||
33285220|NCT01845649|100940187|FG000|Overall Study|Reason not Specified|2|||
33285221|NCT01845649|100940188|FG001|Overall Study|Reason not Specified|1|||
33285222|NCT00264498|100940196|FG000|Randomized Treatment|Death|0|||
33285223|NCT00264498|100940197|FG001|Randomized Treatment|Death|3|||
33285224|NCT00264498|100940196|FG000|Randomized Treatment|Withdrawal by Subject|0|||
33285225|NCT00264498|100940197|FG001|Randomized Treatment|Withdrawal by Subject|1|||
33285226|NCT00264498|100940196|FG000|Randomized Treatment|Objective disease Progression|13|||
33285227|NCT00264498|100940197|FG001|Randomized Treatment|Objective disease Progression|14|||
33285228|NCT00264498|100940196|FG000|Randomized Treatment|Physician Decision|1|||
33285229|NCT00264498|100940197|FG001|Randomized Treatment|Physician Decision|0|||
33285230|NCT00264498|100940196|FG000|Randomized Treatment|Incorrectly randomized|1|||
33285231|NCT00264498|100940197|FG001|Randomized Treatment|Incorrectly randomized|0|||
33285232|NCT00264498|100940196|FG000|Randomized Treatment|Study Closure|1|||
33285233|NCT00264498|100940197|FG001|Randomized Treatment|Study Closure|0|||
33285234|NCT00264498|100940196|FG000|Randomized Treatment|Protocol Violation|1|||
33285235|NCT00264498|100940197|FG001|Randomized Treatment|Protocol Violation|0|||
33285236|NCT00264498|100940196|FG000|Crossover Treatment|Death|1|||
33285237|NCT00264498|100940197|FG001|Crossover Treatment|Death|3|||
33285238|NCT00264498|100940196|FG000|Crossover Treatment|Objective disease progression|4|||
33285239|NCT00264498|100940197|FG001|Crossover Treatment|Objective disease progression|5|||
33285240|NCT00264498|100940196|FG000|Crossover Treatment|Study closure|0|||
33285241|NCT00264498|100940197|FG001|Crossover Treatment|Study closure|1|||
33285242|NCT00264498|100940196|FG000|Crossover Treatment|Withdrawal by Subject|1|||
33285243|NCT00264498|100940197|FG001|Crossover Treatment|Withdrawal by Subject|0|||
33285244|NCT01797562|100940198|FG000|Overall Study|Protocol Violation|5|||
33285245|NCT02381652|100940201|FG000|Overall Study|Withdrawal by Subject|0|||
33285246|NCT02381652|100940202|FG001|Overall Study|Withdrawal by Subject|0|||
33285247|NCT02381652|100940203|FG002|Overall Study|Withdrawal by Subject|1|||
33285248|NCT00874497|100940209|FG000|Overall Study|Lost to Follow-up|2|||
33285249|NCT00874497|100940210|FG001|Overall Study|Lost to Follow-up|4|||
33285250|NCT00874497|100940209|FG000|Overall Study|Adverse Event|9|||
33285251|NCT00874497|100940210|FG001|Overall Study|Adverse Event|4|||
33285252|NCT00874497|100940209|FG000|Overall Study|Sponsor Discontinued Trial|7|||
33285253|NCT00874497|100940210|FG001|Overall Study|Sponsor Discontinued Trial|3|||
33285254|NCT00874497|100940209|FG000|Overall Study|Met Withdrawal Criteria|4|||
33285255|NCT00874497|100940210|FG001|Overall Study|Met Withdrawal Criteria|2|||
33285256|NCT00874497|100940209|FG000|Overall Study|Physician Decision|1|||
33285257|NCT00874497|100940210|FG001|Overall Study|Physician Decision|1|||
33285258|NCT00874497|100940209|FG000|Overall Study|Withdrawal by Subject|5|||
33285259|NCT00874497|100940210|FG001|Overall Study|Withdrawal by Subject|4|||
33285260|NCT00957996|100940211|FG000|Overall Study|Death|4|||
33285261|NCT00957996|100940212|FG001|Overall Study|Death|10|||
33285262|NCT00957996|100940211|FG000|Overall Study|Lost to Follow-up|4|||
33285263|NCT00957996|100940212|FG001|Overall Study|Lost to Follow-up|7|||
33285264|NCT00957996|100940211|FG000|Overall Study|Withdrawal by Subject|9|||
33285265|NCT00957996|100940212|FG001|Overall Study|Withdrawal by Subject|2|||
33285266|NCT00957996|100940211|FG000|Overall Study|Adverse Event|2|||
33285267|NCT00957996|100940212|FG001|Overall Study|Adverse Event|1|||
33285268|NCT00957996|100940211|FG000|Overall Study|Physician Decision|1|||
33285269|NCT00957996|100940212|FG001|Overall Study|Physician Decision|1|||
33285270|NCT00957996|100940211|FG000|Overall Study|Influenza-related complication|0|||
33285271|NCT00957996|100940212|FG001|Overall Study|Influenza-related complication|1|||
33285272|NCT00957996|100940211|FG000|Overall Study|Missing|1|||
33285273|NCT00957996|100940212|FG001|Overall Study|Missing|0|||
33285274|NCT00957996|100940211|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
33285275|NCT00957996|100940212|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
33285276|NCT03269695|100940223|FG000|Overall Study|Adverse Event|2|||
33285277|NCT03269695|100940224|FG001|Overall Study|Adverse Event|1|||
33285278|NCT03269695|100940223|FG000|Overall Study|Lack of Efficacy|0|||
33285279|NCT03269695|100940224|FG001|Overall Study|Lack of Efficacy|1|||
33285280|NCT03269695|100940223|FG000|Overall Study|Withdrawal by Subject|0|||
33285281|NCT03269695|100940224|FG001|Overall Study|Withdrawal by Subject|1|||
33285282|NCT01589523|100940225|FG000|Overall Study|Withdrawal by Subject|1|||
33285283|NCT00792259|100940226|FG000|Overall Study|Poor Quality Scans|1|||
33285284|NCT00792259|100940227|FG001|Overall Study|Poor Quality Scans|0|||
33285285|NCT00792259|100940228|FG002|Overall Study|Poor Quality Scans|0|||
33285286|NCT03730662|100940229|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
33285287|NCT03730662|100940230|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
33285288|NCT03730662|100940231|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
33285289|NCT03730662|100940232|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
33285290|NCT03730662|100940229|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
33285291|NCT03730662|100940230|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
33285292|NCT03730662|100940231|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
33285293|NCT03730662|100940232|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
33285294|NCT03730662|100940229|FG000|Treatment Period (52 Weeks)|Death|6|||
33285295|NCT03730662|100940230|FG001|Treatment Period (52 Weeks)|Death|2|||
33285296|NCT03730662|100940231|FG002|Treatment Period (52 Weeks)|Death|2|||
33285297|NCT03730662|100940232|FG003|Treatment Period (52 Weeks)|Death|9|||
33285298|NCT03730662|100940229|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
33285299|NCT03730662|100940230|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
33285300|NCT03730662|100940231|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
33285301|NCT03730662|100940232|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
33285302|NCT03730662|100940229|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
33285303|NCT03730662|100940230|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
33285304|NCT03730662|100940231|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
33285305|NCT03730662|100940232|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
33285306|NCT03730662|100940229|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
33285307|NCT03730662|100940230|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
33285308|NCT03730662|100940231|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
33285309|NCT03730662|100940232|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
33285310|NCT03730662|100940229|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
33285311|NCT03730662|100940230|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
33285312|NCT03730662|100940231|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
33285313|NCT03730662|100940232|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
33285314|NCT03730662|100940229|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
33285315|NCT03730662|100940230|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
33285316|NCT03730662|100940231|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
33285317|NCT03730662|100940232|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
33285318|NCT03730662|100940229|FG000|Variable Treatment Period|Adverse Event|1|||
33285319|NCT03730662|100940230|FG001|Variable Treatment Period|Adverse Event|2|||
33285320|NCT03730662|100940231|FG002|Variable Treatment Period|Adverse Event|0|||
33285321|NCT03730662|100940232|FG003|Variable Treatment Period|Adverse Event|7|||
33285322|NCT03730662|100940229|FG000|Variable Treatment Period|Death|9|||
33285323|NCT03730662|100940230|FG001|Variable Treatment Period|Death|0|||
33285324|NCT03730662|100940231|FG002|Variable Treatment Period|Death|6|||
33285325|NCT03730662|100940232|FG003|Variable Treatment Period|Death|26|||
33285326|NCT03730662|100940229|FG000|Variable Treatment Period|Lost to Follow-up|2|||
33285327|NCT03730662|100940230|FG001|Variable Treatment Period|Lost to Follow-up|1|||
33285328|NCT03730662|100940231|FG002|Variable Treatment Period|Lost to Follow-up|4|||
33285329|NCT03730662|100940232|FG003|Variable Treatment Period|Lost to Follow-up|11|||
33285330|NCT03730662|100940229|FG000|Variable Treatment Period|Personal Reason|0|||
33285331|NCT03730662|100940230|FG001|Variable Treatment Period|Personal Reason|2|||
33285332|NCT03730662|100940231|FG002|Variable Treatment Period|Personal Reason|1|||
33285333|NCT03730662|100940232|FG003|Variable Treatment Period|Personal Reason|6|||
33285334|NCT03730662|100940229|FG000|Variable Treatment Period|Physician Decision|0|||
33285335|NCT03730662|100940230|FG001|Variable Treatment Period|Physician Decision|0|||
33285336|NCT03730662|100940231|FG002|Variable Treatment Period|Physician Decision|0|||
33285337|NCT03730662|100940232|FG003|Variable Treatment Period|Physician Decision|3|||
33285338|NCT03730662|100940229|FG000|Variable Treatment Period|Protocol Violation|0|||
33285339|NCT03730662|100940230|FG001|Variable Treatment Period|Protocol Violation|1|||
33285340|NCT03730662|100940231|FG002|Variable Treatment Period|Protocol Violation|1|||
33285341|NCT03730662|100940232|FG003|Variable Treatment Period|Protocol Violation|1|||
33285342|NCT03730662|100940229|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
33285343|NCT03730662|100940230|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
33285344|NCT03730662|100940231|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
33285345|NCT03730662|100940232|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
33285346|NCT00730847|100940233|FG000|Overall Study|Adverse Event|1|||
33285347|NCT00730847|100940233|FG000|Overall Study|Protocol Violation|2|||
33285348|NCT00730847|100940233|FG000|Overall Study|Withdrawal by Subject|16|||
33285349|NCT00730847|100940233|FG000|Overall Study|Lost to Follow-up|67|||
33285350|NCT00730847|100940233|FG000|Overall Study|Unknown completion status|21|||
33285351|NCT00730847|100940233|FG000|Overall Study|Other|24|||
33285352|NCT01066936|100940234|FG000|Overall Study|Death|2|||
33285353|NCT01066936|100940234|FG000|Overall Study|Device revised/removed|1|||
33285354|NCT01066936|100940234|FG000|Overall Study|Lost to Follow-up|3|||
33285355|NCT01066936|100940234|FG000|Overall Study|Withdrawal by Subject|4|||
33285356|NCT02624869|100940246|FG000|Overall Study|Lost to Follow-up|0|||
33285357|NCT02624869|100940247|FG001|Overall Study|Lost to Follow-up|0|||
33285358|NCT02624869|100940248|FG002|Overall Study|Lost to Follow-up|1|||
33285359|NCT02624869|100940246|FG000|Overall Study|Withdrawal by Subject|1|||
33285360|NCT02624869|100940247|FG001|Overall Study|Withdrawal by Subject|3|||
33285361|NCT02624869|100940248|FG002|Overall Study|Withdrawal by Subject|1|||
33285362|NCT00935259|100943690|FG000|Period 1|Administrative (scheduling conflict)|1|||
33285363|NCT00935259|100943691|FG001|Period 1|Administrative (scheduling conflict)|1|||
33285364|NCT00721214|100943692|FG000|Overall Study|Chose another center for transplant|1|||
33285365|NCT00721214|100943692|FG000|Overall Study|Death|3|||
33285366|NCT02507687|100943708|FG000|Overall Study|Adverse Event|3|||
33285367|NCT02507687|100943709|FG001|Overall Study|Adverse Event|2|||
33285368|NCT02507687|100943710|FG002|Overall Study|Adverse Event|2|||
33285369|NCT02507687|100943711|FG003|Overall Study|Adverse Event|2|||
33285370|NCT02507687|100943708|FG000|Overall Study|Withdrawal by Subject|1|||
33285371|NCT02507687|100943709|FG001|Overall Study|Withdrawal by Subject|4|||
33285372|NCT02507687|100943710|FG002|Overall Study|Withdrawal by Subject|6|||
33285373|NCT02507687|100943711|FG003|Overall Study|Withdrawal by Subject|6|||
33285374|NCT02507687|100943708|FG000|Overall Study|Protocol Violation|1|||
33285375|NCT02507687|100943709|FG001|Overall Study|Protocol Violation|0|||
33285376|NCT02507687|100943710|FG002|Overall Study|Protocol Violation|2|||
33285377|NCT02507687|100943711|FG003|Overall Study|Protocol Violation|0|||
33285378|NCT02507687|100943708|FG000|Overall Study|Lost to Follow-up|0|||
33285379|NCT02507687|100943709|FG001|Overall Study|Lost to Follow-up|0|||
33285380|NCT02507687|100943710|FG002|Overall Study|Lost to Follow-up|2|||
33285381|NCT02507687|100943711|FG003|Overall Study|Lost to Follow-up|1|||
33285382|NCT02507687|100943708|FG000|Overall Study|Screen Failure|0|||
33285383|NCT02507687|100943709|FG001|Overall Study|Screen Failure|0|||
33285384|NCT02507687|100943710|FG002|Overall Study|Screen Failure|1|||
33285385|NCT02507687|100943711|FG003|Overall Study|Screen Failure|0|||
33285386|NCT02507687|100943708|FG000|Overall Study|Other, Not Specified|0|||
33285387|NCT02507687|100943709|FG001|Overall Study|Other, Not Specified|0|||
33285388|NCT02507687|100943710|FG002|Overall Study|Other, Not Specified|2|||
33285389|NCT02507687|100943711|FG003|Overall Study|Other, Not Specified|4|||
33285390|NCT00195442|100943712|FG000|Overall Study|Less than expected therapeutic effect|38|||
33285391|NCT00195442|100943712|FG000|Overall Study|Lost to Follow-up|27|||
33285392|NCT00195442|100943712|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
33285393|NCT00195442|100943712|FG000|Overall Study|Intermittent product shortage|21|||
33285394|NCT00195442|100943712|FG000|Overall Study|Death|7|||
33285395|NCT00195442|100943712|FG000|Overall Study|No reason specified|4|||
33285396|NCT00195442|100943712|FG000|Overall Study|Poor cooperation|2|||
33285397|NCT00195442|100943712|FG000|Overall Study|Other|14|||
33285398|NCT00576823|100943713|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
33285399|NCT00576823|100943714|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
33285400|NCT00576823|100943715|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
33285401|NCT00576823|100943713|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
33285402|NCT00576823|100943714|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
33285403|NCT00576823|100943715|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
33285404|NCT03544229|100943718|FG000|Overall Study|Adverse Event|1|||
33285405|NCT03544229|100943719|FG001|Overall Study|Adverse Event|0|||
33285406|NCT03544229|100943720|FG002|Overall Study|Adverse Event|1|||
33285407|NCT03544229|100943721|FG003|Overall Study|Adverse Event|0|||
33285408|NCT03544229|100943718|FG000|Overall Study|Protocol Deviation|0|||
33285409|NCT03544229|100943719|FG001|Overall Study|Protocol Deviation|0|||
33285410|NCT03544229|100943720|FG002|Overall Study|Protocol Deviation|1|||
33285411|NCT03544229|100943721|FG003|Overall Study|Protocol Deviation|0|||
33285412|NCT03544229|100943718|FG000|Overall Study|Lost to Follow-up|3|||
33285413|NCT03544229|100943719|FG001|Overall Study|Lost to Follow-up|0|||
33285414|NCT03544229|100943720|FG002|Overall Study|Lost to Follow-up|0|||
33285415|NCT03544229|100943721|FG003|Overall Study|Lost to Follow-up|2|||
33285416|NCT03544229|100943718|FG000|Overall Study|Voluntary Withdrawal|2|||
33285417|NCT03544229|100943719|FG001|Overall Study|Voluntary Withdrawal|1|||
33285418|NCT03544229|100943720|FG002|Overall Study|Voluntary Withdrawal|3|||
33285419|NCT03544229|100943721|FG003|Overall Study|Voluntary Withdrawal|0|||
33285420|NCT03544229|100943718|FG000|Overall Study|Lack of Efficacy|0|||
33285421|NCT03544229|100943719|FG001|Overall Study|Lack of Efficacy|1|||
33285422|NCT03544229|100943720|FG002|Overall Study|Lack of Efficacy|0|||
33285423|NCT03544229|100943721|FG003|Overall Study|Lack of Efficacy|0|||
33285424|NCT01530087|100943724|FG000|Overall Study|Physician Decision|2|||
33285425|NCT04680637|100943728|FG000|Overall Study|Lost to Follow-up|0|||
33285426|NCT04680637|100943729|FG001|Overall Study|Lost to Follow-up|1|||
33285427|NCT04680637|100943730|FG002|Overall Study|Lost to Follow-up|0|||
33285428|NCT04680637|100943731|FG003|Overall Study|Lost to Follow-up|1|||
33285429|NCT04680637|100943728|FG000|Overall Study|Death|1|||
33285430|NCT04680637|100943729|FG001|Overall Study|Death|0|||
33285431|NCT04680637|100943730|FG002|Overall Study|Death|0|||
33285432|NCT04680637|100943731|FG003|Overall Study|Death|0|||
33285433|NCT04680637|100943728|FG000|Overall Study|Withdrawal by Subject|7|||
33285434|NCT04680637|100943729|FG001|Overall Study|Withdrawal by Subject|10|||
33285435|NCT04680637|100943730|FG002|Overall Study|Withdrawal by Subject|17|||
33285436|NCT04680637|100943731|FG003|Overall Study|Withdrawal by Subject|15|||
33285437|NCT04680637|100943728|FG000|Overall Study|Decision by Sponsor|21|||
33285438|NCT04680637|100943729|FG001|Overall Study|Decision by Sponsor|15|||
33285439|NCT04680637|100943730|FG002|Overall Study|Decision by Sponsor|7|||
33285440|NCT04680637|100943731|FG003|Overall Study|Decision by Sponsor|32|||
33285441|NCT01379703|100943745|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
33285442|NCT01379703|100943746|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
33285443|NCT01379703|100943747|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
33285444|NCT01379703|100943745|FG000|Study Start Through 9 Months|Adverse Event|0|||
33285445|NCT01379703|100943746|FG001|Study Start Through 9 Months|Adverse Event|14|||
33285446|NCT01379703|100943747|FG002|Study Start Through 9 Months|Adverse Event|10|||
33285447|NCT01379703|100943745|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
33285448|NCT01379703|100943746|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
33285449|NCT01379703|100943747|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
33285450|NCT01379703|100943745|FG000|Study Start Through 9 Months|Treatment Failure|0|||
33285451|NCT01379703|100943746|FG001|Study Start Through 9 Months|Treatment Failure|2|||
33285452|NCT01379703|100943747|FG002|Study Start Through 9 Months|Treatment Failure|2|||
33285453|NCT01379703|100943745|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
33285454|NCT01379703|100943746|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
33285455|NCT01379703|100943747|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
33285456|NCT01379703|100943745|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
33285457|NCT01379703|100943746|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
33285458|NCT01379703|100943747|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
33285459|NCT01379703|100943745|FG000|Study Start Through 9 Months|Medication not available|0|||
33285460|NCT01379703|100943746|FG001|Study Start Through 9 Months|Medication not available|2|||
33285461|NCT01379703|100943747|FG002|Study Start Through 9 Months|Medication not available|1|||
33285462|NCT01379703|100943745|FG000|Study Start Through 9 Months|Poor general condition|0|||
33285463|NCT01379703|100943746|FG001|Study Start Through 9 Months|Poor general condition|1|||
33285464|NCT01379703|100943747|FG002|Study Start Through 9 Months|Poor general condition|0|||
33285465|NCT01379703|100943745|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
33285466|NCT01379703|100943746|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
33285467|NCT01379703|100943747|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
33285468|NCT01379703|100943745|FG000|Study Start Through 9 Months|Reason unknown|2|||
33285469|NCT01379703|100943746|FG001|Study Start Through 9 Months|Reason unknown|31|||
33489451|NCT03536884|101683339|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
33489452|NCT03536884|101683340|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
33489453|NCT03536884|101683341|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
33489454|NCT03536884|101683342|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
33489455|NCT03536884|101683343|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
33489456|NCT03536884|101683344|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
33489457|NCT03536884|101683345|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
33489458|NCT03536884|101683334|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33489459|NCT03536884|101683335|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33489460|NCT03536884|101683336|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33489461|NCT03536884|101683337|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33489462|NCT03536884|101683338|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33489463|NCT03536884|101683339|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33489464|NCT03536884|101683340|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33489465|NCT03536884|101683341|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33489466|NCT03536884|101683342|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
33489467|NCT03536884|101683343|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
33489468|NCT03536884|101683344|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
33489469|NCT03536884|101683345|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
33489470|NCT03536884|101683334|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33489471|NCT03536884|101683335|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33489472|NCT03536884|101683336|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33489473|NCT03536884|101683337|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33489474|NCT03536884|101683338|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33489475|NCT03536884|101683339|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33489476|NCT03536884|101683340|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33489477|NCT03536884|101683341|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33489478|NCT03536884|101683342|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
33489479|NCT03536884|101683343|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
33489480|NCT03536884|101683344|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
33489481|NCT03536884|101683345|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
33489482|NCT03536884|101683334|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
33489483|NCT03536884|101683335|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
33489484|NCT03536884|101683336|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
33489485|NCT03536884|101683337|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
33489486|NCT03536884|101683338|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
33489487|NCT03536884|101683339|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
33489488|NCT03536884|101683340|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
33489489|NCT03536884|101683341|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
33489490|NCT03536884|101683342|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
33489491|NCT03536884|101683343|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
33489492|NCT03536884|101683344|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
33489493|NCT03536884|101683345|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
33489494|NCT03536884|101683334|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
33489495|NCT03536884|101683335|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
33489496|NCT03536884|101683336|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
33489497|NCT03536884|101683337|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
33489498|NCT03536884|101683338|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
33489499|NCT03536884|101683339|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
33489500|NCT03536884|101683340|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
33489501|NCT03536884|101683341|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
33489502|NCT03536884|101683342|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
33489503|NCT03536884|101683343|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
33489504|NCT03536884|101683344|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
33489505|NCT03536884|101683345|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
33489506|NCT03536884|101683334|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
33489507|NCT03536884|101683335|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
33489508|NCT03536884|101683336|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
33489509|NCT03536884|101683337|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
33489510|NCT03536884|101683338|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
33489511|NCT03536884|101683339|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
33489512|NCT03536884|101683340|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
33489513|NCT03536884|101683341|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
33489514|NCT03536884|101683342|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
33489515|NCT03536884|101683343|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
33489516|NCT03536884|101683344|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
33489517|NCT03536884|101683345|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
33489518|NCT02925403|101683350|FG000|Overall Study|Lost to Follow-up|0|||
33489519|NCT02925403|101683351|FG001|Overall Study|Lost to Follow-up|1|||
33489520|NCT00307086|101686719|FG000|Overall Study|ineligible|5|||
33489521|NCT02501928|101686723|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
33489522|NCT02501928|101686724|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
33489523|NCT02501928|101686725|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
33489524|NCT02501928|101686726|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
33489525|NCT02501928|101686727|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
33489526|NCT02501928|101686728|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
33489527|NCT03296527|101686731|FG000|Overall Study|Adverse Event|15|||
33489528|NCT03296527|101686732|FG001|Overall Study|Adverse Event|33|||
33489529|NCT03296527|101686731|FG000|Overall Study|Protocol Deviation|4|||
33489530|NCT03296527|101686732|FG001|Overall Study|Protocol Deviation|0|||
33489531|NCT03296527|101686731|FG000|Overall Study|Participant withdrew consent|3|||
33489532|NCT03296527|101686732|FG001|Overall Study|Participant withdrew consent|1|||
33489533|NCT03296527|101686731|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
33489534|NCT03296527|101686732|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
33489535|NCT03296527|101686731|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
33489536|NCT03296527|101686732|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
33489537|NCT03296527|101686731|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
33489538|NCT03296527|101686732|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
33489539|NCT03296527|101686731|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
33489540|NCT03296527|101686732|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
33489541|NCT03296527|101686731|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
33489542|NCT03296527|101686732|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
33489543|NCT03971474|101686733|FG000|Overall Study|Adverse Event|11|||
33489544|NCT03971474|101686734|FG001|Overall Study|Adverse Event|7|||
33489545|NCT03971474|101686733|FG000|Overall Study|Refusal unrelated to adverse event|5|||
33489546|NCT03971474|101686734|FG001|Overall Study|Refusal unrelated to adverse event|1|||
33489547|NCT03971474|101686733|FG000|Overall Study|Progression/relapse|40|||
33489548|NCT03971474|101686734|FG001|Overall Study|Progression/relapse|47|||
33489549|NCT03971474|101686733|FG000|Overall Study|Death|6|||
33489550|NCT03971474|101686734|FG001|Overall Study|Death|3|||
33489551|NCT03971474|101686733|FG000|Overall Study|Other - not protocol specified|5|||
33489552|NCT03971474|101686734|FG001|Overall Study|Other - not protocol specified|4|||
33489553|NCT03971474|101686733|FG000|Overall Study|On treatment|0|||
33489554|NCT03971474|101686734|FG001|Overall Study|On treatment|7|||
33489555|NCT01937871|101686738|FG000|Overall Study|Adverse Event|6|||
33489556|NCT01937871|101686739|FG001|Overall Study|Adverse Event|6|||
33489557|NCT01937871|101686740|FG002|Overall Study|Adverse Event|2|||
33489558|NCT01937871|101686738|FG000|Overall Study|Lost to Follow-up|8|||
33489559|NCT01937871|101686739|FG001|Overall Study|Lost to Follow-up|2|||
33489560|NCT01937871|101686740|FG002|Overall Study|Lost to Follow-up|4|||
33489561|NCT01937871|101686738|FG000|Overall Study|Withdrawal by Subject|9|||
33489562|NCT01937871|101686739|FG001|Overall Study|Withdrawal by Subject|6|||
33489563|NCT01937871|101686740|FG002|Overall Study|Withdrawal by Subject|4|||
33489564|NCT01937871|101686738|FG000|Overall Study|Physician Decision|0|||
33489565|NCT01937871|101686739|FG001|Overall Study|Physician Decision|1|||
33489566|NCT01937871|101686740|FG002|Overall Study|Physician Decision|0|||
33489567|NCT01937871|101686738|FG000|Overall Study|Entry Criteria Not Met|1|||
33489568|NCT01937871|101686739|FG001|Overall Study|Entry Criteria Not Met|2|||
33489569|NCT01937871|101686740|FG002|Overall Study|Entry Criteria Not Met|1|||
33489570|NCT00247676|101686744|FG000|Overall Study|Death|5|||
33489571|NCT00247676|101686744|FG000|Overall Study|Adverse Event|11|||
33489572|NCT00247676|101686744|FG000|Overall Study|Lack of Efficacy|15|||
33489573|NCT00247676|101686744|FG000|Overall Study|Other|3|||
33489574|NCT00247676|101686744|FG000|Overall Study|Withdrawal by Subject|2|||
33489575|NCT00261443|101686748|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
33489576|NCT00261443|101686749|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
33489577|NCT00261443|101686750|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
33489578|NCT00261443|101686748|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
33489579|NCT00261443|101686749|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
33489580|NCT00261443|101686750|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
33489581|NCT00261443|101686748|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
33489582|NCT00261443|101686749|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
33489583|NCT00261443|101686750|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
33489584|NCT00261443|101686748|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
33489585|NCT00261443|101686749|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
33489586|NCT00261443|101686750|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
33489587|NCT00261443|101686748|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
33489588|NCT00261443|101686749|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
33489589|NCT00261443|101686750|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
33489590|NCT00261443|101686748|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
33489591|NCT00261443|101686749|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
33489592|NCT00261443|101686750|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
33489593|NCT00261443|101686748|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
33489594|NCT00261443|101686749|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
33489595|NCT00261443|101686750|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
33489596|NCT00261443|101686748|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
33489597|NCT00261443|101686749|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
33489598|NCT00261443|101686750|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
33489599|NCT00261443|101686748|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
33489600|NCT00261443|101686749|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
33489601|NCT00261443|101686750|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
33489602|NCT00261443|101686748|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
33489603|NCT00261443|101686749|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
33489604|NCT00261443|101686750|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
33489605|NCT00261443|101686748|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
33489606|NCT00261443|101686749|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
33489607|NCT00261443|101686750|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
33489608|NCT00261443|101686748|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
33489609|NCT00261443|101686749|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
33489610|NCT00261443|101686750|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
33489611|NCT00261443|101686748|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
33489612|NCT00261443|101686749|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
33489613|NCT00261443|101686750|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
33489614|NCT00261443|101686748|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
33489615|NCT00261443|101686749|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
33489616|NCT00261443|101686750|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
33489617|NCT00261443|101686748|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
33489618|NCT00261443|101686749|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
33489619|NCT00261443|101686750|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
33489620|NCT00261443|101686748|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
33489621|NCT00261443|101686749|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
33489622|NCT00261443|101686750|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
33489623|NCT00261443|101686748|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
33489624|NCT00261443|101686749|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
33489625|NCT00261443|101686750|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
33489626|NCT00261443|101686748|FG000|3: Assessment of Relapse|Adverse Event|0|||
33489627|NCT00261443|101686749|FG001|3: Assessment of Relapse|Adverse Event|15|||
33489628|NCT00261443|101686750|FG002|3: Assessment of Relapse|Adverse Event|19|||
33489629|NCT00261443|101686748|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
33489630|NCT00261443|101686749|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
33489631|NCT00261443|101686750|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
33489632|NCT00261443|101686748|FG000|3: Assessment of Relapse|Death|0|||
33489633|NCT00261443|101686749|FG001|3: Assessment of Relapse|Death|0|||
33489634|NCT00261443|101686750|FG002|3: Assessment of Relapse|Death|1|||
33285470|NCT01379703|100943747|FG002|Study Start Through 9 Months|Reason unknown|24|||
33285471|NCT01379703|100943745|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
33285472|NCT01379703|100943746|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
33285473|NCT01379703|100943747|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
33285474|NCT01379703|100943745|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
33285475|NCT01379703|100943746|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
33285476|NCT01379703|100943747|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
33285477|NCT01379703|100943745|FG000|9 Months Through 18 Months|Adverse Event|0|||
33285478|NCT01379703|100943746|FG001|9 Months Through 18 Months|Adverse Event|6|||
33285479|NCT01379703|100943747|FG002|9 Months Through 18 Months|Adverse Event|0|||
33285480|NCT01379703|100943745|FG000|9 Months Through 18 Months|Treatment failure|0|||
33285481|NCT01379703|100943746|FG001|9 Months Through 18 Months|Treatment failure|5|||
33285482|NCT01379703|100943747|FG002|9 Months Through 18 Months|Treatment failure|0|||
33285483|NCT01379703|100943745|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
33285484|NCT01379703|100943746|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
33285485|NCT01379703|100943747|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
33285486|NCT01379703|100943745|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
33285487|NCT01379703|100943746|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
33285488|NCT01379703|100943747|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
33285489|NCT01379703|100943745|FG000|9 Months Through 18 Months|Fatigue|0|||
33285490|NCT01379703|100943746|FG001|9 Months Through 18 Months|Fatigue|1|||
33285491|NCT01379703|100943747|FG002|9 Months Through 18 Months|Fatigue|0|||
33285492|NCT01379703|100943745|FG000|9 Months Through 18 Months|Reason Unknown|0|||
33285493|NCT01379703|100943746|FG001|9 Months Through 18 Months|Reason Unknown|23|||
33285494|NCT01379703|100943747|FG002|9 Months Through 18 Months|Reason Unknown|0|||
33285495|NCT02654132|100943748|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
33285496|NCT02654132|100943749|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
33285497|NCT02654132|100943748|FG000|Treatment Period|Disease progression|43|||
33285498|NCT02654132|100943749|FG001|Treatment Period|Disease progression|38|||
33285499|NCT02654132|100943748|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
33285500|NCT02654132|100943749|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
33285501|NCT02654132|100943748|FG000|Treatment Period|Other reasons|4|||
33285502|NCT02654132|100943749|FG001|Treatment Period|Other reasons|2|||
33285503|NCT02654132|100943748|FG000|Treatment Period|Study drug toxicity|2|||
33285504|NCT02654132|100943749|FG001|Treatment Period|Study drug toxicity|2|||
33285505|NCT02654132|100943748|FG000|Treatment Period|Withdrawal by Subject|2|||
33285506|NCT02654132|100943749|FG001|Treatment Period|Withdrawal by Subject|1|||
33285507|NCT02654132|100943748|FG000|Treatment Period|Maximum Clinical Benefit|0|||
33285508|NCT02654132|100943749|FG001|Treatment Period|Maximum Clinical Benefit|2|||
33285509|NCT02654132|100943748|FG000|Treatment Period|Participant request to discontinue|2|||
33285510|NCT02654132|100943749|FG001|Treatment Period|Participant request to discontinue|0|||
33285511|NCT02654132|100943748|FG000|Treatment Period|Administrative reasons by sponsor|0|||
33285512|NCT02654132|100943749|FG001|Treatment Period|Administrative reasons by sponsor|1|||
33285513|NCT02654132|100943748|FG000|Treatment Period|Death|1|||
33285514|NCT02654132|100943749|FG001|Treatment Period|Death|0|||
33285515|NCT05523219|100943750|FG000|Overall Study|Wrong inclusion|1|||
33285516|NCT05523219|100943750|FG000|Overall Study|Lost to Follow-up|7|||
33285517|NCT01222533|100943751|FG000|Overall Study|Adverse Event|5|||
33285518|NCT01222533|100943751|FG000|Overall Study|Withdrawal by Subject|5|||
33285519|NCT01222533|100943751|FG000|Overall Study|Other|4|||
33285520|NCT01101997|100943752|FG000|Overall Study|Withdrawal by Subject|2|||
33285521|NCT03561597|100943758|FG000|Overall Study|Lost to Follow-up|20|||
33285522|NCT04522778|100943759|FG000|Overall Study|Patient did not want to wear the device|1|||
33285523|NCT04522778|100943760|FG001|Overall Study|Patient did not want to wear the device|0|||
33285524|NCT04522778|100943759|FG000|Overall Study|Lost to Follow-up|0|||
33285525|NCT04522778|100943760|FG001|Overall Study|Lost to Follow-up|1|||
33285526|NCT00796614|100943767|FG000|Overall Study|Adverse Event|1|||
33285527|NCT00796614|100943768|FG001|Overall Study|Adverse Event|2|||
33285528|NCT00796614|100943769|FG002|Overall Study|Adverse Event|0|||
33285529|NCT00796614|100943770|FG003|Overall Study|Adverse Event|0|||
33489635|NCT00261443|101686748|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
33285530|NCT00796614|100943767|FG000|Overall Study|Protocol Violation|0|||
33285531|NCT00796614|100943768|FG001|Overall Study|Protocol Violation|0|||
33285532|NCT00796614|100943769|FG002|Overall Study|Protocol Violation|2|||
33285533|NCT00796614|100943770|FG003|Overall Study|Protocol Violation|0|||
33285534|NCT00796614|100943767|FG000|Overall Study|Lost to Follow-up|2|||
33285535|NCT00796614|100943768|FG001|Overall Study|Lost to Follow-up|2|||
33285536|NCT00796614|100943769|FG002|Overall Study|Lost to Follow-up|1|||
33285537|NCT00796614|100943770|FG003|Overall Study|Lost to Follow-up|0|||
33285538|NCT00796614|100943767|FG000|Overall Study|Withdrawal by Subject|1|||
33285539|NCT00796614|100943768|FG001|Overall Study|Withdrawal by Subject|0|||
33285540|NCT00796614|100943769|FG002|Overall Study|Withdrawal by Subject|0|||
33285541|NCT00796614|100943770|FG003|Overall Study|Withdrawal by Subject|1|||
33285542|NCT00796614|100943767|FG000|Overall Study|Other than stated|1|||
33285543|NCT00796614|100943768|FG001|Overall Study|Other than stated|0|||
33285544|NCT00796614|100943769|FG002|Overall Study|Other than stated|0|||
33285545|NCT00796614|100943770|FG003|Overall Study|Other than stated|0|||
33285546|NCT02109107|100943771|FG000|Overall Study|Lost to Follow-up|2|||
33285547|NCT01231464|100943772|FG000|Overall Study|Adverse Event|0|||
33285548|NCT01231464|100943773|FG001|Overall Study|Adverse Event|1|||
33285549|NCT01231464|100943772|FG000|Overall Study|Protocol Violation|1|||
33285550|NCT01231464|100943773|FG001|Overall Study|Protocol Violation|2|||
33285551|NCT01231464|100943772|FG000|Overall Study|Lost to Follow-up|1|||
33285552|NCT01231464|100943773|FG001|Overall Study|Lost to Follow-up|2|||
33285553|NCT01231464|100943772|FG000|Overall Study|Withdrawal by Subject|3|||
33285554|NCT01231464|100943773|FG001|Overall Study|Withdrawal by Subject|2|||
33285555|NCT02959177|100943774|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
33285556|NCT02959177|100943775|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
33285557|NCT02959177|100943776|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
33285558|NCT02959177|100943774|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
33285559|NCT02959177|100943775|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
33285560|NCT02959177|100943776|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
33285561|NCT02959177|100943774|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
33285562|NCT02959177|100943775|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
33285563|NCT02959177|100943776|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
33285564|NCT02959177|100943774|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
33285565|NCT02959177|100943775|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
33285566|NCT02959177|100943776|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
33285567|NCT02959177|100943774|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
33285568|NCT02959177|100943775|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
33285569|NCT02959177|100943776|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
33285570|NCT02959177|100943774|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
33285571|NCT02959177|100943775|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
33285572|NCT02959177|100943776|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
33285573|NCT02959177|100943774|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
33285574|NCT02959177|100943775|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
33285575|NCT02959177|100943776|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
33285576|NCT02592707|100943777|FG000|Overall Study|Consent Withdrawn|0|||
33285577|NCT02592707|100943778|FG001|Overall Study|Consent Withdrawn|1|||
33285578|NCT02592707|100943779|FG002|Overall Study|Consent Withdrawn|2|||
33285579|NCT02592707|100943780|FG003|Overall Study|Consent Withdrawn|0|||
33285580|NCT02592707|100943777|FG000|Overall Study|Death|1|||
33285581|NCT02592707|100943778|FG001|Overall Study|Death|0|||
33285582|NCT02592707|100943779|FG002|Overall Study|Death|0|||
33285583|NCT02592707|100943780|FG003|Overall Study|Death|0|||
33285584|NCT02592707|100943777|FG000|Overall Study|Progressive Disease|4|||
33285585|NCT02592707|100943778|FG001|Overall Study|Progressive Disease|4|||
33285586|NCT02592707|100943779|FG002|Overall Study|Progressive Disease|3|||
33285587|NCT02592707|100943780|FG003|Overall Study|Progressive Disease|3|||
33285588|NCT02592707|100943777|FG000|Overall Study|Other|0|||
33285589|NCT02592707|100943778|FG001|Overall Study|Other|0|||
33285590|NCT02592707|100943779|FG002|Overall Study|Other|1|||
33285591|NCT02592707|100943780|FG003|Overall Study|Other|2|||
33285592|NCT02592707|100943777|FG000|Overall Study|Never entered LTFU period|1|||
33285593|NCT02592707|100943778|FG001|Overall Study|Never entered LTFU period|0|||
33285594|NCT02592707|100943779|FG002|Overall Study|Never entered LTFU period|0|||
33285595|NCT02592707|100943780|FG003|Overall Study|Never entered LTFU period|2|||
33285596|NCT01161628|100943783|FG000|Overall Study|Death|6|||
33285597|NCT01161628|100943783|FG000|Overall Study|Lack of Efficacy|2|||
33285598|NCT00816556|100943784|FG000|Overall Study|Adverse Event|1|||
33285599|NCT00816556|100943785|FG001|Overall Study|Adverse Event|1|||
33285600|NCT00816556|100943786|FG002|Overall Study|Adverse Event|1|||
33285601|NCT00816556|100943784|FG000|Overall Study|Withdrawal by Subject|1|||
33285602|NCT00816556|100943785|FG001|Overall Study|Withdrawal by Subject|1|||
33285603|NCT00816556|100943786|FG002|Overall Study|Withdrawal by Subject|1|||
33285604|NCT00816556|100943784|FG000|Overall Study|Lost to Follow-up|0|||
33285605|NCT00816556|100943785|FG001|Overall Study|Lost to Follow-up|0|||
33285606|NCT00816556|100943786|FG002|Overall Study|Lost to Follow-up|1|||
33285607|NCT00560313|100943787|FG000|Overall Study|Adverse Events or Death|2|||
33285608|NCT00560313|100943787|FG000|Overall Study|Withdrawal by Subject|2|||
33285609|NCT00560313|100943787|FG000|Overall Study|Lost to Follow-up|1|||
33285610|NCT00560313|100943787|FG000|Overall Study|Protocol Violation|1|||
33285611|NCT04811339|100943788|FG000|Overall Study|lack of transportation not wanting to return|4|||
33285612|NCT04811339|100943789|FG001|Overall Study|lack of transportation not wanting to return|8|||
33285613|NCT04811339|100943790|FG002|Overall Study|lack of transportation not wanting to return|0|||
33285614|NCT04811339|100943788|FG000|Overall Study|Adverse Event|3|||
33285615|NCT04811339|100943789|FG001|Overall Study|Adverse Event|0|||
33285616|NCT04811339|100943790|FG002|Overall Study|Adverse Event|0|||
33285617|NCT04811339|100943788|FG000|Overall Study|Lost to Follow-up|1|||
33285618|NCT04811339|100943789|FG001|Overall Study|Lost to Follow-up|0|||
33285619|NCT04811339|100943790|FG002|Overall Study|Lost to Follow-up|0|||
33285620|NCT04811339|100943788|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
33285621|NCT04811339|100943789|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
33285622|NCT04811339|100943790|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
33285623|NCT04811339|100943788|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
33285624|NCT04811339|100943789|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
33285625|NCT04811339|100943790|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
33285626|NCT04811339|100943788|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
33285627|NCT04811339|100943789|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
33285628|NCT04811339|100943790|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
33285629|NCT04811339|100943788|FG000|Overall Study|Withdrawal by Subject|0|||
33285630|NCT04811339|100943789|FG001|Overall Study|Withdrawal by Subject|3|||
33285631|NCT04811339|100943790|FG002|Overall Study|Withdrawal by Subject|0|||
33285632|NCT04811339|100943788|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
33285633|NCT04811339|100943789|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
33285634|NCT04811339|100943790|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
33285635|NCT04811339|100943788|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
33285636|NCT04811339|100943789|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
33285637|NCT04811339|100943790|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
33285638|NCT02506881|100943791|FG000|First Intervention (Day 1)|Protocol Violation|0|||
33285639|NCT02506881|100943792|FG001|First Intervention (Day 1)|Protocol Violation|0|||
33285640|NCT02506881|100943793|FG002|First Intervention (Day 1)|Protocol Violation|1|||
33285641|NCT02506881|100943794|FG003|First Intervention (Day 1)|Protocol Violation|0|||
33285642|NCT02506881|100943791|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
33285643|NCT02506881|100943792|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
33285644|NCT02506881|100943793|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
33285645|NCT02506881|100943794|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
33285646|NCT02506881|100943791|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
33285647|NCT02506881|100943792|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
33285648|NCT02506881|100943793|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
33285649|NCT02506881|100943794|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
33285650|NCT02101268|100943795|FG000|Randomized Treatment Phase|Subject Decision|8|||
33285651|NCT02101268|100943796|FG001|Randomized Treatment Phase|Subject Decision|4|||
33285652|NCT02101268|100943797|FG002|Randomized Treatment Phase|Subject Decision|0|||
33285653|NCT02101268|100943798|FG003|Randomized Treatment Phase|Subject Decision|0|||
33285654|NCT02101268|100943795|FG000|Randomized Treatment Phase|Physician Decision|4|||
33285655|NCT02101268|100943796|FG001|Randomized Treatment Phase|Physician Decision|1|||
33285656|NCT02101268|100943797|FG002|Randomized Treatment Phase|Physician Decision|0|||
33285657|NCT02101268|100943798|FG003|Randomized Treatment Phase|Physician Decision|0|||
33285658|NCT02101268|100943795|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
33285659|NCT02101268|100943796|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
33285660|NCT02101268|100943797|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
33285661|NCT02101268|100943798|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
33285662|NCT02101268|100943795|FG000|Randomized Treatment Phase|Adverse Event|6|||
33285663|NCT02101268|100943796|FG001|Randomized Treatment Phase|Adverse Event|0|||
33285664|NCT02101268|100943797|FG002|Randomized Treatment Phase|Adverse Event|0|||
33285665|NCT02101268|100943798|FG003|Randomized Treatment Phase|Adverse Event|0|||
33285666|NCT02101268|100943795|FG000|Randomized Treatment Phase|Death|5|||
33285667|NCT02101268|100943796|FG001|Randomized Treatment Phase|Death|4|||
33285668|NCT02101268|100943797|FG002|Randomized Treatment Phase|Death|0|||
33285669|NCT02101268|100943798|FG003|Randomized Treatment Phase|Death|0|||
33285670|NCT02101268|100943795|FG000|Randomized Treatment Phase|Disease Progression|4|||
33285671|NCT02101268|100943796|FG001|Randomized Treatment Phase|Disease Progression|1|||
33285672|NCT02101268|100943797|FG002|Randomized Treatment Phase|Disease Progression|0|||
33285673|NCT02101268|100943798|FG003|Randomized Treatment Phase|Disease Progression|0|||
33285674|NCT02101268|100943795|FG000|Extended Treatment Phase|Subject Decision|0|||
33285675|NCT02101268|100943796|FG001|Extended Treatment Phase|Subject Decision|0|||
33285676|NCT02101268|100943797|FG002|Extended Treatment Phase|Subject Decision|3|||
33285677|NCT02101268|100943798|FG003|Extended Treatment Phase|Subject Decision|2|||
33285678|NCT02101268|100943795|FG000|Extended Treatment Phase|Physician Decision|0|||
33285679|NCT02101268|100943796|FG001|Extended Treatment Phase|Physician Decision|0|||
33285680|NCT02101268|100943797|FG002|Extended Treatment Phase|Physician Decision|5|||
33285681|NCT02101268|100943798|FG003|Extended Treatment Phase|Physician Decision|2|||
33285682|NCT02101268|100943795|FG000|Extended Treatment Phase|Adverse Event|0|||
33285683|NCT02101268|100943796|FG001|Extended Treatment Phase|Adverse Event|0|||
33285684|NCT02101268|100943797|FG002|Extended Treatment Phase|Adverse Event|14|||
33285685|NCT02101268|100943798|FG003|Extended Treatment Phase|Adverse Event|18|||
33285686|NCT02101268|100943795|FG000|Extended Treatment Phase|Death|0|||
33285687|NCT02101268|100943796|FG001|Extended Treatment Phase|Death|0|||
33285688|NCT02101268|100943797|FG002|Extended Treatment Phase|Death|5|||
33285689|NCT02101268|100943798|FG003|Extended Treatment Phase|Death|1|||
33285690|NCT02101268|100943795|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
33285691|NCT02101268|100943796|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
33285692|NCT02101268|100943797|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
33285693|NCT02101268|100943798|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
33285694|NCT02101268|100943795|FG000|Extended Treatment Phase|Disease Progression|0|||
33285695|NCT02101268|100943796|FG001|Extended Treatment Phase|Disease Progression|0|||
33285696|NCT02101268|100943797|FG002|Extended Treatment Phase|Disease Progression|13|||
33285697|NCT02101268|100943798|FG003|Extended Treatment Phase|Disease Progression|6|||
33285698|NCT02101268|100943795|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
33285699|NCT02101268|100943796|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
33285700|NCT02101268|100943797|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
33285701|NCT02101268|100943798|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
33285702|NCT02330562|100943799|FG000|Overall Study|Adverse Event|0|||
33285703|NCT02330562|100943800|FG001|Overall Study|Adverse Event|0|||
33285704|NCT02330562|100943801|FG002|Overall Study|Adverse Event|3|||
33285705|NCT02330562|100943802|FG003|Overall Study|Adverse Event|0|||
33285706|NCT02330562|100943803|FG004|Overall Study|Adverse Event|3|||
33285707|NCT02330562|100943804|FG005|Overall Study|Adverse Event|1|||
33285708|NCT02330562|100943805|FG006|Overall Study|Adverse Event|0|||
33285709|NCT02330562|100943806|FG007|Overall Study|Adverse Event|0|||
33285710|NCT02330562|100943807|FG008|Overall Study|Adverse Event|0|||
33285711|NCT02330562|100943808|FG009|Overall Study|Adverse Event|1|||
33285712|NCT02330562|100943809|FG010|Overall Study|Adverse Event|1|||
33285713|NCT02330562|100943799|FG000|Overall Study|Participant decision|1|||
33285714|NCT02330562|100943800|FG001|Overall Study|Participant decision|0|||
33285715|NCT02330562|100943801|FG002|Overall Study|Participant decision|4|||
33285716|NCT02330562|100943802|FG003|Overall Study|Participant decision|1|||
33285717|NCT02330562|100943803|FG004|Overall Study|Participant decision|5|||
33285718|NCT02330562|100943804|FG005|Overall Study|Participant decision|2|||
33285719|NCT02330562|100943805|FG006|Overall Study|Participant decision|0|||
33285720|NCT02330562|100943806|FG007|Overall Study|Participant decision|0|||
33285721|NCT02330562|100943807|FG008|Overall Study|Participant decision|0|||
33285722|NCT02330562|100943808|FG009|Overall Study|Participant decision|3|||
33285723|NCT02330562|100943809|FG010|Overall Study|Participant decision|0|||
33285724|NCT02330562|100943799|FG000|Overall Study|Disease progression|5|||
33285725|NCT02330562|100943800|FG001|Overall Study|Disease progression|3|||
33285726|NCT02330562|100943801|FG002|Overall Study|Disease progression|20|||
33285727|NCT02330562|100943802|FG003|Overall Study|Disease progression|28|||
33285728|NCT02330562|100943803|FG004|Overall Study|Disease progression|23|||
33285729|NCT02330562|100943804|FG005|Overall Study|Disease progression|7|||
33285730|NCT02330562|100943805|FG006|Overall Study|Disease progression|1|||
33285731|NCT02330562|100943806|FG007|Overall Study|Disease progression|1|||
33285732|NCT02330562|100943807|FG008|Overall Study|Disease progression|1|||
33285733|NCT02330562|100943808|FG009|Overall Study|Disease progression|0|||
33285734|NCT02330562|100943809|FG010|Overall Study|Disease progression|5|||
33285735|NCT02330562|100943799|FG000|Overall Study|Other reasons|0|||
33285736|NCT02330562|100943800|FG001|Overall Study|Other reasons|0|||
33285737|NCT02330562|100943801|FG002|Overall Study|Other reasons|0|||
33285738|NCT02330562|100943802|FG003|Overall Study|Other reasons|1|||
33285739|NCT02330562|100943803|FG004|Overall Study|Other reasons|0|||
33285740|NCT02330562|100943804|FG005|Overall Study|Other reasons|0|||
33285741|NCT02330562|100943805|FG006|Overall Study|Other reasons|0|||
33285742|NCT02330562|100943806|FG007|Overall Study|Other reasons|0|||
33285743|NCT02330562|100943807|FG008|Overall Study|Other reasons|0|||
33285744|NCT02330562|100943808|FG009|Overall Study|Other reasons|0|||
33285745|NCT02330562|100943809|FG010|Overall Study|Other reasons|0|||
33285746|NCT02330562|100943799|FG000|Overall Study|Withdrawal by Subject|0|||
33285747|NCT02330562|100943800|FG001|Overall Study|Withdrawal by Subject|0|||
33285748|NCT02330562|100943801|FG002|Overall Study|Withdrawal by Subject|0|||
33285749|NCT02330562|100943802|FG003|Overall Study|Withdrawal by Subject|0|||
33285750|NCT02330562|100943803|FG004|Overall Study|Withdrawal by Subject|0|||
33285751|NCT02330562|100943804|FG005|Overall Study|Withdrawal by Subject|0|||
33285752|NCT02330562|100943805|FG006|Overall Study|Withdrawal by Subject|0|||
33285753|NCT02330562|100943806|FG007|Overall Study|Withdrawal by Subject|0|||
33285754|NCT02330562|100943807|FG008|Overall Study|Withdrawal by Subject|0|||
33285755|NCT02330562|100943808|FG009|Overall Study|Withdrawal by Subject|1|||
33285756|NCT02330562|100943809|FG010|Overall Study|Withdrawal by Subject|0|||
33285757|NCT01187407|100943810|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
33285758|NCT01187407|100943811|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33285759|NCT01187407|100943812|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33285760|NCT01187407|100943813|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33285761|NCT01187407|100943814|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
33285762|NCT01187407|100943810|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
33285763|NCT01187407|100943811|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33285764|NCT01187407|100943812|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33285765|NCT01187407|100943813|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33285766|NCT01187407|100943814|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
33285767|NCT01187407|100943810|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
33285768|NCT01187407|100943811|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33285769|NCT01187407|100943812|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33285770|NCT01187407|100943813|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33285771|NCT01187407|100943814|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
33285772|NCT01187407|100943810|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
33285773|NCT01187407|100943811|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33285774|NCT01187407|100943812|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33285775|NCT01187407|100943813|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33285776|NCT01187407|100943814|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
33285777|NCT01187407|100943810|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
33285778|NCT01187407|100943811|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33285779|NCT01187407|100943812|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33285780|NCT01187407|100943813|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33285781|NCT01187407|100943814|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
33285782|NCT01187407|100943810|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
33285783|NCT01187407|100943811|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33285784|NCT01187407|100943812|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33285785|NCT01187407|100943813|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33285786|NCT01187407|100943814|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
33285787|NCT01187407|100943810|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
33285788|NCT01187407|100943811|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33285789|NCT01187407|100943812|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33285790|NCT01187407|100943813|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33285791|NCT01187407|100943814|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
33285792|NCT01187407|100943810|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
33285793|NCT01187407|100943811|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
33285794|NCT01187407|100943812|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
33285795|NCT01187407|100943813|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
33285796|NCT01187407|100943814|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
33285797|NCT01187407|100943810|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
33285798|NCT01187407|100943811|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
33285799|NCT01187407|100943812|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
33285800|NCT01187407|100943813|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
33285801|NCT01187407|100943814|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
33285802|NCT01187407|100943810|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
33285803|NCT01187407|100943811|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
33285804|NCT01187407|100943812|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
33285805|NCT01187407|100943813|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
33285806|NCT01187407|100943814|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
33285807|NCT01187407|100943810|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
33285808|NCT01187407|100943811|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
33285809|NCT01187407|100943812|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
33285810|NCT01187407|100943813|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
33285811|NCT01187407|100943814|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
33285812|NCT01187407|100943810|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
33285813|NCT01187407|100943811|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
33285814|NCT01187407|100943812|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
33285815|NCT01187407|100943813|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
33285816|NCT01187407|100943814|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
33285817|NCT01187407|100943810|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
33285818|NCT01187407|100943811|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
33285819|NCT01187407|100943812|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
33285820|NCT01187407|100943813|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
33285821|NCT01187407|100943814|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
33285822|NCT01187407|100943810|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
33285823|NCT01187407|100943811|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
33285824|NCT01187407|100943812|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
33285825|NCT01187407|100943813|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
33285826|NCT01187407|100943814|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
33285827|NCT01125566|100943815|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
33285828|NCT01125566|100943816|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
33285829|NCT01125566|100943817|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
33285830|NCT01125566|100943815|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
33285831|NCT01125566|100943816|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
33285832|NCT01125566|100943817|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
33285833|NCT01125566|100943815|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
33285834|NCT01125566|100943816|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
33285835|NCT01125566|100943817|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
33285836|NCT01125566|100943815|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
33285837|NCT01125566|100943816|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
33285838|NCT01125566|100943817|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
33285839|NCT01125566|100943815|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
33285840|NCT01125566|100943816|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
33285841|NCT01125566|100943817|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
33285842|NCT01125566|100943815|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
33285843|NCT01125566|100943816|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
33285844|NCT01125566|100943817|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
33285845|NCT01125566|100943815|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
33285846|NCT01125566|100943816|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
33285847|NCT01125566|100943817|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
33285848|NCT01125566|100943815|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
33285849|NCT01125566|100943816|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
33285850|NCT01125566|100943817|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
33285851|NCT01125566|100943815|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
33285852|NCT01125566|100943816|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
33285853|NCT01125566|100943817|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
33285854|NCT01125566|100943815|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
33285855|NCT01125566|100943816|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
33285856|NCT01125566|100943817|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
33285857|NCT01125566|100943815|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
33285858|NCT01125566|100943816|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
33285859|NCT01125566|100943817|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
33285860|NCT01125566|100943815|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
33285861|NCT01125566|100943816|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
33285862|NCT01125566|100943817|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
33285863|NCT01821729|100943823|FG000|Overall Study|Withdrawal by Subject|1|||
33285864|NCT01990313|100943824|FG000|Overall Study|Lost to Follow-up|1|||
33285865|NCT01268098|100943825|FG000|Overall Study|Adverse Event|1|||
33285866|NCT01268098|100943826|FG001|Overall Study|Adverse Event|0|||
33285867|NCT00329550|100943827|FG000|Overall Study|Adverse Event|3|||
33285868|NCT00329550|100943828|FG001|Overall Study|Adverse Event|4|||
33285869|NCT00329550|100943829|FG002|Overall Study|Adverse Event|2|||
33285870|NCT00329550|100943827|FG000|Overall Study|Withdrawal of Consent|1|||
33285871|NCT00329550|100943828|FG001|Overall Study|Withdrawal of Consent|0|||
33285872|NCT00329550|100943829|FG002|Overall Study|Withdrawal of Consent|1|||
33285873|NCT00329550|100943827|FG000|Overall Study|Due to Relocation|0|||
33285874|NCT00329550|100943828|FG001|Overall Study|Due to Relocation|0|||
33285875|NCT00329550|100943829|FG002|Overall Study|Due to Relocation|1|||
33285876|NCT00292981|100943830|FG000|Overall Study|Adverse Event|1|||
33285877|NCT00292981|100943830|FG000|Overall Study|Lost to Follow-up|13|||
33285878|NCT00292981|100943830|FG000|Overall Study|Withdrawal by Subject|22|||
33285879|NCT00292981|100943830|FG000|Overall Study|Other|3|||
33285880|NCT02418845|100943831|FG000|Overall Study|Lost to Follow-up|7|||
33285881|NCT02418845|100943832|FG001|Overall Study|Lost to Follow-up|2|||
33285882|NCT02418845|100943831|FG000|Overall Study|Lack of Efficacy|0|||
33285883|NCT02418845|100943832|FG001|Overall Study|Lack of Efficacy|3|||
33285884|NCT02418845|100943831|FG000|Overall Study|Physician Decision|5|||
33285885|NCT02418845|100943832|FG001|Overall Study|Physician Decision|5|||
33285886|NCT02418845|100943831|FG000|Overall Study|Protocol Violation|1|||
33285887|NCT02418845|100943832|FG001|Overall Study|Protocol Violation|0|||
33285888|NCT02418845|100943831|FG000|Overall Study|Withdrawal by Subject|3|||
33285889|NCT02418845|100943832|FG001|Overall Study|Withdrawal by Subject|2|||
33285890|NCT01255761|100943835|FG000|Overall Study|Adverse Event|29|||
33285891|NCT01255761|100943836|FG001|Overall Study|Adverse Event|43|||
33285892|NCT01255761|100943835|FG000|Overall Study|Lack of Efficacy|86|||
33285893|NCT01255761|100943836|FG001|Overall Study|Lack of Efficacy|74|||
33285894|NCT01255761|100943835|FG000|Overall Study|Protocol Violation|9|||
33285895|NCT01255761|100943836|FG001|Overall Study|Protocol Violation|5|||
33285896|NCT01255761|100943835|FG000|Overall Study|Lost to Follow-up|10|||
33285897|NCT01255761|100943836|FG001|Overall Study|Lost to Follow-up|8|||
33285898|NCT01255761|100943835|FG000|Overall Study|Withdrawal by Subject|11|||
33285899|NCT01255761|100943836|FG001|Overall Study|Withdrawal by Subject|27|||
33285900|NCT01255761|100943835|FG000|Overall Study|Other Reasons|37|||
33285901|NCT01255761|100943836|FG001|Overall Study|Other Reasons|18|||
33285902|NCT02230306|100943837|FG000|Overall Study|Did not receive study treatment|1|||
33285903|NCT01721746|100943838|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
33285904|NCT01721746|100943839|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
33285905|NCT01721746|100943838|FG000|Pre-Treatment|Withdrawal by Subject|1|||
33285906|NCT01721746|100943839|FG001|Pre-Treatment|Withdrawal by Subject|16|||
33285907|NCT01721746|100943838|FG000|Pre-Treatment|Poor/Non-compliance|1|||
33285908|NCT01721746|100943839|FG001|Pre-Treatment|Poor/Non-compliance|0|||
33285909|NCT01721746|100943838|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
33285910|NCT01721746|100943839|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
33285911|NCT01721746|100943838|FG000|Treatment|Disease Progression|192|||
33285912|NCT01721746|100943839|FG001|Treatment|Disease Progression|74|||
33285913|NCT01721746|100943838|FG000|Treatment|Study Drug Toxicity|19|||
33285914|NCT01721746|100943839|FG001|Treatment|Study Drug Toxicity|11|||
33285915|NCT01721746|100943838|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
33285916|NCT01721746|100943839|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
33285917|NCT01721746|100943838|FG000|Treatment|Participant request to discontinue Study treatment|26|||
33285918|NCT01721746|100943839|FG001|Treatment|Participant request to discontinue Study treatment|7|||
33285919|NCT01721746|100943838|FG000|Treatment|Participant withdrew consent|4|||
33285920|NCT01721746|100943839|FG001|Treatment|Participant withdrew consent|2|||
33285921|NCT01721746|100943838|FG000|Treatment|Maximum Clinical Benefit|9|||
33285922|NCT01721746|100943839|FG001|Treatment|Maximum Clinical Benefit|3|||
33285923|NCT01721746|100943838|FG000|Treatment|Poor/Non-compliance|2|||
33285924|NCT01721746|100943839|FG001|Treatment|Poor/Non-compliance|0|||
33285925|NCT01721746|100943838|FG000|Treatment|Participant no longer met Study criteria|4|||
33285926|NCT01721746|100943839|FG001|Treatment|Participant no longer met Study criteria|0|||
33285927|NCT01721746|100943838|FG000|Treatment|Other reasons|6|||
33285928|NCT01721746|100943839|FG001|Treatment|Other reasons|2|||
33285929|NCT02049515|100943840|FG000|Overall Study|Adverse Event|46|||
33285930|NCT02049515|100943841|FG001|Overall Study|Adverse Event|2|||
33285931|NCT02049515|100943840|FG000|Overall Study|Protocol-specified Disease Progression|23|||
33285932|NCT02049515|100943841|FG001|Overall Study|Protocol-specified Disease Progression|2|||
33285933|NCT02049515|100943840|FG000|Overall Study|Death|6|||
33285934|NCT02049515|100943841|FG001|Overall Study|Death|0|||
33285935|NCT02049515|100943840|FG000|Overall Study|Physician Decision|5|||
33285936|NCT02049515|100943841|FG001|Overall Study|Physician Decision|1|||
33285937|NCT02049515|100943840|FG000|Overall Study|Withdrawal by Subject|3|||
33285938|NCT02049515|100943841|FG001|Overall Study|Withdrawal by Subject|0|||
33285939|NCT02049515|100943840|FG000|Overall Study|Termination of the Study by Sponsor|2|||
33285940|NCT02049515|100943841|FG001|Overall Study|Termination of the Study by Sponsor|0|||
33285941|NCT02049515|100943840|FG000|Overall Study|Protocol Violation|1|||
33285942|NCT02049515|100943841|FG001|Overall Study|Protocol Violation|1|||
33285943|NCT02049515|100943840|FG000|Overall Study|Clinical Deterioration|1|||
33285944|NCT02049515|100943841|FG001|Overall Study|Clinical Deterioration|0|||
33285945|NCT02049515|100943840|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
33285946|NCT02049515|100943841|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
33285947|NCT02049515|100943840|FG000|Overall Study|Treatment Interruption >42 Days|1|||
33285948|NCT02049515|100943841|FG001|Overall Study|Treatment Interruption >42 Days|0|||
33285949|NCT02049515|100943840|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
33285950|NCT02049515|100943841|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
33285951|NCT00605566|100943842|FG000|Overall Study|Adverse Event|1|||
33285952|NCT00605566|100943842|FG000|Overall Study|Clinical deterioration|1|||
33285953|NCT00605566|100943842|FG000|Overall Study|Poor compliance in run-in period|1|||
33285954|NCT04353817|100943843|FG000|Overall Study|Adverse Event|0|||
33285955|NCT04353817|100943844|FG001|Overall Study|Adverse Event|1|||
33285956|NCT04969224|100943845|FG000|Overall Study|Adverse Event|1|||
33285957|NCT04969224|100943845|FG000|Overall Study|Enrolled but never dosed|1|||
33285958|NCT03517111|100943848|FG000|Enrolled|Withdrawal by Subject|0|||
33285959|NCT03517111|100943849|FG001|Enrolled|Withdrawal by Subject|1|||
33285960|NCT03517111|100943850|FG002|Enrolled|Withdrawal by Subject|0|||
33285961|NCT03517111|100943848|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
33285962|NCT03517111|100943849|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
33285963|NCT03517111|100943850|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
33285964|NCT03517111|100943848|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
33285965|NCT03517111|100943849|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
33285966|NCT03517111|100943850|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
33285967|NCT03517111|100943848|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
33285968|NCT03517111|100943849|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
33285969|NCT03517111|100943850|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
33285970|NCT03517111|100943848|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
33285971|NCT03517111|100943849|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
33285972|NCT03517111|100943850|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
33285973|NCT02970305|100943852|FG000|Overall Study|Adverse Event|10|||
33285974|NCT02970305|100943853|FG001|Overall Study|Adverse Event|6|||
33285975|NCT02970305|100943852|FG000|Overall Study|Lack of Efficacy|1|||
33285976|NCT02970305|100943853|FG001|Overall Study|Lack of Efficacy|1|||
33285977|NCT02970305|100943852|FG000|Overall Study|Noncompliance with study drug|2|||
33285978|NCT02970305|100943853|FG001|Overall Study|Noncompliance with study drug|4|||
33285979|NCT02970305|100943852|FG000|Overall Study|Protocol Violation|2|||
33285980|NCT02970305|100943853|FG001|Overall Study|Protocol Violation|2|||
33285981|NCT02970305|100943852|FG000|Overall Study|Withdrawal by Subject|12|||
33285982|NCT02970305|100943853|FG001|Overall Study|Withdrawal by Subject|11|||
33285983|NCT02970305|100943852|FG000|Overall Study|Not further specified|1|||
33285984|NCT02970305|100943853|FG001|Overall Study|Not further specified|2|||
33285985|NCT02970305|100943852|FG000|Overall Study|Lost to Follow-up|1|||
33285986|NCT02970305|100943853|FG001|Overall Study|Lost to Follow-up|2|||
33285987|NCT00904722|100943856|FG000|Overall Study|Physician Decision|1|||
33285988|NCT00104637|100943857|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
33285989|NCT00104637|100943858|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
33285990|NCT00591591|100943861|FG000|Overall Study|Withdrawal by Subject|1|||
33285991|NCT00591591|100943862|FG001|Overall Study|Withdrawal by Subject|37|||
33285992|NCT00591591|100943861|FG000|Overall Study|Lack of Efficacy|10|||
33285993|NCT00591591|100943862|FG001|Overall Study|Lack of Efficacy|2|||
33285994|NCT02725528|100943865|FG000|Overall Study|Lost to Follow-up|1|||
33285995|NCT02725528|100943866|FG001|Overall Study|Lost to Follow-up|4|||
33285996|NCT02725528|100943865|FG000|Overall Study|Withdrawal by Subject|0|||
33285997|NCT02725528|100943866|FG001|Overall Study|Withdrawal by Subject|1|||
33285998|NCT01193218|100943867|FG000|0-12 Weeks|Adverse Event|6|||
33285999|NCT01193218|100943868|FG001|0-12 Weeks|Adverse Event|0|||
33286000|NCT01193218|100943869|FG002|0-12 Weeks|Adverse Event|1|||
33286001|NCT01193218|100943870|FG003|0-12 Weeks|Adverse Event|0|||
33286002|NCT01193218|100943871|FG004|0-12 Weeks|Adverse Event|0|||
33286003|NCT01193218|100943872|FG005|0-12 Weeks|Adverse Event|2|||
33286004|NCT01193218|100943873|FG006|0-12 Weeks|Adverse Event|2|||
33286005|NCT01193218|100943874|FG007|0-12 Weeks|Adverse Event|0|||
33286006|NCT01193218|100943867|FG000|0-12 Weeks|Protocol Violation|0|||
33286007|NCT01193218|100943868|FG001|0-12 Weeks|Protocol Violation|0|||
33286008|NCT01193218|100943869|FG002|0-12 Weeks|Protocol Violation|0|||
33286009|NCT01193218|100943870|FG003|0-12 Weeks|Protocol Violation|0|||
33286010|NCT01193218|100943871|FG004|0-12 Weeks|Protocol Violation|1|||
33286011|NCT01193218|100943872|FG005|0-12 Weeks|Protocol Violation|1|||
33286012|NCT01193218|100943873|FG006|0-12 Weeks|Protocol Violation|0|||
33286013|NCT01193218|100943874|FG007|0-12 Weeks|Protocol Violation|0|||
33286014|NCT01193218|100943867|FG000|0-12 Weeks|Withdrawal by Subject|3|||
33286015|NCT01193218|100943868|FG001|0-12 Weeks|Withdrawal by Subject|0|||
33286016|NCT01193218|100943869|FG002|0-12 Weeks|Withdrawal by Subject|2|||
33286017|NCT01193218|100943870|FG003|0-12 Weeks|Withdrawal by Subject|0|||
33286018|NCT01193218|100943871|FG004|0-12 Weeks|Withdrawal by Subject|0|||
33286019|NCT01193218|100943872|FG005|0-12 Weeks|Withdrawal by Subject|0|||
33286020|NCT01193218|100943873|FG006|0-12 Weeks|Withdrawal by Subject|1|||
33286021|NCT01193218|100943874|FG007|0-12 Weeks|Withdrawal by Subject|0|||
33286022|NCT01193218|100943867|FG000|12-52 Weeks|Adverse Event|1|||
33286023|NCT01193218|100943868|FG001|12-52 Weeks|Adverse Event|0|||
33286024|NCT01193218|100943869|FG002|12-52 Weeks|Adverse Event|1|||
33286025|NCT01193218|100943870|FG003|12-52 Weeks|Adverse Event|2|||
33286026|NCT01193218|100943871|FG004|12-52 Weeks|Adverse Event|3|||
33286027|NCT01193218|100943872|FG005|12-52 Weeks|Adverse Event|3|||
33286028|NCT01193218|100943873|FG006|12-52 Weeks|Adverse Event|1|||
33286029|NCT01193218|100943874|FG007|12-52 Weeks|Adverse Event|2|||
33286030|NCT01193218|100943867|FG000|12-52 Weeks|Lack of Efficacy|0|||
33286031|NCT01193218|100943868|FG001|12-52 Weeks|Lack of Efficacy|0|||
33286032|NCT01193218|100943869|FG002|12-52 Weeks|Lack of Efficacy|0|||
33286033|NCT01193218|100943870|FG003|12-52 Weeks|Lack of Efficacy|0|||
33286034|NCT01193218|100943871|FG004|12-52 Weeks|Lack of Efficacy|0|||
33286035|NCT01193218|100943872|FG005|12-52 Weeks|Lack of Efficacy|0|||
33286036|NCT01193218|100943873|FG006|12-52 Weeks|Lack of Efficacy|1|||
33286037|NCT01193218|100943874|FG007|12-52 Weeks|Lack of Efficacy|0|||
33286038|NCT01193218|100943867|FG000|12-52 Weeks|Withdrawal by Subject|3|||
33286039|NCT01193218|100943868|FG001|12-52 Weeks|Withdrawal by Subject|0|||
33286040|NCT01193218|100943869|FG002|12-52 Weeks|Withdrawal by Subject|3|||
33286041|NCT01193218|100943870|FG003|12-52 Weeks|Withdrawal by Subject|0|||
33286042|NCT01193218|100943871|FG004|12-52 Weeks|Withdrawal by Subject|0|||
33286043|NCT01193218|100943872|FG005|12-52 Weeks|Withdrawal by Subject|2|||
33286044|NCT01193218|100943873|FG006|12-52 Weeks|Withdrawal by Subject|1|||
33286045|NCT01193218|100943874|FG007|12-52 Weeks|Withdrawal by Subject|2|||
33286046|NCT01193218|100943867|FG000|12-52 Weeks|Other reason than above|1|||
33286047|NCT01193218|100943868|FG001|12-52 Weeks|Other reason than above|0|||
33286048|NCT01193218|100943869|FG002|12-52 Weeks|Other reason than above|0|||
33286049|NCT01193218|100943870|FG003|12-52 Weeks|Other reason than above|1|||
33286050|NCT01193218|100943871|FG004|12-52 Weeks|Other reason than above|1|||
33286051|NCT01193218|100943872|FG005|12-52 Weeks|Other reason than above|0|||
33286052|NCT01193218|100943873|FG006|12-52 Weeks|Other reason than above|0|||
33286053|NCT01193218|100943874|FG007|12-52 Weeks|Other reason than above|0|||
33286054|NCT03082612|100943875|FG000|Overall Study|Lost to Follow-up|2|||
33286055|NCT03082612|100943876|FG001|Overall Study|Lost to Follow-up|0|||
33286056|NCT02918292|100943877|FG000|Study Enrollment Prior to Transplant|Death|1|||
33286057|NCT02918292|100943877|FG000|Study Follow up After Transplant|Death|6|||
33286058|NCT00087555|100943878|FG000|Overall Study|Adverse Event|3|||
33286059|NCT00087555|100943879|FG001|Overall Study|Adverse Event|6|||
33286060|NCT00087555|100943880|FG002|Overall Study|Adverse Event|14|||
33286061|NCT00087555|100943878|FG000|Overall Study|Lost to Follow-up|0|||
33286062|NCT00087555|100943879|FG001|Overall Study|Lost to Follow-up|1|||
33286063|NCT00087555|100943880|FG002|Overall Study|Lost to Follow-up|1|||
33286064|NCT00087555|100943878|FG000|Overall Study|Non - Compliance|1|||
33286065|NCT00087555|100943879|FG001|Overall Study|Non - Compliance|0|||
33286066|NCT00087555|100943880|FG002|Overall Study|Non - Compliance|0|||
33286067|NCT00087555|100943878|FG000|Overall Study|Protocol Violation|0|||
33286068|NCT00087555|100943879|FG001|Overall Study|Protocol Violation|0|||
33286069|NCT00087555|100943880|FG002|Overall Study|Protocol Violation|2|||
33286070|NCT00087555|100943878|FG000|Overall Study|Screen Failure|1|||
33286071|NCT00087555|100943879|FG001|Overall Study|Screen Failure|1|||
33286072|NCT00087555|100943880|FG002|Overall Study|Screen Failure|0|||
33286073|NCT00087555|100943878|FG000|Overall Study|Pregnancy|0|||
33286074|NCT00087555|100943879|FG001|Overall Study|Pregnancy|1|||
33286075|NCT00087555|100943880|FG002|Overall Study|Pregnancy|1|||
33286076|NCT00087555|100943878|FG000|Overall Study|Withdrawal by Subject|3|||
33286077|NCT00087555|100943879|FG001|Overall Study|Withdrawal by Subject|2|||
33286078|NCT00087555|100943880|FG002|Overall Study|Withdrawal by Subject|1|||
33286079|NCT00087555|100943878|FG000|Overall Study|Lack of Efficacy|2|||
33286080|NCT00087555|100943879|FG001|Overall Study|Lack of Efficacy|0|||
33286081|NCT00087555|100943880|FG002|Overall Study|Lack of Efficacy|1|||
33286082|NCT00087555|100943878|FG000|Overall Study|Non Compliance|0|||
33286083|NCT00087555|100943879|FG001|Overall Study|Non Compliance|0|||
33286084|NCT00087555|100943880|FG002|Overall Study|Non Compliance|1|||
33286085|NCT00087555|100943878|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
33286086|NCT00087555|100943879|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
33286087|NCT00087555|100943880|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
33286088|NCT00087555|100943878|FG000|Overall Study|Patient wanted to go back on Med|1|||
33286089|NCT00087555|100943879|FG001|Overall Study|Patient wanted to go back on Med|0|||
33286090|NCT00087555|100943880|FG002|Overall Study|Patient wanted to go back on Med|0|||
33286091|NCT03475056|100943881|FG000|Overall Study|Lost to Follow-up|0|||
33286092|NCT03475056|100943882|FG001|Overall Study|Lost to Follow-up|1|||
33286093|NCT03475056|100943881|FG000|Overall Study|Moved from Area|0|||
33286094|NCT03475056|100943882|FG001|Overall Study|Moved from Area|2|||
33286095|NCT02175745|100943883|FG000|Overall Study|Not Eligible|1|||
33286096|NCT03440047|100943884|FG000|Overall Study|Withdrawal by Subject|2|||
33286097|NCT02138253|100943886|FG000|Overall Study|Adverse Event|3|||
33286098|NCT02138253|100943887|FG001|Overall Study|Adverse Event|3|||
33286099|NCT02138253|100943886|FG000|Overall Study|Lost to Follow-up|2|||
33286100|NCT02138253|100943887|FG001|Overall Study|Lost to Follow-up|1|||
33286101|NCT02138253|100943886|FG000|Overall Study|Physician Decision|2|||
33286102|NCT02138253|100943887|FG001|Overall Study|Physician Decision|0|||
33286103|NCT02138253|100943886|FG000|Overall Study|Non compliance|1|||
33286104|NCT02138253|100943887|FG001|Overall Study|Non compliance|0|||
33286105|NCT02138253|100943886|FG000|Overall Study|Withdrawal by Subject|1|||
33286106|NCT02138253|100943887|FG001|Overall Study|Withdrawal by Subject|0|||
33286107|NCT00733226|100943890|FG000|Overall Study|Withdrawal by Subject|1|||
33286108|NCT00733226|100943891|FG001|Overall Study|Withdrawal by Subject|0|||
33286109|NCT00733226|100943890|FG000|Overall Study|Lost to Follow-up|2|||
33286110|NCT00733226|100943891|FG001|Overall Study|Lost to Follow-up|0|||
33286111|NCT00733226|100943890|FG000|Overall Study|moved to another place|2|||
33286112|NCT00733226|100943891|FG001|Overall Study|moved to another place|0|||
33286113|NCT00644878|100943892|FG000|Overall Study|Adverse Event|2|||
33286114|NCT00644878|100943892|FG000|Overall Study|Abnormal laboratory value|3|||
33286115|NCT00644878|100943892|FG000|Overall Study|Protocol deviation|2|||
33286116|NCT00644878|100943892|FG000|Overall Study|Treatment duration completed as per protocol|11|||
33286117|NCT02517528|100943893|FG000|Overall Study|Withdrawal by Subject|1|||
33286118|NCT01172639|100943894|FG000|Overall Study|Death|1|||
33286119|NCT01172639|100943895|FG001|Overall Study|Death|1|||
33286120|NCT01172639|100943896|FG002|Overall Study|Death|0|||
33286121|NCT01172639|100943897|FG003|Overall Study|Death|0|||
33286122|NCT01172639|100943898|FG004|Overall Study|Death|0|||
33286123|NCT01172639|100943894|FG000|Overall Study|Lost to Follow-up|9|||
33286124|NCT01172639|100943895|FG001|Overall Study|Lost to Follow-up|7|||
33286125|NCT01172639|100943896|FG002|Overall Study|Lost to Follow-up|11|||
33286126|NCT01172639|100943897|FG003|Overall Study|Lost to Follow-up|6|||
33286127|NCT01172639|100943898|FG004|Overall Study|Lost to Follow-up|6|||
33286128|NCT01172639|100943894|FG000|Overall Study|Withdrawal by Subject|3|||
33286129|NCT01172639|100943895|FG001|Overall Study|Withdrawal by Subject|3|||
33286130|NCT01172639|100943896|FG002|Overall Study|Withdrawal by Subject|5|||
33286131|NCT01172639|100943897|FG003|Overall Study|Withdrawal by Subject|5|||
33286132|NCT01172639|100943898|FG004|Overall Study|Withdrawal by Subject|0|||
33286133|NCT01062971|100943901|FG000|Overall Study|Protocol Violation|1|||
33286134|NCT01062971|100943902|FG001|Overall Study|Protocol Violation|3|||
33286135|NCT01062971|100943901|FG000|Overall Study|Lost to Follow-up|3|||
33286136|NCT01062971|100943902|FG001|Overall Study|Lost to Follow-up|4|||
33286137|NCT00808899|100943903|FG000|Overall Study|Death|1|||
33286138|NCT00808899|100943903|FG000|Overall Study|Physician Decision|3|||
33286139|NCT01580995|100943904|FG000|Overall Study|Lost to Follow-up|2|||
33286140|NCT01580995|100943905|FG001|Overall Study|Lost to Follow-up|2|||
33286141|NCT00461123|100943908|FG000|Overall Study|Adverse Event|1|||
33286142|NCT00461123|100943909|FG001|Overall Study|Adverse Event|0|||
33286143|NCT00461123|100943908|FG000|Overall Study|Lost to Follow-up|1|||
33286144|NCT00461123|100943909|FG001|Overall Study|Lost to Follow-up|1|||
33286145|NCT00461123|100943908|FG000|Overall Study|Protocol Violation|3|||
33286146|NCT00461123|100943909|FG001|Overall Study|Protocol Violation|2|||
33286147|NCT00461123|100943908|FG000|Overall Study|Withdrawal by Subject|1|||
33286148|NCT00461123|100943909|FG001|Overall Study|Withdrawal by Subject|3|||
33286149|NCT00548847|100943910|FG000|Overall Study|Disease progression|7|||
33286150|NCT02154347|100943911|FG000|Double-blind Period|Adverse Event|1|||
33286151|NCT02154347|100943912|FG001|Double-blind Period|Adverse Event|2|||
33286152|NCT02154347|100943911|FG000|Double-blind Period|Lack of Efficacy|1|||
33286153|NCT02154347|100943912|FG001|Double-blind Period|Lack of Efficacy|0|||
33286154|NCT02154347|100943911|FG000|Double-blind Period|Physician Decision|0|||
33286155|NCT02154347|100943912|FG001|Double-blind Period|Physician Decision|1|||
33286156|NCT02154347|100943911|FG000|Double-blind Period|Withdrawal by Subject|1|||
33286157|NCT02154347|100943912|FG001|Double-blind Period|Withdrawal by Subject|1|||
33286158|NCT02154347|100943911|FG000|Open-label Period|Adverse Event|3|||
33286159|NCT02154347|100943912|FG001|Open-label Period|Adverse Event|4|||
33286160|NCT02154347|100943911|FG000|Open-label Period|Lack of Efficacy|4|||
33286161|NCT02154347|100943912|FG001|Open-label Period|Lack of Efficacy|19|||
33286162|NCT02154347|100943911|FG000|Open-label Period|Protocol Violation|0|||
33286163|NCT02154347|100943912|FG001|Open-label Period|Protocol Violation|1|||
33286164|NCT02154347|100943911|FG000|Open-label Period|Withdrawal by Subject|0|||
33286165|NCT02154347|100943912|FG001|Open-label Period|Withdrawal by Subject|1|||
33286166|NCT01232569|100943916|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
33286167|NCT01232569|100943917|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
33286168|NCT01232569|100943918|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
33286169|NCT01232569|100943919|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
33286170|NCT01232569|100943916|FG000|Double-blind Treatment Period|Escape|2|||
33286171|NCT01232569|100943917|FG001|Double-blind Treatment Period|Escape|2|||
33286172|NCT01232569|100943918|FG002|Double-blind Treatment Period|Escape|0|||
33286173|NCT01232569|100943919|FG003|Double-blind Treatment Period|Escape|0|||
33286174|NCT01232569|100943916|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
33286175|NCT01232569|100943917|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
33286176|NCT01232569|100943918|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
33286177|NCT01232569|100943919|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
33286178|NCT01232569|100943916|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
33286179|NCT01232569|100943917|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
33286180|NCT01232569|100943918|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
33286181|NCT01232569|100943919|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
33286182|NCT01232569|100943916|FG000|Double-blind Treatment Period|Physician Decision|1|||
33286183|NCT01232569|100943917|FG001|Double-blind Treatment Period|Physician Decision|0|||
33286184|NCT01232569|100943918|FG002|Double-blind Treatment Period|Physician Decision|0|||
33286185|NCT01232569|100943919|FG003|Double-blind Treatment Period|Physician Decision|0|||
33286186|NCT01232569|100943916|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
33286187|NCT01232569|100943917|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
33286188|NCT01232569|100943918|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
33286189|NCT01232569|100943919|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
33286190|NCT01232569|100943916|FG000|Double-blind Treatment Period|Death|2|||
33286191|NCT01232569|100943917|FG001|Double-blind Treatment Period|Death|0|||
33286192|NCT01232569|100943918|FG002|Double-blind Treatment Period|Death|0|||
33286193|NCT01232569|100943919|FG003|Double-blind Treatment Period|Death|0|||
33286194|NCT02108652|100943920|FG000|Overall Study|Death|253|||
33286195|NCT02108652|100943920|FG000|Overall Study|Lost to Follow-up|2|||
33286196|NCT02108652|100943920|FG000|Overall Study|Withdrawal by Subject|16|||
33286197|NCT02108652|100943920|FG000|Overall Study|Study Terminated By Sponsor|31|||
33286198|NCT02108652|100943920|FG000|Overall Study|Non-Compliance|1|||
33286199|NCT02108652|100943920|FG000|Overall Study|Physician Decision|6|||
33286200|NCT02108652|100943920|FG000|Overall Study|Progression Of Disease|1|||
33286201|NCT00217022|100943921|FG000|Overall Study|Withdrawal by Subject|1|||
33286202|NCT00217022|100943922|FG001|Overall Study|Withdrawal by Subject|1|||
33286203|NCT00887198|100943928|FG000|Randomized Period|Ongoing|42|||
33286204|NCT00887198|100943929|FG001|Randomized Period|Ongoing|0|||
33286205|NCT00887198|100943930|FG002|Randomized Period|Ongoing|0|||
33286206|NCT00887198|100943928|FG000|Randomized Period|Adverse Event|50|||
33286207|NCT00887198|100943929|FG001|Randomized Period|Adverse Event|33|||
33286208|NCT00887198|100943930|FG002|Randomized Period|Adverse Event|0|||
33286209|NCT00887198|100943928|FG000|Randomized Period|Lost to Follow-up|1|||
33286210|NCT00887198|100943929|FG001|Randomized Period|Lost to Follow-up|0|||
33286211|NCT00887198|100943930|FG002|Randomized Period|Lost to Follow-up|0|||
33286212|NCT00887198|100943928|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
33286213|NCT00887198|100943929|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
33286214|NCT00887198|100943930|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
33286215|NCT00887198|100943928|FG000|Randomized Period|Withdrawal by Subject|41|||
33286216|NCT00887198|100943929|FG001|Randomized Period|Withdrawal by Subject|56|||
33286217|NCT00887198|100943930|FG002|Randomized Period|Withdrawal by Subject|0|||
33286218|NCT00887198|100943928|FG000|Randomized Period|Progressive disease|366|||
33286219|NCT00887198|100943929|FG001|Randomized Period|Progressive disease|370|||
33286220|NCT00887198|100943930|FG002|Randomized Period|Progressive disease|0|||
33286221|NCT00887198|100943928|FG000|Randomized Period|Other|42|||
33286222|NCT00887198|100943929|FG001|Randomized Period|Other|30|||
33286223|NCT00887198|100943930|FG002|Randomized Period|Other|0|||
33286224|NCT00887198|100943928|FG000|Randomized Period|Randomized, Not treated|4|||
33286225|NCT00887198|100943929|FG001|Randomized Period|Randomized, Not treated|2|||
33286226|NCT00887198|100943930|FG002|Randomized Period|Randomized, Not treated|0|||
33286227|NCT00887198|100943928|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
33286228|NCT00887198|100943929|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
33286229|NCT00887198|100943930|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
33286230|NCT00887198|100943928|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
33286231|NCT00887198|100943929|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
33286232|NCT00887198|100943930|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
33286233|NCT00887198|100943928|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
33286234|NCT00887198|100943929|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
33286235|NCT00887198|100943930|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
33286236|NCT00887198|100943928|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
33286237|NCT00887198|100943929|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
33286238|NCT00887198|100943930|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
33286239|NCT00887198|100943928|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
33286240|NCT00887198|100943929|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
33286241|NCT00887198|100943930|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
33286242|NCT00887198|100943928|FG000|Cross Over (Placebo to AA)|Other|0|||
33286243|NCT00887198|100943929|FG001|Cross Over (Placebo to AA)|Other|0|||
33286244|NCT00887198|100943930|FG002|Cross Over (Placebo to AA)|Other|19|||
33286245|NCT01309243|100943931|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
33286246|NCT01309243|100943932|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
33286247|NCT01309243|100943931|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
33286248|NCT01309243|100943932|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
33286249|NCT01309243|100943931|FG000|Randomized Phase Through Week 96|Death|0|||
33286250|NCT01309243|100943932|FG001|Randomized Phase Through Week 96|Death|1|||
33286251|NCT01309243|100943931|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
33286252|NCT01309243|100943932|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
33286253|NCT01309243|100943931|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
33286254|NCT01309243|100943932|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
33286255|NCT01309243|100943931|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
33286256|NCT01309243|100943932|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
33286257|NCT01309243|100943931|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
33286258|NCT01309243|100943932|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
33286259|NCT01309243|100943931|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
33286260|NCT01309243|100943932|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
33286261|NCT01309243|100943931|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
33286262|NCT01309243|100943932|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
33286263|NCT01309243|100943931|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
33489636|NCT00261443|101686749|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
33286264|NCT01309243|100943932|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
33489637|NCT00261443|101686750|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
33286265|NCT01309243|100943931|FG000|Extension Phase|Lost to Follow-up|6|||
33286266|NCT01309243|100943932|FG001|Extension Phase|Lost to Follow-up|0|||
33286267|NCT00349622|100943933|FG000|Overall Study|Death|168|||
33286268|NCT00349622|100943934|FG001|Overall Study|Death|86|||
33286269|NCT00349622|100943933|FG000|Overall Study|Lost to Follow-up|5|||
33286270|NCT00349622|100943934|FG001|Overall Study|Lost to Follow-up|1|||
33286271|NCT00349622|100943933|FG000|Overall Study|Withdrawal by Subject|5|||
33286272|NCT00349622|100943934|FG001|Overall Study|Withdrawal by Subject|9|||
33286273|NCT01917006|100943939|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
33286274|NCT01917006|100943940|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
33286275|NCT01917006|100943941|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
33286276|NCT01917006|100943942|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
33286277|NCT01917006|100943943|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
33286278|NCT01917006|100943944|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
33286279|NCT01917006|100943945|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
33286280|NCT01917006|100943946|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
33286281|NCT01917006|100943939|FG000|Randomized-treatment Period|Personal Reasons|0|||
33286282|NCT01917006|100943940|FG001|Randomized-treatment Period|Personal Reasons|0|||
33286283|NCT01917006|100943941|FG002|Randomized-treatment Period|Personal Reasons|0|||
33286284|NCT01917006|100943942|FG003|Randomized-treatment Period|Personal Reasons|0|||
33286285|NCT01917006|100943943|FG004|Randomized-treatment Period|Personal Reasons|0|||
33286286|NCT01917006|100943944|FG005|Randomized-treatment Period|Personal Reasons|1|||
33286287|NCT01917006|100943945|FG006|Randomized-treatment Period|Personal Reasons|0|||
33286288|NCT01917006|100943946|FG007|Randomized-treatment Period|Personal Reasons|0|||
33286289|NCT01917006|100943939|FG000|Randomized-treatment Period|Protocol Violation|1|||
33286290|NCT01917006|100943940|FG001|Randomized-treatment Period|Protocol Violation|0|||
33286291|NCT01917006|100943941|FG002|Randomized-treatment Period|Protocol Violation|0|||
33286292|NCT01917006|100943942|FG003|Randomized-treatment Period|Protocol Violation|0|||
33286293|NCT01917006|100943943|FG004|Randomized-treatment Period|Protocol Violation|0|||
33286294|NCT01917006|100943944|FG005|Randomized-treatment Period|Protocol Violation|0|||
33286295|NCT01917006|100943945|FG006|Randomized-treatment Period|Protocol Violation|0|||
33286296|NCT01917006|100943946|FG007|Randomized-treatment Period|Protocol Violation|0|||
33286297|NCT01917006|100943939|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
33286298|NCT01917006|100943940|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
33286299|NCT01917006|100943941|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
33286300|NCT01917006|100943942|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
33286301|NCT01917006|100943943|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
33286302|NCT01917006|100943944|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
33286303|NCT01917006|100943945|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
33286304|NCT01917006|100943946|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
33286305|NCT01917006|100943939|FG000|Open-label Period|Adverse Event|0|||
33286306|NCT01917006|100943940|FG001|Open-label Period|Adverse Event|0|||
33286307|NCT01917006|100943941|FG002|Open-label Period|Adverse Event|0|||
33286308|NCT01917006|100943942|FG003|Open-label Period|Adverse Event|0|||
33286309|NCT01917006|100943943|FG004|Open-label Period|Adverse Event|0|||
33286310|NCT01917006|100943944|FG005|Open-label Period|Adverse Event|0|||
33286311|NCT01917006|100943945|FG006|Open-label Period|Adverse Event|0|||
33286312|NCT01917006|100943946|FG007|Open-label Period|Adverse Event|1|||
33286313|NCT01917006|100943939|FG000|Open-label Period|Lost to Follow-up|0|||
33286314|NCT01917006|100943940|FG001|Open-label Period|Lost to Follow-up|0|||
33286315|NCT01917006|100943941|FG002|Open-label Period|Lost to Follow-up|0|||
33286316|NCT01917006|100943942|FG003|Open-label Period|Lost to Follow-up|0|||
33286317|NCT01917006|100943943|FG004|Open-label Period|Lost to Follow-up|0|||
33286318|NCT01917006|100943944|FG005|Open-label Period|Lost to Follow-up|0|||
33286319|NCT01917006|100943945|FG006|Open-label Period|Lost to Follow-up|0|||
33286320|NCT01917006|100943946|FG007|Open-label Period|Lost to Follow-up|1|||
33286321|NCT01841112|100943947|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
33286322|NCT01841112|100943948|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
33286323|NCT01841112|100943949|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
33286324|NCT01841112|100943950|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
33286325|NCT01841112|100943951|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
33286326|NCT02204319|100943952|FG000|Overall Study|Pregnancy|1|||
33286327|NCT02204319|100943952|FG000|Overall Study|Withdrawal by Subject|2|||
33286328|NCT02282059|100943953|FG000|Overall Study|Other|15|||
33286329|NCT02282059|100943954|FG001|Overall Study|Other|3|||
33286330|NCT02282059|100943953|FG000|Overall Study|Participant refused further follow-up|8|||
33286331|NCT02282059|100943954|FG001|Overall Study|Participant refused further follow-up|4|||
33286332|NCT02282059|100943953|FG000|Overall Study|Lost to Follow-up|19|||
33286333|NCT02282059|100943954|FG001|Overall Study|Lost to Follow-up|3|||
33286334|NCT02282059|100943953|FG000|Overall Study|Death|40|||
33286335|NCT02282059|100943954|FG001|Overall Study|Death|8|||
33286336|NCT00677092|100943959|FG000|Overall Study|Adverse Event|1|||
33286337|NCT00677092|100943959|FG000|Overall Study|Lost to Follow-up|1|||
33286338|NCT00677092|100943959|FG000|Overall Study|Withdrawal by Subject|3|||
33286339|NCT00677092|100943959|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
33286340|NCT02104505|100943960|FG000|First Intervention (14 Days)|Adverse Event|2|||
33286341|NCT02104505|100943961|FG001|First Intervention (14 Days)|Adverse Event|0|||
33286342|NCT02104505|100943960|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
33286343|NCT02104505|100943961|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
33286344|NCT02104505|100943960|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
33286345|NCT02104505|100943961|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
33286346|NCT02104505|100943960|FG000|First Intervention (14 Days)|exclusionary condition|0|||
33286347|NCT02104505|100943961|FG001|First Intervention (14 Days)|exclusionary condition|1|||
33286348|NCT02104505|100943960|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
33286349|NCT02104505|100943961|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
33286350|NCT02104505|100943960|FG000|Second Intervention (14 Days)|Adverse Event|2|||
33286351|NCT02104505|100943961|FG001|Second Intervention (14 Days)|Adverse Event|0|||
33286352|NCT00092521|100943968|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
33286353|NCT00092521|100943969|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
33286354|NCT00092521|100943970|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
33286355|NCT00092521|100943971|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
33286356|NCT00092521|100943968|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
33286357|NCT00092521|100943969|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
33286358|NCT00092521|100943970|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
33286359|NCT00092521|100943971|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
33286360|NCT00092521|100943968|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
33286361|NCT00092521|100943969|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
33286362|NCT00092521|100943970|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
33286363|NCT00092521|100943971|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
33286364|NCT00092521|100943968|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
33286365|NCT00092521|100943969|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
33286366|NCT00092521|100943970|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
33286367|NCT00092521|100943971|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
33286368|NCT00092521|100943968|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
33286369|NCT00092521|100943969|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
33286370|NCT00092521|100943970|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
33286371|NCT00092521|100943971|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
33286372|NCT00092521|100943968|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
33286373|NCT00092521|100943969|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
33286374|NCT00092521|100943970|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
33286375|NCT00092521|100943971|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
33286376|NCT00092521|100943968|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
33286377|NCT00092521|100943969|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
33286378|NCT00092521|100943970|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
33286379|NCT00092521|100943971|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
33286380|NCT00092521|100943968|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
33286381|NCT00092521|100943969|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
33286382|NCT00092521|100943970|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
33286383|NCT00092521|100943971|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
33286384|NCT00092521|100943968|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
33286385|NCT00092521|100943969|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
33286386|NCT00092521|100943970|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
33286387|NCT00092521|100943971|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
33286388|NCT00092521|100943968|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
33286389|NCT00092521|100943969|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
33286390|NCT00092521|100943970|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
33286391|NCT00092521|100943971|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
33286392|NCT00092521|100943968|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
33286393|NCT00092521|100943969|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
33286394|NCT00092521|100943970|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
33286395|NCT00092521|100943971|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
33286396|NCT00092521|100943968|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
33286397|NCT00092521|100943969|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
33286398|NCT00092521|100943970|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
33286399|NCT00092521|100943971|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
33286400|NCT00092521|100943968|FG000|Follow-Up (After Month 7)|Death|2|||
33286401|NCT00092521|100943969|FG001|Follow-Up (After Month 7)|Death|0|||
33286402|NCT00092521|100943970|FG002|Follow-Up (After Month 7)|Death|1|||
33286403|NCT00092521|100943971|FG003|Follow-Up (After Month 7)|Death|0|||
33286404|NCT00092521|100943968|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
33286405|NCT00092521|100943969|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
33286406|NCT00092521|100943970|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
33489638|NCT00261443|101686748|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
33489639|NCT00261443|101686749|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
33489640|NCT00261443|101686750|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
33489641|NCT00261443|101686748|FG000|3: Assessment of Relapse|Pregnancy|0|||
33489642|NCT00261443|101686749|FG001|3: Assessment of Relapse|Pregnancy|2|||
33489643|NCT00261443|101686750|FG002|3: Assessment of Relapse|Pregnancy|1|||
33489644|NCT00261443|101686748|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
33489645|NCT00261443|101686749|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
33489646|NCT00261443|101686750|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
33489647|NCT00261443|101686748|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
33489648|NCT00261443|101686749|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
33489649|NCT00261443|101686750|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
33489650|NCT00261443|101686748|FG000|3: Assessment of Relapse|Other Reasons|0|||
33489651|NCT00261443|101686749|FG001|3: Assessment of Relapse|Other Reasons|4|||
33489652|NCT00261443|101686750|FG002|3: Assessment of Relapse|Other Reasons|3|||
33489653|NCT00261443|101686748|FG000|4: Extension Phase|Adverse Event|0|||
33489654|NCT00261443|101686749|FG001|4: Extension Phase|Adverse Event|1|||
33489655|NCT00261443|101686750|FG002|4: Extension Phase|Adverse Event|0|||
33489656|NCT00261443|101686748|FG000|4: Extension Phase|Withdrawal by Subject|0|||
33489657|NCT00261443|101686749|FG001|4: Extension Phase|Withdrawal by Subject|1|||
33489658|NCT00261443|101686750|FG002|4: Extension Phase|Withdrawal by Subject|2|||
33489659|NCT00261443|101686748|FG000|4: Extension Phase|Lost to Follow-up|0|||
33489660|NCT00261443|101686749|FG001|4: Extension Phase|Lost to Follow-up|1|||
33489661|NCT00261443|101686750|FG002|4: Extension Phase|Lost to Follow-up|0|||
33489662|NCT01396512|101686751|FG000|Overall Study|Withdrawal by Subject|0|||
33489663|NCT01396512|101686752|FG001|Overall Study|Withdrawal by Subject|1|||
33489664|NCT02324582|101686756|FG000|Overall Study|Screen Failures|0|||
33489665|NCT02324582|101686757|FG001|Overall Study|Screen Failures|5|||
33489666|NCT02016183|101686758|FG000|Overall Study|Case Report Forms Uncollected|13|||
33489667|NCT02016183|101686758|FG000|Overall Study|Protocol Violation|52|||
33489668|NCT01153425|101686759|FG000|Overall Study|Withdrawal by Subject|3|||
33489669|NCT01153425|101686760|FG001|Overall Study|Withdrawal by Subject|3|||
33489670|NCT02723344|101686761|FG000|Overall Study|Lost to Follow-up|0|||
33489671|NCT02723344|101686762|FG001|Overall Study|Lost to Follow-up|4|||
33489672|NCT00946920|101686763|FG000|Overall Study|Withdrawal by Subject|28|||
33489673|NCT00946920|101686764|FG001|Overall Study|Withdrawal by Subject|15|||
33489674|NCT00946920|101686763|FG000|Overall Study|Lost to Follow-up|2|||
33489675|NCT00946920|101686764|FG001|Overall Study|Lost to Follow-up|2|||
33489676|NCT00946920|101686763|FG000|Overall Study|Physician Decision|5|||
33489677|NCT00946920|101686764|FG001|Overall Study|Physician Decision|2|||
33489678|NCT00946920|101686763|FG000|Overall Study|Adverse Event|41|||
33489679|NCT00946920|101686764|FG001|Overall Study|Adverse Event|14|||
33489680|NCT00946920|101686763|FG000|Overall Study|Protocol Violation|16|||
33489681|NCT00946920|101686764|FG001|Overall Study|Protocol Violation|8|||
33489682|NCT00946920|101686763|FG000|Overall Study|Miscellaneous reasons|18|||
33489683|NCT00946920|101686764|FG001|Overall Study|Miscellaneous reasons|3|||
33489684|NCT02540083|101686765|FG000|Overall Study|Withdrawal by Subject|16|||
33489685|NCT03126435|101686766|FG000|Overall Study|Death|90|||
33489686|NCT03126435|101686767|FG001|Overall Study|Death|84|||
33489687|NCT03126435|101686766|FG000|Overall Study|Lost to Follow-up|4|||
33489688|NCT03126435|101686767|FG001|Overall Study|Lost to Follow-up|3|||
33489689|NCT03126435|101686766|FG000|Overall Study|Physician Decision|0|||
33489690|NCT03126435|101686767|FG001|Overall Study|Physician Decision|1|||
33489691|NCT03126435|101686766|FG000|Overall Study|Withdrawal by Subject|6|||
33489692|NCT03126435|101686767|FG001|Overall Study|Withdrawal by Subject|12|||
33489693|NCT03126435|101686766|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
33489694|NCT03126435|101686767|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
33489695|NCT02006732|101686768|FG000|Overall Study|Adverse Event|10|||
33489696|NCT02006732|101686769|FG001|Overall Study|Adverse Event|7|||
33489697|NCT02006732|101686770|FG002|Overall Study|Adverse Event|4|||
33489698|NCT02006732|101686771|FG003|Overall Study|Adverse Event|2|||
33489699|NCT02006732|101686768|FG000|Overall Study|Lack of Efficacy|6|||
33489700|NCT02006732|101686769|FG001|Overall Study|Lack of Efficacy|3|||
33489701|NCT02006732|101686770|FG002|Overall Study|Lack of Efficacy|1|||
33489702|NCT02006732|101686771|FG003|Overall Study|Lack of Efficacy|1|||
33489703|NCT02006732|101686768|FG000|Overall Study|Protocol Violation|1|||
33489704|NCT02006732|101686769|FG001|Overall Study|Protocol Violation|1|||
33489705|NCT02006732|101686770|FG002|Overall Study|Protocol Violation|0|||
33489706|NCT02006732|101686771|FG003|Overall Study|Protocol Violation|0|||
33489707|NCT02006732|101686768|FG000|Overall Study|Lost to Follow-up|0|||
33489708|NCT02006732|101686769|FG001|Overall Study|Lost to Follow-up|1|||
33489709|NCT02006732|101686770|FG002|Overall Study|Lost to Follow-up|0|||
33489710|NCT02006732|101686771|FG003|Overall Study|Lost to Follow-up|0|||
33489711|NCT02006732|101686768|FG000|Overall Study|Withdrawal by Subject|3|||
33489712|NCT02006732|101686769|FG001|Overall Study|Withdrawal by Subject|0|||
33489713|NCT02006732|101686770|FG002|Overall Study|Withdrawal by Subject|4|||
33489714|NCT02006732|101686771|FG003|Overall Study|Withdrawal by Subject|1|||
33489830|NCT02952586|101686779|FG001|LT Follow-up (up to 45 Months)|Death|31|||
33489831|NCT02952586|101686778|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
33489832|NCT02952586|101686779|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
33489833|NCT02952586|101686778|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
33489834|NCT02952586|101686779|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
33489835|NCT02952586|101686778|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
33489836|NCT02952586|101686779|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
33489837|NCT03541317|101686780|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
33489838|NCT03541317|101686781|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
33489839|NCT03541317|101686782|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
33489840|NCT03541317|101686783|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
33489841|NCT03541317|101686784|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
33489842|NCT03541317|101686785|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
33489843|NCT03092219|101686789|FG000|Overall Study|Protocol Violation|7|||
33489844|NCT03092219|101686790|FG001|Overall Study|Protocol Violation|4|||
33489845|NCT02046603|101686791|FG000|Overall Study|Other|11|||
33489846|NCT02046603|101686792|FG001|Overall Study|Other|66|||
33489847|NCT02046603|101686791|FG000|Overall Study|Protocol Violation|0|||
33489848|NCT02046603|101686792|FG001|Overall Study|Protocol Violation|1|||
33489849|NCT02046603|101686791|FG000|Overall Study|Participant/legal guardian decision|1|||
33489850|NCT02046603|101686792|FG001|Overall Study|Participant/legal guardian decision|3|||
33489851|NCT02046603|101686791|FG000|Overall Study|Physician Decision|2|||
33489852|NCT02046603|101686792|FG001|Overall Study|Physician Decision|1|||
33489853|NCT02046603|101686791|FG000|Overall Study|Lost to Follow-up|1|||
33489854|NCT02046603|101686792|FG001|Overall Study|Lost to Follow-up|2|||
33489855|NCT02046603|101686791|FG000|Overall Study|Death|0|||
33489856|NCT02046603|101686792|FG001|Overall Study|Death|1|||
33489857|NCT02046603|101686791|FG000|Overall Study|Adverse Event|0|||
33489858|NCT02046603|101686792|FG001|Overall Study|Adverse Event|1|||
33489859|NCT04324021|101686793|FG000|Overall Study|Adverse Event|1|||
33489860|NCT04324021|101686794|FG001|Overall Study|Adverse Event|0|||
33489861|NCT04324021|101686795|FG002|Overall Study|Adverse Event|0|||
33489862|NCT04324021|101686793|FG000|Overall Study|Lack of Efficacy|0|||
33489863|NCT04324021|101686794|FG001|Overall Study|Lack of Efficacy|0|||
33489864|NCT04324021|101686795|FG002|Overall Study|Lack of Efficacy|1|||
33489865|NCT04324021|101686793|FG000|Overall Study|Death|1|||
33489866|NCT04324021|101686794|FG001|Overall Study|Death|1|||
33489867|NCT04324021|101686795|FG002|Overall Study|Death|0|||
33489868|NCT00668317|101686798|FG000|Overall Study|Adverse Event|2|||
33489869|NCT01526057|101686803|FG000|Overall Study|Withdrawal by Subject|3|||
33489870|NCT01526057|101686804|FG001|Overall Study|Withdrawal by Subject|2|||
33489871|NCT01526057|101686805|FG002|Overall Study|Withdrawal by Subject|2|||
33489872|NCT01526057|101686803|FG000|Overall Study|Adverse Event|3|||
33489873|NCT01526057|101686804|FG001|Overall Study|Adverse Event|1|||
33489874|NCT01526057|101686805|FG002|Overall Study|Adverse Event|1|||
33489875|NCT01526057|101686803|FG000|Overall Study|Death|1|||
33489876|NCT01526057|101686804|FG001|Overall Study|Death|0|||
33489877|NCT01526057|101686805|FG002|Overall Study|Death|0|||
33489878|NCT01526057|101686803|FG000|Overall Study|Lost to Follow-up|1|||
33489879|NCT01526057|101686804|FG001|Overall Study|Lost to Follow-up|0|||
33489880|NCT01526057|101686805|FG002|Overall Study|Lost to Follow-up|1|||
33489881|NCT01526057|101686803|FG000|Overall Study|Other|1|||
33489882|NCT01526057|101686804|FG001|Overall Study|Other|0|||
33489883|NCT01526057|101686805|FG002|Overall Study|Other|1|||
33489884|NCT01526057|101686803|FG000|Overall Study|Protocol Violation|0|||
33489885|NCT01526057|101686804|FG001|Overall Study|Protocol Violation|0|||
33489886|NCT01526057|101686805|FG002|Overall Study|Protocol Violation|1|||
33489887|NCT02585778|101686806|FG000|Overall Study|Adverse Event|17|||
33489888|NCT02585778|101686807|FG001|Overall Study|Adverse Event|4|||
33489889|NCT02585778|101686806|FG000|Overall Study|Participant did not wish to continue|9|||
33489890|NCT02585778|101686807|FG001|Overall Study|Participant did not wish to continue|4|||
33489891|NCT02585778|101686806|FG000|Overall Study|Poor compliance to study protocol|0|||
33489892|NCT02585778|101686807|FG001|Overall Study|Poor compliance to study protocol|2|||
33489893|NCT02585778|101686806|FG000|Overall Study|Death|0|||
33489894|NCT02585778|101686807|FG001|Overall Study|Death|1|||
33489895|NCT02585778|101686806|FG000|Overall Study|Randomized but not treated|1|||
33489896|NCT02585778|101686807|FG001|Overall Study|Randomized but not treated|2|||
33489897|NCT02585778|101686806|FG000|Overall Study|Other than specified above|6|||
33489898|NCT02585778|101686807|FG001|Overall Study|Other than specified above|2|||
33489899|NCT01286753|101686816|FG000|Overall Study|Adverse Event|7|||
33489900|NCT01286753|101686817|FG001|Overall Study|Adverse Event|6|||
33489901|NCT01286753|101686816|FG000|Overall Study|Progression|11|||
33489902|NCT01286753|101686817|FG001|Overall Study|Progression|13|||
33489903|NCT01286753|101686816|FG000|Overall Study|Refused Treatment|1|||
33489904|NCT01286753|101686817|FG001|Overall Study|Refused Treatment|0|||
33489905|NCT01286753|101686816|FG000|Overall Study|Withdrawal of Consent|0|||
33489906|NCT01286753|101686817|FG001|Overall Study|Withdrawal of Consent|2|||
33489907|NCT01286753|101686816|FG000|Overall Study|Discontinued to Join Extension Study|6|||
33489908|NCT01286753|101686817|FG001|Overall Study|Discontinued to Join Extension Study|4|||
33489909|NCT01286753|101686816|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
33489910|NCT01286753|101686817|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
33489911|NCT03552380|101686818|FG000|Study Treatment|Disease Progression|3|||
33489912|NCT03552380|101686819|FG001|Study Treatment|Disease Progression|4|||
33489913|NCT03552380|101686818|FG000|Study Treatment|Adverse Event|2|||
33489914|NCT03552380|101686819|FG001|Study Treatment|Adverse Event|2|||
33489915|NCT03552380|101686818|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
33489916|NCT03552380|101686819|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
33489917|NCT03552380|101686818|FG000|Follow up|Death|3|||
33489918|NCT03552380|101686819|FG001|Follow up|Death|4|||
33489919|NCT03552380|101686818|FG000|Follow up|Site IRB terminated|0|||
33489920|NCT03552380|101686819|FG001|Follow up|Site IRB terminated|1|||
33489921|NCT01982955|101686820|FG000|Overall Study|Randomized but not treated|0|||
33489922|NCT01982955|101686821|FG001|Overall Study|Randomized but not treated|0|||
33489923|NCT01982955|101686822|FG002|Overall Study|Randomized but not treated|0|||
33489924|NCT01982955|101686823|FG003|Overall Study|Randomized but not treated|1|||
33489925|NCT01982955|101686824|FG004|Overall Study|Randomized but not treated|0|||
33489926|NCT03905694|101686825|FG000|Long-term Extension Period|Remained in this Period at Time of Data Cut|18|||
33489927|NCT02431364|101686826|FG000|Overall Study|Adverse Event|0|||
33489928|NCT02431364|101686827|FG001|Overall Study|Adverse Event|1|||
33489929|NCT02431364|101686828|FG002|Overall Study|Adverse Event|0|||
33489930|NCT02431364|101686829|FG003|Overall Study|Adverse Event|0|||
33489931|NCT02431364|101686830|FG004|Overall Study|Adverse Event|0|||
33489932|NCT02431364|101686826|FG000|Overall Study|Randomized but never treated|0|||
33489933|NCT02431364|101686827|FG001|Overall Study|Randomized but never treated|0|||
33489934|NCT02431364|101686828|FG002|Overall Study|Randomized but never treated|0|||
33489935|NCT02431364|101686829|FG003|Overall Study|Randomized but never treated|1|||
33489936|NCT02431364|101686830|FG004|Overall Study|Randomized but never treated|0|||
33489937|NCT02681510|101686831|FG000|Overall Study|Withdrawal by Subject|1|||
33489938|NCT02681510|101686831|FG000|Overall Study|Lost to Follow-up|9|||
33489939|NCT02864992|101686837|FG000|Overall Study|still on treatment|15|||
33489940|NCT02864992|101686838|FG001|Overall Study|still on treatment|1|||
33489941|NCT02864992|101686839|FG002|Overall Study|still on treatment|33|||
33489942|NCT02717455|101686840|FG000|Overall Study|Adverse Event|1|||
33489943|NCT02717455|101686841|FG001|Overall Study|Adverse Event|0|||
33489944|NCT02717455|101686842|FG002|Overall Study|Adverse Event|0|||
33489945|NCT02717455|101686843|FG003|Overall Study|Adverse Event|2|||
33489946|NCT02717455|101686844|FG004|Overall Study|Adverse Event|2|||
33489947|NCT02717455|101686845|FG005|Overall Study|Adverse Event|2|||
33489948|NCT02717455|101686840|FG000|Overall Study|Withdrawal by Subject|1|||
33489949|NCT02717455|101686841|FG001|Overall Study|Withdrawal by Subject|1|||
33489950|NCT02717455|101686842|FG002|Overall Study|Withdrawal by Subject|0|||
33489951|NCT02717455|101686843|FG003|Overall Study|Withdrawal by Subject|2|||
33489952|NCT02717455|101686844|FG004|Overall Study|Withdrawal by Subject|2|||
33489953|NCT02717455|101686845|FG005|Overall Study|Withdrawal by Subject|1|||
33489954|NCT02717455|101686840|FG000|Overall Study|Death|1|||
33489955|NCT02717455|101686841|FG001|Overall Study|Death|0|||
33489956|NCT02717455|101686842|FG002|Overall Study|Death|0|||
33489957|NCT02717455|101686843|FG003|Overall Study|Death|0|||
33489958|NCT02717455|101686844|FG004|Overall Study|Death|1|||
33489959|NCT02717455|101686845|FG005|Overall Study|Death|0|||
33489960|NCT02717455|101686840|FG000|Overall Study|Did not receive study drug|0|||
33489961|NCT02717455|101686841|FG001|Overall Study|Did not receive study drug|0|||
33489962|NCT02717455|101686842|FG002|Overall Study|Did not receive study drug|0|||
33489963|NCT02717455|101686843|FG003|Overall Study|Did not receive study drug|1|||
33489964|NCT02717455|101686844|FG004|Overall Study|Did not receive study drug|0|||
33489965|NCT02717455|101686845|FG005|Overall Study|Did not receive study drug|1|||
33489966|NCT02717455|101686840|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
33489967|NCT02717455|101686841|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
33489968|NCT02717455|101686842|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
33489969|NCT02717455|101686843|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
33489970|NCT02717455|101686844|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
33489971|NCT02717455|101686845|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
33489972|NCT02717455|101686840|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
33489973|NCT02717455|101686841|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
33489974|NCT02717455|101686842|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
33489975|NCT02717455|101686843|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
33489976|NCT02717455|101686844|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
33489977|NCT02717455|101686845|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
33489978|NCT00490841|101686846|FG000|Overall Study|Death|5|||
33489979|NCT00490841|101686846|FG000|Overall Study|Withdrawal by Subject|4|||
33489980|NCT00490841|101686846|FG000|Overall Study|Lost to Follow-up|1|||
33489981|NCT00490841|101686846|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
33489982|NCT00587860|101686853|FG000|Overall Study|Lost to Follow-up|2|||
33489983|NCT00587860|101686854|FG001|Overall Study|Lost to Follow-up|2|||
33489984|NCT00587860|101686853|FG000|Overall Study|Withdrawal by Subject|3|||
33489985|NCT00587860|101686854|FG001|Overall Study|Withdrawal by Subject|3|||
33489986|NCT03519087|101686855|FG000|Clinic Evaluation|Physician Decision|15|||
33489987|NCT03519087|101686856|FG001|Clinic Evaluation|Physician Decision|18|||
33489988|NCT03519087|101686857|FG002|Clinic Evaluation|Physician Decision|0|||
33489989|NCT03519087|101686858|FG003|Clinic Evaluation|Physician Decision|0|||
33489990|NCT03519087|101686859|FG004|Clinic Evaluation|Physician Decision|0|||
33489991|NCT03519087|101686855|FG000|Clinic Evaluation|Protocol Violation|1|||
33489992|NCT03519087|101686856|FG001|Clinic Evaluation|Protocol Violation|0|||
33489993|NCT03519087|101686857|FG002|Clinic Evaluation|Protocol Violation|0|||
33489994|NCT03519087|101686858|FG003|Clinic Evaluation|Protocol Violation|0|||
33489995|NCT03519087|101686859|FG004|Clinic Evaluation|Protocol Violation|0|||
33489996|NCT03519087|101686855|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
33489997|NCT03519087|101686856|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
33489998|NCT03519087|101686857|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
33489999|NCT03519087|101686858|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
33490000|NCT03519087|101686859|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
33490001|NCT03519087|101686855|FG000|Re-randomization for Treatment|Not appropriate|2|||
33490002|NCT03519087|101686856|FG001|Re-randomization for Treatment|Not appropriate|3|||
33490003|NCT03519087|101686857|FG002|Re-randomization for Treatment|Not appropriate|0|||
33490004|NCT03519087|101686858|FG003|Re-randomization for Treatment|Not appropriate|0|||
33490005|NCT03519087|101686859|FG004|Re-randomization for Treatment|Not appropriate|0|||
33490006|NCT03519087|101686855|FG000|Laboratory Testing|Lost to Follow-up|0|||
33490007|NCT03519087|101686856|FG001|Laboratory Testing|Lost to Follow-up|0|||
33490008|NCT03519087|101686857|FG002|Laboratory Testing|Lost to Follow-up|2|||
33490009|NCT03519087|101686858|FG003|Laboratory Testing|Lost to Follow-up|3|||
33490010|NCT03519087|101686859|FG004|Laboratory Testing|Lost to Follow-up|6|||
33490011|NCT03519087|101686855|FG000|Laboratory Testing|Protocol Violation|0|||
33490012|NCT03519087|101686856|FG001|Laboratory Testing|Protocol Violation|0|||
33490013|NCT03519087|101686857|FG002|Laboratory Testing|Protocol Violation|0|||
33490014|NCT03519087|101686858|FG003|Laboratory Testing|Protocol Violation|1|||
33490015|NCT03519087|101686859|FG004|Laboratory Testing|Protocol Violation|0|||
33490016|NCT03348163|101686862|FG000|Overall Study|Withdrawal by Subject|2|||
33490017|NCT03348163|101686863|FG001|Overall Study|Withdrawal by Subject|0|||
33490018|NCT01699815|101686864|FG000|Overall Study|Protocol Violation|4|||
33490019|NCT01699815|101686865|FG001|Overall Study|Protocol Violation|7|||
33490020|NCT01699815|101686864|FG000|Overall Study|record could not be located|1|||
33490021|NCT01699815|101686865|FG001|Overall Study|record could not be located|0|||
33490022|NCT01699815|101686864|FG000|Overall Study|Adverse Event|0|||
33490023|NCT01699815|101686865|FG001|Overall Study|Adverse Event|1|||
33490024|NCT01810302|101686866|FG000|Overall Study|Death|1|||
33490025|NCT01810302|101686867|FG001|Overall Study|Death|0|||
33490026|NCT01810302|101686866|FG000|Overall Study|Physician Decision|0|||
33490027|NCT01810302|101686867|FG001|Overall Study|Physician Decision|1|||
33490028|NCT03267212|101686868|FG000|First Intervention|Lost to Follow-up|0|||
33490029|NCT03267212|101686869|FG001|First Intervention|Lost to Follow-up|2|||
33490030|NCT03267212|101686868|FG000|First Intervention|Withdrawal by Subject|1|||
33490031|NCT03267212|101686869|FG001|First Intervention|Withdrawal by Subject|1|||
33490032|NCT03267212|101686868|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
33490033|NCT03267212|101686869|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
33490034|NCT02308124|101686870|FG000|Overall Study|Lost to Follow-up|6|||
33490035|NCT02308124|101686871|FG001|Overall Study|Lost to Follow-up|6|||
33490036|NCT02308124|101686872|FG002|Overall Study|Lost to Follow-up|6|||
33490037|NCT02308124|101686870|FG000|Overall Study|Adverse Event|0|||
33490038|NCT02308124|101686871|FG001|Overall Study|Adverse Event|2|||
33490039|NCT02308124|101686872|FG002|Overall Study|Adverse Event|2|||
33490040|NCT04146012|101686878|FG000|Overall Study|Study Terminated|30|||
33490041|NCT04146012|101686879|FG001|Overall Study|Study Terminated|15|||
33490042|NCT02207634|101686891|FG000|Overall Study|Withdrawal by Subject|21|||
33490043|NCT02207634|101686892|FG001|Overall Study|Withdrawal by Subject|31|||
33490044|NCT02207634|101686891|FG000|Overall Study|Lost to Follow-up|1|||
33490045|NCT02207634|101686892|FG001|Overall Study|Lost to Follow-up|0|||
33490046|NCT00545714|101686893|FG000|Induction Phase (6 Months)|Physician Decision|3|||
33490047|NCT00545714|101686893|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
33490048|NCT00545714|101686893|FG000|Induction Phase (6 Months)|Disease Progression|1|||
33490049|NCT00545714|101686893|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
33490050|NCT00545714|101686893|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
33490051|NCT00545714|101686893|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
33490052|NCT00545714|101686893|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
33490053|NCT00545714|101686893|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
33492014|NCT01569295|101693852|FG001|Overall Study|Death|15|||
33490054|NCT00545714|101686893|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
33490055|NCT00545714|101686893|FG000|Maintenance Phase (36 Months)|Death|2|||
33490056|NCT01443728|101686898|FG000|Overall Study|Lost to Follow-up|2|||
33490057|NCT01443728|101686899|FG001|Overall Study|Lost to Follow-up|0|||
33490058|NCT01443728|101686898|FG000|Overall Study|Withdrawal by Subject|1|||
33490059|NCT01443728|101686899|FG001|Overall Study|Withdrawal by Subject|1|||
33490060|NCT01443728|101686898|FG000|Overall Study|Adverse Event|0|||
33490061|NCT01443728|101686899|FG001|Overall Study|Adverse Event|2|||
33490062|NCT00100828|101686902|FG000|Overall Study|Physician Decision|6|||
33490063|NCT00613171|101686905|FG000|Overall Study|Adverse Event|7|||
33490064|NCT00613171|101686905|FG000|Overall Study|Withdrawal by Subject|3|||
33490065|NCT00613171|101686905|FG000|Overall Study|Reason not Specified|4|||
33490066|NCT04782076|101686906|FG000|Overall Study|Family Emergency|1|||
33490067|NCT00246324|101686907|FG000|Overall Study|Withdrawal by Subject|1|||
33490068|NCT03889886|101686908|FG000|Overall Study|Other|0|||
33490069|NCT03889886|101686909|FG001|Overall Study|Other|1|||
33490070|NCT03889886|101686910|FG002|Overall Study|Other|0|||
33490071|NCT03889886|101686911|FG003|Overall Study|Other|1|||
33490072|NCT03889886|101686908|FG000|Overall Study|Withdrawal by Subject|0|||
33490073|NCT03889886|101686909|FG001|Overall Study|Withdrawal by Subject|0|||
33490074|NCT03889886|101686910|FG002|Overall Study|Withdrawal by Subject|1|||
33490075|NCT03889886|101686911|FG003|Overall Study|Withdrawal by Subject|0|||
33490076|NCT03889886|101686908|FG000|Overall Study|Adverse Event|0|||
33490077|NCT03889886|101686909|FG001|Overall Study|Adverse Event|0|||
33490078|NCT03889886|101686910|FG002|Overall Study|Adverse Event|0|||
33490079|NCT03889886|101686911|FG003|Overall Study|Adverse Event|6|||
33490080|NCT03288714|101686912|FG000|Overall Study|Lost to Follow-up|2|||
33490081|NCT03288714|101686913|FG001|Overall Study|Lost to Follow-up|1|||
33490082|NCT03288714|101686912|FG000|Overall Study|Non-compliance with study schedule|2|||
33490083|NCT03288714|101686913|FG001|Overall Study|Non-compliance with study schedule|0|||
33490084|NCT03288714|101686912|FG000|Overall Study|Withdrawal by Subject|3|||
33490085|NCT03288714|101686913|FG001|Overall Study|Withdrawal by Subject|1|||
33490086|NCT03288714|101686912|FG000|Overall Study|Clinical Worsening|2|||
33490087|NCT03288714|101686913|FG001|Overall Study|Clinical Worsening|1|||
33490088|NCT03288714|101686912|FG000|Overall Study|Adverse Event|1|||
33490089|NCT03288714|101686913|FG001|Overall Study|Adverse Event|0|||
33490090|NCT00398866|101686914|FG000|Overall Study|Adverse Event|1|||
33490091|NCT00398866|101686915|FG001|Overall Study|Adverse Event|0|||
33490092|NCT00398866|101686916|FG002|Overall Study|Adverse Event|0|||
33490093|NCT00398866|101686914|FG000|Overall Study|Lack of Efficacy|0|||
33490094|NCT00398866|101686915|FG001|Overall Study|Lack of Efficacy|0|||
33490095|NCT00398866|101686916|FG002|Overall Study|Lack of Efficacy|1|||
33490096|NCT00398866|101686914|FG000|Overall Study|Lost to Follow-up|7|||
33490097|NCT00398866|101686915|FG001|Overall Study|Lost to Follow-up|6|||
33490098|NCT00398866|101686916|FG002|Overall Study|Lost to Follow-up|4|||
33490099|NCT00398866|101686914|FG000|Overall Study|Withdrawal by Subject|5|||
33490100|NCT00398866|101686915|FG001|Overall Study|Withdrawal by Subject|1|||
33490101|NCT00398866|101686916|FG002|Overall Study|Withdrawal by Subject|2|||
33490102|NCT00398866|101686914|FG000|Overall Study|Unable to complete requirements of study|1|||
33490103|NCT00398866|101686915|FG001|Overall Study|Unable to complete requirements of study|1|||
33490104|NCT00398866|101686916|FG002|Overall Study|Unable to complete requirements of study|1|||
33490105|NCT01262872|101686923|FG000|Step 2|Death|0|||
33490106|NCT01262872|101686924|FG001|Step 2|Death|0|||
33490107|NCT01262872|101686925|FG002|Step 2|Death|0|||
33490108|NCT01262872|101686926|FG003|Step 2|Death|1|||
33490109|NCT01262872|101686927|FG004|Step 2|Death|0|||
33490110|NCT01262872|101686928|FG005|Step 2|Death|2|||
33490111|NCT01262872|101686929|FG006|Step 2|Death|2|||
33490112|NCT01262872|101686930|FG007|Step 2|Death|1|||
33490113|NCT01262872|101686923|FG000|Step 2|Protocol Violation|0|||
33490114|NCT01262872|101686924|FG001|Step 2|Protocol Violation|0|||
33490115|NCT01262872|101686925|FG002|Step 2|Protocol Violation|1|||
33490116|NCT01262872|101686926|FG003|Step 2|Protocol Violation|0|||
33490117|NCT01262872|101686927|FG004|Step 2|Protocol Violation|0|||
33490118|NCT01262872|101686928|FG005|Step 2|Protocol Violation|0|||
33490119|NCT01262872|101686929|FG006|Step 2|Protocol Violation|3|||
33490120|NCT01262872|101686930|FG007|Step 2|Protocol Violation|1|||
33490121|NCT01262872|101686923|FG000|Step 2|Withdrawal by Subject|0|||
33490122|NCT01262872|101686924|FG001|Step 2|Withdrawal by Subject|0|||
33490123|NCT01262872|101686925|FG002|Step 2|Withdrawal by Subject|4|||
33490124|NCT01262872|101686926|FG003|Step 2|Withdrawal by Subject|6|||
33490125|NCT01262872|101686927|FG004|Step 2|Withdrawal by Subject|3|||
33490126|NCT01262872|101686928|FG005|Step 2|Withdrawal by Subject|1|||
33490127|NCT01262872|101686929|FG006|Step 2|Withdrawal by Subject|2|||
33490128|NCT01262872|101686930|FG007|Step 2|Withdrawal by Subject|1|||
33490129|NCT01262872|101686923|FG000|Step 2|Migrated/moved from study area|0|||
33490130|NCT01262872|101686924|FG001|Step 2|Migrated/moved from study area|0|||
33490131|NCT01262872|101686925|FG002|Step 2|Migrated/moved from study area|4|||
33490132|NCT01262872|101686926|FG003|Step 2|Migrated/moved from study area|3|||
33490133|NCT01262872|101686927|FG004|Step 2|Migrated/moved from study area|2|||
33492015|NCT01569295|101693851|FG000|Overall Study|Physician Decision|13|||
33490134|NCT01262872|101686928|FG005|Step 2|Migrated/moved from study area|6|||
33490135|NCT01262872|101686929|FG006|Step 2|Migrated/moved from study area|2|||
33490136|NCT01262872|101686930|FG007|Step 2|Migrated/moved from study area|3|||
33490137|NCT01597973|101686931|FG000|Overall Study|Found ineligible before study medication started|4|||
33490138|NCT01597973|101686932|FG001|Overall Study|Found ineligible before study medication started|2|||
33490139|NCT01597973|101686931|FG000|Overall Study|Eligible pathogen not confirmed|14|||
33490140|NCT01597973|101686932|FG001|Overall Study|Eligible pathogen not confirmed|15|||
33490141|NCT01597973|101686931|FG000|Overall Study|LAR not authorized to consent|0|||
33490142|NCT01597973|101686932|FG001|Overall Study|LAR not authorized to consent|1|||
33490143|NCT01597973|101686931|FG000|Overall Study|Ineligible due to early seizures|1|||
33490144|NCT01597973|101686932|FG001|Overall Study|Ineligible due to early seizures|0|||
33490145|NCT01597973|101686931|FG000|Overall Study|Ineligible due to non-target infection|1|||
33490146|NCT01597973|101686932|FG001|Overall Study|Ineligible due to non-target infection|1|||
33490147|NCT03345420|101686933|FG000|Overall Study|Withdrawal by Subject|1|||
33490148|NCT02498392|101686934|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
33490149|NCT02498392|101686935|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
33490150|NCT02498392|101686934|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
33490151|NCT02498392|101686935|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
33490152|NCT02498392|101686934|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
33490153|NCT02498392|101686935|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
33490154|NCT02498392|101686934|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
33490155|NCT02498392|101686935|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
33490156|NCT02498392|101686934|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
33490157|NCT02498392|101686935|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
33490158|NCT02498392|101686934|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
33490159|NCT02498392|101686935|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
33490160|NCT00451204|101686936|FG000|Overall Study|Adverse Event|4|||
33490161|NCT00451204|101686937|FG001|Overall Study|Adverse Event|6|||
33490162|NCT00451204|101686936|FG000|Overall Study|Lack of Efficacy|4|||
33490163|NCT00451204|101686937|FG001|Overall Study|Lack of Efficacy|4|||
33490164|NCT00451204|101686936|FG000|Overall Study|Lost to Follow-up|4|||
33490165|NCT00451204|101686937|FG001|Overall Study|Lost to Follow-up|4|||
33490166|NCT00451204|101686936|FG000|Overall Study|Protocol Violation|1|||
33490167|NCT00451204|101686937|FG001|Overall Study|Protocol Violation|0|||
33490168|NCT00451204|101686936|FG000|Overall Study|Patient refusal|8|||
33490169|NCT00451204|101686937|FG001|Overall Study|Patient refusal|4|||
33490170|NCT00451204|101686936|FG000|Overall Study|Other|1|||
33490171|NCT00451204|101686937|FG001|Overall Study|Other|2|||
33490172|NCT02121652|101686943|FG000|Overall Study|Lost to Follow-up|2|||
33490173|NCT02121652|101686944|FG001|Overall Study|Lost to Follow-up|1|||
33490174|NCT02121652|101686943|FG000|Overall Study|Death|1|||
33490175|NCT02121652|101686944|FG001|Overall Study|Death|0|||
33490176|NCT02121652|101686943|FG000|Overall Study|Withdrawal by Subject|3|||
33490177|NCT02121652|101686944|FG001|Overall Study|Withdrawal by Subject|3|||
33490178|NCT00417170|101686945|FG000|Overall Study|Adverse Event|1|||
33490179|NCT00417170|101686946|FG001|Overall Study|Adverse Event|1|||
33490180|NCT00417170|101686945|FG000|Overall Study|Withdrawal by Subject|1|||
33490181|NCT00417170|101686946|FG001|Overall Study|Withdrawal by Subject|1|||
33490182|NCT00417170|101686945|FG000|Overall Study|Lost to Follow-up|0|||
33490183|NCT00417170|101686946|FG001|Overall Study|Lost to Follow-up|1|||
33490184|NCT02553772|101686947|FG000|Overall Study|Adverse Event|2|||
33490185|NCT02553772|101686948|FG001|Overall Study|Adverse Event|3|||
33490186|NCT02553772|101686947|FG000|Overall Study|Lost to Follow-up|2|||
33490187|NCT02553772|101686948|FG001|Overall Study|Lost to Follow-up|1|||
33490188|NCT02553772|101686947|FG000|Overall Study|Withdrawal of Consent|1|||
33490189|NCT02553772|101686948|FG001|Overall Study|Withdrawal of Consent|1|||
33490190|NCT02553772|101686947|FG000|Overall Study|Lack of Efficacy|1|||
33490191|NCT02553772|101686948|FG001|Overall Study|Lack of Efficacy|0|||
33490192|NCT02553772|101686947|FG000|Overall Study|Other Miscellaneous Reasons|0|||
33490193|NCT02553772|101686948|FG001|Overall Study|Other Miscellaneous Reasons|1|||
33490194|NCT02964247|101686953|FG000|Overall Study|Lost to Follow-up|2|||
33490195|NCT02964247|101686954|FG001|Overall Study|Lost to Follow-up|0|||
33490196|NCT02964247|101686953|FG000|Overall Study|Withdrawal by Subject|1|||
33490197|NCT02964247|101686954|FG001|Overall Study|Withdrawal by Subject|2|||
33490198|NCT04825912|101686955|FG000|Overall Study|Death|3|||
33490199|NCT04825912|101686955|FG000|Overall Study|Withdrawal by Subject|1|||
33490200|NCT00709995|101686956|FG000|Overall Study|Adverse Event|4|||
33490201|NCT00709995|101686957|FG001|Overall Study|Adverse Event|2|||
33490202|NCT00709995|101686956|FG000|Overall Study|Withdrawal by Subject|1|||
33490203|NCT00709995|101686957|FG001|Overall Study|Withdrawal by Subject|3|||
33490204|NCT02276807|101686958|FG000|Overall Study|Withdrawal by Subject|8|||
33490205|NCT02276807|101686959|FG001|Overall Study|Withdrawal by Subject|7|||
33490206|NCT02276807|101686958|FG000|Overall Study|Lost to Follow-up|10|||
33490207|NCT02276807|101686959|FG001|Overall Study|Lost to Follow-up|10|||
33490208|NCT04071405|101690431|FG000|Overall Study|Protocol Violation|3|||
33490209|NCT02269098|101690434|FG000|Overall Study|Lost to Follow-up|14|||
33490210|NCT02269098|101690435|FG001|Overall Study|Lost to Follow-up|9|||
33490211|NCT00591773|101690436|FG000|Overall Study|Adverse Event|9|||
33490212|NCT00591773|101690437|FG001|Overall Study|Adverse Event|9|||
33490213|NCT00591773|101690438|FG002|Overall Study|Adverse Event|6|||
33490214|NCT00591773|101690436|FG000|Overall Study|Protocol Violation|2|||
33490215|NCT00591773|101690437|FG001|Overall Study|Protocol Violation|3|||
33490216|NCT00591773|101690438|FG002|Overall Study|Protocol Violation|0|||
33490217|NCT00591773|101690436|FG000|Overall Study|Lost to Follow-up|1|||
33490218|NCT00591773|101690437|FG001|Overall Study|Lost to Follow-up|4|||
33490219|NCT00591773|101690438|FG002|Overall Study|Lost to Follow-up|1|||
33490220|NCT00591773|101690436|FG000|Overall Study|Withdrawal by Subject|2|||
33490221|NCT00591773|101690437|FG001|Overall Study|Withdrawal by Subject|5|||
33490222|NCT00591773|101690438|FG002|Overall Study|Withdrawal by Subject|3|||
33490223|NCT00591773|101690436|FG000|Overall Study|Lack of Efficacy|1|||
33490224|NCT00591773|101690437|FG001|Overall Study|Lack of Efficacy|2|||
33490225|NCT00591773|101690438|FG002|Overall Study|Lack of Efficacy|2|||
33490226|NCT00591773|101690436|FG000|Overall Study|Other|1|||
33490227|NCT00591773|101690437|FG001|Overall Study|Other|1|||
33490228|NCT00591773|101690438|FG002|Overall Study|Other|4|||
33490229|NCT01625091|101690441|FG000|Intervention|Death|1|||
33490230|NCT01625091|101690442|FG001|Intervention|Death|1|||
33490231|NCT01625091|101690441|FG000|Intervention|Withdrawal by Subject|4|||
33490232|NCT01625091|101690442|FG001|Intervention|Withdrawal by Subject|1|||
33490233|NCT01625091|101690441|FG000|Intervention|Adverse Event|0|||
33490234|NCT01625091|101690442|FG001|Intervention|Adverse Event|2|||
33490235|NCT01625091|101690441|FG000|Intervention|Lost to Follow-up|4|||
33490236|NCT01625091|101690442|FG001|Intervention|Lost to Follow-up|4|||
33490237|NCT01625091|101690441|FG000|Intervention|Study termination|2|||
33490238|NCT01625091|101690442|FG001|Intervention|Study termination|3|||
33490239|NCT01625091|101690441|FG000|Post-intervention|Death|0|||
33490240|NCT01625091|101690442|FG001|Post-intervention|Death|1|||
33490241|NCT01625091|101690441|FG000|Post-intervention|Lost to Follow-up|2|||
33490242|NCT01625091|101690442|FG001|Post-intervention|Lost to Follow-up|0|||
33490243|NCT01625091|101690441|FG000|Post-intervention|Study termination|2|||
33490244|NCT01625091|101690442|FG001|Post-intervention|Study termination|1|||
33490245|NCT01433055|101690443|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
33490246|NCT01433055|101690444|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
33490247|NCT01433055|101690443|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
33490248|NCT01433055|101690444|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
33490249|NCT01026194|101690446|FG000|Period 1：Double Blind Period|Adverse Event|2|||
33490250|NCT01026194|101690447|FG001|Period 1：Double Blind Period|Adverse Event|1|||
33490251|NCT01026194|101690446|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
33490252|NCT01026194|101690447|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
33490253|NCT01026194|101690446|FG000|Period 1：Double Blind Period|Physician Decision|0|||
33490254|NCT01026194|101690447|FG001|Period 1：Double Blind Period|Physician Decision|4|||
33490255|NCT01026194|101690446|FG000|Period 2：Open-label Period|Adverse Event|4|||
33490256|NCT01026194|101690447|FG001|Period 2：Open-label Period|Adverse Event|5|||
33490257|NCT01026194|101690446|FG000|Period 2：Open-label Period|Physician Decision|3|||
33490258|NCT01026194|101690447|FG001|Period 2：Open-label Period|Physician Decision|1|||
33490259|NCT01026194|101690446|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
33490260|NCT01026194|101690447|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
33490261|NCT00908544|101690453|FG000|Overall Study|Withdrawal by Subject|2|||
33490262|NCT00908544|101690454|FG001|Overall Study|Withdrawal by Subject|4|||
33490263|NCT00908544|101690453|FG000|Overall Study|Lack of Efficacy|0|||
33490264|NCT00908544|101690454|FG001|Overall Study|Lack of Efficacy|1|||
33490265|NCT00908544|101690453|FG000|Overall Study|Pregnancy|1|||
33490266|NCT00908544|101690454|FG001|Overall Study|Pregnancy|0|||
33490267|NCT00908544|101690453|FG000|Overall Study|Relocation abroad|1|||
33490268|NCT00908544|101690454|FG001|Overall Study|Relocation abroad|1|||
33490269|NCT00908544|101690453|FG000|Overall Study|Unable to visit sutdy center|1|||
33490270|NCT00908544|101690454|FG001|Overall Study|Unable to visit sutdy center|0|||
33490271|NCT01459783|101690455|FG000|Baseline to 6 Months|Death|1|||
33490272|NCT01459783|101690456|FG001|Baseline to 6 Months|Death|0|||
33490273|NCT01459783|101690455|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
33490274|NCT01459783|101690456|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
33490275|NCT01459783|101690455|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
33490276|NCT01459783|101690456|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
33490277|NCT01459783|101690455|FG000|6 Months to 12 Months|Death|0|||
33490278|NCT01459783|101690456|FG001|6 Months to 12 Months|Death|1|||
33490279|NCT01459783|101690455|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
33490280|NCT01459783|101690456|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
33490281|NCT01459783|101690455|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
33490282|NCT01459783|101690456|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
33492016|NCT01569295|101693852|FG001|Overall Study|Physician Decision|18|||
33490283|NCT01459783|101690455|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
33490284|NCT01459783|101690456|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
33490285|NCT02126826|101690457|FG000|Overall Study|Withdrawal by Subject|0|||
33490286|NCT02126826|101690458|FG001|Overall Study|Withdrawal by Subject|0|||
33490287|NCT02126826|101690459|FG002|Overall Study|Withdrawal by Subject|0|||
33490288|NCT02126826|101690460|FG003|Overall Study|Withdrawal by Subject|1|||
33490289|NCT02126826|101690461|FG004|Overall Study|Withdrawal by Subject|0|||
33490290|NCT02126826|101690462|FG005|Overall Study|Withdrawal by Subject|0|||
33490291|NCT02126826|101690463|FG006|Overall Study|Withdrawal by Subject|0|||
33490292|NCT04607135|101690465|FG000|Overall Study|Physician Decision|1|||
33490293|NCT04607135|101690465|FG000|Overall Study|Withdrawal by Subject|1|||
33490294|NCT04607135|101690465|FG000|Overall Study|Equipment not working|3|||
33490295|NCT02856555|101690466|FG000|Overall Study|Adverse Event|1|||
33490296|NCT02856555|101690467|FG001|Overall Study|Adverse Event|0|||
33490297|NCT02856555|101690468|FG002|Overall Study|Adverse Event|0|||
33490298|NCT02856555|101690466|FG000|Overall Study|Lost to Follow-up|1|||
33490299|NCT02856555|101690467|FG001|Overall Study|Lost to Follow-up|3|||
33490300|NCT02856555|101690468|FG002|Overall Study|Lost to Follow-up|0|||
33490301|NCT02856555|101690466|FG000|Overall Study|Withdrawal by Subject|3|||
33490302|NCT02856555|101690467|FG001|Overall Study|Withdrawal by Subject|0|||
33490303|NCT02856555|101690468|FG002|Overall Study|Withdrawal by Subject|0|||
33490304|NCT02856555|101690466|FG000|Overall Study|Randomized but Never Treated|0|||
33490305|NCT02856555|101690467|FG001|Overall Study|Randomized but Never Treated|1|||
33490306|NCT02856555|101690468|FG002|Overall Study|Randomized but Never Treated|0|||
33490307|NCT01289678|101690469|FG000|Overall Study|Physician Decision|6|||
33490308|NCT00580788|101690470|FG000|Overall Study|Adverse Event|0|||
33490309|NCT00580788|101690471|FG001|Overall Study|Adverse Event|0|||
33490310|NCT00580788|101690472|FG002|Overall Study|Adverse Event|0|||
33490311|NCT00580788|101690473|FG003|Overall Study|Adverse Event|1|||
33490312|NCT00124917|101690474|FG000|Overall Study|Physician Decision|3|||
33490313|NCT01207583|101690475|FG000|Overall Study|Withdrawal by Subject|0|||
33490314|NCT01207583|101690476|FG001|Overall Study|Withdrawal by Subject|3|||
33490315|NCT01207583|101690477|FG002|Overall Study|Withdrawal by Subject|1|||
33490316|NCT01207583|101690475|FG000|Overall Study|Participant failed to return|1|||
33490317|NCT01207583|101690476|FG001|Overall Study|Participant failed to return|0|||
33490318|NCT01207583|101690477|FG002|Overall Study|Participant failed to return|0|||
33490319|NCT01207583|101690475|FG000|Overall Study|Lost to Follow-up|0|||
33490320|NCT01207583|101690476|FG001|Overall Study|Lost to Follow-up|2|||
33490321|NCT01207583|101690477|FG002|Overall Study|Lost to Follow-up|0|||
33490322|NCT04447040|101690478|FG000|Overall Study|Lost to Follow-up|2|||
33490323|NCT04447040|101690479|FG001|Overall Study|Lost to Follow-up|1|||
33490324|NCT04447040|101690480|FG002|Overall Study|Lost to Follow-up|3|||
33490325|NCT04447040|101690481|FG003|Overall Study|Lost to Follow-up|3|||
33490326|NCT04447040|101690482|FG004|Overall Study|Lost to Follow-up|1|||
33490327|NCT04447040|101690483|FG005|Overall Study|Lost to Follow-up|3|||
33490328|NCT04447040|101690478|FG000|Overall Study|Withdrawal by Subject|0|||
33490329|NCT04447040|101690479|FG001|Overall Study|Withdrawal by Subject|1|||
33490330|NCT04447040|101690480|FG002|Overall Study|Withdrawal by Subject|1|||
33490331|NCT04447040|101690481|FG003|Overall Study|Withdrawal by Subject|1|||
33490332|NCT04447040|101690482|FG004|Overall Study|Withdrawal by Subject|0|||
33490333|NCT04447040|101690483|FG005|Overall Study|Withdrawal by Subject|0|||
33490334|NCT00725491|101690484|FG000|Overall Study|Adverse Event|3|||
33490335|NCT00725491|101690485|FG001|Overall Study|Adverse Event|2|||
33490336|NCT00725491|101690484|FG000|Overall Study|Pregnancy|0|||
33490337|NCT00725491|101690485|FG001|Overall Study|Pregnancy|3|||
33490338|NCT00725491|101690484|FG000|Overall Study|Risk for hyperstimulation|2|||
33490339|NCT00725491|101690485|FG001|Overall Study|Risk for hyperstimulation|9|||
33490340|NCT00725491|101690484|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
33490341|NCT00725491|101690485|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
33490342|NCT00725491|101690484|FG000|Overall Study|Fertilization failure|0|||
33490343|NCT00725491|101690485|FG001|Overall Study|Fertilization failure|1|||
33490344|NCT00725491|101690484|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
33490345|NCT00725491|101690485|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
33490346|NCT01090414|101690486|FG000|Study 101-99|Progressive Disease|28|||
33490347|NCT01090414|101690487|FG001|Study 101-99|Progressive Disease|48|||
33490348|NCT01090414|101690488|FG002|Study 101-99|Progressive Disease|10|||
33490349|NCT01090414|101690489|FG003|Study 101-99|Progressive Disease|4|||
33490350|NCT01090414|101690486|FG000|Study 101-99|Adverse Event|10|||
33490351|NCT01090414|101690487|FG001|Study 101-99|Adverse Event|28|||
33490352|NCT01090414|101690488|FG002|Study 101-99|Adverse Event|18|||
33490353|NCT01090414|101690489|FG003|Study 101-99|Adverse Event|0|||
33490354|NCT01090414|101690486|FG000|Study 101-99|Investigator Request|1|||
33490355|NCT01090414|101690487|FG001|Study 101-99|Investigator Request|11|||
33490356|NCT01090414|101690488|FG002|Study 101-99|Investigator Request|4|||
33490357|NCT01090414|101690489|FG003|Study 101-99|Investigator Request|0|||
33490358|NCT01090414|101690486|FG000|Study 101-99|Death|3|||
33490359|NCT01090414|101690487|FG001|Study 101-99|Death|8|||
33490360|NCT01090414|101690488|FG002|Study 101-99|Death|1|||
33490361|NCT01090414|101690489|FG003|Study 101-99|Death|0|||
33490362|NCT01090414|101690486|FG000|Study 101-99|Sponsor Discontinued Study|0|||
33490363|NCT01090414|101690487|FG001|Study 101-99|Sponsor Discontinued Study|7|||
33490364|NCT01090414|101690488|FG002|Study 101-99|Sponsor Discontinued Study|5|||
33490365|NCT01090414|101690489|FG003|Study 101-99|Sponsor Discontinued Study|0|||
33490366|NCT01090414|101690486|FG000|Study 101-99|Other (Unknown Reasons)|3|||
33490367|NCT01090414|101690487|FG001|Study 101-99|Other (Unknown Reasons)|3|||
33490368|NCT01090414|101690488|FG002|Study 101-99|Other (Unknown Reasons)|0|||
33490369|NCT01090414|101690489|FG003|Study 101-99|Other (Unknown Reasons)|0|||
33490370|NCT01090414|101690486|FG000|Study 101-99|Withdrew Consent|0|||
33490371|NCT01090414|101690487|FG001|Study 101-99|Withdrew Consent|2|||
33490372|NCT01090414|101690488|FG002|Study 101-99|Withdrew Consent|3|||
33490373|NCT01090414|101690489|FG003|Study 101-99|Withdrew Consent|1|||
33490374|NCT01090414|101690486|FG000|Study 101-99|Participant Request|3|||
33490375|NCT01090414|101690487|FG001|Study 101-99|Participant Request|1|||
33490376|NCT01090414|101690488|FG002|Study 101-99|Participant Request|0|||
33490377|NCT01090414|101690489|FG003|Study 101-99|Participant Request|0|||
33490378|NCT00064987|101690490|FG000|Overall Study|Physician Decision|3|||
33490379|NCT00064987|101690491|FG001|Overall Study|Physician Decision|0|||
33490380|NCT02524847|101690492|FG000|Overall Study|Adverse Event|4|||
33490381|NCT02524847|101690492|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
33490382|NCT02524847|101690492|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
33490383|NCT02524847|101690492|FG000|Overall Study|Death|1|||
33490384|NCT02524847|101690492|FG000|Overall Study|Reason not Specified|1|||
33490385|NCT01565889|101690493|FG000|Part A|Withdrawal by Subject|1|||
33490386|NCT01565889|101690494|FG001|Part A|Withdrawal by Subject|0|||
33490387|NCT01565889|101690495|FG002|Part A|Withdrawal by Subject|0|||
33490388|NCT01565889|101690496|FG003|Part A|Withdrawal by Subject|0|||
33490389|NCT01565889|101690497|FG004|Part A|Withdrawal by Subject|0|||
33490390|NCT01565889|101690498|FG005|Part A|Withdrawal by Subject|0|||
33490391|NCT01565889|101690493|FG000|Part B|Withdrawal by Subject|0|||
33490392|NCT01565889|101690494|FG001|Part B|Withdrawal by Subject|0|||
33490393|NCT01565889|101690495|FG002|Part B|Withdrawal by Subject|0|||
33490394|NCT01565889|101690496|FG003|Part B|Withdrawal by Subject|0|||
33490395|NCT01565889|101690497|FG004|Part B|Withdrawal by Subject|0|||
33490396|NCT01565889|101690498|FG005|Part B|Withdrawal by Subject|1|||
33490397|NCT01565889|101690493|FG000|Part B|Lack of Efficacy|0|||
33490398|NCT01565889|101690494|FG001|Part B|Lack of Efficacy|0|||
33490399|NCT01565889|101690495|FG002|Part B|Lack of Efficacy|0|||
33490400|NCT01565889|101690496|FG003|Part B|Lack of Efficacy|0|||
33490401|NCT01565889|101690497|FG004|Part B|Lack of Efficacy|0|||
33490402|NCT01565889|101690498|FG005|Part B|Lack of Efficacy|2|||
33490403|NCT01565889|101690493|FG000|Part B|Lost to Follow-up|0|||
33490404|NCT01565889|101690494|FG001|Part B|Lost to Follow-up|0|||
33490405|NCT01565889|101690495|FG002|Part B|Lost to Follow-up|0|||
33490406|NCT01565889|101690496|FG003|Part B|Lost to Follow-up|0|||
33490407|NCT01565889|101690497|FG004|Part B|Lost to Follow-up|0|||
33490408|NCT01565889|101690498|FG005|Part B|Lost to Follow-up|1|||
33490409|NCT01895777|101690499|FG000|Overall Study|Adverse Event|1|||
33490410|NCT01895777|101690500|FG001|Overall Study|Adverse Event|2|||
33490411|NCT01895777|101690499|FG000|Overall Study|Lost to Follow-up|2|||
33490412|NCT01895777|101690500|FG001|Overall Study|Lost to Follow-up|0|||
33490413|NCT01895777|101690499|FG000|Overall Study|Not treated|1|||
33490414|NCT01895777|101690500|FG001|Overall Study|Not treated|0|||
33490415|NCT01895777|101690499|FG000|Overall Study|Other reasons|3|||
33490416|NCT01895777|101690500|FG001|Overall Study|Other reasons|2|||
33490417|NCT01895777|101690499|FG000|Overall Study|Non-compliance with the CTP|2|||
33490418|NCT01895777|101690500|FG001|Overall Study|Non-compliance with the CTP|1|||
33490419|NCT02107131|101690501|FG000|Overall Study|Lost to Follow-up|4|||
33490420|NCT02107131|101690502|FG001|Overall Study|Lost to Follow-up|4|||
33490421|NCT02107131|101690501|FG000|Overall Study|Physician Decision|1|||
33490422|NCT02107131|101690502|FG001|Overall Study|Physician Decision|0|||
33490423|NCT02107131|101690501|FG000|Overall Study|Withdrawal by Subject|2|||
33490424|NCT02107131|101690502|FG001|Overall Study|Withdrawal by Subject|0|||
33490425|NCT02107131|101690501|FG000|Overall Study|mental instability|1|||
33490426|NCT02107131|101690502|FG001|Overall Study|mental instability|0|||
33490427|NCT02107131|101690501|FG000|Overall Study|Death|0|||
33490428|NCT02107131|101690502|FG001|Overall Study|Death|1|||
33490429|NCT02107131|101690501|FG000|Overall Study|Protocol Violation|0|||
33490430|NCT02107131|101690502|FG001|Overall Study|Protocol Violation|4|||
33490431|NCT01626690|101690503|FG000|Overall Study|Protocol Violation|1|||
33490432|NCT01626690|101690504|FG001|Overall Study|Protocol Violation|0|||
33490433|NCT01626690|101690503|FG000|Overall Study|Adverse Event|1|||
33490434|NCT01626690|101690504|FG001|Overall Study|Adverse Event|0|||
33490435|NCT00916383|101690507|FG000|Overall Study|Adverse Event|1|||
33490436|NCT00916383|101690507|FG000|Overall Study|Death|1|||
33490437|NCT00916383|101690507|FG000|Overall Study|Protocol Violation|1|||
33490438|NCT02286843|101690509|FG000|Overall Study|Not Treated|4|||
33490439|NCT02286843|101690509|FG000|Overall Study|Protocol Violation|1|||
33490440|NCT02286843|101690509|FG000|Overall Study|Withdrawal by Subject|1|||
33490441|NCT01112059|101690510|FG000|Overall Study|Withdrawal by Subject|1|||
33490442|NCT01112059|101690511|FG001|Overall Study|Withdrawal by Subject|0|||
33490443|NCT01176513|101690512|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
33490444|NCT04108299|101690514|FG000|Overall Study|Not interested in participating|2|||
33490445|NCT04108299|101690515|FG001|Overall Study|Not interested in participating|1|||
33490446|NCT04108299|101690516|FG002|Overall Study|Not interested in participating|2|||
33490447|NCT04108299|101690517|FG003|Overall Study|Not interested in participating|1|||
33490448|NCT02189837|101690525|FG000|Overall Study|Withdrawal by Subject|2|||
33490449|NCT02189837|101690526|FG001|Overall Study|Withdrawal by Subject|1|||
33490450|NCT02189837|101690527|FG002|Overall Study|Withdrawal by Subject|3|||
33490451|NCT02189837|101690528|FG003|Overall Study|Withdrawal by Subject|1|||
33490452|NCT02189837|101690525|FG000|Overall Study|Sponsor Decision|0|||
33490453|NCT02189837|101690526|FG001|Overall Study|Sponsor Decision|0|||
33490454|NCT02189837|101690527|FG002|Overall Study|Sponsor Decision|0|||
33490455|NCT02189837|101690528|FG003|Overall Study|Sponsor Decision|1|||
33490456|NCT02203357|101690534|FG000|Overall Study|Lost to Follow-up|58|||
33490457|NCT02203357|101690535|FG001|Overall Study|Lost to Follow-up|66|||
33490458|NCT02203357|101690536|FG002|Overall Study|Lost to Follow-up|70|||
33490459|NCT01609790|101690537|FG000|Overall Study|Protocol Violation|1|||
33490460|NCT01609790|101690538|FG001|Overall Study|Protocol Violation|7|||
33490461|NCT01609790|101690539|FG002|Overall Study|Protocol Violation|8|||
33490462|NCT01482312|101690546|FG000|Period 1, 90 Minutes of Wear|Other|1|||
33490463|NCT01482312|101690547|FG001|Period 1, 90 Minutes of Wear|Other|0|||
33490464|NCT01482312|101690548|FG002|Period 1, 90 Minutes of Wear|Other|0|||
33490465|NCT01482312|101690546|FG000|Period 2, 90 Minutes of Wear|Other|1|||
33490466|NCT01482312|101690547|FG001|Period 2, 90 Minutes of Wear|Other|0|||
33490467|NCT01482312|101690548|FG002|Period 2, 90 Minutes of Wear|Other|0|||
33490468|NCT00462904|101690549|FG000|Overall Study|Lost to Follow-up|1|||
33490469|NCT02906670|101690556|FG000|Cohort 1, QW|Radiological Progression|1|||
33490470|NCT02906670|101690557|FG001|Cohort 1, QW|Radiological Progression|0|||
33490471|NCT02906670|101690558|FG002|Cohort 1, QW|Radiological Progression|0|||
33490472|NCT02906670|101690559|FG003|Cohort 1, QW|Radiological Progression|0|||
33490473|NCT02906670|101690560|FG004|Cohort 1, QW|Radiological Progression|0|||
33490474|NCT02906670|101690561|FG005|Cohort 1, QW|Radiological Progression|0|||
33490475|NCT02906670|101690562|FG006|Cohort 1, QW|Radiological Progression|0|||
33490476|NCT02906670|101690563|FG007|Cohort 1, QW|Radiological Progression|0|||
33490477|NCT02906670|101690564|FG008|Cohort 1, QW|Radiological Progression|0|||
33490478|NCT02906670|101690565|FG009|Cohort 1, QW|Radiological Progression|0|||
33490479|NCT02906670|101690556|FG000|Cohort 2, QW|Radiological Progression|0|||
33490480|NCT02906670|101690557|FG001|Cohort 2, QW|Radiological Progression|1|||
33490481|NCT02906670|101690558|FG002|Cohort 2, QW|Radiological Progression|0|||
33490482|NCT02906670|101690559|FG003|Cohort 2, QW|Radiological Progression|0|||
33490483|NCT02906670|101690560|FG004|Cohort 2, QW|Radiological Progression|0|||
33490484|NCT02906670|101690561|FG005|Cohort 2, QW|Radiological Progression|0|||
33490485|NCT02906670|101690562|FG006|Cohort 2, QW|Radiological Progression|0|||
33490486|NCT02906670|101690563|FG007|Cohort 2, QW|Radiological Progression|0|||
33490487|NCT02906670|101690564|FG008|Cohort 2, QW|Radiological Progression|0|||
33490488|NCT02906670|101690565|FG009|Cohort 2, QW|Radiological Progression|0|||
33490489|NCT02906670|101690556|FG000|Cohort 3, QW|Radiological Progression|0|||
33490490|NCT02906670|101690557|FG001|Cohort 3, QW|Radiological Progression|0|||
33490491|NCT02906670|101690558|FG002|Cohort 3, QW|Radiological Progression|2|||
33490492|NCT02906670|101690559|FG003|Cohort 3, QW|Radiological Progression|0|||
33490493|NCT02906670|101690560|FG004|Cohort 3, QW|Radiological Progression|0|||
33490494|NCT02906670|101690561|FG005|Cohort 3, QW|Radiological Progression|0|||
33490495|NCT02906670|101690562|FG006|Cohort 3, QW|Radiological Progression|0|||
33490496|NCT02906670|101690563|FG007|Cohort 3, QW|Radiological Progression|0|||
33490497|NCT02906670|101690564|FG008|Cohort 3, QW|Radiological Progression|0|||
33490498|NCT02906670|101690565|FG009|Cohort 3, QW|Radiological Progression|0|||
33490499|NCT02906670|101690556|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
33490500|NCT02906670|101690557|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
33490501|NCT02906670|101690558|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
33490502|NCT02906670|101690559|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
33490503|NCT02906670|101690560|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
33490504|NCT02906670|101690561|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
33490505|NCT02906670|101690562|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
33490506|NCT02906670|101690563|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
33490507|NCT02906670|101690564|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
33490508|NCT02906670|101690565|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
33490509|NCT02906670|101690556|FG000|Cohort 4, Q2W|Radiological Progression|0|||
33490510|NCT02906670|101690557|FG001|Cohort 4, Q2W|Radiological Progression|0|||
33490511|NCT02906670|101690558|FG002|Cohort 4, Q2W|Radiological Progression|0|||
33490512|NCT02906670|101690559|FG003|Cohort 4, Q2W|Radiological Progression|0|||
33490513|NCT02906670|101690560|FG004|Cohort 4, Q2W|Radiological Progression|0|||
33490514|NCT02906670|101690561|FG005|Cohort 4, Q2W|Radiological Progression|1|||
33490515|NCT02906670|101690562|FG006|Cohort 4, Q2W|Radiological Progression|0|||
33490516|NCT02906670|101690563|FG007|Cohort 4, Q2W|Radiological Progression|0|||
33490517|NCT02906670|101690564|FG008|Cohort 4, Q2W|Radiological Progression|0|||
33490518|NCT02906670|101690565|FG009|Cohort 4, Q2W|Radiological Progression|0|||
33490519|NCT02906670|101690556|FG000|Cohort 4, Q2W|Clinical Progression|0|||
33490520|NCT02906670|101690557|FG001|Cohort 4, Q2W|Clinical Progression|0|||
33490521|NCT02906670|101690558|FG002|Cohort 4, Q2W|Clinical Progression|0|||
33490522|NCT02906670|101690559|FG003|Cohort 4, Q2W|Clinical Progression|0|||
33490523|NCT02906670|101690560|FG004|Cohort 4, Q2W|Clinical Progression|0|||
33490524|NCT02906670|101690561|FG005|Cohort 4, Q2W|Clinical Progression|2|||
33490525|NCT02906670|101690562|FG006|Cohort 4, Q2W|Clinical Progression|0|||
33490526|NCT02906670|101690563|FG007|Cohort 4, Q2W|Clinical Progression|0|||
33490527|NCT02906670|101690564|FG008|Cohort 4, Q2W|Clinical Progression|0|||
33490528|NCT02906670|101690565|FG009|Cohort 4, Q2W|Clinical Progression|0|||
33490529|NCT02906670|101690556|FG000|Cohort 5, Q2W|Radiological Progression|0|||
33490530|NCT02906670|101690557|FG001|Cohort 5, Q2W|Radiological Progression|0|||
33490531|NCT02906670|101690558|FG002|Cohort 5, Q2W|Radiological Progression|0|||
33490532|NCT02906670|101690559|FG003|Cohort 5, Q2W|Radiological Progression|0|||
33490533|NCT02906670|101690560|FG004|Cohort 5, Q2W|Radiological Progression|0|||
33490534|NCT02906670|101690561|FG005|Cohort 5, Q2W|Radiological Progression|0|||
33490535|NCT02906670|101690562|FG006|Cohort 5, Q2W|Radiological Progression|4|||
33490536|NCT02906670|101690563|FG007|Cohort 5, Q2W|Radiological Progression|0|||
33490537|NCT02906670|101690564|FG008|Cohort 5, Q2W|Radiological Progression|0|||
33490538|NCT02906670|101690565|FG009|Cohort 5, Q2W|Radiological Progression|0|||
33490539|NCT02906670|101690556|FG000|Cohort 5, Q2W|Clinical Progression|0|||
33490540|NCT02906670|101690557|FG001|Cohort 5, Q2W|Clinical Progression|0|||
33490541|NCT02906670|101690558|FG002|Cohort 5, Q2W|Clinical Progression|0|||
33490542|NCT02906670|101690559|FG003|Cohort 5, Q2W|Clinical Progression|0|||
33490543|NCT02906670|101690560|FG004|Cohort 5, Q2W|Clinical Progression|0|||
33490544|NCT02906670|101690561|FG005|Cohort 5, Q2W|Clinical Progression|0|||
33490545|NCT02906670|101690562|FG006|Cohort 5, Q2W|Clinical Progression|1|||
33490546|NCT02906670|101690563|FG007|Cohort 5, Q2W|Clinical Progression|0|||
33490547|NCT02906670|101690564|FG008|Cohort 5, Q2W|Clinical Progression|0|||
33490548|NCT02906670|101690565|FG009|Cohort 5, Q2W|Clinical Progression|0|||
33490549|NCT02906670|101690556|FG000|Cohort 5, Q2W|Adverse Event|0|||
33490550|NCT02906670|101690557|FG001|Cohort 5, Q2W|Adverse Event|0|||
33490551|NCT02906670|101690558|FG002|Cohort 5, Q2W|Adverse Event|0|||
33490552|NCT02906670|101690559|FG003|Cohort 5, Q2W|Adverse Event|0|||
33490553|NCT02906670|101690560|FG004|Cohort 5, Q2W|Adverse Event|0|||
33490554|NCT02906670|101690561|FG005|Cohort 5, Q2W|Adverse Event|0|||
33490555|NCT02906670|101690562|FG006|Cohort 5, Q2W|Adverse Event|1|||
33490556|NCT02906670|101690563|FG007|Cohort 5, Q2W|Adverse Event|0|||
33490557|NCT02906670|101690564|FG008|Cohort 5, Q2W|Adverse Event|0|||
33490558|NCT02906670|101690565|FG009|Cohort 5, Q2W|Adverse Event|0|||
33490559|NCT02906670|101690556|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33490560|NCT02906670|101690557|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33490561|NCT02906670|101690558|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33490562|NCT02906670|101690559|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33490563|NCT02906670|101690560|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33490564|NCT02906670|101690561|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33490565|NCT02906670|101690562|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
33490566|NCT02906670|101690563|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33490567|NCT02906670|101690564|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33490568|NCT02906670|101690565|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
33490569|NCT02906670|101690556|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
33490570|NCT02906670|101690557|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
33490571|NCT02906670|101690558|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
33490572|NCT02906670|101690559|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
33490573|NCT02906670|101690560|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
33490574|NCT02906670|101690561|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
33490575|NCT02906670|101690562|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
33490576|NCT02906670|101690563|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
33490577|NCT02906670|101690564|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
33490578|NCT02906670|101690565|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
33490579|NCT02906670|101690556|FG000|Cohort 5P, Q2W|Adverse Event|0|||
33490580|NCT02906670|101690557|FG001|Cohort 5P, Q2W|Adverse Event|0|||
33490581|NCT02906670|101690558|FG002|Cohort 5P, Q2W|Adverse Event|0|||
33490582|NCT02906670|101690559|FG003|Cohort 5P, Q2W|Adverse Event|0|||
33490583|NCT02906670|101690560|FG004|Cohort 5P, Q2W|Adverse Event|0|||
33490584|NCT02906670|101690561|FG005|Cohort 5P, Q2W|Adverse Event|0|||
33490585|NCT02906670|101690562|FG006|Cohort 5P, Q2W|Adverse Event|0|||
33490586|NCT02906670|101690563|FG007|Cohort 5P, Q2W|Adverse Event|1|||
33490587|NCT02906670|101690564|FG008|Cohort 5P, Q2W|Adverse Event|0|||
33490588|NCT02906670|101690565|FG009|Cohort 5P, Q2W|Adverse Event|0|||
33490589|NCT02906670|101690556|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
33490590|NCT02906670|101690557|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
33490591|NCT02906670|101690558|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
33490592|NCT02906670|101690559|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
33490593|NCT02906670|101690560|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
33490594|NCT02906670|101690561|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
33490595|NCT02906670|101690562|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
33490596|NCT02906670|101690563|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
33490597|NCT02906670|101690564|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
33490598|NCT02906670|101690565|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
33490599|NCT02906670|101690556|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
33490600|NCT02906670|101690557|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
33490601|NCT02906670|101690558|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
33490602|NCT02906670|101690559|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
33490603|NCT02906670|101690560|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
33490604|NCT02906670|101690561|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
33490605|NCT02906670|101690562|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
33490606|NCT02906670|101690563|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
33490607|NCT02906670|101690564|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
33490608|NCT02906670|101690565|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
33490609|NCT02906670|101690556|FG000|Cohort 4P, QW|Radiological Progression|0|||
33490610|NCT02906670|101690557|FG001|Cohort 4P, QW|Radiological Progression|0|||
33490611|NCT02906670|101690558|FG002|Cohort 4P, QW|Radiological Progression|0|||
33490612|NCT02906670|101690559|FG003|Cohort 4P, QW|Radiological Progression|3|||
33490613|NCT02906670|101690560|FG004|Cohort 4P, QW|Radiological Progression|0|||
33490614|NCT02906670|101690561|FG005|Cohort 4P, QW|Radiological Progression|0|||
33490615|NCT02906670|101690562|FG006|Cohort 4P, QW|Radiological Progression|0|||
33490616|NCT02906670|101690563|FG007|Cohort 4P, QW|Radiological Progression|0|||
33490617|NCT02906670|101690564|FG008|Cohort 4P, QW|Radiological Progression|0|||
33490618|NCT02906670|101690565|FG009|Cohort 4P, QW|Radiological Progression|0|||
33490619|NCT02906670|101690556|FG000|Cohort 7P, Q2W|Adverse Event|0|||
33490620|NCT02906670|101690557|FG001|Cohort 7P, Q2W|Adverse Event|0|||
33490621|NCT02906670|101690558|FG002|Cohort 7P, Q2W|Adverse Event|0|||
33490622|NCT02906670|101690559|FG003|Cohort 7P, Q2W|Adverse Event|0|||
33490623|NCT02906670|101690560|FG004|Cohort 7P, Q2W|Adverse Event|0|||
33490624|NCT02906670|101690561|FG005|Cohort 7P, Q2W|Adverse Event|0|||
33490625|NCT02906670|101690562|FG006|Cohort 7P, Q2W|Adverse Event|0|||
33490626|NCT02906670|101690563|FG007|Cohort 7P, Q2W|Adverse Event|0|||
33490627|NCT02906670|101690564|FG008|Cohort 7P, Q2W|Adverse Event|0|||
33490628|NCT02906670|101690565|FG009|Cohort 7P, Q2W|Adverse Event|1|||
33490629|NCT02906670|101690556|FG000|Cohort 7P, Q2W|Physician Decision|0|||
33490630|NCT02906670|101690557|FG001|Cohort 7P, Q2W|Physician Decision|0|||
33490631|NCT02906670|101690558|FG002|Cohort 7P, Q2W|Physician Decision|0|||
33490632|NCT02906670|101690559|FG003|Cohort 7P, Q2W|Physician Decision|0|||
33490633|NCT02906670|101690560|FG004|Cohort 7P, Q2W|Physician Decision|0|||
33490634|NCT02906670|101690561|FG005|Cohort 7P, Q2W|Physician Decision|0|||
33490635|NCT02906670|101690562|FG006|Cohort 7P, Q2W|Physician Decision|0|||
33490636|NCT02906670|101690563|FG007|Cohort 7P, Q2W|Physician Decision|0|||
33490637|NCT02906670|101690564|FG008|Cohort 7P, Q2W|Physician Decision|0|||
33490638|NCT02906670|101690565|FG009|Cohort 7P, Q2W|Physician Decision|1|||
33490639|NCT02906670|101690556|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33490640|NCT02906670|101690557|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33490641|NCT02906670|101690558|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33490642|NCT02906670|101690559|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33490643|NCT02906670|101690560|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33490644|NCT02906670|101690561|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33490645|NCT02906670|101690562|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33490646|NCT02906670|101690563|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33490647|NCT02906670|101690564|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
33490648|NCT02906670|101690565|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
33490649|NCT02906670|101690556|FG000|Cohort 5P, QW|Radiological Progression|0|||
33490650|NCT02906670|101690557|FG001|Cohort 5P, QW|Radiological Progression|0|||
33490651|NCT02906670|101690558|FG002|Cohort 5P, QW|Radiological Progression|0|||
33490652|NCT02906670|101690559|FG003|Cohort 5P, QW|Radiological Progression|0|||
33490653|NCT02906670|101690560|FG004|Cohort 5P, QW|Radiological Progression|3|||
33490654|NCT02906670|101690561|FG005|Cohort 5P, QW|Radiological Progression|0|||
33490655|NCT02906670|101690562|FG006|Cohort 5P, QW|Radiological Progression|0|||
33490656|NCT02906670|101690563|FG007|Cohort 5P, QW|Radiological Progression|0|||
33490657|NCT02906670|101690564|FG008|Cohort 5P, QW|Radiological Progression|0|||
33490658|NCT02906670|101690565|FG009|Cohort 5P, QW|Radiological Progression|0|||
33490659|NCT05373108|101690567|FG000|Overall Study|Withdrawal by Subject|2|||
33490660|NCT04564092|101690568|FG000|Overall Study|Withdrawal by Subject|1|||
33490661|NCT02719184|101690576|FG000|Overall Study|Other than listed|1|||
33490662|NCT02719184|101690577|FG001|Overall Study|Other than listed|12|||
33490663|NCT02719184|101690578|FG002|Overall Study|Other than listed|13|||
33490664|NCT02719184|101690579|FG003|Overall Study|Other than listed|22|||
33490665|NCT02719184|101690580|FG004|Overall Study|Other than listed|9|||
33490666|NCT02719184|101690576|FG000|Overall Study|Withdrawal by Subject|5|||
33490667|NCT02719184|101690577|FG001|Overall Study|Withdrawal by Subject|3|||
33490668|NCT02719184|101690578|FG002|Overall Study|Withdrawal by Subject|6|||
33490669|NCT02719184|101690579|FG003|Overall Study|Withdrawal by Subject|6|||
33490670|NCT02719184|101690580|FG004|Overall Study|Withdrawal by Subject|0|||
33490671|NCT02719184|101690576|FG000|Overall Study|Lost to Follow-up|0|||
33490672|NCT02719184|101690577|FG001|Overall Study|Lost to Follow-up|4|||
33490673|NCT02719184|101690578|FG002|Overall Study|Lost to Follow-up|1|||
33490674|NCT02719184|101690579|FG003|Overall Study|Lost to Follow-up|3|||
33490675|NCT02719184|101690580|FG004|Overall Study|Lost to Follow-up|0|||
33490676|NCT02719184|101690576|FG000|Overall Study|Protocol Violation|0|||
33490677|NCT02719184|101690577|FG001|Overall Study|Protocol Violation|3|||
33490678|NCT02719184|101690578|FG002|Overall Study|Protocol Violation|0|||
33490679|NCT02719184|101690579|FG003|Overall Study|Protocol Violation|2|||
33490680|NCT02719184|101690580|FG004|Overall Study|Protocol Violation|0|||
33490681|NCT02719184|101690576|FG000|Overall Study|Adverse Event|0|||
33490682|NCT02719184|101690577|FG001|Overall Study|Adverse Event|0|||
33490683|NCT02719184|101690578|FG002|Overall Study|Adverse Event|0|||
33490684|NCT02719184|101690579|FG003|Overall Study|Adverse Event|3|||
33490685|NCT02719184|101690580|FG004|Overall Study|Adverse Event|0|||
33490686|NCT01811472|101690581|FG000|Overall Study|Adverse Event|1|||
33490687|NCT01811472|101690582|FG001|Overall Study|Adverse Event|0|||
33490688|NCT01811472|101690583|FG002|Overall Study|Adverse Event|4|||
33490689|NCT01811472|101690581|FG000|Overall Study|Lost to Follow-up|0|||
33490690|NCT01811472|101690582|FG001|Overall Study|Lost to Follow-up|0|||
33490691|NCT01811472|101690583|FG002|Overall Study|Lost to Follow-up|1|||
33490692|NCT01811472|101690581|FG000|Overall Study|Subject/guardian decision|1|||
33490693|NCT01811472|101690582|FG001|Overall Study|Subject/guardian decision|0|||
33490694|NCT01811472|101690583|FG002|Overall Study|Subject/guardian decision|0|||
33490695|NCT01168427|101690584|FG000|Overall Study|Patient exited prior to implant|1|||
33490696|NCT04123405|101690585|FG000|Overall Study|Adverse Event|1|||
33490697|NCT04123405|101690586|FG001|Overall Study|Adverse Event|2|||
33490698|NCT04123405|101690587|FG002|Overall Study|Adverse Event|3|||
33490699|NCT04123405|101690588|FG003|Overall Study|Adverse Event|3|||
33490700|NCT04123405|101690585|FG000|Overall Study|Exclusion criteria met|1|||
33490701|NCT04123405|101690586|FG001|Overall Study|Exclusion criteria met|2|||
33490702|NCT04123405|101690587|FG002|Overall Study|Exclusion criteria met|0|||
33490703|NCT04123405|101690588|FG003|Overall Study|Exclusion criteria met|2|||
33490704|NCT04123405|101690585|FG000|Overall Study|Withdrawal by Subject|1|||
33490705|NCT04123405|101690586|FG001|Overall Study|Withdrawal by Subject|3|||
33490706|NCT04123405|101690587|FG002|Overall Study|Withdrawal by Subject|0|||
33490707|NCT04123405|101690588|FG003|Overall Study|Withdrawal by Subject|2|||
33490708|NCT04123405|101690585|FG000|Overall Study|Contact to subject lost|0|||
33490709|NCT04123405|101690586|FG001|Overall Study|Contact to subject lost|0|||
33490710|NCT04123405|101690587|FG002|Overall Study|Contact to subject lost|0|||
33490711|NCT04123405|101690588|FG003|Overall Study|Contact to subject lost|1|||
33490712|NCT04123405|101690585|FG000|Overall Study|screening failure|1|||
33490713|NCT04123405|101690586|FG001|Overall Study|screening failure|0|||
33490714|NCT04123405|101690587|FG002|Overall Study|screening failure|0|||
33490715|NCT04123405|101690588|FG003|Overall Study|screening failure|0|||
33490716|NCT02500043|101690589|FG000|Overall Study|Randomized, but not Treated|2|||
33490717|NCT02500043|101690590|FG001|Overall Study|Randomized, but not Treated|2|||
33490718|NCT02500043|101690589|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
33490719|NCT02500043|101690590|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
33490720|NCT02500043|101690589|FG000|Overall Study|Adverse Event|33|||
33490721|NCT02500043|101690590|FG001|Overall Study|Adverse Event|11|||
33490722|NCT02500043|101690589|FG000|Overall Study|Clinical Progression|54|||
33490723|NCT02500043|101690590|FG001|Overall Study|Clinical Progression|35|||
33490724|NCT02500043|101690589|FG000|Overall Study|Radiological Progression|192|||
33490725|NCT02500043|101690590|FG001|Overall Study|Radiological Progression|110|||
33490726|NCT02500043|101690589|FG000|Overall Study|Physician's Decision|11|||
33490727|NCT02500043|101690590|FG001|Overall Study|Physician's Decision|3|||
33490728|NCT02500043|101690589|FG000|Overall Study|Withdrawal by Subject|14|||
33490729|NCT02500043|101690590|FG001|Overall Study|Withdrawal by Subject|4|||
33490730|NCT02500043|101690589|FG000|Overall Study|Death|11|||
33490731|NCT02500043|101690590|FG001|Overall Study|Death|2|||
33490732|NCT02500043|101690589|FG000|Overall Study|Protocol Deviation|1|||
33490733|NCT02500043|101690590|FG001|Overall Study|Protocol Deviation|0|||
33490734|NCT04479787|101690591|FG000|Overall Study|Withdrawal by Subject|19|||
33490735|NCT04479787|101690592|FG001|Overall Study|Withdrawal by Subject|27|||
33490736|NCT04479787|101690591|FG000|Overall Study|Unsuccessful Trial|17|||
33490737|NCT04479787|101690592|FG001|Overall Study|Unsuccessful Trial|7|||
33490738|NCT04479787|101690591|FG000|Overall Study|Subject Participation Terminated By Investigator|14|||
33490739|NCT04479787|101690592|FG001|Overall Study|Subject Participation Terminated By Investigator|5|||
33490740|NCT04479787|101690591|FG000|Overall Study|IPG/Lead(s) Explanted But Not Replaced|4|||
33490741|NCT04479787|101690592|FG001|Overall Study|IPG/Lead(s) Explanted But Not Replaced|4|||
33490742|NCT04479787|101690591|FG000|Overall Study|Lost to Follow-up|3|||
33490743|NCT04479787|101690592|FG001|Overall Study|Lost to Follow-up|3|||
33490744|NCT04479787|101690591|FG000|Overall Study|Death|4|||
33490745|NCT04479787|101690592|FG001|Overall Study|Death|0|||
33490746|NCT04479787|101690591|FG000|Overall Study|Inclusion/Exclusion|2|||
33490747|NCT04479787|101690592|FG001|Overall Study|Inclusion/Exclusion|1|||
33490748|NCT04479787|101690591|FG000|Overall Study|Subject Became Pregnant|1|||
33490749|NCT04479787|101690592|FG001|Overall Study|Subject Became Pregnant|1|||
33490750|NCT04479787|101690591|FG000|Overall Study|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
33490751|NCT04479787|101690592|FG001|Overall Study|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
33490752|NCT04479787|101690591|FG000|Overall Study|Patient's Health Significantly Declined|0|||
33490753|NCT04479787|101690592|FG001|Overall Study|Patient's Health Significantly Declined|1|||
33490754|NCT04479787|101690591|FG000|Overall Study|Subject Had Back Surgery On March 1st|0|||
33490755|NCT04479787|101690592|FG001|Overall Study|Subject Had Back Surgery On March 1st|1|||
33490756|NCT04479787|101690591|FG000|Overall Study|Withdrawn At Sponsor's Request|1|||
33490757|NCT04479787|101690592|FG001|Overall Study|Withdrawn At Sponsor's Request|0|||
33490758|NCT04479787|101690591|FG000|Overall Study|Subject Failed To Comply With The Protocol Requirements|1|||
33490759|NCT04479787|101690592|FG001|Overall Study|Subject Failed To Comply With The Protocol Requirements|0|||
33490760|NCT01495000|101690601|FG000|Overall Study|Lost to Follow-up|2|||
33490761|NCT01495000|101690602|FG001|Overall Study|Lost to Follow-up|2|||
33490762|NCT01495000|101690601|FG000|Overall Study|Protocol Violation|1|||
33490763|NCT01495000|101690602|FG001|Overall Study|Protocol Violation|0|||
33490764|NCT01495000|101690601|FG000|Overall Study|Withdrawal by Subject|10|||
33490765|NCT01495000|101690602|FG001|Overall Study|Withdrawal by Subject|10|||
33490766|NCT02604407|101690615|FG000|Overall Study|Adverse Event|0|||
33490767|NCT02604407|101690616|FG001|Overall Study|Adverse Event|7|||
33490768|NCT02604407|101690617|FG002|Overall Study|Adverse Event|5|||
33490769|NCT02604407|101690615|FG000|Overall Study|Protocol Violation|2|||
33490770|NCT02604407|101690616|FG001|Overall Study|Protocol Violation|0|||
33490771|NCT02604407|101690617|FG002|Overall Study|Protocol Violation|0|||
33490772|NCT02604407|101690615|FG000|Overall Study|Withdrawal by Subject|3|||
33490773|NCT02604407|101690616|FG001|Overall Study|Withdrawal by Subject|3|||
33490774|NCT02604407|101690617|FG002|Overall Study|Withdrawal by Subject|5|||
33490775|NCT02604407|101690615|FG000|Overall Study|Lost to Follow-up|2|||
33490776|NCT02604407|101690616|FG001|Overall Study|Lost to Follow-up|1|||
33490777|NCT02604407|101690617|FG002|Overall Study|Lost to Follow-up|2|||
33490778|NCT02604407|101690615|FG000|Overall Study|Lack of Efficacy|1|||
33490779|NCT02604407|101690616|FG001|Overall Study|Lack of Efficacy|0|||
33490780|NCT02604407|101690617|FG002|Overall Study|Lack of Efficacy|0|||
33490781|NCT02604407|101690615|FG000|Overall Study|Other|3|||
33490782|NCT02604407|101690616|FG001|Overall Study|Other|1|||
33490783|NCT02604407|101690617|FG002|Overall Study|Other|4|||
33490784|NCT01439802|101690619|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
33490785|NCT01439802|101690619|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
33490786|NCT01070953|101690622|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
33490787|NCT01070953|101690622|FG000|Participants for Safety Evaluation|Off-label use|283|||
33490788|NCT01070953|101690622|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
33490789|NCT01070953|101690622|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
33490790|NCT01070953|101690622|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
33490791|NCT01070953|101690622|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
33490792|NCT01070953|101690622|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
33490793|NCT01070953|101690622|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
33490794|NCT01070953|101690622|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
33490795|NCT01070953|101690622|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
33490796|NCT02152605|101690623|FG000|Overall Study|Adverse Event|6|||
33490797|NCT02152605|101690624|FG001|Overall Study|Adverse Event|8|||
33490798|NCT02152605|101690623|FG000|Overall Study|Lack of Efficacy|7|||
33490799|NCT02152605|101690624|FG001|Overall Study|Lack of Efficacy|4|||
33490800|NCT02152605|101690623|FG000|Overall Study|Protocol deviation|1|||
33490801|NCT02152605|101690624|FG001|Overall Study|Protocol deviation|4|||
33490802|NCT02152605|101690623|FG000|Overall Study|Lost to Follow-up|1|||
33490803|NCT02152605|101690624|FG001|Overall Study|Lost to Follow-up|0|||
33490804|NCT02152605|101690623|FG000|Overall Study|Withdrew consent|4|||
33490805|NCT02152605|101690624|FG001|Overall Study|Withdrew consent|2|||
33490806|NCT00185588|101690625|FG000|Overall Study|Adverse Event|3|||
33490807|NCT00185588|101690626|FG001|Overall Study|Adverse Event|1|||
33490808|NCT00185588|101690627|FG002|Overall Study|Adverse Event|4|||
33490809|NCT00185588|101690628|FG003|Overall Study|Adverse Event|2|||
33490810|NCT00185588|101690625|FG000|Overall Study|Lost to Follow-up|0|||
33490811|NCT00185588|101690626|FG001|Overall Study|Lost to Follow-up|0|||
33490812|NCT00185588|101690627|FG002|Overall Study|Lost to Follow-up|1|||
33490813|NCT00185588|101690628|FG003|Overall Study|Lost to Follow-up|2|||
33490814|NCT00185588|101690625|FG000|Overall Study|Withdrawal by Subject|0|||
33490815|NCT00185588|101690626|FG001|Overall Study|Withdrawal by Subject|1|||
33490816|NCT00185588|101690627|FG002|Overall Study|Withdrawal by Subject|0|||
33490817|NCT00185588|101690628|FG003|Overall Study|Withdrawal by Subject|0|||
33490818|NCT00185588|101690625|FG000|Overall Study|Physician Decision|0|||
33490819|NCT00185588|101690626|FG001|Overall Study|Physician Decision|0|||
33490820|NCT00185588|101690627|FG002|Overall Study|Physician Decision|1|||
33490821|NCT00185588|101690628|FG003|Overall Study|Physician Decision|0|||
33490822|NCT00312338|101690634|FG000|Overall Study|Adverse Event|7|||
33490823|NCT00312338|101690635|FG001|Overall Study|Adverse Event|2|||
33490824|NCT00312338|101690634|FG000|Overall Study|Lost to Follow-up|9|||
33490825|NCT00312338|101690635|FG001|Overall Study|Lost to Follow-up|1|||
33490826|NCT00312338|101690634|FG000|Overall Study|Withdrawal by Subject|4|||
33490827|NCT00312338|101690635|FG001|Overall Study|Withdrawal by Subject|0|||
33490828|NCT00312338|101690634|FG000|Overall Study|Subsequent infection|2|||
33490829|NCT00312338|101690635|FG001|Overall Study|Subsequent infection|0|||
33490830|NCT02370238|101690641|FG000|Overall Study|Death|42|||
33490831|NCT02370238|101690642|FG001|Overall Study|Death|35|||
33490832|NCT02370238|101690641|FG000|Overall Study|Lost to Follow-up|1|||
33490833|NCT02370238|101690642|FG001|Overall Study|Lost to Follow-up|3|||
33490834|NCT02370238|101690641|FG000|Overall Study|Withdrawal by Subject|2|||
33490835|NCT02370238|101690642|FG001|Overall Study|Withdrawal by Subject|6|||
33490836|NCT02370238|101690641|FG000|Overall Study|Other|2|||
33490837|NCT02370238|101690642|FG001|Overall Study|Other|1|||
33490838|NCT02854527|101690649|FG000|Overall Study|Adverse Event|0|||
33490839|NCT02854527|101690650|FG001|Overall Study|Adverse Event|0|||
33490840|NCT02854527|101690651|FG002|Overall Study|Adverse Event|0|||
33490841|NCT02854527|101690652|FG003|Overall Study|Adverse Event|0|||
33490842|NCT02854527|101690653|FG004|Overall Study|Adverse Event|1|||
33490843|NCT02854527|101690654|FG005|Overall Study|Adverse Event|0|||
33490844|NCT02854527|101690655|FG006|Overall Study|Adverse Event|0|||
33490845|NCT02854527|101690656|FG007|Overall Study|Adverse Event|0|||
33490846|NCT02854527|101690657|FG008|Overall Study|Adverse Event|0|||
33490847|NCT02854527|101690658|FG009|Overall Study|Adverse Event|0|||
33490848|NCT02854527|101690649|FG000|Overall Study|Lost to Follow-up|0|||
33490849|NCT02854527|101690650|FG001|Overall Study|Lost to Follow-up|0|||
33490850|NCT02854527|101690651|FG002|Overall Study|Lost to Follow-up|0|||
33490851|NCT02854527|101690652|FG003|Overall Study|Lost to Follow-up|1|||
33490852|NCT02854527|101690653|FG004|Overall Study|Lost to Follow-up|0|||
33490853|NCT02854527|101690654|FG005|Overall Study|Lost to Follow-up|0|||
33490854|NCT02854527|101690655|FG006|Overall Study|Lost to Follow-up|0|||
33490855|NCT02854527|101690656|FG007|Overall Study|Lost to Follow-up|0|||
33490856|NCT02854527|101690657|FG008|Overall Study|Lost to Follow-up|0|||
33490857|NCT02854527|101690658|FG009|Overall Study|Lost to Follow-up|0|||
33490858|NCT01547390|101690663|FG000|Overall Study|Withdrawal by Subject|10|||
33490859|NCT01547390|101690664|FG001|Overall Study|Withdrawal by Subject|7|||
33490860|NCT01547390|101690663|FG000|Overall Study|termination of pregnancy|0|||
33490861|NCT01547390|101690664|FG001|Overall Study|termination of pregnancy|1|||
33490862|NCT01547390|101690663|FG000|Overall Study|Lost to Follow-up|0|||
33490863|NCT01547390|101690664|FG001|Overall Study|Lost to Follow-up|2|||
33490864|NCT01547390|101690663|FG000|Overall Study|Adverse Event|3|||
33490865|NCT01547390|101690664|FG001|Overall Study|Adverse Event|0|||
33490866|NCT04211831|101690665|FG000|Overall Study|Withdrawal by Subject|4|||
33490867|NCT04211831|101690666|FG001|Overall Study|Withdrawal by Subject|1|||
33490868|NCT04211831|101690667|FG002|Overall Study|Withdrawal by Subject|1|||
33490869|NCT04211831|101690665|FG000|Overall Study|Protocol Violation|0|||
33490870|NCT04211831|101690666|FG001|Overall Study|Protocol Violation|0|||
33490871|NCT04211831|101690667|FG002|Overall Study|Protocol Violation|1|||
33490872|NCT04211831|101690665|FG000|Overall Study|Adverse Event|0|||
33490873|NCT04211831|101690666|FG001|Overall Study|Adverse Event|1|||
33490874|NCT04211831|101690667|FG002|Overall Study|Adverse Event|0|||
33490875|NCT04211831|101690665|FG000|Overall Study|Lack of Efficacy|0|||
33490876|NCT04211831|101690666|FG001|Overall Study|Lack of Efficacy|0|||
33490877|NCT04211831|101690667|FG002|Overall Study|Lack of Efficacy|1|||
33490878|NCT04211831|101690665|FG000|Overall Study|Lost to Follow-up|0|||
33490879|NCT04211831|101690666|FG001|Overall Study|Lost to Follow-up|0|||
33490880|NCT04211831|101690667|FG002|Overall Study|Lost to Follow-up|2|||
33490881|NCT04211831|101690665|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
33490882|NCT04211831|101690666|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
33490883|NCT04211831|101690667|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
33490884|NCT04211831|101690665|FG000|Overall Study|Other|0|||
33490885|NCT04211831|101690666|FG001|Overall Study|Other|1|||
33490886|NCT04211831|101690667|FG002|Overall Study|Other|0|||
33490887|NCT01807065|101690676|FG000|Overall Study|Receive no sip-T due to IV access|1|||
33490888|NCT01807065|101690677|FG001|Overall Study|Receive no sip-T due to IV access|1|||
33490889|NCT01320293|101690682|FG000|Overall Study|Lack of Efficacy|1|||
33490890|NCT01320293|101690682|FG000|Overall Study|Adverse Event|1|||
33490891|NCT00370552|101690689|FG000|Overall Study|Adverse Event|2|||
33490892|NCT00370552|101690690|FG001|Overall Study|Adverse Event|2|||
33490893|NCT00370552|101690691|FG002|Overall Study|Adverse Event|2|||
33490894|NCT00370552|101690689|FG000|Overall Study|Disease progression|23|||
33490895|NCT00370552|101690690|FG001|Overall Study|Disease progression|23|||
33490896|NCT00370552|101690691|FG002|Overall Study|Disease progression|15|||
33490897|NCT00370552|101690689|FG000|Overall Study|Maximum clinical benefit|3|||
33490898|NCT00370552|101690690|FG001|Overall Study|Maximum clinical benefit|5|||
33490899|NCT00370552|101690691|FG002|Overall Study|Maximum clinical benefit|5|||
33490900|NCT00370552|101690689|FG000|Overall Study|Poor or noncompliance|0|||
33490901|NCT00370552|101690690|FG001|Overall Study|Poor or noncompliance|0|||
33490902|NCT00370552|101690691|FG002|Overall Study|Poor or noncompliance|1|||
33490903|NCT00370552|101690689|FG000|Overall Study|Study drug toxicity|11|||
33490904|NCT00370552|101690690|FG001|Overall Study|Study drug toxicity|8|||
33490905|NCT00370552|101690691|FG002|Overall Study|Study drug toxicity|6|||
33490906|NCT00370552|101690689|FG000|Overall Study|Withdrawal by Subject|2|||
33490907|NCT00370552|101690690|FG001|Overall Study|Withdrawal by Subject|0|||
33490908|NCT00370552|101690691|FG002|Overall Study|Withdrawal by Subject|1|||
33490909|NCT00370552|101690689|FG000|Overall Study|Still on treatment|1|||
33490910|NCT00370552|101690690|FG001|Overall Study|Still on treatment|3|||
33490911|NCT00370552|101690691|FG002|Overall Study|Still on treatment|2|||
33490912|NCT00370552|101690689|FG000|Overall Study|Never treated|1|||
33490913|NCT00370552|101690690|FG001|Overall Study|Never treated|0|||
33490914|NCT00370552|101690691|FG002|Overall Study|Never treated|0|||
33490915|NCT00370552|101690689|FG000|Overall Study|Physician Decision|1|||
33490916|NCT00370552|101690690|FG001|Overall Study|Physician Decision|1|||
33490917|NCT00370552|101690691|FG002|Overall Study|Physician Decision|0|||
33490918|NCT00370552|101690689|FG000|Overall Study|Investigator decision|2|||
33490919|NCT00370552|101690690|FG001|Overall Study|Investigator decision|1|||
33490920|NCT00370552|101690691|FG002|Overall Study|Investigator decision|0|||
33490921|NCT00370552|101690689|FG000|Overall Study|High risk of allergic reaction|0|||
33490922|NCT00370552|101690690|FG001|Overall Study|High risk of allergic reaction|1|||
33490923|NCT00370552|101690691|FG002|Overall Study|High risk of allergic reaction|0|||
33490924|NCT00370552|101690689|FG000|Overall Study|Planned radiation for palliation|0|||
33490925|NCT00370552|101690690|FG001|Overall Study|Planned radiation for palliation|1|||
33490926|NCT00370552|101690691|FG002|Overall Study|Planned radiation for palliation|0|||
33490927|NCT00445432|101690692|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
33490928|NCT00445432|101690693|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
33490929|NCT00445432|101690694|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
33490930|NCT00445432|101690695|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
33490931|NCT00445432|101690692|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
33490932|NCT00445432|101690693|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
33490933|NCT00445432|101690694|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
33490934|NCT00445432|101690695|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
33490935|NCT00445432|101690692|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
33490936|NCT00445432|101690693|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
33490937|NCT00445432|101690694|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
33490938|NCT00445432|101690695|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
33490939|NCT00445432|101690692|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
33490940|NCT00445432|101690693|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
33490941|NCT00445432|101690694|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
33490942|NCT00445432|101690695|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
33490943|NCT00445432|101690692|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
33490944|NCT00445432|101690693|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
33490945|NCT00445432|101690694|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
33490946|NCT00445432|101690695|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
33490947|NCT00445432|101690692|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
33490948|NCT00445432|101690693|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
33490949|NCT00445432|101690694|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
33490950|NCT00445432|101690695|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
33490951|NCT00445432|101690692|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
33490952|NCT00445432|101690693|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
33490953|NCT00445432|101690694|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
33490954|NCT00445432|101690695|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
33490955|NCT02094417|101690696|FG000|Overall Study|Adverse Event|0|||
33490956|NCT02094417|101690697|FG001|Overall Study|Adverse Event|0|||
33490957|NCT02094417|101690698|FG002|Overall Study|Adverse Event|0|||
33490958|NCT02094417|101690699|FG003|Overall Study|Adverse Event|1|||
33490959|NCT02094417|101690696|FG000|Overall Study|Eligibility criteria|0|||
33490960|NCT02094417|101690697|FG001|Overall Study|Eligibility criteria|1|||
33490961|NCT02094417|101690698|FG002|Overall Study|Eligibility criteria|0|||
33490962|NCT02094417|101690699|FG003|Overall Study|Eligibility criteria|0|||
33490963|NCT02094417|101690696|FG000|Overall Study|No responder|4|||
33490964|NCT02094417|101690697|FG001|Overall Study|No responder|4|||
33490965|NCT02094417|101690698|FG002|Overall Study|No responder|4|||
33490966|NCT02094417|101690699|FG003|Overall Study|No responder|3|||
33490967|NCT02094417|101690696|FG000|Overall Study|Unable to conduct observations or assess|0|||
33490968|NCT02094417|101690697|FG001|Overall Study|Unable to conduct observations or assess|1|||
33490969|NCT02094417|101690698|FG002|Overall Study|Unable to conduct observations or assess|0|||
33490970|NCT02094417|101690699|FG003|Overall Study|Unable to conduct observations or assess|0|||
33490971|NCT02094417|101690696|FG000|Overall Study|Withdrawal by Subject|1|||
33490972|NCT02094417|101690697|FG001|Overall Study|Withdrawal by Subject|2|||
33490973|NCT02094417|101690698|FG002|Overall Study|Withdrawal by Subject|1|||
33490974|NCT02094417|101690699|FG003|Overall Study|Withdrawal by Subject|3|||
33490975|NCT01610492|101690700|FG000|Overall Study|Adverse Event|1|||
33490976|NCT01610492|101690700|FG000|Overall Study|Lack of Efficacy|3|||
33490977|NCT01610492|101690700|FG000|Overall Study|Other: Reached stopping criteria|1|||
33490978|NCT01610492|101690700|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
33490979|NCT03772717|101690701|FG000|Overall Study|Withdrawal by Subject|2|||
33490980|NCT00344448|101690702|FG000|Screening|Withdrawal by Subject|0|||
33490981|NCT00344448|101690703|FG001|Screening|Withdrawal by Subject|1|||
33490982|NCT00344448|101690702|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
33490983|NCT00344448|101690703|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
33490984|NCT00344448|101690702|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
33490985|NCT00344448|101690703|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
33490986|NCT00344448|101690702|FG000|Open Label|Withdrawal by Subject|1|||
33490987|NCT00344448|101690703|FG001|Open Label|Withdrawal by Subject|1|||
33490988|NCT00344448|101690702|FG000|Open Label|Study terminated|1|||
33490989|NCT00344448|101690703|FG001|Open Label|Study terminated|0|||
33490990|NCT02439216|101690704|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
33490991|NCT02439216|101690705|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33490992|NCT02439216|101690706|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33490993|NCT02439216|101690707|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33490994|NCT02439216|101690708|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33490995|NCT02439216|101690709|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33490996|NCT02439216|101690710|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33490997|NCT02439216|101690711|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33490998|NCT02439216|101690712|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
33490999|NCT02439216|101690704|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33491000|NCT02439216|101690705|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33491001|NCT02439216|101690706|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33491002|NCT02439216|101690707|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33491003|NCT02439216|101690708|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33491004|NCT02439216|101690709|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33491005|NCT02439216|101690710|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33491006|NCT02439216|101690711|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
33491007|NCT02439216|101690712|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
33491008|NCT02439216|101690704|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
33491009|NCT02439216|101690705|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
33491010|NCT02439216|101690706|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
33491011|NCT02439216|101690707|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
33491012|NCT02439216|101690708|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
33491013|NCT02439216|101690709|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
33491014|NCT02439216|101690710|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
33491015|NCT02439216|101690711|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
33491016|NCT02439216|101690712|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
33491017|NCT02439216|101690704|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33491018|NCT02439216|101690705|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33491019|NCT02439216|101690706|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33491020|NCT02439216|101690707|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33491021|NCT02439216|101690708|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33491022|NCT02439216|101690709|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33491023|NCT02439216|101690710|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33491024|NCT02439216|101690711|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
33491025|NCT02439216|101690712|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
33491026|NCT02439216|101690704|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
33491027|NCT02439216|101690705|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
33491028|NCT02439216|101690706|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
33491029|NCT02439216|101690707|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
33491030|NCT02439216|101690708|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
33491031|NCT02439216|101690709|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
33491032|NCT02439216|101690710|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
33491033|NCT02439216|101690711|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
33491034|NCT02439216|101690712|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
33491035|NCT05048329|101690715|FG000|Overall Study|Withdrawal by Subject|1|||
33491036|NCT05048329|101690715|FG000|Overall Study|Screenfail|1|||
33491037|NCT00577863|101690716|FG000|Overall Study|Adverse Event|4|||
33491038|NCT00577863|101690717|FG001|Overall Study|Adverse Event|2|||
33491039|NCT00577863|101690716|FG000|Overall Study|Death|1|||
33491040|NCT00577863|101690717|FG001|Overall Study|Death|0|||
33491041|NCT00577863|101690716|FG000|Overall Study|Lost to Follow-up|2|||
33491042|NCT00577863|101690717|FG001|Overall Study|Lost to Follow-up|2|||
33491043|NCT00577863|101690716|FG000|Overall Study|Entry Criteria Exclusion|1|||
33491044|NCT00577863|101690717|FG001|Overall Study|Entry Criteria Exclusion|0|||
33491045|NCT00577863|101690716|FG000|Overall Study|Withdrawal by Subject|0|||
33491046|NCT00577863|101690717|FG001|Overall Study|Withdrawal by Subject|2|||
33491047|NCT00577863|101690716|FG000|Overall Study|Sponsor Decision|2|||
33491048|NCT00577863|101690717|FG001|Overall Study|Sponsor Decision|7|||
33491049|NCT00577863|101690716|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
33491050|NCT00577863|101690717|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
33491051|NCT02493660|101690718|FG000|Overall Study|Physician Decision|0|||
33491052|NCT02493660|101690719|FG001|Overall Study|Physician Decision|1|||
33491053|NCT02493660|101690718|FG000|Overall Study|Adverse Event|4|||
33491054|NCT02493660|101690719|FG001|Overall Study|Adverse Event|2|||
33491055|NCT02493660|101690718|FG000|Overall Study|Withdrawal by Subject|2|||
33491056|NCT02493660|101690719|FG001|Overall Study|Withdrawal by Subject|3|||
33491057|NCT02493660|101690718|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
33491058|NCT02493660|101690719|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
33491059|NCT02493660|101690718|FG000|Overall Study|Protocol Violation|0|||
33491060|NCT02493660|101690719|FG001|Overall Study|Protocol Violation|1|||
33491061|NCT02493660|101690718|FG000|Overall Study|Death|0|||
33491062|NCT02493660|101690719|FG001|Overall Study|Death|1|||
33491063|NCT02493660|101690718|FG000|Overall Study|Lost to Follow-up|2|||
33491064|NCT02493660|101690719|FG001|Overall Study|Lost to Follow-up|4|||
33491065|NCT02072980|101690720|FG000|Period 2, Second Wear|Adverse Event|0|||
33491066|NCT02072980|101690721|FG001|Period 2, Second Wear|Adverse Event|1|||
33491067|NCT01392963|101690722|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
33491068|NCT01392963|101690723|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
33491069|NCT01392963|101690722|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
33491070|NCT01392963|101690723|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
33491071|NCT01392963|101690722|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
33491072|NCT01392963|101690723|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
33491073|NCT03633825|101690724|FG000|Enrollment|Did not post on network|5066|||
33491074|NCT03633825|101690725|FG001|Enrollment|Did not post on network|5080|||
33491075|NCT03633825|101690724|FG000|Enrollment|Post not classified as crisis|13967|||
33491076|NCT03633825|101690725|FG001|Enrollment|Post not classified as crisis|13757|||
33491077|NCT03633825|101690724|FG000|Follow up|Lost to Follow-up|478|||
33491078|NCT03633825|101690725|FG001|Follow up|Lost to Follow-up|450|||
33491079|NCT02135614|101690726|FG000|Overall Study|Randomized but Not Treated|2|||
33491080|NCT02135614|101690727|FG001|Overall Study|Randomized but Not Treated|1|||
33491081|NCT02135614|101690726|FG000|Overall Study|Adverse Event|0|||
33491082|NCT02135614|101690727|FG001|Overall Study|Adverse Event|1|||
33491083|NCT02135614|101690726|FG000|Overall Study|Death|1|||
33491084|NCT02135614|101690727|FG001|Overall Study|Death|0|||
33491085|NCT02135614|101690726|FG000|Overall Study|Investigator's Discretion|0|||
33491086|NCT02135614|101690727|FG001|Overall Study|Investigator's Discretion|1|||
33491087|NCT02135614|101690726|FG000|Overall Study|Withdrew Consent|2|||
33491088|NCT02135614|101690727|FG001|Overall Study|Withdrew Consent|2|||
33491089|NCT02135614|101690726|FG000|Overall Study|Lost to Follow-up|3|||
33491090|NCT02135614|101690727|FG001|Overall Study|Lost to Follow-up|0|||
33491091|NCT00799058|101690728|FG000|Overall Study|Withdrawal by Subject|2|||
33491092|NCT00799058|101690729|FG001|Overall Study|Withdrawal by Subject|2|||
33491093|NCT00799058|101690730|FG002|Overall Study|Withdrawal by Subject|2|||
33491094|NCT00799058|101690728|FG000|Overall Study|Lost to Follow-up|1|||
33491095|NCT00799058|101690729|FG001|Overall Study|Lost to Follow-up|2|||
33491096|NCT00799058|101690730|FG002|Overall Study|Lost to Follow-up|1|||
33491097|NCT00799058|101690728|FG000|Overall Study|Adverse Event|0|||
33491098|NCT00799058|101690729|FG001|Overall Study|Adverse Event|2|||
33491099|NCT00799058|101690730|FG002|Overall Study|Adverse Event|0|||
33491100|NCT00799058|101690728|FG000|Overall Study|Pregnancy|1|||
33491101|NCT00799058|101690729|FG001|Overall Study|Pregnancy|0|||
33491102|NCT00799058|101690730|FG002|Overall Study|Pregnancy|0|||
33491103|NCT00799058|101690728|FG000|Overall Study|Not adherent|3|||
33491104|NCT00799058|101690729|FG001|Overall Study|Not adherent|2|||
33491105|NCT00799058|101690730|FG002|Overall Study|Not adherent|1|||
33491106|NCT00799058|101690728|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
33491107|NCT00799058|101690729|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
33491108|NCT00799058|101690730|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
33491109|NCT00799058|101690728|FG000|Overall Study|IP dispensing error|1|||
33491110|NCT00799058|101690729|FG001|Overall Study|IP dispensing error|0|||
33491111|NCT00799058|101690730|FG002|Overall Study|IP dispensing error|0|||
33491112|NCT00799058|101690728|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
33491113|NCT00799058|101690729|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
33491114|NCT00799058|101690730|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
33491115|NCT00799058|101690728|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
33491116|NCT00799058|101690729|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
33491117|NCT00799058|101690730|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
33491118|NCT00799058|101690728|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
33491119|NCT00799058|101690729|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
33491120|NCT00799058|101690730|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
33491121|NCT00799058|101690728|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
33491122|NCT00799058|101690729|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
33491123|NCT00799058|101690730|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
33491124|NCT03594071|101690731|FG000|Overall Study|Re-operation|3|||
33491125|NCT03594071|101690731|FG000|Overall Study|Missed visit|2|||
33491126|NCT00974922|101690732|FG000|Overall Study|study terminated|24|||
33491127|NCT02235454|101690733|FG000|Overall Study|Withdrawal by Subject|2|||
33491128|NCT01147068|101690734|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
33491129|NCT01147068|101690735|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
33491130|NCT01147068|101690736|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
33491131|NCT01147068|101690737|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
33491132|NCT01147068|101690738|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
33491133|NCT01147068|101690739|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
33491134|NCT01147068|101690740|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
33491135|NCT01147068|101690734|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
33491136|NCT01147068|101690735|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
33491137|NCT01147068|101690736|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
33491138|NCT01147068|101690737|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
33491139|NCT01147068|101690738|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
33491140|NCT01147068|101690739|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
33491141|NCT01147068|101690740|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
33491142|NCT01147068|101690734|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
33491143|NCT01147068|101690735|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
33491144|NCT01147068|101690736|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
33491145|NCT01147068|101690737|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
33491146|NCT01147068|101690738|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
33491147|NCT01147068|101690739|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
33491148|NCT01147068|101690740|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
33491149|NCT01147068|101690734|FG000|Subjects That Received 2nd Dose|Other|0|||
33491150|NCT01147068|101690735|FG001|Subjects That Received 2nd Dose|Other|3|||
33491151|NCT01147068|101690736|FG002|Subjects That Received 2nd Dose|Other|3|||
33491152|NCT01147068|101690737|FG003|Subjects That Received 2nd Dose|Other|0|||
33491153|NCT01147068|101690738|FG004|Subjects That Received 2nd Dose|Other|1|||
33491154|NCT01147068|101690739|FG005|Subjects That Received 2nd Dose|Other|0|||
33491155|NCT01147068|101690740|FG006|Subjects That Received 2nd Dose|Other|0|||
33491156|NCT01147068|101690734|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
33491157|NCT01147068|101690735|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
33491158|NCT01147068|101690736|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
33491159|NCT01147068|101690737|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
33491160|NCT01147068|101690738|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
33491161|NCT01147068|101690739|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
33491162|NCT01147068|101690740|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
33491163|NCT01147068|101690734|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
33491164|NCT01147068|101690735|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
33491165|NCT01147068|101690736|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
33491166|NCT01147068|101690737|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
33491167|NCT01147068|101690738|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
33491168|NCT01147068|101690739|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
33491169|NCT01147068|101690740|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
33491170|NCT01147068|101690734|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
33491171|NCT01147068|101690735|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
33491172|NCT01147068|101690736|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
33491173|NCT01147068|101690737|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
33491174|NCT01147068|101690738|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
33491175|NCT01147068|101690739|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
33491176|NCT01147068|101690740|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
33491177|NCT02738138|101690741|FG000|Overall Study|Adverse Event|0|||
33491178|NCT02738138|101690742|FG001|Overall Study|Adverse Event|1|||
33491179|NCT02738138|101690741|FG000|Overall Study|Lost to Follow-up|2|||
33491180|NCT02738138|101690742|FG001|Overall Study|Lost to Follow-up|0|||
33491181|NCT02738138|101690741|FG000|Overall Study|Other - not further specified|1|||
33491182|NCT02738138|101690742|FG001|Overall Study|Other - not further specified|0|||
33491183|NCT03333941|101690743|FG000|Overall Study|Lost to Follow-up|10|||
33491184|NCT03333941|101690743|FG000|Overall Study|Death|2|||
33491185|NCT03333941|101690743|FG000|Overall Study|Adverse Event|1|||
33491186|NCT01742897|101690744|FG000|Overall Study|Adverse Event|3|||
33491187|NCT01742897|101690744|FG000|Overall Study|Withdrawal by Subject|1|||
33491188|NCT01742897|101690744|FG000|Overall Study|Other|1|||
33491189|NCT01256879|101690745|FG000|Overall Study|Withdrawal by Subject|1|||
33491190|NCT03284723|101690746|FG000|Overall Study|Death|0|||
33491191|NCT03284723|101690747|FG001|Overall Study|Death|0|||
33491192|NCT03284723|101690748|FG002|Overall Study|Death|0|||
33491193|NCT03284723|101690749|FG003|Overall Study|Death|1|||
33491194|NCT03284723|101690750|FG004|Overall Study|Death|0|||
33491195|NCT03284723|101690751|FG005|Overall Study|Death|0|||
33491196|NCT03284723|101690752|FG006|Overall Study|Death|1|||
33491197|NCT03284723|101690753|FG007|Overall Study|Death|0|||
33491198|NCT03284723|101690754|FG008|Overall Study|Death|0|||
33491199|NCT03284723|101690755|FG009|Overall Study|Death|2|||
33491200|NCT03284723|101690756|FG010|Overall Study|Death|1|||
33491201|NCT03284723|101690757|FG011|Overall Study|Death|0|||
33491202|NCT03284723|101690746|FG000|Overall Study|Lost to Follow-up|0|||
33491203|NCT03284723|101690747|FG001|Overall Study|Lost to Follow-up|0|||
33491204|NCT03284723|101690748|FG002|Overall Study|Lost to Follow-up|0|||
33491205|NCT03284723|101690749|FG003|Overall Study|Lost to Follow-up|0|||
33491206|NCT03284723|101690750|FG004|Overall Study|Lost to Follow-up|0|||
33491207|NCT03284723|101690751|FG005|Overall Study|Lost to Follow-up|2|||
33491208|NCT03284723|101690752|FG006|Overall Study|Lost to Follow-up|1|||
33491209|NCT03284723|101690753|FG007|Overall Study|Lost to Follow-up|0|||
33491210|NCT03284723|101690754|FG008|Overall Study|Lost to Follow-up|0|||
33491211|NCT03284723|101690755|FG009|Overall Study|Lost to Follow-up|2|||
33491212|NCT03284723|101690756|FG010|Overall Study|Lost to Follow-up|0|||
33491213|NCT03284723|101690757|FG011|Overall Study|Lost to Follow-up|0|||
33491214|NCT03284723|101690746|FG000|Overall Study|Study Terminated By Sponsor|0|||
33491215|NCT03284723|101690747|FG001|Overall Study|Study Terminated By Sponsor|0|||
33491216|NCT03284723|101690748|FG002|Overall Study|Study Terminated By Sponsor|0|||
33491217|NCT03284723|101690749|FG003|Overall Study|Study Terminated By Sponsor|0|||
33491218|NCT03284723|101690750|FG004|Overall Study|Study Terminated By Sponsor|1|||
33491219|NCT03284723|101690751|FG005|Overall Study|Study Terminated By Sponsor|0|||
33491220|NCT03284723|101690752|FG006|Overall Study|Study Terminated By Sponsor|0|||
33491221|NCT03284723|101690753|FG007|Overall Study|Study Terminated By Sponsor|0|||
33491222|NCT03284723|101690754|FG008|Overall Study|Study Terminated By Sponsor|1|||
33491223|NCT03284723|101690755|FG009|Overall Study|Study Terminated By Sponsor|1|||
33491224|NCT03284723|101690756|FG010|Overall Study|Study Terminated By Sponsor|1|||
33491225|NCT03284723|101690757|FG011|Overall Study|Study Terminated By Sponsor|1|||
33491226|NCT03284723|101690746|FG000|Overall Study|Withdrawal by Subject|0|||
33491227|NCT03284723|101690747|FG001|Overall Study|Withdrawal by Subject|0|||
33491228|NCT03284723|101690748|FG002|Overall Study|Withdrawal by Subject|0|||
33491229|NCT03284723|101690749|FG003|Overall Study|Withdrawal by Subject|0|||
33491230|NCT03284723|101690750|FG004|Overall Study|Withdrawal by Subject|5|||
33491231|NCT03284723|101690751|FG005|Overall Study|Withdrawal by Subject|3|||
33491232|NCT03284723|101690752|FG006|Overall Study|Withdrawal by Subject|1|||
33491233|NCT03284723|101690753|FG007|Overall Study|Withdrawal by Subject|0|||
33491234|NCT03284723|101690754|FG008|Overall Study|Withdrawal by Subject|6|||
33491235|NCT03284723|101690755|FG009|Overall Study|Withdrawal by Subject|0|||
33491236|NCT03284723|101690756|FG010|Overall Study|Withdrawal by Subject|3|||
33491237|NCT03284723|101690757|FG011|Overall Study|Withdrawal by Subject|1|||
33491238|NCT03284723|101690746|FG000|Overall Study|Other|1|||
33491239|NCT03284723|101690747|FG001|Overall Study|Other|0|||
33491240|NCT03284723|101690748|FG002|Overall Study|Other|1|||
33491241|NCT03284723|101690749|FG003|Overall Study|Other|0|||
33491242|NCT03284723|101690750|FG004|Overall Study|Other|1|||
33491243|NCT03284723|101690751|FG005|Overall Study|Other|0|||
33491244|NCT03284723|101690752|FG006|Overall Study|Other|0|||
33491245|NCT03284723|101690753|FG007|Overall Study|Other|0|||
33491246|NCT03284723|101690754|FG008|Overall Study|Other|0|||
33491247|NCT03284723|101690755|FG009|Overall Study|Other|0|||
33491248|NCT03284723|101690756|FG010|Overall Study|Other|1|||
33491249|NCT03284723|101690757|FG011|Overall Study|Other|0|||
33491250|NCT03284723|101690746|FG000|Overall Study|Adverse Event|0|||
33491251|NCT03284723|101690747|FG001|Overall Study|Adverse Event|0|||
33491252|NCT03284723|101690748|FG002|Overall Study|Adverse Event|0|||
33491253|NCT03284723|101690749|FG003|Overall Study|Adverse Event|0|||
33491254|NCT03284723|101690750|FG004|Overall Study|Adverse Event|0|||
33491255|NCT03284723|101690751|FG005|Overall Study|Adverse Event|0|||
33491256|NCT03284723|101690752|FG006|Overall Study|Adverse Event|0|||
33491257|NCT03284723|101690753|FG007|Overall Study|Adverse Event|0|||
33491258|NCT03284723|101690754|FG008|Overall Study|Adverse Event|1|||
33491259|NCT03284723|101690755|FG009|Overall Study|Adverse Event|0|||
33491260|NCT03284723|101690756|FG010|Overall Study|Adverse Event|0|||
33491261|NCT03284723|101690757|FG011|Overall Study|Adverse Event|0|||
33491262|NCT02635984|101690767|FG000|Overall Study|Lost to Follow-up|2|||
33491263|NCT02635984|101690768|FG001|Overall Study|Lost to Follow-up|4|||
33491264|NCT02635984|101690767|FG000|Overall Study|Study Arm Closed|1|||
33491265|NCT02635984|101690768|FG001|Overall Study|Study Arm Closed|0|||
33491266|NCT03301649|101690771|FG000|Overall Study|Need alternate therapy due to live lice|17|||
33491267|NCT03301649|101690772|FG001|Overall Study|Need alternate therapy due to live lice|25|||
33491268|NCT03301649|101690773|FG002|Overall Study|Need alternate therapy due to live lice|81|||
33491269|NCT03301649|101690771|FG000|Overall Study|Lost to Follow-up|11|||
33491270|NCT03301649|101690772|FG001|Overall Study|Lost to Follow-up|11|||
33491271|NCT03301649|101690773|FG002|Overall Study|Lost to Follow-up|3|||
33491272|NCT03301649|101690771|FG000|Overall Study|Protocol Violation|0|||
33491273|NCT03301649|101690772|FG001|Overall Study|Protocol Violation|1|||
33491274|NCT03301649|101690773|FG002|Overall Study|Protocol Violation|1|||
33491275|NCT03301649|101690771|FG000|Overall Study|Withdrawal by Subject|10|||
33491276|NCT03301649|101690772|FG001|Overall Study|Withdrawal by Subject|4|||
33491277|NCT03301649|101690773|FG002|Overall Study|Withdrawal by Subject|0|||
33491278|NCT03301649|101690771|FG000|Overall Study|Other than specified|5|||
33491279|NCT03301649|101690772|FG001|Overall Study|Other than specified|3|||
33491280|NCT03301649|101690773|FG002|Overall Study|Other than specified|0|||
33491281|NCT00858273|101690774|FG000|Overall Study|Protocol Violation|3|||
33491282|NCT00858273|101690775|FG001|Overall Study|Protocol Violation|5|||
33491283|NCT00625820|101690776|FG000|Overall Study|Withdrawal by Subject|1|||
33491284|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criterion #1|24|||
33491285|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criterion #1|0|||
33491286|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
33491287|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
33491288|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
33491289|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33491290|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
33491291|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
33491292|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
33491293|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
33491294|NCT03888066|101690777|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
33491295|NCT03888066|101690778|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33491296|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
33491297|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33491298|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
33491299|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
33491300|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
33491301|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33491302|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
33491303|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33491304|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criterion #2|5|||
33491305|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criterion #2|0|||
33491306|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
33491307|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
33491308|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
33491309|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
33491310|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
33491311|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
33491312|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criterion #3|11|||
33491313|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criterion #3|0|||
33491314|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
33491315|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
33491316|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
33491317|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
33491318|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
33491319|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33491320|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criterion #4|3|||
33491321|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criterion #4|0|||
33491322|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
33491323|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
33491324|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
33491325|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
33491326|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
33491327|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
33491328|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
33491329|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
33491330|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
33491331|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33491332|NCT03888066|101690777|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
33491333|NCT03888066|101690778|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
33491334|NCT03888066|101690777|FG000|Run-in Phase|AE (Adverse Event)|17|||
33491335|NCT03888066|101690778|FG001|Run-in Phase|AE (Adverse Event)|0|||
33491336|NCT03888066|101690777|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
33491337|NCT03888066|101690778|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
33491338|NCT03888066|101690777|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
33491339|NCT03888066|101690778|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33491340|NCT03888066|101690777|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
33491341|NCT03888066|101690778|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33491342|NCT03888066|101690777|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
33491343|NCT03888066|101690778|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
33491344|NCT03888066|101690777|FG000|Run-in Phase|Withdrawal by Subject|43|||
33491345|NCT03888066|101690778|FG001|Run-in Phase|Withdrawal by Subject|0|||
33491346|NCT03888066|101690777|FG000|Run-in Phase|AE; Physician Decision|1|||
33491347|NCT03888066|101690778|FG001|Run-in Phase|AE; Physician Decision|0|||
33491348|NCT03888066|101690777|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
33491349|NCT03888066|101690778|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
33491350|NCT03888066|101690777|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
33491351|NCT03888066|101690778|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
33491352|NCT03888066|101690777|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
33491353|NCT03888066|101690778|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
33491354|NCT03888066|101690777|FG000|Run-in Phase|Death|1|||
33491355|NCT03888066|101690778|FG001|Run-in Phase|Death|0|||
33491356|NCT03888066|101690777|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
33491357|NCT03888066|101690778|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
33491358|NCT03888066|101690777|FG000|Run-in Phase|Physician Decision|1|||
33491359|NCT03888066|101690778|FG001|Run-in Phase|Physician Decision|0|||
33491360|NCT03888066|101690777|FG000|Run-in Phase|Protocol Violation|13|||
33491361|NCT03888066|101690778|FG001|Run-in Phase|Protocol Violation|0|||
33491362|NCT03888066|101690777|FG000|Run-in Phase|Sponsor Request|34|||
33491363|NCT03888066|101690778|FG001|Run-in Phase|Sponsor Request|0|||
33491364|NCT03888066|101690777|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
33491365|NCT03888066|101690778|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
33491366|NCT03888066|101690777|FG000|Run-in Phase|Withdrawal Of Consent|1|||
33491367|NCT03888066|101690778|FG001|Run-in Phase|Withdrawal Of Consent|0|||
33491368|NCT03888066|101690777|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
33491369|NCT03888066|101690778|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
33491370|NCT03888066|101690777|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
33491371|NCT03888066|101690778|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
33491372|NCT03888066|101690777|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
33491373|NCT03888066|101690778|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
33491374|NCT03888066|101690777|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
33491375|NCT03888066|101690778|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
33491376|NCT03888066|101690777|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
33491377|NCT03888066|101690778|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
33491378|NCT03888066|101690777|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
33491379|NCT03888066|101690778|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
33491380|NCT03888066|101690777|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
33491381|NCT03888066|101690778|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
33491382|NCT03888066|101690777|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
33491383|NCT03888066|101690778|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
33491384|NCT03888066|101690777|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
33491385|NCT03888066|101690778|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
33491386|NCT03888066|101690777|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
33491387|NCT03888066|101690778|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
33491388|NCT03888066|101690777|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
33491389|NCT03888066|101690778|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
33491390|NCT03888066|101690777|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
33491391|NCT03888066|101690778|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
33491392|NCT01564537|101690779|FG000|Overall Study|Site Terminated by Sponsor|1|||
33491393|NCT01564537|101690780|FG001|Overall Study|Site Terminated by Sponsor|0|||
33491394|NCT01564537|101690779|FG000|Overall Study|Withdrawal by Subject|12|||
33491395|NCT01564537|101690780|FG001|Overall Study|Withdrawal by Subject|14|||
33491396|NCT01564537|101690779|FG000|Overall Study|Lost to Follow-up|7|||
33491397|NCT01564537|101690780|FG001|Overall Study|Lost to Follow-up|3|||
33491398|NCT01564537|101690779|FG000|Overall Study|Reason not specified|81|||
33491399|NCT01564537|101690780|FG001|Overall Study|Reason not specified|82|||
33491400|NCT01295320|101690786|FG000|Overall Study|Adverse Event|2|||
33491401|NCT01295320|101690786|FG000|Overall Study|Lost to Follow-up|4|||
33491402|NCT01295320|101690786|FG000|Overall Study|Withdrawal by Subject|2|||
33491403|NCT01295320|101690786|FG000|Overall Study|Subject was bedridden|1|||
33491404|NCT01295320|101690786|FG000|Overall Study|Unable to travel|1|||
33491405|NCT00742209|101690787|FG000|Overall Study|Adverse Event|11|||
33491406|NCT00742209|101690788|FG001|Overall Study|Adverse Event|4|||
33491407|NCT00742209|101690789|FG002|Overall Study|Adverse Event|17|||
33491408|NCT00742209|101690790|FG003|Overall Study|Adverse Event|16|||
33491409|NCT00742209|101690791|FG004|Overall Study|Adverse Event|13|||
33491410|NCT00742209|101690787|FG000|Overall Study|Participant Withdrew Consent|8|||
33491411|NCT00742209|101690788|FG001|Overall Study|Participant Withdrew Consent|4|||
33491412|NCT00742209|101690789|FG002|Overall Study|Participant Withdrew Consent|14|||
33491413|NCT00742209|101690790|FG003|Overall Study|Participant Withdrew Consent|7|||
33491414|NCT00742209|101690791|FG004|Overall Study|Participant Withdrew Consent|4|||
33491415|NCT00742209|101690787|FG000|Overall Study|Protocol Violation|6|||
33491416|NCT00742209|101690788|FG001|Overall Study|Protocol Violation|5|||
33491417|NCT00742209|101690789|FG002|Overall Study|Protocol Violation|4|||
33491418|NCT00742209|101690790|FG003|Overall Study|Protocol Violation|5|||
33491419|NCT00742209|101690791|FG004|Overall Study|Protocol Violation|3|||
33491420|NCT00742209|101690787|FG000|Overall Study|Lost to Follow-up|3|||
33491421|NCT00742209|101690788|FG001|Overall Study|Lost to Follow-up|4|||
33491422|NCT00742209|101690789|FG002|Overall Study|Lost to Follow-up|5|||
33491423|NCT00742209|101690790|FG003|Overall Study|Lost to Follow-up|5|||
33491424|NCT00742209|101690791|FG004|Overall Study|Lost to Follow-up|3|||
33491425|NCT00742209|101690787|FG000|Overall Study|Lack of Efficacy|6|||
33491426|NCT00742209|101690788|FG001|Overall Study|Lack of Efficacy|1|||
33491427|NCT00742209|101690789|FG002|Overall Study|Lack of Efficacy|1|||
33491428|NCT00742209|101690790|FG003|Overall Study|Lack of Efficacy|3|||
33491429|NCT00742209|101690791|FG004|Overall Study|Lack of Efficacy|1|||
33491430|NCT00742209|101690787|FG000|Overall Study|Investigator Discretion|0|||
33491431|NCT00742209|101690788|FG001|Overall Study|Investigator Discretion|0|||
33491432|NCT00742209|101690789|FG002|Overall Study|Investigator Discretion|5|||
33491433|NCT00742209|101690790|FG003|Overall Study|Investigator Discretion|1|||
33491434|NCT00742209|101690791|FG004|Overall Study|Investigator Discretion|1|||
33491435|NCT04700137|101690796|FG000|Overall Study|Lost to Follow-up|1|||
33491436|NCT04700137|101690797|FG001|Overall Study|Lost to Follow-up|6|||
33491437|NCT04700137|101690798|FG002|Overall Study|Lost to Follow-up|1|||
33491438|NCT04700137|101690799|FG003|Overall Study|Lost to Follow-up|1|||
33491439|NCT04700137|101690796|FG000|Overall Study|Withdrawal by Subject|0|||
33491440|NCT04700137|101690797|FG001|Overall Study|Withdrawal by Subject|0|||
33491441|NCT04700137|101690798|FG002|Overall Study|Withdrawal by Subject|1|||
33491442|NCT04700137|101690799|FG003|Overall Study|Withdrawal by Subject|0|||
33491443|NCT04700137|101690796|FG000|Overall Study|Death|0|||
33491444|NCT04700137|101690797|FG001|Overall Study|Death|0|||
33491445|NCT04700137|101690798|FG002|Overall Study|Death|1|||
33491446|NCT04700137|101690799|FG003|Overall Study|Death|0|||
33491447|NCT03682107|101693693|FG000|Overall Study|Withdrawal by Subject|0|||
33491448|NCT03682107|101693694|FG001|Overall Study|Withdrawal by Subject|1|||
33491449|NCT03682107|101693695|FG002|Overall Study|Withdrawal by Subject|0|||
33491450|NCT03682107|101693696|FG003|Overall Study|Withdrawal by Subject|0|||
33491451|NCT03682107|101693697|FG004|Overall Study|Withdrawal by Subject|0|||
33491452|NCT04981717|101693698|FG000|Overall Study|Protocol Violation|0|||
33491453|NCT04981717|101693699|FG001|Overall Study|Protocol Violation|3|||
33491454|NCT04981717|101693698|FG000|Overall Study|Adverse Event|1|||
33491455|NCT04981717|101693699|FG001|Overall Study|Adverse Event|3|||
33491456|NCT04981717|101693698|FG000|Overall Study|Pregnancy|1|||
33491457|NCT04981717|101693699|FG001|Overall Study|Pregnancy|0|||
33491458|NCT04981717|101693698|FG000|Overall Study|Physician Decision|1|||
33491459|NCT04981717|101693699|FG001|Overall Study|Physician Decision|0|||
33491460|NCT04981717|101693698|FG000|Overall Study|Sponsor Request|157|||
33491461|NCT04981717|101693699|FG001|Overall Study|Sponsor Request|172|||
33491462|NCT04981717|101693698|FG000|Overall Study|Lost to Follow-up|4|||
33491463|NCT04981717|101693699|FG001|Overall Study|Lost to Follow-up|5|||
33491464|NCT04981717|101693698|FG000|Overall Study|Withdrawal by Subject|50|||
33491465|NCT04981717|101693699|FG001|Overall Study|Withdrawal by Subject|37|||
33491466|NCT03125798|101693700|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
33491467|NCT03125798|101693701|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
33491468|NCT03125798|101693700|FG000|Overall Study|Conversion to thoracotomy|7|||
33491469|NCT03125798|101693701|FG001|Overall Study|Conversion to thoracotomy|7|||
33491470|NCT00233948|101693702|FG000|Overall Study|Adverse Event|1|||
33491471|NCT00233948|101693703|FG001|Overall Study|Adverse Event|0|||
33491472|NCT00233948|101693704|FG002|Overall Study|Adverse Event|0|||
33491473|NCT00233948|101693705|FG003|Overall Study|Adverse Event|0|||
33491474|NCT00233948|101693706|FG004|Overall Study|Adverse Event|0|||
33491475|NCT00233948|101693707|FG005|Overall Study|Adverse Event|0|||
33491476|NCT04728802|101693713|FG000|Overall Study|Withdrawal by Subject|4|||
33491477|NCT04728802|101693714|FG001|Overall Study|Withdrawal by Subject|20|||
33491478|NCT04728802|101693713|FG000|Overall Study|Physician Decision|7|||
33491479|NCT04728802|101693714|FG001|Overall Study|Physician Decision|7|||
33491480|NCT04728802|101693713|FG000|Overall Study|Protocol Violation|10|||
33491481|NCT04728802|101693714|FG001|Overall Study|Protocol Violation|4|||
33491482|NCT04728802|101693713|FG000|Overall Study|Transfer|1|||
33491483|NCT04728802|101693714|FG001|Overall Study|Transfer|0|||
33491484|NCT04728802|101693713|FG000|Overall Study|Death|4|||
33491485|NCT04728802|101693714|FG001|Overall Study|Death|5|||
33491486|NCT04728802|101693713|FG000|Overall Study|Other|3|||
33491487|NCT04728802|101693714|FG001|Overall Study|Other|0|||
33491488|NCT00214383|101693715|FG000|Overall Study|Lost to Follow-up|16|||
33491489|NCT00214383|101693716|FG001|Overall Study|Lost to Follow-up|26|||
33491490|NCT02492867|101693717|FG000|Overall Study|Alternate therapy|1|||
33491491|NCT02492867|101693717|FG000|Overall Study|Withdrawal by Subject|2|||
33491492|NCT02492867|101693717|FG000|Overall Study|Disease progression after treatment started|1|||
33491493|NCT02492867|101693717|FG000|Overall Study|Death|1|||
33491494|NCT02174627|101693718|FG000|Overall Study|Missing|0|||
33491495|NCT02174627|101693719|FG001|Overall Study|Missing|1|||
33491496|NCT02174627|101693718|FG000|Overall Study|Incorrect enrolment before randomization|0|||
33491497|NCT02174627|101693719|FG001|Overall Study|Incorrect enrolment before randomization|1|||
33491498|NCT02174627|101693718|FG000|Overall Study|Participant decision|84|||
33491499|NCT02174627|101693719|FG001|Overall Study|Participant decision|128|||
33491500|NCT01060072|101693727|FG000|Overall Study|Adverse Event|1|||
33491501|NCT01060072|101693728|FG001|Overall Study|Adverse Event|1|||
33491502|NCT01060072|101693727|FG000|Overall Study|Physician Decision|0|||
33491503|NCT01060072|101693728|FG001|Overall Study|Physician Decision|2|||
33491504|NCT01060072|101693727|FG000|Overall Study|Protocol Violation|0|||
33491505|NCT01060072|101693728|FG001|Overall Study|Protocol Violation|1|||
33491506|NCT01060072|101693727|FG000|Overall Study|Acute cholecystitis|1|||
33491507|NCT01060072|101693728|FG001|Overall Study|Acute cholecystitis|0|||
33491508|NCT01060072|101693727|FG000|Overall Study|Excluded Medications|0|||
33491509|NCT01060072|101693728|FG001|Overall Study|Excluded Medications|1|||
33491510|NCT01522456|101693729|FG000|Overall Study|Adverse Event|2|||
33491511|NCT01522456|101693729|FG000|Overall Study|Lost to Follow-up|2|||
33491512|NCT01522456|101693729|FG000|Overall Study|Withdrawal by Subject|2|||
33491513|NCT01522456|101693729|FG000|Overall Study|Pregnancy|1|||
33491514|NCT01522456|101693729|FG000|Overall Study|Tolerability Assessment|1|||
33491515|NCT01350271|101693736|FG000|Overall Study|Lost to Follow-up|21|||
33491516|NCT01350271|101693737|FG001|Overall Study|Lost to Follow-up|17|||
33491517|NCT01350271|101693738|FG002|Overall Study|Lost to Follow-up|26|||
33491518|NCT01707290|101693742|FG000|Overall Study|Adverse event (AE)|1|||
33491519|NCT01707290|101693743|FG001|Overall Study|Adverse event (AE)|0|||
33491520|NCT01707290|101693742|FG000|Overall Study|Physician Decision|1|||
33491521|NCT01707290|101693743|FG001|Overall Study|Physician Decision|0|||
33491522|NCT01707290|101693742|FG000|Overall Study|Lost to Follow-up|3|||
33491523|NCT01707290|101693743|FG001|Overall Study|Lost to Follow-up|0|||
33491524|NCT01707290|101693742|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
33491525|NCT01707290|101693743|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
33491526|NCT01707290|101693742|FG000|Overall Study|Commercial drug available|60|||
33491527|NCT01707290|101693743|FG001|Overall Study|Commercial drug available|1|||
33491528|NCT01707290|101693742|FG000|Overall Study|Other unspecified|17|||
33491529|NCT01707290|101693743|FG001|Overall Study|Other unspecified|0|||
33491530|NCT01326845|101693744|FG000|Overall Study|Administrative Problems|5|||
33491531|NCT01326845|101693745|FG001|Overall Study|Administrative Problems|2|||
33491532|NCT01326845|101693744|FG000|Overall Study|Adverse Event|1|||
33491533|NCT01326845|101693745|FG001|Overall Study|Adverse Event|0|||
33491534|NCT01326845|101693744|FG000|Overall Study|Misisng|1|||
33491535|NCT01326845|101693745|FG001|Overall Study|Misisng|3|||
33491536|NCT02456740|101693748|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
33491537|NCT02456740|101693749|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
33491538|NCT02456740|101693750|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
33491539|NCT02456740|101693751|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
33491540|NCT02456740|101693752|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
33491541|NCT02456740|101693753|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
33491542|NCT02456740|101693754|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
33491543|NCT02456740|101693755|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
33491544|NCT02456740|101693756|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
33491545|NCT02456740|101693748|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
33491546|NCT02456740|101693749|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
33491547|NCT02456740|101693750|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
33491548|NCT02456740|101693751|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
33491549|NCT02456740|101693752|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
33491550|NCT02456740|101693753|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
33491551|NCT02456740|101693754|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
33491552|NCT02456740|101693755|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
33491553|NCT02456740|101693756|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
33491554|NCT02456740|101693748|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
33491555|NCT02456740|101693749|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
33491556|NCT02456740|101693750|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
33491557|NCT02456740|101693751|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
33491558|NCT02456740|101693752|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
33491559|NCT02456740|101693753|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
33491560|NCT02456740|101693754|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
33491561|NCT02456740|101693755|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
33491562|NCT02456740|101693756|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
33491563|NCT02456740|101693748|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
33491564|NCT02456740|101693749|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
33491565|NCT02456740|101693750|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
33491566|NCT02456740|101693751|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
33491567|NCT02456740|101693752|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
33491568|NCT02456740|101693753|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
33491569|NCT02456740|101693754|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
33491570|NCT02456740|101693755|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
33491571|NCT02456740|101693756|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
33491572|NCT02456740|101693748|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
33491573|NCT02456740|101693749|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
33491574|NCT02456740|101693750|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
33491575|NCT02456740|101693751|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
33491576|NCT02456740|101693752|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
33491577|NCT02456740|101693753|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
33491578|NCT02456740|101693754|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
33491579|NCT02456740|101693755|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
33491580|NCT02456740|101693756|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
33491581|NCT02456740|101693748|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33491582|NCT02456740|101693749|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33491583|NCT02456740|101693750|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33491584|NCT02456740|101693751|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33491585|NCT02456740|101693752|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33491586|NCT02456740|101693753|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33491587|NCT02456740|101693754|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33491588|NCT02456740|101693755|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
33491589|NCT02456740|101693756|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
33491590|NCT02456740|101693748|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33491591|NCT02456740|101693749|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33491592|NCT02456740|101693750|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
33491593|NCT02456740|101693751|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
33491594|NCT02456740|101693752|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
33491595|NCT02456740|101693753|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
33491596|NCT02456740|101693754|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
33491597|NCT02456740|101693755|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
33491598|NCT02456740|101693756|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
33491599|NCT05219448|101693757|FG000|Overall Study|Lost to Follow-up|9|||
33491600|NCT05219448|101693758|FG001|Overall Study|Lost to Follow-up|0|||
33491601|NCT00678210|101693761|FG000|Overall Study|Adverse Event|1|||
33491602|NCT00678210|101693762|FG001|Overall Study|Adverse Event|2|||
33491603|NCT00678210|101693763|FG002|Overall Study|Adverse Event|3|||
33491604|NCT00678210|101693764|FG003|Overall Study|Adverse Event|3|||
33491605|NCT00678210|101693761|FG000|Overall Study|Lack of Efficacy|2|||
33491606|NCT00678210|101693762|FG001|Overall Study|Lack of Efficacy|3|||
33491607|NCT00678210|101693763|FG002|Overall Study|Lack of Efficacy|1|||
33491608|NCT00678210|101693764|FG003|Overall Study|Lack of Efficacy|9|||
33491609|NCT00678210|101693761|FG000|Overall Study|Lost to Follow-up|4|||
33491610|NCT00678210|101693762|FG001|Overall Study|Lost to Follow-up|2|||
33491611|NCT00678210|101693763|FG002|Overall Study|Lost to Follow-up|0|||
33491612|NCT00678210|101693764|FG003|Overall Study|Lost to Follow-up|1|||
33491613|NCT00678210|101693761|FG000|Overall Study|Withdrawal by Subject|3|||
33491614|NCT00678210|101693762|FG001|Overall Study|Withdrawal by Subject|4|||
33491615|NCT00678210|101693763|FG002|Overall Study|Withdrawal by Subject|1|||
33491616|NCT00678210|101693764|FG003|Overall Study|Withdrawal by Subject|7|||
33491617|NCT00678210|101693761|FG000|Overall Study|Other|1|||
33491618|NCT00678210|101693762|FG001|Overall Study|Other|0|||
33491619|NCT00678210|101693763|FG002|Overall Study|Other|1|||
33491620|NCT00678210|101693764|FG003|Overall Study|Other|0|||
33491621|NCT00266630|101693765|FG000|Overall Study|Adverse Event|8|||
33491622|NCT00266630|101693766|FG001|Overall Study|Adverse Event|6|||
33491623|NCT00266630|101693765|FG000|Overall Study|Lack of Efficacy|1|||
33491624|NCT00266630|101693766|FG001|Overall Study|Lack of Efficacy|4|||
33491625|NCT00266630|101693765|FG000|Overall Study|Entry Criteria not met|1|||
33491626|NCT00266630|101693766|FG001|Overall Study|Entry Criteria not met|0|||
33491627|NCT00266630|101693765|FG000|Overall Study|Protocol Violation|1|||
33491628|NCT00266630|101693766|FG001|Overall Study|Protocol Violation|3|||
33491629|NCT00266630|101693765|FG000|Overall Study|Physician Decision|1|||
33491630|NCT00266630|101693766|FG001|Overall Study|Physician Decision|2|||
33491631|NCT00266630|101693765|FG000|Overall Study|Withdrawal by Subject|10|||
33491632|NCT00266630|101693766|FG001|Overall Study|Withdrawal by Subject|2|||
33491633|NCT00266630|101693765|FG000|Overall Study|Lost to Follow-up|1|||
33491634|NCT00266630|101693766|FG001|Overall Study|Lost to Follow-up|0|||
33491635|NCT00266630|101693765|FG000|Overall Study|Other|19|||
33491636|NCT00266630|101693766|FG001|Overall Study|Other|11|||
33491637|NCT00473590|101693770|FG000|Overall Study|Adverse Event|3|||
33491638|NCT00473590|101693771|FG001|Overall Study|Adverse Event|3|||
33491639|NCT00473590|101693770|FG000|Overall Study|Death|4|||
33491640|NCT00473590|101693771|FG001|Overall Study|Death|2|||
33491641|NCT00473590|101693770|FG000|Overall Study|Progression not resulting in death|24|||
33491642|NCT00473590|101693771|FG001|Overall Study|Progression not resulting in death|20|||
33491643|NCT00473590|101693770|FG000|Overall Study|Non-protocol-specified therapy|7|||
33491644|NCT00473590|101693771|FG001|Overall Study|Non-protocol-specified therapy|5|||
33491645|NCT00473590|101693770|FG000|Overall Study|Physician Decision|2|||
33491646|NCT00473590|101693771|FG001|Overall Study|Physician Decision|4|||
33491647|NCT00473590|101693770|FG000|Overall Study|Withdrawal by Subject|5|||
33491648|NCT00473590|101693771|FG001|Overall Study|Withdrawal by Subject|3|||
33491649|NCT00473590|101693770|FG000|Overall Study|Other|0|||
33491650|NCT00473590|101693771|FG001|Overall Study|Other|1|||
33491651|NCT05244122|101693772|FG000|Overall Study|Withdrawal by Subject|318|||
33491652|NCT01042093|101693782|FG000|Overall Study|Protocol Violation|2|||
33491653|NCT01042093|101693783|FG001|Overall Study|Protocol Violation|2|||
33491654|NCT01042093|101693784|FG002|Overall Study|Protocol Violation|2|||
33491655|NCT01042093|101693785|FG003|Overall Study|Protocol Violation|3|||
33491656|NCT01042093|101693782|FG000|Overall Study|Withdrawal by Subject|0|||
33491657|NCT01042093|101693783|FG001|Overall Study|Withdrawal by Subject|0|||
33491658|NCT01042093|101693784|FG002|Overall Study|Withdrawal by Subject|0|||
33491659|NCT01042093|101693785|FG003|Overall Study|Withdrawal by Subject|1|||
33491660|NCT03305848|101693786|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
33491661|NCT03305848|101693786|FG000|Overall Study|Physician Decision|2|||
33491662|NCT02698163|101693787|FG000|Overall Study|Lost to Follow-up|0|||
33491663|NCT02698163|101693788|FG001|Overall Study|Lost to Follow-up|1|||
33491664|NCT02163057|101693795|FG000|Overall Study|Participant Refusal to Continue|2|||
33491665|NCT02163057|101693796|FG001|Overall Study|Participant Refusal to Continue|2|||
33491666|NCT02163057|101693795|FG000|Overall Study|Participant Significant Noncompliance|0|||
33491667|NCT02163057|101693796|FG001|Overall Study|Participant Significant Noncompliance|1|||
33491668|NCT02163057|101693795|FG000|Overall Study|Progression of Disease|1|||
33491669|NCT02163057|101693796|FG001|Overall Study|Progression of Disease|2|||
33491670|NCT01841593|101693797|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
33491671|NCT01841593|101693798|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
33491672|NCT01841593|101693797|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
33491673|NCT01841593|101693798|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
33491674|NCT03334435|101693808|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
33491675|NCT03334435|101693809|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
33491676|NCT03334435|101693810|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
33491677|NCT03334435|101693811|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
33491678|NCT03334435|101693812|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
33491679|NCT03334435|101693813|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
33491680|NCT03334435|101693814|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
33491681|NCT03334435|101693815|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
33491682|NCT03334435|101693816|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
33491683|NCT03334435|101693817|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
33491684|NCT03334435|101693818|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
33491685|NCT03334435|101693819|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
33491686|NCT03334435|101693820|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
33491687|NCT03334435|101693821|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
33491688|NCT03334435|101693822|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
33491689|NCT03334435|101693808|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
33491690|NCT03334435|101693809|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
33491691|NCT03334435|101693810|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
33491692|NCT03334435|101693811|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
33491693|NCT03334435|101693812|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
33491694|NCT03334435|101693813|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
33491695|NCT03334435|101693814|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
33491696|NCT03334435|101693815|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
33491697|NCT03334435|101693816|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
33491698|NCT03334435|101693817|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
33491699|NCT03334435|101693818|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
33491700|NCT03334435|101693819|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
33491701|NCT03334435|101693820|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
33491702|NCT03334435|101693821|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
33491703|NCT03334435|101693822|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
33491704|NCT03334435|101693808|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
33491705|NCT03334435|101693809|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
33491706|NCT03334435|101693810|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
33491707|NCT03334435|101693811|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
33491708|NCT03334435|101693812|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
33491709|NCT03334435|101693813|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
33491710|NCT03334435|101693814|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
33491711|NCT03334435|101693815|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
33491712|NCT03334435|101693816|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
33491713|NCT03334435|101693817|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
33491714|NCT03334435|101693818|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
33491715|NCT03334435|101693819|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
33491716|NCT03334435|101693820|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
33491717|NCT03334435|101693821|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
33491718|NCT03334435|101693822|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
33491719|NCT03334435|101693808|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
33491720|NCT03334435|101693809|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
33491721|NCT03334435|101693810|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
33491722|NCT03334435|101693811|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
33491723|NCT03334435|101693812|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
33491724|NCT03334435|101693813|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
33491725|NCT03334435|101693814|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
33491726|NCT03334435|101693815|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
33491727|NCT03334435|101693816|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
33491728|NCT03334435|101693817|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
33491729|NCT03334435|101693818|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
33491730|NCT03334435|101693819|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
33491731|NCT03334435|101693820|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
33491732|NCT03334435|101693821|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
33491733|NCT03334435|101693822|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
33491734|NCT03334435|101693808|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
33491735|NCT03334435|101693809|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
33491736|NCT03334435|101693810|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
33491737|NCT03334435|101693811|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
33491738|NCT03334435|101693812|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
33491739|NCT03334435|101693813|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
33491740|NCT03334435|101693814|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
33491741|NCT03334435|101693815|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
33491742|NCT03334435|101693816|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
33491743|NCT03334435|101693817|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
33491744|NCT03334435|101693818|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
33491745|NCT03334435|101693819|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
33491746|NCT03334435|101693820|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
33491747|NCT03334435|101693821|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
33491748|NCT03334435|101693822|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
33491749|NCT03334435|101693808|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
33491750|NCT03334435|101693809|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
33491751|NCT03334435|101693810|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
33491752|NCT03334435|101693811|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
33491753|NCT03334435|101693812|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
33491754|NCT03334435|101693813|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
33491755|NCT03334435|101693814|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
33491756|NCT03334435|101693815|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
33491757|NCT03334435|101693816|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
33491758|NCT03334435|101693817|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
33491759|NCT03334435|101693818|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
33491760|NCT03334435|101693819|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
33491761|NCT03334435|101693820|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
33491762|NCT03334435|101693821|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
33491763|NCT03334435|101693822|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
33491764|NCT03334435|101693808|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
33491765|NCT03334435|101693809|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
33491766|NCT03334435|101693810|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
33491767|NCT03334435|101693811|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
33491768|NCT03334435|101693812|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
33491769|NCT03334435|101693813|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
33491770|NCT03334435|101693814|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
33491771|NCT03334435|101693815|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
33491772|NCT03334435|101693816|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
33491773|NCT03334435|101693817|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
33491774|NCT03334435|101693818|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
33491775|NCT03334435|101693819|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
33491776|NCT03334435|101693820|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
33491777|NCT03334435|101693821|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
33491778|NCT03334435|101693822|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
33491779|NCT03334435|101693808|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
33491780|NCT03334435|101693809|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
33491781|NCT03334435|101693810|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
33491782|NCT03334435|101693811|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
33491783|NCT03334435|101693812|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
33491784|NCT03334435|101693813|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
33491785|NCT03334435|101693814|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
33491786|NCT03334435|101693815|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
33491787|NCT03334435|101693816|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
33491788|NCT03334435|101693817|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
33491789|NCT03334435|101693818|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
33491790|NCT03334435|101693819|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
33491791|NCT03334435|101693820|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
33491792|NCT03334435|101693821|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
33491793|NCT03334435|101693822|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
33491794|NCT03334435|101693808|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
33491795|NCT03334435|101693809|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
33491796|NCT03334435|101693810|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
33491797|NCT03334435|101693811|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
33491798|NCT03334435|101693812|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
33491799|NCT03334435|101693813|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
33491800|NCT03334435|101693814|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
33491801|NCT03334435|101693815|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
33491802|NCT03334435|101693816|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
33491803|NCT03334435|101693817|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
33491804|NCT03334435|101693818|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
33491805|NCT03334435|101693819|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
33491806|NCT03334435|101693820|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
33491807|NCT03334435|101693821|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
33491808|NCT03334435|101693822|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
33491809|NCT03334435|101693808|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
33491810|NCT03334435|101693809|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
33491811|NCT03334435|101693810|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
33491812|NCT03334435|101693811|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
33491813|NCT03334435|101693812|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
33491814|NCT03334435|101693813|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
33491815|NCT03334435|101693814|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
33491816|NCT03334435|101693815|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
33491817|NCT03334435|101693816|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
33491818|NCT03334435|101693817|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
33491819|NCT03334435|101693818|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
33491820|NCT03334435|101693819|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
33491821|NCT03334435|101693820|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
33491822|NCT03334435|101693821|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
33491823|NCT03334435|101693822|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
33491824|NCT03334435|101693808|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
33491825|NCT03334435|101693809|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
33491826|NCT03334435|101693810|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
33491827|NCT03334435|101693811|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
33491828|NCT03334435|101693812|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
33491829|NCT03334435|101693813|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
33491830|NCT03334435|101693814|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
33491831|NCT03334435|101693815|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
33491832|NCT03334435|101693816|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
33491833|NCT03334435|101693817|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
33491834|NCT03334435|101693818|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
33491835|NCT03334435|101693819|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
33491836|NCT03334435|101693820|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
33491837|NCT03334435|101693821|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
33491838|NCT03334435|101693822|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
33491839|NCT03334435|101693808|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
33491840|NCT03334435|101693809|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
33491841|NCT03334435|101693810|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
33491842|NCT03334435|101693811|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
33491843|NCT03334435|101693812|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
33491844|NCT03334435|101693813|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
33491845|NCT03334435|101693814|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
33491846|NCT03334435|101693815|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
33491847|NCT03334435|101693816|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
33491848|NCT03334435|101693817|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
33491849|NCT03334435|101693818|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
33491850|NCT03334435|101693819|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
33491851|NCT03334435|101693820|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
33491852|NCT03334435|101693821|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
33491853|NCT03334435|101693822|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
33491854|NCT03334435|101693808|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
33491855|NCT03334435|101693809|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
33491856|NCT03334435|101693810|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
33491857|NCT03334435|101693811|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
33491858|NCT03334435|101693812|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
33491859|NCT03334435|101693813|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
33491860|NCT03334435|101693814|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
33491861|NCT03334435|101693815|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
33491862|NCT03334435|101693816|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
33491863|NCT03334435|101693817|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
33491864|NCT03334435|101693818|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
33491865|NCT03334435|101693819|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
33491866|NCT03334435|101693820|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
33491867|NCT03334435|101693821|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
33491868|NCT03334435|101693822|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
33491869|NCT03334435|101693808|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
33491870|NCT03334435|101693809|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
33491871|NCT03334435|101693810|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
33491872|NCT03334435|101693811|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
33491873|NCT03334435|101693812|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
33491874|NCT03334435|101693813|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
33491875|NCT03334435|101693814|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
33491876|NCT03334435|101693815|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
33491877|NCT03334435|101693816|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
33491878|NCT03334435|101693817|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
33491879|NCT03334435|101693818|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
33491880|NCT03334435|101693819|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
33491881|NCT03334435|101693820|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
33491882|NCT03334435|101693821|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
33491883|NCT03334435|101693822|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
33491884|NCT03334435|101693808|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
33491885|NCT03334435|101693809|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
33491886|NCT03334435|101693810|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
33491887|NCT03334435|101693811|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
33491888|NCT03334435|101693812|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
33491889|NCT03334435|101693813|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
33491890|NCT03334435|101693814|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
33491891|NCT03334435|101693815|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
33491892|NCT03334435|101693816|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
33491893|NCT03334435|101693817|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
33491894|NCT03334435|101693818|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
33491895|NCT03334435|101693819|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
33491896|NCT03334435|101693820|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
33491897|NCT03334435|101693821|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
33491898|NCT03334435|101693822|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
33491899|NCT03334435|101693808|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
33491900|NCT03334435|101693809|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
33491901|NCT03334435|101693810|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
33491902|NCT03334435|101693811|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
33491903|NCT03334435|101693812|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
33491904|NCT03334435|101693813|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
33491905|NCT03334435|101693814|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
33491906|NCT03334435|101693815|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
33491907|NCT03334435|101693816|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
33491908|NCT03334435|101693817|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
33491909|NCT03334435|101693818|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
33491910|NCT03334435|101693819|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
33491911|NCT03334435|101693820|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
33491912|NCT03334435|101693821|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
33491913|NCT03334435|101693822|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
33491914|NCT03334435|101693808|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
33491915|NCT03334435|101693809|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
33491916|NCT03334435|101693810|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
33491917|NCT03334435|101693811|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
33491918|NCT03334435|101693812|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
33491919|NCT03334435|101693813|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
33491920|NCT03334435|101693814|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
33491921|NCT03334435|101693815|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
33491922|NCT03334435|101693816|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
33491923|NCT03334435|101693817|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
33491924|NCT03334435|101693818|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
33491925|NCT03334435|101693819|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
33491926|NCT03334435|101693820|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
33491927|NCT03334435|101693821|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
33491928|NCT03334435|101693822|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
33491929|NCT03334435|101693808|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
33491930|NCT03334435|101693809|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
33491931|NCT03334435|101693810|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
33491932|NCT03334435|101693811|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
33491933|NCT03334435|101693812|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
33491934|NCT03334435|101693813|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
33491935|NCT03334435|101693814|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
33491936|NCT03334435|101693815|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
33491937|NCT03334435|101693816|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
33491938|NCT03334435|101693817|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
33491939|NCT03334435|101693818|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
33491940|NCT03334435|101693819|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
33491941|NCT03334435|101693820|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
33491942|NCT03334435|101693821|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
33491943|NCT03334435|101693822|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
33491944|NCT03334435|101693808|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
33491945|NCT03334435|101693809|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
33491946|NCT03334435|101693810|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
33491947|NCT03334435|101693811|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
33491948|NCT03334435|101693812|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
33491949|NCT03334435|101693813|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
33491950|NCT03334435|101693814|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
33491951|NCT03334435|101693815|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
33491952|NCT03334435|101693816|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
33491953|NCT03334435|101693817|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
33491954|NCT03334435|101693818|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
33491955|NCT03334435|101693819|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
33491956|NCT03334435|101693820|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
33491957|NCT03334435|101693821|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
33491958|NCT03334435|101693822|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
33491959|NCT01306305|101693832|FG000|Overall Study|Lost to Follow-up|1|||
33491960|NCT01306305|101693833|FG001|Overall Study|Lost to Follow-up|0|||
33491961|NCT01306305|101693832|FG000|Overall Study|Withdrew consent|1|||
33491962|NCT01306305|101693833|FG001|Overall Study|Withdrew consent|0|||
33491963|NCT01027702|101693834|FG000|Overall Study|Received subsequent therapy|1|||
33491964|NCT01027702|101693835|FG001|Overall Study|Received subsequent therapy|2|||
33491965|NCT01027702|101693836|FG002|Overall Study|Received subsequent therapy|0|||
33491966|NCT01027702|101693837|FG003|Overall Study|Received subsequent therapy|4|||
33491967|NCT01027702|101693838|FG004|Overall Study|Received subsequent therapy|1|||
33491968|NCT01027702|101693839|FG005|Overall Study|Received subsequent therapy|0|||
33491969|NCT01027702|101693840|FG006|Overall Study|Received subsequent therapy|1|||
33491970|NCT01027702|101693834|FG000|Overall Study|Death|0|||
33491971|NCT01027702|101693835|FG001|Overall Study|Death|0|||
33491972|NCT01027702|101693836|FG002|Overall Study|Death|1|||
33491973|NCT01027702|101693837|FG003|Overall Study|Death|0|||
33491974|NCT01027702|101693838|FG004|Overall Study|Death|0|||
33286486|NCT03481556|100943977|FG000|Overall Study|Study Terminated by Sponsor|10|||
33286487|NCT03481556|100943978|FG001|Overall Study|Study Terminated by Sponsor|5|||
33286488|NCT03481556|100943979|FG002|Overall Study|Study Terminated by Sponsor|2|||
33286489|NCT03481556|100943980|FG003|Overall Study|Study Terminated by Sponsor|9|||
33286490|NCT02741713|100943981|FG000|Overall Study|Surgery type changed intra-operatively|2|||
33286491|NCT02741713|100943982|FG001|Overall Study|Surgery type changed intra-operatively|1|||
33286492|NCT00833898|100943986|FG000|Overall Study|Withdrawal by Subject|33|||
33286493|NCT00833898|100943987|FG001|Overall Study|Withdrawal by Subject|27|||
33286494|NCT00833898|100943986|FG000|Overall Study|Lost to Follow-up|7|||
33286495|NCT00833898|100943987|FG001|Overall Study|Lost to Follow-up|7|||
33286496|NCT00833898|100943986|FG000|Overall Study|Patient did not receive transplant|0|||
33286497|NCT00833898|100943987|FG001|Overall Study|Patient did not receive transplant|2|||
33286498|NCT01904136|100943988|FG000|Overall Study|Physician Decision|0|||
33286499|NCT01904136|100943989|FG001|Overall Study|Physician Decision|0|||
33286500|NCT01904136|100943990|FG002|Overall Study|Physician Decision|0|||
33286501|NCT01904136|100943991|FG003|Overall Study|Physician Decision|0|||
33286502|NCT01904136|100943992|FG004|Overall Study|Physician Decision|0|||
33286503|NCT01904136|100943993|FG005|Overall Study|Physician Decision|1|||
33286504|NCT01904136|100943994|FG006|Overall Study|Physician Decision|0|||
33286505|NCT01904136|100943995|FG007|Overall Study|Physician Decision|0|||
33286506|NCT01904136|100943996|FG008|Overall Study|Physician Decision|0|||
33286507|NCT04531813|100943997|FG000|Overall Study|Protocol Violation|1|||
33286508|NCT04531813|100943997|FG000|Overall Study|Withdrawal by Subject|1|||
33286509|NCT01167192|100944000|FG000|Overall Study|Adverse Event|1|||
33286510|NCT01167192|100944000|FG000|Overall Study|Death|1|||
33286511|NCT01167192|100944000|FG000|Overall Study|Withdrawal by Subject|1|||
33286512|NCT01167192|100944000|FG000|Overall Study|Insurance denial|1|||
33286513|NCT00233389|100944001|FG000|Overall Study|Adverse Event|5|||
33286514|NCT00233389|100944002|FG001|Overall Study|Adverse Event|5|||
33286515|NCT00233389|100944001|FG000|Overall Study|Lack of Efficacy|11|||
33286516|NCT00233389|100944002|FG001|Overall Study|Lack of Efficacy|8|||
33286517|NCT00233389|100944001|FG000|Overall Study|Lost to Follow-up|1|||
33286518|NCT00233389|100944002|FG001|Overall Study|Lost to Follow-up|1|||
33286519|NCT00233389|100944001|FG000|Overall Study|Physician Decision|1|||
33286520|NCT00233389|100944002|FG001|Overall Study|Physician Decision|0|||
33286521|NCT00233389|100944001|FG000|Overall Study|Protocol Violation|0|||
33286522|NCT00233389|100944002|FG001|Overall Study|Protocol Violation|1|||
33286523|NCT00233389|100944001|FG000|Overall Study|Withdrawal by Subject|0|||
33286524|NCT00233389|100944002|FG001|Overall Study|Withdrawal by Subject|1|||
33491975|NCT01027702|101693839|FG005|Overall Study|Death|0|||
33491976|NCT01027702|101693840|FG006|Overall Study|Death|0|||
33491977|NCT01750190|101693843|FG000|Overall Study|Adverse Event|47|||
33491978|NCT01750190|101693844|FG001|Overall Study|Adverse Event|19|||
33491979|NCT01750190|101693843|FG000|Overall Study|Death|38|||
33491980|NCT01750190|101693844|FG001|Overall Study|Death|11|||
33491981|NCT01750190|101693843|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
33491982|NCT01750190|101693844|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
33491983|NCT01750190|101693843|FG000|Overall Study|Lost to Follow-up|28|||
33491984|NCT01750190|101693844|FG001|Overall Study|Lost to Follow-up|7|||
33491985|NCT01750190|101693843|FG000|Overall Study|Physician Decision|16|||
33491986|NCT01750190|101693844|FG001|Overall Study|Physician Decision|17|||
33491987|NCT01750190|101693843|FG000|Overall Study|Protocol Violation|6|||
33491988|NCT01750190|101693844|FG001|Overall Study|Protocol Violation|5|||
33491989|NCT01750190|101693843|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
33491990|NCT01750190|101693844|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
33491991|NCT01750190|101693843|FG000|Overall Study|Withdrawal by Subject|83|||
33491992|NCT01750190|101693844|FG001|Overall Study|Withdrawal by Subject|89|||
33491993|NCT01750190|101693843|FG000|Overall Study|Kidney Transplant|8|||
33491994|NCT01750190|101693844|FG001|Overall Study|Kidney Transplant|4|||
33491995|NCT01750190|101693843|FG000|Overall Study|Dialysis|22|||
33491996|NCT01750190|101693844|FG001|Overall Study|Dialysis|8|||
33491997|NCT01750190|101693843|FG000|Overall Study|Other than Specified|13|||
33491998|NCT01750190|101693844|FG001|Overall Study|Other than Specified|4|||
33491999|NCT00661193|101693845|FG000|Overall Study|Adverse Event|2|||
33492000|NCT00661193|101693846|FG001|Overall Study|Adverse Event|1|||
33492001|NCT00661193|101693845|FG000|Overall Study|Withdrawal by Subject|3|||
33492002|NCT00661193|101693846|FG001|Overall Study|Withdrawal by Subject|1|||
33492003|NCT00661193|101693845|FG000|Overall Study|Progression|27|||
33492004|NCT00661193|101693846|FG001|Overall Study|Progression|24|||
33492005|NCT00661193|101693845|FG000|Overall Study|Not protocol specified|1|||
33492006|NCT00661193|101693846|FG001|Overall Study|Not protocol specified|0|||
33492007|NCT01569295|101693851|FG000|Overall Study|Progressive Disease|75|||
33492008|NCT01569295|101693852|FG001|Overall Study|Progressive Disease|139|||
33492009|NCT01569295|101693851|FG000|Overall Study|Adverse Event|39|||
33492010|NCT01569295|101693852|FG001|Overall Study|Adverse Event|14|||
33492011|NCT01569295|101693851|FG000|Overall Study|Withdrawal by Subject|25|||
33492012|NCT01569295|101693852|FG001|Overall Study|Withdrawal by Subject|12|||
33492013|NCT01569295|101693851|FG000|Overall Study|Death|19|||
33492017|NCT01569295|101693851|FG000|Overall Study|Study Terminated by Sponsor|24|||
33492018|NCT01569295|101693852|FG001|Overall Study|Study Terminated by Sponsor|2|||
33492019|NCT01569295|101693851|FG000|Overall Study|Other Reason not Specified|3|||
33492020|NCT01569295|101693852|FG001|Overall Study|Other Reason not Specified|5|||
33492021|NCT01569295|101693851|FG000|Overall Study|Non-Compliance with Study Drug|6|||
33492022|NCT01569295|101693852|FG001|Overall Study|Non-Compliance with Study Drug|1|||
33492023|NCT01569295|101693851|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
33492024|NCT01569295|101693852|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
33492025|NCT01569295|101693851|FG000|Overall Study|Lost to Follow-up|1|||
33492026|NCT01569295|101693852|FG001|Overall Study|Lost to Follow-up|1|||
33492027|NCT02288312|101693853|FG000|Overall Study|Pregnancy|1|||
33492028|NCT02288312|101693854|FG001|Overall Study|Pregnancy|0|||
33492029|NCT02288312|101693855|FG002|Overall Study|Pregnancy|0|||
33492030|NCT00153179|101693856|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
33492031|NCT00153179|101693857|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
33492032|NCT00153179|101693858|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
33492033|NCT00153179|101693859|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
33492034|NCT02618759|101693860|FG000|Overall Study|Lost to Follow-up|0|||
33492035|NCT02618759|101693861|FG001|Overall Study|Lost to Follow-up|1|||
33492036|NCT02618759|101693860|FG000|Overall Study|Withdrawal by Subject|1|||
33492037|NCT02618759|101693861|FG001|Overall Study|Withdrawal by Subject|0|||
33492038|NCT02618759|101693860|FG000|Overall Study|Other Reasons|1|||
33492039|NCT02618759|101693861|FG001|Overall Study|Other Reasons|4|||
33492040|NCT02064296|101693863|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
33492041|NCT02064296|101693864|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
33492042|NCT02064296|101693865|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
33492043|NCT02064296|101693863|FG000|Intervention|Withdrawal by Subject|0|||
33492044|NCT02064296|101693864|FG001|Intervention|Withdrawal by Subject|1|||
33492045|NCT02064296|101693865|FG002|Intervention|Withdrawal by Subject|2|||
33492046|NCT03817190|101693866|FG000|Overall Study|Early Termination|13|||
33492047|NCT03817190|101693867|FG001|Overall Study|Early Termination|20|||
33492048|NCT03817190|101693866|FG000|Overall Study|Adverse Event|10|||
33492049|NCT03817190|101693867|FG001|Overall Study|Adverse Event|17|||
33492050|NCT03817190|101693866|FG000|Overall Study|Withdrawal by Subject|12|||
33492051|NCT03817190|101693867|FG001|Overall Study|Withdrawal by Subject|8|||
33492052|NCT03817190|101693866|FG000|Overall Study|Lost to Follow-up|11|||
33492053|NCT03817190|101693867|FG001|Overall Study|Lost to Follow-up|7|||
33492054|NCT03817190|101693866|FG000|Overall Study|Lack of Efficacy|7|||
33492055|NCT03817190|101693867|FG001|Overall Study|Lack of Efficacy|5|||
33492056|NCT03817190|101693866|FG000|Overall Study|Investigator Decision|5|||
33492057|NCT03817190|101693867|FG001|Overall Study|Investigator Decision|1|||
33492058|NCT03817190|101693866|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
33492059|NCT03817190|101693867|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
33492060|NCT03817190|101693866|FG000|Overall Study|Lack of Contact|1|||
33492061|NCT03817190|101693867|FG001|Overall Study|Lack of Contact|0|||
33492062|NCT03817190|101693866|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
33492063|NCT03817190|101693867|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
33492064|NCT01200069|101693868|FG000|Overall Study|Withdrawal by Subject|0|||
33492065|NCT01200069|101693869|FG001|Overall Study|Withdrawal by Subject|1|||
33492066|NCT01133067|101693870|FG000|Overall Study|Death|136|||
33492067|NCT01133067|101693870|FG000|Overall Study|Lost to Follow-up|3|||
33492068|NCT02009722|101693871|FG000|Overall Study|Protocol Violation|1|||
33492069|NCT02009722|101693872|FG001|Overall Study|Protocol Violation|2|||
33492070|NCT02009722|101693871|FG000|Overall Study|Did not receive intervention|0|||
33492071|NCT02009722|101693872|FG001|Overall Study|Did not receive intervention|1|||
33492072|NCT04428034|101693874|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
33492073|NCT00925704|101693876|FG000|First Intervention|Withdrew consent|0|||
33492074|NCT00925704|101693877|FG001|First Intervention|Withdrew consent|0|||
33492075|NCT00925704|101693878|FG002|First Intervention|Withdrew consent|0|||
33492076|NCT00925704|101693879|FG003|First Intervention|Withdrew consent|1|||
33492077|NCT00925704|101693880|FG004|First Intervention|Withdrew consent|1|||
33492078|NCT00925704|101693881|FG005|First Intervention|Withdrew consent|0|||
33492079|NCT00925704|101693876|FG000|Second Intervention|Withdrawal by Subject|1|||
33492080|NCT00925704|101693877|FG001|Second Intervention|Withdrawal by Subject|0|||
33492081|NCT00925704|101693878|FG002|Second Intervention|Withdrawal by Subject|0|||
33492082|NCT00925704|101693879|FG003|Second Intervention|Withdrawal by Subject|0|||
33492083|NCT00925704|101693880|FG004|Second Intervention|Withdrawal by Subject|1|||
33492084|NCT00925704|101693881|FG005|Second Intervention|Withdrawal by Subject|0|||
33492085|NCT00925704|101693876|FG000|Third Intervention|Withdrew consent|0|||
33492086|NCT00925704|101693877|FG001|Third Intervention|Withdrew consent|0|||
33492087|NCT00925704|101693878|FG002|Third Intervention|Withdrew consent|0|||
33492088|NCT00925704|101693879|FG003|Third Intervention|Withdrew consent|0|||
33492089|NCT00925704|101693880|FG004|Third Intervention|Withdrew consent|0|||
33492090|NCT00925704|101693881|FG005|Third Intervention|Withdrew consent|1|||
33492164|NCT02654054|101693919|FG000|Post-Treatment Follow-Up Period|Other|1|||
33492165|NCT02654054|101693920|FG001|Post-Treatment Follow-Up Period|Other|0|||
33492166|NCT02654054|101693921|FG002|Post-Treatment Follow-Up Period|Other|4|||
33492167|NCT02654054|101693919|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
33492168|NCT02654054|101693920|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
33492169|NCT02654054|101693921|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
33492170|NCT02556801|101693922|FG000|Overall Study|Lost to Follow-up|1|||
33492171|NCT02556801|101693923|FG001|Overall Study|Lost to Follow-up|0|||
33492172|NCT02556801|101693924|FG002|Overall Study|Lost to Follow-up|2|||
33492173|NCT02556801|101693925|FG003|Overall Study|Lost to Follow-up|0|||
33492174|NCT02556801|101693922|FG000|Overall Study|Withdrawal by Subject|1|||
33492175|NCT02556801|101693923|FG001|Overall Study|Withdrawal by Subject|1|||
33492176|NCT02556801|101693924|FG002|Overall Study|Withdrawal by Subject|1|||
33492177|NCT02556801|101693925|FG003|Overall Study|Withdrawal by Subject|0|||
33492178|NCT02556801|101693922|FG000|Overall Study|Protocol Violation|0|||
33492179|NCT02556801|101693923|FG001|Overall Study|Protocol Violation|3|||
33492180|NCT02556801|101693924|FG002|Overall Study|Protocol Violation|1|||
33492181|NCT02556801|101693925|FG003|Overall Study|Protocol Violation|1|||
33492182|NCT02556801|101693922|FG000|Overall Study|Adverse Event|0|||
33492183|NCT02556801|101693923|FG001|Overall Study|Adverse Event|2|||
33492184|NCT02556801|101693924|FG002|Overall Study|Adverse Event|0|||
33492185|NCT02556801|101693925|FG003|Overall Study|Adverse Event|3|||
33492186|NCT02556801|101693922|FG000|Overall Study|Pregnancy|0|||
33492187|NCT02556801|101693923|FG001|Overall Study|Pregnancy|1|||
33492188|NCT02556801|101693924|FG002|Overall Study|Pregnancy|0|||
33492189|NCT02556801|101693925|FG003|Overall Study|Pregnancy|0|||
33492190|NCT02556801|101693922|FG000|Overall Study|Personal reasons patient|0|||
33492191|NCT02556801|101693923|FG001|Overall Study|Personal reasons patient|0|||
33492192|NCT02556801|101693924|FG002|Overall Study|Personal reasons patient|0|||
33492193|NCT02556801|101693925|FG003|Overall Study|Personal reasons patient|1|||
33492194|NCT01651117|101693926|FG000|Overall Study|Death|2|||
33492195|NCT01651117|101693927|FG001|Overall Study|Death|3|||
33492196|NCT01651117|101693928|FG002|Overall Study|Death|2|||
33492197|NCT01651117|101693929|FG003|Overall Study|Death|2|||
33492198|NCT02792517|101693934|FG000|Overall Study|Withdrawal by Subject|10|||
33492199|NCT02792517|101693934|FG000|Overall Study|Decision by Sponsor|7|||
33492200|NCT02792517|101693934|FG000|Overall Study|Lost to Follow-up|3|||
33492201|NCT02566889|101693935|FG000|Overall Study|Withdrawal by Subject|3|||
33492202|NCT02566889|101693936|FG001|Overall Study|Withdrawal by Subject|1|||
33492203|NCT02566889|101693935|FG000|Overall Study|Adverse Event|4|||
33492204|NCT02566889|101693936|FG001|Overall Study|Adverse Event|2|||
33492205|NCT02566889|101693935|FG000|Overall Study|Other|6|||
33492206|NCT02566889|101693936|FG001|Overall Study|Other|2|||
33492207|NCT02790437|101693937|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
33492208|NCT02790437|101693938|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
33492209|NCT02790437|101693937|FG000|Overall Study|Adverse Event|1|||
33492210|NCT02790437|101693938|FG001|Overall Study|Adverse Event|0|||
33492211|NCT02790437|101693937|FG000|Overall Study|Withdrawal by Subject|1|||
33492212|NCT02790437|101693938|FG001|Overall Study|Withdrawal by Subject|0|||
33492213|NCT00729937|101693939|FG000|Overall Study|Lost to Follow-up|49|||
33492214|NCT00729937|101693940|FG001|Overall Study|Lost to Follow-up|58|||
33492215|NCT00729937|101693941|FG002|Overall Study|Lost to Follow-up|18|||
33492216|NCT00729937|101693942|FG003|Overall Study|Lost to Follow-up|33|||
33492217|NCT00729937|101693943|FG004|Overall Study|Lost to Follow-up|18|||
33492218|NCT00729937|101693944|FG005|Overall Study|Lost to Follow-up|23|||
33492219|NCT00729937|101693939|FG000|Overall Study|Physician Decision|7|||
33492220|NCT00729937|101693940|FG001|Overall Study|Physician Decision|16|||
33492221|NCT00729937|101693941|FG002|Overall Study|Physician Decision|2|||
33492222|NCT00729937|101693942|FG003|Overall Study|Physician Decision|0|||
33492223|NCT00729937|101693943|FG004|Overall Study|Physician Decision|5|||
33492224|NCT00729937|101693944|FG005|Overall Study|Physician Decision|8|||
33492225|NCT00729937|101693939|FG000|Overall Study|Death|1|||
33492226|NCT00729937|101693940|FG001|Overall Study|Death|0|||
33492227|NCT00729937|101693941|FG002|Overall Study|Death|1|||
33492228|NCT00729937|101693942|FG003|Overall Study|Death|0|||
33492229|NCT00729937|101693943|FG004|Overall Study|Death|0|||
33492230|NCT00729937|101693944|FG005|Overall Study|Death|1|||
33492231|NCT00729937|101693939|FG000|Overall Study|Withdrawal by Subject|3|||
33492232|NCT00729937|101693940|FG001|Overall Study|Withdrawal by Subject|5|||
33492233|NCT00729937|101693941|FG002|Overall Study|Withdrawal by Subject|6|||
33492234|NCT00729937|101693942|FG003|Overall Study|Withdrawal by Subject|0|||
33492235|NCT00729937|101693943|FG004|Overall Study|Withdrawal by Subject|4|||
33492236|NCT00729937|101693944|FG005|Overall Study|Withdrawal by Subject|2|||
33492237|NCT00729937|101693939|FG000|Overall Study|Randomized but not treated|12|||
33492238|NCT00729937|101693940|FG001|Overall Study|Randomized but not treated|6|||
33492239|NCT00729937|101693941|FG002|Overall Study|Randomized but not treated|1|||
33492240|NCT00729937|101693942|FG003|Overall Study|Randomized but not treated|0|||
33492241|NCT00729937|101693943|FG004|Overall Study|Randomized but not treated|1|||
33492242|NCT00729937|101693944|FG005|Overall Study|Randomized but not treated|3|||
33492243|NCT00729937|101693939|FG000|Overall Study|Did not meet eligibility criteria|2|||
33492244|NCT00729937|101693940|FG001|Overall Study|Did not meet eligibility criteria|1|||
33492245|NCT00729937|101693941|FG002|Overall Study|Did not meet eligibility criteria|0|||
33492246|NCT00729937|101693942|FG003|Overall Study|Did not meet eligibility criteria|0|||
33492247|NCT00729937|101693943|FG004|Overall Study|Did not meet eligibility criteria|0|||
33492248|NCT00729937|101693944|FG005|Overall Study|Did not meet eligibility criteria|0|||
33492249|NCT00729937|101693939|FG000|Overall Study|Incarcerated|0|||
33492250|NCT00729937|101693940|FG001|Overall Study|Incarcerated|2|||
33492251|NCT00729937|101693941|FG002|Overall Study|Incarcerated|1|||
33492252|NCT00729937|101693942|FG003|Overall Study|Incarcerated|1|||
33492253|NCT00729937|101693943|FG004|Overall Study|Incarcerated|0|||
33492254|NCT00729937|101693944|FG005|Overall Study|Incarcerated|0|||
33492255|NCT03452943|101693945|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
33492256|NCT03452943|101693946|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
33492257|NCT03452943|101693945|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
33492258|NCT03452943|101693946|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
33492259|NCT03452943|101693945|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
33492260|NCT03452943|101693946|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
33492261|NCT03452943|101693945|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
33492262|NCT03452943|101693946|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
33492263|NCT03452943|101693945|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
33492264|NCT03452943|101693946|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
33492265|NCT03452943|101693945|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
33492266|NCT03452943|101693946|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
33492267|NCT01173120|101693947|FG000|Overall Study|Lack of Efficacy|2|||
33492268|NCT01173120|101693947|FG000|Overall Study|Lost to Follow-up|1|||
33492269|NCT01173120|101693947|FG000|Overall Study|Participant Decision|2|||
33492270|NCT01173120|101693947|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
33492271|NCT01173120|101693947|FG000|Overall Study|Switch-Participant Decision|12|||
33492272|NCT01173120|101693947|FG000|Overall Study|Switch-Difficulty With Device|12|||
33492273|NCT03410056|101693948|FG000|Overall Study|Decision by Sponsor|0|||
33492274|NCT03410056|101693949|FG001|Overall Study|Decision by Sponsor|0|||
33492275|NCT03410056|101693950|FG002|Overall Study|Decision by Sponsor|3|||
33492276|NCT03410056|101693951|FG003|Overall Study|Decision by Sponsor|0|||
33492277|NCT03410056|101693952|FG004|Overall Study|Decision by Sponsor|0|||
33492278|NCT03410056|101693953|FG005|Overall Study|Decision by Sponsor|0|||
33492279|NCT03410056|101693954|FG006|Overall Study|Decision by Sponsor|0|||
33492280|NCT03410056|101693948|FG000|Overall Study|Withdrawal by Subject|0|||
33492281|NCT03410056|101693949|FG001|Overall Study|Withdrawal by Subject|2|||
33492282|NCT03410056|101693950|FG002|Overall Study|Withdrawal by Subject|5|||
33492283|NCT03410056|101693951|FG003|Overall Study|Withdrawal by Subject|5|||
33492284|NCT03410056|101693952|FG004|Overall Study|Withdrawal by Subject|0|||
33492285|NCT03410056|101693953|FG005|Overall Study|Withdrawal by Subject|0|||
33492286|NCT03410056|101693954|FG006|Overall Study|Withdrawal by Subject|0|||
33492287|NCT05024747|101693955|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
33492288|NCT05024747|101693956|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
33492289|NCT05024747|101693955|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
33492290|NCT05024747|101693956|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
33492291|NCT05024747|101693955|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
33492292|NCT05024747|101693956|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
33492293|NCT00662649|101693957|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
33492294|NCT00662649|101693958|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
33492295|NCT00662649|101693959|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
33492296|NCT00662649|101693960|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
33492297|NCT00662649|101693961|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
33492298|NCT00662649|101693957|FG000|Core Study (24 Months)|Adverse Event|22|||
33492299|NCT00662649|101693958|FG001|Core Study (24 Months)|Adverse Event|13|||
33492300|NCT00662649|101693959|FG002|Core Study (24 Months)|Adverse Event|18|||
33492301|NCT00662649|101693960|FG003|Core Study (24 Months)|Adverse Event|0|||
33492302|NCT00662649|101693961|FG004|Core Study (24 Months)|Adverse Event|0|||
33492303|NCT00662649|101693957|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
33492304|NCT00662649|101693958|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
33492305|NCT00662649|101693959|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
33492306|NCT00662649|101693960|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
33492307|NCT00662649|101693961|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
33492308|NCT00662649|101693957|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
33492309|NCT00662649|101693958|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
33492310|NCT00662649|101693959|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
33492311|NCT00662649|101693960|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
33492312|NCT00662649|101693961|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
33492313|NCT00662649|101693957|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
33492314|NCT00662649|101693958|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
33492315|NCT00662649|101693959|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
33492316|NCT00662649|101693960|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
33492317|NCT00662649|101693961|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
33492318|NCT00662649|101693957|FG000|Core Study (24 Months)|Protocol Violation|5|||
33492319|NCT00662649|101693958|FG001|Core Study (24 Months)|Protocol Violation|5|||
33492320|NCT00662649|101693959|FG002|Core Study (24 Months)|Protocol Violation|4|||
33492321|NCT00662649|101693960|FG003|Core Study (24 Months)|Protocol Violation|0|||
33492322|NCT00662649|101693961|FG004|Core Study (24 Months)|Protocol Violation|0|||
33492323|NCT00662649|101693957|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
33492324|NCT00662649|101693958|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
33492325|NCT00662649|101693959|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
33492326|NCT00662649|101693960|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
33492327|NCT00662649|101693961|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
33492328|NCT00662649|101693957|FG000|Core Study (24 Months)|Death|1|||
33492329|NCT00662649|101693958|FG001|Core Study (24 Months)|Death|0|||
33492330|NCT00662649|101693959|FG002|Core Study (24 Months)|Death|2|||
33492331|NCT00662649|101693960|FG003|Core Study (24 Months)|Death|0|||
33492332|NCT00662649|101693961|FG004|Core Study (24 Months)|Death|0|||
33492333|NCT00662649|101693957|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
33492334|NCT00662649|101693958|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
33492335|NCT00662649|101693959|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
33492336|NCT00662649|101693960|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
33492337|NCT00662649|101693961|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
33492338|NCT00662649|101693957|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
33492339|NCT00662649|101693958|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
33492340|NCT00662649|101693959|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
33492341|NCT00662649|101693960|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
33492342|NCT00662649|101693961|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
33492343|NCT00662649|101693957|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
33492344|NCT00662649|101693958|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
33492345|NCT00662649|101693959|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
33492346|NCT00662649|101693960|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
33492347|NCT00662649|101693961|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
33492348|NCT00662649|101693957|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
33492349|NCT00662649|101693958|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
33492350|NCT00662649|101693959|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
33492351|NCT00662649|101693960|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
33492352|NCT00662649|101693961|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
33492353|NCT00662649|101693957|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
33492354|NCT00662649|101693958|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
33492355|NCT00662649|101693959|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
33492356|NCT00662649|101693960|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
33492357|NCT00662649|101693961|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
33492358|NCT00662649|101693957|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
33492359|NCT00662649|101693958|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
33492360|NCT00662649|101693959|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
33492361|NCT00662649|101693960|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
33492362|NCT00662649|101693961|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
33492363|NCT00662649|101693957|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
33492364|NCT00662649|101693958|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
33492365|NCT00662649|101693959|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
33492366|NCT00662649|101693960|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
33492367|NCT00662649|101693961|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
33492368|NCT00662649|101693957|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
33492369|NCT00662649|101693958|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
33492370|NCT00662649|101693959|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
33492371|NCT00662649|101693960|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
33492372|NCT00662649|101693961|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
33492373|NCT00662649|101693957|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
33492374|NCT00662649|101693958|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
33492375|NCT00662649|101693959|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
33492376|NCT00662649|101693960|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
33492377|NCT00662649|101693961|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
33492378|NCT00768248|101693962|FG000|Overall Study|Research coordinator didn't collect data|1|||
33492379|NCT00768248|101693963|FG001|Overall Study|Research coordinator didn't collect data|1|||
33492380|NCT00560391|101693965|FG000|Overall Study|Still on treatment|0|||
33492389|NCT00606632|101693974|FG000|Overall Study|Withdrawal by Subject|13|||
33492390|NCT00606632|101693974|FG000|Overall Study|Miscellaneous reasons|9|||
33492391|NCT01288079|101693975|FG000|Overall Study|Withdrawal by Subject|2|||
33492392|NCT01288079|101693976|FG001|Overall Study|Withdrawal by Subject|4|||
33492393|NCT01288079|101693977|FG002|Overall Study|Withdrawal by Subject|1|||
33492394|NCT01288079|101693978|FG003|Overall Study|Withdrawal by Subject|0|||
33492395|NCT01288079|101693975|FG000|Overall Study|Adverse Event|2|||
33492396|NCT01288079|101693976|FG001|Overall Study|Adverse Event|1|||
33492397|NCT01288079|101693977|FG002|Overall Study|Adverse Event|2|||
33492398|NCT01288079|101693978|FG003|Overall Study|Adverse Event|3|||
33492399|NCT01288079|101693975|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
33492400|NCT01288079|101693976|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
33492401|NCT01288079|101693977|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
33492402|NCT01288079|101693978|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
33492403|NCT01288079|101693975|FG000|Overall Study|Condition under Investigation Worsened|0|||
33492404|NCT01288079|101693976|FG001|Overall Study|Condition under Investigation Worsened|0|||
33492405|NCT01288079|101693977|FG002|Overall Study|Condition under Investigation Worsened|0|||
33492406|NCT01288079|101693978|FG003|Overall Study|Condition under Investigation Worsened|1|||
33492407|NCT01288079|101693975|FG000|Overall Study|Lack of Efficacy|2|||
33492408|NCT01288079|101693976|FG001|Overall Study|Lack of Efficacy|2|||
33492409|NCT01288079|101693977|FG002|Overall Study|Lack of Efficacy|0|||
33492410|NCT01288079|101693978|FG003|Overall Study|Lack of Efficacy|2|||
33492411|NCT01288079|101693975|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
33492412|NCT01288079|101693976|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
33492413|NCT01288079|101693977|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
33492414|NCT01288079|101693978|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
33492415|NCT01288079|101693975|FG000|Overall Study|Lost to Follow-up|1|||
33492416|NCT01288079|101693976|FG001|Overall Study|Lost to Follow-up|1|||
33492417|NCT01288079|101693977|FG002|Overall Study|Lost to Follow-up|1|||
33492418|NCT01288079|101693978|FG003|Overall Study|Lost to Follow-up|0|||
33492419|NCT01288079|101693975|FG000|Overall Study|Other or Study Termination|11|||
33492420|NCT01288079|101693976|FG001|Overall Study|Other or Study Termination|15|||
33492421|NCT01288079|101693977|FG002|Overall Study|Other or Study Termination|14|||
33492422|NCT01288079|101693978|FG003|Overall Study|Other or Study Termination|8|||
33492423|NCT02040805|101693979|FG000|Overall Study|Lost to Follow-up|14|||
33492424|NCT02040805|101693980|FG001|Overall Study|Lost to Follow-up|9|||
33492425|NCT02040805|101693979|FG000|Overall Study|Withdrawal by Subject|28|||
33492426|NCT02040805|101693980|FG001|Overall Study|Withdrawal by Subject|41|||
33492427|NCT03639779|101693983|FG000|Overall Study|Lost to Follow-up|1|||
33492428|NCT01526655|101693987|FG000|Overall Study|Withdrawal by Subject|0|||
33492429|NCT01526655|101693988|FG001|Overall Study|Withdrawal by Subject|1|||
33492430|NCT01276041|101693989|FG000|Overall Study|Adverse Event|2|||
33492431|NCT01276041|101693989|FG000|Overall Study|Protocol Violation|1|||
33492432|NCT01995513|101693990|FG000|Period 1: First Open Label Treatment|Other|34|||
33492433|NCT01995513|101693991|FG001|Period 1: First Open Label Treatment|Other|0|||
33492434|NCT01995513|101693992|FG002|Period 1: First Open Label Treatment|Other|0|||
33492435|NCT01995513|101693993|FG003|Period 1: First Open Label Treatment|Other|0|||
33492436|NCT01995513|101693990|FG000|Period 1: First Open Label Treatment|Death|14|||
33492437|NCT01995513|101693991|FG001|Period 1: First Open Label Treatment|Death|0|||
33492438|NCT01995513|101693992|FG002|Period 1: First Open Label Treatment|Death|0|||
33492439|NCT01995513|101693993|FG003|Period 1: First Open Label Treatment|Death|0|||
33492440|NCT01995513|101693990|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
33492441|NCT01995513|101693991|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
33492442|NCT01995513|101693992|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
33492443|NCT01995513|101693993|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
33492444|NCT01995513|101693990|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
33492445|NCT01995513|101693991|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
33492446|NCT01995513|101693992|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
33492447|NCT01995513|101693993|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
33492448|NCT01995513|101693990|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
33492449|NCT01995513|101693991|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
33492450|NCT01995513|101693992|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
33492451|NCT01995513|101693993|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
33492452|NCT01995513|101693990|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
33492453|NCT01995513|101693991|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
33492454|NCT01995513|101693992|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
33492455|NCT01995513|101693993|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
33492456|NCT01995513|101693990|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
33492457|NCT01995513|101693991|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
33492458|NCT01995513|101693992|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
33492459|NCT01995513|101693993|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
33492460|NCT01995513|101693990|FG000|Period 1: Second Open Label Treatment|Other|0|||
33492461|NCT01995513|101693991|FG001|Period 1: Second Open Label Treatment|Other|2|||
33492462|NCT01995513|101693992|FG002|Period 1: Second Open Label Treatment|Other|0|||
33492463|NCT01995513|101693993|FG003|Period 1: Second Open Label Treatment|Other|0|||
33492464|NCT01995513|101693990|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
33492465|NCT01995513|101693991|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
33492466|NCT01995513|101693992|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
33492467|NCT01995513|101693993|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
33492468|NCT01995513|101693990|FG000|Period 2: Double Blind Treatment|Death|0|||
33492469|NCT01995513|101693991|FG001|Period 2: Double Blind Treatment|Death|0|||
33492470|NCT01995513|101693992|FG002|Period 2: Double Blind Treatment|Death|0|||
33492471|NCT01995513|101693993|FG003|Period 2: Double Blind Treatment|Death|1|||
33492472|NCT01995513|101693990|FG000|Period 2: Double Blind Treatment|Other|0|||
33492473|NCT01995513|101693991|FG001|Period 2: Double Blind Treatment|Other|0|||
33492474|NCT01995513|101693992|FG002|Period 2: Double Blind Treatment|Other|3|||
33492475|NCT01995513|101693993|FG003|Period 2: Double Blind Treatment|Other|3|||
33492476|NCT01995513|101693990|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
33492477|NCT01995513|101693991|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
33492478|NCT01995513|101693992|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
33492479|NCT01995513|101693993|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
33492480|NCT01995513|101693990|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
33492481|NCT01995513|101693991|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
33492482|NCT01995513|101693992|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
33492483|NCT01995513|101693993|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
33492484|NCT01995513|101693990|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
33492485|NCT01995513|101693991|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
33492486|NCT01995513|101693992|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
33492487|NCT01995513|101693993|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
33492488|NCT01995513|101693990|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
33492489|NCT01995513|101693991|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
33492490|NCT01995513|101693992|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
33492491|NCT01995513|101693993|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
33492492|NCT02404805|101693994|FG000|Overall Study|Withdrawal by Subject|1|||
33492493|NCT02404805|101693995|FG001|Overall Study|Withdrawal by Subject|0|||
33492494|NCT02404805|101693996|FG002|Overall Study|Withdrawal by Subject|0|||
33492495|NCT02404805|101693997|FG003|Overall Study|Withdrawal by Subject|0|||
33492496|NCT02404805|101693998|FG004|Overall Study|Withdrawal by Subject|0|||
33492497|NCT02404805|101693999|FG005|Overall Study|Withdrawal by Subject|0|||
33492498|NCT04583735|101694000|FG000|Double-masked Treatment Period|Adverse Event|0|||
33492499|NCT04583735|101694001|FG001|Double-masked Treatment Period|Adverse Event|1|||
33492500|NCT04583735|101694000|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
33492501|NCT04583735|101694001|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
33492502|NCT04583735|101694000|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
33492503|NCT04583735|101694001|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
33492504|NCT04583735|101694000|FG000|Open-label Treatment Period|Adverse Event|1|||
33492505|NCT04583735|101694001|FG001|Open-label Treatment Period|Adverse Event|1|||
33492506|NCT04583735|101694000|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
33492507|NCT04583735|101694001|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
33492508|NCT04583735|101694000|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
33492509|NCT04583735|101694001|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
33492510|NCT04352101|101694002|FG000|Overall Study|Physician Decision|2|||
33492511|NCT04352101|101694003|FG001|Overall Study|Physician Decision|1|||
33492512|NCT01640249|101694004|FG000|Period 1|Withdrawal by Subject|1|||
33492513|NCT01640249|101694005|FG001|Period 1|Withdrawal by Subject|0|||
33492514|NCT01640249|101694006|FG002|Period 1|Withdrawal by Subject|0|||
33492515|NCT01640249|101694007|FG003|Period 1|Withdrawal by Subject|0|||
33492516|NCT01640249|101694008|FG004|Period 1|Withdrawal by Subject|0|||
33492517|NCT01640249|101694009|FG005|Period 1|Withdrawal by Subject|1|||
33492518|NCT01640249|101694010|FG006|Period 1|Withdrawal by Subject|0|||
33492519|NCT02454933|101694011|FG000|Overall Study|Progressive disease|10|||
33492520|NCT02454933|101694012|FG001|Overall Study|Progressive disease|7|||
33492521|NCT02454933|101694011|FG000|Overall Study|Adverse Event|1|||
33492522|NCT02454933|101694012|FG001|Overall Study|Adverse Event|1|||
33492523|NCT02454933|101694011|FG000|Overall Study|Withdrawal by Subject|0|||
33492524|NCT02454933|101694012|FG001|Overall Study|Withdrawal by Subject|3|||
33492525|NCT02454933|101694011|FG000|Overall Study|Lost to Follow-up|1|||
33492526|NCT02454933|101694012|FG001|Overall Study|Lost to Follow-up|0|||
33492527|NCT01197911|101694013|FG000|Overall Study|Adverse Event|0|||
33492528|NCT01197911|101694014|FG001|Overall Study|Adverse Event|0|||
33492529|NCT01197911|101694015|FG002|Overall Study|Adverse Event|1|||
33492530|NCT00470535|101694016|FG000|Overall Study|Disease Progression|13|||
33492531|NCT00470535|101694016|FG000|Overall Study|Withdrawal by Subject|1|||
33492532|NCT00470535|101694016|FG000|Overall Study|Adverse Event|1|||
33492533|NCT00470535|101694016|FG000|Overall Study|Death|1|||
33492534|NCT00470535|101694016|FG000|Overall Study|Other|2|||
